id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
146850531|NCT00432666|529622477|FG000|Main Period|Adverse Event|1|||
146850532|NCT00432666|529622478|FG001|Main Period|Adverse Event|1|||
146850533|NCT00432666|529622477|FG000|Main Period|Consent Withdrawn|1|||
146850534|NCT00432666|529622478|FG001|Main Period|Consent Withdrawn|0|||
146850535|NCT00432666|529622477|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
146850536|NCT00432666|529622478|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
146850537|NCT00432666|529622477|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
146850538|NCT00432666|529622478|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
146850539|NCT00432666|529622477|FG000|Open-Label Extension Period|Adverse Event|5|||
146850540|NCT00432666|529622478|FG001|Open-Label Extension Period|Adverse Event|0|||
146850541|NCT00432666|529622477|FG000|Open-Label Extension Period|Consent withdrawn|10|||
146850542|NCT00432666|529622478|FG001|Open-Label Extension Period|Consent withdrawn|0|||
146850543|NCT00432666|529622477|FG000|Open-Label Extension Period|Physician Decision|3|||
146850544|NCT00432666|529622478|FG001|Open-Label Extension Period|Physician Decision|0|||
146850545|NCT00978627|529622479|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
146850546|NCT00978627|529622480|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
146850547|NCT00978627|529622479|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
146850548|NCT00978627|529622480|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
146850549|NCT00978627|529622479|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
146850550|NCT00978627|529622480|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
146850551|NCT00978627|529622479|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
146850552|NCT00978627|529622480|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
146850553|NCT00978627|529622479|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
146850554|NCT00978627|529622480|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
146850555|NCT00978627|529622479|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
146850556|NCT00978627|529622480|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
146850557|NCT00978627|529622479|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
146850558|NCT00978627|529622480|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
146850559|NCT00978627|529622479|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
146850560|NCT00978627|529622480|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
146850561|NCT00978627|529622479|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
146850562|NCT00978627|529622480|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
146850563|NCT00565851|529622481|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
146850564|NCT00565851|529622482|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
146850565|NCT00565851|529622483|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
146623410|NCT01602224|528795637|FG000|Overall Study|Adverse Event|0|||
146623411|NCT01602224|528795638|FG001|Overall Study|Adverse Event|1|||
146623412|NCT01602224|528795639|FG002|Overall Study|Adverse Event|0|||
146623413|NCT01602224|528795637|FG000|Overall Study|Investigator Decison|1|||
146623414|NCT01602224|528795638|FG001|Overall Study|Investigator Decison|0|||
146850566|NCT00565851|529622484|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
146850567|NCT00565851|529622485|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
146850568|NCT00565851|529622486|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
146850569|NCT00565851|529622487|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
146850570|NCT00565851|529622488|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
146850571|NCT00565851|529622481|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
146850572|NCT00565851|529622482|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
146850573|NCT00565851|529622483|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
146850574|NCT00565851|529622484|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
146850575|NCT00565851|529622485|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
146850576|NCT00565851|529622486|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
146850577|NCT00565851|529622487|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
146850578|NCT00565851|529622488|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
146850579|NCT04058366|529622489|FG000|Overall Study|Adverse Event|14|||
146850580|NCT04058366|529622489|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
146850581|NCT04058366|529622489|FG000|Overall Study|Commercial drug is available for participants|6|||
146850582|NCT04058366|529622489|FG000|Overall Study|Death|1|||
146850583|NCT04058366|529622489|FG000|Overall Study|Other non-compliance|2|||
146850584|NCT04058366|529622489|FG000|Overall Study|Other|6|||
146850585|NCT02594163|529622490|FG000|Treatment Period|Progressive disease|2|||
146850586|NCT02594163|529622491|FG001|Treatment Period|Progressive disease|3|||
146850587|NCT02594163|529622490|FG000|Treatment Period|Adverse Event|1|||
146850588|NCT02594163|529622491|FG001|Treatment Period|Adverse Event|5|||
146850589|NCT02594163|529622490|FG000|Treatment Period|Physician Decision|1|||
146850590|NCT02594163|529622491|FG001|Treatment Period|Physician Decision|3|||
146850591|NCT02594163|529622490|FG000|Treatment Period|Study termination by sponsor|2|||
146850592|NCT02594163|529622491|FG001|Treatment Period|Study termination by sponsor|1|||
146850593|NCT02594163|529622490|FG000|Treatment Period|Other, Non-AE|1|||
146850594|NCT02594163|529622491|FG001|Treatment Period|Other, Non-AE|0|||
146850595|NCT02594163|529622490|FG000|Follow-up Period|Withdrawal by Subject|0|||
146623415|NCT01602224|528795639|FG002|Overall Study|Investigator Decison|0|||
146850596|NCT02594163|529622491|FG001|Follow-up Period|Withdrawal by Subject|1|||
146850597|NCT02594163|529622490|FG000|Follow-up Period|Study Termination by Sponsor|6|||
146850598|NCT02594163|529622491|FG001|Follow-up Period|Study Termination by Sponsor|4|||
146850599|NCT02594163|529622490|FG000|Follow-up Period|Lost to Follow-up|1|||
146850600|NCT02594163|529622491|FG001|Follow-up Period|Lost to Follow-up|0|||
146850601|NCT02594163|529622490|FG000|Follow-up Period|Death|2|||
146850602|NCT02594163|529622491|FG001|Follow-up Period|Death|5|||
146850603|NCT02594163|529622490|FG000|Follow-up Period|Adverse Event|0|||
146850604|NCT02594163|529622491|FG001|Follow-up Period|Adverse Event|1|||
146850605|NCT02594163|529622490|FG000|Follow-up Period|Progressive Disease|2|||
146850606|NCT02594163|529622491|FG001|Follow-up Period|Progressive Disease|0|||
146850607|NCT02594163|529622490|FG000|Follow-up Period|Physician Decision|0|||
146850608|NCT02594163|529622491|FG001|Follow-up Period|Physician Decision|1|||
146850609|NCT02233543|529622494|FG000|Period 1|Withdrawal by Subject|1|||
146850610|NCT02233543|529622495|FG001|Period 1|Withdrawal by Subject|0|||
146850611|NCT02233543|529622494|FG000|Period 1|Participants required other treatment.|2|||
146850612|NCT02233543|529622495|FG001|Period 1|Participants required other treatment.|3|||
146850613|NCT02233543|529622494|FG000|Period 2|Adverse Event|1|||
146850614|NCT02233543|529622495|FG001|Period 2|Adverse Event|0|||
146850615|NCT02233543|529622494|FG000|Period 2|Participant required other treatment.|0|||
146850616|NCT02233543|529622495|FG001|Period 2|Participant required other treatment.|1|||
146850617|NCT02233543|529622494|FG000|Period 2|COPD exacerbation|1|||
146850618|NCT02233543|529622495|FG001|Period 2|COPD exacerbation|0|||
146850619|NCT00603304|529622496|FG000|Overall Study|Lost to Follow-up|5|||
146850620|NCT00603304|529622497|FG001|Overall Study|Lost to Follow-up|7|||
146850621|NCT00603304|529622496|FG000|Overall Study|Withdrawal by Subject|8|||
146850622|NCT00603304|529622497|FG001|Overall Study|Withdrawal by Subject|5|||
146850623|NCT00603304|529622496|FG000|Overall Study|Protocol Violation|1|||
146850624|NCT00603304|529622497|FG001|Overall Study|Protocol Violation|0|||
146850625|NCT00603304|529622496|FG000|Overall Study|Adverse Event|4|||
146850626|NCT00603304|529622497|FG001|Overall Study|Adverse Event|2|||
146963753|NCT00509223|530029507|FG000|Overall Study|Lost to Follow-up|1|||
146963754|NCT00509223|530029508|FG001|Overall Study|Lost to Follow-up|1|||
146963755|NCT00509223|530029507|FG000|Overall Study|Adverse Event|1|||
146963756|NCT00509223|530029508|FG001|Overall Study|Adverse Event|1|||
146963757|NCT00509223|530029507|FG000|Overall Study|Withdrawal by Subject|25|||
146963758|NCT00509223|530029508|FG001|Overall Study|Withdrawal by Subject|6|||
146963759|NCT00509223|530029507|FG000|Overall Study|Including: subject change of address|5|||
146963760|NCT00509223|530029508|FG001|Overall Study|Including: subject change of address|2|||
146850627|NCT00603304|529622496|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
146963761|NCT00509223|530029507|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
146963762|NCT00509223|530029508|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
146963763|NCT00437294|530029514|FG000|Overall Study|Adverse Event|5|||
146963764|NCT00437294|530029515|FG001|Overall Study|Adverse Event|4|||
146963765|NCT00437294|530029514|FG000|Overall Study|Death|5|||
146963766|NCT00437294|530029515|FG001|Overall Study|Death|2|||
146963767|NCT00437294|530029514|FG000|Overall Study|Physician Decision|0|||
146963768|NCT00437294|530029515|FG001|Overall Study|Physician Decision|3|||
146963769|NCT00437294|530029514|FG000|Overall Study|Withdrawal by Subject|5|||
146963770|NCT00437294|530029515|FG001|Overall Study|Withdrawal by Subject|0|||
146963771|NCT00437294|530029514|FG000|Overall Study|Progressive Disease|19|||
146963772|NCT00437294|530029515|FG001|Overall Study|Progressive Disease|23|||
146963773|NCT00437294|530029514|FG000|Overall Study|Sponsor Decision|8|||
146963774|NCT00437294|530029515|FG001|Overall Study|Sponsor Decision|9|||
146963775|NCT00437294|530029514|FG000|Overall Study|Protocol Violation|0|||
146963776|NCT00437294|530029515|FG001|Overall Study|Protocol Violation|1|||
146963777|NCT00437294|530029514|FG000|Overall Study|Entry criteria not met|1|||
146850628|NCT00603304|529622497|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
146850629|NCT00603304|529622496|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
146850630|NCT00603304|529622497|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
146850631|NCT00603304|529622496|FG000|Overall Study|Exclusionary Medication|2|||
146850632|NCT00603304|529622497|FG001|Overall Study|Exclusionary Medication|3|||
146850633|NCT00603304|529622496|FG000|Overall Study|Non-Compliant|0|||
146850634|NCT00603304|529622497|FG001|Overall Study|Non-Compliant|1|||
146850635|NCT00603304|529622496|FG000|Overall Study|Moved Away|0|||
146850636|NCT00603304|529622497|FG001|Overall Study|Moved Away|2|||
146850637|NCT00603304|529622496|FG000|Overall Study|Other|2|||
146850638|NCT00603304|529622497|FG001|Overall Study|Other|0|||
146850639|NCT00603304|529622496|FG000|Overall Study|Patient Decision|2|||
146850640|NCT00603304|529622497|FG001|Overall Study|Patient Decision|0|||
146850641|NCT01076192|529622498|FG000|Overall Study|Other|197|||
146850642|NCT01034176|529622499|FG000|Overall Study|Physician Decision|2|||
146850643|NCT01034176|529622500|FG001|Overall Study|Physician Decision|0|||
146850644|NCT01034176|529622499|FG000|Overall Study|Withdrawal by Subject|0|||
146850645|NCT01034176|529622500|FG001|Overall Study|Withdrawal by Subject|1|||
146850646|NCT01034176|529622499|FG000|Overall Study|Lost to Follow-up|0|||
146850647|NCT01034176|529622500|FG001|Overall Study|Lost to Follow-up|1|||
146850648|NCT05087979|529622503|FG000|Overall Study|Converted to general anesthesia|1|||
146850649|NCT05087979|529622504|FG001|Overall Study|Converted to general anesthesia|0|||
146850650|NCT00616902|529622505|FG000|Overall Study|Termination of study|6|||
146850651|NCT00616902|529622506|FG001|Overall Study|Termination of study|6|||
146850652|NCT02680002|529622508|FG000|Overall Study|Lost to Follow-up|5|||
146850653|NCT02680002|529622509|FG001|Overall Study|Lost to Follow-up|1|||
146850654|NCT02680002|529622510|FG002|Overall Study|Lost to Follow-up|4|||
146850655|NCT02680002|529622511|FG003|Overall Study|Lost to Follow-up|2|||
146850656|NCT02680002|529622512|FG004|Overall Study|Lost to Follow-up|0|||
146623416|NCT01602224|528795637|FG000|Overall Study|Lost to Follow-up|0|||
146623417|NCT01602224|528795638|FG001|Overall Study|Lost to Follow-up|0|||
146623418|NCT01602224|528795639|FG002|Overall Study|Lost to Follow-up|1|||
146623419|NCT01602224|528795637|FG000|Overall Study|Protocol Violation|0|||
146623420|NCT01602224|528795638|FG001|Overall Study|Protocol Violation|1|||
146623421|NCT01602224|528795639|FG002|Overall Study|Protocol Violation|0|||
146623422|NCT01602224|528795637|FG000|Overall Study|Sponsor Decision|2|||
146623423|NCT01602224|528795638|FG001|Overall Study|Sponsor Decision|3|||
146623424|NCT01602224|528795639|FG002|Overall Study|Sponsor Decision|2|||
146623425|NCT01602224|528795637|FG000|Overall Study|Withdrawal by Subject|5|||
146623426|NCT01602224|528795638|FG001|Overall Study|Withdrawal by Subject|3|||
146623427|NCT01602224|528795639|FG002|Overall Study|Withdrawal by Subject|3|||
146623428|NCT00633477|528795640|FG000|Overall Study|Death|1|||
146623429|NCT00633477|528795641|FG001|Overall Study|Death|0|||
146623430|NCT00633477|528795640|FG000|Overall Study|Randomized but not treated|1|||
146623431|NCT00633477|528795641|FG001|Overall Study|Randomized but not treated|0|||
146623432|NCT00770653|528795645|FG000|Overall Study|Adverse Event|13|||
146623433|NCT00770653|528795646|FG001|Overall Study|Adverse Event|5|||
146623434|NCT00770653|528795645|FG000|Overall Study|Protocol Violation|8|||
146623435|NCT00770653|528795646|FG001|Overall Study|Protocol Violation|6|||
146623436|NCT00770653|528795645|FG000|Overall Study|Withdrawal by Subject|4|||
146623437|NCT00770653|528795646|FG001|Overall Study|Withdrawal by Subject|7|||
146623438|NCT00770653|528795645|FG000|Overall Study|Lack of Compliance|1|||
146623439|NCT00770653|528795646|FG001|Overall Study|Lack of Compliance|4|||
146623440|NCT00770653|528795645|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
146623441|NCT00770653|528795646|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
146623442|NCT00770653|528795645|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
146623443|NCT00770653|528795646|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
146623444|NCT00770653|528795645|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
146623445|NCT00770653|528795646|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
146623446|NCT00770653|528795645|FG000|Overall Study|Lost to Follow-up|1|||
146623447|NCT00770653|528795646|FG001|Overall Study|Lost to Follow-up|2|||
146623448|NCT00770653|528795645|FG000|Overall Study|Physician Decision|1|||
146623449|NCT00770653|528795646|FG001|Overall Study|Physician Decision|0|||
146623450|NCT04906499|528795648|FG000|Overall Study|Lack of time|1|||
146623451|NCT00179621|528795649|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
146623452|NCT00179621|528795650|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
146623453|NCT00179621|528795651|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
146623454|NCT00179621|528795652|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
146623455|NCT00179621|528795649|FG000|Double-Blind Period|Adverse Event|2|||
146623456|NCT00179621|528795650|FG001|Double-Blind Period|Adverse Event|7|||
146623457|NCT00179621|528795651|FG002|Double-Blind Period|Adverse Event|4|||
146623458|NCT00179621|528795652|FG003|Double-Blind Period|Adverse Event|0|||
146623459|NCT00179621|528795649|FG000|Double-Blind Period|Withdrawal by Subject|2|||
146623460|NCT00179621|528795650|FG001|Double-Blind Period|Withdrawal by Subject|1|||
146623461|NCT00179621|528795651|FG002|Double-Blind Period|Withdrawal by Subject|3|||
146623462|NCT00179621|528795652|FG003|Double-Blind Period|Withdrawal by Subject|0|||
146623463|NCT00179621|528795649|FG000|Double-Blind Period|Death|0|||
146623464|NCT00179621|528795650|FG001|Double-Blind Period|Death|1|||
146623465|NCT00179621|528795651|FG002|Double-Blind Period|Death|2|||
146623466|NCT00179621|528795652|FG003|Double-Blind Period|Death|0|||
146623467|NCT00179621|528795649|FG000|Double-Blind Period|Protocol Violation|1|||
146623468|NCT00179621|528795650|FG001|Double-Blind Period|Protocol Violation|0|||
146623469|NCT00179621|528795651|FG002|Double-Blind Period|Protocol Violation|0|||
146623470|NCT00179621|528795652|FG003|Double-Blind Period|Protocol Violation|0|||
146623471|NCT00179621|528795649|FG000|Double-Blind Period|Other|0|||
146623472|NCT00179621|528795650|FG001|Double-Blind Period|Other|2|||
146623473|NCT00179621|528795651|FG002|Double-Blind Period|Other|2|||
146623474|NCT00179621|528795652|FG003|Double-Blind Period|Other|0|||
146623475|NCT00179621|528795649|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
146623476|NCT00179621|528795650|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
146850657|NCT02680002|529622513|FG005|Overall Study|Lost to Follow-up|2|||
146850658|NCT02680002|529622508|FG000|Overall Study|Physician Decision|5|||
146850659|NCT02680002|529622509|FG001|Overall Study|Physician Decision|1|||
146963778|NCT00437294|530029515|FG001|Overall Study|Entry criteria not met|1|||
146963779|NCT01473602|530029523|FG000|Overall Study|Adverse Event|1|||
146623477|NCT00179621|528795651|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
146623478|NCT00179621|528795652|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
146623479|NCT00179621|528795649|FG000|Open-Label Period|Adverse Event|0|||
146623480|NCT00179621|528795650|FG001|Open-Label Period|Adverse Event|6|||
146623481|NCT00179621|528795651|FG002|Open-Label Period|Adverse Event|5|||
146623482|NCT00179621|528795652|FG003|Open-Label Period|Adverse Event|6|||
146623483|NCT00179621|528795649|FG000|Open-Label Period|Withdrawal by Subject|0|||
146963780|NCT01473602|530029524|FG001|Overall Study|Adverse Event|2|||
146963781|NCT01473602|530029523|FG000|Overall Study|Death|0|||
146963782|NCT01473602|530029524|FG001|Overall Study|Death|1|||
146963783|NCT01473602|530029523|FG000|Overall Study|Lost to Follow-up|1|||
146963784|NCT01473602|530029524|FG001|Overall Study|Lost to Follow-up|1|||
146963785|NCT01473602|530029523|FG000|Overall Study|Withdrawal by Subject|5|||
146963786|NCT01473602|530029524|FG001|Overall Study|Withdrawal by Subject|4|||
146963787|NCT01473602|530029523|FG000|Overall Study|Physician Decision|1|||
146963788|NCT01473602|530029524|FG001|Overall Study|Physician Decision|0|||
146963789|NCT00449761|530029525|FG000|Overall Study|Disease progression|12|||
146963790|NCT00449761|530029525|FG000|Overall Study|Death|5|||
146963791|NCT00449761|530029525|FG000|Overall Study|New cancer therapy|1|||
146963792|NCT00726882|530029526|FG000|Overall Study|Withdrawal by Subject|5|||
146963793|NCT00726882|530029526|FG000|Overall Study|Lost to Follow-up|7|||
146963794|NCT00726882|530029526|FG000|Overall Study|Other|10|||
146963795|NCT01339273|530029527|FG000|Overall Study|Lost to Follow-up|8|||
146963796|NCT01339273|530029528|FG001|Overall Study|Lost to Follow-up|8|||
146963797|NCT00560573|530029529|FG000|Overall Study|Death|4|||
146623484|NCT00179621|528795650|FG001|Open-Label Period|Withdrawal by Subject|2|||
146623485|NCT00179621|528795651|FG002|Open-Label Period|Withdrawal by Subject|2|||
146623486|NCT00179621|528795652|FG003|Open-Label Period|Withdrawal by Subject|2|||
146623487|NCT00179621|528795649|FG000|Open-Label Period|Death|0|||
146623488|NCT00179621|528795650|FG001|Open-Label Period|Death|0|||
146623489|NCT00179621|528795651|FG002|Open-Label Period|Death|1|||
146623490|NCT00179621|528795652|FG003|Open-Label Period|Death|2|||
146623491|NCT00179621|528795649|FG000|Open-Label Period|Other|0|||
146623492|NCT00179621|528795650|FG001|Open-Label Period|Other|1|||
146623493|NCT00179621|528795651|FG002|Open-Label Period|Other|1|||
146623494|NCT00179621|528795652|FG003|Open-Label Period|Other|2|||
146623495|NCT03525444|528795657|FG000|Overall Study|Adverse Event|0|||
146623496|NCT03525444|528795658|FG001|Overall Study|Adverse Event|1|||
146623497|NCT03525444|528795657|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
146623498|NCT03525444|528795658|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
146623499|NCT03525444|528795657|FG000|Overall Study|Other|0|||
146623500|NCT03525444|528795658|FG001|Overall Study|Other|1|||
146623501|NCT00262860|528795659|FG000|Overall Study|Adverse Event|2|||
146623502|NCT02741128|528795660|FG000|Overall Study|Protocol Violation|4|||
146623503|NCT02741128|528795661|FG001|Overall Study|Protocol Violation|1|||
146623504|NCT02741128|528795660|FG000|Overall Study|Withdrawal by Subject|2|||
146623505|NCT02741128|528795661|FG001|Overall Study|Withdrawal by Subject|0|||
146850660|NCT02680002|529622510|FG002|Overall Study|Physician Decision|1|||
146850661|NCT02680002|529622511|FG003|Overall Study|Physician Decision|1|||
146850662|NCT02680002|529622512|FG004|Overall Study|Physician Decision|1|||
146850663|NCT02680002|529622513|FG005|Overall Study|Physician Decision|1|||
146850664|NCT02680002|529622508|FG000|Overall Study|Protocol Violation|1|||
146850665|NCT02680002|529622509|FG001|Overall Study|Protocol Violation|0|||
146850666|NCT02680002|529622510|FG002|Overall Study|Protocol Violation|1|||
146850667|NCT02680002|529622511|FG003|Overall Study|Protocol Violation|0|||
146850668|NCT02680002|529622512|FG004|Overall Study|Protocol Violation|1|||
146850669|NCT02680002|529622513|FG005|Overall Study|Protocol Violation|2|||
146850670|NCT02680002|529622508|FG000|Overall Study|Withdrawal by Subject|0|||
146850671|NCT02680002|529622509|FG001|Overall Study|Withdrawal by Subject|0|||
146850672|NCT02680002|529622510|FG002|Overall Study|Withdrawal by Subject|1|||
146850673|NCT02680002|529622511|FG003|Overall Study|Withdrawal by Subject|0|||
146850674|NCT02680002|529622512|FG004|Overall Study|Withdrawal by Subject|2|||
146850675|NCT02680002|529622513|FG005|Overall Study|Withdrawal by Subject|2|||
146850676|NCT02680002|529622508|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
146850677|NCT02680002|529622509|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
146850678|NCT02680002|529622510|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
146850679|NCT02680002|529622511|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
146850680|NCT02680002|529622512|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
146850681|NCT02680002|529622513|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
146850682|NCT02680002|529622508|FG000|Overall Study|Other|0|||
146850683|NCT02680002|529622509|FG001|Overall Study|Other|1|||
146850684|NCT02680002|529622510|FG002|Overall Study|Other|0|||
146623506|NCT02741128|528795660|FG000|Overall Study|Lost to Follow-up|1|||
146850685|NCT02680002|529622511|FG003|Overall Study|Other|0|||
146850686|NCT02680002|529622512|FG004|Overall Study|Other|1|||
146850687|NCT02680002|529622513|FG005|Overall Study|Other|0|||
146850688|NCT02680002|529622508|FG000|Overall Study|Adverse Event|0|||
146623507|NCT02741128|528795661|FG001|Overall Study|Lost to Follow-up|0|||
146623508|NCT02973100|528795662|FG000|Overall Study|Adverse Event|1|||
146623509|NCT02973100|528795663|FG001|Overall Study|Adverse Event|2|||
146623510|NCT02973100|528795664|FG002|Overall Study|Adverse Event|1|||
146623511|NCT02973100|528795665|FG003|Overall Study|Adverse Event|2|||
146623512|NCT02973100|528795662|FG000|Overall Study|Lost to Follow-up|3|||
146623513|NCT02973100|528795663|FG001|Overall Study|Lost to Follow-up|1|||
146963798|NCT00560573|530029530|FG001|Overall Study|Death|1|||
146623514|NCT02973100|528795664|FG002|Overall Study|Lost to Follow-up|1|||
146623515|NCT02973100|528795665|FG003|Overall Study|Lost to Follow-up|0|||
146623516|NCT02973100|528795662|FG000|Overall Study|Withdrawal by Subject|3|||
146623517|NCT02973100|528795663|FG001|Overall Study|Withdrawal by Subject|5|||
146623518|NCT02973100|528795664|FG002|Overall Study|Withdrawal by Subject|1|||
146623519|NCT02973100|528795665|FG003|Overall Study|Withdrawal by Subject|4|||
146623520|NCT02973100|528795662|FG000|Overall Study|Notification of change in address|0|||
146623521|NCT02973100|528795663|FG001|Overall Study|Notification of change in address|0|||
146623522|NCT02973100|528795664|FG002|Overall Study|Notification of change in address|0|||
146623523|NCT02973100|528795665|FG003|Overall Study|Notification of change in address|1|||
146623524|NCT02973100|528795662|FG000|Overall Study|Failed to attend Safety followup period|0|||
146963799|NCT00560573|530029531|FG002|Overall Study|Death|4|||
146623525|NCT02973100|528795663|FG001|Overall Study|Failed to attend Safety followup period|0|||
146623526|NCT02973100|528795664|FG002|Overall Study|Failed to attend Safety followup period|1|||
146623527|NCT02973100|528795665|FG003|Overall Study|Failed to attend Safety followup period|0|||
146623528|NCT01419769|528795666|FG000|Overall Study|Did not receive the AXIOS stent|3|||
146623529|NCT01419769|528795666|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
146623530|NCT00878501|528795667|FG000|Overall Study|Adverse Event|11|||
146623531|NCT00878501|528795668|FG001|Overall Study|Adverse Event|3|||
146623532|NCT00878501|528795669|FG002|Overall Study|Adverse Event|3|||
146623533|NCT00878501|528795667|FG000|Overall Study|Lack of Efficacy|2|||
146623534|NCT00878501|528795668|FG001|Overall Study|Lack of Efficacy|1|||
146623535|NCT00878501|528795669|FG002|Overall Study|Lack of Efficacy|0|||
146623536|NCT00878501|528795667|FG000|Overall Study|Withdrawal by Subject|2|||
146623537|NCT00878501|528795668|FG001|Overall Study|Withdrawal by Subject|1|||
146623538|NCT00878501|528795669|FG002|Overall Study|Withdrawal by Subject|2|||
146623539|NCT00878501|528795667|FG000|Overall Study|Protocol Violation|0|||
146623540|NCT00878501|528795668|FG001|Overall Study|Protocol Violation|0|||
146623541|NCT00878501|528795669|FG002|Overall Study|Protocol Violation|1|||
146623542|NCT00878501|528795667|FG000|Overall Study|Incorrect enrolment|1|||
146623543|NCT00878501|528795668|FG001|Overall Study|Incorrect enrolment|2|||
146623544|NCT00878501|528795669|FG002|Overall Study|Incorrect enrolment|0|||
146623545|NCT00878501|528795667|FG000|Overall Study|Intake of prohibited concom. medication|0|||
146623546|NCT00878501|528795668|FG001|Overall Study|Intake of prohibited concom. medication|0|||
146623547|NCT00878501|528795669|FG002|Overall Study|Intake of prohibited concom. medication|1|||
146623548|NCT00878501|528795667|FG000|Overall Study|Mis-randomisation of patient|1|||
146623549|NCT00878501|528795668|FG001|Overall Study|Mis-randomisation of patient|0|||
146623550|NCT00878501|528795669|FG002|Overall Study|Mis-randomisation of patient|0|||
146623551|NCT00878501|528795667|FG000|Overall Study|Administrative|0|||
146623552|NCT00878501|528795668|FG001|Overall Study|Administrative|0|||
146623553|NCT00878501|528795669|FG002|Overall Study|Administrative|1|||
146623554|NCT01959503|528795670|FG000|Overall Study|Death|2|||
146623555|NCT01959503|528795671|FG001|Overall Study|Death|1|||
146623556|NCT01959503|528795670|FG000|Overall Study|Randomized but not treated|1|||
146623557|NCT01959503|528795671|FG001|Overall Study|Randomized but not treated|1|||
146623558|NCT01419236|528795672|FG000|Overall Study|Adverse Event|1|||
146623559|NCT01419236|528795673|FG001|Overall Study|Adverse Event|0|||
146623560|NCT01419236|528795672|FG000|Overall Study|Lack of Efficacy|0|||
146623561|NCT01419236|528795673|FG001|Overall Study|Lack of Efficacy|1|||
146850689|NCT02680002|529622509|FG001|Overall Study|Adverse Event|0|||
146850690|NCT02680002|529622510|FG002|Overall Study|Adverse Event|0|||
146850691|NCT02680002|529622511|FG003|Overall Study|Adverse Event|0|||
146850692|NCT02680002|529622512|FG004|Overall Study|Adverse Event|1|||
146850693|NCT02680002|529622513|FG005|Overall Study|Adverse Event|2|||
146850694|NCT00705679|529622514|FG000|Overall Study|Adverse Event|1|||
146850695|NCT00705679|529622515|FG001|Overall Study|Adverse Event|1|||
146850696|NCT00705679|529622516|FG002|Overall Study|Adverse Event|0|||
146850697|NCT00705679|529622517|FG003|Overall Study|Adverse Event|0|||
146850698|NCT00705679|529622518|FG004|Overall Study|Adverse Event|0|||
146850699|NCT00705679|529622514|FG000|Overall Study|Death|0|||
146850700|NCT00705679|529622515|FG001|Overall Study|Death|0|||
146850701|NCT00705679|529622516|FG002|Overall Study|Death|3|||
146850702|NCT00705679|529622517|FG003|Overall Study|Death|2|||
146850703|NCT00705679|529622518|FG004|Overall Study|Death|1|||
146850704|NCT00705679|529622514|FG000|Overall Study|Lost to Follow-up|32|||
146850705|NCT00705679|529622515|FG001|Overall Study|Lost to Follow-up|60|||
146850706|NCT00705679|529622516|FG002|Overall Study|Lost to Follow-up|44|||
146850707|NCT00705679|529622517|FG003|Overall Study|Lost to Follow-up|30|||
146963800|NCT00560573|530029532|FG003|Overall Study|Death|5|||
146623562|NCT01419236|528795672|FG000|Overall Study|Lost to Follow-up|1|||
146623563|NCT01419236|528795673|FG001|Overall Study|Lost to Follow-up|0|||
146623564|NCT01419236|528795672|FG000|Overall Study|Physician Decision|1|||
146623565|NCT01419236|528795673|FG001|Overall Study|Physician Decision|0|||
146623566|NCT01419236|528795672|FG000|Overall Study|Withdrawal by Subject|1|||
146623567|NCT01419236|528795673|FG001|Overall Study|Withdrawal by Subject|4|||
146623568|NCT01419236|528795672|FG000|Overall Study|Entry Criteria Not Met|1|||
146623569|NCT01419236|528795673|FG001|Overall Study|Entry Criteria Not Met|0|||
146850708|NCT00705679|529622518|FG004|Overall Study|Lost to Follow-up|35|||
146850709|NCT00705679|529622514|FG000|Overall Study|Physician Decision|0|||
146623570|NCT03598036|528795677|FG000|Overall Study|Withdrawal by Subject|1|||
146623571|NCT03598036|528795678|FG001|Overall Study|Withdrawal by Subject|0|||
146623572|NCT04124939|528795681|FG000|Overall Study|Lost to Follow-up|1|||
146623573|NCT04124939|528795682|FG001|Overall Study|Lost to Follow-up|3|||
146623574|NCT04607668|528795689|FG000|Overall Study|Death|49|||
146623575|NCT04607668|528795690|FG001|Overall Study|Death|26|||
146623576|NCT04607668|528795689|FG000|Overall Study|Lost to Follow-up|3|||
146623577|NCT04607668|528795690|FG001|Overall Study|Lost to Follow-up|4|||
146623578|NCT04607668|528795689|FG000|Overall Study|Study terminated by Sponsor|92|||
146623579|NCT04607668|528795690|FG001|Overall Study|Study terminated by Sponsor|114|||
146850710|NCT00705679|529622515|FG001|Overall Study|Physician Decision|1|||
146850711|NCT00705679|529622516|FG002|Overall Study|Physician Decision|0|||
146850712|NCT00705679|529622517|FG003|Overall Study|Physician Decision|1|||
146850713|NCT00705679|529622518|FG004|Overall Study|Physician Decision|0|||
146850714|NCT00705679|529622514|FG000|Overall Study|Withdrawal by Subject|32|||
146850715|NCT00705679|529622515|FG001|Overall Study|Withdrawal by Subject|77|||
146850716|NCT00705679|529622516|FG002|Overall Study|Withdrawal by Subject|68|||
146850717|NCT00705679|529622517|FG003|Overall Study|Withdrawal by Subject|47|||
146850718|NCT00705679|529622518|FG004|Overall Study|Withdrawal by Subject|33|||
146850719|NCT00759915|529622519|FG000|Overall Study|Withdrawal by Subject|1|||
146850720|NCT00759915|529622520|FG001|Overall Study|Withdrawal by Subject|0|||
146850721|NCT00759915|529622519|FG000|Overall Study|Adverse Event|0|||
146850722|NCT00759915|529622520|FG001|Overall Study|Adverse Event|1|||
146850723|NCT03730480|529622521|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
146850724|NCT03245151|529622522|FG000|Overall Study|Withdrawal by Subject|2|||
146850725|NCT03245151|529622523|FG001|Overall Study|Withdrawal by Subject|0|||
146850726|NCT03245151|529622524|FG002|Overall Study|Withdrawal by Subject|0|||
146623580|NCT04607668|528795689|FG000|Overall Study|Withdrawal by Subject|12|||
146623581|NCT04607668|528795690|FG001|Overall Study|Withdrawal by Subject|11|||
146623582|NCT04607668|528795689|FG000|Overall Study|Other, unspecified|8|||
146623583|NCT04607668|528795690|FG001|Overall Study|Other, unspecified|7|||
146623584|NCT02250326|528795691|FG000|Treatment|Death|1|||
146623585|NCT02250326|528795692|FG001|Treatment|Death|13|||
146623586|NCT02250326|528795693|FG002|Treatment|Death|2|||
146623587|NCT02250326|528795691|FG000|Treatment|Adverse Event|8|||
146623588|NCT02250326|528795692|FG001|Treatment|Adverse Event|8|||
146623589|NCT02250326|528795693|FG002|Treatment|Adverse Event|9|||
146623590|NCT02250326|528795691|FG000|Treatment|Progressive Disease|42|||
146623591|NCT02250326|528795692|FG001|Treatment|Progressive Disease|40|||
146623592|NCT02250326|528795693|FG002|Treatment|Progressive Disease|47|||
146623593|NCT02250326|528795691|FG000|Treatment|Symptomatic Deterioration|9|||
146850727|NCT03245151|529622525|FG003|Overall Study|Withdrawal by Subject|2|||
146623594|NCT02250326|528795692|FG001|Treatment|Symptomatic Deterioration|4|||
146623595|NCT02250326|528795693|FG002|Treatment|Symptomatic Deterioration|10|||
146623596|NCT02250326|528795691|FG000|Treatment|Withdrawal by Subject|11|||
146623597|NCT02250326|528795692|FG001|Treatment|Withdrawal by Subject|6|||
146623598|NCT02250326|528795693|FG002|Treatment|Withdrawal by Subject|4|||
146623599|NCT02250326|528795691|FG000|Treatment|Other reasons|8|||
146623600|NCT02250326|528795692|FG001|Treatment|Other reasons|7|||
146623601|NCT02250326|528795693|FG002|Treatment|Other reasons|7|||
146623602|NCT02250326|528795691|FG000|Extension Period|Progressive Disease|0|||
146623603|NCT02250326|528795692|FG001|Extension Period|Progressive Disease|2|||
146623604|NCT02250326|528795693|FG002|Extension Period|Progressive Disease|0|||
146623605|NCT02250326|528795691|FG000|Extension Period|Withdrawal by Subject|0|||
146623606|NCT02250326|528795692|FG001|Extension Period|Withdrawal by Subject|1|||
146623607|NCT02250326|528795693|FG002|Extension Period|Withdrawal by Subject|0|||
146623608|NCT02250326|528795691|FG000|Extension Period|Withdrawal by investigator|0|||
146623609|NCT02250326|528795692|FG001|Extension Period|Withdrawal by investigator|1|||
146623610|NCT02250326|528795693|FG002|Extension Period|Withdrawal by investigator|0|||
146623611|NCT01838694|528795694|FG000|Overall Study|Adverse Event|0|||
146623612|NCT01838694|528795695|FG001|Overall Study|Adverse Event|1|||
146623613|NCT00672555|528795697|FG000|Overall Study|Lost to Follow-up|4|||
146623614|NCT00672555|528795697|FG000|Overall Study|Did not want to answer questionnaire|2|||
146623615|NCT01751061|528795703|FG000|Overall Study|Death|1|||
146623616|NCT01751061|528795704|FG001|Overall Study|Death|0|||
146850728|NCT03245151|529622526|FG004|Overall Study|Withdrawal by Subject|1|||
146623617|NCT01751061|528795703|FG000|Overall Study|patient death|5|||
146623618|NCT01751061|528795704|FG001|Overall Study|patient death|0|||
146623619|NCT01751061|528795703|FG000|Overall Study|Lost to Follow-up|40|||
146623620|NCT01751061|528795704|FG001|Overall Study|Lost to Follow-up|25|||
146850729|NCT03245151|529622522|FG000|Overall Study|Death|3|||
146850730|NCT03245151|529622523|FG001|Overall Study|Death|14|||
146623621|NCT01751061|528795703|FG000|Overall Study|patient regained decisional capacity|4|||
146623622|NCT01751061|528795704|FG001|Overall Study|patient regained decisional capacity|8|||
146623623|NCT01751061|528795703|FG000|Overall Study|Withdrawal by Subject|4|||
146623624|NCT01751061|528795704|FG001|Overall Study|Withdrawal by Subject|1|||
146623625|NCT01751061|528795703|FG000|Overall Study|Physician Decision|2|||
146623626|NCT01751061|528795704|FG001|Overall Study|Physician Decision|0|||
146623627|NCT02153086|528795708|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
146623628|NCT02153086|528795708|FG000|Overall Study|Other|2|||
146623629|NCT00446849|528795709|FG000|Acute Phase|Lack of Efficacy|64|||
146623630|NCT00446849|528795709|FG000|Acute Phase|Protocol Violation|10|||
146623631|NCT00446849|528795709|FG000|Acute Phase|Consent withdrawn|4|||
146623632|NCT00446849|528795709|FG000|Acute Phase|Lost to Follow-up|2|||
146623633|NCT00446849|528795709|FG000|Acute Phase|Physician Decision|1|||
146623634|NCT00446849|528795709|FG000|Acute Phase|noncompliance|1|||
146623635|NCT00446849|528795709|FG000|Maintenance Phase|Lack of Efficacy|40|||
146623636|NCT00446849|528795709|FG000|Maintenance Phase|Protocol Violation|7|||
146623637|NCT00446849|528795709|FG000|Maintenance Phase|Adverse Event|6|||
146623638|NCT00446849|528795709|FG000|Maintenance Phase|Consent withdrawn|5|||
146623639|NCT00446849|528795709|FG000|Maintenance Phase|Lost to Follow-up|3|||
146623640|NCT00446849|528795709|FG000|Maintenance Phase|Pregnancy|1|||
146623641|NCT00446849|528795709|FG000|Maintenance Phase|noncompliance|2|||
146623642|NCT00446849|528795709|FG000|Maintenance Phase|prohibited medication use|2|||
146623643|NCT00446849|528795709|FG000|Maintenance Phase|antibiotic use|1|||
146623644|NCT00446849|528795709|FG000|Maintenance Phase|study closure|1|||
146623645|NCT00446849|528795709|FG000|Maintenance Phase|hydrocodone use|1|||
146623646|NCT00446849|528795709|FG000|Maintenance Phase|concomitant medication use|1|||
146623647|NCT01194830|528795710|FG000|Overall Study|Adverse Event|3|||
146623648|NCT01194830|528795711|FG001|Overall Study|Adverse Event|2|||
146623649|NCT01194830|528795710|FG000|Overall Study|Protocol Violation|5|||
146623650|NCT01194830|528795711|FG001|Overall Study|Protocol Violation|4|||
146623651|NCT01194830|528795710|FG000|Overall Study|Lost to Follow-up|9|||
146623652|NCT01194830|528795711|FG001|Overall Study|Lost to Follow-up|7|||
146623653|NCT01194830|528795710|FG000|Overall Study|Withdrawal by Subject|2|||
146623654|NCT01194830|528795711|FG001|Overall Study|Withdrawal by Subject|1|||
146623655|NCT01194830|528795710|FG000|Overall Study|Lack of Efficacy|1|||
146623656|NCT01194830|528795711|FG001|Overall Study|Lack of Efficacy|1|||
146623657|NCT01194830|528795710|FG000|Overall Study|Non-compliance issues|4|||
146623658|NCT01194830|528795711|FG001|Overall Study|Non-compliance issues|4|||
146623659|NCT01194830|528795710|FG000|Overall Study|Other Reason|12|||
146623660|NCT01194830|528795711|FG001|Overall Study|Other Reason|8|||
146623661|NCT03115359|528795712|FG000|Overall Study|Withdrawal by Subject|29|||
146623662|NCT03115359|528795713|FG001|Overall Study|Withdrawal by Subject|39|||
146623663|NCT03115359|528795712|FG000|Overall Study|Scheduling conflict|25|||
146623664|NCT03115359|528795713|FG001|Overall Study|Scheduling conflict|23|||
146623665|NCT03115359|528795712|FG000|Overall Study|Personal reasons including health|12|||
146623666|NCT03115359|528795713|FG001|Overall Study|Personal reasons including health|9|||
146623667|NCT03115359|528795712|FG000|Overall Study|Transportation barriers|3|||
146623668|NCT03115359|528795713|FG001|Overall Study|Transportation barriers|0|||
146623669|NCT03115359|528795712|FG000|Overall Study|No longer interested|5|||
146623670|NCT03115359|528795713|FG001|Overall Study|No longer interested|4|||
146623671|NCT03115359|528795712|FG000|Overall Study|No reason provided|45|||
146623672|NCT03115359|528795713|FG001|Overall Study|No reason provided|47|||
146623673|NCT01317472|528795716|FG000|Overall Study|Withdrawal by Subject|1|||
146623674|NCT01317472|528795717|FG001|Overall Study|Withdrawal by Subject|0|||
146623675|NCT01317472|528795716|FG000|Overall Study|Unrelated hospitalization|1|||
146623676|NCT01317472|528795717|FG001|Overall Study|Unrelated hospitalization|0|||
146623677|NCT01815918|528795718|FG000|Overall Study|Patient samples not analyzable|3|||
146623678|NCT01815918|528795719|FG001|Overall Study|Patient samples not analyzable|4|||
146623679|NCT01815918|528795718|FG000|Overall Study|Lack of Efficacy|15|||
146623680|NCT01815918|528795719|FG001|Overall Study|Lack of Efficacy|15|||
146623681|NCT03284710|528795722|FG000|Overall Study|Withdrawal by Subject|1|||
146623682|NCT03284710|528795723|FG001|Overall Study|Withdrawal by Subject|0|||
146623683|NCT03284710|528795724|FG002|Overall Study|Withdrawal by Subject|1|||
146623684|NCT03284710|528795725|FG003|Overall Study|Withdrawal by Subject|6|||
146623685|NCT03284710|528795722|FG000|Overall Study|Lost to Follow-up|3|||
146623686|NCT03284710|528795723|FG001|Overall Study|Lost to Follow-up|3|||
146623687|NCT03284710|528795724|FG002|Overall Study|Lost to Follow-up|1|||
146623688|NCT03284710|528795725|FG003|Overall Study|Lost to Follow-up|0|||
146623689|NCT03284710|528795722|FG000|Overall Study|Physician Decision|1|||
146623690|NCT03284710|528795723|FG001|Overall Study|Physician Decision|0|||
146623691|NCT03284710|528795724|FG002|Overall Study|Physician Decision|0|||
146623692|NCT03284710|528795725|FG003|Overall Study|Physician Decision|0|||
146623693|NCT03284710|528795722|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
146623694|NCT03284710|528795723|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
146623695|NCT03284710|528795724|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
146623696|NCT03284710|528795725|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
146623697|NCT03284710|528795722|FG000|Overall Study|HIV Infection|0|||
146623698|NCT03284710|528795723|FG001|Overall Study|HIV Infection|2|||
146623699|NCT03284710|528795724|FG002|Overall Study|HIV Infection|2|||
146623700|NCT03284710|528795725|FG003|Overall Study|HIV Infection|1|||
146623701|NCT02412306|528795728|FG000|Overall Study|Lost to Follow-up|0|||
146623702|NCT02412306|528795729|FG001|Overall Study|Lost to Follow-up|1|||
146623703|NCT02412306|528795730|FG002|Overall Study|Lost to Follow-up|0|||
146623704|NCT02412306|528795731|FG003|Overall Study|Lost to Follow-up|0|||
146623705|NCT02412306|528795732|FG004|Overall Study|Lost to Follow-up|0|||
146623706|NCT02412306|528795728|FG000|Overall Study|Withdrawal by Subject|0|||
146623707|NCT02412306|528795729|FG001|Overall Study|Withdrawal by Subject|0|||
146623708|NCT02412306|528795730|FG002|Overall Study|Withdrawal by Subject|1|||
146623709|NCT02412306|528795731|FG003|Overall Study|Withdrawal by Subject|0|||
146623710|NCT02412306|528795732|FG004|Overall Study|Withdrawal by Subject|0|||
146623711|NCT02412306|528795728|FG000|Overall Study|Death|5|||
146623712|NCT02412306|528795729|FG001|Overall Study|Death|7|||
146623713|NCT02412306|528795730|FG002|Overall Study|Death|15|||
146623714|NCT02412306|528795731|FG003|Overall Study|Death|0|||
146623715|NCT02412306|528795732|FG004|Overall Study|Death|2|||
146623716|NCT03760029|528795742|FG000|Overall Study|Death|1|||
146963801|NCT00560573|530029533|FG004|Overall Study|Death|1|||
146963802|NCT00560573|530029534|FG005|Overall Study|Death|10|||
146963803|NCT00560573|530029529|FG000|Overall Study|Lost to Follow-up|0|||
146963804|NCT00560573|530029530|FG001|Overall Study|Lost to Follow-up|0|||
146963805|NCT00560573|530029531|FG002|Overall Study|Lost to Follow-up|0|||
146963806|NCT00560573|530029532|FG003|Overall Study|Lost to Follow-up|1|||
146963807|NCT00560573|530029533|FG004|Overall Study|Lost to Follow-up|1|||
146963808|NCT00560573|530029534|FG005|Overall Study|Lost to Follow-up|0|||
146963809|NCT00560573|530029529|FG000|Overall Study|Withdrawal by Subject|0|||
146963810|NCT00560573|530029530|FG001|Overall Study|Withdrawal by Subject|0|||
146963811|NCT00560573|530029531|FG002|Overall Study|Withdrawal by Subject|0|||
146963812|NCT00560573|530029532|FG003|Overall Study|Withdrawal by Subject|1|||
146963813|NCT00560573|530029533|FG004|Overall Study|Withdrawal by Subject|1|||
146963814|NCT00560573|530029534|FG005|Overall Study|Withdrawal by Subject|0|||
146963815|NCT00560573|530029529|FG000|Overall Study|Other|2|||
146963816|NCT00560573|530029530|FG001|Overall Study|Other|2|||
146963817|NCT00560573|530029531|FG002|Overall Study|Other|2|||
146963818|NCT00560573|530029532|FG003|Overall Study|Other|3|||
146963819|NCT00560573|530029533|FG004|Overall Study|Other|3|||
146963820|NCT00560573|530029534|FG005|Overall Study|Other|3|||
146963821|NCT00560573|530029529|FG000|Overall Study|Enrolled, not treated|0|||
146963822|NCT00560573|530029530|FG001|Overall Study|Enrolled, not treated|0|||
146963823|NCT00560573|530029531|FG002|Overall Study|Enrolled, not treated|0|||
146963824|NCT00560573|530029532|FG003|Overall Study|Enrolled, not treated|0|||
146963825|NCT00560573|530029533|FG004|Overall Study|Enrolled, not treated|1|||
146623717|NCT03760029|528795743|FG001|Overall Study|Death|0|||
146623718|NCT03760029|528795744|FG002|Overall Study|Death|0|||
146963826|NCT00560573|530029534|FG005|Overall Study|Enrolled, not treated|0|||
146963827|NCT00594568|530029535|FG000|Initial Treatment|Adverse Event|51|||
146963828|NCT00594568|530029536|FG001|Initial Treatment|Adverse Event|121|||
146963829|NCT00594568|530029537|FG002|Initial Treatment|Adverse Event|144|||
146963830|NCT00594568|530029535|FG000|Initial Treatment|Death|6|||
146963831|NCT00594568|530029536|FG001|Initial Treatment|Death|11|||
146963832|NCT00594568|530029537|FG002|Initial Treatment|Death|15|||
146963833|NCT00594568|530029535|FG000|Initial Treatment|Lost to Follow-up|4|||
146963834|NCT00594568|530029536|FG001|Initial Treatment|Lost to Follow-up|1|||
146963835|NCT00594568|530029537|FG002|Initial Treatment|Lost to Follow-up|4|||
146963836|NCT00594568|530029535|FG000|Initial Treatment|Physician Decision|3|||
146963837|NCT00594568|530029536|FG001|Initial Treatment|Physician Decision|2|||
146963838|NCT00594568|530029537|FG002|Initial Treatment|Physician Decision|4|||
146963839|NCT00594568|530029535|FG000|Initial Treatment|Protocol Violation|2|||
146963840|NCT00594568|530029536|FG001|Initial Treatment|Protocol Violation|2|||
146623719|NCT03760029|528795742|FG000|Overall Study|Lost to Follow-up|0|||
146623720|NCT03760029|528795743|FG001|Overall Study|Lost to Follow-up|2|||
146623721|NCT03760029|528795744|FG002|Overall Study|Lost to Follow-up|1|||
146623722|NCT03760029|528795742|FG000|Overall Study|Withdrawal by Subject|1|||
146623723|NCT03760029|528795743|FG001|Overall Study|Withdrawal by Subject|4|||
146623724|NCT03760029|528795744|FG002|Overall Study|Withdrawal by Subject|1|||
146623725|NCT03760029|528795742|FG000|Overall Study|Withdrawal by parent/guardian|4|||
146623726|NCT03760029|528795743|FG001|Overall Study|Withdrawal by parent/guardian|4|||
146623727|NCT03760029|528795744|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146623728|NCT03760029|528795742|FG000|Overall Study|Other|2|||
146623729|NCT03760029|528795743|FG001|Overall Study|Other|1|||
146623730|NCT03760029|528795744|FG002|Overall Study|Other|0|||
146623731|NCT03532542|528795745|FG000|Overall Study|Death|1|||
146623732|NCT03532542|528795746|FG001|Overall Study|Death|0|||
146623733|NCT03532542|528795745|FG000|Overall Study|Study Terminated by Sponsor|41|||
146623734|NCT03532542|528795746|FG001|Overall Study|Study Terminated by Sponsor|65|||
146623735|NCT03532542|528795745|FG000|Overall Study|Withdrawal by Subject|6|||
146623736|NCT03532542|528795746|FG001|Overall Study|Withdrawal by Subject|5|||
146623737|NCT00436332|528795747|FG000|Overall Study|Adverse Event|9|||
146623738|NCT00436332|528795747|FG000|Overall Study|Withdrawal by Subject|2|||
146623739|NCT00436332|528795747|FG000|Overall Study|Progression|59|||
146623740|NCT00436332|528795747|FG000|Overall Study|Death|2|||
146623741|NCT00436332|528795747|FG000|Overall Study|Not Protocol Specified|6|||
146963841|NCT00594568|530029537|FG002|Initial Treatment|Protocol Violation|5|||
146963842|NCT00594568|530029535|FG000|Initial Treatment|Withdrawal by Subject|25|||
146623742|NCT00436332|528795747|FG000|Overall Study|Ineligible|2|||
146623743|NCT00436332|528795747|FG000|Overall Study|Never Received Treatment|3|||
146623744|NCT04698343|528795748|FG000|Overall Study|Withdrawal by Subject|6|||
146623745|NCT04698343|528795748|FG000|Overall Study|Physician Decision|2|||
146623746|NCT04698343|528795748|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
146623747|NCT04698343|528795748|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
146623748|NCT04698343|528795748|FG000|Overall Study|Personal reasons|3|||
146623749|NCT04698343|528795748|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
146623750|NCT00286442|528795749|FG000|Overall Study|Hyperglycemic Rescue|19|||
146623751|NCT00286442|528795750|FG001|Overall Study|Hyperglycemic Rescue|17|||
146623752|NCT00286442|528795751|FG002|Overall Study|Hyperglycemic Rescue|25|||
146623753|NCT00286442|528795749|FG000|Overall Study|Adverse Event|7|||
146623754|NCT00286442|528795750|FG001|Overall Study|Adverse Event|6|||
146623755|NCT00286442|528795751|FG002|Overall Study|Adverse Event|1|||
146623756|NCT00286442|528795749|FG000|Overall Study|Protocol Violation|2|||
146623757|NCT00286442|528795750|FG001|Overall Study|Protocol Violation|4|||
146623758|NCT00286442|528795751|FG002|Overall Study|Protocol Violation|2|||
146623759|NCT00286442|528795749|FG000|Overall Study|Lost to Follow-up|5|||
146623760|NCT00286442|528795750|FG001|Overall Study|Lost to Follow-up|2|||
146623761|NCT00286442|528795751|FG002|Overall Study|Lost to Follow-up|1|||
146623762|NCT00286442|528795749|FG000|Overall Study|Physician Decision|1|||
146623763|NCT00286442|528795750|FG001|Overall Study|Physician Decision|1|||
146623764|NCT00286442|528795751|FG002|Overall Study|Physician Decision|1|||
146623765|NCT00286442|528795749|FG000|Overall Study|Administrative Error|1|||
146623766|NCT00286442|528795750|FG001|Overall Study|Administrative Error|1|||
146623767|NCT00286442|528795751|FG002|Overall Study|Administrative Error|0|||
146623768|NCT00286442|528795749|FG000|Overall Study|Withdrawal by Subject|2|||
146623769|NCT00286442|528795750|FG001|Overall Study|Withdrawal by Subject|14|||
146623770|NCT00286442|528795751|FG002|Overall Study|Withdrawal by Subject|2|||
146623771|NCT02756338|528795752|FG000|Overall Study|Withdrawn by Investigator|1|||
146623772|NCT02756338|528795752|FG000|Overall Study|Device Replaced with Pacemaker|4|||
146623773|NCT01339689|528795753|FG000|Overall Study|Adverse Event|1|||
146623774|NCT01339689|528795754|FG001|Overall Study|Adverse Event|2|||
146623775|NCT01339689|528795753|FG000|Overall Study|Lost to Follow-up|9|||
146623776|NCT01339689|528795754|FG001|Overall Study|Lost to Follow-up|3|||
146623777|NCT01339689|528795753|FG000|Overall Study|Withdrawal by Subject|3|||
146623778|NCT01339689|528795754|FG001|Overall Study|Withdrawal by Subject|0|||
146623779|NCT01339689|528795753|FG000|Overall Study|Noncompliance|1|||
146623780|NCT01339689|528795754|FG001|Overall Study|Noncompliance|0|||
146623781|NCT01339689|528795753|FG000|Overall Study|Relocated out of area|0|||
146623782|NCT01339689|528795754|FG001|Overall Study|Relocated out of area|1|||
146623783|NCT01339689|528795753|FG000|Overall Study|Other|2|||
146623784|NCT01339689|528795754|FG001|Overall Study|Other|2|||
146623785|NCT01339689|528795753|FG000|Overall Study|multiple reasons|1|||
146623786|NCT01339689|528795754|FG001|Overall Study|multiple reasons|1|||
146623787|NCT00467740|528795755|FG000|Overall Study|Adverse Event|0|||
146623788|NCT00467740|528795756|FG001|Overall Study|Adverse Event|0|||
146623789|NCT00467740|528795757|FG002|Overall Study|Adverse Event|1|||
146623790|NCT00467740|528795758|FG003|Overall Study|Adverse Event|0|||
146623791|NCT00467740|528795759|FG004|Overall Study|Adverse Event|0|||
146623792|NCT00467740|528795755|FG000|Overall Study|Protocol Violation|0|||
146623793|NCT00467740|528795756|FG001|Overall Study|Protocol Violation|0|||
146623794|NCT00467740|528795757|FG002|Overall Study|Protocol Violation|1|||
146623795|NCT00467740|528795758|FG003|Overall Study|Protocol Violation|0|||
146623796|NCT00467740|528795759|FG004|Overall Study|Protocol Violation|0|||
146623797|NCT00467740|528795755|FG000|Overall Study|Lost to Follow-up|0|||
146623798|NCT00467740|528795756|FG001|Overall Study|Lost to Follow-up|1|||
146623799|NCT00467740|528795757|FG002|Overall Study|Lost to Follow-up|0|||
146623800|NCT00467740|528795758|FG003|Overall Study|Lost to Follow-up|0|||
146623801|NCT00467740|528795759|FG004|Overall Study|Lost to Follow-up|0|||
146623802|NCT00467740|528795755|FG000|Overall Study|Withdrawal by Subject|1|||
146623803|NCT00467740|528795756|FG001|Overall Study|Withdrawal by Subject|1|||
146623804|NCT00467740|528795757|FG002|Overall Study|Withdrawal by Subject|0|||
146623805|NCT00467740|528795758|FG003|Overall Study|Withdrawal by Subject|1|||
146623806|NCT00467740|528795759|FG004|Overall Study|Withdrawal by Subject|0|||
146623807|NCT00467740|528795755|FG000|Overall Study|Lack of Efficacy|0|||
146623808|NCT00467740|528795756|FG001|Overall Study|Lack of Efficacy|1|||
146623809|NCT00467740|528795757|FG002|Overall Study|Lack of Efficacy|0|||
146623810|NCT00467740|528795758|FG003|Overall Study|Lack of Efficacy|0|||
146623811|NCT00467740|528795759|FG004|Overall Study|Lack of Efficacy|0|||
146623812|NCT00730158|528795760|FG000|Overall Study|Withdrawal by Subject|1|||
146623813|NCT00730158|528795761|FG001|Overall Study|Withdrawal by Subject|1|||
146623814|NCT04999839|528795762|FG000|Overall Study|Adverse Event|1|||
146623815|NCT04999839|528795763|FG001|Overall Study|Adverse Event|1|||
146623816|NCT04999839|528795764|FG002|Overall Study|Adverse Event|1|||
146623817|NCT04999839|528795765|FG003|Overall Study|Adverse Event|1|||
146623818|NCT04999839|528795766|FG004|Overall Study|Adverse Event|1|||
146623819|NCT04999839|528795762|FG000|Overall Study|Lost to Follow-up|2|||
146623820|NCT04999839|528795763|FG001|Overall Study|Lost to Follow-up|0|||
146623821|NCT04999839|528795764|FG002|Overall Study|Lost to Follow-up|2|||
146623822|NCT04999839|528795765|FG003|Overall Study|Lost to Follow-up|4|||
146623823|NCT04999839|528795766|FG004|Overall Study|Lost to Follow-up|1|||
146623824|NCT04999839|528795762|FG000|Overall Study|Withdrawal by Subject|6|||
146623825|NCT04999839|528795763|FG001|Overall Study|Withdrawal by Subject|5|||
146623826|NCT04999839|528795764|FG002|Overall Study|Withdrawal by Subject|3|||
146623827|NCT04999839|528795765|FG003|Overall Study|Withdrawal by Subject|2|||
146623828|NCT04999839|528795766|FG004|Overall Study|Withdrawal by Subject|2|||
146623829|NCT04999839|528795762|FG000|Overall Study|Lack of Efficacy|0|||
146623830|NCT04999839|528795763|FG001|Overall Study|Lack of Efficacy|1|||
146623831|NCT04999839|528795764|FG002|Overall Study|Lack of Efficacy|0|||
146623832|NCT04999839|528795765|FG003|Overall Study|Lack of Efficacy|0|||
146623833|NCT04999839|528795766|FG004|Overall Study|Lack of Efficacy|0|||
146623834|NCT04999839|528795762|FG000|Overall Study|Physician Decision|0|||
146623835|NCT04999839|528795763|FG001|Overall Study|Physician Decision|0|||
146623836|NCT04999839|528795764|FG002|Overall Study|Physician Decision|0|||
146623837|NCT04999839|528795765|FG003|Overall Study|Physician Decision|0|||
146623838|NCT04999839|528795766|FG004|Overall Study|Physician Decision|1|||
146623839|NCT04999839|528795762|FG000|Overall Study|Sponsor request|0|||
146623840|NCT04999839|528795763|FG001|Overall Study|Sponsor request|1|||
146623841|NCT04999839|528795764|FG002|Overall Study|Sponsor request|0|||
146623842|NCT04999839|528795765|FG003|Overall Study|Sponsor request|0|||
146623843|NCT04999839|528795766|FG004|Overall Study|Sponsor request|0|||
146623844|NCT04999839|528795762|FG000|Overall Study|Other|0|||
146623845|NCT04999839|528795763|FG001|Overall Study|Other|0|||
146623846|NCT04999839|528795764|FG002|Overall Study|Other|1|||
146623847|NCT04999839|528795765|FG003|Overall Study|Other|0|||
146623848|NCT04999839|528795766|FG004|Overall Study|Other|0|||
146623849|NCT03740048|528795767|FG000|Overall Study|Withdrawal by Subject|1|||
146623850|NCT03740048|528795768|FG001|Overall Study|Withdrawal by Subject|1|||
146623851|NCT03740048|528795767|FG000|Overall Study|Death|1|||
146623852|NCT03740048|528795768|FG001|Overall Study|Death|6|||
146623853|NCT03740048|528795767|FG000|Overall Study|Switched to thrice-weekly HD|2|||
146623854|NCT03740048|528795768|FG001|Overall Study|Switched to thrice-weekly HD|0|||
146623855|NCT03740048|528795767|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
146623856|NCT03740048|528795768|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
146623857|NCT03740048|528795767|FG000|Overall Study|Lost to Follow-up|0|||
146623858|NCT03740048|528795768|FG001|Overall Study|Lost to Follow-up|1|||
146623859|NCT03740048|528795767|FG000|Overall Study|Non-compliance with HD|0|||
146623860|NCT03740048|528795768|FG001|Overall Study|Non-compliance with HD|1|||
146623861|NCT01476722|528795770|FG000|Overall Study|Adverse Event|1|||
146623862|NCT00528957|528795771|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
146623863|NCT00528957|528795772|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
146963843|NCT00594568|530029536|FG001|Initial Treatment|Withdrawal by Subject|31|||
146963844|NCT00594568|530029537|FG002|Initial Treatment|Withdrawal by Subject|46|||
146963845|NCT00594568|530029535|FG000|Initial Treatment|Sponsor decision|193|||
146963846|NCT00594568|530029536|FG001|Initial Treatment|Sponsor decision|142|||
146963847|NCT00594568|530029537|FG002|Initial Treatment|Sponsor decision|147|||
146963848|NCT00594568|530029535|FG000|Initial Treatment|Caregiver decision|21|||
146963849|NCT00594568|530029536|FG001|Initial Treatment|Caregiver decision|36|||
146963850|NCT00594568|530029537|FG002|Initial Treatment|Caregiver decision|36|||
146963851|NCT00594568|530029535|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
146963852|NCT00594568|530029536|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
146963853|NCT00594568|530029537|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
146623864|NCT00528957|528795771|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
146623865|NCT00528957|528795772|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
146623866|NCT00528957|528795771|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
146623867|NCT00528957|528795772|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
146623868|NCT00528957|528795771|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
146623869|NCT00528957|528795772|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
146623870|NCT00528957|528795771|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
146623871|NCT00528957|528795772|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
146623872|NCT00528957|528795771|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
146623873|NCT00528957|528795772|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
146623874|NCT00528957|528795771|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
146623875|NCT00528957|528795772|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
146623876|NCT00528957|528795771|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
146623877|NCT00528957|528795772|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
146623878|NCT00528957|528795771|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
146623879|NCT00528957|528795772|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
146623880|NCT00528957|528795771|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
146623881|NCT00528957|528795772|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
146623882|NCT00528957|528795771|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
146623883|NCT00528957|528795772|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
146623884|NCT00528957|528795771|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
146623885|NCT00528957|528795772|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
146623886|NCT00528957|528795771|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
146623887|NCT00528957|528795772|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
146623888|NCT00528957|528795771|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
146623889|NCT00528957|528795772|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
146623890|NCT00528957|528795771|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
146623891|NCT00528957|528795772|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
146623892|NCT00528957|528795771|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
146623893|NCT00528957|528795772|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
146623894|NCT00539981|528795773|FG000|Overall Study|Adverse events (AE)|3|||
146623895|NCT00539981|528795774|FG001|Overall Study|Adverse events (AE)|3|||
146623896|NCT00539981|528795773|FG000|Overall Study|Lost to Follow-up|260|||
146623897|NCT00539981|528795774|FG001|Overall Study|Lost to Follow-up|251|||
146623898|NCT00539981|528795773|FG000|Overall Study|Withdrew consent|22|||
146623899|NCT00539981|528795774|FG001|Overall Study|Withdrew consent|14|||
146623900|NCT00539981|528795773|FG000|Overall Study|Death|1|||
146623901|NCT00539981|528795774|FG001|Overall Study|Death|1|||
146623902|NCT00539981|528795773|FG000|Overall Study|Other reason-unspecified|9|||
146623903|NCT00539981|528795774|FG001|Overall Study|Other reason-unspecified|13|||
146623904|NCT01323582|528795775|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
146623905|NCT01323582|528795776|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
146623906|NCT01323582|528795775|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
146623907|NCT01323582|528795776|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
146623908|NCT01323582|528795775|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
146623909|NCT01323582|528795776|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
146623910|NCT03473236|528795778|FG000|Overall Study|Withdrawal by Subject|0|||
146623911|NCT03473236|528795779|FG001|Overall Study|Withdrawal by Subject|0|||
146623912|NCT03473236|528795780|FG002|Overall Study|Withdrawal by Subject|0|||
146623913|NCT03473236|528795781|FG003|Overall Study|Withdrawal by Subject|0|||
146623914|NCT03473236|528795782|FG004|Overall Study|Withdrawal by Subject|0|||
146623915|NCT03473236|528795783|FG005|Overall Study|Withdrawal by Subject|1|||
146623916|NCT03473236|528795784|FG006|Overall Study|Withdrawal by Subject|0|||
146623917|NCT03473236|528795785|FG007|Overall Study|Withdrawal by Subject|0|||
146623918|NCT03473236|528795786|FG008|Overall Study|Withdrawal by Subject|1|||
146623919|NCT03473236|528795787|FG009|Overall Study|Withdrawal by Subject|0|||
146623920|NCT03155724|528795789|FG000|Overall Study|Death|3|||
146623921|NCT03155724|528795789|FG000|Overall Study|Physician Decision|1|||
146623922|NCT03155724|528795789|FG000|Overall Study|Study closure|7|||
146623923|NCT00525512|528795790|FG000|Double-Blind Phase|Adverse Event|48|||
146623924|NCT00525512|528795791|FG001|Double-Blind Phase|Adverse Event|28|||
146623925|NCT00525512|528795792|FG002|Double-Blind Phase|Adverse Event|0|||
146623926|NCT00525512|528795793|FG003|Double-Blind Phase|Adverse Event|0|||
146623927|NCT00525512|528795790|FG000|Double-Blind Phase|Protocol Violation|3|||
146623928|NCT00525512|528795791|FG001|Double-Blind Phase|Protocol Violation|1|||
146623929|NCT00525512|528795792|FG002|Double-Blind Phase|Protocol Violation|0|||
146623930|NCT00525512|528795793|FG003|Double-Blind Phase|Protocol Violation|0|||
146623931|NCT00525512|528795790|FG000|Double-Blind Phase|Lost to Follow-up|3|||
146623932|NCT00525512|528795791|FG001|Double-Blind Phase|Lost to Follow-up|7|||
146623933|NCT00525512|528795792|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146623934|NCT00525512|528795793|FG003|Double-Blind Phase|Lost to Follow-up|0|||
146623935|NCT00525512|528795790|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
146623936|NCT00525512|528795791|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
146623937|NCT00525512|528795792|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
146623938|NCT00525512|528795793|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
146623939|NCT00525512|528795790|FG000|Double-Blind Phase|Lack of Efficacy|13|||
146623940|NCT00525512|528795791|FG001|Double-Blind Phase|Lack of Efficacy|5|||
146623941|NCT00525512|528795792|FG002|Double-Blind Phase|Lack of Efficacy|0|||
146623942|NCT00525512|528795793|FG003|Double-Blind Phase|Lack of Efficacy|0|||
146623943|NCT00525512|528795790|FG000|Double-Blind Phase|Other reason (not specified)|12|||
146623944|NCT00525512|528795791|FG001|Double-Blind Phase|Other reason (not specified)|13|||
146623945|NCT00525512|528795792|FG002|Double-Blind Phase|Other reason (not specified)|0|||
146623946|NCT00525512|528795793|FG003|Double-Blind Phase|Other reason (not specified)|0|||
146623947|NCT00525512|528795790|FG000|Open-Label Phase|Adverse Event|0|||
146623948|NCT00525512|528795791|FG001|Open-Label Phase|Adverse Event|0|||
146623949|NCT00525512|528795792|FG002|Open-Label Phase|Adverse Event|1|||
146623950|NCT00525512|528795793|FG003|Open-Label Phase|Adverse Event|0|||
146623951|NCT00525512|528795790|FG000|Open-Label Phase|Lost to Follow-up|0|||
146623952|NCT00525512|528795791|FG001|Open-Label Phase|Lost to Follow-up|0|||
146623953|NCT00525512|528795792|FG002|Open-Label Phase|Lost to Follow-up|1|||
146623954|NCT00525512|528795793|FG003|Open-Label Phase|Lost to Follow-up|0|||
146623955|NCT00525512|528795790|FG000|Open-Label Phase|Other reason (not specified)|0|||
146623956|NCT00525512|528795791|FG001|Open-Label Phase|Other reason (not specified)|0|||
146623957|NCT00525512|528795792|FG002|Open-Label Phase|Other reason (not specified)|4|||
146623958|NCT00525512|528795793|FG003|Open-Label Phase|Other reason (not specified)|5|||
146623959|NCT05893862|528795798|FG000|Overall Study|Physician Decision|0|||
146623960|NCT05893862|528795799|FG001|Overall Study|Physician Decision|1|||
146623961|NCT05893862|528795800|FG002|Overall Study|Physician Decision|0|||
146623962|NCT05893862|528795801|FG003|Overall Study|Physician Decision|0|||
146623963|NCT05893862|528795802|FG004|Overall Study|Physician Decision|1|||
146623964|NCT05893862|528795803|FG005|Overall Study|Physician Decision|0|||
146623965|NCT05893862|528795798|FG000|Overall Study|Withdrawal by Subject|1|||
146623966|NCT05893862|528795799|FG001|Overall Study|Withdrawal by Subject|7|||
146623967|NCT05893862|528795800|FG002|Overall Study|Withdrawal by Subject|1|||
146623968|NCT05893862|528795801|FG003|Overall Study|Withdrawal by Subject|3|||
146623969|NCT05893862|528795802|FG004|Overall Study|Withdrawal by Subject|3|||
146623970|NCT05893862|528795803|FG005|Overall Study|Withdrawal by Subject|2|||
146623971|NCT05893862|528795798|FG000|Overall Study|Adverse Event|1|||
146623972|NCT05893862|528795799|FG001|Overall Study|Adverse Event|4|||
146623973|NCT05893862|528795800|FG002|Overall Study|Adverse Event|2|||
146623974|NCT05893862|528795801|FG003|Overall Study|Adverse Event|2|||
146623975|NCT05893862|528795802|FG004|Overall Study|Adverse Event|1|||
146623976|NCT05893862|528795803|FG005|Overall Study|Adverse Event|0|||
146623977|NCT02919761|528795804|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
146623978|NCT02919761|528795805|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
146623979|NCT02919761|528795806|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
146623980|NCT02919761|528795804|FG000|Part 1: Open Label|Adverse Event|1|||
146623981|NCT02919761|528795805|FG001|Part 1: Open Label|Adverse Event|0|||
146623982|NCT02919761|528795806|FG002|Part 1: Open Label|Adverse Event|0|||
146623983|NCT02919761|528795804|FG000|Part 1: Open Label|Lost to Follow-up|1|||
146623984|NCT02919761|528795805|FG001|Part 1: Open Label|Lost to Follow-up|0|||
146623985|NCT02919761|528795806|FG002|Part 1: Open Label|Lost to Follow-up|0|||
146623986|NCT02919761|528795804|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
146623987|NCT02919761|528795805|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
146623988|NCT02919761|528795806|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
146623989|NCT02919761|528795804|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
146623990|NCT02919761|528795805|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
146623991|NCT02919761|528795806|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
146623992|NCT02919761|528795804|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
146623993|NCT02919761|528795805|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
146623994|NCT02919761|528795806|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
146623995|NCT02919761|528795804|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
146623996|NCT02919761|528795805|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
146623997|NCT02919761|528795806|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
146623998|NCT02919761|528795804|FG000|Part 1: Open Label|Termination by Sponsor|1|||
146623999|NCT02919761|528795805|FG001|Part 1: Open Label|Termination by Sponsor|0|||
146624000|NCT02919761|528795806|FG002|Part 1: Open Label|Termination by Sponsor|0|||
146624001|NCT02919761|528795804|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
146624002|NCT02919761|528795805|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
146624003|NCT02919761|528795806|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
146624004|NCT02919761|528795804|FG000|Part 2: Double-blind|Adverse Event|0|||
146624005|NCT02919761|528795805|FG001|Part 2: Double-blind|Adverse Event|1|||
146624006|NCT02919761|528795806|FG002|Part 2: Double-blind|Adverse Event|0|||
146624007|NCT02919761|528795804|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
146624008|NCT02919761|528795805|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
146624009|NCT02919761|528795806|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
146624010|NCT02919761|528795804|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
146624011|NCT02919761|528795805|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
146624012|NCT02919761|528795806|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
146624013|NCT02919761|528795804|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
146624014|NCT02919761|528795805|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
146624015|NCT02919761|528795806|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
146624016|NCT02919761|528795804|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
146624017|NCT02919761|528795805|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
146624018|NCT02919761|528795806|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
146624019|NCT02919761|528795804|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
146624020|NCT02919761|528795805|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
146624021|NCT02919761|528795806|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
146624022|NCT02919761|528795804|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
146624023|NCT02919761|528795805|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
146624024|NCT02919761|528795806|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
146624025|NCT00880698|528795809|FG000|Overall Study|Death|0|||
146624026|NCT00880698|528795810|FG001|Overall Study|Death|0|||
146624027|NCT00880698|528795811|FG002|Overall Study|Death|1|||
146624028|NCT00880698|528795812|FG003|Overall Study|Death|2|||
146624029|NCT00880698|528795809|FG000|Overall Study|Lost to Follow-up|1|||
146624030|NCT00880698|528795810|FG001|Overall Study|Lost to Follow-up|3|||
146624031|NCT00880698|528795811|FG002|Overall Study|Lost to Follow-up|0|||
146624032|NCT00880698|528795812|FG003|Overall Study|Lost to Follow-up|1|||
146624033|NCT04972162|528795813|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
146624034|NCT04972162|528795814|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
146624035|NCT05546476|528797378|FG000|Period 1: Part A|Adverse Event|2|||
146624036|NCT05546476|528797379|FG001|Period 1: Part A|Adverse Event|0|||
146624037|NCT05546476|528797380|FG002|Period 1: Part A|Adverse Event|0|||
146624038|NCT05546476|528797381|FG003|Period 1: Part A|Adverse Event|1|||
146624039|NCT05546476|528797378|FG000|Period 1: Part A|Death|4|||
146624040|NCT05546476|528797379|FG001|Period 1: Part A|Death|4|||
146624041|NCT05546476|528797380|FG002|Period 1: Part A|Death|5|||
146624042|NCT05546476|528797381|FG003|Period 1: Part A|Death|6|||
146624043|NCT05546476|528797378|FG000|Period 1: Part A|Lack of Efficacy|0|||
146624044|NCT05546476|528797379|FG001|Period 1: Part A|Lack of Efficacy|0|||
146624045|NCT05546476|528797380|FG002|Period 1: Part A|Lack of Efficacy|0|||
146624046|NCT05546476|528797381|FG003|Period 1: Part A|Lack of Efficacy|1|||
146624047|NCT05546476|528797378|FG000|Period 1: Part A|Lost to Follow-up|0|||
146624048|NCT05546476|528797379|FG001|Period 1: Part A|Lost to Follow-up|0|||
146624049|NCT05546476|528797380|FG002|Period 1: Part A|Lost to Follow-up|0|||
146624050|NCT05546476|528797381|FG003|Period 1: Part A|Lost to Follow-up|1|||
146624051|NCT05546476|528797378|FG000|Period 1: Part A|Physician Decision|1|||
146624052|NCT05546476|528797379|FG001|Period 1: Part A|Physician Decision|0|||
146624053|NCT05546476|528797380|FG002|Period 1: Part A|Physician Decision|0|||
146624054|NCT05546476|528797381|FG003|Period 1: Part A|Physician Decision|0|||
146624055|NCT05546476|528797378|FG000|Period 1: Part A|Progressive disease|3|||
146624056|NCT05546476|528797379|FG001|Period 1: Part A|Progressive disease|5|||
146624057|NCT05546476|528797380|FG002|Period 1: Part A|Progressive disease|0|||
146624058|NCT05546476|528797381|FG003|Period 1: Part A|Progressive disease|1|||
146624059|NCT05546476|528797378|FG000|Period 1: Part A|Withdrawal by Subject|1|||
146624060|NCT05546476|528797379|FG001|Period 1: Part A|Withdrawal by Subject|1|||
146624061|NCT05546476|528797380|FG002|Period 1: Part A|Withdrawal by Subject|1|||
146624062|NCT05546476|528797381|FG003|Period 1: Part A|Withdrawal by Subject|2|||
146624063|NCT05546476|528797378|FG000|Period 1: Part A|Global deterioration of health status|2|||
146624064|NCT05546476|528797379|FG001|Period 1: Part A|Global deterioration of health status|2|||
146624065|NCT05546476|528797380|FG002|Period 1: Part A|Global deterioration of health status|1|||
146624066|NCT05546476|528797381|FG003|Period 1: Part A|Global deterioration of health status|4|||
146624067|NCT05546476|528797378|FG000|Period 1: Part A|Other: Unspecified|0|||
146624068|NCT05546476|528797379|FG001|Period 1: Part A|Other: Unspecified|2|||
146624069|NCT05546476|528797380|FG002|Period 1: Part A|Other: Unspecified|0|||
146624070|NCT05546476|528797381|FG003|Period 1: Part A|Other: Unspecified|0|||
146624071|NCT05546476|528797378|FG000|Period 2: Part B|Ongoing|26|||
146624072|NCT05546476|528797379|FG001|Period 2: Part B|Ongoing|27|||
146624073|NCT05546476|528797380|FG002|Period 2: Part B|Ongoing|35|||
146624074|NCT05546476|528797381|FG003|Period 2: Part B|Ongoing|29|||
146624075|NCT04890652|528797391|FG000|Overall Study|Withdrawal by Subject|2|||
146624076|NCT04750824|528797396|FG000|Overall Study|Toxicity/intolerability|3|||
146624077|NCT04750824|528797397|FG001|Overall Study|Toxicity/intolerability|1|||
146624078|NCT04750824|528797396|FG000|Overall Study|Death|1|||
146624079|NCT04750824|528797397|FG001|Overall Study|Death|3|||
146624080|NCT04750824|528797396|FG000|Overall Study|Scheduled duration of therapy complete|1|||
146624081|NCT04750824|528797397|FG001|Overall Study|Scheduled duration of therapy complete|9|||
146624082|NCT04750824|528797396|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
146624083|NCT04750824|528797397|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
146624084|NCT00807911|528797398|FG000|Overall Study|Withdrawal by Subject|12|||
146624085|NCT00807911|528797399|FG001|Overall Study|Withdrawal by Subject|10|||
146624086|NCT00807911|528797398|FG000|Overall Study|Ineligible|0|||
146624087|NCT00807911|528797399|FG001|Overall Study|Ineligible|4|||
146624088|NCT04349891|528797402|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
146624089|NCT04349891|528797403|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
146624090|NCT04349891|528797402|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
146624091|NCT04349891|528797403|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
146624092|NCT04349891|528797402|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
146624093|NCT04349891|528797403|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
146624094|NCT04349891|528797402|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
146624095|NCT04349891|528797403|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
146624096|NCT00836589|528797408|FG000|Overall Study|Lost to Follow-up|246|||
146624097|NCT00836589|528797408|FG000|Overall Study|Death|429|||
146624098|NCT00836589|528797408|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
146624099|NCT02914639|528797411|FG000|Overall Study|Withdrawal by Subject|0|||
146624100|NCT02914639|528797412|FG001|Overall Study|Withdrawal by Subject|2|||
146624101|NCT01018030|528797413|FG000|Overall Study|Adverse Event|10|||
146624102|NCT01018030|528797414|FG001|Overall Study|Adverse Event|5|||
146624103|NCT01018030|528797415|FG002|Overall Study|Adverse Event|5|||
146624104|NCT01018030|528797413|FG000|Overall Study|Withdrawal by Subject|2|||
146624105|NCT01018030|528797414|FG001|Overall Study|Withdrawal by Subject|2|||
146624106|NCT01018030|528797415|FG002|Overall Study|Withdrawal by Subject|4|||
146624107|NCT01018030|528797413|FG000|Overall Study|Lost to Follow-up|2|||
146624108|NCT01018030|528797414|FG001|Overall Study|Lost to Follow-up|0|||
146624109|NCT01018030|528797415|FG002|Overall Study|Lost to Follow-up|3|||
146624110|NCT01018030|528797413|FG000|Overall Study|Protocol Violation|2|||
146624111|NCT01018030|528797414|FG001|Overall Study|Protocol Violation|1|||
146624112|NCT01018030|528797415|FG002|Overall Study|Protocol Violation|0|||
146624113|NCT01018030|528797413|FG000|Overall Study|Physician Decision|1|||
146624114|NCT01018030|528797414|FG001|Overall Study|Physician Decision|0|||
146624115|NCT01018030|528797415|FG002|Overall Study|Physician Decision|1|||
146624116|NCT01018030|528797413|FG000|Overall Study|Lack of Efficacy|1|||
146624117|NCT01018030|528797414|FG001|Overall Study|Lack of Efficacy|0|||
146624118|NCT01018030|528797415|FG002|Overall Study|Lack of Efficacy|0|||
146624119|NCT01018030|528797413|FG000|Overall Study|Did Not Receive Study Drug|1|||
146624120|NCT01018030|528797414|FG001|Overall Study|Did Not Receive Study Drug|3|||
146624121|NCT01018030|528797415|FG002|Overall Study|Did Not Receive Study Drug|0|||
146624122|NCT00062439|528797416|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
146624123|NCT00062439|528797416|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
146624124|NCT00062439|528797416|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
146624125|NCT00062439|528797416|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
146624126|NCT00062439|528797416|FG000|Post Chemoradiation Assessment|Death|1|||
146624127|NCT00062439|528797416|FG000|Post Chemoradiation Assessment|Disease progression|2|||
146624128|NCT00062439|528797416|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
146624129|NCT00062439|528797416|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
146624130|NCT00062439|528797416|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
146624131|NCT00062439|528797416|FG000|Surgery|Physician Decision|4|||
146624132|NCT00062439|528797416|FG000|Surgery|Death|1|||
146624133|NCT00062439|528797416|FG000|Surgery|Adverse Event|2|||
146624134|NCT00062439|528797416|FG000|Consolidation Chemotherapy|Adverse Event|2|||
146624135|NCT01924845|528797417|FG000|Overall Study|Adverse Event|3|||
146624136|NCT01924845|528797417|FG000|Overall Study|Withdrawal by Subject|2|||
146624137|NCT01924845|528797417|FG000|Overall Study|Protocol Violation|1|||
146624138|NCT04529083|528797418|FG000|Overall Study|Withdrawal by Subject|3|||
146624139|NCT04196686|528797423|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
146624140|NCT04196686|528797424|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
146624141|NCT05106959|528797425|FG000|Overall Study|Lost to Follow-up|1|||
146624142|NCT00265564|528797430|FG000|Overall Study|Lost to Follow-up|5|||
146624143|NCT00265564|528797431|FG001|Overall Study|Lost to Follow-up|7|||
146624144|NCT00265564|528797430|FG000|Overall Study|met exclusion criteria|5|||
146624145|NCT00265564|528797431|FG001|Overall Study|met exclusion criteria|2|||
146624146|NCT01553084|528797434|FG000|Overall Study|Withdrawal by Subject|15|||
146624147|NCT01553084|528797435|FG001|Overall Study|Withdrawal by Subject|13|||
146624148|NCT01553084|528797436|FG002|Overall Study|Withdrawal by Subject|35|||
146624149|NCT00659061|528797439|FG000|Overall Study|Migration due to political unrest|21|||
146624150|NCT00659061|528797440|FG001|Overall Study|Migration due to political unrest|15|||
146624151|NCT00475670|528797446|FG000|Overall Study|Death|0|||
146624152|NCT00475670|528797447|FG001|Overall Study|Death|1|||
146624153|NCT00475670|528797446|FG000|Overall Study|Lack of Efficacy|3|||
146624154|NCT00475670|528797447|FG001|Overall Study|Lack of Efficacy|34|||
146624155|NCT00475670|528797446|FG000|Overall Study|Refused treatment|0|||
146624156|NCT00475670|528797447|FG001|Overall Study|Refused treatment|2|||
146624157|NCT00475670|528797446|FG000|Overall Study|Failure to Return|0|||
146624158|NCT00475670|528797447|FG001|Overall Study|Failure to Return|1|||
146624159|NCT00475670|528797446|FG000|Overall Study|Other|0|||
146624160|NCT00475670|528797447|FG001|Overall Study|Other|3|||
146624161|NCT04949191|528797448|FG000|Overall Study|Non-compliance with Study Drug|1|||
146624162|NCT04949191|528797449|FG001|Overall Study|Non-compliance with Study Drug|0|||
146624163|NCT04949191|528797450|FG002|Overall Study|Non-compliance with Study Drug|0|||
146624164|NCT04949191|528797451|FG003|Overall Study|Non-compliance with Study Drug|0|||
146624165|NCT04949191|528797448|FG000|Overall Study|Progressive Disease|0|||
146624166|NCT04949191|528797449|FG001|Overall Study|Progressive Disease|1|||
146624167|NCT04949191|528797450|FG002|Overall Study|Progressive Disease|0|||
146624168|NCT04949191|528797451|FG003|Overall Study|Progressive Disease|0|||
146624169|NCT04949191|528797448|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
146624170|NCT04949191|528797449|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
146624171|NCT04949191|528797450|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
146624172|NCT04949191|528797451|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
146624173|NCT04949191|528797448|FG000|Overall Study|Sponsor Terminated Study|0|||
146624174|NCT04949191|528797449|FG001|Overall Study|Sponsor Terminated Study|0|||
146624175|NCT04949191|528797450|FG002|Overall Study|Sponsor Terminated Study|1|||
146624176|NCT04949191|528797451|FG003|Overall Study|Sponsor Terminated Study|1|||
146624177|NCT01168349|528797452|FG000|Overall Study|Death|157|||
146624178|NCT01168349|528797452|FG000|Overall Study|Lost to Follow-up|34|||
146624179|NCT01168349|528797452|FG000|Overall Study|Withdrawal by Subject|9|||
146624180|NCT01168349|528797452|FG000|Overall Study|Kidney transplantation|3|||
146624181|NCT01168349|528797452|FG000|Overall Study|Other|22|||
146624182|NCT01168349|528797452|FG000|Overall Study|Protocol Violation|76|||
146624183|NCT02678351|528797453|FG000|Overall Study|Withdrawal by Subject|1|||
146624184|NCT01632020|528797454|FG000|Overall Study|Withdrawal by Subject|1|||
146624185|NCT01632020|528797455|FG001|Overall Study|Withdrawal by Subject|0|||
146624186|NCT01632020|528797454|FG000|Overall Study|Adverse Event|1|||
146624187|NCT01632020|528797455|FG001|Overall Study|Adverse Event|0|||
146624188|NCT02978417|528797456|FG000|Overall Study|Lost to Follow-up|2|||
146624189|NCT02978417|528797457|FG001|Overall Study|Lost to Follow-up|2|||
146624190|NCT03416868|528797467|FG000|Overall Study|Withdrawal by Subject|2|||
146624191|NCT03416868|528797467|FG000|Overall Study|Lost to Follow-up|1|||
146624192|NCT03353675|528797488|FG000|Overall Study|Adverse Event|4|||
146624193|NCT03309020|528797489|FG000|Overall Study|Death|1|||
146624194|NCT03309020|528797490|FG001|Overall Study|Death|0|||
146624195|NCT03309020|528797489|FG000|Overall Study|Did not undergo surgery|2|||
146624196|NCT03309020|528797490|FG001|Overall Study|Did not undergo surgery|1|||
146624197|NCT00402168|528797491|FG000|Randomized|Lost to Follow-up|1|||
146624198|NCT00402168|528797492|FG001|Randomized|Lost to Follow-up|0|||
146624199|NCT00402168|528797491|FG000|Randomized|Withdrawal by Subject|0|||
146624200|NCT00402168|528797492|FG001|Randomized|Withdrawal by Subject|1|||
146624201|NCT00402168|528797491|FG000|Treatment (up to 12 Months)|Death|0|||
146624202|NCT00402168|528797492|FG001|Treatment (up to 12 Months)|Death|1|||
146624203|NCT00402168|528797491|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
146624204|NCT00402168|528797492|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
146624205|NCT00402168|528797491|FG000|Treatment (up to 12 Months)|non-specified|0|||
146624206|NCT00402168|528797492|FG001|Treatment (up to 12 Months)|non-specified|1|||
146624207|NCT00402168|528797491|FG000|Long Term (LT)|Adverse Event|1|||
146624208|NCT00402168|528797492|FG001|Long Term (LT)|Adverse Event|5|||
146624209|NCT00402168|528797491|FG000|Long Term (LT)|Withdrawal by Subject|4|||
146624210|NCT00402168|528797492|FG001|Long Term (LT)|Withdrawal by Subject|7|||
146624211|NCT00402168|528797491|FG000|Long Term (LT)|Pregnancy|0|||
146624212|NCT00402168|528797492|FG001|Long Term (LT)|Pregnancy|1|||
146624213|NCT00402168|528797491|FG000|Long Term (LT)|Lost to Follow-up|1|||
146624214|NCT00402168|528797492|FG001|Long Term (LT)|Lost to Follow-up|0|||
146624215|NCT00402168|528797491|FG000|Long Term (LT)|Death|4|||
146624216|NCT00402168|528797492|FG001|Long Term (LT)|Death|0|||
146624217|NCT00402168|528797491|FG000|Long Term (LT)|Lack of Efficacy|0|||
146624218|NCT00402168|528797492|FG001|Long Term (LT)|Lack of Efficacy|2|||
146624219|NCT00402168|528797491|FG000|Long Term (LT)|non-specified|1|||
146624220|NCT00402168|528797492|FG001|Long Term (LT)|non-specified|2|||
146624221|NCT00402168|528797491|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
146624222|NCT00402168|528797492|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
146624223|NCT00402168|528797491|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
146624224|NCT00402168|528797492|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
146624225|NCT00601835|528797496|FG000|Overall Study|Withdrawal by Subject|9|||
146624226|NCT00601835|528797497|FG001|Overall Study|Withdrawal by Subject|6|||
146624227|NCT00601835|528797496|FG000|Overall Study|Physician Decision|1|||
146624228|NCT00601835|528797497|FG001|Overall Study|Physician Decision|0|||
146624229|NCT00601835|528797496|FG000|Overall Study|Lost to Follow-up|37|||
146624230|NCT00601835|528797497|FG001|Overall Study|Lost to Follow-up|5|||
146624231|NCT00601835|528797496|FG000|Overall Study|Adverse Event|1|||
146624232|NCT00601835|528797497|FG001|Overall Study|Adverse Event|1|||
146624233|NCT00601835|528797496|FG000|Overall Study|Relocate|12|||
146624234|NCT00601835|528797497|FG001|Overall Study|Relocate|2|||
146624235|NCT02370420|528797500|FG000|Overall Study|Physician Decision|3|||
146624236|NCT02370420|528797501|FG001|Overall Study|Physician Decision|3|||
146624237|NCT02370420|528797500|FG000|Overall Study|Lost to Follow-up|11|||
146624238|NCT02370420|528797501|FG001|Overall Study|Lost to Follow-up|9|||
146624239|NCT00880620|528797502|FG000|Overall Study|Adverse Event|4|||
146624240|NCT00880620|528797503|FG001|Overall Study|Adverse Event|5|||
146624241|NCT00880620|528797504|FG002|Overall Study|Adverse Event|15|||
146624242|NCT00880620|528797505|FG003|Overall Study|Adverse Event|15|||
146624243|NCT00880620|528797502|FG000|Overall Study|Death|0|||
146624244|NCT00880620|528797503|FG001|Overall Study|Death|0|||
146624245|NCT00880620|528797504|FG002|Overall Study|Death|1|||
146624246|NCT00880620|528797505|FG003|Overall Study|Death|0|||
146624247|NCT00880620|528797502|FG000|Overall Study|Lack of Efficacy|12|||
146624248|NCT00880620|528797503|FG001|Overall Study|Lack of Efficacy|4|||
146624249|NCT00880620|528797504|FG002|Overall Study|Lack of Efficacy|0|||
146624250|NCT00880620|528797505|FG003|Overall Study|Lack of Efficacy|1|||
146624251|NCT00880620|528797502|FG000|Overall Study|Lost to Follow-up|0|||
146624252|NCT00880620|528797503|FG001|Overall Study|Lost to Follow-up|1|||
146624253|NCT00880620|528797504|FG002|Overall Study|Lost to Follow-up|1|||
146624254|NCT00880620|528797505|FG003|Overall Study|Lost to Follow-up|0|||
146624255|NCT00880620|528797502|FG000|Overall Study|Protocol Violation|0|||
146624256|NCT00880620|528797503|FG001|Overall Study|Protocol Violation|1|||
146624257|NCT00880620|528797504|FG002|Overall Study|Protocol Violation|0|||
146624258|NCT00880620|528797505|FG003|Overall Study|Protocol Violation|2|||
146624259|NCT00880620|528797502|FG000|Overall Study|Withdrawal by Subject|4|||
146624260|NCT00880620|528797503|FG001|Overall Study|Withdrawal by Subject|3|||
146624261|NCT00880620|528797504|FG002|Overall Study|Withdrawal by Subject|1|||
146624262|NCT00880620|528797505|FG003|Overall Study|Withdrawal by Subject|3|||
146624263|NCT00880620|528797502|FG000|Overall Study|Noncompliance|0|||
146624264|NCT00880620|528797503|FG001|Overall Study|Noncompliance|0|||
146624265|NCT00880620|528797504|FG002|Overall Study|Noncompliance|1|||
146624266|NCT00880620|528797505|FG003|Overall Study|Noncompliance|1|||
146624267|NCT00880620|528797502|FG000|Overall Study|Other|1|||
146624268|NCT00880620|528797503|FG001|Overall Study|Other|1|||
146624269|NCT00880620|528797504|FG002|Overall Study|Other|2|||
146624270|NCT00880620|528797505|FG003|Overall Study|Other|2|||
146624271|NCT01400698|528797506|FG000|Overall Study|Lost to Follow-up|2|||
146624272|NCT01400698|528797507|FG001|Overall Study|Lost to Follow-up|5|||
146624273|NCT01400698|528797508|FG002|Overall Study|Lost to Follow-up|2|||
146624274|NCT01400698|528797509|FG003|Overall Study|Lost to Follow-up|1|||
146624275|NCT01400698|528797510|FG004|Overall Study|Lost to Follow-up|4|||
146624276|NCT01400698|528797511|FG005|Overall Study|Lost to Follow-up|3|||
146624277|NCT01400698|528797506|FG000|Overall Study|Withdrawal by Subject|8|||
146624278|NCT01400698|528797507|FG001|Overall Study|Withdrawal by Subject|2|||
146624279|NCT01400698|528797508|FG002|Overall Study|Withdrawal by Subject|0|||
146624280|NCT01400698|528797509|FG003|Overall Study|Withdrawal by Subject|4|||
146624281|NCT01400698|528797510|FG004|Overall Study|Withdrawal by Subject|1|||
146624282|NCT01400698|528797511|FG005|Overall Study|Withdrawal by Subject|3|||
146624283|NCT01400698|528797506|FG000|Overall Study|Protocol Violation|0|||
146624284|NCT01400698|528797507|FG001|Overall Study|Protocol Violation|1|||
146624285|NCT01400698|528797508|FG002|Overall Study|Protocol Violation|0|||
146624286|NCT01400698|528797509|FG003|Overall Study|Protocol Violation|0|||
146624287|NCT01400698|528797510|FG004|Overall Study|Protocol Violation|1|||
146624288|NCT01400698|528797511|FG005|Overall Study|Protocol Violation|0|||
146624289|NCT01400698|528797506|FG000|Overall Study|Non-compliance|0|||
146624290|NCT01400698|528797507|FG001|Overall Study|Non-compliance|1|||
146624291|NCT01400698|528797508|FG002|Overall Study|Non-compliance|0|||
146624292|NCT01400698|528797509|FG003|Overall Study|Non-compliance|1|||
146624293|NCT01400698|528797510|FG004|Overall Study|Non-compliance|0|||
146624294|NCT01400698|528797511|FG005|Overall Study|Non-compliance|0|||
146624295|NCT01400698|528797506|FG000|Overall Study|Adverse Event|1|||
146624296|NCT01400698|528797507|FG001|Overall Study|Adverse Event|0|||
146624297|NCT01400698|528797508|FG002|Overall Study|Adverse Event|0|||
146624298|NCT01400698|528797509|FG003|Overall Study|Adverse Event|0|||
146624299|NCT01400698|528797510|FG004|Overall Study|Adverse Event|0|||
146624300|NCT01400698|528797511|FG005|Overall Study|Adverse Event|0|||
146624301|NCT01400698|528797506|FG000|Overall Study|Other|4|||
146624302|NCT01400698|528797507|FG001|Overall Study|Other|2|||
146624303|NCT01400698|528797508|FG002|Overall Study|Other|0|||
146624304|NCT01400698|528797509|FG003|Overall Study|Other|2|||
146624305|NCT01400698|528797510|FG004|Overall Study|Other|1|||
146624306|NCT01400698|528797511|FG005|Overall Study|Other|0|||
146624307|NCT05316597|528799408|FG000|First Session|Withdrawal by Subject|0|||
146624308|NCT05316597|528799409|FG001|First Session|Withdrawal by Subject|1|||
146624309|NCT05316597|528799408|FG000|Washout Period|Lost to Follow-up|1|||
146624310|NCT05316597|528799409|FG001|Washout Period|Lost to Follow-up|2|||
146624311|NCT05316597|528799408|FG000|Washout Period|Physician Decision|1|||
146624312|NCT05316597|528799409|FG001|Washout Period|Physician Decision|1|||
146624313|NCT05316597|528799408|FG000|Washout Period|Excluded before second session|1|||
146624314|NCT05316597|528799409|FG001|Washout Period|Excluded before second session|1|||
146624315|NCT05316597|528799408|FG000|Washout Period|Withdrawal by Subject|0|||
146624316|NCT05316597|528799409|FG001|Washout Period|Withdrawal by Subject|4|||
146624317|NCT01706458|528799412|FG000|Overall Study|Physician Decision|3|||
146624318|NCT01706458|528799413|FG001|Overall Study|Physician Decision|4|||
146624319|NCT03547518|528799417|FG000|Overall Study|Lost to Follow-up|2|||
146624320|NCT03547518|528799418|FG001|Overall Study|Lost to Follow-up|0|||
146624321|NCT03192176|528799421|FG000|Overall Study|Adverse Event|1|||
146624322|NCT03192176|528799422|FG001|Overall Study|Adverse Event|0|||
146624323|NCT03192176|528799423|FG002|Overall Study|Adverse Event|4|||
146624324|NCT03192176|528799424|FG003|Overall Study|Adverse Event|5|||
146624325|NCT03192176|528799425|FG004|Overall Study|Adverse Event|3|||
146624326|NCT03192176|528799426|FG005|Overall Study|Adverse Event|2|||
146624327|NCT03192176|528799427|FG006|Overall Study|Adverse Event|3|||
146624328|NCT03192176|528799428|FG007|Overall Study|Adverse Event|3|||
146624329|NCT03192176|528799421|FG000|Overall Study|Lost to Follow-up|0|||
146624330|NCT03192176|528799422|FG001|Overall Study|Lost to Follow-up|0|||
146624331|NCT03192176|528799423|FG002|Overall Study|Lost to Follow-up|1|||
146624332|NCT03192176|528799424|FG003|Overall Study|Lost to Follow-up|2|||
146624333|NCT03192176|528799425|FG004|Overall Study|Lost to Follow-up|3|||
146624334|NCT03192176|528799426|FG005|Overall Study|Lost to Follow-up|1|||
146624335|NCT03192176|528799427|FG006|Overall Study|Lost to Follow-up|1|||
146624336|NCT03192176|528799428|FG007|Overall Study|Lost to Follow-up|1|||
146624337|NCT03192176|528799421|FG000|Overall Study|Physician Decision|1|||
146624338|NCT03192176|528799422|FG001|Overall Study|Physician Decision|0|||
146624339|NCT03192176|528799423|FG002|Overall Study|Physician Decision|0|||
146624340|NCT03192176|528799424|FG003|Overall Study|Physician Decision|0|||
146624341|NCT03192176|528799425|FG004|Overall Study|Physician Decision|0|||
146624342|NCT03192176|528799426|FG005|Overall Study|Physician Decision|2|||
146624343|NCT03192176|528799427|FG006|Overall Study|Physician Decision|1|||
146624344|NCT03192176|528799428|FG007|Overall Study|Physician Decision|0|||
146624345|NCT03192176|528799421|FG000|Overall Study|Protocol Deviation|1|||
146624346|NCT03192176|528799422|FG001|Overall Study|Protocol Deviation|1|||
146624347|NCT03192176|528799423|FG002|Overall Study|Protocol Deviation|0|||
146624348|NCT03192176|528799424|FG003|Overall Study|Protocol Deviation|0|||
146624349|NCT03192176|528799425|FG004|Overall Study|Protocol Deviation|2|||
146624350|NCT03192176|528799426|FG005|Overall Study|Protocol Deviation|0|||
146624351|NCT03192176|528799427|FG006|Overall Study|Protocol Deviation|0|||
146624352|NCT03192176|528799428|FG007|Overall Study|Protocol Deviation|0|||
146624353|NCT03192176|528799421|FG000|Overall Study|Withdrawal by Subject|3|||
146624354|NCT03192176|528799422|FG001|Overall Study|Withdrawal by Subject|4|||
146624355|NCT03192176|528799423|FG002|Overall Study|Withdrawal by Subject|0|||
146624356|NCT03192176|528799424|FG003|Overall Study|Withdrawal by Subject|4|||
146624357|NCT03192176|528799425|FG004|Overall Study|Withdrawal by Subject|3|||
146624358|NCT03192176|528799426|FG005|Overall Study|Withdrawal by Subject|4|||
146624359|NCT03192176|528799427|FG006|Overall Study|Withdrawal by Subject|4|||
146624360|NCT03192176|528799428|FG007|Overall Study|Withdrawal by Subject|2|||
146624361|NCT03192176|528799421|FG000|Overall Study|Miscellaneous|1|||
146624362|NCT03192176|528799422|FG001|Overall Study|Miscellaneous|0|||
146624363|NCT03192176|528799423|FG002|Overall Study|Miscellaneous|1|||
146624364|NCT03192176|528799424|FG003|Overall Study|Miscellaneous|1|||
146624365|NCT03192176|528799425|FG004|Overall Study|Miscellaneous|1|||
146624366|NCT03192176|528799426|FG005|Overall Study|Miscellaneous|2|||
146624367|NCT03192176|528799427|FG006|Overall Study|Miscellaneous|0|||
146624368|NCT03192176|528799428|FG007|Overall Study|Miscellaneous|1|||
146624369|NCT02384551|528799431|FG000|Overall Study|Lost to Follow-up|13|||
146624370|NCT02384551|528799432|FG001|Overall Study|Lost to Follow-up|14|||
146624371|NCT02384551|528799433|FG002|Overall Study|Lost to Follow-up|14|||
146624372|NCT02384551|528799434|FG003|Overall Study|Lost to Follow-up|14|||
146624373|NCT04247347|528799439|FG000|Overall Study|Withdrawal by Subject|2|||
146624374|NCT04247347|528799440|FG001|Overall Study|Withdrawal by Subject|3|||
146624375|NCT04247347|528799441|FG002|Overall Study|Withdrawal by Subject|3|||
146624376|NCT04247347|528799439|FG000|Overall Study|Lost to Follow-up|1|||
146624377|NCT04247347|528799440|FG001|Overall Study|Lost to Follow-up|1|||
146624378|NCT04247347|528799441|FG002|Overall Study|Lost to Follow-up|1|||
146624379|NCT03035032|528799442|FG000|Overall Study|Adverse Event|2|||
146624380|NCT03035032|528799442|FG000|Overall Study|Death|9|||
146624381|NCT03035032|528799442|FG000|Overall Study|Lost to Follow-up|1|||
146624382|NCT03035032|528799442|FG000|Overall Study|Progressive Disease|22|||
146624383|NCT03035032|528799442|FG000|Overall Study|Protocol Violation|2|||
146624384|NCT03035032|528799442|FG000|Overall Study|Withdrawal by Subject|2|||
146624385|NCT03035032|528799442|FG000|Overall Study|Physician Decision|5|||
146624386|NCT02399215|528799457|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
146624387|NCT02399215|528799457|FG000|Overall Study|Withdrawal by Subject|1|||
146624388|NCT00772538|528799458|FG000|Overall Study|Adverse Event|6|||
146624389|NCT00772538|528799459|FG001|Overall Study|Adverse Event|6|||
146624390|NCT00772538|528799458|FG000|Overall Study|Protocol Violation|3|||
146624391|NCT00772538|528799459|FG001|Overall Study|Protocol Violation|3|||
146624392|NCT00772538|528799458|FG000|Overall Study|Lost to Follow-up|1|||
146624393|NCT00772538|528799459|FG001|Overall Study|Lost to Follow-up|1|||
146624394|NCT00772538|528799458|FG000|Overall Study|Withdrawal by Subject|3|||
146624395|NCT00772538|528799459|FG001|Overall Study|Withdrawal by Subject|8|||
146624396|NCT00772538|528799458|FG000|Overall Study|Lack of Efficacy|0|||
146624397|NCT00772538|528799459|FG001|Overall Study|Lack of Efficacy|1|||
146624398|NCT00772538|528799458|FG000|Overall Study|Other|7|||
146624399|NCT00772538|528799459|FG001|Overall Study|Other|7|||
146624400|NCT00189540|528799460|FG000|Overall Study|Withdrawal by Subject|3|||
146624401|NCT00189540|528799461|FG001|Overall Study|Withdrawal by Subject|0|||
146624402|NCT00189540|528799460|FG000|Overall Study|Death|4|||
146624403|NCT00189540|528799461|FG001|Overall Study|Death|1|||
146624404|NCT01089504|528799462|FG000|Overall Study|Lost to Follow-up|1|||
146624405|NCT01089504|528799463|FG001|Overall Study|Lost to Follow-up|1|||
146624406|NCT01089504|528799462|FG000|Overall Study|Withdrawal by Subject|2|||
146624407|NCT01089504|528799463|FG001|Overall Study|Withdrawal by Subject|0|||
146624408|NCT00001832|528799464|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
146624409|NCT00001832|528799465|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
146624410|NCT00001832|528799466|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
146624411|NCT00001832|528799467|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
146624412|NCT00001832|528799468|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
146624413|NCT00001832|528799469|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
146624414|NCT00001832|528799470|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
146624415|NCT00001832|528799471|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
146624416|NCT00001832|528799472|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
146624417|NCT00001832|528799473|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
146624418|NCT00001832|528799474|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
146624419|NCT00001832|528799475|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
146624420|NCT00001832|528799476|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
146624421|NCT00001832|528799477|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
146624422|NCT00001832|528799478|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
146624423|NCT00001832|528799464|FG000|Treatment Period|Death during treatment|0|||
146624424|NCT00001832|528799465|FG001|Treatment Period|Death during treatment|0|||
146624425|NCT00001832|528799466|FG002|Treatment Period|Death during treatment|0|||
146624426|NCT00001832|528799467|FG003|Treatment Period|Death during treatment|0|||
146624427|NCT00001832|528799468|FG004|Treatment Period|Death during treatment|0|||
146624428|NCT00001832|528799469|FG005|Treatment Period|Death during treatment|1|||
146624429|NCT00001832|528799470|FG006|Treatment Period|Death during treatment|0|||
146624430|NCT00001832|528799471|FG007|Treatment Period|Death during treatment|0|||
146624431|NCT00001832|528799472|FG008|Treatment Period|Death during treatment|0|||
146624432|NCT00001832|528799473|FG009|Treatment Period|Death during treatment|0|||
146624433|NCT00001832|528799474|FG010|Treatment Period|Death during treatment|0|||
146624434|NCT00001832|528799475|FG011|Treatment Period|Death during treatment|0|||
146624435|NCT00001832|528799476|FG012|Treatment Period|Death during treatment|0|||
146624436|NCT00001832|528799477|FG013|Treatment Period|Death during treatment|0|||
146624437|NCT00001832|528799478|FG014|Treatment Period|Death during treatment|0|||
146624438|NCT00001832|528799464|FG000|Treatment Period|Not treated|0|||
146624439|NCT00001832|528799465|FG001|Treatment Period|Not treated|0|||
146624440|NCT00001832|528799466|FG002|Treatment Period|Not treated|0|||
146624441|NCT00001832|528799467|FG003|Treatment Period|Not treated|0|||
146624442|NCT00001832|528799468|FG004|Treatment Period|Not treated|0|||
146624443|NCT00001832|528799469|FG005|Treatment Period|Not treated|0|||
146624444|NCT00001832|528799470|FG006|Treatment Period|Not treated|0|||
146624445|NCT00001832|528799471|FG007|Treatment Period|Not treated|1|||
146624446|NCT00001832|528799472|FG008|Treatment Period|Not treated|0|||
146624447|NCT00001832|528799473|FG009|Treatment Period|Not treated|0|||
146624448|NCT00001832|528799474|FG010|Treatment Period|Not treated|0|||
146624449|NCT00001832|528799475|FG011|Treatment Period|Not treated|0|||
146624450|NCT00001832|528799476|FG012|Treatment Period|Not treated|0|||
146624451|NCT00001832|528799477|FG013|Treatment Period|Not treated|0|||
146624452|NCT00001832|528799478|FG014|Treatment Period|Not treated|0|||
146624453|NCT00713609|528799479|FG000|Overall Study|Adverse Event|2|||
146624454|NCT00713609|528799480|FG001|Overall Study|Adverse Event|0|||
146624455|NCT00713609|528799481|FG002|Overall Study|Adverse Event|2|||
146624456|NCT00713609|528799482|FG003|Overall Study|Adverse Event|2|||
146624457|NCT00713609|528799483|FG004|Overall Study|Adverse Event|3|||
146624458|NCT00713609|528799484|FG005|Overall Study|Adverse Event|1|||
146624459|NCT00713609|528799479|FG000|Overall Study|Lost to Follow-up|5|||
146624460|NCT00713609|528799480|FG001|Overall Study|Lost to Follow-up|7|||
146624461|NCT00713609|528799481|FG002|Overall Study|Lost to Follow-up|5|||
146624462|NCT00713609|528799482|FG003|Overall Study|Lost to Follow-up|5|||
146624463|NCT00713609|528799483|FG004|Overall Study|Lost to Follow-up|7|||
146624464|NCT00713609|528799484|FG005|Overall Study|Lost to Follow-up|0|||
146624465|NCT00713609|528799479|FG000|Overall Study|Lack of Efficacy|1|||
146624466|NCT00713609|528799480|FG001|Overall Study|Lack of Efficacy|3|||
146624467|NCT00713609|528799481|FG002|Overall Study|Lack of Efficacy|0|||
146624468|NCT00713609|528799482|FG003|Overall Study|Lack of Efficacy|0|||
146624469|NCT00713609|528799483|FG004|Overall Study|Lack of Efficacy|1|||
146624470|NCT00713609|528799484|FG005|Overall Study|Lack of Efficacy|0|||
146624471|NCT00713609|528799479|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
146624472|NCT00713609|528799480|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
146624473|NCT00713609|528799481|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
146624474|NCT00713609|528799482|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
146624475|NCT00713609|528799483|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
146624476|NCT00713609|528799484|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
146624477|NCT00713609|528799479|FG000|Overall Study|Withdrawal by Subject|6|||
146624478|NCT00713609|528799480|FG001|Overall Study|Withdrawal by Subject|1|||
146624479|NCT00713609|528799481|FG002|Overall Study|Withdrawal by Subject|5|||
146624480|NCT00713609|528799482|FG003|Overall Study|Withdrawal by Subject|1|||
146624481|NCT00713609|528799483|FG004|Overall Study|Withdrawal by Subject|5|||
146624482|NCT00713609|528799484|FG005|Overall Study|Withdrawal by Subject|7|||
146624483|NCT00713609|528799479|FG000|Overall Study|Protocol Violation|6|||
146624484|NCT00713609|528799480|FG001|Overall Study|Protocol Violation|3|||
146624485|NCT00713609|528799481|FG002|Overall Study|Protocol Violation|1|||
146624486|NCT00713609|528799482|FG003|Overall Study|Protocol Violation|1|||
146624487|NCT00713609|528799483|FG004|Overall Study|Protocol Violation|2|||
146624488|NCT00713609|528799484|FG005|Overall Study|Protocol Violation|0|||
146624489|NCT01903356|528799485|FG000|Overall Study|Lost to Follow-up|7|||
146624490|NCT01903356|528799485|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
146624491|NCT01903356|528799485|FG000|Overall Study|Violated the dosage and administration|3|||
146624492|NCT03988400|528799491|FG000|Overall Study|Adverse Event|1|||
146624493|NCT03988400|528799492|FG001|Overall Study|Adverse Event|0|||
146650220|NCT01258998|528896680|FG000|Overall Study|Ineligible|1|||
146624494|NCT03988400|528799491|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
146624495|NCT03988400|528799492|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
146624496|NCT03988400|528799491|FG000|Overall Study|Lost to Follow-up|0|||
146624497|NCT03988400|528799492|FG001|Overall Study|Lost to Follow-up|1|||
146624498|NCT02542865|528799494|FG000|Overall Study|Identified as screen failure|1|||
146624499|NCT02542865|528799495|FG001|Overall Study|Identified as screen failure|0|||
146624500|NCT02542865|528799494|FG000|Overall Study|Withdrawal by Subject|16|||
146624501|NCT02542865|528799495|FG001|Overall Study|Withdrawal by Subject|0|||
146624502|NCT03582215|528799496|FG000|Overall Study|Adverse Event|1|||
146624503|NCT03582215|528799497|FG001|Overall Study|Adverse Event|0|||
146624504|NCT03582215|528799498|FG002|Overall Study|Adverse Event|0|||
146624505|NCT03582215|528799499|FG003|Overall Study|Adverse Event|0|||
146624506|NCT03582215|528799500|FG004|Overall Study|Adverse Event|0|||
146624507|NCT03582215|528799501|FG005|Overall Study|Adverse Event|0|||
146624508|NCT03582215|528799502|FG006|Overall Study|Adverse Event|2|||
146624509|NCT03582215|528799503|FG007|Overall Study|Adverse Event|2|||
146624510|NCT04913610|528799504|FG000|Randomized Participants|Did Not Receive Treatment|0|||
146624511|NCT04913610|528799505|FG001|Randomized Participants|Did Not Receive Treatment|0|||
146624512|NCT04913610|528799506|FG002|Randomized Participants|Did Not Receive Treatment|1|||
146624513|NCT04913610|528799507|FG003|Randomized Participants|Did Not Receive Treatment|1|||
146624514|NCT04913610|528799508|FG004|Randomized Participants|Did Not Receive Treatment|0|||
146624515|NCT04913610|528799504|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
146624516|NCT04913610|528799505|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
146624517|NCT04913610|528799506|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
146624518|NCT04913610|528799507|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
146624519|NCT04913610|528799508|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
146624520|NCT03186209|528799511|FG000|Overall Study|Withdrawal by Subject|11|||
146624521|NCT03186209|528799512|FG001|Overall Study|Withdrawal by Subject|22|||
146624522|NCT03186209|528799511|FG000|Overall Study|Pregnancy|1|||
146624523|NCT03186209|528799512|FG001|Overall Study|Pregnancy|0|||
146624524|NCT03186209|528799511|FG000|Overall Study|Adverse Event|4|||
146624525|NCT03186209|528799512|FG001|Overall Study|Adverse Event|0|||
146624526|NCT03186209|528799511|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
146624527|NCT03186209|528799512|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
146624528|NCT03186209|528799511|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
146624529|NCT03186209|528799512|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
146624530|NCT03186209|528799511|FG000|Overall Study|Fail to meet randomization criteria|0|||
146624531|NCT03186209|528799512|FG001|Overall Study|Fail to meet randomization criteria|1|||
146624532|NCT03186209|528799511|FG000|Overall Study|Lost to Follow-up|0|||
146624533|NCT03186209|528799512|FG001|Overall Study|Lost to Follow-up|1|||
146624534|NCT01277744|528799513|FG000|Overall Study|Physician Decision|2|||
146624535|NCT01791244|528799514|FG000|Overall Study|Adverse Event|5|||
146624536|NCT01791244|528799515|FG001|Overall Study|Adverse Event|7|||
146624537|NCT01791244|528799514|FG000|Overall Study|Insufficient clinical response|10|||
146624538|NCT01791244|528799515|FG001|Overall Study|Insufficient clinical response|10|||
146624539|NCT01791244|528799514|FG000|Overall Study|Laboratory Abnormality|0|||
146624540|NCT01791244|528799515|FG001|Overall Study|Laboratory Abnormality|1|||
146624541|NCT02240485|528799520|FG000|3 Months Post-admission|Lost to Follow-up|1|||
146624542|NCT02240485|528799521|FG001|3 Months Post-admission|Lost to Follow-up|5|||
146624543|NCT02240485|528799520|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
146624544|NCT02240485|528799521|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
146624545|NCT02240485|528799520|FG000|9 Months Post-admission|Lost to Follow-up|3|||
146624546|NCT02240485|528799521|FG001|9 Months Post-admission|Lost to Follow-up|1|||
146624547|NCT02240485|528799520|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
146624548|NCT02240485|528799521|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
146624549|NCT02240485|528799520|FG000|18 Months Post-admission|Lost to Follow-up|1|||
146624550|NCT02240485|528799521|FG001|18 Months Post-admission|Lost to Follow-up|1|||
146624551|NCT02240485|528799520|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
146624552|NCT02240485|528799521|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
146624553|NCT00953667|528799522|FG000|Overall Study|Lost to Follow-up|11|||
146624554|NCT00953667|528799522|FG000|Overall Study|Physician Decision|35|||
146624555|NCT00953667|528799522|FG000|Overall Study|Withdrawal by Subject|63|||
146624556|NCT00953667|528799522|FG000|Overall Study|Adverse Event|10|||
146624557|NCT00953667|528799522|FG000|Overall Study|poor venous access,unable to draw blood|4|||
146624558|NCT04038359|528799523|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
146624559|NCT04038359|528799524|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
146624560|NCT04038359|528799523|FG000|Overall Study|Death|8|||
146624561|NCT04038359|528799524|FG001|Overall Study|Death|7|||
146624562|NCT04038359|528799523|FG000|Overall Study|Lost to Follow-up|3|||
146624563|NCT04038359|528799524|FG001|Overall Study|Lost to Follow-up|0|||
146624564|NCT04038359|528799523|FG000|Overall Study|Participant Moved|1|||
146624565|NCT04038359|528799524|FG001|Overall Study|Participant Moved|0|||
146624566|NCT04038359|528799523|FG000|Overall Study|Withdrawal by Subject|4|||
146624567|NCT04038359|528799524|FG001|Overall Study|Withdrawal by Subject|3|||
146624568|NCT04038359|528799523|FG000|Overall Study|Physician Decision|3|||
146624569|NCT04038359|528799524|FG001|Overall Study|Physician Decision|2|||
146624570|NCT04038359|528799523|FG000|Overall Study|Adverse Event|0|||
146624571|NCT04038359|528799524|FG001|Overall Study|Adverse Event|2|||
146624572|NCT04038359|528799523|FG000|Overall Study|Progressive Disease|0|||
146624573|NCT04038359|528799524|FG001|Overall Study|Progressive Disease|1|||
146624574|NCT05468814|528799525|FG000|Overall Study|Lost to Follow-up|5|||
146624575|NCT05468814|528799526|FG001|Overall Study|Lost to Follow-up|6|||
146624576|NCT04716426|528799530|FG000|Overall Study|Vaccination|1|||
146624577|NCT04716426|528799531|FG001|Overall Study|Vaccination|1|||
146624578|NCT04716426|528799530|FG000|Overall Study|Contamination|1|||
146624579|NCT04716426|528799531|FG001|Overall Study|Contamination|0|||
146624580|NCT01046565|528799534|FG000|Overall Study|Adverse Event|2|||
146624581|NCT01046565|528799534|FG000|Overall Study|Withdrawal by Subject|7|||
146624582|NCT01650558|528799535|FG000|Overall Study|Migration out of study area|61|||
146624583|NCT01650558|528799536|FG001|Overall Study|Migration out of study area|71|||
146624584|NCT01650558|528799537|FG002|Overall Study|Migration out of study area|56|||
146624585|NCT01650558|528799535|FG000|Overall Study|Lost to Follow-up|10|||
146624586|NCT01650558|528799536|FG001|Overall Study|Lost to Follow-up|13|||
146624587|NCT01650558|528799537|FG002|Overall Study|Lost to Follow-up|6|||
146624588|NCT01650558|528799535|FG000|Overall Study|Death|10|||
146624589|NCT01650558|528799536|FG001|Overall Study|Death|6|||
146624590|NCT01650558|528799537|FG002|Overall Study|Death|8|||
146624591|NCT01650558|528799535|FG000|Overall Study|Withdrawal by Subject|1|||
146624592|NCT01650558|528799536|FG001|Overall Study|Withdrawal by Subject|1|||
146624593|NCT01650558|528799537|FG002|Overall Study|Withdrawal by Subject|3|||
146624594|NCT01650558|528799535|FG000|Overall Study|Non-compliant participant|1|||
146624595|NCT01650558|528799536|FG001|Overall Study|Non-compliant participant|0|||
146624596|NCT01650558|528799537|FG002|Overall Study|Non-compliant participant|2|||
146624597|NCT01650558|528799535|FG000|Overall Study|Physician Decision|0|||
146624598|NCT01650558|528799536|FG001|Overall Study|Physician Decision|1|||
146624599|NCT01650558|528799537|FG002|Overall Study|Physician Decision|0|||
146624600|NCT02960217|528799538|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
146624601|NCT02960217|528799539|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
146624602|NCT02960217|528799538|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
146624603|NCT02960217|528799539|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
146624604|NCT02960217|528799538|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
146624605|NCT02960217|528799539|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
146624606|NCT02960217|528799538|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
146624607|NCT02960217|528799539|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
146624608|NCT02960217|528799538|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
146624609|NCT02960217|528799539|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
146624610|NCT02960217|528799538|FG000|Open-Label Extension Phase|Adverse Event|1|||
146624611|NCT02960217|528799539|FG001|Open-Label Extension Phase|Adverse Event|0|||
146624612|NCT02960217|528799538|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
146624613|NCT02960217|528799539|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
146624614|NCT02960217|528799538|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
146624615|NCT02960217|528799539|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
146624616|NCT02960217|528799538|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
146624617|NCT02960217|528799539|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
146624618|NCT01069484|528799540|FG000|Overall Study|Death-in-near-family|1|||
146624619|NCT01069484|528799541|FG001|Overall Study|Death-in-near-family|0|||
146624620|NCT01069484|528799540|FG000|Overall Study|No specific reason|8|||
146624621|NCT01069484|528799541|FG001|Overall Study|No specific reason|2|||
146624622|NCT01069484|528799540|FG000|Overall Study|Illness mother or child|3|||
146624623|NCT01069484|528799541|FG001|Overall Study|Illness mother or child|1|||
146624624|NCT05083351|528799547|FG000|Overall Study|Adverse Event|3|||
146624625|NCT05083351|528799547|FG000|Overall Study|Did not meet data inclusion criteria|8|||
146624626|NCT05083351|528799547|FG000|Overall Study|Did not meet eligibility criteria|19|||
146624627|NCT05083351|528799547|FG000|Overall Study|Study Staff Decision|19|||
146624628|NCT00083889|528799550|FG000|Overall Study|Adverse Event|76|||
146624629|NCT00083889|528799551|FG001|Overall Study|Adverse Event|86|||
146624630|NCT00083889|528799550|FG000|Overall Study|Protocol Violation|2|||
146624631|NCT00083889|528799551|FG001|Overall Study|Protocol Violation|2|||
146624632|NCT00083889|528799550|FG000|Overall Study|Withdrawal by Subject|22|||
146624633|NCT00083889|528799551|FG001|Overall Study|Withdrawal by Subject|24|||
146624634|NCT00083889|528799550|FG000|Overall Study|Lack of Efficacy|240|||
146624635|NCT00083889|528799551|FG001|Overall Study|Lack of Efficacy|219|||
146624636|NCT00083889|528799550|FG000|Overall Study|Decision of sponsor|32|||
146624637|NCT00083889|528799551|FG001|Overall Study|Decision of sponsor|4|||
146624638|NCT00083889|528799550|FG000|Overall Study|Randomized: did not take study drug|0|||
146624639|NCT00083889|528799551|FG001|Overall Study|Randomized: did not take study drug|15|||
146624640|NCT00083889|528799550|FG000|Overall Study|Completed on marketed sunitinub|3|||
146624641|NCT00083889|528799551|FG001|Overall Study|Completed on marketed sunitinub|0|||
146624642|NCT00083889|528799550|FG000|Overall Study|Crossover to SU011248|0|||
146624643|NCT00083889|528799551|FG001|Overall Study|Crossover to SU011248|25|||
146624644|NCT00960375|528799552|FG000|Overall Study|Lost to Follow-up|20|||
146624645|NCT00960375|528799553|FG001|Overall Study|Lost to Follow-up|22|||
146624646|NCT03624881|528799554|FG000|Overall Study|Screen Failure|14|||
146624647|NCT03624881|528799555|FG001|Overall Study|Screen Failure|0|||
146624648|NCT03624881|528799554|FG000|Overall Study|No Catheter Inserted|6|||
146624649|NCT03624881|528799555|FG001|Overall Study|No Catheter Inserted|1|||
146624650|NCT03624881|528799554|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
146624651|NCT03624881|528799555|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
146624652|NCT03624881|528799554|FG000|Overall Study|Death|2|||
146624653|NCT03624881|528799555|FG001|Overall Study|Death|0|||
146624654|NCT03624881|528799554|FG000|Overall Study|Lost to Follow-up|10|||
146624655|NCT03624881|528799555|FG001|Overall Study|Lost to Follow-up|4|||
146624656|NCT03624881|528799554|FG000|Overall Study|Withdrawal by Subject|12|||
146624657|NCT03624881|528799555|FG001|Overall Study|Withdrawal by Subject|1|||
146624658|NCT03019406|528799556|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
146624659|NCT03019406|528799557|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
146624660|NCT03019406|528799558|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
146624661|NCT03019406|528799559|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
146624662|NCT03668873|528799560|FG000|Overall Study|Lost to Follow-up|6|||
146624663|NCT03668873|528799561|FG001|Overall Study|Lost to Follow-up|3|||
146624664|NCT00849940|528799571|FG000|Overall Study|Physician Decision|4|||
146624665|NCT04258423|528799572|FG000|Overall Study|Study Closure|2|||
146624666|NCT04258423|528799573|FG001|Overall Study|Study Closure|2|||
146624667|NCT01601535|528799576|FG000|Phase 1|Adverse Event|1|||
146624668|NCT01601535|528799577|FG001|Phase 1|Adverse Event|0|||
146624669|NCT01601535|528799578|FG002|Phase 1|Adverse Event|2|||
146624670|NCT01601535|528799579|FG003|Phase 1|Adverse Event|1|||
146624671|NCT01601535|528799580|FG004|Phase 1|Adverse Event|0|||
146624672|NCT01601535|528799581|FG005|Phase 1|Adverse Event|0|||
146624673|NCT01601535|528799576|FG000|Phase 1|Withdrawal by Subject|2|||
146624674|NCT01601535|528799577|FG001|Phase 1|Withdrawal by Subject|1|||
146624675|NCT01601535|528799578|FG002|Phase 1|Withdrawal by Subject|1|||
146624676|NCT01601535|528799579|FG003|Phase 1|Withdrawal by Subject|2|||
146624677|NCT01601535|528799580|FG004|Phase 1|Withdrawal by Subject|0|||
146624678|NCT01601535|528799581|FG005|Phase 1|Withdrawal by Subject|0|||
146624679|NCT01601535|528799576|FG000|Phase 1|Progressive Disease|2|||
146624680|NCT01601535|528799577|FG001|Phase 1|Progressive Disease|3|||
146624681|NCT01601535|528799578|FG002|Phase 1|Progressive Disease|2|||
146624682|NCT01601535|528799579|FG003|Phase 1|Progressive Disease|1|||
146624683|NCT01601535|528799580|FG004|Phase 1|Progressive Disease|0|||
146624684|NCT01601535|528799581|FG005|Phase 1|Progressive Disease|0|||
146624685|NCT01601535|528799576|FG000|Phase 1|Started Another Treatment|1|||
146624686|NCT01601535|528799577|FG001|Phase 1|Started Another Treatment|2|||
146624687|NCT01601535|528799578|FG002|Phase 1|Started Another Treatment|0|||
146624688|NCT01601535|528799579|FG003|Phase 1|Started Another Treatment|0|||
146624689|NCT01601535|528799580|FG004|Phase 1|Started Another Treatment|0|||
146624690|NCT01601535|528799581|FG005|Phase 1|Started Another Treatment|0|||
146624691|NCT01601535|528799576|FG000|Phase 2|Adverse Event|0|||
146624692|NCT01601535|528799577|FG001|Phase 2|Adverse Event|0|||
146624693|NCT01601535|528799578|FG002|Phase 2|Adverse Event|0|||
146624694|NCT01601535|528799579|FG003|Phase 2|Adverse Event|0|||
146624695|NCT01601535|528799580|FG004|Phase 2|Adverse Event|5|||
146624696|NCT01601535|528799581|FG005|Phase 2|Adverse Event|1|||
146624697|NCT01601535|528799576|FG000|Phase 2|Withdrawal by Subject|0|||
146624698|NCT01601535|528799577|FG001|Phase 2|Withdrawal by Subject|0|||
146624699|NCT01601535|528799578|FG002|Phase 2|Withdrawal by Subject|0|||
146624700|NCT01601535|528799579|FG003|Phase 2|Withdrawal by Subject|0|||
146624701|NCT01601535|528799580|FG004|Phase 2|Withdrawal by Subject|8|||
146624702|NCT01601535|528799581|FG005|Phase 2|Withdrawal by Subject|2|||
146624703|NCT01601535|528799576|FG000|Phase 2|Progressive Disease|0|||
146624704|NCT01601535|528799577|FG001|Phase 2|Progressive Disease|0|||
146624705|NCT01601535|528799578|FG002|Phase 2|Progressive Disease|0|||
146624706|NCT01601535|528799579|FG003|Phase 2|Progressive Disease|0|||
146624707|NCT01601535|528799580|FG004|Phase 2|Progressive Disease|5|||
146624708|NCT01601535|528799581|FG005|Phase 2|Progressive Disease|7|||
146624709|NCT01601535|528799576|FG000|Phase 2|Started Another Treatment|0|||
146624710|NCT01601535|528799577|FG001|Phase 2|Started Another Treatment|0|||
146624711|NCT01601535|528799578|FG002|Phase 2|Started Another Treatment|0|||
146624712|NCT01601535|528799579|FG003|Phase 2|Started Another Treatment|0|||
146624713|NCT01601535|528799580|FG004|Phase 2|Started Another Treatment|1|||
146624714|NCT01601535|528799581|FG005|Phase 2|Started Another Treatment|2|||
146624715|NCT04199351|528801451|FG000|Overall Study|Decision by sponsor|0|||
146624716|NCT04199351|528801452|FG001|Overall Study|Decision by sponsor|0|||
146624717|NCT04199351|528801453|FG002|Overall Study|Decision by sponsor|0|||
146624718|NCT04199351|528801454|FG003|Overall Study|Decision by sponsor|2|||
146624719|NCT04199351|528801455|FG004|Overall Study|Decision by sponsor|0|||
146624720|NCT04199351|528801456|FG005|Overall Study|Decision by sponsor|0|||
146624721|NCT04199351|528801457|FG006|Overall Study|Decision by sponsor|0|||
146624722|NCT04199351|528801458|FG007|Overall Study|Decision by sponsor|0|||
146624723|NCT04199351|528801459|FG008|Overall Study|Decision by sponsor|0|||
146624724|NCT04199351|528801460|FG009|Overall Study|Decision by sponsor|6|||
146624725|NCT04199351|528801451|FG000|Overall Study|Lost to Follow-up|0|||
146624726|NCT04199351|528801452|FG001|Overall Study|Lost to Follow-up|0|||
146624727|NCT04199351|528801453|FG002|Overall Study|Lost to Follow-up|1|||
146624728|NCT04199351|528801454|FG003|Overall Study|Lost to Follow-up|0|||
146624729|NCT04199351|528801455|FG004|Overall Study|Lost to Follow-up|0|||
146624730|NCT04199351|528801456|FG005|Overall Study|Lost to Follow-up|1|||
146624731|NCT04199351|528801457|FG006|Overall Study|Lost to Follow-up|0|||
146624732|NCT04199351|528801458|FG007|Overall Study|Lost to Follow-up|0|||
146624733|NCT04199351|528801459|FG008|Overall Study|Lost to Follow-up|0|||
146624734|NCT04199351|528801460|FG009|Overall Study|Lost to Follow-up|0|||
146624735|NCT04199351|528801451|FG000|Overall Study|Withdrawal by Subject|0|||
146624736|NCT04199351|528801452|FG001|Overall Study|Withdrawal by Subject|1|||
146624737|NCT04199351|528801453|FG002|Overall Study|Withdrawal by Subject|0|||
146624738|NCT04199351|528801454|FG003|Overall Study|Withdrawal by Subject|0|||
146624739|NCT04199351|528801455|FG004|Overall Study|Withdrawal by Subject|1|||
146624740|NCT04199351|528801456|FG005|Overall Study|Withdrawal by Subject|4|||
146624741|NCT04199351|528801457|FG006|Overall Study|Withdrawal by Subject|2|||
146624742|NCT04199351|528801458|FG007|Overall Study|Withdrawal by Subject|0|||
146624743|NCT04199351|528801459|FG008|Overall Study|Withdrawal by Subject|3|||
146624744|NCT04199351|528801460|FG009|Overall Study|Withdrawal by Subject|0|||
146624745|NCT03623243|528801461|FG000|Overall Study|Adverse Event|15|||
146624746|NCT03623243|528801461|FG000|Overall Study|Guardian Decision|1|||
146624747|NCT03623243|528801461|FG000|Overall Study|New Therapy for Study Indication|1|||
146624748|NCT03623243|528801461|FG000|Overall Study|Protocol Deviation|3|||
146624749|NCT03623243|528801461|FG000|Overall Study|Physician Decision|4|||
146624750|NCT03623243|528801461|FG000|Overall Study|Patient Decision|15|||
146624751|NCT03007966|528801462|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
146624752|NCT03007966|528801463|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
146624753|NCT00474487|528801467|FG000|Overall Study|Withdrawal by Subject|6|||
146624754|NCT00474487|528801468|FG001|Overall Study|Withdrawal by Subject|0|||
146624755|NCT00474487|528801469|FG002|Overall Study|Withdrawal by Subject|0|||
146624756|NCT00474487|528801470|FG003|Overall Study|Withdrawal by Subject|0|||
146624757|NCT00474487|528801467|FG000|Overall Study|Lost to Follow-up|20|||
146624758|NCT00474487|528801468|FG001|Overall Study|Lost to Follow-up|1|||
146624759|NCT00474487|528801469|FG002|Overall Study|Lost to Follow-up|7|||
146624760|NCT00474487|528801470|FG003|Overall Study|Lost to Follow-up|0|||
146624761|NCT00474487|528801467|FG000|Overall Study|Inappropriate enrollment|4|||
146624762|NCT00474487|528801468|FG001|Overall Study|Inappropriate enrollment|0|||
146624763|NCT00474487|528801469|FG002|Overall Study|Inappropriate enrollment|7|||
146624764|NCT00474487|528801470|FG003|Overall Study|Inappropriate enrollment|0|||
146624765|NCT00474487|528801467|FG000|Overall Study|Death|0|||
146624766|NCT00474487|528801468|FG001|Overall Study|Death|1|||
146624767|NCT00474487|528801469|FG002|Overall Study|Death|0|||
146624768|NCT00474487|528801470|FG003|Overall Study|Death|0|||
146624769|NCT01428258|528801471|FG000|Intervention 1|Withdrawal by Subject|2|||
146624770|NCT01428258|528801472|FG001|Intervention 1|Withdrawal by Subject|0|||
146624771|NCT00419393|528801473|FG000|Overall Study|Adverse Event|5|||
146624772|NCT00419393|528801473|FG000|Overall Study|Protocol Violation|5|||
146624773|NCT00419393|528801473|FG000|Overall Study|Withdrawal by Subject|7|||
146624774|NCT00419393|528801473|FG000|Overall Study|Other: Sponsor request|3|||
146624775|NCT00419393|528801473|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
146624776|NCT00419393|528801473|FG000|Overall Study|Other: Site closure|1|||
146624777|NCT00419393|528801473|FG000|Overall Study|Other: Other health problems|1|||
146624778|NCT00419393|528801473|FG000|Overall Study|Other: Investigator decision|1|||
146624779|NCT00979901|528801474|FG000|Overall Study|Adverse Event|1|||
146624780|NCT00979901|528801475|FG001|Overall Study|Adverse Event|3|||
146624781|NCT00979901|528801476|FG002|Overall Study|Adverse Event|9|||
146624782|NCT00979901|528801477|FG003|Overall Study|Adverse Event|2|||
146624783|NCT00979901|528801474|FG000|Overall Study|Lack of Efficacy|8|||
146624784|NCT00979901|528801475|FG001|Overall Study|Lack of Efficacy|4|||
146624785|NCT00979901|528801476|FG002|Overall Study|Lack of Efficacy|9|||
146624786|NCT00979901|528801477|FG003|Overall Study|Lack of Efficacy|0|||
146624787|NCT00979901|528801474|FG000|Overall Study|Lost to Follow-up|1|||
146624788|NCT00979901|528801475|FG001|Overall Study|Lost to Follow-up|1|||
146624789|NCT00979901|528801476|FG002|Overall Study|Lost to Follow-up|2|||
146624790|NCT00979901|528801477|FG003|Overall Study|Lost to Follow-up|0|||
146624791|NCT00979901|528801474|FG000|Overall Study|Protocol Violation|2|||
146624792|NCT00979901|528801475|FG001|Overall Study|Protocol Violation|2|||
146624793|NCT00979901|528801476|FG002|Overall Study|Protocol Violation|7|||
146624794|NCT00979901|528801477|FG003|Overall Study|Protocol Violation|1|||
146624795|NCT00979901|528801474|FG000|Overall Study|Withdrawal by Subject|2|||
146624796|NCT00979901|528801475|FG001|Overall Study|Withdrawal by Subject|1|||
146624797|NCT00979901|528801476|FG002|Overall Study|Withdrawal by Subject|1|||
146624798|NCT00979901|528801477|FG003|Overall Study|Withdrawal by Subject|1|||
146624799|NCT00979901|528801474|FG000|Overall Study|Noncompliance|1|||
146624800|NCT00979901|528801475|FG001|Overall Study|Noncompliance|0|||
146624801|NCT00979901|528801476|FG002|Overall Study|Noncompliance|0|||
146624802|NCT00979901|528801477|FG003|Overall Study|Noncompliance|0|||
146624803|NCT00979901|528801474|FG000|Overall Study|out-of-state|1|||
146624804|NCT00979901|528801475|FG001|Overall Study|out-of-state|0|||
146624805|NCT00979901|528801476|FG002|Overall Study|out-of-state|0|||
146624806|NCT00979901|528801477|FG003|Overall Study|out-of-state|0|||
146624807|NCT00979901|528801474|FG000|Overall Study|vacation|1|||
146624808|NCT00979901|528801475|FG001|Overall Study|vacation|0|||
146624809|NCT00979901|528801476|FG002|Overall Study|vacation|0|||
146624810|NCT00979901|528801477|FG003|Overall Study|vacation|0|||
146624811|NCT00979901|528801474|FG000|Overall Study|elevated lab values pre-randomization|1|||
146624812|NCT00979901|528801475|FG001|Overall Study|elevated lab values pre-randomization|0|||
146624813|NCT00979901|528801476|FG002|Overall Study|elevated lab values pre-randomization|0|||
146624814|NCT00979901|528801477|FG003|Overall Study|elevated lab values pre-randomization|0|||
146624815|NCT00979901|528801474|FG000|Overall Study|Discontinued in Error|0|||
146624816|NCT00979901|528801475|FG001|Overall Study|Discontinued in Error|1|||
146624817|NCT00979901|528801476|FG002|Overall Study|Discontinued in Error|0|||
146624818|NCT00979901|528801477|FG003|Overall Study|Discontinued in Error|0|||
146624819|NCT00979901|528801474|FG000|Overall Study|Left Country|0|||
146624820|NCT00979901|528801475|FG001|Overall Study|Left Country|0|||
146624821|NCT00979901|528801476|FG002|Overall Study|Left Country|1|||
146624822|NCT00979901|528801477|FG003|Overall Study|Left Country|0|||
146624823|NCT00979901|528801474|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
146624824|NCT00979901|528801475|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
146624825|NCT00979901|528801476|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
146624826|NCT00979901|528801477|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
146624827|NCT02814916|528801482|FG000|Overall Study|Withdrawal of consent|0|||
146624828|NCT02814916|528801483|FG001|Overall Study|Withdrawal of consent|2|||
146624829|NCT02814916|528801484|FG002|Overall Study|Withdrawal of consent|0|||
146624830|NCT02814916|528801482|FG000|Overall Study|Lost to Follow-up|0|||
146624831|NCT02814916|528801483|FG001|Overall Study|Lost to Follow-up|1|||
146624832|NCT02814916|528801484|FG002|Overall Study|Lost to Follow-up|0|||
146624833|NCT02814916|528801482|FG000|Overall Study|Other, not specified|0|||
146624834|NCT02814916|528801483|FG001|Overall Study|Other, not specified|1|||
146624835|NCT02814916|528801484|FG002|Overall Study|Other, not specified|0|||
146624836|NCT05543265|528801486|FG000|Overall Study|Lost to Follow-up|3|||
146624837|NCT05543265|528801487|FG001|Overall Study|Lost to Follow-up|3|||
146624838|NCT05543265|528801486|FG000|Overall Study|Withdrawal by Subject|0|||
146624839|NCT05543265|528801487|FG001|Overall Study|Withdrawal by Subject|1|||
146624840|NCT02953652|528801490|FG000|Overall Study|Adverse Event|18|||
146624841|NCT02953652|528801490|FG000|Overall Study|Withdrawal by Subject|6|||
146624842|NCT02953652|528801490|FG000|Overall Study|Protocol Violation|1|||
146624843|NCT02953652|528801490|FG000|Overall Study|Disease Progression|27|||
146624844|NCT02927301|528801491|FG000|Overall Study|Death|39|||
146624845|NCT02927301|528801491|FG000|Overall Study|Lost to Follow-up|8|||
146624846|NCT02927301|528801491|FG000|Overall Study|Physician Decision|2|||
146624847|NCT02927301|528801491|FG000|Overall Study|Withdrawal by Subject|12|||
146624848|NCT02927301|528801491|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
146624849|NCT04742556|528801492|FG000|Overall Study|Withdrawal by Subject|0|||
146624850|NCT04742556|528801493|FG001|Overall Study|Withdrawal by Subject|1|||
146624851|NCT04742556|528801494|FG002|Overall Study|Withdrawal by Subject|0|||
146624852|NCT04742556|528801492|FG000|Overall Study|Adverse Event|0|||
146624853|NCT04742556|528801493|FG001|Overall Study|Adverse Event|0|||
146624854|NCT04742556|528801494|FG002|Overall Study|Adverse Event|2|||
146624855|NCT04742556|528801492|FG000|Overall Study|Clinical disease progression|0|||
146624856|NCT04742556|528801493|FG001|Overall Study|Clinical disease progression|1|||
146624857|NCT04742556|528801494|FG002|Overall Study|Clinical disease progression|2|||
146624858|NCT04742556|528801492|FG000|Overall Study|Objective disease progression|3|||
146624859|NCT04742556|528801493|FG001|Overall Study|Objective disease progression|2|||
146624860|NCT04742556|528801494|FG002|Overall Study|Objective disease progression|4|||
146624861|NCT03305666|528801495|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
146624862|NCT03305666|528801496|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
146624863|NCT02546609|528801498|FG000|Overall Study|Withdrawal by Subject|0|||
146624864|NCT02546609|528801499|FG001|Overall Study|Withdrawal by Subject|1|||
146624865|NCT02546609|528801500|FG002|Overall Study|Withdrawal by Subject|2|||
146624866|NCT02546609|528801498|FG000|Overall Study|Adverse Event|0|||
146624867|NCT02546609|528801499|FG001|Overall Study|Adverse Event|6|||
146624868|NCT02546609|528801500|FG002|Overall Study|Adverse Event|1|||
146624869|NCT02546609|528801498|FG000|Overall Study|Protocol Violation|0|||
146624870|NCT02546609|528801499|FG001|Overall Study|Protocol Violation|1|||
146624871|NCT02546609|528801500|FG002|Overall Study|Protocol Violation|1|||
146624872|NCT02546609|528801498|FG000|Overall Study|Lost to Follow-up|2|||
146624873|NCT02546609|528801499|FG001|Overall Study|Lost to Follow-up|3|||
146624874|NCT02546609|528801500|FG002|Overall Study|Lost to Follow-up|1|||
146624875|NCT02546609|528801498|FG000|Overall Study|travel or work schedule restriction|0|||
146624876|NCT02546609|528801499|FG001|Overall Study|travel or work schedule restriction|0|||
146624877|NCT02546609|528801500|FG002|Overall Study|travel or work schedule restriction|2|||
146624878|NCT03780452|528801505|FG000|Overall Study|Screening failure|2|||
146624879|NCT00914849|528801506|FG000|Overall Study|Withdrawal by Subject|1|||
146624880|NCT00914849|528801507|FG001|Overall Study|Withdrawal by Subject|0|||
146624881|NCT00914849|528801506|FG000|Overall Study|Not eligible|0|||
146624882|NCT00914849|528801507|FG001|Overall Study|Not eligible|1|||
146624883|NCT01001221|528801510|FG000|Overall Study|Adverse Event|1|||
146624884|NCT01001221|528801511|FG001|Overall Study|Adverse Event|2|||
146624885|NCT01001221|528801512|FG002|Overall Study|Adverse Event|0|||
146624886|NCT01001221|528801513|FG003|Overall Study|Adverse Event|2|||
146624887|NCT01001221|528801514|FG004|Overall Study|Adverse Event|0|||
146624888|NCT01001221|528801510|FG000|Overall Study|Disease progression|3|||
146624889|NCT01001221|528801511|FG001|Overall Study|Disease progression|2|||
146624890|NCT01001221|528801512|FG002|Overall Study|Disease progression|2|||
146624891|NCT01001221|528801513|FG003|Overall Study|Disease progression|4|||
146624892|NCT01001221|528801514|FG004|Overall Study|Disease progression|0|||
146624893|NCT01001221|528801510|FG000|Overall Study|Other|1|||
146624894|NCT01001221|528801511|FG001|Overall Study|Other|1|||
146624895|NCT01001221|528801512|FG002|Overall Study|Other|0|||
146624896|NCT01001221|528801513|FG003|Overall Study|Other|0|||
146624897|NCT01001221|528801514|FG004|Overall Study|Other|0|||
146624898|NCT01001221|528801510|FG000|Overall Study|Not treated; protocol exclusion|0|||
146624899|NCT01001221|528801511|FG001|Overall Study|Not treated; protocol exclusion|0|||
146624900|NCT01001221|528801512|FG002|Overall Study|Not treated; protocol exclusion|1|||
146624901|NCT01001221|528801513|FG003|Overall Study|Not treated; protocol exclusion|0|||
146624902|NCT01001221|528801514|FG004|Overall Study|Not treated; protocol exclusion|0|||
146624903|NCT02388269|528801515|FG000|Overall Study|Adverse Event|2|||
146624904|NCT02388269|528801516|FG001|Overall Study|Adverse Event|0|||
146624905|NCT02388269|528801517|FG002|Overall Study|Adverse Event|0|||
146624906|NCT02388269|528801515|FG000|Overall Study|Withdrawal by Subject|1|||
146624907|NCT02388269|528801516|FG001|Overall Study|Withdrawal by Subject|2|||
146624908|NCT02388269|528801517|FG002|Overall Study|Withdrawal by Subject|0|||
146624909|NCT02388269|528801515|FG000|Overall Study|less than 50% stimulations|1|||
146624910|NCT02388269|528801516|FG001|Overall Study|less than 50% stimulations|0|||
146624911|NCT02388269|528801517|FG002|Overall Study|less than 50% stimulations|0|||
146624912|NCT02388269|528801515|FG000|Overall Study|no diary data|3|||
146624913|NCT02388269|528801516|FG001|Overall Study|no diary data|0|||
146624914|NCT02388269|528801517|FG002|Overall Study|no diary data|0|||
146624915|NCT02388269|528801515|FG000|Overall Study|Protocol Violation|2|||
146624916|NCT02388269|528801516|FG001|Overall Study|Protocol Violation|0|||
146624917|NCT02388269|528801517|FG002|Overall Study|Protocol Violation|0|||
146624918|NCT02388269|528801515|FG000|Overall Study|Screen Failure|0|||
146624919|NCT02388269|528801516|FG001|Overall Study|Screen Failure|0|||
146624920|NCT02388269|528801517|FG002|Overall Study|Screen Failure|10|||
146624921|NCT03448406|528801518|FG000|Overall Study|Noncompliance of scheduled visits|1|||
146624922|NCT03448406|528801519|FG001|Overall Study|Noncompliance of scheduled visits|2|||
146624923|NCT03448406|528801518|FG000|Overall Study|Withdrawal by Subject|1|||
146624924|NCT03448406|528801519|FG001|Overall Study|Withdrawal by Subject|2|||
146624925|NCT03448406|528801518|FG000|Overall Study|Protocol Violation|1|||
146624926|NCT03448406|528801519|FG001|Overall Study|Protocol Violation|0|||
146624927|NCT03448406|528801518|FG000|Overall Study|Adverse Event|8|||
146624928|NCT03448406|528801519|FG001|Overall Study|Adverse Event|9|||
146624929|NCT01292486|528801520|FG000|Overall Study|Protocol Violation|2|||
146624930|NCT01292486|528801520|FG000|Overall Study|Did not meet screening criteria|2|||
146624931|NCT01292486|528801520|FG000|Overall Study|Adverse Event|1|||
146624932|NCT01292486|528801520|FG000|Overall Study|Physician Decision|1|||
146624933|NCT00087152|528801521|FG000|Overall Study|Ineligible|6|||
146624934|NCT04602390|528801522|FG000|Overall Study|Withdrawal by Subject|0|||
146624935|NCT04602390|528801523|FG001|Overall Study|Withdrawal by Subject|0|||
146624936|NCT04602390|528801524|FG002|Overall Study|Withdrawal by Subject|0|||
146624937|NCT04602390|528801525|FG003|Overall Study|Withdrawal by Subject|0|||
146624938|NCT04602390|528801526|FG004|Overall Study|Withdrawal by Subject|1|||
146624939|NCT04602390|528801527|FG005|Overall Study|Withdrawal by Subject|0|||
146850731|NCT03245151|529622524|FG002|Overall Study|Death|9|||
146624940|NCT04602390|528801522|FG000|Overall Study|Adverse Event|0|||
146624941|NCT04602390|528801523|FG001|Overall Study|Adverse Event|0|||
146624942|NCT04602390|528801524|FG002|Overall Study|Adverse Event|0|||
146624943|NCT04602390|528801525|FG003|Overall Study|Adverse Event|0|||
146850732|NCT03245151|529622525|FG003|Overall Study|Death|16|||
146624944|NCT04602390|528801526|FG004|Overall Study|Adverse Event|0|||
146624945|NCT04602390|528801527|FG005|Overall Study|Adverse Event|1|||
146624946|NCT03882021|528801528|FG000|Enrollment|Procedure aborted/cancelled|2|||
146624947|NCT03882021|528801528|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
146624948|NCT03882021|528801528|FG000|Enrollment to 3-Month|Death|1|||
146624949|NCT03882021|528801528|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
146624950|NCT03882021|528801528|FG000|Enrollment to 3-Month|Missed Visit|4|||
146624951|NCT03882021|528801528|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
146624952|NCT03882021|528801528|FG000|6-Month to 12-Month Visit|Death|1|||
146624953|NCT03882021|528801528|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
146624954|NCT01546857|528801529|FG000|Overall Study|Withdrawal by Subject|2|||
146624955|NCT01546857|528801530|FG001|Overall Study|Withdrawal by Subject|3|||
146624956|NCT05121766|528801538|FG000|Overall Study|Covid reinfection|3|||
146624957|NCT05121766|528801539|FG001|Overall Study|Covid reinfection|0|||
146624958|NCT05121766|528801538|FG000|Overall Study|Withdrawal by Subject|3|||
146624959|NCT05121766|528801539|FG001|Overall Study|Withdrawal by Subject|1|||
146624960|NCT05121766|528801538|FG000|Overall Study|Adverse Event|2|||
146624961|NCT05121766|528801539|FG001|Overall Study|Adverse Event|4|||
146624962|NCT05121766|528801538|FG000|Overall Study|Lost to Follow-up|0|||
146624963|NCT05121766|528801539|FG001|Overall Study|Lost to Follow-up|1|||
146624964|NCT03259230|528801541|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
146624965|NCT03259230|528801542|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
146624966|NCT01033240|528801543|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
146624967|NCT01033240|528801544|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
146624968|NCT01033240|528801545|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
146624969|NCT01033240|528801543|FG000|Overall Study|Death|2|||
146624970|NCT01033240|528801544|FG001|Overall Study|Death|0|||
146624971|NCT01033240|528801545|FG002|Overall Study|Death|0|||
146624972|NCT01033240|528801543|FG000|Overall Study|Withdrew Consent|2|||
146624973|NCT01033240|528801544|FG001|Overall Study|Withdrew Consent|9|||
146624974|NCT01033240|528801545|FG002|Overall Study|Withdrew Consent|2|||
146624975|NCT01033240|528801543|FG000|Overall Study|Disease Progression|35|||
146624976|NCT01033240|528801544|FG001|Overall Study|Disease Progression|32|||
146624977|NCT01033240|528801545|FG002|Overall Study|Disease Progression|41|||
146624978|NCT01033240|528801543|FG000|Overall Study|Investigator Discretion|0|||
146624979|NCT01033240|528801544|FG001|Overall Study|Investigator Discretion|0|||
146624980|NCT01033240|528801545|FG002|Overall Study|Investigator Discretion|2|||
146624981|NCT01033240|528801543|FG000|Overall Study|Other|0|||
146624982|NCT01033240|528801544|FG001|Overall Study|Other|1|||
146624983|NCT01033240|528801545|FG002|Overall Study|Other|2|||
146624984|NCT02913482|528801546|FG000|Overall Study|Death|0|||
146624985|NCT02913482|528801547|FG001|Overall Study|Death|2|||
146624986|NCT02913482|528801548|FG002|Overall Study|Death|2|||
146624987|NCT02913482|528801546|FG000|Overall Study|Progressive Disease|1|||
146624988|NCT02913482|528801547|FG001|Overall Study|Progressive Disease|1|||
146624989|NCT02913482|528801548|FG002|Overall Study|Progressive Disease|1|||
146624990|NCT02913482|528801546|FG000|Overall Study|Reason not specified|0|||
146624991|NCT02913482|528801547|FG001|Overall Study|Reason not specified|0|||
146624992|NCT02913482|528801548|FG002|Overall Study|Reason not specified|1|||
146624993|NCT02913482|528801546|FG000|Overall Study|Withdrawal by Subject|0|||
146624994|NCT02913482|528801547|FG001|Overall Study|Withdrawal by Subject|1|||
146624995|NCT02913482|528801548|FG002|Overall Study|Withdrawal by Subject|1|||
146624996|NCT00918385|528801549|FG000|Monotherapy|Adverse Event|1|||
146624997|NCT00918385|528801550|FG001|Monotherapy|Adverse Event|6|||
146624998|NCT00918385|528801549|FG000|Monotherapy|Complicating illness|1|||
146624999|NCT00918385|528801550|FG001|Monotherapy|Complicating illness|0|||
146625000|NCT00918385|528801549|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
146625001|NCT00918385|528801550|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
146625002|NCT00918385|528801549|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
146625003|NCT00918385|528801550|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
146625004|NCT00918385|528801549|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
146625005|NCT00918385|528801550|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
146625006|NCT00918385|528801549|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
146625007|NCT00918385|528801550|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
146625008|NCT00625131|528801554|FG000|Overall Study|Lost to Follow-up|3|||
146625009|NCT00625131|528801555|FG001|Overall Study|Lost to Follow-up|2|||
146625010|NCT00625131|528801556|FG002|Overall Study|Lost to Follow-up|0|||
146625011|NCT00625131|528801554|FG000|Overall Study|Withdrawal by Subject|1|||
146625012|NCT00625131|528801555|FG001|Overall Study|Withdrawal by Subject|0|||
146625013|NCT00625131|528801556|FG002|Overall Study|Withdrawal by Subject|5|||
146625014|NCT00168844|528801559|FG000|Overall Study|Adverse Event|31|||
146625015|NCT00168844|528801560|FG001|Overall Study|Adverse Event|32|||
146625016|NCT00168844|528801561|FG002|Overall Study|Adverse Event|48|||
146625017|NCT00168844|528801559|FG000|Overall Study|Lost to Follow-up|4|||
146625018|NCT00168844|528801560|FG001|Overall Study|Lost to Follow-up|5|||
146625019|NCT00168844|528801561|FG002|Overall Study|Lost to Follow-up|11|||
146850733|NCT03245151|529622526|FG004|Overall Study|Death|7|||
146625020|NCT00168844|528801559|FG000|Overall Study|Withdrawal by Subject|12|||
146625021|NCT00168844|528801560|FG001|Overall Study|Withdrawal by Subject|9|||
146625022|NCT00168844|528801561|FG002|Overall Study|Withdrawal by Subject|19|||
146625023|NCT00168844|528801559|FG000|Overall Study|Protocol Violation|2|||
146625024|NCT00168844|528801560|FG001|Overall Study|Protocol Violation|2|||
146625025|NCT00168844|528801561|FG002|Overall Study|Protocol Violation|4|||
146625026|NCT00168844|528801559|FG000|Overall Study|Other|6|||
146850734|NCT03245151|529622522|FG000|Overall Study|Sponsor's decision|0|||
146625027|NCT00168844|528801560|FG001|Overall Study|Other|7|||
146625028|NCT00168844|528801561|FG002|Overall Study|Other|9|||
146625029|NCT03557970|528801564|FG000|Overall Study|Study closure|1|||
146625030|NCT03557970|528801565|FG001|Overall Study|Study closure|0|||
146625031|NCT03557970|528801564|FG000|Overall Study|Physician Decision|0|||
146625032|NCT03557970|528801565|FG001|Overall Study|Physician Decision|1|||
146625033|NCT03557970|528801564|FG000|Overall Study|Death|0|||
146625034|NCT03557970|528801565|FG001|Overall Study|Death|1|||
146625035|NCT00112736|528801568|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
146625036|NCT00112736|528801569|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
146625037|NCT02138890|528801570|FG000|Overall Study|Adverse Event|1|||
146625038|NCT02138890|528801571|FG001|Overall Study|Adverse Event|0|||
146625039|NCT05435339|528801572|FG000|Overall Study|Death|1|||
146625040|NCT05435339|528801573|FG001|Overall Study|Death|0|||
146625041|NCT05435339|528801574|FG002|Overall Study|Death|3|||
146625042|NCT05435339|528801575|FG003|Overall Study|Death|1|||
146625043|NCT05435339|528801576|FG004|Overall Study|Death|3|||
146625044|NCT05435339|528801577|FG005|Overall Study|Death|2|||
146625045|NCT05435339|528801578|FG006|Overall Study|Death|4|||
146625046|NCT05435339|528801579|FG007|Overall Study|Death|6|||
146625047|NCT05435339|528801572|FG000|Overall Study|Sponsor Decision|0|||
146625048|NCT05435339|528801573|FG001|Overall Study|Sponsor Decision|1|||
146625049|NCT05435339|528801574|FG002|Overall Study|Sponsor Decision|0|||
146625050|NCT05435339|528801575|FG003|Overall Study|Sponsor Decision|0|||
146625051|NCT05435339|528801576|FG004|Overall Study|Sponsor Decision|2|||
146625052|NCT05435339|528801577|FG005|Overall Study|Sponsor Decision|1|||
146625053|NCT05435339|528801578|FG006|Overall Study|Sponsor Decision|2|||
146625054|NCT05435339|528801579|FG007|Overall Study|Sponsor Decision|2|||
146625055|NCT05435339|528801572|FG000|Overall Study|Withdrawal by Subject|0|||
146625056|NCT05435339|528801573|FG001|Overall Study|Withdrawal by Subject|0|||
146625057|NCT05435339|528801574|FG002|Overall Study|Withdrawal by Subject|0|||
146625058|NCT05435339|528801575|FG003|Overall Study|Withdrawal by Subject|0|||
146625059|NCT05435339|528801576|FG004|Overall Study|Withdrawal by Subject|1|||
146625060|NCT05435339|528801577|FG005|Overall Study|Withdrawal by Subject|0|||
146625061|NCT05435339|528801578|FG006|Overall Study|Withdrawal by Subject|1|||
146625062|NCT05435339|528801579|FG007|Overall Study|Withdrawal by Subject|1|||
146625063|NCT00537394|528801580|FG000|First Year of Follow-up|Death|7|||
146625064|NCT00537394|528801581|FG001|First Year of Follow-up|Death|0|||
146625065|NCT00537394|528801582|FG002|First Year of Follow-up|Death|0|||
146625066|NCT00537394|528801580|FG000|First Year of Follow-up|Severe debilitation|1|||
146625067|NCT00537394|528801581|FG001|First Year of Follow-up|Severe debilitation|0|||
146625068|NCT00537394|528801582|FG002|First Year of Follow-up|Severe debilitation|1|||
146625069|NCT00537394|528801580|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
146625070|NCT00537394|528801581|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
146625071|NCT00537394|528801582|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
146625072|NCT00537394|528801580|FG000|First Year of Follow-up|Lost to Follow-up|1|||
146625073|NCT00537394|528801581|FG001|First Year of Follow-up|Lost to Follow-up|5|||
146625074|NCT00537394|528801582|FG002|First Year of Follow-up|Lost to Follow-up|1|||
146625075|NCT00537394|528801580|FG000|2nd Year of Follow-up|Death|4|||
146736621|NCT00975221|529209230|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
146736622|NCT00975221|529209231|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
146736623|NCT00975221|529209230|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
146736624|NCT00975221|529209231|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
146736625|NCT00975221|529209230|FG000|Titration Phase (Weeks 1-12)|Other|0|||
146736626|NCT00975221|529209231|FG001|Titration Phase (Weeks 1-12)|Other|1|||
146736627|NCT00975221|529209230|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
146736628|NCT00975221|529209231|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
146736629|NCT00975221|529209230|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
146736630|NCT00975221|529209231|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
146736631|NCT00975221|529209230|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
146736632|NCT00975221|529209231|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
146736633|NCT01862991|529209232|FG000|Overall Study|Lost to Follow-up|2|||
146736634|NCT01862991|529209233|FG001|Overall Study|Lost to Follow-up|1|||
146736635|NCT01862991|529209234|FG002|Overall Study|Lost to Follow-up|1|||
146850735|NCT03245151|529622523|FG001|Overall Study|Sponsor's decision|1|||
146736636|NCT01862991|529209232|FG000|Overall Study|Protocol Violation|1|||
146736637|NCT01862991|529209233|FG001|Overall Study|Protocol Violation|0|||
146736638|NCT01862991|529209234|FG002|Overall Study|Protocol Violation|0|||
146736639|NCT02026232|529209235|FG000|Overall Study|incomplete visit/missing data|3|||
146736640|NCT02026232|529209236|FG001|Overall Study|incomplete visit/missing data|2|||
146850736|NCT03245151|529622524|FG002|Overall Study|Sponsor's decision|0|||
146625076|NCT00537394|528801581|FG001|2nd Year of Follow-up|Death|1|||
146625077|NCT00537394|528801582|FG002|2nd Year of Follow-up|Death|2|||
146625078|NCT00537394|528801580|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
146625079|NCT00537394|528801581|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
146625080|NCT00537394|528801582|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
146736641|NCT00605319|529209237|FG000|Overall Study|Adverse Event|6|||
146736642|NCT02670538|529209238|FG000|Overall Study|Withdrawal of Consent|8|||
146736643|NCT02670538|529209239|FG001|Overall Study|Withdrawal of Consent|6|||
146736644|NCT02670538|529209240|FG002|Overall Study|Withdrawal of Consent|5|||
146736645|NCT02670538|529209238|FG000|Overall Study|Lost to Follow-up|8|||
146736646|NCT02670538|529209239|FG001|Overall Study|Lost to Follow-up|12|||
146736647|NCT02670538|529209240|FG002|Overall Study|Lost to Follow-up|7|||
146736648|NCT02670538|529209238|FG000|Overall Study|Adverse Event|5|||
146736649|NCT02670538|529209239|FG001|Overall Study|Adverse Event|5|||
146736650|NCT02670538|529209240|FG002|Overall Study|Adverse Event|11|||
146736651|NCT02670538|529209238|FG000|Overall Study|Lack of Efficacy|7|||
146736652|NCT02670538|529209239|FG001|Overall Study|Lack of Efficacy|1|||
146736653|NCT02670538|529209240|FG002|Overall Study|Lack of Efficacy|2|||
146736654|NCT02670538|529209238|FG000|Overall Study|Protocol Violation|3|||
146736655|NCT02670538|529209239|FG001|Overall Study|Protocol Violation|4|||
146736656|NCT02670538|529209240|FG002|Overall Study|Protocol Violation|1|||
146736657|NCT02670538|529209238|FG000|Overall Study|Noncompliance with Study Drug|1|||
146736658|NCT02670538|529209239|FG001|Overall Study|Noncompliance with Study Drug|3|||
146736659|NCT02670538|529209240|FG002|Overall Study|Noncompliance with Study Drug|2|||
146736660|NCT02670538|529209238|FG000|Overall Study|Other Miscellaneous Reasons|0|||
146736661|NCT02670538|529209239|FG001|Overall Study|Other Miscellaneous Reasons|1|||
146736662|NCT02670538|529209240|FG002|Overall Study|Other Miscellaneous Reasons|2|||
146736663|NCT02110732|529209245|FG000|Overall Study|Physician Decision|5|||
146736664|NCT02110732|529209246|FG001|Overall Study|Physician Decision|2|||
146736665|NCT02110732|529209245|FG000|Overall Study|Lost to Follow-up|1|||
146736666|NCT02110732|529209246|FG001|Overall Study|Lost to Follow-up|1|||
146736667|NCT02312856|529209247|FG000|Overall Study|Death|1|||
146736668|NCT02312856|529209247|FG000|Overall Study|Lost to Follow-up|3|||
146736669|NCT01932294|529209248|FG000|Overall Study|Death|43|||
146736670|NCT01932294|529209248|FG000|Overall Study|Lost to Follow-up|8|||
146736671|NCT01932294|529209248|FG000|Overall Study|VAD Implantation|20|||
146736672|NCT01932294|529209248|FG000|Overall Study|Heart Transplantation|16|||
146736673|NCT01932294|529209248|FG000|Overall Study|Transferred to other hospitals|12|||
146736674|NCT04415151|529209249|FG000|Overall Study|Death|1|||
146736675|NCT04415151|529209250|FG001|Overall Study|Death|1|||
146736676|NCT04415151|529209249|FG000|Overall Study|Withdrawal by Subject|1|||
146736677|NCT04415151|529209250|FG001|Overall Study|Withdrawal by Subject|0|||
146736678|NCT00638235|529209256|FG000|Overall Study|Lost to Follow-up|31|||
146736679|NCT00638235|529209257|FG001|Overall Study|Lost to Follow-up|3|||
146736680|NCT00638235|529209258|FG002|Overall Study|Lost to Follow-up|18|||
146736681|NCT00638235|529209259|FG003|Overall Study|Lost to Follow-up|10|||
146850737|NCT03245151|529622525|FG003|Overall Study|Sponsor's decision|0|||
146736682|NCT00638235|529209260|FG004|Overall Study|Lost to Follow-up|13|||
146736683|NCT00638235|529209261|FG005|Overall Study|Lost to Follow-up|26|||
146736684|NCT00638235|529209262|FG006|Overall Study|Lost to Follow-up|0|||
146736685|NCT00638235|529209263|FG007|Overall Study|Lost to Follow-up|1|||
146736686|NCT00638235|529209264|FG008|Overall Study|Lost to Follow-up|18|||
146736687|NCT01473381|529209269|FG000|Overall Study|Adverse Event|8|||
146736688|NCT01473381|529209270|FG001|Overall Study|Adverse Event|20|||
146736689|NCT01473381|529209271|FG002|Overall Study|Adverse Event|25|||
146736690|NCT01473381|529209272|FG003|Overall Study|Adverse Event|17|||
146736691|NCT01473381|529209269|FG000|Overall Study|Insufficient Therapeutic Response|10|||
146736692|NCT01473381|529209270|FG001|Overall Study|Insufficient Therapeutic Response|1|||
146736693|NCT01473381|529209271|FG002|Overall Study|Insufficient Therapeutic Response|2|||
146736694|NCT01473381|529209272|FG003|Overall Study|Insufficient Therapeutic Response|3|||
146736695|NCT01473381|529209269|FG000|Overall Study|Protocol Violation|17|||
146736696|NCT01473381|529209270|FG001|Overall Study|Protocol Violation|23|||
146736697|NCT01473381|529209271|FG002|Overall Study|Protocol Violation|19|||
146736698|NCT01473381|529209272|FG003|Overall Study|Protocol Violation|17|||
146736699|NCT01473381|529209269|FG000|Overall Study|Withdrawal of Consent|20|||
146736700|NCT01473381|529209270|FG001|Overall Study|Withdrawal of Consent|21|||
146736701|NCT01473381|529209271|FG002|Overall Study|Withdrawal of Consent|20|||
146736702|NCT01473381|529209272|FG003|Overall Study|Withdrawal of Consent|26|||
146736703|NCT01473381|529209269|FG000|Overall Study|Lost to Follow-up|25|||
146736704|NCT01473381|529209270|FG001|Overall Study|Lost to Follow-up|28|||
146736705|NCT01473381|529209271|FG002|Overall Study|Lost to Follow-up|35|||
146736706|NCT01473381|529209272|FG003|Overall Study|Lost to Follow-up|23|||
146736707|NCT01473381|529209269|FG000|Overall Study|Other Reasons|0|||
146736708|NCT01473381|529209270|FG001|Overall Study|Other Reasons|0|||
146736709|NCT01473381|529209271|FG002|Overall Study|Other Reasons|1|||
146736710|NCT01473381|529209272|FG003|Overall Study|Other Reasons|3|||
146736711|NCT00539643|529209273|FG000|Overall Study|Adverse Event|1|||
146736712|NCT00539643|529209274|FG001|Overall Study|Adverse Event|0|||
146736713|NCT00539643|529209273|FG000|Overall Study|Death|2|||
146736714|NCT00539643|529209274|FG001|Overall Study|Death|1|||
146736715|NCT00539643|529209273|FG000|Overall Study|Physician Decision|3|||
146736716|NCT00539643|529209274|FG001|Overall Study|Physician Decision|1|||
146736717|NCT00539643|529209273|FG000|Overall Study|Withdrawal by Subject|0|||
146736718|NCT00539643|529209274|FG001|Overall Study|Withdrawal by Subject|1|||
146736719|NCT01287520|529209275|FG000|Overall Study|Adverse Event|2|||
146736720|NCT01287520|529209276|FG001|Overall Study|Adverse Event|2|||
146736721|NCT01287520|529209277|FG002|Overall Study|Adverse Event|2|||
146736722|NCT01287520|529209278|FG003|Overall Study|Adverse Event|1|||
146736723|NCT01287520|529209279|FG004|Overall Study|Adverse Event|1|||
146736724|NCT01287520|529209280|FG005|Overall Study|Adverse Event|2|||
146736725|NCT01287520|529209281|FG006|Overall Study|Adverse Event|0|||
146736726|NCT01287520|529209282|FG007|Overall Study|Adverse Event|2|||
146736727|NCT01287520|529209283|FG008|Overall Study|Adverse Event|0|||
146736728|NCT01287520|529209275|FG000|Overall Study|Physician Decision|1|||
146736729|NCT01287520|529209276|FG001|Overall Study|Physician Decision|1|||
146736730|NCT01287520|529209277|FG002|Overall Study|Physician Decision|2|||
146736731|NCT01287520|529209278|FG003|Overall Study|Physician Decision|0|||
146736732|NCT01287520|529209279|FG004|Overall Study|Physician Decision|1|||
146736733|NCT01287520|529209280|FG005|Overall Study|Physician Decision|1|||
146736734|NCT01287520|529209281|FG006|Overall Study|Physician Decision|0|||
146736735|NCT01287520|529209282|FG007|Overall Study|Physician Decision|1|||
146736736|NCT01287520|529209283|FG008|Overall Study|Physician Decision|0|||
146736737|NCT01287520|529209275|FG000|Overall Study|Progressive disease|0|||
146736738|NCT01287520|529209276|FG001|Overall Study|Progressive disease|4|||
146736739|NCT01287520|529209277|FG002|Overall Study|Progressive disease|1|||
146736740|NCT01287520|529209278|FG003|Overall Study|Progressive disease|6|||
146736741|NCT01287520|529209279|FG004|Overall Study|Progressive disease|1|||
146736742|NCT01287520|529209280|FG005|Overall Study|Progressive disease|0|||
146736743|NCT01287520|529209281|FG006|Overall Study|Progressive disease|2|||
146736744|NCT01287520|529209282|FG007|Overall Study|Progressive disease|2|||
146736745|NCT01287520|529209283|FG008|Overall Study|Progressive disease|4|||
146736746|NCT01287520|529209275|FG000|Overall Study|Withdrawal by Subject|0|||
146736747|NCT01287520|529209276|FG001|Overall Study|Withdrawal by Subject|0|||
146736748|NCT01287520|529209277|FG002|Overall Study|Withdrawal by Subject|0|||
146736749|NCT01287520|529209278|FG003|Overall Study|Withdrawal by Subject|0|||
146736750|NCT01287520|529209279|FG004|Overall Study|Withdrawal by Subject|0|||
146736751|NCT01287520|529209280|FG005|Overall Study|Withdrawal by Subject|1|||
146736752|NCT01287520|529209281|FG006|Overall Study|Withdrawal by Subject|0|||
146736753|NCT01287520|529209282|FG007|Overall Study|Withdrawal by Subject|0|||
146736754|NCT01287520|529209283|FG008|Overall Study|Withdrawal by Subject|1|||
146736755|NCT03587142|529209284|FG000|Overall Study|Lost to Follow-up|5|||
146736756|NCT03587142|529209285|FG001|Overall Study|Lost to Follow-up|3|||
146736757|NCT03587142|529209284|FG000|Overall Study|Did not complete the f4 visit|3|||
146736758|NCT03587142|529209285|FG001|Overall Study|Did not complete the f4 visit|7|||
146736759|NCT03673462|529209286|FG000|Overall Study|Adverse Event|11|||
146736760|NCT03673462|529209287|FG001|Overall Study|Adverse Event|1|||
146736761|NCT03673462|529209286|FG000|Overall Study|Protocol Violation|25|||
146736762|NCT03673462|529209287|FG001|Overall Study|Protocol Violation|11|||
146736763|NCT03673462|529209286|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
146736764|NCT03673462|529209287|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
146736765|NCT03673462|529209286|FG000|Overall Study|Lost to Follow-up|102|||
146736766|NCT03673462|529209287|FG001|Overall Study|Lost to Follow-up|19|||
146736767|NCT02768662|529209288|FG000|Overall Study|Adverse Event|1|||
146736768|NCT02768662|529209288|FG000|Overall Study|Lost to Follow-up|4|||
146736769|NCT02768662|529209288|FG000|Overall Study|Withdrawal by Subject|3|||
146736770|NCT02768662|529209288|FG000|Overall Study|Study terminated by Sponsor|78|||
146736771|NCT01800201|529209289|FG000|Overall Study|Withdrawal by Subject|2|||
146736772|NCT01800201|529209290|FG001|Overall Study|Withdrawal by Subject|0|||
146736773|NCT01800201|529209289|FG000|Overall Study|patient privacy concerns|1|||
146736774|NCT01800201|529209290|FG001|Overall Study|patient privacy concerns|1|||
146736775|NCT01800201|529209289|FG000|Overall Study|did not want to use device|0|||
146736776|NCT01800201|529209290|FG001|Overall Study|did not want to use device|1|||
146736777|NCT01800201|529209289|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
146736778|NCT01800201|529209290|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
146736779|NCT00708435|529209291|FG000|Overall Study|Death / Serious Adverse Event|10|||
146736780|NCT00708435|529209292|FG001|Overall Study|Death / Serious Adverse Event|5|||
146736781|NCT00708435|529209291|FG000|Overall Study|Lost to Follow-up|9|||
146736782|NCT00708435|529209292|FG001|Overall Study|Lost to Follow-up|4|||
146736783|NCT00708435|529209291|FG000|Overall Study|Withdrawal by Subject|3|||
146736784|NCT00708435|529209292|FG001|Overall Study|Withdrawal by Subject|7|||
146736785|NCT00708435|529209291|FG000|Overall Study|Adverse Event|1|||
146736786|NCT00708435|529209292|FG001|Overall Study|Adverse Event|0|||
146736787|NCT00708435|529209291|FG000|Overall Study|Protocol Violation|0|||
146736788|NCT00708435|529209292|FG001|Overall Study|Protocol Violation|1|||
146736789|NCT00708435|529209291|FG000|Overall Study|Intervention by primary care physician|1|||
146736790|NCT00708435|529209292|FG001|Overall Study|Intervention by primary care physician|0|||
146736791|NCT00708435|529209291|FG000|Overall Study|Refused hospitalization|1|||
146736792|NCT00708435|529209292|FG001|Overall Study|Refused hospitalization|0|||
146736793|NCT05061537|529209298|FG000|Treatment Phase|Progressive disease|0|||
146736794|NCT05061537|529209299|FG001|Treatment Phase|Progressive disease|1|||
146736795|NCT05061537|529209300|FG002|Treatment Phase|Progressive disease|2|||
146850738|NCT03245151|529622526|FG004|Overall Study|Sponsor's decision|0|||
146736796|NCT05061537|529209301|FG003|Treatment Phase|Progressive disease|0|||
146736797|NCT05061537|529209302|FG004|Treatment Phase|Progressive disease|0|||
146736798|NCT05061537|529209298|FG000|Treatment Phase|Adverse Event|0|||
146736799|NCT05061537|529209299|FG001|Treatment Phase|Adverse Event|0|||
146736800|NCT05061537|529209300|FG002|Treatment Phase|Adverse Event|2|||
146736801|NCT05061537|529209301|FG003|Treatment Phase|Adverse Event|0|||
146736802|NCT05061537|529209302|FG004|Treatment Phase|Adverse Event|0|||
146736803|NCT05061537|529209298|FG000|Treatment Phase|Global deterioration of health status|0|||
146736804|NCT05061537|529209299|FG001|Treatment Phase|Global deterioration of health status|1|||
146736805|NCT05061537|529209300|FG002|Treatment Phase|Global deterioration of health status|0|||
146736806|NCT05061537|529209301|FG003|Treatment Phase|Global deterioration of health status|0|||
146736807|NCT05061537|529209302|FG004|Treatment Phase|Global deterioration of health status|0|||
146736808|NCT05061537|529209298|FG000|Follow up|Other|2|||
146736809|NCT05061537|529209299|FG001|Follow up|Other|0|||
146736810|NCT05061537|529209300|FG002|Follow up|Other|2|||
146736811|NCT05061537|529209301|FG003|Follow up|Other|0|||
146736812|NCT05061537|529209302|FG004|Follow up|Other|0|||
146736813|NCT05061537|529209298|FG000|Follow up|Study terminated by sponsor|0|||
146736814|NCT05061537|529209299|FG001|Follow up|Study terminated by sponsor|0|||
146736815|NCT05061537|529209300|FG002|Follow up|Study terminated by sponsor|2|||
146736816|NCT05061537|529209301|FG003|Follow up|Study terminated by sponsor|0|||
146736817|NCT05061537|529209302|FG004|Follow up|Study terminated by sponsor|0|||
146736818|NCT05061537|529209298|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
146736819|NCT05061537|529209299|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
146736820|NCT05061537|529209300|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
146736821|NCT05061537|529209301|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
146736822|NCT05061537|529209302|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
146736823|NCT05061537|529209298|FG000|Long-term Follow-up|Death|0|||
146736824|NCT05061537|529209299|FG001|Long-term Follow-up|Death|1|||
146736825|NCT05061537|529209300|FG002|Long-term Follow-up|Death|0|||
146736826|NCT05061537|529209301|FG003|Long-term Follow-up|Death|0|||
146736827|NCT05061537|529209302|FG004|Long-term Follow-up|Death|0|||
146736828|NCT04503096|529209305|FG000|Overall Study|Withdrawal by Subject|3|||
146736829|NCT01480596|529209306|FG000|Overall Study|Adverse Event|3|||
146736830|NCT01480596|529209307|FG001|Overall Study|Adverse Event|0|||
146736831|NCT01480596|529209306|FG000|Overall Study|MG exacerbation or change in medication|2|||
146736832|NCT01480596|529209307|FG001|Overall Study|MG exacerbation or change in medication|2|||
146736833|NCT01576367|529209310|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146736834|NCT01576367|529209310|FG000|Overall Study|Moved to commercial use after 6 months|1|||
146736835|NCT00988221|529209311|FG000|Part I|Adverse Event|0|||
146736836|NCT00988221|529209312|FG001|Part I|Adverse Event|1|||
146736837|NCT00988221|529209313|FG002|Part I|Adverse Event|2|||
146736838|NCT00988221|529209314|FG003|Part I|Adverse Event|0|||
146736839|NCT00988221|529209311|FG000|Part I|Insufficient Therapeutic Response|4|||
146736840|NCT00988221|529209312|FG001|Part I|Insufficient Therapeutic Response|6|||
146736841|NCT00988221|529209313|FG002|Part I|Insufficient Therapeutic Response|5|||
146736842|NCT00988221|529209314|FG003|Part I|Insufficient Therapeutic Response|0|||
146736843|NCT00988221|529209311|FG000|Part I|Refused Treatment|0|||
146736844|NCT00988221|529209312|FG001|Part I|Refused Treatment|2|||
146736845|NCT00988221|529209313|FG002|Part I|Refused Treatment|1|||
146736846|NCT00988221|529209314|FG003|Part I|Refused Treatment|0|||
146736847|NCT00988221|529209311|FG000|Part I|Lost to Follow-up|0|||
146736848|NCT00988221|529209312|FG001|Part I|Lost to Follow-up|1|||
146736849|NCT00988221|529209313|FG002|Part I|Lost to Follow-up|0|||
146736850|NCT00988221|529209314|FG003|Part I|Lost to Follow-up|0|||
146850739|NCT04772898|529622527|FG000|Overall Study|Withdrawal by Subject|0|||
146850740|NCT04772898|529622528|FG001|Overall Study|Withdrawal by Subject|1|||
146736851|NCT00988221|529209311|FG000|Part II|Adverse Event|1|||
146736852|NCT00988221|529209312|FG001|Part II|Adverse Event|0|||
146736853|NCT00988221|529209313|FG002|Part II|Adverse Event|0|||
146736854|NCT00988221|529209314|FG003|Part II|Adverse Event|1|||
146736855|NCT00988221|529209311|FG000|Part II|Withdrawal by Subject|0|||
146736856|NCT00988221|529209312|FG001|Part II|Withdrawal by Subject|0|||
146850741|NCT01004848|529622534|FG000|Overall Study|Lost to Follow-up|55|||
146736857|NCT00988221|529209313|FG002|Part II|Withdrawal by Subject|2|||
146736858|NCT00988221|529209314|FG003|Part II|Withdrawal by Subject|2|||
146736859|NCT00988221|529209311|FG000|Part II|Reason not Specified|0|||
146736860|NCT00988221|529209312|FG001|Part II|Reason not Specified|0|||
146736861|NCT00988221|529209313|FG002|Part II|Reason not Specified|1|||
146736862|NCT00988221|529209314|FG003|Part II|Reason not Specified|0|||
146736863|NCT00988221|529209311|FG000|Part III|Adverse Event|1|||
146736864|NCT00988221|529209312|FG001|Part III|Adverse Event|0|||
146736865|NCT00988221|529209313|FG002|Part III|Adverse Event|1|||
146736866|NCT00988221|529209314|FG003|Part III|Adverse Event|0|||
146736867|NCT00988221|529209311|FG000|Part III|Insufficient Therapeutic Response|0|||
146736868|NCT00988221|529209312|FG001|Part III|Insufficient Therapeutic Response|1|||
146736869|NCT00988221|529209313|FG002|Part III|Insufficient Therapeutic Response|1|||
146736870|NCT00988221|529209314|FG003|Part III|Insufficient Therapeutic Response|0|||
146736871|NCT00988221|529209311|FG000|Part III|Refused Treatment|0|||
146736872|NCT00988221|529209312|FG001|Part III|Refused Treatment|0|||
146736873|NCT00988221|529209313|FG002|Part III|Refused Treatment|1|||
146736874|NCT00988221|529209314|FG003|Part III|Refused Treatment|0|||
146736875|NCT03592277|529209319|FG000|Overall Study|Withdrawal by Subject|6|||
146736876|NCT03592277|529209320|FG001|Overall Study|Withdrawal by Subject|8|||
146736877|NCT00954733|529209321|FG000|Overall Study|blood gas machine did not work|1|||
146736878|NCT01346514|529209322|FG000|Overall Study|Lost to Follow-up|19|||
146736879|NCT01346514|529209323|FG001|Overall Study|Lost to Follow-up|30|||
146736880|NCT01346514|529209322|FG000|Overall Study|Withdrawal by Subject|7|||
146736881|NCT01346514|529209323|FG001|Overall Study|Withdrawal by Subject|3|||
146736882|NCT01346514|529209322|FG000|Overall Study|Death|3|||
146736883|NCT01346514|529209323|FG001|Overall Study|Death|4|||
146736884|NCT00909480|529209324|FG000|Overall Study|Adverse Event|5|||
146736885|NCT00909480|529209325|FG001|Overall Study|Adverse Event|3|||
146736886|NCT00909480|529209324|FG000|Overall Study|Protocol Violation|6|||
146736887|NCT00909480|529209325|FG001|Overall Study|Protocol Violation|8|||
146736888|NCT00909480|529209324|FG000|Overall Study|Withdrawal criteria|9|||
146736889|NCT00909480|529209325|FG001|Overall Study|Withdrawal criteria|11|||
146736890|NCT00909480|529209324|FG000|Overall Study|Unclassified|18|||
146736891|NCT00909480|529209325|FG001|Overall Study|Unclassified|19|||
146736892|NCT01725386|529209333|FG000|Overall Study|Death|84|||
146736893|NCT01725386|529209334|FG001|Overall Study|Death|40|||
146736894|NCT01725386|529209333|FG000|Overall Study|Lost to Follow-up|81|||
146736895|NCT01725386|529209334|FG001|Overall Study|Lost to Follow-up|6|||
146736896|NCT01725386|529209333|FG000|Overall Study|Withdrawal by Subject|10|||
146736897|NCT01725386|529209334|FG001|Overall Study|Withdrawal by Subject|0|||
146736898|NCT00879996|529209335|FG000|Overall Study|Lost to Follow-up|7|||
146736899|NCT00879996|529209336|FG001|Overall Study|Lost to Follow-up|6|||
146736900|NCT00879996|529209335|FG000|Overall Study|non-compliance|6|||
146736901|NCT00879996|529209336|FG001|Overall Study|non-compliance|4|||
146736902|NCT00879996|529209335|FG000|Overall Study|Physician Decision|1|||
146736903|NCT00879996|529209336|FG001|Overall Study|Physician Decision|2|||
146736904|NCT00879996|529209335|FG000|Overall Study|psychiatric problem|0|||
146736905|NCT00879996|529209336|FG001|Overall Study|psychiatric problem|1|||
146736906|NCT00879996|529209335|FG000|Overall Study|put on parole|1|||
146736907|NCT00879996|529209336|FG001|Overall Study|put on parole|0|||
146736908|NCT04772053|529209348|FG000|Overall Study|Physician Decision|2|||
146736909|NCT04772053|529209348|FG000|Overall Study|Withdrawal by Subject|3|||
146736910|NCT04772053|529209348|FG000|Overall Study|Study Terminated by Sponsor|1|||
146736911|NCT04146896|529209349|FG000|Overall Study|Adverse Event|5|||
146736912|NCT04146896|529209350|FG001|Overall Study|Adverse Event|8|||
146736913|NCT04146896|529209349|FG000|Overall Study|Lack of Efficacy|3|||
146736914|NCT04146896|529209350|FG001|Overall Study|Lack of Efficacy|2|||
146736915|NCT04146896|529209349|FG000|Overall Study|Lost to Follow-up|0|||
146736916|NCT04146896|529209350|FG001|Overall Study|Lost to Follow-up|1|||
146736917|NCT04146896|529209349|FG000|Overall Study|Non-compliance|5|||
146736918|NCT04146896|529209350|FG001|Overall Study|Non-compliance|4|||
146736919|NCT04146896|529209349|FG000|Overall Study|Withdrawal by Subject|3|||
146736920|NCT04146896|529209350|FG001|Overall Study|Withdrawal by Subject|5|||
146736921|NCT04146896|529209349|FG000|Overall Study|Randomized in error|1|||
146736922|NCT04146896|529209350|FG001|Overall Study|Randomized in error|2|||
146736923|NCT02118337|529209351|FG000|Overall Study|Other|1|||
146736924|NCT02118337|529209352|FG001|Overall Study|Other|0|||
146736925|NCT02118337|529209353|FG002|Overall Study|Other|0|||
146736926|NCT02118337|529209354|FG003|Overall Study|Other|0|||
146736927|NCT02118337|529209355|FG004|Overall Study|Other|2|||
146736928|NCT02118337|529209356|FG005|Overall Study|Other|3|||
146736929|NCT02118337|529209357|FG006|Overall Study|Other|1|||
146736930|NCT02118337|529209358|FG007|Overall Study|Other|28|||
146736931|NCT02118337|529209359|FG008|Overall Study|Other|15|||
146736932|NCT02118337|529209351|FG000|Overall Study|Lost to Follow-up|0|||
146736933|NCT02118337|529209352|FG001|Overall Study|Lost to Follow-up|0|||
146736934|NCT02118337|529209353|FG002|Overall Study|Lost to Follow-up|0|||
146736935|NCT02118337|529209354|FG003|Overall Study|Lost to Follow-up|0|||
146736936|NCT02118337|529209355|FG004|Overall Study|Lost to Follow-up|0|||
146736937|NCT02118337|529209356|FG005|Overall Study|Lost to Follow-up|0|||
146736938|NCT02118337|529209357|FG006|Overall Study|Lost to Follow-up|0|||
146736939|NCT02118337|529209358|FG007|Overall Study|Lost to Follow-up|1|||
146736940|NCT02118337|529209359|FG008|Overall Study|Lost to Follow-up|0|||
146736941|NCT02118337|529209351|FG000|Overall Study|Withdrawal by Subject|1|||
146736942|NCT02118337|529209352|FG001|Overall Study|Withdrawal by Subject|3|||
146736943|NCT02118337|529209353|FG002|Overall Study|Withdrawal by Subject|2|||
146736944|NCT02118337|529209354|FG003|Overall Study|Withdrawal by Subject|1|||
146736945|NCT02118337|529209355|FG004|Overall Study|Withdrawal by Subject|2|||
146736946|NCT02118337|529209356|FG005|Overall Study|Withdrawal by Subject|2|||
146736947|NCT02118337|529209357|FG006|Overall Study|Withdrawal by Subject|1|||
146736948|NCT02118337|529209358|FG007|Overall Study|Withdrawal by Subject|4|||
146736949|NCT02118337|529209359|FG008|Overall Study|Withdrawal by Subject|2|||
146736950|NCT02118337|529209351|FG000|Overall Study|Death|2|||
146736951|NCT02118337|529209352|FG001|Overall Study|Death|2|||
146736952|NCT02118337|529209353|FG002|Overall Study|Death|1|||
146736953|NCT02118337|529209354|FG003|Overall Study|Death|2|||
146736954|NCT02118337|529209355|FG004|Overall Study|Death|5|||
146736955|NCT02118337|529209356|FG005|Overall Study|Death|1|||
146736956|NCT02118337|529209357|FG006|Overall Study|Death|2|||
146736957|NCT02118337|529209358|FG007|Overall Study|Death|9|||
146736958|NCT02118337|529209359|FG008|Overall Study|Death|4|||
146736959|NCT04296890|529209360|FG000|Overall Study|Withdrawal by Subject|1|||
146736960|NCT04296890|529209360|FG000|Overall Study|Death|62|||
146736961|NCT04296890|529209360|FG000|Overall Study|Lost to Follow-up|3|||
146736962|NCT04296890|529209360|FG000|Overall Study|Other than specified|2|||
146736963|NCT01931735|529209364|FG000|Randomized Phase|Lost to Follow-up|2|||
146736964|NCT01931735|529209365|FG001|Randomized Phase|Lost to Follow-up|2|||
146736965|NCT01931735|529209366|FG002|Randomized Phase|Lost to Follow-up|5|||
146736966|NCT01931735|529209367|FG003|Randomized Phase|Lost to Follow-up|0|||
146736967|NCT01931735|529209364|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
146736968|NCT01931735|529209365|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
146736969|NCT01931735|529209366|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
146736970|NCT01931735|529209367|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
146736971|NCT01931735|529209364|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
146736972|NCT01931735|529209365|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
146736973|NCT01931735|529209366|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
146736974|NCT01931735|529209367|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
146736975|NCT02719990|529209368|FG000|Overall Study|Physician Decision|2|||
146736976|NCT02719990|529209368|FG000|Overall Study|Withdrawal by Subject|2|||
146736977|NCT02719990|529209368|FG000|Overall Study|Study Terminated By Sponsor|32|||
146736978|NCT02404389|529209369|FG000|Overall Study|Adverse Event|1|||
146736979|NCT02404389|529209370|FG001|Overall Study|Adverse Event|0|||
146736980|NCT02404389|529209371|FG002|Overall Study|Adverse Event|1|||
146736981|NCT02404389|529209372|FG003|Overall Study|Adverse Event|0|||
146736982|NCT02404389|529209373|FG004|Overall Study|Adverse Event|2|||
146736983|NCT02404389|529209369|FG000|Overall Study|Subject/guardian decision|1|||
146736984|NCT02404389|529209370|FG001|Overall Study|Subject/guardian decision|0|||
146736985|NCT02404389|529209371|FG002|Overall Study|Subject/guardian decision|0|||
146736986|NCT02404389|529209372|FG003|Overall Study|Subject/guardian decision|1|||
146736987|NCT02404389|529209373|FG004|Overall Study|Subject/guardian decision|1|||
146736988|NCT05076149|529209377|FG000|Overall Study|Adverse Event|3|||
146736989|NCT05076149|529209378|FG001|Overall Study|Adverse Event|9|||
146736990|NCT05076149|529209377|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
146736991|NCT05076149|529209378|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
146736992|NCT05076149|529209377|FG000|Overall Study|Lost to Follow-up|0|||
146736993|NCT05076149|529209378|FG001|Overall Study|Lost to Follow-up|1|||
146736994|NCT05076149|529209377|FG000|Overall Study|Commercial drug is available for participant|0|||
146736995|NCT05076149|529209378|FG001|Overall Study|Commercial drug is available for participant|1|||
146736996|NCT05076149|529209377|FG000|Overall Study|Other non compliance|1|||
146736997|NCT05076149|529209378|FG001|Overall Study|Other non compliance|1|||
146736998|NCT05076149|529209377|FG000|Overall Study|Physician Decision|0|||
146736999|NCT05076149|529209378|FG001|Overall Study|Physician Decision|1|||
146737000|NCT05076149|529209377|FG000|Overall Study|Other|5|||
146737001|NCT05076149|529209378|FG001|Overall Study|Other|4|||
146737002|NCT00717314|529209379|FG000|Overall Study|Adverse Event|3|||
146737003|NCT00717314|529209380|FG001|Overall Study|Adverse Event|2|||
146737004|NCT00717314|529209379|FG000|Overall Study|Protocol Violation|1|||
146737005|NCT00717314|529209380|FG001|Overall Study|Protocol Violation|0|||
146737006|NCT00717314|529209379|FG000|Overall Study|Lost to Follow-up|1|||
146850742|NCT01004848|529622535|FG001|Overall Study|Lost to Follow-up|45|||
146850743|NCT00768079|529622536|FG000|Overall Study|Lost to Follow-up|2|||
146850744|NCT00768079|529622537|FG001|Overall Study|Lost to Follow-up|0|||
146737007|NCT00717314|529209380|FG001|Overall Study|Lost to Follow-up|5|||
146737008|NCT00717314|529209379|FG000|Overall Study|Withdrawal by Subject|1|||
146737009|NCT00717314|529209380|FG001|Overall Study|Withdrawal by Subject|3|||
146737010|NCT05096208|529209381|FG000|Overall Study|Lost to Follow-up|3|||
146737011|NCT05096208|529209382|FG001|Overall Study|Lost to Follow-up|5|||
146737012|NCT05096208|529209383|FG002|Overall Study|Lost to Follow-up|5|||
146737013|NCT05096208|529209384|FG003|Overall Study|Lost to Follow-up|2|||
146737014|NCT05096208|529209381|FG000|Overall Study|Withdrawal by Subject|0|||
146737015|NCT05096208|529209382|FG001|Overall Study|Withdrawal by Subject|1|||
146737016|NCT05096208|529209383|FG002|Overall Study|Withdrawal by Subject|2|||
146737017|NCT05096208|529209384|FG003|Overall Study|Withdrawal by Subject|3|||
146737018|NCT05096208|529209381|FG000|Overall Study|No longer met eligibility criteria|1|||
146737019|NCT05096208|529209382|FG001|Overall Study|No longer met eligibility criteria|0|||
146737020|NCT05096208|529209383|FG002|Overall Study|No longer met eligibility criteria|0|||
146737021|NCT05096208|529209384|FG003|Overall Study|No longer met eligibility criteria|0|||
146737022|NCT05096208|529209381|FG000|Overall Study|Other|0|||
146737023|NCT05096208|529209382|FG001|Overall Study|Other|0|||
146737024|NCT05096208|529209383|FG002|Overall Study|Other|1|||
146737025|NCT05096208|529209384|FG003|Overall Study|Other|0|||
146850745|NCT00768079|529622538|FG002|Overall Study|Lost to Follow-up|4|||
146737026|NCT00782496|529209385|FG000|Overall Study|Lost to Follow-up|14|||
146737027|NCT00782496|529209386|FG001|Overall Study|Lost to Follow-up|15|||
146737028|NCT00117156|529209390|FG000|Overall Study|Adverse Event|9|||
146737029|NCT00117156|529209390|FG000|Overall Study|Physician Decision|1|||
146737030|NCT00117156|529209390|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
146737031|NCT01919970|529209391|FG000|Overall Study|Withdrawal by Subject|3|||
146737032|NCT01919970|529209392|FG001|Overall Study|Withdrawal by Subject|0|||
146737033|NCT04043962|529209393|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
146737034|NCT04043962|529209393|FG000|Post-Treatment|Withdrawal by Subject|5|||
146737035|NCT04043962|529209393|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
146737036|NCT01987817|529209395|FG000|Overall Study|Adverse Event|4|||
146737037|NCT01987817|529209396|FG001|Overall Study|Adverse Event|0|||
146737038|NCT01987817|529209395|FG000|Overall Study|Withdrawal by Subject|1|||
146737039|NCT01987817|529209396|FG001|Overall Study|Withdrawal by Subject|1|||
146737040|NCT01987817|529209395|FG000|Overall Study|Physician Decision|1|||
146737041|NCT01987817|529209396|FG001|Overall Study|Physician Decision|0|||
146737042|NCT01576718|529209399|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
146737043|NCT01576718|529209400|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146737044|NCT01576718|529209401|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146737045|NCT01576718|529209402|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146737046|NCT01576718|529209403|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146737047|NCT01576718|529209404|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146737048|NCT01576718|529209405|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146737049|NCT01576718|529209399|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
146737050|NCT01576718|529209400|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146737051|NCT01576718|529209401|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146737052|NCT01576718|529209402|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146737053|NCT01576718|529209403|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146737054|NCT01576718|529209404|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146737055|NCT01576718|529209405|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146737056|NCT01576718|529209399|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
146737057|NCT01576718|529209400|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146737058|NCT01576718|529209401|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146737059|NCT01576718|529209402|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146737060|NCT01576718|529209403|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146737061|NCT01576718|529209404|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146737062|NCT01576718|529209405|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146737063|NCT01576718|529209399|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
146737064|NCT01576718|529209400|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146737065|NCT01576718|529209401|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146737066|NCT01576718|529209402|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146737067|NCT01576718|529209403|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146737068|NCT01576718|529209404|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146737069|NCT01576718|529209405|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146737070|NCT01576718|529209399|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
146737071|NCT01576718|529209400|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146737072|NCT01576718|529209401|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146737073|NCT01576718|529209402|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146737074|NCT01576718|529209403|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146737075|NCT01576718|529209404|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146737076|NCT01576718|529209405|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146737077|NCT01576718|529209399|FG000|Treatment Period|Adverse Event|0|||
146737078|NCT01576718|529209400|FG001|Treatment Period|Adverse Event|1|||
146737079|NCT01576718|529209401|FG002|Treatment Period|Adverse Event|1|||
146737080|NCT01576718|529209402|FG003|Treatment Period|Adverse Event|1|||
146737081|NCT01576718|529209403|FG004|Treatment Period|Adverse Event|1|||
146737082|NCT01576718|529209404|FG005|Treatment Period|Adverse Event|1|||
146737083|NCT01576718|529209405|FG006|Treatment Period|Adverse Event|0|||
146737084|NCT01576718|529209399|FG000|Treatment Period|Withdrawal by Subject|0|||
146737085|NCT01576718|529209400|FG001|Treatment Period|Withdrawal by Subject|1|||
146737086|NCT01576718|529209401|FG002|Treatment Period|Withdrawal by Subject|1|||
146737087|NCT01576718|529209402|FG003|Treatment Period|Withdrawal by Subject|0|||
146737088|NCT01576718|529209403|FG004|Treatment Period|Withdrawal by Subject|2|||
146737089|NCT01576718|529209404|FG005|Treatment Period|Withdrawal by Subject|4|||
146737090|NCT01576718|529209405|FG006|Treatment Period|Withdrawal by Subject|2|||
146737091|NCT01576718|529209399|FG000|Treatment Period|Physician Decision|0|||
146737092|NCT01576718|529209400|FG001|Treatment Period|Physician Decision|1|||
146737093|NCT01576718|529209401|FG002|Treatment Period|Physician Decision|1|||
146737094|NCT01576718|529209402|FG003|Treatment Period|Physician Decision|1|||
146737095|NCT01576718|529209403|FG004|Treatment Period|Physician Decision|1|||
146737096|NCT01576718|529209404|FG005|Treatment Period|Physician Decision|0|||
146737097|NCT01576718|529209405|FG006|Treatment Period|Physician Decision|0|||
146737098|NCT01576718|529209399|FG000|Treatment Period|Protocol Violation|0|||
146737099|NCT01576718|529209400|FG001|Treatment Period|Protocol Violation|5|||
146737100|NCT01576718|529209401|FG002|Treatment Period|Protocol Violation|4|||
146737101|NCT01576718|529209402|FG003|Treatment Period|Protocol Violation|10|||
146737102|NCT01576718|529209403|FG004|Treatment Period|Protocol Violation|6|||
146737103|NCT01576718|529209404|FG005|Treatment Period|Protocol Violation|8|||
146737104|NCT01576718|529209405|FG006|Treatment Period|Protocol Violation|12|||
146737105|NCT01576718|529209399|FG000|Treatment Period|Sponsor request|0|||
146737106|NCT01576718|529209400|FG001|Treatment Period|Sponsor request|1|||
146737107|NCT01576718|529209401|FG002|Treatment Period|Sponsor request|0|||
146737108|NCT01576718|529209402|FG003|Treatment Period|Sponsor request|0|||
146737109|NCT01576718|529209403|FG004|Treatment Period|Sponsor request|0|||
146737110|NCT01576718|529209404|FG005|Treatment Period|Sponsor request|1|||
146737111|NCT01576718|529209405|FG006|Treatment Period|Sponsor request|0|||
146737112|NCT01576718|529209399|FG000|Treatment Period|Met stopping criteria|0|||
146737113|NCT01576718|529209400|FG001|Treatment Period|Met stopping criteria|16|||
146737114|NCT01576718|529209401|FG002|Treatment Period|Met stopping criteria|13|||
146737115|NCT01576718|529209402|FG003|Treatment Period|Met stopping criteria|19|||
146850746|NCT00768079|529622536|FG000|Overall Study|Participant incarcerated|0|||
146850747|NCT00768079|529622537|FG001|Overall Study|Participant incarcerated|1|||
146850748|NCT00768079|529622538|FG002|Overall Study|Participant incarcerated|0|||
146850749|NCT01498679|529622539|FG000|Overall Study|Adverse Event|1|||
146850750|NCT01498679|529622540|FG001|Overall Study|Adverse Event|4|||
146850751|NCT01498679|529622539|FG000|Overall Study|Lack of Efficacy|72|||
146850752|NCT01498679|529622540|FG001|Overall Study|Lack of Efficacy|12|||
146850753|NCT01498679|529622539|FG000|Overall Study|Protocol Violation|4|||
146850754|NCT01498679|529622540|FG001|Overall Study|Protocol Violation|0|||
146850755|NCT01498679|529622539|FG000|Overall Study|Physician Decision|0|||
146850756|NCT01498679|529622540|FG001|Overall Study|Physician Decision|2|||
146850757|NCT01498679|529622539|FG000|Overall Study|Withdrawal by Subject|12|||
146963854|NCT00594568|530029535|FG000|Initial Treatment|Entry criteria exclusion|0|||
146737116|NCT01576718|529209403|FG004|Treatment Period|Met stopping criteria|16|||
146737117|NCT01576718|529209404|FG005|Treatment Period|Met stopping criteria|33|||
146737118|NCT01576718|529209405|FG006|Treatment Period|Met stopping criteria|15|||
146737119|NCT01576718|529209399|FG000|Treatment Period|Lost to Follow-up|0|||
146737120|NCT01576718|529209400|FG001|Treatment Period|Lost to Follow-up|0|||
146737121|NCT01576718|529209401|FG002|Treatment Period|Lost to Follow-up|0|||
146737122|NCT01576718|529209402|FG003|Treatment Period|Lost to Follow-up|0|||
146737123|NCT01576718|529209403|FG004|Treatment Period|Lost to Follow-up|1|||
146737124|NCT01576718|529209404|FG005|Treatment Period|Lost to Follow-up|0|||
146737125|NCT01576718|529209405|FG006|Treatment Period|Lost to Follow-up|0|||
146737126|NCT01576718|529209399|FG000|Treatment Period|Noncompliance to study medication|0|||
146737127|NCT01576718|529209400|FG001|Treatment Period|Noncompliance to study medication|0|||
146737128|NCT01576718|529209401|FG002|Treatment Period|Noncompliance to study medication|0|||
146737129|NCT01576718|529209402|FG003|Treatment Period|Noncompliance to study medication|0|||
146737130|NCT01576718|529209403|FG004|Treatment Period|Noncompliance to study medication|0|||
146737131|NCT01576718|529209404|FG005|Treatment Period|Noncompliance to study medication|1|||
146737132|NCT01576718|529209405|FG006|Treatment Period|Noncompliance to study medication|1|||
146737133|NCT01874145|529209406|FG000|Core Period|Non-compliance|1|||
146737134|NCT01874145|529209407|FG001|Core Period|Non-compliance|0|||
146737135|NCT01874145|529209406|FG000|Core Period|Protocol Violation|1|||
146737136|NCT01874145|529209407|FG001|Core Period|Protocol Violation|1|||
146737137|NCT01874145|529209406|FG000|Core Period|Physician Decision|1|||
146737138|NCT01874145|529209407|FG001|Core Period|Physician Decision|1|||
146737139|NCT01874145|529209406|FG000|Core Period|Adverse Event|0|||
146737140|NCT01874145|529209407|FG001|Core Period|Adverse Event|1|||
146737141|NCT01874145|529209406|FG000|Core Period|Withdrawal by Subject|0|||
146737142|NCT01874145|529209407|FG001|Core Period|Withdrawal by Subject|4|||
146737143|NCT01874145|529209406|FG000|Extension Period|Adverse Event|3|||
146737144|NCT01874145|529209407|FG001|Extension Period|Adverse Event|2|||
146737145|NCT01874145|529209406|FG000|Extension Period|Withdrawal by Subject|2|||
146737146|NCT01874145|529209407|FG001|Extension Period|Withdrawal by Subject|1|||
146737147|NCT01874145|529209406|FG000|Extension Period|Lost to Follow-up|1|||
146737148|NCT01874145|529209407|FG001|Extension Period|Lost to Follow-up|1|||
146737149|NCT04631705|529209408|FG000|Overall Study|Withdrawal by Subject|0|||
146737150|NCT04631705|529209409|FG001|Overall Study|Withdrawal by Subject|0|||
146737151|NCT04631705|529209410|FG002|Overall Study|Withdrawal by Subject|0|||
146737152|NCT04631705|529209411|FG003|Overall Study|Withdrawal by Subject|0|||
146737153|NCT04631705|529209412|FG004|Overall Study|Withdrawal by Subject|0|||
146737154|NCT04631705|529209413|FG005|Overall Study|Withdrawal by Subject|0|||
146737155|NCT04631705|529209414|FG006|Overall Study|Withdrawal by Subject|1|||
146737156|NCT04631705|529209415|FG007|Overall Study|Withdrawal by Subject|0|||
146737157|NCT04631705|529209416|FG008|Overall Study|Withdrawal by Subject|0|||
146770059|NCT00792948|529326663|FG000|Overall Study|Insurance denial - not treated|1|||
146770060|NCT00792948|529326663|FG000|Overall Study|Physician Decision|11|||
146770061|NCT00792948|529326663|FG000|Overall Study|Protocol Violation|1|||
146770062|NCT06129045|529326664|FG000|Overall Study|Lost to Follow-up|1|||
146770063|NCT06129045|529326665|FG001|Overall Study|Lost to Follow-up|1|||
146770064|NCT06129045|529326666|FG002|Overall Study|Lost to Follow-up|4|||
146770065|NCT01582269|529326669|FG000|Overall Study|Withdrawal by Subject|1|||
146770066|NCT01582269|529326670|FG001|Overall Study|Withdrawal by Subject|0|||
146770067|NCT01582269|529326671|FG002|Overall Study|Withdrawal by Subject|0|||
146770068|NCT06218251|529326672|FG000|Overall Study|Lost to Follow-up|4|||
146770069|NCT05076266|529326673|FG000|Overall Study|Survey not complete - Participant refusal|2|||
146770070|NCT05076266|529326674|FG001|Overall Study|Survey not complete - Participant refusal|0|||
146770071|NCT05797155|529326675|FG000|Overall Study|Lost to Follow-up|33|||
146770072|NCT05797155|529326676|FG001|Overall Study|Lost to Follow-up|12|||
146770073|NCT03516942|529326679|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
146770074|NCT03516942|529326679|FG000|Registration through baseline survey com|Death|8|||
146770075|NCT03516942|529326679|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
146770076|NCT03516942|529326679|FG000|T0: Baseline|LOST|13|||
146770077|NCT03516942|529326679|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
146850758|NCT01498679|529622540|FG001|Overall Study|Withdrawal by Subject|4|||
146850759|NCT03212989|529622542|FG000|Overall Study|Physician Decision|8|||
146850760|NCT02057523|529622546|FG000|Overall Study|Withdrawal by Subject|1|||
146850761|NCT02057523|529622546|FG000|Overall Study|Lack of Efficacy|1|||
146850762|NCT00158860|529622547|FG000|Overall Study|Adverse Event|3|||
146850763|NCT00158860|529622548|FG001|Overall Study|Adverse Event|6|||
146850764|NCT00158860|529622547|FG000|Overall Study|Lost to Follow-up|11|||
146850765|NCT00158860|529622548|FG001|Overall Study|Lost to Follow-up|17|||
146850766|NCT00158860|529622547|FG000|Overall Study|Protocol Violation|8|||
146850767|NCT00158860|529622548|FG001|Overall Study|Protocol Violation|23|||
146850768|NCT00158860|529622547|FG000|Overall Study|Withdrawal by Subject|7|||
146850769|NCT00158860|529622548|FG001|Overall Study|Withdrawal by Subject|17|||
146850770|NCT00158860|529622547|FG000|Overall Study|MOVING OUT OF STATE|1|||
146850771|NCT00158860|529622548|FG001|Overall Study|MOVING OUT OF STATE|0|||
146850772|NCT00158860|529622547|FG000|Overall Study|Pregnancy|3|||
146850773|NCT00158860|529622548|FG001|Overall Study|Pregnancy|3|||
146850774|NCT00158860|529622547|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
146850775|NCT00158860|529622548|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
146850776|NCT00158860|529622547|FG000|Overall Study|SPONSOR REQUEST|0|||
146850777|NCT00158860|529622548|FG001|Overall Study|SPONSOR REQUEST|1|||
146850778|NCT00158860|529622547|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
146850779|NCT00158860|529622548|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
146850780|NCT00158860|529622547|FG000|Overall Study|Closed per sponsor|0|||
146850781|NCT00158860|529622548|FG001|Overall Study|Closed per sponsor|1|||
146850782|NCT03047395|529622549|FG000|Overall Study|Adverse Event|142|||
146850783|NCT03047395|529622549|FG000|Overall Study|Withdrawal by Subject|155|||
146850784|NCT03047395|529622549|FG000|Overall Study|Lost to Follow-up|144|||
146850785|NCT03047395|529622549|FG000|Overall Study|COVID-19 Infection|2|||
146850786|NCT03047395|529622549|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
146850787|NCT03047395|529622549|FG000|Overall Study|Other, Not Specified|117|||
146850788|NCT01871805|529622554|FG000|Phase I|Death|7|||
146850789|NCT01871805|529622555|FG001|Phase I|Death|4|||
146850790|NCT01871805|529622556|FG002|Phase I|Death|6|||
146850791|NCT01871805|529622557|FG003|Phase I|Death|2|||
146850792|NCT01871805|529622558|FG004|Phase I|Death|9|||
146850793|NCT01871805|529622559|FG005|Phase I|Death|0|||
146850794|NCT01871805|529622554|FG000|Phase I|Alive in Survival Follow-up|0|||
146850795|NCT01871805|529622555|FG001|Phase I|Alive in Survival Follow-up|2|||
146850796|NCT01871805|529622556|FG002|Phase I|Alive in Survival Follow-up|4|||
146850797|NCT01871805|529622557|FG003|Phase I|Alive in Survival Follow-up|5|||
146850798|NCT01871805|529622558|FG004|Phase I|Alive in Survival Follow-up|4|||
146850799|NCT01871805|529622559|FG005|Phase I|Alive in Survival Follow-up|0|||
146850800|NCT01871805|529622554|FG000|Phase I|Lost to Follow-up|0|||
146850801|NCT01871805|529622555|FG001|Phase I|Lost to Follow-up|1|||
146850802|NCT01871805|529622556|FG002|Phase I|Lost to Follow-up|3|||
146850803|NCT01871805|529622557|FG003|Phase I|Lost to Follow-up|0|||
146850804|NCT01871805|529622558|FG004|Phase I|Lost to Follow-up|0|||
146850805|NCT01871805|529622559|FG005|Phase I|Lost to Follow-up|0|||
146850806|NCT01871805|529622554|FG000|Phase II|Death|0|||
146850807|NCT01871805|529622555|FG001|Phase II|Death|0|||
146850808|NCT01871805|529622556|FG002|Phase II|Death|0|||
146850809|NCT01871805|529622557|FG003|Phase II|Death|0|||
146850810|NCT01871805|529622558|FG004|Phase II|Death|0|||
146850811|NCT01871805|529622559|FG005|Phase II|Death|45|||
146850812|NCT01871805|529622554|FG000|Phase II|Alive in Survival Follow-up|0|||
146850813|NCT01871805|529622555|FG001|Phase II|Alive in Survival Follow-up|0|||
146850814|NCT01871805|529622556|FG002|Phase II|Alive in Survival Follow-up|0|||
146850815|NCT01871805|529622557|FG003|Phase II|Alive in Survival Follow-up|0|||
146850816|NCT01871805|529622558|FG004|Phase II|Alive in Survival Follow-up|0|||
146850817|NCT01871805|529622559|FG005|Phase II|Alive in Survival Follow-up|29|||
146850818|NCT01871805|529622554|FG000|Phase II|Lost to Follow-up|0|||
146850819|NCT01871805|529622555|FG001|Phase II|Lost to Follow-up|0|||
146850820|NCT01871805|529622556|FG002|Phase II|Lost to Follow-up|0|||
146850821|NCT01871805|529622557|FG003|Phase II|Lost to Follow-up|0|||
146850822|NCT01871805|529622558|FG004|Phase II|Lost to Follow-up|0|||
146850823|NCT01871805|529622559|FG005|Phase II|Lost to Follow-up|13|||
146850824|NCT00564889|529622560|FG000|Overall Study|Death|7|||
146850825|NCT00564889|529622560|FG000|Overall Study|Adverse Event|12|||
146850826|NCT00564889|529622560|FG000|Overall Study|Alternative treatment|3|||
146850827|NCT00564889|529622560|FG000|Overall Study|Disease progression|3|||
146850828|NCT00564889|529622560|FG000|Overall Study|Other, not specified|4|||
146850829|NCT00635427|529622561|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
146850830|NCT00635427|529622562|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
146850831|NCT00635427|529622563|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
146850832|NCT00635427|529622564|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
146850833|NCT00635427|529622565|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
146850834|NCT00635427|529622561|FG000|Overall Study|Death|0|||
146850835|NCT00635427|529622562|FG001|Overall Study|Death|0|||
146850836|NCT00635427|529622563|FG002|Overall Study|Death|0|||
146850837|NCT00635427|529622564|FG003|Overall Study|Death|1|||
146850838|NCT00635427|529622565|FG004|Overall Study|Death|0|||
146850839|NCT00635427|529622561|FG000|Overall Study|Termination Of Study By Sponsor|12|||
146850840|NCT00635427|529622562|FG001|Overall Study|Termination Of Study By Sponsor|6|||
146850841|NCT00635427|529622563|FG002|Overall Study|Termination Of Study By Sponsor|10|||
146850842|NCT00635427|529622564|FG003|Overall Study|Termination Of Study By Sponsor|6|||
146850843|NCT00635427|529622565|FG004|Overall Study|Termination Of Study By Sponsor|6|||
146850844|NCT00635427|529622561|FG000|Overall Study|Withdrawal Of Consent|0|||
146850845|NCT00635427|529622562|FG001|Overall Study|Withdrawal Of Consent|0|||
146850846|NCT00635427|529622563|FG002|Overall Study|Withdrawal Of Consent|0|||
146850847|NCT00635427|529622564|FG003|Overall Study|Withdrawal Of Consent|2|||
146850848|NCT00635427|529622565|FG004|Overall Study|Withdrawal Of Consent|2|||
146850849|NCT01435616|529622568|FG000|Overall Study|Adverse Event|39|||
146850850|NCT01435616|529622569|FG001|Overall Study|Adverse Event|21|||
146850851|NCT01435616|529622568|FG000|Overall Study|Death|7|||
146850852|NCT01435616|529622569|FG001|Overall Study|Death|2|||
146850853|NCT01435616|529622568|FG000|Overall Study|Lost to Follow-up|22|||
146850854|NCT01435616|529622569|FG001|Overall Study|Lost to Follow-up|13|||
146850855|NCT01435616|529622568|FG000|Overall Study|Protocol Violation|16|||
146850856|NCT01435616|529622569|FG001|Overall Study|Protocol Violation|13|||
146737158|NCT01816763|529211453|FG000|Overall Study|The main reason for an incomplete survey|4|||
146737159|NCT01816763|529211454|FG001|Overall Study|The main reason for an incomplete survey|15|||
146737160|NCT01816763|529211455|FG002|Overall Study|The main reason for an incomplete survey|11|||
146737161|NCT01186328|529211463|FG000|Overall Study|Death|1|||
146737162|NCT01186328|529211464|FG001|Overall Study|Death|0|||
146737163|NCT01186328|529211465|FG002|Overall Study|Death|0|||
146737164|NCT03075501|529211466|FG000|Overall Study|Scheduling difficulties|15|||
146737165|NCT03075501|529211467|FG001|Overall Study|Scheduling difficulties|9|||
146737166|NCT02762981|529211468|FG000|Overall Study|Adverse Event|2|||
146737167|NCT02762981|529211469|FG001|Overall Study|Adverse Event|3|||
146737168|NCT02762981|529211470|FG002|Overall Study|Adverse Event|1|||
146737169|NCT02762981|529211471|FG003|Overall Study|Adverse Event|1|||
146737170|NCT02762981|529211472|FG004|Overall Study|Adverse Event|3|||
146737171|NCT02762981|529211468|FG000|Overall Study|Physician Decision|0|||
146737172|NCT02762981|529211469|FG001|Overall Study|Physician Decision|1|||
146737173|NCT02762981|529211470|FG002|Overall Study|Physician Decision|0|||
146737174|NCT02762981|529211471|FG003|Overall Study|Physician Decision|0|||
146737175|NCT02762981|529211472|FG004|Overall Study|Physician Decision|1|||
146737176|NCT02762981|529211468|FG000|Overall Study|Disease progression|11|||
146737177|NCT02762981|529211469|FG001|Overall Study|Disease progression|23|||
146737178|NCT02762981|529211470|FG002|Overall Study|Disease progression|4|||
146737179|NCT02762981|529211471|FG003|Overall Study|Disease progression|10|||
146737180|NCT02762981|529211472|FG004|Overall Study|Disease progression|1|||
146737181|NCT02762981|529211468|FG000|Overall Study|Enrolled not treated|1|||
146737182|NCT02762981|529211469|FG001|Overall Study|Enrolled not treated|5|||
146737183|NCT02762981|529211470|FG002|Overall Study|Enrolled not treated|0|||
146737184|NCT02762981|529211471|FG003|Overall Study|Enrolled not treated|2|||
146737185|NCT02762981|529211472|FG004|Overall Study|Enrolled not treated|0|||
146737186|NCT02762981|529211468|FG000|Overall Study|Other|2|||
146737187|NCT02762981|529211469|FG001|Overall Study|Other|3|||
146737188|NCT02762981|529211470|FG002|Overall Study|Other|1|||
146737189|NCT02762981|529211471|FG003|Overall Study|Other|0|||
146737190|NCT02762981|529211472|FG004|Overall Study|Other|0|||
146850857|NCT01435616|529622568|FG000|Overall Study|Withdrawal by Subject|66|||
146850858|NCT01435616|529622569|FG001|Overall Study|Withdrawal by Subject|24|||
146850859|NCT01435616|529622568|FG000|Overall Study|Physician Decision|20|||
146737191|NCT02762981|529211468|FG000|Overall Study|Missing|1|||
146737192|NCT02762981|529211469|FG001|Overall Study|Missing|0|||
146737193|NCT02762981|529211470|FG002|Overall Study|Missing|0|||
146850860|NCT01435616|529622569|FG001|Overall Study|Physician Decision|7|||
146850861|NCT01435616|529622568|FG000|Overall Study|Sponsor Decision|1|||
146850862|NCT01435616|529622569|FG001|Overall Study|Sponsor Decision|0|||
146850863|NCT04860297|529622570|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
146850864|NCT04860297|529622571|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
146850865|NCT04860297|529622572|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
146850866|NCT04860297|529622573|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
146850867|NCT04860297|529622574|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
146850868|NCT04860297|529622575|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
146963855|NCT00594568|530029536|FG001|Initial Treatment|Entry criteria exclusion|1|||
146737194|NCT02762981|529211471|FG003|Overall Study|Missing|0|||
146737195|NCT02762981|529211472|FG004|Overall Study|Missing|0|||
146737196|NCT02762981|529211468|FG000|Overall Study|Withdrawal by Subject|0|||
146737197|NCT02762981|529211469|FG001|Overall Study|Withdrawal by Subject|5|||
146737198|NCT02762981|529211470|FG002|Overall Study|Withdrawal by Subject|1|||
146737199|NCT02762981|529211471|FG003|Overall Study|Withdrawal by Subject|3|||
146737200|NCT02762981|529211472|FG004|Overall Study|Withdrawal by Subject|0|||
146737201|NCT02392611|529211474|FG000|Overall Study|Adverse Event|0|||
146737202|NCT02392611|529211475|FG001|Overall Study|Adverse Event|0|||
146737203|NCT02392611|529211476|FG002|Overall Study|Adverse Event|0|||
146737204|NCT02392611|529211477|FG003|Overall Study|Adverse Event|1|||
146737205|NCT02392611|529211478|FG004|Overall Study|Adverse Event|0|||
146737206|NCT02392611|529211479|FG005|Overall Study|Adverse Event|0|||
146737207|NCT02392611|529211480|FG006|Overall Study|Adverse Event|0|||
146737208|NCT02392611|529211481|FG007|Overall Study|Adverse Event|0|||
146737209|NCT02392611|529211482|FG008|Overall Study|Adverse Event|0|||
146737210|NCT02392611|529211474|FG000|Overall Study|Progressive disease|0|||
146737211|NCT02392611|529211475|FG001|Overall Study|Progressive disease|0|||
146737212|NCT02392611|529211476|FG002|Overall Study|Progressive disease|0|||
146737213|NCT02392611|529211477|FG003|Overall Study|Progressive disease|2|||
146737214|NCT02392611|529211478|FG004|Overall Study|Progressive disease|1|||
146737215|NCT02392611|529211479|FG005|Overall Study|Progressive disease|0|||
146737216|NCT02392611|529211480|FG006|Overall Study|Progressive disease|0|||
146737217|NCT02392611|529211481|FG007|Overall Study|Progressive disease|0|||
146737218|NCT02392611|529211482|FG008|Overall Study|Progressive disease|0|||
146737219|NCT02392611|529211474|FG000|Overall Study|Death|1|||
146737220|NCT02392611|529211475|FG001|Overall Study|Death|0|||
146737221|NCT02392611|529211476|FG002|Overall Study|Death|0|||
146737222|NCT02392611|529211477|FG003|Overall Study|Death|0|||
146737223|NCT02392611|529211478|FG004|Overall Study|Death|0|||
146737224|NCT02392611|529211479|FG005|Overall Study|Death|1|||
146737225|NCT02392611|529211480|FG006|Overall Study|Death|0|||
146737226|NCT02392611|529211481|FG007|Overall Study|Death|0|||
146737227|NCT02392611|529211482|FG008|Overall Study|Death|0|||
146737228|NCT02392611|529211474|FG000|Overall Study|Withdrawal by Subject|0|||
146737229|NCT02392611|529211475|FG001|Overall Study|Withdrawal by Subject|0|||
146737230|NCT02392611|529211476|FG002|Overall Study|Withdrawal by Subject|0|||
146737231|NCT02392611|529211477|FG003|Overall Study|Withdrawal by Subject|1|||
146737232|NCT02392611|529211478|FG004|Overall Study|Withdrawal by Subject|0|||
146737233|NCT02392611|529211479|FG005|Overall Study|Withdrawal by Subject|0|||
146737234|NCT02392611|529211480|FG006|Overall Study|Withdrawal by Subject|0|||
146737235|NCT02392611|529211481|FG007|Overall Study|Withdrawal by Subject|0|||
146737236|NCT02392611|529211482|FG008|Overall Study|Withdrawal by Subject|0|||
146737237|NCT02392611|529211474|FG000|Overall Study|Lost to Follow-up|0|||
146737238|NCT02392611|529211475|FG001|Overall Study|Lost to Follow-up|0|||
146737239|NCT02392611|529211476|FG002|Overall Study|Lost to Follow-up|0|||
146737240|NCT02392611|529211477|FG003|Overall Study|Lost to Follow-up|0|||
146737241|NCT02392611|529211478|FG004|Overall Study|Lost to Follow-up|0|||
146737242|NCT02392611|529211479|FG005|Overall Study|Lost to Follow-up|0|||
146737243|NCT02392611|529211480|FG006|Overall Study|Lost to Follow-up|1|||
146737244|NCT02392611|529211481|FG007|Overall Study|Lost to Follow-up|0|||
146737245|NCT02392611|529211482|FG008|Overall Study|Lost to Follow-up|0|||
146737246|NCT02392611|529211474|FG000|Overall Study|Enrolled, not treated|0|||
146737247|NCT02392611|529211475|FG001|Overall Study|Enrolled, not treated|0|||
146737248|NCT02392611|529211476|FG002|Overall Study|Enrolled, not treated|0|||
146737249|NCT02392611|529211477|FG003|Overall Study|Enrolled, not treated|2|||
146737250|NCT02392611|529211478|FG004|Overall Study|Enrolled, not treated|0|||
146737251|NCT02392611|529211479|FG005|Overall Study|Enrolled, not treated|0|||
146737252|NCT02392611|529211480|FG006|Overall Study|Enrolled, not treated|0|||
146737253|NCT02392611|529211481|FG007|Overall Study|Enrolled, not treated|0|||
146737254|NCT02392611|529211482|FG008|Overall Study|Enrolled, not treated|0|||
146737255|NCT02991482|529211485|FG000|Overall Study|Disease progression|56|||
146737256|NCT02991482|529211486|FG001|Overall Study|Disease progression|47|||
146737257|NCT02991482|529211485|FG000|Overall Study|Death|4|||
146737258|NCT02991482|529211486|FG001|Overall Study|Death|4|||
146737259|NCT02991482|529211485|FG000|Overall Study|Adverse Event|1|||
146737260|NCT02991482|529211486|FG001|Overall Study|Adverse Event|6|||
146737261|NCT02991482|529211485|FG000|Overall Study|Patient decision|1|||
146737262|NCT02991482|529211486|FG001|Overall Study|Patient decision|1|||
146737263|NCT02991482|529211485|FG000|Overall Study|Physician Decision|0|||
146737264|NCT02991482|529211486|FG001|Overall Study|Physician Decision|6|||
146737265|NCT02991482|529211485|FG000|Overall Study|Clinical deterioration|1|||
146737266|NCT02991482|529211486|FG001|Overall Study|Clinical deterioration|0|||
146737267|NCT02991482|529211485|FG000|Overall Study|Patient feeling too unwell|1|||
146737268|NCT02991482|529211486|FG001|Overall Study|Patient feeling too unwell|0|||
146737269|NCT02991482|529211485|FG000|Overall Study|Worsening of performance status|0|||
146737270|NCT02991482|529211486|FG001|Overall Study|Worsening of performance status|1|||
146737271|NCT02991482|529211485|FG000|Overall Study|Death prior to study drug initiation|1|||
146737272|NCT02991482|529211486|FG001|Overall Study|Death prior to study drug initiation|0|||
146737273|NCT02991482|529211485|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
146737274|NCT02991482|529211486|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
146737275|NCT01250119|529211487|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
146737276|NCT01250119|529211488|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
146737277|NCT01250119|529211487|FG000|Diagnostic Phase|Participants Not Tested|44|||
146737278|NCT01250119|529211488|FG001|Diagnostic Phase|Participants Not Tested|0|||
146737279|NCT01250119|529211487|FG000|Treatment Phase|Progressive Disease|0|||
146737280|NCT01250119|529211488|FG001|Treatment Phase|Progressive Disease|32|||
146737281|NCT01250119|529211487|FG000|Treatment Phase|Death|0|||
146737282|NCT01250119|529211488|FG001|Treatment Phase|Death|2|||
146737283|NCT01250119|529211487|FG000|Treatment Phase|Withdrawal by Subject|0|||
146737284|NCT01250119|529211488|FG001|Treatment Phase|Withdrawal by Subject|1|||
146737285|NCT01250119|529211487|FG000|Treatment Phase|Adverse Event|0|||
146737286|NCT01250119|529211488|FG001|Treatment Phase|Adverse Event|2|||
146737287|NCT01250119|529211487|FG000|Treatment Phase|Unknown reason|0|||
146737288|NCT01250119|529211488|FG001|Treatment Phase|Unknown reason|4|||
146737289|NCT02887989|529211491|FG000|Overall Study|Withdrawal by Subject|8|||
146737290|NCT02887989|529211492|FG001|Overall Study|Withdrawal by Subject|11|||
146737291|NCT02887989|529211491|FG000|Overall Study|Death|1|||
146737292|NCT02887989|529211492|FG001|Overall Study|Death|0|||
146737293|NCT05648357|529211496|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
146737294|NCT00255346|529211497|FG000|Overall Study|Adverse Event|1|||
146737295|NCT00255346|529211498|FG001|Overall Study|Adverse Event|0|||
146737296|NCT00255346|529211499|FG002|Overall Study|Adverse Event|0|||
146737297|NCT00255346|529211500|FG003|Overall Study|Adverse Event|0|||
146737298|NCT00255346|529211501|FG004|Overall Study|Adverse Event|0|||
146737299|NCT00674323|529211502|FG000|Overall Study|Adverse Event|0|||
146737300|NCT00674323|529211503|FG001|Overall Study|Adverse Event|1|||
146737301|NCT00674323|529211504|FG002|Overall Study|Adverse Event|0|||
146737302|NCT00674323|529211502|FG000|Overall Study|Protocol Violation|1|||
146737303|NCT00674323|529211503|FG001|Overall Study|Protocol Violation|0|||
146737304|NCT00674323|529211504|FG002|Overall Study|Protocol Violation|0|||
146737305|NCT02045433|529211510|FG000|Overall Study|Withdrawal by Subject|1|||
146737306|NCT01559454|529211511|FG000|Overall Study|Lost to Follow-up|3|||
146737307|NCT01559454|529211512|FG001|Overall Study|Lost to Follow-up|2|||
146737308|NCT01559454|529211511|FG000|Overall Study|Withdrawal by Subject|0|||
146737309|NCT01559454|529211512|FG001|Overall Study|Withdrawal by Subject|1|||
146737310|NCT01559454|529211511|FG000|Overall Study|Physician Decision|0|||
146737311|NCT01559454|529211512|FG001|Overall Study|Physician Decision|1|||
146737312|NCT01559454|529211511|FG000|Overall Study|Protocol Violation|0|||
146737313|NCT01559454|529211512|FG001|Overall Study|Protocol Violation|1|||
146737314|NCT01559454|529211511|FG000|Overall Study|Lack of Efficacy|0|||
146737315|NCT01559454|529211512|FG001|Overall Study|Lack of Efficacy|1|||
146737316|NCT02207725|529211513|FG000|Overall Study|Did Not Receive Treatment|0|||
146737317|NCT02207725|529211514|FG001|Overall Study|Did Not Receive Treatment|1|||
146737318|NCT02207725|529211515|FG002|Overall Study|Did Not Receive Treatment|1|||
146737319|NCT02207725|529211516|FG003|Overall Study|Did Not Receive Treatment|1|||
146737320|NCT02948959|529211518|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
146737321|NCT02948959|529211519|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
146737322|NCT02948959|529211518|FG000|52 Weeks Treatment Period|Adverse Event|2|||
146737323|NCT02948959|529211519|FG001|52 Weeks Treatment Period|Adverse Event|5|||
146737324|NCT02948959|529211518|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
146737325|NCT02948959|529211519|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
146737326|NCT02948959|529211518|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
146737327|NCT02948959|529211519|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
146737328|NCT02948959|529211518|FG000|52 Weeks Treatment Period|Randomized by error|0|||
146737329|NCT02948959|529211519|FG001|52 Weeks Treatment Period|Randomized by error|5|||
146737330|NCT02948959|529211518|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
146737331|NCT02948959|529211519|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
146737332|NCT02948959|529211518|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
146737333|NCT02948959|529211519|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
146737334|NCT02948959|529211518|FG000|52 Weeks Treatment Period|Change of residence location|0|||
146737335|NCT02948959|529211519|FG001|52 Weeks Treatment Period|Change of residence location|1|||
146737336|NCT02948959|529211518|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
146737337|NCT02948959|529211519|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
146737338|NCT02948959|529211518|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
146737339|NCT02948959|529211519|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
146737340|NCT02948959|529211518|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
146737341|NCT02948959|529211519|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
146737342|NCT02948959|529211518|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
146737343|NCT02948959|529211519|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
146737344|NCT02948959|529211518|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
146737345|NCT02948959|529211519|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
146737346|NCT02948959|529211518|FG000|12 Weeks Follow-up Period|Study site closure|1|||
146737347|NCT02948959|529211519|FG001|12 Weeks Follow-up Period|Study site closure|0|||
146737348|NCT00409786|529211520|FG000|Overall Study|Withdrawal by Subject|3|||
146737349|NCT00597714|529211521|FG000|Overall Study|Death|56|||
146737350|NCT00597714|529211522|FG001|Overall Study|Death|46|||
146737351|NCT00597714|529211523|FG002|Overall Study|Death|0|||
146737352|NCT00597714|529211521|FG000|Overall Study|Recipient death|0|||
146737353|NCT00597714|529211522|FG001|Overall Study|Recipient death|0|||
146737354|NCT00597714|529211523|FG002|Overall Study|Recipient death|10|||
146737355|NCT01350141|529211524|FG000|Overall Study|Lost to Follow-up|1|||
146737356|NCT01350141|529211525|FG001|Overall Study|Lost to Follow-up|0|||
146737357|NCT01350141|529211526|FG002|Overall Study|Lost to Follow-up|1|||
146737358|NCT01350141|529211524|FG000|Overall Study|Withdrawal by Subject|1|||
146737359|NCT01350141|529211525|FG001|Overall Study|Withdrawal by Subject|0|||
146737360|NCT01350141|529211526|FG002|Overall Study|Withdrawal by Subject|0|||
146737361|NCT01350141|529211524|FG000|Overall Study|Randomized but not treated|1|||
146737362|NCT01350141|529211525|FG001|Overall Study|Randomized but not treated|0|||
146737363|NCT01350141|529211526|FG002|Overall Study|Randomized but not treated|0|||
146737364|NCT00810082|529211527|FG000|Overall Study|Lost to Follow-up|0|||
146737365|NCT00810082|529211528|FG001|Overall Study|Lost to Follow-up|4|||
146737366|NCT01588990|529211529|FG000|Phase A|Withdrawal by Subject|5|||
146737367|NCT01588990|529211529|FG000|Phase A|Physician Decision|11|||
146737368|NCT01588990|529211529|FG000|Phase A|Other|14|||
146737369|NCT01588990|529211529|FG000|Phase A|Lost to Follow-up|1|||
146737370|NCT01588990|529211529|FG000|Phase A|Death|5|||
146737371|NCT01588990|529211529|FG000|Phase A|Adverse Event|28|||
146737372|NCT01588990|529211529|FG000|Phase A|Still on therapy at end of study|6|||
146737373|NCT01588990|529211529|FG000|Phase B|Adverse Event|2|||
146737374|NCT01588990|529211529|FG000|Phase B|Still on therapy at end of study|5|||
146737375|NCT01588990|529211529|FG000|Phase B|Withdrawal by Subject|3|||
146737376|NCT01588990|529211529|FG000|Phase B|Physician Decision|4|||
146737377|NCT01588990|529211529|FG000|Phase B|Other|2|||
146737378|NCT02367716|529211530|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
146737379|NCT02341456|529211531|FG000|Overall Study|Disease progression|2|||
146737380|NCT02341456|529211532|FG001|Overall Study|Disease progression|3|||
146737381|NCT02341456|529211533|FG002|Overall Study|Disease progression|1|||
146737382|NCT02341456|529211531|FG000|Overall Study|Death|1|||
146737383|NCT02341456|529211532|FG001|Overall Study|Death|1|||
146737384|NCT02341456|529211533|FG002|Overall Study|Death|1|||
146737385|NCT02341456|529211531|FG000|Overall Study|Withdrawal by Subject|0|||
146737386|NCT02341456|529211532|FG001|Overall Study|Withdrawal by Subject|1|||
146737387|NCT02341456|529211533|FG002|Overall Study|Withdrawal by Subject|1|||
146737388|NCT02341456|529211531|FG000|Overall Study|Moved to local access programme.|0|||
146737389|NCT02341456|529211532|FG001|Overall Study|Moved to local access programme.|1|||
146737390|NCT02341456|529211533|FG002|Overall Study|Moved to local access programme.|1|||
146737391|NCT02341456|529211531|FG000|Overall Study|Physician Decision|1|||
146737392|NCT02341456|529211532|FG001|Overall Study|Physician Decision|0|||
146737393|NCT02341456|529211533|FG002|Overall Study|Physician Decision|0|||
146737394|NCT03528174|529211538|FG000|Overall Study|Adverse Event|1|||
146737395|NCT03528174|529211538|FG000|Overall Study|sensors dislodged|1|||
146737396|NCT03002038|529211539|FG000|Overall Study|Adverse Event|3|||
146737397|NCT03002038|529211540|FG001|Overall Study|Adverse Event|1|||
146737398|NCT03002038|529211539|FG000|Overall Study|Withdrawal by Subject|8|||
146737399|NCT03002038|529211540|FG001|Overall Study|Withdrawal by Subject|4|||
146737400|NCT03002038|529211539|FG000|Overall Study|Immigration to another region|0|||
146737401|NCT03002038|529211540|FG001|Overall Study|Immigration to another region|2|||
146737402|NCT00979602|529211547|FG000|Overall Study|Serious Adverse Event|5|||
146737403|NCT00979602|529211548|FG001|Overall Study|Serious Adverse Event|3|||
146737404|NCT00979602|529211547|FG000|Overall Study|Protocol Violation|3|||
146737405|NCT00979602|529211548|FG001|Overall Study|Protocol Violation|0|||
146737406|NCT00979602|529211547|FG000|Overall Study|Withdrawal by Subject|31|||
146737407|NCT00979602|529211548|FG001|Overall Study|Withdrawal by Subject|25|||
146737408|NCT00979602|529211547|FG000|Overall Study|Lost to Follow-up|100|||
146737409|NCT00979602|529211548|FG001|Overall Study|Lost to Follow-up|96|||
146737410|NCT00979602|529211547|FG000|Overall Study|Migrated/moved from study area|3|||
146737411|NCT00979602|529211548|FG001|Overall Study|Migrated/moved from study area|6|||
146737412|NCT00979602|529211547|FG000|Overall Study|Others|3|||
146737413|NCT00979602|529211548|FG001|Overall Study|Others|3|||
146737414|NCT02904902|529211549|FG000|Overall Study|Withdrawal by Subject|1|||
146737415|NCT02712398|529211553|FG000|Overall Study|Withdrawal by Subject|6|||
146737416|NCT02712398|529211553|FG000|Overall Study|Lost to Follow-up|6|||
146737417|NCT02712398|529211553|FG000|Overall Study|Sponsor Decision|1|||
146737418|NCT02712398|529211553|FG000|Overall Study|Physician Decision|1|||
146737419|NCT02712398|529211553|FG000|Overall Study|Death|2|||
146737420|NCT02712398|529211553|FG000|Overall Study|Re-operation|21|||
146737421|NCT02002182|529211563|FG000|Overall Study|Withdraw from study|3|||
146737422|NCT02002182|529211564|FG001|Overall Study|Withdraw from study|1|||
146737423|NCT02002182|529211563|FG000|Overall Study|Health Reasons|1|||
146737424|NCT02002182|529211564|FG001|Overall Study|Health Reasons|0|||
146737425|NCT02002182|529211563|FG000|Overall Study|Death|1|||
146737426|NCT02002182|529211564|FG001|Overall Study|Death|0|||
146737427|NCT03787680|529211566|FG000|Overall Study|Physician Decision|2|||
146737428|NCT03787680|529211567|FG001|Overall Study|Physician Decision|3|||
146737429|NCT03787680|529211566|FG000|Overall Study|Adverse Event|7|||
146737430|NCT03787680|529211567|FG001|Overall Study|Adverse Event|3|||
146737431|NCT03787680|529211566|FG000|Overall Study|Withdrawal by Subject|2|||
146737432|NCT03787680|529211567|FG001|Overall Study|Withdrawal by Subject|1|||
146737433|NCT05400746|529211568|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
146737434|NCT05400746|529211569|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
146737435|NCT05400746|529211570|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
146737436|NCT03724396|529211571|FG000|Overall Study|Lost to Follow-up|1|||
146737437|NCT03724396|529211572|FG001|Overall Study|Lost to Follow-up|1|||
146737438|NCT03724396|529211571|FG000|Overall Study|Withdrawal by Subject|1|||
146737439|NCT03724396|529211572|FG001|Overall Study|Withdrawal by Subject|0|||
146737440|NCT01490125|529211573|FG000|Period I|Adverse Event|4|||
146737441|NCT01490125|529211574|FG001|Period I|Adverse Event|1|||
146737442|NCT01490125|529211575|FG002|Period I|Adverse Event|1|||
146737443|NCT01490125|529211576|FG003|Period I|Adverse Event|3|||
146737444|NCT01490125|529211577|FG004|Period I|Adverse Event|2|||
146737445|NCT01490125|529211578|FG005|Period I|Adverse Event|4|||
146737446|NCT01490125|529211573|FG000|Period I|Protocol Violation|1|||
146737447|NCT01490125|529211574|FG001|Period I|Protocol Violation|1|||
146737448|NCT01490125|529211575|FG002|Period I|Protocol Violation|1|||
146737449|NCT01490125|529211576|FG003|Period I|Protocol Violation|1|||
146737450|NCT01490125|529211577|FG004|Period I|Protocol Violation|0|||
146737451|NCT01490125|529211578|FG005|Period I|Protocol Violation|0|||
146737452|NCT01490125|529211573|FG000|Period I|Withdrawal by Subject|1|||
146737453|NCT01490125|529211574|FG001|Period I|Withdrawal by Subject|3|||
146737454|NCT01490125|529211575|FG002|Period I|Withdrawal by Subject|2|||
146737455|NCT01490125|529211576|FG003|Period I|Withdrawal by Subject|1|||
146737456|NCT01490125|529211577|FG004|Period I|Withdrawal by Subject|2|||
146737457|NCT01490125|529211578|FG005|Period I|Withdrawal by Subject|1|||
146737458|NCT01490125|529211573|FG000|Period II|Adverse Event|2|||
146737459|NCT01490125|529211574|FG001|Period II|Adverse Event|3|||
146737460|NCT01490125|529211575|FG002|Period II|Adverse Event|2|||
146737461|NCT01490125|529211576|FG003|Period II|Adverse Event|2|||
146737462|NCT01490125|529211577|FG004|Period II|Adverse Event|4|||
146737463|NCT01490125|529211578|FG005|Period II|Adverse Event|2|||
146737464|NCT01490125|529211573|FG000|Period II|Protocol Violation|0|||
146737465|NCT01490125|529211574|FG001|Period II|Protocol Violation|0|||
146737466|NCT01490125|529211575|FG002|Period II|Protocol Violation|1|||
146737467|NCT01490125|529211576|FG003|Period II|Protocol Violation|1|||
146737468|NCT01490125|529211577|FG004|Period II|Protocol Violation|0|||
146737469|NCT01490125|529211578|FG005|Period II|Protocol Violation|0|||
146737470|NCT01490125|529211573|FG000|Period II|Lost to Follow-up|0|||
146737471|NCT01490125|529211574|FG001|Period II|Lost to Follow-up|1|||
146737472|NCT01490125|529211575|FG002|Period II|Lost to Follow-up|0|||
146737473|NCT01490125|529211576|FG003|Period II|Lost to Follow-up|0|||
146737474|NCT01490125|529211577|FG004|Period II|Lost to Follow-up|0|||
146737475|NCT01490125|529211578|FG005|Period II|Lost to Follow-up|0|||
146737476|NCT01490125|529211573|FG000|Period II|Withdrawal by Subject|1|||
146737477|NCT01490125|529211574|FG001|Period II|Withdrawal by Subject|0|||
146737478|NCT01490125|529211575|FG002|Period II|Withdrawal by Subject|0|||
146737479|NCT01490125|529211576|FG003|Period II|Withdrawal by Subject|0|||
146737480|NCT01490125|529211577|FG004|Period II|Withdrawal by Subject|0|||
146737481|NCT01490125|529211578|FG005|Period II|Withdrawal by Subject|0|||
146737482|NCT01490125|529211573|FG000|Period III|Adverse Event|3|||
146737483|NCT01490125|529211574|FG001|Period III|Adverse Event|1|||
146737484|NCT01490125|529211575|FG002|Period III|Adverse Event|0|||
146737485|NCT01490125|529211576|FG003|Period III|Adverse Event|1|||
146737486|NCT01490125|529211577|FG004|Period III|Adverse Event|0|||
146737487|NCT01490125|529211578|FG005|Period III|Adverse Event|0|||
146737488|NCT01490125|529211573|FG000|Period III|Death|0|||
146737489|NCT01490125|529211574|FG001|Period III|Death|0|||
146737490|NCT01490125|529211575|FG002|Period III|Death|0|||
146737491|NCT01490125|529211576|FG003|Period III|Death|1|||
146737492|NCT01490125|529211577|FG004|Period III|Death|0|||
146737493|NCT01490125|529211578|FG005|Period III|Death|0|||
146737494|NCT01490125|529211573|FG000|Period III|Lack of Efficacy|0|||
146737495|NCT01490125|529211574|FG001|Period III|Lack of Efficacy|0|||
146737496|NCT01490125|529211575|FG002|Period III|Lack of Efficacy|0|||
146737497|NCT01490125|529211576|FG003|Period III|Lack of Efficacy|0|||
146737498|NCT01490125|529211577|FG004|Period III|Lack of Efficacy|1|||
146737499|NCT01490125|529211578|FG005|Period III|Lack of Efficacy|0|||
146737500|NCT04522180|529211579|FG000|Overall Study|Investigator judgement|3|||
146737501|NCT04522180|529211580|FG001|Overall Study|Investigator judgement|4|||
146737502|NCT04522180|529211579|FG000|Overall Study|Voluntary withdrawal|1|||
146737503|NCT04522180|529211580|FG001|Overall Study|Voluntary withdrawal|0|||
146737504|NCT04522180|529211579|FG000|Overall Study|Pregnancy|0|||
146737505|NCT04522180|529211580|FG001|Overall Study|Pregnancy|1|||
146737506|NCT04522180|529211579|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
146737507|NCT04522180|529211580|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
146737508|NCT04522180|529211579|FG000|Overall Study|Reason not specified|8|||
146737509|NCT04522180|529211580|FG001|Overall Study|Reason not specified|5|||
146737510|NCT05807919|529211581|FG000|Overall Study|Received antibiotics - excluded|0|||
146737511|NCT05807919|529211582|FG001|Overall Study|Received antibiotics - excluded|1|||
146737512|NCT05807919|529211581|FG000|Overall Study|Withdrawal by Subject|0|||
146737513|NCT05807919|529211582|FG001|Overall Study|Withdrawal by Subject|3|||
146737514|NCT05807919|529211581|FG000|Overall Study|Adverse Event|1|||
146737515|NCT05807919|529211582|FG001|Overall Study|Adverse Event|1|||
146737516|NCT03635489|529211587|FG000|Overall Study|Death|19|||
146737517|NCT03635489|529211588|FG001|Overall Study|Death|13|||
146737518|NCT03635489|529211587|FG000|Overall Study|Lost to Follow-up|1|||
146737519|NCT03635489|529211588|FG001|Overall Study|Lost to Follow-up|2|||
146737520|NCT03635489|529211587|FG000|Overall Study|Withdrawal by Subject|1|||
146737521|NCT03635489|529211588|FG001|Overall Study|Withdrawal by Subject|2|||
146737522|NCT03635489|529211587|FG000|Overall Study|Study Ended by Sponsor|28|||
146737523|NCT03635489|529211588|FG001|Overall Study|Study Ended by Sponsor|34|||
146737524|NCT01368900|529211589|FG000|Overall Study|Lost to Follow-up|7|||
146737525|NCT02277743|529211599|FG000|Overall Study|Protocol Violation|1|||
146737526|NCT02277743|529211600|FG001|Overall Study|Protocol Violation|1|||
146737527|NCT02277743|529211601|FG002|Overall Study|Protocol Violation|1|||
146737528|NCT02277743|529211599|FG000|Overall Study|Adverse Event|10|||
146737529|NCT02277743|529211600|FG001|Overall Study|Adverse Event|6|||
146737530|NCT02277743|529211601|FG002|Overall Study|Adverse Event|6|||
146737531|NCT02277743|529211599|FG000|Overall Study|Lack of Efficacy|11|||
146737532|NCT02277743|529211600|FG001|Overall Study|Lack of Efficacy|4|||
146737533|NCT02277743|529211601|FG002|Overall Study|Lack of Efficacy|3|||
146737534|NCT02277743|529211599|FG000|Overall Study|Other than specified above|18|||
146737535|NCT02277743|529211600|FG001|Overall Study|Other than specified above|5|||
146737536|NCT02277743|529211601|FG002|Overall Study|Other than specified above|16|||
146737537|NCT01224158|529211602|FG000|Overall Study|Withdrawal by Subject|1|||
146737538|NCT01224158|529211603|FG001|Overall Study|Withdrawal by Subject|0|||
146737539|NCT02055157|529211606|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
146737540|NCT02055157|529211607|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
146737541|NCT02055157|529211608|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
146737542|NCT02055157|529211609|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
146737543|NCT02055157|529211606|FG000|Initial 6 Months|Adverse Event|0|||
146737544|NCT02055157|529211607|FG001|Initial 6 Months|Adverse Event|0|||
146737545|NCT02055157|529211608|FG002|Initial 6 Months|Adverse Event|0|||
146737546|NCT02055157|529211609|FG003|Initial 6 Months|Adverse Event|1|||
146737547|NCT02055157|529211606|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
146737548|NCT02055157|529211607|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
146737549|NCT02055157|529211608|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
146737550|NCT02055157|529211609|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
146737551|NCT02055157|529211606|FG000|18-month Extension|Investigator decision|0|||
146737552|NCT02055157|529211607|FG001|18-month Extension|Investigator decision|1|||
146737553|NCT02055157|529211608|FG002|18-month Extension|Investigator decision|0|||
146737554|NCT02055157|529211609|FG003|18-month Extension|Investigator decision|0|||
146737555|NCT02055157|529211606|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
146737556|NCT02055157|529211607|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
146737557|NCT02055157|529211608|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
146737558|NCT02055157|529211609|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
146737559|NCT03976466|529211610|FG000|Overall Study|Lost to Follow-up|1|||
146737560|NCT03976466|529211611|FG001|Overall Study|Lost to Follow-up|3|||
146737561|NCT00943306|529211616|FG000|Overall Study|Physician Decision|1|||
146737562|NCT00943306|529211616|FG000|Overall Study|Death|1|||
146737563|NCT00943306|529211616|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
146737564|NCT00733499|529211617|FG000|Pre-operative|Protocol Violation|0|||
146737565|NCT00733499|529211618|FG001|Pre-operative|Protocol Violation|1|||
146737566|NCT00733499|529211617|FG000|3 Months Follow-up|Death|1|||
146737567|NCT00733499|529211618|FG001|3 Months Follow-up|Death|2|||
146737568|NCT00733499|529211617|FG000|6 Months Follow-up|Death|0|||
146737569|NCT00733499|529211618|FG001|6 Months Follow-up|Death|2|||
146737570|NCT00733499|529211617|FG000|6 Months Follow-up|Adverse Event|0|||
146737571|NCT00733499|529211618|FG001|6 Months Follow-up|Adverse Event|1|||
146737572|NCT00733499|529211617|FG000|12 Months Follow-up|Death|2|||
146737573|NCT00733499|529211618|FG001|12 Months Follow-up|Death|1|||
146737574|NCT00733499|529211617|FG000|24 Months Follow-up|Death|0|||
146737575|NCT00733499|529211618|FG001|24 Months Follow-up|Death|1|||
146737576|NCT00733499|529211617|FG000|5 Year Followup|Adverse Event|2|||
146737577|NCT00733499|529211618|FG001|5 Year Followup|Adverse Event|2|||
146737578|NCT00733499|529211617|FG000|5 Year Followup|Non device related AE|0|||
146737579|NCT00733499|529211618|FG001|5 Year Followup|Non device related AE|1|||
146737580|NCT00733499|529211617|FG000|5 Year Followup|Revision of Study Implant|0|||
146737581|NCT00733499|529211618|FG001|5 Year Followup|Revision of Study Implant|1|||
146737582|NCT00733499|529211617|FG000|5 Year Followup|Lost to Follow-up|2|||
146737583|NCT00733499|529211618|FG001|5 Year Followup|Lost to Follow-up|0|||
146737584|NCT00733499|529211617|FG000|5 Year Followup|Death|13|||
146737585|NCT00733499|529211618|FG001|5 Year Followup|Death|19|||
146737586|NCT00733499|529211617|FG000|5 Year Followup|missing, unable to locate|0|||
146737587|NCT00733499|529211618|FG001|5 Year Followup|missing, unable to locate|1|||
146737588|NCT00733499|529211617|FG000|5 Year Followup|Withdrawal by Subject|4|||
146737589|NCT00733499|529211618|FG001|5 Year Followup|Withdrawal by Subject|1|||
146737590|NCT00733499|529211617|FG000|10 Year Followup|Death|9|||
146737591|NCT00733499|529211618|FG001|10 Year Followup|Death|7|||
146737592|NCT00733499|529211617|FG000|10 Year Followup|Adverse Event|3|||
146737593|NCT00733499|529211618|FG001|10 Year Followup|Adverse Event|3|||
146737594|NCT00733499|529211617|FG000|10 Year Followup|Lost to Follow-up|3|||
146737595|NCT00733499|529211618|FG001|10 Year Followup|Lost to Follow-up|2|||
146737596|NCT00733499|529211617|FG000|10 Year Followup|Withdrawal by Subject|5|||
146737597|NCT00733499|529211618|FG001|10 Year Followup|Withdrawal by Subject|5|||
146737598|NCT00733499|529211617|FG000|10 Year Followup|missing, unable to locate|0|||
146737599|NCT00733499|529211618|FG001|10 Year Followup|missing, unable to locate|2|||
146737600|NCT00733980|529211619|FG000|Overall Study|Adverse Event|5|||
146737601|NCT00733980|529211620|FG001|Overall Study|Adverse Event|2|||
146737602|NCT00733980|529211619|FG000|Overall Study|Lack of Efficacy|0|||
146737603|NCT00733980|529211620|FG001|Overall Study|Lack of Efficacy|1|||
146737604|NCT00733980|529211619|FG000|Overall Study|Protocol Violation|2|||
146737605|NCT00733980|529211620|FG001|Overall Study|Protocol Violation|1|||
146737606|NCT00733980|529211619|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
146737607|NCT00733980|529211620|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
146737608|NCT00733980|529211619|FG000|Overall Study|Lost to Follow-up|6|||
146737609|NCT00733980|529211620|FG001|Overall Study|Lost to Follow-up|11|||
146737610|NCT00733980|529211619|FG000|Overall Study|Physician Decision|2|||
146737611|NCT00733980|529211620|FG001|Overall Study|Physician Decision|3|||
146737612|NCT00733980|529211619|FG000|Overall Study|Withdrawal by Subject|6|||
146737613|NCT00733980|529211620|FG001|Overall Study|Withdrawal by Subject|2|||
146737614|NCT02739347|529211621|FG000|Overall Study|Adverse Event|3|||
146737615|NCT02739347|529211622|FG001|Overall Study|Adverse Event|0|||
146737616|NCT02739347|529211621|FG000|Overall Study|Protocol Violation|0|||
146737617|NCT02739347|529211622|FG001|Overall Study|Protocol Violation|1|||
146737618|NCT02739347|529211621|FG000|Overall Study|Lost to Follow-up|0|||
146737619|NCT02739347|529211622|FG001|Overall Study|Lost to Follow-up|2|||
146737620|NCT01552954|529211623|FG000|Overall Study|Adverse Event|1|||
146737621|NCT01552954|529211624|FG001|Overall Study|Adverse Event|2|||
146737622|NCT01552954|529211623|FG000|Overall Study|Lost to Follow-up|1|||
146737623|NCT01552954|529211624|FG001|Overall Study|Lost to Follow-up|1|||
146737624|NCT01552954|529211623|FG000|Overall Study|Withdrawal by Subject|1|||
146737625|NCT01552954|529211624|FG001|Overall Study|Withdrawal by Subject|1|||
146737626|NCT01552954|529211623|FG000|Overall Study|Protocol Violation|1|||
146737627|NCT01552954|529211624|FG001|Overall Study|Protocol Violation|2|||
146737628|NCT01552954|529211623|FG000|Overall Study|diagnosed DM|1|||
146737629|NCT01552954|529211624|FG001|Overall Study|diagnosed DM|0|||
146737630|NCT00779779|529211625|FG000|Overall Study|Adverse Event|1|||
146737631|NCT00779779|529211625|FG000|Overall Study|Protocol Violation|14|||
146737632|NCT00779779|529211625|FG000|Overall Study|Withdrawal by Subject|4|||
146737633|NCT00779779|529211625|FG000|Overall Study|Lost to Follow-up|5|||
146737634|NCT01395823|529211626|FG000|Overall Study|Death|4|||
146737635|NCT01395823|529211627|FG001|Overall Study|Death|4|||
146737636|NCT01395823|529211626|FG000|Overall Study|Physician Decision|3|||
146737637|NCT01395823|529211627|FG001|Overall Study|Physician Decision|1|||
146737638|NCT01395823|529211626|FG000|Overall Study|Lost to Follow-up|1|||
146737639|NCT01395823|529211627|FG001|Overall Study|Lost to Follow-up|0|||
146737640|NCT01395823|529211626|FG000|Overall Study|Transplant|1|||
146737641|NCT01395823|529211627|FG001|Overall Study|Transplant|0|||
146737642|NCT01395823|529211626|FG000|Overall Study|GI symptoms|1|||
146737643|NCT01395823|529211627|FG001|Overall Study|GI symptoms|0|||
146737644|NCT01395823|529211626|FG000|Overall Study|Withdrawal by Subject|5|||
146737645|NCT01395823|529211627|FG001|Overall Study|Withdrawal by Subject|4|||
146737646|NCT03300570|529211629|FG000|Overall Study|Adverse Event|0|||
146737647|NCT03300570|529211630|FG001|Overall Study|Adverse Event|1|||
146737648|NCT03300570|529211629|FG000|Overall Study|Withdrawal by Subject|1|||
146737649|NCT03300570|529211630|FG001|Overall Study|Withdrawal by Subject|0|||
146737650|NCT03300570|529211629|FG000|Overall Study|Inadequate bowel prep|1|||
146737651|NCT03300570|529211630|FG001|Overall Study|Inadequate bowel prep|0|||
146737652|NCT02070484|529211634|FG000|Overall Study|Withdrawal by Subject|1|||
146737653|NCT02070484|529211635|FG001|Overall Study|Withdrawal by Subject|0|||
146737654|NCT02658630|529211636|FG000|Overall Study|Withdrawal by Subject|4|||
146737655|NCT02821819|529211637|FG000|Overall Study|Protocol Violation|1|||
146737656|NCT01353222|529211643|FG000|Overall Study|Death|30|||
146737657|NCT01353222|529211644|FG001|Overall Study|Death|30|||
146737658|NCT01353222|529211643|FG000|Overall Study|Withdrawal by Subject|8|||
146737659|NCT01353222|529211644|FG001|Overall Study|Withdrawal by Subject|5|||
146737660|NCT01353222|529211643|FG000|Overall Study|Study Terminated|31|||
146737661|NCT01353222|529211644|FG001|Overall Study|Study Terminated|37|||
146737662|NCT01353222|529211643|FG000|Overall Study|Site closed research department|1|||
146737663|NCT01353222|529211644|FG001|Overall Study|Site closed research department|0|||
146737664|NCT01654601|529211646|FG000|1st Administration|Withdrawal by Subject|2|||
146737665|NCT01654601|529211647|FG001|1st Administration|Withdrawal by Subject|0|||
146737666|NCT01654601|529211646|FG000|1st Administration|Protocol Violation|0|||
146737667|NCT01654601|529211647|FG001|1st Administration|Protocol Violation|2|||
146737668|NCT01654601|529211646|FG000|2nd Administration|Adverse Event|1|||
146737669|NCT01654601|529211647|FG001|2nd Administration|Adverse Event|0|||
146737670|NCT01654601|529211646|FG000|2nd Administration|Protocol Violation|0|||
146737671|NCT01654601|529211647|FG001|2nd Administration|Protocol Violation|1|||
146737672|NCT02636270|529211648|FG000|Overall Study|Adverse Event|1|||
146737673|NCT02636270|529211649|FG001|Overall Study|Adverse Event|0|||
146737674|NCT02636270|529211650|FG002|Overall Study|Adverse Event|0|||
146737675|NCT02636270|529211648|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
146737676|NCT02636270|529211649|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
146737677|NCT02636270|529211650|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
146737678|NCT01833143|529211651|FG000|Overall Study|Not Treated|1|||
146737679|NCT03021668|529211652|FG000|Overall Study|Physician Decision|0|||
146737680|NCT03021668|529211653|FG001|Overall Study|Physician Decision|1|||
146737681|NCT02217280|529211656|FG000|Overall Study|Withdrawal by Subject|2|||
146737682|NCT02217280|529211656|FG000|Overall Study|Post-consent sceen fail|2|||
146737683|NCT00429494|529213344|FG000|Overall Study|Withdrawal by Subject|9|||
146737684|NCT00429494|529213344|FG000|Overall Study|Death|6|||
146737685|NCT00976703|529213345|FG000|Overall Study|Physician Decision|1|||
146737686|NCT00976703|529213346|FG001|Overall Study|Physician Decision|1|||
146737687|NCT00976703|529213345|FG000|Overall Study|ineligible for study|2|||
146737688|NCT00976703|529213346|FG001|Overall Study|ineligible for study|2|||
146737689|NCT01900054|529213351|FG000|Overall Study|Physician Decision|1|||
146737690|NCT01900054|529213351|FG000|Overall Study|Withdrawal by Subject|1|||
146737691|NCT03285295|529213354|FG000|Alinity s HBsAg|Protocol Violation|11|||
146737692|NCT03285295|529213355|FG001|Alinity s HBsAg|Protocol Violation|0|||
146737693|NCT03285295|529213356|FG002|Alinity s HBsAg|Protocol Violation|0|||
146737694|NCT03285295|529213357|FG003|Alinity s HBsAg|Protocol Violation|0|||
146737695|NCT03285295|529213358|FG004|Alinity s HBsAg|Protocol Violation|0|||
146737696|NCT03285295|529213354|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
146737697|NCT03285295|529213355|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
146737698|NCT03285295|529213356|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
146737699|NCT03285295|529213357|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
146737700|NCT03285295|529213358|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
146737701|NCT03285295|529213354|FG000|Alinity s HBsAg|No Results Generated|74|||
146737702|NCT03285295|529213355|FG001|Alinity s HBsAg|No Results Generated|6|||
146737703|NCT03285295|529213356|FG002|Alinity s HBsAg|No Results Generated|0|||
146737704|NCT03285295|529213357|FG003|Alinity s HBsAg|No Results Generated|0|||
146737705|NCT03285295|529213358|FG004|Alinity s HBsAg|No Results Generated|0|||
146737706|NCT03285295|529213354|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
146737707|NCT03285295|529213355|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
146737708|NCT03285295|529213356|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
146737709|NCT03285295|529213357|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
146737710|NCT03285295|529213358|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
146737711|NCT03285295|529213354|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
146737712|NCT03285295|529213355|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
146737713|NCT03285295|529213356|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
146737714|NCT03285295|529213357|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
146737715|NCT03285295|529213358|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
146737716|NCT03285295|529213354|FG000|Alinity s HTLV I/II|No Results Generated|70|||
146737717|NCT03285295|529213355|FG001|Alinity s HTLV I/II|No Results Generated|0|||
146737718|NCT03285295|529213356|FG002|Alinity s HTLV I/II|No Results Generated|0|||
146737719|NCT03285295|529213357|FG003|Alinity s HTLV I/II|No Results Generated|0|||
146737720|NCT03285295|529213358|FG004|Alinity s HTLV I/II|No Results Generated|0|||
146737721|NCT03285295|529213354|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
146737722|NCT03285295|529213355|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
146975289|NCT04388527|530073516|FG000|Overall Study|Lost to Follow-up|1|||
146509807|NCT02000882|528371853|FG000|Overall Study|Adverse Event|3|||
146737723|NCT03285295|529213356|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
146737724|NCT03285295|529213357|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
146737725|NCT03285295|529213358|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
146737726|NCT03285295|529213354|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
146737727|NCT03285295|529213355|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
146737728|NCT03285295|529213356|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
146737729|NCT03285295|529213357|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
146737730|NCT03285295|529213358|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
146737731|NCT03285295|529213354|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
146737732|NCT03285295|529213355|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
146737733|NCT03285295|529213356|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
146737734|NCT03285295|529213357|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
146737735|NCT03285295|529213358|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
146737736|NCT03285295|529213354|FG000|Alinity s Anti-HCV|No Results Generated|71|||
146850869|NCT04860297|529622576|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
146850870|NCT04860297|529622577|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
146850871|NCT04860297|529622570|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
146850872|NCT04860297|529622571|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
146850873|NCT04860297|529622572|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
146850874|NCT04860297|529622573|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
146850875|NCT04860297|529622574|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
146850876|NCT04860297|529622575|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
146850877|NCT04860297|529622576|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
146850878|NCT04860297|529622577|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
146850879|NCT04860297|529622570|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
146850880|NCT04860297|529622571|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
146850881|NCT04860297|529622572|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
146850882|NCT04860297|529622573|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
146850883|NCT04860297|529622574|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
146850884|NCT04860297|529622575|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
146850885|NCT04860297|529622576|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
146850886|NCT04860297|529622577|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
146850887|NCT04860297|529622570|FG000|Part B (Booster Dose)|Other Than Specified|0|||
146850888|NCT04860297|529622571|FG001|Part B (Booster Dose)|Other Than Specified|0|||
146850889|NCT04860297|529622572|FG002|Part B (Booster Dose)|Other Than Specified|0|||
146850890|NCT04860297|529622573|FG003|Part B (Booster Dose)|Other Than Specified|0|||
146850891|NCT04860297|529622574|FG004|Part B (Booster Dose)|Other Than Specified|0|||
146850892|NCT04860297|529622575|FG005|Part B (Booster Dose)|Other Than Specified|1|||
146850893|NCT04860297|529622576|FG006|Part B (Booster Dose)|Other Than Specified|1|||
146850894|NCT04860297|529622577|FG007|Part B (Booster Dose)|Other Than Specified|0|||
146850895|NCT04860297|529622570|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
146850896|NCT04860297|529622571|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
146850897|NCT04860297|529622572|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
146850898|NCT04860297|529622573|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
146850899|NCT04860297|529622574|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
146850900|NCT04860297|529622575|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
146850901|NCT04860297|529622576|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
146850902|NCT04860297|529622577|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
146850903|NCT04860297|529622570|FG000|Part B (Booster Dose)|Death|0|||
146850904|NCT04860297|529622571|FG001|Part B (Booster Dose)|Death|0|||
146850905|NCT04860297|529622572|FG002|Part B (Booster Dose)|Death|0|||
146850906|NCT04860297|529622573|FG003|Part B (Booster Dose)|Death|0|||
146850907|NCT04860297|529622574|FG004|Part B (Booster Dose)|Death|1|||
146850908|NCT04860297|529622575|FG005|Part B (Booster Dose)|Death|2|||
146850909|NCT04860297|529622576|FG006|Part B (Booster Dose)|Death|1|||
146850910|NCT04860297|529622577|FG007|Part B (Booster Dose)|Death|0|||
146850911|NCT04860297|529622570|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
146850912|NCT04860297|529622571|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
146850913|NCT04860297|529622572|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
146850914|NCT04860297|529622573|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
146850915|NCT04860297|529622574|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
146850916|NCT04860297|529622575|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
146850917|NCT04860297|529622576|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
146850918|NCT04860297|529622577|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
146850919|NCT00620282|529622584|FG000|Overall Study|Adverse Event|0|||
146850920|NCT00620282|529622585|FG001|Overall Study|Adverse Event|1|||
146850921|NCT00620282|529622586|FG002|Overall Study|Adverse Event|0|||
146850922|NCT00620282|529622584|FG000|Overall Study|Arterial line unable to be placed|0|||
146850923|NCT00620282|529622585|FG001|Overall Study|Arterial line unable to be placed|0|||
146850924|NCT00620282|529622586|FG002|Overall Study|Arterial line unable to be placed|1|||
146850925|NCT00620282|529622584|FG000|Overall Study|Withdrawal by Subject|0|||
146850926|NCT00620282|529622585|FG001|Overall Study|Withdrawal by Subject|1|||
146850927|NCT00620282|529622586|FG002|Overall Study|Withdrawal by Subject|0|||
146850928|NCT02703259|529622587|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
146850929|NCT02703259|529622588|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
146737737|NCT03285295|529213355|FG001|Alinity s Anti-HCV|No Results Generated|0|||
146737738|NCT03285295|529213356|FG002|Alinity s Anti-HCV|No Results Generated|0|||
146737739|NCT03285295|529213357|FG003|Alinity s Anti-HCV|No Results Generated|0|||
146737740|NCT03285295|529213358|FG004|Alinity s Anti-HCV|No Results Generated|0|||
146737741|NCT03285295|529213354|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
146737742|NCT03285295|529213355|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
146737743|NCT03285295|529213356|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
146737744|NCT03285295|529213357|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
146737745|NCT03285295|529213358|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
146737746|NCT03285295|529213354|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
146737747|NCT03285295|529213355|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
146737748|NCT03285295|529213356|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
146737749|NCT03285295|529213357|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
146737750|NCT03285295|529213358|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
146737751|NCT03285295|529213354|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
146737752|NCT03285295|529213355|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
146737753|NCT03285295|529213356|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
146737754|NCT03285295|529213357|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
146737755|NCT03285295|529213358|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
146737756|NCT03285295|529213354|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
146737757|NCT03285295|529213355|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
146737758|NCT03285295|529213356|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
146737759|NCT03285295|529213357|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
146737760|NCT03285295|529213358|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
146737761|NCT03285295|529213354|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
146737762|NCT03285295|529213355|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
146737763|NCT03285295|529213356|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
146737764|NCT03285295|529213357|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
146737765|NCT03285295|529213358|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
146737766|NCT03285295|529213354|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
146737767|NCT03285295|529213355|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
146737768|NCT03285295|529213356|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
146737769|NCT03285295|529213357|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
146737770|NCT03285295|529213358|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
146737771|NCT03285295|529213354|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
146737772|NCT03285295|529213355|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
146737773|NCT03285295|529213356|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
146737774|NCT03285295|529213357|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
146737775|NCT03285295|529213358|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
146737776|NCT03285295|529213354|FG000|Alinity s Anti-HBc|No Results Generated|70|||
146737777|NCT03285295|529213355|FG001|Alinity s Anti-HBc|No Results Generated|0|||
146737778|NCT03285295|529213356|FG002|Alinity s Anti-HBc|No Results Generated|0|||
146737779|NCT03285295|529213357|FG003|Alinity s Anti-HBc|No Results Generated|0|||
146737780|NCT03285295|529213358|FG004|Alinity s Anti-HBc|No Results Generated|0|||
146737781|NCT03285295|529213354|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
146737782|NCT03285295|529213355|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
146737783|NCT03285295|529213356|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
146737784|NCT03285295|529213357|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
146737785|NCT03285295|529213358|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
146737786|NCT03285295|529213354|FG000|Alinity s Chagas|Protocol Violation|76|||
146737787|NCT03285295|529213355|FG001|Alinity s Chagas|Protocol Violation|0|||
146737788|NCT03285295|529213356|FG002|Alinity s Chagas|Protocol Violation|0|||
146737789|NCT03285295|529213357|FG003|Alinity s Chagas|Protocol Violation|0|||
146737790|NCT03285295|529213358|FG004|Alinity s Chagas|Protocol Violation|0|||
146737791|NCT03285295|529213354|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
146737792|NCT03285295|529213355|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
146737793|NCT03285295|529213356|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
146737794|NCT03285295|529213357|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
146737795|NCT03285295|529213358|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
146737796|NCT03285295|529213354|FG000|Alinity s Chagas|No Results Generated|105|||
146737797|NCT03285295|529213355|FG001|Alinity s Chagas|No Results Generated|0|||
146737798|NCT03285295|529213356|FG002|Alinity s Chagas|No Results Generated|0|||
146737799|NCT03285295|529213357|FG003|Alinity s Chagas|No Results Generated|0|||
146737800|NCT03285295|529213358|FG004|Alinity s Chagas|No Results Generated|0|||
146737801|NCT03285295|529213354|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
146737802|NCT03285295|529213355|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
146737803|NCT03285295|529213356|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
146737804|NCT03285295|529213357|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
146737805|NCT03285295|529213358|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
146737806|NCT00957931|529213361|FG000|Overall Study|Death|4|||
146737807|NCT00857805|529213362|FG000|Overall Study|Withdrawal by Subject|1|||
146737808|NCT00857805|529213363|FG001|Overall Study|Withdrawal by Subject|1|||
146737809|NCT01289041|529213364|FG000|Overall Study|Adverse Event|24|||
146737810|NCT01289041|529213364|FG000|Overall Study|Physician Decision|1|||
146737811|NCT01289041|529213364|FG000|Overall Study|Progressive Disease|41|||
146737812|NCT01289041|529213364|FG000|Overall Study|Withdrawal by Subject|3|||
146737813|NCT01289041|529213364|FG000|Overall Study|Death|1|||
146737814|NCT01062763|529213365|FG000|Overall Study|Adverse Event|3|||
146737815|NCT01062763|529213366|FG001|Overall Study|Adverse Event|4|||
146737816|NCT02714868|529213378|FG000|Overall Study|Withdrawal by Subject|3|||
146737817|NCT02714868|529213379|FG001|Overall Study|Withdrawal by Subject|0|||
146737818|NCT02714868|529213378|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
146737819|NCT02714868|529213379|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
146737820|NCT02714868|529213378|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
146737821|NCT02714868|529213379|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
146737822|NCT00369681|529213380|FG000|Overall Study|Death|1|||
146737823|NCT02508532|529213387|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
146737824|NCT02508532|529213388|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
146737825|NCT02508532|529213389|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
146737826|NCT02508532|529213390|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
146737827|NCT02508532|529213391|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
146737828|NCT02508532|529213392|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
146737829|NCT02508532|529213393|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
146737830|NCT02508532|529213394|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
146737831|NCT02508532|529213395|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
146737832|NCT02508532|529213387|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
146737833|NCT02508532|529213388|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
146737834|NCT02508532|529213389|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
146737835|NCT02508532|529213390|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
146737836|NCT02508532|529213391|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
146737837|NCT02508532|529213392|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
146737838|NCT02508532|529213393|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
146737839|NCT02508532|529213394|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
146737840|NCT02508532|529213395|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
146737841|NCT02508532|529213387|FG000|Part 2 - Treatment|Disease Progression|0|||
146737842|NCT02508532|529213388|FG001|Part 2 - Treatment|Disease Progression|0|||
146737843|NCT02508532|529213389|FG002|Part 2 - Treatment|Disease Progression|0|||
146737844|NCT02508532|529213390|FG003|Part 2 - Treatment|Disease Progression|0|||
146737845|NCT02508532|529213391|FG004|Part 2 - Treatment|Disease Progression|0|||
146737846|NCT02508532|529213392|FG005|Part 2 - Treatment|Disease Progression|0|||
146737847|NCT02508532|529213393|FG006|Part 2 - Treatment|Disease Progression|0|||
146737848|NCT02508532|529213394|FG007|Part 2 - Treatment|Disease Progression|0|||
146737849|NCT02508532|529213395|FG008|Part 2 - Treatment|Disease Progression|118|||
146737850|NCT02508532|529213387|FG000|Part 2 - Treatment|Adverse Event|0|||
146737851|NCT02508532|529213388|FG001|Part 2 - Treatment|Adverse Event|0|||
146737852|NCT02508532|529213389|FG002|Part 2 - Treatment|Adverse Event|0|||
146737853|NCT02508532|529213390|FG003|Part 2 - Treatment|Adverse Event|0|||
146737854|NCT02508532|529213391|FG004|Part 2 - Treatment|Adverse Event|0|||
146737855|NCT02508532|529213392|FG005|Part 2 - Treatment|Adverse Event|0|||
146737856|NCT02508532|529213393|FG006|Part 2 - Treatment|Adverse Event|0|||
146737857|NCT02508532|529213394|FG007|Part 2 - Treatment|Adverse Event|0|||
146737858|NCT02508532|529213395|FG008|Part 2 - Treatment|Adverse Event|49|||
146737859|NCT02508532|529213387|FG000|Part 2 - Treatment|Physician Decision|0|||
146737860|NCT02508532|529213388|FG001|Part 2 - Treatment|Physician Decision|0|||
146737861|NCT02508532|529213389|FG002|Part 2 - Treatment|Physician Decision|0|||
146737862|NCT02508532|529213390|FG003|Part 2 - Treatment|Physician Decision|0|||
146737863|NCT02508532|529213391|FG004|Part 2 - Treatment|Physician Decision|0|||
146737864|NCT02508532|529213392|FG005|Part 2 - Treatment|Physician Decision|0|||
146737865|NCT02508532|529213393|FG006|Part 2 - Treatment|Physician Decision|0|||
146737866|NCT02508532|529213394|FG007|Part 2 - Treatment|Physician Decision|0|||
146737867|NCT02508532|529213395|FG008|Part 2 - Treatment|Physician Decision|12|||
146737868|NCT02508532|529213387|FG000|Part 2 - Treatment|Administrative|0|||
146737869|NCT02508532|529213388|FG001|Part 2 - Treatment|Administrative|0|||
146737870|NCT02508532|529213389|FG002|Part 2 - Treatment|Administrative|0|||
146737871|NCT02508532|529213390|FG003|Part 2 - Treatment|Administrative|0|||
146737872|NCT02508532|529213391|FG004|Part 2 - Treatment|Administrative|0|||
146737873|NCT02508532|529213392|FG005|Part 2 - Treatment|Administrative|0|||
146737874|NCT02508532|529213393|FG006|Part 2 - Treatment|Administrative|0|||
146737875|NCT02508532|529213394|FG007|Part 2 - Treatment|Administrative|0|||
146737876|NCT02508532|529213395|FG008|Part 2 - Treatment|Administrative|3|||
146737877|NCT02508532|529213387|FG000|Part 2 - Treatment|Sponsor Decision|0|||
146737878|NCT02508532|529213388|FG001|Part 2 - Treatment|Sponsor Decision|0|||
146737879|NCT02508532|529213389|FG002|Part 2 - Treatment|Sponsor Decision|0|||
146737880|NCT02508532|529213390|FG003|Part 2 - Treatment|Sponsor Decision|0|||
146737881|NCT02508532|529213391|FG004|Part 2 - Treatment|Sponsor Decision|0|||
146737882|NCT02508532|529213392|FG005|Part 2 - Treatment|Sponsor Decision|0|||
146850930|NCT02703259|529622587|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
146737883|NCT02508532|529213393|FG006|Part 2 - Treatment|Sponsor Decision|0|||
146737884|NCT02508532|529213394|FG007|Part 2 - Treatment|Sponsor Decision|0|||
146737885|NCT02508532|529213395|FG008|Part 2 - Treatment|Sponsor Decision|28|||
146737886|NCT02508532|529213387|FG000|Part 2 - Treatment|Death|0|||
146737887|NCT02508532|529213388|FG001|Part 2 - Treatment|Death|0|||
146737888|NCT02508532|529213389|FG002|Part 2 - Treatment|Death|0|||
146737889|NCT02508532|529213390|FG003|Part 2 - Treatment|Death|0|||
146737890|NCT02508532|529213391|FG004|Part 2 - Treatment|Death|0|||
146737891|NCT02508532|529213392|FG005|Part 2 - Treatment|Death|0|||
146737892|NCT02508532|529213393|FG006|Part 2 - Treatment|Death|0|||
146737893|NCT02508532|529213394|FG007|Part 2 - Treatment|Death|0|||
146737894|NCT02508532|529213395|FG008|Part 2 - Treatment|Death|1|||
146737895|NCT02508532|529213387|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
146737896|NCT02508532|529213388|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
146737897|NCT02508532|529213389|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
146737898|NCT02508532|529213390|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
146737899|NCT02508532|529213391|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
146737900|NCT02508532|529213392|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
146737901|NCT02508532|529213393|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
146737902|NCT02508532|529213394|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
146737903|NCT02508532|529213395|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
146737904|NCT02508532|529213387|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
146737905|NCT02508532|529213388|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
146737906|NCT02508532|529213389|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
146737907|NCT02508532|529213390|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
146737908|NCT02508532|529213391|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
146737909|NCT02508532|529213392|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
146737910|NCT02508532|529213393|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
146737911|NCT02508532|529213394|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
146737912|NCT02508532|529213395|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
146737913|NCT02508532|529213387|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
146737914|NCT02508532|529213388|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
146737915|NCT02508532|529213389|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
146737916|NCT02508532|529213390|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
146737917|NCT02508532|529213391|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
146737918|NCT02508532|529213392|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
146737919|NCT02508532|529213393|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
146737920|NCT02508532|529213394|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
146737921|NCT02508532|529213395|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
146737922|NCT02508532|529213387|FG000|Part 1 and Part 2 End of Study|Death|0|||
146737923|NCT02508532|529213388|FG001|Part 1 and Part 2 End of Study|Death|4|||
146737924|NCT02508532|529213389|FG002|Part 1 and Part 2 End of Study|Death|2|||
146737925|NCT02508532|529213390|FG003|Part 1 and Part 2 End of Study|Death|4|||
146737926|NCT02508532|529213391|FG004|Part 1 and Part 2 End of Study|Death|3|||
146737927|NCT02508532|529213392|FG005|Part 1 and Part 2 End of Study|Death|0|||
146737928|NCT02508532|529213393|FG006|Part 1 and Part 2 End of Study|Death|0|||
146737929|NCT02508532|529213394|FG007|Part 1 and Part 2 End of Study|Death|1|||
146737930|NCT02508532|529213395|FG008|Part 1 and Part 2 End of Study|Death|111|||
146737931|NCT02508532|529213387|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
146737932|NCT02508532|529213388|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
146737933|NCT02508532|529213389|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
146737934|NCT02508532|529213390|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
146737935|NCT02508532|529213391|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
146737936|NCT02508532|529213392|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
146737937|NCT02508532|529213393|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
146737938|NCT02508532|529213394|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
146737939|NCT02508532|529213395|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
146737940|NCT02508532|529213387|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
146737941|NCT02508532|529213388|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
146737942|NCT02508532|529213389|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
146737943|NCT02508532|529213390|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
146737944|NCT02508532|529213391|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
146737945|NCT02508532|529213392|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
146737946|NCT02508532|529213393|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
146737947|NCT02508532|529213394|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
146737948|NCT02508532|529213395|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
146737949|NCT02508532|529213387|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
146737950|NCT02508532|529213388|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
146737951|NCT02508532|529213389|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
146737952|NCT02508532|529213390|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
146737953|NCT02508532|529213391|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
146963856|NCT00594568|530029537|FG002|Initial Treatment|Entry criteria exclusion|1|||
146737954|NCT02508532|529213392|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
146737955|NCT02508532|529213393|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
146737956|NCT02508532|529213394|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
146737957|NCT02508532|529213395|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
146737958|NCT02508532|529213387|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
146737959|NCT02508532|529213388|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
146737960|NCT02508532|529213389|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
146737961|NCT02508532|529213390|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
146737962|NCT02508532|529213391|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
146737963|NCT02508532|529213392|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
146737964|NCT02508532|529213393|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
146737965|NCT02508532|529213394|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
146737966|NCT02508532|529213395|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
146737967|NCT02508532|529213387|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
146737968|NCT02508532|529213388|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
146737969|NCT02508532|529213389|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
146737970|NCT02508532|529213390|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
146737971|NCT02508532|529213391|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
146737972|NCT02508532|529213392|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
146737973|NCT02508532|529213393|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
146737974|NCT02508532|529213394|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
146737975|NCT02508532|529213395|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
146737976|NCT00301080|529213396|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
146737977|NCT00301080|529213397|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
146737978|NCT00301080|529213398|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
146737979|NCT00301080|529213399|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
146737980|NCT00301080|529213400|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
146737981|NCT03502616|529213401|FG000|Up to Week 16|Withdrawal by Subject|1|||
146737982|NCT03502616|529213402|FG001|Up to Week 16|Withdrawal by Subject|2|||
146737983|NCT03502616|529213401|FG000|Up to Week 16|Lost to Follow-up|0|||
146737984|NCT03502616|529213402|FG001|Up to Week 16|Lost to Follow-up|1|||
146737985|NCT03502616|529213401|FG000|Up to Week 16|Randomized, but not treated|1|||
146737986|NCT03502616|529213402|FG001|Up to Week 16|Randomized, but not treated|0|||
146737987|NCT03502616|529213401|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
146737988|NCT03502616|529213402|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
146737989|NCT03502616|529213401|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
146737990|NCT03502616|529213402|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
146737991|NCT04359771|529213404|FG000|Overall Study|Lack of Efficacy|2|||
146737992|NCT04359771|529213405|FG001|Overall Study|Lack of Efficacy|2|||
146737993|NCT02917265|529213406|FG000|Overall Study|Physician Decision|1|||
146737994|NCT02917265|529213407|FG001|Overall Study|Physician Decision|0|||
146737995|NCT02917265|529213406|FG000|Overall Study|Withdrawal by Subject|1|||
146737996|NCT02917265|529213407|FG001|Overall Study|Withdrawal by Subject|0|||
146737997|NCT01216163|529213408|FG000|Overall Study|Withdrawal by Subject|1|||
146737998|NCT01216163|529213409|FG001|Overall Study|Withdrawal by Subject|1|||
146737999|NCT01216163|529213410|FG002|Overall Study|Withdrawal by Subject|0|||
146738000|NCT02237508|529213412|FG000|Overall Study|Withdrawal by Subject|0|||
146738001|NCT02237508|529213413|FG001|Overall Study|Withdrawal by Subject|2|||
146738002|NCT02237508|529213414|FG002|Overall Study|Withdrawal by Subject|0|||
146738003|NCT02237508|529213415|FG003|Overall Study|Withdrawal by Subject|1|||
146738004|NCT02237508|529213416|FG004|Overall Study|Withdrawal by Subject|0|||
146850931|NCT02703259|529622588|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
146850932|NCT02703259|529622587|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
146850933|NCT02703259|529622588|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
146850934|NCT02442336|529622591|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
146850935|NCT02442336|529622591|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
146850936|NCT02442336|529622591|FG000|Overall Study|Lost to Follow-up|11|||
146850937|NCT00998790|529622592|FG000|Overall Study|Withdrawal by Subject|21|||
146850938|NCT01080716|529622593|FG000|Part 1|Physician Decision|1|||
146738005|NCT02237508|529213417|FG005|Overall Study|Withdrawal by Subject|1|||
146738006|NCT02237508|529213418|FG006|Overall Study|Withdrawal by Subject|1|||
146738007|NCT02237508|529213419|FG007|Overall Study|Withdrawal by Subject|0|||
146738008|NCT02237508|529213420|FG008|Overall Study|Withdrawal by Subject|1|||
146738009|NCT02237508|529213421|FG009|Overall Study|Withdrawal by Subject|0|||
146738010|NCT02237508|529213412|FG000|Overall Study|Physician Decision|0|||
146738011|NCT02237508|529213413|FG001|Overall Study|Physician Decision|1|||
146738012|NCT02237508|529213414|FG002|Overall Study|Physician Decision|0|||
146738013|NCT02237508|529213415|FG003|Overall Study|Physician Decision|0|||
146738014|NCT02237508|529213416|FG004|Overall Study|Physician Decision|0|||
146738015|NCT02237508|529213417|FG005|Overall Study|Physician Decision|0|||
146738016|NCT02237508|529213418|FG006|Overall Study|Physician Decision|0|||
146738017|NCT02237508|529213419|FG007|Overall Study|Physician Decision|0|||
146738018|NCT02237508|529213420|FG008|Overall Study|Physician Decision|0|||
146738019|NCT02237508|529213421|FG009|Overall Study|Physician Decision|0|||
146738020|NCT02237508|529213412|FG000|Overall Study|Protocol Violation|0|||
146738021|NCT02237508|529213413|FG001|Overall Study|Protocol Violation|0|||
146738022|NCT02237508|529213414|FG002|Overall Study|Protocol Violation|1|||
146738023|NCT02237508|529213415|FG003|Overall Study|Protocol Violation|0|||
146738024|NCT02237508|529213416|FG004|Overall Study|Protocol Violation|0|||
146738025|NCT02237508|529213417|FG005|Overall Study|Protocol Violation|0|||
146738026|NCT02237508|529213418|FG006|Overall Study|Protocol Violation|0|||
146738027|NCT02237508|529213419|FG007|Overall Study|Protocol Violation|0|||
146738028|NCT02237508|529213420|FG008|Overall Study|Protocol Violation|0|||
146738029|NCT02237508|529213421|FG009|Overall Study|Protocol Violation|0|||
146738030|NCT04000594|529213422|FG000|Overall Study|Withdrawal by Subject|1|||
146738031|NCT04000594|529213423|FG001|Overall Study|Withdrawal by Subject|0|||
146738032|NCT04000594|529213424|FG002|Overall Study|Withdrawal by Subject|0|||
146738033|NCT01905046|529213425|FG000|Months 13-24|Withdrawal by Subject|10|||
146738034|NCT01905046|529213426|FG001|Months 13-24|Withdrawal by Subject|10|||
146738035|NCT01905046|529213425|FG000|Months 13-24|Adverse Event|3|||
146738036|NCT01905046|529213426|FG001|Months 13-24|Adverse Event|2|||
146738037|NCT01905046|529213425|FG000|Months 13-24|Protocol Violation|3|||
146738038|NCT01905046|529213426|FG001|Months 13-24|Protocol Violation|3|||
146738039|NCT01905046|529213425|FG000|Months 13-24|Physician Decision|1|||
146738040|NCT01905046|529213426|FG001|Months 13-24|Physician Decision|0|||
146738041|NCT05672680|529213427|FG000|Overall Study|Patient Did Not Complete the Form|5|||
146738042|NCT05672680|529213428|FG001|Overall Study|Patient Did Not Complete the Form|4|||
146738043|NCT05672680|529213427|FG000|Overall Study|Procedure Aborted|1|||
146738044|NCT05672680|529213428|FG001|Overall Study|Procedure Aborted|0|||
146738045|NCT00116272|529213429|FG000|Overall Study|Lost to Follow-up|11|||
146738046|NCT00116272|529213430|FG001|Overall Study|Lost to Follow-up|6|||
146738047|NCT00576732|529213432|FG000|DOUBLE BLIND|Adverse Event|0|||
146738048|NCT00576732|529213433|FG001|DOUBLE BLIND|Adverse Event|0|||
146738049|NCT00576732|529213434|FG002|DOUBLE BLIND|Adverse Event|1|||
146738050|NCT00576732|529213435|FG003|DOUBLE BLIND|Adverse Event|0|||
146738051|NCT00576732|529213436|FG004|DOUBLE BLIND|Adverse Event|0|||
146738052|NCT00576732|529213437|FG005|DOUBLE BLIND|Adverse Event|0|||
146738053|NCT00576732|529213432|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
146738054|NCT00576732|529213433|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
146738055|NCT00576732|529213434|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
146738056|NCT00576732|529213435|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
146738057|NCT00576732|529213436|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
146738058|NCT00576732|529213437|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
146738059|NCT00576732|529213432|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
146738060|NCT00576732|529213433|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
146738061|NCT00576732|529213434|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
146738062|NCT00576732|529213435|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
146738063|NCT00576732|529213436|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
146738064|NCT00576732|529213437|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
146738065|NCT00576732|529213432|FG000|DOUBLE BLIND|OTHER|0|||
146738066|NCT00576732|529213433|FG001|DOUBLE BLIND|OTHER|2|||
146738067|NCT00576732|529213434|FG002|DOUBLE BLIND|OTHER|1|||
146738068|NCT00576732|529213435|FG003|DOUBLE BLIND|OTHER|0|||
146738069|NCT00576732|529213436|FG004|DOUBLE BLIND|OTHER|0|||
146738070|NCT00576732|529213437|FG005|DOUBLE BLIND|OTHER|0|||
146738071|NCT00576732|529213432|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
146738072|NCT00576732|529213433|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
146738073|NCT00576732|529213434|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
146850939|NCT01080716|529622594|FG001|Part 1|Physician Decision|0|||
146850940|NCT01080716|529622595|FG002|Part 1|Physician Decision|0|||
146850941|NCT01080716|529622596|FG003|Part 1|Physician Decision|0|||
146850942|NCT01011387|529622597|FG000|Overall Study|Withdrawal by Subject|3|||
146850943|NCT01011387|529622597|FG000|Overall Study|Adverse Event|2|||
146850944|NCT01011387|529622597|FG000|Overall Study|Protocol Violation|1|||
146850945|NCT01142115|529622598|FG000|First Intervention|Lack of Efficacy|1|||
146850946|NCT01142115|529622599|FG001|First Intervention|Lack of Efficacy|1|||
146850947|NCT01142115|529622598|FG000|First Intervention|Adverse Event|1|||
146850948|NCT01142115|529622599|FG001|First Intervention|Adverse Event|0|||
146738074|NCT00576732|529213435|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
146738075|NCT00576732|529213436|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
146738076|NCT00576732|529213437|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
146738077|NCT00576732|529213432|FG000|DOUBLE BLIND|Protocol Violation|1|||
146738078|NCT00576732|529213433|FG001|DOUBLE BLIND|Protocol Violation|0|||
146738079|NCT00576732|529213434|FG002|DOUBLE BLIND|Protocol Violation|0|||
146738080|NCT00576732|529213435|FG003|DOUBLE BLIND|Protocol Violation|0|||
146738081|NCT00576732|529213436|FG004|DOUBLE BLIND|Protocol Violation|0|||
146738082|NCT00576732|529213437|FG005|DOUBLE BLIND|Protocol Violation|0|||
146738083|NCT00576732|529213432|FG000|OPEN LABEL|Adverse Event|0|||
146738084|NCT00576732|529213433|FG001|OPEN LABEL|Adverse Event|0|||
146738085|NCT00576732|529213434|FG002|OPEN LABEL|Adverse Event|0|||
146850949|NCT03208036|529622600|FG000|Baseline Assessment|Withdrawal by Subject|1|||
146850950|NCT03208036|529622601|FG001|Baseline Assessment|Withdrawal by Subject|1|||
146738086|NCT00576732|529213435|FG003|OPEN LABEL|Adverse Event|4|||
146738087|NCT00576732|529213436|FG004|OPEN LABEL|Adverse Event|0|||
146738088|NCT00576732|529213437|FG005|OPEN LABEL|Adverse Event|1|||
146738089|NCT00576732|529213432|FG000|OPEN LABEL|Lost to Follow-up|0|||
146738090|NCT00576732|529213433|FG001|OPEN LABEL|Lost to Follow-up|0|||
146738091|NCT00576732|529213434|FG002|OPEN LABEL|Lost to Follow-up|0|||
146738092|NCT00576732|529213435|FG003|OPEN LABEL|Lost to Follow-up|2|||
146738093|NCT00576732|529213436|FG004|OPEN LABEL|Lost to Follow-up|1|||
146738094|NCT00576732|529213437|FG005|OPEN LABEL|Lost to Follow-up|1|||
146738095|NCT00576732|529213432|FG000|OPEN LABEL|Withdrawal by Subject|0|||
146738096|NCT00576732|529213433|FG001|OPEN LABEL|Withdrawal by Subject|0|||
146738097|NCT00576732|529213434|FG002|OPEN LABEL|Withdrawal by Subject|0|||
146738098|NCT00576732|529213435|FG003|OPEN LABEL|Withdrawal by Subject|1|||
146738099|NCT00576732|529213436|FG004|OPEN LABEL|Withdrawal by Subject|0|||
146738100|NCT00576732|529213437|FG005|OPEN LABEL|Withdrawal by Subject|1|||
146738101|NCT00576732|529213432|FG000|OPEN LABEL|OTHER|0|||
146738102|NCT00576732|529213433|FG001|OPEN LABEL|OTHER|0|||
146738103|NCT00576732|529213434|FG002|OPEN LABEL|OTHER|0|||
146738104|NCT00576732|529213435|FG003|OPEN LABEL|OTHER|0|||
146738105|NCT00576732|529213436|FG004|OPEN LABEL|OTHER|0|||
146738106|NCT00576732|529213437|FG005|OPEN LABEL|OTHER|2|||
146738107|NCT00576732|529213432|FG000|OPEN LABEL|Lack of Efficacy|0|||
146738108|NCT00576732|529213433|FG001|OPEN LABEL|Lack of Efficacy|0|||
146738109|NCT00576732|529213434|FG002|OPEN LABEL|Lack of Efficacy|0|||
146738110|NCT00576732|529213435|FG003|OPEN LABEL|Lack of Efficacy|2|||
146738111|NCT00576732|529213436|FG004|OPEN LABEL|Lack of Efficacy|2|||
146738112|NCT00576732|529213437|FG005|OPEN LABEL|Lack of Efficacy|3|||
146738113|NCT00576732|529213432|FG000|OPEN LABEL|Protocol Violation|0|||
146738114|NCT00576732|529213433|FG001|OPEN LABEL|Protocol Violation|0|||
146738115|NCT00576732|529213434|FG002|OPEN LABEL|Protocol Violation|0|||
146738116|NCT00576732|529213435|FG003|OPEN LABEL|Protocol Violation|2|||
146738117|NCT00576732|529213436|FG004|OPEN LABEL|Protocol Violation|1|||
146738118|NCT00576732|529213437|FG005|OPEN LABEL|Protocol Violation|0|||
146738119|NCT03188120|529213438|FG000|Overall Study|Adverse Event|4|||
146738120|NCT03188120|529213438|FG000|Overall Study|Insufficient Effectiveness|8|||
146738121|NCT03188120|529213438|FG000|Overall Study|Improved|12|||
146738122|NCT03188120|529213438|FG000|Overall Study|Lost to Follow-up|7|||
146738123|NCT03188120|529213438|FG000|Overall Study|Other than specified|3|||
146738124|NCT03188120|529213438|FG000|Overall Study|No visit after the first visit|13|||
146738125|NCT01235403|529213439|FG000|Overall Study|Adverse Event|14|||
146738126|NCT01235403|529213439|FG000|Overall Study|Lost to Follow-up|2|||
146738127|NCT01235403|529213439|FG000|Overall Study|Withdrawal by Subject|4|||
146738128|NCT01235403|529213439|FG000|Overall Study|Lack of Efficacy|2|||
146738129|NCT01235403|529213439|FG000|Overall Study|Other reasons for premature termination|4|||
146738130|NCT00990340|529213440|FG000|First 14-day Treatment|Not Compliant|2|||
146738131|NCT00990340|529213441|FG001|First 14-day Treatment|Not Compliant|1|||
146738132|NCT00990340|529213440|FG000|First 14-day Treatment|Lost to Follow-up|2|||
146738133|NCT00990340|529213441|FG001|First 14-day Treatment|Lost to Follow-up|1|||
146738134|NCT00990340|529213440|FG000|First 14-day Treatment|Protocol Violation|2|||
146738135|NCT00990340|529213441|FG001|First 14-day Treatment|Protocol Violation|2|||
146738136|NCT04615182|529213442|FG000|Overall Study|Re-transplanted|2|||
146738137|NCT04615182|529213442|FG000|Overall Study|Protocol Violation|6|||
146738138|NCT04615182|529213442|FG000|Overall Study|Death|6|||
146738139|NCT04615182|529213442|FG000|Overall Study|Death and protocol violation|1|||
146738140|NCT01126060|529213445|FG000|Overall Study|Protocol Violation|0|||
146738141|NCT01126060|529213446|FG001|Overall Study|Protocol Violation|2|||
146738142|NCT02130284|529213450|FG000|Overall Study|Withdrawal by Subject|3|||
146738143|NCT02130284|529213450|FG000|Overall Study|Subject Withdrew Consent|1|||
146738144|NCT02130284|529213450|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
146738145|NCT02130284|529213450|FG000|Overall Study|Subject was screened as backup for study|3|||
146738146|NCT02130284|529213450|FG000|Overall Study|Screen Failure|1|||
146738147|NCT01875185|529213451|FG000|Overall Study|study was terminated|52|||
146738148|NCT01875185|529213452|FG001|Overall Study|study was terminated|48|||
146738149|NCT01521884|529213453|FG000|Overall Study|Non Responders|10|||
146738150|NCT01521884|529213453|FG000|Overall Study|Adverse Event|5|||
146738151|NCT01521884|529213453|FG000|Overall Study|Pregnancy|1|||
146738152|NCT01521884|529213453|FG000|Overall Study|Withdrawal by Subject|1|||
146738153|NCT01521884|529213453|FG000|Overall Study|Physician Decision|2|||
146738154|NCT01521884|529213453|FG000|Overall Study|Protocol Violation|3|||
146738155|NCT01521884|529213453|FG000|Overall Study|Participant non-eligible|1|||
146738156|NCT01521884|529213453|FG000|Overall Study|Lost to Follow-up|4|||
146738157|NCT03565068|529213454|FG000|Overall Study|Protocol Violation|0|||
146738158|NCT03565068|529213455|FG001|Overall Study|Protocol Violation|0|||
146738159|NCT03565068|529213456|FG002|Overall Study|Protocol Violation|0|||
146738160|NCT03565068|529213457|FG003|Overall Study|Protocol Violation|0|||
146509808|NCT02000882|528371853|FG000|Overall Study|Physician Decision|2|||
146738161|NCT03565068|529213458|FG004|Overall Study|Protocol Violation|1|||
146738162|NCT03565068|529213459|FG005|Overall Study|Protocol Violation|0|||
146738163|NCT03565068|529213460|FG006|Overall Study|Protocol Violation|0|||
146738164|NCT03565068|529213461|FG007|Overall Study|Protocol Violation|1|||
146738165|NCT03565068|529213462|FG008|Overall Study|Protocol Violation|0|||
146738166|NCT03565068|529213454|FG000|Overall Study|Sponsor decision|0|||
146738167|NCT03565068|529213455|FG001|Overall Study|Sponsor decision|0|||
146738168|NCT03565068|529213456|FG002|Overall Study|Sponsor decision|0|||
146738169|NCT03565068|529213457|FG003|Overall Study|Sponsor decision|0|||
146738170|NCT03565068|529213458|FG004|Overall Study|Sponsor decision|1|||
146738171|NCT03565068|529213459|FG005|Overall Study|Sponsor decision|1|||
146738172|NCT03565068|529213460|FG006|Overall Study|Sponsor decision|0|||
146738173|NCT03565068|529213461|FG007|Overall Study|Sponsor decision|0|||
146738174|NCT03565068|529213462|FG008|Overall Study|Sponsor decision|0|||
146738175|NCT03565068|529213454|FG000|Overall Study|Withdrawal by Subject|0|||
146738176|NCT03565068|529213455|FG001|Overall Study|Withdrawal by Subject|0|||
146738177|NCT03565068|529213456|FG002|Overall Study|Withdrawal by Subject|1|||
146738178|NCT03565068|529213457|FG003|Overall Study|Withdrawal by Subject|0|||
146738179|NCT03565068|529213458|FG004|Overall Study|Withdrawal by Subject|2|||
146738180|NCT03565068|529213459|FG005|Overall Study|Withdrawal by Subject|0|||
146738181|NCT03565068|529213460|FG006|Overall Study|Withdrawal by Subject|1|||
146738182|NCT03565068|529213461|FG007|Overall Study|Withdrawal by Subject|5|||
146738183|NCT03565068|529213462|FG008|Overall Study|Withdrawal by Subject|1|||
146738184|NCT03565068|529213454|FG000|Overall Study|Physician Decision|0|||
146738185|NCT03565068|529213455|FG001|Overall Study|Physician Decision|0|||
146738186|NCT03565068|529213456|FG002|Overall Study|Physician Decision|0|||
146738187|NCT03565068|529213457|FG003|Overall Study|Physician Decision|0|||
146738188|NCT03565068|529213458|FG004|Overall Study|Physician Decision|0|||
146738189|NCT03565068|529213459|FG005|Overall Study|Physician Decision|0|||
146738190|NCT03565068|529213460|FG006|Overall Study|Physician Decision|0|||
146738191|NCT03565068|529213461|FG007|Overall Study|Physician Decision|1|||
146738192|NCT03565068|529213462|FG008|Overall Study|Physician Decision|0|||
146738193|NCT03565068|529213454|FG000|Overall Study|Lost to Follow-up|0|||
146738194|NCT03565068|529213455|FG001|Overall Study|Lost to Follow-up|0|||
146738195|NCT03565068|529213456|FG002|Overall Study|Lost to Follow-up|0|||
146738196|NCT03565068|529213457|FG003|Overall Study|Lost to Follow-up|0|||
146738197|NCT03565068|529213458|FG004|Overall Study|Lost to Follow-up|0|||
146738198|NCT03565068|529213459|FG005|Overall Study|Lost to Follow-up|0|||
146738199|NCT03565068|529213460|FG006|Overall Study|Lost to Follow-up|0|||
146738200|NCT03565068|529213461|FG007|Overall Study|Lost to Follow-up|1|||
146738201|NCT03565068|529213462|FG008|Overall Study|Lost to Follow-up|0|||
146738202|NCT05778526|529213463|FG000|Overall Study|Lost to Follow-up|0|||
146738203|NCT05778526|529213464|FG001|Overall Study|Lost to Follow-up|1|||
146738204|NCT05778526|529213465|FG002|Overall Study|Lost to Follow-up|3|||
146738205|NCT05778526|529213463|FG000|Overall Study|Protocol Violation|0|||
146738206|NCT05778526|529213464|FG001|Overall Study|Protocol Violation|0|||
146738207|NCT05778526|529213465|FG002|Overall Study|Protocol Violation|8|||
146738208|NCT00085202|529213466|FG000|Overall Study|Still on therapy|2|||
146738209|NCT00085202|529213467|FG001|Overall Study|Still on therapy|0|||
146738210|NCT00085202|529213466|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
146738211|NCT00085202|529213467|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
146738212|NCT00085202|529213466|FG000|Overall Study|Excessive toxicity|6|||
146738213|NCT00085202|529213467|FG001|Overall Study|Excessive toxicity|5|||
146738214|NCT00085202|529213466|FG000|Overall Study|Non-specified|3|||
146738215|NCT00085202|529213467|FG001|Overall Study|Non-specified|5|||
146738216|NCT00085202|529213466|FG000|Overall Study|Withdrawal by Subject|2|||
146850951|NCT03208036|529622600|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
146850952|NCT03208036|529622601|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
146850953|NCT03208036|529622600|FG000|Intervention|Withdrawal by Subject|3|||
146850954|NCT03208036|529622601|FG001|Intervention|Withdrawal by Subject|2|||
146850955|NCT03208036|529622600|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
146850956|NCT03208036|529622601|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
146850957|NCT03406078|529622602|FG000|Overall Study|Death|1|||
146850958|NCT03406078|529622603|FG001|Overall Study|Death|0|||
146850959|NCT03406078|529622602|FG000|Overall Study|Lost to Follow-up|0|||
146850960|NCT03406078|529622603|FG001|Overall Study|Lost to Follow-up|1|||
146850961|NCT03406078|529622602|FG000|Overall Study|Withdrawal by Subject|5|||
146850962|NCT03406078|529622603|FG001|Overall Study|Withdrawal by Subject|2|||
146850963|NCT00700778|529622604|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
146850964|NCT01879553|529622607|FG000|Overall Study|Withdrawal by Subject|1|||
146850965|NCT01879553|529622608|FG001|Overall Study|Withdrawal by Subject|0|||
146850966|NCT00591851|529622609|FG000|Overall Study|Withdrawal by Subject|3|||
146738217|NCT00085202|529213467|FG001|Overall Study|Withdrawal by Subject|1|||
146738218|NCT00085202|529213466|FG000|Overall Study|Physician Decision|4|||
146738219|NCT00085202|529213467|FG001|Overall Study|Physician Decision|1|||
146850967|NCT00591851|529622609|FG000|Overall Study|Adverse Event|2|||
146850968|NCT00591851|529622609|FG000|Overall Study|Progressive Disease|1|||
146850969|NCT00438672|529622610|FG000|Overall Study|Lost to Follow-up|7|||
146850970|NCT00438672|529622611|FG001|Overall Study|Lost to Follow-up|9|||
146738220|NCT00085202|529213466|FG000|Overall Study|Progressive disease|1|||
146738221|NCT00085202|529213467|FG001|Overall Study|Progressive disease|11|||
146850971|NCT00320528|529622612|FG000|Study Period II|Adverse Event|3|||
146850972|NCT00320528|529622613|FG001|Study Period II|Adverse Event|4|||
146850973|NCT00320528|529622614|FG002|Study Period II|Adverse Event|8|||
146850974|NCT00320528|529622612|FG000|Study Period II|Parent/Caregiver Decision|8|||
146850975|NCT00320528|529622613|FG001|Study Period II|Parent/Caregiver Decision|3|||
146850976|NCT00320528|529622614|FG002|Study Period II|Parent/Caregiver Decision|11|||
146850977|NCT00320528|529622612|FG000|Study Period II|Withdrawal by Subject|0|||
146850978|NCT00320528|529622613|FG001|Study Period II|Withdrawal by Subject|1|||
146850979|NCT00320528|529622614|FG002|Study Period II|Withdrawal by Subject|1|||
146850980|NCT00320528|529622612|FG000|Study Period II|Entry Criteria Exclusion|0|||
146850981|NCT00320528|529622613|FG001|Study Period II|Entry Criteria Exclusion|2|||
146850982|NCT00320528|529622614|FG002|Study Period II|Entry Criteria Exclusion|2|||
146850983|NCT00320528|529622612|FG000|Study Period III|Adverse Event|1|||
146850984|NCT00320528|529622613|FG001|Study Period III|Adverse Event|0|||
146850985|NCT00320528|529622614|FG002|Study Period III|Adverse Event|0|||
146850986|NCT00320528|529622612|FG000|Study Period III|Lost to Follow-up|1|||
146850987|NCT00320528|529622613|FG001|Study Period III|Lost to Follow-up|0|||
146850988|NCT00320528|529622614|FG002|Study Period III|Lost to Follow-up|0|||
146850989|NCT00320528|529622612|FG000|Study Period III|Withdrawal by Subject|1|||
146850990|NCT00320528|529622613|FG001|Study Period III|Withdrawal by Subject|1|||
146850991|NCT00320528|529622614|FG002|Study Period III|Withdrawal by Subject|2|||
146850992|NCT00320528|529622612|FG000|Study Period III|Lack of Efficacy|2|||
146850993|NCT00320528|529622613|FG001|Study Period III|Lack of Efficacy|0|||
146850994|NCT00320528|529622614|FG002|Study Period III|Lack of Efficacy|0|||
146850995|NCT00320528|529622612|FG000|Study Period III|Parent/Caregiver Decision|14|||
146850996|NCT00320528|529622613|FG001|Study Period III|Parent/Caregiver Decision|3|||
146850997|NCT00320528|529622614|FG002|Study Period III|Parent/Caregiver Decision|11|||
146850998|NCT00320528|529622612|FG000|Study Period III|Protocol Violation|0|||
146850999|NCT00320528|529622613|FG001|Study Period III|Protocol Violation|1|||
146851000|NCT00320528|529622614|FG002|Study Period III|Protocol Violation|0|||
146851001|NCT00320528|529622612|FG000|Study Period III|Physician Decision|0|||
146851002|NCT00320528|529622613|FG001|Study Period III|Physician Decision|1|||
146851003|NCT00320528|529622614|FG002|Study Period III|Physician Decision|2|||
146851004|NCT00320528|529622612|FG000|Study Period III|Sponsor Decision|0|||
146851005|NCT00320528|529622613|FG001|Study Period III|Sponsor Decision|0|||
146851006|NCT00320528|529622614|FG002|Study Period III|Sponsor Decision|1|||
146851007|NCT00320528|529622612|FG000|Study Period III|Atomoxetine Commercially Available|68|||
146851008|NCT00320528|529622613|FG001|Study Period III|Atomoxetine Commercially Available|25|||
146851009|NCT00320528|529622614|FG002|Study Period III|Atomoxetine Commercially Available|90|||
146851010|NCT04540887|529622622|FG000|Overall Study|Withdrawal by Subject|2|||
146851011|NCT01942785|529622626|FG000|Overall Study|Adverse Event|2|||
146851012|NCT01942785|529622626|FG000|Overall Study|Withdrawal by Subject|1|||
146851013|NCT01942785|529622626|FG000|Overall Study|Protocol Violation|1|||
146851014|NCT05038163|529622630|FG000|Stage 1|Did not complete survey|374|||
146851015|NCT05038163|529622631|FG001|Stage 1|Did not complete survey|0|||
146851016|NCT05038163|529622632|FG002|Stage 1|Did not complete survey|0|||
146851017|NCT05038163|529622633|FG003|Stage 1|Did not complete survey|0|||
146851018|NCT05038163|529622634|FG004|Stage 1|Did not complete survey|0|||
146851019|NCT05038163|529622635|FG005|Stage 1|Did not complete survey|0|||
146851020|NCT05038163|529622630|FG000|Stage 2|Did not complete Stage 2 survey|0|||
146851021|NCT05038163|529622631|FG001|Stage 2|Did not complete Stage 2 survey|29|||
146851022|NCT05038163|529622632|FG002|Stage 2|Did not complete Stage 2 survey|30|||
146851023|NCT05038163|529622633|FG003|Stage 2|Did not complete Stage 2 survey|24|||
146851024|NCT05038163|529622634|FG004|Stage 2|Did not complete Stage 2 survey|21|||
146851025|NCT05038163|529622635|FG005|Stage 2|Did not complete Stage 2 survey|100|||
146851026|NCT00552929|529622638|FG000|Overall Study|Lost to Follow-up|0|||
146851027|NCT00552929|529622639|FG001|Overall Study|Lost to Follow-up|0|||
146851028|NCT00552929|529622640|FG002|Overall Study|Lost to Follow-up|0|||
146851029|NCT00552929|529622641|FG003|Overall Study|Lost to Follow-up|0|||
146851030|NCT00552929|529622642|FG004|Overall Study|Lost to Follow-up|0|||
146851031|NCT00552929|529622643|FG005|Overall Study|Lost to Follow-up|0|||
146851032|NCT00552929|529622644|FG006|Overall Study|Lost to Follow-up|0|||
146851033|NCT00552929|529622645|FG007|Overall Study|Lost to Follow-up|0|||
146851034|NCT00552929|529622646|FG008|Overall Study|Lost to Follow-up|1|||
146851035|NCT00552929|529622647|FG009|Overall Study|Lost to Follow-up|0|||
146851036|NCT00552929|529622638|FG000|Overall Study|Not Eligible|0|||
146851037|NCT00552929|529622639|FG001|Overall Study|Not Eligible|0|||
146851038|NCT00552929|529622640|FG002|Overall Study|Not Eligible|0|||
146851039|NCT00552929|529622641|FG003|Overall Study|Not Eligible|0|||
146851040|NCT00552929|529622642|FG004|Overall Study|Not Eligible|0|||
146851041|NCT00552929|529622643|FG005|Overall Study|Not Eligible|1|||
146851042|NCT00552929|529622644|FG006|Overall Study|Not Eligible|0|||
146851043|NCT00552929|529622645|FG007|Overall Study|Not Eligible|0|||
146851044|NCT00552929|529622646|FG008|Overall Study|Not Eligible|0|||
146851045|NCT00552929|529622647|FG009|Overall Study|Not Eligible|0|||
146851046|NCT03527173|529624108|FG000|Overall Study|Lost to Follow-up|4|||
146851047|NCT03527173|529624109|FG001|Overall Study|Lost to Follow-up|2|||
146851048|NCT03527173|529624108|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
146851049|NCT03527173|529624109|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
146851050|NCT03527173|529624108|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
146851051|NCT03527173|529624109|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
146851052|NCT03527173|529624108|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
146851053|NCT03527173|529624109|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
146851054|NCT01248780|529624112|FG000|Overall Study|Lack of Efficacy|2|||
146851055|NCT01248780|529624113|FG001|Overall Study|Lack of Efficacy|0|||
146851056|NCT01248780|529624112|FG000|Overall Study|Lost to Follow-up|0|||
146851057|NCT01248780|529624113|FG001|Overall Study|Lost to Follow-up|1|||
146851058|NCT01248780|529624112|FG000|Overall Study|Death|0|||
146851059|NCT01248780|529624113|FG001|Overall Study|Death|1|||
146851060|NCT01248780|529624112|FG000|Overall Study|Adverse Event|2|||
146851061|NCT01248780|529624113|FG001|Overall Study|Adverse Event|7|||
146851062|NCT01248780|529624112|FG000|Overall Study|Protocol Violation|1|||
146851063|NCT01248780|529624113|FG001|Overall Study|Protocol Violation|1|||
146851064|NCT01248780|529624112|FG000|Overall Study|Withdrawal by Subject|4|||
146851065|NCT01248780|529624113|FG001|Overall Study|Withdrawal by Subject|4|||
146851066|NCT01248780|529624112|FG000|Overall Study|Not treated|0|||
146851067|NCT01248780|529624113|FG001|Overall Study|Not treated|1|||
146851068|NCT04097301|529624114|FG000|Overall Study|Death|1|||
146851069|NCT04097301|529624114|FG000|Overall Study|Withdrawal by Subject|1|||
146851070|NCT04097301|529624114|FG000|Overall Study|Screening Failure|5|||
146851071|NCT01227577|529624115|FG000|Overall Study|Protocol deviation|3|||
146851072|NCT01227577|529624115|FG000|Overall Study|Death|3|||
146851073|NCT01227577|529624115|FG000|Overall Study|Administrative problems|2|||
146851074|NCT01227577|529624115|FG000|Overall Study|Lost to Follow-up|1|||
146851075|NCT01227577|529624115|FG000|Overall Study|Withdrawal by Subject|4|||
146851076|NCT01227577|529624115|FG000|Overall Study|Lack of Efficacy|5|||
146851077|NCT01227577|529624115|FG000|Overall Study|Adverse Event|17|||
146851078|NCT02480153|529624116|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
146851079|NCT02480153|529624117|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
146851080|NCT02480153|529624118|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
146851081|NCT02480153|529624116|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
146851082|NCT02480153|529624117|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
146851083|NCT02480153|529624118|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
146851084|NCT02480153|529624116|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
146851085|NCT02480153|529624117|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
146851086|NCT02480153|529624118|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
146851087|NCT02480153|529624116|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
146851088|NCT02480153|529624117|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
146851089|NCT02480153|529624118|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
146851090|NCT02480153|529624116|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
146851091|NCT02480153|529624117|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
146851092|NCT02480153|529624118|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
146851093|NCT02480153|529624116|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
146851094|NCT02480153|529624117|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
146851095|NCT02480153|529624118|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
146851096|NCT02480153|529624116|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
146851097|NCT02480153|529624117|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
146851098|NCT02480153|529624118|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
146851099|NCT02480153|529624116|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
146851100|NCT02480153|529624117|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
146851101|NCT02480153|529624118|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
146851102|NCT02480153|529624116|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
146851103|NCT02480153|529624117|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
146851104|NCT02480153|529624118|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
146851105|NCT02480153|529624116|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
146851106|NCT02480153|529624117|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
146851107|NCT02480153|529624118|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
146851108|NCT02480153|529624116|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
146851109|NCT02480153|529624117|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
146851110|NCT02480153|529624118|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
146851111|NCT02480153|529624116|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
146851112|NCT02480153|529624117|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
146851113|NCT02480153|529624118|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
146851114|NCT02480153|529624116|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
146851115|NCT02480153|529624117|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
146851116|NCT02480153|529624118|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
146914633|NCT03303339|529850042|FG000|Overall Study|Death|2|||
146851117|NCT02480153|529624116|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
146851118|NCT02480153|529624117|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
146851119|NCT02480153|529624118|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
146851120|NCT02480153|529624116|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
146851121|NCT02480153|529624117|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
146851122|NCT02480153|529624118|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
146851123|NCT02480153|529624116|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
146851124|NCT02480153|529624117|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
146851125|NCT02480153|529624118|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
146851126|NCT02480153|529624116|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
146851127|NCT02480153|529624117|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
146851128|NCT02480153|529624118|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
146851129|NCT02480153|529624116|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
146851130|NCT02480153|529624117|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
146851131|NCT02480153|529624118|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
146851132|NCT00107120|529624119|FG000|Overall Study|Adverse Event|4|||
146851133|NCT00107120|529624120|FG001|Overall Study|Adverse Event|1|||
146851134|NCT00107120|529624119|FG000|Overall Study|Lack of Efficacy|5|||
146851135|NCT00107120|529624120|FG001|Overall Study|Lack of Efficacy|5|||
146851136|NCT00107120|529624119|FG000|Overall Study|Protocol Violation|3|||
146851137|NCT00107120|529624120|FG001|Overall Study|Protocol Violation|0|||
146851138|NCT00107120|529624119|FG000|Overall Study|Withdrawal by Subject|8|||
146851139|NCT00107120|529624120|FG001|Overall Study|Withdrawal by Subject|9|||
146851140|NCT00107120|529624119|FG000|Overall Study|Lost to Follow-up|8|||
146851141|NCT00107120|529624120|FG001|Overall Study|Lost to Follow-up|6|||
146851142|NCT00107120|529624119|FG000|Overall Study|Pregnancy|0|||
146851143|NCT00107120|529624120|FG001|Overall Study|Pregnancy|1|||
146851144|NCT00107120|529624119|FG000|Overall Study|moving away from site|1|||
146851145|NCT00107120|529624120|FG001|Overall Study|moving away from site|1|||
146851146|NCT00107120|529624119|FG000|Overall Study|death of parent|0|||
146851147|NCT00107120|529624120|FG001|Overall Study|death of parent|1|||
146851148|NCT03241225|529624121|FG000|Overall Study|Lost to Follow-up|2|||
146851149|NCT03241225|529624122|FG001|Overall Study|Lost to Follow-up|1|||
146851150|NCT03241225|529624121|FG000|Overall Study|Protocol Violation|4|||
146851151|NCT03241225|529624122|FG001|Overall Study|Protocol Violation|1|||
146851152|NCT03241225|529624121|FG000|Overall Study|Withdrawal by Subject|1|||
146851153|NCT03241225|529624122|FG001|Overall Study|Withdrawal by Subject|0|||
146851154|NCT00852540|529624123|FG000|Overall Study|Adverse Event|10|||
146851155|NCT00852540|529624124|FG001|Overall Study|Adverse Event|3|||
146851156|NCT00852540|529624123|FG000|Overall Study|Lack of Efficacy|15|||
146851157|NCT00852540|529624124|FG001|Overall Study|Lack of Efficacy|3|||
146851158|NCT00852540|529624123|FG000|Overall Study|Protocol Violation|1|||
146851159|NCT00852540|529624124|FG001|Overall Study|Protocol Violation|2|||
146851160|NCT00852540|529624123|FG000|Overall Study|Lost to Follow-up|2|||
146851161|NCT00852540|529624124|FG001|Overall Study|Lost to Follow-up|3|||
146851162|NCT00852540|529624123|FG000|Overall Study|Investigator Discretion|2|||
146963857|NCT00594568|530029535|FG000|Delayed Start|Death|0|||
146963858|NCT00594568|530029536|FG001|Delayed Start|Death|0|||
146963859|NCT00594568|530029537|FG002|Delayed Start|Death|1|||
146963860|NCT00594568|530029535|FG000|Delayed Start|Adverse Event|12|||
146963861|NCT00594568|530029536|FG001|Delayed Start|Adverse Event|2|||
146963862|NCT00594568|530029537|FG002|Delayed Start|Adverse Event|2|||
146963863|NCT00594568|530029535|FG000|Delayed Start|Withdrawal by Subject|4|||
146963864|NCT00594568|530029536|FG001|Delayed Start|Withdrawal by Subject|3|||
146963865|NCT00594568|530029537|FG002|Delayed Start|Withdrawal by Subject|0|||
146963866|NCT00594568|530029535|FG000|Delayed Start|Physician Decision|0|||
146963867|NCT00594568|530029536|FG001|Delayed Start|Physician Decision|0|||
146963868|NCT00594568|530029537|FG002|Delayed Start|Physician Decision|1|||
146963869|NCT00594568|530029535|FG000|Delayed Start|Lost to Follow-up|0|||
146963870|NCT00594568|530029536|FG001|Delayed Start|Lost to Follow-up|0|||
146963871|NCT00594568|530029537|FG002|Delayed Start|Lost to Follow-up|1|||
146963872|NCT00594568|530029535|FG000|Delayed Start|Caregiver Decision|5|||
146963873|NCT00594568|530029536|FG001|Delayed Start|Caregiver Decision|6|||
146963874|NCT00594568|530029537|FG002|Delayed Start|Caregiver Decision|2|||
146963875|NCT00594568|530029535|FG000|Delayed Start|Sponsor Decision|77|||
146963876|NCT00594568|530029536|FG001|Delayed Start|Sponsor Decision|66|||
146963877|NCT00594568|530029537|FG002|Delayed Start|Sponsor Decision|59|||
146963878|NCT00594568|530029535|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
146963879|NCT00594568|530029536|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
146963880|NCT00594568|530029537|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
146963881|NCT00594568|530029535|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
146963882|NCT00594568|530029536|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
146963883|NCT00594568|530029537|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
146963884|NCT00594568|530029535|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
146963885|NCT00594568|530029536|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
146963886|NCT00594568|530029537|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
146963887|NCT00594568|530029535|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
146963888|NCT00594568|530029536|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
146963889|NCT00594568|530029537|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
146963890|NCT00594568|530029535|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
146963891|NCT00594568|530029536|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
146963892|NCT00594568|530029537|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
146963893|NCT00594568|530029535|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
146963894|NCT00594568|530029536|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
146963895|NCT00594568|530029537|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
146963896|NCT01422876|530029539|FG000|Week 24|Lost to Follow-up|1|||
146963897|NCT01422876|530029540|FG001|Week 24|Lost to Follow-up|1|||
146963898|NCT01422876|530029541|FG002|Week 24|Lost to Follow-up|2|||
146963899|NCT01422876|530029542|FG003|Week 24|Lost to Follow-up|4|||
146963900|NCT01422876|530029543|FG004|Week 24|Lost to Follow-up|2|||
146963901|NCT01422876|530029544|FG005|Week 24|Lost to Follow-up|0|||
146963902|NCT01422876|530029545|FG006|Week 24|Lost to Follow-up|1|||
146963903|NCT01422876|530029546|FG007|Week 24|Lost to Follow-up|3|||
146963904|NCT01422876|530029547|FG008|Week 24|Lost to Follow-up|3|||
146963905|NCT01422876|530029548|FG009|Week 24|Lost to Follow-up|4|||
146963906|NCT01422876|530029539|FG000|Week 24|Consent withdrawn|5|||
146963907|NCT01422876|530029540|FG001|Week 24|Consent withdrawn|1|||
146963908|NCT01422876|530029541|FG002|Week 24|Consent withdrawn|3|||
146963909|NCT01422876|530029542|FG003|Week 24|Consent withdrawn|4|||
146963910|NCT01422876|530029543|FG004|Week 24|Consent withdrawn|5|||
146963911|NCT01422876|530029544|FG005|Week 24|Consent withdrawn|6|||
146963912|NCT01422876|530029545|FG006|Week 24|Consent withdrawn|5|||
146963913|NCT01422876|530029546|FG007|Week 24|Consent withdrawn|4|||
146963914|NCT01422876|530029547|FG008|Week 24|Consent withdrawn|3|||
146963915|NCT01422876|530029548|FG009|Week 24|Consent withdrawn|6|||
146963916|NCT01422876|530029539|FG000|Week 24|Death|0|||
146963917|NCT01422876|530029540|FG001|Week 24|Death|1|||
146963918|NCT01422876|530029541|FG002|Week 24|Death|0|||
146963919|NCT01422876|530029542|FG003|Week 24|Death|0|||
146963920|NCT01422876|530029543|FG004|Week 24|Death|0|||
146963921|NCT01422876|530029544|FG005|Week 24|Death|0|||
146963922|NCT01422876|530029545|FG006|Week 24|Death|0|||
146963923|NCT01422876|530029546|FG007|Week 24|Death|0|||
146963924|NCT01422876|530029547|FG008|Week 24|Death|0|||
146963925|NCT01422876|530029548|FG009|Week 24|Death|0|||
146963926|NCT01422876|530029539|FG000|Week 52|Lost to Follow-up|3|||
146963927|NCT01422876|530029540|FG001|Week 52|Lost to Follow-up|5|||
146963928|NCT01422876|530029541|FG002|Week 52|Lost to Follow-up|7|||
146963929|NCT01422876|530029542|FG003|Week 52|Lost to Follow-up|5|||
146963930|NCT01422876|530029543|FG004|Week 52|Lost to Follow-up|8|||
146963931|NCT01422876|530029544|FG005|Week 52|Lost to Follow-up|5|||
146963932|NCT01422876|530029545|FG006|Week 52|Lost to Follow-up|5|||
146963933|NCT01422876|530029546|FG007|Week 52|Lost to Follow-up|8|||
146963934|NCT01422876|530029547|FG008|Week 52|Lost to Follow-up|7|||
146963935|NCT01422876|530029548|FG009|Week 52|Lost to Follow-up|8|||
146963936|NCT01422876|530029539|FG000|Week 52|Consent withdrawn|9|||
146963937|NCT01422876|530029540|FG001|Week 52|Consent withdrawn|4|||
146963938|NCT01422876|530029541|FG002|Week 52|Consent withdrawn|6|||
146963939|NCT01422876|530029542|FG003|Week 52|Consent withdrawn|12|||
146963940|NCT01422876|530029543|FG004|Week 52|Consent withdrawn|7|||
146963941|NCT01422876|530029544|FG005|Week 52|Consent withdrawn|12|||
146963942|NCT01422876|530029545|FG006|Week 52|Consent withdrawn|10|||
146963943|NCT01422876|530029546|FG007|Week 52|Consent withdrawn|12|||
146963944|NCT01422876|530029547|FG008|Week 52|Consent withdrawn|13|||
146963945|NCT01422876|530029548|FG009|Week 52|Consent withdrawn|9|||
146963946|NCT01422876|530029539|FG000|Week 52|Death|0|||
146963947|NCT01422876|530029540|FG001|Week 52|Death|1|||
146963948|NCT01422876|530029541|FG002|Week 52|Death|0|||
146963949|NCT01422876|530029542|FG003|Week 52|Death|1|||
146963950|NCT01422876|530029543|FG004|Week 52|Death|0|||
146963951|NCT01422876|530029544|FG005|Week 52|Death|0|||
146963952|NCT01422876|530029545|FG006|Week 52|Death|1|||
146963953|NCT01422876|530029546|FG007|Week 52|Death|3|||
146963954|NCT01422876|530029547|FG008|Week 52|Death|1|||
146963955|NCT01422876|530029548|FG009|Week 52|Death|0|||
146963956|NCT02856282|530029549|FG000|Overall Study|Withdrawal by Subject|1|||
146963957|NCT00057330|530029550|FG000|Overall Study|Adverse Event|9|||
146963958|NCT00057330|530029551|FG001|Overall Study|Adverse Event|12|||
146963959|NCT00057330|530029550|FG000|Overall Study|Death|1|||
146963960|NCT00057330|530029551|FG001|Overall Study|Death|0|||
146963961|NCT00057330|530029550|FG000|Overall Study|Protocol Violation|1|||
146963962|NCT00057330|530029551|FG001|Overall Study|Protocol Violation|1|||
146963963|NCT00057330|530029550|FG000|Overall Study|Withdrawal by Subject|115|||
146963964|NCT00057330|530029551|FG001|Overall Study|Withdrawal by Subject|84|||
146963965|NCT00057330|530029550|FG000|Overall Study|Lost to Follow-up|745|||
146963966|NCT00057330|530029551|FG001|Overall Study|Lost to Follow-up|617|||
146963967|NCT00057330|530029550|FG000|Overall Study|Physician Decision|1|||
146963968|NCT00057330|530029551|FG001|Overall Study|Physician Decision|0|||
146963969|NCT00057330|530029550|FG000|Overall Study|Other|260|||
146963970|NCT00057330|530029551|FG001|Overall Study|Other|206|||
146963971|NCT04888377|530029557|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
146963972|NCT04888377|530029558|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
146963973|NCT04888377|530029557|FG000|Overall Study|Physician Decision|6|||
146963974|NCT04888377|530029558|FG001|Overall Study|Physician Decision|6|||
146963975|NCT04888377|530029557|FG000|Overall Study|Withdrawal by Subject|7|||
146963976|NCT04888377|530029558|FG001|Overall Study|Withdrawal by Subject|3|||
146963977|NCT00494234|530029560|FG000|Overall Study|Withdrawal by Subject|1|||
146963978|NCT00494234|530029561|FG001|Overall Study|Withdrawal by Subject|0|||
146963979|NCT00494234|530029560|FG000|Overall Study|Disease progression|11|||
146963980|NCT00494234|530029561|FG001|Overall Study|Disease progression|8|||
146963981|NCT00494234|530029560|FG000|Overall Study|Death|2|||
146963982|NCT00494234|530029561|FG001|Overall Study|Death|1|||
146963983|NCT04359758|530029568|FG000|Overall Study|Protocol Violation|3|||
146963984|NCT04359758|530029569|FG001|Overall Study|Protocol Violation|2|||
146963985|NCT04753606|530029570|FG000|Overall Study|Adverse Event|1|||
146963986|NCT04753606|530029571|FG001|Overall Study|Adverse Event|0|||
146963987|NCT04753606|530029572|FG002|Overall Study|Adverse Event|0|||
146963988|NCT01012609|530029575|FG000|Overall Study|Withdrawal by Subject|1|||
146963989|NCT01012609|530029576|FG001|Overall Study|Withdrawal by Subject|1|||
146963990|NCT03253809|530029577|FG000|Overall Study|Unable to obtain study related data|14|||
146963991|NCT05147311|530029580|FG000|Overall Study|Did not complete survey|2|||
146963992|NCT05147311|530029581|FG001|Overall Study|Did not complete survey|1|||
146963993|NCT05147311|530029580|FG000|Overall Study|Patient too sick|1|||
146963994|NCT05147311|530029581|FG001|Overall Study|Patient too sick|2|||
146963995|NCT05147311|530029580|FG000|Overall Study|Death|0|||
146963996|NCT05147311|530029581|FG001|Overall Study|Death|1|||
146963997|NCT05147311|530029580|FG000|Overall Study|Declined survey|1|||
146963998|NCT05147311|530029581|FG001|Overall Study|Declined survey|0|||
146963999|NCT02279888|530029583|FG000|Overall Study|Death|326|||
146964000|NCT02279888|530029583|FG000|Overall Study|Withdrawal by Subject|38|||
146964001|NCT02279888|530029583|FG000|Overall Study|Lost to Follow-up|21|||
146964002|NCT02279888|530029583|FG000|Overall Study|Physician Decision|62|||
146964003|NCT02279888|530029583|FG000|Overall Study|Subject Non-compliance|43|||
146964004|NCT02279888|530029583|FG000|Overall Study|Not implanted|14|||
146964005|NCT02279888|530029583|FG000|Overall Study|Visit not performed|26|||
146964006|NCT04505592|530029584|FG000|Overall Study|Death|2|||
146964007|NCT04505592|530029585|FG001|Overall Study|Death|1|||
146964008|NCT00262119|530029592|FG000|Overall Study|Lost to Follow-up|38|||
146964009|NCT00262119|530029593|FG001|Overall Study|Lost to Follow-up|51|||
146964010|NCT00262119|530029594|FG002|Overall Study|Lost to Follow-up|42|||
146964011|NCT00262119|530029592|FG000|Overall Study|Death|20|||
146964012|NCT00262119|530029593|FG001|Overall Study|Death|19|||
146964013|NCT00262119|530029594|FG002|Overall Study|Death|16|||
146964014|NCT00071006|530029595|FG000|Overall Study|Lack of Efficacy|7|||
146964015|NCT00071006|530029595|FG000|Overall Study|Adverse Event|1|||
146964016|NCT00071006|530029595|FG000|Overall Study|Withdrawal by Subject|1|||
146964017|NCT00071006|530029595|FG000|Overall Study|Other|3|||
146964018|NCT05261126|530029600|FG000|Overall Study|Death|0|||
146964019|NCT05261126|530029601|FG001|Overall Study|Death|0|||
146964020|NCT05261126|530029602|FG002|Overall Study|Death|1|||
146964021|NCT05261126|530029603|FG003|Overall Study|Death|0|||
146964022|NCT05261126|530029604|FG004|Overall Study|Death|0|||
146964023|NCT05261126|530029600|FG000|Overall Study|Lost to Follow-up|0|||
146964024|NCT05261126|530029601|FG001|Overall Study|Lost to Follow-up|0|||
146964025|NCT05261126|530029602|FG002|Overall Study|Lost to Follow-up|0|||
146964026|NCT05261126|530029603|FG003|Overall Study|Lost to Follow-up|0|||
146964027|NCT05261126|530029604|FG004|Overall Study|Lost to Follow-up|1|||
146964028|NCT05261126|530029600|FG000|Overall Study|Physician Decision|1|||
146964029|NCT05261126|530029601|FG001|Overall Study|Physician Decision|0|||
146964030|NCT05261126|530029602|FG002|Overall Study|Physician Decision|0|||
146964031|NCT05261126|530029603|FG003|Overall Study|Physician Decision|0|||
146964032|NCT05261126|530029604|FG004|Overall Study|Physician Decision|0|||
146964033|NCT05261126|530029600|FG000|Overall Study|Screen Failure|0|||
146964034|NCT05261126|530029601|FG001|Overall Study|Screen Failure|0|||
146964035|NCT05261126|530029602|FG002|Overall Study|Screen Failure|0|||
146964036|NCT05261126|530029603|FG003|Overall Study|Screen Failure|0|||
146964037|NCT05261126|530029604|FG004|Overall Study|Screen Failure|1|||
146964038|NCT05261126|530029600|FG000|Overall Study|Withdrawal by Subject|1|||
146964039|NCT05261126|530029601|FG001|Overall Study|Withdrawal by Subject|0|||
146964040|NCT05261126|530029602|FG002|Overall Study|Withdrawal by Subject|1|||
146964041|NCT05261126|530029603|FG003|Overall Study|Withdrawal by Subject|1|||
146964042|NCT05261126|530029604|FG004|Overall Study|Withdrawal by Subject|0|||
146964043|NCT05261126|530029600|FG000|Overall Study|Not Recorded|0|||
146964044|NCT05261126|530029601|FG001|Overall Study|Not Recorded|0|||
146964045|NCT05261126|530029602|FG002|Overall Study|Not Recorded|0|||
146964046|NCT05261126|530029603|FG003|Overall Study|Not Recorded|1|||
146964047|NCT05261126|530029604|FG004|Overall Study|Not Recorded|0|||
146964048|NCT03901274|530029605|FG000|Overall Study|Lost to Follow-up|120|||
146964049|NCT03901274|530029606|FG001|Overall Study|Lost to Follow-up|124|||
146964050|NCT03901274|530029605|FG000|Overall Study|Withdrawal by Subject|0|||
146964051|NCT03901274|530029606|FG001|Overall Study|Withdrawal by Subject|6|||
146964052|NCT05570604|530029607|FG000|Overall Study|Lost to Follow-up|1|||
146964053|NCT05570604|530029608|FG001|Overall Study|Lost to Follow-up|5|||
146964054|NCT05570604|530029607|FG000|Overall Study|Illness|2|||
146964055|NCT05570604|530029608|FG001|Overall Study|Illness|2|||
146964056|NCT05182840|530029613|FG000|Run-in Period|Not treated|0|||
146964057|NCT05182840|530029614|FG001|Run-in Period|Not treated|1|||
146964058|NCT05182840|530029615|FG002|Run-in Period|Not treated|0|||
146964059|NCT05182840|530029616|FG003|Run-in Period|Not treated|0|||
146964060|NCT05182840|530029617|FG004|Run-in Period|Not treated|0|||
146964061|NCT05182840|530029618|FG005|Run-in Period|Not treated|0|||
146964062|NCT05182840|530029619|FG006|Run-in Period|Not treated|0|||
146964063|NCT05182840|530029620|FG007|Run-in Period|Not treated|0|||
146964064|NCT05182840|530029621|FG008|Run-in Period|Not treated|0|||
146964065|NCT05182840|530029622|FG009|Run-in Period|Not treated|0|||
146964066|NCT05182840|530029613|FG000|Run-in Period|Other reason but not sponsor termination|14|||
146964067|NCT05182840|530029614|FG001|Run-in Period|Other reason but not sponsor termination|18|||
146964068|NCT05182840|530029615|FG002|Run-in Period|Other reason but not sponsor termination|0|||
146964069|NCT05182840|530029616|FG003|Run-in Period|Other reason but not sponsor termination|0|||
146964070|NCT05182840|530029617|FG004|Run-in Period|Other reason but not sponsor termination|0|||
146964071|NCT05182840|530029618|FG005|Run-in Period|Other reason but not sponsor termination|0|||
146964072|NCT05182840|530029619|FG006|Run-in Period|Other reason but not sponsor termination|0|||
146964073|NCT05182840|530029620|FG007|Run-in Period|Other reason but not sponsor termination|0|||
146964074|NCT05182840|530029621|FG008|Run-in Period|Other reason but not sponsor termination|0|||
146964075|NCT05182840|530029622|FG009|Run-in Period|Other reason but not sponsor termination|0|||
146964076|NCT05182840|530029613|FG000|Run-in Period|No reason available|2|||
146964077|NCT05182840|530029614|FG001|Run-in Period|No reason available|2|||
146964078|NCT05182840|530029615|FG002|Run-in Period|No reason available|0|||
146964079|NCT05182840|530029616|FG003|Run-in Period|No reason available|0|||
146964080|NCT05182840|530029617|FG004|Run-in Period|No reason available|0|||
146964081|NCT05182840|530029618|FG005|Run-in Period|No reason available|0|||
146964082|NCT05182840|530029619|FG006|Run-in Period|No reason available|0|||
146964083|NCT05182840|530029620|FG007|Run-in Period|No reason available|0|||
146964084|NCT05182840|530029621|FG008|Run-in Period|No reason available|0|||
146964085|NCT05182840|530029622|FG009|Run-in Period|No reason available|0|||
146964086|NCT05182840|530029613|FG000|Run-in Period|Burden of study procedures|2|||
146964087|NCT05182840|530029614|FG001|Run-in Period|Burden of study procedures|2|||
146964088|NCT05182840|530029615|FG002|Run-in Period|Burden of study procedures|0|||
146964089|NCT05182840|530029616|FG003|Run-in Period|Burden of study procedures|0|||
146964090|NCT05182840|530029617|FG004|Run-in Period|Burden of study procedures|0|||
146964091|NCT05182840|530029618|FG005|Run-in Period|Burden of study procedures|0|||
146964092|NCT05182840|530029619|FG006|Run-in Period|Burden of study procedures|0|||
146964093|NCT05182840|530029620|FG007|Run-in Period|Burden of study procedures|0|||
146964094|NCT05182840|530029621|FG008|Run-in Period|Burden of study procedures|0|||
146964095|NCT05182840|530029622|FG009|Run-in Period|Burden of study procedures|0|||
146964096|NCT05182840|530029613|FG000|Run-in Period|Change of residence|1|||
146964097|NCT05182840|530029614|FG001|Run-in Period|Change of residence|0|||
146964098|NCT05182840|530029615|FG002|Run-in Period|Change of residence|0|||
146964099|NCT05182840|530029616|FG003|Run-in Period|Change of residence|0|||
146964100|NCT05182840|530029617|FG004|Run-in Period|Change of residence|0|||
146964101|NCT05182840|530029618|FG005|Run-in Period|Change of residence|0|||
146964102|NCT05182840|530029619|FG006|Run-in Period|Change of residence|0|||
146964103|NCT05182840|530029620|FG007|Run-in Period|Change of residence|0|||
146964104|NCT05182840|530029621|FG008|Run-in Period|Change of residence|0|||
146964105|NCT05182840|530029622|FG009|Run-in Period|Change of residence|0|||
146964106|NCT05182840|530029613|FG000|Run-in Period|Adverse Event|5|||
146964107|NCT05182840|530029614|FG001|Run-in Period|Adverse Event|5|||
146964108|NCT05182840|530029615|FG002|Run-in Period|Adverse Event|0|||
146964109|NCT05182840|530029616|FG003|Run-in Period|Adverse Event|0|||
146964110|NCT05182840|530029617|FG004|Run-in Period|Adverse Event|0|||
146964111|NCT05182840|530029618|FG005|Run-in Period|Adverse Event|0|||
146964112|NCT05182840|530029619|FG006|Run-in Period|Adverse Event|0|||
146964113|NCT05182840|530029620|FG007|Run-in Period|Adverse Event|0|||
146964114|NCT05182840|530029621|FG008|Run-in Period|Adverse Event|0|||
146964115|NCT05182840|530029622|FG009|Run-in Period|Adverse Event|0|||
146964116|NCT05182840|530029613|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
146964117|NCT05182840|530029614|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
146964118|NCT05182840|530029615|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
146964119|NCT05182840|530029616|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
146964120|NCT05182840|530029617|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
146964121|NCT05182840|530029618|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
146964122|NCT05182840|530029619|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
146964123|NCT05182840|530029620|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
146964124|NCT05182840|530029621|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
146975290|NCT00289731|530073520|FG000|Overall Study|Adverse Event|1|||
146964125|NCT05182840|530029622|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
146964126|NCT05182840|530029613|FG000|Treatment Period|Reason missing|0|||
146964127|NCT05182840|530029614|FG001|Treatment Period|Reason missing|0|||
146964128|NCT05182840|530029615|FG002|Treatment Period|Reason missing|1|||
146964129|NCT05182840|530029616|FG003|Treatment Period|Reason missing|0|||
146964130|NCT05182840|530029617|FG004|Treatment Period|Reason missing|0|||
146964131|NCT05182840|530029618|FG005|Treatment Period|Reason missing|0|||
146964132|NCT05182840|530029619|FG006|Treatment Period|Reason missing|0|||
146964133|NCT05182840|530029620|FG007|Treatment Period|Reason missing|0|||
146964134|NCT05182840|530029621|FG008|Treatment Period|Reason missing|0|||
146964135|NCT05182840|530029622|FG009|Treatment Period|Reason missing|0|||
146964136|NCT05182840|530029613|FG000|Treatment Period|Other but not sponsor termination|0|||
146964137|NCT05182840|530029614|FG001|Treatment Period|Other but not sponsor termination|0|||
146964138|NCT05182840|530029615|FG002|Treatment Period|Other but not sponsor termination|8|||
146964139|NCT05182840|530029616|FG003|Treatment Period|Other but not sponsor termination|6|||
146964140|NCT05182840|530029617|FG004|Treatment Period|Other but not sponsor termination|6|||
146964141|NCT05182840|530029618|FG005|Treatment Period|Other but not sponsor termination|7|||
146964142|NCT05182840|530029619|FG006|Treatment Period|Other but not sponsor termination|5|||
146964143|NCT05182840|530029620|FG007|Treatment Period|Other but not sponsor termination|8|||
146964144|NCT05182840|530029621|FG008|Treatment Period|Other but not sponsor termination|7|||
146964145|NCT05182840|530029622|FG009|Treatment Period|Other but not sponsor termination|2|||
146964146|NCT05182840|530029613|FG000|Treatment Period|Protocol deviation|0|||
146964147|NCT05182840|530029614|FG001|Treatment Period|Protocol deviation|0|||
146964148|NCT05182840|530029615|FG002|Treatment Period|Protocol deviation|0|||
146964149|NCT05182840|530029616|FG003|Treatment Period|Protocol deviation|0|||
146964150|NCT05182840|530029617|FG004|Treatment Period|Protocol deviation|0|||
146964151|NCT05182840|530029618|FG005|Treatment Period|Protocol deviation|0|||
146964152|NCT05182840|530029619|FG006|Treatment Period|Protocol deviation|0|||
146964153|NCT05182840|530029620|FG007|Treatment Period|Protocol deviation|0|||
146964154|NCT05182840|530029621|FG008|Treatment Period|Protocol deviation|1|||
146964155|NCT05182840|530029622|FG009|Treatment Period|Protocol deviation|0|||
146964156|NCT05182840|530029613|FG000|Treatment Period|No reason available|0|||
146964157|NCT05182840|530029614|FG001|Treatment Period|No reason available|0|||
146964158|NCT05182840|530029615|FG002|Treatment Period|No reason available|0|||
146964159|NCT05182840|530029616|FG003|Treatment Period|No reason available|1|||
146964160|NCT05182840|530029617|FG004|Treatment Period|No reason available|0|||
146964161|NCT05182840|530029618|FG005|Treatment Period|No reason available|2|||
146964162|NCT05182840|530029619|FG006|Treatment Period|No reason available|0|||
146964163|NCT05182840|530029620|FG007|Treatment Period|No reason available|1|||
146964164|NCT05182840|530029621|FG008|Treatment Period|No reason available|0|||
146964165|NCT05182840|530029622|FG009|Treatment Period|No reason available|0|||
146964166|NCT05182840|530029613|FG000|Treatment Period|Burden of study procedures|0|||
146964167|NCT05182840|530029614|FG001|Treatment Period|Burden of study procedures|0|||
146964168|NCT05182840|530029615|FG002|Treatment Period|Burden of study procedures|0|||
146964169|NCT05182840|530029616|FG003|Treatment Period|Burden of study procedures|0|||
146964170|NCT05182840|530029617|FG004|Treatment Period|Burden of study procedures|1|||
146964171|NCT05182840|530029618|FG005|Treatment Period|Burden of study procedures|0|||
146964172|NCT05182840|530029619|FG006|Treatment Period|Burden of study procedures|0|||
146964173|NCT05182840|530029620|FG007|Treatment Period|Burden of study procedures|0|||
146964174|NCT05182840|530029621|FG008|Treatment Period|Burden of study procedures|0|||
146964175|NCT05182840|530029622|FG009|Treatment Period|Burden of study procedures|0|||
146964176|NCT05182840|530029613|FG000|Treatment Period|Change of residence|0|||
146964177|NCT05182840|530029614|FG001|Treatment Period|Change of residence|0|||
146964178|NCT05182840|530029615|FG002|Treatment Period|Change of residence|0|||
146964179|NCT05182840|530029616|FG003|Treatment Period|Change of residence|0|||
146964180|NCT05182840|530029617|FG004|Treatment Period|Change of residence|0|||
146964181|NCT05182840|530029618|FG005|Treatment Period|Change of residence|1|||
146964182|NCT05182840|530029619|FG006|Treatment Period|Change of residence|0|||
146964183|NCT05182840|530029620|FG007|Treatment Period|Change of residence|0|||
146964184|NCT05182840|530029621|FG008|Treatment Period|Change of residence|0|||
146964185|NCT05182840|530029622|FG009|Treatment Period|Change of residence|0|||
146964186|NCT05182840|530029613|FG000|Treatment Period|Adverse Event|0|||
146964187|NCT05182840|530029614|FG001|Treatment Period|Adverse Event|0|||
146964188|NCT05182840|530029615|FG002|Treatment Period|Adverse Event|4|||
146964189|NCT05182840|530029616|FG003|Treatment Period|Adverse Event|16|||
146964190|NCT05182840|530029617|FG004|Treatment Period|Adverse Event|12|||
146964191|NCT05182840|530029618|FG005|Treatment Period|Adverse Event|6|||
146964192|NCT05182840|530029619|FG006|Treatment Period|Adverse Event|4|||
146964193|NCT05182840|530029620|FG007|Treatment Period|Adverse Event|8|||
146964194|NCT05182840|530029621|FG008|Treatment Period|Adverse Event|16|||
146964195|NCT05182840|530029622|FG009|Treatment Period|Adverse Event|5|||
146964196|NCT05182840|530029613|FG000|Treatment Period|Not treated with study drug|0|||
146964197|NCT05182840|530029614|FG001|Treatment Period|Not treated with study drug|0|||
146964198|NCT05182840|530029615|FG002|Treatment Period|Not treated with study drug|0|||
146964199|NCT05182840|530029616|FG003|Treatment Period|Not treated with study drug|1|||
146964200|NCT05182840|530029617|FG004|Treatment Period|Not treated with study drug|0|||
146964201|NCT05182840|530029618|FG005|Treatment Period|Not treated with study drug|0|||
146964202|NCT05182840|530029619|FG006|Treatment Period|Not treated with study drug|1|||
146964203|NCT05182840|530029620|FG007|Treatment Period|Not treated with study drug|1|||
146964204|NCT05182840|530029621|FG008|Treatment Period|Not treated with study drug|0|||
146964205|NCT05182840|530029622|FG009|Treatment Period|Not treated with study drug|0|||
146964206|NCT02161380|530029623|FG000|Overall Study|Lost to Follow-up|0|||
146964207|NCT02161380|530029624|FG001|Overall Study|Lost to Follow-up|1|||
146964208|NCT02161380|530029625|FG002|Overall Study|Lost to Follow-up|0|||
146964209|NCT02161380|530029626|FG003|Overall Study|Lost to Follow-up|0|||
146964210|NCT02500732|530029629|FG000|Overall Study|Physician Decision|0|||
146964211|NCT02500732|530029630|FG001|Overall Study|Physician Decision|1|||
146964212|NCT04409262|530029631|FG000|Overall Study|Adverse Event|0|||
146964213|NCT04409262|530029632|FG001|Overall Study|Adverse Event|2|||
146964214|NCT04409262|530029631|FG000|Overall Study|Death|55|||
146964215|NCT04409262|530029632|FG001|Overall Study|Death|97|||
146964216|NCT04409262|530029631|FG000|Overall Study|Lost to Follow-up|12|||
146964217|NCT04409262|530029632|FG001|Overall Study|Lost to Follow-up|23|||
146964218|NCT04409262|530029631|FG000|Overall Study|Lack of Staff|0|||
146964219|NCT04409262|530029632|FG001|Overall Study|Lack of Staff|1|||
146964220|NCT04409262|530029631|FG000|Overall Study|Protocol Violation|3|||
146964221|NCT04409262|530029632|FG001|Overall Study|Protocol Violation|1|||
146964222|NCT04409262|530029631|FG000|Overall Study|Withdrawal by Subject|5|||
146964223|NCT04409262|530029632|FG001|Overall Study|Withdrawal by Subject|10|||
146964224|NCT03205605|530029633|FG000|Overall Study|Withdrawal by Subject|1|||
146964225|NCT02396849|530029634|FG000|Overall Study|Lost to Follow-up|1|||
146964226|NCT02396849|530029635|FG001|Overall Study|Lost to Follow-up|1|||
146964227|NCT02396849|530029634|FG000|Overall Study|Did not tolerate intervention|1|||
146964228|NCT02396849|530029635|FG001|Overall Study|Did not tolerate intervention|1|||
146964229|NCT03328325|530029638|FG000|Overall Study|Lost to Follow-up|4|||
146964230|NCT03328325|530029638|FG000|Overall Study|Physician Decision|1|||
146964231|NCT03328325|530029638|FG000|Overall Study|Withdrawal by Subject|3|||
146964232|NCT03328325|530029638|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
146964233|NCT00948896|530029641|FG000|Randomization to 24 Months of Age|Death|1|||
146964234|NCT00948896|530029642|FG001|Randomization to 24 Months of Age|Death|0|||
146964235|NCT00948896|530029643|FG002|Randomization to 24 Months of Age|Death|0|||
146964236|NCT00948896|530029644|FG003|Randomization to 24 Months of Age|Death|0|||
146964237|NCT00948896|530029645|FG004|Randomization to 24 Months of Age|Death|2|||
146964238|NCT00948896|530029646|FG005|Randomization to 24 Months of Age|Death|1|||
146964239|NCT00948896|530029647|FG006|Randomization to 24 Months of Age|Death|2|||
146964240|NCT00948896|530029648|FG007|Randomization to 24 Months of Age|Death|1|||
146964241|NCT00948896|530029641|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
146964242|NCT00948896|530029642|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
146964243|NCT00948896|530029643|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
146964244|NCT00948896|530029644|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
146964245|NCT00948896|530029645|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
146964246|NCT00948896|530029646|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
146964247|NCT00948896|530029647|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
146964248|NCT00948896|530029648|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
146964249|NCT00948896|530029641|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
146964250|NCT00948896|530029642|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
146964251|NCT00948896|530029643|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
146964252|NCT00948896|530029644|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
146964253|NCT00948896|530029645|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
146964254|NCT00948896|530029646|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
146964255|NCT00948896|530029647|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
146964256|NCT00948896|530029648|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
146964257|NCT00948896|530029641|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
146964258|NCT00948896|530029642|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
146964259|NCT00948896|530029643|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
146964260|NCT00948896|530029644|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
146738222|NCT03238300|529213471|FG000|Baseline (Before Intervention)|Physician Decision|0|||
146738223|NCT03238300|529213472|FG001|Baseline (Before Intervention)|Physician Decision|1|||
146964261|NCT00948896|530029645|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
146964262|NCT00948896|530029646|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
146964263|NCT00948896|530029647|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
146964264|NCT00948896|530029648|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
146964265|NCT00948896|530029641|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
146964266|NCT00948896|530029642|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
146964267|NCT00948896|530029643|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
146964268|NCT00948896|530029644|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
146964269|NCT00948896|530029645|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
146964270|NCT00948896|530029646|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
146964271|NCT00948896|530029647|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
146964272|NCT00948896|530029648|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
146964273|NCT00948896|530029641|FG000|24 Months of Age to 36 Months of Age|Death|0|||
146964274|NCT00948896|530029642|FG001|24 Months of Age to 36 Months of Age|Death|2|||
146964275|NCT00948896|530029643|FG002|24 Months of Age to 36 Months of Age|Death|2|||
146964276|NCT00948896|530029644|FG003|24 Months of Age to 36 Months of Age|Death|0|||
146964277|NCT00948896|530029645|FG004|24 Months of Age to 36 Months of Age|Death|0|||
146964278|NCT00948896|530029646|FG005|24 Months of Age to 36 Months of Age|Death|1|||
146964279|NCT00948896|530029647|FG006|24 Months of Age to 36 Months of Age|Death|0|||
146964280|NCT00948896|530029648|FG007|24 Months of Age to 36 Months of Age|Death|0|||
146964281|NCT00948896|530029641|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
146964282|NCT00948896|530029642|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
146964283|NCT00948896|530029643|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
146964284|NCT00948896|530029644|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
146964285|NCT00948896|530029645|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
146964286|NCT00948896|530029646|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
146964287|NCT00948896|530029647|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
146964288|NCT00948896|530029648|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
146964289|NCT00948896|530029641|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
146964290|NCT00948896|530029642|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
146964291|NCT00948896|530029643|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
146964292|NCT00948896|530029644|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
146964293|NCT00948896|530029645|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
146964294|NCT00948896|530029646|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
146964295|NCT00948896|530029647|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
146964296|NCT00948896|530029648|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
146964297|NCT00948896|530029641|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
146964298|NCT00948896|530029642|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
146964299|NCT00948896|530029643|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
146964300|NCT00948896|530029644|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
146964301|NCT00948896|530029645|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
146964302|NCT00948896|530029646|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
146964303|NCT00948896|530029647|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
146964304|NCT00948896|530029648|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
146964305|NCT00948896|530029641|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
146964306|NCT00948896|530029642|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
146964307|NCT00948896|530029643|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
146964308|NCT00948896|530029644|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
146964309|NCT00948896|530029645|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
146964310|NCT00948896|530029646|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
146964311|NCT00948896|530029647|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
146964312|NCT00948896|530029648|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
146964313|NCT01869959|530029649|FG000|Randomization Period|Physician Decision|0|||
146964314|NCT01869959|530029650|FG001|Randomization Period|Physician Decision|0|||
146964315|NCT01869959|530029651|FG002|Randomization Period|Physician Decision|0|||
146964316|NCT01869959|530029652|FG003|Randomization Period|Physician Decision|0|||
146964317|NCT01869959|530029653|FG004|Randomization Period|Physician Decision|1|||
146964318|NCT01869959|530029649|FG000|Treatment Period|Adverse Event|1|||
146964319|NCT01869959|530029650|FG001|Treatment Period|Adverse Event|0|||
146964320|NCT01869959|530029651|FG002|Treatment Period|Adverse Event|3|||
146964321|NCT01869959|530029652|FG003|Treatment Period|Adverse Event|1|||
146964322|NCT01869959|530029653|FG004|Treatment Period|Adverse Event|0|||
146964323|NCT01869959|530029649|FG000|Treatment Period|Sponsor decision|0|||
146964324|NCT01869959|530029650|FG001|Treatment Period|Sponsor decision|1|||
146964325|NCT01869959|530029651|FG002|Treatment Period|Sponsor decision|0|||
146964326|NCT01869959|530029652|FG003|Treatment Period|Sponsor decision|1|||
146964327|NCT01869959|530029653|FG004|Treatment Period|Sponsor decision|0|||
146964328|NCT01869959|530029649|FG000|Treatment Period|Withdrawal by Subject|0|||
146964329|NCT01869959|530029650|FG001|Treatment Period|Withdrawal by Subject|1|||
146964330|NCT01869959|530029651|FG002|Treatment Period|Withdrawal by Subject|0|||
146964331|NCT01869959|530029652|FG003|Treatment Period|Withdrawal by Subject|0|||
146964332|NCT01869959|530029653|FG004|Treatment Period|Withdrawal by Subject|0|||
146964333|NCT01965600|530029654|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
146964334|NCT01965600|530029655|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
146964335|NCT01965600|530029656|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
146738224|NCT03238300|529213471|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
146964336|NCT01965600|530029657|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
146964337|NCT01965600|530029654|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
146964338|NCT01965600|530029655|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
146964339|NCT01965600|530029656|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
146964340|NCT01965600|530029657|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
146964341|NCT01965600|530029654|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
146964342|NCT01965600|530029655|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
146964343|NCT01965600|530029656|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
146964344|NCT01965600|530029657|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
146964345|NCT01965600|530029654|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
146964346|NCT01965600|530029655|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
146964347|NCT01965600|530029656|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
146964348|NCT01965600|530029657|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
146964349|NCT01965600|530029654|FG000|Second Intervention|Study terminated by Sponsor|0|||
146964350|NCT01965600|530029655|FG001|Second Intervention|Study terminated by Sponsor|0|||
146964351|NCT01965600|530029656|FG002|Second Intervention|Study terminated by Sponsor|2|||
146964352|NCT01965600|530029657|FG003|Second Intervention|Study terminated by Sponsor|2|||
146964353|NCT04678557|530029658|FG000|Overall Study|Withdrawal by Subject|1|||
146964354|NCT04678557|530029659|FG001|Overall Study|Withdrawal by Subject|0|||
146964355|NCT04678557|530029658|FG000|Overall Study|Lack of Efficacy|0|||
146964356|NCT04678557|530029659|FG001|Overall Study|Lack of Efficacy|13|||
146964357|NCT04678557|530029658|FG000|Overall Study|Safety Evaluation|0|||
146964358|NCT04678557|530029659|FG001|Overall Study|Safety Evaluation|1|||
146964359|NCT00157157|530029660|FG000|Overall Study|Withdrawal by Subject|6|||
146964360|NCT00157157|530029660|FG000|Overall Study|Physician Decision|1|||
146964361|NCT00157157|530029660|FG000|Overall Study|Lost to Follow-up|1|||
146964362|NCT00157157|530029660|FG000|Overall Study|Enrolled in another study|1|||
146964363|NCT00157157|530029660|FG000|Overall Study|Met exclusion criteria|1|||
146964364|NCT00157157|530029660|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
146964365|NCT02260804|530029664|FG000|Induction Study Period|Protocol Violation|2|||
146964366|NCT02260804|530029665|FG001|Induction Study Period|Protocol Violation|0|||
146964367|NCT02260804|530029664|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
146964368|NCT02260804|530029665|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
146964369|NCT02260804|530029664|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
146964370|NCT02260804|530029665|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
146964371|NCT02260804|530029664|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
146964372|NCT02260804|530029665|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
146964373|NCT02260804|530029664|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
146964374|NCT02260804|530029665|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
146964375|NCT02260804|530029664|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
146964376|NCT02260804|530029665|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
146964377|NCT02260804|530029664|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
146964378|NCT02260804|530029665|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
146964379|NCT02260804|530029664|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
146964380|NCT02260804|530029665|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
146964381|NCT02260804|530029664|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
146964382|NCT02260804|530029665|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
146964383|NCT02260804|530029664|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
146964384|NCT02260804|530029665|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
146964385|NCT02260804|530029664|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
146964386|NCT02260804|530029665|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
146975291|NCT00289731|530073521|FG001|Overall Study|Adverse Event|2|||
146975292|NCT00289731|530073522|FG002|Overall Study|Adverse Event|2|||
146975293|NCT00289731|530073520|FG000|Overall Study|Other|1|||
146975294|NCT00289731|530073521|FG001|Overall Study|Other|0|||
146975295|NCT00289731|530073522|FG002|Overall Study|Other|0|||
146975296|NCT01830920|530073525|FG000|Overall Study|Adverse Event|1|||
146975297|NCT01830920|530073526|FG001|Overall Study|Adverse Event|0|||
146975298|NCT01830920|530073527|FG002|Overall Study|Adverse Event|1|||
146975299|NCT01830920|530073528|FG003|Overall Study|Adverse Event|0|||
146975300|NCT01830920|530073529|FG004|Overall Study|Adverse Event|0|||
146975301|NCT01830920|530073525|FG000|Overall Study|Withdrawal by Subject|2|||
146975302|NCT01830920|530073526|FG001|Overall Study|Withdrawal by Subject|2|||
146975303|NCT01830920|530073527|FG002|Overall Study|Withdrawal by Subject|1|||
146975304|NCT01830920|530073528|FG003|Overall Study|Withdrawal by Subject|7|||
146975305|NCT01830920|530073529|FG004|Overall Study|Withdrawal by Subject|1|||
146975306|NCT01830920|530073525|FG000|Overall Study|Death|3|||
146975307|NCT01830920|530073526|FG001|Overall Study|Death|3|||
146975308|NCT01830920|530073527|FG002|Overall Study|Death|5|||
146975309|NCT01830920|530073528|FG003|Overall Study|Death|4|||
146964387|NCT02983305|530031158|FG000|Overall Study|incomplete data|2|||
146964388|NCT02983305|530031159|FG001|Overall Study|incomplete data|0|||
146964389|NCT00822237|530031160|FG000|Dose 1 Vaccination|Not vaccinated|3|||
146964390|NCT00822237|530031161|FG001|Dose 1 Vaccination|Not vaccinated|0|||
146964391|NCT00822237|530031160|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
146964392|NCT00822237|530031161|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
146964393|NCT00822237|530031160|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
146964394|NCT00822237|530031161|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
146964395|NCT00822237|530031160|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
146964396|NCT00822237|530031161|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
146964397|NCT00822237|530031160|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
146964398|NCT00822237|530031161|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
146964399|NCT01519635|530031162|FG000|Overall Study|Withdrawal by Subject|0|||
146964400|NCT01519635|530031163|FG001|Overall Study|Withdrawal by Subject|1|||
146964401|NCT01519635|530031162|FG000|Overall Study|No possibility to put a catheter|1|||
146964402|NCT01519635|530031163|FG001|Overall Study|No possibility to put a catheter|2|||
146964403|NCT00518531|530031166|FG000|Treatment Period 1|Adverse Event|5|||
146964404|NCT00518531|530031167|FG001|Treatment Period 1|Adverse Event|0|||
146964405|NCT00518531|530031166|FG000|Treatment Period 1|Lost to Follow-up|5|||
146964406|NCT00518531|530031167|FG001|Treatment Period 1|Lost to Follow-up|3|||
146964407|NCT00518531|530031166|FG000|Treatment Period 1|Physician Decision|1|||
146964408|NCT00518531|530031167|FG001|Treatment Period 1|Physician Decision|0|||
146964409|NCT00518531|530031166|FG000|Treatment Period 1|Protocol Violation|2|||
146964410|NCT00518531|530031167|FG001|Treatment Period 1|Protocol Violation|0|||
146964411|NCT00518531|530031166|FG000|Treatment Period 1|Withdrawal by Subject|4|||
146964412|NCT00518531|530031167|FG001|Treatment Period 1|Withdrawal by Subject|6|||
146964413|NCT00518531|530031166|FG000|Treatment Period 1|Early crossover|1|||
146964414|NCT00518531|530031167|FG001|Treatment Period 1|Early crossover|3|||
146964415|NCT00518531|530031166|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146964416|NCT00518531|530031167|FG001|Treatment Period 2|Withdrawal by Subject|8|||
146964417|NCT00518531|530031166|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
146964418|NCT00518531|530031167|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
146964419|NCT00518531|530031166|FG000|Treatment Period 2|Adverse Event|1|||
146964420|NCT00518531|530031167|FG001|Treatment Period 2|Adverse Event|7|||
146964421|NCT00518531|530031166|FG000|Treatment Period 2|Protocol-specified criteria|0|||
146964422|NCT00518531|530031167|FG001|Treatment Period 2|Protocol-specified criteria|1|||
146964423|NCT00518531|530031166|FG000|Treatment Period 2|Non-compliance|1|||
146964424|NCT00518531|530031167|FG001|Treatment Period 2|Non-compliance|2|||
146964425|NCT04621227|530031170|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
146964426|NCT04621227|530031170|FG000|Period 3 (29 Days)|Adverse Event|1|||
146964427|NCT04621227|530031170|FG000|Period 8 (2 Days)|Adverse Event|1|||
146964428|NCT01728376|530031171|FG000|Overall Study|Adverse Event|1|||
146964429|NCT01728376|530031172|FG001|Overall Study|Adverse Event|1|||
146964430|NCT01728376|530031173|FG002|Overall Study|Adverse Event|1|||
146964431|NCT01728376|530031174|FG003|Overall Study|Adverse Event|1|||
146964432|NCT01728376|530031175|FG004|Overall Study|Adverse Event|1|||
146964433|NCT01728376|530031176|FG005|Overall Study|Adverse Event|0|||
146964434|NCT01728376|530031171|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
146964435|NCT01728376|530031172|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
146964436|NCT01728376|530031173|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
146964437|NCT01728376|530031174|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
146964438|NCT01728376|530031175|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
146964439|NCT01728376|530031176|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
146964440|NCT01728376|530031171|FG000|Overall Study|No relevant bacteria|2|||
146964441|NCT01728376|530031172|FG001|Overall Study|No relevant bacteria|0|||
146964442|NCT01728376|530031173|FG002|Overall Study|No relevant bacteria|0|||
146964443|NCT01728376|530031174|FG003|Overall Study|No relevant bacteria|0|||
146964444|NCT01728376|530031175|FG004|Overall Study|No relevant bacteria|1|||
146964445|NCT01728376|530031176|FG005|Overall Study|No relevant bacteria|1|||
146964446|NCT01728376|530031171|FG000|Overall Study|Did not receive treatment|0|||
146964447|NCT01728376|530031172|FG001|Overall Study|Did not receive treatment|1|||
146964448|NCT01728376|530031173|FG002|Overall Study|Did not receive treatment|0|||
146964449|NCT01728376|530031174|FG003|Overall Study|Did not receive treatment|0|||
146964450|NCT01728376|530031175|FG004|Overall Study|Did not receive treatment|0|||
146964451|NCT01728376|530031176|FG005|Overall Study|Did not receive treatment|0|||
146964452|NCT01728376|530031171|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
146964453|NCT01728376|530031172|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
146964454|NCT01728376|530031173|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
146964455|NCT01728376|530031174|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
146964456|NCT01728376|530031175|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
146964457|NCT01728376|530031176|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
146964458|NCT00812968|530031182|FG000|Overall Study|Relapse after erythroid response|6|||
146964459|NCT00812968|530031182|FG000|Overall Study|Disease progression|1|||
146964460|NCT00812968|530031182|FG000|Overall Study|No further treatment required|1|||
146964461|NCT00812968|530031182|FG000|Overall Study|Study closed due to marketing approval|3|||
146964462|NCT00761969|530031186|FG000|Overall Study|Death|112|||
146964463|NCT00761969|530031187|FG001|Overall Study|Death|47|||
146964464|NCT00761969|530031186|FG000|Overall Study|Lost to Follow-up|88|||
146964465|NCT00761969|530031187|FG001|Overall Study|Lost to Follow-up|93|||
146964466|NCT01725217|530031188|FG000|Overall Study|Withdrawal by Subject|1|||
146964467|NCT01725217|530031189|FG001|Overall Study|Withdrawal by Subject|0|||
146964468|NCT01725217|530031190|FG002|Overall Study|Withdrawal by Subject|0|||
146964469|NCT03992456|530031191|FG000|Overall Study|Withdrawal by Subject|1|||
146964470|NCT03992456|530031192|FG001|Overall Study|Withdrawal by Subject|0|||
146964471|NCT03992456|530031191|FG000|Overall Study|Disease progression|4|||
146964472|NCT03992456|530031192|FG001|Overall Study|Disease progression|5|||
146964473|NCT03992456|530031191|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
146964474|NCT03992456|530031192|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
146964475|NCT01068418|530031195|FG000|Overall Study|Physician Decision|12|||
146964476|NCT00910000|530031196|FG000|Overall Study|Adverse Event|0|||
146964477|NCT00910000|530031197|FG001|Overall Study|Adverse Event|3|||
146964478|NCT00910000|530031198|FG002|Overall Study|Adverse Event|2|||
146964479|NCT00910000|530031199|FG003|Overall Study|Adverse Event|2|||
146964480|NCT00910000|530031200|FG004|Overall Study|Adverse Event|0|||
146964481|NCT00910000|530031201|FG005|Overall Study|Adverse Event|1|||
146964482|NCT00910000|530031196|FG000|Overall Study|Withdrawal by Subject|0|||
146964483|NCT00910000|530031197|FG001|Overall Study|Withdrawal by Subject|0|||
146964484|NCT00910000|530031198|FG002|Overall Study|Withdrawal by Subject|1|||
146964485|NCT00910000|530031199|FG003|Overall Study|Withdrawal by Subject|0|||
146964486|NCT00910000|530031200|FG004|Overall Study|Withdrawal by Subject|1|||
146964487|NCT00910000|530031201|FG005|Overall Study|Withdrawal by Subject|0|||
146964488|NCT04637815|530031202|FG000|Overall Study|Death|1|||
146964489|NCT04637815|530031203|FG001|Overall Study|Death|0|||
146964490|NCT04637815|530031202|FG000|Overall Study|Lost to Follow-up|5|||
146964491|NCT04637815|530031203|FG001|Overall Study|Lost to Follow-up|2|||
146964492|NCT01977625|530031204|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
146964493|NCT01977625|530031205|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
146964494|NCT01977625|530031204|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
146964495|NCT01977625|530031205|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
146964496|NCT02594384|530031206|FG000|Overall Study|Disease Progression|3|||
146964497|NCT02594384|530031207|FG001|Overall Study|Disease Progression|7|||
146964498|NCT02594384|530031208|FG002|Overall Study|Disease Progression|0|||
146964499|NCT02594384|530031209|FG003|Overall Study|Disease Progression|2|||
146650221|NCT01143389|528896681|FG000|Overall Study|Lost to Follow-up|26|||
146964500|NCT02594384|530031210|FG004|Overall Study|Disease Progression|2|||
146650222|NCT01143389|528896682|FG001|Overall Study|Lost to Follow-up|25|||
146964501|NCT02594384|530031211|FG005|Overall Study|Disease Progression|12|||
146964502|NCT02594384|530031212|FG006|Overall Study|Disease Progression|5|||
146964503|NCT02594384|530031213|FG007|Overall Study|Disease Progression|5|||
146964504|NCT02594384|530031206|FG000|Overall Study|Adverse Event|0|||
146964505|NCT02594384|530031207|FG001|Overall Study|Adverse Event|1|||
146964506|NCT02594384|530031208|FG002|Overall Study|Adverse Event|4|||
146964507|NCT02594384|530031209|FG003|Overall Study|Adverse Event|1|||
146964508|NCT02594384|530031210|FG004|Overall Study|Adverse Event|0|||
146964509|NCT02594384|530031211|FG005|Overall Study|Adverse Event|6|||
146964510|NCT02594384|530031212|FG006|Overall Study|Adverse Event|1|||
146964511|NCT02594384|530031213|FG007|Overall Study|Adverse Event|1|||
146964512|NCT02594384|530031206|FG000|Overall Study|Withdrawal by Subject|0|||
146964513|NCT02594384|530031207|FG001|Overall Study|Withdrawal by Subject|0|||
146964514|NCT02594384|530031208|FG002|Overall Study|Withdrawal by Subject|0|||
146964515|NCT02594384|530031209|FG003|Overall Study|Withdrawal by Subject|1|||
146964516|NCT02594384|530031210|FG004|Overall Study|Withdrawal by Subject|0|||
146964517|NCT02594384|530031211|FG005|Overall Study|Withdrawal by Subject|0|||
146964518|NCT02594384|530031212|FG006|Overall Study|Withdrawal by Subject|0|||
146964519|NCT02594384|530031213|FG007|Overall Study|Withdrawal by Subject|1|||
146964520|NCT02594384|530031206|FG000|Overall Study|Physician Decision|0|||
146964521|NCT02594384|530031207|FG001|Overall Study|Physician Decision|0|||
146964522|NCT02594384|530031208|FG002|Overall Study|Physician Decision|0|||
146964523|NCT02594384|530031209|FG003|Overall Study|Physician Decision|0|||
146964524|NCT02594384|530031210|FG004|Overall Study|Physician Decision|0|||
146964525|NCT02594384|530031211|FG005|Overall Study|Physician Decision|1|||
146964526|NCT02594384|530031212|FG006|Overall Study|Physician Decision|2|||
146964527|NCT02594384|530031213|FG007|Overall Study|Physician Decision|0|||
146964528|NCT02594384|530031206|FG000|Overall Study|Progressive Leukocytosis|0|||
146964529|NCT02594384|530031207|FG001|Overall Study|Progressive Leukocytosis|0|||
146964530|NCT02594384|530031208|FG002|Overall Study|Progressive Leukocytosis|1|||
146964531|NCT02594384|530031209|FG003|Overall Study|Progressive Leukocytosis|0|||
146964532|NCT02594384|530031210|FG004|Overall Study|Progressive Leukocytosis|0|||
146964533|NCT02594384|530031211|FG005|Overall Study|Progressive Leukocytosis|0|||
146964534|NCT02594384|530031212|FG006|Overall Study|Progressive Leukocytosis|0|||
146964535|NCT02594384|530031213|FG007|Overall Study|Progressive Leukocytosis|0|||
146964536|NCT02594384|530031206|FG000|Overall Study|Lack of Efficacy|0|||
146964537|NCT02594384|530031207|FG001|Overall Study|Lack of Efficacy|0|||
146964538|NCT02594384|530031208|FG002|Overall Study|Lack of Efficacy|0|||
146964539|NCT02594384|530031209|FG003|Overall Study|Lack of Efficacy|0|||
146964540|NCT02594384|530031210|FG004|Overall Study|Lack of Efficacy|1|||
146964541|NCT02594384|530031211|FG005|Overall Study|Lack of Efficacy|0|||
146964542|NCT02594384|530031212|FG006|Overall Study|Lack of Efficacy|0|||
146964543|NCT02594384|530031213|FG007|Overall Study|Lack of Efficacy|0|||
146964544|NCT02594384|530031206|FG000|Overall Study|Substantial noncompliance|0|||
146964545|NCT02594384|530031207|FG001|Overall Study|Substantial noncompliance|0|||
146964546|NCT02594384|530031208|FG002|Overall Study|Substantial noncompliance|0|||
146964547|NCT02594384|530031209|FG003|Overall Study|Substantial noncompliance|0|||
146964548|NCT02594384|530031210|FG004|Overall Study|Substantial noncompliance|0|||
146964549|NCT02594384|530031211|FG005|Overall Study|Substantial noncompliance|0|||
146964550|NCT02594384|530031212|FG006|Overall Study|Substantial noncompliance|1|||
146964551|NCT02594384|530031213|FG007|Overall Study|Substantial noncompliance|0|||
146964552|NCT03919669|530031217|FG000|Overall Study|Withdrawal by Subject|1|||
146964553|NCT03919669|530031218|FG001|Overall Study|Withdrawal by Subject|0|||
146964554|NCT03919669|530031219|FG002|Overall Study|Withdrawal by Subject|0|||
146964555|NCT02319642|530031220|FG000|Overall Study|Adverse Event|2|||
146964556|NCT02319642|530031221|FG001|Overall Study|Adverse Event|4|||
146625081|NCT00537394|528801580|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
146738225|NCT03238300|529213472|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
146738226|NCT03238300|529213471|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
146738227|NCT03238300|529213472|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
146738228|NCT03238300|529213471|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
146738229|NCT03238300|529213472|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
146738230|NCT01893827|529213473|FG000|Overall Study|Lost to Follow-up|19|||
146738231|NCT01893827|529213474|FG001|Overall Study|Lost to Follow-up|26|||
146738232|NCT02917941|529213475|FG000|Treatment Period|Adverse Event|11|||
146738233|NCT02917941|529213475|FG000|Treatment Period|Progressive Disease|11|||
146738234|NCT02917941|529213475|FG000|Treatment Period|Reason not Specified|2|||
146738235|NCT02917941|529213475|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
146738236|NCT02917941|529213475|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
146964557|NCT02319642|530031220|FG000|Overall Study|Lack of Efficacy|1|||
146964558|NCT02319642|530031221|FG001|Overall Study|Lack of Efficacy|1|||
146964559|NCT02319642|530031220|FG000|Overall Study|Withdrawal by Subject|1|||
146964560|NCT02319642|530031221|FG001|Overall Study|Withdrawal by Subject|1|||
146964561|NCT01265875|530031222|FG000|Overall Study|Uncooperative/unreliable|1|||
146964562|NCT04409509|530031223|FG000|Overall Study|Failure to meet randomization requirement|1|||
146964563|NCT04409509|530031224|FG001|Overall Study|Failure to meet randomization requirement|0|||
146964564|NCT04409509|530031223|FG000|Overall Study|Adverse Event|0|||
146964565|NCT04409509|530031224|FG001|Overall Study|Adverse Event|1|||
146964566|NCT04409509|530031223|FG000|Overall Study|Death|11|||
146964567|NCT04409509|530031224|FG001|Overall Study|Death|10|||
146964568|NCT04409509|530031223|FG000|Overall Study|Non-compliance with study drug|0|||
146964569|NCT04409509|530031224|FG001|Overall Study|Non-compliance with study drug|1|||
146964570|NCT04409509|530031223|FG000|Overall Study|Lost to Follow-up|0|||
146964571|NCT04409509|530031224|FG001|Overall Study|Lost to Follow-up|3|||
146964572|NCT04409509|530031223|FG000|Overall Study|Withdrawal by Subject|0|||
146964573|NCT04409509|530031224|FG001|Overall Study|Withdrawal by Subject|3|||
146964574|NCT04409509|530031223|FG000|Overall Study|Randomized by mistake|0|||
146964575|NCT04409509|530031224|FG001|Overall Study|Randomized by mistake|1|||
146964576|NCT04409509|530031223|FG000|Overall Study|Other|1|||
146964577|NCT04409509|530031224|FG001|Overall Study|Other|1|||
146964578|NCT00483119|530031225|FG000|Overall Study|Adverse Event|0|||
146964579|NCT00483119|530031226|FG001|Overall Study|Adverse Event|1|||
146964580|NCT00483119|530031225|FG000|Overall Study|Physician Decision|1|||
146964581|NCT00483119|530031226|FG001|Overall Study|Physician Decision|0|||
146964582|NCT04668066|530031227|FG000|Part 1: Treatment Phase|Adverse Event|0|||
146964583|NCT04668066|530031228|FG001|Part 1: Treatment Phase|Adverse Event|0|||
146964584|NCT04668066|530031229|FG002|Part 1: Treatment Phase|Adverse Event|0|||
146964585|NCT04668066|530031230|FG003|Part 1: Treatment Phase|Adverse Event|0|||
146964586|NCT04668066|530031231|FG004|Part 1: Treatment Phase|Adverse Event|0|||
146964587|NCT04668066|530031232|FG005|Part 1: Treatment Phase|Adverse Event|0|||
146964588|NCT04668066|530031233|FG006|Part 1: Treatment Phase|Adverse Event|0|||
146964589|NCT04668066|530031234|FG007|Part 1: Treatment Phase|Adverse Event|0|||
146964590|NCT04668066|530031235|FG008|Part 1: Treatment Phase|Adverse Event|0|||
146964591|NCT04668066|530031236|FG009|Part 1: Treatment Phase|Adverse Event|0|||
146964592|NCT04668066|530031237|FG010|Part 1: Treatment Phase|Adverse Event|0|||
146964593|NCT04668066|530031238|FG011|Part 1: Treatment Phase|Adverse Event|1|||
146964594|NCT04668066|530031239|FG012|Part 1: Treatment Phase|Adverse Event|1|||
146964595|NCT04668066|530031240|FG013|Part 1: Treatment Phase|Adverse Event|0|||
146964596|NCT04668066|530031241|FG014|Part 1: Treatment Phase|Adverse Event|0|||
146964597|NCT04668066|530031242|FG015|Part 1: Treatment Phase|Adverse Event|0|||
146964598|NCT04668066|530031243|FG016|Part 1: Treatment Phase|Adverse Event|0|||
146964599|NCT04668066|530031244|FG017|Part 1: Treatment Phase|Adverse Event|0|||
146964600|NCT04668066|530031245|FG018|Part 1: Treatment Phase|Adverse Event|0|||
146964601|NCT04668066|530031227|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
146964602|NCT04668066|530031228|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
146964603|NCT04668066|530031229|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
146964604|NCT04668066|530031230|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
146964605|NCT04668066|530031231|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
146964606|NCT04668066|530031232|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
146964607|NCT04668066|530031233|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
146964608|NCT04668066|530031234|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
146964609|NCT04668066|530031235|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
146964610|NCT04668066|530031236|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
146964611|NCT04668066|530031237|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
146625082|NCT00537394|528801581|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
146738237|NCT00399763|529213476|FG000|Overall Study|Lost to Follow-up|2|||
146964612|NCT04668066|530031238|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
146964613|NCT04668066|530031239|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
146964614|NCT04668066|530031240|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
146964615|NCT04668066|530031241|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
146738238|NCT00399763|529213477|FG001|Overall Study|Lost to Follow-up|3|||
146738239|NCT04182880|529213480|FG000|Overall Study|Pregnancy|1|||
146738240|NCT04182880|529213481|FG001|Overall Study|Pregnancy|0|||
146738241|NCT03389477|529213482|FG000|Step 1|Withdrawal by Subject|1|||
146738242|NCT03389477|529213483|FG001|Step 1|Withdrawal by Subject|0|||
146738243|NCT03389477|529213482|FG000|Step 2|Withdrawal by Subject|1|||
146738244|NCT03389477|529213483|FG001|Step 2|Withdrawal by Subject|2|||
146738245|NCT03389477|529213482|FG000|Step 2|Disease progression|1|||
146738246|NCT03389477|529213483|FG001|Step 2|Disease progression|0|||
146738247|NCT03389477|529213482|FG000|Step 2|Death|0|||
146738248|NCT03389477|529213483|FG001|Step 2|Death|1|||
146738249|NCT03389477|529213482|FG000|Step 2|Poor performance status and nutrition|0|||
146738250|NCT03389477|529213483|FG001|Step 2|Poor performance status and nutrition|1|||
146738251|NCT03389477|529213482|FG000|Step 3|Withdrawal after 3 cycles|0|||
146738252|NCT03389477|529213483|FG001|Step 3|Withdrawal after 3 cycles|1|||
146738253|NCT03389477|529213482|FG000|Step 3|Still receiving active treatment|4|||
146738254|NCT03389477|529213483|FG001|Step 3|Still receiving active treatment|0|||
146738255|NCT03389477|529213482|FG000|Step 3|Progressive disease after 2 cycles|1|||
146738256|NCT03389477|529213483|FG001|Step 3|Progressive disease after 2 cycles|0|||
146738257|NCT04512066|529213486|FG000|Double-blind Treatment Period|Adverse Event|6|||
146738258|NCT04512066|529213487|FG001|Double-blind Treatment Period|Adverse Event|4|||
146738259|NCT04512066|529213488|FG002|Double-blind Treatment Period|Adverse Event|5|||
146738260|NCT04512066|529213489|FG003|Double-blind Treatment Period|Adverse Event|1|||
146738261|NCT04512066|529213490|FG004|Double-blind Treatment Period|Adverse Event|0|||
146738262|NCT04512066|529213491|FG005|Double-blind Treatment Period|Adverse Event|0|||
146738263|NCT04512066|529213486|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
146738264|NCT04512066|529213487|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
146738265|NCT04512066|529213488|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
146738266|NCT04512066|529213489|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
146738267|NCT04512066|529213490|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
146738268|NCT04512066|529213491|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
146738269|NCT04512066|529213486|FG000|Double-blind Treatment Period|Physician Decision|1|||
146738270|NCT04512066|529213487|FG001|Double-blind Treatment Period|Physician Decision|0|||
146738271|NCT04512066|529213488|FG002|Double-blind Treatment Period|Physician Decision|1|||
146738272|NCT04512066|529213489|FG003|Double-blind Treatment Period|Physician Decision|0|||
146738273|NCT04512066|529213490|FG004|Double-blind Treatment Period|Physician Decision|0|||
146738274|NCT04512066|529213491|FG005|Double-blind Treatment Period|Physician Decision|0|||
146738275|NCT04512066|529213486|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
146738276|NCT04512066|529213487|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
146738277|NCT04512066|529213488|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
146738278|NCT04512066|529213489|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
146738279|NCT04512066|529213490|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
146738280|NCT04512066|529213491|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
146738281|NCT04512066|529213486|FG000|Extension Period|Adverse Event|0|||
146738282|NCT04512066|529213487|FG001|Extension Period|Adverse Event|1|||
146738283|NCT04512066|529213488|FG002|Extension Period|Adverse Event|4|||
146738284|NCT04512066|529213489|FG003|Extension Period|Adverse Event|3|||
146738285|NCT04512066|529213490|FG004|Extension Period|Adverse Event|1|||
146738286|NCT04512066|529213491|FG005|Extension Period|Adverse Event|3|||
146738287|NCT04512066|529213486|FG000|Extension Period|Death|0|||
146738288|NCT04512066|529213487|FG001|Extension Period|Death|0|||
146738289|NCT04512066|529213488|FG002|Extension Period|Death|0|||
146738290|NCT04512066|529213489|FG003|Extension Period|Death|0|||
146738291|NCT04512066|529213490|FG004|Extension Period|Death|0|||
146738292|NCT04512066|529213491|FG005|Extension Period|Death|1|||
146738293|NCT04512066|529213486|FG000|Extension Period|Lack of Efficacy|0|||
146738294|NCT04512066|529213487|FG001|Extension Period|Lack of Efficacy|4|||
146738295|NCT04512066|529213488|FG002|Extension Period|Lack of Efficacy|4|||
146738296|NCT04512066|529213489|FG003|Extension Period|Lack of Efficacy|1|||
146738297|NCT04512066|529213490|FG004|Extension Period|Lack of Efficacy|3|||
146738298|NCT04512066|529213491|FG005|Extension Period|Lack of Efficacy|3|||
146738299|NCT04512066|529213486|FG000|Extension Period|Lost to Follow-up|0|||
146738300|NCT04512066|529213487|FG001|Extension Period|Lost to Follow-up|1|||
146738301|NCT04512066|529213488|FG002|Extension Period|Lost to Follow-up|5|||
146738302|NCT04512066|529213489|FG003|Extension Period|Lost to Follow-up|2|||
146738303|NCT04512066|529213490|FG004|Extension Period|Lost to Follow-up|3|||
146738304|NCT04512066|529213491|FG005|Extension Period|Lost to Follow-up|2|||
146738305|NCT04512066|529213486|FG000|Extension Period|Non-compliance with study drug|0|||
146738306|NCT04512066|529213487|FG001|Extension Period|Non-compliance with study drug|1|||
146738307|NCT04512066|529213488|FG002|Extension Period|Non-compliance with study drug|0|||
146738308|NCT04512066|529213489|FG003|Extension Period|Non-compliance with study drug|0|||
146738309|NCT04512066|529213490|FG004|Extension Period|Non-compliance with study drug|0|||
146964616|NCT04668066|530031242|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
146738310|NCT04512066|529213491|FG005|Extension Period|Non-compliance with study drug|1|||
146738311|NCT04512066|529213486|FG000|Extension Period|Other|0|||
146738312|NCT04512066|529213487|FG001|Extension Period|Other|2|||
146964617|NCT04668066|530031243|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
146738313|NCT04512066|529213488|FG002|Extension Period|Other|0|||
146738314|NCT04512066|529213489|FG003|Extension Period|Other|0|||
146738315|NCT04512066|529213490|FG004|Extension Period|Other|0|||
146738316|NCT04512066|529213491|FG005|Extension Period|Other|0|||
146738317|NCT04512066|529213486|FG000|Extension Period|Physician Decision|0|||
146738318|NCT04512066|529213487|FG001|Extension Period|Physician Decision|2|||
146738319|NCT04512066|529213488|FG002|Extension Period|Physician Decision|0|||
146738320|NCT04512066|529213489|FG003|Extension Period|Physician Decision|1|||
146738321|NCT04512066|529213490|FG004|Extension Period|Physician Decision|1|||
146738322|NCT04512066|529213491|FG005|Extension Period|Physician Decision|0|||
146738323|NCT04512066|529213486|FG000|Extension Period|Withdrawal by Subject|0|||
146738324|NCT04512066|529213487|FG001|Extension Period|Withdrawal by Subject|3|||
146738325|NCT04512066|529213488|FG002|Extension Period|Withdrawal by Subject|7|||
146738326|NCT04512066|529213489|FG003|Extension Period|Withdrawal by Subject|11|||
146738327|NCT04512066|529213490|FG004|Extension Period|Withdrawal by Subject|8|||
146738328|NCT04512066|529213491|FG005|Extension Period|Withdrawal by Subject|4|||
146738329|NCT00445679|529213494|FG000|Overall Study|Adverse Event|22|||
146738330|NCT00445679|529213495|FG001|Overall Study|Adverse Event|12|||
146738331|NCT00445679|529213496|FG002|Overall Study|Adverse Event|30|||
146738332|NCT00445679|529213497|FG003|Overall Study|Adverse Event|19|||
146738333|NCT00445679|529213494|FG000|Overall Study|Failed to return|1|||
146738334|NCT00445679|529213495|FG001|Overall Study|Failed to return|3|||
146738335|NCT00445679|529213496|FG002|Overall Study|Failed to return|2|||
146738336|NCT00445679|529213497|FG003|Overall Study|Failed to return|2|||
146738337|NCT00445679|529213494|FG000|Overall Study|Physician Decision|0|||
146738338|NCT00445679|529213495|FG001|Overall Study|Physician Decision|0|||
146738339|NCT00445679|529213496|FG002|Overall Study|Physician Decision|1|||
146738340|NCT00445679|529213497|FG003|Overall Study|Physician Decision|0|||
146738341|NCT00445679|529213494|FG000|Overall Study|Lost to Follow-up|10|||
146738342|NCT00445679|529213495|FG001|Overall Study|Lost to Follow-up|6|||
146738343|NCT00445679|529213496|FG002|Overall Study|Lost to Follow-up|6|||
146738344|NCT00445679|529213497|FG003|Overall Study|Lost to Follow-up|5|||
146738345|NCT00445679|529213494|FG000|Overall Study|Compliance|3|||
146738346|NCT00445679|529213495|FG001|Overall Study|Compliance|2|||
146738347|NCT00445679|529213496|FG002|Overall Study|Compliance|1|||
146738348|NCT00445679|529213497|FG003|Overall Study|Compliance|2|||
146738349|NCT00445679|529213494|FG000|Overall Study|Withdrawal of Informed Consent|0|||
146738350|NCT00445679|529213495|FG001|Overall Study|Withdrawal of Informed Consent|0|||
146738351|NCT00445679|529213496|FG002|Overall Study|Withdrawal of Informed Consent|1|||
146738352|NCT00445679|529213497|FG003|Overall Study|Withdrawal of Informed Consent|0|||
146738353|NCT00445679|529213494|FG000|Overall Study|Protocol Violation|2|||
146738354|NCT00445679|529213495|FG001|Overall Study|Protocol Violation|3|||
146738355|NCT00445679|529213496|FG002|Overall Study|Protocol Violation|3|||
146738356|NCT00445679|529213497|FG003|Overall Study|Protocol Violation|1|||
146738357|NCT00445679|529213494|FG000|Overall Study|Withdrawal by Subject|8|||
146738358|NCT00445679|529213495|FG001|Overall Study|Withdrawal by Subject|14|||
146738359|NCT00445679|529213496|FG002|Overall Study|Withdrawal by Subject|20|||
146738360|NCT00445679|529213497|FG003|Overall Study|Withdrawal by Subject|18|||
146738361|NCT00445679|529213494|FG000|Overall Study|Lack of Efficacy|2|||
146738362|NCT00445679|529213495|FG001|Overall Study|Lack of Efficacy|6|||
146738363|NCT00445679|529213496|FG002|Overall Study|Lack of Efficacy|2|||
146738364|NCT00445679|529213497|FG003|Overall Study|Lack of Efficacy|0|||
146738365|NCT01119898|529213500|FG000|Overall Study|Adverse Event|4|||
146738366|NCT01119898|529213501|FG001|Overall Study|Adverse Event|5|||
146738367|NCT01119898|529213500|FG000|Overall Study|Withdrawal by Subject|1|||
146738368|NCT01119898|529213501|FG001|Overall Study|Withdrawal by Subject|4|||
146738369|NCT01119898|529213500|FG000|Overall Study|Lack of Efficacy|0|||
146738370|NCT01119898|529213501|FG001|Overall Study|Lack of Efficacy|2|||
146738371|NCT01119898|529213500|FG000|Overall Study|Protocol Violation|1|||
146738372|NCT01119898|529213501|FG001|Overall Study|Protocol Violation|1|||
146738373|NCT01119898|529213500|FG000|Overall Study|Medical procedure|1|||
146738374|NCT01119898|529213501|FG001|Overall Study|Medical procedure|0|||
146738375|NCT01119898|529213500|FG000|Overall Study|Randomized in error did not participate|1|||
146738376|NCT01119898|529213501|FG001|Overall Study|Randomized in error did not participate|0|||
146738377|NCT01806584|529213502|FG000|Overall Study|Adverse Event|2|||
146738378|NCT01806584|529213503|FG001|Overall Study|Adverse Event|1|||
146738379|NCT01806584|529213502|FG000|Overall Study|Death|1|||
146738380|NCT01806584|529213503|FG001|Overall Study|Death|0|||
146738381|NCT01806584|529213502|FG000|Overall Study|Lost to Follow-up|0|||
146738382|NCT01806584|529213503|FG001|Overall Study|Lost to Follow-up|2|||
146738383|NCT01806584|529213502|FG000|Overall Study|Study terminated by sponsor|9|||
146738384|NCT01806584|529213503|FG001|Overall Study|Study terminated by sponsor|14|||
146738385|NCT01806584|529213502|FG000|Overall Study|Withdrawal by Subject|1|||
146738386|NCT01806584|529213503|FG001|Overall Study|Withdrawal by Subject|1|||
146738387|NCT01806584|529213502|FG000|Overall Study|Other unspecified|1|||
146738388|NCT01806584|529213503|FG001|Overall Study|Other unspecified|0|||
146738389|NCT00909428|529213504|FG000|Overall Study|Lost to Follow-up|13|||
146738390|NCT00909428|529213505|FG001|Overall Study|Lost to Follow-up|10|||
146738391|NCT00909428|529213506|FG002|Overall Study|Lost to Follow-up|9|||
146738392|NCT00116844|529213507|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
146738393|NCT00116844|529213508|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
146738394|NCT00116844|529213507|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
146738395|NCT00116844|529213508|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
146738396|NCT00116844|529213507|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
146738397|NCT00116844|529213508|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
146738398|NCT00116844|529213507|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
146738399|NCT00116844|529213508|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
146738400|NCT00116844|529213507|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
146738401|NCT00116844|529213508|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
146738402|NCT00116844|529213507|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
146738403|NCT00116844|529213508|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
146738404|NCT00116844|529213507|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
146738405|NCT00116844|529213508|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
146738406|NCT00116844|529213507|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
146738407|NCT00116844|529213508|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
146738408|NCT00116844|529213507|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
146738409|NCT00116844|529213508|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
146738410|NCT03995784|529213509|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
146738411|NCT01786330|529213513|FG000|Overall Study|Withdrawal by Subject|0|||
146738412|NCT01786330|529213514|FG001|Overall Study|Withdrawal by Subject|1|||
146738413|NCT01786330|529213513|FG000|Overall Study|Lost to Follow-up|0|||
146738414|NCT01786330|529213514|FG001|Overall Study|Lost to Follow-up|1|||
146738415|NCT01786330|529213513|FG000|Overall Study|Excluded intraoperatively|0|||
146964618|NCT04668066|530031244|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
146964619|NCT04668066|530031245|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
146964620|NCT04668066|530031227|FG000|Part 1: Treatment Phase|Other|0|||
146964621|NCT04668066|530031228|FG001|Part 1: Treatment Phase|Other|0|||
146964622|NCT04668066|530031229|FG002|Part 1: Treatment Phase|Other|0|||
146964623|NCT04668066|530031230|FG003|Part 1: Treatment Phase|Other|0|||
146964624|NCT04668066|530031231|FG004|Part 1: Treatment Phase|Other|0|||
146964625|NCT04668066|530031232|FG005|Part 1: Treatment Phase|Other|0|||
146964626|NCT04668066|530031233|FG006|Part 1: Treatment Phase|Other|0|||
146964627|NCT04668066|530031234|FG007|Part 1: Treatment Phase|Other|0|||
146964628|NCT04668066|530031235|FG008|Part 1: Treatment Phase|Other|0|||
146964629|NCT04668066|530031236|FG009|Part 1: Treatment Phase|Other|0|||
146964630|NCT04668066|530031237|FG010|Part 1: Treatment Phase|Other|0|||
146964631|NCT04668066|530031238|FG011|Part 1: Treatment Phase|Other|1|||
146964632|NCT04668066|530031239|FG012|Part 1: Treatment Phase|Other|0|||
146964633|NCT04668066|530031240|FG013|Part 1: Treatment Phase|Other|0|||
146964634|NCT04668066|530031241|FG014|Part 1: Treatment Phase|Other|0|||
146964635|NCT04668066|530031242|FG015|Part 1: Treatment Phase|Other|0|||
146964636|NCT04668066|530031243|FG016|Part 1: Treatment Phase|Other|0|||
146964637|NCT04668066|530031244|FG017|Part 1: Treatment Phase|Other|0|||
146964638|NCT04668066|530031245|FG018|Part 1: Treatment Phase|Other|0|||
146964639|NCT04668066|530031227|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146964640|NCT04668066|530031228|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146964641|NCT04668066|530031229|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146964642|NCT04668066|530031230|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146964643|NCT04668066|530031231|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146964644|NCT04668066|530031232|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146964645|NCT04668066|530031233|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146964646|NCT04668066|530031234|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146964647|NCT04668066|530031235|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146964648|NCT04668066|530031236|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146964649|NCT04668066|530031237|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146964650|NCT04668066|530031238|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146964651|NCT04668066|530031239|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
146964652|NCT04668066|530031240|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146964653|NCT04668066|530031241|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146738416|NCT01786330|529213514|FG001|Overall Study|Excluded intraoperatively|1|||
146738417|NCT01786330|529213513|FG000|Overall Study|Protocol Violation|1|||
146738418|NCT01786330|529213514|FG001|Overall Study|Protocol Violation|0|||
146738419|NCT02172625|529213515|FG000|Overall Study|Adverse Event|0|||
146964654|NCT04668066|530031242|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
146964655|NCT04668066|530031243|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146964656|NCT04668066|530031244|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146738420|NCT02172625|529213516|FG001|Overall Study|Adverse Event|1|||
146964657|NCT04668066|530031245|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146964658|NCT04668066|530031227|FG000|Part 1: Follow-Up|Adverse Event|0|||
146964659|NCT04668066|530031228|FG001|Part 1: Follow-Up|Adverse Event|0|||
146964660|NCT04668066|530031229|FG002|Part 1: Follow-Up|Adverse Event|0|||
146964661|NCT04668066|530031230|FG003|Part 1: Follow-Up|Adverse Event|0|||
146964662|NCT04668066|530031231|FG004|Part 1: Follow-Up|Adverse Event|0|||
146964663|NCT04668066|530031232|FG005|Part 1: Follow-Up|Adverse Event|0|||
146964664|NCT04668066|530031233|FG006|Part 1: Follow-Up|Adverse Event|0|||
146964665|NCT04668066|530031234|FG007|Part 1: Follow-Up|Adverse Event|0|||
146964666|NCT04668066|530031235|FG008|Part 1: Follow-Up|Adverse Event|0|||
146964667|NCT04668066|530031236|FG009|Part 1: Follow-Up|Adverse Event|0|||
146964668|NCT04668066|530031237|FG010|Part 1: Follow-Up|Adverse Event|0|||
146964669|NCT04668066|530031238|FG011|Part 1: Follow-Up|Adverse Event|1|||
146964670|NCT04668066|530031239|FG012|Part 1: Follow-Up|Adverse Event|0|||
146964671|NCT04668066|530031240|FG013|Part 1: Follow-Up|Adverse Event|0|||
146964672|NCT04668066|530031241|FG014|Part 1: Follow-Up|Adverse Event|0|||
146964673|NCT04668066|530031242|FG015|Part 1: Follow-Up|Adverse Event|0|||
146964674|NCT04668066|530031243|FG016|Part 1: Follow-Up|Adverse Event|0|||
146964675|NCT04668066|530031244|FG017|Part 1: Follow-Up|Adverse Event|0|||
146964676|NCT04668066|530031245|FG018|Part 1: Follow-Up|Adverse Event|0|||
146964677|NCT04668066|530031227|FG000|Part 1: Follow-Up|Other|0|||
146964678|NCT04668066|530031228|FG001|Part 1: Follow-Up|Other|0|||
146964679|NCT04668066|530031229|FG002|Part 1: Follow-Up|Other|0|||
146964680|NCT04668066|530031230|FG003|Part 1: Follow-Up|Other|0|||
146964681|NCT04668066|530031231|FG004|Part 1: Follow-Up|Other|0|||
146964682|NCT04668066|530031232|FG005|Part 1: Follow-Up|Other|0|||
146964683|NCT04668066|530031233|FG006|Part 1: Follow-Up|Other|0|||
146964684|NCT04668066|530031234|FG007|Part 1: Follow-Up|Other|0|||
146964685|NCT04668066|530031235|FG008|Part 1: Follow-Up|Other|0|||
146964686|NCT04668066|530031236|FG009|Part 1: Follow-Up|Other|0|||
146964687|NCT04668066|530031237|FG010|Part 1: Follow-Up|Other|0|||
146964688|NCT04668066|530031238|FG011|Part 1: Follow-Up|Other|1|||
146964689|NCT04668066|530031239|FG012|Part 1: Follow-Up|Other|1|||
146964690|NCT04668066|530031240|FG013|Part 1: Follow-Up|Other|0|||
146964691|NCT04668066|530031241|FG014|Part 1: Follow-Up|Other|0|||
146964692|NCT04668066|530031242|FG015|Part 1: Follow-Up|Other|0|||
146964693|NCT04668066|530031243|FG016|Part 1: Follow-Up|Other|0|||
146964694|NCT04668066|530031244|FG017|Part 1: Follow-Up|Other|0|||
146964695|NCT04668066|530031245|FG018|Part 1: Follow-Up|Other|0|||
146964696|NCT04668066|530031227|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964697|NCT04668066|530031228|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964698|NCT04668066|530031229|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964699|NCT04668066|530031230|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964700|NCT04668066|530031231|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964701|NCT04668066|530031232|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964702|NCT04668066|530031233|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964703|NCT04668066|530031234|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964704|NCT04668066|530031235|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964705|NCT04668066|530031236|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964706|NCT04668066|530031237|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964707|NCT04668066|530031238|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964708|NCT04668066|530031239|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
146964709|NCT04668066|530031240|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964710|NCT04668066|530031241|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964711|NCT04668066|530031242|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
146964712|NCT04668066|530031243|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964713|NCT04668066|530031244|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964714|NCT04668066|530031245|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
146964715|NCT04668066|530031227|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964716|NCT04668066|530031228|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964717|NCT04668066|530031229|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146509001|NCT02304380|528367709|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
146964718|NCT04668066|530031230|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964719|NCT04668066|530031231|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964720|NCT04668066|530031232|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964721|NCT04668066|530031233|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964722|NCT04668066|530031234|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964723|NCT04668066|530031235|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964724|NCT04668066|530031236|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964725|NCT04668066|530031237|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964726|NCT04668066|530031238|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964727|NCT04668066|530031239|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964728|NCT04668066|530031240|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964729|NCT04668066|530031241|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964730|NCT04668066|530031242|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964731|NCT04668066|530031243|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964732|NCT04668066|530031244|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146964733|NCT04668066|530031245|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
146964734|NCT04668066|530031227|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964735|NCT04668066|530031228|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964736|NCT04668066|530031229|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964737|NCT04668066|530031230|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964738|NCT04668066|530031231|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964739|NCT04668066|530031232|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964740|NCT04668066|530031233|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964741|NCT04668066|530031234|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964742|NCT04668066|530031235|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964743|NCT04668066|530031236|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964744|NCT04668066|530031237|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964745|NCT04668066|530031238|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964746|NCT04668066|530031239|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964747|NCT04668066|530031240|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964748|NCT04668066|530031241|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964749|NCT04668066|530031242|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964750|NCT04668066|530031243|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964751|NCT04668066|530031244|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
146964752|NCT04668066|530031245|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
146964753|NCT04668066|530031227|FG000|Part 2: Treatment Phase|Other|0|||
146964754|NCT04668066|530031228|FG001|Part 2: Treatment Phase|Other|0|||
146964755|NCT04668066|530031229|FG002|Part 2: Treatment Phase|Other|0|||
146964756|NCT04668066|530031230|FG003|Part 2: Treatment Phase|Other|0|||
146964757|NCT04668066|530031231|FG004|Part 2: Treatment Phase|Other|0|||
146964758|NCT04668066|530031232|FG005|Part 2: Treatment Phase|Other|0|||
146964759|NCT04668066|530031233|FG006|Part 2: Treatment Phase|Other|0|||
146964760|NCT04668066|530031234|FG007|Part 2: Treatment Phase|Other|0|||
146964761|NCT04668066|530031235|FG008|Part 2: Treatment Phase|Other|0|||
146964762|NCT04668066|530031236|FG009|Part 2: Treatment Phase|Other|0|||
146964763|NCT04668066|530031237|FG010|Part 2: Treatment Phase|Other|0|||
146964764|NCT04668066|530031238|FG011|Part 2: Treatment Phase|Other|0|||
146964765|NCT04668066|530031239|FG012|Part 2: Treatment Phase|Other|0|||
146964766|NCT04668066|530031240|FG013|Part 2: Treatment Phase|Other|0|||
146964767|NCT04668066|530031241|FG014|Part 2: Treatment Phase|Other|0|||
146964768|NCT04668066|530031242|FG015|Part 2: Treatment Phase|Other|0|||
146964769|NCT04668066|530031243|FG016|Part 2: Treatment Phase|Other|0|||
146964770|NCT04668066|530031244|FG017|Part 2: Treatment Phase|Other|0|||
146964771|NCT04668066|530031245|FG018|Part 2: Treatment Phase|Other|1|||
146964772|NCT04668066|530031227|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964773|NCT04668066|530031228|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964774|NCT04668066|530031229|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964775|NCT04668066|530031230|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964776|NCT04668066|530031231|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964777|NCT04668066|530031232|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964778|NCT04668066|530031233|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964779|NCT04668066|530031234|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964780|NCT04668066|530031235|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964781|NCT04668066|530031236|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964782|NCT04668066|530031237|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964783|NCT04668066|530031238|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964784|NCT04668066|530031239|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964785|NCT04668066|530031240|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964786|NCT04668066|530031241|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964787|NCT04668066|530031242|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964788|NCT04668066|530031243|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964789|NCT04668066|530031244|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
146964790|NCT04668066|530031245|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
146964791|NCT02331680|530031246|FG000|Overall Study|Adverse Event|3|||
146964792|NCT02331680|530031247|FG001|Overall Study|Adverse Event|0|||
146964793|NCT02331680|530031248|FG002|Overall Study|Adverse Event|2|||
146964794|NCT02331680|530031246|FG000|Overall Study|Physician Decision|1|||
146964795|NCT02331680|530031247|FG001|Overall Study|Physician Decision|1|||
146964796|NCT02331680|530031248|FG002|Overall Study|Physician Decision|2|||
146964797|NCT02331680|530031246|FG000|Overall Study|Withdrawal by Subject|0|||
146964798|NCT02331680|530031247|FG001|Overall Study|Withdrawal by Subject|1|||
146964799|NCT02331680|530031248|FG002|Overall Study|Withdrawal by Subject|2|||
146964800|NCT02331680|530031246|FG000|Overall Study|Met withdrawal criteria|2|||
146964801|NCT02331680|530031247|FG001|Overall Study|Met withdrawal criteria|2|||
146964802|NCT02331680|530031248|FG002|Overall Study|Met withdrawal criteria|5|||
146964803|NCT02331680|530031246|FG000|Overall Study|Non-compliance with study drug|0|||
146964804|NCT02331680|530031247|FG001|Overall Study|Non-compliance with study drug|0|||
146964805|NCT02331680|530031248|FG002|Overall Study|Non-compliance with study drug|1|||
146964806|NCT02331680|530031246|FG000|Overall Study|Protocol Violation|0|||
146964807|NCT02331680|530031247|FG001|Overall Study|Protocol Violation|0|||
146964808|NCT02331680|530031248|FG002|Overall Study|Protocol Violation|3|||
146964809|NCT01015118|530031249|FG000|Overall Study|Protocol Violation|5|||
146964810|NCT01015118|530031250|FG001|Overall Study|Protocol Violation|6|||
146964811|NCT01015118|530031249|FG000|Overall Study|Withdrawal by Subject|103|||
146964812|NCT01015118|530031250|FG001|Overall Study|Withdrawal by Subject|27|||
146964813|NCT01015118|530031249|FG000|Overall Study|Other Adverse Event (AE)|141|||
146964814|NCT01015118|530031250|FG001|Overall Study|Other Adverse Event (AE)|33|||
146964815|NCT01015118|530031249|FG000|Overall Study|Worsening or AE of underlying disease|5|||
146964816|NCT01015118|530031250|FG001|Overall Study|Worsening or AE of underlying disease|4|||
146964817|NCT01015118|530031249|FG000|Overall Study|Progressive disease|364|||
146964818|NCT01015118|530031250|FG001|Overall Study|Progressive disease|229|||
146738421|NCT02172625|529213515|FG000|Overall Study|Pregnancy|0|||
146738422|NCT02172625|529213516|FG001|Overall Study|Pregnancy|1|||
146738423|NCT02172625|529213515|FG000|Overall Study|car accident|0|||
146738424|NCT02172625|529213516|FG001|Overall Study|car accident|1|||
146738425|NCT02764775|529215322|FG000|Overall Study|Death|1|||
146738426|NCT02764775|529215322|FG000|Overall Study|Lost to Follow-up|2|||
146738427|NCT02764775|529215322|FG000|Overall Study|Withdrawal by Subject|3|||
146738428|NCT01992549|529215324|FG000|Overall Study|Lost to Follow-up|2|||
146738429|NCT01992549|529215324|FG000|Overall Study|Serious Adverse Event|1|||
146738430|NCT01992549|529215324|FG000|Overall Study|Product Switch to Extend Half Life|1|||
146738431|NCT00767104|529215326|FG000|Overall Study|Lost to Follow-up|1|||
146738432|NCT00767104|529215327|FG001|Overall Study|Lost to Follow-up|2|||
146738433|NCT00840996|529215328|FG000|Overall Study|Withdrawal by Subject|1|||
146738434|NCT00840996|529215329|FG001|Overall Study|Withdrawal by Subject|0|||
146738435|NCT04022889|529215330|FG000|Stage 1: Period 1|Adverse Event|1|||
146738436|NCT04022889|529215331|FG001|Stage 1: Period 1|Adverse Event|0|||
146738437|NCT04022889|529215332|FG002|Stage 1: Period 1|Adverse Event|0|||
146738438|NCT04022889|529215330|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
146738439|NCT04022889|529215331|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
146738440|NCT04022889|529215332|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
146738441|NCT04022889|529215330|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
146738442|NCT04022889|529215331|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
146738443|NCT04022889|529215332|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
146738444|NCT04022889|529215330|FG000|Stage 2|Screen Failure|0|||
146738445|NCT04022889|529215331|FG001|Stage 2|Screen Failure|0|||
146738446|NCT04022889|529215332|FG002|Stage 2|Screen Failure|3|||
146738447|NCT04022889|529215330|FG000|Stage 2|Ineligible for apheresis donation|0|||
146738448|NCT04022889|529215331|FG001|Stage 2|Ineligible for apheresis donation|0|||
146738449|NCT04022889|529215332|FG002|Stage 2|Ineligible for apheresis donation|2|||
146738450|NCT04022889|529215330|FG000|Stage 2|Adverse Event|0|||
146738451|NCT04022889|529215331|FG001|Stage 2|Adverse Event|0|||
146738452|NCT04022889|529215332|FG002|Stage 2|Adverse Event|2|||
146738453|NCT04022889|529215330|FG000|Stage 2|Protocol Violation|0|||
146738454|NCT04022889|529215331|FG001|Stage 2|Protocol Violation|0|||
146738455|NCT04022889|529215332|FG002|Stage 2|Protocol Violation|1|||
146738456|NCT04022889|529215330|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
146964819|NCT01015118|530031249|FG000|Overall Study|Not treated|9|||
146964820|NCT01015118|530031250|FG001|Overall Study|Not treated|5|||
146964821|NCT01015118|530031249|FG000|Overall Study|Other than stated above|42|||
146964822|NCT01015118|530031250|FG001|Overall Study|Other than stated above|23|||
146738457|NCT04022889|529215331|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
146738458|NCT04022889|529215332|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
146738459|NCT03015116|529215335|FG000|Overall Study|Lost to Follow-up|3|||
146738460|NCT03015116|529215336|FG001|Overall Study|Lost to Follow-up|0|||
146738461|NCT03015116|529215337|FG002|Overall Study|Lost to Follow-up|2|||
146738462|NCT03015116|529215335|FG000|Overall Study|Withdrawal by Subject|3|||
146738463|NCT03015116|529215336|FG001|Overall Study|Withdrawal by Subject|1|||
146738464|NCT03015116|529215337|FG002|Overall Study|Withdrawal by Subject|0|||
146738465|NCT03015116|529215335|FG000|Overall Study|Subject has New Medical Status|1|||
146738466|NCT03015116|529215336|FG001|Overall Study|Subject has New Medical Status|0|||
146964823|NCT03522506|530031251|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146964824|NCT03522506|530031252|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146964825|NCT03522506|530031253|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146738467|NCT03015116|529215337|FG002|Overall Study|Subject has New Medical Status|0|||
146738468|NCT03015116|529215335|FG000|Overall Study|Physician Decision|0|||
146738469|NCT03015116|529215336|FG001|Overall Study|Physician Decision|1|||
146738470|NCT03015116|529215337|FG002|Overall Study|Physician Decision|0|||
146738471|NCT00519896|529215349|FG000|Overall Study|Protocol Violation|1|||
146738472|NCT00519896|529215349|FG000|Overall Study|Adverse Event|1|||
146738473|NCT01077362|529215354|FG000|Overall Study|Lack of Efficacy|13|||
146738474|NCT01077362|529215355|FG001|Overall Study|Lack of Efficacy|8|||
146738475|NCT01077362|529215356|FG002|Overall Study|Lack of Efficacy|10|||
146738476|NCT01077362|529215354|FG000|Overall Study|Lost to Follow-up|1|||
146738477|NCT01077362|529215355|FG001|Overall Study|Lost to Follow-up|0|||
146738478|NCT01077362|529215356|FG002|Overall Study|Lost to Follow-up|3|||
146738479|NCT01077362|529215354|FG000|Overall Study|Adverse Event|12|||
146738480|NCT01077362|529215355|FG001|Overall Study|Adverse Event|7|||
146738481|NCT01077362|529215356|FG002|Overall Study|Adverse Event|4|||
146738482|NCT01077362|529215354|FG000|Overall Study|Withdrawal by Subject|5|||
146738483|NCT01077362|529215355|FG001|Overall Study|Withdrawal by Subject|3|||
146738484|NCT01077362|529215356|FG002|Overall Study|Withdrawal by Subject|5|||
146738485|NCT01077362|529215354|FG000|Overall Study|Other|0|||
146738486|NCT01077362|529215355|FG001|Overall Study|Other|1|||
146738487|NCT01077362|529215356|FG002|Overall Study|Other|2|||
146738488|NCT02387216|529215357|FG000|Overall Study|Progressive disease|2|||
146738489|NCT02387216|529215358|FG001|Overall Study|Progressive disease|0|||
146738490|NCT02387216|529215357|FG000|Overall Study|Withdrawal by Subject|3|||
146738491|NCT02387216|529215358|FG001|Overall Study|Withdrawal by Subject|5|||
146738492|NCT02387216|529215357|FG000|Overall Study|Physician Decision|2|||
146738493|NCT02387216|529215358|FG001|Overall Study|Physician Decision|0|||
146738494|NCT02387216|529215357|FG000|Overall Study|Sponsor Decision|28|||
146738495|NCT02387216|529215358|FG001|Overall Study|Sponsor Decision|12|||
146738496|NCT02387216|529215357|FG000|Overall Study|Death|60|||
146738497|NCT02387216|529215358|FG001|Overall Study|Death|23|||
146738498|NCT02387216|529215357|FG000|Overall Study|Other|5|||
146738499|NCT02387216|529215358|FG001|Overall Study|Other|4|||
146738500|NCT02387216|529215357|FG000|Overall Study|Lost to Follow-up|0|||
146738501|NCT02387216|529215358|FG001|Overall Study|Lost to Follow-up|3|||
146738502|NCT02306265|529215359|FG000|Overall Study|Withdrawal by Subject|1|||
146738503|NCT03107377|529215362|FG000|Overall Study|Adverse Event|3|||
146738504|NCT03107377|529215363|FG001|Overall Study|Adverse Event|3|||
146738505|NCT03107377|529215362|FG000|Overall Study|Protocol Violation|9|||
146738506|NCT03107377|529215363|FG001|Overall Study|Protocol Violation|12|||
146738507|NCT03107377|529215362|FG000|Overall Study|Physician Decision|3|||
146738508|NCT03107377|529215363|FG001|Overall Study|Physician Decision|6|||
146738509|NCT03107377|529215362|FG000|Overall Study|Pregnancy|7|||
146738510|NCT03107377|529215363|FG001|Overall Study|Pregnancy|7|||
146738511|NCT03107377|529215362|FG000|Overall Study|Withdrawal by Subject|16|||
146738512|NCT03107377|529215363|FG001|Overall Study|Withdrawal by Subject|22|||
146738513|NCT03107377|529215362|FG000|Overall Study|Lost to Follow-up|37|||
146738514|NCT03107377|529215363|FG001|Overall Study|Lost to Follow-up|34|||
146738515|NCT03107377|529215362|FG000|Overall Study|Other reason not specified|16|||
146738516|NCT03107377|529215363|FG001|Overall Study|Other reason not specified|15|||
146738517|NCT00453102|529215365|FG000|Overall Study|Withdrawal by Subject|2|||
146738518|NCT01650519|529215373|FG000|Overall Study|Withdrawal by Subject|1|||
146738519|NCT01650519|529215374|FG001|Overall Study|Withdrawal by Subject|0|||
146738520|NCT05458024|529215377|FG000|Overall Study|Withdrawal by Subject|1|||
146738521|NCT05458024|529215378|FG001|Overall Study|Withdrawal by Subject|1|||
146964826|NCT03522506|530031254|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
146964827|NCT03522506|530031251|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
146964828|NCT03522506|530031252|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
146964829|NCT03522506|530031253|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
146738522|NCT02954458|529215380|FG000|Overall Study|Adverse Event|0|||
146738523|NCT02954458|529215381|FG001|Overall Study|Adverse Event|0|||
146738524|NCT02954458|529215382|FG002|Overall Study|Adverse Event|0|||
146738525|NCT02954458|529215383|FG003|Overall Study|Adverse Event|1|||
146738526|NCT02954458|529215380|FG000|Overall Study|Withdrawal by Subject|0|||
146738527|NCT02954458|529215381|FG001|Overall Study|Withdrawal by Subject|0|||
146738528|NCT02954458|529215382|FG002|Overall Study|Withdrawal by Subject|0|||
146738529|NCT02954458|529215383|FG003|Overall Study|Withdrawal by Subject|1|||
146738530|NCT02954458|529215380|FG000|Overall Study|Physician Decision|0|||
146738531|NCT02954458|529215381|FG001|Overall Study|Physician Decision|0|||
146738532|NCT02954458|529215382|FG002|Overall Study|Physician Decision|1|||
146738533|NCT02954458|529215383|FG003|Overall Study|Physician Decision|1|||
146738534|NCT02954458|529215380|FG000|Overall Study|Lost to Follow-up|1|||
146738535|NCT02954458|529215381|FG001|Overall Study|Lost to Follow-up|0|||
146738536|NCT02954458|529215382|FG002|Overall Study|Lost to Follow-up|0|||
146738537|NCT02954458|529215383|FG003|Overall Study|Lost to Follow-up|1|||
146738538|NCT02954458|529215380|FG000|Overall Study|Death|0|||
146738539|NCT02954458|529215381|FG001|Overall Study|Death|0|||
146738540|NCT02954458|529215382|FG002|Overall Study|Death|0|||
146738541|NCT02954458|529215383|FG003|Overall Study|Death|1|||
146738542|NCT02954458|529215380|FG000|Overall Study|Other|0|||
146738543|NCT02954458|529215381|FG001|Overall Study|Other|0|||
146738544|NCT02954458|529215382|FG002|Overall Study|Other|0|||
146738545|NCT02954458|529215383|FG003|Overall Study|Other|7|||
146738546|NCT00747123|529215384|FG000|Overall Study|Investigator's request|0|||
146738547|NCT00747123|529215385|FG001|Overall Study|Investigator's request|0|||
146738548|NCT00747123|529215386|FG002|Overall Study|Investigator's request|1|||
146964830|NCT03522506|530031254|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
146964831|NCT03480243|530031255|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
146964832|NCT03480243|530031255|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
146964833|NCT02388906|530031264|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
146964834|NCT02388906|530031265|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
146964835|NCT02388906|530031264|FG000|Treatment Period|Disease progression|121|||
146738549|NCT00747123|529215387|FG003|Overall Study|Investigator's request|0|||
146738550|NCT00747123|529215384|FG000|Overall Study|Withdrew consent|0|||
146738551|NCT00747123|529215385|FG001|Overall Study|Withdrew consent|1|||
146738552|NCT00747123|529215386|FG002|Overall Study|Withdrew consent|0|||
146738553|NCT00747123|529215387|FG003|Overall Study|Withdrew consent|0|||
146738554|NCT00747123|529215384|FG000|Overall Study|Adverse Event|0|||
146738555|NCT00747123|529215385|FG001|Overall Study|Adverse Event|1|||
146738556|NCT00747123|529215386|FG002|Overall Study|Adverse Event|0|||
146738557|NCT00747123|529215387|FG003|Overall Study|Adverse Event|1|||
146738558|NCT01778556|529215390|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
146738559|NCT01778556|529215391|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
146738560|NCT01778556|529215390|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
146738561|NCT01778556|529215391|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
146738562|NCT01778556|529215390|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
146738563|NCT01778556|529215391|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
146738564|NCT01778556|529215390|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
146738565|NCT01778556|529215391|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
146738566|NCT02296190|529215392|FG000|Overall Study|Lost to Follow-up|0|||
146738567|NCT02296190|529215393|FG001|Overall Study|Lost to Follow-up|0|||
146738568|NCT02296190|529215394|FG002|Overall Study|Lost to Follow-up|0|||
146738569|NCT02296190|529215395|FG003|Overall Study|Lost to Follow-up|0|||
146738570|NCT02296190|529215396|FG004|Overall Study|Lost to Follow-up|1|||
146738571|NCT02296190|529215397|FG005|Overall Study|Lost to Follow-up|0|||
146738572|NCT02296190|529215392|FG000|Overall Study|Failure to induce PSVT|6|||
146738573|NCT02296190|529215393|FG001|Overall Study|Failure to induce PSVT|10|||
146738574|NCT02296190|529215394|FG002|Overall Study|Failure to induce PSVT|5|||
146738575|NCT02296190|529215395|FG003|Overall Study|Failure to induce PSVT|13|||
146738576|NCT02296190|529215396|FG004|Overall Study|Failure to induce PSVT|8|||
146738577|NCT02296190|529215397|FG005|Overall Study|Failure to induce PSVT|0|||
146738578|NCT02296190|529215392|FG000|Overall Study|Physician Decision|1|||
146738579|NCT02296190|529215393|FG001|Overall Study|Physician Decision|1|||
146738580|NCT02296190|529215394|FG002|Overall Study|Physician Decision|0|||
146738581|NCT02296190|529215395|FG003|Overall Study|Physician Decision|1|||
146738582|NCT02296190|529215396|FG004|Overall Study|Physician Decision|2|||
146738583|NCT02296190|529215397|FG005|Overall Study|Physician Decision|0|||
146738584|NCT02296190|529215392|FG000|Overall Study|Withdrawal by Subject|0|||
146738585|NCT02296190|529215393|FG001|Overall Study|Withdrawal by Subject|1|||
146738586|NCT02296190|529215394|FG002|Overall Study|Withdrawal by Subject|0|||
146738587|NCT02296190|529215395|FG003|Overall Study|Withdrawal by Subject|0|||
146738588|NCT02296190|529215396|FG004|Overall Study|Withdrawal by Subject|0|||
146738589|NCT02296190|529215397|FG005|Overall Study|Withdrawal by Subject|0|||
146738590|NCT02296190|529215392|FG000|Overall Study|PSVT < 5 minutes|5|||
146738591|NCT02296190|529215393|FG001|Overall Study|PSVT < 5 minutes|6|||
146738592|NCT02296190|529215394|FG002|Overall Study|PSVT < 5 minutes|6|||
146738593|NCT02296190|529215395|FG003|Overall Study|PSVT < 5 minutes|6|||
146738594|NCT02296190|529215396|FG004|Overall Study|PSVT < 5 minutes|5|||
146738595|NCT02296190|529215397|FG005|Overall Study|PSVT < 5 minutes|0|||
146738596|NCT02296190|529215392|FG000|Overall Study|Patient was given Propofol|0|||
146738597|NCT02296190|529215393|FG001|Overall Study|Patient was given Propofol|1|||
146964836|NCT02388906|530031265|FG001|Treatment Period|Disease progression|100|||
146964837|NCT02388906|530031264|FG000|Treatment Period|Study drug toxicity|41|||
146964838|NCT02388906|530031265|FG001|Treatment Period|Study drug toxicity|208|||
146964839|NCT02388906|530031264|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
146964840|NCT02388906|530031265|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
146964841|NCT02388906|530031264|FG000|Treatment Period|Participant request to stop treatment|5|||
146964842|NCT02388906|530031265|FG001|Treatment Period|Participant request to stop treatment|9|||
146964843|NCT02388906|530031264|FG000|Treatment Period|Participant withdrew consent|2|||
146964844|NCT02388906|530031265|FG001|Treatment Period|Participant withdrew consent|3|||
146964845|NCT02388906|530031264|FG000|Treatment Period|Poor/non-compliance|0|||
146964846|NCT02388906|530031265|FG001|Treatment Period|Poor/non-compliance|1|||
146964847|NCT02388906|530031264|FG000|Treatment Period|Participant no longer meets study criteria|0|||
146738598|NCT02296190|529215394|FG002|Overall Study|Patient was given Propofol|0|||
146964848|NCT02388906|530031265|FG001|Treatment Period|Participant no longer meets study criteria|1|||
146738599|NCT02296190|529215395|FG003|Overall Study|Patient was given Propofol|1|||
146738600|NCT02296190|529215396|FG004|Overall Study|Patient was given Propofol|0|||
146738601|NCT02296190|529215397|FG005|Overall Study|Patient was given Propofol|0|||
146738602|NCT02296190|529215392|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
146738603|NCT02296190|529215393|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
146738604|NCT02296190|529215394|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
146738605|NCT02296190|529215395|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
146738606|NCT02296190|529215396|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
146738607|NCT02296190|529215397|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
146738608|NCT02296190|529215392|FG000|Overall Study|Blood pressure <100 after sedation|0|||
146738609|NCT02296190|529215393|FG001|Overall Study|Blood pressure <100 after sedation|0|||
146738610|NCT02296190|529215394|FG002|Overall Study|Blood pressure <100 after sedation|0|||
146738611|NCT02296190|529215395|FG003|Overall Study|Blood pressure <100 after sedation|1|||
146738612|NCT02296190|529215396|FG004|Overall Study|Blood pressure <100 after sedation|0|||
146964849|NCT02388906|530031264|FG000|Treatment Period|Other reasons|3|||
146964850|NCT02388906|530031265|FG001|Treatment Period|Other reasons|3|||
146964851|NCT04365387|530031266|FG000|Overall Study|Adverse Event|4|||
146964852|NCT04365387|530031267|FG001|Overall Study|Adverse Event|2|||
146964853|NCT04365387|530031266|FG000|Overall Study|Participants request|14|||
146964854|NCT04365387|530031267|FG001|Overall Study|Participants request|14|||
146964855|NCT04365387|530031266|FG000|Overall Study|Lost to Follow-up|8|||
146964856|NCT04365387|530031267|FG001|Overall Study|Lost to Follow-up|5|||
146964857|NCT04365387|530031266|FG000|Overall Study|Protocol deviation|3|||
146964858|NCT04365387|530031267|FG001|Overall Study|Protocol deviation|4|||
146964859|NCT04365387|530031266|FG000|Overall Study|Participant compliance with visit schedule|1|||
146964860|NCT04365387|530031267|FG001|Overall Study|Participant compliance with visit schedule|0|||
146964861|NCT04365387|530031266|FG000|Overall Study|Participant incarcerated|1|||
146964862|NCT04365387|530031267|FG001|Overall Study|Participant incarcerated|0|||
146964863|NCT04365387|530031266|FG000|Overall Study|Participant moved out of town (relocated)|0|||
146964864|NCT04365387|530031267|FG001|Overall Study|Participant moved out of town (relocated)|1|||
146964865|NCT04365387|530031266|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
146964866|NCT04365387|530031267|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
146964867|NCT04365387|530031266|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
146964868|NCT04365387|530031267|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
146964869|NCT05770401|530031276|FG000|Overall Study|Lost to Follow-up|5|||
146964870|NCT05770401|530031277|FG001|Overall Study|Lost to Follow-up|4|||
146964871|NCT00402298|530031278|FG000|Overall Study|Withdrawal by Subject|1|||
146964872|NCT00402298|530031279|FG001|Overall Study|Withdrawal by Subject|0|||
146964873|NCT04784455|530031280|FG000|Overall Study|Death|4|||
146964874|NCT04298229|530031281|FG000|Overall Study|Physician Decision|1|||
146738613|NCT02296190|529215397|FG005|Overall Study|Blood pressure <100 after sedation|0|||
146738614|NCT02296190|529215392|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
146738615|NCT02296190|529215393|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
146738616|NCT02296190|529215394|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
146738617|NCT02296190|529215395|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
146738618|NCT02296190|529215396|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
146738619|NCT02296190|529215397|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
146738620|NCT02296190|529215392|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
146738621|NCT02296190|529215393|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
146738622|NCT02296190|529215394|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
146738623|NCT02296190|529215395|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
146738624|NCT02296190|529215396|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
146738625|NCT02296190|529215397|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
146738626|NCT02296190|529215392|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
146738627|NCT02296190|529215393|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
146738628|NCT02296190|529215394|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
146738629|NCT02296190|529215395|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
146738630|NCT02296190|529215396|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
146738631|NCT02296190|529215397|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
146738632|NCT02296190|529215392|FG000|Overall Study|Lab result not available in time|1|||
146738633|NCT02296190|529215393|FG001|Overall Study|Lab result not available in time|0|||
146738634|NCT02296190|529215394|FG002|Overall Study|Lab result not available in time|0|||
146738635|NCT02296190|529215395|FG003|Overall Study|Lab result not available in time|0|||
146738636|NCT02296190|529215396|FG004|Overall Study|Lab result not available in time|0|||
146738637|NCT02296190|529215397|FG005|Overall Study|Lab result not available in time|0|||
146738638|NCT02978443|529215398|FG000|Overall Study|Withdrawal by Subject|1|||
146738639|NCT02978443|529215398|FG000|Overall Study|Adverse Event|3|||
146738640|NCT02978443|529215398|FG000|Overall Study|Disease Progression on study|6|||
146738641|NCT02978443|529215398|FG000|Overall Study|Death|1|||
146964875|NCT04298229|530031282|FG001|Overall Study|Physician Decision|1|||
146964876|NCT04298229|530031281|FG000|Overall Study|Withdrawal by Subject|1|||
146964877|NCT04298229|530031282|FG001|Overall Study|Withdrawal by Subject|1|||
146964878|NCT04298229|530031281|FG000|Overall Study|Did not receive IV loop diuretics|2|||
146964879|NCT04298229|530031282|FG001|Overall Study|Did not receive IV loop diuretics|0|||
146964880|NCT00859313|530031283|FG000|Overall Study|Lack of Efficacy|2|||
146964881|NCT00859313|530031283|FG000|Overall Study|Adverse Event|1|||
146964882|NCT00859313|530031283|FG000|Overall Study|staff error|1|||
146964883|NCT05939388|530031284|FG000|Overall Study|Lost to Follow-up|1|||
146964884|NCT05643573|530031287|FG000|Overall Study|Adverse Event|117|||
146964885|NCT05643573|530031288|FG001|Overall Study|Adverse Event|90|||
146964886|NCT05643573|530031287|FG000|Overall Study|Death|53|||
146964887|NCT05643573|530031288|FG001|Overall Study|Death|57|||
146964888|NCT05643573|530031287|FG000|Overall Study|Lost to Follow-up|6|||
146964889|NCT05643573|530031288|FG001|Overall Study|Lost to Follow-up|3|||
146964890|NCT05643573|530031287|FG000|Overall Study|Other|18|||
146964891|NCT05643573|530031288|FG001|Overall Study|Other|15|||
146964892|NCT05643573|530031287|FG000|Overall Study|Outcome event|64|||
146964893|NCT05643573|530031288|FG001|Overall Study|Outcome event|36|||
146964894|NCT05643573|530031287|FG000|Overall Study|Physician Decision|33|||
146964895|NCT05643573|530031288|FG001|Overall Study|Physician Decision|19|||
146964896|NCT05643573|530031287|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
146964897|NCT05643573|530031288|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
146964898|NCT05643573|530031287|FG000|Overall Study|Site terminated by sponsor|10|||
146964899|NCT05643573|530031288|FG001|Overall Study|Site terminated by sponsor|10|||
146964900|NCT05643573|530031287|FG000|Overall Study|Study terminated by sponsor|1|||
146964901|NCT05643573|530031288|FG001|Overall Study|Study terminated by sponsor|0|||
146738642|NCT02978443|529215398|FG000|Overall Study|Physician Decision|1|||
146738643|NCT02978443|529215398|FG000|Overall Study|Switch to alternative therapy|1|||
146738644|NCT02978443|529215398|FG000|Overall Study|Refused further treatment|1|||
146738645|NCT02087501|529215399|FG000|Overall Study|Death|7|||
146738646|NCT02087501|529215399|FG000|Overall Study|Open repair of aneurysm|1|||
146738647|NCT02087501|529215399|FG000|Overall Study|Lost to Follow-up|2|||
146738648|NCT03682705|529215400|FG000|Overall Study|Adverse Event|1|||
146738649|NCT03682705|529215401|FG001|Overall Study|Adverse Event|1|||
146738650|NCT03682705|529215402|FG002|Overall Study|Adverse Event|1|||
146738651|NCT03682705|529215403|FG003|Overall Study|Adverse Event|0|||
146738652|NCT03682705|529215404|FG004|Overall Study|Adverse Event|1|||
146738653|NCT03682705|529215405|FG005|Overall Study|Adverse Event|1|||
146738654|NCT03682705|529215400|FG000|Overall Study|Withdrawal by Subject|1|||
146738655|NCT03682705|529215401|FG001|Overall Study|Withdrawal by Subject|3|||
146738656|NCT03682705|529215402|FG002|Overall Study|Withdrawal by Subject|2|||
146738657|NCT03682705|529215403|FG003|Overall Study|Withdrawal by Subject|4|||
146738658|NCT03682705|529215404|FG004|Overall Study|Withdrawal by Subject|0|||
146738659|NCT03682705|529215405|FG005|Overall Study|Withdrawal by Subject|1|||
146738660|NCT03682705|529215400|FG000|Overall Study|Other, not specified|0|||
146738661|NCT03682705|529215401|FG001|Overall Study|Other, not specified|0|||
146738662|NCT03682705|529215402|FG002|Overall Study|Other, not specified|0|||
146738663|NCT03682705|529215403|FG003|Overall Study|Other, not specified|1|||
146738664|NCT03682705|529215404|FG004|Overall Study|Other, not specified|2|||
146738665|NCT03682705|529215405|FG005|Overall Study|Other, not specified|0|||
146738666|NCT03682705|529215400|FG000|Overall Study|Lost to Follow-up|0|||
146738667|NCT03682705|529215401|FG001|Overall Study|Lost to Follow-up|0|||
146738668|NCT03682705|529215402|FG002|Overall Study|Lost to Follow-up|0|||
146738669|NCT03682705|529215403|FG003|Overall Study|Lost to Follow-up|0|||
146738670|NCT03682705|529215404|FG004|Overall Study|Lost to Follow-up|3|||
146738671|NCT03682705|529215405|FG005|Overall Study|Lost to Follow-up|0|||
146738672|NCT00094328|529215406|FG000|Overall Study|Lost to Follow-up|1|||
146738673|NCT01483937|529215407|FG000|Overall Study|Withdrawal by Subject|4|||
146738674|NCT01483937|529215408|FG001|Overall Study|Withdrawal by Subject|3|||
146738675|NCT00265330|529215409|FG000|Overall Study|Adverse Event|41|||
146738676|NCT00265330|529215409|FG000|Overall Study|Lost to Follow-up|8|||
146738677|NCT00265330|529215409|FG000|Overall Study|Withdrawal by Subject|34|||
146738678|NCT00265330|529215409|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
146738679|NCT00265330|529215409|FG000|Overall Study|Lack of Efficacy|4|||
146738680|NCT00265330|529215409|FG000|Overall Study|Family Scheduling Conflicts|1|||
146738681|NCT00265330|529215409|FG000|Overall Study|Began Taking Formulary Geodon|1|||
146738682|NCT00265330|529215409|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
146738683|NCT00265330|529215409|FG000|Overall Study|Site Closed by Sponsor|1|||
146738684|NCT00265330|529215409|FG000|Overall Study|Principal Investigators Request|1|||
146738685|NCT00265330|529215409|FG000|Overall Study|Withdrew Consent|1|||
146738686|NCT00265330|529215409|FG000|Overall Study|Protocol Violation|1|||
146738687|NCT02213328|529215410|FG000|Overall Study|Withdrawal by Subject|10|||
146738688|NCT02213328|529215410|FG000|Overall Study|Physician Decision|2|||
146738689|NCT02213328|529215410|FG000|Overall Study|Lost to Follow-up|16|||
146964902|NCT05643573|530031287|FG000|Overall Study|Withdrawal by Subject|178|||
146964903|NCT05643573|530031288|FG001|Overall Study|Withdrawal by Subject|130|||
146964904|NCT01958619|530031289|FG000|Overall Study|Protocol Violation|2|||
146964905|NCT01958619|530031290|FG001|Overall Study|Protocol Violation|0|||
146964906|NCT01958619|530031291|FG002|Overall Study|Protocol Violation|1|||
146964907|NCT01958619|530031292|FG003|Overall Study|Protocol Violation|0|||
146738690|NCT01336621|529215411|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
146738691|NCT01336621|529215411|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
146738692|NCT01336621|529215411|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
146738693|NCT01336621|529215411|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
146738694|NCT01336621|529215411|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
146738695|NCT01336621|529215411|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
146738696|NCT01336621|529215411|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
146738697|NCT01336621|529215411|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
146738698|NCT01336621|529215411|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
146738699|NCT01336621|529215411|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
146964908|NCT04794491|530031293|FG000|Overall Study|Adverse Event|1|||
146964909|NCT04794491|530031293|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
146964910|NCT04794491|530031293|FG000|Overall Study|Noncompliance With Study Intervention|1|||
146964911|NCT04794491|530031293|FG000|Overall Study|Withdrawal by Subject|2|||
146964912|NCT00931515|530031294|FG000|Overall Study|Lost to Follow-up|2|||
146964913|NCT00931515|530031295|FG001|Overall Study|Lost to Follow-up|5|||
146964914|NCT02711306|530031301|FG000|Overall Study|Withdrawal by Subject|2|||
146964915|NCT02711306|530031302|FG001|Overall Study|Withdrawal by Subject|2|||
146964916|NCT03145207|530031307|FG000|Overall Study|volunteer started taking allergy shots|1|||
146964917|NCT03145207|530031307|FG000|Overall Study|baseline blood pressure high|1|||
146964918|NCT01396434|530031309|FG000|Overall Study|Lost to Follow-up|1|||
146964919|NCT01396434|530031310|FG001|Overall Study|Lost to Follow-up|0|||
146964920|NCT01396434|530031311|FG002|Overall Study|Lost to Follow-up|0|||
146964921|NCT01396434|530031309|FG000|Overall Study|Other|10|||
146964922|NCT01396434|530031310|FG001|Overall Study|Other|0|||
146964923|NCT01396434|530031311|FG002|Overall Study|Other|0|||
146964924|NCT03280628|530033401|FG000|Overall Study|Lost to Follow-up|8|||
146964925|NCT03280628|530033402|FG001|Overall Study|Lost to Follow-up|6|||
146738700|NCT01336621|529215411|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
146738701|NCT01336621|529215411|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
146738702|NCT01336621|529215411|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
146738703|NCT01336621|529215411|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
146738704|NCT00402337|529215417|FG000|Overall Study|Adverse Event|0|||
146738705|NCT00402337|529215418|FG001|Overall Study|Adverse Event|2|||
146738706|NCT00402337|529215419|FG002|Overall Study|Adverse Event|2|||
146738707|NCT00402337|529215420|FG003|Overall Study|Adverse Event|3|||
146738708|NCT00402337|529215421|FG004|Overall Study|Adverse Event|2|||
146738709|NCT00402337|529215417|FG000|Overall Study|Noncompliance|0|||
146738710|NCT00402337|529215418|FG001|Overall Study|Noncompliance|0|||
146738711|NCT00402337|529215419|FG002|Overall Study|Noncompliance|0|||
146964926|NCT03280628|530033403|FG002|Overall Study|Lost to Follow-up|11|||
146964927|NCT00706901|530033404|FG000|Overall Study|Lost to Follow-up|2|||
146964928|NCT00706901|530033405|FG001|Overall Study|Lost to Follow-up|3|||
146964929|NCT00706901|530033406|FG002|Overall Study|Lost to Follow-up|2|||
146964930|NCT00706901|530033404|FG000|Overall Study|Withdrawal by Subject|4|||
146964931|NCT00706901|530033405|FG001|Overall Study|Withdrawal by Subject|2|||
146964932|NCT00706901|530033406|FG002|Overall Study|Withdrawal by Subject|5|||
146738712|NCT00402337|529215420|FG003|Overall Study|Noncompliance|0|||
146738713|NCT00402337|529215421|FG004|Overall Study|Noncompliance|2|||
146738714|NCT00402337|529215417|FG000|Overall Study|Withdrawal by Subject|5|||
146738715|NCT00402337|529215418|FG001|Overall Study|Withdrawal by Subject|3|||
146738716|NCT00402337|529215419|FG002|Overall Study|Withdrawal by Subject|1|||
146738717|NCT00402337|529215420|FG003|Overall Study|Withdrawal by Subject|6|||
146738718|NCT00402337|529215421|FG004|Overall Study|Withdrawal by Subject|4|||
146738719|NCT00402337|529215417|FG000|Overall Study|Lost to Follow-up|0|||
146738720|NCT00402337|529215418|FG001|Overall Study|Lost to Follow-up|0|||
146738721|NCT00402337|529215419|FG002|Overall Study|Lost to Follow-up|1|||
146738722|NCT00402337|529215420|FG003|Overall Study|Lost to Follow-up|2|||
146738723|NCT00402337|529215421|FG004|Overall Study|Lost to Follow-up|0|||
146738724|NCT00402337|529215417|FG000|Overall Study|Physician Decision|0|||
146738725|NCT00402337|529215418|FG001|Overall Study|Physician Decision|0|||
146738726|NCT00402337|529215419|FG002|Overall Study|Physician Decision|0|||
146738727|NCT00402337|529215420|FG003|Overall Study|Physician Decision|1|||
146738728|NCT00402337|529215421|FG004|Overall Study|Physician Decision|0|||
146738729|NCT00402337|529215417|FG000|Overall Study|Other Reason|0|||
146738730|NCT00402337|529215418|FG001|Overall Study|Other Reason|1|||
146738731|NCT00402337|529215419|FG002|Overall Study|Other Reason|0|||
146738732|NCT00402337|529215420|FG003|Overall Study|Other Reason|0|||
146738733|NCT00402337|529215421|FG004|Overall Study|Other Reason|0|||
146738734|NCT02178566|529215422|FG000|Overall Study|patient did not complete due to noncompliance|0|||
146738735|NCT02178566|529215423|FG001|Overall Study|patient did not complete due to noncompliance|1|||
146964933|NCT00706901|530033404|FG000|Overall Study|In Jail|1|||
146964934|NCT00706901|530033405|FG001|Overall Study|In Jail|0|||
146964935|NCT00706901|530033406|FG002|Overall Study|In Jail|1|||
146964936|NCT00706901|530033404|FG000|Overall Study|Death|1|||
146964937|NCT00706901|530033405|FG001|Overall Study|Death|0|||
146738736|NCT00682643|529215429|FG000|Overall Study|Adverse Event|12|||
146738737|NCT00682643|529215430|FG001|Overall Study|Adverse Event|23|||
146738738|NCT00682643|529215429|FG000|Overall Study|Lack of Efficacy|2|||
146738739|NCT00682643|529215430|FG001|Overall Study|Lack of Efficacy|0|||
146738740|NCT00682643|529215429|FG000|Overall Study|Protocol Violation|38|||
146738741|NCT00682643|529215430|FG001|Overall Study|Protocol Violation|76|||
146738742|NCT00682643|529215429|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
146738743|NCT00682643|529215430|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
146738744|NCT00682643|529215429|FG000|Overall Study|Lost to Follow-up|1|||
146738745|NCT00682643|529215430|FG001|Overall Study|Lost to Follow-up|6|||
146738746|NCT00682643|529215429|FG000|Overall Study|Physician Decision|2|||
146738747|NCT00682643|529215430|FG001|Overall Study|Physician Decision|6|||
146738748|NCT00682643|529215429|FG000|Overall Study|Withdrawal by Subject|19|||
146738749|NCT00682643|529215430|FG001|Overall Study|Withdrawal by Subject|53|||
146738750|NCT00682643|529215429|FG000|Overall Study|Did Not Receive Study Drug|1|||
146738751|NCT00682643|529215430|FG001|Overall Study|Did Not Receive Study Drug|1|||
146738752|NCT01436201|529215433|FG000|Overall Study|Adverse Event|2|||
146738753|NCT01436201|529215433|FG000|Overall Study|Withdrawal by Subject|1|||
146738754|NCT01436201|529215433|FG000|Overall Study|Protocol Violation|1|||
146738755|NCT01435655|529215435|FG000|Overall Study|Death|2|||
146738756|NCT01435655|529215435|FG000|Overall Study|Other|1|||
146738757|NCT00110890|529215436|FG000|Overall Study|Adverse Event|30|||
146738758|NCT00110890|529215437|FG001|Overall Study|Adverse Event|7|||
146738759|NCT00110890|529215436|FG000|Overall Study|Death|16|||
146738760|NCT00110890|529215437|FG001|Overall Study|Death|9|||
146738761|NCT00110890|529215436|FG000|Overall Study|Lost to Follow-up|3|||
146738762|NCT00110890|529215437|FG001|Overall Study|Lost to Follow-up|1|||
146738763|NCT00110890|529215436|FG000|Overall Study|Physician Decision|4|||
146738764|NCT00110890|529215437|FG001|Overall Study|Physician Decision|5|||
146738765|NCT00110890|529215436|FG000|Overall Study|Withdrawal by Subject|17|||
146738766|NCT00110890|529215437|FG001|Overall Study|Withdrawal by Subject|5|||
146738767|NCT00110890|529215436|FG000|Overall Study|Protocol Deviation|1|||
146738768|NCT00110890|529215437|FG001|Overall Study|Protocol Deviation|0|||
146738769|NCT00110890|529215436|FG000|Overall Study|Noncompliance|10|||
146738770|NCT00110890|529215437|FG001|Overall Study|Noncompliance|0|||
146738771|NCT00110890|529215436|FG000|Overall Study|Kidney Transplant|16|||
146738772|NCT00110890|529215437|FG001|Overall Study|Kidney Transplant|12|||
146738773|NCT00110890|529215436|FG000|Overall Study|Invest. Product Commercially Available|217|||
146738774|NCT00110890|529215437|FG001|Overall Study|Invest. Product Commercially Available|110|||
146738775|NCT00110890|529215436|FG000|Overall Study|Other|34|||
146738776|NCT00110890|529215437|FG001|Overall Study|Other|23|||
146738777|NCT00110890|529215436|FG000|Overall Study|Ineligibility determined|3|||
146738778|NCT00110890|529215437|FG001|Overall Study|Ineligibility determined|0|||
146738779|NCT00110890|529215436|FG000|Overall Study|Requirement for alternative therapy|0|||
146738780|NCT00110890|529215437|FG001|Overall Study|Requirement for alternative therapy|1|||
146738781|NCT00110890|529215436|FG000|Overall Study|Disease progression|0|||
146738782|NCT00110890|529215437|FG001|Overall Study|Disease progression|1|||
146738783|NCT00110890|529215436|FG000|Overall Study|Parathyroidectomy|0|||
146964938|NCT00706901|530033406|FG002|Overall Study|Death|0|||
146964939|NCT00347776|530033407|FG000|1.5 Month Follow-up|Death|2|||
146964940|NCT00347776|530033408|FG001|1.5 Month Follow-up|Death|0|||
146964941|NCT00347776|530033409|FG002|1.5 Month Follow-up|Death|0|||
146964942|NCT00347776|530033407|FG000|1.5 Month Follow-up|reached the endpoint|12|||
146964943|NCT00347776|530033408|FG001|1.5 Month Follow-up|reached the endpoint|8|||
146964944|NCT00347776|530033409|FG002|1.5 Month Follow-up|reached the endpoint|12|||
146964945|NCT00347776|530033407|FG000|6 Month Follow-up|Death|2|||
146964946|NCT00347776|530033408|FG001|6 Month Follow-up|Death|1|||
146964947|NCT00347776|530033409|FG002|6 Month Follow-up|Death|3|||
146964948|NCT00347776|530033407|FG000|6 Month Follow-up|reached endpont|20|||
146964949|NCT00347776|530033408|FG001|6 Month Follow-up|reached endpont|12|||
146964950|NCT00347776|530033409|FG002|6 Month Follow-up|reached endpont|15|||
146964951|NCT00347776|530033407|FG000|12 Month Follow-up|Lost to Follow-up|7|||
146964952|NCT00347776|530033408|FG001|12 Month Follow-up|Lost to Follow-up|6|||
146964953|NCT00347776|530033409|FG002|12 Month Follow-up|Lost to Follow-up|6|||
146964954|NCT00347776|530033407|FG000|12 Month Follow-up|Death|3|||
146964955|NCT00347776|530033408|FG001|12 Month Follow-up|Death|4|||
146964956|NCT00347776|530033409|FG002|12 Month Follow-up|Death|4|||
146964957|NCT00347776|530033407|FG000|12 Month Follow-up|Reached endpoint|13|||
146964958|NCT00347776|530033408|FG001|12 Month Follow-up|Reached endpoint|6|||
146964959|NCT00347776|530033409|FG002|12 Month Follow-up|Reached endpoint|9|||
146964960|NCT00457249|530033410|FG000|Overall Study|Lost to Follow-up|3|||
146964961|NCT00457249|530033411|FG001|Overall Study|Lost to Follow-up|0|||
146964962|NCT00457249|530033410|FG000|Overall Study|Protocol Violation|4|||
146964963|NCT00457249|530033411|FG001|Overall Study|Protocol Violation|1|||
146964964|NCT00457249|530033410|FG000|Overall Study|Withdrawal by Subject|3|||
146964965|NCT00457249|530033411|FG001|Overall Study|Withdrawal by Subject|1|||
146964966|NCT00457249|530033410|FG000|Overall Study|Serious Adverse Events|2|||
146964967|NCT00457249|530033411|FG001|Overall Study|Serious Adverse Events|0|||
146964968|NCT00938392|530033412|FG000|Overall Study|Adverse Event|0|||
146738784|NCT00110890|529215437|FG001|Overall Study|Parathyroidectomy|1|||
146738785|NCT00110890|529215436|FG000|Overall Study|Did not enter follow-up phase|10|||
146738786|NCT00110890|529215437|FG001|Overall Study|Did not enter follow-up phase|4|||
146738787|NCT01686581|529215438|FG000|Overall Study|Side-effects or Health Problems|15|||
146738788|NCT01686581|529215438|FG000|Overall Study|Lack of Efficacy|90|||
146738789|NCT01686581|529215438|FG000|Overall Study|Participant Concerned about Risks|6|||
146738790|NCT01686581|529215438|FG000|Overall Study|Thinks Injections Too Painful|8|||
146738791|NCT01686581|529215438|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
146738792|NCT01686581|529215438|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
146738793|NCT01686581|529215438|FG000|Overall Study|Thinks it is Inconvenient|17|||
146738794|NCT01686581|529215438|FG000|Overall Study|Other Miscellaneous Reasons|36|||
146738795|NCT01686581|529215438|FG000|Overall Study|Reason Missing|1|||
146738796|NCT01975220|529215439|FG000|Test Period 1|Not treated|0|||
146738797|NCT01975220|529215440|FG001|Test Period 1|Not treated|1|||
146738798|NCT01975220|529215441|FG002|Test Period 1|Not treated|0|||
146738799|NCT01975220|529215442|FG003|Test Period 1|Not treated|0|||
146738800|NCT01975220|529215443|FG004|Test Period 1|Not treated|0|||
146738801|NCT01975220|529215444|FG005|Test Period 1|Not treated|0|||
146738802|NCT02839343|529215445|FG000|Overall Study|Withdrawal by Subject|3|||
146738803|NCT02839343|529215446|FG001|Overall Study|Withdrawal by Subject|1|||
146738804|NCT02839343|529215445|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
146738805|NCT02839343|529215446|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
146738806|NCT02839343|529215445|FG000|Overall Study|Adverse Event|1|||
146738807|NCT02839343|529215446|FG001|Overall Study|Adverse Event|0|||
146738808|NCT01852058|529215447|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
146738809|NCT01852058|529215448|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146738810|NCT01852058|529215449|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146738811|NCT01852058|529215450|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146738812|NCT01852058|529215451|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146738813|NCT01852058|529215452|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146738814|NCT01852058|529215453|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146738815|NCT01852058|529215454|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146738816|NCT01852058|529215455|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146738817|NCT01852058|529215456|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146738818|NCT01852058|529215457|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146738819|NCT01852058|529215458|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146738820|NCT01852058|529215447|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146738821|NCT01852058|529215448|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146738822|NCT01852058|529215449|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146738823|NCT01852058|529215450|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146738824|NCT01852058|529215451|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
146738825|NCT01852058|529215452|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146738826|NCT01852058|529215453|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146738827|NCT01852058|529215454|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146738828|NCT01852058|529215455|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146738829|NCT01852058|529215456|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146738830|NCT01852058|529215457|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146738831|NCT01852058|529215458|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146738832|NCT01852058|529215447|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146738833|NCT01852058|529215448|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146738834|NCT01852058|529215449|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146738835|NCT01852058|529215450|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146738836|NCT01852058|529215451|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
146738837|NCT01852058|529215452|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
146738838|NCT01852058|529215453|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146738839|NCT01852058|529215454|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146738840|NCT01852058|529215455|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146738841|NCT01852058|529215456|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146738842|NCT01852058|529215457|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146738843|NCT01852058|529215458|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146738844|NCT01852058|529215447|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146738845|NCT01852058|529215448|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146738846|NCT01852058|529215449|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146738847|NCT01852058|529215450|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146738848|NCT01852058|529215451|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
146738849|NCT01852058|529215452|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146738850|NCT01852058|529215453|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146738851|NCT01852058|529215454|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146964969|NCT00938392|530033413|FG001|Overall Study|Adverse Event|1|||
146964970|NCT00938392|530033412|FG000|Overall Study|Withdrawal by Subject|0|||
146964971|NCT00938392|530033413|FG001|Overall Study|Withdrawal by Subject|1|||
146964972|NCT00938392|530033412|FG000|Overall Study|Lost to Follow-up|2|||
146964973|NCT00938392|530033413|FG001|Overall Study|Lost to Follow-up|2|||
146964974|NCT02916056|530033414|FG000|Overall Study|Adverse Event|6|||
146964975|NCT02916056|530033414|FG000|Overall Study|Lost to Follow-up|1|||
146964976|NCT02916056|530033414|FG000|Overall Study|Other|12|||
146964977|NCT02916056|530033414|FG000|Overall Study|Protocol Violation|1|||
146964978|NCT02916056|530033414|FG000|Overall Study|Withdrawal by Subject|8|||
146964979|NCT02916056|530033414|FG000|Overall Study|Study Terminated by Sponsor|269|||
146964980|NCT00124709|530033415|FG000|Overall Study|Randomized but did not take medication|3|||
146964981|NCT00124709|530033416|FG001|Overall Study|Randomized but did not take medication|1|||
146738852|NCT01852058|529215455|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146738853|NCT01852058|529215456|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146738854|NCT01852058|529215457|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146738855|NCT01852058|529215458|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146738856|NCT01852058|529215447|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146738857|NCT01852058|529215448|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146738858|NCT01852058|529215449|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146738859|NCT01852058|529215450|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146738860|NCT01852058|529215451|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
146738861|NCT01852058|529215452|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
146738862|NCT01852058|529215453|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146738863|NCT01852058|529215454|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146738864|NCT01852058|529215455|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146738865|NCT01852058|529215456|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146738866|NCT01852058|529215457|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146738867|NCT01852058|529215458|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146738868|NCT01852058|529215447|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146738869|NCT01852058|529215448|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146738870|NCT01852058|529215449|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146738871|NCT01852058|529215450|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
146738872|NCT01852058|529215451|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146738873|NCT01852058|529215452|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146738874|NCT01852058|529215453|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146738875|NCT01852058|529215454|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146738876|NCT01852058|529215455|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146738877|NCT01852058|529215456|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146738878|NCT01852058|529215457|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146738879|NCT01852058|529215458|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146738880|NCT01852058|529215447|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146738881|NCT01852058|529215448|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146738882|NCT01852058|529215449|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146738883|NCT01852058|529215450|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146738884|NCT01852058|529215451|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
146738885|NCT01852058|529215452|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
146738886|NCT01852058|529215453|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146738887|NCT01852058|529215454|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146738888|NCT01852058|529215455|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146738889|NCT01852058|529215456|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146738890|NCT01852058|529215457|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146738891|NCT01852058|529215458|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146738892|NCT01852058|529215447|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146738893|NCT01852058|529215448|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146738894|NCT01852058|529215449|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146738895|NCT01852058|529215450|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146738896|NCT01852058|529215451|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146738897|NCT01852058|529215452|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146738898|NCT01852058|529215453|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146964982|NCT00124709|530033415|FG000|Overall Study|Adverse Event|3|||
146964983|NCT00124709|530033416|FG001|Overall Study|Adverse Event|0|||
146964984|NCT00124709|530033415|FG000|Overall Study|Lack of Efficacy|5|||
146964985|NCT00124709|530033416|FG001|Overall Study|Lack of Efficacy|10|||
146964986|NCT00124709|530033415|FG000|Overall Study|Protocol Violation|3|||
146964987|NCT00124709|530033416|FG001|Overall Study|Protocol Violation|5|||
146964988|NCT00124709|530033415|FG000|Overall Study|Withdrawal by Subject|127|||
146964989|NCT00124709|530033416|FG001|Overall Study|Withdrawal by Subject|136|||
146964990|NCT00124709|530033415|FG000|Overall Study|Lost to Follow-up|114|||
146964991|NCT00124709|530033416|FG001|Overall Study|Lost to Follow-up|120|||
146964992|NCT05604521|530033419|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
146964993|NCT05604521|530033420|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
146964994|NCT05604521|530033419|FG000|Overall Study|Adverse Event|1|||
146964995|NCT05604521|530033420|FG001|Overall Study|Adverse Event|0|||
146964996|NCT01491737|530033421|FG000|Overall Study|Withdrawal by Subject|20|||
146964997|NCT01491737|530033422|FG001|Overall Study|Withdrawal by Subject|17|||
146964998|NCT01491737|530033421|FG000|Overall Study|Lost to Follow-up|2|||
146738899|NCT01852058|529215454|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
146738900|NCT01852058|529215455|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146738901|NCT01852058|529215456|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146738902|NCT01852058|529215457|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146738903|NCT01852058|529215458|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146738904|NCT01852058|529215447|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146738905|NCT01852058|529215448|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146738906|NCT01852058|529215449|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146738907|NCT01852058|529215450|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146738908|NCT01852058|529215451|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146738909|NCT01852058|529215452|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146738910|NCT01852058|529215453|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146738911|NCT01852058|529215454|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146738912|NCT01852058|529215455|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
146738913|NCT01852058|529215456|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146738914|NCT01852058|529215457|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146738915|NCT01852058|529215458|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146738916|NCT00263328|529215460|FG000|Overall Study|Death|0|||
146738917|NCT00263328|529215461|FG001|Overall Study|Death|0|||
146738918|NCT00263328|529215462|FG002|Overall Study|Death|1|||
146738919|NCT00263328|529215460|FG000|Overall Study|Lost to Follow-up|1|||
146738920|NCT00263328|529215461|FG001|Overall Study|Lost to Follow-up|1|||
146738921|NCT00263328|529215462|FG002|Overall Study|Lost to Follow-up|0|||
146738922|NCT00263328|529215460|FG000|Overall Study|Withdrawal by Subject|3|||
146738923|NCT00263328|529215461|FG001|Overall Study|Withdrawal by Subject|0|||
146738924|NCT00263328|529215462|FG002|Overall Study|Withdrawal by Subject|1|||
146738925|NCT00263328|529215460|FG000|Overall Study|Other|3|||
146738926|NCT00263328|529215461|FG001|Overall Study|Other|0|||
146738927|NCT00263328|529215462|FG002|Overall Study|Other|1|||
146738928|NCT00263328|529215460|FG000|Overall Study|Adverse Event|1|||
146738929|NCT00263328|529215461|FG001|Overall Study|Adverse Event|1|||
146738930|NCT00263328|529215462|FG002|Overall Study|Adverse Event|4|||
146738931|NCT02613221|529215465|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
146738932|NCT02613221|529215465|FG000|Overall Study|Adverse Event|2|||
146738933|NCT02613221|529215465|FG000|Overall Study|Voluntary Discontinuation|1|||
146738934|NCT02613221|529215465|FG000|Overall Study|Delayed Treatment|1|||
146738935|NCT02613221|529215465|FG000|Overall Study|Enrolled but Not Treated|1|||
146738936|NCT01301274|529215466|FG000|Overall Study|Physician Decision|2|||
146738937|NCT01301274|529215467|FG001|Overall Study|Physician Decision|1|||
146738938|NCT00661661|529215468|FG000|Overall Study|Adverse Event|99|||
146738939|NCT00661661|529215469|FG001|Overall Study|Adverse Event|24|||
146738940|NCT00661661|529215468|FG000|Overall Study|Lack of Efficacy|3|||
146738941|NCT00661661|529215469|FG001|Overall Study|Lack of Efficacy|2|||
146738942|NCT00661661|529215468|FG000|Overall Study|Lost to Follow-up|0|||
146738943|NCT00661661|529215469|FG001|Overall Study|Lost to Follow-up|1|||
146738944|NCT00661661|529215468|FG000|Overall Study|Withdrawal by Subject|15|||
146738945|NCT00661661|529215469|FG001|Overall Study|Withdrawal by Subject|5|||
146738946|NCT00661661|529215468|FG000|Overall Study|Other|22|||
146738947|NCT00661661|529215469|FG001|Overall Study|Other|7|||
146738948|NCT00661661|529215468|FG000|Overall Study|Not assigned treatment|1|||
146738949|NCT00661661|529215469|FG001|Overall Study|Not assigned treatment|0|||
146738950|NCT03535337|529215473|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
146738951|NCT03535337|529215474|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
146738952|NCT03535337|529215475|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
146738953|NCT03535337|529215476|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
146738954|NCT03535337|529215477|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
146738955|NCT03535337|529215478|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
146738956|NCT03535337|529215479|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
146738957|NCT03535337|529215480|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
146738958|NCT03535337|529215481|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
146738959|NCT03535337|529215482|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
146738960|NCT00311155|529217252|FG000|Overall Study|Adverse Event|21|||
146738961|NCT00311155|529217252|FG000|Overall Study|Withdrawal by Subject|17|||
146738962|NCT00311155|529217252|FG000|Overall Study|Did not meet entry criteria|55|||
146738963|NCT01478113|529217262|FG000|Overall Study|Withdrawal by Subject|0|||
146738964|NCT01478113|529217263|FG001|Overall Study|Withdrawal by Subject|1|||
146738965|NCT01478113|529217262|FG000|Overall Study|Physician Decision|1|||
146738966|NCT01478113|529217263|FG001|Overall Study|Physician Decision|0|||
146738967|NCT03097861|529217271|FG000|Overall Study|Adverse Event|3|||
146738968|NCT03097861|529217272|FG001|Overall Study|Adverse Event|8|||
146738969|NCT03097861|529217273|FG002|Overall Study|Adverse Event|4|||
146738970|NCT03097861|529217271|FG000|Overall Study|Investigator Decision|0|||
146738971|NCT03097861|529217272|FG001|Overall Study|Investigator Decision|1|||
146738972|NCT03097861|529217273|FG002|Overall Study|Investigator Decision|0|||
146738973|NCT03097861|529217271|FG000|Overall Study|Lost to Follow-up|0|||
146738974|NCT03097861|529217272|FG001|Overall Study|Lost to Follow-up|7|||
146738975|NCT03097861|529217273|FG002|Overall Study|Lost to Follow-up|1|||
146738976|NCT03097861|529217271|FG000|Overall Study|Withdrawal by Subject|1|||
146738977|NCT03097861|529217272|FG001|Overall Study|Withdrawal by Subject|5|||
146738978|NCT03097861|529217273|FG002|Overall Study|Withdrawal by Subject|3|||
146738979|NCT03097861|529217271|FG000|Overall Study|Reason not provided|3|||
146738980|NCT03097861|529217272|FG001|Overall Study|Reason not provided|1|||
146738981|NCT03097861|529217273|FG002|Overall Study|Reason not provided|1|||
146738982|NCT01785563|529217274|FG000|Overall Study|Physician Decision|10|||
146738983|NCT01785563|529217274|FG000|Overall Study|Withdrawal by Subject|1|||
146738984|NCT01785563|529217274|FG000|Overall Study|Protocol Violation|2|||
146738985|NCT01616771|529217277|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
146738986|NCT00744328|529217278|FG000|Overall Study|Lost to Follow-up|2|||
146738987|NCT00744328|529217279|FG001|Overall Study|Lost to Follow-up|5|||
146738988|NCT00744328|529217280|FG002|Overall Study|Lost to Follow-up|3|||
146738989|NCT00744328|529217278|FG000|Overall Study|Withdrawal by Subject|5|||
146738990|NCT00744328|529217279|FG001|Overall Study|Withdrawal by Subject|3|||
146738991|NCT00744328|529217280|FG002|Overall Study|Withdrawal by Subject|4|||
146738992|NCT00744328|529217278|FG000|Overall Study|Found ineligible after randomization|0|||
146738993|NCT00744328|529217279|FG001|Overall Study|Found ineligible after randomization|0|||
146738994|NCT00744328|529217280|FG002|Overall Study|Found ineligible after randomization|1|||
146738995|NCT04399356|529217285|FG000|Overall Study|Lost to Follow-up|1|||
146738996|NCT04399356|529217286|FG001|Overall Study|Lost to Follow-up|1|||
146738997|NCT04399356|529217285|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
146738998|NCT04399356|529217286|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
146738999|NCT04399356|529217285|FG000|Overall Study|Withdrawal by Subject|1|||
146739000|NCT04399356|529217286|FG001|Overall Study|Withdrawal by Subject|0|||
146739001|NCT03812536|529217290|FG000|Overall Study|Protocol Violation|2|||
146739002|NCT03812536|529217291|FG001|Overall Study|Protocol Violation|0|||
146739003|NCT03812536|529217290|FG000|Overall Study|Withdrawal by Subject|1|||
146739004|NCT03812536|529217291|FG001|Overall Study|Withdrawal by Subject|1|||
146739005|NCT00152009|529217292|FG000|Overall Study|Adverse Event|9|||
146739006|NCT00152009|529217293|FG001|Overall Study|Adverse Event|13|||
146739007|NCT00152009|529217294|FG002|Overall Study|Adverse Event|20|||
146739008|NCT00152009|529217295|FG003|Overall Study|Adverse Event|1|||
146739009|NCT00152009|529217292|FG000|Overall Study|Protocol Violation|3|||
146739010|NCT00152009|529217293|FG001|Overall Study|Protocol Violation|0|||
146739011|NCT00152009|529217294|FG002|Overall Study|Protocol Violation|0|||
146739012|NCT00152009|529217295|FG003|Overall Study|Protocol Violation|1|||
146739013|NCT00152009|529217292|FG000|Overall Study|Withdrawal by Subject|2|||
146739014|NCT00152009|529217293|FG001|Overall Study|Withdrawal by Subject|3|||
146739015|NCT00152009|529217294|FG002|Overall Study|Withdrawal by Subject|4|||
146739016|NCT00152009|529217295|FG003|Overall Study|Withdrawal by Subject|9|||
146739017|NCT00152009|529217292|FG000|Overall Study|Lost to Follow-up|2|||
146739018|NCT00152009|529217293|FG001|Overall Study|Lost to Follow-up|4|||
146739019|NCT00152009|529217294|FG002|Overall Study|Lost to Follow-up|3|||
146739020|NCT00152009|529217295|FG003|Overall Study|Lost to Follow-up|3|||
146739021|NCT00152009|529217292|FG000|Overall Study|Lack of Efficacy|8|||
146739022|NCT00152009|529217293|FG001|Overall Study|Lack of Efficacy|6|||
146739023|NCT00152009|529217294|FG002|Overall Study|Lack of Efficacy|7|||
146739024|NCT00152009|529217295|FG003|Overall Study|Lack of Efficacy|15|||
146739025|NCT00152009|529217292|FG000|Overall Study|ECG abnormalities|2|||
146739026|NCT00152009|529217293|FG001|Overall Study|ECG abnormalities|2|||
146739027|NCT00152009|529217294|FG002|Overall Study|ECG abnormalities|2|||
146739028|NCT00152009|529217295|FG003|Overall Study|ECG abnormalities|1|||
146739029|NCT00152009|529217292|FG000|Overall Study|Sponsor's decision|3|||
146739030|NCT00152009|529217293|FG001|Overall Study|Sponsor's decision|3|||
146739031|NCT00152009|529217294|FG002|Overall Study|Sponsor's decision|1|||
146739032|NCT00152009|529217295|FG003|Overall Study|Sponsor's decision|3|||
146739033|NCT00393523|529217296|FG000|Overall Study|Lost to Follow-up|0|||
146739034|NCT00393523|529217297|FG001|Overall Study|Lost to Follow-up|0|||
146739035|NCT00393523|529217298|FG002|Overall Study|Lost to Follow-up|0|||
146739036|NCT00393523|529217299|FG003|Overall Study|Lost to Follow-up|2|||
146739037|NCT00393523|529217300|FG004|Overall Study|Lost to Follow-up|1|||
146739038|NCT00393523|529217296|FG000|Overall Study|Protocol Violation|6|||
146739039|NCT00393523|529217297|FG001|Overall Study|Protocol Violation|2|||
146739040|NCT00393523|529217298|FG002|Overall Study|Protocol Violation|0|||
146739041|NCT00393523|529217299|FG003|Overall Study|Protocol Violation|1|||
146739042|NCT00393523|529217300|FG004|Overall Study|Protocol Violation|0|||
146739043|NCT00393523|529217296|FG000|Overall Study|Withdrawal by Subject|6|||
146739044|NCT00393523|529217297|FG001|Overall Study|Withdrawal by Subject|7|||
146739045|NCT00393523|529217298|FG002|Overall Study|Withdrawal by Subject|2|||
146739046|NCT00393523|529217299|FG003|Overall Study|Withdrawal by Subject|3|||
146739047|NCT00393523|529217300|FG004|Overall Study|Withdrawal by Subject|0|||
146739048|NCT00393523|529217296|FG000|Overall Study|Difficulties in specimen collection|0|||
146739049|NCT00393523|529217297|FG001|Overall Study|Difficulties in specimen collection|0|||
146739050|NCT00393523|529217298|FG002|Overall Study|Difficulties in specimen collection|1|||
146739051|NCT00393523|529217299|FG003|Overall Study|Difficulties in specimen collection|0|||
146739052|NCT00393523|529217300|FG004|Overall Study|Difficulties in specimen collection|0|||
146739053|NCT00393523|529217296|FG000|Overall Study|Vaccine supply issue|0|||
146739054|NCT00393523|529217297|FG001|Overall Study|Vaccine supply issue|0|||
146739055|NCT00393523|529217298|FG002|Overall Study|Vaccine supply issue|1|||
146739056|NCT00393523|529217299|FG003|Overall Study|Vaccine supply issue|0|||
146739057|NCT00393523|529217300|FG004|Overall Study|Vaccine supply issue|0|||
146739058|NCT04091360|529217303|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
146739059|NCT04091360|529217304|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
146739060|NCT04091360|529217305|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
146739061|NCT04091360|529217306|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
146739062|NCT04091360|529217307|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
146739063|NCT04091360|529217308|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
146739064|NCT04091360|529217309|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
146739065|NCT04091360|529217310|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
146739066|NCT04091360|529217311|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
146739067|NCT04091360|529217312|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
146739068|NCT04091360|529217303|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
146739069|NCT04091360|529217304|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
146739070|NCT04091360|529217305|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
146739071|NCT04091360|529217306|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
146739072|NCT04091360|529217307|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
146739073|NCT04091360|529217308|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
146739074|NCT04091360|529217309|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
146739075|NCT04091360|529217310|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
146739076|NCT04091360|529217311|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
146739077|NCT04091360|529217312|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
146739078|NCT04091360|529217303|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
146739079|NCT04091360|529217304|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
146739080|NCT04091360|529217305|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
146739081|NCT04091360|529217306|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
146739082|NCT04091360|529217307|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
146739083|NCT04091360|529217308|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
146739084|NCT04091360|529217309|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
146739085|NCT04091360|529217310|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
146739086|NCT04091360|529217311|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
146739087|NCT04091360|529217312|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
146739088|NCT01735396|529217313|FG000|Overall Study|not evaluable|1|||
146739089|NCT00572624|529217314|FG000|Overall Study|Lost to Follow-up|10|||
146739090|NCT00572624|529217315|FG001|Overall Study|Lost to Follow-up|4|||
146739091|NCT00572624|529217314|FG000|Overall Study|Wanted to do a different diet program|1|||
146739092|NCT00572624|529217315|FG001|Overall Study|Wanted to do a different diet program|0|||
146739093|NCT00572624|529217314|FG000|Overall Study|Medication change|1|||
146739094|NCT00572624|529217315|FG001|Overall Study|Medication change|0|||
146739095|NCT00572624|529217314|FG000|Overall Study|Started a new job-- no time for study|1|||
146739096|NCT00572624|529217315|FG001|Overall Study|Started a new job-- no time for study|0|||
146739097|NCT00572624|529217314|FG000|Overall Study|Admitted to being a smoker|1|||
146739098|NCT00572624|529217315|FG001|Overall Study|Admitted to being a smoker|0|||
146739099|NCT00572624|529217314|FG000|Overall Study|Refused to do the stress test|1|||
146739100|NCT00572624|529217315|FG001|Overall Study|Refused to do the stress test|0|||
146739101|NCT00572624|529217314|FG000|Overall Study|Problem with vascular access|1|||
146739102|NCT00572624|529217315|FG001|Overall Study|Problem with vascular access|0|||
146739103|NCT00572624|529217314|FG000|Overall Study|Health issues unrelated to the study|1|||
146739104|NCT00572624|529217315|FG001|Overall Study|Health issues unrelated to the study|0|||
146739105|NCT04145037|529217316|FG000|Overall Study|Study terminated|2|||
146739106|NCT04145037|529217317|FG001|Overall Study|Study terminated|0|||
146739107|NCT04145037|529217316|FG000|Overall Study|Withdrawal by Subject|1|||
146739108|NCT04145037|529217317|FG001|Overall Study|Withdrawal by Subject|0|||
146739109|NCT04145037|529217316|FG000|Overall Study|Lost to Follow-up|1|||
146739110|NCT04145037|529217317|FG001|Overall Study|Lost to Follow-up|0|||
146739111|NCT00098254|529217322|FG000|Overall Study|Adverse Event|2|||
146739112|NCT00098254|529217322|FG000|Overall Study|Death|1|||
146739113|NCT00744263|529217325|FG000|Overall Study|Death|3006|||
146739114|NCT00744263|529217326|FG001|Overall Study|Death|3005|||
146739115|NCT00744263|529217325|FG000|Overall Study|Lost to Follow-up|2038|||
146739116|NCT00744263|529217326|FG001|Overall Study|Lost to Follow-up|2135|||
146739117|NCT00744263|529217325|FG000|Overall Study|Withdrawal by Subject|166|||
146739118|NCT00744263|529217326|FG001|Overall Study|Withdrawal by Subject|150|||
146739119|NCT00744263|529217325|FG000|Overall Study|Physician Decision|20|||
146739120|NCT00744263|529217326|FG001|Overall Study|Physician Decision|23|||
146739121|NCT00744263|529217325|FG000|Overall Study|Protocol Violation|3|||
146739122|NCT00744263|529217326|FG001|Overall Study|Protocol Violation|5|||
146739123|NCT00744263|529217325|FG000|Overall Study|Adverse Event|1|||
146739124|NCT00744263|529217326|FG001|Overall Study|Adverse Event|0|||
146739125|NCT00744263|529217325|FG000|Overall Study|Other|2|||
146739126|NCT00744263|529217326|FG001|Overall Study|Other|2|||
146739127|NCT00211237|529217327|FG000|Baseline|Withdrew|1|||
146739128|NCT00211237|529217328|FG001|Baseline|Withdrew|3|||
146739129|NCT00211237|529217329|FG002|Baseline|Withdrew|0|||
146739130|NCT00211237|529217327|FG000|Baseline|Refused random assignment|1|||
146739131|NCT00211237|529217328|FG001|Baseline|Refused random assignment|0|||
146739132|NCT00211237|529217329|FG002|Baseline|Refused random assignment|0|||
146739133|NCT00211237|529217327|FG000|1 Month|Death|2|||
146739134|NCT00211237|529217328|FG001|1 Month|Death|1|||
146739135|NCT00211237|529217329|FG002|1 Month|Death|0|||
146739136|NCT00211237|529217327|FG000|1 Month|Lost to Follow-up|0|||
146739137|NCT00211237|529217328|FG001|1 Month|Lost to Follow-up|2|||
146739138|NCT00211237|529217329|FG002|1 Month|Lost to Follow-up|0|||
146739139|NCT00211237|529217327|FG000|1 Month|Withdrew|0|||
146739140|NCT00211237|529217328|FG001|1 Month|Withdrew|4|||
146739141|NCT00211237|529217329|FG002|1 Month|Withdrew|0|||
146739142|NCT00211237|529217327|FG000|1 Month|Additional surgery needed|1|||
146739143|NCT00211237|529217328|FG001|1 Month|Additional surgery needed|0|||
146739144|NCT00211237|529217329|FG002|1 Month|Additional surgery needed|0|||
146739145|NCT00211237|529217327|FG000|1 Month|Non-medical problem|0|||
146739146|NCT00211237|529217328|FG001|1 Month|Non-medical problem|2|||
146739147|NCT00211237|529217329|FG002|1 Month|Non-medical problem|0|||
146739148|NCT00211237|529217327|FG000|3 Months|Death|7|||
146739149|NCT00211237|529217328|FG001|3 Months|Death|3|||
146739150|NCT00211237|529217329|FG002|3 Months|Death|0|||
146739151|NCT00211237|529217327|FG000|3 Months|Could not comply with protocol|1|||
146739152|NCT00211237|529217328|FG001|3 Months|Could not comply with protocol|0|||
146739153|NCT00211237|529217329|FG002|3 Months|Could not comply with protocol|0|||
146739154|NCT00211237|529217327|FG000|3 Months|Withdrew|0|||
146739155|NCT00211237|529217328|FG001|3 Months|Withdrew|1|||
146739156|NCT00211237|529217329|FG002|3 Months|Withdrew|0|||
146739157|NCT00211237|529217327|FG000|3 Months|Non-medical problem|0|||
146739158|NCT00211237|529217328|FG001|3 Months|Non-medical problem|0|||
146739159|NCT00211237|529217329|FG002|3 Months|Non-medical problem|1|||
146739160|NCT00211237|529217327|FG000|6 Months|Death|6|||
146739161|NCT00211237|529217328|FG001|6 Months|Death|0|||
146739162|NCT00211237|529217329|FG002|6 Months|Death|3|||
146739163|NCT00211237|529217327|FG000|6 Months|Lost to Follow-up|2|||
146739164|NCT00211237|529217328|FG001|6 Months|Lost to Follow-up|0|||
146739165|NCT00211237|529217329|FG002|6 Months|Lost to Follow-up|0|||
146739166|NCT00211237|529217327|FG000|6 Months|Could not comply with protocol|0|||
146739167|NCT00211237|529217328|FG001|6 Months|Could not comply with protocol|2|||
146739168|NCT00211237|529217329|FG002|6 Months|Could not comply with protocol|0|||
146739169|NCT00211237|529217327|FG000|12 Months|Death|8|||
146739170|NCT00211237|529217328|FG001|12 Months|Death|2|||
146739171|NCT00211237|529217329|FG002|12 Months|Death|3|||
146739172|NCT00211237|529217327|FG000|12 Months|Lost to Follow-up|1|||
146739173|NCT00211237|529217328|FG001|12 Months|Lost to Follow-up|0|||
146739174|NCT00211237|529217329|FG002|12 Months|Lost to Follow-up|1|||
146739175|NCT00211237|529217327|FG000|12 Months|Withdrew|0|||
146739176|NCT00211237|529217328|FG001|12 Months|Withdrew|0|||
146739177|NCT00211237|529217329|FG002|12 Months|Withdrew|1|||
146739178|NCT00211237|529217327|FG000|12 Months|unrelated medical problem|0|||
146739179|NCT00211237|529217328|FG001|12 Months|unrelated medical problem|0|||
146739180|NCT00211237|529217329|FG002|12 Months|unrelated medical problem|1|||
146739181|NCT04078035|529217332|FG000|Session 2|Lost to Follow-up|3|||
146739182|NCT04078035|529217333|FG001|Session 2|Lost to Follow-up|1|||
146739183|NCT04078035|529217332|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
146739184|NCT04078035|529217333|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
146739185|NCT03929562|529217336|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
146739186|NCT03929562|529217337|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
146739187|NCT03929562|529217336|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
146739188|NCT03929562|529217337|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
146739189|NCT03929562|529217336|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
146739190|NCT03929562|529217337|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
146739191|NCT01036022|529217345|FG000|Overall Study|Adverse Event|1|||
146739192|NCT01036022|529217346|FG001|Overall Study|Adverse Event|3|||
146739193|NCT01036022|529217347|FG002|Overall Study|Adverse Event|2|||
146739194|NCT01036022|529217348|FG003|Overall Study|Adverse Event|1|||
146739195|NCT01036022|529217349|FG004|Overall Study|Adverse Event|0|||
146739196|NCT01036022|529217350|FG005|Overall Study|Adverse Event|2|||
146739197|NCT01036022|529217345|FG000|Overall Study|Lack of Efficacy|1|||
146739198|NCT01036022|529217346|FG001|Overall Study|Lack of Efficacy|1|||
146739199|NCT01036022|529217347|FG002|Overall Study|Lack of Efficacy|1|||
146739200|NCT01036022|529217348|FG003|Overall Study|Lack of Efficacy|0|||
146739201|NCT01036022|529217349|FG004|Overall Study|Lack of Efficacy|1|||
146739202|NCT01036022|529217350|FG005|Overall Study|Lack of Efficacy|1|||
146739203|NCT01036022|529217345|FG000|Overall Study|Physician Decision|0|||
146739204|NCT01036022|529217346|FG001|Overall Study|Physician Decision|0|||
146739205|NCT01036022|529217347|FG002|Overall Study|Physician Decision|1|||
146739206|NCT01036022|529217348|FG003|Overall Study|Physician Decision|0|||
146739207|NCT01036022|529217349|FG004|Overall Study|Physician Decision|0|||
146739208|NCT01036022|529217350|FG005|Overall Study|Physician Decision|0|||
146739209|NCT01036022|529217345|FG000|Overall Study|Withdrawal by Subject|0|||
146739210|NCT01036022|529217346|FG001|Overall Study|Withdrawal by Subject|0|||
146739211|NCT01036022|529217347|FG002|Overall Study|Withdrawal by Subject|0|||
146739212|NCT01036022|529217348|FG003|Overall Study|Withdrawal by Subject|1|||
146739213|NCT01036022|529217349|FG004|Overall Study|Withdrawal by Subject|2|||
146739214|NCT01036022|529217350|FG005|Overall Study|Withdrawal by Subject|0|||
146739215|NCT03403426|529217366|FG000|Overall Study|Death|1|||
146739216|NCT03403426|529217366|FG000|Overall Study|Lost to Follow-up|2|||
146739217|NCT03520400|529217369|FG000|Overall Study|Physician Decision|15|||
146739218|NCT03520400|529217370|FG001|Overall Study|Physician Decision|7|||
146739219|NCT01933880|529217371|FG000|Overall Study|Withdrawal by Subject|5|||
146739220|NCT01933880|529217372|FG001|Overall Study|Withdrawal by Subject|0|||
146739221|NCT01933880|529217371|FG000|Overall Study|Lack of Efficacy|1|||
146739222|NCT01933880|529217372|FG001|Overall Study|Lack of Efficacy|0|||
146739223|NCT01933880|529217371|FG000|Overall Study|Concomitant medication Interference|0|||
146739224|NCT01933880|529217372|FG001|Overall Study|Concomitant medication Interference|1|||
146739225|NCT01933880|529217371|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
146739226|NCT01933880|529217372|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
146739227|NCT01933880|529217371|FG000|Overall Study|Other|4|||
146739228|NCT01933880|529217372|FG001|Overall Study|Other|0|||
146739229|NCT01933880|529217371|FG000|Overall Study|Protocol Violation|1|||
146739230|NCT01933880|529217372|FG001|Overall Study|Protocol Violation|0|||
146739231|NCT00510458|529217373|FG000|Overall Study|5 year not evaluable/missed|21|||
146739232|NCT00510458|529217373|FG000|Overall Study|Death|1|||
146739233|NCT00510458|529217373|FG000|Overall Study|Terminated|14|||
146739234|NCT00510458|529217373|FG000|Overall Study|Lost to Follow-up|6|||
146739235|NCT00510458|529217373|FG000|Overall Study|Withdrawal by Subject|3|||
146739236|NCT00510458|529217373|FG000|Overall Study|Revision|2|||
146739237|NCT02569710|529217374|FG000|Overall Study|Adverse Event|1|||
146739238|NCT02569710|529217375|FG001|Overall Study|Adverse Event|0|||
146739239|NCT02569710|529217376|FG002|Overall Study|Adverse Event|0|||
146739240|NCT02569710|529217377|FG003|Overall Study|Adverse Event|0|||
146739241|NCT02569710|529217378|FG004|Overall Study|Adverse Event|0|||
146739242|NCT02569710|529217379|FG005|Overall Study|Adverse Event|0|||
146739243|NCT02569710|529217380|FG006|Overall Study|Adverse Event|0|||
146739244|NCT02569710|529217381|FG007|Overall Study|Adverse Event|0|||
146739245|NCT02569710|529217382|FG008|Overall Study|Adverse Event|0|||
146739246|NCT02569710|529217383|FG009|Overall Study|Adverse Event|0|||
146739247|NCT02569710|529217374|FG000|Overall Study|Lost to Follow-up|0|||
146739248|NCT02569710|529217375|FG001|Overall Study|Lost to Follow-up|0|||
146739249|NCT02569710|529217376|FG002|Overall Study|Lost to Follow-up|0|||
146739250|NCT02569710|529217377|FG003|Overall Study|Lost to Follow-up|0|||
146739251|NCT02569710|529217378|FG004|Overall Study|Lost to Follow-up|0|||
146739252|NCT02569710|529217379|FG005|Overall Study|Lost to Follow-up|0|||
146739253|NCT02569710|529217380|FG006|Overall Study|Lost to Follow-up|1|||
146739254|NCT02569710|529217381|FG007|Overall Study|Lost to Follow-up|0|||
146739255|NCT02569710|529217382|FG008|Overall Study|Lost to Follow-up|1|||
146739256|NCT02569710|529217383|FG009|Overall Study|Lost to Follow-up|0|||
146739257|NCT02569710|529217374|FG000|Overall Study|Virologic failure|0|||
146739258|NCT02569710|529217375|FG001|Overall Study|Virologic failure|0|||
146739259|NCT02569710|529217376|FG002|Overall Study|Virologic failure|0|||
146739260|NCT02569710|529217377|FG003|Overall Study|Virologic failure|0|||
146739261|NCT02569710|529217378|FG004|Overall Study|Virologic failure|1|||
146739262|NCT02569710|529217379|FG005|Overall Study|Virologic failure|0|||
146739263|NCT02569710|529217380|FG006|Overall Study|Virologic failure|1|||
146739264|NCT02569710|529217381|FG007|Overall Study|Virologic failure|0|||
146739265|NCT02569710|529217382|FG008|Overall Study|Virologic failure|0|||
146739266|NCT02569710|529217383|FG009|Overall Study|Virologic failure|0|||
146739267|NCT02569710|529217374|FG000|Overall Study|Withdrawal by Subject|0|||
146739268|NCT02569710|529217375|FG001|Overall Study|Withdrawal by Subject|0|||
146739269|NCT02569710|529217376|FG002|Overall Study|Withdrawal by Subject|0|||
146739270|NCT02569710|529217377|FG003|Overall Study|Withdrawal by Subject|0|||
146739271|NCT02569710|529217378|FG004|Overall Study|Withdrawal by Subject|0|||
146739272|NCT02569710|529217379|FG005|Overall Study|Withdrawal by Subject|1|||
146739273|NCT02569710|529217380|FG006|Overall Study|Withdrawal by Subject|0|||
146739274|NCT02569710|529217381|FG007|Overall Study|Withdrawal by Subject|0|||
146739275|NCT02569710|529217382|FG008|Overall Study|Withdrawal by Subject|0|||
146739276|NCT02569710|529217383|FG009|Overall Study|Withdrawal by Subject|0|||
146739277|NCT01125722|529217384|FG000|Overall Study|Withdrawal by Subject|2|||
146739278|NCT01125722|529217385|FG001|Overall Study|Withdrawal by Subject|1|||
146739279|NCT01125722|529217384|FG000|Overall Study|Lost to Follow-up|1|||
146739280|NCT01125722|529217385|FG001|Overall Study|Lost to Follow-up|0|||
146739281|NCT03474549|529217386|FG000|Overall Study|Death|31|||
146739282|NCT03474549|529217386|FG000|Overall Study|Lost to Follow-up|4|||
146739283|NCT03474549|529217386|FG000|Overall Study|Withdrawal by Subject|2|||
146739284|NCT03573908|529217387|FG000|Treatment Period|Adverse Event|4|||
146739285|NCT03573908|529217388|FG001|Treatment Period|Adverse Event|9|||
146739286|NCT03573908|529217389|FG002|Treatment Period|Adverse Event|0|||
146739287|NCT03573908|529217390|FG003|Treatment Period|Adverse Event|0|||
146739288|NCT03573908|529217391|FG004|Treatment Period|Adverse Event|0|||
146739289|NCT03573908|529217387|FG000|Treatment Period|Protocol Violation|1|||
146739290|NCT03573908|529217388|FG001|Treatment Period|Protocol Violation|0|||
146739291|NCT03573908|529217389|FG002|Treatment Period|Protocol Violation|0|||
146739292|NCT03573908|529217390|FG003|Treatment Period|Protocol Violation|0|||
146739293|NCT03573908|529217391|FG004|Treatment Period|Protocol Violation|0|||
146739294|NCT03573908|529217387|FG000|Treatment Period|Withdrawal by Subject|7|||
146739295|NCT03573908|529217388|FG001|Treatment Period|Withdrawal by Subject|5|||
146739296|NCT03573908|529217389|FG002|Treatment Period|Withdrawal by Subject|0|||
146739297|NCT03573908|529217390|FG003|Treatment Period|Withdrawal by Subject|0|||
146739298|NCT03573908|529217391|FG004|Treatment Period|Withdrawal by Subject|0|||
146739299|NCT03573908|529217387|FG000|Treatment Period|Lost to Follow-up|7|||
146739300|NCT03573908|529217388|FG001|Treatment Period|Lost to Follow-up|6|||
146739301|NCT03573908|529217389|FG002|Treatment Period|Lost to Follow-up|0|||
146739302|NCT03573908|529217390|FG003|Treatment Period|Lost to Follow-up|0|||
146739303|NCT03573908|529217391|FG004|Treatment Period|Lost to Follow-up|0|||
146739304|NCT03573908|529217387|FG000|Treatment Period|Pregnancy|1|||
146739305|NCT03573908|529217388|FG001|Treatment Period|Pregnancy|0|||
146739306|NCT03573908|529217389|FG002|Treatment Period|Pregnancy|0|||
146739307|NCT03573908|529217390|FG003|Treatment Period|Pregnancy|0|||
146739308|NCT03573908|529217391|FG004|Treatment Period|Pregnancy|0|||
146739309|NCT03573908|529217387|FG000|Treatment Period|Other, Not Specified|4|||
146739310|NCT03573908|529217388|FG001|Treatment Period|Other, Not Specified|6|||
146739311|NCT03573908|529217389|FG002|Treatment Period|Other, Not Specified|0|||
146739312|NCT03573908|529217390|FG003|Treatment Period|Other, Not Specified|0|||
146739313|NCT03573908|529217391|FG004|Treatment Period|Other, Not Specified|0|||
146739314|NCT03573908|529217387|FG000|Randomized Withdrawal Period|Adverse Event|0|||
146739315|NCT03573908|529217388|FG001|Randomized Withdrawal Period|Adverse Event|0|||
146739316|NCT03573908|529217389|FG002|Randomized Withdrawal Period|Adverse Event|3|||
146739317|NCT03573908|529217390|FG003|Randomized Withdrawal Period|Adverse Event|0|||
146739318|NCT03573908|529217391|FG004|Randomized Withdrawal Period|Adverse Event|0|||
146739319|NCT03573908|529217387|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146739320|NCT03573908|529217388|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146739321|NCT03573908|529217389|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146739322|NCT03573908|529217390|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146739323|NCT03573908|529217391|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
146739324|NCT03573908|529217387|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
146739325|NCT03573908|529217388|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
146739326|NCT03573908|529217389|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
146739327|NCT03573908|529217390|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
146739328|NCT03573908|529217391|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
146739329|NCT03573908|529217387|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
146739330|NCT03573908|529217388|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
146739331|NCT03573908|529217389|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
146739332|NCT03573908|529217390|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
146739333|NCT03573908|529217391|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
146739334|NCT04006925|529217392|FG000|Overall Study|Side effects|2|||
146739335|NCT04006925|529217393|FG001|Overall Study|Side effects|0|||
146739336|NCT00738101|529217400|FG000|Overall Study|Physician Decision|5|||
146739337|NCT00738101|529217400|FG000|Overall Study|Death|1|||
146739338|NCT00738101|529217400|FG000|Overall Study|Repeat enrollment|1|||
146739339|NCT00709059|529217405|FG000|Overall Study|Lost to Follow-up|34|||
146739340|NCT00709059|529217405|FG000|Overall Study|Withdrawal by Subject|19|||
146739341|NCT00709059|529217405|FG000|Overall Study|Physician Decision|7|||
146739342|NCT00709059|529217405|FG000|Overall Study|Disease complication|3|||
146739343|NCT00709059|529217405|FG000|Overall Study|Side effects|20|||
146739344|NCT00709059|529217405|FG000|Overall Study|Serious side effects|11|||
146739345|NCT01396317|529217406|FG000|Overall Study|Adverse Event|1|||
146739346|NCT01396317|529217407|FG001|Overall Study|Adverse Event|0|||
146739347|NCT03315130|529217408|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
146739348|NCT03315130|529217409|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
146739349|NCT03315130|529217410|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
146739350|NCT03315130|529217411|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
146739351|NCT03315130|529217408|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
146739352|NCT03315130|529217409|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
146739353|NCT03315130|529217410|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
146739354|NCT03315130|529217411|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
146739355|NCT03315130|529217408|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
146739356|NCT03315130|529217409|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
146739357|NCT03315130|529217410|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
146739358|NCT03315130|529217411|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
146739359|NCT03315130|529217408|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
146739360|NCT03315130|529217409|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
146739361|NCT03315130|529217410|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
146739362|NCT03315130|529217411|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
146739363|NCT03315130|529217408|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
146739364|NCT03315130|529217409|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
146739365|NCT03315130|529217410|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
146739366|NCT03315130|529217411|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
146739367|NCT03315130|529217408|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
146739368|NCT03315130|529217409|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
146739369|NCT03315130|529217410|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
146739370|NCT03315130|529217411|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
146739371|NCT00524030|529217412|FG000|Overall Study|Lack of Efficacy|10|||
146739372|NCT00524030|529217413|FG001|Overall Study|Lack of Efficacy|24|||
146739373|NCT00524030|529217412|FG000|Overall Study|Lost to Follow-up|0|||
146739374|NCT00524030|529217413|FG001|Overall Study|Lost to Follow-up|2|||
146739375|NCT00524030|529217412|FG000|Overall Study|Withdrawal by Subject|3|||
146739376|NCT00524030|529217413|FG001|Overall Study|Withdrawal by Subject|8|||
146739377|NCT00524030|529217412|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
146739378|NCT00524030|529217413|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
146739379|NCT00524030|529217412|FG000|Overall Study|Protocol Violation|0|||
146739380|NCT00524030|529217413|FG001|Overall Study|Protocol Violation|1|||
146739381|NCT00524030|529217412|FG000|Overall Study|Pregnancy|1|||
146739382|NCT00524030|529217413|FG001|Overall Study|Pregnancy|0|||
146739383|NCT00524030|529217412|FG000|Overall Study|Adverse Event|3|||
146739384|NCT00524030|529217413|FG001|Overall Study|Adverse Event|21|||
146739385|NCT00524030|529217412|FG000|Overall Study|Death|0|||
146739386|NCT00524030|529217413|FG001|Overall Study|Death|1|||
146739387|NCT02944656|529217421|FG000|Overall Study|No longer eligible|3|||
146739388|NCT02944656|529217422|FG001|Overall Study|No longer eligible|0|||
146739389|NCT02944656|529217421|FG000|Overall Study|Lost to Follow-up|7|||
146739390|NCT02944656|529217422|FG001|Overall Study|Lost to Follow-up|10|||
146739391|NCT04398537|529217423|FG000|Overall Study|Physician Decision|10|||
146739392|NCT04398537|529217424|FG001|Overall Study|Physician Decision|15|||
146739393|NCT02089230|529217425|FG000|Overall Study|Death|0|||
146739394|NCT02089230|529217426|FG001|Overall Study|Death|0|||
146739395|NCT02089230|529217427|FG002|Overall Study|Death|2|||
146739396|NCT02089230|529217425|FG000|Overall Study|Seeking Alternative Therapy|0|||
146739397|NCT02089230|529217426|FG001|Overall Study|Seeking Alternative Therapy|0|||
146739398|NCT02089230|529217427|FG002|Overall Study|Seeking Alternative Therapy|4|||
146739399|NCT02243631|529219250|FG000|Overall Study|no synovial fluid on second aspirate|0|||
146739400|NCT02243631|529219251|FG001|Overall Study|no synovial fluid on second aspirate|1|||
146739401|NCT01590771|529219258|FG000|Overall Study|Other Protocol Specified Criteria|5|||
146739402|NCT01590771|529219259|FG001|Overall Study|Other Protocol Specified Criteria|14|||
146739403|NCT01590771|529219258|FG000|Overall Study|Withdrawal by Subject|8|||
146739404|NCT01590771|529219259|FG001|Overall Study|Withdrawal by Subject|15|||
146739405|NCT01590771|529219258|FG000|Overall Study|Protocol Violation|1|||
146739406|NCT01590771|529219259|FG001|Overall Study|Protocol Violation|2|||
146739407|NCT01590771|529219258|FG000|Overall Study|Lost to Follow-up|1|||
146739408|NCT01590771|529219259|FG001|Overall Study|Lost to Follow-up|1|||
146739409|NCT01590771|529219258|FG000|Overall Study|Lack of Efficacy|1|||
146739410|NCT01590771|529219259|FG001|Overall Study|Lack of Efficacy|0|||
146739411|NCT01590771|529219258|FG000|Overall Study|Adverse Event|3|||
146739412|NCT01590771|529219259|FG001|Overall Study|Adverse Event|7|||
146739413|NCT01785628|529219262|FG000|Overall Study|Lost to Follow-up|2|||
146739414|NCT01785628|529219263|FG001|Overall Study|Lost to Follow-up|3|||
146739415|NCT02200939|529219264|FG000|Overall Study|Participant withdrew consent|0|||
146739416|NCT02200939|529219265|FG001|Overall Study|Participant withdrew consent|1|||
146739417|NCT02200939|529219264|FG000|Overall Study|Lost to Follow-up|2|||
146739418|NCT02200939|529219265|FG001|Overall Study|Lost to Follow-up|9|||
146739419|NCT02200939|529219264|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
146739420|NCT02200939|529219265|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
146739421|NCT02746575|529219266|FG000|Overall Study|Surgery cancelled or time chaned|13|||
146739422|NCT02746575|529219266|FG000|Overall Study|Received epidural|10|||
146739423|NCT02746575|529219266|FG000|Overall Study|Withdrawal by Subject|3|||
146739424|NCT02746575|529219266|FG000|Overall Study|Bradycardia/hypotension|9|||
146739425|NCT02746575|529219266|FG000|Overall Study|Study paused|8|||
146739426|NCT02746575|529219266|FG000|Overall Study|put on beta-blocker|3|||
146739427|NCT02746575|529219266|FG000|Overall Study|type of surgery|1|||
146739428|NCT02746575|529219266|FG000|Overall Study|typ of surgery|1|||
146739429|NCT02746575|529219266|FG000|Overall Study|PI unavailable|1|||
146739430|NCT02746575|529219266|FG000|Overall Study|Unknown history of CVA|1|||
146739431|NCT04867785|529219267|FG000|Overall Study|Adverse Event|1|||
146739432|NCT04867785|529219268|FG001|Overall Study|Adverse Event|0|||
146739433|NCT04867785|529219269|FG002|Overall Study|Adverse Event|1|||
146739434|NCT04867785|529219270|FG003|Overall Study|Adverse Event|0|||
146739435|NCT04867785|529219271|FG004|Overall Study|Adverse Event|0|||
146739436|NCT04867785|529219272|FG005|Overall Study|Adverse Event|0|||
146739437|NCT04867785|529219273|FG006|Overall Study|Adverse Event|0|||
146739438|NCT04867785|529219274|FG007|Overall Study|Adverse Event|2|||
146739439|NCT04867785|529219267|FG000|Overall Study|Lost to Follow-up|4|||
146739440|NCT04867785|529219268|FG001|Overall Study|Lost to Follow-up|4|||
146739441|NCT04867785|529219269|FG002|Overall Study|Lost to Follow-up|3|||
146739442|NCT04867785|529219270|FG003|Overall Study|Lost to Follow-up|2|||
146739443|NCT04867785|529219271|FG004|Overall Study|Lost to Follow-up|0|||
146739444|NCT04867785|529219272|FG005|Overall Study|Lost to Follow-up|1|||
146739445|NCT04867785|529219273|FG006|Overall Study|Lost to Follow-up|0|||
146739446|NCT04867785|529219274|FG007|Overall Study|Lost to Follow-up|1|||
146739447|NCT04867785|529219267|FG000|Overall Study|Withdrawal by Subject|6|||
146739448|NCT04867785|529219268|FG001|Overall Study|Withdrawal by Subject|2|||
146739449|NCT04867785|529219269|FG002|Overall Study|Withdrawal by Subject|2|||
146739450|NCT04867785|529219270|FG003|Overall Study|Withdrawal by Subject|1|||
146739451|NCT04867785|529219271|FG004|Overall Study|Withdrawal by Subject|2|||
146739452|NCT04867785|529219272|FG005|Overall Study|Withdrawal by Subject|0|||
146739453|NCT04867785|529219273|FG006|Overall Study|Withdrawal by Subject|2|||
146739454|NCT04867785|529219274|FG007|Overall Study|Withdrawal by Subject|5|||
146739455|NCT04867785|529219267|FG000|Overall Study|Physician Decision|0|||
146739456|NCT04867785|529219268|FG001|Overall Study|Physician Decision|0|||
146739457|NCT04867785|529219269|FG002|Overall Study|Physician Decision|0|||
146739458|NCT04867785|529219270|FG003|Overall Study|Physician Decision|0|||
146739459|NCT04867785|529219271|FG004|Overall Study|Physician Decision|0|||
146739460|NCT04867785|529219272|FG005|Overall Study|Physician Decision|0|||
146739461|NCT04867785|529219273|FG006|Overall Study|Physician Decision|0|||
146739462|NCT04867785|529219274|FG007|Overall Study|Physician Decision|1|||
146739463|NCT04867785|529219267|FG000|Overall Study|Inadvertent Enrollment|0|||
146739464|NCT04867785|529219268|FG001|Overall Study|Inadvertent Enrollment|0|||
146739465|NCT04867785|529219269|FG002|Overall Study|Inadvertent Enrollment|0|||
146739466|NCT04867785|529219270|FG003|Overall Study|Inadvertent Enrollment|1|||
146739467|NCT04867785|529219271|FG004|Overall Study|Inadvertent Enrollment|1|||
146739468|NCT04867785|529219272|FG005|Overall Study|Inadvertent Enrollment|0|||
146739469|NCT04867785|529219273|FG006|Overall Study|Inadvertent Enrollment|0|||
146739470|NCT04867785|529219274|FG007|Overall Study|Inadvertent Enrollment|1|||
146739471|NCT04867785|529219267|FG000|Overall Study|Eligibility Criteria Not Met|0|||
146739472|NCT04867785|529219268|FG001|Overall Study|Eligibility Criteria Not Met|0|||
146739473|NCT04867785|529219269|FG002|Overall Study|Eligibility Criteria Not Met|0|||
146739474|NCT04867785|529219270|FG003|Overall Study|Eligibility Criteria Not Met|0|||
146739475|NCT04867785|529219271|FG004|Overall Study|Eligibility Criteria Not Met|0|||
146739476|NCT04867785|529219272|FG005|Overall Study|Eligibility Criteria Not Met|0|||
146739477|NCT04867785|529219273|FG006|Overall Study|Eligibility Criteria Not Met|0|||
146739478|NCT04867785|529219274|FG007|Overall Study|Eligibility Criteria Not Met|1|||
146739479|NCT01486758|529219275|FG000|Overall Study|Lost to Follow-up|0|||
146739480|NCT01486758|529219276|FG001|Overall Study|Lost to Follow-up|1|||
146739481|NCT02494921|529219277|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
146739482|NCT02494921|529219278|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
146739483|NCT02494921|529219279|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
146739484|NCT02494921|529219280|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
146739485|NCT02494921|529219281|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
146739486|NCT02494921|529219277|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
146739487|NCT02494921|529219278|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
146739488|NCT02494921|529219279|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
146739489|NCT02494921|529219280|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
146739490|NCT02494921|529219281|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
146739491|NCT02494921|529219277|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
146739492|NCT02494921|529219278|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
146739493|NCT02494921|529219279|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
146739494|NCT02494921|529219280|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
146625083|NCT00537394|528801582|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
146739495|NCT02494921|529219281|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
146739496|NCT03239873|529219282|FG000|Overall Study|Lost to Follow-up|15|||
146739497|NCT03239873|529219283|FG001|Overall Study|Lost to Follow-up|16|||
146739498|NCT03239873|529219282|FG000|Overall Study|Physician Decision|1|||
146739499|NCT03239873|529219283|FG001|Overall Study|Physician Decision|0|||
146739500|NCT03239873|529219282|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
146739501|NCT03239873|529219283|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
146739502|NCT03239873|529219282|FG000|Overall Study|Withdrawal by Subject|2|||
146739503|NCT03239873|529219283|FG001|Overall Study|Withdrawal by Subject|0|||
146739504|NCT03239873|529219282|FG000|Overall Study|Contraindication to study medication|1|||
146739505|NCT03239873|529219283|FG001|Overall Study|Contraindication to study medication|0|||
146739506|NCT03239873|529219282|FG000|Overall Study|Protocol Violation|1|||
146739507|NCT03239873|529219283|FG001|Overall Study|Protocol Violation|0|||
146739508|NCT03585296|529219284|FG000|Overall Study|Adverse Event|1|||
146739509|NCT03585296|529219284|FG000|Overall Study|Lost to Follow-up|2|||
146739510|NCT03585296|529219284|FG000|Overall Study|Withdrawal by Subject|2|||
146739511|NCT03980184|529219287|FG000|Overall Study|Dropped out before treatment|2|||
146739512|NCT03980184|529219288|FG001|Overall Study|Dropped out before treatment|2|||
146739513|NCT03980184|529219287|FG000|Overall Study|Lost to Follow-up|11|||
146739514|NCT03980184|529219288|FG001|Overall Study|Lost to Follow-up|13|||
146739515|NCT02002884|529219289|FG000|Main Period (MP)|Other|0|||
146739516|NCT02002884|529219290|FG001|Main Period (MP)|Other|3|||
146739517|NCT02002884|529219291|FG002|Main Period (MP)|Other|3|||
146739518|NCT02002884|529219292|FG003|Main Period (MP)|Other|0|||
146739519|NCT02002884|529219289|FG000|Main Period (MP)|Adverse Event|0|||
146739520|NCT02002884|529219290|FG001|Main Period (MP)|Adverse Event|1|||
146739521|NCT02002884|529219291|FG002|Main Period (MP)|Adverse Event|1|||
146739522|NCT02002884|529219292|FG003|Main Period (MP)|Adverse Event|0|||
146739523|NCT02002884|529219289|FG000|Main Period (MP)|Withdrawal by Subject|6|||
146739524|NCT02002884|529219290|FG001|Main Period (MP)|Withdrawal by Subject|2|||
146739525|NCT02002884|529219291|FG002|Main Period (MP)|Withdrawal by Subject|2|||
146739526|NCT02002884|529219292|FG003|Main Period (MP)|Withdrawal by Subject|0|||
146739527|NCT02002884|529219289|FG000|Main Period (MP)|Lost to Follow-up|0|||
146739528|NCT02002884|529219290|FG001|Main Period (MP)|Lost to Follow-up|0|||
146739529|NCT02002884|529219291|FG002|Main Period (MP)|Lost to Follow-up|2|||
146739530|NCT02002884|529219292|FG003|Main Period (MP)|Lost to Follow-up|0|||
146739531|NCT02002884|529219289|FG000|Open-Label Extension Period (OLEX)|Other|0|||
146739532|NCT02002884|529219290|FG001|Open-Label Extension Period (OLEX)|Other|0|||
146739533|NCT02002884|529219291|FG002|Open-Label Extension Period (OLEX)|Other|0|||
146739534|NCT02002884|529219292|FG003|Open-Label Extension Period (OLEX)|Other|24|||
146739535|NCT02002884|529219289|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
146739536|NCT02002884|529219290|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
146739537|NCT02002884|529219291|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
146739538|NCT02002884|529219292|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
146739539|NCT02002884|529219289|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
146739540|NCT02002884|529219290|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
146739541|NCT02002884|529219291|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
146739542|NCT02002884|529219292|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
146739543|NCT02002884|529219289|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
146739544|NCT02002884|529219290|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
146739545|NCT02002884|529219291|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
146739546|NCT02002884|529219292|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
146739547|NCT02002884|529219289|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
146739548|NCT02002884|529219290|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
146739549|NCT02002884|529219291|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
146739550|NCT02002884|529219292|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
146739551|NCT00462670|529219293|FG000|Overall Study|Adverse Event|3|||
146739552|NCT00462670|529219294|FG001|Overall Study|Adverse Event|5|||
146739553|NCT00462670|529219293|FG000|Overall Study|Lack of Efficacy|1|||
146739554|NCT00462670|529219294|FG001|Overall Study|Lack of Efficacy|0|||
146739555|NCT00462670|529219293|FG000|Overall Study|Protocol Violation|1|||
146739556|NCT00462670|529219294|FG001|Overall Study|Protocol Violation|0|||
146739557|NCT00462670|529219293|FG000|Overall Study|Resolution of signs and symptoms|0|||
146739558|NCT00462670|529219294|FG001|Overall Study|Resolution of signs and symptoms|2|||
146739559|NCT02966002|529219295|FG000|Overall Study|Withdrawal by Subject|2|||
146739560|NCT02966002|529219295|FG000|Overall Study|Adverse Event|1|||
146739561|NCT02966002|529219295|FG000|Overall Study|Lost to Follow-up|1|||
146739562|NCT02291432|529219297|FG000|Overall Study|Withdrawal by Subject|2|||
146739563|NCT02145078|529219300|FG000|Overall Study|Death|1|||
146739564|NCT02145078|529219300|FG000|Overall Study|Reason not given|3|||
146739565|NCT03327402|529219301|FG000|Overall Study|Withdrawal by Subject|1|||
146739566|NCT03327402|529219301|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
146739567|NCT01454830|529219304|FG000|Overall Study|Withdrawal by Subject|4|||
146739568|NCT01454830|529219305|FG001|Overall Study|Withdrawal by Subject|4|||
146739569|NCT01454830|529219304|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
146739570|NCT01454830|529219305|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
146739571|NCT01454830|529219304|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
146739572|NCT01454830|529219305|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
146739573|NCT01454830|529219304|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
146739574|NCT01454830|529219305|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
146739575|NCT01454830|529219304|FG000|Overall Study|Withdrawal - no polysomnography|3|||
146739576|NCT01454830|529219305|FG001|Overall Study|Withdrawal - no polysomnography|2|||
146739577|NCT00584805|529219308|FG000|Overall Study|No longer at risk of exposure|39|||
146739578|NCT00584805|529219308|FG000|Overall Study|Relocation|36|||
146739579|NCT00584805|529219308|FG000|Overall Study|Withdrawal by Subject|18|||
146739580|NCT00584805|529219308|FG000|Overall Study|Non-compliance|1|||
146739581|NCT00584805|529219308|FG000|Overall Study|Lost to follow up|3|||
146739582|NCT00584805|529219308|FG000|Overall Study|Screen failures|2|||
146739583|NCT00154310|529219309|FG000|Overall Study|Adverse Event|19|||
146739584|NCT00154310|529219310|FG001|Overall Study|Adverse Event|9|||
146739585|NCT00154310|529219309|FG000|Overall Study|Lack of Efficacy|5|||
146739586|NCT00154310|529219310|FG001|Overall Study|Lack of Efficacy|4|||
146739587|NCT00154310|529219309|FG000|Overall Study|Protocol Violation|4|||
146739588|NCT00154310|529219310|FG001|Overall Study|Protocol Violation|2|||
146739589|NCT00154310|529219309|FG000|Overall Study|Withdrawal by Subject|9|||
146739590|NCT00154310|529219310|FG001|Overall Study|Withdrawal by Subject|3|||
146739591|NCT00154310|529219309|FG000|Overall Study|Lost to Follow-up|0|||
146739592|NCT00154310|529219310|FG001|Overall Study|Lost to Follow-up|8|||
146739593|NCT00154310|529219309|FG000|Overall Study|Administrative problems|0|||
146739594|NCT00154310|529219310|FG001|Overall Study|Administrative problems|1|||
146739595|NCT00154310|529219309|FG000|Overall Study|Death|0|||
146739596|NCT00154310|529219310|FG001|Overall Study|Death|1|||
146739597|NCT04041440|529219311|FG000|Overall Study|Withdrawal by Subject|0|||
146739598|NCT04041440|529219312|FG001|Overall Study|Withdrawal by Subject|1|||
146739599|NCT04041440|529219311|FG000|Overall Study|Lost to Follow-up|0|||
146739600|NCT04041440|529219312|FG001|Overall Study|Lost to Follow-up|1|||
146739601|NCT02247804|529219317|FG000|Treatment Period 1|Adverse Event|9|||
146739602|NCT02247804|529219318|FG001|Treatment Period 1|Adverse Event|2|||
146739603|NCT02247804|529219319|FG002|Treatment Period 1|Adverse Event|0|||
146739604|NCT02247804|529219317|FG000|Treatment Period 1|Lack of Efficacy|0|||
146739605|NCT02247804|529219318|FG001|Treatment Period 1|Lack of Efficacy|0|||
146739606|NCT02247804|529219319|FG002|Treatment Period 1|Lack of Efficacy|2|||
146739607|NCT02247804|529219317|FG000|Treatment Period 1|Lost to Follow-up|1|||
146739608|NCT02247804|529219318|FG001|Treatment Period 1|Lost to Follow-up|0|||
146739609|NCT02247804|529219319|FG002|Treatment Period 1|Lost to Follow-up|2|||
146739610|NCT02247804|529219317|FG000|Treatment Period 1|Personal Reasons|7|||
146739611|NCT02247804|529219318|FG001|Treatment Period 1|Personal Reasons|1|||
146739612|NCT02247804|529219319|FG002|Treatment Period 1|Personal Reasons|2|||
146739613|NCT02247804|529219317|FG000|Treatment Period 1|Protocol Deviation|0|||
146739614|NCT02247804|529219318|FG001|Treatment Period 1|Protocol Deviation|0|||
146739615|NCT02247804|529219319|FG002|Treatment Period 1|Protocol Deviation|1|||
146739616|NCT02247804|529219317|FG000|Treatment Period 1|Randomized but not Treated|5|||
146739617|NCT02247804|529219318|FG001|Treatment Period 1|Randomized but not Treated|1|||
146739618|NCT02247804|529219319|FG002|Treatment Period 1|Randomized but not Treated|1|||
146739619|NCT02247804|529219317|FG000|Treatment Period 2|Adverse Event|6|||
146739620|NCT02247804|529219318|FG001|Treatment Period 2|Adverse Event|3|||
146739621|NCT02247804|529219319|FG002|Treatment Period 2|Adverse Event|3|||
146739622|NCT02247804|529219317|FG000|Treatment Period 2|Lack of Efficacy|0|||
146739623|NCT02247804|529219318|FG001|Treatment Period 2|Lack of Efficacy|0|||
146739624|NCT02247804|529219319|FG002|Treatment Period 2|Lack of Efficacy|1|||
146739625|NCT02247804|529219317|FG000|Treatment Period 2|Lost to Follow-up|0|||
146739626|NCT02247804|529219318|FG001|Treatment Period 2|Lost to Follow-up|1|||
146739627|NCT02247804|529219319|FG002|Treatment Period 2|Lost to Follow-up|1|||
146739628|NCT02247804|529219317|FG000|Treatment Period 2|Personal Reasons|2|||
146739629|NCT02247804|529219318|FG001|Treatment Period 2|Personal Reasons|1|||
146739630|NCT02247804|529219319|FG002|Treatment Period 2|Personal Reasons|1|||
146739631|NCT02247804|529219317|FG000|Treatment Period 2|Reason not Specified|0|||
146739632|NCT02247804|529219318|FG001|Treatment Period 2|Reason not Specified|0|||
146739633|NCT02247804|529219319|FG002|Treatment Period 2|Reason not Specified|2|||
146739634|NCT02247804|529219317|FG000|Treatment Period 3|Adverse Event|4|||
146739635|NCT02247804|529219318|FG001|Treatment Period 3|Adverse Event|3|||
146739636|NCT02247804|529219319|FG002|Treatment Period 3|Adverse Event|3|||
146739637|NCT02247804|529219317|FG000|Treatment Period 3|Lack of Efficacy|0|||
146739638|NCT02247804|529219318|FG001|Treatment Period 3|Lack of Efficacy|1|||
146739639|NCT02247804|529219319|FG002|Treatment Period 3|Lack of Efficacy|0|||
146739640|NCT02247804|529219317|FG000|Treatment Period 3|Lost to Follow-up|1|||
146739641|NCT02247804|529219318|FG001|Treatment Period 3|Lost to Follow-up|2|||
146739642|NCT02247804|529219319|FG002|Treatment Period 3|Lost to Follow-up|2|||
146739643|NCT02247804|529219317|FG000|Treatment Period 3|Personal Reasons|4|||
146739644|NCT02247804|529219318|FG001|Treatment Period 3|Personal Reasons|3|||
146739645|NCT02247804|529219319|FG002|Treatment Period 3|Personal Reasons|2|||
146739646|NCT02247804|529219317|FG000|Treatment Period 3|Reason not Specified|2|||
146739647|NCT02247804|529219318|FG001|Treatment Period 3|Reason not Specified|1|||
146739648|NCT02247804|529219319|FG002|Treatment Period 3|Reason not Specified|3|||
146739649|NCT03447730|529219320|FG000|Overall Study|Adverse Event|0|||
146739650|NCT03447730|529219321|FG001|Overall Study|Adverse Event|2|||
146739651|NCT03447730|529219322|FG002|Overall Study|Adverse Event|0|||
146739652|NCT01350505|529219326|FG000|Overall Study|Lost to Follow-up|4|||
146739653|NCT04251065|529219327|FG000|Overall Study|Death|2|||
146739654|NCT04251065|529219327|FG000|Overall Study|Lack of Efficacy|3|||
146739655|NCT04251065|529219327|FG000|Overall Study|Death|1|||
146739656|NCT01054573|529219328|FG000|Overall Study|Adverse Event|1|||
146739657|NCT01054573|529219329|FG001|Overall Study|Adverse Event|0|||
146739658|NCT01054573|529219330|FG002|Overall Study|Adverse Event|1|||
146739659|NCT01054573|529219331|FG003|Overall Study|Adverse Event|1|||
146739660|NCT01054573|529219328|FG000|Overall Study|Lost to Follow-up|0|||
146739661|NCT01054573|529219329|FG001|Overall Study|Lost to Follow-up|2|||
146739662|NCT01054573|529219330|FG002|Overall Study|Lost to Follow-up|0|||
146739663|NCT01054573|529219331|FG003|Overall Study|Lost to Follow-up|0|||
146739664|NCT01054573|529219328|FG000|Overall Study|Withdrawal by Subject|0|||
146739665|NCT01054573|529219329|FG001|Overall Study|Withdrawal by Subject|2|||
146739666|NCT01054573|529219330|FG002|Overall Study|Withdrawal by Subject|2|||
146739667|NCT01054573|529219331|FG003|Overall Study|Withdrawal by Subject|1|||
146739668|NCT05266963|529219332|FG000|Drug Period A|Withdrawal by Subject|0|||
146739669|NCT05266963|529219333|FG001|Drug Period A|Withdrawal by Subject|1|||
146739670|NCT01306201|529219334|FG000|Overall Study|Arrhythmia|4|||
146739671|NCT01306201|529219334|FG000|Overall Study|Files could not be processed|3|||
146739672|NCT01306201|529219334|FG000|Overall Study|Files unreadable|3|||
146739673|NCT04702568|529219335|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
146739674|NCT04702568|529219336|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
146739675|NCT04702568|529219335|FG000|Overall Study|Pregnancy|1|||
146739676|NCT04702568|529219336|FG001|Overall Study|Pregnancy|0|||
146739677|NCT04702568|529219335|FG000|Overall Study|Bone marrow transplant|1|||
146739678|NCT04702568|529219336|FG001|Overall Study|Bone marrow transplant|0|||
146739679|NCT04702568|529219335|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
146739680|NCT04702568|529219336|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
146739681|NCT04702568|529219335|FG000|Overall Study|Withdrawal by Subject|0|||
146739682|NCT04702568|529219336|FG001|Overall Study|Withdrawal by Subject|2|||
146739683|NCT02912468|529219337|FG000|Overall Study|Adverse Event|3|||
146739684|NCT02912468|529219338|FG001|Overall Study|Adverse Event|2|||
146739685|NCT02912468|529219337|FG000|Overall Study|Withdrawal by Subject|6|||
146739686|NCT02912468|529219338|FG001|Overall Study|Withdrawal by Subject|2|||
146739687|NCT02912468|529219337|FG000|Overall Study|Randomized and not treated|0|||
146739688|NCT02912468|529219338|FG001|Overall Study|Randomized and not treated|1|||
146739689|NCT00423852|529219343|FG000|Overall Study|Removed pior to the high-dose portion|3|||
146739690|NCT00980005|529219344|FG000|Overall Study|Withdrawal by Subject|6|||
146739691|NCT00980005|529219345|FG001|Overall Study|Withdrawal by Subject|17|||
146739692|NCT00980005|529219344|FG000|Overall Study|Lost to Follow-up|37|||
146739693|NCT00980005|529219345|FG001|Overall Study|Lost to Follow-up|43|||
146739694|NCT00980005|529219344|FG000|Overall Study|Other|4|||
146739695|NCT00980005|529219345|FG001|Overall Study|Other|3|||
146739696|NCT02597933|529219346|FG000|Overall Study|Withdrawal by Subject|7|||
146739697|NCT02597933|529219347|FG001|Overall Study|Withdrawal by Subject|5|||
146739698|NCT02597933|529219346|FG000|Overall Study|Protocol Violation|2|||
146739699|NCT02597933|529219347|FG001|Overall Study|Protocol Violation|2|||
146739700|NCT02597933|529219346|FG000|Overall Study|Adverse Event|20|||
146739701|NCT02597933|529219347|FG001|Overall Study|Adverse Event|28|||
146739702|NCT02597933|529219346|FG000|Overall Study|Not treated|2|||
146739703|NCT02597933|529219347|FG001|Overall Study|Not treated|2|||
146739704|NCT02597933|529219346|FG000|Overall Study|Other than stated above|7|||
146739705|NCT02597933|529219347|FG001|Overall Study|Other than stated above|14|||
146739706|NCT00130793|529219362|FG000|Overall Study|Lost to Follow-up|1|||
146739707|NCT00130793|529219363|FG001|Overall Study|Lost to Follow-up|4|||
146739708|NCT00130793|529219362|FG000|Overall Study|Withdrew consent|2|||
146739709|NCT00130793|529219363|FG001|Overall Study|Withdrew consent|0|||
146739710|NCT01515189|529219364|FG000|Induction|Disease Progression|109|||
146739711|NCT01515189|529219365|FG001|Induction|Disease Progression|155|||
146739712|NCT01515189|529219364|FG000|Induction|Study drug toxicity|86|||
146739713|NCT01515189|529219365|FG001|Induction|Study drug toxicity|36|||
146739714|NCT01515189|529219364|FG000|Induction|Death|24|||
146739715|NCT01515189|529219365|FG001|Induction|Death|17|||
146739716|NCT01515189|529219364|FG000|Induction|Adverse Event|14|||
146739717|NCT01515189|529219365|FG001|Induction|Adverse Event|9|||
146739718|NCT01515189|529219364|FG000|Induction|Withdrawal by Subject|3|||
146739719|NCT01515189|529219365|FG001|Induction|Withdrawal by Subject|9|||
146739720|NCT01515189|529219364|FG000|Induction|No longer meets study criteria|0|||
146739721|NCT01515189|529219365|FG001|Induction|No longer meets study criteria|2|||
146739722|NCT01515189|529219364|FG000|Induction|Lost to Follow-up|1|||
146739723|NCT01515189|529219365|FG001|Induction|Lost to Follow-up|0|||
146739724|NCT01515189|529219364|FG000|Induction|Other|0|||
146739725|NCT01515189|529219365|FG001|Induction|Other|4|||
146739726|NCT01515189|529219364|FG000|First Re-Induction Phase|Disease progression|6|||
146739727|NCT01515189|529219365|FG001|First Re-Induction Phase|Disease progression|14|||
146739728|NCT01515189|529219364|FG000|First Re-Induction Phase|Study drug toxicity|5|||
146739729|NCT01515189|529219365|FG001|First Re-Induction Phase|Study drug toxicity|0|||
146739730|NCT01515189|529219364|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
146739731|NCT01515189|529219365|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
146739732|NCT01515189|529219364|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
146739733|NCT01515189|529219365|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
146739734|NCT01515189|529219364|FG000|First Re-Induction Phase|Other|1|||
146739735|NCT01515189|529219365|FG001|First Re-Induction Phase|Other|0|||
146739736|NCT01013792|529219366|FG000|Overall Study|Study suspended|2|||
146739737|NCT01013792|529219367|FG001|Overall Study|Study suspended|1|||
146739738|NCT01013792|529219366|FG000|Overall Study|Adverse Event|0|||
146739739|NCT01013792|529219367|FG001|Overall Study|Adverse Event|3|||
146739740|NCT01013792|529219366|FG000|Overall Study|Lost to Follow-up|0|||
146739741|NCT01013792|529219367|FG001|Overall Study|Lost to Follow-up|1|||
146739742|NCT02100722|529219368|FG000|Overall Study|Withdrawal pre-procedure|4|||
146739743|NCT02100722|529219369|FG001|Overall Study|Withdrawal pre-procedure|9|||
146739744|NCT02100722|529219368|FG000|Overall Study|Withdrawal post-procedure|0|||
146739745|NCT02100722|529219369|FG001|Overall Study|Withdrawal post-procedure|3|||
146739746|NCT02100722|529219368|FG000|Overall Study|Lost to Follow-up|2|||
146739747|NCT02100722|529219369|FG001|Overall Study|Lost to Follow-up|2|||
146739748|NCT02100722|529219368|FG000|Overall Study|Continuing on study|751|||
146739749|NCT02100722|529219369|FG001|Overall Study|Continuing on study|729|||
146739750|NCT05644353|529219372|FG000|Overall Study|Physician Decision|1|||
146739751|NCT05644353|529219373|FG001|Overall Study|Physician Decision|0|||
146739752|NCT05644353|529219374|FG002|Overall Study|Physician Decision|0|||
146739753|NCT05644353|529219375|FG003|Overall Study|Physician Decision|0|||
146739754|NCT05644353|529219376|FG004|Overall Study|Physician Decision|0|||
146739755|NCT05644353|529219377|FG005|Overall Study|Physician Decision|0|||
146739756|NCT05644353|529219372|FG000|Overall Study|Protocol Violation|1|||
146739757|NCT05644353|529219373|FG001|Overall Study|Protocol Violation|0|||
146739758|NCT05644353|529219374|FG002|Overall Study|Protocol Violation|0|||
146739759|NCT05644353|529219375|FG003|Overall Study|Protocol Violation|0|||
146739760|NCT05644353|529219376|FG004|Overall Study|Protocol Violation|0|||
146739761|NCT05644353|529219377|FG005|Overall Study|Protocol Violation|0|||
146739762|NCT05644353|529219372|FG000|Overall Study|Withdrawal by Subject|0|||
146739763|NCT05644353|529219373|FG001|Overall Study|Withdrawal by Subject|2|||
146739764|NCT05644353|529219374|FG002|Overall Study|Withdrawal by Subject|0|||
146739765|NCT05644353|529219375|FG003|Overall Study|Withdrawal by Subject|0|||
146739766|NCT05644353|529219376|FG004|Overall Study|Withdrawal by Subject|1|||
146739767|NCT05644353|529219377|FG005|Overall Study|Withdrawal by Subject|0|||
146739768|NCT05644353|529219372|FG000|Overall Study|Lost to Follow-up|0|||
146739769|NCT05644353|529219373|FG001|Overall Study|Lost to Follow-up|0|||
146739770|NCT05644353|529219374|FG002|Overall Study|Lost to Follow-up|1|||
146739771|NCT05644353|529219375|FG003|Overall Study|Lost to Follow-up|0|||
146739772|NCT05644353|529219376|FG004|Overall Study|Lost to Follow-up|0|||
146739773|NCT05644353|529219377|FG005|Overall Study|Lost to Follow-up|0|||
146739774|NCT03500640|529219378|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
146739775|NCT03500640|529219379|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
146739776|NCT03500640|529219380|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
146739777|NCT03500640|529219378|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
146739778|NCT03500640|529219379|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
146739779|NCT03500640|529219380|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
146739780|NCT03500640|529219378|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
146739781|NCT03500640|529219379|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
146739782|NCT03500640|529219380|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
146739783|NCT03500640|529219378|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
146739784|NCT03500640|529219379|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
146739785|NCT03500640|529219380|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
146739786|NCT03500640|529219378|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
146739787|NCT03500640|529219379|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
146739788|NCT03500640|529219380|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
146739789|NCT03500640|529219378|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
146739790|NCT03500640|529219379|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
146739791|NCT03500640|529219380|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
146739792|NCT03500640|529219378|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
146739793|NCT03500640|529219379|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
146739794|NCT03500640|529219380|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
146739795|NCT03500640|529219378|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
146739796|NCT03500640|529219379|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
146739797|NCT03500640|529219380|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
146739798|NCT03500640|529219378|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
146739799|NCT03500640|529219379|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
146739800|NCT03500640|529219380|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
146739801|NCT03500640|529219378|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
146739802|NCT03500640|529219379|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
146739803|NCT03500640|529219380|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
146739804|NCT01555164|529219391|FG000|Overall Study|Adverse Event|5|||
146739805|NCT01555164|529219392|FG001|Overall Study|Adverse Event|7|||
146739806|NCT01555164|529219391|FG000|Overall Study|Hyperglycemia|0|||
146739807|NCT01555164|529219392|FG001|Overall Study|Hyperglycemia|1|||
146739808|NCT01555164|529219391|FG000|Overall Study|Investigator's Discretion|2|||
146739809|NCT01555164|529219392|FG001|Overall Study|Investigator's Discretion|2|||
146739810|NCT01555164|529219391|FG000|Overall Study|Lost to Follow-up|4|||
146739811|NCT01555164|529219392|FG001|Overall Study|Lost to Follow-up|3|||
146739812|NCT01555164|529219391|FG000|Overall Study|Protocol Violation|9|||
146739813|NCT01555164|529219392|FG001|Overall Study|Protocol Violation|5|||
146739814|NCT01555164|529219391|FG000|Overall Study|Subject Non-compliance|14|||
146739815|NCT01555164|529219392|FG001|Overall Study|Subject Non-compliance|6|||
146739816|NCT01555164|529219391|FG000|Overall Study|Subject Withdrew Consent|6|||
146739817|NCT01555164|529219392|FG001|Overall Study|Subject Withdrew Consent|11|||
146739818|NCT03443713|529219393|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
146739819|NCT03443713|529219394|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
146739820|NCT03443713|529219395|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
146739821|NCT01672853|529219400|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
146739822|NCT01672853|529219401|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
146739823|NCT01672853|529219402|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
146739824|NCT01672853|529219400|FG000|Overall Study|Pregnancy|0|||
146739825|NCT01672853|529219401|FG001|Overall Study|Pregnancy|1|||
146739826|NCT01672853|529219402|FG002|Overall Study|Pregnancy|0|||
146739827|NCT01672853|529219400|FG000|Overall Study|Investigator's Discretion|1|||
146739828|NCT01672853|529219401|FG001|Overall Study|Investigator's Discretion|0|||
146739829|NCT01672853|529219402|FG002|Overall Study|Investigator's Discretion|0|||
146739830|NCT01672853|529219400|FG000|Overall Study|Withdrew Consent|5|||
146739831|NCT01672853|529219401|FG001|Overall Study|Withdrew Consent|5|||
146739832|NCT01672853|529219402|FG002|Overall Study|Withdrew Consent|5|||
146739833|NCT01672853|529219400|FG000|Overall Study|Adverse Event|4|||
146739834|NCT01672853|529219401|FG001|Overall Study|Adverse Event|6|||
146739835|NCT01672853|529219402|FG002|Overall Study|Adverse Event|8|||
146739836|NCT01672853|529219400|FG000|Overall Study|Lost to Follow-up|0|||
146739837|NCT01672853|529219401|FG001|Overall Study|Lost to Follow-up|1|||
146739838|NCT01672853|529219402|FG002|Overall Study|Lost to Follow-up|0|||
146739839|NCT01672853|529219400|FG000|Overall Study|Randomized but Never Treated|0|||
146739840|NCT01672853|529219401|FG001|Overall Study|Randomized but Never Treated|0|||
146739841|NCT01672853|529219402|FG002|Overall Study|Randomized but Never Treated|1|||
146739842|NCT02969525|529219405|FG000|Double-Blind Period|Adverse Event|0|||
146739843|NCT02969525|529219406|FG001|Double-Blind Period|Adverse Event|0|||
146739844|NCT02969525|529219407|FG002|Double-Blind Period|Adverse Event|1|||
146739845|NCT02969525|529219408|FG003|Double-Blind Period|Adverse Event|1|||
146739846|NCT02969525|529219409|FG004|Double-Blind Period|Adverse Event|0|||
146739847|NCT02969525|529219410|FG005|Double-Blind Period|Adverse Event|0|||
146739848|NCT02969525|529219411|FG006|Double-Blind Period|Adverse Event|0|||
146739849|NCT02969525|529219412|FG007|Double-Blind Period|Adverse Event|0|||
146739850|NCT02969525|529219413|FG008|Double-Blind Period|Adverse Event|0|||
146739851|NCT02969525|529219414|FG009|Double-Blind Period|Adverse Event|0|||
146739852|NCT02969525|529219415|FG010|Double-Blind Period|Adverse Event|0|||
146739853|NCT02969525|529219416|FG011|Double-Blind Period|Adverse Event|0|||
146739854|NCT02969525|529219405|FG000|Double-Blind Period|LOW EGFR|0|||
146739855|NCT02969525|529219406|FG001|Double-Blind Period|LOW EGFR|0|||
146739856|NCT02969525|529219407|FG002|Double-Blind Period|LOW EGFR|0|||
146739857|NCT02969525|529219408|FG003|Double-Blind Period|LOW EGFR|1|||
146739858|NCT02969525|529219409|FG004|Double-Blind Period|LOW EGFR|0|||
146739859|NCT02969525|529219410|FG005|Double-Blind Period|LOW EGFR|0|||
146739860|NCT02969525|529219411|FG006|Double-Blind Period|LOW EGFR|0|||
146739861|NCT02969525|529219412|FG007|Double-Blind Period|LOW EGFR|0|||
146739862|NCT02969525|529219413|FG008|Double-Blind Period|LOW EGFR|0|||
146739863|NCT02969525|529219414|FG009|Double-Blind Period|LOW EGFR|0|||
146739864|NCT02969525|529219415|FG010|Double-Blind Period|LOW EGFR|0|||
146739865|NCT02969525|529219416|FG011|Double-Blind Period|LOW EGFR|0|||
146739866|NCT02969525|529219405|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
146739867|NCT02969525|529219406|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146739868|NCT02969525|529219407|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146770078|NCT03516942|529326679|FG000|T1: 3 Months Survey|Death|10|||
146739869|NCT02969525|529219408|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
146739870|NCT02969525|529219409|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146739871|NCT02969525|529219410|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146739872|NCT02969525|529219411|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146739873|NCT02969525|529219412|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146739874|NCT02969525|529219413|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146739875|NCT02969525|529219414|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146739876|NCT02969525|529219415|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146739877|NCT02969525|529219416|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146739878|NCT02969525|529219405|FG000|Dose-Blind Period|Adverse Event|0|||
146739879|NCT02969525|529219406|FG001|Dose-Blind Period|Adverse Event|0|||
146739880|NCT02969525|529219407|FG002|Dose-Blind Period|Adverse Event|0|||
146739881|NCT02969525|529219408|FG003|Dose-Blind Period|Adverse Event|0|||
146739882|NCT02969525|529219409|FG004|Dose-Blind Period|Adverse Event|0|||
146739883|NCT02969525|529219410|FG005|Dose-Blind Period|Adverse Event|0|||
146739884|NCT02969525|529219411|FG006|Dose-Blind Period|Adverse Event|0|||
146739885|NCT02969525|529219412|FG007|Dose-Blind Period|Adverse Event|0|||
146739886|NCT02969525|529219413|FG008|Dose-Blind Period|Adverse Event|0|||
146739887|NCT02969525|529219414|FG009|Dose-Blind Period|Adverse Event|1|||
146739888|NCT02969525|529219415|FG010|Dose-Blind Period|Adverse Event|1|||
146739889|NCT02969525|529219416|FG011|Dose-Blind Period|Adverse Event|1|||
146739890|NCT02969525|529219405|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
146739891|NCT02969525|529219406|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
146739892|NCT02969525|529219407|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
146739893|NCT02969525|529219408|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
146739894|NCT02969525|529219409|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
146739895|NCT02969525|529219410|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
146739896|NCT02969525|529219411|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
146739897|NCT02969525|529219412|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
146739898|NCT02969525|529219413|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
146739899|NCT02969525|529219414|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
146739900|NCT02969525|529219415|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
146739901|NCT02969525|529219416|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
146739902|NCT02969525|529219405|FG000|Dose-Blind Period|Non-cooperating patient|0|||
146739903|NCT02969525|529219406|FG001|Dose-Blind Period|Non-cooperating patient|0|||
146739904|NCT02969525|529219407|FG002|Dose-Blind Period|Non-cooperating patient|0|||
146739905|NCT02969525|529219408|FG003|Dose-Blind Period|Non-cooperating patient|0|||
146739906|NCT02969525|529219409|FG004|Dose-Blind Period|Non-cooperating patient|0|||
146739907|NCT02969525|529219410|FG005|Dose-Blind Period|Non-cooperating patient|0|||
146739908|NCT02969525|529219411|FG006|Dose-Blind Period|Non-cooperating patient|0|||
146739909|NCT02969525|529219412|FG007|Dose-Blind Period|Non-cooperating patient|0|||
146739910|NCT02969525|529219413|FG008|Dose-Blind Period|Non-cooperating patient|0|||
146739911|NCT02969525|529219414|FG009|Dose-Blind Period|Non-cooperating patient|0|||
146739912|NCT02969525|529219415|FG010|Dose-Blind Period|Non-cooperating patient|0|||
146739913|NCT02969525|529219416|FG011|Dose-Blind Period|Non-cooperating patient|1|||
146739914|NCT02969525|529219405|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146739915|NCT02969525|529219406|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146739916|NCT02969525|529219407|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146739917|NCT02969525|529219408|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146739918|NCT02969525|529219409|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146739919|NCT02969525|529219410|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146739920|NCT02969525|529219411|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146739921|NCT02969525|529219412|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146739922|NCT02969525|529219413|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146739923|NCT02969525|529219414|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146739924|NCT02969525|529219415|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
146739925|NCT02969525|529219416|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146739926|NCT03445065|529219417|FG000|Overall Study|Withdrawal by Subject|3|||
146739927|NCT03445065|529219418|FG001|Overall Study|Withdrawal by Subject|6|||
146739928|NCT03445065|529219419|FG002|Overall Study|Withdrawal by Subject|2|||
146739929|NCT03445065|529219420|FG003|Overall Study|Withdrawal by Subject|2|||
146739930|NCT03445065|529219417|FG000|Overall Study|Other|4|||
146739931|NCT03445065|529219418|FG001|Overall Study|Other|3|||
146739932|NCT03445065|529219419|FG002|Overall Study|Other|3|||
146739933|NCT03445065|529219420|FG003|Overall Study|Other|1|||
146739934|NCT01598298|529219421|FG000|Overall Study|Not eligible|5|||
146739935|NCT01598298|529219422|FG001|Overall Study|Not eligible|5|||
146739936|NCT01598298|529219421|FG000|Overall Study|Adverse Event|21|||
146739937|NCT01598298|529219422|FG001|Overall Study|Adverse Event|19|||
146739938|NCT01598298|529219421|FG000|Overall Study|Progression/relapse|0|||
146739939|NCT01598298|529219422|FG001|Overall Study|Progression/relapse|2|||
146739940|NCT01598298|529219421|FG000|Overall Study|Withdrawal by Subject|10|||
146739941|NCT01598298|529219422|FG001|Overall Study|Withdrawal by Subject|15|||
146739942|NCT01598298|529219421|FG000|Overall Study|Other reason (not protocol specified)|4|||
146739943|NCT01598298|529219422|FG001|Overall Study|Other reason (not protocol specified)|0|||
146739944|NCT04567693|529220880|FG000|Overall Study|Death|0|||
146739945|NCT04567693|529220881|FG001|Overall Study|Death|0|||
146739946|NCT04567693|529220882|FG002|Overall Study|Death|2|||
146739947|NCT04567693|529220880|FG000|Overall Study|Lost to Follow-up|1|||
146739948|NCT04567693|529220881|FG001|Overall Study|Lost to Follow-up|0|||
146739949|NCT04567693|529220882|FG002|Overall Study|Lost to Follow-up|2|||
146739950|NCT04567693|529220880|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
146739951|NCT04567693|529220881|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
146739952|NCT04567693|529220882|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
146739953|NCT00976482|529220885|FG000|Overall Study|Death|208|||
146739954|NCT00976482|529220885|FG000|Overall Study|Withdrawal by Subject|45|||
146739955|NCT00976482|529220885|FG000|Overall Study|Center terminated|1|||
146739956|NCT00976482|529220885|FG000|Overall Study|Protocol Violation|5|||
146739957|NCT03722264|529220888|FG000|Overall Study|Physician Decision|3|||
146739958|NCT00720902|529220889|FG000|Overall Study|Withdrawal by Subject|1|||
146739959|NCT00720902|529220890|FG001|Overall Study|Withdrawal by Subject|0|||
146739960|NCT00720902|529220889|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
146739961|NCT00720902|529220890|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
146739962|NCT02959671|529220891|FG000|Overall Study|Adverse Event|2|||
146739963|NCT02959671|529220891|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
146739964|NCT03462706|529220894|FG000|Overall Study|Polyp was pedunculated|1|||
146739965|NCT03462706|529220895|FG001|Overall Study|Polyp was pedunculated|0|||
146739966|NCT03462706|529220896|FG002|Overall Study|Polyp was pedunculated|1|||
146739967|NCT03462706|529220897|FG003|Overall Study|Polyp was pedunculated|0|||
146739968|NCT03462706|529220894|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
146739969|NCT03462706|529220895|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
146739970|NCT03462706|529220896|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
146739971|NCT03462706|529220897|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
146739972|NCT04105972|529220908|FG000|Overall Study|Adverse Event|2|||
146739973|NCT04105972|529220909|FG001|Overall Study|Adverse Event|1|||
146739974|NCT00553202|529220912|FG000|Overall Study|Death|16|||
146739975|NCT00553202|529220912|FG000|Overall Study|Lost to Follow-up|1|||
146739976|NCT00553202|529220912|FG000|Overall Study|Physician Decision|28|||
146739977|NCT00553202|529220912|FG000|Overall Study|Withdrawal by Subject|1|||
146739978|NCT00553202|529220912|FG000|Overall Study|No donor identified|16|||
146739979|NCT00553202|529220912|FG000|Overall Study|Fails to meet organ function|6|||
146739980|NCT01161472|529220914|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
146739981|NCT01161472|529220915|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
146739982|NCT01161472|529220916|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
146739983|NCT01161472|529220917|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
146739984|NCT00798174|529220919|FG000|Overall Study|inability to implant azygos coil|3|||
146739985|NCT00798174|529220920|FG001|Overall Study|inability to implant azygos coil|3|||
146739986|NCT00798174|529220919|FG000|Overall Study|Inability to sedate for DFT testing|1|||
146739987|NCT00798174|529220920|FG001|Overall Study|Inability to sedate for DFT testing|0|||
146739988|NCT00802659|529220921|FG000|Overall Study|Physician Decision|0|||
146739989|NCT00802659|529220922|FG001|Overall Study|Physician Decision|1|||
146739990|NCT00802659|529220923|FG002|Overall Study|Physician Decision|0|||
146739991|NCT00802659|529220924|FG003|Overall Study|Physician Decision|0|||
146739992|NCT03093428|529220925|FG000|Overall Study|Not eligible for treatment|2|||
146739993|NCT03093428|529220926|FG001|Overall Study|Not eligible for treatment|1|||
146739994|NCT03093428|529220925|FG000|Overall Study|Progression|14|||
146739995|NCT03093428|529220926|FG001|Overall Study|Progression|4|||
146739996|NCT03093428|529220925|FG000|Overall Study|Death|1|||
146739997|NCT03093428|529220926|FG001|Overall Study|Death|0|||
146739998|NCT03093428|529220925|FG000|Overall Study|Adverse Event|1|||
146739999|NCT03093428|529220926|FG001|Overall Study|Adverse Event|0|||
146740000|NCT03093428|529220925|FG000|Overall Study|Withdrawal by Subject|1|||
146740001|NCT03093428|529220926|FG001|Overall Study|Withdrawal by Subject|1|||
146740002|NCT00041756|529220927|FG000|Overall Study|Adverse Event|4|||
146740003|NCT00041756|529220928|FG001|Overall Study|Adverse Event|10|||
146740004|NCT00041756|529220929|FG002|Overall Study|Adverse Event|6|||
146740005|NCT00041756|529220930|FG003|Overall Study|Adverse Event|11|||
146740006|NCT00041756|529220931|FG004|Overall Study|Adverse Event|34|||
146740007|NCT00041756|529220927|FG000|Overall Study|Protocol Violation|1|||
146740008|NCT00041756|529220928|FG001|Overall Study|Protocol Violation|1|||
146740009|NCT00041756|529220929|FG002|Overall Study|Protocol Violation|2|||
146740010|NCT00041756|529220930|FG003|Overall Study|Protocol Violation|2|||
146740011|NCT00041756|529220931|FG004|Overall Study|Protocol Violation|1|||
146740012|NCT00041756|529220927|FG000|Overall Study|Withdrawal by Subject|3|||
146740013|NCT00041756|529220928|FG001|Overall Study|Withdrawal by Subject|3|||
146740014|NCT00041756|529220929|FG002|Overall Study|Withdrawal by Subject|4|||
146740015|NCT00041756|529220930|FG003|Overall Study|Withdrawal by Subject|2|||
146740016|NCT00041756|529220931|FG004|Overall Study|Withdrawal by Subject|3|||
146740017|NCT00041756|529220927|FG000|Overall Study|Lost to Follow-up|0|||
146740018|NCT00041756|529220928|FG001|Overall Study|Lost to Follow-up|1|||
146740019|NCT00041756|529220929|FG002|Overall Study|Lost to Follow-up|0|||
146740020|NCT00041756|529220930|FG003|Overall Study|Lost to Follow-up|1|||
146740021|NCT00041756|529220931|FG004|Overall Study|Lost to Follow-up|0|||
146740022|NCT00041756|529220927|FG000|Overall Study|Unable to meet protocol criteria|0|||
146740023|NCT00041756|529220928|FG001|Overall Study|Unable to meet protocol criteria|0|||
146740024|NCT00041756|529220929|FG002|Overall Study|Unable to meet protocol criteria|1|||
146740025|NCT00041756|529220930|FG003|Overall Study|Unable to meet protocol criteria|0|||
146740026|NCT00041756|529220931|FG004|Overall Study|Unable to meet protocol criteria|1|||
146740027|NCT00041756|529220927|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
146740028|NCT00041756|529220928|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
146740029|NCT00041756|529220929|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
146740030|NCT00041756|529220930|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
146625084|NCT00537394|528801580|FG000|2nd Year of Follow-up|Clinic site closure|1|||
146509002|NCT02304380|528367710|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
146509003|NCT00328094|528367711|FG000|Overall Study|Physician Decision|3|||
146509004|NCT00328094|528367712|FG001|Overall Study|Physician Decision|3|||
146509005|NCT01911780|528367713|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
146509006|NCT01911780|528367714|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
146509007|NCT01911780|528367713|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
146509008|NCT01911780|528367714|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
146509009|NCT01911780|528367713|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
146509010|NCT01911780|528367714|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
146509011|NCT01911780|528367713|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
146509012|NCT01911780|528367714|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
146509013|NCT01911780|528367713|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
146509014|NCT01911780|528367714|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
146509015|NCT01911780|528367713|FG000|Extension Period (52 Weeks)|Personal reason|1|||
146509016|NCT01911780|528367714|FG001|Extension Period (52 Weeks)|Personal reason|1|||
146509017|NCT00985426|528367715|FG000|Overall Study|Adverse Event|0|||
146509018|NCT00985426|528367716|FG001|Overall Study|Adverse Event|1|||
146509019|NCT00985426|528367715|FG000|Overall Study|Subject Non-Compliance|3|||
146509020|NCT00985426|528367716|FG001|Overall Study|Subject Non-Compliance|3|||
146509021|NCT00985426|528367715|FG000|Overall Study|Withdrawal by Subject|12|||
146509022|NCT00985426|528367716|FG001|Overall Study|Withdrawal by Subject|16|||
146509023|NCT00985426|528367715|FG000|Overall Study|Lost to Follow-up|8|||
146509024|NCT00985426|528367716|FG001|Overall Study|Lost to Follow-up|10|||
146509025|NCT00985426|528367715|FG000|Overall Study|Death|7|||
146509026|NCT00985426|528367716|FG001|Overall Study|Death|3|||
146509027|NCT00985426|528367715|FG000|Overall Study|Protocol Violation|2|||
146509028|NCT00985426|528367716|FG001|Overall Study|Protocol Violation|0|||
146509029|NCT00985426|528367715|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
146509030|NCT00985426|528367716|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
146509031|NCT01661933|528367717|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
146509032|NCT01661933|528367717|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
146509033|NCT02052596|528367718|FG000|Active Phase|Adverse Event|3|||
146509034|NCT02052596|528367719|FG001|Active Phase|Adverse Event|2|||
146509035|NCT02052596|528367718|FG000|Active Phase|Lost to Follow-up|8|||
146509036|NCT02052596|528367719|FG001|Active Phase|Lost to Follow-up|11|||
146509037|NCT02052596|528367718|FG000|Active Phase|Protocol Violation|1|||
146509038|NCT02052596|528367719|FG001|Active Phase|Protocol Violation|2|||
146770079|NCT03516942|529326679|FG000|T1: 3 Months Survey|Lost|163|||
146851163|NCT00852540|529624124|FG001|Overall Study|Investigator Discretion|3|||
146851164|NCT00852540|529624123|FG000|Overall Study|Withdrawal by Subject|3|||
146851165|NCT00852540|529624124|FG001|Overall Study|Withdrawal by Subject|1|||
146509809|NCT02000882|528371853|FG000|Overall Study|Withdrawal by Subject|1|||
146509810|NCT00549601|528371854|FG000|Randomized|Protocol Violation|0|||
146509811|NCT00549601|528371855|FG001|Randomized|Protocol Violation|0|||
146509812|NCT00549601|528371856|FG002|Randomized|Protocol Violation|1|||
146740031|NCT00041756|529220931|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
146509813|NCT00549601|528371854|FG000|Randomized|Withdrawal by Subject|0|||
146509814|NCT00549601|528371855|FG001|Randomized|Withdrawal by Subject|1|||
146509815|NCT00549601|528371856|FG002|Randomized|Withdrawal by Subject|1|||
146740032|NCT00067990|529220932|FG000|Overall Study|Death|5|||
146625085|NCT00537394|528801581|FG001|2nd Year of Follow-up|Clinic site closure|0|||
146625086|NCT00537394|528801582|FG002|2nd Year of Follow-up|Clinic site closure|0|||
146625087|NCT04764162|528801584|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
146625088|NCT04764162|528801585|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
146625089|NCT05556265|528801586|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
146625090|NCT05556265|528801587|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
146625091|NCT05556265|528801588|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
146625092|NCT05556265|528801589|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
146625093|NCT05556265|528801590|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
146740033|NCT00067990|529220933|FG001|Overall Study|Death|7|||
146740034|NCT00067990|529220932|FG000|Overall Study|ESRD, Non IF/TA|1|||
146740035|NCT00067990|529220933|FG001|Overall Study|ESRD, Non IF/TA|3|||
146740036|NCT00067990|529220932|FG000|Overall Study|Withdrawal by Subject|4|||
146740037|NCT00067990|529220933|FG001|Overall Study|Withdrawal by Subject|12|||
146740038|NCT02176421|529220936|FG000|Overall Study|Lost to Follow-up|4|||
146740039|NCT02176421|529220936|FG000|Overall Study|Adverse Event|1|||
146740040|NCT01111838|529220943|FG000|Overall Study|Patient Ineligible|2|||
146740041|NCT01111838|529220943|FG000|Overall Study|Not Treated|3|||
146740042|NCT01111838|529220943|FG000|Overall Study|Clinical deterioration|1|||
146740043|NCT01111838|529220943|FG000|Overall Study|Other Complicating Disease|1|||
146740044|NCT01872910|529220947|FG000|Overall Study|Lost to Follow-up|2|||
146740045|NCT01872910|529220948|FG001|Overall Study|Lost to Follow-up|0|||
146740046|NCT01872910|529220949|FG002|Overall Study|Lost to Follow-up|2|||
146740047|NCT01872910|529220950|FG003|Overall Study|Lost to Follow-up|0|||
146740048|NCT01872910|529220951|FG004|Overall Study|Lost to Follow-up|0|||
146740049|NCT01872910|529220952|FG005|Overall Study|Lost to Follow-up|0|||
146740050|NCT01540565|529220953|FG000|Overall Study|Ineligible|2|||
146740051|NCT02091739|529220954|FG000|MP: 16 Weeks|Adverse Event|1|||
146740052|NCT02091739|529220955|FG001|MP: 16 Weeks|Adverse Event|1|||
146740053|NCT02091739|529220956|FG002|MP: 16 Weeks|Adverse Event|1|||
146740054|NCT02091739|529220957|FG003|MP: 16 Weeks|Adverse Event|0|||
146740055|NCT02091739|529220958|FG004|MP: 16 Weeks|Adverse Event|0|||
146740056|NCT02091739|529220954|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
146740057|NCT02091739|529220955|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
146740058|NCT02091739|529220956|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
146740059|NCT02091739|529220957|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
146740060|NCT02091739|529220958|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
146740061|NCT02091739|529220954|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
146740062|NCT02091739|529220955|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
146740063|NCT02091739|529220956|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
146740064|NCT02091739|529220957|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
146740065|NCT02091739|529220958|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
146740066|NCT02091739|529220954|FG000|EP: 48 Weeks|Other|0|||
146740067|NCT02091739|529220955|FG001|EP: 48 Weeks|Other|0|||
146740068|NCT02091739|529220956|FG002|EP: 48 Weeks|Other|0|||
146740069|NCT02091739|529220957|FG003|EP: 48 Weeks|Other|1|||
146740070|NCT02091739|529220958|FG004|EP: 48 Weeks|Other|0|||
146740071|NCT02091739|529220954|FG000|EP: 48 Weeks|Death|0|||
146740072|NCT02091739|529220955|FG001|EP: 48 Weeks|Death|0|||
146740073|NCT02091739|529220956|FG002|EP: 48 Weeks|Death|0|||
146740074|NCT02091739|529220957|FG003|EP: 48 Weeks|Death|3|||
146740075|NCT02091739|529220958|FG004|EP: 48 Weeks|Death|2|||
146740076|NCT02091739|529220954|FG000|EP: 48 Weeks|Adverse Event|0|||
146740077|NCT02091739|529220955|FG001|EP: 48 Weeks|Adverse Event|0|||
146740078|NCT02091739|529220956|FG002|EP: 48 Weeks|Adverse Event|0|||
146740079|NCT02091739|529220957|FG003|EP: 48 Weeks|Adverse Event|2|||
146740080|NCT02091739|529220958|FG004|EP: 48 Weeks|Adverse Event|6|||
146740081|NCT02091739|529220954|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
146740082|NCT02091739|529220955|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
146740083|NCT02091739|529220956|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
146740084|NCT02091739|529220957|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
146740085|NCT02091739|529220958|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
146740086|NCT03469349|529220959|FG000|Overall Study|Withdrawal by Subject|1|||
146740087|NCT03469349|529220960|FG001|Overall Study|Withdrawal by Subject|3|||
146740088|NCT03469349|529220959|FG000|Overall Study|Progressive Disease|0|||
146740089|NCT03469349|529220960|FG001|Overall Study|Progressive Disease|1|||
146740090|NCT03469349|529220959|FG000|Overall Study|Lost to Follow-up|2|||
146740091|NCT03469349|529220960|FG001|Overall Study|Lost to Follow-up|2|||
146740092|NCT03469349|529220959|FG000|Overall Study|Adverse Event|2|||
146740093|NCT03469349|529220960|FG001|Overall Study|Adverse Event|4|||
146740094|NCT02086162|529220963|FG000|Overall Study|Withdrawal by Subject|4|||
146740095|NCT02086162|529220964|FG001|Overall Study|Withdrawal by Subject|4|||
146740096|NCT02086162|529220963|FG000|Overall Study|moved|1|||
146740097|NCT02086162|529220964|FG001|Overall Study|moved|1|||
146740098|NCT02086162|529220963|FG000|Overall Study|Lost to Follow-up|4|||
146740099|NCT02086162|529220964|FG001|Overall Study|Lost to Follow-up|2|||
146740100|NCT02086162|529220963|FG000|Overall Study|Death|1|||
146740101|NCT02086162|529220964|FG001|Overall Study|Death|0|||
146740102|NCT01827254|529220968|FG000|Overall Study|Death|10|||
146740103|NCT01827254|529220968|FG000|Overall Study|Case report form not completed|4|||
146740104|NCT01827254|529220968|FG000|Overall Study|Invalidated centre|3|||
146740105|NCT01827254|529220968|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
146740106|NCT01827254|529220968|FG000|Overall Study|Did not complete re-challenge|1|||
146740107|NCT01827254|529220968|FG000|Overall Study|Disease progression|36|||
146740108|NCT01827254|529220968|FG000|Overall Study|Intolerance to treatment|4|||
146740109|NCT01834222|529220969|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
146740110|NCT00692406|529220975|FG000|Overall Study|PI dropped, bad data|57|||
146740111|NCT04599101|529220980|FG000|Overall Study|Lost to Follow-up|5|||
146740112|NCT04599101|529220981|FG001|Overall Study|Lost to Follow-up|5|||
146740113|NCT00525265|529220986|FG000|Overall Study|Protocol Violation|1|||
146740114|NCT00525265|529220987|FG001|Overall Study|Protocol Violation|0|||
146740115|NCT01913639|529220988|FG000|Overall Study|Not Eligible|3|||
146740116|NCT02541383|529220989|FG000|Overall Study|Death|50|||
146740117|NCT02541383|529220990|FG001|Overall Study|Death|37|||
146740118|NCT02541383|529220991|FG002|Overall Study|Death|48|||
146740119|NCT02541383|529220992|FG003|Overall Study|Death|41|||
146740120|NCT02541383|529220993|FG004|Overall Study|Death|21|||
146740121|NCT02541383|529220994|FG005|Overall Study|Death|25|||
146740122|NCT02541383|529220989|FG000|Overall Study|Lost to Follow-up|5|||
146625094|NCT05556265|528801586|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
146625095|NCT05556265|528801587|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
146625096|NCT05556265|528801588|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
146625097|NCT05556265|528801589|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
146625098|NCT05556265|528801590|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
146625099|NCT05556265|528801586|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
146625100|NCT05556265|528801587|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
146625101|NCT05556265|528801588|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
146625102|NCT05556265|528801589|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
146625103|NCT05556265|528801590|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
146625104|NCT05556265|528801586|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
146625105|NCT05556265|528801587|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
146625106|NCT05556265|528801588|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
146625107|NCT05556265|528801589|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
146625108|NCT05556265|528801590|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
146625109|NCT05556265|528801586|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
146625110|NCT05556265|528801587|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
146625111|NCT05556265|528801588|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
146625112|NCT05556265|528801589|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
146625113|NCT05556265|528801590|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
146625114|NCT05556265|528801586|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
146625115|NCT05556265|528801587|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
146625116|NCT05556265|528801588|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
146625117|NCT05556265|528801589|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
146625118|NCT05556265|528801590|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
146625119|NCT05556265|528801586|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
146625120|NCT05556265|528801587|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
146625121|NCT05556265|528801588|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
146625122|NCT05556265|528801589|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
146625123|NCT05556265|528801590|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
146625124|NCT05556265|528801586|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
146625125|NCT05556265|528801587|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
146625126|NCT05556265|528801588|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
146625127|NCT05556265|528801589|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
146625128|NCT05556265|528801590|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
146625129|NCT05556265|528801586|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
146740123|NCT02541383|529220990|FG001|Overall Study|Lost to Follow-up|3|||
146740124|NCT02541383|529220991|FG002|Overall Study|Lost to Follow-up|1|||
146740125|NCT02541383|529220992|FG003|Overall Study|Lost to Follow-up|1|||
146740126|NCT02541383|529220993|FG004|Overall Study|Lost to Follow-up|3|||
146740127|NCT02541383|529220994|FG005|Overall Study|Lost to Follow-up|0|||
146740128|NCT02541383|529220989|FG000|Overall Study|Consent withdrawn|5|||
146740129|NCT02541383|529220990|FG001|Overall Study|Consent withdrawn|6|||
146740130|NCT02541383|529220991|FG002|Overall Study|Consent withdrawn|1|||
146740131|NCT02541383|529220992|FG003|Overall Study|Consent withdrawn|1|||
146740132|NCT02541383|529220993|FG004|Overall Study|Consent withdrawn|0|||
146740133|NCT02541383|529220994|FG005|Overall Study|Consent withdrawn|0|||
146740134|NCT02541383|529220989|FG000|Overall Study|Sponsor's decision|1|||
146740135|NCT02541383|529220990|FG001|Overall Study|Sponsor's decision|1|||
146740136|NCT02541383|529220991|FG002|Overall Study|Sponsor's decision|0|||
146740137|NCT02541383|529220992|FG003|Overall Study|Sponsor's decision|0|||
146740138|NCT02541383|529220993|FG004|Overall Study|Sponsor's decision|0|||
146740139|NCT02541383|529220994|FG005|Overall Study|Sponsor's decision|0|||
146740140|NCT04395183|529221000|FG000|Overall Study|Withdrawal by Subject|1|||
146740141|NCT04395183|529221001|FG001|Overall Study|Withdrawal by Subject|0|||
146740142|NCT04395183|529221002|FG002|Overall Study|Withdrawal by Subject|2|||
146740143|NCT04395183|529221003|FG003|Overall Study|Withdrawal by Subject|2|||
146740144|NCT01008475|529221004|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
146740145|NCT01008475|529221005|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
146740146|NCT01008475|529221006|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
146740147|NCT01008475|529221007|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
146740148|NCT01008475|529221008|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
146740149|NCT01008475|529221009|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
146740150|NCT01008475|529221010|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
146740151|NCT02668016|529221011|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
146740152|NCT02668016|529221011|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
146740153|NCT02668016|529221011|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
146740154|NCT02668016|529221011|FG000|Month 4|Withdrawal due to severe symptoms|1|||
146740155|NCT02668016|529221011|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
146740156|NCT02668016|529221011|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
146740157|NCT02668016|529221011|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
146740158|NCT02668016|529221011|FG000|Month 6|Withdrawal due to severe symptoms|2|||
146740159|NCT02668016|529221011|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
146740160|NCT02668016|529221011|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
146740161|NCT02668016|529221011|FG000|Month 8|Withdrawal due to severe symptoms|1|||
146740162|NCT02668016|529221011|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
146740163|NCT02668016|529221011|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
146914634|NCT03303339|529850043|FG001|Overall Study|Death|2|||
146509039|NCT02052596|528367718|FG000|Active Phase|Withdrawal by Subject|3|||
146625130|NCT05556265|528801587|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
146625131|NCT05556265|528801588|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
146625132|NCT05556265|528801589|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
146625133|NCT05556265|528801590|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
146625134|NCT03980730|528801591|FG000|Overall Study|Study Terminated by Sponsor|0|||
146625135|NCT03980730|528801592|FG001|Overall Study|Study Terminated by Sponsor|3|||
146625136|NCT03980730|528801591|FG000|Overall Study|Adverse Event|2|||
146625137|NCT03980730|528801592|FG001|Overall Study|Adverse Event|0|||
146625138|NCT03980730|528801591|FG000|Overall Study|Sponsor Request|0|||
146625139|NCT03980730|528801592|FG001|Overall Study|Sponsor Request|1|||
146625140|NCT03724942|528801599|FG000|Overall Study|Adverse Event|20|||
146625141|NCT03724942|528801600|FG001|Overall Study|Adverse Event|14|||
146625142|NCT03724942|528801599|FG000|Overall Study|Lack of Efficacy|0|||
146625143|NCT03724942|528801600|FG001|Overall Study|Lack of Efficacy|1|||
146625144|NCT03724942|528801599|FG000|Overall Study|Physician Decision|5|||
146625145|NCT03724942|528801600|FG001|Overall Study|Physician Decision|2|||
146625146|NCT03724942|528801599|FG000|Overall Study|Protocol Violation|1|||
146625147|NCT03724942|528801600|FG001|Overall Study|Protocol Violation|0|||
146625148|NCT03724942|528801599|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
146625149|NCT03724942|528801600|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
146625150|NCT03724942|528801599|FG000|Overall Study|Withdrawal by Legal Representative|3|||
146625151|NCT03724942|528801600|FG001|Overall Study|Withdrawal by Legal Representative|0|||
146625152|NCT02429830|528801601|FG000|Overall Study|Lost to Follow-up|1|||
146625153|NCT02429830|528801601|FG000|Overall Study|Device Explant|2|||
146625154|NCT01352117|528803827|FG000|Overall Study|Death|15|||
146625155|NCT01352117|528803828|FG001|Overall Study|Death|16|||
146625156|NCT01352117|528803827|FG000|Overall Study|Withdrawal by Subject|1|||
146625157|NCT01352117|528803828|FG001|Overall Study|Withdrawal by Subject|0|||
146625158|NCT01352117|528803827|FG000|Overall Study|Lost to Follow-up|2|||
146625159|NCT01352117|528803828|FG001|Overall Study|Lost to Follow-up|7|||
146625160|NCT01352117|528803827|FG000|Overall Study|Non-adherent to study requirements|1|||
146625161|NCT01352117|528803828|FG001|Overall Study|Non-adherent to study requirements|1|||
146625162|NCT01352117|528803827|FG000|Overall Study|Did not initiate study treatment|1|||
146625163|NCT01352117|528803828|FG001|Overall Study|Did not initiate study treatment|0|||
146625164|NCT01352117|528803827|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
146625165|NCT01352117|528803828|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
146625166|NCT01766050|528803829|FG000|Overall Study|Adverse Event|1|||
146625167|NCT01766050|528803829|FG000|Overall Study|Lost to Follow-up|1|||
146625168|NCT01766050|528803829|FG000|Overall Study|Withdrawal by Subject|2|||
146625169|NCT02081677|528803831|FG000|Overall Study|Adverse Event|0|||
146625170|NCT02081677|528803832|FG001|Overall Study|Adverse Event|0|||
146625171|NCT02081677|528803833|FG002|Overall Study|Adverse Event|1|||
146625172|NCT02081677|528803834|FG003|Overall Study|Adverse Event|0|||
146625173|NCT02081677|528803831|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
146625174|NCT02081677|528803832|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146625175|NCT02081677|528803833|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
146625176|NCT02081677|528803834|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
146625177|NCT02081677|528803831|FG000|Overall Study|Not comfortable with lens care system|1|||
146740164|NCT02668016|529221011|FG000|Month 10|Withdrawal due to severe symptoms|1|||
146740165|NCT02668016|529221011|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
146740166|NCT01657266|529221015|FG000|Overall Study|Lost to Follow-up|2|||
146740167|NCT01657266|529221016|FG001|Overall Study|Lost to Follow-up|2|||
146740168|NCT01657266|529221015|FG000|Overall Study|Adverse Event|2|||
146740169|NCT01657266|529221016|FG001|Overall Study|Adverse Event|3|||
146740170|NCT01122381|529221023|FG000|Overall Study|study terminated early|0|||
146740171|NCT01122381|529221024|FG001|Overall Study|study terminated early|1|||
146740172|NCT00736489|529221025|FG000|Period 1|Lost to Follow-up|1|||
146740173|NCT00736489|529221026|FG001|Period 1|Lost to Follow-up|0|||
146740174|NCT00736489|529221027|FG002|Period 1|Lost to Follow-up|0|||
146740175|NCT00736489|529221028|FG003|Period 1|Lost to Follow-up|0|||
146740176|NCT00736489|529221029|FG004|Period 1|Lost to Follow-up|0|||
146740177|NCT00736489|529221030|FG005|Period 1|Lost to Follow-up|0|||
146740178|NCT00736489|529221025|FG000|Period 1|Withdrawal by Subject|0|||
146740179|NCT00736489|529221026|FG001|Period 1|Withdrawal by Subject|0|||
146740180|NCT00736489|529221027|FG002|Period 1|Withdrawal by Subject|0|||
146740181|NCT00736489|529221028|FG003|Period 1|Withdrawal by Subject|0|||
146740182|NCT00736489|529221029|FG004|Period 1|Withdrawal by Subject|0|||
146740183|NCT00736489|529221030|FG005|Period 1|Withdrawal by Subject|1|||
146740184|NCT02395133|529221035|FG000|Overall Study|Adverse Event|4|||
146740185|NCT02395133|529221036|FG001|Overall Study|Adverse Event|1|||
146740186|NCT02395133|529221037|FG002|Overall Study|Adverse Event|3|||
146740187|NCT02395133|529221038|FG003|Overall Study|Adverse Event|0|||
146740188|NCT02395133|529221035|FG000|Overall Study|Lack of Efficacy|1|||
146740189|NCT02395133|529221036|FG001|Overall Study|Lack of Efficacy|0|||
146740190|NCT02395133|529221037|FG002|Overall Study|Lack of Efficacy|1|||
146740191|NCT02395133|529221038|FG003|Overall Study|Lack of Efficacy|1|||
146740192|NCT02395133|529221035|FG000|Overall Study|Protocol Violation|1|||
146740193|NCT02395133|529221036|FG001|Overall Study|Protocol Violation|1|||
146740194|NCT02395133|529221037|FG002|Overall Study|Protocol Violation|0|||
146740195|NCT02395133|529221038|FG003|Overall Study|Protocol Violation|3|||
146740196|NCT02395133|529221035|FG000|Overall Study|Lost to Follow-up|0|||
146740197|NCT02395133|529221036|FG001|Overall Study|Lost to Follow-up|1|||
146740198|NCT02395133|529221037|FG002|Overall Study|Lost to Follow-up|1|||
146740199|NCT02395133|529221038|FG003|Overall Study|Lost to Follow-up|0|||
146740200|NCT02395133|529221035|FG000|Overall Study|Pregnancy|0|||
146740201|NCT02395133|529221036|FG001|Overall Study|Pregnancy|0|||
146740202|NCT02395133|529221037|FG002|Overall Study|Pregnancy|3|||
146740203|NCT02395133|529221038|FG003|Overall Study|Pregnancy|0|||
146740204|NCT02395133|529221035|FG000|Overall Study|Consent withdrawn with no reason given|1|||
146740205|NCT02395133|529221036|FG001|Overall Study|Consent withdrawn with no reason given|3|||
146740206|NCT02395133|529221037|FG002|Overall Study|Consent withdrawn with no reason given|0|||
146740207|NCT02395133|529221038|FG003|Overall Study|Consent withdrawn with no reason given|2|||
146740208|NCT02395133|529221035|FG000|Overall Study|Consent withdrawn with personal reason|0|||
146740209|NCT02395133|529221036|FG001|Overall Study|Consent withdrawn with personal reason|1|||
146740210|NCT02395133|529221037|FG002|Overall Study|Consent withdrawn with personal reason|0|||
146740211|NCT02395133|529221038|FG003|Overall Study|Consent withdrawn with personal reason|3|||
146740212|NCT02395133|529221035|FG000|Overall Study|Sponsor decision|2|||
146740213|NCT02395133|529221036|FG001|Overall Study|Sponsor decision|0|||
146740214|NCT02395133|529221037|FG002|Overall Study|Sponsor decision|0|||
146740215|NCT02395133|529221038|FG003|Overall Study|Sponsor decision|1|||
146740216|NCT02395133|529221035|FG000|Overall Study|Other than specified above|5|||
146740217|NCT02395133|529221036|FG001|Overall Study|Other than specified above|2|||
146740218|NCT02395133|529221037|FG002|Overall Study|Other than specified above|2|||
146740219|NCT02395133|529221038|FG003|Overall Study|Other than specified above|4|||
146740220|NCT02234063|529221045|FG000|Overall Study|Lost to Follow-up|235|||
146740221|NCT02234063|529221046|FG001|Overall Study|Lost to Follow-up|42|||
146740222|NCT02234063|529221045|FG000|Overall Study|Withdrawal by Subject|20|||
146740223|NCT02234063|529221046|FG001|Overall Study|Withdrawal by Subject|1|||
146740224|NCT02254408|529222428|FG000|Overall Study|Randomized But Not Treated|1|||
146740225|NCT02254408|529222429|FG001|Overall Study|Randomized But Not Treated|3|||
146740226|NCT02254408|529222428|FG000|Overall Study|Adverse Event|1|||
146740227|NCT02254408|529222429|FG001|Overall Study|Adverse Event|0|||
146740228|NCT02254408|529222428|FG000|Overall Study|Death|2|||
146740229|NCT02254408|529222429|FG001|Overall Study|Death|3|||
146740230|NCT02254408|529222428|FG000|Overall Study|Investigator's Discretion|0|||
146740231|NCT02254408|529222429|FG001|Overall Study|Investigator's Discretion|1|||
146740232|NCT02254408|529222428|FG000|Overall Study|Withdrawal by Subject|3|||
146740233|NCT02254408|529222429|FG001|Overall Study|Withdrawal by Subject|3|||
146740234|NCT02254408|529222428|FG000|Overall Study|Lost to Follow-up|1|||
146740235|NCT02254408|529222429|FG001|Overall Study|Lost to Follow-up|0|||
146740236|NCT02914184|529222433|FG000|Overall Study|Lost to Follow-up|7|||
146740237|NCT02914184|529222434|FG001|Overall Study|Lost to Follow-up|10|||
146740238|NCT02914184|529222435|FG002|Overall Study|Lost to Follow-up|8|||
146740239|NCT02914184|529222436|FG003|Overall Study|Lost to Follow-up|7|||
146740240|NCT02914184|529222433|FG000|Overall Study|Withdrawal by Subject|4|||
146740241|NCT02914184|529222434|FG001|Overall Study|Withdrawal by Subject|2|||
146740242|NCT02914184|529222435|FG002|Overall Study|Withdrawal by Subject|7|||
146740243|NCT02914184|529222436|FG003|Overall Study|Withdrawal by Subject|3|||
146740244|NCT02914184|529222433|FG000|Overall Study|Other|1|||
146740245|NCT02914184|529222434|FG001|Overall Study|Other|0|||
146740246|NCT02914184|529222435|FG002|Overall Study|Other|0|||
146740247|NCT02914184|529222436|FG003|Overall Study|Other|0|||
146740248|NCT02914184|529222433|FG000|Overall Study|Migrated/moved from the study area|2|||
146740249|NCT02914184|529222434|FG001|Overall Study|Migrated/moved from the study area|1|||
146740250|NCT02914184|529222435|FG002|Overall Study|Migrated/moved from the study area|2|||
146740251|NCT02914184|529222436|FG003|Overall Study|Migrated/moved from the study area|1|||
146740252|NCT00768430|529222437|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
146740253|NCT00768430|529222438|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
146740254|NCT05340751|529222441|FG000|Overall Study|Physician Decision|3|||
146740255|NCT03810313|529222442|FG000|Overall Study|Study terminated by sponsor|164|||
146740256|NCT03810313|529222443|FG001|Overall Study|Study terminated by sponsor|159|||
146740257|NCT03810313|529222442|FG000|Overall Study|Subject decision|10|||
146740258|NCT03810313|529222443|FG001|Overall Study|Subject decision|11|||
146740259|NCT03810313|529222442|FG000|Overall Study|Lost to Follow-up|3|||
146740260|NCT03810313|529222443|FG001|Overall Study|Lost to Follow-up|3|||
146740261|NCT03810313|529222442|FG000|Overall Study|Adverse Event|2|||
146740262|NCT03810313|529222443|FG001|Overall Study|Adverse Event|1|||
146740263|NCT03810313|529222442|FG000|Overall Study|Death|2|||
146740264|NCT03810313|529222443|FG001|Overall Study|Death|1|||
146740265|NCT03810313|529222442|FG000|Overall Study|Physician Decision|0|||
146740266|NCT03810313|529222443|FG001|Overall Study|Physician Decision|1|||
146740267|NCT03820323|529222444|FG000|Overall Study|Lost to Follow-up|2|||
146740268|NCT03820323|529222445|FG001|Overall Study|Lost to Follow-up|1|||
146740269|NCT03820323|529222444|FG000|Overall Study|Missed 12-month visit|22|||
146740270|NCT03820323|529222445|FG001|Overall Study|Missed 12-month visit|14|||
146740271|NCT03820323|529222444|FG000|Overall Study|Death|2|||
146740272|NCT03820323|529222445|FG001|Overall Study|Death|1|||
146740273|NCT03820323|529222444|FG000|Overall Study|Transferred out|13|||
146740274|NCT03820323|529222445|FG001|Overall Study|Transferred out|11|||
146740275|NCT03820323|529222444|FG000|Overall Study|Terminated|0|||
146740276|NCT03820323|529222445|FG001|Overall Study|Terminated|3|||
146740277|NCT03820323|529222444|FG000|Overall Study|Withdrawal by Subject|1|||
146740278|NCT03820323|529222445|FG001|Overall Study|Withdrawal by Subject|6|||
146740279|NCT01617005|529222446|FG000|Overall Study|Pregnancy|1|||
146740280|NCT01617005|529222446|FG000|Overall Study|Lack of motivation for treatment|1|||
146740281|NCT01320735|529222447|FG000|Overall Study|Adverse Event|3|||
146740282|NCT01320735|529222447|FG000|Overall Study|Withdrawal by Subject|3|||
146740283|NCT01320735|529222447|FG000|Overall Study|Lost to Follow-up|13|||
146740284|NCT01320735|529222447|FG000|Overall Study|Administrative Reason|6|||
146740285|NCT01320735|529222447|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
146740286|NCT01320735|529222447|FG000|Overall Study|Protocol Violation|1|||
146740287|NCT01320735|529222447|FG000|Overall Study|Other|1|||
146740288|NCT01320735|529222447|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
146740289|NCT01320735|529222447|FG000|Overall Study|Investigator Unable to be Contacted|17|||
146740290|NCT02307513|529222448|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
146740291|NCT02307513|529222449|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
146740292|NCT02307513|529222448|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
146740293|NCT02307513|529222449|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
146740294|NCT02307513|529222448|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
146740295|NCT02307513|529222449|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
146740296|NCT02307513|529222448|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
146740297|NCT02307513|529222449|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
146740298|NCT02307513|529222448|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
146740299|NCT02307513|529222449|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
146740300|NCT02307513|529222448|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
146740301|NCT02307513|529222449|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
146740302|NCT02307513|529222448|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
146740303|NCT02307513|529222449|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
146740304|NCT02307513|529222448|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
146740305|NCT02307513|529222449|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
146740306|NCT02307513|529222448|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
146740307|NCT02307513|529222449|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
146740308|NCT02307513|529222448|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
146740309|NCT02307513|529222449|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
146740310|NCT02307513|529222448|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
146740311|NCT02307513|529222449|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
146740312|NCT02307513|529222448|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
146740313|NCT02307513|529222449|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
146740314|NCT02307513|529222448|FG000|Long-term Extension|Physician Decision|1|||
146740315|NCT02307513|529222449|FG001|Long-term Extension|Physician Decision|0|||
146740316|NCT05952297|529222451|FG000|Overall Study|Withdrawal by Subject|1|||
146740317|NCT05952297|529222452|FG001|Overall Study|Withdrawal by Subject|0|||
146740318|NCT01107743|529222455|FG000|Overall Study|Protocol Violation|46|||
146740319|NCT00308737|529222456|FG000|Overall Study|Adverse Event|104|||
146740320|NCT00308737|529222457|FG001|Overall Study|Adverse Event|9|||
146740321|NCT00308737|529222458|FG002|Overall Study|Adverse Event|0|||
146740322|NCT00308737|529222456|FG000|Overall Study|Death|4|||
146740323|NCT00308737|529222457|FG001|Overall Study|Death|3|||
146740324|NCT00308737|529222458|FG002|Overall Study|Death|0|||
146740325|NCT00308737|529222456|FG000|Overall Study|Lost to Follow-up|56|||
146740326|NCT00308737|529222457|FG001|Overall Study|Lost to Follow-up|80|||
146740327|NCT00308737|529222458|FG002|Overall Study|Lost to Follow-up|5|||
146740328|NCT00308737|529222456|FG000|Overall Study|Physician Decision|15|||
146740329|NCT00308737|529222457|FG001|Overall Study|Physician Decision|2|||
146740330|NCT00308737|529222458|FG002|Overall Study|Physician Decision|1|||
146740331|NCT00308737|529222456|FG000|Overall Study|Protocol Violation|34|||
146740332|NCT00308737|529222457|FG001|Overall Study|Protocol Violation|9|||
146740333|NCT00308737|529222458|FG002|Overall Study|Protocol Violation|5|||
146740334|NCT00308737|529222456|FG000|Overall Study|Withdrawal by Subject|218|||
146740335|NCT00308737|529222457|FG001|Overall Study|Withdrawal by Subject|166|||
146740336|NCT00308737|529222458|FG002|Overall Study|Withdrawal by Subject|18|||
146740337|NCT00308737|529222456|FG000|Overall Study|Various|32|||
146740338|NCT00308737|529222457|FG001|Overall Study|Various|20|||
146740339|NCT00308737|529222458|FG002|Overall Study|Various|8|||
146740340|NCT01225822|529222459|FG000|Overall Study|Adverse Event|13|||
146740341|NCT01225822|529222460|FG001|Overall Study|Adverse Event|31|||
146740342|NCT01225822|529222461|FG002|Overall Study|Adverse Event|18|||
146740343|NCT01225822|529222462|FG003|Overall Study|Adverse Event|23|||
146740344|NCT01225822|529222463|FG004|Overall Study|Adverse Event|14|||
146740345|NCT01225822|529222459|FG000|Overall Study|Protocol Violation|6|||
146740346|NCT01225822|529222460|FG001|Overall Study|Protocol Violation|8|||
146740347|NCT01225822|529222461|FG002|Overall Study|Protocol Violation|6|||
146740348|NCT01225822|529222462|FG003|Overall Study|Protocol Violation|7|||
146740349|NCT01225822|529222463|FG004|Overall Study|Protocol Violation|4|||
146740350|NCT01225822|529222459|FG000|Overall Study|Lost to Follow-up|0|||
146740351|NCT01225822|529222460|FG001|Overall Study|Lost to Follow-up|0|||
146740352|NCT01225822|529222461|FG002|Overall Study|Lost to Follow-up|0|||
146740353|NCT01225822|529222462|FG003|Overall Study|Lost to Follow-up|1|||
146740354|NCT01225822|529222463|FG004|Overall Study|Lost to Follow-up|0|||
146740355|NCT01225822|529222459|FG000|Overall Study|Withdrawal by Subject|6|||
146740356|NCT01225822|529222460|FG001|Overall Study|Withdrawal by Subject|7|||
146740357|NCT01225822|529222461|FG002|Overall Study|Withdrawal by Subject|7|||
146740358|NCT01225822|529222462|FG003|Overall Study|Withdrawal by Subject|11|||
146740359|NCT01225822|529222463|FG004|Overall Study|Withdrawal by Subject|6|||
146740360|NCT01225822|529222459|FG000|Overall Study|Other|13|||
146509816|NCT00549601|528371854|FG000|Received Study Drug|Adverse Event|2|||
146740361|NCT01225822|529222460|FG001|Overall Study|Other|10|||
146740362|NCT01225822|529222461|FG002|Overall Study|Other|7|||
146740363|NCT01225822|529222462|FG003|Overall Study|Other|10|||
146740364|NCT01225822|529222463|FG004|Overall Study|Other|7|||
146740365|NCT01290822|529222464|FG000|Overall Study|Withdrawal by Subject|1|||
146740366|NCT01290822|529222464|FG000|Overall Study|Physician Decision|10|||
146740367|NCT01003639|529222465|FG000|Overall Study|Lost to Follow-up|6|||
146740368|NCT01003639|529222466|FG001|Overall Study|Lost to Follow-up|9|||
146740369|NCT01003639|529222465|FG000|Overall Study|Withdrawal by Subject|9|||
146740370|NCT01003639|529222466|FG001|Overall Study|Withdrawal by Subject|5|||
146740371|NCT01003639|529222465|FG000|Overall Study|Lack of Efficacy|1|||
146740372|NCT01003639|529222466|FG001|Overall Study|Lack of Efficacy|6|||
146740373|NCT01003639|529222465|FG000|Overall Study|Adverse Event|0|||
146740374|NCT01003639|529222466|FG001|Overall Study|Adverse Event|1|||
146740375|NCT01003639|529222465|FG000|Overall Study|Protocol Violation|0|||
146740376|NCT01003639|529222466|FG001|Overall Study|Protocol Violation|1|||
146740377|NCT01003639|529222465|FG000|Overall Study|Physician Decision|1|||
146740378|NCT01003639|529222466|FG001|Overall Study|Physician Decision|0|||
146740379|NCT00284089|529222469|FG000|Multiple Dose Phase|Adverse Event|1|||
146740380|NCT00284089|529222470|FG001|Multiple Dose Phase|Adverse Event|0|||
146740381|NCT00284089|529222471|FG002|Multiple Dose Phase|Adverse Event|1|||
146740382|NCT00284089|529222472|FG003|Multiple Dose Phase|Adverse Event|1|||
146740383|NCT00284089|529222469|FG000|Multiple Dose Phase|Protocol Violation|0|||
146740384|NCT00284089|529222470|FG001|Multiple Dose Phase|Protocol Violation|0|||
146740385|NCT00284089|529222471|FG002|Multiple Dose Phase|Protocol Violation|1|||
146740386|NCT00284089|529222472|FG003|Multiple Dose Phase|Protocol Violation|0|||
146740387|NCT00284089|529222469|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
146740388|NCT00284089|529222470|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
146740389|NCT00284089|529222471|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
146740390|NCT00284089|529222472|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
146740391|NCT00284089|529222469|FG000|Multiple Dose Phase|Death|0|||
146740392|NCT00284089|529222470|FG001|Multiple Dose Phase|Death|0|||
146740393|NCT00284089|529222471|FG002|Multiple Dose Phase|Death|1|||
146740394|NCT00284089|529222472|FG003|Multiple Dose Phase|Death|1|||
146740395|NCT00284089|529222469|FG000|Extension Phase|Adverse Event|0|||
146740396|NCT00284089|529222470|FG001|Extension Phase|Adverse Event|0|||
146740397|NCT00284089|529222471|FG002|Extension Phase|Adverse Event|2|||
146740398|NCT00284089|529222472|FG003|Extension Phase|Adverse Event|2|||
146740399|NCT00284089|529222469|FG000|Extension Phase|condition no longer requires study drug|2|||
146740400|NCT00284089|529222470|FG001|Extension Phase|condition no longer requires study drug|0|||
146740401|NCT00284089|529222471|FG002|Extension Phase|condition no longer requires study drug|2|||
146740402|NCT00284089|529222472|FG003|Extension Phase|condition no longer requires study drug|7|||
146740403|NCT00284089|529222469|FG000|Extension Phase|Protocol Violation|0|||
146740404|NCT00284089|529222470|FG001|Extension Phase|Protocol Violation|0|||
146740405|NCT00284089|529222471|FG002|Extension Phase|Protocol Violation|1|||
146740406|NCT00284089|529222472|FG003|Extension Phase|Protocol Violation|0|||
146740407|NCT00284089|529222469|FG000|Extension Phase|Withdrawal by Subject|0|||
146740408|NCT00284089|529222470|FG001|Extension Phase|Withdrawal by Subject|0|||
146740409|NCT00284089|529222471|FG002|Extension Phase|Withdrawal by Subject|1|||
146740410|NCT00284089|529222472|FG003|Extension Phase|Withdrawal by Subject|3|||
146740411|NCT00089895|529222473|FG000|Overall Study|Consent Withdrawn|11|||
146740412|NCT00089895|529222474|FG001|Overall Study|Consent Withdrawn|14|||
146740413|NCT00089895|529222473|FG000|Overall Study|Technical reason|7|||
146740414|NCT00089895|529222474|FG001|Overall Study|Technical reason|2|||
146740415|NCT00089895|529222473|FG000|Overall Study|Surgery|0|||
146740416|NCT00089895|529222474|FG001|Overall Study|Surgery|1|||
146740417|NCT00089895|529222473|FG000|Overall Study|Bleeding|0|||
146740418|NCT00089895|529222474|FG001|Overall Study|Bleeding|2|||
146740419|NCT00089895|529222473|FG000|Overall Study|Physician Decision|3|||
146740420|NCT00089895|529222474|FG001|Overall Study|Physician Decision|7|||
146740421|NCT00089895|529222473|FG000|Overall Study|Exclusion criteria met|6|||
146740422|NCT00089895|529222474|FG001|Overall Study|Exclusion criteria met|6|||
146740423|NCT00089895|529222473|FG000|Overall Study|Not otherwise specified|4|||
146740424|NCT00089895|529222474|FG001|Overall Study|Not otherwise specified|8|||
146740425|NCT00089895|529222473|FG000|Overall Study|Missing|4|||
146740426|NCT00089895|529222474|FG001|Overall Study|Missing|2|||
146740427|NCT02778399|529222475|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
146740428|NCT02778399|529222476|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
146740429|NCT02778399|529222477|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
146740430|NCT02778399|529222478|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
146740431|NCT02778399|529222479|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
146740432|NCT02778399|529222480|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
146740433|NCT02778399|529222475|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
146740434|NCT02778399|529222476|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
146740435|NCT02778399|529222477|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
146740436|NCT02778399|529222478|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
146740437|NCT02778399|529222479|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
146740438|NCT02778399|529222480|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
146740439|NCT02778399|529222475|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
146740440|NCT02778399|529222476|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
146740441|NCT02778399|529222477|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
146740442|NCT02778399|529222478|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
146740443|NCT02778399|529222479|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
146740444|NCT02778399|529222480|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
146740445|NCT02778399|529222475|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
146740446|NCT02778399|529222476|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
146740447|NCT02778399|529222477|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
146740448|NCT02778399|529222478|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
146740449|NCT02778399|529222479|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
146740450|NCT02778399|529222480|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
146740451|NCT02778399|529222475|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
146740452|NCT02778399|529222476|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
146740453|NCT02778399|529222477|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
146740454|NCT02778399|529222478|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
146740455|NCT02778399|529222479|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
146740456|NCT02778399|529222480|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
146740457|NCT02778399|529222475|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
146740458|NCT02778399|529222476|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
146740459|NCT02778399|529222477|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
146740460|NCT02778399|529222478|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
146740461|NCT02778399|529222479|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
146740462|NCT02778399|529222480|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
146740463|NCT02778399|529222475|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
146740464|NCT02778399|529222476|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
146740465|NCT02778399|529222477|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
146914635|NCT03303339|529850044|FG002|Overall Study|Death|2|||
146740466|NCT02778399|529222478|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
146740467|NCT02778399|529222479|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
146740468|NCT02778399|529222480|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
146740469|NCT02778399|529222475|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
146740470|NCT02778399|529222476|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
146740471|NCT02778399|529222477|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
146740472|NCT02778399|529222478|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
146740473|NCT02778399|529222479|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
146740474|NCT02778399|529222480|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
146740475|NCT02778399|529222475|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
146740476|NCT02778399|529222476|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
146740477|NCT02778399|529222477|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
146740478|NCT02778399|529222478|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
146740479|NCT02778399|529222479|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
146740480|NCT02778399|529222480|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
146740481|NCT02778399|529222475|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
146740482|NCT02778399|529222476|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
146740483|NCT02778399|529222477|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
146740484|NCT02778399|529222478|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
146740485|NCT02778399|529222479|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
146740486|NCT02778399|529222480|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
146740487|NCT02778399|529222475|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
146740488|NCT02778399|529222476|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
146740489|NCT02778399|529222477|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
146740490|NCT02778399|529222478|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
146740491|NCT02778399|529222479|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
146740492|NCT02778399|529222480|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
146740493|NCT00405639|529222483|FG000|Overall Study|Withdrawal by Subject|1|||
146740494|NCT00405639|529222484|FG001|Overall Study|Withdrawal by Subject|0|||
146740495|NCT00405639|529222483|FG000|Overall Study|Adverse Event|1|||
146740496|NCT00405639|529222484|FG001|Overall Study|Adverse Event|0|||
146740497|NCT00405639|529222483|FG000|Overall Study|Seizure prior to receiving BNP|1|||
146740498|NCT00405639|529222484|FG001|Overall Study|Seizure prior to receiving BNP|0|||
146740499|NCT00612534|529222487|FG000|Overall Study|Adverse Event|0|||
146740500|NCT00612534|529222488|FG001|Overall Study|Adverse Event|4|||
146740501|NCT00612534|529222489|FG002|Overall Study|Adverse Event|2|||
146740502|NCT00612534|529222490|FG003|Overall Study|Adverse Event|1|||
146740503|NCT00612534|529222487|FG000|Overall Study|Lack of Efficacy|13|||
146740504|NCT00612534|529222488|FG001|Overall Study|Lack of Efficacy|12|||
146740505|NCT00612534|529222489|FG002|Overall Study|Lack of Efficacy|5|||
146740506|NCT00612534|529222490|FG003|Overall Study|Lack of Efficacy|16|||
146740507|NCT00612534|529222487|FG000|Overall Study|Other Reason|0|||
146740508|NCT00612534|529222488|FG001|Overall Study|Other Reason|1|||
146740509|NCT00612534|529222489|FG002|Overall Study|Other Reason|0|||
146740510|NCT00612534|529222490|FG003|Overall Study|Other Reason|0|||
146740511|NCT02487095|529222494|FG000|Dose Expansion|Unable to scan/restage participant|0|||
146740512|NCT02487095|529222495|FG001|Dose Expansion|Unable to scan/restage participant|0|||
146740513|NCT02487095|529222496|FG002|Dose Expansion|Unable to scan/restage participant|0|||
146740514|NCT02487095|529222497|FG003|Dose Expansion|Unable to scan/restage participant|0|||
146740515|NCT02487095|529222498|FG004|Dose Expansion|Unable to scan/restage participant|1|||
146740516|NCT03108157|529222501|FG000|Overall Study|Protocol Violation|15|||
146740517|NCT03108157|529222502|FG001|Overall Study|Protocol Violation|4|||
146740518|NCT01279343|529222505|FG000|Overall Study|Did not receive treatment|2|||
146740519|NCT01279343|529222506|FG001|Overall Study|Did not receive treatment|6|||
146740520|NCT04534114|529222507|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
146740521|NCT04534114|529222508|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
146740522|NCT04534114|529222509|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
146740523|NCT04534114|529222510|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
146740524|NCT04534114|529222507|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
146740525|NCT04534114|529222508|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
146740526|NCT04534114|529222509|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
146740527|NCT04534114|529222510|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
146740528|NCT04534114|529222507|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
146740529|NCT04534114|529222508|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
146740530|NCT04534114|529222509|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
146740531|NCT04534114|529222510|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
146740532|NCT04534114|529222507|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
146740533|NCT04534114|529222508|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
146740534|NCT04534114|529222509|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
146740535|NCT04534114|529222510|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
146740536|NCT04534114|529222507|FG000|Main Treatment Period|Physician Decision|0|||
146740537|NCT04534114|529222508|FG001|Main Treatment Period|Physician Decision|0|||
146740538|NCT04534114|529222509|FG002|Main Treatment Period|Physician Decision|0|||
146740539|NCT04534114|529222510|FG003|Main Treatment Period|Physician Decision|1|||
146740540|NCT04534114|529222507|FG000|Main Treatment Period|Death|1|||
146740541|NCT04534114|529222508|FG001|Main Treatment Period|Death|0|||
146740542|NCT04534114|529222509|FG002|Main Treatment Period|Death|0|||
146740543|NCT04534114|529222510|FG003|Main Treatment Period|Death|1|||
146740544|NCT04534114|529222507|FG000|Main Treatment Period|Other reason|1|||
146740545|NCT04534114|529222508|FG001|Main Treatment Period|Other reason|1|||
146740546|NCT04534114|529222509|FG002|Main Treatment Period|Other reason|0|||
146740547|NCT04534114|529222510|FG003|Main Treatment Period|Other reason|0|||
146740548|NCT04534114|529222507|FG000|Main Treatment Period|Participant decision|1|||
146740549|NCT04534114|529222508|FG001|Main Treatment Period|Participant decision|3|||
146740550|NCT04534114|529222509|FG002|Main Treatment Period|Participant decision|3|||
146740551|NCT04534114|529222510|FG003|Main Treatment Period|Participant decision|1|||
146740552|NCT04534114|529222507|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
146740553|NCT04534114|529222508|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
146740554|NCT04534114|529222509|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
146740555|NCT04534114|529222510|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
146740556|NCT04534114|529222507|FG000|Main Treatment Period|Adverse Event|4|||
146740557|NCT04534114|529222508|FG001|Main Treatment Period|Adverse Event|2|||
146914636|NCT03303339|529850045|FG003|Overall Study|Death|1|||
146509817|NCT00549601|528371855|FG001|Received Study Drug|Adverse Event|5|||
146740558|NCT04534114|529222509|FG002|Main Treatment Period|Adverse Event|1|||
146740559|NCT04534114|529222510|FG003|Main Treatment Period|Adverse Event|2|||
146740560|NCT04534114|529222507|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
146740561|NCT04534114|529222508|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
146740562|NCT04534114|529222509|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
146740563|NCT04534114|529222510|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
146740564|NCT04534114|529222507|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
146740565|NCT04534114|529222508|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
146740566|NCT04534114|529222509|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
146740567|NCT04534114|529222510|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
146740568|NCT04534114|529222507|FG000|Extension Treatment Period|Other reason|0|||
146740569|NCT04534114|529222508|FG001|Extension Treatment Period|Other reason|1|||
146740570|NCT04534114|529222509|FG002|Extension Treatment Period|Other reason|0|||
146740571|NCT04534114|529222510|FG003|Extension Treatment Period|Other reason|0|||
146740572|NCT04534114|529222507|FG000|Extension Treatment Period|Death|0|||
146740573|NCT04534114|529222508|FG001|Extension Treatment Period|Death|0|||
146740574|NCT04534114|529222509|FG002|Extension Treatment Period|Death|1|||
146740575|NCT04534114|529222510|FG003|Extension Treatment Period|Death|2|||
146740576|NCT04534114|529222507|FG000|Extension Treatment Period|Adverse Event|0|||
146740577|NCT04534114|529222508|FG001|Extension Treatment Period|Adverse Event|1|||
146740578|NCT04534114|529222509|FG002|Extension Treatment Period|Adverse Event|0|||
146740579|NCT04534114|529222510|FG003|Extension Treatment Period|Adverse Event|1|||
146740580|NCT04534114|529222507|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
146740581|NCT04534114|529222508|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
146740582|NCT04534114|529222509|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
146740583|NCT04534114|529222510|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
146740584|NCT03287414|529222511|FG000|Treatment Epoch|Adverse Event|0|||
146740585|NCT03287414|529222512|FG001|Treatment Epoch|Adverse Event|1|||
146740586|NCT03287414|529222511|FG000|Treatment Epoch|Study terminated by sponsor|2|||
146740587|NCT03287414|529222512|FG001|Treatment Epoch|Study terminated by sponsor|2|||
146740588|NCT03287414|529222511|FG000|Treatment Epoch|Subject/Guardian decision|4|||
146740589|NCT03287414|529222512|FG001|Treatment Epoch|Subject/Guardian decision|0|||
146740590|NCT03287414|529222511|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
146740591|NCT03287414|529222512|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
146740592|NCT03287414|529222511|FG000|Treatment Epoch|Withdrawal by Subject|1|||
146740593|NCT03287414|529222512|FG001|Treatment Epoch|Withdrawal by Subject|0|||
146740594|NCT03287414|529222511|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
146740595|NCT03287414|529222512|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
146740596|NCT03287414|529222511|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
146740597|NCT03287414|529222512|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
146740598|NCT02759185|529222513|FG000|Stage 1|Adverse Event|0|||
146740599|NCT02759185|529222514|FG001|Stage 1|Adverse Event|1|||
146740600|NCT02759185|529222515|FG002|Stage 1|Adverse Event|3|||
146740601|NCT02759185|529222516|FG003|Stage 1|Adverse Event|0|||
146740602|NCT02759185|529222517|FG004|Stage 1|Adverse Event|0|||
146740603|NCT02759185|529222518|FG005|Stage 1|Adverse Event|0|||
146740604|NCT02759185|529222519|FG006|Stage 1|Adverse Event|0|||
146740605|NCT02759185|529222513|FG000|Stage 1|Withdrawal by Subject|1|||
146740606|NCT02759185|529222514|FG001|Stage 1|Withdrawal by Subject|0|||
146740607|NCT02759185|529222515|FG002|Stage 1|Withdrawal by Subject|0|||
146740608|NCT02759185|529222516|FG003|Stage 1|Withdrawal by Subject|0|||
146740609|NCT02759185|529222517|FG004|Stage 1|Withdrawal by Subject|0|||
146740610|NCT02759185|529222518|FG005|Stage 1|Withdrawal by Subject|0|||
146740611|NCT02759185|529222519|FG006|Stage 1|Withdrawal by Subject|0|||
146740612|NCT02759185|529222513|FG000|Stage 2|Adverse Event|0|||
146740613|NCT02759185|529222514|FG001|Stage 2|Adverse Event|0|||
146740614|NCT02759185|529222515|FG002|Stage 2|Adverse Event|0|||
146740615|NCT02759185|529222516|FG003|Stage 2|Adverse Event|0|||
146740616|NCT02759185|529222517|FG004|Stage 2|Adverse Event|1|||
146740617|NCT02759185|529222518|FG005|Stage 2|Adverse Event|2|||
146740618|NCT02759185|529222519|FG006|Stage 2|Adverse Event|0|||
146740619|NCT02759185|529222513|FG000|Stage 2|Withdrawal by Subject|0|||
146740620|NCT02759185|529222514|FG001|Stage 2|Withdrawal by Subject|0|||
146740621|NCT02759185|529222515|FG002|Stage 2|Withdrawal by Subject|0|||
146740622|NCT02759185|529222516|FG003|Stage 2|Withdrawal by Subject|0|||
146740623|NCT02759185|529222517|FG004|Stage 2|Withdrawal by Subject|1|||
146740624|NCT02759185|529222518|FG005|Stage 2|Withdrawal by Subject|1|||
146740625|NCT02759185|529222519|FG006|Stage 2|Withdrawal by Subject|1|||
146740626|NCT00962247|529222523|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
146740627|NCT00962247|529222523|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
146740628|NCT02946918|529222524|FG000|Overall Study|Patient unblinded himself|1|||
146740629|NCT02946918|529222525|FG001|Overall Study|Patient unblinded himself|0|||
146740630|NCT02946918|529222524|FG000|Overall Study|Physician Decision|0|||
146740631|NCT02946918|529222525|FG001|Overall Study|Physician Decision|2|||
146740632|NCT02946918|529222524|FG000|Overall Study|Ran out of study medication|0|||
146740633|NCT02946918|529222525|FG001|Overall Study|Ran out of study medication|1|||
146740634|NCT01861522|529222526|FG000|Overall Study|Adverse Event|1|||
146740635|NCT01861522|529222527|FG001|Overall Study|Adverse Event|0|||
146740636|NCT01861522|529222526|FG000|Overall Study|Withdrawal by Subject|2|||
146740637|NCT01861522|529222527|FG001|Overall Study|Withdrawal by Subject|0|||
146740638|NCT02716038|529222528|FG000|Overall Study|Not evaluable|1|||
146740639|NCT02716038|529222528|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
146740640|NCT02716038|529222528|FG000|Overall Study|Unresectable|3|||
146740641|NCT00069784|529222529|FG000|Overall Study|Adverse Event|105|||
146740642|NCT00069784|529222530|FG001|Overall Study|Adverse Event|0|||
146740643|NCT00069784|529222529|FG000|Overall Study|Withdrawal by Subject|1090|||
146740644|NCT00069784|529222530|FG001|Overall Study|Withdrawal by Subject|0|||
146740645|NCT00069784|529222529|FG000|Overall Study|Other|17|||
146740646|NCT00069784|529222530|FG001|Overall Study|Other|0|||
146740647|NCT02669095|529222536|FG000|Overall Study|Adverse Event|1|||
146740648|NCT02669095|529222537|FG001|Overall Study|Adverse Event|0|||
146740649|NCT02669095|529222536|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
146740650|NCT02669095|529222537|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
146740651|NCT02669095|529222536|FG000|Overall Study|Torn Lens|0|||
146740652|NCT02669095|529222537|FG001|Overall Study|Torn Lens|1|||
146740653|NCT02669095|529222536|FG000|Overall Study|Visit 5 assessments not completed|0|||
146740654|NCT02669095|529222537|FG001|Overall Study|Visit 5 assessments not completed|1|||
146740655|NCT00926003|529222539|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
146740656|NCT00926003|529222540|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
146740657|NCT00926003|529222541|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
146740658|NCT00926003|529222539|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
146740659|NCT00926003|529222540|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
146740660|NCT00926003|529222541|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
146740661|NCT01103960|529222542|FG000|Overall Study|Adverse Event|2|||
146740662|NCT01103960|529222543|FG001|Overall Study|Adverse Event|1|||
146740663|NCT01103960|529222542|FG000|Overall Study|Withdrawal by Subject|2|||
146740664|NCT01103960|529222543|FG001|Overall Study|Withdrawal by Subject|1|||
146740665|NCT01103960|529222542|FG000|Overall Study|Other|1|||
146740666|NCT01103960|529222543|FG001|Overall Study|Other|0|||
146740667|NCT00118898|529222547|FG000|Overall Study|Death|6|||
146740668|NCT00118898|529222548|FG001|Overall Study|Death|11|||
146740669|NCT00118898|529222549|FG002|Overall Study|Death|6|||
146740670|NCT00118898|529222550|FG003|Overall Study|Death|8|||
146740671|NCT00118898|529222547|FG000|Overall Study|Lost to Follow-up|26|||
146740672|NCT00118898|529222548|FG001|Overall Study|Lost to Follow-up|34|||
146740673|NCT00118898|529222549|FG002|Overall Study|Lost to Follow-up|33|||
146740674|NCT00118898|529222550|FG003|Overall Study|Lost to Follow-up|33|||
146740675|NCT00118898|529222547|FG000|Overall Study|Withdrawal by Subject|10|||
146740676|NCT00118898|529222548|FG001|Overall Study|Withdrawal by Subject|5|||
146740677|NCT00118898|529222549|FG002|Overall Study|Withdrawal by Subject|8|||
146740678|NCT00118898|529222550|FG003|Overall Study|Withdrawal by Subject|8|||
146740679|NCT00118898|529222547|FG000|Overall Study|Site Closure|33|||
146740680|NCT00118898|529222548|FG001|Overall Study|Site Closure|31|||
146740681|NCT00118898|529222549|FG002|Overall Study|Site Closure|28|||
146740682|NCT00118898|529222550|FG003|Overall Study|Site Closure|37|||
146740683|NCT00118898|529222547|FG000|Overall Study|Severe debilitation|1|||
146740684|NCT00118898|529222548|FG001|Overall Study|Severe debilitation|4|||
146740685|NCT00118898|529222549|FG002|Overall Study|Severe debilitation|6|||
146740686|NCT00118898|529222550|FG003|Overall Study|Severe debilitation|4|||
146740687|NCT00118898|529222547|FG000|Overall Study|Not compliant with requirements|11|||
146740688|NCT00118898|529222548|FG001|Overall Study|Not compliant with requirements|13|||
146740689|NCT00118898|529222549|FG002|Overall Study|Not compliant with requirements|11|||
146740690|NCT00118898|529222550|FG003|Overall Study|Not compliant with requirements|11|||
146740691|NCT00118898|529222547|FG000|Overall Study|Not able to get to clinic|34|||
146740692|NCT00118898|529222548|FG001|Overall Study|Not able to get to clinic|43|||
146740693|NCT00118898|529222549|FG002|Overall Study|Not able to get to clinic|31|||
146740694|NCT00118898|529222550|FG003|Overall Study|Not able to get to clinic|40|||
146740695|NCT01338012|529222551|FG000|Overall Study|Death|4|||
146740696|NCT01338012|529222551|FG000|Overall Study|Study terminated|4|||
146740697|NCT02714205|529222552|FG000|Overall Study|Cannot tolerate medication|1|||
146740698|NCT02714205|529222553|FG001|Overall Study|Cannot tolerate medication|0|||
146740699|NCT02714205|529222552|FG000|Overall Study|Adverse Event|2|||
146740700|NCT02714205|529222553|FG001|Overall Study|Adverse Event|0|||
146740701|NCT02714205|529222552|FG000|Overall Study|Too busy|1|||
146740702|NCT02714205|529222553|FG001|Overall Study|Too busy|0|||
146740703|NCT02714205|529222552|FG000|Overall Study|Incomplete outcome data|0|||
146740704|NCT02714205|529222553|FG001|Overall Study|Incomplete outcome data|1|||
146740705|NCT05879198|529222554|FG000|Overall Study|Lost to Follow-up|1|||
146740706|NCT02073097|529222555|FG000|Overall Study|Adverse Event|0|||
146740707|NCT02073097|529222556|FG001|Overall Study|Adverse Event|0|||
146740708|NCT02073097|529222557|FG002|Overall Study|Adverse Event|0|||
146740709|NCT02073097|529222558|FG003|Overall Study|Adverse Event|0|||
146740710|NCT02073097|529222559|FG004|Overall Study|Adverse Event|0|||
146740711|NCT02073097|529222560|FG005|Overall Study|Adverse Event|0|||
146740712|NCT02073097|529222561|FG006|Overall Study|Adverse Event|0|||
146740713|NCT02073097|529222562|FG007|Overall Study|Adverse Event|2|||
146740714|NCT02073097|529222555|FG000|Overall Study|Withdrawal by Subject|0|||
146740715|NCT02073097|529222556|FG001|Overall Study|Withdrawal by Subject|0|||
146740716|NCT02073097|529222557|FG002|Overall Study|Withdrawal by Subject|0|||
146740717|NCT02073097|529222558|FG003|Overall Study|Withdrawal by Subject|0|||
146740718|NCT02073097|529222559|FG004|Overall Study|Withdrawal by Subject|0|||
146740719|NCT02073097|529222560|FG005|Overall Study|Withdrawal by Subject|0|||
146740720|NCT02073097|529222561|FG006|Overall Study|Withdrawal by Subject|0|||
146740721|NCT02073097|529222562|FG007|Overall Study|Withdrawal by Subject|2|||
146740722|NCT02073097|529222555|FG000|Overall Study|Death|0|||
146740723|NCT02073097|529222556|FG001|Overall Study|Death|0|||
146740724|NCT02073097|529222557|FG002|Overall Study|Death|0|||
146740725|NCT02073097|529222558|FG003|Overall Study|Death|0|||
146740726|NCT02073097|529222559|FG004|Overall Study|Death|0|||
146740727|NCT02073097|529222560|FG005|Overall Study|Death|0|||
146740728|NCT02073097|529222561|FG006|Overall Study|Death|0|||
146740729|NCT02073097|529222562|FG007|Overall Study|Death|1|||
146740730|NCT02073097|529222555|FG000|Overall Study|Physician Decision|0|||
146740731|NCT02073097|529222556|FG001|Overall Study|Physician Decision|0|||
146740732|NCT02073097|529222557|FG002|Overall Study|Physician Decision|0|||
146740733|NCT02073097|529222558|FG003|Overall Study|Physician Decision|0|||
146740734|NCT02073097|529222559|FG004|Overall Study|Physician Decision|0|||
146740735|NCT02073097|529222560|FG005|Overall Study|Physician Decision|0|||
146740736|NCT02073097|529222561|FG006|Overall Study|Physician Decision|0|||
146740737|NCT02073097|529222562|FG007|Overall Study|Physician Decision|1|||
146740738|NCT01693692|529222563|FG000|Overall Study|Withdrawal by Subject|12|||
146740739|NCT01693692|529222564|FG001|Overall Study|Withdrawal by Subject|10|||
146740740|NCT01693692|529222565|FG002|Overall Study|Withdrawal by Subject|11|||
146740741|NCT01693692|529222563|FG000|Overall Study|Adverse Event|7|||
146740742|NCT01693692|529222564|FG001|Overall Study|Adverse Event|14|||
146740743|NCT01693692|529222565|FG002|Overall Study|Adverse Event|9|||
146740744|NCT01693692|529222563|FG000|Overall Study|Physician Decision|0|||
146740745|NCT01693692|529222564|FG001|Overall Study|Physician Decision|0|||
146740746|NCT01693692|529222565|FG002|Overall Study|Physician Decision|1|||
146740747|NCT01693692|529222563|FG000|Overall Study|Protocol Violation|5|||
146740748|NCT01693692|529222564|FG001|Overall Study|Protocol Violation|4|||
146740749|NCT01693692|529222565|FG002|Overall Study|Protocol Violation|6|||
146740750|NCT01693692|529222563|FG000|Overall Study|Lost to Follow-up|2|||
146740751|NCT01693692|529222564|FG001|Overall Study|Lost to Follow-up|2|||
146740752|NCT01693692|529222565|FG002|Overall Study|Lost to Follow-up|3|||
146740753|NCT01693692|529222563|FG000|Overall Study|Other|4|||
146740754|NCT01693692|529222564|FG001|Overall Study|Other|4|||
146740755|NCT01693692|529222565|FG002|Overall Study|Other|6|||
146740756|NCT00386308|529224341|FG000|Overall Study|Adverse Event|3|||
146740757|NCT00386308|529224342|FG001|Overall Study|Adverse Event|3|||
146740758|NCT00386308|529224341|FG000|Overall Study|Protocol Violation|2|||
146740759|NCT00386308|529224342|FG001|Overall Study|Protocol Violation|5|||
146740760|NCT00386308|529224341|FG000|Overall Study|Lack of Efficacy|0|||
146740761|NCT00386308|529224342|FG001|Overall Study|Lack of Efficacy|2|||
146740762|NCT00386308|529224341|FG000|Overall Study|Lost to Follow-up|10|||
146740763|NCT00386308|529224342|FG001|Overall Study|Lost to Follow-up|6|||
146740764|NCT00386308|529224341|FG000|Overall Study|Withdrawal by Subject|6|||
146740765|NCT00386308|529224342|FG001|Overall Study|Withdrawal by Subject|2|||
146740766|NCT00386308|529224341|FG000|Overall Study|Other Event|8|||
146740767|NCT00386308|529224342|FG001|Overall Study|Other Event|1|||
146740768|NCT04651114|529224351|FG000|Overall Study|Withdrawal by Subject|8|||
146740769|NCT01923896|529224352|FG000|Overall Study|Adverse Event|1|||
146740770|NCT01923896|529224353|FG001|Overall Study|Adverse Event|0|||
146740771|NCT03545113|529224356|FG000|Overall Study|Surgery Cancelled|1|||
146740772|NCT03545113|529224357|FG001|Overall Study|Surgery Cancelled|0|||
146740773|NCT03545113|529224356|FG000|Overall Study|Death|1|||
146740774|NCT03545113|529224357|FG001|Overall Study|Death|0|||
146740775|NCT03545113|529224356|FG000|Overall Study|Adverse Event|2|||
146740776|NCT03545113|529224357|FG001|Overall Study|Adverse Event|0|||
146740777|NCT03545113|529224356|FG000|Overall Study|Received different surgery|1|||
146740778|NCT03545113|529224357|FG001|Overall Study|Received different surgery|0|||
146740779|NCT00235443|529224358|FG000|Overall Study|Adverse Event|4|||
146740780|NCT00235443|529224359|FG001|Overall Study|Adverse Event|12|||
146740781|NCT00235443|529224360|FG002|Overall Study|Adverse Event|17|||
146740782|NCT00235443|529224361|FG003|Overall Study|Adverse Event|44|||
146740783|NCT00235443|529224362|FG004|Overall Study|Adverse Event|10|||
146740784|NCT00235443|529224363|FG005|Overall Study|Adverse Event|15|||
146740785|NCT00235443|529224358|FG000|Overall Study|Lack of Efficacy|0|||
146740786|NCT00235443|529224359|FG001|Overall Study|Lack of Efficacy|1|||
146740787|NCT00235443|529224360|FG002|Overall Study|Lack of Efficacy|5|||
146740788|NCT00235443|529224361|FG003|Overall Study|Lack of Efficacy|12|||
146740789|NCT00235443|529224362|FG004|Overall Study|Lack of Efficacy|2|||
146740790|NCT00235443|529224363|FG005|Overall Study|Lack of Efficacy|9|||
146740791|NCT00235443|529224358|FG000|Overall Study|Withdrawal by Subject|3|||
146740792|NCT00235443|529224359|FG001|Overall Study|Withdrawal by Subject|9|||
146740793|NCT00235443|529224360|FG002|Overall Study|Withdrawal by Subject|25|||
146740794|NCT00235443|529224361|FG003|Overall Study|Withdrawal by Subject|24|||
146740795|NCT00235443|529224362|FG004|Overall Study|Withdrawal by Subject|10|||
146740796|NCT00235443|529224363|FG005|Overall Study|Withdrawal by Subject|12|||
146740797|NCT00235443|529224358|FG000|Overall Study|Lost to Follow-up|0|||
146740798|NCT00235443|529224359|FG001|Overall Study|Lost to Follow-up|8|||
146740799|NCT00235443|529224360|FG002|Overall Study|Lost to Follow-up|6|||
146740800|NCT00235443|529224361|FG003|Overall Study|Lost to Follow-up|6|||
146740801|NCT00235443|529224362|FG004|Overall Study|Lost to Follow-up|4|||
146740802|NCT00235443|529224363|FG005|Overall Study|Lost to Follow-up|3|||
146740803|NCT00235443|529224358|FG000|Overall Study|Unsatisfactory compliance|0|||
146740804|NCT00235443|529224359|FG001|Overall Study|Unsatisfactory compliance|2|||
146740805|NCT00235443|529224360|FG002|Overall Study|Unsatisfactory compliance|3|||
146740806|NCT00235443|529224361|FG003|Overall Study|Unsatisfactory compliance|4|||
146740807|NCT00235443|529224362|FG004|Overall Study|Unsatisfactory compliance|1|||
146740808|NCT00235443|529224363|FG005|Overall Study|Unsatisfactory compliance|0|||
146740809|NCT00235443|529224358|FG000|Overall Study|Other reasons for premature termination|1|||
146740810|NCT00235443|529224359|FG001|Overall Study|Other reasons for premature termination|6|||
146740811|NCT00235443|529224360|FG002|Overall Study|Other reasons for premature termination|6|||
146740812|NCT00235443|529224361|FG003|Overall Study|Other reasons for premature termination|7|||
146740813|NCT00235443|529224362|FG004|Overall Study|Other reasons for premature termination|3|||
146740814|NCT00235443|529224363|FG005|Overall Study|Other reasons for premature termination|6|||
146740815|NCT02032173|529224364|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
146740816|NCT03321513|529224370|FG000|Overall Study|Death|11|||
146740817|NCT03321513|529224371|FG001|Overall Study|Death|5|||
146740818|NCT03321513|529224370|FG000|Overall Study|Withdrawal by Subject|5|||
146740819|NCT03321513|529224371|FG001|Overall Study|Withdrawal by Subject|10|||
146740820|NCT03321513|529224370|FG000|Overall Study|Lost to Follow-up|10|||
146740821|NCT03321513|529224371|FG001|Overall Study|Lost to Follow-up|11|||
146740822|NCT01683994|529224375|FG000|Overall Study|Withdrawal by Subject|1|||
146740823|NCT01683994|529224376|FG001|Overall Study|Withdrawal by Subject|0|||
146740824|NCT01683994|529224377|FG002|Overall Study|Withdrawal by Subject|0|||
146740825|NCT01683994|529224378|FG003|Overall Study|Withdrawal by Subject|1|||
146740826|NCT01683994|529224379|FG004|Overall Study|Withdrawal by Subject|0|||
146740827|NCT01683994|529224375|FG000|Overall Study|Intercurrent illness|0|||
146740828|NCT01683994|529224376|FG001|Overall Study|Intercurrent illness|0|||
146740829|NCT01683994|529224377|FG002|Overall Study|Intercurrent illness|0|||
146740830|NCT01683994|529224378|FG003|Overall Study|Intercurrent illness|2|||
146740831|NCT01683994|529224379|FG004|Overall Study|Intercurrent illness|1|||
146740832|NCT03638635|529224382|FG000|Initial Hospitalization|Study terminated prematurely|0|||
146740833|NCT03638635|529224383|FG001|Initial Hospitalization|Study terminated prematurely|1|||
146740834|NCT03638635|529224382|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
146740835|NCT03638635|529224383|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
146740836|NCT03638635|529224382|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
146740837|NCT03638635|529224383|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
146740838|NCT02318719|529224386|FG000|Double-blind Phase|Adverse Event|7|||
146740839|NCT02318719|529224387|FG001|Double-blind Phase|Adverse Event|6|||
146740840|NCT02318719|529224388|FG002|Double-blind Phase|Adverse Event|12|||
146740841|NCT02318719|529224389|FG003|Double-blind Phase|Adverse Event|4|||
146740842|NCT02318719|529224390|FG004|Double-blind Phase|Adverse Event|0|||
146740843|NCT02318719|529224386|FG000|Double-blind Phase|Lack of Efficacy|5|||
146740844|NCT02318719|529224387|FG001|Double-blind Phase|Lack of Efficacy|0|||
146740845|NCT02318719|529224388|FG002|Double-blind Phase|Lack of Efficacy|1|||
146740846|NCT02318719|529224389|FG003|Double-blind Phase|Lack of Efficacy|1|||
146740847|NCT02318719|529224390|FG004|Double-blind Phase|Lack of Efficacy|0|||
146740848|NCT02318719|529224386|FG000|Double-blind Phase|Protocol Violation|0|||
146740849|NCT02318719|529224387|FG001|Double-blind Phase|Protocol Violation|1|||
146740850|NCT02318719|529224388|FG002|Double-blind Phase|Protocol Violation|3|||
146740851|NCT02318719|529224389|FG003|Double-blind Phase|Protocol Violation|0|||
146740852|NCT02318719|529224390|FG004|Double-blind Phase|Protocol Violation|0|||
146740853|NCT02318719|529224386|FG000|Double-blind Phase|Withdrawal by Subject|25|||
146740854|NCT02318719|529224387|FG001|Double-blind Phase|Withdrawal by Subject|7|||
146740855|NCT02318719|529224388|FG002|Double-blind Phase|Withdrawal by Subject|9|||
146740856|NCT02318719|529224389|FG003|Double-blind Phase|Withdrawal by Subject|10|||
146740857|NCT02318719|529224390|FG004|Double-blind Phase|Withdrawal by Subject|0|||
146740858|NCT02318719|529224386|FG000|Double-blind Phase|Other|1|||
146740859|NCT02318719|529224387|FG001|Double-blind Phase|Other|2|||
146740860|NCT02318719|529224388|FG002|Double-blind Phase|Other|0|||
146740861|NCT02318719|529224389|FG003|Double-blind Phase|Other|0|||
146740862|NCT02318719|529224390|FG004|Double-blind Phase|Other|0|||
146740863|NCT02318719|529224386|FG000|Open-label Extension Phase|Adverse Event|0|||
146740864|NCT02318719|529224387|FG001|Open-label Extension Phase|Adverse Event|0|||
146740865|NCT02318719|529224388|FG002|Open-label Extension Phase|Adverse Event|0|||
146740866|NCT02318719|529224389|FG003|Open-label Extension Phase|Adverse Event|0|||
146740867|NCT02318719|529224390|FG004|Open-label Extension Phase|Adverse Event|15|||
146740868|NCT02318719|529224386|FG000|Open-label Extension Phase|Death|0|||
146740869|NCT02318719|529224387|FG001|Open-label Extension Phase|Death|0|||
146740870|NCT02318719|529224388|FG002|Open-label Extension Phase|Death|0|||
146740871|NCT02318719|529224389|FG003|Open-label Extension Phase|Death|0|||
146740872|NCT02318719|529224390|FG004|Open-label Extension Phase|Death|1|||
146740873|NCT02318719|529224386|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
146740874|NCT02318719|529224387|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
146740875|NCT02318719|529224388|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
146740876|NCT02318719|529224389|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
146740877|NCT02318719|529224390|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
146740878|NCT02318719|529224386|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
146740879|NCT02318719|529224387|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
146740880|NCT02318719|529224388|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
146740881|NCT02318719|529224389|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
146740882|NCT02318719|529224390|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
146740883|NCT02318719|529224386|FG000|Open-label Extension Phase|Other|0|||
146740884|NCT02318719|529224387|FG001|Open-label Extension Phase|Other|0|||
146740885|NCT02318719|529224388|FG002|Open-label Extension Phase|Other|0|||
146740886|NCT02318719|529224389|FG003|Open-label Extension Phase|Other|0|||
146740887|NCT02318719|529224390|FG004|Open-label Extension Phase|Other|7|||
146740888|NCT00432835|529224394|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
146740889|NCT00432835|529224395|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
146740890|NCT00289770|529224396|FG000|Year 15|Withdrawal by Subject|1|||
146740891|NCT00423293|529224397|FG000|Overall Study|Ineligible / No protocol treatment|11|||
146740892|NCT01014975|529224404|FG000|Overall Study|Withdrawal by Subject|1|||
146740893|NCT01014975|529224405|FG001|Overall Study|Withdrawal by Subject|0|||
146740894|NCT01014975|529224406|FG002|Overall Study|Withdrawal by Subject|1|||
146740895|NCT01014975|529224404|FG000|Overall Study|Death|3|||
146740896|NCT01014975|529224405|FG001|Overall Study|Death|3|||
146740897|NCT01014975|529224406|FG002|Overall Study|Death|4|||
146740898|NCT01014975|529224404|FG000|Overall Study|Lost to Follow-up|0|||
146740899|NCT01014975|529224405|FG001|Overall Study|Lost to Follow-up|0|||
146740900|NCT01014975|529224406|FG002|Overall Study|Lost to Follow-up|1|||
146740901|NCT01336634|529224407|FG000|Overall Study|Study closed/terminated|5|||
146740902|NCT01336634|529224408|FG001|Overall Study|Study closed/terminated|6|||
146740903|NCT01336634|529224409|FG002|Overall Study|Study closed/terminated|6|||
146740904|NCT01336634|529224407|FG000|Overall Study|Lost to Follow-up|2|||
146740905|NCT01336634|529224408|FG001|Overall Study|Lost to Follow-up|1|||
146740906|NCT01336634|529224409|FG002|Overall Study|Lost to Follow-up|1|||
146740907|NCT01336634|529224407|FG000|Overall Study|Physician Decision|1|||
146740908|NCT01336634|529224408|FG001|Overall Study|Physician Decision|1|||
146740909|NCT01336634|529224409|FG002|Overall Study|Physician Decision|0|||
146740910|NCT01336634|529224407|FG000|Overall Study|Withdrawal by Subject|6|||
146740911|NCT01336634|529224408|FG001|Overall Study|Withdrawal by Subject|0|||
146740912|NCT01336634|529224409|FG002|Overall Study|Withdrawal by Subject|2|||
146740913|NCT02567825|529224416|FG000|Overall Study|No follow-up post-randomization|5|||
146740914|NCT02567825|529224417|FG001|Overall Study|No follow-up post-randomization|1|||
146740915|NCT02567825|529224416|FG000|Overall Study|Follow-up less than 23 months|16|||
146740916|NCT02567825|529224417|FG001|Overall Study|Follow-up less than 23 months|20|||
146740917|NCT04741802|529224418|FG000|Overall Study|Death|1|||
146740918|NCT04741802|529224418|FG000|Overall Study|Lost to Follow-up|11|||
146740919|NCT03101241|529224419|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
146740920|NCT03101241|529224420|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
146740921|NCT03101241|529224419|FG000|Overall Study|Participant withdrew consent|3|||
146740922|NCT03101241|529224420|FG001|Overall Study|Participant withdrew consent|1|||
146740923|NCT03101241|529224419|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
146740924|NCT03101241|529224420|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
146740925|NCT03101241|529224419|FG000|Overall Study|Lost to Follow-up|2|||
146740926|NCT03101241|529224420|FG001|Overall Study|Lost to Follow-up|0|||
146740927|NCT03101241|529224419|FG000|Overall Study|Lack of Efficacy|0|||
146740928|NCT03101241|529224420|FG001|Overall Study|Lack of Efficacy|1|||
146740929|NCT03101241|529224419|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
146740930|NCT03101241|529224420|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
146740931|NCT01381874|529224421|FG000|Overall Study|Lost to Follow-up|1|||
146740932|NCT01381874|529224422|FG001|Overall Study|Lost to Follow-up|1|||
146740933|NCT01381874|529224423|FG002|Overall Study|Lost to Follow-up|0|||
146740934|NCT01381874|529224421|FG000|Overall Study|Withdrawal by Subject|9|||
146740935|NCT01381874|529224422|FG001|Overall Study|Withdrawal by Subject|10|||
146740936|NCT01381874|529224423|FG002|Overall Study|Withdrawal by Subject|9|||
146740937|NCT01381874|529224421|FG000|Overall Study|Other|67|||
146740938|NCT01381874|529224422|FG001|Overall Study|Other|52|||
146740939|NCT01381874|529224423|FG002|Overall Study|Other|67|||
146740940|NCT04488003|529224424|FG000|Assessed for Eligibility|Screen Failure|24|||
146740941|NCT04488003|529224425|FG001|Assessed for Eligibility|Screen Failure|0|||
146740942|NCT04488003|529224426|FG002|Assessed for Eligibility|Screen Failure|0|||
146740943|NCT04488003|529224424|FG000|Assessed for Eligibility|Adverse Event|1|||
146740944|NCT04488003|529224425|FG001|Assessed for Eligibility|Adverse Event|0|||
146740945|NCT04488003|529224426|FG002|Assessed for Eligibility|Adverse Event|0|||
146740946|NCT04488003|529224424|FG000|Assessed for Eligibility|Death|1|||
146740947|NCT04488003|529224425|FG001|Assessed for Eligibility|Death|0|||
146740948|NCT04488003|529224426|FG002|Assessed for Eligibility|Death|0|||
146740949|NCT04488003|529224424|FG000|Assessed for Eligibility|Physician Decision|1|||
146740950|NCT04488003|529224425|FG001|Assessed for Eligibility|Physician Decision|0|||
146740951|NCT04488003|529224426|FG002|Assessed for Eligibility|Physician Decision|0|||
146740952|NCT04488003|529224424|FG000|Allocated to Treatment|Progressive Disease|51|||
146740953|NCT04488003|529224425|FG001|Allocated to Treatment|Progressive Disease|0|||
146740954|NCT04488003|529224426|FG002|Allocated to Treatment|Progressive Disease|0|||
146740955|NCT04488003|529224424|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
146740956|NCT04488003|529224425|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
146740957|NCT04488003|529224426|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
146740958|NCT04488003|529224424|FG000|Allocated to Treatment|Adverse Event|6|||
146740959|NCT04488003|529224425|FG001|Allocated to Treatment|Adverse Event|0|||
146740960|NCT04488003|529224426|FG002|Allocated to Treatment|Adverse Event|0|||
146740961|NCT04488003|529224424|FG000|Allocated to Treatment|Other|5|||
146740962|NCT04488003|529224425|FG001|Allocated to Treatment|Other|0|||
146740963|NCT04488003|529224426|FG002|Allocated to Treatment|Other|0|||
146740964|NCT04488003|529224424|FG000|Allocated to Treatment|Physician Decision|4|||
146740965|NCT04488003|529224425|FG001|Allocated to Treatment|Physician Decision|0|||
146740966|NCT04488003|529224426|FG002|Allocated to Treatment|Physician Decision|0|||
146740967|NCT04488003|529224424|FG000|Allocated to Treatment|Death|4|||
146740968|NCT04488003|529224425|FG001|Allocated to Treatment|Death|0|||
146740969|NCT04488003|529224426|FG002|Allocated to Treatment|Death|0|||
146740970|NCT01248962|529224427|FG000|Overall Study|Withdrawal by Subject|1|||
146740971|NCT01248962|529224428|FG001|Overall Study|Withdrawal by Subject|1|||
146740972|NCT01248962|529224427|FG000|Overall Study|Adverse Event|2|||
146740973|NCT01248962|529224428|FG001|Overall Study|Adverse Event|1|||
146740974|NCT01248962|529224427|FG000|Overall Study|Complete Response after 4 Cycles|1|||
146740975|NCT01248962|529224428|FG001|Overall Study|Complete Response after 4 Cycles|0|||
146740976|NCT01248962|529224427|FG000|Overall Study|Complete Response after 3 Cycles|0|||
146740977|NCT01248962|529224428|FG001|Overall Study|Complete Response after 3 Cycles|1|||
146740978|NCT01248962|529224427|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
146740979|NCT01248962|529224428|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
146740980|NCT01003184|529224429|FG000|Overall Study|Adverse Event|12|||
146740981|NCT01003184|529224430|FG001|Overall Study|Adverse Event|5|||
146740982|NCT01003184|529224429|FG000|Overall Study|Lost to Follow-up|1|||
146740983|NCT01003184|529224430|FG001|Overall Study|Lost to Follow-up|0|||
146740984|NCT01003184|529224429|FG000|Overall Study|Loss of glucose control|1|||
146740985|NCT01003184|529224430|FG001|Overall Study|Loss of glucose control|1|||
146740986|NCT01003184|529224429|FG000|Overall Study|Protocol Violation|3|||
146740987|NCT01003184|529224430|FG001|Overall Study|Protocol Violation|0|||
146740988|NCT01003184|529224429|FG000|Overall Study|Withdrawal by Subject|1|||
146740989|NCT01003184|529224430|FG001|Overall Study|Withdrawal by Subject|6|||
146740990|NCT01003184|529224429|FG000|Overall Study|Physician Decision|1|||
146740991|NCT01003184|529224430|FG001|Overall Study|Physician Decision|0|||
146740992|NCT00557622|529224431|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
146740993|NCT00557622|529224432|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
146740994|NCT00557622|529224431|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
146740995|NCT00557622|529224432|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
146740996|NCT00557622|529224431|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
146740997|NCT00557622|529224432|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
146740998|NCT04848662|529224433|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
146740999|NCT04848662|529224434|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
146741000|NCT03151395|529224441|FG000|Overall Study|Adverse Event|2|||
146741001|NCT03151395|529224441|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
146741002|NCT03151395|529224441|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
146741003|NCT03151395|529224441|FG000|Overall Study|Unspecified reason|4|||
146741004|NCT02494206|529224455|FG000|Overall Study|Adverse Event|1|||
146741005|NCT02494206|529224455|FG000|Overall Study|Disease Progression|1|||
146741006|NCT04986982|529224458|FG000|Overall Study|Withdrawal by Subject|3|||
146741007|NCT04986982|529224459|FG001|Overall Study|Withdrawal by Subject|1|||
146741008|NCT04986982|529224458|FG000|Overall Study|Lack of Efficacy|0|||
146741009|NCT04986982|529224459|FG001|Overall Study|Lack of Efficacy|2|||
146741010|NCT04986982|529224458|FG000|Overall Study|Ineligibility|3|||
146741011|NCT04986982|529224459|FG001|Overall Study|Ineligibility|0|||
146741012|NCT04986982|529224458|FG000|Overall Study|Adverse Event|4|||
146741013|NCT04986982|529224459|FG001|Overall Study|Adverse Event|4|||
146741014|NCT04986982|529224458|FG000|Overall Study|Lost to Follow-up|0|||
146741015|NCT04986982|529224459|FG001|Overall Study|Lost to Follow-up|1|||
146741016|NCT04986982|529224458|FG000|Overall Study|Sponsor's discretion|1|||
146741017|NCT04986982|529224459|FG001|Overall Study|Sponsor's discretion|0|||
146741018|NCT05796518|529224460|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
146741019|NCT01535274|529224461|FG000|Overall Study|Determined to be ineligible|0|||
146741020|NCT01535274|529224462|FG001|Overall Study|Determined to be ineligible|1|||
146741021|NCT01535274|529224461|FG000|Overall Study|Misallocated to propofol intervention|0|||
146741022|NCT01535274|529224462|FG001|Overall Study|Misallocated to propofol intervention|1|||
146741023|NCT03679767|529224463|FG000|Overall Study|Death|16|||
146741024|NCT03679767|529224464|FG001|Overall Study|Death|11|||
146741025|NCT03679767|529224465|FG002|Overall Study|Death|17|||
146741026|NCT03679767|529224466|FG003|Overall Study|Death|10|||
146741027|NCT03679767|529224463|FG000|Overall Study|Lost to Follow-up|1|||
146741028|NCT03679767|529224464|FG001|Overall Study|Lost to Follow-up|1|||
146741029|NCT03679767|529224465|FG002|Overall Study|Lost to Follow-up|1|||
146741030|NCT03679767|529224466|FG003|Overall Study|Lost to Follow-up|1|||
146741031|NCT03679767|529224463|FG000|Overall Study|Withdrawal by Subject|0|||
146741032|NCT03679767|529224464|FG001|Overall Study|Withdrawal by Subject|0|||
146741033|NCT03679767|529224465|FG002|Overall Study|Withdrawal by Subject|0|||
146741034|NCT03679767|529224466|FG003|Overall Study|Withdrawal by Subject|1|||
146741035|NCT03679767|529224463|FG000|Overall Study|Follow-up Completed|18|||
146741036|NCT03679767|529224464|FG001|Overall Study|Follow-up Completed|11|||
146741037|NCT03679767|529224465|FG002|Overall Study|Follow-up Completed|11|||
146741038|NCT03679767|529224466|FG003|Overall Study|Follow-up Completed|20|||
146741039|NCT03679767|529224463|FG000|Overall Study|Entered Hospice Care|0|||
146741040|NCT03679767|529224464|FG001|Overall Study|Entered Hospice Care|0|||
146741041|NCT03679767|529224465|FG002|Overall Study|Entered Hospice Care|0|||
146741042|NCT03679767|529224466|FG003|Overall Study|Entered Hospice Care|1|||
146741043|NCT03679767|529224463|FG000|Overall Study|Progressive Disease|0|||
146741044|NCT03679767|529224464|FG001|Overall Study|Progressive Disease|0|||
146741045|NCT03679767|529224465|FG002|Overall Study|Progressive Disease|0|||
146741046|NCT03679767|529224466|FG003|Overall Study|Progressive Disease|1|||
146741047|NCT02690077|529224467|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
146741048|NCT02690077|529224468|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
146741049|NCT02690077|529224467|FG000|Overall Study|Withdrawal by Subject|0|||
146741050|NCT02690077|529224468|FG001|Overall Study|Withdrawal by Subject|5|||
146741051|NCT02690077|529224467|FG000|Overall Study|Excluded by IRB|0|||
146741052|NCT02690077|529224468|FG001|Overall Study|Excluded by IRB|2|||
146741053|NCT05229653|529224469|FG000|Overall Study|Lost to Follow-up|1|||
146741054|NCT05229653|529224470|FG001|Overall Study|Lost to Follow-up|0|||
146741055|NCT01845974|529224471|FG000|Overall Study|screen failure|1|||
146741056|NCT01845974|529224472|FG001|Overall Study|screen failure|0|||
146741057|NCT02667886|529224473|FG000|Dose Escalation (Part A)|Adverse Event|1|||
146741058|NCT02667886|529224474|FG001|Dose Escalation (Part A)|Adverse Event|3|||
146741059|NCT02667886|529224475|FG002|Dose Escalation (Part A)|Adverse Event|1|||
146741060|NCT02667886|529224476|FG003|Dose Escalation (Part A)|Adverse Event|0|||
146741061|NCT02667886|529224477|FG004|Dose Escalation (Part A)|Adverse Event|0|||
146741062|NCT02667886|529224473|FG000|Dose Escalation (Part A)|Disease Progression|1|||
146741063|NCT02667886|529224474|FG001|Dose Escalation (Part A)|Disease Progression|4|||
146741064|NCT02667886|529224475|FG002|Dose Escalation (Part A)|Disease Progression|3|||
146741065|NCT02667886|529224476|FG003|Dose Escalation (Part A)|Disease Progression|0|||
146741066|NCT02667886|529224477|FG004|Dose Escalation (Part A)|Disease Progression|0|||
146741067|NCT02667886|529224473|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
146914637|NCT03303339|529850046|FG004|Overall Study|Death|4|||
146741068|NCT02667886|529224474|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
146741069|NCT02667886|529224475|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
146741070|NCT02667886|529224476|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
146741071|NCT02667886|529224477|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
146741072|NCT02667886|529224473|FG000|Dose Expansion (Part B)|Adverse Event|0|||
146741073|NCT02667886|529224474|FG001|Dose Expansion (Part B)|Adverse Event|0|||
146741074|NCT02667886|529224475|FG002|Dose Expansion (Part B)|Adverse Event|0|||
146741075|NCT02667886|529224476|FG003|Dose Expansion (Part B)|Adverse Event|9|||
146741076|NCT02667886|529224477|FG004|Dose Expansion (Part B)|Adverse Event|0|||
146741077|NCT02667886|529224473|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
146741078|NCT02667886|529224474|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
146741079|NCT02667886|529224475|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
146741080|NCT02667886|529224476|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
146741081|NCT02667886|529224477|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
146741082|NCT02667886|529224473|FG000|Dose Expansion (Part B)|Disease Progression|0|||
146741083|NCT02667886|529224474|FG001|Dose Expansion (Part B)|Disease Progression|0|||
146741084|NCT02667886|529224475|FG002|Dose Expansion (Part B)|Disease Progression|0|||
146741085|NCT02667886|529224476|FG003|Dose Expansion (Part B)|Disease Progression|38|||
146741086|NCT02667886|529224477|FG004|Dose Expansion (Part B)|Disease Progression|0|||
146741087|NCT02667886|529224473|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
146741088|NCT02667886|529224474|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
146741089|NCT02667886|529224475|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
146741090|NCT02667886|529224476|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
146741091|NCT02667886|529224477|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
146741092|NCT02667886|529224473|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
146741093|NCT02667886|529224474|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
146741094|NCT02667886|529224475|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
146741095|NCT02667886|529224476|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
146741096|NCT02667886|529224477|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
146741097|NCT02667886|529224473|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
146741098|NCT02667886|529224474|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
146741099|NCT02667886|529224475|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
146741100|NCT02667886|529224476|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
146741101|NCT02667886|529224477|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
146741102|NCT00594217|529224478|FG000|Overall Study|Withdrawal by Subject|1|||
146741103|NCT00594217|529224479|FG001|Overall Study|Withdrawal by Subject|3|||
146741104|NCT05408468|529224480|FG000|Overall Study|Lost to Follow-up|3|||
146741105|NCT05408468|529224481|FG001|Overall Study|Lost to Follow-up|1|||
146741106|NCT05408468|529224480|FG000|Overall Study|Physician Decision|1|||
146741107|NCT05408468|529224481|FG001|Overall Study|Physician Decision|0|||
146741108|NCT05408468|529224480|FG000|Overall Study|Overwhelmed by clinical situation|3|||
146741109|NCT05408468|529224481|FG001|Overall Study|Overwhelmed by clinical situation|0|||
146741110|NCT05408468|529224480|FG000|Overall Study|Personal illness precluding participation|1|||
146741111|NCT05408468|529224481|FG001|Overall Study|Personal illness precluding participation|0|||
146741112|NCT05408468|529224480|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
146741113|NCT05408468|529224481|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
146741114|NCT04186403|529224482|FG000|Overall Study|Adverse Event|1|||
146741115|NCT04186403|529224483|FG001|Overall Study|Adverse Event|8|||
146741116|NCT04186403|529224482|FG000|Overall Study|Lost to Follow-up|7|||
146741117|NCT04186403|529224483|FG001|Overall Study|Lost to Follow-up|3|||
146741118|NCT04186403|529224482|FG000|Overall Study|Physician Decision|1|||
146741119|NCT04186403|529224483|FG001|Overall Study|Physician Decision|0|||
146741120|NCT04186403|529224482|FG000|Overall Study|Withdrawal by Subject|7|||
146741121|NCT04186403|529224483|FG001|Overall Study|Withdrawal by Subject|8|||
146741122|NCT04186403|529224482|FG000|Overall Study|Other: Not Related to Covid-19|3|||
146741123|NCT04186403|529224483|FG001|Overall Study|Other: Not Related to Covid-19|0|||
146741124|NCT01407354|529224487|FG000|First Intervention|Withdrawal by Subject|0|||
146741125|NCT01407354|529224488|FG001|First Intervention|Withdrawal by Subject|2|||
146741126|NCT01407354|529224487|FG000|First Intervention|Adverse Event|1|||
146741127|NCT01407354|529224488|FG001|First Intervention|Adverse Event|0|||
146741128|NCT01407354|529224487|FG000|First Intervention|Physician Decision|1|||
146741129|NCT01407354|529224488|FG001|First Intervention|Physician Decision|0|||
146741130|NCT02223754|529224489|FG000|Period 1|Adverse Event|1|||
146741131|NCT02223754|529224490|FG001|Period 1|Adverse Event|0|||
146741132|NCT02223754|529224489|FG000|Period 1|Lost to Follow-up|0|||
146741133|NCT02223754|529224490|FG001|Period 1|Lost to Follow-up|1|||
146741134|NCT02223754|529224489|FG000|Period 1|Protocol Violation|2|||
146741135|NCT02223754|529224490|FG001|Period 1|Protocol Violation|4|||
146741136|NCT02223754|529224489|FG000|Period 1|Withdrawal by Subject|0|||
146741137|NCT02223754|529224490|FG001|Period 1|Withdrawal by Subject|4|||
146741138|NCT02223754|529224489|FG000|Period 1|Test Article No Longer Available|1|||
146741139|NCT02223754|529224490|FG001|Period 1|Test Article No Longer Available|5|||
146741140|NCT02223754|529224489|FG000|Period 1|Unsatisfactory Visual Response|0|||
146741141|NCT02223754|529224490|FG001|Period 1|Unsatisfactory Visual Response|1|||
146741142|NCT02223754|529224489|FG000|Period 2|Adverse Event|0|||
146741143|NCT02223754|529224490|FG001|Period 2|Adverse Event|1|||
146741144|NCT02223754|529224489|FG000|Period 2|Protocol Violation|1|||
146741145|NCT02223754|529224490|FG001|Period 2|Protocol Violation|0|||
146741146|NCT02223754|529224489|FG000|Period 2|Lens Discomfort|1|||
146741147|NCT02223754|529224490|FG001|Period 2|Lens Discomfort|1|||
146741148|NCT02223754|529224489|FG000|Period 2|Lost to Follow-up|1|||
146741149|NCT02223754|529224490|FG001|Period 2|Lost to Follow-up|0|||
146741150|NCT02223754|529224489|FG000|Period 2|Test Article No Longer Available|0|||
146741151|NCT02223754|529224490|FG001|Period 2|Test Article No Longer Available|1|||
146741152|NCT01807650|529224498|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
146741153|NCT01807650|529224498|FG000|Overall Study|Adverse Event|5|||
146741154|NCT01807650|529224498|FG000|Overall Study|Other|2|||
146741155|NCT00886639|529224507|FG000|Overall Study|acute exacerbation|14|||
146741156|NCT00886639|529224507|FG000|Overall Study|non-compliance|2|||
146741157|NCT01871558|529224510|FG000|Overall Study|Other reason|0|||
146741158|NCT01871558|529224511|FG001|Overall Study|Other reason|1|||
146741159|NCT01871558|529224510|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
146741160|NCT01871558|529224511|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
146741161|NCT01871558|529224510|FG000|Overall Study|Withdrawal by Subject|2|||
146741162|NCT01871558|529224511|FG001|Overall Study|Withdrawal by Subject|0|||
146741163|NCT03203694|529224512|FG000|Overall Study|Withdrawal by Subject|2|||
146741164|NCT03203694|529224513|FG001|Overall Study|Withdrawal by Subject|0|||
146741165|NCT03203694|529224514|FG002|Overall Study|Withdrawal by Subject|0|||
146741166|NCT03203694|529224515|FG003|Overall Study|Withdrawal by Subject|0|||
146741167|NCT03203694|529224516|FG004|Overall Study|Withdrawal by Subject|0|||
146741168|NCT03203694|529224517|FG005|Overall Study|Withdrawal by Subject|0|||
146741169|NCT01709305|529224520|FG000|Phase 1|Clinical Adverse Event|80|||
146741170|NCT01709305|529224521|FG001|Phase 1|Clinical Adverse Event|0|||
146741171|NCT01709305|529224522|FG002|Phase 1|Clinical Adverse Event|0|||
146741172|NCT01709305|529224523|FG003|Phase 1|Clinical Adverse Event|0|||
146741173|NCT01709305|529224524|FG004|Phase 1|Clinical Adverse Event|0|||
146741174|NCT01709305|529224520|FG000|Phase 1|Death|2|||
146741175|NCT01709305|529224521|FG001|Phase 1|Death|0|||
146741176|NCT01709305|529224522|FG002|Phase 1|Death|0|||
146741177|NCT01709305|529224523|FG003|Phase 1|Death|0|||
146741178|NCT01709305|529224524|FG004|Phase 1|Death|0|||
146741179|NCT01709305|529224520|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
146741180|NCT01709305|529224521|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
146741181|NCT01709305|529224522|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
146741182|NCT01709305|529224523|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
146741183|NCT01709305|529224524|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
146741184|NCT01709305|529224520|FG000|Phase 1|Laboratory Adverse Event|16|||
146741185|NCT01709305|529224521|FG001|Phase 1|Laboratory Adverse Event|0|||
146741186|NCT01709305|529224522|FG002|Phase 1|Laboratory Adverse Event|0|||
146741187|NCT01709305|529224523|FG003|Phase 1|Laboratory Adverse Event|0|||
146741188|NCT01709305|529224524|FG004|Phase 1|Laboratory Adverse Event|0|||
146741189|NCT01709305|529224520|FG000|Phase 1|Lost to Follow-up|147|||
146741190|NCT01709305|529224521|FG001|Phase 1|Lost to Follow-up|0|||
146741191|NCT01709305|529224522|FG002|Phase 1|Lost to Follow-up|0|||
146741192|NCT01709305|529224523|FG003|Phase 1|Lost to Follow-up|0|||
146741193|NCT01709305|529224524|FG004|Phase 1|Lost to Follow-up|0|||
146741194|NCT01709305|529224520|FG000|Phase 1|Travel, moving, etc.|30|||
146741195|NCT01709305|529224521|FG001|Phase 1|Travel, moving, etc.|0|||
146741196|NCT01709305|529224522|FG002|Phase 1|Travel, moving, etc.|0|||
146741197|NCT01709305|529224523|FG003|Phase 1|Travel, moving, etc.|0|||
146741198|NCT01709305|529224524|FG004|Phase 1|Travel, moving, etc.|0|||
146741199|NCT01709305|529224520|FG000|Phase 1|Physician Decision|13|||
146741200|NCT01709305|529224521|FG001|Phase 1|Physician Decision|0|||
146741201|NCT01709305|529224522|FG002|Phase 1|Physician Decision|0|||
146741202|NCT01709305|529224523|FG003|Phase 1|Physician Decision|0|||
146741203|NCT01709305|529224524|FG004|Phase 1|Physician Decision|0|||
146741204|NCT01709305|529224520|FG000|Phase 1|Protocol Violation|118|||
146741205|NCT01709305|529224521|FG001|Phase 1|Protocol Violation|0|||
146741206|NCT01709305|529224522|FG002|Phase 1|Protocol Violation|0|||
146741207|NCT01709305|529224523|FG003|Phase 1|Protocol Violation|0|||
146741208|NCT01709305|529224524|FG004|Phase 1|Protocol Violation|0|||
146741209|NCT01709305|529224520|FG000|Phase 1|Withdrawal by Subject|218|||
146741210|NCT01709305|529224521|FG001|Phase 1|Withdrawal by Subject|0|||
146741211|NCT01709305|529224522|FG002|Phase 1|Withdrawal by Subject|0|||
146741212|NCT01709305|529224523|FG003|Phase 1|Withdrawal by Subject|0|||
146741213|NCT01709305|529224524|FG004|Phase 1|Withdrawal by Subject|0|||
146741214|NCT01709305|529224520|FG000|Phase 2|Clinical Adverse Event|0|||
146741215|NCT01709305|529224521|FG001|Phase 2|Clinical Adverse Event|10|||
146741216|NCT01709305|529224522|FG002|Phase 2|Clinical Adverse Event|10|||
146741217|NCT01709305|529224523|FG003|Phase 2|Clinical Adverse Event|6|||
146741218|NCT01709305|529224524|FG004|Phase 2|Clinical Adverse Event|11|||
146741219|NCT01709305|529224520|FG000|Phase 2|Death|0|||
146741220|NCT01709305|529224521|FG001|Phase 2|Death|0|||
146741221|NCT01709305|529224522|FG002|Phase 2|Death|1|||
146741222|NCT01709305|529224523|FG003|Phase 2|Death|0|||
146741223|NCT01709305|529224524|FG004|Phase 2|Death|0|||
146741224|NCT01709305|529224520|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
146741225|NCT01709305|529224521|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
146741226|NCT01709305|529224522|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
146741227|NCT01709305|529224523|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
146741228|NCT01709305|529224524|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
146741229|NCT01709305|529224520|FG000|Phase 2|Laboratory Adverse Event|0|||
146741230|NCT01709305|529224521|FG001|Phase 2|Laboratory Adverse Event|1|||
146741231|NCT01709305|529224522|FG002|Phase 2|Laboratory Adverse Event|0|||
146741232|NCT01709305|529224523|FG003|Phase 2|Laboratory Adverse Event|1|||
146741233|NCT01709305|529224524|FG004|Phase 2|Laboratory Adverse Event|1|||
146741234|NCT01709305|529224520|FG000|Phase 2|Lost to Follow-up|0|||
146741235|NCT01709305|529224521|FG001|Phase 2|Lost to Follow-up|10|||
146741236|NCT01709305|529224522|FG002|Phase 2|Lost to Follow-up|6|||
146741237|NCT01709305|529224523|FG003|Phase 2|Lost to Follow-up|9|||
146741238|NCT01709305|529224524|FG004|Phase 2|Lost to Follow-up|5|||
146741239|NCT01709305|529224520|FG000|Phase 2|Travel, moving, etc.|0|||
146741240|NCT01709305|529224521|FG001|Phase 2|Travel, moving, etc.|2|||
146741241|NCT01709305|529224522|FG002|Phase 2|Travel, moving, etc.|3|||
146741242|NCT01709305|529224523|FG003|Phase 2|Travel, moving, etc.|3|||
146741243|NCT01709305|529224524|FG004|Phase 2|Travel, moving, etc.|5|||
146741244|NCT01709305|529224520|FG000|Phase 2|Physician Decision|0|||
146741245|NCT01709305|529224521|FG001|Phase 2|Physician Decision|2|||
146741246|NCT01709305|529224522|FG002|Phase 2|Physician Decision|0|||
146741247|NCT01709305|529224523|FG003|Phase 2|Physician Decision|1|||
146741248|NCT01709305|529224524|FG004|Phase 2|Physician Decision|2|||
146741249|NCT01709305|529224520|FG000|Phase 2|Protocol Violation|0|||
146741250|NCT01709305|529224521|FG001|Phase 2|Protocol Violation|19|||
146741251|NCT01709305|529224522|FG002|Phase 2|Protocol Violation|19|||
146741252|NCT01709305|529224523|FG003|Phase 2|Protocol Violation|13|||
146741253|NCT01709305|529224524|FG004|Phase 2|Protocol Violation|9|||
146741254|NCT01709305|529224520|FG000|Phase 2|Withdrawal by Subject|0|||
146741255|NCT01709305|529224521|FG001|Phase 2|Withdrawal by Subject|8|||
146741256|NCT01709305|529224522|FG002|Phase 2|Withdrawal by Subject|6|||
146741257|NCT01709305|529224523|FG003|Phase 2|Withdrawal by Subject|15|||
146741258|NCT01709305|529224524|FG004|Phase 2|Withdrawal by Subject|12|||
146741259|NCT02294474|529224525|FG000|Overall Study|Adverse Event|7|||
146741260|NCT02294474|529224526|FG001|Overall Study|Adverse Event|7|||
146741261|NCT02294474|529224525|FG000|Overall Study|Lack of Efficacy|2|||
146741262|NCT02294474|529224526|FG001|Overall Study|Lack of Efficacy|1|||
146741263|NCT02294474|529224525|FG000|Overall Study|Protocol Violation|4|||
146741264|NCT02294474|529224526|FG001|Overall Study|Protocol Violation|2|||
146741265|NCT02294474|529224525|FG000|Overall Study|Other than specified above|12|||
146741266|NCT02294474|529224526|FG001|Overall Study|Other than specified above|12|||
146741267|NCT03813147|529224531|FG000|Overall Study|Lack of Efficacy|4|||
146741268|NCT03813147|529224532|FG001|Overall Study|Lack of Efficacy|4|||
146741269|NCT03813147|529224531|FG000|Overall Study|Physician Decision|2|||
146741270|NCT03813147|529224532|FG001|Overall Study|Physician Decision|1|||
146741271|NCT01167179|529226881|FG000|Overall Study|disease recurrence|4|||
146741272|NCT01167179|529226882|FG001|Overall Study|disease recurrence|4|||
146741273|NCT01167179|529226881|FG000|Overall Study|Death|4|||
146741274|NCT01167179|529226882|FG001|Overall Study|Death|10|||
146741275|NCT01167179|529226881|FG000|Overall Study|Withdrawal by Subject|1|||
146741276|NCT01167179|529226882|FG001|Overall Study|Withdrawal by Subject|2|||
146741277|NCT01167179|529226881|FG000|Overall Study|diverse|6|||
146741278|NCT01167179|529226882|FG001|Overall Study|diverse|5|||
146741279|NCT00663117|529226883|FG000|Overall Study|Lack of Efficacy|1|||
146741280|NCT00663117|529226884|FG001|Overall Study|Lack of Efficacy|0|||
146741281|NCT01158378|529226885|FG000|Overall Study|Death|4|||
146741282|NCT01158378|529226886|FG001|Overall Study|Death|5|||
146741283|NCT01158378|529226885|FG000|Overall Study|Lost to Follow-up|2|||
146741284|NCT01158378|529226886|FG001|Overall Study|Lost to Follow-up|4|||
146741285|NCT01158378|529226885|FG000|Overall Study|Withdrawal by Subject|4|||
146741286|NCT01158378|529226886|FG001|Overall Study|Withdrawal by Subject|0|||
146741287|NCT02769065|529226887|FG000|Overall Study|Voluntary Withdrawal|1|||
146741288|NCT02769065|529226888|FG001|Overall Study|Voluntary Withdrawal|0|||
146741289|NCT02769065|529226889|FG002|Overall Study|Voluntary Withdrawal|0|||
146741290|NCT02769065|529226890|FG003|Overall Study|Voluntary Withdrawal|0|||
146741291|NCT02769065|529226891|FG004|Overall Study|Voluntary Withdrawal|0|||
146741292|NCT02769065|529226892|FG005|Overall Study|Voluntary Withdrawal|0|||
146741293|NCT02769065|529226893|FG006|Overall Study|Voluntary Withdrawal|0|||
146741294|NCT02769065|529226894|FG007|Overall Study|Voluntary Withdrawal|0|||
146741295|NCT02769065|529226895|FG008|Overall Study|Voluntary Withdrawal|0|||
146741296|NCT02769065|529226896|FG009|Overall Study|Voluntary Withdrawal|0|||
146741297|NCT02769065|529226897|FG010|Overall Study|Voluntary Withdrawal|0|||
146741298|NCT02769065|529226898|FG011|Overall Study|Voluntary Withdrawal|0|||
146741299|NCT02769065|529226899|FG012|Overall Study|Voluntary Withdrawal|0|||
146741300|NCT02769065|529226900|FG013|Overall Study|Voluntary Withdrawal|0|||
146741301|NCT02769065|529226901|FG014|Overall Study|Voluntary Withdrawal|0|||
146741302|NCT02769065|529226902|FG015|Overall Study|Voluntary Withdrawal|0|||
146741303|NCT02769065|529226903|FG016|Overall Study|Voluntary Withdrawal|0|||
146741304|NCT02769065|529226904|FG017|Overall Study|Voluntary Withdrawal|0|||
146741305|NCT02769065|529226905|FG018|Overall Study|Voluntary Withdrawal|0|||
146741306|NCT02769065|529226906|FG019|Overall Study|Voluntary Withdrawal|0|||
146741307|NCT02769065|529226907|FG020|Overall Study|Voluntary Withdrawal|0|||
146741308|NCT02769065|529226908|FG021|Overall Study|Voluntary Withdrawal|0|||
146741309|NCT02769065|529226909|FG022|Overall Study|Voluntary Withdrawal|0|||
146741310|NCT02769065|529226910|FG023|Overall Study|Voluntary Withdrawal|0|||
146741311|NCT02769065|529226911|FG024|Overall Study|Voluntary Withdrawal|0|||
146741312|NCT02769065|529226912|FG025|Overall Study|Voluntary Withdrawal|0|||
146741313|NCT02769065|529226913|FG026|Overall Study|Voluntary Withdrawal|0|||
146741314|NCT02769065|529226914|FG027|Overall Study|Voluntary Withdrawal|0|||
146741315|NCT02769065|529226915|FG028|Overall Study|Voluntary Withdrawal|0|||
146741316|NCT02769065|529226916|FG029|Overall Study|Voluntary Withdrawal|0|||
146741317|NCT02769065|529226887|FG000|Overall Study|Reason Not Specified|0|||
146741318|NCT02769065|529226888|FG001|Overall Study|Reason Not Specified|0|||
146741319|NCT02769065|529226889|FG002|Overall Study|Reason Not Specified|0|||
146741320|NCT02769065|529226890|FG003|Overall Study|Reason Not Specified|0|||
146741321|NCT02769065|529226891|FG004|Overall Study|Reason Not Specified|0|||
146741322|NCT02769065|529226892|FG005|Overall Study|Reason Not Specified|0|||
146741323|NCT02769065|529226893|FG006|Overall Study|Reason Not Specified|1|||
146741324|NCT02769065|529226894|FG007|Overall Study|Reason Not Specified|0|||
146741325|NCT02769065|529226895|FG008|Overall Study|Reason Not Specified|0|||
146741326|NCT02769065|529226896|FG009|Overall Study|Reason Not Specified|0|||
146741327|NCT02769065|529226897|FG010|Overall Study|Reason Not Specified|0|||
146741328|NCT02769065|529226898|FG011|Overall Study|Reason Not Specified|0|||
146741329|NCT02769065|529226899|FG012|Overall Study|Reason Not Specified|0|||
146741330|NCT02769065|529226900|FG013|Overall Study|Reason Not Specified|0|||
146741331|NCT02769065|529226901|FG014|Overall Study|Reason Not Specified|0|||
146741332|NCT02769065|529226902|FG015|Overall Study|Reason Not Specified|0|||
146741333|NCT02769065|529226903|FG016|Overall Study|Reason Not Specified|0|||
146741334|NCT02769065|529226904|FG017|Overall Study|Reason Not Specified|0|||
146741335|NCT02769065|529226905|FG018|Overall Study|Reason Not Specified|0|||
146741336|NCT02769065|529226906|FG019|Overall Study|Reason Not Specified|0|||
146741337|NCT02769065|529226907|FG020|Overall Study|Reason Not Specified|0|||
146741338|NCT02769065|529226908|FG021|Overall Study|Reason Not Specified|0|||
146741339|NCT02769065|529226909|FG022|Overall Study|Reason Not Specified|0|||
146741340|NCT02769065|529226910|FG023|Overall Study|Reason Not Specified|0|||
146741341|NCT02769065|529226911|FG024|Overall Study|Reason Not Specified|0|||
146741342|NCT02769065|529226912|FG025|Overall Study|Reason Not Specified|0|||
146741343|NCT02769065|529226913|FG026|Overall Study|Reason Not Specified|0|||
146741344|NCT02769065|529226914|FG027|Overall Study|Reason Not Specified|0|||
146741345|NCT02769065|529226915|FG028|Overall Study|Reason Not Specified|0|||
146741346|NCT02769065|529226916|FG029|Overall Study|Reason Not Specified|0|||
146741347|NCT02769065|529226887|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741348|NCT02769065|529226888|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741349|NCT02769065|529226889|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741350|NCT02769065|529226890|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741351|NCT02769065|529226891|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741352|NCT02769065|529226892|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741353|NCT02769065|529226893|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741354|NCT02769065|529226894|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741355|NCT02769065|529226895|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741356|NCT02769065|529226896|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741357|NCT02769065|529226897|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
146741358|NCT02769065|529226898|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741359|NCT02769065|529226899|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741360|NCT02769065|529226900|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741361|NCT02769065|529226901|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741362|NCT02769065|529226902|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741363|NCT02769065|529226903|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741364|NCT02769065|529226904|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741365|NCT02769065|529226905|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741366|NCT02769065|529226906|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741367|NCT02769065|529226907|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741368|NCT02769065|529226908|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741369|NCT02769065|529226909|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741370|NCT02769065|529226910|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741371|NCT02769065|529226911|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741372|NCT02769065|529226912|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741373|NCT02769065|529226913|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741374|NCT02769065|529226914|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741375|NCT02769065|529226915|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741376|NCT02769065|529226916|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
146741377|NCT01806740|529226920|FG000|Overall Study|Withdrawal by Subject|4|||
146741378|NCT01806740|529226920|FG000|Overall Study|Physician Decision|1|||
146741379|NCT01806740|529226920|FG000|Overall Study|Patient's refusal of treatment|1|||
146741380|NCT04666922|529226921|FG000|Overall Study|Withdrawal by Subject|1|||
146741381|NCT04666922|529226922|FG001|Overall Study|Withdrawal by Subject|0|||
146741382|NCT04666922|529226923|FG002|Overall Study|Withdrawal by Subject|0|||
146741383|NCT04666922|529226924|FG003|Overall Study|Withdrawal by Subject|0|||
146741384|NCT04666922|529226925|FG004|Overall Study|Withdrawal by Subject|0|||
146741385|NCT04666922|529226926|FG005|Overall Study|Withdrawal by Subject|0|||
146741386|NCT04666922|529226927|FG006|Overall Study|Withdrawal by Subject|0|||
146741387|NCT01382940|529226928|FG000|Overall Study|Adverse Event|19|||
146741388|NCT01382940|529226928|FG000|Overall Study|Lost to Follow-up|4|||
146741389|NCT01382940|529226928|FG000|Overall Study|Physician Decision|7|||
146741390|NCT01382940|529226928|FG000|Overall Study|Withdrawal by Subject|23|||
146741391|NCT01382940|529226928|FG000|Overall Study|Protocol Violation|20|||
146741392|NCT02105636|529226930|FG000|Pre-Treatment|Disease Progression|1|||
146741393|NCT02105636|529226931|FG001|Pre-Treatment|Disease Progression|0|||
146741394|NCT02105636|529226930|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
146741395|NCT02105636|529226931|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
146741396|NCT02105636|529226930|FG000|Pre-Treatment|Participant withdrew consent|0|||
146741397|NCT02105636|529226931|FG001|Pre-Treatment|Participant withdrew consent|6|||
146741398|NCT02105636|529226930|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
146741399|NCT02105636|529226931|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
146741400|NCT02105636|529226930|FG000|Treatment|Study Drug Toxicity|14|||
146741401|NCT02105636|529226931|FG001|Treatment|Study Drug Toxicity|10|||
146741402|NCT02105636|529226930|FG000|Treatment|Adverse event unrelated to study drug|19|||
146741403|NCT02105636|529226931|FG001|Treatment|Adverse event unrelated to study drug|3|||
146741404|NCT02105636|529226930|FG000|Treatment|Participant request to discontinue study treatment|8|||
146741405|NCT02105636|529226931|FG001|Treatment|Participant request to discontinue study treatment|6|||
146741406|NCT02105636|529226930|FG000|Treatment|Participant withdrew consent|5|||
146741407|NCT02105636|529226931|FG001|Treatment|Participant withdrew consent|1|||
146741408|NCT02105636|529226930|FG000|Treatment|Lost to Follow-up|1|||
146741409|NCT02105636|529226931|FG001|Treatment|Lost to Follow-up|0|||
146741410|NCT02105636|529226930|FG000|Treatment|Maximum Clinical Benefit|1|||
146741411|NCT02105636|529226931|FG001|Treatment|Maximum Clinical Benefit|3|||
146741412|NCT02105636|529226930|FG000|Treatment|Poor/Non-compliance|0|||
146741413|NCT02105636|529226931|FG001|Treatment|Poor/Non-compliance|1|||
146741414|NCT02105636|529226930|FG000|Treatment|Participant no longer meets study criteria|1|||
146741415|NCT02105636|529226931|FG001|Treatment|Participant no longer meets study criteria|0|||
146741416|NCT02105636|529226930|FG000|Treatment|Other reasons|1|||
146741417|NCT02105636|529226931|FG001|Treatment|Other reasons|0|||
146741418|NCT02105636|529226930|FG000|Treatment|Disease Progression|185|||
146741419|NCT02105636|529226931|FG001|Treatment|Disease Progression|87|||
146741420|NCT02802319|529226932|FG000|Overall Study|Physician Decision|2|||
146741421|NCT02802319|529226933|FG001|Overall Study|Physician Decision|1|||
146741422|NCT02802319|529226932|FG000|Overall Study|Lost to Follow-up|0|||
146741423|NCT02802319|529226933|FG001|Overall Study|Lost to Follow-up|4|||
146741424|NCT00474929|529226940|FG000|Overall Study|Withdrawal by Subject|0|||
146741425|NCT00474929|529226941|FG001|Overall Study|Withdrawal by Subject|1|||
146741426|NCT00474929|529226942|FG002|Overall Study|Withdrawal by Subject|0|||
146741427|NCT00474929|529226943|FG003|Overall Study|Withdrawal by Subject|0|||
146741428|NCT00474929|529226944|FG004|Overall Study|Withdrawal by Subject|0|||
146741429|NCT00474929|529226940|FG000|Overall Study|Unrelated medical condition|0|||
146741430|NCT00474929|529226941|FG001|Overall Study|Unrelated medical condition|0|||
146741431|NCT00474929|529226942|FG002|Overall Study|Unrelated medical condition|1|||
146741432|NCT00474929|529226943|FG003|Overall Study|Unrelated medical condition|0|||
146741433|NCT00474929|529226944|FG004|Overall Study|Unrelated medical condition|0|||
146741434|NCT00474929|529226940|FG000|Overall Study|Physician Decision|0|||
146741435|NCT00474929|529226941|FG001|Overall Study|Physician Decision|0|||
146741436|NCT00474929|529226942|FG002|Overall Study|Physician Decision|1|||
146741437|NCT00474929|529226943|FG003|Overall Study|Physician Decision|2|||
146741438|NCT00474929|529226944|FG004|Overall Study|Physician Decision|0|||
146741439|NCT03661996|529226945|FG000|Overall Study|Adverse Event|0|||
146741440|NCT03661996|529226946|FG001|Overall Study|Adverse Event|0|||
146741441|NCT03661996|529226947|FG002|Overall Study|Adverse Event|1|||
146741442|NCT03661996|529226948|FG003|Overall Study|Adverse Event|1|||
146741443|NCT03661996|529226949|FG004|Overall Study|Adverse Event|0|||
146741444|NCT03661996|529226945|FG000|Overall Study|Lost to Follow-up|5|||
146741445|NCT03661996|529226946|FG001|Overall Study|Lost to Follow-up|1|||
146741446|NCT03661996|529226947|FG002|Overall Study|Lost to Follow-up|2|||
146741447|NCT03661996|529226948|FG003|Overall Study|Lost to Follow-up|2|||
146741448|NCT03661996|529226949|FG004|Overall Study|Lost to Follow-up|6|||
146741449|NCT03661996|529226945|FG000|Overall Study|Physician Decision|1|||
146741450|NCT03661996|529226946|FG001|Overall Study|Physician Decision|1|||
146741451|NCT03661996|529226947|FG002|Overall Study|Physician Decision|1|||
146741452|NCT03661996|529226948|FG003|Overall Study|Physician Decision|2|||
146741453|NCT03661996|529226949|FG004|Overall Study|Physician Decision|0|||
146741454|NCT03661996|529226945|FG000|Overall Study|Protocol Violation|0|||
146741455|NCT03661996|529226946|FG001|Overall Study|Protocol Violation|0|||
146741456|NCT03661996|529226947|FG002|Overall Study|Protocol Violation|0|||
146741457|NCT03661996|529226948|FG003|Overall Study|Protocol Violation|0|||
146741458|NCT03661996|529226949|FG004|Overall Study|Protocol Violation|1|||
146741459|NCT03661996|529226945|FG000|Overall Study|Withdrawal by Subject|3|||
146741460|NCT03661996|529226946|FG001|Overall Study|Withdrawal by Subject|5|||
146741461|NCT03661996|529226947|FG002|Overall Study|Withdrawal by Subject|1|||
146741462|NCT03661996|529226948|FG003|Overall Study|Withdrawal by Subject|7|||
146741463|NCT03661996|529226949|FG004|Overall Study|Withdrawal by Subject|7|||
146741464|NCT03661996|529226945|FG000|Overall Study|Sponsors Decision|2|||
146741465|NCT03661996|529226946|FG001|Overall Study|Sponsors Decision|0|||
146741466|NCT03661996|529226947|FG002|Overall Study|Sponsors Decision|0|||
146741467|NCT03661996|529226948|FG003|Overall Study|Sponsors Decision|0|||
146741468|NCT03661996|529226949|FG004|Overall Study|Sponsors Decision|0|||
146741469|NCT03661996|529226945|FG000|Overall Study|Other|1|||
146741470|NCT03661996|529226946|FG001|Overall Study|Other|1|||
146741471|NCT03661996|529226947|FG002|Overall Study|Other|1|||
146741472|NCT03661996|529226948|FG003|Overall Study|Other|1|||
146741473|NCT03661996|529226949|FG004|Overall Study|Other|0|||
146741474|NCT03029247|529226950|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
146741475|NCT03029247|529226951|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
146741476|NCT03029247|529226950|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
146741477|NCT03029247|529226951|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
146741478|NCT03029247|529226950|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
146741479|NCT03029247|529226951|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
146741480|NCT03029247|529226950|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
146741481|NCT03029247|529226951|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
146741482|NCT02593305|529226952|FG000|Post 1|Comparison only group. No intervention.|0|||
146741483|NCT02593305|529226953|FG001|Post 1|Comparison only group. No intervention.|0|||
146741484|NCT02593305|529226954|FG002|Post 1|Comparison only group. No intervention.|10|||
146741485|NCT01993017|529226955|FG000|Overall Study|Death|23|||
146741486|NCT01993017|529226956|FG001|Overall Study|Death|26|||
146741487|NCT01993017|529226957|FG002|Overall Study|Death|18|||
146741488|NCT01993017|529226955|FG000|Overall Study|Could not be contacted|43|||
146741489|NCT01993017|529226956|FG001|Overall Study|Could not be contacted|42|||
146741490|NCT01993017|529226957|FG002|Overall Study|Could not be contacted|38|||
146741491|NCT01993017|529226955|FG000|Overall Study|Dropped out|19|||
146741492|NCT01993017|529226956|FG001|Overall Study|Dropped out|6|||
146741493|NCT01993017|529226957|FG002|Overall Study|Dropped out|11|||
146741494|NCT01993017|529226955|FG000|Overall Study|Other reasons|17|||
146741495|NCT01993017|529226956|FG001|Overall Study|Other reasons|11|||
146741496|NCT01993017|529226957|FG002|Overall Study|Other reasons|7|||
146741497|NCT01993017|529226955|FG000|Overall Study|Ineligible after randomization|4|||
146741498|NCT01993017|529226956|FG001|Overall Study|Ineligible after randomization|5|||
146741499|NCT01993017|529226957|FG002|Overall Study|Ineligible after randomization|5|||
146741500|NCT00068380|529226958|FG000|Overall Study|Withdrawal by Subject|3|||
146741501|NCT00068380|529226958|FG000|Overall Study|Adverse Event|2|||
146741502|NCT01976364|529226959|FG000|Main Study (36 Months)|Adverse Event|63|||
146741503|NCT01976364|529226960|FG001|Main Study (36 Months)|Adverse Event|0|||
146741504|NCT01976364|529226961|FG002|Main Study (36 Months)|Adverse Event|0|||
146741505|NCT01976364|529226959|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
146741506|NCT01976364|529226960|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
146741507|NCT01976364|529226961|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
146741508|NCT01976364|529226959|FG000|Main Study (36 Months)|Other|13|||
146741509|NCT01976364|529226960|FG001|Main Study (36 Months)|Other|0|||
146741510|NCT01976364|529226961|FG002|Main Study (36 Months)|Other|0|||
146741511|NCT01976364|529226959|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
146741512|NCT01976364|529226960|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
146741513|NCT01976364|529226961|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
146741514|NCT01976364|529226959|FG000|Main Study (36 Months)|Medication error|1|||
146741515|NCT01976364|529226960|FG001|Main Study (36 Months)|Medication error|0|||
146741516|NCT01976364|529226961|FG002|Main Study (36 Months)|Medication error|0|||
146741517|NCT01976364|529226959|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
146741518|NCT01976364|529226960|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
146741519|NCT01976364|529226961|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
146741520|NCT01976364|529226959|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
146741521|NCT01976364|529226960|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
146741522|NCT01976364|529226961|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
146741523|NCT01976364|529226959|FG000|Main Study (36 Months)|Protocol Violation|13|||
146741524|NCT01976364|529226960|FG001|Main Study (36 Months)|Protocol Violation|0|||
146741525|NCT01976364|529226961|FG002|Main Study (36 Months)|Protocol Violation|0|||
146741526|NCT01976364|529226959|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
146741527|NCT01976364|529226960|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
146741528|NCT01976364|529226961|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
146741529|NCT01976364|529226959|FG000|Main Study (36 Months)|Death|5|||
146741530|NCT01976364|529226960|FG001|Main Study (36 Months)|Death|0|||
146741531|NCT01976364|529226961|FG002|Main Study (36 Months)|Death|0|||
146741532|NCT01976364|529226959|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
146741533|NCT01976364|529226960|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
146741534|NCT01976364|529226961|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
146741535|NCT01976364|529226959|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
146741536|NCT01976364|529226960|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
146741537|NCT01976364|529226961|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
146741538|NCT01976364|529226959|FG000|Sub-study (12 Months)|Protocol Violation|0|||
146741539|NCT01976364|529226960|FG001|Sub-study (12 Months)|Protocol Violation|1|||
146741540|NCT01976364|529226961|FG002|Sub-study (12 Months)|Protocol Violation|1|||
146741541|NCT01976364|529226959|FG000|Sub-study (12 Months)|Adverse Event|0|||
146741542|NCT01976364|529226960|FG001|Sub-study (12 Months)|Adverse Event|4|||
146741543|NCT01976364|529226961|FG002|Sub-study (12 Months)|Adverse Event|3|||
146741544|NCT02757521|529226962|FG000|Overall Study|Adverse Event|1|||
146741545|NCT02757521|529226963|FG001|Overall Study|Adverse Event|0|||
146741546|NCT01190215|529226964|FG000|Up to Month 6|Lost to Follow-up|2|||
146741547|NCT01190215|529226965|FG001|Up to Month 6|Lost to Follow-up|0|||
146741548|NCT00003511|529226966|FG000|Overall Study|Not evaluable|4|||
146741549|NCT00999661|529226987|FG000|Overall Study|Lost to Follow-up|59|||
146741550|NCT00999661|529226987|FG000|Overall Study|Adverse Event|1|||
146741551|NCT00999661|529226987|FG000|Overall Study|Withdrawal by Subject|1|||
146741552|NCT00999661|529226987|FG000|Overall Study|Not meeting eligibility criteria|9|||
146741553|NCT00917267|529226988|FG000|Overall Study|Adverse Event|15|||
146741554|NCT00917267|529226989|FG001|Overall Study|Adverse Event|36|||
146741555|NCT00917267|529226988|FG000|Overall Study|Physician Decision|2|||
146741556|NCT00917267|529226989|FG001|Overall Study|Physician Decision|4|||
146741557|NCT00917267|529226988|FG000|Overall Study|Protocol Violation|9|||
146509818|NCT00549601|528371856|FG002|Received Study Drug|Adverse Event|1|||
146741558|NCT00917267|529226989|FG001|Overall Study|Protocol Violation|18|||
146741559|NCT00917267|529226988|FG000|Overall Study|Withdrawal by Subject|5|||
146741560|NCT00917267|529226989|FG001|Overall Study|Withdrawal by Subject|12|||
146741561|NCT00917267|529226988|FG000|Overall Study|Lost to follow up|0|||
146741562|NCT00917267|529226989|FG001|Overall Study|Lost to follow up|2|||
146741563|NCT00917267|529226988|FG000|Overall Study|Entry Criteria Not Met|1|||
146741564|NCT00917267|529226989|FG001|Overall Study|Entry Criteria Not Met|0|||
146741565|NCT00917267|529226988|FG000|Overall Study|Sponsor Decision|5|||
146741566|NCT00917267|529226989|FG001|Overall Study|Sponsor Decision|5|||
146741567|NCT00917267|529226988|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
146741568|NCT00917267|529226989|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
146741569|NCT02960763|529226990|FG000|Step 1|Withdrawal by Subject|10|||
146741570|NCT02960763|529226991|FG001|Step 1|Withdrawal by Subject|8|||
146741571|NCT02960763|529226992|FG002|Step 1|Withdrawal by Subject|13|||
146741572|NCT02960763|529226993|FG003|Step 1|Withdrawal by Subject|0|||
146741573|NCT02960763|529226994|FG004|Step 1|Withdrawal by Subject|0|||
146741574|NCT02960763|529226990|FG000|Step 1|Lost to Follow-up|7|||
146741575|NCT02960763|529226991|FG001|Step 1|Lost to Follow-up|9|||
146741576|NCT02960763|529226992|FG002|Step 1|Lost to Follow-up|12|||
146741577|NCT02960763|529226993|FG003|Step 1|Lost to Follow-up|0|||
146741578|NCT02960763|529226994|FG004|Step 1|Lost to Follow-up|0|||
146741579|NCT02960763|529226990|FG000|Step 1|Death|1|||
146741580|NCT02960763|529226991|FG001|Step 1|Death|1|||
146741581|NCT02960763|529226992|FG002|Step 1|Death|1|||
146741582|NCT02960763|529226993|FG003|Step 1|Death|0|||
146741583|NCT02960763|529226994|FG004|Step 1|Death|0|||
146741584|NCT02960763|529226990|FG000|Step 1|Investigator discretion|1|||
146741585|NCT02960763|529226991|FG001|Step 1|Investigator discretion|0|||
146741586|NCT02960763|529226992|FG002|Step 1|Investigator discretion|1|||
146741587|NCT02960763|529226993|FG003|Step 1|Investigator discretion|0|||
146741588|NCT02960763|529226994|FG004|Step 1|Investigator discretion|0|||
146741589|NCT02960763|529226990|FG000|Step 1|Other|0|||
146741590|NCT02960763|529226991|FG001|Step 1|Other|0|||
146741591|NCT02960763|529226992|FG002|Step 1|Other|1|||
146741592|NCT02960763|529226993|FG003|Step 1|Other|0|||
146741593|NCT02960763|529226994|FG004|Step 1|Other|0|||
146741594|NCT02960763|529226990|FG000|Step 2|Withdrawal by Subject|0|||
146741595|NCT02960763|529226991|FG001|Step 2|Withdrawal by Subject|0|||
146741596|NCT02960763|529226992|FG002|Step 2|Withdrawal by Subject|0|||
146741597|NCT02960763|529226993|FG003|Step 2|Withdrawal by Subject|7|||
146741598|NCT02960763|529226994|FG004|Step 2|Withdrawal by Subject|3|||
146741599|NCT02960763|529226990|FG000|Step 2|Lost to Follow-up|0|||
146741600|NCT02960763|529226991|FG001|Step 2|Lost to Follow-up|0|||
146741601|NCT02960763|529226992|FG002|Step 2|Lost to Follow-up|0|||
146741602|NCT02960763|529226993|FG003|Step 2|Lost to Follow-up|4|||
146741603|NCT02960763|529226994|FG004|Step 2|Lost to Follow-up|1|||
146741604|NCT02960763|529226990|FG000|Step 2|Investigator discretion|0|||
146741605|NCT02960763|529226991|FG001|Step 2|Investigator discretion|0|||
146741606|NCT02960763|529226992|FG002|Step 2|Investigator discretion|0|||
146741607|NCT02960763|529226993|FG003|Step 2|Investigator discretion|0|||
146741608|NCT02960763|529226994|FG004|Step 2|Investigator discretion|1|||
146741609|NCT00312858|529226995|FG000|Overall Study|Adverse Event|0|||
146741610|NCT00312858|529226996|FG001|Overall Study|Adverse Event|1|||
146741611|NCT00312858|529226995|FG000|Overall Study|Lost to Follow-up|25|||
146741612|NCT00312858|529226996|FG001|Overall Study|Lost to Follow-up|42|||
146741613|NCT00312858|529226995|FG000|Overall Study|Protocol Violation|3|||
146741614|NCT00312858|529226996|FG001|Overall Study|Protocol Violation|8|||
146741615|NCT00312858|529226995|FG000|Overall Study|Withdraw by Participant|20|||
146741616|NCT00312858|529226996|FG001|Overall Study|Withdraw by Participant|20|||
146741617|NCT00312858|529226995|FG000|Overall Study|Participant Moved|11|||
146741618|NCT00312858|529226996|FG001|Overall Study|Participant Moved|10|||
146741619|NCT00312858|529226995|FG000|Overall Study|Other|9|||
146741620|NCT00312858|529226996|FG001|Overall Study|Other|12|||
146741621|NCT00603265|529226997|FG000|Overall Study|Adverse Event|2|||
146741622|NCT00603265|529226998|FG001|Overall Study|Adverse Event|11|||
146741623|NCT00603265|529226999|FG002|Overall Study|Adverse Event|1|||
146741624|NCT00603265|529226997|FG000|Overall Study|Withdrawal by Subject|1|||
146741625|NCT00603265|529226998|FG001|Overall Study|Withdrawal by Subject|2|||
146741626|NCT00603265|529226999|FG002|Overall Study|Withdrawal by Subject|1|||
146741627|NCT00603265|529226997|FG000|Overall Study|Lack of Efficacy|3|||
146741628|NCT00603265|529226998|FG001|Overall Study|Lack of Efficacy|0|||
146741629|NCT00603265|529226999|FG002|Overall Study|Lack of Efficacy|3|||
146741630|NCT00603265|529226997|FG000|Overall Study|Lost to Follow-up|0|||
146741631|NCT00603265|529226998|FG001|Overall Study|Lost to Follow-up|1|||
146741632|NCT00603265|529226999|FG002|Overall Study|Lost to Follow-up|0|||
146741633|NCT00603265|529226997|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
146741634|NCT00603265|529226998|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
146741635|NCT00603265|529226999|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
146741636|NCT00603265|529226997|FG000|Overall Study|Participant Left Country, No Responses|0|||
146741637|NCT00603265|529226998|FG001|Overall Study|Participant Left Country, No Responses|1|||
146741638|NCT00603265|529226999|FG002|Overall Study|Participant Left Country, No Responses|0|||
146741639|NCT00603265|529226997|FG000|Overall Study|Protocol Violation|1|||
146741640|NCT00603265|529226998|FG001|Overall Study|Protocol Violation|0|||
146741641|NCT00603265|529226999|FG002|Overall Study|Protocol Violation|0|||
146741642|NCT04399551|529227001|FG000|Overall Study|Adverse Event|15|||
146741643|NCT04399551|529227001|FG000|Overall Study|Withdrawal by Subject|6|||
146741644|NCT04399551|529227001|FG000|Overall Study|Physician Decision|3|||
146741645|NCT04399551|529227001|FG000|Overall Study|Lost to Follow-up|2|||
146741646|NCT04399551|529227001|FG000|Overall Study|Protocol Deviation|2|||
146741647|NCT01112514|529227005|FG000|Overall Study|Lost to Follow-up|1|||
146741648|NCT03377790|529227006|FG000|Overall Study|Withdrawal by Subject|1|||
146741649|NCT03377790|529227007|FG001|Overall Study|Withdrawal by Subject|0|||
146741650|NCT03377790|529227006|FG000|Overall Study|Adverse Event|1|||
146741651|NCT03377790|529227007|FG001|Overall Study|Adverse Event|0|||
146741652|NCT03377790|529227006|FG000|Overall Study|Lost to Follow-up|0|||
146741653|NCT03377790|529227007|FG001|Overall Study|Lost to Follow-up|2|||
146741654|NCT03377790|529227006|FG000|Overall Study|Randomized but not treated|1|||
146741655|NCT03377790|529227007|FG001|Overall Study|Randomized but not treated|0|||
146741656|NCT03377790|529227006|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
146741657|NCT03377790|529227007|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
146741658|NCT01987596|529227008|FG000|Overall Study|Physician Decision|1|||
146741659|NCT01987596|529227009|FG001|Overall Study|Physician Decision|0|||
146741660|NCT01987596|529227008|FG000|Overall Study|Progressive Disease; missing all period|0|||
146741661|NCT01987596|529227009|FG001|Overall Study|Progressive Disease; missing all period|1|||
146741662|NCT02632786|529227012|FG000|Overall Study|Adverse Event|2|||
146741663|NCT02632786|529227013|FG001|Overall Study|Adverse Event|1|||
146741664|NCT02632786|529227012|FG000|Overall Study|Death|3|||
146741665|NCT02632786|529227013|FG001|Overall Study|Death|2|||
146741666|NCT02632786|529227012|FG000|Overall Study|Physician Decision|5|||
146741667|NCT02632786|529227013|FG001|Overall Study|Physician Decision|4|||
146741668|NCT02632786|529227012|FG000|Overall Study|Withdrawal by Subject|1|||
146741669|NCT02632786|529227013|FG001|Overall Study|Withdrawal by Subject|0|||
146741670|NCT00854295|529227014|FG000|Overall Study|Death|7|||
146741671|NCT00854295|529227015|FG001|Overall Study|Death|0|||
146741672|NCT00854295|529227016|FG002|Overall Study|Death|1|||
146741673|NCT00854295|529227017|FG003|Overall Study|Death|1|||
146741674|NCT00854295|529227014|FG000|Overall Study|Adverse Event|6|||
146741675|NCT00854295|529227015|FG001|Overall Study|Adverse Event|1|||
146741676|NCT00854295|529227016|FG002|Overall Study|Adverse Event|1|||
146741677|NCT00854295|529227017|FG003|Overall Study|Adverse Event|3|||
146741678|NCT00854295|529227014|FG000|Overall Study|Lost to Follow-up|18|||
146741679|NCT00854295|529227015|FG001|Overall Study|Lost to Follow-up|5|||
146741680|NCT00854295|529227016|FG002|Overall Study|Lost to Follow-up|21|||
146741681|NCT00854295|529227017|FG003|Overall Study|Lost to Follow-up|21|||
146741682|NCT00854295|529227014|FG000|Overall Study|Physician Decision|10|||
146741683|NCT00854295|529227015|FG001|Overall Study|Physician Decision|0|||
146741684|NCT00854295|529227016|FG002|Overall Study|Physician Decision|0|||
146741685|NCT00854295|529227017|FG003|Overall Study|Physician Decision|0|||
146741686|NCT00709592|529227018|FG000|Overall Study|Unable to proceed to transplant|0|||
146741687|NCT00709592|529227019|FG001|Overall Study|Unable to proceed to transplant|1|||
146741688|NCT03154359|529227023|FG000|Overall Study|Adverse Event|1|||
146741689|NCT03154359|529227023|FG000|Overall Study|Lack of Efficacy|2|||
146741690|NCT03154359|529227023|FG000|Overall Study|Lost to Follow-up|3|||
146741691|NCT03154359|529227023|FG000|Overall Study|Physician Decision|3|||
146741692|NCT03154359|529227023|FG000|Overall Study|Protocol Violation|4|||
146741693|NCT03154359|529227023|FG000|Overall Study|Withdrawal by Subject|5|||
146741694|NCT03154359|529227023|FG000|Overall Study|Disruption of study due to COVID-19|4|||
146741695|NCT02440594|529227024|FG000|Overall Study|Lost to Follow-up|34|||
146741696|NCT02440594|529227025|FG001|Overall Study|Lost to Follow-up|33|||
146741697|NCT02440594|529227026|FG002|Overall Study|Lost to Follow-up|54|||
146741698|NCT02440594|529227027|FG003|Overall Study|Lost to Follow-up|47|||
146741699|NCT02440594|529227028|FG004|Overall Study|Lost to Follow-up|5|||
146741700|NCT02440594|529227029|FG005|Overall Study|Lost to Follow-up|4|||
146741701|NCT02440594|529227030|FG006|Overall Study|Lost to Follow-up|28|||
146741702|NCT02440594|529227031|FG007|Overall Study|Lost to Follow-up|48|||
146741703|NCT02440594|529227024|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
146741704|NCT02440594|529227025|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
146741705|NCT02440594|529227026|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
146741706|NCT02440594|529227027|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
146741707|NCT02440594|529227028|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
146741708|NCT02440594|529227029|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
146741709|NCT02440594|529227030|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
146741710|NCT02440594|529227031|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
146741711|NCT02440594|529227024|FG000|Overall Study|Withdrawal by Subject|81|||
146741712|NCT02440594|529227025|FG001|Overall Study|Withdrawal by Subject|67|||
146741713|NCT02440594|529227026|FG002|Overall Study|Withdrawal by Subject|59|||
146741714|NCT02440594|529227027|FG003|Overall Study|Withdrawal by Subject|38|||
146741715|NCT02440594|529227028|FG004|Overall Study|Withdrawal by Subject|2|||
146741716|NCT02440594|529227029|FG005|Overall Study|Withdrawal by Subject|2|||
146741717|NCT02440594|529227030|FG006|Overall Study|Withdrawal by Subject|7|||
146741718|NCT02440594|529227031|FG007|Overall Study|Withdrawal by Subject|7|||
146741719|NCT02440594|529227024|FG000|Overall Study|Administratively w/drawn|3|||
146741720|NCT02440594|529227025|FG001|Overall Study|Administratively w/drawn|2|||
146741721|NCT02440594|529227026|FG002|Overall Study|Administratively w/drawn|0|||
146741722|NCT02440594|529227027|FG003|Overall Study|Administratively w/drawn|0|||
146741723|NCT02440594|529227028|FG004|Overall Study|Administratively w/drawn|0|||
146741724|NCT02440594|529227029|FG005|Overall Study|Administratively w/drawn|0|||
146741725|NCT02440594|529227030|FG006|Overall Study|Administratively w/drawn|2|||
146741726|NCT02440594|529227031|FG007|Overall Study|Administratively w/drawn|1|||
146741727|NCT04250337|529227032|FG000|Overall Study|Adverse Event|0|||
146741728|NCT04250337|529227033|FG001|Overall Study|Adverse Event|3|||
146741729|NCT04250337|529227032|FG000|Overall Study|Lack of Efficacy|1|||
146741730|NCT04250337|529227033|FG001|Overall Study|Lack of Efficacy|3|||
146741731|NCT04250337|529227032|FG000|Overall Study|Physician Decision|1|||
146741732|NCT04250337|529227033|FG001|Overall Study|Physician Decision|0|||
146741733|NCT04250337|529227032|FG000|Overall Study|Protocol Deviation|2|||
146741734|NCT04250337|529227033|FG001|Overall Study|Protocol Deviation|2|||
146741735|NCT04250337|529227032|FG000|Overall Study|Withdrawal by Subject|4|||
146741736|NCT04250337|529227033|FG001|Overall Study|Withdrawal by Subject|3|||
146741737|NCT00152763|529227034|FG000|Overall Study|Death|4|||
146741738|NCT00152763|529227035|FG001|Overall Study|Death|1|||
146741739|NCT00152763|529227036|FG002|Overall Study|Death|2|||
146741740|NCT00152763|529227037|FG003|Overall Study|Death|1|||
146741741|NCT00152763|529227034|FG000|Overall Study|Lost to Follow-up|6|||
146741742|NCT00152763|529227035|FG001|Overall Study|Lost to Follow-up|4|||
146741743|NCT00152763|529227036|FG002|Overall Study|Lost to Follow-up|2|||
146741744|NCT00152763|529227037|FG003|Overall Study|Lost to Follow-up|13|||
146741745|NCT03321006|529227040|FG000|Overall Study|Death|1|||
146741746|NCT03321006|529227041|FG001|Overall Study|Death|0|||
146741747|NCT03321006|529227040|FG000|Overall Study|Lack of Efficacy|1|||
146741748|NCT03321006|529227041|FG001|Overall Study|Lack of Efficacy|0|||
146741749|NCT04498247|529227045|FG000|Overall Study|Lost to Follow-up|0|||
146741750|NCT04498247|529227046|FG001|Overall Study|Lost to Follow-up|0|||
146741751|NCT04498247|529227047|FG002|Overall Study|Lost to Follow-up|0|||
146741752|NCT04498247|529227048|FG003|Overall Study|Lost to Follow-up|1|||
146741753|NCT04498247|529227049|FG004|Overall Study|Lost to Follow-up|0|||
146741754|NCT04498247|529227050|FG005|Overall Study|Lost to Follow-up|0|||
146741755|NCT04498247|529227051|FG006|Overall Study|Lost to Follow-up|0|||
146741756|NCT04498247|529227052|FG007|Overall Study|Lost to Follow-up|0|||
146741757|NCT04498247|529227045|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
146741758|NCT04498247|529227046|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
146741759|NCT04498247|529227047|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
146741760|NCT04498247|529227048|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
146741761|NCT04498247|529227049|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
146741762|NCT04498247|529227050|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
146741763|NCT04498247|529227051|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
146741764|NCT04498247|529227052|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
146741765|NCT04498247|529227045|FG000|Overall Study|Withdrawal by Subject|0|||
146741766|NCT04498247|529227046|FG001|Overall Study|Withdrawal by Subject|8|||
146741767|NCT04498247|529227047|FG002|Overall Study|Withdrawal by Subject|0|||
146741768|NCT04498247|529227048|FG003|Overall Study|Withdrawal by Subject|7|||
146741769|NCT04498247|529227049|FG004|Overall Study|Withdrawal by Subject|0|||
146741770|NCT04498247|529227050|FG005|Overall Study|Withdrawal by Subject|0|||
146741771|NCT04498247|529227051|FG006|Overall Study|Withdrawal by Subject|1|||
146741772|NCT04498247|529227052|FG007|Overall Study|Withdrawal by Subject|0|||
146741773|NCT04498247|529227045|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
146741774|NCT04498247|529227046|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
146741775|NCT04498247|529227047|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
146741776|NCT04498247|529227048|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
146741777|NCT04498247|529227049|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
146741778|NCT04498247|529227050|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
146741779|NCT04498247|529227051|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
146741780|NCT04498247|529227052|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
146741781|NCT00669903|529227053|FG000|Overall Study|Adverse Event|0|||
146741782|NCT00669903|529227054|FG001|Overall Study|Adverse Event|1|||
146741783|NCT00669903|529227055|FG002|Overall Study|Adverse Event|3|||
146741784|NCT00669903|529227056|FG003|Overall Study|Adverse Event|1|||
146741785|NCT00669903|529227053|FG000|Overall Study|Withdrawal by Subject|0|||
146741786|NCT00669903|529227054|FG001|Overall Study|Withdrawal by Subject|2|||
146741787|NCT00669903|529227055|FG002|Overall Study|Withdrawal by Subject|2|||
146741788|NCT00669903|529227056|FG003|Overall Study|Withdrawal by Subject|2|||
146741789|NCT00669903|529227053|FG000|Overall Study|Lost to Follow-up|1|||
146741790|NCT00669903|529227054|FG001|Overall Study|Lost to Follow-up|1|||
146741791|NCT00669903|529227055|FG002|Overall Study|Lost to Follow-up|0|||
146741792|NCT00669903|529227056|FG003|Overall Study|Lost to Follow-up|1|||
146741793|NCT00669903|529227053|FG000|Overall Study|Protocol Violation|0|||
146741794|NCT00669903|529227054|FG001|Overall Study|Protocol Violation|1|||
146741795|NCT00669903|529227055|FG002|Overall Study|Protocol Violation|0|||
146741796|NCT00669903|529227056|FG003|Overall Study|Protocol Violation|0|||
146741797|NCT01678820|529227057|FG000|Overall Study|Study Terminated by Sponsor|45|||
146741798|NCT01678820|529227058|FG001|Overall Study|Study Terminated by Sponsor|43|||
146741799|NCT01678820|529227059|FG002|Overall Study|Study Terminated by Sponsor|43|||
146741800|NCT01678820|529227057|FG000|Overall Study|Withdrawal by Subject|2|||
146741801|NCT01678820|529227058|FG001|Overall Study|Withdrawal by Subject|5|||
146741802|NCT01678820|529227059|FG002|Overall Study|Withdrawal by Subject|2|||
146741803|NCT01678820|529227057|FG000|Overall Study|Protocol Specified Criteria|2|||
146741804|NCT01678820|529227058|FG001|Overall Study|Protocol Specified Criteria|3|||
146741805|NCT01678820|529227059|FG002|Overall Study|Protocol Specified Criteria|1|||
146741806|NCT01678820|529227057|FG000|Overall Study|Adverse Event|2|||
146741807|NCT01678820|529227058|FG001|Overall Study|Adverse Event|2|||
146741808|NCT01678820|529227059|FG002|Overall Study|Adverse Event|2|||
146741809|NCT01678820|529227057|FG000|Overall Study|Lost to Follow-up|7|||
146741810|NCT01678820|529227058|FG001|Overall Study|Lost to Follow-up|2|||
146741811|NCT01678820|529227059|FG002|Overall Study|Lost to Follow-up|2|||
146741812|NCT01678820|529227057|FG000|Overall Study|Non-compliance with study drug|0|||
146741813|NCT01678820|529227058|FG001|Overall Study|Non-compliance with study drug|1|||
146741814|NCT01678820|529227059|FG002|Overall Study|Non-compliance with study drug|0|||
146741815|NCT01678820|529227057|FG000|Overall Study|Physician Decision|0|||
146741816|NCT01678820|529227058|FG001|Overall Study|Physician Decision|0|||
146741817|NCT01678820|529227059|FG002|Overall Study|Physician Decision|1|||
146741818|NCT01678820|529227057|FG000|Overall Study|Protocol Violation|4|||
146741819|NCT01678820|529227058|FG001|Overall Study|Protocol Violation|5|||
146741820|NCT01678820|529227059|FG002|Overall Study|Protocol Violation|4|||
146741821|NCT01678820|529227057|FG000|Overall Study|Not treated with double-blind study drug|0|||
146741822|NCT01678820|529227058|FG001|Overall Study|Not treated with double-blind study drug|2|||
146741823|NCT01678820|529227059|FG002|Overall Study|Not treated with double-blind study drug|2|||
146741824|NCT00245856|529227060|FG000|Period Two|Withdrawal by Subject|0|||
146741825|NCT00245856|529227061|FG001|Period Two|Withdrawal by Subject|1|||
146741826|NCT01539863|529227062|FG000|Overall Study|Lost to Follow-up|5|||
146741827|NCT01539863|529227063|FG001|Overall Study|Lost to Follow-up|4|||
146741828|NCT03662997|529227064|FG000|Overall Study|Adverse Event|0|||
146741829|NCT03662997|529227065|FG001|Overall Study|Adverse Event|2|||
146741830|NCT03662997|529227066|FG002|Overall Study|Adverse Event|0|||
146741831|NCT03662997|529227067|FG003|Overall Study|Adverse Event|0|||
146741832|NCT00007475|529227068|FG000|Overall Study|Withdrawal by Subject|1|||
146741833|NCT00007475|529227069|FG001|Overall Study|Withdrawal by Subject|0|||
146741834|NCT00007475|529227070|FG002|Overall Study|Withdrawal by Subject|0|||
146741835|NCT00007475|529227071|FG003|Overall Study|Withdrawal by Subject|0|||
146741836|NCT00007475|529227068|FG000|Overall Study|Adverse Event|3|||
146741837|NCT00007475|529227069|FG001|Overall Study|Adverse Event|0|||
146741838|NCT00007475|529227070|FG002|Overall Study|Adverse Event|0|||
146741839|NCT00007475|529227071|FG003|Overall Study|Adverse Event|0|||
146741840|NCT01719224|529227072|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
146741841|NCT01719224|529227073|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
146741842|NCT03000673|529227074|FG000|Overall Study|Withdrawal by Subject|1|||
146741843|NCT03000673|529227075|FG001|Overall Study|Withdrawal by Subject|0|||
146741844|NCT03000673|529227076|FG002|Overall Study|Withdrawal by Subject|0|||
146741845|NCT03000673|529227077|FG003|Overall Study|Withdrawal by Subject|0|||
146741846|NCT01512745|529227079|FG000|Overall Study|Adverse Event|22|||
146741847|NCT01512745|529227080|FG001|Overall Study|Adverse Event|3|||
146741848|NCT01512745|529227079|FG000|Overall Study|Death|9|||
146741849|NCT01512745|529227080|FG001|Overall Study|Death|13|||
146741850|NCT01512745|529227079|FG000|Overall Study|Withdrawal by Subject|2|||
146741851|NCT01512745|529227080|FG001|Overall Study|Withdrawal by Subject|2|||
146741852|NCT01512745|529227079|FG000|Overall Study|Lost to Follow-up|4|||
146741853|NCT01512745|529227080|FG001|Overall Study|Lost to Follow-up|0|||
146741854|NCT01512745|529227079|FG000|Overall Study|Lack of Efficacy|2|||
146741855|NCT01512745|529227080|FG001|Overall Study|Lack of Efficacy|2|||
146741856|NCT01512745|529227079|FG000|Overall Study|Protocol Violation|1|||
146741857|NCT01512745|529227080|FG001|Overall Study|Protocol Violation|0|||
146741858|NCT02357810|529227081|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
146741859|NCT02357810|529227081|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
146741860|NCT02357810|529227081|FG000|Reached 12 Weeks Response|Adverse Event|5|||
146741861|NCT02357810|529227081|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
146741862|NCT02357810|529227081|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
146741863|NCT02357810|529227081|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
146741864|NCT02357810|529227081|FG000|Reached 12 Weeks Response|Death|1|||
146741865|NCT02357810|529227081|FG000|Reached 12 Weeks Response|Physician Decision|1|||
146741866|NCT02357810|529227081|FG000|Reached 12 Weeks Response|Other|1|||
146741867|NCT02357810|529227081|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
146741868|NCT02357810|529227081|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
146741869|NCT02357810|529227081|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
146741870|NCT02357810|529227081|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
146741871|NCT02357810|529227081|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
146509819|NCT00549601|528371854|FG000|Received Study Drug|Death|0|||
146509820|NCT00549601|528371855|FG001|Received Study Drug|Death|1|||
146509821|NCT00549601|528371856|FG002|Received Study Drug|Death|0|||
146509822|NCT00549601|528371854|FG000|Received Study Drug|Lost to Follow-up|0|||
146509823|NCT00549601|528371855|FG001|Received Study Drug|Lost to Follow-up|1|||
146509824|NCT00549601|528371856|FG002|Received Study Drug|Lost to Follow-up|1|||
146509825|NCT00549601|528371854|FG000|Received Study Drug|Protocol Violation|3|||
146509826|NCT00549601|528371855|FG001|Received Study Drug|Protocol Violation|4|||
146509827|NCT00549601|528371856|FG002|Received Study Drug|Protocol Violation|1|||
146509828|NCT00549601|528371854|FG000|Received Study Drug|Withdrawal by Subject|2|||
146509829|NCT00549601|528371855|FG001|Received Study Drug|Withdrawal by Subject|0|||
146509830|NCT00549601|528371856|FG002|Received Study Drug|Withdrawal by Subject|1|||
146509831|NCT00908596|528371860|FG000|Overall Study|Other reasons|46|||
146509832|NCT00908596|528371861|FG001|Overall Study|Other reasons|6|||
146509833|NCT00908596|528371862|FG002|Overall Study|Other reasons|2|||
146509834|NCT00908596|528371863|FG003|Overall Study|Other reasons|0|||
146509835|NCT00908596|528371860|FG000|Overall Study|Lost to Follow-up|0|||
146509836|NCT00908596|528371861|FG001|Overall Study|Lost to Follow-up|1|||
146509837|NCT00908596|528371862|FG002|Overall Study|Lost to Follow-up|12|||
146509838|NCT00908596|528371863|FG003|Overall Study|Lost to Follow-up|4|||
146509839|NCT00908596|528371860|FG000|Overall Study|Death|0|||
146509840|NCT00908596|528371861|FG001|Overall Study|Death|5|||
146509841|NCT00908596|528371862|FG002|Overall Study|Death|57|||
146509842|NCT00908596|528371863|FG003|Overall Study|Death|32|||
146509843|NCT00908596|528371860|FG000|Overall Study|Protocol Violation|1|||
146509844|NCT00908596|528371861|FG001|Overall Study|Protocol Violation|0|||
146509845|NCT00908596|528371862|FG002|Overall Study|Protocol Violation|0|||
146509846|NCT00908596|528371863|FG003|Overall Study|Protocol Violation|0|||
146509847|NCT00908596|528371860|FG000|Overall Study|Withdrawal by Subject|0|||
146509848|NCT00908596|528371861|FG001|Overall Study|Withdrawal by Subject|1|||
146509849|NCT00908596|528371862|FG002|Overall Study|Withdrawal by Subject|3|||
146509850|NCT00908596|528371863|FG003|Overall Study|Withdrawal by Subject|1|||
146509851|NCT00224406|528371864|FG000|Overall Study|Re-transplant|0|||
146509852|NCT00224406|528371865|FG001|Overall Study|Re-transplant|2|||
146509853|NCT00224406|528371864|FG000|Overall Study|Death|0|||
146509854|NCT00224406|528371865|FG001|Overall Study|Death|1|||
146509855|NCT00224406|528371864|FG000|Overall Study|Transplant cancelled|0|||
146509856|NCT00224406|528371865|FG001|Overall Study|Transplant cancelled|4|||
146509857|NCT00224406|528371864|FG000|Overall Study|Drug not delivered|2|||
146509858|NCT00224406|528371865|FG001|Overall Study|Drug not delivered|0|||
146509859|NCT00224406|528371864|FG000|Overall Study|Other|4|||
146509860|NCT00224406|528371865|FG001|Overall Study|Other|0|||
146509861|NCT00224406|528371864|FG000|Overall Study|Transplant cancelled|3|||
146509862|NCT00224406|528371865|FG001|Overall Study|Transplant cancelled|0|||
146509863|NCT01556997|528371868|FG000|Overall Study|Adverse Event|10|||
146509864|NCT01556997|528371869|FG001|Overall Study|Adverse Event|12|||
146509865|NCT01556997|528371870|FG002|Overall Study|Adverse Event|12|||
146509866|NCT01556997|528371868|FG000|Overall Study|Lost to Follow-up|6|||
146509867|NCT01556997|528371869|FG001|Overall Study|Lost to Follow-up|6|||
146509868|NCT01556997|528371870|FG002|Overall Study|Lost to Follow-up|4|||
146741872|NCT02357810|529227081|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
146741873|NCT00562978|529227082|FG000|Overall Study|Patient had imaging dose only|1|||
146741874|NCT00562978|529227083|FG001|Overall Study|Patient had imaging dose only|11|||
146741875|NCT00152971|529227085|FG000|Overall Study|Adverse Event|12|||
146741876|NCT00152971|529227086|FG001|Overall Study|Adverse Event|10|||
146741877|NCT00152971|529227087|FG002|Overall Study|Adverse Event|9|||
146741878|NCT00152971|529227085|FG000|Overall Study|Protocol Violation|10|||
146741879|NCT00152971|529227086|FG001|Overall Study|Protocol Violation|11|||
146741880|NCT00152971|529227087|FG002|Overall Study|Protocol Violation|8|||
146741881|NCT00152971|529227085|FG000|Overall Study|Lost to Follow-up|17|||
146741882|NCT00152971|529227086|FG001|Overall Study|Lost to Follow-up|14|||
146741883|NCT00152971|529227087|FG002|Overall Study|Lost to Follow-up|13|||
146741884|NCT00152971|529227085|FG000|Overall Study|Withdrawal by Subject|9|||
146741885|NCT00152971|529227086|FG001|Overall Study|Withdrawal by Subject|8|||
146741886|NCT00152971|529227087|FG002|Overall Study|Withdrawal by Subject|14|||
146741887|NCT00152971|529227085|FG000|Overall Study|Other|3|||
146741888|NCT00152971|529227086|FG001|Overall Study|Other|5|||
146741889|NCT00152971|529227087|FG002|Overall Study|Other|5|||
146741890|NCT00152971|529227085|FG000|Treatment|Adverse Event|49|||
146741891|NCT00152971|529227086|FG001|Treatment|Adverse Event|40|||
146741892|NCT00152971|529227087|FG002|Treatment|Adverse Event|54|||
146741893|NCT00152971|529227085|FG000|Treatment|Protocol Violation|8|||
146741894|NCT00152971|529227086|FG001|Treatment|Protocol Violation|6|||
146741895|NCT00152971|529227087|FG002|Treatment|Protocol Violation|10|||
146741896|NCT00152971|529227085|FG000|Treatment|Lost to Follow-up|1|||
146741897|NCT00152971|529227086|FG001|Treatment|Lost to Follow-up|2|||
146741898|NCT00152971|529227087|FG002|Treatment|Lost to Follow-up|1|||
146741899|NCT00152971|529227085|FG000|Treatment|Withdrawal by Subject|4|||
146741900|NCT00152971|529227086|FG001|Treatment|Withdrawal by Subject|4|||
146741901|NCT00152971|529227087|FG002|Treatment|Withdrawal by Subject|5|||
146741902|NCT00152971|529227085|FG000|Treatment|Other|9|||
146741903|NCT00152971|529227086|FG001|Treatment|Other|11|||
146741904|NCT00152971|529227087|FG002|Treatment|Other|10|||
146741905|NCT00675506|529227088|FG000|Overall Study|Lost to Follow-up|1|||
146741906|NCT00675506|529227089|FG001|Overall Study|Lost to Follow-up|5|||
146741907|NCT00675506|529227088|FG000|Overall Study|Lost interest|3|||
146741908|NCT00675506|529227089|FG001|Overall Study|Lost interest|5|||
146741909|NCT00675506|529227088|FG000|Overall Study|Elevated fasting glucose|2|||
146741910|NCT00675506|529227089|FG001|Overall Study|Elevated fasting glucose|1|||
146741911|NCT00675506|529227088|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
146741912|NCT00675506|529227089|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
146741913|NCT00675506|529227088|FG000|Overall Study|Elevated IGF-1|2|||
146741914|NCT00675506|529227089|FG001|Overall Study|Elevated IGF-1|0|||
146741915|NCT00675506|529227088|FG000|Overall Study|Hypersensitivity Reaction|1|||
146741916|NCT00675506|529227089|FG001|Overall Study|Hypersensitivity Reaction|0|||
146741917|NCT00675506|529227088|FG000|Overall Study|Disclosed history of cancer|1|||
146741918|NCT00675506|529227089|FG001|Overall Study|Disclosed history of cancer|0|||
146741919|NCT00675506|529227088|FG000|Overall Study|Declined participation|1|||
146741920|NCT00675506|529227089|FG001|Overall Study|Declined participation|0|||
146741921|NCT00675506|529227088|FG000|Overall Study|Schedule conflict|0|||
146741922|NCT00675506|529227089|FG001|Overall Study|Schedule conflict|1|||
146741923|NCT00936221|529227090|FG000|Overall Study|Withdrawal by Subject|1|||
146741924|NCT00936221|529227091|FG001|Overall Study|Withdrawal by Subject|1|||
146741925|NCT01348776|529227092|FG000|Overall Study|Lost to Follow-up|3|||
146741926|NCT01121484|529227097|FG000|Overall Study|Adverse Event|12|||
146741927|NCT01121484|529227098|FG001|Overall Study|Adverse Event|5|||
146741928|NCT01121484|529227097|FG000|Overall Study|Lack of Efficacy|3|||
146741929|NCT01121484|529227098|FG001|Overall Study|Lack of Efficacy|11|||
146741930|NCT01121484|529227097|FG000|Overall Study|Lost to Follow-up|5|||
146741931|NCT01121484|529227098|FG001|Overall Study|Lost to Follow-up|9|||
146741932|NCT01121484|529227097|FG000|Overall Study|Physician Decision|0|||
146741933|NCT01121484|529227098|FG001|Overall Study|Physician Decision|3|||
146741934|NCT01121484|529227097|FG000|Overall Study|Protocol Violation|1|||
146741935|NCT01121484|529227098|FG001|Overall Study|Protocol Violation|0|||
146741936|NCT01121484|529227097|FG000|Overall Study|Withdrawal by Subject|8|||
146741937|NCT01121484|529227098|FG001|Overall Study|Withdrawal by Subject|7|||
146741938|NCT01121484|529227097|FG000|Overall Study|Discontinuation of study by sponsor|0|||
146741939|NCT01121484|529227098|FG001|Overall Study|Discontinuation of study by sponsor|1|||
146741940|NCT01121484|529227097|FG000|Overall Study|Other|3|||
146741941|NCT01121484|529227098|FG001|Overall Study|Other|3|||
146741942|NCT01121484|529227097|FG000|Overall Study|Randomized, not treated|1|||
146741943|NCT01121484|529227098|FG001|Overall Study|Randomized, not treated|4|||
146741944|NCT00539279|529227099|FG000|Treatment|Withdrawal by Subject|10|||
146741945|NCT00539279|529227100|FG001|Treatment|Withdrawal by Subject|8|||
146741946|NCT00539279|529227099|FG000|Treatment|Death|1|||
146741947|NCT00539279|529227100|FG001|Treatment|Death|0|||
146741948|NCT00539279|529227099|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
146741949|NCT00539279|529227100|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
146741950|NCT00539279|529227099|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
146914638|NCT03303339|529850047|FG005|Overall Study|Death|2|||
146741951|NCT00539279|529227100|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
146741952|NCT03017235|529228589|FG000|Overall Study|Withdrawal by Subject|4|||
146741953|NCT03017235|529228590|FG001|Overall Study|Withdrawal by Subject|3|||
146741954|NCT03017235|529228589|FG000|Overall Study|Lost to Follow-up|2|||
146741955|NCT03017235|529228590|FG001|Overall Study|Lost to Follow-up|7|||
146741956|NCT03017235|529228589|FG000|Overall Study|Adverse Event|0|||
146741957|NCT03017235|529228590|FG001|Overall Study|Adverse Event|1|||
146741958|NCT03017235|529228589|FG000|Overall Study|Protocol Violation|2|||
146741959|NCT03017235|529228590|FG001|Overall Study|Protocol Violation|1|||
146741960|NCT03017235|529228589|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
146509869|NCT01556997|528371868|FG000|Overall Study|Physician Decision|1|||
146509870|NCT01556997|528371869|FG001|Overall Study|Physician Decision|1|||
146509871|NCT01556997|528371870|FG002|Overall Study|Physician Decision|1|||
146509872|NCT01556997|528371868|FG000|Overall Study|Withdrawal by Subject|7|||
146509873|NCT01556997|528371869|FG001|Overall Study|Withdrawal by Subject|6|||
146509874|NCT01556997|528371870|FG002|Overall Study|Withdrawal by Subject|8|||
146509875|NCT01556997|528371868|FG000|Overall Study|Other|2|||
146509876|NCT01556997|528371869|FG001|Overall Study|Other|3|||
146509877|NCT01556997|528371870|FG002|Overall Study|Other|7|||
146509878|NCT01250171|528371874|FG000|Overall Study|Administrative reasons|1|||
146509879|NCT01250171|528371875|FG001|Overall Study|Administrative reasons|0|||
146509880|NCT01250171|528371876|FG002|Overall Study|Administrative reasons|0|||
146509881|NCT02949908|528371877|FG000|Overall Study|Study termination|2|||
146509882|NCT02607280|528371880|FG000|Overall Study|Adverse Event|4|||
146509883|NCT02607280|528371881|FG001|Overall Study|Adverse Event|0|||
146509884|NCT02607280|528371880|FG000|Overall Study|Decrease in CrCl <15|0|||
146509885|NCT02607280|528371881|FG001|Overall Study|Decrease in CrCl <15|1|||
146509886|NCT00590538|528371882|FG000|Overall Study|Study terminated before completed|2|||
146509887|NCT02309723|528371883|FG000|Overall Study|Withdrawal by Subject|24|||
146509888|NCT02309723|528371884|FG001|Overall Study|Withdrawal by Subject|23|||
146509889|NCT02309723|528371885|FG002|Overall Study|Withdrawal by Subject|24|||
146509890|NCT01125813|528371886|FG000|Overall Study|Death|1|||
146509891|NCT01125813|528371886|FG000|Overall Study|Withdrawal by Subject|1|||
146509892|NCT01125813|528371886|FG000|Overall Study|Screen Failures|4|||
146509893|NCT02539134|528371887|FG000|Overall Study|Lost to Follow-up|1|||
146509894|NCT02539134|528371888|FG001|Overall Study|Lost to Follow-up|0|||
146509895|NCT02539134|528371889|FG002|Overall Study|Lost to Follow-up|0|||
146509896|NCT02539134|528371890|FG003|Overall Study|Lost to Follow-up|0|||
146509897|NCT02539134|528371891|FG004|Overall Study|Lost to Follow-up|0|||
146509898|NCT02539134|528371892|FG005|Overall Study|Lost to Follow-up|0|||
146509899|NCT01143064|528371893|FG000|Overall Study|Death|109|||
146509900|NCT01143064|528371894|FG001|Overall Study|Death|91|||
146509901|NCT01143064|528371893|FG000|Overall Study|Adverse Event|0|||
146509902|NCT01143064|528371894|FG001|Overall Study|Adverse Event|1|||
146509903|NCT01143064|528371893|FG000|Overall Study|Withdrawal by Subject|7|||
146509904|NCT01143064|528371894|FG001|Overall Study|Withdrawal by Subject|5|||
146509905|NCT01143064|528371893|FG000|Overall Study|Lost to Follow-up|17|||
146509906|NCT01143064|528371894|FG001|Overall Study|Lost to Follow-up|14|||
146509907|NCT01143064|528371893|FG000|Overall Study|Physician Decision|0|||
146509908|NCT01143064|528371894|FG001|Overall Study|Physician Decision|4|||
146509909|NCT02453282|528371895|FG000|Overall Study|Death|275|||
146509910|NCT02453282|528371896|FG001|Overall Study|Death|277|||
146509911|NCT02453282|528371897|FG002|Overall Study|Death|296|||
146509912|NCT02453282|528371895|FG000|Overall Study|Lost to Follow-up|1|||
146509913|NCT02453282|528371896|FG001|Overall Study|Lost to Follow-up|0|||
146509914|NCT02453282|528371897|FG002|Overall Study|Lost to Follow-up|2|||
146509915|NCT02453282|528371895|FG000|Overall Study|Withdrawal by Subject|12|||
146509916|NCT02453282|528371896|FG001|Overall Study|Withdrawal by Subject|10|||
146509917|NCT02453282|528371897|FG002|Overall Study|Withdrawal by Subject|11|||
146509918|NCT02453282|528371895|FG000|Overall Study|Participants ongoing at data cut-off|85|||
146509919|NCT02453282|528371896|FG001|Overall Study|Participants ongoing at data cut-off|84|||
146509920|NCT02453282|528371897|FG002|Overall Study|Participants ongoing at data cut-off|62|||
146509921|NCT02453282|528371895|FG000|Overall Study|Other|1|||
146509922|NCT02453282|528371896|FG001|Overall Study|Other|1|||
146509923|NCT02453282|528371897|FG002|Overall Study|Other|1|||
146509924|NCT02327013|528371900|FG000|Overall Study|Adverse Event|4|||
146509925|NCT02327013|528371901|FG001|Overall Study|Adverse Event|4|||
146509926|NCT02327013|528371902|FG002|Overall Study|Adverse Event|3|||
146509927|NCT02327013|528371903|FG003|Overall Study|Adverse Event|0|||
146741961|NCT03017235|529228590|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
146509928|NCT02327013|528371904|FG004|Overall Study|Adverse Event|1|||
146509929|NCT02327013|528371900|FG000|Overall Study|Lack of Efficacy|2|||
146509930|NCT02327013|528371901|FG001|Overall Study|Lack of Efficacy|0|||
146509931|NCT02327013|528371902|FG002|Overall Study|Lack of Efficacy|5|||
146509932|NCT02327013|528371903|FG003|Overall Study|Lack of Efficacy|0|||
146509933|NCT02327013|528371904|FG004|Overall Study|Lack of Efficacy|1|||
146509934|NCT02327013|528371900|FG000|Overall Study|Non-compliance with IMP|1|||
146509935|NCT02327013|528371901|FG001|Overall Study|Non-compliance with IMP|2|||
146509936|NCT02327013|528371902|FG002|Overall Study|Non-compliance with IMP|7|||
146509937|NCT02327013|528371903|FG003|Overall Study|Non-compliance with IMP|0|||
146509938|NCT02327013|528371904|FG004|Overall Study|Non-compliance with IMP|0|||
146509939|NCT02327013|528371900|FG000|Overall Study|Withdrawal of Consent|1|||
146509940|NCT02327013|528371901|FG001|Overall Study|Withdrawal of Consent|0|||
146509941|NCT02327013|528371902|FG002|Overall Study|Withdrawal of Consent|3|||
146509942|NCT02327013|528371903|FG003|Overall Study|Withdrawal of Consent|0|||
146509943|NCT02327013|528371904|FG004|Overall Study|Withdrawal of Consent|0|||
146509944|NCT02327013|528371900|FG000|Overall Study|Lost to Follow-up|2|||
146509945|NCT02327013|528371901|FG001|Overall Study|Lost to Follow-up|4|||
146509946|NCT02327013|528371902|FG002|Overall Study|Lost to Follow-up|5|||
146509947|NCT02327013|528371903|FG003|Overall Study|Lost to Follow-up|0|||
146509948|NCT02327013|528371904|FG004|Overall Study|Lost to Follow-up|0|||
146509949|NCT02327013|528371900|FG000|Overall Study|Administrative or other reason(s)|1|||
146509950|NCT02327013|528371901|FG001|Overall Study|Administrative or other reason(s)|5|||
146509951|NCT02327013|528371902|FG002|Overall Study|Administrative or other reason(s)|11|||
146509952|NCT02327013|528371903|FG003|Overall Study|Administrative or other reason(s)|1|||
146509953|NCT02327013|528371904|FG004|Overall Study|Administrative or other reason(s)|1|||
146509954|NCT02327013|528371900|FG000|Overall Study|Protocol Violation|0|||
146509955|NCT02327013|528371901|FG001|Overall Study|Protocol Violation|0|||
146509956|NCT02327013|528371902|FG002|Overall Study|Protocol Violation|3|||
146509957|NCT02327013|528371903|FG003|Overall Study|Protocol Violation|0|||
146509958|NCT02327013|528371904|FG004|Overall Study|Protocol Violation|1|||
146509959|NCT02327013|528371900|FG000|Overall Study|Withdrawal before treatment|2|||
146509960|NCT02327013|528371901|FG001|Overall Study|Withdrawal before treatment|1|||
146509961|NCT02327013|528371902|FG002|Overall Study|Withdrawal before treatment|5|||
146509962|NCT02327013|528371903|FG003|Overall Study|Withdrawal before treatment|0|||
146509963|NCT02327013|528371904|FG004|Overall Study|Withdrawal before treatment|0|||
146509964|NCT02380859|528371905|FG000|Overall Study|Withdrawal by Subject|2|||
146509965|NCT02380859|528371906|FG001|Overall Study|Withdrawal by Subject|0|||
146509966|NCT01565668|528371907|FG000|Overall Study|Death|2|||
146509967|NCT01565668|528371908|FG001|Overall Study|Death|1|||
146509968|NCT01565668|528371907|FG000|Overall Study|Lack of Efficacy|4|||
146509969|NCT01565668|528371908|FG001|Overall Study|Lack of Efficacy|2|||
146509970|NCT01565668|528371907|FG000|Overall Study|Participant went on Hospice Care|1|||
146509971|NCT01565668|528371908|FG001|Overall Study|Participant went on Hospice Care|0|||
146509972|NCT01565668|528371907|FG000|Overall Study|Adverse Event|6|||
146509973|NCT01565668|528371908|FG001|Overall Study|Adverse Event|1|||
146509974|NCT01565668|528371907|FG000|Overall Study|Randomized, but never received drug|0|||
146509975|NCT01565668|528371908|FG001|Overall Study|Randomized, but never received drug|2|||
146509976|NCT01565668|528371907|FG000|Overall Study|Progressive disease|13|||
146509977|NCT01565668|528371908|FG001|Overall Study|Progressive disease|14|||
146509978|NCT01565668|528371907|FG000|Overall Study|Withdrawal by Subject|1|||
146509979|NCT01565668|528371908|FG001|Overall Study|Withdrawal by Subject|3|||
146509980|NCT01565668|528371907|FG000|Overall Study|HSCT Transplant|11|||
146509981|NCT01565668|528371908|FG001|Overall Study|HSCT Transplant|15|||
146509982|NCT04258254|528371909|FG000|Overall Study|Withdrawal by Subject|0|||
146509983|NCT04258254|528371910|FG001|Overall Study|Withdrawal by Subject|1|||
146509984|NCT04258254|528371911|FG002|Overall Study|Withdrawal by Subject|0|||
146509985|NCT02255552|528371912|FG000|Overall Study|Participants enrolled into another study|0|||
146509986|NCT02255552|528371913|FG001|Overall Study|Participants enrolled into another study|11|||
146509987|NCT02255552|528371912|FG000|Overall Study|Withdrawal by Subject|1|||
146509988|NCT02255552|528371913|FG001|Overall Study|Withdrawal by Subject|4|||
146509989|NCT01447446|528371914|FG000|Overall Study|Death|6|||
146509990|NCT01447446|528371915|FG001|Overall Study|Death|3|||
146509991|NCT01447446|528371916|FG002|Overall Study|Death|2|||
146509992|NCT01447446|528371917|FG003|Overall Study|Death|1|||
146509993|NCT01447446|528371918|FG004|Overall Study|Death|7|||
146509994|NCT01447446|528371919|FG005|Overall Study|Death|0|||
146509995|NCT01447446|528371914|FG000|Overall Study|Adverse Event|3|||
146509996|NCT01447446|528371915|FG001|Overall Study|Adverse Event|0|||
146509997|NCT01447446|528371916|FG002|Overall Study|Adverse Event|1|||
146509998|NCT01447446|528371917|FG003|Overall Study|Adverse Event|0|||
146509999|NCT01447446|528371918|FG004|Overall Study|Adverse Event|2|||
146510000|NCT01447446|528371919|FG005|Overall Study|Adverse Event|0|||
146510001|NCT01447446|528371914|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
146510002|NCT01447446|528371915|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
146510003|NCT01447446|528371916|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
146510004|NCT01447446|528371917|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
146510005|NCT01447446|528371918|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
146510006|NCT01447446|528371919|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
146510007|NCT01447446|528371914|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
146510008|NCT01447446|528371915|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
146510009|NCT01447446|528371916|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
146510010|NCT01447446|528371917|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
146510011|NCT01447446|528371918|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
146510012|NCT01447446|528371919|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
146510013|NCT01447446|528371914|FG000|Overall Study|Administrative/Other|34|||
146741962|NCT00437125|529228591|FG000|Overall Study|Adverse Event|12|||
146741963|NCT00437125|529228591|FG000|Overall Study|Death|1|||
146741964|NCT00437125|529228591|FG000|Overall Study|Clinical Relapse|1|||
146741965|NCT00437125|529228591|FG000|Overall Study|Lack of Efficacy|1|||
146741966|NCT00437125|529228591|FG000|Overall Study|Lost to Follow-up|1|||
146741967|NCT00437125|529228591|FG000|Overall Study|Withdrawal by Subject|13|||
146741968|NCT00437125|529228591|FG000|Overall Study|Withdrawal by Caregiver|2|||
146741969|NCT00437125|529228591|FG000|Overall Study|Physician Decision|1|||
146741970|NCT02248961|529228592|FG000|Overall Study|Adverse Event|1|||
146741971|NCT02248961|529228593|FG001|Overall Study|Adverse Event|0|||
146741972|NCT02248961|529228592|FG000|Overall Study|Withdrawal by Subject|1|||
146741973|NCT02248961|529228593|FG001|Overall Study|Withdrawal by Subject|2|||
146741974|NCT02248961|529228592|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
146741975|NCT02248961|529228593|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
146741976|NCT03518658|529228594|FG000|Overall Study|Other|51|||
146741977|NCT03518658|529228595|FG001|Overall Study|Other|0|||
146741978|NCT02531295|529228596|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
146741979|NCT02531295|529228597|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
146741980|NCT02531295|529228598|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
146741981|NCT02531295|529228599|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
146741982|NCT02531295|529228600|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
146741983|NCT02531295|529228601|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
146741984|NCT00649389|529228602|FG000|Overall Study|Adverse Event|22|||
146741985|NCT00649389|529228603|FG001|Overall Study|Adverse Event|46|||
146741986|NCT00649389|529228604|FG002|Overall Study|Adverse Event|38|||
146741987|NCT00649389|529228605|FG003|Overall Study|Adverse Event|48|||
146741988|NCT00649389|529228602|FG000|Overall Study|Lost to Follow-up|15|||
146741989|NCT00649389|529228603|FG001|Overall Study|Lost to Follow-up|17|||
146741990|NCT00649389|529228604|FG002|Overall Study|Lost to Follow-up|21|||
146741991|NCT00649389|529228605|FG003|Overall Study|Lost to Follow-up|26|||
146741992|NCT00649389|529228602|FG000|Overall Study|Protocol Violation|11|||
146741993|NCT00649389|529228603|FG001|Overall Study|Protocol Violation|13|||
146741994|NCT00649389|529228604|FG002|Overall Study|Protocol Violation|9|||
146741995|NCT00649389|529228605|FG003|Overall Study|Protocol Violation|8|||
146741996|NCT00649389|529228602|FG000|Overall Study|Withdrawal by Subject|20|||
146741997|NCT00649389|529228603|FG001|Overall Study|Withdrawal by Subject|21|||
146741998|NCT00649389|529228604|FG002|Overall Study|Withdrawal by Subject|19|||
146741999|NCT00649389|529228605|FG003|Overall Study|Withdrawal by Subject|23|||
146742000|NCT00649389|529228602|FG000|Overall Study|Other|3|||
146742001|NCT00649389|529228603|FG001|Overall Study|Other|9|||
146742002|NCT00649389|529228604|FG002|Overall Study|Other|1|||
146742003|NCT00649389|529228605|FG003|Overall Study|Other|6|||
146742004|NCT00453310|529228608|FG000|Overall Study|Progression of Disease|10|||
146742005|NCT00244374|529228611|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
146742006|NCT00244374|529228612|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
146742007|NCT00244374|529228613|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
146742008|NCT00244374|529228614|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
146742009|NCT00244374|529228615|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
146742010|NCT00244374|529228611|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
146742011|NCT00244374|529228612|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
146742012|NCT00244374|529228613|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
146742013|NCT00244374|529228614|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
146742014|NCT00244374|529228615|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
146742015|NCT00244374|529228611|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
146742016|NCT00244374|529228612|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
146742017|NCT00244374|529228613|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
146742018|NCT00244374|529228614|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
146742019|NCT00244374|529228615|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
146742020|NCT00244374|529228611|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
146742021|NCT00244374|529228612|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
146742022|NCT00244374|529228613|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
146742023|NCT00244374|529228614|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
146742024|NCT00244374|529228615|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
146742025|NCT00244374|529228611|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
146742026|NCT00244374|529228612|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
146742027|NCT00244374|529228613|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
146742028|NCT00244374|529228614|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
146742029|NCT00244374|529228615|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
146510014|NCT01447446|528371915|FG001|Overall Study|Administrative/Other|9|||
146510015|NCT01447446|528371916|FG002|Overall Study|Administrative/Other|10|||
146510016|NCT01447446|528371917|FG003|Overall Study|Administrative/Other|2|||
146510017|NCT01447446|528371918|FG004|Overall Study|Administrative/Other|33|||
146510018|NCT01447446|528371919|FG005|Overall Study|Administrative/Other|4|||
146510019|NCT01447446|528371914|FG000|Overall Study|SVR12 Assessment|13|||
146510020|NCT01447446|528371915|FG001|Overall Study|SVR12 Assessment|1|||
146510021|NCT01447446|528371916|FG002|Overall Study|SVR12 Assessment|2|||
146510022|NCT01447446|528371917|FG003|Overall Study|SVR12 Assessment|1|||
146510023|NCT01447446|528371918|FG004|Overall Study|SVR12 Assessment|5|||
146742030|NCT00244374|529228611|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
146742031|NCT00244374|529228612|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
146742032|NCT00244374|529228613|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
146742033|NCT00244374|529228614|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
146742034|NCT00244374|529228615|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
146742035|NCT00244374|529228611|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
146742036|NCT00244374|529228612|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
146742037|NCT00244374|529228613|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
146742038|NCT00244374|529228614|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
146742039|NCT00244374|529228615|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
146742040|NCT00244374|529228611|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
146742041|NCT00244374|529228612|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
146742042|NCT00244374|529228613|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
146742043|NCT00244374|529228614|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
146742044|NCT00244374|529228615|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
146742045|NCT00244374|529228611|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
146742046|NCT00244374|529228612|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
146742047|NCT00244374|529228613|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
146742048|NCT00244374|529228614|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
146742049|NCT00244374|529228615|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
146742050|NCT01642602|529228630|FG000|Overall Study|Adverse Event|2|||
146742051|NCT02961881|529228631|FG000|Overall Study|Adverse Event|1|||
146742052|NCT02961881|529228632|FG001|Overall Study|Adverse Event|2|||
146742053|NCT02961881|529228633|FG002|Overall Study|Adverse Event|2|||
146742054|NCT02961881|529228634|FG003|Overall Study|Adverse Event|0|||
146742055|NCT02961881|529228635|FG004|Overall Study|Adverse Event|1|||
146742056|NCT02961881|529228631|FG000|Overall Study|Participant request|0|||
146742057|NCT02961881|529228632|FG001|Overall Study|Participant request|2|||
146742058|NCT02961881|529228633|FG002|Overall Study|Participant request|0|||
146742059|NCT02961881|529228634|FG003|Overall Study|Participant request|0|||
146742060|NCT02961881|529228635|FG004|Overall Study|Participant request|0|||
146742061|NCT02961881|529228631|FG000|Overall Study|Disease progression|1|||
146742062|NCT02961881|529228632|FG001|Overall Study|Disease progression|0|||
146742063|NCT02961881|529228633|FG002|Overall Study|Disease progression|1|||
146742064|NCT02961881|529228634|FG003|Overall Study|Disease progression|0|||
146742065|NCT02961881|529228635|FG004|Overall Study|Disease progression|0|||
146742066|NCT01118455|529228636|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
146742067|NCT01118455|529228637|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
146742068|NCT01973491|529228638|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
146742069|NCT01973491|529228638|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
146742070|NCT01973491|529228638|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
146742071|NCT01863043|529228640|FG000|Overall Study|Death|6|||
146742072|NCT01863043|529228641|FG001|Overall Study|Death|1|||
146742073|NCT01863043|529228640|FG000|Overall Study|Withdrawal by Subject|0|||
146742074|NCT01863043|529228641|FG001|Overall Study|Withdrawal by Subject|2|||
146742075|NCT01863043|529228640|FG000|Overall Study|Adverse Event|7|||
146742076|NCT01863043|529228641|FG001|Overall Study|Adverse Event|8|||
146742077|NCT01863043|529228640|FG000|Overall Study|exclusion criteria found after enrollment|0|||
146742078|NCT01863043|529228641|FG001|Overall Study|exclusion criteria found after enrollment|1|||
146742079|NCT01928225|529228642|FG000|Overall Study|Pregnancy|1|||
146742080|NCT01928225|529228643|FG001|Overall Study|Pregnancy|0|||
146742081|NCT01928225|529228642|FG000|Overall Study|basaloid cervical cancer|1|||
146742082|NCT01928225|529228643|FG001|Overall Study|basaloid cervical cancer|0|||
146742083|NCT01928225|529228642|FG000|Overall Study|Lost to Follow-up|1|||
146742084|NCT01928225|529228643|FG001|Overall Study|Lost to Follow-up|3|||
146510024|NCT01447446|528371919|FG005|Overall Study|SVR12 Assessment|5|||
146742085|NCT05033743|529228648|FG000|Overall Study|Lost to Follow-up|1|||
146742086|NCT05033743|529228648|FG000|Overall Study|Protocol Violation|2|||
146742087|NCT05033743|529228648|FG000|Overall Study|Withdrawal by Subject|1|||
146742088|NCT01622348|529228649|FG000|Overall Study|Withdrawal by Subject|1|||
146742089|NCT01622348|529228650|FG001|Overall Study|Withdrawal by Subject|0|||
146742090|NCT01622348|529228651|FG002|Overall Study|Withdrawal by Subject|1|||
146742091|NCT00791921|529228654|FG000|Overall Study|Protocol planed|24|||
146742092|NCT00791921|529228655|FG001|Overall Study|Protocol planed|88|||
146742093|NCT00791921|529228654|FG000|Overall Study|Withdrawal by Subject|1|||
146742094|NCT00791921|529228655|FG001|Overall Study|Withdrawal by Subject|2|||
146742095|NCT00791921|529228654|FG000|Overall Study|Adverse Event|8|||
146742096|NCT00791921|529228655|FG001|Overall Study|Adverse Event|2|||
146742097|NCT00791921|529228654|FG000|Overall Study|Lack of Efficacy|0|||
146742098|NCT00791921|529228655|FG001|Overall Study|Lack of Efficacy|2|||
146742099|NCT00791921|529228654|FG000|Overall Study|Lack of study drug administration|1|||
146742100|NCT00791921|529228655|FG001|Overall Study|Lack of study drug administration|1|||
146742101|NCT00791921|529228654|FG000|Overall Study|Reason other than those above|0|||
146742102|NCT00791921|529228655|FG001|Overall Study|Reason other than those above|1|||
146742103|NCT01592695|529228659|FG000|Overall Study|Lost to Follow-up|8|||
146742104|NCT01592695|529228660|FG001|Overall Study|Lost to Follow-up|4|||
146742105|NCT00422799|529228661|FG000|Overall Study|Withdrawal by Subject|6|||
146742106|NCT00422799|529228661|FG000|Overall Study|Adverse Event|7|||
146742107|NCT01965158|529228662|FG000|Overall Study|Adverse Event|14|||
146742108|NCT01965158|529228663|FG001|Overall Study|Adverse Event|5|||
146742109|NCT01965158|529228662|FG000|Overall Study|Withdrawal by Subject|16|||
146742110|NCT01965158|529228663|FG001|Overall Study|Withdrawal by Subject|24|||
146742111|NCT01965158|529228662|FG000|Overall Study|Lost to Follow-up|7|||
146742112|NCT01965158|529228663|FG001|Overall Study|Lost to Follow-up|5|||
146742113|NCT01965158|529228662|FG000|Overall Study|Protocol Violation|1|||
146742114|NCT01965158|529228663|FG001|Overall Study|Protocol Violation|1|||
146742115|NCT01965158|529228662|FG000|Overall Study|Other - Miscellaneous|3|||
146742116|NCT01965158|529228663|FG001|Overall Study|Other - Miscellaneous|0|||
146742117|NCT00474175|529228664|FG000|Overall Study|Lack of Efficacy|0|||
146742118|NCT00474175|529228665|FG001|Overall Study|Lack of Efficacy|0|||
146742119|NCT00474175|529228666|FG002|Overall Study|Lack of Efficacy|1|||
146742120|NCT00474175|529228664|FG000|Overall Study|Withdrawal by Subject|0|||
146742121|NCT00474175|529228665|FG001|Overall Study|Withdrawal by Subject|1|||
146742122|NCT00474175|529228666|FG002|Overall Study|Withdrawal by Subject|1|||
146742123|NCT00474175|529228664|FG000|Overall Study|Ineligible|1|||
146742124|NCT00474175|529228665|FG001|Overall Study|Ineligible|3|||
146742125|NCT00474175|529228666|FG002|Overall Study|Ineligible|1|||
146742126|NCT00474175|529228664|FG000|Overall Study|Protocol Violation|0|||
146742127|NCT00474175|529228665|FG001|Overall Study|Protocol Violation|2|||
146742128|NCT00474175|529228666|FG002|Overall Study|Protocol Violation|1|||
146742129|NCT00474175|529228664|FG000|Overall Study|Administrative|0|||
146742130|NCT00474175|529228665|FG001|Overall Study|Administrative|1|||
146742131|NCT00474175|529228666|FG002|Overall Study|Administrative|0|||
146742132|NCT00467142|529228668|FG000|Overall Study|Withdrawal by Subject|1|||
146742133|NCT00467142|529228668|FG000|Overall Study|Adverse Event|1|||
146742134|NCT00467142|529228668|FG000|Overall Study|Protocol Violation|1|||
146742135|NCT01619787|529228669|FG000|Overall Study|Lost to Follow-up|5|||
146742136|NCT01737996|529228677|FG000|Overall Study|Adverse Event|0|||
146742137|NCT01737996|529228678|FG001|Overall Study|Adverse Event|1|||
146742138|NCT01737996|529228679|FG002|Overall Study|Adverse Event|1|||
146742139|NCT01737996|529228677|FG000|Overall Study|Withdrawal by Subject|0|||
146742140|NCT01737996|529228678|FG001|Overall Study|Withdrawal by Subject|0|||
146742141|NCT01737996|529228679|FG002|Overall Study|Withdrawal by Subject|1|||
146742142|NCT02693834|529228683|FG000|Baseline Measurement|Withdrawal by Subject|1|||
146742143|NCT02693834|529228684|FG001|Baseline Measurement|Withdrawal by Subject|0|||
146742144|NCT02693834|529228683|FG000|Baseline Measurement|Adverse Event|1|||
146742145|NCT02693834|529228684|FG001|Baseline Measurement|Adverse Event|0|||
146742146|NCT02693834|529228683|FG000|Week 2 Practice|Adverse Event|0|||
146742147|NCT02693834|529228684|FG001|Week 2 Practice|Adverse Event|1|||
146742148|NCT01468922|529228685|FG000|Overall Study|Screening failure|0|||
146510025|NCT01447446|528371914|FG000|Overall Study|New Treatment Started|8|||
146510026|NCT01447446|528371915|FG001|Overall Study|New Treatment Started|2|||
146742149|NCT01468922|529228686|FG001|Overall Study|Screening failure|0|||
146742150|NCT01468922|529228687|FG002|Overall Study|Screening failure|0|||
146742151|NCT01468922|529228688|FG003|Overall Study|Screening failure|0|||
146742152|NCT01468922|529228689|FG004|Overall Study|Screening failure|0|||
146742153|NCT01468922|529228690|FG005|Overall Study|Screening failure|0|||
146742154|NCT01468922|529228691|FG006|Overall Study|Screening failure|0|||
146742155|NCT01468922|529228692|FG007|Overall Study|Screening failure|0|||
146742156|NCT01468922|529228693|FG008|Overall Study|Screening failure|1|||
146742157|NCT01468922|529228685|FG000|Overall Study|Per patient choice|1|||
146742158|NCT01468922|529228686|FG001|Overall Study|Per patient choice|0|||
146742159|NCT01468922|529228687|FG002|Overall Study|Per patient choice|0|||
146742160|NCT01468922|529228688|FG003|Overall Study|Per patient choice|0|||
146742161|NCT01468922|529228689|FG004|Overall Study|Per patient choice|0|||
146742162|NCT01468922|529228690|FG005|Overall Study|Per patient choice|0|||
146742163|NCT01468922|529228691|FG006|Overall Study|Per patient choice|0|||
146742164|NCT01468922|529228692|FG007|Overall Study|Per patient choice|0|||
146742165|NCT01468922|529228693|FG008|Overall Study|Per patient choice|0|||
146742166|NCT01468922|529228685|FG000|Overall Study|Switched to alternative treatment|1|||
146742167|NCT01468922|529228686|FG001|Overall Study|Switched to alternative treatment|0|||
146742168|NCT01468922|529228687|FG002|Overall Study|Switched to alternative treatment|0|||
146742169|NCT01468922|529228688|FG003|Overall Study|Switched to alternative treatment|0|||
146742170|NCT01468922|529228689|FG004|Overall Study|Switched to alternative treatment|1|||
146742171|NCT01468922|529228690|FG005|Overall Study|Switched to alternative treatment|0|||
146742172|NCT01468922|529228691|FG006|Overall Study|Switched to alternative treatment|0|||
146742173|NCT01468922|529228692|FG007|Overall Study|Switched to alternative treatment|0|||
146742174|NCT01468922|529228693|FG008|Overall Study|Switched to alternative treatment|0|||
146742175|NCT01468922|529228685|FG000|Overall Study|Enrolled on new protocol|0|||
146742176|NCT01468922|529228686|FG001|Overall Study|Enrolled on new protocol|0|||
146742177|NCT01468922|529228687|FG002|Overall Study|Enrolled on new protocol|0|||
146742178|NCT01468922|529228688|FG003|Overall Study|Enrolled on new protocol|0|||
146742179|NCT01468922|529228689|FG004|Overall Study|Enrolled on new protocol|1|||
146742180|NCT01468922|529228690|FG005|Overall Study|Enrolled on new protocol|0|||
146742181|NCT01468922|529228691|FG006|Overall Study|Enrolled on new protocol|0|||
146742182|NCT01468922|529228692|FG007|Overall Study|Enrolled on new protocol|0|||
146742183|NCT01468922|529228693|FG008|Overall Study|Enrolled on new protocol|0|||
146742184|NCT01468922|529228685|FG000|Overall Study|Adverse Event|0|||
146742185|NCT01468922|529228686|FG001|Overall Study|Adverse Event|0|||
146742186|NCT01468922|529228687|FG002|Overall Study|Adverse Event|0|||
146742187|NCT01468922|529228688|FG003|Overall Study|Adverse Event|0|||
146742188|NCT01468922|529228689|FG004|Overall Study|Adverse Event|0|||
146742189|NCT01468922|529228690|FG005|Overall Study|Adverse Event|0|||
146742190|NCT01468922|529228691|FG006|Overall Study|Adverse Event|0|||
146742191|NCT01468922|529228692|FG007|Overall Study|Adverse Event|1|||
146742192|NCT01468922|529228693|FG008|Overall Study|Adverse Event|0|||
146742193|NCT01468922|529228685|FG000|Overall Study|Infection of blood|0|||
146742194|NCT01468922|529228686|FG001|Overall Study|Infection of blood|0|||
146742195|NCT01468922|529228687|FG002|Overall Study|Infection of blood|0|||
146742196|NCT01468922|529228688|FG003|Overall Study|Infection of blood|0|||
146742197|NCT01468922|529228689|FG004|Overall Study|Infection of blood|0|||
146742198|NCT01468922|529228690|FG005|Overall Study|Infection of blood|0|||
146742199|NCT01468922|529228691|FG006|Overall Study|Infection of blood|0|||
146742200|NCT01468922|529228692|FG007|Overall Study|Infection of blood|1|||
146742201|NCT01468922|529228693|FG008|Overall Study|Infection of blood|0|||
146742202|NCT01468922|529228685|FG000|Overall Study|Patient choice - surgery|0|||
146742203|NCT01468922|529228686|FG001|Overall Study|Patient choice - surgery|0|||
146742204|NCT01468922|529228687|FG002|Overall Study|Patient choice - surgery|0|||
146742205|NCT01468922|529228688|FG003|Overall Study|Patient choice - surgery|0|||
146742206|NCT01468922|529228689|FG004|Overall Study|Patient choice - surgery|0|||
146742207|NCT01468922|529228690|FG005|Overall Study|Patient choice - surgery|0|||
146742208|NCT01468922|529228691|FG006|Overall Study|Patient choice - surgery|0|||
146742209|NCT01468922|529228692|FG007|Overall Study|Patient choice - surgery|1|||
146742210|NCT01468922|529228693|FG008|Overall Study|Patient choice - surgery|0|||
146742211|NCT01468922|529228685|FG000|Overall Study|Refused further treatment|0|||
146742212|NCT01468922|529228686|FG001|Overall Study|Refused further treatment|0|||
146742213|NCT01468922|529228687|FG002|Overall Study|Refused further treatment|0|||
146742214|NCT01468922|529228688|FG003|Overall Study|Refused further treatment|0|||
146742215|NCT01468922|529228689|FG004|Overall Study|Refused further treatment|0|||
146742216|NCT01468922|529228690|FG005|Overall Study|Refused further treatment|0|||
146742217|NCT01468922|529228691|FG006|Overall Study|Refused further treatment|0|||
146742218|NCT01468922|529228692|FG007|Overall Study|Refused further treatment|1|||
146742219|NCT01468922|529228693|FG008|Overall Study|Refused further treatment|0|||
146742220|NCT01923389|529228694|FG000|Overall Study|Protocol Violation|1|||
146742221|NCT01923389|529228695|FG001|Overall Study|Protocol Violation|0|||
146742222|NCT02761629|529228700|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
146742223|NCT02761629|529228701|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
146742224|NCT02761629|529228700|FG000|Overall Study|Insufficient Therapeutic Response|2|||
146742225|NCT02761629|529228701|FG001|Overall Study|Insufficient Therapeutic Response|7|||
146742226|NCT02761629|529228700|FG000|Overall Study|Failure to Return|2|||
146742227|NCT02761629|529228701|FG001|Overall Study|Failure to Return|4|||
146742228|NCT02761629|529228700|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
146742229|NCT02761629|529228701|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
146742230|NCT02761629|529228700|FG000|Overall Study|Protocol Violation|2|||
146742231|NCT02761629|529228701|FG001|Overall Study|Protocol Violation|2|||
146742232|NCT02761629|529228700|FG000|Overall Study|Withdrawal by Subject|0|||
146742233|NCT02761629|529228701|FG001|Overall Study|Withdrawal by Subject|3|||
146742234|NCT02761629|529228700|FG000|Overall Study|Other|0|||
146742235|NCT02761629|529228701|FG001|Overall Study|Other|2|||
146742236|NCT02761629|529228700|FG000|Overall Study|Lost to Follow-up|4|||
146742237|NCT02761629|529228701|FG001|Overall Study|Lost to Follow-up|1|||
146742238|NCT02761629|529228700|FG000|Overall Study|Randomized But Not Treated|8|||
146742239|NCT02761629|529228701|FG001|Overall Study|Randomized But Not Treated|4|||
146742240|NCT04362137|529228708|FG000|Overall Study|Death|9|||
146742241|NCT04362137|529228709|FG001|Overall Study|Death|3|||
146742242|NCT04362137|529228708|FG000|Overall Study|Patient decision|6|||
146742243|NCT04362137|529228709|FG001|Overall Study|Patient decision|3|||
146742244|NCT04362137|529228708|FG000|Overall Study|Adverse Event|1|||
146742245|NCT04362137|529228709|FG001|Overall Study|Adverse Event|0|||
146742246|NCT04362137|529228708|FG000|Overall Study|Lost to Follow-up|1|||
146742247|NCT04362137|529228709|FG001|Overall Study|Lost to Follow-up|0|||
146742248|NCT04362137|529228708|FG000|Overall Study|Protocol deviation|1|||
146742249|NCT04362137|529228709|FG001|Overall Study|Protocol deviation|0|||
146742250|NCT02204579|529228712|FG000|Overall Study|Screen failures|2|||
146742251|NCT03176238|529228716|FG000|Overall Study|Unacceptable AEs|15|||
146742252|NCT03176238|529228717|FG001|Overall Study|Unacceptable AEs|8|||
146742253|NCT03176238|529228716|FG000|Overall Study|Abnormal lab value(s)|2|||
146742254|NCT03176238|529228717|FG001|Overall Study|Abnormal lab value(s)|0|||
146742255|NCT03176238|529228716|FG000|Overall Study|Inter-current illness|0|||
146742256|NCT03176238|529228717|FG001|Overall Study|Inter-current illness|1|||
146742257|NCT03176238|529228716|FG000|Overall Study|Consent withdrawal|14|||
146742258|NCT03176238|529228717|FG001|Overall Study|Consent withdrawal|2|||
146742259|NCT03176238|529228716|FG000|Overall Study|Lost to Follow-up|3|||
146742260|NCT03176238|529228717|FG001|Overall Study|Lost to Follow-up|0|||
146742261|NCT03176238|529228716|FG000|Overall Study|Administrative problems|1|||
146742262|NCT03176238|529228717|FG001|Overall Study|Administrative problems|0|||
146742263|NCT03176238|529228716|FG000|Overall Study|Death|3|||
146742264|NCT03176238|529228717|FG001|Overall Study|Death|0|||
146742265|NCT03176238|529228716|FG000|Overall Study|Disease Progression|133|||
146742266|NCT03176238|529228717|FG001|Overall Study|Disease Progression|22|||
146742267|NCT03176238|529228716|FG000|Overall Study|Tx duration completed per EAP|0|||
146742268|NCT03176238|529228717|FG001|Overall Study|Tx duration completed per EAP|1|||
146742269|NCT03176238|529228716|FG000|Overall Study|Patient is switched to commercial drug|16|||
146742270|NCT03176238|529228717|FG001|Overall Study|Patient is switched to commercial drug|1|||
146742271|NCT03176238|529228716|FG000|Overall Study|Protocol Violation|1|||
146742272|NCT03176238|529228717|FG001|Overall Study|Protocol Violation|0|||
146742273|NCT03176238|529228716|FG000|Overall Study|Changes in the patient's condition|2|||
146742274|NCT03176238|529228717|FG001|Overall Study|Changes in the patient's condition|1|||
146742275|NCT03176238|529228716|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
146742276|NCT03176238|529228717|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
146742277|NCT03556358|529228718|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
146742278|NCT03556358|529228719|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
146742279|NCT03556358|529228718|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
146742280|NCT03556358|529228719|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
146742281|NCT03556358|529228718|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
146742282|NCT03556358|529228719|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
146742283|NCT03556358|529228718|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
146742284|NCT03556358|529228719|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
146742285|NCT03556358|529228718|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
146742286|NCT03556358|529228719|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
146742287|NCT03556358|529228718|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
146742288|NCT03556358|529228719|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
146742289|NCT03556358|529228718|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
146742290|NCT03556358|529228719|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
146742291|NCT01351025|529228721|FG000|Week 0 - 20|Lost to Follow-up|2|||
146742292|NCT01351025|529228722|FG001|Week 0 - 20|Lost to Follow-up|1|||
146742293|NCT01351025|529228721|FG000|Week 0 - 20|Withdrawal by Subject|1|||
146742294|NCT01351025|529228722|FG001|Week 0 - 20|Withdrawal by Subject|0|||
146742295|NCT01351025|529228721|FG000|Week 24 - 44|Lost to Follow-up|0|||
146742296|NCT01351025|529228722|FG001|Week 24 - 44|Lost to Follow-up|2|||
146742297|NCT01351025|529228721|FG000|Week 24 - 44|Site closed|0|||
146742298|NCT01351025|529228722|FG001|Week 24 - 44|Site closed|1|||
146742299|NCT01351025|529228721|FG000|Week 24 - 44|unable to get to clinic|1|||
146742300|NCT01351025|529228722|FG001|Week 24 - 44|unable to get to clinic|1|||
146742301|NCT05067933|529228726|FG000|Overall Study|Withdrawal by Subject|2|||
146742302|NCT05067933|529228727|FG001|Overall Study|Withdrawal by Subject|0|||
146742303|NCT05067933|529228728|FG002|Overall Study|Withdrawal by Subject|0|||
146742304|NCT05067933|529228729|FG003|Overall Study|Withdrawal by Subject|0|||
146742305|NCT05067933|529228730|FG004|Overall Study|Withdrawal by Subject|0|||
146742306|NCT05067933|529228731|FG005|Overall Study|Withdrawal by Subject|0|||
146742307|NCT05067933|529228726|FG000|Overall Study|Lost to Follow-up|1|||
146742308|NCT05067933|529228727|FG001|Overall Study|Lost to Follow-up|1|||
146742309|NCT05067933|529228728|FG002|Overall Study|Lost to Follow-up|1|||
146742310|NCT05067933|529228729|FG003|Overall Study|Lost to Follow-up|2|||
146742311|NCT05067933|529228730|FG004|Overall Study|Lost to Follow-up|1|||
146742312|NCT05067933|529228731|FG005|Overall Study|Lost to Follow-up|0|||
146742313|NCT05067933|529228726|FG000|Overall Study|Miscellaneous|1|||
146742314|NCT05067933|529228727|FG001|Overall Study|Miscellaneous|0|||
146742315|NCT05067933|529228728|FG002|Overall Study|Miscellaneous|0|||
146742316|NCT05067933|529228729|FG003|Overall Study|Miscellaneous|0|||
146742317|NCT05067933|529228730|FG004|Overall Study|Miscellaneous|0|||
146742318|NCT05067933|529228731|FG005|Overall Study|Miscellaneous|0|||
146742319|NCT05067933|529228726|FG000|Overall Study|Death|0|||
146742320|NCT05067933|529228727|FG001|Overall Study|Death|0|||
146742321|NCT05067933|529228728|FG002|Overall Study|Death|0|||
146742322|NCT05067933|529228729|FG003|Overall Study|Death|1|||
146742323|NCT05067933|529228730|FG004|Overall Study|Death|0|||
146742324|NCT05067933|529228731|FG005|Overall Study|Death|0|||
146742325|NCT01065350|529228732|FG000|Overall Study|Received incorrect drug allocation|0|||
146742326|NCT01065350|529228733|FG001|Overall Study|Received incorrect drug allocation|1|||
146742327|NCT02875834|529228736|FG000|Open-label Phase|Withdrawal by Subject|3|||
146742328|NCT02875834|529228737|FG001|Open-label Phase|Withdrawal by Subject|0|||
146742329|NCT02875834|529228738|FG002|Open-label Phase|Withdrawal by Subject|0|||
146742330|NCT02875834|529228739|FG003|Open-label Phase|Withdrawal by Subject|0|||
146742331|NCT02875834|529228736|FG000|Open-label Phase|(Not collected)|4|||
146742332|NCT02875834|529228737|FG001|Open-label Phase|(Not collected)|0|||
146742333|NCT02875834|529228738|FG002|Open-label Phase|(Not collected)|0|||
146742334|NCT02875834|529228739|FG003|Open-label Phase|(Not collected)|0|||
146742335|NCT02875834|529228736|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
146742336|NCT02875834|529228737|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
146742337|NCT02875834|529228738|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
146742338|NCT02875834|529228739|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
146742339|NCT02875834|529228736|FG000|Randomized Treatment Phase|Protocol Violation|0|||
146742340|NCT02875834|529228737|FG001|Randomized Treatment Phase|Protocol Violation|2|||
146742341|NCT02875834|529228738|FG002|Randomized Treatment Phase|Protocol Violation|0|||
146742342|NCT02875834|529228739|FG003|Randomized Treatment Phase|Protocol Violation|0|||
146742343|NCT02875834|529228736|FG000|Randomized Treatment Phase|(Not collected)|0|||
146742344|NCT02875834|529228737|FG001|Randomized Treatment Phase|(Not collected)|9|||
146742345|NCT02875834|529228738|FG002|Randomized Treatment Phase|(Not collected)|10|||
146742346|NCT02875834|529228739|FG003|Randomized Treatment Phase|(Not collected)|9|||
146742347|NCT05200936|529228741|FG000|Overall Study|Withdrawal by Subject|2|||
146742348|NCT05200936|529228742|FG001|Overall Study|Withdrawal by Subject|2|||
146742349|NCT05200936|529228741|FG000|Overall Study|Lost to Follow-up|2|||
146742350|NCT05200936|529228742|FG001|Overall Study|Lost to Follow-up|0|||
146742351|NCT05200936|529228741|FG000|Overall Study|Pregnancy|0|||
146742352|NCT05200936|529228742|FG001|Overall Study|Pregnancy|1|||
146742353|NCT02906683|529230099|FG000|Overall Study|Adverse Event|0|||
146742354|NCT02906683|529230100|FG001|Overall Study|Adverse Event|1|||
146742355|NCT02906683|529230101|FG002|Overall Study|Adverse Event|0|||
146742356|NCT02906683|529230099|FG000|Overall Study|Physician Decision|0|||
146742357|NCT02906683|529230100|FG001|Overall Study|Physician Decision|1|||
146742358|NCT02906683|529230101|FG002|Overall Study|Physician Decision|1|||
146742359|NCT02906683|529230099|FG000|Overall Study|Withdrawal by Subject|0|||
146742360|NCT02906683|529230100|FG001|Overall Study|Withdrawal by Subject|2|||
146742361|NCT02906683|529230101|FG002|Overall Study|Withdrawal by Subject|1|||
146742362|NCT02906683|529230099|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
146742363|NCT02906683|529230100|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
146742364|NCT02906683|529230101|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
146742365|NCT02906683|529230099|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
146742366|NCT02906683|529230100|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
146742367|NCT02906683|529230101|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
146742368|NCT02781506|529230102|FG000|Overall Study|Adverse Event|5|||
146742369|NCT01340482|529230104|FG000|Overall Study|Adverse Event|2|||
146742370|NCT01340482|529230105|FG001|Overall Study|Adverse Event|0|||
146742371|NCT01340482|529230106|FG002|Overall Study|Adverse Event|0|||
146742372|NCT02593539|529230107|FG000|Overall Study|Adverse Event|1|||
146742373|NCT02791490|529230111|FG000|Overall Study|Lost to Follow-up|1|||
146742374|NCT02791490|529230112|FG001|Overall Study|Lost to Follow-up|2|||
146742375|NCT02791490|529230111|FG000|Overall Study|Withdrawal by Subject|2|||
146742376|NCT02791490|529230112|FG001|Overall Study|Withdrawal by Subject|6|||
146742377|NCT01189890|529230113|FG000|Overall Study|Adverse Event|3|||
146742378|NCT01189890|529230114|FG001|Overall Study|Adverse Event|4|||
146742379|NCT01189890|529230113|FG000|Overall Study|Lack of Efficacy|7|||
146742380|NCT01189890|529230114|FG001|Overall Study|Lack of Efficacy|2|||
146742381|NCT01189890|529230113|FG000|Overall Study|Lost to Follow-up|1|||
146742382|NCT01189890|529230114|FG001|Overall Study|Lost to Follow-up|7|||
146742383|NCT01189890|529230113|FG000|Overall Study|Protocol Violation|1|||
146742384|NCT01189890|529230114|FG001|Overall Study|Protocol Violation|5|||
146742385|NCT01189890|529230113|FG000|Overall Study|Withdrawal by Subject|15|||
146742386|NCT01189890|529230114|FG001|Overall Study|Withdrawal by Subject|11|||
146742387|NCT01189890|529230113|FG000|Overall Study|Non Compliance|0|||
146742388|NCT01189890|529230114|FG001|Overall Study|Non Compliance|1|||
146742389|NCT01189890|529230113|FG000|Overall Study|Physician Decision|5|||
146742390|NCT01189890|529230114|FG001|Overall Study|Physician Decision|4|||
146742391|NCT01189890|529230113|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
146742392|NCT01189890|529230114|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
146742393|NCT00077636|529230115|FG000|Overall Study|Refused Treatment|9|||
146742394|NCT00077636|529230116|FG001|Overall Study|Refused Treatment|31|||
146742395|NCT00077636|529230115|FG000|Overall Study|Admin|3|||
146742396|NCT00077636|529230116|FG001|Overall Study|Admin|3|||
146742397|NCT00077636|529230115|FG000|Overall Study|Withdrawal by Subject|2|||
146742398|NCT00077636|529230116|FG001|Overall Study|Withdrawal by Subject|2|||
146742399|NCT00077636|529230115|FG000|Overall Study|Adverse Event|17|||
146742400|NCT00077636|529230116|FG001|Overall Study|Adverse Event|34|||
146742401|NCT00077636|529230115|FG000|Overall Study|Protocol Violation|0|||
146742402|NCT00077636|529230116|FG001|Overall Study|Protocol Violation|2|||
146742403|NCT00077636|529230115|FG000|Overall Study|Lost to Follow-up|10|||
146742404|NCT00077636|529230116|FG001|Overall Study|Lost to Follow-up|18|||
146742405|NCT00077636|529230115|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
146742406|NCT00077636|529230116|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
146742407|NCT00592319|529230117|FG000|Overall Study|Lost to Follow-up|0|||
146742408|NCT00592319|529230118|FG001|Overall Study|Lost to Follow-up|3|||
146742409|NCT01017120|529230124|FG000|Overall Study|Adverse Event|9|||
146742410|NCT01017120|529230125|FG001|Overall Study|Adverse Event|0|||
146742411|NCT01017120|529230124|FG000|Overall Study|Lost to Follow-up|13|||
146742412|NCT01017120|529230125|FG001|Overall Study|Lost to Follow-up|11|||
146742413|NCT01017120|529230124|FG000|Overall Study|Lack of Efficacy|1|||
146742414|NCT01017120|529230125|FG001|Overall Study|Lack of Efficacy|0|||
146742415|NCT01017120|529230124|FG000|Overall Study|Withdrawal by Subject|39|||
146742416|NCT01017120|529230125|FG001|Overall Study|Withdrawal by Subject|21|||
146742417|NCT01017120|529230124|FG000|Overall Study|Pregnancy|1|||
146742418|NCT01017120|529230125|FG001|Overall Study|Pregnancy|1|||
146742419|NCT01017120|529230124|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
146742420|NCT01017120|529230125|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
146742421|NCT01017120|529230124|FG000|Overall Study|Relocated Out of Town|0|||
146742422|NCT01017120|529230125|FG001|Overall Study|Relocated Out of Town|2|||
146742423|NCT01017120|529230124|FG000|Overall Study|Protocol Violation|1|||
146742424|NCT01017120|529230125|FG001|Overall Study|Protocol Violation|0|||
146742425|NCT01017120|529230124|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
146742426|NCT01017120|529230125|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
146742427|NCT01087723|529230129|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
146742428|NCT01087723|529230130|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
146742429|NCT01087723|529230129|FG000|Overall Study|Withdrawal by Subject|10|||
146742430|NCT01087723|529230130|FG001|Overall Study|Withdrawal by Subject|13|||
146742431|NCT01087723|529230129|FG000|Overall Study|Physician Decision|2|||
146742432|NCT01087723|529230130|FG001|Overall Study|Physician Decision|0|||
146742433|NCT01087723|529230129|FG000|Overall Study|Lost to Follow-up|1|||
146742434|NCT01087723|529230130|FG001|Overall Study|Lost to Follow-up|4|||
146742435|NCT01087723|529230129|FG000|Overall Study|Reason Not Specified|1|||
146742436|NCT01087723|529230130|FG001|Overall Study|Reason Not Specified|2|||
146742437|NCT01868035|529230131|FG000|Overall Study|Lost to Follow-up|3|||
146742438|NCT01868035|529230131|FG000|Overall Study|Withdrawal by Subject|1|||
146742439|NCT01868035|529230131|FG000|Overall Study|Progressive Disease|2|||
146742440|NCT01868035|529230131|FG000|Overall Study|Non-compliance|1|||
146742441|NCT00451217|529230133|FG000|Overall Study|Lost to Follow-up|0|||
146742442|NCT00451217|529230134|FG001|Overall Study|Lost to Follow-up|1|||
146742443|NCT00451217|529230135|FG002|Overall Study|Lost to Follow-up|1|||
146742444|NCT00451217|529230136|FG003|Overall Study|Lost to Follow-up|1|||
146742445|NCT00451217|529230133|FG000|Overall Study|Withdrawal by Subject|1|||
146742446|NCT00451217|529230134|FG001|Overall Study|Withdrawal by Subject|0|||
146742447|NCT00451217|529230135|FG002|Overall Study|Withdrawal by Subject|0|||
146742448|NCT00451217|529230136|FG003|Overall Study|Withdrawal by Subject|0|||
146742449|NCT00451217|529230133|FG000|Overall Study|Not Treated|1|||
146742450|NCT00451217|529230134|FG001|Overall Study|Not Treated|1|||
146742451|NCT00451217|529230135|FG002|Overall Study|Not Treated|3|||
146742452|NCT00451217|529230136|FG003|Overall Study|Not Treated|4|||
146742453|NCT00569803|529230140|FG000|Overall Study|Lost to Follow-up|1|||
146742454|NCT00569803|529230141|FG001|Overall Study|Lost to Follow-up|0|||
146742455|NCT00569803|529230142|FG002|Overall Study|Lost to Follow-up|0|||
146742456|NCT00569803|529230143|FG003|Overall Study|Lost to Follow-up|0|||
146742457|NCT00569803|529230144|FG004|Overall Study|Lost to Follow-up|0|||
146742458|NCT00569803|529230145|FG005|Overall Study|Lost to Follow-up|0|||
146742459|NCT00569803|529230146|FG006|Overall Study|Lost to Follow-up|0|||
146742460|NCT00569803|529230147|FG007|Overall Study|Lost to Follow-up|0|||
146742461|NCT00569803|529230140|FG000|Overall Study|injection syringe leaked during dosing|0|||
146742462|NCT00569803|529230141|FG001|Overall Study|injection syringe leaked during dosing|0|||
146742463|NCT00569803|529230142|FG002|Overall Study|injection syringe leaked during dosing|0|||
146742464|NCT00569803|529230143|FG003|Overall Study|injection syringe leaked during dosing|1|||
146742465|NCT00569803|529230144|FG004|Overall Study|injection syringe leaked during dosing|0|||
146742466|NCT00569803|529230145|FG005|Overall Study|injection syringe leaked during dosing|0|||
146742467|NCT00569803|529230146|FG006|Overall Study|injection syringe leaked during dosing|0|||
146742468|NCT00569803|529230147|FG007|Overall Study|injection syringe leaked during dosing|0|||
146742469|NCT00569803|529230140|FG000|Overall Study|Withdrawal by Subject|0|||
146742470|NCT00569803|529230141|FG001|Overall Study|Withdrawal by Subject|0|||
146742471|NCT00569803|529230142|FG002|Overall Study|Withdrawal by Subject|0|||
146742472|NCT00569803|529230143|FG003|Overall Study|Withdrawal by Subject|0|||
146742473|NCT00569803|529230144|FG004|Overall Study|Withdrawal by Subject|0|||
146742474|NCT00569803|529230145|FG005|Overall Study|Withdrawal by Subject|0|||
146742475|NCT00569803|529230146|FG006|Overall Study|Withdrawal by Subject|0|||
146742476|NCT00569803|529230147|FG007|Overall Study|Withdrawal by Subject|1|||
146742477|NCT04668989|529230148|FG000|First Intervention|Covid-19 related self-isolation|0|||
146742478|NCT04668989|529230149|FG001|First Intervention|Covid-19 related self-isolation|1|||
146742479|NCT04668989|529230148|FG000|Second Intervention|Adverse Event|0|||
146742480|NCT04668989|529230149|FG001|Second Intervention|Adverse Event|1|||
146742481|NCT01993823|529230153|FG000|Overall Study|Requested by the patient|6|||
146742482|NCT01993823|529230154|FG001|Overall Study|Requested by the patient|11|||
146742483|NCT01993823|529230153|FG000|Overall Study|Protocol Violation|0|||
146742484|NCT01993823|529230154|FG001|Overall Study|Protocol Violation|1|||
146742485|NCT01993823|529230153|FG000|Overall Study|Lost to Follow-up|1|||
146742486|NCT01993823|529230154|FG001|Overall Study|Lost to Follow-up|4|||
146742487|NCT01235975|529230156|FG000|Overall Study|Serious Adverse Event|0|||
146742488|NCT01235975|529230157|FG001|Overall Study|Serious Adverse Event|1|||
146742489|NCT01235975|529230156|FG000|Overall Study|Withdrawal by Subject|8|||
146742490|NCT01235975|529230157|FG001|Overall Study|Withdrawal by Subject|2|||
146742491|NCT01235975|529230156|FG000|Overall Study|Migrated/moved from study area|2|||
146742492|NCT01235975|529230157|FG001|Overall Study|Migrated/moved from study area|1|||
146742493|NCT01235975|529230156|FG000|Overall Study|Lost to Follow-up|7|||
146742494|NCT01235975|529230157|FG001|Overall Study|Lost to Follow-up|3|||
146742495|NCT04537897|529230160|FG000|Overall Study|Other than listed|0|||
146742496|NCT04537897|529230161|FG001|Overall Study|Other than listed|0|||
146742497|NCT04537897|529230162|FG002|Overall Study|Other than listed|0|||
146742498|NCT04537897|529230163|FG003|Overall Study|Other than listed|0|||
146742499|NCT04537897|529230164|FG004|Overall Study|Other than listed|0|||
146742500|NCT04537897|529230165|FG005|Overall Study|Other than listed|0|||
146742501|NCT04537897|529230166|FG006|Overall Study|Other than listed|1|||
146742502|NCT04537897|529230167|FG007|Overall Study|Other than listed|0|||
146742503|NCT04537897|529230168|FG008|Overall Study|Other than listed|0|||
146742504|NCT04537897|529230160|FG000|Overall Study|Adverse Event|0|||
146742505|NCT04537897|529230161|FG001|Overall Study|Adverse Event|0|||
146742506|NCT04537897|529230162|FG002|Overall Study|Adverse Event|0|||
146742507|NCT04537897|529230163|FG003|Overall Study|Adverse Event|1|||
146742508|NCT04537897|529230164|FG004|Overall Study|Adverse Event|0|||
146742509|NCT04537897|529230165|FG005|Overall Study|Adverse Event|0|||
146742510|NCT04537897|529230166|FG006|Overall Study|Adverse Event|0|||
146742511|NCT04537897|529230167|FG007|Overall Study|Adverse Event|0|||
146742512|NCT04537897|529230168|FG008|Overall Study|Adverse Event|0|||
146742513|NCT04537897|529230160|FG000|Overall Study|Withdrawal by Subject|0|||
146742514|NCT04537897|529230161|FG001|Overall Study|Withdrawal by Subject|1|||
146742515|NCT04537897|529230162|FG002|Overall Study|Withdrawal by Subject|0|||
146742516|NCT04537897|529230163|FG003|Overall Study|Withdrawal by Subject|0|||
146742517|NCT04537897|529230164|FG004|Overall Study|Withdrawal by Subject|0|||
146742518|NCT04537897|529230165|FG005|Overall Study|Withdrawal by Subject|0|||
146742519|NCT04537897|529230166|FG006|Overall Study|Withdrawal by Subject|0|||
146742520|NCT04537897|529230167|FG007|Overall Study|Withdrawal by Subject|0|||
146742521|NCT04537897|529230168|FG008|Overall Study|Withdrawal by Subject|0|||
146742522|NCT00919893|529230169|FG000|Overall Study|Protocol Violation|19|||
146742523|NCT00919893|529230170|FG001|Overall Study|Protocol Violation|9|||
146742524|NCT03029780|529230178|FG000|Overall Study|Disease Progression|20|||
146742525|NCT03029780|529230179|FG001|Overall Study|Disease Progression|22|||
146742526|NCT03029780|529230178|FG000|Overall Study|Study Drug Toxicity|15|||
146742527|NCT03029780|529230179|FG001|Overall Study|Study Drug Toxicity|11|||
146742528|NCT03029780|529230178|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
146742529|NCT03029780|529230179|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
146742530|NCT03029780|529230178|FG000|Overall Study|Participant request to discontinue study treatment|4|||
146742531|NCT03029780|529230179|FG001|Overall Study|Participant request to discontinue study treatment|1|||
146742532|NCT03029780|529230178|FG000|Overall Study|Maximum clinical benefit|1|||
146742533|NCT03029780|529230179|FG001|Overall Study|Maximum clinical benefit|0|||
146742534|NCT03029780|529230178|FG000|Overall Study|Participant no longer meets study criteria|0|||
146742535|NCT03029780|529230179|FG001|Overall Study|Participant no longer meets study criteria|1|||
146742536|NCT03029780|529230178|FG000|Overall Study|Other reasons|6|||
146742537|NCT03029780|529230179|FG001|Overall Study|Other reasons|6|||
146742538|NCT03029780|529230178|FG000|Overall Study|Not reported|1|||
146742539|NCT03029780|529230179|FG001|Overall Study|Not reported|1|||
146742540|NCT03029780|529230178|FG000|Overall Study|Death|2|||
146742541|NCT03029780|529230179|FG001|Overall Study|Death|6|||
146742542|NCT00197028|529230180|FG000|Overall Study|Adverse Event|2|||
146742543|NCT00197028|529230181|FG001|Overall Study|Adverse Event|2|||
146742544|NCT00197028|529230180|FG000|Overall Study|Protocol Violation|2|||
146742545|NCT00197028|529230181|FG001|Overall Study|Protocol Violation|1|||
146742546|NCT00197028|529230180|FG000|Overall Study|Withdrawal by Subject|8|||
146742547|NCT00197028|529230181|FG001|Overall Study|Withdrawal by Subject|12|||
146742548|NCT00197028|529230180|FG000|Overall Study|Lost to Follow-up|1|||
146742549|NCT00197028|529230181|FG001|Overall Study|Lost to Follow-up|0|||
146742550|NCT00197028|529230180|FG000|Overall Study|Other|3|||
146742551|NCT00197028|529230181|FG001|Overall Study|Other|6|||
146742552|NCT00178256|529230182|FG000|Overall Study|Adverse Event|2|||
146742553|NCT00178256|529230183|FG001|Overall Study|Adverse Event|0|||
146742554|NCT00178256|529230184|FG002|Overall Study|Adverse Event|0|||
146742555|NCT00178256|529230185|FG003|Overall Study|Adverse Event|0|||
146742556|NCT00178256|529230182|FG000|Overall Study|Death|0|||
146742557|NCT00178256|529230183|FG001|Overall Study|Death|1|||
146742558|NCT00178256|529230184|FG002|Overall Study|Death|0|||
146742559|NCT00178256|529230185|FG003|Overall Study|Death|1|||
146742560|NCT00178256|529230182|FG000|Overall Study|Cancer progression|2|||
146742561|NCT00178256|529230183|FG001|Overall Study|Cancer progression|0|||
146742562|NCT00178256|529230184|FG002|Overall Study|Cancer progression|0|||
146742563|NCT00178256|529230185|FG003|Overall Study|Cancer progression|1|||
146742564|NCT03066622|529230188|FG000|Overall Study|Lost to Follow-up|24|||
146742565|NCT03066622|529230189|FG001|Overall Study|Lost to Follow-up|25|||
146742566|NCT03066622|529230188|FG000|Overall Study|Withdrawal by Subject|2|||
146742567|NCT03066622|529230189|FG001|Overall Study|Withdrawal by Subject|1|||
146742568|NCT01763788|529230190|FG000|Overall Study|Lost to Follow-up|0|||
146742569|NCT01763788|529230191|FG001|Overall Study|Lost to Follow-up|0|||
146742570|NCT01763788|529230192|FG002|Overall Study|Lost to Follow-up|1|||
146742571|NCT01763788|529230193|FG003|Overall Study|Lost to Follow-up|0|||
146742572|NCT00641719|529230194|FG000|Overall Study|Lack of Efficacy|1|||
146742573|NCT00641719|529230195|FG001|Overall Study|Lack of Efficacy|2|||
146742574|NCT00641719|529230194|FG000|Overall Study|Adverse Event|24|||
146742575|NCT00641719|529230195|FG001|Overall Study|Adverse Event|29|||
146742576|NCT00641719|529230194|FG000|Overall Study|Withdrawal by Subject|4|||
146742577|NCT00641719|529230195|FG001|Overall Study|Withdrawal by Subject|4|||
146742578|NCT00641719|529230194|FG000|Overall Study|Reason Not Specified|1|||
146742579|NCT00641719|529230195|FG001|Overall Study|Reason Not Specified|2|||
146742580|NCT03303469|529230196|FG000|Overall Study|Lost to Follow-up|2|||
146742581|NCT00885352|529230201|FG000|Overall Study|Adverse Event|2|||
146742582|NCT00885352|529230202|FG001|Overall Study|Adverse Event|3|||
146742583|NCT00885352|529230201|FG000|Overall Study|Lost to Follow-up|2|||
146742584|NCT00885352|529230202|FG001|Overall Study|Lost to Follow-up|2|||
146742585|NCT00885352|529230201|FG000|Overall Study|Physician Decision|0|||
146742586|NCT00885352|529230202|FG001|Overall Study|Physician Decision|3|||
146742587|NCT00885352|529230201|FG000|Overall Study|Protocol Violation|0|||
146742588|NCT00885352|529230202|FG001|Overall Study|Protocol Violation|2|||
146742589|NCT00885352|529230201|FG000|Overall Study|Withdrawal by Subject|1|||
146742590|NCT00885352|529230202|FG001|Overall Study|Withdrawal by Subject|5|||
146742591|NCT00885352|529230201|FG000|Overall Study|Contradiction to study medication|0|||
146742592|NCT00885352|529230202|FG001|Overall Study|Contradiction to study medication|2|||
146742593|NCT00885352|529230201|FG000|Overall Study|Excluded medication|2|||
146742594|NCT00885352|529230202|FG001|Overall Study|Excluded medication|2|||
146742595|NCT00885352|529230201|FG000|Overall Study|Lab abnormalities|1|||
146742596|NCT00885352|529230202|FG001|Overall Study|Lab abnormalities|1|||
146742597|NCT00365378|529230203|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
146742598|NCT00365378|529230204|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
146742599|NCT00365378|529230205|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
146742600|NCT00365378|529230203|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
146742601|NCT00365378|529230204|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
146742602|NCT00365378|529230205|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
146742603|NCT00365378|529230203|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
146742604|NCT00365378|529230204|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
146742605|NCT00365378|529230205|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
146742606|NCT00365378|529230203|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
146742607|NCT00365378|529230204|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
146742608|NCT00365378|529230205|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
146742609|NCT00365378|529230203|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
146742610|NCT00365378|529230204|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
146742611|NCT00365378|529230205|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
146742612|NCT00365378|529230203|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
146742613|NCT00365378|529230204|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
146742614|NCT00365378|529230205|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
146742615|NCT00365378|529230203|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
146742616|NCT00365378|529230204|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
146510027|NCT01447446|528371916|FG002|Overall Study|New Treatment Started|1|||
146742617|NCT00365378|529230205|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
146742618|NCT00365378|529230203|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
146742619|NCT00365378|529230204|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
146742620|NCT00365378|529230205|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
146742621|NCT00365378|529230203|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
146742622|NCT00365378|529230204|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
146742623|NCT00365378|529230205|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
146742624|NCT00365378|529230203|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
146742625|NCT00365378|529230204|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
146742626|NCT00365378|529230205|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
146742627|NCT00365378|529230203|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
146742628|NCT00365378|529230204|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
146742629|NCT00365378|529230205|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
146742630|NCT00365378|529230203|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
146742631|NCT00365378|529230204|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
146742632|NCT00365378|529230205|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
146742633|NCT00365378|529230203|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
146742634|NCT00365378|529230204|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
146742635|NCT00365378|529230205|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
146742636|NCT00365378|529230203|FG000|Extension|Adverse Event|0|||
146742637|NCT00365378|529230204|FG001|Extension|Adverse Event|0|||
146742638|NCT00365378|529230205|FG002|Extension|Adverse Event|1|||
146742639|NCT00365378|529230203|FG000|Extension|Moved|0|||
146742640|NCT00365378|529230204|FG001|Extension|Moved|0|||
146742641|NCT00365378|529230205|FG002|Extension|Moved|8|||
146742642|NCT00365378|529230203|FG000|Extension|Lost to Follow-up|0|||
146742643|NCT00365378|529230204|FG001|Extension|Lost to Follow-up|0|||
146742644|NCT00365378|529230205|FG002|Extension|Lost to Follow-up|57|||
146742645|NCT00365378|529230203|FG000|Extension|Protocol Violation|0|||
146742646|NCT00365378|529230204|FG001|Extension|Protocol Violation|0|||
146742647|NCT00365378|529230205|FG002|Extension|Protocol Violation|2|||
146742648|NCT00365378|529230203|FG000|Extension|Withdrawal by Subject|0|||
146742649|NCT00365378|529230204|FG001|Extension|Withdrawal by Subject|0|||
146742650|NCT00365378|529230205|FG002|Extension|Withdrawal by Subject|98|||
146742651|NCT00365378|529230203|FG000|Extension|Other|0|||
146742652|NCT00365378|529230204|FG001|Extension|Other|0|||
146742653|NCT00365378|529230205|FG002|Extension|Other|31|||
146742654|NCT03560258|529230208|FG000|Overall Study|Lost to Follow-up|3|||
146742655|NCT03560258|529230209|FG001|Overall Study|Lost to Follow-up|0|||
146742656|NCT03560258|529230210|FG002|Overall Study|Lost to Follow-up|0|||
146742657|NCT03560258|529230208|FG000|Overall Study|Protocol Violation|0|||
146742658|NCT03560258|529230209|FG001|Overall Study|Protocol Violation|1|||
146742659|NCT03560258|529230210|FG002|Overall Study|Protocol Violation|0|||
146742660|NCT03560258|529230208|FG000|Overall Study|Withdrawal by Subject|0|||
146742661|NCT03560258|529230209|FG001|Overall Study|Withdrawal by Subject|0|||
146742662|NCT03560258|529230210|FG002|Overall Study|Withdrawal by Subject|1|||
146742663|NCT01460160|529230211|FG000|Treatment Phase|Lack of Efficacy|3|||
146742664|NCT01460160|529230211|FG000|Treatment Phase|Study Drug Toxicity|2|||
146742665|NCT01460160|529230211|FG000|Treatment Phase|Adverse Event|8|||
146742666|NCT01460160|529230211|FG000|Treatment Phase|Withdrawal by Subject|4|||
146742667|NCT01460160|529230211|FG000|Treatment Phase|Death|2|||
146742668|NCT01460160|529230211|FG000|Treatment Phase|Other reasons|9|||
146742669|NCT01460160|529230211|FG000|Follow-up Phase|Withdrawal by Subject|4|||
146742670|NCT01460160|529230211|FG000|Follow-up Phase|Death|14|||
146742671|NCT01460160|529230211|FG000|Follow-up Phase|Lost to Follow-up|7|||
146742672|NCT01460160|529230211|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
146742673|NCT01460160|529230211|FG000|Follow-up Phase|Other and not reported reasons|5|||
146742674|NCT03893825|529230212|FG000|Overall Study|Death|2|||
146742675|NCT03893825|529230213|FG001|Overall Study|Death|1|||
146742676|NCT03893825|529230212|FG000|Overall Study|Adverse Event|0|||
146742677|NCT03893825|529230213|FG001|Overall Study|Adverse Event|2|||
146742678|NCT03893825|529230212|FG000|Overall Study|Withdrawal by Subject|19|||
146742679|NCT03893825|529230213|FG001|Overall Study|Withdrawal by Subject|21|||
146742680|NCT03893825|529230212|FG000|Overall Study|Protocol deviation|1|||
146742681|NCT03893825|529230213|FG001|Overall Study|Protocol deviation|0|||
146742682|NCT03893825|529230212|FG000|Overall Study|Lost to Follow-up|10|||
146742683|NCT03893825|529230213|FG001|Overall Study|Lost to Follow-up|10|||
146742684|NCT03893825|529230212|FG000|Overall Study|Other than specified|7|||
146742685|NCT03893825|529230213|FG001|Overall Study|Other than specified|6|||
146742686|NCT04161807|529230217|FG000|Overall Study|Withdrawal by Subject|2|||
146742687|NCT04161807|529230217|FG000|Overall Study|Performed only 1 treatment|2|||
146742688|NCT02006121|529230218|FG000|Double Blind Phase|Adverse Event|6|||
146742689|NCT02006121|529230219|FG001|Double Blind Phase|Adverse Event|0|||
146742690|NCT02006121|529230218|FG000|Double Blind Phase|Lack of Efficacy|1|||
146742691|NCT02006121|529230219|FG001|Double Blind Phase|Lack of Efficacy|16|||
146742692|NCT02006121|529230218|FG000|Double Blind Phase|Withdrawal by Subject|3|||
146742693|NCT02006121|529230219|FG001|Double Blind Phase|Withdrawal by Subject|4|||
146510028|NCT01447446|528371917|FG003|Overall Study|New Treatment Started|0|||
146742694|NCT02006121|529230218|FG000|Double Blind Phase|Non-compliance with study drug|1|||
146742695|NCT02006121|529230219|FG001|Double Blind Phase|Non-compliance with study drug|3|||
146742696|NCT02006121|529230218|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
146742697|NCT02006121|529230219|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
146742698|NCT02006121|529230218|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
146742699|NCT02006121|529230219|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
146742700|NCT02006121|529230218|FG000|Open Label Phase|Adverse Event|15|||
146742701|NCT02006121|529230219|FG001|Open Label Phase|Adverse Event|0|||
146742702|NCT02006121|529230218|FG000|Open Label Phase|Lack of Efficacy|2|||
146742703|NCT02006121|529230219|FG001|Open Label Phase|Lack of Efficacy|0|||
146742704|NCT02006121|529230218|FG000|Open Label Phase|Protocol Violation|2|||
146742705|NCT02006121|529230219|FG001|Open Label Phase|Protocol Violation|0|||
146742706|NCT02006121|529230218|FG000|Open Label Phase|Withdrawal by Subject|3|||
146742707|NCT02006121|529230219|FG001|Open Label Phase|Withdrawal by Subject|0|||
146742708|NCT02006121|529230218|FG000|Open Label Phase|Non-compliance with study drug|3|||
146742709|NCT02006121|529230219|FG001|Open Label Phase|Non-compliance with study drug|0|||
146742710|NCT00708305|529230232|FG000|Period 1|Protocol Violation|1|||
146742711|NCT00708305|529230233|FG001|Period 1|Protocol Violation|0|||
146742712|NCT00708305|529230234|FG002|Period 1|Protocol Violation|1|||
146742713|NCT00708305|529230235|FG003|Period 1|Protocol Violation|0|||
146742714|NCT00708305|529230232|FG000|Period 1|Other Reason|0|||
146742715|NCT00708305|529230233|FG001|Period 1|Other Reason|0|||
146742716|NCT00708305|529230234|FG002|Period 1|Other Reason|0|||
146742717|NCT00708305|529230235|FG003|Period 1|Other Reason|2|||
146742718|NCT00708305|529230232|FG000|Period 2|Lost to Follow-up|0|||
146742719|NCT00708305|529230233|FG001|Period 2|Lost to Follow-up|1|||
146742720|NCT00708305|529230234|FG002|Period 2|Lost to Follow-up|0|||
146742721|NCT00708305|529230235|FG003|Period 2|Lost to Follow-up|0|||
146742722|NCT00708305|529230232|FG000|Period 2|Protocol Violation|0|||
146742723|NCT00708305|529230233|FG001|Period 2|Protocol Violation|1|||
146742724|NCT00708305|529230234|FG002|Period 2|Protocol Violation|0|||
146742725|NCT00708305|529230235|FG003|Period 2|Protocol Violation|0|||
146742726|NCT00708305|529230232|FG000|Period 2|Other Reason|1|||
146742727|NCT00708305|529230233|FG001|Period 2|Other Reason|0|||
146742728|NCT00708305|529230234|FG002|Period 2|Other Reason|0|||
146742729|NCT00708305|529230235|FG003|Period 2|Other Reason|1|||
146742730|NCT00708305|529230232|FG000|Period 3|Protocol Violation|0|||
146742731|NCT00708305|529230233|FG001|Period 3|Protocol Violation|2|||
146742732|NCT00708305|529230234|FG002|Period 3|Protocol Violation|0|||
146742733|NCT00708305|529230235|FG003|Period 3|Protocol Violation|0|||
146742734|NCT00708305|529230232|FG000|Period 3|Other Reason|1|||
146742735|NCT00708305|529230233|FG001|Period 3|Other Reason|0|||
146742736|NCT00708305|529230234|FG002|Period 3|Other Reason|0|||
146742737|NCT00708305|529230235|FG003|Period 3|Other Reason|0|||
146742738|NCT00192023|529230238|FG000|Period III - Double-Blind|Adverse Event|3|||
146742739|NCT00192023|529230239|FG001|Period III - Double-Blind|Adverse Event|0|||
146742740|NCT00192023|529230238|FG000|Period III - Double-Blind|Physician Decision|2|||
146742741|NCT00192023|529230239|FG001|Period III - Double-Blind|Physician Decision|0|||
146742742|NCT00192023|529230238|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
146742743|NCT00192023|529230239|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
146742744|NCT00192023|529230238|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
146742745|NCT00192023|529230239|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
146742746|NCT00192023|529230238|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
146742747|NCT00192023|529230239|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
146742748|NCT00192023|529230238|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
146742749|NCT00192023|529230239|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
146742750|NCT00192023|529230238|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
146742751|NCT00192023|529230239|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
146742752|NCT00192023|529230238|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
146742753|NCT00192023|529230239|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
146742754|NCT00192023|529230238|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
146742755|NCT00192023|529230239|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
146742756|NCT00192023|529230238|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
146742757|NCT00192023|529230239|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
146742758|NCT02765490|529230247|FG000|Overall Study|Lost to Follow-up|1|||
146742759|NCT02765490|529230248|FG001|Overall Study|Lost to Follow-up|1|||
146510029|NCT01447446|528371918|FG004|Overall Study|New Treatment Started|2|||
146742760|NCT02765490|529230247|FG000|Overall Study|Other|0|||
146742761|NCT02765490|529230248|FG001|Overall Study|Other|1|||
146742762|NCT02765490|529230247|FG000|Overall Study|Death|0|||
146742763|NCT02765490|529230248|FG001|Overall Study|Death|1|||
146742764|NCT02340520|529230252|FG000|Overall Study|Lost to Follow-up|1|||
146742765|NCT02340520|529230252|FG000|Overall Study|Patient did not take drug as specified|1|||
146742766|NCT02340520|529230252|FG000|Overall Study|Withdrawal by Subject|1|||
146742767|NCT00447954|529230253|FG000|Overall Study|Adverse Event|0|||
146742768|NCT00447954|529230254|FG001|Overall Study|Adverse Event|2|||
146742769|NCT00447954|529230255|FG002|Overall Study|Adverse Event|0|||
146742770|NCT00447954|529230253|FG000|Overall Study|Withdrawal by Subject|0|||
146742771|NCT00447954|529230254|FG001|Overall Study|Withdrawal by Subject|1|||
146742772|NCT00447954|529230255|FG002|Overall Study|Withdrawal by Subject|1|||
146742773|NCT00447954|529230253|FG000|Overall Study|Lost to Follow-up|0|||
146742774|NCT00447954|529230254|FG001|Overall Study|Lost to Follow-up|1|||
146742775|NCT00447954|529230255|FG002|Overall Study|Lost to Follow-up|0|||
146742776|NCT00447954|529230253|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
146742777|NCT00447954|529230254|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
146742778|NCT00447954|529230255|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
146742779|NCT01282476|529231445|FG000|Overall Study|Death|11|||
146742780|NCT01811563|529231452|FG000|Overall Study|Lost to Follow-up|5|||
146742781|NCT01811563|529231453|FG001|Overall Study|Lost to Follow-up|2|||
146742782|NCT01811563|529231452|FG000|Overall Study|Incorrect Randomization procedure|0|||
146742783|NCT01811563|529231453|FG001|Overall Study|Incorrect Randomization procedure|1|||
146742784|NCT04424290|529231454|FG000|Overall Study|Not treated|0|||
146742785|NCT04424290|529231455|FG001|Overall Study|Not treated|0|||
146742786|NCT04424290|529231456|FG002|Overall Study|Not treated|1|||
146742787|NCT04424290|529231457|FG003|Overall Study|Not treated|0|||
146742788|NCT04424290|529231458|FG004|Overall Study|Not treated|1|||
146742789|NCT04424290|529231454|FG000|Overall Study|Adverse Event|0|||
146742790|NCT04424290|529231455|FG001|Overall Study|Adverse Event|0|||
146742791|NCT04424290|529231456|FG002|Overall Study|Adverse Event|0|||
146742792|NCT04424290|529231457|FG003|Overall Study|Adverse Event|2|||
146742793|NCT04424290|529231458|FG004|Overall Study|Adverse Event|0|||
146742794|NCT04424290|529231454|FG000|Overall Study|Withdrawal by Subject|0|||
146742795|NCT04424290|529231455|FG001|Overall Study|Withdrawal by Subject|0|||
146742796|NCT04424290|529231456|FG002|Overall Study|Withdrawal by Subject|0|||
146742797|NCT04424290|529231457|FG003|Overall Study|Withdrawal by Subject|0|||
146742798|NCT04424290|529231458|FG004|Overall Study|Withdrawal by Subject|1|||
146742799|NCT04424290|529231454|FG000|Overall Study|Other than listed|0|||
146742800|NCT04424290|529231455|FG001|Overall Study|Other than listed|0|||
146742801|NCT04424290|529231456|FG002|Overall Study|Other than listed|0|||
146742802|NCT04424290|529231457|FG003|Overall Study|Other than listed|1|||
146742803|NCT04424290|529231458|FG004|Overall Study|Other than listed|0|||
146742804|NCT02936037|529231459|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
146742805|NCT02936037|529231460|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
146742806|NCT02936037|529231459|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
146742807|NCT02936037|529231460|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
146742808|NCT02936037|529231459|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
146742809|NCT02936037|529231460|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
146742810|NCT02936037|529231459|FG000|Double-Blind Treatment Period|Death|0|||
146742811|NCT02936037|529231460|FG001|Double-Blind Treatment Period|Death|1|||
146742812|NCT02936037|529231459|FG000|Double-Blind Treatment Period|Adverse Event|11|||
146742813|NCT02936037|529231460|FG001|Double-Blind Treatment Period|Adverse Event|11|||
146742814|NCT02936037|529231459|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
146742815|NCT02936037|529231460|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
146742816|NCT02936037|529231459|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146742817|NCT02936037|529231460|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
146742818|NCT02936037|529231459|FG000|Open Label Extension|Adverse Event|0|||
146742819|NCT02936037|529231460|FG001|Open Label Extension|Adverse Event|3|||
146742820|NCT02936037|529231459|FG000|Open Label Extension|Other|0|||
146742821|NCT02936037|529231460|FG001|Open Label Extension|Other|3|||
146742822|NCT02936037|529231459|FG000|Open Label Extension|Withdrawal by Subject|0|||
146742823|NCT02936037|529231460|FG001|Open Label Extension|Withdrawal by Subject|4|||
146742824|NCT01267825|529231461|FG000|Overall Study|study terminated. no data collected.|1|||
146742825|NCT01267825|529231462|FG001|Overall Study|study terminated. no data collected.|0|||
146742826|NCT00806624|529231463|FG000|Overall Study|Adverse Event|2|||
146742827|NCT00806624|529231464|FG001|Overall Study|Adverse Event|8|||
146742828|NCT00806624|529231465|FG002|Overall Study|Adverse Event|0|||
146742829|NCT00806624|529231463|FG000|Overall Study|Death|0|||
146742830|NCT00806624|529231464|FG001|Overall Study|Death|1|||
146742831|NCT00806624|529231465|FG002|Overall Study|Death|1|||
146742832|NCT00806624|529231463|FG000|Overall Study|Lost to Follow-up|1|||
146742833|NCT00806624|529231464|FG001|Overall Study|Lost to Follow-up|0|||
146742834|NCT00806624|529231465|FG002|Overall Study|Lost to Follow-up|1|||
146742835|NCT00806624|529231463|FG000|Overall Study|Withdrawal by Subject|6|||
146742836|NCT00806624|529231464|FG001|Overall Study|Withdrawal by Subject|3|||
146742837|NCT00806624|529231465|FG002|Overall Study|Withdrawal by Subject|3|||
146742838|NCT00806624|529231463|FG000|Overall Study|discontinued before start of treatment|0|||
146742839|NCT00806624|529231464|FG001|Overall Study|discontinued before start of treatment|0|||
146742840|NCT00806624|529231465|FG002|Overall Study|discontinued before start of treatment|1|||
146742841|NCT01912222|529231470|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
146742842|NCT01912222|529231471|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
146742843|NCT01912222|529231472|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
146742844|NCT01912222|529231470|FG000|Part B: Treatment Period|Progressive disease|10|||
146742845|NCT01912222|529231471|FG001|Part B: Treatment Period|Progressive disease|12|||
146742846|NCT01912222|529231472|FG002|Part B: Treatment Period|Progressive disease|15|||
146742847|NCT01912222|529231470|FG000|Part B: Treatment Period|Adverse Event|1|||
146742848|NCT01912222|529231471|FG001|Part B: Treatment Period|Adverse Event|2|||
146742849|NCT01912222|529231472|FG002|Part B: Treatment Period|Adverse Event|3|||
146742850|NCT01912222|529231470|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
146742851|NCT01912222|529231471|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
146742852|NCT01912222|529231472|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
146742853|NCT01804673|529231473|FG000|Overall Study|Adverse Event|4|||
146742854|NCT01804673|529231473|FG000|Overall Study|Withdrawal by Subject|1|||
146742855|NCT01804673|529231473|FG000|Overall Study|Lack of Efficacy|9|||
146742856|NCT01804673|529231473|FG000|Overall Study|Change to Oral Therapy|37|||
146742857|NCT01804673|529231473|FG000|Overall Study|No Further Therapy Required|84|||
146742858|NCT01804673|529231473|FG000|Overall Study|Use of Prohibited Medication|1|||
146742859|NCT01804673|529231473|FG000|Overall Study|Other|4|||
146742860|NCT01024959|529231474|FG000|Overall Study|ineligible|12|||
146742861|NCT01024959|529231474|FG000|Overall Study|results not evaluable|12|||
146742862|NCT01024959|529231474|FG000|Overall Study|missing results required for analysis|17|||
146742863|NCT00313911|529231482|FG000|Overall Study|Serious adverse event|6|||
146742864|NCT00313911|529231483|FG001|Overall Study|Serious adverse event|1|||
146742865|NCT00313911|529231482|FG000|Overall Study|Adverse Event|2|||
146742866|NCT00313911|529231483|FG001|Overall Study|Adverse Event|3|||
146742867|NCT00313911|529231482|FG000|Overall Study|Protocol Violation|19|||
146742868|NCT00313911|529231483|FG001|Overall Study|Protocol Violation|10|||
146742869|NCT00313911|529231482|FG000|Overall Study|Lost to Follow-up|27|||
146742870|NCT00313911|529231483|FG001|Overall Study|Lost to Follow-up|14|||
146742871|NCT00313911|529231482|FG000|Overall Study|Withdrawal by Subject|39|||
146742872|NCT00313911|529231483|FG001|Overall Study|Withdrawal by Subject|12|||
146742873|NCT00313911|529231482|FG000|Overall Study|Did not meet age criteria|1|||
146742874|NCT00313911|529231483|FG001|Overall Study|Did not meet age criteria|1|||
146742875|NCT00636792|529231486|FG000|Overall Study|Adverse Event|16|||
146742876|NCT00636792|529231486|FG000|Overall Study|Physician Decision|7|||
146742877|NCT00636792|529231486|FG000|Overall Study|Progressive Disease|4|||
146742878|NCT00636792|529231486|FG000|Overall Study|Withdrawal by Subject|3|||
146742879|NCT00636792|529231486|FG000|Overall Study|Other|3|||
146742880|NCT01912781|529231487|FG000|Overall Study|Withdrawal by Subject|2|||
146742881|NCT01912781|529231488|FG001|Overall Study|Withdrawal by Subject|0|||
146742882|NCT01129336|529231491|FG000|Overall Study|Protocol Violation|1|||
146742883|NCT01129336|529231492|FG001|Overall Study|Protocol Violation|0|||
146742884|NCT01129336|529231491|FG000|Overall Study|Disease Progression|1|||
146742885|NCT01129336|529231492|FG001|Overall Study|Disease Progression|4|||
146742886|NCT01129336|529231491|FG000|Overall Study|Lost to Follow-up|1|||
146742887|NCT01129336|529231492|FG001|Overall Study|Lost to Follow-up|0|||
146742888|NCT01129336|529231491|FG000|Overall Study|Withdrawal by Subject|7|||
146742889|NCT01129336|529231492|FG001|Overall Study|Withdrawal by Subject|4|||
146742890|NCT01129336|529231491|FG000|Overall Study|Adverse Event|0|||
146742891|NCT01129336|529231492|FG001|Overall Study|Adverse Event|1|||
146742892|NCT01129336|529231491|FG000|Overall Study|Missing Study Completion Status|2|||
146742893|NCT01129336|529231492|FG001|Overall Study|Missing Study Completion Status|3|||
146742894|NCT01129336|529231491|FG000|Overall Study|Death|0|||
146742895|NCT01129336|529231492|FG001|Overall Study|Death|4|||
146742896|NCT00251927|529231498|FG000|Overall Study|Adverse Event|3|||
146742897|NCT00251927|529231499|FG001|Overall Study|Adverse Event|15|||
146742898|NCT00251927|529231498|FG000|Overall Study|Lack of Efficacy|22|||
146742899|NCT00251927|529231499|FG001|Overall Study|Lack of Efficacy|16|||
146742900|NCT00251927|529231498|FG000|Overall Study|Lost to Follow-up|22|||
146742901|NCT00251927|529231499|FG001|Overall Study|Lost to Follow-up|8|||
146742902|NCT00251927|529231498|FG000|Overall Study|Protocol Violation|1|||
146742903|NCT00251927|529231499|FG001|Overall Study|Protocol Violation|2|||
146742904|NCT00251927|529231498|FG000|Overall Study|Pregnancy|2|||
146742905|NCT00251927|529231499|FG001|Overall Study|Pregnancy|0|||
146742906|NCT00251927|529231498|FG000|Overall Study|Withdrawal by Subject|40|||
146742907|NCT00251927|529231499|FG001|Overall Study|Withdrawal by Subject|25|||
146742908|NCT00251927|529231498|FG000|Overall Study|Study-specific discont. achieved|13|||
146742909|NCT00251927|529231499|FG001|Overall Study|Study-specific discont. achieved|2|||
146742910|NCT00251927|529231498|FG000|Overall Study|Study procedure non-compliance|5|||
146742911|NCT00251927|529231499|FG001|Overall Study|Study procedure non-compliance|6|||
146742912|NCT00452413|529231503|FG000|Overall Study|Progressive Disease|4|||
146742913|NCT00452413|529231504|FG001|Overall Study|Progressive Disease|11|||
146742914|NCT00452413|529231505|FG002|Overall Study|Progressive Disease|30|||
146742915|NCT00452413|529231503|FG000|Overall Study|Withdrawal by Subject|0|||
146742916|NCT00452413|529231504|FG001|Overall Study|Withdrawal by Subject|1|||
146742917|NCT00452413|529231505|FG002|Overall Study|Withdrawal by Subject|4|||
146742918|NCT00452413|529231503|FG000|Overall Study|Adverse Event|0|||
146742919|NCT00452413|529231504|FG001|Overall Study|Adverse Event|0|||
146742920|NCT00452413|529231505|FG002|Overall Study|Adverse Event|5|||
146742921|NCT00452413|529231503|FG000|Overall Study|Physician Decision|0|||
146742922|NCT00452413|529231504|FG001|Overall Study|Physician Decision|0|||
146742923|NCT00452413|529231505|FG002|Overall Study|Physician Decision|4|||
146742924|NCT00452413|529231503|FG000|Overall Study|Death due to study disease|0|||
146742925|NCT00452413|529231504|FG001|Overall Study|Death due to study disease|0|||
146742926|NCT00452413|529231505|FG002|Overall Study|Death due to study disease|2|||
146742927|NCT00452413|529231503|FG000|Overall Study|Death due to adverse event (AE)|0|||
146742928|NCT00452413|529231504|FG001|Overall Study|Death due to adverse event (AE)|0|||
146742929|NCT00452413|529231505|FG002|Overall Study|Death due to adverse event (AE)|1|||
146742930|NCT00452413|529231503|FG000|Overall Study|On treatment|0|||
146742931|NCT00452413|529231504|FG001|Overall Study|On treatment|0|||
146742932|NCT00452413|529231505|FG002|Overall Study|On treatment|3|||
146742933|NCT03237013|529231506|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
146742934|NCT03237013|529231507|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
146742935|NCT03237013|529231508|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
146742936|NCT00258440|529231513|FG000|Overall Study|Withdrawal by Subject|0|||
146742937|NCT00258440|529231514|FG001|Overall Study|Withdrawal by Subject|0|||
146742938|NCT00258440|529231515|FG002|Overall Study|Withdrawal by Subject|1|||
146742939|NCT00737061|529231516|FG000|Waiting Period|Lost to Follow-up|6|||
146742940|NCT00737061|529231516|FG000|Waiting Period|Withdrawal by Subject|1|||
146742941|NCT00737061|529231516|FG000|Waiting Period|Bilateral placement failure|34|||
146742942|NCT00737061|529231516|FG000|Waiting Period|Deemed patent following HSG|26|||
146742943|NCT00737061|529231516|FG000|Waiting Period|Alternative contraception failure|3|||
146742944|NCT00737061|529231516|FG000|Waiting Period|Elected surgical tubal ligation|5|||
146742945|NCT00737061|529231516|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
146742946|NCT00737061|529231516|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
146742947|NCT00737061|529231516|FG000|1 Year Wearing Period|Discontinued reilance|3|||
146742948|NCT00737061|529231516|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
146742949|NCT00439179|529231517|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
146742950|NCT00439179|529231518|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
146742951|NCT00439179|529231519|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
146742952|NCT00439179|529231520|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
146742953|NCT06173570|529231527|FG000|Overall Study|Adverse Event|1|||
146742954|NCT06173570|529231528|FG001|Overall Study|Adverse Event|0|||
146742955|NCT06173570|529231529|FG002|Overall Study|Adverse Event|0|||
146742956|NCT06173570|529231530|FG003|Overall Study|Adverse Event|2|||
146742957|NCT06173570|529231531|FG004|Overall Study|Adverse Event|0|||
146742958|NCT06173570|529231527|FG000|Overall Study|Lost to Follow-up|1|||
146742959|NCT06173570|529231528|FG001|Overall Study|Lost to Follow-up|0|||
146742960|NCT06173570|529231529|FG002|Overall Study|Lost to Follow-up|0|||
146742961|NCT06173570|529231530|FG003|Overall Study|Lost to Follow-up|0|||
146742962|NCT06173570|529231531|FG004|Overall Study|Lost to Follow-up|2|||
146742963|NCT06173570|529231527|FG000|Overall Study|Protocol Violation|0|||
146742964|NCT06173570|529231528|FG001|Overall Study|Protocol Violation|2|||
146742965|NCT06173570|529231529|FG002|Overall Study|Protocol Violation|0|||
146742966|NCT06173570|529231530|FG003|Overall Study|Protocol Violation|0|||
146742967|NCT06173570|529231531|FG004|Overall Study|Protocol Violation|1|||
146742968|NCT06173570|529231527|FG000|Overall Study|Withdrawal by Subject|0|||
146742969|NCT06173570|529231528|FG001|Overall Study|Withdrawal by Subject|1|||
146742970|NCT06173570|529231529|FG002|Overall Study|Withdrawal by Subject|1|||
146742971|NCT06173570|529231530|FG003|Overall Study|Withdrawal by Subject|1|||
146742972|NCT06173570|529231531|FG004|Overall Study|Withdrawal by Subject|1|||
146742973|NCT06173570|529231527|FG000|Overall Study|Non-compliance with Study Drug|1|||
146742974|NCT06173570|529231528|FG001|Overall Study|Non-compliance with Study Drug|0|||
146742975|NCT06173570|529231529|FG002|Overall Study|Non-compliance with Study Drug|0|||
146742976|NCT06173570|529231530|FG003|Overall Study|Non-compliance with Study Drug|0|||
146742977|NCT06173570|529231531|FG004|Overall Study|Non-compliance with Study Drug|0|||
146742978|NCT06173570|529231527|FG000|Overall Study|Screen Failure|0|||
146742979|NCT06173570|529231528|FG001|Overall Study|Screen Failure|0|||
146742980|NCT06173570|529231529|FG002|Overall Study|Screen Failure|0|||
146742981|NCT06173570|529231530|FG003|Overall Study|Screen Failure|0|||
146742982|NCT06173570|529231531|FG004|Overall Study|Screen Failure|1|||
146742983|NCT06173570|529231527|FG000|Overall Study|Other|2|||
146742984|NCT06173570|529231528|FG001|Overall Study|Other|1|||
146742985|NCT06173570|529231529|FG002|Overall Study|Other|0|||
146742986|NCT06173570|529231530|FG003|Overall Study|Other|2|||
146742987|NCT06173570|529231531|FG004|Overall Study|Other|0|||
146742988|NCT00734214|529231532|FG000|Overall Study|Withdrawal by Subject|3|||
146742989|NCT00734214|529231533|FG001|Overall Study|Withdrawal by Subject|4|||
146742990|NCT00734214|529231532|FG000|Overall Study|MD withdrawal|1|||
146742991|NCT00734214|529231533|FG001|Overall Study|MD withdrawal|0|||
146964999|NCT01491737|530033422|FG001|Overall Study|Lost to Follow-up|10|||
146965000|NCT01491737|530033421|FG000|Overall Study|Death|63|||
146742992|NCT00550550|529231534|FG000|Overall Study|Adverse Event|13|||
146742993|NCT00550550|529231535|FG001|Overall Study|Adverse Event|5|||
146965001|NCT01491737|530033422|FG001|Overall Study|Death|57|||
146742994|NCT00550550|529231534|FG000|Overall Study|Treatment Failure|0|||
146742995|NCT00550550|529231535|FG001|Overall Study|Treatment Failure|1|||
146742996|NCT00550550|529231534|FG000|Overall Study|Lost to Follow-up|4|||
146742997|NCT00550550|529231535|FG001|Overall Study|Lost to Follow-up|0|||
146742998|NCT00550550|529231534|FG000|Overall Study|Withdrawal by Subject|10|||
146742999|NCT00550550|529231535|FG001|Overall Study|Withdrawal by Subject|8|||
146743000|NCT00550550|529231534|FG000|Overall Study|Protocol Violation|5|||
146743001|NCT00550550|529231535|FG001|Overall Study|Protocol Violation|14|||
146743002|NCT00550550|529231534|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
146743003|NCT00550550|529231535|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
146743004|NCT00550550|529231534|FG000|Overall Study|Randomized But Not Treated|1|||
146743005|NCT00550550|529231535|FG001|Overall Study|Randomized But Not Treated|0|||
146743006|NCT03311230|529231539|FG000|Overall Study|Withdrawal by Subject|1|||
146743007|NCT03311230|529231540|FG001|Overall Study|Withdrawal by Subject|4|||
146743008|NCT03311230|529231541|FG002|Overall Study|Withdrawal by Subject|2|||
146743009|NCT03311230|529231542|FG003|Overall Study|Withdrawal by Subject|7|||
146743010|NCT03311230|529231539|FG000|Overall Study|Unrelated injury|0|||
146743011|NCT03311230|529231540|FG001|Overall Study|Unrelated injury|1|||
146743012|NCT03311230|529231541|FG002|Overall Study|Unrelated injury|0|||
146743013|NCT03311230|529231542|FG003|Overall Study|Unrelated injury|0|||
146743014|NCT01302938|529231543|FG000|Overall Study|Withdrawal by Subject|1|||
146743015|NCT01302938|529231544|FG001|Overall Study|Withdrawal by Subject|0|||
146743016|NCT01302938|529231543|FG000|Overall Study|Adverse Event|1|||
146743017|NCT01302938|529231544|FG001|Overall Study|Adverse Event|0|||
146743018|NCT00171873|529231545|FG000|Overall Study|Withdrawal by Subject|4|||
146743019|NCT00171873|529231546|FG001|Overall Study|Withdrawal by Subject|2|||
146743020|NCT00171873|529231545|FG000|Overall Study|Adverse Event|5|||
146743021|NCT00171873|529231546|FG001|Overall Study|Adverse Event|0|||
146743022|NCT00171873|529231545|FG000|Overall Study|Switched to Octreotide|0|||
146743023|NCT00171873|529231546|FG001|Overall Study|Switched to Octreotide|1|||
146743024|NCT00621296|529231559|FG000|Overall Study|Adverse Event|2|||
146743025|NCT00621296|529231559|FG000|Overall Study|Lack of Efficacy|1|||
146743026|NCT00621296|529231559|FG000|Overall Study|Physician Decision|7|||
146743027|NCT00621296|529231559|FG000|Overall Study|Unmatch Criteria|1|||
146743028|NCT00621296|529231559|FG000|Overall Study|Stopping Criteria|3|||
146743029|NCT01518946|529231568|FG000|Open-label Phase|Other|4|||
146743030|NCT01518946|529231569|FG001|Open-label Phase|Other|0|||
146743031|NCT01518946|529231570|FG002|Open-label Phase|Other|0|||
146743032|NCT01518946|529231568|FG000|Randomized Phase (First Intervention)|Other|0|||
146743033|NCT01518946|529231569|FG001|Randomized Phase (First Intervention)|Other|1|||
146743034|NCT01518946|529231570|FG002|Randomized Phase (First Intervention)|Other|0|||
146743035|NCT03857841|529231571|FG000|Overall Study|Death|1|||
146743036|NCT03857841|529231572|FG001|Overall Study|Death|0|||
146743037|NCT03857841|529231573|FG002|Overall Study|Death|0|||
146743038|NCT03857841|529231574|FG003|Overall Study|Death|0|||
146743039|NCT03857841|529231571|FG000|Overall Study|Study Terminated by Sponsor|1|||
146743040|NCT03857841|529231572|FG001|Overall Study|Study Terminated by Sponsor|0|||
146743041|NCT03857841|529231573|FG002|Overall Study|Study Terminated by Sponsor|0|||
146743042|NCT03857841|529231574|FG003|Overall Study|Study Terminated by Sponsor|0|||
146743043|NCT00384059|529231575|FG000|Infant Series|Not consented|2|||
146743044|NCT00384059|529231576|FG001|Infant Series|Not consented|6|||
146743045|NCT00384059|529231575|FG000|Infant Series|Withdrawal by Subject|2|||
146743046|NCT00384059|529231576|FG001|Infant Series|Withdrawal by Subject|2|||
146743047|NCT00384059|529231575|FG000|Infant Series|Adverse Event|1|||
146743048|NCT00384059|529231576|FG001|Infant Series|Adverse Event|2|||
146743049|NCT00384059|529231575|FG000|Infant Series|Protocol Violation|1|||
146743050|NCT00384059|529231576|FG001|Infant Series|Protocol Violation|2|||
146743051|NCT00384059|529231575|FG000|Infant Series|Lost to Follow-up|0|||
146743052|NCT00384059|529231576|FG001|Infant Series|Lost to Follow-up|1|||
146743053|NCT00384059|529231575|FG000|After Infant Series|Protocol Violation|2|||
146743054|NCT00384059|529231576|FG001|After Infant Series|Protocol Violation|3|||
146743055|NCT00384059|529231575|FG000|After Infant Series|Withdrawal by Subject|2|||
146743056|NCT00384059|529231576|FG001|After Infant Series|Withdrawal by Subject|2|||
146743057|NCT00384059|529231575|FG000|After Infant Series|Failed to Return|0|||
146743058|NCT00384059|529231576|FG001|After Infant Series|Failed to Return|2|||
146743059|NCT00384059|529231575|FG000|After Infant Series|Adverse Event|0|||
146743060|NCT00384059|529231576|FG001|After Infant Series|Adverse Event|1|||
146743061|NCT00384059|529231575|FG000|After Infant Series|Physician Decision|0|||
146510030|NCT01447446|528371919|FG005|Overall Study|New Treatment Started|0|||
146510031|NCT01447446|528371914|FG000|Overall Study|Reason not Specified|1|||
146743062|NCT00384059|529231576|FG001|After Infant Series|Physician Decision|1|||
146743063|NCT00384059|529231575|FG000|After Infant Series|Lost to Follow-up|0|||
146743064|NCT00384059|529231576|FG001|After Infant Series|Lost to Follow-up|1|||
146743065|NCT00384059|529231575|FG000|Toddler Dose|Lost to Follow-up|1|||
146743066|NCT00384059|529231576|FG001|Toddler Dose|Lost to Follow-up|1|||
146743067|NCT00384059|529231575|FG000|Toddler Dose|Failed to return|0|||
146743068|NCT00384059|529231576|FG001|Toddler Dose|Failed to return|1|||
146743069|NCT00381641|529231579|FG000|Overall Study|Withdrawal by Subject|0|||
146743070|NCT00381641|529231580|FG001|Overall Study|Withdrawal by Subject|2|||
146743071|NCT04921969|529231581|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
146743072|NCT04921969|529231582|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
146743073|NCT04921969|529231583|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
146743074|NCT04921969|529231584|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
146743075|NCT04921969|529231585|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
146743076|NCT04921969|529231586|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
146743077|NCT04921969|529231587|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
146743078|NCT04921969|529231581|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
146743079|NCT04921969|529231582|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146743080|NCT04921969|529231583|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146743081|NCT04921969|529231584|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146743082|NCT04921969|529231585|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146743083|NCT04921969|529231586|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146743084|NCT04921969|529231587|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146743085|NCT04921969|529231581|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
146743086|NCT04921969|529231582|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
146743087|NCT04921969|529231583|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
146743088|NCT04921969|529231584|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146743089|NCT04921969|529231585|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146743090|NCT04921969|529231586|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146743091|NCT04921969|529231587|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146743092|NCT04921969|529231581|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
146743093|NCT04921969|529231582|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
146743094|NCT04921969|529231583|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
146743095|NCT04921969|529231584|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
146743096|NCT04921969|529231585|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
146743097|NCT04921969|529231586|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
146743098|NCT04921969|529231587|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
146743099|NCT04921969|529231581|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
146743100|NCT04921969|529231582|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
146743101|NCT04921969|529231583|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
146743102|NCT04921969|529231584|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
146743103|NCT04921969|529231585|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
146743104|NCT04921969|529231586|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
146743105|NCT04921969|529231587|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
146743106|NCT04921969|529231581|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
146743107|NCT04921969|529231582|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
146743108|NCT04921969|529231583|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
146743109|NCT04921969|529231584|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146743110|NCT04921969|529231585|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146743111|NCT04921969|529231586|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146743112|NCT04921969|529231587|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146743113|NCT04921969|529231581|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
146743114|NCT04921969|529231582|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
146743115|NCT04921969|529231583|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
146743116|NCT04921969|529231584|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
146743117|NCT04921969|529231585|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
146743118|NCT04921969|529231586|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
146743119|NCT04921969|529231587|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
146743120|NCT04921969|529231581|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
146743121|NCT04921969|529231582|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
146743122|NCT04921969|529231583|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
146743123|NCT04921969|529231584|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
146743124|NCT04921969|529231585|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
146743125|NCT04921969|529231586|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
146743126|NCT04921969|529231587|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
146743127|NCT04921969|529231581|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146743128|NCT04921969|529231582|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146743129|NCT04921969|529231583|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146743130|NCT04921969|529231584|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
146743131|NCT04921969|529231585|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146743132|NCT04921969|529231586|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
146743133|NCT04921969|529231587|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
146743134|NCT04921969|529231581|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146743135|NCT04921969|529231582|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146743136|NCT04921969|529231583|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146743137|NCT04921969|529231584|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
146743138|NCT04921969|529231585|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
146743139|NCT04921969|529231586|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
146743140|NCT04921969|529231587|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
146743141|NCT04921969|529231581|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
146743142|NCT04921969|529231582|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
146743143|NCT04921969|529231583|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
146743144|NCT04921969|529231584|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
146743145|NCT04921969|529231585|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
146743146|NCT04921969|529231586|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
146743147|NCT04921969|529231587|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
146743148|NCT04921969|529231581|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146743149|NCT04921969|529231582|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146743150|NCT04921969|529231583|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146743151|NCT04921969|529231584|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
146743152|NCT04921969|529231585|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
146743153|NCT04921969|529231586|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
146743154|NCT04921969|529231587|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
146743155|NCT04921969|529231581|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
146743156|NCT04921969|529231582|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
146743157|NCT04921969|529231583|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
146743158|NCT04921969|529231584|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
146743159|NCT04921969|529231585|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
146743160|NCT04921969|529231586|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
146743161|NCT04921969|529231587|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
146743162|NCT04921969|529231581|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
146743163|NCT04921969|529231582|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
146743164|NCT04921969|529231583|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
146743165|NCT04921969|529231584|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
146743166|NCT04921969|529231585|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
146743167|NCT04921969|529231586|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
146743168|NCT04921969|529231587|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
146743169|NCT04921969|529231581|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
146743170|NCT04921969|529231582|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
146743171|NCT04921969|529231583|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
146743172|NCT04921969|529231584|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
146743173|NCT04921969|529231585|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
146743174|NCT04921969|529231586|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
146743175|NCT04921969|529231587|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
146743176|NCT04287868|529231588|FG000|Overall Study|Screening fail|1|||
146743177|NCT04287868|529231589|FG001|Overall Study|Screening fail|0|||
146743178|NCT04249336|529233637|FG000|Overall Study|Lost to Follow-up|3|||
146743179|NCT04249336|529233638|FG001|Overall Study|Lost to Follow-up|3|||
146743180|NCT04249336|529233639|FG002|Overall Study|Lost to Follow-up|3|||
146743181|NCT04249336|529233640|FG003|Overall Study|Lost to Follow-up|3|||
146743182|NCT01242176|529233641|FG000|Washout Period of 7 Days|Adverse Event|0|||
146510032|NCT01447446|528371915|FG001|Overall Study|Reason not Specified|1|||
146510033|NCT01447446|528371916|FG002|Overall Study|Reason not Specified|1|||
146743183|NCT01242176|529233642|FG001|Washout Period of 7 Days|Adverse Event|2|||
146743184|NCT01242176|529233641|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
146743185|NCT01242176|529233642|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
146743186|NCT00871351|529233643|FG000|Overall Study|Withdrawal by Subject|1|||
146743187|NCT00871351|529233644|FG001|Overall Study|Withdrawal by Subject|0|||
146743188|NCT00871351|529233645|FG002|Overall Study|Withdrawal by Subject|0|||
146743189|NCT00871351|529233643|FG000|Overall Study|Adverse Event|3|||
146743190|NCT00871351|529233644|FG001|Overall Study|Adverse Event|1|||
146743191|NCT00871351|529233645|FG002|Overall Study|Adverse Event|0|||
146743192|NCT02291289|529233647|FG000|Induction Treatment|Withdrawal by Subject|0|||
146743193|NCT02291289|529233648|FG001|Induction Treatment|Withdrawal by Subject|0|||
146743194|NCT02291289|529233649|FG002|Induction Treatment|Withdrawal by Subject|0|||
146743195|NCT02291289|529233650|FG003|Induction Treatment|Withdrawal by Subject|24|||
146743196|NCT02291289|529233651|FG004|Induction Treatment|Withdrawal by Subject|0|||
146743197|NCT02291289|529233652|FG005|Induction Treatment|Withdrawal by Subject|0|||
146743198|NCT02291289|529233653|FG006|Induction Treatment|Withdrawal by Subject|0|||
146743199|NCT02291289|529233654|FG007|Induction Treatment|Withdrawal by Subject|0|||
146743200|NCT02291289|529233655|FG008|Induction Treatment|Withdrawal by Subject|0|||
146743201|NCT02291289|529233656|FG009|Induction Treatment|Withdrawal by Subject|18|||
146743202|NCT02291289|529233657|FG010|Induction Treatment|Withdrawal by Subject|0|||
146743203|NCT02291289|529233658|FG011|Induction Treatment|Withdrawal by Subject|0|||
146743204|NCT02291289|529233659|FG012|Induction Treatment|Withdrawal by Subject|0|||
146743205|NCT02291289|529233647|FG000|Induction Treatment|Adverse Event|0|||
146743206|NCT02291289|529233648|FG001|Induction Treatment|Adverse Event|0|||
146510034|NCT01447446|528371917|FG003|Overall Study|Reason not Specified|1|||
146743207|NCT02291289|529233649|FG002|Induction Treatment|Adverse Event|0|||
146743208|NCT02291289|529233650|FG003|Induction Treatment|Adverse Event|3|||
146743209|NCT02291289|529233651|FG004|Induction Treatment|Adverse Event|0|||
146743210|NCT02291289|529233652|FG005|Induction Treatment|Adverse Event|0|||
146743211|NCT02291289|529233653|FG006|Induction Treatment|Adverse Event|0|||
146743212|NCT02291289|529233654|FG007|Induction Treatment|Adverse Event|0|||
146743213|NCT02291289|529233655|FG008|Induction Treatment|Adverse Event|0|||
146743214|NCT02291289|529233656|FG009|Induction Treatment|Adverse Event|1|||
146743215|NCT02291289|529233657|FG010|Induction Treatment|Adverse Event|0|||
146510035|NCT01447446|528371918|FG004|Overall Study|Reason not Specified|1|||
146510036|NCT01447446|528371919|FG005|Overall Study|Reason not Specified|0|||
146743216|NCT02291289|529233658|FG011|Induction Treatment|Adverse Event|0|||
146743217|NCT02291289|529233659|FG012|Induction Treatment|Adverse Event|0|||
146510037|NCT03747302|528371924|FG000|Overall Study|Withdrawal by Subject|1|||
146510038|NCT03747302|528371925|FG001|Overall Study|Withdrawal by Subject|2|||
146510039|NCT00738062|528371928|FG000|Open Label Treatment|Lack of Efficacy|5|||
146510040|NCT00738062|528371929|FG001|Open Label Treatment|Lack of Efficacy|0|||
146510041|NCT00738062|528371930|FG002|Open Label Treatment|Lack of Efficacy|0|||
146510042|NCT00738062|528371928|FG000|Open Label Treatment|Adverse Event|11|||
146510043|NCT00738062|528371929|FG001|Open Label Treatment|Adverse Event|0|||
146510044|NCT00738062|528371930|FG002|Open Label Treatment|Adverse Event|0|||
146510045|NCT00738062|528371928|FG000|Open Label Treatment|Protocol Violation|2|||
146510046|NCT00738062|528371929|FG001|Open Label Treatment|Protocol Violation|0|||
146510047|NCT00738062|528371930|FG002|Open Label Treatment|Protocol Violation|0|||
146510048|NCT00738062|528371928|FG000|Open Label Treatment|Withdrawal by Subject|9|||
146743218|NCT02291289|529233647|FG000|Induction Treatment|Death|25|||
146743219|NCT02291289|529233648|FG001|Induction Treatment|Death|0|||
146743220|NCT02291289|529233649|FG002|Induction Treatment|Death|0|||
146743221|NCT02291289|529233650|FG003|Induction Treatment|Death|111|||
146743222|NCT02291289|529233651|FG004|Induction Treatment|Death|0|||
146743223|NCT02291289|529233652|FG005|Induction Treatment|Death|0|||
146743224|NCT02291289|529233653|FG006|Induction Treatment|Death|1|||
146743225|NCT02291289|529233654|FG007|Induction Treatment|Death|0|||
146743226|NCT02291289|529233655|FG008|Induction Treatment|Death|0|||
146743227|NCT02291289|529233656|FG009|Induction Treatment|Death|82|||
146743228|NCT02291289|529233657|FG010|Induction Treatment|Death|0|||
146743229|NCT02291289|529233658|FG011|Induction Treatment|Death|0|||
146743230|NCT02291289|529233659|FG012|Induction Treatment|Death|0|||
146743231|NCT02291289|529233647|FG000|Induction Treatment|Lost to Follow-up|1|||
146743232|NCT02291289|529233648|FG001|Induction Treatment|Lost to Follow-up|0|||
146743233|NCT02291289|529233649|FG002|Induction Treatment|Lost to Follow-up|0|||
146743234|NCT02291289|529233650|FG003|Induction Treatment|Lost to Follow-up|12|||
146743235|NCT02291289|529233651|FG004|Induction Treatment|Lost to Follow-up|0|||
146743236|NCT02291289|529233652|FG005|Induction Treatment|Lost to Follow-up|0|||
146743237|NCT02291289|529233653|FG006|Induction Treatment|Lost to Follow-up|0|||
146743238|NCT02291289|529233654|FG007|Induction Treatment|Lost to Follow-up|0|||
146743239|NCT02291289|529233655|FG008|Induction Treatment|Lost to Follow-up|0|||
146743240|NCT02291289|529233656|FG009|Induction Treatment|Lost to Follow-up|9|||
146743241|NCT02291289|529233657|FG010|Induction Treatment|Lost to Follow-up|0|||
146743242|NCT02291289|529233658|FG011|Induction Treatment|Lost to Follow-up|0|||
146743243|NCT02291289|529233659|FG012|Induction Treatment|Lost to Follow-up|0|||
146743244|NCT02291289|529233647|FG000|Induction Treatment|Non-Compliance|0|||
146743245|NCT02291289|529233648|FG001|Induction Treatment|Non-Compliance|0|||
146743246|NCT02291289|529233649|FG002|Induction Treatment|Non-Compliance|0|||
146743247|NCT02291289|529233650|FG003|Induction Treatment|Non-Compliance|1|||
146743248|NCT02291289|529233651|FG004|Induction Treatment|Non-Compliance|0|||
146743249|NCT02291289|529233652|FG005|Induction Treatment|Non-Compliance|0|||
146743250|NCT02291289|529233653|FG006|Induction Treatment|Non-Compliance|0|||
146743251|NCT02291289|529233654|FG007|Induction Treatment|Non-Compliance|0|||
146743252|NCT02291289|529233655|FG008|Induction Treatment|Non-Compliance|0|||
146743253|NCT02291289|529233656|FG009|Induction Treatment|Non-Compliance|1|||
146743254|NCT02291289|529233657|FG010|Induction Treatment|Non-Compliance|0|||
146743255|NCT02291289|529233658|FG011|Induction Treatment|Non-Compliance|0|||
146743256|NCT02291289|529233659|FG012|Induction Treatment|Non-Compliance|0|||
146743257|NCT02291289|529233647|FG000|Induction Treatment|Reason Not Specified|0|||
146743258|NCT02291289|529233648|FG001|Induction Treatment|Reason Not Specified|0|||
146743259|NCT02291289|529233649|FG002|Induction Treatment|Reason Not Specified|0|||
146743260|NCT02291289|529233650|FG003|Induction Treatment|Reason Not Specified|4|||
146743261|NCT02291289|529233651|FG004|Induction Treatment|Reason Not Specified|0|||
146743262|NCT02291289|529233652|FG005|Induction Treatment|Reason Not Specified|0|||
146743263|NCT02291289|529233653|FG006|Induction Treatment|Reason Not Specified|0|||
146743264|NCT02291289|529233654|FG007|Induction Treatment|Reason Not Specified|0|||
146743265|NCT02291289|529233655|FG008|Induction Treatment|Reason Not Specified|0|||
146743266|NCT02291289|529233656|FG009|Induction Treatment|Reason Not Specified|7|||
146743267|NCT02291289|529233657|FG010|Induction Treatment|Reason Not Specified|0|||
146743268|NCT02291289|529233658|FG011|Induction Treatment|Reason Not Specified|0|||
146743269|NCT02291289|529233659|FG012|Induction Treatment|Reason Not Specified|0|||
146743270|NCT02291289|529233647|FG000|Induction Treatment|Physician Decision|0|||
146743271|NCT02291289|529233648|FG001|Induction Treatment|Physician Decision|0|||
146743272|NCT02291289|529233649|FG002|Induction Treatment|Physician Decision|0|||
146743273|NCT02291289|529233650|FG003|Induction Treatment|Physician Decision|3|||
146743274|NCT02291289|529233651|FG004|Induction Treatment|Physician Decision|0|||
146743275|NCT02291289|529233652|FG005|Induction Treatment|Physician Decision|0|||
146743276|NCT02291289|529233653|FG006|Induction Treatment|Physician Decision|0|||
146743277|NCT02291289|529233654|FG007|Induction Treatment|Physician Decision|0|||
146743278|NCT02291289|529233655|FG008|Induction Treatment|Physician Decision|0|||
146743279|NCT02291289|529233656|FG009|Induction Treatment|Physician Decision|1|||
146743280|NCT02291289|529233657|FG010|Induction Treatment|Physician Decision|0|||
146743281|NCT02291289|529233658|FG011|Induction Treatment|Physician Decision|0|||
146743282|NCT02291289|529233659|FG012|Induction Treatment|Physician Decision|0|||
146743283|NCT02291289|529233647|FG000|Induction Treatment|Protocol Violation|0|||
146743284|NCT02291289|529233648|FG001|Induction Treatment|Protocol Violation|0|||
146743285|NCT02291289|529233649|FG002|Induction Treatment|Protocol Violation|0|||
146743286|NCT02291289|529233650|FG003|Induction Treatment|Protocol Violation|3|||
146743287|NCT02291289|529233651|FG004|Induction Treatment|Protocol Violation|0|||
146743288|NCT02291289|529233652|FG005|Induction Treatment|Protocol Violation|0|||
146743289|NCT02291289|529233653|FG006|Induction Treatment|Protocol Violation|0|||
146743290|NCT02291289|529233654|FG007|Induction Treatment|Protocol Violation|0|||
146743291|NCT02291289|529233655|FG008|Induction Treatment|Protocol Violation|0|||
146743292|NCT02291289|529233656|FG009|Induction Treatment|Protocol Violation|2|||
146743293|NCT02291289|529233657|FG010|Induction Treatment|Protocol Violation|0|||
146743294|NCT02291289|529233658|FG011|Induction Treatment|Protocol Violation|0|||
146743295|NCT02291289|529233659|FG012|Induction Treatment|Protocol Violation|0|||
146743296|NCT02291289|529233647|FG000|Induction Treatment|Missing|4|||
146743297|NCT02291289|529233648|FG001|Induction Treatment|Missing|0|||
146743298|NCT02291289|529233649|FG002|Induction Treatment|Missing|0|||
146743299|NCT02291289|529233650|FG003|Induction Treatment|Missing|14|||
146743300|NCT02291289|529233651|FG004|Induction Treatment|Missing|0|||
146743301|NCT02291289|529233652|FG005|Induction Treatment|Missing|0|||
146743302|NCT02291289|529233653|FG006|Induction Treatment|Missing|0|||
146743303|NCT02291289|529233654|FG007|Induction Treatment|Missing|0|||
146743304|NCT02291289|529233655|FG008|Induction Treatment|Missing|0|||
146743305|NCT02291289|529233656|FG009|Induction Treatment|Missing|54|||
146743306|NCT02291289|529233657|FG010|Induction Treatment|Missing|0|||
146743307|NCT02291289|529233658|FG011|Induction Treatment|Missing|0|||
146743308|NCT02291289|529233659|FG012|Induction Treatment|Missing|0|||
146743309|NCT02291289|529233647|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146743310|NCT02291289|529233648|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146743311|NCT02291289|529233649|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146743312|NCT02291289|529233650|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146743313|NCT02291289|529233651|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
146743314|NCT02291289|529233652|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
146743315|NCT02291289|529233653|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146743316|NCT02291289|529233654|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146743317|NCT02291289|529233655|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146743318|NCT02291289|529233656|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146743319|NCT02291289|529233657|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
146743320|NCT02291289|529233658|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
146743321|NCT02291289|529233659|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146743322|NCT02291289|529233647|FG000|Maintenance Treatment Phase|Death|0|||
146743323|NCT02291289|529233648|FG001|Maintenance Treatment Phase|Death|29|||
146743324|NCT02291289|529233649|FG002|Maintenance Treatment Phase|Death|16|||
146743325|NCT02291289|529233650|FG003|Maintenance Treatment Phase|Death|0|||
146743326|NCT02291289|529233651|FG004|Maintenance Treatment Phase|Death|188|||
146743327|NCT02291289|529233652|FG005|Maintenance Treatment Phase|Death|107|||
146743328|NCT02291289|529233653|FG006|Maintenance Treatment Phase|Death|0|||
146743329|NCT02291289|529233654|FG007|Maintenance Treatment Phase|Death|1|||
146743330|NCT02291289|529233655|FG008|Maintenance Treatment Phase|Death|1|||
146743331|NCT02291289|529233656|FG009|Maintenance Treatment Phase|Death|0|||
146743332|NCT02291289|529233657|FG010|Maintenance Treatment Phase|Death|46|||
146743333|NCT02291289|529233658|FG011|Maintenance Treatment Phase|Death|19|||
146743334|NCT02291289|529233659|FG012|Maintenance Treatment Phase|Death|0|||
146743335|NCT02291289|529233647|FG000|Maintenance Treatment Phase|Adverse Event|0|||
146743336|NCT02291289|529233648|FG001|Maintenance Treatment Phase|Adverse Event|0|||
146743337|NCT02291289|529233649|FG002|Maintenance Treatment Phase|Adverse Event|0|||
146743338|NCT02291289|529233650|FG003|Maintenance Treatment Phase|Adverse Event|0|||
146743339|NCT02291289|529233651|FG004|Maintenance Treatment Phase|Adverse Event|1|||
146743340|NCT02291289|529233652|FG005|Maintenance Treatment Phase|Adverse Event|1|||
146743341|NCT02291289|529233653|FG006|Maintenance Treatment Phase|Adverse Event|0|||
146743342|NCT02291289|529233654|FG007|Maintenance Treatment Phase|Adverse Event|0|||
146743343|NCT02291289|529233655|FG008|Maintenance Treatment Phase|Adverse Event|0|||
146743344|NCT02291289|529233656|FG009|Maintenance Treatment Phase|Adverse Event|0|||
146510049|NCT00738062|528371929|FG001|Open Label Treatment|Withdrawal by Subject|0|||
146510050|NCT00738062|528371930|FG002|Open Label Treatment|Withdrawal by Subject|0|||
146510051|NCT00738062|528371928|FG000|Open Label Treatment|Investigator Decision|1|||
146510052|NCT00738062|528371929|FG001|Open Label Treatment|Investigator Decision|0|||
146743345|NCT02291289|529233657|FG010|Maintenance Treatment Phase|Adverse Event|0|||
146743346|NCT02291289|529233658|FG011|Maintenance Treatment Phase|Adverse Event|0|||
146743347|NCT02291289|529233659|FG012|Maintenance Treatment Phase|Adverse Event|0|||
146743348|NCT02291289|529233647|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
146743349|NCT02291289|529233648|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
146743350|NCT02291289|529233649|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
146743351|NCT02291289|529233650|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
146743352|NCT02291289|529233651|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
146510053|NCT00738062|528371930|FG002|Open Label Treatment|Investigator Decision|0|||
146743353|NCT02291289|529233652|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
146743354|NCT02291289|529233653|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
146743355|NCT02291289|529233654|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
146743356|NCT02291289|529233655|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
146743357|NCT02291289|529233656|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
146743358|NCT02291289|529233657|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
146743359|NCT02291289|529233658|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
146743360|NCT02291289|529233659|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
146743361|NCT02291289|529233647|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
146743362|NCT02291289|529233648|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
146743363|NCT02291289|529233649|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
146743364|NCT02291289|529233650|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
146743365|NCT02291289|529233651|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
146743366|NCT02291289|529233652|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
146743367|NCT02291289|529233653|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
146743368|NCT02291289|529233654|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
146743369|NCT02291289|529233655|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
146743370|NCT02291289|529233656|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
146743371|NCT02291289|529233657|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
146743372|NCT02291289|529233658|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
146743373|NCT02291289|529233659|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
146743374|NCT02291289|529233647|FG000|Maintenance Treatment Phase|Physician Decision|0|||
146743375|NCT02291289|529233648|FG001|Maintenance Treatment Phase|Physician Decision|2|||
146743376|NCT02291289|529233649|FG002|Maintenance Treatment Phase|Physician Decision|0|||
146743377|NCT02291289|529233650|FG003|Maintenance Treatment Phase|Physician Decision|0|||
146743378|NCT02291289|529233651|FG004|Maintenance Treatment Phase|Physician Decision|3|||
146743379|NCT02291289|529233652|FG005|Maintenance Treatment Phase|Physician Decision|0|||
146743380|NCT02291289|529233653|FG006|Maintenance Treatment Phase|Physician Decision|0|||
146743381|NCT02291289|529233654|FG007|Maintenance Treatment Phase|Physician Decision|0|||
146743382|NCT02291289|529233655|FG008|Maintenance Treatment Phase|Physician Decision|0|||
146743383|NCT02291289|529233656|FG009|Maintenance Treatment Phase|Physician Decision|0|||
146743384|NCT02291289|529233657|FG010|Maintenance Treatment Phase|Physician Decision|1|||
146743385|NCT02291289|529233658|FG011|Maintenance Treatment Phase|Physician Decision|3|||
146743386|NCT02291289|529233659|FG012|Maintenance Treatment Phase|Physician Decision|0|||
146743387|NCT02291289|529233647|FG000|Maintenance Treatment Phase|Not Treated|0|||
146743388|NCT02291289|529233648|FG001|Maintenance Treatment Phase|Not Treated|0|||
146743389|NCT02291289|529233649|FG002|Maintenance Treatment Phase|Not Treated|2|||
146743390|NCT02291289|529233650|FG003|Maintenance Treatment Phase|Not Treated|0|||
146743391|NCT02291289|529233651|FG004|Maintenance Treatment Phase|Not Treated|0|||
146743392|NCT02291289|529233652|FG005|Maintenance Treatment Phase|Not Treated|0|||
146743393|NCT02291289|529233653|FG006|Maintenance Treatment Phase|Not Treated|0|||
146743394|NCT02291289|529233654|FG007|Maintenance Treatment Phase|Not Treated|0|||
146743395|NCT02291289|529233655|FG008|Maintenance Treatment Phase|Not Treated|0|||
146743396|NCT02291289|529233656|FG009|Maintenance Treatment Phase|Not Treated|0|||
146743397|NCT02291289|529233657|FG010|Maintenance Treatment Phase|Not Treated|0|||
146743398|NCT02291289|529233658|FG011|Maintenance Treatment Phase|Not Treated|0|||
146743399|NCT02291289|529233659|FG012|Maintenance Treatment Phase|Not Treated|0|||
146743400|NCT02291289|529233647|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146743401|NCT02291289|529233648|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
146743402|NCT02291289|529233649|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146743403|NCT02291289|529233650|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146743404|NCT02291289|529233651|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146743405|NCT02291289|529233652|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146743406|NCT02291289|529233653|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146510054|NCT00738062|528371928|FG000|Open-Label Extension|Adverse Event|5|||
146743407|NCT02291289|529233654|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146743408|NCT02291289|529233655|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146743409|NCT02291289|529233656|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146743410|NCT02291289|529233657|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146743411|NCT02291289|529233658|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146743412|NCT02291289|529233659|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146914639|NCT03303339|529850048|FG006|Overall Study|Death|2|||
146510055|NCT00738062|528371929|FG001|Open-Label Extension|Adverse Event|0|||
146510056|NCT00738062|528371930|FG002|Open-Label Extension|Adverse Event|0|||
146510057|NCT00738062|528371928|FG000|Open-Label Extension|Physician Decision|1|||
146510058|NCT00738062|528371929|FG001|Open-Label Extension|Physician Decision|0|||
146510059|NCT00738062|528371930|FG002|Open-Label Extension|Physician Decision|0|||
146510060|NCT00738062|528371928|FG000|Open-Label Extension|Lack of Efficacy|2|||
146510061|NCT00738062|528371929|FG001|Open-Label Extension|Lack of Efficacy|0|||
146510062|NCT00738062|528371930|FG002|Open-Label Extension|Lack of Efficacy|0|||
146510063|NCT00738062|528371928|FG000|Open-Label Extension|Withdrawal by Subject|6|||
146510064|NCT00738062|528371929|FG001|Open-Label Extension|Withdrawal by Subject|0|||
146743413|NCT02291289|529233647|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
146743414|NCT02291289|529233648|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
146743415|NCT02291289|529233649|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
146743416|NCT02291289|529233650|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
146743417|NCT02291289|529233651|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
146743418|NCT02291289|529233652|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
146743419|NCT02291289|529233653|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
146743420|NCT02291289|529233654|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
146743421|NCT02291289|529233655|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
146743422|NCT02291289|529233656|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
146743423|NCT02291289|529233657|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
146743424|NCT02291289|529233658|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
146743425|NCT02291289|529233659|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
146743426|NCT02291289|529233647|FG000|Early Disease Progression|Death|0|||
146743427|NCT02291289|529233648|FG001|Early Disease Progression|Death|0|||
146743428|NCT02291289|529233649|FG002|Early Disease Progression|Death|0|||
146743429|NCT02291289|529233650|FG003|Early Disease Progression|Death|0|||
146743430|NCT02291289|529233651|FG004|Early Disease Progression|Death|0|||
146743431|NCT02291289|529233652|FG005|Early Disease Progression|Death|0|||
146743432|NCT02291289|529233653|FG006|Early Disease Progression|Death|0|||
146743433|NCT02291289|529233654|FG007|Early Disease Progression|Death|0|||
146743434|NCT02291289|529233655|FG008|Early Disease Progression|Death|0|||
146743435|NCT02291289|529233656|FG009|Early Disease Progression|Death|0|||
146743436|NCT02291289|529233657|FG010|Early Disease Progression|Death|0|||
146743437|NCT02291289|529233658|FG011|Early Disease Progression|Death|0|||
146743438|NCT02291289|529233659|FG012|Early Disease Progression|Death|10|||
146743439|NCT02291289|529233647|FG000|Early Disease Progression|Lost to Follow-up|0|||
146743440|NCT02291289|529233648|FG001|Early Disease Progression|Lost to Follow-up|0|||
146743441|NCT02291289|529233649|FG002|Early Disease Progression|Lost to Follow-up|0|||
146743442|NCT02291289|529233650|FG003|Early Disease Progression|Lost to Follow-up|0|||
146743443|NCT02291289|529233651|FG004|Early Disease Progression|Lost to Follow-up|0|||
146743444|NCT02291289|529233652|FG005|Early Disease Progression|Lost to Follow-up|0|||
146743445|NCT02291289|529233653|FG006|Early Disease Progression|Lost to Follow-up|0|||
146743446|NCT02291289|529233654|FG007|Early Disease Progression|Lost to Follow-up|0|||
146743447|NCT02291289|529233655|FG008|Early Disease Progression|Lost to Follow-up|0|||
146743448|NCT02291289|529233656|FG009|Early Disease Progression|Lost to Follow-up|0|||
146743449|NCT02291289|529233657|FG010|Early Disease Progression|Lost to Follow-up|0|||
146743450|NCT02291289|529233658|FG011|Early Disease Progression|Lost to Follow-up|0|||
146743451|NCT02291289|529233659|FG012|Early Disease Progression|Lost to Follow-up|1|||
146743452|NCT00154063|529233660|FG000|Overall Study|Adverse Event|4|||
146743453|NCT00154063|529233661|FG001|Overall Study|Adverse Event|8|||
146743454|NCT00154063|529233660|FG000|Overall Study|Protocol Violation|1|||
146743455|NCT00154063|529233661|FG001|Overall Study|Protocol Violation|1|||
146743456|NCT00154063|529233660|FG000|Overall Study|Investigator or Sponsor Request|0|||
146743457|NCT00154063|529233661|FG001|Overall Study|Investigator or Sponsor Request|1|||
146743458|NCT00154063|529233660|FG000|Overall Study|Withdrawal by Subject|4|||
146743459|NCT00154063|529233661|FG001|Overall Study|Withdrawal by Subject|9|||
146743460|NCT00154063|529233660|FG000|Overall Study|Other|3|||
146743461|NCT00154063|529233661|FG001|Overall Study|Other|3|||
146743462|NCT01857934|529233669|FG000|Overall Study|Relapse or progression|2|||
146743463|NCT01857934|529233669|FG000|Overall Study|Unacceptable toxicity|3|||
146743464|NCT01857934|529233669|FG000|Overall Study|Unwillingness or inability to comply|2|||
146743465|NCT01857934|529233669|FG000|Overall Study|Physician Decision|3|||
146743466|NCT04789577|529233670|FG000|Overall Study|Withdrawal by Subject|1|||
146743467|NCT04789577|529233671|FG001|Overall Study|Withdrawal by Subject|1|||
146743468|NCT04789577|529233672|FG002|Overall Study|Withdrawal by Subject|1|||
146743469|NCT04789577|529233673|FG003|Overall Study|Withdrawal by Subject|3|||
146743470|NCT04789577|529233674|FG004|Overall Study|Withdrawal by Subject|1|||
146743471|NCT04789577|529233675|FG005|Overall Study|Withdrawal by Subject|7|||
146743472|NCT04789577|529233676|FG006|Overall Study|Withdrawal by Subject|1|||
146743473|NCT04789577|529233670|FG000|Overall Study|Lost to Follow-up|7|||
146743474|NCT04789577|529233671|FG001|Overall Study|Lost to Follow-up|12|||
146743475|NCT04789577|529233672|FG002|Overall Study|Lost to Follow-up|7|||
146743476|NCT04789577|529233673|FG003|Overall Study|Lost to Follow-up|10|||
146743477|NCT04789577|529233674|FG004|Overall Study|Lost to Follow-up|8|||
146743478|NCT04789577|529233675|FG005|Overall Study|Lost to Follow-up|6|||
146743479|NCT04789577|529233676|FG006|Overall Study|Lost to Follow-up|10|||
146743480|NCT04789577|529233670|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
146743481|NCT04789577|529233671|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
146743482|NCT04789577|529233672|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
146743483|NCT04789577|529233673|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
146743484|NCT04789577|529233674|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
146743485|NCT04789577|529233675|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
146743486|NCT04789577|529233676|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
146743487|NCT04789577|529233670|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
146743488|NCT04789577|529233671|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
146743489|NCT04789577|529233672|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
146743490|NCT04789577|529233673|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
146743491|NCT04789577|529233674|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
146743492|NCT04789577|529233675|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
146743493|NCT04789577|529233676|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
146743494|NCT01275196|529233678|FG000|Overall Study|Adverse Event|3|||
146743495|NCT01275196|529233679|FG001|Overall Study|Adverse Event|5|||
146743496|NCT01275196|529233678|FG000|Overall Study|Withdrawal by Subject|4|||
146743497|NCT01275196|529233679|FG001|Overall Study|Withdrawal by Subject|5|||
146743498|NCT01275196|529233678|FG000|Overall Study|Lost to Follow-up|1|||
146743499|NCT01275196|529233679|FG001|Overall Study|Lost to Follow-up|0|||
146743500|NCT01275196|529233678|FG000|Overall Study|Disease Progression|6|||
146743501|NCT01275196|529233679|FG001|Overall Study|Disease Progression|5|||
146743502|NCT01275196|529233678|FG000|Overall Study|Protocol Violation|1|||
146743503|NCT01275196|529233679|FG001|Overall Study|Protocol Violation|0|||
146743504|NCT01275196|529233678|FG000|Overall Study|Suboptimal response/treatment failure|5|||
146743505|NCT01275196|529233679|FG001|Overall Study|Suboptimal response/treatment failure|6|||
146743506|NCT01027364|529233680|FG000|Overall Study|Adverse Event|1|||
146743507|NCT01027364|529233681|FG001|Overall Study|Adverse Event|0|||
146743508|NCT01027364|529233682|FG002|Overall Study|Adverse Event|1|||
146743509|NCT01027364|529233683|FG003|Overall Study|Adverse Event|0|||
146743510|NCT01027364|529233680|FG000|Overall Study|Lost to Follow-up|1|||
146743511|NCT01027364|529233681|FG001|Overall Study|Lost to Follow-up|0|||
146743512|NCT01027364|529233682|FG002|Overall Study|Lost to Follow-up|0|||
146743513|NCT01027364|529233683|FG003|Overall Study|Lost to Follow-up|0|||
146743514|NCT01027364|529233680|FG000|Overall Study|Protocol Violation|1|||
146743515|NCT01027364|529233681|FG001|Overall Study|Protocol Violation|0|||
146743516|NCT01027364|529233682|FG002|Overall Study|Protocol Violation|0|||
146743517|NCT01027364|529233683|FG003|Overall Study|Protocol Violation|1|||
146743518|NCT01027364|529233680|FG000|Overall Study|Withdrawal by Subject|1|||
146743519|NCT01027364|529233681|FG001|Overall Study|Withdrawal by Subject|2|||
146743520|NCT01027364|529233682|FG002|Overall Study|Withdrawal by Subject|0|||
146743521|NCT01027364|529233683|FG003|Overall Study|Withdrawal by Subject|0|||
146743522|NCT03119610|529233684|FG000|Overall Study|Adverse Event|1|||
146743523|NCT03119610|529233685|FG001|Overall Study|Adverse Event|0|||
146743524|NCT03119610|529233684|FG000|Overall Study|Lost to Follow-up|0|||
146743525|NCT03119610|529233685|FG001|Overall Study|Lost to Follow-up|1|||
146743526|NCT00114634|529233686|FG000|Overall Study|failure to return forms|3|||
146743527|NCT03283696|529233711|FG000|Overall Study|Physician Decision|5|||
146743528|NCT03283696|529233712|FG001|Overall Study|Physician Decision|6|||
146743529|NCT03283696|529233711|FG000|Overall Study|Withdrawal by Subject|2|||
146743530|NCT03283696|529233712|FG001|Overall Study|Withdrawal by Subject|0|||
146743531|NCT00684762|529233715|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
146743532|NCT00684762|529233716|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
146743533|NCT01844115|529233728|FG000|Overall Study|Adverse Event|4|||
146743534|NCT01844115|529233729|FG001|Overall Study|Adverse Event|22|||
146743535|NCT01844115|529233728|FG000|Overall Study|Lack of Efficacy|1|||
146743536|NCT01844115|529233729|FG001|Overall Study|Lack of Efficacy|4|||
146743537|NCT01844115|529233728|FG000|Overall Study|Protocol Violation|12|||
146743538|NCT01844115|529233729|FG001|Overall Study|Protocol Violation|10|||
146743539|NCT01844115|529233728|FG000|Overall Study|Withdrawal by Subject|11|||
146743540|NCT01844115|529233729|FG001|Overall Study|Withdrawal by Subject|11|||
146743541|NCT01844115|529233728|FG000|Overall Study|Lost to Follow-up|11|||
146743542|NCT01844115|529233729|FG001|Overall Study|Lost to Follow-up|10|||
146743543|NCT01844115|529233728|FG000|Overall Study|Pregnancy|0|||
146743544|NCT01844115|529233729|FG001|Overall Study|Pregnancy|1|||
146743545|NCT00758160|529233730|FG000|Overall Study|No Longer Requires Study Medication|4|||
146743546|NCT00758160|529233730|FG000|Overall Study|Administration Problems|3|||
146743547|NCT00758160|529233730|FG000|Overall Study|Adverse Event|15|||
146743548|NCT00758160|529233730|FG000|Overall Study|Lack of Efficacy|10|||
146743549|NCT00758160|529233730|FG000|Overall Study|Lost to Follow-up|14|||
146510065|NCT00738062|528371930|FG002|Open-Label Extension|Withdrawal by Subject|0|||
146743550|NCT00758160|529233730|FG000|Overall Study|Protocol Violation|12|||
146743551|NCT00758160|529233730|FG000|Overall Study|Withdrawal by Subject|8|||
146743552|NCT00545363|529233731|FG000|Overall Study|Adverse Event|6|||
146743553|NCT00545363|529233732|FG001|Overall Study|Adverse Event|7|||
146743554|NCT00545363|529233731|FG000|Overall Study|Withdrawal by Subject|6|||
146743555|NCT00545363|529233732|FG001|Overall Study|Withdrawal by Subject|5|||
146743556|NCT00545363|529233731|FG000|Overall Study|Non-compliance|3|||
146743557|NCT00545363|529233732|FG001|Overall Study|Non-compliance|1|||
146743558|NCT00545363|529233731|FG000|Overall Study|Did not meet entry criteria|1|||
146743559|NCT00545363|529233732|FG001|Overall Study|Did not meet entry criteria|1|||
146743560|NCT00545363|529233731|FG000|Overall Study|Lost to Follow-up|2|||
146743561|NCT00545363|529233732|FG001|Overall Study|Lost to Follow-up|0|||
146743562|NCT00545363|529233731|FG000|Overall Study|Other|1|||
146743563|NCT00545363|529233732|FG001|Overall Study|Other|1|||
146743564|NCT00366301|529233733|FG000|Overall Study|Lost to Follow-up|4|||
146743565|NCT00366301|529233734|FG001|Overall Study|Lost to Follow-up|4|||
146743566|NCT00366301|529233735|FG002|Overall Study|Lost to Follow-up|3|||
146743567|NCT00366301|529233736|FG003|Overall Study|Lost to Follow-up|7|||
146743568|NCT00366301|529233733|FG000|Overall Study|Withdrawal by Subject|4|||
146743569|NCT00366301|529233734|FG001|Overall Study|Withdrawal by Subject|2|||
146743570|NCT00366301|529233735|FG002|Overall Study|Withdrawal by Subject|1|||
146743571|NCT00366301|529233736|FG003|Overall Study|Withdrawal by Subject|1|||
146743572|NCT01372605|529233737|FG000|Overall Study|Death|1|||
146743573|NCT01372605|529233738|FG001|Overall Study|Death|2|||
146743574|NCT01372605|529233737|FG000|Overall Study|Lost to Follow-up|2|||
146743575|NCT01372605|529233738|FG001|Overall Study|Lost to Follow-up|1|||
146743576|NCT01372605|529233737|FG000|Overall Study|Withdrawal by Subject|4|||
146743577|NCT01372605|529233738|FG001|Overall Study|Withdrawal by Subject|7|||
146743578|NCT01372605|529233737|FG000|Overall Study|Moved|3|||
146743579|NCT01372605|529233738|FG001|Overall Study|Moved|0|||
146743580|NCT01372605|529233737|FG000|Overall Study|Changed medical home|2|||
146743581|NCT01372605|529233738|FG001|Overall Study|Changed medical home|0|||
146743582|NCT01108510|529233739|FG000|Overall Study|Randomized but Not Treated|5|||
146743583|NCT01108510|529233740|FG001|Overall Study|Randomized but Not Treated|1|||
146743584|NCT01108510|529233739|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
146743585|NCT01108510|529233740|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
146743586|NCT01108510|529233739|FG000|Overall Study|Adverse Event|26|||
146743587|NCT01108510|529233740|FG001|Overall Study|Adverse Event|19|||
146743588|NCT01108510|529233739|FG000|Overall Study|Lost to Follow-up|20|||
146743589|NCT01108510|529233740|FG001|Overall Study|Lost to Follow-up|17|||
146743590|NCT01108510|529233739|FG000|Overall Study|Withdrew Consent|21|||
146743591|NCT01108510|529233740|FG001|Overall Study|Withdrew Consent|15|||
146743592|NCT01108510|529233739|FG000|Overall Study|Investigator's Discretion|12|||
146743593|NCT01108510|529233740|FG001|Overall Study|Investigator's Discretion|10|||
146743594|NCT01108510|529233739|FG000|Overall Study|Participant Noncompliance|5|||
146743595|NCT01108510|529233740|FG001|Overall Study|Participant Noncompliance|7|||
146743596|NCT01108510|529233739|FG000|Overall Study|Lack of Efficacy|3|||
146743597|NCT01108510|529233740|FG001|Overall Study|Lack of Efficacy|0|||
146743598|NCT01108510|529233739|FG000|Overall Study|Pregnancy|0|||
146743599|NCT01108510|529233740|FG001|Overall Study|Pregnancy|3|||
146743600|NCT01108510|529233739|FG000|Overall Study|Death|1|||
146743601|NCT01108510|529233740|FG001|Overall Study|Death|1|||
146743602|NCT00210119|529233741|FG000|Overall Study|Protocol Violation|1|||
146743603|NCT00210119|529233741|FG000|Overall Study|Withdrawal by Subject|1|||
146743604|NCT00951509|529233742|FG000|Overall Study|Withdrawal by Subject|2|||
146743605|NCT01830881|529233744|FG000|Overall Study|Changed decision to have an abortion|0|||
146510066|NCT00738062|528371928|FG000|Open-Label Extension|Protocol Violation|1|||
146510067|NCT00738062|528371929|FG001|Open-Label Extension|Protocol Violation|0|||
146743606|NCT01830881|529233745|FG001|Overall Study|Changed decision to have an abortion|1|||
146510068|NCT00738062|528371930|FG002|Open-Label Extension|Protocol Violation|0|||
146510069|NCT00738062|528371928|FG000|Open-Label Extension|Study Terminated|2|||
146743607|NCT03125941|529233746|FG000|Overall Study|did not receive intervention|1|||
146743608|NCT03125941|529233747|FG001|Overall Study|did not receive intervention|2|||
146743609|NCT00582491|529233748|FG000|Overall Study|Withdrawal by Subject|1|||
146743610|NCT00582491|529233749|FG001|Overall Study|Withdrawal by Subject|0|||
146743611|NCT01193582|529233750|FG000|Vaccination Series|Withdrawal by Subject|11|||
146743612|NCT01193582|529233751|FG001|Vaccination Series|Withdrawal by Subject|13|||
146743613|NCT01193582|529233752|FG002|Vaccination Series|Withdrawal by Subject|8|||
146743614|NCT01193582|529233753|FG003|Vaccination Series|Withdrawal by Subject|3|||
146743615|NCT01193582|529233750|FG000|12 Month Follow-up|Death|0|||
146510070|NCT00738062|528371929|FG001|Open-Label Extension|Study Terminated|0|||
146743616|NCT01193582|529233751|FG001|12 Month Follow-up|Death|0|||
146743617|NCT01193582|529233752|FG002|12 Month Follow-up|Death|1|||
146743618|NCT01193582|529233753|FG003|12 Month Follow-up|Death|0|||
146743619|NCT01193582|529233750|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
146743620|NCT01193582|529233751|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
146743621|NCT01193582|529233752|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
146743622|NCT01193582|529233753|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
146743623|NCT01425632|529233754|FG000|Overall Study|Adverse Event|0|||
146743624|NCT01425632|529233755|FG001|Overall Study|Adverse Event|1|||
146743625|NCT01425632|529233756|FG002|Overall Study|Adverse Event|1|||
146743626|NCT01425632|529233754|FG000|Overall Study|Physician Decision|1|||
146743627|NCT01425632|529233755|FG001|Overall Study|Physician Decision|0|||
146743628|NCT01425632|529233756|FG002|Overall Study|Physician Decision|0|||
146743629|NCT01425632|529233754|FG000|Overall Study|Protocol Violation|0|||
146743630|NCT01425632|529233755|FG001|Overall Study|Protocol Violation|0|||
146743631|NCT01425632|529233756|FG002|Overall Study|Protocol Violation|2|||
146743632|NCT01425632|529233754|FG000|Overall Study|Withdrawal by Subject|0|||
146743633|NCT01425632|529233755|FG001|Overall Study|Withdrawal by Subject|0|||
146743634|NCT01425632|529233756|FG002|Overall Study|Withdrawal by Subject|1|||
146743635|NCT00406419|529233763|FG000|Overall Study|Death|3|||
146743636|NCT00406419|529233764|FG001|Overall Study|Death|1|||
146743637|NCT00406419|529233765|FG002|Overall Study|Death|4|||
146743638|NCT00406419|529233763|FG000|Overall Study|Protocol Violation|6|||
146743639|NCT00406419|529233764|FG001|Overall Study|Protocol Violation|2|||
146743640|NCT00406419|529233765|FG002|Overall Study|Protocol Violation|5|||
146743641|NCT00406419|529233763|FG000|Overall Study|Study Terminated by Sponsor|260|||
146743642|NCT00406419|529233764|FG001|Overall Study|Study Terminated by Sponsor|288|||
146743643|NCT00406419|529233765|FG002|Overall Study|Study Terminated by Sponsor|282|||
146743644|NCT00406419|529233763|FG000|Overall Study|Withdrawal by Subject|17|||
146510071|NCT00738062|528371930|FG002|Open-Label Extension|Study Terminated|0|||
146510072|NCT02772276|528371931|FG000|Overall Study|Lost to Follow-up|0|||
146510073|NCT02772276|528371932|FG001|Overall Study|Lost to Follow-up|0|||
146510074|NCT02772276|528371933|FG002|Overall Study|Lost to Follow-up|0|||
146743645|NCT00406419|529233764|FG001|Overall Study|Withdrawal by Subject|24|||
146743646|NCT00406419|529233765|FG002|Overall Study|Withdrawal by Subject|26|||
146510075|NCT02772276|528371934|FG003|Overall Study|Lost to Follow-up|0|||
146743647|NCT00406419|529233763|FG000|Overall Study|Lack of Efficacy|12|||
146743648|NCT00406419|529233764|FG001|Overall Study|Lack of Efficacy|1|||
146743649|NCT00406419|529233765|FG002|Overall Study|Lack of Efficacy|6|||
146743650|NCT00406419|529233763|FG000|Overall Study|Non-Compliance with Study Drug|5|||
146510076|NCT02772276|528371935|FG004|Overall Study|Lost to Follow-up|0|||
146914640|NCT03303339|529850049|FG007|Overall Study|Death|2|||
146914641|NCT03303339|529850050|FG008|Overall Study|Death|3|||
146510077|NCT02772276|528371936|FG005|Overall Study|Lost to Follow-up|0|||
146510078|NCT02772276|528371937|FG006|Overall Study|Lost to Follow-up|1|||
146510079|NCT02772276|528371938|FG007|Overall Study|Lost to Follow-up|0|||
146510080|NCT02772276|528371939|FG008|Overall Study|Lost to Follow-up|0|||
146510081|NCT02772276|528371940|FG009|Overall Study|Lost to Follow-up|0|||
146510082|NCT02772276|528371941|FG010|Overall Study|Lost to Follow-up|0|||
146510083|NCT02772276|528371942|FG011|Overall Study|Lost to Follow-up|0|||
146510084|NCT02772276|528371943|FG012|Overall Study|Lost to Follow-up|0|||
146625178|NCT02081677|528803832|FG001|Overall Study|Not comfortable with lens care system|0|||
146743651|NCT00406419|529233764|FG001|Overall Study|Non-Compliance with Study Drug|6|||
146510085|NCT02772276|528371931|FG000|Overall Study|Withdrew consent|0|||
146510086|NCT02772276|528371932|FG001|Overall Study|Withdrew consent|0|||
146510087|NCT02772276|528371933|FG002|Overall Study|Withdrew consent|0|||
146510088|NCT02772276|528371934|FG003|Overall Study|Withdrew consent|0|||
146510089|NCT02772276|528371935|FG004|Overall Study|Withdrew consent|0|||
146510090|NCT02772276|528371936|FG005|Overall Study|Withdrew consent|0|||
146510091|NCT02772276|528371937|FG006|Overall Study|Withdrew consent|0|||
146510092|NCT02772276|528371938|FG007|Overall Study|Withdrew consent|1|||
146510093|NCT02772276|528371939|FG008|Overall Study|Withdrew consent|0|||
146510094|NCT02772276|528371940|FG009|Overall Study|Withdrew consent|0|||
146510095|NCT02772276|528371941|FG010|Overall Study|Withdrew consent|0|||
146510096|NCT02772276|528371942|FG011|Overall Study|Withdrew consent|0|||
146743652|NCT00406419|529233765|FG002|Overall Study|Non-Compliance with Study Drug|3|||
146510097|NCT02772276|528371943|FG012|Overall Study|Withdrew consent|0|||
146510098|NCT02248974|528371944|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
146510099|NCT02248974|528371945|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
146510100|NCT02248974|528371944|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
146510101|NCT02248974|528371945|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
146510102|NCT02248974|528371944|FG000|1-Day Follow-Up|Enrolled in another study|1|||
146510103|NCT02248974|528371945|FG001|1-Day Follow-Up|Enrolled in another study|0|||
146510104|NCT02248974|528371944|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
146510105|NCT02248974|528371945|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
146510106|NCT02248974|528371944|FG000|1-Week Follow-Up|Enrolled in another study|1|||
146743653|NCT00406419|529233763|FG000|Overall Study|Adverse Event|10|||
146743654|NCT00406419|529233764|FG001|Overall Study|Adverse Event|12|||
146743655|NCT00406419|529233765|FG002|Overall Study|Adverse Event|16|||
146743656|NCT00406419|529233763|FG000|Overall Study|Lost to Follow-up|11|||
146743657|NCT00406419|529233764|FG001|Overall Study|Lost to Follow-up|10|||
146743658|NCT00406419|529233765|FG002|Overall Study|Lost to Follow-up|5|||
146743659|NCT01775930|529233766|FG000|Overall Study|Futility stopping boundary met|1|||
146743660|NCT03915951|529233769|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
146743661|NCT03915951|529233770|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
146743662|NCT03915951|529233769|FG000|Overall Study|Adverse Event|12|||
146743663|NCT03915951|529233770|FG001|Overall Study|Adverse Event|6|||
146743664|NCT03915951|529233769|FG000|Overall Study|Disease progression (radiological)|17|||
146743665|NCT03915951|529233770|FG001|Overall Study|Disease progression (radiological)|15|||
146743666|NCT03915951|529233769|FG000|Overall Study|Disease progression (clinical)|4|||
146743667|NCT03915951|529233770|FG001|Overall Study|Disease progression (clinical)|1|||
146743668|NCT03915951|529233769|FG000|Overall Study|Patient decision|0|||
146743669|NCT03915951|529233770|FG001|Overall Study|Patient decision|4|||
146743670|NCT03915951|529233769|FG000|Overall Study|Investigator decision|0|||
146743671|NCT03915951|529233770|FG001|Overall Study|Investigator decision|1|||
146743672|NCT03915951|529233769|FG000|Overall Study|Consent withdrawn|1|||
146743673|NCT03915951|529233770|FG001|Overall Study|Consent withdrawn|1|||
146743674|NCT03915951|529233769|FG000|Overall Study|Death|0|||
146743675|NCT03915951|529233770|FG001|Overall Study|Death|3|||
146743676|NCT05064735|529233771|FG000|Overall Study|Withdrawal by Subject|7|||
146743677|NCT05064735|529233772|FG001|Overall Study|Withdrawal by Subject|8|||
146743678|NCT05064735|529233771|FG000|Overall Study|Lost to Follow-up|7|||
146743679|NCT05064735|529233772|FG001|Overall Study|Lost to Follow-up|2|||
146743680|NCT05064735|529233771|FG000|Overall Study|Physician Decision|2|||
146743681|NCT05064735|529233772|FG001|Overall Study|Physician Decision|1|||
146743682|NCT05064735|529233771|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
146743683|NCT05064735|529233772|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
146743684|NCT05064735|529233771|FG000|Overall Study|Site Closure|7|||
146743685|NCT05064735|529233772|FG001|Overall Study|Site Closure|2|||
146743686|NCT01396395|529233773|FG000|Overall Study|Withdrawal by Subject|10|||
146743687|NCT01396395|529233774|FG001|Overall Study|Withdrawal by Subject|12|||
146743688|NCT01396395|529233773|FG000|Overall Study|Protocol Violation|3|||
146743689|NCT01396395|529233774|FG001|Overall Study|Protocol Violation|1|||
146743690|NCT01396395|529233773|FG000|Overall Study|Adverse Event|10|||
146743691|NCT01396395|529233774|FG001|Overall Study|Adverse Event|2|||
146743692|NCT01396395|529233773|FG000|Overall Study|Lost to Follow-up|17|||
146743693|NCT01396395|529233774|FG001|Overall Study|Lost to Follow-up|11|||
146743694|NCT01396395|529233773|FG000|Overall Study|Other|0|||
146743695|NCT01396395|529233774|FG001|Overall Study|Other|1|||
146743696|NCT03691948|529233775|FG000|Overall Study|Lost to Follow-up|1|||
146743697|NCT03691948|529233776|FG001|Overall Study|Lost to Follow-up|3|||
146743698|NCT01370005|529233777|FG000|Overall Study|Not treated|1|||
146743699|NCT01370005|529233778|FG001|Overall Study|Not treated|0|||
146743700|NCT01370005|529233779|FG002|Overall Study|Not treated|0|||
146743701|NCT01370005|529233777|FG000|Overall Study|Adverse Event|5|||
146743702|NCT01370005|529233778|FG001|Overall Study|Adverse Event|5|||
146743703|NCT01370005|529233779|FG002|Overall Study|Adverse Event|6|||
146743704|NCT01370005|529233777|FG000|Overall Study|Lack of Efficacy|1|||
146743705|NCT01370005|529233778|FG001|Overall Study|Lack of Efficacy|0|||
146743706|NCT01370005|529233779|FG002|Overall Study|Lack of Efficacy|0|||
146743707|NCT01370005|529233777|FG000|Overall Study|Non compliant with protocol|0|||
146743708|NCT01370005|529233778|FG001|Overall Study|Non compliant with protocol|1|||
146743709|NCT01370005|529233779|FG002|Overall Study|Non compliant with protocol|2|||
146743710|NCT01370005|529233777|FG000|Overall Study|Lost to Follow-up|1|||
146743711|NCT01370005|529233778|FG001|Overall Study|Lost to Follow-up|1|||
146743712|NCT01370005|529233779|FG002|Overall Study|Lost to Follow-up|1|||
146743713|NCT01370005|529233777|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
146743714|NCT01370005|529233778|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
146743715|NCT01370005|529233779|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
146743716|NCT01370005|529233777|FG000|Overall Study|Other reason not defined above|3|||
146743717|NCT01370005|529233778|FG001|Overall Study|Other reason not defined above|0|||
146743718|NCT01370005|529233779|FG002|Overall Study|Other reason not defined above|2|||
146743719|NCT02009696|529233780|FG000|Overall Study|Withdrawal by Subject|2|||
146743720|NCT02120664|529233781|FG000|Overall Study|Withdrawal by Subject|0|||
146743721|NCT02120664|529233782|FG001|Overall Study|Withdrawal by Subject|0|||
146743722|NCT02120664|529233783|FG002|Overall Study|Withdrawal by Subject|0|||
146743723|NCT02120664|529233784|FG003|Overall Study|Withdrawal by Subject|1|||
146743724|NCT02120664|529233785|FG004|Overall Study|Withdrawal by Subject|0|||
146743725|NCT02460263|529233786|FG000|Transition Period|Withdrawal by Subject|1|||
146743726|NCT02460263|529233786|FG000|Transition Period|Death|1|||
146743727|NCT03916744|529233787|FG000|Overall Study|Withdrawal by Subject|0|||
146743728|NCT03916744|529233788|FG001|Overall Study|Withdrawal by Subject|1|||
146743729|NCT03916744|529233789|FG002|Overall Study|Withdrawal by Subject|2|||
146743730|NCT04524598|529233790|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
146625179|NCT02081677|528803833|FG002|Overall Study|Not comfortable with lens care system|0|||
146914642|NCT03303339|529850051|FG009|Overall Study|Death|3|||
146625180|NCT02081677|528803834|FG003|Overall Study|Not comfortable with lens care system|0|||
146743731|NCT04524598|529233791|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
146743732|NCT04524598|529233792|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
146743733|NCT04524598|529233793|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
146743734|NCT04524598|529233794|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
146743735|NCT04524598|529233790|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
146743736|NCT04524598|529233791|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
146743737|NCT04524598|529233792|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
146743738|NCT04524598|529233793|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
146743739|NCT04524598|529233794|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
146743740|NCT04524598|529233790|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
146743741|NCT04524598|529233791|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
146743742|NCT04524598|529233792|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
146743743|NCT04524598|529233793|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
146743744|NCT04524598|529233794|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
146743745|NCT04524598|529233790|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
146743746|NCT04524598|529233791|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
146743747|NCT04524598|529233792|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
146743748|NCT04524598|529233793|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
146743749|NCT04524598|529233794|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
146743750|NCT04524598|529233790|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
146743751|NCT04524598|529233791|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
146743752|NCT04524598|529233792|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
146743753|NCT04524598|529233793|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
146743754|NCT04524598|529233794|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
146743755|NCT04524598|529233790|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
146743756|NCT04524598|529233791|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
146743757|NCT04524598|529233792|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
146743758|NCT04524598|529233793|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
146743759|NCT04524598|529233794|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
146743760|NCT04524598|529233790|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
146743761|NCT04524598|529233791|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
146770080|NCT03516942|529326679|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
146770081|NCT03516942|529326679|FG000|T2: 6 Month Survey|Death|14|||
146510107|NCT02248974|528371945|FG001|1-Week Follow-Up|Enrolled in another study|1|||
146510108|NCT02248974|528371944|FG000|1-Week Follow-Up|Transferred to another facility|1|||
146510109|NCT02248974|528371945|FG001|1-Week Follow-Up|Transferred to another facility|0|||
146510110|NCT02248974|528371944|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
146510111|NCT02248974|528371945|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
146510112|NCT02248974|528371944|FG000|1-Week Follow-Up|Death|1|||
146510113|NCT02248974|528371945|FG001|1-Week Follow-Up|Death|1|||
146510114|NCT02248974|528371944|FG000|1-Week Follow-Up|Excluded because of age|0|||
146510115|NCT02248974|528371945|FG001|1-Week Follow-Up|Excluded because of age|1|||
146510116|NCT02248974|528371944|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
146510117|NCT02248974|528371945|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
146510118|NCT02248974|528371944|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
146510119|NCT02248974|528371945|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
146510120|NCT02248974|528371944|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
146510121|NCT02248974|528371945|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
146510122|NCT02248974|528371944|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
146625181|NCT02081677|528803831|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
146510123|NCT02248974|528371945|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
146510124|NCT02248974|528371944|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
146743762|NCT04524598|529233792|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
146743763|NCT04524598|529233793|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
146743764|NCT04524598|529233794|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
146743765|NCT02301156|529233795|FG000|Overall Study|Adverse Event|13|||
146743766|NCT02301156|529233796|FG001|Overall Study|Adverse Event|14|||
146743767|NCT02301156|529233795|FG000|Overall Study|Death|1|||
146743768|NCT02301156|529233796|FG001|Overall Study|Death|5|||
146743769|NCT02301156|529233795|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
146743770|NCT02301156|529233796|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
146743771|NCT02301156|529233795|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
146743772|NCT02301156|529233796|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
146743773|NCT02301156|529233795|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
146743774|NCT02301156|529233796|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
146743775|NCT02301156|529233795|FG000|Overall Study|Reason not Specified|6|||
146743776|NCT02301156|529233796|FG001|Overall Study|Reason not Specified|3|||
146743777|NCT02638623|529233798|FG000|Overall Study|Surgery timing|5|||
146743778|NCT02638623|529233799|FG001|Overall Study|Surgery timing|6|||
146743779|NCT02638623|529233798|FG000|Overall Study|Not given intervention|2|||
146743780|NCT02638623|529233799|FG001|Overall Study|Not given intervention|0|||
146743781|NCT00180713|529233800|FG000|Overall Study|Withdrawal by Subject|2|||
146743782|NCT00180713|529233801|FG001|Overall Study|Withdrawal by Subject|0|||
146743783|NCT00180713|529233800|FG000|Overall Study|Adverse Event|3|||
146743784|NCT00180713|529233801|FG001|Overall Study|Adverse Event|3|||
146743785|NCT05295732|529233806|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
146743786|NCT05295732|529233807|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
146743787|NCT05295732|529233808|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
146743788|NCT05295732|529233809|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
146743789|NCT05295732|529233810|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
146743790|NCT05295732|529233806|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
146743791|NCT05295732|529233807|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
146743792|NCT05295732|529233808|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
146743793|NCT05295732|529233809|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
146743794|NCT05295732|529233810|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
146743795|NCT02322814|529233811|FG000|Overall Study|Death|7|||
146743796|NCT02322814|529233812|FG001|Overall Study|Death|29|||
146743797|NCT02322814|529233813|FG002|Overall Study|Death|32|||
146743798|NCT02322814|529233814|FG003|Overall Study|Death|23|||
146743799|NCT02322814|529233815|FG004|Overall Study|Death|14|||
146743800|NCT02322814|529233811|FG000|Overall Study|Lost to Follow-up|1|||
146743801|NCT02322814|529233812|FG001|Overall Study|Lost to Follow-up|3|||
146743802|NCT02322814|529233813|FG002|Overall Study|Lost to Follow-up|3|||
146743803|NCT02322814|529233814|FG003|Overall Study|Lost to Follow-up|1|||
146743804|NCT02322814|529233815|FG004|Overall Study|Lost to Follow-up|0|||
146743805|NCT02322814|529233811|FG000|Overall Study|Various Reasons|2|||
146743806|NCT02322814|529233812|FG001|Overall Study|Various Reasons|0|||
146743807|NCT02322814|529233813|FG002|Overall Study|Various Reasons|1|||
146743808|NCT02322814|529233814|FG003|Overall Study|Various Reasons|1|||
146743809|NCT02322814|529233815|FG004|Overall Study|Various Reasons|0|||
146743810|NCT02322814|529233811|FG000|Overall Study|Progressive Disease|0|||
146743811|NCT02322814|529233812|FG001|Overall Study|Progressive Disease|0|||
146743812|NCT02322814|529233813|FG002|Overall Study|Progressive Disease|0|||
146743813|NCT02322814|529233814|FG003|Overall Study|Progressive Disease|1|||
146743814|NCT02322814|529233815|FG004|Overall Study|Progressive Disease|1|||
146743815|NCT02322814|529233811|FG000|Overall Study|Protocol Violation|1|||
146743816|NCT02322814|529233812|FG001|Overall Study|Protocol Violation|0|||
146743817|NCT02322814|529233813|FG002|Overall Study|Protocol Violation|0|||
146743818|NCT02322814|529233814|FG003|Overall Study|Protocol Violation|0|||
146743819|NCT02322814|529233815|FG004|Overall Study|Protocol Violation|0|||
146743820|NCT02322814|529233811|FG000|Overall Study|Study Terminated by Sponsor|0|||
146743821|NCT02322814|529233812|FG001|Overall Study|Study Terminated by Sponsor|7|||
146743822|NCT02322814|529233813|FG002|Overall Study|Study Terminated by Sponsor|9|||
146743823|NCT02322814|529233814|FG003|Overall Study|Study Terminated by Sponsor|5|||
146743824|NCT02322814|529233815|FG004|Overall Study|Study Terminated by Sponsor|13|||
146743825|NCT02322814|529233811|FG000|Overall Study|Withdrawal by Subject|5|||
146743826|NCT02322814|529233812|FG001|Overall Study|Withdrawal by Subject|4|||
146743827|NCT02322814|529233813|FG002|Overall Study|Withdrawal by Subject|2|||
146743828|NCT02322814|529233814|FG003|Overall Study|Withdrawal by Subject|1|||
146743829|NCT02322814|529233815|FG004|Overall Study|Withdrawal by Subject|3|||
146743830|NCT03012061|529233816|FG000|Overall Study|Withdrawal by Subject|1|||
146743831|NCT03012061|529233817|FG001|Overall Study|Withdrawal by Subject|5|||
146743832|NCT03012061|529233818|FG002|Overall Study|Withdrawal by Subject|4|||
146743833|NCT03012061|529233816|FG000|Overall Study|Investigator Site Closed|1|||
146743834|NCT03012061|529233817|FG001|Overall Study|Investigator Site Closed|2|||
146510125|NCT02248974|528371945|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
146510126|NCT00033657|528371946|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
146743835|NCT03012061|529233818|FG002|Overall Study|Investigator Site Closed|0|||
146743836|NCT03012061|529233816|FG000|Overall Study|Lost to Follow-up|2|||
146743837|NCT03012061|529233817|FG001|Overall Study|Lost to Follow-up|1|||
146743838|NCT03012061|529233818|FG002|Overall Study|Lost to Follow-up|0|||
146743839|NCT03012061|529233816|FG000|Overall Study|Study closed/ Terminated|0|||
146743840|NCT03012061|529233817|FG001|Overall Study|Study closed/ Terminated|0|||
146743841|NCT03012061|529233818|FG002|Overall Study|Study closed/ Terminated|1|||
146743842|NCT03012061|529233816|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
146743843|NCT03012061|529233817|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
146743844|NCT03012061|529233818|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
146743845|NCT03012061|529233816|FG000|Overall Study|Protocol Violation|0|||
146510127|NCT00033657|528371947|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
146743846|NCT03012061|529233817|FG001|Overall Study|Protocol Violation|0|||
146510128|NCT00033657|528371946|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
146510129|NCT00033657|528371947|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
146510130|NCT00033657|528371946|FG000|Neoadjuvant Chemotherapy|Death|1|||
146510131|NCT00033657|528371947|FG001|Neoadjuvant Chemotherapy|Death|1|||
146510132|NCT00033657|528371946|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
146510133|NCT00033657|528371947|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
146510134|NCT00033657|528371946|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
146510135|NCT00033657|528371947|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
146510136|NCT00033657|528371946|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
146510137|NCT00033657|528371947|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
146510138|NCT00033657|528371946|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
146510139|NCT00033657|528371947|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
146510140|NCT00033657|528371946|FG000|Surgical Resection|not complete resection|0|||
146510141|NCT00033657|528371947|FG001|Surgical Resection|not complete resection|3|||
146510142|NCT00033657|528371946|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
146510143|NCT00033657|528371947|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
146510144|NCT00033657|528371946|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
146510145|NCT00033657|528371947|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
146510146|NCT00033657|528371946|FG000|Adjuvant Chemotherapy|Death|2|||
146510147|NCT00033657|528371947|FG001|Adjuvant Chemotherapy|Death|1|||
146510148|NCT00033657|528371946|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
146510149|NCT00033657|528371947|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
146510150|NCT00033657|528371946|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
146510151|NCT00033657|528371947|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
146510152|NCT00033657|528371946|FG000|Adjuvant Chemotherapy|Other|0|||
146510153|NCT00033657|528371947|FG001|Adjuvant Chemotherapy|Other|2|||
146510154|NCT02332239|528371948|FG000|Overall Study|Lost to Follow-up|4|||
146510155|NCT02332239|528371949|FG001|Overall Study|Lost to Follow-up|6|||
146510156|NCT00894790|528371950|FG000|Overall Study|Protocol Violation|0|||
146510157|NCT00894790|528371951|FG001|Overall Study|Protocol Violation|1|||
146510158|NCT00894790|528371950|FG000|Overall Study|Lost to Follow-up|0|||
146510159|NCT00894790|528371951|FG001|Overall Study|Lost to Follow-up|1|||
146510160|NCT00894790|528371950|FG000|Overall Study|Did not meet entrance criteria|1|||
146510161|NCT00894790|528371951|FG001|Overall Study|Did not meet entrance criteria|0|||
146510162|NCT04093492|528371952|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
146510163|NCT04093492|528371953|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
146510164|NCT04093492|528371954|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
146510165|NCT04093492|528371955|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
146510166|NCT04093492|528371952|FG000|25 Weeks Gestational Age (GA)|No response|5|||
146510167|NCT04093492|528371953|FG001|25 Weeks Gestational Age (GA)|No response|5|||
146510168|NCT04093492|528371954|FG002|25 Weeks Gestational Age (GA)|No response|5|||
146510169|NCT04093492|528371955|FG003|25 Weeks Gestational Age (GA)|No response|2|||
146510170|NCT04093492|528371952|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
146510171|NCT04093492|528371953|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
146510172|NCT04093492|528371954|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
146510173|NCT04093492|528371955|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
146510174|NCT04093492|528371952|FG000|30 Weeks GA|Delivered before assessment|1|||
146510175|NCT04093492|528371953|FG001|30 Weeks GA|Delivered before assessment|2|||
146510176|NCT04093492|528371954|FG002|30 Weeks GA|Delivered before assessment|0|||
146510177|NCT04093492|528371955|FG003|30 Weeks GA|Delivered before assessment|0|||
146510178|NCT04093492|528371952|FG000|30 Weeks GA|No response|7|||
146510179|NCT04093492|528371953|FG001|30 Weeks GA|No response|5|||
146743847|NCT03012061|529233818|FG002|Overall Study|Protocol Violation|2|||
146743848|NCT03012061|529233816|FG000|Overall Study|Lack of Efficacy|0|||
146743849|NCT03012061|529233817|FG001|Overall Study|Lack of Efficacy|1|||
146510180|NCT04093492|528371954|FG002|30 Weeks GA|No response|5|||
146510181|NCT04093492|528371955|FG003|30 Weeks GA|No response|2|||
146510182|NCT04093492|528371952|FG000|30 Weeks GA|Lost to Follow-up|0|||
146510183|NCT04093492|528371953|FG001|30 Weeks GA|Lost to Follow-up|1|||
146510184|NCT04093492|528371954|FG002|30 Weeks GA|Lost to Follow-up|0|||
146510185|NCT04093492|528371955|FG003|30 Weeks GA|Lost to Follow-up|0|||
146510186|NCT04093492|528371952|FG000|34 Weeks GA|Delivered before assessment|6|||
146510187|NCT04093492|528371953|FG001|34 Weeks GA|Delivered before assessment|3|||
146510188|NCT04093492|528371954|FG002|34 Weeks GA|Delivered before assessment|0|||
146510189|NCT04093492|528371955|FG003|34 Weeks GA|Delivered before assessment|0|||
146510190|NCT04093492|528371952|FG000|34 Weeks GA|No response|0|||
146510191|NCT04093492|528371953|FG001|34 Weeks GA|No response|7|||
146510192|NCT04093492|528371954|FG002|34 Weeks GA|No response|5|||
146510193|NCT04093492|528371955|FG003|34 Weeks GA|No response|3|||
146510194|NCT04093492|528371952|FG000|34 Weeks GA|Lost to Follow-up|0|||
146510195|NCT04093492|528371953|FG001|34 Weeks GA|Lost to Follow-up|1|||
146510196|NCT04093492|528371954|FG002|34 Weeks GA|Lost to Follow-up|0|||
146510197|NCT04093492|528371955|FG003|34 Weeks GA|Lost to Follow-up|0|||
146510198|NCT00006305|528371961|FG000|Overall Study|Withdrawal by Subject|17|||
146510199|NCT00006305|528371962|FG001|Overall Study|Withdrawal by Subject|10|||
146510200|NCT00006305|528371963|FG002|Overall Study|Withdrawal by Subject|15|||
146510201|NCT00006305|528371964|FG003|Overall Study|Withdrawal by Subject|14|||
146510202|NCT00662558|528371965|FG000|Overall Study|Adverse Event|21|||
146510203|NCT00662558|528371966|FG001|Overall Study|Adverse Event|59|||
146510204|NCT00662558|528371965|FG000|Overall Study|Lack of Efficacy|4|||
146510205|NCT00662558|528371966|FG001|Overall Study|Lack of Efficacy|7|||
146510206|NCT00662558|528371965|FG000|Overall Study|Lost to Follow-up|13|||
146510207|NCT00662558|528371966|FG001|Overall Study|Lost to Follow-up|10|||
146510208|NCT00662558|528371965|FG000|Overall Study|Other|9|||
146510209|NCT00662558|528371966|FG001|Overall Study|Other|14|||
146510210|NCT00662558|528371965|FG000|Overall Study|Withdrawal by Subject|7|||
146510211|NCT00662558|528371966|FG001|Overall Study|Withdrawal by Subject|12|||
146510212|NCT00662558|528371965|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
146510213|NCT00662558|528371966|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
146510214|NCT00783224|528371969|FG000|Overall Study|Adverse Event|0|||
146510215|NCT00783224|528371970|FG001|Overall Study|Adverse Event|0|||
146510216|NCT00783224|528371971|FG002|Overall Study|Adverse Event|1|||
146510217|NCT00783224|528371972|FG003|Overall Study|Adverse Event|0|||
146510218|NCT00783224|528371969|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
146510219|NCT00783224|528371970|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
146510220|NCT00783224|528371971|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
146510221|NCT00783224|528371972|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
146510222|NCT00783224|528371969|FG000|Overall Study|Inappropriate as a study subject|0|||
146510223|NCT00783224|528371970|FG001|Overall Study|Inappropriate as a study subject|0|||
146510224|NCT00783224|528371971|FG002|Overall Study|Inappropriate as a study subject|0|||
146510225|NCT00783224|528371972|FG003|Overall Study|Inappropriate as a study subject|1|||
146510226|NCT01711619|528371973|FG000|Overall Study|Early study termination|10|||
146510227|NCT01711619|528371974|FG001|Overall Study|Early study termination|14|||
146510228|NCT01711619|528371973|FG000|Overall Study|Withdrawal by Subject|3|||
146510229|NCT01711619|528371974|FG001|Overall Study|Withdrawal by Subject|7|||
146510230|NCT01711619|528371973|FG000|Overall Study|Protocol Violation|2|||
146510231|NCT01711619|528371974|FG001|Overall Study|Protocol Violation|3|||
146510232|NCT01711619|528371973|FG000|Overall Study|Adverse Event|2|||
146510233|NCT01711619|528371974|FG001|Overall Study|Adverse Event|0|||
146510234|NCT01711619|528371973|FG000|Overall Study|Lost to Follow-up|1|||
146510235|NCT01711619|528371974|FG001|Overall Study|Lost to Follow-up|0|||
146510236|NCT00503997|528371982|FG000|Overall Study|disease progression|1|||
146510237|NCT00503997|528371982|FG000|Overall Study|Adverse Event|5|||
146510238|NCT00503997|528371982|FG000|Overall Study|Death|1|||
146510239|NCT00503997|528371982|FG000|Overall Study|Withdrawal by Subject|1|||
146510240|NCT00980018|528371987|FG000|Overall Study|Adverse Event|8|||
146510241|NCT00980018|528371987|FG000|Overall Study|Patient withdrew consent|3|||
146510242|NCT00980018|528371987|FG000|Overall Study|Lost to Follow-up|1|||
146510243|NCT00087126|528371991|FG000|Overall Study|Ineligible - second primary|1|||
146510244|NCT00087126|528371991|FG000|Overall Study|Never treated|1|||
146510245|NCT01432275|528371992|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
146510246|NCT01432275|528371993|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
146510247|NCT01432275|528371992|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
146510248|NCT01432275|528371993|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
146510249|NCT01432275|528371992|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
146510250|NCT01432275|528371993|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
146510251|NCT01432275|528371992|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
146510252|NCT01432275|528371993|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
146510253|NCT01432275|528371992|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
146510254|NCT01432275|528371993|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
146510255|NCT01432275|528371992|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
146510256|NCT01432275|528371993|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
146510257|NCT01432275|528371992|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
146510258|NCT01432275|528371993|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
146510259|NCT01432275|528371992|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
146510260|NCT01432275|528371993|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
146510261|NCT01432275|528371992|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
146510262|NCT01432275|528371993|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
146510263|NCT01935700|528372000|FG000|Overall Study|Withdrawal by Subject|1|||
146510264|NCT01935700|528372001|FG001|Overall Study|Withdrawal by Subject|0|||
146510265|NCT01935700|528372000|FG000|Overall Study|Physician Decision|4|||
146510266|NCT01935700|528372001|FG001|Overall Study|Physician Decision|0|||
146510267|NCT00772005|528372002|FG000|Overall Study|Adverse Event|9|||
146510268|NCT00772005|528372003|FG001|Overall Study|Adverse Event|14|||
146510269|NCT00772005|528372004|FG002|Overall Study|Adverse Event|10|||
146510270|NCT00772005|528372005|FG003|Overall Study|Adverse Event|13|||
146510271|NCT00772005|528372002|FG000|Overall Study|Lack of Efficacy|0|||
146510272|NCT00772005|528372003|FG001|Overall Study|Lack of Efficacy|1|||
146510273|NCT00772005|528372004|FG002|Overall Study|Lack of Efficacy|0|||
146510274|NCT00772005|528372005|FG003|Overall Study|Lack of Efficacy|0|||
146510275|NCT00772005|528372002|FG000|Overall Study|Withdrawal by Subject|3|||
146510276|NCT00772005|528372003|FG001|Overall Study|Withdrawal by Subject|7|||
146510277|NCT00772005|528372004|FG002|Overall Study|Withdrawal by Subject|10|||
146510278|NCT00772005|528372005|FG003|Overall Study|Withdrawal by Subject|2|||
146510279|NCT00772005|528372002|FG000|Overall Study|Protocol Violation|2|||
146510280|NCT00772005|528372003|FG001|Overall Study|Protocol Violation|4|||
146510281|NCT00772005|528372004|FG002|Overall Study|Protocol Violation|1|||
146510282|NCT00772005|528372005|FG003|Overall Study|Protocol Violation|6|||
146510283|NCT00772005|528372002|FG000|Overall Study|Lost to Follow-up|7|||
146510284|NCT00772005|528372003|FG001|Overall Study|Lost to Follow-up|3|||
146510285|NCT00772005|528372004|FG002|Overall Study|Lost to Follow-up|6|||
146510286|NCT00772005|528372005|FG003|Overall Study|Lost to Follow-up|3|||
146510287|NCT00772005|528372002|FG000|Overall Study|Non-compliance with study procedures|1|||
146510288|NCT00772005|528372003|FG001|Overall Study|Non-compliance with study procedures|1|||
146510289|NCT00772005|528372004|FG002|Overall Study|Non-compliance with study procedures|0|||
146510290|NCT00772005|528372005|FG003|Overall Study|Non-compliance with study procedures|1|||
146743850|NCT03012061|529233818|FG002|Overall Study|Lack of Efficacy|0|||
146510291|NCT00772005|528372002|FG000|Overall Study|Non-compliance with drug administration|3|||
146510292|NCT00772005|528372003|FG001|Overall Study|Non-compliance with drug administration|0|||
146743851|NCT03012061|529233816|FG000|Overall Study|Adverse Event|2|||
146743852|NCT03012061|529233817|FG001|Overall Study|Adverse Event|0|||
146743853|NCT03012061|529233818|FG002|Overall Study|Adverse Event|0|||
146743854|NCT04152343|529233819|FG000|Overall Study|Transplanted|5|||
146510293|NCT00772005|528372004|FG002|Overall Study|Non-compliance with drug administration|1|||
146510294|NCT00772005|528372005|FG003|Overall Study|Non-compliance with drug administration|1|||
146510295|NCT01440569|528372006|FG000|Main Study|Enrolled but not treated|1|||
146510296|NCT01440569|528372007|FG001|Main Study|Enrolled but not treated|0|||
146510297|NCT01440569|528372006|FG000|Main Study|Adverse Event|9|||
146510298|NCT01440569|528372007|FG001|Main Study|Adverse Event|0|||
146510299|NCT01440569|528372006|FG000|Main Study|Pregnancy|1|||
146510300|NCT01440569|528372007|FG001|Main Study|Pregnancy|0|||
146743855|NCT04152343|529233819|FG000|Overall Study|Death|20|||
146510301|NCT01440569|528372006|FG000|Main Study|Investigator's Discretion|1|||
146510302|NCT01440569|528372007|FG001|Main Study|Investigator's Discretion|1|||
146510303|NCT01440569|528372006|FG000|Main Study|Withdrew Consent|7|||
146510304|NCT01440569|528372007|FG001|Main Study|Withdrew Consent|1|||
146510305|NCT01440569|528372006|FG000|Main Study|Lost to Follow-up|13|||
146510306|NCT01440569|528372007|FG001|Main Study|Lost to Follow-up|2|||
146510307|NCT01440569|528372006|FG000|Main Study|Subject Non-Compliance|3|||
146743856|NCT04152343|529233819|FG000|Overall Study|Lost to Follow-up|3|||
146743857|NCT00591864|529233820|FG000|Overall Study|Incomplete Imaging|5|||
146743858|NCT02459093|529233825|FG000|Overall Study|Protocol Violation|6|||
146743859|NCT02459093|529233826|FG001|Overall Study|Protocol Violation|11|||
146743860|NCT02459093|529233825|FG000|Overall Study|Lost to Follow-up|6|||
146743861|NCT02459093|529233826|FG001|Overall Study|Lost to Follow-up|7|||
146743862|NCT00118092|529233827|FG000|Overall Study|Withdrawal by Subject|1|||
146743863|NCT00118092|529233827|FG000|Overall Study|Protocol Violation|1|||
146743864|NCT01965938|529233828|FG000|Overall Study|Withdrawal by Subject|1|||
146743865|NCT01965938|529233829|FG001|Overall Study|Withdrawal by Subject|0|||
146743866|NCT01164228|529233830|FG000|Overall Study|Progression|24|||
146743867|NCT01164228|529233831|FG001|Overall Study|Progression|25|||
146743868|NCT01164228|529233830|FG000|Overall Study|Adverse Event|13|||
146743869|NCT01164228|529233831|FG001|Overall Study|Adverse Event|7|||
146743870|NCT01164228|529233830|FG000|Overall Study|Death|1|||
146743871|NCT01164228|529233831|FG001|Overall Study|Death|1|||
146743872|NCT01164228|529233830|FG000|Overall Study|Withdrawal by Subject|2|||
146743873|NCT01164228|529233831|FG001|Overall Study|Withdrawal by Subject|0|||
146743874|NCT01164228|529233830|FG000|Overall Study|Physician Decision|1|||
146743875|NCT01164228|529233831|FG001|Overall Study|Physician Decision|2|||
146743876|NCT01164228|529233830|FG000|Overall Study|Symptomatic deterioration|1|||
146743877|NCT01164228|529233831|FG001|Overall Study|Symptomatic deterioration|0|||
146743878|NCT01164228|529233830|FG000|Overall Study|Never started treatment|1|||
146743879|NCT01164228|529233831|FG001|Overall Study|Never started treatment|3|||
146743880|NCT01164228|529233830|FG000|Overall Study|Ineligible|1|||
146743881|NCT01164228|529233831|FG001|Overall Study|Ineligible|0|||
146743882|NCT02090634|529233832|FG000|Overall Study|Lost to Follow-up|0|||
146743883|NCT02090634|529233833|FG001|Overall Study|Lost to Follow-up|1|||
146743884|NCT02090634|529233832|FG000|Overall Study|Death|0|||
146743885|NCT02090634|529233833|FG001|Overall Study|Death|1|||
146743886|NCT02090634|529233832|FG000|Overall Study|Protocol Violation|3|||
146743887|NCT02090634|529233833|FG001|Overall Study|Protocol Violation|1|||
146851166|NCT00852540|529624123|FG000|Overall Study|Did Not Receive Study Drug|3|||
146851167|NCT00852540|529624124|FG001|Overall Study|Did Not Receive Study Drug|3|||
146851168|NCT01119105|529624125|FG000|Overall Study|Withdrawal by Subject|1|||
146851169|NCT01119105|529624126|FG001|Overall Study|Withdrawal by Subject|1|||
146851170|NCT01119105|529624127|FG002|Overall Study|Withdrawal by Subject|1|||
146851171|NCT01119105|529624125|FG000|Overall Study|Lost to Follow-up|0|||
146851172|NCT01119105|529624126|FG001|Overall Study|Lost to Follow-up|2|||
146851173|NCT01119105|529624127|FG002|Overall Study|Lost to Follow-up|5|||
146851174|NCT01119105|529624125|FG000|Overall Study|Adverse Event|1|||
146851175|NCT01119105|529624126|FG001|Overall Study|Adverse Event|0|||
146851176|NCT01119105|529624127|FG002|Overall Study|Adverse Event|1|||
146851177|NCT01119105|529624125|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
146851178|NCT01119105|529624126|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
146851179|NCT01119105|529624127|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
146851180|NCT01119105|529624125|FG000|Overall Study|Other|1|||
146851181|NCT01119105|529624126|FG001|Overall Study|Other|1|||
146851182|NCT01119105|529624127|FG002|Overall Study|Other|0|||
146851183|NCT01639495|529624128|FG000|Overall Study|Lost to Follow-up|6|||
146851184|NCT01639495|529624128|FG000|Overall Study|Consented but didn't have study catheter|4|||
146851185|NCT01639495|529624128|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
146851186|NCT01639495|529624128|FG000|Overall Study|No radiofrequency energy applied|2|||
146851187|NCT04214600|529624131|FG000|Overall Study|Lost to Follow-up|9|||
146851188|NCT04214600|529624132|FG001|Overall Study|Lost to Follow-up|14|||
146851189|NCT01635920|529624140|FG000|Overall Study|Adverse Event|1|||
146851190|NCT01635920|529624141|FG001|Overall Study|Adverse Event|0|||
146851191|NCT01635920|529624140|FG000|Overall Study|Lost to Follow-up|0|||
146851192|NCT01635920|529624141|FG001|Overall Study|Lost to Follow-up|1|||
146851193|NCT01635920|529624140|FG000|Overall Study|Subject decision|2|||
146851194|NCT01635920|529624141|FG001|Overall Study|Subject decision|0|||
146851195|NCT01664598|529624142|FG000|Overall Study|Sponsor Decision|1|||
146851196|NCT01664598|529624142|FG000|Overall Study|Withdrawal of Informed Consent|4|||
146851197|NCT01664598|529624142|FG000|Overall Study|Adverse Event|1|||
146851198|NCT00686725|529624143|FG000|Overall Study|Adverse Event|1|||
146851199|NCT00686725|529624144|FG001|Overall Study|Adverse Event|1|||
146851200|NCT00686725|529624143|FG000|Overall Study|Progressive Disease|17|||
146851201|NCT00686725|529624144|FG001|Overall Study|Progressive Disease|23|||
146851202|NCT00686725|529624143|FG000|Overall Study|Lost to Follow-up|7|||
146851203|NCT00686725|529624144|FG001|Overall Study|Lost to Follow-up|5|||
146851204|NCT00686725|529624143|FG000|Overall Study|Death|6|||
146851205|NCT00686725|529624144|FG001|Overall Study|Death|3|||
146851206|NCT00686725|529624143|FG000|Overall Study|Withdrawal by Subject|13|||
146851207|NCT00686725|529624144|FG001|Overall Study|Withdrawal by Subject|4|||
146743888|NCT02090634|529233832|FG000|Overall Study|Adverse Event|2|||
146510308|NCT01440569|528372007|FG001|Main Study|Subject Non-Compliance|0|||
146510309|NCT01440569|528372006|FG000|Main Study|Protocol Violation|1|||
146510310|NCT01440569|528372007|FG001|Main Study|Protocol Violation|0|||
146510311|NCT01440569|528372006|FG000|Open-Label Rollover Phase|Adverse Event|3|||
146510312|NCT01440569|528372007|FG001|Open-Label Rollover Phase|Adverse Event|0|||
146510313|NCT01440569|528372006|FG000|Open-Label Rollover Phase|Pregnancy|1|||
146510314|NCT01440569|528372007|FG001|Open-Label Rollover Phase|Pregnancy|0|||
146510315|NCT01440569|528372006|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
146510316|NCT01440569|528372007|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
146510317|NCT01440569|528372006|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
146510318|NCT01440569|528372007|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
146510319|NCT01440569|528372006|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
146510320|NCT01440569|528372007|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
146510321|NCT01440569|528372006|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
146510322|NCT01440569|528372007|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
146510323|NCT01440569|528372006|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
146510324|NCT01440569|528372007|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
146510325|NCT02584959|528372020|FG000|Period 1|Withdrawn from study|3|||
146510326|NCT02584959|528372021|FG001|Period 1|Withdrawn from study|4|||
146510327|NCT02584959|528372022|FG002|Period 1|Withdrawn from study|0|||
146510328|NCT02584959|528372020|FG000|Period 2|Withdrawn from study|6|||
146510329|NCT02584959|528372021|FG001|Period 2|Withdrawn from study|1|||
146510330|NCT02584959|528372022|FG002|Period 2|Withdrawn from study|2|||
146510331|NCT01162122|528372025|FG000|Overall Study|Withdrawal by Subject|52|||
146510332|NCT01162122|528372026|FG001|Overall Study|Withdrawal by Subject|43|||
146510333|NCT01162122|528372025|FG000|Overall Study|Lost to Follow-up|73|||
146510334|NCT01162122|528372026|FG001|Overall Study|Lost to Follow-up|91|||
146510335|NCT01162122|528372025|FG000|Overall Study|Adverse Event|3|||
146510336|NCT01162122|528372026|FG001|Overall Study|Adverse Event|2|||
146510337|NCT01162122|528372025|FG000|Overall Study|Death|51|||
146510338|NCT01162122|528372026|FG001|Overall Study|Death|46|||
146510339|NCT01162122|528372025|FG000|Overall Study|Protocol Violation|2|||
146510340|NCT01162122|528372026|FG001|Overall Study|Protocol Violation|2|||
146510341|NCT01162122|528372025|FG000|Overall Study|Inappropriate enrollment|5|||
146510342|NCT01162122|528372026|FG001|Overall Study|Inappropriate enrollment|4|||
146510343|NCT01162122|528372025|FG000|Overall Study|Administrative reason|1|||
146510344|NCT01162122|528372026|FG001|Overall Study|Administrative reason|1|||
146510345|NCT01162122|528372025|FG000|Overall Study|Unable to classify|3|||
146510346|NCT01162122|528372026|FG001|Overall Study|Unable to classify|7|||
146510347|NCT01162122|528372025|FG000|Overall Study|Missing primary reason|1|||
146510348|NCT01162122|528372026|FG001|Overall Study|Missing primary reason|0|||
146510349|NCT00483704|528372036|FG000|Randomization|Withdrawal by Subject|19|||
146510350|NCT00483704|528372037|FG001|Randomization|Withdrawal by Subject|28|||
146510351|NCT00483704|528372038|FG002|Randomization|Withdrawal by Subject|18|||
146510352|NCT00483704|528372036|FG000|Randomization|Protocol Violation|14|||
146510353|NCT00483704|528372037|FG001|Randomization|Protocol Violation|25|||
146510354|NCT00483704|528372038|FG002|Randomization|Protocol Violation|22|||
146510355|NCT00483704|528372036|FG000|Randomization|Lost to Follow-up|14|||
146510356|NCT00483704|528372037|FG001|Randomization|Lost to Follow-up|14|||
146510357|NCT00483704|528372038|FG002|Randomization|Lost to Follow-up|19|||
146510358|NCT00483704|528372036|FG000|Randomization|Pregnancy|1|||
146510359|NCT00483704|528372037|FG001|Randomization|Pregnancy|0|||
146510360|NCT00483704|528372038|FG002|Randomization|Pregnancy|0|||
146510361|NCT00483704|528372036|FG000|Randomization|Physician Decision|2|||
146510362|NCT00483704|528372037|FG001|Randomization|Physician Decision|4|||
146510363|NCT00483704|528372038|FG002|Randomization|Physician Decision|0|||
146510364|NCT00483704|528372036|FG000|Randomization|Progressive disease|0|||
146510365|NCT00483704|528372037|FG001|Randomization|Progressive disease|0|||
146510366|NCT00483704|528372038|FG002|Randomization|Progressive disease|1|||
146510367|NCT00483704|528372036|FG000|Randomization|Lack of qualifying migraines|21|||
146510368|NCT00483704|528372037|FG001|Randomization|Lack of qualifying migraines|25|||
146510369|NCT00483704|528372038|FG002|Randomization|Lack of qualifying migraines|31|||
146510370|NCT00483704|528372036|FG000|Treatment|Lack of qualifying migraines|101|||
146510371|NCT00483704|528372037|FG001|Treatment|Lack of qualifying migraines|99|||
146510372|NCT00483704|528372038|FG002|Treatment|Lack of qualifying migraines|116|||
146510373|NCT00483704|528372036|FG000|Treatment|Adverse Event|3|||
146510374|NCT00483704|528372037|FG001|Treatment|Adverse Event|5|||
146510375|NCT00483704|528372038|FG002|Treatment|Adverse Event|4|||
146510376|NCT00483704|528372036|FG000|Treatment|Withdrawal by Subject|16|||
146510377|NCT00483704|528372037|FG001|Treatment|Withdrawal by Subject|12|||
146510378|NCT00483704|528372038|FG002|Treatment|Withdrawal by Subject|21|||
146510379|NCT00483704|528372036|FG000|Treatment|Protocol Violation|6|||
146510380|NCT00483704|528372037|FG001|Treatment|Protocol Violation|3|||
146510381|NCT00483704|528372038|FG002|Treatment|Protocol Violation|5|||
146510382|NCT00483704|528372036|FG000|Treatment|Lost to Follow-up|2|||
146510383|NCT00483704|528372037|FG001|Treatment|Lost to Follow-up|7|||
146510384|NCT00483704|528372038|FG002|Treatment|Lost to Follow-up|5|||
146510385|NCT00483704|528372036|FG000|Treatment|Lack of Efficacy|1|||
146510386|NCT00483704|528372037|FG001|Treatment|Lack of Efficacy|1|||
146510387|NCT00483704|528372038|FG002|Treatment|Lack of Efficacy|1|||
146510388|NCT00483704|528372036|FG000|Treatment|Pregnancy|0|||
146510389|NCT00483704|528372037|FG001|Treatment|Pregnancy|1|||
146510390|NCT00483704|528372038|FG002|Treatment|Pregnancy|0|||
146510391|NCT00483704|528372036|FG000|Treatment|Physician Decision|0|||
146510392|NCT00483704|528372037|FG001|Treatment|Physician Decision|1|||
146510393|NCT00483704|528372038|FG002|Treatment|Physician Decision|4|||
146743889|NCT02090634|529233833|FG001|Overall Study|Adverse Event|0|||
146743890|NCT03757234|529233834|FG000|Overall Study|Adverse Event|0|||
146743891|NCT03757234|529233835|FG001|Overall Study|Adverse Event|0|||
146743892|NCT03757234|529233836|FG002|Overall Study|Adverse Event|0|||
146743893|NCT03757234|529233837|FG003|Overall Study|Adverse Event|0|||
146743894|NCT03757234|529233838|FG004|Overall Study|Adverse Event|1|||
146743895|NCT03757234|529233834|FG000|Overall Study|Lost to Follow-up|1|||
146743896|NCT03757234|529233835|FG001|Overall Study|Lost to Follow-up|0|||
146743897|NCT03757234|529233836|FG002|Overall Study|Lost to Follow-up|0|||
146743898|NCT03757234|529233837|FG003|Overall Study|Lost to Follow-up|0|||
146743899|NCT03757234|529233838|FG004|Overall Study|Lost to Follow-up|1|||
146743900|NCT03757234|529233834|FG000|Overall Study|Withdrawal by Subject|1|||
146743901|NCT03757234|529233835|FG001|Overall Study|Withdrawal by Subject|1|||
146743902|NCT03757234|529233836|FG002|Overall Study|Withdrawal by Subject|0|||
146743903|NCT03757234|529233837|FG003|Overall Study|Withdrawal by Subject|1|||
146743904|NCT03757234|529233838|FG004|Overall Study|Withdrawal by Subject|2|||
146743905|NCT03757234|529233834|FG000|Overall Study|Other|1|||
146743906|NCT03757234|529233835|FG001|Overall Study|Other|1|||
146743907|NCT03757234|529233836|FG002|Overall Study|Other|0|||
146743908|NCT03757234|529233837|FG003|Overall Study|Other|0|||
146743909|NCT03757234|529233838|FG004|Overall Study|Other|0|||
146743910|NCT02736968|529233844|FG000|Overall Study|Lost to Follow-up|0|||
146743911|NCT02736968|529233845|FG001|Overall Study|Lost to Follow-up|0|||
146743912|NCT02736968|529233846|FG002|Overall Study|Lost to Follow-up|0|||
146743913|NCT02736968|529233847|FG003|Overall Study|Lost to Follow-up|0|||
146510394|NCT03191864|528372040|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
146510395|NCT03191864|528372041|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
146510396|NCT03191864|528372042|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
146510397|NCT03191864|528372043|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
146510398|NCT03191864|528372044|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
146510399|NCT03191864|528372045|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
146510400|NCT03191864|528372040|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
146743914|NCT02736968|529233848|FG004|Overall Study|Lost to Follow-up|0|||
146510401|NCT03191864|528372041|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
146510402|NCT03191864|528372042|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
146743915|NCT02736968|529233849|FG005|Overall Study|Lost to Follow-up|0|||
146510403|NCT03191864|528372043|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
146510404|NCT03191864|528372044|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
146510405|NCT03191864|528372045|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
146510406|NCT03191864|528372040|FG000|Baseline Symptom Assessment|Adverse Event|0|||
146510407|NCT03191864|528372041|FG001|Baseline Symptom Assessment|Adverse Event|0|||
146510408|NCT03191864|528372042|FG002|Baseline Symptom Assessment|Adverse Event|0|||
146510409|NCT03191864|528372043|FG003|Baseline Symptom Assessment|Adverse Event|0|||
146510410|NCT03191864|528372044|FG004|Baseline Symptom Assessment|Adverse Event|0|||
146510411|NCT03191864|528372045|FG005|Baseline Symptom Assessment|Adverse Event|2|||
146510412|NCT03191864|528372040|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
146510413|NCT03191864|528372041|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
146510414|NCT03191864|528372042|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
146510415|NCT03191864|528372043|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
146510416|NCT03191864|528372044|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
146510417|NCT03191864|528372045|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
146510418|NCT03191864|528372040|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
146510419|NCT03191864|528372041|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
146510420|NCT03191864|528372042|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
146510421|NCT03191864|528372043|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
146510422|NCT03191864|528372044|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
146510423|NCT03191864|528372045|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
146510424|NCT03191864|528372040|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
146510425|NCT03191864|528372041|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
146510426|NCT03191864|528372042|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
146510427|NCT03191864|528372043|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
146510428|NCT03191864|528372044|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
146510429|NCT03191864|528372045|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
146510430|NCT03191864|528372040|FG000|Part 1 - Induction|Adverse Event|0|||
146510431|NCT03191864|528372041|FG001|Part 1 - Induction|Adverse Event|2|||
146510432|NCT03191864|528372042|FG002|Part 1 - Induction|Adverse Event|0|||
146510433|NCT03191864|528372043|FG003|Part 1 - Induction|Adverse Event|1|||
146510434|NCT03191864|528372044|FG004|Part 1 - Induction|Adverse Event|0|||
146510435|NCT03191864|528372045|FG005|Part 1 - Induction|Adverse Event|2|||
146510436|NCT03191864|528372040|FG000|Part 1 - Induction|Randomized but never dosed|0|||
146510437|NCT03191864|528372041|FG001|Part 1 - Induction|Randomized but never dosed|0|||
146510438|NCT03191864|528372042|FG002|Part 1 - Induction|Randomized but never dosed|1|||
146510439|NCT03191864|528372043|FG003|Part 1 - Induction|Randomized but never dosed|0|||
146510440|NCT03191864|528372044|FG004|Part 1 - Induction|Randomized but never dosed|0|||
146510441|NCT03191864|528372045|FG005|Part 1 - Induction|Randomized but never dosed|0|||
146510442|NCT03191864|528372040|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
146510443|NCT03191864|528372041|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
146510444|NCT03191864|528372042|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
146510445|NCT03191864|528372043|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
146510446|NCT03191864|528372044|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
146510447|NCT03191864|528372045|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
146510448|NCT03191864|528372040|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
146510449|NCT03191864|528372041|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
146510450|NCT03191864|528372042|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
146510451|NCT03191864|528372043|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
146510452|NCT03191864|528372044|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
146510453|NCT03191864|528372045|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
146510454|NCT03191864|528372040|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
146510455|NCT03191864|528372041|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
146510456|NCT03191864|528372042|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
146510457|NCT03191864|528372043|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
146510458|NCT03191864|528372044|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
146510459|NCT03191864|528372045|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
146510460|NCT03191864|528372040|FG000|Part 2 - Maintenance|Physician Decision|1|||
146510461|NCT03191864|528372041|FG001|Part 2 - Maintenance|Physician Decision|0|||
146510462|NCT03191864|528372042|FG002|Part 2 - Maintenance|Physician Decision|0|||
146510463|NCT03191864|528372043|FG003|Part 2 - Maintenance|Physician Decision|0|||
146510464|NCT03191864|528372044|FG004|Part 2 - Maintenance|Physician Decision|0|||
146510465|NCT03191864|528372045|FG005|Part 2 - Maintenance|Physician Decision|0|||
146510466|NCT03191864|528372040|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
146510467|NCT03191864|528372041|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
146510468|NCT03191864|528372042|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
146510469|NCT03191864|528372043|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
146510470|NCT03191864|528372044|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
146510471|NCT03191864|528372045|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
146510472|NCT03191864|528372040|FG000|Part 2 - Maintenance|Adverse Event|0|||
146510473|NCT03191864|528372041|FG001|Part 2 - Maintenance|Adverse Event|0|||
146510474|NCT03191864|528372042|FG002|Part 2 - Maintenance|Adverse Event|0|||
146510475|NCT03191864|528372043|FG003|Part 2 - Maintenance|Adverse Event|0|||
146510476|NCT03191864|528372044|FG004|Part 2 - Maintenance|Adverse Event|1|||
146510477|NCT03191864|528372045|FG005|Part 2 - Maintenance|Adverse Event|0|||
146510478|NCT03191864|528372040|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
146510479|NCT03191864|528372041|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
146510480|NCT03191864|528372042|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
146510481|NCT03191864|528372043|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
146510482|NCT03191864|528372044|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
146510483|NCT03191864|528372045|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
146510484|NCT03191864|528372040|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
146510485|NCT03191864|528372041|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
146510486|NCT03191864|528372042|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
146510487|NCT03191864|528372043|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
146510488|NCT03191864|528372044|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
146510489|NCT03191864|528372045|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
146510490|NCT02342548|528372046|FG000|Overall Study|Adverse Event|12|||
146510491|NCT02342548|528372047|FG001|Overall Study|Adverse Event|17|||
146510492|NCT02342548|528372048|FG002|Overall Study|Adverse Event|13|||
146510493|NCT02342548|528372046|FG000|Overall Study|Lost to Follow-up|0|||
146510494|NCT02342548|528372047|FG001|Overall Study|Lost to Follow-up|1|||
146510495|NCT02342548|528372048|FG002|Overall Study|Lost to Follow-up|0|||
146510496|NCT02342548|528372046|FG000|Overall Study|Study terminated by sponsor|20|||
146510497|NCT02342548|528372047|FG001|Overall Study|Study terminated by sponsor|39|||
146510498|NCT02342548|528372048|FG002|Overall Study|Study terminated by sponsor|25|||
146510499|NCT02342548|528372046|FG000|Overall Study|Protocol Violation|0|||
146510500|NCT02342548|528372047|FG001|Overall Study|Protocol Violation|1|||
146510501|NCT02342548|528372048|FG002|Overall Study|Protocol Violation|0|||
146510502|NCT02342548|528372046|FG000|Overall Study|Withdrawal by Subject|1|||
146510503|NCT02342548|528372047|FG001|Overall Study|Withdrawal by Subject|3|||
146510504|NCT02342548|528372048|FG002|Overall Study|Withdrawal by Subject|4|||
146510505|NCT02342548|528372046|FG000|Overall Study|Other|1|||
146510506|NCT02342548|528372047|FG001|Overall Study|Other|1|||
146510507|NCT02342548|528372048|FG002|Overall Study|Other|1|||
146510508|NCT02987972|528372049|FG000|Overall Study|Adverse Event|1|||
146510509|NCT02987972|528372050|FG001|Overall Study|Adverse Event|1|||
146510510|NCT02987972|528372051|FG002|Overall Study|Adverse Event|0|||
146510511|NCT02987972|528372049|FG000|Overall Study|Death|1|||
146510512|NCT02987972|528372050|FG001|Overall Study|Death|0|||
146510513|NCT02987972|528372051|FG002|Overall Study|Death|0|||
146510514|NCT02987972|528372049|FG000|Overall Study|Lack of Efficacy|9|||
146510515|NCT02987972|528372050|FG001|Overall Study|Lack of Efficacy|12|||
146510516|NCT02987972|528372051|FG002|Overall Study|Lack of Efficacy|12|||
146510517|NCT02987972|528372049|FG000|Overall Study|Lost to Follow-up|7|||
146510518|NCT02987972|528372050|FG001|Overall Study|Lost to Follow-up|8|||
146510519|NCT02987972|528372051|FG002|Overall Study|Lost to Follow-up|4|||
146510520|NCT02987972|528372049|FG000|Overall Study|Physician Decision|1|||
146510521|NCT02987972|528372050|FG001|Overall Study|Physician Decision|6|||
146510522|NCT02987972|528372051|FG002|Overall Study|Physician Decision|0|||
146510523|NCT02987972|528372049|FG000|Overall Study|Protocol Violation|2|||
146510524|NCT02987972|528372050|FG001|Overall Study|Protocol Violation|1|||
146510525|NCT02987972|528372051|FG002|Overall Study|Protocol Violation|5|||
146510526|NCT02987972|528372049|FG000|Overall Study|Withdrawal by Subject|22|||
146510527|NCT02987972|528372050|FG001|Overall Study|Withdrawal by Subject|17|||
146510528|NCT02987972|528372051|FG002|Overall Study|Withdrawal by Subject|21|||
146510529|NCT03800836|528372052|FG000|Overall Study|Other|2|||
146510530|NCT03800836|528372053|FG001|Overall Study|Other|1|||
146510531|NCT03800836|528372054|FG002|Overall Study|Other|0|||
146510532|NCT03800836|528372055|FG003|Overall Study|Other|2|||
146510533|NCT03800836|528372056|FG004|Overall Study|Other|0|||
146510534|NCT03800836|528372057|FG005|Overall Study|Other|1|||
146510535|NCT03800836|528372052|FG000|Overall Study|Lost to Follow-up|2|||
146510536|NCT03800836|528372053|FG001|Overall Study|Lost to Follow-up|0|||
146510537|NCT03800836|528372054|FG002|Overall Study|Lost to Follow-up|1|||
146510538|NCT03800836|528372055|FG003|Overall Study|Lost to Follow-up|1|||
146510539|NCT03800836|528372056|FG004|Overall Study|Lost to Follow-up|3|||
146510540|NCT03800836|528372057|FG005|Overall Study|Lost to Follow-up|0|||
146510541|NCT03800836|528372052|FG000|Overall Study|Withdrawal by Subject|1|||
146510542|NCT03800836|528372053|FG001|Overall Study|Withdrawal by Subject|0|||
146510543|NCT03800836|528372054|FG002|Overall Study|Withdrawal by Subject|0|||
146510544|NCT03800836|528372055|FG003|Overall Study|Withdrawal by Subject|0|||
146510545|NCT03800836|528372056|FG004|Overall Study|Withdrawal by Subject|0|||
146510546|NCT03800836|528372057|FG005|Overall Study|Withdrawal by Subject|0|||
146510547|NCT03800836|528372052|FG000|Overall Study|Physician Decision|31|||
146510548|NCT03800836|528372053|FG001|Overall Study|Physician Decision|3|||
146510549|NCT03800836|528372054|FG002|Overall Study|Physician Decision|6|||
146510550|NCT03800836|528372055|FG003|Overall Study|Physician Decision|4|||
146510551|NCT03800836|528372056|FG004|Overall Study|Physician Decision|4|||
146510552|NCT03800836|528372057|FG005|Overall Study|Physician Decision|5|||
146510553|NCT03800836|528372052|FG000|Overall Study|Death|34|||
146510554|NCT03800836|528372053|FG001|Overall Study|Death|16|||
146510555|NCT03800836|528372054|FG002|Overall Study|Death|5|||
146510556|NCT03800836|528372055|FG003|Overall Study|Death|5|||
146510557|NCT03800836|528372056|FG004|Overall Study|Death|10|||
146510558|NCT03800836|528372057|FG005|Overall Study|Death|0|||
146510559|NCT03800836|528372052|FG000|Overall Study|Symptomatic Deterioration|1|||
146510560|NCT03800836|528372053|FG001|Overall Study|Symptomatic Deterioration|0|||
146510561|NCT03800836|528372054|FG002|Overall Study|Symptomatic Deterioration|1|||
146510562|NCT03800836|528372055|FG003|Overall Study|Symptomatic Deterioration|0|||
146510563|NCT03800836|528372056|FG004|Overall Study|Symptomatic Deterioration|0|||
146510564|NCT03800836|528372057|FG005|Overall Study|Symptomatic Deterioration|0|||
146510565|NCT03309696|528374018|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
146510566|NCT03309696|528374019|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
146510567|NCT03309696|528374020|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
146510568|NCT03309696|528374021|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
146510569|NCT00078949|528374022|FG000|Overall Study|No treated|4|||
146510570|NCT00078949|528374023|FG001|Overall Study|No treated|5|||
146510571|NCT00078949|528374024|FG002|Overall Study|No treated|3|||
146510572|NCT00078949|528374025|FG003|Overall Study|No treated|3|||
146510573|NCT00577005|528374026|FG000|Overall Study|Lost to Follow-up|3|||
146510574|NCT00577005|528374027|FG001|Overall Study|Lost to Follow-up|2|||
146510575|NCT00577005|528374026|FG000|Overall Study|Withdrawal by Subject|2|||
146510576|NCT00577005|528374027|FG001|Overall Study|Withdrawal by Subject|1|||
146743916|NCT02736968|529233850|FG006|Overall Study|Lost to Follow-up|5|||
146510577|NCT01004432|528374028|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
146510578|NCT01004432|528374029|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
146510579|NCT01004432|528374030|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
146510580|NCT01004432|528374031|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
146510581|NCT01004432|528374032|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
146510582|NCT01004432|528374028|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
146510583|NCT01004432|528374029|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
146510584|NCT01004432|528374030|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
146510585|NCT01004432|528374031|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
146510586|NCT01004432|528374032|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
146510587|NCT01004432|528374028|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
146510588|NCT01004432|528374029|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
146510589|NCT01004432|528374030|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
146510590|NCT01004432|528374031|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
146510591|NCT01004432|528374032|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
146510592|NCT01004432|528374028|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
146510593|NCT01004432|528374029|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
146510594|NCT01004432|528374030|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
146510595|NCT01004432|528374031|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
146510596|NCT01004432|528374032|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
146510597|NCT01004432|528374028|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
146510598|NCT01004432|528374029|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
146510599|NCT01004432|528374030|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
146510600|NCT01004432|528374031|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
146510601|NCT01004432|528374032|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
146510602|NCT01004432|528374028|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
146510603|NCT01004432|528374029|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
146510604|NCT01004432|528374030|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
146510605|NCT01004432|528374031|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
146510606|NCT01004432|528374032|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
146510607|NCT01004432|528374028|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
146510608|NCT01004432|528374029|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
146510609|NCT01004432|528374030|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
146510610|NCT01004432|528374031|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
146510611|NCT01004432|528374032|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
146510612|NCT01004432|528374028|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
146510613|NCT01004432|528374029|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
146510614|NCT01004432|528374030|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
146510615|NCT01004432|528374031|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
146510616|NCT01004432|528374032|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
146510617|NCT01004432|528374028|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
146510618|NCT01004432|528374029|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
146510619|NCT01004432|528374030|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
146510620|NCT01004432|528374031|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
146510621|NCT01004432|528374032|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
146510622|NCT01004432|528374028|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
146510623|NCT01004432|528374029|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
146510624|NCT01004432|528374030|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
146510625|NCT01004432|528374031|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
146510626|NCT01004432|528374032|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
146510627|NCT01004432|528374028|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
146510628|NCT01004432|528374029|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
146510629|NCT01004432|528374030|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
146510630|NCT01004432|528374031|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
146510631|NCT01004432|528374032|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
146510632|NCT01004432|528374028|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
146510633|NCT01004432|528374029|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
146510634|NCT01004432|528374030|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
146510635|NCT01004432|528374031|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
146510636|NCT01004432|528374032|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
146510637|NCT01004432|528374028|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
146510638|NCT01004432|528374029|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
146510639|NCT01004432|528374030|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
146510640|NCT01004432|528374031|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
146510641|NCT01004432|528374032|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
146510642|NCT01004432|528374028|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
146510643|NCT01004432|528374029|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
146510644|NCT01004432|528374030|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
146510645|NCT01004432|528374031|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
146510646|NCT01004432|528374032|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
146510647|NCT01004432|528374028|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
146510648|NCT01004432|528374029|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
146510649|NCT01004432|528374030|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
146510650|NCT01004432|528374031|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
146510651|NCT01004432|528374032|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
146510652|NCT04829331|528374033|FG000|Overall Study|Lost to Follow-up|1|||
146510653|NCT04829331|528374034|FG001|Overall Study|Lost to Follow-up|0|||
146510654|NCT02604550|528374037|FG000|Overall Study|Lost to Follow-up|7|||
146510655|NCT02604550|528374038|FG001|Overall Study|Lost to Follow-up|6|||
146510656|NCT02604550|528374037|FG000|Overall Study|Withdrawal by Subject|0|||
146510657|NCT02604550|528374038|FG001|Overall Study|Withdrawal by Subject|1|||
146510658|NCT02604550|528374037|FG000|Overall Study|Incomplete data using paper journal|18|||
146510659|NCT02604550|528374038|FG001|Overall Study|Incomplete data using paper journal|19|||
146510660|NCT01404208|528374039|FG000|Overall Study|Discontinued|3|||
146510661|NCT01404208|528374040|FG001|Overall Study|Discontinued|0|||
146510662|NCT02609724|528374043|FG000|Overall Study|Death|2|||
146510663|NCT02609724|528374044|FG001|Overall Study|Death|0|||
146510664|NCT02609724|528374045|FG002|Overall Study|Death|1|||
146510665|NCT02609724|528374043|FG000|Overall Study|Withdrawal by Subject|1|||
146510666|NCT02609724|528374044|FG001|Overall Study|Withdrawal by Subject|2|||
146510667|NCT02609724|528374045|FG002|Overall Study|Withdrawal by Subject|3|||
146510668|NCT02609724|528374043|FG000|Overall Study|Illness|2|||
146510669|NCT02609724|528374044|FG001|Overall Study|Illness|1|||
146510670|NCT02609724|528374045|FG002|Overall Study|Illness|0|||
146510671|NCT03077659|528374046|FG000|Overall Study|Withdrawal by Subject|0|||
146510672|NCT03077659|528374047|FG001|Overall Study|Withdrawal by Subject|0|||
146510673|NCT03077659|528374048|FG002|Overall Study|Withdrawal by Subject|1|||
146510674|NCT03436199|528374049|FG000|Overall Study|Adverse Event|15|||
146510675|NCT03436199|528374050|FG001|Overall Study|Adverse Event|40|||
146510676|NCT03436199|528374051|FG002|Overall Study|Adverse Event|7|||
146510677|NCT03436199|528374049|FG000|Overall Study|Withdrawal by Subject|4|||
146510678|NCT03436199|528374050|FG001|Overall Study|Withdrawal by Subject|10|||
146510679|NCT03436199|528374051|FG002|Overall Study|Withdrawal by Subject|3|||
146510680|NCT03436199|528374049|FG000|Overall Study|Lost to Follow-up|1|||
146510681|NCT03436199|528374050|FG001|Overall Study|Lost to Follow-up|0|||
146510682|NCT03436199|528374051|FG002|Overall Study|Lost to Follow-up|2|||
146510683|NCT03436199|528374049|FG000|Overall Study|Protocol Violation|1|||
146510684|NCT03436199|528374050|FG001|Overall Study|Protocol Violation|1|||
146510685|NCT03436199|528374051|FG002|Overall Study|Protocol Violation|0|||
146510686|NCT03436199|528374049|FG000|Overall Study|Physician Decision|0|||
146510687|NCT03436199|528374050|FG001|Overall Study|Physician Decision|1|||
146510688|NCT03436199|528374051|FG002|Overall Study|Physician Decision|0|||
146510689|NCT03436199|528374049|FG000|Overall Study|Could not return to clinic|1|||
146510690|NCT03436199|528374050|FG001|Overall Study|Could not return to clinic|0|||
146510691|NCT03436199|528374051|FG002|Overall Study|Could not return to clinic|0|||
146510692|NCT03436199|528374049|FG000|Overall Study|Withdrawn per physician|0|||
146510693|NCT03436199|528374050|FG001|Overall Study|Withdrawn per physician|1|||
146510694|NCT03436199|528374051|FG002|Overall Study|Withdrawn per physician|0|||
146510695|NCT02631070|528374052|FG000|Overall Study|Withdrawal by Subject|35|||
146510696|NCT02631070|528374053|FG001|Overall Study|Withdrawal by Subject|13|||
146510697|NCT02631070|528374052|FG000|Overall Study|Death|45|||
146510698|NCT02631070|528374053|FG001|Overall Study|Death|24|||
146510699|NCT02631070|528374052|FG000|Overall Study|Lost to Follow-up|5|||
146510700|NCT02631070|528374053|FG001|Overall Study|Lost to Follow-up|1|||
146510701|NCT02631070|528374052|FG000|Overall Study|Transition to rollover protocol|52|||
146510702|NCT02631070|528374053|FG001|Overall Study|Transition to rollover protocol|21|||
146510703|NCT02631070|528374052|FG000|Overall Study|Other reasons|12|||
146510704|NCT02631070|528374053|FG001|Overall Study|Other reasons|5|||
146510705|NCT00085098|528374059|FG000|Overall Study|Withdrawal by Subject|0|||
146510706|NCT00085098|528374060|FG001|Overall Study|Withdrawal by Subject|1|||
146510707|NCT00085098|528374059|FG000|Overall Study|Ineligible|1|||
146510708|NCT00085098|528374060|FG001|Overall Study|Ineligible|1|||
146510709|NCT02565706|528374061|FG000|Overall Study|Withdrawal by Subject|5|||
146510710|NCT02565706|528374062|FG001|Overall Study|Withdrawal by Subject|7|||
146510711|NCT02565706|528374063|FG002|Overall Study|Withdrawal by Subject|7|||
146510712|NCT02565706|528374064|FG003|Overall Study|Withdrawal by Subject|11|||
146510713|NCT02565706|528374061|FG000|Overall Study|Lost to Follow-up|72|||
146510714|NCT02565706|528374062|FG001|Overall Study|Lost to Follow-up|75|||
146510715|NCT02565706|528374063|FG002|Overall Study|Lost to Follow-up|82|||
146510716|NCT02565706|528374064|FG003|Overall Study|Lost to Follow-up|74|||
146510717|NCT00934856|528374065|FG000|Feasibility Part|Progressive disease|4|||
146510718|NCT00934856|528374066|FG001|Feasibility Part|Progressive disease|4|||
146510719|NCT00934856|528374067|FG002|Feasibility Part|Progressive disease|2|||
146510720|NCT00934856|528374068|FG003|Feasibility Part|Progressive disease|3|||
146510721|NCT00934856|528374069|FG004|Feasibility Part|Progressive disease|0|||
146510722|NCT00934856|528374070|FG005|Feasibility Part|Progressive disease|0|||
146510723|NCT00934856|528374065|FG000|Feasibility Part|Physician Decision|0|||
146510724|NCT00934856|528374066|FG001|Feasibility Part|Physician Decision|0|||
146510725|NCT00934856|528374067|FG002|Feasibility Part|Physician Decision|1|||
146510726|NCT00934856|528374068|FG003|Feasibility Part|Physician Decision|0|||
146510727|NCT00934856|528374069|FG004|Feasibility Part|Physician Decision|0|||
146510728|NCT00934856|528374070|FG005|Feasibility Part|Physician Decision|0|||
146510729|NCT00934856|528374065|FG000|Feasibility Part|Adverse Event|1|||
146510730|NCT00934856|528374066|FG001|Feasibility Part|Adverse Event|1|||
146510731|NCT00934856|528374067|FG002|Feasibility Part|Adverse Event|0|||
146510732|NCT00934856|528374068|FG003|Feasibility Part|Adverse Event|1|||
146510733|NCT00934856|528374069|FG004|Feasibility Part|Adverse Event|0|||
146510734|NCT00934856|528374070|FG005|Feasibility Part|Adverse Event|2|||
146510735|NCT00934856|528374065|FG000|Feasibility Part|Withdrawal by Subject|0|||
146510736|NCT00934856|528374066|FG001|Feasibility Part|Withdrawal by Subject|0|||
146510737|NCT00934856|528374067|FG002|Feasibility Part|Withdrawal by Subject|0|||
146510738|NCT00934856|528374068|FG003|Feasibility Part|Withdrawal by Subject|1|||
146510739|NCT00934856|528374069|FG004|Feasibility Part|Withdrawal by Subject|0|||
146510740|NCT00934856|528374070|FG005|Feasibility Part|Withdrawal by Subject|1|||
146510741|NCT00934856|528374065|FG000|Extension Part|Adverse Event|0|||
146510742|NCT00934856|528374066|FG001|Extension Part|Adverse Event|0|||
146510743|NCT00934856|528374067|FG002|Extension Part|Adverse Event|0|||
146510744|NCT00934856|528374068|FG003|Extension Part|Adverse Event|1|||
146510745|NCT00934856|528374069|FG004|Extension Part|Adverse Event|4|||
146510746|NCT00934856|528374070|FG005|Extension Part|Adverse Event|4|||
146510747|NCT00934856|528374065|FG000|Extension Part|Progressive disease|0|||
146510748|NCT00934856|528374066|FG001|Extension Part|Progressive disease|0|||
146510749|NCT00934856|528374067|FG002|Extension Part|Progressive disease|0|||
146510750|NCT00934856|528374068|FG003|Extension Part|Progressive disease|1|||
146510751|NCT00934856|528374069|FG004|Extension Part|Progressive disease|0|||
146510752|NCT00934856|528374070|FG005|Extension Part|Progressive disease|0|||
146510753|NCT00934856|528374065|FG000|Extension Part|Non-compliance with drug|0|||
146510754|NCT00934856|528374066|FG001|Extension Part|Non-compliance with drug|0|||
146510755|NCT00934856|528374067|FG002|Extension Part|Non-compliance with drug|0|||
146510756|NCT00934856|528374068|FG003|Extension Part|Non-compliance with drug|0|||
146510757|NCT00934856|528374069|FG004|Extension Part|Non-compliance with drug|0|||
146510758|NCT00934856|528374070|FG005|Extension Part|Non-compliance with drug|1|||
146510759|NCT03887117|528374071|FG000|Overall Study|Discontinued prematurely|0|||
146510760|NCT03887117|528374072|FG001|Overall Study|Discontinued prematurely|1|||
146510761|NCT03887117|528374073|FG002|Overall Study|Discontinued prematurely|1|||
146510762|NCT03887117|528374074|FG003|Overall Study|Discontinued prematurely|2|||
146510763|NCT00926536|528374078|FG000|Overall Study|Physician Decision|1|||
146510764|NCT00926536|528374079|FG001|Overall Study|Physician Decision|2|||
146510765|NCT05087966|528374080|FG000|Overall Study|Lost to Follow-up|1|||
146510766|NCT05087966|528374080|FG000|Overall Study|Withdrawal by Subject|5|||
146510767|NCT01267201|528374081|FG000|First Intervention Period|Withdrawal by Subject|1|||
146510768|NCT01267201|528374082|FG001|First Intervention Period|Withdrawal by Subject|0|||
146510769|NCT01267201|528374083|FG002|First Intervention Period|Withdrawal by Subject|0|||
146510770|NCT01267201|528374084|FG003|First Intervention Period|Withdrawal by Subject|0|||
146510771|NCT01267201|528374085|FG004|First Intervention Period|Withdrawal by Subject|0|||
146510772|NCT01267201|528374086|FG005|First Intervention Period|Withdrawal by Subject|0|||
146510773|NCT01267201|528374081|FG000|Second Intervention Period|Withdrawal by Subject|0|||
146510774|NCT01267201|528374082|FG001|Second Intervention Period|Withdrawal by Subject|1|||
146510775|NCT01267201|528374083|FG002|Second Intervention Period|Withdrawal by Subject|0|||
146510776|NCT01267201|528374084|FG003|Second Intervention Period|Withdrawal by Subject|0|||
146510777|NCT01267201|528374085|FG004|Second Intervention Period|Withdrawal by Subject|0|||
146510778|NCT01267201|528374086|FG005|Second Intervention Period|Withdrawal by Subject|0|||
146510779|NCT02124759|528374087|FG000|Overall Study|Withdrawal by Subject|3|||
146510780|NCT02124759|528374088|FG001|Overall Study|Withdrawal by Subject|1|||
146510781|NCT02124759|528374089|FG002|Overall Study|Withdrawal by Subject|1|||
146510782|NCT02124759|528374087|FG000|Overall Study|Screen Fail|2|||
146510783|NCT02124759|528374088|FG001|Overall Study|Screen Fail|2|||
146510784|NCT02124759|528374089|FG002|Overall Study|Screen Fail|3|||
146510785|NCT03689543|528374092|FG000|Overall Study|Adverse Event|0|||
146510786|NCT03689543|528374093|FG001|Overall Study|Adverse Event|0|||
146510787|NCT03689543|528374094|FG002|Overall Study|Adverse Event|1|||
146510788|NCT00932451|528374105|FG000|Overall Study|Withdrawal by Subject|69|||
146510789|NCT00932451|528374105|FG000|Overall Study|Lost to Follow-up|22|||
146510790|NCT00932451|528374105|FG000|Overall Study|Death|726|||
146510791|NCT00932451|528374105|FG000|Overall Study|Other reasons|5|||
146510792|NCT01634659|528374113|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
146510793|NCT01634659|528374114|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
146510794|NCT01634659|528374113|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
146510795|NCT01634659|528374114|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
146510796|NCT03627416|528374115|FG000|Overall Study|Adverse Event|0|||
146510797|NCT03627416|528374116|FG001|Overall Study|Adverse Event|1|||
146510798|NCT02968433|528374117|FG000|Overall Study|Withdrawal by Subject|1|||
146510799|NCT01294371|528374118|FG000|Overall Study|Adverse Event|1|||
146510800|NCT01294371|528374118|FG000|Overall Study|Withdrawal by Subject|12|||
146510801|NCT01294371|528374118|FG000|Overall Study|Lost to Follow-up|6|||
146510802|NCT01294371|528374118|FG000|Overall Study|Administrative Reason|1|||
146510803|NCT01294371|528374118|FG000|Overall Study|Other|14|||
146510804|NCT05619536|528374119|FG000|Overall Study|Withdrawal by Subject|0|||
146510805|NCT05619536|528374120|FG001|Overall Study|Withdrawal by Subject|1|||
146510806|NCT05619536|528374121|FG002|Overall Study|Withdrawal by Subject|0|||
146510807|NCT05619536|528374122|FG003|Overall Study|Withdrawal by Subject|1|||
146510808|NCT05619536|528374119|FG000|Overall Study|Lost to Follow-up|0|||
146510809|NCT05619536|528374120|FG001|Overall Study|Lost to Follow-up|1|||
146510810|NCT05619536|528374121|FG002|Overall Study|Lost to Follow-up|1|||
146510811|NCT05619536|528374122|FG003|Overall Study|Lost to Follow-up|0|||
146510812|NCT00875433|528374123|FG000|Overall Study|Progressive disease|41|||
146510813|NCT00875433|528374123|FG000|Overall Study|Other Adverse Event|14|||
146510814|NCT00875433|528374123|FG000|Overall Study|Withdrawal by Subject|2|||
146510815|NCT00875433|528374123|FG000|Overall Study|Other|3|||
146510816|NCT04272606|528374124|FG000|Overall Study|Protocol Violation|1|||
146510817|NCT04272606|528374125|FG001|Overall Study|Protocol Violation|1|||
146510818|NCT04272606|528374124|FG000|Overall Study|Physician Decision|0|||
146510819|NCT04272606|528374125|FG001|Overall Study|Physician Decision|1|||
146510820|NCT00725101|528374126|FG000|Overall Study|Death|3|||
146510821|NCT00725101|528374126|FG000|Overall Study|Lost to Follow-up|353|||
146510822|NCT00725101|528374126|FG000|Overall Study|Protocol Violation|1|||
146510823|NCT00725101|528374126|FG000|Overall Study|Withdrawal by Subject|127|||
146510824|NCT00725101|528374126|FG000|Overall Study|not specified/no reason given|11|||
146510825|NCT00622336|528374127|FG000|Treatment Phase|Progression of Disease|181|||
146510826|NCT00622336|528374127|FG000|Treatment Phase|Adverse Event|46|||
146510827|NCT00622336|528374127|FG000|Treatment Phase|Other|40|||
146510828|NCT00622336|528374127|FG000|Treatment Phase|Death|14|||
146510829|NCT00622336|528374127|FG000|Treatment Phase|Lack of therapeutic effect|13|||
146510830|NCT00622336|528374127|FG000|Treatment Phase|Withdrawal by Subject|13|||
146510831|NCT00622336|528374127|FG000|Treatment Phase|Lost to Follow-up|2|||
146510832|NCT00622336|528374127|FG000|Extension Phase|Adverse Event|2|||
146510833|NCT00622336|528374127|FG000|Extension Phase|Progressive Disease|6|||
146510834|NCT00622336|528374127|FG000|Extension Phase|Lack of therapeutic effect|2|||
146510835|NCT00622336|528374127|FG000|Extension Phase|Withdrawal by Subject|1|||
146510836|NCT00622336|528374127|FG000|Extension Phase|Lost to Follow-up|1|||
146510837|NCT00622336|528374127|FG000|Extension Phase|Other|9|||
146510838|NCT02923245|528374128|FG000|Overall Study|ultrasound order was cancelled|2|||
146510839|NCT02923245|528374129|FG001|Overall Study|ultrasound order was cancelled|1|||
146510840|NCT00948506|528374130|FG000|Overall Study|Withdrawal by Subject|3|||
146510841|NCT00948506|528374131|FG001|Overall Study|Withdrawal by Subject|1|||
146510842|NCT03912428|528374132|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
146510843|NCT03912428|528374133|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
146510844|NCT03912428|528374134|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
146510845|NCT03912428|528374135|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
146510846|NCT03912428|528374132|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
146510847|NCT03912428|528374133|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
146510848|NCT03912428|528374134|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
146510849|NCT03912428|528374135|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
146510850|NCT03912428|528374132|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
146510851|NCT03912428|528374133|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
146510852|NCT03912428|528374134|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
146510853|NCT03912428|528374135|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
146510854|NCT03233204|528374136|FG000|Overall Study|Adverse Event|1|||
146510855|NCT03233204|528374136|FG000|Overall Study|Death|1|||
146510856|NCT03233204|528374136|FG000|Overall Study|Withdrawal by Subject|1|||
146510857|NCT03233204|528374136|FG000|Overall Study|Progressive Disease|3|||
146510858|NCT02520427|528374138|FG000|Overall Study|Decision by sponsor|0|||
146510859|NCT02520427|528374139|FG001|Overall Study|Decision by sponsor|0|||
146510860|NCT02520427|528374140|FG002|Overall Study|Decision by sponsor|0|||
146510861|NCT02520427|528374141|FG003|Overall Study|Decision by sponsor|0|||
146510862|NCT02520427|528374142|FG004|Overall Study|Decision by sponsor|0|||
146510863|NCT02520427|528374143|FG005|Overall Study|Decision by sponsor|0|||
146510864|NCT02520427|528374144|FG006|Overall Study|Decision by sponsor|0|||
146510865|NCT02520427|528374145|FG007|Overall Study|Decision by sponsor|0|||
146510866|NCT02520427|528374146|FG008|Overall Study|Decision by sponsor|1|||
146510867|NCT02520427|528374147|FG009|Overall Study|Decision by sponsor|1|||
146510868|NCT02520427|528374148|FG010|Overall Study|Decision by sponsor|0|||
146510869|NCT02520427|528374149|FG011|Overall Study|Decision by sponsor|0|||
146510870|NCT02520427|528374150|FG012|Overall Study|Decision by sponsor|0|||
146510871|NCT02520427|528374151|FG013|Overall Study|Decision by sponsor|0|||
146510872|NCT02520427|528374152|FG014|Overall Study|Decision by sponsor|0|||
146510873|NCT02520427|528374153|FG015|Overall Study|Decision by sponsor|0|||
146510874|NCT02520427|528374154|FG016|Overall Study|Decision by sponsor|0|||
146510875|NCT02520427|528374155|FG017|Overall Study|Decision by sponsor|0|||
146510876|NCT02520427|528374156|FG018|Overall Study|Decision by sponsor|0|||
146510877|NCT02520427|528374157|FG019|Overall Study|Decision by sponsor|0|||
146510878|NCT02520427|528374158|FG020|Overall Study|Decision by sponsor|0|||
146510879|NCT02520427|528374159|FG021|Overall Study|Decision by sponsor|0|||
146510880|NCT02520427|528374160|FG022|Overall Study|Decision by sponsor|0|||
146510881|NCT02520427|528374161|FG023|Overall Study|Decision by sponsor|0|||
146510882|NCT02520427|528374162|FG024|Overall Study|Decision by sponsor|0|||
146510883|NCT02520427|528374163|FG025|Overall Study|Decision by sponsor|0|||
146510884|NCT02520427|528374138|FG000|Overall Study|Withdrawal by Subject|0|||
146510885|NCT02520427|528374139|FG001|Overall Study|Withdrawal by Subject|0|||
146510886|NCT02520427|528374140|FG002|Overall Study|Withdrawal by Subject|1|||
146510887|NCT02520427|528374141|FG003|Overall Study|Withdrawal by Subject|0|||
146510888|NCT02520427|528374142|FG004|Overall Study|Withdrawal by Subject|0|||
146510889|NCT02520427|528374143|FG005|Overall Study|Withdrawal by Subject|0|||
146510890|NCT02520427|528374144|FG006|Overall Study|Withdrawal by Subject|0|||
146510891|NCT02520427|528374145|FG007|Overall Study|Withdrawal by Subject|0|||
146510892|NCT02520427|528374146|FG008|Overall Study|Withdrawal by Subject|0|||
146510893|NCT02520427|528374147|FG009|Overall Study|Withdrawal by Subject|0|||
146510894|NCT02520427|528374148|FG010|Overall Study|Withdrawal by Subject|0|||
146510895|NCT02520427|528374149|FG011|Overall Study|Withdrawal by Subject|0|||
146510896|NCT02520427|528374150|FG012|Overall Study|Withdrawal by Subject|1|||
146510897|NCT02520427|528374151|FG013|Overall Study|Withdrawal by Subject|1|||
146510898|NCT02520427|528374152|FG014|Overall Study|Withdrawal by Subject|1|||
146510899|NCT02520427|528374153|FG015|Overall Study|Withdrawal by Subject|0|||
146510900|NCT02520427|528374154|FG016|Overall Study|Withdrawal by Subject|1|||
146510901|NCT02520427|528374155|FG017|Overall Study|Withdrawal by Subject|0|||
146510902|NCT02520427|528374156|FG018|Overall Study|Withdrawal by Subject|0|||
146510903|NCT02520427|528374157|FG019|Overall Study|Withdrawal by Subject|3|||
146510904|NCT02520427|528374158|FG020|Overall Study|Withdrawal by Subject|2|||
146510905|NCT02520427|528374159|FG021|Overall Study|Withdrawal by Subject|0|||
146510906|NCT02520427|528374160|FG022|Overall Study|Withdrawal by Subject|0|||
146510907|NCT02520427|528374161|FG023|Overall Study|Withdrawal by Subject|0|||
146510908|NCT02520427|528374162|FG024|Overall Study|Withdrawal by Subject|0|||
146510909|NCT02520427|528374163|FG025|Overall Study|Withdrawal by Subject|0|||
146510910|NCT02520427|528374138|FG000|Overall Study|Death|1|||
146510911|NCT02520427|528374139|FG001|Overall Study|Death|0|||
146510912|NCT02520427|528374140|FG002|Overall Study|Death|0|||
146510913|NCT02520427|528374141|FG003|Overall Study|Death|0|||
146510914|NCT02520427|528374142|FG004|Overall Study|Death|0|||
146510915|NCT02520427|528374143|FG005|Overall Study|Death|0|||
146510916|NCT02520427|528374144|FG006|Overall Study|Death|0|||
146510917|NCT02520427|528374145|FG007|Overall Study|Death|0|||
146510918|NCT02520427|528374146|FG008|Overall Study|Death|0|||
146510919|NCT02520427|528374147|FG009|Overall Study|Death|0|||
146510920|NCT02520427|528374148|FG010|Overall Study|Death|0|||
146510921|NCT02520427|528374149|FG011|Overall Study|Death|0|||
146510922|NCT02520427|528374150|FG012|Overall Study|Death|0|||
146510923|NCT02520427|528374151|FG013|Overall Study|Death|0|||
146510924|NCT02520427|528374152|FG014|Overall Study|Death|0|||
146510925|NCT02520427|528374153|FG015|Overall Study|Death|0|||
146510926|NCT02520427|528374154|FG016|Overall Study|Death|2|||
146510927|NCT02520427|528374155|FG017|Overall Study|Death|1|||
146510928|NCT02520427|528374156|FG018|Overall Study|Death|3|||
146510929|NCT02520427|528374157|FG019|Overall Study|Death|2|||
146510930|NCT02520427|528374158|FG020|Overall Study|Death|0|||
146510931|NCT02520427|528374159|FG021|Overall Study|Death|0|||
146510932|NCT02520427|528374160|FG022|Overall Study|Death|1|||
146510933|NCT02520427|528374161|FG023|Overall Study|Death|0|||
146510934|NCT02520427|528374162|FG024|Overall Study|Death|1|||
146510935|NCT02520427|528374163|FG025|Overall Study|Death|0|||
146510936|NCT00793624|528374164|FG000|Overall Study|Adverse Event|18|||
146510937|NCT00793624|528374165|FG001|Overall Study|Adverse Event|16|||
146510938|NCT00793624|528374166|FG002|Overall Study|Adverse Event|15|||
146510939|NCT00793624|528374167|FG003|Overall Study|Adverse Event|20|||
146510940|NCT00793624|528374164|FG000|Overall Study|Lost to Follow-up|2|||
146510941|NCT00793624|528374165|FG001|Overall Study|Lost to Follow-up|2|||
146510942|NCT00793624|528374166|FG002|Overall Study|Lost to Follow-up|4|||
146510943|NCT00793624|528374167|FG003|Overall Study|Lost to Follow-up|0|||
146510944|NCT00793624|528374164|FG000|Overall Study|Withdrawal by Subject|20|||
146510945|NCT00793624|528374165|FG001|Overall Study|Withdrawal by Subject|9|||
146510946|NCT00793624|528374166|FG002|Overall Study|Withdrawal by Subject|11|||
146510947|NCT00793624|528374167|FG003|Overall Study|Withdrawal by Subject|14|||
146510948|NCT00793624|528374164|FG000|Overall Study|Lack of Efficacy|9|||
146510949|NCT00793624|528374165|FG001|Overall Study|Lack of Efficacy|2|||
146510950|NCT00793624|528374166|FG002|Overall Study|Lack of Efficacy|1|||
146510951|NCT00793624|528374167|FG003|Overall Study|Lack of Efficacy|3|||
146510952|NCT00793624|528374164|FG000|Overall Study|Non compliance with protocol|2|||
146510953|NCT00793624|528374165|FG001|Overall Study|Non compliance with protocol|3|||
146510954|NCT00793624|528374166|FG002|Overall Study|Non compliance with protocol|2|||
146510955|NCT00793624|528374167|FG003|Overall Study|Non compliance with protocol|3|||
146510956|NCT00793624|528374164|FG000|Overall Study|Other reason not described above|6|||
146510957|NCT00793624|528374165|FG001|Overall Study|Other reason not described above|4|||
146510958|NCT00793624|528374166|FG002|Overall Study|Other reason not described above|6|||
146510959|NCT00793624|528374167|FG003|Overall Study|Other reason not described above|3|||
146510960|NCT00157248|528374168|FG000|Overall Study|Adverse Event|36|||
146510961|NCT00157248|528374169|FG001|Overall Study|Adverse Event|25|||
146510962|NCT00157248|528374170|FG002|Overall Study|Adverse Event|13|||
146510963|NCT00157248|528374171|FG003|Overall Study|Adverse Event|33|||
146510964|NCT00157248|528374168|FG000|Overall Study|Protocol Violation|4|||
146510965|NCT00157248|528374169|FG001|Overall Study|Protocol Violation|0|||
146510966|NCT00157248|528374170|FG002|Overall Study|Protocol Violation|2|||
146510967|NCT00157248|528374171|FG003|Overall Study|Protocol Violation|2|||
146510968|NCT00157248|528374168|FG000|Overall Study|Lost to Follow-up|0|||
146510969|NCT00157248|528374169|FG001|Overall Study|Lost to Follow-up|1|||
146510970|NCT00157248|528374170|FG002|Overall Study|Lost to Follow-up|0|||
146510971|NCT00157248|528374171|FG003|Overall Study|Lost to Follow-up|0|||
146510972|NCT00157248|528374168|FG000|Overall Study|Withdrawal by Subject|1|||
146510973|NCT00157248|528374169|FG001|Overall Study|Withdrawal by Subject|4|||
146510974|NCT00157248|528374170|FG002|Overall Study|Withdrawal by Subject|3|||
146510975|NCT00157248|528374171|FG003|Overall Study|Withdrawal by Subject|3|||
146510976|NCT00157248|528374168|FG000|Overall Study|site closures, subject moving|7|||
146510977|NCT00157248|528374169|FG001|Overall Study|site closures, subject moving|7|||
146510978|NCT00157248|528374170|FG002|Overall Study|site closures, subject moving|3|||
146510979|NCT00157248|528374171|FG003|Overall Study|site closures, subject moving|9|||
146510980|NCT01447927|528374172|FG000|Overall Study|Adverse Event|4|||
146510981|NCT01447927|528374173|FG001|Overall Study|Adverse Event|3|||
146510982|NCT01447927|528374172|FG000|Overall Study|Withdrawal by Subject|1|||
146510983|NCT01447927|528374173|FG001|Overall Study|Withdrawal by Subject|0|||
146510984|NCT01777139|528375362|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
146510985|NCT01777139|528375363|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
146510986|NCT01777139|528375362|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
146510987|NCT01777139|528375363|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
146510988|NCT01777139|528375362|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
146510989|NCT01777139|528375363|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
146510990|NCT01777139|528375362|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
146510991|NCT01777139|528375363|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
146510992|NCT01777139|528375362|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
146510993|NCT01777139|528375363|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
146510994|NCT01777139|528375362|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
146510995|NCT01777139|528375363|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
146510996|NCT01777139|528375362|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
146510997|NCT01777139|528375363|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
146510998|NCT01777139|528375362|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
146510999|NCT01777139|528375363|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
146511000|NCT02542293|528375364|FG000|Overall Study|Death|367|||
146511001|NCT02542293|528375365|FG001|Overall Study|Death|377|||
146511002|NCT02542293|528375364|FG000|Overall Study|Withdrawal by Subject|8|||
146511003|NCT02542293|528375365|FG001|Overall Study|Withdrawal by Subject|19|||
146511004|NCT03030118|528375366|FG000|Overall Study|Achieved SLE Diagnosis|11|||
146511005|NCT03030118|528375367|FG001|Overall Study|Achieved SLE Diagnosis|10|||
146511006|NCT03030118|528375366|FG000|Overall Study|Adverse Event|1|||
146511007|NCT03030118|528375367|FG001|Overall Study|Adverse Event|1|||
146511008|NCT03030118|528375366|FG000|Overall Study|Pregnancy|2|||
146511009|NCT03030118|528375367|FG001|Overall Study|Pregnancy|2|||
146511010|NCT03030118|528375366|FG000|Overall Study|Lost to Follow-up|5|||
146511011|NCT03030118|528375367|FG001|Overall Study|Lost to Follow-up|6|||
146511012|NCT03030118|528375366|FG000|Overall Study|Concomitant Medications|1|||
146511013|NCT03030118|528375367|FG001|Overall Study|Concomitant Medications|1|||
146511014|NCT03030118|528375366|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
146511015|NCT03030118|528375367|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
146511016|NCT03030118|528375366|FG000|Overall Study|Other|2|||
146511017|NCT03030118|528375367|FG001|Overall Study|Other|0|||
146511018|NCT03030118|528375366|FG000|Overall Study|Withdrawal by Subject|26|||
146511019|NCT03030118|528375367|FG001|Overall Study|Withdrawal by Subject|21|||
146511020|NCT03030118|528375366|FG000|Overall Study|Protocol Violation|1|||
146511021|NCT03030118|528375367|FG001|Overall Study|Protocol Violation|6|||
146511022|NCT04529850|528375368|FG000|Overall Study|Death|2|||
146511023|NCT04529850|528375368|FG000|Overall Study|Physician Decision|1|||
146743917|NCT02736968|529233851|FG007|Overall Study|Lost to Follow-up|2|||
146743918|NCT02736968|529233844|FG000|Overall Study|COVID-19 Pandemic|0|||
146743919|NCT02736968|529233845|FG001|Overall Study|COVID-19 Pandemic|0|||
146743920|NCT02736968|529233846|FG002|Overall Study|COVID-19 Pandemic|0|||
146743921|NCT02736968|529233847|FG003|Overall Study|COVID-19 Pandemic|0|||
146743922|NCT02736968|529233848|FG004|Overall Study|COVID-19 Pandemic|0|||
146743923|NCT02736968|529233849|FG005|Overall Study|COVID-19 Pandemic|0|||
146743924|NCT02736968|529233850|FG006|Overall Study|COVID-19 Pandemic|2|||
146743925|NCT02736968|529233851|FG007|Overall Study|COVID-19 Pandemic|0|||
146743926|NCT02736968|529233844|FG000|Overall Study|Withdrawal by Subject|0|||
146743927|NCT02736968|529233845|FG001|Overall Study|Withdrawal by Subject|0|||
146743928|NCT02736968|529233846|FG002|Overall Study|Withdrawal by Subject|0|||
146743929|NCT02736968|529233847|FG003|Overall Study|Withdrawal by Subject|0|||
146743930|NCT02736968|529233848|FG004|Overall Study|Withdrawal by Subject|0|||
146743931|NCT02736968|529233849|FG005|Overall Study|Withdrawal by Subject|0|||
146511024|NCT04529850|528375368|FG000|Overall Study|Withdrawal by Subject|2|||
146743932|NCT02736968|529233850|FG006|Overall Study|Withdrawal by Subject|1|||
146743933|NCT02736968|529233851|FG007|Overall Study|Withdrawal by Subject|0|||
146743934|NCT03342053|529233854|FG000|Overall Study|Adverse Event|2|||
146743935|NCT03342053|529233855|FG001|Overall Study|Adverse Event|0|||
146743936|NCT03342053|529233854|FG000|Overall Study|Withdrawal by Subject|0|||
146511025|NCT00593606|528375371|FG000|Overall Study|Adverse Event|13|||
146743937|NCT03342053|529233855|FG001|Overall Study|Withdrawal by Subject|1|||
146743938|NCT02961374|529233856|FG000|Overall Study|Adverse Event|4|||
146743939|NCT00735644|529233857|FG000|Overall Study|Did not receive study vaccine|0|||
146743940|NCT00735644|529233858|FG001|Overall Study|Did not receive study vaccine|1|||
146743941|NCT00735644|529233859|FG002|Overall Study|Did not receive study vaccine|0|||
146743942|NCT00735644|529233860|FG003|Overall Study|Did not receive study vaccine|0|||
146743943|NCT00735644|529233861|FG004|Overall Study|Did not receive study vaccine|0|||
146743944|NCT00735644|529233857|FG000|Overall Study|Withdrawal by Subject|0|||
146743945|NCT00735644|529233858|FG001|Overall Study|Withdrawal by Subject|1|||
146743946|NCT00735644|529233859|FG002|Overall Study|Withdrawal by Subject|1|||
146743947|NCT00735644|529233860|FG003|Overall Study|Withdrawal by Subject|1|||
146743948|NCT00735644|529233861|FG004|Overall Study|Withdrawal by Subject|0|||
146743949|NCT02041923|529233864|FG000|Overall Study|Lost to Follow-up|26|||
146743950|NCT02041923|529233865|FG001|Overall Study|Lost to Follow-up|30|||
146743951|NCT01258660|529235504|FG000|Overall Study|Adverse Event|2|||
146743952|NCT01258660|529235505|FG001|Overall Study|Adverse Event|4|||
146743953|NCT01258660|529235504|FG000|Overall Study|Withdrawal by Subject|3|||
146743954|NCT01258660|529235505|FG001|Overall Study|Withdrawal by Subject|0|||
146743955|NCT01258660|529235504|FG000|Overall Study|due to relocation|2|||
146743956|NCT01258660|529235505|FG001|Overall Study|due to relocation|0|||
146743957|NCT01258660|529235504|FG000|Overall Study|Protocol Violation|0|||
146743958|NCT01258660|529235505|FG001|Overall Study|Protocol Violation|1|||
146743959|NCT01258660|529235504|FG000|Overall Study|Invalid for primary analysis data set|4|||
146743960|NCT01258660|529235505|FG001|Overall Study|Invalid for primary analysis data set|6|||
146743961|NCT04192630|529235508|FG000|Overall Study|Discontinued before surgery|2|||
146743962|NCT04192630|529235509|FG001|Overall Study|Discontinued before surgery|0|||
146743963|NCT04192630|529235508|FG000|Overall Study|Discontinued after surgery|5|||
146743964|NCT04192630|529235509|FG001|Overall Study|Discontinued after surgery|3|||
146743965|NCT01208415|529235510|FG000|Overall Study|Death|1|||
146743966|NCT01208415|529235510|FG000|Overall Study|Lost to Follow-up|2|||
146743967|NCT01208415|529235510|FG000|Overall Study|Withdrawal by Subject|3|||
146743968|NCT01208415|529235510|FG000|Overall Study|Device not placed|1|||
146743969|NCT01208415|529235510|FG000|Overall Study|Still be eligible for follow-up|33|||
146743970|NCT01115491|529235511|FG000|Overall Study|Death|22|||
146743971|NCT01115491|529235511|FG000|Overall Study|Adverse Event|3|||
146743972|NCT01115491|529235511|FG000|Overall Study|Lost to Follow-up|3|||
146743973|NCT01115491|529235511|FG000|Overall Study|Withdrawal by Subject|1|||
146743974|NCT01115491|529235511|FG000|Overall Study|Physician Decision|1|||
146743975|NCT03856996|529235512|FG000|Overall Study|Withdrawal by Subject|1|||
146743976|NCT03856996|529235513|FG001|Overall Study|Withdrawal by Subject|0|||
146743977|NCT03856996|529235512|FG000|Overall Study|Lost to Follow-up|0|||
146743978|NCT03856996|529235513|FG001|Overall Study|Lost to Follow-up|1|||
146743979|NCT03856996|529235512|FG000|Overall Study|Adverse Event|1|||
146743980|NCT03856996|529235513|FG001|Overall Study|Adverse Event|1|||
146743981|NCT03856996|529235512|FG000|Overall Study|Other|1|||
146743982|NCT03856996|529235513|FG001|Overall Study|Other|0|||
146743983|NCT01586338|529235515|FG000|Overall Study|Adverse Event|3|||
146743984|NCT01586338|529235515|FG000|Overall Study|Lost to Follow-up|1|||
146743985|NCT01586338|529235515|FG000|Overall Study|Withdrawal by participant|3|||
146743986|NCT01586338|529235515|FG000|Overall Study|Other|1|||
146743987|NCT03306043|529235518|FG000|Overall Study|Adverse Event|1|||
146743988|NCT03306043|529235518|FG000|Overall Study|Lost to Follow-up|1|||
146743989|NCT03306043|529235518|FG000|Overall Study|Withdrawal by Subject|2|||
146743990|NCT01544491|529235519|FG000|Overall Study|Withdrawal by Subject|3|||
146743991|NCT01544491|529235520|FG001|Overall Study|Withdrawal by Subject|2|||
146743992|NCT01544491|529235519|FG000|Overall Study|Lost to Follow-up|0|||
146743993|NCT01544491|529235520|FG001|Overall Study|Lost to Follow-up|1|||
146743994|NCT01544491|529235519|FG000|Overall Study|administrative problems|2|||
146743995|NCT01544491|529235520|FG001|Overall Study|administrative problems|0|||
146743996|NCT01799720|529235521|FG000|Overall Study|Withdrawal by Subject|3|||
146743997|NCT01799720|529235522|FG001|Overall Study|Withdrawal by Subject|0|||
146743998|NCT01799720|529235523|FG002|Overall Study|Withdrawal by Subject|0|||
146743999|NCT01799720|529235521|FG000|Overall Study|Protocol Violation|0|||
146744000|NCT01799720|529235522|FG001|Overall Study|Protocol Violation|1|||
146744001|NCT01799720|529235523|FG002|Overall Study|Protocol Violation|0|||
146744002|NCT01799720|529235521|FG000|Overall Study|Pregnancy|0|||
146744003|NCT01799720|529235522|FG001|Overall Study|Pregnancy|0|||
146744004|NCT01799720|529235523|FG002|Overall Study|Pregnancy|1|||
146744005|NCT00896454|529235525|FG000|Overall Study|Death|10|||
146744006|NCT00896454|529235525|FG000|Overall Study|Adverse Event|8|||
146744007|NCT00896454|529235525|FG000|Overall Study|Disease Progression|5|||
146744008|NCT00896454|529235525|FG000|Overall Study|Other|4|||
146744009|NCT00896454|529235525|FG000|Overall Study|Requirement for alternative therapy|3|||
146744010|NCT00896454|529235525|FG000|Overall Study|Ongoing in study|2|||
146511026|NCT00593606|528375371|FG000|Overall Study|Withdrawal by Subject|1|||
146511027|NCT00593606|528375371|FG000|Overall Study|Protocol Violation|3|||
146744011|NCT00896454|529235525|FG000|Overall Study|Withdrawal by Subject|1|||
146744012|NCT01234649|529235526|FG000|Overall Study|Withdrawal by Subject|32|||
146744013|NCT01234649|529235527|FG001|Overall Study|Withdrawal by Subject|26|||
146744014|NCT01234649|529235526|FG000|Overall Study|Pregnancy|6|||
146744015|NCT01234649|529235527|FG001|Overall Study|Pregnancy|6|||
146744016|NCT01234649|529235526|FG000|Overall Study|intolerant to side effects|4|||
146744017|NCT01234649|529235527|FG001|Overall Study|intolerant to side effects|3|||
146744018|NCT01234649|529235526|FG000|Overall Study|Allergic reaction|1|||
146744019|NCT01234649|529235527|FG001|Overall Study|Allergic reaction|0|||
146744020|NCT01234649|529235526|FG000|Overall Study|Lack of Efficacy|0|||
146744021|NCT01234649|529235527|FG001|Overall Study|Lack of Efficacy|3|||
146744022|NCT01461993|529235532|FG000|Overall Study|Withdrawal by Subject|60|||
146744023|NCT01461993|529235533|FG001|Overall Study|Withdrawal by Subject|53|||
146744024|NCT01461993|529235534|FG002|Overall Study|Withdrawal by Subject|16|||
146744025|NCT01461993|529235532|FG000|Overall Study|Lost to Follow-up|44|||
146744026|NCT01461993|529235533|FG001|Overall Study|Lost to Follow-up|48|||
146744027|NCT01461993|529235534|FG002|Overall Study|Lost to Follow-up|22|||
146744028|NCT01461993|529235532|FG000|Overall Study|Protocol Violation|10|||
146744029|NCT01461993|529235533|FG001|Overall Study|Protocol Violation|9|||
146744030|NCT01461993|529235534|FG002|Overall Study|Protocol Violation|7|||
146744031|NCT01461993|529235532|FG000|Overall Study|Adverse Event|9|||
146744032|NCT01461993|529235533|FG001|Overall Study|Adverse Event|11|||
146744033|NCT01461993|529235534|FG002|Overall Study|Adverse Event|3|||
146744034|NCT01461993|529235532|FG000|Overall Study|No longer met eligibility criteria|13|||
146744035|NCT01461993|529235533|FG001|Overall Study|No longer met eligibility criteria|18|||
146744036|NCT01461993|529235534|FG002|Overall Study|No longer met eligibility criteria|10|||
146744037|NCT01461993|529235532|FG000|Overall Study|Did not meet entrance criteria|2|||
146744038|NCT01461993|529235533|FG001|Overall Study|Did not meet entrance criteria|3|||
146744039|NCT01461993|529235534|FG002|Overall Study|Did not meet entrance criteria|0|||
146744040|NCT01461993|529235532|FG000|Overall Study|Other|13|||
146744041|NCT01461993|529235533|FG001|Overall Study|Other|15|||
146744042|NCT01461993|529235534|FG002|Overall Study|Other|6|||
146744043|NCT00680056|529235536|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
146744044|NCT00680056|529235537|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
146744045|NCT00680056|529235536|FG000|Second Intervention|Protocol Violation|3|||
146744046|NCT00680056|529235537|FG001|Second Intervention|Protocol Violation|1|||
146744047|NCT02733042|529235543|FG000|Overall Study|Adverse Event|1|||
146744048|NCT02733042|529235544|FG001|Overall Study|Adverse Event|0|||
146744049|NCT02733042|529235545|FG002|Overall Study|Adverse Event|1|||
146744050|NCT02733042|529235546|FG003|Overall Study|Adverse Event|1|||
146744051|NCT02733042|529235547|FG004|Overall Study|Adverse Event|0|||
146744052|NCT02733042|529235548|FG005|Overall Study|Adverse Event|0|||
146744053|NCT02733042|529235549|FG006|Overall Study|Adverse Event|0|||
146744054|NCT02733042|529235550|FG007|Overall Study|Adverse Event|0|||
146744055|NCT02733042|529235551|FG008|Overall Study|Adverse Event|0|||
146744056|NCT02733042|529235552|FG009|Overall Study|Adverse Event|0|||
146744057|NCT02733042|529235553|FG010|Overall Study|Adverse Event|2|||
146744058|NCT02733042|529235554|FG011|Overall Study|Adverse Event|2|||
146744059|NCT02733042|529235555|FG012|Overall Study|Adverse Event|0|||
146744060|NCT02733042|529235556|FG013|Overall Study|Adverse Event|2|||
146744061|NCT02733042|529235557|FG014|Overall Study|Adverse Event|0|||
146744062|NCT02733042|529235558|FG015|Overall Study|Adverse Event|0|||
146744063|NCT02733042|529235559|FG016|Overall Study|Adverse Event|0|||
146744064|NCT02733042|529235560|FG017|Overall Study|Adverse Event|1|||
146744065|NCT02733042|529235561|FG018|Overall Study|Adverse Event|0|||
146744066|NCT02733042|529235543|FG000|Overall Study|Progressive Disease|2|||
146744067|NCT02733042|529235544|FG001|Overall Study|Progressive Disease|1|||
146744068|NCT02733042|529235545|FG002|Overall Study|Progressive Disease|3|||
146744069|NCT02733042|529235546|FG003|Overall Study|Progressive Disease|1|||
146744070|NCT02733042|529235547|FG004|Overall Study|Progressive Disease|2|||
146744071|NCT02733042|529235548|FG005|Overall Study|Progressive Disease|3|||
146744072|NCT02733042|529235549|FG006|Overall Study|Progressive Disease|0|||
146744073|NCT02733042|529235550|FG007|Overall Study|Progressive Disease|3|||
146744074|NCT02733042|529235551|FG008|Overall Study|Progressive Disease|3|||
146744075|NCT02733042|529235552|FG009|Overall Study|Progressive Disease|2|||
146744076|NCT02733042|529235553|FG010|Overall Study|Progressive Disease|2|||
146744077|NCT02733042|529235554|FG011|Overall Study|Progressive Disease|2|||
146744078|NCT02733042|529235555|FG012|Overall Study|Progressive Disease|8|||
146744079|NCT02733042|529235556|FG013|Overall Study|Progressive Disease|1|||
146744080|NCT02733042|529235557|FG014|Overall Study|Progressive Disease|4|||
146744081|NCT02733042|529235558|FG015|Overall Study|Progressive Disease|7|||
146744082|NCT02733042|529235559|FG016|Overall Study|Progressive Disease|2|||
146744083|NCT02733042|529235560|FG017|Overall Study|Progressive Disease|3|||
146744084|NCT02733042|529235561|FG018|Overall Study|Progressive Disease|4|||
146744085|NCT02733042|529235543|FG000|Overall Study|Withdrawal by Subject|0|||
146744086|NCT02733042|529235544|FG001|Overall Study|Withdrawal by Subject|1|||
146744087|NCT02733042|529235545|FG002|Overall Study|Withdrawal by Subject|2|||
146744088|NCT02733042|529235546|FG003|Overall Study|Withdrawal by Subject|1|||
146744089|NCT02733042|529235547|FG004|Overall Study|Withdrawal by Subject|1|||
146744090|NCT02733042|529235548|FG005|Overall Study|Withdrawal by Subject|0|||
146744091|NCT02733042|529235549|FG006|Overall Study|Withdrawal by Subject|0|||
146744092|NCT02733042|529235550|FG007|Overall Study|Withdrawal by Subject|0|||
146744093|NCT02733042|529235551|FG008|Overall Study|Withdrawal by Subject|1|||
146744094|NCT02733042|529235552|FG009|Overall Study|Withdrawal by Subject|1|||
146744095|NCT02733042|529235553|FG010|Overall Study|Withdrawal by Subject|0|||
146744096|NCT02733042|529235554|FG011|Overall Study|Withdrawal by Subject|2|||
146744097|NCT02733042|529235555|FG012|Overall Study|Withdrawal by Subject|1|||
146744098|NCT02733042|529235556|FG013|Overall Study|Withdrawal by Subject|1|||
146744099|NCT02733042|529235557|FG014|Overall Study|Withdrawal by Subject|0|||
146744100|NCT02733042|529235558|FG015|Overall Study|Withdrawal by Subject|0|||
146744101|NCT02733042|529235559|FG016|Overall Study|Withdrawal by Subject|0|||
146744102|NCT02733042|529235560|FG017|Overall Study|Withdrawal by Subject|0|||
146744103|NCT02733042|529235561|FG018|Overall Study|Withdrawal by Subject|0|||
146744104|NCT02733042|529235543|FG000|Overall Study|Other Reasons|0|||
146744105|NCT02733042|529235544|FG001|Overall Study|Other Reasons|0|||
146744106|NCT02733042|529235545|FG002|Overall Study|Other Reasons|1|||
146744107|NCT02733042|529235546|FG003|Overall Study|Other Reasons|0|||
146744108|NCT02733042|529235547|FG004|Overall Study|Other Reasons|0|||
146744109|NCT02733042|529235548|FG005|Overall Study|Other Reasons|0|||
146744110|NCT02733042|529235549|FG006|Overall Study|Other Reasons|0|||
146744111|NCT02733042|529235550|FG007|Overall Study|Other Reasons|0|||
146744112|NCT02733042|529235551|FG008|Overall Study|Other Reasons|0|||
146744113|NCT02733042|529235552|FG009|Overall Study|Other Reasons|1|||
146744114|NCT02733042|529235553|FG010|Overall Study|Other Reasons|1|||
146744115|NCT02733042|529235554|FG011|Overall Study|Other Reasons|0|||
146744116|NCT02733042|529235555|FG012|Overall Study|Other Reasons|0|||
146744117|NCT02733042|529235556|FG013|Overall Study|Other Reasons|0|||
146744118|NCT02733042|529235557|FG014|Overall Study|Other Reasons|0|||
146744119|NCT02733042|529235558|FG015|Overall Study|Other Reasons|1|||
146744120|NCT02733042|529235559|FG016|Overall Study|Other Reasons|0|||
146744121|NCT02733042|529235560|FG017|Overall Study|Other Reasons|1|||
146744122|NCT02733042|529235561|FG018|Overall Study|Other Reasons|0|||
146744123|NCT02733042|529235543|FG000|Overall Study|Death|0|||
146744124|NCT02733042|529235544|FG001|Overall Study|Death|0|||
146744125|NCT02733042|529235545|FG002|Overall Study|Death|0|||
146744126|NCT02733042|529235546|FG003|Overall Study|Death|0|||
146744127|NCT02733042|529235547|FG004|Overall Study|Death|0|||
146744128|NCT02733042|529235548|FG005|Overall Study|Death|0|||
146744129|NCT02733042|529235549|FG006|Overall Study|Death|1|||
146744130|NCT02733042|529235550|FG007|Overall Study|Death|0|||
146744131|NCT02733042|529235551|FG008|Overall Study|Death|1|||
146744132|NCT02733042|529235552|FG009|Overall Study|Death|0|||
146744133|NCT02733042|529235553|FG010|Overall Study|Death|1|||
146744134|NCT02733042|529235554|FG011|Overall Study|Death|0|||
146744135|NCT02733042|529235555|FG012|Overall Study|Death|0|||
146744136|NCT02733042|529235556|FG013|Overall Study|Death|0|||
146744137|NCT02733042|529235557|FG014|Overall Study|Death|1|||
146744138|NCT02733042|529235558|FG015|Overall Study|Death|2|||
146744139|NCT02733042|529235559|FG016|Overall Study|Death|0|||
146744140|NCT02733042|529235560|FG017|Overall Study|Death|0|||
146744141|NCT02733042|529235561|FG018|Overall Study|Death|0|||
146744142|NCT02838628|529235563|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
146744143|NCT02838628|529235564|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
146744144|NCT02838628|529235563|FG000|Recurrence Follow-up Period|Adverse Event|1|||
146744145|NCT02838628|529235564|FG001|Recurrence Follow-up Period|Adverse Event|0|||
146744146|NCT02838628|529235563|FG000|Recurrence Follow-up Period|Non-compliance|0|||
146744147|NCT02838628|529235564|FG001|Recurrence Follow-up Period|Non-compliance|1|||
146744148|NCT02838628|529235563|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
146744149|NCT02838628|529235564|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
146744150|NCT02838628|529235563|FG000|Recurrence Follow-up Period|Other un-specified|1|||
146744151|NCT02838628|529235564|FG001|Recurrence Follow-up Period|Other un-specified|1|||
146744152|NCT01821898|529235565|FG000|Overall Study|Withdrawal by Subject|2|||
146744153|NCT01821898|529235566|FG001|Overall Study|Withdrawal by Subject|1|||
146744154|NCT01155661|529235568|FG000|Overall Study|Adverse Event|101|||
146744155|NCT01155661|529235568|FG000|Overall Study|Death|1|||
146744156|NCT01155661|529235568|FG000|Overall Study|Lack of Efficacy|32|||
146744157|NCT01155661|529235568|FG000|Overall Study|Lost to Follow-up|22|||
146744158|NCT01155661|529235568|FG000|Overall Study|Physician Decision|3|||
146744159|NCT01155661|529235568|FG000|Overall Study|Protocol Violation|35|||
146744160|NCT01155661|529235568|FG000|Overall Study|Withdrawal by Subject|73|||
146744161|NCT01155661|529235568|FG000|Overall Study|Sponsor Decision|13|||
146744162|NCT05832437|529235569|FG000|Overall Study|time off work|1|||
146744163|NCT05832437|529235570|FG001|Overall Study|time off work|0|||
146744164|NCT05832437|529235571|FG002|Overall Study|time off work|0|||
146744165|NCT05832437|529235572|FG003|Overall Study|time off work|0|||
146744166|NCT04159415|529235573|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
146770082|NCT03516942|529326679|FG000|T2: 6 Month Survey|Lost|180|||
146744167|NCT04159415|529235574|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
146744168|NCT04159415|529235575|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
146744169|NCT04159415|529235576|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
146744170|NCT04159415|529235577|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
146744171|NCT04159415|529235578|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
146744172|NCT04159415|529235579|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
146744173|NCT04159415|529235580|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
146744174|NCT04159415|529235581|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
146744175|NCT04159415|529235582|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
146744176|NCT04159415|529235573|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146744177|NCT04159415|529235574|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146744178|NCT04159415|529235575|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146744179|NCT04159415|529235576|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146744180|NCT04159415|529235577|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146744181|NCT04159415|529235578|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146744182|NCT04159415|529235579|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146744183|NCT04159415|529235580|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
146744184|NCT04159415|529235581|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146744185|NCT04159415|529235582|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146744186|NCT04159415|529235573|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146744187|NCT04159415|529235574|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146744188|NCT04159415|529235575|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146744189|NCT04159415|529235576|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146744190|NCT04159415|529235577|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146744191|NCT04159415|529235578|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146744192|NCT04159415|529235579|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146744193|NCT04159415|529235580|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
146744194|NCT04159415|529235581|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146744195|NCT04159415|529235582|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146744196|NCT04159415|529235573|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146744197|NCT04159415|529235574|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146744198|NCT04159415|529235575|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146744199|NCT04159415|529235576|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146744200|NCT04159415|529235577|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146744201|NCT04159415|529235578|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146744202|NCT04159415|529235579|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146744203|NCT04159415|529235580|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146744204|NCT04159415|529235581|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146744205|NCT04159415|529235582|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
146744206|NCT00337662|529235583|FG000|Study Period II|Lost to Follow-up|0|||
146744207|NCT00337662|529235584|FG001|Study Period II|Lost to Follow-up|0|||
146744208|NCT00337662|529235585|FG002|Study Period II|Lost to Follow-up|0|||
146744209|NCT00337662|529235586|FG003|Study Period II|Lost to Follow-up|35|||
146744210|NCT00337662|529235583|FG000|Study Period II|Withdrawal by Subject|0|||
146744211|NCT00337662|529235584|FG001|Study Period II|Withdrawal by Subject|0|||
146744212|NCT00337662|529235585|FG002|Study Period II|Withdrawal by Subject|0|||
146744213|NCT00337662|529235586|FG003|Study Period II|Withdrawal by Subject|20|||
146744214|NCT00337662|529235583|FG000|Study Period II|Adverse Event|0|||
146744215|NCT00337662|529235584|FG001|Study Period II|Adverse Event|0|||
146511028|NCT00593606|528375371|FG000|Overall Study|Lost to Follow-up|2|||
146744216|NCT00337662|529235585|FG002|Study Period II|Adverse Event|0|||
146744217|NCT00337662|529235586|FG003|Study Period II|Adverse Event|16|||
146744218|NCT00337662|529235583|FG000|Study Period II|Physician Decision|0|||
146744219|NCT00337662|529235584|FG001|Study Period II|Physician Decision|0|||
146744220|NCT00337662|529235585|FG002|Study Period II|Physician Decision|0|||
146744221|NCT00337662|529235586|FG003|Study Period II|Physician Decision|13|||
146744222|NCT00337662|529235583|FG000|Study Period II|Entry Criteria Not Met|0|||
146744223|NCT00337662|529235584|FG001|Study Period II|Entry Criteria Not Met|0|||
146744224|NCT00337662|529235585|FG002|Study Period II|Entry Criteria Not Met|0|||
146744225|NCT00337662|529235586|FG003|Study Period II|Entry Criteria Not Met|6|||
146744226|NCT00337662|529235583|FG000|Study Period II|Protocol Violation|0|||
146744227|NCT00337662|529235584|FG001|Study Period II|Protocol Violation|0|||
146744228|NCT00337662|529235585|FG002|Study Period II|Protocol Violation|0|||
146744229|NCT00337662|529235586|FG003|Study Period II|Protocol Violation|6|||
146744230|NCT00337662|529235583|FG000|Study Period II|Lack of Efficacy|0|||
146744231|NCT00337662|529235584|FG001|Study Period II|Lack of Efficacy|0|||
146744232|NCT00337662|529235585|FG002|Study Period II|Lack of Efficacy|0|||
146744233|NCT00337662|529235586|FG003|Study Period II|Lack of Efficacy|7|||
146744234|NCT00337662|529235583|FG000|Study Period II|Sponsor Decision|0|||
146744235|NCT00337662|529235584|FG001|Study Period II|Sponsor Decision|0|||
146744236|NCT00337662|529235585|FG002|Study Period II|Sponsor Decision|0|||
146744237|NCT00337662|529235586|FG003|Study Period II|Sponsor Decision|2|||
146744238|NCT00337662|529235583|FG000|Study Period II|Parent/Caregiver Decision|0|||
146744239|NCT00337662|529235584|FG001|Study Period II|Parent/Caregiver Decision|0|||
146744240|NCT00337662|529235585|FG002|Study Period II|Parent/Caregiver Decision|0|||
146744241|NCT00337662|529235586|FG003|Study Period II|Parent/Caregiver Decision|1|||
146744242|NCT00337662|529235583|FG000|Study Period III|Lost to Follow-up|14|||
146744243|NCT00337662|529235584|FG001|Study Period III|Lost to Follow-up|16|||
146744244|NCT00337662|529235585|FG002|Study Period III|Lost to Follow-up|14|||
146744245|NCT00337662|529235586|FG003|Study Period III|Lost to Follow-up|0|||
146744246|NCT00337662|529235583|FG000|Study Period III|Withdrawal by Subject|18|||
146744247|NCT00337662|529235584|FG001|Study Period III|Withdrawal by Subject|14|||
146744248|NCT00337662|529235585|FG002|Study Period III|Withdrawal by Subject|12|||
146744249|NCT00337662|529235586|FG003|Study Period III|Withdrawal by Subject|0|||
146744250|NCT00337662|529235583|FG000|Study Period III|Adverse Event|9|||
146744251|NCT00337662|529235584|FG001|Study Period III|Adverse Event|10|||
146744252|NCT00337662|529235585|FG002|Study Period III|Adverse Event|8|||
146744253|NCT00337662|529235586|FG003|Study Period III|Adverse Event|0|||
146744254|NCT00337662|529235583|FG000|Study Period III|Protocol Violation|3|||
146744255|NCT00337662|529235584|FG001|Study Period III|Protocol Violation|8|||
146744256|NCT00337662|529235585|FG002|Study Period III|Protocol Violation|2|||
146744257|NCT00337662|529235586|FG003|Study Period III|Protocol Violation|0|||
146744258|NCT00337662|529235583|FG000|Study Period III|Physician Decision|6|||
146744259|NCT00337662|529235584|FG001|Study Period III|Physician Decision|5|||
146744260|NCT00337662|529235585|FG002|Study Period III|Physician Decision|0|||
146744261|NCT00337662|529235586|FG003|Study Period III|Physician Decision|0|||
146744262|NCT00337662|529235583|FG000|Study Period III|Entry Criteria Not Met|4|||
146744263|NCT00337662|529235584|FG001|Study Period III|Entry Criteria Not Met|1|||
146744264|NCT00337662|529235585|FG002|Study Period III|Entry Criteria Not Met|3|||
146744265|NCT00337662|529235586|FG003|Study Period III|Entry Criteria Not Met|0|||
146744266|NCT00337662|529235583|FG000|Study Period III|Lack of Efficacy|4|||
146744267|NCT00337662|529235584|FG001|Study Period III|Lack of Efficacy|4|||
146744268|NCT00337662|529235585|FG002|Study Period III|Lack of Efficacy|2|||
146744269|NCT00337662|529235586|FG003|Study Period III|Lack of Efficacy|0|||
146744270|NCT00337662|529235583|FG000|Study Period III|Parent/Caregiver Decision|0|||
146744271|NCT00337662|529235584|FG001|Study Period III|Parent/Caregiver Decision|0|||
146744272|NCT00337662|529235585|FG002|Study Period III|Parent/Caregiver Decision|2|||
146744273|NCT00337662|529235586|FG003|Study Period III|Parent/Caregiver Decision|0|||
146744274|NCT00337662|529235583|FG000|Study Period III|Sponsor Decision|1|||
146744275|NCT00337662|529235584|FG001|Study Period III|Sponsor Decision|0|||
146744276|NCT00337662|529235585|FG002|Study Period III|Sponsor Decision|1|||
146744277|NCT00337662|529235586|FG003|Study Period III|Sponsor Decision|0|||
146744278|NCT00337662|529235583|FG000|Study Period III|Clinical Relapse|1|||
146744279|NCT00337662|529235584|FG001|Study Period III|Clinical Relapse|0|||
146744280|NCT00337662|529235585|FG002|Study Period III|Clinical Relapse|0|||
146744281|NCT00337662|529235586|FG003|Study Period III|Clinical Relapse|0|||
146744282|NCT00882921|529235590|FG000|Overall Study|Death|2|||
146744283|NCT00882921|529235590|FG000|Overall Study|Other|3|||
146744284|NCT00882921|529235590|FG000|Overall Study|Lost to Follow-up|2|||
146744285|NCT00882921|529235590|FG000|Overall Study|Termination By Investigator|3|||
146744286|NCT00882921|529235590|FG000|Overall Study|Withdrawal Of Consent|1|||
146744287|NCT01018563|529235591|FG000|Overall Study|Termination of the study by Sponsor|2|||
146744288|NCT01018563|529235592|FG001|Overall Study|Termination of the study by Sponsor|1|||
146744289|NCT02344537|529235595|FG000|Overall Study|Protocol Violation|1|||
146744290|NCT02344537|529235596|FG001|Overall Study|Protocol Violation|1|||
146744291|NCT02344537|529235595|FG000|Overall Study|Subject started another treatment after wk 6|1|||
146744292|NCT02344537|529235596|FG001|Overall Study|Subject started another treatment after wk 6|0|||
146744293|NCT02344537|529235595|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
146744294|NCT02344537|529235596|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
146744295|NCT00960752|529235605|FG000|Overall Study|Adverse Event|0|||
146744296|NCT00960752|529235606|FG001|Overall Study|Adverse Event|0|||
146744297|NCT00960752|529235607|FG002|Overall Study|Adverse Event|1|||
146744298|NCT00960752|529235605|FG000|Overall Study|Progression|0|||
146744299|NCT00960752|529235606|FG001|Overall Study|Progression|0|||
146744300|NCT00960752|529235607|FG002|Overall Study|Progression|1|||
146744301|NCT04844970|529235608|FG000|Overall Study|Adverse Event|0|||
146744302|NCT04844970|529235609|FG001|Overall Study|Adverse Event|1|||
146744303|NCT04844970|529235608|FG000|Overall Study|Withdrawal by Subject|2|||
146511029|NCT00593606|528375371|FG000|Overall Study|Run-In Failure|5|||
146511030|NCT00593606|528375371|FG000|Overall Study|Screen Failure|3|||
146511031|NCT04643964|528375372|FG000|Overall Study|Lost to Follow-up|55|||
146744304|NCT04844970|529235609|FG001|Overall Study|Withdrawal by Subject|0|||
146744305|NCT05490329|529235610|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
146744306|NCT05490329|529235611|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
146744307|NCT05490329|529235610|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
146744308|NCT05490329|529235611|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
146744309|NCT05490329|529235610|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
146744310|NCT05490329|529235611|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
146744311|NCT03169881|529235612|FG000|Overall Study|Incomplete Follow-up|10|||
146744312|NCT03169881|529235613|FG001|Overall Study|Incomplete Follow-up|15|||
146744313|NCT03169881|529235612|FG000|Overall Study|Lost to Follow-up|18|||
146511032|NCT04643964|528375373|FG001|Overall Study|Lost to Follow-up|59|||
146744314|NCT03169881|529235613|FG001|Overall Study|Lost to Follow-up|20|||
146744315|NCT03169881|529235612|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
146744316|NCT03169881|529235613|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
146744317|NCT00856661|529235614|FG000|Overall Study|Death|15|||
146744318|NCT00856661|529235615|FG001|Overall Study|Death|18|||
146744319|NCT00856661|529235614|FG000|Overall Study|Protocol Violation|2|||
146744320|NCT00856661|529235615|FG001|Overall Study|Protocol Violation|1|||
146744321|NCT00856661|529235614|FG000|Overall Study|Withdrawal by Subject|1|||
146744322|NCT00856661|529235615|FG001|Overall Study|Withdrawal by Subject|2|||
146744323|NCT00856661|529235614|FG000|Overall Study|Lost to Follow-up|1|||
146744324|NCT00856661|529235615|FG001|Overall Study|Lost to Follow-up|3|||
146744325|NCT00856661|529235614|FG000|Overall Study|Physician Judgement|8|||
146744326|NCT00856661|529235615|FG001|Overall Study|Physician Judgement|5|||
146625182|NCT02081677|528803832|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
146744327|NCT03936777|529235616|FG000|Overall Study|Adverse Event|3|||
146744328|NCT03936777|529235616|FG000|Overall Study|Death|3|||
146744329|NCT03936777|529235616|FG000|Overall Study|Lack of Efficacy|24|||
146744330|NCT03936777|529235616|FG000|Overall Study|Lost to Follow-up|3|||
146744331|NCT03936777|529235616|FG000|Overall Study|Physician Decision|1|||
146744332|NCT03936777|529235616|FG000|Overall Study|Withdrawal by Subject|11|||
146744333|NCT03936777|529235616|FG000|Overall Study|Subjected Weaned of ZX008|1|||
146744334|NCT03936777|529235616|FG000|Overall Study|Missing|6|||
146625183|NCT02081677|528803833|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
146744335|NCT02306122|529235617|FG000|Initial Physician Randomization|Physician Decision|0|||
146851208|NCT00686725|529624143|FG000|Overall Study|Protocol Violation|1|||
146744336|NCT02306122|529235618|FG001|Initial Physician Randomization|Physician Decision|0|||
146744337|NCT02306122|529235619|FG002|Initial Physician Randomization|Physician Decision|0|||
146744338|NCT02306122|529235620|FG003|Initial Physician Randomization|Physician Decision|0|||
146744339|NCT02306122|529235621|FG004|Initial Physician Randomization|Physician Decision|0|||
146744340|NCT02306122|529235622|FG005|Initial Physician Randomization|Physician Decision|0|||
146744341|NCT02306122|529235623|FG006|Initial Physician Randomization|Physician Decision|0|||
146744342|NCT02306122|529235624|FG007|Initial Physician Randomization|Physician Decision|0|||
146744343|NCT02306122|529235625|FG008|Initial Physician Randomization|Physician Decision|1|||
146744344|NCT02306122|529235626|FG009|Initial Physician Randomization|Physician Decision|0|||
146744345|NCT02306122|529235627|FG010|Initial Physician Randomization|Physician Decision|0|||
146511033|NCT04643964|528375374|FG002|Overall Study|Lost to Follow-up|54|||
146744346|NCT03734991|529235631|FG000|Overall Study|Adverse Event|4|||
146744347|NCT03734991|529235632|FG001|Overall Study|Adverse Event|0|||
146744348|NCT03734991|529235631|FG000|Overall Study|Lost to Follow-up|4|||
146744349|NCT03734991|529235632|FG001|Overall Study|Lost to Follow-up|0|||
146744350|NCT03734991|529235631|FG000|Overall Study|Physician Decision|0|||
146744351|NCT03734991|529235632|FG001|Overall Study|Physician Decision|1|||
146744352|NCT03734991|529235631|FG000|Overall Study|Pregnancy|1|||
146744353|NCT03734991|529235632|FG001|Overall Study|Pregnancy|0|||
146744354|NCT03734991|529235631|FG000|Overall Study|Withdrawal by Subject|6|||
146744355|NCT03734991|529235632|FG001|Overall Study|Withdrawal by Subject|3|||
146744356|NCT03734991|529235631|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
146744357|NCT03734991|529235632|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
146744358|NCT03734991|529235631|FG000|Overall Study|Other|2|||
146744359|NCT03734991|529235632|FG001|Overall Study|Other|2|||
146744360|NCT00309608|529235635|FG000|Overall Study|Adverse Event|1|||
146744361|NCT00309608|529235636|FG001|Overall Study|Adverse Event|5|||
146744362|NCT00309608|529235637|FG002|Overall Study|Adverse Event|3|||
146744363|NCT00309608|529235638|FG003|Overall Study|Adverse Event|2|||
146744364|NCT00309608|529235639|FG004|Overall Study|Adverse Event|3|||
146744365|NCT00309608|529235635|FG000|Overall Study|Protocol Violation|2|||
146744366|NCT00309608|529235636|FG001|Overall Study|Protocol Violation|0|||
146744367|NCT00309608|529235637|FG002|Overall Study|Protocol Violation|0|||
146744368|NCT00309608|529235638|FG003|Overall Study|Protocol Violation|0|||
146744369|NCT00309608|529235639|FG004|Overall Study|Protocol Violation|0|||
146744370|NCT00309608|529235635|FG000|Overall Study|Lost to Follow-up|0|||
146744371|NCT00309608|529235636|FG001|Overall Study|Lost to Follow-up|0|||
146744372|NCT00309608|529235637|FG002|Overall Study|Lost to Follow-up|2|||
146744373|NCT00309608|529235638|FG003|Overall Study|Lost to Follow-up|0|||
146744374|NCT00309608|529235639|FG004|Overall Study|Lost to Follow-up|1|||
146744375|NCT00309608|529235635|FG000|Overall Study|Withdrawal by Subject|1|||
146744376|NCT00309608|529235636|FG001|Overall Study|Withdrawal by Subject|4|||
146744377|NCT00309608|529235637|FG002|Overall Study|Withdrawal by Subject|2|||
146744378|NCT00309608|529235638|FG003|Overall Study|Withdrawal by Subject|0|||
146744379|NCT00309608|529235639|FG004|Overall Study|Withdrawal by Subject|0|||
146744380|NCT00309608|529235635|FG000|Overall Study|Other incl. Lack of efficacy|10|||
146744381|NCT00309608|529235636|FG001|Overall Study|Other incl. Lack of efficacy|4|||
146744382|NCT00309608|529235637|FG002|Overall Study|Other incl. Lack of efficacy|3|||
146744383|NCT00309608|529235638|FG003|Overall Study|Other incl. Lack of efficacy|4|||
146744384|NCT00309608|529235639|FG004|Overall Study|Other incl. Lack of efficacy|0|||
146744385|NCT00127413|529235640|FG000|Overall Study|Lost to Follow-up|6|||
146744386|NCT00127413|529235641|FG001|Overall Study|Lost to Follow-up|4|||
146744387|NCT00127413|529235642|FG002|Overall Study|Lost to Follow-up|8|||
146744388|NCT00127413|529235643|FG003|Overall Study|Lost to Follow-up|2|||
146744389|NCT01051063|529235646|FG000|Overall Study|Death|2|||
146744390|NCT01051063|529235647|FG001|Overall Study|Death|2|||
146744391|NCT01051063|529235646|FG000|Overall Study|Withdrawal by Subject|1|||
146744392|NCT01051063|529235647|FG001|Overall Study|Withdrawal by Subject|1|||
146744393|NCT01051063|529235646|FG000|Overall Study|Termination of the study|5|||
146744394|NCT01051063|529235647|FG001|Overall Study|Termination of the study|0|||
146744395|NCT01051063|529235646|FG000|Overall Study|Moved from the study site area|1|||
146744396|NCT01051063|529235647|FG001|Overall Study|Moved from the study site area|0|||
146744397|NCT01051063|529235646|FG000|Overall Study|Other|1|||
146744398|NCT01051063|529235647|FG001|Overall Study|Other|0|||
146744399|NCT01051063|529235646|FG000|Overall Study|Lost to Follow-up|0|||
146744400|NCT01051063|529235647|FG001|Overall Study|Lost to Follow-up|1|||
146744401|NCT02023879|529235648|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
146744402|NCT02023879|529235649|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
146744403|NCT02023879|529235650|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
146744404|NCT02023879|529235648|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
146744405|NCT02023879|529235649|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
146744406|NCT02023879|529235650|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
146744407|NCT02023879|529235648|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
146744408|NCT02023879|529235649|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
146744409|NCT02023879|529235650|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
146744410|NCT02023879|529235648|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
146744411|NCT02023879|529235649|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
146744412|NCT02023879|529235650|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
146744413|NCT02023879|529235648|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
146744414|NCT02023879|529235649|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
146744415|NCT02023879|529235650|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
146744416|NCT02023879|529235648|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
146744417|NCT02023879|529235649|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
146744418|NCT02023879|529235650|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
146744419|NCT02023879|529235648|FG000|Extension Open Label Treatment|Adverse Event|1|||
146744420|NCT02023879|529235649|FG001|Extension Open Label Treatment|Adverse Event|7|||
146744421|NCT02023879|529235650|FG002|Extension Open Label Treatment|Adverse Event|3|||
146744422|NCT02023879|529235648|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
146744423|NCT02023879|529235649|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
146744424|NCT02023879|529235650|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
146744425|NCT02023879|529235648|FG000|Extension Open Label Treatment|Participant moved|1|||
146744426|NCT02023879|529235649|FG001|Extension Open Label Treatment|Participant moved|2|||
146744427|NCT02023879|529235650|FG002|Extension Open Label Treatment|Participant moved|0|||
146744428|NCT02023879|529235648|FG000|Extension Open Label Treatment|Other than specified above|2|||
146744429|NCT02023879|529235649|FG001|Extension Open Label Treatment|Other than specified above|7|||
146511034|NCT04643964|528375375|FG003|Overall Study|Lost to Follow-up|129|||
146511035|NCT04643964|528375376|FG004|Overall Study|Lost to Follow-up|48|||
146511036|NCT04643964|528375372|FG000|Overall Study|Failed attention check|1|||
146511037|NCT04643964|528375373|FG001|Overall Study|Failed attention check|8|||
146511038|NCT04643964|528375374|FG002|Overall Study|Failed attention check|2|||
146511039|NCT04643964|528375375|FG003|Overall Study|Failed attention check|14|||
146511040|NCT04643964|528375376|FG004|Overall Study|Failed attention check|11|||
146511041|NCT02638129|528375377|FG000|Overall Study|Study terminated|28|||
146511042|NCT02638129|528375378|FG001|Overall Study|Study terminated|30|||
146511043|NCT00869557|528375379|FG000|Randomized Phase|Lost to Follow-up|2|||
146511044|NCT00869557|528375380|FG001|Randomized Phase|Lost to Follow-up|1|||
146511045|NCT00869557|528375379|FG000|Randomized Phase|Investigator's Discretion|1|||
146511046|NCT00869557|528375380|FG001|Randomized Phase|Investigator's Discretion|0|||
146511047|NCT00869557|528375379|FG000|Randomized Phase|Withdrew Consent|0|||
146511048|NCT00869557|528375380|FG001|Randomized Phase|Withdrew Consent|1|||
146511049|NCT00869557|528375379|FG000|Extension Phase|Adverse Event|2|||
146511050|NCT00869557|528375380|FG001|Extension Phase|Adverse Event|2|||
146511051|NCT00869557|528375379|FG000|Extension Phase|Lack of Efficacy|1|||
146511052|NCT00869557|528375380|FG001|Extension Phase|Lack of Efficacy|0|||
146511053|NCT00869557|528375379|FG000|Extension Phase|Lost to Follow-up|3|||
146511054|NCT00869557|528375380|FG001|Extension Phase|Lost to Follow-up|1|||
146511055|NCT00869557|528375379|FG000|Extension Phase|Investigator's Discretion|2|||
146511056|NCT00869557|528375380|FG001|Extension Phase|Investigator's Discretion|0|||
146511057|NCT00869557|528375379|FG000|Extension Phase|Withdrew Consent|2|||
146511058|NCT00869557|528375380|FG001|Extension Phase|Withdrew Consent|0|||
146511059|NCT01472939|528375383|FG000|Overall Study|Adverse Event|3|||
146851209|NCT00686725|529624144|FG001|Overall Study|Protocol Violation|3|||
146511060|NCT01472939|528375384|FG001|Overall Study|Adverse Event|7|||
146744430|NCT02023879|529235650|FG002|Extension Open Label Treatment|Other than specified above|2|||
146744431|NCT00874432|529235651|FG000|Overall Study|Withdrawal by Subject|1|||
146744432|NCT00874432|529235652|FG001|Overall Study|Withdrawal by Subject|0|||
146744433|NCT00874432|529235653|FG002|Overall Study|Withdrawal by Subject|0|||
146744434|NCT00874432|529235654|FG003|Overall Study|Withdrawal by Subject|0|||
146744435|NCT00874432|529235651|FG000|Overall Study|Physician Decision|1|||
146744436|NCT00874432|529235652|FG001|Overall Study|Physician Decision|0|||
146744437|NCT00874432|529235653|FG002|Overall Study|Physician Decision|0|||
146744438|NCT00874432|529235654|FG003|Overall Study|Physician Decision|0|||
146744439|NCT00874432|529235651|FG000|Overall Study|Other|1|||
146744440|NCT00874432|529235652|FG001|Overall Study|Other|2|||
146744441|NCT00874432|529235653|FG002|Overall Study|Other|8|||
146744442|NCT00874432|529235654|FG003|Overall Study|Other|3|||
146744443|NCT03713021|529235655|FG000|Overall Study|Did not have CT sim scan available|6|||
146744444|NCT03713021|529235655|FG000|Overall Study|Not eligible|4|||
146744445|NCT03713021|529235655|FG000|Overall Study|Issues with TraceIT markers|5|||
146744446|NCT05256381|529235656|FG000|Overall Study|Withdrawal by Subject|4|||
146744447|NCT05256381|529235657|FG001|Overall Study|Withdrawal by Subject|0|||
146744448|NCT05256381|529235658|FG002|Overall Study|Withdrawal by Subject|2|||
146744449|NCT05256381|529235659|FG003|Overall Study|Withdrawal by Subject|2|||
146744450|NCT05256381|529235660|FG004|Overall Study|Withdrawal by Subject|8|||
146744451|NCT05256381|529235661|FG005|Overall Study|Withdrawal by Subject|6|||
146744452|NCT05256381|529235656|FG000|Overall Study|Physician Decision|0|||
146744453|NCT05256381|529235657|FG001|Overall Study|Physician Decision|0|||
146744454|NCT05256381|529235658|FG002|Overall Study|Physician Decision|1|||
146744455|NCT05256381|529235659|FG003|Overall Study|Physician Decision|0|||
146744456|NCT05256381|529235660|FG004|Overall Study|Physician Decision|2|||
146744457|NCT05256381|529235661|FG005|Overall Study|Physician Decision|0|||
146744458|NCT05256381|529235656|FG000|Overall Study|Death|17|||
146744459|NCT05256381|529235657|FG001|Overall Study|Death|3|||
146744460|NCT05256381|529235658|FG002|Overall Study|Death|4|||
146511061|NCT01472939|528375385|FG002|Overall Study|Adverse Event|7|||
146511062|NCT01472939|528375386|FG003|Overall Study|Adverse Event|14|||
146511063|NCT01472939|528375383|FG000|Overall Study|Lack of Efficacy|1|||
146511064|NCT01472939|528375384|FG001|Overall Study|Lack of Efficacy|0|||
146511065|NCT01472939|528375385|FG002|Overall Study|Lack of Efficacy|0|||
146511066|NCT01472939|528375386|FG003|Overall Study|Lack of Efficacy|1|||
146511067|NCT01472939|528375383|FG000|Overall Study|Lost to Follow-up|3|||
146511068|NCT01472939|528375384|FG001|Overall Study|Lost to Follow-up|0|||
146511069|NCT01472939|528375385|FG002|Overall Study|Lost to Follow-up|2|||
146511070|NCT01472939|528375386|FG003|Overall Study|Lost to Follow-up|0|||
146511071|NCT01472939|528375383|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
146511072|NCT01472939|528375384|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
146511073|NCT01472939|528375385|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
146511074|NCT01472939|528375386|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
146511075|NCT01472939|528375383|FG000|Overall Study|Prohibited Medication|0|||
146511076|NCT01472939|528375384|FG001|Overall Study|Prohibited Medication|1|||
146511077|NCT01472939|528375385|FG002|Overall Study|Prohibited Medication|0|||
146511078|NCT01472939|528375386|FG003|Overall Study|Prohibited Medication|0|||
146511079|NCT01472939|528375383|FG000|Overall Study|Withdrawal By PI|1|||
146511080|NCT01472939|528375384|FG001|Overall Study|Withdrawal By PI|0|||
146511081|NCT01472939|528375385|FG002|Overall Study|Withdrawal By PI|0|||
146511082|NCT01472939|528375386|FG003|Overall Study|Withdrawal By PI|0|||
146511083|NCT01472939|528375383|FG000|Overall Study|Protocol Violation|3|||
146511084|NCT01472939|528375384|FG001|Overall Study|Protocol Violation|3|||
146511085|NCT01472939|528375385|FG002|Overall Study|Protocol Violation|0|||
146511086|NCT01472939|528375386|FG003|Overall Study|Protocol Violation|1|||
146511087|NCT01472939|528375383|FG000|Overall Study|Withdrawal by Subject|9|||
146511088|NCT01472939|528375384|FG001|Overall Study|Withdrawal by Subject|3|||
146511089|NCT01472939|528375385|FG002|Overall Study|Withdrawal by Subject|1|||
146511090|NCT01472939|528375386|FG003|Overall Study|Withdrawal by Subject|4|||
146511091|NCT00114738|528375387|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
146511092|NCT00114738|528375388|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
146511093|NCT00114738|528375389|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
146511094|NCT00114738|528375387|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
146511095|NCT00114738|528375388|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
146511096|NCT00114738|528375389|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
146511097|NCT00114738|528375387|FG000|Screening for Randomization|Neuropathy|17|||
146511098|NCT00114738|528375388|FG001|Screening for Randomization|Neuropathy|0|||
146511099|NCT00114738|528375389|FG002|Screening for Randomization|Neuropathy|0|||
146511100|NCT00114738|528375387|FG000|Screening for Randomization|Progressive disease|2|||
146511101|NCT00114738|528375388|FG001|Screening for Randomization|Progressive disease|0|||
146511102|NCT00114738|528375389|FG002|Screening for Randomization|Progressive disease|0|||
146511103|NCT00114738|528375387|FG000|Screening for Randomization|CNS Hemorrhage|1|||
146511104|NCT00114738|528375388|FG001|Screening for Randomization|CNS Hemorrhage|0|||
146511105|NCT00114738|528375389|FG002|Screening for Randomization|CNS Hemorrhage|0|||
146511106|NCT00114738|528375387|FG000|Screening for Randomization|Other|1|||
146511107|NCT00114738|528375388|FG001|Screening for Randomization|Other|0|||
146511108|NCT00114738|528375389|FG002|Screening for Randomization|Other|0|||
146511109|NCT03738800|528375393|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
146511110|NCT03738800|528375394|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
146744461|NCT05256381|529235659|FG003|Overall Study|Death|5|||
146744462|NCT05256381|529235660|FG004|Overall Study|Death|24|||
146744463|NCT05256381|529235661|FG005|Overall Study|Death|21|||
146744464|NCT05256381|529235656|FG000|Overall Study|Other, not specified|0|||
146744465|NCT05256381|529235657|FG001|Overall Study|Other, not specified|0|||
146744466|NCT05256381|529235658|FG002|Overall Study|Other, not specified|0|||
146744467|NCT05256381|529235659|FG003|Overall Study|Other, not specified|0|||
146744468|NCT05256381|529235660|FG004|Overall Study|Other, not specified|2|||
146744469|NCT05256381|529235661|FG005|Overall Study|Other, not specified|1|||
146744470|NCT05256381|529235656|FG000|Overall Study|Study terminated by sponsor|18|||
146744471|NCT05256381|529235657|FG001|Overall Study|Study terminated by sponsor|5|||
146744472|NCT05256381|529235658|FG002|Overall Study|Study terminated by sponsor|5|||
146744473|NCT05256381|529235659|FG003|Overall Study|Study terminated by sponsor|5|||
146744474|NCT05256381|529235660|FG004|Overall Study|Study terminated by sponsor|18|||
146744475|NCT05256381|529235661|FG005|Overall Study|Study terminated by sponsor|11|||
146744476|NCT05256381|529235656|FG000|Overall Study|Lost to Follow-up|1|||
146744477|NCT05256381|529235657|FG001|Overall Study|Lost to Follow-up|0|||
146744478|NCT05256381|529235658|FG002|Overall Study|Lost to Follow-up|0|||
146744479|NCT05256381|529235659|FG003|Overall Study|Lost to Follow-up|0|||
146744480|NCT05256381|529235660|FG004|Overall Study|Lost to Follow-up|1|||
146744481|NCT05256381|529235661|FG005|Overall Study|Lost to Follow-up|0|||
146744482|NCT01702428|529237309|FG000|Overall Study|Adverse Event|2|||
146744483|NCT01702428|529237310|FG001|Overall Study|Adverse Event|0|||
146744484|NCT01702428|529237311|FG002|Overall Study|Adverse Event|0|||
146744485|NCT01702428|529237312|FG003|Overall Study|Adverse Event|0|||
146744486|NCT01702428|529237309|FG000|Overall Study|Lost to Follow-up|33|||
146744487|NCT01702428|529237310|FG001|Overall Study|Lost to Follow-up|41|||
146744488|NCT01702428|529237311|FG002|Overall Study|Lost to Follow-up|37|||
146744489|NCT01702428|529237312|FG003|Overall Study|Lost to Follow-up|44|||
146744490|NCT01702428|529237309|FG000|Overall Study|Parents cannot assist to site|1|||
146744491|NCT01702428|529237310|FG001|Overall Study|Parents cannot assist to site|0|||
146744492|NCT01702428|529237311|FG002|Overall Study|Parents cannot assist to site|1|||
146744493|NCT01702428|529237312|FG003|Overall Study|Parents cannot assist to site|0|||
146744494|NCT01702428|529237309|FG000|Overall Study|Lost Coverage|0|||
146744495|NCT01702428|529237310|FG001|Overall Study|Lost Coverage|0|||
146744496|NCT01702428|529237311|FG002|Overall Study|Lost Coverage|0|||
146744497|NCT01702428|529237312|FG003|Overall Study|Lost Coverage|1|||
146744498|NCT01702428|529237309|FG000|Overall Study|Lost Health Plan|3|||
146744499|NCT01702428|529237310|FG001|Overall Study|Lost Health Plan|5|||
146744500|NCT01702428|529237311|FG002|Overall Study|Lost Health Plan|0|||
146744501|NCT01702428|529237312|FG003|Overall Study|Lost Health Plan|2|||
146744502|NCT01702428|529237309|FG000|Overall Study|Mother transferred care|0|||
146744503|NCT01702428|529237310|FG001|Overall Study|Mother transferred care|1|||
146744504|NCT01702428|529237311|FG002|Overall Study|Mother transferred care|0|||
146744505|NCT01702428|529237312|FG003|Overall Study|Mother transferred care|0|||
146744506|NCT01702428|529237309|FG000|Overall Study|Parents too busy|1|||
146744507|NCT01702428|529237310|FG001|Overall Study|Parents too busy|0|||
146744508|NCT01702428|529237311|FG002|Overall Study|Parents too busy|0|||
146744509|NCT01702428|529237312|FG003|Overall Study|Parents too busy|0|||
146744510|NCT01702428|529237309|FG000|Overall Study|Protocol Violation|3|||
146744511|NCT01702428|529237310|FG001|Overall Study|Protocol Violation|0|||
146744512|NCT01702428|529237311|FG002|Overall Study|Protocol Violation|1|||
146744513|NCT01702428|529237312|FG003|Overall Study|Protocol Violation|0|||
146744514|NCT01702428|529237309|FG000|Overall Study|Withdrawal by Subject|21|||
146744515|NCT01702428|529237310|FG001|Overall Study|Withdrawal by Subject|23|||
146744516|NCT01702428|529237311|FG002|Overall Study|Withdrawal by Subject|14|||
146744517|NCT01702428|529237312|FG003|Overall Study|Withdrawal by Subject|10|||
146744518|NCT02091869|529237315|FG000|Overall Study|Withdrawal by Subject|0|||
146744519|NCT02091869|529237316|FG001|Overall Study|Withdrawal by Subject|3|||
146744520|NCT01533714|529237321|FG000|Overall Study|Adverse Event|0|||
146744521|NCT01533714|529237322|FG001|Overall Study|Adverse Event|1|||
146744522|NCT01533714|529237323|FG002|Overall Study|Adverse Event|2|||
146744523|NCT01533714|529237324|FG003|Overall Study|Adverse Event|2|||
146744524|NCT01533714|529237325|FG004|Overall Study|Adverse Event|2|||
146744525|NCT01533714|529237326|FG005|Overall Study|Adverse Event|1|||
146744526|NCT01533714|529237321|FG000|Overall Study|Lack of Efficacy|0|||
146744527|NCT01533714|529237322|FG001|Overall Study|Lack of Efficacy|0|||
146744528|NCT01533714|529237323|FG002|Overall Study|Lack of Efficacy|0|||
146744529|NCT01533714|529237324|FG003|Overall Study|Lack of Efficacy|0|||
146744530|NCT01533714|529237325|FG004|Overall Study|Lack of Efficacy|0|||
146744531|NCT01533714|529237326|FG005|Overall Study|Lack of Efficacy|1|||
146744532|NCT01533714|529237321|FG000|Overall Study|Withdrawal by Subject|0|||
146744533|NCT01533714|529237322|FG001|Overall Study|Withdrawal by Subject|1|||
146744534|NCT01533714|529237323|FG002|Overall Study|Withdrawal by Subject|0|||
146744535|NCT01533714|529237324|FG003|Overall Study|Withdrawal by Subject|1|||
146744536|NCT01533714|529237325|FG004|Overall Study|Withdrawal by Subject|1|||
146744537|NCT01533714|529237326|FG005|Overall Study|Withdrawal by Subject|0|||
146744538|NCT01533714|529237321|FG000|Overall Study|Exclusion criteria|0|||
146744539|NCT01533714|529237322|FG001|Overall Study|Exclusion criteria|1|||
146744540|NCT01533714|529237323|FG002|Overall Study|Exclusion criteria|0|||
146744541|NCT01533714|529237324|FG003|Overall Study|Exclusion criteria|0|||
146744542|NCT01533714|529237325|FG004|Overall Study|Exclusion criteria|0|||
146744543|NCT01533714|529237326|FG005|Overall Study|Exclusion criteria|0|||
146744544|NCT01533714|529237321|FG000|Overall Study|Positive for purified protein derivative|0|||
146744545|NCT01533714|529237322|FG001|Overall Study|Positive for purified protein derivative|0|||
146744546|NCT01533714|529237323|FG002|Overall Study|Positive for purified protein derivative|1|||
146744547|NCT01533714|529237324|FG003|Overall Study|Positive for purified protein derivative|0|||
146744548|NCT01533714|529237325|FG004|Overall Study|Positive for purified protein derivative|1|||
146744549|NCT01533714|529237326|FG005|Overall Study|Positive for purified protein derivative|0|||
146744550|NCT01533714|529237321|FG000|Overall Study|Withdrawal criteria|0|||
146744551|NCT01533714|529237322|FG001|Overall Study|Withdrawal criteria|0|||
146744552|NCT01533714|529237323|FG002|Overall Study|Withdrawal criteria|1|||
146744553|NCT01533714|529237324|FG003|Overall Study|Withdrawal criteria|0|||
146744554|NCT01533714|529237325|FG004|Overall Study|Withdrawal criteria|3|||
146744555|NCT01533714|529237326|FG005|Overall Study|Withdrawal criteria|1|||
146744556|NCT01533714|529237321|FG000|Overall Study|Ineligibility reason|0|||
146744557|NCT01533714|529237322|FG001|Overall Study|Ineligibility reason|0|||
146744558|NCT01533714|529237323|FG002|Overall Study|Ineligibility reason|0|||
146744559|NCT01533714|529237324|FG003|Overall Study|Ineligibility reason|1|||
146744560|NCT01533714|529237325|FG004|Overall Study|Ineligibility reason|0|||
146744561|NCT01533714|529237326|FG005|Overall Study|Ineligibility reason|0|||
146744562|NCT02564055|529237327|FG000|Overall Study|Adverse Event|1|||
146744563|NCT02564055|529237328|FG001|Overall Study|Adverse Event|0|||
146744564|NCT02564055|529237329|FG002|Overall Study|Adverse Event|4|||
146744565|NCT02564055|529237330|FG003|Overall Study|Adverse Event|1|||
146744566|NCT02564055|529237331|FG004|Overall Study|Adverse Event|4|||
146744567|NCT02564055|529237332|FG005|Overall Study|Adverse Event|1|||
146744568|NCT02564055|529237327|FG000|Overall Study|Protocol Violation|1|||
146744569|NCT02564055|529237328|FG001|Overall Study|Protocol Violation|0|||
146744570|NCT02564055|529237329|FG002|Overall Study|Protocol Violation|0|||
146744571|NCT02564055|529237330|FG003|Overall Study|Protocol Violation|0|||
146744572|NCT02564055|529237331|FG004|Overall Study|Protocol Violation|0|||
146744573|NCT02564055|529237332|FG005|Overall Study|Protocol Violation|0|||
146744574|NCT02564055|529237327|FG000|Overall Study|Reached stopping criteria|0|||
146744575|NCT02564055|529237328|FG001|Overall Study|Reached stopping criteria|0|||
146744576|NCT02564055|529237329|FG002|Overall Study|Reached stopping criteria|0|||
146744577|NCT02564055|529237330|FG003|Overall Study|Reached stopping criteria|0|||
146744578|NCT02564055|529237331|FG004|Overall Study|Reached stopping criteria|0|||
146851210|NCT00686725|529624143|FG000|Overall Study|Other|1|||
146744579|NCT02564055|529237332|FG005|Overall Study|Reached stopping criteria|1|||
146744580|NCT02564055|529237327|FG000|Overall Study|Lost to Follow-up|0|||
146744581|NCT02564055|529237328|FG001|Overall Study|Lost to Follow-up|1|||
146744582|NCT02564055|529237329|FG002|Overall Study|Lost to Follow-up|4|||
146744583|NCT02564055|529237330|FG003|Overall Study|Lost to Follow-up|2|||
146744584|NCT02564055|529237331|FG004|Overall Study|Lost to Follow-up|1|||
146744585|NCT02564055|529237332|FG005|Overall Study|Lost to Follow-up|0|||
146744586|NCT02564055|529237327|FG000|Overall Study|Physician Decision|0|||
146744587|NCT02564055|529237328|FG001|Overall Study|Physician Decision|0|||
146744588|NCT02564055|529237329|FG002|Overall Study|Physician Decision|1|||
146744589|NCT02564055|529237330|FG003|Overall Study|Physician Decision|0|||
146744590|NCT02564055|529237331|FG004|Overall Study|Physician Decision|0|||
146744591|NCT02564055|529237332|FG005|Overall Study|Physician Decision|0|||
146744592|NCT02564055|529237327|FG000|Overall Study|Withdrawal by Subject|4|||
146744593|NCT02564055|529237328|FG001|Overall Study|Withdrawal by Subject|4|||
146511111|NCT03738800|528375395|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146744594|NCT02564055|529237329|FG002|Overall Study|Withdrawal by Subject|3|||
146744595|NCT02564055|529237330|FG003|Overall Study|Withdrawal by Subject|3|||
146851211|NCT00686725|529624144|FG001|Overall Study|Other|3|||
146744596|NCT02564055|529237331|FG004|Overall Study|Withdrawal by Subject|10|||
146744597|NCT02564055|529237332|FG005|Overall Study|Withdrawal by Subject|10|||
146744598|NCT01375959|529237333|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
146744599|NCT01375959|529237334|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
146744600|NCT01375959|529237333|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
146744601|NCT01375959|529237334|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
146744602|NCT01375959|529237333|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
146744603|NCT01375959|529237334|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
146744604|NCT02572817|529237336|FG000|Overall Study|Death|6|||
146744605|NCT02572817|529237337|FG001|Overall Study|Death|3|||
146744606|NCT02572817|529237336|FG000|Overall Study|Lost to Follow-up|3|||
146744607|NCT02572817|529237337|FG001|Overall Study|Lost to Follow-up|3|||
146744608|NCT02310126|529237338|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
146744609|NCT02310126|529237339|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
146744610|NCT02310126|529237338|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
146744611|NCT02310126|529237339|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
146744612|NCT03632434|529237343|FG000|Overall Study|Withdrawal by Subject|2|||
146744613|NCT04297241|529237344|FG000|Overall Study|Withdrawal by Subject|1|||
146744614|NCT04297241|529237344|FG000|Overall Study|Adverse Event|1|||
146744615|NCT04297241|529237344|FG000|Overall Study|Physician Decision|3|||
146744616|NCT03688711|529237357|FG000|Overall Study|Withdrawal by Subject|0|||
146744617|NCT03688711|529237358|FG001|Overall Study|Withdrawal by Subject|1|||
146744618|NCT03904693|529237360|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
146744619|NCT03904693|529237361|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
146744620|NCT03904693|529237362|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
146744621|NCT03904693|529237363|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
146744622|NCT03904693|529237364|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
146744623|NCT03904693|529237365|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
146744624|NCT03904693|529237360|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146744625|NCT03904693|529237361|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146744626|NCT03904693|529237362|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
146744627|NCT03904693|529237363|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146744628|NCT03904693|529237364|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146744629|NCT03904693|529237365|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146744630|NCT03904693|529237360|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
146744631|NCT03904693|529237361|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
146744632|NCT03904693|529237362|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
146744633|NCT03904693|529237363|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
146744634|NCT03904693|529237364|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
146744635|NCT03904693|529237365|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
146744636|NCT03904693|529237360|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
146744637|NCT03904693|529237361|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
146744638|NCT03904693|529237362|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
146744639|NCT03904693|529237363|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
146744640|NCT03904693|529237364|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
146744641|NCT03904693|529237365|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
146744642|NCT03904693|529237360|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
146744643|NCT03904693|529237361|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
146744644|NCT03904693|529237362|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
146744645|NCT03904693|529237363|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
146744646|NCT03904693|529237364|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
146744647|NCT03904693|529237365|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
146744648|NCT03904693|529237360|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
146744649|NCT03904693|529237361|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
146744650|NCT03904693|529237362|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
146744651|NCT03904693|529237363|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
146744652|NCT03904693|529237364|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
146744653|NCT03904693|529237365|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
146744654|NCT03904693|529237360|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
146744655|NCT03904693|529237361|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
146744656|NCT03904693|529237362|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
146744657|NCT03904693|529237363|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
146744658|NCT03904693|529237364|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
146744659|NCT03904693|529237365|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
146511112|NCT03738800|528375393|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
146511113|NCT03738800|528375394|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
146511114|NCT03738800|528375395|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
146511115|NCT03738800|528375393|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
146511116|NCT03738800|528375394|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
146511117|NCT03738800|528375395|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
146511118|NCT02223819|528375401|FG000|Overall Study|Lost to Follow-up|2|||
146511119|NCT01917344|528375403|FG000|Overall Study|Withdrawal by Subject|1|||
146511120|NCT02956057|528375404|FG000|Overall Study|Discontinued intervention|14|||
146511121|NCT02956057|528375405|FG001|Overall Study|Discontinued intervention|10|||
146511122|NCT02956057|528375406|FG002|Overall Study|Discontinued intervention|7|||
146511123|NCT02956057|528375407|FG003|Overall Study|Discontinued intervention|14|||
146511124|NCT02956057|528375408|FG004|Overall Study|Discontinued intervention|4|||
146511125|NCT02956057|528375409|FG005|Overall Study|Discontinued intervention|17|||
146511126|NCT02956057|528375404|FG000|Overall Study|Lost to Follow-up|0|||
146511127|NCT02956057|528375405|FG001|Overall Study|Lost to Follow-up|2|||
146511128|NCT02956057|528375406|FG002|Overall Study|Lost to Follow-up|1|||
146511129|NCT02956057|528375407|FG003|Overall Study|Lost to Follow-up|1|||
146511130|NCT02956057|528375408|FG004|Overall Study|Lost to Follow-up|1|||
146511131|NCT02956057|528375409|FG005|Overall Study|Lost to Follow-up|0|||
146511132|NCT03435224|528375412|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
146511133|NCT00367484|528375413|FG000|Overall Study|Adverse Event|7|||
146511134|NCT00367484|528375413|FG000|Overall Study|Withdrew informed consent|5|||
146511135|NCT00367484|528375413|FG000|Overall Study|Travel to USA|1|||
146511136|NCT00367484|528375413|FG000|Overall Study|Lost to Follow-up|1|||
146511137|NCT00367484|528375413|FG000|Overall Study|Protocol Violation|1|||
146511138|NCT00367484|528375413|FG000|Overall Study|The choice of the patient|1|||
146511139|NCT00367484|528375413|FG000|Overall Study|Lack of Efficacy|1|||
146511140|NCT00908076|528375414|FG000|Overall Study|Lack of Efficacy|1|||
146511141|NCT00908076|528375415|FG001|Overall Study|Lack of Efficacy|1|||
146511142|NCT02382796|528375416|FG000|Overall Study|Global deterioration of health status|1|||
146511143|NCT02382796|528375416|FG000|Overall Study|Objective progression or relapse|3|||
146511144|NCT02382796|528375416|FG000|Overall Study|Commercial dacomitinib became available|3|||
146511145|NCT03769675|528375427|FG000|Overall Study|Lost to Follow-up|1|||
146511146|NCT04068688|528375428|FG000|Overall Study|Lost to Follow-up|1|||
146511147|NCT04068688|528375429|FG001|Overall Study|Lost to Follow-up|1|||
146511148|NCT04068688|528375430|FG002|Overall Study|Lost to Follow-up|0|||
146511149|NCT04068688|528375431|FG003|Overall Study|Lost to Follow-up|0|||
146511150|NCT04068688|528375432|FG004|Overall Study|Lost to Follow-up|5|||
146511151|NCT04068688|528375433|FG005|Overall Study|Lost to Follow-up|5|||
146511152|NCT04068688|528375434|FG006|Overall Study|Lost to Follow-up|0|||
146511153|NCT04068688|528375435|FG007|Overall Study|Lost to Follow-up|0|||
146511154|NCT04068688|528375436|FG008|Overall Study|Lost to Follow-up|1|||
146511155|NCT04068688|528375437|FG009|Overall Study|Lost to Follow-up|0|||
146511156|NCT04068688|528375428|FG000|Overall Study|Withdrawal by Subject|1|||
146511157|NCT04068688|528375429|FG001|Overall Study|Withdrawal by Subject|1|||
146511158|NCT04068688|528375430|FG002|Overall Study|Withdrawal by Subject|0|||
146511159|NCT04068688|528375431|FG003|Overall Study|Withdrawal by Subject|0|||
146511160|NCT04068688|528375432|FG004|Overall Study|Withdrawal by Subject|0|||
146511161|NCT04068688|528375433|FG005|Overall Study|Withdrawal by Subject|0|||
146511162|NCT04068688|528375434|FG006|Overall Study|Withdrawal by Subject|0|||
146511163|NCT04068688|528375435|FG007|Overall Study|Withdrawal by Subject|0|||
146511164|NCT04068688|528375436|FG008|Overall Study|Withdrawal by Subject|0|||
146511165|NCT04068688|528375437|FG009|Overall Study|Withdrawal by Subject|0|||
146511166|NCT04068688|528375428|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
146511167|NCT04068688|528375429|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
146511168|NCT04068688|528375430|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
146511169|NCT04068688|528375431|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
146511170|NCT04068688|528375432|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
146511171|NCT04068688|528375433|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
146511172|NCT04068688|528375434|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
146511173|NCT04068688|528375435|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
146511174|NCT04068688|528375436|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
146914643|NCT03303339|529850052|FG010|Overall Study|Death|4|||
146511175|NCT04068688|528375437|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
146511176|NCT02554318|528375440|FG000|Overall Study|Withdrawal by Subject|10|||
146744660|NCT03904693|529237360|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
146744661|NCT03904693|529237361|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
146744662|NCT03904693|529237362|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
146744663|NCT03904693|529237363|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
146744664|NCT03904693|529237364|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
146744665|NCT03904693|529237365|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
146744666|NCT03904693|529237360|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
146744667|NCT03904693|529237361|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
146744668|NCT03904693|529237362|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
146744669|NCT03904693|529237363|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
146744670|NCT03904693|529237364|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
146744671|NCT03904693|529237365|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
146744672|NCT03904693|529237360|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
146744673|NCT03904693|529237361|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
146744674|NCT03904693|529237362|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
146744675|NCT03904693|529237363|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
146744676|NCT03904693|529237364|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
146744677|NCT03904693|529237365|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
146744678|NCT03904693|529237360|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
146744679|NCT03904693|529237361|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
146744680|NCT03904693|529237362|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
146744681|NCT03904693|529237363|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
146744682|NCT03904693|529237364|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
146744683|NCT03904693|529237365|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
146744684|NCT04654468|529237366|FG000|Overall Study|Death|1|||
146744685|NCT04654468|529237366|FG000|Overall Study|Ongoing in the Study|50|||
146744686|NCT06390826|529237367|FG000|Overall Study|Never Start Protocol Therapy|1|||
146744687|NCT06390826|529237367|FG000|Overall Study|Adverse Event|1|||
146744688|NCT06390826|529237367|FG000|Overall Study|Disease Progression|8|||
146744689|NCT03698019|529237379|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
146744690|NCT03698019|529237380|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
146744691|NCT03698019|529237379|FG000|Step 1: Registration|Withdrawal by Subject|7|||
146744692|NCT03698019|529237380|FG001|Step 1: Registration|Withdrawal by Subject|2|||
146744693|NCT03698019|529237379|FG000|Step 1: Registration|Toxicity|0|||
146744694|NCT03698019|529237380|FG001|Step 1: Registration|Toxicity|1|||
146744695|NCT03698019|529237379|FG000|Step 1: Registration|Disease Progression|0|||
146744696|NCT03698019|529237380|FG001|Step 1: Registration|Disease Progression|12|||
146744697|NCT03698019|529237379|FG000|Step 1: Registration|Co-morbidities|0|||
146744698|NCT03698019|529237380|FG001|Step 1: Registration|Co-morbidities|1|||
146744699|NCT03698019|529237379|FG000|Step 1: Registration|Scheduling Issues|1|||
146744700|NCT03698019|529237380|FG001|Step 1: Registration|Scheduling Issues|0|||
146744701|NCT03698019|529237379|FG000|Step 1: Registration|Participant Refusal|0|||
146744702|NCT03698019|529237380|FG001|Step 1: Registration|Participant Refusal|1|||
146744703|NCT03698019|529237379|FG000|Step 2: Surgery|Participant Refusal|2|||
146744704|NCT03698019|529237380|FG001|Step 2: Surgery|Participant Refusal|1|||
146744705|NCT03698019|529237379|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
146744706|NCT03698019|529237380|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
146744707|NCT03698019|529237379|FG000|Step 2: Surgery|Metastatic Disease|16|||
146744708|NCT03698019|529237380|FG001|Step 2: Surgery|Metastatic Disease|9|||
146744709|NCT03698019|529237379|FG000|Step 2: Surgery|Residual Disease|2|||
146744710|NCT03698019|529237380|FG001|Step 2: Surgery|Residual Disease|1|||
146744711|NCT03698019|529237379|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
146744712|NCT03698019|529237380|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
146744713|NCT03698019|529237379|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
146744714|NCT03698019|529237380|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
146744715|NCT03698019|529237379|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
146744716|NCT03698019|529237380|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
146744717|NCT03698019|529237379|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
146744718|NCT03698019|529237380|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
146744719|NCT03698019|529237379|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
146744720|NCT03698019|529237380|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
146744721|NCT03698019|529237379|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
146744722|NCT03698019|529237380|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
146744723|NCT03698019|529237379|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
146744724|NCT03698019|529237380|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
146744725|NCT03698019|529237379|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
146744726|NCT03698019|529237380|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
146744727|NCT05407311|529237381|FG000|Overall Study|Withdrawal by Subject|5|||
146744728|NCT05407311|529237381|FG000|Overall Study|Protocol Violation|3|||
146744729|NCT05407311|529237381|FG000|Overall Study|Physician Decision|1|||
146744730|NCT05407311|529237381|FG000|Overall Study|Non-compliance|1|||
146744731|NCT05027074|529237386|FG000|Overall Study|Death|47|||
146744732|NCT05027074|529237387|FG001|Overall Study|Death|42|||
146744733|NCT05027074|529237388|FG002|Overall Study|Death|39|||
146744734|NCT05027074|529237386|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146744735|NCT05027074|529237387|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146744736|NCT05027074|529237388|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146744737|NCT05027074|529237386|FG000|Overall Study|Site Terminated By Sponsor|3|||
146744738|NCT05027074|529237387|FG001|Overall Study|Site Terminated By Sponsor|0|||
146744739|NCT05027074|529237388|FG002|Overall Study|Site Terminated By Sponsor|2|||
146744740|NCT05027074|529237386|FG000|Overall Study|Withdrawal by Subject|13|||
146744741|NCT05027074|529237387|FG001|Overall Study|Withdrawal by Subject|8|||
146744742|NCT05027074|529237388|FG002|Overall Study|Withdrawal by Subject|10|||
146744743|NCT05027074|529237386|FG000|Overall Study|Lost to Follow-up|2|||
146744744|NCT05027074|529237387|FG001|Overall Study|Lost to Follow-up|4|||
146744745|NCT05027074|529237388|FG002|Overall Study|Lost to Follow-up|3|||
146744746|NCT05027074|529237386|FG000|Overall Study|Status Not Recorded|0|||
146744747|NCT05027074|529237387|FG001|Overall Study|Status Not Recorded|0|||
146744748|NCT05027074|529237388|FG002|Overall Study|Status Not Recorded|1|||
146744749|NCT04150029|529237389|FG000|Overall Study|Disease Relapse|0|||
146744750|NCT04150029|529237390|FG001|Overall Study|Disease Relapse|18|||
146744751|NCT04150029|529237389|FG000|Overall Study|Progressive Disease|2|||
146744752|NCT04150029|529237390|FG001|Overall Study|Progressive Disease|16|||
146744753|NCT04150029|529237389|FG000|Overall Study|Adverse Event|1|||
146744754|NCT04150029|529237390|FG001|Overall Study|Adverse Event|11|||
146744755|NCT04150029|529237389|FG000|Overall Study|Physician Decision|0|||
146744756|NCT04150029|529237390|FG001|Overall Study|Physician Decision|10|||
146744757|NCT04150029|529237389|FG000|Overall Study|Study Terminated by Sponsor|1|||
146744758|NCT04150029|529237390|FG001|Overall Study|Study Terminated by Sponsor|10|||
146744759|NCT04150029|529237389|FG000|Overall Study|Death|0|||
146744760|NCT04150029|529237390|FG001|Overall Study|Death|8|||
146744761|NCT04150029|529237389|FG000|Overall Study|Participant Decision|0|||
146744762|NCT04150029|529237390|FG001|Overall Study|Participant Decision|7|||
146744763|NCT04150029|529237389|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
146744764|NCT04150029|529237390|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
146744765|NCT02364713|529237394|FG000|Overall Study|Ineligible|2|||
146744766|NCT02364713|529237395|FG001|Overall Study|Ineligible|2|||
146744767|NCT03797326|529237396|FG000|Overall Study|Lost to Follow-up|1|||
146744768|NCT03797326|529237397|FG001|Overall Study|Lost to Follow-up|0|||
146744769|NCT03797326|529237398|FG002|Overall Study|Lost to Follow-up|0|||
146744770|NCT03797326|529237399|FG003|Overall Study|Lost to Follow-up|1|||
146744771|NCT03797326|529237400|FG004|Overall Study|Lost to Follow-up|0|||
146744772|NCT03797326|529237401|FG005|Overall Study|Lost to Follow-up|0|||
146744773|NCT03797326|529237402|FG006|Overall Study|Lost to Follow-up|0|||
146744774|NCT03797326|529237403|FG007|Overall Study|Lost to Follow-up|0|||
146744775|NCT03797326|529237396|FG000|Overall Study|Withdrawal by Subject|0|||
146744776|NCT03797326|529237397|FG001|Overall Study|Withdrawal by Subject|0|||
146744777|NCT03797326|529237398|FG002|Overall Study|Withdrawal by Subject|1|||
146744778|NCT03797326|529237399|FG003|Overall Study|Withdrawal by Subject|3|||
146744779|NCT03797326|529237400|FG004|Overall Study|Withdrawal by Subject|0|||
146744780|NCT03797326|529237401|FG005|Overall Study|Withdrawal by Subject|2|||
146744781|NCT03797326|529237402|FG006|Overall Study|Withdrawal by Subject|2|||
146744782|NCT03797326|529237403|FG007|Overall Study|Withdrawal by Subject|3|||
146744783|NCT03797326|529237396|FG000|Overall Study|Sponsor Decision|3|||
146744784|NCT03797326|529237397|FG001|Overall Study|Sponsor Decision|3|||
146744785|NCT03797326|529237398|FG002|Overall Study|Sponsor Decision|3|||
146744786|NCT03797326|529237399|FG003|Overall Study|Sponsor Decision|6|||
146744787|NCT03797326|529237400|FG004|Overall Study|Sponsor Decision|0|||
146744788|NCT03797326|529237401|FG005|Overall Study|Sponsor Decision|3|||
146744789|NCT03797326|529237402|FG006|Overall Study|Sponsor Decision|3|||
146744790|NCT03797326|529237403|FG007|Overall Study|Sponsor Decision|2|||
146744791|NCT03797326|529237396|FG000|Overall Study|Death|27|||
146744792|NCT03797326|529237397|FG001|Overall Study|Death|28|||
146744793|NCT03797326|529237398|FG002|Overall Study|Death|95|||
146744794|NCT03797326|529237399|FG003|Overall Study|Death|95|||
146744795|NCT03797326|529237400|FG004|Overall Study|Death|30|||
146744796|NCT03797326|529237401|FG005|Overall Study|Death|96|||
146744797|NCT03797326|529237402|FG006|Overall Study|Death|97|||
146744798|NCT03797326|529237403|FG007|Overall Study|Death|98|||
146511177|NCT02554318|528375441|FG001|Overall Study|Withdrawal by Subject|8|||
146511178|NCT00396877|528375442|FG000|Overall Study|Lost to Follow-up|2|||
146511179|NCT00396877|528375443|FG001|Overall Study|Lost to Follow-up|1|||
146511180|NCT00396877|528375442|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
146511181|NCT00396877|528375443|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
146511182|NCT02945254|528375444|FG000|Overall Study|Lost to Follow-up|1|||
146511183|NCT02945254|528375445|FG001|Overall Study|Lost to Follow-up|0|||
146511184|NCT02945254|528375444|FG000|Overall Study|Withdrawal by Subject|1|||
146511185|NCT02945254|528375445|FG001|Overall Study|Withdrawal by Subject|0|||
146511186|NCT00334802|528375446|FG000|Overall Study|Progressive Disease|2|||
146511187|NCT00334802|528375447|FG001|Overall Study|Progressive Disease|24|||
146511188|NCT00334802|528375446|FG000|Overall Study|Toxicity|1|||
146511189|NCT00334802|528375447|FG001|Overall Study|Toxicity|5|||
146511190|NCT00334802|528375446|FG000|Overall Study|Lack of Efficacy|1|||
146511191|NCT00334802|528375447|FG001|Overall Study|Lack of Efficacy|3|||
146511192|NCT00334802|528375446|FG000|Overall Study|Patient Condition Aggrevated|1|||
146511193|NCT00334802|528375447|FG001|Overall Study|Patient Condition Aggrevated|0|||
146511194|NCT00334802|528375446|FG000|Overall Study|Physician Decision|1|||
146511195|NCT00334802|528375447|FG001|Overall Study|Physician Decision|0|||
146511196|NCT00334802|528375446|FG000|Overall Study|Withdrawal by Subject|0|||
146511197|NCT00334802|528375447|FG001|Overall Study|Withdrawal by Subject|4|||
146511198|NCT00334802|528375446|FG000|Overall Study|Adverse Event|0|||
146511199|NCT00334802|528375447|FG001|Overall Study|Adverse Event|3|||
146511200|NCT00334802|528375446|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
146511201|NCT00334802|528375447|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
146511202|NCT02470403|528375448|FG000|Overall Study|Adverse Event|1|||
146511203|NCT02470403|528375449|FG001|Overall Study|Adverse Event|0|||
146511204|NCT02470403|528375450|FG002|Overall Study|Adverse Event|0|||
146511205|NCT02470403|528375451|FG003|Overall Study|Adverse Event|0|||
146511206|NCT02470403|528375452|FG004|Overall Study|Adverse Event|0|||
146511207|NCT02470403|528375448|FG000|Overall Study|Lost to Follow-up|0|||
146511208|NCT02470403|528375449|FG001|Overall Study|Lost to Follow-up|1|||
146511209|NCT02470403|528375450|FG002|Overall Study|Lost to Follow-up|0|||
146511210|NCT02470403|528375451|FG003|Overall Study|Lost to Follow-up|0|||
146511211|NCT02470403|528375452|FG004|Overall Study|Lost to Follow-up|0|||
146511212|NCT02470403|528375448|FG000|Overall Study|Subject/guardian decision|1|||
146511213|NCT02470403|528375449|FG001|Overall Study|Subject/guardian decision|0|||
146511214|NCT02470403|528375450|FG002|Overall Study|Subject/guardian decision|0|||
146511215|NCT02470403|528375451|FG003|Overall Study|Subject/guardian decision|4|||
146511216|NCT02470403|528375452|FG004|Overall Study|Subject/guardian decision|0|||
146511217|NCT03422159|528375453|FG000|Overall Study|Exclusion due to terminal disease|2|||
146511218|NCT03422159|528375454|FG001|Overall Study|Exclusion due to terminal disease|1|||
146511219|NCT01195844|528375457|FG000|Overall Study|Fecal sample not collected|40|||
146511220|NCT03329248|528375458|FG000|Overall Study|Progressive Disease|6|||
146511221|NCT01886781|528375459|FG000|Overall Study|Protocol Violation|5|||
146511222|NCT01886781|528375460|FG001|Overall Study|Protocol Violation|0|||
146511223|NCT01886781|528375459|FG000|Overall Study|Adverse Event|1|||
146511224|NCT01886781|528375460|FG001|Overall Study|Adverse Event|0|||
146511225|NCT01886781|528375459|FG000|Overall Study|Lost to Follow-up|5|||
146511226|NCT01886781|528375460|FG001|Overall Study|Lost to Follow-up|0|||
146511227|NCT01886781|528375459|FG000|Overall Study|Withdrawal by Subject|2|||
146511228|NCT01886781|528375460|FG001|Overall Study|Withdrawal by Subject|1|||
146511229|NCT01886781|528375459|FG000|Overall Study|Worsening of symptoms|1|||
146511230|NCT01886781|528375460|FG001|Overall Study|Worsening of symptoms|1|||
146511231|NCT01522235|528375461|FG000|Overall Study|Physician Decision|1|||
146511232|NCT01522235|528375462|FG001|Overall Study|Physician Decision|1|||
146511233|NCT00195494|528375463|FG000|Year 1|Adverse Event|0|||
146511234|NCT00195494|528375464|FG001|Year 1|Adverse Event|0|||
146511235|NCT00195494|528375465|FG002|Year 1|Adverse Event|0|||
146511236|NCT00195494|528375466|FG003|Year 1|Adverse Event|0|||
146511237|NCT00195494|528375467|FG004|Year 1|Adverse Event|34|||
146511238|NCT00195494|528375468|FG005|Year 1|Adverse Event|27|||
146511239|NCT00195494|528375463|FG000|Year 1|System Toxicity|0|||
146744799|NCT03797326|529237396|FG000|Overall Study|Enrolled in error|0|||
146511240|NCT00195494|528375464|FG001|Year 1|System Toxicity|0|||
146511241|NCT00195494|528375465|FG002|Year 1|System Toxicity|0|||
146511242|NCT00195494|528375466|FG003|Year 1|System Toxicity|0|||
146511243|NCT00195494|528375467|FG004|Year 1|System Toxicity|0|||
146511244|NCT00195494|528375468|FG005|Year 1|System Toxicity|1|||
146511245|NCT00195494|528375463|FG000|Year 1|Lack of Efficacy|0|||
146511246|NCT00195494|528375464|FG001|Year 1|Lack of Efficacy|0|||
146511247|NCT00195494|528375465|FG002|Year 1|Lack of Efficacy|0|||
146511248|NCT00195494|528375466|FG003|Year 1|Lack of Efficacy|0|||
146511249|NCT00195494|528375467|FG004|Year 1|Lack of Efficacy|24|||
146511250|NCT00195494|528375468|FG005|Year 1|Lack of Efficacy|9|||
146511251|NCT00195494|528375463|FG000|Year 1|Compliance|0|||
146744800|NCT03797326|529237397|FG001|Overall Study|Enrolled in error|0|||
146744801|NCT03797326|529237398|FG002|Overall Study|Enrolled in error|3|||
146744802|NCT03797326|529237399|FG003|Overall Study|Enrolled in error|2|||
146744803|NCT03797326|529237400|FG004|Overall Study|Enrolled in error|2|||
146744804|NCT03797326|529237401|FG005|Overall Study|Enrolled in error|1|||
146744805|NCT03797326|529237402|FG006|Overall Study|Enrolled in error|1|||
146744806|NCT03797326|529237403|FG007|Overall Study|Enrolled in error|0|||
146744807|NCT04908449|529237404|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
146744808|NCT04908449|529237405|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
146744809|NCT04908449|529237404|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
146744810|NCT04908449|529237405|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
146744811|NCT00147225|529237406|FG000|Overall Study|Withdrawal by Subject|1|||
146744812|NCT00147225|529237407|FG001|Overall Study|Withdrawal by Subject|0|||
146744813|NCT00147225|529237408|FG002|Overall Study|Withdrawal by Subject|1|||
146744814|NCT00147225|529237409|FG003|Overall Study|Withdrawal by Subject|0|||
146744815|NCT00147225|529237410|FG004|Overall Study|Withdrawal by Subject|0|||
146744816|NCT00147225|529237411|FG005|Overall Study|Withdrawal by Subject|1|||
146744817|NCT00147225|529237406|FG000|Overall Study|Adverse Event|0|||
146744818|NCT00147225|529237407|FG001|Overall Study|Adverse Event|0|||
146744819|NCT00147225|529237408|FG002|Overall Study|Adverse Event|1|||
146744820|NCT00147225|529237409|FG003|Overall Study|Adverse Event|1|||
146744821|NCT00147225|529237410|FG004|Overall Study|Adverse Event|0|||
146744822|NCT00147225|529237411|FG005|Overall Study|Adverse Event|0|||
146744823|NCT00147225|529237406|FG000|Overall Study|Screen Failure|0|||
146744824|NCT00147225|529237407|FG001|Overall Study|Screen Failure|0|||
146744825|NCT00147225|529237408|FG002|Overall Study|Screen Failure|0|||
146744826|NCT00147225|529237409|FG003|Overall Study|Screen Failure|0|||
146744827|NCT00147225|529237410|FG004|Overall Study|Screen Failure|1|||
146744828|NCT00147225|529237411|FG005|Overall Study|Screen Failure|0|||
146744829|NCT00147225|529237406|FG000|Overall Study|Chemotherapy Changed|0|||
146744830|NCT00147225|529237407|FG001|Overall Study|Chemotherapy Changed|0|||
146744831|NCT00147225|529237408|FG002|Overall Study|Chemotherapy Changed|0|||
146744832|NCT00147225|529237409|FG003|Overall Study|Chemotherapy Changed|0|||
146744833|NCT00147225|529237410|FG004|Overall Study|Chemotherapy Changed|0|||
146744834|NCT00147225|529237411|FG005|Overall Study|Chemotherapy Changed|1|||
146744835|NCT01032044|529237412|FG000|Overall Study|Protocol Violation|14|||
146744836|NCT01032044|529237413|FG001|Overall Study|Protocol Violation|8|||
146744837|NCT01032044|529237412|FG000|Overall Study|Adverse Event|0|||
146744838|NCT01032044|529237413|FG001|Overall Study|Adverse Event|1|||
146744839|NCT01032044|529237412|FG000|Overall Study|Lost to Follow-up|11|||
146744840|NCT01032044|529237413|FG001|Overall Study|Lost to Follow-up|11|||
146744841|NCT01233609|529237414|FG000|Overall Study|Death|1|||
146744842|NCT01233609|529237415|FG001|Overall Study|Death|0|||
146744843|NCT01233609|529237414|FG000|Overall Study|Lost to Follow-up|3|||
146744844|NCT01233609|529237415|FG001|Overall Study|Lost to Follow-up|1|||
146744845|NCT01233609|529237414|FG000|Overall Study|Adverse Event|2|||
146744846|NCT01233609|529237415|FG001|Overall Study|Adverse Event|1|||
146744847|NCT01233609|529237414|FG000|Overall Study|Withdrawal by Subject|3|||
146744848|NCT01233609|529237415|FG001|Overall Study|Withdrawal by Subject|0|||
146744849|NCT01567865|529237416|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
146744850|NCT01567865|529237417|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
146744851|NCT01567865|529237418|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
146744852|NCT01567865|529237419|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
146744853|NCT01567865|529237416|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
146744854|NCT01567865|529237417|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
146744855|NCT01567865|529237418|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
146744856|NCT01567865|529237419|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
146975310|NCT01830920|530073529|FG004|Overall Study|Death|4|||
146744857|NCT06385483|529237420|FG000|Overall Study|Withdrawal by Subject|2|||
146744858|NCT06385483|529237420|FG000|Overall Study|Never start protocol therapy|2|||
146744859|NCT06385483|529237420|FG000|Overall Study|Disease progression|15|||
146744860|NCT05569954|529237421|FG000|Overall Study|Lost to Follow-up|3|||
146744861|NCT05569954|529237422|FG001|Overall Study|Lost to Follow-up|4|||
146744862|NCT05569954|529237421|FG000|Overall Study|Protocol Violation|1|||
146744863|NCT05569954|529237422|FG001|Overall Study|Protocol Violation|2|||
146744864|NCT05569954|529237421|FG000|Overall Study|Withdrawal by Subject|4|||
146744865|NCT05569954|529237422|FG001|Overall Study|Withdrawal by Subject|2|||
146744866|NCT04213989|529238524|FG000|Overall Study|Withdrawal by Subject|3|||
146975311|NCT01830920|530073525|FG000|Overall Study|Other|15|||
146975312|NCT01830920|530073526|FG001|Overall Study|Other|1|||
146975313|NCT01830920|530073527|FG002|Overall Study|Other|1|||
146975314|NCT01830920|530073528|FG003|Overall Study|Other|5|||
146975315|NCT01830920|530073529|FG004|Overall Study|Other|3|||
146975316|NCT01313728|530073530|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
146975317|NCT00736333|530073531|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
146975318|NCT00736333|530073531|FG000|Overall Study|Data Missing|2|||
146975319|NCT00736333|530073531|FG000|Overall Study|Tumor Progression|75|||
146975320|NCT00736333|530073531|FG000|Overall Study|Toxicity|6|||
146744867|NCT04213989|529238525|FG001|Overall Study|Withdrawal by Subject|2|||
146744868|NCT04213989|529238524|FG000|Overall Study|Physician Decision|1|||
146744869|NCT04213989|529238525|FG001|Overall Study|Physician Decision|0|||
146744870|NCT04213989|529238524|FG000|Overall Study|Lost to Follow-up|0|||
146744871|NCT04213989|529238525|FG001|Overall Study|Lost to Follow-up|4|||
146744872|NCT03390036|529238528|FG000|Overall Study|Lost to Follow-up|1|||
146744873|NCT03390036|529238529|FG001|Overall Study|Lost to Follow-up|0|||
146744874|NCT03390036|529238530|FG002|Overall Study|Lost to Follow-up|0|||
146744875|NCT03390036|529238528|FG000|Overall Study|Lack of Efficacy|1|||
146744876|NCT03390036|529238529|FG001|Overall Study|Lack of Efficacy|0|||
146744877|NCT03390036|529238530|FG002|Overall Study|Lack of Efficacy|0|||
146744878|NCT00744237|529238533|FG000|Overall Study|Lack of Efficacy|1|||
146744879|NCT00744237|529238534|FG001|Overall Study|Lack of Efficacy|1|||
146744880|NCT00744237|529238535|FG002|Overall Study|Lack of Efficacy|0|||
146744881|NCT00744237|529238533|FG000|Overall Study|Withdrawal by Subject|9|||
146744882|NCT00744237|529238534|FG001|Overall Study|Withdrawal by Subject|5|||
146744883|NCT00744237|529238535|FG002|Overall Study|Withdrawal by Subject|3|||
146744884|NCT00744237|529238533|FG000|Overall Study|Lost to Follow-up|1|||
146744885|NCT00744237|529238534|FG001|Overall Study|Lost to Follow-up|1|||
146744886|NCT00744237|529238535|FG002|Overall Study|Lost to Follow-up|1|||
146744887|NCT00744237|529238533|FG000|Overall Study|Protocol Violation|3|||
146744888|NCT00744237|529238534|FG001|Overall Study|Protocol Violation|4|||
146744889|NCT00744237|529238535|FG002|Overall Study|Protocol Violation|3|||
146744890|NCT00744237|529238533|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
146744891|NCT00744237|529238534|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
146744892|NCT00744237|529238535|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
146744893|NCT00744237|529238533|FG000|Overall Study|Dosing Error|1|||
146744894|NCT00744237|529238534|FG001|Overall Study|Dosing Error|0|||
146744895|NCT00744237|529238535|FG002|Overall Study|Dosing Error|1|||
146744896|NCT00744237|529238533|FG000|Overall Study|Study Drug Error|1|||
146744897|NCT00744237|529238534|FG001|Overall Study|Study Drug Error|0|||
146744898|NCT00744237|529238535|FG002|Overall Study|Study Drug Error|0|||
146744899|NCT00744237|529238533|FG000|Overall Study|Prohibited Concomitant Medication|0|||
146744900|NCT00744237|529238534|FG001|Overall Study|Prohibited Concomitant Medication|0|||
146744901|NCT00744237|529238535|FG002|Overall Study|Prohibited Concomitant Medication|1|||
146744902|NCT00744237|529238533|FG000|Overall Study|Poor Compliance|0|||
146744903|NCT00744237|529238534|FG001|Overall Study|Poor Compliance|2|||
146744904|NCT00744237|529238535|FG002|Overall Study|Poor Compliance|0|||
146744905|NCT00744237|529238533|FG000|Overall Study|Administrative. Site Closed|1|||
146744906|NCT00744237|529238534|FG001|Overall Study|Administrative. Site Closed|1|||
146744907|NCT00744237|529238535|FG002|Overall Study|Administrative. Site Closed|1|||
146744908|NCT00744237|529238533|FG000|Overall Study|Adverse Event|9|||
146744909|NCT00744237|529238534|FG001|Overall Study|Adverse Event|13|||
146744910|NCT00744237|529238535|FG002|Overall Study|Adverse Event|5|||
146744911|NCT01984424|529238536|FG000|Overall Study|Withdrawal by Subject|3|||
146744912|NCT01984424|529238537|FG001|Overall Study|Withdrawal by Subject|5|||
146744913|NCT01984424|529238536|FG000|Overall Study|Sponsor Decision|0|||
146744914|NCT01984424|529238537|FG001|Overall Study|Sponsor Decision|1|||
146744915|NCT01984424|529238536|FG000|Overall Study|Lost to Follow-up|0|||
146744916|NCT01984424|529238537|FG001|Overall Study|Lost to Follow-up|1|||
146744917|NCT01807221|529238538|FG000|Overall Study|Progressive disease|1|||
146744918|NCT01807221|529238539|FG001|Overall Study|Progressive disease|0|||
146744919|NCT01807221|529238540|FG002|Overall Study|Progressive disease|1|||
146744920|NCT01807221|529238541|FG003|Overall Study|Progressive disease|0|||
146744921|NCT01807221|529238542|FG004|Overall Study|Progressive disease|0|||
146744922|NCT01807221|529238543|FG005|Overall Study|Progressive disease|0|||
146744923|NCT01807221|529238538|FG000|Overall Study|Death|7|||
146744924|NCT01807221|529238539|FG001|Overall Study|Death|9|||
146744925|NCT01807221|529238540|FG002|Overall Study|Death|4|||
146744926|NCT01807221|529238541|FG003|Overall Study|Death|2|||
146744927|NCT01807221|529238542|FG004|Overall Study|Death|1|||
146744928|NCT01807221|529238543|FG005|Overall Study|Death|6|||
146511252|NCT00195494|528375464|FG001|Year 1|Compliance|0|||
146744929|NCT01807221|529238538|FG000|Overall Study|Physician Decision|2|||
146744930|NCT01807221|529238539|FG001|Overall Study|Physician Decision|1|||
146744931|NCT01807221|529238540|FG002|Overall Study|Physician Decision|0|||
146744932|NCT01807221|529238541|FG003|Overall Study|Physician Decision|0|||
146744933|NCT01807221|529238542|FG004|Overall Study|Physician Decision|0|||
146744934|NCT01807221|529238543|FG005|Overall Study|Physician Decision|0|||
146744935|NCT01807221|529238538|FG000|Overall Study|Adverse Event|33|||
146744936|NCT01807221|529238539|FG001|Overall Study|Adverse Event|22|||
146744937|NCT01807221|529238540|FG002|Overall Study|Adverse Event|26|||
146744938|NCT01807221|529238541|FG003|Overall Study|Adverse Event|25|||
146744939|NCT01807221|529238542|FG004|Overall Study|Adverse Event|18|||
146744940|NCT01807221|529238543|FG005|Overall Study|Adverse Event|21|||
146511253|NCT00195494|528375465|FG002|Year 1|Compliance|0|||
146744941|NCT01807221|529238538|FG000|Overall Study|Protocol Violation|0|||
146744942|NCT01807221|529238539|FG001|Overall Study|Protocol Violation|2|||
146744943|NCT01807221|529238540|FG002|Overall Study|Protocol Violation|1|||
146744944|NCT01807221|529238541|FG003|Overall Study|Protocol Violation|2|||
146744945|NCT01807221|529238542|FG004|Overall Study|Protocol Violation|0|||
146744946|NCT01807221|529238543|FG005|Overall Study|Protocol Violation|1|||
146744947|NCT01807221|529238538|FG000|Overall Study|Non-compliance|1|||
146744948|NCT01807221|529238539|FG001|Overall Study|Non-compliance|2|||
146744949|NCT01807221|529238540|FG002|Overall Study|Non-compliance|0|||
146744950|NCT01807221|529238541|FG003|Overall Study|Non-compliance|1|||
146744951|NCT01807221|529238542|FG004|Overall Study|Non-compliance|0|||
146744952|NCT01807221|529238543|FG005|Overall Study|Non-compliance|0|||
146744953|NCT01807221|529238538|FG000|Overall Study|Logistical difficulties|0|||
146744954|NCT01807221|529238539|FG001|Overall Study|Logistical difficulties|1|||
146744955|NCT01807221|529238540|FG002|Overall Study|Logistical difficulties|0|||
146744956|NCT01807221|529238541|FG003|Overall Study|Logistical difficulties|0|||
146744957|NCT01807221|529238542|FG004|Overall Study|Logistical difficulties|1|||
146744958|NCT01807221|529238543|FG005|Overall Study|Logistical difficulties|0|||
146744959|NCT01807221|529238538|FG000|Overall Study|Withdrawal by Subject|33|||
146744960|NCT01807221|529238539|FG001|Overall Study|Withdrawal by Subject|15|||
146744961|NCT01807221|529238540|FG002|Overall Study|Withdrawal by Subject|8|||
146744962|NCT01807221|529238541|FG003|Overall Study|Withdrawal by Subject|14|||
146744963|NCT01807221|529238542|FG004|Overall Study|Withdrawal by Subject|16|||
146744964|NCT01807221|529238543|FG005|Overall Study|Withdrawal by Subject|13|||
146744965|NCT01807221|529238538|FG000|Overall Study|Sponsor decision|2|||
146744966|NCT01807221|529238539|FG001|Overall Study|Sponsor decision|0|||
146744967|NCT01807221|529238540|FG002|Overall Study|Sponsor decision|1|||
146744968|NCT01807221|529238541|FG003|Overall Study|Sponsor decision|1|||
146744969|NCT01807221|529238542|FG004|Overall Study|Sponsor decision|0|||
146744970|NCT01807221|529238543|FG005|Overall Study|Sponsor decision|0|||
146744971|NCT01807221|529238538|FG000|Overall Study|Lost to Follow-up|1|||
146744972|NCT01807221|529238539|FG001|Overall Study|Lost to Follow-up|0|||
146744973|NCT01807221|529238540|FG002|Overall Study|Lost to Follow-up|2|||
146744974|NCT01807221|529238541|FG003|Overall Study|Lost to Follow-up|1|||
146744975|NCT01807221|529238542|FG004|Overall Study|Lost to Follow-up|0|||
146744976|NCT01807221|529238543|FG005|Overall Study|Lost to Follow-up|0|||
146744977|NCT06017999|529238544|FG000|Overall Study|Withdrawal by Subject|0|||
146744978|NCT06017999|529238545|FG001|Overall Study|Withdrawal by Subject|4|||
146744979|NCT06017999|529238546|FG002|Overall Study|Withdrawal by Subject|3|||
146744980|NCT06017999|529238544|FG000|Overall Study|Adverse Event|2|||
146744981|NCT06017999|529238545|FG001|Overall Study|Adverse Event|1|||
146744982|NCT06017999|529238546|FG002|Overall Study|Adverse Event|1|||
146744983|NCT06017999|529238544|FG000|Overall Study|Lost to Follow-up|0|||
146744984|NCT06017999|529238545|FG001|Overall Study|Lost to Follow-up|0|||
146744985|NCT06017999|529238546|FG002|Overall Study|Lost to Follow-up|1|||
146744986|NCT06017999|529238544|FG000|Overall Study|Physician Decision|1|||
146744987|NCT06017999|529238545|FG001|Overall Study|Physician Decision|1|||
146744988|NCT06017999|529238546|FG002|Overall Study|Physician Decision|0|||
146744989|NCT06017999|529238544|FG000|Overall Study|Non-Compliance|0|||
146744990|NCT06017999|529238545|FG001|Overall Study|Non-Compliance|0|||
146744991|NCT06017999|529238546|FG002|Overall Study|Non-Compliance|1|||
146744992|NCT06017999|529238544|FG000|Overall Study|Lack of Efficacy|1|||
146744993|NCT06017999|529238545|FG001|Overall Study|Lack of Efficacy|0|||
146744994|NCT06017999|529238546|FG002|Overall Study|Lack of Efficacy|7|||
146744995|NCT06017999|529238544|FG000|Overall Study|COVID Positive|0|||
146744996|NCT06017999|529238545|FG001|Overall Study|COVID Positive|1|||
146744997|NCT06017999|529238546|FG002|Overall Study|COVID Positive|0|||
146744998|NCT06017999|529238544|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
146744999|NCT06017999|529238545|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
146745000|NCT06017999|529238546|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
146745001|NCT04338581|529238547|FG000|Overall Study|Lack of Efficacy|1|||
146745002|NCT04338581|529238548|FG001|Overall Study|Lack of Efficacy|0|||
146745003|NCT04338581|529238547|FG000|Overall Study|Withdrawal by Subject|4|||
146745004|NCT04338581|529238548|FG001|Overall Study|Withdrawal by Subject|4|||
146745005|NCT04338581|529238547|FG000|Overall Study|Prohibited Medication|1|||
146745006|NCT04338581|529238548|FG001|Overall Study|Prohibited Medication|0|||
146745007|NCT01089556|529238551|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
146511254|NCT00195494|528375466|FG003|Year 1|Compliance|0|||
146745008|NCT01089556|529238552|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
146745009|NCT01089556|529238553|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
146745010|NCT01089556|529238554|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
146745011|NCT01089556|529238555|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
146745012|NCT01089556|529238556|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
146745013|NCT01089556|529238551|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
146745014|NCT01089556|529238552|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
146745015|NCT01089556|529238553|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
146745016|NCT01089556|529238554|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
146745017|NCT01089556|529238555|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
146745018|NCT01089556|529238556|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
146745019|NCT01089556|529238551|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
146745020|NCT01089556|529238552|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
146745021|NCT01089556|529238553|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
146745022|NCT01089556|529238554|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
146745023|NCT01089556|529238555|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
146745024|NCT01089556|529238556|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
146745025|NCT01089556|529238551|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
146745026|NCT01089556|529238552|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
146745027|NCT01089556|529238553|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
146745028|NCT01089556|529238554|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
146745029|NCT01089556|529238555|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
146745030|NCT01089556|529238556|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
146745031|NCT01089556|529238551|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
146745032|NCT01089556|529238552|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
146745033|NCT01089556|529238553|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
146745034|NCT01089556|529238554|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
146745035|NCT01089556|529238555|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
146745036|NCT01089556|529238556|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
146745037|NCT01089556|529238551|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
146745038|NCT01089556|529238552|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
146745039|NCT01089556|529238553|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
146745040|NCT01089556|529238554|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
146745041|NCT01089556|529238555|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
146745042|NCT01089556|529238556|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
146745043|NCT01089556|529238551|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
146745044|NCT01089556|529238552|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
146745045|NCT01089556|529238553|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
146745046|NCT01089556|529238554|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
146745047|NCT01089556|529238555|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
146745048|NCT01089556|529238556|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
146745049|NCT01089556|529238551|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
146745050|NCT01089556|529238552|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
146745051|NCT01089556|529238553|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
146745052|NCT01089556|529238554|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
146745053|NCT01089556|529238555|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
146745054|NCT01089556|529238556|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
146745055|NCT01089556|529238551|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
146745056|NCT01089556|529238552|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
146745057|NCT01089556|529238553|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
146745058|NCT01089556|529238554|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
146745059|NCT01089556|529238555|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
146745060|NCT01089556|529238556|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
146745061|NCT01089556|529238551|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
146745062|NCT01089556|529238552|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
146745063|NCT01089556|529238553|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
146745064|NCT01089556|529238554|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
146745065|NCT01089556|529238555|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
146745066|NCT01089556|529238556|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
146745067|NCT01089556|529238551|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
146745068|NCT01089556|529238552|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
146745069|NCT01089556|529238553|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
146745070|NCT01089556|529238554|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
146745071|NCT01089556|529238555|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
146745072|NCT01089556|529238556|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
146745073|NCT01089556|529238551|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
146745074|NCT01089556|529238552|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
146745075|NCT01089556|529238553|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
146745076|NCT01089556|529238554|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
146745077|NCT01089556|529238555|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
146745078|NCT01089556|529238556|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
146745079|NCT01089556|529238551|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
146745080|NCT01089556|529238552|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
146745081|NCT01089556|529238553|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
146745082|NCT01089556|529238554|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
146745083|NCT01089556|529238555|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
146745084|NCT01089556|529238556|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
146745085|NCT01089556|529238551|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
146745086|NCT01089556|529238552|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
146745087|NCT01089556|529238553|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
146745088|NCT01089556|529238554|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
146745089|NCT01089556|529238555|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
146745090|NCT01089556|529238556|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
146745091|NCT01089556|529238551|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
146745092|NCT01089556|529238552|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
146745093|NCT01089556|529238553|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
146745094|NCT01089556|529238554|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
146745095|NCT01089556|529238555|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
146745096|NCT01089556|529238556|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
146745097|NCT01757665|529238559|FG000|Overall Study|Still on Study - Visit Completed|240|||
146745098|NCT01757665|529238560|FG001|Overall Study|Still on Study - Visit Completed|30|||
146745099|NCT01757665|529238559|FG000|Overall Study|Still on Study - Visit Pending|398|||
146745100|NCT01757665|529238560|FG001|Overall Study|Still on Study - Visit Pending|40|||
146745101|NCT01757665|529238559|FG000|Overall Study|Still on Study - Missed Visit|14|||
146745102|NCT01757665|529238560|FG001|Overall Study|Still on Study - Missed Visit|1|||
146745103|NCT01757665|529238559|FG000|Overall Study|Death|25|||
146745104|NCT01757665|529238560|FG001|Overall Study|Death|8|||
146745105|NCT01757665|529238559|FG000|Overall Study|Explant|1|||
146745106|NCT01757665|529238560|FG001|Overall Study|Explant|2|||
146745107|NCT01757665|529238559|FG000|Overall Study|Withdrawal by Subject|10|||
146745108|NCT01757665|529238560|FG001|Overall Study|Withdrawal by Subject|0|||
146745109|NCT01757665|529238559|FG000|Overall Study|Lost to Follow-up|1|||
146745110|NCT01757665|529238560|FG001|Overall Study|Lost to Follow-up|1|||
146745111|NCT01757665|529238559|FG000|Overall Study|Not Implanted with Device|5|||
146745112|NCT01757665|529238560|FG001|Overall Study|Not Implanted with Device|1|||
146745113|NCT00594906|529238561|FG000|Overall Study|Physician Decision|1|||
146745114|NCT00594906|529238562|FG001|Overall Study|Physician Decision|0|||
146745115|NCT00594906|529238561|FG000|Overall Study|Physician Decision|0|||
146745116|NCT00594906|529238562|FG001|Overall Study|Physician Decision|1|||
146745117|NCT00594906|529238561|FG000|Overall Study|Death|0|||
146745118|NCT00594906|529238562|FG001|Overall Study|Death|1|||
146745119|NCT01394250|529238567|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
146745120|NCT01394250|529238568|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
146745121|NCT01394250|529238567|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
146745122|NCT01394250|529238568|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
146745123|NCT02222896|529238569|FG000|Abdomen|Did not qualify|34|||
146745124|NCT02222896|529238570|FG001|Abdomen|Did not qualify|10|||
146745125|NCT02222896|529238571|FG002|Abdomen|Did not qualify|32|||
146745126|NCT02222896|529238569|FG000|Groin|Did not qualify|43|||
146745127|NCT02222896|529238570|FG001|Groin|Did not qualify|9|||
146745128|NCT02222896|529238571|FG002|Groin|Did not qualify|40|||
146745129|NCT02441946|529238572|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
146745130|NCT02441946|529238573|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
146745131|NCT02441946|529238574|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
146745132|NCT02441946|529238572|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
146745133|NCT02441946|529238573|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
146745134|NCT02441946|529238574|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
146745135|NCT02441946|529238572|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
146745136|NCT02441946|529238573|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
146745137|NCT02441946|529238574|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
146745138|NCT02441946|529238572|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
146745139|NCT02441946|529238573|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
146745140|NCT02441946|529238574|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
146745141|NCT02441946|529238572|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
146745142|NCT02441946|529238573|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
146745143|NCT02441946|529238574|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
146745144|NCT02441946|529238572|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
146745145|NCT02441946|529238573|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
146745146|NCT02441946|529238574|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
146745147|NCT02441946|529238572|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
146745148|NCT02441946|529238573|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
146745149|NCT02441946|529238574|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
146745150|NCT02441946|529238572|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
146745151|NCT02441946|529238573|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
146745152|NCT02441946|529238574|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
146745153|NCT02441946|529238572|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
146745154|NCT02441946|529238573|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
146745155|NCT02441946|529238574|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
146745156|NCT02441946|529238572|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
146745157|NCT02441946|529238573|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
146745158|NCT02441946|529238574|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
146745159|NCT02441946|529238572|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
146745160|NCT02441946|529238573|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
146745161|NCT02441946|529238574|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
146745162|NCT02111213|529238575|FG000|Overall Study|Withdrawal by Subject|3|||
146745163|NCT02111213|529238576|FG001|Overall Study|Withdrawal by Subject|2|||
146745164|NCT02111213|529238575|FG000|Overall Study|Lost to Follow-up|3|||
146745165|NCT02111213|529238576|FG001|Overall Study|Lost to Follow-up|4|||
146745166|NCT01613027|529238577|FG000|Overall Study|Lost to Follow-up|5|||
146745167|NCT01613027|529238577|FG000|Overall Study|Switched Physician|1|||
146745168|NCT01613027|529238577|FG000|Overall Study|Lack of Efficacy|1|||
146745169|NCT01613027|529238577|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
146745170|NCT02153359|529238578|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
146745171|NCT02153359|529238579|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
146745172|NCT04422639|529238584|FG000|Overall Study|Death|1|||
146745173|NCT04422639|529238585|FG001|Overall Study|Death|0|||
146745174|NCT04422639|529238584|FG000|Overall Study|study closed prior to completion of FU visits|0|||
146745175|NCT04422639|529238585|FG001|Overall Study|study closed prior to completion of FU visits|2|||
146745176|NCT01964521|529238586|FG000|Overall Study|Lost to Follow-up|4|||
146745177|NCT04267614|529238587|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
146745178|NCT04267614|529238587|FG000|Overall Study|Lost to Follow-up|115|||
146745179|NCT01463293|529238588|FG000|Overall Study|Lost to Follow-up|1|||
146745180|NCT01463293|529238589|FG001|Overall Study|Lost to Follow-up|4|||
146745181|NCT01463293|529238590|FG002|Overall Study|Lost to Follow-up|5|||
146745182|NCT01463293|529238588|FG000|Overall Study|Adverse Event|1|||
146745183|NCT01463293|529238589|FG001|Overall Study|Adverse Event|2|||
146745184|NCT01463293|529238590|FG002|Overall Study|Adverse Event|0|||
146745185|NCT01463293|529238588|FG000|Overall Study|Withdrawal by Subject|4|||
146745186|NCT01463293|529238589|FG001|Overall Study|Withdrawal by Subject|10|||
146745187|NCT01463293|529238590|FG002|Overall Study|Withdrawal by Subject|5|||
146745188|NCT01463293|529238588|FG000|Overall Study|Other|0|||
146745189|NCT01463293|529238589|FG001|Overall Study|Other|0|||
146745190|NCT01463293|529238590|FG002|Overall Study|Other|2|||
146745191|NCT00119262|529238596|FG000|Overall Study|Lack of Efficacy|0|||
146745192|NCT00119262|529238597|FG001|Overall Study|Lack of Efficacy|3|||
146745193|NCT00119262|529238596|FG000|Overall Study|Withdrawal by Subject|12|||
146745194|NCT00119262|529238597|FG001|Overall Study|Withdrawal by Subject|11|||
146745195|NCT00119262|529238596|FG000|Overall Study|Adverse Event|33|||
146745196|NCT00119262|529238597|FG001|Overall Study|Adverse Event|35|||
146745197|NCT00119262|529238596|FG000|Overall Study|other disease|0|||
146745198|NCT00119262|529238597|FG001|Overall Study|other disease|2|||
146745199|NCT00119262|529238596|FG000|Overall Study|ineligble|1|||
146745200|NCT00119262|529238597|FG001|Overall Study|ineligble|2|||
146745201|NCT00119262|529238596|FG000|Overall Study|others|0|||
146745202|NCT00119262|529238597|FG001|Overall Study|others|5|||
146745203|NCT03853317|529238598|FG000|Overall Study|Progressive Disease|5|||
146745204|NCT03853317|529238598|FG000|Overall Study|Adverse Event|1|||
146745205|NCT03853317|529238598|FG000|Overall Study|Death|1|||
146745206|NCT03853317|529238598|FG000|Overall Study|other event|2|||
146745207|NCT00779584|529238603|FG000|Overall Study|Protocol Violation|0|||
146745208|NCT00779584|529238604|FG001|Overall Study|Protocol Violation|0|||
146745209|NCT00779584|529238605|FG002|Overall Study|Protocol Violation|0|||
146745210|NCT00779584|529238606|FG003|Overall Study|Protocol Violation|0|||
146745211|NCT00779584|529238607|FG004|Overall Study|Protocol Violation|0|||
146745212|NCT00779584|529238608|FG005|Overall Study|Protocol Violation|1|||
146745213|NCT00779584|529238609|FG006|Overall Study|Protocol Violation|0|||
146745214|NCT00779584|529238610|FG007|Overall Study|Protocol Violation|0|||
146745215|NCT00779584|529238611|FG008|Overall Study|Protocol Violation|0|||
146745216|NCT00779584|529238603|FG000|Overall Study|Withdrawal by Subject|1|||
146745217|NCT00779584|529238604|FG001|Overall Study|Withdrawal by Subject|1|||
146745218|NCT00779584|529238605|FG002|Overall Study|Withdrawal by Subject|2|||
146745219|NCT00779584|529238606|FG003|Overall Study|Withdrawal by Subject|0|||
146745220|NCT00779584|529238607|FG004|Overall Study|Withdrawal by Subject|0|||
146745221|NCT00779584|529238608|FG005|Overall Study|Withdrawal by Subject|2|||
146745222|NCT00779584|529238609|FG006|Overall Study|Withdrawal by Subject|1|||
146745223|NCT00779584|529238610|FG007|Overall Study|Withdrawal by Subject|0|||
146745224|NCT00779584|529238611|FG008|Overall Study|Withdrawal by Subject|0|||
146745225|NCT00779584|529238603|FG000|Overall Study|Lost to Follow-up|0|||
146745226|NCT00779584|529238604|FG001|Overall Study|Lost to Follow-up|0|||
146745227|NCT00779584|529238605|FG002|Overall Study|Lost to Follow-up|0|||
146745228|NCT00779584|529238606|FG003|Overall Study|Lost to Follow-up|0|||
146745229|NCT00779584|529238607|FG004|Overall Study|Lost to Follow-up|1|||
146745230|NCT00779584|529238608|FG005|Overall Study|Lost to Follow-up|0|||
146745231|NCT00779584|529238609|FG006|Overall Study|Lost to Follow-up|0|||
146745232|NCT00779584|529238610|FG007|Overall Study|Lost to Follow-up|0|||
146745233|NCT00779584|529238611|FG008|Overall Study|Lost to Follow-up|0|||
146511255|NCT00195494|528375467|FG004|Year 1|Compliance|5|||
146745234|NCT00779584|529238603|FG000|Overall Study|Progression of Disease|0|||
146745235|NCT00779584|529238604|FG001|Overall Study|Progression of Disease|1|||
146745236|NCT00779584|529238605|FG002|Overall Study|Progression of Disease|2|||
146745237|NCT00779584|529238606|FG003|Overall Study|Progression of Disease|6|||
146511256|NCT00195494|528375468|FG005|Year 1|Compliance|1|||
146745238|NCT00779584|529238607|FG004|Overall Study|Progression of Disease|5|||
146745239|NCT00779584|529238608|FG005|Overall Study|Progression of Disease|1|||
146745240|NCT00779584|529238609|FG006|Overall Study|Progression of Disease|4|||
146745241|NCT00779584|529238610|FG007|Overall Study|Progression of Disease|2|||
146745242|NCT00779584|529238611|FG008|Overall Study|Progression of Disease|1|||
146745243|NCT00779584|529238603|FG000|Overall Study|Adverse Event|1|||
146745244|NCT00779584|529238604|FG001|Overall Study|Adverse Event|0|||
146745245|NCT00779584|529238605|FG002|Overall Study|Adverse Event|2|||
146745246|NCT00779584|529238606|FG003|Overall Study|Adverse Event|0|||
146745247|NCT00779584|529238607|FG004|Overall Study|Adverse Event|0|||
146745248|NCT00779584|529238608|FG005|Overall Study|Adverse Event|0|||
146745249|NCT00779584|529238609|FG006|Overall Study|Adverse Event|2|||
146745250|NCT00779584|529238610|FG007|Overall Study|Adverse Event|1|||
146745251|NCT00779584|529238611|FG008|Overall Study|Adverse Event|1|||
146745252|NCT00779584|529238603|FG000|Overall Study|Symptomatic Deterioration|1|||
146745253|NCT00779584|529238604|FG001|Overall Study|Symptomatic Deterioration|1|||
146745254|NCT00779584|529238605|FG002|Overall Study|Symptomatic Deterioration|1|||
146745255|NCT00779584|529238606|FG003|Overall Study|Symptomatic Deterioration|0|||
146745256|NCT00779584|529238607|FG004|Overall Study|Symptomatic Deterioration|0|||
146745257|NCT00779584|529238608|FG005|Overall Study|Symptomatic Deterioration|1|||
146745258|NCT00779584|529238609|FG006|Overall Study|Symptomatic Deterioration|1|||
146745259|NCT00779584|529238610|FG007|Overall Study|Symptomatic Deterioration|0|||
146745260|NCT00779584|529238611|FG008|Overall Study|Symptomatic Deterioration|0|||
146745261|NCT00779584|529238603|FG000|Overall Study|Ongoing in Study|0|||
146745262|NCT00779584|529238604|FG001|Overall Study|Ongoing in Study|0|||
146745263|NCT00779584|529238605|FG002|Overall Study|Ongoing in Study|0|||
146745264|NCT00779584|529238606|FG003|Overall Study|Ongoing in Study|0|||
146745265|NCT00779584|529238607|FG004|Overall Study|Ongoing in Study|1|||
146745266|NCT00779584|529238608|FG005|Overall Study|Ongoing in Study|1|||
146745267|NCT00779584|529238609|FG006|Overall Study|Ongoing in Study|0|||
146745268|NCT00779584|529238610|FG007|Overall Study|Ongoing in Study|0|||
146745269|NCT00779584|529238611|FG008|Overall Study|Ongoing in Study|0|||
146745270|NCT00786474|529238617|FG000|Overall Study|Death|5|||
146745271|NCT00786474|529238618|FG001|Overall Study|Death|4|||
146745272|NCT00786474|529238617|FG000|Overall Study|Withdrawal by Subject|23|||
146745273|NCT00786474|529238618|FG001|Overall Study|Withdrawal by Subject|31|||
146745274|NCT00786474|529238617|FG000|Overall Study|Lost to Follow-up|3|||
146745275|NCT00786474|529238618|FG001|Overall Study|Lost to Follow-up|3|||
146745276|NCT00786474|529238617|FG000|Overall Study|Physician Decision|2|||
146745277|NCT00786474|529238618|FG001|Overall Study|Physician Decision|1|||
146745278|NCT00786474|529238617|FG000|Overall Study|Other|4|||
146745279|NCT00786474|529238618|FG001|Overall Study|Other|4|||
146745280|NCT01868074|529238619|FG000|Overall Study|Lost to Follow-up|3|||
146745281|NCT01868074|529238620|FG001|Overall Study|Lost to Follow-up|2|||
146745282|NCT01868074|529238619|FG000|Overall Study|Withdrawal by Subject|4|||
146745283|NCT01868074|529238620|FG001|Overall Study|Withdrawal by Subject|2|||
146745284|NCT04175912|529238624|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
146745285|NCT04175912|529238625|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
146745286|NCT04175912|529238624|FG000|Overall Study|Adverse Event|0|||
146745287|NCT04175912|529238625|FG001|Overall Study|Adverse Event|3|||
146745288|NCT04175912|529238624|FG000|Overall Study|Never started treatment|3|||
146745289|NCT04175912|529238625|FG001|Overall Study|Never started treatment|3|||
146745290|NCT04175912|529238624|FG000|Overall Study|Death|0|||
146745291|NCT04175912|529238625|FG001|Overall Study|Death|1|||
146745292|NCT02303626|529238626|FG000|Overall Study|Lack of Efficacy|1|||
146745293|NCT02303626|529238627|FG001|Overall Study|Lack of Efficacy|0|||
146745294|NCT02303626|529238628|FG002|Overall Study|Lack of Efficacy|1|||
146745295|NCT02303626|529238626|FG000|Overall Study|Adverse Event|0|||
146745296|NCT02303626|529238627|FG001|Overall Study|Adverse Event|2|||
146745297|NCT02303626|529238628|FG002|Overall Study|Adverse Event|0|||
146745298|NCT02303626|529238626|FG000|Overall Study|Protocol Violation|0|||
146745299|NCT02303626|529238627|FG001|Overall Study|Protocol Violation|1|||
146745300|NCT02303626|529238628|FG002|Overall Study|Protocol Violation|0|||
146745301|NCT02303626|529238626|FG000|Overall Study|Pregnancy|0|||
146745302|NCT02303626|529238627|FG001|Overall Study|Pregnancy|0|||
146745303|NCT02303626|529238628|FG002|Overall Study|Pregnancy|1|||
146745304|NCT02303626|529238626|FG000|Overall Study|Subject Non-Compliance|0|||
146745305|NCT02303626|529238627|FG001|Overall Study|Subject Non-Compliance|0|||
146745306|NCT02303626|529238628|FG002|Overall Study|Subject Non-Compliance|1|||
146745307|NCT05376371|529238629|FG000|Overall Study|change in release date|10|||
146745308|NCT00802737|529240007|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
146745309|NCT00802737|529240008|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
146745310|NCT00802737|529240009|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
146745311|NCT00802737|529240007|FG000|Overall Study|Death|6|||
146745312|NCT00802737|529240008|FG001|Overall Study|Death|5|||
146745313|NCT00802737|529240009|FG002|Overall Study|Death|1|||
146745314|NCT00802737|529240007|FG000|Overall Study|Adverse Event|1|||
146745315|NCT00802737|529240008|FG001|Overall Study|Adverse Event|0|||
146745316|NCT00802737|529240009|FG002|Overall Study|Adverse Event|0|||
146745317|NCT00802737|529240007|FG000|Overall Study|Received Prohibited Therapy|1|||
146745318|NCT00802737|529240008|FG001|Overall Study|Received Prohibited Therapy|0|||
146745319|NCT00802737|529240009|FG002|Overall Study|Received Prohibited Therapy|0|||
146745320|NCT00802737|529240007|FG000|Overall Study|Ongoing CLL-Treatment|0|||
146745321|NCT00802737|529240008|FG001|Overall Study|Ongoing CLL-Treatment|1|||
146745322|NCT00802737|529240009|FG002|Overall Study|Ongoing CLL-Treatment|0|||
146745323|NCT00802737|529240007|FG000|Overall Study|Participant too Unwell|0|||
146745324|NCT00802737|529240008|FG001|Overall Study|Participant too Unwell|2|||
146745325|NCT00802737|529240009|FG002|Overall Study|Participant too Unwell|0|||
146745326|NCT03864926|529240010|FG000|Overall Study|Death|0|||
146745327|NCT03864926|529240011|FG001|Overall Study|Death|2|||
146745328|NCT00445601|529240012|FG000|Overall Study|Withdrawal by Subject|11|||
146745329|NCT00445601|529240013|FG001|Overall Study|Withdrawal by Subject|11|||
146745330|NCT00445601|529240012|FG000|Overall Study|TURBT Complication|12|||
146745331|NCT00445601|529240013|FG001|Overall Study|TURBT Complication|8|||
146745332|NCT00445601|529240012|FG000|Overall Study|Incorrect Disease Status|6|||
146745333|NCT00445601|529240013|FG001|Overall Study|Incorrect Disease Status|6|||
146745334|NCT00445601|529240012|FG000|Overall Study|Drug Delivery Issue|2|||
146745335|NCT00445601|529240013|FG001|Overall Study|Drug Delivery Issue|2|||
146745336|NCT00445601|529240012|FG000|Overall Study|Adverse Event|2|||
146745337|NCT00445601|529240013|FG001|Overall Study|Adverse Event|0|||
146745338|NCT00445601|529240012|FG000|Overall Study|Death prior to TURBT|0|||
146745339|NCT00445601|529240013|FG001|Overall Study|Death prior to TURBT|1|||
146745340|NCT01091428|529240014|FG000|Phase 1|Progressive Disease|24|||
146745341|NCT01091428|529240015|FG001|Phase 1|Progressive Disease|8|||
146745342|NCT01091428|529240016|FG002|Phase 1|Progressive Disease|0|||
146745343|NCT01091428|529240017|FG003|Phase 1|Progressive Disease|0|||
146745344|NCT01091428|529240014|FG000|Phase 1|Symptomatic Deterioration|3|||
146745345|NCT01091428|529240015|FG001|Phase 1|Symptomatic Deterioration|2|||
146745346|NCT01091428|529240016|FG002|Phase 1|Symptomatic Deterioration|0|||
146745347|NCT01091428|529240017|FG003|Phase 1|Symptomatic Deterioration|0|||
146745348|NCT01091428|529240014|FG000|Phase 1|Adverse Event|2|||
146745349|NCT01091428|529240015|FG001|Phase 1|Adverse Event|0|||
146745350|NCT01091428|529240016|FG002|Phase 1|Adverse Event|0|||
146745351|NCT01091428|529240017|FG003|Phase 1|Adverse Event|0|||
146745352|NCT01091428|529240014|FG000|Phase 1|Withdrawal by Subject|7|||
146745353|NCT01091428|529240015|FG001|Phase 1|Withdrawal by Subject|0|||
146745354|NCT01091428|529240016|FG002|Phase 1|Withdrawal by Subject|0|||
146745355|NCT01091428|529240017|FG003|Phase 1|Withdrawal by Subject|0|||
146745356|NCT01091428|529240014|FG000|Phase 1|Reason not specified|0|||
146745357|NCT01091428|529240015|FG001|Phase 1|Reason not specified|1|||
146745358|NCT01091428|529240016|FG002|Phase 1|Reason not specified|0|||
146745359|NCT01091428|529240017|FG003|Phase 1|Reason not specified|0|||
146745360|NCT01091428|529240014|FG000|Phase 1|Single-Patient IND|2|||
146745361|NCT01091428|529240015|FG001|Phase 1|Single-Patient IND|0|||
146745362|NCT01091428|529240016|FG002|Phase 1|Single-Patient IND|0|||
146745363|NCT01091428|529240017|FG003|Phase 1|Single-Patient IND|0|||
146745364|NCT01091428|529240014|FG000|Phase 2|Progressive Disease|0|||
146745365|NCT01091428|529240015|FG001|Phase 2|Progressive Disease|0|||
146745366|NCT01091428|529240016|FG002|Phase 2|Progressive Disease|44|||
146745367|NCT01091428|529240017|FG003|Phase 2|Progressive Disease|46|||
146745368|NCT01091428|529240014|FG000|Phase 2|Symptomatic Deterioration|0|||
146745369|NCT01091428|529240015|FG001|Phase 2|Symptomatic Deterioration|0|||
146745370|NCT01091428|529240016|FG002|Phase 2|Symptomatic Deterioration|1|||
146745371|NCT01091428|529240017|FG003|Phase 2|Symptomatic Deterioration|6|||
146745372|NCT01091428|529240014|FG000|Phase 2|Adverse Event|0|||
146745373|NCT01091428|529240015|FG001|Phase 2|Adverse Event|0|||
146745374|NCT01091428|529240016|FG002|Phase 2|Adverse Event|12|||
146745375|NCT01091428|529240017|FG003|Phase 2|Adverse Event|5|||
146745376|NCT01091428|529240014|FG000|Phase 2|Withdrawal by Subject|0|||
146745377|NCT01091428|529240015|FG001|Phase 2|Withdrawal by Subject|0|||
146745378|NCT01091428|529240016|FG002|Phase 2|Withdrawal by Subject|9|||
146745379|NCT01091428|529240017|FG003|Phase 2|Withdrawal by Subject|8|||
146745380|NCT01091428|529240014|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
146745381|NCT01091428|529240015|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
146745382|NCT01091428|529240016|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
146745383|NCT01091428|529240017|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
146745384|NCT01091428|529240014|FG000|Phase 2|Reason not specified|0|||
146745385|NCT01091428|529240015|FG001|Phase 2|Reason not specified|0|||
146745386|NCT01091428|529240016|FG002|Phase 2|Reason not specified|4|||
146745387|NCT01091428|529240017|FG003|Phase 2|Reason not specified|3|||
146745388|NCT01091428|529240014|FG000|Phase 2|Physician Decision|0|||
146745389|NCT01091428|529240015|FG001|Phase 2|Physician Decision|0|||
146745390|NCT01091428|529240016|FG002|Phase 2|Physician Decision|2|||
146745391|NCT01091428|529240017|FG003|Phase 2|Physician Decision|0|||
146745392|NCT01625910|529240024|FG000|Overall Study|Lost to Follow-up|3|||
146745393|NCT01625910|529240025|FG001|Overall Study|Lost to Follow-up|4|||
146745394|NCT02391038|529240026|FG000|Overall Study|Progressive disease|3|||
146745395|NCT02391038|529240027|FG001|Overall Study|Progressive disease|3|||
146745396|NCT02391038|529240028|FG002|Overall Study|Progressive disease|6|||
146745397|NCT02959138|529240029|FG000|Overall Study|Enrolled but Never Treated|0|||
146745398|NCT02959138|529240030|FG001|Overall Study|Enrolled but Never Treated|1|||
146745399|NCT02959138|529240031|FG002|Overall Study|Enrolled but Never Treated|0|||
146745400|NCT01327547|529240037|FG000|Overall Study|Adverse Event|4|||
146745401|NCT01327547|529240038|FG001|Overall Study|Adverse Event|1|||
146745402|NCT01327547|529240037|FG000|Overall Study|Death|1|||
146745403|NCT01327547|529240038|FG001|Overall Study|Death|2|||
146745404|NCT01327547|529240037|FG000|Overall Study|Lost to Follow-up|6|||
146745405|NCT01327547|529240038|FG001|Overall Study|Lost to Follow-up|6|||
146745406|NCT01327547|529240037|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
146745407|NCT01327547|529240038|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
146745408|NCT01327547|529240037|FG000|Overall Study|Withdrawal by Subject|3|||
146745409|NCT01327547|529240038|FG001|Overall Study|Withdrawal by Subject|7|||
146745410|NCT01327547|529240037|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
146745411|NCT01327547|529240038|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
146745412|NCT01327547|529240037|FG000|Overall Study|Protocol Violation|1|||
146745413|NCT01327547|529240038|FG001|Overall Study|Protocol Violation|0|||
146745414|NCT01327547|529240037|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
146745415|NCT01327547|529240038|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
146745416|NCT01327547|529240037|FG000|Overall Study|Required prohibited medication|2|||
146745417|NCT01327547|529240038|FG001|Overall Study|Required prohibited medication|0|||
146745418|NCT01327547|529240037|FG000|Overall Study|Non-compliance with study procedures|1|||
146745419|NCT01327547|529240038|FG001|Overall Study|Non-compliance with study procedures|0|||
146745420|NCT01327547|529240037|FG000|Overall Study|By investigator in subject's interest|0|||
146745421|NCT01327547|529240038|FG001|Overall Study|By investigator in subject's interest|1|||
146745422|NCT00329719|529240039|FG000|Overall Study|Lost to Follow-up|0|||
146745423|NCT00329719|529240040|FG001|Overall Study|Lost to Follow-up|0|||
146745424|NCT00329719|529240041|FG002|Overall Study|Lost to Follow-up|0|||
146745425|NCT00329719|529240042|FG003|Overall Study|Lost to Follow-up|1|||
146745426|NCT03918239|529240043|FG000|Overall Study|Lost to Follow-up|3|||
146745427|NCT03918239|529240044|FG001|Overall Study|Lost to Follow-up|1|||
146745428|NCT03918239|529240043|FG000|Overall Study|Pregnancy|0|||
146511257|NCT00195494|528375463|FG000|Year 1|Lost to Follow-up|0|||
146511258|NCT00195494|528375464|FG001|Year 1|Lost to Follow-up|0|||
146511259|NCT00195494|528375465|FG002|Year 1|Lost to Follow-up|0|||
146511260|NCT00195494|528375466|FG003|Year 1|Lost to Follow-up|0|||
146511261|NCT00195494|528375467|FG004|Year 1|Lost to Follow-up|1|||
146511262|NCT00195494|528375468|FG005|Year 1|Lost to Follow-up|0|||
146511263|NCT00195494|528375463|FG000|Year 1|Missed >4 consecutive doses|0|||
146745429|NCT03918239|529240044|FG001|Overall Study|Pregnancy|2|||
146745430|NCT03918239|529240043|FG000|Overall Study|Withdrawal by Subject|3|||
146745431|NCT03918239|529240044|FG001|Overall Study|Withdrawal by Subject|3|||
146745432|NCT03918239|529240043|FG000|Overall Study|positive urine drug screening results|4|||
146745433|NCT03918239|529240044|FG001|Overall Study|positive urine drug screening results|1|||
146745434|NCT02930122|529240045|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
146511264|NCT00195494|528375464|FG001|Year 1|Missed >4 consecutive doses|0|||
146745435|NCT02930122|529240046|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
146745436|NCT00358215|529240047|FG000|Overall Study|Ineligibility determined|4|||
146745437|NCT00358215|529240048|FG001|Overall Study|Ineligibility determined|3|||
146745438|NCT00358215|529240047|FG000|Overall Study|Adverse Event|83|||
146745439|NCT00358215|529240048|FG001|Overall Study|Adverse Event|65|||
146745440|NCT00358215|529240047|FG000|Overall Study|Withdrawal by Subject|111|||
146745441|NCT00358215|529240048|FG001|Overall Study|Withdrawal by Subject|102|||
146745442|NCT00358215|529240047|FG000|Overall Study|Participant request|65|||
146745443|NCT00358215|529240048|FG001|Overall Study|Participant request|64|||
146745444|NCT00358215|529240047|FG000|Overall Study|Physician Decision|47|||
146745445|NCT00358215|529240048|FG001|Overall Study|Physician Decision|39|||
146745446|NCT00358215|529240047|FG000|Overall Study|Lost to Follow-up|16|||
146511265|NCT00195494|528375465|FG002|Year 1|Missed >4 consecutive doses|0|||
146745447|NCT00358215|529240048|FG001|Overall Study|Lost to Follow-up|22|||
146745448|NCT00358215|529240047|FG000|Overall Study|Death|265|||
146745449|NCT00358215|529240048|FG001|Overall Study|Death|281|||
146745450|NCT00358215|529240047|FG000|Overall Study|Protocol Violation|64|||
146745451|NCT00358215|529240048|FG001|Overall Study|Protocol Violation|59|||
146745452|NCT00358215|529240047|FG000|Overall Study|Pregnancy|1|||
146745453|NCT00358215|529240048|FG001|Overall Study|Pregnancy|0|||
146745454|NCT00358215|529240047|FG000|Overall Study|Other|21|||
146745455|NCT00358215|529240048|FG001|Overall Study|Other|14|||
146745456|NCT00358215|529240047|FG000|Overall Study|Did not receive investigational product|2|||
146745457|NCT00358215|529240048|FG001|Overall Study|Did not receive investigational product|3|||
146745458|NCT01681368|529240051|FG000|Overall Study|Refused further treatment|1|||
146745459|NCT01681368|529240051|FG000|Overall Study|Refused further follow up|1|||
146745460|NCT00373295|529240054|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
146745461|NCT00373295|529240055|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
146745462|NCT00373295|529240056|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
146745463|NCT00373295|529240057|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
146745464|NCT00373295|529240058|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
146745465|NCT00373295|529240059|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
146745466|NCT01238575|529240069|FG000|Overall Study|Lack of Efficacy|2|||
146745467|NCT01238575|529240070|FG001|Overall Study|Lack of Efficacy|4|||
146745468|NCT01238575|529240069|FG000|Overall Study|Adverse Event|2|||
146745469|NCT01238575|529240070|FG001|Overall Study|Adverse Event|0|||
146745470|NCT02771210|529240073|FG000|Period 1|Adverse Event|5|||
146745471|NCT02771210|529240074|FG001|Period 1|Adverse Event|3|||
146745472|NCT02771210|529240073|FG000|Period 1|Lack of Efficacy|3|||
146745473|NCT02771210|529240074|FG001|Period 1|Lack of Efficacy|6|||
146745474|NCT02771210|529240073|FG000|Period 1|Lost to Follow-up|2|||
146745475|NCT02771210|529240074|FG001|Period 1|Lost to Follow-up|0|||
146745476|NCT02771210|529240073|FG000|Period 1|Physician Decision|0|||
146745477|NCT02771210|529240074|FG001|Period 1|Physician Decision|1|||
146745478|NCT02771210|529240073|FG000|Period 1|Withdrawal by Subject|0|||
146745479|NCT02771210|529240074|FG001|Period 1|Withdrawal by Subject|3|||
146745480|NCT02771210|529240073|FG000|Period 1|Withdrawal of informed consent|1|||
146745481|NCT02771210|529240074|FG001|Period 1|Withdrawal of informed consent|5|||
146745482|NCT02771210|529240073|FG000|Period 2|Adverse Event|1|||
146745483|NCT02771210|529240074|FG001|Period 2|Adverse Event|0|||
146745484|NCT02771210|529240073|FG000|Period 2|Lack of Efficacy|0|||
146745485|NCT02771210|529240074|FG001|Period 2|Lack of Efficacy|1|||
146745486|NCT02771210|529240073|FG000|Period 2|Withdrawal by Subject|1|||
146745487|NCT02771210|529240074|FG001|Period 2|Withdrawal by Subject|0|||
146745488|NCT02771210|529240073|FG000|Period 2|Withdrawal of informed consent|0|||
146745489|NCT02771210|529240074|FG001|Period 2|Withdrawal of informed consent|2|||
146745490|NCT04012814|529240079|FG000|Overall Study|Lost to Follow-up|4|||
146745491|NCT04012814|529240079|FG000|Overall Study|Withdrawal by Subject|2|||
146745492|NCT04012814|529240079|FG000|Overall Study|Protocol Violation|1|||
146745493|NCT04012814|529240079|FG000|Overall Study|Adverse Event|1|||
146745494|NCT04397523|529240080|FG000|Overall Study|Lost to Follow-up|3|||
146745495|NCT04397523|529240080|FG000|Overall Study|Transfer from/to other hospital|8|||
146745496|NCT01865617|529240088|FG000|Overall Study|Death|27|||
146745497|NCT01865617|529240089|FG001|Overall Study|Death|3|||
146745498|NCT01865617|529240090|FG002|Overall Study|Death|1|||
146745499|NCT01865617|529240091|FG003|Overall Study|Death|1|||
146745500|NCT01865617|529240092|FG004|Overall Study|Death|5|||
146745501|NCT01865617|529240093|FG005|Overall Study|Death|1|||
146511266|NCT00195494|528375466|FG003|Year 1|Missed >4 consecutive doses|0|||
146745502|NCT01865617|529240094|FG006|Overall Study|Death|11|||
146745503|NCT01865617|529240095|FG007|Overall Study|Death|1|||
146745504|NCT01865617|529240096|FG008|Overall Study|Death|11|||
146511267|NCT00195494|528375467|FG004|Year 1|Missed >4 consecutive doses|3|||
146745505|NCT01865617|529240097|FG009|Overall Study|Death|3|||
146745506|NCT01865617|529240098|FG010|Overall Study|Death|32|||
146745507|NCT01865617|529240099|FG011|Overall Study|Death|6|||
146745508|NCT01865617|529240100|FG012|Overall Study|Death|13|||
146745509|NCT01865617|529240088|FG000|Overall Study|Lost to Follow-up|2|||
146745510|NCT01865617|529240089|FG001|Overall Study|Lost to Follow-up|0|||
146745511|NCT01865617|529240090|FG002|Overall Study|Lost to Follow-up|0|||
146745512|NCT01865617|529240091|FG003|Overall Study|Lost to Follow-up|0|||
146745513|NCT01865617|529240092|FG004|Overall Study|Lost to Follow-up|0|||
146745514|NCT01865617|529240093|FG005|Overall Study|Lost to Follow-up|0|||
146745515|NCT01865617|529240094|FG006|Overall Study|Lost to Follow-up|0|||
146745516|NCT01865617|529240095|FG007|Overall Study|Lost to Follow-up|0|||
146745517|NCT01865617|529240096|FG008|Overall Study|Lost to Follow-up|0|||
146745518|NCT01865617|529240097|FG009|Overall Study|Lost to Follow-up|0|||
146745519|NCT01865617|529240098|FG010|Overall Study|Lost to Follow-up|0|||
146745520|NCT01865617|529240099|FG011|Overall Study|Lost to Follow-up|0|||
146745521|NCT01865617|529240100|FG012|Overall Study|Lost to Follow-up|0|||
146745522|NCT01865617|529240088|FG000|Overall Study|Withdrawal by Subject|1|||
146745523|NCT01865617|529240089|FG001|Overall Study|Withdrawal by Subject|0|||
146745524|NCT01865617|529240090|FG002|Overall Study|Withdrawal by Subject|0|||
146745525|NCT01865617|529240091|FG003|Overall Study|Withdrawal by Subject|0|||
146745526|NCT01865617|529240092|FG004|Overall Study|Withdrawal by Subject|0|||
146745527|NCT01865617|529240093|FG005|Overall Study|Withdrawal by Subject|0|||
146745528|NCT01865617|529240094|FG006|Overall Study|Withdrawal by Subject|0|||
146745529|NCT01865617|529240095|FG007|Overall Study|Withdrawal by Subject|0|||
146745530|NCT01865617|529240096|FG008|Overall Study|Withdrawal by Subject|0|||
146745531|NCT01865617|529240097|FG009|Overall Study|Withdrawal by Subject|0|||
146745532|NCT01865617|529240098|FG010|Overall Study|Withdrawal by Subject|0|||
146745533|NCT01865617|529240099|FG011|Overall Study|Withdrawal by Subject|0|||
146745534|NCT01865617|529240100|FG012|Overall Study|Withdrawal by Subject|0|||
146745535|NCT01865617|529240088|FG000|Overall Study|Patient proceeded to new therapy|0|||
146745536|NCT01865617|529240089|FG001|Overall Study|Patient proceeded to new therapy|0|||
146745537|NCT01865617|529240090|FG002|Overall Study|Patient proceeded to new therapy|0|||
146745538|NCT01865617|529240091|FG003|Overall Study|Patient proceeded to new therapy|0|||
146745539|NCT01865617|529240092|FG004|Overall Study|Patient proceeded to new therapy|2|||
146745540|NCT01865617|529240093|FG005|Overall Study|Patient proceeded to new therapy|0|||
146745541|NCT01865617|529240094|FG006|Overall Study|Patient proceeded to new therapy|0|||
146745542|NCT01865617|529240095|FG007|Overall Study|Patient proceeded to new therapy|0|||
146745543|NCT01865617|529240096|FG008|Overall Study|Patient proceeded to new therapy|0|||
146745544|NCT01865617|529240097|FG009|Overall Study|Patient proceeded to new therapy|0|||
146745545|NCT01865617|529240098|FG010|Overall Study|Patient proceeded to new therapy|0|||
146745546|NCT01865617|529240099|FG011|Overall Study|Patient proceeded to new therapy|0|||
146745547|NCT01865617|529240100|FG012|Overall Study|Patient proceeded to new therapy|0|||
146745548|NCT01865617|529240088|FG000|Overall Study|Other|0|||
146745549|NCT01865617|529240089|FG001|Overall Study|Other|0|||
146745550|NCT01865617|529240090|FG002|Overall Study|Other|0|||
146745551|NCT01865617|529240091|FG003|Overall Study|Other|0|||
146745552|NCT01865617|529240092|FG004|Overall Study|Other|0|||
146745553|NCT01865617|529240093|FG005|Overall Study|Other|0|||
146745554|NCT01865617|529240094|FG006|Overall Study|Other|1|||
146745555|NCT01865617|529240095|FG007|Overall Study|Other|0|||
146745556|NCT01865617|529240096|FG008|Overall Study|Other|0|||
146745557|NCT01865617|529240097|FG009|Overall Study|Other|0|||
146745558|NCT01865617|529240098|FG010|Overall Study|Other|0|||
146745559|NCT01865617|529240099|FG011|Overall Study|Other|0|||
146745560|NCT01865617|529240100|FG012|Overall Study|Other|0|||
146745561|NCT02226172|529240101|FG000|Overall Study|Participant refused further follow-up|4|||
146745562|NCT02226172|529240101|FG000|Overall Study|Other|5|||
146745563|NCT02226172|529240101|FG000|Overall Study|Death|1|||
146745564|NCT02226172|529240101|FG000|Overall Study|Study terminated by sponsor|1|||
146745565|NCT02226172|529240101|FG000|Overall Study|Adverse Event|6|||
146745566|NCT00502996|529240102|FG000|Overall Study|Lost to Follow-up|9|||
146745567|NCT00502996|529240102|FG000|Overall Study|Protocol Violation|2|||
146745568|NCT00502996|529240102|FG000|Overall Study|Treatment failure|25|||
146745569|NCT00502996|529240102|FG000|Overall Study|Withdrawal Informed Consent|6|||
146745570|NCT00502996|529240102|FG000|Overall Study|Adverse Event|2|||
146745571|NCT02500979|529240103|FG000|Period 1|Hyperglycemia|1|||
146745572|NCT02500979|529240104|FG001|Period 1|Hyperglycemia|0|||
146745573|NCT02500979|529240103|FG000|Period 1|Severe non-compliance to protocol|0|||
146745574|NCT02500979|529240104|FG001|Period 1|Severe non-compliance to protocol|1|||
146745575|NCT02500979|529240103|FG000|Period 1|Adverse Event|1|||
146745576|NCT02500979|529240104|FG001|Period 1|Adverse Event|0|||
146745577|NCT02500979|529240103|FG000|Period 1|Subject decision|2|||
146745578|NCT02500979|529240104|FG001|Period 1|Subject decision|0|||
146745579|NCT02500979|529240103|FG000|Period 2|Change in risk|1|||
146745580|NCT02500979|529240104|FG001|Period 2|Change in risk|0|||
146745581|NCT00988351|529240107|FG000|Overall Study|Withdrawal by Subject|8|||
146745582|NCT00988351|529240108|FG001|Overall Study|Withdrawal by Subject|0|||
146745583|NCT00988351|529240107|FG000|Overall Study|Lost to Follow-up|6|||
146745584|NCT00988351|529240108|FG001|Overall Study|Lost to Follow-up|9|||
146745585|NCT00988351|529240107|FG000|Overall Study|not using CPAP|5|||
146745586|NCT00988351|529240108|FG001|Overall Study|not using CPAP|3|||
146745587|NCT04642469|529240110|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
146745588|NCT04642469|529240111|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
146745589|NCT04642469|529240110|FG000|Overall Study|Death|1|||
146745590|NCT04642469|529240111|FG001|Overall Study|Death|2|||
146511268|NCT00195494|528375468|FG005|Year 1|Missed >4 consecutive doses|2|||
146511269|NCT00195494|528375463|FG000|Year 1|Protocol deviation|0|||
146511270|NCT00195494|528375464|FG001|Year 1|Protocol deviation|0|||
146511271|NCT00195494|528375465|FG002|Year 1|Protocol deviation|0|||
146511272|NCT00195494|528375466|FG003|Year 1|Protocol deviation|0|||
146511273|NCT00195494|528375467|FG004|Year 1|Protocol deviation|2|||
146511274|NCT00195494|528375468|FG005|Year 1|Protocol deviation|3|||
146511275|NCT00195494|528375463|FG000|Year 1|Physician Decision|0|||
146511276|NCT00195494|528375464|FG001|Year 1|Physician Decision|0|||
146511277|NCT00195494|528375465|FG002|Year 1|Physician Decision|0|||
146511278|NCT00195494|528375466|FG003|Year 1|Physician Decision|0|||
146511279|NCT00195494|528375467|FG004|Year 1|Physician Decision|1|||
146511280|NCT00195494|528375468|FG005|Year 1|Physician Decision|0|||
146511281|NCT00195494|528375463|FG000|Year 1|Withdrawal by Subject|0|||
146511282|NCT00195494|528375464|FG001|Year 1|Withdrawal by Subject|0|||
146511283|NCT00195494|528375465|FG002|Year 1|Withdrawal by Subject|0|||
146511284|NCT00195494|528375466|FG003|Year 1|Withdrawal by Subject|0|||
146511285|NCT00195494|528375467|FG004|Year 1|Withdrawal by Subject|8|||
146511286|NCT00195494|528375468|FG005|Year 1|Withdrawal by Subject|9|||
146511287|NCT00195494|528375463|FG000|Year 1|Protocol Violation|0|||
146511288|NCT00195494|528375464|FG001|Year 1|Protocol Violation|0|||
146511289|NCT00195494|528375465|FG002|Year 1|Protocol Violation|0|||
146511290|NCT00195494|528375466|FG003|Year 1|Protocol Violation|0|||
146511291|NCT00195494|528375467|FG004|Year 1|Protocol Violation|1|||
146511292|NCT00195494|528375468|FG005|Year 1|Protocol Violation|1|||
146511293|NCT00195494|528375463|FG000|Year 2|Adverse Event|3|||
146511294|NCT00195494|528375464|FG001|Year 2|Adverse Event|7|||
146511295|NCT00195494|528375465|FG002|Year 2|Adverse Event|5|||
146511296|NCT00195494|528375466|FG003|Year 2|Adverse Event|9|||
146511297|NCT00195494|528375467|FG004|Year 2|Adverse Event|0|||
146511298|NCT00195494|528375468|FG005|Year 2|Adverse Event|0|||
146511299|NCT00195494|528375463|FG000|Year 2|Lack of Efficacy|0|||
146511300|NCT00195494|528375464|FG001|Year 2|Lack of Efficacy|1|||
146511301|NCT00195494|528375465|FG002|Year 2|Lack of Efficacy|7|||
146511302|NCT00195494|528375466|FG003|Year 2|Lack of Efficacy|7|||
146511303|NCT00195494|528375467|FG004|Year 2|Lack of Efficacy|0|||
146511304|NCT00195494|528375468|FG005|Year 2|Lack of Efficacy|0|||
146511305|NCT00195494|528375463|FG000|Year 2|Compliance|1|||
146745591|NCT04642469|529240110|FG000|Overall Study|Study/site closed following amendment 1|11|||
146745592|NCT04642469|529240111|FG001|Overall Study|Study/site closed following amendment 1|11|||
146745593|NCT04642469|529240110|FG000|Overall Study|Other|1|||
146745594|NCT04642469|529240111|FG001|Overall Study|Other|1|||
146745595|NCT04642469|529240110|FG000|Overall Study|Withdrawal by Subject|1|||
146745596|NCT04642469|529240111|FG001|Overall Study|Withdrawal by Subject|0|||
146745597|NCT01088529|529240113|FG000|Overall Study|Did not receive study treatment|0|||
146745598|NCT01088529|529240114|FG001|Overall Study|Did not receive study treatment|1|||
146745599|NCT05033080|529240115|FG000|Overall Study|Adverse Event|4|||
146745600|NCT05033080|529240116|FG001|Overall Study|Adverse Event|4|||
146745601|NCT05033080|529240115|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
146745602|NCT05033080|529240116|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
146745603|NCT05033080|529240115|FG000|Overall Study|Lost to Follow-up|1|||
146745604|NCT05033080|529240116|FG001|Overall Study|Lost to Follow-up|0|||
146745605|NCT05033080|529240115|FG000|Overall Study|Other non-compliance|0|||
146745606|NCT05033080|529240116|FG001|Overall Study|Other non-compliance|1|||
146745607|NCT05033080|529240115|FG000|Overall Study|Physician Decision|0|||
146745608|NCT05033080|529240116|FG001|Overall Study|Physician Decision|1|||
146745609|NCT05033080|529240115|FG000|Overall Study|Other|1|||
146745610|NCT05033080|529240116|FG001|Overall Study|Other|1|||
146745611|NCT03560245|529240118|FG000|Overall Study|Withdrawal by Subject|3|||
146745612|NCT03560245|529240119|FG001|Overall Study|Withdrawal by Subject|2|||
146745613|NCT03560245|529240118|FG000|Overall Study|Adverse Event|1|||
146745614|NCT03560245|529240119|FG001|Overall Study|Adverse Event|1|||
146745615|NCT03560245|529240118|FG000|Overall Study|Protocol Violation|1|||
146745616|NCT03560245|529240119|FG001|Overall Study|Protocol Violation|0|||
146745617|NCT03560245|529240118|FG000|Overall Study|Death|0|||
146745618|NCT03560245|529240119|FG001|Overall Study|Death|1|||
146745619|NCT03560245|529240118|FG000|Overall Study|Lost to Follow-up|0|||
146745620|NCT03560245|529240119|FG001|Overall Study|Lost to Follow-up|1|||
146745621|NCT03560245|529240118|FG000|Overall Study|Physician Decision|0|||
146745622|NCT03560245|529240119|FG001|Overall Study|Physician Decision|1|||
146745623|NCT03560245|529240118|FG000|Overall Study|Other|0|||
146745624|NCT03560245|529240119|FG001|Overall Study|Other|1|||
146745625|NCT01265823|529240120|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
146745626|NCT01265823|529240120|FG000|Overall Study|Failure to Return|4|||
146745627|NCT01265823|529240120|FG000|Overall Study|Protocol Violation|1|||
146745628|NCT01265823|529240120|FG000|Overall Study|Participant Request|1|||
146745629|NCT01263106|529240121|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
146745630|NCT01263106|529240122|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
146745631|NCT02302066|529240126|FG000|Overall Study|Adverse Event|1|||
146745632|NCT02302066|529240127|FG001|Overall Study|Adverse Event|1|||
146745633|NCT02302066|529240128|FG002|Overall Study|Adverse Event|3|||
146745634|NCT02302066|529240129|FG003|Overall Study|Adverse Event|0|||
146745635|NCT02302066|529240126|FG000|Overall Study|Lost to Follow-up|4|||
146745636|NCT02302066|529240127|FG001|Overall Study|Lost to Follow-up|5|||
146745637|NCT02302066|529240128|FG002|Overall Study|Lost to Follow-up|24|||
146745638|NCT02302066|529240129|FG003|Overall Study|Lost to Follow-up|7|||
146745639|NCT02302066|529240126|FG000|Overall Study|Withdrawal by Subject|25|||
146745640|NCT02302066|529240127|FG001|Overall Study|Withdrawal by Subject|58|||
146745641|NCT02302066|529240128|FG002|Overall Study|Withdrawal by Subject|124|||
146745642|NCT02302066|529240129|FG003|Overall Study|Withdrawal by Subject|33|||
146745643|NCT02302066|529240126|FG000|Overall Study|Pregnancy|2|||
146745644|NCT02302066|529240127|FG001|Overall Study|Pregnancy|10|||
146745645|NCT02302066|529240128|FG002|Overall Study|Pregnancy|12|||
146745646|NCT02302066|529240129|FG003|Overall Study|Pregnancy|0|||
146745647|NCT02302066|529240126|FG000|Overall Study|Reason Not Specified|1|||
146745648|NCT02302066|529240127|FG001|Overall Study|Reason Not Specified|1|||
146745649|NCT02302066|529240128|FG002|Overall Study|Reason Not Specified|9|||
146745650|NCT02302066|529240129|FG003|Overall Study|Reason Not Specified|1|||
146745651|NCT01734434|529240131|FG000|Overall Study|Death Infant|3|||
146745652|NCT01734434|529240132|FG001|Overall Study|Death Infant|1|||
146745653|NCT01734434|529240133|FG002|Overall Study|Death Infant|17|||
146745654|NCT01734434|529240134|FG003|Overall Study|Death Infant|5|||
146745655|NCT01734434|529240131|FG000|Overall Study|Lost to Follow-up|2|||
146745656|NCT01734434|529240132|FG001|Overall Study|Lost to Follow-up|9|||
146745657|NCT01734434|529240133|FG002|Overall Study|Lost to Follow-up|67|||
146745658|NCT01734434|529240134|FG003|Overall Study|Lost to Follow-up|11|||
146745659|NCT01734434|529240131|FG000|Overall Study|No Live Birth|1|||
146745660|NCT01734434|529240132|FG001|Overall Study|No Live Birth|2|||
146745661|NCT01734434|529240133|FG002|Overall Study|No Live Birth|32|||
146745662|NCT01734434|529240134|FG003|Overall Study|No Live Birth|6|||
146745663|NCT01734434|529240131|FG000|Overall Study|Withdrawal by Subject|4|||
146745664|NCT01734434|529240132|FG001|Overall Study|Withdrawal by Subject|0|||
146745665|NCT01734434|529240133|FG002|Overall Study|Withdrawal by Subject|8|||
146745666|NCT01734434|529240134|FG003|Overall Study|Withdrawal by Subject|1|||
146745667|NCT01734434|529240131|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
146914644|NCT03303339|529850053|FG011|Overall Study|Death|24|||
146745668|NCT01734434|529240132|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
146745669|NCT01734434|529240133|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
146745670|NCT01734434|529240134|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
146745671|NCT01734434|529240131|FG000|Overall Study|Subject Not Reachable|0|||
146745672|NCT01734434|529240132|FG001|Overall Study|Subject Not Reachable|0|||
146745673|NCT01734434|529240133|FG002|Overall Study|Subject Not Reachable|1|||
146745674|NCT01734434|529240134|FG003|Overall Study|Subject Not Reachable|0|||
146745675|NCT01734434|529240131|FG000|Overall Study|Treatment Defaulter|0|||
146745676|NCT01734434|529240132|FG001|Overall Study|Treatment Defaulter|0|||
146745677|NCT01734434|529240133|FG002|Overall Study|Treatment Defaulter|1|||
146745678|NCT01734434|529240134|FG003|Overall Study|Treatment Defaulter|0|||
146745679|NCT01734434|529240131|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
146745680|NCT01734434|529240132|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
146745681|NCT01734434|529240133|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
146745682|NCT01734434|529240134|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
146745683|NCT01734434|529240131|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
146745684|NCT01734434|529240132|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
146745685|NCT01734434|529240133|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
146745686|NCT01734434|529240134|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
146745687|NCT01040780|529241486|FG000|Overall Study|Protocol Violation|1|||
146745688|NCT01040780|529241487|FG001|Overall Study|Protocol Violation|3|||
146745689|NCT03681639|529241488|FG000|Overall Study|Death|4|||
146745690|NCT03681639|529241488|FG000|Overall Study|Lost to Follow-up|2|||
146745691|NCT03681639|529241488|FG000|Overall Study|Withdrawal by Subject|1|||
146745692|NCT03681639|529241488|FG000|Overall Study|Adverse Event|2|||
146745693|NCT00654940|529241489|FG000|Period 1|Adverse Event|0|||
146745694|NCT00654940|529241490|FG001|Period 1|Adverse Event|1|||
146745695|NCT00654940|529241489|FG000|Period 1|Intolerable Pain Level|1|||
146745696|NCT00654940|529241490|FG001|Period 1|Intolerable Pain Level|0|||
146745697|NCT00962585|529241501|FG000|Overall Study|Adverse Event|0|||
146745698|NCT00962585|529241502|FG001|Overall Study|Adverse Event|2|||
146745699|NCT00962585|529241503|FG002|Overall Study|Adverse Event|1|||
146745700|NCT00962585|529241504|FG003|Overall Study|Adverse Event|0|||
146745701|NCT00962585|529241501|FG000|Overall Study|Lost to Follow-up|3|||
146745702|NCT00962585|529241502|FG001|Overall Study|Lost to Follow-up|0|||
146745703|NCT00962585|529241503|FG002|Overall Study|Lost to Follow-up|1|||
146745704|NCT00962585|529241504|FG003|Overall Study|Lost to Follow-up|0|||
146745705|NCT00962585|529241501|FG000|Overall Study|Protocol Violation|0|||
146745706|NCT00962585|529241502|FG001|Overall Study|Protocol Violation|0|||
146745707|NCT00962585|529241503|FG002|Overall Study|Protocol Violation|1|||
146745708|NCT00962585|529241504|FG003|Overall Study|Protocol Violation|0|||
146745709|NCT00962585|529241501|FG000|Overall Study|Withdrawal by Subject|1|||
146745710|NCT00962585|529241502|FG001|Overall Study|Withdrawal by Subject|0|||
146745711|NCT00962585|529241503|FG002|Overall Study|Withdrawal by Subject|0|||
146745712|NCT00962585|529241504|FG003|Overall Study|Withdrawal by Subject|0|||
146745713|NCT00962585|529241501|FG000|Overall Study|Withdrew Consent|2|||
146745714|NCT00962585|529241502|FG001|Overall Study|Withdrew Consent|0|||
146745715|NCT00962585|529241503|FG002|Overall Study|Withdrew Consent|0|||
146745716|NCT00962585|529241504|FG003|Overall Study|Withdrew Consent|0|||
146745717|NCT02254421|529241505|FG000|Overall Study|Randomized but Not Treated|1|||
146745718|NCT02254421|529241506|FG001|Overall Study|Randomized but Not Treated|0|||
146745719|NCT02254421|529241505|FG000|Overall Study|Death|0|||
146745720|NCT02254421|529241506|FG001|Overall Study|Death|2|||
146745721|NCT02254421|529241505|FG000|Overall Study|Withdrew Consent|1|||
146745722|NCT02254421|529241506|FG001|Overall Study|Withdrew Consent|1|||
146745723|NCT01744496|529241511|FG000|Titration Period|Adverse Event|2|||
146745724|NCT01744496|529241512|FG001|Titration Period|Adverse Event|1|||
146745725|NCT01744496|529241511|FG000|Titration Period|Personal reasons|0|||
146745726|NCT01744496|529241512|FG001|Titration Period|Personal reasons|1|||
146745727|NCT01744496|529241511|FG000|Maintenance Period|Adverse Event|1|||
146745728|NCT01744496|529241512|FG001|Maintenance Period|Adverse Event|3|||
146745729|NCT01744496|529241511|FG000|Maintenance Period|Protocol Violation|1|||
146745730|NCT01744496|529241512|FG001|Maintenance Period|Protocol Violation|0|||
146745731|NCT01744496|529241511|FG000|Maintenance Period|Withdrawal by Subject|1|||
146745732|NCT01744496|529241512|FG001|Maintenance Period|Withdrawal by Subject|1|||
146745733|NCT01744496|529241511|FG000|Maintenance Period|Subject left town|1|||
146745734|NCT01744496|529241512|FG001|Maintenance Period|Subject left town|0|||
146745735|NCT03537261|529241513|FG000|Overall Study|Lost to Follow-up|4|||
146745736|NCT03537261|529241514|FG001|Overall Study|Lost to Follow-up|5|||
146745737|NCT03537261|529241513|FG000|Overall Study|Withdrawal by Subject|4|||
146745738|NCT03537261|529241514|FG001|Overall Study|Withdrawal by Subject|6|||
146745739|NCT03537261|529241513|FG000|Overall Study|Did not return study questionnaires|0|||
146745740|NCT03537261|529241514|FG001|Overall Study|Did not return study questionnaires|1|||
146745741|NCT01177813|529241517|FG000|Overall Study|Adverse Event|8|||
146745742|NCT01177813|529241518|FG001|Overall Study|Adverse Event|2|||
146745743|NCT01177813|529241519|FG002|Overall Study|Adverse Event|4|||
146745744|NCT01177813|529241520|FG003|Overall Study|Adverse Event|6|||
146745745|NCT01177813|529241521|FG004|Overall Study|Adverse Event|3|||
146745746|NCT01177813|529241517|FG000|Overall Study|Lack of Efficacy|1|||
146745747|NCT01177813|529241518|FG001|Overall Study|Lack of Efficacy|0|||
146745748|NCT01177813|529241519|FG002|Overall Study|Lack of Efficacy|0|||
146745749|NCT01177813|529241520|FG003|Overall Study|Lack of Efficacy|0|||
146745750|NCT01177813|529241521|FG004|Overall Study|Lack of Efficacy|0|||
146745751|NCT01177813|529241517|FG000|Overall Study|Protocol Violation|3|||
146745752|NCT01177813|529241518|FG001|Overall Study|Protocol Violation|2|||
146745753|NCT01177813|529241519|FG002|Overall Study|Protocol Violation|2|||
146745754|NCT01177813|529241520|FG003|Overall Study|Protocol Violation|0|||
146745755|NCT01177813|529241521|FG004|Overall Study|Protocol Violation|1|||
146745756|NCT01177813|529241517|FG000|Overall Study|Lost to Follow-up|12|||
146745757|NCT01177813|529241518|FG001|Overall Study|Lost to Follow-up|5|||
146745758|NCT01177813|529241519|FG002|Overall Study|Lost to Follow-up|6|||
146745759|NCT01177813|529241520|FG003|Overall Study|Lost to Follow-up|3|||
146745760|NCT01177813|529241521|FG004|Overall Study|Lost to Follow-up|0|||
146745761|NCT01177813|529241517|FG000|Overall Study|Withdrawal by Subject|12|||
146745762|NCT01177813|529241518|FG001|Overall Study|Withdrawal by Subject|7|||
146745763|NCT01177813|529241519|FG002|Overall Study|Withdrawal by Subject|6|||
146745764|NCT01177813|529241520|FG003|Overall Study|Withdrawal by Subject|5|||
146745765|NCT01177813|529241521|FG004|Overall Study|Withdrawal by Subject|3|||
146745766|NCT01177813|529241517|FG000|Overall Study|Other reason not defined above|5|||
146745767|NCT01177813|529241518|FG001|Overall Study|Other reason not defined above|2|||
146745768|NCT01177813|529241519|FG002|Overall Study|Other reason not defined above|2|||
146745769|NCT01177813|529241520|FG003|Overall Study|Other reason not defined above|3|||
146745770|NCT01177813|529241521|FG004|Overall Study|Other reason not defined above|2|||
146745771|NCT01729728|529241522|FG000|Overall Study|Adverse Event|0|||
146745772|NCT01729728|529241523|FG001|Overall Study|Adverse Event|6|||
146745773|NCT01729728|529241524|FG002|Overall Study|Adverse Event|0|||
146745774|NCT01729728|529241522|FG000|Overall Study|Protocol Violation|1|||
146745775|NCT01729728|529241523|FG001|Overall Study|Protocol Violation|0|||
146745776|NCT01729728|529241524|FG002|Overall Study|Protocol Violation|1|||
146745777|NCT03772314|529241527|FG000|Overall Study|Adverse Event|7|||
146745778|NCT03772314|529241528|FG001|Overall Study|Adverse Event|2|||
146745779|NCT02796963|529241529|FG000|Overall Study|Lost to Follow-up|89|||
146745780|NCT02796963|529241530|FG001|Overall Study|Lost to Follow-up|76|||
146745781|NCT02796963|529241531|FG002|Overall Study|Lost to Follow-up|69|||
146745782|NCT02796963|529241532|FG003|Overall Study|Lost to Follow-up|72|||
146745783|NCT01630590|529241542|FG000|Overall Study|Adverse Event|9|||
146745784|NCT01630590|529241542|FG000|Overall Study|Lack of Efficacy|37|||
146745785|NCT01630590|529241542|FG000|Overall Study|Withdrawal by Subject|4|||
146745786|NCT01630590|529241542|FG000|Overall Study|2nd primary tumor|2|||
146745787|NCT01630590|529241542|FG000|Overall Study|Automobile accident|1|||
146745788|NCT01630590|529241542|FG000|Overall Study|Maximum benefit|4|||
146745789|NCT02366936|529241546|FG000|Overall Study|Withdrawal by Subject|2|||
146745790|NCT02366936|529241546|FG000|Overall Study|Lost to Follow-up|4|||
146745791|NCT02366936|529241546|FG000|Overall Study|Physician Decision|2|||
146745792|NCT01751113|529241549|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
146745793|NCT01751113|529241550|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
146745794|NCT01751113|529241551|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
146745795|NCT01751113|529241552|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
146745796|NCT01751113|529241553|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
146745797|NCT01751113|529241554|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
146745798|NCT01751113|529241549|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
146745799|NCT01751113|529241550|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
146745800|NCT01751113|529241551|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
146745801|NCT01751113|529241552|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
146745802|NCT01751113|529241553|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
146745803|NCT01751113|529241554|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
146745804|NCT01551303|529241555|FG000|Overall Study|failed awareness check on vision test|4|||
146745805|NCT01551303|529241556|FG001|Overall Study|failed awareness check on vision test|7|||
146745806|NCT02878213|529241557|FG000|Overall Study|Withdrawal by Subject|2|||
146745807|NCT02878213|529241557|FG000|Overall Study|Adverse Event|1|||
146745808|NCT02471404|529241565|FG000|Overall Study|Adverse Event|7|||
146745809|NCT02471404|529241566|FG001|Overall Study|Adverse Event|1|||
146745810|NCT02471404|529241567|FG002|Overall Study|Adverse Event|2|||
146745811|NCT02471404|529241565|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
146745812|NCT02471404|529241566|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
146745813|NCT02471404|529241567|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
146745814|NCT02471404|529241565|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
146745815|NCT02471404|529241566|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
146745816|NCT02471404|529241567|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
146745817|NCT02471404|529241565|FG000|Overall Study|Lost to Follow-up|1|||
146745818|NCT02471404|529241566|FG001|Overall Study|Lost to Follow-up|1|||
146745819|NCT02471404|529241567|FG002|Overall Study|Lost to Follow-up|3|||
146745820|NCT02471404|529241565|FG000|Overall Study|Protocol Violation|1|||
146745821|NCT02471404|529241566|FG001|Overall Study|Protocol Violation|0|||
146745822|NCT02471404|529241567|FG002|Overall Study|Protocol Violation|0|||
146745823|NCT02471404|529241565|FG000|Overall Study|Withdrawal by Subject|8|||
146745824|NCT02471404|529241566|FG001|Overall Study|Withdrawal by Subject|4|||
146745825|NCT02471404|529241567|FG002|Overall Study|Withdrawal by Subject|5|||
146745826|NCT02471404|529241565|FG000|Overall Study|Other reasons not specified|10|||
146745827|NCT02471404|529241566|FG001|Overall Study|Other reasons not specified|7|||
146745828|NCT02471404|529241567|FG002|Overall Study|Other reasons not specified|12|||
146745829|NCT01927731|529241568|FG000|Overall Study|Graft Failure|1|||
146745830|NCT01927731|529241569|FG001|Overall Study|Graft Failure|2|||
146745831|NCT01927731|529241568|FG000|Overall Study|Physician Decision|2|||
146745832|NCT01927731|529241569|FG001|Overall Study|Physician Decision|3|||
146745833|NCT01927731|529241568|FG000|Overall Study|Withdrawal by Subject|0|||
146745834|NCT01927731|529241569|FG001|Overall Study|Withdrawal by Subject|2|||
146745835|NCT01927731|529241568|FG000|Overall Study|Death|0|||
146745836|NCT01927731|529241569|FG001|Overall Study|Death|3|||
146745837|NCT00305864|529241570|FG000|Overall Study|Ineligible / No protocol treatment|0|||
146745838|NCT00305864|529241571|FG001|Overall Study|Ineligible / No protocol treatment|1|||
146745839|NCT00305864|529241572|FG002|Overall Study|Ineligible / No protocol treatment|1|||
146745840|NCT00305864|529241573|FG003|Overall Study|Ineligible / No protocol treatment|13|||
146745841|NCT01464255|529241574|FG000|Overall Study|unresolve corneal staining|0|||
146745842|NCT01464255|529241575|FG001|Overall Study|unresolve corneal staining|1|||
146745843|NCT02743793|529241576|FG000|Overall Study|Death|1|||
146745844|NCT02743793|529241577|FG001|Overall Study|Death|1|||
146745845|NCT02743793|529241576|FG000|Overall Study|Withdrawal by Subject|0|||
146745846|NCT02743793|529241577|FG001|Overall Study|Withdrawal by Subject|1|||
146745847|NCT02743793|529241576|FG000|Overall Study|Screen Failure|4|||
146745848|NCT02743793|529241577|FG001|Overall Study|Screen Failure|0|||
146745849|NCT02743793|529241576|FG000|Overall Study|No Primary Care Physician|0|||
146745850|NCT02743793|529241577|FG001|Overall Study|No Primary Care Physician|1|||
146745851|NCT02743793|529241576|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
146745852|NCT02743793|529241577|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
146745853|NCT02743793|529241576|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
146745854|NCT02743793|529241577|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
146745855|NCT03053492|529241584|FG000|Overall Study|Adverse Event|1|||
146745856|NCT03053492|529241585|FG001|Overall Study|Adverse Event|1|||
146745857|NCT03053492|529241584|FG000|Overall Study|Withdrawal by Subject|7|||
146745858|NCT03053492|529241585|FG001|Overall Study|Withdrawal by Subject|5|||
146745859|NCT00849680|529241586|FG000|Overall Study|Adverse Event|0|||
146745860|NCT00849680|529241587|FG001|Overall Study|Adverse Event|0|||
146745861|NCT00849680|529241588|FG002|Overall Study|Adverse Event|0|||
146745862|NCT00849680|529241589|FG003|Overall Study|Adverse Event|0|||
146745863|NCT00849680|529241590|FG004|Overall Study|Adverse Event|0|||
146745864|NCT00849680|529241591|FG005|Overall Study|Adverse Event|0|||
146745865|NCT00849680|529241592|FG006|Overall Study|Adverse Event|2|||
146745866|NCT00849680|529241593|FG007|Overall Study|Adverse Event|0|||
146745867|NCT00849680|529241586|FG000|Overall Study|Lost to Follow-up|7|||
146745868|NCT00849680|529241587|FG001|Overall Study|Lost to Follow-up|3|||
146745869|NCT00849680|529241588|FG002|Overall Study|Lost to Follow-up|12|||
146745870|NCT00849680|529241589|FG003|Overall Study|Lost to Follow-up|11|||
146745871|NCT00849680|529241590|FG004|Overall Study|Lost to Follow-up|8|||
146745872|NCT00849680|529241591|FG005|Overall Study|Lost to Follow-up|11|||
146745873|NCT00849680|529241592|FG006|Overall Study|Lost to Follow-up|12|||
146745874|NCT00849680|529241593|FG007|Overall Study|Lost to Follow-up|5|||
146745875|NCT00849680|529241586|FG000|Overall Study|Subject moved|1|||
146745876|NCT00849680|529241587|FG001|Overall Study|Subject moved|0|||
146745877|NCT00849680|529241588|FG002|Overall Study|Subject moved|3|||
146745878|NCT00849680|529241589|FG003|Overall Study|Subject moved|1|||
146745879|NCT00849680|529241590|FG004|Overall Study|Subject moved|0|||
146745880|NCT00849680|529241591|FG005|Overall Study|Subject moved|2|||
146745881|NCT00849680|529241592|FG006|Overall Study|Subject moved|2|||
146745882|NCT00849680|529241593|FG007|Overall Study|Subject moved|2|||
146745883|NCT00849680|529241586|FG000|Overall Study|Withdrawal by Subject|2|||
146745884|NCT00849680|529241587|FG001|Overall Study|Withdrawal by Subject|0|||
146745885|NCT00849680|529241588|FG002|Overall Study|Withdrawal by Subject|0|||
146745886|NCT00849680|529241589|FG003|Overall Study|Withdrawal by Subject|2|||
146745887|NCT00849680|529241590|FG004|Overall Study|Withdrawal by Subject|2|||
146745888|NCT00849680|529241591|FG005|Overall Study|Withdrawal by Subject|2|||
146745889|NCT00849680|529241592|FG006|Overall Study|Withdrawal by Subject|1|||
146745890|NCT00849680|529241593|FG007|Overall Study|Withdrawal by Subject|1|||
146745891|NCT00849680|529241586|FG000|Overall Study|Subject unable to comply with protocol|1|||
146745892|NCT00849680|529241587|FG001|Overall Study|Subject unable to comply with protocol|0|||
146745893|NCT00849680|529241588|FG002|Overall Study|Subject unable to comply with protocol|0|||
146745894|NCT00849680|529241589|FG003|Overall Study|Subject unable to comply with protocol|0|||
146745895|NCT00849680|529241590|FG004|Overall Study|Subject unable to comply with protocol|0|||
146745896|NCT00849680|529241591|FG005|Overall Study|Subject unable to comply with protocol|0|||
146745897|NCT00849680|529241592|FG006|Overall Study|Subject unable to comply with protocol|0|||
146745898|NCT00849680|529241593|FG007|Overall Study|Subject unable to comply with protocol|0|||
146745899|NCT00785538|529241595|FG000|Treatment Period|Adverse Event|1|||
146745900|NCT00785538|529241596|FG001|Treatment Period|Adverse Event|2|||
146745901|NCT00785538|529241597|FG002|Treatment Period|Adverse Event|2|||
146745902|NCT00785538|529241598|FG003|Treatment Period|Adverse Event|0|||
146745903|NCT00785538|529241595|FG000|Treatment Period|Withdrawal by Subject|0|||
146745904|NCT00785538|529241596|FG001|Treatment Period|Withdrawal by Subject|0|||
146745905|NCT00785538|529241597|FG002|Treatment Period|Withdrawal by Subject|0|||
146745906|NCT00785538|529241598|FG003|Treatment Period|Withdrawal by Subject|1|||
146745907|NCT03382600|529241599|FG000|Overall Study|Adverse Event|3|||
146745908|NCT03382600|529241600|FG001|Overall Study|Adverse Event|3|||
146745909|NCT03382600|529241599|FG000|Overall Study|Clinical Disease Progression|2|||
146745910|NCT03382600|529241600|FG001|Overall Study|Clinical Disease Progression|4|||
146745911|NCT03382600|529241599|FG000|Overall Study|Radiological Progression|40|||
146745912|NCT03382600|529241600|FG001|Overall Study|Radiological Progression|31|||
146745913|NCT03382600|529241599|FG000|Overall Study|Withdrawal by Subject|0|||
146745914|NCT03382600|529241600|FG001|Overall Study|Withdrawal by Subject|1|||
146745915|NCT03382600|529241599|FG000|Overall Study|Other|9|||
146745916|NCT03382600|529241600|FG001|Overall Study|Other|7|||
146745917|NCT04276090|529241603|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
146745918|NCT04276090|529241604|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
146745919|NCT00967018|529241605|FG000|Overall Study|Adverse Event|2|||
146745920|NCT00967018|529241605|FG000|Overall Study|Physician Decision|7|||
146745921|NCT00967018|529241605|FG000|Overall Study|Lost to Follow-up|2|||
146745922|NCT00967018|529241605|FG000|Overall Study|Withdrawal by Subject|1|||
146745923|NCT00967018|529241605|FG000|Overall Study|Miscellaneous Reasons|9|||
146745924|NCT02066532|529241608|FG000|Phase II|Withdrawal by Subject|1|||
146745925|NCT02066532|529241609|FG001|Phase II|Withdrawal by Subject|0|||
146745926|NCT02066532|529241610|FG002|Phase II|Withdrawal by Subject|0|||
146745927|NCT02066532|529241611|FG003|Phase II|Withdrawal by Subject|0|||
146745928|NCT01680458|529241614|FG000|Overall Study|Protocol Violation|3|||
146745929|NCT02180438|529241630|FG000|Overall Study|Lost to Follow-up|1|||
146745930|NCT02058290|529241631|FG000|Overall Study|Protocol Violation|2|||
146745931|NCT02058290|529241632|FG001|Overall Study|Protocol Violation|1|||
146745932|NCT02058290|529241631|FG000|Overall Study|Physician Decision|1|||
146745933|NCT02058290|529241632|FG001|Overall Study|Physician Decision|0|||
146745934|NCT02058290|529241631|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
146745935|NCT02058290|529241632|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
146745936|NCT02058290|529241631|FG000|Overall Study|Withdrawal by Subject|0|||
146745937|NCT02058290|529241632|FG001|Overall Study|Withdrawal by Subject|1|||
146745938|NCT00785707|529241634|FG000|Overall Study|Lost to Follow-up|7|||
146745939|NCT00105586|529241637|FG000|Overall Study|Adverse Event|4|||
146745940|NCT00105586|529241638|FG001|Overall Study|Adverse Event|3|||
146745941|NCT00105586|529241637|FG000|Overall Study|Physician Decision|13|||
146745942|NCT00105586|529241638|FG001|Overall Study|Physician Decision|13|||
146745943|NCT02262260|529241639|FG000|Overall Study|Adverse Event|4|||
146745944|NCT02262260|529241640|FG001|Overall Study|Adverse Event|1|||
146745945|NCT02262260|529241639|FG000|Overall Study|Withdrawal of consent|4|||
146745946|NCT02262260|529241640|FG001|Overall Study|Withdrawal of consent|2|||
146745947|NCT02262260|529241639|FG000|Overall Study|Lost to Follow-up|1|||
146745948|NCT02262260|529241640|FG001|Overall Study|Lost to Follow-up|2|||
146745949|NCT02262260|529241639|FG000|Overall Study|Protocol deviation|2|||
146745950|NCT02262260|529241640|FG001|Overall Study|Protocol deviation|5|||
146745951|NCT01794117|529241643|FG000|Overall Study|Adverse Event|1|||
146745952|NCT01794117|529241644|FG001|Overall Study|Adverse Event|0|||
146511306|NCT00195494|528375464|FG001|Year 2|Compliance|0|||
146745953|NCT01794117|529241645|FG002|Overall Study|Adverse Event|0|||
146745954|NCT01794117|529241646|FG003|Overall Study|Adverse Event|0|||
146745955|NCT01794117|529241643|FG000|Overall Study|Participant noncompliance|0|||
146745956|NCT01794117|529241644|FG001|Overall Study|Participant noncompliance|1|||
146745957|NCT01794117|529241645|FG002|Overall Study|Participant noncompliance|0|||
146745958|NCT01794117|529241646|FG003|Overall Study|Participant noncompliance|0|||
146745959|NCT01794117|529241643|FG000|Overall Study|Refused further treatment|0|||
146745960|NCT01794117|529241644|FG001|Overall Study|Refused further treatment|2|||
146745961|NCT01794117|529241645|FG002|Overall Study|Refused further treatment|0|||
146745962|NCT01794117|529241646|FG003|Overall Study|Refused further treatment|0|||
146745963|NCT02696902|529241649|FG000|Overall Study|Lost to Follow-up|0|||
146745964|NCT02696902|529241650|FG001|Overall Study|Lost to Follow-up|1|||
146745965|NCT02696902|529241651|FG002|Overall Study|Lost to Follow-up|1|||
146745966|NCT02696902|529241649|FG000|Overall Study|Withdrawal by Subject|0|||
146745967|NCT02696902|529241650|FG001|Overall Study|Withdrawal by Subject|0|||
146745968|NCT02696902|529241651|FG002|Overall Study|Withdrawal by Subject|1|||
146745969|NCT02696902|529241649|FG000|Overall Study|Death|19|||
146745970|NCT02696902|529241650|FG001|Overall Study|Death|3|||
146745971|NCT02696902|529241651|FG002|Overall Study|Death|24|||
146745972|NCT02696902|529241649|FG000|Overall Study|Participant not fit post-randomization|0|||
146745973|NCT02696902|529241650|FG001|Overall Study|Participant not fit post-randomization|0|||
146745974|NCT02696902|529241651|FG002|Overall Study|Participant not fit post-randomization|1|||
146745975|NCT02696902|529241649|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
146745976|NCT02696902|529241650|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
146745977|NCT02696902|529241651|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
146745978|NCT02696902|529241649|FG000|Overall Study|Principal investigator's decision|1|||
146745979|NCT02696902|529241650|FG001|Overall Study|Principal investigator's decision|0|||
146745980|NCT02696902|529241651|FG002|Overall Study|Principal investigator's decision|0|||
146745981|NCT02696902|529241649|FG000|Overall Study|Sponsor's decision|1|||
146745982|NCT02696902|529241650|FG001|Overall Study|Sponsor's decision|0|||
146745983|NCT02696902|529241651|FG002|Overall Study|Sponsor's decision|0|||
146745984|NCT02696902|529241649|FG000|Overall Study|Transferred to other hospital|1|||
146745985|NCT02696902|529241650|FG001|Overall Study|Transferred to other hospital|0|||
146745986|NCT02696902|529241651|FG002|Overall Study|Transferred to other hospital|0|||
146745987|NCT02401308|529241656|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
146745988|NCT02401308|529241657|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
146745989|NCT02998021|529241658|FG000|Overall Study|Withdrawal by Subject|3|||
146745990|NCT02998021|529241659|FG001|Overall Study|Withdrawal by Subject|1|||
146745991|NCT02998021|529241658|FG000|Overall Study|unsafe home|0|||
146745992|NCT02998021|529241659|FG001|Overall Study|unsafe home|1|||
146745993|NCT00619476|529243541|FG000|Overall Study|Adverse Event|12|||
146745994|NCT00619476|529243542|FG001|Overall Study|Adverse Event|6|||
146745995|NCT00619476|529243543|FG002|Overall Study|Adverse Event|12|||
146745996|NCT00619476|529243544|FG003|Overall Study|Adverse Event|16|||
146745997|NCT00619476|529243541|FG000|Overall Study|Lack of Efficacy|6|||
146745998|NCT00619476|529243542|FG001|Overall Study|Lack of Efficacy|1|||
146745999|NCT00619476|529243543|FG002|Overall Study|Lack of Efficacy|1|||
146746000|NCT00619476|529243544|FG003|Overall Study|Lack of Efficacy|4|||
146746001|NCT00619476|529243541|FG000|Overall Study|Protocol Violation|5|||
146746002|NCT00619476|529243542|FG001|Overall Study|Protocol Violation|4|||
146746003|NCT00619476|529243543|FG002|Overall Study|Protocol Violation|4|||
146746004|NCT00619476|529243544|FG003|Overall Study|Protocol Violation|9|||
146746005|NCT00619476|529243541|FG000|Overall Study|Lost to Follow-up|1|||
146746006|NCT00619476|529243542|FG001|Overall Study|Lost to Follow-up|2|||
146746007|NCT00619476|529243543|FG002|Overall Study|Lost to Follow-up|0|||
146746008|NCT00619476|529243544|FG003|Overall Study|Lost to Follow-up|1|||
146746009|NCT00619476|529243541|FG000|Overall Study|Investigator Discretion|2|||
146746010|NCT00619476|529243542|FG001|Overall Study|Investigator Discretion|2|||
146746011|NCT00619476|529243543|FG002|Overall Study|Investigator Discretion|2|||
146746012|NCT00619476|529243544|FG003|Overall Study|Investigator Discretion|0|||
146746013|NCT00619476|529243541|FG000|Overall Study|Withdrawal by Subject|5|||
146746014|NCT00619476|529243542|FG001|Overall Study|Withdrawal by Subject|7|||
146746015|NCT00619476|529243543|FG002|Overall Study|Withdrawal by Subject|5|||
146746016|NCT00619476|529243544|FG003|Overall Study|Withdrawal by Subject|4|||
146746017|NCT00900627|529243551|FG000|Overall Study|Condition under investigation worsened|4|||
146746018|NCT00900627|529243552|FG001|Overall Study|Condition under investigation worsened|0|||
146746019|NCT00900627|529243553|FG002|Overall Study|Condition under investigation worsened|5|||
146746020|NCT00900627|529243554|FG003|Overall Study|Condition under investigation worsened|3|||
146746021|NCT00900627|529243555|FG004|Overall Study|Condition under investigation worsened|0|||
146746022|NCT00900627|529243556|FG005|Overall Study|Condition under investigation worsened|0|||
146746023|NCT00900627|529243551|FG000|Overall Study|Withdrawal by Subject|1|||
146746024|NCT00900627|529243552|FG001|Overall Study|Withdrawal by Subject|0|||
146746025|NCT00900627|529243553|FG002|Overall Study|Withdrawal by Subject|1|||
146746026|NCT00900627|529243554|FG003|Overall Study|Withdrawal by Subject|0|||
146746027|NCT00900627|529243555|FG004|Overall Study|Withdrawal by Subject|1|||
146746028|NCT00900627|529243556|FG005|Overall Study|Withdrawal by Subject|2|||
146746029|NCT00900627|529243551|FG000|Overall Study|Adverse Event|1|||
146746030|NCT00900627|529243552|FG001|Overall Study|Adverse Event|2|||
146746031|NCT00900627|529243553|FG002|Overall Study|Adverse Event|0|||
146746032|NCT00900627|529243554|FG003|Overall Study|Adverse Event|3|||
146746033|NCT00900627|529243555|FG004|Overall Study|Adverse Event|0|||
146746034|NCT00900627|529243556|FG005|Overall Study|Adverse Event|0|||
146746035|NCT00900627|529243551|FG000|Overall Study|Death|0|||
146746036|NCT00900627|529243552|FG001|Overall Study|Death|0|||
146746037|NCT00900627|529243553|FG002|Overall Study|Death|0|||
146746038|NCT00900627|529243554|FG003|Overall Study|Death|0|||
146746039|NCT00900627|529243555|FG004|Overall Study|Death|28|||
146746040|NCT00900627|529243556|FG005|Overall Study|Death|24|||
146746041|NCT00867490|529243562|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
146746042|NCT00867490|529243562|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
146746043|NCT00867490|529243562|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
146746044|NCT00867490|529243562|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
146746045|NCT00867490|529243562|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
146746046|NCT00358150|529243563|FG000|Overall Study|Adverse Event|3|||
146746047|NCT00358150|529243563|FG000|Overall Study|Withdrawal by Subject|1|||
146746048|NCT00358150|529243563|FG000|Overall Study|Undefined|3|||
146746049|NCT03685708|529243564|FG000|Overall Study|Withdrawal by Subject|0|||
146746050|NCT03685708|529243565|FG001|Overall Study|Withdrawal by Subject|0|||
146746051|NCT03685708|529243566|FG002|Overall Study|Withdrawal by Subject|1|||
146746052|NCT03685708|529243564|FG000|Overall Study|Screen Fail|0|||
146746053|NCT03685708|529243565|FG001|Overall Study|Screen Fail|1|||
146746054|NCT03685708|529243566|FG002|Overall Study|Screen Fail|1|||
146746055|NCT03685708|529243564|FG000|Overall Study|COVID 19 Pandemic|1|||
146746056|NCT03685708|529243565|FG001|Overall Study|COVID 19 Pandemic|1|||
146746057|NCT03685708|529243566|FG002|Overall Study|COVID 19 Pandemic|6|||
146746058|NCT03685708|529243564|FG000|Overall Study|Disease Progression|0|||
146746059|NCT03685708|529243565|FG001|Overall Study|Disease Progression|0|||
146746060|NCT03685708|529243566|FG002|Overall Study|Disease Progression|1|||
146746061|NCT00179010|529243567|FG000|Overall Study|Muscle probe defective|1|||
146746062|NCT00179010|529243568|FG001|Overall Study|Muscle probe defective|1|||
146746063|NCT00179010|529243567|FG000|Overall Study|Failure to place arterial line|0|||
146746064|NCT00179010|529243568|FG001|Overall Study|Failure to place arterial line|1|||
146746065|NCT02823964|529243610|FG000|Overall Study|Adverse Event|2|||
146746066|NCT02823964|529243610|FG000|Overall Study|Physician Decision|1|||
146746067|NCT02823964|529243610|FG000|Overall Study|Lack of Efficacy|1|||
146746068|NCT02823964|529243610|FG000|Overall Study|Withdrawal by Subject|1|||
146746069|NCT04011384|529243632|FG000|Overall Study|Withdrawal by Subject|2|||
146746070|NCT04011384|529243633|FG001|Overall Study|Withdrawal by Subject|0|||
146746071|NCT02001974|529243634|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
146746072|NCT02001974|529243635|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
146746073|NCT02001974|529243636|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
146746074|NCT02001974|529243634|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
146746075|NCT02001974|529243635|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
146746076|NCT02001974|529243636|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
146746077|NCT02001974|529243634|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
146746078|NCT02001974|529243635|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
146746079|NCT02001974|529243636|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
146746080|NCT02001974|529243634|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
146746081|NCT02001974|529243635|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
146746082|NCT02001974|529243636|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
146746083|NCT00993317|529243637|FG000|Overall Study|Adverse Event|2|||
146746084|NCT00993317|529243638|FG001|Overall Study|Adverse Event|4|||
146746085|NCT00993317|529243637|FG000|Overall Study|Lack of Efficacy|18|||
146746086|NCT00993317|529243638|FG001|Overall Study|Lack of Efficacy|18|||
146746087|NCT00993317|529243637|FG000|Overall Study|Withdrawal by Subject|0|||
146746088|NCT00993317|529243638|FG001|Overall Study|Withdrawal by Subject|2|||
146746089|NCT00993317|529243637|FG000|Overall Study|Investigator's opinion|0|||
146746090|NCT00993317|529243638|FG001|Overall Study|Investigator's opinion|1|||
146746091|NCT00993317|529243637|FG000|Overall Study|Early study termination at the site|1|||
146746092|NCT00993317|529243638|FG001|Overall Study|Early study termination at the site|0|||
146746093|NCT01380990|529243639|FG000|Overall Study|Treatment Failure|1|||
146746094|NCT01380990|529243640|FG001|Overall Study|Treatment Failure|0|||
146746095|NCT01380990|529243639|FG000|Overall Study|Death|0|||
146746096|NCT01380990|529243640|FG001|Overall Study|Death|1|||
146746097|NCT00672958|529243641|FG000|Overall Study|Adverse Event|11|||
146746098|NCT00672958|529243642|FG001|Overall Study|Adverse Event|9|||
146746099|NCT00672958|529243641|FG000|Overall Study|Lack of Efficacy|6|||
146746100|NCT00672958|529243642|FG001|Overall Study|Lack of Efficacy|11|||
146746101|NCT00672958|529243641|FG000|Overall Study|Non-compliance with study drug|2|||
146746102|NCT00672958|529243642|FG001|Overall Study|Non-compliance with study drug|3|||
146746103|NCT00672958|529243641|FG000|Overall Study|Protocol deviations|11|||
146746104|NCT00672958|529243642|FG001|Overall Study|Protocol deviations|5|||
146746105|NCT00672958|529243641|FG000|Overall Study|Voluntary withdrawal|12|||
146746106|NCT00672958|529243642|FG001|Overall Study|Voluntary withdrawal|8|||
146746107|NCT00672958|529243641|FG000|Overall Study|Lost to Follow-up|22|||
146746108|NCT00672958|529243642|FG001|Overall Study|Lost to Follow-up|17|||
146746109|NCT00672958|529243641|FG000|Overall Study|Reason not specified|0|||
146746110|NCT00672958|529243642|FG001|Overall Study|Reason not specified|3|||
146746111|NCT02374593|529243643|FG000|Overall Study|non-compliant|2|||
146746112|NCT02374593|529243644|FG001|Overall Study|non-compliant|0|||
146746113|NCT01009047|529243647|FG000|Overall Study|Adverse Event|5|||
146746114|NCT01009047|529243648|FG001|Overall Study|Adverse Event|0|||
146746115|NCT01009047|529243647|FG000|Overall Study|Lost to Follow-up|0|||
146746116|NCT01009047|529243648|FG001|Overall Study|Lost to Follow-up|2|||
146746117|NCT01009047|529243647|FG000|Overall Study|Lack of Efficacy|4|||
146746118|NCT01009047|529243648|FG001|Overall Study|Lack of Efficacy|11|||
146746119|NCT01009047|529243647|FG000|Overall Study|Withdrawal by consent|16|||
146746120|NCT01009047|529243648|FG001|Overall Study|Withdrawal by consent|11|||
146746121|NCT01009047|529243647|FG000|Overall Study|Other|3|||
146746122|NCT01009047|529243648|FG001|Overall Study|Other|2|||
146746123|NCT02141659|529243649|FG000|Overall Study|Major Protocol Deviation|0|||
146746124|NCT02141659|529243650|FG001|Overall Study|Major Protocol Deviation|1|||
146746125|NCT02141659|529243651|FG002|Overall Study|Major Protocol Deviation|0|||
146746126|NCT02141659|529243652|FG003|Overall Study|Major Protocol Deviation|0|||
146746127|NCT02141659|529243653|FG004|Overall Study|Major Protocol Deviation|0|||
146746128|NCT02141659|529243654|FG005|Overall Study|Major Protocol Deviation|0|||
146746129|NCT02141659|529243649|FG000|Overall Study|Lack of Efficacy|0|||
146746130|NCT02141659|529243650|FG001|Overall Study|Lack of Efficacy|0|||
146746131|NCT02141659|529243651|FG002|Overall Study|Lack of Efficacy|0|||
146746132|NCT02141659|529243652|FG003|Overall Study|Lack of Efficacy|0|||
146746133|NCT02141659|529243653|FG004|Overall Study|Lack of Efficacy|0|||
146746134|NCT02141659|529243654|FG005|Overall Study|Lack of Efficacy|1|||
146746135|NCT02141659|529243649|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
146746136|NCT02141659|529243650|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
146746137|NCT02141659|529243651|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
146746138|NCT02141659|529243652|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
146746139|NCT02141659|529243653|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
146746140|NCT02141659|529243654|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
146746141|NCT02836613|529243661|FG000|Overall Study|Accidental drowning|1|||
146746142|NCT02836613|529243662|FG001|Overall Study|Accidental drowning|0|||
146746143|NCT02836613|529243661|FG000|Overall Study|Lost to Follow-up|0|||
146746144|NCT02836613|529243662|FG001|Overall Study|Lost to Follow-up|1|||
146746145|NCT02836613|529243661|FG000|Overall Study|Withdrawal by Subject|0|||
146511307|NCT00195494|528375465|FG002|Year 2|Compliance|0|||
146746146|NCT02836613|529243662|FG001|Overall Study|Withdrawal by Subject|2|||
146746147|NCT03881059|529243663|FG000|Treatment Period - Part A|Adverse Event|1|||
146746148|NCT03881059|529243664|FG001|Treatment Period - Part A|Adverse Event|3|||
146746149|NCT03881059|529243665|FG002|Treatment Period - Part A|Adverse Event|4|||
146746150|NCT03881059|529243663|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
146746151|NCT03881059|529243664|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
146746152|NCT03881059|529243665|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
146746153|NCT03881059|529243663|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
146746154|NCT03881059|529243664|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
146746155|NCT03881059|529243665|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
146746156|NCT03881059|529243663|FG000|Treatment Period - Part A|Other reasons|2|||
146746157|NCT03881059|529243664|FG001|Treatment Period - Part A|Other reasons|1|||
146746158|NCT03881059|529243665|FG002|Treatment Period - Part A|Other reasons|0|||
146746159|NCT03881059|529243663|FG000|Treatment Period - Part B|Adverse Event|0|||
146746160|NCT03881059|529243664|FG001|Treatment Period - Part B|Adverse Event|0|||
146746161|NCT03881059|529243665|FG002|Treatment Period - Part B|Adverse Event|3|||
146746162|NCT03881059|529243663|FG000|Treatment Period - Part B|Death|0|||
146746163|NCT03881059|529243664|FG001|Treatment Period - Part B|Death|1|||
146746164|NCT03881059|529243665|FG002|Treatment Period - Part B|Death|1|||
146746165|NCT03881059|529243663|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
146746166|NCT03881059|529243664|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
146746167|NCT03881059|529243665|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
146746168|NCT03881059|529243663|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
146746169|NCT03881059|529243664|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
146746170|NCT03881059|529243665|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
146746171|NCT03881059|529243663|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
146746172|NCT03881059|529243664|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
146746173|NCT03881059|529243665|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
146746174|NCT03881059|529243663|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
146746175|NCT03881059|529243664|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
146746176|NCT03881059|529243665|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
146746177|NCT03881059|529243663|FG000|Treatment Period - Part B|Other reasons|4|||
146746178|NCT03881059|529243664|FG001|Treatment Period - Part B|Other reasons|3|||
146746179|NCT03881059|529243665|FG002|Treatment Period - Part B|Other reasons|3|||
146746180|NCT05284019|529243666|FG000|Overall Study|Study terminated|2|||
146746181|NCT05284019|529243667|FG001|Overall Study|Study terminated|2|||
146746182|NCT05284019|529243668|FG002|Overall Study|Study terminated|2|||
146746183|NCT05284019|529243669|FG003|Overall Study|Study terminated|5|||
146746184|NCT05284019|529243670|FG004|Overall Study|Study terminated|15|||
146746185|NCT05284019|529243666|FG000|Overall Study|Withdrawal by Subject|0|||
146746186|NCT05284019|529243667|FG001|Overall Study|Withdrawal by Subject|0|||
146746187|NCT05284019|529243668|FG002|Overall Study|Withdrawal by Subject|0|||
146746188|NCT05284019|529243669|FG003|Overall Study|Withdrawal by Subject|1|||
146746189|NCT05284019|529243670|FG004|Overall Study|Withdrawal by Subject|1|||
146746190|NCT05284019|529243666|FG000|Overall Study|Lost to Follow-up|1|||
146746191|NCT05284019|529243667|FG001|Overall Study|Lost to Follow-up|0|||
146746192|NCT05284019|529243668|FG002|Overall Study|Lost to Follow-up|0|||
146746193|NCT05284019|529243669|FG003|Overall Study|Lost to Follow-up|2|||
146746194|NCT05284019|529243670|FG004|Overall Study|Lost to Follow-up|1|||
146746195|NCT02065570|529243671|FG000|Induction Study|Adverse Event|5|||
146746196|NCT02065570|529243672|FG001|Induction Study|Adverse Event|12|||
146746197|NCT02065570|529243673|FG002|Induction Study|Adverse Event|0|||
146746198|NCT02065570|529243674|FG003|Induction Study|Adverse Event|0|||
146746199|NCT02065570|529243671|FG000|Induction Study|Withdrawal by Subject|2|||
146746200|NCT02065570|529243672|FG001|Induction Study|Withdrawal by Subject|3|||
146746201|NCT02065570|529243673|FG002|Induction Study|Withdrawal by Subject|0|||
146746202|NCT02065570|529243674|FG003|Induction Study|Withdrawal by Subject|0|||
146746203|NCT02065570|529243671|FG000|Induction Study|Lost to Follow-up|1|||
146746204|NCT02065570|529243672|FG001|Induction Study|Lost to Follow-up|1|||
146746205|NCT02065570|529243673|FG002|Induction Study|Lost to Follow-up|0|||
146746206|NCT02065570|529243674|FG003|Induction Study|Lost to Follow-up|0|||
146746207|NCT02065570|529243671|FG000|Induction Study|Other, Not Specified|6|||
146746208|NCT02065570|529243672|FG001|Induction Study|Other, Not Specified|5|||
146746209|NCT02065570|529243673|FG002|Induction Study|Other, Not Specified|0|||
146746210|NCT02065570|529243674|FG003|Induction Study|Other, Not Specified|0|||
146746211|NCT02065570|529243671|FG000|Maintenance Study|Adverse Event|0|||
146746212|NCT02065570|529243672|FG001|Maintenance Study|Adverse Event|0|||
146746213|NCT02065570|529243673|FG002|Maintenance Study|Adverse Event|8|||
146746214|NCT02065570|529243674|FG003|Maintenance Study|Adverse Event|8|||
146746215|NCT02065570|529243671|FG000|Maintenance Study|Withdrawal by Subject|0|||
146746216|NCT02065570|529243672|FG001|Maintenance Study|Withdrawal by Subject|0|||
146746217|NCT02065570|529243673|FG002|Maintenance Study|Withdrawal by Subject|1|||
146746218|NCT02065570|529243674|FG003|Maintenance Study|Withdrawal by Subject|4|||
146746219|NCT02065570|529243671|FG000|Maintenance Study|Lost to Follow-up|0|||
146746220|NCT02065570|529243672|FG001|Maintenance Study|Lost to Follow-up|0|||
146746221|NCT02065570|529243673|FG002|Maintenance Study|Lost to Follow-up|2|||
146746222|NCT02065570|529243674|FG003|Maintenance Study|Lost to Follow-up|2|||
146746223|NCT02065570|529243671|FG000|Maintenance Study|Other, Not Specified|0|||
146746224|NCT02065570|529243672|FG001|Maintenance Study|Other, Not Specified|0|||
146746225|NCT02065570|529243673|FG002|Maintenance Study|Other, Not Specified|11|||
146746226|NCT02065570|529243674|FG003|Maintenance Study|Other, Not Specified|5|||
146746227|NCT01231503|529243675|FG000|Overall Study|Adverse Event|0|||
146746228|NCT01231503|529243676|FG001|Overall Study|Adverse Event|0|||
146746229|NCT01231503|529243677|FG002|Overall Study|Adverse Event|0|||
146746230|NCT01231503|529243678|FG003|Overall Study|Adverse Event|0|||
146746231|NCT01231503|529243679|FG004|Overall Study|Adverse Event|0|||
146746232|NCT01231503|529243680|FG005|Overall Study|Adverse Event|1|||
146746233|NCT01231503|529243681|FG006|Overall Study|Adverse Event|0|||
146746234|NCT01231503|529243682|FG007|Overall Study|Adverse Event|0|||
146746235|NCT01231503|529243675|FG000|Overall Study|Adverse event, serious fatal|0|||
146746236|NCT01231503|529243676|FG001|Overall Study|Adverse event, serious fatal|0|||
146746237|NCT01231503|529243677|FG002|Overall Study|Adverse event, serious fatal|1|||
146746238|NCT01231503|529243678|FG003|Overall Study|Adverse event, serious fatal|1|||
146746239|NCT01231503|529243679|FG004|Overall Study|Adverse event, serious fatal|0|||
146746240|NCT01231503|529243680|FG005|Overall Study|Adverse event, serious fatal|1|||
146746241|NCT01231503|529243681|FG006|Overall Study|Adverse event, serious fatal|0|||
146746242|NCT01231503|529243682|FG007|Overall Study|Adverse event, serious fatal|0|||
146746243|NCT01231503|529243675|FG000|Overall Study|Withdrawal by Subject|6|||
146746244|NCT01231503|529243676|FG001|Overall Study|Withdrawal by Subject|3|||
146746245|NCT01231503|529243677|FG002|Overall Study|Withdrawal by Subject|3|||
146746246|NCT01231503|529243678|FG003|Overall Study|Withdrawal by Subject|1|||
146746247|NCT01231503|529243679|FG004|Overall Study|Withdrawal by Subject|3|||
146746248|NCT01231503|529243680|FG005|Overall Study|Withdrawal by Subject|5|||
146746249|NCT01231503|529243681|FG006|Overall Study|Withdrawal by Subject|1|||
146746250|NCT01231503|529243682|FG007|Overall Study|Withdrawal by Subject|2|||
146746251|NCT01231503|529243675|FG000|Overall Study|Lost to Follow-up|8|||
146746252|NCT01231503|529243676|FG001|Overall Study|Lost to Follow-up|10|||
146746253|NCT01231503|529243677|FG002|Overall Study|Lost to Follow-up|8|||
146746254|NCT01231503|529243678|FG003|Overall Study|Lost to Follow-up|5|||
146746255|NCT01231503|529243679|FG004|Overall Study|Lost to Follow-up|7|||
146746256|NCT01231503|529243680|FG005|Overall Study|Lost to Follow-up|9|||
146746257|NCT01231503|529243681|FG006|Overall Study|Lost to Follow-up|6|||
146746258|NCT01231503|529243682|FG007|Overall Study|Lost to Follow-up|6|||
146746259|NCT01231503|529243675|FG000|Overall Study|Protocol Violation|0|||
146746260|NCT01231503|529243676|FG001|Overall Study|Protocol Violation|0|||
146746261|NCT01231503|529243677|FG002|Overall Study|Protocol Violation|0|||
146746262|NCT01231503|529243678|FG003|Overall Study|Protocol Violation|1|||
146746263|NCT01231503|529243679|FG004|Overall Study|Protocol Violation|0|||
146746264|NCT01231503|529243680|FG005|Overall Study|Protocol Violation|0|||
146746265|NCT01231503|529243681|FG006|Overall Study|Protocol Violation|0|||
146746266|NCT01231503|529243682|FG007|Overall Study|Protocol Violation|0|||
146746267|NCT01146574|529243683|FG000|Overall Study|Death|0|||
146746268|NCT01146574|529243684|FG001|Overall Study|Death|1|||
146746269|NCT01146574|529243685|FG002|Overall Study|Death|1|||
146746270|NCT01146574|529243686|FG003|Overall Study|Death|0|||
146746271|NCT01146574|529243687|FG004|Overall Study|Death|0|||
146746272|NCT01146574|529243688|FG005|Overall Study|Death|0|||
146746273|NCT01146574|529243689|FG006|Overall Study|Death|0|||
146746274|NCT01146574|529243683|FG000|Overall Study|Other reasons|0|||
146746275|NCT01146574|529243684|FG001|Overall Study|Other reasons|0|||
146746276|NCT01146574|529243685|FG002|Overall Study|Other reasons|3|||
146746277|NCT01146574|529243686|FG003|Overall Study|Other reasons|0|||
146746278|NCT01146574|529243687|FG004|Overall Study|Other reasons|0|||
146746279|NCT01146574|529243688|FG005|Overall Study|Other reasons|0|||
146746280|NCT01146574|529243689|FG006|Overall Study|Other reasons|0|||
146746281|NCT01146574|529243683|FG000|Overall Study|Kidney transplant|0|||
146746282|NCT01146574|529243684|FG001|Overall Study|Kidney transplant|0|||
146746283|NCT01146574|529243685|FG002|Overall Study|Kidney transplant|1|||
146746284|NCT01146574|529243686|FG003|Overall Study|Kidney transplant|1|||
146746285|NCT01146574|529243687|FG004|Overall Study|Kidney transplant|0|||
146746286|NCT01146574|529243688|FG005|Overall Study|Kidney transplant|0|||
146746287|NCT01146574|529243689|FG006|Overall Study|Kidney transplant|0|||
146746288|NCT01146574|529243683|FG000|Overall Study|Withdrew consent|0|||
146746289|NCT01146574|529243684|FG001|Overall Study|Withdrew consent|0|||
146746290|NCT01146574|529243685|FG002|Overall Study|Withdrew consent|1|||
146746291|NCT01146574|529243686|FG003|Overall Study|Withdrew consent|1|||
146746292|NCT01146574|529243687|FG004|Overall Study|Withdrew consent|2|||
146746293|NCT01146574|529243688|FG005|Overall Study|Withdrew consent|1|||
146746294|NCT01146574|529243689|FG006|Overall Study|Withdrew consent|1|||
146746295|NCT03406702|529243693|FG000|Overall Study|Missed Day 27 Dosing|1|||
146746296|NCT00514046|529243701|FG000|Overall Study|transferred to another protocol|2|||
146746297|NCT00514046|529243702|FG001|Overall Study|transferred to another protocol|1|||
146746298|NCT00514046|529243703|FG002|Overall Study|transferred to another protocol|3|||
146746299|NCT00514046|529243704|FG003|Overall Study|transferred to another protocol|0|||
146746300|NCT00514046|529243705|FG004|Overall Study|transferred to another protocol|1|||
146746301|NCT00514046|529243706|FG005|Overall Study|transferred to another protocol|0|||
146746302|NCT00514046|529243707|FG006|Overall Study|transferred to another protocol|0|||
146746303|NCT00514046|529243708|FG007|Overall Study|transferred to another protocol|0|||
146746304|NCT00514046|529243709|FG008|Overall Study|transferred to another protocol|0|||
146746305|NCT00514046|529243701|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
146746306|NCT00514046|529243702|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
146746307|NCT00514046|529243703|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
146746308|NCT00514046|529243704|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
146746309|NCT00514046|529243705|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
146746310|NCT00514046|529243706|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
146746311|NCT00514046|529243707|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
146746312|NCT00514046|529243708|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
146746313|NCT00514046|529243709|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
146746314|NCT00514046|529243701|FG000|Overall Study|Disease progression on study|0|||
146746315|NCT00514046|529243702|FG001|Overall Study|Disease progression on study|0|||
146746316|NCT00514046|529243703|FG002|Overall Study|Disease progression on study|2|||
146746317|NCT00514046|529243704|FG003|Overall Study|Disease progression on study|0|||
146746318|NCT00514046|529243705|FG004|Overall Study|Disease progression on study|0|||
146746319|NCT00514046|529243706|FG005|Overall Study|Disease progression on study|1|||
146746320|NCT00514046|529243707|FG006|Overall Study|Disease progression on study|0|||
146746321|NCT00514046|529243708|FG007|Overall Study|Disease progression on study|0|||
146746322|NCT00514046|529243709|FG008|Overall Study|Disease progression on study|0|||
146746323|NCT00655551|529243710|FG000|All Periods Combined|Adverse Event|0|||
146746324|NCT00655551|529243711|FG001|All Periods Combined|Adverse Event|3|||
146746325|NCT00655551|529243712|FG002|All Periods Combined|Adverse Event|4|||
146746326|NCT00655551|529243710|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
146746327|NCT00655551|529243711|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
146746328|NCT00655551|529243712|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
146746329|NCT00655551|529243710|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
146746330|NCT00655551|529243711|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
146746331|NCT00655551|529243712|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
146746332|NCT00655551|529243710|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
146746333|NCT00655551|529243711|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
146746334|NCT00655551|529243712|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
146746335|NCT00383240|529243717|FG000|Overall Study|Adverse Event|4|||
146746336|NCT00383240|529243718|FG001|Overall Study|Adverse Event|6|||
146746337|NCT00383240|529243719|FG002|Overall Study|Adverse Event|9|||
146746338|NCT00383240|529243720|FG003|Overall Study|Adverse Event|7|||
146746339|NCT00383240|529243717|FG000|Overall Study|Treatment Failure|8|||
146746340|NCT00383240|529243718|FG001|Overall Study|Treatment Failure|13|||
146746341|NCT00383240|529243719|FG002|Overall Study|Treatment Failure|47|||
146746342|NCT00383240|529243720|FG003|Overall Study|Treatment Failure|46|||
146746343|NCT00383240|529243717|FG000|Overall Study|Lost to Follow-up|3|||
146746344|NCT00383240|529243718|FG001|Overall Study|Lost to Follow-up|0|||
146746345|NCT00383240|529243719|FG002|Overall Study|Lost to Follow-up|0|||
146746346|NCT00383240|529243720|FG003|Overall Study|Lost to Follow-up|2|||
146746347|NCT00383240|529243717|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
146746348|NCT00383240|529243718|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
146746349|NCT00383240|529243719|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
146746350|NCT00383240|529243720|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
146746351|NCT00383240|529243717|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
146746352|NCT00383240|529243718|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
146746353|NCT00383240|529243719|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
146746354|NCT00383240|529243720|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
146746355|NCT00383240|529243717|FG000|Overall Study|Protocol Violation|4|||
146746356|NCT00383240|529243718|FG001|Overall Study|Protocol Violation|5|||
146746357|NCT00383240|529243719|FG002|Overall Study|Protocol Violation|9|||
146746358|NCT00383240|529243720|FG003|Overall Study|Protocol Violation|6|||
146746359|NCT00383240|529243717|FG000|Overall Study|Did not meet protocol eligibility|9|||
146746360|NCT00383240|529243718|FG001|Overall Study|Did not meet protocol eligibility|4|||
146746361|NCT00383240|529243719|FG002|Overall Study|Did not meet protocol eligibility|9|||
146746362|NCT00383240|529243720|FG003|Overall Study|Did not meet protocol eligibility|3|||
146746363|NCT00383240|529243717|FG000|Overall Study|Administrative|1|||
146746364|NCT00383240|529243718|FG001|Overall Study|Administrative|1|||
146746365|NCT00383240|529243719|FG002|Overall Study|Administrative|0|||
146746366|NCT00383240|529243720|FG003|Overall Study|Administrative|0|||
146746367|NCT02049710|529243721|FG000|Overall Study|Lost to Follow-up|319|||
146746368|NCT02049710|529243722|FG001|Overall Study|Lost to Follow-up|324|||
146746369|NCT02044458|529243723|FG000|Overall Study|Protocol Violation|3|||
146746370|NCT02044458|529243724|FG001|Overall Study|Protocol Violation|8|||
146746371|NCT03391960|529243725|FG000|Overall Study|Protocol Violation|0|||
146746372|NCT03391960|529243726|FG001|Overall Study|Protocol Violation|0|||
146746373|NCT02924389|529243728|FG000|Overall Study|Lost to Follow-up|1|||
146511308|NCT00195494|528375466|FG003|Year 2|Compliance|2|||
146746374|NCT02924389|529243729|FG001|Overall Study|Lost to Follow-up|0|||
146746375|NCT02924389|529243728|FG000|Overall Study|Physician Decision|2|||
146746376|NCT02924389|529243729|FG001|Overall Study|Physician Decision|0|||
146746377|NCT02924389|529243728|FG000|Overall Study|Withdrawal by Subject|3|||
146746378|NCT02924389|529243729|FG001|Overall Study|Withdrawal by Subject|0|||
146746379|NCT02924389|529243728|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
146746380|NCT02924389|529243729|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
146746381|NCT00581113|529245940|FG000|Overall Study|Withdrawal by Subject|0|||
146746382|NCT00581113|529245941|FG001|Overall Study|Withdrawal by Subject|1|||
146746383|NCT01818141|529245942|FG000|Overall Study|Withdrawal by Subject|2|||
146746384|NCT01818141|529245943|FG001|Overall Study|Withdrawal by Subject|0|||
146746385|NCT01818141|529245942|FG000|Overall Study|No baseline C.diff colonies|1|||
146746386|NCT01818141|529245943|FG001|Overall Study|No baseline C.diff colonies|1|||
146746387|NCT01818141|529245942|FG000|Overall Study|Lost to Follow-up|0|||
146746388|NCT01818141|529245943|FG001|Overall Study|Lost to Follow-up|2|||
146746389|NCT02169830|529245944|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
146746390|NCT02169830|529245945|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
146746391|NCT02169830|529245946|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
146746392|NCT02169830|529245944|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
146746393|NCT02169830|529245945|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
146746394|NCT02169830|529245946|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
146746395|NCT02169830|529245944|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
146746396|NCT02169830|529245945|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
146746397|NCT02169830|529245946|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
146746398|NCT02169830|529245944|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
146746399|NCT02169830|529245945|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
146746400|NCT02169830|529245946|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
146746401|NCT02169830|529245944|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
146746402|NCT02169830|529245945|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
146746403|NCT02169830|529245946|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
146746404|NCT03204695|529245947|FG000|Overall Study|Death|1|||
146746405|NCT03204695|529245947|FG000|Overall Study|Participant was treated with another device|1|||
146746406|NCT03204695|529245947|FG000|Overall Study|Physician Decision|2|||
146746407|NCT04834362|529245948|FG000|Overall Study|Death|1|||
146746408|NCT04834362|529245949|FG001|Overall Study|Death|2|||
146746409|NCT02555371|529245950|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
146746410|NCT02555371|529245951|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
146746411|NCT02555371|529245952|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
146746412|NCT02555371|529245953|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
146746413|NCT02555371|529245954|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
146746414|NCT02555371|529245950|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
146746415|NCT02555371|529245951|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
146746416|NCT02555371|529245952|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
146746417|NCT02555371|529245953|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
146746418|NCT02555371|529245954|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
146746419|NCT02555371|529245950|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
146746420|NCT02555371|529245951|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
146746421|NCT02555371|529245952|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
146746422|NCT02555371|529245953|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
146746423|NCT02555371|529245954|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
146746424|NCT02555371|529245950|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
146746425|NCT02555371|529245951|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
146746426|NCT02555371|529245952|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
146746427|NCT02555371|529245953|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
146746428|NCT02555371|529245954|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
146746429|NCT02555371|529245950|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
146746430|NCT02555371|529245951|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
146746431|NCT02555371|529245952|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
146746432|NCT02555371|529245953|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
146746433|NCT02555371|529245954|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
146746434|NCT02555371|529245950|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
146746435|NCT02555371|529245951|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
146746436|NCT02555371|529245952|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
146746437|NCT02555371|529245953|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
146746438|NCT02555371|529245954|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
146746439|NCT02555371|529245950|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
146746440|NCT02555371|529245951|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
146746441|NCT02555371|529245952|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
146746442|NCT02555371|529245953|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
146746443|NCT02555371|529245954|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
146746444|NCT02555371|529245950|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
146746445|NCT02555371|529245951|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
146746446|NCT02555371|529245952|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
146746447|NCT02555371|529245953|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
146746448|NCT02555371|529245954|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
146746449|NCT02555371|529245950|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
146746450|NCT02555371|529245951|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
146746451|NCT02555371|529245952|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
146746452|NCT02555371|529245953|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
146746453|NCT02555371|529245954|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
146746454|NCT02555371|529245950|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
146746455|NCT02555371|529245951|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
146746456|NCT02555371|529245952|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
146746457|NCT02555371|529245953|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
146746458|NCT02555371|529245954|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
146746459|NCT02555371|529245950|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
146746460|NCT02555371|529245951|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
146746461|NCT02555371|529245952|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
146746462|NCT02555371|529245953|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
146746463|NCT02555371|529245954|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
146746464|NCT02555371|529245950|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
146746465|NCT02555371|529245951|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
146746466|NCT02555371|529245952|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
146746467|NCT02555371|529245953|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
146746468|NCT02555371|529245954|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
146746469|NCT02555371|529245950|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
146746470|NCT02555371|529245951|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
146746471|NCT02555371|529245952|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
146746472|NCT02555371|529245953|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
146746473|NCT02555371|529245954|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
146746474|NCT02555371|529245950|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
146746475|NCT02555371|529245951|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
146746476|NCT02555371|529245952|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
146746477|NCT02555371|529245953|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
146746478|NCT02555371|529245954|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
146746479|NCT03095599|529245955|FG000|Overall Study|Withdrawal by Subject|1|||
146746480|NCT03095599|529245956|FG001|Overall Study|Withdrawal by Subject|0|||
146746481|NCT03095599|529245955|FG000|Overall Study|Lost to Follow-up|1|||
146746482|NCT03095599|529245956|FG001|Overall Study|Lost to Follow-up|0|||
146746483|NCT03095599|529245955|FG000|Overall Study|Withdrawal prior to vaccination|1|||
146746484|NCT03095599|529245956|FG001|Overall Study|Withdrawal prior to vaccination|0|||
146746485|NCT00742885|529245960|FG000|Overall Study|Lost to Follow-up|1|||
146746486|NCT00742885|529245961|FG001|Overall Study|Lost to Follow-up|0|||
146746487|NCT04781647|529245962|FG000|Overall Study|Study terminated by Sponsor|11|||
146746488|NCT04781647|529245963|FG001|Overall Study|Study terminated by Sponsor|9|||
146746489|NCT04781647|529245964|FG002|Overall Study|Study terminated by Sponsor|9|||
146746490|NCT04781647|529245962|FG000|Overall Study|Withdrawal by Subject|1|||
146746491|NCT04781647|529245963|FG001|Overall Study|Withdrawal by Subject|2|||
146746492|NCT04781647|529245964|FG002|Overall Study|Withdrawal by Subject|0|||
146746493|NCT04781647|529245962|FG000|Overall Study|Adverse Event|0|||
146746494|NCT04781647|529245963|FG001|Overall Study|Adverse Event|1|||
146746495|NCT04781647|529245964|FG002|Overall Study|Adverse Event|1|||
146746496|NCT04781647|529245962|FG000|Overall Study|Protocol Violation|1|||
146746497|NCT04781647|529245963|FG001|Overall Study|Protocol Violation|0|||
146746498|NCT04781647|529245964|FG002|Overall Study|Protocol Violation|0|||
146746499|NCT04781647|529245962|FG000|Overall Study|Pregnancy|0|||
146746500|NCT04781647|529245963|FG001|Overall Study|Pregnancy|0|||
146746501|NCT04781647|529245964|FG002|Overall Study|Pregnancy|1|||
146746502|NCT04781647|529245962|FG000|Overall Study|Virology rebounded|1|||
146746503|NCT04781647|529245963|FG001|Overall Study|Virology rebounded|0|||
146746504|NCT04781647|529245964|FG002|Overall Study|Virology rebounded|0|||
146746505|NCT01755689|529245965|FG000|Overall Study|Withdrawal by Subject|1|||
146746506|NCT01755689|529245966|FG001|Overall Study|Withdrawal by Subject|3|||
146746507|NCT01755689|529245967|FG002|Overall Study|Withdrawal by Subject|2|||
146746508|NCT01755689|529245968|FG003|Overall Study|Withdrawal by Subject|1|||
146746509|NCT01755689|529245969|FG004|Overall Study|Withdrawal by Subject|1|||
146746510|NCT01755689|529245965|FG000|Overall Study|Migrated/moved from study area|0|||
146746511|NCT01755689|529245966|FG001|Overall Study|Migrated/moved from study area|1|||
146746512|NCT01755689|529245967|FG002|Overall Study|Migrated/moved from study area|1|||
146746513|NCT01755689|529245968|FG003|Overall Study|Migrated/moved from study area|1|||
146746514|NCT01755689|529245969|FG004|Overall Study|Migrated/moved from study area|1|||
146746515|NCT01755689|529245965|FG000|Overall Study|Lost to Follow-up|1|||
146746516|NCT01755689|529245966|FG001|Overall Study|Lost to Follow-up|0|||
146746517|NCT01755689|529245967|FG002|Overall Study|Lost to Follow-up|1|||
146746518|NCT01755689|529245968|FG003|Overall Study|Lost to Follow-up|0|||
146746519|NCT01755689|529245969|FG004|Overall Study|Lost to Follow-up|2|||
146746520|NCT01755689|529245965|FG000|Overall Study|Pregnancy|1|||
146746521|NCT01755689|529245966|FG001|Overall Study|Pregnancy|1|||
146746522|NCT01755689|529245967|FG002|Overall Study|Pregnancy|2|||
146746523|NCT01755689|529245968|FG003|Overall Study|Pregnancy|4|||
146746524|NCT01755689|529245969|FG004|Overall Study|Pregnancy|2|||
146746525|NCT02609659|529245970|FG000|Overall Study|Adverse Event|1|||
146746526|NCT02609659|529245970|FG000|Overall Study|Lost to Follow-up|6|||
146746527|NCT02609659|529245970|FG000|Overall Study|Other|1|||
146746528|NCT01155388|529245973|FG000|Overall Study|Adverse Event|1|||
146746529|NCT01155388|529245974|FG001|Overall Study|Adverse Event|0|||
146746530|NCT01004250|529245975|FG000|Induction Therapy Period|Adverse Event|10|||
146746531|NCT01004250|529245975|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
146746532|NCT01004250|529245975|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
146746533|NCT01004250|529245975|FG000|Induction Therapy Period|Physician Decision|2|||
146746534|NCT01004250|529245975|FG000|Maintenance Therapy Period|Adverse Event|15|||
146746535|NCT01004250|529245975|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
146746536|NCT01004250|529245975|FG000|Maintenance Therapy Period|Protocol Violation|1|||
146746537|NCT01004250|529245975|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
146746538|NCT01004250|529245975|FG000|Maintenance Therapy Period|Physician Decision|4|||
146746539|NCT01004250|529245975|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
146746540|NCT03943589|529245976|FG000|Overall Study|Death|1|||
146746541|NCT03943589|529245976|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
146746542|NCT04329104|529245977|FG000|Efficacy Study|Withdrawal by Subject|0|||
146746543|NCT04329104|529245978|FG001|Efficacy Study|Withdrawal by Subject|0|||
146746544|NCT04329104|529245979|FG002|Efficacy Study|Withdrawal by Subject|0|||
146746545|NCT04329104|529245980|FG003|Efficacy Study|Withdrawal by Subject|5|||
146746546|NCT04329104|529245981|FG004|Efficacy Study|Withdrawal by Subject|6|||
146746547|NCT04329104|529245982|FG005|Efficacy Study|Withdrawal by Subject|8|||
146746548|NCT03884231|529245983|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
146746549|NCT03884231|529245983|FG000|Overall Study|Subject Withdrew Consent|1|||
146746550|NCT03884231|529245983|FG000|Overall Study|MRI Scan Not Performed|1|||
146746551|NCT01853254|529245984|FG000|Overall Study|Abnormal Laboratory Test|1|||
146746552|NCT01853254|529245984|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
146746553|NCT01853254|529245984|FG000|Overall Study|Death|1|||
146746554|NCT01853254|529245984|FG000|Overall Study|Failure to Return|43|||
146746555|NCT01853254|529245984|FG000|Overall Study|Insufficient Therapeutic Response|22|||
146746556|NCT01853254|529245984|FG000|Overall Study|Refusal of Treatment|1|||
146746557|NCT01853254|529245984|FG000|Overall Study|Other Protocol Violation|1|||
146746558|NCT01853254|529245984|FG000|Overall Study|Withdrawal of Consent|16|||
146746559|NCT01853254|529245984|FG000|Overall Study|Administrative/Other|16|||
146746560|NCT00830947|529245985|FG000|Overall Study|Lost to Follow-up|4|||
146746561|NCT00830947|529245986|FG001|Overall Study|Lost to Follow-up|4|||
146746562|NCT02462083|529245987|FG000|Overall Study|Sponsor request|39|||
146746563|NCT02462083|529245987|FG000|Overall Study|Withdrawal by Subject|87|||
146746564|NCT02462083|529245987|FG000|Overall Study|Lost to Follow-up|41|||
146746565|NCT02462083|529245987|FG000|Overall Study|Lack of Efficacy|151|||
146746566|NCT02462083|529245987|FG000|Overall Study|Pregnancy|1|||
146746567|NCT02462083|529245987|FG000|Overall Study|Protocol Violation|6|||
146746568|NCT02462083|529245987|FG000|Overall Study|Adverse Event|33|||
146746569|NCT02462083|529245987|FG000|Overall Study|Worsening condition|16|||
146746570|NCT02462083|529245987|FG000|Overall Study|Other than specified|45|||
146746571|NCT01642186|529245988|FG000|Overall Study|Death|0|||
146746572|NCT01642186|529245989|FG001|Overall Study|Death|2|||
146746573|NCT01642186|529245990|FG002|Overall Study|Death|2|||
146746574|NCT01642186|529245988|FG000|Overall Study|Lost to Follow-up|0|||
146746575|NCT01642186|529245989|FG001|Overall Study|Lost to Follow-up|0|||
146746576|NCT01642186|529245990|FG002|Overall Study|Lost to Follow-up|1|||
146746577|NCT01668147|529245991|FG000|Overall Study|Withdrawal by Subject|6|||
146746578|NCT01474512|529245993|FG000|Induction Period|Adverse Event|6|||
146746579|NCT01474512|529245994|FG001|Induction Period|Adverse Event|10|||
146746580|NCT01474512|529245995|FG002|Induction Period|Adverse Event|10|||
146746581|NCT01474512|529245996|FG003|Induction Period|Adverse Event|0|||
146746582|NCT01474512|529245997|FG004|Induction Period|Adverse Event|0|||
146746583|NCT01474512|529245998|FG005|Induction Period|Adverse Event|0|||
146746584|NCT01474512|529245999|FG006|Induction Period|Adverse Event|0|||
146746585|NCT01474512|529246000|FG007|Induction Period|Adverse Event|0|||
146746586|NCT01474512|529246001|FG008|Induction Period|Adverse Event|0|||
146746587|NCT01474512|529246002|FG009|Induction Period|Adverse Event|0|||
146746588|NCT01474512|529246003|FG010|Induction Period|Adverse Event|0|||
146746589|NCT01474512|529246004|FG011|Induction Period|Adverse Event|0|||
146746590|NCT01474512|529246005|FG012|Induction Period|Adverse Event|0|||
146746591|NCT01474512|529246006|FG013|Induction Period|Adverse Event|0|||
146746592|NCT01474512|529246007|FG014|Induction Period|Adverse Event|0|||
146746593|NCT01474512|529246008|FG015|Induction Period|Adverse Event|0|||
146746594|NCT01474512|529246009|FG016|Induction Period|Adverse Event|0|||
146746595|NCT01474512|529246010|FG017|Induction Period|Adverse Event|0|||
146746596|NCT01474512|529245993|FG000|Induction Period|Lack of Efficacy|7|||
146746597|NCT01474512|529245994|FG001|Induction Period|Lack of Efficacy|1|||
146746598|NCT01474512|529245995|FG002|Induction Period|Lack of Efficacy|0|||
146746599|NCT01474512|529245996|FG003|Induction Period|Lack of Efficacy|0|||
146746600|NCT01474512|529245997|FG004|Induction Period|Lack of Efficacy|0|||
146746601|NCT01474512|529245998|FG005|Induction Period|Lack of Efficacy|0|||
146746602|NCT01474512|529245999|FG006|Induction Period|Lack of Efficacy|0|||
146746603|NCT01474512|529246000|FG007|Induction Period|Lack of Efficacy|0|||
146746604|NCT01474512|529246001|FG008|Induction Period|Lack of Efficacy|0|||
146746605|NCT01474512|529246002|FG009|Induction Period|Lack of Efficacy|0|||
146746606|NCT01474512|529246003|FG010|Induction Period|Lack of Efficacy|0|||
146746607|NCT01474512|529246004|FG011|Induction Period|Lack of Efficacy|0|||
146746608|NCT01474512|529246005|FG012|Induction Period|Lack of Efficacy|0|||
146746609|NCT01474512|529246006|FG013|Induction Period|Lack of Efficacy|0|||
146746610|NCT01474512|529246007|FG014|Induction Period|Lack of Efficacy|0|||
146746611|NCT01474512|529246008|FG015|Induction Period|Lack of Efficacy|0|||
146746612|NCT01474512|529246009|FG016|Induction Period|Lack of Efficacy|0|||
146746613|NCT01474512|529246010|FG017|Induction Period|Lack of Efficacy|0|||
146746614|NCT01474512|529245993|FG000|Induction Period|Withdrawal by Subject|6|||
146746615|NCT01474512|529245994|FG001|Induction Period|Withdrawal by Subject|6|||
146746616|NCT01474512|529245995|FG002|Induction Period|Withdrawal by Subject|5|||
146746617|NCT01474512|529245996|FG003|Induction Period|Withdrawal by Subject|0|||
146746618|NCT01474512|529245997|FG004|Induction Period|Withdrawal by Subject|0|||
146746619|NCT01474512|529245998|FG005|Induction Period|Withdrawal by Subject|0|||
146746620|NCT01474512|529245999|FG006|Induction Period|Withdrawal by Subject|0|||
146746621|NCT01474512|529246000|FG007|Induction Period|Withdrawal by Subject|0|||
146746622|NCT01474512|529246001|FG008|Induction Period|Withdrawal by Subject|0|||
146746623|NCT01474512|529246002|FG009|Induction Period|Withdrawal by Subject|0|||
146746624|NCT01474512|529246003|FG010|Induction Period|Withdrawal by Subject|0|||
146746625|NCT01474512|529246004|FG011|Induction Period|Withdrawal by Subject|0|||
146746626|NCT01474512|529246005|FG012|Induction Period|Withdrawal by Subject|0|||
146746627|NCT01474512|529246006|FG013|Induction Period|Withdrawal by Subject|0|||
146746628|NCT01474512|529246007|FG014|Induction Period|Withdrawal by Subject|0|||
146746629|NCT01474512|529246008|FG015|Induction Period|Withdrawal by Subject|0|||
146746630|NCT01474512|529246009|FG016|Induction Period|Withdrawal by Subject|0|||
146746631|NCT01474512|529246010|FG017|Induction Period|Withdrawal by Subject|0|||
146746632|NCT01474512|529245993|FG000|Induction Period|Protocol Violation|3|||
146746633|NCT01474512|529245994|FG001|Induction Period|Protocol Violation|6|||
146746634|NCT01474512|529245995|FG002|Induction Period|Protocol Violation|0|||
146746635|NCT01474512|529245996|FG003|Induction Period|Protocol Violation|0|||
146746636|NCT01474512|529245997|FG004|Induction Period|Protocol Violation|0|||
146746637|NCT01474512|529245998|FG005|Induction Period|Protocol Violation|0|||
146746638|NCT01474512|529245999|FG006|Induction Period|Protocol Violation|0|||
146746639|NCT01474512|529246000|FG007|Induction Period|Protocol Violation|0|||
146746640|NCT01474512|529246001|FG008|Induction Period|Protocol Violation|0|||
146746641|NCT01474512|529246002|FG009|Induction Period|Protocol Violation|0|||
146746642|NCT01474512|529246003|FG010|Induction Period|Protocol Violation|0|||
146746643|NCT01474512|529246004|FG011|Induction Period|Protocol Violation|0|||
146746644|NCT01474512|529246005|FG012|Induction Period|Protocol Violation|0|||
146746645|NCT01474512|529246006|FG013|Induction Period|Protocol Violation|0|||
146746646|NCT01474512|529246007|FG014|Induction Period|Protocol Violation|0|||
146746647|NCT01474512|529246008|FG015|Induction Period|Protocol Violation|0|||
146746648|NCT01474512|529246009|FG016|Induction Period|Protocol Violation|0|||
146746649|NCT01474512|529246010|FG017|Induction Period|Protocol Violation|0|||
146746650|NCT01474512|529245993|FG000|Induction Period|Sponsor Decision|1|||
146746651|NCT01474512|529245994|FG001|Induction Period|Sponsor Decision|1|||
146746652|NCT01474512|529245995|FG002|Induction Period|Sponsor Decision|1|||
146746653|NCT01474512|529245996|FG003|Induction Period|Sponsor Decision|0|||
146746654|NCT01474512|529245997|FG004|Induction Period|Sponsor Decision|0|||
146746655|NCT01474512|529245998|FG005|Induction Period|Sponsor Decision|0|||
146746656|NCT01474512|529245999|FG006|Induction Period|Sponsor Decision|0|||
146746657|NCT01474512|529246000|FG007|Induction Period|Sponsor Decision|0|||
146746658|NCT01474512|529246001|FG008|Induction Period|Sponsor Decision|0|||
146746659|NCT01474512|529246002|FG009|Induction Period|Sponsor Decision|0|||
146746660|NCT01474512|529246003|FG010|Induction Period|Sponsor Decision|0|||
146746661|NCT01474512|529246004|FG011|Induction Period|Sponsor Decision|0|||
146746662|NCT01474512|529246005|FG012|Induction Period|Sponsor Decision|0|||
146746663|NCT01474512|529246006|FG013|Induction Period|Sponsor Decision|0|||
146746664|NCT01474512|529246007|FG014|Induction Period|Sponsor Decision|0|||
146746665|NCT01474512|529246008|FG015|Induction Period|Sponsor Decision|0|||
146746666|NCT01474512|529246009|FG016|Induction Period|Sponsor Decision|0|||
146746667|NCT01474512|529246010|FG017|Induction Period|Sponsor Decision|0|||
146746668|NCT01474512|529245993|FG000|Induction Period|Lost to Follow-up|1|||
146746669|NCT01474512|529245994|FG001|Induction Period|Lost to Follow-up|0|||
146746670|NCT01474512|529245995|FG002|Induction Period|Lost to Follow-up|2|||
146746671|NCT01474512|529245996|FG003|Induction Period|Lost to Follow-up|0|||
146746672|NCT01474512|529245997|FG004|Induction Period|Lost to Follow-up|0|||
146746673|NCT01474512|529245998|FG005|Induction Period|Lost to Follow-up|0|||
146746674|NCT01474512|529245999|FG006|Induction Period|Lost to Follow-up|0|||
146746675|NCT01474512|529246000|FG007|Induction Period|Lost to Follow-up|0|||
146746676|NCT01474512|529246001|FG008|Induction Period|Lost to Follow-up|0|||
146746677|NCT01474512|529246002|FG009|Induction Period|Lost to Follow-up|0|||
146746678|NCT01474512|529246003|FG010|Induction Period|Lost to Follow-up|0|||
146746679|NCT01474512|529246004|FG011|Induction Period|Lost to Follow-up|0|||
146746680|NCT01474512|529246005|FG012|Induction Period|Lost to Follow-up|0|||
146746681|NCT01474512|529246006|FG013|Induction Period|Lost to Follow-up|0|||
146746682|NCT01474512|529246007|FG014|Induction Period|Lost to Follow-up|0|||
146746683|NCT01474512|529246008|FG015|Induction Period|Lost to Follow-up|0|||
146746684|NCT01474512|529246009|FG016|Induction Period|Lost to Follow-up|0|||
146746685|NCT01474512|529246010|FG017|Induction Period|Lost to Follow-up|0|||
146746686|NCT01474512|529245993|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146746687|NCT01474512|529245994|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146746688|NCT01474512|529245995|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146746689|NCT01474512|529245996|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
146746690|NCT01474512|529245997|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
146746691|NCT01474512|529245998|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
146746692|NCT01474512|529245999|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
146746693|NCT01474512|529246000|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146746694|NCT01474512|529246001|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146746695|NCT01474512|529246002|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146746696|NCT01474512|529246003|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146746697|NCT01474512|529246004|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146746698|NCT01474512|529246005|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146746699|NCT01474512|529246006|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146746700|NCT01474512|529246007|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146746701|NCT01474512|529246008|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146746702|NCT01474512|529246009|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146746703|NCT01474512|529246010|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146746704|NCT01474512|529245993|FG000|Maintenance Period|Adverse Event|0|||
146746705|NCT01474512|529245994|FG001|Maintenance Period|Adverse Event|0|||
146746706|NCT01474512|529245995|FG002|Maintenance Period|Adverse Event|0|||
146746707|NCT01474512|529245996|FG003|Maintenance Period|Adverse Event|4|||
146746708|NCT01474512|529245997|FG004|Maintenance Period|Adverse Event|2|||
146746709|NCT01474512|529245998|FG005|Maintenance Period|Adverse Event|7|||
146746710|NCT01474512|529245999|FG006|Maintenance Period|Adverse Event|0|||
146746711|NCT01474512|529246000|FG007|Maintenance Period|Adverse Event|19|||
146746712|NCT01474512|529246001|FG008|Maintenance Period|Adverse Event|1|||
146746713|NCT01474512|529246002|FG009|Maintenance Period|Adverse Event|3|||
146746714|NCT01474512|529246003|FG010|Maintenance Period|Adverse Event|0|||
146746715|NCT01474512|529246004|FG011|Maintenance Period|Adverse Event|0|||
146746716|NCT01474512|529246005|FG012|Maintenance Period|Adverse Event|0|||
146746717|NCT01474512|529246006|FG013|Maintenance Period|Adverse Event|0|||
146746718|NCT01474512|529246007|FG014|Maintenance Period|Adverse Event|0|||
146746719|NCT01474512|529246008|FG015|Maintenance Period|Adverse Event|0|||
146746720|NCT01474512|529246009|FG016|Maintenance Period|Adverse Event|0|||
146746721|NCT01474512|529246010|FG017|Maintenance Period|Adverse Event|0|||
146746722|NCT01474512|529245993|FG000|Maintenance Period|Withdrawal by Subject|0|||
146746723|NCT01474512|529245994|FG001|Maintenance Period|Withdrawal by Subject|0|||
146746724|NCT01474512|529245995|FG002|Maintenance Period|Withdrawal by Subject|0|||
146746725|NCT01474512|529245996|FG003|Maintenance Period|Withdrawal by Subject|6|||
146746726|NCT01474512|529245997|FG004|Maintenance Period|Withdrawal by Subject|2|||
146746727|NCT01474512|529245998|FG005|Maintenance Period|Withdrawal by Subject|3|||
146746728|NCT01474512|529245999|FG006|Maintenance Period|Withdrawal by Subject|1|||
146746729|NCT01474512|529246000|FG007|Maintenance Period|Withdrawal by Subject|6|||
146746730|NCT01474512|529246001|FG008|Maintenance Period|Withdrawal by Subject|3|||
146746731|NCT01474512|529246002|FG009|Maintenance Period|Withdrawal by Subject|1|||
146746732|NCT01474512|529246003|FG010|Maintenance Period|Withdrawal by Subject|0|||
146746733|NCT01474512|529246004|FG011|Maintenance Period|Withdrawal by Subject|0|||
146746734|NCT01474512|529246005|FG012|Maintenance Period|Withdrawal by Subject|0|||
146746735|NCT01474512|529246006|FG013|Maintenance Period|Withdrawal by Subject|0|||
146746736|NCT01474512|529246007|FG014|Maintenance Period|Withdrawal by Subject|0|||
146746737|NCT01474512|529246008|FG015|Maintenance Period|Withdrawal by Subject|0|||
146746738|NCT01474512|529246009|FG016|Maintenance Period|Withdrawal by Subject|0|||
146746739|NCT01474512|529246010|FG017|Maintenance Period|Withdrawal by Subject|0|||
146746740|NCT01474512|529245993|FG000|Maintenance Period|Lost to Follow-up|0|||
146746741|NCT01474512|529245994|FG001|Maintenance Period|Lost to Follow-up|0|||
146746742|NCT01474512|529245995|FG002|Maintenance Period|Lost to Follow-up|0|||
146746743|NCT01474512|529245996|FG003|Maintenance Period|Lost to Follow-up|3|||
146746744|NCT01474512|529245997|FG004|Maintenance Period|Lost to Follow-up|3|||
146746745|NCT01474512|529245998|FG005|Maintenance Period|Lost to Follow-up|0|||
146746746|NCT01474512|529245999|FG006|Maintenance Period|Lost to Follow-up|0|||
146746747|NCT01474512|529246000|FG007|Maintenance Period|Lost to Follow-up|2|||
146746748|NCT01474512|529246001|FG008|Maintenance Period|Lost to Follow-up|1|||
146746749|NCT01474512|529246002|FG009|Maintenance Period|Lost to Follow-up|1|||
146746750|NCT01474512|529246003|FG010|Maintenance Period|Lost to Follow-up|0|||
146746751|NCT01474512|529246004|FG011|Maintenance Period|Lost to Follow-up|0|||
146746752|NCT01474512|529246005|FG012|Maintenance Period|Lost to Follow-up|0|||
146746753|NCT01474512|529246006|FG013|Maintenance Period|Lost to Follow-up|0|||
146746754|NCT01474512|529246007|FG014|Maintenance Period|Lost to Follow-up|0|||
146746755|NCT01474512|529246008|FG015|Maintenance Period|Lost to Follow-up|0|||
146746756|NCT01474512|529246009|FG016|Maintenance Period|Lost to Follow-up|0|||
146746757|NCT01474512|529246010|FG017|Maintenance Period|Lost to Follow-up|0|||
146746758|NCT01474512|529245993|FG000|Maintenance Period|Death|0|||
146746759|NCT01474512|529245994|FG001|Maintenance Period|Death|0|||
146746760|NCT01474512|529245995|FG002|Maintenance Period|Death|0|||
146746761|NCT01474512|529245996|FG003|Maintenance Period|Death|0|||
146746762|NCT01474512|529245997|FG004|Maintenance Period|Death|0|||
146746763|NCT01474512|529245998|FG005|Maintenance Period|Death|2|||
146746764|NCT01474512|529245999|FG006|Maintenance Period|Death|0|||
146746765|NCT01474512|529246000|FG007|Maintenance Period|Death|0|||
146746766|NCT01474512|529246001|FG008|Maintenance Period|Death|0|||
146746767|NCT01474512|529246002|FG009|Maintenance Period|Death|0|||
146746768|NCT01474512|529246003|FG010|Maintenance Period|Death|0|||
146746769|NCT01474512|529246004|FG011|Maintenance Period|Death|0|||
146746770|NCT01474512|529246005|FG012|Maintenance Period|Death|0|||
146746771|NCT01474512|529246006|FG013|Maintenance Period|Death|0|||
146746772|NCT01474512|529246007|FG014|Maintenance Period|Death|0|||
146746773|NCT01474512|529246008|FG015|Maintenance Period|Death|0|||
146746774|NCT01474512|529246009|FG016|Maintenance Period|Death|0|||
146746775|NCT01474512|529246010|FG017|Maintenance Period|Death|0|||
146746776|NCT01474512|529245993|FG000|Maintenance Period|Physician Decision|0|||
146746777|NCT01474512|529245994|FG001|Maintenance Period|Physician Decision|0|||
146746778|NCT01474512|529245995|FG002|Maintenance Period|Physician Decision|0|||
146746779|NCT01474512|529245996|FG003|Maintenance Period|Physician Decision|0|||
146746780|NCT01474512|529245997|FG004|Maintenance Period|Physician Decision|0|||
146746781|NCT01474512|529245998|FG005|Maintenance Period|Physician Decision|1|||
146746782|NCT01474512|529245999|FG006|Maintenance Period|Physician Decision|0|||
146746783|NCT01474512|529246000|FG007|Maintenance Period|Physician Decision|2|||
146746784|NCT01474512|529246001|FG008|Maintenance Period|Physician Decision|0|||
146746785|NCT01474512|529246002|FG009|Maintenance Period|Physician Decision|0|||
146746786|NCT01474512|529246003|FG010|Maintenance Period|Physician Decision|0|||
146746787|NCT01474512|529246004|FG011|Maintenance Period|Physician Decision|0|||
146746788|NCT01474512|529246005|FG012|Maintenance Period|Physician Decision|0|||
146746789|NCT01474512|529246006|FG013|Maintenance Period|Physician Decision|0|||
146746790|NCT01474512|529246007|FG014|Maintenance Period|Physician Decision|0|||
146746791|NCT01474512|529246008|FG015|Maintenance Period|Physician Decision|0|||
146746792|NCT01474512|529246009|FG016|Maintenance Period|Physician Decision|0|||
146746793|NCT01474512|529246010|FG017|Maintenance Period|Physician Decision|0|||
146746794|NCT01474512|529245993|FG000|Maintenance Period|Clinical Relapse|0|||
146746795|NCT01474512|529245994|FG001|Maintenance Period|Clinical Relapse|0|||
146746796|NCT01474512|529245995|FG002|Maintenance Period|Clinical Relapse|0|||
146746797|NCT01474512|529245996|FG003|Maintenance Period|Clinical Relapse|1|||
146746798|NCT01474512|529245997|FG004|Maintenance Period|Clinical Relapse|0|||
146746799|NCT01474512|529245998|FG005|Maintenance Period|Clinical Relapse|0|||
146746800|NCT01474512|529245999|FG006|Maintenance Period|Clinical Relapse|0|||
146746801|NCT01474512|529246000|FG007|Maintenance Period|Clinical Relapse|0|||
146746802|NCT01474512|529246001|FG008|Maintenance Period|Clinical Relapse|0|||
146746803|NCT01474512|529246002|FG009|Maintenance Period|Clinical Relapse|0|||
146746804|NCT01474512|529246003|FG010|Maintenance Period|Clinical Relapse|0|||
146746805|NCT01474512|529246004|FG011|Maintenance Period|Clinical Relapse|0|||
146746806|NCT01474512|529246005|FG012|Maintenance Period|Clinical Relapse|0|||
146746807|NCT01474512|529246006|FG013|Maintenance Period|Clinical Relapse|0|||
146746808|NCT01474512|529246007|FG014|Maintenance Period|Clinical Relapse|0|||
146746809|NCT01474512|529246008|FG015|Maintenance Period|Clinical Relapse|0|||
146746810|NCT01474512|529246009|FG016|Maintenance Period|Clinical Relapse|0|||
146746811|NCT01474512|529246010|FG017|Maintenance Period|Clinical Relapse|0|||
146746812|NCT01474512|529245993|FG000|Maintenance Period|Lack of Efficacy|0|||
146746813|NCT01474512|529245994|FG001|Maintenance Period|Lack of Efficacy|0|||
146746814|NCT01474512|529245995|FG002|Maintenance Period|Lack of Efficacy|0|||
146746815|NCT01474512|529245996|FG003|Maintenance Period|Lack of Efficacy|1|||
146746816|NCT01474512|529245997|FG004|Maintenance Period|Lack of Efficacy|0|||
146746817|NCT01474512|529245998|FG005|Maintenance Period|Lack of Efficacy|0|||
146746818|NCT01474512|529245999|FG006|Maintenance Period|Lack of Efficacy|0|||
146746819|NCT01474512|529246000|FG007|Maintenance Period|Lack of Efficacy|11|||
146746820|NCT01474512|529246001|FG008|Maintenance Period|Lack of Efficacy|11|||
146746821|NCT01474512|529246002|FG009|Maintenance Period|Lack of Efficacy|12|||
146746822|NCT01474512|529246003|FG010|Maintenance Period|Lack of Efficacy|0|||
146746823|NCT01474512|529246004|FG011|Maintenance Period|Lack of Efficacy|0|||
146746824|NCT01474512|529246005|FG012|Maintenance Period|Lack of Efficacy|0|||
146746825|NCT01474512|529246006|FG013|Maintenance Period|Lack of Efficacy|0|||
146746826|NCT01474512|529246007|FG014|Maintenance Period|Lack of Efficacy|0|||
146746827|NCT01474512|529246008|FG015|Maintenance Period|Lack of Efficacy|0|||
146746828|NCT01474512|529246009|FG016|Maintenance Period|Lack of Efficacy|0|||
146746829|NCT01474512|529246010|FG017|Maintenance Period|Lack of Efficacy|0|||
146746830|NCT01474512|529245993|FG000|Maintenance Period|Protocol Violation|0|||
146746831|NCT01474512|529245994|FG001|Maintenance Period|Protocol Violation|0|||
146746832|NCT01474512|529245995|FG002|Maintenance Period|Protocol Violation|0|||
146746833|NCT01474512|529245996|FG003|Maintenance Period|Protocol Violation|1|||
146746834|NCT01474512|529245997|FG004|Maintenance Period|Protocol Violation|0|||
146746835|NCT01474512|529245998|FG005|Maintenance Period|Protocol Violation|0|||
146746836|NCT01474512|529245999|FG006|Maintenance Period|Protocol Violation|0|||
146746837|NCT01474512|529246000|FG007|Maintenance Period|Protocol Violation|1|||
146746838|NCT01474512|529246001|FG008|Maintenance Period|Protocol Violation|0|||
146746839|NCT01474512|529246002|FG009|Maintenance Period|Protocol Violation|1|||
146746840|NCT01474512|529246003|FG010|Maintenance Period|Protocol Violation|0|||
146746841|NCT01474512|529246004|FG011|Maintenance Period|Protocol Violation|0|||
146746842|NCT01474512|529246005|FG012|Maintenance Period|Protocol Violation|0|||
146746843|NCT01474512|529246006|FG013|Maintenance Period|Protocol Violation|0|||
146746844|NCT01474512|529246007|FG014|Maintenance Period|Protocol Violation|0|||
146746845|NCT01474512|529246008|FG015|Maintenance Period|Protocol Violation|0|||
146746846|NCT01474512|529246009|FG016|Maintenance Period|Protocol Violation|0|||
146746847|NCT01474512|529246010|FG017|Maintenance Period|Protocol Violation|0|||
146746848|NCT01474512|529245993|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
146746849|NCT01474512|529245994|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
146746850|NCT01474512|529245995|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
146746851|NCT01474512|529245996|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
146746852|NCT01474512|529245997|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
146746853|NCT01474512|529245998|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
146746854|NCT01474512|529245999|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
146746855|NCT01474512|529246000|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
146746856|NCT01474512|529246001|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
146746857|NCT01474512|529246002|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
146746858|NCT01474512|529246003|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
146746859|NCT01474512|529246004|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
146746860|NCT01474512|529246005|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
146746861|NCT01474512|529246006|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
146746862|NCT01474512|529246007|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
146746863|NCT01474512|529246008|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
146746864|NCT01474512|529246009|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
146746865|NCT01474512|529246010|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
146746866|NCT01474512|529245993|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
146746867|NCT01474512|529245994|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
146746868|NCT01474512|529245995|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
146746869|NCT01474512|529245996|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
146746870|NCT01474512|529245997|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
146746871|NCT01474512|529245998|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
146746872|NCT01474512|529245999|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
146746873|NCT01474512|529246000|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
146746874|NCT01474512|529246001|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
146746875|NCT01474512|529246002|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
146746876|NCT01474512|529246003|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
146746877|NCT01474512|529246004|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
146746878|NCT01474512|529246005|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
146746879|NCT01474512|529246006|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
146746880|NCT01474512|529246007|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
146511309|NCT00195494|528375467|FG004|Year 2|Compliance|0|||
146746881|NCT01474512|529246008|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
146746882|NCT01474512|529246009|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
146746883|NCT01474512|529246010|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
146746884|NCT01474512|529245993|FG000|Long-Term Extension Period|Adverse Event|0|||
146746885|NCT01474512|529245994|FG001|Long-Term Extension Period|Adverse Event|0|||
146746886|NCT01474512|529245995|FG002|Long-Term Extension Period|Adverse Event|0|||
146746887|NCT01474512|529245996|FG003|Long-Term Extension Period|Adverse Event|0|||
146746888|NCT01474512|529245997|FG004|Long-Term Extension Period|Adverse Event|0|||
146746889|NCT01474512|529245998|FG005|Long-Term Extension Period|Adverse Event|0|||
146746890|NCT01474512|529245999|FG006|Long-Term Extension Period|Adverse Event|0|||
146746891|NCT01474512|529246000|FG007|Long-Term Extension Period|Adverse Event|0|||
146746892|NCT01474512|529246001|FG008|Long-Term Extension Period|Adverse Event|0|||
146746893|NCT01474512|529246002|FG009|Long-Term Extension Period|Adverse Event|0|||
146746894|NCT01474512|529246003|FG010|Long-Term Extension Period|Adverse Event|0|||
146746895|NCT01474512|529246004|FG011|Long-Term Extension Period|Adverse Event|1|||
146746896|NCT01474512|529246005|FG012|Long-Term Extension Period|Adverse Event|57|||
146746897|NCT01474512|529246006|FG013|Long-Term Extension Period|Adverse Event|58|||
146746898|NCT01474512|529246007|FG014|Long-Term Extension Period|Adverse Event|0|||
146746899|NCT01474512|529246008|FG015|Long-Term Extension Period|Adverse Event|0|||
146746900|NCT01474512|529246009|FG016|Long-Term Extension Period|Adverse Event|0|||
146746901|NCT01474512|529246010|FG017|Long-Term Extension Period|Adverse Event|0|||
146746902|NCT01474512|529245993|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
146746903|NCT01474512|529245994|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
146746904|NCT01474512|529245995|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
146746905|NCT01474512|529245996|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
146746906|NCT01474512|529245997|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
146746907|NCT01474512|529245998|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
146746908|NCT01474512|529245999|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
146746909|NCT01474512|529246000|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
146746910|NCT01474512|529246001|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
146746911|NCT01474512|529246002|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
146746912|NCT01474512|529246003|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
146746913|NCT01474512|529246004|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
146746914|NCT01474512|529246005|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
146746915|NCT01474512|529246006|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
146746916|NCT01474512|529246007|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
146746917|NCT01474512|529246008|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
146746918|NCT01474512|529246009|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
146746919|NCT01474512|529246010|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
146746920|NCT01474512|529245993|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
146746921|NCT01474512|529245994|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
146746922|NCT01474512|529245995|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
146746923|NCT01474512|529245996|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
146746924|NCT01474512|529245997|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
146746925|NCT01474512|529245998|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
146746926|NCT01474512|529245999|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
146746927|NCT01474512|529246000|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
146746928|NCT01474512|529246001|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
146746929|NCT01474512|529246002|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
146746930|NCT01474512|529246003|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
146746931|NCT01474512|529246004|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
146746932|NCT01474512|529246005|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
146746933|NCT01474512|529246006|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
146746934|NCT01474512|529246007|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
146746935|NCT01474512|529246008|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
146746936|NCT01474512|529246009|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
146746937|NCT01474512|529246010|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
146746938|NCT01474512|529245993|FG000|Long-Term Extension Period|Physician Decision|0|||
146746939|NCT01474512|529245994|FG001|Long-Term Extension Period|Physician Decision|0|||
146746940|NCT01474512|529245995|FG002|Long-Term Extension Period|Physician Decision|0|||
146746941|NCT01474512|529245996|FG003|Long-Term Extension Period|Physician Decision|0|||
146746942|NCT01474512|529245997|FG004|Long-Term Extension Period|Physician Decision|0|||
146746943|NCT01474512|529245998|FG005|Long-Term Extension Period|Physician Decision|0|||
146746944|NCT01474512|529245999|FG006|Long-Term Extension Period|Physician Decision|0|||
146746945|NCT01474512|529246000|FG007|Long-Term Extension Period|Physician Decision|0|||
146746946|NCT01474512|529246001|FG008|Long-Term Extension Period|Physician Decision|0|||
146746947|NCT01474512|529246002|FG009|Long-Term Extension Period|Physician Decision|0|||
146746948|NCT01474512|529246003|FG010|Long-Term Extension Period|Physician Decision|0|||
146746949|NCT01474512|529246004|FG011|Long-Term Extension Period|Physician Decision|0|||
146746950|NCT01474512|529246005|FG012|Long-Term Extension Period|Physician Decision|21|||
146746951|NCT01474512|529246006|FG013|Long-Term Extension Period|Physician Decision|21|||
146746952|NCT01474512|529246007|FG014|Long-Term Extension Period|Physician Decision|0|||
146746953|NCT01474512|529246008|FG015|Long-Term Extension Period|Physician Decision|0|||
146746954|NCT01474512|529246009|FG016|Long-Term Extension Period|Physician Decision|0|||
146746955|NCT01474512|529246010|FG017|Long-Term Extension Period|Physician Decision|0|||
146746956|NCT01474512|529245993|FG000|Long-Term Extension Period|Clinical Relapse|0|||
146746957|NCT01474512|529245994|FG001|Long-Term Extension Period|Clinical Relapse|0|||
146746958|NCT01474512|529245995|FG002|Long-Term Extension Period|Clinical Relapse|0|||
146746959|NCT01474512|529245996|FG003|Long-Term Extension Period|Clinical Relapse|0|||
146746960|NCT01474512|529245997|FG004|Long-Term Extension Period|Clinical Relapse|0|||
146746961|NCT01474512|529245998|FG005|Long-Term Extension Period|Clinical Relapse|0|||
146746962|NCT01474512|529245999|FG006|Long-Term Extension Period|Clinical Relapse|0|||
146746963|NCT01474512|529246000|FG007|Long-Term Extension Period|Clinical Relapse|0|||
146746964|NCT01474512|529246001|FG008|Long-Term Extension Period|Clinical Relapse|0|||
146746965|NCT01474512|529246002|FG009|Long-Term Extension Period|Clinical Relapse|0|||
146746966|NCT01474512|529246003|FG010|Long-Term Extension Period|Clinical Relapse|0|||
146746967|NCT01474512|529246004|FG011|Long-Term Extension Period|Clinical Relapse|0|||
146746968|NCT01474512|529246005|FG012|Long-Term Extension Period|Clinical Relapse|9|||
146746969|NCT01474512|529246006|FG013|Long-Term Extension Period|Clinical Relapse|9|||
146746970|NCT01474512|529246007|FG014|Long-Term Extension Period|Clinical Relapse|0|||
146746971|NCT01474512|529246008|FG015|Long-Term Extension Period|Clinical Relapse|0|||
146746972|NCT01474512|529246009|FG016|Long-Term Extension Period|Clinical Relapse|0|||
146746973|NCT01474512|529246010|FG017|Long-Term Extension Period|Clinical Relapse|0|||
146746974|NCT01474512|529245993|FG000|Long-Term Extension Period|Death|0|||
146746975|NCT01474512|529245994|FG001|Long-Term Extension Period|Death|0|||
146746976|NCT01474512|529245995|FG002|Long-Term Extension Period|Death|0|||
146746977|NCT01474512|529245996|FG003|Long-Term Extension Period|Death|0|||
146746978|NCT01474512|529245997|FG004|Long-Term Extension Period|Death|0|||
146746979|NCT01474512|529245998|FG005|Long-Term Extension Period|Death|0|||
146746980|NCT01474512|529245999|FG006|Long-Term Extension Period|Death|0|||
146746981|NCT01474512|529246000|FG007|Long-Term Extension Period|Death|0|||
146746982|NCT01474512|529246001|FG008|Long-Term Extension Period|Death|0|||
146746983|NCT01474512|529246002|FG009|Long-Term Extension Period|Death|0|||
146746984|NCT01474512|529246003|FG010|Long-Term Extension Period|Death|0|||
146746985|NCT01474512|529246004|FG011|Long-Term Extension Period|Death|0|||
146746986|NCT01474512|529246005|FG012|Long-Term Extension Period|Death|9|||
146746987|NCT01474512|529246006|FG013|Long-Term Extension Period|Death|9|||
146746988|NCT01474512|529246007|FG014|Long-Term Extension Period|Death|0|||
146746989|NCT01474512|529246008|FG015|Long-Term Extension Period|Death|0|||
146746990|NCT01474512|529246009|FG016|Long-Term Extension Period|Death|0|||
146746991|NCT01474512|529246010|FG017|Long-Term Extension Period|Death|0|||
146746992|NCT01474512|529245993|FG000|Long-Term Extension Period|Sponsor Decision|0|||
146746993|NCT01474512|529245994|FG001|Long-Term Extension Period|Sponsor Decision|0|||
146746994|NCT01474512|529245995|FG002|Long-Term Extension Period|Sponsor Decision|0|||
146746995|NCT01474512|529245996|FG003|Long-Term Extension Period|Sponsor Decision|0|||
146746996|NCT01474512|529245997|FG004|Long-Term Extension Period|Sponsor Decision|0|||
146746997|NCT01474512|529245998|FG005|Long-Term Extension Period|Sponsor Decision|0|||
146746998|NCT01474512|529245999|FG006|Long-Term Extension Period|Sponsor Decision|0|||
146746999|NCT01474512|529246000|FG007|Long-Term Extension Period|Sponsor Decision|0|||
146747000|NCT01474512|529246001|FG008|Long-Term Extension Period|Sponsor Decision|0|||
146747001|NCT01474512|529246002|FG009|Long-Term Extension Period|Sponsor Decision|0|||
146747002|NCT01474512|529246003|FG010|Long-Term Extension Period|Sponsor Decision|0|||
146747003|NCT01474512|529246004|FG011|Long-Term Extension Period|Sponsor Decision|0|||
146747004|NCT01474512|529246005|FG012|Long-Term Extension Period|Sponsor Decision|6|||
146747005|NCT01474512|529246006|FG013|Long-Term Extension Period|Sponsor Decision|6|||
146747006|NCT01474512|529246007|FG014|Long-Term Extension Period|Sponsor Decision|0|||
146747007|NCT01474512|529246008|FG015|Long-Term Extension Period|Sponsor Decision|0|||
146747008|NCT01474512|529246009|FG016|Long-Term Extension Period|Sponsor Decision|0|||
146747009|NCT01474512|529246010|FG017|Long-Term Extension Period|Sponsor Decision|0|||
146747010|NCT01474512|529245993|FG000|Long-Term Extension Period|Protocol Violation|0|||
146747011|NCT01474512|529245994|FG001|Long-Term Extension Period|Protocol Violation|0|||
146747012|NCT01474512|529245995|FG002|Long-Term Extension Period|Protocol Violation|0|||
146747013|NCT01474512|529245996|FG003|Long-Term Extension Period|Protocol Violation|0|||
146747014|NCT01474512|529245997|FG004|Long-Term Extension Period|Protocol Violation|0|||
146747015|NCT01474512|529245998|FG005|Long-Term Extension Period|Protocol Violation|0|||
146747016|NCT01474512|529245999|FG006|Long-Term Extension Period|Protocol Violation|0|||
146747017|NCT01474512|529246000|FG007|Long-Term Extension Period|Protocol Violation|0|||
146747018|NCT01474512|529246001|FG008|Long-Term Extension Period|Protocol Violation|0|||
146747019|NCT01474512|529246002|FG009|Long-Term Extension Period|Protocol Violation|0|||
146747020|NCT01474512|529246003|FG010|Long-Term Extension Period|Protocol Violation|0|||
146747021|NCT01474512|529246004|FG011|Long-Term Extension Period|Protocol Violation|0|||
146747022|NCT01474512|529246005|FG012|Long-Term Extension Period|Protocol Violation|5|||
146747023|NCT01474512|529246006|FG013|Long-Term Extension Period|Protocol Violation|5|||
146747024|NCT01474512|529246007|FG014|Long-Term Extension Period|Protocol Violation|0|||
146747025|NCT01474512|529246008|FG015|Long-Term Extension Period|Protocol Violation|0|||
146747026|NCT01474512|529246009|FG016|Long-Term Extension Period|Protocol Violation|0|||
146747027|NCT01474512|529246010|FG017|Long-Term Extension Period|Protocol Violation|0|||
146747028|NCT01474512|529245993|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146747029|NCT01474512|529245994|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146747030|NCT01474512|529245995|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146747031|NCT01474512|529245996|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146747032|NCT01474512|529245997|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146747033|NCT01474512|529245998|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146747034|NCT01474512|529245999|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146747035|NCT01474512|529246000|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146747036|NCT01474512|529246001|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146747037|NCT01474512|529246002|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146747038|NCT01474512|529246003|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146747039|NCT01474512|529246004|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146747040|NCT01474512|529246005|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
146747041|NCT01474512|529246006|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
146747042|NCT01474512|529246007|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146747043|NCT01474512|529246008|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146747044|NCT01474512|529246009|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146747045|NCT01474512|529246010|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146747046|NCT01474512|529245993|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747047|NCT01474512|529245994|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747048|NCT01474512|529245995|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747049|NCT01474512|529245996|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747050|NCT01474512|529245997|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747051|NCT01474512|529245998|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747052|NCT01474512|529245999|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747053|NCT01474512|529246000|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747054|NCT01474512|529246001|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747055|NCT01474512|529246002|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747056|NCT01474512|529246003|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747057|NCT01474512|529246004|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
146747058|NCT01474512|529246005|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747059|NCT01474512|529246006|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747060|NCT01474512|529246007|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747061|NCT01474512|529246008|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747062|NCT01474512|529246009|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747063|NCT01474512|529246010|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146747064|NCT01474512|529245993|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
146747065|NCT01474512|529245994|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
146747066|NCT01474512|529245995|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
146747067|NCT01474512|529245996|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
146747068|NCT01474512|529245997|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
146747069|NCT01474512|529245998|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
146747070|NCT01474512|529245999|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
146747071|NCT01474512|529246000|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
146747072|NCT01474512|529246001|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
146747073|NCT01474512|529246002|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
146747074|NCT01474512|529246003|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
146747075|NCT01474512|529246004|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
146747076|NCT01474512|529246005|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
146747077|NCT01474512|529246006|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
146747078|NCT01474512|529246007|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
146747079|NCT01474512|529246008|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
146747080|NCT01474512|529246009|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
146747081|NCT01474512|529246010|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
146747082|NCT01474512|529245993|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146747083|NCT01474512|529245994|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146747084|NCT01474512|529245995|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146747085|NCT01474512|529245996|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146747086|NCT01474512|529245997|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146747087|NCT01474512|529245998|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146747088|NCT01474512|529245999|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146747089|NCT01474512|529246000|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146747090|NCT01474512|529246001|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146747091|NCT01474512|529246002|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146747092|NCT01474512|529246003|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146747093|NCT01474512|529246004|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146747094|NCT01474512|529246005|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146747095|NCT01474512|529246006|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146747096|NCT01474512|529246007|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
146747097|NCT01474512|529246008|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
146747098|NCT01474512|529246009|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
146747099|NCT01474512|529246010|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
146747100|NCT01474512|529245993|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146747101|NCT01474512|529245994|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146747102|NCT01474512|529245995|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146747103|NCT01474512|529245996|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146747104|NCT01474512|529245997|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146747105|NCT01474512|529245998|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146747106|NCT01474512|529245999|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146747107|NCT01474512|529246000|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146747108|NCT01474512|529246001|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146747109|NCT01474512|529246002|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146747110|NCT01474512|529246003|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146747111|NCT01474512|529246004|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146747112|NCT01474512|529246005|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146747113|NCT01474512|529246006|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146747114|NCT01474512|529246007|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
146747115|NCT01474512|529246008|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
146747116|NCT01474512|529246009|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
146747117|NCT01474512|529246010|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
146747118|NCT01474512|529245993|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146747119|NCT01474512|529245994|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146747120|NCT01474512|529245995|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146747121|NCT01474512|529245996|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146747122|NCT01474512|529245997|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146747123|NCT01474512|529245998|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146747124|NCT01474512|529245999|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146747125|NCT01474512|529246000|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146747126|NCT01474512|529246001|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146747127|NCT01474512|529246002|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146747128|NCT01474512|529246003|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146747129|NCT01474512|529246004|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146747130|NCT01474512|529246005|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146747131|NCT01474512|529246006|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146747132|NCT01474512|529246007|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146747133|NCT01474512|529246008|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146747134|NCT01474512|529246009|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
146747135|NCT01474512|529246010|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
146747136|NCT01474512|529245993|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
146747137|NCT01474512|529245994|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
146747138|NCT01474512|529245995|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
146747139|NCT01474512|529245996|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
146747140|NCT01474512|529245997|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
146747141|NCT01474512|529245998|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
146747142|NCT01474512|529245999|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
146747143|NCT01474512|529246000|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
146747144|NCT01474512|529246001|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
146747145|NCT01474512|529246002|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
146747146|NCT01474512|529246003|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
146747147|NCT01474512|529246004|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
146747148|NCT01474512|529246005|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
146747149|NCT01474512|529246006|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
146747150|NCT01474512|529246007|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
146747151|NCT01474512|529246008|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
146747152|NCT01474512|529246009|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
146747153|NCT01474512|529246010|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
146747154|NCT01474512|529245993|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
146747155|NCT01474512|529245994|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
146747156|NCT01474512|529245995|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
146747157|NCT01474512|529245996|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
146747158|NCT01474512|529245997|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
146511310|NCT00195494|528375468|FG005|Year 2|Compliance|0|||
146511311|NCT00195494|528375463|FG000|Year 2|Lost to Follow-up|0|||
146747159|NCT01474512|529245998|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
146747160|NCT01474512|529245999|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
146747161|NCT01474512|529246000|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
146747162|NCT01474512|529246001|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
146747163|NCT01474512|529246002|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
146747164|NCT01474512|529246003|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
146747165|NCT01474512|529246004|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
146747166|NCT01474512|529246005|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
146747167|NCT01474512|529246006|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
146747168|NCT01474512|529246007|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
146747169|NCT01474512|529246008|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
146747170|NCT01474512|529246009|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
146747171|NCT01474512|529246010|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
146747172|NCT01474512|529245993|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
146747173|NCT01474512|529245994|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
146747174|NCT01474512|529245995|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
146747175|NCT01474512|529245996|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
146747176|NCT01474512|529245997|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
146747177|NCT01474512|529245998|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
146747178|NCT01474512|529245999|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
146747179|NCT01474512|529246000|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
146747180|NCT01474512|529246001|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
146747181|NCT01474512|529246002|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
146747182|NCT01474512|529246003|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
146747183|NCT01474512|529246004|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
146747184|NCT01474512|529246005|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
146747185|NCT01474512|529246006|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
146747186|NCT01474512|529246007|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
146747187|NCT01474512|529246008|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
146747188|NCT01474512|529246009|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
146747189|NCT01474512|529246010|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
146747190|NCT01474512|529245993|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
146747191|NCT01474512|529245994|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
146747192|NCT01474512|529245995|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
146747193|NCT01474512|529245996|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
146747194|NCT01474512|529245997|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
146747195|NCT01474512|529245998|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
146747196|NCT01474512|529245999|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
146747197|NCT01474512|529246000|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
146747198|NCT01474512|529246001|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
146747199|NCT01474512|529246002|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
146747200|NCT01474512|529246003|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
146747201|NCT01474512|529246004|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
146747202|NCT01474512|529246005|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
146747203|NCT01474512|529246006|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
146747204|NCT01474512|529246007|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
146747205|NCT01474512|529246008|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
146747206|NCT01474512|529246009|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
146747207|NCT01474512|529246010|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
146747208|NCT01474512|529245993|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146747209|NCT01474512|529245994|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146747210|NCT01474512|529245995|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146747211|NCT01474512|529245996|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146747212|NCT01474512|529245997|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146747213|NCT01474512|529245998|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146747214|NCT01474512|529245999|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146747215|NCT01474512|529246000|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146747216|NCT01474512|529246001|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146747217|NCT01474512|529246002|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146747218|NCT01474512|529246003|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146747219|NCT01474512|529246004|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146747220|NCT01474512|529246005|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146747221|NCT01474512|529246006|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146747222|NCT01474512|529246007|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
146747223|NCT01474512|529246008|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146747224|NCT01474512|529246009|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146747225|NCT01474512|529246010|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
146747226|NCT01474512|529245993|FG000|Post-Treatment Follow-Up|Death|0|||
146747227|NCT01474512|529245994|FG001|Post-Treatment Follow-Up|Death|0|||
146747228|NCT01474512|529245995|FG002|Post-Treatment Follow-Up|Death|0|||
146747229|NCT01474512|529245996|FG003|Post-Treatment Follow-Up|Death|0|||
146747230|NCT01474512|529245997|FG004|Post-Treatment Follow-Up|Death|0|||
146747231|NCT01474512|529245998|FG005|Post-Treatment Follow-Up|Death|0|||
146747232|NCT01474512|529245999|FG006|Post-Treatment Follow-Up|Death|0|||
146747233|NCT01474512|529246000|FG007|Post-Treatment Follow-Up|Death|0|||
146747234|NCT01474512|529246001|FG008|Post-Treatment Follow-Up|Death|0|||
146747235|NCT01474512|529246002|FG009|Post-Treatment Follow-Up|Death|0|||
146747236|NCT01474512|529246003|FG010|Post-Treatment Follow-Up|Death|0|||
146747237|NCT01474512|529246004|FG011|Post-Treatment Follow-Up|Death|0|||
146747238|NCT01474512|529246005|FG012|Post-Treatment Follow-Up|Death|0|||
146747239|NCT01474512|529246006|FG013|Post-Treatment Follow-Up|Death|0|||
146747240|NCT01474512|529246007|FG014|Post-Treatment Follow-Up|Death|0|||
146747241|NCT01474512|529246008|FG015|Post-Treatment Follow-Up|Death|0|||
146747242|NCT01474512|529246009|FG016|Post-Treatment Follow-Up|Death|1|||
146747243|NCT01474512|529246010|FG017|Post-Treatment Follow-Up|Death|0|||
146747244|NCT01118962|529246013|FG000|Overall Study|Adverse Event|2|||
146747245|NCT01118962|529246013|FG000|Overall Study|Lack of Efficacy|1|||
146747246|NCT01118962|529246013|FG000|Overall Study|Protocol Violation|1|||
146747247|NCT01118962|529246013|FG000|Overall Study|Withdrawal by Subject|4|||
146747248|NCT01118962|529246013|FG000|Overall Study|Pregnancy|1|||
146747249|NCT01118962|529246013|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
146747250|NCT04747275|529246019|FG000|Overall Study|Study terminated|0|||
146747251|NCT04747275|529246020|FG001|Overall Study|Study terminated|1|||
146747252|NCT00531011|529246023|FG000|Overall Study|Withdrawal by Subject|2|||
146747253|NCT00531011|529246024|FG001|Overall Study|Withdrawal by Subject|4|||
146747254|NCT00531011|529246023|FG000|Overall Study|Death|1|||
146747255|NCT00531011|529246024|FG001|Overall Study|Death|0|||
146747256|NCT00531011|529246023|FG000|Overall Study|Lost to Follow-up|1|||
146747257|NCT00531011|529246024|FG001|Overall Study|Lost to Follow-up|0|||
146747258|NCT00531011|529246023|FG000|Overall Study|Physician Decision|0|||
146747259|NCT00531011|529246024|FG001|Overall Study|Physician Decision|3|||
146747260|NCT03268590|529246025|FG000|Overall Study|Previously unknown exclusion criteria|1|||
146747261|NCT02206152|529246028|FG000|Pre-Randomization|Withdrawal by Subject|2|||
146747262|NCT02080520|529246029|FG000|Overall Study|Self-reported symptoms|5|||
146747263|NCT02080520|529246030|FG001|Overall Study|Self-reported symptoms|6|||
146747264|NCT02080520|529246029|FG000|Overall Study|Unable to contact|2|||
146747265|NCT02080520|529246030|FG001|Overall Study|Unable to contact|1|||
146747266|NCT02080520|529246029|FG000|Overall Study|Initiated aspirin|2|||
146747267|NCT02080520|529246030|FG001|Overall Study|Initiated aspirin|0|||
146747268|NCT02080520|529246029|FG000|Overall Study|Atrial fibrillation|1|||
146747269|NCT02080520|529246030|FG001|Overall Study|Atrial fibrillation|1|||
146747270|NCT02080520|529246029|FG000|Overall Study|Cancer|1|||
146747271|NCT02080520|529246030|FG001|Overall Study|Cancer|2|||
146747272|NCT02080520|529246029|FG000|Overall Study|Not interested in study|1|||
146747273|NCT02080520|529246030|FG001|Overall Study|Not interested in study|3|||
146747274|NCT02080520|529246029|FG000|Overall Study|Too busy|1|||
146747275|NCT02080520|529246030|FG001|Overall Study|Too busy|1|||
146747276|NCT02080520|529246029|FG000|Overall Study|Work-related injury|1|||
146747277|NCT02080520|529246030|FG001|Overall Study|Work-related injury|0|||
146747278|NCT02080520|529246029|FG000|Overall Study|Personal reasons|0|||
146747279|NCT02080520|529246030|FG001|Overall Study|Personal reasons|3|||
146747280|NCT00390455|529246032|FG000|Overall Study|Adverse Event|17|||
146747281|NCT00390455|529246033|FG001|Overall Study|Adverse Event|3|||
146747282|NCT00390455|529246032|FG000|Overall Study|Withdrawal by Subject|8|||
146747283|NCT00390455|529246033|FG001|Overall Study|Withdrawal by Subject|8|||
146747284|NCT00390455|529246032|FG000|Overall Study|Alternate Treatment|0|||
146747285|NCT00390455|529246033|FG001|Overall Study|Alternate Treatment|1|||
146747286|NCT00390455|529246032|FG000|Overall Study|Other Medical Reasons|7|||
146747287|NCT00390455|529246033|FG001|Overall Study|Other Medical Reasons|11|||
146747288|NCT04076020|529246036|FG000|Overall Study|Death|4|||
146747289|NCT04076020|529246037|FG001|Overall Study|Death|6|||
146747290|NCT04076020|529246036|FG000|Overall Study|Withdrawal by Subject|12|||
146747291|NCT04076020|529246037|FG001|Overall Study|Withdrawal by Subject|8|||
146747292|NCT01591460|529246038|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
146747293|NCT01591460|529246038|FG000|Overall Study|Futility Rule (Week 12)|7|||
146747294|NCT01591460|529246038|FG000|Overall Study|Futility Rule (Week 24)|3|||
146747295|NCT01591460|529246038|FG000|Overall Study|Rebound or Breakthrough|3|||
146747296|NCT01591460|529246038|FG000|Overall Study|Treatment Discontinued by Error|1|||
146747297|NCT01591460|529246038|FG000|Overall Study|Lost to Follow-up|1|||
146747298|NCT01591460|529246038|FG000|Overall Study|Noncompliance|1|||
146747299|NCT01591460|529246038|FG000|Overall Study|Participant Refusal|3|||
146747300|NCT01591460|529246038|FG000|Overall Study|Withdrawal by Subject|1|||
146747301|NCT01591460|529246038|FG000|Overall Study|Protocol Violation|1|||
146747302|NCT00610675|529246043|FG000|Overall Study|Untreated|4|||
146747303|NCT00610675|529246043|FG000|Overall Study|Adverse Event|67|||
146747304|NCT00610675|529246043|FG000|Overall Study|Insufficient Effect|31|||
146747305|NCT00610675|529246043|FG000|Overall Study|Withdrawal by Subject|28|||
146747306|NCT00610675|529246043|FG000|Overall Study|Reasons unrelated to trial|27|||
146747307|NCT00610675|529246043|FG000|Overall Study|Lack of Compliance|7|||
146747308|NCT00610675|529246043|FG000|Overall Study|Lost to Follow-up|31|||
146747309|NCT00610675|529246043|FG000|Overall Study|Other reason (not specified)|25|||
146747310|NCT00579982|529246046|FG000|Overall Study|Adverse Event|4|||
146747311|NCT00579982|529246046|FG000|Overall Study|Protocol Violation|4|||
146747312|NCT03192215|529246047|FG000|Overall Study|Death|28|||
146747313|NCT03192215|529246048|FG001|Overall Study|Death|23|||
146747314|NCT03192215|529246047|FG000|Overall Study|Lost to Follow-up|10|||
146747315|NCT03192215|529246048|FG001|Overall Study|Lost to Follow-up|15|||
146747316|NCT03192215|529246047|FG000|Overall Study|Withdrawal by Subject|49|||
146747317|NCT03192215|529246048|FG001|Overall Study|Withdrawal by Subject|48|||
146747318|NCT03192215|529246047|FG000|Overall Study|Other as reported in analysis|4|||
146747319|NCT03192215|529246048|FG001|Overall Study|Other as reported in analysis|1|||
146747320|NCT02038764|529246049|FG000|Overall Study|Adverse Event|0|||
146747321|NCT02038764|529246050|FG001|Overall Study|Adverse Event|0|||
146747322|NCT02038764|529246051|FG002|Overall Study|Adverse Event|1|||
146747323|NCT02038764|529246052|FG003|Overall Study|Adverse Event|0|||
146747324|NCT02038764|529246053|FG004|Overall Study|Adverse Event|0|||
146747325|NCT02038764|529246049|FG000|Overall Study|Lost to Follow-up|0|||
146747326|NCT02038764|529246050|FG001|Overall Study|Lost to Follow-up|1|||
146747327|NCT02038764|529246051|FG002|Overall Study|Lost to Follow-up|0|||
146747328|NCT02038764|529246052|FG003|Overall Study|Lost to Follow-up|0|||
146747329|NCT02038764|529246053|FG004|Overall Study|Lost to Follow-up|0|||
146747330|NCT02038764|529246049|FG000|Overall Study|Withdrawal by Subject|0|||
146747331|NCT02038764|529246050|FG001|Overall Study|Withdrawal by Subject|0|||
146747332|NCT02038764|529246051|FG002|Overall Study|Withdrawal by Subject|0|||
146747333|NCT02038764|529246052|FG003|Overall Study|Withdrawal by Subject|0|||
146747334|NCT02038764|529246053|FG004|Overall Study|Withdrawal by Subject|1|||
146747335|NCT02038764|529246049|FG000|Overall Study|Other|1|||
146747336|NCT02038764|529246050|FG001|Overall Study|Other|0|||
146747337|NCT02038764|529246051|FG002|Overall Study|Other|1|||
146747338|NCT02038764|529246052|FG003|Overall Study|Other|0|||
146747339|NCT02038764|529246053|FG004|Overall Study|Other|0|||
146747340|NCT04844918|529246055|FG000|Overall Study|Adverse Event|7|||
146747341|NCT04844918|529246056|FG001|Overall Study|Adverse Event|8|||
146747342|NCT04844918|529246057|FG002|Overall Study|Adverse Event|5|||
146747343|NCT04844918|529246055|FG000|Overall Study|Physician Decision|0|||
146747344|NCT04844918|529246056|FG001|Overall Study|Physician Decision|1|||
146747345|NCT04844918|529246057|FG002|Overall Study|Physician Decision|0|||
146747346|NCT04844918|529246055|FG000|Overall Study|Withdrawal by Subject|6|||
146747347|NCT04844918|529246056|FG001|Overall Study|Withdrawal by Subject|3|||
146747348|NCT04844918|529246057|FG002|Overall Study|Withdrawal by Subject|3|||
146747349|NCT04844918|529246055|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
146747350|NCT04844918|529246056|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
146747351|NCT04844918|529246057|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
146747352|NCT04716881|529246059|FG000|Overall Study|Adverse Event|1|||
146747353|NCT04716881|529246059|FG000|Overall Study|Lost to Follow-up|1|||
146747354|NCT00363896|529246060|FG000|Overall Study|Withdrawal by Subject|29|||
146747355|NCT00363896|529246061|FG001|Overall Study|Withdrawal by Subject|16|||
146747356|NCT00363896|529246060|FG000|Overall Study|Adverse Event|24|||
146747357|NCT00363896|529246061|FG001|Overall Study|Adverse Event|13|||
146747358|NCT00363896|529246060|FG000|Overall Study|COPD exacerbation|13|||
146747359|NCT00363896|529246061|FG001|Overall Study|COPD exacerbation|7|||
146747360|NCT00363896|529246060|FG000|Overall Study|Lack of Efficacy|12|||
146747361|NCT00363896|529246061|FG001|Overall Study|Lack of Efficacy|8|||
146747362|NCT00363896|529246060|FG000|Overall Study|Protocol Violation|6|||
146747363|NCT00363896|529246061|FG001|Overall Study|Protocol Violation|1|||
146747364|NCT00363896|529246060|FG000|Overall Study|Lost to Follow-up|3|||
146747365|NCT00363896|529246061|FG001|Overall Study|Lost to Follow-up|0|||
146747366|NCT00363896|529246060|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
146747367|NCT00363896|529246061|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
146747368|NCT00363896|529246060|FG000|Overall Study|Other|1|||
146747369|NCT00363896|529246061|FG001|Overall Study|Other|2|||
146747370|NCT01558674|529246062|FG000|Part 1|Study Terminated by Sponsor|10|||
146747371|NCT01558674|529246063|FG001|Part 1|Study Terminated by Sponsor|0|||
146747372|NCT01558674|529246062|FG000|Part 1|Withdrawal by Subject|1|||
146747373|NCT01558674|529246063|FG001|Part 1|Withdrawal by Subject|0|||
146747374|NCT00924469|529246064|FG000|Overall Study|Adverse Event|2|||
146747375|NCT00924469|529246065|FG001|Overall Study|Adverse Event|0|||
146747376|NCT00924469|529246064|FG000|Overall Study|Withdrawal by Subject|0|||
146747377|NCT00924469|529246065|FG001|Overall Study|Withdrawal by Subject|1|||
146747378|NCT00924469|529246064|FG000|Overall Study|Lost to Follow-up|0|||
146747379|NCT00924469|529246065|FG001|Overall Study|Lost to Follow-up|1|||
146747380|NCT00630058|529246066|FG000|Overall Study|Adverse Event|1|||
146747381|NCT00630058|529246067|FG001|Overall Study|Adverse Event|1|||
146747382|NCT00630058|529246066|FG000|Overall Study|Withdrawal by Subject|0|||
146747383|NCT00630058|529246067|FG001|Overall Study|Withdrawal by Subject|1|||
146747384|NCT00630058|529246066|FG000|Overall Study|stopping criteria|3|||
146747385|NCT00630058|529246067|FG001|Overall Study|stopping criteria|2|||
146747386|NCT01651936|529246068|FG000|Base Study|Adverse Event|3|||
146747387|NCT01651936|529246069|FG001|Base Study|Adverse Event|0|||
146747388|NCT01651936|529246070|FG002|Base Study|Adverse Event|0|||
146747389|NCT01651936|529246068|FG000|Base Study|Withdrawal by Subject|1|||
146747390|NCT01651936|529246069|FG001|Base Study|Withdrawal by Subject|1|||
146747391|NCT01651936|529246070|FG002|Base Study|Withdrawal by Subject|0|||
146747392|NCT01651936|529246068|FG000|Base Study|Early Escape|2|||
146747393|NCT01651936|529246069|FG001|Base Study|Early Escape|8|||
146747394|NCT01651936|529246070|FG002|Base Study|Early Escape|0|||
146747395|NCT01651936|529246068|FG000|Base Study|Study terminated by sponsor|21|||
146747396|NCT01651936|529246069|FG001|Base Study|Study terminated by sponsor|16|||
146747397|NCT01651936|529246070|FG002|Base Study|Study terminated by sponsor|0|||
146747398|NCT01651936|529246068|FG000|Extension Study|Lack of Efficacy|0|||
146747399|NCT01651936|529246069|FG001|Extension Study|Lack of Efficacy|0|||
146747400|NCT01651936|529246070|FG002|Extension Study|Lack of Efficacy|1|||
146747401|NCT01651936|529246068|FG000|Extension Study|Study terminated by sponsor|0|||
146747402|NCT01651936|529246069|FG001|Extension Study|Study terminated by sponsor|0|||
146747403|NCT01651936|529246070|FG002|Extension Study|Study terminated by sponsor|13|||
146747404|NCT03044353|529246071|FG000|Overall Study|Adverse Event|0|||
146747405|NCT03044353|529246072|FG001|Overall Study|Adverse Event|1|||
146747406|NCT03044353|529246073|FG002|Overall Study|Adverse Event|0|||
146747407|NCT03285113|529246082|FG000|Overall Study|Unable to implant leads|2|||
146747408|NCT01076088|529246086|FG000|Overall Study|Adverse Event|1|||
146747409|NCT01076088|529246087|FG001|Overall Study|Adverse Event|6|||
146747410|NCT01076088|529246088|FG002|Overall Study|Adverse Event|3|||
146747411|NCT01076088|529246089|FG003|Overall Study|Adverse Event|2|||
146747412|NCT01076088|529246090|FG004|Overall Study|Adverse Event|3|||
146747413|NCT01076088|529246091|FG005|Overall Study|Adverse Event|3|||
146747414|NCT01076088|529246086|FG000|Overall Study|Lost to Follow-up|1|||
146747415|NCT01076088|529246087|FG001|Overall Study|Lost to Follow-up|1|||
146747416|NCT01076088|529246088|FG002|Overall Study|Lost to Follow-up|0|||
146747417|NCT01076088|529246089|FG003|Overall Study|Lost to Follow-up|1|||
146747418|NCT01076088|529246090|FG004|Overall Study|Lost to Follow-up|1|||
146747419|NCT01076088|529246091|FG005|Overall Study|Lost to Follow-up|2|||
146747420|NCT01076088|529246086|FG000|Overall Study|Non-compliance with study drug|0|||
146747421|NCT01076088|529246087|FG001|Overall Study|Non-compliance with study drug|0|||
146747422|NCT01076088|529246088|FG002|Overall Study|Non-compliance with study drug|0|||
146747423|NCT01076088|529246089|FG003|Overall Study|Non-compliance with study drug|1|||
146747424|NCT01076088|529246090|FG004|Overall Study|Non-compliance with study drug|0|||
146747425|NCT01076088|529246091|FG005|Overall Study|Non-compliance with study drug|0|||
146747426|NCT01076088|529246086|FG000|Overall Study|Physician Decision|1|||
146747427|NCT01076088|529246087|FG001|Overall Study|Physician Decision|3|||
146747428|NCT01076088|529246088|FG002|Overall Study|Physician Decision|0|||
146747429|NCT01076088|529246089|FG003|Overall Study|Physician Decision|1|||
146747430|NCT01076088|529246090|FG004|Overall Study|Physician Decision|1|||
146747431|NCT01076088|529246091|FG005|Overall Study|Physician Decision|0|||
146747432|NCT01076088|529246086|FG000|Overall Study|Withdrawal by Subject|8|||
146747433|NCT01076088|529246087|FG001|Overall Study|Withdrawal by Subject|8|||
146747434|NCT01076088|529246088|FG002|Overall Study|Withdrawal by Subject|14|||
146747435|NCT01076088|529246089|FG003|Overall Study|Withdrawal by Subject|10|||
146747436|NCT01076088|529246090|FG004|Overall Study|Withdrawal by Subject|11|||
146747437|NCT01076088|529246091|FG005|Overall Study|Withdrawal by Subject|17|||
146747438|NCT01076088|529246086|FG000|Overall Study|Other protocol specified criteria|0|||
146747439|NCT01076088|529246087|FG001|Overall Study|Other protocol specified criteria|0|||
146747440|NCT01076088|529246088|FG002|Overall Study|Other protocol specified criteria|0|||
146747441|NCT01076088|529246089|FG003|Overall Study|Other protocol specified criteria|0|||
146747442|NCT01076088|529246090|FG004|Overall Study|Other protocol specified criteria|0|||
146747443|NCT01076088|529246091|FG005|Overall Study|Other protocol specified criteria|1|||
146747444|NCT02207374|529246094|FG000|Overall Study|Withdrawal by Subject|5|||
146747445|NCT02207374|529246095|FG001|Overall Study|Withdrawal by Subject|9|||
146747446|NCT02207374|529246096|FG002|Overall Study|Withdrawal by Subject|4|||
146747447|NCT02207374|529246094|FG000|Overall Study|Death|1|||
146747448|NCT02207374|529246095|FG001|Overall Study|Death|0|||
146747449|NCT02207374|529246096|FG002|Overall Study|Death|1|||
146747450|NCT02207374|529246094|FG000|Overall Study|Missing follow-up information|0|||
146747451|NCT02207374|529246095|FG001|Overall Study|Missing follow-up information|1|||
146747452|NCT02207374|529246096|FG002|Overall Study|Missing follow-up information|1|||
146747453|NCT00322374|529246097|FG000|Starting Dose|Physician Decision|2|||
146747454|NCT00322374|529246098|FG001|Starting Dose|Physician Decision|0|||
146747455|NCT00322374|529246099|FG002|Starting Dose|Physician Decision|0|||
146747456|NCT00322374|529246100|FG003|Starting Dose|Physician Decision|0|||
146747457|NCT00322374|529246097|FG000|Starting Dose|Study Drug Toxicity|4|||
146747458|NCT00322374|529246098|FG001|Starting Dose|Study Drug Toxicity|0|||
146747459|NCT00322374|529246099|FG002|Starting Dose|Study Drug Toxicity|0|||
146747460|NCT00322374|529246100|FG003|Starting Dose|Study Drug Toxicity|0|||
146747461|NCT00322374|529246097|FG000|First Escalation|Documented Disease Progression|0|||
146747462|NCT00322374|529246098|FG001|First Escalation|Documented Disease Progression|6|||
146747463|NCT00322374|529246099|FG002|First Escalation|Documented Disease Progression|0|||
146747464|NCT00322374|529246100|FG003|First Escalation|Documented Disease Progression|0|||
146747465|NCT00322374|529246097|FG000|First Escalation|Physician Decision|0|||
146747466|NCT00322374|529246098|FG001|First Escalation|Physician Decision|12|||
146747467|NCT00322374|529246099|FG002|First Escalation|Physician Decision|0|||
146747468|NCT00322374|529246100|FG003|First Escalation|Physician Decision|0|||
146747469|NCT00322374|529246097|FG000|First Escalation|Study Drug Toxicity|0|||
146747470|NCT00322374|529246098|FG001|First Escalation|Study Drug Toxicity|11|||
146747471|NCT00322374|529246099|FG002|First Escalation|Study Drug Toxicity|0|||
146747472|NCT00322374|529246100|FG003|First Escalation|Study Drug Toxicity|0|||
146747473|NCT00322374|529246097|FG000|First Escalation|Participant Request|0|||
146747474|NCT00322374|529246098|FG001|First Escalation|Participant Request|1|||
146747475|NCT00322374|529246099|FG002|First Escalation|Participant Request|0|||
146747476|NCT00322374|529246100|FG003|First Escalation|Participant Request|0|||
146747477|NCT00322374|529246097|FG000|Second Escalation|Physician Decision|0|||
146747478|NCT00322374|529246098|FG001|Second Escalation|Physician Decision|0|||
146747479|NCT00322374|529246099|FG002|Second Escalation|Physician Decision|5|||
146747480|NCT00322374|529246100|FG003|Second Escalation|Physician Decision|0|||
146747481|NCT00322374|529246097|FG000|Second Escalation|Study Drug Toxicity|0|||
146747482|NCT00322374|529246098|FG001|Second Escalation|Study Drug Toxicity|0|||
146747483|NCT00322374|529246099|FG002|Second Escalation|Study Drug Toxicity|1|||
146747484|NCT00322374|529246100|FG003|Second Escalation|Study Drug Toxicity|0|||
146747485|NCT01000376|529246106|FG000|Cycle 1 Day 1|Adverse Event|1|||
146747486|NCT01000376|529246107|FG001|Cycle 1 Day 1|Adverse Event|0|||
146747487|NCT01000376|529246106|FG000|Cycle 1 Day 1|Progressive Disease|1|||
146747488|NCT01000376|529246107|FG001|Cycle 1 Day 1|Progressive Disease|0|||
146747489|NCT02372058|529246108|FG000|Overall Study|Withdrawal by Subject|3|||
146747490|NCT00318149|529246109|FG000|Overall Study|Adverse Event|0|||
146747491|NCT00318149|529246110|FG001|Overall Study|Adverse Event|0|||
146747492|NCT00318149|529246111|FG002|Overall Study|Adverse Event|0|||
146747493|NCT00318149|529246112|FG003|Overall Study|Adverse Event|0|||
146747494|NCT00318149|529246113|FG004|Overall Study|Adverse Event|0|||
146747495|NCT00318149|529246114|FG005|Overall Study|Adverse Event|2|||
146747496|NCT00219141|529246115|FG000|Overall Study|Adverse Event|4|||
146747497|NCT00219141|529246116|FG001|Overall Study|Adverse Event|10|||
146747498|NCT00219141|529246117|FG002|Overall Study|Adverse Event|5|||
146747499|NCT00219141|529246115|FG000|Overall Study|Lack of Efficacy|3|||
146747500|NCT00219141|529246116|FG001|Overall Study|Lack of Efficacy|2|||
146747501|NCT00219141|529246117|FG002|Overall Study|Lack of Efficacy|0|||
146747502|NCT00219141|529246115|FG000|Overall Study|Administrative problems|0|||
146747503|NCT00219141|529246116|FG001|Overall Study|Administrative problems|1|||
146747504|NCT00219141|529246117|FG002|Overall Study|Administrative problems|0|||
146747505|NCT00219141|529246115|FG000|Overall Study|Lost to Follow-up|2|||
146747506|NCT00219141|529246116|FG001|Overall Study|Lost to Follow-up|4|||
146747507|NCT00219141|529246117|FG002|Overall Study|Lost to Follow-up|1|||
146747508|NCT00219141|529246115|FG000|Overall Study|Protocol Violation|3|||
146747509|NCT00219141|529246116|FG001|Overall Study|Protocol Violation|1|||
146747510|NCT00219141|529246117|FG002|Overall Study|Protocol Violation|1|||
146747511|NCT00219141|529246115|FG000|Overall Study|Withdrawal by Subject|1|||
146747512|NCT00219141|529246116|FG001|Overall Study|Withdrawal by Subject|3|||
146747513|NCT00219141|529246117|FG002|Overall Study|Withdrawal by Subject|5|||
146747514|NCT00219141|529246115|FG000|Overall Study|Condition no longer requires study drug|1|||
146747515|NCT00219141|529246116|FG001|Overall Study|Condition no longer requires study drug|0|||
146747516|NCT00219141|529246117|FG002|Overall Study|Condition no longer requires study drug|0|||
146511312|NCT00195494|528375464|FG001|Year 2|Lost to Follow-up|0|||
146747517|NCT01994720|529246118|FG000|Overall Study|Withdrawal by Subject|46|||
146747518|NCT01994720|529246119|FG001|Overall Study|Withdrawal by Subject|56|||
146747519|NCT01857622|529246130|FG000|Overall Study|Adverse Event|5|||
146747520|NCT01857622|529246131|FG001|Overall Study|Adverse Event|0|||
146747521|NCT01857622|529246132|FG002|Overall Study|Adverse Event|2|||
146747522|NCT01857622|529246130|FG000|Overall Study|Physician Decision|1|||
146747523|NCT01857622|529246131|FG001|Overall Study|Physician Decision|0|||
146747524|NCT01857622|529246132|FG002|Overall Study|Physician Decision|0|||
146747525|NCT01857622|529246130|FG000|Overall Study|Protocol Violation|4|||
146747526|NCT01857622|529246131|FG001|Overall Study|Protocol Violation|1|||
146747527|NCT01857622|529246132|FG002|Overall Study|Protocol Violation|0|||
146747528|NCT01857622|529246130|FG000|Overall Study|Withdrawal by Subject|1|||
146747529|NCT01857622|529246131|FG001|Overall Study|Withdrawal by Subject|0|||
146747530|NCT01857622|529246132|FG002|Overall Study|Withdrawal by Subject|0|||
146747531|NCT04318093|529246134|FG000|Overall Study|Adverse Event|2|||
146747532|NCT04318093|529246135|FG001|Overall Study|Adverse Event|2|||
146747533|NCT04318093|529246134|FG000|Overall Study|Participant withdrew consent|1|||
146747534|NCT04318093|529246135|FG001|Overall Study|Participant withdrew consent|0|||
146747535|NCT04318093|529246134|FG000|Overall Study|Other reasons|0|||
146747536|NCT04318093|529246135|FG001|Overall Study|Other reasons|1|||
146747537|NCT02855164|529246143|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
146747538|NCT02855164|529246144|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
146747539|NCT02855164|529246145|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
146747540|NCT02855164|529246146|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
146747541|NCT02855164|529246147|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
146747542|NCT02855164|529246148|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
146747543|NCT02855164|529246149|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
146747544|NCT02855164|529246150|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
146747545|NCT02855164|529246143|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
146747546|NCT02855164|529246144|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
146747547|NCT02855164|529246145|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
146747548|NCT02855164|529246146|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
146747549|NCT02855164|529246147|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
146747550|NCT02855164|529246148|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
146747551|NCT02855164|529246149|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
146747552|NCT02855164|529246150|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
146747553|NCT02855164|529246143|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
146747554|NCT02855164|529246144|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
146747555|NCT02855164|529246145|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
146747556|NCT02855164|529246146|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
146747557|NCT02855164|529246147|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
146747558|NCT02855164|529246148|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
146747559|NCT02855164|529246149|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
146747560|NCT02855164|529246150|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
146747561|NCT02855164|529246143|FG000|Part C (Randomized Set)|Adverse Event|0|||
146747562|NCT02855164|529246144|FG001|Part C (Randomized Set)|Adverse Event|0|||
146747563|NCT02855164|529246145|FG002|Part C (Randomized Set)|Adverse Event|0|||
146747564|NCT02855164|529246146|FG003|Part C (Randomized Set)|Adverse Event|0|||
146747565|NCT02855164|529246147|FG004|Part C (Randomized Set)|Adverse Event|0|||
146747566|NCT02855164|529246148|FG005|Part C (Randomized Set)|Adverse Event|5|||
146747567|NCT02855164|529246149|FG006|Part C (Randomized Set)|Adverse Event|9|||
146747568|NCT02855164|529246150|FG007|Part C (Randomized Set)|Adverse Event|2|||
146747569|NCT02855164|529246143|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
146747570|NCT02855164|529246144|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
146747571|NCT02855164|529246145|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
146747572|NCT02855164|529246146|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
146747573|NCT02855164|529246147|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
146747574|NCT02855164|529246148|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
146747575|NCT02855164|529246149|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
146747576|NCT02855164|529246150|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
146747577|NCT02855164|529246143|FG000|Part C (Randomized Set)|Physician Decision|0|||
146747578|NCT02855164|529246144|FG001|Part C (Randomized Set)|Physician Decision|0|||
146747579|NCT02855164|529246145|FG002|Part C (Randomized Set)|Physician Decision|0|||
146747580|NCT02855164|529246146|FG003|Part C (Randomized Set)|Physician Decision|0|||
146747581|NCT02855164|529246147|FG004|Part C (Randomized Set)|Physician Decision|0|||
146747582|NCT02855164|529246148|FG005|Part C (Randomized Set)|Physician Decision|1|||
146747583|NCT02855164|529246149|FG006|Part C (Randomized Set)|Physician Decision|0|||
146747584|NCT02855164|529246150|FG007|Part C (Randomized Set)|Physician Decision|1|||
146747585|NCT02855164|529246143|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
146747586|NCT02855164|529246144|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
146747587|NCT02855164|529246145|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
146747588|NCT02855164|529246146|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
146747589|NCT02855164|529246147|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
146747590|NCT02855164|529246148|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
146747591|NCT02855164|529246149|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
146747592|NCT02855164|529246150|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
146747593|NCT00876460|529246151|FG000|Combination Therapy Phase|Progressive disease|2|||
146747594|NCT00876460|529246152|FG001|Combination Therapy Phase|Progressive disease|3|||
146747595|NCT00876460|529246153|FG002|Combination Therapy Phase|Progressive disease|3|||
146747596|NCT00876460|529246154|FG003|Combination Therapy Phase|Progressive disease|3|||
146747597|NCT00876460|529246155|FG004|Combination Therapy Phase|Progressive disease|3|||
146747598|NCT00876460|529246156|FG005|Combination Therapy Phase|Progressive disease|1|||
146747599|NCT00876460|529246157|FG006|Combination Therapy Phase|Progressive disease|1|||
146747600|NCT00876460|529246158|FG007|Combination Therapy Phase|Progressive disease|1|||
146747601|NCT00876460|529246151|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
146747602|NCT00876460|529246152|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
146747603|NCT00876460|529246153|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
146747604|NCT00876460|529246154|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
146747605|NCT00876460|529246155|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
146747606|NCT00876460|529246156|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
146747607|NCT00876460|529246157|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
146747608|NCT00876460|529246158|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
146747609|NCT00876460|529246151|FG000|Combination Therapy Phase|Adverse Event|0|||
146747610|NCT00876460|529246152|FG001|Combination Therapy Phase|Adverse Event|2|||
146747611|NCT00876460|529246153|FG002|Combination Therapy Phase|Adverse Event|0|||
146747612|NCT00876460|529246154|FG003|Combination Therapy Phase|Adverse Event|2|||
146747613|NCT00876460|529246155|FG004|Combination Therapy Phase|Adverse Event|2|||
146747614|NCT00876460|529246156|FG005|Combination Therapy Phase|Adverse Event|0|||
146747615|NCT00876460|529246157|FG006|Combination Therapy Phase|Adverse Event|3|||
146747616|NCT00876460|529246158|FG007|Combination Therapy Phase|Adverse Event|2|||
146747617|NCT00876460|529246151|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
146747618|NCT00876460|529246152|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
146747619|NCT00876460|529246153|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
146747620|NCT00876460|529246154|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
146747621|NCT00876460|529246155|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
146747622|NCT00876460|529246156|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
146747623|NCT00876460|529246157|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
146747624|NCT00876460|529246158|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
146747625|NCT00876460|529246151|FG000|Combination Therapy Phase|Other reason not defined above|0|||
146747626|NCT00876460|529246152|FG001|Combination Therapy Phase|Other reason not defined above|0|||
146747627|NCT00876460|529246153|FG002|Combination Therapy Phase|Other reason not defined above|0|||
146747628|NCT00876460|529246154|FG003|Combination Therapy Phase|Other reason not defined above|0|||
146747629|NCT00876460|529246155|FG004|Combination Therapy Phase|Other reason not defined above|0|||
146747630|NCT00876460|529246156|FG005|Combination Therapy Phase|Other reason not defined above|0|||
146747631|NCT00876460|529246157|FG006|Combination Therapy Phase|Other reason not defined above|1|||
146747632|NCT00876460|529246158|FG007|Combination Therapy Phase|Other reason not defined above|2|||
146747633|NCT00876460|529246151|FG000|Combination Therapy Phase|Not treated|0|||
146747634|NCT00876460|529246152|FG001|Combination Therapy Phase|Not treated|0|||
146747635|NCT00876460|529246153|FG002|Combination Therapy Phase|Not treated|0|||
146747636|NCT00876460|529246154|FG003|Combination Therapy Phase|Not treated|0|||
146747637|NCT00876460|529246155|FG004|Combination Therapy Phase|Not treated|0|||
146747638|NCT00876460|529246156|FG005|Combination Therapy Phase|Not treated|0|||
146747639|NCT00876460|529246157|FG006|Combination Therapy Phase|Not treated|1|||
146747640|NCT00876460|529246158|FG007|Combination Therapy Phase|Not treated|0|||
146747641|NCT00876460|529246151|FG000|Mono Therapy Phase|Progressive disease|0|||
146747642|NCT00876460|529246152|FG001|Mono Therapy Phase|Progressive disease|0|||
146747643|NCT00876460|529246153|FG002|Mono Therapy Phase|Progressive disease|0|||
146747644|NCT00876460|529246154|FG003|Mono Therapy Phase|Progressive disease|0|||
146747645|NCT00876460|529246155|FG004|Mono Therapy Phase|Progressive disease|2|||
146747646|NCT00876460|529246156|FG005|Mono Therapy Phase|Progressive disease|0|||
146747647|NCT00876460|529246157|FG006|Mono Therapy Phase|Progressive disease|1|||
146747648|NCT00876460|529246158|FG007|Mono Therapy Phase|Progressive disease|3|||
146747649|NCT00876460|529246151|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
146747650|NCT00876460|529246152|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
146747651|NCT00876460|529246153|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
146747652|NCT00876460|529246154|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
146747653|NCT00876460|529246155|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
146747654|NCT00876460|529246156|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
146747655|NCT00876460|529246157|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
146747656|NCT00876460|529246158|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
146747657|NCT00876460|529246151|FG000|Mono Therapy Phase|Adverse Event|0|||
146747658|NCT00876460|529246152|FG001|Mono Therapy Phase|Adverse Event|0|||
146747659|NCT00876460|529246153|FG002|Mono Therapy Phase|Adverse Event|0|||
146747660|NCT00876460|529246154|FG003|Mono Therapy Phase|Adverse Event|1|||
146747661|NCT00876460|529246155|FG004|Mono Therapy Phase|Adverse Event|0|||
146747662|NCT00876460|529246156|FG005|Mono Therapy Phase|Adverse Event|0|||
146747663|NCT00876460|529246157|FG006|Mono Therapy Phase|Adverse Event|0|||
146747664|NCT00876460|529246158|FG007|Mono Therapy Phase|Adverse Event|0|||
146511313|NCT00195494|528375465|FG002|Year 2|Lost to Follow-up|1|||
146747665|NCT00513019|529247931|FG000|Overall Study|Adverse Event|1|||
146747666|NCT00513019|529247932|FG001|Overall Study|Adverse Event|0|||
146747667|NCT00513019|529247931|FG000|Overall Study|Withdrawal by Subject|4|||
146747668|NCT00513019|529247932|FG001|Overall Study|Withdrawal by Subject|5|||
146747669|NCT01500226|529247935|FG000|Overall Study|Adverse Event|31|||
146747670|NCT01500226|529247936|FG001|Overall Study|Adverse Event|38|||
146747671|NCT01500226|529247935|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
146747672|NCT01500226|529247936|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
146747673|NCT01500226|529247935|FG000|Overall Study|Withdrawal by Subject|93|||
146747674|NCT01500226|529247936|FG001|Overall Study|Withdrawal by Subject|96|||
146747675|NCT01500226|529247935|FG000|Overall Study|Death|12|||
146747676|NCT01500226|529247936|FG001|Overall Study|Death|4|||
146747677|NCT01500226|529247935|FG000|Overall Study|Disease Progression|16|||
146747678|NCT01500226|529247936|FG001|Overall Study|Disease Progression|14|||
146747679|NCT01500226|529247935|FG000|Overall Study|Protocol Violation|53|||
146747680|NCT01500226|529247936|FG001|Overall Study|Protocol Violation|39|||
146747681|NCT01500226|529247935|FG000|Overall Study|Physician Decision|17|||
146747682|NCT01500226|529247936|FG001|Overall Study|Physician Decision|15|||
146747683|NCT01500226|529247935|FG000|Overall Study|Lack of Efficacy|14|||
146747684|NCT01500226|529247936|FG001|Overall Study|Lack of Efficacy|30|||
146747685|NCT01500226|529247935|FG000|Overall Study|Lost to Follow-up|9|||
146747686|NCT01500226|529247936|FG001|Overall Study|Lost to Follow-up|5|||
146747687|NCT01500226|529247935|FG000|Overall Study|Other Reasons|19|||
146747688|NCT01500226|529247936|FG001|Overall Study|Other Reasons|16|||
146747689|NCT00506285|529247937|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
146747690|NCT00506285|529247938|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
146747691|NCT00506285|529247937|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
146747692|NCT00506285|529247938|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
146747693|NCT00506285|529247937|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
146747694|NCT00506285|529247938|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
146747695|NCT00506285|529247937|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
146747696|NCT00506285|529247938|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
146747697|NCT00506285|529247937|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
146747698|NCT00506285|529247938|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
146747699|NCT00551213|529247941|FG000|Overall Study|Adverse Event|6|||
146747700|NCT00551213|529247942|FG001|Overall Study|Adverse Event|3|||
146747701|NCT00551213|529247941|FG000|Overall Study|Progressive Disease|41|||
146747702|NCT00551213|529247942|FG001|Overall Study|Progressive Disease|12|||
146747703|NCT00551213|529247941|FG000|Overall Study|Withdrawal by Subject|2|||
146747704|NCT00551213|529247942|FG001|Overall Study|Withdrawal by Subject|0|||
146747705|NCT00551213|529247941|FG000|Overall Study|Not Treated|1|||
146747706|NCT00551213|529247942|FG001|Overall Study|Not Treated|2|||
146747707|NCT01890967|529247943|FG000|Overall Study|Adverse Event|3|||
146747708|NCT01890967|529247944|FG001|Overall Study|Adverse Event|3|||
146747709|NCT01890967|529247945|FG002|Overall Study|Adverse Event|3|||
146747710|NCT01890967|529247946|FG003|Overall Study|Adverse Event|2|||
146747711|NCT01890967|529247947|FG004|Overall Study|Adverse Event|1|||
146747712|NCT01890967|529247948|FG005|Overall Study|Adverse Event|7|||
146747713|NCT01890967|529247943|FG000|Overall Study|Death|1|||
146747714|NCT01890967|529247944|FG001|Overall Study|Death|0|||
146747715|NCT01890967|529247945|FG002|Overall Study|Death|0|||
146747716|NCT01890967|529247946|FG003|Overall Study|Death|0|||
146747717|NCT01890967|529247947|FG004|Overall Study|Death|0|||
146747718|NCT01890967|529247948|FG005|Overall Study|Death|0|||
146747719|NCT01890967|529247943|FG000|Overall Study|Lost to Follow-up|1|||
146747720|NCT01890967|529247944|FG001|Overall Study|Lost to Follow-up|1|||
146747721|NCT01890967|529247945|FG002|Overall Study|Lost to Follow-up|1|||
146747722|NCT01890967|529247946|FG003|Overall Study|Lost to Follow-up|1|||
146747723|NCT01890967|529247947|FG004|Overall Study|Lost to Follow-up|0|||
146747724|NCT01890967|529247948|FG005|Overall Study|Lost to Follow-up|1|||
146747725|NCT01890967|529247943|FG000|Overall Study|Protocol Violation|0|||
146747726|NCT01890967|529247944|FG001|Overall Study|Protocol Violation|3|||
146747727|NCT01890967|529247945|FG002|Overall Study|Protocol Violation|3|||
146747728|NCT01890967|529247946|FG003|Overall Study|Protocol Violation|2|||
146747729|NCT01890967|529247947|FG004|Overall Study|Protocol Violation|4|||
146747730|NCT01890967|529247948|FG005|Overall Study|Protocol Violation|1|||
146747731|NCT01890967|529247943|FG000|Overall Study|Sponsor Decision|2|||
146747732|NCT01890967|529247944|FG001|Overall Study|Sponsor Decision|0|||
146747733|NCT01890967|529247945|FG002|Overall Study|Sponsor Decision|1|||
146747734|NCT01890967|529247946|FG003|Overall Study|Sponsor Decision|3|||
146747735|NCT01890967|529247947|FG004|Overall Study|Sponsor Decision|2|||
146747736|NCT01890967|529247948|FG005|Overall Study|Sponsor Decision|3|||
146747737|NCT01890967|529247943|FG000|Overall Study|Withdrawal by Subject|3|||
146747738|NCT01890967|529247944|FG001|Overall Study|Withdrawal by Subject|4|||
146747739|NCT01890967|529247945|FG002|Overall Study|Withdrawal by Subject|2|||
146747740|NCT01890967|529247946|FG003|Overall Study|Withdrawal by Subject|3|||
146747741|NCT01890967|529247947|FG004|Overall Study|Withdrawal by Subject|3|||
146747742|NCT01890967|529247948|FG005|Overall Study|Withdrawal by Subject|1|||
146747743|NCT01383993|529247951|FG000|Overall Study|Adverse Event|1|||
146747744|NCT01383993|529247952|FG001|Overall Study|Adverse Event|1|||
146747745|NCT01383993|529247953|FG002|Overall Study|Adverse Event|0|||
146747746|NCT01383993|529247951|FG000|Overall Study|Withdrawal by Subject|0|||
146747747|NCT01383993|529247952|FG001|Overall Study|Withdrawal by Subject|0|||
146747748|NCT01383993|529247953|FG002|Overall Study|Withdrawal by Subject|1|||
146747749|NCT01383993|529247951|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
146747750|NCT01383993|529247952|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
146747751|NCT01383993|529247953|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
146747752|NCT00593554|529247954|FG000|Overall Study|Death|1|||
146747753|NCT00593554|529247955|FG001|Overall Study|Death|2|||
146747754|NCT00593554|529247954|FG000|Overall Study|Physician Decision|0|||
146747755|NCT00593554|529247955|FG001|Overall Study|Physician Decision|1|||
146747756|NCT00593554|529247954|FG000|Overall Study|Withdrawal by Subject|1|||
146747757|NCT00593554|529247955|FG001|Overall Study|Withdrawal by Subject|0|||
146747758|NCT00593554|529247954|FG000|Overall Study|Disease Progression|1|||
146747759|NCT00593554|529247955|FG001|Overall Study|Disease Progression|2|||
146747760|NCT01254565|529247963|FG000|Overall Study|Non-compliance to Study Procedures|0|||
146747761|NCT01254565|529247964|FG001|Overall Study|Non-compliance to Study Procedures|0|||
146747762|NCT01254565|529247965|FG002|Overall Study|Non-compliance to Study Procedures|0|||
146747763|NCT01254565|529247966|FG003|Overall Study|Non-compliance to Study Procedures|0|||
146747764|NCT01254565|529247967|FG004|Overall Study|Non-compliance to Study Procedures|1|||
146747765|NCT01254565|529247968|FG005|Overall Study|Non-compliance to Study Procedures|0|||
146747766|NCT01254565|529247963|FG000|Overall Study|Did not Receive Treatment|1|||
146747767|NCT01254565|529247964|FG001|Overall Study|Did not Receive Treatment|1|||
146747768|NCT01254565|529247965|FG002|Overall Study|Did not Receive Treatment|0|||
146747769|NCT01254565|529247966|FG003|Overall Study|Did not Receive Treatment|0|||
146747770|NCT01254565|529247967|FG004|Overall Study|Did not Receive Treatment|3|||
146747771|NCT01254565|529247968|FG005|Overall Study|Did not Receive Treatment|4|||
146747772|NCT01254565|529247963|FG000|Overall Study|Other|0|||
146747773|NCT01254565|529247964|FG001|Overall Study|Other|0|||
146747774|NCT01254565|529247965|FG002|Overall Study|Other|0|||
146747775|NCT01254565|529247966|FG003|Overall Study|Other|1|||
146747776|NCT01254565|529247967|FG004|Overall Study|Other|0|||
146747777|NCT01254565|529247968|FG005|Overall Study|Other|0|||
146747778|NCT02726399|529247969|FG000|Overall Study|Participant Non-Compliance|1|||
146747779|NCT02726399|529247969|FG000|Overall Study|Adverse Event|2|||
146747780|NCT02726399|529247969|FG000|Overall Study|Progression of disease|4|||
146747781|NCT00794820|529247970|FG000|Overall Study|Adverse Event|11|||
146747782|NCT00794820|529247970|FG000|Overall Study|Secondary Malignancies|2|||
146747783|NCT00794820|529247970|FG000|Overall Study|Resistant Disease|2|||
146747784|NCT00794820|529247970|FG000|Overall Study|Ineligible/Screen Failure|1|||
146747785|NCT02406261|529247973|FG000|Period 1|Lost to Follow-up|2|||
146747786|NCT02406261|529247974|FG001|Period 1|Lost to Follow-up|0|||
146747787|NCT02406261|529247973|FG000|Period 1|Adverse Event|1|||
146747788|NCT02406261|529247974|FG001|Period 1|Adverse Event|0|||
146747789|NCT02406261|529247973|FG000|Period 2|Physician Decision|0|||
146747790|NCT02406261|529247974|FG001|Period 2|Physician Decision|1|||
146747791|NCT02406261|529247973|FG000|Period 2|Protocol Violation|0|||
146747792|NCT02406261|529247974|FG001|Period 2|Protocol Violation|1|||
146747793|NCT02406261|529247973|FG000|Period 2|Withdrawal by Subject|0|||
146747794|NCT02406261|529247974|FG001|Period 2|Withdrawal by Subject|1|||
146747795|NCT03230864|529247977|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
146747796|NCT03230864|529247978|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
146747797|NCT03230864|529247979|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
146747798|NCT03230864|529247980|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
146747799|NCT03230864|529247977|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
146747800|NCT03230864|529247978|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
146747801|NCT03230864|529247979|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
146747802|NCT03230864|529247980|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
146747803|NCT03230864|529247977|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
146747804|NCT03230864|529247978|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
146747805|NCT03230864|529247979|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
146747806|NCT03230864|529247980|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
146747807|NCT03230864|529247977|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
146747808|NCT03230864|529247978|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
146747809|NCT03230864|529247979|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
146747810|NCT03230864|529247980|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
146747811|NCT03230864|529247977|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
146747812|NCT03230864|529247978|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
146747813|NCT03230864|529247979|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
146747814|NCT03230864|529247980|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
146747815|NCT03230864|529247977|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
146747816|NCT03230864|529247978|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
146747817|NCT03230864|529247979|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
146747818|NCT03230864|529247980|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
146747819|NCT03230864|529247977|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
146747820|NCT03230864|529247978|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
146747821|NCT03230864|529247979|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
146747822|NCT03230864|529247980|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
146747823|NCT03230864|529247977|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
146747824|NCT03230864|529247978|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
146747825|NCT03230864|529247979|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
146747826|NCT03230864|529247980|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
146747827|NCT03230864|529247977|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
146747828|NCT03230864|529247978|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
146747829|NCT03230864|529247979|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
146747830|NCT03230864|529247980|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
146747831|NCT03230864|529247977|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
146747832|NCT03230864|529247978|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
146747833|NCT03230864|529247979|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
146747834|NCT03230864|529247980|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
146747835|NCT00432679|529247985|FG000|Overall Study|Adverse Event|2|||
146747836|NCT00432679|529247986|FG001|Overall Study|Adverse Event|1|||
146747837|NCT00432679|529247985|FG000|Overall Study|Withdrawal by Subject|3|||
146747838|NCT00432679|529247986|FG001|Overall Study|Withdrawal by Subject|2|||
146747839|NCT01686932|529247993|FG000|Period 1|Adverse Event|1|||
146747840|NCT01686932|529247994|FG001|Period 1|Adverse Event|1|||
146747841|NCT01284140|529247995|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
146747842|NCT01284140|529247996|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
146747843|NCT01284140|529247995|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
146747844|NCT01284140|529247996|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
146747845|NCT04147260|529247998|FG000|Overall Study|Adverse Event|1|||
146747846|NCT04147260|529247999|FG001|Overall Study|Adverse Event|0|||
146747847|NCT04147260|529248000|FG002|Overall Study|Adverse Event|1|||
146747848|NCT04147260|529248001|FG003|Overall Study|Adverse Event|2|||
146747849|NCT04147260|529248002|FG004|Overall Study|Adverse Event|0|||
146747850|NCT04147260|529247998|FG000|Overall Study|Withdrawal by Subject|0|||
146747851|NCT04147260|529247999|FG001|Overall Study|Withdrawal by Subject|0|||
146747852|NCT04147260|529248000|FG002|Overall Study|Withdrawal by Subject|1|||
146747853|NCT04147260|529248001|FG003|Overall Study|Withdrawal by Subject|1|||
146747854|NCT04147260|529248002|FG004|Overall Study|Withdrawal by Subject|0|||
146747855|NCT01555021|529248003|FG000|Overall Study|Lost to Follow-up|1|||
146747856|NCT01555021|529248004|FG001|Overall Study|Lost to Follow-up|2|||
146747857|NCT01313923|529248008|FG000|Overall Study|Physician Decision|3|||
146747858|NCT01388530|529248009|FG000|Overall Study|Lost to Follow-up|5|||
146747859|NCT02204293|529248010|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
146747860|NCT02204293|529248011|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
146747861|NCT02204293|529248012|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
146747862|NCT02204293|529248013|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
146747863|NCT02204293|529248014|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
146747864|NCT02204293|529248015|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
146747865|NCT02204293|529248010|FG000|Core Study Part I|Adverse Event|1|||
146747866|NCT02204293|529248011|FG001|Core Study Part I|Adverse Event|0|||
146747867|NCT02204293|529248012|FG002|Core Study Part I|Adverse Event|0|||
146747868|NCT02204293|529248013|FG003|Core Study Part I|Adverse Event|0|||
146747869|NCT02204293|529248014|FG004|Core Study Part I|Adverse Event|0|||
146747870|NCT02204293|529248015|FG005|Core Study Part I|Adverse Event|0|||
146747871|NCT02204293|529248010|FG000|Core Study Part I|Physician Decision|0|||
146747872|NCT02204293|529248011|FG001|Core Study Part I|Physician Decision|3|||
146747873|NCT02204293|529248012|FG002|Core Study Part I|Physician Decision|0|||
146747874|NCT02204293|529248013|FG003|Core Study Part I|Physician Decision|0|||
146747875|NCT02204293|529248014|FG004|Core Study Part I|Physician Decision|0|||
146747876|NCT02204293|529248015|FG005|Core Study Part I|Physician Decision|0|||
146747877|NCT02204293|529248010|FG000|LTE Phase|Study Suspended|0|||
146747878|NCT02204293|529248011|FG001|LTE Phase|Study Suspended|0|||
146747879|NCT02204293|529248012|FG002|LTE Phase|Study Suspended|0|||
146747880|NCT02204293|529248013|FG003|LTE Phase|Study Suspended|0|||
146747881|NCT02204293|529248014|FG004|LTE Phase|Study Suspended|0|||
146747882|NCT02204293|529248015|FG005|LTE Phase|Study Suspended|7|||
146747883|NCT01990300|529248016|FG000|Overall Study|Case Report Forms Uncollected|89|||
146747884|NCT01990300|529248016|FG000|Overall Study|Protocol Deviation|53|||
146747885|NCT02420327|529248017|FG000|Overall Study|Adverse Event|7|||
146747886|NCT02420327|529248017|FG000|Overall Study|Pregnancy|1|||
146747887|NCT02420327|529248017|FG000|Overall Study|Withdrawal by Subject|6|||
146747888|NCT02420327|529248017|FG000|Overall Study|Lost to Follow-up|1|||
146747889|NCT02420327|529248017|FG000|Overall Study|Protocol Violation|1|||
146747890|NCT01225835|529248020|FG000|Overall Study|Completed protocol|2|||
146747891|NCT01225835|529248021|FG001|Overall Study|Completed protocol|1|||
146747892|NCT01225835|529248020|FG000|Overall Study|Did not meet hCG criterion|2|||
146747893|NCT01225835|529248021|FG001|Overall Study|Did not meet hCG criterion|0|||
146747894|NCT01225835|529248020|FG000|Overall Study|Adverse Event|2|||
146747895|NCT01225835|529248021|FG001|Overall Study|Adverse Event|1|||
146747896|NCT01225835|529248020|FG000|Overall Study|Other|1|||
146747897|NCT01225835|529248021|FG001|Overall Study|Other|1|||
146747898|NCT01266993|529248022|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
146747899|NCT01266993|529248023|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
146511314|NCT00195494|528375466|FG003|Year 2|Lost to Follow-up|1|||
146747900|NCT01266993|529248022|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
146747901|NCT01266993|529248023|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
146747902|NCT02589392|529248024|FG000|Overall Study|Adverse Event|1|||
146747903|NCT02589392|529248025|FG001|Overall Study|Adverse Event|1|||
146747904|NCT02589392|529248024|FG000|Overall Study|Withdrawal by Subject|1|||
146747905|NCT02589392|529248025|FG001|Overall Study|Withdrawal by Subject|2|||
146747906|NCT02589392|529248024|FG000|Overall Study|Protocol Violation|1|||
146747907|NCT02589392|529248025|FG001|Overall Study|Protocol Violation|1|||
146747908|NCT02589392|529248024|FG000|Overall Study|Lost to Follow-up|2|||
146747909|NCT02589392|529248025|FG001|Overall Study|Lost to Follow-up|2|||
146747910|NCT02589392|529248024|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
146747911|NCT02589392|529248025|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
146747912|NCT03051659|529248026|FG000|Treatment Period|Withdrawal by Subject|0|||
146747913|NCT03051659|529248027|FG001|Treatment Period|Withdrawal by Subject|2|||
146747914|NCT03051659|529248026|FG000|Survival Follow-up|Lost to Follow-up|23|||
146747915|NCT03051659|529248027|FG001|Survival Follow-up|Lost to Follow-up|22|||
146747916|NCT02293837|529248028|FG000|Overall Study|Lost to Follow-up|0|||
146747917|NCT02293837|529248029|FG001|Overall Study|Lost to Follow-up|2|||
146747918|NCT02293837|529248030|FG002|Overall Study|Lost to Follow-up|1|||
146747919|NCT02293837|529248031|FG003|Overall Study|Lost to Follow-up|0|||
146747920|NCT02293837|529248028|FG000|Overall Study|Withdrawal by Subject|2|||
146747921|NCT02293837|529248029|FG001|Overall Study|Withdrawal by Subject|1|||
146747922|NCT02293837|529248030|FG002|Overall Study|Withdrawal by Subject|2|||
146747923|NCT02293837|529248031|FG003|Overall Study|Withdrawal by Subject|1|||
146747924|NCT02293837|529248028|FG000|Overall Study|COVID-19 Related|1|||
146747925|NCT02293837|529248029|FG001|Overall Study|COVID-19 Related|1|||
146747926|NCT02293837|529248030|FG002|Overall Study|COVID-19 Related|0|||
146747927|NCT02293837|529248031|FG003|Overall Study|COVID-19 Related|0|||
146747928|NCT02293837|529248028|FG000|Overall Study|Participant ill and could not be infused|0|||
146747929|NCT02293837|529248029|FG001|Overall Study|Participant ill and could not be infused|0|||
146747930|NCT02293837|529248030|FG002|Overall Study|Participant ill and could not be infused|1|||
146747931|NCT02293837|529248031|FG003|Overall Study|Participant ill and could not be infused|0|||
146747932|NCT04779242|529248032|FG000|Overall Study|Adverse Event|1|||
146747933|NCT04779242|529248033|FG001|Overall Study|Adverse Event|1|||
146747934|NCT04779242|529248032|FG000|Overall Study|Lost to Follow-up|2|||
146747935|NCT04779242|529248033|FG001|Overall Study|Lost to Follow-up|4|||
146747936|NCT04779242|529248032|FG000|Overall Study|Withdrawal by Subject|7|||
146747937|NCT04779242|529248033|FG001|Overall Study|Withdrawal by Subject|9|||
146747938|NCT04779242|529248032|FG000|Overall Study|Death|6|||
146747939|NCT04779242|529248033|FG001|Overall Study|Death|6|||
146747940|NCT04779242|529248032|FG000|Overall Study|COVID-19 related reasons|2|||
146747941|NCT04779242|529248033|FG001|Overall Study|COVID-19 related reasons|1|||
146747942|NCT04779242|529248032|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
146747943|NCT04779242|529248033|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
146747944|NCT04779242|529248032|FG000|Overall Study|Martial Law in Ukraine|2|||
146747945|NCT04779242|529248033|FG001|Overall Study|Martial Law in Ukraine|3|||
146747946|NCT02087150|529248034|FG000|Overall Study|Death|0|||
146747947|NCT02087150|529248035|FG001|Overall Study|Death|1|||
146747948|NCT02087150|529248036|FG002|Overall Study|Death|0|||
146747949|NCT02087150|529248034|FG000|Overall Study|Lost to Follow-up|6|||
146747950|NCT02087150|529248035|FG001|Overall Study|Lost to Follow-up|13|||
146747951|NCT02087150|529248036|FG002|Overall Study|Lost to Follow-up|7|||
146747952|NCT02087150|529248034|FG000|Overall Study|Withdrawal by Subject|2|||
146747953|NCT02087150|529248035|FG001|Overall Study|Withdrawal by Subject|5|||
146747954|NCT02087150|529248036|FG002|Overall Study|Withdrawal by Subject|3|||
146747955|NCT02087150|529248034|FG000|Overall Study|Physician Decision|0|||
146747956|NCT02087150|529248035|FG001|Overall Study|Physician Decision|1|||
146747957|NCT02087150|529248036|FG002|Overall Study|Physician Decision|0|||
146747958|NCT02087150|529248034|FG000|Overall Study|Procedure not done|1|||
146747959|NCT02087150|529248035|FG001|Overall Study|Procedure not done|13|||
146747960|NCT02087150|529248036|FG002|Overall Study|Procedure not done|0|||
146747961|NCT02087150|529248034|FG000|Overall Study|F/U not completed w/in study window|0|||
146747962|NCT02087150|529248035|FG001|Overall Study|F/U not completed w/in study window|0|||
146747963|NCT02087150|529248036|FG002|Overall Study|F/U not completed w/in study window|1|||
146747964|NCT02087150|529248034|FG000|Overall Study|Other|1|||
146747965|NCT02087150|529248035|FG001|Overall Study|Other|0|||
146747966|NCT02087150|529248036|FG002|Overall Study|Other|0|||
146747967|NCT02087150|529248034|FG000|Overall Study|Pt moved out of town|0|||
146747968|NCT02087150|529248035|FG001|Overall Study|Pt moved out of town|1|||
146747969|NCT02087150|529248036|FG002|Overall Study|Pt moved out of town|0|||
146747970|NCT01012973|529248037|FG000|Overall Study|Adverse Event|5|||
146747971|NCT01012973|529248038|FG001|Overall Study|Adverse Event|5|||
146747972|NCT01012973|529248037|FG000|Overall Study|Lack of Efficacy|0|||
146747973|NCT01012973|529248038|FG001|Overall Study|Lack of Efficacy|5|||
146747974|NCT01012973|529248037|FG000|Overall Study|Lost to Follow-up|1|||
146747975|NCT01012973|529248038|FG001|Overall Study|Lost to Follow-up|0|||
146747976|NCT01012973|529248037|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
146747977|NCT01012973|529248038|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
146747978|NCT01012973|529248037|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
146747979|NCT01012973|529248038|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
146747980|NCT01012973|529248037|FG000|Overall Study|Protocol Violation|5|||
146747981|NCT01012973|529248038|FG001|Overall Study|Protocol Violation|2|||
146747982|NCT01012973|529248037|FG000|Overall Study|Withdrawal by Subject|4|||
146747983|NCT01012973|529248038|FG001|Overall Study|Withdrawal by Subject|6|||
146747984|NCT02061761|529248039|FG000|Overall Study|Disease progression|2|||
146747985|NCT02061761|529248040|FG001|Overall Study|Disease progression|8|||
146747986|NCT02061761|529248041|FG002|Overall Study|Disease progression|4|||
146747987|NCT02061761|529248042|FG003|Overall Study|Disease progression|5|||
146747988|NCT02061761|529248043|FG004|Overall Study|Disease progression|9|||
146747989|NCT02061761|529248044|FG005|Overall Study|Disease progression|3|||
146747990|NCT02061761|529248045|FG006|Overall Study|Disease progression|1|||
146747991|NCT02061761|529248046|FG007|Overall Study|Disease progression|2|||
146747992|NCT02061761|529248047|FG008|Overall Study|Disease progression|28|||
146747993|NCT02061761|529248039|FG000|Overall Study|Study Drug toxicity|0|||
146747994|NCT02061761|529248040|FG001|Overall Study|Study Drug toxicity|0|||
146747995|NCT02061761|529248041|FG002|Overall Study|Study Drug toxicity|0|||
146747996|NCT02061761|529248042|FG003|Overall Study|Study Drug toxicity|0|||
146747997|NCT02061761|529248043|FG004|Overall Study|Study Drug toxicity|0|||
146747998|NCT02061761|529248044|FG005|Overall Study|Study Drug toxicity|1|||
146747999|NCT02061761|529248045|FG006|Overall Study|Study Drug toxicity|0|||
146748000|NCT02061761|529248046|FG007|Overall Study|Study Drug toxicity|2|||
146748001|NCT02061761|529248047|FG008|Overall Study|Study Drug toxicity|6|||
146748002|NCT02061761|529248039|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
146748003|NCT02061761|529248040|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
146748004|NCT02061761|529248041|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
146748005|NCT02061761|529248042|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
146748006|NCT02061761|529248043|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
146748007|NCT02061761|529248044|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
146748008|NCT02061761|529248045|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
146748009|NCT02061761|529248046|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
146748010|NCT02061761|529248047|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
146748011|NCT02061761|529248039|FG000|Overall Study|Participant request to discontinue study treatment|0|||
146748012|NCT02061761|529248040|FG001|Overall Study|Participant request to discontinue study treatment|0|||
146748013|NCT02061761|529248041|FG002|Overall Study|Participant request to discontinue study treatment|2|||
146748014|NCT02061761|529248042|FG003|Overall Study|Participant request to discontinue study treatment|2|||
146748015|NCT02061761|529248043|FG004|Overall Study|Participant request to discontinue study treatment|0|||
146748016|NCT02061761|529248044|FG005|Overall Study|Participant request to discontinue study treatment|1|||
146748017|NCT02061761|529248045|FG006|Overall Study|Participant request to discontinue study treatment|0|||
146748018|NCT02061761|529248046|FG007|Overall Study|Participant request to discontinue study treatment|0|||
146748019|NCT02061761|529248047|FG008|Overall Study|Participant request to discontinue study treatment|2|||
146748020|NCT02061761|529248039|FG000|Overall Study|Withdrawal by Subject|0|||
146748021|NCT02061761|529248040|FG001|Overall Study|Withdrawal by Subject|0|||
146748022|NCT02061761|529248041|FG002|Overall Study|Withdrawal by Subject|0|||
146748023|NCT02061761|529248042|FG003|Overall Study|Withdrawal by Subject|0|||
146748024|NCT02061761|529248043|FG004|Overall Study|Withdrawal by Subject|0|||
146748025|NCT02061761|529248044|FG005|Overall Study|Withdrawal by Subject|0|||
146748026|NCT02061761|529248045|FG006|Overall Study|Withdrawal by Subject|0|||
146748027|NCT02061761|529248046|FG007|Overall Study|Withdrawal by Subject|0|||
146748028|NCT02061761|529248047|FG008|Overall Study|Withdrawal by Subject|2|||
146748029|NCT02061761|529248039|FG000|Overall Study|Maximum clinical benefit|0|||
146748030|NCT02061761|529248040|FG001|Overall Study|Maximum clinical benefit|0|||
146748031|NCT02061761|529248041|FG002|Overall Study|Maximum clinical benefit|0|||
146748032|NCT02061761|529248042|FG003|Overall Study|Maximum clinical benefit|1|||
146748033|NCT02061761|529248043|FG004|Overall Study|Maximum clinical benefit|0|||
146748034|NCT02061761|529248044|FG005|Overall Study|Maximum clinical benefit|0|||
146748035|NCT02061761|529248045|FG006|Overall Study|Maximum clinical benefit|0|||
146748036|NCT02061761|529248046|FG007|Overall Study|Maximum clinical benefit|0|||
146748037|NCT02061761|529248047|FG008|Overall Study|Maximum clinical benefit|6|||
146748038|NCT02061761|529248039|FG000|Overall Study|Participant no longer meets study criteria|0|||
146748039|NCT02061761|529248040|FG001|Overall Study|Participant no longer meets study criteria|0|||
146748040|NCT02061761|529248041|FG002|Overall Study|Participant no longer meets study criteria|0|||
146748041|NCT02061761|529248042|FG003|Overall Study|Participant no longer meets study criteria|0|||
146748042|NCT02061761|529248043|FG004|Overall Study|Participant no longer meets study criteria|0|||
146748043|NCT02061761|529248044|FG005|Overall Study|Participant no longer meets study criteria|0|||
146748044|NCT02061761|529248045|FG006|Overall Study|Participant no longer meets study criteria|0|||
146748045|NCT02061761|529248046|FG007|Overall Study|Participant no longer meets study criteria|0|||
146748046|NCT02061761|529248047|FG008|Overall Study|Participant no longer meets study criteria|1|||
146748047|NCT02061761|529248039|FG000|Overall Study|Other reasons|0|||
146748048|NCT02061761|529248040|FG001|Overall Study|Other reasons|0|||
146748049|NCT02061761|529248041|FG002|Overall Study|Other reasons|0|||
146748050|NCT02061761|529248042|FG003|Overall Study|Other reasons|0|||
146748051|NCT02061761|529248043|FG004|Overall Study|Other reasons|2|||
146748052|NCT02061761|529248044|FG005|Overall Study|Other reasons|0|||
146748053|NCT02061761|529248045|FG006|Overall Study|Other reasons|0|||
146748054|NCT02061761|529248046|FG007|Overall Study|Other reasons|0|||
146748055|NCT02061761|529248047|FG008|Overall Study|Other reasons|6|||
146748056|NCT02138747|529248048|FG000|Treatment Period 1|Adverse Event|10|||
146748057|NCT02138747|529248049|FG001|Treatment Period 1|Adverse Event|14|||
146748058|NCT02138747|529248050|FG002|Treatment Period 1|Adverse Event|2|||
146748059|NCT02138747|529248051|FG003|Treatment Period 1|Adverse Event|1|||
146748060|NCT02138747|529248048|FG000|Treatment Period 1|Lost to Follow-up|0|||
146748061|NCT02138747|529248049|FG001|Treatment Period 1|Lost to Follow-up|1|||
146748062|NCT02138747|529248050|FG002|Treatment Period 1|Lost to Follow-up|1|||
146748063|NCT02138747|529248051|FG003|Treatment Period 1|Lost to Follow-up|0|||
146748064|NCT02138747|529248048|FG000|Treatment Period 1|Protocol Violation|0|||
146748065|NCT02138747|529248049|FG001|Treatment Period 1|Protocol Violation|2|||
146748066|NCT02138747|529248050|FG002|Treatment Period 1|Protocol Violation|0|||
146748067|NCT02138747|529248051|FG003|Treatment Period 1|Protocol Violation|0|||
146748068|NCT02138747|529248048|FG000|Treatment Period 1|Withdrawal by Subject|8|||
146748069|NCT02138747|529248049|FG001|Treatment Period 1|Withdrawal by Subject|4|||
146748070|NCT02138747|529248050|FG002|Treatment Period 1|Withdrawal by Subject|1|||
146748071|NCT02138747|529248051|FG003|Treatment Period 1|Withdrawal by Subject|3|||
146748072|NCT02138747|529248048|FG000|Treatment Period 1|Other - Miscellaneous|2|||
146748073|NCT02138747|529248049|FG001|Treatment Period 1|Other - Miscellaneous|4|||
146748074|NCT02138747|529248050|FG002|Treatment Period 1|Other - Miscellaneous|0|||
146748075|NCT02138747|529248051|FG003|Treatment Period 1|Other - Miscellaneous|0|||
146748076|NCT02138747|529248048|FG000|Treatment Period 2|Adverse Event|6|||
146748077|NCT02138747|529248049|FG001|Treatment Period 2|Adverse Event|3|||
146748078|NCT02138747|529248050|FG002|Treatment Period 2|Adverse Event|1|||
146511315|NCT00195494|528375467|FG004|Year 2|Lost to Follow-up|0|||
146511316|NCT00195494|528375468|FG005|Year 2|Lost to Follow-up|0|||
146748079|NCT02138747|529248051|FG003|Treatment Period 2|Adverse Event|1|||
146748080|NCT02138747|529248048|FG000|Treatment Period 2|Lost to Follow-up|2|||
146748081|NCT02138747|529248049|FG001|Treatment Period 2|Lost to Follow-up|0|||
146748082|NCT02138747|529248050|FG002|Treatment Period 2|Lost to Follow-up|0|||
146748083|NCT02138747|529248051|FG003|Treatment Period 2|Lost to Follow-up|0|||
146748084|NCT02138747|529248048|FG000|Treatment Period 2|Protocol Violation|1|||
146748085|NCT02138747|529248049|FG001|Treatment Period 2|Protocol Violation|0|||
146748086|NCT02138747|529248050|FG002|Treatment Period 2|Protocol Violation|0|||
146748087|NCT02138747|529248051|FG003|Treatment Period 2|Protocol Violation|0|||
146748088|NCT02138747|529248048|FG000|Treatment Period 2|Withdrawal by Subject|5|||
146748089|NCT02138747|529248049|FG001|Treatment Period 2|Withdrawal by Subject|4|||
146748090|NCT02138747|529248050|FG002|Treatment Period 2|Withdrawal by Subject|1|||
146748091|NCT02138747|529248051|FG003|Treatment Period 2|Withdrawal by Subject|2|||
146748092|NCT02138747|529248048|FG000|Treatment Period 2|Other - Miscellaneous|3|||
146748093|NCT02138747|529248049|FG001|Treatment Period 2|Other - Miscellaneous|0|||
146748094|NCT02138747|529248050|FG002|Treatment Period 2|Other - Miscellaneous|0|||
146748095|NCT02138747|529248051|FG003|Treatment Period 2|Other - Miscellaneous|0|||
146748096|NCT04793464|529248055|FG000|Overall Study|Lost to Follow-up|458|||
146748097|NCT04793464|529248056|FG001|Overall Study|Lost to Follow-up|168|||
146748098|NCT04793464|529248057|FG002|Overall Study|Lost to Follow-up|5|||
146748099|NCT04793464|529248055|FG000|Overall Study|Withdrawal by Subject|43|||
146748100|NCT04793464|529248056|FG001|Overall Study|Withdrawal by Subject|15|||
146748101|NCT04793464|529248057|FG002|Overall Study|Withdrawal by Subject|0|||
146748102|NCT00903786|529248059|FG000|Overall Study|Physician Decision|6|||
146748103|NCT00903786|529248059|FG000|Overall Study|Lack of Efficacy|5|||
146748104|NCT00903786|529248059|FG000|Overall Study|Reason other than lack of efficacy|4|||
146748105|NCT00845871|529248064|FG000|Assessment Period|Adverse Event|2|||
146748106|NCT00845871|529248064|FG000|Assessment Period|Abnormal laboratory values|1|||
146748107|NCT00845871|529248064|FG000|Assessment Period|Abnormal test procedure results|1|||
146748108|NCT00845871|529248064|FG000|Assessment Period|Patient withdrew consent|3|||
146748109|NCT01291225|529248067|FG000|Overall Study|Lost to Follow-up|85|||
146748110|NCT01291225|529248068|FG001|Overall Study|Lost to Follow-up|39|||
146748111|NCT01267253|529248069|FG000|Overall Study|Ineligible - required test not done|1|||
146748112|NCT01267253|529248069|FG000|Overall Study|Inevaluable-never received study treatme|2|||
146748113|NCT00064025|529248070|FG000|Overall Study|Ineligible|4|||
146748114|NCT00064025|529248070|FG000|Overall Study|Inevaluable|3|||
146748115|NCT02468934|529248071|FG000|Overall Study|Withdrawal by Subject|4|||
146748116|NCT02468934|529248071|FG000|Overall Study|Screen Failure|3|||
146748117|NCT01370603|529248072|FG000|Period 1|Adverse Event|5|||
146748118|NCT01370603|529248073|FG001|Period 1|Adverse Event|3|||
146748119|NCT01370603|529248072|FG000|Period 1|Lost to Follow-up|2|||
146748120|NCT01370603|529248073|FG001|Period 1|Lost to Follow-up|0|||
146748121|NCT01370603|529248072|FG000|Period 1|Protocol Violation|2|||
146748122|NCT01370603|529248073|FG001|Period 1|Protocol Violation|2|||
146748123|NCT01370603|529248072|FG000|Period 1|Withdrawal by Subject|5|||
146748124|NCT01370603|529248073|FG001|Period 1|Withdrawal by Subject|5|||
146748125|NCT01370603|529248072|FG000|Crossover Washout|Adverse Event|2|||
146748126|NCT01370603|529248073|FG001|Crossover Washout|Adverse Event|1|||
146748127|NCT01370603|529248072|FG000|Crossover Washout|Lost to Follow-up|2|||
146748128|NCT01370603|529248073|FG001|Crossover Washout|Lost to Follow-up|0|||
146748129|NCT01370603|529248072|FG000|Crossover Washout|Protocol Violation|1|||
146748130|NCT01370603|529248073|FG001|Crossover Washout|Protocol Violation|0|||
146748131|NCT01370603|529248072|FG000|Crossover Washout|Withdrawal by Subject|4|||
146748132|NCT01370603|529248073|FG001|Crossover Washout|Withdrawal by Subject|1|||
146748133|NCT01370603|529248072|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
146748134|NCT01370603|529248073|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
146748135|NCT01370603|529248072|FG000|Period 2|Adverse Event|1|||
146748136|NCT01370603|529248073|FG001|Period 2|Adverse Event|4|||
146748137|NCT01370603|529248072|FG000|Period 2|Lost to Follow-up|1|||
146748138|NCT01370603|529248073|FG001|Period 2|Lost to Follow-up|0|||
146748139|NCT01370603|529248072|FG000|Period 2|Withdrawal by Subject|1|||
146748140|NCT01370603|529248073|FG001|Period 2|Withdrawal by Subject|0|||
146748141|NCT00547911|529248081|FG000|Overall Study|Adverse Event|0|||
146748142|NCT00547911|529248082|FG001|Overall Study|Adverse Event|0|||
146748143|NCT00547911|529248083|FG002|Overall Study|Adverse Event|0|||
146748144|NCT00547911|529248084|FG003|Overall Study|Adverse Event|1|||
146748145|NCT00547911|529248085|FG004|Overall Study|Adverse Event|0|||
146748146|NCT00547911|529248086|FG005|Overall Study|Adverse Event|0|||
146748147|NCT02133924|529248087|FG000|Overall Study|Death|38|||
146748148|NCT02133924|529248087|FG000|Overall Study|Physician Decision|1|||
146748149|NCT02133924|529248087|FG000|Overall Study|Withdrawal by Subject|3|||
146748150|NCT00003458|529248088|FG000|Overall Study|Not evaluable|4|||
146748151|NCT01644474|529248090|FG000|Overall Study|Poor compliance to protocol|1|||
146748152|NCT01644474|529248091|FG001|Overall Study|Poor compliance to protocol|0|||
146748153|NCT01644474|529248090|FG000|Overall Study|Consent withdrawn by participant|0|||
146748154|NCT01644474|529248091|FG001|Overall Study|Consent withdrawn by participant|1|||
146748155|NCT01644474|529248090|FG000|Overall Study|Participant moved|0|||
146748156|NCT01644474|529248091|FG001|Overall Study|Participant moved|1|||
146748157|NCT01644474|529248090|FG000|Overall Study|Adverse Event|4|||
146748158|NCT01644474|529248091|FG001|Overall Study|Adverse Event|5|||
146748159|NCT01644474|529248090|FG000|Overall Study|Site scheduling error|1|||
146748160|NCT01644474|529248091|FG001|Overall Study|Site scheduling error|1|||
146748161|NCT01644474|529248090|FG000|Overall Study|Protocol Violation|1|||
146748162|NCT01644474|529248091|FG001|Overall Study|Protocol Violation|0|||
146748163|NCT01163747|529248097|FG000|Overall Study|Adverse Event|0|||
146748164|NCT01163747|529248098|FG001|Overall Study|Adverse Event|5|||
146748165|NCT01163747|529248097|FG000|Overall Study|Insufficient Therapeutic Response|0|||
146748166|NCT01163747|529248098|FG001|Overall Study|Insufficient Therapeutic Response|1|||
146748167|NCT01163747|529248097|FG000|Overall Study|Protocol Violation|0|||
146748168|NCT01163747|529248098|FG001|Overall Study|Protocol Violation|1|||
146748169|NCT01163747|529248097|FG000|Overall Study|Refused Treatment|6|||
146748170|NCT01163747|529248098|FG001|Overall Study|Refused Treatment|4|||
146748171|NCT01216293|529248102|FG000|Main Study|Adverse Event|1|||
146748172|NCT01216293|529248103|FG001|Main Study|Adverse Event|4|||
146748173|NCT01216293|529248104|FG002|Main Study|Adverse Event|2|||
146748174|NCT01216293|529248102|FG000|Main Study|Major Protocol Deviation|1|||
146748175|NCT01216293|529248103|FG001|Main Study|Major Protocol Deviation|0|||
146748176|NCT01216293|529248104|FG002|Main Study|Major Protocol Deviation|1|||
146748177|NCT01216293|529248102|FG000|Main Study|Lost to Follow-up|3|||
146748178|NCT01216293|529248103|FG001|Main Study|Lost to Follow-up|1|||
146748179|NCT01216293|529248104|FG002|Main Study|Lost to Follow-up|0|||
146748180|NCT01216293|529248102|FG000|Main Study|Voluntary Withdrawal|2|||
146748181|NCT01216293|529248103|FG001|Main Study|Voluntary Withdrawal|2|||
146748182|NCT01216293|529248104|FG002|Main Study|Voluntary Withdrawal|2|||
146748183|NCT01216293|529248102|FG000|Main Study|Other Reason Not Specified|0|||
146748184|NCT01216293|529248103|FG001|Main Study|Other Reason Not Specified|1|||
146748185|NCT01216293|529248104|FG002|Main Study|Other Reason Not Specified|1|||
146748186|NCT01216293|529248102|FG000|Main Study|Randomized, Not Treated|1|||
146748187|NCT01216293|529248103|FG001|Main Study|Randomized, Not Treated|0|||
146748188|NCT01216293|529248104|FG002|Main Study|Randomized, Not Treated|0|||
146748189|NCT01216293|529248102|FG000|Calcium Absorption Substudy|Adverse Event|0|||
146748190|NCT01216293|529248103|FG001|Calcium Absorption Substudy|Adverse Event|2|||
146748191|NCT01216293|529248104|FG002|Calcium Absorption Substudy|Adverse Event|0|||
146748192|NCT01216293|529248102|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
146748193|NCT01216293|529248103|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
146748194|NCT01216293|529248104|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
146748195|NCT01216293|529248102|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
146748196|NCT01216293|529248103|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
146748197|NCT01216293|529248104|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
146748198|NCT04212169|529250073|FG000|Overall Study|Adverse Event|0|||
146748199|NCT04212169|529250074|FG001|Overall Study|Adverse Event|0|||
146748200|NCT04212169|529250075|FG002|Overall Study|Adverse Event|0|||
146748201|NCT04212169|529250076|FG003|Overall Study|Adverse Event|2|||
146748202|NCT04212169|529250073|FG000|Overall Study|Lost to Follow-up|1|||
146748203|NCT04212169|529250074|FG001|Overall Study|Lost to Follow-up|0|||
146748204|NCT04212169|529250075|FG002|Overall Study|Lost to Follow-up|0|||
146748205|NCT04212169|529250076|FG003|Overall Study|Lost to Follow-up|2|||
146748206|NCT04212169|529250073|FG000|Overall Study|Withdrawal by Subject|10|||
146748207|NCT04212169|529250074|FG001|Overall Study|Withdrawal by Subject|2|||
146748208|NCT04212169|529250075|FG002|Overall Study|Withdrawal by Subject|5|||
146748209|NCT04212169|529250076|FG003|Overall Study|Withdrawal by Subject|7|||
146748210|NCT04212169|529250073|FG000|Overall Study|Other reason, unspecified|3|||
146748211|NCT04212169|529250074|FG001|Overall Study|Other reason, unspecified|1|||
146748212|NCT04212169|529250075|FG002|Overall Study|Other reason, unspecified|0|||
146748213|NCT04212169|529250076|FG003|Overall Study|Other reason, unspecified|2|||
146748214|NCT02176928|529250077|FG000|Overall Study|Lost to Follow-up|2|||
146748215|NCT02176928|529250078|FG001|Overall Study|Lost to Follow-up|4|||
146748216|NCT02018861|529250086|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
146748217|NCT02018861|529250087|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
146748218|NCT02018861|529250088|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
146748219|NCT02018861|529250089|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
146748220|NCT02018861|529250090|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
146748221|NCT02018861|529250091|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
146748222|NCT02018861|529250092|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
146748223|NCT02018861|529250093|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
146748224|NCT02018861|529250094|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
146748225|NCT02018861|529250095|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
146748226|NCT02018861|529250086|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
146748227|NCT02018861|529250087|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
146748228|NCT02018861|529250088|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
146748229|NCT02018861|529250089|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
146748230|NCT02018861|529250090|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
146748231|NCT02018861|529250091|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
146748232|NCT02018861|529250092|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
146511317|NCT00195494|528375463|FG000|Year 2|Missed >4 consecutive doses|1|||
146511318|NCT00195494|528375464|FG001|Year 2|Missed >4 consecutive doses|1|||
146511319|NCT00195494|528375465|FG002|Year 2|Missed >4 consecutive doses|1|||
146511320|NCT00195494|528375466|FG003|Year 2|Missed >4 consecutive doses|0|||
146511321|NCT00195494|528375467|FG004|Year 2|Missed >4 consecutive doses|0|||
146511322|NCT00195494|528375468|FG005|Year 2|Missed >4 consecutive doses|0|||
146511323|NCT00195494|528375463|FG000|Year 2|Protocol deviation|0|||
146511324|NCT00195494|528375464|FG001|Year 2|Protocol deviation|1|||
146511325|NCT00195494|528375465|FG002|Year 2|Protocol deviation|0|||
146511326|NCT00195494|528375466|FG003|Year 2|Protocol deviation|0|||
146511327|NCT00195494|528375467|FG004|Year 2|Protocol deviation|0|||
146511328|NCT00195494|528375468|FG005|Year 2|Protocol deviation|0|||
146511329|NCT00195494|528375463|FG000|Year 2|Physician Decision|1|||
146511330|NCT00195494|528375464|FG001|Year 2|Physician Decision|1|||
146511331|NCT00195494|528375465|FG002|Year 2|Physician Decision|0|||
146511332|NCT00195494|528375466|FG003|Year 2|Physician Decision|0|||
146511333|NCT00195494|528375467|FG004|Year 2|Physician Decision|0|||
146511334|NCT00195494|528375468|FG005|Year 2|Physician Decision|0|||
146511335|NCT00195494|528375463|FG000|Year 2|Withdrawal by Subject|1|||
146748233|NCT02018861|529250093|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
146748234|NCT02018861|529250094|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
146748235|NCT02018861|529250095|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
146511336|NCT00195494|528375464|FG001|Year 2|Withdrawal by Subject|5|||
146511337|NCT00195494|528375465|FG002|Year 2|Withdrawal by Subject|4|||
146511338|NCT00195494|528375466|FG003|Year 2|Withdrawal by Subject|3|||
146511339|NCT00195494|528375467|FG004|Year 2|Withdrawal by Subject|0|||
146511340|NCT00195494|528375468|FG005|Year 2|Withdrawal by Subject|0|||
146511341|NCT00195494|528375463|FG000|Year 2|System toxicity|0|||
146511342|NCT00195494|528375464|FG001|Year 2|System toxicity|0|||
146511343|NCT00195494|528375465|FG002|Year 2|System toxicity|0|||
146511344|NCT00195494|528375466|FG003|Year 2|System toxicity|1|||
146511345|NCT00195494|528375467|FG004|Year 2|System toxicity|0|||
146511346|NCT00195494|528375468|FG005|Year 2|System toxicity|0|||
146511347|NCT00513357|528375469|FG000|Overall Study|did not receive allocated placebo|2|||
146511348|NCT00513357|528375470|FG001|Overall Study|did not receive allocated placebo|3|||
146511349|NCT00513357|528375469|FG000|Overall Study|Adverse Event|4|||
146511350|NCT00513357|528375470|FG001|Overall Study|Adverse Event|2|||
146511351|NCT00513357|528375469|FG000|Overall Study|Death|2|||
146511352|NCT00513357|528375470|FG001|Overall Study|Death|0|||
146511353|NCT00513357|528375469|FG000|Overall Study|Withdrawal by Subject|5|||
146511354|NCT00513357|528375470|FG001|Overall Study|Withdrawal by Subject|4|||
146511355|NCT00513357|528375469|FG000|Overall Study|Disease Progression|2|||
146511356|NCT00513357|528375470|FG001|Overall Study|Disease Progression|1|||
146511357|NCT02020512|528375471|FG000|Overall Study|Adverse Event|1|||
146511358|NCT02020512|528375471|FG000|Overall Study|Lost to Follow-up|3|||
146511359|NCT02020512|528375471|FG000|Overall Study|Protocol Violation|4|||
146511360|NCT03301844|528375472|FG000|Overall Study|suspected colon cancer|1|||
146511361|NCT03301844|528375473|FG001|Overall Study|suspected colon cancer|1|||
146511362|NCT00501059|528375474|FG000|Overall Study|Protocol Violation|80|||
146511363|NCT00501059|528375475|FG001|Overall Study|Protocol Violation|69|||
146511364|NCT00501059|528375474|FG000|Overall Study|Death|140|||
146511365|NCT00501059|528375475|FG001|Overall Study|Death|137|||
146511366|NCT00501059|528375474|FG000|Overall Study|Other|236|||
146511367|NCT00501059|528375475|FG001|Overall Study|Other|239|||
146511368|NCT00501059|528375474|FG000|Overall Study|Missing end-of-study page|91|||
146511369|NCT00501059|528375475|FG001|Overall Study|Missing end-of-study page|92|||
146511370|NCT00501059|528375474|FG000|Overall Study|Clinical endpoint reached|110|||
146511371|NCT00501059|528375475|FG001|Overall Study|Clinical endpoint reached|123|||
146511372|NCT00501059|528375474|FG000|Overall Study|Insufficient therapeutic effect|4|||
146511373|NCT00501059|528375475|FG001|Overall Study|Insufficient therapeutic effect|5|||
146511374|NCT00501059|528375474|FG000|Overall Study|Consent withdrawn by subject|817|||
146511375|NCT00501059|528375475|FG001|Overall Study|Consent withdrawn by subject|873|||
146511376|NCT00501059|528375474|FG000|Overall Study|Non-compliant with study treatment|23|||
146511377|NCT00501059|528375475|FG001|Overall Study|Non-compliant with study treatment|16|||
146511378|NCT00501059|528375474|FG000|Overall Study|Reason not given|3|||
146511379|NCT00501059|528375475|FG001|Overall Study|Reason not given|1|||
146511380|NCT00501059|528375474|FG000|Overall Study|Adverse Event|129|||
146511381|NCT00501059|528375475|FG001|Overall Study|Adverse Event|122|||
146511382|NCT00501059|528375474|FG000|Overall Study|Lost to Follow-up|210|||
146511383|NCT00501059|528375475|FG001|Overall Study|Lost to Follow-up|198|||
146511384|NCT00501059|528375474|FG000|Overall Study|Not treated|25|||
146511385|NCT00501059|528375475|FG001|Overall Study|Not treated|17|||
146511386|NCT04249622|528375478|FG000|Overall Study|Withdrawal by Subject|1|||
146511387|NCT04249622|528375479|FG001|Overall Study|Withdrawal by Subject|1|||
146511388|NCT04249622|528375478|FG000|Overall Study|Alternative therapy|1|||
146511389|NCT04249622|528375479|FG001|Overall Study|Alternative therapy|0|||
146511390|NCT04249622|528375478|FG000|Overall Study|Discontinuation of pertuzumab|1|||
146511391|NCT04249622|528375479|FG001|Overall Study|Discontinuation of pertuzumab|0|||
146511392|NCT00637806|528375480|FG000|Double-blind Phase|Study Discontinued|2|||
146511393|NCT00637806|528375481|FG001|Double-blind Phase|Study Discontinued|0|||
146511394|NCT00637806|528375482|FG002|Double-blind Phase|Study Discontinued|1|||
146511395|NCT00637806|528375483|FG003|Double-blind Phase|Study Discontinued|0|||
146511396|NCT00637806|528375480|FG000|Extension Phase|Study Discontinued|0|||
146511397|NCT00637806|528375481|FG001|Extension Phase|Study Discontinued|0|||
146511398|NCT00637806|528375482|FG002|Extension Phase|Study Discontinued|0|||
146511399|NCT00637806|528375483|FG003|Extension Phase|Study Discontinued|1|||
146511400|NCT01592292|528375484|FG000|Overall Study|Follow-up loss|3|||
146511401|NCT01592292|528375485|FG001|Overall Study|Follow-up loss|3|||
146511402|NCT01592292|528375486|FG002|Overall Study|Follow-up loss|1|||
146511403|NCT01592292|528375487|FG003|Overall Study|Follow-up loss|0|||
146511404|NCT01592292|528375484|FG000|Overall Study|Withdrew consent|2|||
146511405|NCT01592292|528375485|FG001|Overall Study|Withdrew consent|1|||
146511406|NCT01592292|528375486|FG002|Overall Study|Withdrew consent|0|||
146511407|NCT01592292|528375487|FG003|Overall Study|Withdrew consent|0|||
146511408|NCT01592292|528375484|FG000|Overall Study|Other|1|||
146511409|NCT01592292|528375485|FG001|Overall Study|Other|1|||
146511410|NCT01592292|528375486|FG002|Overall Study|Other|2|||
146511411|NCT01592292|528375487|FG003|Overall Study|Other|1|||
146511412|NCT00819780|528375491|FG000|Overall Study|Did not receive study drug|3|||
146511413|NCT00819780|528375492|FG001|Overall Study|Did not receive study drug|4|||
146511414|NCT00819780|528375491|FG000|Overall Study|Still in treatment|25|||
146511415|NCT00819780|528375492|FG001|Overall Study|Still in treatment|17|||
146511416|NCT04438499|528375498|FG000|Overall Study|Lack of Efficacy|3|||
146511417|NCT02093390|528375502|FG000|Overall Study|Withdrawal by Subject|0|||
146511418|NCT02093390|528375503|FG001|Overall Study|Withdrawal by Subject|1|||
146511419|NCT01911793|528377136|FG000|Overall Study|Physician Decision|1|||
146511420|NCT01911793|528377137|FG001|Overall Study|Physician Decision|5|||
146511421|NCT03334422|528377138|FG000|Overall Study|Adverse Event|1|||
146511422|NCT03334422|528377139|FG001|Overall Study|Adverse Event|3|||
146511423|NCT03334422|528377140|FG002|Overall Study|Adverse Event|2|||
146511424|NCT03334422|528377141|FG003|Overall Study|Adverse Event|2|||
146511425|NCT03334422|528377138|FG000|Overall Study|Lack of Efficacy|10|||
146511426|NCT03334422|528377139|FG001|Overall Study|Lack of Efficacy|2|||
146511427|NCT03334422|528377140|FG002|Overall Study|Lack of Efficacy|7|||
146511428|NCT03334422|528377141|FG003|Overall Study|Lack of Efficacy|3|||
146511429|NCT03334422|528377138|FG000|Overall Study|Withdrawal by Subject|8|||
146511430|NCT03334422|528377139|FG001|Overall Study|Withdrawal by Subject|3|||
146511431|NCT03334422|528377140|FG002|Overall Study|Withdrawal by Subject|1|||
146511432|NCT03334422|528377141|FG003|Overall Study|Withdrawal by Subject|0|||
146511433|NCT03334422|528377138|FG000|Overall Study|Lost to Follow-up|0|||
146511434|NCT03334422|528377139|FG001|Overall Study|Lost to Follow-up|0|||
146511435|NCT03334422|528377140|FG002|Overall Study|Lost to Follow-up|0|||
146511436|NCT03334422|528377141|FG003|Overall Study|Lost to Follow-up|1|||
146511437|NCT03334422|528377138|FG000|Overall Study|Inability to obtain laboratory samples|0|||
146511438|NCT03334422|528377139|FG001|Overall Study|Inability to obtain laboratory samples|1|||
146511439|NCT03334422|528377140|FG002|Overall Study|Inability to obtain laboratory samples|0|||
146511440|NCT03334422|528377141|FG003|Overall Study|Inability to obtain laboratory samples|0|||
146511441|NCT03334422|528377138|FG000|Overall Study|Pregnancy|0|||
146511442|NCT03334422|528377139|FG001|Overall Study|Pregnancy|1|||
146511443|NCT03334422|528377140|FG002|Overall Study|Pregnancy|0|||
146511444|NCT03334422|528377141|FG003|Overall Study|Pregnancy|0|||
146511445|NCT01313221|528377142|FG000|Overall Study|Protocol Violation|0|||
146511446|NCT01313221|528377143|FG001|Overall Study|Protocol Violation|1|||
146511447|NCT01313221|528377144|FG002|Overall Study|Protocol Violation|1|||
146511448|NCT01313221|528377142|FG000|Overall Study|Non-compliance|3|||
146511449|NCT01313221|528377143|FG001|Overall Study|Non-compliance|0|||
146511450|NCT01313221|528377144|FG002|Overall Study|Non-compliance|2|||
146511451|NCT01313221|528377142|FG000|Overall Study|Withdrawal by Subject|2|||
146511452|NCT01313221|528377143|FG001|Overall Study|Withdrawal by Subject|3|||
146511453|NCT01313221|528377144|FG002|Overall Study|Withdrawal by Subject|5|||
146511454|NCT01313221|528377142|FG000|Overall Study|Requirement for alternative therapy|0|||
146748236|NCT02018861|529250086|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
146748237|NCT02018861|529250087|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
146748238|NCT02018861|529250088|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
146748239|NCT02018861|529250089|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
146748240|NCT02018861|529250090|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
146748241|NCT02018861|529250091|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
146748242|NCT02018861|529250092|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
146748243|NCT02018861|529250093|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
146748244|NCT02018861|529250094|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
146748245|NCT02018861|529250095|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
146748246|NCT02018861|529250086|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
146748247|NCT02018861|529250087|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
146748248|NCT02018861|529250088|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
146748249|NCT02018861|529250089|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
146748250|NCT02018861|529250090|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
146748251|NCT02018861|529250091|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
146748252|NCT02018861|529250092|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
146748253|NCT02018861|529250093|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
146748254|NCT02018861|529250094|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
146748255|NCT02018861|529250095|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
146748256|NCT02018861|529250086|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
146748257|NCT02018861|529250087|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
146748258|NCT02018861|529250088|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
146748259|NCT02018861|529250089|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
146511455|NCT01313221|528377143|FG001|Overall Study|Requirement for alternative therapy|1|||
146511456|NCT01313221|528377144|FG002|Overall Study|Requirement for alternative therapy|1|||
146511457|NCT01313221|528377142|FG000|Overall Study|Lost to Follow-up|6|||
146511458|NCT01313221|528377143|FG001|Overall Study|Lost to Follow-up|3|||
146511459|NCT01313221|528377144|FG002|Overall Study|Lost to Follow-up|1|||
146511460|NCT01313221|528377142|FG000|Overall Study|Other|1|||
146511461|NCT01313221|528377143|FG001|Overall Study|Other|0|||
146511462|NCT01313221|528377144|FG002|Overall Study|Other|0|||
146511463|NCT01313221|528377142|FG000|Overall Study|Adverse Event|0|||
146511464|NCT01313221|528377143|FG001|Overall Study|Adverse Event|0|||
146511465|NCT01313221|528377144|FG002|Overall Study|Adverse Event|7|||
146511466|NCT01313221|528377142|FG000|Overall Study|Disease progression|0|||
146511467|NCT01313221|528377143|FG001|Overall Study|Disease progression|0|||
146511468|NCT01313221|528377144|FG002|Overall Study|Disease progression|2|||
146511469|NCT01313221|528377142|FG000|Overall Study|Physician Decision|0|||
146511470|NCT01313221|528377143|FG001|Overall Study|Physician Decision|0|||
146511471|NCT01313221|528377144|FG002|Overall Study|Physician Decision|2|||
146511472|NCT01313221|528377142|FG000|Overall Study|Pregnancy|0|||
146511473|NCT01313221|528377143|FG001|Overall Study|Pregnancy|0|||
146511474|NCT01313221|528377144|FG002|Overall Study|Pregnancy|2|||
146511475|NCT02864316|528377149|FG000|Overall Study|Progressive Disease|2|||
146511476|NCT02864316|528377150|FG001|Overall Study|Progressive Disease|1|||
146511477|NCT02864316|528377149|FG000|Overall Study|Adverse Event|0|||
146511478|NCT02864316|528377150|FG001|Overall Study|Adverse Event|1|||
146511479|NCT05459558|528377151|FG000|Overall Study|Adverse Event|1|||
146511480|NCT05459558|528377152|FG001|Overall Study|Adverse Event|0|||
146511481|NCT05459558|528377153|FG002|Overall Study|Adverse Event|0|||
146511482|NCT05459558|528377151|FG000|Overall Study|Scheduling issue|0|||
146511483|NCT05459558|528377152|FG001|Overall Study|Scheduling issue|1|||
146511484|NCT05459558|528377153|FG002|Overall Study|Scheduling issue|3|||
146511485|NCT05459558|528377151|FG000|Overall Study|Withdrawal by Subject|0|||
146511486|NCT05459558|528377152|FG001|Overall Study|Withdrawal by Subject|0|||
146511487|NCT05459558|528377153|FG002|Overall Study|Withdrawal by Subject|2|||
146511488|NCT01887288|528377158|FG000|Overall Study|The study was terminated and the PI has|16|||
146511489|NCT01092637|528377159|FG000|Overall Study|Death|47|||
146511490|NCT01092637|528377160|FG001|Overall Study|Death|49|||
146511491|NCT02921750|528377161|FG000|Overall Study|Adverse Event|1|||
146511492|NCT02921750|528377162|FG001|Overall Study|Adverse Event|2|||
146511493|NCT02921750|528377161|FG000|Overall Study|Withdrawal by Subject|1|||
146511494|NCT02921750|528377162|FG001|Overall Study|Withdrawal by Subject|1|||
146511495|NCT02921750|528377161|FG000|Overall Study|Lost to Follow-up|3|||
146511496|NCT02921750|528377162|FG001|Overall Study|Lost to Follow-up|3|||
146511497|NCT02921750|528377161|FG000|Overall Study|Wound healed|3|||
146511498|NCT02921750|528377162|FG001|Overall Study|Wound healed|3|||
146511499|NCT02921750|528377161|FG000|Overall Study|Serious Adverse Event|1|||
146511500|NCT02921750|528377162|FG001|Overall Study|Serious Adverse Event|2|||
146748260|NCT02018861|529250090|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
146748261|NCT02018861|529250091|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
146748262|NCT02018861|529250092|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
146748263|NCT02018861|529250093|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
146748264|NCT02018861|529250094|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
146748265|NCT02018861|529250095|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
146748266|NCT02018861|529250086|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146748267|NCT02018861|529250087|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146748268|NCT02018861|529250088|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146748269|NCT02018861|529250089|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146748270|NCT02018861|529250090|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
146748271|NCT02018861|529250091|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146748272|NCT02018861|529250092|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146748273|NCT02018861|529250093|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146748274|NCT02018861|529250094|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146748275|NCT02018861|529250095|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146748276|NCT02018861|529250086|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
146748277|NCT02018861|529250087|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
146748278|NCT02018861|529250088|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
146748279|NCT02018861|529250089|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
146748280|NCT02018861|529250090|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
146748281|NCT02018861|529250091|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
146511501|NCT03292458|528377167|FG000|Period 1|Adverse Event|2|||
146511502|NCT03292458|528377168|FG001|Period 1|Adverse Event|0|||
146511503|NCT02278367|528377169|FG000|Overall Study|Physician Decision|5|||
146511504|NCT02278367|528377170|FG001|Overall Study|Physician Decision|0|||
146511505|NCT02278367|528377169|FG000|Overall Study|Withdrawal by Subject|5|||
146511506|NCT02278367|528377170|FG001|Overall Study|Withdrawal by Subject|0|||
146511507|NCT02368210|528377172|FG000|Overall Study|Withdrawal by Subject|1|||
146511508|NCT02368210|528377173|FG001|Overall Study|Withdrawal by Subject|0|||
146511509|NCT02368210|528377172|FG000|Overall Study|Adverse Event|0|||
146511510|NCT02368210|528377173|FG001|Overall Study|Adverse Event|1|||
146511511|NCT01492101|528377174|FG000|Overall Study|Death|323|||
146511512|NCT01492101|528377175|FG001|Overall Study|Death|322|||
146511513|NCT01492101|528377174|FG000|Overall Study|Withdrawal by Subject|14|||
146511514|NCT01492101|528377175|FG001|Overall Study|Withdrawal by Subject|18|||
146511515|NCT01492101|528377174|FG000|Overall Study|Lost to Follow-up|0|||
146511516|NCT01492101|528377175|FG001|Overall Study|Lost to Follow-up|2|||
146511517|NCT00316914|528377176|FG000|Overall Study|Withdrawal by Subject|5|||
146511518|NCT00316914|528377177|FG001|Overall Study|Withdrawal by Subject|3|||
146511519|NCT00316914|528377176|FG000|Overall Study|Adverse Event|8|||
146511520|NCT00316914|528377177|FG001|Overall Study|Adverse Event|7|||
146511521|NCT00316914|528377176|FG000|Overall Study|Other Problems|6|||
146511522|NCT00316914|528377177|FG001|Overall Study|Other Problems|11|||
146511523|NCT00316914|528377176|FG000|Overall Study|Missing end of treatment documentation|14|||
146511524|NCT00316914|528377177|FG001|Overall Study|Missing end of treatment documentation|15|||
146511525|NCT01675154|528377178|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
146511526|NCT01675154|528377179|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
146511527|NCT01675154|528377180|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
146511528|NCT01675154|528377181|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
146511529|NCT02971800|528377182|FG000|Overall Study|Protocol Violation|1|||
146511530|NCT02971800|528377182|FG000|Overall Study|Withdrawal by Subject|1|||
146511531|NCT02971800|528377182|FG000|Overall Study|Exclusion criteria prior intervention|1|||
146511532|NCT02971800|528377182|FG000|Overall Study|Number evaluable participant already reached|4|||
146511533|NCT01149421|528377186|FG000|Overall Study|Adverse Event|22|||
146511534|NCT01149421|528377187|FG001|Overall Study|Adverse Event|6|||
146511535|NCT01149421|528377188|FG002|Overall Study|Adverse Event|11|||
146511536|NCT01149421|528377186|FG000|Overall Study|Withdrawal by Subject|20|||
146511537|NCT01149421|528377187|FG001|Overall Study|Withdrawal by Subject|12|||
146511538|NCT01149421|528377188|FG002|Overall Study|Withdrawal by Subject|13|||
146511539|NCT01149421|528377186|FG000|Overall Study|Sponsor Decision|0|||
146511540|NCT01149421|528377187|FG001|Overall Study|Sponsor Decision|1|||
146511541|NCT01149421|528377188|FG002|Overall Study|Sponsor Decision|1|||
146511542|NCT01149421|528377186|FG000|Overall Study|Lost to Follow-up|2|||
146511543|NCT01149421|528377187|FG001|Overall Study|Lost to Follow-up|4|||
146511544|NCT01149421|528377188|FG002|Overall Study|Lost to Follow-up|5|||
146511545|NCT01149421|528377186|FG000|Overall Study|Physician Decision|5|||
146511546|NCT01149421|528377187|FG001|Overall Study|Physician Decision|3|||
146511547|NCT01149421|528377188|FG002|Overall Study|Physician Decision|6|||
146511548|NCT01149421|528377186|FG000|Overall Study|Entry Criteria Not Met|1|||
146511549|NCT01149421|528377187|FG001|Overall Study|Entry Criteria Not Met|1|||
146511550|NCT01149421|528377188|FG002|Overall Study|Entry Criteria Not Met|2|||
146511551|NCT01149421|528377186|FG000|Overall Study|Protocol Violation|2|||
146511552|NCT01149421|528377187|FG001|Overall Study|Protocol Violation|2|||
146511553|NCT01149421|528377188|FG002|Overall Study|Protocol Violation|6|||
146511554|NCT00616603|528377189|FG000|Overall Study|Physician Decision|2|||
146511555|NCT00616603|528377190|FG001|Overall Study|Physician Decision|0|||
146511556|NCT00616603|528377191|FG002|Overall Study|Physician Decision|2|||
146511557|NCT04007107|528377194|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
146511558|NCT04007107|528377195|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
146511559|NCT04007107|528377196|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
146511560|NCT04007107|528377197|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
146511561|NCT04526574|528377198|FG000|Overall Study|Protocol Violation|3|||
146511562|NCT04526574|528377199|FG001|Overall Study|Protocol Violation|1|||
146511563|NCT04526574|528377198|FG000|Overall Study|Withdrawal by Subject|12|||
146511564|NCT04526574|528377199|FG001|Overall Study|Withdrawal by Subject|9|||
146511565|NCT04526574|528377198|FG000|Overall Study|Other|1|||
146511566|NCT04526574|528377199|FG001|Overall Study|Other|2|||
146511567|NCT04526574|528377198|FG000|Overall Study|Adverse Event|1|||
146511568|NCT04526574|528377199|FG001|Overall Study|Adverse Event|1|||
146511569|NCT04526574|528377198|FG000|Overall Study|Death|2|||
146511570|NCT04526574|528377199|FG001|Overall Study|Death|3|||
146511571|NCT04526574|528377198|FG000|Overall Study|Lost to Follow-up|9|||
146511572|NCT04526574|528377199|FG001|Overall Study|Lost to Follow-up|9|||
146511573|NCT04526574|528377198|FG000|Overall Study|No longer meets eligibility criteria|8|||
146511574|NCT04526574|528377199|FG001|Overall Study|No longer meets eligibility criteria|8|||
146511575|NCT04679051|528377205|FG000|Overall Study|felt tired after restricted time in bed|3|||
146511576|NCT04679051|528377206|FG001|Overall Study|felt tired after restricted time in bed|0|||
146511577|NCT04679051|528377205|FG000|Overall Study|discomfort with blood pressure cuff|2|||
146511578|NCT04679051|528377206|FG001|Overall Study|discomfort with blood pressure cuff|0|||
146511579|NCT04679051|528377205|FG000|Overall Study|scheduling conflict|1|||
146511580|NCT04679051|528377206|FG001|Overall Study|scheduling conflict|1|||
146511581|NCT04679051|528377205|FG000|Overall Study|Protocol Violation|0|||
146511582|NCT04679051|528377206|FG001|Overall Study|Protocol Violation|4|||
146511583|NCT00426660|528377207|FG000|Overall Study|Death|14|||
146511584|NCT00426660|528377207|FG000|Overall Study|Adverse Event|23|||
146511585|NCT00426660|528377207|FG000|Overall Study|Insufficient Clinical Response|22|||
146511586|NCT00426660|528377207|FG000|Overall Study|Lost to Follow-up|15|||
146511587|NCT00426660|528377207|FG000|Overall Study|Other|23|||
146511588|NCT00426660|528377207|FG000|Overall Study|Withdrawal by Subject|18|||
146511589|NCT00426660|528377207|FG000|Overall Study|Protocol Violation|1|||
146511590|NCT00426660|528377207|FG000|Overall Study|Enrolled Not Treated|15|||
146511591|NCT00980174|528377208|FG000|Overall Study|Withdrawal by Subject|1|||
146511592|NCT00980174|528377209|FG001|Overall Study|Withdrawal by Subject|4|||
146511593|NCT00980174|528377208|FG000|Overall Study|Adverse Event|0|||
146511594|NCT00980174|528377209|FG001|Overall Study|Adverse Event|3|||
146511595|NCT00980174|528377208|FG000|Overall Study|Ineligibility determined|2|||
146511596|NCT00980174|528377209|FG001|Overall Study|Ineligibility determined|1|||
146511597|NCT00980174|528377208|FG000|Overall Study|Death|1|||
146511598|NCT00980174|528377209|FG001|Overall Study|Death|1|||
146511599|NCT00980174|528377208|FG000|Overall Study|Other|0|||
146511600|NCT00980174|528377209|FG001|Overall Study|Other|1|||
146511601|NCT00329641|528377211|FG000|Overall Study|Did not start treatment|1|||
146511602|NCT00329641|528377211|FG000|Overall Study|Not eligible|1|||
146511603|NCT00329641|528377211|FG000|Overall Study|Adverse Event|3|||
146511604|NCT00329641|528377211|FG000|Overall Study|Other reason, not protocol specified|1|||
146511605|NCT00987402|528377213|FG000|Overall Study|Insufficient data entry|86|||
146511606|NCT00987402|528377214|FG001|Overall Study|Insufficient data entry|98|||
146511607|NCT03000530|528377215|FG000|Overall Study|Adverse Event|0|||
146511608|NCT03000530|528377216|FG001|Overall Study|Adverse Event|0|||
146511609|NCT03000530|528377217|FG002|Overall Study|Adverse Event|2|||
146511610|NCT03000530|528377215|FG000|Overall Study|Lost to Follow-up|0|||
146511611|NCT03000530|528377216|FG001|Overall Study|Lost to Follow-up|3|||
146511612|NCT03000530|528377217|FG002|Overall Study|Lost to Follow-up|1|||
146511613|NCT03000530|528377215|FG000|Overall Study|Withdrawal by Subject|0|||
146511614|NCT03000530|528377216|FG001|Overall Study|Withdrawal by Subject|2|||
146511615|NCT03000530|528377217|FG002|Overall Study|Withdrawal by Subject|1|||
146511616|NCT01430624|528377221|FG000|Overall Study|Lost to Follow-up|23|||
146511617|NCT01430624|528377222|FG001|Overall Study|Lost to Follow-up|29|||
146511618|NCT01430624|528377223|FG002|Overall Study|Lost to Follow-up|27|||
146511619|NCT01430624|528377221|FG000|Overall Study|technical or eligibility|5|||
146511620|NCT01430624|528377222|FG001|Overall Study|technical or eligibility|5|||
146511621|NCT01430624|528377223|FG002|Overall Study|technical or eligibility|2|||
146511622|NCT01362517|528377224|FG000|Overall Study|Protocol Violation|1|||
146511623|NCT01362517|528377224|FG000|Overall Study|Lost to Follow-up|1|||
146511624|NCT01273155|528377225|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
146511625|NCT01273155|528377226|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
146511626|NCT01273155|528377227|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
146511627|NCT01273155|528377228|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
146511628|NCT01273155|528377229|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
146511629|NCT01273155|528377230|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
146511630|NCT01273155|528377231|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
146511631|NCT01273155|528377225|FG000|Overall Study|Change in liver function/no longer eval.|0|||
146511632|NCT01273155|528377226|FG001|Overall Study|Change in liver function/no longer eval.|1|||
146511633|NCT01273155|528377227|FG002|Overall Study|Change in liver function/no longer eval.|0|||
146511634|NCT01273155|528377228|FG003|Overall Study|Change in liver function/no longer eval.|0|||
146511635|NCT01273155|528377229|FG004|Overall Study|Change in liver function/no longer eval.|1|||
146511636|NCT01273155|528377230|FG005|Overall Study|Change in liver function/no longer eval.|0|||
146511637|NCT01273155|528377231|FG006|Overall Study|Change in liver function/no longer eval.|0|||
146511638|NCT01273155|528377225|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
146511639|NCT01273155|528377226|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
146511640|NCT01273155|528377227|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
146511641|NCT01273155|528377228|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
146511642|NCT01273155|528377229|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
146748282|NCT02018861|529250092|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
146748283|NCT02018861|529250093|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
146748284|NCT02018861|529250094|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
146511643|NCT01273155|528377230|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
146511644|NCT01273155|528377231|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
146511645|NCT01273155|528377225|FG000|Overall Study|Died during Cycle 1|0|||
146511646|NCT01273155|528377226|FG001|Overall Study|Died during Cycle 1|0|||
146511647|NCT01273155|528377227|FG002|Overall Study|Died during Cycle 1|1|||
146511648|NCT01273155|528377228|FG003|Overall Study|Died during Cycle 1|1|||
146511649|NCT01273155|528377229|FG004|Overall Study|Died during Cycle 1|0|||
146511650|NCT01273155|528377230|FG005|Overall Study|Died during Cycle 1|2|||
146511651|NCT01273155|528377231|FG006|Overall Study|Died during Cycle 1|2|||
146511652|NCT01273155|528377225|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
146511653|NCT01273155|528377226|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
146511654|NCT01273155|528377227|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
146511655|NCT01273155|528377228|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
146511656|NCT01273155|528377229|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
146511657|NCT01273155|528377230|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
146511658|NCT01273155|528377231|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
146511659|NCT01256385|528377232|FG000|Overall Study|Physician Decision|1|||
146511660|NCT01256385|528377233|FG001|Overall Study|Physician Decision|1|||
146511661|NCT01256385|528377232|FG000|Overall Study|Withdrawal by Subject|2|||
146511662|NCT01256385|528377233|FG001|Overall Study|Withdrawal by Subject|2|||
146511663|NCT00401960|528377234|FG000|Overall Study|Lost to Follow-up|3|||
146511664|NCT00401960|528377235|FG001|Overall Study|Lost to Follow-up|0|||
146511665|NCT00401960|528377234|FG000|Overall Study|Death|2|||
146511666|NCT00401960|528377235|FG001|Overall Study|Death|0|||
146511667|NCT02918552|528377240|FG000|Overall Study|Failed Pharmacokinetics|1|||
146511668|NCT02918552|528377241|FG001|Overall Study|Failed Pharmacokinetics|0|||
146511669|NCT02918552|528377240|FG000|Overall Study|Withdrawal by Subject|0|||
146511670|NCT02918552|528377241|FG001|Overall Study|Withdrawal by Subject|1|||
146511671|NCT02918552|528377240|FG000|Overall Study|Lost to Follow-up|0|||
146511672|NCT02918552|528377241|FG001|Overall Study|Lost to Follow-up|1|||
146511673|NCT04395274|528377242|FG000|Overall Study|Lost to Follow-up|20|||
146511674|NCT04395274|528377243|FG001|Overall Study|Lost to Follow-up|11|||
146511675|NCT04395274|528377242|FG000|Overall Study|Withdrawal by Subject|13|||
146511676|NCT04395274|528377243|FG001|Overall Study|Withdrawal by Subject|10|||
146511677|NCT04395274|528377242|FG000|Overall Study|Moved Abroad|0|||
146511678|NCT04395274|528377243|FG001|Overall Study|Moved Abroad|1|||
146511679|NCT02680834|528377245|FG000|Overall Study|Physician Decision|5|||
146511680|NCT02680834|528377246|FG001|Overall Study|Physician Decision|2|||
146511681|NCT02680834|528377245|FG000|Overall Study|Withdrawal by Subject|6|||
146511682|NCT02680834|528377246|FG001|Overall Study|Withdrawal by Subject|0|||
146511683|NCT02680834|528377245|FG000|Overall Study|Lost to Follow-up|0|||
146511684|NCT02680834|528377246|FG001|Overall Study|Lost to Follow-up|1|||
146511685|NCT01362244|528377247|FG000|Overall Study|Adverse Event|3|||
146511686|NCT01362244|528377248|FG001|Overall Study|Adverse Event|5|||
146511687|NCT01362244|528377247|FG000|Overall Study|Lack of Efficacy|5|||
146511688|NCT01362244|528377248|FG001|Overall Study|Lack of Efficacy|11|||
146511689|NCT01362244|528377247|FG000|Overall Study|Lost to Follow-up|0|||
146511690|NCT01362244|528377248|FG001|Overall Study|Lost to Follow-up|2|||
146511691|NCT01362244|528377247|FG000|Overall Study|Protocol Violation|5|||
146511692|NCT01362244|528377248|FG001|Overall Study|Protocol Violation|1|||
146511693|NCT01362244|528377247|FG000|Overall Study|Withdrawal by Subject|2|||
146511694|NCT01362244|528377248|FG001|Overall Study|Withdrawal by Subject|1|||
146511695|NCT01362244|528377247|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
146511696|NCT01362244|528377248|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
146511697|NCT01362244|528377247|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
146511698|NCT01362244|528377248|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
146511699|NCT02407054|528377251|FG000|Overall Study|Adverse Event|1|||
146511700|NCT02407054|528377252|FG001|Overall Study|Adverse Event|4|||
146511701|NCT02407054|528377253|FG002|Overall Study|Adverse Event|1|||
146511702|NCT02407054|528377251|FG000|Overall Study|Non-compliance with Study|0|||
146511703|NCT02407054|528377252|FG001|Overall Study|Non-compliance with Study|2|||
146511704|NCT02407054|528377253|FG002|Overall Study|Non-compliance with Study|1|||
146748285|NCT02018861|529250095|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
146748286|NCT02018861|529250086|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
146748287|NCT02018861|529250087|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
146748288|NCT02018861|529250088|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
146748289|NCT02018861|529250089|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
146748290|NCT02018861|529250090|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
146748291|NCT02018861|529250091|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
146748292|NCT02018861|529250092|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
146748293|NCT02018861|529250093|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
146748294|NCT02018861|529250094|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
146748295|NCT02018861|529250095|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
146748296|NCT02018861|529250086|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
146511705|NCT02407054|528377251|FG000|Overall Study|Physician Decision|1|||
146511706|NCT02407054|528377252|FG001|Overall Study|Physician Decision|3|||
146511707|NCT02407054|528377253|FG002|Overall Study|Physician Decision|3|||
146511708|NCT02407054|528377251|FG000|Overall Study|Withdrawal by Subject|5|||
146511709|NCT02407054|528377252|FG001|Overall Study|Withdrawal by Subject|9|||
146511710|NCT02407054|528377253|FG002|Overall Study|Withdrawal by Subject|2|||
146511711|NCT00415597|528377254|FG000|Enrollment|Withdrawal by Subject|1|||
146511712|NCT00415597|528377254|FG000|Enrollment|Protocol Violation|1|||
146511713|NCT00415597|528377254|FG000|Treatment|Adverse Event|110|||
146511714|NCT00415597|528377254|FG000|Treatment|Lack of Efficacy|39|||
146511715|NCT00415597|528377254|FG000|Treatment|Protocol Violation|67|||
146511716|NCT00415597|528377254|FG000|Treatment|Physician Decision|3|||
146511717|NCT00415597|528377254|FG000|Treatment|Withdrawal by Subject|51|||
146511718|NCT00415597|528377254|FG000|Treatment|Lost to Follow-up|28|||
146511719|NCT00415597|528377254|FG000|Treatment|Drug Screen|2|||
146511720|NCT00415597|528377254|FG000|Treatment|Administrative|3|||
146511721|NCT00415597|528377254|FG000|Treatment|Sponsor Decision|1|||
146511722|NCT00415597|528377254|FG000|Treatment|Multiple Reasons|1|||
146748297|NCT02018861|529250087|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
146748298|NCT02018861|529250088|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
146748299|NCT02018861|529250089|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
146748300|NCT02018861|529250090|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
146748301|NCT02018861|529250091|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
146748302|NCT02018861|529250092|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
146748303|NCT02018861|529250093|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
146748304|NCT02018861|529250094|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
146748305|NCT02018861|529250095|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
146748306|NCT02018861|529250086|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
146748307|NCT02018861|529250087|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
146748308|NCT02018861|529250088|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
146748309|NCT02018861|529250089|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
146748310|NCT02018861|529250090|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
146748311|NCT02018861|529250091|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
146748312|NCT02018861|529250092|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
146748313|NCT02018861|529250093|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
146748314|NCT02018861|529250094|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
146748315|NCT02018861|529250095|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
146748316|NCT02018861|529250086|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146748317|NCT02018861|529250087|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146748318|NCT02018861|529250088|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146748319|NCT02018861|529250089|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146748320|NCT02018861|529250090|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146748321|NCT02018861|529250091|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146748322|NCT02018861|529250092|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146748323|NCT02018861|529250093|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146748324|NCT02018861|529250094|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
146748325|NCT02018861|529250095|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146748326|NCT02018861|529250086|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146748327|NCT02018861|529250087|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146748328|NCT02018861|529250088|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146748329|NCT02018861|529250089|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146748330|NCT02018861|529250090|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146748331|NCT02018861|529250091|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146748332|NCT02018861|529250092|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146748333|NCT02018861|529250093|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146748334|NCT02018861|529250094|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
146748335|NCT02018861|529250095|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146748336|NCT02018861|529250086|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146748337|NCT02018861|529250087|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146748338|NCT02018861|529250088|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146748339|NCT02018861|529250089|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146748340|NCT02018861|529250090|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146748341|NCT02018861|529250091|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146748342|NCT02018861|529250092|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146748343|NCT02018861|529250093|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146748344|NCT02018861|529250094|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
146748345|NCT02018861|529250095|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146748346|NCT00504348|529250099|FG000|Overall Study|Adverse Event|3|||
146748347|NCT00504348|529250099|FG000|Overall Study|Lack of Efficacy|4|||
146748348|NCT00504348|529250099|FG000|Overall Study|Physician Decision|1|||
146748349|NCT00224133|529250100|FG000|Overall Study|Adverse Event|93|||
146748350|NCT00224133|529250100|FG000|Overall Study|Protocol Violation|6|||
146748351|NCT00224133|529250100|FG000|Overall Study|Withdrawal by Subject|33|||
146748352|NCT00224133|529250100|FG000|Overall Study|Lack of Efficacy|58|||
146748353|NCT00224133|529250100|FG000|Overall Study|Lost to Follow-up|21|||
146748354|NCT00224133|529250100|FG000|Overall Study|Physician Decision|1|||
146748355|NCT00224133|529250100|FG000|Overall Study|Other|14|||
146748356|NCT03699124|529250102|FG000|Overall Study|Adverse Event|6|||
146851212|NCT00092495|529624145|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
146851213|NCT00092495|529624146|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
146748357|NCT03699124|529250103|FG001|Overall Study|Adverse Event|5|||
146748358|NCT03699124|529250104|FG002|Overall Study|Adverse Event|2|||
146748359|NCT03699124|529250102|FG000|Overall Study|Death|0|||
146748360|NCT03699124|529250103|FG001|Overall Study|Death|2|||
146748361|NCT03699124|529250104|FG002|Overall Study|Death|0|||
146851214|NCT00092495|529624147|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
146748362|NCT03699124|529250102|FG000|Overall Study|Lost to Follow-up|20|||
146748363|NCT03699124|529250103|FG001|Overall Study|Lost to Follow-up|16|||
146748364|NCT03699124|529250104|FG002|Overall Study|Lost to Follow-up|15|||
146748365|NCT03699124|529250102|FG000|Overall Study|Protocol Violation|1|||
146748366|NCT03699124|529250103|FG001|Overall Study|Protocol Violation|0|||
146748367|NCT03699124|529250104|FG002|Overall Study|Protocol Violation|0|||
146748368|NCT03699124|529250102|FG000|Overall Study|Withdrawal by Subject|13|||
146748369|NCT03699124|529250103|FG001|Overall Study|Withdrawal by Subject|14|||
146748370|NCT03699124|529250104|FG002|Overall Study|Withdrawal by Subject|13|||
146748371|NCT03699124|529250102|FG000|Overall Study|Other reasons|5|||
146748372|NCT03699124|529250103|FG001|Overall Study|Other reasons|3|||
146748373|NCT03699124|529250104|FG002|Overall Study|Other reasons|10|||
146748374|NCT00795132|529250109|FG000|Overall Study|Death|1|||
146748375|NCT00795132|529250109|FG000|Overall Study|Relapse|2|||
146748376|NCT02561455|529250110|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
146748377|NCT02561455|529250111|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
146748378|NCT02561455|529250112|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
146748379|NCT02561455|529250113|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
146748380|NCT02561455|529250110|FG000|Overall Study|Withdrawal by Subject|1|||
146748381|NCT02561455|529250111|FG001|Overall Study|Withdrawal by Subject|0|||
146748382|NCT02561455|529250112|FG002|Overall Study|Withdrawal by Subject|1|||
146748383|NCT02561455|529250113|FG003|Overall Study|Withdrawal by Subject|0|||
146748384|NCT02561455|529250110|FG000|Overall Study|Disease Progression|0|||
146748385|NCT02561455|529250111|FG001|Overall Study|Disease Progression|1|||
146748386|NCT02561455|529250112|FG002|Overall Study|Disease Progression|0|||
146748387|NCT02561455|529250113|FG003|Overall Study|Disease Progression|0|||
146748388|NCT00262743|529250114|FG000|Overall Study|Adverse Event|0|||
146748389|NCT00262743|529250115|FG001|Overall Study|Adverse Event|9|||
146748390|NCT00262743|529250114|FG000|Overall Study|Disease progression|0|||
146748391|NCT00262743|529250115|FG001|Overall Study|Disease progression|3|||
146748392|NCT01950273|529250123|FG000|Overall Study|Protocol Violation|1|||
146748393|NCT01950273|529250124|FG001|Overall Study|Protocol Violation|0|||
146748394|NCT01950273|529250123|FG000|Overall Study|Withdrawal by Subject|2|||
146748395|NCT01950273|529250124|FG001|Overall Study|Withdrawal by Subject|0|||
146748396|NCT01950273|529250123|FG000|Overall Study|Other not defined above|1|||
146748397|NCT01950273|529250124|FG001|Overall Study|Other not defined above|0|||
146748398|NCT00472186|529250125|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
146748399|NCT00472186|529250126|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
146748400|NCT02264574|529250131|FG000|Overall Study|Death|21|||
146748401|NCT02264574|529250132|FG001|Overall Study|Death|21|||
146748402|NCT02264574|529250131|FG000|Overall Study|Withdrawal by Subject|8|||
146748403|NCT02264574|529250132|FG001|Overall Study|Withdrawal by Subject|6|||
146748404|NCT02264574|529250131|FG000|Overall Study|Other, Not Specified|0|||
146748405|NCT02264574|529250132|FG001|Overall Study|Other, Not Specified|3|||
146748406|NCT04254679|529250135|FG000|Overall Study|Protocol Violation|1|||
146748407|NCT04254679|529250136|FG001|Overall Study|Protocol Violation|1|||
146748408|NCT04254679|529250135|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
146748409|NCT04254679|529250136|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
146748410|NCT02086552|529250137|FG000|Overall Study|Withdrawal by Subject|1|||
146748411|NCT00478608|529250142|FG000|Overall Study|Adverse Event|1|||
146748412|NCT00478608|529250142|FG000|Overall Study|Serious Adverse Event|14|||
146748413|NCT00478608|529250142|FG000|Overall Study|Withdrawal by Subject|2|||
146748414|NCT00478608|529250142|FG000|Overall Study|Protocol Violation|3|||
146748415|NCT01458249|529250143|FG000|Overall Study|Not treated|1|||
146748416|NCT01458249|529250143|FG000|Overall Study|Adverse Event|4|||
146748417|NCT01458249|529250143|FG000|Overall Study|Other|2|||
146748418|NCT01458249|529250143|FG000|Overall Study|Ongoing|1|||
146748419|NCT02056119|529250144|FG000|Overall Study|Death|1|||
146748420|NCT02056119|529250145|FG001|Overall Study|Death|2|||
146748421|NCT02056119|529250144|FG000|Overall Study|Intubated for less than 24 hrs|2|||
146748422|NCT02056119|529250145|FG001|Overall Study|Intubated for less than 24 hrs|7|||
146748423|NCT02056119|529250144|FG000|Overall Study|No aerosol treatments were given.|3|||
146748424|NCT02056119|529250145|FG001|Overall Study|No aerosol treatments were given.|2|||
146748425|NCT02056119|529250144|FG000|Overall Study|Received Metaneb treatment|0|||
146748426|NCT02056119|529250145|FG001|Overall Study|Received Metaneb treatment|2|||
146748427|NCT02056119|529250144|FG000|Overall Study|Protocol Violation|4|||
146851215|NCT00092495|529624148|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
146748428|NCT02056119|529250145|FG001|Overall Study|Protocol Violation|7|||
146748429|NCT01316692|529250146|FG000|Overall Study|Adverse Event|5|||
146748430|NCT01316692|529250146|FG000|Overall Study|Disease Progression|7|||
146748431|NCT03220737|529250147|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
146748432|NCT03220737|529250148|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
146748433|NCT03220737|529250149|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
146748434|NCT03220737|529250150|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
146748435|NCT03220737|529250151|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
146851216|NCT00092495|529624149|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
146851217|NCT00092495|529624145|FG000|Base Study Vaccination Period|Extended|0|||
146851218|NCT00092495|529624146|FG001|Base Study Vaccination Period|Extended|0|||
146851219|NCT00092495|529624147|FG002|Base Study Vaccination Period|Extended|0|||
146851220|NCT00092495|529624148|FG003|Base Study Vaccination Period|Extended|1|||
146851221|NCT00092495|529624149|FG004|Base Study Vaccination Period|Extended|0|||
146748436|NCT03220737|529250152|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
146748437|NCT03220737|529250153|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
146748438|NCT03220737|529250147|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
146748439|NCT03220737|529250148|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
146748440|NCT03220737|529250149|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
146748441|NCT03220737|529250150|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
146748442|NCT03220737|529250151|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
146748443|NCT03220737|529250152|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
146748444|NCT03220737|529250153|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
146748445|NCT03220737|529250147|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
146748446|NCT03220737|529250148|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
146748447|NCT03220737|529250149|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
146748448|NCT03220737|529250150|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
146748449|NCT03220737|529250151|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
146748450|NCT03220737|529250152|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
146748451|NCT03220737|529250153|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
146748452|NCT03220737|529250147|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
146748453|NCT03220737|529250148|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
146748454|NCT03220737|529250149|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
146748455|NCT03220737|529250150|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
146748456|NCT03220737|529250151|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
146748457|NCT03220737|529250152|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
146748458|NCT03220737|529250153|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
146748459|NCT03220737|529250147|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
146748460|NCT03220737|529250148|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
146748461|NCT03220737|529250149|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
146748462|NCT03220737|529250150|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
146748463|NCT03220737|529250151|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
146748464|NCT03220737|529250152|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
146748465|NCT03220737|529250153|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
146748466|NCT03220737|529250147|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
146748467|NCT03220737|529250148|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
146748468|NCT03220737|529250149|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
146748469|NCT03220737|529250150|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
146748470|NCT03220737|529250151|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
146748471|NCT03220737|529250152|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
146748472|NCT03220737|529250153|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
146748473|NCT03220737|529250147|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
146748474|NCT03220737|529250148|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
146748475|NCT03220737|529250149|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
146748476|NCT03220737|529250150|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
146748477|NCT03220737|529250151|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
146748478|NCT03220737|529250152|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
146748479|NCT03220737|529250153|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
146748480|NCT03220737|529250147|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
146748481|NCT03220737|529250148|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
146748482|NCT03220737|529250149|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
146748483|NCT03220737|529250150|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
146748484|NCT03220737|529250151|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
146748485|NCT03220737|529250152|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
146748486|NCT03220737|529250153|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
146748487|NCT01720797|529250154|FG000|Overall Study|Withdrawal by Subject|3|||
146748488|NCT01720797|529250155|FG001|Overall Study|Withdrawal by Subject|0|||
146851222|NCT00092495|529624145|FG000|Base Study Vaccination Period|*Clinical AE|1|||
146851223|NCT00092495|529624146|FG001|Base Study Vaccination Period|*Clinical AE|0|||
146851224|NCT00092495|529624147|FG002|Base Study Vaccination Period|*Clinical AE|1|||
146748489|NCT04827134|529250164|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
146748490|NCT04827134|529250165|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
146851225|NCT00092495|529624148|FG003|Base Study Vaccination Period|*Clinical AE|2|||
146851226|NCT00092495|529624149|FG004|Base Study Vaccination Period|*Clinical AE|0|||
146851227|NCT00092495|529624145|FG000|Base Study Vaccination Period|*Other reasons|1|||
146851228|NCT00092495|529624146|FG001|Base Study Vaccination Period|*Other reasons|0|||
146511723|NCT04102865|528377256|FG000|Overall Study|Adverse Event|4|||
146511724|NCT04102865|528377257|FG001|Overall Study|Adverse Event|0|||
146748491|NCT04827134|529250166|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
146748492|NCT04827134|529250167|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
146748493|NCT00065468|529250168|FG000|Overall Study|Death|172|||
146748494|NCT00065468|529250169|FG001|Overall Study|Death|169|||
146748495|NCT00065468|529250170|FG002|Overall Study|Death|171|||
146748496|NCT00065468|529250168|FG000|Overall Study|Withdrawal by Subject|3|||
146748497|NCT00065468|529250169|FG001|Overall Study|Withdrawal by Subject|4|||
146748498|NCT00065468|529250170|FG002|Overall Study|Withdrawal by Subject|5|||
146748499|NCT00065468|529250168|FG000|Overall Study|Lost to Follow-up|5|||
146748500|NCT00065468|529250169|FG001|Overall Study|Lost to Follow-up|3|||
146748501|NCT00065468|529250170|FG002|Overall Study|Lost to Follow-up|2|||
146748502|NCT00065468|529250168|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
146748503|NCT00065468|529250169|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
146748504|NCT00065468|529250170|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
146748505|NCT00065468|529250168|FG000|Overall Study|Disease progression|0|||
146748506|NCT00065468|529250169|FG001|Overall Study|Disease progression|0|||
146748507|NCT00065468|529250170|FG002|Overall Study|Disease progression|1|||
146748508|NCT00065468|529250168|FG000|Overall Study|Other|14|||
146748509|NCT00065468|529250169|FG001|Overall Study|Other|24|||
146748510|NCT00065468|529250170|FG002|Overall Study|Other|18|||
146748511|NCT02019602|529250172|FG000|Screening Period|Ineligibility|4|||
146748512|NCT02019602|529250173|FG001|Screening Period|Ineligibility|0|||
146748513|NCT02019602|529250172|FG000|Screening Period|Adverse Event|1|||
146748514|NCT02019602|529250173|FG001|Screening Period|Adverse Event|0|||
146748515|NCT00683449|529250174|FG000|Overall Study|Lost to Follow-up|0|||
146748516|NCT00683449|529250175|FG001|Overall Study|Lost to Follow-up|1|||
146748517|NCT00683449|529250176|FG002|Overall Study|Lost to Follow-up|0|||
146748518|NCT00683449|529250177|FG003|Overall Study|Lost to Follow-up|0|||
146748519|NCT00683449|529250178|FG004|Overall Study|Lost to Follow-up|0|||
146748520|NCT01448044|529250179|FG000|Treatment Period|Adverse Event|4|||
146748521|NCT01448044|529250180|FG001|Treatment Period|Adverse Event|3|||
146748522|NCT01448044|529250179|FG000|Treatment Period|Lack of Efficacy|5|||
146748523|NCT01448044|529250180|FG001|Treatment Period|Lack of Efficacy|12|||
146748524|NCT01448044|529250179|FG000|Treatment Period|Subject requested discontinue study drug|1|||
146511725|NCT04102865|528377256|FG000|Overall Study|Lost to Follow-up|1|||
146511726|NCT04102865|528377257|FG001|Overall Study|Lost to Follow-up|0|||
146511727|NCT04102865|528377256|FG000|Overall Study|Withdrawal by Subject|2|||
146748525|NCT01448044|529250180|FG001|Treatment Period|Subject requested discontinue study drug|0|||
146748526|NCT01448044|529250179|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
146511728|NCT04102865|528377257|FG001|Overall Study|Withdrawal by Subject|0|||
146748527|NCT01448044|529250180|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
146748528|NCT01448044|529250179|FG000|Treatment Period|Participant does not meet study criteria|1|||
146748529|NCT01448044|529250180|FG001|Treatment Period|Participant does not meet study criteria|0|||
146748530|NCT01448044|529250179|FG000|Treatment Period|Lost to Follow-up|2|||
146748531|NCT01448044|529250180|FG001|Treatment Period|Lost to Follow-up|1|||
146748532|NCT01448044|529250179|FG000|Treatment Period|Other reason|2|||
146748533|NCT01448044|529250180|FG001|Treatment Period|Other reason|0|||
146748534|NCT01448044|529250179|FG000|Follow Up Period|Withdrawal by Subject|1|||
146748535|NCT01448044|529250180|FG001|Follow Up Period|Withdrawal by Subject|1|||
146748536|NCT01448044|529250179|FG000|Follow Up Period|Lost to Follow-up|6|||
146748537|NCT01448044|529250180|FG001|Follow Up Period|Lost to Follow-up|2|||
146748538|NCT01448044|529250179|FG000|Follow Up Period|Other|5|||
146748539|NCT01448044|529250180|FG001|Follow Up Period|Other|11|||
146748540|NCT00681187|529250181|FG000|Overall Study|Withdrawal by Subject|1|||
146748541|NCT00681187|529250182|FG001|Overall Study|Withdrawal by Subject|0|||
146748542|NCT00681187|529250181|FG000|Overall Study|Death|0|||
146748543|NCT00681187|529250182|FG001|Overall Study|Death|1|||
146851229|NCT00092495|529624147|FG002|Base Study Vaccination Period|*Other reasons|0|||
146851230|NCT00092495|529624148|FG003|Base Study Vaccination Period|*Other reasons|1|||
146748544|NCT00681187|529250181|FG000|Overall Study|Adverse Event|0|||
146748545|NCT00681187|529250182|FG001|Overall Study|Adverse Event|1|||
146748546|NCT04230980|529250183|FG000|Overall Study|Lost to Follow-up|1|||
146748547|NCT04230980|529250184|FG001|Overall Study|Lost to Follow-up|2|||
146748548|NCT04230980|529250183|FG000|Overall Study|Adverse Event|0|||
146748549|NCT04230980|529250184|FG001|Overall Study|Adverse Event|1|||
146748550|NCT02269943|529250187|FG000|Treatment Period|Death|0|||
146748551|NCT02269943|529250188|FG001|Treatment Period|Death|1|||
146748552|NCT02269943|529250187|FG000|Treatment Period|Adverse Event|1|||
146748553|NCT02269943|529250188|FG001|Treatment Period|Adverse Event|10|||
146748554|NCT02269943|529250187|FG000|Treatment Period|Progressive Disease|5|||
146748555|NCT02269943|529250188|FG001|Treatment Period|Progressive Disease|17|||
146511729|NCT01764997|528377258|FG000|Run-in Period|Adverse Event|15|||
146511730|NCT01764997|528377259|FG001|Run-in Period|Adverse Event|0|||
146511731|NCT01764997|528377260|FG002|Run-in Period|Adverse Event|0|||
146748556|NCT02269943|529250187|FG000|Treatment Period|Symptomatic Deterioration|0|||
146748557|NCT02269943|529250188|FG001|Treatment Period|Symptomatic Deterioration|2|||
146748558|NCT02269943|529250187|FG000|Follow-Up Survival Period|Death|3|||
146748559|NCT02269943|529250188|FG001|Follow-Up Survival Period|Death|16|||
146748560|NCT02269943|529250187|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
146748561|NCT02269943|529250188|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
146748562|NCT02269943|529250187|FG000|Follow-Up Survival Period|Alive|2|||
146748563|NCT02269943|529250188|FG001|Follow-Up Survival Period|Alive|8|||
146748564|NCT03541642|529250189|FG000|Overall Study|Withdrawal by Subject|1|||
146748565|NCT03541642|529250190|FG001|Overall Study|Withdrawal by Subject|2|||
146748566|NCT03541642|529250189|FG000|Overall Study|Lost to Follow-up|16|||
146748567|NCT03541642|529250190|FG001|Overall Study|Lost to Follow-up|12|||
146748568|NCT03541642|529250189|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
146748569|NCT03541642|529250190|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
146748570|NCT03523871|529250191|FG000|Overall Study|Death|1|||
146748571|NCT00972179|529250193|FG000|Overall Study|Noncompliance|1|||
146748572|NCT00972179|529250194|FG001|Overall Study|Noncompliance|0|||
146748573|NCT00972179|529250195|FG002|Overall Study|Noncompliance|0|||
146748574|NCT00972179|529250196|FG003|Overall Study|Noncompliance|0|||
146748575|NCT00972179|529250197|FG004|Overall Study|Noncompliance|1|||
146748576|NCT00972179|529250198|FG005|Overall Study|Noncompliance|0|||
146748577|NCT00972179|529250199|FG006|Overall Study|Noncompliance|1|||
146748578|NCT00972179|529250193|FG000|Overall Study|Withdrawal by Subject|0|||
146748579|NCT00972179|529250194|FG001|Overall Study|Withdrawal by Subject|3|||
146748580|NCT00972179|529250195|FG002|Overall Study|Withdrawal by Subject|0|||
146748581|NCT00972179|529250196|FG003|Overall Study|Withdrawal by Subject|1|||
146748582|NCT00972179|529250197|FG004|Overall Study|Withdrawal by Subject|0|||
146851231|NCT00092495|529624149|FG004|Base Study Vaccination Period|*Other reasons|0|||
146748583|NCT00972179|529250198|FG005|Overall Study|Withdrawal by Subject|0|||
146851232|NCT00092495|529624145|FG000|Base Study Vaccination Period|*Pregnancy|0|||
146851233|NCT00092495|529624146|FG001|Base Study Vaccination Period|*Pregnancy|2|||
146851234|NCT00092495|529624147|FG002|Base Study Vaccination Period|*Pregnancy|5|||
146851235|NCT00092495|529624148|FG003|Base Study Vaccination Period|*Pregnancy|7|||
146851236|NCT00092495|529624149|FG004|Base Study Vaccination Period|*Pregnancy|0|||
146851237|NCT00092495|529624145|FG000|Base Study Vaccination Period|Adverse Event|1|||
146851238|NCT00092495|529624146|FG001|Base Study Vaccination Period|Adverse Event|0|||
146851239|NCT00092495|529624147|FG002|Base Study Vaccination Period|Adverse Event|0|||
146851240|NCT00092495|529624148|FG003|Base Study Vaccination Period|Adverse Event|3|||
146851241|NCT00092495|529624149|FG004|Base Study Vaccination Period|Adverse Event|0|||
146851242|NCT00092495|529624145|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
146851243|NCT00092495|529624146|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
146851244|NCT00092495|529624147|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
146851245|NCT00092495|529624148|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
146851246|NCT00092495|529624149|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
146851247|NCT00092495|529624145|FG000|Base Study Vaccination Period|Moved|3|||
146851248|NCT00092495|529624146|FG001|Base Study Vaccination Period|Moved|1|||
146851249|NCT00092495|529624147|FG002|Base Study Vaccination Period|Moved|2|||
146851250|NCT00092495|529624148|FG003|Base Study Vaccination Period|Moved|2|||
146851251|NCT00092495|529624149|FG004|Base Study Vaccination Period|Moved|0|||
146748584|NCT00972179|529250199|FG006|Overall Study|Withdrawal by Subject|2|||
146748585|NCT00972179|529250193|FG000|Overall Study|Administrative Decision|0|||
146748586|NCT00972179|529250194|FG001|Overall Study|Administrative Decision|0|||
146851252|NCT00092495|529624145|FG000|Base Study Vaccination Period|Other|1|||
146851253|NCT00092495|529624146|FG001|Base Study Vaccination Period|Other|1|||
146851254|NCT00092495|529624147|FG002|Base Study Vaccination Period|Other|0|||
146748587|NCT00972179|529250195|FG002|Overall Study|Administrative Decision|0|||
146748588|NCT00972179|529250196|FG003|Overall Study|Administrative Decision|0|||
146748589|NCT00972179|529250197|FG004|Overall Study|Administrative Decision|1|||
146748590|NCT00972179|529250198|FG005|Overall Study|Administrative Decision|0|||
146748591|NCT00972179|529250199|FG006|Overall Study|Administrative Decision|0|||
146748592|NCT00972179|529250193|FG000|Overall Study|Lost to Follow-up|0|||
146748593|NCT00972179|529250194|FG001|Overall Study|Lost to Follow-up|0|||
146748594|NCT00972179|529250195|FG002|Overall Study|Lost to Follow-up|1|||
146748595|NCT00972179|529250196|FG003|Overall Study|Lost to Follow-up|0|||
146748596|NCT00972179|529250197|FG004|Overall Study|Lost to Follow-up|0|||
146748597|NCT00972179|529250198|FG005|Overall Study|Lost to Follow-up|3|||
146748598|NCT00972179|529250199|FG006|Overall Study|Lost to Follow-up|1|||
146748599|NCT03055832|529250200|FG000|Week 2|Withdrawal by Subject|1|||
146748600|NCT03055832|529250201|FG001|Week 2|Withdrawal by Subject|0|||
146748601|NCT03619174|529250202|FG000|Overall Study|Lost to Follow-up|3|||
146748602|NCT03619174|529250203|FG001|Overall Study|Lost to Follow-up|0|||
146748603|NCT03619174|529250202|FG000|Overall Study|Withdrawal by Subject|4|||
146748604|NCT03619174|529250203|FG001|Overall Study|Withdrawal by Subject|3|||
146748605|NCT03619174|529250202|FG000|Overall Study|Pregnancy|1|||
146748606|NCT03619174|529250203|FG001|Overall Study|Pregnancy|1|||
146748607|NCT03619174|529250202|FG000|Overall Study|Discomfort during treatment|1|||
146748608|NCT03619174|529250203|FG001|Overall Study|Discomfort during treatment|0|||
146748609|NCT04285229|529250206|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
146748610|NCT04285229|529250207|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146748611|NCT04285229|529250208|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146748612|NCT04285229|529250209|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146748613|NCT04285229|529250210|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146748614|NCT04285229|529250211|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146748615|NCT04285229|529250206|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
146748616|NCT04285229|529250207|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
146748617|NCT04285229|529250208|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
146748618|NCT04285229|529250209|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
146748619|NCT04285229|529250210|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
146748620|NCT04285229|529250211|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
146748621|NCT04285229|529250206|FG000|Extended Treatment Period|Adverse Event|0|||
146748622|NCT04285229|529250207|FG001|Extended Treatment Period|Adverse Event|0|||
146748623|NCT04285229|529250208|FG002|Extended Treatment Period|Adverse Event|0|||
146748624|NCT04285229|529250209|FG003|Extended Treatment Period|Adverse Event|1|||
146748625|NCT04285229|529250210|FG004|Extended Treatment Period|Adverse Event|0|||
146748626|NCT04285229|529250211|FG005|Extended Treatment Period|Adverse Event|0|||
146748627|NCT04285229|529250206|FG000|Extended Treatment Period|Physician Decision|0|||
146748628|NCT04285229|529250207|FG001|Extended Treatment Period|Physician Decision|0|||
146748629|NCT04285229|529250208|FG002|Extended Treatment Period|Physician Decision|1|||
146748630|NCT04285229|529250209|FG003|Extended Treatment Period|Physician Decision|0|||
146748631|NCT04285229|529250210|FG004|Extended Treatment Period|Physician Decision|0|||
146748632|NCT04285229|529250211|FG005|Extended Treatment Period|Physician Decision|0|||
146748633|NCT04285229|529250206|FG000|Follow-up Period|Adverse Event|0|||
146748634|NCT04285229|529250207|FG001|Follow-up Period|Adverse Event|0|||
146748635|NCT04285229|529250208|FG002|Follow-up Period|Adverse Event|0|||
146748636|NCT04285229|529250209|FG003|Follow-up Period|Adverse Event|0|||
146748637|NCT04285229|529250210|FG004|Follow-up Period|Adverse Event|1|||
146748638|NCT04285229|529250211|FG005|Follow-up Period|Adverse Event|4|||
146748639|NCT04285229|529250206|FG000|Follow-up Period|Withdrawal by Subject|0|||
146748640|NCT04285229|529250207|FG001|Follow-up Period|Withdrawal by Subject|0|||
146748641|NCT04285229|529250208|FG002|Follow-up Period|Withdrawal by Subject|0|||
146748642|NCT04285229|529250209|FG003|Follow-up Period|Withdrawal by Subject|0|||
146748643|NCT04285229|529250210|FG004|Follow-up Period|Withdrawal by Subject|0|||
146748644|NCT04285229|529250211|FG005|Follow-up Period|Withdrawal by Subject|5|||
146748645|NCT04285229|529250206|FG000|Follow-up Period|Covid-19|0|||
146748646|NCT04285229|529250207|FG001|Follow-up Period|Covid-19|0|||
146748647|NCT04285229|529250208|FG002|Follow-up Period|Covid-19|0|||
146748648|NCT04285229|529250209|FG003|Follow-up Period|Covid-19|0|||
146748649|NCT04285229|529250210|FG004|Follow-up Period|Covid-19|0|||
146748650|NCT04285229|529250211|FG005|Follow-up Period|Covid-19|2|||
146748651|NCT04285229|529250206|FG000|Follow-up Period|Physician Decision|0|||
146748652|NCT04285229|529250207|FG001|Follow-up Period|Physician Decision|0|||
146748653|NCT04285229|529250208|FG002|Follow-up Period|Physician Decision|0|||
146748654|NCT04285229|529250209|FG003|Follow-up Period|Physician Decision|0|||
146748655|NCT04285229|529250210|FG004|Follow-up Period|Physician Decision|0|||
146748656|NCT04285229|529250211|FG005|Follow-up Period|Physician Decision|1|||
146748657|NCT01556763|529250223|FG000|Overall Study|Withdrawal by Subject|0|||
146748658|NCT01556763|529250224|FG001|Overall Study|Withdrawal by Subject|1|||
146748659|NCT01556763|529250225|FG002|Overall Study|Withdrawal by Subject|0|||
146748660|NCT02258464|529250226|FG000|Overall Study|Progressive disease (PD)|9|||
146748661|NCT02258464|529250227|FG001|Overall Study|Progressive disease (PD)|17|||
146748662|NCT02258464|529250226|FG000|Overall Study|Study drug never administered|1|||
146748663|NCT02258464|529250227|FG001|Overall Study|Study drug never administered|1|||
146748664|NCT02258464|529250226|FG000|Overall Study|AE not related to clinical PD|1|||
146748665|NCT02258464|529250227|FG001|Overall Study|AE not related to clinical PD|3|||
146748666|NCT02258464|529250226|FG000|Overall Study|Withdrawal by Subject|5|||
146748667|NCT02258464|529250227|FG001|Overall Study|Withdrawal by Subject|4|||
146748668|NCT02258464|529250226|FG000|Overall Study|AE related to clinical PD|1|||
146748669|NCT02258464|529250227|FG001|Overall Study|AE related to clinical PD|0|||
146748670|NCT04170296|529250228|FG000|Overall Study|Adverse Event|1|||
146748671|NCT04170296|529250229|FG001|Overall Study|Adverse Event|0|||
146748672|NCT04170296|529250228|FG000|Overall Study|Withdrawal by Subject|3|||
146748673|NCT04170296|529250229|FG001|Overall Study|Withdrawal by Subject|2|||
146748674|NCT04170296|529250228|FG000|Overall Study|Lost to Follow-up|4|||
146748675|NCT04170296|529250229|FG001|Overall Study|Lost to Follow-up|2|||
146748676|NCT00932646|529250230|FG000|Overall Study|Adverse Event|2|||
146748677|NCT00932646|529250231|FG001|Overall Study|Adverse Event|1|||
146748678|NCT00932646|529250232|FG002|Overall Study|Adverse Event|1|||
146748679|NCT00932646|529250233|FG003|Overall Study|Adverse Event|1|||
146748680|NCT00932646|529250230|FG000|Overall Study|Lost to Follow-up|2|||
146748681|NCT00932646|529250231|FG001|Overall Study|Lost to Follow-up|1|||
146748682|NCT00932646|529250232|FG002|Overall Study|Lost to Follow-up|0|||
146748683|NCT00932646|529250233|FG003|Overall Study|Lost to Follow-up|0|||
146748684|NCT00932646|529250230|FG000|Overall Study|Withdrawal by Subject|1|||
146748685|NCT00932646|529250231|FG001|Overall Study|Withdrawal by Subject|1|||
146748686|NCT00932646|529250232|FG002|Overall Study|Withdrawal by Subject|3|||
146748687|NCT00932646|529250233|FG003|Overall Study|Withdrawal by Subject|0|||
146748688|NCT00653263|529250234|FG000|Overall Study|Withdrawal by Subject|1|||
146748689|NCT00653263|529250234|FG000|Overall Study|Physician Decision|1|||
146748690|NCT00776100|529250235|FG000|Overall Study|Disease Progression|1|||
146748691|NCT00776100|529250236|FG001|Overall Study|Disease Progression|0|||
146748692|NCT02285595|529250237|FG000|Overall Study|Lost to Follow-up|14|||
146748693|NCT02285595|529250237|FG000|Overall Study|Withdrawal by Subject|1|||
146748694|NCT01960790|529250238|FG000|Overall Study|Survey forms could not be recovered|3|||
146748695|NCT01960790|529250238|FG000|Overall Study|Treat with Humira outside survey period|3|||
146748696|NCT01960790|529250238|FG000|Overall Study|Transferred to another hospital|4|||
146748697|NCT01960790|529250238|FG000|Overall Study|Unevaluable for safety|1|||
146748698|NCT00195715|529250239|FG000|Overall Study|Adverse Event|122|||
146748699|NCT00195715|529250239|FG000|Overall Study|Withdrawal by Subject|58|||
146748700|NCT00195715|529250239|FG000|Overall Study|Lost to Follow-up|27|||
146748701|NCT00195715|529250239|FG000|Overall Study|Protocol Violation|13|||
146748702|NCT00195715|529250239|FG000|Overall Study|Lack of Efficacy|93|||
146748703|NCT00195715|529250239|FG000|Overall Study|Pregnancy|14|||
146748704|NCT00195715|529250239|FG000|Overall Study|Investigative site closure|8|||
146748705|NCT00195715|529250239|FG000|Overall Study|Subject moved/relocated|7|||
146748706|NCT00195715|529250239|FG000|Overall Study|Subject non-compliance|6|||
146748707|NCT00195715|529250239|FG000|Overall Study|Subject started commercial Humira|5|||
146748708|NCT00195715|529250239|FG000|Overall Study|Subject choice|3|||
146748709|NCT00195715|529250239|FG000|Overall Study|Loss of response/no improvement|3|||
146748710|NCT00195715|529250239|FG000|Overall Study|Sponsor stopped study|1|||
146748711|NCT00195715|529250239|FG000|Overall Study|Administrative reasons|2|||
146748712|NCT00195715|529250239|FG000|Overall Study|Investigator's decision|2|||
146748713|NCT00195715|529250239|FG000|Overall Study|Subject wants to get pregnant|4|||
146748714|NCT00195715|529250239|FG000|Overall Study|Use of prohibited medication|2|||
146748715|NCT00195715|529250239|FG000|Overall Study|Planned surgery|2|||
146748716|NCT00195715|529250239|FG000|Overall Study|Increased infection rate|1|||
146748717|NCT00195715|529250239|FG000|Overall Study|Ineligible|1|||
146748718|NCT00195715|529250239|FG000|Overall Study|Colonic stricture|1|||
146748719|NCT00195715|529250239|FG000|Overall Study|Sponsor discontinued trial|1|||
146748720|NCT00195715|529250239|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
146748721|NCT05822921|529250244|FG000|Overall Study|Lost to Follow-up|1|||
146748722|NCT05822921|529250245|FG001|Overall Study|Lost to Follow-up|1|||
146748723|NCT00544544|529250247|FG000|Overall Study|Withdrawal by Subject|1|||
146748724|NCT00544544|529250247|FG000|Overall Study|Adverse Event|1|||
146748725|NCT00544544|529250247|FG000|Overall Study|Lost to Follow-up|1|||
146511732|NCT01764997|528377261|FG003|Run-in Period|Adverse Event|0|||
146511733|NCT01764997|528377262|FG004|Run-in Period|Adverse Event|0|||
146511734|NCT01764997|528377258|FG000|Run-in Period|Lack of Efficacy|5|||
146511735|NCT01764997|528377259|FG001|Run-in Period|Lack of Efficacy|0|||
146511736|NCT01764997|528377260|FG002|Run-in Period|Lack of Efficacy|0|||
146511737|NCT01764997|528377261|FG003|Run-in Period|Lack of Efficacy|0|||
146511738|NCT01764997|528377262|FG004|Run-in Period|Lack of Efficacy|0|||
146511739|NCT01764997|528377258|FG000|Run-in Period|Poor compliance to protocol|1|||
146511740|NCT01764997|528377259|FG001|Run-in Period|Poor compliance to protocol|0|||
146511741|NCT01764997|528377260|FG002|Run-in Period|Poor compliance to protocol|0|||
146851255|NCT00092495|529624148|FG003|Base Study Vaccination Period|Other|2|||
146851256|NCT00092495|529624149|FG004|Base Study Vaccination Period|Other|0|||
146851257|NCT00092495|529624145|FG000|Base Study Vaccination Period|Pregnancy|2|||
146851258|NCT00092495|529624146|FG001|Base Study Vaccination Period|Pregnancy|0|||
146851259|NCT00092495|529624147|FG002|Base Study Vaccination Period|Pregnancy|0|||
146851260|NCT00092495|529624148|FG003|Base Study Vaccination Period|Pregnancy|0|||
146851261|NCT00092495|529624149|FG004|Base Study Vaccination Period|Pregnancy|0|||
146851262|NCT00092495|529624145|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
146851263|NCT00092495|529624146|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
146851264|NCT00092495|529624147|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
146851265|NCT00092495|529624148|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
146851266|NCT00092495|529624149|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
146851267|NCT00092495|529624145|FG000|Base Study Vaccination Period|Protocol Violation|1|||
146851268|NCT00092495|529624146|FG001|Base Study Vaccination Period|Protocol Violation|0|||
146851269|NCT00092495|529624147|FG002|Base Study Vaccination Period|Protocol Violation|0|||
146851270|NCT00092495|529624148|FG003|Base Study Vaccination Period|Protocol Violation|0|||
146851271|NCT00092495|529624149|FG004|Base Study Vaccination Period|Protocol Violation|0|||
146851272|NCT00092495|529624145|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
146851273|NCT00092495|529624146|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
146851274|NCT00092495|529624147|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
146851275|NCT00092495|529624148|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
146851276|NCT00092495|529624149|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
146851277|NCT00092495|529624145|FG000|Base Study Follow-up Period|Extended|0|||
146851278|NCT00092495|529624146|FG001|Base Study Follow-up Period|Extended|0|||
146851279|NCT00092495|529624147|FG002|Base Study Follow-up Period|Extended|1|||
146851280|NCT00092495|529624148|FG003|Base Study Follow-up Period|Extended|2|||
146851281|NCT00092495|529624149|FG004|Base Study Follow-up Period|Extended|0|||
146851282|NCT00092495|529624145|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
146851283|NCT00092495|529624146|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
146851284|NCT00092495|529624147|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
146851285|NCT00092495|529624148|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
146851286|NCT00092495|529624149|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
146851287|NCT00092495|529624145|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
146851288|NCT00092495|529624146|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
146851289|NCT00092495|529624147|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
146851290|NCT00092495|529624148|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
146851291|NCT00092495|529624149|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
146851292|NCT00309959|529624157|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
146851293|NCT02947087|529624158|FG000|Overall Study|Withdrawal by Subject|3|||
146851294|NCT02947087|529624159|FG001|Overall Study|Withdrawal by Subject|2|||
146851295|NCT01844687|529624160|FG000|Visit 1|Protocol Violation|3|||
146851296|NCT01844687|529624160|FG000|Visit 1|Lost to Follow-up|5|||
146851297|NCT01844687|529624160|FG000|Visit 2|Withdrawal by Subject|1|||
146851298|NCT01844687|529624160|FG000|Visit 2|Protocol Violation|1|||
146851299|NCT01844687|529624160|FG000|Visit 3|Lost to Follow-up|1|||
146851300|NCT01844687|529624160|FG000|Visit 3|Withdrawal by Subject|3|||
146851301|NCT01844687|529624160|FG000|Visit 3|child care problems|1|||
146511742|NCT01764997|528377261|FG003|Run-in Period|Poor compliance to protocol|0|||
146851302|NCT01844687|529624160|FG000|Visit 4|Pregnancy|1|||
146851303|NCT01844687|529624160|FG000|Visit 4|Lost to Follow-up|1|||
146851304|NCT01844687|529624160|FG000|Visit 4|Withdrawal by Subject|2|||
146511743|NCT01764997|528377262|FG004|Run-in Period|Poor compliance to protocol|0|||
146511744|NCT01764997|528377258|FG000|Run-in Period|Other than specified above|17|||
146851305|NCT00938860|529624171|FG000|Overall Study|Adverse Event|2|||
146851306|NCT00938860|529624172|FG001|Overall Study|Adverse Event|1|||
146851307|NCT00938860|529624171|FG000|Overall Study|Abnormal laboratory values|2|||
146851308|NCT00938860|529624172|FG001|Overall Study|Abnormal laboratory values|2|||
146851309|NCT00938860|529624171|FG000|Overall Study|Withdrawal by Subject|11|||
146851310|NCT00938860|529624172|FG001|Overall Study|Withdrawal by Subject|8|||
146851311|NCT00938860|529624171|FG000|Overall Study|Lost to Follow-up|4|||
146511745|NCT01764997|528377259|FG001|Run-in Period|Other than specified above|0|||
146511746|NCT01764997|528377260|FG002|Run-in Period|Other than specified above|0|||
146511747|NCT01764997|528377261|FG003|Run-in Period|Other than specified above|0|||
146511748|NCT01764997|528377262|FG004|Run-in Period|Other than specified above|0|||
146511749|NCT01764997|528377258|FG000|Study Drug Treatment Period|Adverse Event|0|||
146511750|NCT01764997|528377259|FG001|Study Drug Treatment Period|Adverse Event|1|||
146511751|NCT01764997|528377260|FG002|Study Drug Treatment Period|Adverse Event|0|||
146511752|NCT01764997|528377261|FG003|Study Drug Treatment Period|Adverse Event|0|||
146511753|NCT01764997|528377262|FG004|Study Drug Treatment Period|Adverse Event|24|||
146511754|NCT01764997|528377258|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
146511755|NCT01764997|528377259|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
146511756|NCT01764997|528377260|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
146851312|NCT00938860|529624172|FG001|Overall Study|Lost to Follow-up|4|||
146851313|NCT00938860|529624171|FG000|Overall Study|Administration problems|2|||
146851314|NCT00938860|529624172|FG001|Overall Study|Administration problems|0|||
146851315|NCT00938860|529624171|FG000|Overall Study|Death|1|||
146851316|NCT00938860|529624172|FG001|Overall Study|Death|1|||
146511757|NCT01764997|528377261|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
146851317|NCT00938860|529624171|FG000|Overall Study|Protocol Violation|3|||
146851318|NCT00938860|529624172|FG001|Overall Study|Protocol Violation|1|||
146851319|NCT00324116|529624173|FG000|Overall Study|Adverse Event|5|||
146851320|NCT00324116|529624173|FG000|Overall Study|Lack of Efficacy|17|||
146511758|NCT01764997|528377262|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
146511759|NCT01764997|528377258|FG000|Study Drug Treatment Period|Other than specified above|0|||
146511760|NCT01764997|528377259|FG001|Study Drug Treatment Period|Other than specified above|0|||
146511761|NCT01764997|528377260|FG002|Study Drug Treatment Period|Other than specified above|0|||
146511762|NCT01764997|528377261|FG003|Study Drug Treatment Period|Other than specified above|0|||
146511763|NCT01764997|528377262|FG004|Study Drug Treatment Period|Other than specified above|10|||
146511764|NCT00787917|528377263|FG000|Blinded Treatment|Adverse Event|1|||
146511765|NCT00787917|528377264|FG001|Blinded Treatment|Adverse Event|0|||
146511766|NCT00787917|528377263|FG000|Blinded Treatment|Lack of Efficacy|1|||
146511767|NCT00787917|528377264|FG001|Blinded Treatment|Lack of Efficacy|0|||
146511768|NCT00787917|528377263|FG000|Blinded Treatment|Administrative problems|3|||
146511769|NCT00787917|528377264|FG001|Blinded Treatment|Administrative problems|2|||
146511770|NCT00787917|528377263|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
146511771|NCT00787917|528377264|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
146511772|NCT00787917|528377263|FG000|Open Label|Administrative problems|3|||
146511773|NCT00787917|528377264|FG001|Open Label|Administrative problems|0|||
146511774|NCT02172040|528377267|FG000|Overall Study|Adverse Event|0|||
146511775|NCT02172040|528377268|FG001|Overall Study|Adverse Event|2|||
146511776|NCT02172040|528377269|FG002|Overall Study|Adverse Event|0|||
146511777|NCT02172040|528377270|FG003|Overall Study|Adverse Event|0|||
146511778|NCT02172040|528377267|FG000|Overall Study|Protocol Violation|0|||
146511779|NCT02172040|528377268|FG001|Overall Study|Protocol Violation|1|||
146511780|NCT02172040|528377269|FG002|Overall Study|Protocol Violation|0|||
146511781|NCT02172040|528377270|FG003|Overall Study|Protocol Violation|0|||
146511782|NCT02172040|528377267|FG000|Overall Study|Withdrawal by Subject|0|||
146511783|NCT02172040|528377268|FG001|Overall Study|Withdrawal by Subject|0|||
146511784|NCT02172040|528377269|FG002|Overall Study|Withdrawal by Subject|1|||
146511785|NCT02172040|528377270|FG003|Overall Study|Withdrawal by Subject|0|||
146511786|NCT02172040|528377267|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
146511787|NCT02172040|528377268|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
146511788|NCT02172040|528377269|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
146511789|NCT02172040|528377270|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
146511790|NCT02172040|528377267|FG000|Overall Study|Family emergency abroad|0|||
146511791|NCT02172040|528377268|FG001|Overall Study|Family emergency abroad|0|||
146511792|NCT02172040|528377269|FG002|Overall Study|Family emergency abroad|0|||
146511793|NCT02172040|528377270|FG003|Overall Study|Family emergency abroad|1|||
146511794|NCT01709864|528379040|FG000|Overall Study|Physician Decision|0|||
146511795|NCT01709864|528379041|FG001|Overall Study|Physician Decision|1|||
146511796|NCT01709864|528379040|FG000|Overall Study|subject/guardian decision|5|||
146511797|NCT01709864|528379041|FG001|Overall Study|subject/guardian decision|6|||
146511798|NCT01709864|528379040|FG000|Overall Study|Lost to Follow-up|1|||
146511799|NCT01709864|528379041|FG001|Overall Study|Lost to Follow-up|0|||
146511800|NCT01709864|528379040|FG000|Overall Study|non-compliance with study treatment|1|||
146511801|NCT01709864|528379041|FG001|Overall Study|non-compliance with study treatment|1|||
146511802|NCT01709864|528379040|FG000|Overall Study|Adverse Event|0|||
146511803|NCT01709864|528379041|FG001|Overall Study|Adverse Event|2|||
146511804|NCT01709864|528379040|FG000|Overall Study|Death|0|||
146625184|NCT02081677|528803834|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
146511805|NCT01709864|528379041|FG001|Overall Study|Death|1|||
146511806|NCT01066793|528379048|FG000|Overall Study|Death|4|||
146511807|NCT01066793|528379049|FG001|Overall Study|Death|1|||
146511808|NCT01066793|528379050|FG002|Overall Study|Death|1|||
146511809|NCT01066793|528379051|FG003|Overall Study|Death|0|||
146511810|NCT01066793|528379052|FG004|Overall Study|Death|0|||
146511811|NCT01066793|528379053|FG005|Overall Study|Death|0|||
146511812|NCT01066793|528379048|FG000|Overall Study|Lack of Efficacy|2|||
146511813|NCT01066793|528379049|FG001|Overall Study|Lack of Efficacy|1|||
146511814|NCT01066793|528379050|FG002|Overall Study|Lack of Efficacy|0|||
146511815|NCT01066793|528379051|FG003|Overall Study|Lack of Efficacy|0|||
146511816|NCT01066793|528379052|FG004|Overall Study|Lack of Efficacy|0|||
146511817|NCT01066793|528379053|FG005|Overall Study|Lack of Efficacy|0|||
146511818|NCT01066793|528379048|FG000|Overall Study|Lost to Follow-up|180|||
146511819|NCT01066793|528379049|FG001|Overall Study|Lost to Follow-up|39|||
146511820|NCT01066793|528379050|FG002|Overall Study|Lost to Follow-up|82|||
146511821|NCT01066793|528379051|FG003|Overall Study|Lost to Follow-up|16|||
146511822|NCT01066793|528379052|FG004|Overall Study|Lost to Follow-up|0|||
146511823|NCT01066793|528379053|FG005|Overall Study|Lost to Follow-up|1|||
146511824|NCT01066793|528379048|FG000|Overall Study|Physician Decision|3|||
146511825|NCT01066793|528379049|FG001|Overall Study|Physician Decision|0|||
146511826|NCT01066793|528379050|FG002|Overall Study|Physician Decision|0|||
146511827|NCT01066793|528379051|FG003|Overall Study|Physician Decision|0|||
146511828|NCT01066793|528379052|FG004|Overall Study|Physician Decision|0|||
146511829|NCT01066793|528379053|FG005|Overall Study|Physician Decision|0|||
146511830|NCT01066793|528379048|FG000|Overall Study|Protocol Violation|3|||
146511831|NCT01066793|528379049|FG001|Overall Study|Protocol Violation|2|||
146511832|NCT01066793|528379050|FG002|Overall Study|Protocol Violation|2|||
146511833|NCT01066793|528379051|FG003|Overall Study|Protocol Violation|0|||
146511834|NCT01066793|528379052|FG004|Overall Study|Protocol Violation|0|||
146511835|NCT01066793|528379053|FG005|Overall Study|Protocol Violation|0|||
146511836|NCT01066793|528379048|FG000|Overall Study|Withdrawal by Subject|7|||
146511837|NCT01066793|528379049|FG001|Overall Study|Withdrawal by Subject|4|||
146511838|NCT01066793|528379050|FG002|Overall Study|Withdrawal by Subject|1|||
146511839|NCT01066793|528379051|FG003|Overall Study|Withdrawal by Subject|0|||
146511840|NCT01066793|528379052|FG004|Overall Study|Withdrawal by Subject|0|||
146511841|NCT01066793|528379053|FG005|Overall Study|Withdrawal by Subject|0|||
146511842|NCT01066793|528379048|FG000|Overall Study|Early Termination|3|||
146511843|NCT01066793|528379049|FG001|Overall Study|Early Termination|0|||
146511844|NCT01066793|528379050|FG002|Overall Study|Early Termination|0|||
146511845|NCT01066793|528379051|FG003|Overall Study|Early Termination|0|||
146511846|NCT01066793|528379052|FG004|Overall Study|Early Termination|0|||
146511847|NCT01066793|528379053|FG005|Overall Study|Early Termination|0|||
146511848|NCT01066793|528379048|FG000|Overall Study|Lab test not done|7|||
146511849|NCT01066793|528379049|FG001|Overall Study|Lab test not done|0|||
146511850|NCT01066793|528379050|FG002|Overall Study|Lab test not done|0|||
146511851|NCT01066793|528379051|FG003|Overall Study|Lab test not done|1|||
146511852|NCT01066793|528379052|FG004|Overall Study|Lab test not done|0|||
146511853|NCT01066793|528379053|FG005|Overall Study|Lab test not done|0|||
146511854|NCT01066793|528379048|FG000|Overall Study|Miscellaneous|4|||
146511855|NCT01066793|528379049|FG001|Overall Study|Miscellaneous|5|||
146965002|NCT01491737|530033421|FG000|Overall Study|Study Termination by Sponsor|36|||
146511856|NCT01066793|528379050|FG002|Overall Study|Miscellaneous|6|||
146511857|NCT01066793|528379051|FG003|Overall Study|Miscellaneous|0|||
146511858|NCT01066793|528379052|FG004|Overall Study|Miscellaneous|0|||
146511859|NCT01066793|528379053|FG005|Overall Study|Miscellaneous|0|||
146511860|NCT01066793|528379048|FG000|Overall Study|Non-responders|104|||
146511861|NCT01066793|528379049|FG001|Overall Study|Non-responders|5|||
146511862|NCT01066793|528379050|FG002|Overall Study|Non-responders|11|||
146511863|NCT01066793|528379051|FG003|Overall Study|Non-responders|25|||
146511864|NCT01066793|528379052|FG004|Overall Study|Non-responders|0|||
146511865|NCT01066793|528379053|FG005|Overall Study|Non-responders|0|||
146511866|NCT01066793|528379048|FG000|Overall Study|Other|15|||
146511867|NCT01066793|528379049|FG001|Overall Study|Other|5|||
146511868|NCT01066793|528379050|FG002|Overall Study|Other|6|||
146511869|NCT01066793|528379051|FG003|Overall Study|Other|2|||
146511870|NCT01066793|528379052|FG004|Overall Study|Other|0|||
146511871|NCT01066793|528379053|FG005|Overall Study|Other|0|||
146511872|NCT01066793|528379048|FG000|Overall Study|Relapse|20|||
146511873|NCT01066793|528379049|FG001|Overall Study|Relapse|8|||
146511874|NCT01066793|528379050|FG002|Overall Study|Relapse|2|||
146511875|NCT01066793|528379051|FG003|Overall Study|Relapse|3|||
146511876|NCT01066793|528379052|FG004|Overall Study|Relapse|0|||
146511877|NCT01066793|528379053|FG005|Overall Study|Relapse|0|||
146511878|NCT01066793|528379048|FG000|Overall Study|Result Not Available|1|||
146511879|NCT01066793|528379049|FG001|Overall Study|Result Not Available|0|||
146511880|NCT01066793|528379050|FG002|Overall Study|Result Not Available|0|||
146511881|NCT01066793|528379051|FG003|Overall Study|Result Not Available|0|||
146511882|NCT01066793|528379052|FG004|Overall Study|Result Not Available|0|||
146511883|NCT01066793|528379053|FG005|Overall Study|Result Not Available|0|||
146511884|NCT01066793|528379048|FG000|Overall Study|Treatment Interrupted|1|||
146511885|NCT01066793|528379049|FG001|Overall Study|Treatment Interrupted|1|||
146511886|NCT01066793|528379050|FG002|Overall Study|Treatment Interrupted|0|||
146511887|NCT01066793|528379051|FG003|Overall Study|Treatment Interrupted|0|||
146511888|NCT01066793|528379052|FG004|Overall Study|Treatment Interrupted|0|||
146511889|NCT01066793|528379053|FG005|Overall Study|Treatment Interrupted|0|||
146511890|NCT01066793|528379048|FG000|Overall Study|Treatment Never Started|18|||
146511891|NCT01066793|528379049|FG001|Overall Study|Treatment Never Started|5|||
146511892|NCT01066793|528379050|FG002|Overall Study|Treatment Never Started|4|||
146511893|NCT01066793|528379051|FG003|Overall Study|Treatment Never Started|1|||
146511894|NCT01066793|528379052|FG004|Overall Study|Treatment Never Started|0|||
146511895|NCT01066793|528379053|FG005|Overall Study|Treatment Never Started|0|||
146511896|NCT01066793|528379048|FG000|Overall Study|Treatment Stopped|2|||
146511897|NCT01066793|528379049|FG001|Overall Study|Treatment Stopped|1|||
146511898|NCT01066793|528379050|FG002|Overall Study|Treatment Stopped|0|||
146511899|NCT01066793|528379051|FG003|Overall Study|Treatment Stopped|1|||
146511900|NCT01066793|528379052|FG004|Overall Study|Treatment Stopped|0|||
146511901|NCT01066793|528379053|FG005|Overall Study|Treatment Stopped|0|||
146511902|NCT02697916|528379055|FG000|Overall Study|Death|357|||
146511903|NCT02697916|528379056|FG001|Overall Study|Death|315|||
146511904|NCT02697916|528379055|FG000|Overall Study|Withdrawal by Subject|221|||
146511905|NCT02697916|528379056|FG001|Overall Study|Withdrawal by Subject|393|||
146511906|NCT03246061|528379057|FG000|Overall Study|Still in follow-up|15|||
146511907|NCT03246061|528379058|FG001|Overall Study|Still in follow-up|21|||
146511908|NCT04710368|528379059|FG000|Overall Study|Withdrawal by Subject|9|||
146511909|NCT04710368|528379059|FG000|Overall Study|Lost to Follow-up|4|||
146511910|NCT04710368|528379059|FG000|Overall Study|Death|2|||
146511911|NCT04710368|528379059|FG000|Overall Study|Patient preference|11|||
146511912|NCT04710368|528379059|FG000|Overall Study|Treatment discontinuation|1|||
146511913|NCT02667587|528379063|FG000|Pre-Treatment|Not reported|1|||
146511914|NCT02667587|528379064|FG001|Pre-Treatment|Not reported|0|||
146511915|NCT02667587|528379063|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
146511916|NCT02667587|528379064|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
146511917|NCT02667587|528379063|FG000|Pre-Treatment|Participant withdrew consent|0|||
146511918|NCT02667587|528379064|FG001|Pre-Treatment|Participant withdrew consent|1|||
146511919|NCT02667587|528379063|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
146511920|NCT02667587|528379064|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
146511921|NCT02667587|528379063|FG000|End of Treatment|Disease Progression|193|||
146511922|NCT02667587|528379064|FG001|End of Treatment|Disease Progression|226|||
146511923|NCT02667587|528379063|FG000|End of Treatment|Study Drug Toxicity|75|||
146511924|NCT02667587|528379064|FG001|End of Treatment|Study Drug Toxicity|19|||
146511925|NCT02667587|528379063|FG000|End of Treatment|Death|2|||
146511926|NCT02667587|528379064|FG001|End of Treatment|Death|1|||
146511927|NCT02667587|528379063|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
146511928|NCT02667587|528379064|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
146511929|NCT02667587|528379063|FG000|End of Treatment|participant request to discontinue treatment|33|||
146511930|NCT02667587|528379064|FG001|End of Treatment|participant request to discontinue treatment|35|||
146511931|NCT02667587|528379063|FG000|End of Treatment|participant withdrew consent|5|||
146511932|NCT02667587|528379064|FG001|End of Treatment|participant withdrew consent|6|||
146511933|NCT02667587|528379063|FG000|End of Treatment|Lost to Follow-up|1|||
146511934|NCT02667587|528379064|FG001|End of Treatment|Lost to Follow-up|2|||
146511935|NCT02667587|528379063|FG000|End of Treatment|maximum clinical benefit|4|||
146511936|NCT02667587|528379064|FG001|End of Treatment|maximum clinical benefit|4|||
146511937|NCT02667587|528379063|FG000|End of Treatment|poor or non compliant|0|||
146511938|NCT02667587|528379064|FG001|End of Treatment|poor or non compliant|1|||
146511939|NCT02667587|528379063|FG000|End of Treatment|participant no longer meets study criteria|1|||
146511940|NCT02667587|528379064|FG001|End of Treatment|participant no longer meets study criteria|1|||
146511941|NCT02667587|528379063|FG000|End of Treatment|administrative reason by sponsor|1|||
146511942|NCT02667587|528379064|FG001|End of Treatment|administrative reason by sponsor|29|||
146511943|NCT02667587|528379063|FG000|End of Treatment|other reasonse|21|||
146511944|NCT02667587|528379064|FG001|End of Treatment|other reasonse|10|||
146511945|NCT02696434|528379065|FG000|Overall Study|Adverse Event|3|||
146511946|NCT02696434|528379066|FG001|Overall Study|Adverse Event|1|||
146511947|NCT02696434|528379065|FG000|Overall Study|Lost to Follow-up|5|||
146511948|NCT02696434|528379066|FG001|Overall Study|Lost to Follow-up|4|||
146511949|NCT02696434|528379065|FG000|Overall Study|Withdrawal by Subject|14|||
146511950|NCT02696434|528379066|FG001|Overall Study|Withdrawal by Subject|12|||
146511951|NCT02696434|528379065|FG000|Overall Study|Physician Decision|0|||
146511952|NCT02696434|528379066|FG001|Overall Study|Physician Decision|1|||
146511953|NCT00427999|528379088|FG000|Overall Study|Adverse Event|6|||
146511954|NCT00427999|528379088|FG000|Overall Study|Abnormal laboratory values|1|||
146511955|NCT00427999|528379088|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
146511956|NCT00427999|528379088|FG000|Overall Study|Protocol Violation|2|||
146511957|NCT00427999|528379088|FG000|Overall Study|Withdrawal by Subject|9|||
146511958|NCT00427999|528379088|FG000|Overall Study|Death|1|||
146511959|NCT05323994|528379089|FG000|Overall Study|Protocol Violation|1|||
146511960|NCT00766467|528379090|FG000|Overall Study|Withdrawal by Subject|7|||
146511961|NCT00766467|528379091|FG001|Overall Study|Withdrawal by Subject|2|||
146511962|NCT00766467|528379090|FG000|Overall Study|Adverse Event|1|||
146511963|NCT00766467|528379091|FG001|Overall Study|Adverse Event|1|||
146511964|NCT00766467|528379090|FG000|Overall Study|Protocol Violation|2|||
146511965|NCT00766467|528379091|FG001|Overall Study|Protocol Violation|4|||
146511966|NCT00766467|528379090|FG000|Overall Study|Tumor Progression on Study|0|||
146511967|NCT00766467|528379091|FG001|Overall Study|Tumor Progression on Study|1|||
146511968|NCT00766467|528379090|FG000|Overall Study|Physician Decision|1|||
146851321|NCT00324116|529624173|FG000|Overall Study|Withdrawal by Subject|5|||
146851322|NCT00324116|529624173|FG000|Overall Study|Other|5|||
146851323|NCT02971761|529624174|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
146511969|NCT00766467|528379091|FG001|Overall Study|Physician Decision|0|||
146511970|NCT01420679|528379097|FG000|Overall Study|Disease Progression|3|||
146511971|NCT01420679|528379098|FG001|Overall Study|Disease Progression|2|||
146511972|NCT01420679|528379097|FG000|Overall Study|Adverse Event|4|||
146511973|NCT01420679|528379098|FG001|Overall Study|Adverse Event|0|||
146511974|NCT01420679|528379097|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
146511975|NCT01420679|528379098|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
146511976|NCT01420679|528379097|FG000|Overall Study|Patient Decision|1|||
146511977|NCT01420679|528379098|FG001|Overall Study|Patient Decision|0|||
146511978|NCT01420679|528379097|FG000|Overall Study|Investigator Decision|1|||
146511979|NCT01420679|528379098|FG001|Overall Study|Investigator Decision|2|||
146511980|NCT01420679|528379097|FG000|Overall Study|Sponsor Decision|3|||
146511981|NCT01420679|528379098|FG001|Overall Study|Sponsor Decision|3|||
146511982|NCT01420679|528379097|FG000|Overall Study|Other|1|||
146511983|NCT01420679|528379098|FG001|Overall Study|Other|0|||
146511984|NCT00943670|528379099|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
146511985|NCT00943670|528379099|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
146511986|NCT00943670|528379099|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
146511987|NCT00943670|528379099|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
146511988|NCT00943670|528379099|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
146511989|NCT00943670|528379099|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
146511990|NCT00943670|528379099|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
146511991|NCT00943670|528379099|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
146511992|NCT00943670|528379099|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
146511993|NCT00943670|528379099|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
146511994|NCT04472026|528379100|FG000|Overall Study|Lost to Follow-up|5|||
146511995|NCT01777295|528379101|FG000|Overall Study|Withdrawal by Subject|2|||
146511996|NCT01777295|528379102|FG001|Overall Study|Withdrawal by Subject|2|||
146511997|NCT01777295|528379101|FG000|Overall Study|Pregnancy|0|||
146511998|NCT01777295|528379102|FG001|Overall Study|Pregnancy|1|||
146511999|NCT01777295|528379101|FG000|Overall Study|Personal problem|1|||
146512000|NCT01777295|528379102|FG001|Overall Study|Personal problem|0|||
146512001|NCT01777295|528379101|FG000|Overall Study|Investigator call for AEs check|1|||
146512002|NCT01777295|528379102|FG001|Overall Study|Investigator call for AEs check|0|||
146512003|NCT01546038|528379104|FG000|Overall Study|Death|15|||
146512004|NCT01546038|528379105|FG001|Overall Study|Death|6|||
146512005|NCT01546038|528379106|FG002|Overall Study|Death|4|||
146512006|NCT01546038|528379107|FG003|Overall Study|Death|2|||
146512007|NCT01546038|528379108|FG004|Overall Study|Death|9|||
146512008|NCT01546038|528379109|FG005|Overall Study|Death|3|||
146512009|NCT01546038|528379110|FG006|Overall Study|Death|46|||
146512010|NCT01546038|528379111|FG007|Overall Study|Death|76|||
146512011|NCT01546038|528379112|FG008|Overall Study|Death|39|||
146512012|NCT01546038|528379104|FG000|Overall Study|Lost to Follow-up|0|||
146512013|NCT01546038|528379105|FG001|Overall Study|Lost to Follow-up|0|||
146512014|NCT01546038|528379106|FG002|Overall Study|Lost to Follow-up|0|||
146512015|NCT01546038|528379107|FG003|Overall Study|Lost to Follow-up|0|||
146512016|NCT01546038|528379108|FG004|Overall Study|Lost to Follow-up|1|||
146512017|NCT01546038|528379109|FG005|Overall Study|Lost to Follow-up|0|||
146512018|NCT01546038|528379110|FG006|Overall Study|Lost to Follow-up|2|||
146512019|NCT01546038|528379111|FG007|Overall Study|Lost to Follow-up|1|||
146512020|NCT01546038|528379112|FG008|Overall Study|Lost to Follow-up|0|||
146512021|NCT01546038|528379104|FG000|Overall Study|Withdrawal by Subject|1|||
146512022|NCT01546038|528379105|FG001|Overall Study|Withdrawal by Subject|0|||
146512023|NCT01546038|528379106|FG002|Overall Study|Withdrawal by Subject|0|||
146512024|NCT01546038|528379107|FG003|Overall Study|Withdrawal by Subject|1|||
146512025|NCT01546038|528379108|FG004|Overall Study|Withdrawal by Subject|0|||
146512026|NCT01546038|528379109|FG005|Overall Study|Withdrawal by Subject|1|||
146512027|NCT01546038|528379110|FG006|Overall Study|Withdrawal by Subject|3|||
146512028|NCT01546038|528379111|FG007|Overall Study|Withdrawal by Subject|3|||
146512029|NCT01546038|528379112|FG008|Overall Study|Withdrawal by Subject|1|||
146512030|NCT01546038|528379104|FG000|Overall Study|: Randomized, not treated|0|||
146512031|NCT01546038|528379105|FG001|Overall Study|: Randomized, not treated|0|||
146512032|NCT01546038|528379106|FG002|Overall Study|: Randomized, not treated|0|||
146512033|NCT01546038|528379107|FG003|Overall Study|: Randomized, not treated|0|||
146512034|NCT01546038|528379108|FG004|Overall Study|: Randomized, not treated|0|||
146512035|NCT01546038|528379109|FG005|Overall Study|: Randomized, not treated|0|||
146512036|NCT01546038|528379110|FG006|Overall Study|: Randomized, not treated|2|||
146512037|NCT01546038|528379111|FG007|Overall Study|: Randomized, not treated|4|||
146512038|NCT01546038|528379112|FG008|Overall Study|: Randomized, not treated|3|||
146512039|NCT04245202|528379113|FG000|Overall Study|Lack of Efficacy|10|||
146512040|NCT04245202|528379114|FG001|Overall Study|Lack of Efficacy|1|||
146512041|NCT03515629|528379115|FG000|Overall Study|Death|0|||
146512042|NCT03515629|528379116|FG001|Overall Study|Death|1|||
146851324|NCT02624791|529624175|FG000|Overall Study|Withdrawal by Subject|2|||
146851325|NCT02624791|529624176|FG001|Overall Study|Withdrawal by Subject|0|||
146851326|NCT02624791|529624177|FG002|Overall Study|Withdrawal by Subject|0|||
146851327|NCT02624791|529624178|FG003|Overall Study|Withdrawal by Subject|0|||
146851328|NCT02624791|529624179|FG004|Overall Study|Withdrawal by Subject|0|||
146851329|NCT02624791|529624180|FG005|Overall Study|Withdrawal by Subject|0|||
146851330|NCT01642251|529624181|FG000|Overall Study|Progressive disease|0|||
146851331|NCT01642251|529624182|FG001|Overall Study|Progressive disease|0|||
146851332|NCT01642251|529624183|FG002|Overall Study|Progressive disease|3|||
146851333|NCT01642251|529624184|FG003|Overall Study|Progressive disease|3|||
146851334|NCT01642251|529624181|FG000|Overall Study|Adverse Event|0|||
146851335|NCT01642251|529624182|FG001|Overall Study|Adverse Event|0|||
146625185|NCT00089297|528803835|FG000|Overall Study|Adverse Event|9|||
146625186|NCT00089297|528803835|FG000|Overall Study|Death|1|||
146851336|NCT01642251|529624183|FG002|Overall Study|Adverse Event|5|||
146512043|NCT03515629|528379117|FG002|Overall Study|Death|1|||
146512044|NCT03515629|528379115|FG000|Overall Study|Progressive disease|0|||
146512045|NCT03515629|528379116|FG001|Overall Study|Progressive disease|1|||
146851337|NCT01642251|529624184|FG003|Overall Study|Adverse Event|4|||
146851338|NCT01642251|529624181|FG000|Overall Study|Death|0|||
146851339|NCT01642251|529624182|FG001|Overall Study|Death|0|||
146851340|NCT01642251|529624183|FG002|Overall Study|Death|1|||
146851341|NCT01642251|529624184|FG003|Overall Study|Death|3|||
146851342|NCT01642251|529624181|FG000|Overall Study|Withdrawal by Subject|0|||
146851343|NCT01642251|529624182|FG001|Overall Study|Withdrawal by Subject|0|||
146851344|NCT01642251|529624183|FG002|Overall Study|Withdrawal by Subject|1|||
146851345|NCT01642251|529624184|FG003|Overall Study|Withdrawal by Subject|3|||
146851346|NCT01642251|529624181|FG000|Overall Study|Alternative therapy|0|||
146851347|NCT01642251|529624182|FG001|Overall Study|Alternative therapy|0|||
146851348|NCT01642251|529624183|FG002|Overall Study|Alternative therapy|0|||
146851349|NCT01642251|529624184|FG003|Overall Study|Alternative therapy|2|||
146851350|NCT01642251|529624181|FG000|Overall Study|Other complicating disease|0|||
146851351|NCT01642251|529624182|FG001|Overall Study|Other complicating disease|0|||
146851352|NCT01642251|529624183|FG002|Overall Study|Other complicating disease|1|||
146851353|NCT01642251|529624184|FG003|Overall Study|Other complicating disease|0|||
146851354|NCT01642251|529624181|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
146851355|NCT01642251|529624182|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
146851356|NCT01642251|529624183|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
146851357|NCT01642251|529624184|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
146851358|NCT00895154|529624186|FG000|Overall Study|Lost to Follow-up|1|||
146851359|NCT00895154|529624187|FG001|Overall Study|Lost to Follow-up|1|||
146851360|NCT00895154|529624186|FG000|Overall Study|Withdrawal by Subject|0|||
146851361|NCT00895154|529624187|FG001|Overall Study|Withdrawal by Subject|1|||
146851362|NCT01993927|529624188|FG000|Overall Study|Case Report Forms Uncollected|18|||
146851363|NCT01993927|529624188|FG000|Overall Study|Protocol Violation|11|||
146851364|NCT00287690|529624189|FG000|Overall Study|Protocol Violation|20|||
146851365|NCT00287690|529624190|FG001|Overall Study|Protocol Violation|26|||
146851366|NCT01146782|529624191|FG000|Screening Cohort|Screen Failure|187|||
146851367|NCT01146782|529624191|FG000|Screening Cohort|Lost to Follow-up|4|||
146851368|NCT01146782|529624191|FG000|Screening Cohort|Physician Decision|1|||
146851369|NCT01146782|529624191|FG000|Screening Cohort|Withdrawal by Subject|29|||
146851370|NCT01146782|529624191|FG000|Safety Cohort|Screen Failure|61|||
146851371|NCT01146782|529624191|FG000|Safety Cohort|Withdrawal by Subject|4|||
146851372|NCT01146782|529624191|FG000|Safety Cohort|Control AHI <5|4|||
146851373|NCT01146782|529624191|FG000|Safety Cohort|TST <4 hrs|14|||
146851374|NCT01146782|529624191|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
146851375|NCT01146782|529624191|FG000|Primary Endpoint Cohort|Physician Decision|1|||
146851376|NCT02414932|529624192|FG000|Overall Study|Withdrawal by Subject|2|||
146851377|NCT02414932|529624193|FG001|Overall Study|Withdrawal by Subject|3|||
146851378|NCT02414932|529624192|FG000|Overall Study|Adverse Event|1|||
146851379|NCT02414932|529624193|FG001|Overall Study|Adverse Event|0|||
146851380|NCT00470366|529624194|FG000|Overall Study|Adverse Event|3|||
146851381|NCT00470366|529624194|FG000|Overall Study|Poor compliance|1|||
146851382|NCT00540046|529624195|FG000|Overall Study|Lost to Follow-up|33|||
146851383|NCT00540046|529624196|FG001|Overall Study|Lost to Follow-up|23|||
146851384|NCT01237587|529624199|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
146851385|NCT01237587|529624200|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
146851386|NCT01237587|529624199|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
146851387|NCT01237587|529624200|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
146851388|NCT01237587|529624199|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
146851389|NCT01237587|529624200|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
146851390|NCT01237587|529624199|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
146851391|NCT01237587|529624200|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
146851392|NCT01237587|529624199|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
146851393|NCT01237587|529624200|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
146851394|NCT01237587|529624199|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
146851395|NCT01237587|529624200|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
146851396|NCT01237587|529624199|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
146851397|NCT01237587|529624200|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
146851398|NCT01237587|529624199|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
146851399|NCT01237587|529624200|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
146851400|NCT01237587|529624199|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
146965003|NCT01491737|530033422|FG001|Overall Study|Study Termination by Sponsor|36|||
146625187|NCT00089297|528803835|FG000|Overall Study|Withdrawal by Subject|12|||
146512046|NCT03515629|528379117|FG002|Overall Study|Progressive disease|0|||
146512047|NCT00312572|528379121|FG000|Overall Study|Adverse Event|10|||
146512048|NCT00312572|528379122|FG001|Overall Study|Adverse Event|16|||
146512049|NCT00312572|528379121|FG000|Overall Study|Lost to Follow-up|1|||
146512050|NCT00312572|528379122|FG001|Overall Study|Lost to Follow-up|1|||
146512051|NCT00312572|528379121|FG000|Overall Study|Administrative|4|||
146512052|NCT00312572|528379122|FG001|Overall Study|Administrative|2|||
146512053|NCT00312572|528379121|FG000|Overall Study|Lack of Efficacy|1|||
146512054|NCT00312572|528379122|FG001|Overall Study|Lack of Efficacy|2|||
146512055|NCT05385224|528379123|FG000|Overall Study|Unable to swallow capsule|2|||
146512056|NCT05385224|528379123|FG000|Overall Study|Withdrawal by Subject|2|||
146512057|NCT05385224|528379123|FG000|Overall Study|Did not meet study criteria|1|||
146512058|NCT01133288|528379130|FG000|Eligibility Assessment|met exclusion criteria|5|||
146512059|NCT01133288|528379130|FG000|Intervention Allocation|study terminated|2|||
146512060|NCT03209518|528379131|FG000|Overall Study|Case Report Forms Uncollected|1|||
146512061|NCT03209518|528379131|FG000|Overall Study|Protocol Deviation|1|||
146512062|NCT01832818|528379132|FG000|Overall Study|Lost to Follow-up|6|||
146512063|NCT00551161|528379133|FG000|Overall Study|Withdrawal by Subject|1|||
146512064|NCT00236899|528379138|FG000|Overall Study|Adverse Event (Study Related)|1|||
146512065|NCT00236899|528379139|FG001|Overall Study|Adverse Event (Study Related)|1|||
146512066|NCT00236899|528379140|FG002|Overall Study|Adverse Event (Study Related)|2|||
146512067|NCT00236899|528379141|FG003|Overall Study|Adverse Event (Study Related)|1|||
146512068|NCT00236899|528379138|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
146512069|NCT00236899|528379139|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
146851401|NCT01237587|529624200|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
146512070|NCT00236899|528379140|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
146512071|NCT00236899|528379141|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
146512072|NCT00236899|528379138|FG000|Overall Study|Death (Study Disease)|1|||
146512073|NCT00236899|528379139|FG001|Overall Study|Death (Study Disease)|4|||
146512074|NCT00236899|528379140|FG002|Overall Study|Death (Study Disease)|0|||
146512075|NCT00236899|528379141|FG003|Overall Study|Death (Study Disease)|0|||
146512076|NCT00236899|528379138|FG000|Overall Study|Death (Not Study Related)|2|||
146770083|NCT03516942|529326679|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
146512077|NCT00236899|528379139|FG001|Overall Study|Death (Not Study Related)|0|||
146512078|NCT00236899|528379140|FG002|Overall Study|Death (Not Study Related)|0|||
146512079|NCT00236899|528379141|FG003|Overall Study|Death (Not Study Related)|0|||
146625188|NCT00089297|528803835|FG000|Overall Study|Disease progression|2|||
146851402|NCT01237587|529624199|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
146512080|NCT00236899|528379138|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
146512081|NCT00236899|528379139|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
146851403|NCT01237587|529624200|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
146851404|NCT01237587|529624199|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
146851405|NCT01237587|529624200|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
146851406|NCT01237587|529624199|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
146851407|NCT01237587|529624200|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
146851408|NCT01237587|529624199|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
146851409|NCT01237587|529624200|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
146851410|NCT01237587|529624199|FG000|Taper Phase|Adverse Event|0|||
146851411|NCT01237587|529624200|FG001|Taper Phase|Adverse Event|2|||
146851412|NCT01237587|529624199|FG000|Taper Phase|Protocol Violation|2|||
146851413|NCT01237587|529624200|FG001|Taper Phase|Protocol Violation|0|||
146851414|NCT01237587|529624199|FG000|Taper Phase|Lack of Efficacy|2|||
146851415|NCT01237587|529624200|FG001|Taper Phase|Lack of Efficacy|5|||
146851416|NCT01237587|529624199|FG000|Taper Phase|Parent/Guardian Decision|0|||
146851417|NCT01237587|529624200|FG001|Taper Phase|Parent/Guardian Decision|2|||
146851418|NCT01237587|529624199|FG000|Taper Phase|Sponsor Decision|1|||
146851419|NCT01237587|529624200|FG001|Taper Phase|Sponsor Decision|0|||
146851420|NCT01237587|529624199|FG000|Taper Phase|Withdrawal by Subject|0|||
146625189|NCT00089297|528803835|FG000|Overall Study|Ineligible|11|||
146512082|NCT00236899|528379140|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
146512083|NCT00236899|528379141|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
146512084|NCT00236899|528379138|FG000|Overall Study|Lost to Follow-up|0|||
146512085|NCT00236899|528379139|FG001|Overall Study|Lost to Follow-up|1|||
146512086|NCT00236899|528379140|FG002|Overall Study|Lost to Follow-up|0|||
146512087|NCT00236899|528379141|FG003|Overall Study|Lost to Follow-up|0|||
146512088|NCT00236899|528379138|FG000|Overall Study|Entry Criteria Exclusion|0|||
146512089|NCT00236899|528379139|FG001|Overall Study|Entry Criteria Exclusion|1|||
146512090|NCT00236899|528379140|FG002|Overall Study|Entry Criteria Exclusion|1|||
146512091|NCT00236899|528379141|FG003|Overall Study|Entry Criteria Exclusion|0|||
146512092|NCT00236899|528379138|FG000|Overall Study|Protocol Violation|1|||
146512093|NCT00236899|528379139|FG001|Overall Study|Protocol Violation|0|||
146512094|NCT00236899|528379140|FG002|Overall Study|Protocol Violation|0|||
146512095|NCT00236899|528379141|FG003|Overall Study|Protocol Violation|0|||
146512096|NCT00236899|528379138|FG000|Overall Study|Withdrawal by Subject|6|||
146512097|NCT00236899|528379139|FG001|Overall Study|Withdrawal by Subject|4|||
146512098|NCT00236899|528379140|FG002|Overall Study|Withdrawal by Subject|5|||
146512099|NCT00236899|528379141|FG003|Overall Study|Withdrawal by Subject|2|||
146512100|NCT00236899|528379138|FG000|Overall Study|Physician Decision|7|||
146512101|NCT00236899|528379139|FG001|Overall Study|Physician Decision|8|||
146512102|NCT00236899|528379140|FG002|Overall Study|Physician Decision|7|||
146512103|NCT00236899|528379141|FG003|Overall Study|Physician Decision|6|||
146512104|NCT00236899|528379138|FG000|Overall Study|Satisfactory Response|2|||
146512105|NCT00236899|528379139|FG001|Overall Study|Satisfactory Response|0|||
146770084|NCT03516942|529326679|FG000|T3: 12 Month Survey|Death|19|||
146512106|NCT00236899|528379140|FG002|Overall Study|Satisfactory Response|0|||
146512107|NCT00236899|528379141|FG003|Overall Study|Satisfactory Response|1|||
146512108|NCT00236899|528379138|FG000|Overall Study|Lack of Efficacy|18|||
146512109|NCT00236899|528379139|FG001|Overall Study|Lack of Efficacy|18|||
146512110|NCT00236899|528379140|FG002|Overall Study|Lack of Efficacy|25|||
146512111|NCT00236899|528379141|FG003|Overall Study|Lack of Efficacy|23|||
146512112|NCT01672294|528379143|FG000|Overall Study|Withdrawal by Subject|4|||
146851421|NCT01237587|529624200|FG001|Taper Phase|Withdrawal by Subject|1|||
146851422|NCT01021215|529624201|FG000|Overall Study|Lost to Follow-up|3|||
146512113|NCT01672294|528379144|FG001|Overall Study|Withdrawal by Subject|4|||
146512114|NCT01672294|528379145|FG002|Overall Study|Withdrawal by Subject|4|||
146512115|NCT01672294|528379146|FG003|Overall Study|Withdrawal by Subject|4|||
146512116|NCT01672294|528379143|FG000|Overall Study|Excluded by study|1|||
146512117|NCT01672294|528379144|FG001|Overall Study|Excluded by study|1|||
146512118|NCT01672294|528379145|FG002|Overall Study|Excluded by study|0|||
146512119|NCT01672294|528379146|FG003|Overall Study|Excluded by study|0|||
146770085|NCT03516942|529326679|FG000|T3: 12 Month Survey|Lost|209|||
146770086|NCT01426269|529327374|FG000|Period 1: 12 Weeks|Adverse Event|5|||
146770087|NCT01426269|529327375|FG001|Period 1: 12 Weeks|Adverse Event|0|||
146770088|NCT01426269|529327376|FG002|Period 1: 12 Weeks|Adverse Event|0|||
146770089|NCT01426269|529327374|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
146770090|NCT01426269|529327375|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
146770091|NCT01426269|529327376|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
146770092|NCT01426269|529327374|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
146770093|NCT01426269|529327375|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
146770094|NCT01426269|529327376|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
146770095|NCT01426269|529327374|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
146512120|NCT01672294|528379143|FG000|Overall Study|Lost to Follow-up|1|||
146751052|NCT01349829|529256890|FG000|Overall Study|Lost to Follow-up|4|||
146751053|NCT01349829|529256891|FG001|Overall Study|Lost to Follow-up|8|||
146751054|NCT01349829|529256890|FG000|Overall Study|Consent withdrawal|3|||
146751055|NCT01349829|529256891|FG001|Overall Study|Consent withdrawal|8|||
146751056|NCT01349829|529256890|FG000|Overall Study|Migrated/moved|2|||
146751057|NCT01349829|529256891|FG001|Overall Study|Migrated/moved|7|||
146751058|NCT00777803|529256892|FG000|Overall Study|Lost to Follow-up|12|||
146751059|NCT00777803|529256893|FG001|Overall Study|Lost to Follow-up|5|||
146751060|NCT00777803|529256892|FG000|Overall Study|Adverse Event|1|||
146751061|NCT00777803|529256893|FG001|Overall Study|Adverse Event|0|||
146751062|NCT00777803|529256892|FG000|Overall Study|Non-compliance|2|||
146751063|NCT00777803|529256893|FG001|Overall Study|Non-compliance|2|||
146751064|NCT01995357|529256896|FG000|Period 5|Lack of Efficacy|1|||
146751065|NCT01995357|529256897|FG001|Period 5|Lack of Efficacy|0|||
146751066|NCT01995357|529256898|FG002|Period 5|Lack of Efficacy|0|||
146751067|NCT01995357|529256899|FG003|Period 5|Lack of Efficacy|0|||
146751068|NCT01995357|529256900|FG004|Period 5|Lack of Efficacy|0|||
146751069|NCT01995357|529256901|FG005|Period 5|Lack of Efficacy|0|||
146751070|NCT01995357|529256896|FG000|Period 5|Adverse Event|1|||
146751071|NCT01995357|529256897|FG001|Period 5|Adverse Event|0|||
146751072|NCT01995357|529256898|FG002|Period 5|Adverse Event|1|||
146751073|NCT01995357|529256899|FG003|Period 5|Adverse Event|0|||
146751074|NCT01995357|529256900|FG004|Period 5|Adverse Event|0|||
146751075|NCT01995357|529256901|FG005|Period 5|Adverse Event|0|||
146751076|NCT00322868|529256902|FG000|Overall Study|disease progression|1|||
146751077|NCT01852162|529256904|FG000|Overall Study|Adverse Event|1|||
146751078|NCT01852162|529256905|FG001|Overall Study|Adverse Event|0|||
146751079|NCT01852162|529256904|FG000|Overall Study|Withdrawal by Subject|3|||
146751080|NCT01852162|529256905|FG001|Overall Study|Withdrawal by Subject|1|||
146751081|NCT02955277|529256908|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
146751082|NCT02955277|529256909|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
146751083|NCT02955277|529256908|FG000|Post to Follow-up|Lost to Follow-up|8|||
146751084|NCT02955277|529256909|FG001|Post to Follow-up|Lost to Follow-up|11|||
146751085|NCT00163215|529256910|FG000|Overall Study|Lack of Efficacy|3|||
146751086|NCT00163215|529256910|FG000|Overall Study|Withdrawal by Subject|5|||
146851423|NCT01021215|529624202|FG001|Overall Study|Lost to Follow-up|0|||
146851424|NCT01942590|529624203|FG000|Overall Study|Withdrawal by Subject|0|||
146851425|NCT01942590|529624204|FG001|Overall Study|Withdrawal by Subject|1|||
146851426|NCT01942590|529624203|FG000|Overall Study|Adverse Event|1|||
146851427|NCT01942590|529624204|FG001|Overall Study|Adverse Event|0|||
146851428|NCT03562975|529624216|FG000|Overall Study|Death|1|||
146751087|NCT00163215|529256910|FG000|Overall Study|Other|7|||
146751088|NCT02819479|529256913|FG000|Overall Study|Adverse Event|2|||
146751089|NCT02451930|529256915|FG000|Overall Study|Death|0|||
146751090|NCT02451930|529256916|FG001|Overall Study|Death|15|||
146751091|NCT02451930|529256915|FG000|Overall Study|Lost to Follow-up|0|||
146751092|NCT02451930|529256916|FG001|Overall Study|Lost to Follow-up|3|||
146751093|NCT02451930|529256915|FG000|Overall Study|Sponsor Decision|2|||
146751094|NCT02451930|529256916|FG001|Overall Study|Sponsor Decision|10|||
146751095|NCT02451930|529256915|FG000|Overall Study|Withdrawal by Subject|0|||
146751096|NCT02451930|529256916|FG001|Overall Study|Withdrawal by Subject|1|||
146751097|NCT02451930|529256915|FG000|Overall Study|Other|0|||
146751098|NCT02451930|529256916|FG001|Overall Study|Other|1|||
146751099|NCT04006366|529256921|FG000|Overall Study|Withdrawal by Subject|1|||
146751100|NCT04430335|529256923|FG000|Overall Study|Withdrawal by Subject|1|||
146751101|NCT03249376|529256932|FG000|Overall Study|Adverse Event|11|||
146751102|NCT03249376|529256933|FG001|Overall Study|Adverse Event|5|||
146751103|NCT03249376|529256932|FG000|Overall Study|Lack of Efficacy|2|||
146751104|NCT03249376|529256933|FG001|Overall Study|Lack of Efficacy|4|||
146751105|NCT03249376|529256932|FG000|Overall Study|Protocol Violation|3|||
146751106|NCT03249376|529256933|FG001|Overall Study|Protocol Violation|2|||
146751107|NCT03249376|529256932|FG000|Overall Study|Physician Decision|0|||
146751108|NCT03249376|529256933|FG001|Overall Study|Physician Decision|2|||
146751109|NCT03249376|529256932|FG000|Overall Study|Withdrawal by Subject|3|||
146751110|NCT03249376|529256933|FG001|Overall Study|Withdrawal by Subject|9|||
146751111|NCT03249376|529256932|FG000|Overall Study|LTFU|2|||
146751112|NCT03249376|529256933|FG001|Overall Study|LTFU|1|||
146751113|NCT00627042|529256934|FG000|Overall Study|Withdrawal by Subject|2|||
146751114|NCT01154036|529256935|FG000|Phase I|Physician Decision|0|||
146751115|NCT01154036|529256936|FG001|Phase I|Physician Decision|1|||
146751116|NCT01154036|529256937|FG002|Phase I|Physician Decision|0|||
146751117|NCT01154036|529256938|FG003|Phase I|Physician Decision|0|||
146751118|NCT01154036|529256939|FG004|Phase I|Physician Decision|0|||
146751119|NCT01154036|529256940|FG005|Phase I|Physician Decision|0|||
146751120|NCT01154036|529256941|FG006|Phase I|Physician Decision|0|||
146751121|NCT01154036|529256942|FG007|Phase I|Physician Decision|0|||
146751122|NCT01154036|529256935|FG000|Phase I|Lost to Follow-up|0|||
146751123|NCT01154036|529256936|FG001|Phase I|Lost to Follow-up|3|||
146751124|NCT01154036|529256937|FG002|Phase I|Lost to Follow-up|6|||
146512121|NCT01672294|528379144|FG001|Overall Study|Lost to Follow-up|16|||
146512122|NCT01672294|528379145|FG002|Overall Study|Lost to Follow-up|7|||
146512123|NCT01672294|528379146|FG003|Overall Study|Lost to Follow-up|9|||
146512124|NCT01285492|528379147|FG000|Overall Study|Adverse Event|11|||
146512125|NCT01285492|528379148|FG001|Overall Study|Adverse Event|0|||
146512126|NCT01285492|528379147|FG000|Overall Study|Protocol Violation|3|||
146512127|NCT01285492|528379148|FG001|Overall Study|Protocol Violation|0|||
146512128|NCT01285492|528379147|FG000|Overall Study|Withdrawal by Subject|2|||
146512129|NCT01285492|528379148|FG001|Overall Study|Withdrawal by Subject|1|||
146512130|NCT01285492|528379147|FG000|Overall Study|Death|1|||
146512131|NCT01285492|528379148|FG001|Overall Study|Death|0|||
146512132|NCT03379792|528379149|FG000|Overall Study|Physician Decision|0|||
146512133|NCT03379792|528379150|FG001|Overall Study|Physician Decision|0|||
146512134|NCT03379792|528379151|FG002|Overall Study|Physician Decision|0|||
146512135|NCT03379792|528379152|FG003|Overall Study|Physician Decision|1|||
146512136|NCT03379792|528379153|FG004|Overall Study|Physician Decision|0|||
146512137|NCT03379792|528379154|FG005|Overall Study|Physician Decision|0|||
146512138|NCT03379792|528379149|FG000|Overall Study|Withdrawal by Subject|0|||
146512139|NCT03379792|528379150|FG001|Overall Study|Withdrawal by Subject|0|||
146512140|NCT03379792|528379151|FG002|Overall Study|Withdrawal by Subject|0|||
146512141|NCT03379792|528379152|FG003|Overall Study|Withdrawal by Subject|0|||
146512142|NCT03379792|528379153|FG004|Overall Study|Withdrawal by Subject|1|||
146512143|NCT03379792|528379154|FG005|Overall Study|Withdrawal by Subject|1|||
146512144|NCT01121536|528379155|FG000|Overall Study|Adverse Event|63|||
146512145|NCT01121536|528379155|FG000|Overall Study|Lack of Efficacy|35|||
146512146|NCT01121536|528379155|FG000|Overall Study|Withdrawal by Subject|65|||
146512147|NCT01121536|528379155|FG000|Overall Study|Protocol Violation|20|||
146512148|NCT01121536|528379155|FG000|Overall Study|Noncompliance with study medication|12|||
146512149|NCT01121536|528379155|FG000|Overall Study|Noncompliance with study procedures|9|||
146512150|NCT01121536|528379155|FG000|Overall Study|Lost to Follow-up|39|||
146751125|NCT01154036|529256938|FG003|Phase I|Lost to Follow-up|0|||
146751126|NCT01154036|529256939|FG004|Phase I|Lost to Follow-up|0|||
146512151|NCT01121536|528379155|FG000|Overall Study|Other|118|||
146512152|NCT02649426|528379157|FG000|Overall Study|Follow-up on going|1|||
146512153|NCT02649426|528379158|FG001|Overall Study|Follow-up on going|26|||
146512154|NCT02649426|528379159|FG002|Overall Study|Follow-up on going|28|||
146512155|NCT02649426|528379160|FG003|Overall Study|Follow-up on going|31|||
146512156|NCT01606202|528379161|FG000|Overall Study|Adverse Event|5|||
146512157|NCT01606202|528379162|FG001|Overall Study|Adverse Event|0|||
146512158|NCT01606202|528379161|FG000|Overall Study|Withdrawal by Subject|2|||
146512159|NCT01606202|528379162|FG001|Overall Study|Withdrawal by Subject|1|||
146512160|NCT01606202|528379161|FG000|Overall Study|Personal problems|0|||
146512161|NCT01606202|528379162|FG001|Overall Study|Personal problems|1|||
146512162|NCT01606202|528379161|FG000|Overall Study|Problems with administration|0|||
146512163|NCT01606202|528379162|FG001|Overall Study|Problems with administration|1|||
146512164|NCT00306787|528379163|FG000|Overall Study|Discontinued without taking study drug|208|||
146512165|NCT00306787|528379164|FG001|Overall Study|Discontinued without taking study drug|215|||
146512166|NCT00306787|528379163|FG000|Overall Study|Adverse Event|1|||
146512167|NCT00306787|528379164|FG001|Overall Study|Adverse Event|1|||
146751127|NCT01154036|529256940|FG005|Phase I|Lost to Follow-up|0|||
146751128|NCT01154036|529256941|FG006|Phase I|Lost to Follow-up|0|||
146751129|NCT01154036|529256942|FG007|Phase I|Lost to Follow-up|0|||
146751130|NCT01154036|529256935|FG000|Phase I|Protocol Violation|0|||
146751131|NCT01154036|529256936|FG001|Phase I|Protocol Violation|3|||
146512168|NCT00306787|528379163|FG000|Overall Study|Lack of Efficacy|1|||
146512169|NCT00306787|528379164|FG001|Overall Study|Lack of Efficacy|0|||
146512170|NCT00306787|528379163|FG000|Overall Study|Protocol Violation|8|||
146512171|NCT00306787|528379164|FG001|Overall Study|Protocol Violation|10|||
146512172|NCT00306787|528379163|FG000|Overall Study|Withdrawal by Subject|2|||
146751132|NCT01154036|529256937|FG002|Phase I|Protocol Violation|9|||
146751133|NCT01154036|529256938|FG003|Phase I|Protocol Violation|0|||
146751134|NCT01154036|529256939|FG004|Phase I|Protocol Violation|0|||
146512173|NCT00306787|528379164|FG001|Overall Study|Withdrawal by Subject|9|||
146512174|NCT00306787|528379163|FG000|Overall Study|Lost to Follow-up|9|||
146512175|NCT00306787|528379164|FG001|Overall Study|Lost to Follow-up|6|||
146512176|NCT00306787|528379163|FG000|Overall Study|Administrative problems|4|||
146512177|NCT00306787|528379164|FG001|Overall Study|Administrative problems|0|||
146512178|NCT00306787|528379163|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146512179|NCT00306787|528379164|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146512180|NCT01438814|528379165|FG000|Overall Study|Adverse Event|3|||
146512181|NCT01438814|528379166|FG001|Overall Study|Adverse Event|3|||
146512182|NCT01438814|528379165|FG000|Overall Study|Protocol Violation|1|||
146512183|NCT01438814|528379166|FG001|Overall Study|Protocol Violation|2|||
146751135|NCT01154036|529256940|FG005|Phase I|Protocol Violation|0|||
146751136|NCT01154036|529256941|FG006|Phase I|Protocol Violation|0|||
146751137|NCT01154036|529256942|FG007|Phase I|Protocol Violation|0|||
146751138|NCT01154036|529256935|FG000|Phase I|Withdrawal by Subject|2|||
146751139|NCT01154036|529256936|FG001|Phase I|Withdrawal by Subject|10|||
146751140|NCT01154036|529256937|FG002|Phase I|Withdrawal by Subject|29|||
146751141|NCT01154036|529256938|FG003|Phase I|Withdrawal by Subject|0|||
146751142|NCT01154036|529256939|FG004|Phase I|Withdrawal by Subject|0|||
146751143|NCT01154036|529256940|FG005|Phase I|Withdrawal by Subject|0|||
146751144|NCT01154036|529256941|FG006|Phase I|Withdrawal by Subject|0|||
146751145|NCT01154036|529256942|FG007|Phase I|Withdrawal by Subject|0|||
146751146|NCT01154036|529256935|FG000|Phase I|Adverse Event|1|||
146751147|NCT01154036|529256936|FG001|Phase I|Adverse Event|11|||
146751148|NCT01154036|529256937|FG002|Phase I|Adverse Event|12|||
146751149|NCT01154036|529256938|FG003|Phase I|Adverse Event|0|||
146751150|NCT01154036|529256939|FG004|Phase I|Adverse Event|0|||
146751151|NCT01154036|529256940|FG005|Phase I|Adverse Event|0|||
146751152|NCT01154036|529256941|FG006|Phase I|Adverse Event|0|||
146751153|NCT01154036|529256942|FG007|Phase I|Adverse Event|0|||
146751154|NCT01154036|529256935|FG000|Phase II|Adverse Event|0|||
146751155|NCT01154036|529256936|FG001|Phase II|Adverse Event|0|||
146751156|NCT01154036|529256937|FG002|Phase II|Adverse Event|0|||
146751157|NCT01154036|529256938|FG003|Phase II|Adverse Event|0|||
146751158|NCT01154036|529256939|FG004|Phase II|Adverse Event|1|||
146751159|NCT01154036|529256940|FG005|Phase II|Adverse Event|1|||
146751160|NCT01154036|529256941|FG006|Phase II|Adverse Event|1|||
146751161|NCT01154036|529256942|FG007|Phase II|Adverse Event|1|||
146751162|NCT01154036|529256935|FG000|Phase II|Physician Decision|0|||
146751163|NCT01154036|529256936|FG001|Phase II|Physician Decision|0|||
146751164|NCT01154036|529256937|FG002|Phase II|Physician Decision|0|||
146751165|NCT01154036|529256938|FG003|Phase II|Physician Decision|0|||
146751166|NCT01154036|529256939|FG004|Phase II|Physician Decision|0|||
146751167|NCT01154036|529256940|FG005|Phase II|Physician Decision|0|||
146751168|NCT01154036|529256941|FG006|Phase II|Physician Decision|1|||
146751169|NCT01154036|529256942|FG007|Phase II|Physician Decision|0|||
146751170|NCT01154036|529256935|FG000|Phase II|Lost to Follow-up|0|||
146751171|NCT01154036|529256936|FG001|Phase II|Lost to Follow-up|0|||
146751172|NCT01154036|529256937|FG002|Phase II|Lost to Follow-up|0|||
146751173|NCT01154036|529256938|FG003|Phase II|Lost to Follow-up|1|||
146751174|NCT01154036|529256939|FG004|Phase II|Lost to Follow-up|2|||
146751175|NCT01154036|529256940|FG005|Phase II|Lost to Follow-up|0|||
146751176|NCT01154036|529256941|FG006|Phase II|Lost to Follow-up|2|||
146751177|NCT01154036|529256942|FG007|Phase II|Lost to Follow-up|1|||
146751178|NCT01154036|529256935|FG000|Phase II|Protocol Violation|0|||
146751179|NCT01154036|529256936|FG001|Phase II|Protocol Violation|0|||
146512184|NCT01438814|528379165|FG000|Overall Study|Lost to Follow-up|4|||
146751180|NCT01154036|529256937|FG002|Phase II|Protocol Violation|0|||
146751181|NCT01154036|529256938|FG003|Phase II|Protocol Violation|0|||
146751182|NCT01154036|529256939|FG004|Phase II|Protocol Violation|1|||
146751183|NCT01154036|529256940|FG005|Phase II|Protocol Violation|2|||
146751184|NCT01154036|529256941|FG006|Phase II|Protocol Violation|0|||
146751185|NCT01154036|529256942|FG007|Phase II|Protocol Violation|0|||
146751186|NCT01154036|529256935|FG000|Phase II|Withdrawal by Subject|0|||
146751187|NCT01154036|529256936|FG001|Phase II|Withdrawal by Subject|0|||
146751188|NCT01154036|529256937|FG002|Phase II|Withdrawal by Subject|0|||
146751189|NCT01154036|529256938|FG003|Phase II|Withdrawal by Subject|0|||
146751190|NCT01154036|529256939|FG004|Phase II|Withdrawal by Subject|4|||
146751191|NCT01154036|529256940|FG005|Phase II|Withdrawal by Subject|2|||
146751192|NCT01154036|529256941|FG006|Phase II|Withdrawal by Subject|5|||
146751193|NCT01154036|529256942|FG007|Phase II|Withdrawal by Subject|4|||
146751194|NCT04102540|529256946|FG000|Overall Study|Withdrawn by PI|2|||
146751195|NCT04102540|529256946|FG000|Overall Study|Lost to Follow-up|6|||
146751196|NCT01567163|529256949|FG000|Overall Study|Progressive Disease|2|||
146751197|NCT01567163|529256949|FG000|Overall Study|Lost to Follow-up|2|||
146751198|NCT03405662|529256950|FG000|Overall Study|COVID-19 restriction|1|||
146751199|NCT03405662|529256951|FG001|Overall Study|COVID-19 restriction|0|||
146751200|NCT03405662|529256950|FG000|Overall Study|unblinding|0|||
146751201|NCT03405662|529256951|FG001|Overall Study|unblinding|1|||
146751202|NCT03405662|529256950|FG000|Overall Study|placement in memory care facility|0|||
146751203|NCT03405662|529256951|FG001|Overall Study|placement in memory care facility|2|||
146751204|NCT00280293|529256952|FG000|Overall Study|Protocol Violation|3|||
146512185|NCT01438814|528379166|FG001|Overall Study|Lost to Follow-up|3|||
146512186|NCT01438814|528379165|FG000|Overall Study|Withdrawal by Subject|4|||
146512187|NCT01438814|528379166|FG001|Overall Study|Withdrawal by Subject|2|||
146512188|NCT01438814|528379165|FG000|Overall Study|Other|2|||
146512189|NCT01438814|528379166|FG001|Overall Study|Other|4|||
146512190|NCT02273908|528379167|FG000|Overall Study|Adverse Event|16|||
146512191|NCT02273908|528379168|FG001|Overall Study|Adverse Event|0|||
146512192|NCT02273908|528379167|FG000|Overall Study|Lost to Follow-up|10|||
146512193|NCT02273908|528379168|FG001|Overall Study|Lost to Follow-up|1|||
146512194|NCT02273908|528379167|FG000|Overall Study|Did not meet entrance criteria|3|||
146512195|NCT02273908|528379168|FG001|Overall Study|Did not meet entrance criteria|2|||
146512196|NCT02273908|528379167|FG000|Overall Study|Withdrawal by Subject|4|||
146512197|NCT02273908|528379168|FG001|Overall Study|Withdrawal by Subject|2|||
146512198|NCT00369161|528379169|FG000|Overall Study|Adverse Event|15|||
146512199|NCT00369161|528379170|FG001|Overall Study|Adverse Event|13|||
146512200|NCT00369161|528379169|FG000|Overall Study|Abnormal laboratory value|0|||
146512201|NCT00369161|528379170|FG001|Overall Study|Abnormal laboratory value|1|||
146512202|NCT00369161|528379169|FG000|Overall Study|Lack of Efficacy|3|||
146512203|NCT00369161|528379170|FG001|Overall Study|Lack of Efficacy|1|||
146512204|NCT00369161|528379169|FG000|Overall Study|Protocol Violation|0|||
146512205|NCT00369161|528379170|FG001|Overall Study|Protocol Violation|2|||
146512206|NCT00369161|528379169|FG000|Overall Study|Withdrawal by Subject|2|||
146512207|NCT00369161|528379170|FG001|Overall Study|Withdrawal by Subject|3|||
146512208|NCT00369161|528379169|FG000|Overall Study|Death|1|||
146512209|NCT00369161|528379170|FG001|Overall Study|Death|2|||
146512210|NCT00369161|528379169|FG000|Overall Study|Graft loss|4|||
146512211|NCT00369161|528379170|FG001|Overall Study|Graft loss|0|||
146512212|NCT00369161|528379169|FG000|Overall Study|Administrative Problem|2|||
146512213|NCT00369161|528379170|FG001|Overall Study|Administrative Problem|2|||
146512214|NCT04908475|528379171|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
146512215|NCT04908475|528379172|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146512216|NCT04908475|528379173|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146512217|NCT04908475|528379174|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146512218|NCT04908475|528379175|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146512219|NCT04908475|528379176|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146751205|NCT00280293|529256953|FG001|Overall Study|Protocol Violation|0|||
146751206|NCT00280293|529256952|FG000|Overall Study|Physician Decision|5|||
146751207|NCT00280293|529256953|FG001|Overall Study|Physician Decision|4|||
146751208|NCT00280293|529256952|FG000|Overall Study|Lost to Follow-up|14|||
146751209|NCT00280293|529256953|FG001|Overall Study|Lost to Follow-up|12|||
146751210|NCT00280293|529256952|FG000|Overall Study|Withdrawal by Subject|3|||
146751211|NCT00280293|529256953|FG001|Overall Study|Withdrawal by Subject|5|||
146751212|NCT00280293|529256952|FG000|Overall Study|Incarceration/Legal Reasons|1|||
146851429|NCT03562975|529624216|FG000|Overall Study|Lost to Follow-up|1|||
146851430|NCT03562975|529624216|FG000|Overall Study|Withdrawal by Subject|1|||
146512220|NCT04908475|528379171|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
146512221|NCT04908475|528379172|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
146512222|NCT04908475|528379173|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
146512223|NCT04908475|528379174|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
146512224|NCT04908475|528379175|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
146512225|NCT04908475|528379176|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
146512226|NCT04908475|528379171|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
146512227|NCT04908475|528379172|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
146512228|NCT04908475|528379173|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
146512229|NCT04908475|528379174|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
146751213|NCT00280293|529256953|FG001|Overall Study|Incarceration/Legal Reasons|1|||
146751214|NCT00280293|529256952|FG000|Overall Study|Adverse Event|0|||
146751215|NCT00280293|529256953|FG001|Overall Study|Adverse Event|1|||
146751216|NCT01348854|529256956|FG000|Overall Study|Lost to Follow-up|2|||
146751217|NCT01348854|529256957|FG001|Overall Study|Lost to Follow-up|1|||
146751218|NCT01348854|529256956|FG000|Overall Study|Withdrawal by Subject|1|||
146751219|NCT01348854|529256957|FG001|Overall Study|Withdrawal by Subject|0|||
146751220|NCT00983619|529256960|FG000|Overall Study|Lost to Follow-up|0|||
146751221|NCT00983619|529256961|FG001|Overall Study|Lost to Follow-up|1|||
146751222|NCT00983619|529256962|FG002|Overall Study|Lost to Follow-up|0|||
146751223|NCT00983619|529256963|FG003|Overall Study|Lost to Follow-up|0|||
146751224|NCT00983619|529256964|FG004|Overall Study|Lost to Follow-up|0|||
146751225|NCT00983619|529256965|FG005|Overall Study|Lost to Follow-up|2|||
146751226|NCT00983619|529256966|FG006|Overall Study|Lost to Follow-up|0|||
146751227|NCT00983619|529256967|FG007|Overall Study|Lost to Follow-up|0|||
146751228|NCT00983619|529256968|FG008|Overall Study|Lost to Follow-up|0|||
146751229|NCT00983619|529256969|FG009|Overall Study|Lost to Follow-up|0|||
146751230|NCT00983619|529256970|FG010|Overall Study|Lost to Follow-up|0|||
146751231|NCT00983619|529256971|FG011|Overall Study|Lost to Follow-up|2|||
146751232|NCT00983619|529256960|FG000|Overall Study|Withdrawal by Subject|2|||
146751233|NCT00983619|529256961|FG001|Overall Study|Withdrawal by Subject|1|||
146751234|NCT00983619|529256962|FG002|Overall Study|Withdrawal by Subject|1|||
146751235|NCT00983619|529256963|FG003|Overall Study|Withdrawal by Subject|3|||
146751236|NCT00983619|529256964|FG004|Overall Study|Withdrawal by Subject|1|||
146751237|NCT00983619|529256965|FG005|Overall Study|Withdrawal by Subject|23|||
146751238|NCT00983619|529256966|FG006|Overall Study|Withdrawal by Subject|0|||
146751239|NCT00983619|529256967|FG007|Overall Study|Withdrawal by Subject|0|||
146751240|NCT00983619|529256968|FG008|Overall Study|Withdrawal by Subject|0|||
146751241|NCT00983619|529256969|FG009|Overall Study|Withdrawal by Subject|0|||
146751242|NCT00983619|529256970|FG010|Overall Study|Withdrawal by Subject|1|||
146751243|NCT00983619|529256971|FG011|Overall Study|Withdrawal by Subject|1|||
146751244|NCT00983619|529256960|FG000|Overall Study|Death|0|||
146751245|NCT00983619|529256961|FG001|Overall Study|Death|2|||
146751246|NCT00983619|529256962|FG002|Overall Study|Death|2|||
146751247|NCT00983619|529256963|FG003|Overall Study|Death|1|||
146751248|NCT00983619|529256964|FG004|Overall Study|Death|2|||
146751249|NCT00983619|529256965|FG005|Overall Study|Death|30|||
146751250|NCT00983619|529256966|FG006|Overall Study|Death|1|||
146751251|NCT00983619|529256967|FG007|Overall Study|Death|0|||
146751252|NCT00983619|529256968|FG008|Overall Study|Death|1|||
146751253|NCT00983619|529256969|FG009|Overall Study|Death|2|||
146751254|NCT00983619|529256970|FG010|Overall Study|Death|9|||
146751255|NCT00983619|529256971|FG011|Overall Study|Death|8|||
146751256|NCT00983619|529256960|FG000|Overall Study|Other|1|||
146751257|NCT00983619|529256961|FG001|Overall Study|Other|0|||
146751258|NCT00983619|529256962|FG002|Overall Study|Other|0|||
146751259|NCT00983619|529256963|FG003|Overall Study|Other|1|||
146751260|NCT00983619|529256964|FG004|Overall Study|Other|0|||
146751261|NCT00983619|529256965|FG005|Overall Study|Other|12|||
146751262|NCT00983619|529256966|FG006|Overall Study|Other|2|||
146751263|NCT00983619|529256967|FG007|Overall Study|Other|2|||
146751264|NCT00983619|529256968|FG008|Overall Study|Other|0|||
146751265|NCT00983619|529256969|FG009|Overall Study|Other|1|||
146751266|NCT00983619|529256970|FG010|Overall Study|Other|1|||
146751267|NCT00983619|529256971|FG011|Overall Study|Other|0|||
146751268|NCT00724061|529256972|FG000|Dose Escalation Phase|Adverse Event|2|||
146751269|NCT00724061|529256972|FG000|Dose Escalation Phase|Disease Progression|3|||
146751270|NCT00088205|529256975|FG000|Overall Study|Adverse Event|4|||
146751271|NCT00088205|529256975|FG000|Overall Study|Progressive Disease|51|||
146751272|NCT00088205|529256975|FG000|Overall Study|Physician Decision|1|||
146751273|NCT00088205|529256975|FG000|Overall Study|Death Due to Study Disease|4|||
146751274|NCT02443103|529256980|FG000|Overall Study|Adverse Event|2|||
146751275|NCT02443103|529256980|FG000|Overall Study|Noncompliance|1|||
146751276|NCT03358329|529256985|FG000|Overall Study|Lost to Follow-up|2|||
146851431|NCT01758900|529624221|FG000|Overall Study|difficulty for further intubation|7|||
146851432|NCT01758900|529624222|FG001|Overall Study|difficulty for further intubation|8|||
146751277|NCT03358329|529256985|FG000|Overall Study|Withdrawal by Subject|2|||
146751278|NCT02982720|529256986|FG000|Overall Study|Adverse Event|3|||
146751279|NCT02982720|529256986|FG000|Overall Study|Death|1|||
146751280|NCT03875911|529256989|FG000|Overall Study|Lost to Follow-up|3|||
146751281|NCT03875911|529256990|FG001|Overall Study|Lost to Follow-up|6|||
146751282|NCT03875911|529256991|FG002|Overall Study|Lost to Follow-up|2|||
146751283|NCT03875911|529256989|FG000|Overall Study|Surgery cancelled|1|||
146751284|NCT03875911|529256990|FG001|Overall Study|Surgery cancelled|0|||
146751285|NCT03875911|529256991|FG002|Overall Study|Surgery cancelled|1|||
146751286|NCT03875911|529256989|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
146751287|NCT03875911|529256990|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
146751288|NCT03875911|529256991|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
146751289|NCT03824938|529256996|FG000|Overall Study|Withdrawal by Subject|2|||
146751290|NCT03824938|529256997|FG001|Overall Study|Withdrawal by Subject|1|||
146751291|NCT03824938|529256998|FG002|Overall Study|Withdrawal by Subject|0|||
146751292|NCT03824938|529256999|FG003|Overall Study|Withdrawal by Subject|2|||
146751293|NCT03824938|529257000|FG004|Overall Study|Withdrawal by Subject|0|||
146751294|NCT03824938|529257001|FG005|Overall Study|Withdrawal by Subject|1|||
146751295|NCT03824938|529256996|FG000|Overall Study|Lost to Follow-up|0|||
146751296|NCT03824938|529256997|FG001|Overall Study|Lost to Follow-up|1|||
146751297|NCT03824938|529256998|FG002|Overall Study|Lost to Follow-up|0|||
146751298|NCT03824938|529256999|FG003|Overall Study|Lost to Follow-up|0|||
146751299|NCT03824938|529257000|FG004|Overall Study|Lost to Follow-up|1|||
146751300|NCT03824938|529257001|FG005|Overall Study|Lost to Follow-up|0|||
146751301|NCT00287469|529257005|FG000|Overall Study|serious adverse event|1|||
146751302|NCT00287469|529257006|FG001|Overall Study|serious adverse event|6|||
146751303|NCT00287469|529257005|FG000|Overall Study|Adverse Event|1|||
146751304|NCT00287469|529257006|FG001|Overall Study|Adverse Event|1|||
146751305|NCT00287469|529257005|FG000|Overall Study|moved from area|144|||
146751306|NCT00287469|529257006|FG001|Overall Study|moved from area|138|||
146751307|NCT00287469|529257005|FG000|Overall Study|Lost to Follow-up|74|||
146751308|NCT00287469|529257006|FG001|Overall Study|Lost to Follow-up|69|||
146751309|NCT00507026|529257012|FG000|Overall Study|Lack of Efficacy|6|||
146751310|NCT00507026|529257013|FG001|Overall Study|Lack of Efficacy|4|||
146751311|NCT00507026|529257014|FG002|Overall Study|Lack of Efficacy|21|||
146751312|NCT00507026|529257012|FG000|Overall Study|Withdrawal by Subject|2|||
146751313|NCT00507026|529257013|FG001|Overall Study|Withdrawal by Subject|0|||
146751314|NCT00507026|529257014|FG002|Overall Study|Withdrawal by Subject|0|||
146751315|NCT00507026|529257012|FG000|Overall Study|Investigator Decision|1|||
146751316|NCT00507026|529257013|FG001|Overall Study|Investigator Decision|0|||
146751317|NCT00507026|529257014|FG002|Overall Study|Investigator Decision|0|||
146751318|NCT00507026|529257012|FG000|Overall Study|Adverse Event|2|||
146751319|NCT00507026|529257013|FG001|Overall Study|Adverse Event|0|||
146751320|NCT00507026|529257014|FG002|Overall Study|Adverse Event|0|||
146751321|NCT00507026|529257012|FG000|Overall Study|Protocol Violation|1|||
146751322|NCT00507026|529257013|FG001|Overall Study|Protocol Violation|0|||
146751323|NCT00507026|529257014|FG002|Overall Study|Protocol Violation|0|||
146751324|NCT00507026|529257012|FG000|Overall Study|Other|1|||
146751325|NCT00507026|529257013|FG001|Overall Study|Other|0|||
146751326|NCT00507026|529257014|FG002|Overall Study|Other|0|||
146751327|NCT01058863|529257015|FG000|Overall Study|Lost to Follow-up|1|||
146751328|NCT01058863|529257015|FG000|Overall Study|Withdrawal by Subject|1|||
146751329|NCT01058863|529257015|FG000|Overall Study|Sponsor requested withdrawal|1|||
146751330|NCT01058863|529257015|FG000|Overall Study|Randomized in error|1|||
146751331|NCT03653416|529257016|FG000|Overall Study|Protocol Violation|6|||
146751332|NCT03653416|529257017|FG001|Overall Study|Protocol Violation|1|||
146751333|NCT02788006|529257021|FG000|Overall Study|Patient not treated|1|||
146751334|NCT03050398|529257026|FG000|Overall Study|Study terminated by sponsor|8|||
146751335|NCT01991197|529257027|FG000|Overall Study|Lost to Follow-up|1|||
146751336|NCT01991197|529257028|FG001|Overall Study|Lost to Follow-up|1|||
146751337|NCT01991197|529257027|FG000|Overall Study|Physician Decision|0|||
146751338|NCT01991197|529257028|FG001|Overall Study|Physician Decision|2|||
146751339|NCT01991197|529257027|FG000|Overall Study|Withdrawal by Subject|2|||
146751340|NCT01991197|529257028|FG001|Overall Study|Withdrawal by Subject|0|||
146751341|NCT01010217|529257029|FG000|Overall Study|Lost to Follow-up|4|||
146751342|NCT01010217|529257030|FG001|Overall Study|Lost to Follow-up|5|||
146751343|NCT01010217|529257031|FG002|Overall Study|Lost to Follow-up|1|||
146751344|NCT01010217|529257032|FG003|Overall Study|Lost to Follow-up|0|||
146751345|NCT01010217|529257033|FG004|Overall Study|Lost to Follow-up|0|||
146751346|NCT01010217|529257029|FG000|Overall Study|Withdrawal by Subject|1|||
146751347|NCT01010217|529257030|FG001|Overall Study|Withdrawal by Subject|0|||
146751348|NCT01010217|529257031|FG002|Overall Study|Withdrawal by Subject|0|||
146751349|NCT01010217|529257032|FG003|Overall Study|Withdrawal by Subject|0|||
146751350|NCT01010217|529257033|FG004|Overall Study|Withdrawal by Subject|0|||
146751351|NCT01010217|529257029|FG000|Overall Study|Physician Decision|0|||
146751352|NCT01010217|529257030|FG001|Overall Study|Physician Decision|0|||
146751353|NCT01010217|529257031|FG002|Overall Study|Physician Decision|0|||
146751354|NCT01010217|529257032|FG003|Overall Study|Physician Decision|6|||
146751355|NCT01010217|529257033|FG004|Overall Study|Physician Decision|3|||
146751356|NCT04242875|529257036|FG000|Overall Study|Adverse Event|2|||
146751357|NCT02611830|529257039|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
146751358|NCT02611830|529257040|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
146751359|NCT02611830|529257041|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
146751360|NCT02611830|529257042|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
146751361|NCT02611830|529257039|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
146751362|NCT02611830|529257040|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
146751363|NCT02611830|529257041|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
146751364|NCT02611830|529257042|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
146751365|NCT02611830|529257039|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
146751366|NCT02611830|529257040|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
146751367|NCT02611830|529257041|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
146751368|NCT02611830|529257042|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
146751369|NCT02611830|529257039|FG000|OL Induction Phase|Lack of Efficacy|9|||
146751370|NCT02611830|529257040|FG001|OL Induction Phase|Lack of Efficacy|0|||
146751371|NCT02611830|529257041|FG002|OL Induction Phase|Lack of Efficacy|0|||
146751372|NCT02611830|529257042|FG003|OL Induction Phase|Lack of Efficacy|0|||
146751373|NCT02611830|529257039|FG000|OL Induction Phase|Reason not specified|3|||
146751374|NCT02611830|529257040|FG001|OL Induction Phase|Reason not specified|0|||
146751375|NCT02611830|529257041|FG002|OL Induction Phase|Reason not specified|0|||
146751376|NCT02611830|529257042|FG003|OL Induction Phase|Reason not specified|0|||
146751377|NCT02611830|529257039|FG000|Maintenance Phase|Lack of Efficacy|0|||
146751378|NCT02611830|529257040|FG001|Maintenance Phase|Lack of Efficacy|29|||
146751379|NCT02611830|529257041|FG002|Maintenance Phase|Lack of Efficacy|18|||
146751380|NCT02611830|529257042|FG003|Maintenance Phase|Lack of Efficacy|6|||
146751381|NCT02611830|529257039|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
146751382|NCT02611830|529257040|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
146751383|NCT02611830|529257041|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
146751384|NCT02611830|529257042|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
146751385|NCT02611830|529257039|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
146751386|NCT02611830|529257040|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
146751387|NCT02611830|529257041|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
146751388|NCT02611830|529257042|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
146751389|NCT02611830|529257039|FG000|Maintenance Phase|Lost to Follow-up|0|||
146751390|NCT02611830|529257040|FG001|Maintenance Phase|Lost to Follow-up|0|||
146751391|NCT02611830|529257041|FG002|Maintenance Phase|Lost to Follow-up|0|||
146751392|NCT02611830|529257042|FG003|Maintenance Phase|Lost to Follow-up|1|||
146751393|NCT02611830|529257039|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
146751394|NCT02611830|529257040|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
146751395|NCT02611830|529257041|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
146751396|NCT02611830|529257042|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
146751397|NCT02611830|529257039|FG000|Maintenance Phase|Pregnancy|0|||
146751398|NCT02611830|529257040|FG001|Maintenance Phase|Pregnancy|0|||
146751399|NCT02611830|529257041|FG002|Maintenance Phase|Pregnancy|1|||
146751400|NCT02611830|529257042|FG003|Maintenance Phase|Pregnancy|0|||
146512230|NCT04908475|528379175|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
146512231|NCT04908475|528379176|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
146512232|NCT04908475|528379171|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
146512233|NCT04908475|528379172|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
146512234|NCT04908475|528379173|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
146512235|NCT04908475|528379174|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
146512236|NCT04908475|528379175|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
146751401|NCT02611830|529257039|FG000|Maintenance Phase|Reason not specified|0|||
146751402|NCT02611830|529257040|FG001|Maintenance Phase|Reason not specified|1|||
146751403|NCT02611830|529257041|FG002|Maintenance Phase|Reason not specified|4|||
146751404|NCT02611830|529257042|FG003|Maintenance Phase|Reason not specified|0|||
146751405|NCT03567993|529257045|FG000|Overall Study|Lost to Follow-up|4|||
146751406|NCT03567993|529257046|FG001|Overall Study|Lost to Follow-up|2|||
146751407|NCT03567993|529257045|FG000|Overall Study|Death|1|||
146751408|NCT03567993|529257046|FG001|Overall Study|Death|1|||
146751409|NCT03567993|529257045|FG000|Overall Study|Withdrawal by Subject|1|||
146751410|NCT03567993|529257046|FG001|Overall Study|Withdrawal by Subject|0|||
146751411|NCT01671748|529257047|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
146751412|NCT01671748|529257048|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
146751413|NCT01671748|529257047|FG000|4 Week run-in Phase|Adverse Event|1|||
146751414|NCT01671748|529257048|FG001|4 Week run-in Phase|Adverse Event|0|||
146751415|NCT01671748|529257047|FG000|4 Week run-in Phase|Not eligible|9|||
146751416|NCT01671748|529257048|FG001|4 Week run-in Phase|Not eligible|0|||
146751417|NCT04714216|529258664|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
146512237|NCT04908475|528379176|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
146512238|NCT04908475|528379171|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
146751418|NCT04714216|529258664|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
146751419|NCT04129580|529258667|FG000|Overall Study|Lost to Follow-up|14|||
146851433|NCT00935818|529624224|FG000|Overall Study|Withdrawal by Subject|45|||
146751420|NCT04129580|529258668|FG001|Overall Study|Lost to Follow-up|25|||
146751421|NCT02711995|529258671|FG000|Washout (90 Days)|Conflicting medication|1|||
146751422|NCT03615482|529258672|FG000|Overall Study|Death|1|||
146751423|NCT03615482|529258673|FG001|Overall Study|Death|0|||
146751424|NCT03615482|529258672|FG000|Overall Study|Lost to Follow-up|7|||
146751425|NCT03615482|529258673|FG001|Overall Study|Lost to Follow-up|7|||
146751426|NCT03615482|529258672|FG000|Overall Study|Physician Decision|2|||
146751427|NCT03615482|529258673|FG001|Overall Study|Physician Decision|3|||
146751428|NCT03615482|529258672|FG000|Overall Study|Withdrawal by Subject|7|||
146751429|NCT03615482|529258673|FG001|Overall Study|Withdrawal by Subject|7|||
146751430|NCT01809210|529258683|FG000|Overall Study|Withdrawal by Subject|0|||
146751431|NCT01809210|529258684|FG001|Overall Study|Withdrawal by Subject|0|||
146851434|NCT00935818|529624225|FG001|Overall Study|Withdrawal by Subject|50|||
146751432|NCT01809210|529258685|FG002|Overall Study|Withdrawal by Subject|1|||
146512239|NCT04908475|528379172|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
146512240|NCT04908475|528379173|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
146512241|NCT04908475|528379174|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
146512242|NCT04908475|528379175|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
146512243|NCT04908475|528379176|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
146512244|NCT04908475|528379171|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
146512245|NCT04908475|528379172|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
146512246|NCT04908475|528379173|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
146512247|NCT04908475|528379174|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
146512248|NCT04908475|528379175|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
146512249|NCT04908475|528379176|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
146512250|NCT01870297|528379177|FG000|Overall Study|Adverse Event|0|||
146512251|NCT01870297|528379178|FG001|Overall Study|Adverse Event|0|||
146512252|NCT01870297|528379179|FG002|Overall Study|Adverse Event|0|||
146512253|NCT01870297|528379180|FG003|Overall Study|Adverse Event|0|||
146512254|NCT01870297|528379181|FG004|Overall Study|Adverse Event|2|||
146512255|NCT01870297|528379182|FG005|Overall Study|Adverse Event|0|||
146512256|NCT01870297|528379183|FG006|Overall Study|Adverse Event|0|||
146512257|NCT01870297|528379177|FG000|Overall Study|Lost to Follow-up|0|||
146512258|NCT01870297|528379178|FG001|Overall Study|Lost to Follow-up|1|||
146512259|NCT01870297|528379179|FG002|Overall Study|Lost to Follow-up|1|||
146512260|NCT01870297|528379180|FG003|Overall Study|Lost to Follow-up|0|||
146512261|NCT01870297|528379181|FG004|Overall Study|Lost to Follow-up|0|||
146512262|NCT01870297|528379182|FG005|Overall Study|Lost to Follow-up|0|||
146512263|NCT01870297|528379183|FG006|Overall Study|Lost to Follow-up|0|||
146512264|NCT01870297|528379177|FG000|Overall Study|Withdrawal by Subject|0|||
146512265|NCT01870297|528379178|FG001|Overall Study|Withdrawal by Subject|0|||
146512266|NCT01870297|528379179|FG002|Overall Study|Withdrawal by Subject|0|||
146512267|NCT01870297|528379180|FG003|Overall Study|Withdrawal by Subject|0|||
146512268|NCT01870297|528379181|FG004|Overall Study|Withdrawal by Subject|1|||
146512269|NCT01870297|528379182|FG005|Overall Study|Withdrawal by Subject|1|||
146512270|NCT01870297|528379183|FG006|Overall Study|Withdrawal by Subject|1|||
146512271|NCT01870297|528379177|FG000|Overall Study|Sponsor Decision|0|||
146512272|NCT01870297|528379178|FG001|Overall Study|Sponsor Decision|6|||
146512273|NCT01870297|528379179|FG002|Overall Study|Sponsor Decision|0|||
146512274|NCT01870297|528379180|FG003|Overall Study|Sponsor Decision|0|||
146512275|NCT01870297|528379181|FG004|Overall Study|Sponsor Decision|0|||
146512276|NCT01870297|528379182|FG005|Overall Study|Sponsor Decision|0|||
146512277|NCT01870297|528379183|FG006|Overall Study|Sponsor Decision|1|||
146512278|NCT01739764|528379184|FG000|Overall Study|Adverse Event|0|||
146512279|NCT01739764|528379185|FG001|Overall Study|Adverse Event|3|||
146512280|NCT01739764|528379186|FG002|Overall Study|Adverse Event|4|||
146512281|NCT01739764|528379184|FG000|Overall Study|Death|4|||
146512282|NCT01739764|528379185|FG001|Overall Study|Death|6|||
146512283|NCT01739764|528379186|FG002|Overall Study|Death|38|||
146512284|NCT01739764|528379184|FG000|Overall Study|Lost to Follow-up|0|||
146512285|NCT01739764|528379185|FG001|Overall Study|Lost to Follow-up|0|||
146512286|NCT01739764|528379186|FG002|Overall Study|Lost to Follow-up|5|||
146512287|NCT01739764|528379184|FG000|Overall Study|Non-Compliance|0|||
146512288|NCT01739764|528379185|FG001|Overall Study|Non-Compliance|0|||
146512289|NCT01739764|528379186|FG002|Overall Study|Non-Compliance|1|||
146512290|NCT01739764|528379184|FG000|Overall Study|Multiple Reasons|3|||
146512291|NCT01739764|528379185|FG001|Overall Study|Multiple Reasons|2|||
146512292|NCT01739764|528379186|FG002|Overall Study|Multiple Reasons|3|||
146512293|NCT01739764|528379184|FG000|Overall Study|Physician Decision|2|||
146512294|NCT01739764|528379185|FG001|Overall Study|Physician Decision|2|||
146751433|NCT01809210|529258686|FG003|Overall Study|Withdrawal by Subject|1|||
146751434|NCT01809210|529258687|FG004|Overall Study|Withdrawal by Subject|1|||
146751435|NCT01809210|529258688|FG005|Overall Study|Withdrawal by Subject|0|||
146751436|NCT01809210|529258689|FG006|Overall Study|Withdrawal by Subject|4|||
146512295|NCT01739764|528379186|FG002|Overall Study|Physician Decision|4|||
146512296|NCT01739764|528379184|FG000|Overall Study|Progressive Disease|3|||
146512297|NCT01739764|528379185|FG001|Overall Study|Progressive Disease|5|||
146512298|NCT01739764|528379186|FG002|Overall Study|Progressive Disease|16|||
146512299|NCT01739764|528379184|FG000|Overall Study|Protocol Violation|0|||
146512300|NCT01739764|528379185|FG001|Overall Study|Protocol Violation|0|||
146512301|NCT01739764|528379186|FG002|Overall Study|Protocol Violation|2|||
146512302|NCT01739764|528379184|FG000|Overall Study|Study Terminated by Sponsor|8|||
146512303|NCT01739764|528379185|FG001|Overall Study|Study Terminated by Sponsor|13|||
146512304|NCT01739764|528379186|FG002|Overall Study|Study Terminated by Sponsor|26|||
146512305|NCT01739764|528379184|FG000|Overall Study|Withdrawal by Subject|6|||
146512306|NCT01739764|528379185|FG001|Overall Study|Withdrawal by Subject|5|||
146512307|NCT01739764|528379186|FG002|Overall Study|Withdrawal by Subject|27|||
146512308|NCT00337779|528379187|FG000|Overall Study|Withdrawal by Subject|10|||
146512309|NCT00337779|528379188|FG001|Overall Study|Withdrawal by Subject|12|||
146512310|NCT00337779|528379187|FG000|Overall Study|Sponsor decision|1|||
146512311|NCT00337779|528379188|FG001|Overall Study|Sponsor decision|1|||
146751437|NCT01809210|529258683|FG000|Overall Study|Death|1|||
146751438|NCT01809210|529258684|FG001|Overall Study|Death|1|||
146751439|NCT01809210|529258685|FG002|Overall Study|Death|2|||
146751440|NCT01809210|529258686|FG003|Overall Study|Death|0|||
146751441|NCT01809210|529258687|FG004|Overall Study|Death|1|||
146751442|NCT01809210|529258688|FG005|Overall Study|Death|3|||
146751443|NCT01809210|529258689|FG006|Overall Study|Death|1|||
146751444|NCT01115998|529258691|FG000|Overall Study|Lost to Follow-up|6|||
146751445|NCT01115998|529258692|FG001|Overall Study|Lost to Follow-up|6|||
146751446|NCT00590980|529258693|FG000|Overall Study|Did not meet all inclusion criteria|10|||
146751447|NCT02718417|529258696|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
146751448|NCT02718417|529258697|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
146751449|NCT02718417|529258698|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
146751450|NCT02718417|529258696|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
146751451|NCT02718417|529258697|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
146751452|NCT02718417|529258698|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
146751453|NCT02718417|529258696|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
146751454|NCT02718417|529258697|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
146751455|NCT02718417|529258698|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
146751456|NCT02718417|529258696|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
146751457|NCT02718417|529258697|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
146751458|NCT02718417|529258698|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
146751459|NCT02718417|529258696|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
146751460|NCT02718417|529258697|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
146751461|NCT02718417|529258698|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
146751462|NCT02718417|529258696|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
146751463|NCT02718417|529258697|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
146751464|NCT02718417|529258698|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
146751465|NCT02718417|529258696|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
146751466|NCT02718417|529258697|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
146751467|NCT02718417|529258698|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
146751468|NCT02718417|529258696|FG000|Chemotherapy Phase (CP)|Other|2|||
146751469|NCT02718417|529258697|FG001|Chemotherapy Phase (CP)|Other|0|||
146751470|NCT02718417|529258698|FG002|Chemotherapy Phase (CP)|Other|1|||
146751471|NCT02718417|529258696|FG000|Maintenance Phase (MP)|Adverse Event|21|||
146751472|NCT02718417|529258697|FG001|Maintenance Phase (MP)|Adverse Event|26|||
146751473|NCT02718417|529258698|FG002|Maintenance Phase (MP)|Adverse Event|0|||
146751474|NCT02718417|529258696|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
146751475|NCT02718417|529258697|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
146751476|NCT02718417|529258698|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
146751477|NCT02718417|529258696|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
146751478|NCT02718417|529258697|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
146751479|NCT02718417|529258698|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
146751480|NCT02718417|529258696|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
146751481|NCT02718417|529258697|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
146751482|NCT02718417|529258698|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
146751483|NCT02718417|529258696|FG000|Maintenance Phase (MP)|Physician's decision|6|||
146751484|NCT02718417|529258697|FG001|Maintenance Phase (MP)|Physician's decision|7|||
146751485|NCT02718417|529258698|FG002|Maintenance Phase (MP)|Physician's decision|0|||
146751486|NCT02718417|529258696|FG000|Maintenance Phase (MP)|Progressive disease|100|||
146751487|NCT02718417|529258697|FG001|Maintenance Phase (MP)|Progressive disease|88|||
146751488|NCT02718417|529258698|FG002|Maintenance Phase (MP)|Progressive disease|0|||
146751489|NCT02718417|529258696|FG000|Maintenance Phase (MP)|Other|2|||
146751490|NCT02718417|529258697|FG001|Maintenance Phase (MP)|Other|1|||
146751491|NCT02718417|529258698|FG002|Maintenance Phase (MP)|Other|0|||
146751492|NCT02718417|529258696|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
146751493|NCT02718417|529258697|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
146751494|NCT02718417|529258698|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
146751495|NCT02718417|529258696|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
146751496|NCT02718417|529258697|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
146751497|NCT02718417|529258698|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
146751498|NCT02718417|529258696|FG000|Observation Phase (OP)|Adverse Event|0|||
146751499|NCT02718417|529258697|FG001|Observation Phase (OP)|Adverse Event|0|||
146751500|NCT02718417|529258698|FG002|Observation Phase (OP)|Adverse Event|1|||
146751501|NCT02718417|529258696|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
146751502|NCT02718417|529258697|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
146751503|NCT02718417|529258698|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
146751504|NCT02718417|529258696|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
146751505|NCT02718417|529258697|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
146751506|NCT02718417|529258698|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
146751507|NCT02718417|529258696|FG000|Observation Phase (OP)|Physician Decision|0|||
146751508|NCT02718417|529258697|FG001|Observation Phase (OP)|Physician Decision|0|||
146751509|NCT02718417|529258698|FG002|Observation Phase (OP)|Physician Decision|9|||
146751510|NCT02718417|529258696|FG000|Observation Phase (OP)|Progressive disease|0|||
146751511|NCT02718417|529258697|FG001|Observation Phase (OP)|Progressive disease|0|||
146751512|NCT02718417|529258698|FG002|Observation Phase (OP)|Progressive disease|92|||
146751513|NCT02718417|529258696|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
146751514|NCT02718417|529258697|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
146751515|NCT02718417|529258698|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
146751516|NCT02718417|529258696|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
146751517|NCT02718417|529258697|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
146751518|NCT02718417|529258698|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
146751519|NCT02718417|529258696|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
146751520|NCT02718417|529258697|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
146751521|NCT02718417|529258698|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
146751522|NCT02718417|529258696|FG000|Observation Phase (OP)|Other|0|||
146751523|NCT02718417|529258697|FG001|Observation Phase (OP)|Other|0|||
146751524|NCT02718417|529258698|FG002|Observation Phase (OP)|Other|7|||
146751525|NCT02718417|529258696|FG000|Follow-up Phase|Adverse Event|3|||
146751526|NCT02718417|529258697|FG001|Follow-up Phase|Adverse Event|1|||
146751527|NCT02718417|529258698|FG002|Follow-up Phase|Adverse Event|1|||
146751528|NCT02718417|529258696|FG000|Follow-up Phase|Other|4|||
146751529|NCT02718417|529258697|FG001|Follow-up Phase|Other|6|||
146751530|NCT02718417|529258698|FG002|Follow-up Phase|Other|4|||
146751531|NCT02718417|529258696|FG000|Follow-up Phase|Withdrawal by Subject|19|||
146751532|NCT02718417|529258697|FG001|Follow-up Phase|Withdrawal by Subject|17|||
146751533|NCT02718417|529258698|FG002|Follow-up Phase|Withdrawal by Subject|5|||
146751534|NCT02718417|529258696|FG000|Follow-up Phase|Study terminated by sponsor|100|||
146751535|NCT02718417|529258697|FG001|Follow-up Phase|Study terminated by sponsor|138|||
146751536|NCT02718417|529258698|FG002|Follow-up Phase|Study terminated by sponsor|6|||
146751537|NCT02718417|529258696|FG000|Follow-up Phase|Lost to Follow-up|2|||
146751538|NCT02718417|529258697|FG001|Follow-up Phase|Lost to Follow-up|3|||
146751539|NCT02718417|529258698|FG002|Follow-up Phase|Lost to Follow-up|0|||
146751540|NCT02718417|529258696|FG000|Follow-up Phase|Death leading to discontinuation|7|||
146751541|NCT02718417|529258697|FG001|Follow-up Phase|Death leading to discontinuation|7|||
146751542|NCT02718417|529258698|FG002|Follow-up Phase|Death leading to discontinuation|3|||
146751543|NCT02718417|529258696|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
146751544|NCT02718417|529258697|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
146751545|NCT02718417|529258698|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
146751546|NCT02718417|529258696|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
146751547|NCT02718417|529258697|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
146751548|NCT02718417|529258698|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
146751549|NCT02718417|529258696|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
146751550|NCT02718417|529258697|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
146751551|NCT02718417|529258698|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
146751552|NCT02718417|529258696|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
146751553|NCT02718417|529258697|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
146751554|NCT02718417|529258698|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
146751555|NCT02718417|529258696|FG000|Long-term Follow-up Phase|Other|0|||
146751556|NCT02718417|529258697|FG001|Long-term Follow-up Phase|Other|2|||
146751557|NCT02718417|529258698|FG002|Long-term Follow-up Phase|Other|0|||
146751558|NCT01023308|529258699|FG000|Overall Study|Abnormal test proceedure results|3|||
146751559|NCT01023308|529258700|FG001|Overall Study|Abnormal test proceedure results|8|||
146751560|NCT01023308|529258699|FG000|Overall Study|Administrative problems|2|||
146751561|NCT01023308|529258700|FG001|Overall Study|Administrative problems|1|||
146751562|NCT01023308|529258699|FG000|Overall Study|Adverse Event|130|||
146751563|NCT01023308|529258700|FG001|Overall Study|Adverse Event|66|||
146751564|NCT01023308|529258699|FG000|Overall Study|Death|21|||
146751565|NCT01023308|529258700|FG001|Overall Study|Death|17|||
146751566|NCT01023308|529258699|FG000|Overall Study|Disease progression|82|||
146751567|NCT01023308|529258700|FG001|Overall Study|Disease progression|153|||
146751568|NCT01023308|529258699|FG000|Overall Study|New Cancer therapy|4|||
146751569|NCT01023308|529258700|FG001|Overall Study|New Cancer therapy|7|||
146751570|NCT01023308|529258699|FG000|Overall Study|Protocol Violation|3|||
146751571|NCT01023308|529258700|FG001|Overall Study|Protocol Violation|4|||
146751572|NCT01023308|529258699|FG000|Overall Study|Untreated|5|||
146751573|NCT01023308|529258700|FG001|Overall Study|Untreated|5|||
146751574|NCT01023308|529258699|FG000|Overall Study|Lost to Follow-up|1|||
146751575|NCT01023308|529258700|FG001|Overall Study|Lost to Follow-up|0|||
146751576|NCT01023308|529258699|FG000|Overall Study|Withdrawal by Subject|34|||
146751577|NCT01023308|529258700|FG001|Overall Study|Withdrawal by Subject|18|||
146751578|NCT01646320|529258707|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
146751579|NCT01646320|529258708|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
146751580|NCT01646320|529258707|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
146751581|NCT01646320|529258708|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
146751582|NCT01646320|529258707|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
146751583|NCT01646320|529258708|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
146512312|NCT00337779|528379187|FG000|Overall Study|Physician Decision|3|||
146751584|NCT01646320|529258707|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
146751585|NCT01646320|529258708|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
146751586|NCT01646320|529258707|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
146751587|NCT01646320|529258708|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
146751588|NCT01646320|529258707|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
146751589|NCT01646320|529258708|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
146751590|NCT01646320|529258707|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
146751591|NCT01646320|529258708|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
146751592|NCT01646320|529258707|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
146512313|NCT00337779|528379188|FG001|Overall Study|Physician Decision|6|||
146512314|NCT00337779|528379187|FG000|Overall Study|Protocol Violation|1|||
146512315|NCT00337779|528379188|FG001|Overall Study|Protocol Violation|1|||
146512316|NCT00337779|528379187|FG000|Overall Study|Lost to Follow-up|6|||
146512317|NCT00337779|528379188|FG001|Overall Study|Lost to Follow-up|5|||
146512318|NCT00337779|528379187|FG000|Overall Study|Adverse Event|28|||
146512319|NCT00337779|528379188|FG001|Overall Study|Adverse Event|51|||
146512320|NCT00337779|528379187|FG000|Overall Study|Pregnancy|3|||
146512321|NCT00337779|528379188|FG001|Overall Study|Pregnancy|2|||
146512322|NCT00337779|528379187|FG000|Overall Study|Death|0|||
146512323|NCT00337779|528379188|FG001|Overall Study|Death|1|||
146512324|NCT00404924|528379189|FG000|Overall Study|Adverse Event|75|||
146512325|NCT00404924|528379190|FG001|Overall Study|Adverse Event|16|||
146512326|NCT00404924|528379189|FG000|Overall Study|Condition under investigation worsened|475|||
146512327|NCT00404924|528379190|FG001|Overall Study|Condition under investigation worsened|264|||
146512328|NCT00404924|528379189|FG000|Overall Study|Lost to Follow-up|1|||
146512329|NCT00404924|528379190|FG001|Overall Study|Lost to Follow-up|1|||
146512330|NCT00404924|528379189|FG000|Overall Study|Withdrawal by Subject|26|||
146512331|NCT00404924|528379190|FG001|Overall Study|Withdrawal by Subject|13|||
146512332|NCT00404924|528379189|FG000|Overall Study|Other|25|||
146512333|NCT00404924|528379190|FG001|Overall Study|Other|11|||
146751593|NCT01646320|529258708|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
146751594|NCT01646320|529258707|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
146751595|NCT01646320|529258708|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
146751596|NCT01646320|529258707|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
146751597|NCT01646320|529258708|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
146751598|NCT01646320|529258707|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
146751599|NCT01646320|529258708|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
146751600|NCT01489020|529258709|FG000|Overall Study|Withdrawal by Subject|1|||
146751601|NCT01489020|529258710|FG001|Overall Study|Withdrawal by Subject|0|||
146751602|NCT01489020|529258711|FG002|Overall Study|Withdrawal by Subject|0|||
146751603|NCT01489020|529258712|FG003|Overall Study|Withdrawal by Subject|0|||
146751604|NCT01489020|529258713|FG004|Overall Study|Withdrawal by Subject|0|||
146851435|NCT00935818|529624224|FG000|Overall Study|Lost to Follow-up|40|||
146512334|NCT00404924|528379189|FG000|Overall Study|Randomised but not received treatment|1|||
146512335|NCT00404924|528379190|FG001|Overall Study|Randomised but not received treatment|1|||
146851436|NCT00935818|529624225|FG001|Overall Study|Lost to Follow-up|42|||
146512336|NCT03008278|528379197|FG000|Overall Study|Progressive Disease|0|||
146512337|NCT03008278|528379198|FG001|Overall Study|Progressive Disease|0|||
146751605|NCT01489020|529258714|FG005|Overall Study|Withdrawal by Subject|0|||
146751606|NCT01489020|529258709|FG000|Overall Study|Adverse Event|0|||
146751607|NCT01489020|529258710|FG001|Overall Study|Adverse Event|0|||
146751608|NCT01489020|529258711|FG002|Overall Study|Adverse Event|3|||
146751609|NCT01489020|529258712|FG003|Overall Study|Adverse Event|0|||
146751610|NCT01489020|529258713|FG004|Overall Study|Adverse Event|3|||
146751611|NCT01489020|529258714|FG005|Overall Study|Adverse Event|0|||
146751612|NCT01489020|529258709|FG000|Overall Study|Concomitant disease|0|||
146751613|NCT01489020|529258710|FG001|Overall Study|Concomitant disease|0|||
146751614|NCT01489020|529258711|FG002|Overall Study|Concomitant disease|0|||
146751615|NCT01489020|529258712|FG003|Overall Study|Concomitant disease|0|||
146751616|NCT01489020|529258713|FG004|Overall Study|Concomitant disease|3|||
146751617|NCT01489020|529258714|FG005|Overall Study|Concomitant disease|0|||
146751618|NCT02485353|529258717|FG000|Overall Study|Death|1|||
146751619|NCT02485353|529258717|FG000|Overall Study|Disease Progression|1|||
146751620|NCT00839917|529258722|FG000|Overall Study|Lost to Follow-up|1|||
146751621|NCT00839917|529258723|FG001|Overall Study|Lost to Follow-up|0|||
146751622|NCT00839917|529258722|FG000|Overall Study|Did not receive vaccine|0|||
146751623|NCT00839917|529258723|FG001|Overall Study|Did not receive vaccine|1|||
146751624|NCT03354637|529258724|FG000|Double-blind Period|Protocol Violation|2|||
146751625|NCT03354637|529258725|FG001|Double-blind Period|Protocol Violation|0|||
146751626|NCT03354637|529258726|FG002|Double-blind Period|Protocol Violation|0|||
146751627|NCT03354637|529258724|FG000|Double-blind Period|Adverse Event|1|||
146751628|NCT03354637|529258725|FG001|Double-blind Period|Adverse Event|2|||
146751629|NCT03354637|529258726|FG002|Double-blind Period|Adverse Event|0|||
146751630|NCT03354637|529258724|FG000|Double-blind Period|Lost to Follow-up|3|||
146751631|NCT03354637|529258725|FG001|Double-blind Period|Lost to Follow-up|4|||
146751632|NCT03354637|529258726|FG002|Double-blind Period|Lost to Follow-up|3|||
146751633|NCT03354637|529258724|FG000|Double-blind Period|Withdrawal by Subject|10|||
146751634|NCT03354637|529258725|FG001|Double-blind Period|Withdrawal by Subject|6|||
146751635|NCT03354637|529258726|FG002|Double-blind Period|Withdrawal by Subject|4|||
146751636|NCT03354637|529258724|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
146751637|NCT03354637|529258725|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
146751638|NCT03354637|529258726|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
146751639|NCT03354637|529258724|FG000|Open Label Extension|Adverse Event|0|||
146751640|NCT03354637|529258725|FG001|Open Label Extension|Adverse Event|0|||
146751641|NCT03354637|529258726|FG002|Open Label Extension|Adverse Event|1|||
146751642|NCT03354637|529258724|FG000|Open Label Extension|Lost to Follow-up|0|||
146751643|NCT03354637|529258725|FG001|Open Label Extension|Lost to Follow-up|0|||
146751644|NCT03354637|529258726|FG002|Open Label Extension|Lost to Follow-up|2|||
146751645|NCT03354637|529258724|FG000|Open Label Extension|Withdrawal by Subject|0|||
146751646|NCT03354637|529258725|FG001|Open Label Extension|Withdrawal by Subject|0|||
146751647|NCT03354637|529258726|FG002|Open Label Extension|Withdrawal by Subject|5|||
146751648|NCT03354637|529258724|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
146751649|NCT03354637|529258725|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
146751650|NCT03354637|529258726|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
146751651|NCT03354637|529258724|FG000|Open Label Extension|Subject Noncompliance|0|||
146751652|NCT03354637|529258725|FG001|Open Label Extension|Subject Noncompliance|0|||
146751653|NCT03354637|529258726|FG002|Open Label Extension|Subject Noncompliance|1|||
146751654|NCT03354637|529258724|FG000|Open Label Extension|Lack of Efficacy|0|||
146751655|NCT03354637|529258725|FG001|Open Label Extension|Lack of Efficacy|0|||
146751656|NCT03354637|529258726|FG002|Open Label Extension|Lack of Efficacy|1|||
146751657|NCT03354637|529258724|FG000|Open Label Extension|Physician Decision|0|||
146751658|NCT03354637|529258725|FG001|Open Label Extension|Physician Decision|0|||
146751659|NCT03354637|529258726|FG002|Open Label Extension|Physician Decision|1|||
146751660|NCT02268552|529258731|FG000|Part 1|Death|1|||
146751661|NCT02268552|529258732|FG001|Part 1|Death|1|||
146751662|NCT02268552|529258733|FG002|Part 1|Death|1|||
146851437|NCT00935818|529624224|FG000|Overall Study|Adverse Event|6|||
146851438|NCT00935818|529624225|FG001|Overall Study|Adverse Event|7|||
146851439|NCT00935818|529624224|FG000|Overall Study|Physician Decision|0|||
146851440|NCT00935818|529624225|FG001|Overall Study|Physician Decision|1|||
146851441|NCT00604825|529624228|FG000|Overall Study|Adverse Event|2|||
146851442|NCT00604825|529624229|FG001|Overall Study|Adverse Event|6|||
146851443|NCT00604825|529624230|FG002|Overall Study|Adverse Event|7|||
146851444|NCT00604825|529624231|FG003|Overall Study|Adverse Event|4|||
146751663|NCT02268552|529258734|FG003|Part 1|Death|2|||
146751664|NCT02268552|529258735|FG004|Part 1|Death|0|||
146751665|NCT02268552|529258736|FG005|Part 1|Death|0|||
146751666|NCT02268552|529258737|FG006|Part 1|Death|0|||
146751667|NCT02268552|529258731|FG000|Part 1|Subject/guardian decision|0|||
146751668|NCT02268552|529258732|FG001|Part 1|Subject/guardian decision|0|||
146751669|NCT02268552|529258733|FG002|Part 1|Subject/guardian decision|0|||
146751670|NCT02268552|529258734|FG003|Part 1|Subject/guardian decision|1|||
146751671|NCT02268552|529258735|FG004|Part 1|Subject/guardian decision|0|||
146751672|NCT02268552|529258736|FG005|Part 1|Subject/guardian decision|0|||
146512338|NCT03008278|528379199|FG002|Overall Study|Progressive Disease|32|||
146512339|NCT03008278|528379197|FG000|Overall Study|Adverse Event|0|||
146512340|NCT03008278|528379198|FG001|Overall Study|Adverse Event|0|||
146512341|NCT03008278|528379199|FG002|Overall Study|Adverse Event|4|||
146512342|NCT03008278|528379197|FG000|Overall Study|Withdrawal by Subject|0|||
146512343|NCT03008278|528379198|FG001|Overall Study|Withdrawal by Subject|0|||
146512344|NCT03008278|528379199|FG002|Overall Study|Withdrawal by Subject|3|||
146512345|NCT03008278|528379197|FG000|Overall Study|Physician Decision|0|||
146512346|NCT03008278|528379198|FG001|Overall Study|Physician Decision|2|||
146512347|NCT03008278|528379199|FG002|Overall Study|Physician Decision|0|||
146512348|NCT01074255|528379200|FG000|Overall Study|Did not receive EMEND|2|||
146751673|NCT02268552|529258737|FG006|Part 1|Subject/guardian decision|0|||
146751674|NCT02268552|529258731|FG000|Part 2|Death|0|||
146751675|NCT02268552|529258732|FG001|Part 2|Death|0|||
146751676|NCT02268552|529258733|FG002|Part 2|Death|0|||
146751677|NCT02268552|529258734|FG003|Part 2|Death|0|||
146751678|NCT02268552|529258735|FG004|Part 2|Death|0|||
146751679|NCT02268552|529258736|FG005|Part 2|Death|0|||
146751680|NCT02268552|529258737|FG006|Part 2|Death|2|||
146751681|NCT02268552|529258731|FG000|Part 2|Subject/guardian decision|0|||
146751682|NCT02268552|529258732|FG001|Part 2|Subject/guardian decision|0|||
146751683|NCT02268552|529258733|FG002|Part 2|Subject/guardian decision|0|||
146751684|NCT02268552|529258734|FG003|Part 2|Subject/guardian decision|0|||
146751685|NCT02268552|529258735|FG004|Part 2|Subject/guardian decision|0|||
146751686|NCT02268552|529258736|FG005|Part 2|Subject/guardian decision|0|||
146751687|NCT02268552|529258737|FG006|Part 2|Subject/guardian decision|1|||
146851445|NCT00604825|529624228|FG000|Overall Study|Lost to Follow-up|0|||
146851446|NCT00604825|529624229|FG001|Overall Study|Lost to Follow-up|3|||
146851447|NCT00604825|529624230|FG002|Overall Study|Lost to Follow-up|1|||
146851448|NCT00604825|529624231|FG003|Overall Study|Lost to Follow-up|0|||
146851449|NCT00604825|529624228|FG000|Overall Study|Protocol Violation|0|||
146851450|NCT00604825|529624229|FG001|Overall Study|Protocol Violation|1|||
146751688|NCT02268552|529258731|FG000|Part 3 Extension|Death|0|||
146751689|NCT02268552|529258732|FG001|Part 3 Extension|Death|1|||
146751690|NCT02268552|529258733|FG002|Part 3 Extension|Death|1|||
146751691|NCT02268552|529258734|FG003|Part 3 Extension|Death|1|||
146751692|NCT02268552|529258735|FG004|Part 3 Extension|Death|1|||
146751693|NCT02268552|529258736|FG005|Part 3 Extension|Death|1|||
146751694|NCT02268552|529258737|FG006|Part 3 Extension|Death|0|||
146751695|NCT02268552|529258731|FG000|Part 3 Extension|Early termination of trial|1|||
146751696|NCT02268552|529258732|FG001|Part 3 Extension|Early termination of trial|0|||
146751697|NCT02268552|529258733|FG002|Part 3 Extension|Early termination of trial|0|||
146751698|NCT02268552|529258734|FG003|Part 3 Extension|Early termination of trial|0|||
146751699|NCT02268552|529258735|FG004|Part 3 Extension|Early termination of trial|2|||
146751700|NCT02268552|529258736|FG005|Part 3 Extension|Early termination of trial|9|||
146751701|NCT02268552|529258737|FG006|Part 3 Extension|Early termination of trial|11|||
146751702|NCT02268552|529258731|FG000|Part 3 Extension|Subject/guardian decision|0|||
146751703|NCT02268552|529258732|FG001|Part 3 Extension|Subject/guardian decision|0|||
146751704|NCT02268552|529258733|FG002|Part 3 Extension|Subject/guardian decision|0|||
146751705|NCT02268552|529258734|FG003|Part 3 Extension|Subject/guardian decision|0|||
146751706|NCT02268552|529258735|FG004|Part 3 Extension|Subject/guardian decision|0|||
146751707|NCT02268552|529258736|FG005|Part 3 Extension|Subject/guardian decision|0|||
146751708|NCT02268552|529258737|FG006|Part 3 Extension|Subject/guardian decision|1|||
146751709|NCT00997243|529258738|FG000|Overall Study|Early termination of study by sponsor|7|||
146751710|NCT03415022|529258745|FG000|Overall Study|Withdrawal by Subject|1|||
146751711|NCT03415022|529258746|FG001|Overall Study|Withdrawal by Subject|2|||
146751712|NCT03415022|529258745|FG000|Overall Study|COVID-19 Suspension|2|||
146751713|NCT03415022|529258746|FG001|Overall Study|COVID-19 Suspension|3|||
146751714|NCT03415022|529258745|FG000|Overall Study|Lost to Follow-up|2|||
146751715|NCT03415022|529258746|FG001|Overall Study|Lost to Follow-up|0|||
146751716|NCT03583541|529258749|FG000|Overall Study|Lost to Follow-up|31|||
146751717|NCT03583541|529258750|FG001|Overall Study|Lost to Follow-up|65|||
146751718|NCT00884286|529258751|FG000|Overall Study|Progressive disease|21|||
146751719|NCT00884286|529258752|FG001|Overall Study|Progressive disease|28|||
146751720|NCT00884286|529258751|FG000|Overall Study|Toxicity|4|||
146751721|NCT00884286|529258752|FG001|Overall Study|Toxicity|1|||
146751722|NCT00884286|529258751|FG000|Overall Study|Death|2|||
146751723|NCT00884286|529258752|FG001|Overall Study|Death|2|||
146751724|NCT00884286|529258751|FG000|Overall Study|Physician Decision|1|||
146751725|NCT00884286|529258752|FG001|Overall Study|Physician Decision|0|||
146751726|NCT00884286|529258751|FG000|Overall Study|Septic shock|1|||
146751727|NCT00884286|529258752|FG001|Overall Study|Septic shock|0|||
146512349|NCT00422422|528379201|FG000|Overall Study|Lack of Efficacy|1|||
146512350|NCT00422422|528379201|FG000|Overall Study|Protocol Violation|1|||
146751728|NCT00884286|529258751|FG000|Overall Study|Thrombus in right auricle|1|||
146751729|NCT00884286|529258752|FG001|Overall Study|Thrombus in right auricle|0|||
146751730|NCT00884286|529258751|FG000|Overall Study|Not treated|2|||
146751731|NCT00884286|529258752|FG001|Overall Study|Not treated|1|||
146751732|NCT00884286|529258751|FG000|Overall Study|Comprised lung carcinoma|0|||
146751733|NCT00884286|529258752|FG001|Overall Study|Comprised lung carcinoma|1|||
146751734|NCT01196104|529258753|FG000|Overall Study|Lost to Follow-up|1|||
146751735|NCT01196104|529258754|FG001|Overall Study|Lost to Follow-up|0|||
146751736|NCT01196104|529258753|FG000|Overall Study|Physician Decision|0|||
146751737|NCT01196104|529258754|FG001|Overall Study|Physician Decision|1|||
146751738|NCT01196104|529258753|FG000|Overall Study|Withdrawal by Subject|3|||
146751739|NCT01196104|529258754|FG001|Overall Study|Withdrawal by Subject|3|||
146751740|NCT01196104|529258753|FG000|Overall Study|Various|0|||
146751741|NCT01196104|529258754|FG001|Overall Study|Various|1|||
146751742|NCT00594932|529258759|FG000|First 3 Months|Withdrawal by Subject|1|||
146751743|NCT00594932|529258760|FG001|First 3 Months|Withdrawal by Subject|3|||
146751744|NCT00594932|529258759|FG000|Final 3 Months|Withdrawal by Subject|4|||
146751745|NCT00594932|529258760|FG001|Final 3 Months|Withdrawal by Subject|3|||
146751746|NCT01094171|529258761|FG000|Overall Study|Lost to Follow-up|2|||
146751747|NCT01094171|529258761|FG000|Overall Study|Informed consent withdrawal|4|||
146751748|NCT01094171|529258761|FG000|Overall Study|Migration from the study area|3|||
146751749|NCT01094171|529258761|FG000|Overall Study|Other|1|||
146751750|NCT01536145|529258762|FG000|Overall Study|Progressive disease|3|||
146751751|NCT01536145|529258763|FG001|Overall Study|Progressive disease|4|||
146751752|NCT01536145|529258764|FG002|Overall Study|Progressive disease|1|||
146751753|NCT01536145|529258765|FG003|Overall Study|Progressive disease|2|||
146751754|NCT01536145|529258766|FG004|Overall Study|Progressive disease|1|||
146751755|NCT01536145|529258767|FG005|Overall Study|Progressive disease|2|||
146751756|NCT01536145|529258768|FG006|Overall Study|Progressive disease|1|||
146751757|NCT01536145|529258769|FG007|Overall Study|Progressive disease|2|||
146751758|NCT01536145|529258770|FG008|Overall Study|Progressive disease|1|||
146751759|NCT01536145|529258771|FG009|Overall Study|Progressive disease|3|||
146751760|NCT01536145|529258772|FG010|Overall Study|Progressive disease|3|||
146751761|NCT01536145|529258762|FG000|Overall Study|Withdrawal by Subject|0|||
146751762|NCT01536145|529258763|FG001|Overall Study|Withdrawal by Subject|0|||
146751763|NCT01536145|529258764|FG002|Overall Study|Withdrawal by Subject|1|||
146751764|NCT01536145|529258765|FG003|Overall Study|Withdrawal by Subject|0|||
146751765|NCT01536145|529258766|FG004|Overall Study|Withdrawal by Subject|0|||
146751766|NCT01536145|529258767|FG005|Overall Study|Withdrawal by Subject|1|||
146751767|NCT01536145|529258768|FG006|Overall Study|Withdrawal by Subject|0|||
146751768|NCT01536145|529258769|FG007|Overall Study|Withdrawal by Subject|0|||
146751769|NCT01536145|529258770|FG008|Overall Study|Withdrawal by Subject|2|||
146751770|NCT01536145|529258771|FG009|Overall Study|Withdrawal by Subject|0|||
146751771|NCT01536145|529258772|FG010|Overall Study|Withdrawal by Subject|2|||
146751772|NCT01536145|529258762|FG000|Overall Study|Other|0|||
146751773|NCT01536145|529258763|FG001|Overall Study|Other|0|||
146751774|NCT01536145|529258764|FG002|Overall Study|Other|0|||
146751775|NCT01536145|529258765|FG003|Overall Study|Other|0|||
146751776|NCT01536145|529258766|FG004|Overall Study|Other|1|||
146751777|NCT01536145|529258767|FG005|Overall Study|Other|0|||
146751778|NCT01536145|529258768|FG006|Overall Study|Other|0|||
146751779|NCT01536145|529258769|FG007|Overall Study|Other|0|||
146751780|NCT01536145|529258770|FG008|Overall Study|Other|0|||
146751781|NCT01536145|529258771|FG009|Overall Study|Other|3|||
146751782|NCT01536145|529258772|FG010|Overall Study|Other|2|||
146751783|NCT01536145|529258762|FG000|Overall Study|Death|0|||
146751784|NCT01536145|529258763|FG001|Overall Study|Death|0|||
146751785|NCT01536145|529258764|FG002|Overall Study|Death|0|||
146751786|NCT01536145|529258765|FG003|Overall Study|Death|0|||
146751787|NCT01536145|529258766|FG004|Overall Study|Death|0|||
146751788|NCT01536145|529258767|FG005|Overall Study|Death|0|||
146751789|NCT01536145|529258768|FG006|Overall Study|Death|1|||
146751790|NCT01536145|529258769|FG007|Overall Study|Death|0|||
146751791|NCT01536145|529258770|FG008|Overall Study|Death|0|||
146751792|NCT01536145|529258771|FG009|Overall Study|Death|0|||
146751793|NCT01536145|529258772|FG010|Overall Study|Death|0|||
146751794|NCT01536145|529258762|FG000|Overall Study|Adverse Event|0|||
146751795|NCT01536145|529258763|FG001|Overall Study|Adverse Event|0|||
146751796|NCT01536145|529258764|FG002|Overall Study|Adverse Event|0|||
146751797|NCT01536145|529258765|FG003|Overall Study|Adverse Event|0|||
146751798|NCT01536145|529258766|FG004|Overall Study|Adverse Event|0|||
146751799|NCT01536145|529258767|FG005|Overall Study|Adverse Event|0|||
146751800|NCT01536145|529258768|FG006|Overall Study|Adverse Event|0|||
146751801|NCT01536145|529258769|FG007|Overall Study|Adverse Event|2|||
146751802|NCT01536145|529258770|FG008|Overall Study|Adverse Event|0|||
146751803|NCT01536145|529258771|FG009|Overall Study|Adverse Event|0|||
146751804|NCT01536145|529258772|FG010|Overall Study|Adverse Event|3|||
146751805|NCT05199233|529258775|FG000|Overall Study|Lack of Efficacy|1|||
146751806|NCT01364727|529258780|FG000|Overall Study|Not Eligible|2|||
146751807|NCT00688259|529258781|FG000|Overall Study|Lost to Follow-up|2|||
146751808|NCT00688259|529258782|FG001|Overall Study|Lost to Follow-up|4|||
146751809|NCT00688259|529258781|FG000|Overall Study|Physician Decision|1|||
146751810|NCT00688259|529258782|FG001|Overall Study|Physician Decision|0|||
146751811|NCT00688259|529258781|FG000|Overall Study|Withdrawal by Subject|2|||
146751812|NCT00688259|529258782|FG001|Overall Study|Withdrawal by Subject|0|||
146751813|NCT00688259|529258781|FG000|Overall Study|Declined Interview|2|||
146751814|NCT00688259|529258782|FG001|Overall Study|Declined Interview|3|||
146751815|NCT00688259|529258781|FG000|Overall Study|Hospitalized at Follow-up|0|||
146751816|NCT00688259|529258782|FG001|Overall Study|Hospitalized at Follow-up|1|||
146751817|NCT01676220|529258784|FG000|Overall Study|Randomized But Not Treated|4|||
146751818|NCT01676220|529258785|FG001|Overall Study|Randomized But Not Treated|1|||
146751819|NCT01676220|529258784|FG000|Overall Study|Adverse Event|10|||
146751820|NCT01676220|529258785|FG001|Overall Study|Adverse Event|8|||
146751821|NCT01676220|529258784|FG000|Overall Study|Lack of Efficacy|2|||
146751822|NCT01676220|529258785|FG001|Overall Study|Lack of Efficacy|5|||
146751823|NCT01676220|529258784|FG000|Overall Study|Protocol Violation|11|||
146751824|NCT01676220|529258785|FG001|Overall Study|Protocol Violation|12|||
146751825|NCT01676220|529258784|FG000|Overall Study|Received Rescue Therapy|14|||
146751826|NCT01676220|529258785|FG001|Overall Study|Received Rescue Therapy|22|||
146751827|NCT01676220|529258784|FG000|Overall Study|Personal Reason|34|||
146751828|NCT01676220|529258785|FG001|Overall Study|Personal Reason|45|||
146751829|NCT01676220|529258784|FG000|Overall Study|Lost to Follow-up|11|||
146751830|NCT01676220|529258785|FG001|Overall Study|Lost to Follow-up|18|||
146751831|NCT01676220|529258784|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
146751832|NCT01676220|529258785|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
146751833|NCT01676220|529258784|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
146751834|NCT01676220|529258785|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
146751835|NCT01676220|529258784|FG000|Overall Study|Perceived Lack of Efficacy|3|||
146751836|NCT01676220|529258785|FG001|Overall Study|Perceived Lack of Efficacy|1|||
146751837|NCT01676220|529258784|FG000|Overall Study|Non Serious Hypoglycemia|2|||
146751838|NCT01676220|529258785|FG001|Overall Study|Non Serious Hypoglycemia|0|||
146751839|NCT01676220|529258784|FG000|Overall Study|No More Need of Insulin|1|||
146751840|NCT01676220|529258785|FG001|Overall Study|No More Need of Insulin|0|||
146751841|NCT04227340|529258786|FG000|Overall Study|Withdrawal by Subject|3|||
146751842|NCT00393094|529258789|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
146751843|NCT00393094|529258789|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
146751844|NCT03018106|529258790|FG000|Overall Study|Lost to Follow-up|0|||
146751845|NCT03018106|529258791|FG001|Overall Study|Lost to Follow-up|1|||
146751846|NCT02397460|529258792|FG000|Treatment Period 2|Adverse Event|0|||
146751847|NCT02397460|529258793|FG001|Treatment Period 2|Adverse Event|0|||
146751848|NCT02397460|529258794|FG002|Treatment Period 2|Adverse Event|0|||
146751849|NCT02397460|529258795|FG003|Treatment Period 2|Adverse Event|0|||
146751850|NCT02397460|529258796|FG004|Treatment Period 2|Adverse Event|0|||
146751851|NCT02397460|529258797|FG005|Treatment Period 2|Adverse Event|0|||
146751852|NCT02397460|529258798|FG006|Treatment Period 2|Adverse Event|0|||
146751853|NCT02397460|529258799|FG007|Treatment Period 2|Adverse Event|1|||
146751854|NCT02397460|529258792|FG000|Treatment Period 4|Adverse Event|0|||
146751855|NCT02397460|529258793|FG001|Treatment Period 4|Adverse Event|1|||
146751856|NCT02397460|529258794|FG002|Treatment Period 4|Adverse Event|0|||
146751857|NCT02397460|529258795|FG003|Treatment Period 4|Adverse Event|0|||
146751858|NCT02397460|529258796|FG004|Treatment Period 4|Adverse Event|0|||
146751859|NCT02397460|529258797|FG005|Treatment Period 4|Adverse Event|0|||
146751860|NCT02397460|529258798|FG006|Treatment Period 4|Adverse Event|0|||
146751861|NCT02397460|529258799|FG007|Treatment Period 4|Adverse Event|0|||
146751862|NCT02397460|529258792|FG000|Treatment Period 4|Physician Decision|0|||
146751863|NCT02397460|529258793|FG001|Treatment Period 4|Physician Decision|0|||
146751864|NCT02397460|529258794|FG002|Treatment Period 4|Physician Decision|0|||
146751865|NCT02397460|529258795|FG003|Treatment Period 4|Physician Decision|0|||
146751866|NCT02397460|529258796|FG004|Treatment Period 4|Physician Decision|1|||
146751867|NCT02397460|529258797|FG005|Treatment Period 4|Physician Decision|0|||
146751868|NCT02397460|529258798|FG006|Treatment Period 4|Physician Decision|0|||
146751869|NCT02397460|529258799|FG007|Treatment Period 4|Physician Decision|0|||
146751870|NCT04131907|529258810|FG000|Overall Study|Adverse Event|2|||
146751871|NCT04131907|529258811|FG001|Overall Study|Adverse Event|0|||
146751872|NCT04131907|529258812|FG002|Overall Study|Adverse Event|0|||
146751873|NCT04131907|529258810|FG000|Overall Study|Physician Decision|4|||
146751874|NCT04131907|529258811|FG001|Overall Study|Physician Decision|22|||
146751875|NCT04131907|529258812|FG002|Overall Study|Physician Decision|0|||
146751876|NCT04131907|529258810|FG000|Overall Study|Withdrawal by Subject|2|||
146751877|NCT04131907|529258811|FG001|Overall Study|Withdrawal by Subject|0|||
146751878|NCT04131907|529258812|FG002|Overall Study|Withdrawal by Subject|1|||
146751879|NCT04131907|529258810|FG000|Overall Study|Treatment failure|2|||
146751880|NCT04131907|529258811|FG001|Overall Study|Treatment failure|0|||
146751881|NCT04131907|529258812|FG002|Overall Study|Treatment failure|1|||
146751882|NCT02036515|529258813|FG000|Overall Study|Adverse Event|1|||
146751883|NCT02036515|529258814|FG001|Overall Study|Adverse Event|1|||
146751884|NCT02036515|529258815|FG002|Overall Study|Adverse Event|2|||
146751885|NCT02036515|529258813|FG000|Overall Study|Lost to Follow-up|0|||
146751886|NCT02036515|529258814|FG001|Overall Study|Lost to Follow-up|2|||
146751887|NCT02036515|529258815|FG002|Overall Study|Lost to Follow-up|0|||
146751888|NCT02036515|529258813|FG000|Overall Study|Non-compliance with study drug|0|||
146751889|NCT02036515|529258814|FG001|Overall Study|Non-compliance with study drug|0|||
146751890|NCT02036515|529258815|FG002|Overall Study|Non-compliance with study drug|2|||
146751891|NCT02036515|529258813|FG000|Overall Study|Screen failure|0|||
146751892|NCT02036515|529258814|FG001|Overall Study|Screen failure|2|||
146751893|NCT02036515|529258815|FG002|Overall Study|Screen failure|0|||
146751894|NCT02036515|529258813|FG000|Overall Study|Withdrawal by Subject|4|||
146751895|NCT02036515|529258814|FG001|Overall Study|Withdrawal by Subject|7|||
146751896|NCT02036515|529258815|FG002|Overall Study|Withdrawal by Subject|9|||
146751897|NCT02036515|529258813|FG000|Overall Study|Hyperglycemia|0|||
146751898|NCT02036515|529258814|FG001|Overall Study|Hyperglycemia|0|||
146751899|NCT02036515|529258815|FG002|Overall Study|Hyperglycemia|1|||
146751900|NCT04157686|529258818|FG000|Overall Study|Adverse Event|1|||
146751901|NCT04157686|529258819|FG001|Overall Study|Adverse Event|0|||
146751902|NCT04157686|529258820|FG002|Overall Study|Adverse Event|1|||
146751903|NCT04157686|529258821|FG003|Overall Study|Adverse Event|0|||
146751904|NCT04157686|529258822|FG004|Overall Study|Adverse Event|1|||
146751905|NCT04157686|529258823|FG005|Overall Study|Adverse Event|0|||
146751906|NCT04157686|529258824|FG006|Overall Study|Adverse Event|0|||
146751907|NCT04157686|529258825|FG007|Overall Study|Adverse Event|0|||
146751908|NCT04157686|529258818|FG000|Overall Study|Pregnancy|0|||
146751909|NCT04157686|529258819|FG001|Overall Study|Pregnancy|1|||
146751910|NCT04157686|529258820|FG002|Overall Study|Pregnancy|3|||
146751911|NCT04157686|529258821|FG003|Overall Study|Pregnancy|0|||
146751912|NCT04157686|529258822|FG004|Overall Study|Pregnancy|0|||
146751913|NCT04157686|529258823|FG005|Overall Study|Pregnancy|0|||
146751914|NCT04157686|529258824|FG006|Overall Study|Pregnancy|3|||
146751915|NCT04157686|529258825|FG007|Overall Study|Pregnancy|0|||
146751916|NCT04157686|529258818|FG000|Overall Study|Lost to Follow-up|1|||
146751917|NCT04157686|529258819|FG001|Overall Study|Lost to Follow-up|2|||
146751918|NCT04157686|529258820|FG002|Overall Study|Lost to Follow-up|8|||
146751919|NCT04157686|529258821|FG003|Overall Study|Lost to Follow-up|6|||
146751920|NCT04157686|529258822|FG004|Overall Study|Lost to Follow-up|6|||
146751921|NCT04157686|529258823|FG005|Overall Study|Lost to Follow-up|3|||
146751922|NCT04157686|529258824|FG006|Overall Study|Lost to Follow-up|7|||
146751923|NCT04157686|529258825|FG007|Overall Study|Lost to Follow-up|9|||
146751924|NCT04157686|529258818|FG000|Overall Study|Lack of Efficacy|0|||
146751925|NCT04157686|529258819|FG001|Overall Study|Lack of Efficacy|0|||
146751926|NCT04157686|529258820|FG002|Overall Study|Lack of Efficacy|0|||
146751927|NCT04157686|529258821|FG003|Overall Study|Lack of Efficacy|0|||
146751928|NCT04157686|529258822|FG004|Overall Study|Lack of Efficacy|0|||
146751929|NCT04157686|529258823|FG005|Overall Study|Lack of Efficacy|2|||
146751930|NCT04157686|529258824|FG006|Overall Study|Lack of Efficacy|0|||
146751931|NCT04157686|529258825|FG007|Overall Study|Lack of Efficacy|1|||
146751932|NCT04157686|529258818|FG000|Overall Study|Withdrawal by Subject|10|||
146751933|NCT04157686|529258819|FG001|Overall Study|Withdrawal by Subject|10|||
146751934|NCT04157686|529258820|FG002|Overall Study|Withdrawal by Subject|12|||
146751935|NCT04157686|529258821|FG003|Overall Study|Withdrawal by Subject|20|||
146751936|NCT04157686|529258822|FG004|Overall Study|Withdrawal by Subject|12|||
146751937|NCT04157686|529258823|FG005|Overall Study|Withdrawal by Subject|11|||
146751938|NCT04157686|529258824|FG006|Overall Study|Withdrawal by Subject|18|||
146751939|NCT04157686|529258825|FG007|Overall Study|Withdrawal by Subject|24|||
146751940|NCT04157686|529258818|FG000|Overall Study|Physician Decision|0|||
146751941|NCT04157686|529258819|FG001|Overall Study|Physician Decision|0|||
146751942|NCT04157686|529258820|FG002|Overall Study|Physician Decision|1|||
146751943|NCT04157686|529258821|FG003|Overall Study|Physician Decision|0|||
146751944|NCT04157686|529258822|FG004|Overall Study|Physician Decision|1|||
146751945|NCT04157686|529258823|FG005|Overall Study|Physician Decision|0|||
146751946|NCT04157686|529258824|FG006|Overall Study|Physician Decision|3|||
146751947|NCT04157686|529258825|FG007|Overall Study|Physician Decision|0|||
146751948|NCT04157686|529258818|FG000|Overall Study|Death|0|||
146751949|NCT04157686|529258819|FG001|Overall Study|Death|0|||
146751950|NCT04157686|529258820|FG002|Overall Study|Death|0|||
146751951|NCT04157686|529258821|FG003|Overall Study|Death|2|||
146751952|NCT04157686|529258822|FG004|Overall Study|Death|0|||
146751953|NCT04157686|529258823|FG005|Overall Study|Death|0|||
146751954|NCT04157686|529258824|FG006|Overall Study|Death|0|||
146751955|NCT04157686|529258825|FG007|Overall Study|Death|0|||
146751956|NCT04157686|529258818|FG000|Overall Study|Protocol Violation|0|||
146751957|NCT04157686|529258819|FG001|Overall Study|Protocol Violation|0|||
146751958|NCT04157686|529258820|FG002|Overall Study|Protocol Violation|0|||
146751959|NCT04157686|529258821|FG003|Overall Study|Protocol Violation|0|||
146751960|NCT04157686|529258822|FG004|Overall Study|Protocol Violation|1|||
146512351|NCT00422422|528379201|FG000|Overall Study|Withdrawal by Subject|2|||
146751961|NCT04157686|529258823|FG005|Overall Study|Protocol Violation|0|||
146751962|NCT04157686|529258824|FG006|Overall Study|Protocol Violation|0|||
146751963|NCT04157686|529258825|FG007|Overall Study|Protocol Violation|0|||
146751964|NCT04157686|529258818|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
146751965|NCT04157686|529258819|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
146751966|NCT04157686|529258820|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
146751967|NCT04157686|529258821|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
146751968|NCT04157686|529258822|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
146751969|NCT04157686|529258823|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
146751970|NCT04157686|529258824|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
146751971|NCT04157686|529258825|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
146751972|NCT02601937|529258832|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
146751973|NCT02601937|529258833|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
146751974|NCT02601937|529258834|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
146751975|NCT02601937|529258835|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
146751976|NCT02601937|529258836|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
146751977|NCT02601937|529258837|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
146751978|NCT02601937|529258838|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
146751979|NCT02601937|529258839|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
146751980|NCT02601937|529258840|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
146751981|NCT02601937|529258841|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
146751982|NCT02601937|529258842|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
146751983|NCT02601937|529258832|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
146751984|NCT02601937|529258833|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146751985|NCT02601937|529258834|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146751986|NCT02601937|529258835|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146751987|NCT02601937|529258836|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146751988|NCT02601937|529258837|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146751989|NCT02601937|529258838|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
146751990|NCT02601937|529258839|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146751991|NCT02601937|529258840|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146751992|NCT02601937|529258841|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146751993|NCT02601937|529258842|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146751994|NCT02601937|529258832|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146751995|NCT02601937|529258833|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146751996|NCT02601937|529258834|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
146751997|NCT02601937|529258835|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146751998|NCT02601937|529258836|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146751999|NCT02601937|529258837|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146752000|NCT02601937|529258838|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146752001|NCT02601937|529258839|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146752002|NCT02601937|529258840|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146752003|NCT02601937|529258841|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146752004|NCT02601937|529258842|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146752005|NCT02601937|529258832|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
146752006|NCT02601937|529258833|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
146752007|NCT02601937|529258834|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
146752008|NCT02601937|529258835|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
146752009|NCT02601937|529258836|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
146752010|NCT02601937|529258837|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
146752011|NCT02601937|529258838|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
146752012|NCT02601937|529258839|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
146752013|NCT02601937|529258840|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
146752014|NCT02601937|529258841|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
146752015|NCT02601937|529258842|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
146752016|NCT02601937|529258832|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146752017|NCT02601937|529258833|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146752018|NCT02601937|529258834|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146752019|NCT02601937|529258835|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146752020|NCT02601937|529258836|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146752021|NCT02601937|529258837|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146752022|NCT02601937|529258838|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146752023|NCT02601937|529258839|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146752024|NCT02601937|529258840|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146752025|NCT02601937|529258841|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
146752026|NCT02601937|529258842|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146752027|NCT02601937|529258832|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146752028|NCT02601937|529258833|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146752029|NCT02601937|529258834|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146752030|NCT02601937|529258835|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146752031|NCT02601937|529258836|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146752032|NCT02601937|529258837|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146752033|NCT02601937|529258838|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146851451|NCT00604825|529624230|FG002|Overall Study|Protocol Violation|0|||
146752034|NCT02601937|529258839|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
146752035|NCT02601937|529258840|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146752036|NCT02601937|529258841|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146752037|NCT02601937|529258842|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146752038|NCT02601937|529258832|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146752039|NCT02601937|529258833|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146752040|NCT02601937|529258834|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146752041|NCT02601937|529258835|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146752042|NCT02601937|529258836|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146752043|NCT02601937|529258837|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146752044|NCT02601937|529258838|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146752045|NCT02601937|529258839|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146752046|NCT02601937|529258840|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146752047|NCT02601937|529258841|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
146752048|NCT02601937|529258842|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
146752049|NCT02601937|529258832|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
146752050|NCT02601937|529258833|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
146752051|NCT02601937|529258834|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
146752052|NCT02601937|529258835|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
146752053|NCT02601937|529258836|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
146752054|NCT02601937|529258837|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
146752055|NCT02601937|529258838|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
146752056|NCT02601937|529258839|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
146752057|NCT02601937|529258840|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
146752058|NCT02601937|529258841|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
146752059|NCT02601937|529258842|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
146752060|NCT02601937|529258832|FG000|Period 2: Dose Expansion Cohort|Other|0|||
146752061|NCT02601937|529258833|FG001|Period 2: Dose Expansion Cohort|Other|0|||
146752062|NCT02601937|529258834|FG002|Period 2: Dose Expansion Cohort|Other|0|||
146752063|NCT02601937|529258835|FG003|Period 2: Dose Expansion Cohort|Other|0|||
146752064|NCT02601937|529258836|FG004|Period 2: Dose Expansion Cohort|Other|0|||
146752065|NCT02601937|529258837|FG005|Period 2: Dose Expansion Cohort|Other|0|||
146752066|NCT02601937|529258838|FG006|Period 2: Dose Expansion Cohort|Other|0|||
146752067|NCT02601937|529258839|FG007|Period 2: Dose Expansion Cohort|Other|0|||
146752068|NCT02601937|529258840|FG008|Period 2: Dose Expansion Cohort|Other|2|||
146752069|NCT02601937|529258841|FG009|Period 2: Dose Expansion Cohort|Other|2|||
146752070|NCT02601937|529258842|FG010|Period 2: Dose Expansion Cohort|Other|0|||
146752071|NCT02601937|529258832|FG000|Period 2: Dose Expansion Cohort|Death|0|||
146752072|NCT02601937|529258833|FG001|Period 2: Dose Expansion Cohort|Death|0|||
146752073|NCT02601937|529258834|FG002|Period 2: Dose Expansion Cohort|Death|0|||
146752074|NCT02601937|529258835|FG003|Period 2: Dose Expansion Cohort|Death|0|||
146752075|NCT02601937|529258836|FG004|Period 2: Dose Expansion Cohort|Death|0|||
146752076|NCT02601937|529258837|FG005|Period 2: Dose Expansion Cohort|Death|0|||
146752077|NCT02601937|529258838|FG006|Period 2: Dose Expansion Cohort|Death|0|||
146752078|NCT02601937|529258839|FG007|Period 2: Dose Expansion Cohort|Death|0|||
146752079|NCT02601937|529258840|FG008|Period 2: Dose Expansion Cohort|Death|1|||
146752080|NCT02601937|529258841|FG009|Period 2: Dose Expansion Cohort|Death|0|||
146752081|NCT02601937|529258842|FG010|Period 2: Dose Expansion Cohort|Death|0|||
146752082|NCT02892409|529260594|FG000|Overall Study|Adverse Event|1|||
146752083|NCT02892409|529260595|FG001|Overall Study|Adverse Event|0|||
146752084|NCT02892409|529260594|FG000|Overall Study|Withdrawal by Subject|2|||
146752085|NCT02892409|529260595|FG001|Overall Study|Withdrawal by Subject|1|||
146752086|NCT01174550|529260596|FG000|Overall Study|Death|75|||
146752087|NCT01174550|529260597|FG001|Overall Study|Death|74|||
146752088|NCT01174550|529260596|FG000|Overall Study|Lost to Follow-up|652|||
146752089|NCT01174550|529260597|FG001|Overall Study|Lost to Follow-up|510|||
146752090|NCT01174550|529260596|FG000|Overall Study|Withdrawal by Subject|543|||
146752091|NCT01174550|529260597|FG001|Overall Study|Withdrawal by Subject|289|||
146752092|NCT01536262|529260598|FG000|Overall Study|Adverse Event|6|||
146752093|NCT01536262|529260599|FG001|Overall Study|Adverse Event|1|||
146752094|NCT01536262|529260600|FG002|Overall Study|Adverse Event|2|||
146752095|NCT01536262|529260598|FG000|Overall Study|Withdrawal by Subject|1|||
146752096|NCT01536262|529260599|FG001|Overall Study|Withdrawal by Subject|1|||
146752097|NCT01536262|529260600|FG002|Overall Study|Withdrawal by Subject|0|||
146512352|NCT00422422|528379201|FG000|Overall Study|SAE, non-fatal|1|||
146752098|NCT01536262|529260598|FG000|Overall Study|Other than stated above|1|||
146752099|NCT01536262|529260599|FG001|Overall Study|Other than stated above|0|||
146752100|NCT01536262|529260600|FG002|Overall Study|Other than stated above|0|||
146752101|NCT01781611|529260604|FG000|Overall Study|Adverse Event|4|||
146752102|NCT01781611|529260605|FG001|Overall Study|Adverse Event|0|||
146752103|NCT02459587|529260606|FG000|3-Month Follow-up Assessment|Death|0|||
146851452|NCT00604825|529624231|FG003|Overall Study|Protocol Violation|0|||
146752104|NCT02459587|529260607|FG001|3-Month Follow-up Assessment|Death|2|||
146752105|NCT02459587|529260606|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
146752106|NCT02459587|529260607|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
146752107|NCT02459587|529260606|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
146752108|NCT02459587|529260607|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
146752109|NCT02459587|529260606|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
146752110|NCT02459587|529260607|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
146752111|NCT02459587|529260606|FG000|6-month Follow-up Assessment|Death|2|||
146752112|NCT02459587|529260607|FG001|6-month Follow-up Assessment|Death|1|||
146752113|NCT02459587|529260606|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
146752114|NCT02459587|529260607|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
146752115|NCT02459587|529260606|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
146752116|NCT02459587|529260607|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
146752117|NCT02459587|529260606|FG000|12-month Follow-up Assessment|Death|2|||
146752118|NCT02459587|529260607|FG001|12-month Follow-up Assessment|Death|0|||
146752119|NCT02459587|529260606|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
146752120|NCT02459587|529260607|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
146752121|NCT02459587|529260606|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
146752122|NCT02459587|529260607|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
146752123|NCT02459587|529260606|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
146752124|NCT02459587|529260607|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
146752125|NCT01440049|529260608|FG000|Overall Study|Adverse Event|5|||
146752126|NCT02139982|529260610|FG000|Overall Study|Lack of Efficacy|0|||
146752127|NCT02139982|529260611|FG001|Overall Study|Lack of Efficacy|1|||
146752128|NCT02139982|529260612|FG002|Overall Study|Lack of Efficacy|0|||
146752129|NCT02139982|529260613|FG003|Overall Study|Lack of Efficacy|1|||
146752130|NCT02139982|529260614|FG004|Overall Study|Lack of Efficacy|0|||
146752131|NCT02139982|529260615|FG005|Overall Study|Lack of Efficacy|0|||
146752132|NCT02139982|529260616|FG006|Overall Study|Lack of Efficacy|0|||
146752133|NCT02139982|529260617|FG007|Overall Study|Lack of Efficacy|0|||
146752134|NCT02139982|529260618|FG008|Overall Study|Lack of Efficacy|0|||
146752135|NCT02139982|529260619|FG009|Overall Study|Lack of Efficacy|0|||
146752136|NCT02748512|529260622|FG000|Overall Study|Lost to Follow-up|1|||
146752137|NCT02748512|529260623|FG001|Overall Study|Lost to Follow-up|1|||
146752138|NCT04466618|529260626|FG000|Overall Study|Withdrawal by Subject|0|||
146752139|NCT04466618|529260627|FG001|Overall Study|Withdrawal by Subject|1|||
146752140|NCT00109928|529260631|FG000|Overall Study|Adverse Event|2|||
146752141|NCT00109928|529260631|FG000|Overall Study|Progression|6|||
146752142|NCT00109928|529260631|FG000|Overall Study|Death|2|||
146752143|NCT00109928|529260631|FG000|Overall Study|not protocol specified|2|||
146752144|NCT00109928|529260631|FG000|Overall Study|not eligible|1|||
146752145|NCT02411591|529260636|FG000|Overall Study|Adverse Event|0|||
146752146|NCT02411591|529260637|FG001|Overall Study|Adverse Event|4|||
146752147|NCT02411591|529260638|FG002|Overall Study|Adverse Event|2|||
146752148|NCT02411591|529260636|FG000|Overall Study|Withdrawal by Subject|0|||
146752149|NCT02411591|529260637|FG001|Overall Study|Withdrawal by Subject|3|||
146752150|NCT02411591|529260638|FG002|Overall Study|Withdrawal by Subject|0|||
146752151|NCT02411591|529260636|FG000|Overall Study|Physician Decision|0|||
146752152|NCT02411591|529260637|FG001|Overall Study|Physician Decision|3|||
146752153|NCT02411591|529260638|FG002|Overall Study|Physician Decision|1|||
146752154|NCT02491892|529260639|FG000|Overall Study|Adverse Event|1|||
146752155|NCT02491892|529260640|FG001|Overall Study|Adverse Event|1|||
146752156|NCT02491892|529260639|FG000|Overall Study|Death|1|||
146752157|NCT02491892|529260640|FG001|Overall Study|Death|1|||
146752158|NCT02491892|529260639|FG000|Overall Study|Lack of Efficacy|37|||
146752159|NCT02491892|529260640|FG001|Overall Study|Lack of Efficacy|36|||
146752160|NCT02491892|529260639|FG000|Overall Study|Refused Treatment|1|||
146752161|NCT02491892|529260640|FG001|Overall Study|Refused Treatment|0|||
146752162|NCT02491892|529260639|FG000|Overall Study|Lost to Follow-up|1|||
146752163|NCT02491892|529260640|FG001|Overall Study|Lost to Follow-up|0|||
146752164|NCT01734850|529260641|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
146752165|NCT01734850|529260642|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
146752166|NCT01734850|529260643|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
146752167|NCT01734850|529260641|FG000|Overall Study|Not infused due to manufacturing failure|0|||
146752168|NCT01734850|529260642|FG001|Overall Study|Not infused due to manufacturing failure|0|||
146752169|NCT01734850|529260643|FG002|Overall Study|Not infused due to manufacturing failure|1|||
146752170|NCT00661258|529260645|FG000|Overall Study|Death|1|||
146752171|NCT00661258|529260646|FG001|Overall Study|Death|0|||
146752172|NCT00661258|529260645|FG000|Overall Study|caught by police and in detox center|2|||
146752173|NCT00661258|529260646|FG001|Overall Study|caught by police and in detox center|1|||
146752174|NCT04496167|529260647|FG000|Overall Study|Adverse Event|6|||
146752175|NCT04496167|529260648|FG001|Overall Study|Adverse Event|2|||
146752176|NCT04496167|529260647|FG000|Overall Study|Withdrawal by Subject|7|||
146752177|NCT04496167|529260648|FG001|Overall Study|Withdrawal by Subject|6|||
146752178|NCT04496167|529260647|FG000|Overall Study|Lost to Follow-up|3|||
146752179|NCT04496167|529260648|FG001|Overall Study|Lost to Follow-up|5|||
146752180|NCT04496167|529260647|FG000|Overall Study|Not Treated|1|||
146752181|NCT04496167|529260648|FG001|Overall Study|Not Treated|2|||
146752182|NCT04496167|529260647|FG000|Overall Study|Other Than Specified|1|||
146752183|NCT04496167|529260648|FG001|Overall Study|Other Than Specified|1|||
146752184|NCT00598481|529260651|FG000|Treatment|Physician Decision|1|||
146752185|NCT01083160|529260652|FG000|Overall Study|Adverse Event|1|||
146752186|NCT01951092|529260655|FG000|Overall Study|Lost to Follow-up|10|||
146752187|NCT01951092|529260655|FG000|Overall Study|Incarceration|1|||
146752188|NCT01951092|529260655|FG000|Overall Study|Transfer of Care|1|||
146752189|NCT00918749|529260656|FG000|Overall Study|Adverse Event|1|||
146752190|NCT00918749|529260657|FG001|Overall Study|Adverse Event|0|||
146752191|NCT00918749|529260658|FG002|Overall Study|Adverse Event|1|||
146752192|NCT00918749|529260656|FG000|Overall Study|Lost to Follow-up|0|||
146752193|NCT00918749|529260657|FG001|Overall Study|Lost to Follow-up|0|||
146752194|NCT00918749|529260658|FG002|Overall Study|Lost to Follow-up|1|||
146752195|NCT00918749|529260656|FG000|Overall Study|Withdrawal by Subject|5|||
146752196|NCT00918749|529260657|FG001|Overall Study|Withdrawal by Subject|3|||
146752197|NCT00918749|529260658|FG002|Overall Study|Withdrawal by Subject|5|||
146752198|NCT00918749|529260656|FG000|Overall Study|No Study Medication Taken|1|||
146752199|NCT00918749|529260657|FG001|Overall Study|No Study Medication Taken|0|||
146752200|NCT00918749|529260658|FG002|Overall Study|No Study Medication Taken|0|||
146752201|NCT00136916|529260659|FG000|Overall Study|Never received study treatment|3|||
146752202|NCT00136916|529260660|FG001|Overall Study|Never received study treatment|5|||
146752203|NCT00136916|529260659|FG000|Overall Study|Death|1|||
146752204|NCT00136916|529260660|FG001|Overall Study|Death|3|||
146752205|NCT00136916|529260659|FG000|Overall Study|Adverse Event|27|||
146752206|NCT00136916|529260660|FG001|Overall Study|Adverse Event|8|||
146752207|NCT00136916|529260659|FG000|Overall Study|Laboratory abnormality|0|||
146752208|NCT00136916|529260660|FG001|Overall Study|Laboratory abnormality|1|||
146752209|NCT00136916|529260659|FG000|Overall Study|Lack of Efficacy|13|||
146752210|NCT00136916|529260660|FG001|Overall Study|Lack of Efficacy|3|||
146752211|NCT00136916|529260659|FG000|Overall Study|Lost to Follow-up|12|||
146752212|NCT00136916|529260660|FG001|Overall Study|Lost to Follow-up|14|||
146752213|NCT00136916|529260659|FG000|Overall Study|Withdrawal by Subject|44|||
146752214|NCT00136916|529260660|FG001|Overall Study|Withdrawal by Subject|46|||
146752215|NCT00136916|529260659|FG000|Overall Study|Other|22|||
146752216|NCT00136916|529260660|FG001|Overall Study|Other|24|||
146752217|NCT00136916|529260659|FG000|Overall Study|Discontinued in follow up period|3|||
146752218|NCT00136916|529260660|FG001|Overall Study|Discontinued in follow up period|0|||
146752219|NCT02213055|529260662|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
146752220|NCT02213055|529260663|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
146752221|NCT02213055|529260662|FG000|Overall Study|Protocol was not Followed during Study|1|||
146752222|NCT02213055|529260663|FG001|Overall Study|Protocol was not Followed during Study|0|||
146752223|NCT02213055|529260662|FG000|Overall Study|Documentation Issue at Enrollment|1|||
146752224|NCT02213055|529260663|FG001|Overall Study|Documentation Issue at Enrollment|0|||
146752225|NCT02213055|529260662|FG000|Overall Study|Documentation Issue during Study|10|||
146752226|NCT02213055|529260663|FG001|Overall Study|Documentation Issue during Study|0|||
146752227|NCT02213055|529260662|FG000|Overall Study|Did not have Live Lice|8|||
146752228|NCT02213055|529260663|FG001|Overall Study|Did not have Live Lice|0|||
146752229|NCT02213055|529260662|FG000|Overall Study|Had another Treatment during the Study|3|||
146752230|NCT02213055|529260663|FG001|Overall Study|Had another Treatment during the Study|0|||
146752231|NCT02213055|529260662|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
146752232|NCT02213055|529260663|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
146752233|NCT02213055|529260662|FG000|Overall Study|Did not Return to School|5|||
146752234|NCT02213055|529260663|FG001|Overall Study|Did not Return to School|0|||
146752235|NCT00231894|529260664|FG000|Overall Study|Withdrawal by Subject|1|||
146752236|NCT00231894|529260665|FG001|Overall Study|Withdrawal by Subject|1|||
146752237|NCT02025205|529260667|FG000|Overall Study|Withdrawal by Subject|1|||
146752238|NCT02025205|529260668|FG001|Overall Study|Withdrawal by Subject|1|||
146752239|NCT02025205|529260667|FG000|Overall Study|Protocol Violation|2|||
146752240|NCT02025205|529260668|FG001|Overall Study|Protocol Violation|1|||
146752241|NCT02025205|529260667|FG000|Overall Study|Death|0|||
146752242|NCT02025205|529260668|FG001|Overall Study|Death|1|||
146752243|NCT01767129|529260669|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
146752244|NCT01767129|529260670|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
146512353|NCT00422422|528379201|FG000|Overall Study|AE, non-serious non-fatal|5|||
146752245|NCT01024751|529260671|FG000|Enrolled Participants|Ineligible at baseline|3|||
146752246|NCT01024751|529260672|FG001|Enrolled Participants|Ineligible at baseline|4|||
146752247|NCT01024751|529260671|FG000|Eligible Participants|Withdrawal by Subject|0|||
146752248|NCT01024751|529260672|FG001|Eligible Participants|Withdrawal by Subject|1|||
146752249|NCT01024751|529260671|FG000|Eligible Participants|Lost to Follow-up|0|||
146752250|NCT01024751|529260672|FG001|Eligible Participants|Lost to Follow-up|1|||
146752251|NCT01024751|529260671|FG000|Eligible Participants|Ineligible|0|||
146752252|NCT01024751|529260672|FG001|Eligible Participants|Ineligible|1|||
146752253|NCT01628510|529260675|FG000|Overall Study|Withdrawal by Subject|0|||
146752254|NCT01628510|529260676|FG001|Overall Study|Withdrawal by Subject|4|||
146752255|NCT01628510|529260675|FG000|Overall Study|Death|3|||
146752256|NCT01628510|529260676|FG001|Overall Study|Death|1|||
146752257|NCT01656759|529260677|FG000|Overall Study|Protocol Violation|2|||
146752258|NCT01656759|529260678|FG001|Overall Study|Protocol Violation|3|||
146752259|NCT04707391|529260679|FG000|Overall Study|Adverse Event|5|||
146752260|NCT04707391|529260680|FG001|Overall Study|Adverse Event|8|||
146752261|NCT04707391|529260679|FG000|Overall Study|Lost to Follow-up|44|||
146752262|NCT04707391|529260680|FG001|Overall Study|Lost to Follow-up|31|||
146752263|NCT04707391|529260679|FG000|Overall Study|Protocol Violation|1|||
146752264|NCT04707391|529260680|FG001|Overall Study|Protocol Violation|5|||
146752265|NCT04707391|529260679|FG000|Overall Study|Withdrawal by Subject|27|||
146752266|NCT04707391|529260680|FG001|Overall Study|Withdrawal by Subject|25|||
146752267|NCT04707391|529260679|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
146752268|NCT04707391|529260680|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
146752269|NCT04707391|529260679|FG000|Overall Study|Other|0|||
146752270|NCT04707391|529260680|FG001|Overall Study|Other|2|||
146752271|NCT03246672|529260682|FG000|Overall Study|Lost to Follow-up|2|||
146752272|NCT01932996|529260683|FG000|Overall Study|Protocol Violation|2|||
146752273|NCT01932996|529260684|FG001|Overall Study|Protocol Violation|0|||
146752274|NCT02500316|529260688|FG000|Overall Study|Adverse Event|3|||
146752275|NCT02500316|529260688|FG000|Overall Study|Lost to Follow-up|2|||
146752276|NCT02500316|529260688|FG000|Overall Study|Protocol Violation|1|||
146752277|NCT02500316|529260688|FG000|Overall Study|Withdrawal by Subject|15|||
146752278|NCT02500316|529260688|FG000|Overall Study|Final height achieved|5|||
146752279|NCT02500316|529260688|FG000|Overall Study|Due to war activity|1|||
146752280|NCT01406717|529260689|FG000|Overall Study|Subject non-compliance|4|||
146752281|NCT01406717|529260690|FG001|Overall Study|Subject non-compliance|3|||
146752282|NCT01406717|529260689|FG000|Overall Study|Protocol Violation|5|||
146752283|NCT01406717|529260690|FG001|Overall Study|Protocol Violation|1|||
146752284|NCT01406717|529260689|FG000|Overall Study|Lost to Follow-up|14|||
146752285|NCT01406717|529260690|FG001|Overall Study|Lost to Follow-up|8|||
146752286|NCT01406717|529260689|FG000|Overall Study|Withdrawal by Subject|19|||
146752287|NCT01406717|529260690|FG001|Overall Study|Withdrawal by Subject|15|||
146752288|NCT01406717|529260689|FG000|Overall Study|Adverse Event|1|||
146752289|NCT01406717|529260690|FG001|Overall Study|Adverse Event|2|||
146752290|NCT01406717|529260689|FG000|Overall Study|Lack of Efficacy|0|||
146752291|NCT01406717|529260690|FG001|Overall Study|Lack of Efficacy|1|||
146752292|NCT01406717|529260689|FG000|Overall Study|Non-completion of visit activity|0|||
146752293|NCT01406717|529260690|FG001|Overall Study|Non-completion of visit activity|1|||
146752294|NCT02040090|529260691|FG000|Overall Study|Adverse Event|2|||
146752295|NCT02040090|529260692|FG001|Overall Study|Adverse Event|0|||
146752296|NCT02040090|529260691|FG000|Overall Study|Physician Decision|1|||
146752297|NCT02040090|529260692|FG001|Overall Study|Physician Decision|0|||
146752298|NCT02040090|529260691|FG000|Overall Study|Withdrawal by Subject|0|||
146752299|NCT02040090|529260692|FG001|Overall Study|Withdrawal by Subject|1|||
146752300|NCT02040090|529260691|FG000|Overall Study|Lost to Follow-up|0|||
146752301|NCT02040090|529260692|FG001|Overall Study|Lost to Follow-up|1|||
146752302|NCT03257995|529260693|FG000|Overall Study|Adverse Event|0|||
146752303|NCT03257995|529260694|FG001|Overall Study|Adverse Event|1|||
146752304|NCT03257995|529260695|FG002|Overall Study|Adverse Event|0|||
146752305|NCT03257995|529260696|FG003|Overall Study|Adverse Event|0|||
146752306|NCT03257995|529260697|FG004|Overall Study|Adverse Event|0|||
146752307|NCT03257995|529260698|FG005|Overall Study|Adverse Event|0|||
146752308|NCT03257995|529260693|FG000|Overall Study|Protocol deviation|0|||
146752309|NCT03257995|529260694|FG001|Overall Study|Protocol deviation|0|||
146752310|NCT03257995|529260695|FG002|Overall Study|Protocol deviation|0|||
146752311|NCT03257995|529260696|FG003|Overall Study|Protocol deviation|0|||
146752312|NCT03257995|529260697|FG004|Overall Study|Protocol deviation|0|||
146752313|NCT03257995|529260698|FG005|Overall Study|Protocol deviation|2|||
146752314|NCT02584855|529260706|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
146752315|NCT02584855|529260707|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
146752316|NCT02584855|529260708|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
146752317|NCT02584855|529260709|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
146752318|NCT02584855|529260710|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
146752319|NCT02584855|529260711|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
146752320|NCT02584855|529260706|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
146752321|NCT02584855|529260707|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
146752322|NCT02584855|529260708|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
146752323|NCT02584855|529260709|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
146752324|NCT02584855|529260710|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
146752325|NCT02584855|529260711|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
146752326|NCT02584855|529260706|FG000|Open-Label Treatment Period|Adverse Event|14|||
146752327|NCT02584855|529260707|FG001|Open-Label Treatment Period|Adverse Event|0|||
146752328|NCT02584855|529260708|FG002|Open-Label Treatment Period|Adverse Event|0|||
146752329|NCT02584855|529260709|FG003|Open-Label Treatment Period|Adverse Event|0|||
146752330|NCT02584855|529260710|FG004|Open-Label Treatment Period|Adverse Event|0|||
146752331|NCT02584855|529260711|FG005|Open-Label Treatment Period|Adverse Event|0|||
146752332|NCT02584855|529260706|FG000|Open-Label Treatment Period|Death|2|||
146752333|NCT02584855|529260707|FG001|Open-Label Treatment Period|Death|0|||
146752334|NCT02584855|529260708|FG002|Open-Label Treatment Period|Death|0|||
146752335|NCT02584855|529260709|FG003|Open-Label Treatment Period|Death|0|||
146752336|NCT02584855|529260710|FG004|Open-Label Treatment Period|Death|0|||
146752337|NCT02584855|529260711|FG005|Open-Label Treatment Period|Death|0|||
146752338|NCT02584855|529260706|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
146752339|NCT02584855|529260707|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
146752340|NCT02584855|529260708|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
146752341|NCT02584855|529260709|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
146752342|NCT02584855|529260710|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
146752343|NCT02584855|529260711|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
146752344|NCT02584855|529260706|FG000|Open-Label Treatment Period|Protocol Violation|1|||
146752345|NCT02584855|529260707|FG001|Open-Label Treatment Period|Protocol Violation|0|||
146752346|NCT02584855|529260708|FG002|Open-Label Treatment Period|Protocol Violation|0|||
146752347|NCT02584855|529260709|FG003|Open-Label Treatment Period|Protocol Violation|0|||
146752348|NCT02584855|529260710|FG004|Open-Label Treatment Period|Protocol Violation|0|||
146752349|NCT02584855|529260711|FG005|Open-Label Treatment Period|Protocol Violation|0|||
146752350|NCT02584855|529260706|FG000|Open-Label Treatment Period|No PI Available|2|||
146752351|NCT02584855|529260707|FG001|Open-Label Treatment Period|No PI Available|0|||
146752352|NCT02584855|529260708|FG002|Open-Label Treatment Period|No PI Available|0|||
146752353|NCT02584855|529260709|FG003|Open-Label Treatment Period|No PI Available|0|||
146752354|NCT02584855|529260710|FG004|Open-Label Treatment Period|No PI Available|0|||
146752355|NCT02584855|529260711|FG005|Open-Label Treatment Period|No PI Available|0|||
146752356|NCT02584855|529260706|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
146752357|NCT02584855|529260707|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
146752358|NCT02584855|529260708|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
146752359|NCT02584855|529260709|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
146752360|NCT02584855|529260710|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
146752361|NCT02584855|529260711|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
146752362|NCT02584855|529260706|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
146752363|NCT02584855|529260707|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
146752364|NCT02584855|529260708|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
146752365|NCT02584855|529260709|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
146752366|NCT02584855|529260710|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
146752367|NCT02584855|529260711|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
146752368|NCT02584855|529260706|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
146752369|NCT02584855|529260707|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
146752370|NCT02584855|529260708|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
146752371|NCT02584855|529260709|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
146752372|NCT02584855|529260710|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
146752373|NCT02584855|529260711|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
146752374|NCT02584855|529260706|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
146752375|NCT02584855|529260707|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
146752376|NCT02584855|529260708|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
146752377|NCT02584855|529260709|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
146752378|NCT02584855|529260710|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
146752379|NCT02584855|529260711|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
146752380|NCT02584855|529260706|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
146752381|NCT02584855|529260707|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
146752382|NCT02584855|529260708|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
146752383|NCT02584855|529260709|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
146752384|NCT02584855|529260710|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
146752385|NCT02584855|529260711|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
146752386|NCT02584855|529260706|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146752387|NCT02584855|529260707|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146752388|NCT02584855|529260708|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146752389|NCT02584855|529260709|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146752390|NCT02584855|529260710|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
146752391|NCT02584855|529260711|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146752392|NCT02584855|529260706|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
146752393|NCT02584855|529260707|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
146752394|NCT02584855|529260708|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
146752395|NCT02584855|529260709|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
146752396|NCT02584855|529260710|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
146752397|NCT02584855|529260711|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
146752398|NCT02337478|529260712|FG000|Overall Study|Lack of Efficacy|5|||
146752399|NCT00895843|529260713|FG000|Overall Study|Protocol Violation|12|||
146752400|NCT00895843|529260714|FG001|Overall Study|Protocol Violation|12|||
146752401|NCT04963062|529260718|FG000|Overall Study|withdrew by the study team|4|||
146752402|NCT04963062|529260719|FG001|Overall Study|withdrew by the study team|2|||
146752403|NCT02906202|529260729|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
146752404|NCT01987830|529260730|FG000|Overall Study|Never received baseline scan|1|||
146752405|NCT00057811|529260741|FG000|Overall Study|Lack of Efficacy|1|||
146752406|NCT00057811|529260742|FG001|Overall Study|Lack of Efficacy|4|||
146752407|NCT00057811|529260741|FG000|Overall Study|Physician Decision|1|||
146752408|NCT00057811|529260742|FG001|Overall Study|Physician Decision|0|||
146752409|NCT00057811|529260741|FG000|Overall Study|Withdrawal by Subject|3|||
146752410|NCT00057811|529260742|FG001|Overall Study|Withdrawal by Subject|4|||
146752411|NCT00057811|529260741|FG000|Overall Study|Ineligible|4|||
146752412|NCT00057811|529260742|FG001|Overall Study|Ineligible|2|||
146752413|NCT00057811|529260741|FG000|Overall Study|Inevaluable|1|||
146752414|NCT00057811|529260742|FG001|Overall Study|Inevaluable|2|||
146752415|NCT00556374|529260743|FG000|Overall Study|Withdrawal by Subject|235|||
146752416|NCT00556374|529260744|FG001|Overall Study|Withdrawal by Subject|205|||
146752417|NCT00556374|529260743|FG000|Overall Study|Death|158|||
146752418|NCT00556374|529260744|FG001|Overall Study|Death|127|||
146752419|NCT00556374|529260743|FG000|Overall Study|Lost to Follow-up|24|||
146752420|NCT00556374|529260744|FG001|Overall Study|Lost to Follow-up|17|||
146752421|NCT00556374|529260743|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
146752422|NCT00556374|529260744|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
146752423|NCT05708846|529260745|FG000|Overall Study|Death|5|||
146752424|NCT05708846|529260745|FG000|Overall Study|Withdrawal by Subject|20|||
146752425|NCT03428815|529260746|FG000|Overall Study|Lost to Follow-up|2|||
146752426|NCT03428815|529260747|FG001|Overall Study|Lost to Follow-up|2|||
146752427|NCT03428815|529260746|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
146752428|NCT03428815|529260747|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
146752429|NCT03428815|529260746|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
146752430|NCT03428815|529260747|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
146752431|NCT02218489|529260748|FG000|Overall Study|Withdrawal by Subject|4|||
146752432|NCT02218489|529260749|FG001|Overall Study|Withdrawal by Subject|3|||
146752433|NCT02218489|529260748|FG000|Overall Study|Lost to Follow-up|1|||
146752434|NCT02218489|529260749|FG001|Overall Study|Lost to Follow-up|0|||
146752435|NCT02404493|529260750|FG000|Overall Study|Adverse Event|1|||
146752436|NCT02404493|529260751|FG001|Overall Study|Adverse Event|1|||
146752437|NCT01700348|529260752|FG000|Overall Study|Withdrawal by Subject|22|||
146752438|NCT01700348|529260752|FG000|Overall Study|Lost to Follow-up|1|||
146752439|NCT03958630|529260753|FG000|Overall Study|Withdrawal by Subject|0|||
146752440|NCT03958630|529260754|FG001|Overall Study|Withdrawal by Subject|0|||
146752441|NCT03958630|529260755|FG002|Overall Study|Withdrawal by Subject|1|||
146752442|NCT03958630|529260753|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
146752443|NCT03958630|529260754|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
146752444|NCT03958630|529260755|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
146752445|NCT03038672|529262991|FG000|Initial Treatment|Unacceptable chemistry|0|||
146752446|NCT03038672|529262992|FG001|Initial Treatment|Unacceptable chemistry|1|||
146752447|NCT03038672|529262991|FG000|Initial Treatment|Progression prior to treatment|1|||
146752448|NCT03038672|529262992|FG001|Initial Treatment|Progression prior to treatment|0|||
146752449|NCT03038672|529262991|FG000|Initial Treatment|No treatment per protocol|1|||
146752450|NCT03038672|529262992|FG001|Initial Treatment|No treatment per protocol|0|||
146752451|NCT04423393|529262993|FG000|Overall Study|Withdrawal by Subject|0|||
146752452|NCT04423393|529262994|FG001|Overall Study|Withdrawal by Subject|0|||
146752453|NCT04423393|529262995|FG002|Overall Study|Withdrawal by Subject|0|||
146752454|NCT04423393|529262996|FG003|Overall Study|Withdrawal by Subject|0|||
146752455|NCT04423393|529262997|FG004|Overall Study|Withdrawal by Subject|0|||
146752456|NCT04423393|529262998|FG005|Overall Study|Withdrawal by Subject|1|||
146752457|NCT04423393|529262999|FG006|Overall Study|Withdrawal by Subject|0|||
146752458|NCT04423393|529263000|FG007|Overall Study|Withdrawal by Subject|0|||
146752459|NCT04423393|529263001|FG008|Overall Study|Withdrawal by Subject|0|||
146752460|NCT04423393|529263002|FG009|Overall Study|Withdrawal by Subject|0|||
146752461|NCT04423393|529263003|FG010|Overall Study|Withdrawal by Subject|0|||
146752462|NCT04423393|529263004|FG011|Overall Study|Withdrawal by Subject|0|||
146752463|NCT04423393|529263005|FG012|Overall Study|Withdrawal by Subject|0|||
146752464|NCT04423393|529263006|FG013|Overall Study|Withdrawal by Subject|1|||
146752465|NCT04423393|529263007|FG014|Overall Study|Withdrawal by Subject|0|||
146752466|NCT04423393|529263008|FG015|Overall Study|Withdrawal by Subject|0|||
146752467|NCT04423393|529263009|FG016|Overall Study|Withdrawal by Subject|0|||
146752468|NCT04423393|529263010|FG017|Overall Study|Withdrawal by Subject|0|||
146752469|NCT04423393|529262993|FG000|Overall Study|Sponsor Decision|0|||
146752470|NCT04423393|529262994|FG001|Overall Study|Sponsor Decision|0|||
146752471|NCT04423393|529262995|FG002|Overall Study|Sponsor Decision|0|||
146752472|NCT04423393|529262996|FG003|Overall Study|Sponsor Decision|0|||
146752473|NCT04423393|529262997|FG004|Overall Study|Sponsor Decision|0|||
146752474|NCT04423393|529262998|FG005|Overall Study|Sponsor Decision|0|||
146752475|NCT04423393|529262999|FG006|Overall Study|Sponsor Decision|0|||
146752476|NCT04423393|529263000|FG007|Overall Study|Sponsor Decision|0|||
146752477|NCT04423393|529263001|FG008|Overall Study|Sponsor Decision|0|||
146752478|NCT04423393|529263002|FG009|Overall Study|Sponsor Decision|0|||
146752479|NCT04423393|529263003|FG010|Overall Study|Sponsor Decision|0|||
146752480|NCT04423393|529263004|FG011|Overall Study|Sponsor Decision|0|||
146752481|NCT04423393|529263005|FG012|Overall Study|Sponsor Decision|0|||
146752482|NCT04423393|529263006|FG013|Overall Study|Sponsor Decision|1|||
146752483|NCT04423393|529263007|FG014|Overall Study|Sponsor Decision|0|||
146752484|NCT04423393|529263008|FG015|Overall Study|Sponsor Decision|0|||
146752485|NCT04423393|529263009|FG016|Overall Study|Sponsor Decision|0|||
146752486|NCT04423393|529263010|FG017|Overall Study|Sponsor Decision|0|||
146752487|NCT05220501|529263011|FG000|Overall Study|Withdrawal by Subject|11|||
146752488|NCT05220501|529263012|FG001|Overall Study|Withdrawal by Subject|21|||
146752489|NCT05220501|529263013|FG002|Overall Study|Withdrawal by Subject|32|||
146752490|NCT05220501|529263011|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
146752491|NCT05220501|529263012|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
146752492|NCT05220501|529263013|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
146752493|NCT02692235|529263014|FG000|Overall Study|Withdrawal by Subject|2|||
146752494|NCT02692235|529263015|FG001|Overall Study|Withdrawal by Subject|1|||
146752495|NCT02692235|529263014|FG000|Overall Study|Adverse Event|1|||
146752496|NCT02692235|529263015|FG001|Overall Study|Adverse Event|2|||
146752497|NCT01929993|529263019|FG000|Overall Study|Protocol Violation|4|||
146752498|NCT01929993|529263020|FG001|Overall Study|Protocol Violation|6|||
146752499|NCT01929993|529263019|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
146752500|NCT01929993|529263020|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
146752501|NCT00107380|529263021|FG000|Overall Study|Adverse Event|7|||
146752502|NCT00107380|529263021|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
146752503|NCT00107380|529263021|FG000|Overall Study|Progression/relapse|4|||
146752504|NCT00107380|529263021|FG000|Overall Study|Death|3|||
146752505|NCT00107380|529263021|FG000|Overall Study|Other - not protocol specified|7|||
146752506|NCT00107380|529263021|FG000|Overall Study|Ineligible|2|||
146752507|NCT03673098|529263022|FG000|Overall Study|Lost to Follow-up|2|||
146752508|NCT03673098|529263023|FG001|Overall Study|Lost to Follow-up|3|||
146752509|NCT03673098|529263022|FG000|Overall Study|Withdrawal by Subject|6|||
146752510|NCT03673098|529263023|FG001|Overall Study|Withdrawal by Subject|1|||
146752511|NCT03673098|529263022|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
146752512|NCT03673098|529263023|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
146752513|NCT01268059|529263028|FG000|Overall Study|Lost to Follow-up|0|||
146752514|NCT01268059|529263029|FG001|Overall Study|Lost to Follow-up|1|||
146752515|NCT01268059|529263030|FG002|Overall Study|Lost to Follow-up|0|||
146752516|NCT01268059|529263031|FG003|Overall Study|Lost to Follow-up|0|||
146752517|NCT01268059|529263028|FG000|Overall Study|Withdrawal by Subject|7|||
146752518|NCT01268059|529263029|FG001|Overall Study|Withdrawal by Subject|4|||
146752519|NCT01268059|529263030|FG002|Overall Study|Withdrawal by Subject|0|||
146752520|NCT01268059|529263031|FG003|Overall Study|Withdrawal by Subject|0|||
146752521|NCT01268059|529263028|FG000|Overall Study|Death|20|||
146752522|NCT01268059|529263029|FG001|Overall Study|Death|30|||
146752523|NCT01268059|529263030|FG002|Overall Study|Death|3|||
146752524|NCT01268059|529263031|FG003|Overall Study|Death|5|||
146752525|NCT01268059|529263028|FG000|Overall Study|Progression of disease|1|||
146752526|NCT01268059|529263029|FG001|Overall Study|Progression of disease|0|||
146752527|NCT01268059|529263030|FG002|Overall Study|Progression of disease|0|||
146752528|NCT01268059|529263031|FG003|Overall Study|Progression of disease|0|||
146752529|NCT03660943|529263032|FG000|Overall Study|Adverse Event|5|||
146752530|NCT03660943|529263033|FG001|Overall Study|Adverse Event|3|||
146752531|NCT03660943|529263032|FG000|Overall Study|Death|0|||
146752532|NCT03660943|529263033|FG001|Overall Study|Death|2|||
146752533|NCT03660943|529263032|FG000|Overall Study|Lost to Follow-up|7|||
146752534|NCT03660943|529263033|FG001|Overall Study|Lost to Follow-up|3|||
146752535|NCT03660943|529263032|FG000|Overall Study|Protocol Violation|3|||
146752536|NCT03660943|529263033|FG001|Overall Study|Protocol Violation|5|||
146752537|NCT03660943|529263032|FG000|Overall Study|Withdrawal by Subject|8|||
146752538|NCT03660943|529263033|FG001|Overall Study|Withdrawal by Subject|15|||
146752539|NCT03660943|529263032|FG000|Overall Study|Lack of Efficacy|9|||
146752540|NCT03660943|529263033|FG001|Overall Study|Lack of Efficacy|12|||
146752541|NCT03660943|529263032|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
146752542|NCT03660943|529263033|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
146752543|NCT03850444|529263034|FG000|Overall Study|Adverse Event|16|||
146752544|NCT03850444|529263035|FG001|Overall Study|Adverse Event|10|||
146752545|NCT03850444|529263034|FG000|Overall Study|Death|87|||
146752546|NCT03850444|529263035|FG001|Overall Study|Death|107|||
146752547|NCT03850444|529263034|FG000|Overall Study|Lost to Follow-up|1|||
146752548|NCT03850444|529263035|FG001|Overall Study|Lost to Follow-up|1|||
146752549|NCT03850444|529263034|FG000|Overall Study|Withdrawal by Subject|1|||
146752550|NCT03850444|529263035|FG001|Overall Study|Withdrawal by Subject|5|||
146752551|NCT03850444|529263034|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
146752552|NCT03850444|529263035|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
146752553|NCT03531905|529263036|FG000|Overall Study|Withdrawal by Subject|3|||
146752554|NCT03531905|529263037|FG001|Overall Study|Withdrawal by Subject|3|||
146752555|NCT03531905|529263038|FG002|Overall Study|Withdrawal by Subject|2|||
146752556|NCT03531905|529263036|FG000|Overall Study|Lost to Follow-up|2|||
146752557|NCT03531905|529263037|FG001|Overall Study|Lost to Follow-up|2|||
146752558|NCT03531905|529263038|FG002|Overall Study|Lost to Follow-up|1|||
146752559|NCT03531905|529263036|FG000|Overall Study|Participant was out of town|1|||
146752560|NCT03531905|529263037|FG001|Overall Study|Participant was out of town|0|||
146752561|NCT03531905|529263038|FG002|Overall Study|Participant was out of town|0|||
146752562|NCT03531905|529263036|FG000|Overall Study|Could not speak with the participant|1|||
146752563|NCT03531905|529263037|FG001|Overall Study|Could not speak with the participant|0|||
146752564|NCT03531905|529263038|FG002|Overall Study|Could not speak with the participant|0|||
146752565|NCT01036087|529263039|FG000|Overall Study|Adverse Event|2|||
146752566|NCT01036087|529263039|FG000|Overall Study|Lack of Efficacy|1|||
146752567|NCT01021878|529263040|FG000|Overall Study|Lost to Follow-up|4|||
146752568|NCT01021878|529263041|FG001|Overall Study|Lost to Follow-up|3|||
146752569|NCT01021878|529263040|FG000|Overall Study|Death|0|||
146752570|NCT01021878|529263041|FG001|Overall Study|Death|1|||
146752571|NCT01021878|529263040|FG000|Overall Study|Adverse Event|6|||
146752572|NCT01021878|529263041|FG001|Overall Study|Adverse Event|5|||
146752573|NCT01021878|529263040|FG000|Overall Study|Transplantation|6|||
146752574|NCT01021878|529263041|FG001|Overall Study|Transplantation|1|||
146752575|NCT01155726|529263044|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
146752576|NCT01155726|529263045|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
146752577|NCT01155726|529263046|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
146752578|NCT01155726|529263047|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
146752579|NCT05305040|529263048|FG000|Overall Study|Not Dosed|37|||
146752580|NCT05305040|529263049|FG001|Overall Study|Not Dosed|37|||
146752581|NCT05305040|529263048|FG000|Overall Study|Study Closure|34|||
146752582|NCT05305040|529263049|FG001|Overall Study|Study Closure|46|||
146752583|NCT05305040|529263048|FG000|Overall Study|Death|14|||
146752584|NCT05305040|529263049|FG001|Overall Study|Death|13|||
146752585|NCT05305040|529263048|FG000|Overall Study|Withdrawal by Subject|15|||
146752586|NCT05305040|529263049|FG001|Overall Study|Withdrawal by Subject|10|||
146752587|NCT05305040|529263048|FG000|Overall Study|Other|13|||
146752588|NCT05305040|529263049|FG001|Overall Study|Other|10|||
146752589|NCT05305040|529263048|FG000|Overall Study|Primary Malignancy Relapse|3|||
146752590|NCT05305040|529263049|FG001|Overall Study|Primary Malignancy Relapse|4|||
146752591|NCT05305040|529263048|FG000|Overall Study|Adverse Event|3|||
146752592|NCT05305040|529263049|FG001|Overall Study|Adverse Event|3|||
146752593|NCT05305040|529263048|FG000|Overall Study|Lost to Follow-up|2|||
146752594|NCT05305040|529263049|FG001|Overall Study|Lost to Follow-up|1|||
146752595|NCT05305040|529263048|FG000|Overall Study|Graft versus host disease|2|||
146752596|NCT05305040|529263049|FG001|Overall Study|Graft versus host disease|0|||
146752597|NCT05305040|529263048|FG000|Overall Study|Investigator's Decision|1|||
146752598|NCT05305040|529263049|FG001|Overall Study|Investigator's Decision|1|||
146752599|NCT05305040|529263048|FG000|Overall Study|COVID-19 Reasons|1|||
146752600|NCT05305040|529263049|FG001|Overall Study|COVID-19 Reasons|0|||
146752601|NCT01195675|529263053|FG000|Overall Study|Adverse Event|1|||
146752602|NCT01195675|529263053|FG000|Overall Study|Withdrawal by Subject|2|||
146752603|NCT02424344|529263054|FG000|Overall Study|Lack of Efficacy|0|||
146752604|NCT02424344|529263055|FG001|Overall Study|Lack of Efficacy|1|||
146752605|NCT02424344|529263054|FG000|Overall Study|Withdrawal by Subject|2|||
146752606|NCT02424344|529263055|FG001|Overall Study|Withdrawal by Subject|1|||
146752607|NCT02424344|529263054|FG000|Overall Study|Lost to Follow-up|1|||
146752608|NCT02424344|529263055|FG001|Overall Study|Lost to Follow-up|0|||
146752609|NCT02424344|529263054|FG000|Overall Study|Adverse Event|4|||
146752610|NCT02424344|529263055|FG001|Overall Study|Adverse Event|8|||
146752611|NCT05257837|529263056|FG000|Overall Study|Excluded (did not find the guns)|4|||
146752612|NCT05257837|529263057|FG001|Overall Study|Excluded (did not find the guns)|2|||
146752613|NCT05257837|529263058|FG002|Overall Study|Excluded (did not find the guns)|4|||
146752614|NCT05257837|529263059|FG003|Overall Study|Excluded (did not find the guns)|0|||
146752615|NCT01625338|529263060|FG000|Overall Study|Enrolled but not Treated|0|||
146752616|NCT01625338|529263061|FG001|Overall Study|Enrolled but not Treated|0|||
146752617|NCT01625338|529263062|FG002|Overall Study|Enrolled but not Treated|1|||
146752618|NCT01625338|529263060|FG000|Overall Study|Efficacy Failure|27|||
146752619|NCT01625338|529263061|FG001|Overall Study|Efficacy Failure|39|||
146752620|NCT01625338|529263062|FG002|Overall Study|Efficacy Failure|31|||
146752621|NCT01625338|529263060|FG000|Overall Study|Lost to Follow-up|3|||
146752622|NCT01625338|529263061|FG001|Overall Study|Lost to Follow-up|3|||
146752623|NCT01625338|529263062|FG002|Overall Study|Lost to Follow-up|2|||
146752624|NCT01625338|529263060|FG000|Overall Study|Investigator Decision|0|||
146752625|NCT01625338|529263061|FG001|Overall Study|Investigator Decision|2|||
146752626|NCT01625338|529263062|FG002|Overall Study|Investigator Decision|1|||
146752627|NCT01625338|529263060|FG000|Overall Study|Subject Withdrew Consent|1|||
146752628|NCT01625338|529263061|FG001|Overall Study|Subject Withdrew Consent|0|||
146752629|NCT01625338|529263062|FG002|Overall Study|Subject Withdrew Consent|2|||
146752630|NCT01625338|529263060|FG000|Overall Study|Adverse Event|1|||
146752631|NCT01625338|529263061|FG001|Overall Study|Adverse Event|0|||
146752632|NCT01625338|529263062|FG002|Overall Study|Adverse Event|1|||
146752633|NCT01625338|529263060|FG000|Overall Study|Study Discontinued by Sponsor|0|||
146752634|NCT01625338|529263061|FG001|Overall Study|Study Discontinued by Sponsor|0|||
146752635|NCT01625338|529263062|FG002|Overall Study|Study Discontinued by Sponsor|1|||
146752636|NCT03639675|529263063|FG000|Overall Study|Withdrawal by Subject|1|||
146752637|NCT05343455|529263066|FG000|Overall Study|Withdrawal by Subject|4|||
146752638|NCT05343455|529263067|FG001|Overall Study|Withdrawal by Subject|9|||
146752639|NCT05343455|529263068|FG002|Overall Study|Withdrawal by Subject|7|||
146752640|NCT05343455|529263066|FG000|Overall Study|Adverse Event|2|||
146752641|NCT05343455|529263067|FG001|Overall Study|Adverse Event|1|||
146752642|NCT05343455|529263068|FG002|Overall Study|Adverse Event|2|||
146752643|NCT05343455|529263066|FG000|Overall Study|Lost to Follow-up|1|||
146752644|NCT05343455|529263067|FG001|Overall Study|Lost to Follow-up|1|||
146752645|NCT05343455|529263068|FG002|Overall Study|Lost to Follow-up|3|||
146752646|NCT05343455|529263066|FG000|Overall Study|Pregnancy|1|||
146752647|NCT05343455|529263067|FG001|Overall Study|Pregnancy|0|||
146752648|NCT05343455|529263068|FG002|Overall Study|Pregnancy|0|||
146752649|NCT05343455|529263066|FG000|Overall Study|Physician Decision|0|||
146752650|NCT05343455|529263067|FG001|Overall Study|Physician Decision|0|||
146752651|NCT05343455|529263068|FG002|Overall Study|Physician Decision|1|||
146752652|NCT05343455|529263066|FG000|Overall Study|Protocol Violation|0|||
146752653|NCT05343455|529263067|FG001|Overall Study|Protocol Violation|1|||
146752654|NCT05343455|529263068|FG002|Overall Study|Protocol Violation|1|||
146752655|NCT03468426|529263069|FG000|Overall Study|Progressive disease|3|||
146752656|NCT03468426|529263070|FG001|Overall Study|Progressive disease|0|||
146752657|NCT03468426|529263071|FG002|Overall Study|Progressive disease|4|||
146752658|NCT03468426|529263072|FG003|Overall Study|Progressive disease|20|||
146752659|NCT03468426|529263073|FG004|Overall Study|Progressive disease|23|||
146752660|NCT03468426|529263074|FG005|Overall Study|Progressive disease|15|||
146752661|NCT03468426|529263075|FG006|Overall Study|Progressive disease|24|||
146752662|NCT03468426|529263076|FG007|Overall Study|Progressive disease|27|||
146752663|NCT03468426|529263077|FG008|Overall Study|Progressive disease|13|||
146752664|NCT03468426|529263078|FG009|Overall Study|Progressive disease|13|||
146752665|NCT03468426|529263079|FG010|Overall Study|Progressive disease|0|||
146752666|NCT03468426|529263069|FG000|Overall Study|Other adverse event or clinical progression|0|||
146752667|NCT03468426|529263070|FG001|Overall Study|Other adverse event or clinical progression|1|||
146752668|NCT03468426|529263071|FG002|Overall Study|Other adverse event or clinical progression|3|||
146752669|NCT03468426|529263072|FG003|Overall Study|Other adverse event or clinical progression|14|||
146752670|NCT03468426|529263073|FG004|Overall Study|Other adverse event or clinical progression|10|||
146752671|NCT03468426|529263074|FG005|Overall Study|Other adverse event or clinical progression|8|||
146752672|NCT03468426|529263075|FG006|Overall Study|Other adverse event or clinical progression|5|||
146752673|NCT03468426|529263076|FG007|Overall Study|Other adverse event or clinical progression|4|||
146752674|NCT03468426|529263077|FG008|Overall Study|Other adverse event or clinical progression|6|||
146752675|NCT03468426|529263078|FG009|Overall Study|Other adverse event or clinical progression|11|||
146752676|NCT03468426|529263079|FG010|Overall Study|Other adverse event or clinical progression|0|||
146752677|NCT03468426|529263069|FG000|Overall Study|Refused to continue taking trial medication|0|||
146752678|NCT03468426|529263070|FG001|Overall Study|Refused to continue taking trial medication|0|||
146752679|NCT03468426|529263071|FG002|Overall Study|Refused to continue taking trial medication|0|||
146752680|NCT03468426|529263072|FG003|Overall Study|Refused to continue taking trial medication|2|||
146752681|NCT03468426|529263073|FG004|Overall Study|Refused to continue taking trial medication|0|||
146752682|NCT03468426|529263074|FG005|Overall Study|Refused to continue taking trial medication|3|||
146752683|NCT03468426|529263075|FG006|Overall Study|Refused to continue taking trial medication|0|||
146752684|NCT03468426|529263076|FG007|Overall Study|Refused to continue taking trial medication|0|||
146752685|NCT03468426|529263077|FG008|Overall Study|Refused to continue taking trial medication|1|||
146752686|NCT03468426|529263078|FG009|Overall Study|Refused to continue taking trial medication|0|||
146752687|NCT03468426|529263079|FG010|Overall Study|Refused to continue taking trial medication|0|||
146752688|NCT03468426|529263069|FG000|Overall Study|Other than listed|0|||
146752689|NCT03468426|529263070|FG001|Overall Study|Other than listed|1|||
146752690|NCT03468426|529263071|FG002|Overall Study|Other than listed|0|||
146752691|NCT03468426|529263072|FG003|Overall Study|Other than listed|0|||
146752692|NCT03468426|529263073|FG004|Overall Study|Other than listed|2|||
146752693|NCT03468426|529263074|FG005|Overall Study|Other than listed|2|||
146752694|NCT03468426|529263075|FG006|Overall Study|Other than listed|0|||
146752695|NCT03468426|529263076|FG007|Overall Study|Other than listed|0|||
146752696|NCT03468426|529263077|FG008|Overall Study|Other than listed|4|||
146752697|NCT03468426|529263078|FG009|Overall Study|Other than listed|4|||
146752698|NCT03468426|529263079|FG010|Overall Study|Other than listed|1|||
146752699|NCT03468426|529263069|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146752700|NCT03468426|529263070|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146752701|NCT03468426|529263071|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
146752702|NCT03468426|529263072|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146752703|NCT03468426|529263073|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146752704|NCT03468426|529263074|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146752705|NCT03468426|529263075|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146752706|NCT03468426|529263076|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146752707|NCT03468426|529263077|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146752708|NCT03468426|529263078|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146752709|NCT03468426|529263079|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146752710|NCT03468426|529263069|FG000|Overall Study|missing reason|0|||
146752711|NCT03468426|529263070|FG001|Overall Study|missing reason|0|||
146752712|NCT03468426|529263071|FG002|Overall Study|missing reason|0|||
146752713|NCT03468426|529263072|FG003|Overall Study|missing reason|0|||
146752714|NCT03468426|529263073|FG004|Overall Study|missing reason|0|||
146752715|NCT03468426|529263074|FG005|Overall Study|missing reason|0|||
146752716|NCT03468426|529263075|FG006|Overall Study|missing reason|0|||
146752717|NCT03468426|529263076|FG007|Overall Study|missing reason|0|||
146752718|NCT03468426|529263077|FG008|Overall Study|missing reason|0|||
146752719|NCT03468426|529263078|FG009|Overall Study|missing reason|1|||
146752720|NCT03468426|529263079|FG010|Overall Study|missing reason|0|||
146752721|NCT00750893|529263082|FG000|Overall Study|Adverse Event|5|||
146752722|NCT00750893|529263082|FG000|Overall Study|Withdrawal by Subject|10|||
146752723|NCT00750893|529263082|FG000|Overall Study|Lost to Follow-up|510|||
146752724|NCT00750893|529263082|FG000|Overall Study|Other|17|||
146752725|NCT01712789|529263083|FG000|Overall Study|Lack of Efficacy|2|||
146752726|NCT01712789|529263083|FG000|Overall Study|Lost to Follow-up|1|||
146752727|NCT01712789|529263083|FG000|Overall Study|Progressive Disease|504|||
146752728|NCT01712789|529263083|FG000|Overall Study|Death|57|||
146752729|NCT01712789|529263083|FG000|Overall Study|Adverse Event|52|||
146752730|NCT01712789|529263083|FG000|Overall Study|Miscellaneous|31|||
146752731|NCT01712789|529263083|FG000|Overall Study|Withdrawal by Subject|21|||
146752732|NCT01712789|529263083|FG000|Overall Study|Transition to Commercial Treatment|8|||
146752733|NCT01712789|529263083|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
146752734|NCT01708187|529263084|FG000|Overall Study|Lost to Follow-up|0|||
146752735|NCT01708187|529263085|FG001|Overall Study|Lost to Follow-up|1|||
146752736|NCT01152554|529263087|FG000|Overall Study|Withdrawal by Subject|73|||
146752737|NCT01152554|529263088|FG001|Overall Study|Withdrawal by Subject|28|||
146752738|NCT01152554|529263087|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
146752739|NCT01152554|529263088|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
146752740|NCT01152554|529263087|FG000|Overall Study|Adverse Event|67|||
146752741|NCT01152554|529263088|FG001|Overall Study|Adverse Event|14|||
146752742|NCT01152554|529263087|FG000|Overall Study|Severe non-compliance to protocol|36|||
146752743|NCT01152554|529263088|FG001|Overall Study|Severe non-compliance to protocol|14|||
146752744|NCT01152554|529263087|FG000|Overall Study|Condition under investigation worsened|5|||
146752745|NCT01152554|529263088|FG001|Overall Study|Condition under investigation worsened|2|||
146752746|NCT01152554|529263087|FG000|Overall Study|Lack of Efficacy|20|||
146752747|NCT01152554|529263088|FG001|Overall Study|Lack of Efficacy|3|||
146752748|NCT01152554|529263087|FG000|Overall Study|Study-specific withdrawal criteria|17|||
146752749|NCT01152554|529263088|FG001|Overall Study|Study-specific withdrawal criteria|8|||
146752750|NCT01152554|529263087|FG000|Overall Study|Lost to Follow-up|87|||
146752751|NCT01152554|529263088|FG001|Overall Study|Lost to Follow-up|32|||
146752752|NCT01152554|529263087|FG000|Overall Study|Other|28|||
146752753|NCT01152554|529263088|FG001|Overall Study|Other|8|||
146752754|NCT01152554|529263087|FG000|Overall Study|Death|1|||
146752755|NCT01152554|529263088|FG001|Overall Study|Death|1|||
146752756|NCT02117544|529263089|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
146752757|NCT02117544|529263090|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
146752758|NCT03486899|529263091|FG000|Overall Study|Lost to Follow-up|4|||
146752759|NCT03486899|529263092|FG001|Overall Study|Lost to Follow-up|1|||
146752760|NCT03486899|529263093|FG002|Overall Study|Lost to Follow-up|4|||
146752761|NCT03486899|529263094|FG003|Overall Study|Lost to Follow-up|3|||
146752762|NCT03486899|529263091|FG000|Overall Study|Death|1|||
146752763|NCT03486899|529263092|FG001|Overall Study|Death|0|||
146752764|NCT03486899|529263093|FG002|Overall Study|Death|0|||
146752765|NCT03486899|529263094|FG003|Overall Study|Death|1|||
146752766|NCT03486899|529263091|FG000|Overall Study|Adverse Event|0|||
146752767|NCT03486899|529263092|FG001|Overall Study|Adverse Event|2|||
146752768|NCT03486899|529263093|FG002|Overall Study|Adverse Event|0|||
146752769|NCT03486899|529263094|FG003|Overall Study|Adverse Event|2|||
146752770|NCT03486899|529263091|FG000|Overall Study|Withdrawal by Subject|3|||
146752771|NCT03486899|529263092|FG001|Overall Study|Withdrawal by Subject|7|||
146752772|NCT03486899|529263093|FG002|Overall Study|Withdrawal by Subject|4|||
146752773|NCT03486899|529263094|FG003|Overall Study|Withdrawal by Subject|3|||
146752774|NCT03486899|529263091|FG000|Overall Study|Other Reasons|0|||
146752775|NCT03486899|529263092|FG001|Overall Study|Other Reasons|1|||
146752776|NCT03486899|529263093|FG002|Overall Study|Other Reasons|0|||
146752777|NCT03486899|529263094|FG003|Overall Study|Other Reasons|1|||
146752778|NCT01439711|529263095|FG000|Overall Study|Ineligible|13|||
146752779|NCT01439711|529263095|FG000|Overall Study|Cancel|3|||
146752780|NCT01439711|529263095|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
146752781|NCT01439711|529263095|FG000|Overall Study|Adverse Event|5|||
146752782|NCT01439711|529263095|FG000|Overall Study|Withdrawal by Subject|3|||
146752783|NCT01439711|529263095|FG000|Overall Study|Progression During Active Tx|3|||
146752784|NCT01439711|529263095|FG000|Overall Study|Noncompliance|3|||
146752785|NCT01439711|529263095|FG000|Overall Study|No MRI|9|||
146752786|NCT02408549|529263096|FG000|Overall Study|Adverse Event|15|||
146752787|NCT02408549|529263096|FG000|Overall Study|Death|4|||
146752788|NCT02408549|529263096|FG000|Overall Study|Lack of Efficacy|17|||
146752789|NCT02408549|529263096|FG000|Overall Study|Protocol Violation|4|||
146752790|NCT02408549|529263096|FG000|Overall Study|Lost to Follow-up|6|||
146752791|NCT02408549|529263096|FG000|Overall Study|Consent withdrawn|30|||
146752792|NCT02408549|529263096|FG000|Overall Study|Neurology research program closing at site|1|||
146752793|NCT02408549|529263096|FG000|Overall Study|Site closure|1|||
146752794|NCT02408549|529263096|FG000|Overall Study|Pregnancy|1|||
146752795|NCT02408549|529263096|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
146752796|NCT02408549|529263096|FG000|Overall Study|Subject moved to another place, far from site|1|||
146752797|NCT02408549|529263096|FG000|Overall Study|Study terminated at site|1|||
146752798|NCT02448719|529263100|FG000|Overall Study|Withdrawal by Subject|0|||
146752799|NCT02448719|529263101|FG001|Overall Study|Withdrawal by Subject|0|||
146752800|NCT02448719|529263102|FG002|Overall Study|Withdrawal by Subject|0|||
146752801|NCT02448719|529263103|FG003|Overall Study|Withdrawal by Subject|0|||
146752802|NCT02448719|529263104|FG004|Overall Study|Withdrawal by Subject|1|||
146752803|NCT02448719|529263105|FG005|Overall Study|Withdrawal by Subject|0|||
146752804|NCT02448719|529263106|FG006|Overall Study|Withdrawal by Subject|0|||
146752805|NCT02448719|529263107|FG007|Overall Study|Withdrawal by Subject|0|||
146752806|NCT02448719|529263108|FG008|Overall Study|Withdrawal by Subject|0|||
146752807|NCT02448719|529263109|FG009|Overall Study|Withdrawal by Subject|0|||
146752808|NCT02448719|529263110|FG010|Overall Study|Withdrawal by Subject|0|||
146752809|NCT01232556|529263111|FG000|Overall Study|Withdrawal by Subject|21|||
146752810|NCT01232556|529263112|FG001|Overall Study|Withdrawal by Subject|17|||
146752811|NCT01232556|529263111|FG000|Overall Study|Death|97|||
146752812|NCT01232556|529263112|FG001|Overall Study|Death|97|||
146752813|NCT01232556|529263111|FG000|Overall Study|Lost to Follow-up|0|||
146752814|NCT01232556|529263112|FG001|Overall Study|Lost to Follow-up|2|||
146752815|NCT01232556|529263111|FG000|Overall Study|Terminated by Sponsor|35|||
146752816|NCT01232556|529263112|FG001|Overall Study|Terminated by Sponsor|51|||
146752817|NCT01232556|529263111|FG000|Overall Study|Other|6|||
146752818|NCT01232556|529263112|FG001|Overall Study|Other|4|||
146752819|NCT01473420|529263115|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
146752820|NCT01473420|529263116|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
146752821|NCT01473420|529263115|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
146752822|NCT01473420|529263116|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
146752823|NCT01473420|529263115|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
146752824|NCT01473420|529263116|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
146752825|NCT01473420|529263115|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
146752826|NCT01473420|529263116|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
146752827|NCT01473420|529263115|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
146752828|NCT01473420|529263116|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
146752829|NCT01473420|529263115|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
146752830|NCT01473420|529263116|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
146752831|NCT01473420|529263115|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
146752832|NCT01473420|529263116|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
146752833|NCT01473420|529263115|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
146752834|NCT01473420|529263116|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
146752835|NCT01473420|529263115|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
146752836|NCT01473420|529263116|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
146752837|NCT01473420|529263115|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
146752838|NCT01473420|529263116|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
146752839|NCT01473420|529263115|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
146752840|NCT01473420|529263116|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
146752841|NCT01473420|529263115|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
146752842|NCT01473420|529263116|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
146752843|NCT01473420|529263115|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
146752844|NCT01473420|529263116|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
146752845|NCT04172987|529263119|FG000|Lead In Period|Adverse Event|1|||
146752846|NCT04172987|529263119|FG000|Lead In Period|Protocol Violation|1|||
146752847|NCT04172987|529263119|FG000|Period 1|Physician Decision|1|||
146752848|NCT04172987|529263119|FG000|Period 2|Adverse Event|5|||
146752849|NCT04172987|529263119|FG000|Period 2|Dosing Termination by Sponsor|4|||
146752850|NCT01603121|529263122|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
146752851|NCT01603121|529263123|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
146752852|NCT00577720|529263124|FG000|Overall Study|Adverse Event|2|||
146752853|NCT00577720|529263125|FG001|Overall Study|Adverse Event|1|||
146752854|NCT00577720|529263126|FG002|Overall Study|Adverse Event|0|||
146752855|NCT00577720|529263127|FG003|Overall Study|Adverse Event|4|||
146752856|NCT00577720|529263124|FG000|Overall Study|Lost to Follow-up|0|||
146752857|NCT00577720|529263125|FG001|Overall Study|Lost to Follow-up|0|||
146752858|NCT00577720|529263126|FG002|Overall Study|Lost to Follow-up|1|||
146752859|NCT00577720|529263127|FG003|Overall Study|Lost to Follow-up|0|||
146752860|NCT00577720|529263124|FG000|Overall Study|Protocol Violation|0|||
146752861|NCT00577720|529263125|FG001|Overall Study|Protocol Violation|0|||
146752862|NCT00577720|529263126|FG002|Overall Study|Protocol Violation|0|||
146752863|NCT00577720|529263127|FG003|Overall Study|Protocol Violation|1|||
146752864|NCT00577720|529263124|FG000|Overall Study|Withdrawal by Subject|2|||
146752865|NCT00577720|529263125|FG001|Overall Study|Withdrawal by Subject|0|||
146752866|NCT00577720|529263126|FG002|Overall Study|Withdrawal by Subject|0|||
146752867|NCT00577720|529263127|FG003|Overall Study|Withdrawal by Subject|2|||
146752868|NCT00738530|529263133|FG000|Overall Study|Death|220|||
146752869|NCT00738530|529263134|FG001|Overall Study|Death|224|||
146752870|NCT00738530|529263133|FG000|Overall Study|Lost to Follow-up|8|||
146752871|NCT00738530|529263134|FG001|Overall Study|Lost to Follow-up|6|||
146752872|NCT00738530|529263133|FG000|Overall Study|Withdrawal by Subject|6|||
146752873|NCT00738530|529263134|FG001|Overall Study|Withdrawal by Subject|8|||
146752874|NCT04179461|529263135|FG000|Overall Study|Lost to Follow-up|4|||
146752875|NCT03100838|529263136|FG000|Overall Study|Adverse Event|1|||
146752876|NCT03100838|529263137|FG001|Overall Study|Adverse Event|0|||
146752877|NCT03100838|529263138|FG002|Overall Study|Adverse Event|0|||
146752878|NCT03100838|529263139|FG003|Overall Study|Adverse Event|0|||
146752879|NCT03100838|529263136|FG000|Overall Study|Physician Decision|1|||
146752880|NCT03100838|529263137|FG001|Overall Study|Physician Decision|1|||
146752881|NCT03100838|529263138|FG002|Overall Study|Physician Decision|1|||
146752882|NCT03100838|529263139|FG003|Overall Study|Physician Decision|1|||
146752883|NCT03100838|529263136|FG000|Overall Study|Pregnancy|0|||
146752884|NCT03100838|529263137|FG001|Overall Study|Pregnancy|1|||
146752885|NCT03100838|529263138|FG002|Overall Study|Pregnancy|0|||
146752886|NCT03100838|529263139|FG003|Overall Study|Pregnancy|0|||
146752887|NCT03100838|529263136|FG000|Overall Study|Lost to Follow-up|0|||
146752888|NCT03100838|529263137|FG001|Overall Study|Lost to Follow-up|0|||
146752889|NCT03100838|529263138|FG002|Overall Study|Lost to Follow-up|1|||
146752890|NCT03100838|529263139|FG003|Overall Study|Lost to Follow-up|0|||
146752891|NCT01347645|529263140|FG000|Overall Study|Death|1|||
146752892|NCT01347645|529263141|FG001|Overall Study|Death|5|||
146752893|NCT01347645|529263142|FG002|Overall Study|Death|2|||
146752894|NCT01347645|529263143|FG003|Overall Study|Death|7|||
146752895|NCT01347645|529263144|FG004|Overall Study|Death|7|||
146752896|NCT01347645|529263140|FG000|Overall Study|Lost to Follow-up|1|||
146752897|NCT01347645|529263141|FG001|Overall Study|Lost to Follow-up|1|||
146752898|NCT01347645|529263142|FG002|Overall Study|Lost to Follow-up|0|||
146752899|NCT01347645|529263143|FG003|Overall Study|Lost to Follow-up|1|||
146752900|NCT01347645|529263144|FG004|Overall Study|Lost to Follow-up|1|||
146752901|NCT01347645|529263140|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
146752902|NCT01347645|529263141|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
146752903|NCT01347645|529263142|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
146752904|NCT01347645|529263143|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
146752905|NCT01347645|529263144|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
146752906|NCT01347645|529263140|FG000|Overall Study|Other|1|||
146752907|NCT01347645|529263141|FG001|Overall Study|Other|0|||
146752908|NCT01347645|529263142|FG002|Overall Study|Other|0|||
146752909|NCT01347645|529263143|FG003|Overall Study|Other|0|||
146752910|NCT01347645|529263144|FG004|Overall Study|Other|1|||
146752911|NCT01347645|529263140|FG000|Overall Study|Withdrawal by Subject|0|||
146752912|NCT01347645|529263141|FG001|Overall Study|Withdrawal by Subject|0|||
146752913|NCT01347645|529263142|FG002|Overall Study|Withdrawal by Subject|0|||
146752914|NCT01347645|529263143|FG003|Overall Study|Withdrawal by Subject|3|||
146752915|NCT01347645|529263144|FG004|Overall Study|Withdrawal by Subject|3|||
146752916|NCT01347645|529263140|FG000|Overall Study|Physician Decision|0|||
146752917|NCT01347645|529263141|FG001|Overall Study|Physician Decision|0|||
146752918|NCT01347645|529263142|FG002|Overall Study|Physician Decision|0|||
146752919|NCT01347645|529263143|FG003|Overall Study|Physician Decision|0|||
146752920|NCT01347645|529263144|FG004|Overall Study|Physician Decision|1|||
146752921|NCT01347645|529263140|FG000|Overall Study|Adverse Event|0|||
146752922|NCT01347645|529263141|FG001|Overall Study|Adverse Event|0|||
146752923|NCT01347645|529263142|FG002|Overall Study|Adverse Event|0|||
146752924|NCT01347645|529263143|FG003|Overall Study|Adverse Event|1|||
146752925|NCT01347645|529263144|FG004|Overall Study|Adverse Event|1|||
146512354|NCT01389258|528379202|FG000|Overall Study|Lost to Follow-up|5|||
146752926|NCT00184028|529263145|FG000|Overall Study|Death|1|||
146752927|NCT00184028|529263145|FG000|Overall Study|Lack of Efficacy|4|||
146752928|NCT00184028|529263145|FG000|Overall Study|Adverse Event|2|||
146752929|NCT00184028|529263145|FG000|Overall Study|Withdrawal by Subject|1|||
146752930|NCT00184028|529263145|FG000|Overall Study|Non-compliance|2|||
146752931|NCT01141660|529263146|FG000|Overall Study|Physician Decision|0|||
146752932|NCT01141660|529263147|FG001|Overall Study|Physician Decision|12|||
146752933|NCT00209027|529263149|FG000|Overall Study|study terminated|10|||
146752934|NCT00209027|529263150|FG001|Overall Study|study terminated|0|||
146752935|NCT03785340|529263151|FG000|Overall Study|Lost to Follow-up|2|||
146752936|NCT03785340|529263152|FG001|Overall Study|Lost to Follow-up|0|||
146752937|NCT03785340|529263151|FG000|Overall Study|Adverse Event|1|||
146752938|NCT03785340|529263152|FG001|Overall Study|Adverse Event|0|||
146752939|NCT04504916|529263153|FG000|Overall Study|Study terminated|7|||
146752940|NCT04504916|529263154|FG001|Overall Study|Study terminated|8|||
146752941|NCT04504916|529263153|FG000|Overall Study|Death|54|||
146752942|NCT04504916|529263154|FG001|Overall Study|Death|18|||
146752943|NCT04504916|529263153|FG000|Overall Study|Lost to Follow-up|1|||
146752944|NCT04504916|529263154|FG001|Overall Study|Lost to Follow-up|1|||
146752945|NCT04504916|529263153|FG000|Overall Study|Withdrawal by Subject|8|||
146752946|NCT04504916|529263154|FG001|Overall Study|Withdrawal by Subject|4|||
146752947|NCT04504916|529263153|FG000|Overall Study|Did not agree to follow-up|0|||
146752948|NCT04504916|529263154|FG001|Overall Study|Did not agree to follow-up|1|||
146752949|NCT01368211|529263155|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
146752950|NCT01368211|529263156|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
146752951|NCT01513967|529263160|FG000|Overall Study|Pregnancy|0|||
146752952|NCT01513967|529263161|FG001|Overall Study|Pregnancy|0|||
146752953|NCT01513967|529263162|FG002|Overall Study|Pregnancy|0|||
146752954|NCT01513967|529263163|FG003|Overall Study|Pregnancy|0|||
146752955|NCT01513967|529263164|FG004|Overall Study|Pregnancy|0|||
146752956|NCT01513967|529263165|FG005|Overall Study|Pregnancy|0|||
146752957|NCT01513967|529263166|FG006|Overall Study|Pregnancy|1|||
146752958|NCT01513967|529263167|FG007|Overall Study|Pregnancy|0|||
146752959|NCT01513967|529263160|FG000|Overall Study|missed a study visit|0|||
146752960|NCT01513967|529263161|FG001|Overall Study|missed a study visit|0|||
146752961|NCT01513967|529263162|FG002|Overall Study|missed a study visit|0|||
146752962|NCT01513967|529263163|FG003|Overall Study|missed a study visit|0|||
146752963|NCT01513967|529263164|FG004|Overall Study|missed a study visit|0|||
146752964|NCT01513967|529263165|FG005|Overall Study|missed a study visit|0|||
146752965|NCT01513967|529263166|FG006|Overall Study|missed a study visit|1|||
146752966|NCT01513967|529263167|FG007|Overall Study|missed a study visit|0|||
146752967|NCT01513967|529263160|FG000|Overall Study|excluded due to positive drug screen|0|||
146752968|NCT01513967|529263161|FG001|Overall Study|excluded due to positive drug screen|0|||
146752969|NCT01513967|529263162|FG002|Overall Study|excluded due to positive drug screen|0|||
146752970|NCT01513967|529263163|FG003|Overall Study|excluded due to positive drug screen|0|||
146752971|NCT01513967|529263164|FG004|Overall Study|excluded due to positive drug screen|0|||
146752972|NCT01513967|529263165|FG005|Overall Study|excluded due to positive drug screen|0|||
146752973|NCT01513967|529263166|FG006|Overall Study|excluded due to positive drug screen|0|||
146752974|NCT01513967|529263167|FG007|Overall Study|excluded due to positive drug screen|2|||
146752975|NCT01513967|529263160|FG000|Overall Study|Physician Decision|0|||
146851453|NCT00604825|529624228|FG000|Overall Study|Withdrawal by Subject|4|||
146851454|NCT00604825|529624229|FG001|Overall Study|Withdrawal by Subject|3|||
146851455|NCT00604825|529624230|FG002|Overall Study|Withdrawal by Subject|5|||
146851456|NCT00604825|529624231|FG003|Overall Study|Withdrawal by Subject|5|||
146851457|NCT00604825|529624228|FG000|Overall Study|Lack of Efficacy|3|||
146851458|NCT00604825|529624229|FG001|Overall Study|Lack of Efficacy|2|||
146851459|NCT00604825|529624230|FG002|Overall Study|Lack of Efficacy|1|||
146752976|NCT01513967|529263161|FG001|Overall Study|Physician Decision|0|||
146752977|NCT01513967|529263162|FG002|Overall Study|Physician Decision|0|||
146752978|NCT01513967|529263163|FG003|Overall Study|Physician Decision|0|||
146752979|NCT01513967|529263164|FG004|Overall Study|Physician Decision|0|||
146752980|NCT01513967|529263165|FG005|Overall Study|Physician Decision|1|||
146752981|NCT01513967|529263166|FG006|Overall Study|Physician Decision|0|||
146752982|NCT01513967|529263167|FG007|Overall Study|Physician Decision|0|||
146752983|NCT01349660|529263168|FG000|Overall Study|Still Receiving Study Treatment|0|||
146752984|NCT01349660|529263169|FG001|Overall Study|Still Receiving Study Treatment|0|||
146752985|NCT01349660|529263170|FG002|Overall Study|Still Receiving Study Treatment|1|||
146752986|NCT01349660|529263168|FG000|Overall Study|Disease Progression|2|||
146752987|NCT01349660|529263169|FG001|Overall Study|Disease Progression|4|||
146752988|NCT01349660|529263170|FG002|Overall Study|Disease Progression|50|||
146752989|NCT01349660|529263168|FG000|Overall Study|Adverse Event|1|||
146752990|NCT01349660|529263169|FG001|Overall Study|Adverse Event|1|||
146752991|NCT01349660|529263170|FG002|Overall Study|Adverse Event|12|||
146752992|NCT01349660|529263168|FG000|Overall Study|Withdrawal by Subject|2|||
146752993|NCT01349660|529263169|FG001|Overall Study|Withdrawal by Subject|0|||
146752994|NCT01349660|529263170|FG002|Overall Study|Withdrawal by Subject|9|||
146752995|NCT01349660|529263168|FG000|Overall Study|Death|1|||
146752996|NCT01349660|529263169|FG001|Overall Study|Death|1|||
146752997|NCT01349660|529263170|FG002|Overall Study|Death|0|||
146752998|NCT01349660|529263168|FG000|Overall Study|Non-Permitted Interventions|0|||
146752999|NCT01349660|529263169|FG001|Overall Study|Non-Permitted Interventions|0|||
146753000|NCT01349660|529263170|FG002|Overall Study|Non-Permitted Interventions|2|||
146753001|NCT01349660|529263168|FG000|Overall Study|Study Compliance|0|||
146753002|NCT01349660|529263169|FG001|Overall Study|Study Compliance|0|||
146753003|NCT01349660|529263170|FG002|Overall Study|Study Compliance|1|||
146753004|NCT01349660|529263168|FG000|Overall Study|Declining Performance Status|0|||
146753005|NCT01349660|529263169|FG001|Overall Study|Declining Performance Status|0|||
146851460|NCT00604825|529624231|FG003|Overall Study|Lack of Efficacy|0|||
146851461|NCT00604825|529624228|FG000|Overall Study|Did not meet eligibility criteria|0|||
146851462|NCT00604825|529624229|FG001|Overall Study|Did not meet eligibility criteria|0|||
146753006|NCT01349660|529263170|FG002|Overall Study|Declining Performance Status|1|||
146851463|NCT00604825|529624230|FG002|Overall Study|Did not meet eligibility criteria|2|||
146851464|NCT00604825|529624231|FG003|Overall Study|Did not meet eligibility criteria|0|||
146851465|NCT00604825|529624228|FG000|Overall Study|Physician Decision|0|||
146851466|NCT00604825|529624229|FG001|Overall Study|Physician Decision|0|||
146851467|NCT00604825|529624230|FG002|Overall Study|Physician Decision|0|||
146851468|NCT00604825|529624231|FG003|Overall Study|Physician Decision|1|||
146851469|NCT00604825|529624228|FG000|Overall Study|Exclusion criterion met|0|||
146851470|NCT00604825|529624229|FG001|Overall Study|Exclusion criterion met|0|||
146851471|NCT00604825|529624230|FG002|Overall Study|Exclusion criterion met|0|||
146851472|NCT00604825|529624231|FG003|Overall Study|Exclusion criterion met|1|||
146851473|NCT05593445|529624232|FG000|12-Week DBVC Period|Adverse Event|1|||
146851474|NCT05593445|529624233|FG001|12-Week DBVC Period|Adverse Event|0|||
146851475|NCT05593445|529624234|FG002|12-Week DBVC Period|Adverse Event|0|||
146851476|NCT05593445|529624235|FG003|12-Week DBVC Period|Adverse Event|0|||
146851477|NCT05593445|529624232|FG000|12-Week DBVC Period|Physician Decision|0|||
146851478|NCT05593445|529624233|FG001|12-Week DBVC Period|Physician Decision|1|||
146851479|NCT05593445|529624234|FG002|12-Week DBVC Period|Physician Decision|0|||
146851480|NCT05593445|529624235|FG003|12-Week DBVC Period|Physician Decision|0|||
146851481|NCT05593445|529624232|FG000|12-Week DBVC Period|Protocol Violation|0|||
146851482|NCT05593445|529624233|FG001|12-Week DBVC Period|Protocol Violation|1|||
146851483|NCT05593445|529624234|FG002|12-Week DBVC Period|Protocol Violation|0|||
146851484|NCT05593445|529624235|FG003|12-Week DBVC Period|Protocol Violation|0|||
146851485|NCT05593445|529624232|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
146851486|NCT05593445|529624233|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
146851487|NCT05593445|529624234|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
146851488|NCT05593445|529624235|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
146851489|NCT05593445|529624232|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
146851490|NCT05593445|529624233|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
146851491|NCT05593445|529624234|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
146851492|NCT05593445|529624235|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
146851493|NCT05593445|529624232|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
146851494|NCT05593445|529624233|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
146851495|NCT05593445|529624234|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
146851496|NCT05593445|529624235|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
146851497|NCT05593445|529624232|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
146851498|NCT05593445|529624233|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
146851499|NCT05593445|529624234|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
146851500|NCT05593445|529624235|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
146851501|NCT05593445|529624232|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146851502|NCT05593445|529624233|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146851503|NCT05593445|529624234|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
146851504|NCT05593445|529624235|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146851505|NCT03647488|529626090|FG000|Overall Study|Progressive disease|10|||
146851506|NCT03647488|529626091|FG001|Overall Study|Progressive disease|0|||
146851507|NCT03647488|529626092|FG002|Overall Study|Progressive disease|0|||
146851508|NCT03647488|529626090|FG000|Overall Study|Adverse Event|5|||
146851509|NCT03647488|529626091|FG001|Overall Study|Adverse Event|0|||
146851510|NCT03647488|529626092|FG002|Overall Study|Adverse Event|0|||
146851511|NCT03647488|529626090|FG000|Overall Study|Clinical progression|2|||
146851512|NCT03647488|529626091|FG001|Overall Study|Clinical progression|0|||
146851513|NCT03647488|529626092|FG002|Overall Study|Clinical progression|0|||
146851514|NCT03647488|529626090|FG000|Overall Study|Participant refused to take investigational product|1|||
146753007|NCT00847301|529263171|FG000|Overall Study|Adverse Event|35|||
146753008|NCT00847301|529263171|FG000|Overall Study|Switch to other anticoagulants|16|||
146753009|NCT00847301|529263171|FG000|Overall Study|Lost to Follow-up|1|||
146753010|NCT00847301|529263171|FG000|Overall Study|No prescription after hospital discharge|1|||
146753011|NCT00847301|529263171|FG000|Overall Study|Other reason not defined above|1|||
146753012|NCT00996580|529263175|FG000|Overall Study|Adverse Event|466|||
146753013|NCT00996580|529263175|FG000|Overall Study|Lost to Follow-up|480|||
146753014|NCT00996580|529263175|FG000|Overall Study|Noncompliance with the protocol|137|||
146851515|NCT03647488|529626091|FG001|Overall Study|Participant refused to take investigational product|0|||
146851516|NCT03647488|529626092|FG002|Overall Study|Participant refused to take investigational product|0|||
146851517|NCT00812331|529626093|FG000|Overall Study|Adverse Event|1|||
146851518|NCT00812331|529626094|FG001|Overall Study|Adverse Event|0|||
146851519|NCT00812331|529626095|FG002|Overall Study|Adverse Event|0|||
146851520|NCT00812331|529626096|FG003|Overall Study|Adverse Event|0|||
146851521|NCT00812331|529626097|FG004|Overall Study|Adverse Event|0|||
146512355|NCT02943785|528379203|FG000|Overall Study|Adverse Event|112|||
146851522|NCT01506453|529626098|FG000|Overall Study|Withdrawal prior to treatment|0|||
146851523|NCT01506453|529626099|FG001|Overall Study|Withdrawal prior to treatment|2|||
146512356|NCT02943785|528379204|FG001|Overall Study|Adverse Event|97|||
146512357|NCT02943785|528379203|FG000|Overall Study|Withdrawal by Subject|63|||
146753015|NCT00996580|529263175|FG000|Overall Study|Physician Decision|5|||
146753016|NCT00996580|529263175|FG000|Overall Study|Pregnancy|68|||
146753017|NCT00996580|529263175|FG000|Overall Study|Protocol Violation|16|||
146753018|NCT00996580|529263175|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
146753019|NCT00996580|529263175|FG000|Overall Study|Withdrawal by Subject|217|||
146753020|NCT00996580|529263175|FG000|Overall Study|Other|29|||
146753021|NCT04248465|529263176|FG000|Randomized-Controlled Period|Death|12|||
146753022|NCT04248465|529263177|FG001|Randomized-Controlled Period|Death|5|||
146753023|NCT04248465|529263176|FG000|Randomized-Controlled Period|Adverse Event|2|||
146753024|NCT04248465|529263177|FG001|Randomized-Controlled Period|Adverse Event|0|||
146753025|NCT04248465|529263176|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
146753026|NCT04248465|529263177|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
146753027|NCT04248465|529263176|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
146753028|NCT04248465|529263177|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
146753029|NCT04248465|529263176|FG000|Randomized-Controlled Period|Physician Decision|1|||
146753030|NCT04248465|529263177|FG001|Randomized-Controlled Period|Physician Decision|1|||
146753031|NCT04248465|529263176|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
146753032|NCT04248465|529263177|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
146753033|NCT04248465|529263176|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
146753034|NCT04248465|529263177|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
146753035|NCT04248465|529263176|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
146753036|NCT04248465|529263177|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
146753037|NCT00238420|529263178|FG000|Overall Study|Protocol Violation|1|||
146753038|NCT00238420|529263179|FG001|Overall Study|Protocol Violation|1|||
146753039|NCT00641186|529263180|FG000|Overall Study|Adverse Event|3|||
146753040|NCT05221749|529263181|FG000|Overall Study|Lost to Follow-up|2|||
146753041|NCT05221749|529263182|FG001|Overall Study|Lost to Follow-up|3|||
146753042|NCT04140890|529263183|FG000|Overall Study|Withdrawal by Subject|0|||
146753043|NCT04140890|529263184|FG001|Overall Study|Withdrawal by Subject|1|||
146753044|NCT00519636|529263185|FG000|Treatment Period 1|Adverse Event|1|||
146753045|NCT00519636|529263186|FG001|Treatment Period 1|Adverse Event|0|||
146753046|NCT00519636|529263187|FG002|Treatment Period 1|Adverse Event|1|||
146753047|NCT00519636|529263188|FG003|Treatment Period 1|Adverse Event|0|||
146753048|NCT00519636|529263185|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
146753049|NCT00519636|529263186|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
146753050|NCT00519636|529263187|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
146753051|NCT00519636|529263188|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
146753052|NCT00519636|529263185|FG000|Washout Period|Adverse Event|2|||
146753053|NCT00519636|529263186|FG001|Washout Period|Adverse Event|1|||
146753054|NCT00519636|529263187|FG002|Washout Period|Adverse Event|1|||
146753055|NCT00519636|529263188|FG003|Washout Period|Adverse Event|0|||
146753056|NCT00519636|529263185|FG000|Washout Period|Lost to Follow-up|1|||
146753057|NCT00519636|529263186|FG001|Washout Period|Lost to Follow-up|0|||
146753058|NCT00519636|529263187|FG002|Washout Period|Lost to Follow-up|0|||
146753059|NCT00519636|529263188|FG003|Washout Period|Lost to Follow-up|0|||
146753060|NCT00519636|529263185|FG000|Washout Period|Protocol Violation|0|||
146753061|NCT00519636|529263186|FG001|Washout Period|Protocol Violation|0|||
146753062|NCT00519636|529263187|FG002|Washout Period|Protocol Violation|1|||
146753063|NCT00519636|529263188|FG003|Washout Period|Protocol Violation|2|||
146753064|NCT00519636|529263185|FG000|Washout Period|Withdrawal by Subject|1|||
146753065|NCT00519636|529263186|FG001|Washout Period|Withdrawal by Subject|0|||
146753066|NCT00519636|529263187|FG002|Washout Period|Withdrawal by Subject|1|||
146753067|NCT00519636|529263188|FG003|Washout Period|Withdrawal by Subject|0|||
146753068|NCT00519636|529263185|FG000|Washout Period|Failed to meet continuation criteria|14|||
146753069|NCT00519636|529263186|FG001|Washout Period|Failed to meet continuation criteria|11|||
146753070|NCT00519636|529263187|FG002|Washout Period|Failed to meet continuation criteria|9|||
146753071|NCT00519636|529263188|FG003|Washout Period|Failed to meet continuation criteria|3|||
146753072|NCT00519636|529263185|FG000|Washout Period|Out of pollen area > 48 hours|1|||
146753073|NCT00519636|529263186|FG001|Washout Period|Out of pollen area > 48 hours|0|||
146753074|NCT00519636|529263187|FG002|Washout Period|Out of pollen area > 48 hours|0|||
146753075|NCT00519636|529263188|FG003|Washout Period|Out of pollen area > 48 hours|0|||
146753076|NCT00519636|529263185|FG000|Washout Period|Participating in study at another site|1|||
146753077|NCT00519636|529263186|FG001|Washout Period|Participating in study at another site|0|||
146753078|NCT00519636|529263187|FG002|Washout Period|Participating in study at another site|0|||
146753079|NCT00519636|529263188|FG003|Washout Period|Participating in study at another site|0|||
146753080|NCT00519636|529263185|FG000|Washout Period|Non-compliant|0|||
146753081|NCT00519636|529263186|FG001|Washout Period|Non-compliant|1|||
146753082|NCT00519636|529263187|FG002|Washout Period|Non-compliant|0|||
146753083|NCT00519636|529263188|FG003|Washout Period|Non-compliant|0|||
146753084|NCT00519636|529263185|FG000|Washout Period|Per doctors request|0|||
146753085|NCT00519636|529263186|FG001|Washout Period|Per doctors request|1|||
146753086|NCT00519636|529263187|FG002|Washout Period|Per doctors request|0|||
146753087|NCT00519636|529263188|FG003|Washout Period|Per doctors request|0|||
146753088|NCT00519636|529263185|FG000|Washout Period|Subject randomized in error|0|||
146753089|NCT00519636|529263186|FG001|Washout Period|Subject randomized in error|0|||
146753090|NCT00519636|529263187|FG002|Washout Period|Subject randomized in error|1|||
146753091|NCT00519636|529263188|FG003|Washout Period|Subject randomized in error|0|||
146753092|NCT00519636|529263185|FG000|Washout Period|Prohibited medications|0|||
146753093|NCT00519636|529263186|FG001|Washout Period|Prohibited medications|0|||
146753094|NCT00519636|529263187|FG002|Washout Period|Prohibited medications|1|||
146753095|NCT00519636|529263188|FG003|Washout Period|Prohibited medications|0|||
146753096|NCT00519636|529263185|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
146753097|NCT00519636|529263186|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
146851524|NCT03694275|529626100|FG000|Overall Study|Adverse Event|0|||
146625190|NCT00089297|528803835|FG000|Overall Study|Secondary malignancy|1|||
146851525|NCT03694275|529626101|FG001|Overall Study|Adverse Event|1|||
146851526|NCT03694275|529626100|FG000|Overall Study|Reason not Specified|0|||
146851527|NCT03694275|529626101|FG001|Overall Study|Reason not Specified|1|||
146851528|NCT02502799|529626102|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
146851529|NCT02502799|529626103|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
146851530|NCT02502799|529626104|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
146851531|NCT02502799|529626105|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
146851532|NCT02502799|529626102|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
146851533|NCT02502799|529626103|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
146851534|NCT02502799|529626104|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
146851535|NCT02502799|529626105|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
146851536|NCT02502799|529626102|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
146851537|NCT02502799|529626103|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
146851538|NCT02502799|529626104|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
146851539|NCT02502799|529626105|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
146851540|NCT02502799|529626102|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
146851541|NCT02502799|529626103|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
146851542|NCT02502799|529626104|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
146851543|NCT02502799|529626105|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
146851544|NCT02502799|529626102|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
146851545|NCT02502799|529626103|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
146851546|NCT02502799|529626104|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
146851547|NCT02502799|529626105|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
146851548|NCT00153062|529626111|FG000|Overall Study|Death|360|||
146851549|NCT00153062|529626112|FG001|Overall Study|Death|352|||
146851550|NCT00153062|529626113|FG002|Overall Study|Death|369|||
146851551|NCT00153062|529626114|FG003|Overall Study|Death|365|||
146851552|NCT00153062|529626111|FG000|Overall Study|Withdrawal by Subject|14|||
146851553|NCT00153062|529626112|FG001|Overall Study|Withdrawal by Subject|30|||
146851554|NCT00153062|529626113|FG002|Overall Study|Withdrawal by Subject|27|||
146851555|NCT00153062|529626114|FG003|Overall Study|Withdrawal by Subject|28|||
146851556|NCT00153062|529626111|FG000|Overall Study|Lost to Follow-up|12|||
146851557|NCT00153062|529626112|FG001|Overall Study|Lost to Follow-up|20|||
146851558|NCT00153062|529626113|FG002|Overall Study|Lost to Follow-up|15|||
146851559|NCT00153062|529626114|FG003|Overall Study|Lost to Follow-up|16|||
146851560|NCT00153062|529626111|FG000|Overall Study|Adverse Event|0|||
146851561|NCT00153062|529626112|FG001|Overall Study|Adverse Event|1|||
146851562|NCT00153062|529626113|FG002|Overall Study|Adverse Event|1|||
146851563|NCT00153062|529626114|FG003|Overall Study|Adverse Event|0|||
146851564|NCT00153062|529626111|FG000|Overall Study|Protocol Violation|0|||
146851565|NCT00153062|529626112|FG001|Overall Study|Protocol Violation|2|||
146851566|NCT00153062|529626113|FG002|Overall Study|Protocol Violation|1|||
146851567|NCT00153062|529626114|FG003|Overall Study|Protocol Violation|1|||
146851568|NCT00153062|529626111|FG000|Overall Study|No disposition data available|1|||
146851569|NCT00153062|529626112|FG001|Overall Study|No disposition data available|1|||
146851570|NCT00153062|529626113|FG002|Overall Study|No disposition data available|1|||
146851571|NCT00153062|529626114|FG003|Overall Study|No disposition data available|1|||
146851572|NCT00153062|529626111|FG000|Overall Study|Other|0|||
146851573|NCT00153062|529626112|FG001|Overall Study|Other|0|||
146851574|NCT00153062|529626113|FG002|Overall Study|Other|1|||
146851575|NCT00153062|529626114|FG003|Overall Study|Other|0|||
146851576|NCT01589237|529626136|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
146851577|NCT01589237|529626137|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
146851578|NCT01589237|529626138|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
146851579|NCT01589237|529626139|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
146851580|NCT01589237|529626136|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
146753098|NCT00519636|529263187|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
146753099|NCT00519636|529263188|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
146753100|NCT00519636|529263185|FG000|Treatment Period 2|Subject randomized in error|0|||
146753101|NCT00519636|529263186|FG001|Treatment Period 2|Subject randomized in error|1|||
146753102|NCT00519636|529263187|FG002|Treatment Period 2|Subject randomized in error|0|||
146753103|NCT00519636|529263188|FG003|Treatment Period 2|Subject randomized in error|0|||
146753104|NCT00519636|529263185|FG000|Treatment Period 2|Per doctors request|0|||
146753105|NCT00519636|529263186|FG001|Treatment Period 2|Per doctors request|0|||
146851581|NCT01589237|529626137|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
146851582|NCT01589237|529626138|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
146851583|NCT01589237|529626139|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
146851584|NCT01589237|529626136|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
146851585|NCT01589237|529626137|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
146753106|NCT00519636|529263187|FG002|Treatment Period 2|Per doctors request|1|||
146753107|NCT00519636|529263188|FG003|Treatment Period 2|Per doctors request|0|||
146753108|NCT00519636|529263185|FG000|Treatment Period 2|Subject misrandomized|0|||
146753109|NCT00519636|529263186|FG001|Treatment Period 2|Subject misrandomized|0|||
146753110|NCT00519636|529263187|FG002|Treatment Period 2|Subject misrandomized|0|||
146753111|NCT00519636|529263188|FG003|Treatment Period 2|Subject misrandomized|1|||
146753112|NCT00519636|529263185|FG000|Post Study Period|Subject randomized in error|0|||
146753113|NCT00519636|529263186|FG001|Post Study Period|Subject randomized in error|0|||
146753114|NCT00519636|529263187|FG002|Post Study Period|Subject randomized in error|0|||
146753115|NCT00519636|529263188|FG003|Post Study Period|Subject randomized in error|1|||
146753116|NCT02388074|529263189|FG000|Overall Study|Lost in Transit|2|||
146753117|NCT02388074|529263189|FG000|Overall Study|Sample Not Returned|1|||
146753118|NCT01778062|529263192|FG000|Overall Study|Adverse Event|1|||
146753119|NCT01778062|529263193|FG001|Overall Study|Adverse Event|3|||
146753120|NCT01778062|529263192|FG000|Overall Study|Consent Withdrawal|1|||
146753121|NCT01778062|529263193|FG001|Overall Study|Consent Withdrawal|5|||
146753122|NCT01778062|529263192|FG000|Overall Study|major protocol deviation|4|||
146753123|NCT01778062|529263193|FG001|Overall Study|major protocol deviation|3|||
146753124|NCT01254890|529263196|FG000|Overall Study|Ineligible|0|||
146753125|NCT01254890|529263197|FG001|Overall Study|Ineligible|3|||
146753126|NCT01254890|529263196|FG000|Overall Study|Withdrawal by Subject|1|||
146753127|NCT01254890|529263197|FG001|Overall Study|Withdrawal by Subject|2|||
146753128|NCT01254890|529263196|FG000|Overall Study|Disease Progression|0|||
146753129|NCT01254890|529263197|FG001|Overall Study|Disease Progression|5|||
146753130|NCT01824472|529263198|FG000|Overall Study|Lost to Follow-up|0|||
146753131|NCT01824472|529263199|FG001|Overall Study|Lost to Follow-up|0|||
146753132|NCT01824472|529263200|FG002|Overall Study|Lost to Follow-up|1|||
146753133|NCT01824472|529263198|FG000|Overall Study|Withdrawal by Subject|1|||
146753134|NCT01824472|529263199|FG001|Overall Study|Withdrawal by Subject|5|||
146753135|NCT01824472|529263200|FG002|Overall Study|Withdrawal by Subject|3|||
146753136|NCT01824472|529263198|FG000|Overall Study|Ineligible post randomization&screening|0|||
146753137|NCT01824472|529263199|FG001|Overall Study|Ineligible post randomization&screening|2|||
146753138|NCT01824472|529263200|FG002|Overall Study|Ineligible post randomization&screening|0|||
146753139|NCT04039503|529263201|FG000|Overall Study|Adverse Event|3|||
146753140|NCT04039503|529263202|FG001|Overall Study|Adverse Event|0|||
146753141|NCT04039503|529263203|FG002|Overall Study|Adverse Event|2|||
146753142|NCT04039503|529263204|FG003|Overall Study|Adverse Event|0|||
146753143|NCT04039503|529263201|FG000|Overall Study|Lost to Follow-up|0|||
146753144|NCT04039503|529263202|FG001|Overall Study|Lost to Follow-up|0|||
146753145|NCT04039503|529263203|FG002|Overall Study|Lost to Follow-up|1|||
146753146|NCT04039503|529263204|FG003|Overall Study|Lost to Follow-up|0|||
146753147|NCT04039503|529263201|FG000|Overall Study|Protocol Violation|0|||
146753148|NCT04039503|529263202|FG001|Overall Study|Protocol Violation|1|||
146753149|NCT04039503|529263203|FG002|Overall Study|Protocol Violation|2|||
146753150|NCT04039503|529263204|FG003|Overall Study|Protocol Violation|1|||
146753151|NCT04039503|529263201|FG000|Overall Study|Withdrawal by Subject|4|||
146753152|NCT04039503|529263202|FG001|Overall Study|Withdrawal by Subject|3|||
146753153|NCT04039503|529263203|FG002|Overall Study|Withdrawal by Subject|5|||
146753154|NCT04039503|529263204|FG003|Overall Study|Withdrawal by Subject|2|||
146753155|NCT01815736|529263205|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
146753156|NCT01815736|529263206|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
146753157|NCT01815736|529263205|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
146753158|NCT01815736|529263206|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
146753159|NCT01815736|529263205|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
146753160|NCT01815736|529263206|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
146753161|NCT01815736|529263205|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
146753162|NCT01815736|529263206|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
146753163|NCT01815736|529263205|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
146753164|NCT01815736|529263206|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
146753165|NCT01815736|529263205|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
146753166|NCT01815736|529263206|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
146753167|NCT01815736|529263205|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
146753168|NCT01815736|529263206|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
146753169|NCT01815736|529263205|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
146753170|NCT01815736|529263206|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
146753171|NCT01815736|529263205|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
146753172|NCT01815736|529263206|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
146753173|NCT01815736|529263205|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
146753174|NCT01815736|529263206|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
146753175|NCT01815736|529263205|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
146753176|NCT01815736|529263206|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
146753177|NCT01815736|529263205|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
146753178|NCT01815736|529263206|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
146753179|NCT01815736|529263205|FG000|Extension Treatment Phase- After Week 96|Death|1|||
146753180|NCT01815736|529263206|FG001|Extension Treatment Phase- After Week 96|Death|0|||
146753181|NCT02846558|529263207|FG000|Overall Study|Adverse Event|1|||
146753182|NCT02846558|529263208|FG001|Overall Study|Adverse Event|0|||
146753183|NCT02846558|529263209|FG002|Overall Study|Adverse Event|0|||
146753184|NCT02846558|529263210|FG003|Overall Study|Adverse Event|0|||
146753185|NCT02846558|529263207|FG000|Overall Study|Withdrawal by Subject|5|||
146753186|NCT02846558|529263208|FG001|Overall Study|Withdrawal by Subject|4|||
146753187|NCT02846558|529263209|FG002|Overall Study|Withdrawal by Subject|2|||
146753188|NCT02846558|529263210|FG003|Overall Study|Withdrawal by Subject|2|||
146753189|NCT02846558|529263207|FG000|Overall Study|Lost to Follow-up|2|||
146753190|NCT02846558|529263208|FG001|Overall Study|Lost to Follow-up|0|||
146753191|NCT02846558|529263209|FG002|Overall Study|Lost to Follow-up|0|||
146753192|NCT02846558|529263210|FG003|Overall Study|Lost to Follow-up|0|||
146753193|NCT04445155|529263211|FG000|Overall Study|Lost to Follow-up|11|||
146753194|NCT04445155|529263212|FG001|Overall Study|Lost to Follow-up|2|||
146753195|NCT04445155|529263213|FG002|Overall Study|Lost to Follow-up|3|||
146753196|NCT04445155|529263214|FG003|Overall Study|Lost to Follow-up|0|||
146753197|NCT04445155|529263211|FG000|Overall Study|Withdrawal by Subject|8|||
146753198|NCT04445155|529263212|FG001|Overall Study|Withdrawal by Subject|0|||
146753199|NCT04445155|529263213|FG002|Overall Study|Withdrawal by Subject|0|||
146753200|NCT04445155|529263214|FG003|Overall Study|Withdrawal by Subject|0|||
146753201|NCT04445155|529263211|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
146753202|NCT04445155|529263212|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
146753203|NCT04445155|529263213|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
146753204|NCT04445155|529263214|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
146753205|NCT04445155|529263211|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
146753206|NCT04445155|529263212|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
146753207|NCT04445155|529263213|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
146753208|NCT04445155|529263214|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
146753209|NCT03363659|529263216|FG000|Overall Study|Adverse Event|1|||
146753210|NCT03363659|529263216|FG000|Overall Study|Screen fail|1|||
146753211|NCT03363659|529263216|FG000|Overall Study|Withdrawal by Subject|1|||
146753212|NCT00904150|529263218|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
146753213|NCT00904150|529263219|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
146753214|NCT00904150|529263218|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
146753215|NCT00904150|529263219|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
146753216|NCT03872388|529263220|FG000|Overall Study|Disease Progression|0|||
146753217|NCT03872388|529263221|FG001|Overall Study|Disease Progression|0|||
146753218|NCT03872388|529263222|FG002|Overall Study|Disease Progression|0|||
146753219|NCT03872388|529263223|FG003|Overall Study|Disease Progression|0|||
146753220|NCT03872388|529263224|FG004|Overall Study|Disease Progression|0|||
146753221|NCT03872388|529263225|FG005|Overall Study|Disease Progression|0|||
146753222|NCT03872388|529263226|FG006|Overall Study|Disease Progression|1|||
146753223|NCT03872388|529263227|FG007|Overall Study|Disease Progression|1|||
146753224|NCT01349907|529264667|FG000|Overall Study|Adverse Event|37|||
146753225|NCT01349907|529264668|FG001|Overall Study|Adverse Event|11|||
146753226|NCT01349907|529264667|FG000|Overall Study|Treatment failure|13|||
146753227|NCT01349907|529264668|FG001|Overall Study|Treatment failure|4|||
146753228|NCT01349907|529264667|FG000|Overall Study|Lost to Follow-up|25|||
146753229|NCT01349907|529264668|FG001|Overall Study|Lost to Follow-up|6|||
146753230|NCT01349907|529264667|FG000|Overall Study|Withdrawal by Subject|30|||
146753231|NCT01349907|529264668|FG001|Overall Study|Withdrawal by Subject|8|||
146753232|NCT01349907|529264667|FG000|Overall Study|Protocol Violation|33|||
146753233|NCT01349907|529264668|FG001|Overall Study|Protocol Violation|13|||
146753234|NCT01349907|529264667|FG000|Overall Study|Administrative|1|||
146753235|NCT01349907|529264668|FG001|Overall Study|Administrative|1|||
146753236|NCT01477749|529264671|FG000|Overall Study|Physician Decision|4|||
146753237|NCT04004208|529264675|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146753238|NCT04004208|529264676|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146753239|NCT04004208|529264675|FG000|Overall Study|Death|3|||
146753240|NCT04004208|529264676|FG001|Overall Study|Death|0|||
146753241|NCT04004208|529264675|FG000|Overall Study|COVID-19 pandemic|1|||
146753242|NCT04004208|529264676|FG001|Overall Study|COVID-19 pandemic|0|||
146753243|NCT04004208|529264675|FG000|Overall Study|Physician Decision|1|||
146753244|NCT04004208|529264676|FG001|Overall Study|Physician Decision|0|||
146753245|NCT04004208|529264675|FG000|Overall Study|Adverse Event|1|||
146753246|NCT04004208|529264676|FG001|Overall Study|Adverse Event|1|||
146753247|NCT01310868|529264682|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
146753248|NCT01628874|529264689|FG000|Overall Study|Physician Decision|1|||
146753249|NCT01628874|529264690|FG001|Overall Study|Physician Decision|1|||
146753250|NCT01628874|529264689|FG000|Overall Study|Age >4 months|4|||
146753251|NCT01628874|529264690|FG001|Overall Study|Age >4 months|2|||
146753252|NCT00873093|529264691|FG000|Overall Study|Adverse Event|0|||
146753253|NCT00873093|529264692|FG001|Overall Study|Adverse Event|2|||
146753254|NCT00873093|529264693|FG002|Overall Study|Adverse Event|0|||
146753255|NCT00873093|529264694|FG003|Overall Study|Adverse Event|0|||
146753256|NCT00873093|529264695|FG004|Overall Study|Adverse Event|0|||
146753257|NCT00873093|529264691|FG000|Overall Study|Death|0|||
146753258|NCT00873093|529264692|FG001|Overall Study|Death|3|||
146753259|NCT00873093|529264693|FG002|Overall Study|Death|2|||
146753260|NCT00873093|529264694|FG003|Overall Study|Death|0|||
146753261|NCT00873093|529264695|FG004|Overall Study|Death|0|||
146753262|NCT00873093|529264691|FG000|Overall Study|Physician Decision|0|||
146753263|NCT00873093|529264692|FG001|Overall Study|Physician Decision|17|||
146753264|NCT00873093|529264693|FG002|Overall Study|Physician Decision|10|||
146753265|NCT00873093|529264694|FG003|Overall Study|Physician Decision|10|||
146753266|NCT00873093|529264695|FG004|Overall Study|Physician Decision|2|||
146753267|NCT00873093|529264691|FG000|Overall Study|Withdrawal by Subject|1|||
146753268|NCT00873093|529264692|FG001|Overall Study|Withdrawal by Subject|4|||
146753269|NCT00873093|529264693|FG002|Overall Study|Withdrawal by Subject|4|||
146753270|NCT00873093|529264694|FG003|Overall Study|Withdrawal by Subject|0|||
146753271|NCT00873093|529264695|FG004|Overall Study|Withdrawal by Subject|0|||
146753272|NCT00873093|529264691|FG000|Overall Study|Ineligible|0|||
146753273|NCT00873093|529264692|FG001|Overall Study|Ineligible|1|||
146753274|NCT00873093|529264693|FG002|Overall Study|Ineligible|0|||
146753275|NCT00873093|529264694|FG003|Overall Study|Ineligible|1|||
146753276|NCT00873093|529264695|FG004|Overall Study|Ineligible|0|||
146753277|NCT01848834|529264696|FG000|Overall Study|Adverse Event|3|||
146753278|NCT01848834|529264697|FG001|Overall Study|Adverse Event|11|||
146753279|NCT01848834|529264698|FG002|Overall Study|Adverse Event|3|||
146753280|NCT01848834|529264699|FG003|Overall Study|Adverse Event|5|||
146753281|NCT01848834|529264700|FG004|Overall Study|Adverse Event|9|||
146753282|NCT01848834|529264696|FG000|Overall Study|Death|2|||
146753283|NCT01848834|529264697|FG001|Overall Study|Death|11|||
146753284|NCT01848834|529264698|FG002|Overall Study|Death|1|||
146753285|NCT01848834|529264699|FG003|Overall Study|Death|8|||
146753286|NCT01848834|529264700|FG004|Overall Study|Death|27|||
146753287|NCT01848834|529264696|FG000|Overall Study|Excluded Medication|5|||
146753288|NCT01848834|529264697|FG001|Overall Study|Excluded Medication|4|||
146753289|NCT01848834|529264698|FG002|Overall Study|Excluded Medication|3|||
146753290|NCT01848834|529264699|FG003|Overall Study|Excluded Medication|6|||
146753291|NCT01848834|529264700|FG004|Overall Study|Excluded Medication|6|||
146753292|NCT01848834|529264696|FG000|Overall Study|Lost to Follow-up|5|||
146753293|NCT01848834|529264697|FG001|Overall Study|Lost to Follow-up|5|||
146753294|NCT01848834|529264698|FG002|Overall Study|Lost to Follow-up|3|||
146851586|NCT01589237|529626138|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
146851587|NCT01589237|529626139|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
146851588|NCT01589237|529626136|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
146851589|NCT01589237|529626137|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
146851590|NCT01589237|529626138|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
146851591|NCT01589237|529626139|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
146851592|NCT00117845|529626140|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
146851593|NCT01022268|529626141|FG000|Overall Study|Withdrawal by Subject|1|||
146851594|NCT01022268|529626142|FG001|Overall Study|Withdrawal by Subject|0|||
146851595|NCT01022268|529626141|FG000|Overall Study|Withdrawal by Subject|1|||
146851596|NCT01022268|529626142|FG001|Overall Study|Withdrawal by Subject|0|||
146851597|NCT00734097|529626143|FG000|Screening|Protocol Violation|12|||
146851598|NCT00734097|529626143|FG000|Screening|Withdrawal by Subject|5|||
146851599|NCT00734097|529626143|FG000|Screening|Lost to Follow-up|2|||
146851600|NCT00734097|529626143|FG000|Screening|Unconfirmed pregnancy|1|||
146851601|NCT00734097|529626143|FG000|Open Label|Lost to Follow-up|7|||
146851602|NCT00734097|529626143|FG000|Open Label|Withdrawal by Subject|5|||
146753295|NCT01848834|529264699|FG003|Overall Study|Lost to Follow-up|0|||
146753296|NCT01848834|529264700|FG004|Overall Study|Lost to Follow-up|3|||
146753297|NCT01848834|529264696|FG000|Overall Study|Physician Decision|1|||
146753298|NCT01848834|529264697|FG001|Overall Study|Physician Decision|3|||
146753299|NCT01848834|529264698|FG002|Overall Study|Physician Decision|4|||
146753300|NCT01848834|529264699|FG003|Overall Study|Physician Decision|0|||
146753301|NCT01848834|529264700|FG004|Overall Study|Physician Decision|11|||
146753302|NCT01848834|529264696|FG000|Overall Study|Protocol Violation|0|||
146753303|NCT01848834|529264697|FG001|Overall Study|Protocol Violation|0|||
146753304|NCT01848834|529264698|FG002|Overall Study|Protocol Violation|0|||
146753305|NCT01848834|529264699|FG003|Overall Study|Protocol Violation|0|||
146753306|NCT01848834|529264700|FG004|Overall Study|Protocol Violation|1|||
146753307|NCT01848834|529264696|FG000|Overall Study|Sponsor Decision|1|||
146753308|NCT01848834|529264697|FG001|Overall Study|Sponsor Decision|1|||
146753309|NCT01848834|529264698|FG002|Overall Study|Sponsor Decision|0|||
146753310|NCT01848834|529264699|FG003|Overall Study|Sponsor Decision|1|||
146753311|NCT01848834|529264700|FG004|Overall Study|Sponsor Decision|1|||
146753312|NCT01848834|529264696|FG000|Overall Study|Withdrawal by Subject|2|||
146753313|NCT01848834|529264697|FG001|Overall Study|Withdrawal by Subject|13|||
146753314|NCT01848834|529264698|FG002|Overall Study|Withdrawal by Subject|10|||
146753315|NCT01848834|529264699|FG003|Overall Study|Withdrawal by Subject|6|||
146753316|NCT01848834|529264700|FG004|Overall Study|Withdrawal by Subject|36|||
146753317|NCT03259373|529264705|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
146753318|NCT03259373|529264706|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
146753319|NCT03259373|529264705|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
146753320|NCT03259373|529264706|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
146753321|NCT03259373|529264705|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
146753322|NCT03259373|529264706|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
146753323|NCT03259373|529264705|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
146753324|NCT03259373|529264706|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
146753325|NCT03259373|529264705|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
146753326|NCT03259373|529264706|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
146753327|NCT03259373|529264705|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
146753328|NCT03259373|529264706|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
146753329|NCT00885495|529264707|FG000|Overall Study|Adverse Event|1|||
146753330|NCT00885495|529264708|FG001|Overall Study|Adverse Event|2|||
146753331|NCT00885495|529264707|FG000|Overall Study|Protocol Violation|0|||
146753332|NCT00885495|529264708|FG001|Overall Study|Protocol Violation|1|||
146753333|NCT00885495|529264707|FG000|Overall Study|Withdrawal by Subject|1|||
146753334|NCT00885495|529264708|FG001|Overall Study|Withdrawal by Subject|0|||
146753335|NCT01563978|529264710|FG000|Overall Study|Physician Decision|1|||
146753336|NCT01563978|529264711|FG001|Overall Study|Physician Decision|0|||
146753337|NCT01563978|529264710|FG000|Overall Study|Lost to Follow-up|1|||
146753338|NCT01563978|529264711|FG001|Overall Study|Lost to Follow-up|0|||
146753339|NCT01563978|529264710|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
146753340|NCT01563978|529264711|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
146753341|NCT01563978|529264710|FG000|Overall Study|Adverse Event|1|||
146753342|NCT01563978|529264711|FG001|Overall Study|Adverse Event|2|||
146753343|NCT05764239|529264712|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
146851603|NCT00734097|529626143|FG000|Open Label|Protocol Violation|4|||
146851604|NCT00910689|529626144|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
146753344|NCT05764239|529264712|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
146851605|NCT00910689|529626145|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
146851606|NCT00910689|529626146|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
146851607|NCT00910689|529626147|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
146851608|NCT00910689|529626144|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
146851609|NCT00910689|529626145|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
146851610|NCT00910689|529626146|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
146851611|NCT00910689|529626147|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
146851612|NCT00910689|529626144|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
146851613|NCT00910689|529626145|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
146851614|NCT00910689|529626146|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
146851615|NCT00910689|529626147|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
146851616|NCT00910689|529626144|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
146851617|NCT00910689|529626145|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
146851618|NCT00910689|529626146|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
146851619|NCT00910689|529626147|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
146851620|NCT00910689|529626144|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
146851621|NCT00910689|529626145|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
146851622|NCT00910689|529626146|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
146851623|NCT00910689|529626147|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
146851624|NCT00910689|529626144|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
146851625|NCT00910689|529626145|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
146851626|NCT00910689|529626146|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
146851627|NCT00910689|529626147|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
146851628|NCT00910689|529626144|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
146851629|NCT00910689|529626145|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
146851630|NCT00910689|529626146|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
146851631|NCT00910689|529626147|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
146851632|NCT00910689|529626144|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
146851633|NCT00910689|529626145|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
146851634|NCT00910689|529626146|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
146851635|NCT00910689|529626147|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
146851636|NCT00910689|529626144|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
146851637|NCT00910689|529626145|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
146851638|NCT00910689|529626146|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
146851639|NCT00910689|529626147|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
146851640|NCT00910689|529626144|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
146851641|NCT00910689|529626145|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
146851642|NCT00910689|529626146|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
146851643|NCT00910689|529626147|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
146851644|NCT00910689|529626144|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
146851645|NCT00910689|529626145|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
146851646|NCT00910689|529626146|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
146851647|NCT00910689|529626147|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
146851648|NCT00910689|529626144|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
146851649|NCT00910689|529626145|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
146851650|NCT00910689|529626146|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
146851651|NCT00910689|529626147|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
146851652|NCT00910689|529626144|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
146851653|NCT00910689|529626145|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
146851654|NCT00910689|529626146|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
146851655|NCT00910689|529626147|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
146851656|NCT00910689|529626144|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
146851657|NCT00910689|529626145|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
146851658|NCT00910689|529626146|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
146851659|NCT00910689|529626147|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
146851660|NCT00910689|529626144|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
146851661|NCT00910689|529626145|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
146851662|NCT00910689|529626146|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
146851663|NCT00910689|529626147|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
146851664|NCT00910689|529626144|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
146851665|NCT00910689|529626145|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
146851666|NCT00910689|529626146|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
146851667|NCT00910689|529626147|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
146851668|NCT00910689|529626144|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
146851669|NCT00910689|529626145|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
146851670|NCT00910689|529626146|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
146851671|NCT00910689|529626147|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
146851672|NCT00910689|529626144|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
146625191|NCT00089297|528803835|FG000|Overall Study|IRB approval not ready|1|||
146625192|NCT00089297|528803835|FG000|Overall Study|Non-compliance|1|||
146753345|NCT05764239|529264712|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
146965004|NCT01491737|530033421|FG000|Overall Study|Reason Not Specified|8|||
146851673|NCT00910689|529626145|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
146753346|NCT05764239|529264712|FG000|DEP (Part 1)|Adverse Event|1|||
146753347|NCT05764239|529264712|FG000|DEP (Part 1)|Lost to Follow-up|1|||
146753348|NCT05764239|529264712|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
146753349|NCT05764239|529264712|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
146753350|NCT05764239|529264712|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
146753351|NCT05764239|529264712|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
146753352|NCT04630756|529264713|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
146753353|NCT04630756|529264714|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
146753354|NCT04630756|529264715|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
146753355|NCT05593211|529264717|FG000|Overall Study|Withdrawal by Subject|1|||
146753356|NCT03077620|529264718|FG000|Overall Study|Unable to place lumbar catheter|1|||
146753357|NCT03077620|529264719|FG001|Overall Study|Unable to place lumbar catheter|0|||
146753358|NCT03077620|529264720|FG002|Overall Study|Unable to place lumbar catheter|1|||
146753359|NCT03077620|529264721|FG003|Overall Study|Unable to place lumbar catheter|0|||
146851674|NCT00910689|529626146|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
146851675|NCT00910689|529626147|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
146851676|NCT00910689|529626144|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
146851677|NCT00910689|529626145|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
146851678|NCT00910689|529626146|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
146851679|NCT00910689|529626147|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
146851680|NCT00910689|529626144|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
146851681|NCT00910689|529626145|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
146851682|NCT00910689|529626146|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
146851683|NCT00910689|529626147|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
146851684|NCT00910689|529626144|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
146851685|NCT00910689|529626145|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
146851686|NCT00910689|529626146|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
146851687|NCT00910689|529626147|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
146851688|NCT00645801|529626148|FG000|Overall Study|unclear if patient took all the medication.|1|||
146851689|NCT00645801|529626149|FG001|Overall Study|unclear if patient took all the medication.|0|||
146851690|NCT00645801|529626148|FG000|Overall Study|Lost to Follow-up|19|||
146851691|NCT00645801|529626149|FG001|Overall Study|Lost to Follow-up|15|||
146851692|NCT01403610|529626152|FG000|Overall Study|Withdrawal by Subject|2|||
146851693|NCT01403610|529626153|FG001|Overall Study|Withdrawal by Subject|0|||
146851694|NCT01403610|529626154|FG002|Overall Study|Withdrawal by Subject|0|||
146851695|NCT01403610|529626155|FG003|Overall Study|Withdrawal by Subject|0|||
146851696|NCT01403610|529626152|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
146851697|NCT01403610|529626153|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
146851698|NCT01403610|529626154|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
146851699|NCT01403610|529626155|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
146851700|NCT00203476|529626156|FG000|Overall Study|Lost to Follow-up|1|||
146851701|NCT00203476|529626157|FG001|Overall Study|Lost to Follow-up|0|||
146851702|NCT00203476|529626158|FG002|Overall Study|Lost to Follow-up|0|||
146851703|NCT00203476|529626156|FG000|Overall Study|Withdrawal by Subject|0|||
146851704|NCT00203476|529626157|FG001|Overall Study|Withdrawal by Subject|1|||
146851705|NCT00203476|529626158|FG002|Overall Study|Withdrawal by Subject|0|||
146851706|NCT01190514|529626159|FG000|First Intervention (Period 1)|Adverse Event|1|||
146851707|NCT01190514|529626160|FG001|First Intervention (Period 1)|Adverse Event|0|||
146851708|NCT01190514|529626161|FG002|First Intervention (Period 1)|Adverse Event|0|||
146851709|NCT01190514|529626162|FG003|First Intervention (Period 1)|Adverse Event|0|||
146851710|NCT01190514|529626159|FG000|Third Intervention (Period 3)|Adverse Event|1|||
146851711|NCT01190514|529626160|FG001|Third Intervention (Period 3)|Adverse Event|0|||
146851712|NCT01190514|529626161|FG002|Third Intervention (Period 3)|Adverse Event|0|||
146851713|NCT01190514|529626162|FG003|Third Intervention (Period 3)|Adverse Event|0|||
146851714|NCT01775475|529626167|FG000|Overall Study|Death|3|||
146851715|NCT01775475|529626168|FG001|Overall Study|Death|3|||
146851716|NCT00896051|529626170|FG000|Overall Study|Adverse Event|2|||
146851717|NCT00896051|529626171|FG001|Overall Study|Adverse Event|1|||
146851718|NCT00896051|529626170|FG000|Overall Study|Lost to Follow-up|3|||
146851719|NCT00896051|529626171|FG001|Overall Study|Lost to Follow-up|2|||
146851720|NCT00896051|529626170|FG000|Overall Study|Withdrawal by Subject|3|||
146851721|NCT00896051|529626171|FG001|Overall Study|Withdrawal by Subject|2|||
146851722|NCT00896051|529626170|FG000|Overall Study|Subject noncompliant|1|||
146851723|NCT00896051|529626171|FG001|Overall Study|Subject noncompliant|3|||
146851724|NCT00896051|529626170|FG000|Overall Study|Other|1|||
146851725|NCT00896051|529626171|FG001|Overall Study|Other|1|||
146851726|NCT02935452|529626172|FG000|Overall Study|work and life commintment|3|||
146851727|NCT02935452|529626173|FG001|Overall Study|work and life commintment|1|||
146851728|NCT01813929|529626174|FG000|Overall Study|Withdrawal by Subject|0|||
146851729|NCT01813929|529626175|FG001|Overall Study|Withdrawal by Subject|1|||
146753360|NCT03077620|529264718|FG000|Overall Study|Withdrawal by Subject|0|||
146753361|NCT03077620|529264719|FG001|Overall Study|Withdrawal by Subject|1|||
146753362|NCT03077620|529264720|FG002|Overall Study|Withdrawal by Subject|0|||
146753363|NCT03077620|529264721|FG003|Overall Study|Withdrawal by Subject|0|||
146753364|NCT03077620|529264718|FG000|Overall Study|Physician Decision|0|||
146753365|NCT03077620|529264719|FG001|Overall Study|Physician Decision|0|||
146753366|NCT03077620|529264720|FG002|Overall Study|Physician Decision|1|||
146753367|NCT03077620|529264721|FG003|Overall Study|Physician Decision|0|||
146753368|NCT03225846|529264722|FG000|Overall Study|Adverse Event|0|||
146753369|NCT03225846|529264723|FG001|Overall Study|Adverse Event|0|||
146753370|NCT03225846|529264724|FG002|Overall Study|Adverse Event|0|||
146753371|NCT03225846|529264725|FG003|Overall Study|Adverse Event|0|||
146753372|NCT03225846|529264726|FG004|Overall Study|Adverse Event|0|||
146753373|NCT03225846|529264727|FG005|Overall Study|Adverse Event|0|||
146753374|NCT03225846|529264728|FG006|Overall Study|Adverse Event|6|||
146753375|NCT03225846|529264722|FG000|Overall Study|Withdrawal by Subject|0|||
146753376|NCT03225846|529264723|FG001|Overall Study|Withdrawal by Subject|1|||
146753377|NCT03225846|529264724|FG002|Overall Study|Withdrawal by Subject|0|||
146753378|NCT03225846|529264725|FG003|Overall Study|Withdrawal by Subject|0|||
146753379|NCT03225846|529264726|FG004|Overall Study|Withdrawal by Subject|0|||
146753380|NCT03225846|529264727|FG005|Overall Study|Withdrawal by Subject|0|||
146753381|NCT03225846|529264728|FG006|Overall Study|Withdrawal by Subject|0|||
146753382|NCT03225846|529264722|FG000|Overall Study|Death|0|||
146753383|NCT03225846|529264723|FG001|Overall Study|Death|1|||
146753384|NCT03225846|529264724|FG002|Overall Study|Death|0|||
146753385|NCT03225846|529264725|FG003|Overall Study|Death|0|||
146753386|NCT03225846|529264726|FG004|Overall Study|Death|0|||
146753387|NCT03225846|529264727|FG005|Overall Study|Death|0|||
146753388|NCT03225846|529264728|FG006|Overall Study|Death|0|||
146753389|NCT03225846|529264722|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
146753390|NCT03225846|529264723|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
146753391|NCT03225846|529264724|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
146753392|NCT03225846|529264725|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
146753393|NCT03225846|529264726|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
146753394|NCT03225846|529264727|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
146753395|NCT03225846|529264728|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
146753396|NCT03225846|529264722|FG000|Overall Study|Patient decision|0|||
146753397|NCT03225846|529264723|FG001|Overall Study|Patient decision|0|||
146753398|NCT03225846|529264724|FG002|Overall Study|Patient decision|0|||
146753399|NCT03225846|529264725|FG003|Overall Study|Patient decision|0|||
146753400|NCT03225846|529264726|FG004|Overall Study|Patient decision|0|||
146753401|NCT03225846|529264727|FG005|Overall Study|Patient decision|0|||
146753402|NCT03225846|529264728|FG006|Overall Study|Patient decision|1|||
146753403|NCT03621982|529264729|FG000|Overall Study|Withdrawal by Subject|1|||
146753404|NCT03621982|529264730|FG001|Overall Study|Withdrawal by Subject|0|||
146753405|NCT03621982|529264731|FG002|Overall Study|Withdrawal by Subject|0|||
146753406|NCT03621982|529264732|FG003|Overall Study|Withdrawal by Subject|1|||
146753407|NCT03621982|529264733|FG004|Overall Study|Withdrawal by Subject|0|||
146753408|NCT03621982|529264734|FG005|Overall Study|Withdrawal by Subject|1|||
146753409|NCT03621982|529264735|FG006|Overall Study|Withdrawal by Subject|1|||
146753410|NCT03621982|529264736|FG007|Overall Study|Withdrawal by Subject|0|||
146753411|NCT03621982|529264737|FG008|Overall Study|Withdrawal by Subject|1|||
146753412|NCT03621982|529264738|FG009|Overall Study|Withdrawal by Subject|0|||
146753413|NCT03621982|529264739|FG010|Overall Study|Withdrawal by Subject|2|||
146753414|NCT03621982|529264740|FG011|Overall Study|Withdrawal by Subject|1|||
146753415|NCT03621982|529264741|FG012|Overall Study|Withdrawal by Subject|2|||
146753416|NCT03621982|529264742|FG013|Overall Study|Withdrawal by Subject|2|||
146753417|NCT03621982|529264729|FG000|Overall Study|Investigator/Sponsor decision|0|||
146753418|NCT03621982|529264730|FG001|Overall Study|Investigator/Sponsor decision|0|||
146753419|NCT03621982|529264731|FG002|Overall Study|Investigator/Sponsor decision|0|||
146753420|NCT03621982|529264732|FG003|Overall Study|Investigator/Sponsor decision|0|||
146753421|NCT03621982|529264733|FG004|Overall Study|Investigator/Sponsor decision|0|||
146753422|NCT03621982|529264734|FG005|Overall Study|Investigator/Sponsor decision|0|||
146753423|NCT03621982|529264735|FG006|Overall Study|Investigator/Sponsor decision|0|||
146753424|NCT03621982|529264736|FG007|Overall Study|Investigator/Sponsor decision|0|||
146753425|NCT03621982|529264737|FG008|Overall Study|Investigator/Sponsor decision|0|||
146753426|NCT03621982|529264738|FG009|Overall Study|Investigator/Sponsor decision|0|||
146753427|NCT03621982|529264739|FG010|Overall Study|Investigator/Sponsor decision|0|||
146753428|NCT03621982|529264740|FG011|Overall Study|Investigator/Sponsor decision|4|||
146753429|NCT03621982|529264741|FG012|Overall Study|Investigator/Sponsor decision|0|||
146753430|NCT03621982|529264742|FG013|Overall Study|Investigator/Sponsor decision|2|||
146753431|NCT03621982|529264729|FG000|Overall Study|Death|2|||
146753432|NCT03621982|529264730|FG001|Overall Study|Death|4|||
146753433|NCT03621982|529264731|FG002|Overall Study|Death|4|||
146753434|NCT03621982|529264732|FG003|Overall Study|Death|3|||
146753435|NCT03621982|529264733|FG004|Overall Study|Death|8|||
146753436|NCT03621982|529264734|FG005|Overall Study|Death|4|||
146753437|NCT03621982|529264735|FG006|Overall Study|Death|6|||
146753438|NCT03621982|529264736|FG007|Overall Study|Death|3|||
146753439|NCT03621982|529264737|FG008|Overall Study|Death|0|||
146753440|NCT03621982|529264738|FG009|Overall Study|Death|3|||
146753441|NCT03621982|529264739|FG010|Overall Study|Death|8|||
146753442|NCT03621982|529264740|FG011|Overall Study|Death|4|||
146753443|NCT03621982|529264741|FG012|Overall Study|Death|2|||
146753444|NCT03621982|529264742|FG013|Overall Study|Death|2|||
146753445|NCT03621982|529264729|FG000|Overall Study|Lost to Follow-up|0|||
146753446|NCT03621982|529264730|FG001|Overall Study|Lost to Follow-up|0|||
146753447|NCT03621982|529264731|FG002|Overall Study|Lost to Follow-up|1|||
146753448|NCT03621982|529264732|FG003|Overall Study|Lost to Follow-up|0|||
146753449|NCT03621982|529264733|FG004|Overall Study|Lost to Follow-up|0|||
146753450|NCT03621982|529264734|FG005|Overall Study|Lost to Follow-up|0|||
146753451|NCT03621982|529264735|FG006|Overall Study|Lost to Follow-up|1|||
146753452|NCT03621982|529264736|FG007|Overall Study|Lost to Follow-up|0|||
146753453|NCT03621982|529264737|FG008|Overall Study|Lost to Follow-up|0|||
146753454|NCT03621982|529264738|FG009|Overall Study|Lost to Follow-up|1|||
146753455|NCT03621982|529264739|FG010|Overall Study|Lost to Follow-up|0|||
146753456|NCT03621982|529264740|FG011|Overall Study|Lost to Follow-up|0|||
146753457|NCT03621982|529264741|FG012|Overall Study|Lost to Follow-up|0|||
146753458|NCT03621982|529264742|FG013|Overall Study|Lost to Follow-up|0|||
146753459|NCT00442286|529264743|FG000|Overall Study|Death|2|||
146753460|NCT00442286|529264744|FG001|Overall Study|Death|2|||
146753461|NCT00442286|529264743|FG000|Overall Study|Lost to Follow-up|1|||
146753462|NCT00442286|529264744|FG001|Overall Study|Lost to Follow-up|0|||
146753463|NCT00442286|529264743|FG000|Overall Study|Withdrawal by Subject|2|||
146753464|NCT00442286|529264744|FG001|Overall Study|Withdrawal by Subject|0|||
146753465|NCT00442286|529264743|FG000|Overall Study|System explanted|1|||
146753466|NCT00442286|529264744|FG001|Overall Study|System explanted|0|||
146753467|NCT00442286|529264743|FG000|Overall Study|Patient Injury|1|||
146753468|NCT00442286|529264744|FG001|Overall Study|Patient Injury|0|||
146753469|NCT02102464|529264747|FG000|Randomized Study|Withdrawal by Subject|0|||
146753470|NCT02102464|529264748|FG001|Randomized Study|Withdrawal by Subject|1|||
146753471|NCT02102464|529264749|FG002|Randomized Study|Withdrawal by Subject|0|||
146753472|NCT03387514|529264755|FG000|Overall Study|Withdrawal by Subject|2|||
146753473|NCT03387514|529264755|FG000|Overall Study|Physician Decision|1|||
146753474|NCT03387514|529264755|FG000|Overall Study|Lost to Follow-up|2|||
146851730|NCT00007345|529626176|FG000|Overall Study|Refused further treatment|0|||
146851731|NCT00007345|529626177|FG001|Overall Study|Refused further treatment|7|||
146851732|NCT00007345|529626176|FG000|Overall Study|Switched to alternative treatment|0|||
146851733|NCT00007345|529626177|FG001|Overall Study|Switched to alternative treatment|3|||
146851734|NCT00007345|529626176|FG000|Overall Study|Intercurrent illness|1|||
146851735|NCT00007345|529626177|FG001|Overall Study|Intercurrent illness|0|||
146851736|NCT00007345|529626176|FG000|Overall Study|Death on study|1|||
146851737|NCT00007345|529626177|FG001|Overall Study|Death on study|1|||
146851738|NCT04433585|529626178|FG000|Overall Study|Withdrawal by Subject|15|||
146851739|NCT04433585|529626179|FG001|Overall Study|Withdrawal by Subject|3|||
146851740|NCT04433585|529626180|FG002|Overall Study|Withdrawal by Subject|15|||
146851741|NCT04433585|529626181|FG003|Overall Study|Withdrawal by Subject|6|||
146851742|NCT04433585|529626178|FG000|Overall Study|Adverse Event|10|||
146851743|NCT04433585|529626179|FG001|Overall Study|Adverse Event|4|||
146851744|NCT04433585|529626180|FG002|Overall Study|Adverse Event|1|||
146851745|NCT04433585|529626181|FG003|Overall Study|Adverse Event|0|||
146851746|NCT04433585|529626178|FG000|Overall Study|Due to the conflict in Ukraine|2|||
146851747|NCT04433585|529626179|FG001|Overall Study|Due to the conflict in Ukraine|1|||
146851748|NCT04433585|529626180|FG002|Overall Study|Due to the conflict in Ukraine|1|||
146851749|NCT04433585|529626181|FG003|Overall Study|Due to the conflict in Ukraine|2|||
146851750|NCT04433585|529626178|FG000|Overall Study|Physician Decision|1|||
146851751|NCT04433585|529626179|FG001|Overall Study|Physician Decision|2|||
146851752|NCT04433585|529626180|FG002|Overall Study|Physician Decision|0|||
146851753|NCT04433585|529626181|FG003|Overall Study|Physician Decision|0|||
146851754|NCT04433585|529626178|FG000|Overall Study|Lost to Follow-up|1|||
146851755|NCT04433585|529626179|FG001|Overall Study|Lost to Follow-up|1|||
146851756|NCT04433585|529626180|FG002|Overall Study|Lost to Follow-up|1|||
146851757|NCT04433585|529626181|FG003|Overall Study|Lost to Follow-up|0|||
146851758|NCT04433585|529626178|FG000|Overall Study|Lack of Efficacy|0|||
146851759|NCT04433585|529626179|FG001|Overall Study|Lack of Efficacy|1|||
146851760|NCT04433585|529626180|FG002|Overall Study|Lack of Efficacy|1|||
146851761|NCT04433585|529626181|FG003|Overall Study|Lack of Efficacy|1|||
146851762|NCT04433585|529626178|FG000|Overall Study|Death|0|||
146851763|NCT04433585|529626179|FG001|Overall Study|Death|1|||
146851764|NCT04433585|529626180|FG002|Overall Study|Death|0|||
146851765|NCT04433585|529626181|FG003|Overall Study|Death|0|||
146851766|NCT02074553|529626182|FG000|Intervention Period 1|Family Emergency|0|||
146851767|NCT02074553|529626183|FG001|Intervention Period 1|Family Emergency|0|||
146851768|NCT02074553|529626184|FG002|Intervention Period 1|Family Emergency|0|||
146851769|NCT02074553|529626185|FG003|Intervention Period 1|Family Emergency|1|||
146851770|NCT02074553|529626186|FG004|Intervention Period 1|Family Emergency|0|||
146851771|NCT02074553|529626187|FG005|Intervention Period 1|Family Emergency|0|||
146753475|NCT00245011|529264764|FG000|Overall Study|Lack of Efficacy|1|||
146753476|NCT03040687|529264769|FG000|Overall Study|Withdrawal by Subject|1|||
146753477|NCT03040687|529264770|FG001|Overall Study|Withdrawal by Subject|0|||
146753478|NCT03040687|529264771|FG002|Overall Study|Withdrawal by Subject|0|||
146753479|NCT03317379|529264772|FG000|Overall Study|Lost to Follow-up|0|||
146753480|NCT03317379|529264773|FG001|Overall Study|Lost to Follow-up|3|||
146753481|NCT03317379|529264774|FG002|Overall Study|Lost to Follow-up|2|||
146753482|NCT00550173|529264775|FG000|Overall Study|Death|45|||
146753483|NCT00550173|529264776|FG001|Overall Study|Death|38|||
146753484|NCT00550173|529264777|FG002|Overall Study|Death|50|||
146753485|NCT00550173|529264775|FG000|Overall Study|Physician Decision|1|||
146851772|NCT02074553|529626188|FG006|Intervention Period 1|Family Emergency|0|||
146851773|NCT02074553|529626189|FG007|Intervention Period 1|Family Emergency|0|||
146851774|NCT02074553|529626182|FG000|Washout Period 1|Adverse Event|1|||
146851775|NCT02074553|529626183|FG001|Washout Period 1|Adverse Event|0|||
146851776|NCT02074553|529626184|FG002|Washout Period 1|Adverse Event|0|||
146851777|NCT02074553|529626185|FG003|Washout Period 1|Adverse Event|0|||
146851778|NCT02074553|529626186|FG004|Washout Period 1|Adverse Event|0|||
146851779|NCT02074553|529626187|FG005|Washout Period 1|Adverse Event|0|||
146851780|NCT02074553|529626188|FG006|Washout Period 1|Adverse Event|0|||
146851781|NCT02074553|529626189|FG007|Washout Period 1|Adverse Event|0|||
146851782|NCT02074553|529626182|FG000|Washout Period 1|Physician Decision|0|||
146851783|NCT02074553|529626183|FG001|Washout Period 1|Physician Decision|0|||
146851784|NCT02074553|529626184|FG002|Washout Period 1|Physician Decision|0|||
146851785|NCT02074553|529626185|FG003|Washout Period 1|Physician Decision|1|||
146851786|NCT02074553|529626186|FG004|Washout Period 1|Physician Decision|0|||
146851787|NCT02074553|529626187|FG005|Washout Period 1|Physician Decision|0|||
146753486|NCT00550173|529264776|FG001|Overall Study|Physician Decision|2|||
146851788|NCT02074553|529626188|FG006|Washout Period 1|Physician Decision|0|||
146851789|NCT02074553|529626189|FG007|Washout Period 1|Physician Decision|0|||
146851790|NCT02074553|529626182|FG000|Washout Period 1|Other|0|||
146851791|NCT02074553|529626183|FG001|Washout Period 1|Other|0|||
146851792|NCT02074553|529626184|FG002|Washout Period 1|Other|0|||
146851793|NCT02074553|529626185|FG003|Washout Period 1|Other|0|||
146851794|NCT02074553|529626186|FG004|Washout Period 1|Other|0|||
146851795|NCT02074553|529626187|FG005|Washout Period 1|Other|1|||
146851796|NCT02074553|529626188|FG006|Washout Period 1|Other|0|||
146851797|NCT02074553|529626189|FG007|Washout Period 1|Other|0|||
146851798|NCT02074553|529626182|FG000|Washout Period 2|Adverse Event|0|||
146851799|NCT02074553|529626183|FG001|Washout Period 2|Adverse Event|0|||
146851800|NCT02074553|529626184|FG002|Washout Period 2|Adverse Event|0|||
146851801|NCT02074553|529626185|FG003|Washout Period 2|Adverse Event|0|||
146851802|NCT02074553|529626186|FG004|Washout Period 2|Adverse Event|0|||
146851803|NCT02074553|529626187|FG005|Washout Period 2|Adverse Event|0|||
146851804|NCT02074553|529626188|FG006|Washout Period 2|Adverse Event|1|||
146851805|NCT02074553|529626189|FG007|Washout Period 2|Adverse Event|0|||
146851806|NCT02074553|529626182|FG000|Washout Period 2|Physician Decision|0|||
146851807|NCT02074553|529626183|FG001|Washout Period 2|Physician Decision|0|||
146851808|NCT02074553|529626184|FG002|Washout Period 2|Physician Decision|0|||
146851809|NCT02074553|529626185|FG003|Washout Period 2|Physician Decision|0|||
146851810|NCT02074553|529626186|FG004|Washout Period 2|Physician Decision|0|||
146851811|NCT02074553|529626187|FG005|Washout Period 2|Physician Decision|1|||
146851812|NCT02074553|529626188|FG006|Washout Period 2|Physician Decision|0|||
146851813|NCT02074553|529626189|FG007|Washout Period 2|Physician Decision|0|||
146851814|NCT02074553|529626182|FG000|Washout Period 2|Lost to Follow-up|0|||
146851815|NCT02074553|529626183|FG001|Washout Period 2|Lost to Follow-up|0|||
146851816|NCT02074553|529626184|FG002|Washout Period 2|Lost to Follow-up|1|||
146851817|NCT02074553|529626185|FG003|Washout Period 2|Lost to Follow-up|0|||
146851818|NCT02074553|529626186|FG004|Washout Period 2|Lost to Follow-up|0|||
146851819|NCT02074553|529626187|FG005|Washout Period 2|Lost to Follow-up|0|||
146851820|NCT02074553|529626188|FG006|Washout Period 2|Lost to Follow-up|0|||
146851821|NCT02074553|529626189|FG007|Washout Period 2|Lost to Follow-up|0|||
146851822|NCT02074553|529626182|FG000|Washout Period 3|Physician Decision|0|||
146851823|NCT02074553|529626183|FG001|Washout Period 3|Physician Decision|0|||
146851824|NCT02074553|529626184|FG002|Washout Period 3|Physician Decision|0|||
146851825|NCT02074553|529626185|FG003|Washout Period 3|Physician Decision|0|||
146851826|NCT02074553|529626186|FG004|Washout Period 3|Physician Decision|0|||
146851827|NCT02074553|529626187|FG005|Washout Period 3|Physician Decision|0|||
146851828|NCT02074553|529626188|FG006|Washout Period 3|Physician Decision|0|||
146851829|NCT02074553|529626189|FG007|Washout Period 3|Physician Decision|1|||
146851830|NCT00194987|529626190|FG000|Overall Study|Withdrawal by Subject|0|||
146851831|NCT00194987|529626191|FG001|Overall Study|Withdrawal by Subject|3|||
146851832|NCT02342743|529626192|FG000|Baseline Period|Withdrawal by Subject|3|||
146851833|NCT02342743|529626192|FG000|Baseline Period|Lost to Follow-up|2|||
146851834|NCT02342743|529626192|FG000|Baseline Period|Change in prophylactic medication|3|||
146851835|NCT02342743|529626192|FG000|Baseline Period|Screening failure regarding baseline|7|||
146851836|NCT02342743|529626192|FG000|Treatment Period|Withdrawal by Subject|2|||
146851837|NCT02342743|529626192|FG000|Treatment Period|Lost to Follow-up|8|||
146851838|NCT02342743|529626192|FG000|Treatment Period|Change in prophylactic medication|1|||
146851839|NCT04875676|529626193|FG000|Overall Study|Lost to Follow-up|1|||
146851840|NCT04875676|529626194|FG001|Overall Study|Lost to Follow-up|0|||
146851841|NCT04875676|529626195|FG002|Overall Study|Lost to Follow-up|0|||
146851842|NCT03103763|529626198|FG000|Overall Study|Death|15|||
146851843|NCT03103763|529626199|FG001|Overall Study|Death|5|||
146851844|NCT03103763|529626200|FG002|Overall Study|Death|5|||
146851845|NCT03103763|529626198|FG000|Overall Study|Withdrawal by Subject|0|||
146851846|NCT03103763|529626199|FG001|Overall Study|Withdrawal by Subject|3|||
146851847|NCT03103763|529626200|FG002|Overall Study|Withdrawal by Subject|2|||
146851848|NCT00938470|529626201|FG000|Overall Study|Disease Progression|3|||
146851849|NCT00938470|529626202|FG001|Overall Study|Disease Progression|0|||
146851850|NCT00938470|529626201|FG000|Overall Study|Alternate Treatment|1|||
146851851|NCT00938470|529626202|FG001|Overall Study|Alternate Treatment|0|||
146851852|NCT00938470|529626201|FG000|Overall Study|Death|3|||
146851853|NCT00938470|529626202|FG001|Overall Study|Death|2|||
146851854|NCT00938470|529626201|FG000|Overall Study|Other Reason|0|||
146851855|NCT00938470|529626202|FG001|Overall Study|Other Reason|1|||
146851856|NCT01970345|529626204|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
146851857|NCT01970345|529626205|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
146851858|NCT01970345|529626204|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
146851859|NCT01970345|529626205|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
146851860|NCT01346475|529626206|FG000|First Intervention|Lost to Follow-up|4|||
146851861|NCT01346475|529626207|FG001|First Intervention|Lost to Follow-up|3|||
146851862|NCT01552603|529626208|FG000|Overall Study|Physician Decision|1|||
146851863|NCT00618618|529626209|FG000|Overall Study|Patient Request|0|||
146851864|NCT00618618|529626210|FG001|Overall Study|Patient Request|0|||
146851865|NCT00618618|529626211|FG002|Overall Study|Patient Request|2|||
146851866|NCT00618618|529626212|FG003|Overall Study|Patient Request|0|||
146851867|NCT00618618|529626209|FG000|Overall Study|Inability to Complete Study Procedures|0|||
146851868|NCT00618618|529626210|FG001|Overall Study|Inability to Complete Study Procedures|1|||
146851869|NCT00618618|529626211|FG002|Overall Study|Inability to Complete Study Procedures|0|||
146851870|NCT00618618|529626212|FG003|Overall Study|Inability to Complete Study Procedures|0|||
146851871|NCT00618618|529626209|FG000|Overall Study|Lost to Follow-up|3|||
146851872|NCT00618618|529626210|FG001|Overall Study|Lost to Follow-up|0|||
146851873|NCT00618618|529626211|FG002|Overall Study|Lost to Follow-up|0|||
146851874|NCT00618618|529626212|FG003|Overall Study|Lost to Follow-up|1|||
146851875|NCT00618618|529626209|FG000|Overall Study|Non-compliance|1|||
146851876|NCT00618618|529626210|FG001|Overall Study|Non-compliance|1|||
146851877|NCT00618618|529626211|FG002|Overall Study|Non-compliance|0|||
146851878|NCT00618618|529626212|FG003|Overall Study|Non-compliance|0|||
146851879|NCT00618618|529626209|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
146851880|NCT00618618|529626210|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
146851881|NCT00618618|529626211|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
146851882|NCT00618618|529626212|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
146851883|NCT00618618|529626209|FG000|Overall Study|Death|0|||
146851884|NCT00618618|529626210|FG001|Overall Study|Death|1|||
146851885|NCT00618618|529626211|FG002|Overall Study|Death|0|||
146851886|NCT00618618|529626212|FG003|Overall Study|Death|0|||
146851887|NCT04797650|529626218|FG000|Overall Study|Reason Not Specified|5|||
146851888|NCT04797650|529626219|FG001|Overall Study|Reason Not Specified|12|||
146851889|NCT04797650|529626220|FG002|Overall Study|Reason Not Specified|5|||
146851890|NCT04797650|529626218|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
146851891|NCT04797650|529626219|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
146851892|NCT04797650|529626220|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
146851893|NCT04797650|529626218|FG000|Overall Study|Lack of Efficacy|1|||
146851894|NCT04797650|529626219|FG001|Overall Study|Lack of Efficacy|0|||
146851895|NCT04797650|529626220|FG002|Overall Study|Lack of Efficacy|1|||
146851896|NCT04797650|529626218|FG000|Overall Study|Non-compliance with Study Drug|0|||
146851897|NCT04797650|529626219|FG001|Overall Study|Non-compliance with Study Drug|0|||
146851898|NCT04797650|529626220|FG002|Overall Study|Non-compliance with Study Drug|2|||
146851899|NCT04797650|529626218|FG000|Overall Study|Lost to Follow-up|4|||
146851900|NCT04797650|529626219|FG001|Overall Study|Lost to Follow-up|6|||
146851901|NCT04797650|529626220|FG002|Overall Study|Lost to Follow-up|1|||
146851902|NCT01183234|529626223|FG000|First Intervention|Adverse Event|1|||
146851903|NCT01183234|529626224|FG001|First Intervention|Adverse Event|0|||
146851904|NCT00473265|529626229|FG000|Overall Study|Unrelated adverse event|5|||
146851905|NCT00473265|529626229|FG000|Overall Study|Off treatment early|15|||
146851906|NCT01160289|529626232|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
146851907|NCT01160289|529626233|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
146851908|NCT01160289|529626234|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
146851909|NCT01160289|529626235|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
146851910|NCT01160289|529626236|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
146851911|NCT01160289|529626237|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
146851912|NCT01160289|529626232|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
146851913|NCT01160289|529626233|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
146851914|NCT01160289|529626234|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
146851915|NCT01160289|529626235|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
146851916|NCT01160289|529626236|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
146851917|NCT01160289|529626237|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
146851918|NCT01160289|529626232|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
146851919|NCT01160289|529626233|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
146851920|NCT01160289|529626234|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
146851921|NCT01160289|529626235|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
146851922|NCT01160289|529626236|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
146851923|NCT01160289|529626237|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
146851924|NCT01160289|529626232|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
146851925|NCT01160289|529626233|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
146851926|NCT01160289|529626234|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
146851927|NCT01160289|529626235|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
146851928|NCT01160289|529626236|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
146851929|NCT01160289|529626237|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
146851930|NCT01160289|529626232|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
146851931|NCT01160289|529626233|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
146851932|NCT01160289|529626234|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
146851933|NCT01160289|529626235|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
146851934|NCT01160289|529626236|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
146851935|NCT01160289|529626237|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
146851936|NCT01160289|529626232|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
146851937|NCT01160289|529626233|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
146851938|NCT01160289|529626234|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
146851939|NCT01160289|529626235|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
146851940|NCT01160289|529626236|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
146851941|NCT01160289|529626237|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
146851942|NCT01160289|529626232|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
146851943|NCT01160289|529626233|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
146851944|NCT01160289|529626234|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
146851945|NCT01160289|529626235|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
146851946|NCT01160289|529626236|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
146851947|NCT01160289|529626237|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
146753487|NCT00550173|529264777|FG002|Overall Study|Physician Decision|2|||
146753488|NCT00550173|529264775|FG000|Overall Study|Withdrawal by Subject|9|||
146753489|NCT00550173|529264776|FG001|Overall Study|Withdrawal by Subject|12|||
146753490|NCT00550173|529264777|FG002|Overall Study|Withdrawal by Subject|17|||
146851948|NCT01160289|529626232|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
146851949|NCT01160289|529626233|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
146851950|NCT01160289|529626234|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
146851951|NCT01160289|529626235|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
146851952|NCT01160289|529626236|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
146851953|NCT01160289|529626237|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
146851954|NCT01160289|529626232|FG000|Post-Randomization Period|Adverse Event|0|||
146851955|NCT01160289|529626233|FG001|Post-Randomization Period|Adverse Event|4|||
146851956|NCT01160289|529626234|FG002|Post-Randomization Period|Adverse Event|4|||
146851957|NCT01160289|529626235|FG003|Post-Randomization Period|Adverse Event|2|||
146851958|NCT01160289|529626236|FG004|Post-Randomization Period|Adverse Event|0|||
146851959|NCT01160289|529626237|FG005|Post-Randomization Period|Adverse Event|0|||
146851960|NCT01160289|529626232|FG000|Post-Randomization Period|Death|0|||
146851961|NCT01160289|529626233|FG001|Post-Randomization Period|Death|0|||
146851962|NCT01160289|529626234|FG002|Post-Randomization Period|Death|0|||
146851963|NCT01160289|529626235|FG003|Post-Randomization Period|Death|1|||
146851964|NCT01160289|529626236|FG004|Post-Randomization Period|Death|0|||
146851965|NCT01160289|529626237|FG005|Post-Randomization Period|Death|0|||
146851966|NCT01160289|529626232|FG000|Post-Randomization Period|Lack of Efficacy|0|||
146851967|NCT01160289|529626233|FG001|Post-Randomization Period|Lack of Efficacy|1|||
146851968|NCT01160289|529626234|FG002|Post-Randomization Period|Lack of Efficacy|0|||
146851969|NCT01160289|529626235|FG003|Post-Randomization Period|Lack of Efficacy|3|||
146851970|NCT01160289|529626236|FG004|Post-Randomization Period|Lack of Efficacy|0|||
146851971|NCT01160289|529626237|FG005|Post-Randomization Period|Lack of Efficacy|0|||
146851972|NCT01160289|529626232|FG000|Post-Randomization Period|Lost to Follow-up|0|||
146851973|NCT01160289|529626233|FG001|Post-Randomization Period|Lost to Follow-up|3|||
146851974|NCT01160289|529626234|FG002|Post-Randomization Period|Lost to Follow-up|2|||
146851975|NCT01160289|529626235|FG003|Post-Randomization Period|Lost to Follow-up|5|||
146851976|NCT01160289|529626236|FG004|Post-Randomization Period|Lost to Follow-up|3|||
146851977|NCT01160289|529626237|FG005|Post-Randomization Period|Lost to Follow-up|4|||
146851978|NCT01160289|529626232|FG000|Post-Randomization Period|Physician Decision|0|||
146851979|NCT01160289|529626233|FG001|Post-Randomization Period|Physician Decision|0|||
146851980|NCT01160289|529626234|FG002|Post-Randomization Period|Physician Decision|1|||
146851981|NCT01160289|529626235|FG003|Post-Randomization Period|Physician Decision|0|||
146851982|NCT01160289|529626236|FG004|Post-Randomization Period|Physician Decision|0|||
146851983|NCT01160289|529626237|FG005|Post-Randomization Period|Physician Decision|0|||
146851984|NCT01160289|529626232|FG000|Post-Randomization Period|Protocol Violation|0|||
146851985|NCT01160289|529626233|FG001|Post-Randomization Period|Protocol Violation|4|||
146851986|NCT01160289|529626234|FG002|Post-Randomization Period|Protocol Violation|2|||
146851987|NCT01160289|529626235|FG003|Post-Randomization Period|Protocol Violation|0|||
146851988|NCT01160289|529626236|FG004|Post-Randomization Period|Protocol Violation|1|||
146851989|NCT01160289|529626237|FG005|Post-Randomization Period|Protocol Violation|3|||
146851990|NCT01160289|529626232|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
146753491|NCT00550173|529264775|FG000|Overall Study|Sponsor Decision|13|||
146753492|NCT00550173|529264776|FG001|Overall Study|Sponsor Decision|7|||
146753493|NCT00550173|529264777|FG002|Overall Study|Sponsor Decision|1|||
146753494|NCT00550173|529264775|FG000|Overall Study|Lost to Follow-up|4|||
146753495|NCT00550173|529264776|FG001|Overall Study|Lost to Follow-up|4|||
146753496|NCT00550173|529264777|FG002|Overall Study|Lost to Follow-up|3|||
146753497|NCT01950390|529264787|FG000|Overall Study|Never started treatment|3|||
146753498|NCT01950390|529264788|FG001|Overall Study|Never started treatment|2|||
146753499|NCT01950390|529264787|FG000|Overall Study|Disease progression|45|||
146753500|NCT01950390|529264788|FG001|Overall Study|Disease progression|52|||
146753501|NCT01950390|529264787|FG000|Overall Study|Adverse Event|22|||
146753502|NCT01950390|529264788|FG001|Overall Study|Adverse Event|16|||
146753503|NCT01950390|529264787|FG000|Overall Study|Death|5|||
146753504|NCT01950390|529264788|FG001|Overall Study|Death|3|||
146753505|NCT01950390|529264787|FG000|Overall Study|Withdrawal by Subject|5|||
146753506|NCT01950390|529264788|FG001|Overall Study|Withdrawal by Subject|1|||
146753507|NCT01950390|529264787|FG000|Overall Study|Alternative therapy|0|||
146753508|NCT01950390|529264788|FG001|Overall Study|Alternative therapy|3|||
146851991|NCT01160289|529626233|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
146753509|NCT01950390|529264787|FG000|Overall Study|Complicating disease|1|||
146753510|NCT01950390|529264788|FG001|Overall Study|Complicating disease|0|||
146753511|NCT01950390|529264787|FG000|Overall Study|On treatment|1|||
146753512|NCT01950390|529264788|FG001|Overall Study|On treatment|0|||
146753513|NCT01950390|529264787|FG000|Overall Study|Symptomatic deterioration|2|||
146753514|NCT01950390|529264788|FG001|Overall Study|Symptomatic deterioration|1|||
146753515|NCT01950390|529264787|FG000|Overall Study|Physician Decision|0|||
146753516|NCT01950390|529264788|FG001|Overall Study|Physician Decision|4|||
146753517|NCT01950390|529264787|FG000|Overall Study|Lack of clinical benefit|0|||
146753518|NCT01950390|529264788|FG001|Overall Study|Lack of clinical benefit|1|||
146753519|NCT01950390|529264787|FG000|Overall Study|Maintained PR and moved to observation only|0|||
146753520|NCT01950390|529264788|FG001|Overall Study|Maintained PR and moved to observation only|1|||
146753521|NCT03280563|529265909|FG000|Stage 1|Death|2|||
146753522|NCT03280563|529265910|FG001|Stage 1|Death|1|||
146753523|NCT03280563|529265911|FG002|Stage 1|Death|0|||
146753524|NCT03280563|529265912|FG003|Stage 1|Death|0|||
146753525|NCT03280563|529265913|FG004|Stage 1|Death|0|||
146753526|NCT03280563|529265914|FG005|Stage 1|Death|3|||
146753527|NCT03280563|529265915|FG006|Stage 1|Death|0|||
146753528|NCT03280563|529265916|FG007|Stage 1|Death|0|||
146753529|NCT03280563|529265917|FG008|Stage 1|Death|0|||
146753530|NCT03280563|529265909|FG000|Stage 1|Study Ended by Sponsor|0|||
146753531|NCT03280563|529265910|FG001|Stage 1|Study Ended by Sponsor|0|||
146753532|NCT03280563|529265911|FG002|Stage 1|Study Ended by Sponsor|1|||
146753533|NCT03280563|529265912|FG003|Stage 1|Study Ended by Sponsor|0|||
146753534|NCT03280563|529265913|FG004|Stage 1|Study Ended by Sponsor|0|||
146753535|NCT03280563|529265914|FG005|Stage 1|Study Ended by Sponsor|1|||
146753536|NCT03280563|529265915|FG006|Stage 1|Study Ended by Sponsor|0|||
146753537|NCT03280563|529265916|FG007|Stage 1|Study Ended by Sponsor|0|||
146753538|NCT03280563|529265917|FG008|Stage 1|Study Ended by Sponsor|0|||
146753539|NCT03280563|529265909|FG000|Stage 1|Withdrawal by Subject|5|||
146753540|NCT03280563|529265910|FG001|Stage 1|Withdrawal by Subject|1|||
146753541|NCT03280563|529265911|FG002|Stage 1|Withdrawal by Subject|2|||
146753542|NCT03280563|529265912|FG003|Stage 1|Withdrawal by Subject|0|||
146753543|NCT03280563|529265913|FG004|Stage 1|Withdrawal by Subject|0|||
146753544|NCT03280563|529265914|FG005|Stage 1|Withdrawal by Subject|2|||
146753545|NCT03280563|529265915|FG006|Stage 1|Withdrawal by Subject|0|||
146753546|NCT03280563|529265916|FG007|Stage 1|Withdrawal by Subject|0|||
146753547|NCT03280563|529265917|FG008|Stage 1|Withdrawal by Subject|0|||
146753548|NCT03280563|529265909|FG000|Stage 1|Reason Not Specified|0|||
146753549|NCT03280563|529265910|FG001|Stage 1|Reason Not Specified|0|||
146753550|NCT03280563|529265911|FG002|Stage 1|Reason Not Specified|0|||
146753551|NCT03280563|529265912|FG003|Stage 1|Reason Not Specified|0|||
146753552|NCT03280563|529265913|FG004|Stage 1|Reason Not Specified|0|||
146753553|NCT03280563|529265914|FG005|Stage 1|Reason Not Specified|1|||
146753554|NCT03280563|529265915|FG006|Stage 1|Reason Not Specified|0|||
146753555|NCT03280563|529265916|FG007|Stage 1|Reason Not Specified|0|||
146753556|NCT03280563|529265917|FG008|Stage 1|Reason Not Specified|0|||
146753557|NCT03280563|529265909|FG000|Stage 1|Physician Decision|0|||
146753558|NCT03280563|529265910|FG001|Stage 1|Physician Decision|1|||
146753559|NCT03280563|529265911|FG002|Stage 1|Physician Decision|0|||
146753560|NCT03280563|529265912|FG003|Stage 1|Physician Decision|0|||
146753561|NCT03280563|529265913|FG004|Stage 1|Physician Decision|0|||
146753562|NCT03280563|529265914|FG005|Stage 1|Physician Decision|0|||
146753563|NCT03280563|529265915|FG006|Stage 1|Physician Decision|0|||
146753564|NCT03280563|529265916|FG007|Stage 1|Physician Decision|0|||
146753565|NCT03280563|529265917|FG008|Stage 1|Physician Decision|0|||
146753566|NCT03280563|529265909|FG000|Stage 2|Death|0|||
146753567|NCT03280563|529265910|FG001|Stage 2|Death|0|||
146753568|NCT03280563|529265911|FG002|Stage 2|Death|0|||
146753569|NCT03280563|529265912|FG003|Stage 2|Death|0|||
146753570|NCT03280563|529265913|FG004|Stage 2|Death|0|||
146753571|NCT03280563|529265914|FG005|Stage 2|Death|0|||
146753572|NCT03280563|529265915|FG006|Stage 2|Death|0|||
146753573|NCT03280563|529265916|FG007|Stage 2|Death|1|||
146753574|NCT03280563|529265917|FG008|Stage 2|Death|0|||
146753575|NCT03280563|529265909|FG000|Stage 2|Progressive Disease|0|||
146753576|NCT03280563|529265910|FG001|Stage 2|Progressive Disease|0|||
146753577|NCT03280563|529265911|FG002|Stage 2|Progressive Disease|0|||
146753578|NCT03280563|529265912|FG003|Stage 2|Progressive Disease|0|||
146753579|NCT03280563|529265913|FG004|Stage 2|Progressive Disease|0|||
146753580|NCT03280563|529265914|FG005|Stage 2|Progressive Disease|0|||
146753581|NCT03280563|529265915|FG006|Stage 2|Progressive Disease|2|||
146753582|NCT03280563|529265916|FG007|Stage 2|Progressive Disease|0|||
146753583|NCT03280563|529265917|FG008|Stage 2|Progressive Disease|0|||
146753584|NCT03280563|529265909|FG000|Long-term Survival Follow-up|Death|10|||
146753585|NCT03280563|529265910|FG001|Long-term Survival Follow-up|Death|14|||
146753586|NCT03280563|529265911|FG002|Long-term Survival Follow-up|Death|15|||
146753587|NCT03280563|529265912|FG003|Long-term Survival Follow-up|Death|3|||
146753588|NCT03280563|529265913|FG004|Long-term Survival Follow-up|Death|6|||
146753589|NCT03280563|529265914|FG005|Long-term Survival Follow-up|Death|18|||
146753590|NCT03280563|529265915|FG006|Long-term Survival Follow-up|Death|11|||
146753591|NCT03280563|529265916|FG007|Long-term Survival Follow-up|Death|1|||
146753592|NCT03280563|529265917|FG008|Long-term Survival Follow-up|Death|3|||
146753593|NCT03280563|529265909|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
146753594|NCT03280563|529265910|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
146753595|NCT03280563|529265911|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
146753596|NCT03280563|529265912|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
146753597|NCT03280563|529265913|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
146753598|NCT03280563|529265914|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
146753599|NCT03280563|529265915|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
146753600|NCT03280563|529265916|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
146753601|NCT03280563|529265917|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
146753602|NCT03280563|529265909|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
146753603|NCT03280563|529265910|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
146753604|NCT03280563|529265911|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
146753605|NCT03280563|529265912|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
146753606|NCT03280563|529265913|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
146753607|NCT03280563|529265914|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
146753608|NCT03280563|529265915|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
146753609|NCT03280563|529265916|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
146753610|NCT03280563|529265917|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
146753611|NCT03280563|529265909|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
146753612|NCT03280563|529265910|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
146753613|NCT03280563|529265911|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
146753614|NCT03280563|529265912|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
146753615|NCT03280563|529265913|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
146753616|NCT03280563|529265914|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
146753617|NCT03280563|529265915|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
146753618|NCT03280563|529265916|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
146753619|NCT03280563|529265917|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
146753620|NCT04213846|529265918|FG000|Overall Study|Withdrawal by Subject|7|||
146753621|NCT04213846|529265919|FG001|Overall Study|Withdrawal by Subject|6|||
146753622|NCT04213846|529265918|FG000|Overall Study|Lost to Follow-up|15|||
146753623|NCT04213846|529265919|FG001|Overall Study|Lost to Follow-up|21|||
146753624|NCT02107274|529265920|FG000|Treatment vs. Placebo|Adverse Event|3|||
146753625|NCT02107274|529265921|FG001|Treatment vs. Placebo|Adverse Event|0|||
146753626|NCT02107274|529265920|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
146753627|NCT02107274|529265921|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
146753628|NCT02107274|529265920|FG000|Control Phase|Lost to Follow-up|1|||
146753629|NCT02107274|529265921|FG001|Control Phase|Lost to Follow-up|1|||
146753630|NCT02107274|529265920|FG000|Control Phase|Death|2|||
146753631|NCT02107274|529265921|FG001|Control Phase|Death|0|||
146753632|NCT02107274|529265920|FG000|Control Phase|Adverse Event|0|||
146753633|NCT02107274|529265921|FG001|Control Phase|Adverse Event|1|||
146753634|NCT03158948|529265925|FG000|Overall Study|Death|1|||
146753635|NCT03158948|529265926|FG001|Overall Study|Death|1|||
146753636|NCT03158948|529265927|FG002|Overall Study|Death|3|||
146753637|NCT03158948|529265928|FG003|Overall Study|Death|2|||
146753638|NCT03158948|529265925|FG000|Overall Study|Physician Decision|0|||
146753639|NCT03158948|529265926|FG001|Overall Study|Physician Decision|0|||
146753640|NCT03158948|529265927|FG002|Overall Study|Physician Decision|0|||
146753641|NCT03158948|529265928|FG003|Overall Study|Physician Decision|1|||
146753642|NCT04730947|529265929|FG000|Overall Study|Withdrawal by Subject|0|||
146753643|NCT04730947|529265930|FG001|Overall Study|Withdrawal by Subject|1|||
146753644|NCT00354029|529265933|FG000|Overall Study|Protocol Violation|4|||
146753645|NCT00354029|529265934|FG001|Overall Study|Protocol Violation|2|||
146753646|NCT01021332|529265935|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
146753647|NCT01021332|529265935|FG000|Overall Study|Adverse Event|43|||
146753648|NCT01021332|529265935|FG000|Overall Study|Lack of Efficacy|19|||
146753649|NCT01021332|529265935|FG000|Overall Study|Withdrawal of Consent|23|||
146753650|NCT01021332|529265935|FG000|Overall Study|Lost to Follow-up|4|||
146753651|NCT01021332|529265935|FG000|Overall Study|Protocol Violation|9|||
146753652|NCT01021332|529265935|FG000|Overall Study|Miscellaneous|3|||
146753653|NCT04894903|529265945|FG000|Overall Study|Death|1|||
146753654|NCT04894903|529265946|FG001|Overall Study|Death|0|||
146753655|NCT04894903|529265945|FG000|Overall Study|Pregnancy|1|||
146851992|NCT01160289|529626234|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
146851993|NCT01160289|529626235|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
146851994|NCT01160289|529626236|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
146851995|NCT01160289|529626237|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
146851996|NCT01160289|529626232|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
146851997|NCT01160289|529626233|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
146851998|NCT01160289|529626234|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
146851999|NCT01160289|529626235|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
146852000|NCT01160289|529626236|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
146852001|NCT01160289|529626237|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
146852002|NCT01160289|529626232|FG000|Post-Randomization Period|Sponsor Decision|0|||
146852003|NCT01160289|529626233|FG001|Post-Randomization Period|Sponsor Decision|1|||
146852004|NCT01160289|529626234|FG002|Post-Randomization Period|Sponsor Decision|0|||
146852005|NCT01160289|529626235|FG003|Post-Randomization Period|Sponsor Decision|0|||
146852006|NCT01160289|529626236|FG004|Post-Randomization Period|Sponsor Decision|0|||
146852007|NCT01160289|529626237|FG005|Post-Randomization Period|Sponsor Decision|0|||
146852008|NCT01156792|529626238|FG000|Overall Study|Adverse Event|1|||
146852009|NCT01156792|529626238|FG000|Overall Study|Lack of Efficacy|36|||
146852010|NCT01156792|529626238|FG000|Overall Study|Protocol Violation|6|||
146852011|NCT01156792|529626238|FG000|Overall Study|Lost to Follow-up|3|||
146852012|NCT01156792|529626238|FG000|Overall Study|Physician Decision|3|||
146852013|NCT01156792|529626238|FG000|Overall Study|Withdrawal by Subject|9|||
146852014|NCT01156792|529626238|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
146852015|NCT01097707|529626239|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
146852016|NCT01097707|529626240|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
146852017|NCT01097707|529626241|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
146852018|NCT01097707|529626242|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
146852019|NCT01097707|529626243|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
146852020|NCT01097707|529626239|FG000|Overall Study|Adverse Event|4|||
146852021|NCT01097707|529626240|FG001|Overall Study|Adverse Event|2|||
146852022|NCT01097707|529626241|FG002|Overall Study|Adverse Event|3|||
146852023|NCT01097707|529626242|FG003|Overall Study|Adverse Event|1|||
146852024|NCT01097707|529626243|FG004|Overall Study|Adverse Event|3|||
146852025|NCT01097707|529626239|FG000|Overall Study|Entry Criteria Not Met|2|||
146852026|NCT01097707|529626240|FG001|Overall Study|Entry Criteria Not Met|1|||
146852027|NCT01097707|529626241|FG002|Overall Study|Entry Criteria Not Met|1|||
146852028|NCT01097707|529626242|FG003|Overall Study|Entry Criteria Not Met|0|||
146852029|NCT01097707|529626243|FG004|Overall Study|Entry Criteria Not Met|1|||
146852030|NCT01097707|529626239|FG000|Overall Study|Lack of Efficacy|1|||
146852031|NCT01097707|529626240|FG001|Overall Study|Lack of Efficacy|0|||
146852032|NCT01097707|529626241|FG002|Overall Study|Lack of Efficacy|0|||
146852033|NCT01097707|529626242|FG003|Overall Study|Lack of Efficacy|1|||
146852034|NCT01097707|529626243|FG004|Overall Study|Lack of Efficacy|0|||
146852035|NCT01097707|529626239|FG000|Overall Study|Lost to Follow-up|1|||
146852036|NCT01097707|529626240|FG001|Overall Study|Lost to Follow-up|1|||
146852037|NCT01097707|529626241|FG002|Overall Study|Lost to Follow-up|2|||
146852038|NCT01097707|529626242|FG003|Overall Study|Lost to Follow-up|0|||
146852039|NCT01097707|529626243|FG004|Overall Study|Lost to Follow-up|3|||
146852040|NCT01097707|529626239|FG000|Overall Study|Protocol Violation|2|||
146852041|NCT01097707|529626240|FG001|Overall Study|Protocol Violation|2|||
146852042|NCT01097707|529626241|FG002|Overall Study|Protocol Violation|3|||
146852043|NCT01097707|529626242|FG003|Overall Study|Protocol Violation|2|||
146852044|NCT01097707|529626243|FG004|Overall Study|Protocol Violation|2|||
146852045|NCT01097707|529626239|FG000|Overall Study|Sponsor Decision|31|||
146852046|NCT01097707|529626240|FG001|Overall Study|Sponsor Decision|31|||
146852047|NCT01097707|529626241|FG002|Overall Study|Sponsor Decision|34|||
146852048|NCT01097707|529626242|FG003|Overall Study|Sponsor Decision|35|||
146852049|NCT01097707|529626243|FG004|Overall Study|Sponsor Decision|36|||
146852050|NCT01097707|529626239|FG000|Overall Study|Withdrawal by Subject|3|||
146852051|NCT01097707|529626240|FG001|Overall Study|Withdrawal by Subject|6|||
146852052|NCT01097707|529626241|FG002|Overall Study|Withdrawal by Subject|1|||
146852053|NCT01097707|529626242|FG003|Overall Study|Withdrawal by Subject|4|||
146852054|NCT01097707|529626243|FG004|Overall Study|Withdrawal by Subject|3|||
146852055|NCT01097707|529626239|FG000|Overall Study|Reason unknown|0|||
146852056|NCT01097707|529626240|FG001|Overall Study|Reason unknown|0|||
146852057|NCT01097707|529626241|FG002|Overall Study|Reason unknown|0|||
146852058|NCT01097707|529626242|FG003|Overall Study|Reason unknown|0|||
146852059|NCT01097707|529626243|FG004|Overall Study|Reason unknown|1|||
146852060|NCT01236534|529626246|FG000|Overall Study|Adverse Event|3|||
146852061|NCT01236534|529626247|FG001|Overall Study|Adverse Event|0|||
146965005|NCT01491737|530033422|FG001|Overall Study|Reason Not Specified|9|||
146852062|NCT01605019|529626250|FG000|Overall Study|pt did not meet transplant endpoint|3|||
146852063|NCT01605019|529626251|FG001|Overall Study|pt did not meet transplant endpoint|0|||
146852064|NCT01226095|529626255|FG000|Overall Study|Poor compliance|1|||
146852065|NCT01688830|529626256|FG000|Overall Study|Lost to Follow-up|0|||
146852066|NCT01688830|529626257|FG001|Overall Study|Lost to Follow-up|0|||
146753656|NCT04894903|529265946|FG001|Overall Study|Pregnancy|0|||
146753657|NCT04894903|529265945|FG000|Overall Study|Withdrawal by Subject|1|||
146753658|NCT04894903|529265946|FG001|Overall Study|Withdrawal by Subject|1|||
146753659|NCT04894903|529265945|FG000|Overall Study|moved or exited health system|1|||
146753660|NCT04894903|529265946|FG001|Overall Study|moved or exited health system|3|||
146753661|NCT01670500|529265947|FG000|Overall Study|Withdrawal by Subject|1|||
146753662|NCT01670500|529265948|FG001|Overall Study|Withdrawal by Subject|0|||
146753663|NCT01923428|529265950|FG000|Overall Study|Adverse Event|8|||
146753664|NCT01923428|529265951|FG001|Overall Study|Adverse Event|6|||
146753665|NCT01923428|529265952|FG002|Overall Study|Adverse Event|3|||
146753666|NCT01923428|529265953|FG003|Overall Study|Adverse Event|3|||
146753667|NCT01923428|529265950|FG000|Overall Study|Withdrawal by Subject|5|||
146753668|NCT01923428|529265951|FG001|Overall Study|Withdrawal by Subject|3|||
146753669|NCT01923428|529265952|FG002|Overall Study|Withdrawal by Subject|0|||
146753670|NCT01923428|529265953|FG003|Overall Study|Withdrawal by Subject|4|||
146753671|NCT01923428|529265950|FG000|Overall Study|Lost to Follow-up|2|||
146753672|NCT01923428|529265951|FG001|Overall Study|Lost to Follow-up|1|||
146753673|NCT01923428|529265952|FG002|Overall Study|Lost to Follow-up|5|||
146753674|NCT01923428|529265953|FG003|Overall Study|Lost to Follow-up|0|||
146753675|NCT01923428|529265950|FG000|Overall Study|Protocol Violation|3|||
146753676|NCT01923428|529265951|FG001|Overall Study|Protocol Violation|0|||
146753677|NCT01923428|529265952|FG002|Overall Study|Protocol Violation|2|||
146753678|NCT01923428|529265953|FG003|Overall Study|Protocol Violation|1|||
146753679|NCT01923428|529265950|FG000|Overall Study|Non Compliance to treatment|1|||
146753680|NCT01923428|529265951|FG001|Overall Study|Non Compliance to treatment|2|||
146753681|NCT01923428|529265952|FG002|Overall Study|Non Compliance to treatment|0|||
146753682|NCT01923428|529265953|FG003|Overall Study|Non Compliance to treatment|1|||
146753683|NCT01923428|529265950|FG000|Overall Study|Lack of Efficacy|0|||
146753684|NCT01923428|529265951|FG001|Overall Study|Lack of Efficacy|0|||
146753685|NCT01923428|529265952|FG002|Overall Study|Lack of Efficacy|1|||
146753686|NCT01923428|529265953|FG003|Overall Study|Lack of Efficacy|1|||
146753687|NCT01822353|529265954|FG000|Overall Study|Adverse Event|1|||
146753688|NCT01822353|529265955|FG001|Overall Study|Adverse Event|3|||
146753689|NCT01822353|529265956|FG002|Overall Study|Adverse Event|1|||
146753690|NCT01822353|529265954|FG000|Overall Study|Pregnancy|0|||
146753691|NCT01822353|529265955|FG001|Overall Study|Pregnancy|1|||
146753692|NCT01822353|529265956|FG002|Overall Study|Pregnancy|0|||
146753693|NCT01822353|529265954|FG000|Overall Study|Withdrawal by Subject|3|||
146753694|NCT01822353|529265955|FG001|Overall Study|Withdrawal by Subject|1|||
146753695|NCT01822353|529265956|FG002|Overall Study|Withdrawal by Subject|0|||
146753696|NCT02550873|529265957|FG000|Randomized Double Blind|Adverse Event|3|||
146753697|NCT02550873|529265958|FG001|Randomized Double Blind|Adverse Event|1|||
146753698|NCT02550873|529265959|FG002|Randomized Double Blind|Adverse Event|0|||
146753699|NCT02550873|529265957|FG000|Randomized Double Blind|Disease progression|1|||
146753700|NCT02550873|529265958|FG001|Randomized Double Blind|Disease progression|1|||
146753701|NCT02550873|529265959|FG002|Randomized Double Blind|Disease progression|0|||
146753702|NCT02550873|529265957|FG000|Open Label Extension|Study ongoing|0|||
146753703|NCT02550873|529265958|FG001|Open Label Extension|Study ongoing|0|||
146753704|NCT02550873|529265959|FG002|Open Label Extension|Study ongoing|111|||
146753705|NCT04320615|529265960|FG000|Overall Study|Withdrawal by Subject|4|||
146753706|NCT04320615|529265961|FG001|Overall Study|Withdrawal by Subject|10|||
146753707|NCT04320615|529265960|FG000|Overall Study|Physician Decision|2|||
146753708|NCT04320615|529265961|FG001|Overall Study|Physician Decision|0|||
146753709|NCT04320615|529265960|FG000|Overall Study|Other|2|||
146753710|NCT04320615|529265961|FG001|Overall Study|Other|0|||
146753711|NCT04320615|529265960|FG000|Overall Study|Lost to Follow-up|5|||
146753712|NCT04320615|529265961|FG001|Overall Study|Lost to Follow-up|23|||
146753713|NCT04320615|529265960|FG000|Overall Study|Death|35|||
146852067|NCT01688830|529626258|FG002|Overall Study|Lost to Follow-up|0|||
146852068|NCT01688830|529626259|FG003|Overall Study|Lost to Follow-up|0|||
146852069|NCT01688830|529626260|FG004|Overall Study|Lost to Follow-up|0|||
146753714|NCT04320615|529265961|FG001|Overall Study|Death|71|||
146753715|NCT01857323|529265962|FG000|Overall Study|Adverse Event|1|||
146753716|NCT01857323|529265962|FG000|Overall Study|Withdrawal by Subject|3|||
146753717|NCT01857323|529265962|FG000|Overall Study|Non-compliance|1|||
146753718|NCT01857323|529265962|FG000|Overall Study|Protocol Violation|6|||
146753719|NCT01857323|529265962|FG000|Overall Study|Lost to Follow-up|1|||
146753720|NCT01857323|529265962|FG000|Overall Study|Other|4|||
146753721|NCT01857323|529265962|FG000|Overall Study|Did not complete 180 doses|48|||
146753722|NCT03873246|529265963|FG000|Overall Study|Adverse Event|1|||
146753723|NCT03873246|529265964|FG001|Overall Study|Adverse Event|3|||
146753724|NCT03873246|529265965|FG002|Overall Study|Adverse Event|3|||
146753725|NCT03873246|529265963|FG000|Overall Study|Lost to Follow-up|4|||
146753726|NCT03873246|529265964|FG001|Overall Study|Lost to Follow-up|4|||
146852070|NCT01688830|529626261|FG005|Overall Study|Lost to Follow-up|0|||
146753727|NCT03873246|529265965|FG002|Overall Study|Lost to Follow-up|5|||
146753728|NCT03873246|529265963|FG000|Overall Study|Protocol Violation|0|||
146753729|NCT03873246|529265964|FG001|Overall Study|Protocol Violation|1|||
146852071|NCT01688830|529626262|FG006|Overall Study|Lost to Follow-up|0|||
146852072|NCT01688830|529626263|FG007|Overall Study|Lost to Follow-up|0|||
146852073|NCT01688830|529626264|FG008|Overall Study|Lost to Follow-up|0|||
146852074|NCT01688830|529626265|FG009|Overall Study|Lost to Follow-up|0|||
146852075|NCT01688830|529626266|FG010|Overall Study|Lost to Follow-up|1|||
146852076|NCT01688830|529626267|FG011|Overall Study|Lost to Follow-up|0|||
146852077|NCT01688830|529626268|FG012|Overall Study|Lost to Follow-up|0|||
146852078|NCT01688830|529626269|FG013|Overall Study|Lost to Follow-up|0|||
146852079|NCT01688830|529626270|FG014|Overall Study|Lost to Follow-up|0|||
146852080|NCT01688830|529626271|FG015|Overall Study|Lost to Follow-up|0|||
146852081|NCT01688830|529626272|FG016|Overall Study|Lost to Follow-up|0|||
146852082|NCT01688830|529626273|FG017|Overall Study|Lost to Follow-up|0|||
146852083|NCT01688830|529626274|FG018|Overall Study|Lost to Follow-up|0|||
146852084|NCT01688830|529626275|FG019|Overall Study|Lost to Follow-up|0|||
146852085|NCT01688830|529626276|FG020|Overall Study|Lost to Follow-up|0|||
146852086|NCT04822597|529626277|FG000|Overall Study|Withdrawal by Subject|0|||
146852087|NCT04822597|529626278|FG001|Overall Study|Withdrawal by Subject|1|||
146852088|NCT04822597|529626279|FG002|Overall Study|Withdrawal by Subject|1|||
146852089|NCT04822597|529626280|FG003|Overall Study|Withdrawal by Subject|0|||
146852090|NCT04822597|529626277|FG000|Overall Study|Physician Decision|0|||
146852091|NCT04822597|529626278|FG001|Overall Study|Physician Decision|0|||
146852092|NCT04822597|529626279|FG002|Overall Study|Physician Decision|1|||
146852093|NCT04822597|529626280|FG003|Overall Study|Physician Decision|1|||
146852094|NCT04822597|529626277|FG000|Overall Study|Subject withdrawn after enrollment|0|||
146852095|NCT04822597|529626278|FG001|Overall Study|Subject withdrawn after enrollment|1|||
146852096|NCT04822597|529626279|FG002|Overall Study|Subject withdrawn after enrollment|0|||
146852097|NCT04822597|529626280|FG003|Overall Study|Subject withdrawn after enrollment|1|||
146852098|NCT04822597|529626277|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
146852099|NCT04822597|529626278|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
146852100|NCT04822597|529626279|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
146753730|NCT03873246|529265965|FG002|Overall Study|Protocol Violation|0|||
146753731|NCT03873246|529265963|FG000|Overall Study|Withdrawal by Subject|0|||
146753732|NCT03873246|529265964|FG001|Overall Study|Withdrawal by Subject|4|||
146852101|NCT04822597|529626280|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
146852102|NCT01285609|529626281|FG000|Randomized|Progressive Disease|41|||
146852103|NCT01285609|529626282|FG001|Randomized|Progressive Disease|61|||
146753733|NCT03873246|529265965|FG002|Overall Study|Withdrawal by Subject|1|||
146753734|NCT02107443|529265966|FG000|Overall Study|Death|42|||
146753735|NCT02107443|529265967|FG001|Overall Study|Death|30|||
146753736|NCT02107443|529265966|FG000|Overall Study|Study Protocol Violation|3|||
146753737|NCT02107443|529265967|FG001|Overall Study|Study Protocol Violation|1|||
146753738|NCT02107443|529265966|FG000|Overall Study|Registered but Not Eligible|0|||
146753739|NCT02107443|529265967|FG001|Overall Study|Registered but Not Eligible|1|||
146753740|NCT02107443|529265966|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
146753741|NCT02107443|529265967|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
146753742|NCT02107443|529265966|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
146753743|NCT02107443|529265967|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
146753744|NCT02107443|529265966|FG000|Overall Study|Withdrawal: Changed Mind|2|||
146753745|NCT02107443|529265967|FG001|Overall Study|Withdrawal: Changed Mind|0|||
146753746|NCT02107443|529265966|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
146753747|NCT02107443|529265967|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
146753748|NCT02107443|529265966|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
146753749|NCT02107443|529265967|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
146753750|NCT02107443|529265966|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
146753751|NCT02107443|529265967|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
146753752|NCT02107443|529265966|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
146753753|NCT02107443|529265967|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
146753754|NCT02107443|529265966|FG000|Overall Study|Withdrawal: Other Medical|9|||
146753755|NCT02107443|529265967|FG001|Overall Study|Withdrawal: Other Medical|5|||
146753756|NCT02107443|529265966|FG000|Overall Study|Withdrawal: Disease Progression|4|||
146753757|NCT02107443|529265967|FG001|Overall Study|Withdrawal: Disease Progression|2|||
146753758|NCT02107443|529265966|FG000|Overall Study|Withdrawal: Personal Issues|0|||
146753759|NCT02107443|529265967|FG001|Overall Study|Withdrawal: Personal Issues|3|||
146753760|NCT01400893|529265968|FG000|Overall Study|Death|27|||
146753761|NCT01400893|529265969|FG001|Overall Study|Death|21|||
146753762|NCT01400893|529265968|FG000|Overall Study|Lost to Follow-up|0|||
146852104|NCT01285609|529626281|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
146852105|NCT01285609|529626282|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
146852106|NCT01285609|529626281|FG000|Randomized|Study Drug Toxicity|13|||
146852107|NCT01285609|529626282|FG001|Randomized|Study Drug Toxicity|14|||
146852108|NCT01285609|529626281|FG000|Randomized|Death|5|||
146753763|NCT01400893|529265969|FG001|Overall Study|Lost to Follow-up|6|||
146753764|NCT00946647|529265970|FG000|Phase 1 Part|Adverse Event|2|||
146852109|NCT01285609|529626282|FG001|Randomized|Death|7|||
146852110|NCT01285609|529626281|FG000|Randomized|Withdrawal by Subject|8|||
146852111|NCT01285609|529626282|FG001|Randomized|Withdrawal by Subject|11|||
146852112|NCT01285609|529626281|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
146753765|NCT00946647|529265971|FG001|Phase 1 Part|Adverse Event|5|||
146753766|NCT00946647|529265972|FG002|Phase 1 Part|Adverse Event|3|||
146753767|NCT00946647|529265973|FG003|Phase 1 Part|Adverse Event|0|||
146753768|NCT00946647|529265974|FG004|Phase 1 Part|Adverse Event|0|||
146753769|NCT00946647|529265970|FG000|Phase 1 Part|Disease progression|3|||
146753770|NCT00946647|529265971|FG001|Phase 1 Part|Disease progression|6|||
146753771|NCT00946647|529265972|FG002|Phase 1 Part|Disease progression|1|||
146753772|NCT00946647|529265973|FG003|Phase 1 Part|Disease progression|0|||
146753773|NCT00946647|529265974|FG004|Phase 1 Part|Disease progression|0|||
146753774|NCT00946647|529265970|FG000|Phase 1 Part|Withdrawal by Subject|1|||
146753775|NCT00946647|529265971|FG001|Phase 1 Part|Withdrawal by Subject|4|||
146753776|NCT00946647|529265972|FG002|Phase 1 Part|Withdrawal by Subject|3|||
146753777|NCT00946647|529265973|FG003|Phase 1 Part|Withdrawal by Subject|0|||
146753778|NCT00946647|529265974|FG004|Phase 1 Part|Withdrawal by Subject|0|||
146753779|NCT00946647|529265970|FG000|Phase 1 Part|Abnormal values|0|||
146753780|NCT00946647|529265971|FG001|Phase 1 Part|Abnormal values|2|||
146753781|NCT00946647|529265972|FG002|Phase 1 Part|Abnormal values|0|||
146753782|NCT00946647|529265973|FG003|Phase 1 Part|Abnormal values|0|||
146753783|NCT00946647|529265974|FG004|Phase 1 Part|Abnormal values|0|||
146753784|NCT00946647|529265970|FG000|Phase 1 Part|Reason missing|0|||
146753785|NCT00946647|529265971|FG001|Phase 1 Part|Reason missing|1|||
146753786|NCT00946647|529265972|FG002|Phase 1 Part|Reason missing|0|||
146753787|NCT00946647|529265973|FG003|Phase 1 Part|Reason missing|0|||
146753788|NCT00946647|529265974|FG004|Phase 1 Part|Reason missing|0|||
146753789|NCT00946647|529265970|FG000|Phase ll Part|Untreated|0|||
146753790|NCT00946647|529265971|FG001|Phase ll Part|Untreated|0|||
146753791|NCT00946647|529265972|FG002|Phase ll Part|Untreated|0|||
146753792|NCT00946647|529265973|FG003|Phase ll Part|Untreated|0|||
146753793|NCT00946647|529265974|FG004|Phase ll Part|Untreated|2|||
146753794|NCT00946647|529265970|FG000|Phase ll Part|Adverse Event|0|||
146753795|NCT00946647|529265971|FG001|Phase ll Part|Adverse Event|0|||
146753796|NCT00946647|529265972|FG002|Phase ll Part|Adverse Event|0|||
146753797|NCT00946647|529265973|FG003|Phase ll Part|Adverse Event|10|||
146753798|NCT00946647|529265974|FG004|Phase ll Part|Adverse Event|6|||
146753799|NCT00946647|529265970|FG000|Phase ll Part|Withdrawal by Subject|0|||
146753800|NCT00946647|529265971|FG001|Phase ll Part|Withdrawal by Subject|0|||
146753801|NCT00946647|529265972|FG002|Phase ll Part|Withdrawal by Subject|0|||
146753802|NCT00946647|529265973|FG003|Phase ll Part|Withdrawal by Subject|8|||
146753803|NCT00946647|529265974|FG004|Phase ll Part|Withdrawal by Subject|6|||
146753804|NCT00946647|529265970|FG000|Phase ll Part|Administrative problems|0|||
146753805|NCT00946647|529265971|FG001|Phase ll Part|Administrative problems|0|||
146753806|NCT00946647|529265972|FG002|Phase ll Part|Administrative problems|0|||
146753807|NCT00946647|529265973|FG003|Phase ll Part|Administrative problems|3|||
146753808|NCT00946647|529265974|FG004|Phase ll Part|Administrative problems|8|||
146753809|NCT00946647|529265970|FG000|Phase ll Part|Death|0|||
146753810|NCT00946647|529265971|FG001|Phase ll Part|Death|0|||
146753811|NCT00946647|529265972|FG002|Phase ll Part|Death|0|||
146753812|NCT00946647|529265973|FG003|Phase ll Part|Death|7|||
146753813|NCT00946647|529265974|FG004|Phase ll Part|Death|4|||
146753814|NCT00946647|529265970|FG000|Phase ll Part|Disease progression|0|||
146753815|NCT00946647|529265971|FG001|Phase ll Part|Disease progression|0|||
146753816|NCT00946647|529265972|FG002|Phase ll Part|Disease progression|0|||
146753817|NCT00946647|529265973|FG003|Phase ll Part|Disease progression|6|||
146753818|NCT00946647|529265974|FG004|Phase ll Part|Disease progression|14|||
146753819|NCT00946647|529265970|FG000|Phase ll Part|Protocol Violation|0|||
146753820|NCT00946647|529265971|FG001|Phase ll Part|Protocol Violation|0|||
146753821|NCT00946647|529265972|FG002|Phase ll Part|Protocol Violation|0|||
146852113|NCT01285609|529626282|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
146852114|NCT01285609|529626281|FG000|Randomized|Undisclosed Reasons|1|||
146852115|NCT01285609|529626282|FG001|Randomized|Undisclosed Reasons|0|||
146753822|NCT00946647|529265973|FG003|Phase ll Part|Protocol Violation|4|||
146753823|NCT00946647|529265974|FG004|Phase ll Part|Protocol Violation|2|||
146753824|NCT00946647|529265970|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
146753825|NCT00946647|529265971|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
146753826|NCT00946647|529265972|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
146753827|NCT00946647|529265973|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
146753828|NCT00946647|529265974|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
146753829|NCT04209790|529265975|FG000|Overall Study|Physician Decision|1|||
146753830|NCT03057834|529265976|FG000|Overall Study|Withdrawal by Subject|25|||
146753831|NCT03057834|529265977|FG001|Overall Study|Withdrawal by Subject|29|||
146753832|NCT05617040|529265980|FG000|Overall Study|Adverse Event|0|||
146753833|NCT05617040|529265981|FG001|Overall Study|Adverse Event|1|||
146753834|NCT05617040|529265982|FG002|Overall Study|Adverse Event|0|||
146753835|NCT05617040|529265980|FG000|Overall Study|Death|0|||
146753836|NCT05617040|529265981|FG001|Overall Study|Death|0|||
146753837|NCT05617040|529265982|FG002|Overall Study|Death|1|||
146753838|NCT03990363|529265983|FG000|Overall Study|Withdrawal by Subject|10|||
146852116|NCT01285609|529626281|FG000|Randomized|Randomized but not Treated|4|||
146753839|NCT03990363|529265984|FG001|Overall Study|Withdrawal by Subject|9|||
146852117|NCT01285609|529626282|FG001|Randomized|Randomized but not Treated|4|||
146852118|NCT01285609|529626281|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
146852119|NCT01285609|529626282|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
146852120|NCT01285609|529626281|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
146852121|NCT01285609|529626282|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
146852122|NCT01285609|529626281|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
146852123|NCT01285609|529626282|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
146852124|NCT01285609|529626281|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
146852125|NCT01285609|529626282|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
146852126|NCT01285609|529626281|FG000|Treated With Blinded Therapy|Death|11|||
146852127|NCT01285609|529626282|FG001|Treated With Blinded Therapy|Death|3|||
146852128|NCT01285609|529626281|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
146852129|NCT01285609|529626282|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
146852130|NCT01285609|529626281|FG000|Treated With Blinded Therapy|Not Reported|0|||
146852131|NCT01285609|529626282|FG001|Treated With Blinded Therapy|Not Reported|2|||
146852132|NCT01285609|529626281|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
146852133|NCT01285609|529626282|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
146852134|NCT01285609|529626281|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
146852135|NCT01285609|529626282|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
146852136|NCT01285609|529626281|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
146852137|NCT01285609|529626282|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
146852138|NCT01285609|529626281|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
146852139|NCT01285609|529626282|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
146852140|NCT01285609|529626281|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
146852141|NCT01285609|529626282|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
146852142|NCT01285609|529626281|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
146852143|NCT01285609|529626282|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
146852144|NCT01285609|529626281|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
146852145|NCT01285609|529626282|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
146852146|NCT01285609|529626281|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
146852147|NCT01285609|529626282|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
146852148|NCT01285609|529626281|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
146852149|NCT01285609|529626282|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
146852150|NCT01285609|529626281|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
146852151|NCT01285609|529626282|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
146852152|NCT00911768|529626287|FG000|Overall Study|Protocol Violation|5|||
146852153|NCT00911768|529626288|FG001|Overall Study|Protocol Violation|4|||
146852154|NCT00911768|529626287|FG000|Overall Study|Withdrawal by Subject|1|||
146852155|NCT00911768|529626288|FG001|Overall Study|Withdrawal by Subject|0|||
146965006|NCT05993299|530033424|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
146965007|NCT05993299|530033424|FG000|Overall Study|Ongoing|4|||
146965008|NCT05644756|530033425|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
146965009|NCT05644756|530033425|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
146965010|NCT03110107|530033426|FG000|Treatment Period|Disease Progression|3|||
146965011|NCT03110107|530033427|FG001|Treatment Period|Disease Progression|9|||
146965012|NCT03110107|530033428|FG002|Treatment Period|Disease Progression|8|||
146965013|NCT03110107|530033429|FG003|Treatment Period|Disease Progression|11|||
146965014|NCT03110107|530033430|FG004|Treatment Period|Disease Progression|8|||
146965015|NCT03110107|530033431|FG005|Treatment Period|Disease Progression|4|||
146965016|NCT03110107|530033432|FG006|Treatment Period|Disease Progression|6|||
146965017|NCT03110107|530033433|FG007|Treatment Period|Disease Progression|7|||
146965018|NCT03110107|530033434|FG008|Treatment Period|Disease Progression|2|||
146965019|NCT03110107|530033435|FG009|Treatment Period|Disease Progression|10|||
146965020|NCT03110107|530033436|FG010|Treatment Period|Disease Progression|5|||
146965021|NCT03110107|530033437|FG011|Treatment Period|Disease Progression|2|||
146965022|NCT03110107|530033438|FG012|Treatment Period|Disease Progression|0|||
146965023|NCT03110107|530033439|FG013|Treatment Period|Disease Progression|5|||
146965024|NCT03110107|530033440|FG014|Treatment Period|Disease Progression|14|||
146965025|NCT03110107|530033441|FG015|Treatment Period|Disease Progression|14|||
146965026|NCT03110107|530033442|FG016|Treatment Period|Disease Progression|4|||
146965027|NCT03110107|530033443|FG017|Treatment Period|Disease Progression|3|||
146965028|NCT03110107|530033444|FG018|Treatment Period|Disease Progression|16|||
146965029|NCT03110107|530033445|FG019|Treatment Period|Disease Progression|14|||
146965030|NCT03110107|530033446|FG020|Treatment Period|Disease Progression|12|||
146965031|NCT03110107|530033447|FG021|Treatment Period|Disease Progression|16|||
146965032|NCT03110107|530033448|FG022|Treatment Period|Disease Progression|18|||
146965033|NCT03110107|530033449|FG023|Treatment Period|Disease Progression|13|||
146852156|NCT00515853|529626290|FG000|Overall Study|Lost to Follow-up|9|||
146965034|NCT03110107|530033450|FG024|Treatment Period|Disease Progression|16|||
146965035|NCT03110107|530033451|FG025|Treatment Period|Disease Progression|31|||
146753840|NCT03990363|529265985|FG002|Overall Study|Withdrawal by Subject|18|||
146753841|NCT03990363|529265986|FG003|Overall Study|Withdrawal by Subject|11|||
146753842|NCT03990363|529265987|FG004|Overall Study|Withdrawal by Subject|9|||
146753843|NCT03990363|529265983|FG000|Overall Study|Physician Decision|1|||
146753844|NCT03990363|529265984|FG001|Overall Study|Physician Decision|0|||
146753845|NCT03990363|529265985|FG002|Overall Study|Physician Decision|0|||
146753846|NCT03990363|529265986|FG003|Overall Study|Physician Decision|0|||
146753847|NCT03990363|529265987|FG004|Overall Study|Physician Decision|0|||
146753848|NCT03990363|529265983|FG000|Overall Study|Adverse Event|1|||
146753849|NCT03990363|529265984|FG001|Overall Study|Adverse Event|3|||
146753850|NCT03990363|529265985|FG002|Overall Study|Adverse Event|2|||
146753851|NCT03990363|529265986|FG003|Overall Study|Adverse Event|2|||
146753852|NCT03990363|529265987|FG004|Overall Study|Adverse Event|0|||
146753853|NCT03990363|529265983|FG000|Overall Study|Death|14|||
146753854|NCT03990363|529265984|FG001|Overall Study|Death|8|||
146753855|NCT03990363|529265985|FG002|Overall Study|Death|14|||
146753856|NCT03990363|529265986|FG003|Overall Study|Death|10|||
146753857|NCT03990363|529265987|FG004|Overall Study|Death|11|||
146753858|NCT03990363|529265983|FG000|Overall Study|Failure to meet randomization criteria|0|||
146753859|NCT03990363|529265984|FG001|Overall Study|Failure to meet randomization criteria|1|||
146753860|NCT03990363|529265985|FG002|Overall Study|Failure to meet randomization criteria|1|||
146753861|NCT03990363|529265986|FG003|Overall Study|Failure to meet randomization criteria|0|||
146753862|NCT03990363|529265987|FG004|Overall Study|Failure to meet randomization criteria|0|||
146753863|NCT03990363|529265983|FG000|Overall Study|Lost to Follow-up|0|||
146753864|NCT03990363|529265984|FG001|Overall Study|Lost to Follow-up|0|||
146753865|NCT03990363|529265985|FG002|Overall Study|Lost to Follow-up|0|||
146753866|NCT03990363|529265986|FG003|Overall Study|Lost to Follow-up|1|||
146753867|NCT03990363|529265987|FG004|Overall Study|Lost to Follow-up|2|||
146753868|NCT03990363|529265983|FG000|Overall Study|Non-compliance with study drug|2|||
146753869|NCT03990363|529265984|FG001|Overall Study|Non-compliance with study drug|1|||
146753870|NCT03990363|529265985|FG002|Overall Study|Non-compliance with study drug|2|||
146753871|NCT03990363|529265986|FG003|Overall Study|Non-compliance with study drug|0|||
146753872|NCT03990363|529265987|FG004|Overall Study|Non-compliance with study drug|0|||
146753873|NCT03990363|529265983|FG000|Overall Study|Study terminated by sponsor|0|||
146753874|NCT03990363|529265984|FG001|Overall Study|Study terminated by sponsor|1|||
146753875|NCT03990363|529265985|FG002|Overall Study|Study terminated by sponsor|0|||
146753876|NCT03990363|529265986|FG003|Overall Study|Study terminated by sponsor|0|||
146753877|NCT03990363|529265987|FG004|Overall Study|Study terminated by sponsor|0|||
146753878|NCT03990363|529265983|FG000|Overall Study|Site terminated by sponsor|2|||
146753879|NCT03990363|529265984|FG001|Overall Study|Site terminated by sponsor|1|||
146753880|NCT03990363|529265985|FG002|Overall Study|Site terminated by sponsor|2|||
146753881|NCT03990363|529265986|FG003|Overall Study|Site terminated by sponsor|0|||
146753882|NCT03990363|529265987|FG004|Overall Study|Site terminated by sponsor|2|||
146753883|NCT03990363|529265983|FG000|Overall Study|Not categorized|5|||
146753884|NCT03990363|529265984|FG001|Overall Study|Not categorized|5|||
146753885|NCT03990363|529265985|FG002|Overall Study|Not categorized|3|||
146753886|NCT03990363|529265986|FG003|Overall Study|Not categorized|2|||
146753887|NCT03990363|529265987|FG004|Overall Study|Not categorized|2|||
146753888|NCT04562779|529265988|FG000|Overall Study|Lost to Follow-up|7|||
146753889|NCT04562779|529265989|FG001|Overall Study|Lost to Follow-up|5|||
146753890|NCT04562779|529265990|FG002|Overall Study|Lost to Follow-up|10|||
146753891|NCT04562779|529265988|FG000|Overall Study|Protocol Violation|2|||
146753892|NCT04562779|529265989|FG001|Overall Study|Protocol Violation|2|||
146753893|NCT04562779|529265990|FG002|Overall Study|Protocol Violation|0|||
146753894|NCT03173248|529265991|FG000|Overall Study|Death|28|||
146753895|NCT03173248|529265992|FG001|Overall Study|Death|46|||
146753896|NCT03173248|529265991|FG000|Overall Study|Lost to Follow-up|0|||
146753897|NCT03173248|529265992|FG001|Overall Study|Lost to Follow-up|1|||
146753898|NCT03173248|529265991|FG000|Overall Study|Withdrawal by Subject|6|||
146753899|NCT03173248|529265992|FG001|Overall Study|Withdrawal by Subject|4|||
146753900|NCT03173248|529265991|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
146753901|NCT03173248|529265992|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
146753902|NCT01544582|529265993|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
146753903|NCT01544582|529265994|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
146753904|NCT01544582|529265995|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
146753905|NCT01544582|529265996|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
146753906|NCT01544582|529265993|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
146753907|NCT01544582|529265994|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
146753908|NCT01544582|529265995|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
146753909|NCT01544582|529265996|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
146753910|NCT01544582|529265993|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
146753911|NCT01544582|529265994|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
146753912|NCT01544582|529265995|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
146753913|NCT01544582|529265996|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
146852157|NCT00515853|529626291|FG001|Overall Study|Lost to Follow-up|13|||
146753914|NCT01544582|529265993|FG000|Analysis Population|Physician Decision|0|||
146753915|NCT01544582|529265994|FG001|Analysis Population|Physician Decision|13|||
146753916|NCT01544582|529265995|FG002|Analysis Population|Physician Decision|10|||
146753917|NCT01544582|529265996|FG003|Analysis Population|Physician Decision|9|||
146753918|NCT01544582|529265993|FG000|Analysis Population|Safety Reason|0|||
146753919|NCT01544582|529265994|FG001|Analysis Population|Safety Reason|33|||
146753920|NCT01544582|529265995|FG002|Analysis Population|Safety Reason|31|||
146753921|NCT01544582|529265996|FG003|Analysis Population|Safety Reason|8|||
146753922|NCT01544582|529265993|FG000|Analysis Population|Effectiveness Reason|0|||
146753923|NCT01544582|529265994|FG001|Analysis Population|Effectiveness Reason|48|||
146753924|NCT01544582|529265995|FG002|Analysis Population|Effectiveness Reason|29|||
146753925|NCT01544582|529265996|FG003|Analysis Population|Effectiveness Reason|12|||
146753926|NCT01544582|529265993|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
146753927|NCT01544582|529265994|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
146753928|NCT01544582|529265995|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
146753929|NCT01544582|529265996|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
146753930|NCT01544582|529265993|FG000|Analysis Population|Lost to Follow-up|0|||
146753931|NCT01544582|529265994|FG001|Analysis Population|Lost to Follow-up|6|||
146753932|NCT01544582|529265995|FG002|Analysis Population|Lost to Follow-up|6|||
146753933|NCT01544582|529265996|FG003|Analysis Population|Lost to Follow-up|5|||
146753934|NCT01544582|529265993|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
146753935|NCT01544582|529265994|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
146753936|NCT01544582|529265995|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
146753937|NCT01544582|529265996|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
146753938|NCT01544582|529265993|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
146753939|NCT01544582|529265994|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
146753940|NCT01544582|529265995|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
146753941|NCT01544582|529265996|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
146753942|NCT01544582|529265993|FG000|Analysis Population|Intolerance|0|||
146753943|NCT01544582|529265994|FG001|Analysis Population|Intolerance|1|||
146753944|NCT01544582|529265995|FG002|Analysis Population|Intolerance|0|||
146753945|NCT01544582|529265996|FG003|Analysis Population|Intolerance|0|||
146753946|NCT01544582|529265993|FG000|Analysis Population|Liver Transplantation|0|||
146852158|NCT00515853|529626290|FG000|Overall Study|Withdrawal by Subject|6|||
146852159|NCT00515853|529626291|FG001|Overall Study|Withdrawal by Subject|4|||
146852160|NCT02631577|529626297|FG000|Overall Study|Death|1|||
146852161|NCT02631577|529626298|FG001|Overall Study|Death|7|||
146852162|NCT02631577|529626297|FG000|Overall Study|Withdrawal by Subject|0|||
146852163|NCT02631577|529626298|FG001|Overall Study|Withdrawal by Subject|3|||
146753947|NCT01544582|529265994|FG001|Analysis Population|Liver Transplantation|0|||
146753948|NCT01544582|529265995|FG002|Analysis Population|Liver Transplantation|1|||
146753949|NCT01544582|529265996|FG003|Analysis Population|Liver Transplantation|0|||
146753950|NCT01544582|529265993|FG000|Analysis Population|No Social Insurance|0|||
146753951|NCT01544582|529265994|FG001|Analysis Population|No Social Insurance|0|||
146753952|NCT01544582|529265995|FG002|Analysis Population|No Social Insurance|1|||
146753953|NCT01544582|529265996|FG003|Analysis Population|No Social Insurance|0|||
146852164|NCT00979134|529626299|FG000|Overall Study|Disease progression|18|||
146852165|NCT00979134|529626300|FG001|Overall Study|Disease progression|2|||
146852166|NCT00979134|529626301|FG002|Overall Study|Disease progression|5|||
146852167|NCT00979134|529626299|FG000|Overall Study|Adverse Event|0|||
146852168|NCT00979134|529626300|FG001|Overall Study|Adverse Event|0|||
146852169|NCT00979134|529626301|FG002|Overall Study|Adverse Event|2|||
146852170|NCT00979134|529626299|FG000|Overall Study|Withdrawal by Subject|1|||
146852171|NCT00979134|529626300|FG001|Overall Study|Withdrawal by Subject|1|||
146852172|NCT00979134|529626301|FG002|Overall Study|Withdrawal by Subject|2|||
146852173|NCT00979134|529626299|FG000|Overall Study|Lost to Follow-up|2|||
146852174|NCT00979134|529626300|FG001|Overall Study|Lost to Follow-up|2|||
146852175|NCT00979134|529626301|FG002|Overall Study|Lost to Follow-up|0|||
146852176|NCT00979134|529626299|FG000|Overall Study|Death|4|||
146852177|NCT00979134|529626300|FG001|Overall Study|Death|0|||
146852178|NCT00979134|529626301|FG002|Overall Study|Death|26|||
146852179|NCT00979134|529626299|FG000|Overall Study|Other|8|||
146852180|NCT00979134|529626300|FG001|Overall Study|Other|1|||
146852181|NCT00979134|529626301|FG002|Overall Study|Other|5|||
146852182|NCT00867308|529626302|FG000|Overall Study|Death|1|||
146852183|NCT00867308|529626303|FG001|Overall Study|Death|0|||
146852184|NCT00867308|529626302|FG000|Overall Study|Adverse Event|1|||
146852185|NCT00867308|529626303|FG001|Overall Study|Adverse Event|4|||
146753954|NCT01544582|529265993|FG000|Analysis Population|Poor Adherence|0|||
146753955|NCT01544582|529265994|FG001|Analysis Population|Poor Adherence|0|||
146753956|NCT01544582|529265995|FG002|Analysis Population|Poor Adherence|1|||
146753957|NCT01544582|529265996|FG003|Analysis Population|Poor Adherence|0|||
146753958|NCT01544582|529265993|FG000|Analysis Population|Poor Participant Compliance|0|||
146753959|NCT01544582|529265994|FG001|Analysis Population|Poor Participant Compliance|1|||
146852186|NCT00867308|529626302|FG000|Overall Study|Lack of Efficacy|6|||
146852187|NCT00867308|529626303|FG001|Overall Study|Lack of Efficacy|12|||
146852188|NCT00867308|529626302|FG000|Overall Study|Withdrawal by Subject|1|||
146852189|NCT00867308|529626303|FG001|Overall Study|Withdrawal by Subject|2|||
146852190|NCT03207009|529627816|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
146852191|NCT02924428|529627817|FG000|Overall Study|Adverse Event|1|||
146852192|NCT02924428|529627818|FG001|Overall Study|Adverse Event|0|||
146852193|NCT02924428|529627817|FG000|Overall Study|Physician Decision|1|||
146852194|NCT02924428|529627818|FG001|Overall Study|Physician Decision|0|||
146852195|NCT02924428|529627817|FG000|Overall Study|Lost to Follow-up|2|||
146852196|NCT02924428|529627818|FG001|Overall Study|Lost to Follow-up|4|||
146852197|NCT02924428|529627817|FG000|Overall Study|Pregnancy|0|||
146852198|NCT02924428|529627818|FG001|Overall Study|Pregnancy|1|||
146852199|NCT00932113|529627819|FG000|Overall Study|Lost to Follow-up|1|||
146852200|NCT00932113|529627820|FG001|Overall Study|Lost to Follow-up|0|||
146852201|NCT00512317|529627821|FG000|Overall Study|Insufficient clinical response|36|||
146852202|NCT00512317|529627821|FG000|Overall Study|Withdrawal by Subject|23|||
146852203|NCT00512317|529627821|FG000|Overall Study|Sponsor closure of study|21|||
146852204|NCT00512317|529627821|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
146852205|NCT00512317|529627821|FG000|Overall Study|Adverse Event|13|||
146852206|NCT00512317|529627821|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
146852207|NCT00512317|529627821|FG000|Overall Study|Lost to Follow-up|2|||
146852208|NCT00512317|529627821|FG000|Overall Study|Other|2|||
146852209|NCT03064035|529627824|FG000|Overall Study|Did not receive allocated intervention|4|||
146852210|NCT03064035|529627825|FG001|Overall Study|Did not receive allocated intervention|2|||
146852211|NCT03064035|529627824|FG000|Overall Study|Lost to Follow-up|1|||
146852212|NCT03064035|529627825|FG001|Overall Study|Lost to Follow-up|1|||
146852213|NCT01143038|529627826|FG000|Overall Study|Withdrawal by Subject|4|||
146852214|NCT01143038|529627826|FG000|Overall Study|Requirement for alternative therapy|5|||
146852215|NCT01143038|529627826|FG000|Overall Study|Adverse Event|3|||
146852216|NCT01143038|529627826|FG000|Overall Study|Lost to Follow-up|2|||
146852217|NCT01143038|529627826|FG000|Overall Study|Protocol Deviation|1|||
146852218|NCT01143038|529627826|FG000|Overall Study|Death|1|||
146852219|NCT00618982|529627827|FG000|Overall Study|Adverse Event|23|||
146852220|NCT00618982|529627827|FG000|Overall Study|Withdrawal by Subject|1|||
146852221|NCT00618982|529627827|FG000|Overall Study|Protocol Violation|1|||
146852222|NCT00618982|529627827|FG000|Overall Study|ongoing, still treated with study med.|25|||
146852223|NCT04289051|529627830|FG000|Overall Study|Lost to Follow-up|0|||
146852224|NCT04289051|529627831|FG001|Overall Study|Lost to Follow-up|0|||
146852225|NCT04289051|529627832|FG002|Overall Study|Lost to Follow-up|2|||
146852226|NCT00717067|529627833|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
146852227|NCT00717067|529627834|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
146852228|NCT00717067|529627835|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
146852229|NCT00717067|529627836|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
146852230|NCT00717067|529627837|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
146852231|NCT00657020|529627838|FG000|PERIOD 1|Adverse Event|0|||
146852232|NCT00657020|529627839|FG001|PERIOD 1|Adverse Event|1|||
146852233|NCT00822172|529627842|FG000|Overall Study|Adverse Event|10|||
146852234|NCT00822172|529627843|FG001|Overall Study|Adverse Event|12|||
146852235|NCT00822172|529627842|FG000|Overall Study|Death|1|||
146753960|NCT01544582|529265995|FG002|Analysis Population|Poor Participant Compliance|0|||
146753961|NCT01544582|529265996|FG003|Analysis Population|Poor Participant Compliance|0|||
146753962|NCT01544582|529265993|FG000|Analysis Population|Programmed Surgery|0|||
146753963|NCT01544582|529265994|FG001|Analysis Population|Programmed Surgery|1|||
146753964|NCT01544582|529265995|FG002|Analysis Population|Programmed Surgery|0|||
146753965|NCT01544582|529265996|FG003|Analysis Population|Programmed Surgery|0|||
146753966|NCT01544582|529265993|FG000|Analysis Population|Participant in Jail|0|||
146753967|NCT01544582|529265994|FG001|Analysis Population|Participant in Jail|0|||
146753968|NCT01544582|529265995|FG002|Analysis Population|Participant in Jail|1|||
146753969|NCT01544582|529265996|FG003|Analysis Population|Participant in Jail|0|||
146753970|NCT00810641|529266001|FG000|Overall Study|Withdrawal by Subject|0|||
146753971|NCT00810641|529266002|FG001|Overall Study|Withdrawal by Subject|1|||
146753972|NCT00810641|529266003|FG002|Overall Study|Withdrawal by Subject|2|||
146753973|NCT01388543|529266004|FG000|Day 14|Adverse Event|1|||
146753974|NCT01388543|529266005|FG001|Day 14|Adverse Event|4|||
146753975|NCT01556243|529266006|FG000|Overall Study|Ineligible|34|||
146753976|NCT01556243|529266006|FG000|Overall Study|Converted to mastectomy|14|||
146753977|NCT01556243|529266006|FG000|Overall Study|Unable to achieve negative margins|2|||
146753978|NCT01556243|529266006|FG000|Overall Study|Withdrawal by Subject|16|||
146753979|NCT02325713|529266009|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146753980|NCT02325713|529266010|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146753981|NCT02325713|529266011|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146852236|NCT00822172|529627843|FG001|Overall Study|Death|0|||
146852237|NCT00822172|529627842|FG000|Overall Study|Lost to Follow-up|3|||
146852238|NCT00822172|529627843|FG001|Overall Study|Lost to Follow-up|1|||
146753982|NCT02325713|529266012|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146753983|NCT02325713|529266013|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146753984|NCT02325713|529266014|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146753985|NCT02325713|529266015|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146753986|NCT02325713|529266016|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146753987|NCT02325713|529266017|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146753988|NCT02325713|529266018|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146753989|NCT02325713|529266019|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
146753990|NCT02325713|529266020|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146753991|NCT02325713|529266021|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146753992|NCT02325713|529266022|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146753993|NCT02325713|529266023|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146753994|NCT02325713|529266024|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146753995|NCT02325713|529266009|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
146753996|NCT02325713|529266010|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146753997|NCT02325713|529266011|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146753998|NCT02325713|529266012|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146753999|NCT02325713|529266013|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146754000|NCT02325713|529266014|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146754001|NCT02325713|529266015|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146754002|NCT02325713|529266016|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146754003|NCT02325713|529266017|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146754004|NCT02325713|529266018|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146754005|NCT02325713|529266019|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146754006|NCT02325713|529266020|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146754007|NCT02325713|529266021|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146754008|NCT02325713|529266022|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146754009|NCT02325713|529266023|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146754010|NCT02325713|529266024|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146754011|NCT02325713|529266009|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146754012|NCT02325713|529266010|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146754013|NCT02325713|529266011|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146754014|NCT02325713|529266012|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146754015|NCT02325713|529266013|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146754016|NCT02325713|529266014|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146754017|NCT02325713|529266015|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146754018|NCT02325713|529266016|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146754019|NCT02325713|529266017|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146754020|NCT02325713|529266018|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
146754021|NCT02325713|529266019|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146754022|NCT02325713|529266020|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146754023|NCT02325713|529266021|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146754024|NCT02325713|529266022|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146754025|NCT02325713|529266023|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146754026|NCT02325713|529266024|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146754027|NCT01213173|529266025|FG000|Overall Study|Protocol Violation|2|||
146754028|NCT01213173|529266026|FG001|Overall Study|Protocol Violation|0|||
146754029|NCT01213173|529266025|FG000|Overall Study|Adverse Event|4|||
146754030|NCT01213173|529266026|FG001|Overall Study|Adverse Event|8|||
146754031|NCT01213173|529266025|FG000|Overall Study|Withdrawal by Subject|5|||
146754032|NCT01213173|529266026|FG001|Overall Study|Withdrawal by Subject|5|||
146754033|NCT01213173|529266025|FG000|Overall Study|Incorrect Enrollment|1|||
146754034|NCT01213173|529266026|FG001|Overall Study|Incorrect Enrollment|3|||
146754035|NCT02253316|529266027|FG000|Consolidation|Progression|4|||
146754036|NCT02253316|529266028|FG001|Consolidation|Progression|0|||
146754037|NCT02253316|529266029|FG002|Consolidation|Progression|0|||
146754038|NCT02253316|529266027|FG000|Consolidation|Non-Compliance|1|||
146754039|NCT02253316|529266028|FG001|Consolidation|Non-Compliance|0|||
146754040|NCT02253316|529266029|FG002|Consolidation|Non-Compliance|0|||
146754041|NCT02253316|529266027|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
146512358|NCT02943785|528379204|FG001|Overall Study|Withdrawal by Subject|126|||
146754042|NCT02253316|529266028|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
146754043|NCT02253316|529266029|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
146754044|NCT02253316|529266027|FG000|Consolidation|Secondary Malignancy|2|||
146754045|NCT02253316|529266028|FG001|Consolidation|Secondary Malignancy|0|||
146754046|NCT02253316|529266029|FG002|Consolidation|Secondary Malignancy|0|||
146754047|NCT02253316|529266027|FG000|Consolidation|Adverse Event|7|||
146754048|NCT02253316|529266028|FG001|Consolidation|Adverse Event|0|||
146754049|NCT02253316|529266029|FG002|Consolidation|Adverse Event|0|||
146852239|NCT00822172|529627842|FG000|Overall Study|Withdrawal by Subject|1|||
146852240|NCT00822172|529627843|FG001|Overall Study|Withdrawal by Subject|4|||
146852241|NCT00822172|529627842|FG000|Overall Study|site closed|0|||
146852242|NCT00822172|529627843|FG001|Overall Study|site closed|1|||
146852243|NCT00822172|529627842|FG000|Overall Study|Other|0|||
146852244|NCT00822172|529627843|FG001|Overall Study|Other|1|||
146852245|NCT00700258|529627844|FG000|Overall Study|Premature discontinuation of documentation|136|||
146852246|NCT00700258|529627844|FG000|Overall Study|Type of study end not documented|1|||
146852247|NCT00700258|529627844|FG000|Overall Study|Lost to Follow-up|81|||
146852248|NCT00700258|529627844|FG000|Overall Study|Premature discontinuation of therapy|1013|||
146852249|NCT00370331|529627845|FG000|Overall Study|Adverse Event|4|||
146852250|NCT00370331|529627846|FG001|Overall Study|Adverse Event|13|||
146852251|NCT00370331|529627845|FG000|Overall Study|Withdrawal by Subject|2|||
146852252|NCT00370331|529627846|FG001|Overall Study|Withdrawal by Subject|4|||
146852253|NCT00370331|529627845|FG000|Overall Study|Lost to Follow-up|0|||
146852254|NCT00370331|529627846|FG001|Overall Study|Lost to Follow-up|3|||
146852255|NCT00370331|529627845|FG000|Overall Study|Lack of Efficacy|0|||
146852256|NCT00370331|529627846|FG001|Overall Study|Lack of Efficacy|1|||
146852257|NCT00370331|529627845|FG000|Overall Study|Non-compliance|0|||
146852258|NCT00370331|529627846|FG001|Overall Study|Non-compliance|1|||
146852259|NCT00370331|529627845|FG000|Overall Study|Protocol Violation|1|||
146852260|NCT00370331|529627846|FG001|Overall Study|Protocol Violation|1|||
146852261|NCT02937454|529627847|FG000|Overall Study|Adverse Event|0|||
146852262|NCT02937454|529627848|FG001|Overall Study|Adverse Event|1|||
146852263|NCT02937454|529627847|FG000|Overall Study|Death|98|||
146852264|NCT02937454|529627848|FG001|Overall Study|Death|95|||
146852265|NCT02937454|529627847|FG000|Overall Study|Lost to Follow-up|1|||
146852266|NCT02937454|529627848|FG001|Overall Study|Lost to Follow-up|1|||
146852267|NCT02937454|529627847|FG000|Overall Study|Physician Decision|0|||
146852268|NCT02937454|529627848|FG001|Overall Study|Physician Decision|1|||
146852269|NCT02937454|529627847|FG000|Overall Study|Protocol Violation|6|||
146852270|NCT02937454|529627848|FG001|Overall Study|Protocol Violation|10|||
146852271|NCT02937454|529627847|FG000|Overall Study|Withdrawal by Subject|27|||
146852272|NCT02937454|529627848|FG001|Overall Study|Withdrawal by Subject|15|||
146852273|NCT02937454|529627847|FG000|Overall Study|Other|8|||
146852274|NCT02937454|529627848|FG001|Overall Study|Other|5|||
146852275|NCT00993668|529627852|FG000|Single-Blind Period|Adverse Event|1|||
146852276|NCT00993668|529627853|FG001|Single-Blind Period|Adverse Event|1|||
146852277|NCT00993668|529627852|FG000|Single-Blind Period|Lack of Efficacy|0|||
146852278|NCT00993668|529627853|FG001|Single-Blind Period|Lack of Efficacy|1|||
146852279|NCT00993668|529627852|FG000|Single-Blind Period|Lost to Follow-up|3|||
146852280|NCT00993668|529627853|FG001|Single-Blind Period|Lost to Follow-up|1|||
146852281|NCT00993668|529627852|FG000|Open-Label Period|Adverse Event|9|||
146852282|NCT00993668|529627853|FG001|Open-Label Period|Adverse Event|8|||
146852283|NCT00993668|529627852|FG000|Open-Label Period|Lack of Efficacy|4|||
146852284|NCT00993668|529627853|FG001|Open-Label Period|Lack of Efficacy|3|||
146852285|NCT00993668|529627852|FG000|Open-Label Period|Withdrawal by Subject|4|||
146852286|NCT00993668|529627853|FG001|Open-Label Period|Withdrawal by Subject|3|||
146852287|NCT00993668|529627852|FG000|Open-Label Period|Lost to Follow-up|6|||
146852288|NCT00993668|529627853|FG001|Open-Label Period|Lost to Follow-up|1|||
146852289|NCT03606668|529627857|FG000|Overall Study|Screen Failure|1|||
146852290|NCT03606668|529627857|FG000|Overall Study|Lost to Follow-up|1|||
146852291|NCT01014143|529627858|FG000|Second Intervention|Lost to Follow-up|2|||
146852292|NCT01014143|529627859|FG001|Second Intervention|Lost to Follow-up|0|||
146852293|NCT01014143|529627860|FG002|Second Intervention|Lost to Follow-up|0|||
146852294|NCT03215810|529627863|FG000|Overall Study|Still responding to nivolumab|1|||
146852295|NCT03215810|529627863|FG000|Overall Study|Insufficient TIL growth|1|||
146852296|NCT03215810|529627863|FG000|Overall Study|Decline in performance status|1|||
146852297|NCT03215810|529627863|FG000|Overall Study|Withdrawal by Subject|1|||
146852298|NCT01029652|529627867|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
146852299|NCT01029652|529627868|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
146852300|NCT01029652|529627867|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
146852301|NCT01029652|529627868|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
146852302|NCT01029652|529627867|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
146852303|NCT01029652|529627868|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
146852304|NCT01029652|529627867|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
146852305|NCT01029652|529627868|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
146852306|NCT01029652|529627867|FG000|Core Study (0-12 Weeks)|Death|0|||
146852307|NCT01029652|529627868|FG001|Core Study (0-12 Weeks)|Death|1|||
146852308|NCT01029652|529627867|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
146852309|NCT01029652|529627868|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
146852310|NCT01029652|529627867|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
146852311|NCT01029652|529627868|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
146852312|NCT01029652|529627867|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
146852313|NCT01029652|529627868|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
146852314|NCT01029652|529627867|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
146852315|NCT01029652|529627868|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
146625193|NCT01097668|528803836|FG000|Overall Study|Withdrawal by Subject|1|||
146625194|NCT01097668|528803837|FG001|Overall Study|Withdrawal by Subject|2|||
146625195|NCT01097668|528803836|FG000|Overall Study|Lost to Follow-up|1|||
146625196|NCT01097668|528803837|FG001|Overall Study|Lost to Follow-up|0|||
146625197|NCT00385671|528803838|FG000|Overall Study|Adverse Event|14|||
146625198|NCT00385671|528803839|FG001|Overall Study|Adverse Event|27|||
146625199|NCT00385671|528803840|FG002|Overall Study|Adverse Event|18|||
146625200|NCT00385671|528803838|FG000|Overall Study|Lack of Efficacy|5|||
146625201|NCT00385671|528803839|FG001|Overall Study|Lack of Efficacy|9|||
146625202|NCT00385671|528803840|FG002|Overall Study|Lack of Efficacy|5|||
146625203|NCT00385671|528803838|FG000|Overall Study|Lost to Follow-up|6|||
146625204|NCT00385671|528803839|FG001|Overall Study|Lost to Follow-up|6|||
146625205|NCT00385671|528803840|FG002|Overall Study|Lost to Follow-up|5|||
146625206|NCT00385671|528803838|FG000|Overall Study|Physician Decision|2|||
146625207|NCT00385671|528803839|FG001|Overall Study|Physician Decision|1|||
146625208|NCT00385671|528803840|FG002|Overall Study|Physician Decision|2|||
146625209|NCT00385671|528803838|FG000|Overall Study|Protocol Violation|5|||
146625210|NCT00385671|528803839|FG001|Overall Study|Protocol Violation|2|||
146625211|NCT00385671|528803840|FG002|Overall Study|Protocol Violation|1|||
146625212|NCT00385671|528803838|FG000|Overall Study|Sponsor Decision|2|||
146625213|NCT00385671|528803839|FG001|Overall Study|Sponsor Decision|2|||
146625214|NCT00385671|528803840|FG002|Overall Study|Sponsor Decision|1|||
146625215|NCT00385671|528803838|FG000|Overall Study|Withdrawal by Subject|4|||
146625216|NCT00385671|528803839|FG001|Overall Study|Withdrawal by Subject|4|||
146625217|NCT00385671|528803840|FG002|Overall Study|Withdrawal by Subject|4|||
146625218|NCT01910298|528803841|FG000|Overall Study|Adverse Event|1|||
146625219|NCT01910298|528803842|FG001|Overall Study|Adverse Event|0|||
146625220|NCT01910298|528803841|FG000|Overall Study|Withdrawal by Subject|2|||
146625221|NCT01910298|528803842|FG001|Overall Study|Withdrawal by Subject|7|||
146625222|NCT01910298|528803841|FG000|Overall Study|Protocol Deviation|0|||
146625223|NCT01910298|528803842|FG001|Overall Study|Protocol Deviation|5|||
146625224|NCT01910298|528803841|FG000|Overall Study|Lost to Follow-up|1|||
146625225|NCT01910298|528803842|FG001|Overall Study|Lost to Follow-up|1|||
146625226|NCT01910298|528803841|FG000|Overall Study|Study Terminated by Sponsor|1|||
146625227|NCT01910298|528803842|FG001|Overall Study|Study Terminated by Sponsor|17|||
146625228|NCT01910298|528803841|FG000|Overall Study|Other Miscellaneous Reasons|0|||
146625229|NCT01910298|528803842|FG001|Overall Study|Other Miscellaneous Reasons|2|||
146625230|NCT03037385|528803845|FG000|Overall Study|Adverse Event|0|||
146625231|NCT03037385|528803846|FG001|Overall Study|Adverse Event|0|||
146625232|NCT03037385|528803847|FG002|Overall Study|Adverse Event|1|||
146625233|NCT03037385|528803848|FG003|Overall Study|Adverse Event|0|||
146625234|NCT03037385|528803849|FG004|Overall Study|Adverse Event|0|||
146625235|NCT03037385|528803850|FG005|Overall Study|Adverse Event|0|||
146625236|NCT03037385|528803851|FG006|Overall Study|Adverse Event|0|||
146625237|NCT03037385|528803852|FG007|Overall Study|Adverse Event|0|||
146625238|NCT03037385|528803853|FG008|Overall Study|Adverse Event|0|||
146852316|NCT01029652|529627867|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
146852317|NCT01029652|529627868|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
146852318|NCT01029652|529627867|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
146852319|NCT01029652|529627868|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
146852320|NCT01029652|529627867|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
146852321|NCT01029652|529627868|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
146852322|NCT02313233|529627872|FG000|Overall Study|Withdrawal by Subject|1|||
146852323|NCT02313233|529627873|FG001|Overall Study|Withdrawal by Subject|2|||
146852324|NCT02313233|529627872|FG000|Overall Study|Administrative reason|1|||
146852325|NCT02313233|529627873|FG001|Overall Study|Administrative reason|1|||
146852326|NCT02095951|529627874|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
146852327|NCT02095951|529627875|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
146852328|NCT03618823|529627876|FG000|Overall Study|Lost to Follow-up|63|||
146852329|NCT03618823|529627877|FG001|Overall Study|Lost to Follow-up|61|||
146852330|NCT04638920|529627878|FG000|Overall Study|Withdrawal by Subject|5|||
146852331|NCT05383508|529627879|FG000|Overall Study|Withdrawal by Subject|1|||
146852332|NCT05383508|529627880|FG001|Overall Study|Withdrawal by Subject|0|||
146852333|NCT05383508|529627881|FG002|Overall Study|Withdrawal by Subject|1|||
146852334|NCT05383508|529627882|FG003|Overall Study|Withdrawal by Subject|1|||
146852335|NCT05383508|529627883|FG004|Overall Study|Withdrawal by Subject|2|||
146852336|NCT05383508|529627884|FG005|Overall Study|Withdrawal by Subject|0|||
146852337|NCT03775434|529627886|FG000|Overall Study|Adverse Event|2|||
146852338|NCT03775434|529627886|FG000|Overall Study|Withdrawal by Subject|1|||
146852339|NCT01621568|529627887|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
146852340|NCT01621568|529627888|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
146852341|NCT01621568|529627887|FG000|Week 5-6 No Treatment|Death|1|||
146852342|NCT01621568|529627888|FG001|Week 5-6 No Treatment|Death|0|||
146852343|NCT01859988|529627889|FG000|Overall Study|Withdrawal by Subject|6|||
146852344|NCT01859988|529627890|FG001|Overall Study|Withdrawal by Subject|3|||
146852345|NCT01859988|529627891|FG002|Overall Study|Withdrawal by Subject|4|||
146852346|NCT01859988|529627892|FG003|Overall Study|Withdrawal by Subject|3|||
146852347|NCT01859988|529627893|FG004|Overall Study|Withdrawal by Subject|2|||
146852348|NCT01859988|529627894|FG005|Overall Study|Withdrawal by Subject|2|||
146852349|NCT01859988|529627889|FG000|Overall Study|Lack of Efficacy|1|||
146852350|NCT01859988|529627890|FG001|Overall Study|Lack of Efficacy|1|||
146852351|NCT01859988|529627891|FG002|Overall Study|Lack of Efficacy|5|||
146852352|NCT01859988|529627892|FG003|Overall Study|Lack of Efficacy|0|||
146852353|NCT01859988|529627893|FG004|Overall Study|Lack of Efficacy|7|||
146852354|NCT01859988|529627894|FG005|Overall Study|Lack of Efficacy|9|||
146852355|NCT01859988|529627889|FG000|Overall Study|Physician Decision|1|||
146852356|NCT01859988|529627890|FG001|Overall Study|Physician Decision|3|||
146852357|NCT01859988|529627891|FG002|Overall Study|Physician Decision|1|||
146852358|NCT01859988|529627892|FG003|Overall Study|Physician Decision|3|||
146852359|NCT01859988|529627893|FG004|Overall Study|Physician Decision|4|||
146852360|NCT01859988|529627894|FG005|Overall Study|Physician Decision|1|||
146852361|NCT01859988|529627889|FG000|Overall Study|Adverse Event|2|||
146852362|NCT01859988|529627890|FG001|Overall Study|Adverse Event|1|||
146852363|NCT01859988|529627891|FG002|Overall Study|Adverse Event|3|||
146852364|NCT01859988|529627892|FG003|Overall Study|Adverse Event|1|||
146852365|NCT01859988|529627893|FG004|Overall Study|Adverse Event|2|||
146852366|NCT01859988|529627894|FG005|Overall Study|Adverse Event|2|||
146852367|NCT01859988|529627889|FG000|Overall Study|Lost to Follow-up|1|||
146852368|NCT01859988|529627890|FG001|Overall Study|Lost to Follow-up|2|||
146852369|NCT01859988|529627891|FG002|Overall Study|Lost to Follow-up|3|||
146852370|NCT01859988|529627892|FG003|Overall Study|Lost to Follow-up|0|||
146852371|NCT01859988|529627893|FG004|Overall Study|Lost to Follow-up|3|||
146852372|NCT01859988|529627894|FG005|Overall Study|Lost to Follow-up|2|||
146852373|NCT01859988|529627889|FG000|Overall Study|Protocol Violation|0|||
146852374|NCT01859988|529627890|FG001|Overall Study|Protocol Violation|0|||
146852375|NCT01859988|529627891|FG002|Overall Study|Protocol Violation|1|||
146852376|NCT01859988|529627892|FG003|Overall Study|Protocol Violation|0|||
146852377|NCT01859988|529627893|FG004|Overall Study|Protocol Violation|0|||
146852378|NCT01859988|529627894|FG005|Overall Study|Protocol Violation|0|||
146852379|NCT01859988|529627889|FG000|Overall Study|Other than specified above|0|||
146852380|NCT01859988|529627890|FG001|Overall Study|Other than specified above|2|||
146852381|NCT01859988|529627891|FG002|Overall Study|Other than specified above|11|||
146852382|NCT01859988|529627892|FG003|Overall Study|Other than specified above|3|||
146852383|NCT01859988|529627893|FG004|Overall Study|Other than specified above|5|||
146852384|NCT01859988|529627894|FG005|Overall Study|Other than specified above|3|||
146852385|NCT02081417|529627895|FG000|Overall Study|Lost to Follow-up|26|||
146852386|NCT02081417|529627896|FG001|Overall Study|Lost to Follow-up|23|||
146852387|NCT02081417|529627895|FG000|Overall Study|Moved Away|1|||
146852388|NCT02081417|529627896|FG001|Overall Study|Moved Away|2|||
146852389|NCT02081417|529627895|FG000|Overall Study|Incarcerated|2|||
146852390|NCT02081417|529627896|FG001|Overall Study|Incarcerated|2|||
146852391|NCT02081417|529627895|FG000|Overall Study|Death|4|||
146852392|NCT02081417|529627896|FG001|Overall Study|Death|3|||
146754050|NCT02253316|529266027|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
146754051|NCT02253316|529266028|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
146754052|NCT02253316|529266029|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
146754053|NCT02253316|529266027|FG000|Maintenance|Physician Decision|0|||
146754054|NCT02253316|529266028|FG001|Maintenance|Physician Decision|7|||
146754055|NCT02253316|529266029|FG002|Maintenance|Physician Decision|16|||
146754056|NCT02253316|529266027|FG000|Maintenance|Non-Compliance|0|||
146754057|NCT02253316|529266028|FG001|Maintenance|Non-Compliance|1|||
146754058|NCT02253316|529266029|FG002|Maintenance|Non-Compliance|1|||
146754059|NCT02253316|529266027|FG000|Maintenance|Secondary Malignancy|0|||
146754060|NCT02253316|529266028|FG001|Maintenance|Secondary Malignancy|2|||
146754061|NCT02253316|529266029|FG002|Maintenance|Secondary Malignancy|6|||
146754062|NCT02253316|529266027|FG000|Maintenance|Adverse Event|0|||
146754063|NCT02253316|529266028|FG001|Maintenance|Adverse Event|8|||
146754064|NCT02253316|529266029|FG002|Maintenance|Adverse Event|12|||
146754065|NCT02253316|529266027|FG000|Maintenance|Still receiving active treatment|0|||
146754066|NCT02253316|529266028|FG001|Maintenance|Still receiving active treatment|4|||
146754067|NCT02253316|529266029|FG002|Maintenance|Still receiving active treatment|0|||
146754068|NCT02353832|529266030|FG000|Overall Study|Ineligible after enrollment|1|||
146754069|NCT02353832|529266030|FG000|Overall Study|Lost to Follow-up|1|||
146754070|NCT02684903|529266031|FG000|Overall Study|COVID-19 shutdown of lab|4|||
146754071|NCT02684903|529266032|FG001|Overall Study|COVID-19 shutdown of lab|6|||
146754072|NCT02684903|529266031|FG000|Overall Study|Lost to Follow-up|31|||
146754073|NCT02684903|529266032|FG001|Overall Study|Lost to Follow-up|41|||
146754074|NCT00731042|529267960|FG000|Second Intervention|Did not meet inclusion criteria|0|||
146754075|NCT00731042|529267961|FG001|Second Intervention|Did not meet inclusion criteria|2|||
146754076|NCT00802841|529267970|FG000|Overall Study|Administrative problems|1|||
146754077|NCT00802841|529267971|FG001|Overall Study|Administrative problems|0|||
146754078|NCT00802841|529267970|FG000|Overall Study|Lost to Follow-up|2|||
146754079|NCT00802841|529267971|FG001|Overall Study|Lost to Follow-up|1|||
146754080|NCT00802841|529267970|FG000|Overall Study|Death|1|||
146754081|NCT00802841|529267971|FG001|Overall Study|Death|2|||
146754082|NCT00802841|529267970|FG000|Overall Study|Adverse Event|8|||
146754083|NCT00802841|529267971|FG001|Overall Study|Adverse Event|2|||
146754084|NCT00802841|529267970|FG000|Overall Study|Disease progression|7|||
146754085|NCT00802841|529267971|FG001|Overall Study|Disease progression|3|||
146754086|NCT00802841|529267970|FG000|Overall Study|Withdrawal by Subject|9|||
146754087|NCT00802841|529267971|FG001|Overall Study|Withdrawal by Subject|5|||
146754088|NCT00802841|529267970|FG000|Overall Study|Protocol deviation|2|||
146754089|NCT00802841|529267971|FG001|Overall Study|Protocol deviation|6|||
146754090|NCT00802841|529267970|FG000|Overall Study|Treatment duration completed|66|||
146754091|NCT00802841|529267971|FG001|Overall Study|Treatment duration completed|76|||
146754092|NCT00432159|529267974|FG000|Overall Study|Death|0|||
146754093|NCT00432159|529267975|FG001|Overall Study|Death|1|||
146754094|NCT00432159|529267976|FG002|Overall Study|Death|0|||
146754095|NCT00432159|529267977|FG003|Overall Study|Death|0|||
146754096|NCT00432159|529267978|FG004|Overall Study|Death|0|||
146754097|NCT00432159|529267974|FG000|Overall Study|Failure|9|||
146754098|NCT00432159|529267975|FG001|Overall Study|Failure|5|||
146754099|NCT00432159|529267976|FG002|Overall Study|Failure|3|||
146754100|NCT00432159|529267977|FG003|Overall Study|Failure|2|||
146754101|NCT00432159|529267978|FG004|Overall Study|Failure|3|||
146754102|NCT00432159|529267974|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
146754103|NCT00432159|529267975|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
146754104|NCT00432159|529267976|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
146754105|NCT00432159|529267977|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
146754106|NCT00432159|529267978|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
146754107|NCT04096365|529267980|FG000|Overall Study|Adverse Event|1|||
146754108|NCT01939158|529267983|FG000|Overall Study|Adverse Event|1|||
146754109|NCT01939158|529267984|FG001|Overall Study|Adverse Event|0|||
146754110|NCT01939158|529267985|FG002|Overall Study|Adverse Event|0|||
146754111|NCT01939158|529267986|FG003|Overall Study|Adverse Event|0|||
146754112|NCT01939158|529267983|FG000|Overall Study|Withdrawal by Subject|22|||
146754113|NCT01939158|529267984|FG001|Overall Study|Withdrawal by Subject|25|||
146754114|NCT01939158|529267985|FG002|Overall Study|Withdrawal by Subject|15|||
146754115|NCT01939158|529267986|FG003|Overall Study|Withdrawal by Subject|17|||
146754116|NCT01939158|529267983|FG000|Overall Study|Migrated/moved from study area|5|||
146754117|NCT01939158|529267984|FG001|Overall Study|Migrated/moved from study area|7|||
146754118|NCT01939158|529267985|FG002|Overall Study|Migrated/moved from study area|3|||
146754119|NCT01939158|529267986|FG003|Overall Study|Migrated/moved from study area|6|||
146754120|NCT01939158|529267983|FG000|Overall Study|Lost to Follow-up|18|||
146754121|NCT01939158|529267984|FG001|Overall Study|Lost to Follow-up|17|||
146754122|NCT01939158|529267985|FG002|Overall Study|Lost to Follow-up|17|||
146754123|NCT01939158|529267986|FG003|Overall Study|Lost to Follow-up|17|||
146754124|NCT01939158|529267983|FG000|Overall Study|Death|0|||
146754125|NCT01939158|529267984|FG001|Overall Study|Death|0|||
146754126|NCT01939158|529267985|FG002|Overall Study|Death|1|||
146754127|NCT01939158|529267986|FG003|Overall Study|Death|1|||
146754128|NCT01939158|529267983|FG000|Overall Study|No longer meets eligibility criteria|0|||
146754129|NCT01939158|529267984|FG001|Overall Study|No longer meets eligibility criteria|0|||
146754130|NCT01939158|529267985|FG002|Overall Study|No longer meets eligibility criteria|1|||
146754131|NCT01939158|529267986|FG003|Overall Study|No longer meets eligibility criteria|0|||
146754132|NCT01939158|529267983|FG000|Overall Study|Other|1|||
146754133|NCT01939158|529267984|FG001|Overall Study|Other|3|||
146754134|NCT01939158|529267985|FG002|Overall Study|Other|4|||
146852393|NCT02081417|529627895|FG000|Overall Study|Withdrawal by Subject|4|||
146852394|NCT02081417|529627896|FG001|Overall Study|Withdrawal by Subject|0|||
146852395|NCT02081417|529627895|FG000|Overall Study|Admitted to Residential Treatment|2|||
146852396|NCT02081417|529627896|FG001|Overall Study|Admitted to Residential Treatment|0|||
146852397|NCT02081417|529627895|FG000|Overall Study|Did not start treatment|17|||
146852398|NCT02081417|529627896|FG001|Overall Study|Did not start treatment|21|||
146754135|NCT01939158|529267986|FG003|Overall Study|Other|3|||
146754136|NCT05310084|529267987|FG000|Overall Study|Withdrawal by Subject|2|||
146754137|NCT05310084|529267988|FG001|Overall Study|Withdrawal by Subject|3|||
146754138|NCT05310084|529267987|FG000|Overall Study|Participant availability|0|||
146754139|NCT05310084|529267988|FG001|Overall Study|Participant availability|4|||
146754140|NCT05310084|529267987|FG000|Overall Study|Lost to Follow-up|1|||
146754141|NCT05310084|529267988|FG001|Overall Study|Lost to Follow-up|1|||
146754142|NCT05310084|529267987|FG000|Overall Study|Adverse Event|1|||
146754143|NCT05310084|529267988|FG001|Overall Study|Adverse Event|1|||
146754144|NCT05310084|529267987|FG000|Overall Study|Randomized but not vaccinated|4|||
146754145|NCT05310084|529267988|FG001|Overall Study|Randomized but not vaccinated|2|||
146754146|NCT02065245|529267990|FG000|Infusion 1|Lost to Follow-up|0|||
146852399|NCT01157676|529627900|FG000|Randomization|Death|1|||
146852400|NCT01157676|529627901|FG001|Randomization|Death|1|||
146754147|NCT02065245|529267991|FG001|Infusion 1|Lost to Follow-up|0|||
146754148|NCT02065245|529267992|FG002|Infusion 1|Lost to Follow-up|0|||
146754149|NCT02065245|529267993|FG003|Infusion 1|Lost to Follow-up|0|||
146754150|NCT02065245|529267994|FG004|Infusion 1|Lost to Follow-up|0|||
146754151|NCT02065245|529267995|FG005|Infusion 1|Lost to Follow-up|0|||
146754152|NCT02065245|529267996|FG006|Infusion 1|Lost to Follow-up|1|||
146754153|NCT02065245|529267990|FG000|Infusion 1|Death|0|||
146754154|NCT02065245|529267991|FG001|Infusion 1|Death|0|||
146754155|NCT02065245|529267992|FG002|Infusion 1|Death|1|||
146754156|NCT02065245|529267993|FG003|Infusion 1|Death|0|||
146754157|NCT02065245|529267994|FG004|Infusion 1|Death|1|||
146754158|NCT02065245|529267995|FG005|Infusion 1|Death|0|||
146754159|NCT02065245|529267996|FG006|Infusion 1|Death|0|||
146754160|NCT02065245|529267990|FG000|Infusion 2|Death|0|||
146754161|NCT02065245|529267991|FG001|Infusion 2|Death|0|||
146754162|NCT02065245|529267992|FG002|Infusion 2|Death|0|||
146754163|NCT02065245|529267993|FG003|Infusion 2|Death|0|||
146754164|NCT02065245|529267994|FG004|Infusion 2|Death|0|||
146754165|NCT02065245|529267995|FG005|Infusion 2|Death|0|||
146754166|NCT02065245|529267996|FG006|Infusion 2|Death|1|||
146754167|NCT02065245|529267990|FG000|Infusion 3|Lost to Follow-up|1|||
146754168|NCT02065245|529267991|FG001|Infusion 3|Lost to Follow-up|1|||
146754169|NCT02065245|529267992|FG002|Infusion 3|Lost to Follow-up|0|||
146754170|NCT02065245|529267993|FG003|Infusion 3|Lost to Follow-up|0|||
146754171|NCT02065245|529267994|FG004|Infusion 3|Lost to Follow-up|0|||
146754172|NCT02065245|529267995|FG005|Infusion 3|Lost to Follow-up|0|||
146754173|NCT02065245|529267996|FG006|Infusion 3|Lost to Follow-up|0|||
146754174|NCT01518257|529267997|FG000|Overall Study|Lost to Follow-up|1|||
146754175|NCT01518257|529267998|FG001|Overall Study|Lost to Follow-up|0|||
146754176|NCT01518257|529267997|FG000|Overall Study|Other Miscellaneous Reason|1|||
146754177|NCT01518257|529267998|FG001|Overall Study|Other Miscellaneous Reason|0|||
146754178|NCT01460381|529268001|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
146754179|NCT01460381|529268002|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
146754180|NCT01033643|529268004|FG000|Overall Study|Withdrew Consent|0|||
146754181|NCT01033643|529268005|FG001|Overall Study|Withdrew Consent|3|||
146754182|NCT01033643|529268006|FG002|Overall Study|Withdrew Consent|0|||
146754183|NCT01033643|529268007|FG003|Overall Study|Withdrew Consent|0|||
146754184|NCT01033643|529268008|FG004|Overall Study|Withdrew Consent|0|||
146754185|NCT01033643|529268009|FG005|Overall Study|Withdrew Consent|1|||
146754186|NCT03527277|529268010|FG000|Overall Study|Withdrawal by Subject|5|||
146754187|NCT03527277|529268011|FG001|Overall Study|Withdrawal by Subject|0|||
146754188|NCT03527277|529268010|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
146754189|NCT03527277|529268011|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
146852401|NCT01157676|529627900|FG000|Randomization|unresectable|2|||
146754190|NCT03527277|529268010|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
146754191|NCT03527277|529268011|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
146852402|NCT01157676|529627901|FG001|Randomization|unresectable|3|||
146852403|NCT01157676|529627900|FG000|Randomization|Withdrawal by Subject|17|||
146852404|NCT01157676|529627901|FG001|Randomization|Withdrawal by Subject|13|||
146852405|NCT01157676|529627900|FG000|Randomization|Physician Decision|1|||
146852406|NCT01157676|529627901|FG001|Randomization|Physician Decision|0|||
146852407|NCT01157676|529627900|FG000|Surgery|underwent open cystectomy|0|||
146852408|NCT01157676|529627901|FG001|Surgery|underwent open cystectomy|4|||
146852409|NCT01157676|529627900|FG000|Surgery|converted to open procedure|0|||
146852410|NCT01157676|529627901|FG001|Surgery|converted to open procedure|5|||
146852411|NCT01157676|529627900|FG000|Surgery|underwent robotic cystectomy|1|||
146852412|NCT01157676|529627901|FG001|Surgery|underwent robotic cystectomy|0|||
146852413|NCT00682890|529627902|FG000|Overall Study|Lost to Follow-up|1|||
146852414|NCT00682890|529627903|FG001|Overall Study|Lost to Follow-up|1|||
146852415|NCT00682890|529627902|FG000|Overall Study|subject moved away|0|||
146852416|NCT00682890|529627903|FG001|Overall Study|subject moved away|1|||
146852417|NCT00682890|529627902|FG000|Overall Study|heavy menstrual bleeding|1|||
146852418|NCT00682890|529627903|FG001|Overall Study|heavy menstrual bleeding|0|||
146852419|NCT00141219|529627907|FG000|Overall Study|Protocol violations|5|||
146852420|NCT00141219|529627908|FG001|Overall Study|Protocol violations|4|||
146852421|NCT00141219|529627907|FG000|Overall Study|Adverse Event|8|||
146852422|NCT00141219|529627908|FG001|Overall Study|Adverse Event|6|||
146852423|NCT00141219|529627907|FG000|Overall Study|Lack of Efficacy|5|||
146852424|NCT00141219|529627908|FG001|Overall Study|Lack of Efficacy|4|||
146852425|NCT00141219|529627907|FG000|Overall Study|Withdrawal by Subject|6|||
146852426|NCT00141219|529627908|FG001|Overall Study|Withdrawal by Subject|2|||
146852427|NCT01506609|529627909|FG000|Overall Study|Adverse Event Related to Progression|0|||
146852428|NCT01506609|529627910|FG001|Overall Study|Adverse Event Related to Progression|0|||
146852429|NCT01506609|529627911|FG002|Overall Study|Adverse Event Related to Progression|0|||
146852430|NCT01506609|529627912|FG003|Overall Study|Adverse Event Related to Progression|3|||
146852431|NCT01506609|529627913|FG004|Overall Study|Adverse Event Related to Progression|7|||
146852432|NCT01506609|529627914|FG005|Overall Study|Adverse Event Related to Progression|3|||
146852433|NCT01506609|529627909|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
146852434|NCT01506609|529627910|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
146852435|NCT01506609|529627911|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
146852436|NCT01506609|529627912|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
146852437|NCT01506609|529627913|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
146852438|NCT01506609|529627914|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
146852439|NCT01506609|529627909|FG000|Overall Study|Withdrawal by Subject|0|||
146852440|NCT01506609|529627910|FG001|Overall Study|Withdrawal by Subject|0|||
146852441|NCT01506609|529627911|FG002|Overall Study|Withdrawal by Subject|0|||
146852442|NCT01506609|529627912|FG003|Overall Study|Withdrawal by Subject|9|||
146852443|NCT01506609|529627913|FG004|Overall Study|Withdrawal by Subject|7|||
146852444|NCT01506609|529627914|FG005|Overall Study|Withdrawal by Subject|7|||
146852445|NCT01506609|529627909|FG000|Overall Study|Lost to Follow-up|0|||
146852446|NCT01506609|529627910|FG001|Overall Study|Lost to Follow-up|0|||
146852447|NCT01506609|529627911|FG002|Overall Study|Lost to Follow-up|0|||
146852448|NCT01506609|529627912|FG003|Overall Study|Lost to Follow-up|1|||
146852449|NCT01506609|529627913|FG004|Overall Study|Lost to Follow-up|2|||
146852450|NCT01506609|529627914|FG005|Overall Study|Lost to Follow-up|0|||
146852451|NCT01506609|529627909|FG000|Overall Study|Sponsor Discontinued Study|0|||
146852452|NCT01506609|529627910|FG001|Overall Study|Sponsor Discontinued Study|0|||
146852453|NCT01506609|529627911|FG002|Overall Study|Sponsor Discontinued Study|0|||
146852454|NCT01506609|529627912|FG003|Overall Study|Sponsor Discontinued Study|2|||
146512359|NCT02943785|528379203|FG000|Overall Study|Physician Decision|23|||
146512360|NCT02943785|528379204|FG001|Overall Study|Physician Decision|47|||
146512361|NCT02943785|528379203|FG000|Overall Study|Death|46|||
146512362|NCT02943785|528379204|FG001|Overall Study|Death|46|||
146512363|NCT02943785|528379203|FG000|Overall Study|Lost to Follow-up|1|||
146512364|NCT02943785|528379204|FG001|Overall Study|Lost to Follow-up|0|||
146512365|NCT02943785|528379203|FG000|Overall Study|Other|16|||
146512366|NCT02943785|528379204|FG001|Overall Study|Other|19|||
146512367|NCT02943785|528379203|FG000|Overall Study|Did not receive any study medication|21|||
146512368|NCT02943785|528379204|FG001|Overall Study|Did not receive any study medication|28|||
146512369|NCT03313310|528379206|FG000|Phase 2|Lost to Follow-up|4|||
146512370|NCT03313310|528379207|FG001|Phase 2|Lost to Follow-up|0|||
146512371|NCT03313310|528379206|FG000|Phase 3|Lost to Follow-up|0|||
146512372|NCT03313310|528379207|FG001|Phase 3|Lost to Follow-up|1|||
146512373|NCT03170609|528379208|FG000|Overall Study|Death|0|||
146852455|NCT01506609|529627913|FG004|Overall Study|Sponsor Discontinued Study|2|||
146852456|NCT01506609|529627914|FG005|Overall Study|Sponsor Discontinued Study|0|||
146852457|NCT01506609|529627909|FG000|Overall Study|Progressive Disease per Protocol|1|||
146852458|NCT01506609|529627910|FG001|Overall Study|Progressive Disease per Protocol|0|||
146852459|NCT01506609|529627911|FG002|Overall Study|Progressive Disease per Protocol|0|||
146512374|NCT03170609|528379209|FG001|Overall Study|Death|0|||
146512375|NCT03170609|528379210|FG002|Overall Study|Death|1|||
146512376|NCT03170609|528379211|FG003|Overall Study|Death|0|||
146754192|NCT02652130|529268016|FG000|Overall Study|Death|1|||
146754193|NCT03930186|529268017|FG000|Weeks 0 to 16|Adverse Event|6|||
146754194|NCT03930186|529268017|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
146754195|NCT03930186|529268017|FG000|Weeks 16 to 32|Adverse Event|1|||
146754196|NCT03930186|529268017|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
146754197|NCT02013687|529268031|FG000|Overall Study|Lost to Follow-up|0|||
146754198|NCT02013687|529268032|FG001|Overall Study|Lost to Follow-up|0|||
146754199|NCT02013687|529268033|FG002|Overall Study|Lost to Follow-up|1|||
146754200|NCT02013687|529268034|FG003|Overall Study|Lost to Follow-up|0|||
146754201|NCT02013687|529268031|FG000|Overall Study|Protocol Violation|0|||
146754202|NCT02013687|529268032|FG001|Overall Study|Protocol Violation|0|||
146754203|NCT02013687|529268033|FG002|Overall Study|Protocol Violation|0|||
146754204|NCT02013687|529268034|FG003|Overall Study|Protocol Violation|1|||
146754205|NCT02013687|529268031|FG000|Overall Study|Withdrawal by Subject|0|||
146754206|NCT02013687|529268032|FG001|Overall Study|Withdrawal by Subject|0|||
146754207|NCT02013687|529268033|FG002|Overall Study|Withdrawal by Subject|0|||
146754208|NCT02013687|529268034|FG003|Overall Study|Withdrawal by Subject|1|||
146754209|NCT02013687|529268031|FG000|Overall Study|Missed visits due to patient travel|0|||
146754210|NCT02013687|529268032|FG001|Overall Study|Missed visits due to patient travel|0|||
146754211|NCT02013687|529268033|FG002|Overall Study|Missed visits due to patient travel|1|||
146754212|NCT02013687|529268034|FG003|Overall Study|Missed visits due to patient travel|0|||
146754213|NCT01782326|529268035|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
146754214|NCT01782326|529268036|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
146754215|NCT01782326|529268035|FG000|Planned Treatment Epoch|Death|29|||
146754216|NCT01782326|529268036|FG001|Planned Treatment Epoch|Death|30|||
146754217|NCT01782326|529268035|FG000|Planned Treatment Epoch|Physician Decision|18|||
146754218|NCT01782326|529268036|FG001|Planned Treatment Epoch|Physician Decision|16|||
146754219|NCT01782326|529268035|FG000|Planned Treatment Epoch|Protocol deviation|2|||
146754220|NCT01782326|529268036|FG001|Planned Treatment Epoch|Protocol deviation|3|||
146754221|NCT01782326|529268035|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
146754222|NCT01782326|529268036|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
146754223|NCT01782326|529268035|FG000|Planned Treatment Epoch|Technical problems|0|||
146754224|NCT01782326|529268036|FG001|Planned Treatment Epoch|Technical problems|4|||
146754225|NCT01782326|529268035|FG000|Double-blind Treatment|Adverse Event|129|||
146754226|NCT01782326|529268036|FG001|Double-blind Treatment|Adverse Event|145|||
146754227|NCT01782326|529268035|FG000|Double-blind Treatment|Subject/guardian decision|111|||
146754228|NCT01782326|529268036|FG001|Double-blind Treatment|Subject/guardian decision|125|||
146754229|NCT01782326|529268035|FG000|Double-blind Treatment|Lack of Efficacy|17|||
146754230|NCT01782326|529268036|FG001|Double-blind Treatment|Lack of Efficacy|22|||
146754231|NCT01782326|529268035|FG000|Double-blind Treatment|Physician Decision|13|||
146754232|NCT01782326|529268036|FG001|Double-blind Treatment|Physician Decision|16|||
146754233|NCT01782326|529268035|FG000|Double-blind Treatment|Protocol deviation|8|||
146754234|NCT01782326|529268036|FG001|Double-blind Treatment|Protocol deviation|7|||
146754235|NCT01782326|529268035|FG000|Double-blind Treatment|Technical problems|0|||
146754236|NCT01782326|529268036|FG001|Double-blind Treatment|Technical problems|5|||
146754237|NCT02559817|529268037|FG000|Treatment Period|Adverse Event|1|||
146754238|NCT02559817|529268038|FG001|Treatment Period|Adverse Event|0|||
146754239|NCT02559817|529268039|FG002|Treatment Period|Adverse Event|1|||
146754240|NCT02559817|529268040|FG003|Treatment Period|Adverse Event|0|||
146754241|NCT02559817|529268041|FG004|Treatment Period|Adverse Event|0|||
146852460|NCT01506609|529627912|FG003|Overall Study|Progressive Disease per Protocol|64|||
146852461|NCT01506609|529627913|FG004|Overall Study|Progressive Disease per Protocol|57|||
146754242|NCT02559817|529268037|FG000|Treatment Period|Lack of Efficacy|0|||
146754243|NCT02559817|529268038|FG001|Treatment Period|Lack of Efficacy|1|||
146754244|NCT02559817|529268039|FG002|Treatment Period|Lack of Efficacy|0|||
146754245|NCT02559817|529268040|FG003|Treatment Period|Lack of Efficacy|0|||
146754246|NCT02559817|529268041|FG004|Treatment Period|Lack of Efficacy|0|||
146754247|NCT02559817|529268037|FG000|Treatment Period|Lost to Follow-up|0|||
146754248|NCT02559817|529268038|FG001|Treatment Period|Lost to Follow-up|1|||
146754249|NCT02559817|529268039|FG002|Treatment Period|Lost to Follow-up|0|||
146754250|NCT02559817|529268040|FG003|Treatment Period|Lost to Follow-up|1|||
146754251|NCT02559817|529268041|FG004|Treatment Period|Lost to Follow-up|0|||
146754252|NCT02559817|529268037|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
146754253|NCT02559817|529268038|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
146754254|NCT02559817|529268039|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
146754255|NCT02559817|529268040|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
146754256|NCT02559817|529268041|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
146754257|NCT02559817|529268037|FG000|Treatment Period|Protocol Violation|0|||
146754258|NCT02559817|529268038|FG001|Treatment Period|Protocol Violation|0|||
146754259|NCT02559817|529268039|FG002|Treatment Period|Protocol Violation|0|||
146754260|NCT02559817|529268040|FG003|Treatment Period|Protocol Violation|1|||
146754261|NCT02559817|529268041|FG004|Treatment Period|Protocol Violation|0|||
146512377|NCT03170609|528379212|FG004|Overall Study|Death|0|||
146512378|NCT03170609|528379213|FG005|Overall Study|Death|0|||
146512379|NCT03170609|528379214|FG006|Overall Study|Death|0|||
146512380|NCT03170609|528379208|FG000|Overall Study|Withdrawal by Subject|1|||
146512381|NCT03170609|528379209|FG001|Overall Study|Withdrawal by Subject|2|||
146512382|NCT03170609|528379210|FG002|Overall Study|Withdrawal by Subject|0|||
146512383|NCT03170609|528379211|FG003|Overall Study|Withdrawal by Subject|0|||
146512384|NCT03170609|528379212|FG004|Overall Study|Withdrawal by Subject|0|||
146512385|NCT03170609|528379213|FG005|Overall Study|Withdrawal by Subject|0|||
146512386|NCT03170609|528379214|FG006|Overall Study|Withdrawal by Subject|1|||
146512387|NCT03170609|528379208|FG000|Overall Study|Lost to Follow-up|1|||
146512388|NCT03170609|528379209|FG001|Overall Study|Lost to Follow-up|0|||
146512389|NCT03170609|528379210|FG002|Overall Study|Lost to Follow-up|5|||
146512390|NCT03170609|528379211|FG003|Overall Study|Lost to Follow-up|2|||
146512391|NCT03170609|528379212|FG004|Overall Study|Lost to Follow-up|1|||
146512392|NCT03170609|528379213|FG005|Overall Study|Lost to Follow-up|1|||
146512393|NCT03170609|528379214|FG006|Overall Study|Lost to Follow-up|0|||
146512394|NCT03170609|528379208|FG000|Overall Study|Other|1|||
146512395|NCT03170609|528379209|FG001|Overall Study|Other|0|||
146512396|NCT03170609|528379210|FG002|Overall Study|Other|0|||
146512397|NCT03170609|528379211|FG003|Overall Study|Other|0|||
146512398|NCT03170609|528379212|FG004|Overall Study|Other|0|||
146512399|NCT03170609|528379213|FG005|Overall Study|Other|1|||
146512400|NCT03170609|528379214|FG006|Overall Study|Other|0|||
146512401|NCT01281956|528379215|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
146512402|NCT01281956|528379216|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
146512403|NCT01593254|528379220|FG000|Overall Study|Disease progression|2|||
146512404|NCT01593254|528379221|FG001|Overall Study|Disease progression|7|||
146512405|NCT01593254|528379220|FG000|Overall Study|Study drug toxicity|6|||
146512406|NCT01593254|528379221|FG001|Overall Study|Study drug toxicity|20|||
146512407|NCT01593254|528379220|FG000|Overall Study|Death|3|||
146512408|NCT01593254|528379221|FG001|Overall Study|Death|3|||
146512409|NCT01593254|528379220|FG000|Overall Study|AE unrelated to study drug|0|||
146512410|NCT01593254|528379221|FG001|Overall Study|AE unrelated to study drug|1|||
146512411|NCT01593254|528379220|FG000|Overall Study|participant request to discontinue study treatment|1|||
146512412|NCT01593254|528379221|FG001|Overall Study|participant request to discontinue study treatment|3|||
146512413|NCT01593254|528379220|FG000|Overall Study|participant withdrew consent|0|||
146512414|NCT01593254|528379221|FG001|Overall Study|participant withdrew consent|9|||
146512415|NCT01593254|528379220|FG000|Overall Study|lost to follow up|1|||
146512416|NCT01593254|528379221|FG001|Overall Study|lost to follow up|6|||
146512417|NCT01593254|528379220|FG000|Overall Study|maximum clinical benefit|1|||
146512418|NCT01593254|528379221|FG001|Overall Study|maximum clinical benefit|2|||
146512419|NCT01593254|528379220|FG000|Overall Study|Poor/non compliance|1|||
146512420|NCT01593254|528379221|FG001|Overall Study|Poor/non compliance|1|||
146512421|NCT01593254|528379220|FG000|Overall Study|Pregnancy|0|||
146512422|NCT01593254|528379221|FG001|Overall Study|Pregnancy|3|||
146512423|NCT01593254|528379220|FG000|Overall Study|participant no longer meets study criteria|1|||
146512424|NCT01593254|528379221|FG001|Overall Study|participant no longer meets study criteria|1|||
146512425|NCT01593254|528379220|FG000|Overall Study|Admin reason by sponsor|7|||
146512426|NCT01593254|528379221|FG001|Overall Study|Admin reason by sponsor|3|||
146512427|NCT01593254|528379220|FG000|Overall Study|Imatinib treatment failure|2|||
146512428|NCT01593254|528379221|FG001|Overall Study|Imatinib treatment failure|0|||
146512429|NCT01593254|528379220|FG000|Overall Study|Other Reasons|61|||
146512430|NCT01593254|528379221|FG001|Overall Study|Other Reasons|115|||
146512431|NCT00791492|528379224|FG000|Overall Study|Withdrawal by Subject|1|||
146512432|NCT00791492|528379225|FG001|Overall Study|Withdrawal by Subject|2|||
146512433|NCT00791492|528379224|FG000|Overall Study|Liver transplantation|5|||
146512434|NCT00791492|528379225|FG001|Overall Study|Liver transplantation|1|||
146754262|NCT03389893|529268042|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
146754263|NCT03389893|529268043|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
146754264|NCT03389893|529268044|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
146754265|NCT03389893|529268045|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
146754266|NCT03389893|529268042|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
146512435|NCT01217385|528379226|FG000|Overall Study|Withdrawal by Subject|3|||
146512436|NCT01217385|528379226|FG000|Overall Study|DOSI not performed/not eval|12|||
146512437|NCT01217385|528379226|FG000|Overall Study|Central Path not Available|1|||
146512438|NCT01217385|528379226|FG000|Overall Study|Normal Breast TOI not available|10|||
146512439|NCT03482167|528379228|FG000|Allocated to Intervention|Physician Decision|1|||
146512440|NCT03482167|528379229|FG001|Allocated to Intervention|Physician Decision|2|||
146512441|NCT03482167|528379228|FG000|Received Intervention|Adverse Event|3|||
146512442|NCT03482167|528379229|FG001|Received Intervention|Adverse Event|1|||
146754267|NCT03389893|529268043|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
146512443|NCT03482167|528379228|FG000|Received Intervention|Physician Decision|1|||
146512444|NCT03482167|528379229|FG001|Received Intervention|Physician Decision|1|||
146512445|NCT03482167|528379228|FG000|Received Intervention|Withdrawal by Subject|1|||
146512446|NCT03482167|528379229|FG001|Received Intervention|Withdrawal by Subject|0|||
146512447|NCT02168777|528381201|FG000|Overall Study|Withdrawal by Subject|1|||
146512448|NCT02168777|528381202|FG001|Overall Study|Withdrawal by Subject|0|||
146512449|NCT02168777|528381203|FG002|Overall Study|Withdrawal by Subject|2|||
146512450|NCT02168777|528381201|FG000|Overall Study|Adverse Event|1|||
146512451|NCT02168777|528381202|FG001|Overall Study|Adverse Event|0|||
146512452|NCT02168777|528381203|FG002|Overall Study|Adverse Event|1|||
146512453|NCT02168777|528381201|FG000|Overall Study|Disease recurrence|0|||
146512454|NCT02168777|528381202|FG001|Overall Study|Disease recurrence|0|||
146512455|NCT02168777|528381203|FG002|Overall Study|Disease recurrence|1|||
146512456|NCT02168777|528381201|FG000|Overall Study|Radiological disease progression|0|||
146512457|NCT02168777|528381202|FG001|Overall Study|Radiological disease progression|5|||
146512458|NCT02168777|528381203|FG002|Overall Study|Radiological disease progression|5|||
146512459|NCT02168777|528381201|FG000|Overall Study|Clinical disease progression|0|||
146512460|NCT02168777|528381202|FG001|Overall Study|Clinical disease progression|1|||
146512461|NCT02168777|528381203|FG002|Overall Study|Clinical disease progression|2|||
146512462|NCT02168777|528381201|FG000|Overall Study|Other reason|0|||
146512463|NCT02168777|528381202|FG001|Overall Study|Other reason|1|||
146512464|NCT02168777|528381203|FG002|Overall Study|Other reason|0|||
146512465|NCT01663857|528381204|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
146512466|NCT01663857|528381205|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
146512467|NCT01663857|528381206|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
146512468|NCT01663857|528381207|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
146512469|NCT01663857|528381204|FG000|Overall Study|Lost to Follow-up|0|||
146512470|NCT01663857|528381205|FG001|Overall Study|Lost to Follow-up|0|||
146512471|NCT01663857|528381206|FG002|Overall Study|Lost to Follow-up|3|||
146512472|NCT01663857|528381207|FG003|Overall Study|Lost to Follow-up|1|||
146512473|NCT03774394|528381208|FG000|Overall Study|Withdrawal by Subject|2|||
146512474|NCT03774394|528381209|FG001|Overall Study|Withdrawal by Subject|0|||
146512475|NCT00994214|528381210|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
146512476|NCT00994214|528381211|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
146512477|NCT00994214|528381212|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
146512478|NCT00994214|528381213|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
146512479|NCT00994214|528381210|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
146512480|NCT00994214|528381211|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
146512481|NCT00994214|528381212|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
146512482|NCT00994214|528381213|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
146512483|NCT00994214|528381210|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
146512484|NCT00994214|528381211|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
146512485|NCT00994214|528381212|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
146512486|NCT00994214|528381213|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
146512487|NCT00994214|528381210|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
146512488|NCT00994214|528381211|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
146512489|NCT00994214|528381212|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
146512490|NCT00994214|528381213|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
146512491|NCT00994214|528381210|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
146512492|NCT00994214|528381211|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
146512493|NCT00994214|528381212|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
146512494|NCT00994214|528381213|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
146512495|NCT00994214|528381210|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
146512496|NCT00994214|528381211|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
146512497|NCT00994214|528381212|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
146512498|NCT00994214|528381213|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
146512499|NCT05940077|528381218|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
146512500|NCT00388297|528381219|FG000|Overall Study|Lost to Follow-up|16|||
146512501|NCT00388297|528381220|FG001|Overall Study|Lost to Follow-up|12|||
146512502|NCT00388297|528381221|FG002|Overall Study|Lost to Follow-up|11|||
146512503|NCT00388297|528381222|FG003|Overall Study|Lost to Follow-up|8|||
146512504|NCT04105010|528381226|FG000|Overall Study|Death|3|||
146754268|NCT03389893|529268044|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
146754269|NCT03389893|529268045|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
146754270|NCT03389893|529268042|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
146754271|NCT03389893|529268043|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
146754272|NCT03389893|529268044|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
146754273|NCT03389893|529268045|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
146512505|NCT04105010|528381227|FG001|Overall Study|Death|1|||
146512506|NCT04105010|528381228|FG002|Overall Study|Death|1|||
146512507|NCT04105010|528381229|FG003|Overall Study|Death|54|||
146512508|NCT04105010|528381226|FG000|Overall Study|Lost to Follow-up|0|||
146512509|NCT04105010|528381227|FG001|Overall Study|Lost to Follow-up|0|||
146754274|NCT03389893|529268042|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
146512510|NCT04105010|528381228|FG002|Overall Study|Lost to Follow-up|0|||
146512511|NCT04105010|528381229|FG003|Overall Study|Lost to Follow-up|4|||
146512512|NCT04105010|528381226|FG000|Overall Study|Withdrawal by Subject|8|||
146512513|NCT04105010|528381227|FG001|Overall Study|Withdrawal by Subject|1|||
146512514|NCT04105010|528381228|FG002|Overall Study|Withdrawal by Subject|1|||
146754275|NCT03389893|529268043|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
146754276|NCT03389893|529268044|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
146754277|NCT03389893|529268045|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
146754278|NCT00388362|529268048|FG000|Enrolled|Ineligible|1|||
146754279|NCT00388362|529268048|FG000|Enrolled|Adverse Event|9|||
146754280|NCT00388362|529268048|FG000|Enrolled|Death|1|||
146754281|NCT00388362|529268048|FG000|Enrolled|Loss insurance|1|||
146754282|NCT00388362|529268048|FG000|Enrolled|Withdrawal by Subject|1|||
146754283|NCT00388362|529268048|FG000|Remained on Study Median of 514 Days|Death|2|||
146754284|NCT02335268|529268049|FG000|Overall Study|Physician Decision|5|||
146754285|NCT02335268|529268050|FG001|Overall Study|Physician Decision|1|||
146754286|NCT02335268|529268049|FG000|Overall Study|Lack of Efficacy|2|||
146754287|NCT02335268|529268050|FG001|Overall Study|Lack of Efficacy|1|||
146754288|NCT02335268|529268049|FG000|Overall Study|Adverse Event|5|||
146754289|NCT02335268|529268050|FG001|Overall Study|Adverse Event|2|||
146754290|NCT02335268|529268049|FG000|Overall Study|increase blasts|2|||
146754291|NCT02335268|529268050|FG001|Overall Study|increase blasts|0|||
146754292|NCT02335268|529268049|FG000|Overall Study|Withdrawal by Subject|3|||
146754293|NCT02335268|529268050|FG001|Overall Study|Withdrawal by Subject|2|||
146754294|NCT03160079|529268053|FG000|Overall Study|Adverse Event|2|||
146754295|NCT03160079|529268054|FG001|Overall Study|Adverse Event|0|||
146754296|NCT03160079|529268053|FG000|Overall Study|Disease Progression|1|||
146754297|NCT03160079|529268054|FG001|Overall Study|Disease Progression|0|||
146754298|NCT03160079|529268053|FG000|Overall Study|Physician Decision|1|||
146754299|NCT03160079|529268054|FG001|Overall Study|Physician Decision|0|||
146852462|NCT01506609|529627914|FG005|Overall Study|Progressive Disease per Protocol|74|||
146754300|NCT05893797|529268055|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
146754301|NCT05893797|529268055|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
146754302|NCT05893797|529268055|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
146852463|NCT01506609|529627909|FG000|Overall Study|Other, Not Specified|0|||
146512515|NCT04105010|528381229|FG003|Overall Study|Withdrawal by Subject|4|||
146512516|NCT04105010|528381226|FG000|Overall Study|Other reason|4|||
146512517|NCT04105010|528381227|FG001|Overall Study|Other reason|7|||
146512518|NCT04105010|528381228|FG002|Overall Study|Other reason|0|||
146512519|NCT04105010|528381229|FG003|Overall Study|Other reason|19|||
146512520|NCT03570554|528381232|FG000|Overall Study|Non-compliance with study drug|0|||
146512521|NCT03570554|528381233|FG001|Overall Study|Non-compliance with study drug|0|||
146512522|NCT03570554|528381234|FG002|Overall Study|Non-compliance with study drug|1|||
146512523|NCT03570554|528381235|FG003|Overall Study|Non-compliance with study drug|0|||
146512524|NCT03570554|528381232|FG000|Overall Study|Adverse Event|0|||
146512525|NCT03570554|528381233|FG001|Overall Study|Adverse Event|0|||
146512526|NCT03570554|528381234|FG002|Overall Study|Adverse Event|0|||
146512527|NCT03570554|528381235|FG003|Overall Study|Adverse Event|1|||
146512528|NCT03114657|528381250|FG000|Overall Study|Adverse Event|9|||
146512529|NCT03114657|528381251|FG001|Overall Study|Adverse Event|6|||
146512530|NCT03114657|528381250|FG000|Overall Study|Death|4|||
146512531|NCT03114657|528381251|FG001|Overall Study|Death|0|||
146512532|NCT03114657|528381250|FG000|Overall Study|Multiple Reasons|1|||
146512533|NCT03114657|528381251|FG001|Overall Study|Multiple Reasons|2|||
146512534|NCT03114657|528381250|FG000|Overall Study|Physician Decision|2|||
146512535|NCT03114657|528381251|FG001|Overall Study|Physician Decision|2|||
146512536|NCT03114657|528381250|FG000|Overall Study|Study Terminated By Sponsor|355|||
146512537|NCT03114657|528381251|FG001|Overall Study|Study Terminated By Sponsor|374|||
146512538|NCT03114657|528381250|FG000|Overall Study|Symptomatic Deterioration|0|||
146512539|NCT03114657|528381251|FG001|Overall Study|Symptomatic Deterioration|1|||
146512540|NCT03114657|528381250|FG000|Overall Study|Withdrawal by Subject|28|||
146512541|NCT03114657|528381251|FG001|Overall Study|Withdrawal by Subject|22|||
146512542|NCT00115037|528381252|FG000|Phase1|Lost to Follow-up|16|||
146512543|NCT00115037|528381253|FG001|Phase1|Lost to Follow-up|23|||
146754303|NCT05893797|529268055|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
146754304|NCT04770220|529268056|FG000|Overall Study|Adverse Event|2|||
146754305|NCT04770220|529268057|FG001|Overall Study|Adverse Event|11|||
146754306|NCT04770220|529268056|FG000|Overall Study|Withdrawal by Subject|5|||
146754307|NCT04770220|529268057|FG001|Overall Study|Withdrawal by Subject|11|||
146754308|NCT04770220|529268056|FG000|Overall Study|Lost to Follow-up|4|||
146754309|NCT04770220|529268057|FG001|Overall Study|Lost to Follow-up|3|||
146754310|NCT04770220|529268056|FG000|Overall Study|not otherwise specified|2|||
146754311|NCT04770220|529268057|FG001|Overall Study|not otherwise specified|3|||
146754312|NCT04770220|529268056|FG000|Overall Study|Physician Decision|1|||
146754313|NCT04770220|529268057|FG001|Overall Study|Physician Decision|3|||
146754314|NCT04955626|529268058|FG000|Blinded Period|Lost to Follow-up|28|||
146754315|NCT04955626|529268059|FG001|Blinded Period|Lost to Follow-up|28|||
146754316|NCT04955626|529268060|FG002|Blinded Period|Lost to Follow-up|7|||
146754317|NCT04955626|529268061|FG003|Blinded Period|Lost to Follow-up|14|||
146754318|NCT04955626|529268062|FG004|Blinded Period|Lost to Follow-up|3|||
146512544|NCT00115037|528381254|FG002|Phase1|Lost to Follow-up|0|||
146512545|NCT00115037|528381255|FG003|Phase1|Lost to Follow-up|0|||
146754319|NCT04955626|529268063|FG005|Blinded Period|Lost to Follow-up|2|||
146754320|NCT04955626|529268064|FG006|Blinded Period|Lost to Follow-up|6|||
146754321|NCT04955626|529268065|FG007|Blinded Period|Lost to Follow-up|4|||
146754322|NCT04955626|529268066|FG008|Blinded Period|Lost to Follow-up|5|||
146754323|NCT04955626|529268067|FG009|Blinded Period|Lost to Follow-up|8|||
146754324|NCT04955626|529268068|FG010|Blinded Period|Lost to Follow-up|10|||
146754325|NCT04955626|529268069|FG011|Blinded Period|Lost to Follow-up|32|||
146754326|NCT04955626|529268070|FG012|Blinded Period|Lost to Follow-up|0|||
146754327|NCT04955626|529268071|FG013|Blinded Period|Lost to Follow-up|0|||
146754328|NCT04955626|529268072|FG014|Blinded Period|Lost to Follow-up|0|||
146754329|NCT04955626|529268073|FG015|Blinded Period|Lost to Follow-up|12|||
146754330|NCT04955626|529268074|FG016|Blinded Period|Lost to Follow-up|2|||
146754331|NCT04955626|529268075|FG017|Blinded Period|Lost to Follow-up|5|||
146852464|NCT01506609|529627910|FG001|Overall Study|Other, Not Specified|0|||
146512546|NCT00115037|528381256|FG004|Phase1|Lost to Follow-up|0|||
146512547|NCT00115037|528381257|FG005|Phase1|Lost to Follow-up|0|||
146512548|NCT00115037|528381252|FG000|Phase1|Withdrawal by Subject|9|||
146512549|NCT00115037|528381253|FG001|Phase1|Withdrawal by Subject|4|||
146512550|NCT00115037|528381254|FG002|Phase1|Withdrawal by Subject|0|||
146512551|NCT00115037|528381255|FG003|Phase1|Withdrawal by Subject|0|||
146512552|NCT00115037|528381256|FG004|Phase1|Withdrawal by Subject|0|||
146512553|NCT00115037|528381257|FG005|Phase1|Withdrawal by Subject|0|||
146512554|NCT00115037|528381252|FG000|Phase2|Death|0|||
146512555|NCT00115037|528381253|FG001|Phase2|Death|0|||
146512556|NCT00115037|528381254|FG002|Phase2|Death|1|||
146512557|NCT00115037|528381255|FG003|Phase2|Death|0|||
146512558|NCT00115037|528381256|FG004|Phase2|Death|0|||
146512559|NCT00115037|528381257|FG005|Phase2|Death|1|||
146512560|NCT00115037|528381252|FG000|Phase2|Withdrawal by Subject|0|||
146512561|NCT00115037|528381253|FG001|Phase2|Withdrawal by Subject|0|||
146512562|NCT00115037|528381254|FG002|Phase2|Withdrawal by Subject|2|||
146512563|NCT00115037|528381255|FG003|Phase2|Withdrawal by Subject|1|||
146512564|NCT00115037|528381256|FG004|Phase2|Withdrawal by Subject|2|||
146512565|NCT00115037|528381257|FG005|Phase2|Withdrawal by Subject|1|||
146512566|NCT00115037|528381252|FG000|Phase2|Lost to Follow-up|0|||
146512567|NCT00115037|528381253|FG001|Phase2|Lost to Follow-up|0|||
146512568|NCT00115037|528381254|FG002|Phase2|Lost to Follow-up|12|||
146512569|NCT00115037|528381255|FG003|Phase2|Lost to Follow-up|14|||
146754332|NCT04955626|529268076|FG018|Blinded Period|Lost to Follow-up|0|||
146754333|NCT04955626|529268077|FG019|Blinded Period|Lost to Follow-up|0|||
146852465|NCT01506609|529627911|FG002|Overall Study|Other, Not Specified|0|||
146852466|NCT01506609|529627912|FG003|Overall Study|Other, Not Specified|10|||
146852467|NCT01506609|529627913|FG004|Overall Study|Other, Not Specified|7|||
146512570|NCT00115037|528381256|FG004|Phase2|Lost to Follow-up|4|||
146754334|NCT04955626|529268078|FG020|Blinded Period|Lost to Follow-up|0|||
146754335|NCT04955626|529268079|FG021|Blinded Period|Lost to Follow-up|0|||
146754336|NCT04955626|529268080|FG022|Blinded Period|Lost to Follow-up|0|||
146754337|NCT04955626|529268081|FG023|Blinded Period|Lost to Follow-up|0|||
146754338|NCT04955626|529268082|FG024|Blinded Period|Lost to Follow-up|3|||
146754339|NCT04955626|529268083|FG025|Blinded Period|Lost to Follow-up|1|||
146754340|NCT04955626|529268084|FG026|Blinded Period|Lost to Follow-up|2|||
146754341|NCT04955626|529268085|FG027|Blinded Period|Lost to Follow-up|2|||
146754342|NCT04955626|529268086|FG028|Blinded Period|Lost to Follow-up|2|||
146754343|NCT04955626|529268087|FG029|Blinded Period|Lost to Follow-up|0|||
146754344|NCT04955626|529268088|FG030|Blinded Period|Lost to Follow-up|0|||
146754345|NCT04955626|529268089|FG031|Blinded Period|Lost to Follow-up|0|||
146754346|NCT04955626|529268090|FG032|Blinded Period|Lost to Follow-up|0|||
146754347|NCT04955626|529268091|FG033|Blinded Period|Lost to Follow-up|0|||
146754348|NCT04955626|529268092|FG034|Blinded Period|Lost to Follow-up|0|||
146754349|NCT04955626|529268093|FG035|Blinded Period|Lost to Follow-up|0|||
146754350|NCT04955626|529268058|FG000|Blinded Period|Protocol Violation|5|||
146754351|NCT04955626|529268059|FG001|Blinded Period|Protocol Violation|14|||
146754352|NCT04955626|529268060|FG002|Blinded Period|Protocol Violation|0|||
146754353|NCT04955626|529268061|FG003|Blinded Period|Protocol Violation|1|||
146754354|NCT04955626|529268062|FG004|Blinded Period|Protocol Violation|2|||
146754355|NCT04955626|529268063|FG005|Blinded Period|Protocol Violation|2|||
146754356|NCT04955626|529268064|FG006|Blinded Period|Protocol Violation|0|||
146754357|NCT04955626|529268065|FG007|Blinded Period|Protocol Violation|0|||
146754358|NCT04955626|529268066|FG008|Blinded Period|Protocol Violation|0|||
146754359|NCT04955626|529268067|FG009|Blinded Period|Protocol Violation|4|||
146754360|NCT04955626|529268068|FG010|Blinded Period|Protocol Violation|6|||
146754361|NCT04955626|529268069|FG011|Blinded Period|Protocol Violation|1|||
146754362|NCT04955626|529268070|FG012|Blinded Period|Protocol Violation|0|||
146754363|NCT04955626|529268071|FG013|Blinded Period|Protocol Violation|0|||
146754364|NCT04955626|529268072|FG014|Blinded Period|Protocol Violation|2|||
146754365|NCT04955626|529268073|FG015|Blinded Period|Protocol Violation|6|||
146754366|NCT04955626|529268074|FG016|Blinded Period|Protocol Violation|4|||
146754367|NCT04955626|529268075|FG017|Blinded Period|Protocol Violation|6|||
146754368|NCT04955626|529268076|FG018|Blinded Period|Protocol Violation|0|||
146512571|NCT00115037|528381257|FG005|Phase2|Lost to Follow-up|10|||
146512572|NCT01179737|528381258|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
146512573|NCT01179737|528381259|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
146512574|NCT01179737|528381260|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
146512575|NCT01179737|528381261|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
146512576|NCT01179737|528381258|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
146512577|NCT01179737|528381259|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
146754369|NCT04955626|529268077|FG019|Blinded Period|Protocol Violation|1|||
146754370|NCT04955626|529268078|FG020|Blinded Period|Protocol Violation|0|||
146754371|NCT04955626|529268079|FG021|Blinded Period|Protocol Violation|1|||
146754372|NCT04955626|529268080|FG022|Blinded Period|Protocol Violation|0|||
146754373|NCT04955626|529268081|FG023|Blinded Period|Protocol Violation|0|||
146754374|NCT04955626|529268082|FG024|Blinded Period|Protocol Violation|4|||
146754375|NCT04955626|529268083|FG025|Blinded Period|Protocol Violation|6|||
146754376|NCT04955626|529268084|FG026|Blinded Period|Protocol Violation|5|||
146754377|NCT04955626|529268085|FG027|Blinded Period|Protocol Violation|3|||
146754378|NCT04955626|529268086|FG028|Blinded Period|Protocol Violation|4|||
146512578|NCT01179737|528381260|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
146512579|NCT01179737|528381261|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
146512580|NCT01179737|528381258|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
146512581|NCT01179737|528381259|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
146512582|NCT01179737|528381260|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
146512583|NCT01179737|528381261|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
146512584|NCT01179737|528381258|FG000|Cohort 1 & Cohort 2|Death|0|||
146512585|NCT01179737|528381259|FG001|Cohort 1 & Cohort 2|Death|0|||
146512586|NCT01179737|528381260|FG002|Cohort 1 & Cohort 2|Death|1|||
146512587|NCT01179737|528381261|FG003|Cohort 1 & Cohort 2|Death|0|||
146512588|NCT01179737|528381258|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
146512589|NCT01179737|528381259|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
146512590|NCT01179737|528381260|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
146512591|NCT01179737|528381261|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
146512592|NCT01179737|528381258|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
146512593|NCT01179737|528381259|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
146512594|NCT01179737|528381260|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
146512595|NCT01179737|528381261|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
146512596|NCT01179737|528381258|FG000|Extension|The study was terminated|3|||
146512597|NCT01179737|528381259|FG001|Extension|The study was terminated|0|||
146512598|NCT01179737|528381260|FG002|Extension|The study was terminated|0|||
146512599|NCT01179737|528381261|FG003|Extension|The study was terminated|0|||
146512600|NCT01398410|528381262|FG000|Overall Study|Adverse Event|12|||
146512601|NCT01398410|528381263|FG001|Overall Study|Adverse Event|16|||
146512602|NCT01398410|528381262|FG000|Overall Study|Participants Choice|8|||
146512603|NCT01398410|528381263|FG001|Overall Study|Participants Choice|11|||
146512604|NCT01398410|528381262|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
146512605|NCT01398410|528381263|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
146512606|NCT01398410|528381262|FG000|Overall Study|Other|36|||
146512607|NCT01398410|528381263|FG001|Overall Study|Other|29|||
146512608|NCT00717275|528381264|FG000|Overall Study|Premature study termination.|3|||
146512609|NCT00424021|528381266|FG000|NCT00046319 Study Period|Adverse Event|1|||
146512610|NCT00424021|528381267|FG001|NCT00046319 Study Period|Adverse Event|0|||
146512611|NCT00424021|528381268|FG002|NCT00046319 Study Period|Adverse Event|1|||
146512612|NCT00424021|528381269|FG003|NCT00046319 Study Period|Adverse Event|1|||
146512613|NCT00424021|528381266|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
146512614|NCT00424021|528381267|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
146512615|NCT00424021|528381268|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
146512616|NCT00424021|528381269|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
146512617|NCT00424021|528381266|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
146512618|NCT00424021|528381267|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
146512619|NCT00424021|528381268|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
146512620|NCT00424021|528381269|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
146754379|NCT04955626|529268087|FG029|Blinded Period|Protocol Violation|3|||
146754380|NCT04955626|529268088|FG030|Blinded Period|Protocol Violation|0|||
146754381|NCT04955626|529268089|FG031|Blinded Period|Protocol Violation|0|||
146754382|NCT04955626|529268090|FG032|Blinded Period|Protocol Violation|0|||
146754383|NCT04955626|529268091|FG033|Blinded Period|Protocol Violation|0|||
146754384|NCT04955626|529268092|FG034|Blinded Period|Protocol Violation|0|||
146754385|NCT04955626|529268093|FG035|Blinded Period|Protocol Violation|0|||
146754386|NCT04955626|529268058|FG000|Blinded Period|Death|0|||
146754387|NCT04955626|529268059|FG001|Blinded Period|Death|2|||
146754388|NCT04955626|529268060|FG002|Blinded Period|Death|0|||
146754389|NCT04955626|529268061|FG003|Blinded Period|Death|0|||
146754390|NCT04955626|529268062|FG004|Blinded Period|Death|0|||
146754391|NCT04955626|529268063|FG005|Blinded Period|Death|0|||
146754392|NCT04955626|529268064|FG006|Blinded Period|Death|0|||
146754393|NCT04955626|529268065|FG007|Blinded Period|Death|2|||
146754394|NCT04955626|529268066|FG008|Blinded Period|Death|1|||
146754395|NCT04955626|529268067|FG009|Blinded Period|Death|1|||
146754396|NCT04955626|529268068|FG010|Blinded Period|Death|0|||
146852468|NCT01506609|529627914|FG005|Overall Study|Other, Not Specified|3|||
146512621|NCT00424021|528381266|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
146512622|NCT00424021|528381267|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
146512623|NCT00424021|528381268|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
146512624|NCT00424021|528381269|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
146512625|NCT00424021|528381266|FG000|AMB-220-E Study Period|Adverse Event|1|||
146512626|NCT00424021|528381267|FG001|AMB-220-E Study Period|Adverse Event|1|||
146512627|NCT00424021|528381268|FG002|AMB-220-E Study Period|Adverse Event|3|||
146512628|NCT00424021|528381269|FG003|AMB-220-E Study Period|Adverse Event|7|||
146512629|NCT00424021|528381266|FG000|AMB-220-E Study Period|Death|0|||
146754397|NCT04955626|529268069|FG011|Blinded Period|Death|2|||
146754398|NCT04955626|529268070|FG012|Blinded Period|Death|0|||
146754399|NCT04955626|529268071|FG013|Blinded Period|Death|0|||
146754400|NCT04955626|529268072|FG014|Blinded Period|Death|0|||
146754401|NCT04955626|529268073|FG015|Blinded Period|Death|0|||
146754402|NCT04955626|529268074|FG016|Blinded Period|Death|0|||
146512630|NCT00424021|528381267|FG001|AMB-220-E Study Period|Death|0|||
146512631|NCT00424021|528381268|FG002|AMB-220-E Study Period|Death|1|||
146512632|NCT00424021|528381269|FG003|AMB-220-E Study Period|Death|1|||
146512633|NCT00424021|528381266|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
146754403|NCT04955626|529268075|FG017|Blinded Period|Death|0|||
146754404|NCT04955626|529268076|FG018|Blinded Period|Death|0|||
146754405|NCT04955626|529268077|FG019|Blinded Period|Death|0|||
146754406|NCT04955626|529268078|FG020|Blinded Period|Death|0|||
146754407|NCT04955626|529268079|FG021|Blinded Period|Death|0|||
146754408|NCT04955626|529268080|FG022|Blinded Period|Death|0|||
146754409|NCT04955626|529268081|FG023|Blinded Period|Death|1|||
146754410|NCT04955626|529268082|FG024|Blinded Period|Death|0|||
146754411|NCT04955626|529268083|FG025|Blinded Period|Death|0|||
146754412|NCT04955626|529268084|FG026|Blinded Period|Death|1|||
146754413|NCT04955626|529268085|FG027|Blinded Period|Death|1|||
146754414|NCT04955626|529268086|FG028|Blinded Period|Death|0|||
146754415|NCT04955626|529268087|FG029|Blinded Period|Death|1|||
146754416|NCT04955626|529268088|FG030|Blinded Period|Death|0|||
146754417|NCT04955626|529268089|FG031|Blinded Period|Death|0|||
146754418|NCT04955626|529268090|FG032|Blinded Period|Death|0|||
146754419|NCT04955626|529268091|FG033|Blinded Period|Death|0|||
146754420|NCT04955626|529268092|FG034|Blinded Period|Death|0|||
146754421|NCT04955626|529268093|FG035|Blinded Period|Death|0|||
146754422|NCT04955626|529268058|FG000|Blinded Period|Adverse Event|0|||
146754423|NCT04955626|529268059|FG001|Blinded Period|Adverse Event|1|||
146754424|NCT04955626|529268060|FG002|Blinded Period|Adverse Event|1|||
146754425|NCT04955626|529268061|FG003|Blinded Period|Adverse Event|1|||
146754426|NCT04955626|529268062|FG004|Blinded Period|Adverse Event|0|||
146754427|NCT04955626|529268063|FG005|Blinded Period|Adverse Event|0|||
146754428|NCT04955626|529268064|FG006|Blinded Period|Adverse Event|0|||
146754429|NCT04955626|529268065|FG007|Blinded Period|Adverse Event|0|||
146754430|NCT04955626|529268066|FG008|Blinded Period|Adverse Event|0|||
146754431|NCT04955626|529268067|FG009|Blinded Period|Adverse Event|1|||
146754432|NCT04955626|529268068|FG010|Blinded Period|Adverse Event|1|||
146754433|NCT04955626|529268069|FG011|Blinded Period|Adverse Event|0|||
146754434|NCT04955626|529268070|FG012|Blinded Period|Adverse Event|0|||
146754435|NCT04955626|529268071|FG013|Blinded Period|Adverse Event|0|||
146754436|NCT04955626|529268072|FG014|Blinded Period|Adverse Event|0|||
146754437|NCT04955626|529268073|FG015|Blinded Period|Adverse Event|0|||
146754438|NCT04955626|529268074|FG016|Blinded Period|Adverse Event|0|||
146754439|NCT04955626|529268075|FG017|Blinded Period|Adverse Event|0|||
146754440|NCT04955626|529268076|FG018|Blinded Period|Adverse Event|1|||
146754441|NCT04955626|529268077|FG019|Blinded Period|Adverse Event|0|||
146754442|NCT04955626|529268078|FG020|Blinded Period|Adverse Event|0|||
146754443|NCT04955626|529268079|FG021|Blinded Period|Adverse Event|0|||
146754444|NCT04955626|529268080|FG022|Blinded Period|Adverse Event|0|||
146754445|NCT04955626|529268081|FG023|Blinded Period|Adverse Event|0|||
146754446|NCT04955626|529268082|FG024|Blinded Period|Adverse Event|0|||
146754447|NCT04955626|529268083|FG025|Blinded Period|Adverse Event|0|||
146754448|NCT04955626|529268084|FG026|Blinded Period|Adverse Event|1|||
146754449|NCT04955626|529268085|FG027|Blinded Period|Adverse Event|0|||
146754450|NCT04955626|529268086|FG028|Blinded Period|Adverse Event|0|||
146754451|NCT04955626|529268087|FG029|Blinded Period|Adverse Event|0|||
146754452|NCT04955626|529268088|FG030|Blinded Period|Adverse Event|0|||
146754453|NCT04955626|529268089|FG031|Blinded Period|Adverse Event|0|||
146754454|NCT04955626|529268090|FG032|Blinded Period|Adverse Event|0|||
146754455|NCT04955626|529268091|FG033|Blinded Period|Adverse Event|0|||
146754456|NCT04955626|529268092|FG034|Blinded Period|Adverse Event|0|||
146754457|NCT04955626|529268093|FG035|Blinded Period|Adverse Event|0|||
146754458|NCT04955626|529268058|FG000|Blinded Period|No longer meets eligibility criteria|1|||
146754459|NCT04955626|529268059|FG001|Blinded Period|No longer meets eligibility criteria|2|||
146754460|NCT04955626|529268060|FG002|Blinded Period|No longer meets eligibility criteria|0|||
146754461|NCT04955626|529268061|FG003|Blinded Period|No longer meets eligibility criteria|1|||
146852469|NCT01506609|529627909|FG000|Overall Study|Missing / Unknown Reason|1|||
146754462|NCT04955626|529268062|FG004|Blinded Period|No longer meets eligibility criteria|0|||
146512634|NCT00424021|528381267|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
146512635|NCT00424021|528381268|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
146754463|NCT04955626|529268063|FG005|Blinded Period|No longer meets eligibility criteria|0|||
146754464|NCT04955626|529268064|FG006|Blinded Period|No longer meets eligibility criteria|0|||
146754465|NCT04955626|529268065|FG007|Blinded Period|No longer meets eligibility criteria|0|||
146754466|NCT04955626|529268066|FG008|Blinded Period|No longer meets eligibility criteria|1|||
146754467|NCT04955626|529268067|FG009|Blinded Period|No longer meets eligibility criteria|0|||
146754468|NCT04955626|529268068|FG010|Blinded Period|No longer meets eligibility criteria|1|||
146754469|NCT04955626|529268069|FG011|Blinded Period|No longer meets eligibility criteria|1|||
146754470|NCT04955626|529268070|FG012|Blinded Period|No longer meets eligibility criteria|0|||
146754471|NCT04955626|529268071|FG013|Blinded Period|No longer meets eligibility criteria|0|||
146754472|NCT04955626|529268072|FG014|Blinded Period|No longer meets eligibility criteria|0|||
146852470|NCT01506609|529627910|FG001|Overall Study|Missing / Unknown Reason|0|||
146512636|NCT00424021|528381269|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
146754473|NCT04955626|529268073|FG015|Blinded Period|No longer meets eligibility criteria|3|||
146754474|NCT04955626|529268074|FG016|Blinded Period|No longer meets eligibility criteria|0|||
146754475|NCT04955626|529268075|FG017|Blinded Period|No longer meets eligibility criteria|2|||
146754476|NCT04955626|529268076|FG018|Blinded Period|No longer meets eligibility criteria|0|||
146754477|NCT04955626|529268077|FG019|Blinded Period|No longer meets eligibility criteria|0|||
146754478|NCT04955626|529268078|FG020|Blinded Period|No longer meets eligibility criteria|0|||
146754479|NCT04955626|529268079|FG021|Blinded Period|No longer meets eligibility criteria|0|||
146754480|NCT04955626|529268080|FG022|Blinded Period|No longer meets eligibility criteria|0|||
146754481|NCT04955626|529268081|FG023|Blinded Period|No longer meets eligibility criteria|0|||
146754482|NCT04955626|529268082|FG024|Blinded Period|No longer meets eligibility criteria|1|||
146754483|NCT04955626|529268083|FG025|Blinded Period|No longer meets eligibility criteria|0|||
146754484|NCT04955626|529268084|FG026|Blinded Period|No longer meets eligibility criteria|0|||
146754485|NCT04955626|529268085|FG027|Blinded Period|No longer meets eligibility criteria|1|||
146754486|NCT04955626|529268086|FG028|Blinded Period|No longer meets eligibility criteria|0|||
146754487|NCT04955626|529268087|FG029|Blinded Period|No longer meets eligibility criteria|0|||
146754488|NCT04955626|529268088|FG030|Blinded Period|No longer meets eligibility criteria|0|||
146754489|NCT04955626|529268089|FG031|Blinded Period|No longer meets eligibility criteria|0|||
146754490|NCT04955626|529268090|FG032|Blinded Period|No longer meets eligibility criteria|0|||
146754491|NCT04955626|529268091|FG033|Blinded Period|No longer meets eligibility criteria|0|||
146754492|NCT04955626|529268092|FG034|Blinded Period|No longer meets eligibility criteria|0|||
146754493|NCT04955626|529268093|FG035|Blinded Period|No longer meets eligibility criteria|0|||
146754494|NCT04955626|529268058|FG000|Blinded Period|Other|54|||
146754495|NCT04955626|529268059|FG001|Blinded Period|Other|3|||
146754496|NCT04955626|529268060|FG002|Blinded Period|Other|4|||
146754497|NCT04955626|529268061|FG003|Blinded Period|Other|2|||
146754498|NCT04955626|529268062|FG004|Blinded Period|Other|0|||
146754499|NCT04955626|529268063|FG005|Blinded Period|Other|0|||
146754500|NCT04955626|529268064|FG006|Blinded Period|Other|2|||
146754501|NCT04955626|529268065|FG007|Blinded Period|Other|2|||
146754502|NCT04955626|529268066|FG008|Blinded Period|Other|1|||
146754503|NCT04955626|529268067|FG009|Blinded Period|Other|0|||
146754504|NCT04955626|529268068|FG010|Blinded Period|Other|1|||
146754505|NCT04955626|529268069|FG011|Blinded Period|Other|1|||
146754506|NCT04955626|529268070|FG012|Blinded Period|Other|0|||
146754507|NCT04955626|529268071|FG013|Blinded Period|Other|0|||
146754508|NCT04955626|529268072|FG014|Blinded Period|Other|0|||
146512637|NCT00424021|528381266|FG000|AMB-220-E Study Period|Physician Decision|0|||
146512638|NCT00424021|528381267|FG001|AMB-220-E Study Period|Physician Decision|0|||
146512639|NCT00424021|528381268|FG002|AMB-220-E Study Period|Physician Decision|0|||
146512640|NCT00424021|528381269|FG003|AMB-220-E Study Period|Physician Decision|1|||
146512641|NCT01254721|528381270|FG000|Overall Study|Lost to Follow-up|0|||
146512642|NCT01254721|528381271|FG001|Overall Study|Lost to Follow-up|4|||
146512643|NCT01254721|528381270|FG000|Overall Study|Lack of Efficacy|4|||
146754509|NCT04955626|529268073|FG015|Blinded Period|Other|0|||
146754510|NCT04955626|529268074|FG016|Blinded Period|Other|0|||
146512644|NCT01254721|528381271|FG001|Overall Study|Lack of Efficacy|2|||
146754511|NCT04955626|529268075|FG017|Blinded Period|Other|1|||
146754512|NCT04955626|529268076|FG018|Blinded Period|Other|0|||
146754513|NCT04955626|529268077|FG019|Blinded Period|Other|0|||
146754514|NCT04955626|529268078|FG020|Blinded Period|Other|0|||
146512645|NCT01254721|528381270|FG000|Overall Study|Death|0|||
146512646|NCT01254721|528381271|FG001|Overall Study|Death|1|||
146754515|NCT04955626|529268079|FG021|Blinded Period|Other|0|||
146754516|NCT04955626|529268080|FG022|Blinded Period|Other|0|||
146754517|NCT04955626|529268081|FG023|Blinded Period|Other|0|||
146754518|NCT04955626|529268082|FG024|Blinded Period|Other|0|||
146754519|NCT04955626|529268083|FG025|Blinded Period|Other|0|||
146754520|NCT04955626|529268084|FG026|Blinded Period|Other|2|||
146754521|NCT04955626|529268085|FG027|Blinded Period|Other|0|||
146754522|NCT04955626|529268086|FG028|Blinded Period|Other|0|||
146512647|NCT01254721|528381270|FG000|Overall Study|technical problum|1|||
146512648|NCT01254721|528381271|FG001|Overall Study|technical problum|0|||
146512649|NCT01254721|528381270|FG000|Overall Study|Adverse Event|2|||
146512650|NCT01254721|528381271|FG001|Overall Study|Adverse Event|3|||
146512651|NCT01254721|528381270|FG000|Overall Study|Withdrawal by Subject|8|||
146512652|NCT01254721|528381271|FG001|Overall Study|Withdrawal by Subject|11|||
146512653|NCT01254721|528381270|FG000|Overall Study|Wrongly randomization|0|||
146512654|NCT01254721|528381271|FG001|Overall Study|Wrongly randomization|1|||
146512655|NCT03769194|528381272|FG000|Overall Study|Withdrawal by Subject|0|||
146512656|NCT03769194|528381273|FG001|Overall Study|Withdrawal by Subject|7|||
146512657|NCT03769194|528381274|FG002|Overall Study|Withdrawal by Subject|4|||
146512658|NCT03769194|528381275|FG003|Overall Study|Withdrawal by Subject|1|||
146512659|NCT03769194|528381272|FG000|Overall Study|moved from study area|0|||
146512660|NCT03769194|528381273|FG001|Overall Study|moved from study area|2|||
146512661|NCT03769194|528381274|FG002|Overall Study|moved from study area|1|||
146754523|NCT04955626|529268087|FG029|Blinded Period|Other|0|||
146754524|NCT04955626|529268088|FG030|Blinded Period|Other|0|||
146754525|NCT04955626|529268089|FG031|Blinded Period|Other|0|||
146754526|NCT04955626|529268090|FG032|Blinded Period|Other|0|||
146754527|NCT04955626|529268091|FG033|Blinded Period|Other|0|||
146754528|NCT04955626|529268092|FG034|Blinded Period|Other|0|||
146754529|NCT04955626|529268093|FG035|Blinded Period|Other|0|||
146754530|NCT04955626|529268058|FG000|Blinded Period|Physician Decision|1|||
146754531|NCT04955626|529268059|FG001|Blinded Period|Physician Decision|1|||
146754532|NCT04955626|529268060|FG002|Blinded Period|Physician Decision|0|||
146512662|NCT03769194|528381275|FG003|Overall Study|moved from study area|1|||
146512663|NCT03769194|528381272|FG000|Overall Study|Lost to Follow-up|3|||
146512664|NCT03769194|528381273|FG001|Overall Study|Lost to Follow-up|6|||
146512665|NCT03769194|528381274|FG002|Overall Study|Lost to Follow-up|3|||
146512666|NCT03769194|528381275|FG003|Overall Study|Lost to Follow-up|6|||
146512667|NCT03769194|528381272|FG000|Overall Study|other|1|||
146754533|NCT04955626|529268061|FG003|Blinded Period|Physician Decision|3|||
146754534|NCT04955626|529268062|FG004|Blinded Period|Physician Decision|0|||
146512668|NCT03769194|528381273|FG001|Overall Study|other|3|||
146512669|NCT03769194|528381274|FG002|Overall Study|other|0|||
146754535|NCT04955626|529268063|FG005|Blinded Period|Physician Decision|0|||
146754536|NCT04955626|529268064|FG006|Blinded Period|Physician Decision|1|||
146754537|NCT04955626|529268065|FG007|Blinded Period|Physician Decision|1|||
146754538|NCT04955626|529268066|FG008|Blinded Period|Physician Decision|0|||
146512670|NCT03769194|528381275|FG003|Overall Study|other|1|||
146512671|NCT03597022|528381276|FG000|Overall Study|Premature termination of the study|7|||
146512672|NCT03597022|528381277|FG001|Overall Study|Premature termination of the study|7|||
146512673|NCT03597022|528381278|FG002|Overall Study|Premature termination of the study|8|||
146512674|NCT03597022|528381276|FG000|Overall Study|Serious adverse event|1|||
146512675|NCT03597022|528381277|FG001|Overall Study|Serious adverse event|1|||
146512676|NCT03597022|528381278|FG002|Overall Study|Serious adverse event|0|||
146512677|NCT00553358|528381279|FG000|Overall Study|Randomized but did not receive treatment|3|||
146512678|NCT00553358|528381280|FG001|Overall Study|Randomized but did not receive treatment|3|||
146512679|NCT00553358|528381281|FG002|Overall Study|Randomized but did not receive treatment|1|||
146512680|NCT00553358|528381279|FG000|Overall Study|Lost to Follow-up|22|||
146512681|NCT00553358|528381280|FG001|Overall Study|Lost to Follow-up|26|||
146512682|NCT00553358|528381281|FG002|Overall Study|Lost to Follow-up|18|||
146512683|NCT00553358|528381279|FG000|Overall Study|Withdrew completely|23|||
146512684|NCT00553358|528381280|FG001|Overall Study|Withdrew completely|33|||
146512685|NCT00553358|528381281|FG002|Overall Study|Withdrew completely|34|||
146512686|NCT00553358|528381279|FG000|Overall Study|Died during clinical follow-up|25|||
146512687|NCT00553358|528381280|FG001|Overall Study|Died during clinical follow-up|29|||
146512688|NCT00553358|528381281|FG002|Overall Study|Died during clinical follow-up|32|||
146512689|NCT00553358|528381279|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
146512690|NCT00553358|528381280|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
146512691|NCT00553358|528381281|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
146512692|NCT00553358|528381279|FG000|Overall Study|Died after clinical follow-up ended|1|||
146512693|NCT00553358|528381280|FG001|Overall Study|Died after clinical follow-up ended|2|||
146512694|NCT00553358|528381281|FG002|Overall Study|Died after clinical follow-up ended|0|||
146512695|NCT00553358|528381279|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
146512696|NCT00553358|528381280|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
146512697|NCT00553358|528381281|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
146512698|NCT03013985|528381284|FG000|Overall Study|Protocol Violation|2|||
146512699|NCT03013985|528381285|FG001|Overall Study|Protocol Violation|2|||
146512700|NCT03013985|528381284|FG000|Overall Study|Withdrawal by Subject|14|||
146512701|NCT03013985|528381285|FG001|Overall Study|Withdrawal by Subject|17|||
146512702|NCT00076999|528381288|FG000|Overall Study|Adverse Event|2|||
146512703|NCT00076999|528381289|FG001|Overall Study|Adverse Event|8|||
146512704|NCT00076999|528381290|FG002|Overall Study|Adverse Event|6|||
146512705|NCT00076999|528381291|FG003|Overall Study|Adverse Event|0|||
146512706|NCT00076999|528381292|FG004|Overall Study|Adverse Event|2|||
146512707|NCT00076999|528381288|FG000|Overall Study|Protocol Violation|0|||
146512708|NCT00076999|528381289|FG001|Overall Study|Protocol Violation|3|||
146512709|NCT00076999|528381290|FG002|Overall Study|Protocol Violation|4|||
146512710|NCT00076999|528381291|FG003|Overall Study|Protocol Violation|0|||
146512711|NCT00076999|528381292|FG004|Overall Study|Protocol Violation|9|||
146512712|NCT00076999|528381288|FG000|Overall Study|Lost to Follow-up|2|||
146512713|NCT00076999|528381289|FG001|Overall Study|Lost to Follow-up|1|||
146512714|NCT00076999|528381290|FG002|Overall Study|Lost to Follow-up|0|||
146512715|NCT00076999|528381291|FG003|Overall Study|Lost to Follow-up|0|||
146512716|NCT00076999|528381292|FG004|Overall Study|Lost to Follow-up|0|||
146512717|NCT00076999|528381288|FG000|Overall Study|Withdrawal by Subject|0|||
146512718|NCT00076999|528381289|FG001|Overall Study|Withdrawal by Subject|4|||
146512719|NCT00076999|528381290|FG002|Overall Study|Withdrawal by Subject|3|||
146512720|NCT00076999|528381291|FG003|Overall Study|Withdrawal by Subject|0|||
146512721|NCT00076999|528381292|FG004|Overall Study|Withdrawal by Subject|1|||
146512722|NCT00076999|528381288|FG000|Overall Study|Other reason (not specified)|8|||
146512723|NCT00076999|528381289|FG001|Overall Study|Other reason (not specified)|8|||
146512724|NCT00076999|528381290|FG002|Overall Study|Other reason (not specified)|4|||
146754539|NCT04955626|529268067|FG009|Blinded Period|Physician Decision|0|||
146754540|NCT04955626|529268068|FG010|Blinded Period|Physician Decision|0|||
146754541|NCT04955626|529268069|FG011|Blinded Period|Physician Decision|5|||
146754542|NCT04955626|529268070|FG012|Blinded Period|Physician Decision|0|||
146754543|NCT04955626|529268071|FG013|Blinded Period|Physician Decision|0|||
146754544|NCT04955626|529268072|FG014|Blinded Period|Physician Decision|0|||
146512725|NCT00076999|528381291|FG003|Overall Study|Other reason (not specified)|1|||
146512726|NCT00076999|528381292|FG004|Overall Study|Other reason (not specified)|13|||
146512727|NCT00090987|528381295|FG000|Overall Study|Adverse Event|5|||
146512728|NCT00090987|528381295|FG000|Overall Study|Lack of Efficacy|7|||
146512729|NCT00090987|528381295|FG000|Overall Study|Withdrawal by Subject|3|||
146512730|NCT00090987|528381295|FG000|Overall Study|alternative therapy|1|||
146512731|NCT00090987|528381295|FG000|Overall Study|Non-compliance|4|||
146512732|NCT00090987|528381295|FG000|Overall Study|Incarcerated|1|||
146754545|NCT04955626|529268073|FG015|Blinded Period|Physician Decision|0|||
146754546|NCT04955626|529268074|FG016|Blinded Period|Physician Decision|0|||
146754547|NCT04955626|529268075|FG017|Blinded Period|Physician Decision|0|||
146754548|NCT04955626|529268076|FG018|Blinded Period|Physician Decision|0|||
146754549|NCT04955626|529268077|FG019|Blinded Period|Physician Decision|0|||
146754550|NCT04955626|529268078|FG020|Blinded Period|Physician Decision|0|||
146754551|NCT04955626|529268079|FG021|Blinded Period|Physician Decision|0|||
146754552|NCT04955626|529268080|FG022|Blinded Period|Physician Decision|0|||
146754553|NCT04955626|529268081|FG023|Blinded Period|Physician Decision|0|||
146754554|NCT04955626|529268082|FG024|Blinded Period|Physician Decision|0|||
146754555|NCT04955626|529268083|FG025|Blinded Period|Physician Decision|0|||
146754556|NCT04955626|529268084|FG026|Blinded Period|Physician Decision|0|||
146754557|NCT04955626|529268085|FG027|Blinded Period|Physician Decision|0|||
146754558|NCT04955626|529268086|FG028|Blinded Period|Physician Decision|0|||
146754559|NCT04955626|529268087|FG029|Blinded Period|Physician Decision|0|||
146754560|NCT04955626|529268088|FG030|Blinded Period|Physician Decision|0|||
146754561|NCT04955626|529268089|FG031|Blinded Period|Physician Decision|0|||
146754562|NCT04955626|529268090|FG032|Blinded Period|Physician Decision|0|||
146754563|NCT04955626|529268091|FG033|Blinded Period|Physician Decision|0|||
146754564|NCT04955626|529268092|FG034|Blinded Period|Physician Decision|0|||
146754565|NCT04955626|529268093|FG035|Blinded Period|Physician Decision|0|||
146754566|NCT04955626|529268058|FG000|Blinded Period|Withdrawal by Subject|26|||
146754567|NCT04955626|529268059|FG001|Blinded Period|Withdrawal by Subject|62|||
146754568|NCT04955626|529268060|FG002|Blinded Period|Withdrawal by Subject|14|||
146754569|NCT04955626|529268061|FG003|Blinded Period|Withdrawal by Subject|16|||
146754570|NCT04955626|529268062|FG004|Blinded Period|Withdrawal by Subject|1|||
146754571|NCT04955626|529268063|FG005|Blinded Period|Withdrawal by Subject|2|||
146754572|NCT04955626|529268064|FG006|Blinded Period|Withdrawal by Subject|9|||
146754573|NCT04955626|529268065|FG007|Blinded Period|Withdrawal by Subject|5|||
146754574|NCT04955626|529268066|FG008|Blinded Period|Withdrawal by Subject|3|||
146754575|NCT04955626|529268067|FG009|Blinded Period|Withdrawal by Subject|15|||
146754576|NCT04955626|529268068|FG010|Blinded Period|Withdrawal by Subject|11|||
146754577|NCT04955626|529268069|FG011|Blinded Period|Withdrawal by Subject|7|||
146754578|NCT04955626|529268070|FG012|Blinded Period|Withdrawal by Subject|2|||
146754579|NCT04955626|529268071|FG013|Blinded Period|Withdrawal by Subject|0|||
146754580|NCT04955626|529268072|FG014|Blinded Period|Withdrawal by Subject|1|||
146754581|NCT04955626|529268073|FG015|Blinded Period|Withdrawal by Subject|11|||
146754582|NCT04955626|529268074|FG016|Blinded Period|Withdrawal by Subject|2|||
146754583|NCT04955626|529268075|FG017|Blinded Period|Withdrawal by Subject|5|||
146754584|NCT04955626|529268076|FG018|Blinded Period|Withdrawal by Subject|0|||
146754585|NCT04955626|529268077|FG019|Blinded Period|Withdrawal by Subject|0|||
146754586|NCT04955626|529268078|FG020|Blinded Period|Withdrawal by Subject|1|||
146754587|NCT04955626|529268079|FG021|Blinded Period|Withdrawal by Subject|0|||
146852471|NCT01506609|529627911|FG002|Overall Study|Missing / Unknown Reason|1|||
146852472|NCT01506609|529627912|FG003|Overall Study|Missing / Unknown Reason|4|||
146754588|NCT04955626|529268080|FG022|Blinded Period|Withdrawal by Subject|0|||
146754589|NCT04955626|529268081|FG023|Blinded Period|Withdrawal by Subject|0|||
146852473|NCT01506609|529627913|FG004|Overall Study|Missing / Unknown Reason|4|||
146852474|NCT01506609|529627914|FG005|Overall Study|Missing / Unknown Reason|2|||
146852475|NCT00577473|529627919|FG000|Overall Study|Protocol Violation|1|||
146754590|NCT04955626|529268082|FG024|Blinded Period|Withdrawal by Subject|5|||
146754591|NCT04955626|529268083|FG025|Blinded Period|Withdrawal by Subject|1|||
146754592|NCT04955626|529268084|FG026|Blinded Period|Withdrawal by Subject|5|||
146754593|NCT04955626|529268085|FG027|Blinded Period|Withdrawal by Subject|1|||
146754594|NCT04955626|529268086|FG028|Blinded Period|Withdrawal by Subject|4|||
146754595|NCT04955626|529268087|FG029|Blinded Period|Withdrawal by Subject|2|||
146754596|NCT04955626|529268088|FG030|Blinded Period|Withdrawal by Subject|0|||
146754597|NCT04955626|529268089|FG031|Blinded Period|Withdrawal by Subject|0|||
146625239|NCT03037385|528803854|FG009|Overall Study|Adverse Event|6|||
146754598|NCT04955626|529268090|FG032|Blinded Period|Withdrawal by Subject|0|||
146754599|NCT04955626|529268091|FG033|Blinded Period|Withdrawal by Subject|0|||
146754600|NCT04955626|529268092|FG034|Blinded Period|Withdrawal by Subject|0|||
146754601|NCT04955626|529268093|FG035|Blinded Period|Withdrawal by Subject|0|||
146754602|NCT04955626|529268058|FG000|Blinded Period|Refused further study procedures|0|||
146754603|NCT04955626|529268059|FG001|Blinded Period|Refused further study procedures|0|||
146754604|NCT04955626|529268060|FG002|Blinded Period|Refused further study procedures|0|||
146754605|NCT04955626|529268061|FG003|Blinded Period|Refused further study procedures|0|||
146852476|NCT00577473|529627920|FG001|Overall Study|Protocol Violation|4|||
146754606|NCT04955626|529268062|FG004|Blinded Period|Refused further study procedures|0|||
146754607|NCT04955626|529268063|FG005|Blinded Period|Refused further study procedures|0|||
146754608|NCT04955626|529268064|FG006|Blinded Period|Refused further study procedures|1|||
146754609|NCT04955626|529268065|FG007|Blinded Period|Refused further study procedures|0|||
146754610|NCT04955626|529268066|FG008|Blinded Period|Refused further study procedures|0|||
146754611|NCT04955626|529268067|FG009|Blinded Period|Refused further study procedures|0|||
146754612|NCT04955626|529268068|FG010|Blinded Period|Refused further study procedures|0|||
146852477|NCT00577473|529627919|FG000|Overall Study|Adverse Event|8|||
146852478|NCT00577473|529627920|FG001|Overall Study|Adverse Event|5|||
146852479|NCT00577473|529627919|FG000|Overall Study|Withdrawal by Subject|2|||
146852480|NCT00577473|529627920|FG001|Overall Study|Withdrawal by Subject|6|||
146852481|NCT00577473|529627919|FG000|Overall Study|Physician Decision|2|||
146852482|NCT00577473|529627920|FG001|Overall Study|Physician Decision|2|||
146852483|NCT00577473|529627919|FG000|Overall Study|Lack of Efficacy|8|||
146852484|NCT00577473|529627920|FG001|Overall Study|Lack of Efficacy|7|||
146852485|NCT02595073|529627923|FG000|Overall Study|Progressive Disease|0|||
146512733|NCT00990665|528381296|FG000|Overall Study|Unsuccessful Implant|8|||
146754613|NCT04955626|529268069|FG011|Blinded Period|Refused further study procedures|2|||
146754614|NCT04955626|529268070|FG012|Blinded Period|Refused further study procedures|0|||
146754615|NCT04955626|529268071|FG013|Blinded Period|Refused further study procedures|0|||
146754616|NCT04955626|529268072|FG014|Blinded Period|Refused further study procedures|0|||
146754617|NCT04955626|529268073|FG015|Blinded Period|Refused further study procedures|0|||
146754618|NCT04955626|529268074|FG016|Blinded Period|Refused further study procedures|0|||
146754619|NCT04955626|529268075|FG017|Blinded Period|Refused further study procedures|0|||
146754620|NCT04955626|529268076|FG018|Blinded Period|Refused further study procedures|0|||
146754621|NCT04955626|529268077|FG019|Blinded Period|Refused further study procedures|0|||
146754622|NCT04955626|529268078|FG020|Blinded Period|Refused further study procedures|0|||
146754623|NCT04955626|529268079|FG021|Blinded Period|Refused further study procedures|0|||
146754624|NCT04955626|529268080|FG022|Blinded Period|Refused further study procedures|0|||
146754625|NCT04955626|529268081|FG023|Blinded Period|Refused further study procedures|0|||
146754626|NCT04955626|529268082|FG024|Blinded Period|Refused further study procedures|0|||
146754627|NCT04955626|529268083|FG025|Blinded Period|Refused further study procedures|0|||
146754628|NCT04955626|529268084|FG026|Blinded Period|Refused further study procedures|0|||
146754629|NCT04955626|529268085|FG027|Blinded Period|Refused further study procedures|0|||
146754630|NCT04955626|529268086|FG028|Blinded Period|Refused further study procedures|0|||
146754631|NCT04955626|529268087|FG029|Blinded Period|Refused further study procedures|0|||
146754632|NCT04955626|529268088|FG030|Blinded Period|Refused further study procedures|0|||
146754633|NCT04955626|529268089|FG031|Blinded Period|Refused further study procedures|0|||
146754634|NCT04955626|529268090|FG032|Blinded Period|Refused further study procedures|0|||
146754635|NCT04955626|529268091|FG033|Blinded Period|Refused further study procedures|0|||
146754636|NCT04955626|529268092|FG034|Blinded Period|Refused further study procedures|0|||
146754637|NCT04955626|529268093|FG035|Blinded Period|Refused further study procedures|0|||
146754638|NCT04955626|529268058|FG000|Blinded Period|Participants entered open label period|4544|||
146754639|NCT04955626|529268059|FG001|Blinded Period|Participants entered open label period|4906|||
146754640|NCT04955626|529268060|FG002|Blinded Period|Participants entered open label period|0|||
146754641|NCT04955626|529268061|FG003|Blinded Period|Participants entered open label period|0|||
146754642|NCT04955626|529268062|FG004|Blinded Period|Participants entered open label period|0|||
146754643|NCT04955626|529268063|FG005|Blinded Period|Participants entered open label period|0|||
146754644|NCT04955626|529268064|FG006|Blinded Period|Participants entered open label period|0|||
146754645|NCT04955626|529268065|FG007|Blinded Period|Participants entered open label period|0|||
146754646|NCT04955626|529268066|FG008|Blinded Period|Participants entered open label period|0|||
146754647|NCT04955626|529268067|FG009|Blinded Period|Participants entered open label period|0|||
146754648|NCT04955626|529268068|FG010|Blinded Period|Participants entered open label period|0|||
146852486|NCT02595073|529627924|FG001|Overall Study|Progressive Disease|1|||
146965036|NCT03110107|530033426|FG000|Treatment Period|Study drug toxicity|1|||
146965037|NCT03110107|530033427|FG001|Treatment Period|Study drug toxicity|0|||
146965038|NCT03110107|530033428|FG002|Treatment Period|Study drug toxicity|1|||
146965039|NCT03110107|530033429|FG003|Treatment Period|Study drug toxicity|2|||
146965040|NCT03110107|530033430|FG004|Treatment Period|Study drug toxicity|0|||
146965041|NCT03110107|530033431|FG005|Treatment Period|Study drug toxicity|3|||
146965042|NCT03110107|530033432|FG006|Treatment Period|Study drug toxicity|1|||
146965043|NCT03110107|530033433|FG007|Treatment Period|Study drug toxicity|1|||
146965044|NCT03110107|530033434|FG008|Treatment Period|Study drug toxicity|3|||
146965045|NCT03110107|530033435|FG009|Treatment Period|Study drug toxicity|2|||
146965046|NCT03110107|530033436|FG010|Treatment Period|Study drug toxicity|0|||
146965047|NCT03110107|530033437|FG011|Treatment Period|Study drug toxicity|2|||
146965048|NCT03110107|530033438|FG012|Treatment Period|Study drug toxicity|0|||
146965049|NCT03110107|530033439|FG013|Treatment Period|Study drug toxicity|0|||
146754649|NCT04955626|529268069|FG011|Blinded Period|Participants entered open label period|0|||
146754650|NCT04955626|529268070|FG012|Blinded Period|Participants entered open label period|0|||
146852487|NCT02595073|529627923|FG000|Overall Study|Protocol Violation|2|||
146852488|NCT02595073|529627924|FG001|Overall Study|Protocol Violation|0|||
146852489|NCT01990560|529627927|FG000|Overall Study|Withdrawal by Subject|1|||
146852490|NCT02884908|529627928|FG000|Overall Study|Lost to Follow-up|13|||
146852491|NCT02884908|529627929|FG001|Overall Study|Lost to Follow-up|18|||
146852492|NCT01324440|529627930|FG000|Overall Study|Subject moved|0|||
146852493|NCT01324440|529627931|FG001|Overall Study|Subject moved|1|||
146852494|NCT01801735|529627937|FG000|Overall Study|Adverse Event|79|||
146852495|NCT01801735|529627937|FG000|Overall Study|Lack of Efficacy|28|||
146852496|NCT01801735|529627937|FG000|Overall Study|Withdrawal by Subject|27|||
146852497|NCT01801735|529627937|FG000|Overall Study|Protocol Violation|25|||
146852498|NCT01801735|529627937|FG000|Overall Study|Lost to Follow-up|15|||
146852499|NCT01801735|529627937|FG000|Overall Study|Non-compliance with Trial Drug|13|||
146852500|NCT01801735|529627937|FG000|Overall Study|Physician Decision|3|||
146852501|NCT01801735|529627937|FG000|Overall Study|Death|1|||
146852502|NCT01801735|529627937|FG000|Overall Study|Other, including site closure|19|||
146852503|NCT00468559|529627938|FG000|Open-label Treatment Phase|Adverse Event|5|||
146852504|NCT00468559|529627939|FG001|Open-label Treatment Phase|Adverse Event|0|||
146852505|NCT00468559|529627940|FG002|Open-label Treatment Phase|Adverse Event|0|||
146852506|NCT00468559|529627938|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
146852507|NCT00468559|529627939|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
146754651|NCT04955626|529268071|FG013|Blinded Period|Participants entered open label period|0|||
146754652|NCT04955626|529268072|FG014|Blinded Period|Participants entered open label period|0|||
146754653|NCT04955626|529268073|FG015|Blinded Period|Participants entered open label period|0|||
146754654|NCT04955626|529268074|FG016|Blinded Period|Participants entered open label period|0|||
146754655|NCT04955626|529268075|FG017|Blinded Period|Participants entered open label period|0|||
146754656|NCT04955626|529268076|FG018|Blinded Period|Participants entered open label period|0|||
146754657|NCT04955626|529268077|FG019|Blinded Period|Participants entered open label period|0|||
146754658|NCT04955626|529268078|FG020|Blinded Period|Participants entered open label period|0|||
146754659|NCT04955626|529268079|FG021|Blinded Period|Participants entered open label period|0|||
146754660|NCT04955626|529268080|FG022|Blinded Period|Participants entered open label period|0|||
146754661|NCT04955626|529268081|FG023|Blinded Period|Participants entered open label period|0|||
146754662|NCT04955626|529268082|FG024|Blinded Period|Participants entered open label period|0|||
146754663|NCT04955626|529268083|FG025|Blinded Period|Participants entered open label period|0|||
146754664|NCT04955626|529268084|FG026|Blinded Period|Participants entered open label period|0|||
146754665|NCT04955626|529268085|FG027|Blinded Period|Participants entered open label period|0|||
146754666|NCT04955626|529268086|FG028|Blinded Period|Participants entered open label period|0|||
146754667|NCT04955626|529268087|FG029|Blinded Period|Participants entered open label period|0|||
146754668|NCT04955626|529268088|FG030|Blinded Period|Participants entered open label period|0|||
146754669|NCT04955626|529268089|FG031|Blinded Period|Participants entered open label period|0|||
146754670|NCT04955626|529268090|FG032|Blinded Period|Participants entered open label period|0|||
146754671|NCT04955626|529268091|FG033|Blinded Period|Participants entered open label period|0|||
146754672|NCT04955626|529268092|FG034|Blinded Period|Participants entered open label period|0|||
146754673|NCT04955626|529268093|FG035|Blinded Period|Participants entered open label period|0|||
146754674|NCT04955626|529268058|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
146754675|NCT04955626|529268059|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
146754676|NCT04955626|529268060|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
146754677|NCT04955626|529268061|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
146754678|NCT04955626|529268062|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
146754679|NCT04955626|529268063|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
146754680|NCT04955626|529268064|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
146754681|NCT04955626|529268065|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
146754682|NCT04955626|529268066|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
146754683|NCT04955626|529268067|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
146754684|NCT04955626|529268068|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
146754685|NCT04955626|529268069|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
146754686|NCT04955626|529268070|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
146754687|NCT04955626|529268071|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
146754688|NCT04955626|529268072|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
146754689|NCT04955626|529268073|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
146754690|NCT04955626|529268074|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
146754691|NCT04955626|529268075|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
146754692|NCT04955626|529268076|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
146754693|NCT04955626|529268077|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
146754694|NCT04955626|529268078|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
146852508|NCT00468559|529627940|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
146852509|NCT00468559|529627938|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
146852510|NCT00468559|529627939|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
146852511|NCT00468559|529627940|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
146754695|NCT04955626|529268079|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
146754696|NCT04955626|529268080|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
146754697|NCT04955626|529268081|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
146754698|NCT04955626|529268082|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
146754699|NCT04955626|529268083|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
146754700|NCT04955626|529268084|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
146754701|NCT04955626|529268085|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
146754702|NCT04955626|529268086|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
146754703|NCT04955626|529268087|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
146754704|NCT04955626|529268088|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
146754705|NCT04955626|529268089|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
146512734|NCT00990665|528381296|FG000|Overall Study|Death|29|||
146512735|NCT00990665|528381296|FG000|Overall Study|Heart Transplant|1|||
146754706|NCT04955626|529268090|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
146512736|NCT00990665|528381296|FG000|Overall Study|Withdrawal by Subject|6|||
146754707|NCT04955626|529268091|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
146754708|NCT04955626|529268092|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
146852512|NCT00468559|529627938|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
146852513|NCT00468559|529627939|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
146852514|NCT00468559|529627940|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
146852515|NCT00468559|529627938|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
146852516|NCT00468559|529627939|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
146852517|NCT00468559|529627940|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
146852518|NCT01153958|529627941|FG000|Overall Study|Study Terminated|36|||
146852519|NCT01153958|529627942|FG001|Overall Study|Study Terminated|32|||
146852520|NCT01034163|529627944|FG000|Overall Study|Treatment completed as per protocol|8|||
146852521|NCT01034163|529627945|FG001|Overall Study|Treatment completed as per protocol|7|||
146852522|NCT01034163|529627944|FG000|Overall Study|Withdrawal by Subject|8|||
146852523|NCT01034163|529627945|FG001|Overall Study|Withdrawal by Subject|2|||
146852524|NCT01034163|529627944|FG000|Overall Study|Protocol deviation|1|||
146852525|NCT01034163|529627945|FG001|Overall Study|Protocol deviation|0|||
146852526|NCT01034163|529627944|FG000|Overall Study|Disease progression|3|||
146852527|NCT01034163|529627945|FG001|Overall Study|Disease progression|4|||
146852528|NCT01034163|529627944|FG000|Overall Study|Adverse Event|6|||
146852529|NCT01034163|529627945|FG001|Overall Study|Adverse Event|0|||
146852530|NCT01034163|529627944|FG000|Overall Study|Administrative problems|0|||
146852531|NCT01034163|529627945|FG001|Overall Study|Administrative problems|1|||
146852532|NCT01034163|529627944|FG000|Overall Study|Abnormal laboratory value|1|||
146852533|NCT01034163|529627945|FG001|Overall Study|Abnormal laboratory value|0|||
146852534|NCT02996474|529627946|FG000|Overall Study|Physician Decision|5|||
146512737|NCT00990665|528381296|FG000|Overall Study|Lost to Follow-up|1|||
146512738|NCT00990665|528381296|FG000|Overall Study|System Explant|3|||
146754709|NCT04955626|529268093|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
146754710|NCT04955626|529268058|FG000|Blinded Period|Medication error|0|||
146754711|NCT04955626|529268059|FG001|Blinded Period|Medication error|0|||
146754712|NCT04955626|529268060|FG002|Blinded Period|Medication error|0|||
146754713|NCT04955626|529268061|FG003|Blinded Period|Medication error|0|||
146754714|NCT04955626|529268062|FG004|Blinded Period|Medication error|0|||
146754715|NCT04955626|529268063|FG005|Blinded Period|Medication error|0|||
146754716|NCT04955626|529268064|FG006|Blinded Period|Medication error|0|||
146754717|NCT04955626|529268065|FG007|Blinded Period|Medication error|0|||
146754718|NCT04955626|529268066|FG008|Blinded Period|Medication error|0|||
146754719|NCT04955626|529268067|FG009|Blinded Period|Medication error|0|||
146754720|NCT04955626|529268068|FG010|Blinded Period|Medication error|2|||
146754721|NCT04955626|529268069|FG011|Blinded Period|Medication error|0|||
146754722|NCT04955626|529268070|FG012|Blinded Period|Medication error|0|||
146754723|NCT04955626|529268071|FG013|Blinded Period|Medication error|0|||
146754724|NCT04955626|529268072|FG014|Blinded Period|Medication error|0|||
146754725|NCT04955626|529268073|FG015|Blinded Period|Medication error|0|||
146754726|NCT04955626|529268074|FG016|Blinded Period|Medication error|0|||
146754727|NCT04955626|529268075|FG017|Blinded Period|Medication error|0|||
146754728|NCT04955626|529268076|FG018|Blinded Period|Medication error|0|||
146754729|NCT04955626|529268077|FG019|Blinded Period|Medication error|0|||
146754730|NCT04955626|529268078|FG020|Blinded Period|Medication error|0|||
146754731|NCT04955626|529268079|FG021|Blinded Period|Medication error|0|||
146754732|NCT04955626|529268080|FG022|Blinded Period|Medication error|0|||
146754733|NCT04955626|529268081|FG023|Blinded Period|Medication error|0|||
146754734|NCT04955626|529268082|FG024|Blinded Period|Medication error|0|||
146754735|NCT04955626|529268083|FG025|Blinded Period|Medication error|0|||
146754736|NCT04955626|529268084|FG026|Blinded Period|Medication error|0|||
146754737|NCT04955626|529268085|FG027|Blinded Period|Medication error|0|||
146754738|NCT04955626|529268086|FG028|Blinded Period|Medication error|4|||
146754739|NCT04955626|529268087|FG029|Blinded Period|Medication error|0|||
146754740|NCT04955626|529268088|FG030|Blinded Period|Medication error|0|||
146754741|NCT04955626|529268089|FG031|Blinded Period|Medication error|0|||
146754742|NCT04955626|529268090|FG032|Blinded Period|Medication error|0|||
146754743|NCT04955626|529268091|FG033|Blinded Period|Medication error|0|||
146754744|NCT04955626|529268092|FG034|Blinded Period|Medication error|0|||
146754745|NCT04955626|529268093|FG035|Blinded Period|Medication error|0|||
146754746|NCT04955626|529268058|FG000|Open-Label Period|Lost to Follow-up|109|||
146754747|NCT04955626|529268059|FG001|Open-Label Period|Lost to Follow-up|41|||
146754748|NCT04955626|529268060|FG002|Open-Label Period|Lost to Follow-up|0|||
146754749|NCT04955626|529268061|FG003|Open-Label Period|Lost to Follow-up|0|||
146754750|NCT04955626|529268062|FG004|Open-Label Period|Lost to Follow-up|0|||
146754751|NCT04955626|529268063|FG005|Open-Label Period|Lost to Follow-up|0|||
146754752|NCT04955626|529268064|FG006|Open-Label Period|Lost to Follow-up|0|||
146754753|NCT04955626|529268065|FG007|Open-Label Period|Lost to Follow-up|0|||
146754754|NCT04955626|529268066|FG008|Open-Label Period|Lost to Follow-up|0|||
146754755|NCT04955626|529268067|FG009|Open-Label Period|Lost to Follow-up|0|||
146754756|NCT04955626|529268068|FG010|Open-Label Period|Lost to Follow-up|0|||
146852535|NCT04493502|529627947|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
146852536|NCT04493502|529627948|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
146852537|NCT04493502|529627947|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
146852538|NCT04493502|529627948|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
146512739|NCT02603562|528381299|FG000|Overall Study|Lost to Follow-up|1|||
146512740|NCT01534208|528381303|FG000|Overall Study|Lost to Follow-up|19|||
146512741|NCT01534208|528381304|FG001|Overall Study|Lost to Follow-up|14|||
146512742|NCT01534208|528381303|FG000|Overall Study|Withdrawal by Subject|6|||
146512743|NCT01534208|528381304|FG001|Overall Study|Withdrawal by Subject|20|||
146512744|NCT01534208|528381303|FG000|Overall Study|Adverse Event|15|||
146512745|NCT01534208|528381304|FG001|Overall Study|Adverse Event|8|||
146512746|NCT01534208|528381303|FG000|Overall Study|Physician Decision|2|||
146512747|NCT01534208|528381304|FG001|Overall Study|Physician Decision|0|||
146512748|NCT01534208|528381303|FG000|Overall Study|Lack of Efficacy|0|||
146512749|NCT01534208|528381304|FG001|Overall Study|Lack of Efficacy|3|||
146512750|NCT01534208|528381303|FG000|Overall Study|Protocol Violation|2|||
146512751|NCT01534208|528381304|FG001|Overall Study|Protocol Violation|2|||
146512752|NCT01534208|528381303|FG000|Overall Study|Sponsor decision|4|||
146512753|NCT01534208|528381304|FG001|Overall Study|Sponsor decision|1|||
146512754|NCT01534208|528381303|FG000|Overall Study|Subject relocation|2|||
146512755|NCT01534208|528381304|FG001|Overall Study|Subject relocation|0|||
146512756|NCT01534208|528381303|FG000|Overall Study|Lab assessment|2|||
146512757|NCT01534208|528381304|FG001|Overall Study|Lab assessment|1|||
146512758|NCT01534208|528381303|FG000|Overall Study|Eligibility error|3|||
146512759|NCT01534208|528381304|FG001|Overall Study|Eligibility error|0|||
146512760|NCT01534208|528381303|FG000|Overall Study|PCP decision|1|||
146512761|NCT01534208|528381304|FG001|Overall Study|PCP decision|0|||
146512762|NCT01534208|528381303|FG000|Overall Study|Needed prohibited meds|1|||
146512763|NCT01534208|528381304|FG001|Overall Study|Needed prohibited meds|0|||
146512764|NCT01904903|528381305|FG000|Overall Study|Withdrawal by Subject|1|||
146512765|NCT03578146|528381310|FG000|Overall Study|Did Not Receive Treatment|1|||
146512766|NCT03578146|528381311|FG001|Overall Study|Did Not Receive Treatment|0|||
146512767|NCT03578146|528381312|FG002|Overall Study|Did Not Receive Treatment|0|||
146512768|NCT03578146|528381313|FG003|Overall Study|Did Not Receive Treatment|0|||
146512769|NCT03578146|528381314|FG004|Overall Study|Did Not Receive Treatment|0|||
146512770|NCT03578146|528381315|FG005|Overall Study|Did Not Receive Treatment|2|||
146512771|NCT03578146|528381310|FG000|Overall Study|Lost to Follow-up|0|||
146512772|NCT03578146|528381311|FG001|Overall Study|Lost to Follow-up|1|||
146512773|NCT03578146|528381312|FG002|Overall Study|Lost to Follow-up|1|||
146512774|NCT03578146|528381313|FG003|Overall Study|Lost to Follow-up|0|||
146512775|NCT03578146|528381314|FG004|Overall Study|Lost to Follow-up|0|||
146512776|NCT03578146|528381315|FG005|Overall Study|Lost to Follow-up|1|||
146512777|NCT00634049|528381316|FG000|Overall Study|Never received study drug|1|||
146512778|NCT00634049|528381316|FG000|Overall Study|Died prior to receiving study drug|1|||
146512779|NCT00634049|528381316|FG000|Overall Study|Screening failure|1|||
146512780|NCT01717391|528381317|FG000|Overall Study|Withdrawal by Subject|5|||
146512781|NCT01717391|528381317|FG000|Overall Study|Physician Decision|1|||
146512782|NCT01717391|528381317|FG000|Overall Study|FLT technical failure|3|||
146512783|NCT00314132|528381318|FG000|Overall Study|Lost to Follow-up|3|||
146512784|NCT00314132|528381319|FG001|Overall Study|Lost to Follow-up|13|||
146512785|NCT00314132|528381318|FG000|Overall Study|Withdrawal by Subject|3|||
146512786|NCT00314132|528381319|FG001|Overall Study|Withdrawal by Subject|5|||
146512787|NCT00314132|528381318|FG000|Overall Study|Adverse Event|1|||
146512788|NCT00314132|528381319|FG001|Overall Study|Adverse Event|0|||
146512789|NCT00314132|528381318|FG000|Overall Study|Physician Decision|1|||
146512790|NCT00314132|528381319|FG001|Overall Study|Physician Decision|0|||
146512791|NCT04769739|528381320|FG000|Overall Study|Colorectal cancer obstruction|2|||
146512792|NCT04769739|528381321|FG001|Overall Study|Colorectal cancer obstruction|0|||
146512793|NCT04769739|528381322|FG002|Overall Study|Colorectal cancer obstruction|0|||
146512794|NCT04769739|528381323|FG003|Overall Study|Colorectal cancer obstruction|0|||
146512795|NCT04769739|528381320|FG000|Overall Study|Failed cecal intubation|1|||
146512796|NCT04769739|528381321|FG001|Overall Study|Failed cecal intubation|0|||
146512797|NCT04769739|528381322|FG002|Overall Study|Failed cecal intubation|0|||
146754757|NCT04955626|529268069|FG011|Open-Label Period|Lost to Follow-up|0|||
146754758|NCT04955626|529268070|FG012|Open-Label Period|Lost to Follow-up|0|||
146754759|NCT04955626|529268071|FG013|Open-Label Period|Lost to Follow-up|0|||
146754760|NCT04955626|529268072|FG014|Open-Label Period|Lost to Follow-up|0|||
146754761|NCT04955626|529268073|FG015|Open-Label Period|Lost to Follow-up|0|||
146754762|NCT04955626|529268074|FG016|Open-Label Period|Lost to Follow-up|0|||
146754763|NCT04955626|529268075|FG017|Open-Label Period|Lost to Follow-up|0|||
146754764|NCT04955626|529268076|FG018|Open-Label Period|Lost to Follow-up|0|||
146754765|NCT04955626|529268077|FG019|Open-Label Period|Lost to Follow-up|0|||
146512798|NCT04769739|528381323|FG003|Overall Study|Failed cecal intubation|1|||
146512799|NCT04769739|528381320|FG000|Overall Study|Poor bowel preparation|0|||
146512800|NCT04769739|528381321|FG001|Overall Study|Poor bowel preparation|0|||
146512801|NCT04769739|528381322|FG002|Overall Study|Poor bowel preparation|0|||
146512802|NCT04769739|528381323|FG003|Overall Study|Poor bowel preparation|1|||
146512803|NCT01260584|528381324|FG000|Period 1|Protocol Violation|0|||
146512804|NCT01260584|528381325|FG001|Period 1|Protocol Violation|0|||
146512805|NCT01260584|528381326|FG002|Period 1|Protocol Violation|1|||
146512806|NCT01260584|528381327|FG003|Period 1|Protocol Violation|1|||
146754766|NCT04955626|529268078|FG020|Open-Label Period|Lost to Follow-up|0|||
146512807|NCT01260584|528381324|FG000|Period 1|Adverse Event|0|||
146512808|NCT01260584|528381325|FG001|Period 1|Adverse Event|0|||
146512809|NCT01260584|528381326|FG002|Period 1|Adverse Event|1|||
146512810|NCT01260584|528381327|FG003|Period 1|Adverse Event|0|||
146512811|NCT01260584|528381324|FG000|Period 2|Protocol Violation|0|||
146512812|NCT01260584|528381325|FG001|Period 2|Protocol Violation|2|||
146512813|NCT01260584|528381326|FG002|Period 2|Protocol Violation|3|||
146512814|NCT01260584|528381327|FG003|Period 2|Protocol Violation|1|||
146512815|NCT01260584|528381324|FG000|Period 2|Adverse Event|1|||
146512816|NCT01260584|528381325|FG001|Period 2|Adverse Event|0|||
146512817|NCT01260584|528381326|FG002|Period 2|Adverse Event|2|||
146512818|NCT01260584|528381327|FG003|Period 2|Adverse Event|0|||
146512819|NCT01260584|528381324|FG000|Period 2|Withdrawal by Subject|0|||
146512820|NCT01260584|528381325|FG001|Period 2|Withdrawal by Subject|1|||
146512821|NCT01260584|528381326|FG002|Period 2|Withdrawal by Subject|0|||
146512822|NCT01260584|528381327|FG003|Period 2|Withdrawal by Subject|0|||
146512823|NCT00045734|528381328|FG000|Overall Study|Protocol Violation|1|||
146512824|NCT02069093|528381329|FG000|Overall Study|Disease progression|14|||
146512825|NCT02069093|528381329|FG000|Overall Study|New cancer therapy|1|||
146512826|NCT02069093|528381329|FG000|Overall Study|Death|1|||
146512827|NCT02069093|528381329|FG000|Overall Study|Administrative problems|1|||
146512828|NCT02069093|528381329|FG000|Overall Study|Withdrawal by Subject|2|||
146512829|NCT02069093|528381329|FG000|Overall Study|Abnormal laboratory values|1|||
146512830|NCT02069093|528381329|FG000|Overall Study|Adverse Event|10|||
146512831|NCT00586508|528381330|FG000|Overall Study|Progressive disease|52|||
146512832|NCT00586508|528381331|FG001|Overall Study|Progressive disease|8|||
146512833|NCT00586508|528381330|FG000|Overall Study|Death|0|||
146512834|NCT00586508|528381331|FG001|Overall Study|Death|1|||
146512835|NCT00586508|528381330|FG000|Overall Study|Adverse Event|12|||
146512836|NCT00586508|528381331|FG001|Overall Study|Adverse Event|4|||
146512837|NCT00586508|528381330|FG000|Overall Study|Withdrawal by Subject|4|||
146512838|NCT00586508|528381331|FG001|Overall Study|Withdrawal by Subject|0|||
146512839|NCT02079636|528381332|FG000|Overall Study|Death|2|||
146512840|NCT02079636|528381333|FG001|Overall Study|Death|1|||
146512841|NCT02079636|528381334|FG002|Overall Study|Death|0|||
146512842|NCT02079636|528381335|FG003|Overall Study|Death|5|||
146512843|NCT02079636|528381336|FG004|Overall Study|Death|1|||
146512844|NCT02079636|528381337|FG005|Overall Study|Death|2|||
146512845|NCT02079636|528381338|FG006|Overall Study|Death|1|||
146512846|NCT02079636|528381339|FG007|Overall Study|Death|0|||
146512847|NCT02079636|528381340|FG008|Overall Study|Death|0|||
146512848|NCT02079636|528381341|FG009|Overall Study|Death|0|||
146512849|NCT02079636|528381342|FG010|Overall Study|Death|0|||
146512850|NCT02079636|528381343|FG011|Overall Study|Death|1|||
146512851|NCT02079636|528381344|FG012|Overall Study|Death|1|||
146512852|NCT02079636|528381345|FG013|Overall Study|Death|0|||
146512853|NCT02079636|528381346|FG014|Overall Study|Death|2|||
146512854|NCT02079636|528381332|FG000|Overall Study|Adverse Event|1|||
146512855|NCT02079636|528381333|FG001|Overall Study|Adverse Event|1|||
146512856|NCT02079636|528381334|FG002|Overall Study|Adverse Event|0|||
146512857|NCT02079636|528381335|FG003|Overall Study|Adverse Event|1|||
146512858|NCT02079636|528381336|FG004|Overall Study|Adverse Event|1|||
146512859|NCT02079636|528381337|FG005|Overall Study|Adverse Event|2|||
146512860|NCT02079636|528381338|FG006|Overall Study|Adverse Event|0|||
146512861|NCT02079636|528381339|FG007|Overall Study|Adverse Event|0|||
146512862|NCT02079636|528381340|FG008|Overall Study|Adverse Event|0|||
146512863|NCT02079636|528381341|FG009|Overall Study|Adverse Event|0|||
146512864|NCT02079636|528381342|FG010|Overall Study|Adverse Event|0|||
146512865|NCT02079636|528381343|FG011|Overall Study|Adverse Event|0|||
146512866|NCT02079636|528381344|FG012|Overall Study|Adverse Event|0|||
146512867|NCT02079636|528381345|FG013|Overall Study|Adverse Event|0|||
146512868|NCT02079636|528381346|FG014|Overall Study|Adverse Event|0|||
146852539|NCT04493502|529627947|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
146852540|NCT04493502|529627948|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
146852541|NCT04493502|529627947|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
146512869|NCT02079636|528381332|FG000|Overall Study|Progressive disease|0|||
146512870|NCT02079636|528381333|FG001|Overall Study|Progressive disease|0|||
146512871|NCT02079636|528381334|FG002|Overall Study|Progressive disease|0|||
146852542|NCT04493502|529627948|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
146512872|NCT02079636|528381335|FG003|Overall Study|Progressive disease|2|||
146512873|NCT02079636|528381336|FG004|Overall Study|Progressive disease|0|||
146512874|NCT02079636|528381337|FG005|Overall Study|Progressive disease|0|||
146512875|NCT02079636|528381338|FG006|Overall Study|Progressive disease|0|||
146512876|NCT02079636|528381339|FG007|Overall Study|Progressive disease|0|||
146512877|NCT02079636|528381340|FG008|Overall Study|Progressive disease|0|||
146512878|NCT02079636|528381341|FG009|Overall Study|Progressive disease|0|||
146512879|NCT02079636|528381342|FG010|Overall Study|Progressive disease|0|||
146512880|NCT02079636|528381343|FG011|Overall Study|Progressive disease|0|||
146512881|NCT02079636|528381344|FG012|Overall Study|Progressive disease|1|||
146512882|NCT02079636|528381345|FG013|Overall Study|Progressive disease|0|||
146512883|NCT02079636|528381346|FG014|Overall Study|Progressive disease|0|||
146512884|NCT02079636|528381332|FG000|Overall Study|Withdrawal by Subject|0|||
146512885|NCT02079636|528381333|FG001|Overall Study|Withdrawal by Subject|0|||
146512886|NCT02079636|528381334|FG002|Overall Study|Withdrawal by Subject|0|||
146512887|NCT02079636|528381335|FG003|Overall Study|Withdrawal by Subject|4|||
146512888|NCT02079636|528381336|FG004|Overall Study|Withdrawal by Subject|0|||
146512889|NCT02079636|528381337|FG005|Overall Study|Withdrawal by Subject|1|||
146512890|NCT02079636|528381338|FG006|Overall Study|Withdrawal by Subject|0|||
146512891|NCT02079636|528381339|FG007|Overall Study|Withdrawal by Subject|0|||
146512892|NCT02079636|528381340|FG008|Overall Study|Withdrawal by Subject|0|||
146512893|NCT02079636|528381341|FG009|Overall Study|Withdrawal by Subject|2|||
146512894|NCT02079636|528381342|FG010|Overall Study|Withdrawal by Subject|1|||
146512895|NCT02079636|528381343|FG011|Overall Study|Withdrawal by Subject|1|||
146512896|NCT02079636|528381344|FG012|Overall Study|Withdrawal by Subject|1|||
146512897|NCT02079636|528381345|FG013|Overall Study|Withdrawal by Subject|0|||
146512898|NCT02079636|528381346|FG014|Overall Study|Withdrawal by Subject|2|||
146512899|NCT02079636|528381332|FG000|Overall Study|Physician Decision|0|||
146512900|NCT02079636|528381333|FG001|Overall Study|Physician Decision|0|||
146754767|NCT04955626|529268079|FG021|Open-Label Period|Lost to Follow-up|0|||
146754768|NCT04955626|529268080|FG022|Open-Label Period|Lost to Follow-up|0|||
146754769|NCT04955626|529268081|FG023|Open-Label Period|Lost to Follow-up|0|||
146754770|NCT04955626|529268082|FG024|Open-Label Period|Lost to Follow-up|0|||
146754771|NCT04955626|529268083|FG025|Open-Label Period|Lost to Follow-up|0|||
146754772|NCT04955626|529268084|FG026|Open-Label Period|Lost to Follow-up|0|||
146754773|NCT04955626|529268085|FG027|Open-Label Period|Lost to Follow-up|0|||
146754774|NCT04955626|529268086|FG028|Open-Label Period|Lost to Follow-up|0|||
146754775|NCT04955626|529268087|FG029|Open-Label Period|Lost to Follow-up|0|||
146754776|NCT04955626|529268088|FG030|Open-Label Period|Lost to Follow-up|0|||
146754777|NCT04955626|529268089|FG031|Open-Label Period|Lost to Follow-up|0|||
146754778|NCT04955626|529268090|FG032|Open-Label Period|Lost to Follow-up|0|||
146754779|NCT04955626|529268091|FG033|Open-Label Period|Lost to Follow-up|0|||
146754780|NCT04955626|529268092|FG034|Open-Label Period|Lost to Follow-up|0|||
146754781|NCT04955626|529268093|FG035|Open-Label Period|Lost to Follow-up|0|||
146754782|NCT04955626|529268058|FG000|Open-Label Period|Protocol Violation|377|||
146754783|NCT04955626|529268059|FG001|Open-Label Period|Protocol Violation|48|||
146754784|NCT04955626|529268060|FG002|Open-Label Period|Protocol Violation|0|||
146754785|NCT04955626|529268061|FG003|Open-Label Period|Protocol Violation|0|||
146754786|NCT04955626|529268062|FG004|Open-Label Period|Protocol Violation|0|||
146754787|NCT04955626|529268063|FG005|Open-Label Period|Protocol Violation|0|||
146754788|NCT04955626|529268064|FG006|Open-Label Period|Protocol Violation|0|||
146754789|NCT04955626|529268065|FG007|Open-Label Period|Protocol Violation|0|||
146754790|NCT04955626|529268066|FG008|Open-Label Period|Protocol Violation|0|||
146754791|NCT04955626|529268067|FG009|Open-Label Period|Protocol Violation|0|||
146754792|NCT04955626|529268068|FG010|Open-Label Period|Protocol Violation|0|||
146754793|NCT04955626|529268069|FG011|Open-Label Period|Protocol Violation|0|||
146754794|NCT04955626|529268070|FG012|Open-Label Period|Protocol Violation|0|||
146754795|NCT04955626|529268071|FG013|Open-Label Period|Protocol Violation|0|||
146754796|NCT04955626|529268072|FG014|Open-Label Period|Protocol Violation|0|||
146754797|NCT04955626|529268073|FG015|Open-Label Period|Protocol Violation|0|||
146754798|NCT04955626|529268074|FG016|Open-Label Period|Protocol Violation|0|||
146754799|NCT04955626|529268075|FG017|Open-Label Period|Protocol Violation|0|||
146754800|NCT04955626|529268076|FG018|Open-Label Period|Protocol Violation|0|||
146754801|NCT04955626|529268077|FG019|Open-Label Period|Protocol Violation|0|||
146754802|NCT04955626|529268078|FG020|Open-Label Period|Protocol Violation|0|||
146754803|NCT04955626|529268079|FG021|Open-Label Period|Protocol Violation|0|||
146754804|NCT04955626|529268080|FG022|Open-Label Period|Protocol Violation|0|||
146754805|NCT04955626|529268081|FG023|Open-Label Period|Protocol Violation|0|||
146754806|NCT04955626|529268082|FG024|Open-Label Period|Protocol Violation|0|||
146754807|NCT04955626|529268083|FG025|Open-Label Period|Protocol Violation|0|||
146754808|NCT04955626|529268084|FG026|Open-Label Period|Protocol Violation|0|||
146754809|NCT04955626|529268085|FG027|Open-Label Period|Protocol Violation|0|||
146754810|NCT04955626|529268086|FG028|Open-Label Period|Protocol Violation|0|||
146754811|NCT04955626|529268087|FG029|Open-Label Period|Protocol Violation|0|||
146754812|NCT04955626|529268088|FG030|Open-Label Period|Protocol Violation|0|||
146754813|NCT04955626|529268089|FG031|Open-Label Period|Protocol Violation|0|||
146754814|NCT04955626|529268090|FG032|Open-Label Period|Protocol Violation|0|||
146754815|NCT04955626|529268091|FG033|Open-Label Period|Protocol Violation|0|||
146754816|NCT04955626|529268092|FG034|Open-Label Period|Protocol Violation|0|||
146754817|NCT04955626|529268093|FG035|Open-Label Period|Protocol Violation|0|||
146754818|NCT04955626|529268058|FG000|Open-Label Period|Death|5|||
146754819|NCT04955626|529268059|FG001|Open-Label Period|Death|5|||
146754820|NCT04955626|529268060|FG002|Open-Label Period|Death|0|||
146512901|NCT02079636|528381334|FG002|Overall Study|Physician Decision|0|||
146512902|NCT02079636|528381335|FG003|Overall Study|Physician Decision|0|||
146512903|NCT02079636|528381336|FG004|Overall Study|Physician Decision|0|||
146512904|NCT02079636|528381337|FG005|Overall Study|Physician Decision|1|||
146512905|NCT02079636|528381338|FG006|Overall Study|Physician Decision|0|||
146512906|NCT02079636|528381339|FG007|Overall Study|Physician Decision|0|||
146512907|NCT02079636|528381340|FG008|Overall Study|Physician Decision|0|||
146512908|NCT02079636|528381341|FG009|Overall Study|Physician Decision|1|||
146512909|NCT02079636|528381342|FG010|Overall Study|Physician Decision|1|||
146512910|NCT02079636|528381343|FG011|Overall Study|Physician Decision|0|||
146512911|NCT02079636|528381344|FG012|Overall Study|Physician Decision|0|||
146512912|NCT02079636|528381345|FG013|Overall Study|Physician Decision|0|||
146512913|NCT02079636|528381346|FG014|Overall Study|Physician Decision|1|||
146512914|NCT02079636|528381332|FG000|Overall Study|Lost to Follow-up|0|||
146512915|NCT02079636|528381333|FG001|Overall Study|Lost to Follow-up|0|||
146512916|NCT02079636|528381334|FG002|Overall Study|Lost to Follow-up|0|||
146512917|NCT02079636|528381335|FG003|Overall Study|Lost to Follow-up|0|||
146512918|NCT02079636|528381336|FG004|Overall Study|Lost to Follow-up|0|||
146512919|NCT02079636|528381337|FG005|Overall Study|Lost to Follow-up|0|||
146512920|NCT02079636|528381338|FG006|Overall Study|Lost to Follow-up|0|||
146512921|NCT02079636|528381339|FG007|Overall Study|Lost to Follow-up|1|||
146512922|NCT02079636|528381340|FG008|Overall Study|Lost to Follow-up|0|||
146512923|NCT02079636|528381341|FG009|Overall Study|Lost to Follow-up|0|||
146512924|NCT02079636|528381342|FG010|Overall Study|Lost to Follow-up|0|||
146512925|NCT02079636|528381343|FG011|Overall Study|Lost to Follow-up|0|||
146512926|NCT02079636|528381344|FG012|Overall Study|Lost to Follow-up|0|||
146512927|NCT02079636|528381345|FG013|Overall Study|Lost to Follow-up|0|||
146512928|NCT02079636|528381346|FG014|Overall Study|Lost to Follow-up|0|||
146512929|NCT00561470|528381347|FG000|Overall Study|Adverse Event|74|||
146512930|NCT00561470|528381348|FG001|Overall Study|Adverse Event|163|||
146512931|NCT00561470|528381347|FG000|Overall Study|Disease progression|437|||
146512932|NCT00561470|528381348|FG001|Overall Study|Disease progression|305|||
146512933|NCT00561470|528381347|FG000|Overall Study|poor compliance to protocol|4|||
146512934|NCT00561470|528381348|FG001|Overall Study|poor compliance to protocol|4|||
146512935|NCT00561470|528381347|FG000|Overall Study|Lost to Follow-up|2|||
146512936|NCT00561470|528381348|FG001|Overall Study|Lost to Follow-up|0|||
146512937|NCT00561470|528381347|FG000|Overall Study|Physician Decision|21|||
146512938|NCT00561470|528381348|FG001|Overall Study|Physician Decision|20|||
146512939|NCT00561470|528381347|FG000|Overall Study|Consent Withdrawn|2|||
146512940|NCT00561470|528381348|FG001|Overall Study|Consent Withdrawn|6|||
146512941|NCT00561470|528381347|FG000|Overall Study|Subject request|43|||
146512942|NCT00561470|528381348|FG001|Overall Study|Subject request|77|||
146512943|NCT00561470|528381347|FG000|Overall Study|Metastatic surgery|10|||
146512944|NCT00561470|528381348|FG001|Overall Study|Metastatic surgery|12|||
146512945|NCT00561470|528381347|FG000|Overall Study|Unauthorized procedure|3|||
146512946|NCT00561470|528381348|FG001|Overall Study|Unauthorized procedure|1|||
146512947|NCT00561470|528381347|FG000|Overall Study|Randomized but not treated|5|||
146512948|NCT00561470|528381348|FG001|Overall Study|Randomized but not treated|5|||
146512949|NCT00561470|528381347|FG000|Overall Study|Missed visit window|1|||
146512950|NCT00561470|528381348|FG001|Overall Study|Missed visit window|4|||
146512951|NCT00561470|528381347|FG000|Overall Study|Planning surgery|1|||
146512952|NCT00561470|528381348|FG001|Overall Study|Planning surgery|1|||
146512953|NCT00561470|528381347|FG000|Overall Study|Ongoing Treatment|11|||
146512954|NCT00561470|528381348|FG001|Overall Study|Ongoing Treatment|14|||
146512955|NCT03434249|528381349|FG000|Overall Study|Adverse Event|1|||
146512956|NCT03434249|528381350|FG001|Overall Study|Adverse Event|0|||
146512957|NCT03434249|528381349|FG000|Overall Study|Lost to Follow-up|0|||
146512958|NCT03434249|528381350|FG001|Overall Study|Lost to Follow-up|1|||
146512959|NCT03434249|528381349|FG000|Overall Study|Non-compliance of family|2|||
146512960|NCT03434249|528381350|FG001|Overall Study|Non-compliance of family|1|||
146512961|NCT03434249|528381349|FG000|Overall Study|Difficulties in completing daily diary|2|||
146512962|NCT03434249|528381350|FG001|Overall Study|Difficulties in completing daily diary|1|||
146512963|NCT03325894|528381351|FG000|Overall Study|Adverse Event|2|||
146512964|NCT03325894|528381352|FG001|Overall Study|Adverse Event|3|||
146512965|NCT03325894|528381351|FG000|Overall Study|Protocol Violation|1|||
146512966|NCT03325894|528381352|FG001|Overall Study|Protocol Violation|2|||
146512967|NCT03325894|528381351|FG000|Overall Study|Withdrawal by Subject|10|||
146512968|NCT03325894|528381352|FG001|Overall Study|Withdrawal by Subject|6|||
146512969|NCT03325894|528381351|FG000|Overall Study|Lost to Follow-up|4|||
146512970|NCT03325894|528381352|FG001|Overall Study|Lost to Follow-up|9|||
146512971|NCT03325894|528381351|FG000|Overall Study|Lack of Efficacy|8|||
146512972|NCT03325894|528381352|FG001|Overall Study|Lack of Efficacy|14|||
146512973|NCT03325894|528381351|FG000|Overall Study|Study Terminated by Sponsor|38|||
146512974|NCT03325894|528381352|FG001|Overall Study|Study Terminated by Sponsor|43|||
146512975|NCT03325894|528381351|FG000|Overall Study|Other (Not received Treatment)|1|||
146512976|NCT03325894|528381352|FG001|Overall Study|Other (Not received Treatment)|0|||
146512977|NCT02450552|528381356|FG000|Overall Study|Withdrawal by Subject|4|||
146512978|NCT02450552|528381357|FG001|Overall Study|Withdrawal by Subject|0|||
146512979|NCT02450552|528381358|FG002|Overall Study|Withdrawal by Subject|4|||
146512980|NCT02450552|528381356|FG000|Overall Study|Physician Decision|1|||
146512981|NCT02450552|528381357|FG001|Overall Study|Physician Decision|0|||
146512982|NCT02450552|528381358|FG002|Overall Study|Physician Decision|1|||
146512983|NCT04148287|528381372|FG000|Overall Study|Death|2|||
146512984|NCT00824382|528381374|FG000|Overall Study|Adverse Event|4|||
146512985|NCT00824382|528381375|FG001|Overall Study|Adverse Event|1|||
146512986|NCT00824382|528381376|FG002|Overall Study|Adverse Event|1|||
146512987|NCT00824382|528381377|FG003|Overall Study|Adverse Event|4|||
146512988|NCT00824382|528381374|FG000|Overall Study|Protocol Violation|1|||
146512989|NCT00824382|528381375|FG001|Overall Study|Protocol Violation|0|||
146512990|NCT00824382|528381376|FG002|Overall Study|Protocol Violation|0|||
146512991|NCT00824382|528381377|FG003|Overall Study|Protocol Violation|1|||
146512992|NCT00824382|528381374|FG000|Overall Study|Investigator's decision|0|||
146512993|NCT00824382|528381375|FG001|Overall Study|Investigator's decision|1|||
146512994|NCT00824382|528381376|FG002|Overall Study|Investigator's decision|2|||
146512995|NCT00824382|528381377|FG003|Overall Study|Investigator's decision|0|||
146512996|NCT02824562|528383186|FG000|Overall Study|Lost to Follow-up|3|||
146512997|NCT02824562|528383187|FG001|Overall Study|Lost to Follow-up|4|||
146512998|NCT02824562|528383186|FG000|Overall Study|Death|0|||
146512999|NCT02824562|528383187|FG001|Overall Study|Death|1|||
146513000|NCT01172808|528383188|FG000|Overall Study|Adverse Event|8|||
146513001|NCT01172808|528383189|FG001|Overall Study|Adverse Event|4|||
146513002|NCT01172808|528383190|FG002|Overall Study|Adverse Event|8|||
146513003|NCT01172808|528383191|FG003|Overall Study|Adverse Event|3|||
146513004|NCT01172808|528383188|FG000|Overall Study|Lack of Efficacy|1|||
146513005|NCT01172808|528383189|FG001|Overall Study|Lack of Efficacy|0|||
146513006|NCT01172808|528383190|FG002|Overall Study|Lack of Efficacy|0|||
146513007|NCT01172808|528383191|FG003|Overall Study|Lack of Efficacy|0|||
146513008|NCT01172808|528383188|FG000|Overall Study|Protocol Violation|2|||
146513009|NCT01172808|528383189|FG001|Overall Study|Protocol Violation|2|||
146513010|NCT01172808|528383190|FG002|Overall Study|Protocol Violation|2|||
146513011|NCT01172808|528383191|FG003|Overall Study|Protocol Violation|0|||
146513012|NCT01172808|528383188|FG000|Overall Study|Lost to Follow-up|0|||
146513013|NCT01172808|528383189|FG001|Overall Study|Lost to Follow-up|1|||
146513014|NCT01172808|528383190|FG002|Overall Study|Lost to Follow-up|1|||
146513015|NCT01172808|528383191|FG003|Overall Study|Lost to Follow-up|3|||
146513016|NCT01172808|528383188|FG000|Overall Study|Withdrawal by Subject|4|||
146513017|NCT01172808|528383189|FG001|Overall Study|Withdrawal by Subject|1|||
146513018|NCT01172808|528383190|FG002|Overall Study|Withdrawal by Subject|3|||
146513019|NCT01172808|528383191|FG003|Overall Study|Withdrawal by Subject|2|||
146513020|NCT01172808|528383188|FG000|Overall Study|Other|6|||
146513021|NCT01172808|528383189|FG001|Overall Study|Other|5|||
146513022|NCT01172808|528383190|FG002|Overall Study|Other|9|||
146513023|NCT01172808|528383191|FG003|Overall Study|Other|7|||
146513024|NCT00290693|528383193|FG000|Overall Study|Withdrawal by Subject|2|||
146513025|NCT05625477|528383194|FG000|Overall Study|Lost to Follow-up|2|||
146513026|NCT05625477|528383195|FG001|Overall Study|Lost to Follow-up|2|||
146513027|NCT05625477|528383196|FG002|Overall Study|Lost to Follow-up|1|||
146513028|NCT05625477|528383197|FG003|Overall Study|Lost to Follow-up|1|||
146513029|NCT05625477|528383198|FG004|Overall Study|Lost to Follow-up|0|||
146513030|NCT05625477|528383194|FG000|Overall Study|Covid quarantine|1|||
146754821|NCT04955626|529268061|FG003|Open-Label Period|Death|0|||
146754822|NCT04955626|529268062|FG004|Open-Label Period|Death|0|||
146754823|NCT04955626|529268063|FG005|Open-Label Period|Death|0|||
146754824|NCT04955626|529268064|FG006|Open-Label Period|Death|0|||
146754825|NCT04955626|529268065|FG007|Open-Label Period|Death|0|||
146754826|NCT04955626|529268066|FG008|Open-Label Period|Death|0|||
146625240|NCT03037385|528803845|FG000|Overall Study|Death|1|||
146625241|NCT03037385|528803846|FG001|Overall Study|Death|4|||
146625242|NCT03037385|528803847|FG002|Overall Study|Death|2|||
146513031|NCT05625477|528383195|FG001|Overall Study|Covid quarantine|0|||
146513032|NCT05625477|528383196|FG002|Overall Study|Covid quarantine|0|||
146513033|NCT05625477|528383197|FG003|Overall Study|Covid quarantine|0|||
146754827|NCT04955626|529268067|FG009|Open-Label Period|Death|0|||
146754828|NCT04955626|529268068|FG010|Open-Label Period|Death|0|||
146754829|NCT04955626|529268069|FG011|Open-Label Period|Death|0|||
146513034|NCT05625477|528383198|FG004|Overall Study|Covid quarantine|0|||
146513035|NCT04849416|528383201|FG000|Overall Study|Ongoing Treatment|12|||
146513036|NCT04849416|528383202|FG001|Overall Study|Ongoing Treatment|5|||
146513037|NCT04849416|528383203|FG002|Overall Study|Ongoing Treatment|3|||
146513038|NCT04849416|528383201|FG000|Overall Study|On Post-Treatment Follow-up|8|||
146513039|NCT04849416|528383202|FG001|Overall Study|On Post-Treatment Follow-up|9|||
146625243|NCT03037385|528803848|FG003|Overall Study|Death|2|||
146754830|NCT04955626|529268070|FG012|Open-Label Period|Death|0|||
146513040|NCT04849416|528383203|FG002|Overall Study|On Post-Treatment Follow-up|10|||
146754831|NCT04955626|529268071|FG013|Open-Label Period|Death|0|||
146513041|NCT04849416|528383201|FG000|Overall Study|Withdrawal by Subject|0|||
146513042|NCT04849416|528383202|FG001|Overall Study|Withdrawal by Subject|0|||
146513043|NCT04849416|528383203|FG002|Overall Study|Withdrawal by Subject|1|||
146625244|NCT03037385|528803849|FG004|Overall Study|Death|5|||
146754832|NCT04955626|529268072|FG014|Open-Label Period|Death|0|||
146754833|NCT04955626|529268073|FG015|Open-Label Period|Death|0|||
146513044|NCT04849416|528383201|FG000|Overall Study|Lost to Follow-up|1|||
146513045|NCT04849416|528383202|FG001|Overall Study|Lost to Follow-up|0|||
146513046|NCT04849416|528383203|FG002|Overall Study|Lost to Follow-up|0|||
146513047|NCT01211483|528383206|FG000|Phase 1b|Death|6|||
146513048|NCT01211483|528383207|FG001|Phase 1b|Death|0|||
146513049|NCT01211483|528383208|FG002|Phase 1b|Death|0|||
146513050|NCT01211483|528383209|FG003|Phase 1b|Death|0|||
146513051|NCT01211483|528383206|FG000|Phase 1b|Withdrawal by Subject|1|||
146513052|NCT01211483|528383207|FG001|Phase 1b|Withdrawal by Subject|0|||
146513053|NCT01211483|528383208|FG002|Phase 1b|Withdrawal by Subject|0|||
146513054|NCT01211483|528383209|FG003|Phase 1b|Withdrawal by Subject|0|||
146513055|NCT01211483|528383206|FG000|Phase 2|Lost to Follow-up|0|||
146513056|NCT01211483|528383207|FG001|Phase 2|Lost to Follow-up|1|||
146513057|NCT01211483|528383208|FG002|Phase 2|Lost to Follow-up|1|||
146513058|NCT01211483|528383209|FG003|Phase 2|Lost to Follow-up|2|||
146513059|NCT01211483|528383206|FG000|Phase 2|Death|0|||
146513060|NCT01211483|528383207|FG001|Phase 2|Death|64|||
146513061|NCT01211483|528383208|FG002|Phase 2|Death|53|||
146513062|NCT01211483|528383209|FG003|Phase 2|Death|53|||
146513063|NCT01211483|528383206|FG000|Phase 2|Withdrawal by Subject|0|||
146513064|NCT01211483|528383207|FG001|Phase 2|Withdrawal by Subject|1|||
146513065|NCT01211483|528383208|FG002|Phase 2|Withdrawal by Subject|10|||
146513066|NCT01211483|528383209|FG003|Phase 2|Withdrawal by Subject|5|||
146513067|NCT01211483|528383206|FG000|Phase 2|Study terminated by Sponsor|0|||
146513068|NCT01211483|528383207|FG001|Phase 2|Study terminated by Sponsor|6|||
146513069|NCT01211483|528383208|FG002|Phase 2|Study terminated by Sponsor|8|||
146513070|NCT01211483|528383209|FG003|Phase 2|Study terminated by Sponsor|11|||
146513071|NCT02284568|528383210|FG000|Overall Study|Adverse Event|2|||
146513072|NCT02284568|528383211|FG001|Overall Study|Adverse Event|9|||
146513073|NCT02284568|528383212|FG002|Overall Study|Adverse Event|4|||
146513074|NCT02284568|528383210|FG000|Overall Study|Withdrawal by Subject|22|||
146513075|NCT02284568|528383211|FG001|Overall Study|Withdrawal by Subject|21|||
146513076|NCT02284568|528383212|FG002|Overall Study|Withdrawal by Subject|1|||
146513077|NCT02284568|528383210|FG000|Overall Study|Noncompliance with study drug admin|1|||
146513078|NCT02284568|528383211|FG001|Overall Study|Noncompliance with study drug admin|2|||
146513079|NCT02284568|528383212|FG002|Overall Study|Noncompliance with study drug admin|0|||
146513080|NCT02284568|528383210|FG000|Overall Study|Noncompliance|1|||
146513081|NCT02284568|528383211|FG001|Overall Study|Noncompliance|0|||
146513082|NCT02284568|528383212|FG002|Overall Study|Noncompliance|0|||
146513083|NCT02284568|528383210|FG000|Overall Study|Protocol Violation|0|||
146513084|NCT02284568|528383211|FG001|Overall Study|Protocol Violation|1|||
146513085|NCT02284568|528383212|FG002|Overall Study|Protocol Violation|0|||
146513086|NCT02284568|528383210|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
146513087|NCT02284568|528383211|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
146513088|NCT02284568|528383212|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
146513089|NCT02284568|528383210|FG000|Overall Study|Lost to Follow-up|0|||
146513090|NCT02284568|528383211|FG001|Overall Study|Lost to Follow-up|3|||
146513091|NCT02284568|528383212|FG002|Overall Study|Lost to Follow-up|0|||
146513092|NCT02284568|528383210|FG000|Overall Study|Lack of Efficacy|4|||
146513093|NCT02284568|528383211|FG001|Overall Study|Lack of Efficacy|7|||
146513094|NCT02284568|528383212|FG002|Overall Study|Lack of Efficacy|0|||
146513095|NCT02284568|528383210|FG000|Overall Study|Other|1|||
146513096|NCT02284568|528383211|FG001|Overall Study|Other|2|||
146513097|NCT02284568|528383212|FG002|Overall Study|Other|0|||
146513098|NCT02284568|528383210|FG000|Overall Study|Withdrew before taking study drug|0|||
146513099|NCT02284568|528383211|FG001|Overall Study|Withdrew before taking study drug|1|||
146513100|NCT02284568|528383212|FG002|Overall Study|Withdrew before taking study drug|0|||
146513101|NCT00460265|528383213|FG000|Overall Study|Lost to Follow-up|14|||
146513102|NCT00460265|528383214|FG001|Overall Study|Lost to Follow-up|15|||
146513103|NCT00460265|528383213|FG000|Overall Study|Physician Decision|1|||
146513104|NCT00460265|528383214|FG001|Overall Study|Physician Decision|2|||
146513105|NCT00460265|528383213|FG000|Overall Study|Withdrawal by Subject|10|||
146513106|NCT00460265|528383214|FG001|Overall Study|Withdrawal by Subject|25|||
146513107|NCT00460265|528383213|FG000|Overall Study|Ongoing|60|||
146513108|NCT00460265|528383214|FG001|Overall Study|Ongoing|47|||
146513109|NCT03411902|528383217|FG000|Overall Study|Lost to Follow-up|3|||
146513110|NCT03411902|528383218|FG001|Overall Study|Lost to Follow-up|0|||
146513111|NCT00574795|528383226|FG000|Infant Series|Withdrawal by Subject|2|||
146513112|NCT00574795|528383226|FG000|Infant Series|Protocol Violation|2|||
146513113|NCT00574795|528383226|FG000|Infant Series|Adverse Event|1|||
146513114|NCT00574795|528383226|FG000|After Infant Series|Withdrawal by Subject|1|||
146513115|NCT00574795|528383226|FG000|After Infant Series|Adverse Event|2|||
146513116|NCT00574795|528383226|FG000|Toddler Dose|Withdrawal by Subject|1|||
146513117|NCT00672841|528383227|FG000|Overall Study|Comfort care|1|||
146513118|NCT00672841|528383228|FG001|Overall Study|Comfort care|4|||
146513119|NCT00672841|528383227|FG000|Overall Study|icteric specimens|0|||
146513120|NCT00672841|528383228|FG001|Overall Study|icteric specimens|3|||
146513121|NCT00672841|528383227|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
146513122|NCT00672841|528383228|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
146513123|NCT00672841|528383227|FG000|Overall Study|Adverse Event|0|||
146513124|NCT00672841|528383228|FG001|Overall Study|Adverse Event|3|||
146513125|NCT00672841|528383227|FG000|Overall Study|Pregnancy|0|||
146513126|NCT00672841|528383228|FG001|Overall Study|Pregnancy|1|||
146513127|NCT02638259|528383229|FG000|Treatment Period 1|Adverse Event|1|||
146513128|NCT02638259|528383230|FG001|Treatment Period 1|Adverse Event|5|||
146513129|NCT02638259|528383229|FG000|Treatment Period 1|Death|0|||
146513130|NCT02638259|528383230|FG001|Treatment Period 1|Death|1|||
146513131|NCT02638259|528383229|FG000|Treatment Period 1|Lack of Efficacy|0|||
146513132|NCT02638259|528383230|FG001|Treatment Period 1|Lack of Efficacy|1|||
146513133|NCT02638259|528383229|FG000|Treatment Period 1|Protocol Violation|0|||
146513134|NCT02638259|528383230|FG001|Treatment Period 1|Protocol Violation|3|||
146513135|NCT02638259|528383229|FG000|Treatment Period 1|Withdrawal by Subject|4|||
146513136|NCT02638259|528383230|FG001|Treatment Period 1|Withdrawal by Subject|6|||
146513137|NCT02638259|528383229|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
146513138|NCT02638259|528383230|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
146513139|NCT02638259|528383229|FG000|Treatment Period 2|Adverse Event|5|||
146513140|NCT02638259|528383230|FG001|Treatment Period 2|Adverse Event|4|||
146513141|NCT02638259|528383229|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146513142|NCT02638259|528383230|FG001|Treatment Period 2|Withdrawal by Subject|7|||
146513143|NCT04299048|528383231|FG000|Overall Study|Death|1|||
146513144|NCT04299048|528383231|FG000|Overall Study|Global deterioration of health status|2|||
146513145|NCT04299048|528383231|FG000|Overall Study|Enrolled and not treated|1|||
146513146|NCT03677934|528383233|FG000|Overall Study|Adverse Event|1|||
146513147|NCT03677934|528383234|FG001|Overall Study|Adverse Event|1|||
146513148|NCT03677934|528383233|FG000|Overall Study|Death|8|||
146513149|NCT03677934|528383234|FG001|Overall Study|Death|4|||
146513150|NCT03677934|528383233|FG000|Overall Study|Lost to Follow-up|3|||
146513151|NCT03677934|528383234|FG001|Overall Study|Lost to Follow-up|0|||
146513152|NCT03677934|528383233|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146513153|NCT03677934|528383234|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146513154|NCT03677934|528383233|FG000|Overall Study|Physician Decision|0|||
146513155|NCT03677934|528383234|FG001|Overall Study|Physician Decision|1|||
146513156|NCT03677934|528383233|FG000|Overall Study|Withdrawal by Subject|1|||
146513157|NCT03677934|528383234|FG001|Overall Study|Withdrawal by Subject|7|||
146513158|NCT00335959|528383258|FG000|Overall Study|Adverse Event|2|||
146513159|NCT00335959|528383258|FG000|Overall Study|Ineligible|1|||
146513160|NCT01001598|528383259|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
146513161|NCT01001598|528383259|FG000|Overall Study|Adverse Event|1|||
146513162|NCT05079230|528383263|FG000|Overall Study|Study Terminated by Sponsor|101|||
146513163|NCT05079230|528383264|FG001|Overall Study|Study Terminated by Sponsor|102|||
146513164|NCT05079230|528383263|FG000|Overall Study|Death|72|||
146513165|NCT05079230|528383264|FG001|Overall Study|Death|66|||
146513166|NCT05079230|528383263|FG000|Overall Study|Withdrew Consent|16|||
146513167|NCT05079230|528383264|FG001|Overall Study|Withdrew Consent|18|||
146513168|NCT05079230|528383263|FG000|Overall Study|Lost to Follow-up|0|||
146513169|NCT05079230|528383264|FG001|Overall Study|Lost to Follow-up|3|||
146513170|NCT01524783|528383265|FG000|Blinded Period|Adverse Event|64|||
146513171|NCT01524783|528383266|FG001|Blinded Period|Adverse Event|7|||
146513172|NCT01524783|528383267|FG002|Blinded Period|Adverse Event|0|||
146513173|NCT01524783|528383265|FG000|Blinded Period|Disease Progression|89|||
146513174|NCT01524783|528383266|FG001|Blinded Period|Disease Progression|75|||
146513175|NCT01524783|528383267|FG002|Blinded Period|Disease Progression|0|||
146513176|NCT01524783|528383265|FG000|Blinded Period|Withdrawal by Subject|19|||
146513177|NCT01524783|528383266|FG001|Blinded Period|Withdrawal by Subject|6|||
146513178|NCT01524783|528383267|FG002|Blinded Period|Withdrawal by Subject|0|||
146513179|NCT01524783|528383265|FG000|Blinded Period|Protocol deviation|2|||
146513180|NCT01524783|528383266|FG001|Blinded Period|Protocol deviation|1|||
146513181|NCT01524783|528383267|FG002|Blinded Period|Protocol deviation|0|||
146513182|NCT01524783|528383265|FG000|Blinded Period|Death|5|||
146513183|NCT01524783|528383266|FG001|Blinded Period|Death|2|||
146513184|NCT01524783|528383267|FG002|Blinded Period|Death|0|||
146513185|NCT01524783|528383265|FG000|Open-label Period|Disease progression|13|||
146513186|NCT01524783|528383266|FG001|Open-label Period|Disease progression|0|||
146513187|NCT01524783|528383267|FG002|Open-label Period|Disease progression|2|||
146513188|NCT01524783|528383265|FG000|Open-label Period|Administrative problems|5|||
146513189|NCT01524783|528383266|FG001|Open-label Period|Administrative problems|0|||
146513190|NCT01524783|528383267|FG002|Open-label Period|Administrative problems|2|||
146513191|NCT01524783|528383265|FG000|Open-label Period|Adverse Event|5|||
146513192|NCT01524783|528383266|FG001|Open-label Period|Adverse Event|0|||
146513193|NCT01524783|528383267|FG002|Open-label Period|Adverse Event|1|||
146754834|NCT04955626|529268074|FG016|Open-Label Period|Death|0|||
146513194|NCT01524783|528383265|FG000|Open-label Period|Withdrawal by Subject|2|||
146513195|NCT01524783|528383266|FG001|Open-label Period|Withdrawal by Subject|0|||
146513196|NCT01524783|528383267|FG002|Open-label Period|Withdrawal by Subject|1|||
146513197|NCT01524783|528383265|FG000|Open-label Period|Protocol deviation|1|||
146513198|NCT01524783|528383266|FG001|Open-label Period|Protocol deviation|0|||
146513199|NCT01524783|528383267|FG002|Open-label Period|Protocol deviation|0|||
146513200|NCT03164265|528383269|FG000|Overall Study|Physician Decision|3|||
146754835|NCT04955626|529268075|FG017|Open-Label Period|Death|0|||
146513201|NCT02240069|528383270|FG000|Overall Study|Withdrawal by Subject|5|||
146513202|NCT02240069|528383271|FG001|Overall Study|Withdrawal by Subject|5|||
146513203|NCT02240069|528383272|FG002|Overall Study|Withdrawal by Subject|2|||
146513204|NCT01096589|528383273|FG000|Overall Study|Adverse Event|2|||
146513205|NCT01096589|528383274|FG001|Overall Study|Adverse Event|1|||
146513206|NCT01096589|528383275|FG002|Overall Study|Adverse Event|2|||
146513207|NCT01096589|528383276|FG003|Overall Study|Adverse Event|1|||
146513208|NCT01096589|528383273|FG000|Overall Study|Withdrawal by Subject|2|||
146513209|NCT01096589|528383274|FG001|Overall Study|Withdrawal by Subject|1|||
146513210|NCT01096589|528383275|FG002|Overall Study|Withdrawal by Subject|1|||
146513211|NCT01096589|528383276|FG003|Overall Study|Withdrawal by Subject|1|||
146513212|NCT01096589|528383273|FG000|Overall Study|Compliance with protocol|0|||
146513213|NCT01096589|528383274|FG001|Overall Study|Compliance with protocol|0|||
146513214|NCT01096589|528383275|FG002|Overall Study|Compliance with protocol|1|||
146513215|NCT01096589|528383276|FG003|Overall Study|Compliance with protocol|0|||
146513216|NCT01096589|528383273|FG000|Overall Study|found treatment exhausting|0|||
146513217|NCT01096589|528383274|FG001|Overall Study|found treatment exhausting|0|||
146513218|NCT01096589|528383275|FG002|Overall Study|found treatment exhausting|0|||
146513219|NCT01096589|528383276|FG003|Overall Study|found treatment exhausting|1|||
146513220|NCT00721279|528383277|FG000|Overall Study|Lack of Efficacy|6|||
146513221|NCT00721279|528383278|FG001|Overall Study|Lack of Efficacy|3|||
146513222|NCT00721279|528383277|FG000|Overall Study|Tolerability insufficient|5|||
146513223|NCT00721279|528383278|FG001|Overall Study|Tolerability insufficient|2|||
146513224|NCT00721279|528383277|FG000|Overall Study|Withdrawal by Subject|13|||
146513225|NCT00721279|528383278|FG001|Overall Study|Withdrawal by Subject|3|||
146513226|NCT00721279|528383277|FG000|Overall Study|Other|12|||
146513227|NCT00721279|528383278|FG001|Overall Study|Other|16|||
146513228|NCT03673345|528383279|FG000|Overall Study|Lost to Follow-up|1|||
146513229|NCT03673345|528383280|FG001|Overall Study|Lost to Follow-up|0|||
146513230|NCT03673345|528383281|FG002|Overall Study|Lost to Follow-up|3|||
146513231|NCT03673345|528383282|FG003|Overall Study|Lost to Follow-up|3|||
146513232|NCT03673345|528383283|FG004|Overall Study|Lost to Follow-up|2|||
146513233|NCT03673345|528383284|FG005|Overall Study|Lost to Follow-up|1|||
146513234|NCT03673345|528383285|FG006|Overall Study|Lost to Follow-up|0|||
146513235|NCT03673345|528383286|FG007|Overall Study|Lost to Follow-up|0|||
146513236|NCT03673345|528383279|FG000|Overall Study|Withdrawal by Subject|1|||
146513237|NCT03673345|528383280|FG001|Overall Study|Withdrawal by Subject|0|||
146513238|NCT03673345|528383281|FG002|Overall Study|Withdrawal by Subject|4|||
146513239|NCT03673345|528383282|FG003|Overall Study|Withdrawal by Subject|2|||
146513240|NCT03673345|528383283|FG004|Overall Study|Withdrawal by Subject|0|||
146513241|NCT03673345|528383284|FG005|Overall Study|Withdrawal by Subject|0|||
146513242|NCT03673345|528383285|FG006|Overall Study|Withdrawal by Subject|0|||
146513243|NCT03673345|528383286|FG007|Overall Study|Withdrawal by Subject|0|||
146513244|NCT03673345|528383279|FG000|Overall Study|Physician Decision|0|||
146513245|NCT03673345|528383280|FG001|Overall Study|Physician Decision|0|||
146513246|NCT03673345|528383281|FG002|Overall Study|Physician Decision|2|||
146513247|NCT03673345|528383282|FG003|Overall Study|Physician Decision|0|||
146513248|NCT03673345|528383283|FG004|Overall Study|Physician Decision|0|||
146513249|NCT03673345|528383284|FG005|Overall Study|Physician Decision|0|||
146513250|NCT03673345|528383285|FG006|Overall Study|Physician Decision|0|||
146513251|NCT03673345|528383286|FG007|Overall Study|Physician Decision|0|||
146513252|NCT05153148|528383287|FG000|Overall Study|Adverse Event|1|||
146754836|NCT04955626|529268076|FG018|Open-Label Period|Death|0|||
146754837|NCT04955626|529268077|FG019|Open-Label Period|Death|0|||
146754838|NCT04955626|529268078|FG020|Open-Label Period|Death|0|||
146754839|NCT04955626|529268079|FG021|Open-Label Period|Death|0|||
146754840|NCT04955626|529268080|FG022|Open-Label Period|Death|0|||
146754841|NCT04955626|529268081|FG023|Open-Label Period|Death|0|||
146754842|NCT04955626|529268082|FG024|Open-Label Period|Death|0|||
146754843|NCT04955626|529268083|FG025|Open-Label Period|Death|0|||
146754844|NCT04955626|529268084|FG026|Open-Label Period|Death|0|||
146754845|NCT04955626|529268085|FG027|Open-Label Period|Death|0|||
146754846|NCT04955626|529268086|FG028|Open-Label Period|Death|0|||
146754847|NCT04955626|529268087|FG029|Open-Label Period|Death|0|||
146754848|NCT04955626|529268088|FG030|Open-Label Period|Death|0|||
146754849|NCT04955626|529268089|FG031|Open-Label Period|Death|0|||
146754850|NCT04955626|529268090|FG032|Open-Label Period|Death|0|||
146754851|NCT04955626|529268091|FG033|Open-Label Period|Death|0|||
146965050|NCT03110107|530033440|FG014|Treatment Period|Study drug toxicity|2|||
146513253|NCT05153148|528383288|FG001|Overall Study|Adverse Event|0|||
146513254|NCT05153148|528383289|FG002|Overall Study|Adverse Event|3|||
146513255|NCT05153148|528383290|FG003|Overall Study|Adverse Event|5|||
146513256|NCT05153148|528383287|FG000|Overall Study|Lost to Follow-up|1|||
146513257|NCT05153148|528383288|FG001|Overall Study|Lost to Follow-up|1|||
146513258|NCT05153148|528383289|FG002|Overall Study|Lost to Follow-up|2|||
146513259|NCT05153148|528383290|FG003|Overall Study|Lost to Follow-up|0|||
146513260|NCT05153148|528383287|FG000|Overall Study|Withdrawal by Subject|6|||
146513261|NCT05153148|528383288|FG001|Overall Study|Withdrawal by Subject|8|||
146754852|NCT04955626|529268092|FG034|Open-Label Period|Death|0|||
146513262|NCT05153148|528383289|FG002|Overall Study|Withdrawal by Subject|6|||
146513263|NCT05153148|528383290|FG003|Overall Study|Withdrawal by Subject|8|||
146513264|NCT05153148|528383287|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
146513265|NCT05153148|528383288|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
146754853|NCT04955626|529268093|FG035|Open-Label Period|Death|0|||
146754854|NCT04955626|529268058|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
146754855|NCT04955626|529268059|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
146513266|NCT05153148|528383289|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
146513267|NCT05153148|528383290|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
146513268|NCT05153148|528383287|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
146513269|NCT05153148|528383288|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
146513270|NCT05153148|528383289|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
146513271|NCT05153148|528383290|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
146513272|NCT05153148|528383287|FG000|Overall Study|Reason not Specified|1|||
146513273|NCT05153148|528383288|FG001|Overall Study|Reason not Specified|1|||
146513274|NCT05153148|528383289|FG002|Overall Study|Reason not Specified|1|||
146513275|NCT05153148|528383290|FG003|Overall Study|Reason not Specified|1|||
146513276|NCT00232596|528383291|FG000|6-Week Titration Phase|Adverse Event|6|||
146513277|NCT00232596|528383292|FG001|6-Week Titration Phase|Adverse Event|19|||
146513278|NCT00232596|528383291|FG000|6-Week Titration Phase|Failed to Return|2|||
146513279|NCT00232596|528383292|FG001|6-Week Titration Phase|Failed to Return|1|||
146513280|NCT00232596|528383291|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
146513281|NCT00232596|528383292|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
146513282|NCT00232596|528383291|FG000|6-Week Titration Phase|Protocol Violation|1|||
146513283|NCT00232596|528383292|FG001|6-Week Titration Phase|Protocol Violation|3|||
146513284|NCT00232596|528383291|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
146513285|NCT00232596|528383292|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
146513286|NCT00232596|528383291|FG000|6-Week Titration Phase|Other|3|||
146513287|NCT00232596|528383292|FG001|6-Week Titration Phase|Other|3|||
146513288|NCT00232596|528383291|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
146513289|NCT00232596|528383292|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
146513290|NCT00232596|528383291|FG000|12-Week Maintenance Phase|Adverse Event|7|||
146513291|NCT00232596|528383292|FG001|12-Week Maintenance Phase|Adverse Event|22|||
146513292|NCT00232596|528383291|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
146513293|NCT00232596|528383292|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
146513294|NCT00232596|528383291|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
146513295|NCT00232596|528383292|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
146513296|NCT00232596|528383291|FG000|12-Week Maintenance Phase|Other|1|||
146513297|NCT00232596|528383292|FG001|12-Week Maintenance Phase|Other|3|||
146513298|NCT01253174|528383293|FG000|Period 1|Randomized but not treated|0|||
146513299|NCT01253174|528383294|FG001|Period 1|Randomized but not treated|1|||
146513300|NCT01253174|528383295|FG002|Period 1|Randomized but not treated|1|||
146513301|NCT01253174|528383296|FG003|Period 1|Randomized but not treated|0|||
146513302|NCT01253174|528383297|FG004|Period 1|Randomized but not treated|1|||
146513303|NCT01253174|528383298|FG005|Period 1|Randomized but not treated|0|||
146754856|NCT04955626|529268060|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
146754857|NCT04955626|529268061|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
146754858|NCT04955626|529268062|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
146754859|NCT04955626|529268063|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
146754860|NCT04955626|529268064|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
146754861|NCT04955626|529268065|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
146754862|NCT04955626|529268066|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
146754863|NCT04955626|529268067|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
146754864|NCT04955626|529268068|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
146754865|NCT04955626|529268069|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
146754866|NCT04955626|529268070|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
146754867|NCT04955626|529268071|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
146754868|NCT04955626|529268072|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
146754869|NCT04955626|529268073|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
146754870|NCT04955626|529268074|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
146754871|NCT04955626|529268075|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
146754872|NCT04955626|529268076|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
146754873|NCT04955626|529268077|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
146754874|NCT04955626|529268078|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
146754875|NCT04955626|529268079|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
146754876|NCT04955626|529268080|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
146754877|NCT04955626|529268081|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
146513304|NCT01253174|528383293|FG000|Period 2|Adverse Event|0|||
146513305|NCT01253174|528383294|FG001|Period 2|Adverse Event|0|||
146513306|NCT01253174|528383295|FG002|Period 2|Adverse Event|1|||
146513307|NCT01253174|528383296|FG003|Period 2|Adverse Event|0|||
146513308|NCT01253174|528383297|FG004|Period 2|Adverse Event|0|||
146513309|NCT01253174|528383298|FG005|Period 2|Adverse Event|0|||
146513310|NCT01253174|528383293|FG000|Period 3|Withdrawal by Subject|0|||
146513311|NCT01253174|528383294|FG001|Period 3|Withdrawal by Subject|1|||
146513312|NCT01253174|528383295|FG002|Period 3|Withdrawal by Subject|0|||
146513313|NCT01253174|528383296|FG003|Period 3|Withdrawal by Subject|0|||
146513314|NCT01253174|528383297|FG004|Period 3|Withdrawal by Subject|1|||
146513315|NCT01253174|528383298|FG005|Period 3|Withdrawal by Subject|0|||
146513316|NCT01253174|528383293|FG000|Period 3|Pregnancy|0|||
146513317|NCT01253174|528383294|FG001|Period 3|Pregnancy|0|||
146513318|NCT01253174|528383295|FG002|Period 3|Pregnancy|1|||
146513319|NCT01253174|528383296|FG003|Period 3|Pregnancy|0|||
146513320|NCT01253174|528383297|FG004|Period 3|Pregnancy|0|||
146513321|NCT01253174|528383298|FG005|Period 3|Pregnancy|0|||
146513322|NCT02267135|528383299|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
146513323|NCT02267135|528383300|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
146513324|NCT02267135|528383299|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
146852543|NCT04493502|529627947|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
146852544|NCT04493502|529627948|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
146852545|NCT04493502|529627947|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
146852546|NCT04493502|529627948|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
146852547|NCT04493502|529627947|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
146852548|NCT04493502|529627948|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
146852549|NCT04493502|529627947|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
146852550|NCT04493502|529627948|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
146852551|NCT04493502|529627947|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
146852552|NCT04493502|529627948|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
146852553|NCT04493502|529627947|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
146852554|NCT04493502|529627948|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
146852555|NCT04493502|529627947|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
146852556|NCT04493502|529627948|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
146852557|NCT04493502|529627947|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
146852558|NCT04493502|529627948|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
146852559|NCT04493502|529627947|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
146513325|NCT02267135|528383300|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
146513326|NCT02267135|528383299|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
146513327|NCT02267135|528383300|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
146513328|NCT02267135|528383299|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
146513329|NCT02267135|528383300|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
146513330|NCT02267135|528383299|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
146513331|NCT02267135|528383300|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
146513332|NCT03806231|528383301|FG000|Overall Study|Physician Decision|1|||
146513333|NCT03806231|528383302|FG001|Overall Study|Physician Decision|0|||
146513334|NCT03806231|528383301|FG000|Overall Study|Withdrawal by Subject|1|||
146513335|NCT03806231|528383302|FG001|Overall Study|Withdrawal by Subject|0|||
146513336|NCT00900731|528383303|FG000|Overall Study|Adverse Event|31|||
146513337|NCT00900731|528383304|FG001|Overall Study|Adverse Event|27|||
146513338|NCT00900731|528383303|FG000|Overall Study|Withdrawal by Subject|8|||
146513339|NCT00900731|528383304|FG001|Overall Study|Withdrawal by Subject|7|||
146513340|NCT00900731|528383303|FG000|Overall Study|Protocol Deviation|8|||
146513341|NCT00900731|528383304|FG001|Overall Study|Protocol Deviation|11|||
146513342|NCT00900731|528383303|FG000|Overall Study|Administrative Problems|5|||
146513343|NCT00900731|528383304|FG001|Overall Study|Administrative Problems|4|||
146852560|NCT04493502|529627948|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
146513344|NCT00900731|528383303|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
146513345|NCT00900731|528383304|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
146852561|NCT02533531|529627950|FG000|Overall Study|Device did not turn on|1|||
146852562|NCT02047903|529627951|FG000|Overall Study|Adverse Event|14|||
146513346|NCT00900731|528383303|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
146513347|NCT00900731|528383304|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
146513348|NCT00900731|528383303|FG000|Overall Study|Lost to Follow-up|2|||
146513349|NCT00900731|528383304|FG001|Overall Study|Lost to Follow-up|3|||
146513350|NCT00900731|528383303|FG000|Overall Study|Lack of Efficacy|1|||
146513351|NCT00900731|528383304|FG001|Overall Study|Lack of Efficacy|3|||
146513352|NCT00900731|528383303|FG000|Overall Study|Death|0|||
146513353|NCT00900731|528383304|FG001|Overall Study|Death|2|||
146513354|NCT02919267|528383305|FG000|Overall Study|Protocol Violation|0|||
146513355|NCT02919267|528383306|FG001|Overall Study|Protocol Violation|3|||
146513356|NCT02919267|528383307|FG002|Overall Study|Protocol Violation|3|||
146513357|NCT02919267|528383308|FG003|Overall Study|Protocol Violation|4|||
146513358|NCT03467763|528383309|FG000|Overall Study|Lost to Follow-up|1|||
146513359|NCT03467763|528383309|FG000|Overall Study|Protocol Violation|2|||
146513360|NCT00932698|528383310|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
146513361|NCT00932698|528383311|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
146513362|NCT00932698|528383312|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
146513363|NCT00932698|528383313|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
146513364|NCT00932698|528383314|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
146513365|NCT00932698|528383315|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
146513366|NCT00932698|528383316|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
146513367|NCT00932698|528383317|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
146513368|NCT00932698|528383318|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
146513369|NCT00932698|528383319|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
146513370|NCT00932698|528383320|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
146513371|NCT00932698|528383310|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
146513372|NCT00932698|528383311|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
146513373|NCT00932698|528383312|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
146513374|NCT00932698|528383313|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
146513375|NCT00932698|528383314|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
146513376|NCT00932698|528383315|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
146513377|NCT00932698|528383316|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
146513378|NCT00932698|528383317|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
146513379|NCT00932698|528383318|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
146513380|NCT00932698|528383319|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
146513381|NCT00932698|528383320|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
146513382|NCT00932698|528383310|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
146513383|NCT00932698|528383311|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
146513384|NCT00932698|528383312|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
146513385|NCT00932698|528383313|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
146513386|NCT00932698|528383314|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
146513387|NCT00932698|528383315|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
146513388|NCT00932698|528383316|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
146513389|NCT00932698|528383317|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
146513390|NCT00932698|528383318|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
146754878|NCT04955626|529268082|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
146754879|NCT04955626|529268083|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
146754880|NCT04955626|529268084|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
146754881|NCT04955626|529268085|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
146754882|NCT04955626|529268086|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
146754883|NCT04955626|529268087|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
146754884|NCT04955626|529268088|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
146513391|NCT00932698|528383319|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
146513392|NCT00932698|528383320|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
146513393|NCT00932698|528383310|FG000|Part 1 (Dose Escalation)|Other|0|||
146513394|NCT00932698|528383311|FG001|Part 1 (Dose Escalation)|Other|0|||
146513395|NCT00932698|528383312|FG002|Part 1 (Dose Escalation)|Other|1|||
146513396|NCT00932698|528383313|FG003|Part 1 (Dose Escalation)|Other|0|||
146513397|NCT00932698|528383314|FG004|Part 1 (Dose Escalation)|Other|0|||
146513398|NCT00932698|528383315|FG005|Part 1 (Dose Escalation)|Other|0|||
146513399|NCT00932698|528383316|FG006|Part 1 (Dose Escalation)|Other|1|||
146513400|NCT00932698|528383317|FG007|Part 1 (Dose Escalation)|Other|0|||
146513401|NCT00932698|528383318|FG008|Part 1 (Dose Escalation)|Other|0|||
146513402|NCT00932698|528383319|FG009|Part 1 (Dose Escalation)|Other|0|||
146513403|NCT00932698|528383320|FG010|Part 1 (Dose Escalation)|Other|0|||
146513404|NCT00932698|528383310|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
146513405|NCT00932698|528383311|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
146513406|NCT00932698|528383312|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
146513407|NCT00932698|528383313|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
146513408|NCT00932698|528383314|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
146513409|NCT00932698|528383315|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
146513410|NCT00932698|528383316|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
146513411|NCT00932698|528383317|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
146513412|NCT00932698|528383318|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
146513413|NCT00932698|528383319|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
146513414|NCT00932698|528383320|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
146513415|NCT00932698|528383310|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
146513416|NCT00932698|528383311|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
146513417|NCT00932698|528383312|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
146513418|NCT00932698|528383313|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
146513419|NCT00932698|528383314|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
146513420|NCT00932698|528383315|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
146513421|NCT00932698|528383316|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
146513422|NCT00932698|528383317|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
146513423|NCT00932698|528383318|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
146513424|NCT00932698|528383319|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
146513425|NCT00932698|528383320|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
146513426|NCT00932698|528383310|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
146513427|NCT00932698|528383311|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
146513428|NCT00932698|528383312|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
146513429|NCT00932698|528383313|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
146513430|NCT00932698|528383314|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
146513431|NCT00932698|528383315|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
146513432|NCT00932698|528383316|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
146513433|NCT00932698|528383317|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
146513434|NCT00932698|528383318|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
146513435|NCT00932698|528383319|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
146513436|NCT00932698|528383320|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
146513437|NCT00131365|528383323|FG000|Overall Study|Withdrawal by Subject|1|||
146513438|NCT00131365|528383323|FG000|Overall Study|Alternative treatment|3|||
146513439|NCT04608344|528383324|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
146513440|NCT04608344|528383325|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
146513441|NCT04608344|528383324|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
146513442|NCT04608344|528383325|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
146513443|NCT05249127|528383326|FG000|Overall Study|Protocol Violation|13|||
146513444|NCT05249127|528383326|FG000|Overall Study|Physician Decision|4|||
146513445|NCT05249127|528383326|FG000|Overall Study|Withdrawal by Subject|2|||
146513446|NCT05249127|528383326|FG000|Overall Study|Participant Non-compliance|1|||
146513447|NCT02908074|528383327|FG000|Overall Study|sponsor/ICON decision|0|||
146513448|NCT02908074|528383328|FG001|Overall Study|sponsor/ICON decision|0|||
146513449|NCT02908074|528383329|FG002|Overall Study|sponsor/ICON decision|1|||
146513450|NCT02908074|528383330|FG003|Overall Study|sponsor/ICON decision|0|||
146513451|NCT02908074|528383331|FG004|Overall Study|sponsor/ICON decision|0|||
146513452|NCT02908074|528383332|FG005|Overall Study|sponsor/ICON decision|0|||
146513453|NCT02908074|528383327|FG000|Overall Study|Protocol Violation|0|||
146513454|NCT02908074|528383328|FG001|Overall Study|Protocol Violation|1|||
146513455|NCT02908074|528383329|FG002|Overall Study|Protocol Violation|0|||
146513456|NCT02908074|528383330|FG003|Overall Study|Protocol Violation|0|||
146513457|NCT02908074|528383331|FG004|Overall Study|Protocol Violation|0|||
146513458|NCT02908074|528383332|FG005|Overall Study|Protocol Violation|0|||
146513459|NCT02908074|528383327|FG000|Overall Study|Adverse Event|5|||
146513460|NCT02908074|528383328|FG001|Overall Study|Adverse Event|2|||
146513461|NCT02908074|528383329|FG002|Overall Study|Adverse Event|0|||
146513462|NCT02908074|528383330|FG003|Overall Study|Adverse Event|0|||
146513463|NCT02908074|528383331|FG004|Overall Study|Adverse Event|1|||
146513464|NCT02908074|528383332|FG005|Overall Study|Adverse Event|0|||
146513465|NCT02908074|528383327|FG000|Overall Study|AESI|1|||
146513466|NCT02908074|528383328|FG001|Overall Study|AESI|0|||
146513467|NCT02908074|528383329|FG002|Overall Study|AESI|1|||
146513468|NCT02908074|528383330|FG003|Overall Study|AESI|0|||
146513469|NCT02908074|528383331|FG004|Overall Study|AESI|1|||
146513470|NCT02908074|528383332|FG005|Overall Study|AESI|0|||
146513471|NCT02908074|528383327|FG000|Overall Study|Discontinuation criteria per protocol|0|||
146513472|NCT02908074|528383328|FG001|Overall Study|Discontinuation criteria per protocol|0|||
146513473|NCT02908074|528383329|FG002|Overall Study|Discontinuation criteria per protocol|1|||
146513474|NCT02908074|528383330|FG003|Overall Study|Discontinuation criteria per protocol|0|||
146513475|NCT02908074|528383331|FG004|Overall Study|Discontinuation criteria per protocol|0|||
146513476|NCT02908074|528383332|FG005|Overall Study|Discontinuation criteria per protocol|1|||
146513477|NCT02908074|528383327|FG000|Overall Study|Withdrawal by Subject|3|||
146513478|NCT02908074|528383328|FG001|Overall Study|Withdrawal by Subject|2|||
146513479|NCT02908074|528383329|FG002|Overall Study|Withdrawal by Subject|2|||
146513480|NCT02908074|528383330|FG003|Overall Study|Withdrawal by Subject|2|||
146513481|NCT02908074|528383331|FG004|Overall Study|Withdrawal by Subject|2|||
146513482|NCT02908074|528383332|FG005|Overall Study|Withdrawal by Subject|2|||
146513483|NCT02908074|528383327|FG000|Overall Study|Lost to Follow-up|0|||
146513484|NCT02908074|528383328|FG001|Overall Study|Lost to Follow-up|1|||
146513485|NCT02908074|528383329|FG002|Overall Study|Lost to Follow-up|1|||
146513486|NCT02908074|528383330|FG003|Overall Study|Lost to Follow-up|1|||
146513487|NCT02908074|528383331|FG004|Overall Study|Lost to Follow-up|0|||
146513488|NCT02908074|528383332|FG005|Overall Study|Lost to Follow-up|1|||
146513489|NCT02073565|528383333|FG000|Cohort A|Withdrawal by Subject|1|||
146513490|NCT02073565|528383334|FG001|Cohort A|Withdrawal by Subject|0|||
146513491|NCT02073565|528383333|FG000|Cohort B|Withdrawal by Subject|1|||
146513492|NCT02073565|528383334|FG001|Cohort B|Withdrawal by Subject|2|||
146513493|NCT02073565|528383333|FG000|Cohort C|Withdrawal by Subject|0|||
146513494|NCT02073565|528383334|FG001|Cohort C|Withdrawal by Subject|2|||
146513495|NCT02073565|528383333|FG000|Cohort C|Lost to Follow-up|0|||
146513496|NCT02073565|528383334|FG001|Cohort C|Lost to Follow-up|2|||
146513497|NCT01554176|528383335|FG000|Treatment Phase|Protocol Violation|1|||
146513498|NCT01554176|528383336|FG001|Treatment Phase|Protocol Violation|2|||
146513499|NCT01554176|528383337|FG002|Treatment Phase|Protocol Violation|0|||
146513500|NCT01554176|528383338|FG003|Treatment Phase|Protocol Violation|0|||
146513501|NCT01554176|528383339|FG004|Treatment Phase|Protocol Violation|0|||
146513502|NCT01554176|528383335|FG000|Treatment Phase|Physician Decision|1|||
146513503|NCT01554176|528383336|FG001|Treatment Phase|Physician Decision|1|||
146513504|NCT01554176|528383337|FG002|Treatment Phase|Physician Decision|0|||
146513505|NCT01554176|528383338|FG003|Treatment Phase|Physician Decision|0|||
146513506|NCT01554176|528383339|FG004|Treatment Phase|Physician Decision|0|||
146513507|NCT01554176|528383335|FG000|Treatment Phase|Lack of Efficacy|0|||
146513508|NCT01554176|528383336|FG001|Treatment Phase|Lack of Efficacy|1|||
146513509|NCT01554176|528383337|FG002|Treatment Phase|Lack of Efficacy|0|||
146513510|NCT01554176|528383338|FG003|Treatment Phase|Lack of Efficacy|0|||
146513511|NCT01554176|528383339|FG004|Treatment Phase|Lack of Efficacy|0|||
146513512|NCT01554176|528383335|FG000|Treatment Phase|Adverse event, non-fatal|1|||
146513513|NCT01554176|528383336|FG001|Treatment Phase|Adverse event, non-fatal|1|||
146513514|NCT01554176|528383337|FG002|Treatment Phase|Adverse event, non-fatal|0|||
146513515|NCT01554176|528383338|FG003|Treatment Phase|Adverse event, non-fatal|0|||
146513516|NCT01554176|528383339|FG004|Treatment Phase|Adverse event, non-fatal|0|||
146513517|NCT01554176|528383335|FG000|Treatment Phase|Non-compliance with study drug|1|||
146513518|NCT01554176|528383336|FG001|Treatment Phase|Non-compliance with study drug|0|||
146513519|NCT01554176|528383337|FG002|Treatment Phase|Non-compliance with study drug|0|||
146513520|NCT01554176|528383338|FG003|Treatment Phase|Non-compliance with study drug|0|||
146513521|NCT01554176|528383339|FG004|Treatment Phase|Non-compliance with study drug|0|||
146513522|NCT01554176|528383335|FG000|Treatment Phase|Withdrawal by Subject|1|||
146513523|NCT01554176|528383336|FG001|Treatment Phase|Withdrawal by Subject|0|||
146513524|NCT01554176|528383337|FG002|Treatment Phase|Withdrawal by Subject|0|||
146513525|NCT01554176|528383338|FG003|Treatment Phase|Withdrawal by Subject|0|||
146513526|NCT01554176|528383339|FG004|Treatment Phase|Withdrawal by Subject|0|||
146513527|NCT01554176|528383335|FG000|Treatment Phase|Lost to Follow-up|3|||
146513528|NCT01554176|528383336|FG001|Treatment Phase|Lost to Follow-up|0|||
146513529|NCT01554176|528383337|FG002|Treatment Phase|Lost to Follow-up|0|||
146513530|NCT01554176|528383338|FG003|Treatment Phase|Lost to Follow-up|0|||
146513531|NCT01554176|528383339|FG004|Treatment Phase|Lost to Follow-up|0|||
146513532|NCT01554176|528383335|FG000|Run-out Phase|Protocol Violation|0|||
146513533|NCT01554176|528383336|FG001|Run-out Phase|Protocol Violation|0|||
146513534|NCT01554176|528383337|FG002|Run-out Phase|Protocol Violation|0|||
146513535|NCT01554176|528383338|FG003|Run-out Phase|Protocol Violation|1|||
146513536|NCT01554176|528383339|FG004|Run-out Phase|Protocol Violation|0|||
146513537|NCT02607306|528383342|FG000|Overall Study|Adverse Event|8|||
146513538|NCT02607306|528383343|FG001|Overall Study|Adverse Event|6|||
146513539|NCT02607306|528383344|FG002|Overall Study|Adverse Event|6|||
146513540|NCT02607306|528383342|FG000|Overall Study|Unclassified|1|||
146513541|NCT02607306|528383343|FG001|Overall Study|Unclassified|4|||
146513542|NCT02607306|528383344|FG002|Overall Study|Unclassified|0|||
146513543|NCT02607306|528383342|FG000|Overall Study|Withdrawal by Subject|8|||
146513544|NCT02607306|528383343|FG001|Overall Study|Withdrawal by Subject|10|||
146513545|NCT02607306|528383344|FG002|Overall Study|Withdrawal by Subject|2|||
146513546|NCT02607306|528383342|FG000|Overall Study|Lack of Efficacy|0|||
146513547|NCT02607306|528383343|FG001|Overall Study|Lack of Efficacy|1|||
146513548|NCT02607306|528383344|FG002|Overall Study|Lack of Efficacy|1|||
146513549|NCT02607306|528383342|FG000|Overall Study|Protocol Violation|4|||
146513550|NCT02607306|528383343|FG001|Overall Study|Protocol Violation|2|||
146513551|NCT02607306|528383344|FG002|Overall Study|Protocol Violation|1|||
146513552|NCT02333383|528383345|FG000|Overall Study|Adalimumab discontinuation|21|||
146513553|NCT02333383|528383345|FG000|Overall Study|Lost to Follow-up|15|||
146513554|NCT02333383|528383345|FG000|Overall Study|Withdrawal by Subject|3|||
146513555|NCT02333383|528383345|FG000|Overall Study|Transfer to another hospital|2|||
146513556|NCT00463840|528383346|FG000|Overall Study|Disease progression|7|||
146513557|NCT00463840|528383346|FG000|Overall Study|Withdrawal by Subject|2|||
146513558|NCT00463840|528383346|FG000|Overall Study|Adverse Event|3|||
146513559|NCT01653327|528383347|FG000|Overall Study|Withdrawal by Subject|1|||
146513560|NCT02227368|528384721|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
146513561|NCT02227368|528384722|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
146513562|NCT02227368|528384721|FG000|Overall Study|Lost to Follow-up|1|||
146513563|NCT02227368|528384722|FG001|Overall Study|Lost to Follow-up|0|||
146513564|NCT02227368|528384721|FG000|Overall Study|Adverse Event|1|||
146513565|NCT02227368|528384722|FG001|Overall Study|Adverse Event|0|||
146513566|NCT03959488|528384723|FG000|Season 1|Other|6|||
146513567|NCT03959488|528384724|FG001|Season 1|Other|7|||
146513568|NCT03959488|528384725|FG002|Season 1|Other|0|||
146513569|NCT03959488|528384726|FG003|Season 1|Other|0|||
146513570|NCT03959488|528384727|FG004|Season 1|Other|0|||
146513571|NCT03959488|528384723|FG000|Season 1|Withdrawal by parent/guardian|43|||
146513572|NCT03959488|528384724|FG001|Season 1|Withdrawal by parent/guardian|28|||
146513573|NCT03959488|528384725|FG002|Season 1|Withdrawal by parent/guardian|0|||
146513574|NCT03959488|528384726|FG003|Season 1|Withdrawal by parent/guardian|0|||
146513575|NCT03959488|528384727|FG004|Season 1|Withdrawal by parent/guardian|0|||
146513576|NCT03959488|528384723|FG000|Season 1|Due to COVID-19 pandemic|2|||
146513577|NCT03959488|528384724|FG001|Season 1|Due to COVID-19 pandemic|3|||
146513578|NCT03959488|528384725|FG002|Season 1|Due to COVID-19 pandemic|0|||
146513579|NCT03959488|528384726|FG003|Season 1|Due to COVID-19 pandemic|0|||
146513580|NCT03959488|528384727|FG004|Season 1|Due to COVID-19 pandemic|0|||
146513581|NCT03959488|528384723|FG000|Season 1|Lost to Follow-up|17|||
146513582|NCT03959488|528384724|FG001|Season 1|Lost to Follow-up|7|||
146513583|NCT03959488|528384725|FG002|Season 1|Lost to Follow-up|0|||
146852563|NCT02047903|529627951|FG000|Overall Study|Serious adverse event|10|||
146513584|NCT03959488|528384726|FG003|Season 1|Lost to Follow-up|0|||
146513585|NCT03959488|528384727|FG004|Season 1|Lost to Follow-up|0|||
146513586|NCT03959488|528384723|FG000|Season 1|Death|5|||
146513587|NCT03959488|528384724|FG001|Season 1|Death|1|||
146513588|NCT03959488|528384725|FG002|Season 1|Death|0|||
146513589|NCT03959488|528384726|FG003|Season 1|Death|0|||
146513590|NCT03959488|528384727|FG004|Season 1|Death|0|||
146513591|NCT03959488|528384723|FG000|Season 2|Other|0|||
146513592|NCT03959488|528384724|FG001|Season 2|Other|0|||
146513593|NCT03959488|528384725|FG002|Season 2|Other|2|||
146513594|NCT03959488|528384726|FG003|Season 2|Other|0|||
146513595|NCT03959488|528384727|FG004|Season 2|Other|0|||
146513596|NCT03959488|528384723|FG000|Season 2|Withdrawal by parent/guardian|0|||
146513597|NCT03959488|528384724|FG001|Season 2|Withdrawal by parent/guardian|0|||
146513598|NCT03959488|528384725|FG002|Season 2|Withdrawal by parent/guardian|3|||
146513599|NCT03959488|528384726|FG003|Season 2|Withdrawal by parent/guardian|1|||
146513600|NCT03959488|528384727|FG004|Season 2|Withdrawal by parent/guardian|1|||
146513601|NCT03959488|528384723|FG000|Season 2|Lost to Follow-up|0|||
146513602|NCT03959488|528384724|FG001|Season 2|Lost to Follow-up|0|||
146513603|NCT03959488|528384725|FG002|Season 2|Lost to Follow-up|1|||
146513604|NCT03959488|528384726|FG003|Season 2|Lost to Follow-up|0|||
146513605|NCT03959488|528384727|FG004|Season 2|Lost to Follow-up|1|||
146513606|NCT04767529|528384729|FG000|Overall Study|Adverse Event|0|||
146513607|NCT04767529|528384730|FG001|Overall Study|Adverse Event|4|||
146513608|NCT04767529|528384731|FG002|Overall Study|Adverse Event|3|||
146513609|NCT04767529|528384729|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
146513610|NCT04767529|528384730|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
146513611|NCT04767529|528384731|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
146513612|NCT04767529|528384729|FG000|Overall Study|Required use of a prohibited medication|0|||
146513613|NCT04767529|528384730|FG001|Overall Study|Required use of a prohibited medication|1|||
146513614|NCT04767529|528384731|FG002|Overall Study|Required use of a prohibited medication|0|||
146513615|NCT04767529|528384729|FG000|Overall Study|Withdrawal by Subject|7|||
146513616|NCT04767529|528384730|FG001|Overall Study|Withdrawal by Subject|5|||
146513617|NCT04767529|528384731|FG002|Overall Study|Withdrawal by Subject|4|||
146513618|NCT04767529|528384729|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
146513619|NCT04767529|528384730|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
146513620|NCT04767529|528384731|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
146513621|NCT04767529|528384729|FG000|Overall Study|Lost to Follow-up|0|||
146513622|NCT04767529|528384730|FG001|Overall Study|Lost to Follow-up|2|||
146513623|NCT04767529|528384731|FG002|Overall Study|Lost to Follow-up|3|||
146513624|NCT00981058|528384743|FG000|Overall Study|Progressive Disease|38|||
146513625|NCT00981058|528384744|FG001|Overall Study|Progressive Disease|31|||
146513626|NCT00981058|528384743|FG000|Overall Study|Lost to Follow-up|3|||
146513627|NCT00981058|528384744|FG001|Overall Study|Lost to Follow-up|2|||
146513628|NCT00981058|528384743|FG000|Overall Study|Physician Decision|4|||
146513629|NCT00981058|528384744|FG001|Overall Study|Physician Decision|5|||
146513630|NCT00981058|528384743|FG000|Overall Study|Randomization Error|0|||
146513631|NCT00981058|528384744|FG001|Overall Study|Randomization Error|1|||
146513632|NCT00981058|528384743|FG000|Overall Study|Withdrawal by Subject|24|||
146513633|NCT00981058|528384744|FG001|Overall Study|Withdrawal by Subject|22|||
146513634|NCT05916131|528384745|FG000|Overall Study|Lost to Follow-up|0|||
146513635|NCT05916131|528384746|FG001|Overall Study|Lost to Follow-up|0|||
146513636|NCT05916131|528384747|FG002|Overall Study|Lost to Follow-up|1|||
146513637|NCT05916131|528384748|FG003|Overall Study|Lost to Follow-up|0|||
146513638|NCT01636947|528384751|FG000|Overall Study|Not Treated|2|||
146513639|NCT01636947|528384752|FG001|Overall Study|Not Treated|2|||
146513640|NCT01636947|528384751|FG000|Overall Study|Lost to Follow-up|4|||
146852564|NCT02047903|529627951|FG000|Overall Study|Withdrawal by Subject|16|||
146852565|NCT02047903|529627951|FG000|Overall Study|Lost to Follow-up|4|||
146852566|NCT02047903|529627951|FG000|Overall Study|Reason not listed|6|||
146852567|NCT02047903|529627951|FG000|Overall Study|Not Treated|9|||
146513641|NCT01636947|528384752|FG001|Overall Study|Lost to Follow-up|0|||
146513642|NCT01636947|528384751|FG000|Overall Study|Protocol Violation|1|||
146513643|NCT01636947|528384752|FG001|Overall Study|Protocol Violation|1|||
146513644|NCT01636947|528384751|FG000|Overall Study|Withdrawal by Subject|3|||
146513645|NCT01636947|528384752|FG001|Overall Study|Withdrawal by Subject|3|||
146513646|NCT01636947|528384751|FG000|Overall Study|Adverse Event|1|||
146513647|NCT01636947|528384752|FG001|Overall Study|Adverse Event|1|||
146513648|NCT01636947|528384751|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
146513649|NCT01636947|528384752|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
146513650|NCT02719353|528384763|FG000|First Intervention|Physician Decision|0|||
146513651|NCT02719353|528384764|FG001|First Intervention|Physician Decision|1|||
146513652|NCT03956615|528384766|FG000|Overall Study|No multiple myeloma confirmed|2|||
146513653|NCT03956615|528384766|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
146513654|NCT03956615|528384766|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
146852568|NCT01877837|529630111|FG000|Overall Study|Lost to Follow-up|1|||
146852569|NCT01877837|529630111|FG000|Overall Study|Ineligible|4|||
146852570|NCT01773291|529630114|FG000|Overall Study|Protocol Violation|1|||
146852571|NCT01773291|529630115|FG001|Overall Study|Protocol Violation|0|||
146852572|NCT01773291|529630116|FG002|Overall Study|Protocol Violation|0|||
146852573|NCT01773291|529630114|FG000|Overall Study|Withdrawal by Subject|0|||
146852574|NCT01773291|529630115|FG001|Overall Study|Withdrawal by Subject|0|||
146852575|NCT01773291|529630116|FG002|Overall Study|Withdrawal by Subject|1|||
146852576|NCT01491672|529630117|FG000|Overall Study|Lost to Follow-up|0|||
146852577|NCT01491672|529630118|FG001|Overall Study|Lost to Follow-up|4|||
146852578|NCT01491672|529630119|FG002|Overall Study|Lost to Follow-up|1|||
146852579|NCT01491672|529630117|FG000|Overall Study|Withdrawal by Subject|6|||
146852580|NCT01491672|529630118|FG001|Overall Study|Withdrawal by Subject|7|||
146852581|NCT01491672|529630119|FG002|Overall Study|Withdrawal by Subject|0|||
146852582|NCT01491672|529630117|FG000|Overall Study|Adverse Event|8|||
146852583|NCT01491672|529630118|FG001|Overall Study|Adverse Event|10|||
146852584|NCT01491672|529630119|FG002|Overall Study|Adverse Event|4|||
146852585|NCT01491672|529630117|FG000|Overall Study|Disease progression|42|||
146852586|NCT01491672|529630118|FG001|Overall Study|Disease progression|34|||
146852587|NCT01491672|529630119|FG002|Overall Study|Disease progression|6|||
146852588|NCT01491672|529630117|FG000|Overall Study|Protocol deviation|0|||
146852589|NCT01491672|529630118|FG001|Overall Study|Protocol deviation|1|||
146852590|NCT01491672|529630119|FG002|Overall Study|Protocol deviation|0|||
146852591|NCT01491672|529630117|FG000|Overall Study|Death|0|||
146852592|NCT01491672|529630118|FG001|Overall Study|Death|4|||
146852593|NCT01491672|529630119|FG002|Overall Study|Death|0|||
146852594|NCT02336178|529630120|FG000|Overall Study|Lost to Follow-up|1|||
146852595|NCT02336178|529630120|FG000|Overall Study|Protocol Violation|1|||
146852596|NCT02336178|529630120|FG000|Overall Study|Withdrawal by Subject|1|||
146852597|NCT02336178|529630120|FG000|Overall Study|Other|1|||
146852598|NCT03310268|529630121|FG000|Overall Study|(Not specified)|1|||
146852599|NCT03310268|529630122|FG001|Overall Study|(Not specified)|5|||
146852600|NCT03310268|529630123|FG002|Overall Study|(Not specified)|0|||
146852601|NCT00706433|529630127|FG000|Overall Study|Lost to Follow-up|3|||
146852602|NCT00706433|529630128|FG001|Overall Study|Lost to Follow-up|1|||
146852603|NCT00706433|529630129|FG002|Overall Study|Lost to Follow-up|6|||
146852604|NCT00706433|529630130|FG003|Overall Study|Lost to Follow-up|0|||
146852605|NCT00706433|529630127|FG000|Overall Study|Withdrawal by Subject|1|||
146852606|NCT00706433|529630128|FG001|Overall Study|Withdrawal by Subject|2|||
146852607|NCT00706433|529630129|FG002|Overall Study|Withdrawal by Subject|3|||
146852608|NCT00706433|529630130|FG003|Overall Study|Withdrawal by Subject|1|||
146852609|NCT00706433|529630127|FG000|Overall Study|Adverse Event|0|||
146852610|NCT00706433|529630128|FG001|Overall Study|Adverse Event|0|||
146852611|NCT00706433|529630129|FG002|Overall Study|Adverse Event|1|||
146852612|NCT00706433|529630130|FG003|Overall Study|Adverse Event|0|||
146852613|NCT00706433|529630127|FG000|Overall Study|Protocol Violation|1|||
146852614|NCT00706433|529630128|FG001|Overall Study|Protocol Violation|0|||
146852615|NCT00706433|529630129|FG002|Overall Study|Protocol Violation|0|||
146852616|NCT00706433|529630130|FG003|Overall Study|Protocol Violation|0|||
146852617|NCT00706433|529630127|FG000|Overall Study|new job|0|||
146852618|NCT00706433|529630128|FG001|Overall Study|new job|0|||
146852619|NCT00706433|529630129|FG002|Overall Study|new job|0|||
146852620|NCT00706433|529630130|FG003|Overall Study|new job|1|||
146852621|NCT01236365|529630132|FG000|Overall Study|Lost to Follow-up|0|||
146852622|NCT01236365|529630133|FG001|Overall Study|Lost to Follow-up|2|||
146852623|NCT01236365|529630132|FG000|Overall Study|Moved Out of State|1|||
146852624|NCT01236365|529630133|FG001|Overall Study|Moved Out of State|0|||
146852625|NCT01236365|529630132|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
146852626|NCT01236365|529630133|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
146852627|NCT01874431|529630135|FG000|Overall Study|Physician Decision|0|||
146852628|NCT01874431|529630136|FG001|Overall Study|Physician Decision|0|||
146852629|NCT01874431|529630137|FG002|Overall Study|Physician Decision|1|||
146852630|NCT01874431|529630138|FG003|Overall Study|Physician Decision|0|||
146852631|NCT01874431|529630139|FG004|Overall Study|Physician Decision|0|||
146852632|NCT01874431|529630140|FG005|Overall Study|Physician Decision|0|||
146852633|NCT01874431|529630141|FG006|Overall Study|Physician Decision|0|||
146852634|NCT01874431|529630142|FG007|Overall Study|Physician Decision|0|||
146852635|NCT01874431|529630135|FG000|Overall Study|Adverse Event|5|||
146852636|NCT01874431|529630136|FG001|Overall Study|Adverse Event|4|||
146852637|NCT01874431|529630137|FG002|Overall Study|Adverse Event|6|||
146852638|NCT01874431|529630138|FG003|Overall Study|Adverse Event|5|||
146852639|NCT01874431|529630139|FG004|Overall Study|Adverse Event|2|||
146852640|NCT01874431|529630140|FG005|Overall Study|Adverse Event|8|||
146852641|NCT01874431|529630141|FG006|Overall Study|Adverse Event|2|||
146852642|NCT01874431|529630142|FG007|Overall Study|Adverse Event|3|||
146852643|NCT01874431|529630135|FG000|Overall Study|Protocol Violation|1|||
146852644|NCT01874431|529630136|FG001|Overall Study|Protocol Violation|1|||
146852645|NCT01874431|529630137|FG002|Overall Study|Protocol Violation|1|||
146852646|NCT01874431|529630138|FG003|Overall Study|Protocol Violation|0|||
146852647|NCT01874431|529630139|FG004|Overall Study|Protocol Violation|3|||
146852648|NCT01874431|529630140|FG005|Overall Study|Protocol Violation|2|||
146852649|NCT01874431|529630141|FG006|Overall Study|Protocol Violation|1|||
146513655|NCT03956615|528384766|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
146513656|NCT00412217|528384767|FG000|Overall Study|Insufficient Data Available|8|||
146513657|NCT00412217|528384768|FG001|Overall Study|Insufficient Data Available|3|||
146513658|NCT00412217|528384767|FG000|Overall Study|Death|5|||
146513659|NCT00412217|528384768|FG001|Overall Study|Death|4|||
146513660|NCT00412217|528384767|FG000|Overall Study|Disease Progression|2|||
146513661|NCT00412217|528384768|FG001|Overall Study|Disease Progression|3|||
146513662|NCT00412217|528384767|FG000|Overall Study|Investigator Decision|1|||
146513663|NCT00412217|528384768|FG001|Overall Study|Investigator Decision|0|||
146513664|NCT00412217|528384767|FG000|Overall Study|Withdrawal by Subject|2|||
146513665|NCT00412217|528384768|FG001|Overall Study|Withdrawal by Subject|0|||
146513666|NCT00412217|528384767|FG000|Overall Study|Lost to Follow-up|1|||
146513667|NCT00412217|528384768|FG001|Overall Study|Lost to Follow-up|4|||
146513668|NCT00412217|528384767|FG000|Overall Study|Study Terminated by Sponsor|26|||
146513669|NCT00412217|528384768|FG001|Overall Study|Study Terminated by Sponsor|33|||
146513670|NCT00412217|528384767|FG000|Overall Study|Other|1|||
146513671|NCT00412217|528384768|FG001|Overall Study|Other|1|||
146513672|NCT01069419|528384769|FG000|Overall Study|Adverse Event|233|||
146513673|NCT01069419|528384769|FG000|Overall Study|Lack of Efficacy|332|||
146513674|NCT01069419|528384769|FG000|Overall Study|Lost to Follow-up|49|||
146513675|NCT01069419|528384769|FG000|Overall Study|Remission of disease|11|||
146513676|NCT01069419|528384769|FG000|Overall Study|Withdrawal by Subject|34|||
146513677|NCT01069419|528384769|FG000|Overall Study|Other Reason|43|||
146513678|NCT01069419|528384769|FG000|Overall Study|Missing termination information|13|||
146513679|NCT00904839|528384772|FG000|Overall Study|Adverse Event|0|||
146513680|NCT00904839|528384773|FG001|Overall Study|Adverse Event|5|||
146513681|NCT00904839|528384774|FG002|Overall Study|Adverse Event|4|||
146513682|NCT00904839|528384772|FG000|Overall Study|Protocol Violation|0|||
146513683|NCT00904839|528384773|FG001|Overall Study|Protocol Violation|1|||
146513684|NCT00904839|528384774|FG002|Overall Study|Protocol Violation|1|||
146513685|NCT00904839|528384772|FG000|Overall Study|Lost to Follow-up|0|||
146513686|NCT00904839|528384773|FG001|Overall Study|Lost to Follow-up|1|||
146513687|NCT00904839|528384774|FG002|Overall Study|Lost to Follow-up|2|||
146513688|NCT00904839|528384772|FG000|Overall Study|Withdrawal by Subject|0|||
146513689|NCT00904839|528384773|FG001|Overall Study|Withdrawal by Subject|2|||
146513690|NCT00904839|528384774|FG002|Overall Study|Withdrawal by Subject|0|||
146513691|NCT00904839|528384772|FG000|Overall Study|Not treated|1|||
146513692|NCT00904839|528384773|FG001|Overall Study|Not treated|0|||
146513693|NCT00904839|528384774|FG002|Overall Study|Not treated|1|||
146513694|NCT00904839|528384772|FG000|Overall Study|Other than above|0|||
146754885|NCT04955626|529268089|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
146754886|NCT04955626|529268090|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
146754887|NCT04955626|529268091|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
146754888|NCT04955626|529268092|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
146754889|NCT04955626|529268093|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
146754890|NCT04955626|529268058|FG000|Open-Label Period|Other|621|||
146754891|NCT04955626|529268059|FG001|Open-Label Period|Other|429|||
146754892|NCT04955626|529268060|FG002|Open-Label Period|Other|0|||
146754893|NCT04955626|529268061|FG003|Open-Label Period|Other|0|||
146754894|NCT04955626|529268062|FG004|Open-Label Period|Other|0|||
146754895|NCT04955626|529268063|FG005|Open-Label Period|Other|0|||
146754896|NCT04955626|529268064|FG006|Open-Label Period|Other|0|||
146754897|NCT04955626|529268065|FG007|Open-Label Period|Other|0|||
146754898|NCT04955626|529268066|FG008|Open-Label Period|Other|0|||
146754899|NCT04955626|529268067|FG009|Open-Label Period|Other|0|||
146754900|NCT04955626|529268068|FG010|Open-Label Period|Other|0|||
146754901|NCT04955626|529268069|FG011|Open-Label Period|Other|0|||
146754902|NCT04955626|529268070|FG012|Open-Label Period|Other|0|||
146754903|NCT04955626|529268071|FG013|Open-Label Period|Other|0|||
146754904|NCT04955626|529268072|FG014|Open-Label Period|Other|0|||
146754905|NCT04955626|529268073|FG015|Open-Label Period|Other|0|||
146754906|NCT04955626|529268074|FG016|Open-Label Period|Other|0|||
146754907|NCT04955626|529268075|FG017|Open-Label Period|Other|0|||
146754908|NCT04955626|529268076|FG018|Open-Label Period|Other|0|||
146513695|NCT00904839|528384773|FG001|Overall Study|Other than above|9|||
146513696|NCT00904839|528384774|FG002|Overall Study|Other than above|7|||
146513697|NCT04521114|528384777|FG000|Overall Study|Lost to Follow-up|1|||
146513698|NCT04521114|528384778|FG001|Overall Study|Lost to Follow-up|2|||
146513699|NCT04521114|528384779|FG002|Overall Study|Lost to Follow-up|0|||
146754909|NCT04955626|529268077|FG019|Open-Label Period|Other|0|||
146754910|NCT04955626|529268078|FG020|Open-Label Period|Other|0|||
146513700|NCT04521114|528384777|FG000|Overall Study|Withdrawal by Subject|1|||
146513701|NCT04521114|528384778|FG001|Overall Study|Withdrawal by Subject|2|||
146513702|NCT04521114|528384779|FG002|Overall Study|Withdrawal by Subject|2|||
146513703|NCT04521114|528384777|FG000|Overall Study|Adverse Event|1|||
146513704|NCT04521114|528384778|FG001|Overall Study|Adverse Event|0|||
146513705|NCT04521114|528384779|FG002|Overall Study|Adverse Event|0|||
146754911|NCT04955626|529268079|FG021|Open-Label Period|Other|0|||
146754912|NCT04955626|529268080|FG022|Open-Label Period|Other|0|||
146754913|NCT04955626|529268081|FG023|Open-Label Period|Other|0|||
146754914|NCT04955626|529268082|FG024|Open-Label Period|Other|0|||
146852650|NCT01874431|529630142|FG007|Overall Study|Protocol Violation|1|||
146852651|NCT01874431|529630135|FG000|Overall Study|Non-compliance|0|||
146852652|NCT01874431|529630136|FG001|Overall Study|Non-compliance|0|||
146852653|NCT01874431|529630137|FG002|Overall Study|Non-compliance|0|||
146852654|NCT01874431|529630138|FG003|Overall Study|Non-compliance|0|||
146852655|NCT01874431|529630139|FG004|Overall Study|Non-compliance|1|||
146852656|NCT01874431|529630140|FG005|Overall Study|Non-compliance|0|||
146852657|NCT01874431|529630141|FG006|Overall Study|Non-compliance|1|||
146852658|NCT01874431|529630142|FG007|Overall Study|Non-compliance|0|||
146852659|NCT01874431|529630135|FG000|Overall Study|Logistical difficulties|0|||
146852660|NCT01874431|529630136|FG001|Overall Study|Logistical difficulties|0|||
146852661|NCT01874431|529630137|FG002|Overall Study|Logistical difficulties|0|||
146852662|NCT01874431|529630138|FG003|Overall Study|Logistical difficulties|0|||
146852663|NCT01874431|529630139|FG004|Overall Study|Logistical difficulties|0|||
146852664|NCT01874431|529630140|FG005|Overall Study|Logistical difficulties|0|||
146852665|NCT01874431|529630141|FG006|Overall Study|Logistical difficulties|1|||
146852666|NCT01874431|529630142|FG007|Overall Study|Logistical difficulties|0|||
146852667|NCT01874431|529630135|FG000|Overall Study|Withdrawal by Subject|0|||
146852668|NCT01874431|529630136|FG001|Overall Study|Withdrawal by Subject|0|||
146852669|NCT01874431|529630137|FG002|Overall Study|Withdrawal by Subject|1|||
146852670|NCT01874431|529630138|FG003|Overall Study|Withdrawal by Subject|2|||
146852671|NCT01874431|529630139|FG004|Overall Study|Withdrawal by Subject|1|||
146852672|NCT01874431|529630140|FG005|Overall Study|Withdrawal by Subject|1|||
146852673|NCT01874431|529630141|FG006|Overall Study|Withdrawal by Subject|3|||
146852674|NCT01874431|529630142|FG007|Overall Study|Withdrawal by Subject|0|||
146852675|NCT01874431|529630135|FG000|Overall Study|Sponsor decision|0|||
146852676|NCT01874431|529630136|FG001|Overall Study|Sponsor decision|0|||
146852677|NCT01874431|529630137|FG002|Overall Study|Sponsor decision|0|||
146852678|NCT01874431|529630138|FG003|Overall Study|Sponsor decision|0|||
146852679|NCT01874431|529630139|FG004|Overall Study|Sponsor decision|1|||
146513706|NCT04521114|528384777|FG000|Overall Study|Sponsor Wish|1|||
146513707|NCT04521114|528384778|FG001|Overall Study|Sponsor Wish|0|||
146513708|NCT04521114|528384779|FG002|Overall Study|Sponsor Wish|0|||
146513709|NCT04521114|528384777|FG000|Overall Study|Withdrawal of Consent|2|||
146513710|NCT04521114|528384778|FG001|Overall Study|Withdrawal of Consent|2|||
146513711|NCT04521114|528384779|FG002|Overall Study|Withdrawal of Consent|0|||
146513712|NCT02854605|528384780|FG000|Overall Study|Adverse Event|1|||
146513713|NCT02854605|528384781|FG001|Overall Study|Adverse Event|5|||
146513714|NCT02854605|528384782|FG002|Overall Study|Adverse Event|2|||
146513715|NCT02854605|528384780|FG000|Overall Study|Lost to Follow-up|0|||
146513716|NCT02854605|528384781|FG001|Overall Study|Lost to Follow-up|2|||
146513717|NCT02854605|528384782|FG002|Overall Study|Lost to Follow-up|0|||
146513718|NCT02854605|528384780|FG000|Overall Study|Withdrew Consent|1|||
146513719|NCT02854605|528384781|FG001|Overall Study|Withdrew Consent|0|||
146513720|NCT02854605|528384782|FG002|Overall Study|Withdrew Consent|1|||
146513721|NCT02854605|528384780|FG000|Overall Study|Investigator's Discretion|1|||
146513722|NCT02854605|528384781|FG001|Overall Study|Investigator's Discretion|0|||
146513723|NCT02854605|528384782|FG002|Overall Study|Investigator's Discretion|0|||
146513724|NCT02854605|528384780|FG000|Overall Study|Protocol Violation|0|||
146513725|NCT02854605|528384781|FG001|Overall Study|Protocol Violation|0|||
146513726|NCT02854605|528384782|FG002|Overall Study|Protocol Violation|1|||
146513727|NCT00568334|528384783|FG000|Overall Study|Withdrawal by Subject|0|||
146513728|NCT00568334|528384784|FG001|Overall Study|Withdrawal by Subject|1|||
146513729|NCT00568334|528384783|FG000|Overall Study|Lost to Follow-up|1|||
146513730|NCT00568334|528384784|FG001|Overall Study|Lost to Follow-up|0|||
146513731|NCT01897571|528384785|FG000|Overall Study|Lost to Follow-up|3|||
146513732|NCT01897571|528384786|FG001|Overall Study|Lost to Follow-up|0|||
146513733|NCT01897571|528384787|FG002|Overall Study|Lost to Follow-up|0|||
146513734|NCT01897571|528384788|FG003|Overall Study|Lost to Follow-up|0|||
146513735|NCT01897571|528384789|FG004|Overall Study|Lost to Follow-up|2|||
146513736|NCT01897571|528384790|FG005|Overall Study|Lost to Follow-up|0|||
146513737|NCT01897571|528384791|FG006|Overall Study|Lost to Follow-up|0|||
146513738|NCT01897571|528384792|FG007|Overall Study|Lost to Follow-up|0|||
146513739|NCT01897571|528384793|FG008|Overall Study|Lost to Follow-up|1|||
146513740|NCT01897571|528384794|FG009|Overall Study|Lost to Follow-up|2|||
146513741|NCT01897571|528384795|FG010|Overall Study|Lost to Follow-up|4|||
146513742|NCT01897571|528384785|FG000|Overall Study|Withdrawal by Subject|0|||
146513743|NCT01897571|528384786|FG001|Overall Study|Withdrawal by Subject|0|||
146513744|NCT01897571|528384787|FG002|Overall Study|Withdrawal by Subject|0|||
146513745|NCT01897571|528384788|FG003|Overall Study|Withdrawal by Subject|0|||
146513746|NCT01897571|528384789|FG004|Overall Study|Withdrawal by Subject|0|||
146513747|NCT01897571|528384790|FG005|Overall Study|Withdrawal by Subject|0|||
146513748|NCT01897571|528384791|FG006|Overall Study|Withdrawal by Subject|0|||
146513749|NCT01897571|528384792|FG007|Overall Study|Withdrawal by Subject|1|||
146513750|NCT01897571|528384793|FG008|Overall Study|Withdrawal by Subject|4|||
146513751|NCT01897571|528384794|FG009|Overall Study|Withdrawal by Subject|3|||
146513752|NCT01897571|528384795|FG010|Overall Study|Withdrawal by Subject|1|||
146513753|NCT01897571|528384785|FG000|Overall Study|Other|1|||
146513754|NCT01897571|528384786|FG001|Overall Study|Other|0|||
146513755|NCT01897571|528384787|FG002|Overall Study|Other|0|||
146513756|NCT01897571|528384788|FG003|Overall Study|Other|3|||
146513757|NCT01897571|528384789|FG004|Overall Study|Other|3|||
146513758|NCT01897571|528384790|FG005|Overall Study|Other|4|||
146513759|NCT01897571|528384791|FG006|Overall Study|Other|7|||
146513760|NCT01897571|528384792|FG007|Overall Study|Other|0|||
146513761|NCT01897571|528384793|FG008|Overall Study|Other|0|||
146513762|NCT01897571|528384794|FG009|Overall Study|Other|0|||
146513763|NCT01897571|528384795|FG010|Overall Study|Other|0|||
146513764|NCT01897571|528384785|FG000|Overall Study|Enrolled in rollover study|0|||
146513765|NCT01897571|528384786|FG001|Overall Study|Enrolled in rollover study|0|||
146513766|NCT01897571|528384787|FG002|Overall Study|Enrolled in rollover study|0|||
146513767|NCT01897571|528384788|FG003|Overall Study|Enrolled in rollover study|0|||
146513768|NCT01897571|528384789|FG004|Overall Study|Enrolled in rollover study|0|||
146513769|NCT01897571|528384790|FG005|Overall Study|Enrolled in rollover study|0|||
146513770|NCT01897571|528384791|FG006|Overall Study|Enrolled in rollover study|0|||
146513771|NCT01897571|528384792|FG007|Overall Study|Enrolled in rollover study|9|||
146513772|NCT01897571|528384793|FG008|Overall Study|Enrolled in rollover study|7|||
146513773|NCT01897571|528384794|FG009|Overall Study|Enrolled in rollover study|9|||
146513774|NCT01897571|528384795|FG010|Overall Study|Enrolled in rollover study|1|||
146754915|NCT04955626|529268083|FG025|Open-Label Period|Other|0|||
146754916|NCT04955626|529268084|FG026|Open-Label Period|Other|0|||
146754917|NCT04955626|529268085|FG027|Open-Label Period|Other|0|||
146754918|NCT04955626|529268086|FG028|Open-Label Period|Other|0|||
146754919|NCT04955626|529268087|FG029|Open-Label Period|Other|0|||
146513775|NCT01897571|528384785|FG000|Overall Study|Death|2|||
146513776|NCT01897571|528384786|FG001|Overall Study|Death|2|||
146513777|NCT01897571|528384787|FG002|Overall Study|Death|3|||
146513778|NCT01897571|528384788|FG003|Overall Study|Death|6|||
146513779|NCT01897571|528384789|FG004|Overall Study|Death|7|||
146513780|NCT01897571|528384790|FG005|Overall Study|Death|9|||
146754920|NCT04955626|529268088|FG030|Open-Label Period|Other|0|||
146852680|NCT01874431|529630140|FG005|Overall Study|Sponsor decision|0|||
146852681|NCT01874431|529630141|FG006|Overall Study|Sponsor decision|0|||
146852682|NCT01874431|529630142|FG007|Overall Study|Sponsor decision|0|||
146852683|NCT01874431|529630135|FG000|Overall Study|Lost to Follow-up|0|||
146852684|NCT01874431|529630136|FG001|Overall Study|Lost to Follow-up|0|||
146852685|NCT01874431|529630137|FG002|Overall Study|Lost to Follow-up|1|||
146852686|NCT01874431|529630138|FG003|Overall Study|Lost to Follow-up|0|||
146852687|NCT01874431|529630139|FG004|Overall Study|Lost to Follow-up|0|||
146852688|NCT01874431|529630140|FG005|Overall Study|Lost to Follow-up|0|||
146852689|NCT01874431|529630141|FG006|Overall Study|Lost to Follow-up|0|||
146852690|NCT01874431|529630142|FG007|Overall Study|Lost to Follow-up|0|||
146852691|NCT00545051|529630143|FG000|Overall Study|Adverse Event|7|||
146852692|NCT00545051|529630144|FG001|Overall Study|Adverse Event|3|||
146852693|NCT00545051|529630143|FG000|Overall Study|Death|1|||
146852694|NCT00545051|529630144|FG001|Overall Study|Death|0|||
146852695|NCT00545051|529630143|FG000|Overall Study|Violation of inclusion/exclusion|0|||
146852696|NCT00545051|529630144|FG001|Overall Study|Violation of inclusion/exclusion|2|||
146852697|NCT00545051|529630143|FG000|Overall Study|Protocol Violation|1|||
146852698|NCT00545051|529630144|FG001|Overall Study|Protocol Violation|0|||
146852699|NCT00545051|529630143|FG000|Overall Study|Withdrawal by Subject|0|||
146852700|NCT00545051|529630144|FG001|Overall Study|Withdrawal by Subject|1|||
146852701|NCT00545051|529630143|FG000|Overall Study|Administrative reasons|0|||
146852702|NCT00545051|529630144|FG001|Overall Study|Administrative reasons|1|||
146852703|NCT03271021|529630146|FG000|Overall Study|Adverse Event|3|||
146852704|NCT03271021|529630147|FG001|Overall Study|Adverse Event|2|||
146852705|NCT03271021|529630146|FG000|Overall Study|Withdrawal by Subject|36|||
146852706|NCT03271021|529630147|FG001|Overall Study|Withdrawal by Subject|53|||
146852707|NCT03271021|529630146|FG000|Overall Study|Lost to Follow-up|34|||
146852708|NCT03271021|529630147|FG001|Overall Study|Lost to Follow-up|39|||
146852709|NCT03271021|529630146|FG000|Overall Study|Protocol Violation|6|||
146852710|NCT03271021|529630147|FG001|Overall Study|Protocol Violation|4|||
146852711|NCT03271021|529630146|FG000|Overall Study|Abnormal Lab Results|1|||
146852712|NCT03271021|529630147|FG001|Overall Study|Abnormal Lab Results|0|||
146852713|NCT03271021|529630146|FG000|Overall Study|Miscellaneous|9|||
146852714|NCT03271021|529630147|FG001|Overall Study|Miscellaneous|8|||
146852715|NCT01474434|529630148|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
146852716|NCT01474434|529630149|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
146852717|NCT01474434|529630150|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
146852718|NCT01474434|529630151|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
146852719|NCT01474434|529630148|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
146852720|NCT01474434|529630149|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
146852721|NCT01474434|529630150|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
146852722|NCT01474434|529630151|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
146852723|NCT01474434|529630148|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
146852724|NCT01474434|529630149|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
146852725|NCT01474434|529630150|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
146852726|NCT01474434|529630151|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
146852727|NCT02207569|529630152|FG000|1-Month|Death|6|||
146852728|NCT02207569|529630152|FG000|1-Month|Withdrawal by Subject|2|||
146852729|NCT02207569|529630152|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
146852730|NCT02207569|529630152|FG000|6-Month|Death|8|||
146852731|NCT02207569|529630152|FG000|6-Month|Withdrawal by Subject|2|||
146852732|NCT02207569|529630152|FG000|12-Month|Death|14|||
146965051|NCT03110107|530033441|FG015|Treatment Period|Study drug toxicity|3|||
146852733|NCT02207569|529630152|FG000|12-Month|Withdrawal by Subject|2|||
146852734|NCT02207569|529630152|FG000|24-Month|Death|23|||
146852735|NCT02207569|529630152|FG000|24-Month|Withdrawal by Subject|3|||
146852736|NCT02207569|529630152|FG000|36-Month|Death|23|||
146852737|NCT02207569|529630152|FG000|36-Month|Withdrawal by Subject|4|||
146852738|NCT02207569|529630152|FG000|48-Month|Death|25|||
146852739|NCT02207569|529630152|FG000|48-Month|Withdrawal by Subject|2|||
146852740|NCT02207569|529630152|FG000|48-Month|Lost to Follow-up|4|||
146852741|NCT02207569|529630152|FG000|60-Month|Death|1|||
146852742|NCT02207569|529630152|FG000|60-Month|Lost to Follow-up|1|||
146852743|NCT02207569|529630152|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
146513781|NCT01897571|528384791|FG006|Overall Study|Death|5|||
146513782|NCT01897571|528384792|FG007|Overall Study|Death|22|||
146513783|NCT01897571|528384793|FG008|Overall Study|Death|23|||
146513784|NCT01897571|528384794|FG009|Overall Study|Death|129|||
146513785|NCT01897571|528384795|FG010|Overall Study|Death|59|||
146513786|NCT01797094|528384796|FG000|Overall Study|Adverse Event|1|||
146513787|NCT01797094|528384797|FG001|Overall Study|Adverse Event|1|||
146513788|NCT01797094|528384796|FG000|Overall Study|Personal Reasons|4|||
146513789|NCT01797094|528384797|FG001|Overall Study|Personal Reasons|0|||
146513790|NCT01797094|528384796|FG000|Overall Study|Protocol Violation|0|||
146513791|NCT01797094|528384797|FG001|Overall Study|Protocol Violation|1|||
146513792|NCT01797094|528384796|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146513793|NCT01797094|528384797|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146513794|NCT03217968|528384798|FG000|Overall Study|Withdrawal by Subject|4|||
146513795|NCT03217968|528384798|FG000|Overall Study|Lost to Follow-up|1|||
146513796|NCT03217968|528384798|FG000|Overall Study|Protocol Violation|6|||
146513797|NCT05268016|528384801|FG000|Overall Study|Unacceptable toxicity or AE|2|||
146513798|NCT05268016|528384802|FG001|Overall Study|Unacceptable toxicity or AE|2|||
146513799|NCT05268016|528384803|FG002|Overall Study|Unacceptable toxicity or AE|4|||
146513800|NCT05268016|528384804|FG003|Overall Study|Unacceptable toxicity or AE|3|||
146513801|NCT05268016|528384805|FG004|Overall Study|Unacceptable toxicity or AE|1|||
146513802|NCT05268016|528384801|FG000|Overall Study|Withdrawal by Subject|1|||
146513803|NCT05268016|528384802|FG001|Overall Study|Withdrawal by Subject|3|||
146513804|NCT05268016|528384803|FG002|Overall Study|Withdrawal by Subject|2|||
146754921|NCT04955626|529268089|FG031|Open-Label Period|Other|0|||
146754922|NCT04955626|529268090|FG032|Open-Label Period|Other|0|||
146754923|NCT04955626|529268091|FG033|Open-Label Period|Other|0|||
146754924|NCT04955626|529268092|FG034|Open-Label Period|Other|0|||
146754925|NCT04955626|529268093|FG035|Open-Label Period|Other|0|||
146754926|NCT04955626|529268058|FG000|Open-Label Period|Physician Decision|2|||
146754927|NCT04955626|529268059|FG001|Open-Label Period|Physician Decision|0|||
146754928|NCT04955626|529268060|FG002|Open-Label Period|Physician Decision|0|||
146754929|NCT04955626|529268061|FG003|Open-Label Period|Physician Decision|0|||
146754930|NCT04955626|529268062|FG004|Open-Label Period|Physician Decision|0|||
146754931|NCT04955626|529268063|FG005|Open-Label Period|Physician Decision|0|||
146754932|NCT04955626|529268064|FG006|Open-Label Period|Physician Decision|0|||
146754933|NCT04955626|529268065|FG007|Open-Label Period|Physician Decision|0|||
146754934|NCT04955626|529268066|FG008|Open-Label Period|Physician Decision|0|||
146754935|NCT04955626|529268067|FG009|Open-Label Period|Physician Decision|0|||
146754936|NCT04955626|529268068|FG010|Open-Label Period|Physician Decision|0|||
146754937|NCT04955626|529268069|FG011|Open-Label Period|Physician Decision|0|||
146754938|NCT04955626|529268070|FG012|Open-Label Period|Physician Decision|0|||
146754939|NCT04955626|529268071|FG013|Open-Label Period|Physician Decision|0|||
146754940|NCT04955626|529268072|FG014|Open-Label Period|Physician Decision|0|||
146754941|NCT04955626|529268073|FG015|Open-Label Period|Physician Decision|0|||
146754942|NCT04955626|529268074|FG016|Open-Label Period|Physician Decision|0|||
146754943|NCT04955626|529268075|FG017|Open-Label Period|Physician Decision|0|||
146754944|NCT04955626|529268076|FG018|Open-Label Period|Physician Decision|0|||
146754945|NCT04955626|529268077|FG019|Open-Label Period|Physician Decision|0|||
146754946|NCT04955626|529268078|FG020|Open-Label Period|Physician Decision|0|||
146754947|NCT04955626|529268079|FG021|Open-Label Period|Physician Decision|0|||
146754948|NCT04955626|529268080|FG022|Open-Label Period|Physician Decision|0|||
146754949|NCT04955626|529268081|FG023|Open-Label Period|Physician Decision|0|||
146754950|NCT04955626|529268082|FG024|Open-Label Period|Physician Decision|0|||
146754951|NCT04955626|529268083|FG025|Open-Label Period|Physician Decision|0|||
146754952|NCT04955626|529268084|FG026|Open-Label Period|Physician Decision|0|||
146754953|NCT04955626|529268085|FG027|Open-Label Period|Physician Decision|0|||
146754954|NCT04955626|529268086|FG028|Open-Label Period|Physician Decision|0|||
146754955|NCT04955626|529268087|FG029|Open-Label Period|Physician Decision|0|||
146513805|NCT05268016|528384804|FG003|Overall Study|Withdrawal by Subject|2|||
146513806|NCT05268016|528384805|FG004|Overall Study|Withdrawal by Subject|1|||
146513807|NCT05268016|528384801|FG000|Overall Study|Lost to Follow-up|4|||
146513808|NCT05268016|528384802|FG001|Overall Study|Lost to Follow-up|7|||
146513809|NCT05268016|528384803|FG002|Overall Study|Lost to Follow-up|1|||
146513810|NCT05268016|528384804|FG003|Overall Study|Lost to Follow-up|3|||
146513811|NCT05268016|528384805|FG004|Overall Study|Lost to Follow-up|5|||
146754956|NCT04955626|529268088|FG030|Open-Label Period|Physician Decision|0|||
146754957|NCT04955626|529268089|FG031|Open-Label Period|Physician Decision|0|||
146754958|NCT04955626|529268090|FG032|Open-Label Period|Physician Decision|0|||
146754959|NCT04955626|529268091|FG033|Open-Label Period|Physician Decision|0|||
146754960|NCT04955626|529268092|FG034|Open-Label Period|Physician Decision|0|||
146754961|NCT04955626|529268093|FG035|Open-Label Period|Physician Decision|0|||
146754962|NCT04955626|529268058|FG000|Open-Label Period|Withdrawal by Subject|135|||
146754963|NCT04955626|529268059|FG001|Open-Label Period|Withdrawal by Subject|25|||
146513812|NCT05268016|528384801|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
146513813|NCT05268016|528384802|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
146852744|NCT02207569|529630152|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
146513814|NCT05268016|528384803|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
146513815|NCT05268016|528384804|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
146513816|NCT05268016|528384805|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
146513817|NCT05268016|528384801|FG000|Overall Study|Lack of Efficacy|0|||
146513818|NCT05268016|528384802|FG001|Overall Study|Lack of Efficacy|0|||
146513819|NCT05268016|528384803|FG002|Overall Study|Lack of Efficacy|0|||
146513820|NCT05268016|528384804|FG003|Overall Study|Lack of Efficacy|0|||
146513821|NCT05268016|528384805|FG004|Overall Study|Lack of Efficacy|4|||
146513822|NCT05268016|528384801|FG000|Overall Study|Physician Decision|0|||
146513823|NCT05268016|528384802|FG001|Overall Study|Physician Decision|0|||
146513824|NCT05268016|528384803|FG002|Overall Study|Physician Decision|0|||
146513825|NCT05268016|528384804|FG003|Overall Study|Physician Decision|1|||
146513826|NCT05268016|528384805|FG004|Overall Study|Physician Decision|0|||
146513827|NCT05268016|528384801|FG000|Overall Study|Other|1|||
146513828|NCT05268016|528384802|FG001|Overall Study|Other|0|||
146513829|NCT05268016|528384803|FG002|Overall Study|Other|1|||
146513830|NCT05268016|528384804|FG003|Overall Study|Other|2|||
146513831|NCT05268016|528384805|FG004|Overall Study|Other|0|||
146513832|NCT00089635|528384806|FG000|Overall Study|Adverse Event|2|||
146513833|NCT00089635|528384806|FG000|Overall Study|Death|17|||
146513834|NCT00089635|528384806|FG000|Overall Study|Disease Progression|12|||
146513835|NCT00089635|528384806|FG000|Overall Study|Lost to Follow-up|3|||
146513836|NCT00089635|528384806|FG000|Overall Study|Withdrawal by Subject|6|||
146513837|NCT00089635|528384806|FG000|Overall Study|Ineligibility determined|1|||
146513838|NCT00089635|528384806|FG000|Overall Study|Other|2|||
146513839|NCT00821015|528384809|FG000|Overall Study|Lost to Follow-up|12|||
146513840|NCT01887678|528384810|FG000|Overall Study|Adverse Event|4|||
146513841|NCT01887678|528384811|FG001|Overall Study|Adverse Event|6|||
146513842|NCT01887678|528384810|FG000|Overall Study|Exceeded rescue medication dosage|4|||
146513843|NCT01887678|528384811|FG001|Overall Study|Exceeded rescue medication dosage|5|||
146513844|NCT01887678|528384810|FG000|Overall Study|Withdrawal of consent|3|||
146513845|NCT01887678|528384811|FG001|Overall Study|Withdrawal of consent|4|||
146513846|NCT01887678|528384810|FG000|Overall Study|Lost to Follow-up|4|||
146513847|NCT01887678|528384811|FG001|Overall Study|Lost to Follow-up|2|||
146513848|NCT01887678|528384810|FG000|Overall Study|Deterioration of clinical condition|0|||
146513849|NCT01887678|528384811|FG001|Overall Study|Deterioration of clinical condition|4|||
146513850|NCT01887678|528384810|FG000|Overall Study|Lack of Efficacy|1|||
146513851|NCT01887678|528384811|FG001|Overall Study|Lack of Efficacy|2|||
146513852|NCT01887678|528384810|FG000|Overall Study|Non-compliance|0|||
146513853|NCT01887678|528384811|FG001|Overall Study|Non-compliance|3|||
146513854|NCT01887678|528384810|FG000|Overall Study|Specified|1|||
146513855|NCT01887678|528384811|FG001|Overall Study|Specified|2|||
146513856|NCT00270231|528384820|FG000|First Intervention|Lost to Follow-up|1|||
146513857|NCT00270231|528384821|FG001|First Intervention|Lost to Follow-up|1|||
146513858|NCT00270231|528384820|FG000|Washout Period|Lost to Follow-up|1|||
146513859|NCT00270231|528384821|FG001|Washout Period|Lost to Follow-up|0|||
146513860|NCT00270231|528384820|FG000|Second Intervention|Lost to Follow-up|0|||
146513861|NCT00270231|528384821|FG001|Second Intervention|Lost to Follow-up|1|||
146513862|NCT01080391|528384830|FG000|Overall Study|Randomized but not treated|7|||
146513863|NCT01080391|528384831|FG001|Overall Study|Randomized but not treated|4|||
146513864|NCT00106639|528384834|FG000|Overall Study|Adverse Event|3|||
146513865|NCT00106639|528384835|FG001|Overall Study|Adverse Event|4|||
146513866|NCT00106639|528384836|FG002|Overall Study|Adverse Event|1|||
146513867|NCT00106639|528384834|FG000|Overall Study|Protocol Violation|0|||
146513868|NCT00106639|528384835|FG001|Overall Study|Protocol Violation|1|||
146513869|NCT00106639|528384836|FG002|Overall Study|Protocol Violation|0|||
146513870|NCT00106639|528384834|FG000|Overall Study|Withdrawal by Subject|0|||
146513871|NCT00106639|528384835|FG001|Overall Study|Withdrawal by Subject|1|||
146513872|NCT00106639|528384836|FG002|Overall Study|Withdrawal by Subject|0|||
146513873|NCT00106639|528384834|FG000|Overall Study|Participant defaulted|0|||
146513874|NCT00106639|528384835|FG001|Overall Study|Participant defaulted|1|||
146513875|NCT00106639|528384836|FG002|Overall Study|Participant defaulted|1|||
146513876|NCT01876979|528384837|FG000|Overall Study|Physician Decision|2|||
146513877|NCT01876979|528384838|FG001|Overall Study|Physician Decision|3|||
146513878|NCT01712334|528384842|FG000|Treatment Period 1|Randomized in Error|0|||
146513879|NCT01712334|528384843|FG001|Treatment Period 1|Randomized in Error|2|||
146513880|NCT03646305|528384844|FG000|Overall Study|Lost to Follow-up|4|||
146513881|NCT03646305|528384845|FG001|Overall Study|Lost to Follow-up|2|||
146513882|NCT03646305|528384846|FG002|Overall Study|Lost to Follow-up|2|||
146513883|NCT03646305|528384847|FG003|Overall Study|Lost to Follow-up|1|||
146513884|NCT03646305|528384844|FG000|Overall Study|Withdrawal by Subject|1|||
146513885|NCT03646305|528384845|FG001|Overall Study|Withdrawal by Subject|0|||
146513886|NCT03646305|528384846|FG002|Overall Study|Withdrawal by Subject|0|||
146513887|NCT03646305|528384847|FG003|Overall Study|Withdrawal by Subject|1|||
146513888|NCT04683939|528384854|FG000|Overall Study|Study termination by the sponsor|0|||
146513889|NCT04683939|528384855|FG001|Overall Study|Study termination by the sponsor|1|||
146513890|NCT04683939|528384856|FG002|Overall Study|Study termination by the sponsor|2|||
146513891|NCT04683939|528384857|FG003|Overall Study|Study termination by the sponsor|2|||
146513892|NCT04683939|528384854|FG000|Overall Study|Death|1|||
146513893|NCT04683939|528384855|FG001|Overall Study|Death|1|||
146513894|NCT04683939|528384856|FG002|Overall Study|Death|2|||
146513895|NCT04683939|528384857|FG003|Overall Study|Death|1|||
146513896|NCT04683939|528384854|FG000|Overall Study|Withdrawal by Subject|1|||
146513897|NCT04683939|528384855|FG001|Overall Study|Withdrawal by Subject|0|||
146513898|NCT04683939|528384856|FG002|Overall Study|Withdrawal by Subject|0|||
146513899|NCT04683939|528384857|FG003|Overall Study|Withdrawal by Subject|0|||
146513900|NCT04683939|528384854|FG000|Overall Study|Physician Decision|1|||
146513901|NCT04683939|528384855|FG001|Overall Study|Physician Decision|0|||
146513902|NCT04683939|528384856|FG002|Overall Study|Physician Decision|0|||
146513903|NCT04683939|528384857|FG003|Overall Study|Physician Decision|0|||
146513904|NCT04683939|528384854|FG000|Overall Study|Lost to Follow-up|0|||
146513905|NCT04683939|528384855|FG001|Overall Study|Lost to Follow-up|1|||
146513906|NCT04683939|528384856|FG002|Overall Study|Lost to Follow-up|0|||
146513907|NCT04683939|528384857|FG003|Overall Study|Lost to Follow-up|0|||
146513908|NCT02510820|528386591|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
146513909|NCT02510820|528386592|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
146513910|NCT02510820|528386591|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
146513911|NCT02510820|528386592|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
146513912|NCT03046056|528386593|FG000|Overall Study|Non-responder at Week 10|6|||
146513913|NCT03046056|528386594|FG001|Overall Study|Non-responder at Week 10|6|||
146513914|NCT03046056|528386595|FG002|Overall Study|Non-responder at Week 10|4|||
146513915|NCT03046056|528386593|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
146513916|NCT03046056|528386594|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
146513917|NCT03046056|528386595|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
146513918|NCT03046056|528386593|FG000|Overall Study|Adverse Event|1|||
146513919|NCT03046056|528386594|FG001|Overall Study|Adverse Event|5|||
146513920|NCT03046056|528386595|FG002|Overall Study|Adverse Event|0|||
146513921|NCT03046056|528386593|FG000|Overall Study|Non-compliance With Study Drug|0|||
146513922|NCT03046056|528386594|FG001|Overall Study|Non-compliance With Study Drug|0|||
146513923|NCT03046056|528386595|FG002|Overall Study|Non-compliance With Study Drug|2|||
146513924|NCT03046056|528386593|FG000|Overall Study|Protocol Violation|1|||
146513925|NCT03046056|528386594|FG001|Overall Study|Protocol Violation|1|||
146513926|NCT03046056|528386595|FG002|Overall Study|Protocol Violation|0|||
146513927|NCT03046056|528386593|FG000|Overall Study|Investigator's Discretion|0|||
146513928|NCT03046056|528386594|FG001|Overall Study|Investigator's Discretion|1|||
146513929|NCT03046056|528386595|FG002|Overall Study|Investigator's Discretion|0|||
146513930|NCT03046056|528386593|FG000|Overall Study|Withdrew Consent|1|||
146513931|NCT03046056|528386594|FG001|Overall Study|Withdrew Consent|0|||
146513932|NCT03046056|528386595|FG002|Overall Study|Withdrew Consent|0|||
146513933|NCT03089853|528386596|FG000|Overall Study|Lost to Follow-up|2|||
146513934|NCT03089853|528386597|FG001|Overall Study|Lost to Follow-up|1|||
146513935|NCT00642954|528386598|FG000|Overall Study|Progressive Disease|3|||
146513936|NCT00642954|528386599|FG001|Overall Study|Progressive Disease|3|||
146513937|NCT00642954|528386600|FG002|Overall Study|Progressive Disease|3|||
146513938|NCT00642954|528386601|FG003|Overall Study|Progressive Disease|3|||
146513939|NCT00642954|528386602|FG004|Overall Study|Progressive Disease|9|||
146513940|NCT00642954|528386598|FG000|Overall Study|Withdrawal by Subject|0|||
146513941|NCT00642954|528386599|FG001|Overall Study|Withdrawal by Subject|0|||
146513942|NCT00642954|528386600|FG002|Overall Study|Withdrawal by Subject|0|||
146513943|NCT00642954|528386601|FG003|Overall Study|Withdrawal by Subject|0|||
146513944|NCT00642954|528386602|FG004|Overall Study|Withdrawal by Subject|1|||
146513945|NCT00642954|528386598|FG000|Overall Study|Adverse Event|1|||
146513946|NCT00642954|528386599|FG001|Overall Study|Adverse Event|1|||
146965052|NCT03110107|530033442|FG016|Treatment Period|Study drug toxicity|3|||
146513947|NCT00642954|528386600|FG002|Overall Study|Adverse Event|0|||
146513948|NCT00642954|528386601|FG003|Overall Study|Adverse Event|0|||
146513949|NCT00642954|528386602|FG004|Overall Study|Adverse Event|6|||
146513950|NCT02913105|528386603|FG000|Overall Study|Adverse Event|11|||
146513951|NCT02913105|528386604|FG001|Overall Study|Adverse Event|0|||
146513952|NCT02913105|528386605|FG002|Overall Study|Adverse Event|4|||
146513953|NCT02913105|528386603|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146513954|NCT02913105|528386604|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146513955|NCT02913105|528386605|FG002|Overall Study|Non-Compliance With Study Drug|1|||
146513956|NCT02913105|528386603|FG000|Overall Study|Reason Not Specified|3|||
146513957|NCT02913105|528386604|FG001|Overall Study|Reason Not Specified|1|||
146513958|NCT02913105|528386605|FG002|Overall Study|Reason Not Specified|1|||
146513959|NCT02913105|528386603|FG000|Overall Study|Physician Decision|1|||
146513960|NCT02913105|528386604|FG001|Overall Study|Physician Decision|1|||
146513961|NCT02913105|528386605|FG002|Overall Study|Physician Decision|0|||
146513962|NCT02913105|528386603|FG000|Overall Study|Withdrawal by Subject|0|||
146754964|NCT04955626|529268060|FG002|Open-Label Period|Withdrawal by Subject|0|||
146754965|NCT04955626|529268061|FG003|Open-Label Period|Withdrawal by Subject|0|||
146754966|NCT04955626|529268062|FG004|Open-Label Period|Withdrawal by Subject|0|||
146754967|NCT04955626|529268063|FG005|Open-Label Period|Withdrawal by Subject|0|||
146754968|NCT04955626|529268064|FG006|Open-Label Period|Withdrawal by Subject|0|||
146754969|NCT04955626|529268065|FG007|Open-Label Period|Withdrawal by Subject|0|||
146754970|NCT04955626|529268066|FG008|Open-Label Period|Withdrawal by Subject|0|||
146754971|NCT04955626|529268067|FG009|Open-Label Period|Withdrawal by Subject|0|||
146754972|NCT04955626|529268068|FG010|Open-Label Period|Withdrawal by Subject|0|||
146754973|NCT04955626|529268069|FG011|Open-Label Period|Withdrawal by Subject|0|||
146754974|NCT04955626|529268070|FG012|Open-Label Period|Withdrawal by Subject|0|||
146754975|NCT04955626|529268071|FG013|Open-Label Period|Withdrawal by Subject|0|||
146754976|NCT04955626|529268072|FG014|Open-Label Period|Withdrawal by Subject|0|||
146754977|NCT04955626|529268073|FG015|Open-Label Period|Withdrawal by Subject|0|||
146754978|NCT04955626|529268074|FG016|Open-Label Period|Withdrawal by Subject|0|||
146754979|NCT04955626|529268075|FG017|Open-Label Period|Withdrawal by Subject|0|||
146754980|NCT04955626|529268076|FG018|Open-Label Period|Withdrawal by Subject|0|||
146754981|NCT04955626|529268077|FG019|Open-Label Period|Withdrawal by Subject|0|||
146754982|NCT04955626|529268078|FG020|Open-Label Period|Withdrawal by Subject|0|||
146754983|NCT04955626|529268079|FG021|Open-Label Period|Withdrawal by Subject|0|||
146754984|NCT04955626|529268080|FG022|Open-Label Period|Withdrawal by Subject|0|||
146754985|NCT04955626|529268081|FG023|Open-Label Period|Withdrawal by Subject|0|||
146754986|NCT04955626|529268082|FG024|Open-Label Period|Withdrawal by Subject|0|||
146754987|NCT04955626|529268083|FG025|Open-Label Period|Withdrawal by Subject|0|||
146754988|NCT04955626|529268084|FG026|Open-Label Period|Withdrawal by Subject|0|||
146754989|NCT04955626|529268085|FG027|Open-Label Period|Withdrawal by Subject|0|||
146754990|NCT04955626|529268086|FG028|Open-Label Period|Withdrawal by Subject|0|||
146754991|NCT04955626|529268087|FG029|Open-Label Period|Withdrawal by Subject|0|||
146754992|NCT04955626|529268088|FG030|Open-Label Period|Withdrawal by Subject|0|||
146754993|NCT04955626|529268089|FG031|Open-Label Period|Withdrawal by Subject|0|||
146754994|NCT04955626|529268090|FG032|Open-Label Period|Withdrawal by Subject|0|||
146754995|NCT04955626|529268091|FG033|Open-Label Period|Withdrawal by Subject|0|||
146754996|NCT04955626|529268092|FG034|Open-Label Period|Withdrawal by Subject|0|||
146754997|NCT04955626|529268093|FG035|Open-Label Period|Withdrawal by Subject|0|||
146513963|NCT02913105|528386604|FG001|Overall Study|Withdrawal by Subject|3|||
146513964|NCT02913105|528386605|FG002|Overall Study|Withdrawal by Subject|1|||
146513965|NCT01317004|528386606|FG000|Overall Study|Withdrawal by Subject|1|||
146513966|NCT01317004|528386607|FG001|Overall Study|Withdrawal by Subject|4|||
146513967|NCT01317004|528386606|FG000|Overall Study|Protocol Violation|0|||
146513968|NCT01317004|528386607|FG001|Overall Study|Protocol Violation|2|||
146513969|NCT01317004|528386606|FG000|Overall Study|Adverse Event|3|||
146513970|NCT01317004|528386607|FG001|Overall Study|Adverse Event|3|||
146513971|NCT05243563|528386608|FG000|Overall Study|Withdrawal by Subject|1|||
146513972|NCT05243563|528386609|FG001|Overall Study|Withdrawal by Subject|0|||
146513973|NCT05243563|528386608|FG000|Overall Study|Physician Decision|1|||
146513974|NCT05243563|528386609|FG001|Overall Study|Physician Decision|0|||
146513975|NCT00441363|528386610|FG000|Overall Study|Adverse Event|4|||
146513976|NCT00441363|528386611|FG001|Overall Study|Adverse Event|2|||
146513977|NCT00441363|528386610|FG000|Overall Study|Withdrawal by Subject|3|||
146513978|NCT00441363|528386611|FG001|Overall Study|Withdrawal by Subject|4|||
146754998|NCT04955626|529268058|FG000|Open-Label Period|Refused further study procedures|1|||
146754999|NCT04955626|529268059|FG001|Open-Label Period|Refused further study procedures|0|||
146755000|NCT04955626|529268060|FG002|Open-Label Period|Refused further study procedures|0|||
146755001|NCT04955626|529268061|FG003|Open-Label Period|Refused further study procedures|0|||
146755002|NCT04955626|529268062|FG004|Open-Label Period|Refused further study procedures|0|||
146513979|NCT00441363|528386610|FG000|Overall Study|Physician Decision|6|||
146513980|NCT00441363|528386611|FG001|Overall Study|Physician Decision|7|||
146513981|NCT00441363|528386610|FG000|Overall Study|Lost to Follow-up|2|||
146513982|NCT00441363|528386611|FG001|Overall Study|Lost to Follow-up|2|||
146755003|NCT04955626|529268063|FG005|Open-Label Period|Refused further study procedures|0|||
146852745|NCT00495586|529630158|FG000|Overall Study|Withdrawal by Subject|4|||
146852746|NCT00495586|529630159|FG001|Overall Study|Withdrawal by Subject|4|||
146852747|NCT03038438|529630160|FG000|Overall Study|Death|3|||
146852748|NCT03038438|529630160|FG000|Overall Study|Lost to Follow-up|8|||
146852749|NCT03038438|529630160|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
146852750|NCT03038438|529630160|FG000|Overall Study|Withdrawal by Subject|5|||
146852751|NCT03038438|529630160|FG000|Overall Study|No 36-Month Follow-Up|18|||
146852752|NCT02038543|529630161|FG000|Overall Study|Screen Failure|0|||
146852753|NCT02038543|529630162|FG001|Overall Study|Screen Failure|0|||
146852754|NCT02038543|529630163|FG002|Overall Study|Screen Failure|0|||
146852755|NCT02038543|529630164|FG003|Overall Study|Screen Failure|1|||
146852756|NCT02038543|529630161|FG000|Overall Study|Withdrawal by Subject|0|||
146852757|NCT02038543|529630162|FG001|Overall Study|Withdrawal by Subject|0|||
146852758|NCT02038543|529630163|FG002|Overall Study|Withdrawal by Subject|0|||
146852759|NCT02038543|529630164|FG003|Overall Study|Withdrawal by Subject|1|||
146852760|NCT02647866|529630165|FG000|Overall Study|Adverse Event|0|||
146852761|NCT02647866|529630166|FG001|Overall Study|Adverse Event|0|||
146852762|NCT02647866|529630167|FG002|Overall Study|Adverse Event|2|||
146513983|NCT00441363|528386610|FG000|Overall Study|Other|2|||
146755004|NCT04955626|529268064|FG006|Open-Label Period|Refused further study procedures|0|||
146755005|NCT04955626|529268065|FG007|Open-Label Period|Refused further study procedures|0|||
146755006|NCT04955626|529268066|FG008|Open-Label Period|Refused further study procedures|0|||
146755007|NCT04955626|529268067|FG009|Open-Label Period|Refused further study procedures|0|||
146755008|NCT04955626|529268068|FG010|Open-Label Period|Refused further study procedures|0|||
146755009|NCT04955626|529268069|FG011|Open-Label Period|Refused further study procedures|0|||
146755010|NCT04955626|529268070|FG012|Open-Label Period|Refused further study procedures|0|||
146755011|NCT04955626|529268071|FG013|Open-Label Period|Refused further study procedures|0|||
146755012|NCT04955626|529268072|FG014|Open-Label Period|Refused further study procedures|0|||
146755013|NCT04955626|529268073|FG015|Open-Label Period|Refused further study procedures|0|||
146755014|NCT04955626|529268074|FG016|Open-Label Period|Refused further study procedures|0|||
146755015|NCT04955626|529268075|FG017|Open-Label Period|Refused further study procedures|0|||
146755016|NCT04955626|529268076|FG018|Open-Label Period|Refused further study procedures|0|||
146755017|NCT04955626|529268077|FG019|Open-Label Period|Refused further study procedures|0|||
146755018|NCT04955626|529268078|FG020|Open-Label Period|Refused further study procedures|0|||
146755019|NCT04955626|529268079|FG021|Open-Label Period|Refused further study procedures|0|||
146755020|NCT04955626|529268080|FG022|Open-Label Period|Refused further study procedures|0|||
146755021|NCT04955626|529268081|FG023|Open-Label Period|Refused further study procedures|0|||
146755022|NCT04955626|529268082|FG024|Open-Label Period|Refused further study procedures|0|||
146755023|NCT04955626|529268083|FG025|Open-Label Period|Refused further study procedures|0|||
146755024|NCT04955626|529268084|FG026|Open-Label Period|Refused further study procedures|0|||
146755025|NCT04955626|529268085|FG027|Open-Label Period|Refused further study procedures|0|||
146755026|NCT04955626|529268086|FG028|Open-Label Period|Refused further study procedures|0|||
146755027|NCT04955626|529268087|FG029|Open-Label Period|Refused further study procedures|0|||
146755028|NCT04955626|529268088|FG030|Open-Label Period|Refused further study procedures|0|||
146755029|NCT04955626|529268089|FG031|Open-Label Period|Refused further study procedures|0|||
146755030|NCT04955626|529268090|FG032|Open-Label Period|Refused further study procedures|0|||
146755031|NCT04955626|529268091|FG033|Open-Label Period|Refused further study procedures|0|||
146755032|NCT04955626|529268092|FG034|Open-Label Period|Refused further study procedures|0|||
146755033|NCT04955626|529268093|FG035|Open-Label Period|Refused further study procedures|0|||
146755034|NCT04955626|529268058|FG000|Open-Label Period|Adverse Event|1|||
146755035|NCT04955626|529268059|FG001|Open-Label Period|Adverse Event|0|||
146755036|NCT04955626|529268060|FG002|Open-Label Period|Adverse Event|0|||
146755037|NCT04955626|529268061|FG003|Open-Label Period|Adverse Event|0|||
146755038|NCT04955626|529268062|FG004|Open-Label Period|Adverse Event|0|||
146755039|NCT04955626|529268063|FG005|Open-Label Period|Adverse Event|0|||
146755040|NCT04955626|529268064|FG006|Open-Label Period|Adverse Event|0|||
146755041|NCT04955626|529268065|FG007|Open-Label Period|Adverse Event|0|||
146755042|NCT04955626|529268066|FG008|Open-Label Period|Adverse Event|0|||
146755043|NCT04955626|529268067|FG009|Open-Label Period|Adverse Event|0|||
146755044|NCT04955626|529268068|FG010|Open-Label Period|Adverse Event|0|||
146755045|NCT04955626|529268069|FG011|Open-Label Period|Adverse Event|0|||
146755046|NCT04955626|529268070|FG012|Open-Label Period|Adverse Event|0|||
146755047|NCT04955626|529268071|FG013|Open-Label Period|Adverse Event|0|||
146755048|NCT04955626|529268072|FG014|Open-Label Period|Adverse Event|0|||
146755049|NCT04955626|529268073|FG015|Open-Label Period|Adverse Event|0|||
146755050|NCT04955626|529268074|FG016|Open-Label Period|Adverse Event|0|||
146755051|NCT04955626|529268075|FG017|Open-Label Period|Adverse Event|0|||
146755052|NCT04955626|529268076|FG018|Open-Label Period|Adverse Event|0|||
146755053|NCT04955626|529268077|FG019|Open-Label Period|Adverse Event|0|||
146755054|NCT04955626|529268078|FG020|Open-Label Period|Adverse Event|0|||
146755055|NCT04955626|529268079|FG021|Open-Label Period|Adverse Event|0|||
146755056|NCT04955626|529268080|FG022|Open-Label Period|Adverse Event|0|||
146755057|NCT04955626|529268081|FG023|Open-Label Period|Adverse Event|0|||
146755058|NCT04955626|529268082|FG024|Open-Label Period|Adverse Event|0|||
146755059|NCT04955626|529268083|FG025|Open-Label Period|Adverse Event|0|||
146755060|NCT04955626|529268084|FG026|Open-Label Period|Adverse Event|0|||
146755061|NCT04955626|529268085|FG027|Open-Label Period|Adverse Event|0|||
146755062|NCT04955626|529268086|FG028|Open-Label Period|Adverse Event|0|||
146755063|NCT04955626|529268087|FG029|Open-Label Period|Adverse Event|0|||
146755064|NCT04955626|529268088|FG030|Open-Label Period|Adverse Event|0|||
146755065|NCT04955626|529268089|FG031|Open-Label Period|Adverse Event|0|||
146755066|NCT04955626|529268090|FG032|Open-Label Period|Adverse Event|0|||
146755067|NCT04955626|529268091|FG033|Open-Label Period|Adverse Event|0|||
146755068|NCT04955626|529268092|FG034|Open-Label Period|Adverse Event|0|||
146755069|NCT04955626|529268093|FG035|Open-Label Period|Adverse Event|0|||
146755070|NCT04955626|529268058|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
146755071|NCT04955626|529268059|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
146755072|NCT04955626|529268060|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
146755073|NCT04955626|529268061|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
146755074|NCT04955626|529268062|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
146755075|NCT04955626|529268063|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
146755076|NCT04955626|529268064|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
146755077|NCT04955626|529268065|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
146965053|NCT03110107|530033443|FG017|Treatment Period|Study drug toxicity|3|||
146755078|NCT04955626|529268066|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
146755079|NCT04955626|529268067|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
146755080|NCT04955626|529268068|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
146755081|NCT04955626|529268069|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
146755082|NCT04955626|529268070|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
146755083|NCT04955626|529268071|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
146755084|NCT04955626|529268072|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
146755085|NCT04955626|529268073|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
146755086|NCT04955626|529268074|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
146755087|NCT04955626|529268075|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
146755088|NCT04955626|529268076|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
146755089|NCT04955626|529268077|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
146755090|NCT04955626|529268078|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
146755091|NCT04955626|529268079|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
146755092|NCT04955626|529268080|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
146755093|NCT04955626|529268081|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
146755094|NCT04955626|529268082|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
146755095|NCT04955626|529268083|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
146755096|NCT04955626|529268084|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
146755097|NCT04955626|529268085|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
146755098|NCT04955626|529268086|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
146755099|NCT04955626|529268087|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
146755100|NCT04955626|529268088|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
146755101|NCT04955626|529268089|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
146755102|NCT04955626|529268090|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
146755103|NCT04955626|529268091|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
146755104|NCT04955626|529268092|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
146755105|NCT04955626|529268093|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
146755106|NCT04955626|529268058|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755107|NCT04955626|529268059|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
146755108|NCT04955626|529268060|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755109|NCT04955626|529268061|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755110|NCT04955626|529268062|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755111|NCT04955626|529268063|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755112|NCT04955626|529268064|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755113|NCT04955626|529268065|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755114|NCT04955626|529268066|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755115|NCT04955626|529268067|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755116|NCT04955626|529268068|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755117|NCT04955626|529268069|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755118|NCT04955626|529268070|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755119|NCT04955626|529268071|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755120|NCT04955626|529268072|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755121|NCT04955626|529268073|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755122|NCT04955626|529268074|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755123|NCT04955626|529268075|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755124|NCT04955626|529268076|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755125|NCT04955626|529268077|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755126|NCT04955626|529268078|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755127|NCT04955626|529268079|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755128|NCT04955626|529268080|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146852763|NCT02647866|529630168|FG003|Overall Study|Adverse Event|2|||
146852764|NCT02647866|529630169|FG004|Overall Study|Adverse Event|1|||
146513984|NCT00441363|528386611|FG001|Overall Study|Other|0|||
146513985|NCT02437188|528386614|FG000|Overall Study|Randomized but did not receive surgery|4|||
146513986|NCT02437188|528386615|FG001|Overall Study|Randomized but did not receive surgery|8|||
146513987|NCT02437188|528386614|FG000|Overall Study|Adverse Event|0|||
146513988|NCT02437188|528386615|FG001|Overall Study|Adverse Event|1|||
146513989|NCT02661061|528386616|FG000|Overall Study|Lack of Efficacy|1|||
146513990|NCT02661061|528386617|FG001|Overall Study|Lack of Efficacy|1|||
146513991|NCT02661061|528386616|FG000|Overall Study|Withdrawal by Subject|1|||
146513992|NCT02661061|528386617|FG001|Overall Study|Withdrawal by Subject|1|||
146513993|NCT03052920|528386620|FG000|Overall Study|Withdrawal by Subject|1|||
146513994|NCT02578940|528386621|FG000|Overall Study|Screening failure|5|||
146513995|NCT02578940|528386621|FG000|Overall Study|Lost to Follow-up|1|||
146513996|NCT01937715|528386630|FG000|Overall Study|Death|0|||
146513997|NCT01937715|528386631|FG001|Overall Study|Death|0|||
146513998|NCT01937715|528386632|FG002|Overall Study|Death|0|||
146513999|NCT01937715|528386633|FG003|Overall Study|Death|1|||
146514000|NCT01937715|528386634|FG004|Overall Study|Death|0|||
146514001|NCT01937715|528386630|FG000|Overall Study|Withdrawal by Subject|0|||
146514002|NCT01937715|528386631|FG001|Overall Study|Withdrawal by Subject|1|||
146514003|NCT01937715|528386632|FG002|Overall Study|Withdrawal by Subject|0|||
146514004|NCT01937715|528386633|FG003|Overall Study|Withdrawal by Subject|0|||
146514005|NCT01937715|528386634|FG004|Overall Study|Withdrawal by Subject|2|||
146514006|NCT01937715|528386630|FG000|Overall Study|Other|0|||
146514007|NCT01937715|528386631|FG001|Overall Study|Other|0|||
146514008|NCT01937715|528386632|FG002|Overall Study|Other|0|||
146514009|NCT01937715|528386633|FG003|Overall Study|Other|3|||
146514010|NCT01937715|528386634|FG004|Overall Study|Other|0|||
146514011|NCT01698268|528386637|FG000|Overall Study|Physician Decision|2|||
146514012|NCT01698268|528386638|FG001|Overall Study|Physician Decision|1|||
146514013|NCT02469168|528386640|FG000|Overall Study|Trial closed|1|||
146514014|NCT02469168|528386641|FG001|Overall Study|Trial closed|0|||
146514015|NCT00298363|528386642|FG000|Overall Study|Lost to Follow-up|0|||
146514016|NCT00298363|528386643|FG001|Overall Study|Lost to Follow-up|0|||
146514017|NCT00298363|528386644|FG002|Overall Study|Lost to Follow-up|1|||
146514018|NCT00298363|528386642|FG000|Overall Study|Physician Decision|4|||
146514019|NCT00298363|528386643|FG001|Overall Study|Physician Decision|1|||
146514020|NCT00298363|528386644|FG002|Overall Study|Physician Decision|0|||
146514021|NCT00298363|528386642|FG000|Overall Study|Protocol Violation|1|||
146514022|NCT00298363|528386643|FG001|Overall Study|Protocol Violation|1|||
146514023|NCT00298363|528386644|FG002|Overall Study|Protocol Violation|0|||
146514024|NCT00298363|528386642|FG000|Overall Study|Withdrawal by Subject|5|||
146514025|NCT00298363|528386643|FG001|Overall Study|Withdrawal by Subject|1|||
146514026|NCT00298363|528386644|FG002|Overall Study|Withdrawal by Subject|3|||
146514027|NCT00298363|528386642|FG000|Overall Study|Adverse Event|5|||
146514028|NCT00298363|528386643|FG001|Overall Study|Adverse Event|2|||
146514029|NCT00298363|528386644|FG002|Overall Study|Adverse Event|2|||
146514030|NCT00298363|528386642|FG000|Overall Study|Lack of Efficacy|2|||
146514031|NCT00298363|528386643|FG001|Overall Study|Lack of Efficacy|3|||
146514032|NCT00298363|528386644|FG002|Overall Study|Lack of Efficacy|0|||
146514033|NCT00135356|528386645|FG000|Overall Study|Adverse Event|6|||
146514034|NCT00135356|528386646|FG001|Overall Study|Adverse Event|2|||
146514035|NCT00135356|528386645|FG000|Overall Study|Lack of Efficacy|2|||
146514036|NCT00135356|528386646|FG001|Overall Study|Lack of Efficacy|0|||
146514037|NCT00135356|528386645|FG000|Overall Study|Lost to Follow-up|3|||
146514038|NCT00135356|528386646|FG001|Overall Study|Lost to Follow-up|1|||
146514039|NCT00135356|528386645|FG000|Overall Study|Surgery for abdominal fat|1|||
146514040|NCT00135356|528386646|FG001|Overall Study|Surgery for abdominal fat|0|||
146514041|NCT00135356|528386645|FG000|Overall Study|Change in antiviral regimen|0|||
146514042|NCT00135356|528386646|FG001|Overall Study|Change in antiviral regimen|1|||
146514043|NCT00135356|528386645|FG000|Overall Study|Poor/noncompliance|1|||
146514044|NCT00135356|528386646|FG001|Overall Study|Poor/noncompliance|1|||
146514045|NCT00135356|528386645|FG000|Overall Study|No longer meets study criteria|2|||
146514046|NCT00135356|528386646|FG001|Overall Study|No longer meets study criteria|0|||
146514047|NCT00135356|528386645|FG000|Overall Study|Withdrawal by Subject|2|||
146514048|NCT00135356|528386646|FG001|Overall Study|Withdrawal by Subject|4|||
146514049|NCT00153816|528386647|FG000|Overall Study|Death|6|||
146514050|NCT00153816|528386648|FG001|Overall Study|Death|5|||
146514051|NCT00153816|528386649|FG002|Overall Study|Death|4|||
146514052|NCT00153816|528386650|FG003|Overall Study|Death|6|||
146514053|NCT00153816|528386651|FG004|Overall Study|Death|0|||
146514054|NCT00153816|528386652|FG005|Overall Study|Death|2|||
146514055|NCT00153816|528386647|FG000|Overall Study|Lost to Follow-up|7|||
146514056|NCT00153816|528386648|FG001|Overall Study|Lost to Follow-up|8|||
146514057|NCT00153816|528386649|FG002|Overall Study|Lost to Follow-up|5|||
146514058|NCT00153816|528386650|FG003|Overall Study|Lost to Follow-up|8|||
146514059|NCT00153816|528386651|FG004|Overall Study|Lost to Follow-up|7|||
146514060|NCT00153816|528386652|FG005|Overall Study|Lost to Follow-up|9|||
146514061|NCT00153816|528386647|FG000|Overall Study|Withdrawal by Subject|9|||
146514062|NCT00153816|528386648|FG001|Overall Study|Withdrawal by Subject|9|||
146514063|NCT00153816|528386649|FG002|Overall Study|Withdrawal by Subject|9|||
146514064|NCT00153816|528386650|FG003|Overall Study|Withdrawal by Subject|4|||
146514065|NCT00153816|528386651|FG004|Overall Study|Withdrawal by Subject|1|||
146514066|NCT00153816|528386652|FG005|Overall Study|Withdrawal by Subject|5|||
146514067|NCT00153816|528386647|FG000|Overall Study|Follow-up exam not done|8|||
146514068|NCT00153816|528386648|FG001|Overall Study|Follow-up exam not done|7|||
146514069|NCT00153816|528386649|FG002|Overall Study|Follow-up exam not done|11|||
146514070|NCT00153816|528386650|FG003|Overall Study|Follow-up exam not done|10|||
146514071|NCT00153816|528386651|FG004|Overall Study|Follow-up exam not done|8|||
146514072|NCT00153816|528386652|FG005|Overall Study|Follow-up exam not done|9|||
146514073|NCT00153816|528386647|FG000|Overall Study|Follow-up exam done, histology missing|2|||
146514074|NCT00153816|528386648|FG001|Overall Study|Follow-up exam done, histology missing|3|||
146514075|NCT00153816|528386649|FG002|Overall Study|Follow-up exam done, histology missing|3|||
146514076|NCT00153816|528386650|FG003|Overall Study|Follow-up exam done, histology missing|3|||
146514077|NCT00153816|528386651|FG004|Overall Study|Follow-up exam done, histology missing|1|||
146514078|NCT00153816|528386652|FG005|Overall Study|Follow-up exam done, histology missing|2|||
146514079|NCT01533688|528386655|FG000|Overall Study|Withdrawal by Subject|5|||
146514080|NCT01533688|528386656|FG001|Overall Study|Withdrawal by Subject|4|||
146514081|NCT01533688|528386657|FG002|Overall Study|Withdrawal by Subject|3|||
146514082|NCT01533688|528386655|FG000|Overall Study|Medically unstable|1|||
146514083|NCT01533688|528386656|FG001|Overall Study|Medically unstable|3|||
146514084|NCT01533688|528386657|FG002|Overall Study|Medically unstable|3|||
146514085|NCT01533688|528386655|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
146514086|NCT01533688|528386656|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
146514087|NCT01533688|528386657|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
146514088|NCT02263729|528386658|FG000|Overall Study|Lost to Follow-up|1|||
146514089|NCT02263729|528386659|FG001|Overall Study|Lost to Follow-up|1|||
146514090|NCT04591015|528386660|FG000|Overall Study|Death|6|||
146514091|NCT04591015|528386661|FG001|Overall Study|Death|4|||
146514092|NCT04591015|528386660|FG000|Overall Study|Withdrawal by Subject|6|||
146514093|NCT04591015|528386661|FG001|Overall Study|Withdrawal by Subject|3|||
146755129|NCT04955626|529268081|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146514094|NCT04591015|528386660|FG000|Overall Study|Lost to Follow-up|16|||
146514095|NCT04591015|528386661|FG001|Overall Study|Lost to Follow-up|11|||
146514096|NCT02509078|528386662|FG000|Overall Study|Protocol Violation|1|||
146755130|NCT04955626|529268082|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755131|NCT04955626|529268083|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755132|NCT04955626|529268084|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755133|NCT04955626|529268085|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755134|NCT04955626|529268086|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755135|NCT04955626|529268087|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755136|NCT04955626|529268088|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755137|NCT04955626|529268089|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755138|NCT04955626|529268090|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755139|NCT04955626|529268091|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755140|NCT04955626|529268092|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755141|NCT04955626|529268093|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146755142|NCT00003509|529268094|FG000|Overall Study|Not evaluable|5|||
146755143|NCT04951479|529268095|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
146755144|NCT04060680|529268097|FG000|Overall Study|Unsuccessful implant|17|||
146755145|NCT04060680|529268098|FG001|Overall Study|Unsuccessful implant|2|||
146755146|NCT04060680|529268097|FG000|Overall Study|Adverse Event|3|||
146755147|NCT04060680|529268098|FG001|Overall Study|Adverse Event|0|||
146755148|NCT04060680|529268097|FG000|Overall Study|Death|2|||
146755149|NCT04060680|529268098|FG001|Overall Study|Death|0|||
146755150|NCT04060680|529268097|FG000|Overall Study|Study product no longer in use|1|||
146755151|NCT04060680|529268098|FG001|Overall Study|Study product no longer in use|0|||
146755152|NCT04060680|529268097|FG000|Overall Study|Withdrawal by Subject|1|||
146755153|NCT04060680|529268098|FG001|Overall Study|Withdrawal by Subject|0|||
146755154|NCT03706690|529268099|FG000|Overall Study|Withdrawal by Subject|8|||
146755155|NCT03706690|529268100|FG001|Overall Study|Withdrawal by Subject|8|||
146755156|NCT03706690|529268099|FG000|Overall Study|Death|143|||
146755157|NCT03706690|529268100|FG001|Overall Study|Death|75|||
146514097|NCT02509078|528386663|FG001|Overall Study|Protocol Violation|1|||
146514098|NCT02686814|528386664|FG000|Overall Study|Physician Decision|14|||
146514099|NCT02686814|528386664|FG000|Overall Study|Withdrawal by Subject|4|||
146514100|NCT02686814|528386664|FG000|Overall Study|Death|1|||
146514101|NCT01760447|528386667|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
146514102|NCT01760447|528386668|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
146755158|NCT03706690|529268099|FG000|Overall Study|Ongoing at DCO|121|||
146755159|NCT03706690|529268100|FG001|Overall Study|Ongoing at DCO|52|||
146755160|NCT02711826|529268101|FG000|Overall Study|Physician Decision|0|||
146755161|NCT02711826|529268102|FG001|Overall Study|Physician Decision|0|||
146755162|NCT02711826|529268103|FG002|Overall Study|Physician Decision|0|||
146755163|NCT02711826|529268104|FG003|Overall Study|Physician Decision|1|||
146755164|NCT02711826|529268105|FG004|Overall Study|Physician Decision|0|||
146755165|NCT02711826|529268101|FG000|Overall Study|Withdrawal by Subject|0|||
146755166|NCT02711826|529268102|FG001|Overall Study|Withdrawal by Subject|1|||
146755167|NCT02711826|529268103|FG002|Overall Study|Withdrawal by Subject|0|||
146755168|NCT02711826|529268104|FG003|Overall Study|Withdrawal by Subject|4|||
146755169|NCT02711826|529268105|FG004|Overall Study|Withdrawal by Subject|0|||
146755170|NCT02711826|529268101|FG000|Overall Study|Failure to manufacture cellular product|0|||
146755171|NCT02711826|529268102|FG001|Overall Study|Failure to manufacture cellular product|0|||
146755172|NCT02711826|529268103|FG002|Overall Study|Failure to manufacture cellular product|5|||
146755173|NCT02711826|529268104|FG003|Overall Study|Failure to manufacture cellular product|0|||
146755174|NCT02711826|529268105|FG004|Overall Study|Failure to manufacture cellular product|0|||
146755175|NCT02711826|529268101|FG000|Overall Study|Infusion canceled for active infection|0|||
146755176|NCT02711826|529268102|FG001|Overall Study|Infusion canceled for active infection|1|||
146755177|NCT02711826|529268103|FG002|Overall Study|Infusion canceled for active infection|0|||
146755178|NCT02711826|529268104|FG003|Overall Study|Infusion canceled for active infection|0|||
146755179|NCT02711826|529268105|FG004|Overall Study|Infusion canceled for active infection|0|||
146755180|NCT02711826|529268101|FG000|Overall Study|Screen failures|0|||
146755181|NCT02711826|529268102|FG001|Overall Study|Screen failures|0|||
146755182|NCT02711826|529268103|FG002|Overall Study|Screen failures|0|||
146755183|NCT02711826|529268104|FG003|Overall Study|Screen failures|4|||
146755184|NCT02711826|529268105|FG004|Overall Study|Screen failures|0|||
146755185|NCT00729690|529268107|FG000|Overall Study|IT Catheter Malfunction|0|||
146755186|NCT00729690|529268108|FG001|Overall Study|IT Catheter Malfunction|2|||
146755187|NCT00729690|529268109|FG002|Overall Study|IT Catheter Malfunction|2|||
146755188|NCT02169219|529268110|FG000|Overall Study|Lack of Efficacy|6|||
146755189|NCT02886936|529268111|FG000|Overall Study|Lost to Follow-up|4|||
146755190|NCT02886936|529268112|FG001|Overall Study|Lost to Follow-up|3|||
146755191|NCT02886936|529268113|FG002|Overall Study|Lost to Follow-up|0|||
146755192|NCT02507219|529268114|FG000|Overall Study|Physician Decision|1|||
146755193|NCT02507219|529268115|FG001|Overall Study|Physician Decision|0|||
146755194|NCT02507219|529268116|FG002|Overall Study|Physician Decision|0|||
146755195|NCT02507219|529268117|FG003|Overall Study|Physician Decision|0|||
146755196|NCT02507219|529268118|FG004|Overall Study|Physician Decision|0|||
146755197|NCT02507219|529268119|FG005|Overall Study|Physician Decision|0|||
146755198|NCT02507219|529268114|FG000|Overall Study|Withdrawal by Subject|0|||
146755199|NCT02507219|529268115|FG001|Overall Study|Withdrawal by Subject|0|||
146755200|NCT02507219|529268116|FG002|Overall Study|Withdrawal by Subject|0|||
146755201|NCT02507219|529268117|FG003|Overall Study|Withdrawal by Subject|0|||
146755202|NCT02507219|529268118|FG004|Overall Study|Withdrawal by Subject|1|||
146755203|NCT02507219|529268119|FG005|Overall Study|Withdrawal by Subject|0|||
146755204|NCT02320721|529268120|FG000|Overall Study|Adverse Event|6|||
146755205|NCT02320721|529268121|FG001|Overall Study|Adverse Event|6|||
146755206|NCT02320721|529268120|FG000|Overall Study|Lack of Efficacy|2|||
146755207|NCT02320721|529268121|FG001|Overall Study|Lack of Efficacy|0|||
146755208|NCT02320721|529268120|FG000|Overall Study|Poor compliance to protocol|3|||
146755209|NCT02320721|529268121|FG001|Overall Study|Poor compliance to protocol|7|||
146755210|NCT02320721|529268120|FG000|Overall Study|Randomized but not treated|0|||
146755211|NCT02320721|529268121|FG001|Overall Study|Randomized but not treated|1|||
146755212|NCT02320721|529268120|FG000|Overall Study|Hypoglycemia|1|||
146755213|NCT02320721|529268121|FG001|Overall Study|Hypoglycemia|0|||
146755214|NCT02320721|529268120|FG000|Overall Study|Other than specified above|15|||
146755215|NCT02320721|529268121|FG001|Overall Study|Other than specified above|20|||
146755216|NCT02419755|529268122|FG000|Overall Study|Death|1|||
146755217|NCT02419755|529268123|FG001|Overall Study|Death|3|||
146755218|NCT02419755|529268122|FG000|Overall Study|Relapse|0|||
146755219|NCT02419755|529268123|FG001|Overall Study|Relapse|1|||
146755220|NCT02419755|529268122|FG000|Overall Study|Ineligible|1|||
146755221|NCT02419755|529268123|FG001|Overall Study|Ineligible|0|||
146755222|NCT02419755|529268122|FG000|Overall Study|Withdrawal by Subject|1|||
146755223|NCT02419755|529268123|FG001|Overall Study|Withdrawal by Subject|0|||
146755224|NCT05397470|529268124|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
146755225|NCT05397470|529268125|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
146755226|NCT05397470|529268126|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
146755227|NCT05397470|529268124|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
146755228|NCT05397470|529268125|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
146755229|NCT05397470|529268126|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
146755230|NCT05397470|529268124|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
146755231|NCT05397470|529268125|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
146755232|NCT05397470|529268126|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
146755233|NCT05397470|529268124|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
146755234|NCT05397470|529268125|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
146755235|NCT05397470|529268126|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
146755236|NCT05397470|529268124|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
146755237|NCT05397470|529268125|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
146514103|NCT01760447|528386669|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
146514104|NCT01760447|528386670|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
146514105|NCT01760447|528386667|FG000|Weeks 0-20|Withdrawal by Subject|2|||
146514106|NCT01760447|528386668|FG001|Weeks 0-20|Withdrawal by Subject|0|||
146514107|NCT01760447|528386669|FG002|Weeks 0-20|Withdrawal by Subject|1|||
146514108|NCT01760447|528386670|FG003|Weeks 0-20|Withdrawal by Subject|0|||
146514109|NCT01760447|528386667|FG000|Weeks 0-20|Lost to Follow-up|1|||
146514110|NCT01760447|528386668|FG001|Weeks 0-20|Lost to Follow-up|0|||
146514111|NCT01760447|528386669|FG002|Weeks 0-20|Lost to Follow-up|1|||
146514112|NCT01760447|528386670|FG003|Weeks 0-20|Lost to Follow-up|1|||
146514113|NCT01760447|528386667|FG000|Weeks 0-20|Randomized but not treated|0|||
146514114|NCT01760447|528386668|FG001|Weeks 0-20|Randomized but not treated|0|||
146514115|NCT01760447|528386669|FG002|Weeks 0-20|Randomized but not treated|2|||
146514116|NCT01760447|528386670|FG003|Weeks 0-20|Randomized but not treated|0|||
146514117|NCT01760447|528386667|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
146514118|NCT01760447|528386668|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
146514119|NCT01760447|528386669|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
146514120|NCT01760447|528386670|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
146514121|NCT01760447|528386667|FG000|Weeks 20-54|Withdrawal by Subject|2|||
146514122|NCT01760447|528386668|FG001|Weeks 20-54|Withdrawal by Subject|1|||
146514123|NCT01760447|528386669|FG002|Weeks 20-54|Withdrawal by Subject|1|||
146514124|NCT01760447|528386670|FG003|Weeks 20-54|Withdrawal by Subject|2|||
146514125|NCT01760447|528386667|FG000|Weeks 20-54|Lost to Follow-up|0|||
146514126|NCT01760447|528386668|FG001|Weeks 20-54|Lost to Follow-up|0|||
146514127|NCT01760447|528386669|FG002|Weeks 20-54|Lost to Follow-up|1|||
146514128|NCT01760447|528386670|FG003|Weeks 20-54|Lost to Follow-up|2|||
146514129|NCT02290925|528386677|FG000|First Period of Three Months|Lost to Follow-up|2|||
146514130|NCT02290925|528386678|FG001|First Period of Three Months|Lost to Follow-up|1|||
146514131|NCT02290925|528386677|FG000|First Period of Three Months|Death|1|||
146514132|NCT02290925|528386678|FG001|First Period of Three Months|Death|0|||
146514133|NCT02290925|528386677|FG000|First Period of Three Months|Insulin Started|1|||
146514134|NCT02290925|528386678|FG001|First Period of Three Months|Insulin Started|1|||
146514135|NCT02290925|528386677|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
146514136|NCT02290925|528386678|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
146514137|NCT02290925|528386677|FG000|Second Period of 3 Months|insulin started|0|||
146514138|NCT02290925|528386678|FG001|Second Period of 3 Months|insulin started|1|||
146514139|NCT01716520|528386679|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
146514140|NCT01716520|528386680|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
146514141|NCT01716520|528386681|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
146514142|NCT01716520|528386682|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
146514143|NCT01716520|528386683|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
146514144|NCT01716520|528386684|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
146514145|NCT01716520|528386679|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
146514146|NCT01716520|528386680|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
146514147|NCT01716520|528386681|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
146514148|NCT01716520|528386682|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
146514149|NCT01716520|528386683|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
146514150|NCT01716520|528386684|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
146514151|NCT01716520|528386679|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146514152|NCT01716520|528386680|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
146514153|NCT01716520|528386681|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146514154|NCT01716520|528386682|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146514155|NCT01716520|528386683|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146514156|NCT01716520|528386684|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146514157|NCT01716520|528386679|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
146514158|NCT01716520|528386680|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
146852765|NCT02647866|529630165|FG000|Overall Study|Disease Worsening|3|||
146852766|NCT02647866|529630166|FG001|Overall Study|Disease Worsening|1|||
146514159|NCT01716520|528386681|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
146514160|NCT01716520|528386682|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
146514161|NCT01716520|528386683|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
146514162|NCT01716520|528386684|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
146514163|NCT01716520|528386679|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
146514164|NCT01716520|528386680|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
146514165|NCT01716520|528386681|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
146514166|NCT01716520|528386682|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
146514167|NCT01716520|528386683|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
146514168|NCT01716520|528386684|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
146514169|NCT01716520|528386679|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
146625245|NCT03037385|528803850|FG005|Overall Study|Death|2|||
146852767|NCT02647866|529630167|FG002|Overall Study|Disease Worsening|0|||
146852768|NCT02647866|529630168|FG003|Overall Study|Disease Worsening|0|||
146852769|NCT02647866|529630169|FG004|Overall Study|Disease Worsening|1|||
146852770|NCT02647866|529630165|FG000|Overall Study|Withdrawal by Subject|1|||
146852771|NCT02647866|529630166|FG001|Overall Study|Withdrawal by Subject|1|||
146852772|NCT02647866|529630167|FG002|Overall Study|Withdrawal by Subject|2|||
146514170|NCT01716520|528386680|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
146514171|NCT01716520|528386681|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
146514172|NCT01716520|528386682|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
146514173|NCT01716520|528386683|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
146514174|NCT01716520|528386684|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
146514175|NCT01716520|528386679|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
146514176|NCT01716520|528386680|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
146852773|NCT02647866|529630168|FG003|Overall Study|Withdrawal by Subject|4|||
146852774|NCT02647866|529630169|FG004|Overall Study|Withdrawal by Subject|4|||
146852775|NCT02647866|529630165|FG000|Overall Study|Physician Decision|0|||
146852776|NCT02647866|529630166|FG001|Overall Study|Physician Decision|1|||
146852777|NCT02647866|529630167|FG002|Overall Study|Physician Decision|1|||
146852778|NCT02647866|529630168|FG003|Overall Study|Physician Decision|0|||
146852779|NCT02647866|529630169|FG004|Overall Study|Physician Decision|2|||
146852780|NCT02647866|529630165|FG000|Overall Study|Death|0|||
146852781|NCT02647866|529630166|FG001|Overall Study|Death|1|||
146852782|NCT02647866|529630167|FG002|Overall Study|Death|0|||
146852783|NCT02647866|529630168|FG003|Overall Study|Death|0|||
146852784|NCT02647866|529630169|FG004|Overall Study|Death|0|||
146852785|NCT02647866|529630165|FG000|Overall Study|Subject moved to different country|1|||
146852786|NCT02647866|529630166|FG001|Overall Study|Subject moved to different country|0|||
146852787|NCT02647866|529630167|FG002|Overall Study|Subject moved to different country|0|||
146852788|NCT02647866|529630168|FG003|Overall Study|Subject moved to different country|0|||
146852789|NCT02647866|529630169|FG004|Overall Study|Subject moved to different country|0|||
146852790|NCT03406260|529630170|FG000|Period 1|Adverse Event|0|||
146852791|NCT03406260|529630171|FG001|Period 1|Adverse Event|0|||
146852792|NCT03406260|529630172|FG002|Period 1|Adverse Event|0|||
146852793|NCT03406260|529630173|FG003|Period 1|Adverse Event|0|||
146852794|NCT03406260|529630174|FG004|Period 1|Adverse Event|1|||
146852795|NCT03406260|529630175|FG005|Period 1|Adverse Event|0|||
146852796|NCT02399254|529630178|FG000|Overall Study|Physician Decision|2|||
146852797|NCT02292927|529630185|FG000|Overall Study|Protocol Violation|13|||
146852798|NCT02292927|529630186|FG001|Overall Study|Protocol Violation|7|||
146852799|NCT01656733|529630190|FG000|Overall Study|No permission to collect birth outcomes|0|||
146852800|NCT01656733|529630191|FG001|Overall Study|No permission to collect birth outcomes|1|||
146852801|NCT01656733|529630190|FG000|Overall Study|Delivery at another hospital|0|||
146852802|NCT01656733|529630191|FG001|Overall Study|Delivery at another hospital|2|||
146852803|NCT01656733|529630190|FG000|Overall Study|Spontaneous abortion|0|||
146852804|NCT01656733|529630191|FG001|Overall Study|Spontaneous abortion|1|||
146852805|NCT02054741|529630193|FG000|Overall Study|Protocol Violation|13|||
146852806|NCT02054741|529630194|FG001|Overall Study|Protocol Violation|2|||
146852807|NCT02054741|529630193|FG000|Overall Study|Withdrawal by Subject|10|||
146852808|NCT02054741|529630194|FG001|Overall Study|Withdrawal by Subject|5|||
146852809|NCT02054741|529630193|FG000|Overall Study|Death|94|||
146852810|NCT02054741|529630194|FG001|Overall Study|Death|90|||
146755238|NCT05397470|529268126|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
146755239|NCT05397470|529268124|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
146755240|NCT05397470|529268125|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
146755241|NCT05397470|529268126|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
146755242|NCT05397470|529268124|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
146755243|NCT05397470|529268125|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
146755244|NCT05397470|529268126|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
146755245|NCT05567952|529269670|FG000|Overall Study|Lost to Follow-up|3|||
146755246|NCT05567952|529269671|FG001|Overall Study|Lost to Follow-up|2|||
146755247|NCT05567952|529269670|FG000|Overall Study|Withdrawal by Subject|6|||
146755248|NCT05567952|529269671|FG001|Overall Study|Withdrawal by Subject|3|||
146755249|NCT05567952|529269670|FG000|Overall Study|Other|3|||
146755250|NCT05567952|529269671|FG001|Overall Study|Other|1|||
146755251|NCT05194735|529269672|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
146755252|NCT05194735|529269673|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
146755253|NCT05194735|529269674|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
146755254|NCT05194735|529269672|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
146755255|NCT05194735|529269673|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
146755256|NCT05194735|529269674|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
146755257|NCT05194735|529269672|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
146755258|NCT05194735|529269673|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
146755259|NCT05194735|529269674|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
146755260|NCT05194735|529269672|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
146755261|NCT05194735|529269673|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
146755262|NCT05194735|529269674|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
146755263|NCT01616563|529269676|FG000|Overall Study|Lost to Follow-up|40|||
146755264|NCT01106287|529269677|FG000|Overall Study|Adverse Event|1|||
146755265|NCT01106287|529269678|FG001|Overall Study|Adverse Event|0|||
146755266|NCT01106287|529269679|FG002|Overall Study|Adverse Event|0|||
146755267|NCT01106287|529269680|FG003|Overall Study|Adverse Event|0|||
146755268|NCT00072475|529269681|FG000|Overall Study|Adverse Event|44|||
146755269|NCT00072475|529269681|FG000|Overall Study|Death|3|||
146755270|NCT00072475|529269681|FG000|Overall Study|Withdrawal by Subject|46|||
146755271|NCT00072475|529269681|FG000|Overall Study|Patient/Investigator Decision|4|||
146755272|NCT02123966|529269682|FG000|Overall Study|Intercurrent Illness|1|||
146755273|NCT01097655|529269683|FG000|Overall Study|Withdrawal by Subject|1|||
146755274|NCT01097655|529269683|FG000|Overall Study|Subject Documented Twice|1|||
146755275|NCT01097655|529269683|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
146755276|NCT02028884|529269686|FG000|Double-blind Period|Adverse Event|5|||
146755277|NCT02028884|529269687|FG001|Double-blind Period|Adverse Event|3|||
146755278|NCT02028884|529269688|FG002|Double-blind Period|Adverse Event|0|||
146755279|NCT02028884|529269686|FG000|Double-blind Period|Eligibility Violation|1|||
146755280|NCT02028884|529269687|FG001|Double-blind Period|Eligibility Violation|0|||
146755281|NCT02028884|529269688|FG002|Double-blind Period|Eligibility Violation|0|||
146755282|NCT02028884|529269686|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
146755283|NCT02028884|529269687|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
146755284|NCT02028884|529269688|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
146755285|NCT02028884|529269686|FG000|Double-blind Period|Withdrawal by Subject|2|||
146755286|NCT02028884|529269687|FG001|Double-blind Period|Withdrawal by Subject|0|||
146755287|NCT02028884|529269688|FG002|Double-blind Period|Withdrawal by Subject|0|||
146755288|NCT02028884|529269686|FG000|Open-label Extension Period|Adverse Event|3|||
146755289|NCT02028884|529269687|FG001|Open-label Extension Period|Adverse Event|1|||
146755290|NCT02028884|529269688|FG002|Open-label Extension Period|Adverse Event|0|||
146755291|NCT02028884|529269686|FG000|Open-label Extension Period|Lack of Efficacy|3|||
146755292|NCT02028884|529269687|FG001|Open-label Extension Period|Lack of Efficacy|0|||
146755293|NCT02028884|529269688|FG002|Open-label Extension Period|Lack of Efficacy|0|||
146755294|NCT02028884|529269686|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
146755295|NCT02028884|529269687|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
146755296|NCT02028884|529269688|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
146755297|NCT02028884|529269686|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
146755298|NCT02028884|529269687|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
146755299|NCT02028884|529269688|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
146755300|NCT02028884|529269686|FG000|Open-label Extension Period|Switched to another treatment option|3|||
146755301|NCT02028884|529269687|FG001|Open-label Extension Period|Switched to another treatment option|0|||
146755302|NCT02028884|529269688|FG002|Open-label Extension Period|Switched to another treatment option|0|||
146755303|NCT02403674|529269689|FG000|Base Study|Death|1|||
146755304|NCT02403674|529269690|FG001|Base Study|Death|4|||
146852811|NCT02054741|529630193|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
146852812|NCT02054741|529630194|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
146852813|NCT02325557|529630198|FG000|Overall Study|Progressive disease|1|||
146852814|NCT02325557|529630199|FG001|Overall Study|Progressive disease|0|||
146852815|NCT02325557|529630200|FG002|Overall Study|Progressive disease|0|||
146514177|NCT01716520|528386681|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
146514178|NCT01716520|528386682|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
146514179|NCT01716520|528386683|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
146514180|NCT01716520|528386684|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
146514181|NCT01716520|528386679|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146514182|NCT01716520|528386680|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146514183|NCT01716520|528386681|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146514184|NCT01716520|528386682|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146514185|NCT01716520|528386683|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
146514186|NCT01716520|528386684|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146514187|NCT01716520|528386679|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
146514188|NCT01716520|528386680|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
146514189|NCT01716520|528386681|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
146514190|NCT01716520|528386682|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
146514191|NCT01716520|528386683|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
146514192|NCT01716520|528386684|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
146514193|NCT01716520|528386679|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
146514194|NCT01716520|528386680|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
146625246|NCT03037385|528803851|FG006|Overall Study|Death|1|||
146625247|NCT03037385|528803852|FG007|Overall Study|Death|4|||
146514195|NCT01716520|528386681|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
146514196|NCT01716520|528386682|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
146514197|NCT01716520|528386683|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
146514198|NCT01716520|528386684|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
146514199|NCT01716520|528386679|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
146514200|NCT01716520|528386680|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
146514201|NCT01716520|528386681|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
146514202|NCT01716520|528386682|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
146514203|NCT01716520|528386683|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
146514204|NCT01716520|528386684|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
146514205|NCT01716520|528386679|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
146514206|NCT01716520|528386680|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
146514207|NCT01716520|528386681|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
146514208|NCT01716520|528386682|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
146514209|NCT01716520|528386683|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
146514210|NCT01716520|528386684|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
146514211|NCT01716520|528386679|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
146514212|NCT01716520|528386680|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
146514213|NCT01716520|528386681|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
146514214|NCT01716520|528386682|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
146514215|NCT01716520|528386683|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
146514216|NCT01716520|528386684|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
146514217|NCT01716520|528386679|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146514218|NCT01716520|528386680|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146514219|NCT01716520|528386681|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146514220|NCT01716520|528386682|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146514221|NCT01716520|528386683|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146514222|NCT01716520|528386684|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
146514223|NCT01716520|528386679|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
146514224|NCT01716520|528386680|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
146514225|NCT01716520|528386681|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
146514226|NCT01716520|528386682|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
146514227|NCT01716520|528386683|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
146514228|NCT01716520|528386684|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
146514229|NCT00253370|528386685|FG000|Overall Study|Adverse Event|18|||
146514230|NCT00253370|528386685|FG000|Overall Study|Disease progression|13|||
146514231|NCT00253370|528386685|FG000|Overall Study|Death|2|||
146514232|NCT00253370|528386685|FG000|Overall Study|Withdrawal by Subject|6|||
146514233|NCT00253370|528386685|FG000|Overall Study|Non-protocol therapy|1|||
146514234|NCT00253370|528386685|FG000|Overall Study|Physician Decision|1|||
146514235|NCT00253370|528386685|FG000|Overall Study|Protocol Violation|1|||
146514236|NCT00253370|528386685|FG000|Overall Study|Abdominal pain due to disease|1|||
146514237|NCT02305446|528386695|FG000|Overall Study|Adverse Event|1|||
146514238|NCT01167634|528386698|FG000|Overall Study|Lost to Follow-up|1|||
146514239|NCT01167634|528386699|FG001|Overall Study|Lost to Follow-up|3|||
146514240|NCT01167634|528386700|FG002|Overall Study|Lost to Follow-up|3|||
146514241|NCT01167634|528386701|FG003|Overall Study|Lost to Follow-up|4|||
146625248|NCT03037385|528803853|FG008|Overall Study|Death|3|||
146755305|NCT02403674|529269689|FG000|Base Study|Adverse Event|11|||
146755306|NCT02403674|529269690|FG001|Base Study|Adverse Event|26|||
146755307|NCT02403674|529269689|FG000|Base Study|Lack of Efficacy|31|||
146755308|NCT02403674|529269690|FG001|Base Study|Lack of Efficacy|23|||
146755309|NCT02403674|529269689|FG000|Base Study|Lost to Follow-up|6|||
146755310|NCT02403674|529269690|FG001|Base Study|Lost to Follow-up|8|||
146755311|NCT02403674|529269689|FG000|Base Study|Withdrawal by Subject|10|||
146755312|NCT02403674|529269690|FG001|Base Study|Withdrawal by Subject|17|||
146755313|NCT02403674|529269689|FG000|Base Study|Physician Decision|2|||
146755314|NCT02403674|529269690|FG001|Base Study|Physician Decision|2|||
146755315|NCT02403674|529269689|FG000|Base Study|Pregnancy|2|||
146755316|NCT02403674|529269690|FG001|Base Study|Pregnancy|2|||
146755317|NCT02403674|529269689|FG000|Base Study|Protocol Violation|8|||
146755318|NCT02403674|529269690|FG001|Base Study|Protocol Violation|4|||
146755319|NCT02403674|529269689|FG000|Base Study|Non-Compliance with study drug|1|||
146755320|NCT02403674|529269690|FG001|Base Study|Non-Compliance with study drug|4|||
146755321|NCT02403674|529269689|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
146755322|NCT02403674|529269690|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
146755323|NCT02403674|529269689|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
146755324|NCT02403674|529269690|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
146755325|NCT02403674|529269689|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
146755326|NCT02403674|529269690|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
146755327|NCT02403674|529269689|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
146755328|NCT02403674|529269690|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
146755329|NCT02403674|529269689|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
146755330|NCT02403674|529269690|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
146755331|NCT02403674|529269689|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
146755332|NCT02403674|529269690|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
146755333|NCT02403674|529269689|FG000|Study Extension 1 (Open-Label)|Death|1|||
146755334|NCT02403674|529269690|FG001|Study Extension 1 (Open-Label)|Death|0|||
146755335|NCT02403674|529269689|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
146755336|NCT02403674|529269690|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
146755337|NCT02403674|529269689|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
146755338|NCT02403674|529269690|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
146755339|NCT02403674|529269689|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
146755340|NCT02403674|529269690|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
146755341|NCT02403674|529269689|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
146755342|NCT02403674|529269690|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
146755343|NCT02403674|529269689|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
146755344|NCT02403674|529269690|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
146755345|NCT02403674|529269689|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
146755346|NCT02403674|529269690|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
146755347|NCT02403674|529269689|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
146755348|NCT02403674|529269690|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
146755349|NCT02403674|529269689|FG000|Study Extension 2 (Open-Label)|Death|2|||
146755350|NCT02403674|529269690|FG001|Study Extension 2 (Open-Label)|Death|2|||
146755351|NCT02403674|529269689|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
146755352|NCT02403674|529269690|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
146755353|NCT02403674|529269689|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
146755354|NCT02403674|529269690|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
146755355|NCT02403674|529269689|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
146755356|NCT02403674|529269690|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
146755357|NCT02403674|529269689|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
146755358|NCT02403674|529269690|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
146755359|NCT02403674|529269689|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
146755360|NCT02403674|529269690|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
146755361|NCT02403674|529269689|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
146755362|NCT02403674|529269690|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
146755363|NCT02403674|529269689|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
146755364|NCT02403674|529269690|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
146755365|NCT00826280|529269691|FG000|Overall Study|Randomized but drug not received|1|||
146755366|NCT00826280|529269692|FG001|Overall Study|Randomized but drug not received|0|||
146755367|NCT00826280|529269693|FG002|Overall Study|Randomized but drug not received|1|||
146755368|NCT00826280|529269691|FG000|Overall Study|Adverse Event|1|||
146755369|NCT00826280|529269692|FG001|Overall Study|Adverse Event|3|||
146755370|NCT00826280|529269693|FG002|Overall Study|Adverse Event|0|||
146755371|NCT00826280|529269691|FG000|Overall Study|Lost to Follow-up|0|||
146755372|NCT00826280|529269692|FG001|Overall Study|Lost to Follow-up|1|||
146755373|NCT00826280|529269693|FG002|Overall Study|Lost to Follow-up|0|||
146755374|NCT00826280|529269691|FG000|Overall Study|Sponsor discontinued subject or study|1|||
146755375|NCT00826280|529269692|FG001|Overall Study|Sponsor discontinued subject or study|0|||
146755376|NCT00826280|529269693|FG002|Overall Study|Sponsor discontinued subject or study|0|||
146755377|NCT00826280|529269691|FG000|Overall Study|Reversible ischemic defect not present|43|||
146755378|NCT00826280|529269692|FG001|Overall Study|Reversible ischemic defect not present|40|||
146755379|NCT00826280|529269693|FG002|Overall Study|Reversible ischemic defect not present|44|||
146755380|NCT00826280|529269691|FG000|Overall Study|Interpretation Failure|1|||
146755381|NCT00826280|529269692|FG001|Overall Study|Interpretation Failure|0|||
146755382|NCT00826280|529269693|FG002|Overall Study|Interpretation Failure|0|||
146755383|NCT00826280|529269691|FG000|Overall Study|Machine Failure|1|||
146755384|NCT00826280|529269692|FG001|Overall Study|Machine Failure|1|||
146755385|NCT00826280|529269693|FG002|Overall Study|Machine Failure|0|||
146755386|NCT00826280|529269691|FG000|Overall Study|One or more non-interpretable scan|0|||
146755387|NCT00826280|529269692|FG001|Overall Study|One or more non-interpretable scan|1|||
146755388|NCT00826280|529269693|FG002|Overall Study|One or more non-interpretable scan|1|||
146755389|NCT03487666|529269694|FG000|Overall Study|Disease progression|4|||
146755390|NCT03487666|529269695|FG001|Overall Study|Disease progression|2|||
146755391|NCT03487666|529269696|FG002|Overall Study|Disease progression|0|||
146755392|NCT03487666|529269694|FG000|Overall Study|Adverse Event|0|||
146755393|NCT03487666|529269695|FG001|Overall Study|Adverse Event|0|||
146755394|NCT03487666|529269696|FG002|Overall Study|Adverse Event|1|||
146755395|NCT03201757|529269697|FG000|Overall Study|Withdrawal by Subject|133|||
146755396|NCT03201757|529269697|FG000|Overall Study|Adverse Event|44|||
146755397|NCT03201757|529269697|FG000|Overall Study|Lost to Follow-up|37|||
146755398|NCT03201757|529269697|FG000|Overall Study|Pregnancy|2|||
146755399|NCT03201757|529269697|FG000|Overall Study|Lack of Efficacy|1|||
146755400|NCT03201757|529269697|FG000|Overall Study|Protocol Violation|20|||
146755401|NCT03201757|529269697|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
146755402|NCT03201757|529269697|FG000|Overall Study|Not Yet Determined|5|||
146755403|NCT03201757|529269697|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
146755404|NCT03201757|529269697|FG000|Overall Study|Other|20|||
146755405|NCT00765362|529269699|FG000|Overall Study|Death|9|||
146755406|NCT00765362|529269699|FG000|Overall Study|Adverse Event|2|||
146755407|NCT00765362|529269699|FG000|Overall Study|Protocol Violation|18|||
146755408|NCT00765362|529269699|FG000|Overall Study|Withdrawal by Subject|13|||
146755409|NCT00765362|529269699|FG000|Overall Study|Lost to Follow-up|95|||
146755410|NCT00664521|529269701|FG000|Overall Study|Adverse Event|4|||
146755411|NCT00664521|529269702|FG001|Overall Study|Adverse Event|1|||
146755412|NCT00664521|529269701|FG000|Overall Study|Lost to Follow-up|1|||
146755413|NCT00664521|529269702|FG001|Overall Study|Lost to Follow-up|0|||
146755414|NCT00664521|529269701|FG000|Overall Study|Other|1|||
146755415|NCT00664521|529269702|FG001|Overall Study|Other|0|||
146755416|NCT02800928|529269703|FG000|Overall Study|Withdrawal by Subject|1|||
146755417|NCT02800928|529269704|FG001|Overall Study|Withdrawal by Subject|1|||
146755418|NCT02800928|529269703|FG000|Overall Study|Protocol Violation|1|||
146755419|NCT02800928|529269704|FG001|Overall Study|Protocol Violation|1|||
146755420|NCT02886728|529269711|FG000|Overall Study|Withdrew Consent|31|||
146755421|NCT02886728|529269712|FG001|Overall Study|Withdrew Consent|13|||
146755422|NCT02886728|529269713|FG002|Overall Study|Withdrew Consent|11|||
146755423|NCT02886728|529269714|FG003|Overall Study|Withdrew Consent|47|||
146755424|NCT02886728|529269711|FG000|Overall Study|Lost to Follow-up|12|||
146755425|NCT02886728|529269712|FG001|Overall Study|Lost to Follow-up|6|||
146755426|NCT02886728|529269713|FG002|Overall Study|Lost to Follow-up|13|||
146755427|NCT02886728|529269714|FG003|Overall Study|Lost to Follow-up|12|||
146755428|NCT02886728|529269711|FG000|Overall Study|Adverse Event|13|||
146755429|NCT02886728|529269712|FG001|Overall Study|Adverse Event|5|||
146755430|NCT02886728|529269713|FG002|Overall Study|Adverse Event|5|||
146755431|NCT02886728|529269714|FG003|Overall Study|Adverse Event|11|||
146755432|NCT02886728|529269711|FG000|Overall Study|Investigator's Discretion|11|||
146755433|NCT02886728|529269712|FG001|Overall Study|Investigator's Discretion|7|||
146755434|NCT02886728|529269713|FG002|Overall Study|Investigator's Discretion|5|||
146755435|NCT02886728|529269714|FG003|Overall Study|Investigator's Discretion|11|||
146755436|NCT02886728|529269711|FG000|Overall Study|Death|3|||
146755437|NCT02886728|529269712|FG001|Overall Study|Death|1|||
146755438|NCT02886728|529269713|FG002|Overall Study|Death|0|||
146755439|NCT02886728|529269714|FG003|Overall Study|Death|0|||
146755440|NCT02886728|529269711|FG000|Overall Study|Protocol Violation|0|||
146755441|NCT02886728|529269712|FG001|Overall Study|Protocol Violation|0|||
146755442|NCT02886728|529269713|FG002|Overall Study|Protocol Violation|0|||
146755443|NCT02886728|529269714|FG003|Overall Study|Protocol Violation|4|||
146755444|NCT02886728|529269711|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146755445|NCT02886728|529269712|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146755446|NCT02886728|529269713|FG002|Overall Study|Non-Compliance with Study Drug|1|||
146755447|NCT02886728|529269714|FG003|Overall Study|Non-Compliance with Study Drug|0|||
146755448|NCT02886728|529269711|FG000|Overall Study|Pregnancy|0|||
146755449|NCT02886728|529269712|FG001|Overall Study|Pregnancy|0|||
146755450|NCT02886728|529269713|FG002|Overall Study|Pregnancy|1|||
146755451|NCT02886728|529269714|FG003|Overall Study|Pregnancy|0|||
146755452|NCT02886728|529269711|FG000|Overall Study|Randomized but Not Dosed|1|||
146755453|NCT02886728|529269712|FG001|Overall Study|Randomized but Not Dosed|0|||
146755454|NCT02886728|529269713|FG002|Overall Study|Randomized but Not Dosed|0|||
146755455|NCT02886728|529269714|FG003|Overall Study|Randomized but Not Dosed|2|||
146755456|NCT04990440|529269723|FG000|Overall Study|Sponsor's Decision|0|||
146755457|NCT04990440|529269724|FG001|Overall Study|Sponsor's Decision|0|||
146755458|NCT04990440|529269725|FG002|Overall Study|Sponsor's Decision|1|||
146755459|NCT03712098|529269726|FG000|Overall Study|Lost to Follow-up|3|||
146755460|NCT03712098|529269727|FG001|Overall Study|Lost to Follow-up|7|||
146755461|NCT03712098|529269726|FG000|Overall Study|Withdrawal by Subject|9|||
146755462|NCT03712098|529269727|FG001|Overall Study|Withdrawal by Subject|4|||
146755463|NCT03712098|529269726|FG000|Overall Study|Protocol Violation|2|||
146755464|NCT03712098|529269727|FG001|Overall Study|Protocol Violation|1|||
146755465|NCT02118714|529269736|FG000|Overall Study|Lost to Follow-up|2|||
146755466|NCT02118714|529269736|FG000|Overall Study|Protocol Violation|1|||
146625249|NCT03037385|528803854|FG009|Overall Study|Death|240|||
146755467|NCT02954575|529269737|FG000|Overall Study|Withdrawal by Subject|2|||
146755468|NCT02954575|529269737|FG000|Overall Study|Adverse Event|1|||
146514242|NCT01167634|528386698|FG000|Overall Study|Withdrawal by Subject|1|||
146514243|NCT01167634|528386699|FG001|Overall Study|Withdrawal by Subject|1|||
146514244|NCT01167634|528386700|FG002|Overall Study|Withdrawal by Subject|0|||
146514245|NCT01167634|528386701|FG003|Overall Study|Withdrawal by Subject|0|||
146514246|NCT02614131|528386702|FG000|Overall Study|Withdrawal by Subject|1|||
146514247|NCT02614131|528386703|FG001|Overall Study|Withdrawal by Subject|0|||
146514248|NCT02614131|528386704|FG002|Overall Study|Withdrawal by Subject|0|||
146514249|NCT02614131|528386705|FG003|Overall Study|Withdrawal by Subject|0|||
146514250|NCT02614131|528386706|FG004|Overall Study|Withdrawal by Subject|0|||
146514251|NCT02614131|528386707|FG005|Overall Study|Withdrawal by Subject|0|||
146514252|NCT02614131|528386708|FG006|Overall Study|Withdrawal by Subject|0|||
146514253|NCT02614131|528386702|FG000|Overall Study|Adverse Event|0|||
146514254|NCT02614131|528386703|FG001|Overall Study|Adverse Event|0|||
146514255|NCT02614131|528386704|FG002|Overall Study|Adverse Event|0|||
146514256|NCT02614131|528386705|FG003|Overall Study|Adverse Event|0|||
146514257|NCT02614131|528386706|FG004|Overall Study|Adverse Event|0|||
146514258|NCT02614131|528386707|FG005|Overall Study|Adverse Event|0|||
146514259|NCT02614131|528386708|FG006|Overall Study|Adverse Event|1|||
146514260|NCT02603107|528386709|FG000|Randomized Phase|Withdrew consent|8|||
146514261|NCT02603107|528386710|FG001|Randomized Phase|Withdrew consent|15|||
146514262|NCT02603107|528386709|FG000|Randomized Phase|Lost to Follow-up|1|||
146514263|NCT02603107|528386710|FG001|Randomized Phase|Lost to Follow-up|3|||
146514264|NCT02603107|528386709|FG000|Randomized Phase|Adverse Event|2|||
146514265|NCT02603107|528386710|FG001|Randomized Phase|Adverse Event|0|||
146514266|NCT02603107|528386709|FG000|Randomized Phase|Death|1|||
146514267|NCT02603107|528386710|FG001|Randomized Phase|Death|1|||
146514268|NCT02603107|528386709|FG000|Randomized Phase|Non-compliance with study drug|1|||
146514269|NCT02603107|528386710|FG001|Randomized Phase|Non-compliance with study drug|1|||
146514270|NCT02603107|528386709|FG000|Randomized Phase|Investigator's discretion|0|||
146514271|NCT02603107|528386710|FG001|Randomized Phase|Investigator's discretion|1|||
146514272|NCT02603107|528386709|FG000|Randomized Phase|Lack of Efficacy|1|||
146514273|NCT02603107|528386710|FG001|Randomized Phase|Lack of Efficacy|0|||
146514274|NCT02603107|528386709|FG000|Randomized Phase|Protocol Violation|1|||
146514275|NCT02603107|528386710|FG001|Randomized Phase|Protocol Violation|0|||
146514276|NCT02603107|528386709|FG000|Optional Extension Phase|Lost to Follow-up|3|||
146514277|NCT02603107|528386710|FG001|Optional Extension Phase|Lost to Follow-up|3|||
146514278|NCT02603107|528386709|FG000|Optional Extension Phase|Withdrew consent|3|||
146514279|NCT02603107|528386710|FG001|Optional Extension Phase|Withdrew consent|2|||
146514280|NCT02603107|528386709|FG000|Optional Extension Phase|Investigator's discretion|2|||
146514281|NCT02603107|528386710|FG001|Optional Extension Phase|Investigator's discretion|2|||
146514282|NCT02603107|528386709|FG000|Optional Extension Phase|Pregnancy|0|||
146514283|NCT02603107|528386710|FG001|Optional Extension Phase|Pregnancy|3|||
146514284|NCT02603107|528386709|FG000|Optional Extension Phase|Adverse Event|0|||
146514285|NCT02603107|528386710|FG001|Optional Extension Phase|Adverse Event|2|||
146514286|NCT02603107|528386709|FG000|Optional Extension Phase|Not treated in extension phase|0|||
146514287|NCT02603107|528386710|FG001|Optional Extension Phase|Not treated in extension phase|1|||
146514288|NCT02603107|528386709|FG000|Optional Extension Phase|Protocol Violation|1|||
146514289|NCT02603107|528386710|FG001|Optional Extension Phase|Protocol Violation|0|||
146514290|NCT00187278|528386717|FG000|Overall Study|Protocol Violation|10|||
146514291|NCT00187278|528386718|FG001|Overall Study|Protocol Violation|13|||
146514292|NCT01857102|528386719|FG000|Period 1|No longer meets Eligibility Criteria|0|||
146514293|NCT01857102|528386720|FG001|Period 1|No longer meets Eligibility Criteria|2|||
146514294|NCT01857102|528386719|FG000|Period 1|Lost to Follow-up|0|||
146514295|NCT01857102|528386720|FG001|Period 1|Lost to Follow-up|3|||
146514296|NCT01857102|528386719|FG000|Period 1|Unsatisfactory Lens Fit|1|||
146514297|NCT01857102|528386720|FG001|Period 1|Unsatisfactory Lens Fit|0|||
146514298|NCT01857102|528386719|FG000|Period 1|Unsatisfactory Visual Response|1|||
146514299|NCT01857102|528386720|FG001|Period 1|Unsatisfactory Visual Response|0|||
146514300|NCT01857102|528386719|FG000|Period 1|Physician Decision|1|||
146514301|NCT01857102|528386720|FG001|Period 1|Physician Decision|0|||
146514302|NCT01857102|528386719|FG000|Period 2|Lens Discomfort|1|||
146514303|NCT01857102|528386720|FG001|Period 2|Lens Discomfort|0|||
146514304|NCT01857102|528386719|FG000|Period 2|Unsatisfactory Lens Fit|1|||
146514305|NCT01857102|528386720|FG001|Period 2|Unsatisfactory Lens Fit|0|||
146514306|NCT00090584|528386726|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
146514307|NCT00090584|528386727|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
146514308|NCT00090584|528386726|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
146514309|NCT00090584|528386727|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
146514310|NCT02920177|528386731|FG000|Overall Study|Withdrawal by Subject|1|||
146514311|NCT02920177|528386732|FG001|Overall Study|Withdrawal by Subject|1|||
146514312|NCT02920177|528386731|FG000|Overall Study|Physician Decision|1|||
146514313|NCT02920177|528386732|FG001|Overall Study|Physician Decision|0|||
146514314|NCT02920177|528386731|FG000|Overall Study|Lost to Follow-up|0|||
146514315|NCT02920177|528386732|FG001|Overall Study|Lost to Follow-up|1|||
146514316|NCT02054910|528386733|FG000|Overall Study|Lost to Follow-up|4|||
146514317|NCT02054910|528386734|FG001|Overall Study|Lost to Follow-up|1|||
146514318|NCT04907227|528386735|FG000|Overall Study|Death|12|||
146514319|NCT04907227|528386736|FG001|Overall Study|Death|8|||
146514320|NCT04907227|528386735|FG000|Overall Study|Withdrawal by Subject|2|||
146852816|NCT02325557|529630201|FG003|Overall Study|Progressive disease|0|||
146852817|NCT02325557|529630198|FG000|Overall Study|Withdrawal by Subject|4|||
146852818|NCT02325557|529630199|FG001|Overall Study|Withdrawal by Subject|0|||
146852819|NCT02325557|529630200|FG002|Overall Study|Withdrawal by Subject|0|||
146852820|NCT02325557|529630201|FG003|Overall Study|Withdrawal by Subject|15|||
146852821|NCT02325557|529630198|FG000|Overall Study|Death|5|||
146852822|NCT02325557|529630199|FG001|Overall Study|Death|1|||
146852823|NCT02325557|529630200|FG002|Overall Study|Death|1|||
146852824|NCT02325557|529630201|FG003|Overall Study|Death|16|||
146852825|NCT02325557|529630198|FG000|Overall Study|Lost to Follow-up|0|||
146852826|NCT02325557|529630199|FG001|Overall Study|Lost to Follow-up|0|||
146852827|NCT02325557|529630200|FG002|Overall Study|Lost to Follow-up|1|||
146852828|NCT02325557|529630201|FG003|Overall Study|Lost to Follow-up|1|||
146852829|NCT02325557|529630198|FG000|Overall Study|Other|0|||
146852830|NCT02325557|529630199|FG001|Overall Study|Other|0|||
146852831|NCT02325557|529630200|FG002|Overall Study|Other|0|||
146852832|NCT02325557|529630201|FG003|Overall Study|Other|5|||
146514321|NCT04907227|528386736|FG001|Overall Study|Withdrawal by Subject|2|||
146514322|NCT04907227|528386735|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
146514323|NCT04907227|528386736|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
146514324|NCT04907227|528386735|FG000|Overall Study|Sponsor Decision|25|||
146514325|NCT04907227|528386736|FG001|Overall Study|Sponsor Decision|30|||
146514326|NCT04907227|528386735|FG000|Overall Study|Physician Decision|1|||
146514327|NCT04907227|528386736|FG001|Overall Study|Physician Decision|0|||
146514328|NCT03723070|528386737|FG000|Overall Study|Lost to Follow-up|2|||
146514329|NCT03723070|528386737|FG000|Overall Study|Physician Decision|1|||
146514330|NCT03723070|528386737|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
146514331|NCT03053427|528386738|FG000|Overall Study|Adverse Event|4|||
146514332|NCT03053427|528386739|FG001|Overall Study|Adverse Event|4|||
146514333|NCT03053427|528386738|FG000|Overall Study|Lack of Efficacy|1|||
146514334|NCT03053427|528386739|FG001|Overall Study|Lack of Efficacy|3|||
146514335|NCT03053427|528386738|FG000|Overall Study|Lost to Follow-up|2|||
146514336|NCT03053427|528386739|FG001|Overall Study|Lost to Follow-up|2|||
146514337|NCT03053427|528386738|FG000|Overall Study|Worsening of the target disease|0|||
146514338|NCT03053427|528386739|FG001|Overall Study|Worsening of the target disease|1|||
146514339|NCT03053427|528386738|FG000|Overall Study|Protocol Deviation|3|||
146514340|NCT03053427|528386739|FG001|Overall Study|Protocol Deviation|3|||
146852833|NCT01502631|529630202|FG000|Overall Study|Adverse Event|5|||
146852834|NCT01502631|529630203|FG001|Overall Study|Adverse Event|8|||
146852835|NCT01502631|529630202|FG000|Overall Study|Lost to Follow-up|2|||
146852836|NCT01502631|529630203|FG001|Overall Study|Lost to Follow-up|2|||
146852837|NCT01502631|529630202|FG000|Overall Study|Participant withdrew consent|2|||
146852838|NCT01502631|529630203|FG001|Overall Study|Participant withdrew consent|4|||
146852839|NCT01502631|529630202|FG000|Overall Study|Participant non-compliant|1|||
146852840|NCT01502631|529630203|FG001|Overall Study|Participant non-compliant|0|||
146852841|NCT01502631|529630202|FG000|Overall Study|Investigator's decision|0|||
146852842|NCT01502631|529630203|FG001|Overall Study|Investigator's decision|1|||
146852843|NCT01502631|529630202|FG000|Overall Study|Other|10|||
146852844|NCT01502631|529630203|FG001|Overall Study|Other|5|||
146852845|NCT01488487|529630204|FG000|Overall Study|Adverse Event|6|||
146852846|NCT01488487|529630204|FG000|Overall Study|Death|1|||
146852847|NCT01488487|529630204|FG000|Overall Study|Withdrawal by Subject|2|||
146852848|NCT02084056|529630205|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
146852849|NCT02084056|529630206|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
146852850|NCT02084056|529630207|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
146852851|NCT02084056|529630208|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
146852852|NCT02084056|529630205|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
146852853|NCT02084056|529630206|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
146852854|NCT02084056|529630207|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
146514341|NCT03053427|528386738|FG000|Overall Study|Withdrawal by Subject|3|||
146852855|NCT02084056|529630208|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
146852856|NCT01293487|529630210|FG000|Overall Study|Lost to Follow-up|0|||
146514342|NCT03053427|528386739|FG001|Overall Study|Withdrawal by Subject|2|||
146514343|NCT03053427|528386738|FG000|Overall Study|Miscellaneous|0|||
146514344|NCT03053427|528386739|FG001|Overall Study|Miscellaneous|1|||
146852857|NCT01293487|529630211|FG001|Overall Study|Lost to Follow-up|0|||
146852858|NCT01293487|529630212|FG002|Overall Study|Lost to Follow-up|0|||
146852859|NCT01293487|529630213|FG003|Overall Study|Lost to Follow-up|1|||
146852860|NCT01293487|529630214|FG004|Overall Study|Lost to Follow-up|0|||
146852861|NCT01293487|529630215|FG005|Overall Study|Lost to Follow-up|0|||
146514345|NCT01324570|528386747|FG000|Overall Study|Adverse Event|4|||
146514346|NCT01324570|528386748|FG001|Overall Study|Adverse Event|7|||
146852862|NCT01293487|529630216|FG006|Overall Study|Lost to Follow-up|0|||
146852863|NCT01293487|529630217|FG007|Overall Study|Lost to Follow-up|0|||
146852864|NCT01293487|529630210|FG000|Overall Study|Withdrawal by Subject|0|||
146852865|NCT01293487|529630211|FG001|Overall Study|Withdrawal by Subject|0|||
146514347|NCT01324570|528386747|FG000|Overall Study|Withdrawal by Subject|0|||
146514348|NCT01324570|528386748|FG001|Overall Study|Withdrawal by Subject|3|||
146514349|NCT01324570|528386747|FG000|Overall Study|Lack of Efficacy|0|||
146514350|NCT01324570|528386748|FG001|Overall Study|Lack of Efficacy|1|||
146514351|NCT01324570|528386747|FG000|Overall Study|Confirmed or suspected diversion|0|||
146514352|NCT01324570|528386748|FG001|Overall Study|Confirmed or suspected diversion|1|||
146514353|NCT01324570|528386747|FG000|Overall Study|Administrative|0|||
146514354|NCT01324570|528386748|FG001|Overall Study|Administrative|2|||
146514355|NCT00207727|528386753|FG000|Overall Study|Withdrawal by Subject|0|||
146514356|NCT00207727|528386754|FG001|Overall Study|Withdrawal by Subject|0|||
146514357|NCT00207727|528386755|FG002|Overall Study|Withdrawal by Subject|0|||
146514358|NCT00207727|528386756|FG003|Overall Study|Withdrawal by Subject|0|||
146514359|NCT00207727|528386757|FG004|Overall Study|Withdrawal by Subject|1|||
146514360|NCT00207727|528386753|FG000|Overall Study|Lost to Follow-up|0|||
146514361|NCT00207727|528386754|FG001|Overall Study|Lost to Follow-up|1|||
146514362|NCT00207727|528386755|FG002|Overall Study|Lost to Follow-up|0|||
146514363|NCT00207727|528386756|FG003|Overall Study|Lost to Follow-up|0|||
146514364|NCT00207727|528386757|FG004|Overall Study|Lost to Follow-up|0|||
146514365|NCT00207727|528386753|FG000|Overall Study|Other|38|||
146514366|NCT00207727|528386754|FG001|Overall Study|Other|41|||
146514367|NCT00207727|528386755|FG002|Overall Study|Other|41|||
146514368|NCT00207727|528386756|FG003|Overall Study|Other|37|||
146514369|NCT00207727|528386757|FG004|Overall Study|Other|33|||
146514370|NCT00539032|528386761|FG000|Overall Study|Withdrawal by Subject|2|||
146514371|NCT00539032|528386762|FG001|Overall Study|Withdrawal by Subject|1|||
146514372|NCT04114656|528388217|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
146514373|NCT04114656|528388218|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
146514374|NCT04114656|528388217|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
146514375|NCT04114656|528388218|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
146514376|NCT04114656|528388217|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
146514377|NCT04114656|528388218|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
146514378|NCT04114656|528388217|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
146514379|NCT04114656|528388218|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
146514380|NCT04114656|528388217|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
146514381|NCT04114656|528388218|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
146514382|NCT01980628|528388219|FG000|Overall Study|Adverse Event|12|||
146514383|NCT01980628|528388219|FG000|Overall Study|Physician Decision|5|||
146514384|NCT01980628|528388219|FG000|Overall Study|Withdrawal by Subject|4|||
146514385|NCT01980628|528388219|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
146514386|NCT03341936|528388222|FG000|Overall Study|Ineligible|1|||
146514387|NCT03341936|528388222|FG000|Overall Study|Disease Progression|2|||
146514388|NCT03341936|528388222|FG000|Overall Study|Withdrew Consent|4|||
146514389|NCT03341936|528388222|FG000|Overall Study|Non-Compliance|1|||
146514390|NCT03341936|528388222|FG000|Overall Study|Physician Decision|1|||
146514391|NCT03341936|528388222|FG000|Overall Study|Withdrawal by Subject|1|||
146514392|NCT03341936|528388222|FG000|Overall Study|Other|1|||
146514393|NCT02368886|528388223|FG000|Overall Study|Cancel|1|||
146514394|NCT02368886|528388224|FG001|Overall Study|Cancel|1|||
146514395|NCT02368886|528388225|FG002|Overall Study|Cancel|1|||
146514396|NCT02368886|528388226|FG003|Overall Study|Cancel|3|||
146514397|NCT02368886|528388223|FG000|Overall Study|Ineligible|0|||
146514398|NCT02368886|528388224|FG001|Overall Study|Ineligible|0|||
146514399|NCT02368886|528388225|FG002|Overall Study|Ineligible|0|||
146514400|NCT02368886|528388226|FG003|Overall Study|Ineligible|1|||
146514401|NCT02131636|528388230|FG000|Overall Study|Personal Reasons|4|||
146514402|NCT02131636|528388231|FG001|Overall Study|Personal Reasons|4|||
146755469|NCT01066156|529269739|FG000|Overall Study|ineligible|2|||
146755470|NCT01066156|529269739|FG000|Overall Study|Lost to Follow-up|7|||
146755471|NCT01066156|529269739|FG000|Overall Study|Withdrawal by Subject|1|||
146755472|NCT00570661|529269740|FG000|Overall Study|Disease worsening|5|||
146755473|NCT00570661|529269740|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
146755474|NCT00570661|529269740|FG000|Overall Study|Adverse Event|1|||
146755475|NCT01734382|529269744|FG000|Part 1|Adverse Event|2|||
146755476|NCT01734382|529269745|FG001|Part 1|Adverse Event|0|||
146755477|NCT01734382|529269746|FG002|Part 1|Adverse Event|0|||
146755478|NCT01734382|529269744|FG000|Part 2|Adverse Event|0|||
146755479|NCT01734382|529269745|FG001|Part 2|Adverse Event|0|||
146755480|NCT01734382|529269746|FG002|Part 2|Adverse Event|1|||
146755481|NCT01734382|529269744|FG000|Part 2|Lack of Efficacy|0|||
146514403|NCT02131636|528388230|FG000|Overall Study|Lost to Follow-up|4|||
146514404|NCT02131636|528388231|FG001|Overall Study|Lost to Follow-up|0|||
146755482|NCT01734382|529269745|FG001|Part 2|Lack of Efficacy|1|||
146514405|NCT02131636|528388230|FG000|Overall Study|Adverse Event|4|||
146514406|NCT02131636|528388231|FG001|Overall Study|Adverse Event|1|||
146514407|NCT06226649|528388232|FG000|Overall Study|Withdrawal by Subject|4|||
146755483|NCT01734382|529269746|FG002|Part 2|Lack of Efficacy|1|||
146755484|NCT01734382|529269744|FG000|Part 2|Other|0|||
146852866|NCT01293487|529630212|FG002|Overall Study|Withdrawal by Subject|0|||
146852867|NCT01293487|529630213|FG003|Overall Study|Withdrawal by Subject|0|||
146852868|NCT01293487|529630214|FG004|Overall Study|Withdrawal by Subject|0|||
146852869|NCT01293487|529630215|FG005|Overall Study|Withdrawal by Subject|0|||
146852870|NCT01293487|529630216|FG006|Overall Study|Withdrawal by Subject|0|||
146852871|NCT01293487|529630217|FG007|Overall Study|Withdrawal by Subject|2|||
146852872|NCT00395460|529630219|FG000|Overall Study|Withdrawal by Subject|1|||
146852873|NCT00395460|529630220|FG001|Overall Study|Withdrawal by Subject|0|||
146852874|NCT00528645|529630222|FG000|Overall Study|Adverse Event|3|||
146852875|NCT01445301|529630223|FG000|Overall Study|Adverse Event|15|||
146852876|NCT01445301|529630224|FG001|Overall Study|Adverse Event|25|||
146852877|NCT01445301|529630225|FG002|Overall Study|Adverse Event|4|||
146852878|NCT01445301|529630223|FG000|Overall Study|Lack of Efficacy|0|||
146852879|NCT01445301|529630224|FG001|Overall Study|Lack of Efficacy|1|||
146852880|NCT01445301|529630225|FG002|Overall Study|Lack of Efficacy|0|||
146852881|NCT01445301|529630223|FG000|Overall Study|Protocol Violation|1|||
146852882|NCT01445301|529630224|FG001|Overall Study|Protocol Violation|0|||
146852883|NCT01445301|529630225|FG002|Overall Study|Protocol Violation|0|||
146852884|NCT01445301|529630223|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
146852885|NCT01445301|529630224|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
146852886|NCT01445301|529630225|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
146852887|NCT01445301|529630223|FG000|Overall Study|Physician Decision|0|||
146514408|NCT06226649|528388233|FG001|Overall Study|Withdrawal by Subject|1|||
146514409|NCT00004088|528388235|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
146514410|NCT00004088|528388235|FG000|Overall Study|Withdrawal by Subject|1|||
146514411|NCT00004088|528388235|FG000|Overall Study|Protocol Violation|3|||
146514412|NCT00004088|528388235|FG000|Overall Study|Physician Decision|1|||
146514413|NCT01955109|528388236|FG000|Overall Study|Adverse Event|2|||
146514414|NCT01955109|528388237|FG001|Overall Study|Adverse Event|0|||
146514415|NCT01955109|528388236|FG000|Overall Study|Participant unwilling to continue|35|||
146514416|NCT01955109|528388237|FG001|Overall Study|Participant unwilling to continue|7|||
146514417|NCT01955109|528388236|FG000|Overall Study|Physician Decision|2|||
146514418|NCT01955109|528388237|FG001|Overall Study|Physician Decision|0|||
146514419|NCT01955109|528388236|FG000|Overall Study|Lost to Follow-up|3|||
146514420|NCT01955109|528388237|FG001|Overall Study|Lost to Follow-up|1|||
146514421|NCT01955109|528388236|FG000|Overall Study|Non-compliance|3|||
146514422|NCT01955109|528388237|FG001|Overall Study|Non-compliance|1|||
146514423|NCT00419159|528388243|FG000|Overall Study|Adverse Event|7|||
146514424|NCT00419159|528388244|FG001|Overall Study|Adverse Event|15|||
146514425|NCT00419159|528388243|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146852888|NCT01445301|529630224|FG001|Overall Study|Physician Decision|2|||
146852889|NCT01445301|529630225|FG002|Overall Study|Physician Decision|0|||
146852890|NCT01445301|529630223|FG000|Overall Study|Withdrawal by Subject|5|||
146852891|NCT01445301|529630224|FG001|Overall Study|Withdrawal by Subject|6|||
146852892|NCT01445301|529630225|FG002|Overall Study|Withdrawal by Subject|4|||
146852893|NCT00752557|529630226|FG000|Overall Study|Withdrawal by Subject|4|||
146514426|NCT00419159|528388244|FG001|Overall Study|Abnormal laboratory value(s)|2|||
146514427|NCT00419159|528388243|FG000|Overall Study|Subject's no longer requires study drug|0|||
146514428|NCT00419159|528388244|FG001|Overall Study|Subject's no longer requires study drug|1|||
146514429|NCT00419159|528388243|FG000|Overall Study|Protocol Violation|1|||
146514430|NCT00419159|528388244|FG001|Overall Study|Protocol Violation|0|||
146514431|NCT00419159|528388243|FG000|Overall Study|Withdrawal by Subject|10|||
146514432|NCT00419159|528388244|FG001|Overall Study|Withdrawal by Subject|3|||
146514433|NCT00419159|528388243|FG000|Overall Study|Lost to Follow-up|0|||
146514434|NCT00419159|528388244|FG001|Overall Study|Lost to Follow-up|1|||
146514435|NCT00419159|528388243|FG000|Overall Study|Death|2|||
146852894|NCT00752557|529630227|FG001|Overall Study|Withdrawal by Subject|3|||
146852895|NCT00752557|529630228|FG002|Overall Study|Withdrawal by Subject|3|||
146852896|NCT00752557|529630226|FG000|Overall Study|Unspecified resaons|0|||
146852897|NCT00752557|529630227|FG001|Overall Study|Unspecified resaons|2|||
146852898|NCT00752557|529630228|FG002|Overall Study|Unspecified resaons|2|||
146852899|NCT00752557|529630226|FG000|Overall Study|Lost to Follow-up|1|||
146852900|NCT00752557|529630227|FG001|Overall Study|Lost to Follow-up|0|||
146852901|NCT00752557|529630228|FG002|Overall Study|Lost to Follow-up|1|||
146852902|NCT00190749|529630229|FG000|Overall Study|Lost to Follow-up|8|||
146852903|NCT00190749|529630230|FG001|Overall Study|Lost to Follow-up|11|||
146852904|NCT00190749|529630229|FG000|Overall Study|Withdrawal by Subject|10|||
146852905|NCT00190749|529630230|FG001|Overall Study|Withdrawal by Subject|6|||
146852906|NCT00190749|529630229|FG000|Overall Study|Protocol Violation|5|||
146852907|NCT00190749|529630230|FG001|Overall Study|Protocol Violation|4|||
146852908|NCT00190749|529630229|FG000|Overall Study|Adverse Event|0|||
146514436|NCT00419159|528388244|FG001|Overall Study|Death|2|||
146514437|NCT00419159|528388243|FG000|Overall Study|Disease progression|79|||
146514438|NCT00419159|528388244|FG001|Overall Study|Disease progression|76|||
146514439|NCT01017601|528388245|FG000|Overall Study|Disease Progression|12|||
146514440|NCT01017601|528388246|FG001|Overall Study|Disease Progression|12|||
146514441|NCT01017601|528388245|FG000|Overall Study|Withdrawal by Subject|0|||
146514442|NCT01017601|528388246|FG001|Overall Study|Withdrawal by Subject|1|||
146514443|NCT02735096|528388247|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
146514444|NCT02117713|528388248|FG000|Week 48|Adverse Event|4|||
146514445|NCT02117713|528388248|FG000|Week 48|Withdrawal by caregiver|2|||
146514446|NCT02117713|528388248|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
146514447|NCT02117713|528388248|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
146514448|NCT02117713|528388248|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
146514449|NCT02117713|528388248|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
146514450|NCT01094782|528388249|FG000|Overall Study|Withdrawal by Subject|5|||
146514451|NCT01094782|528388250|FG001|Overall Study|Withdrawal by Subject|5|||
146514452|NCT01094782|528388251|FG002|Overall Study|Withdrawal by Subject|1|||
146514453|NCT01094782|528388252|FG003|Overall Study|Withdrawal by Subject|5|||
146514454|NCT01094782|528388253|FG004|Overall Study|Withdrawal by Subject|5|||
146514455|NCT01094782|528388254|FG005|Overall Study|Withdrawal by Subject|0|||
146514456|NCT01094782|528388249|FG000|Overall Study|Lost to Follow-up|1|||
146514457|NCT01094782|528388250|FG001|Overall Study|Lost to Follow-up|0|||
146514458|NCT01094782|528388251|FG002|Overall Study|Lost to Follow-up|0|||
146514459|NCT01094782|528388252|FG003|Overall Study|Lost to Follow-up|2|||
146514460|NCT01094782|528388253|FG004|Overall Study|Lost to Follow-up|1|||
146514461|NCT01094782|528388254|FG005|Overall Study|Lost to Follow-up|4|||
146514462|NCT01094782|528388249|FG000|Overall Study|Positive Drug Screen|2|||
146514463|NCT01094782|528388250|FG001|Overall Study|Positive Drug Screen|2|||
146514464|NCT01094782|528388251|FG002|Overall Study|Positive Drug Screen|1|||
146514465|NCT01094782|528388252|FG003|Overall Study|Positive Drug Screen|1|||
146514466|NCT01094782|528388253|FG004|Overall Study|Positive Drug Screen|3|||
146514467|NCT01094782|528388254|FG005|Overall Study|Positive Drug Screen|2|||
146514468|NCT01094782|528388249|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
146514469|NCT01094782|528388250|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
146514470|NCT01094782|528388251|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
146514471|NCT01094782|528388252|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
146514472|NCT01094782|528388253|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
146514473|NCT01094782|528388254|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
146514474|NCT01094782|528388249|FG000|Overall Study|Unable to Complete Questionnaires|0|||
146514475|NCT01094782|528388250|FG001|Overall Study|Unable to Complete Questionnaires|1|||
146514476|NCT01094782|528388251|FG002|Overall Study|Unable to Complete Questionnaires|0|||
146514477|NCT01094782|528388252|FG003|Overall Study|Unable to Complete Questionnaires|0|||
146514478|NCT01094782|528388253|FG004|Overall Study|Unable to Complete Questionnaires|0|||
146514479|NCT01094782|528388254|FG005|Overall Study|Unable to Complete Questionnaires|0|||
146514480|NCT01094782|528388249|FG000|Overall Study|Healthy Subject Had Pain|0|||
146514481|NCT01094782|528388250|FG001|Overall Study|Healthy Subject Had Pain|1|||
146514482|NCT01094782|528388251|FG002|Overall Study|Healthy Subject Had Pain|0|||
146514483|NCT01094782|528388252|FG003|Overall Study|Healthy Subject Had Pain|0|||
146514484|NCT01094782|528388253|FG004|Overall Study|Healthy Subject Had Pain|0|||
146514485|NCT01094782|528388254|FG005|Overall Study|Healthy Subject Had Pain|0|||
146514486|NCT01094782|528388249|FG000|Overall Study|Hypertension|0|||
146514487|NCT01094782|528388250|FG001|Overall Study|Hypertension|0|||
146514488|NCT01094782|528388251|FG002|Overall Study|Hypertension|1|||
146514489|NCT01094782|528388252|FG003|Overall Study|Hypertension|0|||
146514490|NCT01094782|528388253|FG004|Overall Study|Hypertension|0|||
146514491|NCT01094782|528388254|FG005|Overall Study|Hypertension|0|||
146514492|NCT01094782|528388249|FG000|Overall Study|Wrong Pain Condition|0|||
146514493|NCT01094782|528388250|FG001|Overall Study|Wrong Pain Condition|0|||
146514494|NCT01094782|528388251|FG002|Overall Study|Wrong Pain Condition|0|||
146514495|NCT01094782|528388252|FG003|Overall Study|Wrong Pain Condition|2|||
146514496|NCT01094782|528388253|FG004|Overall Study|Wrong Pain Condition|1|||
146514497|NCT01094782|528388254|FG005|Overall Study|Wrong Pain Condition|1|||
146514498|NCT01094782|528388249|FG000|Overall Study|Recent Interventional Injection|0|||
146514499|NCT01094782|528388250|FG001|Overall Study|Recent Interventional Injection|0|||
146514500|NCT01094782|528388251|FG002|Overall Study|Recent Interventional Injection|0|||
146852909|NCT00190749|529630230|FG001|Overall Study|Adverse Event|5|||
146852910|NCT00190749|529630229|FG000|Overall Study|Lack of Efficacy|2|||
146514501|NCT01094782|528388252|FG003|Overall Study|Recent Interventional Injection|0|||
146514502|NCT01094782|528388253|FG004|Overall Study|Recent Interventional Injection|0|||
146514503|NCT01094782|528388254|FG005|Overall Study|Recent Interventional Injection|1|||
146514504|NCT01094782|528388249|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
146852911|NCT00190749|529630230|FG001|Overall Study|Lack of Efficacy|3|||
146852912|NCT00190749|529630229|FG000|Overall Study|Reason Not Specified|0|||
146852913|NCT00190749|529630230|FG001|Overall Study|Reason Not Specified|2|||
146852914|NCT00190749|529630229|FG000|Overall Study|Sponsor Decision|1|||
146852915|NCT00190749|529630230|FG001|Overall Study|Sponsor Decision|0|||
146852916|NCT01605916|529630233|FG000|Overall Study|Adverse Event|1|||
146852917|NCT01605916|529630234|FG001|Overall Study|Adverse Event|0|||
146852918|NCT01605916|529630235|FG002|Overall Study|Adverse Event|0|||
146852919|NCT01605916|529630236|FG003|Overall Study|Adverse Event|1|||
146852920|NCT01605916|529630237|FG004|Overall Study|Adverse Event|0|||
146852921|NCT01605916|529630233|FG000|Overall Study|Lack of Efficacy|2|||
146852922|NCT01605916|529630234|FG001|Overall Study|Lack of Efficacy|3|||
146514505|NCT01094782|528388250|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
146514506|NCT01094782|528388251|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
146514507|NCT01094782|528388252|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
146514508|NCT01094782|528388253|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
146514509|NCT01094782|528388254|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
146514510|NCT01094782|528388249|FG000|Overall Study|Noncompliance With Study Schedule|0|||
146514511|NCT01094782|528388250|FG001|Overall Study|Noncompliance With Study Schedule|0|||
146852923|NCT01605916|529630235|FG002|Overall Study|Lack of Efficacy|3|||
146514512|NCT01094782|528388251|FG002|Overall Study|Noncompliance With Study Schedule|0|||
146514513|NCT01094782|528388252|FG003|Overall Study|Noncompliance With Study Schedule|1|||
146514514|NCT01094782|528388253|FG004|Overall Study|Noncompliance With Study Schedule|0|||
146514515|NCT01094782|528388254|FG005|Overall Study|Noncompliance With Study Schedule|0|||
146514516|NCT02083653|528388256|FG000|Overall Study|Randomized but not Treated|0|||
146514517|NCT02083653|528388257|FG001|Overall Study|Randomized but not Treated|2|||
146514518|NCT02083653|528388258|FG002|Overall Study|Randomized but not Treated|7|||
146514519|NCT02083653|528388256|FG000|Overall Study|Adverse Event|12|||
146514520|NCT02083653|528388257|FG001|Overall Study|Adverse Event|5|||
146514521|NCT02083653|528388258|FG002|Overall Study|Adverse Event|4|||
146514522|NCT02083653|528388256|FG000|Overall Study|Lost to Follow-up|1|||
146514523|NCT02083653|528388257|FG001|Overall Study|Lost to Follow-up|0|||
146514524|NCT02083653|528388258|FG002|Overall Study|Lost to Follow-up|0|||
146514525|NCT02083653|528388256|FG000|Overall Study|Death|2|||
146514526|NCT02083653|528388257|FG001|Overall Study|Death|2|||
146514527|NCT02083653|528388258|FG002|Overall Study|Death|2|||
146514528|NCT02083653|528388256|FG000|Overall Study|Progressive Disease|65|||
146514529|NCT02083653|528388257|FG001|Overall Study|Progressive Disease|73|||
146514530|NCT02083653|528388258|FG002|Overall Study|Progressive Disease|63|||
146514531|NCT02083653|528388256|FG000|Overall Study|Withdrawal by Subject|2|||
146514532|NCT02083653|528388257|FG001|Overall Study|Withdrawal by Subject|1|||
146514533|NCT02083653|528388258|FG002|Overall Study|Withdrawal by Subject|2|||
146514534|NCT02083653|528388256|FG000|Overall Study|Other Events|0|||
146514535|NCT02083653|528388257|FG001|Overall Study|Other Events|2|||
146514536|NCT02083653|528388258|FG002|Overall Study|Other Events|2|||
146514537|NCT02083653|528388256|FG000|Overall Study|Reason Missing|0|||
146514538|NCT02083653|528388257|FG001|Overall Study|Reason Missing|0|||
146514539|NCT02083653|528388258|FG002|Overall Study|Reason Missing|4|||
146514540|NCT00957905|528388259|FG000|Part B|Not Treated|0|||
146514541|NCT00957905|528388260|FG001|Part B|Not Treated|1|||
146514542|NCT00957905|528388259|FG000|Part B|Physician Decision|0|||
146514543|NCT00957905|528388260|FG001|Part B|Physician Decision|1|||
146514544|NCT00957905|528388259|FG000|Part B|Death|0|||
146514545|NCT00957905|528388260|FG001|Part B|Death|1|||
146514546|NCT00957905|528388259|FG000|Part B|Protocol Violation|0|||
146514547|NCT00957905|528388260|FG001|Part B|Protocol Violation|1|||
146514548|NCT02073656|528388261|FG000|Primary Study|Lost to Follow-up|6|||
146514549|NCT02073656|528388261|FG000|Primary Study|Death|1|||
146514550|NCT02073656|528388261|FG000|Primary Study|Withdrew Consent|1|||
146514551|NCT01987232|528388265|FG000|Overall Study|Ongoing in Study|0|||
146514552|NCT01987232|528388266|FG001|Overall Study|Ongoing in Study|0|||
146514553|NCT01987232|528388267|FG002|Overall Study|Ongoing in Study|0|||
146514554|NCT01987232|528388268|FG003|Overall Study|Ongoing in Study|1|||
146514555|NCT01987232|528388269|FG004|Overall Study|Ongoing in Study|0|||
146514556|NCT01969084|528388270|FG000|Overall Study|Adverse Event|0|||
146514557|NCT01969084|528388271|FG001|Overall Study|Adverse Event|1|||
146514558|NCT03564795|528388274|FG000|Overall Study|Withdrawal by Subject|3|||
146514559|NCT03564795|528388274|FG000|Overall Study|Lost to Follow-up|6|||
146514560|NCT03564795|528388274|FG000|Overall Study|Physician Decision|2|||
146514561|NCT00862459|528388275|FG000|Overall Study|Lost to Follow-up|1|||
146514562|NCT00862459|528388276|FG001|Overall Study|Lost to Follow-up|2|||
146514563|NCT00862459|528388277|FG002|Overall Study|Lost to Follow-up|2|||
146514564|NCT00862459|528388275|FG000|Overall Study|Protocol Violation|1|||
146514565|NCT00862459|528388276|FG001|Overall Study|Protocol Violation|0|||
146514566|NCT00862459|528388277|FG002|Overall Study|Protocol Violation|0|||
146514567|NCT00862459|528388275|FG000|Overall Study|Withdrawal by Subject|1|||
146514568|NCT00862459|528388276|FG001|Overall Study|Withdrawal by Subject|1|||
146514569|NCT00862459|528388277|FG002|Overall Study|Withdrawal by Subject|3|||
146514570|NCT00862459|528388275|FG000|Overall Study|Adverse Event|0|||
146514571|NCT00862459|528388276|FG001|Overall Study|Adverse Event|1|||
146514572|NCT00862459|528388277|FG002|Overall Study|Adverse Event|0|||
146514573|NCT00862459|528388275|FG000|Overall Study|Personal reasons|1|||
146514574|NCT00862459|528388276|FG001|Overall Study|Personal reasons|0|||
146514575|NCT00862459|528388277|FG002|Overall Study|Personal reasons|0|||
146514576|NCT00862459|528388275|FG000|Overall Study|Operation|1|||
146514577|NCT00862459|528388276|FG001|Overall Study|Operation|1|||
146514578|NCT00862459|528388277|FG002|Overall Study|Operation|0|||
146514579|NCT00862459|528388275|FG000|Overall Study|Intravenous (IV) site problems|1|||
146514580|NCT00862459|528388276|FG001|Overall Study|Intravenous (IV) site problems|0|||
146514581|NCT00862459|528388277|FG002|Overall Study|Intravenous (IV) site problems|1|||
146514582|NCT00862459|528388275|FG000|Overall Study|Unable to hold still for imaging|0|||
146514583|NCT00862459|528388276|FG001|Overall Study|Unable to hold still for imaging|1|||
146514584|NCT00862459|528388277|FG002|Overall Study|Unable to hold still for imaging|0|||
146514585|NCT00862459|528388275|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
146514586|NCT00862459|528388276|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
146514587|NCT00862459|528388277|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
146514588|NCT00862459|528388275|FG000|Overall Study|Administrative problems|0|||
146514589|NCT00862459|528388276|FG001|Overall Study|Administrative problems|1|||
146514590|NCT00862459|528388277|FG002|Overall Study|Administrative problems|0|||
146514591|NCT00564395|528388282|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
146514592|NCT00564395|528388283|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
146514593|NCT00564395|528388282|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
146514594|NCT00564395|528388283|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
146514595|NCT02208050|528388290|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
146514596|NCT02208050|528388291|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
146514597|NCT00477607|528388292|FG000|Overall Study|Lost to Follow-up|7|||
146514598|NCT00477607|528388293|FG001|Overall Study|Lost to Follow-up|7|||
146514599|NCT01732471|528388294|FG000|Overall Study|Withdrawal by Subject|1|||
146514600|NCT00474786|528388297|FG000|Overall Study|Not Meeting Study Criteria|0|||
146514601|NCT00474786|528388298|FG001|Overall Study|Not Meeting Study Criteria|1|||
146514602|NCT00474786|528388297|FG000|Overall Study|Investigator Request|2|||
146514603|NCT00474786|528388298|FG001|Overall Study|Investigator Request|1|||
146514604|NCT00474786|528388297|FG000|Overall Study|Death|189|||
146514605|NCT00474786|528388298|FG001|Overall Study|Death|170|||
146514606|NCT00474786|528388297|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
146514607|NCT00474786|528388298|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
146514608|NCT00474786|528388297|FG000|Overall Study|Lost to Follow-up|4|||
146514609|NCT00474786|528388298|FG001|Overall Study|Lost to Follow-up|7|||
146514610|NCT00474786|528388297|FG000|Overall Study|Protocol Violation|2|||
146514611|NCT00474786|528388298|FG001|Overall Study|Protocol Violation|0|||
146514612|NCT00474786|528388297|FG000|Overall Study|Withdrawal by Subject|15|||
146514613|NCT00474786|528388298|FG001|Overall Study|Withdrawal by Subject|15|||
146514614|NCT00474786|528388297|FG000|Overall Study|Other|5|||
146514615|NCT00474786|528388298|FG001|Overall Study|Other|0|||
146514616|NCT02892513|528388299|FG000|Overall Study|Withdrawal by Subject|0|||
146514617|NCT02892513|528388300|FG001|Overall Study|Withdrawal by Subject|1|||
146514618|NCT00432276|528388301|FG000|Overall Study|Hyperglycemic Rescue|44|||
146514619|NCT00432276|528388302|FG001|Overall Study|Hyperglycemic Rescue|87|||
146514620|NCT00432276|528388301|FG000|Overall Study|Adverse Event|13|||
146514621|NCT00432276|528388302|FG001|Overall Study|Adverse Event|16|||
146514622|NCT00432276|528388301|FG000|Overall Study|Protocol Violation|25|||
146514623|NCT00432276|528388302|FG001|Overall Study|Protocol Violation|20|||
146514624|NCT00432276|528388301|FG000|Overall Study|Lost to Follow-up|6|||
146514625|NCT00432276|528388302|FG001|Overall Study|Lost to Follow-up|2|||
146514626|NCT00432276|528388301|FG000|Overall Study|Withdrawal by Subject|25|||
146514627|NCT00432276|528388302|FG001|Overall Study|Withdrawal by Subject|20|||
146514628|NCT00432276|528388301|FG000|Overall Study|Physician Decision|6|||
146514629|NCT00432276|528388302|FG001|Overall Study|Physician Decision|8|||
146514630|NCT00432276|528388301|FG000|Overall Study|Other|2|||
146514631|NCT00432276|528388302|FG001|Overall Study|Other|3|||
146514632|NCT00655681|528388303|FG000|Overall Study|Lost to Follow-up|1|||
146514633|NCT00655681|528388304|FG001|Overall Study|Lost to Follow-up|1|||
146514634|NCT00467961|528388306|FG000|Overall Study|Technical Failures|5|||
146514635|NCT00467961|528388306|FG000|Overall Study|Disease Progression|2|||
146514636|NCT04776018|528388307|FG000|Overall Study|Death|0|||
146514637|NCT04776018|528388308|FG001|Overall Study|Death|1|||
146514638|NCT04776018|528388309|FG002|Overall Study|Death|4|||
146514639|NCT04776018|528388310|FG003|Overall Study|Death|1|||
146514640|NCT04776018|528388311|FG004|Overall Study|Death|4|||
146514641|NCT04776018|528388312|FG005|Overall Study|Death|0|||
146514642|NCT04776018|528388313|FG006|Overall Study|Death|0|||
146514643|NCT04776018|528388307|FG000|Overall Study|Study terminated by sponsor|2|||
146514644|NCT04776018|528388308|FG001|Overall Study|Study terminated by sponsor|1|||
146514645|NCT04776018|528388309|FG002|Overall Study|Study terminated by sponsor|4|||
146514646|NCT04776018|528388310|FG003|Overall Study|Study terminated by sponsor|0|||
146514647|NCT04776018|528388311|FG004|Overall Study|Study terminated by sponsor|3|||
146514648|NCT04776018|528388312|FG005|Overall Study|Study terminated by sponsor|0|||
146514649|NCT04776018|528388313|FG006|Overall Study|Study terminated by sponsor|0|||
146514650|NCT04776018|528388307|FG000|Overall Study|Withdrawal by Subject|1|||
146514651|NCT04776018|528388308|FG001|Overall Study|Withdrawal by Subject|0|||
146514652|NCT04776018|528388309|FG002|Overall Study|Withdrawal by Subject|0|||
146514653|NCT04776018|528388310|FG003|Overall Study|Withdrawal by Subject|2|||
146514654|NCT04776018|528388311|FG004|Overall Study|Withdrawal by Subject|1|||
146514655|NCT04776018|528388312|FG005|Overall Study|Withdrawal by Subject|0|||
146514656|NCT04776018|528388313|FG006|Overall Study|Withdrawal by Subject|0|||
146514657|NCT04776018|528388307|FG000|Overall Study|Other|0|||
146514658|NCT04776018|528388308|FG001|Overall Study|Other|1|||
146514659|NCT04776018|528388309|FG002|Overall Study|Other|1|||
146514660|NCT04776018|528388310|FG003|Overall Study|Other|0|||
146514661|NCT04776018|528388311|FG004|Overall Study|Other|0|||
146514662|NCT04776018|528388312|FG005|Overall Study|Other|0|||
146514663|NCT04776018|528388313|FG006|Overall Study|Other|0|||
146514664|NCT04776018|528388307|FG000|Overall Study|Lost to Follow-up|0|||
146514665|NCT04776018|528388308|FG001|Overall Study|Lost to Follow-up|0|||
146514666|NCT04776018|528388309|FG002|Overall Study|Lost to Follow-up|1|||
146514667|NCT04776018|528388310|FG003|Overall Study|Lost to Follow-up|0|||
146514668|NCT04776018|528388311|FG004|Overall Study|Lost to Follow-up|0|||
146514669|NCT04776018|528388312|FG005|Overall Study|Lost to Follow-up|0|||
146514670|NCT04776018|528388313|FG006|Overall Study|Lost to Follow-up|0|||
146514671|NCT02429310|528388315|FG000|Overall Study|Lost to Follow-up|1|||
146514672|NCT02429310|528388316|FG001|Overall Study|Lost to Follow-up|2|||
146514673|NCT02429310|528388315|FG000|Overall Study|Protocol Violation|1|||
146514674|NCT02429310|528388316|FG001|Overall Study|Protocol Violation|1|||
146514675|NCT00394433|528388317|FG000|Overall Study|Adverse Event|2|||
146514676|NCT00394433|528388317|FG000|Overall Study|Alternative Therapy|1|||
146514677|NCT00594386|528388320|FG000|Overall Study|Major protocol violation|2|||
146514678|NCT00594386|528388320|FG000|Overall Study|Lack of Efficacy|12|||
146514679|NCT00594386|528388320|FG000|Overall Study|Adverse Event|68|||
146514680|NCT00594386|528388320|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
146514681|NCT00594386|528388320|FG000|Overall Study|Subject withdrew consent|35|||
146514682|NCT00594386|528388320|FG000|Overall Study|Study ended per sponsor|115|||
146514683|NCT00594386|528388320|FG000|Overall Study|Lost to Follow-up|6|||
146514684|NCT00594386|528388320|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
146514685|NCT00594386|528388320|FG000|Overall Study|Other: Subject moved to Seattle|1|||
146514686|NCT00594386|528388320|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
146514687|NCT00594386|528388320|FG000|Overall Study|Other: Study terminated per investigator|2|||
146514688|NCT00594386|528388320|FG000|Overall Study|Other: Sponsor closure of study|1|||
146514689|NCT00594386|528388320|FG000|Overall Study|Other: Site terminated participation|1|||
146514690|NCT00594386|528388320|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
146514691|NCT00594386|528388320|FG000|Overall Study|Other: Loss of drivers license|1|||
146514692|NCT03417024|528388321|FG000|Overall Study|Study Termination prior to follow-up|11|||
146514693|NCT03417024|528388321|FG000|Overall Study|Physician Decision|2|||
146514694|NCT03168919|528388322|FG000|Overall Study|Withdrawal by Subject|2|||
146514695|NCT01085136|528388323|FG000|Part A|Other Adverse event|223|||
146514696|NCT01085136|528388324|FG001|Part A|Other Adverse event|0|||
146514697|NCT01085136|528388325|FG002|Part A|Other Adverse event|0|||
146514698|NCT01085136|528388323|FG000|Part A|Protocol Violation|3|||
146514699|NCT01085136|528388324|FG001|Part A|Protocol Violation|0|||
146514700|NCT01085136|528388325|FG002|Part A|Protocol Violation|0|||
146514701|NCT01085136|528388323|FG000|Part A|Lost to Follow-up|3|||
146514702|NCT01085136|528388324|FG001|Part A|Lost to Follow-up|0|||
146514703|NCT01085136|528388325|FG002|Part A|Lost to Follow-up|0|||
146514704|NCT01085136|528388323|FG000|Part A|Refusal to continue trial medication|64|||
146514705|NCT01085136|528388324|FG001|Part A|Refusal to continue trial medication|0|||
146514706|NCT01085136|528388325|FG002|Part A|Refusal to continue trial medication|0|||
146514707|NCT01085136|528388323|FG000|Part A|Other reason not defined above|30|||
146514708|NCT01085136|528388324|FG001|Part A|Other reason not defined above|0|||
146514709|NCT01085136|528388325|FG002|Part A|Other reason not defined above|0|||
146514710|NCT01085136|528388323|FG000|Part B|Other AE|0|||
146514711|NCT01085136|528388324|FG001|Part B|Other AE|29|||
146514712|NCT01085136|528388325|FG002|Part B|Other AE|8|||
146514713|NCT01085136|528388323|FG000|Part B|Refusal to continue trial medication|0|||
146514714|NCT01085136|528388324|FG001|Part B|Refusal to continue trial medication|12|||
146514715|NCT01085136|528388325|FG002|Part B|Refusal to continue trial medication|7|||
146514716|NCT01085136|528388323|FG000|Part B|Not treated|0|||
146514717|NCT01085136|528388324|FG001|Part B|Not treated|4|||
146514718|NCT01085136|528388325|FG002|Part B|Not treated|8|||
146514719|NCT01085136|528388323|FG000|Part B|Other reason not defined above|0|||
146514720|NCT01085136|528388324|FG001|Part B|Other reason not defined above|6|||
146514721|NCT01085136|528388325|FG002|Part B|Other reason not defined above|3|||
146514722|NCT02195427|528388326|FG000|Overall Study|Did not consent to study extension|13|||
146514723|NCT02195427|528388327|FG001|Overall Study|Did not consent to study extension|9|||
146514724|NCT02195427|528388326|FG000|Overall Study|Withdrawal by Subject|4|||
146514725|NCT02195427|528388327|FG001|Overall Study|Withdrawal by Subject|2|||
146514726|NCT02195427|528388326|FG000|Overall Study|Lost to Follow-up|0|||
146514727|NCT02195427|528388327|FG001|Overall Study|Lost to Follow-up|1|||
146514728|NCT02195427|528388326|FG000|Overall Study|Protocol Violation|7|||
146514729|NCT02195427|528388327|FG001|Overall Study|Protocol Violation|14|||
146514730|NCT02195427|528388326|FG000|Overall Study|Conditional re-treatment at W52|2|||
146514731|NCT02195427|528388327|FG001|Overall Study|Conditional re-treatment at W52|1|||
146514732|NCT01210144|528388331|FG000|Overall Study|Lack of ovarian response|1|||
146514733|NCT01210144|528388332|FG001|Overall Study|Lack of ovarian response|0|||
146514734|NCT01210144|528388331|FG000|Overall Study|No fertilization|1|||
146514735|NCT01210144|528388332|FG001|Overall Study|No fertilization|0|||
146514736|NCT01210144|528388331|FG000|Overall Study|No transfer|1|||
146514737|NCT01210144|528388332|FG001|Overall Study|No transfer|0|||
146514738|NCT00386425|528388333|FG000|Overall Study|Physician Decision|3|||
146514739|NCT00386425|528388334|FG001|Overall Study|Physician Decision|0|||
146514740|NCT00386425|528388335|FG002|Overall Study|Physician Decision|0|||
146514741|NCT00386425|528388333|FG000|Overall Study|Withdrawal by Subject|0|||
146514742|NCT00386425|528388334|FG001|Overall Study|Withdrawal by Subject|1|||
146514743|NCT00386425|528388335|FG002|Overall Study|Withdrawal by Subject|0|||
146514744|NCT02678000|528388336|FG000|PART 2|Adverse Event|0|||
146514745|NCT02678000|528388337|FG001|PART 2|Adverse Event|0|||
146514746|NCT02678000|528388338|FG002|PART 2|Adverse Event|2|||
146514747|NCT02678000|528388339|FG003|PART 2|Adverse Event|1|||
146514748|NCT02678000|528388340|FG004|PART 2|Adverse Event|0|||
146514749|NCT02678000|528388336|FG000|PART 2|Withdrawal by Subject|0|||
146514750|NCT02678000|528388337|FG001|PART 2|Withdrawal by Subject|0|||
146514751|NCT02678000|528388338|FG002|PART 2|Withdrawal by Subject|1|||
146514752|NCT02678000|528388339|FG003|PART 2|Withdrawal by Subject|0|||
146514753|NCT02678000|528388340|FG004|PART 2|Withdrawal by Subject|0|||
146514754|NCT02360475|528388341|FG000|Overall Study|Lost to Follow-up|4|||
146514755|NCT02360475|528388342|FG001|Overall Study|Lost to Follow-up|12|||
146514756|NCT02360475|528388343|FG002|Overall Study|Lost to Follow-up|6|||
146514757|NCT02360475|528388344|FG003|Overall Study|Lost to Follow-up|4|||
146514758|NCT02360475|528388341|FG000|Overall Study|Withdrawal by Subject|0|||
146514759|NCT02360475|528388342|FG001|Overall Study|Withdrawal by Subject|1|||
146514760|NCT02360475|528388343|FG002|Overall Study|Withdrawal by Subject|2|||
146514761|NCT02360475|528388344|FG003|Overall Study|Withdrawal by Subject|0|||
146514762|NCT02360475|528388341|FG000|Overall Study|Migrated/moved from study area|0|||
146514763|NCT02360475|528388342|FG001|Overall Study|Migrated/moved from study area|0|||
146514764|NCT02360475|528388343|FG002|Overall Study|Migrated/moved from study area|0|||
146514765|NCT02360475|528388344|FG003|Overall Study|Migrated/moved from study area|1|||
146514766|NCT03759366|528388346|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
146514767|NCT03759366|528388346|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
146514768|NCT03759366|528388346|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
146514769|NCT03759366|528388346|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
146514770|NCT03759366|528388346|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
146514771|NCT03759366|528388346|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
146514772|NCT03759366|528388346|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
146514773|NCT02669082|528388347|FG000|Overall Study|Adverse Event|1|||
146514774|NCT04918355|528388348|FG000|Overall Study|no qualifying health encounter|497|||
146514775|NCT04918355|528388349|FG001|Overall Study|no qualifying health encounter|192|||
146514776|NCT04918355|528388350|FG002|Overall Study|no qualifying health encounter|438|||
146514777|NCT04918355|528388351|FG003|Overall Study|no qualifying health encounter|424|||
146514778|NCT04852276|528388352|FG000|Overall Study|Death|2|||
146514779|NCT04852276|528388353|FG001|Overall Study|Death|0|||
146514780|NCT04852276|528388352|FG000|Overall Study|Lost to Follow-up|15|||
146514781|NCT04852276|528388353|FG001|Overall Study|Lost to Follow-up|9|||
146514782|NCT04852276|528388352|FG000|Overall Study|Withdrawal by Subject|26|||
146514783|NCT04852276|528388353|FG001|Overall Study|Withdrawal by Subject|6|||
146514784|NCT01890759|528390425|FG000|Overall Study|Protocol Violation|0|||
146514785|NCT01890759|528390426|FG001|Overall Study|Protocol Violation|2|||
146514786|NCT01890759|528390425|FG000|Overall Study|Lost to Follow-up|0|||
146514787|NCT01890759|528390426|FG001|Overall Study|Lost to Follow-up|2|||
146514788|NCT01890759|528390425|FG000|Overall Study|Withdrawal by Subject|2|||
146514789|NCT01890759|528390426|FG001|Overall Study|Withdrawal by Subject|8|||
146514790|NCT00703326|528390427|FG000|Overall Study|Lost to Follow-up|47|||
146514791|NCT00703326|528390428|FG001|Overall Study|Lost to Follow-up|18|||
146514792|NCT00703326|528390427|FG000|Overall Study|Withdrawal by Subject|54|||
146514793|NCT00703326|528390428|FG001|Overall Study|Withdrawal by Subject|20|||
146514794|NCT00703326|528390427|FG000|Overall Study|Adverse Event|1|||
146514795|NCT00703326|528390428|FG001|Overall Study|Adverse Event|0|||
146514796|NCT01393106|528390430|FG000|Overall Study|Adverse Event|3|||
146514797|NCT01393106|528390430|FG000|Overall Study|Withdrawal by Subject|1|||
146514798|NCT01393106|528390430|FG000|Overall Study|Lack of Efficacy|1|||
146514799|NCT03041467|528390431|FG000|Overall Study|Death|46|||
146514800|NCT03041467|528390432|FG001|Overall Study|Death|39|||
146514801|NCT03041467|528390431|FG000|Overall Study|Withdrawal by Subject|36|||
146514802|NCT03041467|528390432|FG001|Overall Study|Withdrawal by Subject|37|||
146514803|NCT03041467|528390431|FG000|Overall Study|Lost to Follow-up|6|||
146514804|NCT03041467|528390432|FG001|Overall Study|Lost to Follow-up|8|||
146514805|NCT03041467|528390431|FG000|Overall Study|Declined consent for study extension|21|||
146514806|NCT03041467|528390432|FG001|Overall Study|Declined consent for study extension|33|||
146514807|NCT03041467|528390431|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
146514808|NCT03041467|528390432|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
146514809|NCT02732015|528390434|FG000|Overall Study|Lost to Follow-up|0|||
146514810|NCT02732015|528390435|FG001|Overall Study|Lost to Follow-up|1|||
146514811|NCT05437640|528390438|FG000|Washout (1 Week)|Adverse Event|1|||
146514812|NCT05437640|528390439|FG001|Washout (1 Week)|Adverse Event|0|||
146514813|NCT02474355|528390440|FG000|Overall Study|Other|43|||
146514814|NCT02474355|528390440|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
146514815|NCT02474355|528390440|FG000|Overall Study|Lost to Follow-up|98|||
146514816|NCT02474355|528390440|FG000|Overall Study|Withdrawal by Subject|124|||
146514817|NCT02474355|528390440|FG000|Overall Study|Death|1361|||
146514818|NCT00734656|528390445|FG000|Lab Session 1|Withdrawal by Subject|2|||
146514819|NCT00734656|528390446|FG001|Lab Session 1|Withdrawal by Subject|0|||
146514820|NCT00734656|528390447|FG002|Lab Session 1|Withdrawal by Subject|0|||
146514821|NCT00734656|528390448|FG003|Lab Session 1|Withdrawal by Subject|0|||
146514822|NCT00734656|528390445|FG000|Washout 1|Withdrawal by Subject|1|||
146514823|NCT00734656|528390446|FG001|Washout 1|Withdrawal by Subject|5|||
146514824|NCT00734656|528390447|FG002|Washout 1|Withdrawal by Subject|2|||
146514825|NCT00734656|528390448|FG003|Washout 1|Withdrawal by Subject|3|||
146514826|NCT00734656|528390445|FG000|Lab Session 2|Withdrawal by Subject|1|||
146514827|NCT00734656|528390446|FG001|Lab Session 2|Withdrawal by Subject|0|||
146514828|NCT00734656|528390447|FG002|Lab Session 2|Withdrawal by Subject|0|||
146514829|NCT00734656|528390448|FG003|Lab Session 2|Withdrawal by Subject|1|||
146514830|NCT00734656|528390445|FG000|Washout 2|Withdrawal by Subject|1|||
146514831|NCT00734656|528390446|FG001|Washout 2|Withdrawal by Subject|1|||
146514832|NCT00734656|528390447|FG002|Washout 2|Withdrawal by Subject|1|||
146514833|NCT00734656|528390448|FG003|Washout 2|Withdrawal by Subject|0|||
146514834|NCT00734656|528390445|FG000|Washout 3|Withdrawal by Subject|1|||
146514835|NCT00734656|528390446|FG001|Washout 3|Withdrawal by Subject|0|||
146514836|NCT00734656|528390447|FG002|Washout 3|Withdrawal by Subject|0|||
146514837|NCT00734656|528390448|FG003|Washout 3|Withdrawal by Subject|1|||
146514838|NCT00734656|528390445|FG000|Lab Session 4|Withdrawal by Subject|0|||
146514839|NCT00734656|528390446|FG001|Lab Session 4|Withdrawal by Subject|0|||
146514840|NCT00734656|528390447|FG002|Lab Session 4|Withdrawal by Subject|0|||
146514841|NCT00734656|528390448|FG003|Lab Session 4|Withdrawal by Subject|1|||
146514842|NCT03214679|528390450|FG000|Overall Study|Lost to Follow-up|12|||
146514843|NCT03214679|528390451|FG001|Overall Study|Lost to Follow-up|14|||
146514844|NCT03214679|528390450|FG000|Overall Study|not eligible|2|||
146514845|NCT03214679|528390451|FG001|Overall Study|not eligible|0|||
146514846|NCT05025332|528390460|FG000|Screening|Screen failure|12|||
146514847|NCT05025332|528390460|FG000|Treatment & Follow Up|Protocol Violation|1|||
146514848|NCT05025332|528390460|FG000|Treatment & Follow Up|Adverse Event|4|||
146514849|NCT01306214|528390461|FG000|Overall Study|Death|0|||
146514850|NCT01306214|528390462|FG001|Overall Study|Death|0|||
146514851|NCT01306214|528390463|FG002|Overall Study|Death|1|||
146514852|NCT01306214|528390461|FG000|Overall Study|Lost to Follow-up|3|||
146514853|NCT01306214|528390462|FG001|Overall Study|Lost to Follow-up|5|||
146514854|NCT01306214|528390463|FG002|Overall Study|Lost to Follow-up|4|||
146514855|NCT01306214|528390461|FG000|Overall Study|Withdrawal by Subject|24|||
146514856|NCT01306214|528390462|FG001|Overall Study|Withdrawal by Subject|22|||
146514857|NCT01306214|528390463|FG002|Overall Study|Withdrawal by Subject|16|||
146514858|NCT01306214|528390461|FG000|Overall Study|Not treated|1|||
146514859|NCT01306214|528390462|FG001|Overall Study|Not treated|1|||
146514860|NCT01306214|528390463|FG002|Overall Study|Not treated|1|||
146514861|NCT02173379|528390464|FG000|Overall Study|Lost to Follow-up|89|||
146514862|NCT02173379|528390465|FG001|Overall Study|Lost to Follow-up|81|||
146514863|NCT02173379|528390464|FG000|Overall Study|Withdrawal by Subject|24|||
146514864|NCT02173379|528390465|FG001|Overall Study|Withdrawal by Subject|29|||
146514865|NCT02173379|528390464|FG000|Overall Study|Physician Decision|8|||
146514866|NCT02173379|528390465|FG001|Overall Study|Physician Decision|8|||
146514867|NCT02173379|528390464|FG000|Overall Study|Death|75|||
146514868|NCT02173379|528390465|FG001|Overall Study|Death|72|||
146514869|NCT02173379|528390464|FG000|Overall Study|Other Reason|1|||
146514870|NCT02173379|528390465|FG001|Overall Study|Other Reason|0|||
146514871|NCT04278924|528390466|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
146514872|NCT04278924|528390467|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
146514873|NCT04278924|528390468|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
146514874|NCT04278924|528390469|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
146514875|NCT04278924|528390470|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
146514876|NCT04278924|528390471|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
146514877|NCT04278924|528390472|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
146514878|NCT04278924|528390466|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
146514879|NCT04278924|528390467|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
146514880|NCT04278924|528390468|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
146514881|NCT04278924|528390469|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
146514882|NCT04278924|528390470|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
146514883|NCT04278924|528390471|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
146514884|NCT04278924|528390472|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
146514885|NCT05600036|528390473|FG000|Overall Study|Adverse Event|0|||
146514886|NCT05600036|528390474|FG001|Overall Study|Adverse Event|2|||
146514887|NCT05600036|528390475|FG002|Overall Study|Adverse Event|1|||
146514888|NCT05600036|528390476|FG003|Overall Study|Adverse Event|0|||
146514889|NCT05600036|528390477|FG004|Overall Study|Adverse Event|1|||
146514890|NCT05600036|528390478|FG005|Overall Study|Adverse Event|0|||
146514891|NCT05600036|528390473|FG000|Overall Study|Lost to Follow-up|0|||
146514892|NCT05600036|528390474|FG001|Overall Study|Lost to Follow-up|2|||
146514893|NCT05600036|528390475|FG002|Overall Study|Lost to Follow-up|1|||
146514894|NCT05600036|528390476|FG003|Overall Study|Lost to Follow-up|1|||
146514895|NCT05600036|528390477|FG004|Overall Study|Lost to Follow-up|0|||
146514896|NCT05600036|528390478|FG005|Overall Study|Lost to Follow-up|0|||
146514897|NCT05600036|528390473|FG000|Overall Study|Protocol Violation|0|||
146514898|NCT05600036|528390474|FG001|Overall Study|Protocol Violation|0|||
146514899|NCT05600036|528390475|FG002|Overall Study|Protocol Violation|2|||
146514900|NCT05600036|528390476|FG003|Overall Study|Protocol Violation|0|||
146514901|NCT05600036|528390477|FG004|Overall Study|Protocol Violation|0|||
146514902|NCT05600036|528390478|FG005|Overall Study|Protocol Violation|0|||
146514903|NCT05600036|528390473|FG000|Overall Study|Withdrawal by Subject|0|||
146514904|NCT05600036|528390474|FG001|Overall Study|Withdrawal by Subject|1|||
146514905|NCT05600036|528390475|FG002|Overall Study|Withdrawal by Subject|2|||
146514906|NCT05600036|528390476|FG003|Overall Study|Withdrawal by Subject|0|||
146514907|NCT05600036|528390477|FG004|Overall Study|Withdrawal by Subject|3|||
146514908|NCT05600036|528390478|FG005|Overall Study|Withdrawal by Subject|5|||
146514909|NCT05600036|528390473|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
146514910|NCT05600036|528390474|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
146514911|NCT05600036|528390475|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
146514912|NCT05600036|528390476|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
146514913|NCT05600036|528390477|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
146514914|NCT05600036|528390478|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
146514915|NCT05600036|528390473|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
146514916|NCT05600036|528390474|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
146514917|NCT05600036|528390475|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
146514918|NCT05600036|528390476|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
146514919|NCT05600036|528390477|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
146514920|NCT05600036|528390478|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
146514921|NCT05600036|528390473|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
146514922|NCT05600036|528390474|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
146514923|NCT05600036|528390475|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
146514924|NCT05600036|528390476|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
146514925|NCT05600036|528390477|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
146514926|NCT05600036|528390478|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
146514927|NCT00631163|528390479|FG000|Number of Participants in Year 1|Adverse Event|12|||
146514928|NCT00631163|528390479|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
146514929|NCT00631163|528390479|FG000|Number of Participants in Year 1|Death|6|||
146514930|NCT00631163|528390479|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
146514931|NCT00631163|528390479|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
146514932|NCT00631163|528390479|FG000|Number of Participants in Year 1|Administrative problems|6|||
146514933|NCT00631163|528390479|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
146514934|NCT00631163|528390479|FG000|Number of Participants in Year 2|Adverse Event|1|||
146514935|NCT00631163|528390479|FG000|Number of Participants in Year 2|Protocol Violation|1|||
146514936|NCT00631163|528390479|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
146514937|NCT00715520|528390480|FG000|Overall Study|Screen failure|8|||
146514938|NCT00715520|528390481|FG001|Overall Study|Screen failure|1|||
146514939|NCT00715520|528390482|FG002|Overall Study|Screen failure|1|||
146514940|NCT00715520|528390480|FG000|Overall Study|Withdrawal by Subject|2|||
146514941|NCT00715520|528390481|FG001|Overall Study|Withdrawal by Subject|0|||
146514942|NCT00715520|528390482|FG002|Overall Study|Withdrawal by Subject|1|||
146514943|NCT04122625|528390483|FG000|Part A (up to 2.92 Years)|Death|2|||
146514944|NCT04122625|528390484|FG001|Part A (up to 2.92 Years)|Death|4|||
146514945|NCT04122625|528390485|FG002|Part A (up to 2.92 Years)|Death|0|||
146514946|NCT04122625|528390486|FG003|Part A (up to 2.92 Years)|Death|0|||
146514947|NCT04122625|528390487|FG004|Part A (up to 2.92 Years)|Death|0|||
146514948|NCT04122625|528390488|FG005|Part A (up to 2.92 Years)|Death|0|||
146514949|NCT04122625|528390483|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
146514950|NCT04122625|528390484|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
146514951|NCT04122625|528390485|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
146514952|NCT04122625|528390486|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
146514953|NCT04122625|528390487|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
146514954|NCT04122625|528390488|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
146514955|NCT04122625|528390483|FG000|Part B (up to 2.33 Years)|Death|0|||
146514956|NCT04122625|528390484|FG001|Part B (up to 2.33 Years)|Death|0|||
146514957|NCT04122625|528390485|FG002|Part B (up to 2.33 Years)|Death|5|||
146514958|NCT04122625|528390486|FG003|Part B (up to 2.33 Years)|Death|7|||
146514959|NCT04122625|528390487|FG004|Part B (up to 2.33 Years)|Death|6|||
146514960|NCT04122625|528390488|FG005|Part B (up to 2.33 Years)|Death|7|||
146514961|NCT02697591|528390489|FG000|Overall Study|Lost to Follow-up|0|||
146514962|NCT02697591|528390490|FG001|Overall Study|Lost to Follow-up|0|||
146514963|NCT02697591|528390491|FG002|Overall Study|Lost to Follow-up|0|||
146514964|NCT02697591|528390492|FG003|Overall Study|Lost to Follow-up|0|||
146514965|NCT02697591|528390493|FG004|Overall Study|Lost to Follow-up|0|||
146514966|NCT02697591|528390494|FG005|Overall Study|Lost to Follow-up|1|||
146514967|NCT02697591|528390495|FG006|Overall Study|Lost to Follow-up|1|||
146514968|NCT02697591|528390496|FG007|Overall Study|Lost to Follow-up|0|||
146514969|NCT02697591|528390497|FG008|Overall Study|Lost to Follow-up|0|||
146514970|NCT02697591|528390498|FG009|Overall Study|Lost to Follow-up|1|||
146755485|NCT01734382|529269745|FG001|Part 2|Other|0|||
146755486|NCT01734382|529269746|FG002|Part 2|Other|1|||
146755487|NCT01734382|529269744|FG000|Part 2|Physician Decision|0|||
146755488|NCT01734382|529269745|FG001|Part 2|Physician Decision|0|||
146852924|NCT01605916|529630236|FG003|Overall Study|Lack of Efficacy|5|||
146755489|NCT01734382|529269746|FG002|Part 2|Physician Decision|3|||
146755490|NCT01734382|529269744|FG000|Part 2|Protocol Violation|0|||
146755491|NCT01734382|529269745|FG001|Part 2|Protocol Violation|1|||
146755492|NCT01734382|529269746|FG002|Part 2|Protocol Violation|0|||
146755493|NCT01734382|529269744|FG000|Part 2|Withdrawal by Subject|0|||
146755494|NCT01734382|529269745|FG001|Part 2|Withdrawal by Subject|0|||
146755495|NCT01734382|529269746|FG002|Part 2|Withdrawal by Subject|1|||
146755496|NCT02015663|529269748|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
146755497|NCT02015663|529269749|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
146514971|NCT02697591|528390489|FG000|Overall Study|Withdrawal by Subject|1|||
146514972|NCT02697591|528390490|FG001|Overall Study|Withdrawal by Subject|1|||
146514973|NCT02697591|528390491|FG002|Overall Study|Withdrawal by Subject|2|||
146514974|NCT02697591|528390492|FG003|Overall Study|Withdrawal by Subject|1|||
146514975|NCT02697591|528390493|FG004|Overall Study|Withdrawal by Subject|7|||
146514976|NCT02697591|528390494|FG005|Overall Study|Withdrawal by Subject|6|||
146514977|NCT02697591|528390495|FG006|Overall Study|Withdrawal by Subject|9|||
146514978|NCT02697591|528390496|FG007|Overall Study|Withdrawal by Subject|1|||
146514979|NCT02697591|528390497|FG008|Overall Study|Withdrawal by Subject|6|||
146514980|NCT02697591|528390498|FG009|Overall Study|Withdrawal by Subject|10|||
146514981|NCT02697591|528390489|FG000|Overall Study|Physician Decision|1|||
146514982|NCT02697591|528390490|FG001|Overall Study|Physician Decision|0|||
146514983|NCT02697591|528390491|FG002|Overall Study|Physician Decision|0|||
146514984|NCT02697591|528390492|FG003|Overall Study|Physician Decision|0|||
146852925|NCT01605916|529630237|FG004|Overall Study|Lack of Efficacy|4|||
146852926|NCT01605916|529630233|FG000|Overall Study|Withdrawal by Subject|1|||
146852927|NCT01605916|529630234|FG001|Overall Study|Withdrawal by Subject|1|||
146852928|NCT01605916|529630235|FG002|Overall Study|Withdrawal by Subject|0|||
146852929|NCT01605916|529630236|FG003|Overall Study|Withdrawal by Subject|0|||
146852930|NCT01605916|529630237|FG004|Overall Study|Withdrawal by Subject|2|||
146852931|NCT01465347|529630238|FG000|Overall Study|Withdrawal by Subject|1|||
146852932|NCT01465347|529630239|FG001|Overall Study|Withdrawal by Subject|1|||
146852933|NCT01465347|529630238|FG000|Overall Study|Physician Decision|0|||
146852934|NCT01465347|529630239|FG001|Overall Study|Physician Decision|1|||
146852935|NCT01465347|529630238|FG000|Overall Study|Admitted to hospice|0|||
146852936|NCT01465347|529630239|FG001|Overall Study|Admitted to hospice|1|||
146852937|NCT02891837|529630240|FG000|Overall Study|Lost to Follow-up|2|||
146852938|NCT02891837|529630241|FG001|Overall Study|Lost to Follow-up|0|||
146852939|NCT02891837|529630240|FG000|Overall Study|Withdrawal by Subject|1|||
146852940|NCT02891837|529630241|FG001|Overall Study|Withdrawal by Subject|0|||
146852941|NCT01103362|529630244|FG000|Overall Study|study terminated|596|||
146852942|NCT03538301|529630247|FG000|Overall Study|Adverse Event|1|||
146852943|NCT03538301|529630248|FG001|Overall Study|Adverse Event|4|||
146852944|NCT03538301|529630249|FG002|Overall Study|Adverse Event|4|||
146852945|NCT03538301|529630247|FG000|Overall Study|Death|1|||
146852946|NCT03538301|529630248|FG001|Overall Study|Death|1|||
146852947|NCT03538301|529630249|FG002|Overall Study|Death|0|||
146852948|NCT03538301|529630247|FG000|Overall Study|Physician Decision|0|||
146514985|NCT02697591|528390493|FG004|Overall Study|Physician Decision|1|||
146514986|NCT02697591|528390494|FG005|Overall Study|Physician Decision|2|||
146514987|NCT02697591|528390495|FG006|Overall Study|Physician Decision|0|||
146514988|NCT02697591|528390496|FG007|Overall Study|Physician Decision|0|||
146514989|NCT02697591|528390497|FG008|Overall Study|Physician Decision|1|||
146514990|NCT02697591|528390498|FG009|Overall Study|Physician Decision|1|||
146514991|NCT02697591|528390489|FG000|Overall Study|Death|2|||
146514992|NCT02697591|528390490|FG001|Overall Study|Death|3|||
146514993|NCT02697591|528390491|FG002|Overall Study|Death|1|||
146514994|NCT02697591|528390492|FG003|Overall Study|Death|1|||
146514995|NCT02697591|528390493|FG004|Overall Study|Death|4|||
146514996|NCT02697591|528390494|FG005|Overall Study|Death|5|||
146514997|NCT02697591|528390495|FG006|Overall Study|Death|3|||
146514998|NCT02697591|528390496|FG007|Overall Study|Death|1|||
146514999|NCT02697591|528390497|FG008|Overall Study|Death|1|||
146515000|NCT02697591|528390498|FG009|Overall Study|Death|5|||
146515001|NCT02697591|528390489|FG000|Overall Study|Reason not Specified|0|||
146515002|NCT02697591|528390490|FG001|Overall Study|Reason not Specified|0|||
146515003|NCT02697591|528390491|FG002|Overall Study|Reason not Specified|0|||
146515004|NCT02697591|528390492|FG003|Overall Study|Reason not Specified|1|||
146515005|NCT02697591|528390493|FG004|Overall Study|Reason not Specified|1|||
146515006|NCT02697591|528390494|FG005|Overall Study|Reason not Specified|2|||
146515007|NCT02697591|528390495|FG006|Overall Study|Reason not Specified|3|||
146515008|NCT02697591|528390496|FG007|Overall Study|Reason not Specified|1|||
146515009|NCT02697591|528390497|FG008|Overall Study|Reason not Specified|1|||
146515010|NCT02697591|528390498|FG009|Overall Study|Reason not Specified|3|||
146515011|NCT01937884|528390499|FG000|Overall Study|Withdrawal by Subject|1|||
146852949|NCT03538301|529630248|FG001|Overall Study|Physician Decision|1|||
146852950|NCT03538301|529630249|FG002|Overall Study|Physician Decision|0|||
146852951|NCT03538301|529630247|FG000|Overall Study|Protocol Violation|0|||
146515012|NCT01937884|528390500|FG001|Overall Study|Withdrawal by Subject|0|||
146515013|NCT00438256|528390510|FG000|Overall Study|Ineligible for Resection|2|||
146515014|NCT00438256|528390511|FG001|Overall Study|Ineligible for Resection|1|||
146515015|NCT00438256|528390512|FG002|Overall Study|Ineligible for Resection|1|||
146515016|NCT00438256|528390513|FG003|Overall Study|Ineligible for Resection|7|||
146515017|NCT00438256|528390510|FG000|Overall Study|Excluded final Diagnosis|0|||
146515018|NCT00438256|528390511|FG001|Overall Study|Excluded final Diagnosis|0|||
146515019|NCT00438256|528390512|FG002|Overall Study|Excluded final Diagnosis|0|||
146515020|NCT00438256|528390513|FG003|Overall Study|Excluded final Diagnosis|2|||
146852952|NCT03538301|529630248|FG001|Overall Study|Protocol Violation|0|||
146515021|NCT02191046|528390521|FG000|Overall Study|low compliance|5|||
146852953|NCT03538301|529630249|FG002|Overall Study|Protocol Violation|1|||
146852954|NCT03538301|529630247|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
146852955|NCT03538301|529630248|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
146852956|NCT03538301|529630249|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
146852957|NCT03616977|529630250|FG000|Period 1|Physician Decision|0|||
146852958|NCT03616977|529630251|FG001|Period 1|Physician Decision|1|||
146852959|NCT03616977|529630250|FG000|Period 3|Adverse Event|1|||
146515022|NCT02191046|528390522|FG001|Overall Study|low compliance|1|||
146515023|NCT02147067|528390523|FG000|Overall Study|Withdrawal by Subject|2|||
146515024|NCT02147067|528390524|FG001|Overall Study|Withdrawal by Subject|2|||
146515025|NCT03742258|528390526|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
146515026|NCT03742258|528390527|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
146515027|NCT03742258|528390528|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
146515028|NCT03742258|528390526|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
146515029|NCT03742258|528390527|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
146515030|NCT03742258|528390528|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
146515031|NCT03742258|528390526|FG000|Survival Follow-Up|Still in Follow-up|0|||
146515032|NCT03742258|528390527|FG001|Survival Follow-Up|Still in Follow-up|0|||
146515033|NCT03742258|528390528|FG002|Survival Follow-Up|Still in Follow-up|2|||
146515034|NCT01380691|528390532|FG000|Washout (7 Days)|Protocol Violation|0|||
146515035|NCT01380691|528390533|FG001|Washout (7 Days)|Protocol Violation|0|||
146515036|NCT01380691|528390534|FG002|Washout (7 Days)|Protocol Violation|0|||
146515037|NCT01380691|528390535|FG003|Washout (7 Days)|Protocol Violation|1|||
146515038|NCT01380691|528390532|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
146515039|NCT01380691|528390533|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
146515040|NCT01380691|528390534|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
146515041|NCT01380691|528390535|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
146515042|NCT02536781|528390536|FG000|Overall Study|Lost to Follow-up|2|||
146515043|NCT02536781|528390537|FG001|Overall Study|Lost to Follow-up|0|||
146515044|NCT03423147|528390538|FG000|Overall Study|Lost to Follow-up|5|||
146515045|NCT03423147|528390539|FG001|Overall Study|Lost to Follow-up|8|||
146515046|NCT03423147|528390538|FG000|Overall Study|Withdrawal by Subject|1|||
146515047|NCT03423147|528390539|FG001|Overall Study|Withdrawal by Subject|0|||
146515048|NCT03423147|528390538|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
146515049|NCT03423147|528390539|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
146515050|NCT03423147|528390538|FG000|Overall Study|Age < 18|1|||
146515051|NCT03423147|528390539|FG001|Overall Study|Age < 18|0|||
146515052|NCT03423147|528390538|FG000|Overall Study|No Trial of Labor|0|||
146515053|NCT03423147|528390539|FG001|Overall Study|No Trial of Labor|1|||
146515054|NCT00508157|528390540|FG000|Overall Study|Adverse Event|0|||
146515055|NCT00508157|528390541|FG001|Overall Study|Adverse Event|1|||
146515056|NCT00508157|528390540|FG000|Overall Study|Subject Withdrew Consent|1|||
146515057|NCT00508157|528390541|FG001|Overall Study|Subject Withdrew Consent|0|||
146515058|NCT00508157|528390540|FG000|Overall Study|Lost to Follow-up|1|||
146515059|NCT00508157|528390541|FG001|Overall Study|Lost to Follow-up|0|||
146515060|NCT00508157|528390540|FG000|Overall Study|Subject no longer met study criteria|0|||
146515061|NCT00508157|528390541|FG001|Overall Study|Subject no longer met study criteria|1|||
146515062|NCT00508157|528390540|FG000|Overall Study|Other known cause|0|||
146515063|NCT00508157|528390541|FG001|Overall Study|Other known cause|1|||
146515064|NCT01952080|528390542|FG000|Overall Study|Withdrawal by Subject|0|||
146515065|NCT01952080|528390543|FG001|Overall Study|Withdrawal by Subject|0|||
146515066|NCT01952080|528390544|FG002|Overall Study|Withdrawal by Subject|0|||
146515067|NCT01952080|528390545|FG003|Overall Study|Withdrawal by Subject|1|||
146515068|NCT01952080|528390542|FG000|Overall Study|Protocol Non-compliance|0|||
146515069|NCT01952080|528390543|FG001|Overall Study|Protocol Non-compliance|1|||
146515070|NCT01952080|528390544|FG002|Overall Study|Protocol Non-compliance|0|||
146515071|NCT01952080|528390545|FG003|Overall Study|Protocol Non-compliance|0|||
146515072|NCT02028169|528390546|FG000|Overall Study|Lost to Follow-up|21|||
146515073|NCT02028169|528390546|FG000|Overall Study|Lack of Efficacy|2|||
146515074|NCT02028169|528390546|FG000|Overall Study|Withdrawal by Subject|2|||
146515075|NCT02028169|528390546|FG000|Overall Study|Adverse Event|1|||
146852960|NCT03616977|529630251|FG001|Period 3|Adverse Event|1|||
146852961|NCT02665338|529630252|FG000|Overall Study|Withdrawal by Subject|0|||
146852962|NCT02665338|529630253|FG001|Overall Study|Withdrawal by Subject|1|||
146515076|NCT02028169|528390546|FG000|Overall Study|Cessation of Drug|1|||
146515077|NCT02028169|528390546|FG000|Overall Study|Concomitant Medication Usage|1|||
146515078|NCT02258334|528390547|FG000|Overall Study|Adverse Event|1|||
146515079|NCT02258334|528390548|FG001|Overall Study|Adverse Event|0|||
146852963|NCT05326815|529630255|FG000|Overall Study|Withdrawal by Subject|3|||
146852964|NCT05326815|529630255|FG000|Overall Study|Did not complete required labs|6|||
146515080|NCT02258334|528390549|FG002|Overall Study|Adverse Event|0|||
146515081|NCT02258334|528390550|FG003|Overall Study|Adverse Event|0|||
146515082|NCT01625689|528390551|FG000|Overall Study|Migration|2|||
146515083|NCT01625689|528390552|FG001|Overall Study|Migration|1|||
146515084|NCT01333956|528390563|FG000|Overall Study|Lost to Follow-up|1|||
146852965|NCT05326815|529630255|FG000|Overall Study|Screen fail- abnormal labs|5|||
146852966|NCT04617275|529630256|FG000|Treatment Period|Adverse Event|1|||
146852967|NCT04617275|529630257|FG001|Treatment Period|Adverse Event|6|||
146852968|NCT04617275|529630258|FG002|Treatment Period|Adverse Event|4|||
146852969|NCT04617275|529630259|FG003|Treatment Period|Adverse Event|6|||
146852970|NCT04617275|529630260|FG004|Treatment Period|Adverse Event|7|||
146852971|NCT04617275|529630261|FG005|Treatment Period|Adverse Event|8|||
146852972|NCT04617275|529630262|FG006|Treatment Period|Adverse Event|0|||
146852973|NCT04617275|529630263|FG007|Treatment Period|Adverse Event|12|||
146852974|NCT04617275|529630256|FG000|Treatment Period|Lost to Follow-up|0|||
146852975|NCT04617275|529630257|FG001|Treatment Period|Lost to Follow-up|0|||
146852976|NCT04617275|529630258|FG002|Treatment Period|Lost to Follow-up|2|||
146852977|NCT04617275|529630259|FG003|Treatment Period|Lost to Follow-up|0|||
146852978|NCT04617275|529630260|FG004|Treatment Period|Lost to Follow-up|0|||
146852979|NCT04617275|529630261|FG005|Treatment Period|Lost to Follow-up|3|||
146852980|NCT04617275|529630262|FG006|Treatment Period|Lost to Follow-up|0|||
146852981|NCT04617275|529630263|FG007|Treatment Period|Lost to Follow-up|2|||
146852982|NCT04617275|529630256|FG000|Treatment Period|No longer meets eligibility criteria|0|||
146852983|NCT04617275|529630257|FG001|Treatment Period|No longer meets eligibility criteria|0|||
146852984|NCT04617275|529630258|FG002|Treatment Period|No longer meets eligibility criteria|0|||
146852985|NCT04617275|529630259|FG003|Treatment Period|No longer meets eligibility criteria|1|||
146852986|NCT04617275|529630260|FG004|Treatment Period|No longer meets eligibility criteria|0|||
146852987|NCT04617275|529630261|FG005|Treatment Period|No longer meets eligibility criteria|0|||
146852988|NCT04617275|529630262|FG006|Treatment Period|No longer meets eligibility criteria|0|||
146852989|NCT04617275|529630263|FG007|Treatment Period|No longer meets eligibility criteria|0|||
146852990|NCT04617275|529630256|FG000|Treatment Period|Other|0|||
146852991|NCT04617275|529630257|FG001|Treatment Period|Other|1|||
146852992|NCT04617275|529630258|FG002|Treatment Period|Other|0|||
146852993|NCT04617275|529630259|FG003|Treatment Period|Other|0|||
146852994|NCT04617275|529630260|FG004|Treatment Period|Other|0|||
146852995|NCT04617275|529630261|FG005|Treatment Period|Other|0|||
146852996|NCT04617275|529630262|FG006|Treatment Period|Other|0|||
146852997|NCT04617275|529630263|FG007|Treatment Period|Other|0|||
146852998|NCT04617275|529630256|FG000|Treatment Period|Withdrawal by Subject|2|||
146852999|NCT04617275|529630257|FG001|Treatment Period|Withdrawal by Subject|0|||
146853000|NCT04617275|529630258|FG002|Treatment Period|Withdrawal by Subject|0|||
146853001|NCT04617275|529630259|FG003|Treatment Period|Withdrawal by Subject|2|||
146853002|NCT04617275|529630260|FG004|Treatment Period|Withdrawal by Subject|2|||
146853003|NCT04617275|529630261|FG005|Treatment Period|Withdrawal by Subject|0|||
146853004|NCT04617275|529630262|FG006|Treatment Period|Withdrawal by Subject|1|||
146853005|NCT04617275|529630263|FG007|Treatment Period|Withdrawal by Subject|2|||
146853006|NCT04617275|529630256|FG000|Follow-up Period|Adverse Event|1|||
146853007|NCT04617275|529630257|FG001|Follow-up Period|Adverse Event|1|||
146853008|NCT04617275|529630258|FG002|Follow-up Period|Adverse Event|2|||
146853009|NCT04617275|529630259|FG003|Follow-up Period|Adverse Event|3|||
146853010|NCT04617275|529630260|FG004|Follow-up Period|Adverse Event|4|||
146853011|NCT04617275|529630261|FG005|Follow-up Period|Adverse Event|3|||
146853012|NCT04617275|529630262|FG006|Follow-up Period|Adverse Event|0|||
146853013|NCT04617275|529630263|FG007|Follow-up Period|Adverse Event|3|||
146853014|NCT04617275|529630256|FG000|Follow-up Period|Lost to Follow-up|0|||
146853015|NCT04617275|529630257|FG001|Follow-up Period|Lost to Follow-up|1|||
146853016|NCT04617275|529630258|FG002|Follow-up Period|Lost to Follow-up|2|||
146853017|NCT04617275|529630259|FG003|Follow-up Period|Lost to Follow-up|0|||
146853018|NCT04617275|529630260|FG004|Follow-up Period|Lost to Follow-up|0|||
146853019|NCT04617275|529630261|FG005|Follow-up Period|Lost to Follow-up|4|||
146853020|NCT04617275|529630262|FG006|Follow-up Period|Lost to Follow-up|0|||
146853021|NCT04617275|529630263|FG007|Follow-up Period|Lost to Follow-up|3|||
146853022|NCT04617275|529630256|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
146853023|NCT04617275|529630257|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
146853024|NCT04617275|529630258|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
146853025|NCT04617275|529630259|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
146853026|NCT04617275|529630260|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
146853027|NCT04617275|529630261|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
146853028|NCT04617275|529630262|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
146853029|NCT04617275|529630263|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
146853030|NCT04617275|529630256|FG000|Follow-up Period|Other|0|||
146853031|NCT04617275|529630257|FG001|Follow-up Period|Other|1|||
146853032|NCT04617275|529630258|FG002|Follow-up Period|Other|0|||
146853033|NCT04617275|529630259|FG003|Follow-up Period|Other|0|||
146853034|NCT04617275|529630260|FG004|Follow-up Period|Other|0|||
146853035|NCT04617275|529630261|FG005|Follow-up Period|Other|0|||
146853036|NCT04617275|529630262|FG006|Follow-up Period|Other|0|||
146853037|NCT04617275|529630263|FG007|Follow-up Period|Other|0|||
146853038|NCT04617275|529630256|FG000|Follow-up Period|Withdrawal by Subject|2|||
146515085|NCT01333956|528390564|FG001|Overall Study|Lost to Follow-up|2|||
146515086|NCT01333956|528390565|FG002|Overall Study|Lost to Follow-up|0|||
146515087|NCT01333956|528390566|FG003|Overall Study|Lost to Follow-up|1|||
146515088|NCT01333956|528390563|FG000|Overall Study|Unable to complete study procedure|1|||
146515089|NCT01333956|528390564|FG001|Overall Study|Unable to complete study procedure|0|||
146515090|NCT01333956|528390565|FG002|Overall Study|Unable to complete study procedure|0|||
146515091|NCT01333956|528390566|FG003|Overall Study|Unable to complete study procedure|1|||
146515092|NCT01333956|528390563|FG000|Overall Study|Withdrawal by Subject|0|||
146515093|NCT01333956|528390564|FG001|Overall Study|Withdrawal by Subject|2|||
146515094|NCT01333956|528390565|FG002|Overall Study|Withdrawal by Subject|1|||
146515095|NCT01333956|528390566|FG003|Overall Study|Withdrawal by Subject|0|||
146515096|NCT02134353|528390567|FG000|Overall Study|Adverse Event|10|||
146515097|NCT02134353|528390568|FG001|Overall Study|Adverse Event|6|||
146515098|NCT02134353|528390567|FG000|Overall Study|Lost to Follow-up|1|||
146515099|NCT02134353|528390568|FG001|Overall Study|Lost to Follow-up|1|||
146515100|NCT02134353|528390567|FG000|Overall Study|Lack of Efficacy|2|||
146515101|NCT02134353|528390568|FG001|Overall Study|Lack of Efficacy|1|||
146515102|NCT02134353|528390567|FG000|Overall Study|Withdrawal by Subject|12|||
146515103|NCT02134353|528390568|FG001|Overall Study|Withdrawal by Subject|13|||
146515104|NCT02134353|528390567|FG000|Overall Study|Death|0|||
146515105|NCT02134353|528390568|FG001|Overall Study|Death|1|||
146515106|NCT02134353|528390567|FG000|Overall Study|Pregnancy|0|||
146515107|NCT02134353|528390568|FG001|Overall Study|Pregnancy|1|||
146515108|NCT02134353|528390567|FG000|Overall Study|Relocation|1|||
146515109|NCT02134353|528390568|FG001|Overall Study|Relocation|0|||
146515110|NCT02134353|528390567|FG000|Overall Study|Other - Patient's Choice|0|||
146515111|NCT02134353|528390568|FG001|Overall Study|Other - Patient's Choice|1|||
146515112|NCT03426436|528390569|FG000|Overall Study|Incorrect lead placement|12|||
146515113|NCT03426436|528390569|FG000|Overall Study|Withdrawal by Subject|2|||
146515114|NCT03426436|528390569|FG000|Overall Study|Consent issue|1|||
146515115|NCT03426436|528390569|FG000|Overall Study|ECGs not saved|4|||
146515116|NCT04226495|528390570|FG000|Overall Study|Withdrawal by Subject|3|||
146515117|NCT04226495|528390571|FG001|Overall Study|Withdrawal by Subject|3|||
146515118|NCT04226495|528390570|FG000|Overall Study|PI discretion|3|||
146515119|NCT04226495|528390571|FG001|Overall Study|PI discretion|4|||
146515120|NCT00435019|528390572|FG000|Overall Study|Adverse Event|1|||
146515121|NCT00435019|528390573|FG001|Overall Study|Adverse Event|0|||
146515122|NCT00435019|528390572|FG000|Overall Study|Lack of Efficacy|1|||
146515123|NCT00435019|528390573|FG001|Overall Study|Lack of Efficacy|2|||
146515124|NCT00435019|528390572|FG000|Overall Study|Protocol Violation|3|||
146515125|NCT00435019|528390573|FG001|Overall Study|Protocol Violation|1|||
146515126|NCT00435019|528390572|FG000|Overall Study|Personal reasons for withdrawal|8|||
146515127|NCT00435019|528390573|FG001|Overall Study|Personal reasons for withdrawal|7|||
146515128|NCT00505661|528390578|FG000|Overall Study|Not Eligible|4|||
146515129|NCT01783821|528390581|FG000|Overall Study|Screen Failure|1|||
146515130|NCT01783821|528390582|FG001|Overall Study|Screen Failure|1|||
146515131|NCT04459598|528390583|FG000|Overall Study|Adverse Event|1|||
146515132|NCT04459598|528390584|FG001|Overall Study|Adverse Event|1|||
146515133|NCT01907217|528390585|FG000|Overall Study|Withdrawal by Subject|0|||
146515134|NCT01907217|528390586|FG001|Overall Study|Withdrawal by Subject|2|||
146515135|NCT00866333|528390593|FG000|Overall Study|Withdrawal of consent|0|||
146515136|NCT00866333|528390594|FG001|Overall Study|Withdrawal of consent|1|||
146515137|NCT00866333|528390595|FG002|Overall Study|Withdrawal of consent|2|||
146515138|NCT00866333|528390593|FG000|Overall Study|Reason not Specified|3|||
146515139|NCT00866333|528390594|FG001|Overall Study|Reason not Specified|1|||
146515140|NCT00866333|528390595|FG002|Overall Study|Reason not Specified|1|||
146515141|NCT00866333|528390593|FG000|Overall Study|Study Terminated by Sponsor|2|||
146515142|NCT00866333|528390594|FG001|Overall Study|Study Terminated by Sponsor|5|||
146515143|NCT00866333|528390595|FG002|Overall Study|Study Terminated by Sponsor|9|||
146853039|NCT04617275|529630257|FG001|Follow-up Period|Withdrawal by Subject|0|||
146515144|NCT01764659|528390596|FG000|Overall Study|Death|1|||
146515145|NCT01764659|528390596|FG000|Overall Study|Physician Decision|1|||
146515146|NCT01210352|528390597|FG000|Overall Study|Adverse Event|0|||
146515147|NCT01210352|528390598|FG001|Overall Study|Adverse Event|0|||
146515148|NCT01210352|528390599|FG002|Overall Study|Adverse Event|0|||
146515149|NCT01210352|528390600|FG003|Overall Study|Adverse Event|0|||
146515150|NCT01210352|528390601|FG004|Overall Study|Adverse Event|0|||
146515151|NCT01210352|528390602|FG005|Overall Study|Adverse Event|0|||
146515152|NCT01210352|528390603|FG006|Overall Study|Adverse Event|0|||
146515153|NCT01210352|528390604|FG007|Overall Study|Adverse Event|2|||
146515154|NCT01210352|528390605|FG008|Overall Study|Adverse Event|1|||
146853040|NCT04617275|529630258|FG002|Follow-up Period|Withdrawal by Subject|0|||
146515155|NCT01210352|528390597|FG000|Overall Study|Lack of Efficacy|0|||
146515156|NCT01210352|528390598|FG001|Overall Study|Lack of Efficacy|0|||
146515157|NCT01210352|528390599|FG002|Overall Study|Lack of Efficacy|0|||
146853041|NCT04617275|529630259|FG003|Follow-up Period|Withdrawal by Subject|2|||
146515158|NCT01210352|528390600|FG003|Overall Study|Lack of Efficacy|0|||
146515159|NCT01210352|528390601|FG004|Overall Study|Lack of Efficacy|0|||
146515160|NCT01210352|528390602|FG005|Overall Study|Lack of Efficacy|0|||
146515161|NCT01210352|528390603|FG006|Overall Study|Lack of Efficacy|1|||
146515162|NCT01210352|528390604|FG007|Overall Study|Lack of Efficacy|0|||
146515163|NCT01210352|528390605|FG008|Overall Study|Lack of Efficacy|0|||
146515164|NCT01210352|528390597|FG000|Overall Study|Physician Decision|0|||
146515165|NCT01210352|528390598|FG001|Overall Study|Physician Decision|0|||
146515166|NCT01210352|528390599|FG002|Overall Study|Physician Decision|0|||
146515167|NCT01210352|528390600|FG003|Overall Study|Physician Decision|0|||
146515168|NCT01210352|528390601|FG004|Overall Study|Physician Decision|0|||
146515169|NCT01210352|528390602|FG005|Overall Study|Physician Decision|0|||
146515170|NCT01210352|528390603|FG006|Overall Study|Physician Decision|0|||
146515171|NCT01210352|528390604|FG007|Overall Study|Physician Decision|1|||
146515172|NCT01210352|528390605|FG008|Overall Study|Physician Decision|2|||
146515173|NCT01210352|528390597|FG000|Overall Study|Withdrawal by Subject|0|||
146515174|NCT01210352|528390598|FG001|Overall Study|Withdrawal by Subject|0|||
146853042|NCT04617275|529630260|FG004|Follow-up Period|Withdrawal by Subject|2|||
146853043|NCT04617275|529630261|FG005|Follow-up Period|Withdrawal by Subject|0|||
146853044|NCT04617275|529630262|FG006|Follow-up Period|Withdrawal by Subject|1|||
146853045|NCT04617275|529630263|FG007|Follow-up Period|Withdrawal by Subject|2|||
146853046|NCT04927884|529630264|FG000|Overall Study|Progressive Disease|2|||
146853047|NCT05917470|529630265|FG000|Overall Study|Progressive Disease|1|||
146853048|NCT05917470|529630266|FG001|Overall Study|Progressive Disease|1|||
146853049|NCT05917470|529630267|FG002|Overall Study|Progressive Disease|2|||
146515175|NCT01210352|528390599|FG002|Overall Study|Withdrawal by Subject|1|||
146515176|NCT01210352|528390600|FG003|Overall Study|Withdrawal by Subject|0|||
146515177|NCT01210352|528390601|FG004|Overall Study|Withdrawal by Subject|0|||
146515178|NCT01210352|528390602|FG005|Overall Study|Withdrawal by Subject|0|||
146853050|NCT05917470|529630268|FG003|Overall Study|Progressive Disease|3|||
146853051|NCT05917470|529630269|FG004|Overall Study|Progressive Disease|1|||
146853052|NCT05917470|529630270|FG005|Overall Study|Progressive Disease|1|||
146853053|NCT05917470|529630271|FG006|Overall Study|Progressive Disease|0|||
146853054|NCT05917470|529630272|FG007|Overall Study|Progressive Disease|0|||
146853055|NCT05917470|529630265|FG000|Overall Study|Withdrawal by Subject|0|||
146853056|NCT05917470|529630266|FG001|Overall Study|Withdrawal by Subject|0|||
146853057|NCT05917470|529630267|FG002|Overall Study|Withdrawal by Subject|1|||
146853058|NCT05917470|529630268|FG003|Overall Study|Withdrawal by Subject|0|||
146853059|NCT05917470|529630269|FG004|Overall Study|Withdrawal by Subject|0|||
146853060|NCT05917470|529630270|FG005|Overall Study|Withdrawal by Subject|0|||
146853061|NCT05917470|529630271|FG006|Overall Study|Withdrawal by Subject|0|||
146853062|NCT05917470|529630272|FG007|Overall Study|Withdrawal by Subject|0|||
146853063|NCT05917470|529630265|FG000|Overall Study|Sponsor Decision|0|||
146853064|NCT05917470|529630266|FG001|Overall Study|Sponsor Decision|0|||
146853065|NCT05917470|529630267|FG002|Overall Study|Sponsor Decision|1|||
146853066|NCT05917470|529630268|FG003|Overall Study|Sponsor Decision|0|||
146853067|NCT05917470|529630269|FG004|Overall Study|Sponsor Decision|2|||
146853068|NCT05917470|529630270|FG005|Overall Study|Sponsor Decision|1|||
146853069|NCT05917470|529630271|FG006|Overall Study|Sponsor Decision|3|||
146853070|NCT05917470|529630272|FG007|Overall Study|Sponsor Decision|3|||
146853071|NCT05917470|529630265|FG000|Overall Study|Adverse Event|0|||
146853072|NCT05917470|529630266|FG001|Overall Study|Adverse Event|0|||
146853073|NCT05917470|529630267|FG002|Overall Study|Adverse Event|0|||
146853074|NCT05917470|529630268|FG003|Overall Study|Adverse Event|0|||
146853075|NCT05917470|529630269|FG004|Overall Study|Adverse Event|0|||
146853076|NCT05917470|529630270|FG005|Overall Study|Adverse Event|1|||
146853077|NCT05917470|529630271|FG006|Overall Study|Adverse Event|0|||
146853078|NCT05917470|529630272|FG007|Overall Study|Adverse Event|0|||
146853079|NCT01290029|529633528|FG000|Overall Study|Other|2|||
146515179|NCT01210352|528390603|FG006|Overall Study|Withdrawal by Subject|1|||
146515180|NCT01210352|528390604|FG007|Overall Study|Withdrawal by Subject|0|||
146515181|NCT01210352|528390605|FG008|Overall Study|Withdrawal by Subject|1|||
146515182|NCT01210352|528390597|FG000|Overall Study|Patient Discharged Early|0|||
146515183|NCT01210352|528390598|FG001|Overall Study|Patient Discharged Early|0|||
146853080|NCT00189488|529633529|FG000|Overall Study|Ineligibility determined|1|||
146515184|NCT01210352|528390599|FG002|Overall Study|Patient Discharged Early|1|||
146515185|NCT01210352|528390600|FG003|Overall Study|Patient Discharged Early|0|||
146515186|NCT01210352|528390601|FG004|Overall Study|Patient Discharged Early|0|||
146853081|NCT00189488|529633530|FG001|Overall Study|Ineligibility determined|0|||
146853082|NCT00189488|529633529|FG000|Overall Study|Protocol deviation|2|||
146853083|NCT00189488|529633530|FG001|Overall Study|Protocol deviation|1|||
146853084|NCT00189488|529633529|FG000|Overall Study|Adverse Event|2|||
146853085|NCT00189488|529633530|FG001|Overall Study|Adverse Event|1|||
146853086|NCT00189488|529633529|FG000|Overall Study|Withdrawal by Subject|2|||
146515187|NCT01210352|528390602|FG005|Overall Study|Patient Discharged Early|0|||
146515188|NCT01210352|528390603|FG006|Overall Study|Patient Discharged Early|0|||
146515189|NCT01210352|528390604|FG007|Overall Study|Patient Discharged Early|0|||
146853087|NCT00189488|529633530|FG001|Overall Study|Withdrawal by Subject|6|||
146853088|NCT00189488|529633529|FG000|Overall Study|Disease progression|2|||
146515190|NCT01210352|528390605|FG008|Overall Study|Patient Discharged Early|0|||
146515191|NCT03338569|528390606|FG000|Overall Study|Physician Decision|8|||
146515192|NCT03338569|528390607|FG001|Overall Study|Physician Decision|3|||
146515193|NCT03338569|528390606|FG000|Overall Study|Withdrawal by Subject|0|||
146515194|NCT03338569|528390607|FG001|Overall Study|Withdrawal by Subject|1|||
146515195|NCT03338569|528390606|FG000|Overall Study|Lost to Follow-up|0|||
146515196|NCT03338569|528390607|FG001|Overall Study|Lost to Follow-up|1|||
146515197|NCT02012959|528390608|FG000|Treatment Phase A|Adverse Event|2|||
146515198|NCT02012959|528390609|FG001|Treatment Phase A|Adverse Event|0|||
146515199|NCT02012959|528390610|FG002|Treatment Phase A|Adverse Event|0|||
146515200|NCT02012959|528390611|FG003|Treatment Phase A|Adverse Event|0|||
146515201|NCT02012959|528390612|FG004|Treatment Phase A|Adverse Event|0|||
146515202|NCT01744483|528392530|FG000|Overall Study|Death|9|||
146515203|NCT01744483|528392531|FG001|Overall Study|Death|4|||
146515204|NCT01744483|528392532|FG002|Overall Study|Death|11|||
146515205|NCT01744483|528392530|FG000|Overall Study|Lost to Follow-up|8|||
146515206|NCT01744483|528392531|FG001|Overall Study|Lost to Follow-up|9|||
146515207|NCT01744483|528392532|FG002|Overall Study|Lost to Follow-up|11|||
146515208|NCT01744483|528392530|FG000|Overall Study|Protocol Violation|1|||
146515209|NCT01744483|528392531|FG001|Overall Study|Protocol Violation|2|||
146515210|NCT01744483|528392532|FG002|Overall Study|Protocol Violation|1|||
146515211|NCT01744483|528392530|FG000|Overall Study|Withdrawal by Subject|4|||
146515212|NCT01744483|528392531|FG001|Overall Study|Withdrawal by Subject|6|||
146515213|NCT01744483|528392532|FG002|Overall Study|Withdrawal by Subject|2|||
146515214|NCT01744483|528392530|FG000|Overall Study|No ICU Admit|5|||
146515215|NCT01744483|528392531|FG001|Overall Study|No ICU Admit|1|||
146515216|NCT01744483|528392532|FG002|Overall Study|No ICU Admit|2|||
146515217|NCT01744483|528392530|FG000|Overall Study|Routed to OSH|2|||
146515218|NCT01744483|528392531|FG001|Overall Study|Routed to OSH|0|||
146515219|NCT01744483|528392532|FG002|Overall Study|Routed to OSH|1|||
146515220|NCT01190189|528392533|FG000|Overall Study|Lost to Follow-up|4|||
146515221|NCT01190189|528392533|FG000|Overall Study|Withdrawal by Subject|1|||
146515222|NCT01190189|528392533|FG000|Overall Study|Migrated/moved from study area|1|||
146515223|NCT04228965|528392534|FG000|Overall Study|Lost to Follow-up|26|||
146515224|NCT04228965|528392535|FG001|Overall Study|Lost to Follow-up|11|||
146515225|NCT04228965|528392534|FG000|Overall Study|Withdrawal by Subject|18|||
146515226|NCT04228965|528392535|FG001|Overall Study|Withdrawal by Subject|5|||
146515227|NCT03915626|528392536|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
146515228|NCT03015194|528392537|FG000|Overall Study|Death|10|||
146515229|NCT03015194|528392537|FG000|Overall Study|Withdrawal by Subject|2|||
146515230|NCT01754766|528392538|FG000|Overall Study|Personal reasons|1|||
146515231|NCT01754766|528392539|FG001|Overall Study|Personal reasons|1|||
146515232|NCT01754766|528392540|FG002|Overall Study|Personal reasons|0|||
146515233|NCT00433017|528392541|FG000|Overall Study|Adverse Event|5|||
146515234|NCT00433017|528392542|FG001|Overall Study|Adverse Event|3|||
146515235|NCT00433017|528392541|FG000|Overall Study|Withdrawal by Subject|4|||
146515236|NCT00433017|528392542|FG001|Overall Study|Withdrawal by Subject|5|||
146515237|NCT00433017|528392541|FG000|Overall Study|Lost to Follow-up|3|||
146515238|NCT00433017|528392542|FG001|Overall Study|Lost to Follow-up|4|||
146515239|NCT00433017|528392541|FG000|Overall Study|Administrative problems|80|||
146515240|NCT00433017|528392542|FG001|Overall Study|Administrative problems|86|||
146515241|NCT00433017|528392541|FG000|Overall Study|Protocol Violation|1|||
146515242|NCT00433017|528392542|FG001|Overall Study|Protocol Violation|0|||
146515243|NCT00433017|528392541|FG000|Overall Study|Death|2|||
146515244|NCT00433017|528392542|FG001|Overall Study|Death|2|||
146515245|NCT00433017|528392541|FG000|Overall Study|Subject no longer requires study drug|1|||
146515246|NCT00433017|528392542|FG001|Overall Study|Subject no longer requires study drug|1|||
146515247|NCT01026818|528392543|FG000|Screening Period|Entry Criteria Not Met|105|||
146515248|NCT01026818|528392544|FG001|Screening Period|Entry Criteria Not Met|0|||
146515249|NCT01026818|528392545|FG002|Screening Period|Entry Criteria Not Met|0|||
146515250|NCT01026818|528392546|FG003|Screening Period|Entry Criteria Not Met|0|||
146515251|NCT01026818|528392543|FG000|Screening Period|Withdrawal by Subject|49|||
146515252|NCT01026818|528392544|FG001|Screening Period|Withdrawal by Subject|0|||
146515253|NCT01026818|528392545|FG002|Screening Period|Withdrawal by Subject|0|||
146515254|NCT01026818|528392546|FG003|Screening Period|Withdrawal by Subject|0|||
146515255|NCT01026818|528392543|FG000|Screening Period|Protocol Deviation|3|||
146515256|NCT01026818|528392544|FG001|Screening Period|Protocol Deviation|0|||
146515257|NCT01026818|528392545|FG002|Screening Period|Protocol Deviation|0|||
146515258|NCT01026818|528392546|FG003|Screening Period|Protocol Deviation|0|||
146515259|NCT01026818|528392543|FG000|Screening Period|Adverse Event|2|||
146515260|NCT01026818|528392544|FG001|Screening Period|Adverse Event|0|||
146515261|NCT01026818|528392545|FG002|Screening Period|Adverse Event|0|||
146515262|NCT01026818|528392546|FG003|Screening Period|Adverse Event|0|||
146515263|NCT01026818|528392543|FG000|Screening Period|Physician Decision|1|||
146515264|NCT01026818|528392544|FG001|Screening Period|Physician Decision|0|||
146515265|NCT01026818|528392545|FG002|Screening Period|Physician Decision|0|||
146515266|NCT01026818|528392546|FG003|Screening Period|Physician Decision|0|||
146515267|NCT01026818|528392543|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
146515268|NCT01026818|528392544|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
146515269|NCT01026818|528392545|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
146515270|NCT01026818|528392546|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
146515271|NCT01026818|528392543|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
146515272|NCT01026818|528392544|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
146515273|NCT01026818|528392545|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
146515274|NCT01026818|528392546|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
146515275|NCT01026818|528392543|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
146515276|NCT01026818|528392544|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
146515277|NCT01026818|528392545|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
146515278|NCT01026818|528392546|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
146515279|NCT01026818|528392543|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
146515280|NCT01026818|528392544|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
146515281|NCT01026818|528392545|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
146755498|NCT02015663|529269748|FG000|Overall Study|Withdrawal by Subject|1|||
146755499|NCT02015663|529269749|FG001|Overall Study|Withdrawal by Subject|0|||
146755500|NCT02015663|529269748|FG000|Overall Study|Protocol Violation|0|||
146755501|NCT02015663|529269749|FG001|Overall Study|Protocol Violation|1|||
146755502|NCT02015663|529269748|FG000|Overall Study|Adverse Event|3|||
146755503|NCT02015663|529269749|FG001|Overall Study|Adverse Event|0|||
146755504|NCT02015663|529269748|FG000|Overall Study|Administrative problems|10|||
146755505|NCT02015663|529269749|FG001|Overall Study|Administrative problems|11|||
146755506|NCT00146640|529269756|FG000|Overall Study|Adverse Event|12|||
146755507|NCT00146640|529269757|FG001|Overall Study|Adverse Event|10|||
146755508|NCT00146640|529269756|FG000|Overall Study|Medical Reasons|3|||
146755509|NCT00146640|529269757|FG001|Overall Study|Medical Reasons|0|||
146755510|NCT00146640|529269756|FG000|Overall Study|Non-Medical Reasons|8|||
146755511|NCT00146640|529269757|FG001|Overall Study|Non-Medical Reasons|4|||
146755512|NCT02059161|529269758|FG000|Overall Study|Pregnancy|0|||
146755513|NCT02059161|529269759|FG001|Overall Study|Pregnancy|2|||
146755514|NCT02059161|529269758|FG000|Overall Study|Adverse Event|2|||
146755515|NCT02059161|529269759|FG001|Overall Study|Adverse Event|6|||
146755516|NCT02059161|529269758|FG000|Overall Study|Lost to Follow-up|20|||
146755517|NCT02059161|529269759|FG001|Overall Study|Lost to Follow-up|12|||
146755518|NCT02059161|529269758|FG000|Overall Study|Physician Decision|4|||
146755519|NCT02059161|529269759|FG001|Overall Study|Physician Decision|4|||
146755520|NCT02059161|529269758|FG000|Overall Study|Protocol Violation|1|||
146755521|NCT02059161|529269759|FG001|Overall Study|Protocol Violation|1|||
146755522|NCT02059161|529269758|FG000|Overall Study|Withdrawal by Subject|16|||
146755523|NCT02059161|529269759|FG001|Overall Study|Withdrawal by Subject|13|||
146755524|NCT02059161|529269758|FG000|Overall Study|Randomized in error, no study drug|0|||
146755525|NCT02059161|529269759|FG001|Overall Study|Randomized in error, no study drug|1|||
146755526|NCT02059161|529269758|FG000|Overall Study|Non-compliance with study drug|6|||
146755527|NCT02059161|529269759|FG001|Overall Study|Non-compliance with study drug|2|||
146755528|NCT03293485|529269760|FG000|Overall Study|Death|1|||
146755529|NCT03293485|529269760|FG000|Overall Study|Screen Failure|2|||
146755530|NCT03293485|529269760|FG000|Overall Study|Withdrawal by Subject|2|||
146755531|NCT01723826|529269764|FG000|Overall Study|Adverse Event|4|||
146755532|NCT01723826|529269765|FG001|Overall Study|Adverse Event|1|||
146755533|NCT01723826|529269766|FG002|Overall Study|Adverse Event|4|||
146755534|NCT01723826|529269767|FG003|Overall Study|Adverse Event|5|||
146755535|NCT01723826|529269764|FG000|Overall Study|Death according to AE eCRF|2|||
146755536|NCT01723826|529269765|FG001|Overall Study|Death according to AE eCRF|3|||
146755537|NCT01723826|529269766|FG002|Overall Study|Death according to AE eCRF|3|||
146755538|NCT01723826|529269767|FG003|Overall Study|Death according to AE eCRF|7|||
146755539|NCT01723826|529269764|FG000|Overall Study|Lost to Follow-up|1|||
146755540|NCT01723826|529269765|FG001|Overall Study|Lost to Follow-up|3|||
146755541|NCT01723826|529269766|FG002|Overall Study|Lost to Follow-up|1|||
146755542|NCT01723826|529269767|FG003|Overall Study|Lost to Follow-up|1|||
146755543|NCT01723826|529269764|FG000|Overall Study|Non-compliance|0|||
146755544|NCT01723826|529269765|FG001|Overall Study|Non-compliance|1|||
146755545|NCT01723826|529269766|FG002|Overall Study|Non-compliance|3|||
146755546|NCT01723826|529269767|FG003|Overall Study|Non-compliance|3|||
146755547|NCT01723826|529269764|FG000|Overall Study|Non-compliance With Study Drug|0|||
146755548|NCT01723826|529269765|FG001|Overall Study|Non-compliance With Study Drug|1|||
146755549|NCT01723826|529269766|FG002|Overall Study|Non-compliance With Study Drug|0|||
146755550|NCT01723826|529269767|FG003|Overall Study|Non-compliance With Study Drug|0|||
146755551|NCT01723826|529269764|FG000|Overall Study|Other Reason|8|||
146755552|NCT01723826|529269765|FG001|Overall Study|Other Reason|6|||
146755553|NCT01723826|529269766|FG002|Overall Study|Other Reason|12|||
146515282|NCT01026818|528392546|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
146755554|NCT01723826|529269767|FG003|Overall Study|Other Reason|14|||
146755555|NCT01723826|529269764|FG000|Overall Study|Physician Decision|1|||
146755556|NCT01723826|529269765|FG001|Overall Study|Physician Decision|3|||
146755557|NCT01723826|529269766|FG002|Overall Study|Physician Decision|4|||
146755558|NCT01723826|529269767|FG003|Overall Study|Physician Decision|11|||
146853089|NCT00189488|529633530|FG001|Overall Study|Disease progression|4|||
146853090|NCT00189488|529633529|FG000|Overall Study|Administrative Decision|0|||
146853091|NCT00189488|529633530|FG001|Overall Study|Administrative Decision|2|||
146853092|NCT00189488|529633529|FG000|Overall Study|Death|5|||
146853093|NCT00189488|529633530|FG001|Overall Study|Death|8|||
146853094|NCT00189488|529633529|FG000|Overall Study|Other|1|||
146853095|NCT00189488|529633530|FG001|Overall Study|Other|0|||
146853096|NCT02349425|529633531|FG000|Period 1|Adverse Event|1|||
146853097|NCT02349425|529633532|FG001|Period 1|Adverse Event|1|||
146853098|NCT02349425|529633533|FG002|Period 1|Adverse Event|0|||
146853099|NCT02349425|529633534|FG003|Period 1|Adverse Event|0|||
146853100|NCT02349425|529633531|FG000|Period 2|Adverse Event|0|||
146853101|NCT02349425|529633532|FG001|Period 2|Adverse Event|1|||
146853102|NCT02349425|529633533|FG002|Period 2|Adverse Event|1|||
146853103|NCT02349425|529633534|FG003|Period 2|Adverse Event|0|||
146853104|NCT02090959|529633535|FG000|Overall Study|Withdrawal by Subject|10|||
146853105|NCT02090959|529633535|FG000|Overall Study|Adverse Event|1|||
146853106|NCT02090959|529633535|FG000|Overall Study|Investigator decision|2|||
146853107|NCT02090959|529633535|FG000|Overall Study|Study termination|6|||
146853108|NCT02090959|529633535|FG000|Overall Study|Enrolled but not treated|1|||
146853109|NCT02090959|529633535|FG000|Overall Study|Transfer for compassionate use medicine|4|||
146853110|NCT02090959|529633535|FG000|Overall Study|Move to medical need program|3|||
146853111|NCT02090959|529633535|FG000|Overall Study|Entered in to other study|34|||
146853112|NCT02090959|529633535|FG000|Overall Study|Switched to commercial supply|88|||
146853113|NCT02090959|529633535|FG000|Overall Study|Other than specified|2|||
146853114|NCT02808143|529633538|FG000|Maintenance Phase|Disease recurrence|1|||
146853115|NCT02808143|529633539|FG001|Maintenance Phase|Disease recurrence|3|||
146853116|NCT02808143|529633538|FG000|Maintenance Phase|Disease progression|1|||
146853117|NCT02808143|529633539|FG001|Maintenance Phase|Disease progression|2|||
146853118|NCT02808143|529633538|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
146853119|NCT02808143|529633539|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
146853120|NCT02808143|529633538|FG000|Survival Follow-Up|Disease recurrence|0|||
146853121|NCT02808143|529633539|FG001|Survival Follow-Up|Disease recurrence|2|||
146853122|NCT02808143|529633538|FG000|Survival Follow-Up|Adverse Event|0|||
146853123|NCT02808143|529633539|FG001|Survival Follow-Up|Adverse Event|1|||
146853124|NCT02808143|529633538|FG000|Survival Follow-Up|Death|1|||
146853125|NCT02808143|529633539|FG001|Survival Follow-Up|Death|0|||
146853126|NCT00522873|529633540|FG000|Overall Study|Adverse Event|41|||
146853127|NCT00522873|529633541|FG001|Overall Study|Adverse Event|26|||
146853128|NCT00522873|529633540|FG000|Overall Study|Withdrawal by Subject|20|||
146853129|NCT00522873|529633541|FG001|Overall Study|Withdrawal by Subject|9|||
146853130|NCT00522873|529633540|FG000|Overall Study|Protocol Violation|14|||
146853131|NCT00522873|529633541|FG001|Overall Study|Protocol Violation|4|||
146853132|NCT00522873|529633540|FG000|Overall Study|Lost to Follow-up|11|||
146853133|NCT00522873|529633541|FG001|Overall Study|Lost to Follow-up|3|||
146853134|NCT00522873|529633540|FG000|Overall Study|Personal Reasons|8|||
146853135|NCT00522873|529633541|FG001|Overall Study|Personal Reasons|1|||
146853136|NCT00522873|529633540|FG000|Overall Study|Medication Errors|1|||
146853137|NCT00522873|529633541|FG001|Overall Study|Medication Errors|1|||
146853138|NCT00522873|529633540|FG000|Overall Study|Never Received Medication|1|||
146853139|NCT00522873|529633541|FG001|Overall Study|Never Received Medication|0|||
146853140|NCT01375114|529633543|FG000|Overall Study|Lost to Follow-up|1|||
146853141|NCT01375114|529633544|FG001|Overall Study|Lost to Follow-up|0|||
146853142|NCT01375114|529633545|FG002|Overall Study|Lost to Follow-up|1|||
146853143|NCT01375114|529633543|FG000|Overall Study|Disease Progression|3|||
146853144|NCT01375114|529633544|FG001|Overall Study|Disease Progression|2|||
146853145|NCT01375114|529633545|FG002|Overall Study|Disease Progression|2|||
146853146|NCT01375114|529633543|FG000|Overall Study|Patient Changed Mind|0|||
146853147|NCT01375114|529633544|FG001|Overall Study|Patient Changed Mind|0|||
146853148|NCT01375114|529633545|FG002|Overall Study|Patient Changed Mind|2|||
146853149|NCT01375114|529633543|FG000|Overall Study|Pruritus|0|||
146515283|NCT01026818|528392543|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
146515284|NCT01026818|528392544|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
146515285|NCT01026818|528392545|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
146515286|NCT01026818|528392546|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
146515287|NCT01026818|528392543|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
146515288|NCT01026818|528392544|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
146515289|NCT01026818|528392545|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
146515290|NCT01026818|528392546|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
146515291|NCT01026818|528392543|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
146515292|NCT01026818|528392544|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
146515293|NCT01026818|528392545|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
146853150|NCT01375114|529633544|FG001|Overall Study|Pruritus|0|||
146853151|NCT01375114|529633545|FG002|Overall Study|Pruritus|1|||
146853152|NCT01375114|529633543|FG000|Overall Study|Restlessness|0|||
146965054|NCT03110107|530033444|FG018|Treatment Period|Study drug toxicity|1|||
146853153|NCT01375114|529633544|FG001|Overall Study|Restlessness|0|||
146515294|NCT01026818|528392546|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
146515295|NCT01026818|528392543|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
146515296|NCT01026818|528392544|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
146515297|NCT01026818|528392545|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
146515298|NCT01026818|528392546|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
146515299|NCT01026818|528392543|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
146515300|NCT01026818|528392544|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
146515301|NCT01026818|528392545|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
146515302|NCT01026818|528392546|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
146515303|NCT01026818|528392543|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
146515304|NCT01026818|528392544|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
146515305|NCT01026818|528392545|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
146515306|NCT01026818|528392546|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
146515307|NCT01026818|528392543|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
146515308|NCT01026818|528392544|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
146515309|NCT01026818|528392545|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
146515310|NCT01026818|528392546|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
146515311|NCT01026818|528392543|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
146515312|NCT01026818|528392544|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
146515313|NCT01026818|528392545|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
146515314|NCT01026818|528392546|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
146515315|NCT01026818|528392543|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
146515316|NCT01026818|528392544|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
146515317|NCT01026818|528392545|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
146515318|NCT01026818|528392546|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
146515319|NCT01026818|528392543|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
146515320|NCT01026818|528392544|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
146515321|NCT01026818|528392545|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
146515322|NCT01026818|528392546|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
146515323|NCT01026818|528392543|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
146515324|NCT01026818|528392544|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
146515325|NCT01026818|528392545|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
146515326|NCT01026818|528392546|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
146515327|NCT01026818|528392543|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
146515328|NCT01026818|528392544|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
146515329|NCT01026818|528392545|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
146515330|NCT01026818|528392546|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
146515331|NCT01026818|528392543|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
146515332|NCT01026818|528392544|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
146515333|NCT01026818|528392545|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
146515334|NCT01026818|528392546|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
146515335|NCT01026818|528392543|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
146515336|NCT01026818|528392544|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
146515337|NCT01026818|528392545|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
146515338|NCT01026818|528392546|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
146515339|NCT01026818|528392543|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
146515340|NCT01026818|528392544|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
146515341|NCT01026818|528392545|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
146515342|NCT01026818|528392546|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
146515343|NCT02634801|528392547|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
146515344|NCT02634801|528392548|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
146515345|NCT02634801|528392549|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
146515346|NCT02634801|528392547|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
146755559|NCT01723826|529269764|FG000|Overall Study|Protocol Violation|1|||
146755560|NCT01723826|529269765|FG001|Overall Study|Protocol Violation|1|||
146755561|NCT01723826|529269766|FG002|Overall Study|Protocol Violation|3|||
146755562|NCT01723826|529269767|FG003|Overall Study|Protocol Violation|1|||
146755563|NCT01723826|529269764|FG000|Overall Study|Withdrawal by Subject|10|||
146755564|NCT01723826|529269765|FG001|Overall Study|Withdrawal by Subject|17|||
146755565|NCT01723826|529269766|FG002|Overall Study|Withdrawal by Subject|27|||
146755566|NCT01723826|529269767|FG003|Overall Study|Withdrawal by Subject|48|||
146755567|NCT01627340|529269768|FG000|Overall Study|Adverse Event|1|||
146755568|NCT01627340|529269769|FG001|Overall Study|Adverse Event|0|||
146755569|NCT01627340|529269768|FG000|Overall Study|Lost to Follow-up|8|||
146755570|NCT01627340|529269769|FG001|Overall Study|Lost to Follow-up|4|||
146755571|NCT01627340|529269768|FG000|Overall Study|Pregnancy|1|||
146755572|NCT01627340|529269769|FG001|Overall Study|Pregnancy|0|||
146755573|NCT01627340|529269768|FG000|Overall Study|Withdrawal by Subject|2|||
146755574|NCT01627340|529269769|FG001|Overall Study|Withdrawal by Subject|0|||
146515347|NCT02634801|528392548|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
146515348|NCT02634801|528392549|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
146515349|NCT02634801|528392547|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
146515350|NCT02634801|528392548|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
146515351|NCT02634801|528392549|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
146515352|NCT02634801|528392547|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
146515353|NCT02634801|528392548|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
146515354|NCT02634801|528392549|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
146515355|NCT02634801|528392547|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
146515356|NCT02634801|528392548|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
146515357|NCT02634801|528392549|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
146515358|NCT02634801|528392547|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
146515359|NCT02634801|528392548|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
146515360|NCT02634801|528392549|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
146515361|NCT02634801|528392547|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
146515362|NCT02634801|528392548|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
146515363|NCT02634801|528392549|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
146515364|NCT02634801|528392547|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
146515365|NCT02634801|528392548|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
146515366|NCT02634801|528392549|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
146515367|NCT02634801|528392547|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
146515368|NCT02634801|528392548|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
146515369|NCT02634801|528392549|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
146515370|NCT02634801|528392547|FG000|Follow-up Period|Lost to Follow-up|3|||
146515371|NCT02634801|528392548|FG001|Follow-up Period|Lost to Follow-up|1|||
146515372|NCT02634801|528392549|FG002|Follow-up Period|Lost to Follow-up|2|||
146515373|NCT02634801|528392547|FG000|Follow-up Period|Physician Decision|0|||
146515374|NCT02634801|528392548|FG001|Follow-up Period|Physician Decision|0|||
146515375|NCT02634801|528392549|FG002|Follow-up Period|Physician Decision|1|||
146515376|NCT02634801|528392547|FG000|Follow-up Period|Withdrawal by Subject|1|||
146515377|NCT02634801|528392548|FG001|Follow-up Period|Withdrawal by Subject|2|||
146515378|NCT02634801|528392549|FG002|Follow-up Period|Withdrawal by Subject|5|||
146515379|NCT02634801|528392547|FG000|Follow-up Period|Adverse Event|1|||
146515380|NCT02634801|528392548|FG001|Follow-up Period|Adverse Event|5|||
146515381|NCT02634801|528392549|FG002|Follow-up Period|Adverse Event|0|||
146515382|NCT02335346|528392552|FG000|Overall Study|Adverse Event|11|||
146515383|NCT02335346|528392552|FG000|Overall Study|Withdrawal by Subject|1|||
146515384|NCT01548768|528392553|FG000|Overall Study|Withdrawal by Subject|0|||
146515385|NCT01548768|528392554|FG001|Overall Study|Withdrawal by Subject|2|||
146515386|NCT01548768|528392555|FG002|Overall Study|Withdrawal by Subject|1|||
146515387|NCT01548768|528392556|FG003|Overall Study|Withdrawal by Subject|0|||
146515388|NCT01548768|528392553|FG000|Overall Study|Physician Decision|1|||
146515389|NCT01548768|528392554|FG001|Overall Study|Physician Decision|0|||
146515390|NCT01548768|528392555|FG002|Overall Study|Physician Decision|0|||
146515391|NCT01548768|528392556|FG003|Overall Study|Physician Decision|0|||
146515392|NCT01548768|528392553|FG000|Overall Study|Adverse Event|0|||
146515393|NCT01548768|528392554|FG001|Overall Study|Adverse Event|0|||
146515394|NCT01548768|528392555|FG002|Overall Study|Adverse Event|0|||
146515395|NCT01548768|528392556|FG003|Overall Study|Adverse Event|1|||
146515396|NCT01548768|528392553|FG000|Overall Study|Non-Compliance|0|||
146515397|NCT01548768|528392554|FG001|Overall Study|Non-Compliance|0|||
146515398|NCT01548768|528392555|FG002|Overall Study|Non-Compliance|0|||
146515399|NCT01548768|528392556|FG003|Overall Study|Non-Compliance|3|||
146515400|NCT02907619|528392557|FG000|Overall Study|Study terminated by sponsor|18|||
146515401|NCT02907619|528392558|FG001|Overall Study|Study terminated by sponsor|18|||
146515402|NCT02907619|528392559|FG002|Overall Study|Study terminated by sponsor|19|||
146515403|NCT02907619|528392557|FG000|Overall Study|Death|0|||
146515404|NCT02907619|528392558|FG001|Overall Study|Death|0|||
146515405|NCT02907619|528392559|FG002|Overall Study|Death|1|||
146515406|NCT02907619|528392557|FG000|Overall Study|Withdrawal by Subject|1|||
146515407|NCT02907619|528392558|FG001|Overall Study|Withdrawal by Subject|1|||
146515408|NCT02907619|528392559|FG002|Overall Study|Withdrawal by Subject|0|||
146515409|NCT02907619|528392557|FG000|Overall Study|Other|0|||
146515410|NCT02907619|528392558|FG001|Overall Study|Other|1|||
146515411|NCT02907619|528392559|FG002|Overall Study|Other|0|||
146515412|NCT01375374|528392560|FG000|Overall Study|Adverse Event|1|||
146515413|NCT01908582|528392561|FG000|Period 2|Physician Decision|1|||
146515414|NCT01908582|528392561|FG000|Period 2|Withdrawal by Subject|1|||
146515415|NCT03594955|528392562|FG000|Overall Study|Adverse Event|1|||
146515416|NCT03594955|528392562|FG000|Overall Study|Progressive disease|5|||
146515417|NCT03594955|528392562|FG000|Overall Study|Sponsor's decision|1|||
146515418|NCT02065518|528392564|FG000|Overall Study|Lost to Follow-up|3|||
146515419|NCT02065518|528392565|FG001|Overall Study|Lost to Follow-up|4|||
146515420|NCT02065518|528392566|FG002|Overall Study|Lost to Follow-up|0|||
146515421|NCT02065518|528392567|FG003|Overall Study|Lost to Follow-up|3|||
146515422|NCT02065518|528392564|FG000|Overall Study|Withdrawal by Subject|3|||
146515423|NCT02065518|528392565|FG001|Overall Study|Withdrawal by Subject|4|||
146515424|NCT02065518|528392566|FG002|Overall Study|Withdrawal by Subject|9|||
146515425|NCT02065518|528392567|FG003|Overall Study|Withdrawal by Subject|2|||
146515426|NCT00564278|528392569|FG000|Overall Study|Lost to Follow-up|35|||
146515427|NCT00564278|528392570|FG001|Overall Study|Lost to Follow-up|33|||
146515428|NCT00564278|528392569|FG000|Overall Study|Physician Decision|1|||
146515429|NCT00564278|528392570|FG001|Overall Study|Physician Decision|2|||
146515430|NCT00564278|528392569|FG000|Overall Study|Withdrawal by Subject|11|||
146515431|NCT00564278|528392570|FG001|Overall Study|Withdrawal by Subject|7|||
146515432|NCT00560703|528392571|FG000|Overall Study|Adverse Event|0|||
146515433|NCT00560703|528392572|FG001|Overall Study|Adverse Event|2|||
146515434|NCT00560703|528392571|FG000|Overall Study|Protocol Violation|0|||
146515435|NCT00560703|528392572|FG001|Overall Study|Protocol Violation|2|||
146515436|NCT00560703|528392571|FG000|Overall Study|Withdrawal by Subject|0|||
146515437|NCT00560703|528392572|FG001|Overall Study|Withdrawal by Subject|1|||
146515438|NCT00560703|528392571|FG000|Overall Study|non-compliance|0|||
146515439|NCT00560703|528392572|FG001|Overall Study|non-compliance|1|||
146515440|NCT06439095|528392573|FG000|Overall Study|Lost to Follow-up|2|||
146515441|NCT03484403|528392575|FG000|Overall Study|Withdrawal by Subject|6|||
146515442|NCT03484403|528392576|FG001|Overall Study|Withdrawal by Subject|4|||
146515443|NCT04847232|528392577|FG000|Overall Study|Death|123|||
146515444|NCT04847232|528392578|FG001|Overall Study|Death|115|||
146515445|NCT04847232|528392577|FG000|Overall Study|Lost to Follow-up|3|||
146515446|NCT04847232|528392578|FG001|Overall Study|Lost to Follow-up|10|||
146515447|NCT04847232|528392577|FG000|Overall Study|Withdrawal by Subject|73|||
146515448|NCT04847232|528392578|FG001|Overall Study|Withdrawal by Subject|101|||
146515449|NCT04847232|528392577|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
146515450|NCT04847232|528392578|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
146515451|NCT02476916|528392583|FG000|Core Period|Adverse Event|2|||
146515452|NCT02476916|528392584|FG001|Core Period|Adverse Event|2|||
146515453|NCT02476916|528392583|FG000|Core Period|Investigator decision|1|||
146515454|NCT02476916|528392584|FG001|Core Period|Investigator decision|1|||
146515455|NCT02476916|528392583|FG000|Core Period|Withdrawal by Subject|3|||
146515456|NCT02476916|528392584|FG001|Core Period|Withdrawal by Subject|0|||
146515457|NCT02476916|528392583|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
146515458|NCT02476916|528392584|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
146515459|NCT02476916|528392583|FG000|Extension Period|On Treatment|12|||
146515460|NCT02476916|528392584|FG001|Extension Period|On Treatment|17|||
146515461|NCT03332095|528392585|FG000|Overall Study|Lost to Follow-up|1|||
146515462|NCT03332095|528392586|FG001|Overall Study|Lost to Follow-up|0|||
146515463|NCT03332095|528392585|FG000|Overall Study|Pregnancy|0|||
146515464|NCT03332095|528392586|FG001|Overall Study|Pregnancy|1|||
146515465|NCT02570750|528392592|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
146515466|NCT02570750|528392593|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
146515467|NCT02570750|528392592|FG000|Overall Study|Protocol deviation|4|||
146515468|NCT02570750|528392593|FG001|Overall Study|Protocol deviation|2|||
146515469|NCT02570750|528392592|FG000|Overall Study|Withdrawal by Subject|5|||
146515470|NCT02570750|528392593|FG001|Overall Study|Withdrawal by Subject|0|||
146515471|NCT02570750|528392592|FG000|Overall Study|Lost to Follow-up|2|||
146515472|NCT02570750|528392593|FG001|Overall Study|Lost to Follow-up|2|||
146515473|NCT02570750|528392592|FG000|Overall Study|Adverse Event|2|||
146515474|NCT02570750|528392593|FG001|Overall Study|Adverse Event|1|||
146853154|NCT01375114|529633545|FG002|Overall Study|Restlessness|1|||
146853155|NCT01375114|529633543|FG000|Overall Study|Diarrhea|0|||
146853156|NCT01375114|529633544|FG001|Overall Study|Diarrhea|0|||
146853157|NCT01375114|529633545|FG002|Overall Study|Diarrhea|1|||
146853158|NCT01375114|529633543|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
146853159|NCT01375114|529633544|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
146853160|NCT01375114|529633545|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
146853161|NCT01375114|529633543|FG000|Overall Study|Nausea|0|||
146853162|NCT01375114|529633544|FG001|Overall Study|Nausea|1|||
146853163|NCT01375114|529633545|FG002|Overall Study|Nausea|0|||
146853164|NCT01375114|529633543|FG000|Overall Study|Increased AST/ALT|0|||
146515475|NCT01410240|528392594|FG000|Overall Study|Physician Decision|0|||
146515476|NCT01410240|528392595|FG001|Overall Study|Physician Decision|0|||
146515477|NCT01410240|528392596|FG002|Overall Study|Physician Decision|1|||
146515478|NCT01410240|528392594|FG000|Overall Study|Missed week 6 assessments|1|||
146515479|NCT01410240|528392595|FG001|Overall Study|Missed week 6 assessments|1|||
146853165|NCT01375114|529633544|FG001|Overall Study|Increased AST/ALT|1|||
146515480|NCT01410240|528392596|FG002|Overall Study|Missed week 6 assessments|1|||
146515481|NCT04348500|528392597|FG000|Overall Study|Death|2|||
146515482|NCT04348500|528392598|FG001|Overall Study|Death|2|||
146515483|NCT04348500|528392597|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
146515484|NCT04348500|528392598|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
146853166|NCT01375114|529633545|FG002|Overall Study|Increased AST/ALT|0|||
146853167|NCT01375114|529633543|FG000|Overall Study|Vaginal Hemorrhage|0|||
146853168|NCT01375114|529633544|FG001|Overall Study|Vaginal Hemorrhage|1|||
146853169|NCT01375114|529633545|FG002|Overall Study|Vaginal Hemorrhage|0|||
146853170|NCT01375114|529633543|FG000|Overall Study|Family problem|0|||
146853171|NCT01375114|529633544|FG001|Overall Study|Family problem|1|||
146853172|NCT01375114|529633545|FG002|Overall Study|Family problem|0|||
146853173|NCT01375114|529633543|FG000|Overall Study|Protocol Violation|2|||
146853174|NCT01375114|529633544|FG001|Overall Study|Protocol Violation|0|||
146853175|NCT01375114|529633545|FG002|Overall Study|Protocol Violation|0|||
146853176|NCT01888900|529633546|FG000|Overall Study|failed treatment|0|||
146853177|NCT01888900|529633547|FG001|Overall Study|failed treatment|2|||
146853178|NCT00523640|529633550|FG000|Overall Study|Death|1|||
146853179|NCT02334423|529633551|FG000|Overall Study|Protocol Violation|10|||
146853180|NCT02334423|529633552|FG001|Overall Study|Protocol Violation|3|||
146853181|NCT02930226|529633553|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
146853182|NCT02930226|529633554|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
146853183|NCT02930226|529633555|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
146853184|NCT02930226|529633556|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
146853185|NCT02930226|529633557|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
146853186|NCT02930226|529633558|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
146853187|NCT00652327|529633559|FG000|Overall Study|Adverse Event|0|||
146853188|NCT00652327|529633560|FG001|Overall Study|Adverse Event|2|||
146853189|NCT00652327|529633559|FG000|Overall Study|Lost to Follow-up|0|||
146853190|NCT00652327|529633560|FG001|Overall Study|Lost to Follow-up|3|||
146853191|NCT01076647|529633561|FG000|Overall Study|Adverse Event|4|||
146853192|NCT01076647|529633562|FG001|Overall Study|Adverse Event|1|||
146853193|NCT01076647|529633561|FG000|Overall Study|Lack of Efficacy|0|||
146853194|NCT01076647|529633562|FG001|Overall Study|Lack of Efficacy|1|||
146853195|NCT01076647|529633561|FG000|Overall Study|Protocol Violation|7|||
146853196|NCT01076647|529633562|FG001|Overall Study|Protocol Violation|9|||
146853197|NCT01076647|529633561|FG000|Overall Study|Withdrawal criteria|2|||
146853198|NCT01076647|529633562|FG001|Overall Study|Withdrawal criteria|2|||
146853199|NCT01076647|529633561|FG000|Overall Study|Unclassified|12|||
146853200|NCT01076647|529633562|FG001|Overall Study|Unclassified|12|||
146853201|NCT01065844|529633566|FG000|Overall Study|Adverse Event|5|||
146853202|NCT02224690|529633567|FG000|Overall Study|Adverse Event|8|||
146853203|NCT02224690|529633568|FG001|Overall Study|Adverse Event|1|||
146853204|NCT02224690|529633567|FG000|Overall Study|Met Withdrawal Criteria|4|||
146853205|NCT02224690|529633568|FG001|Overall Study|Met Withdrawal Criteria|0|||
146853206|NCT02224690|529633567|FG000|Overall Study|Use of G-tube|1|||
146853207|NCT02224690|529633568|FG001|Overall Study|Use of G-tube|0|||
146853208|NCT02224690|529633567|FG000|Overall Study|Did not meet eligibility criteria|1|||
146853209|NCT02224690|529633568|FG001|Overall Study|Did not meet eligibility criteria|0|||
146515485|NCT02776670|528392599|FG000|Overall Study|Adverse Event|0|||
146515486|NCT02776670|528392600|FG001|Overall Study|Adverse Event|2|||
146515487|NCT02776670|528392599|FG000|Overall Study|Protocol Violation|0|||
146515488|NCT02776670|528392600|FG001|Overall Study|Protocol Violation|2|||
146515489|NCT02776670|528392599|FG000|Overall Study|Withdrawal by Subject|0|||
146515490|NCT02776670|528392600|FG001|Overall Study|Withdrawal by Subject|1|||
146515491|NCT02776670|528392599|FG000|Overall Study|Other - Reason not given|0|||
146515492|NCT02776670|528392600|FG001|Overall Study|Other - Reason not given|1|||
146515493|NCT03699540|528392601|FG000|Overall Study|Lost to Follow-up|1|||
146515494|NCT02636699|528392604|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
146515495|NCT02636699|528392605|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
146515496|NCT02636699|528392606|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
146515497|NCT02636699|528392604|FG000|Screening Period|Withdrawal by Subject|0|||
146515498|NCT02636699|528392605|FG001|Screening Period|Withdrawal by Subject|0|||
146515499|NCT02636699|528392606|FG002|Screening Period|Withdrawal by Subject|23|||
146515500|NCT02636699|528392604|FG000|Screening Period|Adverse Event|0|||
146515501|NCT02636699|528392605|FG001|Screening Period|Adverse Event|0|||
146515502|NCT02636699|528392606|FG002|Screening Period|Adverse Event|1|||
146515503|NCT02636699|528392604|FG000|Screening Period|Other not specified|0|||
146515504|NCT02636699|528392605|FG001|Screening Period|Other not specified|0|||
146515505|NCT02636699|528392606|FG002|Screening Period|Other not specified|3|||
146515506|NCT02636699|528392604|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
146515507|NCT02636699|528392605|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
146515508|NCT02636699|528392606|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
146515509|NCT02636699|528392604|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
146515510|NCT02636699|528392605|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
146515511|NCT02636699|528392606|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
146515512|NCT02636699|528392604|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
146515513|NCT02636699|528392605|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
146515514|NCT02636699|528392606|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
146515515|NCT02636699|528392604|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
146515516|NCT02636699|528392605|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
146515517|NCT02636699|528392606|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
146515518|NCT02636699|528392604|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
146515519|NCT02636699|528392605|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
146515520|NCT02636699|528392606|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
146755575|NCT03633903|529269772|FG000|Overall Study|Withdrawal by Subject|1|||
146755576|NCT03633903|529269773|FG001|Overall Study|Withdrawal by Subject|2|||
146755577|NCT03633903|529269772|FG000|Overall Study|Lost to Follow-up|5|||
146755578|NCT03633903|529269773|FG001|Overall Study|Lost to Follow-up|5|||
146755579|NCT02687919|529269784|FG000|Overall Study|Withdrawal by Subject|6|||
146755580|NCT02687919|529269785|FG001|Overall Study|Withdrawal by Subject|6|||
146755581|NCT02687919|529269784|FG000|Overall Study|Protocol Violation|2|||
146755582|NCT02687919|529269785|FG001|Overall Study|Protocol Violation|0|||
146755583|NCT00419003|529269786|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
146755584|NCT00419003|529269787|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
146755585|NCT00419003|529269786|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
146755586|NCT00419003|529269787|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
146755587|NCT01653847|529269788|FG000|Overall Study|Withdrawal by Subject|1|||
146755588|NCT01653847|529269789|FG001|Overall Study|Withdrawal by Subject|0|||
146755589|NCT00131911|529269790|FG000|Overall Study|Withdrawal by Subject|1|||
146755590|NCT00131911|529269791|FG001|Overall Study|Withdrawal by Subject|0|||
146755591|NCT02554513|529269792|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
146755592|NCT02554513|529269793|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
146755593|NCT01606189|529269796|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
146755594|NCT01606189|529269797|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
146755595|NCT01606189|529269798|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
146755596|NCT01606189|529269799|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
146755597|NCT01606189|529269800|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
146755598|NCT01606189|529269801|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
146755599|NCT01606189|529269796|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
146755600|NCT01606189|529269797|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
146755601|NCT01606189|529269798|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
146755602|NCT01606189|529269799|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
146755603|NCT01606189|529269800|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
146755604|NCT01606189|529269801|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
146755605|NCT01354938|529269802|FG000|Overall Study|Lost to Follow-up|1|||
146755606|NCT01167023|529269803|FG000|Overall Study|Lost to Follow-up|0|||
146515521|NCT02636699|528392604|FG000|Treatment and Follow-up Periods|Other|3|||
146755607|NCT01167023|529269804|FG001|Overall Study|Lost to Follow-up|1|||
146755608|NCT01167023|529269805|FG002|Overall Study|Lost to Follow-up|1|||
146515522|NCT02636699|528392605|FG001|Treatment and Follow-up Periods|Other|1|||
146515523|NCT02636699|528392606|FG002|Treatment and Follow-up Periods|Other|0|||
146515524|NCT00624832|528392607|FG000|Overall Study|Adverse Event|0|||
146515525|NCT00624832|528392608|FG001|Overall Study|Adverse Event|1|||
146515526|NCT00624832|528392609|FG002|Overall Study|Adverse Event|0|||
146515527|NCT00624832|528392610|FG003|Overall Study|Adverse Event|1|||
146515528|NCT00624832|528392607|FG000|Overall Study|Abnormal Laboratory Value|2|||
146515529|NCT00624832|528392608|FG001|Overall Study|Abnormal Laboratory Value|0|||
146515530|NCT00624832|528392609|FG002|Overall Study|Abnormal Laboratory Value|0|||
146515531|NCT00624832|528392610|FG003|Overall Study|Abnormal Laboratory Value|0|||
146515532|NCT03003000|528392617|FG000|Overall Study|Adverse Event|1|||
146515533|NCT03003000|528392618|FG001|Overall Study|Adverse Event|2|||
146515534|NCT03003000|528392619|FG002|Overall Study|Adverse Event|3|||
146515535|NCT03003000|528392617|FG000|Overall Study|Lack of Efficacy|1|||
146515536|NCT03003000|528392618|FG001|Overall Study|Lack of Efficacy|0|||
146515537|NCT03003000|528392619|FG002|Overall Study|Lack of Efficacy|0|||
146515538|NCT03003000|528392617|FG000|Overall Study|Non-compliant with protocol|0|||
146515539|NCT03003000|528392618|FG001|Overall Study|Non-compliant with protocol|1|||
146515540|NCT03003000|528392619|FG002|Overall Study|Non-compliant with protocol|1|||
146515541|NCT03003000|528392617|FG000|Overall Study|Refused to continue medication|2|||
146515542|NCT03003000|528392618|FG001|Overall Study|Refused to continue medication|0|||
146515543|NCT03003000|528392619|FG002|Overall Study|Refused to continue medication|0|||
146755609|NCT01167023|529269803|FG000|Overall Study|Screen Failure|0|||
146755610|NCT01167023|529269804|FG001|Overall Study|Screen Failure|1|||
146755611|NCT01167023|529269805|FG002|Overall Study|Screen Failure|0|||
146755612|NCT01167023|529269803|FG000|Overall Study|Sponsor Decision|0|||
146755613|NCT01167023|529269804|FG001|Overall Study|Sponsor Decision|1|||
146755614|NCT01167023|529269805|FG002|Overall Study|Sponsor Decision|0|||
146755615|NCT01167023|529269803|FG000|Overall Study|Withdrawal by Subject|0|||
146755616|NCT01167023|529269804|FG001|Overall Study|Withdrawal by Subject|0|||
146755617|NCT01167023|529269805|FG002|Overall Study|Withdrawal by Subject|1|||
146755618|NCT03658811|529269820|FG000|Overall Study|Lost to Follow-up|3|||
146755619|NCT03803774|529269822|FG000|Dose Escalation|Withdrawal by Subject|0|||
146755620|NCT03803774|529269823|FG001|Dose Escalation|Withdrawal by Subject|0|||
146755621|NCT03803774|529269824|FG002|Dose Escalation|Withdrawal by Subject|0|||
146755622|NCT03803774|529269825|FG003|Dose Escalation|Withdrawal by Subject|1|||
146755623|NCT03803774|529269826|FG004|Dose Escalation|Withdrawal by Subject|0|||
146755624|NCT06403605|529269829|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
146755625|NCT06403605|529269830|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
146755626|NCT06403605|529269829|FG000|Follow-up|Adverse Event|4|||
146755627|NCT06403605|529269830|FG001|Follow-up|Adverse Event|2|||
146755628|NCT06403605|529269829|FG000|Follow-up|Withdrawal by Subject|2|||
146755629|NCT06403605|529269830|FG001|Follow-up|Withdrawal by Subject|3|||
146755630|NCT06403605|529269829|FG000|Follow-up|Lost to Follow-up|1|||
146755631|NCT06403605|529269830|FG001|Follow-up|Lost to Follow-up|0|||
146755632|NCT06403605|529269829|FG000|Follow-up|Death|1|||
146755633|NCT06403605|529269830|FG001|Follow-up|Death|0|||
146755634|NCT06403605|529269829|FG000|Follow-up|Other reasons|0|||
146755635|NCT06403605|529269830|FG001|Follow-up|Other reasons|4|||
146755636|NCT00394095|529271169|FG000|Screening|Withdrawal by Subject|1|||
146755637|NCT00394095|529271170|FG001|Screening|Withdrawal by Subject|0|||
146755638|NCT00394095|529271169|FG000|Randomized|Withdrawal by Subject|5|||
146755639|NCT00394095|529271170|FG001|Randomized|Withdrawal by Subject|1|||
146755640|NCT00394095|529271169|FG000|Randomized|Adverse Event|1|||
146755641|NCT00394095|529271170|FG001|Randomized|Adverse Event|1|||
146755642|NCT00394095|529271169|FG000|Randomized|Overdose|1|||
146755643|NCT00394095|529271170|FG001|Randomized|Overdose|0|||
146755644|NCT00394095|529271169|FG000|Randomized|Lost to Follow-up|1|||
146755645|NCT00394095|529271170|FG001|Randomized|Lost to Follow-up|2|||
146755646|NCT01256476|529271172|FG000|Overall Study|Adverse Event|2|||
146755647|NCT01256476|529271173|FG001|Overall Study|Adverse Event|1|||
146755648|NCT01256476|529271172|FG000|Overall Study|Withdrawal by Subject|2|||
146515544|NCT03003000|528392617|FG000|Overall Study|Other than listed|1|||
146515545|NCT03003000|528392618|FG001|Overall Study|Other than listed|1|||
146515546|NCT03003000|528392619|FG002|Overall Study|Other than listed|1|||
146515547|NCT04933617|528392620|FG000|Dose Escalation|Early closure of study|0|||
146515548|NCT04933617|528392621|FG001|Dose Escalation|Early closure of study|3|||
146755649|NCT01256476|529271173|FG001|Overall Study|Withdrawal by Subject|1|||
146515549|NCT04933617|528392622|FG002|Dose Escalation|Early closure of study|0|||
146755650|NCT01256476|529271172|FG000|Overall Study|Lost to Follow-up|1|||
146755651|NCT01256476|529271173|FG001|Overall Study|Lost to Follow-up|2|||
146755652|NCT01256476|529271172|FG000|Overall Study|Persistent ALT or AST elevation|1|||
146755653|NCT01256476|529271173|FG001|Overall Study|Persistent ALT or AST elevation|0|||
146755654|NCT01256476|529271172|FG000|Overall Study|Physician Decision|0|||
146515550|NCT04933617|528392623|FG003|Dose Escalation|Early closure of study|0|||
146515551|NCT04933617|528392624|FG004|Dose Escalation|Early closure of study|0|||
146755655|NCT01256476|529271173|FG001|Overall Study|Physician Decision|1|||
146755656|NCT01256476|529271172|FG000|Overall Study|Subject non-compliance|0|||
146755657|NCT01256476|529271173|FG001|Overall Study|Subject non-compliance|1|||
146853210|NCT01577745|529633569|FG000|Overall Study|Withdrawal by Subject|0|||
146853211|NCT01577745|529633570|FG001|Overall Study|Withdrawal by Subject|1|||
146853212|NCT01577745|529633571|FG002|Overall Study|Withdrawal by Subject|0|||
146853213|NCT01577745|529633572|FG003|Overall Study|Withdrawal by Subject|3|||
146853214|NCT01577745|529633573|FG004|Overall Study|Withdrawal by Subject|2|||
146853215|NCT01577745|529633574|FG005|Overall Study|Withdrawal by Subject|0|||
146853216|NCT01577745|529633569|FG000|Overall Study|Death|3|||
146853217|NCT01577745|529633570|FG001|Overall Study|Death|2|||
146853218|NCT01577745|529633571|FG002|Overall Study|Death|2|||
146853219|NCT01577745|529633572|FG003|Overall Study|Death|1|||
146853220|NCT01577745|529633573|FG004|Overall Study|Death|1|||
146853221|NCT01577745|529633574|FG005|Overall Study|Death|3|||
146853222|NCT01577745|529633569|FG000|Overall Study|Physician Decision|0|||
146853223|NCT01577745|529633570|FG001|Overall Study|Physician Decision|0|||
146853224|NCT01577745|529633571|FG002|Overall Study|Physician Decision|0|||
146853225|NCT01577745|529633572|FG003|Overall Study|Physician Decision|1|||
146853226|NCT01577745|529633573|FG004|Overall Study|Physician Decision|1|||
146853227|NCT01577745|529633574|FG005|Overall Study|Physician Decision|0|||
146853228|NCT01577745|529633569|FG000|Overall Study|Lost to Follow-up|0|||
146853229|NCT01577745|529633570|FG001|Overall Study|Lost to Follow-up|0|||
146853230|NCT01577745|529633571|FG002|Overall Study|Lost to Follow-up|0|||
146853231|NCT01577745|529633572|FG003|Overall Study|Lost to Follow-up|0|||
146853232|NCT01577745|529633573|FG004|Overall Study|Lost to Follow-up|0|||
146853233|NCT01577745|529633574|FG005|Overall Study|Lost to Follow-up|1|||
146853234|NCT01577745|529633569|FG000|Overall Study|Alternative Therapy|0|||
146853235|NCT01577745|529633570|FG001|Overall Study|Alternative Therapy|0|||
146853236|NCT01577745|529633571|FG002|Overall Study|Alternative Therapy|0|||
146853237|NCT01577745|529633572|FG003|Overall Study|Alternative Therapy|1|||
146853238|NCT01577745|529633573|FG004|Overall Study|Alternative Therapy|1|||
146853239|NCT01577745|529633574|FG005|Overall Study|Alternative Therapy|0|||
146853240|NCT00122460|529633575|FG000|Overall Study|investigational study phase ongoing|7|||
146853241|NCT00122460|529633576|FG001|Overall Study|investigational study phase ongoing|1|||
146853242|NCT00825916|529633577|FG000|Overall Study|Lost to Follow-up|4|||
146853243|NCT00825916|529633578|FG001|Overall Study|Lost to Follow-up|2|||
146853244|NCT00825916|529633579|FG002|Overall Study|Lost to Follow-up|1|||
146853245|NCT02962960|529633580|FG000|Overall Study|Withdrawal by Subject|1|||
146853246|NCT02962960|529633581|FG001|Overall Study|Withdrawal by Subject|1|||
146515552|NCT01964716|528392632|FG000|Overall Study|Withdrawal by Subject|2|||
146515553|NCT01964716|528392633|FG001|Overall Study|Withdrawal by Subject|3|||
146515554|NCT01964716|528392632|FG000|Overall Study|Lost to Follow-up|1|||
146515555|NCT01964716|528392633|FG001|Overall Study|Lost to Follow-up|2|||
146515556|NCT01964716|528392632|FG000|Overall Study|No longer met eligibility criteria|1|||
146515557|NCT01964716|528392633|FG001|Overall Study|No longer met eligibility criteria|1|||
146515558|NCT01964716|528392632|FG000|Overall Study|Death|1|||
146515559|NCT01964716|528392633|FG001|Overall Study|Death|0|||
146515560|NCT03913104|528392638|FG000|Overall Study|Lost to Follow-up|20|||
146515561|NCT03913104|528392638|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
146515562|NCT03913104|528392638|FG000|Overall Study|Withdrawal by Subject|2|||
146853247|NCT02962960|529633582|FG002|Overall Study|Withdrawal by Subject|0|||
146853248|NCT02962960|529633580|FG000|Overall Study|Adverse Event|1|||
146853249|NCT02962960|529633581|FG001|Overall Study|Adverse Event|1|||
146515563|NCT01119846|528392639|FG000|Overall Study|Adverse Event|1|||
146515564|NCT01119846|528392640|FG001|Overall Study|Adverse Event|0|||
146515565|NCT01119846|528392641|FG002|Overall Study|Adverse Event|6|||
146515566|NCT01119846|528392639|FG000|Overall Study|Physician Decision|1|||
146515567|NCT01119846|528392640|FG001|Overall Study|Physician Decision|0|||
146515568|NCT01119846|528392641|FG002|Overall Study|Physician Decision|0|||
146515569|NCT01119846|528392639|FG000|Overall Study|Protocol Violation|0|||
146515570|NCT01119846|528392640|FG001|Overall Study|Protocol Violation|0|||
146515571|NCT01119846|528392641|FG002|Overall Study|Protocol Violation|1|||
146515572|NCT01119846|528392639|FG000|Overall Study|Withdrawal by Subject|0|||
146515573|NCT01119846|528392640|FG001|Overall Study|Withdrawal by Subject|0|||
146515574|NCT01119846|528392641|FG002|Overall Study|Withdrawal by Subject|4|||
146515575|NCT01490697|528392645|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
146515576|NCT01490697|528392646|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
146515577|NCT00379808|528392647|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
146515578|NCT00379808|528392648|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
146515579|NCT01048099|528392656|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
146515580|NCT01048099|528392656|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
146515581|NCT01731470|528392658|FG000|Overall Study|Withdrawal by Subject|1|||
146515582|NCT01731470|528392658|FG000|Overall Study|Did not meet study criteria|1|||
146515583|NCT00358956|528392663|FG000|Overall Study|Adverse Event|3|||
146515584|NCT00358956|528392663|FG000|Overall Study|condition under investigation worsened|4|||
146515585|NCT00358956|528392663|FG000|Overall Study|Withdrawal by Subject|1|||
146515586|NCT03611582|528392664|FG000|Overall Study|Adverse Event|26|||
146515587|NCT03611582|528392665|FG001|Overall Study|Adverse Event|6|||
146515588|NCT03611582|528392664|FG000|Overall Study|Protocol Violation|0|||
146515589|NCT03611582|528392665|FG001|Overall Study|Protocol Violation|1|||
146515590|NCT03611582|528392664|FG000|Overall Study|Pregnancy|1|||
146515591|NCT03611582|528392665|FG001|Overall Study|Pregnancy|2|||
146515592|NCT03611582|528392664|FG000|Overall Study|Lack of Efficacy|0|||
146515593|NCT03611582|528392665|FG001|Overall Study|Lack of Efficacy|1|||
146515594|NCT03611582|528392664|FG000|Overall Study|At the discretion of the investigator|1|||
146515595|NCT03611582|528392665|FG001|Overall Study|At the discretion of the investigator|0|||
146515596|NCT03611582|528392664|FG000|Overall Study|Safety concern as judged by the investigator|1|||
146515597|NCT03611582|528392665|FG001|Overall Study|Safety concern as judged by the investigator|2|||
146515598|NCT03611582|528392664|FG000|Overall Study|Withdrawal by Subject|4|||
146515599|NCT03611582|528392665|FG001|Overall Study|Withdrawal by Subject|3|||
146515600|NCT03611582|528392664|FG000|Overall Study|Lost to Follow-up|18|||
146515601|NCT03611582|528392665|FG001|Overall Study|Lost to Follow-up|7|||
146515602|NCT03611582|528392664|FG000|Overall Study|other|17|||
146515603|NCT03611582|528392665|FG001|Overall Study|other|16|||
146515604|NCT00422292|528392666|FG000|Overall Study|Serious adverse events|1|||
146515605|NCT00422292|528392667|FG001|Overall Study|Serious adverse events|4|||
146515606|NCT00422292|528392668|FG002|Overall Study|Serious adverse events|0|||
146515607|NCT00422292|528392669|FG003|Overall Study|Serious adverse events|0|||
146515608|NCT00422292|528392666|FG000|Overall Study|Adverse Event|1|||
146515609|NCT00422292|528392667|FG001|Overall Study|Adverse Event|0|||
146515610|NCT00422292|528392668|FG002|Overall Study|Adverse Event|1|||
146515611|NCT00422292|528392669|FG003|Overall Study|Adverse Event|0|||
146515612|NCT00422292|528392666|FG000|Overall Study|Protocol Violation|4|||
146515613|NCT00422292|528392667|FG001|Overall Study|Protocol Violation|25|||
146515614|NCT00422292|528392668|FG002|Overall Study|Protocol Violation|8|||
146515615|NCT00422292|528392669|FG003|Overall Study|Protocol Violation|5|||
146515616|NCT00422292|528392666|FG000|Overall Study|Lost to Follow-up|6|||
146853250|NCT02962960|529633582|FG002|Overall Study|Adverse Event|0|||
146853251|NCT02962960|529633580|FG000|Overall Study|Protocol Violation|1|||
146515617|NCT00422292|528392667|FG001|Overall Study|Lost to Follow-up|12|||
146853252|NCT02962960|529633581|FG001|Overall Study|Protocol Violation|0|||
146853253|NCT02962960|529633582|FG002|Overall Study|Protocol Violation|0|||
146853254|NCT02344004|529633588|FG000|Overall Study|Adverse Event|11|||
146755658|NCT01256476|529271172|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
146755659|NCT01256476|529271173|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
146755660|NCT02401529|529271176|FG000|Overall Study|Lost to Follow-up|2|||
146755661|NCT02401529|529271177|FG001|Overall Study|Lost to Follow-up|1|||
146755662|NCT02401529|529271176|FG000|Overall Study|Physician Decision|2|||
146755663|NCT02401529|529271177|FG001|Overall Study|Physician Decision|6|||
146755664|NCT02401529|529271176|FG000|Overall Study|Protocol Violation|5|||
146755665|NCT02401529|529271177|FG001|Overall Study|Protocol Violation|0|||
146755666|NCT00924664|529271180|FG000|Overall Study|Adverse Event|23|||
146755667|NCT00924664|529271181|FG001|Overall Study|Adverse Event|39|||
146755668|NCT00924664|529271180|FG000|Overall Study|Lack of Efficacy|10|||
146755669|NCT00924664|529271181|FG001|Overall Study|Lack of Efficacy|15|||
146755670|NCT00924664|529271180|FG000|Overall Study|Lost to Follow-up|10|||
146755671|NCT00924664|529271181|FG001|Overall Study|Lost to Follow-up|12|||
146755672|NCT00924664|529271180|FG000|Overall Study|Withdrawal by Subject|47|||
146755673|NCT00924664|529271181|FG001|Overall Study|Withdrawal by Subject|71|||
146755674|NCT00924664|529271180|FG000|Overall Study|Protocol Violation|2|||
146755675|NCT00924664|529271181|FG001|Overall Study|Protocol Violation|5|||
146755676|NCT00924664|529271180|FG000|Overall Study|Pregnancy|1|||
146755677|NCT00924664|529271181|FG001|Overall Study|Pregnancy|1|||
146755678|NCT00924664|529271180|FG000|Overall Study|Death|0|||
146755679|NCT00924664|529271181|FG001|Overall Study|Death|2|||
146755680|NCT00924664|529271180|FG000|Overall Study|Study terminated by sponsor|199|||
146755681|NCT00924664|529271181|FG001|Overall Study|Study terminated by sponsor|330|||
146755682|NCT00924664|529271180|FG000|Overall Study|Other|29|||
146755683|NCT00924664|529271181|FG001|Overall Study|Other|52|||
146755684|NCT00924664|529271180|FG000|Overall Study|Randomized but not Treated|1|||
146755685|NCT00924664|529271181|FG001|Overall Study|Randomized but not Treated|0|||
146755686|NCT01598987|529271182|FG000|Baseline to Month 12|Administrative problems|2|||
146755687|NCT01598987|529271182|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
146755688|NCT01598987|529271182|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
146755689|NCT01598987|529271182|FG000|Baseline to 24 Month|Administrative problems|2|||
146755690|NCT01598987|529271182|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
146755691|NCT01450943|529271184|FG000|Overall Study|Screen failure, loss to follow-up|2|||
146755692|NCT01450943|529271185|FG001|Overall Study|Screen failure, loss to follow-up|7|||
146755693|NCT01450943|529271186|FG002|Overall Study|Screen failure, loss to follow-up|6|||
146755694|NCT03303105|529271189|FG000|Overall Study|Adverse Event|0|||
146755695|NCT03303105|529271190|FG001|Overall Study|Adverse Event|2|||
146755696|NCT03303105|529271189|FG000|Overall Study|Lack of Efficacy|1|||
146755697|NCT03303105|529271190|FG001|Overall Study|Lack of Efficacy|0|||
146755698|NCT03303105|529271189|FG000|Overall Study|Protocol Violation|1|||
146755699|NCT03303105|529271190|FG001|Overall Study|Protocol Violation|0|||
146853255|NCT02344004|529633589|FG001|Overall Study|Adverse Event|1|||
146853256|NCT02344004|529633588|FG000|Overall Study|Death|9|||
146755700|NCT03303105|529271189|FG000|Overall Study|Withdrawal by Subject|0|||
146755701|NCT03303105|529271190|FG001|Overall Study|Withdrawal by Subject|2|||
146755702|NCT04822298|529271193|FG000|Overall Study|Death|3|||
146755703|NCT01333943|529271197|FG000|Overall Study|Known neuropathy|1|||
146755704|NCT01333943|529271198|FG001|Overall Study|Known neuropathy|0|||
146755705|NCT01789203|529271199|FG000|Overall Study|Adverse Event|2|||
146515618|NCT00422292|528392668|FG002|Overall Study|Lost to Follow-up|6|||
146515619|NCT00422292|528392669|FG003|Overall Study|Lost to Follow-up|6|||
146515620|NCT00422292|528392666|FG000|Overall Study|Withdrawal by Subject|6|||
146515621|NCT00422292|528392667|FG001|Overall Study|Withdrawal by Subject|25|||
146515622|NCT00422292|528392668|FG002|Overall Study|Withdrawal by Subject|7|||
146515623|NCT00422292|528392669|FG003|Overall Study|Withdrawal by Subject|13|||
146515624|NCT02440854|528392670|FG000|Overall Study|Relocation of patient|1|||
146515625|NCT02440854|528392670|FG000|Overall Study|Death|6|||
146515626|NCT02440854|528392670|FG000|Overall Study|Lost to Follow-up|10|||
146755706|NCT01789203|529271200|FG001|Overall Study|Adverse Event|2|||
146755707|NCT01789203|529271199|FG000|Overall Study|Withdrawal by Subject|1|||
146755708|NCT01789203|529271200|FG001|Overall Study|Withdrawal by Subject|0|||
146755709|NCT01789203|529271199|FG000|Overall Study|Death|1|||
146755710|NCT01789203|529271200|FG001|Overall Study|Death|0|||
146755711|NCT01789203|529271199|FG000|Overall Study|Protocol Violation|2|||
146755712|NCT01789203|529271200|FG001|Overall Study|Protocol Violation|1|||
146755713|NCT01789203|529271199|FG000|Overall Study|Other|1|||
146755714|NCT01789203|529271200|FG001|Overall Study|Other|1|||
146755715|NCT01789203|529271199|FG000|Overall Study|patient non-adherent|2|||
146755716|NCT01789203|529271200|FG001|Overall Study|patient non-adherent|0|||
146755717|NCT01254305|529271207|FG000|Overall Study|Adverse Event|6|||
146755718|NCT01254305|529271208|FG001|Overall Study|Adverse Event|3|||
146755719|NCT01254305|529271209|FG002|Overall Study|Adverse Event|2|||
146755720|NCT01254305|529271207|FG000|Overall Study|Lack of Efficacy|1|||
146755721|NCT01254305|529271208|FG001|Overall Study|Lack of Efficacy|0|||
146755722|NCT01254305|529271209|FG002|Overall Study|Lack of Efficacy|1|||
146755723|NCT01254305|529271207|FG000|Overall Study|Protocol Violation|1|||
146755724|NCT01254305|529271208|FG001|Overall Study|Protocol Violation|7|||
146755725|NCT01254305|529271209|FG002|Overall Study|Protocol Violation|3|||
146755726|NCT01254305|529271207|FG000|Overall Study|Withdrawal by Subject|4|||
146755727|NCT01254305|529271208|FG001|Overall Study|Withdrawal by Subject|2|||
146755728|NCT01254305|529271209|FG002|Overall Study|Withdrawal by Subject|4|||
146755729|NCT01254305|529271207|FG000|Overall Study|Lost to Follow-up|10|||
146755730|NCT01254305|529271208|FG001|Overall Study|Lost to Follow-up|6|||
146755731|NCT01254305|529271209|FG002|Overall Study|Lost to Follow-up|5|||
146755732|NCT01254305|529271207|FG000|Overall Study|Other Reasons|0|||
146755733|NCT01254305|529271208|FG001|Overall Study|Other Reasons|0|||
146755734|NCT01254305|529271209|FG002|Overall Study|Other Reasons|2|||
146755735|NCT03019458|529271213|FG000|Overall Study|Death|0|||
146755736|NCT03019458|529271214|FG001|Overall Study|Death|1|||
146755737|NCT00557505|529271215|FG000|Overall Study|Death|0|||
146755738|NCT00557505|529271216|FG001|Overall Study|Death|0|||
146755739|NCT00557505|529271217|FG002|Overall Study|Death|0|||
146755740|NCT00557505|529271218|FG003|Overall Study|Death|0|||
146755741|NCT00557505|529271219|FG004|Overall Study|Death|0|||
146755742|NCT00557505|529271220|FG005|Overall Study|Death|0|||
146755743|NCT00557505|529271221|FG006|Overall Study|Death|0|||
146755744|NCT00557505|529271222|FG007|Overall Study|Death|0|||
146755745|NCT00557505|529271223|FG008|Overall Study|Death|1|||
146755746|NCT00557505|529271215|FG000|Overall Study|Adverse Event|0|||
146755747|NCT00557505|529271216|FG001|Overall Study|Adverse Event|0|||
146755748|NCT00557505|529271217|FG002|Overall Study|Adverse Event|1|||
146755749|NCT00557505|529271218|FG003|Overall Study|Adverse Event|0|||
146755750|NCT00557505|529271219|FG004|Overall Study|Adverse Event|0|||
146755751|NCT00557505|529271220|FG005|Overall Study|Adverse Event|0|||
146755752|NCT00557505|529271221|FG006|Overall Study|Adverse Event|1|||
146755753|NCT00557505|529271222|FG007|Overall Study|Adverse Event|0|||
146755754|NCT00557505|529271223|FG008|Overall Study|Adverse Event|0|||
146755755|NCT00557505|529271215|FG000|Overall Study|Global deterioration of health|1|||
146755756|NCT00557505|529271216|FG001|Overall Study|Global deterioration of health|0|||
146755757|NCT00557505|529271217|FG002|Overall Study|Global deterioration of health|0|||
146755758|NCT00557505|529271218|FG003|Overall Study|Global deterioration of health|0|||
146755759|NCT00557505|529271219|FG004|Overall Study|Global deterioration of health|0|||
146755760|NCT00557505|529271220|FG005|Overall Study|Global deterioration of health|0|||
146755761|NCT00557505|529271221|FG006|Overall Study|Global deterioration of health|0|||
146755762|NCT00557505|529271222|FG007|Overall Study|Global deterioration of health|0|||
146755763|NCT00557505|529271223|FG008|Overall Study|Global deterioration of health|0|||
146755764|NCT00557505|529271215|FG000|Overall Study|Objective progression or relapse|2|||
146755765|NCT00557505|529271216|FG001|Overall Study|Objective progression or relapse|3|||
146755766|NCT00557505|529271217|FG002|Overall Study|Objective progression or relapse|3|||
146755767|NCT00557505|529271218|FG003|Overall Study|Objective progression or relapse|2|||
146755768|NCT00557505|529271219|FG004|Overall Study|Objective progression or relapse|2|||
146755769|NCT00557505|529271220|FG005|Overall Study|Objective progression or relapse|3|||
146755770|NCT00557505|529271221|FG006|Overall Study|Objective progression or relapse|2|||
146515627|NCT02440854|528392670|FG000|Overall Study|Afatinib discontinuation|46|||
146515628|NCT02440854|528392670|FG000|Overall Study|stopped study at earlier timepoint|14|||
146755771|NCT00557505|529271222|FG007|Overall Study|Objective progression or relapse|5|||
146755772|NCT00557505|529271223|FG008|Overall Study|Objective progression or relapse|15|||
146853257|NCT02344004|529633589|FG001|Overall Study|Death|7|||
146853258|NCT02344004|529633588|FG000|Overall Study|Physician Decision|4|||
146853259|NCT02344004|529633589|FG001|Overall Study|Physician Decision|1|||
146853260|NCT02344004|529633588|FG000|Overall Study|Withdrawal by Subject|22|||
146853261|NCT02344004|529633589|FG001|Overall Study|Withdrawal by Subject|5|||
146853262|NCT02344004|529633588|FG000|Overall Study|Rescue Medication|2|||
146853263|NCT02344004|529633589|FG001|Overall Study|Rescue Medication|0|||
146853264|NCT02344004|529633588|FG000|Overall Study|Other Not Specified|12|||
146853265|NCT02344004|529633589|FG001|Overall Study|Other Not Specified|0|||
146853266|NCT02344004|529633588|FG000|Overall Study|Protocol Violation|1|||
146853267|NCT02344004|529633589|FG001|Overall Study|Protocol Violation|0|||
146853268|NCT02319525|529633590|FG000|Overall Study|Withdrawal by Subject|2|||
146853269|NCT02319525|529633591|FG001|Overall Study|Withdrawal by Subject|1|||
146853270|NCT04223830|529633594|FG000|Overall Study|Lost to Follow-up|9|||
146853271|NCT04223830|529633594|FG000|Overall Study|Adverse Event|1|||
146853272|NCT00862719|529633595|FG000|Overall Study|Disease Progression|5|||
146853273|NCT00862719|529633596|FG001|Overall Study|Disease Progression|0|||
146853274|NCT00862719|529633597|FG002|Overall Study|Disease Progression|1|||
146853275|NCT00862719|529633598|FG003|Overall Study|Disease Progression|0|||
146853276|NCT00862719|529633595|FG000|Overall Study|Death|5|||
146853277|NCT00862719|529633596|FG001|Overall Study|Death|6|||
146853278|NCT00862719|529633597|FG002|Overall Study|Death|1|||
146853279|NCT00862719|529633598|FG003|Overall Study|Death|1|||
146853280|NCT00862719|529633595|FG000|Overall Study|Engraftment failure|0|||
146853281|NCT00862719|529633596|FG001|Overall Study|Engraftment failure|0|||
146853282|NCT00862719|529633597|FG002|Overall Study|Engraftment failure|1|||
146853283|NCT00862719|529633598|FG003|Overall Study|Engraftment failure|0|||
146853284|NCT00862719|529633595|FG000|Overall Study|Veno-Occlusive Disease|0|||
146853285|NCT00862719|529633596|FG001|Overall Study|Veno-Occlusive Disease|0|||
146853286|NCT00862719|529633597|FG002|Overall Study|Veno-Occlusive Disease|1|||
146853287|NCT00862719|529633598|FG003|Overall Study|Veno-Occlusive Disease|0|||
146853288|NCT01806623|529633599|FG000|Overall Study|Withdrawal by Subject|1|||
146853289|NCT01806623|529633599|FG000|Overall Study|Adverse Event|1|||
146853290|NCT01806623|529633599|FG000|Overall Study|Did not meet the inclusion criteria|56|||
146853291|NCT01737827|529633600|FG000|Overall Study|Adverse Event|3|||
146853292|NCT01737827|529633601|FG001|Overall Study|Adverse Event|6|||
146853293|NCT01737827|529633602|FG002|Overall Study|Adverse Event|0|||
146853294|NCT01737827|529633600|FG000|Overall Study|Lost to Follow-up|0|||
146853295|NCT01737827|529633601|FG001|Overall Study|Lost to Follow-up|1|||
146853296|NCT01737827|529633602|FG002|Overall Study|Lost to Follow-up|0|||
146853297|NCT01737827|529633600|FG000|Overall Study|Physician Decision|0|||
146853298|NCT01737827|529633601|FG001|Overall Study|Physician Decision|2|||
146515629|NCT02440854|528392670|FG000|Overall Study|Study medication not received|1|||
146515630|NCT02440854|528392670|FG000|Overall Study|Violation of inclusion criteria|2|||
146515631|NCT02243046|528392671|FG000|Overall Study|Lost to Follow-up|1|||
146515632|NCT02243046|528392672|FG001|Overall Study|Lost to Follow-up|1|||
146515633|NCT02243046|528392673|FG002|Overall Study|Lost to Follow-up|4|||
146515634|NCT04607980|528392674|FG000|Overall Study|Adverse Event|3|||
146515635|NCT04607980|528392675|FG001|Overall Study|Adverse Event|4|||
146515636|NCT04607980|528392674|FG000|Overall Study|Death|0|||
146515637|NCT04607980|528392675|FG001|Overall Study|Death|1|||
146515638|NCT04607980|528392674|FG000|Overall Study|Withdrawal by Subject|2|||
146515639|NCT04607980|528392675|FG001|Overall Study|Withdrawal by Subject|5|||
146515640|NCT04607980|528392674|FG000|Overall Study|Lost to Follow-up|4|||
146515641|NCT04607980|528392675|FG001|Overall Study|Lost to Follow-up|8|||
146515642|NCT04607980|528392674|FG000|Overall Study|Protocol Violation|0|||
146515643|NCT04607980|528392675|FG001|Overall Study|Protocol Violation|3|||
146515644|NCT04607980|528392674|FG000|Overall Study|Other|3|||
146515645|NCT04607980|528392675|FG001|Overall Study|Other|0|||
146515646|NCT01854879|528392676|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
146515647|NCT01854879|528392676|FG000|Overall Study|screen fail|3|||
146515648|NCT01854879|528392676|FG000|Overall Study|incomplete data set|1|||
146515649|NCT01859949|528394233|FG000|Overall Study|Family Matters|0|||
146515650|NCT01859949|528394234|FG001|Overall Study|Family Matters|1|||
146515651|NCT01859949|528394233|FG000|Overall Study|Physician Decision|2|||
146515652|NCT01859949|528394234|FG001|Overall Study|Physician Decision|4|||
146515653|NCT01859949|528394233|FG000|Overall Study|Withdrawal by Subject|11|||
146515654|NCT01859949|528394234|FG001|Overall Study|Withdrawal by Subject|10|||
146515655|NCT01859949|528394233|FG000|Overall Study|Protocol Violation|1|||
146515656|NCT01859949|528394234|FG001|Overall Study|Protocol Violation|1|||
146515657|NCT01859949|528394233|FG000|Overall Study|Adverse Event|0|||
146515658|NCT01859949|528394234|FG001|Overall Study|Adverse Event|1|||
146515659|NCT01344759|528394235|FG000|Overall Study|Patients failed to reach sedation level|0|||
146515660|NCT01344759|528394236|FG001|Overall Study|Patients failed to reach sedation level|2|||
146515661|NCT04494425|528394241|FG000|Overall Study|Death|160|||
146515662|NCT04494425|528394242|FG001|Overall Study|Death|166|||
146515663|NCT04494425|528394241|FG000|Overall Study|Withdrawal by Subject|10|||
146515664|NCT04494425|528394242|FG001|Overall Study|Withdrawal by Subject|40|||
146515665|NCT04494425|528394241|FG000|Overall Study|Other|1|||
146515666|NCT04494425|528394242|FG001|Overall Study|Other|1|||
146515667|NCT04494425|528394241|FG000|Overall Study|Ongoing at the time of PCD|265|||
146515668|NCT04494425|528394242|FG001|Overall Study|Ongoing at the time of PCD|223|||
146515669|NCT01270321|528394243|FG000|Overall Study|Death|3|||
146515670|NCT01270321|528394244|FG001|Overall Study|Death|1|||
146515671|NCT01270321|528394245|FG002|Overall Study|Death|4|||
146515672|NCT01270321|528394243|FG000|Overall Study|Adverse Event|7|||
146515673|NCT01270321|528394244|FG001|Overall Study|Adverse Event|9|||
146515674|NCT01270321|528394245|FG002|Overall Study|Adverse Event|5|||
146515675|NCT04003623|528394249|FG000|Overall Study|Withdrawal by Subject|1|||
146515676|NCT04003623|528394250|FG001|Overall Study|Withdrawal by Subject|0|||
146515677|NCT04575584|528394253|FG000|Overall Study|Death|6|||
146515678|NCT04575584|528394254|FG001|Overall Study|Death|4|||
146515679|NCT04575584|528394255|FG002|Overall Study|Death|6|||
146515680|NCT04575584|528394256|FG003|Overall Study|Death|2|||
146515681|NCT04575584|528394257|FG004|Overall Study|Death|0|||
146515682|NCT04575584|528394258|FG005|Overall Study|Death|0|||
146515683|NCT04575584|528394253|FG000|Overall Study|Lost to Follow-up|1|||
146515684|NCT04575584|528394254|FG001|Overall Study|Lost to Follow-up|1|||
146515685|NCT04575584|528394255|FG002|Overall Study|Lost to Follow-up|1|||
146515686|NCT04575584|528394256|FG003|Overall Study|Lost to Follow-up|1|||
146515687|NCT04575584|528394257|FG004|Overall Study|Lost to Follow-up|0|||
146515688|NCT04575584|528394258|FG005|Overall Study|Lost to Follow-up|0|||
146515689|NCT04575584|528394253|FG000|Overall Study|Physician Decision|0|||
146515690|NCT04575584|528394254|FG001|Overall Study|Physician Decision|1|||
146515691|NCT04575584|528394255|FG002|Overall Study|Physician Decision|1|||
146515692|NCT04575584|528394256|FG003|Overall Study|Physician Decision|1|||
146515693|NCT04575584|528394257|FG004|Overall Study|Physician Decision|0|||
146515694|NCT04575584|528394258|FG005|Overall Study|Physician Decision|0|||
146515695|NCT04575584|528394253|FG000|Overall Study|Withdrawal by Subject|7|||
146515696|NCT04575584|528394254|FG001|Overall Study|Withdrawal by Subject|9|||
146515697|NCT04575584|528394255|FG002|Overall Study|Withdrawal by Subject|5|||
146515698|NCT04575584|528394256|FG003|Overall Study|Withdrawal by Subject|3|||
146515699|NCT04575584|528394257|FG004|Overall Study|Withdrawal by Subject|0|||
146515700|NCT04575584|528394258|FG005|Overall Study|Withdrawal by Subject|0|||
146515701|NCT04575584|528394253|FG000|Overall Study|Not recorded|0|||
146515702|NCT04575584|528394254|FG001|Overall Study|Not recorded|0|||
146515703|NCT04575584|528394255|FG002|Overall Study|Not recorded|0|||
146515704|NCT04575584|528394256|FG003|Overall Study|Not recorded|1|||
146515705|NCT04575584|528394257|FG004|Overall Study|Not recorded|0|||
146515706|NCT04575584|528394258|FG005|Overall Study|Not recorded|0|||
146515707|NCT03300050|528394259|FG000|Overall Study|Lost to Follow-up|2|||
146515708|NCT03300050|528394260|FG001|Overall Study|Lost to Follow-up|1|||
146755773|NCT00557505|529271215|FG000|Overall Study|Withdrawal by Subject|0|||
146755774|NCT00557505|529271216|FG001|Overall Study|Withdrawal by Subject|0|||
146755775|NCT00557505|529271217|FG002|Overall Study|Withdrawal by Subject|0|||
146755776|NCT00557505|529271218|FG003|Overall Study|Withdrawal by Subject|1|||
146755777|NCT00557505|529271219|FG004|Overall Study|Withdrawal by Subject|0|||
146755778|NCT00557505|529271220|FG005|Overall Study|Withdrawal by Subject|0|||
146755779|NCT00557505|529271221|FG006|Overall Study|Withdrawal by Subject|0|||
146755780|NCT00557505|529271222|FG007|Overall Study|Withdrawal by Subject|0|||
146755781|NCT00557505|529271223|FG008|Overall Study|Withdrawal by Subject|1|||
146755782|NCT00031447|529271224|FG000|Overall Study|Lost to Follow-up|0|||
146755783|NCT00031447|529271225|FG001|Overall Study|Lost to Follow-up|1|||
146755784|NCT00031447|529271224|FG000|Overall Study|Non-compliant|1|||
146755785|NCT00031447|529271225|FG001|Overall Study|Non-compliant|1|||
146755786|NCT00031447|529271224|FG000|Overall Study|Re-activation of Disease|2|||
146755787|NCT00031447|529271225|FG001|Overall Study|Re-activation of Disease|1|||
146755788|NCT00031447|529271224|FG000|Overall Study|Disruption of blinded study drug supply|7|||
146755789|NCT00031447|529271225|FG001|Overall Study|Disruption of blinded study drug supply|4|||
146755790|NCT01636362|529271226|FG000|Overall Study|Physician Decision|6|||
146755791|NCT01636362|529271226|FG000|Overall Study|Subject healed, not returning|1|||
146755792|NCT01636362|529271226|FG000|Overall Study|Withdrawal by Subject|1|||
146755793|NCT00519779|529271229|FG000|Overall Study|Withdrawal by Subject|0|||
146755794|NCT00519779|529271230|FG001|Overall Study|Withdrawal by Subject|1|||
146755795|NCT03330119|529271231|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
146755796|NCT03330119|529271232|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
146755797|NCT01561079|529271233|FG000|Overall Study|Physician Decision|17|||
146755798|NCT01561079|529271233|FG000|Overall Study|Withdrawal by Subject|59|||
146755799|NCT01561079|529271233|FG000|Overall Study|Protocol Violation|2|||
146755800|NCT01323660|529271234|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
146755801|NCT01323660|529271235|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
146755802|NCT01323660|529271236|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
146755803|NCT01323660|529271237|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
146755804|NCT01323660|529271238|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
146755805|NCT01323660|529271239|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
146755806|NCT01323660|529271234|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
146755807|NCT01323660|529271235|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
146755808|NCT01323660|529271236|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
146755809|NCT01323660|529271237|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
146755810|NCT01323660|529271238|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
146755811|NCT01323660|529271239|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
146755812|NCT01323660|529271234|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
146755813|NCT01323660|529271235|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
146755814|NCT01323660|529271236|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
146755815|NCT01323660|529271237|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
146755816|NCT01323660|529271238|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
146755817|NCT01323660|529271239|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
146755818|NCT01323660|529271234|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
146755819|NCT01323660|529271235|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
146755820|NCT01323660|529271236|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
146755821|NCT01323660|529271237|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
146755822|NCT01323660|529271238|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
146755823|NCT01323660|529271239|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
146755824|NCT01323660|529271234|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146755825|NCT01323660|529271235|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146755826|NCT01323660|529271236|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146755827|NCT01323660|529271237|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146755828|NCT01323660|529271238|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
146755829|NCT01323660|529271239|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146755830|NCT01323660|529271234|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
146755831|NCT01323660|529271235|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146965055|NCT03110107|530033445|FG019|Treatment Period|Study drug toxicity|2|||
146853299|NCT01737827|529633602|FG002|Overall Study|Physician Decision|0|||
146853300|NCT01737827|529633600|FG000|Overall Study|Progressive Disease|5|||
146515709|NCT03300050|528394261|FG002|Overall Study|Lost to Follow-up|0|||
146515710|NCT03300050|528394262|FG003|Overall Study|Lost to Follow-up|0|||
146515711|NCT03300050|528394263|FG004|Overall Study|Lost to Follow-up|1|||
146853301|NCT01737827|529633601|FG001|Overall Study|Progressive Disease|16|||
146853302|NCT01737827|529633602|FG002|Overall Study|Progressive Disease|2|||
146515712|NCT03300050|528394259|FG000|Overall Study|Withdrawal by Subject|1|||
146515713|NCT03300050|528394260|FG001|Overall Study|Withdrawal by Subject|1|||
146515714|NCT03300050|528394261|FG002|Overall Study|Withdrawal by Subject|1|||
146515715|NCT03300050|528394262|FG003|Overall Study|Withdrawal by Subject|0|||
146515716|NCT03300050|528394263|FG004|Overall Study|Withdrawal by Subject|0|||
146515717|NCT03300050|528394259|FG000|Overall Study|Death|0|||
146515718|NCT03300050|528394260|FG001|Overall Study|Death|0|||
146515719|NCT03300050|528394261|FG002|Overall Study|Death|1|||
146515720|NCT03300050|528394262|FG003|Overall Study|Death|0|||
146515721|NCT03300050|528394263|FG004|Overall Study|Death|0|||
146515722|NCT03300050|528394259|FG000|Overall Study|Not Eligible at Randomization|0|||
146515723|NCT03300050|528394260|FG001|Overall Study|Not Eligible at Randomization|0|||
146515724|NCT03300050|528394261|FG002|Overall Study|Not Eligible at Randomization|1|||
146515725|NCT03300050|528394262|FG003|Overall Study|Not Eligible at Randomization|1|||
146515726|NCT03300050|528394263|FG004|Overall Study|Not Eligible at Randomization|0|||
146515727|NCT03326518|528394264|FG000|Overall Study|Protocol Violation|1|||
146515728|NCT03326518|528394265|FG001|Overall Study|Protocol Violation|0|||
146515729|NCT03326518|528394266|FG002|Overall Study|Protocol Violation|0|||
146515730|NCT03326518|528394264|FG000|Overall Study|Withdrawal by Subject|1|||
146515731|NCT03326518|528394265|FG001|Overall Study|Withdrawal by Subject|0|||
146515732|NCT03326518|528394266|FG002|Overall Study|Withdrawal by Subject|0|||
146515733|NCT03326518|528394264|FG000|Overall Study|Lost to Follow-up|1|||
146515734|NCT03326518|528394265|FG001|Overall Study|Lost to Follow-up|0|||
146515735|NCT03326518|528394266|FG002|Overall Study|Lost to Follow-up|1|||
146515736|NCT04401202|528394268|FG000|Overall Study|Lost to Follow-up|2|||
146515737|NCT04401202|528394269|FG001|Overall Study|Lost to Follow-up|2|||
146515738|NCT04401202|528394268|FG000|Overall Study|Adverse Event|0|||
146515739|NCT04401202|528394269|FG001|Overall Study|Adverse Event|1|||
146515740|NCT04401202|528394268|FG000|Overall Study|Hospitalized|4|||
146515741|NCT04401202|528394269|FG001|Overall Study|Hospitalized|1|||
146515742|NCT02714036|528394270|FG000|Overall Study|Adverse Event|9|||
146515743|NCT02714036|528394271|FG001|Overall Study|Adverse Event|2|||
146515744|NCT02714036|528394270|FG000|Overall Study|Withdrawal by Subject|3|||
146515745|NCT02714036|528394271|FG001|Overall Study|Withdrawal by Subject|2|||
146515746|NCT01006590|528394273|FG000|Overall Study|Adverse Event|2|||
146515747|NCT01006590|528394274|FG001|Overall Study|Adverse Event|3|||
146515748|NCT01006590|528394273|FG000|Overall Study|Death|1|||
146515749|NCT01006590|528394274|FG001|Overall Study|Death|1|||
146515750|NCT01006590|528394273|FG000|Overall Study|Lost to Follow-up|1|||
146515751|NCT01006590|528394274|FG001|Overall Study|Lost to Follow-up|1|||
146515752|NCT01006590|528394273|FG000|Overall Study|Protocol Violation|1|||
146515753|NCT01006590|528394274|FG001|Overall Study|Protocol Violation|0|||
146515754|NCT01006590|528394273|FG000|Overall Study|Withdrawal by Subject|4|||
146515755|NCT01006590|528394274|FG001|Overall Study|Withdrawal by Subject|2|||
146515756|NCT01006590|528394273|FG000|Overall Study|Study specific discontinuation criteria|16|||
146515757|NCT01006590|528394274|FG001|Overall Study|Study specific discontinuation criteria|23|||
146515758|NCT01006590|528394273|FG000|Overall Study|Other|3|||
146515759|NCT01006590|528394274|FG001|Overall Study|Other|2|||
146515760|NCT01939223|528394275|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
146515761|NCT01939223|528394276|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
146515762|NCT01939223|528394275|FG000|Overall Study|Disease recurrence (radiological)|1|||
146515763|NCT01939223|528394276|FG001|Overall Study|Disease recurrence (radiological)|3|||
146515764|NCT01939223|528394275|FG000|Overall Study|Study stopped by Sponsor|5|||
146515765|NCT01939223|528394276|FG001|Overall Study|Study stopped by Sponsor|7|||
146853303|NCT01737827|529633600|FG000|Overall Study|Study Terminated by Sponsor|0|||
146515766|NCT01939223|528394275|FG000|Overall Study|Withdrawal by Subject|6|||
146515767|NCT01939223|528394276|FG001|Overall Study|Withdrawal by Subject|0|||
146515768|NCT00957424|528394278|FG000|Overall Study|Lost to Follow-up|19|||
146515769|NCT00957424|528394278|FG000|Overall Study|Protocol Violation|3|||
146515770|NCT00957424|528394278|FG000|Overall Study|Withdrawal by Subject|1|||
146853304|NCT01737827|529633601|FG001|Overall Study|Study Terminated by Sponsor|1|||
146515771|NCT02700698|528394279|FG000|Overall Study|Withdrawal by Subject|1|||
146515772|NCT02700698|528394280|FG001|Overall Study|Withdrawal by Subject|0|||
146515773|NCT00703118|528394281|FG000|Overall Study|Adverse Event|1|||
146515774|NCT00703118|528394282|FG001|Overall Study|Adverse Event|2|||
146515775|NCT00703118|528394283|FG002|Overall Study|Adverse Event|2|||
146515776|NCT00703118|528394281|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
146515777|NCT00703118|528394282|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
146515778|NCT00703118|528394283|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
146853305|NCT01737827|529633602|FG002|Overall Study|Study Terminated by Sponsor|0|||
146515779|NCT00703118|528394281|FG000|Overall Study|Lost to Follow-up|6|||
146853306|NCT01737827|529633600|FG000|Overall Study|Subject/Guardian Decision|0|||
146853307|NCT01737827|529633601|FG001|Overall Study|Subject/Guardian Decision|2|||
146853308|NCT01737827|529633602|FG002|Overall Study|Subject/Guardian Decision|0|||
146853309|NCT01451827|529633603|FG000|Overall Study|Adverse Event|2|||
146853310|NCT01451827|529633604|FG001|Overall Study|Adverse Event|0|||
146853311|NCT01451827|529633605|FG002|Overall Study|Adverse Event|1|||
146853312|NCT01451827|529633606|FG003|Overall Study|Adverse Event|1|||
146853313|NCT01451827|529633603|FG000|Overall Study|Protocol deviation|1|||
146853314|NCT01451827|529633604|FG001|Overall Study|Protocol deviation|0|||
146515780|NCT00703118|528394282|FG001|Overall Study|Lost to Follow-up|4|||
146515781|NCT00703118|528394283|FG002|Overall Study|Lost to Follow-up|4|||
146515782|NCT00703118|528394281|FG000|Overall Study|Withdrawal by Subject|8|||
146515783|NCT00703118|528394282|FG001|Overall Study|Withdrawal by Subject|7|||
146515784|NCT00703118|528394283|FG002|Overall Study|Withdrawal by Subject|13|||
146515785|NCT00703118|528394281|FG000|Overall Study|Other|0|||
146515786|NCT00703118|528394282|FG001|Overall Study|Other|0|||
146515787|NCT00703118|528394283|FG002|Overall Study|Other|1|||
146515788|NCT04165135|528394284|FG000|Overall Study|Protocol Violation|10|||
146515789|NCT04165135|528394284|FG000|Overall Study|Participants withdrawal of consent|5|||
146515790|NCT00530790|528394285|FG000|Overall Study|Adverse Event|2|||
146515791|NCT00530790|528394285|FG000|Overall Study|Withdrawal by Subject|2|||
146515792|NCT00530790|528394285|FG000|Overall Study|Physician Decision|1|||
146515793|NCT05053035|528394290|FG000|Overall Study|Withdrawal by Subject|1|||
146515794|NCT05053035|528394291|FG001|Overall Study|Withdrawal by Subject|0|||
146515795|NCT01618916|528394293|FG000|Overall Study|Adverse Event|1|||
146515796|NCT01618916|528394294|FG001|Overall Study|Adverse Event|0|||
146515797|NCT01618916|528394295|FG002|Overall Study|Adverse Event|0|||
146515798|NCT01618916|528394296|FG003|Overall Study|Adverse Event|0|||
146515799|NCT01618916|528394297|FG004|Overall Study|Adverse Event|0|||
146515800|NCT01618916|528394298|FG005|Overall Study|Adverse Event|0|||
146515801|NCT01618916|528394293|FG000|Overall Study|Withdrawal by Subject|0|||
146515802|NCT01618916|528394294|FG001|Overall Study|Withdrawal by Subject|1|||
146515803|NCT01618916|528394295|FG002|Overall Study|Withdrawal by Subject|1|||
146515804|NCT01618916|528394296|FG003|Overall Study|Withdrawal by Subject|0|||
146515805|NCT01618916|528394297|FG004|Overall Study|Withdrawal by Subject|1|||
146515806|NCT01618916|528394298|FG005|Overall Study|Withdrawal by Subject|0|||
146515807|NCT01618916|528394293|FG000|Overall Study|Lost to Follow-up|1|||
146515808|NCT01618916|528394294|FG001|Overall Study|Lost to Follow-up|0|||
146515809|NCT01618916|528394295|FG002|Overall Study|Lost to Follow-up|0|||
146515810|NCT01618916|528394296|FG003|Overall Study|Lost to Follow-up|2|||
146515811|NCT01618916|528394297|FG004|Overall Study|Lost to Follow-up|0|||
146515812|NCT01618916|528394298|FG005|Overall Study|Lost to Follow-up|0|||
146515813|NCT01853696|528394299|FG000|Overall Study|Withdrawal by Subject|1|||
146515814|NCT01853696|528394300|FG001|Overall Study|Withdrawal by Subject|1|||
146515815|NCT01853696|528394299|FG000|Overall Study|Lost to Follow-up|5|||
146515816|NCT01853696|528394300|FG001|Overall Study|Lost to Follow-up|4|||
146515817|NCT03004924|528394301|FG000|Overall Study|Adverse Event|6|||
146515818|NCT03004924|528394302|FG001|Overall Study|Adverse Event|5|||
146515819|NCT03004924|528394303|FG002|Overall Study|Adverse Event|10|||
146515820|NCT03004924|528394301|FG000|Overall Study|Protocol Violation|4|||
146515821|NCT03004924|528394302|FG001|Overall Study|Protocol Violation|0|||
146515822|NCT03004924|528394303|FG002|Overall Study|Protocol Violation|1|||
146515823|NCT03004924|528394301|FG000|Overall Study|Withdrawal by Subject|5|||
146515824|NCT03004924|528394302|FG001|Overall Study|Withdrawal by Subject|3|||
146515825|NCT03004924|528394303|FG002|Overall Study|Withdrawal by Subject|5|||
146515826|NCT03004924|528394301|FG000|Overall Study|Lost to Follow-up|6|||
146515827|NCT03004924|528394302|FG001|Overall Study|Lost to Follow-up|1|||
146515828|NCT03004924|528394303|FG002|Overall Study|Lost to Follow-up|4|||
146515829|NCT03004924|528394301|FG000|Overall Study|Lack of Efficacy|2|||
146515830|NCT03004924|528394302|FG001|Overall Study|Lack of Efficacy|4|||
146853315|NCT01451827|529633605|FG002|Overall Study|Protocol deviation|0|||
146853316|NCT01451827|529633606|FG003|Overall Study|Protocol deviation|0|||
146515831|NCT03004924|528394303|FG002|Overall Study|Lack of Efficacy|2|||
146515832|NCT03004924|528394301|FG000|Overall Study|Physician Decision|1|||
146515833|NCT03004924|528394302|FG001|Overall Study|Physician Decision|0|||
146515834|NCT03004924|528394303|FG002|Overall Study|Physician Decision|1|||
146853317|NCT01451827|529633603|FG000|Overall Study|Lost to Follow-up|0|||
146515835|NCT03004924|528394301|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146515836|NCT03004924|528394302|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146515837|NCT03004924|528394303|FG002|Overall Study|Withdrawal by parent/guardian|2|||
146515838|NCT03004924|528394301|FG000|Overall Study|Screen Failure|1|||
146515839|NCT03004924|528394302|FG001|Overall Study|Screen Failure|0|||
146515840|NCT03004924|528394303|FG002|Overall Study|Screen Failure|0|||
146515841|NCT03004924|528394301|FG000|Overall Study|Pregnancy|0|||
146515842|NCT03004924|528394302|FG001|Overall Study|Pregnancy|1|||
146515843|NCT03004924|528394303|FG002|Overall Study|Pregnancy|0|||
146515844|NCT03004924|528394301|FG000|Overall Study|Terminated by Sponsor|0|||
146853318|NCT01451827|529633604|FG001|Overall Study|Lost to Follow-up|3|||
146515845|NCT03004924|528394302|FG001|Overall Study|Terminated by Sponsor|0|||
146515846|NCT03004924|528394303|FG002|Overall Study|Terminated by Sponsor|1|||
146515847|NCT03004924|528394301|FG000|Overall Study|Missed Study Visit|0|||
146515848|NCT03004924|528394302|FG001|Overall Study|Missed Study Visit|0|||
146515849|NCT03004924|528394303|FG002|Overall Study|Missed Study Visit|2|||
146515850|NCT03004924|528394301|FG000|Overall Study|HSV1 Positive|1|||
146515851|NCT03004924|528394302|FG001|Overall Study|HSV1 Positive|0|||
146515852|NCT03004924|528394303|FG002|Overall Study|HSV1 Positive|0|||
146515853|NCT02005627|528394314|FG000|Overall Study|Lost to Follow-up|1|||
146515854|NCT02005627|528394315|FG001|Overall Study|Lost to Follow-up|2|||
146515855|NCT02005627|528394314|FG000|Overall Study|Withdrawal by Subject|1|||
146515856|NCT02005627|528394315|FG001|Overall Study|Withdrawal by Subject|2|||
146515857|NCT00048997|528394319|FG000|Overall Study|Protocol Violation|7|||
146515858|NCT00048997|528394320|FG001|Overall Study|Protocol Violation|2|||
146515859|NCT00048997|528394319|FG000|Overall Study|Withdrawal by Subject|6|||
146515860|NCT00048997|528394320|FG001|Overall Study|Withdrawal by Subject|1|||
146515861|NCT00048165|528394321|FG000|Completed 6 Months Study|Administration/Other|8|||
146515862|NCT00048165|528394322|FG001|Completed 6 Months Study|Administration/Other|8|||
146515863|NCT00048165|528394321|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
146515864|NCT00048165|528394322|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
146515865|NCT00048165|528394321|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
146515866|NCT00048165|528394322|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
146515867|NCT00048165|528394321|FG000|Completed 6 Months Study|Death|12|||
146515868|NCT00048165|528394322|FG001|Completed 6 Months Study|Death|6|||
146515869|NCT00048165|528394321|FG000|Completed 6 Months Study|Insufficient therapy|1|||
146515870|NCT00048165|528394322|FG001|Completed 6 Months Study|Insufficient therapy|4|||
146515871|NCT00048165|528394321|FG000|Completed 6 Months Study|Other violation|4|||
146515872|NCT00048165|528394322|FG001|Completed 6 Months Study|Other violation|6|||
146515873|NCT00048165|528394321|FG000|Completed 6 Months Study|Refused treatment|5|||
146515874|NCT00048165|528394322|FG001|Completed 6 Months Study|Refused treatment|5|||
146515875|NCT00048165|528394321|FG000|Completed 6 Months Study|Violation criteria|0|||
146515876|NCT00048165|528394322|FG001|Completed 6 Months Study|Violation criteria|2|||
146515877|NCT00048165|528394321|FG000|Completed 6 Months Study|Did not receive study drug|6|||
146515878|NCT00048165|528394322|FG001|Completed 6 Months Study|Did not receive study drug|6|||
146515879|NCT00048165|528394321|FG000|Completed 12 Months Study|Administration/Other|0|||
146515880|NCT00048165|528394322|FG001|Completed 12 Months Study|Administration/Other|2|||
146515881|NCT00048165|528394321|FG000|Completed 12 Months Study|Death|2|||
146515882|NCT00048165|528394322|FG001|Completed 12 Months Study|Death|1|||
146515883|NCT00048165|528394321|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
146755832|NCT01323660|529271236|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
146755833|NCT01323660|529271237|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
146755834|NCT01323660|529271238|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
146755835|NCT01323660|529271239|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146755836|NCT01323660|529271234|FG000|Washout Period (14 Days)|Adverse Event|0|||
146755837|NCT01323660|529271235|FG001|Washout Period (14 Days)|Adverse Event|0|||
146755838|NCT01323660|529271236|FG002|Washout Period (14 Days)|Adverse Event|0|||
146755839|NCT01323660|529271237|FG003|Washout Period (14 Days)|Adverse Event|0|||
146755840|NCT01323660|529271238|FG004|Washout Period (14 Days)|Adverse Event|1|||
146755841|NCT01323660|529271239|FG005|Washout Period (14 Days)|Adverse Event|0|||
146755842|NCT01323660|529271234|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
146755843|NCT01323660|529271235|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
146755844|NCT01323660|529271236|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
146755845|NCT01323660|529271237|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
146755846|NCT01323660|529271238|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
146755847|NCT01323660|529271239|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
146755848|NCT01323660|529271234|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
146755849|NCT01323660|529271235|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
146755850|NCT01323660|529271236|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
146755851|NCT01323660|529271237|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
146755852|NCT01323660|529271238|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
146755853|NCT01323660|529271239|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
146755854|NCT01323660|529271234|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
146755855|NCT01323660|529271235|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
146755856|NCT01323660|529271236|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
146515884|NCT00048165|528394322|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
146515885|NCT01370616|528394323|FG000|Overall Study|Adverse Event|11|||
146515886|NCT01370616|528394324|FG001|Overall Study|Adverse Event|16|||
146853319|NCT01451827|529633605|FG002|Overall Study|Lost to Follow-up|0|||
146515887|NCT01370616|528394323|FG000|Overall Study|Death|1|||
146515888|NCT01370616|528394324|FG001|Overall Study|Death|0|||
146515889|NCT01370616|528394323|FG000|Overall Study|Lack of Efficacy|6|||
146515890|NCT01370616|528394324|FG001|Overall Study|Lack of Efficacy|2|||
146515891|NCT01370616|528394323|FG000|Overall Study|Lost to Follow-up|0|||
146515892|NCT01370616|528394324|FG001|Overall Study|Lost to Follow-up|3|||
146515893|NCT01370616|528394323|FG000|Overall Study|Physician Decision|6|||
146515894|NCT01370616|528394324|FG001|Overall Study|Physician Decision|6|||
146515895|NCT01370616|528394323|FG000|Overall Study|Progressive Disease|0|||
146515896|NCT01370616|528394324|FG001|Overall Study|Progressive Disease|1|||
146515897|NCT01370616|528394323|FG000|Overall Study|Recovery|1|||
146515898|NCT01370616|528394324|FG001|Overall Study|Recovery|0|||
146515899|NCT01370616|528394323|FG000|Overall Study|Technical Problems|3|||
146515900|NCT01370616|528394324|FG001|Overall Study|Technical Problems|5|||
146515901|NCT01370616|528394323|FG000|Overall Study|Withdrawal by Subject|34|||
146515902|NCT01370616|528394324|FG001|Overall Study|Withdrawal by Subject|34|||
146515903|NCT01693185|528394327|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
146515904|NCT01693185|528394328|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
146515905|NCT01084538|528394337|FG000|Overall Study|Drug not available|30|||
146515906|NCT01084538|528394337|FG000|Overall Study|Adverse Event|9|||
146515907|NCT01084538|528394337|FG000|Overall Study|Kidney transplant|6|||
146515908|NCT01084538|528394337|FG000|Overall Study|Serious Adverse Event|3|||
146515909|NCT01084538|528394337|FG000|Overall Study|Lack of effectiveness|2|||
146515910|NCT01084538|528394337|FG000|Overall Study|Patient noncompliance|2|||
146515911|NCT01084538|528394337|FG000|Overall Study|Hyperphosphatemia|2|||
146515912|NCT01084538|528394337|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
146515913|NCT01084538|528394337|FG000|Overall Study|Change of residence|2|||
146515914|NCT01084538|528394337|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
146515915|NCT01084538|528394337|FG000|Overall Study|Reason unknown|8|||
146515916|NCT01429441|528394338|FG000|Overall Study|Adverse Event|5|||
146515917|NCT01429441|528394339|FG001|Overall Study|Adverse Event|1|||
146515918|NCT01429441|528394338|FG000|Overall Study|Death|0|||
146515919|NCT01429441|528394339|FG001|Overall Study|Death|2|||
146515920|NCT01429441|528394338|FG000|Overall Study|Lost to Follow-up|5|||
146515921|NCT01429441|528394339|FG001|Overall Study|Lost to Follow-up|2|||
146515922|NCT01429441|528394338|FG000|Overall Study|Physician Decision|1|||
146515923|NCT01429441|528394339|FG001|Overall Study|Physician Decision|0|||
146515924|NCT01429441|528394338|FG000|Overall Study|Withdrawal by Subject|27|||
146515925|NCT01429441|528394339|FG001|Overall Study|Withdrawal by Subject|18|||
146515926|NCT00803205|528394344|FG000|Overall Study|Adverse Event|7|||
146515927|NCT00803205|528394345|FG001|Overall Study|Adverse Event|2|||
146515928|NCT00803205|528394344|FG000|Overall Study|Lost to Follow-up|1|||
146515929|NCT00803205|528394345|FG001|Overall Study|Lost to Follow-up|0|||
146515930|NCT00803205|528394344|FG000|Overall Study|Withdrawal by Subject|9|||
146515931|NCT00803205|528394345|FG001|Overall Study|Withdrawal by Subject|9|||
146515932|NCT00803205|528394344|FG000|Overall Study|Physician Decision|1|||
146515933|NCT00803205|528394345|FG001|Overall Study|Physician Decision|0|||
146515934|NCT00803205|528394344|FG000|Overall Study|Protocol Violation|1|||
146515935|NCT00803205|528394345|FG001|Overall Study|Protocol Violation|1|||
146515936|NCT00803205|528394344|FG000|Overall Study|Medical Monitor Decision|1|||
146755857|NCT01323660|529271237|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
146755858|NCT01323660|529271238|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
146755859|NCT01323660|529271239|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
146755860|NCT01323660|529271234|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
146755861|NCT01323660|529271235|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
146755862|NCT01323660|529271236|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
146755863|NCT01323660|529271237|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
146755864|NCT01323660|529271238|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
146755865|NCT01323660|529271239|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
146755866|NCT01323660|529271234|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
146755867|NCT01323660|529271235|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
146755868|NCT01323660|529271236|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
146755869|NCT01323660|529271237|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
146755870|NCT01323660|529271238|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
146755871|NCT01323660|529271239|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
146755872|NCT01323660|529271234|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146755873|NCT01323660|529271235|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146755874|NCT01323660|529271236|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146755875|NCT01323660|529271237|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146755876|NCT01323660|529271238|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
146515937|NCT00803205|528394345|FG001|Overall Study|Medical Monitor Decision|0|||
146515938|NCT00803205|528394344|FG000|Overall Study|Acquired a Lung Infection|0|||
146515939|NCT00803205|528394345|FG001|Overall Study|Acquired a Lung Infection|1|||
146515940|NCT00803205|528394344|FG000|Overall Study|Sponsor Decision|0|||
146515941|NCT00803205|528394345|FG001|Overall Study|Sponsor Decision|1|||
146515942|NCT00621517|528394353|FG000|Overall Study|Lost to Follow-up|3|||
146515943|NCT00621517|528394354|FG001|Overall Study|Lost to Follow-up|3|||
146515944|NCT00621517|528394353|FG000|Overall Study|Withdrawal by Subject|3|||
146515945|NCT00621517|528394354|FG001|Overall Study|Withdrawal by Subject|4|||
146515946|NCT00621517|528394353|FG000|Overall Study|Adverse Event|1|||
146515947|NCT00621517|528394354|FG001|Overall Study|Adverse Event|0|||
146965056|NCT03110107|530033446|FG020|Treatment Period|Study drug toxicity|2|||
146515948|NCT01863732|528394355|FG000|Overall Study|Adverse Event|2|||
146515949|NCT01863732|528394356|FG001|Overall Study|Adverse Event|0|||
146515950|NCT01863732|528394357|FG002|Overall Study|Adverse Event|3|||
146515951|NCT01863732|528394358|FG003|Overall Study|Adverse Event|3|||
146515952|NCT01863732|528394355|FG000|Overall Study|Lack of Efficacy|1|||
146515953|NCT01863732|528394356|FG001|Overall Study|Lack of Efficacy|0|||
146515954|NCT01863732|528394357|FG002|Overall Study|Lack of Efficacy|2|||
146515955|NCT01863732|528394358|FG003|Overall Study|Lack of Efficacy|1|||
146515956|NCT01863732|528394355|FG000|Overall Study|Lost to Follow-up|2|||
146515957|NCT01863732|528394356|FG001|Overall Study|Lost to Follow-up|2|||
146515958|NCT01863732|528394357|FG002|Overall Study|Lost to Follow-up|1|||
146515959|NCT01863732|528394358|FG003|Overall Study|Lost to Follow-up|1|||
146515960|NCT01863732|528394355|FG000|Overall Study|Physician Decision|1|||
146515961|NCT01863732|528394356|FG001|Overall Study|Physician Decision|0|||
146515962|NCT01863732|528394357|FG002|Overall Study|Physician Decision|1|||
146515963|NCT01863732|528394358|FG003|Overall Study|Physician Decision|0|||
146515964|NCT01863732|528394355|FG000|Overall Study|Pregnancy|0|||
146515965|NCT01863732|528394356|FG001|Overall Study|Pregnancy|0|||
146515966|NCT01863732|528394357|FG002|Overall Study|Pregnancy|0|||
146515967|NCT01863732|528394358|FG003|Overall Study|Pregnancy|1|||
146515968|NCT01863732|528394355|FG000|Overall Study|Technical problems|0|||
146515969|NCT01863732|528394356|FG001|Overall Study|Technical problems|1|||
146515970|NCT01863732|528394357|FG002|Overall Study|Technical problems|1|||
146515971|NCT01863732|528394358|FG003|Overall Study|Technical problems|0|||
146515972|NCT01863732|528394355|FG000|Overall Study|Subject/guardian decision|6|||
146515973|NCT01863732|528394356|FG001|Overall Study|Subject/guardian decision|9|||
146515974|NCT01863732|528394357|FG002|Overall Study|Subject/guardian decision|3|||
146515975|NCT01863732|528394358|FG003|Overall Study|Subject/guardian decision|1|||
146515976|NCT01863732|528394355|FG000|Overall Study|Death|1|||
146515977|NCT01863732|528394356|FG001|Overall Study|Death|0|||
146515978|NCT01863732|528394357|FG002|Overall Study|Death|0|||
146515979|NCT01863732|528394358|FG003|Overall Study|Death|1|||
146515980|NCT03084315|528394359|FG000|Overall Study|Lost to Follow-up|8|||
146515981|NCT03084315|528394360|FG001|Overall Study|Lost to Follow-up|7|||
146515982|NCT03084315|528394359|FG000|Overall Study|Withdrawal by Subject|2|||
146515983|NCT03084315|528394360|FG001|Overall Study|Withdrawal by Subject|2|||
146515984|NCT02906033|528394363|FG000|Baseline|Protocol Violation|37|||
146515985|NCT02906033|528394364|FG001|Baseline|Protocol Violation|33|||
146515986|NCT02906033|528394363|FG000|Follow-up|Lost to Follow-up|46|||
146515987|NCT02906033|528394364|FG001|Follow-up|Lost to Follow-up|62|||
146515988|NCT01709409|528396149|FG000|Overall Study|Protocol Violation|1|||
146515989|NCT01709409|528396150|FG001|Overall Study|Protocol Violation|0|||
146515990|NCT02412878|528396151|FG000|Overall Study|Withdrawal by Subject|19|||
146515991|NCT02412878|528396152|FG001|Overall Study|Withdrawal by Subject|10|||
146515992|NCT02412878|528396151|FG000|Overall Study|Lost to Follow-up|2|||
146515993|NCT02412878|528396152|FG001|Overall Study|Lost to Follow-up|3|||
146515994|NCT02190721|528396153|FG000|Overall Study|Patient was out of the city|0|||
146515995|NCT02190721|528396154|FG001|Overall Study|Patient was out of the city|1|||
146515996|NCT02190721|528396155|FG002|Overall Study|Patient was out of the city|0|||
146515997|NCT04571385|528396156|FG000|Overall Study|Participant non-compliance|1|||
146515998|NCT04571385|528396157|FG001|Overall Study|Participant non-compliance|0|||
146515999|NCT04571385|528396158|FG002|Overall Study|Participant non-compliance|0|||
146516000|NCT04571385|528396156|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
146516001|NCT04571385|528396157|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
146516002|NCT04571385|528396158|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
146516003|NCT04571385|528396156|FG000|Overall Study|Screen failure|0|||
146516004|NCT04571385|528396157|FG001|Overall Study|Screen failure|0|||
146516005|NCT04571385|528396158|FG002|Overall Study|Screen failure|1|||
146516006|NCT01928199|528396160|FG000|Overall Study|Lost to Follow-up|2|||
146516007|NCT01928199|528396161|FG001|Overall Study|Lost to Follow-up|1|||
146516008|NCT01928199|528396160|FG000|Overall Study|Withdrawal by Subject|3|||
146516009|NCT01928199|528396161|FG001|Overall Study|Withdrawal by Subject|5|||
146755877|NCT01323660|529271239|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146755878|NCT01052662|529271240|FG000|Overall Study|Lost to Follow-up|15|||
146755879|NCT01052662|529271241|FG001|Overall Study|Lost to Follow-up|13|||
146755880|NCT01052662|529271242|FG002|Overall Study|Lost to Follow-up|18|||
146755881|NCT01052662|529271240|FG000|Overall Study|Withdrawal by Subject|3|||
146755882|NCT01052662|529271241|FG001|Overall Study|Withdrawal by Subject|2|||
146755883|NCT01052662|529271242|FG002|Overall Study|Withdrawal by Subject|1|||
146755884|NCT01052662|529271240|FG000|Overall Study|Pharmacy issue|1|||
146755885|NCT01052662|529271241|FG001|Overall Study|Pharmacy issue|3|||
146755886|NCT01052662|529271242|FG002|Overall Study|Pharmacy issue|3|||
146755887|NCT01052662|529271240|FG000|Overall Study|Adverse Event|1|||
146755888|NCT01052662|529271241|FG001|Overall Study|Adverse Event|1|||
146755889|NCT01052662|529271242|FG002|Overall Study|Adverse Event|0|||
146755890|NCT01052662|529271240|FG000|Overall Study|Legal Problem|2|||
146755891|NCT01052662|529271241|FG001|Overall Study|Legal Problem|0|||
146755892|NCT01052662|529271242|FG002|Overall Study|Legal Problem|0|||
146516010|NCT01066663|528396189|FG000|Overall Study|Adverse Event|0|||
146516011|NCT01066663|528396190|FG001|Overall Study|Adverse Event|0|||
146516012|NCT01066663|528396191|FG002|Overall Study|Adverse Event|1|||
146516013|NCT01090050|528396192|FG000|Overall Study|Lost to Follow-up|0|||
146516014|NCT01090050|528396193|FG001|Overall Study|Lost to Follow-up|1|||
146516015|NCT01090050|528396192|FG000|Overall Study|Lack of Efficacy|1|||
146516016|NCT01090050|528396193|FG001|Overall Study|Lack of Efficacy|5|||
146516017|NCT01090050|528396192|FG000|Overall Study|Physician Decision|0|||
146516018|NCT01090050|528396193|FG001|Overall Study|Physician Decision|1|||
146516019|NCT03539484|528396194|FG000|Overall Study|Death|1|||
146516020|NCT03539484|528396195|FG001|Overall Study|Death|0|||
146516021|NCT03539484|528396196|FG002|Overall Study|Death|0|||
146516022|NCT03539484|528396197|FG003|Overall Study|Death|2|||
146516023|NCT03539484|528396198|FG004|Overall Study|Death|8|||
146516024|NCT03539484|528396199|FG005|Overall Study|Death|3|||
146516025|NCT03539484|528396200|FG006|Overall Study|Death|0|||
146516026|NCT03539484|528396194|FG000|Overall Study|Lost to Follow-up|0|||
146516027|NCT03539484|528396195|FG001|Overall Study|Lost to Follow-up|1|||
146516028|NCT03539484|528396196|FG002|Overall Study|Lost to Follow-up|0|||
146516029|NCT03539484|528396197|FG003|Overall Study|Lost to Follow-up|0|||
146516030|NCT03539484|528396198|FG004|Overall Study|Lost to Follow-up|1|||
146755893|NCT01052662|529271240|FG000|Overall Study|Administrative|0|||
146755894|NCT01052662|529271241|FG001|Overall Study|Administrative|3|||
146853320|NCT01451827|529633606|FG003|Overall Study|Lost to Follow-up|2|||
146853321|NCT01451827|529633603|FG000|Overall Study|Participant met withdrawal criteria|0|||
146853322|NCT01451827|529633604|FG001|Overall Study|Participant met withdrawal criteria|2|||
146853323|NCT01451827|529633605|FG002|Overall Study|Participant met withdrawal criteria|0|||
146853324|NCT01451827|529633606|FG003|Overall Study|Participant met withdrawal criteria|0|||
146853325|NCT01451827|529633603|FG000|Overall Study|Withdrawal by Subject|0|||
146853326|NCT01451827|529633604|FG001|Overall Study|Withdrawal by Subject|0|||
146853327|NCT01451827|529633605|FG002|Overall Study|Withdrawal by Subject|1|||
146853328|NCT01451827|529633606|FG003|Overall Study|Withdrawal by Subject|1|||
146853329|NCT01964924|529633607|FG000|Trametinib Monotherapy|Progression|19|||
146853330|NCT01964924|529633608|FG001|Trametinib Monotherapy|Progression|0|||
146853331|NCT01528345|529633609|FG000|Overall Study|Adverse Event|10|||
146853332|NCT01528345|529633610|FG001|Overall Study|Adverse Event|1|||
146853333|NCT01528345|529633609|FG000|Overall Study|Death|1|||
146853334|NCT01528345|529633610|FG001|Overall Study|Death|1|||
146853335|NCT01528345|529633609|FG000|Overall Study|Non-compliance with study treatment|1|||
146853336|NCT01528345|529633610|FG001|Overall Study|Non-compliance with study treatment|0|||
146853337|NCT01528345|529633609|FG000|Overall Study|Progressive Disease|26|||
146853338|NCT01528345|529633610|FG001|Overall Study|Progressive Disease|40|||
146853339|NCT01528345|529633609|FG000|Overall Study|Study Terminated by Sponsor|4|||
146755895|NCT01052662|529271242|FG002|Overall Study|Administrative|0|||
146755896|NCT00479674|529271243|FG000|Overall Study|Adverse Event|18|||
146755897|NCT00479674|529271243|FG000|Overall Study|Withdrawal by Subject|6|||
146755898|NCT00479674|529271243|FG000|Overall Study|Physician Decision|14|||
146755899|NCT00479674|529271243|FG000|Overall Study|none provided|3|||
146755900|NCT01272011|529271246|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
146755901|NCT01272011|529271247|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
146755902|NCT01272011|529271248|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
146755903|NCT02240680|529271249|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
146755904|NCT02240680|529271250|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
146755905|NCT02240680|529271251|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
146755906|NCT02240680|529271252|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
146755907|NCT02240680|529271249|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
146755908|NCT02240680|529271250|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
146755909|NCT02240680|529271251|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
146755910|NCT02240680|529271252|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
146755911|NCT02240680|529271249|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
146853340|NCT01528345|529633610|FG001|Overall Study|Study Terminated by Sponsor|8|||
146853341|NCT01528345|529633609|FG000|Overall Study|Subject/Guardian Decision|5|||
146516031|NCT03539484|528396199|FG005|Overall Study|Lost to Follow-up|0|||
146516032|NCT03539484|528396200|FG006|Overall Study|Lost to Follow-up|0|||
146516033|NCT03539484|528396194|FG000|Overall Study|Withdrawal by Subject|0|||
146516034|NCT03539484|528396195|FG001|Overall Study|Withdrawal by Subject|0|||
146516035|NCT03539484|528396196|FG002|Overall Study|Withdrawal by Subject|0|||
146516036|NCT03539484|528396197|FG003|Overall Study|Withdrawal by Subject|0|||
146516037|NCT03539484|528396198|FG004|Overall Study|Withdrawal by Subject|2|||
146516038|NCT03539484|528396199|FG005|Overall Study|Withdrawal by Subject|0|||
146755912|NCT02240680|529271250|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
146853342|NCT01528345|529633610|FG001|Overall Study|Subject/Guardian Decision|0|||
146853343|NCT02424734|529633611|FG000|Overall Study|Treatment stopped to be discharged home|2|||
146516039|NCT03539484|528396200|FG006|Overall Study|Withdrawal by Subject|1|||
146516040|NCT03539484|528396194|FG000|Overall Study|Study Terminated by Sponsor|0|||
146516041|NCT03539484|528396195|FG001|Overall Study|Study Terminated by Sponsor|0|||
146853344|NCT02424734|529633612|FG001|Overall Study|Treatment stopped to be discharged home|2|||
146853345|NCT02424734|529633613|FG002|Overall Study|Treatment stopped to be discharged home|0|||
146853346|NCT02150343|529633618|FG000|Overall Study|Adverse Event|2|||
146853347|NCT02150343|529633619|FG001|Overall Study|Adverse Event|0|||
146853348|NCT02150343|529633620|FG002|Overall Study|Adverse Event|1|||
146853349|NCT02150343|529633621|FG003|Overall Study|Adverse Event|1|||
146853350|NCT02150343|529633618|FG000|Overall Study|Withdrawal by Subject|13|||
146853351|NCT02150343|529633619|FG001|Overall Study|Withdrawal by Subject|10|||
146853352|NCT02150343|529633620|FG002|Overall Study|Withdrawal by Subject|9|||
146853353|NCT02150343|529633621|FG003|Overall Study|Withdrawal by Subject|4|||
146853354|NCT02150343|529633618|FG000|Overall Study|Lost to Follow-up|4|||
146853355|NCT02150343|529633619|FG001|Overall Study|Lost to Follow-up|4|||
146853356|NCT02150343|529633620|FG002|Overall Study|Lost to Follow-up|2|||
146853357|NCT02150343|529633621|FG003|Overall Study|Lost to Follow-up|3|||
146516042|NCT03539484|528396196|FG002|Overall Study|Study Terminated by Sponsor|1|||
146516043|NCT03539484|528396197|FG003|Overall Study|Study Terminated by Sponsor|1|||
146516044|NCT03539484|528396198|FG004|Overall Study|Study Terminated by Sponsor|2|||
146516045|NCT03539484|528396199|FG005|Overall Study|Study Terminated by Sponsor|2|||
146516046|NCT03539484|528396200|FG006|Overall Study|Study Terminated by Sponsor|1|||
146853358|NCT02150343|529633618|FG000|Overall Study|Other|2|||
146853359|NCT02150343|529633619|FG001|Overall Study|Other|6|||
146853360|NCT02150343|529633620|FG002|Overall Study|Other|0|||
146853361|NCT02150343|529633621|FG003|Overall Study|Other|2|||
146853362|NCT02729753|529633622|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
146516047|NCT02232061|528396201|FG000|Overall Study|Administrative problems|1|||
146516048|NCT02232061|528396201|FG000|Overall Study|Withdrawal by Subject|1|||
146516049|NCT00571103|528396202|FG000|Overall Study|Withdrawal by Subject|1|||
146516050|NCT00571103|528396202|FG000|Overall Study|Lost to Follow-up|1|||
146516051|NCT06010732|528396204|FG000|Crossover Period 1|Protocol Violation|0|||
146516052|NCT06010732|528396205|FG001|Crossover Period 1|Protocol Violation|0|||
146516053|NCT06010732|528396206|FG002|Crossover Period 1|Protocol Violation|1|||
146516054|NCT06010732|528396207|FG003|Crossover Period 1|Protocol Violation|0|||
146516055|NCT06010732|528396208|FG004|Crossover Period 1|Protocol Violation|1|||
146516056|NCT06010732|528396209|FG005|Crossover Period 1|Protocol Violation|0|||
146516057|NCT06010732|528396204|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
146516058|NCT06010732|528396205|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
146516059|NCT06010732|528396206|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
146516060|NCT06010732|528396207|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
146516061|NCT06010732|528396208|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
146516062|NCT06010732|528396209|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
146516063|NCT06010732|528396204|FG000|Crossover Period 2|Adverse Event|0|||
146516064|NCT06010732|528396205|FG001|Crossover Period 2|Adverse Event|1|||
146516065|NCT06010732|528396206|FG002|Crossover Period 2|Adverse Event|0|||
146516066|NCT06010732|528396207|FG003|Crossover Period 2|Adverse Event|0|||
146516067|NCT06010732|528396208|FG004|Crossover Period 2|Adverse Event|0|||
146516068|NCT06010732|528396209|FG005|Crossover Period 2|Adverse Event|0|||
146516069|NCT06010732|528396204|FG000|Crossover Period 2|broken denture|0|||
146516070|NCT06010732|528396205|FG001|Crossover Period 2|broken denture|0|||
146516071|NCT06010732|528396206|FG002|Crossover Period 2|broken denture|1|||
146516072|NCT06010732|528396207|FG003|Crossover Period 2|broken denture|0|||
146516073|NCT06010732|528396208|FG004|Crossover Period 2|broken denture|0|||
146516074|NCT06010732|528396209|FG005|Crossover Period 2|broken denture|0|||
146516075|NCT04942210|528396211|FG000|Overall Study|Adverse Event|0|||
146516076|NCT04942210|528396212|FG001|Overall Study|Adverse Event|1|||
146516077|NCT04942210|528396211|FG000|Overall Study|Protocol Deviation|4|||
146516078|NCT04942210|528396212|FG001|Overall Study|Protocol Deviation|1|||
146516079|NCT04942210|528396211|FG000|Overall Study|Withdrawal by Subject|5|||
146516080|NCT04942210|528396212|FG001|Overall Study|Withdrawal by Subject|2|||
146516081|NCT04942210|528396211|FG000|Overall Study|Lost to Follow-up|16|||
146516082|NCT04942210|528396212|FG001|Overall Study|Lost to Follow-up|7|||
146516083|NCT04942210|528396211|FG000|Overall Study|Ongoing at the time of DBL date|60|||
146516084|NCT04942210|528396212|FG001|Overall Study|Ongoing at the time of DBL date|25|||
146516085|NCT04942210|528396211|FG000|Overall Study|Randomized but did not receive vaccination|3|||
146853363|NCT02729753|529633623|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
146853364|NCT01090427|529633624|FG000|After Controlled Period|Death|0|||
146516086|NCT04942210|528396212|FG001|Overall Study|Randomized but did not receive vaccination|0|||
146516087|NCT05697627|528396213|FG000|Overall Study|Adverse Event|1|||
146516088|NCT02722746|528396216|FG000|Overall Study|Withdrawal by Subject|0|||
146516089|NCT02722746|528396217|FG001|Overall Study|Withdrawal by Subject|1|||
146516090|NCT02722746|528396218|FG002|Overall Study|Withdrawal by Subject|0|||
146516091|NCT02722746|528396216|FG000|Overall Study|Protocol Violation|8|||
146853365|NCT01090427|529633625|FG001|After Controlled Period|Death|0|||
146853366|NCT01090427|529633626|FG002|After Controlled Period|Death|0|||
146853367|NCT01090427|529633627|FG003|After Controlled Period|Death|0|||
146853368|NCT01090427|529633628|FG004|After Controlled Period|Death|0|||
146516092|NCT02722746|528396217|FG001|Overall Study|Protocol Violation|4|||
146516093|NCT02722746|528396218|FG002|Overall Study|Protocol Violation|6|||
146516094|NCT04379700|528396223|FG000|Overall Study|Withdrawal by Subject|10|||
146516095|NCT04379700|528396223|FG000|Overall Study|Screen Fail|4|||
146516096|NCT04379700|528396223|FG000|Overall Study|Lost to Follow-up|3|||
146516097|NCT03624569|528396224|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
146516098|NCT03624569|528396225|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
146516099|NCT03624569|528396224|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
146516100|NCT03624569|528396225|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
146516101|NCT01038752|528396226|FG000|Overall Study|Tumor Progression|2|||
146516102|NCT01038752|528396227|FG001|Overall Study|Tumor Progression|2|||
146516103|NCT01038752|528396226|FG000|Overall Study|Lost to Follow-up|3|||
146516104|NCT01038752|528396227|FG001|Overall Study|Lost to Follow-up|3|||
146516105|NCT01404949|528396246|FG000|Overall Study|Not Treated|1|||
146516106|NCT00002525|528396247|FG000|Overall Study|Adverse Event|36|||
146516107|NCT00002525|528396248|FG001|Overall Study|Adverse Event|0|||
146516108|NCT00002525|528396247|FG000|Overall Study|Death|5|||
146516109|NCT00002525|528396248|FG001|Overall Study|Death|0|||
146516110|NCT00002525|528396247|FG000|Overall Study|Withdrawal by Subject|11|||
146516111|NCT00002525|528396248|FG001|Overall Study|Withdrawal by Subject|0|||
146516112|NCT00002525|528396247|FG000|Overall Study|Start non-protocol therapy|1|||
146516113|NCT00002525|528396248|FG001|Overall Study|Start non-protocol therapy|0|||
146516114|NCT00002525|528396247|FG000|Overall Study|Other complicating disease|1|||
146516115|NCT00002525|528396248|FG001|Overall Study|Other complicating disease|0|||
146516116|NCT00002525|528396247|FG000|Overall Study|Duke's A, B1, D disease|92|||
146516117|NCT00002525|528396248|FG001|Overall Study|Duke's A, B1, D disease|0|||
146516118|NCT00002525|528396247|FG000|Overall Study|Error|6|||
146516119|NCT00002525|528396248|FG001|Overall Study|Error|0|||
146516120|NCT00002525|528396247|FG000|Overall Study|Other|26|||
146516121|NCT00002525|528396248|FG001|Overall Study|Other|0|||
146516122|NCT00002525|528396247|FG000|Overall Study|Never start protocol therapy|8|||
146516123|NCT00002525|528396248|FG001|Overall Study|Never start protocol therapy|0|||
146516124|NCT02651688|528396256|FG000|Overall Study|Non-compliance|0|||
146516125|NCT02651688|528396257|FG001|Overall Study|Non-compliance|0|||
146516126|NCT02651688|528396258|FG002|Overall Study|Non-compliance|1|||
146516127|NCT02651688|528396256|FG000|Overall Study|Principal Investigator (PI) decision|0|||
146516128|NCT02651688|528396257|FG001|Overall Study|Principal Investigator (PI) decision|2|||
146516129|NCT02651688|528396258|FG002|Overall Study|Principal Investigator (PI) decision|0|||
146516130|NCT02651688|528396256|FG000|Overall Study|Lost to Follow-up|1|||
146516131|NCT02651688|528396257|FG001|Overall Study|Lost to Follow-up|3|||
146516132|NCT02651688|528396258|FG002|Overall Study|Lost to Follow-up|0|||
146516133|NCT02651688|528396256|FG000|Overall Study|Withdrawal by Subject|1|||
146516134|NCT02651688|528396257|FG001|Overall Study|Withdrawal by Subject|0|||
146516135|NCT02651688|528396258|FG002|Overall Study|Withdrawal by Subject|2|||
146516136|NCT04527978|528396259|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
146516137|NCT04527978|528396260|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
146516138|NCT00055497|528396261|FG000|Overall Study|Adverse Event|1|||
146516139|NCT00055497|528396262|FG001|Overall Study|Adverse Event|1|||
146516140|NCT00055497|528396263|FG002|Overall Study|Adverse Event|1|||
146516141|NCT00055497|528396264|FG003|Overall Study|Adverse Event|28|||
146755913|NCT02240680|529271251|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
146755914|NCT02240680|529271252|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
146755915|NCT02240680|529271249|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
146755916|NCT02240680|529271250|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
146755917|NCT02240680|529271251|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
146755918|NCT02240680|529271252|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
146755919|NCT02240680|529271249|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
146755920|NCT02240680|529271250|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
146755921|NCT02240680|529271251|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
146755922|NCT02240680|529271252|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
146755923|NCT02240680|529271249|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
146755924|NCT02240680|529271250|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
146755925|NCT02240680|529271251|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
146755926|NCT02240680|529271252|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
146755927|NCT02240680|529271249|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
146755928|NCT02240680|529271250|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
146516142|NCT00055497|528396261|FG000|Overall Study|Withdrawal by Subject|3|||
146516143|NCT00055497|528396262|FG001|Overall Study|Withdrawal by Subject|1|||
146516144|NCT00055497|528396263|FG002|Overall Study|Withdrawal by Subject|1|||
146516145|NCT00055497|528396264|FG003|Overall Study|Withdrawal by Subject|15|||
146516146|NCT00055497|528396261|FG000|Overall Study|Lost to Follow-up|0|||
146516147|NCT00055497|528396262|FG001|Overall Study|Lost to Follow-up|1|||
146755929|NCT02240680|529271251|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
146853369|NCT01090427|529633629|FG005|After Controlled Period|Death|1|||
146516148|NCT00055497|528396263|FG002|Overall Study|Lost to Follow-up|0|||
146516149|NCT00055497|528396264|FG003|Overall Study|Lost to Follow-up|5|||
146516150|NCT00055497|528396261|FG000|Overall Study|Protocol Violation|0|||
146516151|NCT00055497|528396262|FG001|Overall Study|Protocol Violation|0|||
146516152|NCT00055497|528396263|FG002|Overall Study|Protocol Violation|0|||
146516153|NCT00055497|528396264|FG003|Overall Study|Protocol Violation|3|||
146516154|NCT00055497|528396261|FG000|Overall Study|Lack of Efficacy|1|||
146516155|NCT00055497|528396262|FG001|Overall Study|Lack of Efficacy|0|||
146516156|NCT00055497|528396263|FG002|Overall Study|Lack of Efficacy|0|||
146516157|NCT00055497|528396264|FG003|Overall Study|Lack of Efficacy|27|||
146516158|NCT00055497|528396261|FG000|Overall Study|Administrative Reasons|0|||
146516159|NCT00055497|528396262|FG001|Overall Study|Administrative Reasons|0|||
146516160|NCT00055497|528396263|FG002|Overall Study|Administrative Reasons|0|||
146516161|NCT00055497|528396264|FG003|Overall Study|Administrative Reasons|1|||
146516162|NCT00055497|528396261|FG000|Overall Study|Other|0|||
146516163|NCT00055497|528396262|FG001|Overall Study|Other|0|||
146516164|NCT00055497|528396263|FG002|Overall Study|Other|0|||
146516165|NCT00055497|528396264|FG003|Overall Study|Other|11|||
146516166|NCT02112877|528396266|FG000|Overall Study|Withdrawal by Subject|1|||
146516167|NCT02112877|528396267|FG001|Overall Study|Withdrawal by Subject|7|||
146516168|NCT02112877|528396266|FG000|Overall Study|Visit Missed|1|||
146516169|NCT02112877|528396267|FG001|Overall Study|Visit Missed|6|||
146516170|NCT00380718|528396268|FG000|Overall Study|Adverse Event|1|||
146516171|NCT00380718|528396268|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
146516172|NCT01606748|528396273|FG000|Overall Study|Adverse Event|1|||
146516173|NCT01606748|528396274|FG001|Overall Study|Adverse Event|0|||
146516174|NCT01606748|528396273|FG000|Overall Study|Progressive Disease|1|||
146516175|NCT01606748|528396274|FG001|Overall Study|Progressive Disease|0|||
146516176|NCT01606748|528396273|FG000|Overall Study|Withdrawal by Subject|1|||
146516177|NCT01606748|528396274|FG001|Overall Study|Withdrawal by Subject|0|||
146516178|NCT01706575|528396275|FG000|Overall Study|Participant Withdrew Consent|4|||
146516179|NCT01706575|528396275|FG000|Overall Study|Lost to Follow-up|2|||
146516180|NCT01706575|528396275|FG000|Overall Study|Started but not Treated|6|||
146516181|NCT02912455|528396276|FG000|Overall Study|Withdrawal by Subject|0|||
146516182|NCT02912455|528396277|FG001|Overall Study|Withdrawal by Subject|1|||
146516183|NCT02912455|528396276|FG000|Overall Study|Lack of Efficacy|0|||
146516184|NCT02912455|528396277|FG001|Overall Study|Lack of Efficacy|1|||
146516185|NCT02912455|528396276|FG000|Overall Study|Lost to Follow-up|2|||
146516186|NCT02912455|528396277|FG001|Overall Study|Lost to Follow-up|1|||
146516187|NCT01810783|528396278|FG000|Overall Study|Adverse Event|32|||
146516188|NCT01810783|528396278|FG000|Overall Study|Withdrawal by Subject|22|||
146516189|NCT01810783|528396278|FG000|Overall Study|Lack of Efficacy|12|||
146516190|NCT01810783|528396278|FG000|Overall Study|Lost to Follow-up|10|||
146516191|NCT01810783|528396278|FG000|Overall Study|Protocol Violation|5|||
146516192|NCT01810783|528396278|FG000|Overall Study|Non-compliance with IMP|4|||
146516193|NCT01810783|528396278|FG000|Overall Study|Adminstrative or other reason(s)|23|||
146516194|NCT01810783|528396278|FG000|Overall Study|Enrolled, not treated|1|||
146516195|NCT00094536|528396283|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
146516196|NCT00094536|528396283|FG000|Treatment and Follow-up|Adverse Event|4|||
146516197|NCT00094536|528396283|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
146516198|NCT00094536|528396283|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
146516199|NCT00094536|528396283|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
146516200|NCT00094536|528396283|FG000|Treatment and Follow-up|Subject non-compliance|9|||
146516201|NCT00094536|528396283|FG000|Treatment and Follow-up|Unable to attend visits|1|||
146516202|NCT02655419|528396284|FG000|Overall Study|Enrolled but not treated|1|||
146516203|NCT02655419|528396285|FG001|Overall Study|Enrolled but not treated|5|||
146516204|NCT02655419|528396284|FG000|Overall Study|Withdrawal by Subject|4|||
146516205|NCT02655419|528396285|FG001|Overall Study|Withdrawal by Subject|1|||
146516206|NCT02655419|528396284|FG000|Overall Study|Other|0|||
146516207|NCT02655419|528396285|FG001|Overall Study|Other|1|||
146516208|NCT01900431|528396286|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
146516209|NCT01900431|528396287|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
146516210|NCT01900431|528396288|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
146755930|NCT02240680|529271252|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
146755931|NCT02240680|529271249|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
146516211|NCT01900431|528396286|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
146516212|NCT01900431|528396287|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
146516213|NCT01900431|528396288|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
146516214|NCT01900431|528396286|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
146516215|NCT01900431|528396287|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
146516216|NCT01900431|528396288|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
146516217|NCT01900431|528396286|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
146516218|NCT01900431|528396287|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
146516219|NCT01900431|528396288|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
146516220|NCT01900431|528396286|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
146516221|NCT01900431|528396287|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
146516222|NCT01900431|528396288|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
146853370|NCT01090427|529633630|FG006|After Controlled Period|Death|0|||
146853371|NCT01090427|529633624|FG000|After Controlled Period|Lack of Efficacy|0|||
146853372|NCT01090427|529633625|FG001|After Controlled Period|Lack of Efficacy|0|||
146853373|NCT01090427|529633626|FG002|After Controlled Period|Lack of Efficacy|0|||
146853374|NCT01090427|529633627|FG003|After Controlled Period|Lack of Efficacy|0|||
146853375|NCT01090427|529633628|FG004|After Controlled Period|Lack of Efficacy|0|||
146853376|NCT01090427|529633629|FG005|After Controlled Period|Lack of Efficacy|3|||
146853377|NCT01090427|529633630|FG006|After Controlled Period|Lack of Efficacy|2|||
146516223|NCT01900431|528396286|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
146516224|NCT01900431|528396287|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
146516225|NCT01900431|528396288|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
146516226|NCT01900431|528396286|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
146516227|NCT01900431|528396287|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
146516228|NCT01900431|528396288|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
146516229|NCT01900431|528396286|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
146516230|NCT01900431|528396287|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
146516231|NCT01900431|528396288|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
146853378|NCT01090427|529633624|FG000|After Controlled Period|Adverse Event|0|||
146853379|NCT01090427|529633625|FG001|After Controlled Period|Adverse Event|0|||
146853380|NCT01090427|529633626|FG002|After Controlled Period|Adverse Event|0|||
146853381|NCT01090427|529633627|FG003|After Controlled Period|Adverse Event|2|||
146853382|NCT01090427|529633628|FG004|After Controlled Period|Adverse Event|0|||
146853383|NCT01090427|529633629|FG005|After Controlled Period|Adverse Event|1|||
146853384|NCT01090427|529633630|FG006|After Controlled Period|Adverse Event|0|||
146853385|NCT01154010|529633631|FG000|Overall Study|Lost to Follow-up|0|||
146853386|NCT01154010|529633632|FG001|Overall Study|Lost to Follow-up|1|||
146853387|NCT00439231|529633633|FG000|Overall Study|Lack of Efficacy|28|||
146853388|NCT02413333|529633639|FG000|Period 1|Adverse Event|1|||
146516232|NCT01900431|528396286|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
146516233|NCT01900431|528396287|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
146516234|NCT01900431|528396288|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
146516235|NCT04503668|528396289|FG000|Overall Study|Incomplete data|4|||
146516236|NCT04503668|528396290|FG001|Overall Study|Incomplete data|3|||
146516237|NCT04503668|528396289|FG000|Overall Study|Withdrawal by Subject|1|||
146516238|NCT04503668|528396290|FG001|Overall Study|Withdrawal by Subject|1|||
146516239|NCT04503668|528396289|FG000|Overall Study|Adverse Event|2|||
146516240|NCT04503668|528396290|FG001|Overall Study|Adverse Event|0|||
146516241|NCT03782974|528396291|FG000|Overall Study|Withdrawal by Subject|7|||
146516242|NCT03782974|528396292|FG001|Overall Study|Withdrawal by Subject|7|||
146516243|NCT03782974|528396291|FG000|Overall Study|Pregnancy|1|||
146516244|NCT03782974|528396292|FG001|Overall Study|Pregnancy|0|||
146516245|NCT03403621|528396293|FG000|Overall Study|Withdrawal by Subject|2|||
146516246|NCT03403621|528396294|FG001|Overall Study|Withdrawal by Subject|2|||
146516247|NCT00395642|528396295|FG000|Overall Study|Death|4|||
146516248|NCT00395642|528396295|FG000|Overall Study|Lost to Follow-up|1|||
146516249|NCT00395642|528396295|FG000|Overall Study|Physician Decision|7|||
146516250|NCT00395642|528396295|FG000|Overall Study|Withdrawal by Subject|1|||
146516251|NCT01078298|528396298|FG000|Overall Study|Lost to Follow-up|12|||
146516252|NCT01078298|528396299|FG001|Overall Study|Lost to Follow-up|13|||
146516253|NCT01078298|528396298|FG000|Overall Study|Withdrawal by Subject|31|||
146516254|NCT01078298|528396299|FG001|Overall Study|Withdrawal by Subject|33|||
146516255|NCT01078298|528396298|FG000|Overall Study|Protocol Violation|6|||
146516256|NCT01078298|528396299|FG001|Overall Study|Protocol Violation|6|||
146516257|NCT01078298|528396298|FG000|Overall Study|Adverse Event|6|||
146516258|NCT01078298|528396299|FG001|Overall Study|Adverse Event|5|||
146516259|NCT01078298|528396298|FG000|Overall Study|Death|2|||
146516260|NCT01078298|528396299|FG001|Overall Study|Death|0|||
146516261|NCT01078298|528396298|FG000|Overall Study|Did not meet entrance criteria|0|||
146516262|NCT01078298|528396299|FG001|Overall Study|Did not meet entrance criteria|1|||
146516263|NCT01078298|528396298|FG000|Overall Study|Other|24|||
146516264|NCT01078298|528396299|FG001|Overall Study|Other|32|||
146516265|NCT00659776|528396307|FG000|Overall Study|Withdrawal by Subject|12|||
146853389|NCT02413333|529633640|FG001|Period 1|Adverse Event|0|||
146516266|NCT00659776|528396308|FG001|Overall Study|Withdrawal by Subject|2|||
146516267|NCT00659776|528396309|FG002|Overall Study|Withdrawal by Subject|0|||
146516268|NCT00628927|528396310|FG000|Overall Study|Problems performing blood draw|6|||
146516269|NCT00628927|528396311|FG001|Overall Study|Problems performing blood draw|0|||
146516270|NCT00628927|528396310|FG000|Overall Study|Lost to Follow-up|1|||
146516271|NCT00628927|528396311|FG001|Overall Study|Lost to Follow-up|0|||
146853390|NCT02413333|529633639|FG000|Period 1|Reason Not Specified|0|||
146853391|NCT02413333|529633640|FG001|Period 1|Reason Not Specified|1|||
146853392|NCT02413333|529633639|FG000|Period 2|Protocol Deviation|1|||
146853393|NCT02413333|529633640|FG001|Period 2|Protocol Deviation|0|||
146853394|NCT00709852|529633641|FG000|Period 1|Adverse Event|2|||
146853395|NCT00709852|529633642|FG001|Period 1|Adverse Event|0|||
146853396|NCT00709852|529633641|FG000|Period 1|Withdrawal by Subject|4|||
146516272|NCT00628927|528396310|FG000|Overall Study|Equipment failure|1|||
146516273|NCT00628927|528396311|FG001|Overall Study|Equipment failure|0|||
146516274|NCT00448812|528396312|FG000|Year 2|Missed visit but remained in study|4|||
146516275|NCT00448812|528396313|FG001|Year 2|Missed visit but remained in study|1|||
146516276|NCT00448812|528396312|FG000|Year 3|Withdrawal by Subject|1|||
146516277|NCT00448812|528396313|FG001|Year 3|Withdrawal by Subject|3|||
146516278|NCT00448812|528396312|FG000|Year 3|Lost to Follow-up|1|||
146516279|NCT00448812|528396313|FG001|Year 3|Lost to Follow-up|0|||
146516280|NCT00448812|528396312|FG000|Year 3|Missed visit but remained in study|2|||
146516281|NCT00448812|528396313|FG001|Year 3|Missed visit but remained in study|0|||
146516282|NCT00448812|528396312|FG000|Year 5|Missed visit but remained in study|1|||
146516283|NCT00448812|528396313|FG001|Year 5|Missed visit but remained in study|0|||
146516284|NCT01687283|528397981|FG000|Overall Study|Adverse Event|11|||
146516285|NCT01687283|528397982|FG001|Overall Study|Adverse Event|4|||
146516286|NCT01687283|528397981|FG000|Overall Study|Lack of Efficacy|3|||
146516287|NCT01687283|528397982|FG001|Overall Study|Lack of Efficacy|1|||
146516288|NCT01687283|528397981|FG000|Overall Study|Protocol Violation|1|||
146516289|NCT01687283|528397982|FG001|Overall Study|Protocol Violation|3|||
146516290|NCT01687283|528397981|FG000|Overall Study|protocol defined stopping criteria|8|||
146516291|NCT01687283|528397982|FG001|Overall Study|protocol defined stopping criteria|10|||
146516292|NCT01687283|528397981|FG000|Overall Study|Lost to Follow-up|1|||
146516293|NCT01687283|528397982|FG001|Overall Study|Lost to Follow-up|1|||
146516294|NCT01687283|528397981|FG000|Overall Study|Investigator discretion|2|||
146516295|NCT01687283|528397982|FG001|Overall Study|Investigator discretion|0|||
146516296|NCT01687283|528397981|FG000|Overall Study|Withdrawal by Subject|9|||
146516297|NCT01687283|528397982|FG001|Overall Study|Withdrawal by Subject|8|||
146516298|NCT01153009|528397986|FG000|Overall Study|Adverse Event|4|||
146516299|NCT01153009|528397987|FG001|Overall Study|Adverse Event|14|||
146516300|NCT01153009|528397988|FG002|Overall Study|Adverse Event|14|||
146516301|NCT01153009|528397989|FG003|Overall Study|Adverse Event|10|||
146516302|NCT01153009|528397986|FG000|Overall Study|Lack of Efficacy|9|||
146516303|NCT01153009|528397987|FG001|Overall Study|Lack of Efficacy|0|||
146516304|NCT01153009|528397988|FG002|Overall Study|Lack of Efficacy|2|||
146516305|NCT01153009|528397989|FG003|Overall Study|Lack of Efficacy|1|||
146516306|NCT01153009|528397986|FG000|Overall Study|Noncompliance with Study Medication|1|||
146516307|NCT01153009|528397987|FG001|Overall Study|Noncompliance with Study Medication|3|||
146516308|NCT01153009|528397988|FG002|Overall Study|Noncompliance with Study Medication|4|||
146516309|NCT01153009|528397989|FG003|Overall Study|Noncompliance with Study Medication|1|||
146516310|NCT01153009|528397986|FG000|Overall Study|Protocol Deviations|4|||
146516311|NCT01153009|528397987|FG001|Overall Study|Protocol Deviations|3|||
146516312|NCT01153009|528397988|FG002|Overall Study|Protocol Deviations|3|||
146516313|NCT01153009|528397989|FG003|Overall Study|Protocol Deviations|2|||
146516314|NCT01153009|528397986|FG000|Overall Study|Withdrawal of Consent|5|||
146516315|NCT01153009|528397987|FG001|Overall Study|Withdrawal of Consent|5|||
146516316|NCT01153009|528397988|FG002|Overall Study|Withdrawal of Consent|4|||
146516317|NCT01153009|528397989|FG003|Overall Study|Withdrawal of Consent|6|||
146516318|NCT01153009|528397986|FG000|Overall Study|Lost to Follow-up|8|||
146853397|NCT00709852|529633642|FG001|Period 1|Withdrawal by Subject|2|||
146853398|NCT00709852|529633641|FG000|Period 1|Protocol Violation|1|||
146853399|NCT00709852|529633642|FG001|Period 1|Protocol Violation|0|||
146853400|NCT00709852|529633641|FG000|Period 1|Defective scanner|0|||
146853401|NCT00709852|529633642|FG001|Period 1|Defective scanner|1|||
146853402|NCT00709852|529633641|FG000|Period 1|Lost to Follow-up|1|||
146853403|NCT00709852|529633642|FG001|Period 1|Lost to Follow-up|0|||
146853404|NCT00709852|529633641|FG000|Period 2|Protocol Violation|4|||
146853405|NCT00709852|529633642|FG001|Period 2|Protocol Violation|1|||
146853406|NCT00709852|529633641|FG000|Period 2|Adverse Event|1|||
146853407|NCT00709852|529633642|FG001|Period 2|Adverse Event|1|||
146853408|NCT00709852|529633641|FG000|Period 2|Lost to Follow-up|1|||
146853409|NCT00709852|529633642|FG001|Period 2|Lost to Follow-up|0|||
146853410|NCT00709852|529633641|FG000|Period 2|No 72-hour follow-up|3|||
146853411|NCT00709852|529633642|FG001|Period 2|No 72-hour follow-up|0|||
146853412|NCT01048671|529633649|FG000|Overall Study|Protocol Violation|0|||
146853413|NCT01048671|529633650|FG001|Overall Study|Protocol Violation|1|||
146516319|NCT01153009|528397987|FG001|Overall Study|Lost to Follow-up|8|||
146516320|NCT01153009|528397988|FG002|Overall Study|Lost to Follow-up|11|||
146516321|NCT01153009|528397989|FG003|Overall Study|Lost to Follow-up|15|||
146853414|NCT01048671|529633651|FG002|Overall Study|Protocol Violation|1|||
146853415|NCT00296400|529633652|FG000|Overall Study|Adverse Event|7|||
146853416|NCT00296400|529633653|FG001|Overall Study|Adverse Event|7|||
146516322|NCT01153009|528397986|FG000|Overall Study|Other|1|||
146516323|NCT01153009|528397987|FG001|Overall Study|Other|1|||
146516324|NCT01153009|528397988|FG002|Overall Study|Other|3|||
146516325|NCT01153009|528397989|FG003|Overall Study|Other|2|||
146516326|NCT00410072|528397990|FG000|Day 1 to Week 48|Adverse Event|1|||
146516327|NCT00410072|528397991|FG001|Day 1 to Week 48|Adverse Event|2|||
146516328|NCT00410072|528397990|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
146516329|NCT00410072|528397991|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
146853417|NCT00296400|529633654|FG002|Overall Study|Adverse Event|7|||
146853418|NCT00296400|529633652|FG000|Overall Study|Withdrawal by Subject|5|||
146516330|NCT00410072|528397990|FG000|Day 1 to Week 48|Other|0|||
146516331|NCT00410072|528397991|FG001|Day 1 to Week 48|Other|1|||
146516332|NCT00410072|528397990|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
146516333|NCT00410072|528397991|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
146516334|NCT00410072|528397990|FG000|Day 1 to Week 48|Pregnancy|0|||
146516335|NCT00410072|528397991|FG001|Day 1 to Week 48|Pregnancy|2|||
146516336|NCT00410072|528397990|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
146516337|NCT00410072|528397991|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
146516338|NCT00410072|528397990|FG000|After Week 48 to Week 96|Adverse Event|1|||
146516339|NCT00410072|528397991|FG001|After Week 48 to Week 96|Adverse Event|2|||
146516340|NCT00410072|528397990|FG000|After Week 48 to Week 96|Death|0|||
146516341|NCT00410072|528397991|FG001|After Week 48 to Week 96|Death|1|||
146516342|NCT00410072|528397990|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
146516343|NCT00410072|528397991|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
146516344|NCT00410072|528397990|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
146516345|NCT00410072|528397991|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
146516346|NCT00410072|528397990|FG000|After Week 48 to Week 96|Other|2|||
146516347|NCT00410072|528397991|FG001|After Week 48 to Week 96|Other|0|||
146516348|NCT00410072|528397990|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
146516349|NCT00410072|528397991|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
146516350|NCT00410072|528397990|FG000|After Week 48 to Week 96|Pregnancy|0|||
146516351|NCT00410072|528397991|FG001|After Week 48 to Week 96|Pregnancy|2|||
146516352|NCT00410072|528397990|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
146516353|NCT00410072|528397991|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
146516354|NCT03307837|528397993|FG000|Overall Study|Withdrawal by Subject|0|||
146516355|NCT03307837|528397994|FG001|Overall Study|Withdrawal by Subject|0|||
146516356|NCT03307837|528397995|FG002|Overall Study|Withdrawal by Subject|1|||
146516357|NCT03307837|528397996|FG003|Overall Study|Withdrawal by Subject|0|||
146516358|NCT03307837|528397997|FG004|Overall Study|Withdrawal by Subject|0|||
146516359|NCT03307837|528397998|FG005|Overall Study|Withdrawal by Subject|1|||
146516360|NCT03307837|528397993|FG000|Overall Study|Lost to Follow-up|1|||
146516361|NCT03307837|528397994|FG001|Overall Study|Lost to Follow-up|1|||
146516362|NCT03307837|528397995|FG002|Overall Study|Lost to Follow-up|0|||
146516363|NCT03307837|528397996|FG003|Overall Study|Lost to Follow-up|0|||
146516364|NCT03307837|528397997|FG004|Overall Study|Lost to Follow-up|0|||
146853419|NCT00296400|529633653|FG001|Overall Study|Withdrawal by Subject|6|||
146853420|NCT00296400|529633654|FG002|Overall Study|Withdrawal by Subject|2|||
146516365|NCT03307837|528397998|FG005|Overall Study|Lost to Follow-up|1|||
146853421|NCT00296400|529633652|FG000|Overall Study|Incorrect enrollment|2|||
146853422|NCT00296400|529633653|FG001|Overall Study|Incorrect enrollment|0|||
146853423|NCT00296400|529633654|FG002|Overall Study|Incorrect enrollment|0|||
146853424|NCT00296400|529633652|FG000|Overall Study|Protocol Violation|1|||
146853425|NCT00296400|529633653|FG001|Overall Study|Protocol Violation|1|||
146853426|NCT00296400|529633654|FG002|Overall Study|Protocol Violation|1|||
146853427|NCT00296400|529633652|FG000|Overall Study|Lost to Follow-up|1|||
146853428|NCT00296400|529633653|FG001|Overall Study|Lost to Follow-up|1|||
146853429|NCT00296400|529633654|FG002|Overall Study|Lost to Follow-up|2|||
146853430|NCT00296400|529633652|FG000|Overall Study|Study specific discontinuation criteria|0|||
146853431|NCT00296400|529633653|FG001|Overall Study|Study specific discontinuation criteria|0|||
146516366|NCT00904917|528398000|FG000|Overall Study|Lost to Follow-up|2|||
146516367|NCT00904917|528398001|FG001|Overall Study|Lost to Follow-up|2|||
146516368|NCT00904917|528398002|FG002|Overall Study|Lost to Follow-up|2|||
146516369|NCT00904917|528398003|FG003|Overall Study|Lost to Follow-up|2|||
146755932|NCT02240680|529271250|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
146755933|NCT02240680|529271251|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
146755934|NCT02240680|529271252|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
146755935|NCT01657032|529271253|FG000|Overall Study|Lost to Follow-up|0|||
146755936|NCT01657032|529271254|FG001|Overall Study|Lost to Follow-up|7|||
146755937|NCT05968482|529271255|FG000|First Crossover Period|Withdrawal by Subject|0|||
146755938|NCT05968482|529271256|FG001|First Crossover Period|Withdrawal by Subject|0|||
146755939|NCT05968482|529271257|FG002|First Crossover Period|Withdrawal by Subject|1|||
146755940|NCT05968482|529271258|FG003|First Crossover Period|Withdrawal by Subject|0|||
146755941|NCT05968482|529271259|FG004|First Crossover Period|Withdrawal by Subject|0|||
146755942|NCT05968482|529271260|FG005|First Crossover Period|Withdrawal by Subject|0|||
146755943|NCT05968482|529271255|FG000|First Crossover Period|Adverse Event|0|||
146755944|NCT05968482|529271256|FG001|First Crossover Period|Adverse Event|0|||
146755945|NCT05968482|529271257|FG002|First Crossover Period|Adverse Event|0|||
146755946|NCT05968482|529271258|FG003|First Crossover Period|Adverse Event|0|||
146755947|NCT05968482|529271259|FG004|First Crossover Period|Adverse Event|0|||
146755948|NCT05968482|529271260|FG005|First Crossover Period|Adverse Event|1|||
146755949|NCT05968482|529271255|FG000|Second Crossover Period|Withdrawal by Subject|0|||
146755950|NCT05968482|529271256|FG001|Second Crossover Period|Withdrawal by Subject|0|||
146755951|NCT05968482|529271257|FG002|Second Crossover Period|Withdrawal by Subject|0|||
146755952|NCT05968482|529271258|FG003|Second Crossover Period|Withdrawal by Subject|0|||
146853432|NCT00296400|529633654|FG002|Overall Study|Study specific discontinuation criteria|1|||
146516370|NCT00762034|528398004|FG000|Induction Period|Protocol Violation|1|||
146516371|NCT00762034|528398005|FG001|Induction Period|Protocol Violation|2|||
146516372|NCT00762034|528398004|FG000|Induction Period|Entry Criterion Not Met|12|||
146516373|NCT00762034|528398005|FG001|Induction Period|Entry Criterion Not Met|11|||
146516374|NCT00762034|528398004|FG000|Induction Period|Adverse Event|27|||
146516375|NCT00762034|528398005|FG001|Induction Period|Adverse Event|38|||
146755953|NCT05968482|529271259|FG004|Second Crossover Period|Withdrawal by Subject|1|||
146755954|NCT05968482|529271260|FG005|Second Crossover Period|Withdrawal by Subject|0|||
146755955|NCT05968482|529271255|FG000|Third Crossover Period|Adverse Event|0|||
146755956|NCT05968482|529271256|FG001|Third Crossover Period|Adverse Event|0|||
146755957|NCT05968482|529271257|FG002|Third Crossover Period|Adverse Event|0|||
146755958|NCT05968482|529271258|FG003|Third Crossover Period|Adverse Event|0|||
146755959|NCT05968482|529271259|FG004|Third Crossover Period|Adverse Event|1|||
146755960|NCT05968482|529271260|FG005|Third Crossover Period|Adverse Event|0|||
146755961|NCT05968482|529271255|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
146755962|NCT05968482|529271256|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
146755963|NCT05968482|529271257|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
146755964|NCT05968482|529271258|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
146755965|NCT05968482|529271259|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
146755966|NCT05968482|529271260|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
146755967|NCT01925170|529271263|FG000|Overall Study|Unverified cancer status|53|||
146755968|NCT01077024|529271264|FG000|Overall Study|Lost to Follow-up|20|||
146755969|NCT01077024|529271265|FG001|Overall Study|Lost to Follow-up|14|||
146755970|NCT01077024|529271264|FG000|Overall Study|Withdrawal by Subject|0|||
146755971|NCT01077024|529271265|FG001|Overall Study|Withdrawal by Subject|2|||
146755972|NCT01077024|529271264|FG000|Overall Study|Incarcerated|7|||
146755973|NCT01077024|529271265|FG001|Overall Study|Incarcerated|8|||
146755974|NCT01077024|529271264|FG000|Overall Study|Other|4|||
146755975|NCT01077024|529271265|FG001|Overall Study|Other|4|||
146755976|NCT02034435|529271266|FG000|Overall Study|Withdrawal by Subject|1|||
146755977|NCT02034435|529271267|FG001|Overall Study|Withdrawal by Subject|0|||
146755978|NCT02034435|529271268|FG002|Overall Study|Withdrawal by Subject|0|||
146755979|NCT02034435|529271269|FG003|Overall Study|Withdrawal by Subject|0|||
146755980|NCT02034435|529271266|FG000|Overall Study|Illness|0|||
146755981|NCT02034435|529271267|FG001|Overall Study|Illness|2|||
146755982|NCT02034435|529271268|FG002|Overall Study|Illness|0|||
146755983|NCT02034435|529271269|FG003|Overall Study|Illness|0|||
146755984|NCT02034435|529271266|FG000|Overall Study|Inadequate IV access|1|||
146755985|NCT02034435|529271267|FG001|Overall Study|Inadequate IV access|0|||
146755986|NCT02034435|529271268|FG002|Overall Study|Inadequate IV access|0|||
146755987|NCT02034435|529271269|FG003|Overall Study|Inadequate IV access|1|||
146755988|NCT02300311|529271272|FG000|Overall Study|Other than the reason specified|1|||
146755989|NCT02300311|529271273|FG001|Overall Study|Other than the reason specified|0|||
146755990|NCT02300311|529271272|FG000|Overall Study|Refused to continue taking medication|18|||
146755991|NCT02300311|529271273|FG001|Overall Study|Refused to continue taking medication|0|||
146755992|NCT02839681|529271274|FG000|Overall Study|Death|2|||
146755993|NCT00772928|529271275|FG000|Overall Study|Lost to Follow-up|9|||
146755994|NCT00772928|529271276|FG001|Overall Study|Lost to Follow-up|6|||
146755995|NCT00772928|529271275|FG000|Overall Study|Protocol Violation|10|||
146755996|NCT00772928|529271276|FG001|Overall Study|Protocol Violation|12|||
146755997|NCT00772928|529271275|FG000|Overall Study|Withdrawal by Subject|25|||
146755998|NCT00772928|529271276|FG001|Overall Study|Withdrawal by Subject|22|||
146755999|NCT00772928|529271275|FG000|Overall Study|Did not receive vaccine|0|||
146756000|NCT00772928|529271276|FG001|Overall Study|Did not receive vaccine|1|||
146756001|NCT00801242|529271281|FG000|Overall Study|Adverse Event|10|||
146756002|NCT00801242|529271281|FG000|Overall Study|Withdrawal by Subject|13|||
146756003|NCT00801242|529271281|FG000|Overall Study|Protocol Violation|5|||
146756004|NCT00801242|529271281|FG000|Overall Study|Physician Decision|3|||
146756005|NCT00801242|529271281|FG000|Overall Study|Lost to Follow-up|1|||
146756006|NCT00801242|529271281|FG000|Overall Study|Miscellaneous reasons|20|||
146756007|NCT02015195|529271283|FG000|Overall Study|Adverse Event|0|||
146756008|NCT02015195|529271284|FG001|Overall Study|Adverse Event|0|||
146756009|NCT02015195|529271285|FG002|Overall Study|Adverse Event|0|||
146756010|NCT02015195|529271286|FG003|Overall Study|Adverse Event|1|||
146756011|NCT02015195|529271287|FG004|Overall Study|Adverse Event|0|||
146756012|NCT02015195|529271288|FG005|Overall Study|Adverse Event|0|||
146756013|NCT02015195|529271289|FG006|Overall Study|Adverse Event|0|||
146756014|NCT01318811|529271290|FG000|Overall Study|Physician Decision|1|||
146756015|NCT01318811|529271291|FG001|Overall Study|Physician Decision|1|||
146756016|NCT01318811|529271290|FG000|Overall Study|CRRT stopped for head CT|0|||
146756017|NCT01318811|529271291|FG001|Overall Study|CRRT stopped for head CT|1|||
146516376|NCT00762034|528398004|FG000|Induction Period|Lost to Follow-up|1|||
146756018|NCT01318811|529271290|FG000|Overall Study|Death|0|||
146756019|NCT01318811|529271291|FG001|Overall Study|Death|1|||
146756020|NCT01318811|529271290|FG000|Overall Study|CRRT stopped for head MRI|0|||
146756021|NCT01318811|529271291|FG001|Overall Study|CRRT stopped for head MRI|1|||
146516377|NCT00762034|528398005|FG001|Induction Period|Lost to Follow-up|1|||
146516378|NCT00762034|528398004|FG000|Induction Period|Progressive Disease|73|||
146516379|NCT00762034|528398005|FG001|Induction Period|Progressive Disease|55|||
146516380|NCT00762034|528398004|FG000|Induction Period|Physician Decision|21|||
146516381|NCT00762034|528398005|FG001|Induction Period|Physician Decision|20|||
146516382|NCT00762034|528398004|FG000|Induction Period|Withdrawal by Subject|15|||
146516383|NCT00762034|528398005|FG001|Induction Period|Withdrawal by Subject|19|||
146516384|NCT00762034|528398004|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
146516385|NCT00762034|528398005|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
146516386|NCT00762034|528398004|FG000|Induction Period|Deaths Due to Study Disease|9|||
146516387|NCT00762034|528398005|FG001|Induction Period|Deaths Due to Study Disease|9|||
146516388|NCT00762034|528398004|FG000|Maintenance Period|Protocol Violation|1|||
146516389|NCT00762034|528398005|FG001|Maintenance Period|Protocol Violation|3|||
146516390|NCT00762034|528398004|FG000|Maintenance Period|Entry Criterion Not Met|0|||
146516391|NCT00762034|528398005|FG001|Maintenance Period|Entry Criterion Not Met|2|||
146516392|NCT00762034|528398004|FG000|Maintenance Period|Adverse Event|42|||
146516393|NCT00762034|528398005|FG001|Maintenance Period|Adverse Event|26|||
146516394|NCT00762034|528398004|FG000|Maintenance Period|Progressive Disease|186|||
146516395|NCT00762034|528398005|FG001|Maintenance Period|Progressive Disease|224|||
146516396|NCT00762034|528398004|FG000|Maintenance Period|Physician Decision|25|||
146516397|NCT00762034|528398005|FG001|Maintenance Period|Physician Decision|20|||
146516398|NCT00762034|528398004|FG000|Maintenance Period|Withdrawal by Subject|34|||
146516399|NCT00762034|528398005|FG001|Maintenance Period|Withdrawal by Subject|14|||
146516400|NCT00762034|528398004|FG000|Maintenance Period|Death not due to study disease|2|||
146516401|NCT00762034|528398005|FG001|Maintenance Period|Death not due to study disease|5|||
146516402|NCT00762034|528398004|FG000|Maintenance Period|Death due to study disease|3|||
146516403|NCT00762034|528398005|FG001|Maintenance Period|Death due to study disease|3|||
146516404|NCT00762034|528398004|FG000|Maintenance Period|Other|1|||
146516405|NCT00762034|528398005|FG001|Maintenance Period|Other|1|||
146516406|NCT02442206|528398006|FG000|Period 1|Adverse Event|1|||
146516407|NCT02442206|528398007|FG001|Period 1|Adverse Event|1|||
146516408|NCT02442206|528398006|FG000|Period 1|withdrew consent|0|||
146516409|NCT02442206|528398007|FG001|Period 1|withdrew consent|1|||
146516410|NCT02442206|528398006|FG000|Period 1|COPD exacerbation|0|||
146516411|NCT02442206|528398007|FG001|Period 1|COPD exacerbation|1|||
146516412|NCT02442206|528398006|FG000|Period 2|Adverse Event|1|||
146516413|NCT02442206|528398007|FG001|Period 2|Adverse Event|0|||
146516414|NCT01212159|528398010|FG000|Overall Study|Withdrawal by Subject|12|||
146516415|NCT01212159|528398011|FG001|Overall Study|Withdrawal by Subject|12|||
146516416|NCT04676152|528398012|FG000|Overall Study|screen fail|9|||
146516417|NCT00948922|528398014|FG000|Overall Study|Did not start study treatment|2|||
146756022|NCT00577629|529271292|FG000|Treatment Period|Death|1|||
146756023|NCT00577629|529271292|FG000|Long Term Follow-Up|Death|15|||
146756024|NCT00577629|529271292|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
146756025|NCT00577629|529271292|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
146756026|NCT00577629|529271292|FG000|Long Term Follow-Up|Physician Decision|1|||
146756027|NCT01449721|529271293|FG000|Overall Study|Physician Decision|0|||
146756028|NCT01449721|529271294|FG001|Overall Study|Physician Decision|1|||
146756029|NCT01449721|529271293|FG000|Overall Study|Physician Decision|0|||
146756030|NCT01449721|529271294|FG001|Overall Study|Physician Decision|1|||
146756031|NCT00114959|529271300|FG000|Overall Study|Lack of Efficacy|6|||
146756032|NCT00114959|529271300|FG000|Overall Study|Physician Decision|1|||
146756033|NCT00114959|529271300|FG000|Overall Study|Death|1|||
146756034|NCT03212365|529271307|FG000|Overall Study|Discharged prior to Xa level|12|||
146756035|NCT03212365|529271308|FG001|Overall Study|Discharged prior to Xa level|8|||
146756036|NCT03212365|529271307|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
146756037|NCT03212365|529271308|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
146756038|NCT03212365|529271307|FG000|Overall Study|Refused study medication|3|||
146756039|NCT03212365|529271308|FG001|Overall Study|Refused study medication|0|||
146756040|NCT03212365|529271307|FG000|Overall Study|Initiated heparin infusion on floor|1|||
146756041|NCT03212365|529271308|FG001|Overall Study|Initiated heparin infusion on floor|1|||
146756042|NCT03212365|529271307|FG000|Overall Study|Unexpected return to OR|1|||
146756043|NCT03212365|529271308|FG001|Overall Study|Unexpected return to OR|1|||
146756044|NCT03212365|529271307|FG000|Overall Study|Medication distribution error|1|||
146756045|NCT03212365|529271308|FG001|Overall Study|Medication distribution error|0|||
146756046|NCT03212365|529271307|FG000|Overall Study|Required epidural placement|1|||
146756047|NCT03212365|529271308|FG001|Overall Study|Required epidural placement|0|||
146756048|NCT03212365|529271307|FG000|Overall Study|Withdrawal by Subject|0|||
146516418|NCT00948922|528398015|FG001|Overall Study|Did not start study treatment|5|||
146516419|NCT00948922|528398016|FG002|Overall Study|Did not start study treatment|0|||
146516420|NCT00948922|528398014|FG000|Overall Study|Withdrawal by Subject|0|||
146756049|NCT03212365|529271308|FG001|Overall Study|Withdrawal by Subject|1|||
146756050|NCT03212365|529271307|FG000|Overall Study|developed acute renal failure|0|||
146756051|NCT03212365|529271308|FG001|Overall Study|developed acute renal failure|1|||
146516421|NCT00948922|528398015|FG001|Overall Study|Withdrawal by Subject|2|||
146516422|NCT00948922|528398016|FG002|Overall Study|Withdrawal by Subject|1|||
146516423|NCT00948922|528398014|FG000|Overall Study|Death|3|||
146516424|NCT00948922|528398015|FG001|Overall Study|Death|0|||
146516425|NCT00948922|528398016|FG002|Overall Study|Death|0|||
146516426|NCT00948922|528398014|FG000|Overall Study|Disease progression|0|||
146516427|NCT00948922|528398015|FG001|Overall Study|Disease progression|1|||
146853433|NCT00296400|529633652|FG000|Overall Study|Visit 10 was performed earlier|0|||
146853434|NCT00296400|529633653|FG001|Overall Study|Visit 10 was performed earlier|1|||
146853435|NCT00296400|529633654|FG002|Overall Study|Visit 10 was performed earlier|0|||
146853436|NCT00296400|529633652|FG000|Overall Study|Pregnancy|1|||
146853437|NCT00296400|529633653|FG001|Overall Study|Pregnancy|2|||
146853438|NCT00296400|529633654|FG002|Overall Study|Pregnancy|0|||
146853439|NCT01014533|529633655|FG000|Overall Study|Protocol Violation|3|||
146853440|NCT01014533|529633656|FG001|Overall Study|Protocol Violation|2|||
146853441|NCT01014533|529633655|FG000|Overall Study|Withdrawal by Subject|2|||
146853442|NCT01014533|529633656|FG001|Overall Study|Withdrawal by Subject|0|||
146853443|NCT01014533|529633655|FG000|Overall Study|unable to come to appointment|0|||
146853444|NCT01014533|529633656|FG001|Overall Study|unable to come to appointment|3|||
146853445|NCT00412061|529633661|FG000|Double Blind Phase|Disease Progression|101|||
146853446|NCT00412061|529633662|FG001|Double Blind Phase|Disease Progression|154|||
146853447|NCT00412061|529633661|FG000|Double Blind Phase|Adverse Event|61|||
146516428|NCT00948922|528398016|FG002|Overall Study|Disease progression|0|||
146516429|NCT00948922|528398014|FG000|Overall Study|Insurance issues|1|||
146516430|NCT00948922|528398015|FG001|Overall Study|Insurance issues|0|||
146516431|NCT00948922|528398016|FG002|Overall Study|Insurance issues|0|||
146516432|NCT00948922|528398014|FG000|Overall Study|Transplant eligibility issues|2|||
146516433|NCT00948922|528398015|FG001|Overall Study|Transplant eligibility issues|3|||
146516434|NCT00948922|528398016|FG002|Overall Study|Transplant eligibility issues|0|||
146516435|NCT00948922|528398014|FG000|Overall Study|Not evaluable at time of analysis|0|||
146516436|NCT00948922|528398015|FG001|Overall Study|Not evaluable at time of analysis|3|||
146516437|NCT00948922|528398016|FG002|Overall Study|Not evaluable at time of analysis|0|||
146516438|NCT02784288|528398017|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
146516439|NCT02757625|528398018|FG000|Overall Study|Investigator's discretion|0|||
146516440|NCT02757625|528398019|FG001|Overall Study|Investigator's discretion|0|||
146516441|NCT02757625|528398020|FG002|Overall Study|Investigator's discretion|1|||
146516442|NCT02757625|528398021|FG003|Overall Study|Investigator's discretion|0|||
146516443|NCT02757625|528398018|FG000|Overall Study|Adverse Event|0|||
146516444|NCT02757625|528398019|FG001|Overall Study|Adverse Event|0|||
146516445|NCT02757625|528398020|FG002|Overall Study|Adverse Event|1|||
146516446|NCT02757625|528398021|FG003|Overall Study|Adverse Event|0|||
146516447|NCT02131233|528398022|FG000|Overall Study|Not Treated|2|||
146516448|NCT02131233|528398023|FG001|Overall Study|Not Treated|3|||
146516449|NCT02131233|528398022|FG000|Overall Study|Adverse Event|7|||
146516450|NCT02131233|528398023|FG001|Overall Study|Adverse Event|6|||
146516451|NCT02131233|528398022|FG000|Overall Study|Death|0|||
146516452|NCT02131233|528398023|FG001|Overall Study|Death|1|||
146516453|NCT02131233|528398022|FG000|Overall Study|Lack of Efficacy|6|||
146516454|NCT02131233|528398023|FG001|Overall Study|Lack of Efficacy|3|||
146516455|NCT02131233|528398022|FG000|Overall Study|Lost to Follow-up|14|||
146516456|NCT02131233|528398023|FG001|Overall Study|Lost to Follow-up|13|||
146516457|NCT02131233|528398022|FG000|Overall Study|Non-Compliance With Study Drug|8|||
146516458|NCT02131233|528398023|FG001|Overall Study|Non-Compliance With Study Drug|5|||
146516459|NCT02131233|528398022|FG000|Overall Study|Physician Decision|7|||
146516460|NCT02131233|528398023|FG001|Overall Study|Physician Decision|0|||
146516461|NCT02131233|528398022|FG000|Overall Study|Pregnancy|4|||
146516462|NCT02131233|528398023|FG001|Overall Study|Pregnancy|0|||
146516463|NCT02131233|528398022|FG000|Overall Study|Withdrawal by Subject|18|||
146516464|NCT02131233|528398023|FG001|Overall Study|Withdrawal by Subject|11|||
146516465|NCT00645671|528398024|FG000|Overall Study|Protocol Violation|1|||
146516466|NCT00645671|528398025|FG001|Overall Study|Protocol Violation|0|||
146853448|NCT00412061|529633662|FG001|Double Blind Phase|Adverse Event|16|||
146853449|NCT00412061|529633661|FG000|Double Blind Phase|Final Primary Analysis|26|||
146853450|NCT00412061|529633662|FG001|Double Blind Phase|Final Primary Analysis|14|||
146853451|NCT00412061|529633661|FG000|Double Blind Phase|Withdrawal by Subject|18|||
146853452|NCT00412061|529633662|FG001|Double Blind Phase|Withdrawal by Subject|20|||
146853453|NCT00412061|529633661|FG000|Double Blind Phase|Death|6|||
146516467|NCT00645671|528398024|FG000|Overall Study|Withdrawal by Subject|0|||
146516468|NCT00645671|528398025|FG001|Overall Study|Withdrawal by Subject|4|||
146516469|NCT00645671|528398024|FG000|Overall Study|Adverse Event|0|||
146516470|NCT00645671|528398025|FG001|Overall Study|Adverse Event|1|||
146516471|NCT00645671|528398024|FG000|Overall Study|Physician Decision|0|||
146516472|NCT00645671|528398025|FG001|Overall Study|Physician Decision|1|||
146516473|NCT02095197|528398026|FG000|Overall Study|Lost to Follow-up|0|||
146516474|NCT02095197|528398027|FG001|Overall Study|Lost to Follow-up|3|||
146516475|NCT01597492|528398029|FG000|Overall Study|Withdrawal by Subject|1|||
146516476|NCT01597492|528398030|FG001|Overall Study|Withdrawal by Subject|2|||
146516477|NCT01597492|528398029|FG000|Overall Study|Adverse Event|3|||
146516478|NCT01597492|528398030|FG001|Overall Study|Adverse Event|0|||
146516479|NCT01597492|528398029|FG000|Overall Study|Lost to Follow-up|0|||
146516480|NCT01597492|528398030|FG001|Overall Study|Lost to Follow-up|2|||
146516481|NCT01597492|528398029|FG000|Overall Study|Other Reason|2|||
146516482|NCT01597492|528398030|FG001|Overall Study|Other Reason|0|||
146516483|NCT03517449|528398033|FG000|Overall Study|Death|184|||
146516484|NCT03517449|528398034|FG001|Overall Study|Death|236|||
146516485|NCT03517449|528398033|FG000|Overall Study|Lost to Follow-up|0|||
146853454|NCT00412061|529633662|FG001|Double Blind Phase|Death|3|||
146853455|NCT00412061|529633661|FG000|Double Blind Phase|Protocol Violation|3|||
146853456|NCT00412061|529633662|FG001|Double Blind Phase|Protocol Violation|4|||
146853457|NCT00412061|529633661|FG000|Double Blind Phase|New Cander Therapy|1|||
146516486|NCT03517449|528398034|FG001|Overall Study|Lost to Follow-up|2|||
146516487|NCT03517449|528398033|FG000|Overall Study|Withdrawal by Subject|7|||
146853458|NCT00412061|529633662|FG001|Double Blind Phase|New Cander Therapy|1|||
146516488|NCT03517449|528398034|FG001|Overall Study|Withdrawal by Subject|26|||
146516489|NCT03517449|528398033|FG000|Overall Study|Participants Ongoing|220|||
146516490|NCT03517449|528398034|FG001|Overall Study|Participants Ongoing|152|||
146516491|NCT00269477|528398039|FG000|Overall Study|Protocol Violation|5|||
146516492|NCT00269477|528398040|FG001|Overall Study|Protocol Violation|5|||
146516493|NCT00269477|528398041|FG002|Overall Study|Protocol Violation|1|||
146516494|NCT00269477|528398042|FG003|Overall Study|Protocol Violation|0|||
146516495|NCT00269477|528398039|FG000|Overall Study|Missed post-vaccination blood draw|0|||
146516496|NCT00269477|528398040|FG001|Overall Study|Missed post-vaccination blood draw|1|||
146516497|NCT00269477|528398041|FG002|Overall Study|Missed post-vaccination blood draw|0|||
146853459|NCT00412061|529633661|FG000|Double Blind Phase|Lost to Follow-up|0|||
146853460|NCT00412061|529633662|FG001|Double Blind Phase|Lost to Follow-up|1|||
146853461|NCT00412061|529633661|FG000|Open Label Phase|Disease Progression|0|||
146853462|NCT00412061|529633662|FG001|Open Label Phase|Disease Progression|86|||
146853463|NCT00412061|529633661|FG000|Open Label Phase|Adverse Event|0|||
146853464|NCT00412061|529633662|FG001|Open Label Phase|Adverse Event|46|||
146853465|NCT00412061|529633661|FG000|Open Label Phase|Withdrawal by Subject|0|||
146853466|NCT00412061|529633662|FG001|Open Label Phase|Withdrawal by Subject|15|||
146853467|NCT00412061|529633661|FG000|Open Label Phase|Administrative Problems|0|||
146853468|NCT00412061|529633662|FG001|Open Label Phase|Administrative Problems|13|||
146853469|NCT00412061|529633661|FG000|Open Label Phase|Death|0|||
146853470|NCT00412061|529633662|FG001|Open Label Phase|Death|7|||
146853471|NCT00412061|529633661|FG000|Open Label Phase|Lost to Follow-up|0|||
146853472|NCT00412061|529633662|FG001|Open Label Phase|Lost to Follow-up|2|||
146853473|NCT00412061|529633661|FG000|Open Label Phase|New Cancer Therapy|0|||
146853474|NCT00412061|529633662|FG001|Open Label Phase|New Cancer Therapy|1|||
146853475|NCT02689518|529633664|FG000|Overall Study|Withdrawal by Subject|3|||
146853476|NCT02433340|529633668|FG000|Overall Study|Adverse Event|0|||
146853477|NCT02433340|529633669|FG001|Overall Study|Adverse Event|0|||
146853478|NCT02433340|529633670|FG002|Overall Study|Adverse Event|1|||
146853479|NCT02433340|529633671|FG003|Overall Study|Adverse Event|0|||
146853480|NCT02433340|529633668|FG000|Overall Study|Withdrawal by Subject|1|||
146853481|NCT02433340|529633669|FG001|Overall Study|Withdrawal by Subject|0|||
146853482|NCT02433340|529633670|FG002|Overall Study|Withdrawal by Subject|1|||
146853483|NCT02433340|529633671|FG003|Overall Study|Withdrawal by Subject|2|||
146853484|NCT02433340|529633668|FG000|Overall Study|Lost to Follow-up|0|||
146853485|NCT02433340|529633669|FG001|Overall Study|Lost to Follow-up|1|||
146853486|NCT02433340|529633670|FG002|Overall Study|Lost to Follow-up|0|||
146853487|NCT02433340|529633671|FG003|Overall Study|Lost to Follow-up|0|||
146516498|NCT00269477|528398042|FG003|Overall Study|Missed post-vaccination blood draw|0|||
146516499|NCT00431067|528398043|FG000|Overall Study|Other Adverse Event|9|||
146516500|NCT00431067|528398043|FG000|Overall Study|Progressive disease|30|||
146516501|NCT00431067|528398043|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
146516502|NCT00548249|528398044|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
146516503|NCT00548249|528398045|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
146516504|NCT00548249|528398046|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
146516505|NCT00548249|528398047|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
146516506|NCT00548249|528398048|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
146516507|NCT00548249|528398044|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
146516508|NCT00548249|528398045|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
146516509|NCT00548249|528398046|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
146516510|NCT00548249|528398047|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
146516511|NCT00548249|528398048|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
146516512|NCT00548249|528398044|FG000|Overall Study|Protocol Violation|1|||
146516513|NCT00548249|528398045|FG001|Overall Study|Protocol Violation|1|||
146516514|NCT00548249|528398046|FG002|Overall Study|Protocol Violation|4|||
146516515|NCT00548249|528398047|FG003|Overall Study|Protocol Violation|0|||
146516516|NCT00548249|528398048|FG004|Overall Study|Protocol Violation|3|||
146516517|NCT00548249|528398044|FG000|Overall Study|Miscellaneous|2|||
146516518|NCT00548249|528398045|FG001|Overall Study|Miscellaneous|3|||
146516519|NCT00548249|528398046|FG002|Overall Study|Miscellaneous|2|||
146516520|NCT00548249|528398047|FG003|Overall Study|Miscellaneous|0|||
146516521|NCT00548249|528398048|FG004|Overall Study|Miscellaneous|2|||
146516522|NCT00548249|528398044|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
146516523|NCT00548249|528398045|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
146516524|NCT00548249|528398046|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
146516525|NCT00548249|528398047|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
146516526|NCT00548249|528398048|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
146516527|NCT00548249|528398044|FG000|Overall Study|Adverse Event|2|||
146516528|NCT00548249|528398045|FG001|Overall Study|Adverse Event|2|||
146516529|NCT00548249|528398046|FG002|Overall Study|Adverse Event|0|||
146853488|NCT02433340|529633668|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
146853489|NCT02433340|529633669|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
146853490|NCT02433340|529633670|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
146853491|NCT02433340|529633671|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
146853492|NCT02433340|529633668|FG000|Overall Study|Other|0|||
146516530|NCT00548249|528398047|FG003|Overall Study|Adverse Event|1|||
146516531|NCT00548249|528398048|FG004|Overall Study|Adverse Event|1|||
146516532|NCT00548249|528398044|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
146853493|NCT02433340|529633669|FG001|Overall Study|Other|1|||
146853494|NCT02433340|529633670|FG002|Overall Study|Other|0|||
146516533|NCT00548249|528398045|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
146516534|NCT00548249|528398046|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
146516535|NCT00548249|528398047|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
146516536|NCT00548249|528398048|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
146516537|NCT00548249|528398044|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
146516538|NCT00548249|528398045|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
146516539|NCT00548249|528398046|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
146516540|NCT00548249|528398047|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
146516541|NCT00548249|528398048|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
146516542|NCT00548249|528398044|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
146516543|NCT00548249|528398045|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
146516544|NCT00548249|528398046|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
146516545|NCT00548249|528398047|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
146516546|NCT00548249|528398048|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
146516547|NCT00548249|528398044|FG000|Overall Study|Prolonged hospitalization|0|||
146516548|NCT00548249|528398045|FG001|Overall Study|Prolonged hospitalization|0|||
146516549|NCT00548249|528398046|FG002|Overall Study|Prolonged hospitalization|2|||
146516550|NCT00548249|528398047|FG003|Overall Study|Prolonged hospitalization|1|||
146516551|NCT00548249|528398048|FG004|Overall Study|Prolonged hospitalization|0|||
146516552|NCT00548249|528398044|FG000|Overall Study|Withdrawal by Subject|2|||
146516553|NCT00548249|528398045|FG001|Overall Study|Withdrawal by Subject|0|||
146516554|NCT00548249|528398046|FG002|Overall Study|Withdrawal by Subject|0|||
146516555|NCT00548249|528398047|FG003|Overall Study|Withdrawal by Subject|0|||
146516556|NCT00548249|528398048|FG004|Overall Study|Withdrawal by Subject|0|||
146516557|NCT00548249|528398044|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
146516558|NCT00548249|528398045|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
146516559|NCT00548249|528398046|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
146516560|NCT00548249|528398047|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
146516561|NCT00548249|528398048|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
146516562|NCT00548249|528398044|FG000|Overall Study|Sponsor's request|0|||
146516563|NCT00548249|528398045|FG001|Overall Study|Sponsor's request|0|||
146516564|NCT00548249|528398046|FG002|Overall Study|Sponsor's request|0|||
146516565|NCT00548249|528398047|FG003|Overall Study|Sponsor's request|1|||
146516566|NCT00548249|528398048|FG004|Overall Study|Sponsor's request|0|||
146516567|NCT00938587|528398049|FG000|Overall Study|Adverse Event|2|||
146516568|NCT00938587|528398050|FG001|Overall Study|Adverse Event|0|||
146516569|NCT00938587|528398051|FG002|Overall Study|Adverse Event|0|||
146516570|NCT00938587|528398052|FG003|Overall Study|Adverse Event|2|||
146516571|NCT00938587|528398049|FG000|Overall Study|Did not meet entrance criteria|0|||
146516572|NCT00938587|528398050|FG001|Overall Study|Did not meet entrance criteria|0|||
146516573|NCT00938587|528398051|FG002|Overall Study|Did not meet entrance criteria|1|||
146516574|NCT00938587|528398052|FG003|Overall Study|Did not meet entrance criteria|0|||
146516575|NCT00938587|528398049|FG000|Overall Study|Withdrawal by Subject|1|||
146516576|NCT00938587|528398050|FG001|Overall Study|Withdrawal by Subject|1|||
146516577|NCT00938587|528398051|FG002|Overall Study|Withdrawal by Subject|0|||
146516578|NCT00938587|528398052|FG003|Overall Study|Withdrawal by Subject|0|||
146516579|NCT03760458|528398057|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
146516580|NCT03760458|528398058|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
146516581|NCT03760458|528398059|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
146516582|NCT03760458|528398060|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
146516583|NCT03760458|528398061|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
146516584|NCT01464619|528398062|FG000|Overall Study|Lost to Follow-up|3|||
146516585|NCT01464619|528398063|FG001|Overall Study|Lost to Follow-up|4|||
146516586|NCT00435188|528398070|FG000|Overall Study|Death|1|||
146516587|NCT00435188|528398071|FG001|Overall Study|Death|6|||
146516588|NCT00435188|528398070|FG000|Overall Study|Withdrawal by Subject|16|||
146516589|NCT00435188|528398071|FG001|Overall Study|Withdrawal by Subject|11|||
146516590|NCT00435188|528398070|FG000|Overall Study|Lost to Follow-up|5|||
146516591|NCT00435188|528398071|FG001|Overall Study|Lost to Follow-up|6|||
146516592|NCT00575510|528398074|FG000|Overall Study|Lost to Follow-up|4|||
146516593|NCT00575510|528398075|FG001|Overall Study|Lost to Follow-up|6|||
146516594|NCT00575510|528398076|FG002|Overall Study|Lost to Follow-up|9|||
146516595|NCT00575510|528398074|FG000|Overall Study|Withdrawal by Subject|1|||
146516596|NCT00575510|528398075|FG001|Overall Study|Withdrawal by Subject|0|||
146756052|NCT00333138|529271310|FG000|Core Study (6 Months)|Adverse Event|4|||
146756053|NCT00333138|529271311|FG001|Core Study (6 Months)|Adverse Event|5|||
146756054|NCT00333138|529271312|FG002|Core Study (6 Months)|Adverse Event|8|||
146756055|NCT00333138|529271310|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
146756056|NCT00333138|529271311|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
146756057|NCT00333138|529271312|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
146756058|NCT00333138|529271310|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
146516597|NCT00575510|528398076|FG002|Overall Study|Withdrawal by Subject|0|||
146516598|NCT00575510|528398074|FG000|Overall Study|Clinic Called Patient|7|||
146516599|NCT00575510|528398075|FG001|Overall Study|Clinic Called Patient|7|||
146516600|NCT00575510|528398076|FG002|Overall Study|Clinic Called Patient|7|||
146756059|NCT00333138|529271311|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
146756060|NCT00333138|529271312|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
146756061|NCT00333138|529271310|FG000|Core Study (6 Months)|Protocol Violation|1|||
146756062|NCT00333138|529271311|FG001|Core Study (6 Months)|Protocol Violation|0|||
146756063|NCT00333138|529271312|FG002|Core Study (6 Months)|Protocol Violation|1|||
146756064|NCT00333138|529271310|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
146756065|NCT00333138|529271311|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
146756066|NCT00333138|529271312|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
146756067|NCT00333138|529271310|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
146756068|NCT00333138|529271311|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
146756069|NCT00333138|529271312|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
146756070|NCT00333138|529271310|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
146756071|NCT00333138|529271311|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
146756072|NCT00333138|529271312|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
146756073|NCT00333138|529271310|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
146853495|NCT02433340|529633671|FG003|Overall Study|Other|0|||
146516601|NCT00575510|528398074|FG000|Overall Study|Pregnancy|0|||
146516602|NCT00575510|528398075|FG001|Overall Study|Pregnancy|0|||
146516603|NCT00575510|528398076|FG002|Overall Study|Pregnancy|1|||
146516604|NCT00731731|528398077|FG000|Overall Study|Protocol Violation|0|||
146516605|NCT00731731|528398078|FG001|Overall Study|Protocol Violation|0|||
146516606|NCT00731731|528398079|FG002|Overall Study|Protocol Violation|1|||
146516607|NCT00731731|528398077|FG000|Overall Study|Cancel prior to treatment|0|||
146516608|NCT00731731|528398078|FG001|Overall Study|Cancel prior to treatment|0|||
146516609|NCT00731731|528398079|FG002|Overall Study|Cancel prior to treatment|2|||
146516610|NCT00625183|528398080|FG000|Overall Study|Disease Progression|1|||
146516611|NCT01578499|528398084|FG000|Overall Study|Reason not Specified|0|||
146516612|NCT01578499|528398085|FG001|Overall Study|Reason not Specified|1|||
146516613|NCT01578499|528398084|FG000|Overall Study|Lost to Follow-up|2|||
146516614|NCT01578499|528398085|FG001|Overall Study|Lost to Follow-up|1|||
146516615|NCT01578499|528398084|FG000|Overall Study|Withdrawal by Subject|10|||
146516616|NCT01578499|528398085|FG001|Overall Study|Withdrawal by Subject|16|||
146516617|NCT01578499|528398084|FG000|Overall Study|Death|20|||
146516618|NCT01578499|528398085|FG001|Overall Study|Death|25|||
146516619|NCT01578499|528398084|FG000|Overall Study|Died and End of Study Page not Completed|2|||
146516620|NCT01578499|528398085|FG001|Overall Study|Died and End of Study Page not Completed|0|||
146516621|NCT02670382|528398088|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
146516622|NCT02670382|528398089|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
146516623|NCT03244618|528398092|FG000|Overall Study|Lost to Follow-up|3|||
146516624|NCT03244618|528398093|FG001|Overall Study|Lost to Follow-up|4|||
146516625|NCT03244618|528398092|FG000|Overall Study|Protocol Violation|4|||
146516626|NCT03244618|528398093|FG001|Overall Study|Protocol Violation|3|||
146516627|NCT03244618|528398092|FG000|Overall Study|Withdrawal by Subject|0|||
146516628|NCT03244618|528398093|FG001|Overall Study|Withdrawal by Subject|2|||
146516629|NCT00394771|528398095|FG000|Overall Study|Did not meet protocol requirements|1|||
146516630|NCT00394771|528398096|FG001|Overall Study|Did not meet protocol requirements|0|||
146516631|NCT00394771|528398097|FG002|Overall Study|Did not meet protocol requirements|2|||
146516632|NCT00394771|528398098|FG003|Overall Study|Did not meet protocol requirements|0|||
146516633|NCT00394771|528398095|FG000|Overall Study|Protocol Violation|2|||
146516634|NCT00394771|528398096|FG001|Overall Study|Protocol Violation|4|||
146516635|NCT00394771|528398097|FG002|Overall Study|Protocol Violation|9|||
146516636|NCT00394771|528398098|FG003|Overall Study|Protocol Violation|7|||
146516637|NCT00394771|528398095|FG000|Overall Study|Withdrawal by Subject|10|||
146516638|NCT00394771|528398096|FG001|Overall Study|Withdrawal by Subject|6|||
146516639|NCT00394771|528398097|FG002|Overall Study|Withdrawal by Subject|8|||
146516640|NCT00394771|528398098|FG003|Overall Study|Withdrawal by Subject|12|||
146516641|NCT00394771|528398095|FG000|Overall Study|Adverse Event|10|||
146516642|NCT00394771|528398096|FG001|Overall Study|Adverse Event|5|||
146516643|NCT00394771|528398097|FG002|Overall Study|Adverse Event|12|||
146516644|NCT00394771|528398098|FG003|Overall Study|Adverse Event|8|||
146516645|NCT00394771|528398095|FG000|Overall Study|Participant pregnant|0|||
146516646|NCT00394771|528398096|FG001|Overall Study|Participant pregnant|1|||
146516647|NCT00394771|528398097|FG002|Overall Study|Participant pregnant|2|||
146516648|NCT00394771|528398098|FG003|Overall Study|Participant pregnant|2|||
146516649|NCT00394771|528398095|FG000|Overall Study|Lost to Follow-up|15|||
146516650|NCT00394771|528398096|FG001|Overall Study|Lost to Follow-up|15|||
146516651|NCT00394771|528398097|FG002|Overall Study|Lost to Follow-up|13|||
146516652|NCT00394771|528398098|FG003|Overall Study|Lost to Follow-up|10|||
146516653|NCT00394771|528398095|FG000|Overall Study|Other|3|||
146516654|NCT00394771|528398096|FG001|Overall Study|Other|3|||
146516655|NCT00394771|528398097|FG002|Overall Study|Other|1|||
146516656|NCT00394771|528398098|FG003|Overall Study|Other|0|||
146516657|NCT02839876|528398099|FG000|Overall Study|Protocol Violation|10|||
146516658|NCT02839876|528398100|FG001|Overall Study|Protocol Violation|11|||
146516659|NCT03816007|528398103|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
146516660|NCT03816007|528398104|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
146516661|NCT03816007|528398103|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
146516662|NCT03816007|528398104|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
146516663|NCT03816007|528398103|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
146516664|NCT03816007|528398104|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
146516665|NCT01428115|528398105|FG000|Overall Study|Lack of Efficacy|3|||
146516666|NCT01428115|528398105|FG000|Overall Study|Lost to Follow-up|10|||
146516667|NCT01428115|528398105|FG000|Overall Study|Pregnancy|1|||
146516668|NCT01428115|528398105|FG000|Overall Study|Protocol Violation|3|||
146516669|NCT01428115|528398105|FG000|Overall Study|Withdrawal by Subject|4|||
146516670|NCT02620384|528398106|FG000|Overall Study|Adverse Event|2|||
146516671|NCT02620384|528398107|FG001|Overall Study|Adverse Event|1|||
146516672|NCT02620384|528398106|FG000|Overall Study|Discharged prior to 2nd dose|2|||
146516673|NCT02620384|528398107|FG001|Overall Study|Discharged prior to 2nd dose|5|||
146516674|NCT02620384|528398106|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
146516675|NCT02620384|528398107|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
146516676|NCT02071082|528398108|FG000|Overall Study|Enrolled and Never Treated|1|||
146516677|NCT02071082|528398109|FG001|Overall Study|Enrolled and Never Treated|1|||
146516678|NCT02071082|528398108|FG000|Overall Study|Adverse Event|0|||
146516679|NCT02071082|528398109|FG001|Overall Study|Adverse Event|1|||
146516680|NCT02071082|528398108|FG000|Overall Study|Withdrew Consent|0|||
146516681|NCT02071082|528398109|FG001|Overall Study|Withdrew Consent|4|||
146516682|NCT02071082|528398108|FG000|Overall Study|Lost to Follow-up|1|||
146516683|NCT02071082|528398109|FG001|Overall Study|Lost to Follow-up|1|||
146516684|NCT00630747|528398112|FG000|Overall Study|Death|1|||
146516685|NCT00630747|528398112|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
146516686|NCT00630747|528398112|FG000|Overall Study|Returned to country of origin|1|||
146516687|NCT01298141|528398116|FG000|Overall Study|Adverse Event|3|||
146516688|NCT01298141|528398116|FG000|Overall Study|Refusal of Required Study Procedures|1|||
146516689|NCT01298141|528398116|FG000|Overall Study|Withdrawal by Subject|6|||
146516690|NCT01298141|528398116|FG000|Overall Study|Termination of Study by the Investigator|5|||
146516691|NCT01298141|528398116|FG000|Overall Study|Other|5|||
146516692|NCT01298141|528398116|FG000|Overall Study|Lost to Follow-up|1|||
146516693|NCT01298141|528398116|FG000|Overall Study|Death|6|||
146516694|NCT01298141|528398116|FG000|Overall Study|Not treated|4|||
146516695|NCT01421147|528399617|FG000|Treatment Period|Adverse Event|2|||
146516696|NCT01421147|528399618|FG001|Treatment Period|Adverse Event|3|||
146516697|NCT01421147|528399617|FG000|Treatment Period|Lost to Follow-up|2|||
146516698|NCT01421147|528399618|FG001|Treatment Period|Lost to Follow-up|1|||
146516699|NCT01421147|528399617|FG000|Treatment Period|Physician Decision|2|||
146516700|NCT01421147|528399618|FG001|Treatment Period|Physician Decision|2|||
146516701|NCT01421147|528399617|FG000|Treatment Period|Withdrawal by Subject|10|||
146516702|NCT01421147|528399618|FG001|Treatment Period|Withdrawal by Subject|5|||
146516703|NCT01421147|528399617|FG000|Extension Period|Adverse Event|0|||
146516704|NCT01421147|528399618|FG001|Extension Period|Adverse Event|2|||
146516705|NCT01421147|528399617|FG000|Extension Period|Death|0|||
146516706|NCT01421147|528399618|FG001|Extension Period|Death|1|||
146516707|NCT01421147|528399617|FG000|Extension Period|Lost to Follow-up|2|||
146516708|NCT01421147|528399618|FG001|Extension Period|Lost to Follow-up|5|||
146516709|NCT01421147|528399617|FG000|Extension Period|Physician Decision|1|||
146516710|NCT01421147|528399618|FG001|Extension Period|Physician Decision|0|||
146756074|NCT00333138|529271311|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
146756075|NCT00333138|529271312|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
146756076|NCT00333138|529271310|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
146756077|NCT00333138|529271311|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
146756078|NCT00333138|529271312|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
146756079|NCT00333138|529271310|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
146756080|NCT00333138|529271311|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
146756081|NCT00333138|529271312|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
146756082|NCT00333138|529271310|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
146756083|NCT00333138|529271311|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
146756084|NCT00333138|529271312|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
146756085|NCT00333138|529271310|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
146756086|NCT00333138|529271311|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
146756087|NCT00333138|529271312|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
146756088|NCT00333138|529271310|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
146756089|NCT00333138|529271311|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
146756090|NCT00333138|529271312|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
146756091|NCT00333138|529271310|FG000|Extension Study (Month6 to End of Study)|Death|0|||
146756092|NCT00333138|529271311|FG001|Extension Study (Month6 to End of Study)|Death|1|||
146756093|NCT00333138|529271312|FG002|Extension Study (Month6 to End of Study)|Death|0|||
146756094|NCT01342887|529271313|FG000|Overall Study|Death|2|||
146756095|NCT04880161|529271315|FG000|Overall Study|Withdrawal by Subject|1|||
146756096|NCT04880161|529271316|FG001|Overall Study|Withdrawal by Subject|0|||
146756097|NCT04880161|529271315|FG000|Overall Study|Lack of Compliance|1|||
146756098|NCT04880161|529271316|FG001|Overall Study|Lack of Compliance|1|||
146756099|NCT04880161|529271315|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
146756100|NCT04880161|529271316|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
146756101|NCT04880161|529271315|FG000|Overall Study|Screen Failure|0|||
146756102|NCT04880161|529271316|FG001|Overall Study|Screen Failure|1|||
146756103|NCT01354106|529271317|FG000|Overall Study|Withdrawal by Subject|2|||
146756104|NCT02491411|529273178|FG000|Overall Study|Physician Decision|4|||
146756105|NCT04034238|529273179|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
146756106|NCT04034238|529273180|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
146756107|NCT04034238|529273181|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
146756108|NCT04034238|529273182|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
146516711|NCT01421147|528399617|FG000|Extension Period|Withdrawal by Subject|5|||
146516712|NCT01421147|528399618|FG001|Extension Period|Withdrawal by Subject|3|||
146516713|NCT00171158|528399621|FG000|Core Study|Death|27|||
146516714|NCT00171158|528399621|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
146516715|NCT00171158|528399621|FG000|Core Study|Protocol Violation|4|||
146853496|NCT01178385|529633672|FG000|Overall Study|Withdrawal by Subject|2|||
146853497|NCT01178385|529633673|FG001|Overall Study|Withdrawal by Subject|0|||
146516716|NCT00171158|528399621|FG000|Core Study|Administrative problems|1|||
146516717|NCT00171158|528399621|FG000|Core Study|Adverse event, non-fatal|21|||
146853498|NCT02679508|529633677|FG000|Healing Phase|Protocol Violation|1|||
146853499|NCT02679508|529633678|FG001|Healing Phase|Protocol Violation|1|||
146853500|NCT02679508|529633677|FG000|Healing Phase|Lost to Follow-up|1|||
146516718|NCT00171158|528399621|FG000|Core Study|Consent withdrawn by subject|6|||
146516719|NCT00171158|528399621|FG000|Core Study|No longer required drug (BMT)|14|||
146516720|NCT00171158|528399621|FG000|Core Study|Abnormal Laboratory Values|2|||
146516721|NCT00171158|528399621|FG000|Core Study|Lost to Follow-up|1|||
146853501|NCT02679508|529633678|FG001|Healing Phase|Lost to Follow-up|0|||
146853502|NCT02679508|529633677|FG000|Maintenance Phase|Adverse Event|12|||
146853503|NCT02679508|529633678|FG001|Maintenance Phase|Adverse Event|2|||
146853504|NCT02679508|529633677|FG000|Maintenance Phase|Lost to Follow-up|0|||
146853505|NCT02679508|529633678|FG001|Maintenance Phase|Lost to Follow-up|1|||
146853506|NCT02679508|529633677|FG000|Maintenance Phase|Withdrawal by Subject|15|||
146853507|NCT02679508|529633678|FG001|Maintenance Phase|Withdrawal by Subject|8|||
146516722|NCT00171158|528399621|FG000|E2 Extension|Other|7|||
146516723|NCT02757352|528399623|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
146516724|NCT02757352|528399624|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
146516725|NCT02757352|528399625|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
146516726|NCT02757352|528399626|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
146516727|NCT02757352|528399627|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
146516728|NCT02757352|528399628|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
146516729|NCT02757352|528399629|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
146853508|NCT02679508|529633677|FG000|Maintenance Phase|Other|5|||
146853509|NCT02679508|529633678|FG001|Maintenance Phase|Other|4|||
146853510|NCT03143166|529633679|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
146516730|NCT02757352|528399630|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
146853511|NCT03683823|529633681|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
146853512|NCT03683823|529633682|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
146516731|NCT02757352|528399631|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
146516732|NCT02757352|528399632|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
146516733|NCT02757352|528399623|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
146516734|NCT02757352|528399624|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
146516735|NCT02757352|528399625|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
146516736|NCT02757352|528399626|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
146516737|NCT02757352|528399627|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
146516738|NCT02757352|528399628|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
146516739|NCT02757352|528399629|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
146516740|NCT02757352|528399630|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
146516741|NCT02757352|528399631|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
146516742|NCT02757352|528399632|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
146516743|NCT02757352|528399623|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
146516744|NCT02757352|528399624|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
146516745|NCT02757352|528399625|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
146516746|NCT02757352|528399626|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
146516747|NCT02757352|528399627|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
146516748|NCT02757352|528399628|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
146516749|NCT02757352|528399629|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
146516750|NCT02757352|528399630|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
146516751|NCT02757352|528399631|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
146516752|NCT02757352|528399632|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
146516753|NCT02757352|528399623|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
146516754|NCT02757352|528399624|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
146516755|NCT02757352|528399625|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
146516756|NCT02757352|528399626|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
146853513|NCT03683823|529633681|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
146516757|NCT02757352|528399627|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
146516758|NCT02757352|528399628|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
146516759|NCT02757352|528399629|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
146516760|NCT02757352|528399630|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
146516761|NCT02757352|528399631|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
146516762|NCT02757352|528399632|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
146516763|NCT02757352|528399623|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146516764|NCT02757352|528399624|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
146853514|NCT03683823|529633682|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
146516765|NCT02757352|528399625|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146516766|NCT02757352|528399626|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146516767|NCT02757352|528399627|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146516768|NCT02757352|528399628|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146516769|NCT02757352|528399629|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146516770|NCT02757352|528399630|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146516771|NCT02757352|528399631|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146516772|NCT02757352|528399632|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146516773|NCT02757352|528399623|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
146516774|NCT02757352|528399624|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
146516775|NCT02757352|528399625|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
146516776|NCT02757352|528399626|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
146516777|NCT02757352|528399627|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
146516778|NCT02757352|528399628|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
146516779|NCT02757352|528399629|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
146516780|NCT02757352|528399630|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
146516781|NCT02757352|528399631|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
146516782|NCT02757352|528399632|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
146516783|NCT02757352|528399623|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
146516784|NCT02757352|528399624|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
146516785|NCT02757352|528399625|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
146516786|NCT02757352|528399626|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
146516787|NCT02757352|528399627|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
146516788|NCT02757352|528399628|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
146516789|NCT02757352|528399629|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
146516790|NCT02757352|528399630|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
146516791|NCT02757352|528399631|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
146516792|NCT02757352|528399632|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
146516793|NCT02757352|528399623|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
146516794|NCT02757352|528399624|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
146516795|NCT02757352|528399625|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
146516796|NCT02757352|528399626|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
146516797|NCT02757352|528399627|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
146516798|NCT02757352|528399628|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
146516799|NCT02757352|528399629|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
146516800|NCT02757352|528399630|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
146516801|NCT02757352|528399631|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
146516802|NCT02757352|528399632|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
146516803|NCT02757352|528399623|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146516804|NCT02757352|528399624|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146516805|NCT02757352|528399625|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146516806|NCT02757352|528399626|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
146516807|NCT02757352|528399627|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
146516808|NCT02757352|528399628|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
146516809|NCT02757352|528399629|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146516810|NCT02757352|528399630|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146516811|NCT02757352|528399631|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146516812|NCT02757352|528399632|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146516813|NCT02757352|528399623|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
146516814|NCT02757352|528399624|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
146516815|NCT02757352|528399625|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
146516816|NCT02757352|528399626|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
146516817|NCT02757352|528399627|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
146516818|NCT02757352|528399628|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
146516819|NCT02757352|528399629|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
146516820|NCT02757352|528399630|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
146516821|NCT02757352|528399631|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
146516822|NCT02757352|528399632|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
146516823|NCT02757352|528399623|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
146516824|NCT02757352|528399624|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
146516825|NCT02757352|528399625|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
146756109|NCT04034238|529273179|FG000|Dose Escalation Phase|Screen failures|0|||
146756110|NCT04034238|529273180|FG001|Dose Escalation Phase|Screen failures|0|||
146516826|NCT02757352|528399626|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
146516827|NCT02757352|528399627|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
146516828|NCT02757352|528399628|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
146516829|NCT02757352|528399629|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
146516830|NCT02757352|528399630|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
146516831|NCT02757352|528399631|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
146516832|NCT02757352|528399632|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
146516833|NCT02757352|528399623|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
146516834|NCT02757352|528399624|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
146516835|NCT02757352|528399625|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
146516836|NCT02757352|528399626|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
146516837|NCT02757352|528399627|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
146516838|NCT02757352|528399628|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
146516839|NCT02757352|528399629|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
146516840|NCT02757352|528399630|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
146516841|NCT02757352|528399631|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
146516842|NCT02757352|528399632|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
146516843|NCT02757352|528399623|FG000|Follow-Up Period|Adverse Event|0|||
146516844|NCT02757352|528399624|FG001|Follow-Up Period|Adverse Event|0|||
146516845|NCT02757352|528399625|FG002|Follow-Up Period|Adverse Event|0|||
146516846|NCT02757352|528399626|FG003|Follow-Up Period|Adverse Event|0|||
146516847|NCT02757352|528399627|FG004|Follow-Up Period|Adverse Event|0|||
146516848|NCT02757352|528399628|FG005|Follow-Up Period|Adverse Event|0|||
146516849|NCT02757352|528399629|FG006|Follow-Up Period|Adverse Event|1|||
146516850|NCT02757352|528399630|FG007|Follow-Up Period|Adverse Event|0|||
146516851|NCT02757352|528399631|FG008|Follow-Up Period|Adverse Event|2|||
146516852|NCT02757352|528399632|FG009|Follow-Up Period|Adverse Event|0|||
146516853|NCT02757352|528399623|FG000|Follow-Up Period|Lost to Follow-up|0|||
146516854|NCT02757352|528399624|FG001|Follow-Up Period|Lost to Follow-up|0|||
146516855|NCT02757352|528399625|FG002|Follow-Up Period|Lost to Follow-up|0|||
146516856|NCT02757352|528399626|FG003|Follow-Up Period|Lost to Follow-up|0|||
146516857|NCT02757352|528399627|FG004|Follow-Up Period|Lost to Follow-up|0|||
146516858|NCT02757352|528399628|FG005|Follow-Up Period|Lost to Follow-up|0|||
146516859|NCT02757352|528399629|FG006|Follow-Up Period|Lost to Follow-up|0|||
146516860|NCT02757352|528399630|FG007|Follow-Up Period|Lost to Follow-up|0|||
146516861|NCT02757352|528399631|FG008|Follow-Up Period|Lost to Follow-up|1|||
146516862|NCT02757352|528399632|FG009|Follow-Up Period|Lost to Follow-up|0|||
146516863|NCT02757352|528399623|FG000|Follow-Up Period|Lack of Efficacy|0|||
146516864|NCT02757352|528399624|FG001|Follow-Up Period|Lack of Efficacy|0|||
146516865|NCT02757352|528399625|FG002|Follow-Up Period|Lack of Efficacy|0|||
146516866|NCT02757352|528399626|FG003|Follow-Up Period|Lack of Efficacy|0|||
146516867|NCT02757352|528399627|FG004|Follow-Up Period|Lack of Efficacy|0|||
146516868|NCT02757352|528399628|FG005|Follow-Up Period|Lack of Efficacy|0|||
146516869|NCT02757352|528399629|FG006|Follow-Up Period|Lack of Efficacy|0|||
146516870|NCT02757352|528399630|FG007|Follow-Up Period|Lack of Efficacy|0|||
146516871|NCT02757352|528399631|FG008|Follow-Up Period|Lack of Efficacy|1|||
146516872|NCT02757352|528399632|FG009|Follow-Up Period|Lack of Efficacy|1|||
146516873|NCT02757352|528399623|FG000|Follow-Up Period|Withdrawal by Subject|0|||
146516874|NCT02757352|528399624|FG001|Follow-Up Period|Withdrawal by Subject|0|||
146516875|NCT02757352|528399625|FG002|Follow-Up Period|Withdrawal by Subject|0|||
146516876|NCT02757352|528399626|FG003|Follow-Up Period|Withdrawal by Subject|0|||
146516877|NCT02757352|528399627|FG004|Follow-Up Period|Withdrawal by Subject|0|||
146516878|NCT02757352|528399628|FG005|Follow-Up Period|Withdrawal by Subject|0|||
146516879|NCT02757352|528399629|FG006|Follow-Up Period|Withdrawal by Subject|0|||
146516880|NCT02757352|528399630|FG007|Follow-Up Period|Withdrawal by Subject|1|||
146516881|NCT02757352|528399631|FG008|Follow-Up Period|Withdrawal by Subject|6|||
146516882|NCT02757352|528399632|FG009|Follow-Up Period|Withdrawal by Subject|2|||
146516883|NCT00497146|528399634|FG000|Treatment Period|Adverse Event|6|||
146516884|NCT00497146|528399635|FG001|Treatment Period|Adverse Event|2|||
146516885|NCT00497146|528399634|FG000|Treatment Period|Withdrawal by Subject|5|||
146516886|NCT00497146|528399635|FG001|Treatment Period|Withdrawal by Subject|9|||
146516887|NCT00497146|528399634|FG000|Treatment Period|Lost to Follow-up|1|||
146516888|NCT00497146|528399635|FG001|Treatment Period|Lost to Follow-up|3|||
146516889|NCT00497146|528399634|FG000|Treatment Period|Required dialysis|4|||
146516890|NCT00497146|528399635|FG001|Treatment Period|Required dialysis|1|||
146516891|NCT00497146|528399634|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
146516892|NCT00497146|528399635|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
146516893|NCT00497146|528399634|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
146516894|NCT00497146|528399635|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
146516895|NCT00497146|528399634|FG000|Treatment Period|Other Reason|2|||
146516896|NCT00497146|528399635|FG001|Treatment Period|Other Reason|3|||
146516897|NCT00497146|528399634|FG000|Long-term Follow-up Period|Adverse Event|2|||
146516898|NCT00497146|528399635|FG001|Long-term Follow-up Period|Adverse Event|2|||
146516899|NCT00497146|528399634|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
146516900|NCT00497146|528399635|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
146516901|NCT00497146|528399634|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
146516902|NCT00497146|528399635|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
146516903|NCT00497146|528399634|FG000|Long-term Follow-up Period|Other|0|||
146516904|NCT00497146|528399635|FG001|Long-term Follow-up Period|Other|1|||
146516905|NCT01471444|528399636|FG000|Overall Study|Physician Decision|3|||
146516906|NCT01471444|528399637|FG001|Overall Study|Physician Decision|2|||
146516907|NCT01471444|528399636|FG000|Overall Study|Withdrawal by Subject|0|||
146516908|NCT01471444|528399637|FG001|Overall Study|Withdrawal by Subject|1|||
146516909|NCT02107313|528399638|FG000|Overall Study|One participant did not do the FED cohor|0|||
146516910|NCT02107313|528399639|FG001|Overall Study|One participant did not do the FED cohor|1|||
146516911|NCT01031004|528399642|FG000|Overall Study|Protocol Violation|0|||
146516912|NCT01031004|528399643|FG001|Overall Study|Protocol Violation|1|||
146516913|NCT01031004|528399642|FG000|Overall Study|Lost to Follow-up|1|||
146516914|NCT01031004|528399643|FG001|Overall Study|Lost to Follow-up|0|||
146516915|NCT01641471|528399644|FG000|Overall Study|Withdrawal by Subject|19|||
146516916|NCT01641471|528399645|FG001|Overall Study|Withdrawal by Subject|19|||
146516917|NCT01641471|528399644|FG000|Overall Study|Lost to Follow-up|2|||
146516918|NCT01641471|528399645|FG001|Overall Study|Lost to Follow-up|4|||
146516919|NCT01641471|528399644|FG000|Overall Study|Protocol Violation|2|||
146516920|NCT01641471|528399645|FG001|Overall Study|Protocol Violation|4|||
146516921|NCT01214668|528399658|FG000|Overall Study|Adverse Event|0|||
146516922|NCT01214668|528399659|FG001|Overall Study|Adverse Event|1|||
146853515|NCT03683823|529633681|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
146853516|NCT03683823|529633682|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
146853517|NCT03965351|529633683|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
146853518|NCT03965351|529633684|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
146853519|NCT03965351|529633683|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
146853520|NCT03965351|529633684|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
146853521|NCT01323972|529633686|FG000|Overall Study|Withdrawal by Subject|1|||
146853522|NCT01323972|529633687|FG001|Overall Study|Withdrawal by Subject|0|||
146853523|NCT01323972|529633688|FG002|Overall Study|Withdrawal by Subject|1|||
146853524|NCT01323972|529633689|FG003|Overall Study|Withdrawal by Subject|0|||
146853525|NCT01323972|529633686|FG000|Overall Study|Migrated/moved from study area|1|||
146853526|NCT01323972|529633687|FG001|Overall Study|Migrated/moved from study area|2|||
146853527|NCT01323972|529633688|FG002|Overall Study|Migrated/moved from study area|0|||
146853528|NCT01323972|529633689|FG003|Overall Study|Migrated/moved from study area|0|||
146853529|NCT01323972|529633686|FG000|Overall Study|Lost to Follow-up|0|||
146853530|NCT01323972|529633687|FG001|Overall Study|Lost to Follow-up|1|||
146516923|NCT01214668|528399660|FG002|Overall Study|Adverse Event|0|||
146516924|NCT01214668|528399661|FG003|Overall Study|Adverse Event|2|||
146516925|NCT01214668|528399662|FG004|Overall Study|Adverse Event|1|||
146516926|NCT01214668|528399663|FG005|Overall Study|Adverse Event|1|||
146516927|NCT01214668|528399658|FG000|Overall Study|Death|0|||
146516928|NCT01214668|528399659|FG001|Overall Study|Death|0|||
146516929|NCT01214668|528399660|FG002|Overall Study|Death|1|||
146516930|NCT01214668|528399661|FG003|Overall Study|Death|0|||
146853531|NCT01323972|529633688|FG002|Overall Study|Lost to Follow-up|1|||
146853532|NCT01323972|529633689|FG003|Overall Study|Lost to Follow-up|1|||
146516931|NCT01214668|528399662|FG004|Overall Study|Death|0|||
146516932|NCT01214668|528399663|FG005|Overall Study|Death|0|||
146516933|NCT01214668|528399658|FG000|Overall Study|Progressive Disease|4|||
146516934|NCT01214668|528399659|FG001|Overall Study|Progressive Disease|2|||
146516935|NCT01214668|528399660|FG002|Overall Study|Progressive Disease|5|||
146516936|NCT01214668|528399661|FG003|Overall Study|Progressive Disease|4|||
146516937|NCT01214668|528399662|FG004|Overall Study|Progressive Disease|4|||
146516938|NCT01214668|528399663|FG005|Overall Study|Progressive Disease|5|||
146516939|NCT01214668|528399658|FG000|Overall Study|Withdrawal by Subject|0|||
146516940|NCT01214668|528399659|FG001|Overall Study|Withdrawal by Subject|0|||
146516941|NCT01214668|528399660|FG002|Overall Study|Withdrawal by Subject|0|||
146516942|NCT01214668|528399661|FG003|Overall Study|Withdrawal by Subject|0|||
146516943|NCT01214668|528399662|FG004|Overall Study|Withdrawal by Subject|1|||
146516944|NCT01214668|528399663|FG005|Overall Study|Withdrawal by Subject|0|||
146516945|NCT02815267|528399664|FG000|Double-Blind Phase|Adverse Event|0|||
146516946|NCT02815267|528399665|FG001|Double-Blind Phase|Adverse Event|3|||
146516947|NCT02815267|528399664|FG000|Double-Blind Phase|Lost to Follow-up|17|||
146516948|NCT02815267|528399665|FG001|Double-Blind Phase|Lost to Follow-up|9|||
146516949|NCT02815267|528399664|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
146516950|NCT02815267|528399665|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
146516951|NCT02815267|528399664|FG000|Double-Blind Phase|Protocol Violation|3|||
146516952|NCT02815267|528399665|FG001|Double-Blind Phase|Protocol Violation|2|||
146516953|NCT02815267|528399664|FG000|Double-Blind Phase|Site withdrawal|1|||
146516954|NCT02815267|528399665|FG001|Double-Blind Phase|Site withdrawal|6|||
146516955|NCT02815267|528399664|FG000|Double-Blind Phase|Received a disallowed medication|1|||
146516956|NCT02815267|528399665|FG001|Double-Blind Phase|Received a disallowed medication|1|||
146516957|NCT02815267|528399664|FG000|Open-Label Phase|Adverse Event|1|||
146516958|NCT02815267|528399665|FG001|Open-Label Phase|Adverse Event|1|||
146516959|NCT02815267|528399664|FG000|Open-Label Phase|Lost to Follow-up|23|||
146516960|NCT02815267|528399665|FG001|Open-Label Phase|Lost to Follow-up|9|||
146516961|NCT02815267|528399664|FG000|Open-Label Phase|Withdrawal by Subject|24|||
146516962|NCT02815267|528399665|FG001|Open-Label Phase|Withdrawal by Subject|13|||
146516963|NCT02815267|528399664|FG000|Open-Label Phase|Protocol Violation|0|||
146516964|NCT02815267|528399665|FG001|Open-Label Phase|Protocol Violation|1|||
146516965|NCT02815267|528399664|FG000|Open-Label Phase|Administrative|21|||
146516966|NCT02815267|528399665|FG001|Open-Label Phase|Administrative|12|||
146516967|NCT02815267|528399664|FG000|Open-Label Phase|Other|2|||
146516968|NCT02815267|528399665|FG001|Open-Label Phase|Other|5|||
146516969|NCT01108237|528399666|FG000|Overall Study|No alignment data|2|||
146516970|NCT01108237|528399667|FG001|Overall Study|No alignment data|15|||
146516971|NCT01108237|528399666|FG000|Overall Study|Did not meet criteria for analysis|7|||
146516972|NCT01108237|528399667|FG001|Overall Study|Did not meet criteria for analysis|0|||
146516973|NCT02178358|528399672|FG000|Overall Study|Withdrawal by Subject|0|||
146516974|NCT02178358|528399673|FG001|Overall Study|Withdrawal by Subject|2|||
146516975|NCT02178358|528399674|FG002|Overall Study|Withdrawal by Subject|2|||
146516976|NCT02178358|528399672|FG000|Overall Study|Lost to Follow-up|1|||
146516977|NCT02178358|528399673|FG001|Overall Study|Lost to Follow-up|0|||
146516978|NCT02178358|528399674|FG002|Overall Study|Lost to Follow-up|0|||
146516979|NCT00790556|528399675|FG000|Treatment Period 1|Physician Decision|1|||
146516980|NCT00790556|528399676|FG001|Treatment Period 1|Physician Decision|0|||
146516981|NCT00790556|528399675|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146516982|NCT00790556|528399676|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146516983|NCT00339833|528399679|FG000|Overall Study|Withdrawal by Subject|1|||
146516984|NCT00339833|528399680|FG001|Overall Study|Withdrawal by Subject|2|||
146516985|NCT00339833|528399679|FG000|Overall Study|toothache|0|||
146516986|NCT00339833|528399680|FG001|Overall Study|toothache|1|||
146516987|NCT00339833|528399679|FG000|Overall Study|indigestion|0|||
146516988|NCT00339833|528399680|FG001|Overall Study|indigestion|1|||
146516989|NCT00339833|528399679|FG000|Overall Study|Chest pain|0|||
146516990|NCT00339833|528399680|FG001|Overall Study|Chest pain|1|||
146516991|NCT00339833|528399679|FG000|Overall Study|minor infection|0|||
146516992|NCT00339833|528399680|FG001|Overall Study|minor infection|1|||
146516993|NCT00339833|528399679|FG000|Overall Study|Poor venous access|2|||
146516994|NCT00339833|528399680|FG001|Overall Study|Poor venous access|2|||
146516995|NCT00339833|528399679|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
146516996|NCT00339833|528399680|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
146516997|NCT00339833|528399679|FG000|Overall Study|Error in data records|1|||
146516998|NCT00339833|528399680|FG001|Overall Study|Error in data records|0|||
146516999|NCT00217581|528399681|FG000|Overall Study|Withdrawal by Subject|1|||
146517000|NCT02829047|528399682|FG000|Overall Study|Withdrawal by Subject|1|||
146756111|NCT04034238|529273181|FG002|Dose Escalation Phase|Screen failures|0|||
146756112|NCT04034238|529273182|FG003|Dose Escalation Phase|Screen failures|2|||
146756113|NCT04034238|529273179|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
146756114|NCT04034238|529273180|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
146756115|NCT04034238|529273181|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
146756116|NCT04034238|529273182|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
146756117|NCT04034238|529273179|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
146756118|NCT04034238|529273180|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
146756119|NCT04034238|529273181|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
146756120|NCT04034238|529273182|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
146756121|NCT00465361|529273183|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
146756122|NCT01511536|529273184|FG000|Phase 1|Other|0|||
146756123|NCT01511536|529273185|FG001|Phase 1|Other|1|||
146756124|NCT01511536|529273186|FG002|Phase 1|Other|0|||
146756125|NCT01511536|529273184|FG000|Phase 2|Other|0|||
146756126|NCT01511536|529273185|FG001|Phase 2|Other|0|||
146756127|NCT01511536|529273186|FG002|Phase 2|Other|9|||
146756128|NCT02297503|529273190|FG000|Overall Study|Withdrawal by Subject|1|||
146756129|NCT02297503|529273191|FG001|Overall Study|Withdrawal by Subject|1|||
146756130|NCT02297503|529273190|FG000|Overall Study|Protocol Violation|1|||
146756131|NCT02297503|529273191|FG001|Overall Study|Protocol Violation|0|||
146517001|NCT00482170|528399683|FG000|Overall Study|Adverse Event|5|||
146517002|NCT00482170|528399684|FG001|Overall Study|Adverse Event|14|||
146517003|NCT00482170|528399683|FG000|Overall Study|Withdrawal by Subject|6|||
146517004|NCT00482170|528399684|FG001|Overall Study|Withdrawal by Subject|1|||
146756132|NCT02297503|529273190|FG000|Overall Study|Pregnancy|0|||
146517005|NCT00482170|528399683|FG000|Overall Study|Protocol Violation|2|||
146517006|NCT00482170|528399684|FG001|Overall Study|Protocol Violation|3|||
146517007|NCT00482170|528399683|FG000|Overall Study|Lost to Follow-up|2|||
146517008|NCT00482170|528399684|FG001|Overall Study|Lost to Follow-up|0|||
146517009|NCT00482170|528399683|FG000|Overall Study|Unspecified reason|0|||
146517010|NCT00482170|528399684|FG001|Overall Study|Unspecified reason|2|||
146756133|NCT02297503|529273191|FG001|Overall Study|Pregnancy|1|||
146517011|NCT01134263|528399685|FG000|Overall Study|Serious adverse event|2|||
146517012|NCT01134263|528399686|FG001|Overall Study|Serious adverse event|1|||
146517013|NCT01134263|528399687|FG002|Overall Study|Serious adverse event|1|||
146517014|NCT01134263|528399688|FG003|Overall Study|Serious adverse event|1|||
146517015|NCT01134263|528399689|FG004|Overall Study|Serious adverse event|1|||
146517016|NCT01134263|528399685|FG000|Overall Study|Other adverse event|1|||
146517017|NCT01134263|528399686|FG001|Overall Study|Other adverse event|2|||
146517018|NCT01134263|528399687|FG002|Overall Study|Other adverse event|5|||
146517019|NCT01134263|528399688|FG003|Overall Study|Other adverse event|3|||
146517020|NCT01134263|528399689|FG004|Overall Study|Other adverse event|0|||
146517021|NCT01134263|528399685|FG000|Overall Study|Protocol Violation|8|||
146517022|NCT01134263|528399686|FG001|Overall Study|Protocol Violation|7|||
146517023|NCT01134263|528399687|FG002|Overall Study|Protocol Violation|2|||
146517024|NCT01134263|528399688|FG003|Overall Study|Protocol Violation|4|||
146517025|NCT01134263|528399689|FG004|Overall Study|Protocol Violation|2|||
146517026|NCT01134263|528399685|FG000|Overall Study|Lost to Follow-up|4|||
146517027|NCT01134263|528399686|FG001|Overall Study|Lost to Follow-up|3|||
146517028|NCT01134263|528399687|FG002|Overall Study|Lost to Follow-up|5|||
146517029|NCT01134263|528399688|FG003|Overall Study|Lost to Follow-up|3|||
146517030|NCT01134263|528399689|FG004|Overall Study|Lost to Follow-up|1|||
146517031|NCT01134263|528399685|FG000|Overall Study|Withdrawal by Subject|8|||
146517032|NCT01134263|528399686|FG001|Overall Study|Withdrawal by Subject|6|||
146517033|NCT01134263|528399687|FG002|Overall Study|Withdrawal by Subject|16|||
146517034|NCT01134263|528399688|FG003|Overall Study|Withdrawal by Subject|7|||
146517035|NCT01134263|528399689|FG004|Overall Study|Withdrawal by Subject|5|||
146517036|NCT01134263|528399685|FG000|Overall Study|Enrolled, but not treated|1|||
146517037|NCT01134263|528399686|FG001|Overall Study|Enrolled, but not treated|1|||
146517038|NCT01134263|528399687|FG002|Overall Study|Enrolled, but not treated|0|||
146517039|NCT01134263|528399688|FG003|Overall Study|Enrolled, but not treated|1|||
146517040|NCT01134263|528399689|FG004|Overall Study|Enrolled, but not treated|0|||
146517041|NCT01204918|528399690|FG000|Overall Study|Withdrawal by Subject|4|||
146517042|NCT01204918|528399691|FG001|Overall Study|Withdrawal by Subject|10|||
146517043|NCT01204918|528399692|FG002|Overall Study|Withdrawal by Subject|5|||
146517044|NCT01280682|528399695|FG000|Overall Study|Lost to Follow-up|0|||
146517045|NCT01280682|528399696|FG001|Overall Study|Lost to Follow-up|6|||
146517046|NCT01280682|528399695|FG000|Overall Study|Withdrawal by Subject|0|||
146517047|NCT01280682|528399696|FG001|Overall Study|Withdrawal by Subject|7|||
146517048|NCT00849290|528399697|FG000|Overall Study|Adverse Event|3|||
146517049|NCT00849290|528399697|FG000|Overall Study|Death|14|||
146517050|NCT00849290|528399697|FG000|Overall Study|Withdrawal by Subject|11|||
146517051|NCT00849290|528399697|FG000|Overall Study|Lost to Follow-up|2|||
146517052|NCT00849290|528399697|FG000|Overall Study|Protocol Violation|5|||
146517053|NCT00849290|528399697|FG000|Overall Study|Disease Progression|20|||
146517054|NCT00750919|528399698|FG000|Overall Study|Adverse Event|9|||
146517055|NCT00750919|528399698|FG000|Overall Study|Withdrawal by Subject|1|||
146517056|NCT00750919|528399698|FG000|Overall Study|Lack of Efficacy|8|||
146517057|NCT00750919|528399698|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
146517058|NCT00750919|528399698|FG000|Overall Study|Other|36|||
146517059|NCT00080483|528399701|FG000|Overall Study|Lost to Follow-up|1|||
146517060|NCT00080483|528399702|FG001|Overall Study|Lost to Follow-up|1|||
146517061|NCT00080483|528399701|FG000|Overall Study|Physician Decision|1|||
146517062|NCT00080483|528399702|FG001|Overall Study|Physician Decision|1|||
146517063|NCT02819440|528399703|FG000|Overall Study|Adverse Event|3|||
146517064|NCT02819440|528399704|FG001|Overall Study|Adverse Event|1|||
146517065|NCT02819440|528399703|FG000|Overall Study|Lost to Follow-up|1|||
146517066|NCT02819440|528399704|FG001|Overall Study|Lost to Follow-up|3|||
146517067|NCT02819440|528399703|FG000|Overall Study|Withdrawal by Subject|9|||
146517068|NCT02819440|528399704|FG001|Overall Study|Withdrawal by Subject|8|||
146517069|NCT02007278|528399707|FG000|Overall Study|Failure to comply with an eligibility|0|||
146517070|NCT02007278|528399708|FG001|Overall Study|Failure to comply with an eligibility|1|||
146517071|NCT02007278|528399707|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
146517072|NCT02007278|528399708|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
146517073|NCT02007278|528399707|FG000|Overall Study|Incorrect medication administration|1|||
146517074|NCT02007278|528399708|FG001|Overall Study|Incorrect medication administration|0|||
146517075|NCT02007278|528399707|FG000|Overall Study|Mis-randomization|1|||
146517076|NCT02007278|528399708|FG001|Overall Study|Mis-randomization|1|||
146517077|NCT03230838|528399714|FG000|Overall Study|Withdrawal by Subject|3|||
146517078|NCT03230838|528399715|FG001|Overall Study|Withdrawal by Subject|0|||
146517079|NCT03230838|528399714|FG000|Overall Study|Temperature excursion|1|||
146517080|NCT03230838|528399715|FG001|Overall Study|Temperature excursion|0|||
146517081|NCT03304184|528399716|FG000|Overall Study|Withdrawal by Subject|1|||
146517082|NCT03304184|528399717|FG001|Overall Study|Withdrawal by Subject|2|||
146517083|NCT01915771|528399718|FG000|Day 1|Withdrawal by Subject|1|||
146517084|NCT01915771|528399718|FG000|Day 15|Withdrawal by Subject|1|||
146517085|NCT03420222|528399721|FG000|Overall Study|Withdrawal by Subject|5|||
146517086|NCT03420222|528399722|FG001|Overall Study|Withdrawal by Subject|0|||
146517087|NCT03420222|528399721|FG000|Overall Study|Physician Decision|0|||
146517088|NCT03420222|528399722|FG001|Overall Study|Physician Decision|1|||
146756134|NCT02297503|529273190|FG000|Overall Study|Lost to Follow-up|0|||
146756135|NCT02297503|529273191|FG001|Overall Study|Lost to Follow-up|1|||
146756136|NCT02297503|529273190|FG000|Overall Study|Medical reason|0|||
146756137|NCT02297503|529273191|FG001|Overall Study|Medical reason|1|||
146756138|NCT02703532|529273193|FG000|Overall Study|Withdrawal by Subject|0|||
146756139|NCT02703532|529273194|FG001|Overall Study|Withdrawal by Subject|1|||
146756140|NCT02703532|529273195|FG002|Overall Study|Withdrawal by Subject|0|||
146756141|NCT02703532|529273196|FG003|Overall Study|Withdrawal by Subject|1|||
146756142|NCT02703532|529273193|FG000|Overall Study|Lost to Follow-up|2|||
146756143|NCT02703532|529273194|FG001|Overall Study|Lost to Follow-up|0|||
146756144|NCT02703532|529273195|FG002|Overall Study|Lost to Follow-up|2|||
146756145|NCT02703532|529273196|FG003|Overall Study|Lost to Follow-up|0|||
146756146|NCT03738241|529273200|FG000|Overall Study|Withdrawal by Subject|0|||
146756147|NCT03738241|529273201|FG001|Overall Study|Withdrawal by Subject|0|||
146756148|NCT03738241|529273202|FG002|Overall Study|Withdrawal by Subject|0|||
146756149|NCT03738241|529273203|FG003|Overall Study|Withdrawal by Subject|0|||
146756150|NCT03738241|529273204|FG004|Overall Study|Withdrawal by Subject|0|||
146756151|NCT03738241|529273205|FG005|Overall Study|Withdrawal by Subject|0|||
146756152|NCT03738241|529273206|FG006|Overall Study|Withdrawal by Subject|0|||
146756153|NCT03738241|529273207|FG007|Overall Study|Withdrawal by Subject|0|||
146756154|NCT03738241|529273208|FG008|Overall Study|Withdrawal by Subject|0|||
146756155|NCT03738241|529273209|FG009|Overall Study|Withdrawal by Subject|1|||
146756156|NCT03738241|529273200|FG000|Overall Study|Physician Decision|0|||
146756157|NCT03738241|529273201|FG001|Overall Study|Physician Decision|0|||
146756158|NCT03738241|529273202|FG002|Overall Study|Physician Decision|0|||
146756159|NCT03738241|529273203|FG003|Overall Study|Physician Decision|0|||
146756160|NCT03738241|529273204|FG004|Overall Study|Physician Decision|0|||
146756161|NCT03738241|529273205|FG005|Overall Study|Physician Decision|0|||
146756162|NCT03738241|529273206|FG006|Overall Study|Physician Decision|0|||
146756163|NCT03738241|529273207|FG007|Overall Study|Physician Decision|0|||
146756164|NCT03738241|529273208|FG008|Overall Study|Physician Decision|1|||
146756165|NCT03738241|529273209|FG009|Overall Study|Physician Decision|0|||
146756166|NCT03738241|529273200|FG000|Overall Study|Adverse Event|1|||
146756167|NCT03738241|529273201|FG001|Overall Study|Adverse Event|0|||
146756168|NCT03738241|529273202|FG002|Overall Study|Adverse Event|0|||
146756169|NCT03738241|529273203|FG003|Overall Study|Adverse Event|0|||
146756170|NCT03738241|529273204|FG004|Overall Study|Adverse Event|0|||
146756171|NCT03738241|529273205|FG005|Overall Study|Adverse Event|0|||
146756172|NCT03738241|529273206|FG006|Overall Study|Adverse Event|0|||
146756173|NCT03738241|529273207|FG007|Overall Study|Adverse Event|0|||
146756174|NCT03738241|529273208|FG008|Overall Study|Adverse Event|0|||
146756175|NCT03738241|529273209|FG009|Overall Study|Adverse Event|0|||
146756176|NCT01244763|529273210|FG000|Overall Study|Adverse Event|1|||
146756177|NCT01244763|529273211|FG001|Overall Study|Adverse Event|0|||
146756178|NCT01244763|529273212|FG002|Overall Study|Adverse Event|0|||
146756179|NCT01244763|529273213|FG003|Overall Study|Adverse Event|0|||
146756180|NCT01244763|529273214|FG004|Overall Study|Adverse Event|0|||
146756181|NCT01244763|529273215|FG005|Overall Study|Adverse Event|1|||
146756182|NCT01244763|529273210|FG000|Overall Study|Death|1|||
146756183|NCT01244763|529273211|FG001|Overall Study|Death|0|||
146756184|NCT01244763|529273212|FG002|Overall Study|Death|1|||
146756185|NCT01244763|529273213|FG003|Overall Study|Death|0|||
146756186|NCT01244763|529273214|FG004|Overall Study|Death|2|||
146756187|NCT01244763|529273215|FG005|Overall Study|Death|0|||
146756188|NCT01244763|529273210|FG000|Overall Study|Physician Decision|0|||
146756189|NCT01244763|529273211|FG001|Overall Study|Physician Decision|0|||
146756190|NCT01244763|529273212|FG002|Overall Study|Physician Decision|1|||
146756191|NCT01244763|529273213|FG003|Overall Study|Physician Decision|0|||
146756192|NCT01244763|529273214|FG004|Overall Study|Physician Decision|0|||
146756193|NCT01244763|529273215|FG005|Overall Study|Physician Decision|0|||
146756194|NCT01244763|529273210|FG000|Overall Study|Withdrawal by Subject|1|||
146756195|NCT01244763|529273211|FG001|Overall Study|Withdrawal by Subject|2|||
146756196|NCT01244763|529273212|FG002|Overall Study|Withdrawal by Subject|0|||
146756197|NCT01244763|529273213|FG003|Overall Study|Withdrawal by Subject|1|||
146756198|NCT01244763|529273214|FG004|Overall Study|Withdrawal by Subject|1|||
146756199|NCT01244763|529273215|FG005|Overall Study|Withdrawal by Subject|2|||
146756200|NCT01244763|529273210|FG000|Overall Study|Lost to Follow-up|0|||
146756201|NCT01244763|529273211|FG001|Overall Study|Lost to Follow-up|1|||
146756202|NCT01244763|529273212|FG002|Overall Study|Lost to Follow-up|0|||
146756203|NCT01244763|529273213|FG003|Overall Study|Lost to Follow-up|0|||
146756204|NCT01244763|529273214|FG004|Overall Study|Lost to Follow-up|0|||
146756205|NCT01244763|529273215|FG005|Overall Study|Lost to Follow-up|0|||
146756206|NCT01244763|529273210|FG000|Overall Study|Enrolled into the Extension Study|0|||
146756207|NCT01244763|529273211|FG001|Overall Study|Enrolled into the Extension Study|0|||
146756208|NCT01244763|529273212|FG002|Overall Study|Enrolled into the Extension Study|0|||
146756209|NCT01244763|529273213|FG003|Overall Study|Enrolled into the Extension Study|0|||
146756210|NCT01244763|529273214|FG004|Overall Study|Enrolled into the Extension Study|0|||
146756211|NCT01244763|529273215|FG005|Overall Study|Enrolled into the Extension Study|1|||
146517089|NCT02334384|528399723|FG000|Overall Study|Lost to Follow-up|1|||
146517090|NCT02334384|528399724|FG001|Overall Study|Lost to Follow-up|1|||
146517091|NCT02279745|528399725|FG000|Overall Study|Adverse Event|7|||
146517092|NCT02279745|528399725|FG000|Overall Study|Death|6|||
146517093|NCT02279745|528399725|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
146517094|NCT02279745|528399725|FG000|Overall Study|Withdrawal by Subject|2|||
146517095|NCT02279745|528399725|FG000|Overall Study|Pregnancy|1|||
146517096|NCT02279745|528399725|FG000|Overall Study|Study Non-compliance|1|||
146517097|NCT02279745|528399725|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
146517098|NCT00793546|528399728|FG000|Overall Study|Death|3|||
146517099|NCT00793546|528399729|FG001|Overall Study|Death|0|||
146517100|NCT00793546|528399728|FG000|Overall Study|Lost to Follow-up|1|||
146517101|NCT00793546|528399729|FG001|Overall Study|Lost to Follow-up|0|||
146517102|NCT00793546|528399728|FG000|Overall Study|Withdrawal by Subject|1|||
146517103|NCT00793546|528399729|FG001|Overall Study|Withdrawal by Subject|1|||
146517104|NCT00793546|528399728|FG000|Overall Study|Study Terminated by Sponsor|8|||
146517105|NCT00793546|528399729|FG001|Overall Study|Study Terminated by Sponsor|27|||
146517106|NCT00793546|528399728|FG000|Overall Study|Other|1|||
146517107|NCT00793546|528399729|FG001|Overall Study|Other|0|||
146517108|NCT02101359|528399730|FG000|Overall Study|Not included|23|||
146517109|NCT02101359|528399731|FG001|Overall Study|Not included|13|||
146517110|NCT02101359|528399730|FG000|Overall Study|Withdrawal by Subject|5|||
146517111|NCT02101359|528399731|FG001|Overall Study|Withdrawal by Subject|4|||
146517112|NCT02101359|528399730|FG000|Overall Study|Lost to Follow-up|1|||
146517113|NCT02101359|528399731|FG001|Overall Study|Lost to Follow-up|0|||
146517114|NCT02101359|528399730|FG000|Overall Study|Protocol Violation|0|||
146517115|NCT02101359|528399731|FG001|Overall Study|Protocol Violation|2|||
146517116|NCT00494221|528399732|FG000|Overall Study|Death|15|||
146517117|NCT00494221|528399733|FG001|Overall Study|Death|9|||
146517118|NCT00494221|528399734|FG002|Overall Study|Death|14|||
146517119|NCT00494221|528399732|FG000|Overall Study|Withdrawal by Subject|1|||
146517120|NCT00494221|528399733|FG001|Overall Study|Withdrawal by Subject|2|||
146517121|NCT00494221|528399734|FG002|Overall Study|Withdrawal by Subject|0|||
146517122|NCT03172364|528399739|FG000|Overall Study|Adverse Event|1|||
146517123|NCT03172364|528399740|FG001|Overall Study|Adverse Event|1|||
146517124|NCT03172364|528399739|FG000|Overall Study|Protocol Violation|1|||
146517125|NCT03172364|528399740|FG001|Overall Study|Protocol Violation|0|||
146517126|NCT03755518|528399741|FG000|Overall Study|Lack of Efficacy|10|||
146517127|NCT03755518|528399741|FG000|Overall Study|Adverse Event|7|||
146517128|NCT03755518|528399741|FG000|Overall Study|Study Terminated by Sponsor|5|||
146517129|NCT03755518|528399741|FG000|Overall Study|Death|1|||
146517130|NCT03755518|528399741|FG000|Overall Study|Withdrawal by Subject|3|||
146517131|NCT03755518|528399741|FG000|Overall Study|Progressive Disease|4|||
146517132|NCT03755518|528399741|FG000|Overall Study|Bone Marrow Transplant|4|||
146517133|NCT03755518|528399741|FG000|Overall Study|Physicians Decision|1|||
146517134|NCT03755518|528399741|FG000|Overall Study|Relapse|1|||
146517135|NCT03755518|528399741|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
146517136|NCT03755518|528399741|FG000|Overall Study|Withdrawal by PI|1|||
146517137|NCT01714609|528399742|FG000|Overall Study|Protocol Violation|1|||
146517138|NCT01714609|528399743|FG001|Overall Study|Protocol Violation|0|||
146517139|NCT02732327|528399744|FG000|Overall Study|Protocol Violation|0|||
146517140|NCT02732327|528399745|FG001|Overall Study|Protocol Violation|1|||
146517141|NCT02306694|528399746|FG000|Overall Study|Withdrawal by Subject|3|||
146517142|NCT02306694|528399746|FG000|Overall Study|Lost to Follow-up|1|||
146517143|NCT00603382|528399747|FG000|Overall Study|Adverse Event|0|||
146517144|NCT00603382|528399748|FG001|Overall Study|Adverse Event|1|||
146517145|NCT00603382|528399749|FG002|Overall Study|Adverse Event|1|||
146517146|NCT00603382|528399750|FG003|Overall Study|Adverse Event|2|||
146517147|NCT00603382|528399751|FG004|Overall Study|Adverse Event|1|||
146517148|NCT00603382|528399752|FG005|Overall Study|Adverse Event|2|||
146517149|NCT00603382|528399747|FG000|Overall Study|Lack of Efficacy|14|||
146517150|NCT00603382|528399748|FG001|Overall Study|Lack of Efficacy|9|||
146517151|NCT00603382|528399749|FG002|Overall Study|Lack of Efficacy|3|||
146517152|NCT00603382|528399750|FG003|Overall Study|Lack of Efficacy|6|||
146517153|NCT00603382|528399751|FG004|Overall Study|Lack of Efficacy|6|||
146517154|NCT00603382|528399752|FG005|Overall Study|Lack of Efficacy|11|||
146517155|NCT00603382|528399747|FG000|Overall Study|Protocol Violation|1|||
146517156|NCT00603382|528399748|FG001|Overall Study|Protocol Violation|0|||
146517157|NCT00603382|528399749|FG002|Overall Study|Protocol Violation|1|||
146517158|NCT00603382|528399750|FG003|Overall Study|Protocol Violation|2|||
146517159|NCT00603382|528399751|FG004|Overall Study|Protocol Violation|1|||
146517160|NCT00603382|528399752|FG005|Overall Study|Protocol Violation|0|||
146517161|NCT00603382|528399747|FG000|Overall Study|Lost to Follow-up|0|||
146517162|NCT00603382|528399748|FG001|Overall Study|Lost to Follow-up|1|||
146517163|NCT00603382|528399749|FG002|Overall Study|Lost to Follow-up|1|||
146517164|NCT00603382|528399750|FG003|Overall Study|Lost to Follow-up|1|||
146517165|NCT00603382|528399751|FG004|Overall Study|Lost to Follow-up|0|||
146517166|NCT00603382|528399752|FG005|Overall Study|Lost to Follow-up|1|||
146517167|NCT00603382|528399747|FG000|Overall Study|Physician Decision|0|||
146517168|NCT00603382|528399748|FG001|Overall Study|Physician Decision|0|||
146517169|NCT00603382|528399749|FG002|Overall Study|Physician Decision|2|||
146517170|NCT00603382|528399750|FG003|Overall Study|Physician Decision|0|||
146517171|NCT00603382|528399751|FG004|Overall Study|Physician Decision|1|||
146517172|NCT00603382|528399752|FG005|Overall Study|Physician Decision|3|||
146517173|NCT00603382|528399747|FG000|Overall Study|Withdrawal by Subject|3|||
146517174|NCT00603382|528399748|FG001|Overall Study|Withdrawal by Subject|3|||
146517175|NCT00603382|528399749|FG002|Overall Study|Withdrawal by Subject|1|||
146517176|NCT00603382|528399750|FG003|Overall Study|Withdrawal by Subject|1|||
146517177|NCT00603382|528399751|FG004|Overall Study|Withdrawal by Subject|0|||
146517178|NCT00603382|528399752|FG005|Overall Study|Withdrawal by Subject|1|||
146517179|NCT00583102|528399753|FG000|Overall Study|Adverse Event|3|||
146517180|NCT00742027|528399758|FG000|Overall Study|Disease Progression|76|||
146517181|NCT00742027|528399758|FG000|Overall Study|New Cancer Therapy|19|||
146517182|NCT00742027|528399758|FG000|Overall Study|Withdrawal by Subject|18|||
146517183|NCT00742027|528399758|FG000|Overall Study|Death|7|||
146517184|NCT00742027|528399758|FG000|Overall Study|Lost to Follow-up|4|||
146517185|NCT00742027|528399758|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
146517186|NCT00742027|528399758|FG000|Overall Study|Missing|2|||
146517187|NCT00742027|528399758|FG000|Overall Study|Administrative Problems|1|||
146517188|NCT01180049|528399759|FG000|Overall Study|Other|9|||
146517189|NCT01180049|528399760|FG001|Overall Study|Other|7|||
146517190|NCT01180049|528399759|FG000|Overall Study|Lost to Follow-up|8|||
146517191|NCT01180049|528399760|FG001|Overall Study|Lost to Follow-up|6|||
146517192|NCT01180049|528399759|FG000|Overall Study|Death|36|||
146517193|NCT01180049|528399760|FG001|Overall Study|Death|35|||
146517194|NCT01738191|528399761|FG000|Overall Study|Withdrawal by Subject|4|||
146517195|NCT01738191|528399762|FG001|Overall Study|Withdrawal by Subject|1|||
146517196|NCT02483572|528399763|FG000|Overall Study|Withdrawal by Subject|1|||
146517197|NCT02483572|528399764|FG001|Overall Study|Withdrawal by Subject|0|||
146517198|NCT02483572|528399763|FG000|Overall Study|Lost to Follow-up|1|||
146517199|NCT02483572|528399764|FG001|Overall Study|Lost to Follow-up|0|||
146517200|NCT02483572|528399763|FG000|Overall Study|Physician Decision|0|||
146517201|NCT02483572|528399764|FG001|Overall Study|Physician Decision|1|||
146517202|NCT00350779|528399768|FG000|Overall Study|Adverse Event|4|||
146517203|NCT00350779|528399769|FG001|Overall Study|Adverse Event|2|||
146517204|NCT00350779|528399768|FG000|Overall Study|Lack of Efficacy|0|||
146517205|NCT00350779|528399769|FG001|Overall Study|Lack of Efficacy|4|||
146517206|NCT00350779|528399768|FG000|Overall Study|Lost to Follow-up|2|||
146517207|NCT00350779|528399769|FG001|Overall Study|Lost to Follow-up|0|||
146517208|NCT00350779|528399768|FG000|Overall Study|Physician Decision|2|||
146517209|NCT00350779|528399769|FG001|Overall Study|Physician Decision|4|||
146517210|NCT00350779|528399768|FG000|Overall Study|Protocol Violation|3|||
146517211|NCT00350779|528399769|FG001|Overall Study|Protocol Violation|1|||
146517212|NCT00350779|528399768|FG000|Overall Study|Withdrawal by Subject|9|||
146517213|NCT00350779|528399769|FG001|Overall Study|Withdrawal by Subject|8|||
146517214|NCT00350779|528399768|FG000|Overall Study|Patient Moved|2|||
146517215|NCT00350779|528399769|FG001|Overall Study|Patient Moved|1|||
146517216|NCT00350779|528399768|FG000|Overall Study|Non-compliance with study procedures|0|||
146517217|NCT00350779|528399769|FG001|Overall Study|Non-compliance with study procedures|1|||
146517218|NCT02432144|528399770|FG000|Overall Study|Participant Non-Compliance|1|||
146517219|NCT00385827|528401202|FG000|Part 1|Adverse Event|1|||
146517220|NCT00385827|528401203|FG001|Part 1|Adverse Event|0|||
146517221|NCT00385827|528401204|FG002|Part 1|Adverse Event|0|||
146517222|NCT00385827|528401202|FG000|Part 1|Death|2|||
146517223|NCT00385827|528401203|FG001|Part 1|Death|0|||
146517224|NCT00385827|528401204|FG002|Part 1|Death|0|||
146517225|NCT00385827|528401202|FG000|Part 1|Lack of Efficacy|5|||
146517226|NCT00385827|528401203|FG001|Part 1|Lack of Efficacy|0|||
146517227|NCT00385827|528401204|FG002|Part 1|Lack of Efficacy|0|||
146517228|NCT00385827|528401202|FG000|Part 1|Other|1|||
146517229|NCT00385827|528401203|FG001|Part 1|Other|0|||
146517230|NCT00385827|528401204|FG002|Part 1|Other|0|||
146517231|NCT00385827|528401202|FG000|Part 2|Adverse Event|0|||
146517232|NCT00385827|528401203|FG001|Part 2|Adverse Event|6|||
146517233|NCT00385827|528401204|FG002|Part 2|Adverse Event|10|||
146517234|NCT00385827|528401202|FG000|Part 2|Death|0|||
146517235|NCT00385827|528401203|FG001|Part 2|Death|0|||
146517236|NCT00385827|528401204|FG002|Part 2|Death|2|||
146517237|NCT00385827|528401202|FG000|Part 2|Lack of Efficacy|0|||
146517238|NCT00385827|528401203|FG001|Part 2|Lack of Efficacy|14|||
146517239|NCT00385827|528401204|FG002|Part 2|Lack of Efficacy|13|||
146517240|NCT00385827|528401202|FG000|Part 2|Randomized but not treated|0|||
146517241|NCT00385827|528401203|FG001|Part 2|Randomized but not treated|2|||
146517242|NCT00385827|528401204|FG002|Part 2|Randomized but not treated|2|||
146517243|NCT00385827|528401202|FG000|Part 2|Other|0|||
146517244|NCT00385827|528401203|FG001|Part 2|Other|11|||
146517245|NCT00385827|528401204|FG002|Part 2|Other|21|||
146517246|NCT03536663|528401207|FG000|Endexo|Protocol Violation|1|||
146517247|NCT01964989|528401215|FG000|Overall Study|Protocol Violation|3|||
146517248|NCT01964989|528401216|FG001|Overall Study|Protocol Violation|4|||
146517249|NCT01964989|528401215|FG000|Overall Study|Administrative Reason|103|||
146517250|NCT01964989|528401216|FG001|Overall Study|Administrative Reason|95|||
146625250|NCT03037385|528803845|FG000|Overall Study|Initiation of Another Therapy|1|||
146756212|NCT03169361|529273216|FG000|Overall Study|Protocol Violation|32|||
146756213|NCT02788656|529273217|FG000|Overall Study|Withdrawal by Subject|1|||
146756214|NCT02788656|529273218|FG001|Overall Study|Withdrawal by Subject|0|||
146756215|NCT02263885|529273219|FG000|Overall Study|Withdrawal by Subject|7|||
146756216|NCT02263885|529273219|FG000|Overall Study|Alternative Treatment|3|||
146756217|NCT00751790|529273234|FG000|Overall Study|Lost to Follow-up|1|||
146756218|NCT00751790|529273234|FG000|Overall Study|Death|3|||
146756219|NCT00751790|529273234|FG000|Overall Study|Withdrawal by Subject|1|||
146756220|NCT03302910|529273235|FG000|Overall Study|Protocol Violation|1|||
146756221|NCT03302910|529273236|FG001|Overall Study|Protocol Violation|0|||
146756222|NCT01106976|529273237|FG000|Overall Study|Lost to Follow-up|8|||
146756223|NCT04170023|529273244|FG000|LTE Period|Withdrawal by Subject|1|||
146756224|NCT04170023|529273245|FG001|LTE Period|Withdrawal by Subject|0|||
146756225|NCT04170023|529273246|FG002|LTE Period|Withdrawal by Subject|0|||
146756226|NCT04170023|529273244|FG000|LTE Period|Study Termination|11|||
146756227|NCT04170023|529273245|FG001|LTE Period|Study Termination|11|||
146756228|NCT04170023|529273246|FG002|LTE Period|Study Termination|5|||
146756229|NCT00953160|529273249|FG000|Overall Study|Lost to Follow-up|23|||
146756230|NCT00953160|529273249|FG000|Overall Study|Withdrawal by Subject|4|||
146756231|NCT03566680|529273252|FG000|Overall Study|Pregnancy|1|||
146756232|NCT03566680|529273252|FG000|Overall Study|Lost to Follow-up|13|||
146756233|NCT03566680|529273252|FG000|Overall Study|Withdrawal by Subject|3|||
146756234|NCT03836664|529273253|FG000|Overall Study|Didn't complete forms and lost drug|3|||
146756235|NCT03836664|529273254|FG001|Overall Study|Didn't complete forms and lost drug|3|||
146756236|NCT02724020|529273255|FG000|Overall Study|Death|16|||
146756237|NCT02724020|529273256|FG001|Overall Study|Death|18|||
146756238|NCT02724020|529273257|FG002|Overall Study|Death|19|||
146756239|NCT02724020|529273255|FG000|Overall Study|Lost to Follow-up|0|||
146756240|NCT02724020|529273256|FG001|Overall Study|Lost to Follow-up|3|||
146756241|NCT02724020|529273257|FG002|Overall Study|Lost to Follow-up|0|||
146756242|NCT02724020|529273255|FG000|Overall Study|Site Terminated by Sponsor|15|||
146756243|NCT02724020|529273256|FG001|Overall Study|Site Terminated by Sponsor|8|||
146756244|NCT02724020|529273257|FG002|Overall Study|Site Terminated by Sponsor|8|||
146756245|NCT02724020|529273255|FG000|Overall Study|Withdrawal by Subject|1|||
146756246|NCT02724020|529273256|FG001|Overall Study|Withdrawal by Subject|3|||
146756247|NCT02724020|529273257|FG002|Overall Study|Withdrawal by Subject|5|||
146756248|NCT00425503|529273258|FG000|Overall Study|Adverse Event|2|||
146756249|NCT00425503|529273258|FG000|Overall Study|Protocol Violation|1|||
146756250|NCT02179918|529273259|FG000|Overall Study|Death|0|||
146756251|NCT02179918|529273260|FG001|Overall Study|Death|0|||
146756252|NCT02179918|529273261|FG002|Overall Study|Death|0|||
146756253|NCT02179918|529273262|FG003|Overall Study|Death|1|||
146756254|NCT02179918|529273263|FG004|Overall Study|Death|0|||
146756255|NCT02179918|529273259|FG000|Overall Study|Lost to Follow-up|0|||
146756256|NCT02179918|529273260|FG001|Overall Study|Lost to Follow-up|0|||
146756257|NCT02179918|529273261|FG002|Overall Study|Lost to Follow-up|1|||
146756258|NCT02179918|529273262|FG003|Overall Study|Lost to Follow-up|0|||
146756259|NCT02179918|529273263|FG004|Overall Study|Lost to Follow-up|0|||
146756260|NCT02179918|529273259|FG000|Overall Study|Progressive Disease|4|||
146756261|NCT02179918|529273260|FG001|Overall Study|Progressive Disease|1|||
146756262|NCT02179918|529273261|FG002|Overall Study|Progressive Disease|1|||
146756263|NCT02179918|529273262|FG003|Overall Study|Progressive Disease|2|||
146756264|NCT02179918|529273263|FG004|Overall Study|Progressive Disease|6|||
146756265|NCT02179918|529273259|FG000|Overall Study|Other|0|||
146756266|NCT02179918|529273260|FG001|Overall Study|Other|1|||
146756267|NCT02179918|529273261|FG002|Overall Study|Other|0|||
146756268|NCT02179918|529273262|FG003|Overall Study|Other|0|||
146756269|NCT02179918|529273263|FG004|Overall Study|Other|1|||
146756270|NCT02179918|529273259|FG000|Overall Study|Subject refused further follow-up|0|||
146756271|NCT02179918|529273260|FG001|Overall Study|Subject refused further follow-up|1|||
146756272|NCT02179918|529273261|FG002|Overall Study|Subject refused further follow-up|0|||
146756273|NCT02179918|529273262|FG003|Overall Study|Subject refused further follow-up|0|||
146756274|NCT02179918|529273263|FG004|Overall Study|Subject refused further follow-up|1|||
146756275|NCT03890120|529273268|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
146756276|NCT03890120|529273269|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
146756277|NCT03890120|529273270|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
146756278|NCT03890120|529273271|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
146853533|NCT00994682|529633690|FG000|Double Bilnd|Withdrawal by Subject|5|||
146853534|NCT00994682|529633691|FG001|Double Bilnd|Withdrawal by Subject|6|||
146756279|NCT03890120|529273268|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
146756280|NCT03890120|529273269|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
146756281|NCT03890120|529273270|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
146756282|NCT03890120|529273271|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
146756283|NCT03890120|529273268|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
146756284|NCT03890120|529273269|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
146756285|NCT03890120|529273270|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
146517251|NCT01964989|528401215|FG000|Overall Study|Adverse Event|0|||
146517252|NCT01964989|528401216|FG001|Overall Study|Adverse Event|1|||
146517253|NCT01964989|528401215|FG000|Overall Study|Death|1|||
146517254|NCT01964989|528401216|FG001|Overall Study|Death|3|||
146517255|NCT01964989|528401215|FG000|Overall Study|Withdrawal by Subject|156|||
146517256|NCT01964989|528401216|FG001|Overall Study|Withdrawal by Subject|160|||
146517257|NCT01964989|528401215|FG000|Overall Study|Lost to Follow-up|254|||
146517258|NCT01964989|528401216|FG001|Overall Study|Lost to Follow-up|232|||
146517259|NCT01964989|528401215|FG000|Overall Study|Other|267|||
146517260|NCT01964989|528401216|FG001|Overall Study|Other|252|||
146517261|NCT02769312|528401217|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
146517262|NCT02769312|528401218|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
146517263|NCT02769312|528401217|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
146517264|NCT02769312|528401218|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
146517265|NCT02769312|528401217|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
146517266|NCT02769312|528401218|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
146517267|NCT02769312|528401217|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
146517268|NCT02769312|528401218|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
146517269|NCT02769312|528401217|FG000|Follow-up|Lost to Follow-up|1|||
146517270|NCT02769312|528401218|FG001|Follow-up|Lost to Follow-up|1|||
146517271|NCT00424593|528401219|FG000|Acute Double-Blind Period|Adverse Event|16|||
146517272|NCT00424593|528401220|FG001|Acute Double-Blind Period|Adverse Event|7|||
146517273|NCT00424593|528401219|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
146517274|NCT00424593|528401220|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
146517275|NCT00424593|528401219|FG000|Acute Double-Blind Period|Protocol Violation|2|||
146517276|NCT00424593|528401220|FG001|Acute Double-Blind Period|Protocol Violation|2|||
146517277|NCT00424593|528401219|FG000|Acute Double-Blind Period|Physician Decision|1|||
146517278|NCT00424593|528401220|FG001|Acute Double-Blind Period|Physician Decision|2|||
146517279|NCT00424593|528401219|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
146517280|NCT00424593|528401220|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
146517281|NCT00424593|528401219|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
146517282|NCT00424593|528401220|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
146517283|NCT00424593|528401219|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
146517284|NCT00424593|528401220|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
146517285|NCT00424593|528401219|FG000|Dose-Blind Extension Period|Adverse Event|18|||
146517286|NCT00424593|528401220|FG001|Dose-Blind Extension Period|Adverse Event|0|||
146517287|NCT00424593|528401219|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
146517288|NCT00424593|528401220|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
146517289|NCT00424593|528401219|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
146517290|NCT00424593|528401220|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
146517291|NCT00424593|528401219|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
146517292|NCT00424593|528401220|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
146517293|NCT00424593|528401219|FG000|Dose-Blind Extension Period|Physician Decision|3|||
146517294|NCT00424593|528401220|FG001|Dose-Blind Extension Period|Physician Decision|0|||
146517295|NCT02496039|528401221|FG000|Overall Study|Adverse Event|3|||
146517296|NCT02496039|528401221|FG000|Overall Study|Protocol Violation|1|||
146517297|NCT03297021|528401222|FG000|Overall Study|Incomplete/illegible data sheet|4|||
146517298|NCT03297021|528401223|FG001|Overall Study|Incomplete/illegible data sheet|2|||
146517299|NCT03297021|528401224|FG002|Overall Study|Incomplete/illegible data sheet|3|||
146517300|NCT03297021|528401222|FG000|Overall Study|Missing Post-Op Data|1|||
146517301|NCT03297021|528401223|FG001|Overall Study|Missing Post-Op Data|2|||
146517302|NCT03297021|528401224|FG002|Overall Study|Missing Post-Op Data|1|||
146517303|NCT02734862|528401226|FG000|Part A|Death|3|||
146517304|NCT02734862|528401227|FG001|Part A|Death|4|||
146517305|NCT02734862|528401228|FG002|Part A|Death|6|||
146517306|NCT02734862|528401226|FG000|Part A|Lost to Follow-up|2|||
146517307|NCT02734862|528401227|FG001|Part A|Lost to Follow-up|1|||
146517308|NCT02734862|528401228|FG002|Part A|Lost to Follow-up|1|||
146517309|NCT02734862|528401226|FG000|Part A|Withdrawal by Subject|1|||
146517310|NCT02734862|528401227|FG001|Part A|Withdrawal by Subject|1|||
146517311|NCT02734862|528401228|FG002|Part A|Withdrawal by Subject|2|||
146517312|NCT02734862|528401226|FG000|Part A|Physician Decision|2|||
146517313|NCT02734862|528401227|FG001|Part A|Physician Decision|0|||
146517314|NCT02734862|528401228|FG002|Part A|Physician Decision|1|||
146517315|NCT02734862|528401226|FG000|Part A|Adverse Event|2|||
146517316|NCT02734862|528401227|FG001|Part A|Adverse Event|0|||
146517317|NCT02734862|528401228|FG002|Part A|Adverse Event|1|||
146517318|NCT02734862|528401226|FG000|Part A|Noncompliance|1|||
146517319|NCT02734862|528401227|FG001|Part A|Noncompliance|1|||
146625251|NCT03037385|528803846|FG001|Overall Study|Initiation of Another Therapy|0|||
146625252|NCT03037385|528803847|FG002|Overall Study|Initiation of Another Therapy|0|||
146517320|NCT02734862|528401228|FG002|Part A|Noncompliance|0|||
146517321|NCT02734862|528401226|FG000|Part A|Other|1|||
146517322|NCT02734862|528401227|FG001|Part A|Other|1|||
146517323|NCT02734862|528401228|FG002|Part A|Other|3|||
146517324|NCT02734862|528401226|FG000|Part B|Death|8|||
146517325|NCT02734862|528401227|FG001|Part B|Death|3|||
146517326|NCT02734862|528401228|FG002|Part B|Death|5|||
146517327|NCT02734862|528401226|FG000|Part B|Lost to Follow-up|2|||
146517328|NCT02734862|528401227|FG001|Part B|Lost to Follow-up|2|||
146517329|NCT02734862|528401228|FG002|Part B|Lost to Follow-up|0|||
146517330|NCT02734862|528401226|FG000|Part B|Withdrawal by Subject|3|||
146517331|NCT02734862|528401227|FG001|Part B|Withdrawal by Subject|1|||
146517332|NCT02734862|528401228|FG002|Part B|Withdrawal by Subject|0|||
146517333|NCT02734862|528401226|FG000|Part B|Other|0|||
146517334|NCT02734862|528401227|FG001|Part B|Other|1|||
146517335|NCT02734862|528401228|FG002|Part B|Other|0|||
146517336|NCT05114564|528401230|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
146517337|NCT05114564|528401231|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
146517338|NCT05114564|528401230|FG000|First Intervention|Adverse Event|0|||
146756286|NCT03890120|529273271|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
146756287|NCT03890120|529273268|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
146756288|NCT03890120|529273269|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
146756289|NCT03890120|529273270|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
146756290|NCT03890120|529273271|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
146756291|NCT03890120|529273268|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
146756292|NCT03890120|529273269|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
146756293|NCT03890120|529273270|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
146756294|NCT03890120|529273271|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
146756295|NCT03890120|529273268|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
146756296|NCT03890120|529273269|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
146756297|NCT03890120|529273270|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
146756298|NCT03890120|529273271|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
146756299|NCT03890120|529273268|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
146756300|NCT03890120|529273269|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
146756301|NCT03890120|529273270|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
146756302|NCT03890120|529273271|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
146756303|NCT03890120|529273268|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
146756304|NCT03890120|529273269|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
146756305|NCT03890120|529273270|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
146756306|NCT03890120|529273271|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
146756307|NCT03890120|529273268|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
146756308|NCT03890120|529273269|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
146756309|NCT03890120|529273270|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
146756310|NCT03890120|529273271|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
146756311|NCT03890120|529273268|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
146756312|NCT03890120|529273269|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
146756313|NCT03890120|529273270|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
146756314|NCT03890120|529273271|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
146756315|NCT03890120|529273268|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
146756316|NCT03890120|529273269|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
146756317|NCT03890120|529273270|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
146756318|NCT03890120|529273271|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
146756319|NCT03890120|529273268|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
146756320|NCT03890120|529273269|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
146756321|NCT03890120|529273270|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
146756322|NCT03890120|529273271|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
146756323|NCT03890120|529273268|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
146756324|NCT03890120|529273269|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
146756325|NCT03890120|529273270|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
146756326|NCT03890120|529273271|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
146756327|NCT04537949|529273272|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
146756328|NCT04537949|529273273|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
146756329|NCT04537949|529273274|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
146756330|NCT04537949|529273275|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
146756331|NCT04537949|529273276|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
146756332|NCT04537949|529273277|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
146756333|NCT04537949|529273278|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
146756334|NCT04537949|529273279|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
146756335|NCT04537949|529273272|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
146756336|NCT04537949|529273273|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
146517339|NCT05114564|528401231|FG001|First Intervention|Adverse Event|1|||
146517340|NCT00493311|528401232|FG000|Overall Study|Need for rescue medication|2|||
146517341|NCT00493311|528401233|FG001|Overall Study|Need for rescue medication|2|||
146517342|NCT02779075|528401234|FG000|Overall Study|Withdrawal by Subject|1|||
146517343|NCT02779075|528401235|FG001|Overall Study|Withdrawal by Subject|3|||
146517344|NCT02779075|528401234|FG000|Overall Study|IV lost during 2nd study|1|||
146517345|NCT02779075|528401235|FG001|Overall Study|IV lost during 2nd study|0|||
146517346|NCT00255840|528401236|FG000|Overall Study|Lost to Follow-up|10|||
146517347|NCT00255840|528401237|FG001|Overall Study|Lost to Follow-up|14|||
146517348|NCT00255840|528401236|FG000|Overall Study|Discontinued intervention|53|||
146517349|NCT00255840|528401237|FG001|Overall Study|Discontinued intervention|56|||
146517350|NCT01005901|528401238|FG000|Overall Study|Withdrawal by Subject|38|||
146517351|NCT01005901|528401239|FG001|Overall Study|Withdrawal by Subject|14|||
146517352|NCT01005901|528401238|FG000|Overall Study|Adverse Event|30|||
146517353|NCT01005901|528401239|FG001|Overall Study|Adverse Event|16|||
146517354|NCT01005901|528401238|FG000|Overall Study|Administrative problems|21|||
146517355|NCT01005901|528401239|FG001|Overall Study|Administrative problems|13|||
146517356|NCT01005901|528401238|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
146517357|NCT01005901|528401239|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
146517358|NCT01005901|528401238|FG000|Overall Study|Protocol Violation|4|||
146517359|NCT01005901|528401239|FG001|Overall Study|Protocol Violation|3|||
146517360|NCT01005901|528401238|FG000|Overall Study|Death|2|||
146517361|NCT01005901|528401239|FG001|Overall Study|Death|3|||
146517362|NCT01005901|528401238|FG000|Overall Study|Lost to Follow-up|1|||
146517363|NCT01005901|528401239|FG001|Overall Study|Lost to Follow-up|2|||
146517364|NCT01005901|528401238|FG000|Overall Study|Patient's inability to use the device|1|||
146517365|NCT01005901|528401239|FG001|Overall Study|Patient's inability to use the device|1|||
146517366|NCT01005901|528401238|FG000|Overall Study|No longer requires study drug|0|||
146517367|NCT01005901|528401239|FG001|Overall Study|No longer requires study drug|1|||
146517368|NCT00760487|528401240|FG000|Overall Study|Unilateral implantation|3|||
146517369|NCT00496587|528401244|FG000|Overall Study|Adverse Event|2|||
146517370|NCT00496587|528401244|FG000|Overall Study|Progressive Disease|24|||
146517371|NCT00496587|528401244|FG000|Overall Study|Withdrawal by Subject|2|||
146517372|NCT00496587|528401244|FG000|Overall Study|Death|1|||
146517373|NCT00496587|528401244|FG000|Overall Study|Complications unrelated|2|||
146517374|NCT05259917|528401249|FG000|Overall Study|Protocol Violation|0|||
146517375|NCT05259917|528401250|FG001|Overall Study|Protocol Violation|0|||
146517376|NCT05259917|528401251|FG002|Overall Study|Protocol Violation|1|||
146517377|NCT05259917|528401252|FG003|Overall Study|Protocol Violation|0|||
146517378|NCT05259917|528401253|FG004|Overall Study|Protocol Violation|0|||
146517379|NCT05259917|528401254|FG005|Overall Study|Protocol Violation|0|||
146517380|NCT05259917|528401249|FG000|Overall Study|Lost to Follow-up|0|||
146517381|NCT05259917|528401250|FG001|Overall Study|Lost to Follow-up|0|||
146517382|NCT05259917|528401251|FG002|Overall Study|Lost to Follow-up|1|||
146517383|NCT05259917|528401252|FG003|Overall Study|Lost to Follow-up|0|||
146517384|NCT05259917|528401253|FG004|Overall Study|Lost to Follow-up|0|||
146517385|NCT05259917|528401254|FG005|Overall Study|Lost to Follow-up|1|||
146517386|NCT05259917|528401249|FG000|Overall Study|Physician Decision|0|||
146517387|NCT05259917|528401250|FG001|Overall Study|Physician Decision|1|||
146517388|NCT05259917|528401251|FG002|Overall Study|Physician Decision|0|||
146517389|NCT05259917|528401252|FG003|Overall Study|Physician Decision|0|||
146517390|NCT05259917|528401253|FG004|Overall Study|Physician Decision|0|||
146517391|NCT05259917|528401254|FG005|Overall Study|Physician Decision|0|||
146517392|NCT05259917|528401249|FG000|Overall Study|Withdrawal by Subject|0|||
146517393|NCT05259917|528401250|FG001|Overall Study|Withdrawal by Subject|1|||
146517394|NCT05259917|528401251|FG002|Overall Study|Withdrawal by Subject|0|||
146517395|NCT05259917|528401252|FG003|Overall Study|Withdrawal by Subject|0|||
146517396|NCT05259917|528401253|FG004|Overall Study|Withdrawal by Subject|1|||
146517397|NCT05259917|528401254|FG005|Overall Study|Withdrawal by Subject|1|||
146517398|NCT05259917|528401249|FG000|Overall Study|Trial Termination by Sponsor|7|||
146517399|NCT05259917|528401250|FG001|Overall Study|Trial Termination by Sponsor|2|||
146517400|NCT05259917|528401251|FG002|Overall Study|Trial Termination by Sponsor|3|||
146517401|NCT05259917|528401252|FG003|Overall Study|Trial Termination by Sponsor|5|||
146517402|NCT05259917|528401253|FG004|Overall Study|Trial Termination by Sponsor|11|||
146517403|NCT05259917|528401254|FG005|Overall Study|Trial Termination by Sponsor|4|||
146517404|NCT05259917|528401249|FG000|Overall Study|Other|1|||
146517405|NCT05259917|528401250|FG001|Overall Study|Other|0|||
146517406|NCT05259917|528401251|FG002|Overall Study|Other|2|||
146517407|NCT05259917|528401252|FG003|Overall Study|Other|0|||
146517408|NCT05259917|528401253|FG004|Overall Study|Other|0|||
146517409|NCT05259917|528401254|FG005|Overall Study|Other|0|||
146517410|NCT00592592|528401255|FG000|Overall Study|Patient found ineligible upon chart review|1|||
146517411|NCT01557517|528401256|FG000|Overall Study|Death|1|||
146517412|NCT01557517|528401257|FG001|Overall Study|Death|0|||
146517413|NCT01557517|528401256|FG000|Overall Study|Refused further treatment|0|||
146517414|NCT01557517|528401257|FG001|Overall Study|Refused further treatment|2|||
146517415|NCT01557517|528401256|FG000|Overall Study|Adverse Event|0|||
146517416|NCT01557517|528401257|FG001|Overall Study|Adverse Event|2|||
146517417|NCT01557517|528401256|FG000|Overall Study|Pt declined before treatment started|1|||
146517418|NCT01557517|528401257|FG001|Overall Study|Pt declined before treatment started|0|||
146517419|NCT00162097|528401258|FG000|Overall Study|Participant no longer met study criteria|0|||
146517420|NCT00162097|528401259|FG001|Overall Study|Participant no longer met study criteria|0|||
146517421|NCT00162097|528401260|FG002|Overall Study|Participant no longer met study criteria|0|||
146517422|NCT00162097|528401261|FG003|Overall Study|Participant no longer met study criteria|1|||
146517423|NCT03585712|528401262|FG000|Treatment Period 1|Protocol Violation|1|||
146517424|NCT03585712|528401263|FG001|Treatment Period 1|Protocol Violation|0|||
146517425|NCT03585712|528401264|FG002|Treatment Period 1|Protocol Violation|0|||
146517426|NCT03585712|528401262|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
146517427|NCT03585712|528401263|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
146517428|NCT03585712|528401264|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
146517429|NCT03585712|528401262|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
146517430|NCT03585712|528401263|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
146517431|NCT03585712|528401264|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
146517432|NCT03585712|528401262|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
146517433|NCT03585712|528401263|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
146517434|NCT03585712|528401264|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
146517435|NCT02324699|528401265|FG000|Overall Study|study terminated|1|||
146517436|NCT01098162|528401266|FG000|Overall Study|Adverse Event|37|||
146517437|NCT01098162|528401266|FG000|Overall Study|Lack of Efficacy|4|||
146517438|NCT01098162|528401266|FG000|Overall Study|Wish of Patient|7|||
146517439|NCT01098162|528401266|FG000|Overall Study|Lost to Follow-up|9|||
146517440|NCT01098162|528401266|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
146517441|NCT01098162|528401266|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
146517442|NCT01098162|528401266|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
146517443|NCT01098162|528401266|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
146517444|NCT01098162|528401266|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
146517445|NCT01098162|528401266|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
146517446|NCT01098162|528401266|FG000|Overall Study|Other Reason|1|||
146517447|NCT01098162|528401266|FG000|Overall Study|Reason Unknown|26|||
146517448|NCT03469999|528401269|FG000|Overall Study|Lost to Follow-up|2|||
146517449|NCT04424914|528401273|FG000|Overall Study|Other|0|||
146517450|NCT04424914|528401274|FG001|Overall Study|Other|0|||
146517451|NCT04424914|528401275|FG002|Overall Study|Other|28|||
146517452|NCT04424914|528401273|FG000|Overall Study|Withdrawal by Subject|3|||
146517453|NCT04424914|528401274|FG001|Overall Study|Withdrawal by Subject|0|||
146517454|NCT04424914|528401275|FG002|Overall Study|Withdrawal by Subject|0|||
146517455|NCT04424914|528401273|FG000|Overall Study|Study terminated by sponsor|23|||
146517456|NCT04424914|528401274|FG001|Overall Study|Study terminated by sponsor|7|||
146517457|NCT04424914|528401275|FG002|Overall Study|Study terminated by sponsor|0|||
146517458|NCT04424914|528401273|FG000|Overall Study|Lost to Follow-up|0|||
146517459|NCT04424914|528401274|FG001|Overall Study|Lost to Follow-up|0|||
146517460|NCT04424914|528401275|FG002|Overall Study|Lost to Follow-up|1|||
146517461|NCT04424914|528401273|FG000|Overall Study|Death|3|||
146517462|NCT04424914|528401274|FG001|Overall Study|Death|1|||
146517463|NCT04424914|528401275|FG002|Overall Study|Death|0|||
146517464|NCT00460746|528401278|FG000|Overall Study|Adverse Event|1|||
146517465|NCT00460746|528401278|FG000|Overall Study|Lost to Follow-up|1|||
146517466|NCT01778751|528401281|FG000|Overall Study|Lost to Follow-up|1|||
146517467|NCT01778751|528401282|FG001|Overall Study|Lost to Follow-up|0|||
146517468|NCT01778751|528401281|FG000|Overall Study|Withdrawal by Subject|0|||
146517469|NCT01778751|528401282|FG001|Overall Study|Withdrawal by Subject|2|||
146517470|NCT01778751|528401281|FG000|Overall Study|Transfered care|1|||
146517471|NCT01778751|528401282|FG001|Overall Study|Transfered care|0|||
146517472|NCT02791438|528401287|FG000|Treatment Period|Adverse Event|1|||
146517473|NCT02791438|528401288|FG001|Treatment Period|Adverse Event|0|||
146517474|NCT02791438|528401287|FG000|Treatment Period|Withdrawal by Subject|0|||
146517475|NCT02791438|528401288|FG001|Treatment Period|Withdrawal by Subject|1|||
146517476|NCT02791438|528401287|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
146517477|NCT02791438|528401288|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
146517478|NCT02669667|528401289|FG000|Overall Study|Lost to Follow-up|0|||
146517479|NCT02669667|528401290|FG001|Overall Study|Lost to Follow-up|0|||
146517480|NCT02669667|528401291|FG002|Overall Study|Lost to Follow-up|0|||
146517481|NCT02669667|528401292|FG003|Overall Study|Lost to Follow-up|0|||
146517482|NCT02669667|528401293|FG004|Overall Study|Lost to Follow-up|0|||
146517483|NCT02669667|528401294|FG005|Overall Study|Lost to Follow-up|1|||
146517484|NCT02669667|528401295|FG006|Overall Study|Lost to Follow-up|0|||
146517485|NCT01603394|528401296|FG000|Overall Study|Adverse Event|1|||
146517486|NCT00840034|528401297|FG000|Acute Treatment Phase|Adverse Event|6|||
146756337|NCT04537949|529273274|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
146517487|NCT00840034|528401298|FG001|Acute Treatment Phase|Adverse Event|8|||
146517488|NCT00840034|528401297|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
146517489|NCT00840034|528401298|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
146517490|NCT00840034|528401297|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
146517491|NCT00840034|528401298|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
146517492|NCT00840034|528401297|FG000|Acute Treatment Phase|Physician Decision|0|||
146517493|NCT00840034|528401298|FG001|Acute Treatment Phase|Physician Decision|1|||
146517494|NCT00840034|528401297|FG000|Acute Treatment Phase|Protocol Violation|2|||
146517495|NCT00840034|528401298|FG001|Acute Treatment Phase|Protocol Violation|4|||
146517496|NCT00840034|528401297|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
146517497|NCT00840034|528401298|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
146517498|NCT00840034|528401297|FG000|Taper Phase|Adverse Event|1|||
146517499|NCT00840034|528401298|FG001|Taper Phase|Adverse Event|0|||
146517500|NCT00840034|528401297|FG000|Taper Phase|Lost to Follow-up|1|||
146517501|NCT00840034|528401298|FG001|Taper Phase|Lost to Follow-up|1|||
146517502|NCT00840034|528401297|FG000|Taper Phase|Withdrawal by Subject|1|||
146517503|NCT00840034|528401298|FG001|Taper Phase|Withdrawal by Subject|1|||
146517504|NCT01215435|528401299|FG000|Overall Study|Adverse Event|1|||
146517505|NCT01215435|528401300|FG001|Overall Study|Adverse Event|0|||
146517506|NCT01215435|528401299|FG000|Overall Study|Protocol Violation|2|||
146517507|NCT01215435|528401300|FG001|Overall Study|Protocol Violation|0|||
146517508|NCT01215435|528401299|FG000|Overall Study|Withdrawal Criteria|8|||
146517509|NCT01215435|528401300|FG001|Overall Study|Withdrawal Criteria|11|||
146517510|NCT01215435|528401299|FG000|Overall Study|Lost to Follow-up|3|||
146517511|NCT01215435|528401300|FG001|Overall Study|Lost to Follow-up|0|||
146517512|NCT01215435|528401299|FG000|Overall Study|Unclassified|5|||
146517513|NCT01215435|528401300|FG001|Overall Study|Unclassified|5|||
146517514|NCT03383692|528401315|FG000|Overall Study|Progressive disease as per RECIST|3|||
146517515|NCT03383692|528401316|FG001|Overall Study|Progressive disease as per RECIST|3|||
146517516|NCT03383692|528401315|FG000|Overall Study|Clinical progression|0|||
146517517|NCT03383692|528401316|FG001|Overall Study|Clinical progression|1|||
146517518|NCT03383692|528401315|FG000|Overall Study|Adverse Event|3|||
146517519|NCT03383692|528401316|FG001|Overall Study|Adverse Event|0|||
146517520|NCT00586898|528401319|FG000|Overall Study|Adverse Event|1|||
146517521|NCT00586898|528401319|FG000|Overall Study|Patiemt Non-compliance|1|||
146517522|NCT00586898|528401319|FG000|Overall Study|Evaluable for Toxicity Only|5|||
146517523|NCT01156051|528401320|FG000|Overall Study|Lost to Follow-up|1|||
146517524|NCT01156051|528401321|FG001|Overall Study|Lost to Follow-up|0|||
146517525|NCT01156051|528401320|FG000|Overall Study|patient not compliant with protocol|0|||
146517526|NCT01156051|528401321|FG001|Overall Study|patient not compliant with protocol|1|||
146517527|NCT01994902|528401324|FG000|Test Period 1|Withdrawal by Subject|3|||
146517528|NCT01994902|528401325|FG001|Test Period 1|Withdrawal by Subject|0|||
146517529|NCT01994902|528401324|FG000|Test Period 1|device deficiency with adverse event|0|||
146517530|NCT01994902|528401325|FG001|Test Period 1|device deficiency with adverse event|1|||
146756338|NCT04537949|529273275|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
146756339|NCT04537949|529273276|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
146756340|NCT04537949|529273277|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
146756341|NCT04537949|529273278|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
146756342|NCT04537949|529273279|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
146756343|NCT04537949|529273272|FG000|Follow-up Phase|Lost to Follow-up|0|||
146756344|NCT04537949|529273273|FG001|Follow-up Phase|Lost to Follow-up|3|||
146756345|NCT04537949|529273274|FG002|Follow-up Phase|Lost to Follow-up|0|||
146756346|NCT04537949|529273275|FG003|Follow-up Phase|Lost to Follow-up|0|||
146756347|NCT04537949|529273276|FG004|Follow-up Phase|Lost to Follow-up|0|||
146756348|NCT04537949|529273277|FG005|Follow-up Phase|Lost to Follow-up|0|||
146756349|NCT04537949|529273278|FG006|Follow-up Phase|Lost to Follow-up|0|||
146756350|NCT04537949|529273279|FG007|Follow-up Phase|Lost to Follow-up|0|||
146756351|NCT04537949|529273272|FG000|Follow-up Phase|personal reasons|0|||
146756352|NCT04537949|529273273|FG001|Follow-up Phase|personal reasons|0|||
146756353|NCT04537949|529273274|FG002|Follow-up Phase|personal reasons|0|||
146756354|NCT04537949|529273275|FG003|Follow-up Phase|personal reasons|1|||
146756355|NCT04537949|529273276|FG004|Follow-up Phase|personal reasons|1|||
146756356|NCT04537949|529273277|FG005|Follow-up Phase|personal reasons|0|||
146756357|NCT04537949|529273278|FG006|Follow-up Phase|personal reasons|0|||
146756358|NCT04537949|529273279|FG007|Follow-up Phase|personal reasons|0|||
146756359|NCT04537949|529273272|FG000|Follow-up Phase|Withdrawal by Subject|0|||
146756360|NCT04537949|529273273|FG001|Follow-up Phase|Withdrawal by Subject|0|||
146756361|NCT04537949|529273274|FG002|Follow-up Phase|Withdrawal by Subject|0|||
146756362|NCT04537949|529273275|FG003|Follow-up Phase|Withdrawal by Subject|0|||
146756363|NCT04537949|529273276|FG004|Follow-up Phase|Withdrawal by Subject|1|||
146756364|NCT04537949|529273277|FG005|Follow-up Phase|Withdrawal by Subject|0|||
146756365|NCT04537949|529273278|FG006|Follow-up Phase|Withdrawal by Subject|0|||
146756366|NCT04537949|529273279|FG007|Follow-up Phase|Withdrawal by Subject|0|||
146756367|NCT04003974|529273280|FG000|Overall Study|Missing|1|||
146756368|NCT04003974|529273281|FG001|Overall Study|Missing|0|||
146756369|NCT04003974|529273280|FG000|Overall Study|Withdrawal by Subject|0|||
146756370|NCT04003974|529273281|FG001|Overall Study|Withdrawal by Subject|2|||
146517531|NCT01994902|528401324|FG000|Test Period 1|Adverse Event|2|||
146517532|NCT01994902|528401325|FG001|Test Period 1|Adverse Event|1|||
146517533|NCT01994902|528401324|FG000|Test Period 1|Lack of Efficacy|0|||
146517534|NCT01994902|528401325|FG001|Test Period 1|Lack of Efficacy|1|||
146517535|NCT01994902|528401324|FG000|Test Period 1|bag too small|1|||
146517536|NCT01994902|528401325|FG001|Test Period 1|bag too small|0|||
146756371|NCT02400307|529273282|FG000|Overall Study|Enrolled and Never Dosed|1|||
146756372|NCT02400307|529273283|FG001|Overall Study|Enrolled and Never Dosed|0|||
146756373|NCT03023332|529273287|FG000|Overall Study|Withdrawal by Subject|10|||
146517537|NCT01994902|528401324|FG000|Test Period 2|Withdrawal by Subject|0|||
146517538|NCT01994902|528401325|FG001|Test Period 2|Withdrawal by Subject|2|||
146517539|NCT01994902|528401324|FG000|Test Period 2|Lack of Efficacy|0|||
146517540|NCT01994902|528401325|FG001|Test Period 2|Lack of Efficacy|1|||
146517541|NCT01994902|528401324|FG000|Test Period 2|Other|0|||
146517542|NCT01994902|528401325|FG001|Test Period 2|Other|3|||
146517543|NCT00528372|528401328|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
146517544|NCT00528372|528401329|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
146517545|NCT00528372|528401330|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
146517546|NCT00528372|528401331|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
146517547|NCT00528372|528401332|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
146517548|NCT00528372|528401333|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
146517549|NCT00528372|528401334|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
146517550|NCT00528372|528401335|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
146517551|NCT00528372|528401336|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
146517552|NCT00528372|528401328|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
146517553|NCT00528372|528401329|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
146517554|NCT00528372|528401330|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
146517555|NCT00528372|528401331|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
146517556|NCT00528372|528401332|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
146517557|NCT00528372|528401333|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
146853535|NCT00994682|529633690|FG000|Double Bilnd|Lost to Follow-up|3|||
146517558|NCT00528372|528401334|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
146517559|NCT00528372|528401335|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
146517560|NCT00528372|528401336|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
146517561|NCT00528372|528401328|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
146517562|NCT00528372|528401329|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
146517563|NCT00528372|528401330|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
146517564|NCT00528372|528401331|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
146517565|NCT00528372|528401332|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
146517566|NCT00528372|528401333|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
146517567|NCT00528372|528401334|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
146517568|NCT00528372|528401335|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
146517569|NCT00528372|528401336|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
146517570|NCT00528372|528401328|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
146517571|NCT00528372|528401329|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
146517572|NCT00528372|528401330|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
146517573|NCT00528372|528401331|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
146517574|NCT00528372|528401332|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
146517575|NCT00528372|528401333|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
146517576|NCT00528372|528401334|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
146517577|NCT00528372|528401335|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
146517578|NCT00528372|528401336|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
146517579|NCT00528372|528401328|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
146517580|NCT00528372|528401329|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
146517581|NCT00528372|528401330|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
146517582|NCT00528372|528401331|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
146517583|NCT00528372|528401332|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
146517584|NCT00528372|528401333|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
146517585|NCT00528372|528401334|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
146517586|NCT00528372|528401335|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
146517587|NCT00528372|528401336|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
146517588|NCT00528372|528401328|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
146517589|NCT00528372|528401329|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
146517590|NCT00528372|528401330|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
146517591|NCT00528372|528401331|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
146517592|NCT00528372|528401332|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
146517593|NCT00528372|528401333|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
146517594|NCT00528372|528401334|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
146517595|NCT00528372|528401335|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
146517596|NCT00528372|528401336|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
146517597|NCT00528372|528401328|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
146517598|NCT00528372|528401329|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
146517599|NCT00528372|528401330|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
146517600|NCT00528372|528401331|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
146517601|NCT00528372|528401332|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
146517602|NCT00528372|528401333|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
146517603|NCT00528372|528401334|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
146517604|NCT00528372|528401335|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
146517605|NCT00528372|528401336|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
146517606|NCT00528372|528401328|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
146517607|NCT00528372|528401329|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
146517608|NCT00528372|528401330|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
146517609|NCT00528372|528401331|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
146517610|NCT00528372|528401332|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
146517611|NCT00528372|528401333|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
146517612|NCT00528372|528401334|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
146517613|NCT00528372|528401335|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
146517614|NCT00528372|528401336|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
146517615|NCT00528372|528401328|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
146517616|NCT00528372|528401329|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
146517617|NCT00528372|528401330|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
146517618|NCT00528372|528401331|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
146517619|NCT00528372|528401332|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
146517620|NCT00528372|528401333|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
146517621|NCT00528372|528401334|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
146517622|NCT00528372|528401335|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
146517623|NCT00528372|528401336|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
146517624|NCT00528372|528401328|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
146517625|NCT00528372|528401329|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
146517626|NCT00528372|528401330|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
146517627|NCT00528372|528401331|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
146517628|NCT00528372|528401332|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
146517629|NCT00528372|528401333|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
146517630|NCT00528372|528401334|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
146517631|NCT00528372|528401335|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
146517632|NCT00528372|528401336|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
146517633|NCT00528372|528401328|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
146517634|NCT00528372|528401329|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
146517635|NCT00528372|528401330|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
146517636|NCT00528372|528401331|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
146517637|NCT00528372|528401332|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
146517638|NCT00528372|528401333|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
146517639|NCT00528372|528401334|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
146517640|NCT00528372|528401335|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
146517641|NCT00528372|528401336|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
146517642|NCT00528372|528401328|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
146517643|NCT00528372|528401329|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
146517644|NCT00528372|528401330|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
146517645|NCT00528372|528401331|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
146517646|NCT00528372|528401332|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
146517647|NCT00528372|528401333|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
146517648|NCT00528372|528401334|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
146517649|NCT00528372|528401335|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
146517650|NCT00528372|528401336|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
146517651|NCT00528372|528401328|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
146517652|NCT00528372|528401329|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
146517653|NCT00528372|528401330|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
146517654|NCT00528372|528401331|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
146517655|NCT00528372|528401332|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
146517656|NCT00528372|528401333|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
146517657|NCT00528372|528401334|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
146517658|NCT00528372|528401335|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
146517659|NCT00528372|528401336|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
146517660|NCT00528372|528401328|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
146517661|NCT00528372|528401329|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
146517662|NCT00528372|528401330|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
146517663|NCT00528372|528401331|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
146517664|NCT00528372|528401332|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
146517665|NCT00528372|528401333|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
146517666|NCT00528372|528401334|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
146517667|NCT00528372|528401335|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
146517668|NCT00528372|528401336|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
146517669|NCT00528372|528401328|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
146517670|NCT00528372|528401329|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
146517671|NCT00528372|528401330|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
146517672|NCT00528372|528401331|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
146517673|NCT00528372|528401332|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
146517674|NCT00528372|528401333|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
146517675|NCT00528372|528401334|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
146517676|NCT00528372|528401335|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
146517677|NCT00528372|528401336|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
146517678|NCT01483599|528401342|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
146517679|NCT01483599|528401343|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
146517680|NCT01483599|528401344|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
146517681|NCT01483599|528401345|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
146517682|NCT01483599|528401346|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
146517683|NCT01483599|528401347|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
146853536|NCT00994682|529633691|FG001|Double Bilnd|Lost to Follow-up|3|||
146517684|NCT01483599|528401348|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
146517685|NCT01483599|528401349|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
146517686|NCT01483599|528401350|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
146517687|NCT01483599|528401351|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
146517688|NCT01483599|528401352|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
146517689|NCT01483599|528401353|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
146517690|NCT01483599|528401354|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
146517691|NCT01483599|528401355|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
146517692|NCT01483599|528401342|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
146517693|NCT01483599|528401343|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
146517694|NCT01483599|528401344|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
146517695|NCT01483599|528401345|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
146517696|NCT01483599|528401346|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
146517697|NCT01483599|528401347|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
146517698|NCT01483599|528401348|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
146517699|NCT01483599|528401349|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
146517700|NCT01483599|528401350|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
146517701|NCT01483599|528401351|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
146517702|NCT01483599|528401352|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
146517703|NCT01483599|528401353|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
146517704|NCT01483599|528401354|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
146517705|NCT01483599|528401355|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
146517706|NCT01483599|528401342|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
146517707|NCT01483599|528401343|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146517708|NCT01483599|528401344|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146517709|NCT01483599|528401345|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146517710|NCT01483599|528401346|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146517711|NCT01483599|528401347|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146517712|NCT01483599|528401348|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146517713|NCT01483599|528401349|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146517714|NCT01483599|528401350|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146517715|NCT01483599|528401351|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146517716|NCT01483599|528401352|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146517717|NCT01483599|528401353|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146517718|NCT01483599|528401354|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146517719|NCT01483599|528401355|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146517720|NCT01483599|528401342|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
146517721|NCT01483599|528401343|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
146517722|NCT01483599|528401344|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
146517723|NCT01483599|528401345|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
146517724|NCT01483599|528401346|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
146517725|NCT01483599|528401347|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
146517726|NCT01483599|528401348|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
146517727|NCT01483599|528401349|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
146517728|NCT01483599|528401350|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
146517729|NCT01483599|528401351|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
146517730|NCT01483599|528401352|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
146517731|NCT01483599|528401353|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
146517732|NCT01483599|528401354|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
146517733|NCT01483599|528401355|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
146517734|NCT01483599|528401342|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
146517735|NCT01483599|528401343|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
146517736|NCT01483599|528401344|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
146517737|NCT01483599|528401345|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
146517738|NCT01483599|528401346|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
146517739|NCT01483599|528401347|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
146517740|NCT01483599|528401348|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
146517741|NCT01483599|528401349|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
146517742|NCT01483599|528401350|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
146517743|NCT01483599|528401351|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
146517744|NCT01483599|528401352|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
146517745|NCT01483599|528401353|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
146517746|NCT01483599|528401354|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
146517747|NCT01483599|528401355|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
146517748|NCT01483599|528401342|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
146517749|NCT01483599|528401343|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
146853537|NCT00994682|529633690|FG000|Double Bilnd|Adverse Event|1|||
146853538|NCT00994682|529633691|FG001|Double Bilnd|Adverse Event|0|||
146517750|NCT01483599|528401344|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
146517751|NCT01483599|528401345|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
146517752|NCT01483599|528401346|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
146517753|NCT01483599|528401347|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
146517754|NCT01483599|528401348|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
146517755|NCT01483599|528401349|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
146517756|NCT01483599|528401350|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
146517757|NCT01483599|528401351|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
146517758|NCT01483599|528401352|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
146517759|NCT01483599|528401353|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
146517760|NCT01483599|528401354|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
146517761|NCT01483599|528401355|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
146517762|NCT01483599|528401342|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
146517763|NCT01483599|528401343|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
146517764|NCT01483599|528401344|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
146517765|NCT01483599|528401345|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
146517766|NCT01483599|528401346|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
146517767|NCT01483599|528401347|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
146517768|NCT01483599|528401348|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
146517769|NCT01483599|528401349|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
146517770|NCT01483599|528401350|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
146517771|NCT01483599|528401351|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
146517772|NCT01483599|528401352|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
146517773|NCT01483599|528401353|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
146517774|NCT01483599|528401354|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
146517775|NCT01483599|528401355|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
146517776|NCT01483599|528401342|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
146517777|NCT01483599|528401343|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
146517778|NCT01483599|528401344|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
146517779|NCT01483599|528401345|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
146517780|NCT01483599|528401346|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
146517781|NCT01483599|528401347|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
146517782|NCT01483599|528401348|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
146517783|NCT01483599|528401349|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
146517784|NCT01483599|528401350|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
146517785|NCT01483599|528401351|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
146517786|NCT01483599|528401352|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
146517787|NCT01483599|528401353|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
146517788|NCT01483599|528401354|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
146517789|NCT01483599|528401355|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
146517790|NCT01483599|528401342|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
146517791|NCT01483599|528401343|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
146517792|NCT01483599|528401344|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
146517793|NCT01483599|528401345|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
146517794|NCT01483599|528401346|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
146517795|NCT01483599|528401347|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
146517796|NCT01483599|528401348|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
146517797|NCT01483599|528401349|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
146517798|NCT01483599|528401350|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
146517799|NCT01483599|528401351|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
146517800|NCT01483599|528401352|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
146517801|NCT01483599|528401353|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
146517802|NCT01483599|528401354|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
146517803|NCT01483599|528401355|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
146517804|NCT01483599|528401342|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
146517805|NCT01483599|528401343|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
146517806|NCT01483599|528401344|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
146517807|NCT01483599|528401345|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
146517808|NCT01483599|528401346|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
146517809|NCT01483599|528401347|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
146517810|NCT01483599|528401348|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
146517811|NCT01483599|528401349|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
146517812|NCT01483599|528401350|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
146517813|NCT01483599|528401351|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
146517814|NCT01483599|528401352|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
146517815|NCT01483599|528401353|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
146517816|NCT01483599|528401354|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
146517817|NCT01483599|528401355|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
146517818|NCT02109445|528401356|FG000|Overall Study|Symptomatic deterioration|2|||
146517819|NCT02109445|528401356|FG000|Overall Study|Adverse Event|1|||
146517820|NCT00958412|528401359|FG000|Overall Study|Study prematurely terminated|18|||
146517821|NCT00966355|528401360|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
146517822|NCT00966355|528401361|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
146517823|NCT00966355|528401362|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
146517824|NCT00966355|528401360|FG000|Overall Study|newly diagnosed advanced HCC|11|||
146517825|NCT00966355|528401361|FG001|Overall Study|newly diagnosed advanced HCC|12|||
146517826|NCT00966355|528401362|FG002|Overall Study|newly diagnosed advanced HCC|10|||
146517827|NCT00966355|528401360|FG000|Overall Study|Lost to Follow-up|5|||
146517828|NCT00966355|528401361|FG001|Overall Study|Lost to Follow-up|4|||
146517829|NCT00966355|528401362|FG002|Overall Study|Lost to Follow-up|3|||
146517830|NCT02552888|528401363|FG000|Overall Study|Lost to Follow-up|1|||
146517831|NCT02552888|528401364|FG001|Overall Study|Lost to Follow-up|1|||
146517832|NCT04227405|528403130|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
146517833|NCT04227405|528403131|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
146517834|NCT04227405|528403130|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
146517835|NCT04227405|528403131|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
146517836|NCT04227405|528403130|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
146517837|NCT04227405|528403131|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
146517838|NCT04985942|528403132|FG000|Overall Study|Adverse Event|14|||
146517839|NCT04985942|528403133|FG001|Overall Study|Adverse Event|2|||
146517840|NCT04985942|528403132|FG000|Overall Study|Lack of Efficacy|0|||
146517841|NCT04985942|528403133|FG001|Overall Study|Lack of Efficacy|3|||
146517842|NCT04985942|528403132|FG000|Overall Study|Lost to Follow-up|1|||
146517843|NCT04985942|528403133|FG001|Overall Study|Lost to Follow-up|1|||
146517844|NCT04985942|528403132|FG000|Overall Study|Protocol Violation|1|||
146517845|NCT04985942|528403133|FG001|Overall Study|Protocol Violation|1|||
146517846|NCT04985942|528403132|FG000|Overall Study|Withdrawal by Subject|5|||
146517847|NCT04985942|528403133|FG001|Overall Study|Withdrawal by Subject|4|||
146517848|NCT03252145|528403135|FG000|Overall Study|Withdrawal by Subject|1|||
146517849|NCT03252145|528403136|FG001|Overall Study|Withdrawal by Subject|0|||
146517850|NCT03252145|528403135|FG000|Overall Study|Complicating Disease|1|||
146517851|NCT03252145|528403136|FG001|Overall Study|Complicating Disease|2|||
146517852|NCT03488563|528403137|FG000|Overall Study|Lost to Follow-up|7|||
146517853|NCT03488563|528403138|FG001|Overall Study|Lost to Follow-up|6|||
146517854|NCT03488563|528403139|FG002|Overall Study|Lost to Follow-up|7|||
146517855|NCT03488563|528403137|FG000|Overall Study|Withdrawal by Subject|8|||
146517856|NCT03488563|528403138|FG001|Overall Study|Withdrawal by Subject|7|||
146517857|NCT03488563|528403139|FG002|Overall Study|Withdrawal by Subject|7|||
146517858|NCT03488563|528403137|FG000|Overall Study|Physician Decision|0|||
146517859|NCT03488563|528403138|FG001|Overall Study|Physician Decision|0|||
146517860|NCT03488563|528403139|FG002|Overall Study|Physician Decision|1|||
146517861|NCT03488563|528403137|FG000|Overall Study|Protocol Violation|3|||
146517862|NCT03488563|528403138|FG001|Overall Study|Protocol Violation|2|||
146517863|NCT03488563|528403139|FG002|Overall Study|Protocol Violation|6|||
146517864|NCT03488563|528403137|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
146517865|NCT03488563|528403138|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
146517866|NCT03488563|528403139|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
146517867|NCT03488563|528403137|FG000|Overall Study|Use of prohibited medication|2|||
146517868|NCT03488563|528403138|FG001|Overall Study|Use of prohibited medication|0|||
146517869|NCT03488563|528403139|FG002|Overall Study|Use of prohibited medication|0|||
146517870|NCT03488563|528403137|FG000|Overall Study|Adverse Event|1|||
146517871|NCT03488563|528403138|FG001|Overall Study|Adverse Event|0|||
146517872|NCT03488563|528403139|FG002|Overall Study|Adverse Event|1|||
146517873|NCT03488563|528403137|FG000|Overall Study|Subject returned for ET visit|0|||
146517874|NCT03488563|528403138|FG001|Overall Study|Subject returned for ET visit|1|||
146517875|NCT03488563|528403139|FG002|Overall Study|Subject returned for ET visit|0|||
146517876|NCT03488563|528403137|FG000|Overall Study|Sponsor's decision|0|||
146517877|NCT03488563|528403138|FG001|Overall Study|Sponsor's decision|0|||
146517878|NCT03488563|528403139|FG002|Overall Study|Sponsor's decision|1|||
146756374|NCT03023332|529273288|FG001|Overall Study|Withdrawal by Subject|5|||
146756375|NCT03023332|529273289|FG002|Overall Study|Withdrawal by Subject|4|||
146756376|NCT03023332|529273290|FG003|Overall Study|Withdrawal by Subject|7|||
146756377|NCT03023332|529273287|FG000|Overall Study|Lost to Follow-up|13|||
146756378|NCT03023332|529273288|FG001|Overall Study|Lost to Follow-up|16|||
146517879|NCT00582426|528403144|FG000|Overall Study|Lost to Follow-up|0|||
146517880|NCT00582426|528403145|FG001|Overall Study|Lost to Follow-up|2|||
146517881|NCT00582426|528403144|FG000|Overall Study|Adverse Event|4|||
146756379|NCT03023332|529273289|FG002|Overall Study|Lost to Follow-up|8|||
146517882|NCT00582426|528403145|FG001|Overall Study|Adverse Event|2|||
146517883|NCT00582426|528403144|FG000|Overall Study|Protocol Violation|6|||
146517884|NCT00582426|528403145|FG001|Overall Study|Protocol Violation|2|||
146517885|NCT00582426|528403144|FG000|Overall Study|Death|4|||
146517886|NCT00582426|528403145|FG001|Overall Study|Death|3|||
146517887|NCT00582426|528403144|FG000|Overall Study|Withdrawal by Subject|3|||
146517888|NCT00582426|528403145|FG001|Overall Study|Withdrawal by Subject|2|||
146517889|NCT00582426|528403144|FG000|Overall Study|Disease Progression|2|||
146517890|NCT00582426|528403145|FG001|Overall Study|Disease Progression|2|||
146517891|NCT00582426|528403144|FG000|Overall Study|Use of illicit drugs|1|||
146517892|NCT00582426|528403145|FG001|Overall Study|Use of illicit drugs|0|||
146517893|NCT02626000|528403146|FG000|Overall Study|Decision by Sponsor|1|||
146517894|NCT02626000|528403146|FG000|Overall Study|Death|29|||
146517895|NCT00662311|528403147|FG000|Overall Study|Respiratory Infection|1|||
146517896|NCT00662311|528403148|FG001|Overall Study|Respiratory Infection|0|||
146517897|NCT00662311|528403149|FG002|Overall Study|Respiratory Infection|0|||
146517898|NCT02164318|528403150|FG000|Overall Study|Withdrawal by Subject|0|||
146517899|NCT02164318|528403151|FG001|Overall Study|Withdrawal by Subject|1|||
146517900|NCT02164318|528403152|FG002|Overall Study|Withdrawal by Subject|0|||
146517901|NCT02164318|528403153|FG003|Overall Study|Withdrawal by Subject|1|||
146517902|NCT01467271|528403156|FG000|Overall Study|Death|84|||
146517903|NCT01467271|528403156|FG000|Overall Study|Lost to Follow-up|83|||
146517904|NCT01467271|528403156|FG000|Overall Study|Retraction of patient's consent|21|||
146517905|NCT01467271|528403156|FG000|Overall Study|Other reason|14|||
146517906|NCT03084302|528403161|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
146517907|NCT03084302|528403161|FG000|Overall Study|No valid objective monitor data|6|||
146517908|NCT01411319|528403162|FG000|Overall Study|Lost to Follow-up|1|||
146517909|NCT02499263|528403163|FG000|Overall Study|Lost to Follow-up|9|||
146517910|NCT02499263|528403163|FG000|Overall Study|Participant's withdrawal of consent|4|||
146517911|NCT02499263|528403163|FG000|Overall Study|Lack of Efficacy|22|||
146517912|NCT02499263|528403163|FG000|Overall Study|investigator's judgment|12|||
146517913|NCT02499263|528403163|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
146517914|NCT02499263|528403163|FG000|Overall Study|Participant's decision|3|||
146517915|NCT02499263|528403163|FG000|Overall Study|Pregnancy|1|||
146517916|NCT04126317|528403182|FG000|Overall Study|Adverse Event|0|||
146517917|NCT04126317|528403183|FG001|Overall Study|Adverse Event|1|||
146517918|NCT04126317|528403182|FG000|Overall Study|Withdrawal by Subject|4|||
146517919|NCT04126317|528403183|FG001|Overall Study|Withdrawal by Subject|1|||
146517920|NCT02985021|528403186|FG000|Overall Study|Inability to comply with study procedures|1|||
146517921|NCT04854057|528403187|FG000|Overall Study|Adverse Event|0|||
146517922|NCT04854057|528403188|FG001|Overall Study|Adverse Event|1|||
146517923|NCT01951573|528403191|FG000|Washout Period|Adverse Event|0|||
146517924|NCT01951573|528403192|FG001|Washout Period|Adverse Event|1|||
146517925|NCT03077607|528403193|FG000|Period 1 (15 Days)|Adverse Event|1|||
146517926|NCT03077607|528403194|FG001|Period 1 (15 Days)|Adverse Event|0|||
146517927|NCT03077607|528403193|FG000|Period 1 (15 Days)|Death|1|||
146517928|NCT03077607|528403194|FG001|Period 1 (15 Days)|Death|0|||
146517929|NCT03077607|528403193|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
146517930|NCT03077607|528403194|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
146517931|NCT03077607|528403193|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
146517932|NCT03077607|528403194|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
146517933|NCT00460239|528403195|FG000|Overall Study|Physician Decision|0|||
146517934|NCT00460239|528403196|FG001|Overall Study|Physician Decision|1|||
146517935|NCT00460239|528403197|FG002|Overall Study|Physician Decision|0|||
146517936|NCT00460239|528403198|FG003|Overall Study|Physician Decision|0|||
146517937|NCT00460239|528403199|FG004|Overall Study|Physician Decision|0|||
146517938|NCT00460239|528403200|FG005|Overall Study|Physician Decision|2|||
146517939|NCT00460239|528403201|FG006|Overall Study|Physician Decision|0|||
146517940|NCT00460239|528403202|FG007|Overall Study|Physician Decision|0|||
146517941|NCT00460239|528403203|FG008|Overall Study|Physician Decision|0|||
146517942|NCT00460239|528403195|FG000|Overall Study|Withdrawal by Subject|0|||
146517943|NCT00460239|528403196|FG001|Overall Study|Withdrawal by Subject|0|||
146517944|NCT00460239|528403197|FG002|Overall Study|Withdrawal by Subject|0|||
146517945|NCT00460239|528403198|FG003|Overall Study|Withdrawal by Subject|0|||
146517946|NCT00460239|528403199|FG004|Overall Study|Withdrawal by Subject|0|||
146517947|NCT00460239|528403200|FG005|Overall Study|Withdrawal by Subject|1|||
146517948|NCT00460239|528403201|FG006|Overall Study|Withdrawal by Subject|0|||
146517949|NCT00460239|528403202|FG007|Overall Study|Withdrawal by Subject|0|||
146517950|NCT00460239|528403203|FG008|Overall Study|Withdrawal by Subject|0|||
146517951|NCT02087943|528403224|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
146517952|NCT02087943|528403225|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
146517953|NCT02087943|528403226|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
146517954|NCT02087943|528403227|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
146517955|NCT02087943|528403228|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
146517956|NCT02087943|528403224|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
146517957|NCT02087943|528403225|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
146517958|NCT02087943|528403226|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
146517959|NCT02087943|528403227|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
146517960|NCT02087943|528403228|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
146517961|NCT02087943|528403224|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
146517962|NCT02087943|528403225|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
146517963|NCT02087943|528403226|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
146517964|NCT02087943|528403227|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
146517965|NCT02087943|528403228|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
146517966|NCT02087943|528403224|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
146517967|NCT02087943|528403225|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
146517968|NCT02087943|528403226|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
146517969|NCT02087943|528403227|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
146517970|NCT02087943|528403228|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
146517971|NCT02087943|528403224|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
146517972|NCT02087943|528403225|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
146517973|NCT02087943|528403226|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
146517974|NCT02087943|528403227|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
146517975|NCT02087943|528403228|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
146517976|NCT02087943|528403224|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
146517977|NCT02087943|528403225|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
146517978|NCT02087943|528403226|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
146517979|NCT02087943|528403227|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
146517980|NCT02087943|528403228|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
146517981|NCT02087943|528403224|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
146517982|NCT02087943|528403225|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
146517983|NCT02087943|528403226|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
146517984|NCT02087943|528403227|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
146517985|NCT02087943|528403228|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
146517986|NCT02087943|528403224|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
146517987|NCT02087943|528403225|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
146517988|NCT02087943|528403226|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
146517989|NCT02087943|528403227|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
146517990|NCT02087943|528403228|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
146517991|NCT02087943|528403224|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
146517992|NCT02087943|528403225|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
146517993|NCT02087943|528403226|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
146517994|NCT02087943|528403227|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
146517995|NCT02087943|528403228|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
146517996|NCT02087943|528403224|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
146517997|NCT02087943|528403225|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
146517998|NCT02087943|528403226|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
146517999|NCT02087943|528403227|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
146518000|NCT02087943|528403228|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
146518001|NCT03836209|528403230|FG000|Overall Study|Adverse Event|5|||
146518002|NCT03836209|528403231|FG001|Overall Study|Adverse Event|2|||
146518003|NCT03836209|528403230|FG000|Overall Study|Death|4|||
146518004|NCT03836209|528403231|FG001|Overall Study|Death|1|||
146518005|NCT03836209|528403230|FG000|Overall Study|Lack of Efficacy|7|||
146518006|NCT03836209|528403231|FG001|Overall Study|Lack of Efficacy|10|||
146518007|NCT03836209|528403230|FG000|Overall Study|Physician Decision|7|||
146518008|NCT03836209|528403231|FG001|Overall Study|Physician Decision|11|||
146518009|NCT03836209|528403230|FG000|Overall Study|Protocol Violation|0|||
146518010|NCT03836209|528403231|FG001|Overall Study|Protocol Violation|3|||
146518011|NCT03836209|528403230|FG000|Overall Study|Withdrawal by Subject|2|||
146518012|NCT03836209|528403231|FG001|Overall Study|Withdrawal by Subject|10|||
146518013|NCT03836209|528403230|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
146518014|NCT03836209|528403231|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
146518015|NCT03739710|528403232|FG000|Overall Study|Screen Failed|81|||
146518016|NCT01753115|528403233|FG000|Overall Study|Lost to Follow-up|3|||
146518017|NCT01753115|528403234|FG001|Overall Study|Lost to Follow-up|6|||
146518018|NCT01753115|528403235|FG002|Overall Study|Lost to Follow-up|8|||
146518019|NCT01753115|528403233|FG000|Overall Study|Withdrawal by Subject|6|||
146518020|NCT01753115|528403234|FG001|Overall Study|Withdrawal by Subject|5|||
146518021|NCT01753115|528403235|FG002|Overall Study|Withdrawal by Subject|6|||
146518022|NCT01753115|528403233|FG000|Overall Study|Subject non-compliant|3|||
146518023|NCT01753115|528403234|FG001|Overall Study|Subject non-compliant|3|||
146518024|NCT01753115|528403235|FG002|Overall Study|Subject non-compliant|0|||
146518025|NCT01753115|528403233|FG000|Overall Study|Used excluded drug|0|||
146518026|NCT01753115|528403234|FG001|Overall Study|Used excluded drug|1|||
146518027|NCT01753115|528403235|FG002|Overall Study|Used excluded drug|0|||
146518028|NCT04313400|528403241|FG000|Overall Study|Withdrawal by Subject|0|||
146518029|NCT04313400|528403242|FG001|Overall Study|Withdrawal by Subject|0|||
146518030|NCT04313400|528403243|FG002|Overall Study|Withdrawal by Subject|0|||
146518031|NCT04313400|528403244|FG003|Overall Study|Withdrawal by Subject|0|||
146518032|NCT04313400|528403245|FG004|Overall Study|Withdrawal by Subject|0|||
146518033|NCT04313400|528403246|FG005|Overall Study|Withdrawal by Subject|4|||
146518034|NCT04313400|528403247|FG006|Overall Study|Withdrawal by Subject|1|||
146518035|NCT04313400|528403241|FG000|Overall Study|Adverse Event|0|||
146518036|NCT04313400|528403242|FG001|Overall Study|Adverse Event|0|||
146518037|NCT04313400|528403243|FG002|Overall Study|Adverse Event|0|||
146518038|NCT04313400|528403244|FG003|Overall Study|Adverse Event|0|||
146518039|NCT04313400|528403245|FG004|Overall Study|Adverse Event|0|||
146518040|NCT04313400|528403246|FG005|Overall Study|Adverse Event|1|||
146518041|NCT04313400|528403247|FG006|Overall Study|Adverse Event|0|||
146518042|NCT04313400|528403241|FG000|Overall Study|Lost to Follow-up|0|||
146518043|NCT04313400|528403242|FG001|Overall Study|Lost to Follow-up|0|||
146518044|NCT04313400|528403243|FG002|Overall Study|Lost to Follow-up|0|||
146518045|NCT04313400|528403244|FG003|Overall Study|Lost to Follow-up|0|||
146518046|NCT04313400|528403245|FG004|Overall Study|Lost to Follow-up|0|||
146518047|NCT04313400|528403246|FG005|Overall Study|Lost to Follow-up|1|||
146518048|NCT04313400|528403247|FG006|Overall Study|Lost to Follow-up|0|||
146518049|NCT00329745|528403254|FG000|Overall Study|Protocol Violation|1|||
146518050|NCT00329745|528403255|FG001|Overall Study|Protocol Violation|0|||
146518051|NCT00329745|528403254|FG000|Overall Study|Withdrawal by Subject|0|||
146518052|NCT00329745|528403255|FG001|Overall Study|Withdrawal by Subject|1|||
146518053|NCT00329745|528403254|FG000|Overall Study|Lost to Follow-up|86|||
146518054|NCT00329745|528403255|FG001|Overall Study|Lost to Follow-up|101|||
146518055|NCT03224624|528403258|FG000|Overall Study|Lost to Follow-up|9|||
146518056|NCT03224624|528403259|FG001|Overall Study|Lost to Follow-up|4|||
146518057|NCT03224624|528403258|FG000|Overall Study|Death|1|||
146518058|NCT03224624|528403259|FG001|Overall Study|Death|0|||
146518059|NCT01424241|528403260|FG000|Overall Study|Withdrawal by Subject|1|||
146518060|NCT01424241|528403260|FG000|Overall Study|Time constraints|2|||
146518061|NCT02886884|528403263|FG000|Follow-up|Withdrawal by Subject|0|||
146518062|NCT02886884|528403264|FG001|Follow-up|Withdrawal by Subject|0|||
146518063|NCT02886884|528403265|FG002|Follow-up|Withdrawal by Subject|0|||
146518064|NCT02886884|528403266|FG003|Follow-up|Withdrawal by Subject|1|||
146518065|NCT02697734|528403272|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
146518066|NCT02697734|528403273|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
146518067|NCT02697734|528403272|FG000|Core Phase - up to Week 48|Adverse Event|1|||
146518068|NCT02697734|528403273|FG001|Core Phase - up to Week 48|Adverse Event|2|||
146518069|NCT02697734|528403272|FG000|Core Phase - up to Week 48|Physician Decision|1|||
146518070|NCT02697734|528403273|FG001|Core Phase - up to Week 48|Physician Decision|0|||
146518071|NCT02697734|528403272|FG000|Optional Extension Phase|Adverse Event|5|||
146518072|NCT02697734|528403273|FG001|Optional Extension Phase|Adverse Event|1|||
146518073|NCT02697734|528403272|FG000|Optional Extension Phase|Physician Decision|0|||
146518074|NCT02697734|528403273|FG001|Optional Extension Phase|Physician Decision|1|||
146518075|NCT03970200|528403274|FG000|Overall Study|Death|2|||
146518076|NCT03970200|528403275|FG001|Overall Study|Death|2|||
146518077|NCT03970200|528403276|FG002|Overall Study|Death|1|||
146518078|NCT03970200|528403274|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
146518079|NCT03970200|528403275|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
146518080|NCT03970200|528403276|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
146518081|NCT01607346|528403277|FG000|Overall Study|Adverse Event|3|||
146518082|NCT01605825|528403278|FG000|Overall Study|Adverse Event|4|||
146518083|NCT01605825|528403279|FG001|Overall Study|Adverse Event|2|||
146518084|NCT01605825|528403278|FG000|Overall Study|Withdrawal by Subject|0|||
146518085|NCT01605825|528403279|FG001|Overall Study|Withdrawal by Subject|1|||
146518086|NCT01605825|528403278|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
146518087|NCT01605825|528403279|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
146518088|NCT01605825|528403278|FG000|Overall Study|Non-Compliance with Protocol|3|||
146518089|NCT01605825|528403279|FG001|Overall Study|Non-Compliance with Protocol|0|||
146518090|NCT00830518|528403280|FG000|Overall Study|Progressive Disease|18|||
146518091|NCT00830518|528403281|FG001|Overall Study|Progressive Disease|8|||
146518092|NCT00830518|528403280|FG000|Overall Study|Symptomatic Deterioration|4|||
146518093|NCT00830518|528403281|FG001|Overall Study|Symptomatic Deterioration|1|||
146518094|NCT00830518|528403280|FG000|Overall Study|Adverse Event|14|||
146518095|NCT00830518|528403281|FG001|Overall Study|Adverse Event|1|||
146518096|NCT00830518|528403280|FG000|Overall Study|Withdrawal by Patient|2|||
146518097|NCT00830518|528403281|FG001|Overall Study|Withdrawal by Patient|0|||
146518098|NCT00830518|528403280|FG000|Overall Study|Reason not Specified|8|||
146518099|NCT00830518|528403281|FG001|Overall Study|Reason not Specified|1|||
146518100|NCT02155322|528403282|FG000|Overall Study|Adverse Event|1|||
146518101|NCT02155322|528403282|FG000|Overall Study|Physician Decision|1|||
146518102|NCT02155322|528403282|FG000|Overall Study|Relapse/Recurrence|8|||
146518103|NCT02155322|528403282|FG000|Overall Study|Withdrawal by Subject|4|||
146518104|NCT00636961|528403294|FG000|Period 1|Administrative problems|1|||
146518105|NCT00636961|528403295|FG001|Period 1|Administrative problems|1|||
146518106|NCT00636961|528403294|FG000|Period 2|Adverse Event|1|||
146518107|NCT00636961|528403295|FG001|Period 2|Adverse Event|0|||
146518108|NCT02179749|528403297|FG000|Overall Study|Adverse Event|0|||
146518109|NCT02179749|528403298|FG001|Overall Study|Adverse Event|0|||
146518110|NCT02179749|528403299|FG002|Overall Study|Adverse Event|1|||
146518111|NCT02179749|528403297|FG000|Overall Study|Withdrawal by Subject|0|||
146518112|NCT02179749|528403298|FG001|Overall Study|Withdrawal by Subject|0|||
146518113|NCT02179749|528403299|FG002|Overall Study|Withdrawal by Subject|1|||
146518114|NCT01841567|528403300|FG000|Overall Study|Adverse Event|3|||
146518115|NCT01573754|528403305|FG000|Overall Study|Noncompliance or remission not achieved|3|||
146518116|NCT01573754|528403306|FG001|Overall Study|Noncompliance or remission not achieved|15|||
146518117|NCT03630705|528404852|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
146518118|NCT03630705|528404853|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
146518119|NCT03630705|528404854|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
146518120|NCT03630705|528404855|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146518121|NCT03630705|528404852|FG000|Overall Study|Lost to Follow-up|1|||
146518122|NCT03630705|528404853|FG001|Overall Study|Lost to Follow-up|2|||
146518123|NCT03630705|528404854|FG002|Overall Study|Lost to Follow-up|0|||
146518124|NCT03630705|528404855|FG003|Overall Study|Lost to Follow-up|0|||
146518125|NCT02688764|528404858|FG000|Overall Study|Adverse Event|3|||
146518126|NCT02688764|528404859|FG001|Overall Study|Adverse Event|3|||
146518127|NCT02688764|528404858|FG000|Overall Study|AE/Kidney transplant|1|||
146518128|NCT02688764|528404859|FG001|Overall Study|AE/Kidney transplant|0|||
146518129|NCT02688764|528404858|FG000|Overall Study|AE/Lack of efficacy|1|||
146518130|NCT02688764|528404859|FG001|Overall Study|AE/Lack of efficacy|0|||
146518131|NCT02688764|528404858|FG000|Overall Study|AE/Non-compl.|1|||
146518132|NCT02688764|528404859|FG001|Overall Study|AE/Non-compl.|0|||
146518133|NCT02688764|528404858|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
146518134|NCT02688764|528404859|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
146518135|NCT02688764|528404858|FG000|Overall Study|AE/Other|0|||
146518136|NCT02688764|528404859|FG001|Overall Study|AE/Other|1|||
146518137|NCT02688764|528404858|FG000|Overall Study|AE/Physician decision|1|||
146518138|NCT02688764|528404859|FG001|Overall Study|AE/Physician decision|0|||
146518139|NCT02688764|528404858|FG000|Overall Study|AE/Withd. parent|3|||
146518140|NCT02688764|528404859|FG001|Overall Study|AE/Withd. parent|0|||
146518141|NCT02688764|528404858|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
146518142|NCT02688764|528404859|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
146518143|NCT02688764|528404858|FG000|Overall Study|AE/Withd. subject|1|||
146518144|NCT02688764|528404859|FG001|Overall Study|AE/Withd. subject|0|||
146518145|NCT02688764|528404858|FG000|Overall Study|Kidney transplant|10|||
146518146|NCT02688764|528404859|FG001|Overall Study|Kidney transplant|4|||
146518147|NCT02688764|528404858|FG000|Overall Study|Lack of Efficacy|3|||
146518148|NCT02688764|528404859|FG001|Overall Study|Lack of Efficacy|2|||
146518149|NCT02688764|528404858|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
146518150|NCT02688764|528404859|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
146518151|NCT02688764|528404858|FG000|Overall Study|Non-compliance with study drug|4|||
146518152|NCT02688764|528404859|FG001|Overall Study|Non-compliance with study drug|0|||
146518153|NCT02688764|528404858|FG000|Overall Study|Non-compl./Physician decision|2|||
146518154|NCT02688764|528404859|FG001|Overall Study|Non-compl./Physician decision|0|||
146518155|NCT02688764|528404858|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
146518156|NCT02688764|528404859|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
146518157|NCT02688764|528404858|FG000|Overall Study|Non-compl./Withd. subject|0|||
146518158|NCT02688764|528404859|FG001|Overall Study|Non-compl./Withd. subject|2|||
146518159|NCT02688764|528404858|FG000|Overall Study|Phosphorus level outside safe range|0|||
146518160|NCT02688764|528404859|FG001|Overall Study|Phosphorus level outside safe range|1|||
146518161|NCT02688764|528404858|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
146518162|NCT02688764|528404859|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
146518163|NCT02688764|528404858|FG000|Overall Study|Study drug taste/Withd. parent|1|||
146518164|NCT02688764|528404859|FG001|Overall Study|Study drug taste/Withd. parent|0|||
146518165|NCT02688764|528404858|FG000|Overall Study|Subject moving out|2|||
146518166|NCT02688764|528404859|FG001|Overall Study|Subject moving out|0|||
146853539|NCT00994682|529633690|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
146853540|NCT00994682|529633691|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
146853541|NCT00994682|529633690|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
146853542|NCT00994682|529633691|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
146853543|NCT00994682|529633690|FG000|Pioglitazone Open Label|Physician Decision|6|||
146853544|NCT00994682|529633691|FG001|Pioglitazone Open Label|Physician Decision|1|||
146853545|NCT00928018|529633692|FG000|Overall Study|Withdrawal by Subject|1|||
146853546|NCT00928018|529633693|FG001|Overall Study|Withdrawal by Subject|0|||
146853547|NCT00943111|529633696|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
146853548|NCT00943111|529633697|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
146853549|NCT00943111|529633698|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
146853550|NCT00943111|529633696|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
146853551|NCT00943111|529633697|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
146853552|NCT00943111|529633698|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
146853553|NCT00943111|529633696|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
146853554|NCT00943111|529633697|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
146853555|NCT00943111|529633698|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
146853556|NCT00943111|529633696|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
146853557|NCT00943111|529633697|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
146853558|NCT00943111|529633698|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
146853559|NCT00943111|529633696|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
146853560|NCT00943111|529633697|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
146518167|NCT02688764|528404858|FG000|Overall Study|Subject taken off dialysis|1|||
146518168|NCT02688764|528404859|FG001|Overall Study|Subject taken off dialysis|0|||
146518169|NCT02688764|528404858|FG000|Overall Study|Withdrawal by parent|3|||
146518170|NCT02688764|528404859|FG001|Overall Study|Withdrawal by parent|0|||
146518171|NCT02113007|528404860|FG000|Overall Study|Progressive disease|2|||
146518172|NCT00885378|528404861|FG000|Overall Study|Lack of Efficacy|2|||
146518173|NCT00885378|528404862|FG001|Overall Study|Lack of Efficacy|2|||
146518174|NCT00885378|528404861|FG000|Overall Study|Withdrawal by Subject|1|||
146518175|NCT00885378|528404862|FG001|Overall Study|Withdrawal by Subject|2|||
146518176|NCT00885378|528404861|FG000|Overall Study|Lost to Follow-up|1|||
146518177|NCT00885378|528404862|FG001|Overall Study|Lost to Follow-up|2|||
146853561|NCT00943111|529633698|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
146853562|NCT00943111|529633696|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
146853563|NCT00943111|529633697|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
146853564|NCT00943111|529633698|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
146853565|NCT00943111|529633696|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
146853566|NCT00943111|529633697|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
146853567|NCT00943111|529633698|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
146853568|NCT00943111|529633696|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
146853569|NCT00943111|529633697|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
146853570|NCT00943111|529633698|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
146853571|NCT02859324|529633699|FG000|Overall Study|Death|4|||
146853572|NCT02859324|529633700|FG001|Overall Study|Death|6|||
146853573|NCT02859324|529633701|FG002|Overall Study|Death|5|||
146853574|NCT02859324|529633699|FG000|Overall Study|Other reasons|3|||
146853575|NCT02859324|529633700|FG001|Overall Study|Other reasons|3|||
146853576|NCT02859324|529633701|FG002|Overall Study|Other reasons|0|||
146853577|NCT00589121|529633704|FG000|Overall Study|Protocol Violation|2|||
146853578|NCT00589121|529633705|FG001|Overall Study|Protocol Violation|6|||
146853579|NCT00589121|529633704|FG000|Overall Study|No protocol treatment received|0|||
146853580|NCT00589121|529633705|FG001|Overall Study|No protocol treatment received|1|||
146853581|NCT00998335|529633706|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
146853582|NCT00998335|529633707|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
146853583|NCT00847808|529633708|FG000|Overall Study|Adverse Event|7|||
146853584|NCT00847808|529633708|FG000|Overall Study|Protocol Violation|1|||
146853585|NCT00847808|529633708|FG000|Overall Study|Lost to Follow-up|1|||
146853586|NCT00847808|529633708|FG000|Overall Study|Withdrawal by Subject|4|||
146853587|NCT00847808|529633708|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
146853588|NCT00847808|529633708|FG000|Overall Study|Participant Took Excluded Medication|1|||
146853589|NCT00925132|529633709|FG000|Overall Study|Withdrawal by Subject|2|||
146853590|NCT00925132|529633710|FG001|Overall Study|Withdrawal by Subject|0|||
146853591|NCT00925132|529633711|FG002|Overall Study|Withdrawal by Subject|0|||
146853592|NCT00925132|529633712|FG003|Overall Study|Withdrawal by Subject|0|||
146853593|NCT00925132|529633713|FG004|Overall Study|Withdrawal by Subject|1|||
146853594|NCT00925132|529633709|FG000|Overall Study|Removed due to disease progression|0|||
146853595|NCT00925132|529633710|FG001|Overall Study|Removed due to disease progression|0|||
146853596|NCT00925132|529633711|FG002|Overall Study|Removed due to disease progression|0|||
146853597|NCT00925132|529633712|FG003|Overall Study|Removed due to disease progression|0|||
146853598|NCT00925132|529633713|FG004|Overall Study|Removed due to disease progression|4|||
146853599|NCT02545933|529633714|FG000|Overall Study|Adverse Event|3|||
146853600|NCT02545933|529633715|FG001|Overall Study|Adverse Event|0|||
146853601|NCT02545933|529633716|FG002|Overall Study|Adverse Event|0|||
146853602|NCT02545933|529633714|FG000|Overall Study|Withdrawal by Subject|2|||
146853603|NCT02545933|529633715|FG001|Overall Study|Withdrawal by Subject|3|||
146853604|NCT02545933|529633716|FG002|Overall Study|Withdrawal by Subject|3|||
146853605|NCT02545933|529633714|FG000|Overall Study|Protocol Violation|1|||
146853606|NCT02545933|529633715|FG001|Overall Study|Protocol Violation|0|||
146853607|NCT02545933|529633716|FG002|Overall Study|Protocol Violation|1|||
146853608|NCT01370590|529633717|FG000|Period 1|Adverse Event|8|||
146853609|NCT01370590|529633718|FG001|Period 1|Adverse Event|4|||
146853610|NCT01370590|529633717|FG000|Period 1|Lost to Follow-up|2|||
146853611|NCT01370590|529633718|FG001|Period 1|Lost to Follow-up|2|||
146853612|NCT01370590|529633717|FG000|Period 1|Protocol Violation|2|||
146518178|NCT00885378|528404861|FG000|Overall Study|Poor/Noncompliance|2|||
146518179|NCT00885378|528404862|FG001|Overall Study|Poor/Noncompliance|2|||
146518180|NCT00885378|528404861|FG000|Overall Study|Protocol Violation|2|||
146518181|NCT00885378|528404862|FG001|Overall Study|Protocol Violation|0|||
146518182|NCT04076319|528404863|FG000|Overall Study|Withdrawal by Subject|2|||
146518183|NCT04076319|528404864|FG001|Overall Study|Withdrawal by Subject|0|||
146518184|NCT04076319|528404863|FG000|Overall Study|Death|1|||
146518185|NCT04076319|528404864|FG001|Overall Study|Death|0|||
146518186|NCT01054222|528404865|FG000|Overall Study|Lack of Efficacy|1|||
146518187|NCT01054222|528404865|FG000|Overall Study|Lost to Follow-up|4|||
146518188|NCT01054222|528404865|FG000|Overall Study|Withdrawal by Subject|6|||
146518189|NCT00824655|528404866|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
146518190|NCT00824655|528404867|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
146518191|NCT00824655|528404866|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
146518192|NCT00824655|528404867|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
146518193|NCT03782571|528404868|FG000|Period 1|Withdrawal by Subject|1|||
146518194|NCT03782571|528404869|FG001|Period 1|Withdrawal by Subject|0|||
146518195|NCT03782571|528404870|FG002|Period 1|Withdrawal by Subject|0|||
146518196|NCT03782571|528404871|FG003|Period 1|Withdrawal by Subject|0|||
146518197|NCT03782571|528404868|FG000|Period 3|Subject Unable to Attend V5|1|||
146518198|NCT03782571|528404869|FG001|Period 3|Subject Unable to Attend V5|0|||
146518199|NCT03782571|528404870|FG002|Period 3|Subject Unable to Attend V5|0|||
146518200|NCT03782571|528404871|FG003|Period 3|Subject Unable to Attend V5|0|||
146518201|NCT03782571|528404868|FG000|Period 3|Adverse Event|1|||
146518202|NCT03782571|528404869|FG001|Period 3|Adverse Event|0|||
146518203|NCT03782571|528404870|FG002|Period 3|Adverse Event|0|||
146518204|NCT03782571|528404871|FG003|Period 3|Adverse Event|0|||
146518205|NCT03504189|528404872|FG000|Overall Study|Withdrawal by Subject|1|||
146518206|NCT03504189|528404872|FG000|Overall Study|Screening Failure|1|||
146518207|NCT03504189|528404872|FG000|Overall Study|Device Failure|2|||
146518208|NCT03091738|528404873|FG000|Overall Study|Adverse Event|1|||
146518209|NCT03091738|528404873|FG000|Overall Study|Lost to Follow-up|1|||
146518210|NCT00660595|528404879|FG000|Overall Study|Lost to Follow-up|0|||
146518211|NCT00660595|528404880|FG001|Overall Study|Lost to Follow-up|1|||
146518212|NCT00660595|528404879|FG000|Overall Study|Did not consent to participate in study|12|||
146518213|NCT00660595|528404880|FG001|Overall Study|Did not consent to participate in study|8|||
146518214|NCT00660595|528404879|FG000|Overall Study|Participant left hospital|1|||
146518215|NCT00660595|528404880|FG001|Overall Study|Participant left hospital|0|||
146518216|NCT00660595|528404879|FG000|Overall Study|Non Specified reasons|5|||
146518217|NCT00660595|528404880|FG001|Overall Study|Non Specified reasons|0|||
146518218|NCT01148459|528404881|FG000|Overall Study|Serious Adverse Event|5|||
146518219|NCT01148459|528404882|FG001|Overall Study|Serious Adverse Event|4|||
146518220|NCT01148459|528404881|FG000|Overall Study|Withdrawal by Subject|1|||
146518221|NCT01148459|528404882|FG001|Overall Study|Withdrawal by Subject|0|||
146518222|NCT01148459|528404881|FG000|Overall Study|Migrated/moved from study area|3|||
146518223|NCT01148459|528404882|FG001|Overall Study|Migrated/moved from study area|6|||
146518224|NCT01148459|528404881|FG000|Overall Study|Lost to Follow-up|2|||
146518225|NCT01148459|528404882|FG001|Overall Study|Lost to Follow-up|0|||
146518226|NCT01148459|528404881|FG000|Overall Study|Refusal|1|||
146518227|NCT01148459|528404882|FG001|Overall Study|Refusal|0|||
146518228|NCT01148459|528404881|FG000|Overall Study|Failure to comply with study procedures|0|||
146518229|NCT01148459|528404882|FG001|Overall Study|Failure to comply with study procedures|1|||
146518230|NCT04399889|528404889|FG000|Overall Study|Death|5|||
146518231|NCT04399889|528404890|FG001|Overall Study|Death|1|||
146518232|NCT04399889|528404891|FG002|Overall Study|Death|1|||
146518233|NCT01152996|528404895|FG000|Overall Study|Withdrawal by Subject|142|||
146518234|NCT01152996|528404895|FG000|Overall Study|Adverse Event|115|||
146518235|NCT01152996|528404895|FG000|Overall Study|Lost to Follow-up|112|||
146518236|NCT01152996|528404895|FG000|Overall Study|Lack of Efficacy|68|||
146518237|NCT01152996|528404895|FG000|Overall Study|Noncompliance|41|||
146518238|NCT01152996|528404895|FG000|Overall Study|Other|36|||
146518239|NCT01152996|528404895|FG000|Overall Study|Protocol Violation|22|||
146518240|NCT01152996|528404895|FG000|Overall Study|Elevated liver enzymes|1|||
146518241|NCT04217317|528404898|FG000|Overall Study|Lack of Efficacy|4|||
146518242|NCT04217317|528404898|FG000|Overall Study|Physician Decision|1|||
146518243|NCT01884545|528404901|FG000|Overall Study|Lost to Follow-up|6|||
146518244|NCT01884545|528404902|FG001|Overall Study|Lost to Follow-up|4|||
146518245|NCT01884545|528404903|FG002|Overall Study|Lost to Follow-up|9|||
146518246|NCT01884545|528404904|FG003|Overall Study|Lost to Follow-up|4|||
146518247|NCT01884545|528404901|FG000|Overall Study|Patient withdrawn|7|||
146518248|NCT01884545|528404902|FG001|Overall Study|Patient withdrawn|12|||
146518249|NCT01884545|528404903|FG002|Overall Study|Patient withdrawn|5|||
146518250|NCT01884545|528404904|FG003|Overall Study|Patient withdrawn|5|||
146518251|NCT01884545|528404901|FG000|Overall Study|Non-adherence|0|||
146518252|NCT01884545|528404902|FG001|Overall Study|Non-adherence|2|||
146518253|NCT01884545|528404903|FG002|Overall Study|Non-adherence|0|||
146518254|NCT01884545|528404904|FG003|Overall Study|Non-adherence|0|||
146518255|NCT02782377|528404905|FG000|Overall Study|Physician Decision|5|||
146518256|NCT02347072|528404908|FG000|Overall Study|Adverse Event|2|||
146518257|NCT02347072|528404908|FG000|Overall Study|Withdrawal by Subject|6|||
146518258|NCT02347072|528404908|FG000|Overall Study|Physician Decision|1|||
146518259|NCT02347072|528404908|FG000|Overall Study|Lost to Follow-up|2|||
146518260|NCT02347072|528404908|FG000|Overall Study|Protocol Violation|1|||
146518261|NCT02347072|528404908|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
146518262|NCT04318132|528404909|FG000|Overall Study|Protocol Violation|0|||
146518263|NCT04318132|528404910|FG001|Overall Study|Protocol Violation|0|||
146518264|NCT04318132|528404911|FG002|Overall Study|Protocol Violation|3|||
146518265|NCT04318132|528404912|FG003|Overall Study|Protocol Violation|0|||
146518266|NCT00073008|528404913|FG000|Overall Study|Missing|6|||
146518267|NCT00073008|528404914|FG001|Overall Study|Missing|6|||
146518268|NCT00073008|528404913|FG000|Overall Study|Withdrawal by Subject|2|||
146518269|NCT00073008|528404914|FG001|Overall Study|Withdrawal by Subject|2|||
146518270|NCT00073008|528404913|FG000|Overall Study|Lost to Follow-up|1|||
146518271|NCT00073008|528404914|FG001|Overall Study|Lost to Follow-up|3|||
146518272|NCT00073008|528404913|FG000|Overall Study|Death|46|||
146518273|NCT00073008|528404914|FG001|Overall Study|Death|47|||
146518274|NCT00073008|528404913|FG000|Overall Study|"Other selected on Case Report Form"|7|||
146518275|NCT00073008|528404914|FG001|Overall Study|"Other selected on Case Report Form"|5|||
146518276|NCT01926197|528404915|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
146518277|NCT01926197|528404916|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
146518278|NCT01926197|528404915|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
146518279|NCT01926197|528404916|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
146518280|NCT03628716|528404917|FG000|Overall Study|Adverse Event|1|||
146518281|NCT03628716|528404918|FG001|Overall Study|Adverse Event|1|||
146518282|NCT03628716|528404917|FG000|Overall Study|Death|1|||
146518283|NCT03628716|528404918|FG001|Overall Study|Death|0|||
146518284|NCT03628716|528404917|FG000|Overall Study|Lack of Efficacy|15|||
146518285|NCT03628716|528404918|FG001|Overall Study|Lack of Efficacy|20|||
146518286|NCT03628716|528404917|FG000|Overall Study|Withdrawal by Subject|1|||
146518287|NCT03628716|528404918|FG001|Overall Study|Withdrawal by Subject|2|||
146518288|NCT03628716|528404917|FG000|Overall Study|Study Terminated by Sponsor|1|||
146518289|NCT03628716|528404918|FG001|Overall Study|Study Terminated by Sponsor|0|||
146518290|NCT00856843|528404919|FG000|Overall Study|Withdrawal by Subject|1|||
146518291|NCT00856843|528404920|FG001|Overall Study|Withdrawal by Subject|5|||
146518292|NCT00856843|528404919|FG000|Overall Study|Lack of Efficacy|1|||
146518293|NCT00856843|528404920|FG001|Overall Study|Lack of Efficacy|0|||
146518294|NCT00829829|528404921|FG000|Overall Study|Protocol Violation|0|||
146518295|NCT00829829|528404922|FG001|Overall Study|Protocol Violation|3|||
146518296|NCT00829829|528404923|FG002|Overall Study|Protocol Violation|0|||
146518297|NCT00829829|528404921|FG000|Overall Study|Adverse Event|4|||
146518298|NCT00829829|528404922|FG001|Overall Study|Adverse Event|4|||
146518299|NCT00829829|528404923|FG002|Overall Study|Adverse Event|3|||
146518300|NCT00829829|528404921|FG000|Overall Study|Withdrawal by Subject|8|||
146518301|NCT00829829|528404922|FG001|Overall Study|Withdrawal by Subject|4|||
146518302|NCT00829829|528404923|FG002|Overall Study|Withdrawal by Subject|2|||
146518303|NCT00829829|528404921|FG000|Overall Study|Decision by the Sponsor|1|||
146518304|NCT00829829|528404922|FG001|Overall Study|Decision by the Sponsor|0|||
146518305|NCT00829829|528404923|FG002|Overall Study|Decision by the Sponsor|2|||
146518306|NCT00829829|528404921|FG000|Overall Study|Lost to Follow-up|7|||
146518307|NCT00829829|528404922|FG001|Overall Study|Lost to Follow-up|3|||
146518308|NCT00829829|528404923|FG002|Overall Study|Lost to Follow-up|3|||
146518309|NCT00829829|528404921|FG000|Overall Study|Other than specified above|2|||
146518310|NCT00829829|528404922|FG001|Overall Study|Other than specified above|2|||
146518311|NCT00829829|528404923|FG002|Overall Study|Other than specified above|1|||
146518312|NCT02984267|528404924|FG000|Overall Study|Protocol Violation|1|||
146518313|NCT02984267|528404925|FG001|Overall Study|Protocol Violation|0|||
146518314|NCT02984267|528404924|FG000|Overall Study|Withdrawal by Subject|0|||
146518315|NCT02984267|528404925|FG001|Overall Study|Withdrawal by Subject|1|||
146518316|NCT02685072|528404926|FG000|Treatment Period|Lost to Follow-up|12|||
146518317|NCT02685072|528404927|FG001|Treatment Period|Lost to Follow-up|6|||
146518318|NCT02685072|528404926|FG000|Treatment Period|Withdrawal by Subject|1|||
146518319|NCT02685072|528404927|FG001|Treatment Period|Withdrawal by Subject|3|||
146518320|NCT02685072|528404926|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
146518321|NCT02685072|528404927|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
146518322|NCT01249833|528404929|FG000|Overall Study|Lost to Follow-up|0|||
146518323|NCT01249833|528404930|FG001|Overall Study|Lost to Follow-up|1|||
146518324|NCT03796676|528404931|FG000|Overall Study|Adverse Event|2|||
146518325|NCT03796676|528404932|FG001|Overall Study|Adverse Event|1|||
146518326|NCT03796676|528404933|FG002|Overall Study|Adverse Event|2|||
146518327|NCT03796676|528404931|FG000|Overall Study|Lost to Follow-up|2|||
146518328|NCT03796676|528404932|FG001|Overall Study|Lost to Follow-up|1|||
146518329|NCT03796676|528404933|FG002|Overall Study|Lost to Follow-up|0|||
146518330|NCT03796676|528404931|FG000|Overall Study|Protocol Violation|0|||
146518331|NCT03796676|528404932|FG001|Overall Study|Protocol Violation|0|||
146518332|NCT03796676|528404933|FG002|Overall Study|Protocol Violation|1|||
146518333|NCT03796676|528404931|FG000|Overall Study|Withdrawal by Subject|1|||
146518334|NCT03796676|528404932|FG001|Overall Study|Withdrawal by Subject|1|||
146518335|NCT03796676|528404933|FG002|Overall Study|Withdrawal by Subject|0|||
146518336|NCT03796676|528404931|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
146518337|NCT03796676|528404932|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
146518338|NCT03796676|528404933|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
146518339|NCT00262002|528404940|FG000|Overall Study|Adverse Event|2|||
146518340|NCT00262002|528404941|FG001|Overall Study|Adverse Event|1|||
146518341|NCT00262002|528404942|FG002|Overall Study|Adverse Event|0|||
146518342|NCT00262002|528404943|FG003|Overall Study|Adverse Event|0|||
146518343|NCT00262002|528404944|FG004|Overall Study|Adverse Event|0|||
146518344|NCT00262002|528404945|FG005|Overall Study|Adverse Event|1|||
146518345|NCT00262002|528404946|FG006|Overall Study|Adverse Event|0|||
146518346|NCT00262002|528404940|FG000|Overall Study|Withdrawal by Subject|4|||
146518347|NCT00262002|528404941|FG001|Overall Study|Withdrawal by Subject|2|||
146518348|NCT00262002|528404942|FG002|Overall Study|Withdrawal by Subject|0|||
146518349|NCT00262002|528404943|FG003|Overall Study|Withdrawal by Subject|1|||
146518350|NCT00262002|528404944|FG004|Overall Study|Withdrawal by Subject|2|||
146518351|NCT00262002|528404945|FG005|Overall Study|Withdrawal by Subject|2|||
146518352|NCT00262002|528404946|FG006|Overall Study|Withdrawal by Subject|2|||
146518353|NCT00262002|528404940|FG000|Overall Study|Lost to Follow-up|2|||
146518354|NCT00262002|528404941|FG001|Overall Study|Lost to Follow-up|0|||
146518355|NCT00262002|528404942|FG002|Overall Study|Lost to Follow-up|0|||
146518356|NCT00262002|528404943|FG003|Overall Study|Lost to Follow-up|2|||
146518357|NCT00262002|528404944|FG004|Overall Study|Lost to Follow-up|0|||
146518358|NCT00262002|528404945|FG005|Overall Study|Lost to Follow-up|1|||
146518359|NCT00262002|528404946|FG006|Overall Study|Lost to Follow-up|0|||
146518360|NCT00262002|528404940|FG000|Overall Study|Inapropriate enrollment|0|||
146518361|NCT00262002|528404941|FG001|Overall Study|Inapropriate enrollment|1|||
146518362|NCT00262002|528404942|FG002|Overall Study|Inapropriate enrollment|0|||
146518363|NCT00262002|528404943|FG003|Overall Study|Inapropriate enrollment|0|||
146518364|NCT00262002|528404944|FG004|Overall Study|Inapropriate enrollment|0|||
146518365|NCT00262002|528404945|FG005|Overall Study|Inapropriate enrollment|0|||
146518366|NCT00262002|528404946|FG006|Overall Study|Inapropriate enrollment|0|||
146518367|NCT00262002|528404940|FG000|Overall Study|Protocol Violation|3|||
146518368|NCT00262002|528404941|FG001|Overall Study|Protocol Violation|2|||
146518369|NCT00262002|528404942|FG002|Overall Study|Protocol Violation|0|||
146518370|NCT00262002|528404943|FG003|Overall Study|Protocol Violation|2|||
146518371|NCT00262002|528404944|FG004|Overall Study|Protocol Violation|5|||
146518372|NCT00262002|528404945|FG005|Overall Study|Protocol Violation|3|||
146518373|NCT00262002|528404946|FG006|Overall Study|Protocol Violation|2|||
146518374|NCT00262002|528404940|FG000|Overall Study|Unable to classify|0|||
146518375|NCT00262002|528404941|FG001|Overall Study|Unable to classify|0|||
146518376|NCT00262002|528404942|FG002|Overall Study|Unable to classify|0|||
146518377|NCT00262002|528404943|FG003|Overall Study|Unable to classify|0|||
146518378|NCT00262002|528404944|FG004|Overall Study|Unable to classify|0|||
146518379|NCT00262002|528404945|FG005|Overall Study|Unable to classify|0|||
146518380|NCT00262002|528404946|FG006|Overall Study|Unable to classify|2|||
146518381|NCT01085084|528404947|FG000|Overall Study|Withdrawal by Subject|1|||
146518382|NCT01085084|528404948|FG001|Overall Study|Withdrawal by Subject|0|||
146518383|NCT01085084|528404949|FG002|Overall Study|Withdrawal by Subject|0|||
146518384|NCT01085084|528404947|FG000|Overall Study|Lost to Follow-up|2|||
146518385|NCT01085084|528404948|FG001|Overall Study|Lost to Follow-up|1|||
146518386|NCT01085084|528404949|FG002|Overall Study|Lost to Follow-up|1|||
146518387|NCT01085084|528404947|FG000|Overall Study|Adverse Event|4|||
146518388|NCT01085084|528404948|FG001|Overall Study|Adverse Event|3|||
146518389|NCT01085084|528404949|FG002|Overall Study|Adverse Event|6|||
146518390|NCT01085084|528404947|FG000|Overall Study|Treatment Failure|0|||
146518391|NCT01085084|528404948|FG001|Overall Study|Treatment Failure|1|||
146518392|NCT01085084|528404949|FG002|Overall Study|Treatment Failure|2|||
146518393|NCT02749799|528404950|FG000|Overall Study|Adverse Event|2|||
146518394|NCT02749799|528404950|FG000|Overall Study|Lost to Follow-up|4|||
146518395|NCT02749799|528404950|FG000|Overall Study|Protocol Violation|1|||
146518396|NCT02749799|528404950|FG000|Overall Study|Withdrawal by Subject|1|||
146853613|NCT01370590|529633718|FG001|Period 1|Protocol Violation|2|||
146518397|NCT02070978|528404951|FG000|Overall Study|Adverse Event|6|||
146518398|NCT02070978|528404952|FG001|Overall Study|Adverse Event|2|||
146518399|NCT02070978|528404953|FG002|Overall Study|Adverse Event|0|||
146518400|NCT02070978|528404951|FG000|Overall Study|Lost to Follow-up|1|||
146518401|NCT02070978|528404952|FG001|Overall Study|Lost to Follow-up|3|||
146518402|NCT02070978|528404953|FG002|Overall Study|Lost to Follow-up|4|||
146518403|NCT02070978|528404951|FG000|Overall Study|Withdrawal by Subject|3|||
146518404|NCT02070978|528404952|FG001|Overall Study|Withdrawal by Subject|5|||
146518405|NCT02070978|528404953|FG002|Overall Study|Withdrawal by Subject|3|||
146518406|NCT02070978|528404951|FG000|Overall Study|Protocol Violation|1|||
146518407|NCT02070978|528404952|FG001|Overall Study|Protocol Violation|0|||
146518408|NCT02070978|528404953|FG002|Overall Study|Protocol Violation|3|||
146518409|NCT02070978|528404951|FG000|Overall Study|Lack of Efficacy|0|||
146518410|NCT02070978|528404952|FG001|Overall Study|Lack of Efficacy|1|||
146518411|NCT02070978|528404953|FG002|Overall Study|Lack of Efficacy|0|||
146518412|NCT02070978|528404951|FG000|Overall Study|Death|0|||
146518413|NCT02070978|528404952|FG001|Overall Study|Death|0|||
146518414|NCT02070978|528404953|FG002|Overall Study|Death|2|||
146518415|NCT02070978|528404951|FG000|Overall Study|Un-specified|3|||
146518416|NCT02070978|528404952|FG001|Overall Study|Un-specified|2|||
146518417|NCT02070978|528404953|FG002|Overall Study|Un-specified|2|||
146518418|NCT02070978|528404951|FG000|Overall Study|Terminated by Sponsor|33|||
146518419|NCT02070978|528404952|FG001|Overall Study|Terminated by Sponsor|40|||
146518420|NCT02070978|528404953|FG002|Overall Study|Terminated by Sponsor|39|||
146518421|NCT03951753|528404954|FG000|Overall Study|Adverse Event|1|||
146518422|NCT03951753|528404955|FG001|Overall Study|Adverse Event|0|||
146518423|NCT03951753|528404956|FG002|Overall Study|Adverse Event|3|||
146518424|NCT03951753|528404954|FG000|Overall Study|Withdrawal by Subject|3|||
146518425|NCT03951753|528404955|FG001|Overall Study|Withdrawal by Subject|1|||
146518426|NCT03951753|528404956|FG002|Overall Study|Withdrawal by Subject|0|||
146518427|NCT03951753|528404954|FG000|Overall Study|Lost to Follow-up|0|||
146518428|NCT03951753|528404955|FG001|Overall Study|Lost to Follow-up|0|||
146518429|NCT03951753|528404956|FG002|Overall Study|Lost to Follow-up|1|||
146518430|NCT01905592|528404959|FG000|Overall Study|Disease Progression|51|||
146518431|NCT01905592|528404960|FG001|Overall Study|Disease Progression|110|||
146518432|NCT01905592|528404959|FG000|Overall Study|Toxicity|1|||
146518433|NCT01905592|528404960|FG001|Overall Study|Toxicity|16|||
146518434|NCT01905592|528404959|FG000|Overall Study|Physician Decision|0|||
146518435|NCT01905592|528404960|FG001|Overall Study|Physician Decision|2|||
146518436|NCT01905592|528404959|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
146518437|NCT01905592|528404960|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
146518438|NCT01905592|528404959|FG000|Overall Study|Protocol Violation|0|||
146518439|NCT01905592|528404960|FG001|Overall Study|Protocol Violation|1|||
146518440|NCT01905592|528404959|FG000|Overall Study|Sponsor's decision|1|||
146518441|NCT01905592|528404960|FG001|Overall Study|Sponsor's decision|1|||
146518442|NCT01905592|528404959|FG000|Overall Study|Not treated|7|||
146518443|NCT01905592|528404960|FG001|Overall Study|Not treated|3|||
146518444|NCT01905592|528404959|FG000|Overall Study|Withdrawal by Subject|10|||
146518445|NCT01905592|528404960|FG001|Overall Study|Withdrawal by Subject|2|||
146518446|NCT02669043|528404961|FG000|Overall Study|Didn't meet I/E criteria|4|||
146518447|NCT00467558|528404966|FG000|Overall Study|Lost to Follow-up|2|||
146518448|NCT00467558|528404967|FG001|Overall Study|Lost to Follow-up|0|||
146518449|NCT02636439|528404969|FG000|Overall Study|Adverse Event|2|||
146518450|NCT02636439|528404970|FG001|Overall Study|Adverse Event|2|||
146518451|NCT02636439|528404969|FG000|Overall Study|Lost to Follow-up|1|||
146518452|NCT02636439|528404970|FG001|Overall Study|Lost to Follow-up|0|||
146518453|NCT02636439|528404969|FG000|Overall Study|Non-compliance|1|||
146518454|NCT02636439|528404970|FG001|Overall Study|Non-compliance|1|||
146518455|NCT02636439|528404969|FG000|Overall Study|Personal reasons|2|||
146518456|NCT02636439|528404970|FG001|Overall Study|Personal reasons|0|||
146518457|NCT02494401|528404971|FG000|Overall Study|Lost to Follow-up|22|||
146518458|NCT02494401|528404972|FG001|Overall Study|Lost to Follow-up|25|||
146518459|NCT02494401|528404971|FG000|Overall Study|Withdrawal by Subject|3|||
146518460|NCT02494401|528404972|FG001|Overall Study|Withdrawal by Subject|2|||
146518461|NCT04378569|528406574|FG000|Overall Study|Adverse Event|0|||
146518462|NCT04378569|528406575|FG001|Overall Study|Adverse Event|0|||
146518463|NCT04378569|528406576|FG002|Overall Study|Adverse Event|2|||
146518464|NCT04378569|528406577|FG003|Overall Study|Adverse Event|0|||
146518465|NCT04378569|528406578|FG004|Overall Study|Adverse Event|3|||
146518466|NCT04378569|528406579|FG005|Overall Study|Adverse Event|3|||
146518467|NCT04378569|528406574|FG000|Overall Study|Lost to Follow-up|0|||
146518468|NCT04378569|528406575|FG001|Overall Study|Lost to Follow-up|3|||
146518469|NCT04378569|528406576|FG002|Overall Study|Lost to Follow-up|1|||
146518470|NCT04378569|528406577|FG003|Overall Study|Lost to Follow-up|0|||
146518471|NCT04378569|528406578|FG004|Overall Study|Lost to Follow-up|1|||
146518472|NCT04378569|528406579|FG005|Overall Study|Lost to Follow-up|1|||
146518473|NCT04378569|528406574|FG000|Overall Study|Protocol Violation|0|||
146518474|NCT04378569|528406575|FG001|Overall Study|Protocol Violation|0|||
146518475|NCT04378569|528406576|FG002|Overall Study|Protocol Violation|0|||
146518476|NCT04378569|528406577|FG003|Overall Study|Protocol Violation|0|||
146518477|NCT04378569|528406578|FG004|Overall Study|Protocol Violation|0|||
146518478|NCT04378569|528406579|FG005|Overall Study|Protocol Violation|1|||
146518479|NCT04378569|528406574|FG000|Overall Study|Withdrawal by Subject|0|||
146518480|NCT04378569|528406575|FG001|Overall Study|Withdrawal by Subject|6|||
146518481|NCT04378569|528406576|FG002|Overall Study|Withdrawal by Subject|7|||
146518482|NCT04378569|528406577|FG003|Overall Study|Withdrawal by Subject|4|||
146518483|NCT04378569|528406578|FG004|Overall Study|Withdrawal by Subject|5|||
146518484|NCT04378569|528406579|FG005|Overall Study|Withdrawal by Subject|4|||
146518485|NCT04378569|528406574|FG000|Overall Study|Lack of response|0|||
146518486|NCT04378569|528406575|FG001|Overall Study|Lack of response|0|||
146518487|NCT04378569|528406576|FG002|Overall Study|Lack of response|1|||
146518488|NCT04378569|528406577|FG003|Overall Study|Lack of response|0|||
146518489|NCT04378569|528406578|FG004|Overall Study|Lack of response|1|||
146518490|NCT04378569|528406579|FG005|Overall Study|Lack of response|1|||
146518491|NCT01048944|528406580|FG000|Overall Study|Protocol Violation|8|||
146518492|NCT01048944|528406581|FG001|Overall Study|Protocol Violation|10|||
146518493|NCT01048944|528406582|FG002|Overall Study|Protocol Violation|10|||
146518494|NCT01048944|528406583|FG003|Overall Study|Protocol Violation|2|||
146518495|NCT01844817|528406584|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
146518496|NCT01844817|528406585|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
146518497|NCT01844817|528406584|FG000|Treatment|Progressive Disease|27|||
146518498|NCT01844817|528406585|FG001|Treatment|Progressive Disease|36|||
146518499|NCT01844817|528406584|FG000|Treatment|Adverse Event|17|||
146518500|NCT01844817|528406585|FG001|Treatment|Adverse Event|9|||
146518501|NCT01844817|528406584|FG000|Treatment|Withdrawal by Subject|10|||
146518502|NCT01844817|528406585|FG001|Treatment|Withdrawal by Subject|6|||
146518503|NCT01844817|528406584|FG000|Treatment|Death|10|||
146518504|NCT01844817|528406585|FG001|Treatment|Death|8|||
146518505|NCT01844817|528406584|FG000|Treatment|Lost to Follow-up|0|||
146518506|NCT01844817|528406585|FG001|Treatment|Lost to Follow-up|1|||
146518507|NCT01844817|528406584|FG000|Treatment|Other|0|||
146518508|NCT01844817|528406585|FG001|Treatment|Other|3|||
146518509|NCT02207400|528406586|FG000|Overall Study|Adverse Event|1|||
146518510|NCT02207400|528406587|FG001|Overall Study|Adverse Event|1|||
146518511|NCT02207400|528406586|FG000|Overall Study|Lost to Follow-up|6|||
146518512|NCT02207400|528406587|FG001|Overall Study|Lost to Follow-up|7|||
146518513|NCT02207400|528406586|FG000|Overall Study|Protocol Violation|1|||
146518514|NCT02207400|528406587|FG001|Overall Study|Protocol Violation|1|||
146518515|NCT02207400|528406586|FG000|Overall Study|Withdrawal by Subject|8|||
146518516|NCT02207400|528406587|FG001|Overall Study|Withdrawal by Subject|4|||
146518517|NCT02207400|528406586|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
146518518|NCT02207400|528406587|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
146518519|NCT03638466|528406588|FG000|Overall Study|Early Termination|0|||
146518520|NCT03638466|528406589|FG001|Overall Study|Early Termination|1|||
146518521|NCT01128400|528406590|FG000|Overall Study|Lost to Follow-up|1|||
146518522|NCT01128400|528406591|FG001|Overall Study|Lost to Follow-up|0|||
146518523|NCT01128400|528406592|FG002|Overall Study|Lost to Follow-up|1|||
146518524|NCT01128400|528406590|FG000|Overall Study|Screening failure|1|||
146518525|NCT01128400|528406591|FG001|Overall Study|Screening failure|0|||
146518526|NCT01128400|528406592|FG002|Overall Study|Screening failure|0|||
146518527|NCT01128400|528406590|FG000|Overall Study|were not invited to participate on taste|0|||
146518528|NCT01128400|528406591|FG001|Overall Study|were not invited to participate on taste|0|||
146518529|NCT01128400|528406592|FG002|Overall Study|were not invited to participate on taste|15|||
146518530|NCT01128400|528406590|FG000|Overall Study|Excluded due to sinus problems|0|||
146518531|NCT01128400|528406591|FG001|Overall Study|Excluded due to sinus problems|1|||
146518532|NCT01128400|528406592|FG002|Overall Study|Excluded due to sinus problems|0|||
146518533|NCT02362425|528406593|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
146518534|NCT02362425|528406594|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
146518535|NCT02362425|528406595|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
146518536|NCT02362425|528406596|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
146518537|NCT02362425|528406593|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
146518538|NCT02362425|528406594|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
146518539|NCT02362425|528406595|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
146518540|NCT02362425|528406596|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
146518541|NCT02362425|528406593|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
146518542|NCT02362425|528406594|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
146518543|NCT02362425|528406595|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
146518544|NCT02362425|528406596|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
146518545|NCT02362425|528406593|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
146518546|NCT02362425|528406594|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
146518547|NCT02362425|528406595|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
146518548|NCT02362425|528406596|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
146518549|NCT02362425|528406593|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
146518550|NCT02362425|528406594|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
146518551|NCT02362425|528406595|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
146518552|NCT02362425|528406596|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
146518553|NCT02362425|528406593|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
146518554|NCT02362425|528406594|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
146518555|NCT02362425|528406595|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
146518556|NCT02362425|528406596|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
146518557|NCT02362425|528406593|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
146518558|NCT02362425|528406594|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
146518559|NCT02362425|528406595|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
146518560|NCT02362425|528406596|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
146518561|NCT02362425|528406593|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
146518562|NCT02362425|528406594|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
146568715|NCT00328172|528595434|FG003|Overall Study|Withdrawal by Subject|6|||
146518563|NCT02362425|528406595|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
146518564|NCT02362425|528406596|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
146518565|NCT02155309|528406599|FG000|Overall Study|Protocol Violation|0|||
146518566|NCT02155309|528406600|FG001|Overall Study|Protocol Violation|0|||
146518567|NCT02155309|528406601|FG002|Overall Study|Protocol Violation|1|||
146518568|NCT00314808|528406607|FG000|Overall Study|Disease Progression without AE|4|||
146518569|NCT00314808|528406607|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
146518570|NCT04304508|528406608|FG000|Overall Study|Subject Decision|29|||
146518571|NCT04304508|528406609|FG001|Overall Study|Subject Decision|39|||
146518572|NCT04304508|528406610|FG002|Overall Study|Subject Decision|37|||
146518573|NCT04304508|528406611|FG003|Overall Study|Subject Decision|48|||
146518574|NCT04304508|528406608|FG000|Overall Study|Death|6|||
146518575|NCT04304508|528406609|FG001|Overall Study|Death|1|||
146518576|NCT04304508|528406610|FG002|Overall Study|Death|8|||
146518577|NCT04304508|528406611|FG003|Overall Study|Death|5|||
146518578|NCT04304508|528406608|FG000|Overall Study|Non-compliance With Study Drug|3|||
146518579|NCT04304508|528406609|FG001|Overall Study|Non-compliance With Study Drug|1|||
146518580|NCT04304508|528406610|FG002|Overall Study|Non-compliance With Study Drug|2|||
146518581|NCT04304508|528406611|FG003|Overall Study|Non-compliance With Study Drug|0|||
146518582|NCT04304508|528406608|FG000|Overall Study|Switching To Other Therapy|1|||
146518583|NCT04304508|528406609|FG001|Overall Study|Switching To Other Therapy|1|||
146518584|NCT04304508|528406610|FG002|Overall Study|Switching To Other Therapy|1|||
146518585|NCT04304508|528406611|FG003|Overall Study|Switching To Other Therapy|2|||
146518586|NCT04304508|528406608|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
146518587|NCT04304508|528406609|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
146518588|NCT04304508|528406610|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
146518589|NCT04304508|528406611|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
146518590|NCT04304508|528406608|FG000|Overall Study|Withdrawal by Subject|7|||
146518591|NCT04304508|528406609|FG001|Overall Study|Withdrawal by Subject|5|||
146518592|NCT04304508|528406610|FG002|Overall Study|Withdrawal by Subject|11|||
146518593|NCT04304508|528406611|FG003|Overall Study|Withdrawal by Subject|6|||
146518594|NCT04304508|528406608|FG000|Overall Study|Logistical Difficulties|2|||
146518595|NCT04304508|528406609|FG001|Overall Study|Logistical Difficulties|2|||
146518596|NCT04304508|528406610|FG002|Overall Study|Logistical Difficulties|3|||
146518597|NCT04304508|528406611|FG003|Overall Study|Logistical Difficulties|2|||
146518598|NCT04304508|528406608|FG000|Overall Study|Missing Information|1|||
146518599|NCT04304508|528406609|FG001|Overall Study|Missing Information|2|||
146518600|NCT04304508|528406610|FG002|Overall Study|Missing Information|1|||
146518601|NCT04304508|528406611|FG003|Overall Study|Missing Information|3|||
146518602|NCT04304508|528406608|FG000|Overall Study|Other|7|||
146518603|NCT04304508|528406609|FG001|Overall Study|Other|6|||
146518604|NCT04304508|528406610|FG002|Overall Study|Other|5|||
146518605|NCT04304508|528406611|FG003|Overall Study|Other|4|||
146518606|NCT04304508|528406608|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
146518607|NCT04304508|528406609|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
146518608|NCT04304508|528406610|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
146518609|NCT04304508|528406611|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
146518610|NCT04304508|528406608|FG000|Overall Study|Physician Decision|3|||
146518611|NCT04304508|528406609|FG001|Overall Study|Physician Decision|4|||
146518612|NCT04304508|528406610|FG002|Overall Study|Physician Decision|9|||
146518613|NCT04304508|528406611|FG003|Overall Study|Physician Decision|7|||
146518614|NCT04304508|528406608|FG000|Overall Study|Study drug never administered|10|||
146518615|NCT04304508|528406609|FG001|Overall Study|Study drug never administered|4|||
146518616|NCT04304508|528406610|FG002|Overall Study|Study drug never administered|4|||
146518617|NCT04304508|528406611|FG003|Overall Study|Study drug never administered|4|||
146518618|NCT04304508|528406608|FG000|Overall Study|Adverse Event|49|||
146518619|NCT04304508|528406609|FG001|Overall Study|Adverse Event|50|||
146518620|NCT04304508|528406610|FG002|Overall Study|Adverse Event|51|||
146518621|NCT04304508|528406611|FG003|Overall Study|Adverse Event|56|||
146518622|NCT04304508|528406608|FG000|Overall Study|Lost to Follow-up|1|||
146518623|NCT04304508|528406609|FG001|Overall Study|Lost to Follow-up|5|||
146518624|NCT04304508|528406610|FG002|Overall Study|Lost to Follow-up|2|||
146518625|NCT04304508|528406611|FG003|Overall Study|Lost to Follow-up|3|||
146518626|NCT04750278|528406618|FG000|Overall Study|Death|9|||
146518627|NCT04750278|528406619|FG001|Overall Study|Death|10|||
146518628|NCT04750278|528406620|FG002|Overall Study|Death|10|||
146518629|NCT04750278|528406618|FG000|Overall Study|Withdrawal by Subject|4|||
146518630|NCT04750278|528406619|FG001|Overall Study|Withdrawal by Subject|1|||
146518631|NCT04750278|528406620|FG002|Overall Study|Withdrawal by Subject|2|||
146518632|NCT04750278|528406618|FG000|Overall Study|Lost to Follow-up|1|||
146518633|NCT04750278|528406619|FG001|Overall Study|Lost to Follow-up|1|||
146518634|NCT04750278|528406620|FG002|Overall Study|Lost to Follow-up|1|||
146518635|NCT04750278|528406618|FG000|Overall Study|Pregnancy|1|||
146518636|NCT04750278|528406619|FG001|Overall Study|Pregnancy|0|||
146518637|NCT04750278|528406620|FG002|Overall Study|Pregnancy|0|||
146965057|NCT03110107|530033447|FG021|Treatment Period|Study drug toxicity|0|||
146518638|NCT04750278|528406618|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
146518639|NCT04750278|528406619|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
146518640|NCT04750278|528406620|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
146518641|NCT04750278|528406618|FG000|Overall Study|Non-compliance|0|||
146518642|NCT04750278|528406619|FG001|Overall Study|Non-compliance|0|||
146518643|NCT04750278|528406620|FG002|Overall Study|Non-compliance|1|||
146518644|NCT04750278|528406618|FG000|Overall Study|Transfer to Outside Facility|0|||
146518645|NCT04750278|528406619|FG001|Overall Study|Transfer to Outside Facility|2|||
146518646|NCT04750278|528406620|FG002|Overall Study|Transfer to Outside Facility|1|||
146518647|NCT04750278|528406618|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
146518648|NCT04750278|528406619|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
146518649|NCT04750278|528406620|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
146518650|NCT04750278|528406618|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
146518651|NCT04750278|528406619|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
146518652|NCT04750278|528406620|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
146518653|NCT01775787|528406621|FG000|First 7-10 Days|Adverse Event|0|||
146518654|NCT01775787|528406622|FG001|First 7-10 Days|Adverse Event|1|||
146518655|NCT01775787|528406621|FG000|First 7-10 Days|family emergency|0|||
146518656|NCT01775787|528406622|FG001|First 7-10 Days|family emergency|1|||
146518657|NCT01775787|528406621|FG000|First 7-10 Days|time commitment|0|||
146518658|NCT01775787|528406622|FG001|First 7-10 Days|time commitment|2|||
146518659|NCT01775787|528406621|FG000|First 7-10 Days|concerns with using IV|1|||
146518660|NCT01775787|528406622|FG001|First 7-10 Days|concerns with using IV|2|||
146518661|NCT01775787|528406621|FG000|Second 7-10 Days|time commitment|0|||
146518662|NCT01775787|528406622|FG001|Second 7-10 Days|time commitment|1|||
146518663|NCT01775787|528406621|FG000|Second 7-10 Days|concerns with using IV|0|||
146518664|NCT01775787|528406622|FG001|Second 7-10 Days|concerns with using IV|1|||
146518665|NCT01299896|528406623|FG000|Overall Study|Withdrawal by Subject|1|||
146518666|NCT01299896|528406624|FG001|Overall Study|Withdrawal by Subject|7|||
146518667|NCT01299896|528406623|FG000|Overall Study|Lost to Follow-up|0|||
146518668|NCT01299896|528406624|FG001|Overall Study|Lost to Follow-up|11|||
146518669|NCT01502956|528406629|FG000|Overall Study|Death|0|||
146518670|NCT01502956|528406630|FG001|Overall Study|Death|2|||
146518671|NCT01502956|528406629|FG000|Overall Study|Lost to Follow-up|14|||
146518672|NCT01502956|528406630|FG001|Overall Study|Lost to Follow-up|11|||
146518673|NCT01502956|528406629|FG000|Overall Study|Physician Decision|2|||
146518674|NCT01502956|528406630|FG001|Overall Study|Physician Decision|3|||
146518675|NCT01502956|528406629|FG000|Overall Study|Withdrawal by Subject|8|||
146518676|NCT01502956|528406630|FG001|Overall Study|Withdrawal by Subject|10|||
146518677|NCT01616758|528406631|FG000|Overall Study|Adverse Event|1|||
146518678|NCT01616758|528406631|FG000|Overall Study|Withdrawal by Subject|2|||
146518679|NCT01616758|528406631|FG000|Overall Study|Disease progression|18|||
146518680|NCT01616758|528406631|FG000|Overall Study|Study termination by Sponsor|1|||
146518681|NCT03026283|528406632|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
146518682|NCT03026283|528406633|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
146518683|NCT03026283|528406634|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
146518684|NCT03026283|528406635|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
146518685|NCT03026283|528406636|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
146518686|NCT03026283|528406637|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
146518687|NCT03026283|528406638|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
146518688|NCT03026283|528406639|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
146518689|NCT03026283|528406632|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
146518690|NCT03026283|528406633|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
146518691|NCT03026283|528406634|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
146518692|NCT03026283|528406635|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
146518693|NCT03026283|528406636|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
146518694|NCT03026283|528406637|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
146518695|NCT03026283|528406638|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
146518696|NCT03026283|528406639|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
146518697|NCT03026283|528406632|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
146518698|NCT03026283|528406633|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
146518699|NCT03026283|528406634|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
146518700|NCT03026283|528406635|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
146518701|NCT03026283|528406636|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
146518702|NCT03026283|528406637|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
146518703|NCT03026283|528406638|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
146518704|NCT03026283|528406639|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
146518705|NCT03026283|528406632|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
146518706|NCT03026283|528406633|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
146518707|NCT03026283|528406634|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
146518708|NCT03026283|528406635|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
146518709|NCT03026283|528406636|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
146518710|NCT03026283|528406637|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
146518711|NCT03026283|528406638|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
146518712|NCT03026283|528406639|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
146518713|NCT03026283|528406632|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
146518714|NCT03026283|528406633|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
146518715|NCT03026283|528406634|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
146518716|NCT03026283|528406635|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
146518717|NCT03026283|528406636|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
146518718|NCT03026283|528406637|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
146518719|NCT03026283|528406638|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
146518720|NCT03026283|528406639|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
146518721|NCT03026283|528406632|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
146518722|NCT03026283|528406633|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
146518723|NCT03026283|528406634|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
146518724|NCT03026283|528406635|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
146518725|NCT03026283|528406636|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
146518726|NCT03026283|528406637|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
146518727|NCT03026283|528406638|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
146518728|NCT03026283|528406639|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
146518729|NCT03026283|528406632|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
146518730|NCT03026283|528406633|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
146518731|NCT03026283|528406634|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
146518732|NCT03026283|528406635|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
146518733|NCT03026283|528406636|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
146518734|NCT03026283|528406637|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
146518735|NCT03026283|528406638|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
146518736|NCT03026283|528406639|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
146518737|NCT03026283|528406632|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
146518738|NCT03026283|528406633|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
146518739|NCT03026283|528406634|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
146518740|NCT03026283|528406635|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
146518741|NCT03026283|528406636|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
146518742|NCT03026283|528406637|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
146518743|NCT03026283|528406638|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
146518744|NCT03026283|528406639|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
146518745|NCT03026283|528406632|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
146518746|NCT03026283|528406633|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
146518747|NCT03026283|528406634|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
146518748|NCT03026283|528406635|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
146518749|NCT03026283|528406636|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
146518750|NCT03026283|528406637|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
146518751|NCT03026283|528406638|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
146518752|NCT03026283|528406639|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
146518753|NCT00199849|528406646|FG000|Overall Study|Unrelated illness or complication|0|||
146518754|NCT00199849|528406647|FG001|Overall Study|Unrelated illness or complication|1|||
146518755|NCT00199849|528406648|FG002|Overall Study|Unrelated illness or complication|0|||
146518756|NCT00199849|528406646|FG000|Overall Study|Progressive disease requiring intervention|0|||
146518757|NCT00199849|528406647|FG001|Overall Study|Progressive disease requiring intervention|0|||
146518758|NCT00199849|528406648|FG002|Overall Study|Progressive disease requiring intervention|1|||
146518759|NCT00199849|528406646|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
146518760|NCT00199849|528406647|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
146518761|NCT00199849|528406648|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
146518762|NCT04727528|528406649|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
146518763|NCT04727528|528406650|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
146518764|NCT04727528|528406649|FG000|Open-label Period|Randomized who did not receive treatment|1|||
146518765|NCT04727528|528406650|FG001|Open-label Period|Randomized who did not receive treatment|0|||
146518766|NCT04727528|528406649|FG000|Double-blind Treatment Phase|Adverse Event|0|||
146518767|NCT04727528|528406650|FG001|Double-blind Treatment Phase|Adverse Event|1|||
146518768|NCT04727528|528406649|FG000|Double-blind Treatment Phase|Death|0|||
146518769|NCT04727528|528406650|FG001|Double-blind Treatment Phase|Death|1|||
146518770|NCT04727528|528406649|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
146756380|NCT03023332|529273290|FG003|Overall Study|Lost to Follow-up|13|||
146518771|NCT04727528|528406650|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
146518772|NCT04727528|528406649|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
146518773|NCT04727528|528406650|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
146518774|NCT04727528|528406649|FG000|Double-blind Treatment Phase|Physician Decision|0|||
146518775|NCT04727528|528406650|FG001|Double-blind Treatment Phase|Physician Decision|1|||
146518776|NCT04727528|528406649|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
146518777|NCT04727528|528406650|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146518778|NCT01826981|528406660|FG000|Overall Study|Lack of Efficacy|0|||
146518779|NCT01826981|528406661|FG001|Overall Study|Lack of Efficacy|1|||
146518780|NCT01826981|528406662|FG002|Overall Study|Lack of Efficacy|0|||
146518781|NCT01826981|528406663|FG003|Overall Study|Lack of Efficacy|0|||
146518782|NCT01826981|528406664|FG004|Overall Study|Lack of Efficacy|5|||
146518783|NCT01826981|528406665|FG005|Overall Study|Lack of Efficacy|0|||
146518784|NCT01826981|528406666|FG006|Overall Study|Lack of Efficacy|0|||
146518785|NCT01826981|528406667|FG007|Overall Study|Lack of Efficacy|8|||
146518786|NCT01826981|528406668|FG008|Overall Study|Lack of Efficacy|7|||
146518787|NCT01826981|528406669|FG009|Overall Study|Lack of Efficacy|0|||
146518788|NCT01826981|528406670|FG010|Overall Study|Lack of Efficacy|1|||
146518789|NCT01826981|528406671|FG011|Overall Study|Lack of Efficacy|0|||
146518790|NCT01826981|528406672|FG012|Overall Study|Lack of Efficacy|0|||
146518791|NCT01826981|528406673|FG013|Overall Study|Lack of Efficacy|3|||
146518792|NCT01826981|528406674|FG014|Overall Study|Lack of Efficacy|0|||
146518793|NCT01826981|528406660|FG000|Overall Study|Lost to Follow-up|0|||
146518794|NCT01826981|528406661|FG001|Overall Study|Lost to Follow-up|0|||
146518795|NCT01826981|528406662|FG002|Overall Study|Lost to Follow-up|0|||
146518796|NCT01826981|528406663|FG003|Overall Study|Lost to Follow-up|0|||
146518797|NCT01826981|528406664|FG004|Overall Study|Lost to Follow-up|1|||
146518798|NCT01826981|528406665|FG005|Overall Study|Lost to Follow-up|1|||
146518799|NCT01826981|528406666|FG006|Overall Study|Lost to Follow-up|0|||
146518800|NCT01826981|528406667|FG007|Overall Study|Lost to Follow-up|1|||
146518801|NCT01826981|528406668|FG008|Overall Study|Lost to Follow-up|0|||
146518802|NCT01826981|528406669|FG009|Overall Study|Lost to Follow-up|1|||
146518803|NCT01826981|528406670|FG010|Overall Study|Lost to Follow-up|1|||
146518804|NCT01826981|528406671|FG011|Overall Study|Lost to Follow-up|1|||
146518805|NCT01826981|528406672|FG012|Overall Study|Lost to Follow-up|1|||
146518806|NCT01826981|528406673|FG013|Overall Study|Lost to Follow-up|0|||
146518807|NCT01826981|528406674|FG014|Overall Study|Lost to Follow-up|0|||
146518808|NCT01826981|528406660|FG000|Overall Study|Withdrew Consent|0|||
146518809|NCT01826981|528406661|FG001|Overall Study|Withdrew Consent|0|||
146518810|NCT01826981|528406662|FG002|Overall Study|Withdrew Consent|0|||
146518811|NCT01826981|528406663|FG003|Overall Study|Withdrew Consent|0|||
146518812|NCT01826981|528406664|FG004|Overall Study|Withdrew Consent|0|||
146518813|NCT01826981|528406665|FG005|Overall Study|Withdrew Consent|0|||
146518814|NCT01826981|528406666|FG006|Overall Study|Withdrew Consent|1|||
146518815|NCT01826981|528406667|FG007|Overall Study|Withdrew Consent|1|||
146518816|NCT01826981|528406668|FG008|Overall Study|Withdrew Consent|0|||
146518817|NCT01826981|528406669|FG009|Overall Study|Withdrew Consent|0|||
146518818|NCT01826981|528406670|FG010|Overall Study|Withdrew Consent|0|||
146518819|NCT01826981|528406671|FG011|Overall Study|Withdrew Consent|1|||
146518820|NCT01826981|528406672|FG012|Overall Study|Withdrew Consent|0|||
146518821|NCT01826981|528406673|FG013|Overall Study|Withdrew Consent|1|||
146518822|NCT01826981|528406674|FG014|Overall Study|Withdrew Consent|0|||
146518823|NCT01826981|528406660|FG000|Overall Study|Adverse Event|0|||
146518824|NCT01826981|528406661|FG001|Overall Study|Adverse Event|0|||
146518825|NCT01826981|528406662|FG002|Overall Study|Adverse Event|0|||
146518826|NCT01826981|528406663|FG003|Overall Study|Adverse Event|0|||
146518827|NCT01826981|528406664|FG004|Overall Study|Adverse Event|1|||
146518828|NCT01826981|528406665|FG005|Overall Study|Adverse Event|0|||
146518829|NCT01826981|528406666|FG006|Overall Study|Adverse Event|0|||
146518830|NCT01826981|528406667|FG007|Overall Study|Adverse Event|0|||
146518831|NCT01826981|528406668|FG008|Overall Study|Adverse Event|0|||
146518832|NCT01826981|528406669|FG009|Overall Study|Adverse Event|0|||
146518833|NCT01826981|528406670|FG010|Overall Study|Adverse Event|0|||
146518834|NCT01826981|528406671|FG011|Overall Study|Adverse Event|0|||
146518835|NCT01826981|528406672|FG012|Overall Study|Adverse Event|0|||
146518836|NCT01826981|528406673|FG013|Overall Study|Adverse Event|0|||
146518837|NCT01826981|528406674|FG014|Overall Study|Adverse Event|0|||
146518838|NCT01826981|528406660|FG000|Overall Study|Upper G-I Haemorrhage|0|||
146518839|NCT01826981|528406661|FG001|Overall Study|Upper G-I Haemorrhage|0|||
146518840|NCT01826981|528406662|FG002|Overall Study|Upper G-I Haemorrhage|0|||
146518841|NCT01826981|528406663|FG003|Overall Study|Upper G-I Haemorrhage|0|||
146518842|NCT01826981|528406664|FG004|Overall Study|Upper G-I Haemorrhage|0|||
146518843|NCT01826981|528406665|FG005|Overall Study|Upper G-I Haemorrhage|0|||
146518844|NCT01826981|528406666|FG006|Overall Study|Upper G-I Haemorrhage|0|||
146518845|NCT01826981|528406667|FG007|Overall Study|Upper G-I Haemorrhage|0|||
146518846|NCT01826981|528406668|FG008|Overall Study|Upper G-I Haemorrhage|0|||
146518847|NCT01826981|528406669|FG009|Overall Study|Upper G-I Haemorrhage|0|||
146518848|NCT01826981|528406670|FG010|Overall Study|Upper G-I Haemorrhage|0|||
146518849|NCT01826981|528406671|FG011|Overall Study|Upper G-I Haemorrhage|0|||
146518850|NCT01826981|528406672|FG012|Overall Study|Upper G-I Haemorrhage|0|||
146518851|NCT01826981|528406673|FG013|Overall Study|Upper G-I Haemorrhage|1|||
146518852|NCT01826981|528406674|FG014|Overall Study|Upper G-I Haemorrhage|0|||
146518853|NCT01826981|528406660|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
146518854|NCT01826981|528406661|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
146518855|NCT01826981|528406662|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
146518856|NCT01826981|528406663|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
146518857|NCT01826981|528406664|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
146518858|NCT01826981|528406665|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
146518859|NCT01826981|528406666|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
146518860|NCT01826981|528406667|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
146518861|NCT01826981|528406668|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
146518862|NCT01826981|528406669|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
146518863|NCT01826981|528406670|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
146518864|NCT01826981|528406671|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
146518865|NCT01826981|528406672|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
146518866|NCT01826981|528406673|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
146518867|NCT01826981|528406674|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
146518868|NCT03479008|528406683|FG000|Overall Study|Withdrawal by Subject|3|||
146518869|NCT01796301|528406684|FG000|Overall Study|Withdrawal by Subject|15|||
146518870|NCT01796301|528406685|FG001|Overall Study|Withdrawal by Subject|15|||
146518871|NCT01796301|528406684|FG000|Overall Study|Lost to Follow-up|3|||
146518872|NCT01796301|528406685|FG001|Overall Study|Lost to Follow-up|3|||
146518873|NCT01796301|528406684|FG000|Overall Study|Death|0|||
146518874|NCT01796301|528406685|FG001|Overall Study|Death|1|||
146518875|NCT01796301|528406684|FG000|Overall Study|Decision by Sponsor|0|||
146518876|NCT01796301|528406685|FG001|Overall Study|Decision by Sponsor|1|||
146518877|NCT01704755|528406686|FG000|Overall Study|Adverse Event|4|||
146518878|NCT01704755|528406687|FG001|Overall Study|Adverse Event|1|||
146518879|NCT01704755|528406686|FG000|Overall Study|Lost to Follow-up|3|||
146518880|NCT01704755|528406687|FG001|Overall Study|Lost to Follow-up|4|||
146518881|NCT01704755|528406686|FG000|Overall Study|Withdrew consent|1|||
146518882|NCT01704755|528406687|FG001|Overall Study|Withdrew consent|1|||
146518883|NCT01704755|528406686|FG000|Overall Study|Other (not specified)|3|||
146518884|NCT01704755|528406687|FG001|Overall Study|Other (not specified)|1|||
146518885|NCT01704755|528406686|FG000|Overall Study|Withdrew consent and personal issues|1|||
146518886|NCT01704755|528406687|FG001|Overall Study|Withdrew consent and personal issues|0|||
146518887|NCT00667563|528406688|FG000|Overall Study|Protocol Violation|24|||
146518888|NCT00264290|528406705|FG000|Intervention (8 Weeks)|Adverse Event|1|||
146518889|NCT00264290|528406706|FG001|Intervention (8 Weeks)|Adverse Event|0|||
146518890|NCT00707980|528406707|FG000|Overall Study|Adverse Event|49|||
146518891|NCT00707980|528406707|FG000|Overall Study|Lack of Efficacy|35|||
146518892|NCT00707980|528406707|FG000|Overall Study|Non-Compliance with Study Drug|28|||
146518893|NCT00707980|528406707|FG000|Overall Study|Protocol Deviations|19|||
146518894|NCT00707980|528406707|FG000|Overall Study|Withdrawal of Consent|81|||
146518895|NCT00707980|528406707|FG000|Overall Study|Lost to Follow-up|59|||
146518896|NCT00707980|528406707|FG000|Overall Study|Other|39|||
146518897|NCT00303472|528406711|FG000|Treatment Period|Adverse Event|0|||
146518898|NCT00303472|528406712|FG001|Treatment Period|Adverse Event|0|||
146518899|NCT00303472|528406713|FG002|Treatment Period|Adverse Event|0|||
146518900|NCT00303472|528406714|FG003|Treatment Period|Adverse Event|0|||
146518901|NCT00303472|528406715|FG004|Treatment Period|Adverse Event|1|||
146518902|NCT00303472|528406716|FG005|Treatment Period|Adverse Event|0|||
146518903|NCT00303472|528406717|FG006|Treatment Period|Adverse Event|0|||
146518904|NCT00303472|528406711|FG000|Treatment Period|Death|0|||
146518905|NCT00303472|528406712|FG001|Treatment Period|Death|0|||
146518906|NCT00303472|528406713|FG002|Treatment Period|Death|0|||
146518907|NCT00303472|528406714|FG003|Treatment Period|Death|1|||
146518908|NCT00303472|528406715|FG004|Treatment Period|Death|0|||
146518909|NCT00303472|528406716|FG005|Treatment Period|Death|0|||
146518910|NCT00303472|528406717|FG006|Treatment Period|Death|1|||
146518911|NCT00303472|528406711|FG000|Treatment Period|Withdrawal by Subject|0|||
146518912|NCT00303472|528406712|FG001|Treatment Period|Withdrawal by Subject|0|||
146518913|NCT00303472|528406713|FG002|Treatment Period|Withdrawal by Subject|0|||
146518914|NCT00303472|528406714|FG003|Treatment Period|Withdrawal by Subject|1|||
146518915|NCT00303472|528406715|FG004|Treatment Period|Withdrawal by Subject|0|||
146518916|NCT00303472|528406716|FG005|Treatment Period|Withdrawal by Subject|1|||
146518917|NCT00303472|528406717|FG006|Treatment Period|Withdrawal by Subject|0|||
146518918|NCT00303472|528406711|FG000|Treatment Period|Other|0|||
146518919|NCT00303472|528406712|FG001|Treatment Period|Other|0|||
146518920|NCT00303472|528406713|FG002|Treatment Period|Other|0|||
146518921|NCT00303472|528406714|FG003|Treatment Period|Other|0|||
146518922|NCT00303472|528406715|FG004|Treatment Period|Other|1|||
146518923|NCT00303472|528406716|FG005|Treatment Period|Other|0|||
146518924|NCT00303472|528406717|FG006|Treatment Period|Other|1|||
146518925|NCT00303472|528406711|FG000|Treatment Period|Disease Progression (to AML)|0|||
146518926|NCT00303472|528406712|FG001|Treatment Period|Disease Progression (to AML)|0|||
146518927|NCT00303472|528406713|FG002|Treatment Period|Disease Progression (to AML)|0|||
146518928|NCT00303472|528406714|FG003|Treatment Period|Disease Progression (to AML)|0|||
146518929|NCT00303472|528406715|FG004|Treatment Period|Disease Progression (to AML)|1|||
146518930|NCT00303472|528406716|FG005|Treatment Period|Disease Progression (to AML)|0|||
146518931|NCT00303472|528406717|FG006|Treatment Period|Disease Progression (to AML)|0|||
146518932|NCT00303472|528406711|FG000|Treatment Extension (Optional)|Adverse Event|1|||
146518933|NCT00303472|528406712|FG001|Treatment Extension (Optional)|Adverse Event|0|||
146518934|NCT00303472|528406713|FG002|Treatment Extension (Optional)|Adverse Event|1|||
146518935|NCT00303472|528406714|FG003|Treatment Extension (Optional)|Adverse Event|0|||
146518936|NCT00303472|528406715|FG004|Treatment Extension (Optional)|Adverse Event|0|||
146518937|NCT00303472|528406716|FG005|Treatment Extension (Optional)|Adverse Event|0|||
146518938|NCT00303472|528406717|FG006|Treatment Extension (Optional)|Adverse Event|0|||
146518939|NCT00303472|528406711|FG000|Treatment Extension (Optional)|Death|2|||
146518940|NCT00303472|528406712|FG001|Treatment Extension (Optional)|Death|0|||
146518941|NCT00303472|528406713|FG002|Treatment Extension (Optional)|Death|1|||
146518942|NCT00303472|528406714|FG003|Treatment Extension (Optional)|Death|0|||
146518943|NCT00303472|528406715|FG004|Treatment Extension (Optional)|Death|0|||
146518944|NCT00303472|528406716|FG005|Treatment Extension (Optional)|Death|0|||
146518945|NCT00303472|528406717|FG006|Treatment Extension (Optional)|Death|0|||
146518946|NCT00303472|528406711|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
146518947|NCT00303472|528406712|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
146518948|NCT00303472|528406713|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
146518949|NCT00303472|528406714|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
146518950|NCT00303472|528406715|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
146518951|NCT00303472|528406716|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
146518952|NCT00303472|528406717|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
146518953|NCT00303472|528406711|FG000|Treatment Extension (Optional)|Physician Decision|0|||
146518954|NCT00303472|528406712|FG001|Treatment Extension (Optional)|Physician Decision|4|||
146518955|NCT00303472|528406713|FG002|Treatment Extension (Optional)|Physician Decision|2|||
146518956|NCT00303472|528406714|FG003|Treatment Extension (Optional)|Physician Decision|3|||
146518957|NCT00303472|528406715|FG004|Treatment Extension (Optional)|Physician Decision|2|||
146518958|NCT00303472|528406716|FG005|Treatment Extension (Optional)|Physician Decision|0|||
146518959|NCT00303472|528406717|FG006|Treatment Extension (Optional)|Physician Decision|0|||
146518960|NCT00303472|528406711|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
146518961|NCT00303472|528406712|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
146518962|NCT00303472|528406713|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
146518963|NCT00303472|528406714|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
146518964|NCT00303472|528406715|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
146518965|NCT00303472|528406716|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
146518966|NCT00303472|528406717|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
146518967|NCT00303472|528406711|FG000|Treatment Extension (Optional)|Other|0|||
146518968|NCT00303472|528406712|FG001|Treatment Extension (Optional)|Other|2|||
146518969|NCT00303472|528406713|FG002|Treatment Extension (Optional)|Other|4|||
146518970|NCT00303472|528406714|FG003|Treatment Extension (Optional)|Other|2|||
146518971|NCT00303472|528406715|FG004|Treatment Extension (Optional)|Other|1|||
146518972|NCT00303472|528406716|FG005|Treatment Extension (Optional)|Other|0|||
146518973|NCT00303472|528406717|FG006|Treatment Extension (Optional)|Other|0|||
146518974|NCT00303472|528406711|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
146518975|NCT00303472|528406712|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
146518976|NCT00303472|528406713|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
146518977|NCT00303472|528406714|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
146518978|NCT00303472|528406715|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
146518979|NCT00303472|528406716|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
146518980|NCT00303472|528406717|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
146518981|NCT02937636|528406721|FG000|Overall Study|Other (Not specified)|3|||
146518982|NCT02937636|528406722|FG001|Overall Study|Other (Not specified)|2|||
146518983|NCT00770913|528406723|FG000|Overall Study|Adverse Event|1|||
146518984|NCT00770913|528406724|FG001|Overall Study|Adverse Event|3|||
146518985|NCT00770913|528406725|FG002|Overall Study|Adverse Event|6|||
146518986|NCT00770913|528406723|FG000|Overall Study|Refusal to continue participation|6|||
146518987|NCT00770913|528406724|FG001|Overall Study|Refusal to continue participation|4|||
146518988|NCT00770913|528406725|FG002|Overall Study|Refusal to continue participation|5|||
146518989|NCT00770913|528406723|FG000|Overall Study|Physician Decision|0|||
146518990|NCT00770913|528406724|FG001|Overall Study|Physician Decision|1|||
146518991|NCT00770913|528406725|FG002|Overall Study|Physician Decision|1|||
146518992|NCT00770913|528406723|FG000|Overall Study|Protocol Violation|3|||
146518993|NCT00770913|528406724|FG001|Overall Study|Protocol Violation|0|||
146518994|NCT00770913|528406725|FG002|Overall Study|Protocol Violation|1|||
146518995|NCT00770913|528406723|FG000|Overall Study|Incorrect drug was allocated|1|||
146518996|NCT00770913|528406724|FG001|Overall Study|Incorrect drug was allocated|0|||
146518997|NCT00770913|528406725|FG002|Overall Study|Incorrect drug was allocated|0|||
146518998|NCT04208412|528406733|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
146518999|NCT04208412|528406734|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
146519000|NCT04208412|528406733|FG000|Overall Study|Withdrawal by Subject|1|||
146519001|NCT04208412|528406734|FG001|Overall Study|Withdrawal by Subject|0|||
146519002|NCT04208412|528406733|FG000|Overall Study|Lost to Follow-up|0|||
146519003|NCT04208412|528406734|FG001|Overall Study|Lost to Follow-up|1|||
146519004|NCT01808222|528406737|FG000|Overall Study|mpMR scan was not performed|1|||
146519005|NCT01146561|528406738|FG000|Overall Study|Withdrawal by Subject|1|||
146519006|NCT01146561|528406738|FG000|Overall Study|Lost to Follow-up|1|||
146519007|NCT02756364|528406741|FG000|Overall Study|Site Terminated by Sponsor|24|||
146519008|NCT02756364|528406742|FG001|Overall Study|Site Terminated by Sponsor|30|||
146519009|NCT02756364|528406743|FG002|Overall Study|Site Terminated by Sponsor|21|||
146519010|NCT02756364|528406741|FG000|Overall Study|Death|20|||
146519011|NCT02756364|528406742|FG001|Overall Study|Death|15|||
146519012|NCT02756364|528406743|FG002|Overall Study|Death|18|||
146519013|NCT02756364|528406741|FG000|Overall Study|Withdrawal by Patient|2|||
146519014|NCT02756364|528406742|FG001|Overall Study|Withdrawal by Patient|1|||
146519015|NCT02756364|528406743|FG002|Overall Study|Withdrawal by Patient|8|||
146519016|NCT02756364|528406741|FG000|Overall Study|Lost to Follow-up|0|||
146519017|NCT02756364|528406742|FG001|Overall Study|Lost to Follow-up|1|||
146519018|NCT02756364|528406743|FG002|Overall Study|Lost to Follow-up|1|||
146519019|NCT02223364|528406744|FG000|Overall Study|Protocol Violation|3|||
146519020|NCT02223364|528406745|FG001|Overall Study|Protocol Violation|0|||
146519021|NCT02223364|528406746|FG002|Overall Study|Protocol Violation|3|||
146519022|NCT02223364|528406744|FG000|Overall Study|subject expired before surgery|1|||
146519023|NCT02223364|528406745|FG001|Overall Study|subject expired before surgery|0|||
146519024|NCT02223364|528406746|FG002|Overall Study|subject expired before surgery|0|||
146519025|NCT02223364|528406744|FG000|Overall Study|Physician Decision|1|||
146519026|NCT02223364|528406745|FG001|Overall Study|Physician Decision|0|||
146519027|NCT02223364|528406746|FG002|Overall Study|Physician Decision|0|||
146519028|NCT04811664|528406749|FG000|Overall Study|Lost to Follow-up|78|||
146519029|NCT04811664|528406750|FG001|Overall Study|Lost to Follow-up|125|||
146519030|NCT04811664|528406751|FG002|Overall Study|Lost to Follow-up|46|||
146519031|NCT04811664|528406749|FG000|Overall Study|Withdrawal by Subject|39|||
146519032|NCT04811664|528406750|FG001|Overall Study|Withdrawal by Subject|76|||
146519033|NCT04811664|528406751|FG002|Overall Study|Withdrawal by Subject|12|||
146519034|NCT04811664|528406749|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
146519035|NCT04811664|528406750|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
146519036|NCT04811664|528406751|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
146519037|NCT04811664|528406749|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
146519038|NCT04811664|528406750|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
146519039|NCT04811664|528406751|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
146519040|NCT04811664|528406749|FG000|Overall Study|Protocol Violation|0|||
146519041|NCT04811664|528406750|FG001|Overall Study|Protocol Violation|5|||
146519042|NCT04811664|528406751|FG002|Overall Study|Protocol Violation|11|||
146519043|NCT04811664|528406749|FG000|Overall Study|Study Terminated by Sponsor|4|||
146519044|NCT04811664|528406750|FG001|Overall Study|Study Terminated by Sponsor|3|||
146519045|NCT04811664|528406751|FG002|Overall Study|Study Terminated by Sponsor|34|||
146519046|NCT04811664|528406749|FG000|Overall Study|Early Study Closure|3|||
146519047|NCT04811664|528406750|FG001|Overall Study|Early Study Closure|7|||
146519048|NCT04811664|528406751|FG002|Overall Study|Early Study Closure|79|||
146519049|NCT04811664|528406749|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
146519050|NCT04811664|528406750|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
146519051|NCT04811664|528406751|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
146519052|NCT01900899|528406754|FG000|Overall Study|Withdrawal by Subject|7|||
146519053|NCT01900899|528406755|FG001|Overall Study|Withdrawal by Subject|1|||
146519054|NCT01900899|528406754|FG000|Overall Study|Migrated from study area|2|||
146519055|NCT01900899|528406755|FG001|Overall Study|Migrated from study area|0|||
146519056|NCT00723697|528406756|FG000|Overall Study|Physician questionnaires not received|2|||
146519057|NCT00723697|528406756|FG000|Overall Study|Missing Informed Consent Form|10|||
146519058|NCT00723697|528406756|FG000|Overall Study|Other exclusion criteria applied|6|||
146519059|NCT02774005|528406757|FG000|Overall Study|Adverse Event|8|||
146519060|NCT02774005|528406757|FG000|Overall Study|Withdrawal by Subject|23|||
146519061|NCT02774005|528406757|FG000|Overall Study|Lost to Follow-up|7|||
146519062|NCT02774005|528406757|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
146519063|NCT02774005|528406757|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
146519064|NCT02774005|528406757|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
146519065|NCT02774005|528406757|FG000|Overall Study|Death|1|||
146519066|NCT02774005|528406757|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
146519067|NCT02774005|528406757|FG000|Overall Study|Lack of compliance with study medication|4|||
146519068|NCT02774005|528406757|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
146519069|NCT02774005|528406757|FG000|Overall Study|another study|1|||
146519070|NCT02774005|528406757|FG000|Overall Study|cardiologist imposed travel restriction|1|||
146519071|NCT01289574|528406758|FG000|Overall Study|Lack of Efficacy|4|||
146519072|NCT01289574|528406759|FG001|Overall Study|Lack of Efficacy|0|||
146519073|NCT01289574|528406760|FG002|Overall Study|Lack of Efficacy|1|||
146519074|NCT01289574|528406758|FG000|Overall Study|Lost to Follow-up|2|||
146519075|NCT01289574|528406759|FG001|Overall Study|Lost to Follow-up|0|||
146519076|NCT01289574|528406760|FG002|Overall Study|Lost to Follow-up|1|||
146519077|NCT01289574|528406758|FG000|Overall Study|Withdrawal by Subject|1|||
146519078|NCT01289574|528406759|FG001|Overall Study|Withdrawal by Subject|1|||
146519079|NCT01289574|528406760|FG002|Overall Study|Withdrawal by Subject|1|||
146519080|NCT01289574|528406758|FG000|Overall Study|Adverse Event|0|||
146519081|NCT01289574|528406759|FG001|Overall Study|Adverse Event|1|||
146519082|NCT01289574|528406760|FG002|Overall Study|Adverse Event|0|||
146519083|NCT01289574|528406758|FG000|Overall Study|Subject wanted alternate treatment|0|||
146519084|NCT01289574|528406759|FG001|Overall Study|Subject wanted alternate treatment|1|||
146519085|NCT01289574|528406760|FG002|Overall Study|Subject wanted alternate treatment|0|||
146519086|NCT03885999|528406761|FG000|Overall Study|Adverse Event|1|||
146519087|NCT02452554|528406762|FG000|Overall Study|Death|2|||
146519088|NCT02452554|528406763|FG001|Overall Study|Death|1|||
146519089|NCT02452554|528406764|FG002|Overall Study|Death|0|||
146519090|NCT02452554|528406765|FG003|Overall Study|Death|0|||
146519091|NCT02452554|528406766|FG004|Overall Study|Death|0|||
146519092|NCT02452554|528406767|FG005|Overall Study|Death|0|||
146519093|NCT02452554|528406762|FG000|Overall Study|Lack of Efficacy|13|||
146519094|NCT02452554|528406763|FG001|Overall Study|Lack of Efficacy|14|||
146519095|NCT02452554|528406764|FG002|Overall Study|Lack of Efficacy|9|||
146519096|NCT02452554|528406765|FG003|Overall Study|Lack of Efficacy|1|||
146519097|NCT02452554|528406766|FG004|Overall Study|Lack of Efficacy|5|||
146519098|NCT02452554|528406767|FG005|Overall Study|Lack of Efficacy|8|||
146519099|NCT02452554|528406762|FG000|Overall Study|Physician Decision|0|||
146519100|NCT02452554|528406763|FG001|Overall Study|Physician Decision|1|||
146519101|NCT02452554|528406764|FG002|Overall Study|Physician Decision|0|||
146519102|NCT02452554|528406765|FG003|Overall Study|Physician Decision|0|||
146519103|NCT02452554|528406766|FG004|Overall Study|Physician Decision|0|||
146519104|NCT02452554|528406767|FG005|Overall Study|Physician Decision|0|||
146519105|NCT02452554|528406762|FG000|Overall Study|Withdrawal by Subject|1|||
146519106|NCT02452554|528406763|FG001|Overall Study|Withdrawal by Subject|0|||
146519107|NCT02452554|528406764|FG002|Overall Study|Withdrawal by Subject|2|||
146519108|NCT02452554|528406765|FG003|Overall Study|Withdrawal by Subject|0|||
146519109|NCT02452554|528406766|FG004|Overall Study|Withdrawal by Subject|0|||
146519110|NCT02452554|528406767|FG005|Overall Study|Withdrawal by Subject|1|||
146519111|NCT02452554|528406762|FG000|Overall Study|Ineligible|0|||
146519112|NCT02452554|528406763|FG001|Overall Study|Ineligible|1|||
146519113|NCT02452554|528406764|FG002|Overall Study|Ineligible|0|||
146519114|NCT02452554|528406765|FG003|Overall Study|Ineligible|0|||
146519115|NCT02452554|528406766|FG004|Overall Study|Ineligible|0|||
146519116|NCT02452554|528406767|FG005|Overall Study|Ineligible|0|||
146519117|NCT02452554|528406762|FG000|Overall Study|Never Received Treatment|1|||
146519118|NCT02452554|528406763|FG001|Overall Study|Never Received Treatment|0|||
146519119|NCT02452554|528406764|FG002|Overall Study|Never Received Treatment|0|||
146756381|NCT03023332|529273287|FG000|Overall Study|Death|1|||
146756382|NCT03023332|529273288|FG001|Overall Study|Death|0|||
146756383|NCT03023332|529273289|FG002|Overall Study|Death|0|||
146756384|NCT03023332|529273290|FG003|Overall Study|Death|0|||
146756385|NCT01657682|529273291|FG000|Overall Study|Lost to Follow-up|1|||
146756386|NCT01657682|529273292|FG001|Overall Study|Lost to Follow-up|0|||
146756387|NCT01657682|529273293|FG002|Overall Study|Lost to Follow-up|0|||
146756388|NCT01657682|529273291|FG000|Overall Study|Withdrawal by Subject|0|||
146756389|NCT01657682|529273292|FG001|Overall Study|Withdrawal by Subject|1|||
146519120|NCT02452554|528406765|FG003|Overall Study|Never Received Treatment|0|||
146519121|NCT02452554|528406766|FG004|Overall Study|Never Received Treatment|0|||
146519122|NCT02452554|528406767|FG005|Overall Study|Never Received Treatment|0|||
146519123|NCT05188729|528406768|FG000|Overall Study|Withdrawal by Subject|0|||
146519124|NCT05188729|528406769|FG001|Overall Study|Withdrawal by Subject|0|||
146519125|NCT05188729|528406770|FG002|Overall Study|Withdrawal by Subject|0|||
146519126|NCT05188729|528406771|FG003|Overall Study|Withdrawal by Subject|0|||
146519127|NCT05188729|528406772|FG004|Overall Study|Withdrawal by Subject|0|||
146519128|NCT05188729|528406773|FG005|Overall Study|Withdrawal by Subject|0|||
146519129|NCT05188729|528406774|FG006|Overall Study|Withdrawal by Subject|0|||
146519130|NCT05188729|528406775|FG007|Overall Study|Withdrawal by Subject|0|||
146519131|NCT05188729|528406776|FG008|Overall Study|Withdrawal by Subject|0|||
146519132|NCT05188729|528406777|FG009|Overall Study|Withdrawal by Subject|1|||
146519133|NCT05188729|528406778|FG010|Overall Study|Withdrawal by Subject|0|||
146519134|NCT05188729|528406779|FG011|Overall Study|Withdrawal by Subject|0|||
146519135|NCT05188729|528406780|FG012|Overall Study|Withdrawal by Subject|0|||
146519136|NCT05188729|528406768|FG000|Overall Study|Lost to Follow-up|0|||
146519137|NCT05188729|528406769|FG001|Overall Study|Lost to Follow-up|0|||
146519138|NCT05188729|528406770|FG002|Overall Study|Lost to Follow-up|0|||
146519139|NCT05188729|528406771|FG003|Overall Study|Lost to Follow-up|0|||
146519140|NCT05188729|528406772|FG004|Overall Study|Lost to Follow-up|0|||
146519141|NCT05188729|528406773|FG005|Overall Study|Lost to Follow-up|0|||
146519142|NCT05188729|528406774|FG006|Overall Study|Lost to Follow-up|0|||
146519143|NCT05188729|528406775|FG007|Overall Study|Lost to Follow-up|0|||
146519144|NCT05188729|528406776|FG008|Overall Study|Lost to Follow-up|0|||
146519145|NCT05188729|528406777|FG009|Overall Study|Lost to Follow-up|0|||
146519146|NCT05188729|528406778|FG010|Overall Study|Lost to Follow-up|1|||
146519147|NCT05188729|528406779|FG011|Overall Study|Lost to Follow-up|1|||
146519148|NCT05188729|528406780|FG012|Overall Study|Lost to Follow-up|0|||
146519149|NCT00520767|528406784|FG000|Overall Study|Death|2|||
146519150|NCT00376532|528409270|FG000|Overall Study|Lack sufficient blood sample|6|||
146519151|NCT00376532|528409271|FG001|Overall Study|Lack sufficient blood sample|6|||
146519152|NCT01133704|528409272|FG000|Overall Study|Death|44|||
146519153|NCT01133704|528409273|FG001|Overall Study|Death|26|||
146519154|NCT01133704|528409272|FG000|Overall Study|Patient refused to continue|4|||
146519155|NCT01133704|528409273|FG001|Overall Study|Patient refused to continue|0|||
146519156|NCT01133704|528409272|FG000|Overall Study|Study Closure|1|||
146519157|NCT01133704|528409273|FG001|Overall Study|Study Closure|0|||
146519158|NCT03746405|528409277|FG000|Overall Study|Withdrawal by Subject|3|||
146519159|NCT03746405|528409278|FG001|Overall Study|Withdrawal by Subject|0|||
146519160|NCT03746405|528409277|FG000|Overall Study|technical difficulties|0|||
146519161|NCT03746405|528409278|FG001|Overall Study|technical difficulties|2|||
146519162|NCT02753816|528409279|FG000|Overall Study|Protocol Violation|0|||
146519163|NCT02753816|528409280|FG001|Overall Study|Protocol Violation|1|||
146519164|NCT02753816|528409281|FG002|Overall Study|Protocol Violation|0|||
146519165|NCT02372383|528409285|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
146519166|NCT02372383|528409286|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
146519167|NCT02372383|528409287|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
146519168|NCT03130959|528409291|FG000|Overall Study|Disease progression|19|||
146519169|NCT03130959|528409292|FG001|Overall Study|Disease progression|7|||
146519170|NCT03130959|528409293|FG002|Overall Study|Disease progression|12|||
146519171|NCT03130959|528409294|FG003|Overall Study|Disease progression|7|||
146519172|NCT03130959|528409295|FG004|Overall Study|Disease progression|12|||
146519173|NCT03130959|528409296|FG005|Overall Study|Disease progression|3|||
146519174|NCT03130959|528409297|FG006|Overall Study|Disease progression|6|||
146519175|NCT03130959|528409298|FG007|Overall Study|Disease progression|3|||
146519176|NCT03130959|528409299|FG008|Overall Study|Disease progression|15|||
146519177|NCT03130959|528409300|FG009|Overall Study|Disease progression|8|||
146519178|NCT03130959|528409291|FG000|Overall Study|Study drug toxicity|2|||
146519179|NCT03130959|528409292|FG001|Overall Study|Study drug toxicity|2|||
146519180|NCT03130959|528409293|FG002|Overall Study|Study drug toxicity|1|||
146519181|NCT03130959|528409294|FG003|Overall Study|Study drug toxicity|2|||
146519182|NCT03130959|528409295|FG004|Overall Study|Study drug toxicity|1|||
146519183|NCT03130959|528409296|FG005|Overall Study|Study drug toxicity|1|||
146519184|NCT03130959|528409297|FG006|Overall Study|Study drug toxicity|3|||
146519185|NCT03130959|528409298|FG007|Overall Study|Study drug toxicity|0|||
146519186|NCT03130959|528409299|FG008|Overall Study|Study drug toxicity|3|||
146519187|NCT03130959|528409300|FG009|Overall Study|Study drug toxicity|3|||
146519188|NCT03130959|528409291|FG000|Overall Study|Other reasons|0|||
146519189|NCT03130959|528409292|FG001|Overall Study|Other reasons|0|||
146519190|NCT03130959|528409293|FG002|Overall Study|Other reasons|0|||
146519191|NCT03130959|528409294|FG003|Overall Study|Other reasons|0|||
146519192|NCT03130959|528409295|FG004|Overall Study|Other reasons|0|||
146519193|NCT03130959|528409296|FG005|Overall Study|Other reasons|1|||
146519194|NCT03130959|528409297|FG006|Overall Study|Other reasons|1|||
146519195|NCT03130959|528409298|FG007|Overall Study|Other reasons|0|||
146519196|NCT03130959|528409299|FG008|Overall Study|Other reasons|0|||
146519197|NCT03130959|528409300|FG009|Overall Study|Other reasons|0|||
146519198|NCT03130959|528409291|FG000|Overall Study|Subject request to discontinue therapy|0|||
146519199|NCT03130959|528409292|FG001|Overall Study|Subject request to discontinue therapy|0|||
146519200|NCT03130959|528409293|FG002|Overall Study|Subject request to discontinue therapy|1|||
146519201|NCT03130959|528409294|FG003|Overall Study|Subject request to discontinue therapy|1|||
146519202|NCT03130959|528409295|FG004|Overall Study|Subject request to discontinue therapy|0|||
146519203|NCT03130959|528409296|FG005|Overall Study|Subject request to discontinue therapy|0|||
146519204|NCT03130959|528409297|FG006|Overall Study|Subject request to discontinue therapy|1|||
146519205|NCT03130959|528409298|FG007|Overall Study|Subject request to discontinue therapy|1|||
146519206|NCT03130959|528409299|FG008|Overall Study|Subject request to discontinue therapy|0|||
146519207|NCT03130959|528409300|FG009|Overall Study|Subject request to discontinue therapy|0|||
146519208|NCT03130959|528409291|FG000|Overall Study|Not reported|0|||
146519209|NCT03130959|528409292|FG001|Overall Study|Not reported|0|||
146519210|NCT03130959|528409293|FG002|Overall Study|Not reported|0|||
146519211|NCT03130959|528409294|FG003|Overall Study|Not reported|1|||
146519212|NCT03130959|528409295|FG004|Overall Study|Not reported|0|||
146519213|NCT03130959|528409296|FG005|Overall Study|Not reported|1|||
146519214|NCT03130959|528409297|FG006|Overall Study|Not reported|0|||
146519215|NCT03130959|528409298|FG007|Overall Study|Not reported|0|||
146519216|NCT03130959|528409299|FG008|Overall Study|Not reported|0|||
146625253|NCT03037385|528803848|FG003|Overall Study|Initiation of Another Therapy|0|||
146625254|NCT03037385|528803849|FG004|Overall Study|Initiation of Another Therapy|0|||
146853614|NCT01370590|529633717|FG000|Period 1|Withdrawal by Subject|4|||
146853615|NCT01370590|529633718|FG001|Period 1|Withdrawal by Subject|2|||
146853616|NCT01370590|529633717|FG000|Period 1|Could not access randomization system|0|||
146853617|NCT01370590|529633718|FG001|Period 1|Could not access randomization system|1|||
146853618|NCT01370590|529633717|FG000|Crossover Washout Period|Adverse Event|1|||
146853619|NCT01370590|529633718|FG001|Crossover Washout Period|Adverse Event|4|||
146853620|NCT01370590|529633717|FG000|Crossover Washout Period|Lost to Follow-up|2|||
146853621|NCT01370590|529633718|FG001|Crossover Washout Period|Lost to Follow-up|0|||
146519217|NCT03130959|528409300|FG009|Overall Study|Not reported|1|||
146519218|NCT03130959|528409291|FG000|Overall Study|Adverse Event unrelated to drug|0|||
146519219|NCT03130959|528409292|FG001|Overall Study|Adverse Event unrelated to drug|0|||
146519220|NCT03130959|528409293|FG002|Overall Study|Adverse Event unrelated to drug|1|||
146519221|NCT03130959|528409294|FG003|Overall Study|Adverse Event unrelated to drug|1|||
146519222|NCT03130959|528409295|FG004|Overall Study|Adverse Event unrelated to drug|1|||
146519223|NCT03130959|528409296|FG005|Overall Study|Adverse Event unrelated to drug|0|||
146519224|NCT03130959|528409297|FG006|Overall Study|Adverse Event unrelated to drug|1|||
146519225|NCT03130959|528409298|FG007|Overall Study|Adverse Event unrelated to drug|0|||
146519226|NCT03130959|528409299|FG008|Overall Study|Adverse Event unrelated to drug|1|||
146519227|NCT03130959|528409300|FG009|Overall Study|Adverse Event unrelated to drug|1|||
146519228|NCT03130959|528409291|FG000|Overall Study|Participant withdrew consent|0|||
146519229|NCT03130959|528409292|FG001|Overall Study|Participant withdrew consent|1|||
146519230|NCT03130959|528409293|FG002|Overall Study|Participant withdrew consent|0|||
146519231|NCT03130959|528409294|FG003|Overall Study|Participant withdrew consent|2|||
146519232|NCT03130959|528409295|FG004|Overall Study|Participant withdrew consent|1|||
146519233|NCT03130959|528409296|FG005|Overall Study|Participant withdrew consent|0|||
146519234|NCT03130959|528409297|FG006|Overall Study|Participant withdrew consent|0|||
146519235|NCT03130959|528409298|FG007|Overall Study|Participant withdrew consent|0|||
146519236|NCT03130959|528409299|FG008|Overall Study|Participant withdrew consent|0|||
146519237|NCT03130959|528409300|FG009|Overall Study|Participant withdrew consent|2|||
146519238|NCT03130959|528409291|FG000|Overall Study|Administrative reason by sponsor|1|||
146519239|NCT03130959|528409292|FG001|Overall Study|Administrative reason by sponsor|0|||
146519240|NCT03130959|528409293|FG002|Overall Study|Administrative reason by sponsor|1|||
146519241|NCT03130959|528409294|FG003|Overall Study|Administrative reason by sponsor|0|||
146519242|NCT03130959|528409295|FG004|Overall Study|Administrative reason by sponsor|0|||
146519243|NCT03130959|528409296|FG005|Overall Study|Administrative reason by sponsor|0|||
146519244|NCT03130959|528409297|FG006|Overall Study|Administrative reason by sponsor|0|||
146519245|NCT03130959|528409298|FG007|Overall Study|Administrative reason by sponsor|0|||
146519246|NCT03130959|528409299|FG008|Overall Study|Administrative reason by sponsor|0|||
146519247|NCT03130959|528409300|FG009|Overall Study|Administrative reason by sponsor|0|||
146519248|NCT03130959|528409291|FG000|Overall Study|Lost to Follow-up|1|||
146519249|NCT03130959|528409292|FG001|Overall Study|Lost to Follow-up|0|||
146519250|NCT03130959|528409293|FG002|Overall Study|Lost to Follow-up|0|||
146519251|NCT03130959|528409294|FG003|Overall Study|Lost to Follow-up|0|||
146519252|NCT03130959|528409295|FG004|Overall Study|Lost to Follow-up|0|||
146519253|NCT03130959|528409296|FG005|Overall Study|Lost to Follow-up|0|||
146519254|NCT03130959|528409297|FG006|Overall Study|Lost to Follow-up|0|||
146519255|NCT03130959|528409298|FG007|Overall Study|Lost to Follow-up|0|||
146519256|NCT03130959|528409299|FG008|Overall Study|Lost to Follow-up|0|||
146519257|NCT03130959|528409300|FG009|Overall Study|Lost to Follow-up|0|||
146519258|NCT02384538|528409301|FG000|Overall Study|Adverse Event|1|||
146519259|NCT02384538|528409302|FG001|Overall Study|Adverse Event|4|||
146519260|NCT02384538|528409301|FG000|Overall Study|Lack of Efficacy|4|||
146519261|NCT02384538|528409302|FG001|Overall Study|Lack of Efficacy|4|||
146519262|NCT02384538|528409301|FG000|Overall Study|Withdrew Consent|0|||
146519263|NCT02384538|528409302|FG001|Overall Study|Withdrew Consent|4|||
146519264|NCT02384538|528409301|FG000|Overall Study|Other|1|||
146519265|NCT02384538|528409302|FG001|Overall Study|Other|3|||
146519266|NCT02187029|528409305|FG000|Overall Study|Adverse Event|0|||
146519267|NCT02187029|528409306|FG001|Overall Study|Adverse Event|1|||
146519268|NCT02187029|528409307|FG002|Overall Study|Adverse Event|1|||
146519269|NCT02187029|528409308|FG003|Overall Study|Adverse Event|0|||
146519270|NCT02187029|528409305|FG000|Overall Study|Study Terminated by Sponsor|0|||
146519271|NCT02187029|528409306|FG001|Overall Study|Study Terminated by Sponsor|0|||
146519272|NCT02187029|528409307|FG002|Overall Study|Study Terminated by Sponsor|10|||
146519273|NCT02187029|528409308|FG003|Overall Study|Study Terminated by Sponsor|3|||
146519274|NCT02187029|528409305|FG000|Overall Study|Withdrawal by Subject|1|||
146519275|NCT02187029|528409306|FG001|Overall Study|Withdrawal by Subject|0|||
146519276|NCT02187029|528409307|FG002|Overall Study|Withdrawal by Subject|0|||
146519277|NCT02187029|528409308|FG003|Overall Study|Withdrawal by Subject|0|||
146519278|NCT03042910|528409309|FG000|Overall Study|Adverse Event|1|||
146519279|NCT03042910|528409309|FG000|Overall Study|Disease Progression|2|||
146519280|NCT03042910|528409309|FG000|Overall Study|Withdrawal by Subject|3|||
146519281|NCT03042910|528409309|FG000|Overall Study|Enrolled but not treated|1|||
146519282|NCT04472494|528409310|FG000|Pre-treatment|Other reasons|2|||
146519283|NCT04472494|528409311|FG001|Pre-treatment|Other reasons|0|||
146519284|NCT04472494|528409310|FG000|Treatment|Death|5|||
146519285|NCT04472494|528409311|FG001|Treatment|Death|2|||
146519286|NCT04472494|528409310|FG000|Treatment|Hospital discharge|1|||
146519287|NCT04472494|528409311|FG001|Treatment|Hospital discharge|1|||
146519288|NCT00809094|528409317|FG000|Overall Study|Lost to Follow-up|0|||
146519289|NCT00809094|528409318|FG001|Overall Study|Lost to Follow-up|1|||
146519290|NCT02768792|528409321|FG000|Overall Study|Adverse Event|1|||
146519291|NCT01690299|528409322|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
146519292|NCT01690299|528409323|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
146519293|NCT01690299|528409324|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
146519294|NCT01690299|528409325|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
146519295|NCT01690299|528409326|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
146519296|NCT01690299|528409327|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
146519297|NCT01690299|528409322|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
146519298|NCT01690299|528409323|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
146519299|NCT01690299|528409324|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
146519300|NCT01690299|528409325|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
146519301|NCT01690299|528409326|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
146519302|NCT01690299|528409327|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
146519303|NCT01690299|528409322|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
146519304|NCT01690299|528409323|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
146519305|NCT01690299|528409324|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
146519306|NCT01690299|528409325|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
146519307|NCT01690299|528409326|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
146519308|NCT01690299|528409327|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
146519309|NCT01690299|528409322|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
146519310|NCT01690299|528409323|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
146519311|NCT01690299|528409324|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
146519312|NCT01690299|528409325|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
146519313|NCT01690299|528409326|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
146519314|NCT01690299|528409327|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
146519315|NCT01690299|528409322|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
146519316|NCT01690299|528409323|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
146519317|NCT01690299|528409324|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
146519318|NCT01690299|528409325|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
146519319|NCT01690299|528409326|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
146519320|NCT01690299|528409327|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
146519321|NCT01690299|528409322|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
146519322|NCT01690299|528409323|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
146519323|NCT01690299|528409324|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
146519324|NCT01690299|528409325|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
146519325|NCT01690299|528409326|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
146519326|NCT01690299|528409327|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
146519327|NCT01690299|528409322|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
146519328|NCT01690299|528409323|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
146519329|NCT01690299|528409324|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
146519330|NCT01690299|528409325|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
146519331|NCT01690299|528409326|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
146519332|NCT01690299|528409327|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
146519333|NCT01690299|528409322|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
146519334|NCT01690299|528409323|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
146519335|NCT01690299|528409324|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
146519336|NCT01690299|528409325|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
146519337|NCT01690299|528409326|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
146519338|NCT01690299|528409327|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
146519339|NCT01690299|528409322|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
146519340|NCT01690299|528409323|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
146519341|NCT01690299|528409324|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
146519342|NCT01690299|528409325|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
146519343|NCT01690299|528409326|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
146519344|NCT01690299|528409327|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
146519345|NCT01690299|528409322|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
146519346|NCT01690299|528409323|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
146519347|NCT01690299|528409324|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
146519348|NCT01690299|528409325|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
146519349|NCT01690299|528409326|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
146519350|NCT01690299|528409327|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
146519351|NCT04676724|528409330|FG000|Overall Study|Adverse Event|2|||
146519352|NCT04676724|528409331|FG001|Overall Study|Adverse Event|0|||
146519353|NCT04676724|528409330|FG000|Overall Study|Lost to Follow-up|1|||
146519354|NCT04676724|528409331|FG001|Overall Study|Lost to Follow-up|0|||
146625255|NCT03037385|528803850|FG005|Overall Study|Initiation of Another Therapy|0|||
146519355|NCT04676724|528409330|FG000|Overall Study|Physician Decision|0|||
146519356|NCT04676724|528409331|FG001|Overall Study|Physician Decision|1|||
146519357|NCT04676724|528409330|FG000|Overall Study|Withdrawal by Subject|3|||
146519358|NCT04676724|528409331|FG001|Overall Study|Withdrawal by Subject|2|||
146519359|NCT01188668|528409332|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
146519360|NCT01188668|528409332|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
146519361|NCT01188668|528409332|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
146519362|NCT00359294|528409336|FG000|Overall Study|Progressive disease|1|||
146519363|NCT00359294|528409337|FG001|Overall Study|Progressive disease|1|||
146519364|NCT00359294|528409338|FG002|Overall Study|Progressive disease|2|||
146519365|NCT00359294|528409339|FG003|Overall Study|Progressive disease|3|||
146519366|NCT00359294|528409340|FG004|Overall Study|Progressive disease|2|||
146519367|NCT00359294|528409336|FG000|Overall Study|Withdrawal by Subject|0|||
146519368|NCT00359294|528409337|FG001|Overall Study|Withdrawal by Subject|0|||
146519369|NCT00359294|528409338|FG002|Overall Study|Withdrawal by Subject|0|||
146519370|NCT00359294|528409339|FG003|Overall Study|Withdrawal by Subject|0|||
146519371|NCT00359294|528409340|FG004|Overall Study|Withdrawal by Subject|1|||
146519372|NCT00359294|528409336|FG000|Overall Study|Not treated|0|||
146519373|NCT00359294|528409337|FG001|Overall Study|Not treated|0|||
146519374|NCT00359294|528409338|FG002|Overall Study|Not treated|0|||
146519375|NCT00359294|528409339|FG003|Overall Study|Not treated|1|||
146519376|NCT00359294|528409340|FG004|Overall Study|Not treated|0|||
146519377|NCT00359294|528409336|FG000|Overall Study|Physician Decision|0|||
146519378|NCT00359294|528409337|FG001|Overall Study|Physician Decision|0|||
146519379|NCT00359294|528409338|FG002|Overall Study|Physician Decision|1|||
146519380|NCT00359294|528409339|FG003|Overall Study|Physician Decision|0|||
146519381|NCT00359294|528409340|FG004|Overall Study|Physician Decision|0|||
146519382|NCT01348100|528409343|FG000|Overall Study|Subject Withdrew Consent|0|||
146519383|NCT01348100|528409344|FG001|Overall Study|Subject Withdrew Consent|0|||
146519384|NCT01348100|528409345|FG002|Overall Study|Subject Withdrew Consent|2|||
146519385|NCT01348100|528409346|FG003|Overall Study|Subject Withdrew Consent|0|||
146519386|NCT01348100|528409347|FG004|Overall Study|Subject Withdrew Consent|1|||
146519387|NCT01348100|528409348|FG005|Overall Study|Subject Withdrew Consent|0|||
146519388|NCT01348100|528409349|FG006|Overall Study|Subject Withdrew Consent|1|||
146519389|NCT01348100|528409343|FG000|Overall Study|Protocol Deviation|0|||
146519390|NCT01348100|528409344|FG001|Overall Study|Protocol Deviation|0|||
146519391|NCT01348100|528409345|FG002|Overall Study|Protocol Deviation|0|||
146519392|NCT01348100|528409346|FG003|Overall Study|Protocol Deviation|1|||
146519393|NCT01348100|528409347|FG004|Overall Study|Protocol Deviation|0|||
146519394|NCT01348100|528409348|FG005|Overall Study|Protocol Deviation|0|||
146519395|NCT01348100|528409349|FG006|Overall Study|Protocol Deviation|0|||
146519396|NCT01348100|528409343|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146519397|NCT01348100|528409344|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146519398|NCT01348100|528409345|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146519399|NCT01348100|528409346|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146519400|NCT01348100|528409347|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146519401|NCT01348100|528409348|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
146519402|NCT01348100|528409349|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146519403|NCT01348100|528409343|FG000|Overall Study|Lost to Follow-up|0|||
146519404|NCT01348100|528409344|FG001|Overall Study|Lost to Follow-up|0|||
146519405|NCT01348100|528409345|FG002|Overall Study|Lost to Follow-up|0|||
146519406|NCT01348100|528409346|FG003|Overall Study|Lost to Follow-up|0|||
146519407|NCT01348100|528409347|FG004|Overall Study|Lost to Follow-up|0|||
146519408|NCT01348100|528409348|FG005|Overall Study|Lost to Follow-up|0|||
146519409|NCT01348100|528409349|FG006|Overall Study|Lost to Follow-up|1|||
146519410|NCT01348100|528409343|FG000|Overall Study|Administrative Problems|0|||
146519411|NCT01348100|528409344|FG001|Overall Study|Administrative Problems|0|||
146519412|NCT01348100|528409345|FG002|Overall Study|Administrative Problems|0|||
146519413|NCT01348100|528409346|FG003|Overall Study|Administrative Problems|0|||
146519414|NCT01348100|528409347|FG004|Overall Study|Administrative Problems|0|||
146519415|NCT01348100|528409348|FG005|Overall Study|Administrative Problems|1|||
146519416|NCT01348100|528409349|FG006|Overall Study|Administrative Problems|1|||
146519417|NCT03883477|528409350|FG000|Overall Study|Death|1|||
146519418|NCT03883477|528409351|FG001|Overall Study|Death|0|||
146519419|NCT03883477|528409350|FG000|Overall Study|Protocol Violation|0|||
146519420|NCT03883477|528409351|FG001|Overall Study|Protocol Violation|1|||
146519421|NCT03853291|528409352|FG000|Overall Study|Lost to Follow-up|1|||
146519422|NCT03853291|528409353|FG001|Overall Study|Lost to Follow-up|2|||
146519423|NCT03853291|528409354|FG002|Overall Study|Lost to Follow-up|0|||
146519424|NCT03853291|528409355|FG003|Overall Study|Lost to Follow-up|0|||
146519425|NCT03853291|528409356|FG004|Overall Study|Lost to Follow-up|0|||
146519426|NCT03853291|528409357|FG005|Overall Study|Lost to Follow-up|0|||
146519427|NCT03853291|528409352|FG000|Overall Study|Determined to be ineligible|1|||
146519428|NCT03853291|528409353|FG001|Overall Study|Determined to be ineligible|1|||
146519429|NCT03853291|528409354|FG002|Overall Study|Determined to be ineligible|0|||
146519430|NCT03853291|528409355|FG003|Overall Study|Determined to be ineligible|0|||
146519431|NCT03853291|528409356|FG004|Overall Study|Determined to be ineligible|0|||
146519432|NCT03853291|528409357|FG005|Overall Study|Determined to be ineligible|0|||
146519433|NCT03882957|528409360|FG000|Overall Study|Did not complete all three arms|1|||
146519434|NCT01134393|528409366|FG000|Overall Study|Adverse Event|18|||
146519435|NCT01134393|528409366|FG000|Overall Study|Lack of Efficacy|2|||
146519436|NCT01134393|528409366|FG000|Overall Study|Protocol Violation|12|||
146519437|NCT01134393|528409366|FG000|Overall Study|Lost to Follow-up|3|||
146519438|NCT01134393|528409366|FG000|Overall Study|Withdrawal by Subject|11|||
146519439|NCT01134393|528409366|FG000|Overall Study|Other|6|||
146519440|NCT01658904|528409370|FG000|Overall Study|Principal Investigator discretion|2|||
146519441|NCT01658904|528409371|FG001|Overall Study|Principal Investigator discretion|0|||
146519442|NCT01658904|528409372|FG002|Overall Study|Principal Investigator discretion|0|||
146519443|NCT03762681|528409375|FG000|Part 1|Withdrawal by Subject|0|||
146519444|NCT03762681|528409376|FG001|Part 1|Withdrawal by Subject|0|||
146519445|NCT03762681|528409377|FG002|Part 1|Withdrawal by Subject|0|||
146519446|NCT03762681|528409378|FG003|Part 1|Withdrawal by Subject|1|||
146519447|NCT03762681|528409379|FG004|Part 1|Withdrawal by Subject|0|||
146519448|NCT03762681|528409380|FG005|Part 1|Withdrawal by Subject|0|||
146519449|NCT03762681|528409381|FG006|Part 1|Withdrawal by Subject|0|||
146519450|NCT03762681|528409382|FG007|Part 1|Withdrawal by Subject|0|||
146519451|NCT03762681|528409375|FG000|Part 2a|Pandemic Travel Restrictions|0|||
146519452|NCT03762681|528409376|FG001|Part 2a|Pandemic Travel Restrictions|0|||
146519453|NCT03762681|528409377|FG002|Part 2a|Pandemic Travel Restrictions|0|||
146519454|NCT03762681|528409378|FG003|Part 2a|Pandemic Travel Restrictions|0|||
146519455|NCT03762681|528409379|FG004|Part 2a|Pandemic Travel Restrictions|0|||
146519456|NCT03762681|528409380|FG005|Part 2a|Pandemic Travel Restrictions|0|||
146519457|NCT03762681|528409381|FG006|Part 2a|Pandemic Travel Restrictions|0|||
146519458|NCT03762681|528409382|FG007|Part 2a|Pandemic Travel Restrictions|1|||
146519459|NCT00524680|528409385|FG000|Overall Study|progression|0|||
146519460|NCT00524680|528409386|FG001|Overall Study|progression|0|||
146519461|NCT00524680|528409387|FG002|Overall Study|progression|0|||
146519462|NCT00524680|528409388|FG003|Overall Study|progression|1|||
146519463|NCT00524680|528409385|FG000|Overall Study|Adverse Event|2|||
146519464|NCT00524680|528409386|FG001|Overall Study|Adverse Event|0|||
146519465|NCT00524680|528409387|FG002|Overall Study|Adverse Event|0|||
146519466|NCT00524680|528409388|FG003|Overall Study|Adverse Event|1|||
146519467|NCT00524680|528409385|FG000|Overall Study|Other|0|||
146519468|NCT00524680|528409386|FG001|Overall Study|Other|1|||
146519469|NCT00524680|528409387|FG002|Overall Study|Other|2|||
146519470|NCT00524680|528409388|FG003|Overall Study|Other|3|||
146519471|NCT00524680|528409385|FG000|Overall Study|Withdrawal by Subject|1|||
146519472|NCT00524680|528409386|FG001|Overall Study|Withdrawal by Subject|0|||
146519473|NCT00524680|528409387|FG002|Overall Study|Withdrawal by Subject|1|||
146519474|NCT00524680|528409388|FG003|Overall Study|Withdrawal by Subject|1|||
146519475|NCT00913770|528409395|FG000|Overall Study|Unable to contact|24|||
146519476|NCT00913770|528409396|FG001|Overall Study|Unable to contact|19|||
146519477|NCT00913770|528409397|FG002|Overall Study|Unable to contact|13|||
146519478|NCT00913770|528409395|FG000|Overall Study|Refused|11|||
146519479|NCT00913770|528409396|FG001|Overall Study|Refused|10|||
146519480|NCT00913770|528409397|FG002|Overall Study|Refused|8|||
146519481|NCT03337048|528409398|FG000|Overall Study|Withdrawal by Subject|2|||
146519482|NCT03337048|528409399|FG001|Overall Study|Withdrawal by Subject|0|||
146519483|NCT03337048|528409400|FG002|Overall Study|Withdrawal by Subject|0|||
146519484|NCT04399538|528409402|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
146519485|NCT04399538|528409403|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
146519486|NCT04399538|528409404|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
146519487|NCT04399538|528409405|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
146519488|NCT04399538|528409406|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
146519489|NCT04399538|528409402|FG000|Double-Blind Treatment|Adverse Event|0|||
146519490|NCT04399538|528409403|FG001|Double-Blind Treatment|Adverse Event|0|||
146519491|NCT04399538|528409404|FG002|Double-Blind Treatment|Adverse Event|0|||
146519492|NCT04399538|528409405|FG003|Double-Blind Treatment|Adverse Event|0|||
146519493|NCT04399538|528409406|FG004|Double-Blind Treatment|Adverse Event|1|||
146519494|NCT04399538|528409402|FG000|Follow-Up|Adverse Event|0|||
146519495|NCT04399538|528409403|FG001|Follow-Up|Adverse Event|0|||
146519496|NCT04399538|528409404|FG002|Follow-Up|Adverse Event|0|||
146519497|NCT04399538|528409405|FG003|Follow-Up|Adverse Event|0|||
146519498|NCT04399538|528409406|FG004|Follow-Up|Adverse Event|1|||
146519499|NCT04399538|528409402|FG000|Follow-Up|Withdrawal by Subject|0|||
146519500|NCT04399538|528409403|FG001|Follow-Up|Withdrawal by Subject|0|||
146519501|NCT04399538|528409404|FG002|Follow-Up|Withdrawal by Subject|0|||
146519502|NCT04399538|528409405|FG003|Follow-Up|Withdrawal by Subject|2|||
146519503|NCT04399538|528409406|FG004|Follow-Up|Withdrawal by Subject|0|||
146519504|NCT00893971|528409407|FG000|Overall Study|Physician Decision|3|||
146519505|NCT03268005|528409408|FG000|Overall Study|Death|2|||
146519506|NCT03268005|528409409|FG001|Overall Study|Death|1|||
146519507|NCT03268005|528409408|FG000|Overall Study|Lost to Follow-up|2|||
146519508|NCT03268005|528409409|FG001|Overall Study|Lost to Follow-up|2|||
146519509|NCT03268005|528409408|FG000|Overall Study|Withdrawal by Subject|11|||
146519510|NCT03268005|528409409|FG001|Overall Study|Withdrawal by Subject|11|||
146519511|NCT00492232|528409410|FG000|Placebo Run-in|Adverse Event|0|||
146519512|NCT00492232|528409411|FG001|Placebo Run-in|Adverse Event|2|||
146519513|NCT00492232|528409410|FG000|Placebo Run-in|Protocol Violation|0|||
146519514|NCT00492232|528409411|FG001|Placebo Run-in|Protocol Violation|3|||
146519515|NCT00492232|528409410|FG000|Placebo Run-in|Lost to Follow-up|0|||
146519516|NCT00492232|528409411|FG001|Placebo Run-in|Lost to Follow-up|3|||
146519517|NCT00492232|528409410|FG000|Placebo Run-in|Withdrawal by Subject|0|||
146519518|NCT00492232|528409411|FG001|Placebo Run-in|Withdrawal by Subject|8|||
146519519|NCT00492232|528409410|FG000|Placebo Run-in|Pregnancy|0|||
146519520|NCT00492232|528409411|FG001|Placebo Run-in|Pregnancy|1|||
146519521|NCT00492232|528409410|FG000|Placebo Run-in|Entrance criteria not met|0|||
146519522|NCT00492232|528409411|FG001|Placebo Run-in|Entrance criteria not met|45|||
146519523|NCT00492232|528409410|FG000|Placebo Run-in|Other|0|||
146519524|NCT00492232|528409411|FG001|Placebo Run-in|Other|6|||
146519525|NCT00492232|528409410|FG000|Placebo Run-in|Missing|0|||
146519526|NCT00492232|528409411|FG001|Placebo Run-in|Missing|2|||
146519527|NCT00492232|528409410|FG000|Double-Blind Treatment|Adverse Event|1|||
146519528|NCT00492232|528409411|FG001|Double-Blind Treatment|Adverse Event|2|||
146519529|NCT00492232|528409410|FG000|Double-Blind Treatment|Protocol Violation|3|||
146519530|NCT00492232|528409411|FG001|Double-Blind Treatment|Protocol Violation|7|||
146519531|NCT00492232|528409410|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
146519532|NCT00492232|528409411|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
146519533|NCT00492232|528409410|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
146519534|NCT00492232|528409411|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
146519535|NCT00492232|528409410|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
146519536|NCT00492232|528409411|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
146519537|NCT00492232|528409410|FG000|Double-Blind Treatment|Other|6|||
146519538|NCT00492232|528409411|FG001|Double-Blind Treatment|Other|5|||
146519539|NCT00492232|528409410|FG000|Double-Blind Treatment|Randomized not treated|1|||
146519540|NCT00492232|528409411|FG001|Double-Blind Treatment|Randomized not treated|0|||
146519541|NCT00492232|528409410|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
146519542|NCT00492232|528409411|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
146519543|NCT01416155|528409413|FG000|Overall Study|Adverse Event|8|||
146519544|NCT01416155|528409413|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
146519545|NCT01416155|528409413|FG000|Overall Study|Withdrawal by Subject|33|||
146519546|NCT01416155|528409413|FG000|Overall Study|Investigator decision|8|||
146519547|NCT01416155|528409413|FG000|Overall Study|Other|7|||
146519548|NCT03597139|528409417|FG000|Overall Study|Adverse Event|3|||
146519549|NCT03597139|528409418|FG001|Overall Study|Adverse Event|0|||
146519550|NCT03597139|528409417|FG000|Overall Study|Protocol Non-compliance|1|||
146519551|NCT03597139|528409418|FG001|Overall Study|Protocol Non-compliance|0|||
146519552|NCT00382109|528409419|FG000|Overall Study|Adverse Event|3|||
146519553|NCT00382109|528409420|FG001|Overall Study|Adverse Event|0|||
146519554|NCT00382109|528409419|FG000|Overall Study|Physician Decision|6|||
146519555|NCT00382109|528409420|FG001|Overall Study|Physician Decision|1|||
146519556|NCT00382109|528409419|FG000|Overall Study|Withdrawal by Subject|1|||
146519557|NCT00382109|528409420|FG001|Overall Study|Withdrawal by Subject|0|||
146519558|NCT00382109|528409419|FG000|Overall Study|ineligible|2|||
146519559|NCT00382109|528409420|FG001|Overall Study|ineligible|0|||
146519560|NCT00382109|528409419|FG000|Overall Study|Other|0|||
146519561|NCT00382109|528409420|FG001|Overall Study|Other|2|||
146519562|NCT00382109|528409419|FG000|Overall Study|consent withdrawal|0|||
146519563|NCT00382109|528409420|FG001|Overall Study|consent withdrawal|1|||
146519564|NCT02717442|528409421|FG000|Overall Study|Study Terminated by Sponsor|31|||
146519565|NCT02717442|528409422|FG001|Overall Study|Study Terminated by Sponsor|29|||
146519566|NCT02717442|528409421|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
146519567|NCT02717442|528409422|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
146519568|NCT02717442|528409421|FG000|Overall Study|Other - Not Specified|2|||
146756390|NCT01657682|529273293|FG002|Overall Study|Withdrawal by Subject|1|||
146756391|NCT01657682|529273291|FG000|Overall Study|Adverse Event|0|||
146756392|NCT01657682|529273292|FG001|Overall Study|Adverse Event|1|||
146756393|NCT01657682|529273293|FG002|Overall Study|Adverse Event|0|||
146756394|NCT01719861|529273295|FG000|Cycle 1|Death|4|||
146519569|NCT02717442|528409422|FG001|Overall Study|Other - Not Specified|0|||
146519570|NCT05052697|528409423|FG000|Substudy A|Lost to Follow-up|0|||
146519571|NCT05052697|528409424|FG001|Substudy A|Lost to Follow-up|0|||
146519572|NCT05052697|528409425|FG002|Substudy A|Lost to Follow-up|0|||
146519573|NCT05052697|528409426|FG003|Substudy A|Lost to Follow-up|0|||
146519574|NCT05052697|528409427|FG004|Substudy A|Lost to Follow-up|0|||
146519575|NCT05052697|528409428|FG005|Substudy A|Lost to Follow-up|1|||
146519576|NCT05052697|528409429|FG006|Substudy A|Lost to Follow-up|0|||
146519577|NCT05052697|528409430|FG007|Substudy A|Lost to Follow-up|0|||
146519578|NCT05052697|528409431|FG008|Substudy A|Lost to Follow-up|0|||
146519579|NCT05052697|528409432|FG009|Substudy A|Lost to Follow-up|0|||
146519580|NCT05052697|528409433|FG010|Substudy A|Lost to Follow-up|0|||
146519581|NCT05052697|528409434|FG011|Substudy A|Lost to Follow-up|0|||
146519582|NCT05052697|528409435|FG012|Substudy A|Lost to Follow-up|0|||
146519583|NCT05052697|528409436|FG013|Substudy A|Lost to Follow-up|0|||
146519584|NCT05052697|528409437|FG014|Substudy A|Lost to Follow-up|0|||
146519585|NCT05052697|528409438|FG015|Substudy A|Lost to Follow-up|2|||
146519586|NCT05052697|528409439|FG016|Substudy A|Lost to Follow-up|0|||
146519587|NCT05052697|528409440|FG017|Substudy A|Lost to Follow-up|0|||
146519588|NCT05052697|528409441|FG018|Substudy A|Lost to Follow-up|0|||
146519589|NCT05052697|528409442|FG019|Substudy A|Lost to Follow-up|0|||
146519590|NCT05052697|528409443|FG020|Substudy A|Lost to Follow-up|0|||
146519591|NCT05052697|528409444|FG021|Substudy A|Lost to Follow-up|0|||
146519592|NCT05052697|528409445|FG022|Substudy A|Lost to Follow-up|0|||
146519593|NCT05052697|528409446|FG023|Substudy A|Lost to Follow-up|0|||
146519594|NCT05052697|528409447|FG024|Substudy A|Lost to Follow-up|0|||
146519595|NCT05052697|528409448|FG025|Substudy A|Lost to Follow-up|0|||
146519596|NCT05052697|528409449|FG026|Substudy A|Lost to Follow-up|0|||
146519597|NCT05052697|528409450|FG027|Substudy A|Lost to Follow-up|0|||
146519598|NCT05052697|528409451|FG028|Substudy A|Lost to Follow-up|0|||
146519599|NCT05052697|528409452|FG029|Substudy A|Lost to Follow-up|0|||
146519600|NCT05052697|528409453|FG030|Substudy A|Lost to Follow-up|0|||
146519601|NCT05052697|528409454|FG031|Substudy A|Lost to Follow-up|0|||
146519602|NCT05052697|528409455|FG032|Substudy A|Lost to Follow-up|0|||
146519603|NCT05052697|528409456|FG033|Substudy A|Lost to Follow-up|0|||
146519604|NCT05052697|528409423|FG000|Substudy A|No longer met eligibility criteria|0|||
146519605|NCT05052697|528409424|FG001|Substudy A|No longer met eligibility criteria|0|||
146519606|NCT05052697|528409425|FG002|Substudy A|No longer met eligibility criteria|0|||
146519607|NCT05052697|528409426|FG003|Substudy A|No longer met eligibility criteria|0|||
146519608|NCT05052697|528409427|FG004|Substudy A|No longer met eligibility criteria|0|||
146519609|NCT05052697|528409428|FG005|Substudy A|No longer met eligibility criteria|0|||
146519610|NCT05052697|528409429|FG006|Substudy A|No longer met eligibility criteria|0|||
146519611|NCT05052697|528409430|FG007|Substudy A|No longer met eligibility criteria|0|||
146519612|NCT05052697|528409431|FG008|Substudy A|No longer met eligibility criteria|0|||
146519613|NCT05052697|528409432|FG009|Substudy A|No longer met eligibility criteria|0|||
146519614|NCT05052697|528409433|FG010|Substudy A|No longer met eligibility criteria|0|||
146519615|NCT05052697|528409434|FG011|Substudy A|No longer met eligibility criteria|0|||
146519616|NCT05052697|528409435|FG012|Substudy A|No longer met eligibility criteria|0|||
146519617|NCT05052697|528409436|FG013|Substudy A|No longer met eligibility criteria|1|||
146519618|NCT05052697|528409437|FG014|Substudy A|No longer met eligibility criteria|0|||
146519619|NCT05052697|528409438|FG015|Substudy A|No longer met eligibility criteria|0|||
146519620|NCT05052697|528409439|FG016|Substudy A|No longer met eligibility criteria|0|||
146519621|NCT05052697|528409440|FG017|Substudy A|No longer met eligibility criteria|0|||
146519622|NCT05052697|528409441|FG018|Substudy A|No longer met eligibility criteria|0|||
146519623|NCT05052697|528409442|FG019|Substudy A|No longer met eligibility criteria|0|||
146519624|NCT05052697|528409443|FG020|Substudy A|No longer met eligibility criteria|0|||
146519625|NCT05052697|528409444|FG021|Substudy A|No longer met eligibility criteria|0|||
146519626|NCT05052697|528409445|FG022|Substudy A|No longer met eligibility criteria|0|||
146519627|NCT05052697|528409446|FG023|Substudy A|No longer met eligibility criteria|0|||
146519628|NCT05052697|528409447|FG024|Substudy A|No longer met eligibility criteria|0|||
146519629|NCT05052697|528409448|FG025|Substudy A|No longer met eligibility criteria|0|||
146519630|NCT05052697|528409449|FG026|Substudy A|No longer met eligibility criteria|0|||
146519631|NCT05052697|528409450|FG027|Substudy A|No longer met eligibility criteria|0|||
146519632|NCT05052697|528409451|FG028|Substudy A|No longer met eligibility criteria|0|||
146519633|NCT05052697|528409452|FG029|Substudy A|No longer met eligibility criteria|0|||
146519634|NCT05052697|528409453|FG030|Substudy A|No longer met eligibility criteria|0|||
146519635|NCT05052697|528409454|FG031|Substudy A|No longer met eligibility criteria|0|||
146519636|NCT05052697|528409455|FG032|Substudy A|No longer met eligibility criteria|0|||
146519637|NCT05052697|528409456|FG033|Substudy A|No longer met eligibility criteria|0|||
146519638|NCT05052697|528409423|FG000|Substudy A|Not vaccinated|0|||
146519639|NCT05052697|528409424|FG001|Substudy A|Not vaccinated|0|||
146519640|NCT05052697|528409425|FG002|Substudy A|Not vaccinated|0|||
146519641|NCT05052697|528409426|FG003|Substudy A|Not vaccinated|1|||
146519642|NCT05052697|528409427|FG004|Substudy A|Not vaccinated|0|||
146519643|NCT05052697|528409428|FG005|Substudy A|Not vaccinated|0|||
146519644|NCT05052697|528409429|FG006|Substudy A|Not vaccinated|0|||
146519645|NCT05052697|528409430|FG007|Substudy A|Not vaccinated|0|||
146519646|NCT05052697|528409431|FG008|Substudy A|Not vaccinated|1|||
146519647|NCT05052697|528409432|FG009|Substudy A|Not vaccinated|0|||
146519648|NCT05052697|528409433|FG010|Substudy A|Not vaccinated|0|||
146519649|NCT05052697|528409434|FG011|Substudy A|Not vaccinated|0|||
146519650|NCT05052697|528409435|FG012|Substudy A|Not vaccinated|0|||
146519651|NCT05052697|528409436|FG013|Substudy A|Not vaccinated|0|||
146519652|NCT05052697|528409437|FG014|Substudy A|Not vaccinated|0|||
146519653|NCT05052697|528409438|FG015|Substudy A|Not vaccinated|0|||
146519654|NCT05052697|528409439|FG016|Substudy A|Not vaccinated|0|||
146519655|NCT05052697|528409440|FG017|Substudy A|Not vaccinated|0|||
146519656|NCT05052697|528409441|FG018|Substudy A|Not vaccinated|0|||
146519657|NCT05052697|528409442|FG019|Substudy A|Not vaccinated|0|||
146519658|NCT05052697|528409443|FG020|Substudy A|Not vaccinated|0|||
146519659|NCT05052697|528409444|FG021|Substudy A|Not vaccinated|0|||
146519660|NCT05052697|528409445|FG022|Substudy A|Not vaccinated|0|||
146519661|NCT05052697|528409446|FG023|Substudy A|Not vaccinated|0|||
146519662|NCT05052697|528409447|FG024|Substudy A|Not vaccinated|0|||
146519663|NCT05052697|528409448|FG025|Substudy A|Not vaccinated|0|||
146519664|NCT05052697|528409449|FG026|Substudy A|Not vaccinated|0|||
146519665|NCT05052697|528409450|FG027|Substudy A|Not vaccinated|0|||
146519666|NCT05052697|528409451|FG028|Substudy A|Not vaccinated|0|||
146519667|NCT05052697|528409452|FG029|Substudy A|Not vaccinated|0|||
146519668|NCT05052697|528409453|FG030|Substudy A|Not vaccinated|0|||
146519669|NCT05052697|528409454|FG031|Substudy A|Not vaccinated|0|||
146519670|NCT05052697|528409455|FG032|Substudy A|Not vaccinated|0|||
146519671|NCT05052697|528409456|FG033|Substudy A|Not vaccinated|0|||
146519672|NCT05052697|528409423|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519673|NCT05052697|528409424|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519674|NCT05052697|528409425|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519675|NCT05052697|528409426|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519676|NCT05052697|528409427|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519677|NCT05052697|528409428|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519678|NCT05052697|528409429|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519679|NCT05052697|528409430|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519680|NCT05052697|528409431|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519681|NCT05052697|528409432|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519682|NCT05052697|528409433|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519683|NCT05052697|528409434|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519684|NCT05052697|528409435|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519685|NCT05052697|528409436|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519686|NCT05052697|528409437|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519687|NCT05052697|528409438|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519688|NCT05052697|528409439|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519689|NCT05052697|528409440|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519690|NCT05052697|528409441|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
146519691|NCT05052697|528409442|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
146519692|NCT05052697|528409443|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519693|NCT05052697|528409444|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
146519694|NCT05052697|528409445|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
146519695|NCT05052697|528409446|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519696|NCT05052697|528409447|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519697|NCT05052697|528409448|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519698|NCT05052697|528409449|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519699|NCT05052697|528409450|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519700|NCT05052697|528409451|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519701|NCT05052697|528409452|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519702|NCT05052697|528409453|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519703|NCT05052697|528409454|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519704|NCT05052697|528409455|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519705|NCT05052697|528409456|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146519706|NCT05052697|528409423|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519707|NCT05052697|528409424|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519708|NCT05052697|528409425|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519709|NCT05052697|528409426|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519710|NCT05052697|528409427|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519711|NCT05052697|528409428|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519712|NCT05052697|528409429|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519713|NCT05052697|528409430|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519714|NCT05052697|528409431|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519715|NCT05052697|528409432|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519716|NCT05052697|528409433|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519717|NCT05052697|528409434|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519718|NCT05052697|528409435|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519719|NCT05052697|528409436|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519720|NCT05052697|528409437|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519721|NCT05052697|528409438|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519722|NCT05052697|528409439|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519723|NCT05052697|528409440|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
146519724|NCT05052697|528409441|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519725|NCT05052697|528409442|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519726|NCT05052697|528409443|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519727|NCT05052697|528409444|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519728|NCT05052697|528409445|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519729|NCT05052697|528409446|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519730|NCT05052697|528409447|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519731|NCT05052697|528409448|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519732|NCT05052697|528409449|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519733|NCT05052697|528409450|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519734|NCT05052697|528409451|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519735|NCT05052697|528409452|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519736|NCT05052697|528409453|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519737|NCT05052697|528409454|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519738|NCT05052697|528409455|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519739|NCT05052697|528409456|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
146519740|NCT05052697|528409423|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519741|NCT05052697|528409424|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519742|NCT05052697|528409425|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519743|NCT05052697|528409426|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519744|NCT05052697|528409427|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519745|NCT05052697|528409428|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519746|NCT05052697|528409429|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519747|NCT05052697|528409430|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519748|NCT05052697|528409431|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519749|NCT05052697|528409432|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519750|NCT05052697|528409433|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519751|NCT05052697|528409434|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519752|NCT05052697|528409435|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519753|NCT05052697|528409436|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519754|NCT05052697|528409437|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519755|NCT05052697|528409438|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519756|NCT05052697|528409439|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519757|NCT05052697|528409440|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519758|NCT05052697|528409441|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519759|NCT05052697|528409442|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
146519760|NCT05052697|528409443|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519761|NCT05052697|528409444|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519762|NCT05052697|528409445|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519763|NCT05052697|528409446|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519764|NCT05052697|528409447|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519765|NCT05052697|528409448|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519766|NCT05052697|528409449|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519767|NCT05052697|528409450|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519768|NCT05052697|528409451|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519769|NCT05052697|528409452|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519770|NCT05052697|528409453|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519771|NCT05052697|528409454|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519772|NCT05052697|528409455|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519773|NCT05052697|528409456|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
146519774|NCT05052697|528409423|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519775|NCT05052697|528409424|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519776|NCT05052697|528409425|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519777|NCT05052697|528409426|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519778|NCT05052697|528409427|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519779|NCT05052697|528409428|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519780|NCT05052697|528409429|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519781|NCT05052697|528409430|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519782|NCT05052697|528409431|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519783|NCT05052697|528409432|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519784|NCT05052697|528409433|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519785|NCT05052697|528409434|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519786|NCT05052697|528409435|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519787|NCT05052697|528409436|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519788|NCT05052697|528409437|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519789|NCT05052697|528409438|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519790|NCT05052697|528409439|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519791|NCT05052697|528409440|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
146519792|NCT05052697|528409441|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519793|NCT05052697|528409442|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519794|NCT05052697|528409443|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519795|NCT05052697|528409444|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519796|NCT05052697|528409445|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519797|NCT05052697|528409446|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519798|NCT05052697|528409447|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519799|NCT05052697|528409448|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
146519800|NCT05052697|528409449|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519801|NCT05052697|528409450|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
146519802|NCT05052697|528409451|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146625256|NCT03037385|528803851|FG006|Overall Study|Initiation of Another Therapy|0|||
146853622|NCT01370590|529633717|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
146519803|NCT05052697|528409452|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519804|NCT05052697|528409453|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519805|NCT05052697|528409454|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519806|NCT05052697|528409455|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519807|NCT05052697|528409456|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146519808|NCT05052697|528409423|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519809|NCT05052697|528409424|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519810|NCT05052697|528409425|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519811|NCT05052697|528409426|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519812|NCT05052697|528409427|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519813|NCT05052697|528409428|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519814|NCT05052697|528409429|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519815|NCT05052697|528409430|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519816|NCT05052697|528409431|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519817|NCT05052697|528409432|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519818|NCT05052697|528409433|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519819|NCT05052697|528409434|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519820|NCT05052697|528409435|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519821|NCT05052697|528409436|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519822|NCT05052697|528409437|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519823|NCT05052697|528409438|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519824|NCT05052697|528409439|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519825|NCT05052697|528409440|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519826|NCT05052697|528409441|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519827|NCT05052697|528409442|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519828|NCT05052697|528409443|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519829|NCT05052697|528409444|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519830|NCT05052697|528409445|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519831|NCT05052697|528409446|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519832|NCT05052697|528409447|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519833|NCT05052697|528409448|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519834|NCT05052697|528409449|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519835|NCT05052697|528409450|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519836|NCT05052697|528409451|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
146519837|NCT05052697|528409452|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519838|NCT05052697|528409453|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
146519839|NCT05052697|528409454|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
146519840|NCT05052697|528409455|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
146519841|NCT05052697|528409456|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146519842|NCT05052697|528409423|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519843|NCT05052697|528409424|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519844|NCT05052697|528409425|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519845|NCT05052697|528409426|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519846|NCT05052697|528409427|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519847|NCT05052697|528409428|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519848|NCT05052697|528409429|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519849|NCT05052697|528409430|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519850|NCT05052697|528409431|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519851|NCT05052697|528409432|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519852|NCT05052697|528409433|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519853|NCT05052697|528409434|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519854|NCT05052697|528409435|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519855|NCT05052697|528409436|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519856|NCT05052697|528409437|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519857|NCT05052697|528409438|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519858|NCT05052697|528409439|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519859|NCT05052697|528409440|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519860|NCT05052697|528409441|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519861|NCT05052697|528409442|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519862|NCT05052697|528409443|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519863|NCT05052697|528409444|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519864|NCT05052697|528409445|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519865|NCT05052697|528409446|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519866|NCT05052697|528409447|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519867|NCT05052697|528409448|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519868|NCT05052697|528409449|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519869|NCT05052697|528409450|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519870|NCT05052697|528409451|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
146519871|NCT05052697|528409452|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
146519872|NCT05052697|528409453|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
146519873|NCT05052697|528409454|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
146519874|NCT05052697|528409455|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
146519875|NCT05052697|528409456|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
146519876|NCT05052697|528409423|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519877|NCT05052697|528409424|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519878|NCT05052697|528409425|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519879|NCT05052697|528409426|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519880|NCT05052697|528409427|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519881|NCT05052697|528409428|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519882|NCT05052697|528409429|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519883|NCT05052697|528409430|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519884|NCT05052697|528409431|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519885|NCT05052697|528409432|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519886|NCT05052697|528409433|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519887|NCT05052697|528409434|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519888|NCT05052697|528409435|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519889|NCT05052697|528409436|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519890|NCT05052697|528409437|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519891|NCT05052697|528409438|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519892|NCT05052697|528409439|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519893|NCT05052697|528409440|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519894|NCT05052697|528409441|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519895|NCT05052697|528409442|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519896|NCT05052697|528409443|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519897|NCT05052697|528409444|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519898|NCT05052697|528409445|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519899|NCT05052697|528409446|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519900|NCT05052697|528409447|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519901|NCT05052697|528409448|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519902|NCT05052697|528409449|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519903|NCT05052697|528409450|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519904|NCT05052697|528409451|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519905|NCT05052697|528409452|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519906|NCT05052697|528409453|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519907|NCT05052697|528409454|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519908|NCT05052697|528409455|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
146519909|NCT05052697|528409456|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146519910|NCT05052697|528409423|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519911|NCT05052697|528409424|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519912|NCT05052697|528409425|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519913|NCT05052697|528409426|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519914|NCT05052697|528409427|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519915|NCT05052697|528409428|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519916|NCT05052697|528409429|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519917|NCT05052697|528409430|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519918|NCT05052697|528409431|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519919|NCT05052697|528409432|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519920|NCT05052697|528409433|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519921|NCT05052697|528409434|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519922|NCT05052697|528409435|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519923|NCT05052697|528409436|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519924|NCT05052697|528409437|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519925|NCT05052697|528409438|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519926|NCT05052697|528409439|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519927|NCT05052697|528409440|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519928|NCT05052697|528409441|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519929|NCT05052697|528409442|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519930|NCT05052697|528409443|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519931|NCT05052697|528409444|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519932|NCT05052697|528409445|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519933|NCT05052697|528409446|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519934|NCT05052697|528409447|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519935|NCT05052697|528409448|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146756395|NCT01719861|529273295|FG000|Cycle 2|Death|1|||
146519936|NCT05052697|528409449|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519937|NCT05052697|528409450|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519938|NCT05052697|528409451|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
146519939|NCT05052697|528409452|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
146519940|NCT05052697|528409453|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
146519941|NCT05052697|528409454|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519942|NCT05052697|528409455|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519943|NCT05052697|528409456|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146519944|NCT00248833|528409457|FG000|Overall Study|Adverse Event|2|||
146519945|NCT00248833|528409458|FG001|Overall Study|Adverse Event|0|||
146519946|NCT00248833|528409459|FG002|Overall Study|Adverse Event|0|||
146519947|NCT00248833|528409457|FG000|Overall Study|Withdrawal by Subject|0|||
146519948|NCT00248833|528409458|FG001|Overall Study|Withdrawal by Subject|1|||
146519949|NCT00248833|528409459|FG002|Overall Study|Withdrawal by Subject|1|||
146519950|NCT00248833|528409457|FG000|Overall Study|Lost to Follow-up|1|||
146519951|NCT00248833|528409458|FG001|Overall Study|Lost to Follow-up|1|||
146519952|NCT00248833|528409459|FG002|Overall Study|Lost to Follow-up|1|||
146519953|NCT00248833|528409457|FG000|Overall Study|Other|0|||
146519954|NCT00248833|528409458|FG001|Overall Study|Other|1|||
146519955|NCT00248833|528409459|FG002|Overall Study|Other|0|||
146519956|NCT02772809|528409460|FG000|Overall Study|not completed some tasks|6|||
146519957|NCT00534105|528409463|FG000|Overall Study|Lost to Follow-up|23|||
146853623|NCT01370590|529633718|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
146853624|NCT01370590|529633717|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
146853625|NCT01370590|529633718|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
146853626|NCT01370590|529633717|FG000|Period 2|Adverse Event|0|||
146519958|NCT00534105|528409464|FG001|Overall Study|Lost to Follow-up|39|||
146519959|NCT00978341|528409465|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
146519960|NCT00978341|528409466|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
146519961|NCT03035916|528409467|FG000|Overall Study|Puncture failed|0|||
146519962|NCT03035916|528409468|FG001|Overall Study|Puncture failed|2|||
146519963|NCT03035916|528409469|FG002|Overall Study|Puncture failed|0|||
146519964|NCT01451554|528409470|FG000|Overall Study|Withdrawal by Subject|14|||
146519965|NCT01451554|528409471|FG001|Overall Study|Withdrawal by Subject|9|||
146519966|NCT01402986|528409472|FG000|Overall Study|Withdrawal by Subject|7|||
146519967|NCT01402986|528409473|FG001|Overall Study|Withdrawal by Subject|10|||
146519968|NCT01402986|528409474|FG002|Overall Study|Withdrawal by Subject|7|||
146519969|NCT01402986|528409475|FG003|Overall Study|Withdrawal by Subject|13|||
146519970|NCT01402986|528409472|FG000|Overall Study|Death|0|||
146519971|NCT01402986|528409473|FG001|Overall Study|Death|0|||
146519972|NCT01402986|528409474|FG002|Overall Study|Death|0|||
146519973|NCT01402986|528409475|FG003|Overall Study|Death|2|||
146519974|NCT01402986|528409472|FG000|Overall Study|Lost to Follow-up|0|||
146519975|NCT01402986|528409473|FG001|Overall Study|Lost to Follow-up|0|||
146519976|NCT01402986|528409474|FG002|Overall Study|Lost to Follow-up|0|||
146519977|NCT01402986|528409475|FG003|Overall Study|Lost to Follow-up|1|||
146519978|NCT01402986|528409472|FG000|Overall Study|Other|2|||
146519979|NCT01402986|528409473|FG001|Overall Study|Other|5|||
146519980|NCT01402986|528409474|FG002|Overall Study|Other|1|||
146519981|NCT01402986|528409475|FG003|Overall Study|Other|6|||
146519982|NCT02427802|528409476|FG000|Overall Study|Adverse Event|11|||
146519983|NCT02427802|528409477|FG001|Overall Study|Adverse Event|3|||
146519984|NCT02427802|528409478|FG002|Overall Study|Adverse Event|7|||
146519985|NCT02427802|528409476|FG000|Overall Study|Death|0|||
146519986|NCT02427802|528409477|FG001|Overall Study|Death|4|||
146519987|NCT02427802|528409478|FG002|Overall Study|Death|1|||
146519988|NCT02427802|528409476|FG000|Overall Study|Lost to Follow-up|13|||
146519989|NCT02427802|528409477|FG001|Overall Study|Lost to Follow-up|8|||
146519990|NCT02427802|528409478|FG002|Overall Study|Lost to Follow-up|8|||
146519991|NCT02427802|528409476|FG000|Overall Study|Physician Decision|4|||
146519992|NCT02427802|528409477|FG001|Overall Study|Physician Decision|2|||
146519993|NCT02427802|528409478|FG002|Overall Study|Physician Decision|4|||
146519994|NCT02427802|528409476|FG000|Overall Study|Withdrawal by Subject|10|||
146519995|NCT02427802|528409477|FG001|Overall Study|Withdrawal by Subject|5|||
146519996|NCT02427802|528409478|FG002|Overall Study|Withdrawal by Subject|11|||
146519997|NCT02427802|528409476|FG000|Overall Study|Protocol Violation|3|||
146519998|NCT02427802|528409477|FG001|Overall Study|Protocol Violation|1|||
146519999|NCT02427802|528409478|FG002|Overall Study|Protocol Violation|1|||
146520000|NCT02427802|528409476|FG000|Overall Study|protocol specific treatment unrelated|18|||
146520001|NCT02427802|528409477|FG001|Overall Study|protocol specific treatment unrelated|11|||
146520002|NCT02427802|528409478|FG002|Overall Study|protocol specific treatment unrelated|11|||
146520003|NCT02634983|528409479|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
146520004|NCT02634983|528409480|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
146520005|NCT03178851|528409481|FG000|Overall Study|Death|48|||
146520006|NCT03178851|528409482|FG001|Overall Study|Death|2|||
146520007|NCT03178851|528409483|FG002|Overall Study|Death|25|||
146520008|NCT03178851|528409481|FG000|Overall Study|Withdrawal by Subject|8|||
146520009|NCT03178851|528409482|FG001|Overall Study|Withdrawal by Subject|0|||
146520010|NCT03178851|528409483|FG002|Overall Study|Withdrawal by Subject|0|||
146520011|NCT03178851|528409481|FG000|Overall Study|Lost to Follow-up|5|||
146520012|NCT03178851|528409482|FG001|Overall Study|Lost to Follow-up|2|||
146520013|NCT03178851|528409483|FG002|Overall Study|Lost to Follow-up|0|||
146520014|NCT03178851|528409481|FG000|Overall Study|Adverse Event|0|||
146520015|NCT03178851|528409482|FG001|Overall Study|Adverse Event|0|||
146520016|NCT03178851|528409483|FG002|Overall Study|Adverse Event|1|||
146520017|NCT03178851|528409481|FG000|Overall Study|Study Termination by Sponsor|31|||
146520018|NCT03178851|528409482|FG001|Overall Study|Study Termination by Sponsor|7|||
146520019|NCT03178851|528409483|FG002|Overall Study|Study Termination by Sponsor|26|||
146520020|NCT02226120|528409484|FG000|Overall Study|Adverse Event|60|||
146520021|NCT02226120|528409484|FG000|Overall Study|Death|172|||
146520022|NCT02226120|528409484|FG000|Overall Study|Study terminated by sponsor|1|||
146520023|NCT02226120|528409484|FG000|Overall Study|Technical problems|4|||
146520024|NCT02226120|528409484|FG000|Overall Study|Lost to Follow-up|13|||
146520025|NCT02226120|528409484|FG000|Overall Study|Physician Decision|21|||
146520026|NCT02226120|528409484|FG000|Overall Study|Withdrawal by parent/guardian|36|||
146520027|NCT02226120|528409484|FG000|Overall Study|Non-compliance with study drug|10|||
146520028|NCT02226120|528409484|FG000|Overall Study|Protocol deviation|1|||
146520029|NCT02226120|528409484|FG000|Overall Study|missing treatment disposition pages|2|||
146520030|NCT03396822|528411573|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
146520031|NCT03396822|528411573|FG000|Overall Study|Physician Decision|1|||
146520032|NCT02849704|528411576|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
146520033|NCT02849704|528411577|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
146520034|NCT02849704|528411576|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
146520035|NCT02849704|528411577|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
146520036|NCT02849704|528411576|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
146520037|NCT02849704|528411577|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
146520038|NCT03251482|528411578|FG000|Overall Study|Withdrawal by Subject|0|||
146520039|NCT03251482|528411579|FG001|Overall Study|Withdrawal by Subject|1|||
146520040|NCT03251482|528411580|FG002|Overall Study|Withdrawal by Subject|0|||
146520041|NCT03251482|528411581|FG003|Overall Study|Withdrawal by Subject|0|||
146520042|NCT03251482|528411582|FG004|Overall Study|Withdrawal by Subject|0|||
146520043|NCT02447328|528411585|FG000|Overall Study|Withdrawal by Subject|1|||
146520044|NCT04336475|528411592|FG000|Overall Study|pain|1|||
146520045|NCT04336475|528411593|FG001|Overall Study|pain|0|||
146520046|NCT04336475|528411592|FG000|Overall Study|upper respiratory infection|1|||
146520047|NCT04336475|528411593|FG001|Overall Study|upper respiratory infection|0|||
146520048|NCT04336475|528411592|FG000|Overall Study|Lost to Follow-up|0|||
146520049|NCT04336475|528411593|FG001|Overall Study|Lost to Follow-up|2|||
146520050|NCT01990573|528411598|FG000|Overall Study|Physician Decision|0|||
146520051|NCT01990573|528411599|FG001|Overall Study|Physician Decision|0|||
146520052|NCT01990573|528411600|FG002|Overall Study|Physician Decision|1|||
146520053|NCT01763827|528411609|FG000|Overall Study|Withdrawal by Subject|1|||
146520054|NCT01763827|528411610|FG001|Overall Study|Withdrawal by Subject|0|||
146520055|NCT01763827|528411611|FG002|Overall Study|Withdrawal by Subject|0|||
146520056|NCT01763827|528411612|FG003|Overall Study|Withdrawal by Subject|0|||
146520057|NCT01763827|528411613|FG004|Overall Study|Withdrawal by Subject|2|||
146520058|NCT01763827|528411614|FG005|Overall Study|Withdrawal by Subject|0|||
146520059|NCT01763827|528411609|FG000|Overall Study|Decision by sponsor|2|||
146520060|NCT01763827|528411610|FG001|Overall Study|Decision by sponsor|0|||
146520061|NCT01763827|528411611|FG002|Overall Study|Decision by sponsor|3|||
146520062|NCT01763827|528411612|FG003|Overall Study|Decision by sponsor|0|||
146520063|NCT01763827|528411613|FG004|Overall Study|Decision by sponsor|2|||
146520064|NCT01763827|528411614|FG005|Overall Study|Decision by sponsor|1|||
146520065|NCT01763827|528411609|FG000|Overall Study|Lost to Follow-up|0|||
146520066|NCT01763827|528411610|FG001|Overall Study|Lost to Follow-up|1|||
146520067|NCT01763827|528411611|FG002|Overall Study|Lost to Follow-up|1|||
146520068|NCT01763827|528411612|FG003|Overall Study|Lost to Follow-up|1|||
146520069|NCT01763827|528411613|FG004|Overall Study|Lost to Follow-up|2|||
146520070|NCT01763827|528411614|FG005|Overall Study|Lost to Follow-up|1|||
146520071|NCT02906579|528411615|FG000|Overall Study|Adverse Event|1|||
146520072|NCT02906579|528411615|FG000|Overall Study|Physician Decision|1|||
146520073|NCT02030119|528411616|FG000|Overall Study|Withdrawal by Subject|3|||
146520074|NCT02030119|528411617|FG001|Overall Study|Withdrawal by Subject|1|||
146853627|NCT01370590|529633718|FG001|Period 2|Adverse Event|1|||
146520075|NCT02030119|528411618|FG002|Overall Study|Withdrawal by Subject|5|||
146520076|NCT02030119|528411619|FG003|Overall Study|Withdrawal by Subject|3|||
146520077|NCT02030119|528411616|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
146520078|NCT02030119|528411617|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
146520079|NCT02030119|528411618|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
146520080|NCT02030119|528411619|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
146520081|NCT00759655|528411620|FG000|Overall Study|Termination of the study by sponsor|1|||
146520082|NCT00412932|528411623|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
146520083|NCT00412932|528411623|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
146520084|NCT00412932|528411623|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
146520085|NCT00412932|528411623|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
146520086|NCT00412932|528411623|FG000|Olmesartan (Olm) 20 mg|Other|1|||
146520087|NCT00412932|528411623|FG000|Olmesartan 40 mg|Adverse Event|4|||
146520088|NCT00412932|528411623|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
146520089|NCT00412932|528411623|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
146520090|NCT00412932|528411623|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
146520091|NCT00412932|528411623|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
146520092|NCT00412932|528411623|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
146520093|NCT00412932|528411623|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
146520094|NCT02259400|528411630|FG000|Overall Study|Death|0|||
146520095|NCT02259400|528411631|FG001|Overall Study|Death|2|||
146520096|NCT03498313|528411633|FG000|Experimental Period 1|Adverse Event|1|||
146520097|NCT03498313|528411634|FG001|Experimental Period 1|Adverse Event|0|||
146520098|NCT03498313|528411635|FG002|Experimental Period 1|Adverse Event|0|||
146520099|NCT03498313|528411636|FG003|Experimental Period 1|Adverse Event|1|||
146520100|NCT03498313|528411637|FG004|Experimental Period 1|Adverse Event|0|||
146520101|NCT03498313|528411638|FG005|Experimental Period 1|Adverse Event|0|||
146520102|NCT03498313|528411633|FG000|Experimental Period 1|Withdrawal by Subject|0|||
146520103|NCT03498313|528411634|FG001|Experimental Period 1|Withdrawal by Subject|1|||
146520104|NCT03498313|528411635|FG002|Experimental Period 1|Withdrawal by Subject|0|||
146520105|NCT03498313|528411636|FG003|Experimental Period 1|Withdrawal by Subject|0|||
146520106|NCT03498313|528411637|FG004|Experimental Period 1|Withdrawal by Subject|0|||
146520107|NCT03498313|528411638|FG005|Experimental Period 1|Withdrawal by Subject|0|||
146520108|NCT03498313|528411633|FG000|Washout Period 1|Anovulation|1|||
146520109|NCT03498313|528411634|FG001|Washout Period 1|Anovulation|0|||
146520110|NCT03498313|528411635|FG002|Washout Period 1|Anovulation|0|||
146520111|NCT03498313|528411636|FG003|Washout Period 1|Anovulation|0|||
146520112|NCT03498313|528411637|FG004|Washout Period 1|Anovulation|0|||
146520113|NCT03498313|528411638|FG005|Washout Period 1|Anovulation|0|||
146520114|NCT03498313|528411633|FG000|Washout Period 1|Withdrawal by Subject|0|||
146520115|NCT03498313|528411634|FG001|Washout Period 1|Withdrawal by Subject|3|||
146520116|NCT03498313|528411635|FG002|Washout Period 1|Withdrawal by Subject|0|||
146520117|NCT03498313|528411636|FG003|Washout Period 1|Withdrawal by Subject|1|||
146520118|NCT03498313|528411637|FG004|Washout Period 1|Withdrawal by Subject|0|||
146520119|NCT03498313|528411638|FG005|Washout Period 1|Withdrawal by Subject|1|||
146520120|NCT03498313|528411633|FG000|Experimental Period 2|Adverse Event|0|||
146520121|NCT03498313|528411634|FG001|Experimental Period 2|Adverse Event|0|||
146520122|NCT03498313|528411635|FG002|Experimental Period 2|Adverse Event|0|||
146520123|NCT03498313|528411636|FG003|Experimental Period 2|Adverse Event|0|||
146520124|NCT03498313|528411637|FG004|Experimental Period 2|Adverse Event|1|||
146520125|NCT03498313|528411638|FG005|Experimental Period 2|Adverse Event|2|||
146520126|NCT03498313|528411633|FG000|Washout Period 2|Physician Decision|1|||
146520127|NCT03498313|528411634|FG001|Washout Period 2|Physician Decision|0|||
146520128|NCT03498313|528411635|FG002|Washout Period 2|Physician Decision|0|||
146520129|NCT03498313|528411636|FG003|Washout Period 2|Physician Decision|1|||
146520130|NCT03498313|528411637|FG004|Washout Period 2|Physician Decision|0|||
146520131|NCT03498313|528411638|FG005|Washout Period 2|Physician Decision|1|||
146520132|NCT03498313|528411633|FG000|Washout Period 2|Withdrawal by Subject|3|||
146520133|NCT03498313|528411634|FG001|Washout Period 2|Withdrawal by Subject|2|||
146520134|NCT03498313|528411635|FG002|Washout Period 2|Withdrawal by Subject|0|||
146520135|NCT03498313|528411636|FG003|Washout Period 2|Withdrawal by Subject|0|||
146520136|NCT03498313|528411637|FG004|Washout Period 2|Withdrawal by Subject|2|||
146520137|NCT03498313|528411638|FG005|Washout Period 2|Withdrawal by Subject|0|||
146520138|NCT03498313|528411633|FG000|Washout Period 2|Anovulation|0|||
146520139|NCT03498313|528411634|FG001|Washout Period 2|Anovulation|0|||
146520140|NCT03498313|528411635|FG002|Washout Period 2|Anovulation|0|||
146520141|NCT03498313|528411636|FG003|Washout Period 2|Anovulation|0|||
146520142|NCT03498313|528411637|FG004|Washout Period 2|Anovulation|0|||
146520143|NCT03498313|528411638|FG005|Washout Period 2|Anovulation|1|||
146520144|NCT02630563|528411639|FG000|Overall Study|Administrative|1|||
146520145|NCT02239640|528411640|FG000|Overall Study|Withdrawal by Subject|3|||
146520146|NCT02239640|528411640|FG000|Overall Study|Lost to Follow-up|72|||
146520147|NCT02239640|528411640|FG000|Overall Study|Death|142|||
146520148|NCT00929994|528411643|FG000|Overall Study|Withdrawal by Subject|1|||
146520149|NCT00929994|528411643|FG000|Overall Study|medical issue unrelated to intervention|4|||
146520150|NCT00929994|528411643|FG000|Overall Study|employment|1|||
146520151|NCT02061813|528411646|FG000|Overall Study|Withdrawal by Subject|1|||
146520152|NCT02061813|528411646|FG000|Overall Study|Protocol Violation|2|||
146520153|NCT00206427|528411647|FG000|Overall Study|Adverse Event|2|||
146520154|NCT00572455|528411648|FG000|Stage I (14 Days)|Adverse Event|0|||
146520155|NCT00572455|528411649|FG001|Stage I (14 Days)|Adverse Event|0|||
146520156|NCT00572455|528411650|FG002|Stage I (14 Days)|Adverse Event|0|||
146520157|NCT00572455|528411651|FG003|Stage I (14 Days)|Adverse Event|0|||
146520158|NCT00572455|528411652|FG004|Stage I (14 Days)|Adverse Event|0|||
146520159|NCT00572455|528411653|FG005|Stage I (14 Days)|Adverse Event|3|||
146520160|NCT00572455|528411654|FG006|Stage I (14 Days)|Adverse Event|0|||
146520161|NCT00572455|528411655|FG007|Stage I (14 Days)|Adverse Event|0|||
146520162|NCT00572455|528411656|FG008|Stage I (14 Days)|Adverse Event|0|||
146520163|NCT00572455|528411657|FG009|Stage I (14 Days)|Adverse Event|0|||
146520164|NCT00572455|528411658|FG010|Stage I (14 Days)|Adverse Event|0|||
146520165|NCT00572455|528411659|FG011|Stage I (14 Days)|Adverse Event|0|||
146520166|NCT00572455|528411660|FG012|Stage I (14 Days)|Adverse Event|0|||
146520167|NCT00572455|528411661|FG013|Stage I (14 Days)|Adverse Event|0|||
146520168|NCT00572455|528411648|FG000|Stage I (14 Days)|Other|0|||
146520169|NCT00572455|528411649|FG001|Stage I (14 Days)|Other|0|||
146520170|NCT00572455|528411650|FG002|Stage I (14 Days)|Other|0|||
146520171|NCT00572455|528411651|FG003|Stage I (14 Days)|Other|0|||
146520172|NCT00572455|528411652|FG004|Stage I (14 Days)|Other|1|||
146520173|NCT00572455|528411653|FG005|Stage I (14 Days)|Other|0|||
146520174|NCT00572455|528411654|FG006|Stage I (14 Days)|Other|0|||
146520175|NCT00572455|528411655|FG007|Stage I (14 Days)|Other|0|||
146520176|NCT00572455|528411656|FG008|Stage I (14 Days)|Other|0|||
146520177|NCT00572455|528411657|FG009|Stage I (14 Days)|Other|0|||
146520178|NCT00572455|528411658|FG010|Stage I (14 Days)|Other|0|||
146520179|NCT00572455|528411659|FG011|Stage I (14 Days)|Other|0|||
146520180|NCT00572455|528411660|FG012|Stage I (14 Days)|Other|0|||
146520181|NCT00572455|528411661|FG013|Stage I (14 Days)|Other|0|||
146520182|NCT00572455|528411648|FG000|Stage II (28 Days)|Adverse Event|0|||
146520183|NCT00572455|528411649|FG001|Stage II (28 Days)|Adverse Event|0|||
146520184|NCT00572455|528411650|FG002|Stage II (28 Days)|Adverse Event|0|||
146520185|NCT00572455|528411651|FG003|Stage II (28 Days)|Adverse Event|0|||
146520186|NCT00572455|528411652|FG004|Stage II (28 Days)|Adverse Event|0|||
146520187|NCT00572455|528411653|FG005|Stage II (28 Days)|Adverse Event|0|||
146520188|NCT00572455|528411654|FG006|Stage II (28 Days)|Adverse Event|0|||
146520189|NCT00572455|528411655|FG007|Stage II (28 Days)|Adverse Event|0|||
146520190|NCT00572455|528411656|FG008|Stage II (28 Days)|Adverse Event|1|||
146520191|NCT00572455|528411657|FG009|Stage II (28 Days)|Adverse Event|3|||
146520192|NCT00572455|528411658|FG010|Stage II (28 Days)|Adverse Event|3|||
146520193|NCT00572455|528411659|FG011|Stage II (28 Days)|Adverse Event|4|||
146520194|NCT00572455|528411660|FG012|Stage II (28 Days)|Adverse Event|5|||
146520195|NCT00572455|528411661|FG013|Stage II (28 Days)|Adverse Event|1|||
146520196|NCT00572455|528411648|FG000|Stage II (28 Days)|Death|0|||
146520197|NCT00572455|528411649|FG001|Stage II (28 Days)|Death|0|||
146520198|NCT00572455|528411650|FG002|Stage II (28 Days)|Death|0|||
146520199|NCT00572455|528411651|FG003|Stage II (28 Days)|Death|0|||
146520200|NCT00572455|528411652|FG004|Stage II (28 Days)|Death|0|||
146520201|NCT00572455|528411653|FG005|Stage II (28 Days)|Death|0|||
146520202|NCT00572455|528411654|FG006|Stage II (28 Days)|Death|0|||
146520203|NCT00572455|528411655|FG007|Stage II (28 Days)|Death|0|||
146520204|NCT00572455|528411656|FG008|Stage II (28 Days)|Death|1|||
146520205|NCT00572455|528411657|FG009|Stage II (28 Days)|Death|0|||
146520206|NCT00572455|528411658|FG010|Stage II (28 Days)|Death|0|||
146520207|NCT00572455|528411659|FG011|Stage II (28 Days)|Death|0|||
146520208|NCT00572455|528411660|FG012|Stage II (28 Days)|Death|0|||
146520209|NCT00572455|528411661|FG013|Stage II (28 Days)|Death|0|||
146520210|NCT00572455|528411648|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
146520211|NCT00572455|528411649|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
146520212|NCT00572455|528411650|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
146520213|NCT00572455|528411651|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
146520214|NCT00572455|528411652|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
146520215|NCT00572455|528411653|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
146520216|NCT00572455|528411654|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
146520217|NCT00572455|528411655|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
146520218|NCT00572455|528411656|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
146520219|NCT00572455|528411657|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
146520220|NCT00572455|528411658|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
146520221|NCT00572455|528411659|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
146520222|NCT00572455|528411660|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
146520223|NCT00572455|528411661|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
146520224|NCT00572455|528411648|FG000|Stage II (28 Days)|Other|0|||
146520225|NCT00572455|528411649|FG001|Stage II (28 Days)|Other|0|||
146520226|NCT00572455|528411650|FG002|Stage II (28 Days)|Other|0|||
146520227|NCT00572455|528411651|FG003|Stage II (28 Days)|Other|0|||
146520228|NCT00572455|528411652|FG004|Stage II (28 Days)|Other|0|||
146520229|NCT00572455|528411653|FG005|Stage II (28 Days)|Other|0|||
146520230|NCT00572455|528411654|FG006|Stage II (28 Days)|Other|0|||
146520231|NCT00572455|528411655|FG007|Stage II (28 Days)|Other|0|||
146520232|NCT00572455|528411656|FG008|Stage II (28 Days)|Other|1|||
146520233|NCT00572455|528411657|FG009|Stage II (28 Days)|Other|0|||
146520234|NCT00572455|528411658|FG010|Stage II (28 Days)|Other|0|||
146520235|NCT00572455|528411659|FG011|Stage II (28 Days)|Other|0|||
146520236|NCT00572455|528411660|FG012|Stage II (28 Days)|Other|0|||
146520237|NCT00572455|528411661|FG013|Stage II (28 Days)|Other|0|||
146520238|NCT00572455|528411648|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
146520239|NCT00572455|528411649|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
146520240|NCT00572455|528411650|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
146520241|NCT00572455|528411651|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
146520242|NCT00572455|528411652|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
146520243|NCT00572455|528411653|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
146520244|NCT00572455|528411654|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
146520245|NCT00572455|528411655|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
146520246|NCT00572455|528411656|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
146520247|NCT00572455|528411657|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
146520248|NCT00572455|528411658|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
146520249|NCT00572455|528411659|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
146520250|NCT00572455|528411660|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
146520251|NCT00572455|528411661|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
146520252|NCT00313586|528411662|FG000|Overall Study|Disease progression|14|||
146520253|NCT00313586|528411663|FG001|Overall Study|Disease progression|19|||
146520254|NCT00313586|528411664|FG002|Overall Study|Disease progression|10|||
146520255|NCT00313586|528411665|FG003|Overall Study|Disease progression|3|||
146520256|NCT00313586|528411662|FG000|Overall Study|Adverse Event|12|||
146520257|NCT00313586|528411663|FG001|Overall Study|Adverse Event|18|||
146520258|NCT00313586|528411664|FG002|Overall Study|Adverse Event|3|||
146520259|NCT00313586|528411665|FG003|Overall Study|Adverse Event|10|||
146520260|NCT00313586|528411662|FG000|Overall Study|Death|11|||
146520261|NCT00313586|528411663|FG001|Overall Study|Death|8|||
146520262|NCT00313586|528411664|FG002|Overall Study|Death|1|||
146520263|NCT00313586|528411665|FG003|Overall Study|Death|7|||
146520264|NCT00313586|528411662|FG000|Overall Study|Withdrawal by Subject|13|||
146520265|NCT00313586|528411663|FG001|Overall Study|Withdrawal by Subject|6|||
146520266|NCT00313586|528411664|FG002|Overall Study|Withdrawal by Subject|6|||
146520267|NCT00313586|528411665|FG003|Overall Study|Withdrawal by Subject|2|||
146520268|NCT00313586|528411662|FG000|Overall Study|Alternative therapy|3|||
146520269|NCT00313586|528411663|FG001|Overall Study|Alternative therapy|6|||
146520270|NCT00313586|528411664|FG002|Overall Study|Alternative therapy|2|||
146520271|NCT00313586|528411665|FG003|Overall Study|Alternative therapy|0|||
146520272|NCT00313586|528411662|FG000|Overall Study|Other complicating disease|2|||
146520273|NCT00313586|528411663|FG001|Overall Study|Other complicating disease|2|||
146520274|NCT00313586|528411664|FG002|Overall Study|Other complicating disease|0|||
146520275|NCT00313586|528411665|FG003|Overall Study|Other complicating disease|0|||
146520276|NCT00313586|528411662|FG000|Overall Study|Did not achieve HI-major/better response|10|||
146520277|NCT00313586|528411663|FG001|Overall Study|Did not achieve HI-major/better response|7|||
146520278|NCT00313586|528411664|FG002|Overall Study|Did not achieve HI-major/better response|2|||
146520279|NCT00313586|528411665|FG003|Overall Study|Did not achieve HI-major/better response|1|||
146520280|NCT00313586|528411662|FG000|Overall Study|Physician Decision|2|||
146520281|NCT00313586|528411663|FG001|Overall Study|Physician Decision|1|||
146520282|NCT00313586|528411664|FG002|Overall Study|Physician Decision|0|||
146520283|NCT00313586|528411665|FG003|Overall Study|Physician Decision|0|||
146625257|NCT03037385|528803852|FG007|Overall Study|Initiation of Another Therapy|1|||
146520284|NCT00313586|528411662|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
146520285|NCT00313586|528411663|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
146520286|NCT00313586|528411664|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
146520287|NCT00313586|528411665|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
146520288|NCT00313586|528411662|FG000|Overall Study|Lost insurance|0|||
146520289|NCT00313586|528411663|FG001|Overall Study|Lost insurance|1|||
146520290|NCT00313586|528411664|FG002|Overall Study|Lost insurance|0|||
146520291|NCT00313586|528411665|FG003|Overall Study|Lost insurance|0|||
146520292|NCT00313586|528411662|FG000|Overall Study|Moved|0|||
146520293|NCT00313586|528411663|FG001|Overall Study|Moved|1|||
146520294|NCT00313586|528411664|FG002|Overall Study|Moved|0|||
146520295|NCT00313586|528411665|FG003|Overall Study|Moved|0|||
146520296|NCT00313586|528411662|FG000|Overall Study|Death before starting treatment|1|||
146520297|NCT00313586|528411663|FG001|Overall Study|Death before starting treatment|0|||
146520298|NCT00313586|528411664|FG002|Overall Study|Death before starting treatment|0|||
146520299|NCT00313586|528411665|FG003|Overall Study|Death before starting treatment|0|||
146520300|NCT02087670|528411666|FG000|Overall Study|Withdrawal by Subject|3|||
146520301|NCT02087670|528411667|FG001|Overall Study|Withdrawal by Subject|2|||
146520302|NCT03519919|528411669|FG000|Overall Study|Withdrawal by Subject|1|||
146520303|NCT03519919|528411669|FG000|Overall Study|Lack of Efficacy|1|||
146520304|NCT03519919|528411669|FG000|Overall Study|Screen Failure|1|||
146520305|NCT03076996|528411670|FG000|Overall Study|Withdrawal by Subject|2|||
146520306|NCT03076996|528411670|FG000|Overall Study|Lost to Follow-up|3|||
146520307|NCT03076996|528411670|FG000|Overall Study|Literacy precluded participation|1|||
146520308|NCT02144077|528411674|FG000|Overall Study|Withdrawal by Subject|3|||
146520309|NCT02144077|528411675|FG001|Overall Study|Withdrawal by Subject|3|||
146520310|NCT02144077|528411674|FG000|Overall Study|Adverse Event|2|||
146520311|NCT02144077|528411675|FG001|Overall Study|Adverse Event|3|||
146520312|NCT02144077|528411674|FG000|Overall Study|Lost to Follow-up|2|||
146520313|NCT02144077|528411675|FG001|Overall Study|Lost to Follow-up|2|||
146520314|NCT02144077|528411674|FG000|Overall Study|Protocol Violation|1|||
146520315|NCT02144077|528411675|FG001|Overall Study|Protocol Violation|2|||
146520316|NCT02144077|528411674|FG000|Overall Study|Death|0|||
146520317|NCT02144077|528411675|FG001|Overall Study|Death|1|||
146520318|NCT02144077|528411674|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
146520319|NCT02144077|528411675|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
146520320|NCT01909973|528411676|FG000|Overall Study|Lost to Follow-up|1|||
146520321|NCT01909973|528411677|FG001|Overall Study|Lost to Follow-up|0|||
146520322|NCT00169104|528411678|FG000|Overall Study|Withdrawal by Subject|2|||
146520323|NCT00169104|528411679|FG001|Overall Study|Withdrawal by Subject|0|||
146520324|NCT00169104|528411678|FG000|Overall Study|Protocol Violation|0|||
146520325|NCT00169104|528411679|FG001|Overall Study|Protocol Violation|1|||
146520326|NCT00169104|528411678|FG000|Overall Study|Physician Decision|0|||
146520327|NCT00169104|528411679|FG001|Overall Study|Physician Decision|1|||
146520328|NCT00715299|528411685|FG000|Overall Study|Withdrawal by Subject|1|||
146520329|NCT00715299|528411685|FG000|Overall Study|Adverse Event|3|||
146520330|NCT00715299|528411685|FG000|Overall Study|failed the pre-screen exercise test|2|||
146520331|NCT02020889|528411686|FG000|Overall Study|Adverse Event|0|||
146520332|NCT02020889|528411687|FG001|Overall Study|Adverse Event|1|||
146520333|NCT02020889|528411686|FG000|Overall Study|Lack of Efficacy|1|||
146520334|NCT02020889|528411687|FG001|Overall Study|Lack of Efficacy|0|||
146520335|NCT02020889|528411686|FG000|Overall Study|Lost to Follow-up|1|||
146520336|NCT02020889|528411687|FG001|Overall Study|Lost to Follow-up|0|||
146520337|NCT02020889|528411686|FG000|Overall Study|Physician Decision|2|||
146520338|NCT02020889|528411687|FG001|Overall Study|Physician Decision|0|||
146520339|NCT02020889|528411686|FG000|Overall Study|Withdrawal by Subject|3|||
146520340|NCT02020889|528411687|FG001|Overall Study|Withdrawal by Subject|2|||
146520341|NCT01540981|528411688|FG000|Overall Study|Withdrawal by Subject|1|||
146520342|NCT01540981|528411689|FG001|Overall Study|Withdrawal by Subject|0|||
146520343|NCT01535443|528411691|FG000|Overall Study|Physician Decision|3|||
146520344|NCT00232557|528411692|FG000|Overall Study|Lost to Follow-up|3|||
146520345|NCT00232557|528411693|FG001|Overall Study|Lost to Follow-up|5|||
146520346|NCT02260817|528411694|FG000|Overall Study|Lost to Follow-up|0|||
146520347|NCT02260817|528411695|FG001|Overall Study|Lost to Follow-up|14|||
146520348|NCT02260817|528411694|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
146520349|NCT02260817|528411695|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
146520350|NCT02260817|528411694|FG000|Overall Study|Observation, no biopsy|0|||
146520351|NCT02260817|528411695|FG001|Overall Study|Observation, no biopsy|1|||
146520352|NCT02260817|528411694|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
146520353|NCT02260817|528411695|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
146520354|NCT02260817|528411694|FG000|Overall Study|Protocol Violation|0|||
146520355|NCT02260817|528411695|FG001|Overall Study|Protocol Violation|14|||
146520356|NCT04435808|528411698|FG000|Overall Study|Study stopped by DSMB|0|||
146520357|NCT04435808|528411699|FG001|Overall Study|Study stopped by DSMB|1|||
146520358|NCT03299101|528411700|FG000|Overall Study|Lost to Follow-up|1|||
146520359|NCT03299101|528411700|FG000|Overall Study|Withdrawal by Subject|5|||
146520360|NCT03299101|528411700|FG000|Overall Study|Surgery was changed|3|||
146520361|NCT03299101|528411700|FG000|Overall Study|Not enough time to complete prehab|1|||
146520362|NCT01882803|528411701|FG000|Overall Study|Disease Progression|1|||
146520363|NCT01882803|528411701|FG000|Overall Study|Withdrawal by Subject|9|||
146520364|NCT01882803|528411701|FG000|Overall Study|Death|68|||
146520365|NCT01882803|528411701|FG000|Overall Study|Physician Decision|3|||
146520366|NCT01882803|528411701|FG000|Overall Study|Lost to Follow-up|3|||
146520367|NCT01882803|528411701|FG000|Overall Study|Follow-up Completed|39|||
146520368|NCT01882803|528411701|FG000|Overall Study|Study Terminated by the Sponsor|6|||
146520369|NCT01563913|528411702|FG000|Overall Study|Physician Decision|1|||
146520370|NCT01563913|528411703|FG001|Overall Study|Physician Decision|0|||
146520371|NCT01563913|528411702|FG000|Overall Study|Spouse Passed Away|1|||
146520372|NCT01563913|528411703|FG001|Overall Study|Spouse Passed Away|0|||
146520373|NCT00551525|528411704|FG000|Overall Study|Protocol Violation|5|||
146520374|NCT00398047|528411710|FG000|Overall Study|all patient progressed before completion|3|||
146520375|NCT02521792|528411711|FG000|Overall Study|Study Terminated|6|||
146520376|NCT00237692|528411712|FG000|Overall Study|Lost to Follow-up|9|||
146520377|NCT00237692|528411713|FG001|Overall Study|Lost to Follow-up|3|||
146520378|NCT00237692|528411714|FG002|Overall Study|Lost to Follow-up|5|||
146520379|NCT00237692|528411715|FG003|Overall Study|Lost to Follow-up|3|||
146520380|NCT00237692|528411712|FG000|Overall Study|Death|1|||
146520381|NCT00237692|528411713|FG001|Overall Study|Death|2|||
146520382|NCT00237692|528411714|FG002|Overall Study|Death|2|||
146520383|NCT00237692|528411715|FG003|Overall Study|Death|3|||
146520384|NCT00237692|528411712|FG000|Overall Study|Excluded - did not meet criteria|4|||
146520385|NCT00237692|528411713|FG001|Overall Study|Excluded - did not meet criteria|3|||
146520386|NCT00237692|528411714|FG002|Overall Study|Excluded - did not meet criteria|5|||
146520387|NCT00237692|528411715|FG003|Overall Study|Excluded - did not meet criteria|9|||
146520388|NCT00237692|528411712|FG000|Overall Study|Withdrawal by Subject|4|||
146520389|NCT00237692|528411713|FG001|Overall Study|Withdrawal by Subject|6|||
146520390|NCT00237692|528411714|FG002|Overall Study|Withdrawal by Subject|10|||
146520391|NCT00237692|528411715|FG003|Overall Study|Withdrawal by Subject|4|||
146520392|NCT01151345|528411720|FG000|First Intervention Period|Protocol Violation|0|||
146520393|NCT01151345|528411721|FG001|First Intervention Period|Protocol Violation|1|||
146520394|NCT02588092|528411722|FG000|Overall Study|Death|4|||
146520395|NCT02588092|528411723|FG001|Overall Study|Death|3|||
146520396|NCT02588092|528411724|FG002|Overall Study|Death|3|||
146520397|NCT02588092|528411725|FG003|Overall Study|Death|3|||
146520398|NCT02588092|528411726|FG004|Overall Study|Death|2|||
146520399|NCT02588092|528411727|FG005|Overall Study|Death|2|||
146520400|NCT02588092|528411728|FG006|Overall Study|Death|2|||
146520401|NCT02588092|528411729|FG007|Overall Study|Death|1|||
146756396|NCT00958009|529273296|FG000|Overall Study|Adverse Event|1|||
146756397|NCT00958009|529273296|FG000|Overall Study|Subject found device difficult to use|1|||
146756398|NCT00087490|529273299|FG000|Overall Study|Death|6|||
146756399|NCT00087490|529273300|FG001|Overall Study|Death|4|||
146756400|NCT00087490|529273299|FG000|Overall Study|Adverse Event|3|||
146756401|NCT00087490|529273300|FG001|Overall Study|Adverse Event|8|||
146756402|NCT00087490|529273299|FG000|Overall Study|Lack of Efficacy|0|||
146756403|NCT00087490|529273300|FG001|Overall Study|Lack of Efficacy|2|||
146756404|NCT00087490|529273299|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
146756405|NCT00087490|529273300|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
146520402|NCT02588092|528411730|FG008|Overall Study|Death|5|||
146520403|NCT02588092|528411731|FG009|Overall Study|Death|2|||
146520404|NCT02588092|528411722|FG000|Overall Study|Withdrawal by Subject|0|||
146520405|NCT02588092|528411723|FG001|Overall Study|Withdrawal by Subject|0|||
146520406|NCT02588092|528411724|FG002|Overall Study|Withdrawal by Subject|0|||
146520407|NCT02588092|528411725|FG003|Overall Study|Withdrawal by Subject|0|||
146520408|NCT02588092|528411726|FG004|Overall Study|Withdrawal by Subject|0|||
146520409|NCT02588092|528411727|FG005|Overall Study|Withdrawal by Subject|1|||
146520410|NCT02588092|528411728|FG006|Overall Study|Withdrawal by Subject|1|||
146520411|NCT02588092|528411729|FG007|Overall Study|Withdrawal by Subject|2|||
146520412|NCT02588092|528411730|FG008|Overall Study|Withdrawal by Subject|0|||
146520413|NCT02588092|528411731|FG009|Overall Study|Withdrawal by Subject|0|||
146520414|NCT02588092|528411722|FG000|Overall Study|Started Another Treatment|0|||
146520415|NCT02588092|528411723|FG001|Overall Study|Started Another Treatment|0|||
146520416|NCT02588092|528411724|FG002|Overall Study|Started Another Treatment|0|||
146520417|NCT02588092|528411725|FG003|Overall Study|Started Another Treatment|0|||
146520418|NCT02588092|528411726|FG004|Overall Study|Started Another Treatment|1|||
146520419|NCT02588092|528411727|FG005|Overall Study|Started Another Treatment|0|||
146520420|NCT02588092|528411728|FG006|Overall Study|Started Another Treatment|0|||
146520421|NCT02588092|528411729|FG007|Overall Study|Started Another Treatment|1|||
146520422|NCT02588092|528411730|FG008|Overall Study|Started Another Treatment|0|||
146520423|NCT02588092|528411731|FG009|Overall Study|Started Another Treatment|0|||
146520424|NCT02588092|528411722|FG000|Overall Study|Sponsor Decision|0|||
146520425|NCT02588092|528411723|FG001|Overall Study|Sponsor Decision|0|||
146520426|NCT02588092|528411724|FG002|Overall Study|Sponsor Decision|0|||
146520427|NCT02588092|528411725|FG003|Overall Study|Sponsor Decision|0|||
146520428|NCT02588092|528411726|FG004|Overall Study|Sponsor Decision|0|||
146520429|NCT02588092|528411727|FG005|Overall Study|Sponsor Decision|0|||
146520430|NCT02588092|528411728|FG006|Overall Study|Sponsor Decision|0|||
146520431|NCT02588092|528411729|FG007|Overall Study|Sponsor Decision|0|||
146520432|NCT02588092|528411730|FG008|Overall Study|Sponsor Decision|1|||
146520433|NCT02588092|528411731|FG009|Overall Study|Sponsor Decision|1|||
146520434|NCT03148067|528411732|FG000|Overall Study|Lost to Follow-up|3|||
146520435|NCT03148067|528411732|FG000|Overall Study|Death|1|||
146520436|NCT04074330|528411739|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
146520437|NCT04074330|528411740|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
146520438|NCT04074330|528411741|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
146520439|NCT04074330|528411742|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
146520440|NCT04074330|528411743|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
146520441|NCT04074330|528411744|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
146520442|NCT04074330|528411745|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
146520443|NCT04074330|528411746|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
146520444|NCT04074330|528411747|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
146520445|NCT04074330|528411748|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
146520446|NCT04074330|528411739|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
146520447|NCT04074330|528411740|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
146520448|NCT04074330|528411741|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
146520449|NCT04074330|528411742|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
146520450|NCT04074330|528411743|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
146520451|NCT04074330|528411744|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
146520452|NCT04074330|528411745|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
146520453|NCT04074330|528411746|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
146520454|NCT04074330|528411747|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
146520455|NCT04074330|528411748|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
146520456|NCT04074330|528411739|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
146520457|NCT04074330|528411740|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
146520458|NCT04074330|528411741|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
146520459|NCT04074330|528411742|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
146520460|NCT04074330|528411743|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
146520461|NCT04074330|528411744|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
146520462|NCT04074330|528411745|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
146520463|NCT04074330|528411746|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
146520464|NCT04074330|528411747|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
146520465|NCT04074330|528411748|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
146520466|NCT04074330|528411739|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
146520467|NCT04074330|528411740|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
146520468|NCT04074330|528411741|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
146520469|NCT04074330|528411742|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
146520470|NCT04074330|528411743|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
146520471|NCT04074330|528411744|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
146520472|NCT04074330|528411745|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
146520473|NCT04074330|528411746|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
146520474|NCT04074330|528411747|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
146520475|NCT04074330|528411748|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
146520476|NCT04074330|528411739|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
146520477|NCT04074330|528411740|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
146520478|NCT04074330|528411741|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
146520479|NCT04074330|528411742|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
146520480|NCT04074330|528411743|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
146520481|NCT04074330|528411744|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
146520482|NCT04074330|528411745|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
146520483|NCT04074330|528411746|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
146520484|NCT04074330|528411747|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
146520485|NCT04074330|528411748|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
146520486|NCT04074330|528411739|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
146520487|NCT04074330|528411740|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
146520488|NCT04074330|528411741|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
146520489|NCT04074330|528411742|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
146520490|NCT04074330|528411743|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
146520491|NCT04074330|528411744|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
146520492|NCT04074330|528411745|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
146520493|NCT04074330|528411746|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
146520494|NCT04074330|528411747|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
146520495|NCT04074330|528411748|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
146520496|NCT04074330|528411739|FG000|Dose Expansion (up to 42 Months)|Death|0|||
146520497|NCT04074330|528411740|FG001|Dose Expansion (up to 42 Months)|Death|0|||
146520498|NCT04074330|528411741|FG002|Dose Expansion (up to 42 Months)|Death|0|||
146520499|NCT04074330|528411742|FG003|Dose Expansion (up to 42 Months)|Death|0|||
146520500|NCT04074330|528411743|FG004|Dose Expansion (up to 42 Months)|Death|0|||
146520501|NCT04074330|528411744|FG005|Dose Expansion (up to 42 Months)|Death|0|||
146520502|NCT04074330|528411745|FG006|Dose Expansion (up to 42 Months)|Death|0|||
146520503|NCT04074330|528411746|FG007|Dose Expansion (up to 42 Months)|Death|0|||
146520504|NCT04074330|528411747|FG008|Dose Expansion (up to 42 Months)|Death|1|||
146520505|NCT04074330|528411748|FG009|Dose Expansion (up to 42 Months)|Death|0|||
146520506|NCT04074330|528411739|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
146520507|NCT04074330|528411740|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
146520508|NCT04074330|528411741|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
146520509|NCT04074330|528411742|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
146520510|NCT04074330|528411743|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
146520511|NCT04074330|528411744|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
146520512|NCT04074330|528411745|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
146520513|NCT04074330|528411746|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
146520514|NCT04074330|528411747|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
146520515|NCT04074330|528411748|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
146520516|NCT03124537|528411749|FG000|Overall Study|Lost to Follow-up|3|||
146520517|NCT03124537|528411750|FG001|Overall Study|Lost to Follow-up|5|||
146520518|NCT03124537|528411749|FG000|Overall Study|App Crash, Incomplete Data|7|||
146520519|NCT03124537|528411750|FG001|Overall Study|App Crash, Incomplete Data|8|||
146520520|NCT03301831|528411751|FG000|Overall Study|Lost to Follow-up|5|||
146520521|NCT03301831|528411752|FG001|Overall Study|Lost to Follow-up|3|||
146520522|NCT03301831|528411751|FG000|Overall Study|Protocol Violation|4|||
146520523|NCT03301831|528411752|FG001|Overall Study|Protocol Violation|0|||
146520524|NCT03301831|528411751|FG000|Overall Study|Withdrawal by Subject|11|||
146520525|NCT03301831|528411752|FG001|Overall Study|Withdrawal by Subject|0|||
146520526|NCT02348008|528411753|FG000|Overall Study|Adverse Event|2|||
146520527|NCT02348008|528411754|FG001|Overall Study|Adverse Event|3|||
146520528|NCT02348008|528411755|FG002|Overall Study|Adverse Event|3|||
146520529|NCT02348008|528411753|FG000|Overall Study|Disease Progression|1|||
146520530|NCT02348008|528411754|FG001|Overall Study|Disease Progression|5|||
146520531|NCT02348008|528411755|FG002|Overall Study|Disease Progression|16|||
146520532|NCT02348008|528411753|FG000|Overall Study|Withdrawal by Subject|0|||
146520533|NCT02348008|528411754|FG001|Overall Study|Withdrawal by Subject|1|||
146520534|NCT02348008|528411755|FG002|Overall Study|Withdrawal by Subject|0|||
146520535|NCT02348008|528411753|FG000|Overall Study|Symptomatic Deterioration|0|||
146520536|NCT02348008|528411754|FG001|Overall Study|Symptomatic Deterioration|1|||
146520537|NCT02348008|528411755|FG002|Overall Study|Symptomatic Deterioration|0|||
146520538|NCT00401193|528414552|FG000|Overall Study|Adverse Event|1|||
146520539|NCT00401193|528414553|FG001|Overall Study|Adverse Event|3|||
146520540|NCT00401193|528414554|FG002|Overall Study|Adverse Event|1|||
146520541|NCT00401193|528414552|FG000|Overall Study|Protocol Violation|3|||
146756406|NCT00087490|529273299|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
146756407|NCT00087490|529273300|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
146756408|NCT00087490|529273299|FG000|Overall Study|Randomized but not treated|7|||
146756409|NCT00087490|529273300|FG001|Overall Study|Randomized but not treated|18|||
146756410|NCT00761774|529273301|FG000|Overall Study|Adverse Event|17|||
146756411|NCT00761774|529273301|FG000|Overall Study|Lack of Efficacy|37|||
146756412|NCT00761774|529273301|FG000|Overall Study|Lost to Follow-up|2|||
146756413|NCT00761774|529273301|FG000|Overall Study|Withdrawal by Subject|9|||
146756414|NCT00761774|529273301|FG000|Overall Study|Non-compliance|4|||
146756415|NCT00761774|529273301|FG000|Overall Study|End of study|2|||
146756416|NCT00761774|529273301|FG000|Overall Study|Reclassification of seizures|1|||
146756417|NCT00761774|529273301|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
146756418|NCT00761774|529273301|FG000|Overall Study|Sponsor decision|1|||
146756419|NCT00761774|529273301|FG000|Overall Study|Investigator clinical judgement|1|||
146756420|NCT00761774|529273301|FG000|Overall Study|Patient moved out of study area|1|||
146756421|NCT00761774|529273301|FG000|Overall Study|Coordinator leaving site|1|||
146756422|NCT00761774|529273301|FG000|Overall Study|Subject IP non-compliance|1|||
146756423|NCT00761774|529273301|FG000|Overall Study|IP stopped by hospital physician|1|||
146756424|NCT02303574|529273309|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146756425|NCT02303574|529273310|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146756426|NCT02303574|529273311|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
146756427|NCT02303574|529273312|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146756428|NCT02303574|529273313|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146756429|NCT02303574|529273314|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146756430|NCT02303574|529273315|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146756431|NCT02303574|529273316|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146756432|NCT02303574|529273317|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146756433|NCT02303574|529273318|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146756434|NCT02303574|529273309|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146756435|NCT02303574|529273310|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146756436|NCT02303574|529273311|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146756437|NCT02303574|529273312|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146756438|NCT02303574|529273313|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146756439|NCT02303574|529273314|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146756440|NCT02303574|529273315|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146756441|NCT02303574|529273316|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
146756442|NCT02303574|529273317|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146520542|NCT00401193|528414553|FG001|Overall Study|Protocol Violation|1|||
146520543|NCT00401193|528414554|FG002|Overall Study|Protocol Violation|1|||
146520544|NCT00401193|528414552|FG000|Overall Study|Lost to Follow-up|6|||
146520545|NCT00401193|528414553|FG001|Overall Study|Lost to Follow-up|5|||
146520546|NCT00401193|528414554|FG002|Overall Study|Lost to Follow-up|1|||
146520547|NCT00401193|528414552|FG000|Overall Study|Withdrawal by Subject|2|||
146520548|NCT00401193|528414553|FG001|Overall Study|Withdrawal by Subject|0|||
146520549|NCT00401193|528414554|FG002|Overall Study|Withdrawal by Subject|1|||
146520550|NCT00401193|528414552|FG000|Overall Study|Other Event|3|||
146520551|NCT00401193|528414553|FG001|Overall Study|Other Event|2|||
146520552|NCT00401193|528414554|FG002|Overall Study|Other Event|2|||
146520553|NCT02526160|528414555|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
146520554|NCT02526160|528414556|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
146520555|NCT02526160|528414555|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
146520556|NCT02526160|528414556|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
146520557|NCT02526160|528414555|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
146520558|NCT02526160|528414556|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
146520559|NCT02526160|528414555|FG000|Open-Label Treatment Extension Period I|Death|0|||
146520560|NCT02526160|528414556|FG001|Open-Label Treatment Extension Period I|Death|1|||
146520561|NCT02526160|528414555|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
146520562|NCT02526160|528414556|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
146520563|NCT02526160|528414555|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
146520564|NCT02526160|528414556|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
146520565|NCT02526160|528414555|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
146520566|NCT02526160|528414556|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
146520567|NCT02526160|528414555|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
146520568|NCT02526160|528414556|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
146520569|NCT00398216|528414557|FG000|Overall Study|Adverse Event|4|||
146520570|NCT00398216|528414558|FG001|Overall Study|Adverse Event|2|||
146520571|NCT00398216|528414559|FG002|Overall Study|Adverse Event|5|||
146520572|NCT00398216|528414560|FG003|Overall Study|Adverse Event|7|||
146520573|NCT00398216|528414561|FG004|Overall Study|Adverse Event|2|||
146520574|NCT00398216|528414557|FG000|Overall Study|Protocol Violation|2|||
146520575|NCT00398216|528414558|FG001|Overall Study|Protocol Violation|4|||
146520576|NCT00398216|528414559|FG002|Overall Study|Protocol Violation|5|||
146520577|NCT00398216|528414560|FG003|Overall Study|Protocol Violation|7|||
146520578|NCT00398216|528414561|FG004|Overall Study|Protocol Violation|5|||
146520579|NCT00398216|528414557|FG000|Overall Study|Lost to Follow-up|1|||
146520580|NCT00398216|528414558|FG001|Overall Study|Lost to Follow-up|6|||
146520581|NCT00398216|528414559|FG002|Overall Study|Lost to Follow-up|4|||
146520582|NCT00398216|528414560|FG003|Overall Study|Lost to Follow-up|4|||
146520583|NCT00398216|528414561|FG004|Overall Study|Lost to Follow-up|1|||
146520584|NCT00398216|528414557|FG000|Overall Study|Death|0|||
146520585|NCT00398216|528414558|FG001|Overall Study|Death|3|||
146520586|NCT00398216|528414559|FG002|Overall Study|Death|0|||
146520587|NCT00398216|528414560|FG003|Overall Study|Death|0|||
146520588|NCT00398216|528414561|FG004|Overall Study|Death|0|||
146520589|NCT00398216|528414557|FG000|Overall Study|Withdrawal by Subject|1|||
146520590|NCT00398216|528414558|FG001|Overall Study|Withdrawal by Subject|0|||
146520591|NCT00398216|528414559|FG002|Overall Study|Withdrawal by Subject|3|||
146520592|NCT00398216|528414560|FG003|Overall Study|Withdrawal by Subject|1|||
146520593|NCT00398216|528414561|FG004|Overall Study|Withdrawal by Subject|2|||
146520594|NCT00398216|528414557|FG000|Overall Study|administrative reasons|3|||
146520595|NCT00398216|528414558|FG001|Overall Study|administrative reasons|4|||
146520596|NCT00398216|528414559|FG002|Overall Study|administrative reasons|4|||
146520597|NCT00398216|528414560|FG003|Overall Study|administrative reasons|3|||
146520598|NCT00398216|528414561|FG004|Overall Study|administrative reasons|3|||
146520599|NCT00398216|528414557|FG000|Overall Study|entrance criteria|0|||
146520600|NCT00398216|528414558|FG001|Overall Study|entrance criteria|0|||
146520601|NCT00398216|528414559|FG002|Overall Study|entrance criteria|0|||
146520602|NCT00398216|528414560|FG003|Overall Study|entrance criteria|0|||
146520603|NCT00398216|528414561|FG004|Overall Study|entrance criteria|2|||
146520604|NCT01962948|528414564|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
146520605|NCT01962948|528414565|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
146520606|NCT01962948|528414566|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
146520607|NCT01962948|528414567|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
146520608|NCT00802672|528414569|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
146520609|NCT00802672|528414570|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
146520610|NCT00802672|528414571|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
146520611|NCT00802672|528414569|FG000|Overall Study|Adverse Event|1|||
146520612|NCT00802672|528414570|FG001|Overall Study|Adverse Event|1|||
146520613|NCT00802672|528414571|FG002|Overall Study|Adverse Event|1|||
146520614|NCT00802672|528414569|FG000|Overall Study|Protocol Violation|2|||
146520615|NCT00802672|528414570|FG001|Overall Study|Protocol Violation|1|||
146520616|NCT00802672|528414571|FG002|Overall Study|Protocol Violation|1|||
146520617|NCT00802672|528414569|FG000|Overall Study|Lost to Follow-up|5|||
146520618|NCT00802672|528414570|FG001|Overall Study|Lost to Follow-up|5|||
146520619|NCT00802672|528414571|FG002|Overall Study|Lost to Follow-up|3|||
146520620|NCT00802672|528414569|FG000|Overall Study|Withdrawal by Subject|1|||
146520621|NCT00802672|528414570|FG001|Overall Study|Withdrawal by Subject|1|||
146520622|NCT00802672|528414571|FG002|Overall Study|Withdrawal by Subject|2|||
146520623|NCT00802672|528414569|FG000|Overall Study|other|3|||
146520624|NCT00802672|528414570|FG001|Overall Study|other|1|||
146520625|NCT00802672|528414571|FG002|Overall Study|other|2|||
146520626|NCT02579382|528414572|FG000|Main Study Phase|Lost to Follow-up|0|||
146520627|NCT02579382|528414573|FG001|Main Study Phase|Lost to Follow-up|0|||
146520628|NCT02579382|528414574|FG002|Main Study Phase|Lost to Follow-up|2|||
146520629|NCT02579382|528414575|FG003|Main Study Phase|Lost to Follow-up|0|||
146520630|NCT02579382|528414572|FG000|Main Study Phase|Withdrew Consent|0|||
146520631|NCT02579382|528414573|FG001|Main Study Phase|Withdrew Consent|0|||
146520632|NCT02579382|528414574|FG002|Main Study Phase|Withdrew Consent|0|||
146520633|NCT02579382|528414575|FG003|Main Study Phase|Withdrew Consent|2|||
146520634|NCT02579382|528414572|FG000|Main Study Phase|Lack of Efficacy|0|||
146520635|NCT02579382|528414573|FG001|Main Study Phase|Lack of Efficacy|0|||
146520636|NCT02579382|528414574|FG002|Main Study Phase|Lack of Efficacy|0|||
146520637|NCT02579382|528414575|FG003|Main Study Phase|Lack of Efficacy|1|||
146520638|NCT02579382|528414572|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
146520639|NCT02579382|528414573|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
146520640|NCT02579382|528414574|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
146520641|NCT02579382|528414575|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
146520642|NCT02579382|528414572|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
146520643|NCT02579382|528414573|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
146520644|NCT02579382|528414574|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
146520645|NCT02579382|528414575|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
146520646|NCT02579382|528414572|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
146520647|NCT02579382|528414573|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
146520648|NCT02579382|528414574|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
146520649|NCT02579382|528414575|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
146520650|NCT02579382|528414572|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
146520651|NCT02579382|528414573|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
146520652|NCT02579382|528414574|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
146520653|NCT02579382|528414575|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
146520654|NCT02579382|528414572|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
146520655|NCT02579382|528414573|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
146520656|NCT02579382|528414574|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
146520657|NCT02579382|528414575|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
146853628|NCT01370590|529633717|FG000|Period 2|Withdrawal by Subject|1|||
146853629|NCT01370590|529633718|FG001|Period 2|Withdrawal by Subject|1|||
146853630|NCT05172050|529633719|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
146853631|NCT05172050|529633720|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
146853632|NCT05172050|529633721|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
146853633|NCT05172050|529633719|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
146853634|NCT05172050|529633720|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
146853635|NCT05172050|529633721|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
146853636|NCT05172050|529633719|FG000|Overall Study|Other|2|||
146853637|NCT05172050|529633720|FG001|Overall Study|Other|2|||
146853638|NCT05172050|529633721|FG002|Overall Study|Other|1|||
146853639|NCT05180500|529633722|FG000|Overall Study|Adverse Event|1|||
146853640|NCT05180500|529633723|FG001|Overall Study|Adverse Event|0|||
146853641|NCT05180500|529633722|FG000|Overall Study|Withdrawal by Subject|2|||
146853642|NCT05180500|529633723|FG001|Overall Study|Withdrawal by Subject|0|||
146853643|NCT03992846|529633724|FG000|Overall Study|Adverse Event|8|||
146853644|NCT03992846|529633725|FG001|Overall Study|Adverse Event|6|||
146853645|NCT03992846|529633726|FG002|Overall Study|Adverse Event|3|||
146853646|NCT03992846|529633724|FG000|Overall Study|Lost to Follow-up|0|||
146853647|NCT03992846|529633725|FG001|Overall Study|Lost to Follow-up|1|||
146853648|NCT03992846|529633726|FG002|Overall Study|Lost to Follow-up|1|||
146853649|NCT03992846|529633724|FG000|Overall Study|Pregnancy|2|||
146853650|NCT03992846|529633725|FG001|Overall Study|Pregnancy|0|||
146853651|NCT03992846|529633726|FG002|Overall Study|Pregnancy|1|||
146520658|NCT02579382|528414572|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
146520659|NCT02579382|528414573|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
146520660|NCT02579382|528414574|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
146853652|NCT03992846|529633724|FG000|Overall Study|Protocol Violation|1|||
146853653|NCT03992846|529633725|FG001|Overall Study|Protocol Violation|2|||
146520661|NCT02579382|528414575|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
146520662|NCT00667992|528414576|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
146520663|NCT00667992|528414577|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
146520664|NCT00667992|528414576|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
146520665|NCT00667992|528414577|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
146520666|NCT00667992|528414576|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
146520667|NCT00667992|528414577|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
146520668|NCT00667992|528414576|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
146520669|NCT00667992|528414577|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
146520670|NCT00667992|528414576|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
146520671|NCT00667992|528414577|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
146520672|NCT00667992|528414576|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
146520673|NCT00667992|528414577|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
146520674|NCT00667992|528414576|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
146520675|NCT00667992|528414577|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
146520676|NCT00667992|528414576|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
146520677|NCT00667992|528414577|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
146520678|NCT00667992|528414576|FG000|Wash-out|Not within one doubling dilution|4|||
146520679|NCT00667992|528414577|FG001|Wash-out|Not within one doubling dilution|3|||
146520680|NCT00667992|528414576|FG000|Wash-out|Failure to wash-out|2|||
146520681|NCT00667992|528414577|FG001|Wash-out|Failure to wash-out|2|||
146520682|NCT00667992|528414576|FG000|Wash-out|Withdrawal by Subject|1|||
146520683|NCT00667992|528414577|FG001|Wash-out|Withdrawal by Subject|0|||
146520684|NCT00667992|528414576|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
146520685|NCT00667992|528414577|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
146520686|NCT00667992|528414576|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
146520687|NCT00667992|528414577|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
146520688|NCT02213380|528414578|FG000|Underwent Randomization|Withdrawal by Subject|2|||
146520689|NCT02213380|528414579|FG001|Underwent Randomization|Withdrawal by Subject|0|||
146520690|NCT02213380|528414578|FG000|Underwent Randomization|Not treated|3|||
146520691|NCT02213380|528414579|FG001|Underwent Randomization|Not treated|3|||
146520692|NCT02213380|528414578|FG000|Per-protocol Analysis|Protocol Violation|32|||
146520693|NCT02213380|528414579|FG001|Per-protocol Analysis|Protocol Violation|36|||
146853654|NCT03992846|529633726|FG002|Overall Study|Protocol Violation|0|||
146853655|NCT03992846|529633724|FG000|Overall Study|Withdrawal by Subject|8|||
146520694|NCT01310127|528414583|FG000|Overall Study|Protocol Violation|1|||
146520695|NCT01310127|528414584|FG001|Overall Study|Protocol Violation|1|||
146520696|NCT01310127|528414583|FG000|Overall Study|advanced psc cataract outlier|1|||
146520697|NCT01310127|528414584|FG001|Overall Study|advanced psc cataract outlier|0|||
146520698|NCT01490840|528414585|FG000|Phase 1|Lost to Follow-up|1|||
146520699|NCT01490840|528414586|FG001|Phase 1|Lost to Follow-up|0|||
146520700|NCT01490840|528414585|FG000|Phase 1|Adverse Event|2|||
146520701|NCT01490840|528414586|FG001|Phase 1|Adverse Event|1|||
146520702|NCT01490840|528414585|FG000|Phase 1|Withdrawal by Subject|6|||
146520703|NCT01490840|528414586|FG001|Phase 1|Withdrawal by Subject|5|||
146520704|NCT01490840|528414585|FG000|Phase 1|Visit 6a omitted|1|||
146520705|NCT01490840|528414586|FG001|Phase 1|Visit 6a omitted|0|||
146520706|NCT01490840|528414585|FG000|Phase 2|Withdrawal by Subject|4|||
146520707|NCT01490840|528414586|FG001|Phase 2|Withdrawal by Subject|3|||
146520708|NCT01490840|528414585|FG000|Phase 2|Permanent interruption of fingolimod|0|||
146520709|NCT01490840|528414586|FG001|Phase 2|Permanent interruption of fingolimod|1|||
146520710|NCT01490840|528414585|FG000|Phase 2|Lost to Follow-up|1|||
146520711|NCT01490840|528414586|FG001|Phase 2|Lost to Follow-up|1|||
146520712|NCT01490840|528414585|FG000|Phase 2|Adverse Event|1|||
146520713|NCT01490840|528414586|FG001|Phase 2|Adverse Event|1|||
146520714|NCT01025284|528414590|FG000|Overall Study|Investigator Decision|0|||
146853656|NCT03992846|529633725|FG001|Overall Study|Withdrawal by Subject|10|||
146853657|NCT03992846|529633726|FG002|Overall Study|Withdrawal by Subject|20|||
146853658|NCT03992846|529633724|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
146853659|NCT03992846|529633725|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
146853660|NCT03992846|529633726|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
146520715|NCT01025284|528414591|FG001|Overall Study|Investigator Decision|1|||
146520716|NCT01025284|528414592|FG002|Overall Study|Investigator Decision|0|||
146520717|NCT01025284|528414590|FG000|Overall Study|Withdrawal by Subject|0|||
146853661|NCT02359877|529634878|FG000|Overall Study|Withdrawal by Subject|1|||
146853662|NCT02359877|529634879|FG001|Overall Study|Withdrawal by Subject|0|||
146520718|NCT01025284|528414591|FG001|Overall Study|Withdrawal by Subject|1|||
146520719|NCT01025284|528414592|FG002|Overall Study|Withdrawal by Subject|0|||
146520720|NCT00905567|528414593|FG000|Washout|Withdrawal by Subject|0|||
146520721|NCT00905567|528414594|FG001|Washout|Withdrawal by Subject|1|||
146520722|NCT02542397|528414595|FG000|Overall Study|Death|2|||
146520723|NCT02542397|528414595|FG000|Overall Study|Physician Decision|6|||
146853663|NCT02359877|529634880|FG002|Overall Study|Withdrawal by Subject|0|||
146853664|NCT02359877|529634881|FG003|Overall Study|Withdrawal by Subject|2|||
146853665|NCT02359877|529634878|FG000|Overall Study|Adverse Event|0|||
146853666|NCT02359877|529634879|FG001|Overall Study|Adverse Event|0|||
146853667|NCT02359877|529634880|FG002|Overall Study|Adverse Event|0|||
146853668|NCT02359877|529634881|FG003|Overall Study|Adverse Event|1|||
146853669|NCT02186223|529634883|FG000|Overall Study|Not eligible for device placement|6|||
146853670|NCT02186223|529634883|FG000|Overall Study|Unable to obtain femoral access|3|||
146853671|NCT02186223|529634883|FG000|Overall Study|Death|3|||
146853672|NCT02186223|529634883|FG000|Overall Study|Device in place less than 48 hours|9|||
146853673|NCT00252733|529634884|FG000|Overall Study|Withdrawal by Subject|73|||
146853674|NCT00252733|529634885|FG001|Overall Study|Withdrawal by Subject|67|||
146853675|NCT00252733|529634884|FG000|Overall Study|Death|7|||
146853676|NCT00252733|529634885|FG001|Overall Study|Death|5|||
146853677|NCT00252733|529634884|FG000|Overall Study|Lost to Follow-up|12|||
146853678|NCT00252733|529634885|FG001|Overall Study|Lost to Follow-up|6|||
146853679|NCT00252733|529634884|FG000|Overall Study|Multiple Reasons|14|||
146853680|NCT00252733|529634885|FG001|Overall Study|Multiple Reasons|14|||
146853681|NCT00876928|529634886|FG000|Overall Study|Lost to Follow-up|2|||
146853682|NCT00876928|529634887|FG001|Overall Study|Lost to Follow-up|5|||
146853683|NCT00876928|529634886|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
146853684|NCT00876928|529634887|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
146853685|NCT01111474|529634888|FG000|Overall Study|Lost to Follow-up|12|||
146853686|NCT04101318|529634891|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
146853687|NCT04101318|529634892|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
146853688|NCT04101318|529634891|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
146853689|NCT04101318|529634892|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
146853690|NCT04101318|529634891|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
146853691|NCT04101318|529634892|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
146853692|NCT00558259|529634893|FG000|Overall Study|Adverse Event|50|||
146853693|NCT00558259|529634894|FG001|Overall Study|Adverse Event|81|||
146853694|NCT00558259|529634893|FG000|Overall Study|Protocol Violation|9|||
146853695|NCT00558259|529634894|FG001|Overall Study|Protocol Violation|5|||
146853696|NCT00558259|529634893|FG000|Overall Study|Withdrawal by Subject|12|||
146853697|NCT00558259|529634894|FG001|Overall Study|Withdrawal by Subject|13|||
146853698|NCT02874924|529634895|FG000|Overall Study|Adverse Event|2|||
146853699|NCT02874924|529634896|FG001|Overall Study|Adverse Event|0|||
146853700|NCT02874924|529634897|FG002|Overall Study|Adverse Event|0|||
146853701|NCT02874924|529634895|FG000|Overall Study|Withdrawal by Subject|1|||
146853702|NCT02874924|529634896|FG001|Overall Study|Withdrawal by Subject|0|||
146853703|NCT02874924|529634897|FG002|Overall Study|Withdrawal by Subject|0|||
146520724|NCT02542397|528414595|FG000|Overall Study|Withdrawal by Subject|6|||
146520725|NCT02542397|528414595|FG000|Overall Study|Lost to Follow-up|2|||
146520726|NCT01473940|528414601|FG000|Induction Therapy|Death|0|||
146520727|NCT01473940|528414602|FG001|Induction Therapy|Death|0|||
146520728|NCT01473940|528414603|FG002|Induction Therapy|Death|1|||
146520729|NCT01473940|528414604|FG003|Induction Therapy|Death|1|||
146520730|NCT01473940|528414601|FG000|Induction Therapy|Progressive Disease|0|||
146520731|NCT01473940|528414602|FG001|Induction Therapy|Progressive Disease|1|||
146520732|NCT01473940|528414603|FG002|Induction Therapy|Progressive Disease|1|||
146520733|NCT01473940|528414604|FG003|Induction Therapy|Progressive Disease|0|||
146520734|NCT01473940|528414601|FG000|Maintenance Therapy|Progressive Disease|1|||
146520735|NCT01473940|528414602|FG001|Maintenance Therapy|Progressive Disease|2|||
146520736|NCT01473940|528414603|FG002|Maintenance Therapy|Progressive Disease|1|||
146520737|NCT01473940|528414604|FG003|Maintenance Therapy|Progressive Disease|4|||
146520738|NCT00547248|528414605|FG000|Overall Study|Protocol Violation|0|||
146520739|NCT00547248|528414606|FG001|Overall Study|Protocol Violation|0|||
146756443|NCT02303574|529273318|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146756444|NCT00994279|529273323|FG000|Overall Study|Withdrawal by Subject|2|||
146756445|NCT00994279|529273324|FG001|Overall Study|Withdrawal by Subject|2|||
146756446|NCT00994279|529273323|FG000|Overall Study|Toxicity|1|||
146756447|NCT00994279|529273324|FG001|Overall Study|Toxicity|0|||
146756448|NCT00994279|529273323|FG000|Overall Study|Multiple reasons|1|||
146756449|NCT00994279|529273324|FG001|Overall Study|Multiple reasons|3|||
146756450|NCT02459964|529274794|FG000|Overall Study|Withdrawal by Subject|0|||
146756451|NCT02459964|529274795|FG001|Overall Study|Withdrawal by Subject|0|||
146756452|NCT02459964|529274796|FG002|Overall Study|Withdrawal by Subject|1|||
146756453|NCT02459964|529274794|FG000|Overall Study|Abnormal EKG changes|0|||
146756454|NCT02459964|529274795|FG001|Overall Study|Abnormal EKG changes|0|||
146756455|NCT02459964|529274796|FG002|Overall Study|Abnormal EKG changes|1|||
146756456|NCT00550732|529274797|FG000|Overall Study|Death|4|||
146756457|NCT00550732|529274797|FG000|Overall Study|Withdrawal by Subject|2|||
146756458|NCT00550732|529274797|FG000|Overall Study|Physician Decision|2|||
146756459|NCT00550732|529274797|FG000|Overall Study|Lost to Follow-up|1|||
146756460|NCT00550732|529274797|FG000|Overall Study|Palliative care|1|||
146756461|NCT00550732|529274797|FG000|Overall Study|Adverse Event|1|||
146756462|NCT04337489|529274799|FG000|Overall Study|Withdrawal by Subject|1|||
146756463|NCT01113463|529274809|FG000|Overall Study|Physician Decision|5|||
146756464|NCT00562965|529274810|FG000|Overall Study|Withdrawal by Subject|0|||
146756465|NCT00562965|529274811|FG001|Overall Study|Withdrawal by Subject|1|||
146756466|NCT00562965|529274810|FG000|Overall Study|Death|2|||
146756467|NCT00562965|529274811|FG001|Overall Study|Death|4|||
146756468|NCT00562965|529274810|FG000|Overall Study|Lost to Follow-up|1|||
146756469|NCT00562965|529274811|FG001|Overall Study|Lost to Follow-up|0|||
146756470|NCT00562965|529274810|FG000|Overall Study|Other|0|||
146756471|NCT00562965|529274811|FG001|Overall Study|Other|1|||
146756472|NCT03379233|529274813|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
146756473|NCT03379233|529274814|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
146756474|NCT00965484|529274815|FG000|Overall Study|Protocol Violation|1|||
146756475|NCT00965484|529274815|FG000|Overall Study|Withdrawal by Subject|1|||
146756476|NCT00848211|529274816|FG000|Overall Study|Protocol Violation|0|||
146756477|NCT00848211|529274817|FG001|Overall Study|Protocol Violation|1|||
146756478|NCT00848211|529274818|FG002|Overall Study|Protocol Violation|1|||
146756479|NCT00848211|529274819|FG003|Overall Study|Protocol Violation|0|||
146756480|NCT00848211|529274816|FG000|Overall Study|Adverse Event|0|||
146756481|NCT00848211|529274817|FG001|Overall Study|Adverse Event|0|||
146756482|NCT00848211|529274818|FG002|Overall Study|Adverse Event|0|||
146756483|NCT00848211|529274819|FG003|Overall Study|Adverse Event|0|||
146756484|NCT02531438|529274820|FG000|Overall Study|Adverse Event|7|||
146756485|NCT02531438|529274821|FG001|Overall Study|Adverse Event|9|||
146756486|NCT02531438|529274820|FG000|Overall Study|Lost to Follow-up|0|||
146756487|NCT02531438|529274821|FG001|Overall Study|Lost to Follow-up|3|||
146756488|NCT02531438|529274820|FG000|Overall Study|Withdrawal by Subject|7|||
146756489|NCT02531438|529274821|FG001|Overall Study|Withdrawal by Subject|8|||
146756490|NCT02531438|529274820|FG000|Overall Study|Physician Decision|0|||
146756491|NCT02531438|529274821|FG001|Overall Study|Physician Decision|1|||
146756492|NCT02531438|529274820|FG000|Overall Study|Death|6|||
146756493|NCT02531438|529274821|FG001|Overall Study|Death|3|||
146756494|NCT02531438|529274820|FG000|Overall Study|Randomized, but Not Treated|4|||
146756495|NCT02531438|529274821|FG001|Overall Study|Randomized, but Not Treated|0|||
146756496|NCT02531438|529274820|FG000|Overall Study|Missed EOT/PTE Visit|5|||
146756497|NCT02531438|529274821|FG001|Overall Study|Missed EOT/PTE Visit|2|||
146756498|NCT02531438|529274820|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
146756499|NCT02531438|529274821|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
146756500|NCT01124617|529274822|FG000|Overall Study|Adverse Event|5|||
146756501|NCT01124617|529274823|FG001|Overall Study|Adverse Event|2|||
146756502|NCT01124617|529274822|FG000|Overall Study|Lack of Efficacy|2|||
146520740|NCT00547248|528414607|FG002|Overall Study|Protocol Violation|1|||
146520741|NCT00547248|528414608|FG003|Overall Study|Protocol Violation|1|||
146756503|NCT01124617|529274823|FG001|Overall Study|Lack of Efficacy|1|||
146520742|NCT00547248|528414605|FG000|Overall Study|Migrated/moved from study area|0|||
146520743|NCT00547248|528414606|FG001|Overall Study|Migrated/moved from study area|0|||
146520744|NCT00547248|528414607|FG002|Overall Study|Migrated/moved from study area|2|||
146520745|NCT00547248|528414608|FG003|Overall Study|Migrated/moved from study area|0|||
146520746|NCT00547248|528414605|FG000|Overall Study|Withdrawal by Subject|0|||
146520747|NCT00547248|528414606|FG001|Overall Study|Withdrawal by Subject|0|||
146520748|NCT00547248|528414607|FG002|Overall Study|Withdrawal by Subject|7|||
146520749|NCT00547248|528414608|FG003|Overall Study|Withdrawal by Subject|1|||
146520750|NCT00534248|528414609|FG000|Overall Study|Adverse Event|19|||
146520751|NCT00534248|528414610|FG001|Overall Study|Adverse Event|29|||
146520752|NCT00534248|528414609|FG000|Overall Study|Lost to Follow-up|353|||
146520753|NCT00534248|528414610|FG001|Overall Study|Lost to Follow-up|375|||
146520754|NCT00534248|528414609|FG000|Overall Study|Other protocol specified criteria|13|||
146520755|NCT00534248|528414610|FG001|Overall Study|Other protocol specified criteria|3|||
146520756|NCT00534248|528414609|FG000|Overall Study|Physician Decision|10|||
146520757|NCT00534248|528414610|FG001|Overall Study|Physician Decision|7|||
146520758|NCT00534248|528414609|FG000|Overall Study|Protocol Violation|3|||
146520759|NCT00534248|528414610|FG001|Overall Study|Protocol Violation|4|||
146520760|NCT00534248|528414609|FG000|Overall Study|Withdrawal by Subject|263|||
146520761|NCT00534248|528414610|FG001|Overall Study|Withdrawal by Subject|255|||
146520762|NCT00697593|528414615|FG000|Overall Study|Adverse Event|3|||
146520763|NCT00697593|528414615|FG000|Overall Study|Protocol Violation|1|||
146520764|NCT00697593|528414615|FG000|Overall Study|Lack of Efficacy|3|||
146520765|NCT00697593|528414615|FG000|Overall Study|Suspension of the study by sponsor|12|||
146520766|NCT01705080|528414618|FG000|Overall Study|Missed visit|10|||
146520767|NCT01705080|528414619|FG001|Overall Study|Missed visit|4|||
146520768|NCT01705080|528414620|FG002|Overall Study|Missed visit|1|||
146520769|NCT01705080|528414618|FG000|Overall Study|Death|4|||
146520770|NCT01705080|528414619|FG001|Overall Study|Death|4|||
146520771|NCT01705080|528414620|FG002|Overall Study|Death|6|||
146520772|NCT01705080|528414618|FG000|Overall Study|Withdrawal by Subject|61|||
146520773|NCT01705080|528414619|FG001|Overall Study|Withdrawal by Subject|44|||
146520774|NCT01705080|528414620|FG002|Overall Study|Withdrawal by Subject|9|||
146520775|NCT00281697|528414621|FG000|Overall Study|> 60 days since last dose of study drug|4|||
146520776|NCT00281697|528414622|FG001|Overall Study|> 60 days since last dose of study drug|4|||
146520777|NCT00281697|528414621|FG000|Overall Study|Adverse Event|54|||
146520778|NCT00281697|528414622|FG001|Overall Study|Adverse Event|15|||
146520779|NCT00281697|528414621|FG000|Overall Study|Death|8|||
146520780|NCT00281697|528414622|FG001|Overall Study|Death|3|||
146520781|NCT00281697|528414621|FG000|Overall Study|Disease progression|279|||
146520782|NCT00281697|528414622|FG001|Overall Study|Disease progression|149|||
146520783|NCT00281697|528414621|FG000|Overall Study|Other|5|||
146520784|NCT00281697|528414622|FG001|Overall Study|Other|6|||
146520785|NCT00281697|528414621|FG000|Overall Study|Physician's decision to withdraw|15|||
146520786|NCT00281697|528414622|FG001|Overall Study|Physician's decision to withdraw|12|||
146520787|NCT00281697|528414621|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
146520788|NCT00281697|528414622|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
146520789|NCT00281697|528414621|FG000|Overall Study|Did not receive study drug|3|||
146520790|NCT00281697|528414622|FG001|Overall Study|Did not receive study drug|2|||
146520791|NCT00632125|528414623|FG000|Overall Study|Death|82|||
146520792|NCT00632125|528414623|FG000|Overall Study|Withdrawal by Subject|44|||
146520793|NCT00632125|528414623|FG000|Overall Study|Adverse Event|36|||
146520794|NCT00632125|528414623|FG000|Overall Study|Renal transplantation|17|||
146520795|NCT00632125|528414623|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
146520796|NCT00632125|528414623|FG000|Overall Study|Non-compliance|8|||
146520797|NCT00632125|528414623|FG000|Overall Study|Development of uncontrolled hypertension|5|||
146520798|NCT00632125|528414623|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
146520799|NCT02075008|528414636|FG000|Overall Study|Technical problems|1|||
146520800|NCT02075008|528414636|FG000|Overall Study|Pregnancy|1|||
146520801|NCT02075008|528414636|FG000|Overall Study|Physician Decision|1|||
146520802|NCT02075008|528414636|FG000|Overall Study|Lost to Follow-up|1|||
146520803|NCT02075008|528414636|FG000|Overall Study|Lack of Efficacy|1|||
146520804|NCT02075008|528414636|FG000|Overall Study|Death|1|||
146520805|NCT02075008|528414636|FG000|Overall Study|Adverse Event|5|||
146520806|NCT02075008|528414636|FG000|Overall Study|Withdrawal by Subject|6|||
146520807|NCT02075008|528414636|FG000|Overall Study|Study terminated by Sponsor|159|||
146520808|NCT04446429|528414637|FG000|Overall Study|Lost to Follow-up|6|||
146520809|NCT04446429|528414638|FG001|Overall Study|Lost to Follow-up|0|||
146520810|NCT05205005|528414639|FG000|Overall Study|Withdrawal by Subject|1|||
146520811|NCT05205005|528414640|FG001|Overall Study|Withdrawal by Subject|0|||
146520812|NCT05205005|528414639|FG000|Overall Study|Adverse Event|1|||
146520813|NCT05205005|528414640|FG001|Overall Study|Adverse Event|0|||
146520814|NCT00694356|528414644|FG000|Overall Study|Adverse Event|1|||
146520815|NCT00694356|528414645|FG001|Overall Study|Adverse Event|0|||
146520816|NCT00694356|528414646|FG002|Overall Study|Adverse Event|0|||
146520817|NCT00694356|528414644|FG000|Overall Study|Progressive Disease|2|||
146520818|NCT00694356|528414645|FG001|Overall Study|Progressive Disease|6|||
146520819|NCT00694356|528414646|FG002|Overall Study|Progressive Disease|6|||
146520820|NCT01763203|528414653|FG000|Overall Study|Death|4|||
146520821|NCT01763203|528414654|FG001|Overall Study|Death|7|||
146520822|NCT01763203|528414653|FG000|Overall Study|Lost to Follow-up|12|||
146520823|NCT01763203|528414654|FG001|Overall Study|Lost to Follow-up|12|||
146520824|NCT01763203|528414653|FG000|Overall Study|Withdrawal by Subject|8|||
146520825|NCT01763203|528414654|FG001|Overall Study|Withdrawal by Subject|12|||
146625258|NCT03037385|528803853|FG008|Overall Study|Initiation of Another Therapy|0|||
146520826|NCT01763203|528414653|FG000|Overall Study|Moved out of study region|7|||
146520827|NCT01763203|528414654|FG001|Overall Study|Moved out of study region|10|||
146520828|NCT01763203|528414653|FG000|Overall Study|Physician Decision|2|||
146520829|NCT01763203|528414654|FG001|Overall Study|Physician Decision|1|||
146520830|NCT02187861|528414658|FG000|Overall Study|Adverse Event|2|||
146520831|NCT02187861|528414659|FG001|Overall Study|Adverse Event|1|||
146520832|NCT02187861|528414660|FG002|Overall Study|Adverse Event|2|||
146520833|NCT02187861|528414661|FG003|Overall Study|Adverse Event|1|||
146520834|NCT02187861|528414658|FG000|Overall Study|Death|0|||
146520835|NCT02187861|528414659|FG001|Overall Study|Death|3|||
146520836|NCT02187861|528414660|FG002|Overall Study|Death|1|||
146520837|NCT02187861|528414661|FG003|Overall Study|Death|2|||
146520838|NCT02187861|528414658|FG000|Overall Study|Physician Decision|0|||
146520839|NCT02187861|528414659|FG001|Overall Study|Physician Decision|1|||
146520840|NCT02187861|528414660|FG002|Overall Study|Physician Decision|0|||
146520841|NCT02187861|528414661|FG003|Overall Study|Physician Decision|3|||
146520842|NCT02187861|528414658|FG000|Overall Study|Progressive Disease|4|||
146520843|NCT02187861|528414659|FG001|Overall Study|Progressive Disease|42|||
146520844|NCT02187861|528414660|FG002|Overall Study|Progressive Disease|19|||
146520845|NCT02187861|528414661|FG003|Overall Study|Progressive Disease|22|||
146520846|NCT02187861|528414658|FG000|Overall Study|Withdrawal by Subject|0|||
146520847|NCT02187861|528414659|FG001|Overall Study|Withdrawal by Subject|0|||
146520848|NCT02187861|528414660|FG002|Overall Study|Withdrawal by Subject|3|||
146520849|NCT02187861|528414661|FG003|Overall Study|Withdrawal by Subject|3|||
146520850|NCT02187861|528414658|FG000|Overall Study|Other|0|||
146520851|NCT02187861|528414659|FG001|Overall Study|Other|1|||
146520852|NCT02187861|528414660|FG002|Overall Study|Other|7|||
146520853|NCT02187861|528414661|FG003|Overall Study|Other|1|||
146520854|NCT02756819|528414662|FG000|Overall Study|Lost for observation|23|||
146520855|NCT02756819|528414662|FG000|Overall Study|Patient's unwillingness|16|||
146520856|NCT02756819|528414662|FG000|Overall Study|Insufficient efficacy|2|||
146520857|NCT02756819|528414662|FG000|Overall Study|Adverse Event|2|||
146520858|NCT02756819|528414662|FG000|Overall Study|Reason not Specified|9|||
146520859|NCT01491841|528414664|FG000|Overall Study|Screen Failure|10|||
146520860|NCT01491841|528414664|FG000|Overall Study|Withdrawal by Subject|1|||
146520861|NCT02933528|528414665|FG000|Overall Study|Lost to Follow-up|2|||
146520862|NCT00741598|528414666|FG000|Overall Study|Lost to Follow-up|3|||
146520863|NCT00741598|528414667|FG001|Overall Study|Lost to Follow-up|4|||
146520864|NCT00741598|528414666|FG000|Overall Study|Lack of Efficacy|1|||
146520865|NCT00741598|528414667|FG001|Overall Study|Lack of Efficacy|2|||
146520866|NCT00741598|528414666|FG000|Overall Study|Physician Decision|1|||
146520867|NCT00741598|528414667|FG001|Overall Study|Physician Decision|1|||
146520868|NCT00741598|528414666|FG000|Overall Study|Pregnancy|1|||
146520869|NCT00741598|528414667|FG001|Overall Study|Pregnancy|0|||
146520870|NCT00741598|528414666|FG000|Overall Study|Withdrawal by Subject|3|||
146520871|NCT00741598|528414667|FG001|Overall Study|Withdrawal by Subject|2|||
146520872|NCT01301079|528414668|FG000|Overall Study|Lost to Follow-up|2|||
146520873|NCT01301079|528414669|FG001|Overall Study|Lost to Follow-up|2|||
146520874|NCT04105842|528414672|FG000|Overall Study|Withdrawal by Subject|2|||
146520875|NCT01639703|528414673|FG000|Overall Study|Withdrawal by Subject|5|||
146520876|NCT01639703|528414673|FG000|Overall Study|Other reason|7|||
146520877|NCT01308463|528414674|FG000|Overall Study|Study Discontinued|23|||
146520878|NCT01308463|528414674|FG000|Overall Study|Death|4|||
146520879|NCT01308463|528414674|FG000|Overall Study|Revision|2|||
146520880|NCT01042392|528414675|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
146520881|NCT01042392|528414676|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
146520882|NCT01042392|528414677|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
146520883|NCT01042392|528414678|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
146520884|NCT01042392|528414675|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
146520885|NCT01042392|528414676|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
146520886|NCT01042392|528414677|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
146520887|NCT01042392|528414678|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
146520888|NCT01042392|528414675|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
146520889|NCT01042392|528414676|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
146520890|NCT01042392|528414677|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
146520891|NCT01042392|528414678|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
146520892|NCT01042392|528414675|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
146520893|NCT01042392|528414676|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
146853704|NCT02029846|529634900|FG000|Overall Study|n=1 each arm|1|||
146853705|NCT02029846|529634901|FG001|Overall Study|n=1 each arm|1|||
146853706|NCT02966301|529634905|FG000|Overall Study|Death|2|||
146520894|NCT01042392|528414677|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
146520895|NCT01042392|528414678|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
146520896|NCT01042392|528414675|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
146520897|NCT01042392|528414676|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
146520898|NCT01042392|528414677|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
146520899|NCT01042392|528414678|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
146520900|NCT01042392|528414675|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
146520901|NCT01042392|528414676|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
146625259|NCT03037385|528803854|FG009|Overall Study|Initiation of Another Therapy|2|||
146520902|NCT01042392|528414677|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
146520903|NCT01042392|528414678|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
146520904|NCT01042392|528414675|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
146520905|NCT01042392|528414676|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
146520906|NCT01042392|528414677|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
146520907|NCT01042392|528414678|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
146520908|NCT01042392|528414675|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
146520909|NCT01042392|528414676|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
146520910|NCT01042392|528414677|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
146520911|NCT01042392|528414678|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
146520912|NCT01042392|528414675|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
146520913|NCT01042392|528414676|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
146520914|NCT01042392|528414677|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
146520915|NCT01042392|528414678|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
146520916|NCT03117361|528414679|FG000|Overall Study|Progressive disease|5|||
146520917|NCT03117361|528414679|FG000|Overall Study|Death|1|||
146520918|NCT03117361|528414679|FG000|Overall Study|Physician Decision|2|||
146520919|NCT03117361|528414679|FG000|Overall Study|On study treatment at the end of study|1|||
146520920|NCT03117361|528414679|FG000|Overall Study|Treatment-related adverse event|1|||
146520921|NCT00587795|528414680|FG000|Overall Study|Withdrawal by Subject|1|||
146520922|NCT00587795|528414681|FG001|Overall Study|Withdrawal by Subject|0|||
146520923|NCT00943592|528414682|FG000|Overall Study|Death|3|||
146520924|NCT02072941|528414683|FG000|Overall Study|Withdrawal by Subject|29|||
146520925|NCT02072941|528414684|FG001|Overall Study|Withdrawal by Subject|21|||
146520926|NCT02072941|528414683|FG000|Overall Study|Lost to Follow-up|4|||
146520927|NCT02072941|528414684|FG001|Overall Study|Lost to Follow-up|4|||
146520928|NCT02072941|528414683|FG000|Overall Study|Death|3|||
146520929|NCT02072941|528414684|FG001|Overall Study|Death|2|||
146520930|NCT02072941|528414683|FG000|Overall Study|Removed by Study Staff|2|||
146520931|NCT02072941|528414684|FG001|Overall Study|Removed by Study Staff|2|||
146520932|NCT01247350|528414685|FG000|Overall Study|Adverse Event|0|||
146853707|NCT02966301|529634905|FG000|Overall Study|Withdrawal by Subject|1|||
146853708|NCT01415531|529634908|FG000|Overall Study|Adverse Event|7|||
146853709|NCT01415531|529634909|FG001|Overall Study|Adverse Event|10|||
146853710|NCT01415531|529634908|FG000|Overall Study|Lack of Efficacy|3|||
146853711|NCT01415531|529634909|FG001|Overall Study|Lack of Efficacy|2|||
146853712|NCT01415531|529634908|FG000|Overall Study|Protocol Violation|0|||
146853713|NCT01415531|529634909|FG001|Overall Study|Protocol Violation|1|||
146853714|NCT01415531|529634908|FG000|Overall Study|Withdrawal by Subject|5|||
146853715|NCT01415531|529634909|FG001|Overall Study|Withdrawal by Subject|4|||
146520933|NCT01247350|528414686|FG001|Overall Study|Adverse Event|0|||
146520934|NCT01247350|528414687|FG002|Overall Study|Adverse Event|1|||
146520935|NCT01247350|528414688|FG003|Overall Study|Adverse Event|0|||
146520936|NCT01247350|528414689|FG004|Overall Study|Adverse Event|0|||
146520937|NCT01247350|528414685|FG000|Overall Study|Withdrawal by Subject|0|||
146520938|NCT01247350|528414686|FG001|Overall Study|Withdrawal by Subject|0|||
146520939|NCT01247350|528414687|FG002|Overall Study|Withdrawal by Subject|0|||
146520940|NCT01247350|528414688|FG003|Overall Study|Withdrawal by Subject|1|||
146520941|NCT01247350|528414689|FG004|Overall Study|Withdrawal by Subject|0|||
146520942|NCT01247350|528414685|FG000|Overall Study|Entry criteria not met|0|||
146520943|NCT01247350|528414686|FG001|Overall Study|Entry criteria not met|0|||
146520944|NCT01247350|528414687|FG002|Overall Study|Entry criteria not met|0|||
146520945|NCT01247350|528414688|FG003|Overall Study|Entry criteria not met|0|||
146520946|NCT01247350|528414689|FG004|Overall Study|Entry criteria not met|1|||
146520947|NCT02438280|528414692|FG000|Overall Study|Physician Decision|1|||
146520948|NCT02438280|528414693|FG001|Overall Study|Physician Decision|0|||
146520949|NCT02982863|528414694|FG000|Overall Study|Not eligible patients|809|||
146520950|NCT02982863|528414695|FG001|Overall Study|Not eligible patients|4261|||
146520951|NCT02982863|528414696|FG002|Overall Study|Not eligible patients|1852|||
146520952|NCT02982863|528414697|FG003|Overall Study|Not eligible patients|1400|||
146520953|NCT02982863|528414698|FG004|Overall Study|Not eligible patients|492|||
146520954|NCT02457195|528414699|FG000|Overall Study|Adverse Event|3|||
146520955|NCT02457195|528414699|FG000|Overall Study|Protocol Violation|2|||
146520956|NCT02457195|528414699|FG000|Overall Study|Withdrawal by Subject|4|||
146520957|NCT05359952|528414700|FG000|Overall Study|Lost to Follow-up|1|||
146520958|NCT05359952|528414701|FG001|Overall Study|Lost to Follow-up|0|||
146520959|NCT05980013|528414702|FG000|Overall Study|Withdrawal by Subject|0|||
146520960|NCT05980013|528414703|FG001|Overall Study|Withdrawal by Subject|1|||
146520961|NCT05980013|528414702|FG000|Overall Study|Device Error|0|||
146520962|NCT05980013|528414703|FG001|Overall Study|Device Error|1|||
146520963|NCT03066778|528414704|FG000|Overall Study|Death|195|||
146520964|NCT03066778|528414705|FG001|Overall Study|Death|205|||
146520965|NCT03066778|528414704|FG000|Overall Study|Withdrawal by Subject|5|||
146520966|NCT03066778|528414705|FG001|Overall Study|Withdrawal by Subject|7|||
146520967|NCT02091414|528414706|FG000|Overall Study|Withdrawal by Subject|2|||
146520968|NCT02091414|528414706|FG000|Overall Study|Death|2|||
146520969|NCT03146741|528414707|FG000|Overall Study|Txp with non-HCV+ heart|4|||
146520970|NCT03146741|528414707|FG000|Overall Study|Listeted for MOT|2|||
146520971|NCT03146741|528414707|FG000|Overall Study|Physician Decision|2|||
146625260|NCT03037385|528803845|FG000|Overall Study|Lost to Follow-up|0|||
146853716|NCT01415531|529634908|FG000|Overall Study|Lost to Follow-up|6|||
146520972|NCT03146741|528414707|FG000|Overall Study|Awaiting txp|2|||
146520973|NCT00902746|528414708|FG000|Overall Study|Protocol Violation|7|||
146520974|NCT00902746|528414708|FG000|Overall Study|Withdrawal by Subject|16|||
146520975|NCT00902746|528414708|FG000|Overall Study|Adverse Event|8|||
146520976|NCT00902746|528414708|FG000|Overall Study|Lost to Follow-up|3|||
146520977|NCT00902746|528414708|FG000|Overall Study|Physician Decision|2|||
146520978|NCT02081001|528414710|FG000|Overall Study|Adverse Event|0|||
146520979|NCT02081001|528414711|FG001|Overall Study|Adverse Event|0|||
146520980|NCT02081001|528414712|FG002|Overall Study|Adverse Event|0|||
146520981|NCT02081001|528414713|FG003|Overall Study|Adverse Event|0|||
146520982|NCT02081001|528414714|FG004|Overall Study|Adverse Event|1|||
146520983|NCT02081001|528414715|FG005|Overall Study|Adverse Event|0|||
146520984|NCT02081001|528414716|FG006|Overall Study|Adverse Event|0|||
146520985|NCT02081001|528414717|FG007|Overall Study|Adverse Event|0|||
146520986|NCT02081001|528414718|FG008|Overall Study|Adverse Event|0|||
146520987|NCT02081001|528414719|FG009|Overall Study|Adverse Event|0|||
146520988|NCT02081001|528414720|FG010|Overall Study|Adverse Event|0|||
146520989|NCT02081001|528414721|FG011|Overall Study|Adverse Event|0|||
146520990|NCT01765569|528414728|FG000|Period B|Withdrawal by Subject|1|||
146520991|NCT01765569|528414728|FG000|Period C|Death|1|||
146520992|NCT01030718|528414729|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
146520993|NCT01030718|528414730|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
146520994|NCT01030718|528414731|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
146520995|NCT01030718|528414729|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
146520996|NCT01030718|528414730|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
146520997|NCT01030718|528414731|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
146520998|NCT01030718|528414729|FG000|Studies CA180-031 and -036 Combined|Death|0|||
146520999|NCT01030718|528414730|FG001|Studies CA180-031 and -036 Combined|Death|1|||
146521000|NCT01030718|528414731|FG002|Studies CA180-031 and -036 Combined|Death|0|||
146521001|NCT01030718|528414729|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
146521002|NCT01030718|528414730|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
146521003|NCT01030718|528414731|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
146521004|NCT01030718|528414729|FG000|Study CA180-036 Only|insufficient effect|1|||
146521005|NCT01030718|528414730|FG001|Study CA180-036 Only|insufficient effect|1|||
146521006|NCT01030718|528414731|FG002|Study CA180-036 Only|insufficient effect|5|||
146521007|NCT01030718|528414729|FG000|Study CA180-036 Only|Adverse Event|2|||
146521008|NCT01030718|528414730|FG001|Study CA180-036 Only|Adverse Event|3|||
146521009|NCT01030718|528414731|FG002|Study CA180-036 Only|Adverse Event|0|||
146521010|NCT01030718|528414729|FG000|Study CA180-036 Only|Death|0|||
146521011|NCT01030718|528414730|FG001|Study CA180-036 Only|Death|1|||
146521012|NCT01030718|528414731|FG002|Study CA180-036 Only|Death|0|||
146521013|NCT01030718|528414729|FG000|Study CA180-036 Only|Other Reasons|0|||
146521014|NCT01030718|528414730|FG001|Study CA180-036 Only|Other Reasons|2|||
146756504|NCT01124617|529274822|FG000|Overall Study|Protocol Violation|1|||
146756505|NCT01124617|529274823|FG001|Overall Study|Protocol Violation|1|||
146756506|NCT01124617|529274822|FG000|Overall Study|Withdrawal by Subject|9|||
146756507|NCT01124617|529274823|FG001|Overall Study|Withdrawal by Subject|1|||
146756508|NCT01124617|529274822|FG000|Overall Study|Other|2|||
146756509|NCT01124617|529274823|FG001|Overall Study|Other|1|||
146756510|NCT01813422|529274824|FG000|Overall Study|Withdrawal by Subject|14|||
146756511|NCT01813422|529274825|FG001|Overall Study|Withdrawal by Subject|8|||
146756512|NCT01813422|529274824|FG000|Overall Study|Death|2|||
146756513|NCT01813422|529274825|FG001|Overall Study|Death|3|||
146756514|NCT01813422|529274824|FG000|Overall Study|Sponsor Decision|2|||
146756515|NCT01813422|529274825|FG001|Overall Study|Sponsor Decision|1|||
146756516|NCT01813422|529274824|FG000|Overall Study|Lost to Follow-up|2|||
146756517|NCT01813422|529274825|FG001|Overall Study|Lost to Follow-up|4|||
146756518|NCT01653743|529274826|FG000|Overall Study|Withdrawal by Subject|1|||
146756519|NCT01653743|529274827|FG001|Overall Study|Withdrawal by Subject|0|||
146756520|NCT01653743|529274826|FG000|Overall Study|Investigator discretion|3|||
146756521|NCT01653743|529274827|FG001|Overall Study|Investigator discretion|0|||
146756522|NCT00811187|529274829|FG000|Overall Study|Unable to place device / procedure abort|3|||
146756523|NCT00811187|529274830|FG001|Overall Study|Unable to place device / procedure abort|3|||
146756524|NCT02825043|529274831|FG000|Overall Study|Lost to Follow-up|4|||
146756525|NCT00329303|529274832|FG000|Overall Study|Lack of Efficacy|1|||
146756526|NCT00329303|529274833|FG001|Overall Study|Lack of Efficacy|0|||
146756527|NCT00329303|529274832|FG000|Overall Study|Decision of the sponsor|0|||
146756528|NCT00329303|529274833|FG001|Overall Study|Decision of the sponsor|1|||
146756529|NCT00329303|529274832|FG000|Overall Study|Patient no longer available|1|||
146756530|NCT00329303|529274833|FG001|Overall Study|Patient no longer available|0|||
146521015|NCT01030718|528414731|FG002|Study CA180-036 Only|Other Reasons|0|||
146521016|NCT00423813|528414732|FG000|Overall Study|Adverse Event|11|||
146521017|NCT00423813|528414733|FG001|Overall Study|Adverse Event|30|||
146521018|NCT00423813|528414734|FG002|Overall Study|Adverse Event|40|||
146521019|NCT00423813|528414732|FG000|Overall Study|Withdrawal by Subject|6|||
146521020|NCT00423813|528414733|FG001|Overall Study|Withdrawal by Subject|8|||
146756531|NCT00329303|529274832|FG000|Overall Study|Patient relocated|0|||
146853717|NCT01415531|529634909|FG001|Overall Study|Lost to Follow-up|14|||
146853718|NCT01415531|529634908|FG000|Overall Study|Lack of Compliance|1|||
146853719|NCT01415531|529634909|FG001|Overall Study|Lack of Compliance|4|||
146853720|NCT01415531|529634908|FG000|Overall Study|Other Reasons|3|||
146853721|NCT01415531|529634909|FG001|Overall Study|Other Reasons|2|||
146853722|NCT01200589|529634910|FG000|Overall Study|Withdrawal by Subject|13|||
146625261|NCT03037385|528803846|FG001|Overall Study|Lost to Follow-up|0|||
146853723|NCT01200589|529634911|FG001|Overall Study|Withdrawal by Subject|11|||
146853724|NCT01200589|529634910|FG000|Overall Study|Physician Decision|2|||
146853725|NCT01200589|529634911|FG001|Overall Study|Physician Decision|2|||
146853726|NCT01200589|529634910|FG000|Overall Study|Lost to Follow-up|5|||
146853727|NCT01200589|529634911|FG001|Overall Study|Lost to Follow-up|4|||
146853728|NCT01200589|529634910|FG000|Overall Study|Study terminated|170|||
146853729|NCT01200589|529634911|FG001|Overall Study|Study terminated|172|||
146853730|NCT00185965|529634912|FG000|Overall Study|Adverse Event|0|||
146853731|NCT00185965|529634913|FG001|Overall Study|Adverse Event|1|||
146853732|NCT03814187|529634914|FG000|Overall Study|Sponsor's Administrative Decision|0|||
146853733|NCT03814187|529634915|FG001|Overall Study|Sponsor's Administrative Decision|0|||
146853734|NCT03814187|529634916|FG002|Overall Study|Sponsor's Administrative Decision|272|||
146853735|NCT03814187|529634914|FG000|Overall Study|Death|80|||
146853736|NCT03814187|529634915|FG001|Overall Study|Death|81|||
146853737|NCT03814187|529634916|FG002|Overall Study|Death|4|||
146853738|NCT03814187|529634914|FG000|Overall Study|Withdrew Consent|77|||
146853739|NCT03814187|529634915|FG001|Overall Study|Withdrew Consent|78|||
146853740|NCT03814187|529634916|FG002|Overall Study|Withdrew Consent|2|||
146853741|NCT03814187|529634914|FG000|Overall Study|Lost to Follow-up|47|||
146853742|NCT03814187|529634915|FG001|Overall Study|Lost to Follow-up|52|||
146853743|NCT03814187|529634916|FG002|Overall Study|Lost to Follow-up|1|||
146853744|NCT03814187|529634914|FG000|Overall Study|Adverse Event|22|||
146853745|NCT03814187|529634915|FG001|Overall Study|Adverse Event|23|||
146853746|NCT03814187|529634916|FG002|Overall Study|Adverse Event|0|||
146853747|NCT03814187|529634914|FG000|Overall Study|Physician Decision|7|||
146853748|NCT03814187|529634915|FG001|Overall Study|Physician Decision|4|||
146853749|NCT03814187|529634916|FG002|Overall Study|Physician Decision|2|||
146853750|NCT03814187|529634914|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
146853751|NCT03814187|529634915|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
146853752|NCT03814187|529634916|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
146521021|NCT00423813|528414734|FG002|Overall Study|Withdrawal by Subject|5|||
146521022|NCT00423813|528414732|FG000|Overall Study|Lost to Follow-up|5|||
146521023|NCT00423813|528414733|FG001|Overall Study|Lost to Follow-up|4|||
146521024|NCT00423813|528414734|FG002|Overall Study|Lost to Follow-up|4|||
146521025|NCT00423813|528414732|FG000|Overall Study|Lack of Efficacy|23|||
146853753|NCT03814187|529634914|FG000|Overall Study|Other reasons|34|||
146853754|NCT03814187|529634915|FG001|Overall Study|Other reasons|40|||
146853755|NCT03814187|529634916|FG002|Overall Study|Other reasons|2|||
146853756|NCT02009761|529634918|FG000|Overall Study|Adverse Event|4|||
146853757|NCT00825825|529634919|FG000|First Medication Period (14 Days)|Adverse Event|1|||
146853758|NCT00825825|529634920|FG001|First Medication Period (14 Days)|Adverse Event|0|||
146853759|NCT00825825|529634921|FG002|First Medication Period (14 Days)|Adverse Event|0|||
146853760|NCT00825825|529634922|FG003|First Medication Period (14 Days)|Adverse Event|0|||
146853761|NCT00825825|529634923|FG004|First Medication Period (14 Days)|Adverse Event|0|||
146853762|NCT00825825|529634924|FG005|First Medication Period (14 Days)|Adverse Event|1|||
146853763|NCT00825825|529634919|FG000|First Medication Period (14 Days)|Physician Decision|2|||
146853764|NCT00825825|529634920|FG001|First Medication Period (14 Days)|Physician Decision|0|||
146853765|NCT00825825|529634921|FG002|First Medication Period (14 Days)|Physician Decision|1|||
146853766|NCT00825825|529634922|FG003|First Medication Period (14 Days)|Physician Decision|0|||
146853767|NCT00825825|529634923|FG004|First Medication Period (14 Days)|Physician Decision|0|||
146853768|NCT00825825|529634924|FG005|First Medication Period (14 Days)|Physician Decision|1|||
146853769|NCT00825825|529634919|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
146853770|NCT00825825|529634920|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
146853771|NCT00825825|529634921|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
146853772|NCT00825825|529634922|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
146853773|NCT00825825|529634923|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
146853774|NCT00825825|529634924|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
146853775|NCT00825825|529634919|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
146853776|NCT00825825|529634920|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
146853777|NCT00825825|529634921|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
146853778|NCT00825825|529634922|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
146853779|NCT00825825|529634923|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
146853780|NCT00825825|529634924|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
146853781|NCT00825825|529634919|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
146853782|NCT00825825|529634920|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
146853783|NCT00825825|529634921|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
146853784|NCT00825825|529634922|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
146521026|NCT00423813|528414733|FG001|Overall Study|Lack of Efficacy|18|||
146521027|NCT00423813|528414734|FG002|Overall Study|Lack of Efficacy|19|||
146521028|NCT00423813|528414732|FG000|Overall Study|Physician Decision|2|||
146521029|NCT00423813|528414733|FG001|Overall Study|Physician Decision|0|||
146521030|NCT00423813|528414734|FG002|Overall Study|Physician Decision|0|||
146521031|NCT00423813|528414732|FG000|Overall Study|Sponsor Decision|0|||
146521032|NCT00423813|528414733|FG001|Overall Study|Sponsor Decision|1|||
146521033|NCT00423813|528414734|FG002|Overall Study|Sponsor Decision|0|||
146521034|NCT00423813|528414732|FG000|Overall Study|Protocol Violation|9|||
146521035|NCT00423813|528414733|FG001|Overall Study|Protocol Violation|4|||
146521036|NCT00423813|528414734|FG002|Overall Study|Protocol Violation|4|||
146521037|NCT00423813|528414732|FG000|Overall Study|Pregnancy|0|||
146521038|NCT00423813|528414733|FG001|Overall Study|Pregnancy|0|||
146521039|NCT00423813|528414734|FG002|Overall Study|Pregnancy|1|||
146521040|NCT00423813|528414732|FG000|Overall Study|Subject started night shift work|1|||
146521041|NCT00423813|528414733|FG001|Overall Study|Subject started night shift work|0|||
146521042|NCT00423813|528414734|FG002|Overall Study|Subject started night shift work|0|||
146521043|NCT00423813|528414732|FG000|Overall Study|Will start exclusionary medications|0|||
146521044|NCT00423813|528414733|FG001|Overall Study|Will start exclusionary medications|1|||
146521045|NCT00423813|528414734|FG002|Overall Study|Will start exclusionary medications|0|||
146521046|NCT00423813|528414732|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
146521047|NCT00423813|528414733|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
146521048|NCT00423813|528414734|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
146521049|NCT00531947|528414736|FG000|Overall Study|Adverse Event|5|||
146521050|NCT00531947|528414737|FG001|Overall Study|Adverse Event|10|||
146521051|NCT00531947|528414736|FG000|Overall Study|Lost to Follow-up|12|||
146521052|NCT00531947|528414737|FG001|Overall Study|Lost to Follow-up|9|||
146521053|NCT00531947|528414736|FG000|Overall Study|Withdrawal by Subject|14|||
146521054|NCT00531947|528414737|FG001|Overall Study|Withdrawal by Subject|19|||
146521055|NCT00531947|528414736|FG000|Overall Study|Protocol Violation|2|||
146521056|NCT00531947|528414737|FG001|Overall Study|Protocol Violation|1|||
146521057|NCT00531947|528414736|FG000|Overall Study|Non-Compliance|4|||
146521058|NCT00531947|528414737|FG001|Overall Study|Non-Compliance|7|||
146521059|NCT00531947|528414736|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
146521060|NCT00531947|528414737|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
146521061|NCT02383355|528414742|FG000|Overall Study|Adverse Event|2|||
146521062|NCT02383355|528414743|FG001|Overall Study|Adverse Event|0|||
146521063|NCT03681184|528414747|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
146521064|NCT03681184|528414748|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
146521065|NCT02787083|528414749|FG000|Overall Study|Adverse Event|1|||
146521066|NCT02787083|528414750|FG001|Overall Study|Adverse Event|0|||
146521067|NCT02787083|528414749|FG000|Overall Study|Withdrawal by Subject|2|||
146521068|NCT02787083|528414750|FG001|Overall Study|Withdrawal by Subject|2|||
146521069|NCT03162328|528414751|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
146521070|NCT03162328|528414752|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
146521071|NCT03162328|528414753|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
146521072|NCT03162328|528414751|FG000|Screening Period|Withdrawal by Subject|1|||
146521073|NCT03162328|528414752|FG001|Screening Period|Withdrawal by Subject|0|||
146521074|NCT03162328|528414753|FG002|Screening Period|Withdrawal by Subject|0|||
146521075|NCT03162328|528414751|FG000|Study Period|Withdrawal by Subject|0|||
146521076|NCT03162328|528414752|FG001|Study Period|Withdrawal by Subject|0|||
146521077|NCT03162328|528414753|FG002|Study Period|Withdrawal by Subject|1|||
146521078|NCT03275389|528414755|FG000|Overall Study|Lost to Follow-up|10|||
146521079|NCT03275389|528414756|FG001|Overall Study|Lost to Follow-up|10|||
146521080|NCT03275389|528414757|FG002|Overall Study|Lost to Follow-up|19|||
146521081|NCT03275389|528414758|FG003|Overall Study|Lost to Follow-up|12|||
146521082|NCT03275389|528414759|FG004|Overall Study|Lost to Follow-up|11|||
146521083|NCT03275389|528414760|FG005|Overall Study|Lost to Follow-up|12|||
146521084|NCT03275389|528414761|FG006|Overall Study|Lost to Follow-up|21|||
146521085|NCT03275389|528414762|FG007|Overall Study|Lost to Follow-up|15|||
146521086|NCT03275389|528414763|FG008|Overall Study|Lost to Follow-up|12|||
146521087|NCT03275389|528414764|FG009|Overall Study|Lost to Follow-up|14|||
146521088|NCT03275389|528414755|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
146521089|NCT03275389|528414756|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
146521090|NCT03275389|528414757|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
146521091|NCT03275389|528414758|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
146521092|NCT03275389|528414759|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
146521093|NCT03275389|528414760|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
146521094|NCT03275389|528414761|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
146521095|NCT03275389|528414762|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
146521096|NCT03275389|528414763|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
146521097|NCT03275389|528414764|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
146521098|NCT03275389|528414755|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
146521099|NCT03275389|528414756|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
146521100|NCT03275389|528414757|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
146521101|NCT03275389|528414758|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
146521102|NCT03275389|528414759|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
146521103|NCT03275389|528414760|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
146521104|NCT03275389|528414761|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
146521105|NCT03275389|528414762|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
146521106|NCT03275389|528414763|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
146521107|NCT03275389|528414764|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
146521108|NCT03275389|528414755|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146521109|NCT03275389|528414756|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
146521110|NCT03275389|528414757|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146521111|NCT03275389|528414758|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
146521112|NCT03275389|528414759|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146521113|NCT03275389|528414760|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146521114|NCT03275389|528414761|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146521115|NCT03275389|528414762|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146521116|NCT03275389|528414763|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146521117|NCT03275389|528414764|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146521118|NCT03275389|528414755|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
146521119|NCT03275389|528414756|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
146521120|NCT03275389|528414757|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
146521121|NCT03275389|528414758|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
146521122|NCT03275389|528414759|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
146521123|NCT03275389|528414760|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
146521124|NCT03275389|528414761|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
146521125|NCT03275389|528414762|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
146521126|NCT03275389|528414763|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
146521127|NCT03275389|528414764|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
146521128|NCT03275389|528414755|FG000|Overall Study|Other|0|||
146521129|NCT03275389|528414756|FG001|Overall Study|Other|4|||
146521130|NCT03275389|528414757|FG002|Overall Study|Other|3|||
146521131|NCT03275389|528414758|FG003|Overall Study|Other|2|||
146521132|NCT03275389|528414759|FG004|Overall Study|Other|2|||
146521133|NCT03275389|528414760|FG005|Overall Study|Other|2|||
146521134|NCT03275389|528414761|FG006|Overall Study|Other|0|||
146521135|NCT03275389|528414762|FG007|Overall Study|Other|0|||
146521136|NCT03275389|528414763|FG008|Overall Study|Other|1|||
146756532|NCT00329303|529274833|FG001|Overall Study|Patient relocated|1|||
146756533|NCT03582137|529274839|FG000|Overall Study|Adverse Event|1|||
146756534|NCT03582137|529274840|FG001|Overall Study|Adverse Event|0|||
146756535|NCT03704298|529274841|FG000|Overall Study|Death|3|||
146756536|NCT03704298|529274842|FG001|Overall Study|Death|1|||
146756537|NCT03704298|529274843|FG002|Overall Study|Death|1|||
146756538|NCT03704298|529274844|FG003|Overall Study|Death|0|||
146756539|NCT03704298|529274841|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
146756540|NCT03704298|529274842|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
146756541|NCT03704298|529274843|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
146756542|NCT03704298|529274844|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
146756543|NCT03704298|529274841|FG000|Overall Study|Withdrawal by Subject|1|||
146756544|NCT03704298|529274842|FG001|Overall Study|Withdrawal by Subject|0|||
146756545|NCT03704298|529274843|FG002|Overall Study|Withdrawal by Subject|0|||
146756546|NCT03704298|529274844|FG003|Overall Study|Withdrawal by Subject|0|||
146756547|NCT03704298|529274841|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
146756548|NCT03704298|529274842|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
146756549|NCT03704298|529274843|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
146756550|NCT03704298|529274844|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
146756551|NCT00859014|529274846|FG000|Overall Study|Death|4|||
146756552|NCT00859014|529274846|FG000|Overall Study|Lost to Follow-up|1|||
146756553|NCT00162942|529274847|FG000|Overall Study|Adverse Event|10|||
146756554|NCT00162942|529274848|FG001|Overall Study|Adverse Event|6|||
146756555|NCT00162942|529274847|FG000|Overall Study|Death|1|||
146756556|NCT00162942|529274848|FG001|Overall Study|Death|0|||
146756557|NCT00162942|529274847|FG000|Overall Study|Withdrawal by Subject|3|||
146756558|NCT00162942|529274848|FG001|Overall Study|Withdrawal by Subject|6|||
146756559|NCT00162942|529274847|FG000|Overall Study|Physician Decision|1|||
146756560|NCT00162942|529274848|FG001|Overall Study|Physician Decision|0|||
146756561|NCT00162942|529274847|FG000|Overall Study|Enter Open-Label Study|76|||
146756562|NCT00162942|529274848|FG001|Overall Study|Enter Open-Label Study|35|||
146756563|NCT00162942|529274847|FG000|Overall Study|Alternate Therapy|6|||
146756564|NCT00162942|529274848|FG001|Overall Study|Alternate Therapy|2|||
146756565|NCT00162942|529274847|FG000|Overall Study|Lack of Efficacy|1|||
146756566|NCT00162942|529274848|FG001|Overall Study|Lack of Efficacy|0|||
146756567|NCT00162942|529274847|FG000|Overall Study|Flare During Active Treatment|7|||
146756568|NCT00162942|529274848|FG001|Overall Study|Flare During Active Treatment|3|||
146756569|NCT00162942|529274847|FG000|Overall Study|2 or more consecutive treatments missed|1|||
146756570|NCT00162942|529274848|FG001|Overall Study|2 or more consecutive treatments missed|0|||
146756571|NCT04796935|529274849|FG000|Overall Study|Withdrawal by Subject|0|||
146756572|NCT04796935|529274850|FG001|Overall Study|Withdrawal by Subject|1|||
146756573|NCT04796935|529274849|FG000|Overall Study|Physician Decision|0|||
146756574|NCT04796935|529274850|FG001|Overall Study|Physician Decision|1|||
146756575|NCT04796935|529274849|FG000|Overall Study|Device not available|1|||
146756576|NCT04796935|529274850|FG001|Overall Study|Device not available|0|||
146756577|NCT04796935|529274849|FG000|Overall Study|Trained provider not available|1|||
146756578|NCT04796935|529274850|FG001|Overall Study|Trained provider not available|0|||
146756579|NCT00410384|529274851|FG000|Overall Study|Withdrawal by Subject|28|||
146756580|NCT00410384|529274852|FG001|Overall Study|Withdrawal by Subject|17|||
146756581|NCT00410384|529274853|FG002|Overall Study|Withdrawal by Subject|20|||
146756582|NCT00410384|529274851|FG000|Overall Study|Adverse Event|23|||
146756583|NCT00410384|529274852|FG001|Overall Study|Adverse Event|18|||
146756584|NCT00410384|529274853|FG002|Overall Study|Adverse Event|23|||
146756585|NCT00410384|529274851|FG000|Overall Study|Lack of Efficacy|20|||
146756586|NCT00410384|529274852|FG001|Overall Study|Lack of Efficacy|12|||
146756587|NCT00410384|529274853|FG002|Overall Study|Lack of Efficacy|17|||
146756588|NCT00410384|529274851|FG000|Overall Study|Lack of Compliance|2|||
146756589|NCT00410384|529274852|FG001|Overall Study|Lack of Compliance|2|||
146756590|NCT00410384|529274853|FG002|Overall Study|Lack of Compliance|2|||
146756591|NCT00410384|529274851|FG000|Overall Study|Lost to Follow-up|4|||
146756592|NCT00410384|529274852|FG001|Overall Study|Lost to Follow-up|6|||
146756593|NCT00410384|529274853|FG002|Overall Study|Lost to Follow-up|6|||
146521137|NCT03275389|528414764|FG009|Overall Study|Other|0|||
146521138|NCT01790516|528414765|FG000|Overall Study|Physician Decision|1|||
146521139|NCT01790516|528414766|FG001|Overall Study|Physician Decision|0|||
146756594|NCT00410384|529274851|FG000|Overall Study|Protocol Violation|6|||
146756595|NCT00410384|529274852|FG001|Overall Study|Protocol Violation|6|||
146521140|NCT03749109|528414767|FG000|Overall Study|Adverse Event|2|||
146521141|NCT03749109|528414768|FG001|Overall Study|Adverse Event|0|||
146521142|NCT03034135|528414769|FG000|Overall Study|Withdrawal by Subject|2|||
146521143|NCT02576977|528416473|FG000|Overall Study|Adverse Event|13|||
146521144|NCT02576977|528416474|FG001|Overall Study|Adverse Event|2|||
146521145|NCT02576977|528416473|FG000|Overall Study|Death|73|||
146521146|NCT02576977|528416474|FG001|Overall Study|Death|60|||
146521147|NCT02576977|528416473|FG000|Overall Study|Screen failure|1|||
146521148|NCT02576977|528416474|FG001|Overall Study|Screen failure|0|||
146521149|NCT02576977|528416473|FG000|Overall Study|Study Terminated at Selected Sites|27|||
146521150|NCT02576977|528416474|FG001|Overall Study|Study Terminated at Selected Sites|50|||
146521151|NCT02576977|528416473|FG000|Overall Study|Withdrawal by Subject|11|||
146521152|NCT02576977|528416474|FG001|Overall Study|Withdrawal by Subject|11|||
146521153|NCT02576977|528416473|FG000|Overall Study|Final Disposition Unknown|0|||
146521154|NCT02576977|528416474|FG001|Overall Study|Final Disposition Unknown|1|||
146521155|NCT02576977|528416473|FG000|Overall Study|Lost to Follow-up|1|||
146521156|NCT02576977|528416474|FG001|Overall Study|Lost to Follow-up|0|||
146521157|NCT02576977|528416473|FG000|Overall Study|Progressive Disease|0|||
146521158|NCT02576977|528416474|FG001|Overall Study|Progressive Disease|1|||
146521159|NCT02823470|528416481|FG000|Overall Study|Adverse Event|1|||
146521160|NCT02823470|528416482|FG001|Overall Study|Adverse Event|0|||
146521161|NCT02823470|528416481|FG000|Overall Study|Study terminated by sponsor|8|||
146521162|NCT02823470|528416482|FG001|Overall Study|Study terminated by sponsor|15|||
146521163|NCT01073163|528416484|FG000|Overall Study|Adverse Event|1|||
146521164|NCT01073163|528416484|FG000|Overall Study|Disease Progression|1|||
146521165|NCT01073163|528416484|FG000|Overall Study|Early termination|1|||
146521166|NCT00703677|528416485|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
146521167|NCT04441788|528416486|FG000|Overall Study|Voluntary Withdrawl|0|||
146521168|NCT04441788|528416487|FG001|Overall Study|Voluntary Withdrawl|1|||
146521169|NCT04441788|528416488|FG002|Overall Study|Voluntary Withdrawl|0|||
146521170|NCT04441788|528416486|FG000|Overall Study|Ineligibility|1|||
146521171|NCT04441788|528416487|FG001|Overall Study|Ineligibility|0|||
146521172|NCT04441788|528416488|FG002|Overall Study|Ineligibility|0|||
146521173|NCT04441788|528416486|FG000|Overall Study|Adverse Event|0|||
146521174|NCT04441788|528416487|FG001|Overall Study|Adverse Event|0|||
146521175|NCT04441788|528416488|FG002|Overall Study|Adverse Event|4|||
146521176|NCT04441788|528416486|FG000|Overall Study|Study Terminated by Sponsor|16|||
146521177|NCT04441788|528416487|FG001|Overall Study|Study Terminated by Sponsor|16|||
146521178|NCT04441788|528416488|FG002|Overall Study|Study Terminated by Sponsor|12|||
146521179|NCT03859648|528416491|FG000|Overall Study|Lost to Follow-up|1|||
146521180|NCT03859648|528416491|FG000|Overall Study|Adverse Event|1|||
146521181|NCT02315664|528416492|FG000|Overall Study|Lost to Follow-up|1|||
146521182|NCT02315664|528416493|FG001|Overall Study|Lost to Follow-up|1|||
146521183|NCT02315664|528416492|FG000|Overall Study|Withdrawal by Subject|0|||
146521184|NCT02315664|528416493|FG001|Overall Study|Withdrawal by Subject|3|||
146521185|NCT01677182|528416494|FG000|Overall Study|Adverse Event|2|||
146521186|NCT01677182|528416495|FG001|Overall Study|Adverse Event|1|||
146521187|NCT01677182|528416496|FG002|Overall Study|Adverse Event|8|||
146521188|NCT01677182|528416494|FG000|Overall Study|Protocol Violation|5|||
146521189|NCT01677182|528416495|FG001|Overall Study|Protocol Violation|1|||
146521190|NCT01677182|528416496|FG002|Overall Study|Protocol Violation|4|||
146521191|NCT01677182|528416494|FG000|Overall Study|Lost to Follow-up|4|||
146521192|NCT01677182|528416495|FG001|Overall Study|Lost to Follow-up|0|||
146521193|NCT01677182|528416496|FG002|Overall Study|Lost to Follow-up|3|||
146521194|NCT01677182|528416494|FG000|Overall Study|Withdrawal by Subject|7|||
146521195|NCT01677182|528416495|FG001|Overall Study|Withdrawal by Subject|12|||
146521196|NCT01677182|528416496|FG002|Overall Study|Withdrawal by Subject|10|||
146521197|NCT01677182|528416494|FG000|Overall Study|Study termination|12|||
146521198|NCT01677182|528416495|FG001|Overall Study|Study termination|9|||
146521199|NCT01677182|528416496|FG002|Overall Study|Study termination|11|||
146521200|NCT01677182|528416494|FG000|Overall Study|Lack of Efficacy|3|||
146521201|NCT01677182|528416495|FG001|Overall Study|Lack of Efficacy|0|||
146521202|NCT01677182|528416496|FG002|Overall Study|Lack of Efficacy|1|||
146521203|NCT01677182|528416494|FG000|Overall Study|Other reasons|1|||
146521204|NCT01677182|528416495|FG001|Overall Study|Other reasons|5|||
146521205|NCT01677182|528416496|FG002|Overall Study|Other reasons|2|||
146853785|NCT00825825|529634923|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
146853786|NCT00825825|529634924|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
146853787|NCT00825825|529634919|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
146853788|NCT00825825|529634920|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
146521206|NCT02501161|528416497|FG000|Overall Study|Adverse Event|2|||
146521207|NCT02501161|528416498|FG001|Overall Study|Adverse Event|6|||
146521208|NCT02501161|528416497|FG000|Overall Study|Lost to Follow-up|7|||
146521209|NCT02501161|528416498|FG001|Overall Study|Lost to Follow-up|4|||
146521210|NCT02501161|528416497|FG000|Overall Study|Withdrawal by Subject|10|||
146521211|NCT02501161|528416498|FG001|Overall Study|Withdrawal by Subject|15|||
146521212|NCT02501161|528416497|FG000|Overall Study|Other|3|||
146521213|NCT02501161|528416498|FG001|Overall Study|Other|0|||
146521214|NCT02793947|528416500|FG000|Overall Study|Death|1|||
146521215|NCT02793947|528416501|FG001|Overall Study|Death|0|||
146521216|NCT02793947|528416500|FG000|Overall Study|Physician Decision|1|||
146521217|NCT02793947|528416501|FG001|Overall Study|Physician Decision|5|||
146521218|NCT01465230|528416505|FG000|Overall Study|Withdrawal by Subject|2|||
146521219|NCT01738919|528416507|FG000|Overall Study|Lost to Follow-up|1|||
146521220|NCT01738919|528416508|FG001|Overall Study|Lost to Follow-up|0|||
146521221|NCT01738919|528416507|FG000|Overall Study|Immigrated|0|||
146521222|NCT01738919|528416508|FG001|Overall Study|Immigrated|1|||
146521223|NCT01738919|528416507|FG000|Overall Study|Withdrawal by Subject|0|||
146521224|NCT01738919|528416508|FG001|Overall Study|Withdrawal by Subject|1|||
146521225|NCT01738919|528416507|FG000|Overall Study|Not treated in accordance to guidelines|0|||
146521226|NCT01738919|528416508|FG001|Overall Study|Not treated in accordance to guidelines|1|||
146521227|NCT02849171|528416512|FG000|Overall Study|Withdrawal by Subject|1|||
146521228|NCT02849171|528416512|FG000|Overall Study|Not treated|1|||
146521229|NCT02532257|528416513|FG000|Overall Study|Adverse Event|2|||
146521230|NCT02532257|528416513|FG000|Overall Study|Physician Decision|4|||
146521231|NCT02532257|528416513|FG000|Overall Study|Withdrawal by Subject|3|||
146521232|NCT02532257|528416513|FG000|Overall Study|Progressive Disease|10|||
146521233|NCT02090283|528416515|FG000|Overall Study|Withdrawal by Subject|6|||
146521234|NCT02090283|528416516|FG001|Overall Study|Withdrawal by Subject|6|||
146521235|NCT02090283|528416517|FG002|Overall Study|Withdrawal by Subject|6|||
146853789|NCT00825825|529634921|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
146853790|NCT00825825|529634922|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
146853791|NCT00825825|529634923|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
146521236|NCT02090283|528416515|FG000|Overall Study|Sponsor Terminated Study|6|||
146521237|NCT02090283|528416516|FG001|Overall Study|Sponsor Terminated Study|6|||
146521238|NCT02090283|528416517|FG002|Overall Study|Sponsor Terminated Study|1|||
146521239|NCT02090283|528416515|FG000|Overall Study|Lost to Follow-up|2|||
146521240|NCT02090283|528416516|FG001|Overall Study|Lost to Follow-up|2|||
146521241|NCT02090283|528416517|FG002|Overall Study|Lost to Follow-up|3|||
146521242|NCT02090283|528416515|FG000|Overall Study|Adverse Event|1|||
146521243|NCT02090283|528416516|FG001|Overall Study|Adverse Event|1|||
146521244|NCT02090283|528416517|FG002|Overall Study|Adverse Event|0|||
146521245|NCT02090283|528416515|FG000|Overall Study|Protocol Violation|2|||
146521246|NCT02090283|528416516|FG001|Overall Study|Protocol Violation|0|||
146521247|NCT02090283|528416517|FG002|Overall Study|Protocol Violation|0|||
146521248|NCT02964338|528416519|FG000|Overall Study|Sponsor terminated study for futility|12|||
146853792|NCT00825825|529634924|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
146853793|NCT00825825|529634919|FG000|Third Medication Period (14 Days)|poor data quality|0|||
146853794|NCT00825825|529634920|FG001|Third Medication Period (14 Days)|poor data quality|1|||
146853795|NCT00825825|529634921|FG002|Third Medication Period (14 Days)|poor data quality|0|||
146853796|NCT00825825|529634922|FG003|Third Medication Period (14 Days)|poor data quality|0|||
146853797|NCT00825825|529634923|FG004|Third Medication Period (14 Days)|poor data quality|0|||
146853798|NCT00825825|529634924|FG005|Third Medication Period (14 Days)|poor data quality|0|||
146853799|NCT01047293|529634926|FG000|Overall Study|DLT criteria not fulfilled|1|||
146853800|NCT01047293|529634927|FG001|Overall Study|DLT criteria not fulfilled|1|||
146853801|NCT01047293|529634928|FG002|Overall Study|DLT criteria not fulfilled|0|||
146853802|NCT01047293|529634929|FG003|Overall Study|DLT criteria not fulfilled|0|||
146853803|NCT00757783|529634933|FG000|Overall Study|Adverse Event|0|||
146853804|NCT00757783|529634934|FG001|Overall Study|Adverse Event|2|||
146853805|NCT00757783|529634933|FG000|Overall Study|Lost to Follow-up|1|||
146853806|NCT00757783|529634934|FG001|Overall Study|Lost to Follow-up|1|||
146853807|NCT00757783|529634933|FG000|Overall Study|Protocol Violation|1|||
146853808|NCT00757783|529634934|FG001|Overall Study|Protocol Violation|0|||
146853809|NCT00757783|529634933|FG000|Overall Study|Withdrawal by Subject|2|||
146853810|NCT00757783|529634934|FG001|Overall Study|Withdrawal by Subject|1|||
146853811|NCT00757783|529634933|FG000|Overall Study|Other|1|||
146853812|NCT00757783|529634934|FG001|Overall Study|Other|2|||
146521249|NCT02964338|528416520|FG001|Overall Study|Sponsor terminated study for futility|15|||
146521250|NCT02964338|528416521|FG002|Overall Study|Sponsor terminated study for futility|14|||
146521251|NCT02964338|528416519|FG000|Overall Study|Lack of Efficacy|0|||
146853813|NCT02372136|529634939|FG000|Overall Study|Death|3|||
146756596|NCT00410384|529274853|FG002|Overall Study|Protocol Violation|6|||
146756597|NCT00410384|529274851|FG000|Overall Study|Physician Decision|3|||
146756598|NCT00410384|529274852|FG001|Overall Study|Physician Decision|3|||
146756599|NCT00410384|529274853|FG002|Overall Study|Physician Decision|4|||
146756600|NCT00410384|529274851|FG000|Overall Study|Other|3|||
146756601|NCT00410384|529274852|FG001|Overall Study|Other|8|||
146756602|NCT00410384|529274853|FG002|Overall Study|Other|4|||
146853814|NCT02372136|529634940|FG001|Overall Study|Death|1|||
146853815|NCT00985946|529634941|FG000|Overall Study|Lost to Follow-up|6|||
146853816|NCT00985946|529634941|FG000|Overall Study|Withdrawal by Subject|1|||
146853817|NCT03265938|529634945|FG000|Overall Study|Withdrawal by Subject|1|||
146853818|NCT03265938|529634945|FG000|Overall Study|Physician Decision|1|||
146521252|NCT02964338|528416520|FG001|Overall Study|Lack of Efficacy|3|||
146521253|NCT02964338|528416521|FG002|Overall Study|Lack of Efficacy|0|||
146521254|NCT02964338|528416519|FG000|Overall Study|Lost to Follow-up|1|||
146521255|NCT02964338|528416520|FG001|Overall Study|Lost to Follow-up|0|||
146521256|NCT02964338|528416521|FG002|Overall Study|Lost to Follow-up|3|||
146521257|NCT02964338|528416519|FG000|Overall Study|Protocol Violation|0|||
146521258|NCT02964338|528416520|FG001|Overall Study|Protocol Violation|1|||
146521259|NCT02964338|528416521|FG002|Overall Study|Protocol Violation|0|||
146521260|NCT02964338|528416519|FG000|Overall Study|Withdrawal by Subject|1|||
146521261|NCT02964338|528416520|FG001|Overall Study|Withdrawal by Subject|3|||
146521262|NCT02964338|528416521|FG002|Overall Study|Withdrawal by Subject|1|||
146521263|NCT02964338|528416519|FG000|Overall Study|Adverse Event|2|||
146521264|NCT02964338|528416520|FG001|Overall Study|Adverse Event|1|||
146521265|NCT02964338|528416521|FG002|Overall Study|Adverse Event|1|||
146521266|NCT02964338|528416519|FG000|Overall Study|Non-compliant with e-diary|0|||
146521267|NCT02964338|528416520|FG001|Overall Study|Non-compliant with e-diary|1|||
146521268|NCT02964338|528416521|FG002|Overall Study|Non-compliant with e-diary|0|||
146521269|NCT02964338|528416519|FG000|Overall Study|Did not meet criteria|1|||
146521270|NCT02964338|528416520|FG001|Overall Study|Did not meet criteria|0|||
146521271|NCT02964338|528416521|FG002|Overall Study|Did not meet criteria|0|||
146521272|NCT00621257|528416522|FG000|Overall Study|Lost to Follow-up|4|||
146521273|NCT00621257|528416523|FG001|Overall Study|Lost to Follow-up|0|||
146521274|NCT00621257|528416524|FG002|Overall Study|Lost to Follow-up|2|||
146521275|NCT00621257|528416525|FG003|Overall Study|Lost to Follow-up|4|||
146521276|NCT00621257|528416526|FG004|Overall Study|Lost to Follow-up|7|||
146521277|NCT00621257|528416522|FG000|Overall Study|Adverse Event|0|||
146521278|NCT00621257|528416523|FG001|Overall Study|Adverse Event|1|||
146521279|NCT00621257|528416524|FG002|Overall Study|Adverse Event|1|||
146521280|NCT00621257|528416525|FG003|Overall Study|Adverse Event|0|||
146521281|NCT00621257|528416526|FG004|Overall Study|Adverse Event|0|||
146521282|NCT00621257|528416522|FG000|Overall Study|Physician Decision|0|||
146521283|NCT00621257|528416523|FG001|Overall Study|Physician Decision|2|||
146521284|NCT00621257|528416524|FG002|Overall Study|Physician Decision|0|||
146521285|NCT00621257|528416525|FG003|Overall Study|Physician Decision|1|||
146521286|NCT00621257|528416526|FG004|Overall Study|Physician Decision|1|||
146521287|NCT00621257|528416522|FG000|Overall Study|Withdrawal by Subject|0|||
146521288|NCT00621257|528416523|FG001|Overall Study|Withdrawal by Subject|0|||
146521289|NCT00621257|528416524|FG002|Overall Study|Withdrawal by Subject|0|||
146521290|NCT00621257|528416525|FG003|Overall Study|Withdrawal by Subject|1|||
146521291|NCT00621257|528416526|FG004|Overall Study|Withdrawal by Subject|1|||
146521292|NCT01255904|528416530|FG000|Overall Study|Physician Decision|1|||
146521293|NCT01255904|528416531|FG001|Overall Study|Physician Decision|4|||
146521294|NCT00184002|528416533|FG000|Overall Study|Adverse Event|9|||
146521295|NCT00184002|528416533|FG000|Overall Study|Death|3|||
146521296|NCT00184002|528416533|FG000|Overall Study|Physician Decision|1|||
146521297|NCT00184002|528416533|FG000|Overall Study|Withdrawal by Subject|4|||
146521298|NCT02171429|528416534|FG000|Overall Study|Other|0|||
146521299|NCT02171429|528416535|FG001|Overall Study|Other|1|||
146521300|NCT02171429|528416536|FG002|Overall Study|Other|1|||
146521301|NCT02171429|528416534|FG000|Overall Study|Non-Compliance|0|||
146521302|NCT02171429|528416535|FG001|Overall Study|Non-Compliance|0|||
146521303|NCT02171429|528416536|FG002|Overall Study|Non-Compliance|1|||
146625262|NCT03037385|528803847|FG002|Overall Study|Lost to Follow-up|0|||
146756603|NCT01253200|529274854|FG000|Overall Study|Death|1|||
146756604|NCT01253200|529274855|FG001|Overall Study|Death|0|||
146756605|NCT01253200|529274856|FG002|Overall Study|Death|0|||
146756606|NCT01253200|529274857|FG003|Overall Study|Death|0|||
146756607|NCT01253200|529274858|FG004|Overall Study|Death|0|||
146756608|NCT01253200|529274854|FG000|Overall Study|Lost to Follow-up|1|||
146756609|NCT01253200|529274855|FG001|Overall Study|Lost to Follow-up|1|||
146756610|NCT01253200|529274856|FG002|Overall Study|Lost to Follow-up|0|||
146756611|NCT01253200|529274857|FG003|Overall Study|Lost to Follow-up|0|||
146756612|NCT01253200|529274858|FG004|Overall Study|Lost to Follow-up|0|||
146756613|NCT01253200|529274854|FG000|Overall Study|Withdrawal by Subject|2|||
146756614|NCT01253200|529274855|FG001|Overall Study|Withdrawal by Subject|0|||
146756615|NCT01253200|529274856|FG002|Overall Study|Withdrawal by Subject|0|||
146756616|NCT01253200|529274857|FG003|Overall Study|Withdrawal by Subject|0|||
146756617|NCT01253200|529274858|FG004|Overall Study|Withdrawal by Subject|0|||
146756618|NCT01253200|529274854|FG000|Overall Study|Protocol Violation|1|||
146756619|NCT01253200|529274855|FG001|Overall Study|Protocol Violation|4|||
146756620|NCT01253200|529274856|FG002|Overall Study|Protocol Violation|0|||
146756621|NCT01253200|529274857|FG003|Overall Study|Protocol Violation|0|||
146756622|NCT01253200|529274858|FG004|Overall Study|Protocol Violation|5|||
146756623|NCT01253200|529274854|FG000|Overall Study|intents|10|||
146756624|NCT01253200|529274855|FG001|Overall Study|intents|10|||
146756625|NCT01253200|529274856|FG002|Overall Study|intents|1|||
146756626|NCT01253200|529274857|FG003|Overall Study|intents|3|||
146756627|NCT01253200|529274858|FG004|Overall Study|intents|0|||
146756628|NCT01253200|529274854|FG000|Overall Study|Attempts|6|||
146756629|NCT01253200|529274855|FG001|Overall Study|Attempts|4|||
146756630|NCT01253200|529274856|FG002|Overall Study|Attempts|1|||
146756631|NCT01253200|529274857|FG003|Overall Study|Attempts|2|||
146756632|NCT01253200|529274858|FG004|Overall Study|Attempts|0|||
146756633|NCT02049437|529274859|FG000|Period 1|Adverse Event|1|||
146756634|NCT02049437|529274860|FG001|Period 1|Adverse Event|1|||
146756635|NCT02049437|529274859|FG000|Period 1|Adverse Event|1|||
146756636|NCT02049437|529274860|FG001|Period 1|Adverse Event|0|||
146756637|NCT01163149|529274866|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
146756638|NCT01163149|529274867|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
146756639|NCT01163149|529274868|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
146756640|NCT01163149|529274866|FG000|Extension Treatment Period|Adverse Event|0|||
146756641|NCT01163149|529274867|FG001|Extension Treatment Period|Adverse Event|1|||
146756642|NCT01163149|529274868|FG002|Extension Treatment Period|Adverse Event|0|||
146756643|NCT01163149|529274866|FG000|Extension Treatment Period|Noncompliance|0|||
146756644|NCT01163149|529274867|FG001|Extension Treatment Period|Noncompliance|0|||
146756645|NCT01163149|529274868|FG002|Extension Treatment Period|Noncompliance|1|||
146756646|NCT01192295|529274869|FG000|Overall Study|Adverse Event|3|||
146756647|NCT01192295|529274870|FG001|Overall Study|Adverse Event|7|||
146756648|NCT01192295|529274869|FG000|Overall Study|Withdrawal by Subject|3|||
146756649|NCT01192295|529274870|FG001|Overall Study|Withdrawal by Subject|4|||
146756650|NCT01192295|529274869|FG000|Overall Study|Lost to Follow-up|0|||
146756651|NCT01192295|529274870|FG001|Overall Study|Lost to Follow-up|1|||
146756652|NCT01192295|529274869|FG000|Overall Study|Lack of Efficacy|0|||
146756653|NCT01192295|529274870|FG001|Overall Study|Lack of Efficacy|5|||
146756654|NCT01192295|529274869|FG000|Overall Study|Administrative|4|||
146756655|NCT01192295|529274870|FG001|Overall Study|Administrative|6|||
146756656|NCT00630539|529274871|FG000|Overall Study|Adverse Event|1|||
146756657|NCT00630539|529274872|FG001|Overall Study|Adverse Event|3|||
146756658|NCT00630539|529274873|FG002|Overall Study|Adverse Event|1|||
146756659|NCT00630539|529274874|FG003|Overall Study|Adverse Event|2|||
146756660|NCT00630539|529274871|FG000|Overall Study|Withdrawal by Subject|0|||
146756661|NCT00630539|529274872|FG001|Overall Study|Withdrawal by Subject|1|||
146756662|NCT00630539|529274873|FG002|Overall Study|Withdrawal by Subject|0|||
146756663|NCT00630539|529274874|FG003|Overall Study|Withdrawal by Subject|1|||
146756664|NCT01700530|529274877|FG000|Overall Study|Withdrawal by Subject|0|||
146756665|NCT01700530|529274878|FG001|Overall Study|Withdrawal by Subject|3|||
146756666|NCT01700530|529274879|FG002|Overall Study|Withdrawal by Subject|1|||
146756667|NCT02806336|529274890|FG000|Overall Study|Physician Decision|1|||
146756668|NCT02806336|529274891|FG001|Overall Study|Physician Decision|0|||
146756669|NCT02806336|529274890|FG000|Overall Study|Withdrawal by Subject|2|||
146756670|NCT02806336|529274891|FG001|Overall Study|Withdrawal by Subject|4|||
146756671|NCT02806336|529274890|FG000|Overall Study|COVID-19 research shut down|3|||
146756672|NCT02806336|529274891|FG001|Overall Study|COVID-19 research shut down|4|||
146756673|NCT02806336|529274890|FG000|Overall Study|Lack of Efficacy|0|||
146756674|NCT02806336|529274891|FG001|Overall Study|Lack of Efficacy|1|||
146756675|NCT04159896|529274892|FG000|Overall Study|Lack of Efficacy|7|||
146756676|NCT04159896|529274892|FG000|Overall Study|Withdrawal by Subject|1|||
146756677|NCT04159896|529274892|FG000|Overall Study|Adverse Event|1|||
146756678|NCT04159896|529274892|FG000|Overall Study|A transient ischaemic attack|1|||
146756679|NCT05705167|529274893|FG000|Overall Study|Randomised but not Treated|0|||
146756680|NCT05705167|529274894|FG001|Overall Study|Randomised but not Treated|2|||
146756681|NCT05705167|529274895|FG002|Overall Study|Randomised but not Treated|0|||
146756682|NCT05705167|529274896|FG003|Overall Study|Randomised but not Treated|7|||
146756683|NCT05705167|529274897|FG004|Overall Study|Randomised but not Treated|0|||
146756684|NCT05705167|529274898|FG005|Overall Study|Randomised but not Treated|0|||
146756685|NCT05705167|529274899|FG006|Overall Study|Randomised but not Treated|0|||
146756686|NCT05705167|529274893|FG000|Overall Study|Death|0|||
146756687|NCT05705167|529274894|FG001|Overall Study|Death|0|||
146756688|NCT05705167|529274895|FG002|Overall Study|Death|3|||
146756689|NCT05705167|529274896|FG003|Overall Study|Death|0|||
146756690|NCT05705167|529274897|FG004|Overall Study|Death|1|||
146756691|NCT05705167|529274898|FG005|Overall Study|Death|1|||
146756692|NCT05705167|529274899|FG006|Overall Study|Death|1|||
146756693|NCT05705167|529274893|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
146756694|NCT05705167|529274894|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
146756695|NCT05705167|529274895|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
146853819|NCT03265938|529634945|FG000|Overall Study|friable mass|6|||
146521304|NCT02171429|528416534|FG000|Overall Study|Physician Decision|0|||
146521305|NCT02171429|528416535|FG001|Overall Study|Physician Decision|0|||
146521306|NCT02171429|528416536|FG002|Overall Study|Physician Decision|1|||
146521307|NCT02171429|528416534|FG000|Overall Study|Withdrawal by Subject|1|||
146521308|NCT02171429|528416535|FG001|Overall Study|Withdrawal by Subject|1|||
146521309|NCT02171429|528416536|FG002|Overall Study|Withdrawal by Subject|1|||
146521310|NCT02171429|528416534|FG000|Overall Study|Lost to Follow-up|0|||
146521311|NCT02171429|528416535|FG001|Overall Study|Lost to Follow-up|1|||
146521312|NCT02171429|528416536|FG002|Overall Study|Lost to Follow-up|0|||
146521313|NCT02171429|528416534|FG000|Overall Study|Death|0|||
146521314|NCT02171429|528416535|FG001|Overall Study|Death|0|||
146521315|NCT02171429|528416536|FG002|Overall Study|Death|1|||
146521316|NCT01724177|528416541|FG000|Overall Study|Adverse Event|8|||
146521317|NCT01724177|528416541|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
146521318|NCT01724177|528416541|FG000|Overall Study|Nervous participant|1|||
146521319|NCT01724177|528416541|FG000|Overall Study|Serious Adverse Event Related|1|||
146521320|NCT02821416|528416546|FG000|Overall Study|Adverse Event|0|||
146521321|NCT02821416|528416547|FG001|Overall Study|Adverse Event|1|||
146521322|NCT02821416|528416546|FG000|Overall Study|Withdrawal by Subject|2|||
146521323|NCT02821416|528416547|FG001|Overall Study|Withdrawal by Subject|0|||
146521324|NCT02821416|528416546|FG000|Overall Study|Lost to Follow-up|1|||
146521325|NCT02821416|528416547|FG001|Overall Study|Lost to Follow-up|0|||
146521326|NCT02256917|528416548|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
146521327|NCT02256917|528416548|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
146521328|NCT02256917|528416548|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
146521329|NCT02256917|528416548|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
146521330|NCT02256917|528416548|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
146521331|NCT00807612|528416550|FG000|Overall Study|Death|8|||
146521332|NCT00807612|528416550|FG000|Overall Study|Study early termination|5|||
146521333|NCT00807612|528416550|FG000|Overall Study|Withdrawal by Subject|1|||
146521334|NCT04819438|528416551|FG000|Overall Study|Withdrawal by Subject|1|||
146521335|NCT04819438|528416552|FG001|Overall Study|Withdrawal by Subject|0|||
146521336|NCT04819438|528416551|FG000|Overall Study|Adverse Event|0|||
146521337|NCT04819438|528416552|FG001|Overall Study|Adverse Event|1|||
146521338|NCT04819438|528416551|FG000|Overall Study|Protocol Violation|0|||
146521339|NCT04819438|528416552|FG001|Overall Study|Protocol Violation|1|||
146521340|NCT04607135|528416553|FG000|Overall Study|Physician Decision|1|||
146521341|NCT04607135|528416553|FG000|Overall Study|Withdrawal by Subject|1|||
146521342|NCT04607135|528416553|FG000|Overall Study|Equipment not working|3|||
146521343|NCT02869893|528416554|FG000|Overall Study|participant aversion to IV|5|||
146521344|NCT02869893|528416554|FG000|Overall Study|participant fear of MRI scanner|2|||
146521345|NCT02328937|528416555|FG000|Period 1|Lost to Follow-up|0|||
146521346|NCT02328937|528416556|FG001|Period 1|Lost to Follow-up|0|||
146521347|NCT02328937|528416557|FG002|Period 1|Lost to Follow-up|0|||
146521348|NCT02328937|528416558|FG003|Period 1|Lost to Follow-up|1|||
146521349|NCT02328937|528416559|FG004|Period 1|Lost to Follow-up|0|||
146521350|NCT02328937|528416560|FG005|Period 1|Lost to Follow-up|0|||
146521351|NCT02328937|528416555|FG000|Period 2|Adverse Event|0|||
146521352|NCT02328937|528416556|FG001|Period 2|Adverse Event|0|||
146521353|NCT02328937|528416557|FG002|Period 2|Adverse Event|1|||
146521354|NCT02328937|528416558|FG003|Period 2|Adverse Event|0|||
146521355|NCT02328937|528416559|FG004|Period 2|Adverse Event|0|||
146521356|NCT02328937|528416560|FG005|Period 2|Adverse Event|0|||
146521357|NCT00435461|528416563|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
146521358|NCT00435461|528416564|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
146521359|NCT00435461|528416565|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
146521360|NCT00435461|528416563|FG000|Overall Study|Protocol Violation|6|||
146521361|NCT00435461|528416564|FG001|Overall Study|Protocol Violation|9|||
146521362|NCT00435461|528416565|FG002|Overall Study|Protocol Violation|10|||
146521363|NCT00435461|528416563|FG000|Overall Study|Participant randomized(inadequate score)|1|||
146521364|NCT00435461|528416564|FG001|Overall Study|Participant randomized(inadequate score)|0|||
146521365|NCT00435461|528416565|FG002|Overall Study|Participant randomized(inadequate score)|0|||
146521366|NCT00435461|528416563|FG000|Overall Study|Compliance less than 80 percent|1|||
146521367|NCT00435461|528416564|FG001|Overall Study|Compliance less than 80 percent|0|||
146521368|NCT00435461|528416565|FG002|Overall Study|Compliance less than 80 percent|0|||
146521369|NCT00435461|528416563|FG000|Overall Study|In error, two study medications switched|1|||
146521370|NCT00435461|528416564|FG001|Overall Study|In error, two study medications switched|0|||
146521371|NCT00435461|528416565|FG002|Overall Study|In error, two study medications switched|0|||
146521372|NCT00435461|528416563|FG000|Overall Study|Lack of Efficacy|2|||
146521373|NCT00435461|528416564|FG001|Overall Study|Lack of Efficacy|1|||
146521374|NCT00435461|528416565|FG002|Overall Study|Lack of Efficacy|0|||
146521375|NCT00435461|528416563|FG000|Overall Study|Withdrawal by Subject|1|||
146521376|NCT00435461|528416564|FG001|Overall Study|Withdrawal by Subject|0|||
146521377|NCT00435461|528416565|FG002|Overall Study|Withdrawal by Subject|2|||
146521378|NCT00435461|528416563|FG000|Overall Study|Randomized in error|1|||
146521379|NCT00435461|528416564|FG001|Overall Study|Randomized in error|0|||
146521380|NCT00435461|528416565|FG002|Overall Study|Randomized in error|0|||
146521381|NCT00435461|528416563|FG000|Overall Study|Participant could not tolerate symptoms|0|||
146521382|NCT00435461|528416564|FG001|Overall Study|Participant could not tolerate symptoms|0|||
146521383|NCT00435461|528416565|FG002|Overall Study|Participant could not tolerate symptoms|1|||
146521384|NCT00435461|528416563|FG000|Overall Study|Participant could not swallow capsule|0|||
146521385|NCT00435461|528416564|FG001|Overall Study|Participant could not swallow capsule|0|||
146521386|NCT00435461|528416565|FG002|Overall Study|Participant could not swallow capsule|1|||
146521387|NCT00435461|528416563|FG000|Overall Study|Pregnancy|2|||
146521388|NCT00435461|528416564|FG001|Overall Study|Pregnancy|0|||
146521389|NCT00435461|528416565|FG002|Overall Study|Pregnancy|0|||
146521390|NCT00435461|528416563|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
146521391|NCT00435461|528416564|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
146521392|NCT00435461|528416565|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
146521393|NCT00435461|528416563|FG000|Overall Study|Participant ended study one day early|1|||
146521394|NCT00435461|528416564|FG001|Overall Study|Participant ended study one day early|0|||
146521395|NCT00435461|528416565|FG002|Overall Study|Participant ended study one day early|0|||
146521396|NCT00435461|528416563|FG000|Overall Study|Noncompliance with study requirements|1|||
146521397|NCT00435461|528416564|FG001|Overall Study|Noncompliance with study requirements|1|||
146521398|NCT00435461|528416565|FG002|Overall Study|Noncompliance with study requirements|1|||
146521399|NCT00435461|528416563|FG000|Overall Study|Adverse Event|1|||
146521400|NCT00435461|528416564|FG001|Overall Study|Adverse Event|2|||
146521401|NCT00435461|528416565|FG002|Overall Study|Adverse Event|6|||
146521402|NCT00435461|528416563|FG000|Overall Study|Non-Compliance of diary|2|||
146521403|NCT00435461|528416564|FG001|Overall Study|Non-Compliance of diary|0|||
146521404|NCT00435461|528416565|FG002|Overall Study|Non-Compliance of diary|1|||
146521405|NCT00435461|528416563|FG000|Overall Study|Lost to Follow-up|1|||
146521406|NCT00435461|528416564|FG001|Overall Study|Lost to Follow-up|1|||
146521407|NCT00435461|528416565|FG002|Overall Study|Lost to Follow-up|2|||
146521408|NCT01768559|528416566|FG000|Overall Study|Randomized but not treated|0|||
146521409|NCT01768559|528416567|FG001|Overall Study|Randomized but not treated|0|||
146521410|NCT01768559|528416568|FG002|Overall Study|Randomized but not treated|1|||
146521411|NCT01768559|528416566|FG000|Overall Study|Adverse Event|15|||
146521412|NCT01768559|528416567|FG001|Overall Study|Adverse Event|2|||
146521413|NCT01768559|528416568|FG002|Overall Study|Adverse Event|5|||
146521414|NCT01768559|528416566|FG000|Overall Study|Lack of Efficacy|6|||
146521415|NCT01768559|528416567|FG001|Overall Study|Lack of Efficacy|4|||
146521416|NCT01768559|528416568|FG002|Overall Study|Lack of Efficacy|0|||
146521417|NCT01768559|528416566|FG000|Overall Study|Poor compliance to protocol|0|||
146521418|NCT01768559|528416567|FG001|Overall Study|Poor compliance to protocol|3|||
146521419|NCT01768559|528416568|FG002|Overall Study|Poor compliance to protocol|2|||
146521420|NCT01768559|528416566|FG000|Overall Study|Other than specified|9|||
146521421|NCT01768559|528416567|FG001|Overall Study|Other than specified|8|||
146521422|NCT01768559|528416568|FG002|Overall Study|Other than specified|5|||
146521423|NCT00685360|528416576|FG000|Overall Study|Lost to Follow-up|0|||
146521424|NCT00685360|528416577|FG001|Overall Study|Lost to Follow-up|1|||
146521425|NCT00685360|528416578|FG002|Overall Study|Lost to Follow-up|2|||
146521426|NCT00685360|528416576|FG000|Overall Study|Adverse Event|4|||
146521427|NCT00685360|528416577|FG001|Overall Study|Adverse Event|6|||
146521428|NCT00685360|528416578|FG002|Overall Study|Adverse Event|4|||
146521429|NCT00685360|528416576|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
146521430|NCT00685360|528416577|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
146521431|NCT00685360|528416578|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
146521432|NCT00685360|528416576|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
146521433|NCT00685360|528416577|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
146521434|NCT00685360|528416578|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
146521435|NCT00685360|528416576|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
146521436|NCT00685360|528416577|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
146521437|NCT00685360|528416578|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
146521438|NCT00685360|528416576|FG000|Overall Study|Protocol Deviation|0|||
146521439|NCT00685360|528416577|FG001|Overall Study|Protocol Deviation|1|||
146521440|NCT00685360|528416578|FG002|Overall Study|Protocol Deviation|1|||
146521441|NCT01386944|528416579|FG000|Overall Study|Adverse Event|26|||
146521442|NCT01386944|528416579|FG000|Overall Study|Lack of Efficacy|14|||
146521443|NCT01386944|528416579|FG000|Overall Study|Lost to Follow-up|8|||
146521444|NCT01386944|528416579|FG000|Overall Study|Unspecified reason|8|||
146521445|NCT04186221|528416580|FG000|Overall Study|Death|1|||
146521446|NCT01904032|528416587|FG000|Overall Study|Adverse Event|3|||
146521447|NCT01904032|528416588|FG001|Overall Study|Adverse Event|1|||
146521448|NCT01904032|528416587|FG000|Overall Study|Lost to Follow-up|4|||
146521449|NCT01904032|528416588|FG001|Overall Study|Lost to Follow-up|2|||
146521450|NCT00972283|528416592|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
146521451|NCT00972283|528416593|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
146521452|NCT00972283|528416592|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
146521453|NCT00972283|528416593|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
146853820|NCT02673515|529634946|FG000|Overall Study|Lack of motivation|2|||
146853821|NCT02673515|529634947|FG001|Overall Study|Lack of motivation|1|||
146853822|NCT02008877|529634948|FG000|Overall Study|Inevaluable|0|||
146853823|NCT02008877|529634949|FG001|Overall Study|Inevaluable|1|||
146853824|NCT02008877|529634950|FG002|Overall Study|Inevaluable|0|||
146853825|NCT01049217|529634951|FG000|Overall Study|Adverse Event|2|||
146853826|NCT01049217|529634952|FG001|Overall Study|Adverse Event|1|||
146853827|NCT01049217|529634951|FG000|Overall Study|Lack of Efficacy|1|||
146853828|NCT01049217|529634952|FG001|Overall Study|Lack of Efficacy|1|||
146965058|NCT03110107|530033448|FG022|Treatment Period|Study drug toxicity|2|||
146853829|NCT01049217|529634951|FG000|Overall Study|Lost to Follow-up|3|||
146853830|NCT01049217|529634952|FG001|Overall Study|Lost to Follow-up|8|||
146853831|NCT01049217|529634951|FG000|Overall Study|Withdrawal by Subject|4|||
146853832|NCT01049217|529634952|FG001|Overall Study|Withdrawal by Subject|3|||
146853833|NCT01049217|529634951|FG000|Overall Study|Protocol Violation|1|||
146853834|NCT01049217|529634952|FG001|Overall Study|Protocol Violation|3|||
146853835|NCT01049217|529634951|FG000|Overall Study|Pregnancy|1|||
146853836|NCT01049217|529634952|FG001|Overall Study|Pregnancy|0|||
146853837|NCT01049217|529634951|FG000|Overall Study|Study Terminated by Sponsor|43|||
146853838|NCT01049217|529634952|FG001|Overall Study|Study Terminated by Sponsor|43|||
146853839|NCT01049217|529634951|FG000|Overall Study|Other|1|||
146853840|NCT01049217|529634952|FG001|Overall Study|Other|2|||
146853841|NCT01049217|529634951|FG000|Overall Study|Randomized but not Treated|0|||
146853842|NCT01049217|529634952|FG001|Overall Study|Randomized but not Treated|2|||
146853843|NCT01946438|529634953|FG000|Overall Study|Adverse Event|0|||
146853844|NCT01946438|529634954|FG001|Overall Study|Adverse Event|0|||
146853845|NCT01946438|529634955|FG002|Overall Study|Adverse Event|0|||
146853846|NCT01946438|529634956|FG003|Overall Study|Adverse Event|1|||
146853847|NCT01946438|529634953|FG000|Overall Study|Serious Adverse event|1|||
146853848|NCT01946438|529634954|FG001|Overall Study|Serious Adverse event|0|||
146853849|NCT01946438|529634955|FG002|Overall Study|Serious Adverse event|0|||
146853850|NCT01946438|529634956|FG003|Overall Study|Serious Adverse event|0|||
146853851|NCT01946438|529634953|FG000|Overall Study|Protocol Violation|0|||
146853852|NCT01946438|529634954|FG001|Overall Study|Protocol Violation|0|||
146853853|NCT01946438|529634955|FG002|Overall Study|Protocol Violation|1|||
146853854|NCT01946438|529634956|FG003|Overall Study|Protocol Violation|0|||
146853855|NCT01946438|529634953|FG000|Overall Study|Withdrawal by Subject|1|||
146853856|NCT01946438|529634954|FG001|Overall Study|Withdrawal by Subject|0|||
146853857|NCT01946438|529634955|FG002|Overall Study|Withdrawal by Subject|0|||
146853858|NCT01946438|529634956|FG003|Overall Study|Withdrawal by Subject|0|||
146853859|NCT02412371|529634957|FG000|Overall Study|Withdrawal by Subject|0|||
146853860|NCT02412371|529634958|FG001|Overall Study|Withdrawal by Subject|2|||
146853861|NCT02412371|529634959|FG002|Overall Study|Withdrawal by Subject|0|||
146853862|NCT02412371|529634960|FG003|Overall Study|Withdrawal by Subject|1|||
146853863|NCT02412371|529634961|FG004|Overall Study|Withdrawal by Subject|1|||
146853864|NCT02412371|529634962|FG005|Overall Study|Withdrawal by Subject|0|||
146853865|NCT02412371|529634957|FG000|Overall Study|Sponsor Discontinued Study|1|||
146853866|NCT02412371|529634958|FG001|Overall Study|Sponsor Discontinued Study|4|||
146853867|NCT02412371|529634959|FG002|Overall Study|Sponsor Discontinued Study|6|||
146853868|NCT02412371|529634960|FG003|Overall Study|Sponsor Discontinued Study|4|||
146853869|NCT02412371|529634961|FG004|Overall Study|Sponsor Discontinued Study|5|||
146853870|NCT02412371|529634962|FG005|Overall Study|Sponsor Discontinued Study|0|||
146853871|NCT02412371|529634957|FG000|Overall Study|Death|4|||
146853872|NCT02412371|529634958|FG001|Overall Study|Death|2|||
146853873|NCT02412371|529634959|FG002|Overall Study|Death|1|||
146853874|NCT02412371|529634960|FG003|Overall Study|Death|3|||
146853875|NCT02412371|529634961|FG004|Overall Study|Death|5|||
146853876|NCT02412371|529634962|FG005|Overall Study|Death|2|||
146853877|NCT02412371|529634957|FG000|Overall Study|Other|2|||
146853878|NCT02412371|529634958|FG001|Overall Study|Other|1|||
146853879|NCT02412371|529634959|FG002|Overall Study|Other|0|||
146853880|NCT02412371|529634960|FG003|Overall Study|Other|0|||
146853881|NCT02412371|529634961|FG004|Overall Study|Other|1|||
146853882|NCT02412371|529634962|FG005|Overall Study|Other|3|||
146853883|NCT05000931|529634971|FG000|Overall Study|Lost to Follow-up|1|||
146853884|NCT03149549|529634972|FG000|Study Discontinuation--Treatment Period|Death|0|||
146853885|NCT03149549|529634973|FG001|Study Discontinuation--Treatment Period|Death|0|||
146853886|NCT03149549|529634974|FG002|Study Discontinuation--Treatment Period|Death|0|||
146853887|NCT03149549|529634975|FG003|Study Discontinuation--Treatment Period|Death|1|||
146853888|NCT03149549|529634976|FG004|Study Discontinuation--Treatment Period|Death|2|||
146853889|NCT03149549|529634977|FG005|Study Discontinuation--Treatment Period|Death|1|||
146853890|NCT03149549|529634978|FG006|Study Discontinuation--Treatment Period|Death|1|||
146853891|NCT03149549|529634979|FG007|Study Discontinuation--Treatment Period|Death|2|||
146853892|NCT03149549|529634980|FG008|Study Discontinuation--Treatment Period|Death|4|||
146853893|NCT03149549|529634981|FG009|Study Discontinuation--Treatment Period|Death|1|||
146853894|NCT03149549|529634982|FG010|Study Discontinuation--Treatment Period|Death|0|||
146853895|NCT03149549|529634983|FG011|Study Discontinuation--Treatment Period|Death|0|||
146853896|NCT03149549|529634984|FG012|Study Discontinuation--Treatment Period|Death|1|||
146853897|NCT03149549|529634972|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146853898|NCT03149549|529634973|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146853899|NCT03149549|529634974|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146853900|NCT03149549|529634975|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146853901|NCT03149549|529634976|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146853902|NCT03149549|529634977|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146853903|NCT03149549|529634978|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146853904|NCT03149549|529634979|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
146853905|NCT03149549|529634980|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146853906|NCT03149549|529634981|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146853907|NCT03149549|529634982|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146853908|NCT03149549|529634983|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146853909|NCT03149549|529634984|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
146853910|NCT03149549|529634972|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
146853911|NCT03149549|529634973|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
146853912|NCT03149549|529634974|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
146853913|NCT03149549|529634975|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
146853914|NCT03149549|529634976|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
146853915|NCT03149549|529634977|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
146853916|NCT03149549|529634978|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
146853917|NCT03149549|529634979|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
146853918|NCT03149549|529634980|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
146853919|NCT03149549|529634981|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
146853920|NCT03149549|529634982|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
146853921|NCT03149549|529634983|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
146853922|NCT03149549|529634984|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
146853923|NCT03149549|529634972|FG000|Study Discontinuation--Treatment Period|Other|0|||
146853924|NCT03149549|529634973|FG001|Study Discontinuation--Treatment Period|Other|0|||
146853925|NCT03149549|529634974|FG002|Study Discontinuation--Treatment Period|Other|0|||
146853926|NCT03149549|529634975|FG003|Study Discontinuation--Treatment Period|Other|0|||
146853927|NCT03149549|529634976|FG004|Study Discontinuation--Treatment Period|Other|0|||
146853928|NCT03149549|529634977|FG005|Study Discontinuation--Treatment Period|Other|0|||
146853929|NCT03149549|529634978|FG006|Study Discontinuation--Treatment Period|Other|0|||
146853930|NCT03149549|529634979|FG007|Study Discontinuation--Treatment Period|Other|1|||
146853931|NCT03149549|529634980|FG008|Study Discontinuation--Treatment Period|Other|0|||
146853932|NCT03149549|529634981|FG009|Study Discontinuation--Treatment Period|Other|1|||
146853933|NCT03149549|529634982|FG010|Study Discontinuation--Treatment Period|Other|0|||
146853934|NCT03149549|529634983|FG011|Study Discontinuation--Treatment Period|Other|0|||
146853935|NCT03149549|529634984|FG012|Study Discontinuation--Treatment Period|Other|0|||
146853936|NCT03149549|529634972|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146853937|NCT03149549|529634973|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146853938|NCT03149549|529634974|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146853939|NCT03149549|529634975|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146853940|NCT03149549|529634976|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146853941|NCT03149549|529634977|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
146853942|NCT03149549|529634978|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
146853943|NCT03149549|529634979|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146853944|NCT03149549|529634980|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
146853945|NCT03149549|529634981|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146853946|NCT03149549|529634982|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146853947|NCT03149549|529634983|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146853948|NCT03149549|529634984|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146853949|NCT03149549|529634972|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
146853950|NCT03149549|529634973|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
146853951|NCT03149549|529634974|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
146853952|NCT03149549|529634975|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
146853953|NCT03149549|529634976|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
146853954|NCT03149549|529634977|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
146853955|NCT03149549|529634978|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
146853956|NCT03149549|529634979|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
146853957|NCT03149549|529634980|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
146853958|NCT03149549|529634981|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
146853959|NCT03149549|529634982|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
146853960|NCT03149549|529634983|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
146853961|NCT03149549|529634984|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
146853962|NCT03149549|529634972|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
146853963|NCT03149549|529634973|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
146853964|NCT03149549|529634974|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
146853965|NCT03149549|529634975|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
146853966|NCT03149549|529634976|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
146853967|NCT03149549|529634977|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
146853968|NCT03149549|529634978|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
146756696|NCT05705167|529274896|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
146756697|NCT05705167|529274897|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
146756698|NCT05705167|529274898|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
146756699|NCT05705167|529274899|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
146756700|NCT04529538|529274900|FG000|Overall Study|Lost to Follow-up|3|||
146756701|NCT04529538|529274901|FG001|Overall Study|Lost to Follow-up|2|||
146756702|NCT04529538|529274902|FG002|Overall Study|Lost to Follow-up|1|||
146756703|NCT04529538|529274903|FG003|Overall Study|Lost to Follow-up|0|||
146756704|NCT04529538|529274904|FG004|Overall Study|Lost to Follow-up|1|||
146756705|NCT04529538|529274905|FG005|Overall Study|Lost to Follow-up|1|||
146756706|NCT04529538|529274906|FG006|Overall Study|Lost to Follow-up|2|||
146756707|NCT04529538|529274907|FG007|Overall Study|Lost to Follow-up|0|||
146756708|NCT04529538|529274900|FG000|Overall Study|Not eligible at enrollment|0|||
146756709|NCT04529538|529274901|FG001|Overall Study|Not eligible at enrollment|1|||
146756710|NCT04529538|529274902|FG002|Overall Study|Not eligible at enrollment|2|||
146756711|NCT04529538|529274903|FG003|Overall Study|Not eligible at enrollment|1|||
146756712|NCT04529538|529274904|FG004|Overall Study|Not eligible at enrollment|0|||
146756713|NCT04529538|529274905|FG005|Overall Study|Not eligible at enrollment|0|||
146756714|NCT04529538|529274906|FG006|Overall Study|Not eligible at enrollment|0|||
146756715|NCT04529538|529274907|FG007|Overall Study|Not eligible at enrollment|1|||
146756716|NCT04529538|529274900|FG000|Overall Study|Withdrawal by Subject|0|||
146756717|NCT04529538|529274901|FG001|Overall Study|Withdrawal by Subject|1|||
146756718|NCT04529538|529274902|FG002|Overall Study|Withdrawal by Subject|1|||
146756719|NCT04529538|529274903|FG003|Overall Study|Withdrawal by Subject|2|||
146756720|NCT04529538|529274904|FG004|Overall Study|Withdrawal by Subject|0|||
146756721|NCT04529538|529274905|FG005|Overall Study|Withdrawal by Subject|2|||
146756722|NCT04529538|529274906|FG006|Overall Study|Withdrawal by Subject|3|||
146756723|NCT04529538|529274907|FG007|Overall Study|Withdrawal by Subject|0|||
146756724|NCT04529538|529274900|FG000|Overall Study|Other|0|||
146756725|NCT04529538|529274901|FG001|Overall Study|Other|1|||
146756726|NCT04529538|529274902|FG002|Overall Study|Other|0|||
146756727|NCT04529538|529274903|FG003|Overall Study|Other|0|||
146756728|NCT04529538|529274904|FG004|Overall Study|Other|0|||
146756729|NCT04529538|529274905|FG005|Overall Study|Other|0|||
146756730|NCT04529538|529274906|FG006|Overall Study|Other|0|||
146756731|NCT04529538|529274907|FG007|Overall Study|Other|0|||
146756732|NCT04529538|529274900|FG000|Overall Study|Adverse Event|0|||
146756733|NCT04529538|529274901|FG001|Overall Study|Adverse Event|0|||
146756734|NCT04529538|529274902|FG002|Overall Study|Adverse Event|0|||
146756735|NCT04529538|529274903|FG003|Overall Study|Adverse Event|1|||
146756736|NCT04529538|529274904|FG004|Overall Study|Adverse Event|0|||
146756737|NCT04529538|529274905|FG005|Overall Study|Adverse Event|0|||
146756738|NCT04529538|529274906|FG006|Overall Study|Adverse Event|0|||
146756739|NCT04529538|529274907|FG007|Overall Study|Adverse Event|0|||
146756740|NCT04529538|529274900|FG000|Overall Study|Protocol Deviation|0|||
146756741|NCT04529538|529274901|FG001|Overall Study|Protocol Deviation|0|||
146756742|NCT04529538|529274902|FG002|Overall Study|Protocol Deviation|0|||
146756743|NCT04529538|529274903|FG003|Overall Study|Protocol Deviation|1|||
146756744|NCT04529538|529274904|FG004|Overall Study|Protocol Deviation|0|||
146756745|NCT04529538|529274905|FG005|Overall Study|Protocol Deviation|0|||
146756746|NCT04529538|529274906|FG006|Overall Study|Protocol Deviation|0|||
146756747|NCT04529538|529274907|FG007|Overall Study|Protocol Deviation|0|||
146756748|NCT04529538|529274900|FG000|Overall Study|Physician Decision|0|||
146756749|NCT04529538|529274901|FG001|Overall Study|Physician Decision|0|||
146756750|NCT04529538|529274902|FG002|Overall Study|Physician Decision|0|||
146756751|NCT04529538|529274903|FG003|Overall Study|Physician Decision|0|||
146756752|NCT04529538|529274904|FG004|Overall Study|Physician Decision|0|||
146756753|NCT04529538|529274905|FG005|Overall Study|Physician Decision|1|||
146756754|NCT04529538|529274906|FG006|Overall Study|Physician Decision|0|||
146756755|NCT04529538|529274907|FG007|Overall Study|Physician Decision|1|||
146756756|NCT02223182|529274908|FG000|Double-Blind Period|Adverse Event|0|||
146756757|NCT02223182|529274909|FG001|Double-Blind Period|Adverse Event|2|||
146756758|NCT02223182|529274910|FG002|Double-Blind Period|Adverse Event|1|||
146756759|NCT02223182|529274911|FG003|Double-Blind Period|Adverse Event|0|||
146756760|NCT02223182|529274908|FG000|Double-Blind Period|Withdrawal by Subject|1|||
146756761|NCT02223182|529274909|FG001|Double-Blind Period|Withdrawal by Subject|1|||
146756762|NCT02223182|529274910|FG002|Double-Blind Period|Withdrawal by Subject|1|||
146756763|NCT02223182|529274911|FG003|Double-Blind Period|Withdrawal by Subject|0|||
146756764|NCT02223182|529274908|FG000|Double-Blind Period|Lost to Follow-up|0|||
146756765|NCT02223182|529274909|FG001|Double-Blind Period|Lost to Follow-up|1|||
146756766|NCT02223182|529274910|FG002|Double-Blind Period|Lost to Follow-up|0|||
146756767|NCT02223182|529274911|FG003|Double-Blind Period|Lost to Follow-up|0|||
146756768|NCT02223182|529274908|FG000|Double-Blind Period|Non Compliance|0|||
146756769|NCT02223182|529274909|FG001|Double-Blind Period|Non Compliance|0|||
146756770|NCT02223182|529274910|FG002|Double-Blind Period|Non Compliance|0|||
146756771|NCT02223182|529274911|FG003|Double-Blind Period|Non Compliance|1|||
146756772|NCT02223182|529274908|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
146853969|NCT03149549|529634979|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
146853970|NCT03149549|529634980|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
146853971|NCT03149549|529634981|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
146853972|NCT03149549|529634982|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
146853973|NCT03149549|529634983|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
146853974|NCT03149549|529634984|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
146853975|NCT03149549|529634972|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
146853976|NCT03149549|529634973|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
146853977|NCT03149549|529634974|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
146853978|NCT03149549|529634975|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
146853979|NCT03149549|529634976|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
146853980|NCT03149549|529634977|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
146853981|NCT03149549|529634978|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
146853982|NCT03149549|529634979|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
146853983|NCT03149549|529634980|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
146853984|NCT03149549|529634981|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
146853985|NCT03149549|529634982|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
146853986|NCT03149549|529634983|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
146853987|NCT03149549|529634984|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
146853988|NCT03149549|529634972|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
146853989|NCT03149549|529634973|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
146853990|NCT03149549|529634974|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
146853991|NCT03149549|529634975|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
146853992|NCT03149549|529634976|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
146853993|NCT03149549|529634977|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
146853994|NCT03149549|529634978|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
146853995|NCT03149549|529634979|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
146853996|NCT03149549|529634980|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
146853997|NCT03149549|529634981|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
146853998|NCT03149549|529634982|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
146853999|NCT03149549|529634983|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
146854000|NCT03149549|529634984|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
146854001|NCT01892540|529634987|FG000|Overall Study|Did not complete PET/MRI|0|||
146854002|NCT01892540|529634988|FG001|Overall Study|Did not complete PET/MRI|0|||
146854003|NCT01892540|529634989|FG002|Overall Study|Did not complete PET/MRI|2|||
146854004|NCT01892540|529634987|FG000|Overall Study|Did not fit in scanner|0|||
146854005|NCT01892540|529634988|FG001|Overall Study|Did not fit in scanner|0|||
146854006|NCT01892540|529634989|FG002|Overall Study|Did not fit in scanner|1|||
146854007|NCT03141905|529634992|FG000|Overall Study|Death|3|||
146854008|NCT03141905|529634993|FG001|Overall Study|Death|2|||
146854009|NCT03141905|529634992|FG000|Overall Study|Withdrawal by Subject|1|||
146854010|NCT03141905|529634993|FG001|Overall Study|Withdrawal by Subject|0|||
146854011|NCT03141905|529634992|FG000|Overall Study|Lost to Follow-up|3|||
146854012|NCT03141905|529634993|FG001|Overall Study|Lost to Follow-up|7|||
146854013|NCT03141905|529634992|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
146854014|NCT03141905|529634993|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
146854015|NCT04227704|529634999|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
146854016|NCT04227704|529635000|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
146854017|NCT04227704|529635001|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
146854018|NCT04227704|529634999|FG000|Overall Study|due to C/S being cancelled|1|||
146854019|NCT04227704|529635000|FG001|Overall Study|due to C/S being cancelled|0|||
146854020|NCT04227704|529635001|FG002|Overall Study|due to C/S being cancelled|0|||
146854021|NCT01775124|529635005|FG000|Core Period|Disease Progression|0|||
146854022|NCT01775124|529635006|FG001|Core Period|Disease Progression|1|||
146854023|NCT01775124|529635005|FG000|Core Period|Physician Decision|1|||
146854024|NCT01775124|529635006|FG001|Core Period|Physician Decision|1|||
146854025|NCT01775124|529635005|FG000|Core Period|Death|0|||
146854026|NCT01775124|529635006|FG001|Core Period|Death|1|||
146854027|NCT01775124|529635005|FG000|Core Period|Administrative problems|1|||
146854028|NCT01775124|529635006|FG001|Core Period|Administrative problems|0|||
146854029|NCT01775124|529635005|FG000|Core Period|Withdrawal by Subject|4|||
146854030|NCT01775124|529635006|FG001|Core Period|Withdrawal by Subject|2|||
146854031|NCT01775124|529635005|FG000|Core Period|Adverse Event|5|||
146854032|NCT01775124|529635006|FG001|Core Period|Adverse Event|5|||
146854033|NCT01775124|529635005|FG000|Extension Period|Adverse Event|3|||
146854034|NCT01775124|529635006|FG001|Extension Period|Adverse Event|2|||
146854035|NCT01775124|529635005|FG000|Extension Period|Physician Decision|0|||
146854036|NCT01775124|529635006|FG001|Extension Period|Physician Decision|2|||
146854037|NCT01775124|529635005|FG000|Extension Period|Administrative problems|0|||
146625263|NCT03037385|528803848|FG003|Overall Study|Lost to Follow-up|0|||
146854038|NCT01775124|529635006|FG001|Extension Period|Administrative problems|1|||
146854039|NCT01775124|529635005|FG000|Extension Period|Lost to Follow-up|0|||
146854040|NCT01775124|529635006|FG001|Extension Period|Lost to Follow-up|1|||
146854041|NCT01775124|529635005|FG000|Extension Period|Withdrawal by Subject|9|||
146854042|NCT01775124|529635006|FG001|Extension Period|Withdrawal by Subject|12|||
146854043|NCT02317432|529635007|FG000|Overall Study|Death|4|||
146854044|NCT02317432|529635008|FG001|Overall Study|Death|1|||
146854045|NCT02317432|529635007|FG000|Overall Study|Lost to Follow-up|0|||
146854046|NCT02317432|529635008|FG001|Overall Study|Lost to Follow-up|5|||
146854047|NCT02317432|529635007|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
146854048|NCT02317432|529635008|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
146854049|NCT00727311|529635013|FG000|Overall Study|Did not receive drug|316|||
146854050|NCT00727311|529635013|FG000|Overall Study|Missing end of therapy data|205|||
146854051|NCT00727311|529635013|FG000|Overall Study|Adverse Event|58|||
146854052|NCT00727311|529635013|FG000|Overall Study|Lack of Efficacy|242|||
146854053|NCT00727311|529635013|FG000|Overall Study|Lost to Follow-up|73|||
146854054|NCT00727311|529635013|FG000|Overall Study|Withdrawal by Subject|77|||
146854055|NCT00727311|529635013|FG000|Overall Study|Other|97|||
146854056|NCT00727311|529635013|FG000|Overall Study|Multiple reasons|39|||
146854057|NCT00156819|529637074|FG000|Overall Study|Lost to Follow-up|1|||
146854058|NCT00156819|529637075|FG001|Overall Study|Lost to Follow-up|1|||
146854059|NCT00156819|529637076|FG002|Overall Study|Lost to Follow-up|3|||
146854060|NCT01689337|529637077|FG000|Overall Study|Study Discontinuation|1|||
146854061|NCT00642772|529637079|FG000|Overall Study|Lost to Follow-up|3|||
146854062|NCT00642772|529637079|FG000|Overall Study|Withdrawal by Subject|7|||
146854063|NCT03718533|529637080|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
146854064|NCT03718533|529637080|FG000|Overall Study|Protocol deviation|1|||
146854065|NCT03718533|529637080|FG000|Overall Study|Disease progression|1|||
146854066|NCT03718533|529637080|FG000|Overall Study|Relapse|1|||
146854067|NCT03718533|529637080|FG000|Overall Study|Physician Decision|2|||
146854068|NCT03718533|529637080|FG000|Overall Study|Physician Decision and Adverse Event|1|||
146854069|NCT05398237|529637088|FG000|Overall Study|Withdrawal by Subject|1|||
146854070|NCT01312857|529637094|FG000|Overall Study|Adverse Event|1|||
146854071|NCT01312857|529637095|FG001|Overall Study|Adverse Event|1|||
146854072|NCT01312857|529637094|FG000|Overall Study|Lost to Follow-up|2|||
146854073|NCT01312857|529637095|FG001|Overall Study|Lost to Follow-up|0|||
146854074|NCT01312857|529637094|FG000|Overall Study|Physician Decision|3|||
146854075|NCT01312857|529637095|FG001|Overall Study|Physician Decision|0|||
146854076|NCT01312857|529637094|FG000|Overall Study|Withdrawal by Subject|2|||
146854077|NCT01312857|529637095|FG001|Overall Study|Withdrawal by Subject|0|||
146854078|NCT01248065|529637096|FG000|Overall Study|Lost to Follow-up|3|||
146854079|NCT01248065|529637097|FG001|Overall Study|Lost to Follow-up|5|||
146854080|NCT01248065|529637096|FG000|Overall Study|Withdrawal by Subject|14|||
146854081|NCT01248065|529637097|FG001|Overall Study|Withdrawal by Subject|11|||
146854082|NCT01248065|529637096|FG000|Overall Study|Adverse Event|3|||
146854083|NCT01248065|529637097|FG001|Overall Study|Adverse Event|0|||
146854084|NCT01248065|529637096|FG000|Overall Study|Third treatment failure event|3|||
146854085|NCT01248065|529637097|FG001|Overall Study|Third treatment failure event|1|||
146854086|NCT01248065|529637096|FG000|Overall Study|Other|3|||
146854087|NCT01248065|529637097|FG001|Overall Study|Other|5|||
146854088|NCT02518490|529637106|FG000|Overall Study|Withdrawal by Subject|1|||
146854089|NCT02518490|529637107|FG001|Overall Study|Withdrawal by Subject|1|||
146854090|NCT04256629|529637108|FG000|Overall Study|Adverse Event|0|||
146854091|NCT04256629|529637109|FG001|Overall Study|Adverse Event|0|||
146854092|NCT04256629|529637110|FG002|Overall Study|Adverse Event|0|||
146854093|NCT04256629|529637111|FG003|Overall Study|Adverse Event|0|||
146854094|NCT04256629|529637112|FG004|Overall Study|Adverse Event|0|||
146854095|NCT04256629|529637113|FG005|Overall Study|Adverse Event|1|||
146854096|NCT04256629|529637108|FG000|Overall Study|Protocol Violation|0|||
146854097|NCT04256629|529637109|FG001|Overall Study|Protocol Violation|1|||
146854098|NCT04256629|529637110|FG002|Overall Study|Protocol Violation|0|||
146854099|NCT04256629|529637111|FG003|Overall Study|Protocol Violation|0|||
146854100|NCT04256629|529637112|FG004|Overall Study|Protocol Violation|0|||
146854101|NCT04256629|529637113|FG005|Overall Study|Protocol Violation|0|||
146854102|NCT00321373|529637114|FG000|Overall Study|Adverse Event|0|||
146854103|NCT00321373|529637115|FG001|Overall Study|Adverse Event|0|||
146854104|NCT00321373|529637116|FG002|Overall Study|Adverse Event|1|||
146854105|NCT00321373|529637114|FG000|Overall Study|Lost to Follow-up|1|||
146854106|NCT00321373|529637115|FG001|Overall Study|Lost to Follow-up|0|||
146854107|NCT00321373|529637116|FG002|Overall Study|Lost to Follow-up|1|||
146854108|NCT00321373|529637114|FG000|Overall Study|Withdrawal by Subject|1|||
146854109|NCT00321373|529637115|FG001|Overall Study|Withdrawal by Subject|0|||
146854110|NCT00321373|529637116|FG002|Overall Study|Withdrawal by Subject|0|||
146854111|NCT00321373|529637114|FG000|Overall Study|Other|0|||
146854112|NCT00321373|529637115|FG001|Overall Study|Other|0|||
146854113|NCT00321373|529637116|FG002|Overall Study|Other|1|||
146854114|NCT01774487|529637117|FG000|Overall Study|Did not tolerate taste|4|||
146854115|NCT01774487|529637118|FG001|Overall Study|Did not tolerate taste|4|||
146854116|NCT00346632|529637119|FG000|Overall Study|Progressive Disease|2|||
146854117|NCT00346632|529637120|FG001|Overall Study|Progressive Disease|2|||
146854118|NCT00346632|529637121|FG002|Overall Study|Progressive Disease|4|||
146854119|NCT00346632|529637122|FG003|Overall Study|Progressive Disease|3|||
146854120|NCT00346632|529637123|FG004|Overall Study|Progressive Disease|3|||
146854121|NCT00346632|529637124|FG005|Overall Study|Progressive Disease|1|||
146854122|NCT00346632|529637125|FG006|Overall Study|Progressive Disease|2|||
146854123|NCT00346632|529637126|FG007|Overall Study|Progressive Disease|2|||
146854124|NCT00346632|529637127|FG008|Overall Study|Progressive Disease|2|||
146854125|NCT00346632|529637128|FG009|Overall Study|Progressive Disease|2|||
146854126|NCT00346632|529637119|FG000|Overall Study|Adverse Event|0|||
146854127|NCT00346632|529637120|FG001|Overall Study|Adverse Event|0|||
146854128|NCT00346632|529637121|FG002|Overall Study|Adverse Event|0|||
146854129|NCT00346632|529637122|FG003|Overall Study|Adverse Event|0|||
146854130|NCT00346632|529637123|FG004|Overall Study|Adverse Event|1|||
146854131|NCT00346632|529637124|FG005|Overall Study|Adverse Event|1|||
146854132|NCT00346632|529637125|FG006|Overall Study|Adverse Event|1|||
146854133|NCT00346632|529637126|FG007|Overall Study|Adverse Event|0|||
146854134|NCT00346632|529637127|FG008|Overall Study|Adverse Event|0|||
146854135|NCT00346632|529637128|FG009|Overall Study|Adverse Event|0|||
146854136|NCT00346632|529637119|FG000|Overall Study|Death|0|||
146854137|NCT00346632|529637120|FG001|Overall Study|Death|0|||
146854138|NCT00346632|529637121|FG002|Overall Study|Death|1|||
146854139|NCT00346632|529637122|FG003|Overall Study|Death|0|||
146854140|NCT00346632|529637123|FG004|Overall Study|Death|0|||
146854141|NCT00346632|529637124|FG005|Overall Study|Death|0|||
146854142|NCT00346632|529637125|FG006|Overall Study|Death|0|||
146854143|NCT00346632|529637126|FG007|Overall Study|Death|0|||
146854144|NCT00346632|529637127|FG008|Overall Study|Death|0|||
146854145|NCT00346632|529637128|FG009|Overall Study|Death|0|||
146854146|NCT00346632|529637119|FG000|Overall Study|Protocol Violation|0|||
146854147|NCT00346632|529637120|FG001|Overall Study|Protocol Violation|0|||
146854148|NCT00346632|529637121|FG002|Overall Study|Protocol Violation|0|||
146854149|NCT00346632|529637122|FG003|Overall Study|Protocol Violation|0|||
146854150|NCT00346632|529637123|FG004|Overall Study|Protocol Violation|0|||
146854151|NCT00346632|529637124|FG005|Overall Study|Protocol Violation|0|||
146854152|NCT00346632|529637125|FG006|Overall Study|Protocol Violation|1|||
146854153|NCT00346632|529637126|FG007|Overall Study|Protocol Violation|0|||
146854154|NCT00346632|529637127|FG008|Overall Study|Protocol Violation|0|||
146854155|NCT00346632|529637128|FG009|Overall Study|Protocol Violation|0|||
146854156|NCT00346632|529637119|FG000|Overall Study|Withdrawal by Subject|0|||
146854157|NCT00346632|529637120|FG001|Overall Study|Withdrawal by Subject|0|||
146854158|NCT00346632|529637121|FG002|Overall Study|Withdrawal by Subject|0|||
146854159|NCT00346632|529637122|FG003|Overall Study|Withdrawal by Subject|0|||
146854160|NCT00346632|529637123|FG004|Overall Study|Withdrawal by Subject|0|||
146854161|NCT00346632|529637124|FG005|Overall Study|Withdrawal by Subject|0|||
146854162|NCT00346632|529637125|FG006|Overall Study|Withdrawal by Subject|1|||
146854163|NCT00346632|529637126|FG007|Overall Study|Withdrawal by Subject|0|||
146854164|NCT00346632|529637127|FG008|Overall Study|Withdrawal by Subject|0|||
146854165|NCT00346632|529637128|FG009|Overall Study|Withdrawal by Subject|0|||
146854166|NCT00346632|529637119|FG000|Overall Study|Switched to alternative treatment|0|||
146854167|NCT00346632|529637120|FG001|Overall Study|Switched to alternative treatment|0|||
146854168|NCT00346632|529637121|FG002|Overall Study|Switched to alternative treatment|1|||
146854169|NCT00346632|529637122|FG003|Overall Study|Switched to alternative treatment|0|||
146854170|NCT00346632|529637123|FG004|Overall Study|Switched to alternative treatment|0|||
146854171|NCT00346632|529637124|FG005|Overall Study|Switched to alternative treatment|0|||
146854172|NCT00346632|529637125|FG006|Overall Study|Switched to alternative treatment|0|||
146854173|NCT00346632|529637126|FG007|Overall Study|Switched to alternative treatment|0|||
146854174|NCT00346632|529637127|FG008|Overall Study|Switched to alternative treatment|0|||
146854175|NCT00346632|529637128|FG009|Overall Study|Switched to alternative treatment|0|||
146854176|NCT00346632|529637119|FG000|Overall Study|Not Stated|1|||
146854177|NCT00346632|529637120|FG001|Overall Study|Not Stated|1|||
146854178|NCT00346632|529637121|FG002|Overall Study|Not Stated|0|||
146854179|NCT00346632|529637122|FG003|Overall Study|Not Stated|0|||
146854180|NCT00346632|529637123|FG004|Overall Study|Not Stated|0|||
146854181|NCT00346632|529637124|FG005|Overall Study|Not Stated|0|||
146854182|NCT00346632|529637125|FG006|Overall Study|Not Stated|0|||
146854183|NCT00346632|529637126|FG007|Overall Study|Not Stated|2|||
146854184|NCT00346632|529637127|FG008|Overall Study|Not Stated|2|||
146854185|NCT00346632|529637128|FG009|Overall Study|Not Stated|1|||
146854186|NCT00477334|529637129|FG000|Overall Study|Discontinued prior to taking study drug|106|||
146854187|NCT00477334|529637130|FG001|Overall Study|Discontinued prior to taking study drug|53|||
146854188|NCT00477334|529637129|FG000|Overall Study|Adverse Event|1|||
146854189|NCT00477334|529637130|FG001|Overall Study|Adverse Event|2|||
146854190|NCT00477334|529637129|FG000|Overall Study|Withdrawal by Subject|2|||
146854191|NCT00477334|529637130|FG001|Overall Study|Withdrawal by Subject|1|||
146854192|NCT00477334|529637129|FG000|Overall Study|Lost to Follow-up|15|||
146854193|NCT00477334|529637130|FG001|Overall Study|Lost to Follow-up|4|||
146854194|NCT00477334|529637129|FG000|Overall Study|Administrative Problems|39|||
146854195|NCT00477334|529637130|FG001|Overall Study|Administrative Problems|15|||
146854196|NCT00477334|529637129|FG000|Overall Study|Protocol Violation|7|||
146854197|NCT00477334|529637130|FG001|Overall Study|Protocol Violation|1|||
146854198|NCT04275089|529637131|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
146854199|NCT02354508|529637132|FG000|Period 1: Core Phase|Adverse Event|1|||
146854200|NCT02354508|529637133|FG001|Period 1: Core Phase|Adverse Event|1|||
146854201|NCT02354508|529637134|FG002|Period 1: Core Phase|Adverse Event|2|||
146854202|NCT02354508|529637132|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
146854203|NCT02354508|529637133|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
146854204|NCT02354508|529637134|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
146854205|NCT02354508|529637132|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
146854206|NCT02354508|529637133|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
146854207|NCT02354508|529637134|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
146854208|NCT02354508|529637132|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
146854209|NCT02354508|529637133|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
146854210|NCT02354508|529637134|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
146854211|NCT02354508|529637132|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
146854212|NCT02354508|529637133|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
146854213|NCT02354508|529637134|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
146854214|NCT02354508|529637132|FG000|Period 2: Extension Phase|Physician Decision|5|||
146854215|NCT02354508|529637133|FG001|Period 2: Extension Phase|Physician Decision|0|||
146854216|NCT02354508|529637134|FG002|Period 2: Extension Phase|Physician Decision|1|||
146854217|NCT02354508|529637132|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
146854218|NCT02354508|529637133|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
146854219|NCT02354508|529637134|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
146854220|NCT02354508|529637132|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
146854221|NCT02354508|529637133|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
146854222|NCT02354508|529637134|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
146854223|NCT02354508|529637132|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
146854224|NCT02354508|529637133|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
146854225|NCT02354508|529637134|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
146854226|NCT00297232|529637135|FG000|Overall Study|Lack of Efficacy|7|||
146854227|NCT00297232|529637135|FG000|Overall Study|Lost to Follow-up|10|||
146854228|NCT00297232|529637135|FG000|Overall Study|Adverse Event|63|||
146854229|NCT00297232|529637135|FG000|Overall Study|Voluntary Withdrawal|120|||
146521454|NCT00972283|528416592|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
146521455|NCT00972283|528416593|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
146521456|NCT00972283|528416592|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
146756773|NCT02223182|529274909|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
146756774|NCT02223182|529274910|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
146756775|NCT02223182|529274911|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
146756776|NCT02223182|529274908|FG000|Open-Label 500 Period|Adverse Event|1|||
146756777|NCT02223182|529274909|FG001|Open-Label 500 Period|Adverse Event|0|||
146756778|NCT02223182|529274910|FG002|Open-Label 500 Period|Adverse Event|2|||
146756779|NCT02223182|529274911|FG003|Open-Label 500 Period|Adverse Event|1|||
146756780|NCT02223182|529274908|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
146756781|NCT02223182|529274909|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
146756782|NCT02223182|529274910|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
146756783|NCT02223182|529274911|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
146756784|NCT02223182|529274908|FG000|Open-Label 500 Period|Physician Decision|0|||
146756785|NCT02223182|529274909|FG001|Open-Label 500 Period|Physician Decision|0|||
146756786|NCT02223182|529274910|FG002|Open-Label 500 Period|Physician Decision|0|||
146756787|NCT02223182|529274911|FG003|Open-Label 500 Period|Physician Decision|1|||
146756788|NCT02223182|529274908|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
146756789|NCT02223182|529274909|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
146756790|NCT02223182|529274910|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
146756791|NCT02223182|529274911|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
146756792|NCT02223182|529274908|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
146756793|NCT02223182|529274909|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
146756794|NCT02223182|529274910|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
146756795|NCT02223182|529274911|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
146756796|NCT02223182|529274908|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
146521457|NCT00972283|528416593|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
146521458|NCT00972283|528416592|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
146756797|NCT02223182|529274909|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
146854230|NCT00297232|529637135|FG000|Overall Study|Subject was Noncompliant|9|||
146854231|NCT00297232|529637135|FG000|Overall Study|Death|9|||
146965059|NCT03110107|530033449|FG023|Treatment Period|Study drug toxicity|6|||
146965060|NCT03110107|530033450|FG024|Treatment Period|Study drug toxicity|7|||
146756798|NCT02223182|529274910|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
146756799|NCT02223182|529274911|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
146756800|NCT02223182|529274908|FG000|Open-Label 300 Period|Non Compliance|0|||
146756801|NCT02223182|529274909|FG001|Open-Label 300 Period|Non Compliance|2|||
146756802|NCT02223182|529274910|FG002|Open-Label 300 Period|Non Compliance|1|||
146756803|NCT02223182|529274911|FG003|Open-Label 300 Period|Non Compliance|0|||
146756804|NCT02099539|529274916|FG000|Overall Study|Progressive Disease|3|||
146756805|NCT02099539|529274917|FG001|Overall Study|Progressive Disease|2|||
146756806|NCT02099539|529274918|FG002|Overall Study|Progressive Disease|2|||
146756807|NCT02099539|529274919|FG003|Overall Study|Progressive Disease|1|||
146756808|NCT02099539|529274920|FG004|Overall Study|Progressive Disease|4|||
146756809|NCT02099539|529274921|FG005|Overall Study|Progressive Disease|2|||
146756810|NCT02099539|529274922|FG006|Overall Study|Progressive Disease|0|||
146756811|NCT02099539|529274916|FG000|Overall Study|Adverse Event|0|||
146756812|NCT02099539|529274917|FG001|Overall Study|Adverse Event|0|||
146756813|NCT02099539|529274918|FG002|Overall Study|Adverse Event|1|||
146756814|NCT02099539|529274919|FG003|Overall Study|Adverse Event|1|||
146756815|NCT02099539|529274920|FG004|Overall Study|Adverse Event|0|||
146756816|NCT02099539|529274921|FG005|Overall Study|Adverse Event|0|||
146756817|NCT02099539|529274922|FG006|Overall Study|Adverse Event|0|||
146756818|NCT02099539|529274916|FG000|Overall Study|Physician Decision|0|||
146756819|NCT02099539|529274917|FG001|Overall Study|Physician Decision|0|||
146756820|NCT02099539|529274918|FG002|Overall Study|Physician Decision|0|||
146756821|NCT02099539|529274919|FG003|Overall Study|Physician Decision|0|||
146756822|NCT02099539|529274920|FG004|Overall Study|Physician Decision|0|||
146756823|NCT02099539|529274921|FG005|Overall Study|Physician Decision|1|||
146756824|NCT02099539|529274922|FG006|Overall Study|Physician Decision|0|||
146756825|NCT03473756|529274924|FG000|Overall Study|Withdrawal by Subject|1|||
146756826|NCT03473756|529274925|FG001|Overall Study|Withdrawal by Subject|4|||
146756827|NCT03473756|529274924|FG000|Overall Study|Adverse Event|6|||
146756828|NCT03473756|529274925|FG001|Overall Study|Adverse Event|7|||
146756829|NCT03473756|529274924|FG000|Overall Study|Lack of Efficacy|3|||
146756830|NCT03473756|529274925|FG001|Overall Study|Lack of Efficacy|10|||
146756831|NCT03473756|529274924|FG000|Overall Study|Physician Decision|0|||
146756832|NCT03473756|529274925|FG001|Overall Study|Physician Decision|2|||
146756833|NCT03473756|529274924|FG000|Overall Study|End of study treatment|0|||
146756834|NCT03473756|529274925|FG001|Overall Study|End of study treatment|2|||
146756835|NCT03473756|529274924|FG000|Overall Study|Lost to Follow-up|0|||
146756836|NCT03473756|529274925|FG001|Overall Study|Lost to Follow-up|1|||
146756837|NCT03714022|529274926|FG000|Overall Study|Adverse Event|1|||
146756838|NCT03714022|529274927|FG001|Overall Study|Adverse Event|0|||
146756839|NCT03714022|529274926|FG000|Overall Study|Consent withdrawal|0|||
146756840|NCT03714022|529274927|FG001|Overall Study|Consent withdrawal|1|||
146756841|NCT03714022|529274926|FG000|Overall Study|Lost to Follow-up|3|||
146756842|NCT03714022|529274927|FG001|Overall Study|Lost to Follow-up|2|||
146756843|NCT01007552|529274928|FG000|Overall Study|Withdrawal by Subject|1|||
146756844|NCT00231179|529276953|FG000|Overall Study|Lost to Follow-up|21|||
146756845|NCT00231179|529276954|FG001|Overall Study|Lost to Follow-up|21|||
146756846|NCT00231179|529276953|FG000|Overall Study|Withdrawal by Subject|3|||
146756847|NCT00231179|529276954|FG001|Overall Study|Withdrawal by Subject|3|||
146756848|NCT02206685|529276955|FG000|Overall Study|Surgery cancelled/changed|2|||
146756849|NCT02206685|529276956|FG001|Overall Study|Surgery cancelled/changed|3|||
146756850|NCT02206685|529276955|FG000|Overall Study|Withdrawal by Subject|1|||
146756851|NCT02206685|529276956|FG001|Overall Study|Withdrawal by Subject|2|||
146756852|NCT02206685|529276955|FG000|Overall Study|Protocol Violation|2|||
146756853|NCT02206685|529276956|FG001|Overall Study|Protocol Violation|2|||
146756854|NCT01345292|529276957|FG000|Overall Study|Withdrawal by Subject|2|||
146756855|NCT01345292|529276958|FG001|Overall Study|Withdrawal by Subject|0|||
146756856|NCT01345292|529276959|FG002|Overall Study|Withdrawal by Subject|1|||
146756857|NCT05406791|529276963|FG000|Overall Study|Lost to Follow-up|13|||
146756858|NCT05406791|529276964|FG001|Overall Study|Lost to Follow-up|10|||
146756859|NCT00515086|529276965|FG000|Overall Study|Adverse Event|1|||
146756860|NCT00515086|529276966|FG001|Overall Study|Adverse Event|1|||
146756861|NCT00515086|529276967|FG002|Overall Study|Adverse Event|2|||
146756862|NCT00515086|529276968|FG003|Overall Study|Adverse Event|3|||
146756863|NCT00515086|529276965|FG000|Overall Study|Administrative|1|||
146756864|NCT00515086|529276966|FG001|Overall Study|Administrative|1|||
146756865|NCT00515086|529276967|FG002|Overall Study|Administrative|0|||
146756866|NCT00515086|529276968|FG003|Overall Study|Administrative|0|||
146756867|NCT00515086|529276965|FG000|Overall Study|Withdrawal by Subject|1|||
146756868|NCT00515086|529276966|FG001|Overall Study|Withdrawal by Subject|0|||
146756869|NCT00515086|529276967|FG002|Overall Study|Withdrawal by Subject|0|||
146756870|NCT00515086|529276968|FG003|Overall Study|Withdrawal by Subject|1|||
146756871|NCT00515086|529276965|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
146756872|NCT00515086|529276966|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
146756873|NCT00515086|529276967|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
146756874|NCT00515086|529276968|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
146756875|NCT00515086|529276965|FG000|Overall Study|Lost to Follow-up|1|||
146756876|NCT00515086|529276966|FG001|Overall Study|Lost to Follow-up|0|||
146756877|NCT00515086|529276967|FG002|Overall Study|Lost to Follow-up|0|||
146756878|NCT00515086|529276968|FG003|Overall Study|Lost to Follow-up|0|||
146756879|NCT00515086|529276965|FG000|Overall Study|Study drug no longer required|0|||
146756880|NCT00515086|529276966|FG001|Overall Study|Study drug no longer required|1|||
146756881|NCT00515086|529276967|FG002|Overall Study|Study drug no longer required|0|||
146756882|NCT00515086|529276968|FG003|Overall Study|Study drug no longer required|0|||
146756883|NCT00515086|529276965|FG000|Overall Study|Death|2|||
146756884|NCT00515086|529276966|FG001|Overall Study|Death|0|||
146756885|NCT00515086|529276967|FG002|Overall Study|Death|0|||
146756886|NCT00515086|529276968|FG003|Overall Study|Death|0|||
146756887|NCT02373813|529276969|FG000|Run-In Period|Other, Not Specified|5|||
146756888|NCT02373813|529276970|FG001|Run-In Period|Other, Not Specified|0|||
146756889|NCT02373813|529276971|FG002|Run-In Period|Other, Not Specified|0|||
146756890|NCT02373813|529276972|FG003|Run-In Period|Other, Not Specified|0|||
146756891|NCT02373813|529276969|FG000|Run-In Period|Withdrawal by Subject|16|||
146756892|NCT02373813|529276970|FG001|Run-In Period|Withdrawal by Subject|0|||
146756893|NCT02373813|529276971|FG002|Run-In Period|Withdrawal by Subject|0|||
146756894|NCT02373813|529276972|FG003|Run-In Period|Withdrawal by Subject|0|||
146756895|NCT02373813|529276969|FG000|Run-In Period|Decision by Sponsor|11|||
146756896|NCT02373813|529276970|FG001|Run-In Period|Decision by Sponsor|0|||
146756897|NCT02373813|529276971|FG002|Run-In Period|Decision by Sponsor|0|||
146756898|NCT02373813|529276972|FG003|Run-In Period|Decision by Sponsor|0|||
146756899|NCT02373813|529276969|FG000|Run-In Period|Protocol Violation|75|||
146756900|NCT02373813|529276970|FG001|Run-In Period|Protocol Violation|0|||
146756901|NCT02373813|529276971|FG002|Run-In Period|Protocol Violation|0|||
146756902|NCT02373813|529276972|FG003|Run-In Period|Protocol Violation|0|||
146756903|NCT02373813|529276969|FG000|Run-In Period|Lost to Follow-up|2|||
146756904|NCT02373813|529276970|FG001|Run-In Period|Lost to Follow-up|0|||
146756905|NCT02373813|529276971|FG002|Run-In Period|Lost to Follow-up|0|||
146756906|NCT02373813|529276972|FG003|Run-In Period|Lost to Follow-up|0|||
146756907|NCT02373813|529276969|FG000|Run-In Period|Adverse Event|3|||
146756908|NCT02373813|529276970|FG001|Run-In Period|Adverse Event|0|||
146756909|NCT02373813|529276971|FG002|Run-In Period|Adverse Event|0|||
146756910|NCT02373813|529276972|FG003|Run-In Period|Adverse Event|0|||
146756911|NCT02373813|529276969|FG000|Run-In Period|Noncompliance|1|||
146756912|NCT02373813|529276970|FG001|Run-In Period|Noncompliance|0|||
146756913|NCT02373813|529276971|FG002|Run-In Period|Noncompliance|0|||
146756914|NCT02373813|529276972|FG003|Run-In Period|Noncompliance|0|||
146756915|NCT02373813|529276969|FG000|Run-In Period|Ineligibility Determined|3|||
146756916|NCT02373813|529276970|FG001|Run-In Period|Ineligibility Determined|0|||
146756917|NCT02373813|529276971|FG002|Run-In Period|Ineligibility Determined|0|||
146756918|NCT02373813|529276972|FG003|Run-In Period|Ineligibility Determined|0|||
146756919|NCT02373813|529276969|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
146756920|NCT02373813|529276970|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
146756921|NCT02373813|529276971|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
146756922|NCT02373813|529276972|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
146756923|NCT02373813|529276969|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
146756924|NCT02373813|529276970|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
146756925|NCT02373813|529276971|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
146756926|NCT02373813|529276972|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
146756927|NCT02373813|529276969|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146756928|NCT02373813|529276970|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
146756929|NCT02373813|529276971|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
146756930|NCT02373813|529276972|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
146756931|NCT02373813|529276969|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146756932|NCT02373813|529276970|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
146756933|NCT02373813|529276971|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
146756934|NCT02373813|529276972|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
146756935|NCT01764386|529276980|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
146756936|NCT01764386|529276981|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
146756937|NCT01764386|529276980|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
146756938|NCT01764386|529276981|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
146756939|NCT01764386|529276980|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
146756940|NCT01764386|529276981|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
146756941|NCT01764386|529276980|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
146756942|NCT01764386|529276981|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
146756943|NCT01764386|529276980|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
146756944|NCT01764386|529276981|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
146756945|NCT01764386|529276980|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
146756946|NCT01764386|529276981|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
146756947|NCT01764386|529276980|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
146756948|NCT01764386|529276981|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
146756949|NCT01764386|529276980|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
146854232|NCT00297232|529637135|FG000|Overall Study|Anti-natalizumab Positive|8|||
146854233|NCT00297232|529637135|FG000|Overall Study|Switched to Commercial Tysabri|22|||
146521459|NCT00972283|528416593|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
146756950|NCT01764386|529276981|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
146756951|NCT02271594|529276982|FG000|Overall Study|Study closed; recruiting failure|19|||
146756952|NCT02271594|529276983|FG001|Overall Study|Study closed; recruiting failure|12|||
146756953|NCT00495469|529276984|FG000|Overall Study|Adverse Event|0|||
146756954|NCT00495469|529276985|FG001|Overall Study|Adverse Event|1|||
146756955|NCT00495469|529276986|FG002|Overall Study|Adverse Event|3|||
146756956|NCT00495469|529276987|FG003|Overall Study|Adverse Event|0|||
146756957|NCT00495469|529276988|FG004|Overall Study|Adverse Event|1|||
146756958|NCT00495469|529276989|FG005|Overall Study|Adverse Event|1|||
146756959|NCT00495469|529276990|FG006|Overall Study|Adverse Event|1|||
146756960|NCT00495469|529276984|FG000|Overall Study|Lost to Follow-up|1|||
146756961|NCT00495469|529276985|FG001|Overall Study|Lost to Follow-up|1|||
146756962|NCT00495469|529276986|FG002|Overall Study|Lost to Follow-up|3|||
146756963|NCT00495469|529276987|FG003|Overall Study|Lost to Follow-up|1|||
146756964|NCT00495469|529276988|FG004|Overall Study|Lost to Follow-up|0|||
146756965|NCT00495469|529276989|FG005|Overall Study|Lost to Follow-up|0|||
146756966|NCT00495469|529276990|FG006|Overall Study|Lost to Follow-up|0|||
146756967|NCT00495469|529276984|FG000|Overall Study|Protocol Violation|0|||
146756968|NCT00495469|529276985|FG001|Overall Study|Protocol Violation|0|||
146756969|NCT00495469|529276986|FG002|Overall Study|Protocol Violation|0|||
146756970|NCT00495469|529276987|FG003|Overall Study|Protocol Violation|0|||
146756971|NCT00495469|529276988|FG004|Overall Study|Protocol Violation|1|||
146756972|NCT00495469|529276989|FG005|Overall Study|Protocol Violation|2|||
146756973|NCT00495469|529276990|FG006|Overall Study|Protocol Violation|0|||
146756974|NCT00495469|529276984|FG000|Overall Study|Withdrawal by Subject|5|||
146756975|NCT00495469|529276985|FG001|Overall Study|Withdrawal by Subject|3|||
146756976|NCT00495469|529276986|FG002|Overall Study|Withdrawal by Subject|1|||
146756977|NCT00495469|529276987|FG003|Overall Study|Withdrawal by Subject|3|||
146756978|NCT00495469|529276988|FG004|Overall Study|Withdrawal by Subject|3|||
146756979|NCT00495469|529276989|FG005|Overall Study|Withdrawal by Subject|2|||
146756980|NCT00495469|529276990|FG006|Overall Study|Withdrawal by Subject|3|||
146756981|NCT00495469|529276984|FG000|Overall Study|Lack of Efficacy|0|||
146756982|NCT00495469|529276985|FG001|Overall Study|Lack of Efficacy|0|||
146756983|NCT00495469|529276986|FG002|Overall Study|Lack of Efficacy|0|||
146756984|NCT00495469|529276987|FG003|Overall Study|Lack of Efficacy|0|||
146756985|NCT00495469|529276988|FG004|Overall Study|Lack of Efficacy|0|||
146756986|NCT00495469|529276989|FG005|Overall Study|Lack of Efficacy|0|||
146756987|NCT00495469|529276990|FG006|Overall Study|Lack of Efficacy|1|||
146756988|NCT00495469|529276984|FG000|Overall Study|Liver function test abnormality|0|||
146756989|NCT00495469|529276985|FG001|Overall Study|Liver function test abnormality|1|||
146756990|NCT00495469|529276986|FG002|Overall Study|Liver function test abnormality|0|||
146756991|NCT00495469|529276987|FG003|Overall Study|Liver function test abnormality|0|||
146756992|NCT00495469|529276988|FG004|Overall Study|Liver function test abnormality|0|||
146756993|NCT00495469|529276989|FG005|Overall Study|Liver function test abnormality|0|||
146756994|NCT00495469|529276990|FG006|Overall Study|Liver function test abnormality|0|||
146756995|NCT00495469|529276984|FG000|Overall Study|ST depression at randomisation in ECG|0|||
146756996|NCT00495469|529276985|FG001|Overall Study|ST depression at randomisation in ECG|1|||
146756997|NCT00495469|529276986|FG002|Overall Study|ST depression at randomisation in ECG|0|||
146756998|NCT00495469|529276987|FG003|Overall Study|ST depression at randomisation in ECG|0|||
146756999|NCT00495469|529276988|FG004|Overall Study|ST depression at randomisation in ECG|0|||
146757000|NCT00495469|529276989|FG005|Overall Study|ST depression at randomisation in ECG|0|||
146757001|NCT00495469|529276990|FG006|Overall Study|ST depression at randomisation in ECG|0|||
146757002|NCT04454567|529276992|FG000|Overall Study|Study Terminated by Sponsor|1|||
146757003|NCT04454567|529276993|FG001|Overall Study|Study Terminated by Sponsor|1|||
146757004|NCT01123161|529276997|FG000|Overall Study|Lost to Follow-up|1|||
146757005|NCT01123161|529276998|FG001|Overall Study|Lost to Follow-up|0|||
146757006|NCT01123161|529276997|FG000|Overall Study|Withdrawal by Subject|1|||
146757007|NCT01123161|529276998|FG001|Overall Study|Withdrawal by Subject|0|||
146757008|NCT00926393|529276999|FG000|Overall Study|Withdrawal by Subject|1|||
146757009|NCT00926393|529277000|FG001|Overall Study|Withdrawal by Subject|2|||
146757010|NCT00926393|529276999|FG000|Overall Study|Adverse Event|1|||
146757011|NCT00926393|529277000|FG001|Overall Study|Adverse Event|1|||
146757012|NCT02851511|529277008|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
146757013|NCT02851511|529277009|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
146757014|NCT02851511|529277010|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
146757015|NCT02851511|529277011|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
146757016|NCT02851511|529277008|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
146757017|NCT02851511|529277009|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
146757018|NCT02851511|529277010|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
146854234|NCT00297232|529637135|FG000|Overall Study|Disease Progression|8|||
146854235|NCT00297232|529637135|FG000|Overall Study|Fear of PML|10|||
146625264|NCT03037385|528803849|FG004|Overall Study|Lost to Follow-up|0|||
146757019|NCT02851511|529277011|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
146757020|NCT02851511|529277008|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
146757021|NCT02851511|529277009|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
146757022|NCT02851511|529277010|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
146757023|NCT02851511|529277011|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
146757024|NCT02851511|529277008|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
146757025|NCT02851511|529277009|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
146757026|NCT02851511|529277010|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
146757027|NCT02851511|529277011|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
146757028|NCT02851511|529277008|FG000|Phase I|Physician Decision|0|||
146757029|NCT02851511|529277009|FG001|Phase I|Physician Decision|0|||
146757030|NCT02851511|529277010|FG002|Phase I|Physician Decision|0|||
146757031|NCT02851511|529277011|FG003|Phase I|Physician Decision|1|||
146757032|NCT02851511|529277008|FG000|Phase I|Withdrawal by Subject|2|||
146757033|NCT02851511|529277009|FG001|Phase I|Withdrawal by Subject|1|||
146757034|NCT02851511|529277010|FG002|Phase I|Withdrawal by Subject|0|||
146757035|NCT02851511|529277011|FG003|Phase I|Withdrawal by Subject|3|||
146757036|NCT02851511|529277008|FG000|Phase II|Physician Decision|18|||
146757037|NCT02851511|529277009|FG001|Phase II|Physician Decision|16|||
146757038|NCT02851511|529277010|FG002|Phase II|Physician Decision|0|||
146757039|NCT02851511|529277011|FG003|Phase II|Physician Decision|0|||
146757040|NCT02851511|529277008|FG000|Phase II|Withdrawal by Subject|18|||
146757041|NCT02851511|529277009|FG001|Phase II|Withdrawal by Subject|16|||
146757042|NCT02851511|529277010|FG002|Phase II|Withdrawal by Subject|0|||
146757043|NCT02851511|529277011|FG003|Phase II|Withdrawal by Subject|0|||
146757044|NCT02851511|529277008|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
146757045|NCT02851511|529277009|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
146757046|NCT02851511|529277010|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
146757047|NCT02851511|529277011|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
146757048|NCT02851511|529277008|FG000|Phase II|Lost to Follow-up|0|||
146757049|NCT02851511|529277009|FG001|Phase II|Lost to Follow-up|1|||
146757050|NCT02851511|529277010|FG002|Phase II|Lost to Follow-up|0|||
146757051|NCT02851511|529277011|FG003|Phase II|Lost to Follow-up|0|||
146757052|NCT00051311|529277012|FG000|Overall Study|Starting new study|0|||
146757053|NCT00051311|529277013|FG001|Overall Study|Starting new study|1|||
146757054|NCT00051311|529277012|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
146757055|NCT00051311|529277013|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
146757056|NCT00051311|529277012|FG000|Overall Study|Death of recipient|8|||
146757057|NCT00051311|529277013|FG001|Overall Study|Death of recipient|8|||
146757058|NCT00051311|529277012|FG000|Overall Study|Recipient taken off study|4|||
146757059|NCT00051311|529277013|FG001|Overall Study|Recipient taken off study|4|||
146757060|NCT02256969|529277014|FG000|Overall Study|Screenfailed or withdrew|2|||
146757061|NCT02256969|529277015|FG001|Overall Study|Screenfailed or withdrew|1|||
146757062|NCT02256969|529277016|FG002|Overall Study|Screenfailed or withdrew|1|||
146757063|NCT01427907|529277017|FG000|Overall Study|Withdrawal by Subject|3|||
146757064|NCT01427907|529277018|FG001|Overall Study|Withdrawal by Subject|4|||
146757065|NCT00335153|529277019|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
146757066|NCT00335153|529277019|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
146757067|NCT00335153|529277019|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
146757068|NCT00335153|529277019|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
146757069|NCT00335153|529277019|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
146757070|NCT00335153|529277019|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
146757071|NCT00335153|529277019|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
146757072|NCT00335153|529277019|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
146757073|NCT00335153|529277019|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
146757074|NCT00335153|529277019|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
146757075|NCT02478359|529277020|FG000|Overall Study|Disenrolled from health plan|106|||
146757076|NCT02478359|529277021|FG001|Overall Study|Disenrolled from health plan|65|||
146757077|NCT00372528|529277022|FG000|Overall Study|Lack of Efficacy|1|||
146757078|NCT00372528|529277022|FG000|Overall Study|Adverse Event|1|||
146757079|NCT00372528|529277022|FG000|Overall Study|Study Terminated by Sponsor|18|||
146521460|NCT00972283|528416592|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
146757080|NCT00372528|529277022|FG000|Overall Study|Other|1|||
146757081|NCT02412761|529277023|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146757082|NCT02412761|529277024|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
146757083|NCT02412761|529277025|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
146757084|NCT02412761|529277026|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146757085|NCT02412761|529277027|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146757086|NCT02412761|529277028|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
146757087|NCT01818700|529277029|FG000|Overall Study|Adverse Event|67|||
146757088|NCT01818700|529277029|FG000|Overall Study|Lack of Efficacy|2|||
146757089|NCT01818700|529277029|FG000|Overall Study|Lost to Follow-up|5|||
146854236|NCT00297232|529637135|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
146854237|NCT00297232|529637135|FG000|Overall Study|Miscellaneous|5|||
146854238|NCT00297232|529637135|FG000|Overall Study|Sponsor Decision|34|||
146854239|NCT00297232|529637135|FG000|Overall Study|Subject Relocated|7|||
146854240|NCT00297232|529637135|FG000|Overall Study|Subject Withdrew Consent|37|||
146854241|NCT00297232|529637135|FG000|Overall Study|Persistently Positive Antibodies|11|||
146854242|NCT00297232|529637135|FG000|Overall Study|Investigator Withdrew From Program|19|||
146854243|NCT00297232|529637135|FG000|Overall Study|Did Not Enroll to Week 264|34|||
146854244|NCT00297232|529637135|FG000|Overall Study|Did Not Enroll to Week 480|17|||
146854245|NCT00297232|529637135|FG000|Overall Study|No data available after Week 264|161|||
146854246|NCT00297232|529637135|FG000|Overall Study|Other|1|||
146854247|NCT02257567|529637136|FG000|Overall Study|Adverse Event|0|||
146854248|NCT02257567|529637137|FG001|Overall Study|Adverse Event|0|||
146854249|NCT02257567|529637138|FG002|Overall Study|Adverse Event|0|||
146854250|NCT02257567|529637139|FG003|Overall Study|Adverse Event|1|||
146854251|NCT02257567|529637140|FG004|Overall Study|Adverse Event|1|||
146854252|NCT02257567|529637141|FG005|Overall Study|Adverse Event|0|||
146854253|NCT02257567|529637142|FG006|Overall Study|Adverse Event|0|||
146854254|NCT02257567|529637143|FG007|Overall Study|Adverse Event|0|||
146854255|NCT02257567|529637144|FG008|Overall Study|Adverse Event|1|||
146854256|NCT02257567|529637145|FG009|Overall Study|Adverse Event|0|||
146854257|NCT02257567|529637146|FG010|Overall Study|Adverse Event|0|||
146854258|NCT02257567|529637136|FG000|Overall Study|Death|2|||
146854259|NCT02257567|529637137|FG001|Overall Study|Death|2|||
146854260|NCT02257567|529637138|FG002|Overall Study|Death|2|||
146854261|NCT02257567|529637139|FG003|Overall Study|Death|4|||
146854262|NCT02257567|529637140|FG004|Overall Study|Death|15|||
146854263|NCT02257567|529637141|FG005|Overall Study|Death|11|||
146854264|NCT02257567|529637142|FG006|Overall Study|Death|26|||
146854265|NCT02257567|529637143|FG007|Overall Study|Death|30|||
146854266|NCT02257567|529637144|FG008|Overall Study|Death|2|||
146854267|NCT02257567|529637145|FG009|Overall Study|Death|18|||
146854268|NCT02257567|529637146|FG010|Overall Study|Death|65|||
146854269|NCT02257567|529637136|FG000|Overall Study|Lost to Follow-up|0|||
146854270|NCT02257567|529637137|FG001|Overall Study|Lost to Follow-up|0|||
146854271|NCT02257567|529637138|FG002|Overall Study|Lost to Follow-up|0|||
146854272|NCT02257567|529637139|FG003|Overall Study|Lost to Follow-up|0|||
146854273|NCT02257567|529637140|FG004|Overall Study|Lost to Follow-up|2|||
146854274|NCT02257567|529637141|FG005|Overall Study|Lost to Follow-up|2|||
146854275|NCT02257567|529637142|FG006|Overall Study|Lost to Follow-up|0|||
146854276|NCT02257567|529637143|FG007|Overall Study|Lost to Follow-up|0|||
146854277|NCT02257567|529637144|FG008|Overall Study|Lost to Follow-up|0|||
146854278|NCT02257567|529637145|FG009|Overall Study|Lost to Follow-up|1|||
146854279|NCT02257567|529637146|FG010|Overall Study|Lost to Follow-up|1|||
146854280|NCT02257567|529637136|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146854281|NCT02257567|529637137|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146854282|NCT02257567|529637138|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146854283|NCT02257567|529637139|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146854284|NCT02257567|529637140|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
146854285|NCT02257567|529637141|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146854286|NCT02257567|529637142|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
146854287|NCT02257567|529637143|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146854288|NCT02257567|529637144|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146854289|NCT02257567|529637145|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146854290|NCT02257567|529637146|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146854291|NCT02257567|529637136|FG000|Overall Study|Physician Decision|0|||
146521461|NCT00972283|528416593|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
146521462|NCT00972283|528416592|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
146521463|NCT00972283|528416593|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
146521464|NCT00972283|528416592|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
146521465|NCT00972283|528416593|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
146521466|NCT00972283|528416592|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
146521467|NCT00972283|528416593|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
146521468|NCT00972283|528416592|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
146521469|NCT00972283|528416593|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
146521470|NCT00980655|528416595|FG000|Overall Study|Adverse Event|13|||
146625265|NCT03037385|528803850|FG005|Overall Study|Lost to Follow-up|1|||
146854292|NCT02257567|529637137|FG001|Overall Study|Physician Decision|0|||
146854293|NCT02257567|529637138|FG002|Overall Study|Physician Decision|0|||
146757090|NCT01818700|529277029|FG000|Overall Study|Withdrawal by Subject|27|||
146757091|NCT01818700|529277029|FG000|Overall Study|Protocol Violation|2|||
146757092|NCT01818700|529277029|FG000|Overall Study|Other|1|||
146757093|NCT01417000|529277036|FG000|Overall Study|Death|59|||
146757094|NCT01417000|529277037|FG001|Overall Study|Death|28|||
146757095|NCT01417000|529277036|FG000|Overall Study|Lost to Follow-up|1|||
146757096|NCT01417000|529277037|FG001|Overall Study|Lost to Follow-up|0|||
146757097|NCT01417000|529277036|FG000|Overall Study|Study Terminated by Sponsor|1|||
146757098|NCT01417000|529277037|FG001|Overall Study|Study Terminated by Sponsor|1|||
146757099|NCT00945477|529277038|FG000|Overall Study|Adverse Event|3|||
146757100|NCT00945477|529277038|FG000|Overall Study|Lack of Efficacy|2|||
146757101|NCT00945477|529277038|FG000|Overall Study|Withdrawal by Subject|1|||
146757102|NCT00558753|529277044|FG000|Overall Study|Lost to Follow-up|5|||
146757103|NCT00558753|529277045|FG001|Overall Study|Lost to Follow-up|7|||
146757104|NCT00783718|529277048|FG000|Induction Phase|Adverse Event|4|||
146757105|NCT00783718|529277049|FG001|Induction Phase|Adverse Event|0|||
146757106|NCT00783718|529277050|FG002|Induction Phase|Adverse Event|7|||
146757107|NCT00783718|529277051|FG003|Induction Phase|Adverse Event|0|||
146757108|NCT00783718|529277052|FG004|Induction Phase|Adverse Event|0|||
146757109|NCT00783718|529277053|FG005|Induction Phase|Adverse Event|0|||
146757110|NCT00783718|529277054|FG006|Induction Phase|Adverse Event|0|||
146757111|NCT00783718|529277048|FG000|Induction Phase|Protocol Violation|1|||
146757112|NCT00783718|529277049|FG001|Induction Phase|Protocol Violation|1|||
146757113|NCT00783718|529277050|FG002|Induction Phase|Protocol Violation|6|||
146757114|NCT00783718|529277051|FG003|Induction Phase|Protocol Violation|0|||
146757115|NCT00783718|529277052|FG004|Induction Phase|Protocol Violation|0|||
146757116|NCT00783718|529277053|FG005|Induction Phase|Protocol Violation|0|||
146757117|NCT00783718|529277054|FG006|Induction Phase|Protocol Violation|0|||
146757118|NCT00783718|529277048|FG000|Induction Phase|Lack of Efficacy|5|||
146757119|NCT00783718|529277049|FG001|Induction Phase|Lack of Efficacy|2|||
146757120|NCT00783718|529277050|FG002|Induction Phase|Lack of Efficacy|14|||
146757121|NCT00783718|529277051|FG003|Induction Phase|Lack of Efficacy|0|||
146757122|NCT00783718|529277052|FG004|Induction Phase|Lack of Efficacy|0|||
146757123|NCT00783718|529277053|FG005|Induction Phase|Lack of Efficacy|0|||
146757124|NCT00783718|529277054|FG006|Induction Phase|Lack of Efficacy|0|||
146757125|NCT00783718|529277048|FG000|Induction Phase|Withdrawal by Subject|3|||
146757126|NCT00783718|529277049|FG001|Induction Phase|Withdrawal by Subject|4|||
146757127|NCT00783718|529277050|FG002|Induction Phase|Withdrawal by Subject|8|||
146757128|NCT00783718|529277051|FG003|Induction Phase|Withdrawal by Subject|0|||
146757129|NCT00783718|529277052|FG004|Induction Phase|Withdrawal by Subject|0|||
146757130|NCT00783718|529277053|FG005|Induction Phase|Withdrawal by Subject|0|||
146757131|NCT00783718|529277054|FG006|Induction Phase|Withdrawal by Subject|0|||
146757132|NCT00783718|529277048|FG000|Induction Phase|Lost to Follow-up|1|||
146757133|NCT00783718|529277049|FG001|Induction Phase|Lost to Follow-up|0|||
146757134|NCT00783718|529277050|FG002|Induction Phase|Lost to Follow-up|1|||
146757135|NCT00783718|529277051|FG003|Induction Phase|Lost to Follow-up|0|||
146757136|NCT00783718|529277052|FG004|Induction Phase|Lost to Follow-up|0|||
146757137|NCT00783718|529277053|FG005|Induction Phase|Lost to Follow-up|0|||
146757138|NCT00783718|529277054|FG006|Induction Phase|Lost to Follow-up|0|||
146757139|NCT00783718|529277048|FG000|Maintenance Phase|Adverse Event|12|||
146757140|NCT00783718|529277049|FG001|Maintenance Phase|Adverse Event|0|||
146757141|NCT00783718|529277050|FG002|Maintenance Phase|Adverse Event|0|||
146757142|NCT00783718|529277051|FG003|Maintenance Phase|Adverse Event|15|||
146757143|NCT00783718|529277052|FG004|Maintenance Phase|Adverse Event|7|||
146757144|NCT00783718|529277053|FG005|Maintenance Phase|Adverse Event|6|||
146757145|NCT00783718|529277054|FG006|Maintenance Phase|Adverse Event|16|||
146757146|NCT00783718|529277048|FG000|Maintenance Phase|Protocol Violation|1|||
146757147|NCT00783718|529277049|FG001|Maintenance Phase|Protocol Violation|0|||
146757148|NCT00783718|529277050|FG002|Maintenance Phase|Protocol Violation|0|||
146757149|NCT00783718|529277051|FG003|Maintenance Phase|Protocol Violation|0|||
146757150|NCT00783718|529277052|FG004|Maintenance Phase|Protocol Violation|0|||
146757151|NCT00783718|529277053|FG005|Maintenance Phase|Protocol Violation|0|||
146757152|NCT00783718|529277054|FG006|Maintenance Phase|Protocol Violation|2|||
146757153|NCT00783718|529277048|FG000|Maintenance Phase|Lack of Efficacy|83|||
146757154|NCT00783718|529277049|FG001|Maintenance Phase|Lack of Efficacy|0|||
146757155|NCT00783718|529277050|FG002|Maintenance Phase|Lack of Efficacy|0|||
146757156|NCT00783718|529277051|FG003|Maintenance Phase|Lack of Efficacy|61|||
146757157|NCT00783718|529277052|FG004|Maintenance Phase|Lack of Efficacy|31|||
146757158|NCT00783718|529277053|FG005|Maintenance Phase|Lack of Efficacy|33|||
146757159|NCT00783718|529277054|FG006|Maintenance Phase|Lack of Efficacy|155|||
146757160|NCT00783718|529277048|FG000|Maintenance Phase|Withdrawal by Subject|6|||
146757161|NCT00783718|529277049|FG001|Maintenance Phase|Withdrawal by Subject|0|||
146757162|NCT00783718|529277050|FG002|Maintenance Phase|Withdrawal by Subject|0|||
146757163|NCT00783718|529277051|FG003|Maintenance Phase|Withdrawal by Subject|2|||
146757164|NCT00783718|529277052|FG004|Maintenance Phase|Withdrawal by Subject|5|||
146757165|NCT00783718|529277053|FG005|Maintenance Phase|Withdrawal by Subject|2|||
146757166|NCT00783718|529277054|FG006|Maintenance Phase|Withdrawal by Subject|20|||
146757167|NCT00783718|529277048|FG000|Maintenance Phase|Lost to Follow-up|3|||
146521471|NCT00980655|528416596|FG001|Overall Study|Adverse Event|31|||
146521472|NCT00980655|528416595|FG000|Overall Study|Death|0|||
146521473|NCT00980655|528416596|FG001|Overall Study|Death|7|||
146521474|NCT00980655|528416595|FG000|Overall Study|Protocol Violation|2|||
146521475|NCT00980655|528416596|FG001|Overall Study|Protocol Violation|7|||
146521476|NCT00980655|528416595|FG000|Overall Study|Withdrawal by Subject|0|||
146521477|NCT00980655|528416596|FG001|Overall Study|Withdrawal by Subject|4|||
146521478|NCT00980655|528416595|FG000|Overall Study|Lost to Follow-up|0|||
146521479|NCT00980655|528416596|FG001|Overall Study|Lost to Follow-up|1|||
146521480|NCT00980655|528416595|FG000|Overall Study|Parent/legal guardian request|1|||
146521481|NCT00980655|528416596|FG001|Overall Study|Parent/legal guardian request|0|||
146521482|NCT00980655|528416595|FG000|Overall Study|Other|0|||
146757168|NCT00783718|529277049|FG001|Maintenance Phase|Lost to Follow-up|0|||
146757169|NCT00783718|529277050|FG002|Maintenance Phase|Lost to Follow-up|0|||
146757170|NCT00783718|529277051|FG003|Maintenance Phase|Lost to Follow-up|0|||
146757171|NCT00783718|529277052|FG004|Maintenance Phase|Lost to Follow-up|2|||
146757172|NCT00783718|529277053|FG005|Maintenance Phase|Lost to Follow-up|0|||
146757173|NCT00783718|529277054|FG006|Maintenance Phase|Lost to Follow-up|2|||
146757174|NCT01605136|529277056|FG000|Study Period|Withdrawal by Subject|2|||
146757175|NCT01605136|529277057|FG001|Study Period|Withdrawal by Subject|0|||
146757176|NCT01605136|529277056|FG000|Study Period|Physician Decision|1|||
146757177|NCT01605136|529277057|FG001|Study Period|Physician Decision|1|||
146757178|NCT01605136|529277056|FG000|Study Period|Lost to Follow-up|0|||
146757179|NCT01605136|529277057|FG001|Study Period|Lost to Follow-up|2|||
146757180|NCT01605136|529277056|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
146757181|NCT01605136|529277057|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
146757182|NCT01072929|529277058|FG000|Overall Study|Adverse Event|8|||
146757183|NCT01072929|529277059|FG001|Overall Study|Adverse Event|11|||
146757184|NCT01072929|529277060|FG002|Overall Study|Adverse Event|2|||
146757185|NCT01072929|529277058|FG000|Overall Study|Lack of Efficacy|7|||
146757186|NCT01072929|529277059|FG001|Overall Study|Lack of Efficacy|4|||
146757187|NCT01072929|529277060|FG002|Overall Study|Lack of Efficacy|0|||
146757188|NCT01072929|529277058|FG000|Overall Study|Withdrawal by Subject|7|||
146757189|NCT01072929|529277059|FG001|Overall Study|Withdrawal by Subject|15|||
146757190|NCT01072929|529277060|FG002|Overall Study|Withdrawal by Subject|3|||
146757191|NCT01072929|529277058|FG000|Overall Study|Protocol Violation|13|||
146757192|NCT01072929|529277059|FG001|Overall Study|Protocol Violation|11|||
146757193|NCT01072929|529277060|FG002|Overall Study|Protocol Violation|2|||
146757194|NCT01072929|529277058|FG000|Overall Study|Lost to Follow-up|8|||
146757195|NCT01072929|529277059|FG001|Overall Study|Lost to Follow-up|4|||
146757196|NCT01072929|529277060|FG002|Overall Study|Lost to Follow-up|1|||
146757197|NCT01072929|529277058|FG000|Overall Study|Noncompliance with study medication|0|||
146757198|NCT01072929|529277059|FG001|Overall Study|Noncompliance with study medication|3|||
146757199|NCT01072929|529277060|FG002|Overall Study|Noncompliance with study medication|0|||
146757200|NCT01072929|529277058|FG000|Overall Study|Noncompliance with study procedures|1|||
146757201|NCT01072929|529277059|FG001|Overall Study|Noncompliance with study procedures|0|||
146757202|NCT01072929|529277060|FG002|Overall Study|Noncompliance with study procedures|1|||
146757203|NCT01072929|529277058|FG000|Overall Study|Other|0|||
146757204|NCT01072929|529277059|FG001|Overall Study|Other|3|||
146757205|NCT01072929|529277060|FG002|Overall Study|Other|0|||
146757206|NCT01027871|529277061|FG000|Overall Study|Physician Decision|1|||
146757207|NCT01027871|529277062|FG001|Overall Study|Physician Decision|5|||
146757208|NCT01027871|529277063|FG002|Overall Study|Physician Decision|0|||
146757209|NCT01027871|529277061|FG000|Overall Study|Protocol Violation|0|||
146757210|NCT01027871|529277062|FG001|Overall Study|Protocol Violation|2|||
146757211|NCT01027871|529277063|FG002|Overall Study|Protocol Violation|2|||
146757212|NCT01027871|529277061|FG000|Overall Study|Withdrawal by Subject|1|||
146757213|NCT01027871|529277062|FG001|Overall Study|Withdrawal by Subject|2|||
146757214|NCT01027871|529277063|FG002|Overall Study|Withdrawal by Subject|2|||
146521483|NCT00980655|528416596|FG001|Overall Study|Other|1|||
146521484|NCT00845676|528416602|FG000|Overall Study|Virologic breakthrough at week 20|1|||
146757215|NCT01027871|529277061|FG000|Overall Study|Adverse Event|0|||
146757216|NCT01027871|529277062|FG001|Overall Study|Adverse Event|2|||
146521485|NCT00845676|528416602|FG000|Overall Study|Adverse Event|1|||
146521486|NCT03373461|528416603|FG000|Part 2|Adverse Event|0|||
146757217|NCT01027871|529277063|FG002|Overall Study|Adverse Event|2|||
146757218|NCT01027871|529277061|FG000|Overall Study|Sponsor Decision|0|||
146757219|NCT01027871|529277062|FG001|Overall Study|Sponsor Decision|2|||
146757220|NCT01027871|529277063|FG002|Overall Study|Sponsor Decision|0|||
146854294|NCT02257567|529637139|FG003|Overall Study|Physician Decision|0|||
146521487|NCT03373461|528416604|FG001|Part 2|Adverse Event|1|||
146757221|NCT01027871|529277061|FG000|Overall Study|Discontinued Prior to Treatment|0|||
146757222|NCT01027871|529277062|FG001|Overall Study|Discontinued Prior to Treatment|0|||
146757223|NCT01027871|529277063|FG002|Overall Study|Discontinued Prior to Treatment|1|||
146757224|NCT04833855|529277064|FG000|Overall Study|Decision by sponsor|0|||
146757225|NCT04833855|529277065|FG001|Overall Study|Decision by sponsor|1|||
146521488|NCT03373461|528416605|FG002|Part 2|Adverse Event|0|||
146521489|NCT03373461|528416606|FG003|Part 2|Adverse Event|0|||
146854295|NCT02257567|529637140|FG004|Overall Study|Physician Decision|0|||
146854296|NCT02257567|529637141|FG005|Overall Study|Physician Decision|0|||
146854297|NCT02257567|529637142|FG006|Overall Study|Physician Decision|0|||
146854298|NCT02257567|529637143|FG007|Overall Study|Physician Decision|2|||
146854299|NCT02257567|529637144|FG008|Overall Study|Physician Decision|0|||
146854300|NCT02257567|529637145|FG009|Overall Study|Physician Decision|1|||
146854301|NCT02257567|529637146|FG010|Overall Study|Physician Decision|0|||
146854302|NCT02257567|529637136|FG000|Overall Study|Withdrawal by Subject|0|||
146854303|NCT02257567|529637137|FG001|Overall Study|Withdrawal by Subject|0|||
146854304|NCT02257567|529637138|FG002|Overall Study|Withdrawal by Subject|2|||
146854305|NCT02257567|529637139|FG003|Overall Study|Withdrawal by Subject|0|||
146854306|NCT02257567|529637140|FG004|Overall Study|Withdrawal by Subject|0|||
146854307|NCT02257567|529637141|FG005|Overall Study|Withdrawal by Subject|6|||
146854308|NCT02257567|529637142|FG006|Overall Study|Withdrawal by Subject|6|||
146854309|NCT02257567|529637143|FG007|Overall Study|Withdrawal by Subject|6|||
146854310|NCT02257567|529637144|FG008|Overall Study|Withdrawal by Subject|1|||
146854311|NCT02257567|529637145|FG009|Overall Study|Withdrawal by Subject|1|||
146854312|NCT02257567|529637146|FG010|Overall Study|Withdrawal by Subject|10|||
146854313|NCT03625895|529637149|FG000|Overall Study|Protocol Violation|585|||
146854314|NCT00552240|529637152|FG000|Overall Study|Adverse Event|9|||
146854315|NCT00552240|529637153|FG001|Overall Study|Adverse Event|9|||
146854316|NCT00552240|529637152|FG000|Overall Study|Protocol Violation|1|||
146854317|NCT00552240|529637153|FG001|Overall Study|Protocol Violation|1|||
146854318|NCT00552240|529637152|FG000|Overall Study|Lost to Follow-up|5|||
146854319|NCT00552240|529637153|FG001|Overall Study|Lost to Follow-up|6|||
146854320|NCT00552240|529637152|FG000|Overall Study|Withdrawal by Subject|2|||
146854321|NCT00552240|529637153|FG001|Overall Study|Withdrawal by Subject|2|||
146854322|NCT00552240|529637152|FG000|Overall Study|Lack of Efficacy|6|||
146854323|NCT00552240|529637153|FG001|Overall Study|Lack of Efficacy|0|||
146854324|NCT00552240|529637152|FG000|Overall Study|Other|1|||
146854325|NCT00552240|529637153|FG001|Overall Study|Other|0|||
146854326|NCT02679573|529637154|FG000|Overall Study|Adverse Event|13|||
146854327|NCT02679573|529637155|FG001|Overall Study|Adverse Event|6|||
146854328|NCT02679573|529637154|FG000|Overall Study|Lack of Efficacy|12|||
146854329|NCT02679573|529637155|FG001|Overall Study|Lack of Efficacy|15|||
146854330|NCT02679573|529637154|FG000|Overall Study|Could not complete required study visits|6|||
146854331|NCT02679573|529637155|FG001|Overall Study|Could not complete required study visits|2|||
146854332|NCT02679573|529637154|FG000|Overall Study|Withdrawal by Subject|2|||
146854333|NCT02679573|529637155|FG001|Overall Study|Withdrawal by Subject|9|||
146854334|NCT02679573|529637154|FG000|Overall Study|Death|2|||
146854335|NCT02679573|529637155|FG001|Overall Study|Death|0|||
146854336|NCT02679573|529637154|FG000|Overall Study|Physician Decision|2|||
146854337|NCT02679573|529637155|FG001|Overall Study|Physician Decision|4|||
146854338|NCT02679573|529637154|FG000|Overall Study|Lost to Follow-up|0|||
146854339|NCT02679573|529637155|FG001|Overall Study|Lost to Follow-up|3|||
146854340|NCT03545503|529637156|FG000|Overall Study|Protocol Violation|14|||
146854341|NCT03545503|529637157|FG001|Overall Study|Protocol Violation|16|||
146854342|NCT05753670|529637158|FG000|Overall Study|Withdrawal by Subject|6|||
146854343|NCT05753670|529637159|FG001|Overall Study|Withdrawal by Subject|8|||
146854344|NCT05753670|529637158|FG000|Overall Study|Protocol Violation|3|||
146854345|NCT05753670|529637159|FG001|Overall Study|Protocol Violation|1|||
146854346|NCT02483585|529637160|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
146854347|NCT02483585|529637161|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
146854348|NCT02483585|529637160|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
146854349|NCT02483585|529637161|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
146854350|NCT02483585|529637160|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
146854351|NCT02483585|529637161|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
146854352|NCT02483585|529637160|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
146854353|NCT02483585|529637161|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
146854354|NCT02483585|529637160|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
146854355|NCT02483585|529637161|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
146854356|NCT02483585|529637160|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
146854357|NCT02483585|529637161|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
146854358|NCT02483585|529637160|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
146521490|NCT03373461|528416607|FG004|Part 2|Adverse Event|1|||
146854359|NCT02483585|529637161|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
146854360|NCT01236339|529637167|FG000|Overall Study|Termination of study by sponsor|11|||
146854361|NCT01236339|529637168|FG001|Overall Study|Termination of study by sponsor|13|||
146854362|NCT01098097|529637169|FG000|Overall Study|Adverse Event|17|||
146854363|NCT01098097|529637169|FG000|Overall Study|Lost to Follow-up|18|||
146854364|NCT01098097|529637169|FG000|Overall Study|Status unknown|16|||
146854365|NCT01098097|529637169|FG000|Overall Study|No reason reported|31|||
146854366|NCT00394082|529637170|FG000|Overall Study|Unacceptable toxicity|15|||
146854367|NCT00394082|529637170|FG000|Overall Study|Adverse Event|4|||
146854368|NCT00394082|529637170|FG000|Overall Study|Physician Decision|4|||
146854369|NCT00394082|529637170|FG000|Overall Study|Withdrawal by Subject|2|||
146854370|NCT00394082|529637170|FG000|Overall Study|Other|1|||
146854371|NCT01945060|529637171|FG000|Overall Study|Lost to follow up|1|||
146854372|NCT01945060|529637172|FG001|Overall Study|Lost to follow up|0|||
146854373|NCT01945060|529637171|FG000|Overall Study|Distress related to IV access|0|||
146854374|NCT01945060|529637172|FG001|Overall Study|Distress related to IV access|1|||
146854375|NCT00577577|529637180|FG000|Overall Study|Adverse Event|3|||
146854376|NCT00577577|529637181|FG001|Overall Study|Adverse Event|2|||
146854377|NCT00577577|529637180|FG000|Overall Study|Lost to Follow-up|1|||
146854378|NCT00577577|529637181|FG001|Overall Study|Lost to Follow-up|0|||
146854379|NCT00577577|529637180|FG000|Overall Study|Protocol Violation|0|||
146854380|NCT00577577|529637181|FG001|Overall Study|Protocol Violation|3|||
146854381|NCT00577577|529637180|FG000|Overall Study|Transportation|1|||
146854382|NCT00577577|529637181|FG001|Overall Study|Transportation|0|||
146854383|NCT00232544|529637182|FG000|Overall Study|Lost to Follow-up|20|||
146854384|NCT00232544|529637183|FG001|Overall Study|Lost to Follow-up|15|||
146854385|NCT00116753|529637184|FG000|Overall Study|Adverse Event|16|||
146854386|NCT00116753|529637185|FG001|Overall Study|Adverse Event|10|||
146854387|NCT00116753|529637186|FG002|Overall Study|Adverse Event|7|||
146854388|NCT00116753|529637184|FG000|Overall Study|Withdrawal by Subject|11|||
146854389|NCT00116753|529637185|FG001|Overall Study|Withdrawal by Subject|12|||
146854390|NCT00116753|529637186|FG002|Overall Study|Withdrawal by Subject|8|||
146854391|NCT00116753|529637184|FG000|Overall Study|Lost to Follow-up|0|||
146854392|NCT00116753|529637185|FG001|Overall Study|Lost to Follow-up|2|||
146854393|NCT00116753|529637186|FG002|Overall Study|Lost to Follow-up|1|||
146854394|NCT00116753|529637184|FG000|Overall Study|Protocol Violation|0|||
146854395|NCT00116753|529637185|FG001|Overall Study|Protocol Violation|0|||
146854396|NCT00116753|529637186|FG002|Overall Study|Protocol Violation|1|||
146854397|NCT00116753|529637184|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
146854398|NCT00116753|529637185|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
146854399|NCT00116753|529637186|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
146854400|NCT00116753|529637184|FG000|Overall Study|Disease Progression|3|||
146854401|NCT00116753|529637185|FG001|Overall Study|Disease Progression|4|||
146854402|NCT00116753|529637186|FG002|Overall Study|Disease Progression|3|||
146854403|NCT00116753|529637184|FG000|Overall Study|Abnormal Echocardiogram|0|||
146854404|NCT00116753|529637185|FG001|Overall Study|Abnormal Echocardiogram|0|||
146854405|NCT00116753|529637186|FG002|Overall Study|Abnormal Echocardiogram|1|||
146854406|NCT00116753|529637184|FG000|Overall Study|Progressive Parkinson's Disease|1|||
146854407|NCT00116753|529637185|FG001|Overall Study|Progressive Parkinson's Disease|0|||
146854408|NCT00116753|529637186|FG002|Overall Study|Progressive Parkinson's Disease|0|||
146854409|NCT00116753|529637184|FG000|Overall Study|Dosing Error|0|||
146854410|NCT00116753|529637185|FG001|Overall Study|Dosing Error|1|||
146854411|NCT00116753|529637186|FG002|Overall Study|Dosing Error|0|||
146854412|NCT01590082|529637187|FG000|Overall Study|Withdrawal by Subject|1|||
146854413|NCT01590082|529637188|FG001|Overall Study|Withdrawal by Subject|0|||
146854414|NCT01590082|529637187|FG000|Overall Study|Ineligible|1|||
146854415|NCT01590082|529637188|FG001|Overall Study|Ineligible|0|||
146854416|NCT01210664|529637189|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
146854417|NCT01210664|529637190|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
146854418|NCT01210664|529637191|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
146854419|NCT01210664|529637192|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
146854420|NCT01210664|529637189|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
146854421|NCT01210664|529637190|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
146854422|NCT01210664|529637191|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
146854423|NCT01210664|529637192|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
146854424|NCT01210664|529637189|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
146854425|NCT01210664|529637190|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
146854426|NCT01210664|529637191|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
146854427|NCT01210664|529637192|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
146854428|NCT01853644|529637193|FG000|Registration and Treatment Start|Did not start treatment|1|||
146854429|NCT01853644|529637193|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
146854430|NCT01853644|529637193|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
146854431|NCT01853644|529637193|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
146854432|NCT01853644|529637193|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
146854433|NCT01853644|529637193|FG000|Continued Treatment After First Response|Adverse Event|2|||
146854434|NCT01853644|529637193|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
146854435|NCT02891408|529637194|FG000|Overall Study|Lost to Follow-up|0|||
146854436|NCT02891408|529637195|FG001|Overall Study|Lost to Follow-up|0|||
146854437|NCT02891408|529637196|FG002|Overall Study|Lost to Follow-up|1|||
146854438|NCT02891408|529637197|FG003|Overall Study|Lost to Follow-up|0|||
146854439|NCT02891408|529637198|FG004|Overall Study|Lost to Follow-up|0|||
146854440|NCT02891408|529637199|FG005|Overall Study|Lost to Follow-up|0|||
146854441|NCT02891408|529637200|FG006|Overall Study|Lost to Follow-up|0|||
146854442|NCT01054170|529637201|FG000|Overall Study|Protocol Violation|1|||
146854443|NCT01054170|529637202|FG001|Overall Study|Protocol Violation|0|||
146854444|NCT01054170|529637201|FG000|Overall Study|Withdrawal by Subject|3|||
146854445|NCT01054170|529637202|FG001|Overall Study|Withdrawal by Subject|2|||
146521491|NCT04530838|528417971|FG000|Overall Study|Other|2|||
146521492|NCT04530838|528417972|FG001|Overall Study|Other|1|||
146757226|NCT04833855|529277066|FG002|Overall Study|Decision by sponsor|0|||
146757227|NCT04833855|529277067|FG003|Overall Study|Decision by sponsor|0|||
146757228|NCT04833855|529277064|FG000|Overall Study|Withdrawal by Subject|4|||
146757229|NCT04833855|529277065|FG001|Overall Study|Withdrawal by Subject|1|||
146757230|NCT04833855|529277066|FG002|Overall Study|Withdrawal by Subject|3|||
146757231|NCT04833855|529277067|FG003|Overall Study|Withdrawal by Subject|1|||
146757232|NCT04833855|529277064|FG000|Overall Study|Lost to Follow-up|1|||
146757233|NCT04833855|529277065|FG001|Overall Study|Lost to Follow-up|0|||
146757234|NCT04833855|529277066|FG002|Overall Study|Lost to Follow-up|2|||
146757235|NCT04833855|529277067|FG003|Overall Study|Lost to Follow-up|2|||
146757236|NCT04833855|529277064|FG000|Overall Study|Protocol specified criteria|0|||
146757237|NCT04833855|529277065|FG001|Overall Study|Protocol specified criteria|0|||
146757238|NCT04833855|529277066|FG002|Overall Study|Protocol specified criteria|2|||
146757239|NCT04833855|529277067|FG003|Overall Study|Protocol specified criteria|1|||
146757240|NCT01414166|529277068|FG000|Overall Study|Adverse Event|10|||
146757241|NCT01414166|529277069|FG001|Overall Study|Adverse Event|2|||
146757242|NCT01414166|529277068|FG000|Overall Study|Lost to Follow-up|4|||
146757243|NCT01414166|529277069|FG001|Overall Study|Lost to Follow-up|1|||
146757244|NCT01414166|529277068|FG000|Overall Study|Non-compliance with study drug|2|||
146757245|NCT01414166|529277069|FG001|Overall Study|Non-compliance with study drug|0|||
146757246|NCT01414166|529277068|FG000|Overall Study|Physician Decision|2|||
146757247|NCT01414166|529277069|FG001|Overall Study|Physician Decision|0|||
146757248|NCT01414166|529277068|FG000|Overall Study|Protocol Violation|2|||
146757249|NCT01414166|529277069|FG001|Overall Study|Protocol Violation|0|||
146757250|NCT01414166|529277068|FG000|Overall Study|Study terminated by Sponsor|68|||
146757251|NCT01414166|529277069|FG001|Overall Study|Study terminated by Sponsor|75|||
146757252|NCT01414166|529277068|FG000|Overall Study|Withdrawal by Subject|3|||
146521493|NCT04530838|528417973|FG002|Overall Study|Other|0|||
146521494|NCT04530838|528417971|FG000|Overall Study|Physician Decision|0|||
146757253|NCT01414166|529277069|FG001|Overall Study|Withdrawal by Subject|5|||
146757254|NCT03782727|529277070|FG000|Overall Study|Lost to Follow-up|32|||
146757255|NCT03682536|529277073|FG000|Randomization|Withdrawal by Subject|0|||
146757256|NCT03682536|529277074|FG001|Randomization|Withdrawal by Subject|2|||
146757257|NCT03682536|529277073|FG000|Treatment|Other Reasons|8|||
146757258|NCT03682536|529277074|FG001|Treatment|Other Reasons|7|||
146757259|NCT03682536|529277073|FG000|Treatment|Physician Decision|5|||
146757260|NCT03682536|529277074|FG001|Treatment|Physician Decision|5|||
146757261|NCT03682536|529277073|FG000|Treatment|Protocol Violation|1|||
146757262|NCT03682536|529277074|FG001|Treatment|Protocol Violation|0|||
146757263|NCT03682536|529277073|FG000|Treatment|Study Terminated by Sponsor|1|||
146757264|NCT03682536|529277074|FG001|Treatment|Study Terminated by Sponsor|2|||
146757265|NCT03682536|529277073|FG000|Treatment|Lost to Follow-up|0|||
146757266|NCT03682536|529277074|FG001|Treatment|Lost to Follow-up|1|||
146757267|NCT03682536|529277073|FG000|Treatment|Withdrawal by Subject|16|||
146757268|NCT03682536|529277074|FG001|Treatment|Withdrawal by Subject|18|||
146757269|NCT03682536|529277073|FG000|Treatment|Lack of Efficacy|41|||
146757270|NCT03682536|529277074|FG001|Treatment|Lack of Efficacy|68|||
146757271|NCT03682536|529277073|FG000|Treatment|Disease Progression|9|||
146757272|NCT03682536|529277074|FG001|Treatment|Disease Progression|7|||
146757273|NCT03682536|529277073|FG000|Treatment|Adverse Event|9|||
146757274|NCT03682536|529277074|FG001|Treatment|Adverse Event|5|||
146757275|NCT03682536|529277073|FG000|Treatment|Death|14|||
146757276|NCT03682536|529277074|FG001|Treatment|Death|13|||
146757277|NCT04824131|529277075|FG000|CAB LA Oral Phase|Adverse Event|1|||
146757278|NCT04824131|529277075|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
146757279|NCT04824131|529277075|FG000|Step 3|Withdrawal by Subject|2|||
146757280|NCT05489224|529277076|FG000|Treatment Period I|Withdrawal by Subject|6|||
146757281|NCT05489224|529277077|FG001|Treatment Period I|Withdrawal by Subject|5|||
146757282|NCT05489224|529277078|FG002|Treatment Period I|Withdrawal by Subject|0|||
146757283|NCT05489224|529277076|FG000|Treatment Period I|Adverse Event|3|||
146757284|NCT05489224|529277077|FG001|Treatment Period I|Adverse Event|11|||
146757285|NCT05489224|529277078|FG002|Treatment Period I|Adverse Event|0|||
146757286|NCT05489224|529277076|FG000|Treatment Period I|Lost to Follow-up|0|||
146757287|NCT05489224|529277077|FG001|Treatment Period I|Lost to Follow-up|1|||
146757288|NCT05489224|529277078|FG002|Treatment Period I|Lost to Follow-up|0|||
146757289|NCT05489224|529277076|FG000|Treatment Period I|Physician Decision|0|||
146757290|NCT05489224|529277077|FG001|Treatment Period I|Physician Decision|1|||
146757291|NCT05489224|529277078|FG002|Treatment Period I|Physician Decision|0|||
146757292|NCT05489224|529277076|FG000|Treatment Period II up to Week 32|Ongoing|222|||
146757293|NCT05489224|529277077|FG001|Treatment Period II up to Week 32|Ongoing|107|||
146757294|NCT05489224|529277078|FG002|Treatment Period II up to Week 32|Ongoing|107|||
146757295|NCT05489224|529277076|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
146757296|NCT05489224|529277077|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
146757297|NCT05489224|529277078|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
146757298|NCT05489224|529277076|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
146757299|NCT05489224|529277077|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
146757300|NCT05489224|529277078|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
146757301|NCT03686384|529277080|FG000|Overall Study|Lack of Efficacy|4|||
146757302|NCT03686384|529277081|FG001|Overall Study|Lack of Efficacy|13|||
146757303|NCT03686384|529277080|FG000|Overall Study|Lost to Follow-up|3|||
146757304|NCT03686384|529277081|FG001|Overall Study|Lost to Follow-up|0|||
146757305|NCT03686384|529277080|FG000|Overall Study|Physician Decision|0|||
146757306|NCT03686384|529277081|FG001|Overall Study|Physician Decision|1|||
146757307|NCT03686384|529277080|FG000|Overall Study|Took prohibited medication|0|||
146757308|NCT03686384|529277081|FG001|Overall Study|Took prohibited medication|1|||
146757309|NCT04887285|529277082|FG000|Overall Study|Lost to Follow-up|0|||
146757310|NCT04887285|529277083|FG001|Overall Study|Lost to Follow-up|2|||
146757311|NCT04887285|529277084|FG002|Overall Study|Lost to Follow-up|3|||
146757312|NCT04640571|529277085|FG000|Overall Study|Withdrawal by Subject|0|||
146757313|NCT04640571|529277086|FG001|Overall Study|Withdrawal by Subject|0|||
146757314|NCT04640571|529277087|FG002|Overall Study|Withdrawal by Subject|0|||
146757315|NCT04640571|529277088|FG003|Overall Study|Withdrawal by Subject|0|||
146757316|NCT04640571|529277089|FG004|Overall Study|Withdrawal by Subject|0|||
146757317|NCT04640571|529277090|FG005|Overall Study|Withdrawal by Subject|2|||
146757318|NCT03008122|529277092|FG000|Overall Study|Physician Decision|3|||
146757319|NCT03008122|529277093|FG001|Overall Study|Physician Decision|2|||
146757320|NCT03008122|529277094|FG002|Overall Study|Physician Decision|0|||
146757321|NCT03008122|529277092|FG000|Overall Study|Withdrawal by Subject|1|||
146757322|NCT03008122|529277093|FG001|Overall Study|Withdrawal by Subject|3|||
146757323|NCT03008122|529277094|FG002|Overall Study|Withdrawal by Subject|0|||
146757324|NCT03008122|529277092|FG000|Overall Study|Lost to Follow-up|4|||
146757325|NCT03008122|529277093|FG001|Overall Study|Lost to Follow-up|8|||
146757326|NCT03008122|529277094|FG002|Overall Study|Lost to Follow-up|3|||
146757327|NCT03008122|529277092|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
146757328|NCT03008122|529277093|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
146757329|NCT03008122|529277094|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
146757330|NCT03008122|529277092|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
146757331|NCT03008122|529277093|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
146757332|NCT03008122|529277094|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
146757333|NCT03008122|529277092|FG000|Overall Study|Death|0|||
146757334|NCT03008122|529277093|FG001|Overall Study|Death|0|||
146757335|NCT03008122|529277094|FG002|Overall Study|Death|1|||
146757336|NCT02338609|529277097|FG000|Overall Study|Physician Decision|1|||
146757337|NCT02338609|529277097|FG000|Overall Study|Death|1|||
146757338|NCT04736056|529277099|FG000|Overall Study|Death|0|||
146757339|NCT04736056|529277100|FG001|Overall Study|Death|0|||
146757340|NCT04736056|529277101|FG002|Overall Study|Death|0|||
146757341|NCT04736056|529277102|FG003|Overall Study|Death|1|||
146757342|NCT04736056|529277099|FG000|Overall Study|Lost to Follow-up|1|||
146757343|NCT04736056|529277100|FG001|Overall Study|Lost to Follow-up|0|||
146757344|NCT04736056|529277101|FG002|Overall Study|Lost to Follow-up|1|||
146521495|NCT04530838|528417972|FG001|Overall Study|Physician Decision|0|||
146521496|NCT04530838|528417973|FG002|Overall Study|Physician Decision|1|||
146521497|NCT04530838|528417971|FG000|Overall Study|Death|0|||
146521498|NCT04530838|528417972|FG001|Overall Study|Death|0|||
146521499|NCT04530838|528417973|FG002|Overall Study|Death|1|||
146521500|NCT04530838|528417971|FG000|Overall Study|Adverse Event|0|||
146521501|NCT04530838|528417972|FG001|Overall Study|Adverse Event|1|||
146521502|NCT04530838|528417973|FG002|Overall Study|Adverse Event|0|||
146521503|NCT04530838|528417971|FG000|Overall Study|No longer meets eligibility criteria|1|||
146521504|NCT04530838|528417972|FG001|Overall Study|No longer meets eligibility criteria|0|||
146521505|NCT04530838|528417973|FG002|Overall Study|No longer meets eligibility criteria|2|||
146521506|NCT04530838|528417971|FG000|Overall Study|Withdrawal by parent/guardian|5|||
146521507|NCT04530838|528417972|FG001|Overall Study|Withdrawal by parent/guardian|2|||
146521508|NCT04530838|528417973|FG002|Overall Study|Withdrawal by parent/guardian|2|||
146521509|NCT00803712|528417974|FG000|Overall Study|Noncompliance|3|||
146521510|NCT00803712|528417975|FG001|Overall Study|Noncompliance|0|||
146521511|NCT00803712|528417974|FG000|Overall Study|Adverse Event|5|||
146521512|NCT00803712|528417975|FG001|Overall Study|Adverse Event|0|||
146521513|NCT00803712|528417974|FG000|Overall Study|Death|8|||
146625266|NCT03037385|528803851|FG006|Overall Study|Lost to Follow-up|0|||
146757345|NCT04736056|529277102|FG003|Overall Study|Lost to Follow-up|1|||
146757346|NCT04736056|529277099|FG000|Overall Study|Withdrawal by Subject|2|||
146757347|NCT04736056|529277100|FG001|Overall Study|Withdrawal by Subject|0|||
146521514|NCT00803712|528417975|FG001|Overall Study|Death|7|||
146521515|NCT00803712|528417974|FG000|Overall Study|Lost to Follow-up|3|||
146521516|NCT00803712|528417975|FG001|Overall Study|Lost to Follow-up|1|||
146521517|NCT00803712|528417974|FG000|Overall Study|Withdrawal by Subject|2|||
146521518|NCT00803712|528417975|FG001|Overall Study|Withdrawal by Subject|4|||
146521519|NCT00803712|528417974|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
146521520|NCT00803712|528417975|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
146521521|NCT00803712|528417974|FG000|Overall Study|Protocol criteria (other)|0|||
146521522|NCT00803712|528417975|FG001|Overall Study|Protocol criteria (other)|2|||
146521523|NCT00803712|528417974|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
146521524|NCT00803712|528417975|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
146521525|NCT00803712|528417974|FG000|Overall Study|Administrative decision|2|||
146521526|NCT00803712|528417975|FG001|Overall Study|Administrative decision|3|||
146521527|NCT00803712|528417974|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
146521528|NCT00803712|528417975|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
146521529|NCT00762762|528417984|FG000|Overall Study|Did not return for appointments|6|||
146521530|NCT00762762|528417985|FG001|Overall Study|Did not return for appointments|8|||
146521531|NCT02489448|528417986|FG000|Overall Study|Death|3|||
146521532|NCT02489448|528417986|FG000|Overall Study|Withdrawal by Subject|2|||
146521533|NCT02748057|528417987|FG000|Overall Study|Adverse Event|1|||
146521534|NCT02748057|528417988|FG001|Overall Study|Adverse Event|0|||
146521535|NCT02748057|528417987|FG000|Overall Study|Physician Decision|0|||
146521536|NCT02748057|528417988|FG001|Overall Study|Physician Decision|1|||
146521537|NCT02748057|528417987|FG000|Overall Study|Protocol Violation|2|||
146521538|NCT02748057|528417988|FG001|Overall Study|Protocol Violation|1|||
146521539|NCT02748057|528417987|FG000|Overall Study|Participant Moved|1|||
146521540|NCT02748057|528417988|FG001|Overall Study|Participant Moved|0|||
146521541|NCT02748057|528417987|FG000|Overall Study|Withdrawal by Subject|1|||
146521542|NCT02748057|528417988|FG001|Overall Study|Withdrawal by Subject|0|||
146521543|NCT04152083|528417997|FG000|Overall Study|Lost to Follow-up|2|||
146521544|NCT04152083|528417998|FG001|Overall Study|Lost to Follow-up|1|||
146521545|NCT04152083|528417997|FG000|Overall Study|Adverse Event|1|||
146521546|NCT04152083|528417998|FG001|Overall Study|Adverse Event|0|||
146521547|NCT04152083|528417997|FG000|Overall Study|Randomized but not treated|3|||
146521548|NCT04152083|528417998|FG001|Overall Study|Randomized but not treated|2|||
146521549|NCT02609386|528417999|FG000|Overall Study|Withdrawal by Subject|6|||
146521550|NCT02609386|528418000|FG001|Overall Study|Withdrawal by Subject|1|||
146521551|NCT02609386|528417999|FG000|Overall Study|Lost to Follow-up|3|||
146521552|NCT02609386|528418000|FG001|Overall Study|Lost to Follow-up|5|||
146521553|NCT02609386|528417999|FG000|Overall Study|Death|19|||
146521554|NCT02609386|528418000|FG001|Overall Study|Death|9|||
146521555|NCT02609386|528417999|FG000|Overall Study|Physician Decision|0|||
146521556|NCT02609386|528418000|FG001|Overall Study|Physician Decision|2|||
146521557|NCT00540644|528418001|FG000|Overall Study|Adverse Event|3|||
146521558|NCT00540644|528418002|FG001|Overall Study|Adverse Event|1|||
146521559|NCT00540644|528418001|FG000|Overall Study|Disease Progression|3|||
146521560|NCT00540644|528418002|FG001|Overall Study|Disease Progression|1|||
146521561|NCT00540644|528418001|FG000|Overall Study|Physician Decision|0|||
146521562|NCT00540644|528418002|FG001|Overall Study|Physician Decision|5|||
146521563|NCT00540644|528418001|FG000|Overall Study|Withdrawal by Subject|2|||
146521564|NCT00540644|528418002|FG001|Overall Study|Withdrawal by Subject|2|||
146521565|NCT00540644|528418001|FG000|Overall Study|Noncomplilance|1|||
146521566|NCT00540644|528418002|FG001|Overall Study|Noncomplilance|0|||
146521567|NCT03280056|528418003|FG000|Overall Study|Withdrawal by Subject|12|||
146521568|NCT03280056|528418004|FG001|Overall Study|Withdrawal by Subject|14|||
146521569|NCT03280056|528418003|FG000|Overall Study|Death|9|||
146521570|NCT03280056|528418004|FG001|Overall Study|Death|2|||
146521571|NCT03280056|528418003|FG000|Overall Study|Adverse Event|1|||
146521572|NCT03280056|528418004|FG001|Overall Study|Adverse Event|3|||
146521573|NCT03280056|528418003|FG000|Overall Study|Lost to Follow-up|1|||
146521574|NCT03280056|528418004|FG001|Overall Study|Lost to Follow-up|1|||
146521575|NCT03280056|528418003|FG000|Overall Study|Physician Decision|0|||
146521576|NCT03280056|528418004|FG001|Overall Study|Physician Decision|1|||
146521577|NCT03280056|528418003|FG000|Overall Study|Early Discontinuation|1|||
146757348|NCT04736056|529277101|FG002|Overall Study|Withdrawal by Subject|0|||
146757349|NCT04736056|529277102|FG003|Overall Study|Withdrawal by Subject|0|||
146521578|NCT03280056|528418004|FG001|Overall Study|Early Discontinuation|0|||
146625267|NCT03037385|528803852|FG007|Overall Study|Lost to Follow-up|0|||
146757350|NCT04736056|529277099|FG000|Overall Study|Physician Decision|1|||
146521579|NCT01869777|528418005|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
146521580|NCT01135524|528418012|FG000|Overall Study|Withdrawal by Subject|14|||
146521581|NCT01135524|528418012|FG000|Overall Study|Adverse Event|20|||
146521582|NCT01135524|528418012|FG000|Overall Study|Lost to Follow-up|3|||
146521583|NCT01135524|528418012|FG000|Overall Study|Administrative|151|||
146521584|NCT01135524|528418012|FG000|Overall Study|Lack of Efficacy|8|||
146521585|NCT03318003|528418013|FG000|Overall Study|Withdrawal by Subject|1|||
146521586|NCT03318003|528418014|FG001|Overall Study|Withdrawal by Subject|1|||
146521587|NCT03318003|528418013|FG000|Overall Study|fetal loss|0|||
146854446|NCT01054170|529637201|FG000|Overall Study|Adverse Event|0|||
146854447|NCT01054170|529637202|FG001|Overall Study|Adverse Event|4|||
146854448|NCT02951767|529637203|FG000|Overall Study|Study Terminated By Sponsor|9|||
146854449|NCT02951767|529637203|FG000|Overall Study|Withdrawal by Subject|11|||
146854450|NCT02951767|529637203|FG000|Overall Study|Death|96|||
146854451|NCT02951767|529637203|FG000|Overall Study|Lost to Follow-up|2|||
146854452|NCT02951767|529637203|FG000|Overall Study|Physician Decision|1|||
146854453|NCT02549196|529637204|FG000|Overall Study|Protocol Violation|0|||
146854454|NCT02549196|529637205|FG001|Overall Study|Protocol Violation|0|||
146854455|NCT02549196|529637206|FG002|Overall Study|Protocol Violation|0|||
146854456|NCT02549196|529637207|FG003|Overall Study|Protocol Violation|1|||
146854457|NCT02549196|529637204|FG000|Overall Study|Withdrawal by Subject|1|||
146854458|NCT02549196|529637205|FG001|Overall Study|Withdrawal by Subject|0|||
146854459|NCT02549196|529637206|FG002|Overall Study|Withdrawal by Subject|1|||
146854460|NCT02549196|529637207|FG003|Overall Study|Withdrawal by Subject|0|||
146854461|NCT01442779|529637208|FG000|Overall Study|Withdrawal by Subject|3|||
146854462|NCT01442779|529637208|FG000|Overall Study|Death|3|||
146854463|NCT01442779|529637208|FG000|Overall Study|Non-compliance|1|||
146757351|NCT04736056|529277100|FG001|Overall Study|Physician Decision|0|||
146757352|NCT04736056|529277101|FG002|Overall Study|Physician Decision|1|||
146757353|NCT04736056|529277102|FG003|Overall Study|Physician Decision|0|||
146757354|NCT02148718|529277103|FG000|Overall Study|Protocol Violation|26|||
146757355|NCT02148718|529277103|FG000|Overall Study|Discontinued Study Prematurely|5|||
146757356|NCT02956967|529277104|FG000|Overall Study|Adverse Event|3|||
146757357|NCT02956967|529277104|FG000|Overall Study|Reason non-related to neutropenia|10|||
146757358|NCT02956967|529277104|FG000|Overall Study|Lost to Follow-up|5|||
146757359|NCT02956967|529277104|FG000|Overall Study|Missing|1|||
146757360|NCT02956967|529277104|FG000|Overall Study|Termination of Nivestim administration|29|||
146757361|NCT02322775|529277105|FG000|Overall Study|Adverse Event|1|||
146757362|NCT02322775|529277106|FG001|Overall Study|Adverse Event|0|||
146757363|NCT02322775|529277105|FG000|Overall Study|Lost to Follow-up|0|||
146757364|NCT02322775|529277106|FG001|Overall Study|Lost to Follow-up|1|||
146757365|NCT02322775|529277105|FG000|Overall Study|Protocol Violation|1|||
146757366|NCT02322775|529277106|FG001|Overall Study|Protocol Violation|0|||
146757367|NCT02322775|529277105|FG000|Overall Study|Withdrawal by Subject|3|||
146757368|NCT02322775|529277106|FG001|Overall Study|Withdrawal by Subject|4|||
146757369|NCT02322775|529277105|FG000|Overall Study|Not willing to perform all FU visits|0|||
146757370|NCT02322775|529277106|FG001|Overall Study|Not willing to perform all FU visits|1|||
146757371|NCT04482855|529277107|FG000|Overall Study|Lost to Follow-up|1|||
146757372|NCT04482855|529277108|FG001|Overall Study|Lost to Follow-up|0|||
146757373|NCT04482855|529277107|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
146757374|NCT04482855|529277108|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
146757375|NCT04482855|529277107|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
146757376|NCT04482855|529277108|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
146757377|NCT04011033|529277113|FG000|Overall Study|Physician Decision|2|||
146757378|NCT04011033|529277114|FG001|Overall Study|Physician Decision|3|||
146757379|NCT04011033|529277113|FG000|Overall Study|Withdrawal by Subject|1|||
146757380|NCT04011033|529277114|FG001|Overall Study|Withdrawal by Subject|0|||
146757381|NCT01823341|529277115|FG000|Overall Study|Failed run-in|7|||
146757382|NCT01823341|529277115|FG000|Overall Study|Withdrawal by Subject|7|||
146757383|NCT01823341|529277115|FG000|Overall Study|Adverse Event|1|||
146757384|NCT00663962|529277116|FG000|Overall Study|somnolence|1|||
146757385|NCT00663962|529277117|FG001|Overall Study|somnolence|0|||
146757386|NCT00604786|529277118|FG000|Overall Study|Lost to Follow-up|2|||
146757387|NCT00604786|529277119|FG001|Overall Study|Lost to Follow-up|0|||
146757388|NCT01449929|529277124|FG000|Randomization Phase 96 Week|Adverse Event|5|||
146757389|NCT01449929|529277125|FG001|Randomization Phase 96 Week|Adverse Event|13|||
146757390|NCT01449929|529277126|FG002|Randomization Phase 96 Week|Adverse Event|0|||
146757391|NCT01449929|529277124|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
146757392|NCT01449929|529277125|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
146757393|NCT01449929|529277126|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
146757394|NCT01449929|529277124|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
146757395|NCT01449929|529277125|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
146854464|NCT00196976|529637209|FG000|Primary Study|Migrated from study area|0|||
146854465|NCT00196976|529637210|FG001|Primary Study|Migrated from study area|0|||
146854466|NCT00196976|529637211|FG002|Primary Study|Migrated from study area|0|||
146854467|NCT00196976|529637212|FG003|Primary Study|Migrated from study area|0|||
146757396|NCT01449929|529277126|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
146757397|NCT01449929|529277124|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
146757398|NCT01449929|529277125|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
146757399|NCT01449929|529277126|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
146757400|NCT01449929|529277124|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
146521588|NCT03318003|528418014|FG001|Overall Study|fetal loss|1|||
146521589|NCT02620787|528418019|FG000|Overall Study|Adverse Event|1|||
146521590|NCT02620787|528418020|FG001|Overall Study|Adverse Event|0|||
146757401|NCT01449929|529277125|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
146757402|NCT01449929|529277126|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
146757403|NCT01449929|529277124|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
146757404|NCT01449929|529277125|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
146757405|NCT01449929|529277126|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
146757406|NCT01449929|529277124|FG000|Randomization Phase 96 Week|Physician Decision|2|||
146757407|NCT01449929|529277125|FG001|Randomization Phase 96 Week|Physician Decision|3|||
146757408|NCT01449929|529277126|FG002|Randomization Phase 96 Week|Physician Decision|0|||
146757409|NCT01449929|529277124|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
146757410|NCT01449929|529277125|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
146757411|NCT01449929|529277126|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
146757412|NCT01449929|529277124|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
146757413|NCT01449929|529277125|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
146757414|NCT01449929|529277126|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
146757415|NCT01449929|529277124|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
146757416|NCT01449929|529277125|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
146757417|NCT01449929|529277126|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
146757418|NCT01449929|529277124|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
146757419|NCT01449929|529277125|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
146757420|NCT01449929|529277126|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
146757421|NCT03015740|529277127|FG000|Overall Study|Adverse Event|1|||
146757422|NCT03015740|529277128|FG001|Overall Study|Adverse Event|0|||
146757423|NCT03015740|529277129|FG002|Overall Study|Adverse Event|0|||
146757424|NCT03015740|529277127|FG000|Overall Study|Death|3|||
146757425|NCT03015740|529277128|FG001|Overall Study|Death|5|||
146757426|NCT03015740|529277129|FG002|Overall Study|Death|0|||
146757427|NCT03015740|529277127|FG000|Overall Study|Withdrawal by Subject|2|||
146757428|NCT03015740|529277128|FG001|Overall Study|Withdrawal by Subject|0|||
146757429|NCT03015740|529277129|FG002|Overall Study|Withdrawal by Subject|0|||
146757430|NCT03253653|529277134|FG000|Overall Study|Withdrawal by Subject|4|||
146757431|NCT03253653|529277135|FG001|Overall Study|Withdrawal by Subject|1|||
146757432|NCT03253653|529277134|FG000|Overall Study|Protocol Violation|0|||
146757433|NCT03253653|529277135|FG001|Overall Study|Protocol Violation|5|||
146757434|NCT02624778|529279155|FG000|Overall Study|Lost to Follow-up|0|||
146757435|NCT02624778|529279156|FG001|Overall Study|Lost to Follow-up|0|||
146757436|NCT02624778|529279157|FG002|Overall Study|Lost to Follow-up|1|||
146757437|NCT02624778|529279158|FG003|Overall Study|Lost to Follow-up|0|||
146757438|NCT02624778|529279159|FG004|Overall Study|Lost to Follow-up|0|||
146757439|NCT02624778|529279160|FG005|Overall Study|Lost to Follow-up|0|||
146757440|NCT02624778|529279161|FG006|Overall Study|Lost to Follow-up|0|||
146757441|NCT02624778|529279162|FG007|Overall Study|Lost to Follow-up|0|||
146757442|NCT02624778|529279163|FG008|Overall Study|Lost to Follow-up|0|||
146757443|NCT02624778|529279155|FG000|Overall Study|Withdrawal by Subject|0|||
146757444|NCT02624778|529279156|FG001|Overall Study|Withdrawal by Subject|1|||
146757445|NCT02624778|529279157|FG002|Overall Study|Withdrawal by Subject|0|||
146757446|NCT02624778|529279158|FG003|Overall Study|Withdrawal by Subject|0|||
146757447|NCT02624778|529279159|FG004|Overall Study|Withdrawal by Subject|0|||
146757448|NCT02624778|529279160|FG005|Overall Study|Withdrawal by Subject|1|||
146757449|NCT02624778|529279161|FG006|Overall Study|Withdrawal by Subject|1|||
146757450|NCT02624778|529279162|FG007|Overall Study|Withdrawal by Subject|1|||
146757451|NCT02624778|529279163|FG008|Overall Study|Withdrawal by Subject|1|||
146757452|NCT02624778|529279155|FG000|Overall Study|Adverse Event|0|||
146757453|NCT02624778|529279156|FG001|Overall Study|Adverse Event|0|||
146757454|NCT02624778|529279157|FG002|Overall Study|Adverse Event|0|||
146757455|NCT02624778|529279158|FG003|Overall Study|Adverse Event|0|||
146854468|NCT00196976|529637213|FG004|Primary Study|Migrated from study area|0|||
146854469|NCT00196976|529637214|FG005|Primary Study|Migrated from study area|0|||
146521591|NCT02620787|528418019|FG000|Overall Study|Eligibility Criteria Not Met|1|||
146521592|NCT02620787|528418020|FG001|Overall Study|Eligibility Criteria Not Met|0|||
146521593|NCT03465709|528418021|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
146521594|NCT03465709|528418021|FG000|Overall Study|Withdrawal by Subject|3|||
146521595|NCT04892446|528418022|FG000|Overall Study|Death|4|||
146521596|NCT04892446|528418023|FG001|Overall Study|Death|4|||
146521597|NCT04892446|528418024|FG002|Overall Study|Death|0|||
146521598|NCT04892446|528418022|FG000|Overall Study|Withdrew consent|3|||
146521599|NCT04892446|528418023|FG001|Overall Study|Withdrew consent|0|||
146521600|NCT04892446|528418024|FG002|Overall Study|Withdrew consent|1|||
146521601|NCT04892446|528418022|FG000|Overall Study|Investigator's discretion|1|||
146854470|NCT00196976|529637215|FG006|Primary Study|Migrated from study area|0|||
146854471|NCT00196976|529637216|FG007|Primary Study|Migrated from study area|1|||
146854472|NCT00196976|529637217|FG008|Primary Study|Migrated from study area|0|||
146854473|NCT00196976|529637218|FG009|Primary Study|Migrated from study area|0|||
146854474|NCT00196976|529637219|FG010|Primary Study|Migrated from study area|0|||
146854475|NCT00196976|529637220|FG011|Primary Study|Migrated from study area|0|||
146854476|NCT00196976|529637221|FG012|Primary Study|Migrated from study area|0|||
146854477|NCT00196976|529637222|FG013|Primary Study|Migrated from study area|0|||
146854478|NCT00196976|529637209|FG000|Primary Study|Protocol Violation|0|||
146854479|NCT00196976|529637210|FG001|Primary Study|Protocol Violation|1|||
146854480|NCT00196976|529637211|FG002|Primary Study|Protocol Violation|1|||
146854481|NCT00196976|529637212|FG003|Primary Study|Protocol Violation|0|||
146854482|NCT00196976|529637213|FG004|Primary Study|Protocol Violation|0|||
146854483|NCT00196976|529637214|FG005|Primary Study|Protocol Violation|0|||
146854484|NCT00196976|529637215|FG006|Primary Study|Protocol Violation|0|||
146854485|NCT00196976|529637216|FG007|Primary Study|Protocol Violation|0|||
146854486|NCT00196976|529637217|FG008|Primary Study|Protocol Violation|0|||
146854487|NCT00196976|529637218|FG009|Primary Study|Protocol Violation|0|||
146854488|NCT00196976|529637219|FG010|Primary Study|Protocol Violation|0|||
146854489|NCT00196976|529637220|FG011|Primary Study|Protocol Violation|0|||
146854490|NCT00196976|529637221|FG012|Primary Study|Protocol Violation|0|||
146854491|NCT00196976|529637222|FG013|Primary Study|Protocol Violation|0|||
146854492|NCT00196976|529637209|FG000|Primary Study|Withdrawal by Subject|1|||
146854493|NCT00196976|529637210|FG001|Primary Study|Withdrawal by Subject|0|||
146854494|NCT00196976|529637211|FG002|Primary Study|Withdrawal by Subject|1|||
146854495|NCT00196976|529637212|FG003|Primary Study|Withdrawal by Subject|1|||
146854496|NCT00196976|529637213|FG004|Primary Study|Withdrawal by Subject|2|||
146854497|NCT00196976|529637214|FG005|Primary Study|Withdrawal by Subject|1|||
146854498|NCT00196976|529637215|FG006|Primary Study|Withdrawal by Subject|0|||
146854499|NCT00196976|529637216|FG007|Primary Study|Withdrawal by Subject|0|||
146854500|NCT00196976|529637217|FG008|Primary Study|Withdrawal by Subject|0|||
146854501|NCT00196976|529637218|FG009|Primary Study|Withdrawal by Subject|1|||
146854502|NCT00196976|529637219|FG010|Primary Study|Withdrawal by Subject|0|||
146854503|NCT00196976|529637220|FG011|Primary Study|Withdrawal by Subject|0|||
146854504|NCT00196976|529637221|FG012|Primary Study|Withdrawal by Subject|0|||
146854505|NCT00196976|529637222|FG013|Primary Study|Withdrawal by Subject|0|||
146854506|NCT00196976|529637209|FG000|Primary Study|Lost to Follow-up|0|||
146854507|NCT00196976|529637210|FG001|Primary Study|Lost to Follow-up|0|||
146854508|NCT00196976|529637211|FG002|Primary Study|Lost to Follow-up|0|||
146854509|NCT00196976|529637212|FG003|Primary Study|Lost to Follow-up|0|||
146854510|NCT00196976|529637213|FG004|Primary Study|Lost to Follow-up|1|||
146854511|NCT00196976|529637214|FG005|Primary Study|Lost to Follow-up|1|||
146854512|NCT00196976|529637215|FG006|Primary Study|Lost to Follow-up|0|||
146854513|NCT00196976|529637216|FG007|Primary Study|Lost to Follow-up|2|||
146854514|NCT00196976|529637217|FG008|Primary Study|Lost to Follow-up|0|||
146854515|NCT00196976|529637218|FG009|Primary Study|Lost to Follow-up|0|||
146854516|NCT00196976|529637219|FG010|Primary Study|Lost to Follow-up|0|||
146854517|NCT00196976|529637220|FG011|Primary Study|Lost to Follow-up|0|||
146854518|NCT00196976|529637221|FG012|Primary Study|Lost to Follow-up|0|||
146521602|NCT04892446|528418023|FG001|Overall Study|Investigator's discretion|1|||
146854519|NCT00196976|529637222|FG013|Primary Study|Lost to Follow-up|0|||
146854520|NCT00196976|529637209|FG000|Primary Study|Other|0|||
146854521|NCT00196976|529637210|FG001|Primary Study|Other|0|||
146854522|NCT00196976|529637211|FG002|Primary Study|Other|2|||
146854523|NCT00196976|529637212|FG003|Primary Study|Other|0|||
146854524|NCT00196976|529637213|FG004|Primary Study|Other|0|||
146854525|NCT00196976|529637214|FG005|Primary Study|Other|0|||
146854526|NCT00196976|529637215|FG006|Primary Study|Other|0|||
146521603|NCT04892446|528418024|FG002|Overall Study|Investigator's discretion|0|||
146854527|NCT00196976|529637216|FG007|Primary Study|Other|0|||
146854528|NCT00196976|529637217|FG008|Primary Study|Other|0|||
146854529|NCT00196976|529637218|FG009|Primary Study|Other|0|||
146854530|NCT00196976|529637219|FG010|Primary Study|Other|0|||
146854531|NCT00196976|529637220|FG011|Primary Study|Other|0|||
146854532|NCT00196976|529637221|FG012|Primary Study|Other|0|||
146521604|NCT04892446|528418022|FG000|Overall Study|Study terminated by sponsor|0|||
146854533|NCT00196976|529637222|FG013|Primary Study|Other|0|||
146521605|NCT04892446|528418023|FG001|Overall Study|Study terminated by sponsor|0|||
146521606|NCT04892446|528418024|FG002|Overall Study|Study terminated by sponsor|2|||
146521607|NCT03193047|528418026|FG000|Overall Study|Physician Decision|1|||
146521608|NCT03193047|528418027|FG001|Overall Study|Physician Decision|0|||
146521609|NCT03193047|528418026|FG000|Overall Study|Participant Left State|1|||
146521610|NCT03193047|528418027|FG001|Overall Study|Participant Left State|0|||
146521611|NCT00705341|528418028|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
146521612|NCT00705341|528418029|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
146521613|NCT00705341|528418030|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
146757456|NCT02624778|529279159|FG004|Overall Study|Adverse Event|0|||
146757457|NCT02624778|529279160|FG005|Overall Study|Adverse Event|0|||
146757458|NCT02624778|529279161|FG006|Overall Study|Adverse Event|0|||
146757459|NCT02624778|529279162|FG007|Overall Study|Adverse Event|0|||
146757460|NCT02624778|529279163|FG008|Overall Study|Adverse Event|2|||
146757461|NCT02624778|529279155|FG000|Overall Study|Death|0|||
146757462|NCT02624778|529279156|FG001|Overall Study|Death|0|||
146757463|NCT02624778|529279157|FG002|Overall Study|Death|0|||
146757464|NCT02624778|529279158|FG003|Overall Study|Death|0|||
146757465|NCT02624778|529279159|FG004|Overall Study|Death|0|||
146757466|NCT02624778|529279160|FG005|Overall Study|Death|0|||
146757467|NCT02624778|529279161|FG006|Overall Study|Death|1|||
146757468|NCT02624778|529279162|FG007|Overall Study|Death|0|||
146757469|NCT02624778|529279163|FG008|Overall Study|Death|0|||
146757470|NCT02624778|529279155|FG000|Overall Study|Physician Decision|0|||
146757471|NCT02624778|529279156|FG001|Overall Study|Physician Decision|0|||
146757472|NCT02624778|529279157|FG002|Overall Study|Physician Decision|0|||
146757473|NCT02624778|529279158|FG003|Overall Study|Physician Decision|0|||
146757474|NCT02624778|529279159|FG004|Overall Study|Physician Decision|0|||
146757475|NCT02624778|529279160|FG005|Overall Study|Physician Decision|0|||
146757476|NCT02624778|529279161|FG006|Overall Study|Physician Decision|0|||
146757477|NCT02624778|529279162|FG007|Overall Study|Physician Decision|3|||
146757478|NCT02624778|529279163|FG008|Overall Study|Physician Decision|3|||
146757479|NCT04610684|529279166|FG000|Study Treatment|Withdrawal by Subject|1|||
146757480|NCT04610684|529279166|FG000|Study Treatment|Disease Progression|2|||
146757481|NCT04610684|529279166|FG000|Follow up|Death|2|||
146757482|NCT04610684|529279166|FG000|Follow up|Withdrawal by Subject|1|||
146757483|NCT02153788|529279168|FG000|Overall Study|Physician Decision|2|||
146757484|NCT02153788|529279169|FG001|Overall Study|Physician Decision|1|||
146757485|NCT04672460|529279170|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
146757486|NCT04672460|529279171|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
146757487|NCT04672460|529279170|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
146757488|NCT04672460|529279171|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
146757489|NCT04672460|529279170|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
146757490|NCT04672460|529279171|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
146757491|NCT04672460|529279170|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
146757492|NCT04672460|529279171|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
146757493|NCT04672460|529279170|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
146757494|NCT04672460|529279171|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
146757495|NCT04672460|529279170|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
146757496|NCT04672460|529279171|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
146757497|NCT04672460|529279170|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
146757498|NCT04672460|529279171|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
146757499|NCT04672460|529279170|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
146757500|NCT04672460|529279171|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
146757501|NCT04672460|529279170|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
146757502|NCT04672460|529279171|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
146757503|NCT04672460|529279170|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
146757504|NCT04672460|529279171|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
146757505|NCT04672460|529279170|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
146757506|NCT04672460|529279171|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
146757507|NCT04672460|529279170|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
146757508|NCT04672460|529279171|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
146757509|NCT04672460|529279170|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
146757510|NCT04672460|529279171|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
146757511|NCT04672460|529279170|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
146757512|NCT04672460|529279171|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
146757513|NCT04672460|529279170|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
146757514|NCT04672460|529279171|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
146757515|NCT04672460|529279170|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
146757516|NCT04672460|529279171|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
146757517|NCT04672460|529279170|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
146757518|NCT04672460|529279171|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
146854534|NCT00196976|529637209|FG000|Booster Study|Withdrawal by Subject|0|||
146854535|NCT00196976|529637210|FG001|Booster Study|Withdrawal by Subject|0|||
146854536|NCT00196976|529637211|FG002|Booster Study|Withdrawal by Subject|0|||
146854537|NCT00196976|529637212|FG003|Booster Study|Withdrawal by Subject|0|||
146854538|NCT00196976|529637213|FG004|Booster Study|Withdrawal by Subject|0|||
146854539|NCT00196976|529637214|FG005|Booster Study|Withdrawal by Subject|0|||
146854540|NCT00196976|529637215|FG006|Booster Study|Withdrawal by Subject|0|||
146854541|NCT00196976|529637216|FG007|Booster Study|Withdrawal by Subject|0|||
146854542|NCT00196976|529637217|FG008|Booster Study|Withdrawal by Subject|0|||
146854543|NCT00196976|529637218|FG009|Booster Study|Withdrawal by Subject|0|||
146854544|NCT00196976|529637219|FG010|Booster Study|Withdrawal by Subject|1|||
146854545|NCT00196976|529637220|FG011|Booster Study|Withdrawal by Subject|0|||
146854546|NCT00196976|529637221|FG012|Booster Study|Withdrawal by Subject|0|||
146854547|NCT00196976|529637222|FG013|Booster Study|Withdrawal by Subject|0|||
146854548|NCT00196976|529637209|FG000|Booster Study|Lost to Follow-up|0|||
146854549|NCT00196976|529637210|FG001|Booster Study|Lost to Follow-up|0|||
146854550|NCT00196976|529637211|FG002|Booster Study|Lost to Follow-up|0|||
146854551|NCT00196976|529637212|FG003|Booster Study|Lost to Follow-up|0|||
146854552|NCT00196976|529637213|FG004|Booster Study|Lost to Follow-up|0|||
146854553|NCT00196976|529637214|FG005|Booster Study|Lost to Follow-up|0|||
146854554|NCT00196976|529637215|FG006|Booster Study|Lost to Follow-up|0|||
146854555|NCT00196976|529637216|FG007|Booster Study|Lost to Follow-up|0|||
146854556|NCT00196976|529637217|FG008|Booster Study|Lost to Follow-up|0|||
146854557|NCT00196976|529637218|FG009|Booster Study|Lost to Follow-up|0|||
146854558|NCT00196976|529637219|FG010|Booster Study|Lost to Follow-up|1|||
146854559|NCT00196976|529637220|FG011|Booster Study|Lost to Follow-up|2|||
146854560|NCT00196976|529637221|FG012|Booster Study|Lost to Follow-up|0|||
146854561|NCT00196976|529637222|FG013|Booster Study|Lost to Follow-up|0|||
146854562|NCT01535560|529637223|FG000|Overall Study|Adverse Event|12|||
146854563|NCT01535560|529637224|FG001|Overall Study|Adverse Event|7|||
146854564|NCT01535560|529637223|FG000|Overall Study|Lost to Follow-up|1|||
146854565|NCT01535560|529637224|FG001|Overall Study|Lost to Follow-up|3|||
146854566|NCT01535560|529637223|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
146854567|NCT01535560|529637224|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
146854568|NCT01535560|529637223|FG000|Overall Study|Treatment Failure|21|||
146854569|NCT01535560|529637224|FG001|Overall Study|Treatment Failure|83|||
146854570|NCT01535560|529637223|FG000|Overall Study|Other|0|||
146854571|NCT01535560|529637224|FG001|Overall Study|Other|1|||
146854572|NCT01535560|529637223|FG000|Overall Study|Randomized in Error|0|||
146854573|NCT01535560|529637224|FG001|Overall Study|Randomized in Error|1|||
146854574|NCT00609765|529637229|FG000|Overall Study|Study ended prior to 12 months|1|||
146854575|NCT00950950|529637230|FG000|Overall Study|Adverse Event|1|||
146854576|NCT00950950|529637231|FG001|Overall Study|Adverse Event|0|||
146854577|NCT00950950|529637230|FG000|Overall Study|Withdrawal by Subject|0|||
146854578|NCT00950950|529637231|FG001|Overall Study|Withdrawal by Subject|1|||
146854579|NCT01920854|529637234|FG000|Overall Study|Withdrawal by Subject|1|||
146854580|NCT01920854|529637235|FG001|Overall Study|Withdrawal by Subject|0|||
146854581|NCT01920854|529637236|FG002|Overall Study|Withdrawal by Subject|0|||
146854582|NCT01920854|529637237|FG003|Overall Study|Withdrawal by Subject|0|||
146854583|NCT01920854|529637238|FG004|Overall Study|Withdrawal by Subject|1|||
146854584|NCT01920854|529637239|FG005|Overall Study|Withdrawal by Subject|0|||
146854585|NCT01920854|529637240|FG006|Overall Study|Withdrawal by Subject|1|||
146854586|NCT00729378|529639683|FG000|Baseline|Did not complete study measurements|72|||
146854587|NCT00729378|529639684|FG001|Baseline|Did not complete study measurements|33|||
146854588|NCT00729378|529639683|FG000|Baseline|Withdrawal by Subject|66|||
146854589|NCT00729378|529639684|FG001|Baseline|Withdrawal by Subject|59|||
146854590|NCT00729378|529639683|FG000|12-months|Lost to Follow-up|100|||
146854591|NCT00729378|529639684|FG001|12-months|Lost to Follow-up|65|||
146854592|NCT00729378|529639683|FG000|24-months|Lost to Follow-up|72|||
146854593|NCT00729378|529639684|FG001|24-months|Lost to Follow-up|51|||
146854594|NCT00729378|529639683|FG000|36-months|Lost to Follow-up|15|||
146854595|NCT00729378|529639684|FG001|36-months|Lost to Follow-up|6|||
146854596|NCT01586910|529639685|FG000|Overall Study|Death|4|||
146854597|NCT01586910|529639686|FG001|Overall Study|Death|4|||
146854598|NCT01586910|529639685|FG000|Overall Study|Withdrawal by Subject|6|||
146854599|NCT01586910|529639686|FG001|Overall Study|Withdrawal by Subject|43|||
146854600|NCT01586910|529639685|FG000|Overall Study|Physician withdrew Subject|5|||
146854601|NCT01586910|529639686|FG001|Overall Study|Physician withdrew Subject|24|||
146854602|NCT00346268|529639687|FG000|Overall Study|Adverse Event|1|||
146854603|NCT00346268|529639688|FG001|Overall Study|Adverse Event|0|||
146854604|NCT00346268|529639687|FG000|Overall Study|Protocol Violation|1|||
146854605|NCT00346268|529639688|FG001|Overall Study|Protocol Violation|0|||
146854606|NCT00346268|529639687|FG000|Overall Study|Participant refused|0|||
146854607|NCT00346268|529639688|FG001|Overall Study|Participant refused|3|||
146854608|NCT00031551|529639689|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
146854609|NCT00031551|529639690|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
146854610|NCT02164383|529639691|FG000|Overall Study|Lost to Follow-up|1|||
146854611|NCT02164383|529639692|FG001|Overall Study|Lost to Follow-up|0|||
146854612|NCT00743275|529639693|FG000|Overall Study|Protocol Violation|0|||
146854613|NCT00743275|529639694|FG001|Overall Study|Protocol Violation|1|||
146854614|NCT01672723|529639695|FG000|First Intervention|Adverse Event|3|||
146854615|NCT01672723|529639696|FG001|First Intervention|Adverse Event|0|||
146854616|NCT00484289|529639707|FG000|Long Term Phase|Adverse Event|1|||
146854617|NCT00484289|529639708|FG001|Long Term Phase|Adverse Event|17|||
146854618|NCT00484289|529639709|FG002|Long Term Phase|Adverse Event|5|||
146854619|NCT00484289|529639707|FG000|Long Term Phase|Withdrawal by Subject|0|||
146854620|NCT00484289|529639708|FG001|Long Term Phase|Withdrawal by Subject|7|||
146854621|NCT00484289|529639709|FG002|Long Term Phase|Withdrawal by Subject|6|||
146854622|NCT00484289|529639707|FG000|Long Term Phase|Inadequate response|2|||
146854623|NCT00484289|529639708|FG001|Long Term Phase|Inadequate response|7|||
146854624|NCT00484289|529639709|FG002|Long Term Phase|Inadequate response|4|||
146854625|NCT00484289|529639707|FG000|Long Term Phase|Other Reason|0|||
146854626|NCT00484289|529639708|FG001|Long Term Phase|Other Reason|5|||
146854627|NCT00484289|529639709|FG002|Long Term Phase|Other Reason|1|||
146854628|NCT00484289|529639707|FG000|Post Marketing Phase|Adverse Event|0|||
146854629|NCT00484289|529639708|FG001|Post Marketing Phase|Adverse Event|1|||
146854630|NCT00484289|529639709|FG002|Post Marketing Phase|Adverse Event|0|||
146854631|NCT02831387|529639710|FG000|Overall Study|Withdrawal by Subject|1|||
146854632|NCT02831387|529639711|FG001|Overall Study|Withdrawal by Subject|1|||
146854633|NCT02831387|529639710|FG000|Overall Study|Discontinued due to stock recovery|0|||
146854634|NCT02831387|529639711|FG001|Overall Study|Discontinued due to stock recovery|1|||
146854635|NCT00192647|529639712|FG000|Overall Study|Death|1|||
146854636|NCT00192647|529639713|FG001|Overall Study|Death|1|||
146854637|NCT00192647|529639712|FG000|Overall Study|Adverse Event|35|||
146854638|NCT00192647|529639713|FG001|Overall Study|Adverse Event|29|||
146854639|NCT00192647|529639712|FG000|Overall Study|Laboratory Test Abnormality|4|||
146854640|NCT00192647|529639713|FG001|Overall Study|Laboratory Test Abnormality|2|||
146854641|NCT00192647|529639712|FG000|Overall Study|Insufficient Therapeutic Response|53|||
146854642|NCT00192647|529639713|FG001|Overall Study|Insufficient Therapeutic Response|83|||
146854643|NCT00192647|529639712|FG000|Overall Study|Entry Criteria Violation|6|||
146854644|NCT00192647|529639713|FG001|Overall Study|Entry Criteria Violation|6|||
146757519|NCT01876043|529279174|FG000|Overall Study|Death|1|||
146757520|NCT01876043|529279174|FG000|Overall Study|Withdrawal by Subject|1|||
146757521|NCT00079937|529279176|FG000|Overall Study|Adverse Event|2|||
146757522|NCT00079937|529279177|FG001|Overall Study|Adverse Event|1|||
146757523|NCT00079937|529279176|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146757524|NCT00079937|529279177|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146757525|NCT00079937|529279176|FG000|Overall Study|Subject no longer requires study drug|3|||
146757526|NCT00079937|529279177|FG001|Overall Study|Subject no longer requires study drug|0|||
146757527|NCT00079937|529279176|FG000|Overall Study|Protocol Violation|8|||
146757528|NCT00079937|529279177|FG001|Overall Study|Protocol Violation|6|||
146854645|NCT00192647|529639712|FG000|Overall Study|Protocol Violation|3|||
146854646|NCT00192647|529639713|FG001|Overall Study|Protocol Violation|1|||
146854647|NCT00192647|529639712|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
146854648|NCT00192647|529639713|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
146854649|NCT00192647|529639712|FG000|Overall Study|Failure to Return|11|||
146854650|NCT00192647|529639713|FG001|Overall Study|Failure to Return|13|||
146854651|NCT00192647|529639712|FG000|Overall Study|Other/Administrative|5|||
146854652|NCT00192647|529639713|FG001|Overall Study|Other/Administrative|3|||
146854653|NCT01828073|529639714|FG000|Overall Study|Lost to Follow-up|1|||
146854654|NCT01828073|529639715|FG001|Overall Study|Lost to Follow-up|2|||
146854655|NCT00690443|529639720|FG000|Overall Study|Adverse Event|1|||
146854656|NCT00690443|529639721|FG001|Overall Study|Adverse Event|2|||
146854657|NCT03057977|529639722|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
146854658|NCT03057977|529639723|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
146854659|NCT03057977|529639722|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
146854660|NCT03057977|529639723|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
146854661|NCT03057977|529639722|FG000|Discontinuation From Treatment|Protocol Violation|6|||
146854662|NCT03057977|529639723|FG001|Discontinuation From Treatment|Protocol Violation|5|||
146854663|NCT03057977|529639722|FG000|Discontinuation From Treatment|Not treated|4|||
146854664|NCT03057977|529639723|FG001|Discontinuation From Treatment|Not treated|0|||
146854665|NCT03057977|529639722|FG000|Discontinuation From Treatment|Adverse Event|343|||
146854666|NCT03057977|529639723|FG001|Discontinuation From Treatment|Adverse Event|337|||
146854667|NCT03057977|529639722|FG000|Discontinuation From Treatment|Reason Unknown|0|||
146854668|NCT03057977|529639723|FG001|Discontinuation From Treatment|Reason Unknown|1|||
146854669|NCT03057977|529639722|FG000|Discontinuation From Treatment|Personal Reasons|1|||
146854670|NCT03057977|529639723|FG001|Discontinuation From Treatment|Personal Reasons|1|||
146854671|NCT03057977|529639722|FG000|Discontinuation From Treatment|Unblinded medication|1|||
146854672|NCT03057977|529639723|FG001|Discontinuation From Treatment|Unblinded medication|0|||
146854673|NCT03057977|529639722|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
146854674|NCT03057977|529639723|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
146854675|NCT03057977|529639722|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
146854676|NCT03057977|529639723|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
146854677|NCT03057977|529639722|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
146854678|NCT03057977|529639723|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
146854679|NCT03057977|529639722|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
146854680|NCT03057977|529639723|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
146521614|NCT00705341|528418031|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
146521615|NCT00705341|528418028|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
146854681|NCT03057977|529639722|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
146854682|NCT03057977|529639723|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
146854683|NCT03057977|529639722|FG000|Discontinuation From Treatment|Not attending study visit|3|||
146965061|NCT03110107|530033451|FG025|Treatment Period|Study drug toxicity|6|||
146965062|NCT03110107|530033426|FG000|Treatment Period|Death|0|||
146757529|NCT00079937|529279176|FG000|Overall Study|Withdrawal by Subject|21|||
146757530|NCT00079937|529279177|FG001|Overall Study|Withdrawal by Subject|7|||
146757531|NCT00079937|529279176|FG000|Overall Study|Lost to Follow-up|12|||
146757532|NCT00079937|529279177|FG001|Overall Study|Lost to Follow-up|5|||
146757533|NCT00079937|529279176|FG000|Overall Study|Administrative problems|22|||
146757534|NCT00079937|529279177|FG001|Overall Study|Administrative problems|11|||
146757535|NCT02949271|529279180|FG000|Overall Study|Lack of Efficacy|5|||
146757536|NCT02949271|529279181|FG001|Overall Study|Lack of Efficacy|4|||
146757537|NCT02949271|529279180|FG000|Overall Study|Lost to Follow-up|3|||
146757538|NCT02949271|529279181|FG001|Overall Study|Lost to Follow-up|6|||
146757539|NCT02949271|529279180|FG000|Overall Study|Physician Decision|5|||
146757540|NCT02949271|529279181|FG001|Overall Study|Physician Decision|5|||
146757541|NCT02949271|529279180|FG000|Overall Study|Protocol Violation|6|||
146757542|NCT02949271|529279181|FG001|Overall Study|Protocol Violation|3|||
146757543|NCT02949271|529279180|FG000|Overall Study|Withdrawal by Subject|1|||
146757544|NCT02949271|529279181|FG001|Overall Study|Withdrawal by Subject|0|||
146757545|NCT02949271|529279180|FG000|Overall Study|Delivered prior to intervention|7|||
146757546|NCT02949271|529279181|FG001|Overall Study|Delivered prior to intervention|9|||
146757547|NCT02949271|529279180|FG000|Overall Study|Outside the window for cervical dilation|2|||
146757548|NCT02949271|529279181|FG001|Overall Study|Outside the window for cervical dilation|3|||
146757549|NCT05458102|529279184|FG000|Overall Study|Withdrew consent|2|||
146757550|NCT05458102|529279185|FG001|Overall Study|Withdrew consent|0|||
146757551|NCT05458102|529279184|FG000|Overall Study|Adverse Event|1|||
146757552|NCT05458102|529279185|FG001|Overall Study|Adverse Event|0|||
146757553|NCT05458102|529279184|FG000|Overall Study|Enrolled but never treated|1|||
146757554|NCT05458102|529279185|FG001|Overall Study|Enrolled but never treated|0|||
146757555|NCT05458102|529279184|FG000|Overall Study|Protocol Violation|1|||
146757556|NCT05458102|529279185|FG001|Overall Study|Protocol Violation|0|||
146757557|NCT00852475|529279190|FG000|Overall Study|Lost to Follow-up|3|||
146757558|NCT00852475|529279191|FG001|Overall Study|Lost to Follow-up|4|||
146757559|NCT00367237|529279193|FG000|Overall Study|Adverse Event|7|||
146757560|NCT00367237|529279194|FG001|Overall Study|Adverse Event|2|||
146757561|NCT00367237|529279193|FG000|Overall Study|Lost to Follow-up|1|||
146757562|NCT00367237|529279194|FG001|Overall Study|Lost to Follow-up|0|||
146757563|NCT00367237|529279193|FG000|Overall Study|Withdrawal by Subject|0|||
146757564|NCT00367237|529279194|FG001|Overall Study|Withdrawal by Subject|4|||
146757565|NCT00367237|529279193|FG000|Overall Study|Protocol Violation|2|||
146757566|NCT00367237|529279194|FG001|Overall Study|Protocol Violation|5|||
146757567|NCT01175707|529279195|FG000|Overall Study|Adverse Event|4|||
146757568|NCT01175707|529279196|FG001|Overall Study|Adverse Event|6|||
146757569|NCT04531540|529279208|FG000|Overall Study|Adverse Event|1|||
146757570|NCT04531540|529279208|FG000|Overall Study|Protocol Violation|3|||
146757571|NCT04531540|529279208|FG000|Overall Study|Withdrawal by Subject|4|||
146757572|NCT04531540|529279208|FG000|Overall Study|Found to be Ineligible|1|||
146757573|NCT03239210|529279209|FG000|Overall Study|Lost to Follow-up|2|||
146757574|NCT03239210|529279210|FG001|Overall Study|Lost to Follow-up|2|||
146757575|NCT03239210|529279209|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
146757576|NCT03239210|529279210|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
146757577|NCT03239210|529279209|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
146757578|NCT03239210|529279210|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
146757579|NCT01575860|529279213|FG000|Overall Study|Withdrawal by Subject|1|||
146757580|NCT01575860|529279213|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
146757581|NCT01403987|529279214|FG000|Overall Study|Residents forgot their secret PIN|18|||
146757582|NCT01403987|529279215|FG001|Overall Study|Residents forgot their secret PIN|17|||
146757583|NCT01403987|529279216|FG002|Overall Study|Residents forgot their secret PIN|18|||
146757584|NCT00180674|529279217|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
146757585|NCT00180674|529279217|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
146757586|NCT00278564|529279218|FG000|Overall Study|Lack of Efficacy|4|||
146757587|NCT01094743|529279219|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
146757588|NCT03606460|529279220|FG000|Overall Study|Lost to Follow-up|1|||
146757589|NCT03606460|529279221|FG001|Overall Study|Lost to Follow-up|8|||
146757590|NCT00003377|529279222|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
146757591|NCT00003377|529279223|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
146757592|NCT00003377|529279224|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
146757593|NCT00003377|529279225|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
146757594|NCT00003377|529279226|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
146757595|NCT00003377|529279222|FG000|Period II|Ureteral stent complications|0|||
146757596|NCT00003377|529279223|FG001|Period II|Ureteral stent complications|0|||
146757597|NCT00003377|529279224|FG002|Period II|Ureteral stent complications|0|||
146757598|NCT00003377|529279225|FG003|Period II|Ureteral stent complications|0|||
146757599|NCT00003377|529279226|FG004|Period II|Ureteral stent complications|1|||
146757600|NCT04541186|529279231|FG000|Main Study|Adverse Event|0|||
146757601|NCT04541186|529279232|FG001|Main Study|Adverse Event|0|||
146625268|NCT03037385|528803853|FG008|Overall Study|Lost to Follow-up|0|||
146521616|NCT00705341|528418029|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
146521617|NCT00705341|528418030|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
146521618|NCT00705341|528418031|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
146521619|NCT03665077|528418032|FG000|Overall Study|Lost to Follow-up|2|||
146757602|NCT04541186|529279233|FG002|Main Study|Adverse Event|4|||
146757603|NCT04541186|529279234|FG003|Main Study|Adverse Event|0|||
146757604|NCT04541186|529279235|FG004|Main Study|Adverse Event|0|||
146757605|NCT04541186|529279231|FG000|Main Study|Investigator Decision|0|||
146757606|NCT04541186|529279232|FG001|Main Study|Investigator Decision|0|||
146757607|NCT04541186|529279233|FG002|Main Study|Investigator Decision|1|||
146757608|NCT04541186|529279234|FG003|Main Study|Investigator Decision|1|||
146757609|NCT04541186|529279235|FG004|Main Study|Investigator Decision|0|||
146757610|NCT04541186|529279231|FG000|Main Study|Withdrawal by Subject|1|||
146757611|NCT04541186|529279232|FG001|Main Study|Withdrawal by Subject|1|||
146757612|NCT04541186|529279233|FG002|Main Study|Withdrawal by Subject|0|||
146757613|NCT04541186|529279234|FG003|Main Study|Withdrawal by Subject|0|||
146757614|NCT04541186|529279235|FG004|Main Study|Withdrawal by Subject|0|||
146757615|NCT04541186|529279231|FG000|Main Study|COVID-19-related Dose Interruption|0|||
146757616|NCT04541186|529279232|FG001|Main Study|COVID-19-related Dose Interruption|0|||
146757617|NCT04541186|529279233|FG002|Main Study|COVID-19-related Dose Interruption|0|||
146757618|NCT04541186|529279234|FG003|Main Study|COVID-19-related Dose Interruption|0|||
146757619|NCT04541186|529279235|FG004|Main Study|COVID-19-related Dose Interruption|1|||
146757620|NCT04541186|529279231|FG000|Main Study|Randomized in Error Not Treated|0|||
146757621|NCT04541186|529279232|FG001|Main Study|Randomized in Error Not Treated|0|||
146757622|NCT04541186|529279233|FG002|Main Study|Randomized in Error Not Treated|1|||
146757623|NCT04541186|529279234|FG003|Main Study|Randomized in Error Not Treated|0|||
146757624|NCT04541186|529279235|FG004|Main Study|Randomized in Error Not Treated|0|||
146757625|NCT04541186|529279231|FG000|Fibrate Expansion Study|Other than Specified|0|||
146757626|NCT04541186|529279232|FG001|Fibrate Expansion Study|Other than Specified|0|||
146757627|NCT04541186|529279233|FG002|Fibrate Expansion Study|Other than Specified|0|||
146757628|NCT04541186|529279234|FG003|Fibrate Expansion Study|Other than Specified|0|||
146757629|NCT04541186|529279235|FG004|Fibrate Expansion Study|Other than Specified|1|||
146757630|NCT00303303|529279245|FG000|Overall Study|Withdrawal by Subject|0|||
146757631|NCT00303303|529279246|FG001|Overall Study|Withdrawal by Subject|0|||
146757632|NCT00303303|529279247|FG002|Overall Study|Withdrawal by Subject|1|||
146757633|NCT00058058|529279249|FG000|Overall Study|Withdrawal by Subject|4|||
146757634|NCT00058058|529279249|FG000|Overall Study|Ineligible|20|||
146757635|NCT00058058|529279249|FG000|Overall Study|Claustrophobic|5|||
146757636|NCT00058058|529279249|FG000|Overall Study|technical issues|6|||
146757637|NCT00058058|529279249|FG000|Overall Study|Poor positioning, illness,pain|3|||
146757638|NCT03085017|529279250|FG000|Overall Study|Death|0|||
146757639|NCT03085017|529279251|FG001|Overall Study|Death|3|||
146757640|NCT00582790|529279254|FG000|Overall Study|Rapid progression of disease|1|||
146757641|NCT02374957|529279255|FG000|Overall Study|Patient did not complete forms correctly|1|||
146757642|NCT02374957|529279256|FG001|Overall Study|Patient did not complete forms correctly|0|||
146757643|NCT02820051|529279257|FG000|Overall Study|Lost to Follow-up|7|||
146757644|NCT02820051|529279258|FG001|Overall Study|Lost to Follow-up|4|||
146757645|NCT01222247|529279263|FG000|Overall Study|Lost to Follow-up|2|||
146757646|NCT01222247|529279264|FG001|Overall Study|Lost to Follow-up|2|||
146757647|NCT03289455|529279265|FG000|Overall Study|Death|1|||
146757648|NCT03289455|529279266|FG001|Overall Study|Death|0|||
146757649|NCT03289455|529279267|FG002|Overall Study|Death|0|||
146757650|NCT03289455|529279265|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
146757651|NCT03289455|529279266|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
146757652|NCT03289455|529279267|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
146757653|NCT03289455|529279265|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
146757654|NCT03289455|529279266|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
146757655|NCT03289455|529279267|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
146757656|NCT03289455|529279265|FG000|Overall Study|Progressive disease|3|||
146757657|NCT03289455|529279266|FG001|Overall Study|Progressive disease|4|||
146757658|NCT03289455|529279267|FG002|Overall Study|Progressive disease|5|||
146757659|NCT00333788|529279268|FG000|Overall Study|Adverse Event|44|||
146757660|NCT00333788|529279268|FG000|Overall Study|Lack of Efficacy|80|||
146757661|NCT00333788|529279268|FG000|Overall Study|Lost to Follow-up|2|||
146757662|NCT00333788|529279268|FG000|Overall Study|Withdrawal by Subject|24|||
146757663|NCT00333788|529279268|FG000|Overall Study|Other: Non-compliance|2|||
146757664|NCT00333788|529279268|FG000|Overall Study|Other: Moved|2|||
146757665|NCT00333788|529279268|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
146757666|NCT00333788|529279268|FG000|Overall Study|Other: Investigator decision|1|||
146521620|NCT03665077|528418032|FG000|Overall Study|Physician Decision|2|||
146757667|NCT00333788|529279268|FG000|Overall Study|Other: Quality of life concern|1|||
146757668|NCT00333788|529279268|FG000|Overall Study|Other: Sponsor decision|1|||
146757669|NCT00333788|529279268|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
146757670|NCT00333788|529279268|FG000|Overall Study|Other: Medical monitor decision|1|||
146854684|NCT03057977|529639723|FG001|Discontinuation From Treatment|Not attending study visit|10|||
146854685|NCT03057977|529639722|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
146854686|NCT03057977|529639723|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
146854687|NCT03057977|529639722|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
146854688|NCT03057977|529639723|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
146854689|NCT03057977|529639722|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
146854690|NCT03057977|529639723|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
146854691|NCT03057977|529639722|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
146854692|NCT03057977|529639723|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
146854693|NCT03057977|529639722|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
146854694|NCT03057977|529639723|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
146854695|NCT00953407|529639724|FG000|Overall Study|Failed inclusion criteria|1|||
146854696|NCT00953407|529639725|FG001|Overall Study|Failed inclusion criteria|1|||
146854697|NCT00953407|529639726|FG002|Overall Study|Failed inclusion criteria|1|||
146854698|NCT00953407|529639727|FG003|Overall Study|Failed inclusion criteria|1|||
146854699|NCT00953407|529639728|FG004|Overall Study|Failed inclusion criteria|1|||
146854700|NCT00953407|529639724|FG000|Overall Study|Lost to Follow-up|0|||
146521621|NCT00837967|528418037|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
146521622|NCT00837967|528418038|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
146521623|NCT02504320|528418039|FG000|Treatment Period 1|Positive Drug Screen|0|||
146521624|NCT02504320|528418040|FG001|Treatment Period 1|Positive Drug Screen|0|||
146521625|NCT02504320|528418041|FG002|Treatment Period 1|Positive Drug Screen|1|||
146521626|NCT02504320|528418042|FG003|Treatment Period 1|Positive Drug Screen|0|||
146521627|NCT02504320|528418039|FG000|Treatment Period 2|Positive Drug Screen|0|||
146521628|NCT02504320|528418040|FG001|Treatment Period 2|Positive Drug Screen|1|||
146521629|NCT02504320|528418041|FG002|Treatment Period 2|Positive Drug Screen|0|||
146521630|NCT02504320|528418042|FG003|Treatment Period 2|Positive Drug Screen|0|||
146521631|NCT02504320|528418039|FG000|Treatment Period 3|Positive Drug Screen|0|||
146521632|NCT02504320|528418040|FG001|Treatment Period 3|Positive Drug Screen|0|||
146521633|NCT02504320|528418041|FG002|Treatment Period 3|Positive Drug Screen|0|||
146521634|NCT02504320|528418042|FG003|Treatment Period 3|Positive Drug Screen|1|||
146521635|NCT02504320|528418039|FG000|Treatment Period 3|Adverse Event|0|||
146521636|NCT02504320|528418040|FG001|Treatment Period 3|Adverse Event|0|||
146521637|NCT02504320|528418041|FG002|Treatment Period 3|Adverse Event|1|||
146521638|NCT02504320|528418042|FG003|Treatment Period 3|Adverse Event|0|||
146521639|NCT01210222|528418043|FG000|Overall Study|Ineligible|2|||
146521640|NCT01210222|528418043|FG000|Overall Study|Never treated|1|||
146521641|NCT01737879|528418044|FG000|Overall Study|Death|1|||
146521642|NCT01737879|528418044|FG000|Overall Study|Sponsor decision|40|||
146521643|NCT03293394|528418045|FG000|Follow-up (6 Months)|Adverse Event|4|||
146521644|NCT03293394|528418046|FG001|Follow-up (6 Months)|Adverse Event|2|||
146521645|NCT00784719|528418047|FG000|Overall Study|Adverse Event|0|||
146521646|NCT00784719|528418048|FG001|Overall Study|Adverse Event|2|||
146521647|NCT00784719|528418049|FG002|Overall Study|Adverse Event|0|||
146521648|NCT00784719|528418050|FG003|Overall Study|Adverse Event|0|||
146521649|NCT00784719|528418051|FG004|Overall Study|Adverse Event|1|||
146521650|NCT00784719|528418052|FG005|Overall Study|Adverse Event|1|||
146521651|NCT00784719|528418053|FG006|Overall Study|Adverse Event|1|||
146521652|NCT00784719|528418047|FG000|Overall Study|Lost to Follow-up|0|||
146521653|NCT00784719|528418048|FG001|Overall Study|Lost to Follow-up|0|||
146521654|NCT00784719|528418049|FG002|Overall Study|Lost to Follow-up|0|||
146521655|NCT00784719|528418050|FG003|Overall Study|Lost to Follow-up|0|||
146521656|NCT00784719|528418051|FG004|Overall Study|Lost to Follow-up|1|||
146521657|NCT00784719|528418052|FG005|Overall Study|Lost to Follow-up|1|||
146521658|NCT00784719|528418053|FG006|Overall Study|Lost to Follow-up|0|||
146521659|NCT00784719|528418047|FG000|Overall Study|Other|2|||
146521660|NCT00784719|528418048|FG001|Overall Study|Other|1|||
146521661|NCT00784719|528418049|FG002|Overall Study|Other|1|||
146521662|NCT00784719|528418050|FG003|Overall Study|Other|0|||
146854701|NCT00953407|529639725|FG001|Overall Study|Lost to Follow-up|0|||
146854702|NCT00953407|529639726|FG002|Overall Study|Lost to Follow-up|0|||
146854703|NCT00953407|529639727|FG003|Overall Study|Lost to Follow-up|1|||
146854704|NCT00953407|529639728|FG004|Overall Study|Lost to Follow-up|0|||
146854705|NCT02502097|529639729|FG000|Period 1|Adverse Event|0|||
146854706|NCT02502097|529639730|FG001|Period 1|Adverse Event|0|||
146965063|NCT03110107|530033427|FG001|Treatment Period|Death|0|||
146521663|NCT00784719|528418051|FG004|Overall Study|Other|2|||
146521664|NCT00784719|528418052|FG005|Overall Study|Other|1|||
146521665|NCT00784719|528418053|FG006|Overall Study|Other|3|||
146521666|NCT00784719|528418047|FG000|Overall Study|Withdrawal by Subject|1|||
146521667|NCT00784719|528418048|FG001|Overall Study|Withdrawal by Subject|0|||
146521668|NCT00784719|528418049|FG002|Overall Study|Withdrawal by Subject|0|||
146521669|NCT00784719|528418050|FG003|Overall Study|Withdrawal by Subject|0|||
146521670|NCT00784719|528418051|FG004|Overall Study|Withdrawal by Subject|2|||
146521671|NCT00784719|528418052|FG005|Overall Study|Withdrawal by Subject|0|||
146521672|NCT00784719|528418053|FG006|Overall Study|Withdrawal by Subject|1|||
146854707|NCT02502097|529639731|FG002|Period 1|Adverse Event|1|||
146521673|NCT04978337|528418056|FG000|Overall Study|Withdrawal by Subject|0|||
146757671|NCT00333788|529279268|FG000|Overall Study|Other: Physician decision|1|||
146757672|NCT00333788|529279268|FG000|Overall Study|Other: Signed consent for another study|1|||
146757673|NCT00764868|529279275|FG000|Overall Study|Adverse Event|18|||
146757674|NCT00764868|529279275|FG000|Overall Study|Withdrawal by Subject|31|||
146757675|NCT00764868|529279275|FG000|Overall Study|Non-compliance|16|||
146757676|NCT00764868|529279275|FG000|Overall Study|Lost to Follow-up|25|||
146757677|NCT00764868|529279275|FG000|Overall Study|Lack of Efficacy|5|||
146757678|NCT00764868|529279275|FG000|Overall Study|Subject moved|7|||
146757679|NCT00764868|529279275|FG000|Overall Study|Pregnancy|3|||
146757680|NCT00764868|529279275|FG000|Overall Study|Prohibited medication|1|||
146757681|NCT00764868|529279275|FG000|Overall Study|Out of town|1|||
146757682|NCT00764868|529279275|FG000|Overall Study|Misuse and compliance of study drug|1|||
146757683|NCT00764868|529279275|FG000|Overall Study|Subject sent to boarding school|1|||
146757684|NCT00764868|529279275|FG000|Overall Study|Met an exclusion criteria|1|||
146757685|NCT00764868|529279275|FG000|Overall Study|Positive drug screen|2|||
146757686|NCT00764868|529279275|FG000|Overall Study|Sponsor requested withdrawal|1|||
146757687|NCT00819234|529279280|FG000|Overall Study|Withdrawal by Subject|8|||
146757688|NCT00819234|529279281|FG001|Overall Study|Withdrawal by Subject|13|||
146757689|NCT00819234|529279282|FG002|Overall Study|Withdrawal by Subject|6|||
146757690|NCT00819234|529279283|FG003|Overall Study|Withdrawal by Subject|3|||
146757691|NCT00819234|529279284|FG004|Overall Study|Withdrawal by Subject|0|||
146757692|NCT00819234|529279285|FG005|Overall Study|Withdrawal by Subject|4|||
146757693|NCT00819234|529279286|FG006|Overall Study|Withdrawal by Subject|4|||
146757694|NCT00819234|529279287|FG007|Overall Study|Withdrawal by Subject|8|||
146757695|NCT00819234|529279288|FG008|Overall Study|Withdrawal by Subject|5|||
146757696|NCT00819234|529279289|FG009|Overall Study|Withdrawal by Subject|3|||
146757697|NCT00819234|529279280|FG000|Overall Study|Adverse Event|0|||
146757698|NCT00819234|529279281|FG001|Overall Study|Adverse Event|0|||
146757699|NCT00819234|529279282|FG002|Overall Study|Adverse Event|1|||
146757700|NCT00819234|529279283|FG003|Overall Study|Adverse Event|0|||
146757701|NCT00819234|529279284|FG004|Overall Study|Adverse Event|0|||
146757702|NCT00819234|529279285|FG005|Overall Study|Adverse Event|2|||
146757703|NCT00819234|529279286|FG006|Overall Study|Adverse Event|0|||
146757704|NCT00819234|529279287|FG007|Overall Study|Adverse Event|0|||
146757705|NCT00819234|529279288|FG008|Overall Study|Adverse Event|0|||
146757706|NCT00819234|529279289|FG009|Overall Study|Adverse Event|0|||
146757707|NCT00819234|529279280|FG000|Overall Study|Physician Decision|0|||
146757708|NCT00819234|529279281|FG001|Overall Study|Physician Decision|0|||
146757709|NCT00819234|529279282|FG002|Overall Study|Physician Decision|0|||
146757710|NCT00819234|529279283|FG003|Overall Study|Physician Decision|1|||
146757711|NCT00819234|529279284|FG004|Overall Study|Physician Decision|0|||
146757712|NCT00819234|529279285|FG005|Overall Study|Physician Decision|0|||
146757713|NCT00819234|529279286|FG006|Overall Study|Physician Decision|0|||
146757714|NCT00819234|529279287|FG007|Overall Study|Physician Decision|0|||
146757715|NCT00819234|529279288|FG008|Overall Study|Physician Decision|0|||
146757716|NCT00819234|529279289|FG009|Overall Study|Physician Decision|2|||
146757717|NCT00819234|529279280|FG000|Overall Study|Protocol Violation|0|||
146757718|NCT00819234|529279281|FG001|Overall Study|Protocol Violation|0|||
146757719|NCT00819234|529279282|FG002|Overall Study|Protocol Violation|1|||
146757720|NCT00819234|529279283|FG003|Overall Study|Protocol Violation|0|||
146757721|NCT00819234|529279284|FG004|Overall Study|Protocol Violation|0|||
146757722|NCT00819234|529279285|FG005|Overall Study|Protocol Violation|0|||
146757723|NCT00819234|529279286|FG006|Overall Study|Protocol Violation|0|||
146757724|NCT00819234|529279287|FG007|Overall Study|Protocol Violation|0|||
146757725|NCT00819234|529279288|FG008|Overall Study|Protocol Violation|0|||
146757726|NCT00819234|529279289|FG009|Overall Study|Protocol Violation|0|||
146757727|NCT00819234|529279280|FG000|Overall Study|Lost to Follow-up|2|||
146757728|NCT00819234|529279281|FG001|Overall Study|Lost to Follow-up|2|||
146757729|NCT00819234|529279282|FG002|Overall Study|Lost to Follow-up|0|||
146757730|NCT00819234|529279283|FG003|Overall Study|Lost to Follow-up|2|||
146757731|NCT00819234|529279284|FG004|Overall Study|Lost to Follow-up|1|||
146757732|NCT00819234|529279285|FG005|Overall Study|Lost to Follow-up|1|||
146854708|NCT02502097|529639732|FG003|Period 1|Adverse Event|0|||
146625269|NCT03037385|528803854|FG009|Overall Study|Lost to Follow-up|16|||
146757733|NCT00819234|529279286|FG006|Overall Study|Lost to Follow-up|1|||
146757734|NCT00819234|529279287|FG007|Overall Study|Lost to Follow-up|1|||
146757735|NCT00819234|529279288|FG008|Overall Study|Lost to Follow-up|1|||
146757736|NCT00819234|529279289|FG009|Overall Study|Lost to Follow-up|2|||
146757737|NCT04438785|529279290|FG000|Overall Study|change of weight, give up intervention|2|||
146757738|NCT04438785|529279291|FG001|Overall Study|change of weight, give up intervention|10|||
146757739|NCT02027935|529279292|FG000|Overall Study|Death|1|||
146757740|NCT02027935|529279292|FG000|Overall Study|Lack of Efficacy|5|||
146757741|NCT02027935|529279292|FG000|Overall Study|Study Closure|1|||
146757742|NCT05174065|529279293|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
146757743|NCT05174065|529279294|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
146757744|NCT05174065|529279295|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
146854709|NCT02502097|529639729|FG000|Wash Out Period|Adverse Event|0|||
146854710|NCT02502097|529639730|FG001|Wash Out Period|Adverse Event|1|||
146854711|NCT02502097|529639731|FG002|Wash Out Period|Adverse Event|1|||
146854712|NCT02502097|529639732|FG003|Wash Out Period|Adverse Event|1|||
146854713|NCT02502097|529639729|FG000|Period 2|Adverse Event|0|||
146854714|NCT02502097|529639730|FG001|Period 2|Adverse Event|0|||
146854715|NCT02502097|529639731|FG002|Period 2|Adverse Event|1|||
146854716|NCT02502097|529639732|FG003|Period 2|Adverse Event|0|||
146854717|NCT01350336|529639733|FG000|Overall Study|Lost to Follow-up|31|||
146854718|NCT01350336|529639733|FG000|Overall Study|Withdrawal by Subject|14|||
146854719|NCT01350336|529639733|FG000|Overall Study|Physician Decision|8|||
146854720|NCT01350336|529639733|FG000|Overall Study|Death|4|||
146854721|NCT01016977|529639741|FG000|Overall Study|Lost to Follow-up|1|||
146854722|NCT01016977|529639742|FG001|Overall Study|Lost to Follow-up|0|||
146854723|NCT01016977|529639741|FG000|Overall Study|Withdrawal by Subject|2|||
146854724|NCT01016977|529639742|FG001|Overall Study|Withdrawal by Subject|2|||
146854725|NCT05081388|529639745|FG000|Overall Study|Adverse Event|1|||
146854726|NCT05081388|529639746|FG001|Overall Study|Adverse Event|0|||
146854727|NCT05081388|529639747|FG002|Overall Study|Adverse Event|0|||
146854728|NCT05081388|529639748|FG003|Overall Study|Adverse Event|0|||
146854729|NCT05081388|529639749|FG004|Overall Study|Adverse Event|0|||
146854730|NCT05081388|529639745|FG000|Overall Study|Lost to Follow-up|0|||
146854731|NCT05081388|529639746|FG001|Overall Study|Lost to Follow-up|1|||
146854732|NCT05081388|529639747|FG002|Overall Study|Lost to Follow-up|0|||
146854733|NCT05081388|529639748|FG003|Overall Study|Lost to Follow-up|0|||
146854734|NCT05081388|529639749|FG004|Overall Study|Lost to Follow-up|0|||
146854735|NCT05081388|529639745|FG000|Overall Study|Subject decision|0|||
146854736|NCT05081388|529639746|FG001|Overall Study|Subject decision|0|||
146854737|NCT05081388|529639747|FG002|Overall Study|Subject decision|0|||
146854738|NCT05081388|529639748|FG003|Overall Study|Subject decision|1|||
146854739|NCT05081388|529639749|FG004|Overall Study|Subject decision|0|||
146854740|NCT01776541|529639750|FG000|Overall Study|Administrative Reason|6|||
146854741|NCT01776541|529639751|FG001|Overall Study|Administrative Reason|2|||
146854742|NCT01776541|529639750|FG000|Overall Study|Death|4|||
146854743|NCT01776541|529639751|FG001|Overall Study|Death|0|||
146854744|NCT01776541|529639750|FG000|Overall Study|Lost to Follow-up|27|||
146854745|NCT01776541|529639751|FG001|Overall Study|Lost to Follow-up|48|||
146854746|NCT01776541|529639750|FG000|Overall Study|Unclassified|5|||
146854747|NCT01776541|529639751|FG001|Overall Study|Unclassified|4|||
146854748|NCT01776541|529639750|FG000|Overall Study|Protocol Violation|2|||
146854749|NCT01776541|529639751|FG001|Overall Study|Protocol Violation|1|||
146854750|NCT01776541|529639750|FG000|Overall Study|Withdrawal by Subject|12|||
146854751|NCT01776541|529639751|FG001|Overall Study|Withdrawal by Subject|20|||
146854752|NCT04279392|529639752|FG000|Overall Study|Physician Decision|1|||
146854753|NCT04279392|529639753|FG001|Overall Study|Physician Decision|0|||
146854754|NCT01171807|529639754|FG000|Overall Study|Treatment failure|2|||
146854755|NCT01171807|529639755|FG001|Overall Study|Treatment failure|4|||
146854756|NCT01171807|529639754|FG000|Overall Study|Non compliance|1|||
146854757|NCT01171807|529639755|FG001|Overall Study|Non compliance|0|||
146854758|NCT01171807|529639754|FG000|Overall Study|Lost to Follow-up|3|||
146854759|NCT01171807|529639755|FG001|Overall Study|Lost to Follow-up|0|||
146854760|NCT01901341|529639756|FG000|Overall Study|Adverse Event|4|||
146854761|NCT01901341|529639757|FG001|Overall Study|Adverse Event|2|||
146854762|NCT01901341|529639756|FG000|Overall Study|Lack of Efficacy|0|||
146854763|NCT01901341|529639757|FG001|Overall Study|Lack of Efficacy|2|||
146854764|NCT01901341|529639756|FG000|Overall Study|Lost to Follow-up|0|||
146854765|NCT01901341|529639757|FG001|Overall Study|Lost to Follow-up|1|||
146854766|NCT01901341|529639756|FG000|Overall Study|Protocol Violation|2|||
146854767|NCT01901341|529639757|FG001|Overall Study|Protocol Violation|0|||
146854768|NCT01901341|529639756|FG000|Overall Study|Study Terminated by Sponsor|13|||
146854769|NCT01901341|529639757|FG001|Overall Study|Study Terminated by Sponsor|15|||
146854770|NCT01901341|529639756|FG000|Overall Study|Withdrawal by Subject|1|||
146854771|NCT01901341|529639757|FG001|Overall Study|Withdrawal by Subject|1|||
146854772|NCT01981473|529639758|FG000|Overall Study|Incorrect diagnosis of RA|0|||
146854773|NCT01981473|529639759|FG001|Overall Study|Incorrect diagnosis of RA|0|||
146854774|NCT01981473|529639760|FG002|Overall Study|Incorrect diagnosis of RA|1|||
146854775|NCT01981473|529639758|FG000|Overall Study|Received treatment for < 6 months|0|||
146854776|NCT01981473|529639759|FG001|Overall Study|Received treatment for < 6 months|0|||
146854777|NCT01981473|529639760|FG002|Overall Study|Received treatment for < 6 months|1|||
146854778|NCT01981473|529639758|FG000|Overall Study|Received treatment for >24 months|2|||
146854779|NCT01981473|529639759|FG001|Overall Study|Received treatment for >24 months|0|||
146854780|NCT01981473|529639760|FG002|Overall Study|Received treatment for >24 months|6|||
146854781|NCT00738582|529639761|FG000|Combination Therapy|Completed Combination Therapy|1|||
146854782|NCT00738582|529639762|FG001|Combination Therapy|Completed Combination Therapy|0|||
146854783|NCT00738582|529639761|FG000|Combination Therapy|Physician Decision|1|||
146854784|NCT00738582|529639762|FG001|Combination Therapy|Physician Decision|0|||
146854785|NCT00738582|529639761|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
146854786|NCT00738582|529639762|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
146854787|NCT00738582|529639761|FG000|Combination Therapy|Other|5|||
146854788|NCT00738582|529639762|FG001|Combination Therapy|Other|0|||
146854789|NCT00738582|529639761|FG000|Combination Therapy|Adverse Event|16|||
146854790|NCT00738582|529639762|FG001|Combination Therapy|Adverse Event|0|||
146854791|NCT00738582|529639761|FG000|Combination Therapy|Progressive Disease|9|||
146854792|NCT00738582|529639762|FG001|Combination Therapy|Progressive Disease|0|||
146854793|NCT00738582|529639761|FG000|Maintenance Therapy|Other|0|||
146854794|NCT00738582|529639762|FG001|Maintenance Therapy|Other|2|||
146854795|NCT00738582|529639761|FG000|Maintenance Therapy|Adverse Event|0|||
146854796|NCT00738582|529639762|FG001|Maintenance Therapy|Adverse Event|6|||
146854797|NCT00738582|529639761|FG000|Maintenance Therapy|Progressive Disease|0|||
146854798|NCT00738582|529639762|FG001|Maintenance Therapy|Progressive Disease|47|||
146854799|NCT00738582|529639761|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
146854800|NCT00738582|529639762|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
146854801|NCT00757588|529639763|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
146854802|NCT00757588|529639764|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
146854803|NCT00757588|529639763|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
146854804|NCT00757588|529639764|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
146521674|NCT04978337|528418057|FG001|Overall Study|Withdrawal by Subject|1|||
146521675|NCT01408901|528418058|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
146757745|NCT05174065|529279293|FG000|Placebo-controlled Period|Other|0|||
146757746|NCT05174065|529279294|FG001|Placebo-controlled Period|Other|1|||
146757747|NCT05174065|529279295|FG002|Placebo-controlled Period|Other|0|||
146757748|NCT05174065|529279293|FG000|Placebo-controlled Period|Adverse Event|1|||
146757749|NCT05174065|529279294|FG001|Placebo-controlled Period|Adverse Event|1|||
146757750|NCT05174065|529279295|FG002|Placebo-controlled Period|Adverse Event|0|||
146757751|NCT05174065|529279293|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
146757752|NCT05174065|529279294|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
146757753|NCT05174065|529279295|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
146757754|NCT05174065|529279293|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
146757755|NCT05174065|529279294|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
146757756|NCT05174065|529279295|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
146757757|NCT05174065|529279293|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
146757758|NCT05174065|529279294|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
146757759|NCT05174065|529279295|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
146757760|NCT00689104|529279296|FG000|Overall Study|Eligibility criterion not met|5|||
146757761|NCT00689104|529279297|FG001|Overall Study|Eligibility criterion not met|8|||
146757762|NCT00689104|529279298|FG002|Overall Study|Eligibility criterion not met|0|||
146757763|NCT00689104|529279299|FG003|Overall Study|Eligibility criterion not met|4|||
146757764|NCT00689104|529279296|FG000|Overall Study|Adverse Event|13|||
146757765|NCT00689104|529279297|FG001|Overall Study|Adverse Event|25|||
146757766|NCT00689104|529279298|FG002|Overall Study|Adverse Event|16|||
146757767|NCT00689104|529279299|FG003|Overall Study|Adverse Event|24|||
146757768|NCT00689104|529279296|FG000|Overall Study|Lack of Efficacy|5|||
146757769|NCT00689104|529279297|FG001|Overall Study|Lack of Efficacy|6|||
146854805|NCT00757588|529639763|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
146854806|NCT00757588|529639764|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
146854807|NCT00757588|529639763|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
146854808|NCT00757588|529639764|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
146854809|NCT00757588|529639763|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
146854810|NCT00757588|529639764|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
146854811|NCT00757588|529639763|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
146854812|NCT00757588|529639764|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
146854813|NCT00757588|529639763|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
146854814|NCT00757588|529639764|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
146854815|NCT00757588|529639763|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
146854816|NCT00757588|529639764|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
146854817|NCT00757588|529639763|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
146854818|NCT00757588|529639764|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
146854819|NCT00757588|529639763|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
146854820|NCT00757588|529639764|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
146854821|NCT00757588|529639763|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
146854822|NCT00757588|529639764|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
146854823|NCT00757588|529639763|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
146854824|NCT00757588|529639764|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
146854825|NCT00757588|529639763|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
146854826|NCT00757588|529639764|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
146854827|NCT00757588|529639763|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
146854828|NCT00757588|529639764|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
146854829|NCT00757588|529639763|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
146854830|NCT00757588|529639764|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
146854831|NCT00757588|529639763|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
146854832|NCT00757588|529639764|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
146854833|NCT00799513|529639769|FG000|Overall Study|Physician Decision|1|||
146854834|NCT00799513|529639769|FG000|Overall Study|Adverse Event|1|||
146854835|NCT02781844|529639775|FG000|Treatment Period 1|Adverse Event|0|||
146854836|NCT02781844|529639776|FG001|Treatment Period 1|Adverse Event|0|||
146854837|NCT02781844|529639777|FG002|Treatment Period 1|Adverse Event|0|||
146854838|NCT02781844|529639778|FG003|Treatment Period 1|Adverse Event|0|||
146854839|NCT02781844|529639779|FG004|Treatment Period 1|Adverse Event|0|||
146854840|NCT02781844|529639780|FG005|Treatment Period 1|Adverse Event|1|||
146854841|NCT02781844|529639781|FG006|Treatment Period 1|Adverse Event|0|||
146854842|NCT02781844|529639782|FG007|Treatment Period 1|Adverse Event|0|||
146854843|NCT01383499|529639785|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
146854844|NCT01383499|529639786|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
146854845|NCT01383499|529639787|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
146854846|NCT01383499|529639788|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
146854847|NCT01079663|529639791|FG000|Overall Study|Adverse Event|0|||
146854848|NCT01079663|529639792|FG001|Overall Study|Adverse Event|2|||
146854849|NCT01079663|529639791|FG000|Overall Study|Protocol Violation|0|||
146854850|NCT01079663|529639792|FG001|Overall Study|Protocol Violation|2|||
146854851|NCT03587974|529639797|FG000|Overall Study|caregiver demented, care recipient died|3|||
146854852|NCT03587974|529639798|FG001|Overall Study|caregiver demented, care recipient died|3|||
146854853|NCT03587974|529639797|FG000|Overall Study|Withdrawal by Subject|2|||
146854854|NCT03587974|529639798|FG001|Overall Study|Withdrawal by Subject|1|||
146854855|NCT02585232|529639801|FG000|Overall Study|Lost to Follow-up|8|||
146854856|NCT02585232|529639802|FG001|Overall Study|Lost to Follow-up|8|||
146854857|NCT02585232|529639801|FG000|Overall Study|Withdrawal by Subject|4|||
146854858|NCT02585232|529639802|FG001|Overall Study|Withdrawal by Subject|8|||
146854859|NCT00461032|529639803|FG000|Overall Study|Adverse Event|5|||
146854860|NCT00461032|529639804|FG001|Overall Study|Adverse Event|6|||
146854861|NCT00461032|529639803|FG000|Overall Study|Lack of Efficacy|5|||
146854862|NCT00461032|529639804|FG001|Overall Study|Lack of Efficacy|1|||
146854863|NCT00461032|529639803|FG000|Overall Study|Lost to Follow-up|7|||
146854864|NCT00461032|529639804|FG001|Overall Study|Lost to Follow-up|12|||
146854865|NCT00461032|529639803|FG000|Overall Study|Protocol Violation|4|||
146854866|NCT00461032|529639804|FG001|Overall Study|Protocol Violation|4|||
146854867|NCT00461032|529639803|FG000|Overall Study|Withdrawal by Subject|7|||
146854868|NCT00461032|529639804|FG001|Overall Study|Withdrawal by Subject|15|||
146854869|NCT00461032|529639803|FG000|Overall Study|Patient Moved or Relocated|2|||
146854870|NCT00461032|529639804|FG001|Overall Study|Patient Moved or Relocated|1|||
146854871|NCT00461032|529639803|FG000|Overall Study|Other|7|||
146854872|NCT00461032|529639804|FG001|Overall Study|Other|5|||
146854873|NCT04447846|529639805|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
146854874|NCT03536143|529639809|FG000|Overall Study|Early termination, Sponsor decision|1|||
146854875|NCT01878214|529639810|FG000|Overall Study|Withdrawal by Subject|18|||
146854876|NCT01878214|529639811|FG001|Overall Study|Withdrawal by Subject|7|||
146854877|NCT01878214|529639810|FG000|Overall Study|Death|0|||
146854878|NCT01878214|529639811|FG001|Overall Study|Death|1|||
146854879|NCT01878214|529639810|FG000|Overall Study|Lost to Follow-up|35|||
146854880|NCT01878214|529639811|FG001|Overall Study|Lost to Follow-up|36|||
146854881|NCT01174160|529639812|FG000|Overall Study|Adverse Event|1|||
146854882|NCT01174160|529639813|FG001|Overall Study|Adverse Event|0|||
146854883|NCT01174160|529639812|FG000|Overall Study|Lost to Follow-up|1|||
146854884|NCT01174160|529639813|FG001|Overall Study|Lost to Follow-up|0|||
146854885|NCT01174160|529639812|FG000|Overall Study|Physician Decision|1|||
146854886|NCT01174160|529639813|FG001|Overall Study|Physician Decision|0|||
146854887|NCT01174160|529639812|FG000|Overall Study|Protocol Violation|4|||
146854888|NCT01174160|529639813|FG001|Overall Study|Protocol Violation|6|||
146854889|NCT01174160|529639812|FG000|Overall Study|Withdrawal by Subject|1|||
146854890|NCT01174160|529639813|FG001|Overall Study|Withdrawal by Subject|0|||
146854891|NCT01590017|529639814|FG000|Overall Study|Adverse Event|1|||
146854892|NCT01590017|529639814|FG000|Overall Study|Withdrawal by Subject|1|||
146854893|NCT01590017|529639814|FG000|Overall Study|Lack of Efficacy|1|||
146854894|NCT01590017|529639814|FG000|Overall Study|Physician Decision|1|||
146854895|NCT00871780|529639815|FG000|Overall Study|Enrolled But Not Treated|6|||
146854896|NCT00871780|529639815|FG000|Overall Study|Withdrawal by Subject|9|||
146854897|NCT00871780|529639815|FG000|Overall Study|Adverse Event|6|||
146854898|NCT00871780|529639815|FG000|Overall Study|Voluntary Discontinuation|4|||
146854899|NCT00871780|529639815|FG000|Overall Study|Death|1|||
146854900|NCT00871780|529639815|FG000|Overall Study|Physician Decision|1|||
146854901|NCT02527343|529639816|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
146854902|NCT02527343|529639817|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
146854903|NCT02527343|529639818|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
146854904|NCT02527343|529639819|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
146854905|NCT02527343|529639820|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
146854906|NCT02527343|529639821|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
146854907|NCT02527343|529639816|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
146854908|NCT02527343|529639817|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
146854909|NCT02527343|529639818|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
146854910|NCT02527343|529639819|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
146854911|NCT02527343|529639820|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
146854912|NCT02527343|529639821|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
146854913|NCT02527343|529639816|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
146854914|NCT02527343|529639817|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
146854915|NCT02527343|529639818|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
146854916|NCT02527343|529639819|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
146854917|NCT02527343|529639820|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
146854918|NCT02527343|529639821|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
146854919|NCT02527343|529639816|FG000|RT Period: Weeks 1 to 52|Other|4|||
146854920|NCT02527343|529639817|FG001|RT Period: Weeks 1 to 52|Other|3|||
146854921|NCT02527343|529639818|FG002|RT Period: Weeks 1 to 52|Other|0|||
146854922|NCT02527343|529639819|FG003|RT Period: Weeks 1 to 52|Other|0|||
146854923|NCT02527343|529639820|FG004|RT Period: Weeks 1 to 52|Other|0|||
146854924|NCT02527343|529639821|FG005|RT Period: Weeks 1 to 52|Other|0|||
146854925|NCT02527343|529639816|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
146854926|NCT02527343|529639817|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
146854927|NCT02527343|529639818|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
146854928|NCT02527343|529639819|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
146854929|NCT02527343|529639820|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
146854930|NCT02527343|529639821|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
146854931|NCT02527343|529639816|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
146854932|NCT02527343|529639817|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
146854933|NCT02527343|529639818|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
146854934|NCT02527343|529639819|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
146521676|NCT01408901|528418059|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
146521677|NCT01408901|528418060|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
146521678|NCT01408901|528418061|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
146854935|NCT02527343|529639820|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
146854936|NCT02527343|529639821|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
146854937|NCT02527343|529639816|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
146854938|NCT02527343|529639817|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
146854939|NCT02527343|529639818|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
146854940|NCT02527343|529639819|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
146854941|NCT02527343|529639820|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
146854942|NCT02527343|529639821|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
146854943|NCT02527343|529639816|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
146521679|NCT01408901|528418058|FG000|6-Week Follow-Up|Death|1|||
146521680|NCT01408901|528418059|FG001|6-Week Follow-Up|Death|0|||
146521681|NCT01408901|528418060|FG002|6-Week Follow-Up|Death|0|||
146521682|NCT01408901|528418061|FG003|6-Week Follow-Up|Death|0|||
146521683|NCT01408901|528418058|FG000|6-Week Follow-Up|Cancelled visit|0|||
146521684|NCT01408901|528418059|FG001|6-Week Follow-Up|Cancelled visit|1|||
146521685|NCT01408901|528418060|FG002|6-Week Follow-Up|Cancelled visit|0|||
146521686|NCT01408901|528418061|FG003|6-Week Follow-Up|Cancelled visit|2|||
146521687|NCT01408901|528418058|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
146854944|NCT02527343|529639817|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
146854945|NCT02527343|529639818|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
146854946|NCT02527343|529639819|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
146854947|NCT02527343|529639820|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
146854948|NCT02527343|529639821|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
146854949|NCT02527343|529639816|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
146854950|NCT02527343|529639817|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
146854951|NCT02527343|529639818|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
146854952|NCT02527343|529639819|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
146854953|NCT02527343|529639820|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
146854954|NCT02527343|529639821|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
146854955|NCT02527343|529639816|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
146854956|NCT02527343|529639817|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
146854957|NCT02527343|529639818|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
146854958|NCT02527343|529639819|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
146854959|NCT02527343|529639820|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
146854960|NCT02527343|529639821|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
146854961|NCT02527343|529639816|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
146854962|NCT02527343|529639817|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
146854963|NCT02527343|529639818|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
146854964|NCT02527343|529639819|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
146854965|NCT02527343|529639820|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
146854966|NCT02527343|529639821|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
146854967|NCT02527343|529639816|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
146854968|NCT02527343|529639817|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
146854969|NCT02527343|529639818|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
146854970|NCT02527343|529639819|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
146854971|NCT02527343|529639820|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
146854972|NCT02527343|529639821|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
146854973|NCT02527343|529639816|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
146854974|NCT02527343|529639817|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
146854975|NCT02527343|529639818|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
146854976|NCT02527343|529639819|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
146854977|NCT02527343|529639820|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
146854978|NCT02527343|529639821|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
146854979|NCT05767021|529639822|FG000|Overall Study|Adverse Event|2|||
146854980|NCT05767021|529639822|FG000|Overall Study|Protocol Deviation|1|||
146854981|NCT05767021|529639822|FG000|Overall Study|Withdrawal by Subject|1|||
146854982|NCT05767021|529639822|FG000|Overall Study|Physician Decision|1|||
146854983|NCT05767021|529639822|FG000|Overall Study|Lack of Efficacy|11|||
146854984|NCT05767021|529639822|FG000|Overall Study|Assigned Treatment by Mistake|1|||
146854985|NCT06377488|529639823|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
146854986|NCT06377488|529639823|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
146854987|NCT06377488|529639823|FG000|Overall Study|Protocol Violation|1|||
146854988|NCT06377488|529639823|FG000|Overall Study|Lost to Follow-up|1|||
146854989|NCT06377488|529639823|FG000|Overall Study|Incorrect Lens Dispensed|2|||
146854990|NCT01831856|529639826|FG000|Overall Study|Adverse Event|5|||
146854991|NCT01831856|529639827|FG001|Overall Study|Adverse Event|8|||
146854992|NCT01831856|529639826|FG000|Overall Study|Lack of Efficacy|13|||
146854993|NCT01831856|529639827|FG001|Overall Study|Lack of Efficacy|11|||
146854994|NCT01831856|529639826|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
146854995|NCT01831856|529639827|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
146854996|NCT05208866|529639828|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
146854997|NCT00906945|529639830|FG000|Overall Study|Found to be not eligible|0|||
146854998|NCT00906945|529639831|FG001|Overall Study|Found to be not eligible|0|||
146854999|NCT00906945|529639832|FG002|Overall Study|Found to be not eligible|0|||
146855000|NCT00906945|529639833|FG003|Overall Study|Found to be not eligible|1|||
146855001|NCT00906945|529639834|FG004|Overall Study|Found to be not eligible|1|||
146855002|NCT00906945|529639835|FG005|Overall Study|Found to be not eligible|1|||
146855003|NCT00906945|529639830|FG000|Overall Study|Physician Decision|0|||
146855004|NCT00906945|529639831|FG001|Overall Study|Physician Decision|0|||
146965064|NCT03110107|530033428|FG002|Treatment Period|Death|0|||
146521688|NCT01408901|528418059|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
146521689|NCT01408901|528418060|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
146855005|NCT00906945|529639832|FG002|Overall Study|Physician Decision|0|||
146855006|NCT00906945|529639833|FG003|Overall Study|Physician Decision|0|||
146855007|NCT00906945|529639834|FG004|Overall Study|Physician Decision|0|||
146855008|NCT00906945|529639835|FG005|Overall Study|Physician Decision|1|||
146855009|NCT02751320|529639837|FG000|Overall Study|Adverse Event|2|||
146855010|NCT02751320|529639837|FG000|Overall Study|Withdrawal by Subject|1|||
146855011|NCT05249829|529639838|FG000|Overall Study|Participant Relocation|0|||
146855012|NCT05249829|529639839|FG001|Overall Study|Participant Relocation|1|||
146855013|NCT05249829|529639840|FG002|Overall Study|Participant Relocation|2|||
146855014|NCT05249829|529639841|FG003|Overall Study|Participant Relocation|2|||
146855015|NCT05249829|529639838|FG000|Overall Study|Withdrawal by Subject|9|||
146855016|NCT05249829|529639839|FG001|Overall Study|Withdrawal by Subject|17|||
146855017|NCT05249829|529639840|FG002|Overall Study|Withdrawal by Subject|40|||
146855018|NCT05249829|529639841|FG003|Overall Study|Withdrawal by Subject|35|||
146855019|NCT05249829|529639838|FG000|Overall Study|Physician Decision|1|||
146855020|NCT05249829|529639839|FG001|Overall Study|Physician Decision|0|||
146855021|NCT05249829|529639840|FG002|Overall Study|Physician Decision|0|||
146855022|NCT05249829|529639841|FG003|Overall Study|Physician Decision|0|||
146855023|NCT05249829|529639838|FG000|Overall Study|Lost to Follow-up|16|||
146855024|NCT05249829|529639839|FG001|Overall Study|Lost to Follow-up|16|||
146855025|NCT05249829|529639840|FG002|Overall Study|Lost to Follow-up|57|||
146855026|NCT05249829|529639841|FG003|Overall Study|Lost to Follow-up|60|||
146855027|NCT05249829|529639838|FG000|Overall Study|Adverse Event|2|||
146855028|NCT05249829|529639839|FG001|Overall Study|Adverse Event|2|||
146855029|NCT05249829|529639840|FG002|Overall Study|Adverse Event|2|||
146855030|NCT05249829|529639841|FG003|Overall Study|Adverse Event|2|||
146855031|NCT05249829|529639838|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
146855032|NCT05249829|529639839|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
146855033|NCT05249829|529639840|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
146855034|NCT05249829|529639841|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
146855035|NCT05249829|529639838|FG000|Overall Study|Protocol Violation|2|||
146855036|NCT05249829|529639839|FG001|Overall Study|Protocol Violation|0|||
146855037|NCT05249829|529639840|FG002|Overall Study|Protocol Violation|5|||
146855038|NCT05249829|529639841|FG003|Overall Study|Protocol Violation|3|||
146855039|NCT05249829|529639838|FG000|Overall Study|Death|0|||
146855040|NCT05249829|529639839|FG001|Overall Study|Death|1|||
146855041|NCT05249829|529639840|FG002|Overall Study|Death|2|||
146855042|NCT05249829|529639841|FG003|Overall Study|Death|4|||
146855043|NCT00513604|529639842|FG000|Overall Study|Not treated|2|||
146855044|NCT00513604|529639843|FG001|Overall Study|Not treated|0|||
146855045|NCT00513604|529639844|FG002|Overall Study|Not treated|1|||
146855046|NCT00513604|529639845|FG003|Overall Study|Not treated|0|||
146855047|NCT00513604|529639846|FG004|Overall Study|Not treated|0|||
146855048|NCT00513604|529639842|FG000|Overall Study|Death during treatment|0|||
146855049|NCT00513604|529639843|FG001|Overall Study|Death during treatment|3|||
146855050|NCT00513604|529639844|FG002|Overall Study|Death during treatment|2|||
146855051|NCT00513604|529639845|FG003|Overall Study|Death during treatment|0|||
146855052|NCT00513604|529639846|FG004|Overall Study|Death during treatment|0|||
146855053|NCT02842827|529639847|FG000|Overall Study|Adverse Event|0|||
146855054|NCT02842827|529639848|FG001|Overall Study|Adverse Event|1|||
146855055|NCT02842827|529639849|FG002|Overall Study|Adverse Event|0|||
146855056|NCT02842827|529639850|FG003|Overall Study|Adverse Event|1|||
146855057|NCT02842827|529639851|FG004|Overall Study|Adverse Event|0|||
146855058|NCT02842827|529639852|FG005|Overall Study|Adverse Event|1|||
146855059|NCT02842827|529639853|FG006|Overall Study|Adverse Event|0|||
146855060|NCT02842827|529639854|FG007|Overall Study|Adverse Event|0|||
146855061|NCT02842827|529639847|FG000|Overall Study|Death|1|||
146855062|NCT02842827|529639848|FG001|Overall Study|Death|0|||
146855063|NCT02842827|529639849|FG002|Overall Study|Death|2|||
146855064|NCT02842827|529639850|FG003|Overall Study|Death|3|||
146855065|NCT02842827|529639851|FG004|Overall Study|Death|2|||
146855066|NCT02842827|529639852|FG005|Overall Study|Death|1|||
146855067|NCT02842827|529639853|FG006|Overall Study|Death|0|||
146855068|NCT02842827|529639854|FG007|Overall Study|Death|4|||
146855069|NCT02842827|529639847|FG000|Overall Study|Physician Decision|1|||
146855070|NCT02842827|529639848|FG001|Overall Study|Physician Decision|3|||
146855071|NCT02842827|529639849|FG002|Overall Study|Physician Decision|0|||
146855072|NCT02842827|529639850|FG003|Overall Study|Physician Decision|0|||
146855073|NCT02842827|529639851|FG004|Overall Study|Physician Decision|1|||
146855074|NCT02842827|529639852|FG005|Overall Study|Physician Decision|4|||
146855075|NCT02842827|529639853|FG006|Overall Study|Physician Decision|2|||
146855076|NCT02842827|529639854|FG007|Overall Study|Physician Decision|1|||
146855077|NCT02842827|529639847|FG000|Overall Study|Protocol Defined Disease Progression|0|||
146855078|NCT02842827|529639848|FG001|Overall Study|Protocol Defined Disease Progression|0|||
146855079|NCT02842827|529639849|FG002|Overall Study|Protocol Defined Disease Progression|0|||
146855080|NCT02842827|529639850|FG003|Overall Study|Protocol Defined Disease Progression|0|||
146855081|NCT02842827|529639851|FG004|Overall Study|Protocol Defined Disease Progression|0|||
146855082|NCT02842827|529639852|FG005|Overall Study|Protocol Defined Disease Progression|1|||
146855083|NCT02842827|529639853|FG006|Overall Study|Protocol Defined Disease Progression|0|||
146855084|NCT02842827|529639854|FG007|Overall Study|Protocol Defined Disease Progression|0|||
146855085|NCT02842827|529639847|FG000|Overall Study|Participant Withdrawal of Consent|1|||
146855086|NCT02842827|529639848|FG001|Overall Study|Participant Withdrawal of Consent|2|||
146855087|NCT02842827|529639849|FG002|Overall Study|Participant Withdrawal of Consent|2|||
146855088|NCT02842827|529639850|FG003|Overall Study|Participant Withdrawal of Consent|2|||
146855089|NCT02842827|529639851|FG004|Overall Study|Participant Withdrawal of Consent|2|||
146855090|NCT02842827|529639852|FG005|Overall Study|Participant Withdrawal of Consent|1|||
146855091|NCT02842827|529639853|FG006|Overall Study|Participant Withdrawal of Consent|2|||
146855092|NCT02842827|529639854|FG007|Overall Study|Participant Withdrawal of Consent|1|||
146855093|NCT02649946|529639860|FG000|Overall Study|Withdrawal by Subject|1|||
146855094|NCT02649946|529639861|FG001|Overall Study|Withdrawal by Subject|1|||
146855095|NCT02649946|529639860|FG000|Overall Study|Death|7|||
146855096|NCT02649946|529639861|FG001|Overall Study|Death|9|||
146855097|NCT02649946|529639860|FG000|Overall Study|Physician Decision|1|||
146855098|NCT02649946|529639861|FG001|Overall Study|Physician Decision|0|||
146855099|NCT02649946|529639860|FG000|Overall Study|Lost to Follow-up|2|||
146855100|NCT02649946|529639861|FG001|Overall Study|Lost to Follow-up|1|||
146855101|NCT02649946|529639860|FG000|Overall Study|Erroneously enrolled|1|||
146855102|NCT02649946|529639861|FG001|Overall Study|Erroneously enrolled|0|||
146855103|NCT02649946|529639860|FG000|Overall Study|Missed 6-month follow-up visit|0|||
146855104|NCT02649946|529639861|FG001|Overall Study|Missed 6-month follow-up visit|4|||
146855105|NCT02054520|529639862|FG000|Overall Study|Adverse Event|1|||
146855106|NCT02054520|529639863|FG001|Overall Study|Adverse Event|4|||
146855107|NCT02054520|529639864|FG002|Overall Study|Adverse Event|2|||
146855108|NCT02054520|529639865|FG003|Overall Study|Adverse Event|1|||
146855109|NCT02054520|529639866|FG004|Overall Study|Adverse Event|1|||
146855110|NCT02054520|529639867|FG005|Overall Study|Adverse Event|0|||
146855111|NCT02054520|529639862|FG000|Overall Study|Lack of Efficacy|7|||
146855112|NCT02054520|529639863|FG001|Overall Study|Lack of Efficacy|0|||
146855113|NCT02054520|529639864|FG002|Overall Study|Lack of Efficacy|2|||
146855114|NCT02054520|529639865|FG003|Overall Study|Lack of Efficacy|1|||
146855115|NCT02054520|529639866|FG004|Overall Study|Lack of Efficacy|3|||
146855116|NCT02054520|529639867|FG005|Overall Study|Lack of Efficacy|2|||
146855117|NCT02054520|529639862|FG000|Overall Study|Withdrawal by Subject|1|||
146855118|NCT02054520|529639863|FG001|Overall Study|Withdrawal by Subject|0|||
146855119|NCT02054520|529639864|FG002|Overall Study|Withdrawal by Subject|0|||
146855120|NCT02054520|529639865|FG003|Overall Study|Withdrawal by Subject|2|||
146855121|NCT02054520|529639866|FG004|Overall Study|Withdrawal by Subject|1|||
146855122|NCT02054520|529639867|FG005|Overall Study|Withdrawal by Subject|0|||
146855123|NCT02054520|529639862|FG000|Overall Study|Physician Decision|0|||
146855124|NCT02054520|529639863|FG001|Overall Study|Physician Decision|1|||
146855125|NCT02054520|529639864|FG002|Overall Study|Physician Decision|0|||
146855126|NCT02054520|529639865|FG003|Overall Study|Physician Decision|1|||
146855127|NCT02054520|529639866|FG004|Overall Study|Physician Decision|0|||
146757770|NCT00689104|529279298|FG002|Overall Study|Lack of Efficacy|2|||
146757771|NCT00689104|529279299|FG003|Overall Study|Lack of Efficacy|3|||
146757772|NCT00689104|529279296|FG000|Overall Study|Withdrawal by Subject|12|||
146757773|NCT00689104|529279297|FG001|Overall Study|Withdrawal by Subject|11|||
146757774|NCT00689104|529279298|FG002|Overall Study|Withdrawal by Subject|18|||
146757775|NCT00689104|529279299|FG003|Overall Study|Withdrawal by Subject|11|||
146757776|NCT00689104|529279296|FG000|Overall Study|Lost to Follow-up|4|||
146757777|NCT00689104|529279297|FG001|Overall Study|Lost to Follow-up|3|||
146757778|NCT00689104|529279298|FG002|Overall Study|Lost to Follow-up|2|||
146757779|NCT00689104|529279299|FG003|Overall Study|Lost to Follow-up|5|||
146757780|NCT00689104|529279296|FG000|Overall Study|Protocol Violation|2|||
146757781|NCT00689104|529279297|FG001|Overall Study|Protocol Violation|3|||
146757782|NCT00689104|529279298|FG002|Overall Study|Protocol Violation|5|||
146855128|NCT02054520|529639867|FG005|Overall Study|Physician Decision|1|||
146855129|NCT02054520|529639862|FG000|Overall Study|Study terminated by Sponsor|0|||
146855130|NCT02054520|529639863|FG001|Overall Study|Study terminated by Sponsor|0|||
146855131|NCT02054520|529639864|FG002|Overall Study|Study terminated by Sponsor|2|||
146855132|NCT02054520|529639865|FG003|Overall Study|Study terminated by Sponsor|1|||
146757783|NCT00689104|529279299|FG003|Overall Study|Protocol Violation|3|||
146855133|NCT02054520|529639866|FG004|Overall Study|Study terminated by Sponsor|0|||
146855134|NCT02054520|529639867|FG005|Overall Study|Study terminated by Sponsor|0|||
146757784|NCT00689104|529279296|FG000|Overall Study|Randomized but never received study drug|2|||
146757785|NCT00689104|529279297|FG001|Overall Study|Randomized but never received study drug|1|||
146855135|NCT01272804|529639868|FG000|Overall Study|Adverse Event|1|||
146855136|NCT01272804|529639869|FG001|Overall Study|Adverse Event|0|||
146855137|NCT01272804|529639870|FG002|Overall Study|Adverse Event|0|||
146855138|NCT01272804|529639871|FG003|Overall Study|Adverse Event|0|||
146855139|NCT01272804|529639872|FG004|Overall Study|Adverse Event|2|||
146855140|NCT01272804|529639873|FG005|Overall Study|Adverse Event|1|||
146855141|NCT03801915|529639874|FG000|Overall Study|Screen failure|0|||
146855142|NCT03801915|529639875|FG001|Overall Study|Screen failure|0|||
146855143|NCT03801915|529639876|FG002|Overall Study|Screen failure|1|||
146855144|NCT03801915|529639874|FG000|Overall Study|Ineligible|1|||
146855145|NCT03801915|529639875|FG001|Overall Study|Ineligible|0|||
146855146|NCT03801915|529639876|FG002|Overall Study|Ineligible|0|||
146855147|NCT03801915|529639874|FG000|Overall Study|Physician Decision|2|||
146855148|NCT03801915|529639875|FG001|Overall Study|Physician Decision|1|||
146855149|NCT03801915|529639876|FG002|Overall Study|Physician Decision|0|||
146855150|NCT01328717|529641740|FG000|Overall Study|Adverse Event|1|||
146855151|NCT01201317|529641741|FG000|Overall Study|Withdrawal by Subject|5|||
146855152|NCT01201317|529641742|FG001|Overall Study|Withdrawal by Subject|0|||
146855153|NCT01201317|529641743|FG002|Overall Study|Withdrawal by Subject|3|||
146855154|NCT01201317|529641741|FG000|Overall Study|Adverse Event|2|||
146855155|NCT01201317|529641742|FG001|Overall Study|Adverse Event|2|||
146855156|NCT01201317|529641743|FG002|Overall Study|Adverse Event|2|||
146855157|NCT01201317|529641741|FG000|Overall Study|Screen failure|1|||
146855158|NCT01201317|529641742|FG001|Overall Study|Screen failure|1|||
146855159|NCT01201317|529641743|FG002|Overall Study|Screen failure|0|||
146855160|NCT01201317|529641741|FG000|Overall Study|Protocol Violation|0|||
146855161|NCT01201317|529641742|FG001|Overall Study|Protocol Violation|1|||
146855162|NCT01201317|529641743|FG002|Overall Study|Protocol Violation|1|||
146855163|NCT01201317|529641741|FG000|Overall Study|Death|0|||
146855164|NCT01201317|529641742|FG001|Overall Study|Death|1|||
146855165|NCT01201317|529641743|FG002|Overall Study|Death|0|||
146855166|NCT01201317|529641741|FG000|Overall Study|Study-specific withdrawal criteria|0|||
146855167|NCT01201317|529641742|FG001|Overall Study|Study-specific withdrawal criteria|0|||
146855168|NCT01201317|529641743|FG002|Overall Study|Study-specific withdrawal criteria|1|||
146855169|NCT01201317|529641741|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
146855170|NCT01201317|529641742|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
146855171|NCT01201317|529641743|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
146855172|NCT01201317|529641741|FG000|Overall Study|Decrease in renal function|0|||
146855173|NCT01201317|529641742|FG001|Overall Study|Decrease in renal function|1|||
146855174|NCT01201317|529641743|FG002|Overall Study|Decrease in renal function|0|||
146855175|NCT01201317|529641741|FG000|Overall Study|Lack of Efficacy|1|||
146855176|NCT01201317|529641742|FG001|Overall Study|Lack of Efficacy|0|||
146855177|NCT01201317|529641743|FG002|Overall Study|Lack of Efficacy|0|||
146855178|NCT01201317|529641741|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
146855179|NCT01201317|529641742|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
146855180|NCT01201317|529641743|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
146855181|NCT02079610|529641744|FG000|Overall Study|Withdrawal by Subject|1|||
146855182|NCT02079610|529641745|FG001|Overall Study|Withdrawal by Subject|1|||
146855183|NCT04964388|529641746|FG000|Overall Study|Lost to Follow-up|3|||
146855184|NCT04964388|529641747|FG001|Overall Study|Lost to Follow-up|2|||
146855185|NCT01052103|529641749|FG000|Overall Study|Adverse Event|10|||
146855186|NCT01052103|529641750|FG001|Overall Study|Adverse Event|6|||
146855187|NCT01052103|529641749|FG000|Overall Study|Entry Criteria Not Met|3|||
146855188|NCT01052103|529641750|FG001|Overall Study|Entry Criteria Not Met|1|||
146855189|NCT01052103|529641749|FG000|Overall Study|Lost to Follow-up|3|||
146855190|NCT01052103|529641750|FG001|Overall Study|Lost to Follow-up|5|||
146855191|NCT01052103|529641749|FG000|Overall Study|Protocol Violation|10|||
146855192|NCT01052103|529641750|FG001|Overall Study|Protocol Violation|4|||
146855193|NCT01052103|529641749|FG000|Overall Study|Scheduling conflict|2|||
146855194|NCT01052103|529641750|FG001|Overall Study|Scheduling conflict|1|||
146855195|NCT01052103|529641749|FG000|Overall Study|Sponsor Decision|2|||
146855196|NCT01052103|529641750|FG001|Overall Study|Sponsor Decision|0|||
146855197|NCT01052103|529641749|FG000|Overall Study|Withdrawal by Subject|3|||
146855198|NCT01052103|529641750|FG001|Overall Study|Withdrawal by Subject|6|||
146855199|NCT01052103|529641749|FG000|Overall Study|Perceived Lack of Efficacy|1|||
146855200|NCT01052103|529641750|FG001|Overall Study|Perceived Lack of Efficacy|0|||
146855201|NCT04874415|529641751|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146855202|NCT04874415|529641752|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146855203|NCT04874415|529641753|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146855204|NCT04874415|529641754|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146855205|NCT04874415|529641755|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146855206|NCT04874415|529641756|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146855207|NCT04874415|529641757|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
146855208|NCT04874415|529641758|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146855209|NCT04874415|529641759|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
146855210|NCT04874415|529641760|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
146855211|NCT04874415|529641761|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146855212|NCT04874415|529641762|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
146521690|NCT01408901|528418061|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
146757786|NCT00689104|529279298|FG002|Overall Study|Randomized but never received study drug|1|||
146757787|NCT00689104|529279299|FG003|Overall Study|Randomized but never received study drug|0|||
146757788|NCT00689104|529279296|FG000|Overall Study|Physician Decision|1|||
146757789|NCT00689104|529279297|FG001|Overall Study|Physician Decision|0|||
146757790|NCT00689104|529279298|FG002|Overall Study|Physician Decision|0|||
146757791|NCT00689104|529279299|FG003|Overall Study|Physician Decision|0|||
146757792|NCT00689104|529279296|FG000|Overall Study|Non-compliance with study procedures|0|||
146757793|NCT00689104|529279297|FG001|Overall Study|Non-compliance with study procedures|0|||
146757794|NCT00689104|529279298|FG002|Overall Study|Non-compliance with study procedures|1|||
146757795|NCT00689104|529279299|FG003|Overall Study|Non-compliance with study procedures|0|||
146757796|NCT04873817|529279300|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
146757797|NCT04873817|529279300|FG000|Overall Study|Lost to Follow-up|4|||
146757798|NCT04873817|529279300|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
146757799|NCT04873817|529279300|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
146757800|NCT04873817|529279300|FG000|Overall Study|Other Reasons|3|||
146757801|NCT00924560|529279304|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
146757802|NCT00924560|529279305|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
146757803|NCT00924560|529279306|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
146757804|NCT00924560|529279304|FG000|Overall Study|Non Compliance with the Protocol|20|||
146757805|NCT00924560|529279305|FG001|Overall Study|Non Compliance with the Protocol|15|||
146757806|NCT00924560|529279306|FG002|Overall Study|Non Compliance with the Protocol|4|||
146757807|NCT00924560|529279304|FG000|Overall Study|Physician Decision|2|||
146757808|NCT00924560|529279305|FG001|Overall Study|Physician Decision|3|||
146757809|NCT00924560|529279306|FG002|Overall Study|Physician Decision|4|||
146757810|NCT00924560|529279304|FG000|Overall Study|Withdrawal by Subject|50|||
146757811|NCT00924560|529279305|FG001|Overall Study|Withdrawal by Subject|44|||
146757812|NCT00924560|529279306|FG002|Overall Study|Withdrawal by Subject|18|||
146757813|NCT00924560|529279304|FG000|Overall Study|Adverse Event|39|||
146757814|NCT00924560|529279305|FG001|Overall Study|Adverse Event|33|||
146757815|NCT00924560|529279306|FG002|Overall Study|Adverse Event|0|||
146757816|NCT00924560|529279304|FG000|Overall Study|Pregnancy|5|||
146757817|NCT00924560|529279305|FG001|Overall Study|Pregnancy|7|||
146757818|NCT00924560|529279306|FG002|Overall Study|Pregnancy|1|||
146757819|NCT00924560|529279304|FG000|Overall Study|Lost to Follow-up|78|||
146757820|NCT00924560|529279305|FG001|Overall Study|Lost to Follow-up|94|||
146757821|NCT00924560|529279306|FG002|Overall Study|Lost to Follow-up|45|||
146757822|NCT00924560|529279304|FG000|Overall Study|Miscellaneous Reasons|13|||
146757823|NCT00924560|529279305|FG001|Overall Study|Miscellaneous Reasons|10|||
146757824|NCT00924560|529279306|FG002|Overall Study|Miscellaneous Reasons|10|||
146757825|NCT00665561|529279309|FG000|Overall Study|Death recorded on subject summary pages|75|||
146757826|NCT00665561|529279310|FG001|Overall Study|Death recorded on subject summary pages|75|||
146757827|NCT00665561|529279309|FG000|Overall Study|Does not meet entrance criteria|19|||
146757828|NCT00665561|529279310|FG001|Overall Study|Does not meet entrance criteria|21|||
146757829|NCT00665561|529279309|FG000|Overall Study|Lost to Follow-up|203|||
146757830|NCT00665561|529279310|FG001|Overall Study|Lost to Follow-up|264|||
146757831|NCT00665561|529279309|FG000|Overall Study|Withdrawal by Subject|74|||
146757832|NCT00665561|529279310|FG001|Overall Study|Withdrawal by Subject|65|||
146757833|NCT00665561|529279309|FG000|Overall Study|Other|123|||
146757834|NCT00665561|529279310|FG001|Overall Study|Other|108|||
146757835|NCT00665561|529279309|FG000|Overall Study|Site closed|8|||
146757836|NCT00665561|529279310|FG001|Overall Study|Site closed|0|||
146757837|NCT00665561|529279309|FG000|Overall Study|Withdrawn due to pregnancy|0|||
146757838|NCT00665561|529279310|FG001|Overall Study|Withdrawn due to pregnancy|1|||
146757839|NCT02337361|529279311|FG000|3-month Follow-up|Lost to Follow-up|19|||
146757840|NCT02337361|529279312|FG001|3-month Follow-up|Lost to Follow-up|14|||
146757841|NCT02337361|529279311|FG000|6-month Follow-up|Lost to Follow-up|2|||
146757842|NCT02337361|529279312|FG001|6-month Follow-up|Lost to Follow-up|4|||
146521691|NCT01408901|528418058|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
146521692|NCT01408901|528418059|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
146757843|NCT01641861|529279313|FG000|Overall Study|Lost to Follow-up|21|||
146757844|NCT01641861|529279314|FG001|Overall Study|Lost to Follow-up|16|||
146757845|NCT01641861|529279313|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
146757846|NCT01641861|529279314|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
146757847|NCT01641861|529279313|FG000|Overall Study|Died due to drowning|0|||
146757848|NCT01641861|529279314|FG001|Overall Study|Died due to drowning|1|||
146757849|NCT01101542|529279315|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
146757850|NCT01101542|529279315|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
146757851|NCT01101542|529279315|FG000|Year 4 Surveillance Period|Other|287|||
146757852|NCT01101542|529279315|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
146757853|NCT01101542|529279315|FG000|Year 5 Surveillance Period|Pregnancy|1|||
146757854|NCT01101542|529279315|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
146757855|NCT01101542|529279315|FG000|Year 6 Surveillance Period|Pregnancy|1|||
146757856|NCT01101542|529279315|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
146855213|NCT04874415|529641763|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
146855214|NCT04874415|529641764|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146855215|NCT04874415|529641765|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
146855216|NCT04874415|529641766|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
146855217|NCT04874415|529641751|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
146855218|NCT04874415|529641752|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
146855219|NCT04874415|529641753|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
146855220|NCT04874415|529641754|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
146855221|NCT04874415|529641755|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
146855222|NCT04874415|529641756|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
146855223|NCT04874415|529641757|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
146855224|NCT04874415|529641758|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
146855225|NCT04874415|529641759|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
146855226|NCT04874415|529641760|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
146855227|NCT04874415|529641761|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
146855228|NCT04874415|529641762|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
146855229|NCT04874415|529641763|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
146855230|NCT04874415|529641764|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
146855231|NCT04874415|529641765|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
146855232|NCT04874415|529641766|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
146855233|NCT04874415|529641751|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146855234|NCT04874415|529641752|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146855235|NCT04874415|529641753|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146855236|NCT04874415|529641754|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146855237|NCT04874415|529641755|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
146855238|NCT04874415|529641756|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146855239|NCT04874415|529641757|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146855240|NCT04874415|529641758|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146855241|NCT04874415|529641759|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146855242|NCT04874415|529641760|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146855243|NCT04874415|529641761|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146855244|NCT04874415|529641762|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146855245|NCT04874415|529641763|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146855246|NCT04874415|529641764|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146855247|NCT04874415|529641765|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146855248|NCT04874415|529641766|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146965065|NCT03110107|530033429|FG003|Treatment Period|Death|0|||
146757857|NCT00701311|529279316|FG000|Overall Study|Lack of Efficacy|3|||
146757858|NCT00701311|529279316|FG000|Overall Study|Adverse Event|3|||
146757859|NCT00701311|529279316|FG000|Overall Study|Withdrawal by Subject|2|||
146757860|NCT00814489|529279342|FG000|Overall Study|Other|2|||
146757861|NCT00814489|529279343|FG001|Overall Study|Other|0|||
146757862|NCT00814489|529279344|FG002|Overall Study|Other|1|||
146757863|NCT01515319|529279345|FG000|Overall Study|Withdrawal by Subject|0|||
146757864|NCT01515319|529279346|FG001|Overall Study|Withdrawal by Subject|0|||
146757865|NCT01515319|529279347|FG002|Overall Study|Withdrawal by Subject|0|||
146757866|NCT01515319|529279348|FG003|Overall Study|Withdrawal by Subject|0|||
146757867|NCT01515319|529279349|FG004|Overall Study|Withdrawal by Subject|0|||
146757868|NCT01515319|529279350|FG005|Overall Study|Withdrawal by Subject|0|||
146757869|NCT01515319|529279351|FG006|Overall Study|Withdrawal by Subject|1|||
146757870|NCT01515319|529279352|FG007|Overall Study|Withdrawal by Subject|0|||
146757871|NCT01515319|529279353|FG008|Overall Study|Withdrawal by Subject|0|||
146757872|NCT01515319|529279354|FG009|Overall Study|Withdrawal by Subject|0|||
146757873|NCT01515319|529279345|FG000|Overall Study|Adverse Event|0|||
146757874|NCT01515319|529279346|FG001|Overall Study|Adverse Event|0|||
146757875|NCT01515319|529279347|FG002|Overall Study|Adverse Event|0|||
146757876|NCT01515319|529279348|FG003|Overall Study|Adverse Event|0|||
146757877|NCT01515319|529279349|FG004|Overall Study|Adverse Event|0|||
146757878|NCT01515319|529279350|FG005|Overall Study|Adverse Event|0|||
146757879|NCT01515319|529279351|FG006|Overall Study|Adverse Event|0|||
146757880|NCT01515319|529279352|FG007|Overall Study|Adverse Event|0|||
146757881|NCT01515319|529279353|FG008|Overall Study|Adverse Event|3|||
146757882|NCT01515319|529279354|FG009|Overall Study|Adverse Event|0|||
146757883|NCT01515319|529279345|FG000|Overall Study|Protocol Violation|0|||
146757884|NCT01515319|529279346|FG001|Overall Study|Protocol Violation|0|||
146757885|NCT01515319|529279347|FG002|Overall Study|Protocol Violation|0|||
146757886|NCT01515319|529279348|FG003|Overall Study|Protocol Violation|0|||
146757887|NCT01515319|529279349|FG004|Overall Study|Protocol Violation|0|||
146757888|NCT01515319|529279350|FG005|Overall Study|Protocol Violation|0|||
146757889|NCT01515319|529279351|FG006|Overall Study|Protocol Violation|0|||
146757890|NCT01515319|529279352|FG007|Overall Study|Protocol Violation|0|||
146757891|NCT01515319|529279353|FG008|Overall Study|Protocol Violation|2|||
146757892|NCT01515319|529279354|FG009|Overall Study|Protocol Violation|0|||
146757893|NCT00498186|529281524|FG000|Overall Study|Protocol Violation|10|||
146757894|NCT00498186|529281524|FG000|Overall Study|Lack of Efficacy|31|||
146757895|NCT00498186|529281524|FG000|Overall Study|Adverse Event|89|||
146757896|NCT00498186|529281524|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
146757897|NCT00498186|529281524|FG000|Overall Study|Withdrawal by Subject|18|||
146757898|NCT00498186|529281524|FG000|Overall Study|Lost to Follow-up|3|||
146757899|NCT00498186|529281524|FG000|Overall Study|Other|10|||
146757900|NCT03929302|529281525|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
146757901|NCT03929302|529281526|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
146757902|NCT03929302|529281527|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
146757903|NCT03929302|529281525|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
146757904|NCT03929302|529281526|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
146757905|NCT03929302|529281527|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
146757906|NCT03929302|529281525|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
146757907|NCT03929302|529281526|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
146757908|NCT03929302|529281527|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
146757909|NCT02321540|529281528|FG000|Overall Study|Death|0|||
146757910|NCT02321540|529281529|FG001|Overall Study|Death|1|||
146757911|NCT02321540|529281528|FG000|Overall Study|Progression|3|||
146757912|NCT02321540|529281529|FG001|Overall Study|Progression|9|||
146757913|NCT00372567|529281530|FG000|Phase 3 Study|Adverse Event|5|||
146757914|NCT00372567|529281531|FG001|Phase 3 Study|Adverse Event|1|||
146757915|NCT00372567|529281532|FG002|Phase 3 Study|Adverse Event|1|||
146757916|NCT00372567|529281530|FG000|Phase 3 Study|Death|1|||
146757917|NCT00372567|529281531|FG001|Phase 3 Study|Death|1|||
146757918|NCT00372567|529281532|FG002|Phase 3 Study|Death|0|||
146757919|NCT00372567|529281530|FG000|Phase 3 Study|Protocol Violation|0|||
146757920|NCT00372567|529281531|FG001|Phase 3 Study|Protocol Violation|0|||
146757921|NCT00372567|529281532|FG002|Phase 3 Study|Protocol Violation|1|||
146757922|NCT00372567|529281530|FG000|Phase 3 Study|Objective progression or relapse|10|||
146757923|NCT00372567|529281531|FG001|Phase 3 Study|Objective progression or relapse|13|||
146757924|NCT00372567|529281532|FG002|Phase 3 Study|Objective progression or relapse|4|||
146757925|NCT00372567|529281530|FG000|Phase 3 Study|Global deterioration of health status|0|||
146757926|NCT00372567|529281531|FG001|Phase 3 Study|Global deterioration of health status|1|||
146757927|NCT00372567|529281532|FG002|Phase 3 Study|Global deterioration of health status|0|||
146757928|NCT00372567|529281530|FG000|Phase 3 Study|Other|2|||
146757929|NCT00372567|529281531|FG001|Phase 3 Study|Other|2|||
146757930|NCT00372567|529281532|FG002|Phase 3 Study|Other|1|||
146757931|NCT00372567|529281530|FG000|Phase 3 Study|study terminated by sponsor|13|||
146757932|NCT00372567|529281531|FG001|Phase 3 Study|study terminated by sponsor|8|||
146757933|NCT00372567|529281532|FG002|Phase 3 Study|study terminated by sponsor|5|||
146757934|NCT02347943|529281533|FG000|Overall Study|Study was cancelled|140|||
146757935|NCT02347943|529281534|FG001|Overall Study|Study was cancelled|67|||
146757936|NCT02347943|529281535|FG002|Overall Study|Study was cancelled|45|||
146757937|NCT00691028|529281536|FG000|Open-label Period|Adverse Event|0|||
146757938|NCT00691028|529281537|FG001|Open-label Period|Adverse Event|0|||
146757939|NCT00691028|529281538|FG002|Open-label Period|Adverse Event|0|||
146757940|NCT00691028|529281539|FG003|Open-label Period|Adverse Event|16|||
146757941|NCT00691028|529281536|FG000|Open-label Period|Withdrawal by Subject|0|||
146757942|NCT00691028|529281537|FG001|Open-label Period|Withdrawal by Subject|0|||
146757943|NCT00691028|529281538|FG002|Open-label Period|Withdrawal by Subject|0|||
146757944|NCT00691028|529281539|FG003|Open-label Period|Withdrawal by Subject|3|||
146757945|NCT00691028|529281536|FG000|Open-label Period|not come to a hospital|0|||
146757946|NCT00691028|529281537|FG001|Open-label Period|not come to a hospital|0|||
146757947|NCT00691028|529281538|FG002|Open-label Period|not come to a hospital|0|||
146757948|NCT00691028|529281539|FG003|Open-label Period|not come to a hospital|1|||
146757949|NCT00691028|529281536|FG000|Double-blind Period|Adverse Event|8|||
146757950|NCT00691028|529281537|FG001|Double-blind Period|Adverse Event|9|||
146757951|NCT00691028|529281538|FG002|Double-blind Period|Adverse Event|6|||
146757952|NCT00691028|529281539|FG003|Double-blind Period|Adverse Event|0|||
146757953|NCT00691028|529281536|FG000|Double-blind Period|Lack of Efficacy|4|||
146757954|NCT00691028|529281537|FG001|Double-blind Period|Lack of Efficacy|3|||
146757955|NCT00691028|529281538|FG002|Double-blind Period|Lack of Efficacy|2|||
146757956|NCT00691028|529281539|FG003|Double-blind Period|Lack of Efficacy|0|||
146757957|NCT00691028|529281536|FG000|Double-blind Period|Withdrawal by Subject|1|||
146757958|NCT00691028|529281537|FG001|Double-blind Period|Withdrawal by Subject|0|||
146757959|NCT00691028|529281538|FG002|Double-blind Period|Withdrawal by Subject|1|||
146757960|NCT00691028|529281539|FG003|Double-blind Period|Withdrawal by Subject|0|||
146757961|NCT00691028|529281536|FG000|Double-blind Period|not come to a hospital.|0|||
146757962|NCT00691028|529281537|FG001|Double-blind Period|not come to a hospital.|1|||
146757963|NCT00691028|529281538|FG002|Double-blind Period|not come to a hospital.|0|||
146757964|NCT00691028|529281539|FG003|Double-blind Period|not come to a hospital.|0|||
146855249|NCT05062759|529641767|FG000|Overall Study|Death|0|||
146855250|NCT05062759|529641768|FG001|Overall Study|Death|1|||
146855251|NCT05062759|529641767|FG000|Overall Study|Lost to Follow-up|1|||
146855252|NCT05062759|529641768|FG001|Overall Study|Lost to Follow-up|0|||
146855253|NCT00903006|529641769|FG000|Overall Study|Withdrawal by Subject|2|||
146855254|NCT00903006|529641770|FG001|Overall Study|Withdrawal by Subject|0|||
146855255|NCT00903006|529641771|FG002|Overall Study|Withdrawal by Subject|0|||
146855256|NCT00903006|529641772|FG003|Overall Study|Withdrawal by Subject|0|||
146855257|NCT00903006|529641769|FG000|Overall Study|Progressive Disease|0|||
146855258|NCT00903006|529641770|FG001|Overall Study|Progressive Disease|3|||
146855259|NCT00903006|529641771|FG002|Overall Study|Progressive Disease|1|||
146855260|NCT00903006|529641772|FG003|Overall Study|Progressive Disease|0|||
146855261|NCT03405792|529641773|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
146855262|NCT03405792|529641774|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
146855263|NCT03405792|529641773|FG000|Overall Study|o Did not receive pembrolizumab|1|||
146855264|NCT03405792|529641774|FG001|Overall Study|o Did not receive pembrolizumab|0|||
146855265|NCT02572882|529641775|FG000|Overall Study|Withdrawal by Subject|1|||
146855266|NCT02572882|529641775|FG000|Overall Study|Participant received kidney transplant|1|||
146855267|NCT03486457|529641776|FG000|Up to Month 3|Adverse Event|2|||
146855268|NCT03486457|529641777|FG001|Up to Month 3|Adverse Event|5|||
146855269|NCT03486457|529641776|FG000|Up to Month 3|Lack of Efficacy|1|||
146855270|NCT03486457|529641777|FG001|Up to Month 3|Lack of Efficacy|0|||
146855271|NCT03486457|529641776|FG000|Up to Month 3|Withdrawal by Subject|1|||
146855272|NCT03486457|529641777|FG001|Up to Month 3|Withdrawal by Subject|0|||
146855273|NCT03486457|529641776|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
146855274|NCT03486457|529641777|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
146855275|NCT03486457|529641776|FG000|Up to Month 3|Other|1|||
146855276|NCT03486457|529641777|FG001|Up to Month 3|Other|0|||
146855277|NCT03486457|529641776|FG000|Month 3 to Month 6|Adverse Event|2|||
146855278|NCT03486457|529641777|FG001|Month 3 to Month 6|Adverse Event|0|||
146855279|NCT03486457|529641776|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
146855280|NCT03486457|529641777|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
146855281|NCT03486457|529641776|FG000|Month 3 to Month 6|Pregnancy|0|||
146855282|NCT03486457|529641777|FG001|Month 3 to Month 6|Pregnancy|1|||
146855283|NCT03486457|529641776|FG000|Month 3 to Month 6|Other|1|||
146855284|NCT03486457|529641777|FG001|Month 3 to Month 6|Other|0|||
146855285|NCT00372229|529641778|FG000|Study Phase|Graft loss|0|||
146855286|NCT00372229|529641779|FG001|Study Phase|Graft loss|3|||
146855287|NCT00372229|529641778|FG000|Study Phase|Protocol Violation|3|||
146855288|NCT00372229|529641779|FG001|Study Phase|Protocol Violation|4|||
146855289|NCT00372229|529641778|FG000|Study Phase|Consent withdrawn|16|||
146855290|NCT00372229|529641779|FG001|Study Phase|Consent withdrawn|14|||
146855291|NCT00372229|529641778|FG000|Study Phase|Refused treatment/did not cooperate|3|||
146855292|NCT00372229|529641779|FG001|Study Phase|Refused treatment/did not cooperate|1|||
146855293|NCT00372229|529641778|FG000|Study Phase|Death|3|||
146855294|NCT00372229|529641779|FG001|Study Phase|Death|2|||
146855295|NCT00372229|529641778|FG000|Study Phase|Reason not specified|3|||
146855296|NCT00372229|529641779|FG001|Study Phase|Reason not specified|2|||
146855297|NCT00372229|529641778|FG000|Study Phase|Lost to Follow-up|3|||
146855298|NCT00372229|529641779|FG001|Study Phase|Lost to Follow-up|3|||
146855299|NCT00372229|529641778|FG000|Follow-Up Phase|Graft loss|8|||
146855300|NCT00372229|529641779|FG001|Follow-Up Phase|Graft loss|7|||
146855301|NCT00372229|529641778|FG000|Follow-Up Phase|Consent withdrawn|13|||
146855302|NCT00372229|529641779|FG001|Follow-Up Phase|Consent withdrawn|19|||
146855303|NCT00372229|529641778|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
146855304|NCT00372229|529641779|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
146855305|NCT00372229|529641778|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
146855306|NCT00372229|529641779|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
146855307|NCT00372229|529641778|FG000|Follow-Up Phase|Death|9|||
146855308|NCT00372229|529641779|FG001|Follow-Up Phase|Death|12|||
146855309|NCT00372229|529641778|FG000|Follow-Up Phase|Administrative|1|||
146855310|NCT00372229|529641779|FG001|Follow-Up Phase|Administrative|0|||
146855311|NCT00372229|529641778|FG000|Follow-Up Phase|Reason not specified|2|||
146855312|NCT00372229|529641779|FG001|Follow-Up Phase|Reason not specified|3|||
146855313|NCT00372229|529641778|FG000|Follow-Up Phase|Lost to Follow-up|12|||
146855314|NCT00372229|529641779|FG001|Follow-Up Phase|Lost to Follow-up|10|||
146965066|NCT03110107|530033430|FG004|Treatment Period|Death|0|||
146855315|NCT00946101|529641780|FG000|Overall Study|Lost to Follow-up|2|||
146855316|NCT00946101|529641781|FG001|Overall Study|Lost to Follow-up|1|||
146855317|NCT00946101|529641780|FG000|Overall Study|Withdrawal of consent|2|||
146855318|NCT00946101|529641781|FG001|Overall Study|Withdrawal of consent|0|||
146855319|NCT00946101|529641780|FG000|Overall Study|Physician Decision|0|||
146855320|NCT00946101|529641781|FG001|Overall Study|Physician Decision|1|||
146855321|NCT01347762|529641782|FG000|Overall Study|Lost to Follow-up|0|||
146855322|NCT01347762|529641783|FG001|Overall Study|Lost to Follow-up|1|||
146855323|NCT01347762|529641784|FG002|Overall Study|Lost to Follow-up|6|||
146855324|NCT01347762|529641785|FG003|Overall Study|Lost to Follow-up|5|||
146855325|NCT01347762|529641782|FG000|Overall Study|Withdrawal by Subject|4|||
146855326|NCT01347762|529641783|FG001|Overall Study|Withdrawal by Subject|1|||
146855327|NCT01347762|529641784|FG002|Overall Study|Withdrawal by Subject|3|||
146855328|NCT01347762|529641785|FG003|Overall Study|Withdrawal by Subject|3|||
146855329|NCT00093808|529641786|FG000|Overall Study|Cancel participation before receiving tx|1|||
146855330|NCT00093808|529641786|FG000|Overall Study|Protocol Violation|1|||
146855331|NCT00701220|529641787|FG000|Overall Study|Withdrawal by Subject|0|||
146855332|NCT00701220|529641788|FG001|Overall Study|Withdrawal by Subject|2|||
146855333|NCT00701220|529641787|FG000|Overall Study|Protocol Violation|2|||
146855334|NCT00701220|529641788|FG001|Overall Study|Protocol Violation|0|||
146855335|NCT03235284|529641789|FG000|Overall Study|Adverse Event|1|||
146855336|NCT03235284|529641790|FG001|Overall Study|Adverse Event|2|||
146855337|NCT03235284|529641791|FG002|Overall Study|Adverse Event|1|||
146855338|NCT00310037|529641792|FG000|Overall Study|Adverse Event|7|||
146855339|NCT00310037|529641793|FG001|Overall Study|Adverse Event|14|||
146855340|NCT00310037|529641792|FG000|Overall Study|Withdrawal by Subject|4|||
146855341|NCT00310037|529641793|FG001|Overall Study|Withdrawal by Subject|3|||
146855342|NCT00310037|529641792|FG000|Overall Study|Progression|6|||
146855343|NCT00310037|529641793|FG001|Overall Study|Progression|0|||
146855344|NCT00310037|529641792|FG000|Overall Study|Non-protocol treatment|1|||
146855345|NCT00310037|529641793|FG001|Overall Study|Non-protocol treatment|0|||
146855346|NCT01382706|529641798|FG000|Overall Study|Adverse Event|1|||
146855347|NCT01382706|529641798|FG000|Overall Study|Withdrawal by Subject|1|||
146855348|NCT05559099|529641799|FG000|Overall Study|Death|5|||
146855349|NCT05559099|529641800|FG001|Overall Study|Death|4|||
146855350|NCT05559099|529641799|FG000|Overall Study|Lost to Follow-up|0|||
146855351|NCT05559099|529641800|FG001|Overall Study|Lost to Follow-up|2|||
146855352|NCT05559099|529641799|FG000|Overall Study|Adverse Event|1|||
146855353|NCT05559099|529641800|FG001|Overall Study|Adverse Event|1|||
146855354|NCT04018092|529641801|FG000|Overall Study|Withdrawal by Subject|1|||
146855355|NCT04018092|529641802|FG001|Overall Study|Withdrawal by Subject|1|||
146855356|NCT04018092|529641801|FG000|Overall Study|Withdrawal by Subject|1|||
146855357|NCT04018092|529641802|FG001|Overall Study|Withdrawal by Subject|1|||
146855358|NCT04055090|529641805|FG000|Overall Study|screen failure|1|||
146855359|NCT04055090|529641806|FG001|Overall Study|screen failure|0|||
146855360|NCT04055090|529641805|FG000|Overall Study|Withdrawal by Subject|1|||
146855361|NCT04055090|529641806|FG001|Overall Study|Withdrawal by Subject|0|||
146855362|NCT04745026|529641807|FG000|Overall Study|Physician Decision|1|||
146855363|NCT04745026|529641808|FG001|Overall Study|Physician Decision|0|||
146855364|NCT04745026|529641807|FG000|Overall Study|Adverse Event|2|||
146521693|NCT01408901|528418060|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
146521694|NCT01408901|528418061|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
146521695|NCT01408901|528418058|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
146521696|NCT01408901|528418059|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
146521697|NCT01408901|528418060|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
146521698|NCT01408901|528418061|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
146521699|NCT01408901|528418058|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
146521700|NCT01408901|528418059|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
146521701|NCT01408901|528418060|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
146521702|NCT01408901|528418061|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
146521703|NCT01408901|528418058|FG000|26-Week Follow-Up|Death|0|||
146521704|NCT01408901|528418059|FG001|26-Week Follow-Up|Death|1|||
146521705|NCT01408901|528418060|FG002|26-Week Follow-Up|Death|0|||
146521706|NCT01408901|528418061|FG003|26-Week Follow-Up|Death|0|||
146521707|NCT02497404|528418062|FG000|Overall Study|Adverse Event|1|||
146521708|NCT01436227|528418066|FG000|Overall Study|Adverse Event|7|||
146521709|NCT01436227|528418066|FG000|Overall Study|Death|1|||
146521710|NCT01436227|528418066|FG000|Overall Study|Lack of Efficacy|1|||
146521711|NCT01436227|528418066|FG000|Overall Study|Lost to Follow-up|3|||
146521712|NCT01436227|528418066|FG000|Overall Study|Physician Decision|1|||
146521713|NCT01436227|528418066|FG000|Overall Study|Withdrawal by Subject|7|||
146521714|NCT01436227|528418066|FG000|Overall Study|Disease progression, relapse|6|||
146521715|NCT04865419|528418071|FG000|Overall Study|Other|1|||
146521716|NCT04865419|528418072|FG001|Overall Study|Other|2|||
146855365|NCT04745026|529641808|FG001|Overall Study|Adverse Event|2|||
146855366|NCT04745026|529641807|FG000|Overall Study|Protocol Violation|1|||
146855367|NCT04745026|529641808|FG001|Overall Study|Protocol Violation|3|||
146855368|NCT04745026|529641807|FG000|Overall Study|Lost to Follow-up|4|||
146855369|NCT04745026|529641808|FG001|Overall Study|Lost to Follow-up|3|||
146521717|NCT04865419|528418073|FG002|Overall Study|Other|2|||
146521718|NCT04865419|528418074|FG003|Overall Study|Other|1|||
146521719|NCT04865419|528418075|FG004|Overall Study|Other|3|||
146521720|NCT04865419|528418076|FG005|Overall Study|Other|0|||
146855370|NCT04745026|529641807|FG000|Overall Study|Withdrawal by Subject|5|||
146855371|NCT04745026|529641808|FG001|Overall Study|Withdrawal by Subject|5|||
146855372|NCT05478499|529641809|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
146855373|NCT05478499|529641810|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
146855374|NCT05478499|529641809|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
146855375|NCT05478499|529641810|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
146855376|NCT05478499|529641809|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
146855377|NCT05478499|529641810|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
146855378|NCT05478499|529641809|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
146855379|NCT05478499|529641810|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
146855380|NCT05478499|529641809|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
146855381|NCT05478499|529641810|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
146855382|NCT05478499|529641809|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
146855383|NCT05478499|529641810|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
146855384|NCT05478499|529641809|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
146855385|NCT05478499|529641810|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
146855386|NCT05478499|529641809|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
146855387|NCT05478499|529641810|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
146855388|NCT05478499|529641809|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
146855389|NCT05478499|529641810|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
146855390|NCT05478499|529641809|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
146855391|NCT05478499|529641810|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
146855392|NCT05478499|529641809|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
146855393|NCT05478499|529641810|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
146855394|NCT04426851|529641811|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
146855395|NCT04426851|529641812|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
146855396|NCT04426851|529641811|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
146855397|NCT04426851|529641812|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
146855398|NCT03256851|529641816|FG000|Overall Study|Withdrawal by Subject|1|||
146855399|NCT03256851|529641817|FG001|Overall Study|Withdrawal by Subject|0|||
146855400|NCT02476279|529641819|FG000|Overall Study|Lost to Follow-up|1|||
146855401|NCT02476279|529641820|FG001|Overall Study|Lost to Follow-up|1|||
146855402|NCT00319839|529641821|FG000|Overall Study|Adverse Event|5|||
146855403|NCT00319839|529641821|FG000|Overall Study|Withdrawal by Subject|1|||
146855404|NCT02128542|529641822|FG000|Overall Study|Lost to Follow-up|3|||
146855405|NCT02128542|529641823|FG001|Overall Study|Lost to Follow-up|0|||
146855406|NCT02128542|529641822|FG000|Overall Study|Withdrew Consent|1|||
146855407|NCT02128542|529641823|FG001|Overall Study|Withdrew Consent|0|||
146855408|NCT01778023|529641824|FG000|Overall Study|Withdrawal by Subject|0|||
146855409|NCT01778023|529641825|FG001|Overall Study|Withdrawal by Subject|3|||
146855410|NCT00903630|529641826|FG000|Phase 2|Adverse Event|0|||
146855411|NCT00903630|529641827|FG001|Phase 2|Adverse Event|0|||
146855412|NCT00903630|529641828|FG002|Phase 2|Adverse Event|1|||
146855413|NCT00138671|529641831|FG000|Overall Study|Death|0|||
146855414|NCT00138671|529641832|FG001|Overall Study|Death|3|||
146855415|NCT00138671|529641831|FG000|Overall Study|Adverse Event|6|||
146855416|NCT00138671|529641832|FG001|Overall Study|Adverse Event|3|||
146855417|NCT00138671|529641831|FG000|Overall Study|Lost to Follow-up|1|||
146855418|NCT00138671|529641832|FG001|Overall Study|Lost to Follow-up|2|||
146855419|NCT00138671|529641831|FG000|Overall Study|Withdrawal by Subject|3|||
146855420|NCT00138671|529641832|FG001|Overall Study|Withdrawal by Subject|5|||
146855421|NCT00138671|529641831|FG000|Overall Study|Other|3|||
146855422|NCT00138671|529641832|FG001|Overall Study|Other|3|||
146855423|NCT00402597|529641833|FG000|Overall Study|Death|15|||
146855424|NCT00402597|529641834|FG001|Overall Study|Death|7|||
146855425|NCT00402597|529641835|FG002|Overall Study|Death|6|||
146855426|NCT00402597|529641836|FG003|Overall Study|Death|4|||
146855427|NCT00402597|529641837|FG004|Overall Study|Death|6|||
146855428|NCT00402597|529641833|FG000|Overall Study|Adverse Event|81|||
146855429|NCT00402597|529641834|FG001|Overall Study|Adverse Event|18|||
146855430|NCT00402597|529641835|FG002|Overall Study|Adverse Event|106|||
146855431|NCT00402597|529641836|FG003|Overall Study|Adverse Event|39|||
146855432|NCT00402597|529641837|FG004|Overall Study|Adverse Event|71|||
146855433|NCT00402597|529641833|FG000|Overall Study|Lost to Follow-up|8|||
146855434|NCT00402597|529641834|FG001|Overall Study|Lost to Follow-up|1|||
146855435|NCT00402597|529641835|FG002|Overall Study|Lost to Follow-up|8|||
146855436|NCT00402597|529641836|FG003|Overall Study|Lost to Follow-up|2|||
146855437|NCT00402597|529641837|FG004|Overall Study|Lost to Follow-up|3|||
146855438|NCT00402597|529641833|FG000|Overall Study|Withdrawal by Subject|57|||
146855439|NCT00402597|529641834|FG001|Overall Study|Withdrawal by Subject|16|||
146855440|NCT00402597|529641835|FG002|Overall Study|Withdrawal by Subject|65|||
146855441|NCT00402597|529641836|FG003|Overall Study|Withdrawal by Subject|15|||
146855442|NCT00402597|529641837|FG004|Overall Study|Withdrawal by Subject|24|||
146855443|NCT00402597|529641833|FG000|Overall Study|reason not specified|30|||
146855444|NCT00402597|529641834|FG001|Overall Study|reason not specified|4|||
146855445|NCT00402597|529641835|FG002|Overall Study|reason not specified|27|||
146855446|NCT00402597|529641836|FG003|Overall Study|reason not specified|14|||
146855447|NCT00402597|529641837|FG004|Overall Study|reason not specified|20|||
146855448|NCT02581631|529641848|FG000|Overall Study|Disease progression|29|||
146855449|NCT02581631|529641849|FG001|Overall Study|Disease progression|19|||
146855450|NCT02581631|529641850|FG002|Overall Study|Disease progression|13|||
146855451|NCT02581631|529641851|FG003|Overall Study|Disease progression|5|||
146855452|NCT02581631|529641852|FG004|Overall Study|Disease progression|8|||
146855453|NCT02581631|529641848|FG000|Overall Study|Study drug toxicity|4|||
146855454|NCT02581631|529641849|FG001|Overall Study|Study drug toxicity|6|||
146855455|NCT02581631|529641850|FG002|Overall Study|Study drug toxicity|7|||
146855456|NCT02581631|529641851|FG003|Overall Study|Study drug toxicity|0|||
146855457|NCT02581631|529641852|FG004|Overall Study|Study drug toxicity|3|||
146855458|NCT02581631|529641848|FG000|Overall Study|AE unrelated to study drug|3|||
146855459|NCT02581631|529641849|FG001|Overall Study|AE unrelated to study drug|1|||
146855460|NCT02581631|529641850|FG002|Overall Study|AE unrelated to study drug|1|||
146855461|NCT02581631|529641851|FG003|Overall Study|AE unrelated to study drug|0|||
146855462|NCT02581631|529641852|FG004|Overall Study|AE unrelated to study drug|2|||
146855463|NCT02581631|529641848|FG000|Overall Study|Request to discontinue|1|||
146855464|NCT02581631|529641849|FG001|Overall Study|Request to discontinue|0|||
146855465|NCT02581631|529641850|FG002|Overall Study|Request to discontinue|3|||
146855466|NCT02581631|529641851|FG003|Overall Study|Request to discontinue|0|||
146855467|NCT02581631|529641852|FG004|Overall Study|Request to discontinue|1|||
146855468|NCT02581631|529641848|FG000|Overall Study|participant withdrew consent|3|||
146855469|NCT02581631|529641849|FG001|Overall Study|participant withdrew consent|0|||
146855470|NCT02581631|529641850|FG002|Overall Study|participant withdrew consent|1|||
146855471|NCT02581631|529641851|FG003|Overall Study|participant withdrew consent|0|||
146855472|NCT02581631|529641852|FG004|Overall Study|participant withdrew consent|0|||
146855473|NCT02581631|529641848|FG000|Overall Study|Maximum clinical benefit|1|||
146855474|NCT02581631|529641849|FG001|Overall Study|Maximum clinical benefit|7|||
146855475|NCT02581631|529641850|FG002|Overall Study|Maximum clinical benefit|1|||
146855476|NCT02581631|529641851|FG003|Overall Study|Maximum clinical benefit|3|||
146855477|NCT02581631|529641852|FG004|Overall Study|Maximum clinical benefit|13|||
146855478|NCT02581631|529641848|FG000|Overall Study|Other Reasons|1|||
146855479|NCT02581631|529641849|FG001|Overall Study|Other Reasons|0|||
146855480|NCT02581631|529641850|FG002|Overall Study|Other Reasons|2|||
146855481|NCT02581631|529641851|FG003|Overall Study|Other Reasons|2|||
146855482|NCT02581631|529641852|FG004|Overall Study|Other Reasons|3|||
146855483|NCT02581631|529641848|FG000|Overall Study|Poor/Non-Compliance|0|||
146855484|NCT02581631|529641849|FG001|Overall Study|Poor/Non-Compliance|0|||
146855485|NCT02581631|529641850|FG002|Overall Study|Poor/Non-Compliance|1|||
146855486|NCT02581631|529641851|FG003|Overall Study|Poor/Non-Compliance|0|||
146855487|NCT02581631|529641852|FG004|Overall Study|Poor/Non-Compliance|0|||
146855488|NCT00986973|529641853|FG000|Overall Study|Withdrawn by study team|1|||
146855489|NCT00598273|529641854|FG000|Overall Study|Adverse Event|4|||
146855490|NCT00598273|529641855|FG001|Overall Study|Adverse Event|5|||
146855491|NCT00598273|529641856|FG002|Overall Study|Adverse Event|2|||
146855492|NCT00598273|529641854|FG000|Overall Study|Death|6|||
146855493|NCT00598273|529641855|FG001|Overall Study|Death|12|||
146855494|NCT00598273|529641856|FG002|Overall Study|Death|8|||
146855495|NCT00598273|529641854|FG000|Overall Study|Lost to Follow-up|8|||
146855496|NCT00598273|529641855|FG001|Overall Study|Lost to Follow-up|3|||
146855497|NCT00598273|529641856|FG002|Overall Study|Lost to Follow-up|5|||
146855498|NCT00598273|529641854|FG000|Overall Study|Physician Decision|0|||
146855499|NCT00598273|529641855|FG001|Overall Study|Physician Decision|0|||
146855500|NCT00598273|529641856|FG002|Overall Study|Physician Decision|1|||
146855501|NCT00598273|529641854|FG000|Overall Study|Withdrawal by Subject|12|||
146855502|NCT00598273|529641855|FG001|Overall Study|Withdrawal by Subject|10|||
146855503|NCT00598273|529641856|FG002|Overall Study|Withdrawal by Subject|10|||
146855504|NCT00598273|529641854|FG000|Overall Study|Noncompliance|3|||
146855505|NCT00598273|529641855|FG001|Overall Study|Noncompliance|2|||
146855506|NCT00598273|529641856|FG002|Overall Study|Noncompliance|3|||
146855507|NCT00598273|529641854|FG000|Overall Study|Relocation|0|||
146855508|NCT00598273|529641855|FG001|Overall Study|Relocation|2|||
146855509|NCT00598273|529641856|FG002|Overall Study|Relocation|4|||
146855510|NCT00598273|529641854|FG000|Overall Study|Renal transplant|1|||
146855511|NCT00598273|529641855|FG001|Overall Study|Renal transplant|0|||
146855512|NCT00598273|529641856|FG002|Overall Study|Renal transplant|1|||
146855513|NCT00598273|529641854|FG000|Overall Study|Site elected to close|1|||
146855514|NCT00598273|529641855|FG001|Overall Study|Site elected to close|0|||
146855515|NCT00598273|529641856|FG002|Overall Study|Site elected to close|0|||
146855516|NCT00598273|529641854|FG000|Overall Study|Started dialysis|6|||
146855517|NCT00598273|529641855|FG001|Overall Study|Started dialysis|4|||
146855518|NCT00598273|529641856|FG002|Overall Study|Started dialysis|5|||
146855519|NCT03426605|529641857|FG000|Overall Study|AML relapse or progression|2|||
146855520|NCT03426605|529641858|FG001|Overall Study|AML relapse or progression|1|||
146855521|NCT03426605|529641859|FG002|Overall Study|AML relapse or progression|2|||
146855522|NCT03426605|529641860|FG003|Overall Study|AML relapse or progression|2|||
146855523|NCT03426605|529641857|FG000|Overall Study|Treatment failure|3|||
146855524|NCT03426605|529641858|FG001|Overall Study|Treatment failure|2|||
146855525|NCT03426605|529641859|FG002|Overall Study|Treatment failure|0|||
146855526|NCT03426605|529641860|FG003|Overall Study|Treatment failure|0|||
146855527|NCT03426605|529641857|FG000|Overall Study|Adverse Event|1|||
146855528|NCT03426605|529641858|FG001|Overall Study|Adverse Event|0|||
146965067|NCT03110107|530033431|FG005|Treatment Period|Death|0|||
146855529|NCT03426605|529641859|FG002|Overall Study|Adverse Event|1|||
146855530|NCT03426605|529641860|FG003|Overall Study|Adverse Event|1|||
146855531|NCT03426605|529641857|FG000|Overall Study|Withdrawal by Subject|0|||
146855532|NCT03426605|529641858|FG001|Overall Study|Withdrawal by Subject|0|||
146855533|NCT03426605|529641859|FG002|Overall Study|Withdrawal by Subject|1|||
146855534|NCT03426605|529641860|FG003|Overall Study|Withdrawal by Subject|1|||
146855535|NCT01815138|529641863|FG000|Overall Study|Withdrawal by Subject|0|||
146855536|NCT01815138|529641864|FG001|Overall Study|Withdrawal by Subject|1|||
146855537|NCT01815138|529641863|FG000|Overall Study|Physician Decision|8|||
146855538|NCT01815138|529641864|FG001|Overall Study|Physician Decision|5|||
146855539|NCT01211288|529641867|FG000|Overall Study|Lost to Follow-up|1|||
146855540|NCT01211288|529641868|FG001|Overall Study|Lost to Follow-up|1|||
146855541|NCT01588496|529641869|FG000|Overall Study|Withdrawal by Subject|0|||
146855542|NCT01588496|529641870|FG001|Overall Study|Withdrawal by Subject|1|||
146855543|NCT01588496|529641871|FG002|Overall Study|Withdrawal by Subject|0|||
146855544|NCT01551212|529641872|FG000|Overall Study|Graft loss/Retransplantation|0|||
146855545|NCT01551212|529641873|FG001|Overall Study|Graft loss/Retransplantation|1|||
146855546|NCT01551212|529641872|FG000|Overall Study|Administrative problems|1|||
146855547|NCT01551212|529641873|FG001|Overall Study|Administrative problems|2|||
146855548|NCT01551212|529641872|FG000|Overall Study|Lost to Follow-up|0|||
146855549|NCT01551212|529641873|FG001|Overall Study|Lost to Follow-up|1|||
146855550|NCT01551212|529641872|FG000|Overall Study|Protocol Violation|0|||
146855551|NCT01551212|529641873|FG001|Overall Study|Protocol Violation|1|||
146855552|NCT01551212|529641872|FG000|Overall Study|Withdrawal by Subject|0|||
146855553|NCT01551212|529641873|FG001|Overall Study|Withdrawal by Subject|7|||
146855554|NCT01551212|529641872|FG000|Overall Study|Death|2|||
146855555|NCT01551212|529641873|FG001|Overall Study|Death|4|||
146855556|NCT01551212|529641872|FG000|Overall Study|Never Received Study Treatment|2|||
146855557|NCT01551212|529641873|FG001|Overall Study|Never Received Study Treatment|4|||
146855558|NCT05924945|529641874|FG000|Overall Study|Withdrawal by Subject|3|||
146855559|NCT05924945|529641875|FG001|Overall Study|Withdrawal by Subject|4|||
146855560|NCT02471833|529641876|FG000|Overall Study|Lost to Follow-up|1|||
146855561|NCT02471833|529641877|FG001|Overall Study|Lost to Follow-up|0|||
146855562|NCT02471833|529641878|FG002|Overall Study|Lost to Follow-up|0|||
146855563|NCT02471833|529641876|FG000|Overall Study|Withdrawal by Subject|2|||
146855564|NCT02471833|529641877|FG001|Overall Study|Withdrawal by Subject|1|||
146855565|NCT02471833|529641878|FG002|Overall Study|Withdrawal by Subject|5|||
146855566|NCT04217590|529641879|FG000|Overall Study|Other|1|||
146855567|NCT04217590|529641880|FG001|Overall Study|Other|1|||
146855568|NCT04217590|529641879|FG000|Overall Study|Withdrawal by Subject|3|||
146855569|NCT04217590|529641880|FG001|Overall Study|Withdrawal by Subject|1|||
146855570|NCT04217590|529641879|FG000|Overall Study|Death|0|||
146855571|NCT04217590|529641880|FG001|Overall Study|Death|1|||
146855572|NCT02232243|529641883|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
146855573|NCT02232243|529641884|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
146855574|NCT02232243|529641885|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
146855575|NCT05026710|529641886|FG000|Overall Study|No longer met eligibility criteria|3|||
146855576|NCT05026710|529641887|FG001|Overall Study|No longer met eligibility criteria|1|||
146855577|NCT00490724|529641888|FG000|Period I|Physician Decision|0|||
146855578|NCT00490724|529641889|FG001|Period I|Physician Decision|0|||
146855579|NCT00490724|529641890|FG002|Period I|Physician Decision|1|||
146855580|NCT00490724|529641888|FG000|Period II|Treatment Discontinuation|3|||
146855581|NCT00490724|529641889|FG001|Period II|Treatment Discontinuation|1|||
146855582|NCT00490724|529641890|FG002|Period II|Treatment Discontinuation|3|||
146855583|NCT03218397|529641891|FG000|Overall Study|Prior positive blood culture|8|||
146855584|NCT03218397|529641892|FG001|Overall Study|Prior positive blood culture|13|||
146855585|NCT03218397|529641891|FG000|Overall Study|Comfort care|8|||
146855586|NCT03218397|529641892|FG001|Overall Study|Comfort care|5|||
146855587|NCT03218397|529641891|FG000|Overall Study|Comfort care and positive blood culture|1|||
146855588|NCT03218397|529641892|FG001|Overall Study|Comfort care and positive blood culture|0|||
146855589|NCT03218397|529641891|FG000|Overall Study|Comfort care and mixed culture|0|||
146855590|NCT03218397|529641892|FG001|Overall Study|Comfort care and mixed culture|1|||
146855591|NCT03218397|529641891|FG000|Overall Study|Mixed culture|2|||
146855592|NCT03218397|529641892|FG001|Overall Study|Mixed culture|2|||
146855593|NCT03218397|529641891|FG000|Overall Study|Inaccessible hospital records|2|||
146855594|NCT03218397|529641892|FG001|Overall Study|Inaccessible hospital records|5|||
146855595|NCT03218397|529641891|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
146855596|NCT03218397|529641892|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
146855597|NCT03218397|529641891|FG000|Overall Study|Randomized during laboratory off hours|2|||
146855598|NCT03218397|529641892|FG001|Overall Study|Randomized during laboratory off hours|1|||
146855599|NCT01796548|529641893|FG000|Overall Study|Lost to Follow-up|1|||
146855600|NCT01796548|529641893|FG000|Overall Study|Other|2|||
146855601|NCT00126503|529641894|FG000|Overall Study|disease progression|23|||
146855602|NCT00126503|529641895|FG001|Overall Study|disease progression|14|||
146855603|NCT00126503|529641894|FG000|Overall Study|Withdrawal by Subject|0|||
146855604|NCT00126503|529641895|FG001|Overall Study|Withdrawal by Subject|1|||
146521721|NCT04865419|528418077|FG006|Overall Study|Other|0|||
146521722|NCT04865419|528418078|FG007|Overall Study|Other|1|||
146521723|NCT04865419|528418079|FG008|Overall Study|Other|0|||
146757965|NCT02680756|529281556|FG000|Overall Study|Adverse Event|10|||
146757966|NCT02680756|529281557|FG001|Overall Study|Adverse Event|2|||
146757967|NCT02680756|529281556|FG000|Overall Study|Lost to Follow-up|7|||
146757968|NCT02680756|529281557|FG001|Overall Study|Lost to Follow-up|6|||
146757969|NCT02680756|529281556|FG000|Overall Study|Withdrawal by Subject|5|||
146757970|NCT02680756|529281557|FG001|Overall Study|Withdrawal by Subject|5|||
146757971|NCT02680756|529281556|FG000|Overall Study|Physician Decision|4|||
146757972|NCT02680756|529281557|FG001|Overall Study|Physician Decision|1|||
146757973|NCT02680756|529281556|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
146757974|NCT02680756|529281557|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
146757975|NCT02680756|529281556|FG000|Overall Study|Blood transfusion for any reason|0|||
146757976|NCT02680756|529281557|FG001|Overall Study|Blood transfusion for any reason|1|||
146757977|NCT02680756|529281556|FG000|Overall Study|Death|1|||
146757978|NCT02680756|529281557|FG001|Overall Study|Death|0|||
146757979|NCT02680756|529281556|FG000|Overall Study|Protocol Violation|1|||
146757980|NCT02680756|529281557|FG001|Overall Study|Protocol Violation|0|||
146757981|NCT02680756|529281556|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
146757982|NCT02680756|529281557|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
146757983|NCT02680756|529281556|FG000|Overall Study|None of above or not recorded|3|||
146757984|NCT02680756|529281557|FG001|Overall Study|None of above or not recorded|2|||
146757985|NCT00480441|529281558|FG000|Screening|Not Eligible|37|||
146757986|NCT00480441|529281559|FG001|Screening|Not Eligible|0|||
146757987|NCT00480441|529281560|FG002|Screening|Not Eligible|0|||
146757988|NCT00480441|529281558|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
146757989|NCT00480441|529281559|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
146757990|NCT00480441|529281560|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
146757991|NCT00480441|529281558|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
146757992|NCT00480441|529281559|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
146757993|NCT00480441|529281560|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
146757994|NCT00480441|529281558|FG000|Baseline Functional MRI|physical contraindication|4|||
146757995|NCT00480441|529281559|FG001|Baseline Functional MRI|physical contraindication|0|||
146757996|NCT00480441|529281560|FG002|Baseline Functional MRI|physical contraindication|0|||
146757997|NCT00480441|529281558|FG000|Randomization|Lost to Follow-up|0|||
146757998|NCT00480441|529281559|FG001|Randomization|Lost to Follow-up|7|||
146757999|NCT00480441|529281560|FG002|Randomization|Lost to Follow-up|2|||
146758000|NCT03681691|529281561|FG000|Overall Study|COVID|1|||
146758001|NCT03681691|529281562|FG001|Overall Study|COVID|0|||
146758002|NCT03681691|529281561|FG000|Overall Study|prolonged bleeding|1|||
146758003|NCT03681691|529281562|FG001|Overall Study|prolonged bleeding|0|||
146758004|NCT03681691|529281561|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
146758005|NCT03681691|529281562|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
146758006|NCT00748969|529281563|FG000|Overall Study|Withdrawal by Subject|1|||
146758007|NCT00748969|529281564|FG001|Overall Study|Withdrawal by Subject|0|||
146758008|NCT00748969|529281563|FG000|Overall Study|Withdrawal by Subject|0|||
146758009|NCT00748969|529281564|FG001|Overall Study|Withdrawal by Subject|1|||
146758010|NCT02334306|529281565|FG000|Double-blind Period|Adverse Event|0|||
146758011|NCT02334306|529281566|FG001|Double-blind Period|Adverse Event|1|||
146758012|NCT02334306|529281565|FG000|Double-blind Period|Withdrawal by Subject|1|||
146758013|NCT02334306|529281566|FG001|Double-blind Period|Withdrawal by Subject|1|||
146758014|NCT01687270|529281567|FG000|Overall Study|Lack of Efficacy|11|||
146758015|NCT01687270|529281567|FG000|Overall Study|Lost to Follow-up|1|||
146758016|NCT00465985|529281568|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
146758017|NCT00465985|529281569|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
146758018|NCT00465985|529281568|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
146758019|NCT00465985|529281569|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
146758020|NCT00465985|529281568|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
146758021|NCT00465985|529281569|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
146758022|NCT00465985|529281568|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
146758023|NCT00465985|529281569|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
146758024|NCT03302156|529281570|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
146758025|NCT03302156|529281571|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
146758026|NCT03302156|529281572|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
146758027|NCT02390557|529281573|FG000|Wave 2|Survey non-respondent|72|||
146758028|NCT02390557|529281574|FG001|Wave 2|Survey non-respondent|41|||
146758029|NCT02390557|529281575|FG002|Wave 2|Survey non-respondent|23|||
146758030|NCT03278028|529281578|FG000|Overall Study|Lost to Follow-up|1|||
146758031|NCT03278028|529281579|FG001|Overall Study|Lost to Follow-up|0|||
146758032|NCT03278028|529281578|FG000|Overall Study|Withdrawal by Subject|3|||
146758033|NCT03278028|529281579|FG001|Overall Study|Withdrawal by Subject|1|||
146758034|NCT03278028|529281578|FG000|Overall Study|Pregnancy|0|||
146758035|NCT03278028|529281579|FG001|Overall Study|Pregnancy|1|||
146758036|NCT00463151|529281580|FG000|Overall Study|Adverse Event|0|||
146855605|NCT00126503|529641894|FG000|Overall Study|alternative therapy|1|||
146855606|NCT00126503|529641895|FG001|Overall Study|alternative therapy|1|||
146855607|NCT00126503|529641894|FG000|Overall Study|other complicating disease|4|||
146855608|NCT00126503|529641895|FG001|Overall Study|other complicating disease|1|||
146855609|NCT00126503|529641894|FG000|Overall Study|Death|3|||
146855610|NCT00126503|529641895|FG001|Overall Study|Death|0|||
146855611|NCT00126503|529641894|FG000|Overall Study|Adverse Event|13|||
146855612|NCT00126503|529641895|FG001|Overall Study|Adverse Event|3|||
146855613|NCT00126503|529641894|FG000|Overall Study|non-compliant|1|||
146855614|NCT00126503|529641895|FG001|Overall Study|non-compliant|0|||
146855615|NCT00126503|529641894|FG000|Overall Study|Physician Decision|2|||
146855616|NCT00126503|529641895|FG001|Overall Study|Physician Decision|1|||
146855617|NCT02457559|529641896|FG000|Overall Study|Progressive Disease|1|||
146855618|NCT02457559|529641897|FG001|Overall Study|Progressive Disease|2|||
146855619|NCT02457559|529641898|FG002|Overall Study|Progressive Disease|3|||
146855620|NCT02457559|529641899|FG003|Overall Study|Progressive Disease|0|||
146855621|NCT02457559|529641900|FG004|Overall Study|Progressive Disease|0|||
146855622|NCT02457559|529641901|FG005|Overall Study|Progressive Disease|2|||
146855623|NCT02457559|529641902|FG006|Overall Study|Progressive Disease|1|||
146855624|NCT02457559|529641903|FG007|Overall Study|Progressive Disease|0|||
146855625|NCT02457559|529641904|FG008|Overall Study|Progressive Disease|1|||
146855626|NCT02457559|529641905|FG009|Overall Study|Progressive Disease|1|||
146855627|NCT02457559|529641906|FG010|Overall Study|Progressive Disease|1|||
146855628|NCT02457559|529641896|FG000|Overall Study|Investigator's Discretion|0|||
146855629|NCT02457559|529641897|FG001|Overall Study|Investigator's Discretion|0|||
146855630|NCT02457559|529641898|FG002|Overall Study|Investigator's Discretion|2|||
146855631|NCT02457559|529641899|FG003|Overall Study|Investigator's Discretion|0|||
146855632|NCT02457559|529641900|FG004|Overall Study|Investigator's Discretion|1|||
146855633|NCT02457559|529641901|FG005|Overall Study|Investigator's Discretion|0|||
146855634|NCT02457559|529641902|FG006|Overall Study|Investigator's Discretion|1|||
146855635|NCT02457559|529641903|FG007|Overall Study|Investigator's Discretion|0|||
146855636|NCT02457559|529641904|FG008|Overall Study|Investigator's Discretion|1|||
146855637|NCT02457559|529641905|FG009|Overall Study|Investigator's Discretion|0|||
146855638|NCT02457559|529641906|FG010|Overall Study|Investigator's Discretion|1|||
146855639|NCT02457559|529641896|FG000|Overall Study|Adverse Event|0|||
146855640|NCT02457559|529641897|FG001|Overall Study|Adverse Event|1|||
146855641|NCT02457559|529641898|FG002|Overall Study|Adverse Event|2|||
146855642|NCT02457559|529641899|FG003|Overall Study|Adverse Event|0|||
146855643|NCT02457559|529641900|FG004|Overall Study|Adverse Event|0|||
146855644|NCT02457559|529641901|FG005|Overall Study|Adverse Event|0|||
146855645|NCT02457559|529641902|FG006|Overall Study|Adverse Event|0|||
146855646|NCT02457559|529641903|FG007|Overall Study|Adverse Event|0|||
146855647|NCT02457559|529641904|FG008|Overall Study|Adverse Event|0|||
146855648|NCT02457559|529641905|FG009|Overall Study|Adverse Event|0|||
146855649|NCT02457559|529641906|FG010|Overall Study|Adverse Event|0|||
146855650|NCT02457559|529641896|FG000|Overall Study|Reason not Specified|1|||
146855651|NCT02457559|529641897|FG001|Overall Study|Reason not Specified|0|||
146855652|NCT02457559|529641898|FG002|Overall Study|Reason not Specified|0|||
146855653|NCT02457559|529641899|FG003|Overall Study|Reason not Specified|0|||
146855654|NCT02457559|529641900|FG004|Overall Study|Reason not Specified|0|||
146855655|NCT02457559|529641901|FG005|Overall Study|Reason not Specified|0|||
146855656|NCT02457559|529641902|FG006|Overall Study|Reason not Specified|0|||
146855657|NCT02457559|529641903|FG007|Overall Study|Reason not Specified|0|||
146855658|NCT02457559|529641904|FG008|Overall Study|Reason not Specified|0|||
146855659|NCT02457559|529641905|FG009|Overall Study|Reason not Specified|2|||
146855660|NCT02457559|529641906|FG010|Overall Study|Reason not Specified|0|||
146855661|NCT02457559|529641896|FG000|Overall Study|Death|0|||
146855662|NCT02457559|529641897|FG001|Overall Study|Death|0|||
146855663|NCT02457559|529641898|FG002|Overall Study|Death|0|||
146855664|NCT02457559|529641899|FG003|Overall Study|Death|0|||
146855665|NCT02457559|529641900|FG004|Overall Study|Death|0|||
146855666|NCT02457559|529641901|FG005|Overall Study|Death|0|||
146855667|NCT02457559|529641902|FG006|Overall Study|Death|0|||
146855668|NCT02457559|529641903|FG007|Overall Study|Death|0|||
146855669|NCT02457559|529641904|FG008|Overall Study|Death|1|||
146855670|NCT02457559|529641905|FG009|Overall Study|Death|1|||
146855671|NCT02457559|529641906|FG010|Overall Study|Death|0|||
146965068|NCT03110107|530033432|FG006|Treatment Period|Death|0|||
146965069|NCT03110107|530033433|FG007|Treatment Period|Death|0|||
146855672|NCT02374671|529641909|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
146855673|NCT02374671|529641910|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
146855674|NCT02374671|529641911|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
146855675|NCT02374671|529641909|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
146855676|NCT02374671|529641910|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
146855677|NCT02374671|529641911|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
146855678|NCT02374671|529641909|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
146855679|NCT02374671|529641910|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
146855680|NCT02374671|529641911|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
146855681|NCT02374671|529641909|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
146521724|NCT04865419|528418080|FG009|Overall Study|Other|0|||
146521725|NCT04865419|528418081|FG010|Overall Study|Other|0|||
146521726|NCT04865419|528418071|FG000|Overall Study|Withdrawal by Subject|0|||
146521727|NCT04865419|528418072|FG001|Overall Study|Withdrawal by Subject|1|||
146521728|NCT04865419|528418073|FG002|Overall Study|Withdrawal by Subject|1|||
146521729|NCT04865419|528418074|FG003|Overall Study|Withdrawal by Subject|0|||
146855682|NCT02374671|529641910|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
146855683|NCT02374671|529641911|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
146855684|NCT02374671|529641909|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
146855685|NCT02374671|529641910|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
146855686|NCT02374671|529641911|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
146855687|NCT02495792|529641914|FG000|Overall Study|Lost to Follow-up|5|||
146855688|NCT02495792|529641915|FG001|Overall Study|Lost to Follow-up|9|||
146855689|NCT02495792|529641914|FG000|Overall Study|Protocol Violation|32|||
146855690|NCT02495792|529641915|FG001|Overall Study|Protocol Violation|31|||
146855691|NCT02523599|529641916|FG000|Overall Study|Adverse Event|1|||
146855692|NCT02523599|529641917|FG001|Overall Study|Adverse Event|0|||
146855693|NCT02523599|529641916|FG000|Overall Study|Physician Decision|1|||
146855694|NCT02523599|529641917|FG001|Overall Study|Physician Decision|0|||
146855695|NCT02523599|529641916|FG000|Overall Study|Lost to Follow-up|4|||
146855696|NCT02523599|529641917|FG001|Overall Study|Lost to Follow-up|1|||
146855697|NCT02523599|529641916|FG000|Overall Study|Did not return for Day 30 visit|2|||
146855698|NCT02523599|529641917|FG001|Overall Study|Did not return for Day 30 visit|0|||
146855699|NCT06729606|529641918|FG000|Overall Study|Adverse Event|0|||
146855700|NCT06729606|529641919|FG001|Overall Study|Adverse Event|2|||
146855701|NCT06729606|529641918|FG000|Overall Study|Death|1|||
146855702|NCT06729606|529641919|FG001|Overall Study|Death|0|||
146855703|NCT06729606|529641918|FG000|Overall Study|Physician Decision|0|||
146855704|NCT06729606|529641919|FG001|Overall Study|Physician Decision|1|||
146855705|NCT06729606|529641918|FG000|Overall Study|Withdrawal by Subject|2|||
146855706|NCT06729606|529641919|FG001|Overall Study|Withdrawal by Subject|4|||
146855715|NCT01177722|529643998|FG000|Overall Study|Serious Adverse Event|0|||
146855716|NCT01177722|529643999|FG001|Overall Study|Serious Adverse Event|0|||
146855717|NCT01177722|529644000|FG002|Overall Study|Serious Adverse Event|1|||
146855718|NCT01177722|529644001|FG003|Overall Study|Serious Adverse Event|0|||
146855719|NCT01177722|529643998|FG000|Overall Study|Protocol Violation|0|||
146855720|NCT01177722|529643999|FG001|Overall Study|Protocol Violation|0|||
146855721|NCT01177722|529644000|FG002|Overall Study|Protocol Violation|1|||
146855722|NCT01177722|529644001|FG003|Overall Study|Protocol Violation|0|||
146855723|NCT01177722|529643998|FG000|Overall Study|Lost to Follow-up|3|||
146855724|NCT01177722|529643999|FG001|Overall Study|Lost to Follow-up|4|||
146855725|NCT01177722|529644000|FG002|Overall Study|Lost to Follow-up|3|||
146855726|NCT01177722|529644001|FG003|Overall Study|Lost to Follow-up|1|||
146855727|NCT01177722|529643998|FG000|Overall Study|Withdrawal by Subject|10|||
146855728|NCT01177722|529643999|FG001|Overall Study|Withdrawal by Subject|6|||
146855729|NCT01177722|529644000|FG002|Overall Study|Withdrawal by Subject|4|||
146855730|NCT01177722|529644001|FG003|Overall Study|Withdrawal by Subject|6|||
146855731|NCT02563522|529644004|FG000|Overall Study|Adverse Event|2|||
146855732|NCT02563522|529644005|FG001|Overall Study|Adverse Event|3|||
146855733|NCT02563522|529644004|FG000|Overall Study|Lost to Follow-up|1|||
146855734|NCT02563522|529644005|FG001|Overall Study|Lost to Follow-up|0|||
146855735|NCT02563522|529644004|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
146855736|NCT02563522|529644005|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
146855737|NCT00918580|529644006|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
146855738|NCT00918580|529644006|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
146521730|NCT04865419|528418075|FG004|Overall Study|Withdrawal by Subject|0|||
146521731|NCT04865419|528418076|FG005|Overall Study|Withdrawal by Subject|0|||
146855739|NCT00918580|529644006|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
146855740|NCT00918580|529644006|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
146855741|NCT00918580|529644006|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
146855742|NCT00918580|529644006|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
146855743|NCT00918580|529644006|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
146855744|NCT02208999|529644019|FG000|Overall Study|Lost to Follow-up|1|||
146855745|NCT04494256|529644020|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
146855746|NCT04494256|529644021|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
146855747|NCT04494256|529644022|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
146965070|NCT03110107|530033434|FG008|Treatment Period|Death|0|||
146855748|NCT04494256|529644023|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
146855749|NCT04494256|529644024|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
146855750|NCT04494256|529644025|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
146855751|NCT04494256|529644026|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
146855752|NCT04494256|529644020|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
146855753|NCT04494256|529644021|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
146855754|NCT04494256|529644022|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
146855755|NCT04494256|529644023|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
146855756|NCT04494256|529644024|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
146855757|NCT04494256|529644025|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
146855758|NCT04494256|529644026|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
146855759|NCT04494256|529644020|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
146855760|NCT04494256|529644021|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
146855761|NCT04494256|529644022|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
146855762|NCT04494256|529644023|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
146855763|NCT04494256|529644024|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
146855764|NCT04494256|529644025|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
146855765|NCT04494256|529644026|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
146855766|NCT04494256|529644020|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146855767|NCT04494256|529644021|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146855768|NCT04494256|529644022|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146855769|NCT04494256|529644023|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
146855770|NCT04494256|529644024|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
146855771|NCT04494256|529644025|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146855772|NCT04494256|529644026|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146855773|NCT04494256|529644020|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
146855774|NCT04494256|529644021|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
146855775|NCT04494256|529644022|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
146855776|NCT04494256|529644023|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
146855777|NCT04494256|529644024|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
146855778|NCT04494256|529644025|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
146855779|NCT04494256|529644026|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
146855780|NCT04494256|529644020|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
146855781|NCT04494256|529644021|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
146855782|NCT04494256|529644022|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
146855783|NCT04494256|529644023|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
146855784|NCT04494256|529644024|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
146855785|NCT04494256|529644025|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
146855786|NCT04494256|529644026|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
146855787|NCT04494256|529644020|FG000|Part 2: Open Label Period|Death|0|||
146855788|NCT04494256|529644021|FG001|Part 2: Open Label Period|Death|0|||
146855789|NCT04494256|529644022|FG002|Part 2: Open Label Period|Death|0|||
146855790|NCT04494256|529644023|FG003|Part 2: Open Label Period|Death|0|||
146855791|NCT04494256|529644024|FG004|Part 2: Open Label Period|Death|0|||
146855792|NCT04494256|529644025|FG005|Part 2: Open Label Period|Death|4|||
146855793|NCT04494256|529644026|FG006|Part 2: Open Label Period|Death|2|||
146855794|NCT04494256|529644020|FG000|Part 2: Open Label Period|Adverse Event|0|||
146855795|NCT04494256|529644021|FG001|Part 2: Open Label Period|Adverse Event|0|||
146855796|NCT04494256|529644022|FG002|Part 2: Open Label Period|Adverse Event|0|||
146855797|NCT04494256|529644023|FG003|Part 2: Open Label Period|Adverse Event|0|||
146855798|NCT04494256|529644024|FG004|Part 2: Open Label Period|Adverse Event|0|||
146855799|NCT04494256|529644025|FG005|Part 2: Open Label Period|Adverse Event|0|||
146855800|NCT04494256|529644026|FG006|Part 2: Open Label Period|Adverse Event|2|||
146855801|NCT04494256|529644020|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
146855802|NCT04494256|529644021|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
146855803|NCT04494256|529644022|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
146855804|NCT04494256|529644023|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
146855805|NCT04494256|529644024|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
146855806|NCT04494256|529644025|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
146855807|NCT04494256|529644026|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
146855808|NCT04494256|529644020|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
146855809|NCT04494256|529644021|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
146855810|NCT04494256|529644022|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
146855811|NCT04494256|529644023|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
146855812|NCT04494256|529644024|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
146855813|NCT04494256|529644025|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
146855814|NCT04494256|529644026|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
146855815|NCT04494256|529644020|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
146855816|NCT04494256|529644021|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
146855817|NCT04494256|529644022|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
146855818|NCT04494256|529644023|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
146855819|NCT04494256|529644024|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
146855820|NCT04494256|529644025|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
146855821|NCT04494256|529644026|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
146855822|NCT04494256|529644020|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146855823|NCT04494256|529644021|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146855824|NCT04494256|529644022|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146855825|NCT04494256|529644023|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146855826|NCT04494256|529644024|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146855827|NCT04494256|529644025|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
146855828|NCT04494256|529644026|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
146855829|NCT04494256|529644020|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
146855830|NCT04494256|529644021|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
146855831|NCT04494256|529644022|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
146855832|NCT04494256|529644023|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
146855833|NCT04494256|529644024|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
146855834|NCT04494256|529644025|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
146855835|NCT04494256|529644026|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
146855836|NCT00262951|529644027|FG000|Overall Study|Progressive disease/relapse|3|||
146855837|NCT00262951|529644027|FG000|Overall Study|Adverse Event|7|||
146855838|NCT00262951|529644027|FG000|Overall Study|Death|1|||
146855839|NCT00262951|529644027|FG000|Overall Study|Withdrawal by Subject|1|||
146855840|NCT00262951|529644027|FG000|Overall Study|Alternative treatment|3|||
146855841|NCT00262951|529644027|FG000|Overall Study|Off treatment for other disease|1|||
146855842|NCT04025580|529644028|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
146855843|NCT04025580|529644029|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
146855844|NCT04025580|529644030|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
146855845|NCT01249274|529644034|FG000|Overall Study|Lost to Follow-up|3|||
146855846|NCT01249274|529644035|FG001|Overall Study|Lost to Follow-up|4|||
146855847|NCT01249274|529644034|FG000|Overall Study|Received inpatient substance treatment|1|||
146855848|NCT01249274|529644035|FG001|Overall Study|Received inpatient substance treatment|2|||
146855849|NCT01000636|529644036|FG000|Overall Study|Withdrawal by Subject|1|||
146855850|NCT01000636|529644036|FG000|Overall Study|Adverse Event|1|||
146758037|NCT00463151|529281581|FG001|Overall Study|Adverse Event|0|||
146758038|NCT00463151|529281582|FG002|Overall Study|Adverse Event|1|||
146758039|NCT00463151|529281583|FG003|Overall Study|Adverse Event|0|||
146758040|NCT00463151|529281580|FG000|Overall Study|Lack of Efficacy|2|||
146758041|NCT00463151|529281581|FG001|Overall Study|Lack of Efficacy|5|||
146758042|NCT00463151|529281582|FG002|Overall Study|Lack of Efficacy|2|||
146758043|NCT00463151|529281583|FG003|Overall Study|Lack of Efficacy|5|||
146758044|NCT00463151|529281580|FG000|Overall Study|Protocol Violation|0|||
146625270|NCT03037385|528803845|FG000|Overall Study|Physician Decision|0|||
146758045|NCT00463151|529281581|FG001|Overall Study|Protocol Violation|0|||
146758046|NCT00463151|529281582|FG002|Overall Study|Protocol Violation|0|||
146758047|NCT00463151|529281583|FG003|Overall Study|Protocol Violation|1|||
146758048|NCT00463151|529281580|FG000|Overall Study|Withdrawal by Subject|0|||
146855851|NCT03658668|529644037|FG000|Overall Study|Time Commitment|1|||
146855852|NCT03658668|529644038|FG001|Overall Study|Time Commitment|1|||
146855853|NCT04634825|529644039|FG000|Overall Study|Death|10|||
146855854|NCT04634825|529644040|FG001|Overall Study|Death|3|||
146855855|NCT04634825|529644039|FG000|Overall Study|Lost to Follow-up|1|||
146855856|NCT04634825|529644040|FG001|Overall Study|Lost to Follow-up|0|||
146855857|NCT04634825|529644039|FG000|Overall Study|Study terminated by sponsor|35|||
146855858|NCT04634825|529644040|FG001|Overall Study|Study terminated by sponsor|11|||
146855859|NCT04634825|529644039|FG000|Overall Study|Withdrawal by Subject|2|||
146855860|NCT04634825|529644040|FG001|Overall Study|Withdrawal by Subject|0|||
146855861|NCT01100034|529644043|FG000|Overall Study|Lost to Follow-up|11|||
146855862|NCT01100034|529644043|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
146855863|NCT01100034|529644043|FG000|Overall Study|Withdrawal by Subject|4|||
146855864|NCT01100034|529644043|FG000|Overall Study|Sponsor decision|21|||
146855865|NCT01100034|529644043|FG000|Overall Study|Participated in another clinical trial|1|||
146855866|NCT01100034|529644043|FG000|Overall Study|Participants moved to another hospital|4|||
146855867|NCT01100034|529644043|FG000|Overall Study|Site closed due to non-responsiveness|1|||
146855868|NCT04964414|529644044|FG000|Overall Study|Lost to Follow-up|10|||
146855869|NCT04964414|529644045|FG001|Overall Study|Lost to Follow-up|8|||
146855870|NCT04964414|529644044|FG000|Overall Study|Withdrawal by Subject|1|||
146855871|NCT04964414|529644045|FG001|Overall Study|Withdrawal by Subject|1|||
146855872|NCT00819390|529644046|FG000|Overall Study|Lost to Follow-up|1|||
146855873|NCT00819390|529644047|FG001|Overall Study|Lost to Follow-up|1|||
146855874|NCT00819390|529644048|FG002|Overall Study|Lost to Follow-up|0|||
146521732|NCT04865419|528418077|FG006|Overall Study|Withdrawal by Subject|0|||
146521733|NCT04865419|528418078|FG007|Overall Study|Withdrawal by Subject|1|||
146521734|NCT04865419|528418079|FG008|Overall Study|Withdrawal by Subject|2|||
146521735|NCT04865419|528418080|FG009|Overall Study|Withdrawal by Subject|1|||
146521736|NCT04865419|528418081|FG010|Overall Study|Withdrawal by Subject|0|||
146521737|NCT04865419|528418071|FG000|Overall Study|Study terminated by Sponsor|0|||
146521738|NCT04865419|528418072|FG001|Overall Study|Study terminated by Sponsor|0|||
146521739|NCT04865419|528418073|FG002|Overall Study|Study terminated by Sponsor|0|||
146521740|NCT04865419|528418074|FG003|Overall Study|Study terminated by Sponsor|2|||
146521741|NCT04865419|528418075|FG004|Overall Study|Study terminated by Sponsor|2|||
146521742|NCT04865419|528418076|FG005|Overall Study|Study terminated by Sponsor|0|||
146521743|NCT04865419|528418077|FG006|Overall Study|Study terminated by Sponsor|0|||
146855875|NCT00819390|529644049|FG003|Overall Study|Lost to Follow-up|0|||
146855876|NCT00819390|529644046|FG000|Overall Study|Withdrawal by Subject|2|||
146855877|NCT00819390|529644047|FG001|Overall Study|Withdrawal by Subject|0|||
146855878|NCT00819390|529644048|FG002|Overall Study|Withdrawal by Subject|0|||
146855879|NCT00819390|529644049|FG003|Overall Study|Withdrawal by Subject|0|||
146855880|NCT00819390|529644046|FG000|Overall Study|Adverse Event|0|||
146521744|NCT04865419|528418078|FG007|Overall Study|Study terminated by Sponsor|0|||
146521745|NCT04865419|528418079|FG008|Overall Study|Study terminated by Sponsor|0|||
146521746|NCT04865419|528418080|FG009|Overall Study|Study terminated by Sponsor|0|||
146758049|NCT00463151|529281581|FG001|Overall Study|Withdrawal by Subject|0|||
146758050|NCT00463151|529281582|FG002|Overall Study|Withdrawal by Subject|0|||
146758051|NCT00463151|529281583|FG003|Overall Study|Withdrawal by Subject|1|||
146758052|NCT05349084|529281584|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
146758053|NCT00972543|529281585|FG000|Overall Study|Adverse Event|1|||
146758054|NCT00972543|529281586|FG001|Overall Study|Adverse Event|0|||
146758055|NCT00972543|529281585|FG000|Overall Study|Early study termination by sponsor|4|||
146758056|NCT00972543|529281586|FG001|Overall Study|Early study termination by sponsor|1|||
146758057|NCT00293462|529281587|FG000|Overall Study|Withdrawal by Subject|4|||
146758058|NCT00293462|529281588|FG001|Overall Study|Withdrawal by Subject|3|||
146758059|NCT00293462|529281589|FG002|Overall Study|Withdrawal by Subject|8|||
146758060|NCT00293462|529281587|FG000|Overall Study|Death|1|||
146758061|NCT00293462|529281588|FG001|Overall Study|Death|0|||
146758062|NCT00293462|529281589|FG002|Overall Study|Death|0|||
146758063|NCT00293462|529281587|FG000|Overall Study|Lost to Follow-up|0|||
146758064|NCT00293462|529281588|FG001|Overall Study|Lost to Follow-up|1|||
146758065|NCT00293462|529281589|FG002|Overall Study|Lost to Follow-up|0|||
146758066|NCT00293462|529281587|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
146521747|NCT04865419|528418081|FG010|Overall Study|Study terminated by Sponsor|1|||
146521748|NCT04865419|528418071|FG000|Overall Study|Death|3|||
146758067|NCT00293462|529281588|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
146758068|NCT00293462|529281589|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
146758069|NCT00293462|529281587|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
146855881|NCT00819390|529644047|FG001|Overall Study|Adverse Event|0|||
146855882|NCT00819390|529644048|FG002|Overall Study|Adverse Event|1|||
146855883|NCT00819390|529644049|FG003|Overall Study|Adverse Event|0|||
146855884|NCT01191268|529644050|FG000|Overall Study|Withdrawal by Subject|19|||
146855885|NCT01191268|529644051|FG001|Overall Study|Withdrawal by Subject|25|||
146855886|NCT01191268|529644052|FG002|Overall Study|Withdrawal by Subject|21|||
146521749|NCT04865419|528418072|FG001|Overall Study|Death|1|||
146521750|NCT04865419|528418073|FG002|Overall Study|Death|4|||
146855887|NCT01191268|529644050|FG000|Overall Study|Adverse Event|21|||
146855888|NCT01191268|529644051|FG001|Overall Study|Adverse Event|13|||
146855889|NCT01191268|529644052|FG002|Overall Study|Adverse Event|8|||
146855890|NCT01191268|529644050|FG000|Overall Study|Physician Decision|6|||
146855891|NCT01191268|529644051|FG001|Overall Study|Physician Decision|8|||
146855892|NCT01191268|529644052|FG002|Overall Study|Physician Decision|9|||
146855893|NCT01191268|529644050|FG000|Overall Study|Lost to Follow-up|8|||
146521751|NCT04865419|528418074|FG003|Overall Study|Death|2|||
146855894|NCT01191268|529644051|FG001|Overall Study|Lost to Follow-up|5|||
146855895|NCT01191268|529644052|FG002|Overall Study|Lost to Follow-up|9|||
146855896|NCT01191268|529644050|FG000|Overall Study|Entry Criteria Not Met|3|||
146855897|NCT01191268|529644051|FG001|Overall Study|Entry Criteria Not Met|1|||
146855898|NCT01191268|529644052|FG002|Overall Study|Entry Criteria Not Met|1|||
146855899|NCT01191268|529644050|FG000|Overall Study|Death|0|||
146855900|NCT01191268|529644051|FG001|Overall Study|Death|1|||
146855901|NCT01191268|529644052|FG002|Overall Study|Death|3|||
146855902|NCT01191268|529644050|FG000|Overall Study|Protocol Violation|1|||
146855903|NCT01191268|529644051|FG001|Overall Study|Protocol Violation|0|||
146855904|NCT01191268|529644052|FG002|Overall Study|Protocol Violation|1|||
146855905|NCT01191268|529644050|FG000|Overall Study|Sponsor Decision|0|||
146855906|NCT01191268|529644051|FG001|Overall Study|Sponsor Decision|2|||
146855907|NCT01191268|529644052|FG002|Overall Study|Sponsor Decision|0|||
146855908|NCT00336895|529644053|FG000|Overall Study|diarrhea|1|||
146855909|NCT00336895|529644053|FG000|Overall Study|nausea and upset stomach|1|||
146855910|NCT00336895|529644053|FG000|Overall Study|Physician Decision|1|||
146855911|NCT00336895|529644053|FG000|Overall Study|screen failed|1|||
146855912|NCT02308020|529644054|FG000|Overall Study|Lost to Follow-up|1|||
146855913|NCT02308020|529644055|FG001|Overall Study|Lost to Follow-up|7|||
146855914|NCT02308020|529644056|FG002|Overall Study|Lost to Follow-up|0|||
146855915|NCT02308020|529644057|FG003|Overall Study|Lost to Follow-up|0|||
146855916|NCT02308020|529644058|FG004|Overall Study|Lost to Follow-up|1|||
146855917|NCT02308020|529644059|FG005|Overall Study|Lost to Follow-up|2|||
146855918|NCT02308020|529644054|FG000|Overall Study|Sponsor Decision|0|||
146855919|NCT02308020|529644055|FG001|Overall Study|Sponsor Decision|8|||
146855920|NCT02308020|529644056|FG002|Overall Study|Sponsor Decision|0|||
146855921|NCT02308020|529644057|FG003|Overall Study|Sponsor Decision|2|||
146855922|NCT02308020|529644058|FG004|Overall Study|Sponsor Decision|2|||
146855923|NCT02308020|529644059|FG005|Overall Study|Sponsor Decision|1|||
146855924|NCT02308020|529644054|FG000|Overall Study|Withdrawal by Subject|3|||
146855925|NCT02308020|529644055|FG001|Overall Study|Withdrawal by Subject|5|||
146855926|NCT02308020|529644056|FG002|Overall Study|Withdrawal by Subject|3|||
146855927|NCT02308020|529644057|FG003|Overall Study|Withdrawal by Subject|2|||
146855928|NCT02308020|529644058|FG004|Overall Study|Withdrawal by Subject|1|||
146855929|NCT02308020|529644059|FG005|Overall Study|Withdrawal by Subject|2|||
146855930|NCT01270971|529644060|FG000|Overall Study|Withdrawal by Subject|24|||
146855931|NCT01270971|529644061|FG001|Overall Study|Withdrawal by Subject|11|||
146855932|NCT01270971|529644060|FG000|Overall Study|Lost to Follow-up|18|||
146855933|NCT01270971|529644061|FG001|Overall Study|Lost to Follow-up|5|||
146855934|NCT01270971|529644060|FG000|Overall Study|Adverse Event|1|||
146855935|NCT01270971|529644061|FG001|Overall Study|Adverse Event|2|||
146521752|NCT04865419|528418075|FG004|Overall Study|Death|5|||
146521753|NCT04865419|528418076|FG005|Overall Study|Death|2|||
146521754|NCT04865419|528418077|FG006|Overall Study|Death|1|||
146521755|NCT04865419|528418078|FG007|Overall Study|Death|1|||
146521756|NCT04865419|528418079|FG008|Overall Study|Death|2|||
146521757|NCT04865419|528418080|FG009|Overall Study|Death|2|||
146521758|NCT04865419|528418081|FG010|Overall Study|Death|1|||
146521759|NCT04865419|528418071|FG000|Overall Study|Lost to Follow-up|0|||
146521760|NCT04865419|528418072|FG001|Overall Study|Lost to Follow-up|0|||
146521761|NCT04865419|528418073|FG002|Overall Study|Lost to Follow-up|0|||
146521762|NCT04865419|528418074|FG003|Overall Study|Lost to Follow-up|0|||
146521763|NCT04865419|528418075|FG004|Overall Study|Lost to Follow-up|0|||
146521764|NCT04865419|528418076|FG005|Overall Study|Lost to Follow-up|0|||
146855936|NCT01270971|529644060|FG000|Overall Study|Non compliance|2|||
146855937|NCT01270971|529644061|FG001|Overall Study|Non compliance|2|||
146855938|NCT01270971|529644060|FG000|Overall Study|Non-specific|7|||
146855939|NCT01270971|529644061|FG001|Overall Study|Non-specific|3|||
146855940|NCT03333837|529644065|FG000|Overall Study|Adverse Event|2|||
146855941|NCT03333837|529644066|FG001|Overall Study|Adverse Event|1|||
146855942|NCT03333837|529644067|FG002|Overall Study|Adverse Event|1|||
146855943|NCT03333837|529644068|FG003|Overall Study|Adverse Event|1|||
146855944|NCT03333837|529644069|FG004|Overall Study|Adverse Event|0|||
146855945|NCT03333837|529644065|FG000|Overall Study|Caregiver withdrew|0|||
146855946|NCT03333837|529644066|FG001|Overall Study|Caregiver withdrew|2|||
146855947|NCT03333837|529644067|FG002|Overall Study|Caregiver withdrew|1|||
146521765|NCT04865419|528418077|FG006|Overall Study|Lost to Follow-up|0|||
146521766|NCT04865419|528418078|FG007|Overall Study|Lost to Follow-up|0|||
146521767|NCT04865419|528418079|FG008|Overall Study|Lost to Follow-up|0|||
146855948|NCT03333837|529644068|FG003|Overall Study|Caregiver withdrew|0|||
146855949|NCT03333837|529644069|FG004|Overall Study|Caregiver withdrew|0|||
146855950|NCT03333837|529644065|FG000|Overall Study|Withdrawal by Subject|0|||
146855951|NCT03333837|529644066|FG001|Overall Study|Withdrawal by Subject|0|||
146855952|NCT03333837|529644067|FG002|Overall Study|Withdrawal by Subject|1|||
146855953|NCT03333837|529644068|FG003|Overall Study|Withdrawal by Subject|1|||
146855954|NCT03333837|529644069|FG004|Overall Study|Withdrawal by Subject|3|||
146855955|NCT03333837|529644065|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
146855956|NCT03333837|529644066|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
146855957|NCT03333837|529644067|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
146855958|NCT03333837|529644068|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
146855959|NCT03333837|529644069|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
146855960|NCT00705523|529644070|FG000|Overall Study|Lost to Follow-up|2|||
146855961|NCT00705523|529644071|FG001|Overall Study|Lost to Follow-up|3|||
146855962|NCT01013285|529644072|FG000|Overall Study|Death|48|||
146855963|NCT01013285|529644073|FG001|Overall Study|Death|89|||
146855964|NCT02003573|529644077|FG000|Overall Study|Progressive disease|2|||
146855965|NCT02003573|529644078|FG001|Overall Study|Progressive disease|0|||
146855966|NCT02003573|529644079|FG002|Overall Study|Progressive disease|1|||
146855967|NCT02003573|529644077|FG000|Overall Study|Other Adverse event|0|||
146855968|NCT02003573|529644078|FG001|Overall Study|Other Adverse event|1|||
146855969|NCT02003573|529644079|FG002|Overall Study|Other Adverse event|1|||
146855970|NCT02003573|529644077|FG000|Overall Study|Refuse to take trial medication|0|||
146855971|NCT02003573|529644078|FG001|Overall Study|Refuse to take trial medication|1|||
146855972|NCT02003573|529644079|FG002|Overall Study|Refuse to take trial medication|1|||
146855973|NCT02003573|529644077|FG000|Overall Study|Other than specified|1|||
146855974|NCT02003573|529644078|FG001|Overall Study|Other than specified|2|||
146855975|NCT02003573|529644079|FG002|Overall Study|Other than specified|3|||
146855976|NCT00704405|529644086|FG000|Overall Study (NC Population)|Adverse Event|1|||
146855977|NCT00704405|529644087|FG001|Overall Study (NC Population)|Adverse Event|0|||
146855978|NCT00704405|529644088|FG002|Overall Study (NC Population)|Adverse Event|0|||
146855979|NCT00704405|529644089|FG003|Overall Study (NC Population)|Adverse Event|0|||
146855980|NCT00704405|529644090|FG004|Overall Study (NC Population)|Adverse Event|0|||
146855981|NCT00704405|529644086|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
146855982|NCT00704405|529644087|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
146855983|NCT00704405|529644088|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
146855984|NCT00704405|529644089|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
146855985|NCT00704405|529644090|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
146855986|NCT00704405|529644086|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
146855987|NCT00704405|529644087|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
146855988|NCT00704405|529644088|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
146855989|NCT00704405|529644089|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
146855990|NCT00704405|529644090|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
146855991|NCT00704405|529644086|FG000|Overall Study (NC Population)|Other|0|||
146855992|NCT00704405|529644087|FG001|Overall Study (NC Population)|Other|0|||
146855993|NCT00704405|529644088|FG002|Overall Study (NC Population)|Other|0|||
146855994|NCT00704405|529644089|FG003|Overall Study (NC Population)|Other|0|||
146855995|NCT00704405|529644090|FG004|Overall Study (NC Population)|Other|1|||
146855996|NCT00704405|529644086|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
146855997|NCT00704405|529644087|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
146855998|NCT00704405|529644088|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
146855999|NCT00704405|529644089|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
146856000|NCT00704405|529644090|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
146856001|NCT00704405|529644086|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
146856002|NCT00704405|529644087|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
146856003|NCT00704405|529644088|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
146856004|NCT00704405|529644089|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
146856005|NCT00704405|529644090|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
146856006|NCT01395888|529644091|FG000|2-week Run-in Period|Adverse Event|2|||
146856007|NCT01395888|529644092|FG001|2-week Run-in Period|Adverse Event|0|||
146856008|NCT01395888|529644093|FG002|2-week Run-in Period|Adverse Event|0|||
146856009|NCT01395888|529644091|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
146856010|NCT01395888|529644092|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
146856011|NCT01395888|529644093|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
146856012|NCT01395888|529644091|FG000|2-week Run-in Period|Lost to Follow-up|1|||
146856013|NCT01395888|529644092|FG001|2-week Run-in Period|Lost to Follow-up|0|||
146856014|NCT01395888|529644093|FG002|2-week Run-in Period|Lost to Follow-up|0|||
146856015|NCT01395888|529644091|FG000|2-week Run-in Period|Protocol Violation|2|||
146856016|NCT01395888|529644092|FG001|2-week Run-in Period|Protocol Violation|0|||
146856017|NCT01395888|529644093|FG002|2-week Run-in Period|Protocol Violation|0|||
146856018|NCT01395888|529644091|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
146856019|NCT01395888|529644092|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
146856020|NCT01395888|529644093|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
146856021|NCT01395888|529644091|FG000|Treatment Period (TP)|Adverse Event|0|||
146856022|NCT01395888|529644092|FG001|Treatment Period (TP)|Adverse Event|7|||
146856023|NCT01395888|529644093|FG002|Treatment Period (TP)|Adverse Event|6|||
146856024|NCT01395888|529644091|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
146856025|NCT01395888|529644092|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
146856026|NCT01395888|529644093|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
146856027|NCT01395888|529644091|FG000|Treatment Period (TP)|Protocol Violation|0|||
146856028|NCT01395888|529644092|FG001|Treatment Period (TP)|Protocol Violation|1|||
146856029|NCT01395888|529644093|FG002|Treatment Period (TP)|Protocol Violation|5|||
146856030|NCT01395888|529644091|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
146856031|NCT01395888|529644092|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
146856032|NCT01395888|529644093|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
146856033|NCT01395888|529644091|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
146856034|NCT01395888|529644092|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
146856035|NCT01395888|529644093|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
146856036|NCT00903682|529644094|FG000|Overall Study|Adverse Event|6|||
146856037|NCT00903682|529644095|FG001|Overall Study|Adverse Event|13|||
146856038|NCT00903682|529644094|FG000|Overall Study|Lost to Follow-up|1|||
146856039|NCT00903682|529644095|FG001|Overall Study|Lost to Follow-up|0|||
146856040|NCT00903682|529644094|FG000|Overall Study|Withdrawal by Subject|5|||
146856041|NCT00903682|529644095|FG001|Overall Study|Withdrawal by Subject|0|||
146856042|NCT00903682|529644094|FG000|Overall Study|Pregnancy|0|||
146856043|NCT00903682|529644095|FG001|Overall Study|Pregnancy|1|||
146856044|NCT00903682|529644094|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
146856045|NCT00903682|529644095|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
146856046|NCT00903682|529644094|FG000|Overall Study|Subject Non-Compliant|1|||
146856047|NCT00903682|529644095|FG001|Overall Study|Subject Non-Compliant|0|||
146856048|NCT00903682|529644094|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
146856049|NCT00903682|529644095|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
146856050|NCT00903682|529644094|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
146856051|NCT00903682|529644095|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
146856052|NCT03866473|529644096|FG000|Phase 1|Death|1|||
146856053|NCT03866473|529644097|FG001|Phase 1|Death|0|||
146856054|NCT03866473|529644096|FG000|Phase 2|Death|0|||
146856055|NCT03866473|529644097|FG001|Phase 2|Death|2|||
146856056|NCT03866473|529644096|FG000|Phase 2|Dropped|1|||
146856057|NCT03866473|529644097|FG001|Phase 2|Dropped|1|||
146856058|NCT03866473|529644096|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
146856059|NCT03866473|529644097|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
146856060|NCT03169101|529644098|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
146856061|NCT03169101|529644099|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
146856062|NCT03169101|529644100|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
146856063|NCT03169101|529644101|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
146856064|NCT00600886|529644102|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
146856065|NCT00600886|529644103|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
146856066|NCT00600886|529644102|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
146856067|NCT00600886|529644103|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
146856068|NCT00600886|529644102|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
146856069|NCT00600886|529644103|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
146856070|NCT00600886|529644102|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
146856071|NCT00600886|529644103|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
146856072|NCT00600886|529644102|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
146856073|NCT00600886|529644103|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
146856074|NCT00600886|529644102|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
146856075|NCT00600886|529644103|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
146856076|NCT00600886|529644102|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
146856077|NCT00600886|529644103|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
146856078|NCT00600886|529644102|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
146856079|NCT00600886|529644103|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
146856080|NCT00600886|529644102|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
146856081|NCT00600886|529644103|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
146856082|NCT00600886|529644102|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
146856083|NCT00600886|529644103|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
146856084|NCT00600886|529644102|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
146856085|NCT00600886|529644103|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
146856086|NCT00600886|529644102|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
146856087|NCT00600886|529644103|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
146856088|NCT00600886|529644102|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
146856089|NCT00600886|529644103|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
146965071|NCT03110107|530033435|FG009|Treatment Period|Death|0|||
146965072|NCT03110107|530033436|FG010|Treatment Period|Death|0|||
146521768|NCT04865419|528418080|FG009|Overall Study|Lost to Follow-up|1|||
146856090|NCT00600886|529644102|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
146856091|NCT00600886|529644103|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
146856092|NCT00600886|529644102|FG000|Extension - Same Treatment (FAS)|Death|1|||
146856093|NCT00600886|529644103|FG001|Extension - Same Treatment (FAS)|Death|1|||
146856094|NCT00600886|529644102|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
146856095|NCT00600886|529644103|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
146856096|NCT00600886|529644102|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
146856097|NCT00600886|529644103|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
146856098|NCT00600886|529644102|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
146856099|NCT00600886|529644103|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
146856100|NCT00600886|529644102|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
146856101|NCT00600886|529644103|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
146856102|NCT00600886|529644102|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
146856103|NCT00600886|529644103|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
146856104|NCT00600886|529644102|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
146856105|NCT00600886|529644103|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
146856106|NCT00600886|529644102|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
146856107|NCT00600886|529644103|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
146856108|NCT00600886|529644102|FG000|Extension - After Crossover (CAS)|Death|1|||
146856109|NCT00600886|529644103|FG001|Extension - After Crossover (CAS)|Death|0|||
146856110|NCT02053792|529644104|FG000|Overall Study|Physician Decision|0|||
146856111|NCT02053792|529644105|FG001|Overall Study|Physician Decision|1|||
146856112|NCT02053792|529644104|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
146856113|NCT02053792|529644105|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
146856114|NCT02053792|529644104|FG000|Overall Study|Lack of Efficacy|1|||
146856115|NCT02053792|529644105|FG001|Overall Study|Lack of Efficacy|0|||
146856116|NCT02053792|529644104|FG000|Overall Study|Adverse Event|1|||
146856117|NCT02053792|529644105|FG001|Overall Study|Adverse Event|0|||
146856118|NCT02053792|529644104|FG000|Overall Study|Withdrawal by Subject|2|||
146856119|NCT02053792|529644105|FG001|Overall Study|Withdrawal by Subject|2|||
146856120|NCT02053792|529644104|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
146856121|NCT02053792|529644105|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
146856122|NCT02053792|529644104|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
146856123|NCT02053792|529644105|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
146856124|NCT00790751|529644116|FG000|Overall Study|Protocol non-compliance|16|||
146856125|NCT00790751|529644117|FG001|Overall Study|Protocol non-compliance|16|||
146856126|NCT00790751|529644118|FG002|Overall Study|Protocol non-compliance|10|||
146856127|NCT00790751|529644119|FG003|Overall Study|Protocol non-compliance|11|||
146856128|NCT00790751|529644116|FG000|Overall Study|Lost to Follow-up|4|||
146856129|NCT00790751|529644117|FG001|Overall Study|Lost to Follow-up|9|||
146856130|NCT00790751|529644118|FG002|Overall Study|Lost to Follow-up|4|||
146856131|NCT00790751|529644119|FG003|Overall Study|Lost to Follow-up|5|||
146856132|NCT00790751|529644116|FG000|Overall Study|Adverse Event|5|||
146856133|NCT00790751|529644117|FG001|Overall Study|Adverse Event|3|||
146856134|NCT00790751|529644118|FG002|Overall Study|Adverse Event|5|||
146856135|NCT00790751|529644119|FG003|Overall Study|Adverse Event|4|||
146856136|NCT00790751|529644116|FG000|Overall Study|Requirement for restricted medication|0|||
146856137|NCT00790751|529644117|FG001|Overall Study|Requirement for restricted medication|2|||
146856138|NCT00790751|529644118|FG002|Overall Study|Requirement for restricted medication|0|||
146856139|NCT00790751|529644119|FG003|Overall Study|Requirement for restricted medication|0|||
146856140|NCT00790751|529644116|FG000|Overall Study|Death|0|||
146856141|NCT00790751|529644117|FG001|Overall Study|Death|0|||
146856142|NCT00790751|529644118|FG002|Overall Study|Death|1|||
146856143|NCT00790751|529644119|FG003|Overall Study|Death|0|||
146856144|NCT00790751|529644116|FG000|Overall Study|Physician Decision|0|||
146856145|NCT00790751|529644117|FG001|Overall Study|Physician Decision|0|||
146856146|NCT00790751|529644118|FG002|Overall Study|Physician Decision|0|||
146856147|NCT00790751|529644119|FG003|Overall Study|Physician Decision|1|||
146856148|NCT05590884|529644120|FG000|Overall Study|Withdrawal by Subject|1|||
146856149|NCT05590884|529644121|FG001|Overall Study|Withdrawal by Subject|0|||
146856150|NCT05590884|529644122|FG002|Overall Study|Withdrawal by Subject|0|||
146521769|NCT04865419|528418081|FG010|Overall Study|Lost to Follow-up|0|||
146965073|NCT03110107|530033437|FG011|Treatment Period|Death|0|||
146965074|NCT03110107|530033438|FG012|Treatment Period|Death|1|||
146521770|NCT05446142|528418082|FG000|Period 2|Adverse Event|1|||
146856163|NCT04976621|529644126|FG000|Overall Study|Lost to Follow-up|2|||
146856164|NCT04976621|529644127|FG001|Overall Study|Lost to Follow-up|2|||
146856165|NCT04976621|529644126|FG000|Overall Study|Withdrawal by Subject|1|||
146856166|NCT04976621|529644127|FG001|Overall Study|Withdrawal by Subject|1|||
146856167|NCT04443153|529644129|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
146856168|NCT04443153|529644130|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
146856169|NCT04443153|529644129|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
146856170|NCT04443153|529644130|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
146856171|NCT04443153|529644129|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
146856172|NCT04443153|529644130|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
146856173|NCT04443153|529644129|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
146856174|NCT04443153|529644130|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
146856175|NCT05182125|529644131|FG000|Overall Study|Withdrawal by Subject|0|||
146856176|NCT05182125|529644132|FG001|Overall Study|Withdrawal by Subject|0|||
146856177|NCT05182125|529644133|FG002|Overall Study|Withdrawal by Subject|0|||
146856178|NCT05182125|529644134|FG003|Overall Study|Withdrawal by Subject|0|||
146856179|NCT05182125|529644135|FG004|Overall Study|Withdrawal by Subject|2|||
146856180|NCT05182125|529644136|FG005|Overall Study|Withdrawal by Subject|0|||
146856181|NCT05182125|529644131|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
146856182|NCT05182125|529644132|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
146856183|NCT05182125|529644133|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
146856184|NCT05182125|529644134|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
146856185|NCT05182125|529644135|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
146856186|NCT05182125|529644136|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
146856187|NCT05182125|529644131|FG000|Overall Study|Death|0|||
146856188|NCT05182125|529644132|FG001|Overall Study|Death|0|||
146856189|NCT05182125|529644133|FG002|Overall Study|Death|0|||
146856190|NCT05182125|529644134|FG003|Overall Study|Death|0|||
146856191|NCT05182125|529644135|FG004|Overall Study|Death|1|||
146856192|NCT05182125|529644136|FG005|Overall Study|Death|0|||
146856193|NCT03519971|529644137|FG000|Overall Study|Death|142|||
146856194|NCT03519971|529644138|FG001|Overall Study|Death|69|||
146856195|NCT03519971|529644137|FG000|Overall Study|Lost to Follow-up|0|||
146856196|NCT03519971|529644138|FG001|Overall Study|Lost to Follow-up|1|||
146856197|NCT03519971|529644137|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
146856198|NCT03519971|529644138|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
146856199|NCT03519971|529644137|FG000|Overall Study|Withdrawal by Subject|3|||
146856200|NCT03519971|529644138|FG001|Overall Study|Withdrawal by Subject|2|||
146856201|NCT03519971|529644137|FG000|Overall Study|Other|1|||
146856202|NCT03519971|529644138|FG001|Overall Study|Other|0|||
146856203|NCT01078454|529644143|FG000|Overall Study|Adverse Event|1|||
146856204|NCT01078454|529644144|FG001|Overall Study|Adverse Event|1|||
146856205|NCT01078454|529644143|FG000|Overall Study|Death|0|||
146856206|NCT01078454|529644144|FG001|Overall Study|Death|1|||
146856207|NCT05227703|529644145|FG000|Overall Study|Adverse Event|2|||
146856208|NCT05227703|529644146|FG001|Overall Study|Adverse Event|6|||
146856209|NCT05227703|529644147|FG002|Overall Study|Adverse Event|4|||
146856210|NCT05227703|529644145|FG000|Overall Study|Lack of Efficacy|4|||
146856211|NCT05227703|529644146|FG001|Overall Study|Lack of Efficacy|0|||
146856212|NCT05227703|529644147|FG002|Overall Study|Lack of Efficacy|1|||
146856213|NCT05227703|529644145|FG000|Overall Study|Physician Decision|2|||
146856214|NCT05227703|529644146|FG001|Overall Study|Physician Decision|2|||
146856215|NCT05227703|529644147|FG002|Overall Study|Physician Decision|1|||
146856216|NCT05227703|529644145|FG000|Overall Study|Protocol Violation|2|||
146856217|NCT05227703|529644146|FG001|Overall Study|Protocol Violation|1|||
146856218|NCT05227703|529644147|FG002|Overall Study|Protocol Violation|0|||
146856219|NCT05227703|529644145|FG000|Overall Study|Withdrawal by Subject|17|||
146856220|NCT05227703|529644146|FG001|Overall Study|Withdrawal by Subject|26|||
146856221|NCT05227703|529644147|FG002|Overall Study|Withdrawal by Subject|32|||
146856222|NCT05227703|529644145|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
146856223|NCT05227703|529644146|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
146856224|NCT05227703|529644147|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
146856225|NCT05227703|529644145|FG000|Overall Study|Other|1|||
146856226|NCT05227703|529644146|FG001|Overall Study|Other|1|||
146856227|NCT05227703|529644147|FG002|Overall Study|Other|0|||
146856228|NCT04134845|529644149|FG000|Overall Study|withdrawl by PI|12|||
146856229|NCT04134845|529644150|FG001|Overall Study|withdrawl by PI|5|||
146521771|NCT05446142|528418083|FG001|Period 2|Adverse Event|0|||
146856230|NCT03110224|529644151|FG000|Overall Study|Death|3|||
146856231|NCT03110224|529644151|FG000|Overall Study|Lost to Follow-up|132|||
146856232|NCT03110224|529644151|FG000|Overall Study|Physician Decision|2|||
146856233|NCT03110224|529644151|FG000|Overall Study|Site Closed by Physician|35|||
146856234|NCT03110224|529644151|FG000|Overall Study|Site Closed by Sponsor|202|||
146856235|NCT03110224|529644151|FG000|Overall Study|Withdrawal by Subject|9|||
146856236|NCT05328167|529644152|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
146856237|NCT05328167|529644152|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
146856238|NCT00112047|529644153|FG000|Randomized Phase|Lost to Follow-up|26|||
146856239|NCT00112047|529644154|FG001|Randomized Phase|Lost to Follow-up|33|||
146856240|NCT00112047|529644153|FG000|Randomized Phase|Adverse Event|10|||
146856241|NCT00112047|529644154|FG001|Randomized Phase|Adverse Event|10|||
146856242|NCT00112047|529644153|FG000|Randomized Phase|Withrawal of consent|10|||
146856243|NCT00112047|529644154|FG001|Randomized Phase|Withrawal of consent|18|||
146521772|NCT05446142|528418084|FG002|Period 2|Adverse Event|0|||
146521773|NCT05446142|528418085|FG003|Period 2|Adverse Event|0|||
146521774|NCT05446142|528418086|FG004|Period 2|Adverse Event|0|||
146521775|NCT05446142|528418087|FG005|Period 2|Adverse Event|0|||
146521776|NCT02098395|528418092|FG000|Overall Study|Protocol Violation|2|||
146521777|NCT02098395|528418093|FG001|Overall Study|Protocol Violation|2|||
146521778|NCT02098395|528418094|FG002|Overall Study|Protocol Violation|0|||
146521779|NCT02098395|528418095|FG003|Overall Study|Protocol Violation|7|||
146521780|NCT02098395|528418092|FG000|Overall Study|Withdrawal by Subject|10|||
146521781|NCT02098395|528418093|FG001|Overall Study|Withdrawal by Subject|10|||
146521782|NCT02098395|528418094|FG002|Overall Study|Withdrawal by Subject|5|||
146521783|NCT02098395|528418095|FG003|Overall Study|Withdrawal by Subject|13|||
146521784|NCT02098395|528418092|FG000|Overall Study|Adverse Event|12|||
146521785|NCT02098395|528418093|FG001|Overall Study|Adverse Event|19|||
146521786|NCT02098395|528418094|FG002|Overall Study|Adverse Event|34|||
146521787|NCT02098395|528418095|FG003|Overall Study|Adverse Event|2|||
146521788|NCT02098395|528418092|FG000|Overall Study|Lost to Follow-up|2|||
146521789|NCT02098395|528418093|FG001|Overall Study|Lost to Follow-up|1|||
146521790|NCT02098395|528418094|FG002|Overall Study|Lost to Follow-up|0|||
146521791|NCT02098395|528418095|FG003|Overall Study|Lost to Follow-up|3|||
146521792|NCT02098395|528418092|FG000|Overall Study|Unclassified|0|||
146521793|NCT02098395|528418093|FG001|Overall Study|Unclassified|0|||
146521794|NCT02098395|528418094|FG002|Overall Study|Unclassified|3|||
146521795|NCT02098395|528418095|FG003|Overall Study|Unclassified|2|||
146521796|NCT00547157|528418098|FG000|Overall Study|Other|1|||
146521797|NCT00547157|528418099|FG001|Overall Study|Other|0|||
146521798|NCT00547157|528418098|FG000|Overall Study|Death|38|||
146521799|NCT00547157|528418099|FG001|Overall Study|Death|18|||
146521800|NCT00547157|528418098|FG000|Overall Study|Withdrawal by Subject|3|||
146521801|NCT00547157|528418099|FG001|Overall Study|Withdrawal by Subject|1|||
146521802|NCT00547157|528418098|FG000|Overall Study|Administrative decision|3|||
146521803|NCT00547157|528418099|FG001|Overall Study|Administrative decision|2|||
146521804|NCT00547157|528418098|FG000|Overall Study|Lost to Follow-up|4|||
146521805|NCT00547157|528418099|FG001|Overall Study|Lost to Follow-up|2|||
146521806|NCT04633226|528418103|FG000|Overall Study|Withdrawal by parent/guardian|4|||
146521807|NCT04633226|528418103|FG000|Overall Study|Randomized by mistake without study treatment|1|||
146521808|NCT00334295|528418105|FG000|Overall Study|Patients received fewer than 3 injection|5|||
146521809|NCT00792116|528418108|FG000|Overall Study|Lost to Follow-up|0|||
146521810|NCT00792116|528418109|FG001|Overall Study|Lost to Follow-up|1|||
146521811|NCT00792116|528418108|FG000|Overall Study|Discontnued intervention|1|||
146521812|NCT00792116|528418109|FG001|Overall Study|Discontnued intervention|0|||
146521813|NCT02453256|528418110|FG000|Double Blind Period|Death|1|||
146521814|NCT02453256|528418111|FG001|Double Blind Period|Death|1|||
146521815|NCT02453256|528418110|FG000|Double Blind Period|Adverse Event|3|||
146521816|NCT02453256|528418111|FG001|Double Blind Period|Adverse Event|2|||
146521817|NCT02453256|528418110|FG000|Double Blind Period|Withdrawal by Subject|9|||
146521818|NCT02453256|528418111|FG001|Double Blind Period|Withdrawal by Subject|5|||
146521819|NCT02453256|528418110|FG000|Double Blind Period|Other|0|||
146521820|NCT02453256|528418111|FG001|Double Blind Period|Other|1|||
146521821|NCT02453256|528418110|FG000|Open Label Period|Adverse Event|1|||
146521822|NCT02453256|528418111|FG001|Open Label Period|Adverse Event|3|||
146521823|NCT02453256|528418110|FG000|Open Label Period|Death|0|||
146521824|NCT02453256|528418111|FG001|Open Label Period|Death|1|||
146521825|NCT02453256|528418110|FG000|Open Label Period|Lost to Follow-up|1|||
146521826|NCT02453256|528418111|FG001|Open Label Period|Lost to Follow-up|0|||
146521827|NCT02453256|528418110|FG000|Open Label Period|Other|0|||
146521828|NCT02453256|528418111|FG001|Open Label Period|Other|2|||
146521829|NCT02453256|528418110|FG000|Open Label Period|Withdrawal by Subject|5|||
146521830|NCT02453256|528418111|FG001|Open Label Period|Withdrawal by Subject|1|||
146521831|NCT01972464|528418112|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
146521832|NCT01972464|528418113|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
146521833|NCT01972464|528418112|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
146521834|NCT01972464|528418113|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
146521835|NCT01972464|528418112|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
146856244|NCT00112047|529644153|FG000|Randomized Phase|Sub-optimal virological response|3|||
146856245|NCT00112047|529644154|FG001|Randomized Phase|Sub-optimal virological response|13|||
146521836|NCT01972464|528418113|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
146856246|NCT00112047|529644153|FG000|Randomized Phase|Noncompliance|8|||
146521837|NCT01972464|528418112|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
146521838|NCT01972464|528418113|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
146521839|NCT02861664|528419801|FG000|Overall Study|Withdrawal of Consent|0|||
146521840|NCT02861664|528419802|FG001|Overall Study|Withdrawal of Consent|1|||
146521841|NCT00905632|528419803|FG000|Overall Study|Adverse Event|0|||
146521842|NCT00905632|528419804|FG001|Overall Study|Adverse Event|0|||
146521843|NCT00905632|528419805|FG002|Overall Study|Adverse Event|0|||
146521844|NCT00905632|528419806|FG003|Overall Study|Adverse Event|0|||
146521845|NCT00905632|528419807|FG004|Overall Study|Adverse Event|0|||
146758070|NCT00293462|529281588|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
146758071|NCT00293462|529281589|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
146758072|NCT00293462|529281587|FG000|Overall Study|Refuse Radiation Treatment|1|||
146758073|NCT00293462|529281588|FG001|Overall Study|Refuse Radiation Treatment|0|||
146758074|NCT00293462|529281589|FG002|Overall Study|Refuse Radiation Treatment|0|||
146758075|NCT00293462|529281587|FG000|Overall Study|No Show|0|||
146758076|NCT00293462|529281588|FG001|Overall Study|No Show|0|||
146758077|NCT00293462|529281589|FG002|Overall Study|No Show|1|||
146758078|NCT00293462|529281587|FG000|Overall Study|Went back to his home country|0|||
146758079|NCT00293462|529281588|FG001|Overall Study|Went back to his home country|0|||
146758080|NCT00293462|529281589|FG002|Overall Study|Went back to his home country|1|||
146758081|NCT00293462|529281587|FG000|Overall Study|Blood clot after chemotherapy|0|||
146758082|NCT00293462|529281588|FG001|Overall Study|Blood clot after chemotherapy|0|||
146758083|NCT00293462|529281589|FG002|Overall Study|Blood clot after chemotherapy|1|||
146758084|NCT00293462|529281587|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
146758085|NCT00293462|529281588|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
146758086|NCT00293462|529281589|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
146758087|NCT00293462|529281587|FG000|Overall Study|Possible Tracheostomy leakage|0|||
146758088|NCT00293462|529281588|FG001|Overall Study|Possible Tracheostomy leakage|1|||
146758089|NCT00293462|529281589|FG002|Overall Study|Possible Tracheostomy leakage|0|||
146758090|NCT00293462|529281587|FG000|Overall Study|Low radiation dose in oral cavity|0|||
146758091|NCT00293462|529281588|FG001|Overall Study|Low radiation dose in oral cavity|1|||
146758092|NCT00293462|529281589|FG002|Overall Study|Low radiation dose in oral cavity|0|||
146758093|NCT00293462|529281587|FG000|Overall Study|Physician Decision|0|||
146758094|NCT00293462|529281588|FG001|Overall Study|Physician Decision|1|||
146758095|NCT00293462|529281589|FG002|Overall Study|Physician Decision|0|||
146758096|NCT00688688|529281590|FG000|Overall Study|Eligibility criterion not met|7|||
146758097|NCT00688688|529281591|FG001|Overall Study|Eligibility criterion not met|7|||
146758098|NCT00688688|529281592|FG002|Overall Study|Eligibility criterion not met|10|||
146758099|NCT00688688|529281590|FG000|Overall Study|Adverse Event|52|||
146758100|NCT00688688|529281591|FG001|Overall Study|Adverse Event|51|||
146758101|NCT00688688|529281592|FG002|Overall Study|Adverse Event|50|||
146758102|NCT00688688|529281590|FG000|Overall Study|Lack of Efficacy|34|||
146758103|NCT00688688|529281591|FG001|Overall Study|Lack of Efficacy|25|||
146758104|NCT00688688|529281592|FG002|Overall Study|Lack of Efficacy|45|||
146758105|NCT00688688|529281590|FG000|Overall Study|Withdrawal by Subject|66|||
146758106|NCT00688688|529281591|FG001|Overall Study|Withdrawal by Subject|75|||
146758107|NCT00688688|529281592|FG002|Overall Study|Withdrawal by Subject|65|||
146758108|NCT00688688|529281590|FG000|Overall Study|Lost to Follow-up|14|||
146758109|NCT00688688|529281591|FG001|Overall Study|Lost to Follow-up|7|||
146758110|NCT00688688|529281592|FG002|Overall Study|Lost to Follow-up|7|||
146758111|NCT00688688|529281590|FG000|Overall Study|Protocol Violation|6|||
146758112|NCT00688688|529281591|FG001|Overall Study|Protocol Violation|9|||
146758113|NCT00688688|529281592|FG002|Overall Study|Protocol Violation|11|||
146758114|NCT00688688|529281590|FG000|Overall Study|Randomized but never received study drug|1|||
146758115|NCT00688688|529281591|FG001|Overall Study|Randomized but never received study drug|0|||
146758116|NCT00688688|529281592|FG002|Overall Study|Randomized but never received study drug|0|||
146758117|NCT00688688|529281590|FG000|Overall Study|Non-compliance with study procedures|5|||
146758118|NCT00688688|529281591|FG001|Overall Study|Non-compliance with study procedures|3|||
146758119|NCT00688688|529281592|FG002|Overall Study|Non-compliance with study procedures|4|||
146758120|NCT00688688|529281590|FG000|Overall Study|Taking exclusionary medications|1|||
146758121|NCT00688688|529281591|FG001|Overall Study|Taking exclusionary medications|0|||
146758122|NCT00688688|529281592|FG002|Overall Study|Taking exclusionary medications|0|||
146758123|NCT00688688|529281590|FG000|Overall Study|Site closure|0|||
146758124|NCT00688688|529281591|FG001|Overall Study|Site closure|1|||
146521846|NCT00905632|528419808|FG005|Overall Study|Adverse Event|1|||
146521847|NCT00905632|528419809|FG006|Overall Study|Adverse Event|4|||
146758125|NCT00688688|529281592|FG002|Overall Study|Site closure|0|||
146758126|NCT00688688|529281590|FG000|Overall Study|Violation of exclusion criterion|0|||
146758127|NCT00688688|529281591|FG001|Overall Study|Violation of exclusion criterion|1|||
146758128|NCT00688688|529281592|FG002|Overall Study|Violation of exclusion criterion|0|||
146758129|NCT03283553|529281596|FG000|Patient Participant Flow|Death|5|||
146758130|NCT03283553|529281597|FG001|Patient Participant Flow|Death|10|||
146758131|NCT03283553|529281596|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
146758132|NCT03283553|529281597|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
146521848|NCT02585713|528419811|FG000|Overall Study|Withdrew prior to treatment|2|||
146521849|NCT02585713|528419812|FG001|Overall Study|Withdrew prior to treatment|7|||
146521850|NCT02585713|528419811|FG000|Overall Study|Other|3|||
146758133|NCT03283553|529281596|FG000|Patient Participant Flow|Lost to Follow-up|1|||
146758134|NCT03283553|529281597|FG001|Patient Participant Flow|Lost to Follow-up|1|||
146758135|NCT03283553|529281596|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
146758136|NCT03283553|529281597|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
146758137|NCT03283553|529281596|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
146758138|NCT03283553|529281597|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
146758139|NCT03283553|529281596|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
146758140|NCT03283553|529281597|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
146758141|NCT03686683|529281598|FG000|Overall Study|Withdrawal by Subject|52|||
146758142|NCT03686683|529281599|FG001|Overall Study|Withdrawal by Subject|32|||
146758143|NCT03686683|529281598|FG000|Overall Study|Lost to Follow-up|23|||
146758144|NCT03686683|529281599|FG001|Overall Study|Lost to Follow-up|19|||
146758145|NCT03686683|529281598|FG000|Overall Study|Adverse Event|1|||
146758146|NCT03686683|529281599|FG001|Overall Study|Adverse Event|0|||
146758147|NCT03686683|529281598|FG000|Overall Study|Death|10|||
146758148|NCT03686683|529281599|FG001|Overall Study|Death|5|||
146758149|NCT03686683|529281598|FG000|Overall Study|Progressive Disease|1|||
146758150|NCT03686683|529281599|FG001|Overall Study|Progressive Disease|1|||
146758151|NCT03686683|529281598|FG000|Overall Study|Noncompliance|1|||
146758152|NCT03686683|529281599|FG001|Overall Study|Noncompliance|0|||
146758153|NCT03686683|529281598|FG000|Overall Study|Physician Decision|1|||
146758154|NCT03686683|529281599|FG001|Overall Study|Physician Decision|1|||
146758155|NCT03686683|529281598|FG000|Overall Study|Screen fail post-randomization|1|||
146758156|NCT03686683|529281599|FG001|Overall Study|Screen fail post-randomization|0|||
146758157|NCT03686683|529281598|FG000|Overall Study|Protocol Violation|3|||
146758158|NCT03686683|529281599|FG001|Overall Study|Protocol Violation|0|||
146758159|NCT03686683|529281598|FG000|Overall Study|No data available|1|||
146758160|NCT03686683|529281599|FG001|Overall Study|No data available|0|||
146758161|NCT03255941|529281600|FG000|Overall Study|Not eligible or refused injection|37|||
146758162|NCT03255941|529281601|FG001|Overall Study|Not eligible or refused injection|44|||
146758163|NCT03255941|529281602|FG002|Overall Study|Not eligible or refused injection|5|||
146758164|NCT03255941|529281603|FG003|Overall Study|Not eligible or refused injection|6|||
146758165|NCT03255941|529281600|FG000|Overall Study|Did not complete exit interview|1|||
146758166|NCT03255941|529281601|FG001|Overall Study|Did not complete exit interview|2|||
146758167|NCT03255941|529281602|FG002|Overall Study|Did not complete exit interview|0|||
146758168|NCT03255941|529281603|FG003|Overall Study|Did not complete exit interview|0|||
146758169|NCT00372060|529281604|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
146758170|NCT00372060|529281605|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
146758171|NCT00372060|529281604|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
146758172|NCT00372060|529281605|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
146758173|NCT00372060|529281604|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
146758174|NCT00372060|529281605|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
146758175|NCT00372060|529281604|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
146758176|NCT00372060|529281605|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
146758177|NCT00372060|529281604|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
146758178|NCT00372060|529281605|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
146758179|NCT00372060|529281604|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
146758180|NCT00372060|529281605|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
146758181|NCT01579578|529281617|FG000|Overall Study|Death|4|||
146758182|NCT01579578|529281618|FG001|Overall Study|Death|1|||
146758183|NCT01579578|529281617|FG000|Overall Study|Lost to Follow-up|1|||
146758184|NCT01579578|529281618|FG001|Overall Study|Lost to Follow-up|1|||
146758185|NCT01579578|529281617|FG000|Overall Study|Withdrawal by Subject|2|||
146758186|NCT01579578|529281618|FG001|Overall Study|Withdrawal by Subject|1|||
146758187|NCT01579578|529281617|FG000|Overall Study|Eligibility criteria|3|||
146758188|NCT01579578|529281618|FG001|Overall Study|Eligibility criteria|9|||
146758189|NCT01579578|529281617|FG000|Overall Study|Ongoing|3|||
146758190|NCT01579578|529281618|FG001|Overall Study|Ongoing|0|||
146758191|NCT01004263|529281619|FG000|Overall Study|Adverse Event|15|||
146758192|NCT01004263|529281619|FG000|Overall Study|Withdrawal by Subject|58|||
146758193|NCT01004263|529281619|FG000|Overall Study|Protocol Violation|10|||
146758194|NCT01004263|529281619|FG000|Overall Study|Lost to Follow-up|64|||
146521851|NCT02585713|528419812|FG001|Overall Study|Other|1|||
146758195|NCT01004263|529281619|FG000|Overall Study|Lack of Efficacy|13|||
146758196|NCT01004263|529281619|FG000|Overall Study|Pregnancy|2|||
146758197|NCT01004263|529281619|FG000|Overall Study|Physician Decision|15|||
146758198|NCT01004263|529281619|FG000|Overall Study|Lack of Qualifying Event|2|||
146758199|NCT01770860|529281620|FG000|Overall Study|Withdrawal by Subject|4|||
146758200|NCT01770860|529281620|FG000|Overall Study|Lost to Follow-up|1|||
146758201|NCT01770860|529281620|FG000|Overall Study|Administrative decision made by the PI|1|||
146521852|NCT03173456|528419815|FG000|Baseline|Medication dispensing system malfunction'|0|||
146856247|NCT00112047|529644154|FG001|Randomized Phase|Noncompliance|4|||
146856248|NCT00112047|529644153|FG000|Randomized Phase|Protocol Violation|2|||
146856249|NCT00112047|529644154|FG001|Randomized Phase|Protocol Violation|0|||
146856250|NCT00112047|529644153|FG000|Randomized Phase|Pregnancy|3|||
146856251|NCT00112047|529644154|FG001|Randomized Phase|Pregnancy|1|||
146856252|NCT00112047|529644153|FG000|Randomized Phase|Death|1|||
146856253|NCT00112047|529644154|FG001|Randomized Phase|Death|3|||
146856254|NCT00112047|529644153|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
146856255|NCT00112047|529644154|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
146856256|NCT00112047|529644153|FG000|Randomized Phase|Inability to swallow pills|0|||
146856257|NCT00112047|529644154|FG001|Randomized Phase|Inability to swallow pills|1|||
146856258|NCT00112047|529644153|FG000|Randomized Phase|Incarceration|3|||
146856259|NCT00112047|529644154|FG001|Randomized Phase|Incarceration|2|||
146856260|NCT00112047|529644153|FG000|Randomized Phase|Moved out of State|0|||
146856261|NCT00112047|529644154|FG001|Randomized Phase|Moved out of State|1|||
146856262|NCT00112047|529644153|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
146856263|NCT00112047|529644154|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
146856264|NCT00112047|529644153|FG000|Randomized Phase|High Hepatitis B DNA|0|||
146856265|NCT00112047|529644154|FG001|Randomized Phase|High Hepatitis B DNA|1|||
146856266|NCT00112047|529644153|FG000|Atripla Phase|Adverse Event|2|||
146856267|NCT00112047|529644154|FG001|Atripla Phase|Adverse Event|1|||
146856268|NCT00112047|529644153|FG000|Atripla Phase|Lost to Follow-up|5|||
146856269|NCT00112047|529644154|FG001|Atripla Phase|Lost to Follow-up|7|||
146856270|NCT00112047|529644153|FG000|Atripla Phase|Pregnancy|0|||
146856271|NCT00112047|529644154|FG001|Atripla Phase|Pregnancy|1|||
146856272|NCT00112047|529644153|FG000|Atripla Phase|Death|0|||
146856273|NCT00112047|529644154|FG001|Atripla Phase|Death|2|||
146856274|NCT00112047|529644153|FG000|Atripla Phase|Withdrew consent|7|||
146856275|NCT00112047|529644154|FG001|Atripla Phase|Withdrew consent|7|||
146856276|NCT00112047|529644153|FG000|Atripla Phase|Sub-optimal virological response|0|||
146856277|NCT00112047|529644154|FG001|Atripla Phase|Sub-optimal virological response|1|||
146856278|NCT00112047|529644153|FG000|Atripla Phase|Non-compliance|1|||
146856279|NCT00112047|529644154|FG001|Atripla Phase|Non-compliance|0|||
146856280|NCT00112047|529644153|FG000|Atripla Phase|Other|3|||
146856281|NCT00112047|529644154|FG001|Atripla Phase|Other|1|||
146856282|NCT01307579|529644155|FG000|Overall Study|Death|3|||
146856283|NCT01307579|529644156|FG001|Overall Study|Death|6|||
146856284|NCT01307579|529644155|FG000|Overall Study|Physician Decision|26|||
146856285|NCT01307579|529644156|FG001|Overall Study|Physician Decision|29|||
146856286|NCT01307579|529644155|FG000|Overall Study|Withdrawal by Subject|7|||
146856287|NCT01307579|529644156|FG001|Overall Study|Withdrawal by Subject|3|||
146856288|NCT01307579|529644155|FG000|Overall Study|Institutional diagnosis of IFD|21|||
146856289|NCT01307579|529644156|FG001|Overall Study|Institutional diagnosis of IFD|36|||
146856290|NCT01307579|529644155|FG000|Overall Study|Begin conditioning for HSCT|42|||
146856291|NCT01307579|529644156|FG001|Overall Study|Begin conditioning for HSCT|44|||
146856292|NCT01307579|529644155|FG000|Overall Study|Refractory or relapsed AML|38|||
146856293|NCT01307579|529644156|FG001|Overall Study|Refractory or relapsed AML|23|||
146856294|NCT01307579|529644155|FG000|Overall Study|Ineligible|3|||
146856295|NCT01307579|529644156|FG001|Overall Study|Ineligible|4|||
146856296|NCT03727438|529644157|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
146856297|NCT03727438|529644158|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
146856298|NCT03727438|529644157|FG000|Intervention Period|Excluded (health)|1|||
146856299|NCT03727438|529644158|FG001|Intervention Period|Excluded (health)|0|||
146856300|NCT03727438|529644157|FG000|Intervention Period|Withdrawal by Subject|3|||
146856301|NCT03727438|529644158|FG001|Intervention Period|Withdrawal by Subject|1|||
146856302|NCT03727438|529644157|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
146856303|NCT03727438|529644158|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
146856304|NCT03727438|529644157|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
146856305|NCT03727438|529644158|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
146856306|NCT03727438|529644157|FG000|8 Week Assessment|Withdrawal by Subject|6|||
146856307|NCT03727438|529644158|FG001|8 Week Assessment|Withdrawal by Subject|1|||
146856308|NCT03727438|529644157|FG000|6 mo Assessment|did not complete assessment|10|||
146856309|NCT03727438|529644158|FG001|6 mo Assessment|did not complete assessment|11|||
146856310|NCT03170349|529644165|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
146856311|NCT03170349|529644165|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
146856312|NCT03170349|529644165|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
146856313|NCT03170349|529644165|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
146856314|NCT03170349|529644165|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
146856315|NCT03170349|529644165|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
146856316|NCT03170349|529644165|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
146856317|NCT03170349|529644165|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
146856318|NCT03170349|529644165|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
146521853|NCT03173456|528419816|FG001|Baseline|Medication dispensing system malfunction'|1|||
146521854|NCT03173456|528419817|FG002|Baseline|Medication dispensing system malfunction'|0|||
146856319|NCT03170349|529644165|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
146856320|NCT03170349|529644165|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
146856321|NCT03170349|529644165|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
146856322|NCT03170349|529644165|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
146856323|NCT03170349|529644165|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
146856324|NCT03170349|529644165|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
146856325|NCT03170349|529644165|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
146856326|NCT05195489|529646086|FG000|Overall Study|Lost to Follow-up|1|||
146856327|NCT05195489|529646087|FG001|Overall Study|Lost to Follow-up|0|||
146856328|NCT05195489|529646086|FG000|Overall Study|Protocol Violation|0|||
146856329|NCT05195489|529646087|FG001|Overall Study|Protocol Violation|2|||
146856330|NCT05195489|529646086|FG000|Overall Study|Withdrawal by Subject|1|||
146856331|NCT05195489|529646087|FG001|Overall Study|Withdrawal by Subject|1|||
146856332|NCT05195489|529646086|FG000|Overall Study|Removed|0|||
146521855|NCT03173456|528419818|FG003|Baseline|Medication dispensing system malfunction'|0|||
146856333|NCT05195489|529646087|FG001|Overall Study|Removed|1|||
146856334|NCT03440320|529646089|FG000|Overall Study|Withdrawal by Subject|0|||
146856335|NCT03440320|529646090|FG001|Overall Study|Withdrawal by Subject|1|||
146856336|NCT00409773|529646091|FG000|Overall Study|Adverse Event|3|||
146521856|NCT03173456|528419819|FG004|Baseline|Medication dispensing system malfunction'|2|||
146521857|NCT03173456|528419815|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
146521858|NCT03173456|528419816|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
146521859|NCT03173456|528419817|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
146521860|NCT03173456|528419818|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
146521861|NCT03173456|528419819|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
146521862|NCT01733121|528419820|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
146521863|NCT01733121|528419821|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
146521864|NCT01733121|528419820|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
146521865|NCT01733121|528419821|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
146521866|NCT01733121|528419820|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
146521867|NCT01733121|528419821|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
146521868|NCT01733121|528419820|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
146521869|NCT01733121|528419821|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
146521870|NCT03061188|528419824|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
146521871|NCT03061188|528419825|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
146521872|NCT03061188|528419826|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
146521873|NCT03061188|528419827|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
146521874|NCT03061188|528419824|FG000|On Follow-up for 3 Years|Death|0|||
146521875|NCT03061188|528419825|FG001|On Follow-up for 3 Years|Death|3|||
146521876|NCT03061188|528419826|FG002|On Follow-up for 3 Years|Death|5|||
146521877|NCT03061188|528419827|FG003|On Follow-up for 3 Years|Death|4|||
146521878|NCT03061188|528419824|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
146521879|NCT03061188|528419825|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
146521880|NCT03061188|528419826|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
146521881|NCT03061188|528419827|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
146521882|NCT02609984|528419829|FG000|Overall Study|Death|29|||
146521883|NCT02609984|528419830|FG001|Overall Study|Death|26|||
146521884|NCT02609984|528419829|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
146521885|NCT02609984|528419830|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
146521886|NCT02609984|528419829|FG000|Overall Study|Lost to Follow-up|1|||
146521887|NCT02609984|528419830|FG001|Overall Study|Lost to Follow-up|2|||
146521888|NCT02609984|528419829|FG000|Overall Study|Withdrawal by Subject|0|||
146521889|NCT02609984|528419830|FG001|Overall Study|Withdrawal by Subject|1|||
146521890|NCT02609984|528419829|FG000|Overall Study|Disease Progression|2|||
146521891|NCT02609984|528419830|FG001|Overall Study|Disease Progression|0|||
146521892|NCT02306850|528419836|FG000|Overall Study|Lack of Efficacy|2|||
146521893|NCT02420262|528419837|FG000|Overall Study|Adverse Event|1|||
146521894|NCT02420262|528419838|FG001|Overall Study|Adverse Event|0|||
146521895|NCT02420262|528419837|FG000|Overall Study|Withdrawal by Subject|1|||
146521896|NCT02420262|528419838|FG001|Overall Study|Withdrawal by Subject|4|||
146521897|NCT02420262|528419837|FG000|Overall Study|Unclassified|0|||
146521898|NCT02420262|528419838|FG001|Overall Study|Unclassified|1|||
146521899|NCT00941304|528419839|FG000|Overall Study|Lost to Follow-up|1|||
146521900|NCT00941304|528419840|FG001|Overall Study|Lost to Follow-up|0|||
146521901|NCT00941304|528419841|FG002|Overall Study|Lost to Follow-up|0|||
146521902|NCT00941304|528419842|FG003|Overall Study|Lost to Follow-up|0|||
146521903|NCT00941304|528419843|FG004|Overall Study|Lost to Follow-up|0|||
146521904|NCT05415462|528419850|FG000|Overall Study|Death|18|||
146856337|NCT00409773|529646092|FG001|Overall Study|Adverse Event|4|||
146856338|NCT00409773|529646093|FG002|Overall Study|Adverse Event|4|||
146521905|NCT05415462|528419851|FG001|Overall Study|Death|10|||
146521906|NCT05415462|528419850|FG000|Overall Study|Lost to Follow-up|72|||
146856339|NCT00409773|529646094|FG003|Overall Study|Adverse Event|2|||
146856340|NCT00409773|529646095|FG004|Overall Study|Adverse Event|6|||
146521907|NCT05415462|528419851|FG001|Overall Study|Lost to Follow-up|64|||
146521908|NCT05415462|528419850|FG000|Overall Study|Physician Decision|5|||
146521909|NCT05415462|528419851|FG001|Overall Study|Physician Decision|5|||
146521910|NCT05415462|528419850|FG000|Overall Study|Protocol Deviation|1|||
146521911|NCT05415462|528419851|FG001|Overall Study|Protocol Deviation|0|||
146521912|NCT05415462|528419850|FG000|Overall Study|Withdrawal by Subject|129|||
146521913|NCT05415462|528419851|FG001|Overall Study|Withdrawal by Subject|101|||
146521914|NCT05415462|528419850|FG000|Overall Study|Other Than Specified|8|||
146521915|NCT05415462|528419851|FG001|Overall Study|Other Than Specified|8|||
146521916|NCT01087203|528419856|FG000|Overall Study|Lost to Follow-up|2|||
146521917|NCT01087203|528419857|FG001|Overall Study|Lost to Follow-up|0|||
146521918|NCT01087203|528419856|FG000|Overall Study|Withdrawal by Subject|2|||
146521919|NCT01087203|528419857|FG001|Overall Study|Withdrawal by Subject|6|||
146856341|NCT00409773|529646091|FG000|Overall Study|Lost to Follow-up|6|||
146856342|NCT00409773|529646092|FG001|Overall Study|Lost to Follow-up|1|||
146856343|NCT00409773|529646093|FG002|Overall Study|Lost to Follow-up|2|||
146856344|NCT00409773|529646094|FG003|Overall Study|Lost to Follow-up|3|||
146856345|NCT00409773|529646095|FG004|Overall Study|Lost to Follow-up|1|||
146856346|NCT00409773|529646091|FG000|Overall Study|Physician Decision|0|||
146856347|NCT00409773|529646092|FG001|Overall Study|Physician Decision|0|||
146856348|NCT00409773|529646093|FG002|Overall Study|Physician Decision|0|||
146856349|NCT00409773|529646094|FG003|Overall Study|Physician Decision|2|||
146856350|NCT00409773|529646095|FG004|Overall Study|Physician Decision|0|||
146856351|NCT00409773|529646091|FG000|Overall Study|Protocol Violation|0|||
146856352|NCT00409773|529646092|FG001|Overall Study|Protocol Violation|2|||
146856353|NCT00409773|529646093|FG002|Overall Study|Protocol Violation|3|||
146856354|NCT00409773|529646094|FG003|Overall Study|Protocol Violation|3|||
146856355|NCT00409773|529646095|FG004|Overall Study|Protocol Violation|1|||
146856356|NCT00409773|529646091|FG000|Overall Study|Withdrawal by Subject|0|||
146856357|NCT00409773|529646092|FG001|Overall Study|Withdrawal by Subject|0|||
146856358|NCT00409773|529646093|FG002|Overall Study|Withdrawal by Subject|0|||
146856359|NCT00409773|529646094|FG003|Overall Study|Withdrawal by Subject|2|||
146856360|NCT00409773|529646095|FG004|Overall Study|Withdrawal by Subject|1|||
146856361|NCT00409773|529646091|FG000|Overall Study|Lack of Eligibility|0|||
146856362|NCT00409773|529646092|FG001|Overall Study|Lack of Eligibility|0|||
146856363|NCT00409773|529646093|FG002|Overall Study|Lack of Eligibility|0|||
146856364|NCT00409773|529646094|FG003|Overall Study|Lack of Eligibility|0|||
146856365|NCT00409773|529646095|FG004|Overall Study|Lack of Eligibility|1|||
146856366|NCT01201343|529646096|FG000|Overall Study|Adverse Event|6|||
146856367|NCT01201343|529646096|FG000|Overall Study|Withdrawal by Subject|5|||
146856368|NCT01201343|529646096|FG000|Overall Study|Lost to Follow-up|2|||
146856369|NCT01201343|529646096|FG000|Overall Study|Lack of Efficacy|2|||
146856370|NCT01201343|529646096|FG000|Overall Study|Participant wrongly included in trial|1|||
146856371|NCT01201343|529646096|FG000|Overall Study|Randomized, not treated|3|||
146856372|NCT01919814|529646097|FG000|Overall Study|Adverse Event|1|||
146856373|NCT01919814|529646098|FG001|Overall Study|Adverse Event|0|||
146856374|NCT01919814|529646097|FG000|Overall Study|Protocol Violation|1|||
146856375|NCT01919814|529646098|FG001|Overall Study|Protocol Violation|0|||
146856376|NCT01919814|529646097|FG000|Overall Study|Withdrawal by Subject|1|||
146856377|NCT01919814|529646098|FG001|Overall Study|Withdrawal by Subject|0|||
146856378|NCT01440374|529646100|FG000|Part 1: Open-label Phase|Adverse Event|5|||
146856379|NCT01440374|529646101|FG001|Part 1: Open-label Phase|Adverse Event|0|||
146856380|NCT01440374|529646102|FG002|Part 1: Open-label Phase|Adverse Event|0|||
146856381|NCT01440374|529646103|FG003|Part 1: Open-label Phase|Adverse Event|0|||
146856382|NCT01440374|529646100|FG000|Part 1: Open-label Phase|Physician Decision|1|||
146856383|NCT01440374|529646101|FG001|Part 1: Open-label Phase|Physician Decision|0|||
146856384|NCT01440374|529646102|FG002|Part 1: Open-label Phase|Physician Decision|0|||
146856385|NCT01440374|529646103|FG003|Part 1: Open-label Phase|Physician Decision|0|||
146856386|NCT01440374|529646100|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
146856387|NCT01440374|529646101|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
146521920|NCT01087203|528419856|FG000|Overall Study|Lack of Efficacy|1|||
146521921|NCT01087203|528419857|FG001|Overall Study|Lack of Efficacy|2|||
146521922|NCT01087203|528419856|FG000|Overall Study|Study terminated by sponsor|27|||
146521923|NCT01087203|528419857|FG001|Overall Study|Study terminated by sponsor|27|||
146521924|NCT02559570|528419859|FG000|Overall Study|Adverse Event|0|||
146521925|NCT02559570|528419860|FG001|Overall Study|Adverse Event|2|||
146521926|NCT02559570|528419861|FG002|Overall Study|Adverse Event|0|||
146856388|NCT01440374|529646102|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
146856389|NCT01440374|529646103|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
146856390|NCT01440374|529646100|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
146856391|NCT01440374|529646101|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
146856392|NCT01440374|529646102|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
146521927|NCT02559570|528419862|FG003|Overall Study|Adverse Event|1|||
146856393|NCT01440374|529646103|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
146521928|NCT02559570|528419863|FG004|Overall Study|Adverse Event|0|||
146521929|NCT02559570|528419859|FG000|Overall Study|Withdrawal of Consent|0|||
146521930|NCT02559570|528419860|FG001|Overall Study|Withdrawal of Consent|0|||
146856394|NCT01440374|529646100|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
146856395|NCT01440374|529646101|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
146856396|NCT01440374|529646102|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
146856397|NCT01440374|529646103|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
146856398|NCT01440374|529646100|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
146856399|NCT01440374|529646101|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
146856400|NCT01440374|529646102|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
146856401|NCT01440374|529646103|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
146856402|NCT01440374|529646100|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
146856403|NCT01440374|529646101|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
146856404|NCT01440374|529646102|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
146856405|NCT01440374|529646103|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
146856406|NCT01440374|529646100|FG000|Part 2; Double-blind Phase|Not treated|0|||
146856407|NCT01440374|529646101|FG001|Part 2; Double-blind Phase|Not treated|0|||
146856408|NCT01440374|529646102|FG002|Part 2; Double-blind Phase|Not treated|1|||
146856409|NCT01440374|529646103|FG003|Part 2; Double-blind Phase|Not treated|0|||
146856410|NCT01440374|529646100|FG000|Part 3: Extension|Withdrawal by Subject|0|||
146856411|NCT01440374|529646101|FG001|Part 3: Extension|Withdrawal by Subject|0|||
146856412|NCT01440374|529646102|FG002|Part 3: Extension|Withdrawal by Subject|0|||
146856413|NCT01440374|529646103|FG003|Part 3: Extension|Withdrawal by Subject|5|||
146856414|NCT01440374|529646100|FG000|Part 3: Extension|Adverse Event|0|||
146856415|NCT01440374|529646101|FG001|Part 3: Extension|Adverse Event|0|||
146856416|NCT01440374|529646102|FG002|Part 3: Extension|Adverse Event|0|||
146856417|NCT01440374|529646103|FG003|Part 3: Extension|Adverse Event|13|||
146856418|NCT01440374|529646100|FG000|Part 3: Extension|Physician Decision|0|||
146856419|NCT01440374|529646101|FG001|Part 3: Extension|Physician Decision|0|||
146856420|NCT01440374|529646102|FG002|Part 3: Extension|Physician Decision|0|||
146856421|NCT01440374|529646103|FG003|Part 3: Extension|Physician Decision|14|||
146856422|NCT01036763|529646104|FG000|Overall Study|Adverse Event|25|||
146856423|NCT01036763|529646104|FG000|Overall Study|Lost to Follow-up|28|||
146856424|NCT01036763|529646104|FG000|Overall Study|Other reason (not specified)|40|||
146856425|NCT04812548|529646106|FG000|Overall Study|Adverse Event|2|||
146856426|NCT04812548|529646107|FG001|Overall Study|Adverse Event|7|||
146856427|NCT04812548|529646106|FG000|Overall Study|HSCT Planned|2|||
146856428|NCT04812548|529646107|FG001|Overall Study|HSCT Planned|3|||
146856429|NCT04812548|529646106|FG000|Overall Study|Progressive Disease|0|||
146856430|NCT04812548|529646107|FG001|Overall Study|Progressive Disease|2|||
146856431|NCT04812548|529646106|FG000|Overall Study|Death|0|||
146856432|NCT04812548|529646107|FG001|Overall Study|Death|1|||
146856433|NCT04812548|529646106|FG000|Overall Study|Post Study Access to Treatment|0|||
146856434|NCT04812548|529646107|FG001|Overall Study|Post Study Access to Treatment|1|||
146856435|NCT04812548|529646106|FG000|Overall Study|Withdrawal by Subject|0|||
146856436|NCT04812548|529646107|FG001|Overall Study|Withdrawal by Subject|1|||
146856437|NCT04812548|529646106|FG000|Overall Study|Physician Decision|1|||
146856438|NCT04812548|529646107|FG001|Overall Study|Physician Decision|0|||
146856439|NCT02141984|529646113|FG000|Overall Study|Lack of Efficacy|2|||
146856440|NCT05220254|529646114|FG000|Overall Study|Withdrawal by Subject|4|||
146856441|NCT05220254|529646114|FG000|Overall Study|Removed due to ineligibility|1|||
146856442|NCT05220254|529646114|FG000|Overall Study|Lost to Follow-up|7|||
146856443|NCT03184870|529646116|FG000|Initial Treatment|Death|6|||
146856444|NCT03184870|529646117|FG001|Initial Treatment|Death|6|||
146856445|NCT03184870|529646118|FG002|Initial Treatment|Death|8|||
146856446|NCT03184870|529646119|FG003|Initial Treatment|Death|8|||
146856447|NCT03184870|529646120|FG004|Initial Treatment|Death|6|||
146856448|NCT03184870|529646121|FG005|Initial Treatment|Death|6|||
146856449|NCT03184870|529646122|FG006|Initial Treatment|Death|6|||
146856450|NCT03184870|529646123|FG007|Initial Treatment|Death|7|||
146856451|NCT03184870|529646124|FG008|Initial Treatment|Death|1|||
146856452|NCT03184870|529646125|FG009|Initial Treatment|Death|2|||
146856453|NCT03184870|529646126|FG010|Initial Treatment|Death|26|||
146856454|NCT03184870|529646127|FG011|Initial Treatment|Death|28|||
146856455|NCT03184870|529646128|FG012|Initial Treatment|Death|10|||
146856456|NCT03184870|529646129|FG013|Initial Treatment|Death|33|||
146856457|NCT03184870|529646130|FG014|Initial Treatment|Death|34|||
146856458|NCT03184870|529646131|FG015|Initial Treatment|Death|26|||
146856459|NCT03184870|529646132|FG016|Initial Treatment|Death|20|||
146856460|NCT03184870|529646133|FG017|Initial Treatment|Death|18|||
146856461|NCT03184870|529646116|FG000|Initial Treatment|Other Reasons|2|||
146856462|NCT03184870|529646117|FG001|Initial Treatment|Other Reasons|2|||
146856463|NCT03184870|529646118|FG002|Initial Treatment|Other Reasons|0|||
146856464|NCT03184870|529646119|FG003|Initial Treatment|Other Reasons|1|||
146856465|NCT03184870|529646120|FG004|Initial Treatment|Other Reasons|0|||
146856466|NCT03184870|529646121|FG005|Initial Treatment|Other Reasons|0|||
146856467|NCT03184870|529646122|FG006|Initial Treatment|Other Reasons|0|||
146856468|NCT03184870|529646123|FG007|Initial Treatment|Other Reasons|2|||
146856469|NCT03184870|529646124|FG008|Initial Treatment|Other Reasons|0|||
146856470|NCT03184870|529646125|FG009|Initial Treatment|Other Reasons|0|||
146856471|NCT03184870|529646126|FG010|Initial Treatment|Other Reasons|4|||
146856472|NCT03184870|529646127|FG011|Initial Treatment|Other Reasons|2|||
146521931|NCT02559570|528419861|FG002|Overall Study|Withdrawal of Consent|1|||
146521932|NCT02559570|528419862|FG003|Overall Study|Withdrawal of Consent|2|||
146521933|NCT02559570|528419863|FG004|Overall Study|Withdrawal of Consent|1|||
146521934|NCT02559570|528419859|FG000|Overall Study|Lost to Follow-up|1|||
146521935|NCT02559570|528419860|FG001|Overall Study|Lost to Follow-up|0|||
146521936|NCT02559570|528419861|FG002|Overall Study|Lost to Follow-up|0|||
146521937|NCT02559570|528419862|FG003|Overall Study|Lost to Follow-up|0|||
146521938|NCT02559570|528419863|FG004|Overall Study|Lost to Follow-up|0|||
146758202|NCT01528709|529281621|FG000|Overall Study|Death|2|||
146758203|NCT01528709|529281622|FG001|Overall Study|Death|0|||
146758204|NCT01528709|529281621|FG000|Overall Study|Withdrawal by Subject|10|||
146758205|NCT01528709|529281622|FG001|Overall Study|Withdrawal by Subject|15|||
146758206|NCT01528709|529281621|FG000|Overall Study|allergy|1|||
146758207|NCT01528709|529281622|FG001|Overall Study|allergy|0|||
146758208|NCT01237678|529281623|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
146758209|NCT01237678|529281624|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
146758210|NCT01237678|529281625|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
146758211|NCT01237678|529281623|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
146758212|NCT01237678|529281624|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
146758213|NCT01237678|529281625|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
146758214|NCT01237678|529281623|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
146758215|NCT01237678|529281624|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
146758216|NCT01237678|529281625|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
146758217|NCT01237678|529281623|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
146758218|NCT01237678|529281624|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
146758219|NCT01237678|529281625|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
146758220|NCT01237678|529281623|FG000|Phase II|Adverse Event|0|||
146758221|NCT01237678|529281624|FG001|Phase II|Adverse Event|39|||
146758222|NCT01237678|529281625|FG002|Phase II|Adverse Event|9|||
146758223|NCT01237678|529281623|FG000|Phase II|Death|0|||
146758224|NCT01237678|529281624|FG001|Phase II|Death|0|||
146758225|NCT01237678|529281625|FG002|Phase II|Death|2|||
146758226|NCT01237678|529281623|FG000|Phase II|Lack of Efficacy|0|||
146758227|NCT01237678|529281624|FG001|Phase II|Lack of Efficacy|25|||
146758228|NCT01237678|529281625|FG002|Phase II|Lack of Efficacy|3|||
146758229|NCT01237678|529281623|FG000|Phase II|Withdrawal by Subject|0|||
146758230|NCT01237678|529281624|FG001|Phase II|Withdrawal by Subject|1|||
146758231|NCT01237678|529281625|FG002|Phase II|Withdrawal by Subject|5|||
146758232|NCT01237678|529281623|FG000|Phase II|Completed Cycles 4-6|0|||
146758233|NCT01237678|529281624|FG001|Phase II|Completed Cycles 4-6|11|||
146758234|NCT01237678|529281625|FG002|Phase II|Completed Cycles 4-6|21|||
146758235|NCT01237678|529281623|FG000|Phase II|Sponsor Decision/Study Closed|0|||
146758236|NCT01237678|529281624|FG001|Phase II|Sponsor Decision/Study Closed|18|||
146758237|NCT01237678|529281625|FG002|Phase II|Sponsor Decision/Study Closed|7|||
146758238|NCT01237678|529281623|FG000|Phase II|Randomized but were not treated|0|||
146758239|NCT01237678|529281624|FG001|Phase II|Randomized but were not treated|4|||
146758240|NCT01237678|529281625|FG002|Phase II|Randomized but were not treated|3|||
146758241|NCT05124899|529281629|FG000|Overall Study|Lost to Follow-up|3|||
146758242|NCT03432533|529281633|FG000|Overall Study|Lost to Follow-up|1|||
146758243|NCT03432533|529281634|FG001|Overall Study|Lost to Follow-up|2|||
146758244|NCT03432533|529281633|FG000|Overall Study|Withdrawal by Subject|14|||
146758245|NCT03432533|529281634|FG001|Overall Study|Withdrawal by Subject|9|||
146758246|NCT01648283|529281635|FG000|Overall Study|Withdrawal by Subject|14|||
146758247|NCT00797225|529281639|FG000|Weeks 1 to 12|Adverse Event|0|||
146758248|NCT00797225|529281640|FG001|Weeks 1 to 12|Adverse Event|0|||
146758249|NCT00797225|529281641|FG002|Weeks 1 to 12|Adverse Event|1|||
146758250|NCT00797225|529281642|FG003|Weeks 1 to 12|Adverse Event|0|||
146758251|NCT00797225|529281643|FG004|Weeks 1 to 12|Adverse Event|0|||
146758252|NCT00797225|529281644|FG005|Weeks 1 to 12|Adverse Event|0|||
146758253|NCT00797225|529281645|FG006|Weeks 1 to 12|Adverse Event|0|||
146758254|NCT00797225|529281646|FG007|Weeks 1 to 12|Adverse Event|0|||
146758255|NCT00797225|529281639|FG000|Weeks 1 to 12|Non-compliance|0|||
146758256|NCT00797225|529281640|FG001|Weeks 1 to 12|Non-compliance|1|||
146758257|NCT00797225|529281641|FG002|Weeks 1 to 12|Non-compliance|0|||
146758258|NCT00797225|529281642|FG003|Weeks 1 to 12|Non-compliance|0|||
146758259|NCT00797225|529281643|FG004|Weeks 1 to 12|Non-compliance|0|||
146758260|NCT00797225|529281644|FG005|Weeks 1 to 12|Non-compliance|0|||
146758261|NCT00797225|529281645|FG006|Weeks 1 to 12|Non-compliance|0|||
146758262|NCT00797225|529281646|FG007|Weeks 1 to 12|Non-compliance|0|||
146758263|NCT00797225|529281639|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
146758264|NCT00797225|529281640|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
146758265|NCT00797225|529281641|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
146758266|NCT00797225|529281642|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
146758267|NCT00797225|529281643|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
146758268|NCT00797225|529281644|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
146521939|NCT02559570|528419859|FG000|Overall Study|Protocol Violation|1|||
146521940|NCT02559570|528419860|FG001|Overall Study|Protocol Violation|0|||
146521941|NCT02559570|528419861|FG002|Overall Study|Protocol Violation|0|||
146521942|NCT02559570|528419862|FG003|Overall Study|Protocol Violation|0|||
146521943|NCT02559570|528419863|FG004|Overall Study|Protocol Violation|1|||
146521944|NCT02559570|528419859|FG000|Overall Study|Other Miscellaneous Reasons|0|||
146521945|NCT02559570|528419860|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146521946|NCT02559570|528419861|FG002|Overall Study|Other Miscellaneous Reasons|1|||
146521947|NCT02559570|528419862|FG003|Overall Study|Other Miscellaneous Reasons|0|||
146758269|NCT00797225|529281645|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
146758270|NCT00797225|529281646|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
146758271|NCT00797225|529281639|FG000|Weeks 1 to 12|Sponsor Decision|1|||
146758272|NCT00797225|529281640|FG001|Weeks 1 to 12|Sponsor Decision|0|||
146758273|NCT00797225|529281641|FG002|Weeks 1 to 12|Sponsor Decision|0|||
146758274|NCT00797225|529281642|FG003|Weeks 1 to 12|Sponsor Decision|0|||
146758275|NCT00797225|529281643|FG004|Weeks 1 to 12|Sponsor Decision|0|||
146758276|NCT00797225|529281644|FG005|Weeks 1 to 12|Sponsor Decision|0|||
146758277|NCT00797225|529281645|FG006|Weeks 1 to 12|Sponsor Decision|0|||
146758278|NCT00797225|529281646|FG007|Weeks 1 to 12|Sponsor Decision|0|||
146758279|NCT00797225|529281639|FG000|Weeks 13 to 24|Non-compliance|0|||
146758280|NCT00797225|529281640|FG001|Weeks 13 to 24|Non-compliance|2|||
146758281|NCT00797225|529281641|FG002|Weeks 13 to 24|Non-compliance|0|||
146758282|NCT00797225|529281642|FG003|Weeks 13 to 24|Non-compliance|0|||
146758283|NCT00797225|529281643|FG004|Weeks 13 to 24|Non-compliance|0|||
146758284|NCT00797225|529281644|FG005|Weeks 13 to 24|Non-compliance|0|||
146758285|NCT00797225|529281645|FG006|Weeks 13 to 24|Non-compliance|0|||
146758286|NCT00797225|529281646|FG007|Weeks 13 to 24|Non-compliance|0|||
146758287|NCT00797225|529281639|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
146758288|NCT00797225|529281640|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
146758289|NCT00797225|529281641|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
146758290|NCT00797225|529281642|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
146758291|NCT00797225|529281643|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
146758292|NCT00797225|529281644|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
146758293|NCT00797225|529281645|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
146758294|NCT00797225|529281646|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
146758295|NCT00797225|529281639|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
146758296|NCT00797225|529281640|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
146758297|NCT00797225|529281641|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
146758298|NCT00797225|529281642|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
146758299|NCT00797225|529281643|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
146758300|NCT00797225|529281644|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
146758301|NCT00797225|529281645|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
146758302|NCT00797225|529281646|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
146758303|NCT00797225|529281639|FG000|Weeks 13 to 24|Adverse Event|0|||
146758304|NCT00797225|529281640|FG001|Weeks 13 to 24|Adverse Event|1|||
146758305|NCT00797225|529281641|FG002|Weeks 13 to 24|Adverse Event|0|||
146758306|NCT00797225|529281642|FG003|Weeks 13 to 24|Adverse Event|0|||
146758307|NCT00797225|529281643|FG004|Weeks 13 to 24|Adverse Event|0|||
146758308|NCT00797225|529281644|FG005|Weeks 13 to 24|Adverse Event|0|||
146758309|NCT00797225|529281645|FG006|Weeks 13 to 24|Adverse Event|1|||
146758310|NCT00797225|529281646|FG007|Weeks 13 to 24|Adverse Event|0|||
146758311|NCT00797225|529281639|FG000|Weeks 13 to 24|Sponsor Decision|0|||
146758312|NCT00797225|529281640|FG001|Weeks 13 to 24|Sponsor Decision|0|||
146758313|NCT00797225|529281641|FG002|Weeks 13 to 24|Sponsor Decision|0|||
146856473|NCT03184870|529646128|FG012|Initial Treatment|Other Reasons|2|||
146856474|NCT03184870|529646129|FG013|Initial Treatment|Other Reasons|0|||
146856475|NCT03184870|529646130|FG014|Initial Treatment|Other Reasons|0|||
146521948|NCT02559570|528419863|FG004|Overall Study|Other Miscellaneous Reasons|0|||
146521949|NCT05095311|528419870|FG000|Overall Study|Lost to Follow-up|7|||
146521950|NCT05095311|528419871|FG001|Overall Study|Lost to Follow-up|0|||
146521951|NCT05095311|528419872|FG002|Overall Study|Lost to Follow-up|0|||
146521952|NCT02588664|528419877|FG000|Overall Study|Death|56|||
146521953|NCT02588664|528419878|FG001|Overall Study|Death|55|||
146521954|NCT02588664|528419877|FG000|Overall Study|Lost to Follow-up|1305|||
146521955|NCT02588664|528419878|FG001|Overall Study|Lost to Follow-up|990|||
146521956|NCT00534638|528419881|FG000|Overall Study|Withdrawal by Subject|3|||
146521957|NCT00534638|528419882|FG001|Overall Study|Withdrawal by Subject|4|||
146521958|NCT00534638|528419881|FG000|Overall Study|Migrated/moved from study area|13|||
146521959|NCT00534638|528419882|FG001|Overall Study|Migrated/moved from study area|11|||
146521960|NCT00534638|528419881|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
146758314|NCT00797225|529281642|FG003|Weeks 13 to 24|Sponsor Decision|0|||
146758315|NCT00797225|529281643|FG004|Weeks 13 to 24|Sponsor Decision|0|||
146758316|NCT00797225|529281644|FG005|Weeks 13 to 24|Sponsor Decision|0|||
146758317|NCT00797225|529281645|FG006|Weeks 13 to 24|Sponsor Decision|1|||
146758318|NCT00797225|529281646|FG007|Weeks 13 to 24|Sponsor Decision|0|||
146758319|NCT00578227|529281647|FG000|Overall Study|Lost to Follow-up|0|||
146758320|NCT00578227|529281648|FG001|Overall Study|Lost to Follow-up|1|||
146521961|NCT00534638|528419882|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
146856476|NCT03184870|529646131|FG015|Initial Treatment|Other Reasons|1|||
146521962|NCT00534638|528419881|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
146521963|NCT00534638|528419882|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
146758321|NCT00578227|529281649|FG002|Overall Study|Lost to Follow-up|1|||
146758322|NCT00578227|529281647|FG000|Overall Study|Withdrawal by Subject|5|||
146758323|NCT00578227|529281648|FG001|Overall Study|Withdrawal by Subject|1|||
146758324|NCT00578227|529281649|FG002|Overall Study|Withdrawal by Subject|3|||
146758325|NCT01511250|529281650|FG000|Overall Study|Withdrawal of Consent|1|||
146758326|NCT01511250|529281651|FG001|Overall Study|Withdrawal of Consent|0|||
146758327|NCT01511250|529281652|FG002|Overall Study|Withdrawal of Consent|0|||
146758328|NCT01511250|529281653|FG003|Overall Study|Withdrawal of Consent|0|||
146758329|NCT01511250|529281654|FG004|Overall Study|Withdrawal of Consent|0|||
146758330|NCT01511250|529281655|FG005|Overall Study|Withdrawal of Consent|0|||
146758331|NCT01511250|529281656|FG006|Overall Study|Withdrawal of Consent|0|||
146758332|NCT01511250|529281657|FG007|Overall Study|Withdrawal of Consent|1|||
146758333|NCT01511250|529281658|FG008|Overall Study|Withdrawal of Consent|1|||
146758334|NCT01511250|529281659|FG009|Overall Study|Withdrawal of Consent|0|||
146758335|NCT01511250|529281650|FG000|Overall Study|Sponsor/Investigator Decision|1|||
146758336|NCT01511250|529281651|FG001|Overall Study|Sponsor/Investigator Decision|0|||
146758337|NCT01511250|529281652|FG002|Overall Study|Sponsor/Investigator Decision|0|||
146758338|NCT01511250|529281653|FG003|Overall Study|Sponsor/Investigator Decision|0|||
146758339|NCT01511250|529281654|FG004|Overall Study|Sponsor/Investigator Decision|0|||
146758340|NCT01511250|529281655|FG005|Overall Study|Sponsor/Investigator Decision|0|||
146758341|NCT01511250|529281656|FG006|Overall Study|Sponsor/Investigator Decision|0|||
146758342|NCT01511250|529281657|FG007|Overall Study|Sponsor/Investigator Decision|0|||
146758343|NCT01511250|529281658|FG008|Overall Study|Sponsor/Investigator Decision|0|||
146758344|NCT01511250|529281659|FG009|Overall Study|Sponsor/Investigator Decision|0|||
146758345|NCT01511250|529281650|FG000|Overall Study|Lost to Follow-up|7|||
146758346|NCT01511250|529281651|FG001|Overall Study|Lost to Follow-up|3|||
146758347|NCT01511250|529281652|FG002|Overall Study|Lost to Follow-up|3|||
146758348|NCT01511250|529281653|FG003|Overall Study|Lost to Follow-up|3|||
146758349|NCT01511250|529281654|FG004|Overall Study|Lost to Follow-up|0|||
146758350|NCT01511250|529281655|FG005|Overall Study|Lost to Follow-up|0|||
146758351|NCT01511250|529281656|FG006|Overall Study|Lost to Follow-up|2|||
146758352|NCT01511250|529281657|FG007|Overall Study|Lost to Follow-up|3|||
146758353|NCT01511250|529281658|FG008|Overall Study|Lost to Follow-up|13|||
146758354|NCT01511250|529281659|FG009|Overall Study|Lost to Follow-up|5|||
146758355|NCT01511250|529281650|FG000|Overall Study|Protocol Violation|0|||
146758356|NCT01511250|529281651|FG001|Overall Study|Protocol Violation|2|||
146758357|NCT01511250|529281652|FG002|Overall Study|Protocol Violation|1|||
146758358|NCT01511250|529281653|FG003|Overall Study|Protocol Violation|0|||
146758359|NCT01511250|529281654|FG004|Overall Study|Protocol Violation|0|||
146758360|NCT01511250|529281655|FG005|Overall Study|Protocol Violation|0|||
146758361|NCT01511250|529281656|FG006|Overall Study|Protocol Violation|0|||
146758362|NCT01511250|529281657|FG007|Overall Study|Protocol Violation|0|||
146758363|NCT01511250|529281658|FG008|Overall Study|Protocol Violation|0|||
146758364|NCT01511250|529281659|FG009|Overall Study|Protocol Violation|0|||
146758365|NCT01763047|529281664|FG000|Period 1|Test Article Not Available|4|||
146758366|NCT01763047|529281665|FG001|Period 1|Test Article Not Available|1|||
146758367|NCT01763047|529281664|FG000|Period 1|Protocol Violation|4|||
146758368|NCT01763047|529281665|FG001|Period 1|Protocol Violation|4|||
146758369|NCT01763047|529281664|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
146758370|NCT01763047|529281665|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
146758371|NCT01763047|529281664|FG000|Period 1|Adverse Event|0|||
146758372|NCT01763047|529281665|FG001|Period 1|Adverse Event|1|||
146758373|NCT01763047|529281664|FG000|Period 1|Unsatisfactory Visual Response|0|||
146758374|NCT01763047|529281665|FG001|Period 1|Unsatisfactory Visual Response|3|||
146758375|NCT01763047|529281664|FG000|Period 1|Lens Power Not Available|0|||
146758376|NCT01763047|529281665|FG001|Period 1|Lens Power Not Available|1|||
146758377|NCT01763047|529281664|FG000|Period 1|Study Site office Closed|0|||
146758378|NCT01763047|529281665|FG001|Period 1|Study Site office Closed|1|||
146758379|NCT01763047|529281664|FG000|Period 2|Lens Discomfort|1|||
146758380|NCT01763047|529281665|FG001|Period 2|Lens Discomfort|0|||
146758381|NCT01763047|529281664|FG000|Period 2|No longer meets Eligibility Criteria|1|||
146758382|NCT01763047|529281665|FG001|Period 2|No longer meets Eligibility Criteria|0|||
146758383|NCT01763047|529281664|FG000|Period 2|Study Site office Closed|1|||
146758384|NCT01763047|529281665|FG001|Period 2|Study Site office Closed|1|||
146758385|NCT01763047|529281664|FG000|Period 2|Unsatisfactory Visual Response|1|||
146758386|NCT01763047|529281665|FG001|Period 2|Unsatisfactory Visual Response|1|||
146758387|NCT01763047|529281664|FG000|Period 2|Protocol Violation|0|||
146758388|NCT01763047|529281665|FG001|Period 2|Protocol Violation|2|||
146758389|NCT01763047|529281664|FG000|Period 2|Unsatisfactory lens Fitting|0|||
146758390|NCT01763047|529281665|FG001|Period 2|Unsatisfactory lens Fitting|1|||
146758391|NCT00916006|529281669|FG000|Overall Study|Adverse Event|1|||
146758392|NCT00916006|529281670|FG001|Overall Study|Adverse Event|1|||
146758393|NCT00916006|529281669|FG000|Overall Study|Withdrawal by Subject|2|||
146758394|NCT00916006|529281670|FG001|Overall Study|Withdrawal by Subject|5|||
146521964|NCT00534638|528419881|FG000|Overall Study|Other|1685|||
146758395|NCT00916006|529281669|FG000|Overall Study|Protocol Violation|0|||
146758396|NCT00916006|529281670|FG001|Overall Study|Protocol Violation|1|||
146856477|NCT03184870|529646132|FG016|Initial Treatment|Other Reasons|0|||
146521965|NCT00534638|528419882|FG001|Overall Study|Other|902|||
146521966|NCT02903420|528419885|FG000|Overall Study|Death|3|||
146521967|NCT02500719|528419888|FG000|Overall Study|Lost to Follow-up|2|||
146521968|NCT02500719|528419889|FG001|Overall Study|Lost to Follow-up|3|||
146521969|NCT02500719|528419888|FG000|Overall Study|Trauma history|1|||
146521970|NCT02500719|528419889|FG001|Overall Study|Trauma history|0|||
146521971|NCT02500719|528419888|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
146521972|NCT02500719|528419889|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
146521973|NCT02500719|528419888|FG000|Overall Study|Did not meet criteria for PTSD|0|||
146521974|NCT02500719|528419889|FG001|Overall Study|Did not meet criteria for PTSD|1|||
146521975|NCT02500719|528419888|FG000|Overall Study|Claustrophobia|0|||
146856478|NCT03184870|529646133|FG017|Initial Treatment|Other Reasons|2|||
146856479|NCT03184870|529646116|FG000|Initial Treatment|Lost to Follow-up|2|||
146856480|NCT03184870|529646117|FG001|Initial Treatment|Lost to Follow-up|0|||
146856481|NCT03184870|529646118|FG002|Initial Treatment|Lost to Follow-up|0|||
146856482|NCT03184870|529646119|FG003|Initial Treatment|Lost to Follow-up|1|||
146856483|NCT03184870|529646120|FG004|Initial Treatment|Lost to Follow-up|1|||
146856484|NCT03184870|529646121|FG005|Initial Treatment|Lost to Follow-up|1|||
146856485|NCT03184870|529646122|FG006|Initial Treatment|Lost to Follow-up|0|||
146856486|NCT03184870|529646123|FG007|Initial Treatment|Lost to Follow-up|2|||
146856487|NCT03184870|529646124|FG008|Initial Treatment|Lost to Follow-up|0|||
146856488|NCT03184870|529646125|FG009|Initial Treatment|Lost to Follow-up|0|||
146856489|NCT03184870|529646126|FG010|Initial Treatment|Lost to Follow-up|2|||
146856490|NCT03184870|529646127|FG011|Initial Treatment|Lost to Follow-up|0|||
146856491|NCT03184870|529646128|FG012|Initial Treatment|Lost to Follow-up|2|||
146856492|NCT03184870|529646129|FG013|Initial Treatment|Lost to Follow-up|2|||
146856493|NCT03184870|529646130|FG014|Initial Treatment|Lost to Follow-up|0|||
146856494|NCT03184870|529646131|FG015|Initial Treatment|Lost to Follow-up|0|||
146856495|NCT03184870|529646132|FG016|Initial Treatment|Lost to Follow-up|2|||
146856496|NCT03184870|529646133|FG017|Initial Treatment|Lost to Follow-up|2|||
146856497|NCT03184870|529646116|FG000|Initial Treatment|Withdrawal by Subject|0|||
146521976|NCT02500719|528419889|FG001|Overall Study|Claustrophobia|1|||
146521977|NCT02500719|528419888|FG000|Overall Study|History of head trauma|0|||
146521978|NCT02500719|528419889|FG001|Overall Study|History of head trauma|1|||
146521979|NCT00181883|528419892|FG000|Overall Study|Lack of Efficacy|2|||
146521980|NCT00181883|528419892|FG000|Overall Study|Treatment Limiting AEs|3|||
146521981|NCT00181883|528419892|FG000|Overall Study|Withdrawal by Subject|4|||
146521982|NCT00181883|528419892|FG000|Overall Study|Lost to Follow-up|1|||
146521983|NCT02710084|528419893|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
146521984|NCT02710084|528419894|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
146521985|NCT05305989|528419895|FG000|Overall Study|Other|3|||
146521986|NCT05305989|528419896|FG001|Overall Study|Other|2|||
146521987|NCT05305989|528419897|FG002|Overall Study|Other|0|||
146521988|NCT05305989|528419895|FG000|Overall Study|Sponsor decision|2|||
146521989|NCT05305989|528419896|FG001|Overall Study|Sponsor decision|1|||
146521990|NCT05305989|528419897|FG002|Overall Study|Sponsor decision|0|||
146521991|NCT05305989|528419895|FG000|Overall Study|Protocol Violation|0|||
146521992|NCT05305989|528419896|FG001|Overall Study|Protocol Violation|1|||
146521993|NCT05305989|528419897|FG002|Overall Study|Protocol Violation|0|||
146521994|NCT05305989|528419895|FG000|Overall Study|Investigator decision|1|||
146521995|NCT05305989|528419896|FG001|Overall Study|Investigator decision|2|||
146521996|NCT05305989|528419897|FG002|Overall Study|Investigator decision|0|||
146521997|NCT05305989|528419895|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
146521998|NCT05305989|528419896|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
146521999|NCT05305989|528419897|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
146522000|NCT05305989|528419895|FG000|Overall Study|Adverse Event|1|||
146522001|NCT05305989|528419896|FG001|Overall Study|Adverse Event|1|||
146522002|NCT05305989|528419897|FG002|Overall Study|Adverse Event|0|||
146522003|NCT05305989|528419895|FG000|Overall Study|Enrolled but never dosed|3|||
146856498|NCT03184870|529646117|FG001|Initial Treatment|Withdrawal by Subject|0|||
146856499|NCT03184870|529646118|FG002|Initial Treatment|Withdrawal by Subject|2|||
146856500|NCT03184870|529646119|FG003|Initial Treatment|Withdrawal by Subject|1|||
146856501|NCT03184870|529646120|FG004|Initial Treatment|Withdrawal by Subject|1|||
146856502|NCT03184870|529646121|FG005|Initial Treatment|Withdrawal by Subject|0|||
146856503|NCT03184870|529646122|FG006|Initial Treatment|Withdrawal by Subject|1|||
146856504|NCT03184870|529646123|FG007|Initial Treatment|Withdrawal by Subject|0|||
146856505|NCT03184870|529646124|FG008|Initial Treatment|Withdrawal by Subject|0|||
146522004|NCT05305989|528419896|FG001|Overall Study|Enrolled but never dosed|2|||
146522005|NCT05305989|528419897|FG002|Overall Study|Enrolled but never dosed|1|||
146522006|NCT00282152|528419898|FG000|Overall Study|Withdrawal by Subject|1|||
146522007|NCT00282152|528419899|FG001|Overall Study|Withdrawal by Subject|0|||
146522008|NCT00585325|528419900|FG000|Overall Study|Withdrawal by Subject|1|||
146522009|NCT00585325|528419901|FG001|Overall Study|Withdrawal by Subject|1|||
146856506|NCT03184870|529646125|FG009|Initial Treatment|Withdrawal by Subject|0|||
146856507|NCT03184870|529646126|FG010|Initial Treatment|Withdrawal by Subject|0|||
146522010|NCT03092791|528419902|FG000|Overall Study|Lost to Follow-up|0|||
146522011|NCT03092791|528419903|FG001|Overall Study|Lost to Follow-up|0|||
146758397|NCT02929108|529281675|FG000|Overall Study|Hospice patient death|100|||
146758398|NCT02929108|529281676|FG001|Overall Study|Hospice patient death|64|||
146758399|NCT02929108|529281677|FG002|Overall Study|Hospice patient death|28|||
146758400|NCT02929108|529281678|FG003|Overall Study|Hospice patient death|46|||
146758401|NCT02929108|529281679|FG004|Overall Study|Hospice patient death|55|||
146758402|NCT02929108|529281680|FG005|Overall Study|Hospice patient death|28|||
146758403|NCT02929108|529281681|FG006|Overall Study|Hospice patient death|78|||
146758404|NCT01008748|529281682|FG000|Overall Study|Lost to Follow-up|80|||
146758405|NCT01008748|529281682|FG000|Overall Study|Other|1|||
146758406|NCT00052962|529281683|FG000|Overall Study|Not evaluable|0|||
146758407|NCT00052962|529281684|FG001|Overall Study|Not evaluable|2|||
146758408|NCT00052962|529281683|FG000|Overall Study|Not randomized/not evaluable|1|||
146758409|NCT00052962|529281684|FG001|Overall Study|Not randomized/not evaluable|0|||
146758410|NCT02084082|529281690|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
146758411|NCT02084082|529281691|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
146758412|NCT02084082|529281692|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
146758413|NCT02084082|529281693|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
146758414|NCT02084082|529281690|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
146758415|NCT02084082|529281691|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
146758416|NCT02084082|529281692|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
146758417|NCT02084082|529281693|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
146758418|NCT00832780|529281694|FG000|Overall Study|Death|16|||
146758419|NCT00832780|529281694|FG000|Overall Study|Lost to Follow-up|4|||
146758420|NCT00832780|529281694|FG000|Overall Study|no reason given|2|||
146758421|NCT00832780|529281694|FG000|Overall Study|other complicating condition|2|||
146758422|NCT00832780|529281694|FG000|Overall Study|Physician Decision|1|||
146758423|NCT01767909|529281701|FG000|Overall Study|Withdrawal by Subject|4|||
146758424|NCT01767909|529281702|FG001|Overall Study|Withdrawal by Subject|7|||
146758425|NCT01767909|529281701|FG000|Overall Study|Adverse Event|3|||
146758426|NCT01767909|529281702|FG001|Overall Study|Adverse Event|1|||
146758427|NCT01767909|529281701|FG000|Overall Study|Withdrawal by Study Partner|3|||
146758428|NCT01767909|529281702|FG001|Overall Study|Withdrawal by Study Partner|1|||
146758429|NCT01767909|529281701|FG000|Overall Study|Non-Compliance|2|||
146758430|NCT01767909|529281702|FG001|Overall Study|Non-Compliance|0|||
146758431|NCT01767909|529281701|FG000|Overall Study|Perceived Lack of Efficacy|1|||
146758432|NCT01767909|529281702|FG001|Overall Study|Perceived Lack of Efficacy|0|||
146758433|NCT01767909|529281701|FG000|Overall Study|Investigator Recommendation|0|||
146758434|NCT01767909|529281702|FG001|Overall Study|Investigator Recommendation|1|||
146758435|NCT01767909|529281701|FG000|Overall Study|Lost to Follow-up|0|||
146758436|NCT01767909|529281702|FG001|Overall Study|Lost to Follow-up|1|||
146758437|NCT01767909|529281701|FG000|Overall Study|LP uncessessful|0|||
146758438|NCT01767909|529281702|FG001|Overall Study|LP uncessessful|1|||
146758439|NCT04739423|529281721|FG000|Overall Study|Protocol Violation|0|||
146758440|NCT04739423|529281722|FG001|Overall Study|Protocol Violation|1|||
146758441|NCT04739423|529281723|FG002|Overall Study|Protocol Violation|0|||
146758442|NCT04739423|529281724|FG003|Overall Study|Protocol Violation|0|||
146758443|NCT04739423|529281725|FG004|Overall Study|Protocol Violation|0|||
146758444|NCT04739423|529281726|FG005|Overall Study|Protocol Violation|0|||
146758445|NCT04739423|529281721|FG000|Overall Study|Adverse Event|0|||
146758446|NCT04739423|529281722|FG001|Overall Study|Adverse Event|0|||
146758447|NCT04739423|529281723|FG002|Overall Study|Adverse Event|1|||
146758448|NCT04739423|529281724|FG003|Overall Study|Adverse Event|0|||
146758449|NCT04739423|529281725|FG004|Overall Study|Adverse Event|1|||
146758450|NCT04739423|529281726|FG005|Overall Study|Adverse Event|0|||
146758451|NCT04739423|529281721|FG000|Overall Study|Withdrawal by Subject|0|||
146758452|NCT04739423|529281722|FG001|Overall Study|Withdrawal by Subject|0|||
146758453|NCT04739423|529281723|FG002|Overall Study|Withdrawal by Subject|0|||
146758454|NCT04739423|529281724|FG003|Overall Study|Withdrawal by Subject|0|||
146758455|NCT04739423|529281725|FG004|Overall Study|Withdrawal by Subject|0|||
146758456|NCT04739423|529281726|FG005|Overall Study|Withdrawal by Subject|1|||
146758457|NCT01221181|529281737|FG000|Overall Study|Lost to Follow-up|1|||
146758458|NCT00429793|529281738|FG000|Overall Study|Improper pre-protocol treatment|3|||
146758459|NCT00429793|529281738|FG000|Overall Study|Required test not done|1|||
146758460|NCT00429793|529281738|FG000|Overall Study|Never treated|1|||
146758461|NCT00429793|529281738|FG000|Overall Study|Non-measurable|1|||
146758462|NCT01394991|529281739|FG000|Overall Study|Adverse Event|0|||
146758463|NCT01394991|529281740|FG001|Overall Study|Adverse Event|4|||
146758464|NCT01394991|529281739|FG000|Overall Study|Lack of Efficacy|5|||
146758465|NCT01394991|529281740|FG001|Overall Study|Lack of Efficacy|7|||
146758466|NCT01394991|529281739|FG000|Overall Study|Lost to Follow-up|6|||
146758467|NCT01394991|529281740|FG001|Overall Study|Lost to Follow-up|8|||
146758468|NCT01394991|529281739|FG000|Overall Study|Physician Decision|1|||
146522012|NCT03092791|528419904|FG002|Overall Study|Lost to Follow-up|0|||
146758469|NCT01394991|529281740|FG001|Overall Study|Physician Decision|3|||
146758470|NCT01394991|529281739|FG000|Overall Study|Protocol Violation|1|||
146522013|NCT03092791|528419905|FG003|Overall Study|Lost to Follow-up|0|||
146856508|NCT03184870|529646127|FG011|Initial Treatment|Withdrawal by Subject|2|||
146856509|NCT03184870|529646128|FG012|Initial Treatment|Withdrawal by Subject|3|||
146856510|NCT03184870|529646129|FG013|Initial Treatment|Withdrawal by Subject|0|||
146856511|NCT03184870|529646130|FG014|Initial Treatment|Withdrawal by Subject|1|||
146856512|NCT03184870|529646131|FG015|Initial Treatment|Withdrawal by Subject|5|||
146856513|NCT03184870|529646132|FG016|Initial Treatment|Withdrawal by Subject|2|||
146856514|NCT03184870|529646133|FG017|Initial Treatment|Withdrawal by Subject|2|||
146856515|NCT03184870|529646116|FG000|Initial Treatment|Moved to crossover treatment|0|||
146856516|NCT03184870|529646117|FG001|Initial Treatment|Moved to crossover treatment|0|||
146856517|NCT03184870|529646118|FG002|Initial Treatment|Moved to crossover treatment|0|||
146856518|NCT03184870|529646119|FG003|Initial Treatment|Moved to crossover treatment|0|||
146856519|NCT03184870|529646120|FG004|Initial Treatment|Moved to crossover treatment|0|||
146856520|NCT03184870|529646121|FG005|Initial Treatment|Moved to crossover treatment|0|||
146856521|NCT03184870|529646122|FG006|Initial Treatment|Moved to crossover treatment|0|||
146856522|NCT03184870|529646123|FG007|Initial Treatment|Moved to crossover treatment|0|||
146856523|NCT03184870|529646124|FG008|Initial Treatment|Moved to crossover treatment|0|||
146856524|NCT03184870|529646125|FG009|Initial Treatment|Moved to crossover treatment|0|||
146856525|NCT03184870|529646126|FG010|Initial Treatment|Moved to crossover treatment|0|||
146856526|NCT03184870|529646127|FG011|Initial Treatment|Moved to crossover treatment|0|||
146856527|NCT03184870|529646128|FG012|Initial Treatment|Moved to crossover treatment|9|||
146856528|NCT03184870|529646129|FG013|Initial Treatment|Moved to crossover treatment|0|||
146856529|NCT03184870|529646130|FG014|Initial Treatment|Moved to crossover treatment|0|||
146856530|NCT03184870|529646131|FG015|Initial Treatment|Moved to crossover treatment|0|||
146856531|NCT03184870|529646132|FG016|Initial Treatment|Moved to crossover treatment|0|||
146856532|NCT03184870|529646133|FG017|Initial Treatment|Moved to crossover treatment|0|||
146856533|NCT03184870|529646116|FG000|Crossover Treatment|Other reasons|0|||
146856534|NCT03184870|529646117|FG001|Crossover Treatment|Other reasons|0|||
146856535|NCT03184870|529646118|FG002|Crossover Treatment|Other reasons|0|||
146856536|NCT03184870|529646119|FG003|Crossover Treatment|Other reasons|0|||
146856537|NCT03184870|529646120|FG004|Crossover Treatment|Other reasons|0|||
146856538|NCT03184870|529646121|FG005|Crossover Treatment|Other reasons|0|||
146856539|NCT03184870|529646122|FG006|Crossover Treatment|Other reasons|0|||
146856540|NCT03184870|529646123|FG007|Crossover Treatment|Other reasons|0|||
146856541|NCT03184870|529646124|FG008|Crossover Treatment|Other reasons|0|||
146856542|NCT03184870|529646125|FG009|Crossover Treatment|Other reasons|0|||
146856543|NCT03184870|529646126|FG010|Crossover Treatment|Other reasons|0|||
146856544|NCT03184870|529646127|FG011|Crossover Treatment|Other reasons|0|||
146856545|NCT03184870|529646128|FG012|Crossover Treatment|Other reasons|0|||
146856546|NCT03184870|529646129|FG013|Crossover Treatment|Other reasons|0|||
146856547|NCT03184870|529646130|FG014|Crossover Treatment|Other reasons|0|||
146856548|NCT03184870|529646131|FG015|Crossover Treatment|Other reasons|0|||
146856549|NCT03184870|529646132|FG016|Crossover Treatment|Other reasons|0|||
146856550|NCT03184870|529646133|FG017|Crossover Treatment|Other reasons|2|||
146856551|NCT03184870|529646116|FG000|Crossover Treatment|Death|0|||
146856552|NCT03184870|529646117|FG001|Crossover Treatment|Death|0|||
146856553|NCT03184870|529646118|FG002|Crossover Treatment|Death|0|||
146856554|NCT03184870|529646119|FG003|Crossover Treatment|Death|0|||
146856555|NCT03184870|529646120|FG004|Crossover Treatment|Death|0|||
146856556|NCT03184870|529646121|FG005|Crossover Treatment|Death|0|||
146856557|NCT03184870|529646122|FG006|Crossover Treatment|Death|0|||
146856558|NCT03184870|529646123|FG007|Crossover Treatment|Death|0|||
146856559|NCT03184870|529646124|FG008|Crossover Treatment|Death|0|||
146856560|NCT03184870|529646125|FG009|Crossover Treatment|Death|0|||
146856561|NCT03184870|529646126|FG010|Crossover Treatment|Death|0|||
146856562|NCT03184870|529646127|FG011|Crossover Treatment|Death|0|||
146856563|NCT03184870|529646128|FG012|Crossover Treatment|Death|0|||
146856564|NCT03184870|529646129|FG013|Crossover Treatment|Death|0|||
146856565|NCT03184870|529646130|FG014|Crossover Treatment|Death|0|||
146856566|NCT03184870|529646131|FG015|Crossover Treatment|Death|0|||
146856567|NCT03184870|529646132|FG016|Crossover Treatment|Death|0|||
146856568|NCT03184870|529646133|FG017|Crossover Treatment|Death|7|||
146856569|NCT04363801|529646135|FG000|Overall Study|Death|18|||
146856570|NCT04363801|529646136|FG001|Overall Study|Death|14|||
146856571|NCT04363801|529646137|FG002|Overall Study|Death|16|||
146965075|NCT03110107|530033439|FG013|Treatment Period|Death|0|||
146856572|NCT04363801|529646138|FG003|Overall Study|Death|48|||
146856573|NCT04363801|529646139|FG004|Overall Study|Death|38|||
146856574|NCT04363801|529646135|FG000|Overall Study|Withdrawal by Subject|1|||
146856575|NCT04363801|529646136|FG001|Overall Study|Withdrawal by Subject|6|||
146856576|NCT04363801|529646137|FG002|Overall Study|Withdrawal by Subject|1|||
146856577|NCT04363801|529646138|FG003|Overall Study|Withdrawal by Subject|4|||
146856578|NCT04363801|529646139|FG004|Overall Study|Withdrawal by Subject|14|||
146856579|NCT04363801|529646135|FG000|Overall Study|Sponsor Decision|6|||
146856580|NCT04363801|529646136|FG001|Overall Study|Sponsor Decision|4|||
146856581|NCT04363801|529646137|FG002|Overall Study|Sponsor Decision|10|||
146856582|NCT04363801|529646138|FG003|Overall Study|Sponsor Decision|33|||
146856583|NCT04363801|529646139|FG004|Overall Study|Sponsor Decision|32|||
146856584|NCT04363801|529646135|FG000|Overall Study|Lost to Follow-up|0|||
146856585|NCT04363801|529646136|FG001|Overall Study|Lost to Follow-up|0|||
146522014|NCT03092791|528419906|FG004|Overall Study|Lost to Follow-up|0|||
146522015|NCT03092791|528419907|FG005|Overall Study|Lost to Follow-up|0|||
146856586|NCT04363801|529646137|FG002|Overall Study|Lost to Follow-up|1|||
146856587|NCT04363801|529646138|FG003|Overall Study|Lost to Follow-up|0|||
146856588|NCT04363801|529646139|FG004|Overall Study|Lost to Follow-up|1|||
146856589|NCT00250679|529646142|FG000|Overall Study|Adverse Event|12|||
146856590|NCT00250679|529646143|FG001|Overall Study|Adverse Event|15|||
146856591|NCT00250679|529646144|FG002|Overall Study|Adverse Event|16|||
146856592|NCT00250679|529646142|FG000|Overall Study|Protocol Violation|2|||
146856593|NCT00250679|529646143|FG001|Overall Study|Protocol Violation|4|||
146856594|NCT00250679|529646144|FG002|Overall Study|Protocol Violation|3|||
146856595|NCT00250679|529646142|FG000|Overall Study|Withdrawal by Subject|15|||
146856596|NCT00250679|529646143|FG001|Overall Study|Withdrawal by Subject|18|||
146856597|NCT00250679|529646144|FG002|Overall Study|Withdrawal by Subject|15|||
146856598|NCT00250679|529646142|FG000|Overall Study|Lost to Follow-up|3|||
146856599|NCT00250679|529646143|FG001|Overall Study|Lost to Follow-up|4|||
146856600|NCT00250679|529646144|FG002|Overall Study|Lost to Follow-up|2|||
146856601|NCT00250679|529646142|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
146856602|NCT00250679|529646143|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
146856603|NCT00250679|529646144|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
146856604|NCT00250679|529646142|FG000|Overall Study|Lack of Efficacy|0|||
146856605|NCT00250679|529646143|FG001|Overall Study|Lack of Efficacy|1|||
146856606|NCT00250679|529646144|FG002|Overall Study|Lack of Efficacy|3|||
146856607|NCT00250679|529646142|FG000|Overall Study|Technical Holter issues|1|||
146856608|NCT00250679|529646143|FG001|Overall Study|Technical Holter issues|0|||
146856609|NCT00250679|529646144|FG002|Overall Study|Technical Holter issues|2|||
146856610|NCT00250679|529646142|FG000|Overall Study|Moved|1|||
146856611|NCT00250679|529646143|FG001|Overall Study|Moved|1|||
146856612|NCT00250679|529646144|FG002|Overall Study|Moved|0|||
146856613|NCT00250679|529646142|FG000|Overall Study|Non-compliance|1|||
146856614|NCT00250679|529646143|FG001|Overall Study|Non-compliance|1|||
146856615|NCT00250679|529646144|FG002|Overall Study|Non-compliance|0|||
146856616|NCT00250679|529646142|FG000|Overall Study|various single events: hip surgery,diary|3|||
146856617|NCT00250679|529646143|FG001|Overall Study|various single events: hip surgery,diary|1|||
146856618|NCT00250679|529646144|FG002|Overall Study|various single events: hip surgery,diary|1|||
146856619|NCT00448279|529646145|FG000|Overall Study|Lost to Follow-up|2|||
146856620|NCT00448279|529646146|FG001|Overall Study|Lost to Follow-up|2|||
146856621|NCT00448279|529646145|FG000|Overall Study|Adverse Event|1|||
146856622|NCT00448279|529646146|FG001|Overall Study|Adverse Event|1|||
146856623|NCT00448279|529646145|FG000|Overall Study|Disease progression|16|||
146856624|NCT00448279|529646146|FG001|Overall Study|Disease progression|18|||
146856625|NCT00448279|529646145|FG000|Overall Study|Withdrawal by Subject|4|||
146856626|NCT00448279|529646146|FG001|Overall Study|Withdrawal by Subject|3|||
146856627|NCT00448279|529646145|FG000|Overall Study|Other|6|||
146856628|NCT00448279|529646146|FG001|Overall Study|Other|4|||
146856629|NCT00448279|529646145|FG000|Overall Study|Protocol Violation|0|||
146522016|NCT03092791|528419908|FG006|Overall Study|Lost to Follow-up|1|||
146522017|NCT03092791|528419909|FG007|Overall Study|Lost to Follow-up|0|||
146522018|NCT03092791|528419902|FG000|Overall Study|Withdrawal of Consent|0|||
146522019|NCT03092791|528419903|FG001|Overall Study|Withdrawal of Consent|0|||
146522020|NCT03092791|528419904|FG002|Overall Study|Withdrawal of Consent|0|||
146522021|NCT03092791|528419905|FG003|Overall Study|Withdrawal of Consent|0|||
146522022|NCT03092791|528419906|FG004|Overall Study|Withdrawal of Consent|4|||
146522023|NCT03092791|528419907|FG005|Overall Study|Withdrawal of Consent|12|||
146522024|NCT03092791|528419908|FG006|Overall Study|Withdrawal of Consent|6|||
146522025|NCT03092791|528419909|FG007|Overall Study|Withdrawal of Consent|4|||
146522026|NCT03092791|528419902|FG000|Overall Study|Study Termination|0|||
146522027|NCT03092791|528419903|FG001|Overall Study|Study Termination|0|||
146522028|NCT03092791|528419904|FG002|Overall Study|Study Termination|0|||
146522029|NCT03092791|528419905|FG003|Overall Study|Study Termination|0|||
146522030|NCT03092791|528419906|FG004|Overall Study|Study Termination|55|||
146522031|NCT03092791|528419907|FG005|Overall Study|Study Termination|46|||
146522032|NCT03092791|528419908|FG006|Overall Study|Study Termination|53|||
146856630|NCT00448279|529646146|FG001|Overall Study|Protocol Violation|1|||
146522033|NCT03092791|528419909|FG007|Overall Study|Study Termination|55|||
146522034|NCT03092791|528419902|FG000|Overall Study|Death|0|||
146522035|NCT03092791|528419903|FG001|Overall Study|Death|0|||
146522036|NCT03092791|528419904|FG002|Overall Study|Death|0|||
146522037|NCT03092791|528419905|FG003|Overall Study|Death|0|||
146522038|NCT03092791|528419906|FG004|Overall Study|Death|0|||
146856631|NCT03907410|529646147|FG000|Overall Study|Lost to Follow-up|4|||
146856632|NCT03907410|529646148|FG001|Overall Study|Lost to Follow-up|1|||
146856633|NCT03907410|529646149|FG002|Overall Study|Lost to Follow-up|1|||
146856634|NCT03907410|529646147|FG000|Overall Study|Lost to follow-up and research burden|0|||
146856635|NCT03907410|529646148|FG001|Overall Study|Lost to follow-up and research burden|0|||
146856636|NCT03907410|529646149|FG002|Overall Study|Lost to follow-up and research burden|1|||
146856637|NCT04776148|529646150|FG000|Overall Study|Death|249|||
146856638|NCT04776148|529646151|FG001|Overall Study|Death|260|||
146856639|NCT04776148|529646150|FG000|Overall Study|Lost to Follow-up|0|||
146522039|NCT03092791|528419907|FG005|Overall Study|Death|1|||
146522040|NCT03092791|528419908|FG006|Overall Study|Death|0|||
146522041|NCT03092791|528419909|FG007|Overall Study|Death|1|||
146522042|NCT03092791|528419902|FG000|Overall Study|Reason Not Specified|0|||
146522043|NCT03092791|528419903|FG001|Overall Study|Reason Not Specified|0|||
146522044|NCT03092791|528419904|FG002|Overall Study|Reason Not Specified|0|||
146522045|NCT03092791|528419905|FG003|Overall Study|Reason Not Specified|0|||
146522046|NCT03092791|528419906|FG004|Overall Study|Reason Not Specified|1|||
146522047|NCT03092791|528419907|FG005|Overall Study|Reason Not Specified|1|||
146522048|NCT03092791|528419908|FG006|Overall Study|Reason Not Specified|0|||
146522049|NCT03092791|528419909|FG007|Overall Study|Reason Not Specified|0|||
146522050|NCT02182830|528419910|FG000|Overall Study|Not Treated|1|||
146522051|NCT02182830|528419911|FG001|Overall Study|Not Treated|1|||
146522052|NCT02182830|528419910|FG000|Overall Study|Trial stopped, reason missing|3|||
146522053|NCT02182830|528419911|FG001|Overall Study|Trial stopped, reason missing|3|||
146522054|NCT02182830|528419910|FG000|Overall Study|Consent withdrawn|8|||
146522055|NCT02182830|528419911|FG001|Overall Study|Consent withdrawn|8|||
146522056|NCT02182830|528419910|FG000|Overall Study|Lost to Follow-up|3|||
146522057|NCT02182830|528419911|FG001|Overall Study|Lost to Follow-up|3|||
146522058|NCT01990768|528419912|FG000|Intervention Started|Found to be ineligible|14|||
146522059|NCT01990768|528419913|FG001|Intervention Started|Found to be ineligible|13|||
146522060|NCT01990768|528419914|FG002|Intervention Started|Found to be ineligible|11|||
146522061|NCT01990768|528419912|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
146522062|NCT01990768|528419913|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
146522063|NCT01990768|528419914|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
146522064|NCT01990768|528419912|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
146522065|NCT01990768|528419913|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
146522066|NCT01990768|528419914|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
146522067|NCT01990768|528419912|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
146522068|NCT01990768|528419913|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
146522069|NCT01990768|528419914|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
146522070|NCT01990768|528419912|FG000|Intervention Started|Patient care priority|1|||
146522071|NCT01990768|528419913|FG001|Intervention Started|Patient care priority|2|||
146522072|NCT01990768|528419914|FG002|Intervention Started|Patient care priority|3|||
146522073|NCT01990768|528419912|FG000|Intervention Started|IV lost|2|||
146522074|NCT01990768|528419913|FG001|Intervention Started|IV lost|2|||
146522075|NCT01990768|528419914|FG002|Intervention Started|IV lost|2|||
146522076|NCT01990768|528419912|FG000|Intervention Started|Required CPR|1|||
146522077|NCT01990768|528419913|FG001|Intervention Started|Required CPR|1|||
146522078|NCT01990768|528419914|FG002|Intervention Started|Required CPR|0|||
146522079|NCT01990768|528419912|FG000|Intervention Started|Seizure or hx of seizure|0|||
146522080|NCT01990768|528419913|FG001|Intervention Started|Seizure or hx of seizure|0|||
146522081|NCT01990768|528419914|FG002|Intervention Started|Seizure or hx of seizure|2|||
146522082|NCT01990768|528419912|FG000|Intervention Started|Discovered to be pregnant|0|||
146522083|NCT01990768|528419913|FG001|Intervention Started|Discovered to be pregnant|1|||
146522084|NCT01990768|528419914|FG002|Intervention Started|Discovered to be pregnant|0|||
146522085|NCT01990768|528419912|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
146522086|NCT01990768|528419913|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
146758471|NCT01394991|529281740|FG001|Overall Study|Protocol Violation|1|||
146758472|NCT01394991|529281739|FG000|Overall Study|Withdrawal by Subject|20|||
146758473|NCT01394991|529281740|FG001|Overall Study|Withdrawal by Subject|17|||
146758474|NCT01394991|529281739|FG000|Overall Study|Chemotherapy Termination|10|||
146758475|NCT01394991|529281740|FG001|Overall Study|Chemotherapy Termination|15|||
146758476|NCT01394991|529281739|FG000|Overall Study|Disease Progression|7|||
146758477|NCT01394991|529281740|FG001|Overall Study|Disease Progression|7|||
146758478|NCT01394991|529281739|FG000|Overall Study|Prematurely Termination of Trial|9|||
146758479|NCT01394991|529281740|FG001|Overall Study|Prematurely Termination of Trial|10|||
146758480|NCT03073005|529281741|FG000|Overall Study|Death|6|||
146758481|NCT03073005|529281742|FG001|Overall Study|Death|0|||
146758482|NCT03073005|529281743|FG002|Overall Study|Death|7|||
146758483|NCT03073005|529281744|FG003|Overall Study|Death|0|||
146758484|NCT03073005|529281741|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
146758485|NCT03073005|529281742|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
146758486|NCT03073005|529281743|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
146758487|NCT03073005|529281744|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
146758488|NCT03073005|529281741|FG000|Overall Study|Lost to Follow-up|2|||
146758489|NCT03073005|529281742|FG001|Overall Study|Lost to Follow-up|2|||
146522087|NCT01990768|528419914|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
146522088|NCT01990768|528419912|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
146758490|NCT03073005|529281743|FG002|Overall Study|Lost to Follow-up|1|||
146758491|NCT03073005|529281744|FG003|Overall Study|Lost to Follow-up|2|||
146522089|NCT01990768|528419913|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
146522090|NCT01990768|528419914|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
146758492|NCT03073005|529281741|FG000|Overall Study|Withdrawal by Subject|0|||
146856640|NCT04776148|529646151|FG001|Overall Study|Lost to Follow-up|1|||
146856641|NCT04776148|529646150|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146856642|NCT04776148|529646151|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146856643|NCT04776148|529646150|FG000|Overall Study|Withdrawal by Subject|3|||
146856644|NCT04776148|529646151|FG001|Overall Study|Withdrawal by Subject|4|||
146856645|NCT04776148|529646150|FG000|Overall Study|Sponsor Decision|30|||
146856646|NCT04776148|529646151|FG001|Overall Study|Sponsor Decision|15|||
146856647|NCT00666679|529646155|FG000|First Intervention|Lost to Follow-up|1|||
146856648|NCT00666679|529646156|FG001|First Intervention|Lost to Follow-up|0|||
146856649|NCT00666679|529646155|FG000|First Intervention|Protocol Violation|1|||
146856650|NCT00666679|529646156|FG001|First Intervention|Protocol Violation|0|||
146856651|NCT00666679|529646155|FG000|First Intervention|Withdrawal by Subject|1|||
146856652|NCT00666679|529646156|FG001|First Intervention|Withdrawal by Subject|0|||
146856653|NCT00666679|529646155|FG000|First Intervention|Randomized did not start treatment|1|||
146856654|NCT00666679|529646156|FG001|First Intervention|Randomized did not start treatment|1|||
146856655|NCT00666679|529646155|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
146856656|NCT00666679|529646156|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
146856657|NCT00666679|529646155|FG000|Washout Period of 1 Week|Protocol Violation|0|||
146856658|NCT00666679|529646156|FG001|Washout Period of 1 Week|Protocol Violation|1|||
146856659|NCT00666679|529646155|FG000|Second Intervention|Adverse Event|1|||
146856660|NCT00666679|529646156|FG001|Second Intervention|Adverse Event|0|||
146856661|NCT00666679|529646155|FG000|Second Intervention|Death|0|||
146856662|NCT00666679|529646156|FG001|Second Intervention|Death|1|||
146856663|NCT04882995|529646159|FG000|Overall Study|Withdrawal by Subject|1|||
146856664|NCT04882995|529646160|FG001|Overall Study|Withdrawal by Subject|2|||
146856665|NCT04882995|529646159|FG000|Overall Study|Protocol Violation|4|||
146856666|NCT04882995|529646160|FG001|Overall Study|Protocol Violation|4|||
146856667|NCT04882995|529646159|FG000|Overall Study|Surgery postponed due to COVID|1|||
146856668|NCT04882995|529646160|FG001|Overall Study|Surgery postponed due to COVID|1|||
146856669|NCT04371198|529646161|FG000|Overall Study|inadequate sample|4|||
146856670|NCT04754477|529646162|FG000|Overall Study|Withdrawal by Subject|1|||
146856671|NCT00440999|529646163|FG000|Overall Study|Adverse Event|0|||
146856672|NCT00440999|529646164|FG001|Overall Study|Adverse Event|2|||
146856673|NCT00440999|529646163|FG000|Overall Study|Lack of Efficacy|6|||
146856674|NCT00440999|529646164|FG001|Overall Study|Lack of Efficacy|7|||
146856675|NCT00440999|529646163|FG000|Overall Study|Lost to Follow-up|19|||
146856676|NCT00440999|529646164|FG001|Overall Study|Lost to Follow-up|12|||
146856677|NCT00440999|529646163|FG000|Overall Study|Protocol Violation|1|||
146856678|NCT00440999|529646164|FG001|Overall Study|Protocol Violation|0|||
146856679|NCT00440999|529646163|FG000|Overall Study|Withdrawal by Subject|2|||
146856680|NCT00440999|529646164|FG001|Overall Study|Withdrawal by Subject|5|||
146856681|NCT00440999|529646163|FG000|Overall Study|Subjets missed the visit|1|||
146856682|NCT00440999|529646164|FG001|Overall Study|Subjets missed the visit|0|||
146856683|NCT00440999|529646163|FG000|Overall Study|Mixed infection at entry|1|||
146856684|NCT00440999|529646164|FG001|Overall Study|Mixed infection at entry|0|||
146856685|NCT00440999|529646163|FG000|Overall Study|P. falciparum malaria|5|||
146856686|NCT00440999|529646164|FG001|Overall Study|P. falciparum malaria|14|||
146856687|NCT00440999|529646163|FG000|Overall Study|Subj left hosp without inform staff|0|||
146856688|NCT00440999|529646164|FG001|Overall Study|Subj left hosp without inform staff|1|||
146856689|NCT04572841|529646165|FG000|Overall Study|Adverse Event|1|||
146856690|NCT04572841|529646166|FG001|Overall Study|Adverse Event|1|||
146856691|NCT04572841|529646165|FG000|Overall Study|Withdrawal by Subject|2|||
146856692|NCT04572841|529646166|FG001|Overall Study|Withdrawal by Subject|1|||
146856693|NCT05041101|529646167|FG000|Overall Study|Adverse Event|1|||
146856694|NCT05041101|529646168|FG001|Overall Study|Adverse Event|0|||
146856695|NCT05041101|529646169|FG002|Overall Study|Adverse Event|0|||
146856696|NCT05041101|529646167|FG000|Overall Study|Diease Progression|5|||
146856697|NCT05041101|529646168|FG001|Overall Study|Diease Progression|0|||
146856698|NCT05041101|529646169|FG002|Overall Study|Diease Progression|0|||
146856699|NCT01205152|529646170|FG000|Overall Study|Death|1|||
146856700|NCT00249002|529646171|FG000|Overall Study|Adverse Event|2|||
146856701|NCT00249002|529646171|FG000|Overall Study|Study cancellation|3|||
146856702|NCT00249002|529646171|FG000|Overall Study|Other|2|||
146856703|NCT00069108|529646172|FG000|Overall Study|Withdrawal by Subject|5|||
146856704|NCT00069108|529646173|FG001|Overall Study|Withdrawal by Subject|9|||
146856705|NCT00069108|529646172|FG000|Overall Study|Adverse Event|64|||
146856706|NCT00069108|529646173|FG001|Overall Study|Adverse Event|42|||
146856707|NCT00069108|529646172|FG000|Overall Study|Death|6|||
146856708|NCT00069108|529646173|FG001|Overall Study|Death|6|||
146522091|NCT01990768|528419912|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
146522092|NCT01990768|528419913|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
146522093|NCT01990768|528419914|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
146522094|NCT01990768|528419912|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
146522095|NCT01990768|528419913|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
146522096|NCT01990768|528419914|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
146522097|NCT01990768|528419912|FG000|Prehospital Study Drug Infusion|Death|3|||
146522098|NCT01990768|528419913|FG001|Prehospital Study Drug Infusion|Death|1|||
146522099|NCT01990768|528419914|FG002|Prehospital Study Drug Infusion|Death|1|||
146522100|NCT01990768|528419912|FG000|Prehospital Study Drug Infusion|Discharged|2|||
146522101|NCT01990768|528419913|FG001|Prehospital Study Drug Infusion|Discharged|1|||
146522102|NCT01990768|528419914|FG002|Prehospital Study Drug Infusion|Discharged|0|||
146522103|NCT01990768|528419912|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
146522104|NCT01990768|528419913|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
146522105|NCT01990768|528419914|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
146522106|NCT01990768|528419912|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
146522107|NCT01990768|528419913|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
146625271|NCT03037385|528803846|FG001|Overall Study|Physician Decision|0|||
146758493|NCT03073005|529281742|FG001|Overall Study|Withdrawal by Subject|4|||
146758494|NCT03073005|529281743|FG002|Overall Study|Withdrawal by Subject|4|||
146758495|NCT03073005|529281744|FG003|Overall Study|Withdrawal by Subject|4|||
146758496|NCT02427646|529281745|FG000|Overall Study|Lack of Efficacy|2|||
146758497|NCT02427646|529281746|FG001|Overall Study|Lack of Efficacy|3|||
146758498|NCT02427646|529281745|FG000|Overall Study|Physician Decision|1|||
146758499|NCT02427646|529281746|FG001|Overall Study|Physician Decision|4|||
146758500|NCT02427646|529281745|FG000|Overall Study|Protocol Violation|3|||
146758501|NCT02427646|529281746|FG001|Overall Study|Protocol Violation|3|||
146758502|NCT02427646|529281745|FG000|Overall Study|Bothersome hand weakness|2|||
146758503|NCT02427646|529281746|FG001|Overall Study|Bothersome hand weakness|4|||
146758504|NCT01734811|529281747|FG000|Overall Study|Lost to Follow-up|2|||
146758505|NCT01734811|529281748|FG001|Overall Study|Lost to Follow-up|3|||
146758506|NCT01734811|529281747|FG000|Overall Study|Withdrawal by Subject|2|||
146758507|NCT01734811|529281748|FG001|Overall Study|Withdrawal by Subject|0|||
146758508|NCT03824236|529281749|FG000|Overall Study|Lost to Follow-up|0|||
146758509|NCT03824236|529281750|FG001|Overall Study|Lost to Follow-up|0|||
146758510|NCT03824236|529281751|FG002|Overall Study|Lost to Follow-up|1|||
146758511|NCT04091672|529283766|FG000|Overall Study|Death|6|||
146758512|NCT04091672|529283767|FG001|Overall Study|Death|6|||
146758513|NCT04091672|529283766|FG000|Overall Study|Lost to Follow-up|7|||
146758514|NCT04091672|529283767|FG001|Overall Study|Lost to Follow-up|7|||
146758515|NCT04091672|529283766|FG000|Overall Study|Withdrawal by Subject|3|||
146758516|NCT04091672|529283767|FG001|Overall Study|Withdrawal by Subject|3|||
146758517|NCT04091672|529283766|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
146758518|NCT04091672|529283767|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
146758519|NCT05296629|529283768|FG000|Overall Study|Withdrawal by Subject|3|||
146758520|NCT05296629|529283769|FG001|Overall Study|Withdrawal by Subject|10|||
146758521|NCT05296629|529283770|FG002|Overall Study|Withdrawal by Subject|4|||
146758522|NCT05296629|529283768|FG000|Overall Study|Lost to Follow-up|2|||
146758523|NCT05296629|529283769|FG001|Overall Study|Lost to Follow-up|7|||
146758524|NCT05296629|529283770|FG002|Overall Study|Lost to Follow-up|1|||
146758525|NCT05296629|529283768|FG000|Overall Study|Adverse Event|0|||
146758526|NCT05296629|529283769|FG001|Overall Study|Adverse Event|4|||
146758527|NCT05296629|529283770|FG002|Overall Study|Adverse Event|2|||
146758528|NCT05296629|529283768|FG000|Overall Study|Protocol Violation|0|||
146758529|NCT05296629|529283769|FG001|Overall Study|Protocol Violation|2|||
146758530|NCT05296629|529283770|FG002|Overall Study|Protocol Violation|0|||
146758531|NCT02268396|529283771|FG000|Overall Study|Adverse Event|3|||
146758532|NCT02268396|529283771|FG000|Overall Study|Administrative|2|||
146758533|NCT02268396|529283771|FG000|Overall Study|Withdrawal by Subject|1|||
146758534|NCT02268396|529283771|FG000|Overall Study|Lost to Follow-up|2|||
146758535|NCT02268396|529283771|FG000|Overall Study|Protocol-Specified Criteria|2|||
146758536|NCT02268396|529283771|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
146758537|NCT01304706|529283772|FG000|Overall Study|Adverse Event|2|||
146758538|NCT01304706|529283772|FG000|Overall Study|Lack of Efficacy|1|||
146758539|NCT01304706|529283772|FG000|Overall Study|Death|3|||
146758540|NCT01304706|529283772|FG000|Overall Study|Withdrawal by Subject|3|||
146758541|NCT01304706|529283772|FG000|Overall Study|Lost to Follow-up|7|||
146758542|NCT01304706|529283772|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
146758543|NCT04978363|529283778|FG000|Overall Study|Other medical issues unrelated to the study|0|||
146758544|NCT04978363|529283779|FG001|Overall Study|Other medical issues unrelated to the study|0|||
146758545|NCT04978363|529283780|FG002|Overall Study|Other medical issues unrelated to the study|0|||
146758546|NCT04978363|529283781|FG003|Overall Study|Other medical issues unrelated to the study|0|||
146758547|NCT04978363|529283782|FG004|Overall Study|Other medical issues unrelated to the study|1|||
146758548|NCT04978363|529283783|FG005|Overall Study|Other medical issues unrelated to the study|0|||
146758549|NCT04978363|529283784|FG006|Overall Study|Other medical issues unrelated to the study|0|||
146856709|NCT00069108|529646172|FG000|Overall Study|Administration|15|||
146856710|NCT00069108|529646173|FG001|Overall Study|Administration|4|||
146856711|NCT00069108|529646172|FG000|Overall Study|Insufficient therapy|117|||
146856712|NCT00069108|529646173|FG001|Overall Study|Insufficient therapy|144|||
146856713|NCT00069108|529646172|FG000|Overall Study|Violation criteria|1|||
146856714|NCT00069108|529646173|FG001|Overall Study|Violation criteria|4|||
146856715|NCT00069108|529646172|FG000|Overall Study|Refused treatment|5|||
146856716|NCT00069108|529646173|FG001|Overall Study|Refused treatment|10|||
146856717|NCT02783768|529646174|FG000|Overall Study|Lost to Follow-up|1|||
146856718|NCT02783768|529646175|FG001|Overall Study|Lost to Follow-up|0|||
146856719|NCT01323647|529646176|FG000|Overall Study|Migrated/moved from study area|2|||
146856720|NCT01323647|529646177|FG001|Overall Study|Migrated/moved from study area|0|||
146856721|NCT01323647|529646176|FG000|Overall Study|Withdrawal by Subject|5|||
146856722|NCT01323647|529646177|FG001|Overall Study|Withdrawal by Subject|0|||
146856723|NCT01323647|529646176|FG000|Overall Study|Lost to Follow-up|2|||
146856724|NCT01323647|529646177|FG001|Overall Study|Lost to Follow-up|0|||
146856725|NCT01853137|529646178|FG000|Overall Study|Lost to Follow-up|4|||
146856726|NCT01853137|529646179|FG001|Overall Study|Lost to Follow-up|1|||
146856727|NCT03401229|529646180|FG000|Overall Study|Lost to Follow-up|2|||
146856728|NCT03401229|529646181|FG001|Overall Study|Lost to Follow-up|1|||
146856729|NCT03401229|529646180|FG000|Overall Study|Other|1|||
146856730|NCT03401229|529646181|FG001|Overall Study|Other|3|||
146856731|NCT03401229|529646180|FG000|Overall Study|Adverse Event|8|||
146856732|NCT03401229|529646181|FG001|Overall Study|Adverse Event|6|||
146856733|NCT03401229|529646180|FG000|Overall Study|Withdrawal by Subject|29|||
146856734|NCT03401229|529646181|FG001|Overall Study|Withdrawal by Subject|26|||
146856735|NCT03401229|529646180|FG000|Overall Study|COVID-19|0|||
146856736|NCT03401229|529646181|FG001|Overall Study|COVID-19|1|||
146856737|NCT00690820|529646182|FG000|Period 1|Withdrawal by Subject|0|||
146856738|NCT00690820|529646183|FG001|Period 1|Withdrawal by Subject|1|||
146856739|NCT05333224|529646184|FG000|Overall Study - Infants|Lost to Follow-up|1|||
146856740|NCT05333224|529646185|FG001|Overall Study - Infants|Lost to Follow-up|1|||
146856741|NCT01411215|529646187|FG000|Overall Study|Adverse Event|1|||
146856742|NCT01411215|529646188|FG001|Overall Study|Adverse Event|2|||
146522108|NCT01990768|528419914|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
146522109|NCT01990768|528419912|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
146522110|NCT01990768|528419913|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
146522111|NCT01990768|528419914|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
146522112|NCT01990768|528419912|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
146522113|NCT01990768|528419913|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
146522114|NCT01990768|528419914|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
146522115|NCT01990768|528419912|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
146522116|NCT01990768|528419913|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
146522117|NCT01990768|528419914|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
146522118|NCT01990768|528419912|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
146522119|NCT01990768|528419913|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
146522120|NCT01990768|528419914|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
146522121|NCT01990768|528419912|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
146522122|NCT01990768|528419913|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
146522123|NCT01990768|528419914|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
146522124|NCT01990768|528419912|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
146522125|NCT01990768|528419913|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
146522126|NCT01990768|528419914|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
146522127|NCT01990768|528419912|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
146522128|NCT01990768|528419913|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
146522129|NCT01990768|528419914|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
146522130|NCT01990768|528419912|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
146522131|NCT01990768|528419913|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
146522132|NCT01990768|528419914|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
146522133|NCT01990768|528419912|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
146522134|NCT01990768|528419913|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
146522135|NCT01990768|528419914|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
146522136|NCT01990768|528419912|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
146856743|NCT01411215|529646187|FG000|Overall Study|Lack of Efficacy|2|||
146522137|NCT01990768|528419913|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
146856744|NCT01411215|529646188|FG001|Overall Study|Lack of Efficacy|4|||
146856745|NCT01411215|529646187|FG000|Overall Study|Lost to Follow-up|12|||
146856746|NCT01411215|529646188|FG001|Overall Study|Lost to Follow-up|18|||
146856747|NCT01411215|529646187|FG000|Overall Study|Did not meet entrance criteria|0|||
146856748|NCT01411215|529646188|FG001|Overall Study|Did not meet entrance criteria|1|||
146856749|NCT01411215|529646187|FG000|Overall Study|Study terminated by sponsor|2|||
146856750|NCT01411215|529646188|FG001|Overall Study|Study terminated by sponsor|15|||
146856751|NCT01411215|529646187|FG000|Overall Study|Protocol Violation|3|||
146856752|NCT01411215|529646188|FG001|Overall Study|Protocol Violation|5|||
146856753|NCT01411215|529646187|FG000|Overall Study|Withdrawal by Subject|34|||
146856754|NCT01411215|529646188|FG001|Overall Study|Withdrawal by Subject|21|||
146856755|NCT01411215|529646187|FG000|Overall Study|Other|12|||
146856756|NCT01411215|529646188|FG001|Overall Study|Other|17|||
146856757|NCT01411215|529646187|FG000|Overall Study|Screen failure|0|||
146856758|NCT01411215|529646188|FG001|Overall Study|Screen failure|1|||
146856759|NCT00848926|529646189|FG000|Treatment Period|Progressive disease|45|||
146856760|NCT00848926|529646189|FG000|Treatment Period|Adverse Event|20|||
146856761|NCT00848926|529646189|FG000|Treatment Period|Physician Decision|12|||
146856762|NCT00848926|529646189|FG000|Treatment Period|Withdrawal by Subject|7|||
146856763|NCT00848926|529646189|FG000|Follow-up Period|Lost to Follow-up|7|||
146856764|NCT00848926|529646189|FG000|Follow-up Period|Withdrawal by Subject|3|||
146856765|NCT00848926|529646189|FG000|Follow-up Period|Other|2|||
146856766|NCT02203695|529646190|FG000|Overall Study|Patient withdrew consent|1|||
146856767|NCT02203695|529646191|FG001|Overall Study|Patient withdrew consent|1|||
146856768|NCT02203695|529646190|FG000|Overall Study|Started non-study treatment|1|||
146856769|NCT02203695|529646191|FG001|Overall Study|Started non-study treatment|0|||
146856770|NCT01768117|529646192|FG000|Overall Study|Lost to Follow-up|1|||
146856771|NCT01768117|529646192|FG000|Overall Study|Withdrawal by Subject|2|||
146856772|NCT01768117|529646192|FG000|Overall Study|Protocol Violation|3|||
146856773|NCT03451162|529646194|FG000|Overall Study|Lost to Follow-up|1|||
146856774|NCT03451162|529646195|FG001|Overall Study|Lost to Follow-up|0|||
146856775|NCT03451162|529646196|FG002|Overall Study|Lost to Follow-up|0|||
146856776|NCT03451162|529646197|FG003|Overall Study|Lost to Follow-up|0|||
146856777|NCT03451162|529646198|FG004|Overall Study|Lost to Follow-up|0|||
146856778|NCT03451162|529646194|FG000|Overall Study|Physician Decision|0|||
146856779|NCT03451162|529646195|FG001|Overall Study|Physician Decision|1|||
146856780|NCT03451162|529646196|FG002|Overall Study|Physician Decision|0|||
146856781|NCT03451162|529646197|FG003|Overall Study|Physician Decision|0|||
146856782|NCT03451162|529646198|FG004|Overall Study|Physician Decision|0|||
146856783|NCT03451162|529646194|FG000|Overall Study|Withdrawal by Subject|1|||
146856784|NCT03451162|529646195|FG001|Overall Study|Withdrawal by Subject|1|||
146856785|NCT03451162|529646196|FG002|Overall Study|Withdrawal by Subject|0|||
146856786|NCT03451162|529646197|FG003|Overall Study|Withdrawal by Subject|0|||
146856787|NCT03451162|529646198|FG004|Overall Study|Withdrawal by Subject|0|||
146856788|NCT03305731|529646199|FG000|Overall Study|Protocol Violation|1|||
146856789|NCT01952054|529646200|FG000|Overall Study|Physician Decision|1|||
146856790|NCT01127139|529646201|FG000|Overall Study|Adverse Event|40|||
146856791|NCT01127139|529646201|FG000|Overall Study|Incompliance|12|||
146856792|NCT01127139|529646201|FG000|Overall Study|Lack of Efficacy|4|||
146856793|NCT01127139|529646201|FG000|Overall Study|Reason not specified|1|||
146856794|NCT01136772|529646202|FG000|Overall Study|Adverse Event|15|||
146856795|NCT01136772|529646203|FG001|Overall Study|Adverse Event|14|||
146856796|NCT01136772|529646202|FG000|Overall Study|Lack of Efficacy|42|||
146856797|NCT01136772|529646203|FG001|Overall Study|Lack of Efficacy|39|||
146856798|NCT01136772|529646202|FG000|Overall Study|Administrative|14|||
146856799|NCT01136772|529646203|FG001|Overall Study|Administrative|12|||
146856800|NCT01136772|529646202|FG000|Overall Study|Withdrawal by Subject|33|||
146856801|NCT01136772|529646203|FG001|Overall Study|Withdrawal by Subject|36|||
146856802|NCT01136772|529646202|FG000|Overall Study|Did not receive injection|10|||
146856803|NCT01136772|529646203|FG001|Overall Study|Did not receive injection|7|||
146856804|NCT01136772|529646202|FG000|Overall Study|Did not follow up after first injection|2|||
146856805|NCT01136772|529646203|FG001|Overall Study|Did not follow up after first injection|2|||
146856806|NCT01498653|529646205|FG000|Overall Study|Adverse Event|2|||
146856807|NCT01498653|529646206|FG001|Overall Study|Adverse Event|2|||
146856808|NCT01498653|529646205|FG000|Overall Study|Lack of Efficacy|12|||
146856809|NCT01498653|529646206|FG001|Overall Study|Lack of Efficacy|26|||
146856810|NCT01498653|529646205|FG000|Overall Study|Protocol Violation|0|||
146856811|NCT01498653|529646206|FG001|Overall Study|Protocol Violation|4|||
146856812|NCT01498653|529646205|FG000|Overall Study|Lost to Follow-up|1|||
146856813|NCT01498653|529646206|FG001|Overall Study|Lost to Follow-up|0|||
146856814|NCT01498653|529646205|FG000|Overall Study|Physician Decision|2|||
146856815|NCT01498653|529646206|FG001|Overall Study|Physician Decision|0|||
146856816|NCT01498653|529646205|FG000|Overall Study|Withdrawal by Subject|2|||
146856817|NCT01498653|529646206|FG001|Overall Study|Withdrawal by Subject|3|||
146856818|NCT00836095|529646212|FG000|Overall Study|Physician Decision|0|||
146856819|NCT00836095|529646213|FG001|Overall Study|Physician Decision|3|||
146856820|NCT01602562|529646214|FG000|Overall Study|Adverse Event|3|||
146856821|NCT01602562|529646215|FG001|Overall Study|Adverse Event|1|||
146856822|NCT01602562|529646214|FG000|Overall Study|Physician Decision|1|||
146856823|NCT01602562|529646215|FG001|Overall Study|Physician Decision|1|||
146856824|NCT01602562|529646214|FG000|Overall Study|Withdrawal by Subject|1|||
146856825|NCT01602562|529646215|FG001|Overall Study|Withdrawal by Subject|1|||
146856826|NCT02112708|529646230|FG000|Baseline|Physician Decision|16|||
146856827|NCT02112708|529646231|FG001|Baseline|Physician Decision|11|||
146856828|NCT02112708|529646230|FG000|Baseline|Lost to Follow-up|12|||
146856829|NCT02112708|529646231|FG001|Baseline|Lost to Follow-up|0|||
146856830|NCT02112708|529646230|FG000|4 Month|Death|0|||
146856831|NCT02112708|529646231|FG001|4 Month|Death|1|||
146856832|NCT02112708|529646230|FG000|4 Month|Withdrawal by Subject|12|||
146856833|NCT02112708|529646231|FG001|4 Month|Withdrawal by Subject|0|||
146856834|NCT04948333|529646232|FG000|Overall Study|Adverse Event|6|||
146856835|NCT04948333|529646233|FG001|Overall Study|Adverse Event|4|||
146856836|NCT04948333|529646234|FG002|Overall Study|Adverse Event|0|||
146856837|NCT04948333|529646235|FG003|Overall Study|Adverse Event|2|||
146856838|NCT04948333|529646232|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
146856839|NCT04948333|529646233|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
146856840|NCT04948333|529646234|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146856841|NCT04948333|529646235|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146856842|NCT04948333|529646232|FG000|Overall Study|Progressive Disease|1|||
146856843|NCT04948333|529646233|FG001|Overall Study|Progressive Disease|5|||
146856844|NCT04948333|529646234|FG002|Overall Study|Progressive Disease|0|||
146856845|NCT04948333|529646235|FG003|Overall Study|Progressive Disease|0|||
146856846|NCT04948333|529646232|FG000|Overall Study|Physician Decision|2|||
146856847|NCT04948333|529646233|FG001|Overall Study|Physician Decision|2|||
146856848|NCT04948333|529646234|FG002|Overall Study|Physician Decision|0|||
146856849|NCT04948333|529646235|FG003|Overall Study|Physician Decision|0|||
146856850|NCT04948333|529646232|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
146856851|NCT04948333|529646233|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
146856852|NCT04948333|529646234|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
146856853|NCT04948333|529646235|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
146522138|NCT01990768|528419914|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
146522139|NCT01990768|528419912|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
146522140|NCT01990768|528419913|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
146522141|NCT01990768|528419914|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
146522142|NCT01990768|528419912|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
146522143|NCT01990768|528419913|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
146522144|NCT01990768|528419914|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
146522145|NCT01990768|528419912|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
146522146|NCT01990768|528419913|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
146522147|NCT01990768|528419914|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
146522148|NCT01990768|528419912|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
146522149|NCT01990768|528419913|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
146522150|NCT01990768|528419914|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
146522151|NCT01990768|528419912|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
146522152|NCT01990768|528419913|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
146522153|NCT01990768|528419914|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
146522154|NCT01990768|528419912|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
146522155|NCT01990768|528419913|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
146522156|NCT01990768|528419914|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
146522157|NCT01990768|528419912|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
146856854|NCT04948333|529646232|FG000|Overall Study|Withdrawal by Subject|2|||
146856855|NCT04948333|529646233|FG001|Overall Study|Withdrawal by Subject|0|||
146856856|NCT04948333|529646234|FG002|Overall Study|Withdrawal by Subject|0|||
146856857|NCT04948333|529646235|FG003|Overall Study|Withdrawal by Subject|1|||
146856858|NCT04948333|529646232|FG000|Overall Study|Protocol Violation|0|||
146856859|NCT04948333|529646233|FG001|Overall Study|Protocol Violation|1|||
146856860|NCT04948333|529646234|FG002|Overall Study|Protocol Violation|0|||
146856861|NCT04948333|529646235|FG003|Overall Study|Protocol Violation|0|||
146914645|NCT03303339|529850042|FG000|Overall Study|Study Terminated by Sponsor|0|||
146522158|NCT01990768|528419913|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
146625272|NCT03037385|528803847|FG002|Overall Study|Physician Decision|0|||
146856862|NCT04948333|529646232|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
146856863|NCT04948333|529646233|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
146856864|NCT04948333|529646234|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
146856865|NCT04948333|529646235|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
146856866|NCT01912456|529647750|FG000|Period 1|Physician Decision|0|||
146856867|NCT01912456|529647751|FG001|Period 1|Physician Decision|0|||
146856868|NCT01912456|529647752|FG002|Period 1|Physician Decision|1|||
146856869|NCT01912456|529647753|FG003|Period 1|Physician Decision|0|||
146856870|NCT01912456|529647750|FG000|Period 1|non-compliance|1|||
146856871|NCT01912456|529647751|FG001|Period 1|non-compliance|0|||
146856872|NCT01912456|529647752|FG002|Period 1|non-compliance|0|||
146856873|NCT01912456|529647753|FG003|Period 1|non-compliance|1|||
146856874|NCT01912456|529647750|FG000|Period 1|Adverse Event|1|||
146856875|NCT01912456|529647751|FG001|Period 1|Adverse Event|0|||
146856876|NCT01912456|529647752|FG002|Period 1|Adverse Event|0|||
146856877|NCT01912456|529647753|FG003|Period 1|Adverse Event|1|||
146856878|NCT01912456|529647750|FG000|Period 1|Withdrawal by Subject|0|||
146522159|NCT01990768|528419914|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
146522160|NCT01990768|528419912|FG000|6-Month Follow-up|No contact information|5|||
146522161|NCT01990768|528419913|FG001|6-Month Follow-up|No contact information|6|||
146522162|NCT01990768|528419914|FG002|6-Month Follow-up|No contact information|5|||
146522163|NCT01990768|528419912|FG000|6-Month Follow-up|Homeless|4|||
146522164|NCT01990768|528419913|FG001|6-Month Follow-up|Homeless|3|||
146522165|NCT01990768|528419914|FG002|6-Month Follow-up|Homeless|6|||
146522166|NCT01990768|528419912|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
146522167|NCT01990768|528419913|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
146522168|NCT01990768|528419914|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
146522169|NCT01990768|528419912|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
146856879|NCT01912456|529647751|FG001|Period 1|Withdrawal by Subject|1|||
146856880|NCT01912456|529647752|FG002|Period 1|Withdrawal by Subject|1|||
146856881|NCT01912456|529647753|FG003|Period 1|Withdrawal by Subject|1|||
146856882|NCT01912456|529647750|FG000|Period 2|Lack of Efficacy|0|||
146522170|NCT01990768|528419913|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
146522171|NCT01990768|528419914|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
146522172|NCT01990768|528419912|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
146522173|NCT01990768|528419913|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
146758550|NCT04978363|529283785|FG007|Overall Study|Other medical issues unrelated to the study|0|||
146758551|NCT04978363|529283786|FG008|Overall Study|Other medical issues unrelated to the study|0|||
146758552|NCT04978363|529283787|FG009|Overall Study|Other medical issues unrelated to the study|0|||
146758553|NCT04978363|529283788|FG010|Overall Study|Other medical issues unrelated to the study|0|||
146758554|NCT04978363|529283778|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
146758555|NCT04978363|529283779|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
146758556|NCT04978363|529283780|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
146758557|NCT04978363|529283781|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
146758558|NCT04978363|529283782|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
146758559|NCT04978363|529283783|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
146758560|NCT04978363|529283784|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
146758561|NCT04978363|529283785|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
146758562|NCT04978363|529283786|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
146758563|NCT04978363|529283787|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
146758564|NCT04978363|529283788|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
146758565|NCT04978363|529283778|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146758566|NCT04978363|529283779|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
146758567|NCT04978363|529283780|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146758568|NCT04978363|529283781|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146758569|NCT04978363|529283782|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146758570|NCT04978363|529283783|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146758571|NCT04978363|529283784|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146758572|NCT04978363|529283785|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146758573|NCT04978363|529283786|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146758574|NCT04978363|529283787|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146758575|NCT04978363|529283788|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146758576|NCT01251614|529283789|FG000|Overall Study|Adverse Event|1|||
146856883|NCT01912456|529647751|FG001|Period 2|Lack of Efficacy|2|||
146856884|NCT01912456|529647752|FG002|Period 2|Lack of Efficacy|0|||
146856885|NCT01912456|529647753|FG003|Period 2|Lack of Efficacy|0|||
146856886|NCT01912456|529647750|FG000|Period 2|Adverse Event|0|||
146522174|NCT01990768|528419914|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
146522175|NCT00154375|528419915|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
146856887|NCT01912456|529647751|FG001|Period 2|Adverse Event|0|||
146856888|NCT01912456|529647752|FG002|Period 2|Adverse Event|0|||
146856889|NCT01912456|529647753|FG003|Period 2|Adverse Event|1|||
146856890|NCT00171704|529647758|FG000|Overall Study|Adverse Event|24|||
146856891|NCT00171704|529647759|FG001|Overall Study|Adverse Event|33|||
146856892|NCT00171704|529647758|FG000|Overall Study|Disease Progression|14|||
146856893|NCT00171704|529647759|FG001|Overall Study|Disease Progression|9|||
146856894|NCT00171704|529647758|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
146856895|NCT00171704|529647759|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
146856896|NCT00171704|529647758|FG000|Overall Study|Administrative Problems|2|||
146856897|NCT00171704|529647759|FG001|Overall Study|Administrative Problems|1|||
146856898|NCT00171704|529647758|FG000|Overall Study|Death|2|||
146856899|NCT00171704|529647759|FG001|Overall Study|Death|2|||
146856900|NCT00171704|529647758|FG000|Overall Study|Withdrawal by Subject|1|||
146856901|NCT00171704|529647759|FG001|Overall Study|Withdrawal by Subject|3|||
146856902|NCT00171704|529647758|FG000|Overall Study|Protocol Violation|0|||
146856903|NCT00171704|529647759|FG001|Overall Study|Protocol Violation|1|||
146856904|NCT03938545|529647762|FG000|Overall Study|Lost to Follow-up|0|||
146856905|NCT03938545|529647763|FG001|Overall Study|Lost to Follow-up|0|||
146856906|NCT03938545|529647764|FG002|Overall Study|Lost to Follow-up|0|||
146856907|NCT03938545|529647765|FG003|Overall Study|Lost to Follow-up|1|||
146856908|NCT03938545|529647762|FG000|Overall Study|Non-compliance with study drug|0|||
146856909|NCT03938545|529647763|FG001|Overall Study|Non-compliance with study drug|0|||
146856910|NCT03938545|529647764|FG002|Overall Study|Non-compliance with study drug|1|||
146856911|NCT03938545|529647765|FG003|Overall Study|Non-compliance with study drug|0|||
146856912|NCT03938545|529647762|FG000|Overall Study|Pregnancy|1|||
146856913|NCT03938545|529647763|FG001|Overall Study|Pregnancy|0|||
146856914|NCT03938545|529647764|FG002|Overall Study|Pregnancy|0|||
146856915|NCT03938545|529647765|FG003|Overall Study|Pregnancy|0|||
146856916|NCT03938545|529647762|FG000|Overall Study|Study terminated by sponsor|6|||
146856917|NCT03938545|529647763|FG001|Overall Study|Study terminated by sponsor|4|||
146856918|NCT03938545|529647764|FG002|Overall Study|Study terminated by sponsor|2|||
146856919|NCT03938545|529647765|FG003|Overall Study|Study terminated by sponsor|4|||
146856920|NCT03938545|529647762|FG000|Overall Study|Withdrawal by Subject|0|||
146856921|NCT03938545|529647763|FG001|Overall Study|Withdrawal by Subject|1|||
146856922|NCT03938545|529647764|FG002|Overall Study|Withdrawal by Subject|0|||
146856923|NCT03938545|529647765|FG003|Overall Study|Withdrawal by Subject|0|||
146856924|NCT03938545|529647762|FG000|Overall Study|Adverse Event|1|||
146856925|NCT03938545|529647763|FG001|Overall Study|Adverse Event|0|||
146856926|NCT03938545|529647764|FG002|Overall Study|Adverse Event|0|||
146856927|NCT03938545|529647765|FG003|Overall Study|Adverse Event|0|||
146856928|NCT01060540|529647766|FG000|Overall Study|Withdrawal by Subject|10|||
146856929|NCT01060540|529647767|FG001|Overall Study|Withdrawal by Subject|20|||
146856930|NCT01060540|529647766|FG000|Overall Study|Lost to Follow-up|52|||
146856931|NCT01060540|529647767|FG001|Overall Study|Lost to Follow-up|43|||
146856932|NCT01060540|529647766|FG000|Overall Study|Death|2|||
146856933|NCT01060540|529647767|FG001|Overall Study|Death|1|||
146856934|NCT01060540|529647766|FG000|Overall Study|Physician Decision|0|||
146856935|NCT01060540|529647767|FG001|Overall Study|Physician Decision|1|||
146856936|NCT01222507|529647771|FG000|Overall Study|Physician Decision|1|||
146856937|NCT01222507|529647771|FG000|Overall Study|Withdrawal by Subject|1|||
146856938|NCT02647320|529647772|FG000|Overall Study|Adverse Event|0|||
146856939|NCT02647320|529647773|FG001|Overall Study|Adverse Event|1|||
146856940|NCT02647320|529647774|FG002|Overall Study|Adverse Event|3|||
146856941|NCT02647320|529647775|FG003|Overall Study|Adverse Event|2|||
146856942|NCT02647320|529647776|FG004|Overall Study|Adverse Event|1|||
146856943|NCT02647320|529647772|FG000|Overall Study|Protocol Violation|0|||
146856944|NCT02647320|529647773|FG001|Overall Study|Protocol Violation|0|||
146856945|NCT02647320|529647774|FG002|Overall Study|Protocol Violation|3|||
146856946|NCT02647320|529647775|FG003|Overall Study|Protocol Violation|0|||
146856947|NCT02647320|529647776|FG004|Overall Study|Protocol Violation|0|||
146856948|NCT02647320|529647772|FG000|Overall Study|Withdrawal by Subject|7|||
146856949|NCT02647320|529647773|FG001|Overall Study|Withdrawal by Subject|4|||
146856950|NCT02647320|529647774|FG002|Overall Study|Withdrawal by Subject|2|||
146856951|NCT02647320|529647775|FG003|Overall Study|Withdrawal by Subject|2|||
146856952|NCT02647320|529647776|FG004|Overall Study|Withdrawal by Subject|7|||
146856953|NCT02647320|529647772|FG000|Overall Study|Persistent hyperglycemia|0|||
146856954|NCT02647320|529647773|FG001|Overall Study|Persistent hyperglycemia|1|||
146856955|NCT02647320|529647774|FG002|Overall Study|Persistent hyperglycemia|1|||
146856956|NCT02647320|529647775|FG003|Overall Study|Persistent hyperglycemia|1|||
146856957|NCT02647320|529647776|FG004|Overall Study|Persistent hyperglycemia|1|||
146856958|NCT02647320|529647772|FG000|Overall Study|Study terminated by sponsor|1|||
146856959|NCT02647320|529647773|FG001|Overall Study|Study terminated by sponsor|1|||
146856960|NCT02647320|529647774|FG002|Overall Study|Study terminated by sponsor|1|||
146856961|NCT02647320|529647775|FG003|Overall Study|Study terminated by sponsor|1|||
146856962|NCT02647320|529647776|FG004|Overall Study|Study terminated by sponsor|2|||
146856963|NCT02647320|529647772|FG000|Overall Study|Reason not provided|0|||
146856964|NCT02647320|529647773|FG001|Overall Study|Reason not provided|0|||
146856965|NCT02647320|529647774|FG002|Overall Study|Reason not provided|1|||
146856966|NCT02647320|529647775|FG003|Overall Study|Reason not provided|0|||
146856967|NCT02647320|529647776|FG004|Overall Study|Reason not provided|2|||
146856968|NCT02647320|529647772|FG000|Overall Study|Lost to Follow-up|1|||
146856969|NCT02647320|529647773|FG001|Overall Study|Lost to Follow-up|1|||
146856970|NCT02647320|529647774|FG002|Overall Study|Lost to Follow-up|0|||
146856971|NCT02647320|529647775|FG003|Overall Study|Lost to Follow-up|0|||
146856972|NCT02647320|529647776|FG004|Overall Study|Lost to Follow-up|0|||
146856973|NCT02647320|529647772|FG000|Overall Study|Develop anemia|1|||
146856974|NCT02647320|529647773|FG001|Overall Study|Develop anemia|0|||
146856975|NCT02647320|529647774|FG002|Overall Study|Develop anemia|0|||
146856976|NCT02647320|529647775|FG003|Overall Study|Develop anemia|0|||
146856977|NCT02647320|529647776|FG004|Overall Study|Develop anemia|0|||
146856978|NCT02647320|529647772|FG000|Overall Study|Lack of Efficacy|0|||
146856979|NCT02647320|529647773|FG001|Overall Study|Lack of Efficacy|0|||
146856980|NCT02647320|529647774|FG002|Overall Study|Lack of Efficacy|0|||
146856981|NCT02647320|529647775|FG003|Overall Study|Lack of Efficacy|1|||
146856982|NCT02647320|529647776|FG004|Overall Study|Lack of Efficacy|0|||
146856983|NCT02647320|529647772|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
146856984|NCT02647320|529647773|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
146856985|NCT02647320|529647774|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
146856986|NCT02647320|529647775|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
146856987|NCT02647320|529647776|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
146856988|NCT00596427|529647778|FG000|Overall Study|Withdrawal by Subject|2|||
146856989|NCT00596427|529647779|FG001|Overall Study|Withdrawal by Subject|2|||
146856990|NCT00596427|529647778|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
146856991|NCT00596427|529647779|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
146856992|NCT00596427|529647778|FG000|Overall Study|Protocol Violation|1|||
146856993|NCT00596427|529647779|FG001|Overall Study|Protocol Violation|0|||
146856994|NCT00320541|529647780|FG000|Overall Study|Adverse Event|21|||
146856995|NCT00320541|529647781|FG001|Overall Study|Adverse Event|19|||
146856996|NCT00320541|529647780|FG000|Overall Study|Protocol Violation|0|||
146856997|NCT00320541|529647781|FG001|Overall Study|Protocol Violation|1|||
146856998|NCT00320541|529647780|FG000|Overall Study|Withdrawal by Subject|12|||
146856999|NCT00320541|529647781|FG001|Overall Study|Withdrawal by Subject|16|||
146857000|NCT00320541|529647780|FG000|Overall Study|Physician Decision|9|||
146857001|NCT00320541|529647781|FG001|Overall Study|Physician Decision|13|||
146857002|NCT00320541|529647780|FG000|Overall Study|Other|3|||
146857003|NCT00320541|529647781|FG001|Overall Study|Other|4|||
146857004|NCT00320541|529647780|FG000|Overall Study|Sponsor Decision|2|||
146857005|NCT00320541|529647781|FG001|Overall Study|Sponsor Decision|1|||
146857006|NCT00320541|529647780|FG000|Overall Study|Death due to Study Disease|1|||
146857007|NCT00320541|529647781|FG001|Overall Study|Death due to Study Disease|3|||
146857008|NCT00320541|529647780|FG000|Overall Study|Death due to Adverse Event(s)|1|||
146857009|NCT00320541|529647781|FG001|Overall Study|Death due to Adverse Event(s)|0|||
146857010|NCT00320541|529647780|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
146857011|NCT00320541|529647781|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
146857012|NCT02401867|529647784|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
146857013|NCT02401867|529647784|FG000|Analysis|Cervical assay could not be conducted|9|||
146857014|NCT01650246|529647785|FG000|Overall Study|Adverse Event|23|||
146857015|NCT01650246|529647785|FG000|Overall Study|Protocol Violation|5|||
146857016|NCT01650246|529647785|FG000|Overall Study|Sponsor terminated study|53|||
146857017|NCT01650246|529647785|FG000|Overall Study|Lost to Follow-up|5|||
146857018|NCT01650246|529647785|FG000|Overall Study|Withdrawal by Subject|26|||
146857019|NCT01650246|529647785|FG000|Overall Study|Death|1|||
146857020|NCT01650246|529647785|FG000|Overall Study|Lack of Efficacy|30|||
146857021|NCT00081770|529647786|FG000|Overall Study|Adverse Event|130|||
146857022|NCT00081770|529647787|FG001|Overall Study|Adverse Event|98|||
146857023|NCT00081770|529647788|FG002|Overall Study|Adverse Event|136|||
146857024|NCT00081770|529647786|FG000|Overall Study|Lack of Efficacy|262|||
146857025|NCT00081770|529647787|FG001|Overall Study|Lack of Efficacy|357|||
146857026|NCT00081770|529647788|FG002|Overall Study|Lack of Efficacy|211|||
146857027|NCT00081770|529647786|FG000|Overall Study|Lost to Follow-up|45|||
146857028|NCT00081770|529647787|FG001|Overall Study|Lost to Follow-up|34|||
146857029|NCT00081770|529647788|FG002|Overall Study|Lost to Follow-up|45|||
146857030|NCT00081770|529647786|FG000|Overall Study|Protocol Violation|15|||
146857031|NCT00081770|529647787|FG001|Overall Study|Protocol Violation|10|||
146857032|NCT00081770|529647788|FG002|Overall Study|Protocol Violation|10|||
146625273|NCT03037385|528803848|FG003|Overall Study|Physician Decision|0|||
146857033|NCT00081770|529647786|FG000|Overall Study|Withdrawal by Subject|45|||
146857034|NCT00081770|529647787|FG001|Overall Study|Withdrawal by Subject|40|||
146857035|NCT00081770|529647788|FG002|Overall Study|Withdrawal by Subject|42|||
146857036|NCT00081770|529647786|FG000|Overall Study|Did not meet protocol eligibility|2|||
146857037|NCT00081770|529647787|FG001|Overall Study|Did not meet protocol eligibility|0|||
146857038|NCT00081770|529647788|FG002|Overall Study|Did not meet protocol eligibility|3|||
146857039|NCT00081770|529647786|FG000|Overall Study|Administrative|1|||
146857040|NCT00081770|529647787|FG001|Overall Study|Administrative|0|||
146522176|NCT00154375|528419916|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
146522177|NCT00154375|528419915|FG000|Overall Study|Adverse Event|18|||
146522178|NCT00154375|528419916|FG001|Overall Study|Adverse Event|20|||
146522179|NCT00154375|528419915|FG000|Overall Study|Withdrawal by Subject|14|||
146522180|NCT00154375|528419916|FG001|Overall Study|Withdrawal by Subject|10|||
146522181|NCT00154375|528419915|FG000|Overall Study|Death|5|||
146522182|NCT00154375|528419916|FG001|Overall Study|Death|13|||
146522183|NCT00154375|528419915|FG000|Overall Study|Study drug no longer required|5|||
146522184|NCT00154375|528419916|FG001|Overall Study|Study drug no longer required|3|||
146522185|NCT00154375|528419915|FG000|Overall Study|Lost to Follow-up|2|||
146522186|NCT00154375|528419916|FG001|Overall Study|Lost to Follow-up|1|||
146522187|NCT00154375|528419915|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146522188|NCT00154375|528419916|FG001|Overall Study|Abnormal laboratory value(s)|2|||
146522189|NCT00154375|528419915|FG000|Overall Study|Protocol Violation|0|||
146522190|NCT00154375|528419916|FG001|Overall Study|Protocol Violation|1|||
146522191|NCT00154375|528419915|FG000|Overall Study|Suspected progression of disease|44|||
146522192|NCT00154375|528419916|FG001|Overall Study|Suspected progression of disease|30|||
146522193|NCT01588405|528419919|FG000|Overall Study|Adverse Event|1|||
146522194|NCT01588405|528419919|FG000|Overall Study|Clinical Worsening|1|||
146522195|NCT01216332|528419920|FG000|Overall Study|Withdrawal by Subject|4|||
146522196|NCT01216332|528419921|FG001|Overall Study|Withdrawal by Subject|0|||
146522197|NCT01066871|528419923|FG000|Overall Study|Lost to Follow-up|0|||
146522198|NCT01066871|528419924|FG001|Overall Study|Lost to Follow-up|2|||
146522199|NCT01066871|528419925|FG002|Overall Study|Lost to Follow-up|2|||
146522200|NCT01066871|528419926|FG003|Overall Study|Lost to Follow-up|0|||
146522201|NCT01066871|528419923|FG000|Overall Study|Protocol Violation|1|||
146522202|NCT01066871|528419924|FG001|Overall Study|Protocol Violation|0|||
146522203|NCT01066871|528419925|FG002|Overall Study|Protocol Violation|3|||
146522204|NCT01066871|528419926|FG003|Overall Study|Protocol Violation|2|||
146522205|NCT01066871|528419923|FG000|Overall Study|Lack of Efficacy|0|||
146522206|NCT01066871|528419924|FG001|Overall Study|Lack of Efficacy|0|||
146522207|NCT01066871|528419925|FG002|Overall Study|Lack of Efficacy|0|||
146522208|NCT01066871|528419926|FG003|Overall Study|Lack of Efficacy|1|||
146522209|NCT01066871|528419923|FG000|Overall Study|Withdrawal by Subject|3|||
146522210|NCT01066871|528419924|FG001|Overall Study|Withdrawal by Subject|1|||
146522211|NCT01066871|528419925|FG002|Overall Study|Withdrawal by Subject|0|||
146522212|NCT01066871|528419926|FG003|Overall Study|Withdrawal by Subject|0|||
146522213|NCT01066871|528419923|FG000|Overall Study|Other|0|||
146758577|NCT01251614|529283790|FG001|Overall Study|Adverse Event|0|||
146758578|NCT01251614|529283791|FG002|Overall Study|Adverse Event|1|||
146758579|NCT01251614|529283789|FG000|Overall Study|Lack of Efficacy|1|||
146758580|NCT01251614|529283790|FG001|Overall Study|Lack of Efficacy|9|||
146758581|NCT01251614|529283791|FG002|Overall Study|Lack of Efficacy|4|||
146758582|NCT01251614|529283789|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
146758583|NCT01251614|529283790|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
146758584|NCT01251614|529283791|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
146758585|NCT01251614|529283789|FG000|Overall Study|Pregnancy|0|||
146758586|NCT01251614|529283790|FG001|Overall Study|Pregnancy|0|||
146758587|NCT01251614|529283791|FG002|Overall Study|Pregnancy|2|||
146758588|NCT01251614|529283789|FG000|Overall Study|Loss of Disease Control|0|||
146758589|NCT01251614|529283790|FG001|Overall Study|Loss of Disease Control|1|||
146758590|NCT01251614|529283791|FG002|Overall Study|Loss of Disease Control|0|||
146758591|NCT01251614|529283789|FG000|Overall Study|Withdrawal by Subject|0|||
146758592|NCT01251614|529283790|FG001|Overall Study|Withdrawal by Subject|2|||
146758593|NCT01251614|529283791|FG002|Overall Study|Withdrawal by Subject|1|||
146758594|NCT01251614|529283789|FG000|Overall Study|Lost to Follow-up|0|||
146758595|NCT01251614|529283790|FG001|Overall Study|Lost to Follow-up|1|||
146758596|NCT01251614|529283791|FG002|Overall Study|Lost to Follow-up|0|||
146758597|NCT00049517|529283792|FG000|Induction|Disease progression|0|||
146758598|NCT00049517|529283793|FG001|Induction|Disease progression|0|||
146758599|NCT00049517|529283794|FG002|Induction|Disease progression|0|||
146758600|NCT00049517|529283795|FG003|Induction|Disease progression|0|||
146758601|NCT00049517|529283796|FG004|Induction|Disease progression|18|||
146758602|NCT00049517|529283797|FG005|Induction|Disease progression|11|||
146758603|NCT00049517|529283792|FG000|Induction|Adverse Event|0|||
146758604|NCT00049517|529283793|FG001|Induction|Adverse Event|0|||
146758605|NCT00049517|529283794|FG002|Induction|Adverse Event|0|||
146758606|NCT00049517|529283795|FG003|Induction|Adverse Event|0|||
146758607|NCT00049517|529283796|FG004|Induction|Adverse Event|5|||
146758608|NCT00049517|529283797|FG005|Induction|Adverse Event|7|||
146758609|NCT00049517|529283792|FG000|Induction|Death|0|||
146758610|NCT00049517|529283793|FG001|Induction|Death|0|||
146522214|NCT01066871|528419924|FG001|Overall Study|Other|2|||
146522215|NCT01066871|528419925|FG002|Overall Study|Other|1|||
146522216|NCT01066871|528419926|FG003|Overall Study|Other|2|||
146522217|NCT04162795|528419929|FG000|Overall Study|Other|16|||
146522218|NCT04162795|528419929|FG000|Overall Study|Screen failures|10|||
146522219|NCT02029274|528419932|FG000|Overall Study|Adverse Event|1|||
146522220|NCT02029274|528419933|FG001|Overall Study|Adverse Event|0|||
146758611|NCT00049517|529283794|FG002|Induction|Death|0|||
146857041|NCT00081770|529647788|FG002|Overall Study|Administrative|1|||
146857042|NCT00081770|529647786|FG000|Overall Study|Other|2|||
146857043|NCT00081770|529647787|FG001|Overall Study|Other|7|||
146857044|NCT00081770|529647788|FG002|Overall Study|Other|8|||
146857045|NCT03435497|529647790|FG000|Overall Study|Lost to Follow-up|1|||
146857046|NCT03435497|529647791|FG001|Overall Study|Lost to Follow-up|0|||
146857047|NCT03435497|529647790|FG000|Overall Study|Death|1|||
146857048|NCT03435497|529647791|FG001|Overall Study|Death|0|||
146857049|NCT03435497|529647790|FG000|Overall Study|Withdrawal by Subject|0|||
146857050|NCT03435497|529647791|FG001|Overall Study|Withdrawal by Subject|4|||
146857051|NCT03435497|529647790|FG000|Overall Study|Wrong survey administered|0|||
146857052|NCT03435497|529647791|FG001|Overall Study|Wrong survey administered|2|||
146857053|NCT02795429|529647801|FG000|Overall Study|Adverse Event|1|||
146857054|NCT02795429|529647802|FG001|Overall Study|Adverse Event|2|||
146857055|NCT02795429|529647803|FG002|Overall Study|Adverse Event|1|||
146857056|NCT02795429|529647804|FG003|Overall Study|Adverse Event|2|||
146857057|NCT02795429|529647805|FG004|Overall Study|Adverse Event|1|||
146857058|NCT02795429|529647801|FG000|Overall Study|Death|1|||
146857059|NCT02795429|529647802|FG001|Overall Study|Death|0|||
146857060|NCT02795429|529647803|FG002|Overall Study|Death|1|||
146857061|NCT02795429|529647804|FG003|Overall Study|Death|2|||
146857062|NCT02795429|529647805|FG004|Overall Study|Death|1|||
146857063|NCT02795429|529647801|FG000|Overall Study|Physician Decision|0|||
146857064|NCT02795429|529647802|FG001|Overall Study|Physician Decision|0|||
146857065|NCT02795429|529647803|FG002|Overall Study|Physician Decision|2|||
146857066|NCT02795429|529647804|FG003|Overall Study|Physician Decision|1|||
146857067|NCT02795429|529647805|FG004|Overall Study|Physician Decision|5|||
146857068|NCT02795429|529647801|FG000|Overall Study|Progressive disease|3|||
146857069|NCT02795429|529647802|FG001|Overall Study|Progressive disease|7|||
146857070|NCT02795429|529647803|FG002|Overall Study|Progressive disease|6|||
146857071|NCT02795429|529647804|FG003|Overall Study|Progressive disease|26|||
146857072|NCT02795429|529647805|FG004|Overall Study|Progressive disease|20|||
146857073|NCT02795429|529647801|FG000|Overall Study|Subject/guardian decision|1|||
146857074|NCT02795429|529647802|FG001|Overall Study|Subject/guardian decision|1|||
146857075|NCT02795429|529647803|FG002|Overall Study|Subject/guardian decision|1|||
146857076|NCT02795429|529647804|FG003|Overall Study|Subject/guardian decision|1|||
146857077|NCT02795429|529647805|FG004|Overall Study|Subject/guardian decision|3|||
146857078|NCT01640054|529647808|FG000|Overall Study|Study-specific disc criteria|1|||
146857079|NCT01640054|529647808|FG000|Overall Study|Lack of Efficacy|3|||
146857080|NCT01640054|529647808|FG000|Overall Study|Adverse Event|2|||
146857081|NCT02080221|529647812|FG000|Overall Study|Withdrawal by Subject|1|||
146857082|NCT02080221|529647812|FG000|Overall Study|Clinical Progression of Disease|1|||
146857083|NCT03786783|529647816|FG000|Overall Study|Death|1|||
146857084|NCT03786783|529647816|FG000|Overall Study|Physician Decision|6|||
146857085|NCT03786783|529647816|FG000|Overall Study|Withdrawal by Subject|2|||
146857086|NCT03786783|529647816|FG000|Overall Study|Disease Progression|7|||
146857087|NCT03786783|529647816|FG000|Overall Study|Patient/Parent Refusal|4|||
146857088|NCT00655486|529647821|FG000|Overall Study|Adverse Event|10|||
146857089|NCT00655486|529647821|FG000|Overall Study|Lack of Efficacy|8|||
146857090|NCT00655486|529647821|FG000|Overall Study|Withdrawal by Subject|4|||
146857091|NCT00655486|529647821|FG000|Overall Study|Protocol Violation|1|||
146857092|NCT00655486|529647821|FG000|Overall Study|Unsatisfactory compliance|2|||
146857093|NCT00655486|529647821|FG000|Overall Study|Other: Pregnancy|1|||
146857094|NCT00655486|529647821|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
146857095|NCT00655486|529647821|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
146857096|NCT04218084|529647822|FG000|Overall Study|Adverse Event|7|||
146857097|NCT04218084|529647823|FG001|Overall Study|Adverse Event|2|||
146857098|NCT04218084|529647822|FG000|Overall Study|Withdrawal of Consent|4|||
146857099|NCT04218084|529647823|FG001|Overall Study|Withdrawal of Consent|5|||
146857100|NCT04218084|529647822|FG000|Overall Study|Physician Decision|1|||
146857101|NCT04218084|529647823|FG001|Overall Study|Physician Decision|1|||
146857102|NCT04218084|529647822|FG000|Overall Study|Lost to Follow-up|1|||
146857103|NCT04218084|529647823|FG001|Overall Study|Lost to Follow-up|1|||
146857104|NCT04218084|529647822|FG000|Overall Study|Non-compliance with study drug|1|||
146857105|NCT04218084|529647823|FG001|Overall Study|Non-compliance with study drug|1|||
146857106|NCT04218084|529647822|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
146857107|NCT04218084|529647823|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
146857108|NCT04218084|529647822|FG000|Overall Study|Other|0|||
146857109|NCT04218084|529647823|FG001|Overall Study|Other|1|||
146857110|NCT04218084|529647822|FG000|Overall Study|Ongoing at data cut-off date|62|||
146857111|NCT04218084|529647823|FG001|Overall Study|Ongoing at data cut-off date|58|||
146857112|NCT06469242|529647824|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
146857113|NCT06469242|529647825|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
146857114|NCT06469242|529647824|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
146857115|NCT06469242|529647825|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
146857116|NCT00966277|529647827|FG000|Overall Study|Withdrawal by Subject|3|||
146857117|NCT00966277|529647828|FG001|Overall Study|Withdrawal by Subject|0|||
146857118|NCT00966277|529647827|FG000|Overall Study|Ineligible|1|||
146522221|NCT02029274|528419934|FG002|Overall Study|Adverse Event|2|||
146522222|NCT02029274|528419935|FG003|Overall Study|Adverse Event|2|||
146522223|NCT01124292|528419936|FG000|Overall Study|Lost to Follow-up|2|||
146522224|NCT01124292|528419937|FG001|Overall Study|Lost to Follow-up|4|||
146522225|NCT01124292|528419938|FG002|Overall Study|Lost to Follow-up|3|||
146522226|NCT01124292|528419936|FG000|Overall Study|Physician Decision|0|||
146522227|NCT01124292|528419937|FG001|Overall Study|Physician Decision|3|||
146522228|NCT01124292|528419938|FG002|Overall Study|Physician Decision|2|||
146522229|NCT01124292|528419936|FG000|Overall Study|Withdrawal by Subject|0|||
146522230|NCT01124292|528419937|FG001|Overall Study|Withdrawal by Subject|6|||
146522231|NCT01124292|528419938|FG002|Overall Study|Withdrawal by Subject|2|||
146522232|NCT01124292|528419936|FG000|Overall Study|medical issue unrelated to the study|0|||
146522233|NCT01124292|528419937|FG001|Overall Study|medical issue unrelated to the study|0|||
146522234|NCT01124292|528419938|FG002|Overall Study|medical issue unrelated to the study|2|||
146522235|NCT01124292|528419936|FG000|Overall Study|piercing track closed|0|||
146522236|NCT01124292|528419937|FG001|Overall Study|piercing track closed|2|||
146522237|NCT01124292|528419938|FG002|Overall Study|piercing track closed|1|||
146522238|NCT00481767|528419940|FG000|Overall Study|Withdrawal by Subject|16|||
146522239|NCT00481767|528419941|FG001|Overall Study|Withdrawal by Subject|11|||
146522240|NCT00481767|528419940|FG000|Overall Study|Lost to Follow-up|16|||
146522241|NCT00481767|528419941|FG001|Overall Study|Lost to Follow-up|10|||
146522242|NCT00524173|528419942|FG000|Overall Study|Lost to Follow-up|0|||
146522243|NCT00524173|528419943|FG001|Overall Study|Lost to Follow-up|1|||
146522244|NCT00524173|528419942|FG000|Overall Study|Death|1|||
146522245|NCT00524173|528419943|FG001|Overall Study|Death|0|||
146522246|NCT00524173|528419942|FG000|Overall Study|Had not reached endpoint at study close|4|||
146522247|NCT00524173|528419943|FG001|Overall Study|Had not reached endpoint at study close|1|||
146522248|NCT01237327|528419944|FG000|Overall Study|Protocol Violation: Core Study|1|||
146522249|NCT01237327|528419945|FG001|Overall Study|Protocol Violation: Core Study|0|||
146522250|NCT01237327|528419944|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
146522251|NCT01237327|528419945|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
146522252|NCT01237327|528419944|FG000|Overall Study|Progression of Disease: Core Study|18|||
146522253|NCT01237327|528419945|FG001|Overall Study|Progression of Disease: Core Study|22|||
146758612|NCT00049517|529283795|FG003|Induction|Death|0|||
146758613|NCT00049517|529283796|FG004|Induction|Death|9|||
146758614|NCT00049517|529283797|FG005|Induction|Death|6|||
146758615|NCT00049517|529283792|FG000|Induction|Withdrawal by Subject|0|||
146758616|NCT00049517|529283793|FG001|Induction|Withdrawal by Subject|0|||
146758617|NCT00049517|529283794|FG002|Induction|Withdrawal by Subject|0|||
146758618|NCT00049517|529283795|FG003|Induction|Withdrawal by Subject|0|||
146758619|NCT00049517|529283796|FG004|Induction|Withdrawal by Subject|1|||
146758620|NCT00049517|529283797|FG005|Induction|Withdrawal by Subject|3|||
146758621|NCT00049517|529283792|FG000|Induction|Alternative therapy|0|||
146758622|NCT00049517|529283793|FG001|Induction|Alternative therapy|0|||
146758623|NCT00049517|529283794|FG002|Induction|Alternative therapy|0|||
146758624|NCT00049517|529283795|FG003|Induction|Alternative therapy|0|||
146758625|NCT00049517|529283796|FG004|Induction|Alternative therapy|2|||
146758626|NCT00049517|529283797|FG005|Induction|Alternative therapy|2|||
146758627|NCT00049517|529283792|FG000|Induction|Other complicating disease|0|||
146758628|NCT00049517|529283793|FG001|Induction|Other complicating disease|0|||
146758629|NCT00049517|529283794|FG002|Induction|Other complicating disease|0|||
146758630|NCT00049517|529283795|FG003|Induction|Other complicating disease|0|||
146758631|NCT00049517|529283796|FG004|Induction|Other complicating disease|3|||
146758632|NCT00049517|529283797|FG005|Induction|Other complicating disease|0|||
146758633|NCT00049517|529283792|FG000|Induction|Reasons not reported|0|||
146758634|NCT00049517|529283793|FG001|Induction|Reasons not reported|0|||
146758635|NCT00049517|529283794|FG002|Induction|Reasons not reported|0|||
146758636|NCT00049517|529283795|FG003|Induction|Reasons not reported|0|||
146758637|NCT00049517|529283796|FG004|Induction|Reasons not reported|22|||
146758638|NCT00049517|529283797|FG005|Induction|Reasons not reported|25|||
146758639|NCT00049517|529283792|FG000|Conditioning/Transplant|Disease progression|14|||
146758640|NCT00049517|529283793|FG001|Conditioning/Transplant|Disease progression|6|||
146758641|NCT00049517|529283794|FG002|Conditioning/Transplant|Disease progression|10|||
146758642|NCT00049517|529283795|FG003|Conditioning/Transplant|Disease progression|6|||
146758643|NCT00049517|529283796|FG004|Conditioning/Transplant|Disease progression|0|||
146758644|NCT00049517|529283797|FG005|Conditioning/Transplant|Disease progression|0|||
146758645|NCT00049517|529283792|FG000|Conditioning/Transplant|Adverse Event|2|||
146758646|NCT00049517|529283793|FG001|Conditioning/Transplant|Adverse Event|1|||
146758647|NCT00049517|529283794|FG002|Conditioning/Transplant|Adverse Event|4|||
146758648|NCT00049517|529283795|FG003|Conditioning/Transplant|Adverse Event|8|||
146758649|NCT00049517|529283796|FG004|Conditioning/Transplant|Adverse Event|0|||
146758650|NCT00049517|529283797|FG005|Conditioning/Transplant|Adverse Event|0|||
146758651|NCT00049517|529283792|FG000|Conditioning/Transplant|Death|1|||
146758652|NCT00049517|529283793|FG001|Conditioning/Transplant|Death|0|||
146758653|NCT00049517|529283794|FG002|Conditioning/Transplant|Death|0|||
146758654|NCT00049517|529283795|FG003|Conditioning/Transplant|Death|2|||
146758655|NCT00049517|529283796|FG004|Conditioning/Transplant|Death|0|||
146522254|NCT01237327|528419944|FG000|Overall Study|Progression of Disease: Extension Study|15|||
146522255|NCT01237327|528419945|FG001|Overall Study|Progression of Disease: Extension Study|13|||
146522256|NCT01237327|528419944|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
146522257|NCT01237327|528419945|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
146522258|NCT01237327|528419944|FG000|Overall Study|Withdrawal by Subject|1|||
146522259|NCT01237327|528419945|FG001|Overall Study|Withdrawal by Subject|3|||
146522260|NCT01237327|528419944|FG000|Overall Study|Lost to Follow-up|3|||
146522261|NCT01237327|528419945|FG001|Overall Study|Lost to Follow-up|0|||
146522262|NCT01554163|528419950|FG000|Overall Study|Adverse Event|3|||
146522263|NCT01554163|528419951|FG001|Overall Study|Adverse Event|0|||
146522264|NCT01554163|528419950|FG000|Overall Study|Lack of Efficacy|1|||
146522265|NCT01554163|528419951|FG001|Overall Study|Lack of Efficacy|0|||
146522266|NCT01554163|528419950|FG000|Overall Study|Lost to Follow-up|1|||
146522267|NCT01554163|528419951|FG001|Overall Study|Lost to Follow-up|0|||
146522268|NCT01554163|528419950|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146522269|NCT01554163|528419951|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146522270|NCT01554163|528419950|FG000|Overall Study|Protocol Violation|0|||
146522271|NCT01554163|528419951|FG001|Overall Study|Protocol Violation|4|||
146522272|NCT01554163|528419950|FG000|Overall Study|Withdrawal by Subject|1|||
146522273|NCT01554163|528419951|FG001|Overall Study|Withdrawal by Subject|5|||
146522274|NCT01554163|528419950|FG000|Overall Study|Not Treated|1|||
146522275|NCT01554163|528419951|FG001|Overall Study|Not Treated|0|||
146522276|NCT01941537|528419952|FG000|Overall Study|Lack of Efficacy|1|||
146522277|NCT01941537|528419953|FG001|Overall Study|Lack of Efficacy|2|||
146522278|NCT01941537|528419952|FG000|Overall Study|Lost to Follow-up|1|||
146522279|NCT01941537|528419953|FG001|Overall Study|Lost to Follow-up|0|||
146522280|NCT01941537|528419952|FG000|Overall Study|Pregnancy|1|||
146522281|NCT01941537|528419953|FG001|Overall Study|Pregnancy|0|||
146522282|NCT01941537|528419952|FG000|Overall Study|Adverse Event|1|||
146522283|NCT01941537|528419953|FG001|Overall Study|Adverse Event|0|||
146522284|NCT01941537|528419952|FG000|Overall Study|Withdrawal by Subject|0|||
146522285|NCT01941537|528419953|FG001|Overall Study|Withdrawal by Subject|1|||
146522286|NCT02557516|528419955|FG000|Overall Study|Adverse Event|1|||
146522287|NCT02557516|528419956|FG001|Overall Study|Adverse Event|0|||
146522288|NCT02557516|528419957|FG002|Overall Study|Adverse Event|2|||
146522289|NCT02557516|528419958|FG003|Overall Study|Adverse Event|1|||
146522290|NCT02557516|528419955|FG000|Overall Study|Disease progression|0|||
146522291|NCT02557516|528419956|FG001|Overall Study|Disease progression|2|||
146522292|NCT02557516|528419957|FG002|Overall Study|Disease progression|0|||
146522293|NCT02557516|528419958|FG003|Overall Study|Disease progression|0|||
146522294|NCT02557516|528419955|FG000|Overall Study|Physician Decision|0|||
146522295|NCT02557516|528419956|FG001|Overall Study|Physician Decision|2|||
146522296|NCT02557516|528419957|FG002|Overall Study|Physician Decision|0|||
146522297|NCT02557516|528419958|FG003|Overall Study|Physician Decision|0|||
146522298|NCT02557516|528419955|FG000|Overall Study|Sponsor decision|0|||
146522299|NCT02557516|528419956|FG001|Overall Study|Sponsor decision|1|||
146522300|NCT02557516|528419957|FG002|Overall Study|Sponsor decision|2|||
146522301|NCT02557516|528419958|FG003|Overall Study|Sponsor decision|8|||
146522302|NCT03335813|528421721|FG000|Overall Study|Withdrawal by Subject|1|||
146522303|NCT00577772|528421722|FG000|Overall Study|Lost to Follow-up|0|||
146522304|NCT00577772|528421723|FG001|Overall Study|Lost to Follow-up|1|||
146522305|NCT00856999|528421726|FG000|Overall Study|Withdrawal by Subject|5|||
146522306|NCT00610168|528421728|FG000|Overall Study|Withdrawal by Subject|2|||
146522307|NCT00610168|528421729|FG001|Overall Study|Withdrawal by Subject|0|||
146522308|NCT00878800|528421736|FG000|Overall Study|Adverse Event|0|||
146522309|NCT00878800|528421737|FG001|Overall Study|Adverse Event|0|||
146522310|NCT00878800|528421738|FG002|Overall Study|Adverse Event|2|||
146522311|NCT00878800|528421739|FG003|Overall Study|Adverse Event|0|||
146522312|NCT00878800|528421740|FG004|Overall Study|Adverse Event|1|||
146522313|NCT00878800|528421736|FG000|Overall Study|Progressive disease|1|||
146522314|NCT00878800|528421737|FG001|Overall Study|Progressive disease|5|||
146522315|NCT00878800|528421738|FG002|Overall Study|Progressive disease|6|||
146522316|NCT00878800|528421739|FG003|Overall Study|Progressive disease|5|||
146522317|NCT00878800|528421740|FG004|Overall Study|Progressive disease|13|||
146522318|NCT00878800|528421736|FG000|Overall Study|Withdrew consent|1|||
146522319|NCT00878800|528421737|FG001|Overall Study|Withdrew consent|1|||
146522320|NCT00878800|528421738|FG002|Overall Study|Withdrew consent|0|||
146522321|NCT00878800|528421739|FG003|Overall Study|Withdrew consent|1|||
146522322|NCT00878800|528421740|FG004|Overall Study|Withdrew consent|1|||
146522323|NCT00878800|528421736|FG000|Overall Study|Death|0|||
146522324|NCT00878800|528421737|FG001|Overall Study|Death|0|||
146522325|NCT00878800|528421738|FG002|Overall Study|Death|1|||
146522326|NCT00878800|528421739|FG003|Overall Study|Death|0|||
146522327|NCT00878800|528421740|FG004|Overall Study|Death|0|||
146522328|NCT00878800|528421736|FG000|Overall Study|Other|1|||
146522329|NCT00878800|528421737|FG001|Overall Study|Other|1|||
146522330|NCT00878800|528421738|FG002|Overall Study|Other|0|||
146522331|NCT00878800|528421739|FG003|Overall Study|Other|0|||
146522332|NCT00878800|528421740|FG004|Overall Study|Other|1|||
146522333|NCT00613821|528421741|FG000|Overall Study|Withdrawal by Subject|1|||
146857119|NCT00966277|529647828|FG001|Overall Study|Ineligible|3|||
146857120|NCT00966277|529647827|FG000|Overall Study|Treatment Plan Changed|0|||
146857121|NCT00966277|529647828|FG001|Overall Study|Treatment Plan Changed|1|||
146857122|NCT03881553|529647832|FG000|Overall Study|Discharged prior to participation|1|||
146857123|NCT03881553|529647833|FG001|Overall Study|Discharged prior to participation|1|||
146857124|NCT03881553|529647834|FG002|Overall Study|Discharged prior to participation|0|||
146857125|NCT03881553|529647832|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
146857126|NCT03881553|529647833|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
146857127|NCT03881553|529647834|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
146857128|NCT01718353|529647835|FG000|Overall Study|Lost to Follow-up|0|||
146857129|NCT01718353|529647836|FG001|Overall Study|Lost to Follow-up|1|||
146857130|NCT01718353|529647835|FG000|Overall Study|Principal Investigator's Decision|10|||
146857131|NCT01718353|529647836|FG001|Overall Study|Principal Investigator's Decision|4|||
146857132|NCT01718353|529647835|FG000|Overall Study|Randomized but not treated|2|||
146857133|NCT01718353|529647836|FG001|Overall Study|Randomized but not treated|0|||
146857134|NCT01959516|529647837|FG000|Epoch 1|Adverse Event|4|||
146857135|NCT01959516|529647838|FG001|Epoch 1|Adverse Event|1|||
146857136|NCT01959516|529647837|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
146857137|NCT01959516|529647838|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
146857138|NCT01959516|529647837|FG000|Epoch 1|Subject withdrew consent|3|||
146857139|NCT01959516|529647838|FG001|Epoch 1|Subject withdrew consent|2|||
146857140|NCT01959516|529647837|FG000|Epoch 1|Administrative problems|1|||
146857141|NCT01959516|529647838|FG001|Epoch 1|Administrative problems|0|||
146857142|NCT01959516|529647837|FG000|Epoch 1|Use of prohibited treatment|1|||
146857143|NCT01959516|529647838|FG001|Epoch 1|Use of prohibited treatment|0|||
146857144|NCT01959516|529647837|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
146857145|NCT01959516|529647838|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
146857146|NCT01959516|529647837|FG000|Epoch 1|Protocol deviation|0|||
146857147|NCT01959516|529647838|FG001|Epoch 1|Protocol deviation|1|||
146857148|NCT01959516|529647837|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
146522334|NCT00613821|528421742|FG001|Overall Study|Withdrawal by Subject|0|||
146522335|NCT00613821|528421741|FG000|Overall Study|Physician Decision|1|||
146522336|NCT00613821|528421742|FG001|Overall Study|Physician Decision|1|||
146522337|NCT01266824|528421744|FG000|Overall Study|Study terminated prior to completion|2|||
146522338|NCT01266824|528421745|FG001|Overall Study|Study terminated prior to completion|3|||
146522339|NCT02302846|528421746|FG000|Overall Study|Withdrawal by Subject|1|||
146522340|NCT00411450|528421747|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
146522341|NCT00397189|528421748|FG000|3 Weeks Period|Lost to Follow-up|5|||
146522342|NCT00397189|528421749|FG001|3 Weeks Period|Lost to Follow-up|4|||
146522343|NCT00397189|528421748|FG000|3 Weeks Period|Adverse Event|3|||
146522344|NCT00397189|528421749|FG001|3 Weeks Period|Adverse Event|2|||
146522345|NCT00397189|528421748|FG000|3 Weeks Period|Withdrawal by Subject|13|||
146522346|NCT00397189|528421749|FG001|3 Weeks Period|Withdrawal by Subject|9|||
146522347|NCT00397189|528421748|FG000|3 Weeks Period|Physician Decision|0|||
146522348|NCT00397189|528421749|FG001|3 Weeks Period|Physician Decision|2|||
146522349|NCT00397189|528421748|FG000|3 Weeks Period|Protocol Violation|0|||
146522350|NCT00397189|528421749|FG001|3 Weeks Period|Protocol Violation|3|||
146522351|NCT00397189|528421748|FG000|3 Weeks Period|Other|0|||
146522352|NCT00397189|528421749|FG001|3 Weeks Period|Other|2|||
146522353|NCT01059773|528421750|FG000|Overall Study|Adverse Event|2|||
146522354|NCT01059773|528421751|FG001|Overall Study|Adverse Event|2|||
146522355|NCT01059773|528421750|FG000|Overall Study|Withdrawal by Subject|1|||
146522356|NCT01059773|528421751|FG001|Overall Study|Withdrawal by Subject|5|||
146522357|NCT01059773|528421750|FG000|Overall Study|Lost to Follow-up|1|||
146522358|NCT01059773|528421751|FG001|Overall Study|Lost to Follow-up|1|||
146522359|NCT01059773|528421750|FG000|Overall Study|Pregnancy|1|||
146522360|NCT01059773|528421751|FG001|Overall Study|Pregnancy|1|||
146522361|NCT01059773|528421750|FG000|Overall Study|Protocol Violation|6|||
146522362|NCT01059773|528421751|FG001|Overall Study|Protocol Violation|2|||
146522363|NCT01059773|528421750|FG000|Overall Study|Physician Decision|5|||
146522364|NCT01059773|528421751|FG001|Overall Study|Physician Decision|4|||
146522365|NCT01059773|528421750|FG000|Overall Study|Lack of Efficacy|3|||
146522366|NCT01059773|528421751|FG001|Overall Study|Lack of Efficacy|3|||
146522367|NCT01059773|528421750|FG000|Overall Study|Death|0|||
146522368|NCT01059773|528421751|FG001|Overall Study|Death|1|||
146522369|NCT01059773|528421750|FG000|Overall Study|Malignancy including squamous cell skin|0|||
146522370|NCT01059773|528421751|FG001|Overall Study|Malignancy including squamous cell skin|1|||
146522371|NCT01059773|528421750|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
146522372|NCT01059773|528421751|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
146522373|NCT01059773|528421750|FG000|Overall Study|Other|1|||
146857149|NCT01959516|529647838|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
146857150|NCT01959516|529647837|FG000|Epoch 2|Subject withdrew consent|1|||
146857151|NCT01959516|529647838|FG001|Epoch 2|Subject withdrew consent|0|||
146857152|NCT01959516|529647837|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
146857153|NCT01959516|529647838|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
146522374|NCT01059773|528421751|FG001|Overall Study|Other|3|||
146625274|NCT03037385|528803849|FG004|Overall Study|Physician Decision|0|||
146758656|NCT00049517|529283797|FG005|Conditioning/Transplant|Death|0|||
146758657|NCT00049517|529283792|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
146758658|NCT00049517|529283793|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
146758659|NCT00049517|529283794|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
146758660|NCT00049517|529283795|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
146758661|NCT00049517|529283796|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
146758662|NCT00049517|529283797|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
146758663|NCT00049517|529283792|FG000|Conditioning/Transplant|Alternative therapy|4|||
146758664|NCT00049517|529283793|FG001|Conditioning/Transplant|Alternative therapy|4|||
146758665|NCT00049517|529283794|FG002|Conditioning/Transplant|Alternative therapy|2|||
146758666|NCT00049517|529283795|FG003|Conditioning/Transplant|Alternative therapy|1|||
146758667|NCT00049517|529283796|FG004|Conditioning/Transplant|Alternative therapy|1|||
146758668|NCT00049517|529283797|FG005|Conditioning/Transplant|Alternative therapy|0|||
146758669|NCT00049517|529283792|FG000|Conditioning/Transplant|Other complicating disease|2|||
146758670|NCT00049517|529283793|FG001|Conditioning/Transplant|Other complicating disease|0|||
146758671|NCT00049517|529283794|FG002|Conditioning/Transplant|Other complicating disease|0|||
146758672|NCT00049517|529283795|FG003|Conditioning/Transplant|Other complicating disease|4|||
146758673|NCT00049517|529283796|FG004|Conditioning/Transplant|Other complicating disease|0|||
146758674|NCT00049517|529283797|FG005|Conditioning/Transplant|Other complicating disease|1|||
146758675|NCT00049517|529283792|FG000|Conditioning/Transplant|Reasons not reported|25|||
146758676|NCT00049517|529283793|FG001|Conditioning/Transplant|Reasons not reported|31|||
146758677|NCT00049517|529283794|FG002|Conditioning/Transplant|Reasons not reported|18|||
146758678|NCT00049517|529283795|FG003|Conditioning/Transplant|Reasons not reported|15|||
146758679|NCT00049517|529283796|FG004|Conditioning/Transplant|Reasons not reported|5|||
146758680|NCT00049517|529283797|FG005|Conditioning/Transplant|Reasons not reported|5|||
146758681|NCT00940017|529283798|FG000|Overall Study|did not meet entrance criteria|3|||
146758682|NCT00940017|529283798|FG000|Overall Study|Adverse Event|1|||
146758683|NCT01684046|529283799|FG000|Period 1, First 30 Days|Adverse Event|0|||
146758684|NCT01684046|529283800|FG001|Period 1, First 30 Days|Adverse Event|2|||
146758685|NCT02790606|529283810|FG000|Overall Study|Death|27|||
146758686|NCT02790606|529283810|FG000|Overall Study|Lost to Follow-up|4|||
146758687|NCT02790606|529283810|FG000|Overall Study|Physician Decision|3|||
146758688|NCT02790606|529283810|FG000|Overall Study|Withdrawal by Subject|1|||
146758689|NCT02735915|529283811|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
146758690|NCT02735915|529283811|FG000|Overall Study|Withdrawal following SAE|2|||
146758691|NCT02735915|529283811|FG000|Overall Study|Withdrawal by Subject|1|||
146758692|NCT05328973|529283812|FG000|Overall Study|Withdrawal by Subject|0|||
146758693|NCT05328973|529283813|FG001|Overall Study|Withdrawal by Subject|1|||
146758694|NCT03532178|529283814|FG000|First Period|Withdrawal by Subject|1|||
146758695|NCT03532178|529283815|FG001|First Period|Withdrawal by Subject|3|||
146758696|NCT03532178|529283814|FG000|First Period|technical issues in data collection Technical issues|0|||
146758697|NCT03532178|529283815|FG001|First Period|technical issues in data collection Technical issues|1|||
146758698|NCT03532178|529283814|FG000|Second Period|Withdrawal by Subject|1|||
146758699|NCT03532178|529283815|FG001|Second Period|Withdrawal by Subject|1|||
146758700|NCT03532178|529283814|FG000|Second Period|Technical issues|0|||
146758701|NCT03532178|529283815|FG001|Second Period|Technical issues|1|||
146758702|NCT03635112|529283816|FG000|Overall Study|Adverse Event|5|||
146758703|NCT03635112|529283817|FG001|Overall Study|Adverse Event|9|||
146758704|NCT03635112|529283818|FG002|Overall Study|Adverse Event|14|||
146758705|NCT03635112|529283816|FG000|Overall Study|Lost to Follow-up|1|||
146758706|NCT03635112|529283817|FG001|Overall Study|Lost to Follow-up|0|||
146758707|NCT03635112|529283818|FG002|Overall Study|Lost to Follow-up|1|||
146758708|NCT03635112|529283816|FG000|Overall Study|Physician Decision|5|||
146758709|NCT03635112|529283817|FG001|Overall Study|Physician Decision|7|||
146758710|NCT03635112|529283818|FG002|Overall Study|Physician Decision|5|||
146758711|NCT03635112|529283816|FG000|Overall Study|Protocol Violation|0|||
146758712|NCT03635112|529283817|FG001|Overall Study|Protocol Violation|0|||
146758713|NCT03635112|529283818|FG002|Overall Study|Protocol Violation|1|||
146758714|NCT03635112|529283816|FG000|Overall Study|Study Terminated by Sponsor|11|||
146758715|NCT03635112|529283817|FG001|Overall Study|Study Terminated by Sponsor|17|||
146758716|NCT03635112|529283818|FG002|Overall Study|Study Terminated by Sponsor|21|||
146758717|NCT03635112|529283816|FG000|Overall Study|Withdrawal by Subject|4|||
146758718|NCT03635112|529283817|FG001|Overall Study|Withdrawal by Subject|9|||
146758719|NCT03635112|529283818|FG002|Overall Study|Withdrawal by Subject|7|||
146758720|NCT03635112|529283816|FG000|Overall Study|Miscellaneous|0|||
146758721|NCT03635112|529283817|FG001|Overall Study|Miscellaneous|0|||
146758722|NCT03635112|529283818|FG002|Overall Study|Miscellaneous|1|||
146758723|NCT04296942|529283819|FG000|Overall Study|Study closure by sponsor|1|||
146758724|NCT04296942|529283820|FG001|Overall Study|Study closure by sponsor|0|||
146758725|NCT04296942|529283821|FG002|Overall Study|Study closure by sponsor|0|||
146758726|NCT00530777|529283827|FG000|Overall Study|Lost to Follow-up|0|||
146758727|NCT00530777|529283828|FG001|Overall Study|Lost to Follow-up|1|||
146758728|NCT00530777|529283827|FG000|Overall Study|Death|1|||
146857154|NCT01477333|529647839|FG000|Overall Study|Adverse Event|1|||
146857155|NCT01477333|529647839|FG000|Overall Study|Withdrawal by Subject|1|||
146857156|NCT01477333|529647839|FG000|Overall Study|Clinical Deterioration|1|||
146857157|NCT00455325|529647840|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
146857158|NCT00455325|529647841|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
146857159|NCT00455325|529647842|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
146857160|NCT00455325|529647843|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
146857161|NCT00455325|529647840|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
146857162|NCT00455325|529647841|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
146857163|NCT00455325|529647842|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
146857164|NCT00455325|529647843|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
146857165|NCT00455325|529647840|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
146857166|NCT00455325|529647841|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
146857167|NCT00455325|529647842|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
146857168|NCT00455325|529647843|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
146857169|NCT00455325|529647840|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
146857170|NCT00455325|529647841|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
146857171|NCT00455325|529647842|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
146857172|NCT00455325|529647843|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
146857173|NCT00455325|529647840|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
146857174|NCT00455325|529647841|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
146857175|NCT00455325|529647842|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
146857176|NCT00455325|529647843|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
146857177|NCT00455325|529647840|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
146857178|NCT00455325|529647841|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
146857179|NCT00455325|529647842|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
146857180|NCT00455325|529647843|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
146857181|NCT00455325|529647840|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
146857182|NCT00455325|529647841|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
146857183|NCT00455325|529647842|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
146857184|NCT00455325|529647843|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
146857185|NCT04620811|529647844|FG000|Overall Study|Withdrawal by Subject|18|||
146857186|NCT04620811|529647845|FG001|Overall Study|Withdrawal by Subject|15|||
146857187|NCT04620811|529647844|FG000|Overall Study|Adverse Event|6|||
146857188|NCT04620811|529647845|FG001|Overall Study|Adverse Event|11|||
146857189|NCT04620811|529647844|FG000|Overall Study|Lost to Follow-up|4|||
146857190|NCT04620811|529647845|FG001|Overall Study|Lost to Follow-up|8|||
146857191|NCT04620811|529647844|FG000|Overall Study|Physician Decision|1|||
146857192|NCT04620811|529647845|FG001|Overall Study|Physician Decision|4|||
146857193|NCT04620811|529647844|FG000|Overall Study|Sponsor Decision|0|||
146857194|NCT04620811|529647845|FG001|Overall Study|Sponsor Decision|1|||
146857195|NCT04620811|529647844|FG000|Overall Study|Elevation of ALT or AST|1|||
146857196|NCT04620811|529647845|FG001|Overall Study|Elevation of ALT or AST|0|||
146857197|NCT04620811|529647844|FG000|Overall Study|Other|3|||
146857198|NCT04620811|529647845|FG001|Overall Study|Other|5|||
146857199|NCT01078675|529647846|FG000|Overall Study|Withdrawal by Subject|7|||
146857200|NCT01078675|529647847|FG001|Overall Study|Withdrawal by Subject|3|||
146857201|NCT01078675|529647846|FG000|Overall Study|Protocol Violation|56|||
146857202|NCT01078675|529647847|FG001|Overall Study|Protocol Violation|0|||
146857203|NCT01078675|529647846|FG000|Overall Study|Provided in CRF for specific reasons|2|||
146857204|NCT01078675|529647847|FG001|Overall Study|Provided in CRF for specific reasons|3|||
146857205|NCT01078675|529647846|FG000|Overall Study|Adverse Event|3|||
146857206|NCT01078675|529647847|FG001|Overall Study|Adverse Event|0|||
146857207|NCT00928746|529647857|FG000|Overall Study|Adverse Event|2|||
146857208|NCT00928746|529647857|FG000|Overall Study|Protocol Violation|1|||
146857209|NCT00928746|529647857|FG000|Overall Study|Withdrawal by Subject|1|||
146857210|NCT00928746|529647857|FG000|Overall Study|Other|2|||
146857211|NCT02004353|529647860|FG000|Overall Study|Voluntary participation|1334|||
146857212|NCT01759368|529647864|FG000|Overall Study|Lost to Follow-up|1|||
146857213|NCT01759368|529647865|FG001|Overall Study|Lost to Follow-up|0|||
146857214|NCT03110185|529647873|FG000|Overall Study|Death|0|||
146857215|NCT03110185|529647874|FG001|Overall Study|Death|1|||
146857216|NCT03110185|529647873|FG000|Overall Study|Withdrawal by Subject|2|||
146857217|NCT03110185|529647874|FG001|Overall Study|Withdrawal by Subject|7|||
146857218|NCT03110185|529647873|FG000|Overall Study|Time Constraints|0|||
146857219|NCT03110185|529647874|FG001|Overall Study|Time Constraints|6|||
146857220|NCT03110185|529647873|FG000|Overall Study|Conflict with care|5|||
146857221|NCT03110185|529647874|FG001|Overall Study|Conflict with care|12|||
146857222|NCT03110185|529647873|FG000|Overall Study|Protocol Violation|1|||
146857223|NCT03110185|529647874|FG001|Overall Study|Protocol Violation|4|||
146522375|NCT00141518|528421754|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
146857224|NCT03110185|529647873|FG000|Overall Study|MRI Incompatible|2|||
146857225|NCT03110185|529647874|FG001|Overall Study|MRI Incompatible|0|||
146857226|NCT03110185|529647873|FG000|Overall Study|Patient Refusal|0|||
146857227|NCT03110185|529647874|FG001|Overall Study|Patient Refusal|1|||
146857228|NCT02641496|529647875|FG000|Overall Study|Lost to Follow-up|13|||
146857229|NCT02641496|529647876|FG001|Overall Study|Lost to Follow-up|12|||
146857230|NCT02641496|529647875|FG000|Overall Study|Withdrawal by Subject|1|||
146857231|NCT02641496|529647876|FG001|Overall Study|Withdrawal by Subject|0|||
146857232|NCT03075410|529647879|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
146857233|NCT03075410|529647880|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
146857234|NCT03075410|529647881|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
146857235|NCT03075410|529647882|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
146857236|NCT03075410|529647883|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
146857237|NCT03075410|529647884|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
146857238|NCT03075410|529647885|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
146857239|NCT03075410|529647886|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
146857240|NCT03075410|529647887|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
146857241|NCT03075410|529647879|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
146857242|NCT03075410|529647880|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
146857243|NCT03075410|529647881|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
146857244|NCT03075410|529647882|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
146857245|NCT03075410|529647883|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
146857246|NCT03075410|529647884|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
146857247|NCT03075410|529647885|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
146857248|NCT03075410|529647886|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
146857249|NCT03075410|529647887|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
146857250|NCT01427751|529647888|FG000|Overall Study|Adverse Event|18|||
146857251|NCT01427751|529647889|FG001|Overall Study|Adverse Event|2|||
146857252|NCT01427751|529647888|FG000|Overall Study|No further treatment benefit expected|5|||
146857253|NCT01427751|529647889|FG001|Overall Study|No further treatment benefit expected|1|||
146857254|NCT01427751|529647888|FG000|Overall Study|Lost to Follow-up|3|||
146857255|NCT01427751|529647889|FG001|Overall Study|Lost to Follow-up|1|||
146857256|NCT01427751|529647888|FG000|Overall Study|Withdrawal of consent|2|||
146857257|NCT01427751|529647889|FG001|Overall Study|Withdrawal of consent|2|||
146857258|NCT01427751|529647888|FG000|Overall Study|Protocol Violation|6|||
146857259|NCT01427751|529647889|FG001|Overall Study|Protocol Violation|4|||
146857260|NCT01427751|529647888|FG000|Overall Study|Death|2|||
146857261|NCT01427751|529647889|FG001|Overall Study|Death|0|||
146857262|NCT01427751|529647888|FG000|Overall Study|Other miscellaneous reasons|6|||
146857263|NCT01427751|529647889|FG001|Overall Study|Other miscellaneous reasons|4|||
146857264|NCT01028027|529647890|FG000|Overall Study|Lost to Follow-up|4|||
146857265|NCT01028027|529647891|FG001|Overall Study|Lost to Follow-up|1|||
146857266|NCT01028027|529647890|FG000|Overall Study|Withdrawal by Subject|5|||
146857267|NCT01028027|529647891|FG001|Overall Study|Withdrawal by Subject|3|||
146857268|NCT01028027|529647890|FG000|Overall Study|Adverse Event|4|||
146857269|NCT01028027|529647891|FG001|Overall Study|Adverse Event|7|||
146857270|NCT01028027|529647890|FG000|Overall Study|Protocol Violation|3|||
146857271|NCT01028027|529647891|FG001|Overall Study|Protocol Violation|1|||
146522376|NCT00141518|528421755|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
146522377|NCT00141518|528421756|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
146522378|NCT00141518|528421754|FG000|Overall Study|Adverse Event|7|||
146522379|NCT00141518|528421755|FG001|Overall Study|Adverse Event|5|||
146522380|NCT00141518|528421756|FG002|Overall Study|Adverse Event|2|||
146522381|NCT00141518|528421754|FG000|Overall Study|Withdrawal by Subject|2|||
146522382|NCT00141518|528421755|FG001|Overall Study|Withdrawal by Subject|0|||
146522383|NCT00141518|528421756|FG002|Overall Study|Withdrawal by Subject|2|||
146522384|NCT00141518|528421754|FG000|Overall Study|Protocol Violation|1|||
146522385|NCT00141518|528421755|FG001|Overall Study|Protocol Violation|1|||
146522386|NCT00141518|528421756|FG002|Overall Study|Protocol Violation|2|||
146522387|NCT00141518|528421754|FG000|Overall Study|Lack of Efficacy|5|||
146522388|NCT00141518|528421755|FG001|Overall Study|Lack of Efficacy|0|||
146522389|NCT00141518|528421756|FG002|Overall Study|Lack of Efficacy|0|||
146522390|NCT01029262|528421760|FG000|Overall Study|Adverse Event|9|||
146857272|NCT01028027|529647890|FG000|Overall Study|Lack of Efficacy|0|||
146857273|NCT01028027|529647891|FG001|Overall Study|Lack of Efficacy|1|||
146857274|NCT05330312|529647893|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
146522391|NCT01029262|528421761|FG001|Overall Study|Adverse Event|52|||
146857275|NCT05330312|529647894|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
146857276|NCT05330312|529647895|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
146857277|NCT05330312|529647893|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
146857278|NCT05330312|529647894|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
146857279|NCT05330312|529647895|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
146857280|NCT05330312|529647893|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
146857281|NCT05330312|529647894|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
146857282|NCT05330312|529647895|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
146522392|NCT01029262|528421760|FG000|Overall Study|Lack of therapeutic effect|57|||
146522393|NCT01029262|528421761|FG001|Overall Study|Lack of therapeutic effect|76|||
146857283|NCT05330312|529647893|FG000|Pivotal Investigation - Part 2|Death|1|||
146857284|NCT05330312|529647894|FG001|Pivotal Investigation - Part 2|Death|4|||
146857285|NCT05330312|529647895|FG002|Pivotal Investigation - Part 2|Death|0|||
146857286|NCT02572843|529647896|FG000|Accrual|Brain metastasis retrospectively detected|1|||
146857287|NCT02572843|529647896|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
146857288|NCT02572843|529647896|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
146857289|NCT02572843|529647896|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
146857290|NCT02572843|529647896|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
146857291|NCT02572843|529647896|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
146857292|NCT02572843|529647896|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
146857293|NCT02572843|529647896|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
146857294|NCT02572843|529647896|FG000|Surgery|lost to follow up|7|||
146857295|NCT02572843|529647896|FG000|Surgery|Death|1|||
146857296|NCT03464097|529647901|FG000|Overall Study|Withdrawal by Subject|15|||
146857297|NCT03464097|529647902|FG001|Overall Study|Withdrawal by Subject|13|||
146857298|NCT03464097|529647903|FG002|Overall Study|Withdrawal by Subject|11|||
146857299|NCT03464097|529647901|FG000|Overall Study|Study terminated by sponsor|47|||
146857300|NCT03464097|529647902|FG001|Overall Study|Study terminated by sponsor|44|||
146857301|NCT03464097|529647903|FG002|Overall Study|Study terminated by sponsor|40|||
146857302|NCT03464097|529647901|FG000|Overall Study|Pregnancy|0|||
146857303|NCT03464097|529647902|FG001|Overall Study|Pregnancy|1|||
146857304|NCT03464097|529647903|FG002|Overall Study|Pregnancy|0|||
146857305|NCT03464097|529647901|FG000|Overall Study|Other reasons|5|||
146857306|NCT03464097|529647902|FG001|Overall Study|Other reasons|12|||
146857307|NCT03464097|529647903|FG002|Overall Study|Other reasons|14|||
146857308|NCT03464097|529647901|FG000|Overall Study|Lost to Follow-up|0|||
146857309|NCT03464097|529647902|FG001|Overall Study|Lost to Follow-up|1|||
146857310|NCT03464097|529647903|FG002|Overall Study|Lost to Follow-up|1|||
146857311|NCT03464097|529647901|FG000|Overall Study|Lack of Efficacy|11|||
146857312|NCT03464097|529647902|FG001|Overall Study|Lack of Efficacy|18|||
146857313|NCT03464097|529647903|FG002|Overall Study|Lack of Efficacy|30|||
146857314|NCT03464097|529647901|FG000|Overall Study|Death|1|||
146857315|NCT03464097|529647902|FG001|Overall Study|Death|0|||
146857316|NCT03464097|529647903|FG002|Overall Study|Death|0|||
146857317|NCT03464097|529647901|FG000|Overall Study|Adverse Event|13|||
146857318|NCT03464097|529647902|FG001|Overall Study|Adverse Event|6|||
146857319|NCT03464097|529647903|FG002|Overall Study|Adverse Event|8|||
146857320|NCT03035201|529647904|FG000|Overall Study|Death|9|||
146965076|NCT03110107|530033440|FG014|Treatment Period|Death|0|||
146522394|NCT01029262|528421760|FG000|Overall Study|Withdrawal by Subject|10|||
146522395|NCT01029262|528421761|FG001|Overall Study|Withdrawal by Subject|17|||
146522396|NCT01029262|528421760|FG000|Overall Study|Protocol Violation|2|||
146522397|NCT01029262|528421761|FG001|Overall Study|Protocol Violation|3|||
146522398|NCT01029262|528421760|FG000|Overall Study|Miscellaneous|1|||
146522399|NCT01029262|528421761|FG001|Overall Study|Miscellaneous|9|||
146522400|NCT01029262|528421760|FG000|Overall Study|Death|0|||
146522401|NCT01029262|528421761|FG001|Overall Study|Death|3|||
146522402|NCT03410992|528421762|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
146522403|NCT03410992|528421763|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
146522404|NCT03410992|528421764|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
146522405|NCT03410992|528421765|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
146522406|NCT03410992|528421766|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
146522407|NCT03410992|528421767|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
146522408|NCT03410992|528421768|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
146522409|NCT03410992|528421769|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
146522410|NCT03410992|528421770|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
146522411|NCT03410992|528421771|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
146522412|NCT03410992|528421772|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
146522413|NCT03410992|528421762|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
146522414|NCT03410992|528421763|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
146522415|NCT03410992|528421764|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
146522416|NCT03410992|528421765|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
146522417|NCT03410992|528421766|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
146522418|NCT03410992|528421767|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
146522419|NCT03410992|528421768|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
146522420|NCT03410992|528421769|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
146522421|NCT03410992|528421770|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
146522422|NCT03410992|528421771|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
146522423|NCT03410992|528421772|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
146522424|NCT03410992|528421762|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
146522425|NCT03410992|528421763|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
146522426|NCT03410992|528421764|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
146522427|NCT03410992|528421765|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
146522428|NCT03410992|528421766|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
146522429|NCT03410992|528421767|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
146522430|NCT03410992|528421768|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
146522431|NCT03410992|528421769|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
146522432|NCT03410992|528421770|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
146522433|NCT03410992|528421771|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
146522434|NCT03410992|528421772|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
146522435|NCT03410992|528421762|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
146522436|NCT03410992|528421763|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
146625275|NCT03037385|528803850|FG005|Overall Study|Physician Decision|0|||
146758729|NCT00530777|529283828|FG001|Overall Study|Death|2|||
146758730|NCT00530777|529283827|FG000|Overall Study|Physician Decision|1|||
146758731|NCT00530777|529283828|FG001|Overall Study|Physician Decision|0|||
146758732|NCT00530777|529283827|FG000|Overall Study|Withdrawal by Subject|0|||
146758733|NCT00530777|529283828|FG001|Overall Study|Withdrawal by Subject|1|||
146758734|NCT00530777|529283827|FG000|Overall Study|Unable to adhere to visit schedule|5|||
146758735|NCT00530777|529283828|FG001|Overall Study|Unable to adhere to visit schedule|1|||
146758736|NCT01582243|529283833|FG000|Overall Study|Withdrawal by Subject|1|||
146758737|NCT01582243|529283833|FG000|Overall Study|Adverse Event|1|||
146758738|NCT01582243|529283833|FG000|Overall Study|Lost to Follow-up|1|||
146758739|NCT03382821|529283834|FG000|Overall Study|Did not receive allocated intervention.|0|||
146758740|NCT03382821|529283835|FG001|Overall Study|Did not receive allocated intervention.|3|||
146758741|NCT02096003|529283839|FG000|Overall Study|Protocol Violation|0|||
146758742|NCT02096003|529283840|FG001|Overall Study|Protocol Violation|2|||
146758743|NCT02096003|529283839|FG000|Overall Study|additional surgery|2|||
146758744|NCT02096003|529283840|FG001|Overall Study|additional surgery|1|||
146758745|NCT03178201|529283841|FG000|Overall Study|Off study|5|||
146758746|NCT04668144|529283842|FG000|Overall Study|Protocol Violation|0|||
146758747|NCT04668144|529283843|FG001|Overall Study|Protocol Violation|1|||
146758748|NCT04668144|529283844|FG002|Overall Study|Protocol Violation|2|||
146758749|NCT01723774|529283845|FG000|Neoadjuvant|Ki67 > 10%|4|||
146758750|NCT01723774|529283846|FG001|Neoadjuvant|Ki67 > 10%|0|||
146758751|NCT01723774|529283847|FG002|Neoadjuvant|Ki67 > 10%|10|||
146758752|NCT01723774|529283848|FG003|Neoadjuvant|Ki67 > 10%|0|||
146758753|NCT01723774|529283845|FG000|Neoadjuvant|Withdrawal by Subject|3|||
146758754|NCT01723774|529283846|FG001|Neoadjuvant|Withdrawal by Subject|1|||
146758755|NCT01723774|529283847|FG002|Neoadjuvant|Withdrawal by Subject|0|||
146522437|NCT03410992|528421764|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
146522438|NCT03410992|528421765|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
146522439|NCT03410992|528421766|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
146522440|NCT03410992|528421767|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
146522441|NCT03410992|528421768|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
146522442|NCT03410992|528421769|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
146522443|NCT03410992|528421770|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
146522444|NCT03410992|528421771|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
146522445|NCT03410992|528421772|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
146522446|NCT03410992|528421762|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
146522447|NCT03410992|528421763|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
146522448|NCT03410992|528421764|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
146522449|NCT03410992|528421765|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
146522450|NCT03410992|528421766|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
146522451|NCT03410992|528421767|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
146522452|NCT03410992|528421768|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
146522453|NCT03410992|528421769|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
146522454|NCT03410992|528421770|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
146522455|NCT03410992|528421771|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
146522456|NCT03410992|528421772|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
146522457|NCT03410992|528421762|FG000|Week 16 Assessment|Incorrect escapers|0|||
146522458|NCT03410992|528421763|FG001|Week 16 Assessment|Incorrect escapers|6|||
146522459|NCT03410992|528421764|FG002|Week 16 Assessment|Incorrect escapers|0|||
146522460|NCT03410992|528421765|FG003|Week 16 Assessment|Incorrect escapers|0|||
146522461|NCT03410992|528421766|FG004|Week 16 Assessment|Incorrect escapers|0|||
146522462|NCT03410992|528421767|FG005|Week 16 Assessment|Incorrect escapers|0|||
146522463|NCT03410992|528421768|FG006|Week 16 Assessment|Incorrect escapers|0|||
146522464|NCT03410992|528421769|FG007|Week 16 Assessment|Incorrect escapers|0|||
146522465|NCT03410992|528421770|FG008|Week 16 Assessment|Incorrect escapers|0|||
146522466|NCT03410992|528421771|FG009|Week 16 Assessment|Incorrect escapers|0|||
146522467|NCT03410992|528421772|FG010|Week 16 Assessment|Incorrect escapers|0|||
146522468|NCT03410992|528421762|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
146522469|NCT03410992|528421763|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
146522470|NCT03410992|528421764|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
146522471|NCT03410992|528421765|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
146522472|NCT03410992|528421766|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
146522473|NCT03410992|528421767|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
146522474|NCT03410992|528421768|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
146522475|NCT03410992|528421769|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
146522476|NCT03410992|528421770|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
146522477|NCT03410992|528421771|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
146522478|NCT03410992|528421772|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
146522479|NCT03410992|528421762|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
146522480|NCT03410992|528421763|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
146522481|NCT03410992|528421764|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
146522482|NCT03410992|528421765|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
146522483|NCT03410992|528421766|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
146522484|NCT03410992|528421767|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
146522485|NCT03410992|528421768|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
146522486|NCT03410992|528421769|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
146522487|NCT03410992|528421770|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
146758756|NCT01723774|529283848|FG003|Neoadjuvant|Withdrawal by Subject|0|||
146758757|NCT01723774|529283845|FG000|Neoadjuvant|Disease progression|0|||
146758758|NCT01723774|529283846|FG001|Neoadjuvant|Disease progression|1|||
146758759|NCT01723774|529283847|FG002|Neoadjuvant|Disease progression|1|||
146758760|NCT01723774|529283848|FG003|Neoadjuvant|Disease progression|0|||
146758761|NCT01723774|529283845|FG000|Neoadjuvant|Adverse Event|0|||
146758762|NCT01723774|529283846|FG001|Neoadjuvant|Adverse Event|1|||
146758763|NCT01723774|529283847|FG002|Neoadjuvant|Adverse Event|2|||
146758764|NCT01723774|529283848|FG003|Neoadjuvant|Adverse Event|0|||
146758765|NCT01723774|529283845|FG000|Neoadjuvant|High estradiol|0|||
146758766|NCT01723774|529283846|FG001|Neoadjuvant|High estradiol|1|||
146758767|NCT01723774|529283847|FG002|Neoadjuvant|High estradiol|0|||
146758768|NCT01723774|529283848|FG003|Neoadjuvant|High estradiol|0|||
146758769|NCT04956692|529283851|FG000|Overall Study|Death|115|||
146758770|NCT04956692|529283852|FG001|Overall Study|Death|47|||
146758771|NCT04956692|529283851|FG000|Overall Study|Lost to Follow-up|0|||
146758772|NCT04956692|529283852|FG001|Overall Study|Lost to Follow-up|1|||
146758773|NCT04956692|529283851|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
146758774|NCT04956692|529283852|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146758775|NCT04956692|529283851|FG000|Overall Study|Withdrawal by Subject|5|||
146758776|NCT04956692|529283852|FG001|Overall Study|Withdrawal by Subject|2|||
146758777|NCT04956692|529283851|FG000|Overall Study|Ongoing in Study|236|||
146758778|NCT04956692|529283852|FG001|Overall Study|Ongoing in Study|123|||
146758779|NCT04639947|529283853|FG000|Overall Study|Screen fail|1|||
146758780|NCT02696785|529283858|FG000|Blinded Treatment Period|Adverse Event|0|||
146758781|NCT02696785|529283859|FG001|Blinded Treatment Period|Adverse Event|1|||
146758782|NCT02696785|529283860|FG002|Blinded Treatment Period|Adverse Event|3|||
146758783|NCT02696785|529283861|FG003|Blinded Treatment Period|Adverse Event|0|||
146758784|NCT02696785|529283858|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
146758785|NCT02696785|529283859|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
146758786|NCT02696785|529283860|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
146758787|NCT02696785|529283861|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
146758788|NCT02696785|529283858|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
146758789|NCT02696785|529283859|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
146758790|NCT02696785|529283860|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
146758791|NCT02696785|529283861|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
146758792|NCT02696785|529283858|FG000|Blinded Treatment Period|Screen Failure|1|||
146758793|NCT02696785|529283859|FG001|Blinded Treatment Period|Screen Failure|0|||
146758794|NCT02696785|529283860|FG002|Blinded Treatment Period|Screen Failure|0|||
146758795|NCT02696785|529283861|FG003|Blinded Treatment Period|Screen Failure|0|||
146758796|NCT02696785|529283858|FG000|Washout Period|Withdrawal by Subject|0|||
146758797|NCT02696785|529283859|FG001|Washout Period|Withdrawal by Subject|1|||
146758798|NCT02696785|529283860|FG002|Washout Period|Withdrawal by Subject|0|||
146758799|NCT02696785|529283861|FG003|Washout Period|Withdrawal by Subject|0|||
146758800|NCT02696785|529283858|FG000|Washout Period|Lack of Efficacy|0|||
146758801|NCT02696785|529283859|FG001|Washout Period|Lack of Efficacy|1|||
146758802|NCT02696785|529283860|FG002|Washout Period|Lack of Efficacy|0|||
146758803|NCT02696785|529283861|FG003|Washout Period|Lack of Efficacy|0|||
146758804|NCT02696785|529283858|FG000|Extended Treatment Period|Adverse Event|2|||
146758805|NCT02696785|529283859|FG001|Extended Treatment Period|Adverse Event|3|||
146758806|NCT02696785|529283860|FG002|Extended Treatment Period|Adverse Event|2|||
146758807|NCT02696785|529283861|FG003|Extended Treatment Period|Adverse Event|1|||
146758808|NCT02696785|529283858|FG000|Extended Treatment Period|Lack of Efficacy|0|||
146758809|NCT02696785|529283859|FG001|Extended Treatment Period|Lack of Efficacy|1|||
146758810|NCT02696785|529283860|FG002|Extended Treatment Period|Lack of Efficacy|0|||
146758811|NCT02696785|529283861|FG003|Extended Treatment Period|Lack of Efficacy|0|||
146758812|NCT02696785|529283858|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
146758813|NCT02696785|529283859|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
146758814|NCT02696785|529283860|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
146758815|NCT02696785|529283861|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
146758816|NCT02696785|529283858|FG000|Follow-up Period|Adverse Event|0|||
146758817|NCT02696785|529283859|FG001|Follow-up Period|Adverse Event|0|||
146758818|NCT02696785|529283860|FG002|Follow-up Period|Adverse Event|8|||
146758819|NCT02696785|529283861|FG003|Follow-up Period|Adverse Event|2|||
146758820|NCT02696785|529283858|FG000|Follow-up Period|Lost to Follow-up|0|||
146758821|NCT02696785|529283859|FG001|Follow-up Period|Lost to Follow-up|0|||
146758822|NCT02696785|529283860|FG002|Follow-up Period|Lost to Follow-up|0|||
146758823|NCT02696785|529283861|FG003|Follow-up Period|Lost to Follow-up|1|||
146758824|NCT02696785|529283858|FG000|Follow-up Period|Lack of Efficacy|0|||
146758825|NCT02696785|529283859|FG001|Follow-up Period|Lack of Efficacy|0|||
146758826|NCT02696785|529283860|FG002|Follow-up Period|Lack of Efficacy|0|||
146758827|NCT02696785|529283861|FG003|Follow-up Period|Lack of Efficacy|1|||
146758828|NCT02696785|529283858|FG000|Follow-up Period|Withdrawal by Subject|1|||
146758829|NCT02696785|529283859|FG001|Follow-up Period|Withdrawal by Subject|0|||
146758830|NCT02696785|529283860|FG002|Follow-up Period|Withdrawal by Subject|5|||
146758831|NCT02696785|529283861|FG003|Follow-up Period|Withdrawal by Subject|4|||
146758832|NCT04863898|529283865|FG000|Overall Study|Away from study clinic during intervention training period|2|||
146758833|NCT04863898|529283865|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
146758834|NCT04863898|529283865|FG000|Overall Study|Lost to Follow-up|3|||
146758835|NCT04863898|529283865|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
146758836|NCT04863898|529283865|FG000|Overall Study|No longer employed at clinic|3|||
146758837|NCT03285711|529283866|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
146758838|NCT03285711|529283867|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
146758839|NCT03285711|529283868|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
146758840|NCT03285711|529283869|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
146758841|NCT03285711|529283866|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
146758842|NCT03285711|529283867|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
146758843|NCT03285711|529283868|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
146758844|NCT03285711|529283869|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
146758845|NCT03285711|529283866|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
146758846|NCT03285711|529283867|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
146758847|NCT03285711|529283868|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
146857321|NCT03035201|529647905|FG001|Overall Study|Death|12|||
146857322|NCT03035201|529647906|FG002|Overall Study|Death|9|||
146857323|NCT03035201|529647907|FG003|Overall Study|Death|10|||
146857324|NCT03035201|529647904|FG000|Overall Study|Withdrawal by Subject|51|||
146857325|NCT03035201|529647905|FG001|Overall Study|Withdrawal by Subject|49|||
146857326|NCT03035201|529647906|FG002|Overall Study|Withdrawal by Subject|37|||
146857327|NCT03035201|529647907|FG003|Overall Study|Withdrawal by Subject|46|||
146857328|NCT03035201|529647904|FG000|Overall Study|Lost to Follow-up|67|||
146857329|NCT03035201|529647905|FG001|Overall Study|Lost to Follow-up|51|||
146857330|NCT03035201|529647906|FG002|Overall Study|Lost to Follow-up|64|||
146857331|NCT03035201|529647907|FG003|Overall Study|Lost to Follow-up|69|||
146857332|NCT05572021|529647914|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
146857333|NCT05572021|529647915|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
146857334|NCT04576455|529647916|FG000|Overall Study|Ongoing in the Study|48|||
146857335|NCT04576455|529647917|FG001|Overall Study|Ongoing in the Study|58|||
146857336|NCT04576455|529647916|FG000|Overall Study|Death|83|||
146857337|NCT04576455|529647917|FG001|Overall Study|Death|77|||
146857338|NCT04576455|529647916|FG000|Overall Study|Lost to Follow-up|4|||
146857339|NCT04576455|529647917|FG001|Overall Study|Lost to Follow-up|5|||
146857340|NCT04576455|529647916|FG000|Overall Study|Withdrawal by Subject|16|||
146857341|NCT04576455|529647917|FG001|Overall Study|Withdrawal by Subject|12|||
146857342|NCT03432260|529647918|FG000|Overall Study|Lost to Follow-up|1|||
146857343|NCT03432260|529647919|FG001|Overall Study|Lost to Follow-up|1|||
146857344|NCT03432260|529647920|FG002|Overall Study|Lost to Follow-up|0|||
146857345|NCT03432260|529647921|FG003|Overall Study|Lost to Follow-up|0|||
146857346|NCT03432260|529647922|FG004|Overall Study|Lost to Follow-up|1|||
146857347|NCT02186847|529647923|FG000|Overall Study|Protocol Violation|3|||
146857348|NCT02186847|529647924|FG001|Overall Study|Protocol Violation|0|||
146857349|NCT04873232|529647928|FG000|Overall Study|Lost to Follow-up|1|||
146857350|NCT04873232|529647929|FG001|Overall Study|Lost to Follow-up|4|||
146857351|NCT04873232|529647928|FG000|Overall Study|Withdrawal by Subject|1|||
146857352|NCT04873232|529647929|FG001|Overall Study|Withdrawal by Subject|0|||
146857353|NCT00001962|529649968|FG000|Overall Study|Lack of Efficacy|18|||
146857354|NCT00001962|529649968|FG000|Overall Study|Lack of Accrual|6|||
146857355|NCT00001962|529649968|FG000|Overall Study|Death|1|||
146857356|NCT00001962|529649968|FG000|Overall Study|Lost to Follow-up|2|||
146857357|NCT00001962|529649968|FG000|Overall Study|Adverse Event|1|||
146857358|NCT04281004|529649971|FG000|Overall Study|Physician Decision|1|||
146857359|NCT04281004|529649972|FG001|Overall Study|Physician Decision|0|||
146857360|NCT00701779|529649973|FG000|Overall Study|Adverse Event|6|||
146857361|NCT00701779|529649973|FG000|Overall Study|Lost to Follow-up|1|||
146857362|NCT00701779|529649973|FG000|Overall Study|Withdrawal by Subject|2|||
146857363|NCT03442985|529649974|FG000|Overall Study|Sponsor Request|55|||
146857364|NCT03442985|529649975|FG001|Overall Study|Sponsor Request|60|||
146857365|NCT03442985|529649976|FG002|Overall Study|Sponsor Request|54|||
146857366|NCT03442985|529649974|FG000|Overall Study|Lost to Follow-up|5|||
146857367|NCT03442985|529649975|FG001|Overall Study|Lost to Follow-up|2|||
146857368|NCT03442985|529649976|FG002|Overall Study|Lost to Follow-up|7|||
146857369|NCT03442985|529649974|FG000|Overall Study|Withdrawal by Subject|2|||
146857370|NCT03442985|529649975|FG001|Overall Study|Withdrawal by Subject|3|||
146857371|NCT03442985|529649976|FG002|Overall Study|Withdrawal by Subject|4|||
146857372|NCT03442985|529649974|FG000|Overall Study|Adverse Event|0|||
146857373|NCT03442985|529649975|FG001|Overall Study|Adverse Event|1|||
146857374|NCT03442985|529649976|FG002|Overall Study|Adverse Event|0|||
146857375|NCT01620255|529649977|FG000|Overall Study|Withdrawal by Subject|4|||
146857376|NCT01620255|529649978|FG001|Overall Study|Withdrawal by Subject|1|||
146857377|NCT01620255|529649979|FG002|Overall Study|Withdrawal by Subject|1|||
146857378|NCT01620255|529649980|FG003|Overall Study|Withdrawal by Subject|2|||
146857379|NCT01620255|529649981|FG004|Overall Study|Withdrawal by Subject|4|||
146857380|NCT01620255|529649977|FG000|Overall Study|Participant underwent fecal transplant|0|||
146857381|NCT01620255|529649978|FG001|Overall Study|Participant underwent fecal transplant|0|||
146857382|NCT01620255|529649979|FG002|Overall Study|Participant underwent fecal transplant|1|||
146857383|NCT01620255|529649980|FG003|Overall Study|Participant underwent fecal transplant|0|||
146857384|NCT01620255|529649981|FG004|Overall Study|Participant underwent fecal transplant|0|||
146522488|NCT03410992|528421771|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
146522489|NCT03410992|528421772|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
146857385|NCT01620255|529649977|FG000|Overall Study|Non-compliance|0|||
146857386|NCT01620255|529649978|FG001|Overall Study|Non-compliance|1|||
146857387|NCT01620255|529649979|FG002|Overall Study|Non-compliance|0|||
146857388|NCT01620255|529649980|FG003|Overall Study|Non-compliance|0|||
146857389|NCT01620255|529649981|FG004|Overall Study|Non-compliance|0|||
146857390|NCT01620255|529649977|FG000|Overall Study|Adverse Event|0|||
146857391|NCT01620255|529649978|FG001|Overall Study|Adverse Event|4|||
146857392|NCT01620255|529649979|FG002|Overall Study|Adverse Event|0|||
146857393|NCT01620255|529649980|FG003|Overall Study|Adverse Event|1|||
146857394|NCT01620255|529649981|FG004|Overall Study|Adverse Event|1|||
146965077|NCT03110107|530033441|FG015|Treatment Period|Death|0|||
146522490|NCT03410992|528421762|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
146522491|NCT03410992|528421763|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
146522492|NCT03410992|528421764|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
146522493|NCT03410992|528421765|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
146522494|NCT03410992|528421766|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
146522495|NCT03410992|528421767|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
146522496|NCT03410992|528421768|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
146522497|NCT03410992|528421769|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
146522498|NCT03410992|528421770|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
146522499|NCT03410992|528421771|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
146758848|NCT03285711|529283869|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
146758849|NCT03285711|529283866|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
146758850|NCT03285711|529283867|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
146758851|NCT03285711|529283868|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
146758852|NCT03285711|529283869|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
146758853|NCT02431533|529283870|FG000|Overall Study|Withdrawal by Subject|1|||
146758854|NCT02431533|529283871|FG001|Overall Study|Withdrawal by Subject|3|||
146758855|NCT02431533|529283870|FG000|Overall Study|Developed Exclusionary criteria|1|||
146758856|NCT02431533|529283871|FG001|Overall Study|Developed Exclusionary criteria|0|||
146758857|NCT00235495|529283872|FG000|Overall Study|Death|52|||
146758858|NCT00235495|529283873|FG001|Overall Study|Death|42|||
146758859|NCT00235495|529283872|FG000|Overall Study|Withdrawal by Subject|5|||
146758860|NCT00235495|529283873|FG001|Overall Study|Withdrawal by Subject|3|||
146758861|NCT00235495|529283872|FG000|Overall Study|Lost to Follow-up|11|||
146758862|NCT00235495|529283873|FG001|Overall Study|Lost to Follow-up|13|||
146758863|NCT00235495|529283872|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
146758864|NCT00235495|529283873|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
146758865|NCT02234310|529283874|FG000|Overall Study|Physician Decision|1|||
146758866|NCT02234310|529283874|FG000|Overall Study|Adverse Event|1|||
146758867|NCT02234310|529283874|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
146758868|NCT02234310|529283874|FG000|Overall Study|Withdrawal by Subject|2|||
146758869|NCT03251378|529283875|FG000|Overall Study|Death|3|||
146758870|NCT03251378|529283876|FG001|Overall Study|Death|2|||
146758871|NCT03251378|529283877|FG002|Overall Study|Death|3|||
146758872|NCT03251378|529283878|FG003|Overall Study|Death|30|||
146758873|NCT03251378|529283879|FG004|Overall Study|Death|24|||
146758874|NCT03251378|529283880|FG005|Overall Study|Death|12|||
146758875|NCT03251378|529283881|FG006|Overall Study|Death|12|||
146758876|NCT03251378|529283875|FG000|Overall Study|Lost to Follow-up|0|||
146758877|NCT03251378|529283876|FG001|Overall Study|Lost to Follow-up|0|||
146758878|NCT03251378|529283877|FG002|Overall Study|Lost to Follow-up|1|||
146758879|NCT03251378|529283878|FG003|Overall Study|Lost to Follow-up|3|||
146758880|NCT03251378|529283879|FG004|Overall Study|Lost to Follow-up|0|||
146758881|NCT03251378|529283880|FG005|Overall Study|Lost to Follow-up|0|||
146758882|NCT03251378|529283881|FG006|Overall Study|Lost to Follow-up|0|||
146758883|NCT03251378|529283875|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
146758884|NCT03251378|529283876|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
146758885|NCT03251378|529283877|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
146758886|NCT03251378|529283878|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
146758887|NCT03251378|529283879|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
146625276|NCT03037385|528803851|FG006|Overall Study|Physician Decision|0|||
146625277|NCT03037385|528803852|FG007|Overall Study|Physician Decision|0|||
146758888|NCT03251378|529283880|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
146758889|NCT03251378|529283881|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
146758890|NCT03251378|529283875|FG000|Overall Study|Progressive disease|2|||
146758891|NCT03251378|529283876|FG001|Overall Study|Progressive disease|0|||
146758892|NCT03251378|529283877|FG002|Overall Study|Progressive disease|0|||
146758893|NCT03251378|529283878|FG003|Overall Study|Progressive disease|1|||
146758894|NCT03251378|529283879|FG004|Overall Study|Progressive disease|0|||
146758895|NCT03251378|529283880|FG005|Overall Study|Progressive disease|0|||
146758896|NCT03251378|529283881|FG006|Overall Study|Progressive disease|0|||
146857395|NCT01620255|529649977|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
146522500|NCT03410992|528421772|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
146625278|NCT03037385|528803853|FG008|Overall Study|Physician Decision|0|||
146758897|NCT03251378|529283875|FG000|Overall Study|Physician Decision|0|||
146758898|NCT03251378|529283876|FG001|Overall Study|Physician Decision|2|||
146758899|NCT03251378|529283877|FG002|Overall Study|Physician Decision|0|||
146758900|NCT03251378|529283878|FG003|Overall Study|Physician Decision|0|||
146758901|NCT03251378|529283879|FG004|Overall Study|Physician Decision|0|||
146758902|NCT03251378|529283880|FG005|Overall Study|Physician Decision|0|||
146758903|NCT03251378|529283881|FG006|Overall Study|Physician Decision|0|||
146758904|NCT03251378|529283875|FG000|Overall Study|Other|2|||
146857396|NCT01620255|529649978|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
146857397|NCT01620255|529649979|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
146857398|NCT01620255|529649980|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
146857399|NCT01620255|529649981|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
146522501|NCT03410992|528421762|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
146522502|NCT03410992|528421763|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
146522503|NCT03410992|528421764|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
146522504|NCT03410992|528421765|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
146522505|NCT03410992|528421766|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
146857400|NCT01716117|529649985|FG000|Overall Study|Death|5|||
146857401|NCT01716117|529649986|FG001|Overall Study|Death|2|||
146857402|NCT01716117|529649985|FG000|Overall Study|Withdrawal by Subject|2|||
146857403|NCT01716117|529649986|FG001|Overall Study|Withdrawal by Subject|0|||
146857404|NCT01557283|529649987|FG000|Overall Study|Lost to Follow-up|7|||
146857405|NCT01557283|529649987|FG000|Overall Study|Non-responder|19|||
146857406|NCT01557283|529649987|FG000|Overall Study|Adverse Event|7|||
146857407|NCT01557283|529649987|FG000|Overall Study|Lack of Efficacy|1|||
146857408|NCT01557283|529649987|FG000|Overall Study|Non-compliance|1|||
146857409|NCT01557283|529649987|FG000|Overall Study|Withdrawal by Subject|1|||
146857410|NCT01557283|529649987|FG000|Overall Study|Participant's weight too high for dose|1|||
146857411|NCT01557283|529649987|FG000|Overall Study|Worsening of psoriasis|1|||
146857412|NCT01557283|529649987|FG000|Overall Study|Other|6|||
146857413|NCT03645057|529649988|FG000|Randomization to Baseline|Lost to Follow-up|1|||
146857414|NCT03645057|529649989|FG001|Randomization to Baseline|Lost to Follow-up|0|||
146857415|NCT03645057|529649990|FG002|Randomization to Baseline|Lost to Follow-up|1|||
146857416|NCT03645057|529649991|FG003|Randomization to Baseline|Lost to Follow-up|0|||
146857417|NCT03645057|529649988|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
146857418|NCT03645057|529649989|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
146857419|NCT03645057|529649990|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
146857420|NCT03645057|529649991|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
146857421|NCT03645057|529649988|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
146857422|NCT03645057|529649989|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
146857423|NCT03645057|529649990|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
146857424|NCT03645057|529649991|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
146857425|NCT03645057|529649988|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
146857426|NCT03645057|529649989|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
146857427|NCT03645057|529649990|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
146857428|NCT03645057|529649991|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
146857429|NCT01873495|529649992|FG000|Overall Study|Withdrawal by Subject|1|||
146857430|NCT01873495|529649992|FG000|Overall Study|Physician Decision|3|||
146857431|NCT01873495|529649992|FG000|Overall Study|Adverse Event|1|||
146857432|NCT01873495|529649992|FG000|Overall Study|Removed for Transplantation|1|||
146857433|NCT01873495|529649992|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
146857434|NCT01206777|529649993|FG000|Overall Study|Death|1|||
146857435|NCT01206777|529649993|FG000|Overall Study|Adverse Event|1|||
146857436|NCT00120406|529649998|FG000|Overall Study|Death|9|||
146857437|NCT00120406|529649999|FG001|Overall Study|Death|4|||
146857438|NCT00120406|529649998|FG000|Overall Study|Withdrawal by Subject|5|||
146857439|NCT00120406|529649999|FG001|Overall Study|Withdrawal by Subject|7|||
146857440|NCT00120406|529649998|FG000|Overall Study|Lost to Follow-up|5|||
146857441|NCT00120406|529649999|FG001|Overall Study|Lost to Follow-up|2|||
146857442|NCT00120406|529649998|FG000|Overall Study|received non-study stent|0|||
146857443|NCT00120406|529649999|FG001|Overall Study|received non-study stent|2|||
146857444|NCT00120406|529649998|FG000|Overall Study|patient moved but has not withdrawn|0|||
146857445|NCT00120406|529649999|FG001|Overall Study|patient moved but has not withdrawn|1|||
146857446|NCT01155375|529650000|FG000|Overall Study|Adverse Event|1|||
146857447|NCT01155375|529650001|FG001|Overall Study|Adverse Event|0|||
146857448|NCT00762970|529650002|FG000|Overall Study|Withdrawal by Subject|7|||
146857449|NCT00762970|529650003|FG001|Overall Study|Withdrawal by Subject|4|||
146857450|NCT00762970|529650004|FG002|Overall Study|Withdrawal by Subject|0|||
146857451|NCT00762970|529650002|FG000|Overall Study|Protocol Violation|3|||
146857452|NCT00762970|529650003|FG001|Overall Study|Protocol Violation|1|||
146857453|NCT00762970|529650004|FG002|Overall Study|Protocol Violation|1|||
146857454|NCT00762970|529650002|FG000|Overall Study|Lost to Follow-up|1|||
146857455|NCT00762970|529650003|FG001|Overall Study|Lost to Follow-up|2|||
146857456|NCT00762970|529650004|FG002|Overall Study|Lost to Follow-up|0|||
146857457|NCT00762970|529650002|FG000|Overall Study|Difficulty of handling lens|1|||
146857458|NCT00762970|529650003|FG001|Overall Study|Difficulty of handling lens|2|||
146857459|NCT00762970|529650004|FG002|Overall Study|Difficulty of handling lens|0|||
146857460|NCT00975507|529650005|FG000|Overall Study|Adverse Event|1|||
146857461|NCT00975507|529650006|FG001|Overall Study|Adverse Event|0|||
146857462|NCT00975507|529650005|FG000|Overall Study|Lost to Follow-up|7|||
146857463|NCT00975507|529650006|FG001|Overall Study|Lost to Follow-up|1|||
146857464|NCT00975507|529650005|FG000|Overall Study|Protocol Violation|2|||
146857465|NCT00975507|529650006|FG001|Overall Study|Protocol Violation|0|||
146522506|NCT03410992|528421767|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
146522507|NCT03410992|528421768|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
146522508|NCT03410992|528421769|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
146522509|NCT03410992|528421770|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
146522510|NCT03410992|528421771|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
146522511|NCT03410992|528421772|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
146758905|NCT03251378|529283876|FG001|Overall Study|Other|3|||
146758906|NCT03251378|529283877|FG002|Overall Study|Other|2|||
146758907|NCT03251378|529283878|FG003|Overall Study|Other|0|||
146758908|NCT03251378|529283879|FG004|Overall Study|Other|1|||
146758909|NCT03251378|529283880|FG005|Overall Study|Other|1|||
146758910|NCT03251378|529283881|FG006|Overall Study|Other|1|||
146758911|NCT03251378|529283875|FG000|Overall Study|Other|0|||
146758912|NCT03251378|529283876|FG001|Overall Study|Other|0|||
146758913|NCT03251378|529283877|FG002|Overall Study|Other|0|||
146758914|NCT03251378|529283878|FG003|Overall Study|Other|4|||
146758915|NCT03251378|529283879|FG004|Overall Study|Other|13|||
146758916|NCT03251378|529283880|FG005|Overall Study|Other|0|||
146758917|NCT03251378|529283881|FG006|Overall Study|Other|0|||
146758918|NCT00783692|529283891|FG000|Induction Phase|Adverse Event|7|||
146758919|NCT00783692|529283892|FG001|Induction Phase|Adverse Event|9|||
146758920|NCT00783692|529283893|FG002|Induction Phase|Adverse Event|24|||
146758921|NCT00783692|529283894|FG003|Induction Phase|Adverse Event|0|||
146758922|NCT00783692|529283895|FG004|Induction Phase|Adverse Event|0|||
146758923|NCT00783692|529283896|FG005|Induction Phase|Adverse Event|0|||
146758924|NCT00783692|529283897|FG006|Induction Phase|Adverse Event|0|||
146758925|NCT00783692|529283891|FG000|Induction Phase|Protocol Violation|0|||
146758926|NCT00783692|529283892|FG001|Induction Phase|Protocol Violation|0|||
146758927|NCT00783692|529283893|FG002|Induction Phase|Protocol Violation|1|||
146758928|NCT00783692|529283894|FG003|Induction Phase|Protocol Violation|0|||
146758929|NCT00783692|529283895|FG004|Induction Phase|Protocol Violation|0|||
146758930|NCT00783692|529283896|FG005|Induction Phase|Protocol Violation|0|||
146758931|NCT00783692|529283897|FG006|Induction Phase|Protocol Violation|0|||
146758932|NCT00783692|529283891|FG000|Induction Phase|Lack of Efficacy|1|||
146758933|NCT00783692|529283892|FG001|Induction Phase|Lack of Efficacy|3|||
146758934|NCT00783692|529283893|FG002|Induction Phase|Lack of Efficacy|28|||
146758935|NCT00783692|529283894|FG003|Induction Phase|Lack of Efficacy|0|||
146758936|NCT00783692|529283895|FG004|Induction Phase|Lack of Efficacy|0|||
146758937|NCT00783692|529283896|FG005|Induction Phase|Lack of Efficacy|0|||
146758938|NCT00783692|529283897|FG006|Induction Phase|Lack of Efficacy|0|||
146758939|NCT00783692|529283891|FG000|Induction Phase|Withdrawal by Subject|3|||
146758940|NCT00783692|529283892|FG001|Induction Phase|Withdrawal by Subject|9|||
146758941|NCT00783692|529283893|FG002|Induction Phase|Withdrawal by Subject|16|||
146758942|NCT00783692|529283894|FG003|Induction Phase|Withdrawal by Subject|0|||
146758943|NCT00783692|529283895|FG004|Induction Phase|Withdrawal by Subject|0|||
146758944|NCT00783692|529283896|FG005|Induction Phase|Withdrawal by Subject|0|||
146758945|NCT00783692|529283897|FG006|Induction Phase|Withdrawal by Subject|0|||
146758946|NCT00783692|529283891|FG000|Induction Phase|Lost to Follow-up|0|||
146758947|NCT00783692|529283892|FG001|Induction Phase|Lost to Follow-up|0|||
146758948|NCT00783692|529283893|FG002|Induction Phase|Lost to Follow-up|3|||
146758949|NCT00783692|529283894|FG003|Induction Phase|Lost to Follow-up|0|||
146758950|NCT00783692|529283895|FG004|Induction Phase|Lost to Follow-up|0|||
146758951|NCT00783692|529283896|FG005|Induction Phase|Lost to Follow-up|0|||
146758952|NCT00783692|529283897|FG006|Induction Phase|Lost to Follow-up|0|||
146758953|NCT00783692|529283891|FG000|Induction Phase|Other|0|||
146758954|NCT00783692|529283892|FG001|Induction Phase|Other|0|||
146758955|NCT00783692|529283893|FG002|Induction Phase|Other|2|||
146758956|NCT00783692|529283894|FG003|Induction Phase|Other|0|||
146758957|NCT00783692|529283895|FG004|Induction Phase|Other|0|||
146758958|NCT00783692|529283896|FG005|Induction Phase|Other|0|||
146758959|NCT00783692|529283897|FG006|Induction Phase|Other|0|||
146758960|NCT00783692|529283891|FG000|Maintenance Phase|Adverse Event|7|||
146758961|NCT00783692|529283892|FG001|Maintenance Phase|Adverse Event|0|||
146758962|NCT00783692|529283893|FG002|Maintenance Phase|Adverse Event|0|||
146522512|NCT03410992|528421762|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
146758963|NCT00783692|529283894|FG003|Maintenance Phase|Adverse Event|15|||
146758964|NCT00783692|529283895|FG004|Maintenance Phase|Adverse Event|12|||
146758965|NCT00783692|529283896|FG005|Maintenance Phase|Adverse Event|9|||
146758966|NCT00783692|529283897|FG006|Maintenance Phase|Adverse Event|38|||
146758967|NCT00783692|529283891|FG000|Maintenance Phase|Protocol Violation|0|||
146758968|NCT00783692|529283892|FG001|Maintenance Phase|Protocol Violation|0|||
146758969|NCT00783692|529283893|FG002|Maintenance Phase|Protocol Violation|0|||
146758970|NCT00783692|529283894|FG003|Maintenance Phase|Protocol Violation|1|||
146758971|NCT00783692|529283895|FG004|Maintenance Phase|Protocol Violation|2|||
146758972|NCT00783692|529283896|FG005|Maintenance Phase|Protocol Violation|3|||
146758973|NCT00783692|529283897|FG006|Maintenance Phase|Protocol Violation|4|||
146758974|NCT00783692|529283891|FG000|Maintenance Phase|Lack of Efficacy|79|||
146758975|NCT00783692|529283892|FG001|Maintenance Phase|Lack of Efficacy|0|||
146857466|NCT00975507|529650005|FG000|Overall Study|Withdrawal by Subject|10|||
146857467|NCT00975507|529650006|FG001|Overall Study|Withdrawal by Subject|3|||
146857468|NCT01295034|529650007|FG000|Overall Study|Lost to Follow-up|5|||
146857469|NCT01295034|529650008|FG001|Overall Study|Lost to Follow-up|5|||
146857470|NCT03818204|529650009|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857471|NCT03818204|529650010|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857472|NCT03818204|529650011|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857473|NCT03818204|529650012|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857474|NCT03818204|529650013|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
146857475|NCT03818204|529650014|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857476|NCT03818204|529650015|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857477|NCT03818204|529650016|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857478|NCT03818204|529650017|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857479|NCT03818204|529650018|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857480|NCT03818204|529650019|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857481|NCT03818204|529650020|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857482|NCT03818204|529650021|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857483|NCT03818204|529650022|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
146857484|NCT03818204|529650023|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857485|NCT03818204|529650024|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857486|NCT03818204|529650025|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857487|NCT03818204|529650026|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857488|NCT03818204|529650027|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146857489|NCT03818204|529650009|FG000|Overall Study|Physician Decision|0|||
146857490|NCT03818204|529650010|FG001|Overall Study|Physician Decision|0|||
146857491|NCT03818204|529650011|FG002|Overall Study|Physician Decision|0|||
146857492|NCT03818204|529650012|FG003|Overall Study|Physician Decision|0|||
146857493|NCT03818204|529650013|FG004|Overall Study|Physician Decision|0|||
146857494|NCT03818204|529650014|FG005|Overall Study|Physician Decision|0|||
146857495|NCT03818204|529650015|FG006|Overall Study|Physician Decision|0|||
146857496|NCT03818204|529650016|FG007|Overall Study|Physician Decision|0|||
146857497|NCT03818204|529650017|FG008|Overall Study|Physician Decision|0|||
146857498|NCT03818204|529650018|FG009|Overall Study|Physician Decision|0|||
146857499|NCT03818204|529650019|FG010|Overall Study|Physician Decision|0|||
146857500|NCT03818204|529650020|FG011|Overall Study|Physician Decision|0|||
146857501|NCT03818204|529650021|FG012|Overall Study|Physician Decision|0|||
146857502|NCT03818204|529650022|FG013|Overall Study|Physician Decision|0|||
146857503|NCT03818204|529650023|FG014|Overall Study|Physician Decision|1|||
146857504|NCT03818204|529650024|FG015|Overall Study|Physician Decision|0|||
146857505|NCT03818204|529650025|FG016|Overall Study|Physician Decision|0|||
146857506|NCT03818204|529650026|FG017|Overall Study|Physician Decision|0|||
146857507|NCT03818204|529650027|FG018|Overall Study|Physician Decision|0|||
146857508|NCT00887250|529650028|FG000|Overall Study|Adverse Event|3|||
146857509|NCT00887250|529650029|FG001|Overall Study|Adverse Event|0|||
146857510|NCT00887250|529650030|FG002|Overall Study|Adverse Event|7|||
146857511|NCT00887250|529650028|FG000|Overall Study|Lack of Efficacy|9|||
146857512|NCT00887250|529650029|FG001|Overall Study|Lack of Efficacy|6|||
146857513|NCT00887250|529650030|FG002|Overall Study|Lack of Efficacy|1|||
146857514|NCT00887250|529650028|FG000|Overall Study|Lost to Follow-up|2|||
146857515|NCT00887250|529650029|FG001|Overall Study|Lost to Follow-up|3|||
146857516|NCT00887250|529650030|FG002|Overall Study|Lost to Follow-up|1|||
146857517|NCT00887250|529650028|FG000|Overall Study|Protocol Violation|2|||
146857518|NCT00887250|529650029|FG001|Overall Study|Protocol Violation|2|||
146857519|NCT00887250|529650030|FG002|Overall Study|Protocol Violation|1|||
146857520|NCT00887250|529650028|FG000|Overall Study|Withdrawal by Subject|2|||
146857521|NCT00887250|529650029|FG001|Overall Study|Withdrawal by Subject|1|||
146857522|NCT00887250|529650030|FG002|Overall Study|Withdrawal by Subject|2|||
146857523|NCT00887250|529650028|FG000|Overall Study|Patient uncooperative|0|||
146857524|NCT00887250|529650029|FG001|Overall Study|Patient uncooperative|0|||
146857525|NCT00887250|529650030|FG002|Overall Study|Patient uncooperative|1|||
146857526|NCT05754333|529650031|FG000|Overall Study|Miscellaneous|3|||
146857527|NCT05754333|529650032|FG001|Overall Study|Miscellaneous|0|||
146857528|NCT05754333|529650033|FG002|Overall Study|Miscellaneous|0|||
146857529|NCT05754333|529650034|FG003|Overall Study|Miscellaneous|0|||
146857530|NCT05754333|529650031|FG000|Overall Study|Lost to Follow-up|2|||
146857531|NCT05754333|529650032|FG001|Overall Study|Lost to Follow-up|1|||
146857532|NCT05754333|529650033|FG002|Overall Study|Lost to Follow-up|0|||
146857533|NCT05754333|529650034|FG003|Overall Study|Lost to Follow-up|1|||
146857534|NCT03864146|529650035|FG000|Overall Study|Lost to Follow-up|14|||
146857535|NCT03864146|529650036|FG001|Overall Study|Lost to Follow-up|23|||
146857536|NCT03864146|529650035|FG000|Overall Study|Withdrawal by Subject|3|||
146857537|NCT03864146|529650036|FG001|Overall Study|Withdrawal by Subject|2|||
146857538|NCT00879762|529650037|FG000|Overall Study|Lost to Follow-up|3|||
146857539|NCT00879762|529650038|FG001|Overall Study|Lost to Follow-up|1|||
146522513|NCT03410992|528421763|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
146522514|NCT03410992|528421764|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
146522515|NCT03410992|528421765|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
146522516|NCT03410992|528421766|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
146857540|NCT04981366|529650039|FG000|Overall Study|Withdrawal by Subject|5|||
146857541|NCT04981366|529650040|FG001|Overall Study|Withdrawal by Subject|4|||
146857542|NCT04981366|529650041|FG002|Overall Study|Withdrawal by Subject|8|||
146857543|NCT04981366|529650039|FG000|Overall Study|Health issues unrelated to the trial|1|||
146857544|NCT04981366|529650040|FG001|Overall Study|Health issues unrelated to the trial|2|||
146857545|NCT04981366|529650041|FG002|Overall Study|Health issues unrelated to the trial|0|||
146857546|NCT00881608|529650042|FG000|Overall Study|Study prematurely terminated|11|||
146857547|NCT03214094|529650043|FG000|Overall Study|Case Report Forms Uncollected|14|||
146857548|NCT03214094|529650043|FG000|Overall Study|Protocol Deviation|46|||
146857549|NCT01313637|529650046|FG000|Overall Study|Adverse Event|17|||
146857550|NCT01313637|529650047|FG001|Overall Study|Adverse Event|24|||
146857551|NCT01313637|529650048|FG002|Overall Study|Adverse Event|25|||
146857552|NCT01313637|529650049|FG003|Overall Study|Adverse Event|18|||
146857553|NCT01313637|529650046|FG000|Overall Study|Lack of Efficacy|44|||
146857554|NCT01313637|529650047|FG001|Overall Study|Lack of Efficacy|38|||
146857555|NCT01313637|529650048|FG002|Overall Study|Lack of Efficacy|37|||
146857556|NCT01313637|529650049|FG003|Overall Study|Lack of Efficacy|24|||
146857557|NCT01313637|529650046|FG000|Overall Study|Protocol Violation|4|||
146857558|NCT01313637|529650047|FG001|Overall Study|Protocol Violation|3|||
146857559|NCT01313637|529650048|FG002|Overall Study|Protocol Violation|11|||
146857560|NCT01313637|529650049|FG003|Overall Study|Protocol Violation|5|||
146857561|NCT01313637|529650046|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
146857562|NCT01313637|529650047|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
146857563|NCT01313637|529650048|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
146857564|NCT01313637|529650049|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
146857565|NCT01313637|529650046|FG000|Overall Study|Lost to Follow-up|0|||
146857566|NCT01313637|529650047|FG001|Overall Study|Lost to Follow-up|2|||
146857567|NCT01313637|529650048|FG002|Overall Study|Lost to Follow-up|1|||
146857568|NCT01313637|529650049|FG003|Overall Study|Lost to Follow-up|3|||
146857569|NCT01313637|529650046|FG000|Overall Study|Withdrawal by Subject|11|||
146857570|NCT01313637|529650047|FG001|Overall Study|Withdrawal by Subject|13|||
146857571|NCT01313637|529650048|FG002|Overall Study|Withdrawal by Subject|18|||
146857572|NCT01313637|529650049|FG003|Overall Study|Withdrawal by Subject|15|||
146857573|NCT00795951|529650050|FG000|Overall Study|Lost to Follow-up|1|||
146857574|NCT00795951|529650050|FG000|Overall Study|Withdrawal by Subject|1|||
146857575|NCT00986674|529650052|FG000|Overall Study|Lack of Efficacy|28|||
146857576|NCT00986674|529650053|FG001|Overall Study|Lack of Efficacy|25|||
146857577|NCT00986674|529650054|FG002|Overall Study|Lack of Efficacy|23|||
146857578|NCT00986674|529650052|FG000|Overall Study|Adverse Event|4|||
146857579|NCT00986674|529650053|FG001|Overall Study|Adverse Event|8|||
146857580|NCT00986674|529650054|FG002|Overall Study|Adverse Event|9|||
146857581|NCT00986674|529650052|FG000|Overall Study|Death|5|||
146857582|NCT00986674|529650053|FG001|Overall Study|Death|0|||
146857583|NCT00986674|529650054|FG002|Overall Study|Death|4|||
146857584|NCT00986674|529650052|FG000|Overall Study|Withdrawal by Subject|6|||
146857585|NCT00986674|529650053|FG001|Overall Study|Withdrawal by Subject|2|||
146857586|NCT00986674|529650054|FG002|Overall Study|Withdrawal by Subject|1|||
146857587|NCT00986674|529650052|FG000|Overall Study|alternative therapy|0|||
146857588|NCT00986674|529650053|FG001|Overall Study|alternative therapy|0|||
146857589|NCT00986674|529650054|FG002|Overall Study|alternative therapy|1|||
146857590|NCT00986674|529650052|FG000|Overall Study|not start protocol therapy|4|||
146857591|NCT00986674|529650053|FG001|Overall Study|not start protocol therapy|3|||
146857592|NCT00986674|529650054|FG002|Overall Study|not start protocol therapy|1|||
146857593|NCT00986674|529650052|FG000|Overall Study|unknown/not specify|0|||
146857594|NCT00986674|529650053|FG001|Overall Study|unknown/not specify|7|||
146522517|NCT03410992|528421767|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
146857595|NCT00986674|529650054|FG002|Overall Study|unknown/not specify|9|||
146522518|NCT03410992|528421768|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
146857596|NCT03421431|529650059|FG000|Overall Study|Adverse Event|2|||
146857597|NCT03421431|529650060|FG001|Overall Study|Adverse Event|1|||
146857598|NCT03421431|529650061|FG002|Overall Study|Adverse Event|12|||
146857599|NCT03421431|529650059|FG000|Overall Study|Lost to Follow-up|1|||
146857600|NCT03421431|529650060|FG001|Overall Study|Lost to Follow-up|1|||
146522519|NCT03410992|528421769|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
146857601|NCT03421431|529650061|FG002|Overall Study|Lost to Follow-up|1|||
146857602|NCT03421431|529650059|FG000|Overall Study|Withdrawal by Subject|3|||
146522520|NCT03410992|528421770|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
146625279|NCT03037385|528803854|FG009|Overall Study|Physician Decision|1|||
146857603|NCT03421431|529650060|FG001|Overall Study|Withdrawal by Subject|2|||
146857604|NCT03421431|529650061|FG002|Overall Study|Withdrawal by Subject|1|||
146857605|NCT03421431|529650059|FG000|Overall Study|Protocol Violation|0|||
146857606|NCT03421431|529650060|FG001|Overall Study|Protocol Violation|1|||
146857607|NCT03421431|529650061|FG002|Overall Study|Protocol Violation|0|||
146857608|NCT03421431|529650059|FG000|Overall Study|Participant met Stopping Rules|0|||
146857609|NCT03421431|529650060|FG001|Overall Study|Participant met Stopping Rules|1|||
146857610|NCT03421431|529650061|FG002|Overall Study|Participant met Stopping Rules|0|||
146857611|NCT00141726|529650062|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
146857612|NCT02216357|529650063|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
146857613|NCT02216357|529650064|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
146857614|NCT00235326|529650069|FG000|Overall Study|Lost to Follow-up|746|||
146857615|NCT00235326|529650070|FG001|Overall Study|Lost to Follow-up|1400|||
146857616|NCT01178671|529650071|FG000|Overall Study|Adverse Event|4|||
146857617|NCT01178671|529650072|FG001|Overall Study|Adverse Event|6|||
146857618|NCT01178671|529650071|FG000|Overall Study|Protocol Violation|1|||
146857619|NCT01178671|529650072|FG001|Overall Study|Protocol Violation|1|||
146857620|NCT01178671|529650071|FG000|Overall Study|Lack of Efficacy|0|||
146857621|NCT01178671|529650072|FG001|Overall Study|Lack of Efficacy|1|||
146857622|NCT01178671|529650071|FG000|Overall Study|Lost to Follow-up|3|||
146857623|NCT01178671|529650072|FG001|Overall Study|Lost to Follow-up|1|||
146857624|NCT01178671|529650071|FG000|Overall Study|Physician Decision|4|||
146857625|NCT01178671|529650072|FG001|Overall Study|Physician Decision|6|||
146857626|NCT02435966|529650073|FG000|Overall Study|Withdrawal by Subject|0|||
146857627|NCT02435966|529650074|FG001|Overall Study|Withdrawal by Subject|1|||
146857628|NCT02435966|529650075|FG002|Overall Study|Withdrawal by Subject|0|||
146857629|NCT02745392|529650079|FG000|Overall Study|Lost to Follow-up|0|||
146857630|NCT02745392|529650080|FG001|Overall Study|Lost to Follow-up|1|||
146857631|NCT02745392|529650081|FG002|Overall Study|Lost to Follow-up|0|||
146857632|NCT02745392|529650082|FG003|Overall Study|Lost to Follow-up|0|||
146857633|NCT02513303|529650083|FG000|Overall Study|Withdrawal by Subject|9|||
146857634|NCT02513303|529650084|FG001|Overall Study|Withdrawal by Subject|7|||
146857635|NCT02513303|529650085|FG002|Overall Study|Withdrawal by Subject|2|||
146857636|NCT02513303|529650083|FG000|Overall Study|Lost to Follow-up|2|||
146857637|NCT02513303|529650084|FG001|Overall Study|Lost to Follow-up|4|||
146857638|NCT02513303|529650085|FG002|Overall Study|Lost to Follow-up|0|||
146857639|NCT02513303|529650083|FG000|Overall Study|Adverse Event|0|||
146857640|NCT02513303|529650084|FG001|Overall Study|Adverse Event|1|||
146857641|NCT02513303|529650085|FG002|Overall Study|Adverse Event|0|||
146857642|NCT02513303|529650083|FG000|Overall Study|Physician Decision|1|||
146857643|NCT02513303|529650084|FG001|Overall Study|Physician Decision|1|||
146857644|NCT02513303|529650085|FG002|Overall Study|Physician Decision|0|||
146857645|NCT02513303|529650083|FG000|Overall Study|Death|8|||
146857646|NCT02513303|529650084|FG001|Overall Study|Death|4|||
146857647|NCT02513303|529650085|FG002|Overall Study|Death|2|||
146857648|NCT01691768|529650086|FG000|Overall Study|Death|0|||
146857649|NCT01691768|529650087|FG001|Overall Study|Death|2|||
146857650|NCT01691768|529650086|FG000|Overall Study|Lost to Follow-up|4|||
146857651|NCT01691768|529650087|FG001|Overall Study|Lost to Follow-up|3|||
146857652|NCT01691768|529650086|FG000|Overall Study|Withdrawal by Subject|10|||
146857653|NCT01691768|529650087|FG001|Overall Study|Withdrawal by Subject|9|||
146857654|NCT01691768|529650086|FG000|Overall Study|Relocated|0|||
146857655|NCT01691768|529650087|FG001|Overall Study|Relocated|1|||
146857656|NCT01691768|529650086|FG000|Overall Study|Investigator decision|1|||
146857657|NCT01691768|529650087|FG001|Overall Study|Investigator decision|1|||
146857658|NCT01959334|529650090|FG000|Second Dose|Adverse Event|1|||
146857659|NCT01959334|529650091|FG001|Second Dose|Adverse Event|0|||
146857660|NCT01959334|529650090|FG000|Third Dose|Adverse Event|0|||
146857661|NCT01959334|529650091|FG001|Third Dose|Adverse Event|1|||
146857662|NCT01313689|529650092|FG000|24-Week Randomization 1|Adverse Event|10|||
146857663|NCT01313689|529650093|FG001|24-Week Randomization 1|Adverse Event|5|||
146857664|NCT01313689|529650094|FG002|24-Week Randomization 1|Adverse Event|0|||
146857665|NCT01313689|529650095|FG003|24-Week Randomization 1|Adverse Event|0|||
146857666|NCT01313689|529650096|FG004|24-Week Randomization 1|Adverse Event|0|||
146857667|NCT01313689|529650092|FG000|24-Week Randomization 1|Physician Decision|4|||
146857668|NCT01313689|529650093|FG001|24-Week Randomization 1|Physician Decision|5|||
146857669|NCT01313689|529650094|FG002|24-Week Randomization 1|Physician Decision|0|||
146857670|NCT01313689|529650095|FG003|24-Week Randomization 1|Physician Decision|0|||
146857671|NCT01313689|529650096|FG004|24-Week Randomization 1|Physician Decision|0|||
146857672|NCT01313689|529650092|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
146857673|NCT01313689|529650093|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
146857674|NCT01313689|529650094|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
146857675|NCT01313689|529650095|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
146857676|NCT01313689|529650096|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
146857677|NCT01313689|529650092|FG000|24-Week Randomization 2|Adverse Event|0|||
146857678|NCT01313689|529650093|FG001|24-Week Randomization 2|Adverse Event|0|||
146857679|NCT01313689|529650094|FG002|24-Week Randomization 2|Adverse Event|2|||
146857680|NCT01313689|529650095|FG003|24-Week Randomization 2|Adverse Event|0|||
146857681|NCT01313689|529650096|FG004|24-Week Randomization 2|Adverse Event|8|||
146857682|NCT01313689|529650092|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
146857683|NCT01313689|529650093|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
146857684|NCT01313689|529650094|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
146522521|NCT03410992|528421771|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
146522522|NCT03410992|528421772|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
146522523|NCT03410992|528421762|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
146758976|NCT00783692|529283893|FG002|Maintenance Phase|Lack of Efficacy|0|||
146758977|NCT00783692|529283894|FG003|Maintenance Phase|Lack of Efficacy|64|||
146758978|NCT00783692|529283895|FG004|Maintenance Phase|Lack of Efficacy|58|||
146758979|NCT00783692|529283896|FG005|Maintenance Phase|Lack of Efficacy|48|||
146758980|NCT00783692|529283897|FG006|Maintenance Phase|Lack of Efficacy|177|||
146758981|NCT00783692|529283891|FG000|Maintenance Phase|Withdrawal by Subject|7|||
146758982|NCT00783692|529283892|FG001|Maintenance Phase|Withdrawal by Subject|0|||
146758983|NCT00783692|529283893|FG002|Maintenance Phase|Withdrawal by Subject|0|||
146758984|NCT00783692|529283894|FG003|Maintenance Phase|Withdrawal by Subject|7|||
146758985|NCT00783692|529283895|FG004|Maintenance Phase|Withdrawal by Subject|6|||
146758986|NCT00783692|529283896|FG005|Maintenance Phase|Withdrawal by Subject|9|||
146758987|NCT00783692|529283897|FG006|Maintenance Phase|Withdrawal by Subject|24|||
146758988|NCT00783692|529283891|FG000|Maintenance Phase|Lost to Follow-up|2|||
146758989|NCT00783692|529283892|FG001|Maintenance Phase|Lost to Follow-up|0|||
146758990|NCT00783692|529283893|FG002|Maintenance Phase|Lost to Follow-up|0|||
146758991|NCT00783692|529283894|FG003|Maintenance Phase|Lost to Follow-up|1|||
146758992|NCT00783692|529283895|FG004|Maintenance Phase|Lost to Follow-up|3|||
146758993|NCT00783692|529283896|FG005|Maintenance Phase|Lost to Follow-up|2|||
146758994|NCT00783692|529283897|FG006|Maintenance Phase|Lost to Follow-up|5|||
146758995|NCT00783692|529283891|FG000|Maintenance Phase|Other|0|||
146758996|NCT00783692|529283892|FG001|Maintenance Phase|Other|0|||
146758997|NCT00783692|529283893|FG002|Maintenance Phase|Other|0|||
146758998|NCT00783692|529283894|FG003|Maintenance Phase|Other|1|||
146758999|NCT00783692|529283895|FG004|Maintenance Phase|Other|0|||
146759000|NCT00783692|529283896|FG005|Maintenance Phase|Other|1|||
146759001|NCT00783692|529283897|FG006|Maintenance Phase|Other|1|||
146759002|NCT03005288|529283902|FG000|Overall Study|Withdrawal by Subject|7|||
146759003|NCT03005288|529283903|FG001|Overall Study|Withdrawal by Subject|5|||
146759004|NCT03005288|529283902|FG000|Overall Study|Lost to Follow-up|0|||
146759005|NCT03005288|529283903|FG001|Overall Study|Lost to Follow-up|1|||
146759006|NCT03005288|529283902|FG000|Overall Study|Adverse Event|5|||
146759007|NCT03005288|529283903|FG001|Overall Study|Adverse Event|0|||
146759008|NCT03005288|529283902|FG000|Overall Study|Protocol deviation|0|||
146759009|NCT03005288|529283903|FG001|Overall Study|Protocol deviation|1|||
146759010|NCT03005288|529283902|FG000|Overall Study|Physician Decision|0|||
146759011|NCT03005288|529283903|FG001|Overall Study|Physician Decision|1|||
146759012|NCT00209274|529283906|FG000|Overall Study|Missed visit|3|||
146759013|NCT00209274|529283907|FG001|Overall Study|Missed visit|2|||
146759014|NCT00209274|529283906|FG000|Overall Study|Death|32|||
146759015|NCT00209274|529283907|FG001|Overall Study|Death|15|||
146759016|NCT00209274|529283906|FG000|Overall Study|Withdrawal by Subject|30|||
146759017|NCT00209274|529283907|FG001|Overall Study|Withdrawal by Subject|15|||
146759018|NCT00209274|529283906|FG000|Overall Study|Randomized not treated (RNT)|6|||
146759019|NCT00209274|529283907|FG001|Overall Study|Randomized not treated (RNT)|15|||
146759020|NCT02753530|529283908|FG000|Overall Study|Adverse Event|7|||
146759021|NCT02753530|529283909|FG001|Overall Study|Adverse Event|1|||
146759022|NCT02753530|529283908|FG000|Overall Study|Death|0|||
146759023|NCT02753530|529283909|FG001|Overall Study|Death|1|||
146759024|NCT02753530|529283908|FG000|Overall Study|Physician Decision|0|||
146759025|NCT02753530|529283909|FG001|Overall Study|Physician Decision|1|||
146759026|NCT02753530|529283908|FG000|Overall Study|Protocol Violation|1|||
146759027|NCT02753530|529283909|FG001|Overall Study|Protocol Violation|0|||
146759028|NCT02753530|529283908|FG000|Overall Study|Withdrawal by Subject|4|||
146759029|NCT02753530|529283909|FG001|Overall Study|Withdrawal by Subject|3|||
146759030|NCT03590743|529283911|FG000|Overall Study|Withdrawal by Subject|0|||
146759031|NCT03590743|529283912|FG001|Overall Study|Withdrawal by Subject|1|||
146759032|NCT02696226|529283913|FG000|Overall Study|Study terminated - lack of enrollment|1|||
146759033|NCT02696226|529283914|FG001|Overall Study|Study terminated - lack of enrollment|0|||
146759034|NCT02696226|529283915|FG002|Overall Study|Study terminated - lack of enrollment|2|||
146759035|NCT02696226|529283916|FG003|Overall Study|Study terminated - lack of enrollment|0|||
146759036|NCT00097370|529283921|FG000|Stage 1|Adverse Event|3|||
146759037|NCT00097370|529283921|FG000|Stage 1|Withdrawal by Subject|1|||
146759038|NCT00097370|529283921|FG000|Stage 1|Lack of Efficacy|2|||
146759039|NCT00097370|529283921|FG000|Stage 2|Adverse Event|5|||
146759040|NCT00097370|529283921|FG000|Stage 2|Withdrawal by Subject|1|||
146759041|NCT00097370|529283921|FG000|Stage 2|Lack of Efficacy|3|||
146759042|NCT00097370|529283921|FG000|Stage 2|Pregnancy|1|||
146759043|NCT00097370|529283921|FG000|Stage 2|Sponsor Terminated Study|2|||
146759044|NCT00097370|529283921|FG000|Stage 2|Lost to Follow-up|1|||
146759045|NCT00097370|529283921|FG000|Stage 3|Adverse Event|2|||
146759046|NCT00097370|529283921|FG000|Stage 3|Withdrawal by Subject|3|||
146759047|NCT00097370|529283921|FG000|Stage 3|Lack of Efficacy|1|||
146522524|NCT03410992|528421763|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
146759048|NCT00097370|529283921|FG000|Stage 3|Sponsor Terminated Study|52|||
146759049|NCT00097370|529283921|FG000|Stage 3|Lost to Follow-up|1|||
146759050|NCT00062868|529283924|FG000|Dose Level 1|Death|2|||
146857685|NCT01313689|529650095|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
146857686|NCT01313689|529650096|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
146857687|NCT01313689|529650092|FG000|24-Week Randomization 2|Physician Decision|0|||
146857688|NCT01313689|529650093|FG001|24-Week Randomization 2|Physician Decision|0|||
146857689|NCT01313689|529650094|FG002|24-Week Randomization 2|Physician Decision|0|||
146857690|NCT01313689|529650095|FG003|24-Week Randomization 2|Physician Decision|0|||
146857691|NCT01313689|529650096|FG004|24-Week Randomization 2|Physician Decision|4|||
146857692|NCT02294227|529650099|FG000|Overall Study|Death|0|||
146857693|NCT02294227|529650100|FG001|Overall Study|Death|0|||
146857694|NCT02294227|529650101|FG002|Overall Study|Death|1|||
146857695|NCT02294227|529650099|FG000|Overall Study|Subject/Guardian Decision|6|||
146857696|NCT02294227|529650100|FG001|Overall Study|Subject/Guardian Decision|3|||
146857697|NCT02294227|529650101|FG002|Overall Study|Subject/Guardian Decision|7|||
146857698|NCT02294227|529650099|FG000|Overall Study|Physician Decision|1|||
146857699|NCT02294227|529650100|FG001|Overall Study|Physician Decision|2|||
146857700|NCT02294227|529650101|FG002|Overall Study|Physician Decision|1|||
146857701|NCT02294227|529650099|FG000|Overall Study|Lost to Follow-up|1|||
146857702|NCT02294227|529650100|FG001|Overall Study|Lost to Follow-up|0|||
146857703|NCT02294227|529650101|FG002|Overall Study|Lost to Follow-up|0|||
146857704|NCT02294227|529650099|FG000|Overall Study|Lack of Efficacy|11|||
146857705|NCT02294227|529650100|FG001|Overall Study|Lack of Efficacy|12|||
146857706|NCT02294227|529650101|FG002|Overall Study|Lack of Efficacy|8|||
146857707|NCT02294227|529650099|FG000|Overall Study|Adverse Event|6|||
146857708|NCT02294227|529650100|FG001|Overall Study|Adverse Event|8|||
146857709|NCT02294227|529650101|FG002|Overall Study|Adverse Event|2|||
146857710|NCT01768637|529650103|FG000|Overall Study|Lost to Follow-up|2|||
146857711|NCT01768637|529650104|FG001|Overall Study|Lost to Follow-up|7|||
146857712|NCT01768637|529650103|FG000|Overall Study|Difficult blood draw|1|||
146857713|NCT01768637|529650104|FG001|Overall Study|Difficult blood draw|0|||
146857714|NCT01007448|529650105|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
146857715|NCT01007448|529650106|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
146857716|NCT01007448|529650105|FG000|Overall Study|Staph Skin Infection Flare|1|||
146857717|NCT01007448|529650106|FG001|Overall Study|Staph Skin Infection Flare|0|||
146857718|NCT01007448|529650105|FG000|Overall Study|Participant Leaving the Country|1|||
146857719|NCT01007448|529650106|FG001|Overall Study|Participant Leaving the Country|0|||
146857720|NCT01007448|529650105|FG000|Overall Study|Participant Given Prohibited Medication|1|||
146857721|NCT01007448|529650106|FG001|Overall Study|Participant Given Prohibited Medication|0|||
146857722|NCT01007448|529650105|FG000|Overall Study|Progressive Disease|1|||
146857723|NCT01007448|529650106|FG001|Overall Study|Progressive Disease|2|||
146857724|NCT01007448|529650105|FG000|Overall Study|Lack of Efficacy|2|||
146857725|NCT01007448|529650106|FG001|Overall Study|Lack of Efficacy|0|||
146857726|NCT01007448|529650105|FG000|Overall Study|Withdrawal by Subject|2|||
146857727|NCT01007448|529650106|FG001|Overall Study|Withdrawal by Subject|3|||
146857728|NCT01007448|529650105|FG000|Overall Study|Adverse Event|1|||
146857729|NCT01007448|529650106|FG001|Overall Study|Adverse Event|4|||
146857730|NCT02481947|529650107|FG000|Overall Study|Withdrawal by Subject|24|||
146857731|NCT02481947|529650108|FG001|Overall Study|Withdrawal by Subject|10|||
146857732|NCT02481947|529650107|FG000|Overall Study|Lost to Follow-up|11|||
146857733|NCT02481947|529650108|FG001|Overall Study|Lost to Follow-up|5|||
146857734|NCT02481947|529650107|FG000|Overall Study|Adverse Event|6|||
146857735|NCT02481947|529650108|FG001|Overall Study|Adverse Event|11|||
146857736|NCT02481947|529650107|FG000|Overall Study|Physician Decision|4|||
146857737|NCT02481947|529650108|FG001|Overall Study|Physician Decision|5|||
146857738|NCT02481947|529650107|FG000|Overall Study|Protocol Violation|1|||
146857739|NCT02481947|529650108|FG001|Overall Study|Protocol Violation|5|||
146857740|NCT00887432|529650109|FG000|Overall Study|Start Excluded Therapy|3|||
146857741|NCT00887432|529650110|FG001|Overall Study|Start Excluded Therapy|0|||
146857742|NCT00887432|529650109|FG000|Overall Study|Did not complete treatment|6|||
146857743|NCT00887432|529650110|FG001|Overall Study|Did not complete treatment|8|||
146857744|NCT00887432|529650109|FG000|Overall Study|Protocol Violation|2|||
146857745|NCT00887432|529650110|FG001|Overall Study|Protocol Violation|3|||
146857746|NCT00887432|529650109|FG000|Overall Study|Withdrawal by Subject|3|||
146857747|NCT00887432|529650110|FG001|Overall Study|Withdrawal by Subject|2|||
146857748|NCT00887432|529650109|FG000|Overall Study|Lost to Follow-up|1|||
146857749|NCT00887432|529650110|FG001|Overall Study|Lost to Follow-up|0|||
146857750|NCT00887432|529650109|FG000|Overall Study|No reason provided|0|||
146857751|NCT00887432|529650110|FG001|Overall Study|No reason provided|1|||
146857752|NCT00899548|529650111|FG000|Overall Study|Physician Decision|3|||
146857753|NCT01337115|529650115|FG000|Overall Study|Protocol Violation|2|||
146857754|NCT01337115|529650116|FG001|Overall Study|Protocol Violation|0|||
146857755|NCT03426267|529650121|FG000|Overall Study|Physician Decision|1|||
146857756|NCT03426267|529650122|FG001|Overall Study|Physician Decision|4|||
146857757|NCT03426267|529650121|FG000|Overall Study|Lost to Follow-up|1|||
146857758|NCT03426267|529650122|FG001|Overall Study|Lost to Follow-up|0|||
146857759|NCT03426267|529650121|FG000|Overall Study|Withdrawal by Subject|4|||
146857760|NCT03426267|529650122|FG001|Overall Study|Withdrawal by Subject|10|||
146857761|NCT03426267|529650121|FG000|Overall Study|Protocol Violation|1|||
146857762|NCT03426267|529650122|FG001|Overall Study|Protocol Violation|3|||
146522525|NCT03410992|528421764|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
146522526|NCT03410992|528421765|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
146522527|NCT03410992|528421766|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
146522528|NCT03410992|528421767|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
146522529|NCT03410992|528421768|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
146522530|NCT03410992|528421769|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
146522531|NCT03410992|528421770|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
146522532|NCT03410992|528421771|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
146522533|NCT03410992|528421772|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
146522534|NCT00614874|528421773|FG000|Overall Study|Protocol Violation|1|||
146522535|NCT00614874|528421773|FG000|Overall Study|Withdrawal by Subject|1|||
146522536|NCT03904420|528421774|FG000|Overall Study|Study terminated|2|||
146522537|NCT03904420|528421775|FG001|Overall Study|Study terminated|2|||
146522538|NCT01468454|528421776|FG000|Overall Study|Did not have surgery after PET|9|||
146522539|NCT01896193|528421779|FG000|Overall Study|Lack of Efficacy|20|||
146522540|NCT01896193|528421780|FG001|Overall Study|Lack of Efficacy|11|||
146522541|NCT01896193|528421779|FG000|Overall Study|Protocol Violation|0|||
146522542|NCT01896193|528421780|FG001|Overall Study|Protocol Violation|1|||
146522543|NCT01896193|528421779|FG000|Overall Study|Withdrew Consent|1|||
146522544|NCT01896193|528421780|FG001|Overall Study|Withdrew Consent|0|||
146522545|NCT02959918|528421784|FG000|Overall Study|Adverse Event|1|||
146522546|NCT02959918|528421785|FG001|Overall Study|Adverse Event|1|||
146522547|NCT02959918|528421786|FG002|Overall Study|Adverse Event|2|||
146522548|NCT02959918|528421787|FG003|Overall Study|Adverse Event|0|||
146522549|NCT02959918|528421788|FG004|Overall Study|Adverse Event|0|||
146522550|NCT02959918|528421789|FG005|Overall Study|Adverse Event|2|||
146522551|NCT02959918|528421790|FG006|Overall Study|Adverse Event|2|||
146522552|NCT02959918|528421791|FG007|Overall Study|Adverse Event|1|||
146522553|NCT02959918|528421792|FG008|Overall Study|Adverse Event|2|||
146522554|NCT02959918|528421793|FG009|Overall Study|Adverse Event|1|||
146522555|NCT02959918|528421794|FG010|Overall Study|Adverse Event|1|||
146522556|NCT02959918|528421795|FG011|Overall Study|Adverse Event|3|||
146522557|NCT02959918|528421796|FG012|Overall Study|Adverse Event|2|||
146522558|NCT02959918|528421797|FG013|Overall Study|Adverse Event|4|||
146522559|NCT02959918|528421784|FG000|Overall Study|Lost to Follow-up|0|||
146522560|NCT02959918|528421785|FG001|Overall Study|Lost to Follow-up|0|||
146522561|NCT02959918|528421786|FG002|Overall Study|Lost to Follow-up|0|||
146522562|NCT02959918|528421787|FG003|Overall Study|Lost to Follow-up|0|||
146522563|NCT02959918|528421788|FG004|Overall Study|Lost to Follow-up|0|||
146522564|NCT02959918|528421789|FG005|Overall Study|Lost to Follow-up|0|||
146522565|NCT02959918|528421790|FG006|Overall Study|Lost to Follow-up|0|||
146522566|NCT02959918|528421791|FG007|Overall Study|Lost to Follow-up|0|||
146522567|NCT02959918|528421792|FG008|Overall Study|Lost to Follow-up|0|||
146522568|NCT02959918|528421793|FG009|Overall Study|Lost to Follow-up|1|||
146522569|NCT02959918|528421794|FG010|Overall Study|Lost to Follow-up|0|||
146522570|NCT02959918|528421795|FG011|Overall Study|Lost to Follow-up|0|||
146522571|NCT02959918|528421796|FG012|Overall Study|Lost to Follow-up|1|||
146522572|NCT02959918|528421797|FG013|Overall Study|Lost to Follow-up|0|||
146522573|NCT02959918|528421784|FG000|Overall Study|Withdrawal by Subject|0|||
146522574|NCT02959918|528421785|FG001|Overall Study|Withdrawal by Subject|0|||
146522575|NCT02959918|528421786|FG002|Overall Study|Withdrawal by Subject|1|||
146522576|NCT02959918|528421787|FG003|Overall Study|Withdrawal by Subject|2|||
146522577|NCT02959918|528421788|FG004|Overall Study|Withdrawal by Subject|0|||
146522578|NCT02959918|528421789|FG005|Overall Study|Withdrawal by Subject|0|||
146522579|NCT02959918|528421790|FG006|Overall Study|Withdrawal by Subject|1|||
146522580|NCT02959918|528421791|FG007|Overall Study|Withdrawal by Subject|0|||
146522581|NCT02959918|528421792|FG008|Overall Study|Withdrawal by Subject|1|||
146522582|NCT02959918|528421793|FG009|Overall Study|Withdrawal by Subject|1|||
146522583|NCT02959918|528421794|FG010|Overall Study|Withdrawal by Subject|2|||
146522584|NCT02959918|528421795|FG011|Overall Study|Withdrawal by Subject|3|||
146522585|NCT02959918|528421796|FG012|Overall Study|Withdrawal by Subject|1|||
146522586|NCT02959918|528421797|FG013|Overall Study|Withdrawal by Subject|1|||
146522587|NCT02959918|528421784|FG000|Overall Study|Protocol Violation|0|||
146522588|NCT02959918|528421785|FG001|Overall Study|Protocol Violation|0|||
146522589|NCT02959918|528421786|FG002|Overall Study|Protocol Violation|1|||
146522590|NCT02959918|528421787|FG003|Overall Study|Protocol Violation|0|||
146522591|NCT02959918|528421788|FG004|Overall Study|Protocol Violation|0|||
146522592|NCT02959918|528421789|FG005|Overall Study|Protocol Violation|1|||
146522593|NCT02959918|528421790|FG006|Overall Study|Protocol Violation|0|||
146522594|NCT02959918|528421791|FG007|Overall Study|Protocol Violation|0|||
146522595|NCT02959918|528421792|FG008|Overall Study|Protocol Violation|2|||
146522596|NCT02959918|528421793|FG009|Overall Study|Protocol Violation|1|||
146522597|NCT02959918|528421794|FG010|Overall Study|Protocol Violation|0|||
146522598|NCT02959918|528421795|FG011|Overall Study|Protocol Violation|1|||
146522599|NCT02959918|528421796|FG012|Overall Study|Protocol Violation|1|||
146522600|NCT02959918|528421797|FG013|Overall Study|Protocol Violation|0|||
146522601|NCT02959918|528421784|FG000|Overall Study|Stopping Rule Met|1|||
146522602|NCT02959918|528421785|FG001|Overall Study|Stopping Rule Met|0|||
146522603|NCT02959918|528421786|FG002|Overall Study|Stopping Rule Met|3|||
146522604|NCT02959918|528421787|FG003|Overall Study|Stopping Rule Met|4|||
146522605|NCT02959918|528421788|FG004|Overall Study|Stopping Rule Met|5|||
146522606|NCT02959918|528421789|FG005|Overall Study|Stopping Rule Met|3|||
146522607|NCT02959918|528421790|FG006|Overall Study|Stopping Rule Met|2|||
146522608|NCT02959918|528421791|FG007|Overall Study|Stopping Rule Met|4|||
146522609|NCT02959918|528421792|FG008|Overall Study|Stopping Rule Met|1|||
146522610|NCT02959918|528421793|FG009|Overall Study|Stopping Rule Met|1|||
146522611|NCT02959918|528421794|FG010|Overall Study|Stopping Rule Met|3|||
146522612|NCT02959918|528421795|FG011|Overall Study|Stopping Rule Met|5|||
146522613|NCT02959918|528421796|FG012|Overall Study|Stopping Rule Met|2|||
146522614|NCT02959918|528421797|FG013|Overall Study|Stopping Rule Met|1|||
146522615|NCT02959918|528421784|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
146522616|NCT02959918|528421785|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
146522617|NCT02959918|528421786|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
146522618|NCT02959918|528421787|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
146522619|NCT02959918|528421788|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
146522620|NCT02959918|528421789|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
146522621|NCT02959918|528421790|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
146522622|NCT02959918|528421791|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
146522623|NCT02959918|528421792|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
146522624|NCT02959918|528421793|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
146522625|NCT02959918|528421794|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
146522626|NCT02959918|528421795|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
146522627|NCT02959918|528421796|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
146522628|NCT02959918|528421797|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
146522629|NCT02959918|528421784|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
146522630|NCT02959918|528421785|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
146522631|NCT02959918|528421786|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
146522632|NCT02959918|528421787|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
146522633|NCT02959918|528421788|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
146522634|NCT02959918|528421789|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
146522635|NCT02959918|528421790|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
146522636|NCT02959918|528421791|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
146522637|NCT02959918|528421792|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
146522638|NCT02959918|528421793|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
146522639|NCT02959918|528421794|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
146522640|NCT02959918|528421795|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
146625280|NCT03037385|528803845|FG000|Overall Study|Progressive Disease|0|||
146759051|NCT00062868|529283925|FG001|Dose Level 1|Death|0|||
146759052|NCT00062868|529283926|FG002|Dose Level 1|Death|0|||
146759053|NCT00062868|529283927|FG003|Dose Level 1|Death|2|||
146759054|NCT00062868|529283928|FG004|Dose Level 1|Death|0|||
146759055|NCT00062868|529283929|FG005|Dose Level 1|Death|0|||
146759056|NCT00062868|529283930|FG006|Dose Level 1|Death|3|||
146759057|NCT00062868|529283931|FG007|Dose Level 1|Death|0|||
146759058|NCT00062868|529283932|FG008|Dose Level 1|Death|0|||
146759059|NCT00062868|529283933|FG009|Dose Level 1|Death|0|||
146759060|NCT00062868|529283934|FG010|Dose Level 1|Death|0|||
146759061|NCT00062868|529283935|FG011|Dose Level 1|Death|0|||
146759062|NCT00062868|529283936|FG012|Dose Level 1|Death|0|||
146759063|NCT00062868|529283937|FG013|Dose Level 1|Death|0|||
146759064|NCT00062868|529283938|FG014|Dose Level 1|Death|0|||
146759065|NCT00062868|529283939|FG015|Dose Level 1|Death|0|||
146759066|NCT00062868|529283940|FG016|Dose Level 1|Death|0|||
146759067|NCT00062868|529283941|FG017|Dose Level 1|Death|0|||
146759068|NCT00062868|529283942|FG018|Dose Level 1|Death|7|||
146759069|NCT00062868|529283943|FG019|Dose Level 1|Death|0|||
146759070|NCT00062868|529283944|FG020|Dose Level 1|Death|1|||
146759071|NCT00062868|529283924|FG000|Dose Level 1|Lost to Follow-up|0|||
146759072|NCT00062868|529283925|FG001|Dose Level 1|Lost to Follow-up|0|||
146759073|NCT00062868|529283926|FG002|Dose Level 1|Lost to Follow-up|0|||
146759074|NCT00062868|529283927|FG003|Dose Level 1|Lost to Follow-up|0|||
146759075|NCT00062868|529283928|FG004|Dose Level 1|Lost to Follow-up|0|||
146759076|NCT00062868|529283929|FG005|Dose Level 1|Lost to Follow-up|0|||
146759077|NCT00062868|529283930|FG006|Dose Level 1|Lost to Follow-up|0|||
146759078|NCT00062868|529283931|FG007|Dose Level 1|Lost to Follow-up|0|||
146759079|NCT00062868|529283932|FG008|Dose Level 1|Lost to Follow-up|0|||
146759080|NCT00062868|529283933|FG009|Dose Level 1|Lost to Follow-up|0|||
146759081|NCT00062868|529283934|FG010|Dose Level 1|Lost to Follow-up|0|||
146625281|NCT03037385|528803846|FG001|Overall Study|Progressive Disease|1|||
146759082|NCT00062868|529283935|FG011|Dose Level 1|Lost to Follow-up|0|||
146759083|NCT00062868|529283936|FG012|Dose Level 1|Lost to Follow-up|1|||
146759084|NCT00062868|529283937|FG013|Dose Level 1|Lost to Follow-up|0|||
146759085|NCT00062868|529283938|FG014|Dose Level 1|Lost to Follow-up|0|||
146857763|NCT03426267|529650121|FG000|Overall Study|Adverse Event|9|||
146857764|NCT03426267|529650122|FG001|Overall Study|Adverse Event|27|||
146857765|NCT03426267|529650121|FG000|Overall Study|Prohibited Treatment Intake|2|||
146857766|NCT03426267|529650122|FG001|Overall Study|Prohibited Treatment Intake|3|||
146857767|NCT03426267|529650121|FG000|Overall Study|Lack of Efficacy|0|||
146857768|NCT03426267|529650122|FG001|Overall Study|Lack of Efficacy|25|||
146857769|NCT03426267|529650121|FG000|Overall Study|other|3|||
146857770|NCT03426267|529650122|FG001|Overall Study|other|0|||
146857771|NCT01636960|529650127|FG000|Induction Phase|Adverse Event|2|||
146857772|NCT01636960|529650127|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
146857773|NCT01636960|529650127|FG000|Maintenance Phase|Adverse Event|3|||
146857774|NCT01636960|529650127|FG000|Maintenance Phase|Progressive disease|1|||
146857775|NCT01580969|529650128|FG000|Overall Study|Physician Decision|3|||
146857776|NCT01580969|529650129|FG001|Overall Study|Physician Decision|0|||
146857777|NCT01580969|529650130|FG002|Overall Study|Physician Decision|0|||
146857778|NCT01209780|529650131|FG000|Overall Study|Adverse Event|0|||
146857779|NCT01209780|529650132|FG001|Overall Study|Adverse Event|1|||
146857780|NCT01209780|529650133|FG002|Overall Study|Adverse Event|0|||
146857781|NCT01209780|529650134|FG003|Overall Study|Adverse Event|0|||
146857782|NCT01209780|529650135|FG004|Overall Study|Adverse Event|0|||
146857783|NCT01209780|529650131|FG000|Overall Study|Withdrawal by Subject|9|||
146857784|NCT01209780|529650132|FG001|Overall Study|Withdrawal by Subject|2|||
146857785|NCT01209780|529650133|FG002|Overall Study|Withdrawal by Subject|1|||
146857786|NCT01209780|529650134|FG003|Overall Study|Withdrawal by Subject|1|||
146857787|NCT01209780|529650135|FG004|Overall Study|Withdrawal by Subject|0|||
146857788|NCT01209780|529650131|FG000|Overall Study|Lost to Follow-up|17|||
146857789|NCT01209780|529650132|FG001|Overall Study|Lost to Follow-up|12|||
146857790|NCT01209780|529650133|FG002|Overall Study|Lost to Follow-up|3|||
146857791|NCT01209780|529650134|FG003|Overall Study|Lost to Follow-up|9|||
146857792|NCT01209780|529650135|FG004|Overall Study|Lost to Follow-up|4|||
146857793|NCT01209780|529650131|FG000|Overall Study|Protocol Violation|0|||
146857794|NCT01209780|529650132|FG001|Overall Study|Protocol Violation|1|||
146857795|NCT01209780|529650133|FG002|Overall Study|Protocol Violation|0|||
146857796|NCT01209780|529650134|FG003|Overall Study|Protocol Violation|0|||
146857797|NCT01209780|529650135|FG004|Overall Study|Protocol Violation|0|||
146857798|NCT01209780|529650131|FG000|Overall Study|Inappropriate enrollment|0|||
146857799|NCT01209780|529650132|FG001|Overall Study|Inappropriate enrollment|2|||
146857800|NCT01209780|529650133|FG002|Overall Study|Inappropriate enrollment|0|||
146857801|NCT01209780|529650134|FG003|Overall Study|Inappropriate enrollment|0|||
146857802|NCT01209780|529650135|FG004|Overall Study|Inappropriate enrollment|1|||
146857803|NCT01745848|529650136|FG000|Overall Study|Adverse Event|6|||
146857804|NCT00448123|529650137|FG000|Overall Study|Lost to Follow-up|9|||
146857805|NCT00448123|529650138|FG001|Overall Study|Lost to Follow-up|6|||
146857806|NCT00448123|529650137|FG000|Overall Study|Physician Decision|6|||
146857807|NCT00448123|529650138|FG001|Overall Study|Physician Decision|6|||
146857808|NCT02027623|529650139|FG000|Overall Study|Lost to Follow-up|3|||
146857809|NCT02027623|529650140|FG001|Overall Study|Lost to Follow-up|3|||
146857810|NCT02027623|529650139|FG000|Overall Study|Withdrawal by Subject|6|||
146857811|NCT02027623|529650140|FG001|Overall Study|Withdrawal by Subject|9|||
146857812|NCT01886378|529650143|FG000|Overall Study|Adverse Event|1|||
146857813|NCT01886378|529650143|FG000|Overall Study|Withdrawal by Subject|4|||
146857814|NCT02318797|529650144|FG000|Overall Study|Death|3|||
146857815|NCT02318797|529650145|FG001|Overall Study|Death|6|||
146857816|NCT02318797|529650144|FG000|Overall Study|Lost to Follow-up|85|||
146857817|NCT02318797|529650145|FG001|Overall Study|Lost to Follow-up|96|||
146857818|NCT02709096|529650155|FG000|Overall Study|non-compliance|1|||
146857819|NCT02709096|529650156|FG001|Overall Study|non-compliance|1|||
146857820|NCT01079741|529650157|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
146857821|NCT01079741|529650158|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
146857822|NCT01079741|529650159|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
146857823|NCT01079741|529650160|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
146857824|NCT01079741|529650161|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
146857825|NCT01079741|529650157|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
146857826|NCT01079741|529650158|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
146857827|NCT01079741|529650159|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
146857828|NCT01079741|529650160|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
146857829|NCT01079741|529650161|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
146857830|NCT00406653|529650162|FG000|Induction Period|Adverse Event|1|||
146857831|NCT00406653|529650163|FG001|Induction Period|Adverse Event|10|||
146857832|NCT00406653|529650164|FG002|Induction Period|Adverse Event|4|||
146857833|NCT00406653|529650165|FG003|Induction Period|Adverse Event|11|||
146857834|NCT00406653|529650166|FG004|Induction Period|Adverse Event|0|||
146857835|NCT00406653|529650167|FG005|Induction Period|Adverse Event|0|||
146857836|NCT00406653|529650168|FG006|Induction Period|Adverse Event|0|||
146857837|NCT00406653|529650162|FG000|Induction Period|Lack of Efficacy|11|||
146857838|NCT00406653|529650163|FG001|Induction Period|Lack of Efficacy|14|||
146857839|NCT00406653|529650164|FG002|Induction Period|Lack of Efficacy|8|||
146857840|NCT00406653|529650165|FG003|Induction Period|Lack of Efficacy|10|||
146857841|NCT00406653|529650166|FG004|Induction Period|Lack of Efficacy|0|||
146857842|NCT00406653|529650167|FG005|Induction Period|Lack of Efficacy|0|||
146857843|NCT00406653|529650168|FG006|Induction Period|Lack of Efficacy|0|||
146857844|NCT00406653|529650162|FG000|Induction Period|Lost to Follow-up|0|||
146857845|NCT00406653|529650163|FG001|Induction Period|Lost to Follow-up|2|||
146857846|NCT00406653|529650164|FG002|Induction Period|Lost to Follow-up|0|||
146857847|NCT00406653|529650165|FG003|Induction Period|Lost to Follow-up|0|||
146857848|NCT00406653|529650166|FG004|Induction Period|Lost to Follow-up|0|||
146857849|NCT00406653|529650167|FG005|Induction Period|Lost to Follow-up|0|||
146857850|NCT00406653|529650168|FG006|Induction Period|Lost to Follow-up|0|||
146857851|NCT00406653|529650162|FG000|Induction Period|Withdrawal of Consent|2|||
146857852|NCT00406653|529650163|FG001|Induction Period|Withdrawal of Consent|5|||
146857853|NCT00406653|529650164|FG002|Induction Period|Withdrawal of Consent|1|||
146857854|NCT00406653|529650165|FG003|Induction Period|Withdrawal of Consent|2|||
146857855|NCT00406653|529650166|FG004|Induction Period|Withdrawal of Consent|0|||
146857856|NCT00406653|529650167|FG005|Induction Period|Withdrawal of Consent|0|||
146857857|NCT00406653|529650168|FG006|Induction Period|Withdrawal of Consent|0|||
146857858|NCT00406653|529650162|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
146857859|NCT00406653|529650163|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
146857860|NCT00406653|529650164|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
146857861|NCT00406653|529650165|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
146857862|NCT00406653|529650166|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
146857863|NCT00406653|529650167|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
146857864|NCT00406653|529650168|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
146857865|NCT00406653|529650162|FG000|Induction Period|Pregnancy|1|||
146857866|NCT00406653|529650163|FG001|Induction Period|Pregnancy|0|||
146857867|NCT00406653|529650164|FG002|Induction Period|Pregnancy|0|||
146857868|NCT00406653|529650165|FG003|Induction Period|Pregnancy|0|||
146857869|NCT00406653|529650166|FG004|Induction Period|Pregnancy|0|||
146857870|NCT00406653|529650167|FG005|Induction Period|Pregnancy|0|||
146857871|NCT00406653|529650168|FG006|Induction Period|Pregnancy|0|||
146857872|NCT00406653|529650162|FG000|Induction Period|Declined participation but followup done|0|||
146857873|NCT00406653|529650163|FG001|Induction Period|Declined participation but followup done|2|||
146857874|NCT00406653|529650164|FG002|Induction Period|Declined participation but followup done|1|||
146857875|NCT00406653|529650165|FG003|Induction Period|Declined participation but followup done|1|||
146522641|NCT02959918|528421796|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
146522642|NCT02959918|528421797|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
146522643|NCT02959918|528421784|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
146522644|NCT02959918|528421785|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
146522645|NCT02959918|528421786|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
146522646|NCT02959918|528421787|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
146522647|NCT02959918|528421788|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
146522648|NCT02959918|528421789|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
146522649|NCT02959918|528421790|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
146522650|NCT02959918|528421791|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
146522651|NCT02959918|528421792|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
146522652|NCT02959918|528421793|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
146522653|NCT02959918|528421794|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
146522654|NCT02959918|528421795|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
146522655|NCT02959918|528421796|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
146522656|NCT02959918|528421797|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
146522657|NCT02959918|528421784|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
146522658|NCT02959918|528421785|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
146522659|NCT02959918|528421786|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
146522660|NCT02959918|528421787|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
146522661|NCT02959918|528421788|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
146522662|NCT02959918|528421789|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
146522663|NCT02959918|528421790|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
146522664|NCT02959918|528421791|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
146522665|NCT02959918|528421792|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
146522666|NCT02959918|528421793|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
146522667|NCT02959918|528421794|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
146857876|NCT00406653|529650166|FG004|Induction Period|Declined participation but followup done|0|||
146857877|NCT00406653|529650167|FG005|Induction Period|Declined participation but followup done|0|||
146857878|NCT00406653|529650168|FG006|Induction Period|Declined participation but followup done|0|||
146522668|NCT02959918|528421795|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
146522669|NCT02959918|528421796|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
146522670|NCT02959918|528421797|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
146522671|NCT02364388|528421798|FG000|Overall Study|Protocol Violation|1|||
146522672|NCT02364388|528421798|FG000|Overall Study|Technical Failure|3|||
146522673|NCT02364388|528421798|FG000|Overall Study|No OA/US data|2|||
146522674|NCT02364388|528421798|FG000|Overall Study|No Biopsy|2|||
146522675|NCT00436826|528421800|FG000|Double Blind Period (DBP)|Adverse Event|2|||
146522676|NCT00436826|528421801|FG001|Double Blind Period (DBP)|Adverse Event|0|||
146522677|NCT00436826|528421802|FG002|Double Blind Period (DBP)|Adverse Event|0|||
146522678|NCT00436826|528421803|FG003|Double Blind Period (DBP)|Adverse Event|0|||
146522679|NCT00436826|528421804|FG004|Double Blind Period (DBP)|Adverse Event|0|||
146522680|NCT00436826|528421805|FG005|Double Blind Period (DBP)|Adverse Event|0|||
146759086|NCT00062868|529283939|FG015|Dose Level 1|Lost to Follow-up|0|||
146759087|NCT00062868|529283940|FG016|Dose Level 1|Lost to Follow-up|0|||
146759088|NCT00062868|529283941|FG017|Dose Level 1|Lost to Follow-up|0|||
146759089|NCT00062868|529283942|FG018|Dose Level 1|Lost to Follow-up|2|||
146759090|NCT00062868|529283943|FG019|Dose Level 1|Lost to Follow-up|0|||
146759091|NCT00062868|529283944|FG020|Dose Level 1|Lost to Follow-up|1|||
146759092|NCT00062868|529283924|FG000|Dose Level 2|Death|0|||
146759093|NCT00062868|529283925|FG001|Dose Level 2|Death|3|||
146759094|NCT00062868|529283926|FG002|Dose Level 2|Death|0|||
146759095|NCT00062868|529283927|FG003|Dose Level 2|Death|0|||
146759096|NCT00062868|529283928|FG004|Dose Level 2|Death|2|||
146759097|NCT00062868|529283929|FG005|Dose Level 2|Death|0|||
146759098|NCT00062868|529283930|FG006|Dose Level 2|Death|0|||
146759099|NCT00062868|529283931|FG007|Dose Level 2|Death|0|||
146759100|NCT00062868|529283932|FG008|Dose Level 2|Death|0|||
146759101|NCT00062868|529283933|FG009|Dose Level 2|Death|0|||
146759102|NCT00062868|529283934|FG010|Dose Level 2|Death|1|||
146759103|NCT00062868|529283935|FG011|Dose Level 2|Death|0|||
146759104|NCT00062868|529283936|FG012|Dose Level 2|Death|0|||
146759105|NCT00062868|529283937|FG013|Dose Level 2|Death|0|||
146759106|NCT00062868|529283938|FG014|Dose Level 2|Death|0|||
146759107|NCT00062868|529283939|FG015|Dose Level 2|Death|0|||
146759108|NCT00062868|529283940|FG016|Dose Level 2|Death|2|||
146759109|NCT00062868|529283941|FG017|Dose Level 2|Death|0|||
146759110|NCT00062868|529283942|FG018|Dose Level 2|Death|0|||
146759111|NCT00062868|529283943|FG019|Dose Level 2|Death|0|||
146759112|NCT00062868|529283944|FG020|Dose Level 2|Death|0|||
146759113|NCT00062868|529283924|FG000|Dose Level 2|Lost to Follow-up|0|||
146759114|NCT00062868|529283925|FG001|Dose Level 2|Lost to Follow-up|0|||
146759115|NCT00062868|529283926|FG002|Dose Level 2|Lost to Follow-up|0|||
146759116|NCT00062868|529283927|FG003|Dose Level 2|Lost to Follow-up|0|||
146759117|NCT00062868|529283928|FG004|Dose Level 2|Lost to Follow-up|0|||
146759118|NCT00062868|529283929|FG005|Dose Level 2|Lost to Follow-up|0|||
146759119|NCT00062868|529283930|FG006|Dose Level 2|Lost to Follow-up|0|||
146759120|NCT00062868|529283931|FG007|Dose Level 2|Lost to Follow-up|0|||
146759121|NCT00062868|529283932|FG008|Dose Level 2|Lost to Follow-up|0|||
146759122|NCT00062868|529283933|FG009|Dose Level 2|Lost to Follow-up|0|||
146759123|NCT00062868|529283934|FG010|Dose Level 2|Lost to Follow-up|0|||
146759124|NCT00062868|529283935|FG011|Dose Level 2|Lost to Follow-up|0|||
146759125|NCT00062868|529283936|FG012|Dose Level 2|Lost to Follow-up|0|||
146759126|NCT00062868|529283937|FG013|Dose Level 2|Lost to Follow-up|1|||
146759127|NCT00062868|529283938|FG014|Dose Level 2|Lost to Follow-up|0|||
146759128|NCT00062868|529283939|FG015|Dose Level 2|Lost to Follow-up|0|||
146759129|NCT00062868|529283940|FG016|Dose Level 2|Lost to Follow-up|1|||
146759130|NCT00062868|529283941|FG017|Dose Level 2|Lost to Follow-up|0|||
146759131|NCT00062868|529283942|FG018|Dose Level 2|Lost to Follow-up|0|||
146759132|NCT00062868|529283943|FG019|Dose Level 2|Lost to Follow-up|0|||
146759133|NCT00062868|529283944|FG020|Dose Level 2|Lost to Follow-up|0|||
146759134|NCT00062868|529283924|FG000|Dose Level 3|Death|0|||
146759135|NCT00062868|529283925|FG001|Dose Level 3|Death|0|||
146759136|NCT00062868|529283926|FG002|Dose Level 3|Death|0|||
146759137|NCT00062868|529283927|FG003|Dose Level 3|Death|0|||
146759138|NCT00062868|529283928|FG004|Dose Level 3|Death|0|||
146759139|NCT00062868|529283929|FG005|Dose Level 3|Death|0|||
146759140|NCT00062868|529283930|FG006|Dose Level 3|Death|0|||
146759141|NCT00062868|529283931|FG007|Dose Level 3|Death|0|||
146857879|NCT00406653|529650162|FG000|Induction Period|Given prohibited drug|0|||
146522681|NCT00436826|528421800|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
146625282|NCT03037385|528803847|FG002|Overall Study|Progressive Disease|1|||
146759142|NCT00062868|529283932|FG008|Dose Level 3|Death|0|||
146759143|NCT00062868|529283933|FG009|Dose Level 3|Death|0|||
146759144|NCT00062868|529283934|FG010|Dose Level 3|Death|0|||
146759145|NCT00062868|529283935|FG011|Dose Level 3|Death|1|||
146759146|NCT00062868|529283936|FG012|Dose Level 3|Death|0|||
146759147|NCT00062868|529283937|FG013|Dose Level 3|Death|0|||
146759148|NCT00062868|529283938|FG014|Dose Level 3|Death|0|||
146759149|NCT00062868|529283939|FG015|Dose Level 3|Death|0|||
146759150|NCT00062868|529283940|FG016|Dose Level 3|Death|0|||
146759151|NCT00062868|529283941|FG017|Dose Level 3|Death|1|||
146759152|NCT00062868|529283942|FG018|Dose Level 3|Death|0|||
146759153|NCT00062868|529283943|FG019|Dose Level 3|Death|0|||
146759154|NCT00062868|529283944|FG020|Dose Level 3|Death|0|||
146857880|NCT00406653|529650163|FG001|Induction Period|Given prohibited drug|1|||
146857881|NCT00406653|529650164|FG002|Induction Period|Given prohibited drug|2|||
146857882|NCT00406653|529650165|FG003|Induction Period|Given prohibited drug|0|||
146857883|NCT00406653|529650166|FG004|Induction Period|Given prohibited drug|0|||
146857884|NCT00406653|529650167|FG005|Induction Period|Given prohibited drug|0|||
146857885|NCT00406653|529650168|FG006|Induction Period|Given prohibited drug|0|||
146857886|NCT00406653|529650162|FG000|Induction Period|Incarcerated|0|||
146857887|NCT00406653|529650163|FG001|Induction Period|Incarcerated|0|||
146857888|NCT00406653|529650164|FG002|Induction Period|Incarcerated|1|||
146522682|NCT00436826|528421801|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
146522683|NCT00436826|528421802|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
146522684|NCT00436826|528421803|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
146522685|NCT00436826|528421804|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
146522686|NCT00436826|528421805|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
146522687|NCT00436826|528421800|FG000|Double Blind Period (DBP)|Other|10|||
146522688|NCT00436826|528421801|FG001|Double Blind Period (DBP)|Other|11|||
146522689|NCT00436826|528421802|FG002|Double Blind Period (DBP)|Other|0|||
146522690|NCT00436826|528421803|FG003|Double Blind Period (DBP)|Other|0|||
146522691|NCT00436826|528421804|FG004|Double Blind Period (DBP)|Other|0|||
146522692|NCT00436826|528421805|FG005|Double Blind Period (DBP)|Other|0|||
146522693|NCT00436826|528421800|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
146522694|NCT00436826|528421801|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
146522695|NCT00436826|528421802|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
146522696|NCT00436826|528421803|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
146522697|NCT00436826|528421804|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
146522698|NCT00436826|528421805|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
146522699|NCT00436826|528421800|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
146522700|NCT00436826|528421801|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
146522701|NCT00436826|528421802|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
146522702|NCT00436826|528421803|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
146522703|NCT00436826|528421804|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
146522704|NCT00436826|528421805|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
146522705|NCT00436826|528421800|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
146522706|NCT00436826|528421801|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
146522707|NCT00436826|528421802|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
146522708|NCT00436826|528421803|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
146522709|NCT00436826|528421804|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
146522710|NCT00436826|528421805|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
146522711|NCT00110357|528421811|FG000|Overall Study|Deterioration without progression|2|||
146522712|NCT00110357|528421812|FG001|Overall Study|Deterioration without progression|0|||
146522713|NCT00110357|528421811|FG000|Overall Study|Disease progression/relapse|20|||
146522714|NCT00110357|528421812|FG001|Overall Study|Disease progression/relapse|15|||
146522715|NCT00110357|528421811|FG000|Overall Study|Study Closure|1|||
146522716|NCT00110357|528421812|FG001|Overall Study|Study Closure|0|||
146759155|NCT00062868|529283924|FG000|Dose Level 3|Lost to Follow-up|0|||
146759156|NCT00062868|529283925|FG001|Dose Level 3|Lost to Follow-up|0|||
146759157|NCT00062868|529283926|FG002|Dose Level 3|Lost to Follow-up|0|||
146759158|NCT00062868|529283927|FG003|Dose Level 3|Lost to Follow-up|0|||
146759159|NCT00062868|529283928|FG004|Dose Level 3|Lost to Follow-up|0|||
146759160|NCT00062868|529283929|FG005|Dose Level 3|Lost to Follow-up|0|||
146759161|NCT00062868|529283930|FG006|Dose Level 3|Lost to Follow-up|0|||
146759162|NCT00062868|529283931|FG007|Dose Level 3|Lost to Follow-up|0|||
146759163|NCT00062868|529283932|FG008|Dose Level 3|Lost to Follow-up|0|||
146759164|NCT00062868|529283933|FG009|Dose Level 3|Lost to Follow-up|0|||
146759165|NCT00062868|529283934|FG010|Dose Level 3|Lost to Follow-up|0|||
146759166|NCT00062868|529283935|FG011|Dose Level 3|Lost to Follow-up|0|||
146759167|NCT00062868|529283936|FG012|Dose Level 3|Lost to Follow-up|0|||
146759168|NCT00062868|529283937|FG013|Dose Level 3|Lost to Follow-up|0|||
146759169|NCT00062868|529283938|FG014|Dose Level 3|Lost to Follow-up|1|||
146759170|NCT00062868|529283939|FG015|Dose Level 3|Lost to Follow-up|0|||
146759171|NCT00062868|529283940|FG016|Dose Level 3|Lost to Follow-up|0|||
146759172|NCT00062868|529283941|FG017|Dose Level 3|Lost to Follow-up|0|||
146759173|NCT00062868|529283942|FG018|Dose Level 3|Lost to Follow-up|0|||
146759174|NCT00062868|529283943|FG019|Dose Level 3|Lost to Follow-up|0|||
146759175|NCT00062868|529283944|FG020|Dose Level 3|Lost to Follow-up|0|||
146759176|NCT00062868|529283924|FG000|Dose Level 3|Withdrew|0|||
146759177|NCT00062868|529283925|FG001|Dose Level 3|Withdrew|0|||
146759178|NCT00062868|529283926|FG002|Dose Level 3|Withdrew|2|||
146759179|NCT00062868|529283927|FG003|Dose Level 3|Withdrew|0|||
146759180|NCT00062868|529283928|FG004|Dose Level 3|Withdrew|0|||
146759181|NCT00062868|529283929|FG005|Dose Level 3|Withdrew|0|||
146759182|NCT00062868|529283930|FG006|Dose Level 3|Withdrew|0|||
146759183|NCT00062868|529283931|FG007|Dose Level 3|Withdrew|0|||
146759184|NCT00062868|529283932|FG008|Dose Level 3|Withdrew|0|||
146857889|NCT00406653|529650165|FG003|Induction Period|Incarcerated|0|||
146857890|NCT00406653|529650166|FG004|Induction Period|Incarcerated|0|||
146857891|NCT00406653|529650167|FG005|Induction Period|Incarcerated|0|||
146857892|NCT00406653|529650168|FG006|Induction Period|Incarcerated|0|||
146857893|NCT00406653|529650162|FG000|Induction Period|Patient relocated|0|||
146857894|NCT00406653|529650163|FG001|Induction Period|Patient relocated|0|||
146857895|NCT00406653|529650164|FG002|Induction Period|Patient relocated|1|||
146857896|NCT00406653|529650165|FG003|Induction Period|Patient relocated|0|||
146857897|NCT00406653|529650166|FG004|Induction Period|Patient relocated|0|||
146857898|NCT00406653|529650167|FG005|Induction Period|Patient relocated|0|||
146857899|NCT00406653|529650168|FG006|Induction Period|Patient relocated|0|||
146857900|NCT00406653|529650162|FG000|Maintenance Period|Adverse Event|0|||
146857901|NCT00406653|529650163|FG001|Maintenance Period|Adverse Event|0|||
146857902|NCT00406653|529650164|FG002|Maintenance Period|Adverse Event|0|||
146857903|NCT00406653|529650165|FG003|Maintenance Period|Adverse Event|0|||
146857904|NCT00406653|529650166|FG004|Maintenance Period|Adverse Event|1|||
146857905|NCT00406653|529650167|FG005|Maintenance Period|Adverse Event|1|||
146857906|NCT00406653|529650168|FG006|Maintenance Period|Adverse Event|0|||
146857907|NCT00406653|529650162|FG000|Maintenance Period|Lack of Efficacy|0|||
146857908|NCT00406653|529650163|FG001|Maintenance Period|Lack of Efficacy|0|||
146857909|NCT00406653|529650164|FG002|Maintenance Period|Lack of Efficacy|0|||
146857910|NCT00406653|529650165|FG003|Maintenance Period|Lack of Efficacy|0|||
146857911|NCT00406653|529650166|FG004|Maintenance Period|Lack of Efficacy|20|||
146857912|NCT00406653|529650167|FG005|Maintenance Period|Lack of Efficacy|26|||
146857913|NCT00406653|529650168|FG006|Maintenance Period|Lack of Efficacy|0|||
146857914|NCT00406653|529650162|FG000|Maintenance Period|Lost to Follow-up|0|||
146857915|NCT00406653|529650163|FG001|Maintenance Period|Lost to Follow-up|0|||
146857916|NCT00406653|529650164|FG002|Maintenance Period|Lost to Follow-up|0|||
146857917|NCT00406653|529650165|FG003|Maintenance Period|Lost to Follow-up|0|||
146857918|NCT00406653|529650166|FG004|Maintenance Period|Lost to Follow-up|2|||
146857919|NCT00406653|529650167|FG005|Maintenance Period|Lost to Follow-up|1|||
146857920|NCT00406653|529650168|FG006|Maintenance Period|Lost to Follow-up|0|||
146857921|NCT00406653|529650162|FG000|Maintenance Period|Withdrawal of Consent|0|||
146857922|NCT00406653|529650163|FG001|Maintenance Period|Withdrawal of Consent|0|||
146857923|NCT00406653|529650164|FG002|Maintenance Period|Withdrawal of Consent|0|||
146857924|NCT00406653|529650165|FG003|Maintenance Period|Withdrawal of Consent|0|||
146857925|NCT00406653|529650166|FG004|Maintenance Period|Withdrawal of Consent|2|||
146857926|NCT00406653|529650167|FG005|Maintenance Period|Withdrawal of Consent|0|||
146857927|NCT00406653|529650168|FG006|Maintenance Period|Withdrawal of Consent|0|||
146857928|NCT00406653|529650162|FG000|Maintenance Period|Pregnancy|0|||
146857929|NCT00406653|529650163|FG001|Maintenance Period|Pregnancy|0|||
146857930|NCT00406653|529650164|FG002|Maintenance Period|Pregnancy|0|||
146857931|NCT00406653|529650165|FG003|Maintenance Period|Pregnancy|0|||
146857932|NCT00406653|529650166|FG004|Maintenance Period|Pregnancy|0|||
146857933|NCT00406653|529650167|FG005|Maintenance Period|Pregnancy|1|||
146857934|NCT00406653|529650168|FG006|Maintenance Period|Pregnancy|0|||
146857935|NCT00406653|529650162|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
146857936|NCT00406653|529650163|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
146857937|NCT00406653|529650164|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
146857938|NCT00406653|529650165|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
146857939|NCT00406653|529650166|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
146857940|NCT00406653|529650167|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
146857941|NCT00406653|529650168|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
146857942|NCT00406653|529650162|FG000|Maintenance Period|Error in disease score evaluation|0|||
146857943|NCT00406653|529650163|FG001|Maintenance Period|Error in disease score evaluation|0|||
146857944|NCT00406653|529650164|FG002|Maintenance Period|Error in disease score evaluation|0|||
146857945|NCT00406653|529650165|FG003|Maintenance Period|Error in disease score evaluation|0|||
146857946|NCT00406653|529650166|FG004|Maintenance Period|Error in disease score evaluation|1|||
146857947|NCT00406653|529650167|FG005|Maintenance Period|Error in disease score evaluation|0|||
146857948|NCT00406653|529650168|FG006|Maintenance Period|Error in disease score evaluation|0|||
146857949|NCT00406653|529650162|FG000|Open-Label Period|Death|0|||
146857950|NCT00406653|529650163|FG001|Open-Label Period|Death|0|||
146857951|NCT00406653|529650164|FG002|Open-Label Period|Death|0|||
146857952|NCT00406653|529650165|FG003|Open-Label Period|Death|0|||
146857953|NCT00406653|529650166|FG004|Open-Label Period|Death|0|||
146857954|NCT00406653|529650167|FG005|Open-Label Period|Death|0|||
146857955|NCT00406653|529650168|FG006|Open-Label Period|Death|1|||
146857956|NCT00406653|529650162|FG000|Open-Label Period|Adverse Event|0|||
146857957|NCT00406653|529650163|FG001|Open-Label Period|Adverse Event|0|||
146857958|NCT00406653|529650164|FG002|Open-Label Period|Adverse Event|0|||
146857959|NCT00406653|529650165|FG003|Open-Label Period|Adverse Event|0|||
146857960|NCT00406653|529650166|FG004|Open-Label Period|Adverse Event|0|||
146857961|NCT00406653|529650167|FG005|Open-Label Period|Adverse Event|0|||
146857962|NCT00406653|529650168|FG006|Open-Label Period|Adverse Event|18|||
146857963|NCT00406653|529650162|FG000|Open-Label Period|Lack of Efficacy|0|||
146857964|NCT00406653|529650163|FG001|Open-Label Period|Lack of Efficacy|0|||
146857965|NCT00406653|529650164|FG002|Open-Label Period|Lack of Efficacy|0|||
146857966|NCT00406653|529650165|FG003|Open-Label Period|Lack of Efficacy|0|||
146857967|NCT00406653|529650166|FG004|Open-Label Period|Lack of Efficacy|0|||
146857968|NCT00406653|529650167|FG005|Open-Label Period|Lack of Efficacy|0|||
146857969|NCT00406653|529650168|FG006|Open-Label Period|Lack of Efficacy|160|||
146857970|NCT00406653|529650162|FG000|Open-Label Period|Lost to Follow-up|0|||
146857971|NCT00406653|529650163|FG001|Open-Label Period|Lost to Follow-up|0|||
146857972|NCT00406653|529650164|FG002|Open-Label Period|Lost to Follow-up|0|||
146857973|NCT00406653|529650165|FG003|Open-Label Period|Lost to Follow-up|0|||
146857974|NCT00406653|529650166|FG004|Open-Label Period|Lost to Follow-up|0|||
146857975|NCT00406653|529650167|FG005|Open-Label Period|Lost to Follow-up|0|||
146857976|NCT00406653|529650168|FG006|Open-Label Period|Lost to Follow-up|6|||
146857977|NCT00406653|529650162|FG000|Open-Label Period|Withdrawal of Consent|0|||
146857978|NCT00406653|529650163|FG001|Open-Label Period|Withdrawal of Consent|0|||
146857979|NCT00406653|529650164|FG002|Open-Label Period|Withdrawal of Consent|0|||
146857980|NCT00406653|529650165|FG003|Open-Label Period|Withdrawal of Consent|0|||
146857981|NCT00406653|529650166|FG004|Open-Label Period|Withdrawal of Consent|0|||
146857982|NCT00406653|529650167|FG005|Open-Label Period|Withdrawal of Consent|0|||
146857983|NCT00406653|529650168|FG006|Open-Label Period|Withdrawal of Consent|11|||
146857984|NCT00406653|529650162|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
146857985|NCT00406653|529650163|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
146857986|NCT00406653|529650164|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
146857987|NCT00406653|529650165|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
146857988|NCT00406653|529650166|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
146857989|NCT00406653|529650167|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
146857990|NCT00406653|529650168|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
146857991|NCT00406653|529650162|FG000|Open-Label Period|Pregnancy|0|||
146857992|NCT00406653|529650163|FG001|Open-Label Period|Pregnancy|0|||
146857993|NCT00406653|529650164|FG002|Open-Label Period|Pregnancy|0|||
146857994|NCT00406653|529650165|FG003|Open-Label Period|Pregnancy|0|||
146857995|NCT00406653|529650166|FG004|Open-Label Period|Pregnancy|0|||
146522717|NCT00110357|528421811|FG000|Overall Study|Study Drug Toxicity|1|||
146522718|NCT00110357|528421812|FG001|Overall Study|Study Drug Toxicity|3|||
146522719|NCT00110357|528421811|FG000|Overall Study|Withdrawal by Subject|3|||
146522720|NCT00110357|528421812|FG001|Overall Study|Withdrawal by Subject|1|||
146522721|NCT04004260|528421813|FG000|Overall Study|Withdrawal by Subject|7|||
146522722|NCT04004260|528421814|FG001|Overall Study|Withdrawal by Subject|3|||
146522723|NCT04004260|528421813|FG000|Overall Study|Lost to Follow-up|22|||
146522724|NCT04004260|528421814|FG001|Overall Study|Lost to Follow-up|12|||
146522725|NCT04004260|528421813|FG000|Overall Study|Did not engage in intervention|13|||
146522726|NCT04004260|528421814|FG001|Overall Study|Did not engage in intervention|17|||
146522727|NCT03382418|528421815|FG000|Overall Study|Withdrawal by Subject|1|||
146522728|NCT03382418|528421816|FG001|Overall Study|Withdrawal by Subject|0|||
146522729|NCT03382418|528421817|FG002|Overall Study|Withdrawal by Subject|0|||
146522730|NCT03382418|528421815|FG000|Overall Study|Lost to Follow-up|2|||
146522731|NCT03382418|528421816|FG001|Overall Study|Lost to Follow-up|3|||
146522732|NCT03382418|528421817|FG002|Overall Study|Lost to Follow-up|0|||
146522733|NCT02360280|528421818|FG000|Overall Study|Withdrawal by Subject|2|||
146522734|NCT02360280|528421819|FG001|Overall Study|Withdrawal by Subject|0|||
146857996|NCT00406653|529650167|FG005|Open-Label Period|Pregnancy|0|||
146857997|NCT00406653|529650168|FG006|Open-Label Period|Pregnancy|2|||
146857998|NCT00406653|529650162|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
146857999|NCT00406653|529650163|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
146858000|NCT00406653|529650164|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
146858001|NCT00406653|529650165|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
146858002|NCT00406653|529650166|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
146858003|NCT00406653|529650167|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
146858004|NCT00406653|529650168|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
146858005|NCT00406653|529650162|FG000|Open-Label Period|Declined participation but followup done|0|||
146858006|NCT00406653|529650163|FG001|Open-Label Period|Declined participation but followup done|0|||
146858007|NCT00406653|529650164|FG002|Open-Label Period|Declined participation but followup done|0|||
146858008|NCT00406653|529650165|FG003|Open-Label Period|Declined participation but followup done|0|||
146858009|NCT00406653|529650166|FG004|Open-Label Period|Declined participation but followup done|0|||
146858010|NCT00406653|529650167|FG005|Open-Label Period|Declined participation but followup done|0|||
146858011|NCT00406653|529650168|FG006|Open-Label Period|Declined participation but followup done|8|||
146858012|NCT00406653|529650162|FG000|Open-Label Period|Discontinued by Sponsor|0|||
146858013|NCT00406653|529650163|FG001|Open-Label Period|Discontinued by Sponsor|0|||
146522735|NCT02360280|528421818|FG000|Overall Study|Adverse Event|0|||
146522736|NCT02360280|528421819|FG001|Overall Study|Adverse Event|1|||
146522737|NCT02360280|528421818|FG000|Overall Study|Lost to Follow-up|1|||
146522738|NCT02360280|528421819|FG001|Overall Study|Lost to Follow-up|0|||
146522739|NCT05464420|528421820|FG000|Overall Study|Death|0|||
146522740|NCT05464420|528421821|FG001|Overall Study|Death|0|||
146522741|NCT05464420|528421822|FG002|Overall Study|Death|0|||
146522742|NCT05464420|528421823|FG003|Overall Study|Death|1|||
146522743|NCT05464420|528421820|FG000|Overall Study|Lost to Follow-up|16|||
146522744|NCT05464420|528421821|FG001|Overall Study|Lost to Follow-up|11|||
146522745|NCT05464420|528421822|FG002|Overall Study|Lost to Follow-up|11|||
146522746|NCT05464420|528421823|FG003|Overall Study|Lost to Follow-up|11|||
146759185|NCT00062868|529283933|FG009|Dose Level 3|Withdrew|0|||
146759186|NCT00062868|529283934|FG010|Dose Level 3|Withdrew|0|||
146759187|NCT00062868|529283935|FG011|Dose Level 3|Withdrew|0|||
146759188|NCT00062868|529283936|FG012|Dose Level 3|Withdrew|0|||
146759189|NCT00062868|529283937|FG013|Dose Level 3|Withdrew|0|||
146759190|NCT00062868|529283938|FG014|Dose Level 3|Withdrew|0|||
146759191|NCT00062868|529283939|FG015|Dose Level 3|Withdrew|0|||
146759192|NCT00062868|529283940|FG016|Dose Level 3|Withdrew|0|||
146759193|NCT00062868|529283941|FG017|Dose Level 3|Withdrew|0|||
146759194|NCT00062868|529283942|FG018|Dose Level 3|Withdrew|0|||
146759195|NCT00062868|529283943|FG019|Dose Level 3|Withdrew|0|||
146759196|NCT00062868|529283944|FG020|Dose Level 3|Withdrew|0|||
146759197|NCT01290094|529283947|FG000|Overall Study|Withdrawal by Subject|1|||
146759198|NCT01290094|529283947|FG000|Overall Study|Lost to Follow-up|5|||
146759199|NCT01712685|529283952|FG000|Overall Study|pt declined to participate before trmt|1|||
146759200|NCT01871285|529283953|FG000|First Intervention (1 Day)|Adverse Event|1|||
146759201|NCT01871285|529283954|FG001|First Intervention (1 Day)|Adverse Event|0|||
146759202|NCT01871285|529283955|FG002|First Intervention (1 Day)|Adverse Event|0|||
146759203|NCT01871285|529283956|FG003|First Intervention (1 Day)|Adverse Event|0|||
146759204|NCT01871285|529283953|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
146759205|NCT01871285|529283954|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
146759206|NCT01871285|529283955|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
146759207|NCT01871285|529283956|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
146759208|NCT00359619|529285479|FG000|Overall Study|Adverse Event|0|||
146759209|NCT00359619|529285480|FG001|Overall Study|Adverse Event|0|||
146759210|NCT00359619|529285481|FG002|Overall Study|Adverse Event|1|||
146759211|NCT00359619|529285482|FG003|Overall Study|Adverse Event|0|||
146759212|NCT00359619|529285483|FG004|Overall Study|Adverse Event|0|||
146759213|NCT00359619|529285484|FG005|Overall Study|Adverse Event|0|||
146759214|NCT00359619|529285485|FG006|Overall Study|Adverse Event|1|||
146759215|NCT00359619|529285479|FG000|Overall Study|Withdrawal by Subject|3|||
146759216|NCT00359619|529285480|FG001|Overall Study|Withdrawal by Subject|1|||
146759217|NCT00359619|529285481|FG002|Overall Study|Withdrawal by Subject|4|||
146759218|NCT00359619|529285482|FG003|Overall Study|Withdrawal by Subject|2|||
146759219|NCT00359619|529285483|FG004|Overall Study|Withdrawal by Subject|2|||
146759220|NCT00359619|529285484|FG005|Overall Study|Withdrawal by Subject|0|||
146759221|NCT00359619|529285485|FG006|Overall Study|Withdrawal by Subject|3|||
146759222|NCT00359619|529285479|FG000|Overall Study|Other|1|||
146759223|NCT00359619|529285480|FG001|Overall Study|Other|0|||
146759224|NCT00359619|529285481|FG002|Overall Study|Other|0|||
146759225|NCT00359619|529285482|FG003|Overall Study|Other|0|||
146759226|NCT00359619|529285483|FG004|Overall Study|Other|0|||
146759227|NCT00359619|529285484|FG005|Overall Study|Other|0|||
146759228|NCT00359619|529285485|FG006|Overall Study|Other|0|||
146759229|NCT00359619|529285479|FG000|Overall Study|Lost to Follow-up|4|||
146759230|NCT00359619|529285480|FG001|Overall Study|Lost to Follow-up|4|||
146759231|NCT00359619|529285481|FG002|Overall Study|Lost to Follow-up|2|||
146759232|NCT00359619|529285482|FG003|Overall Study|Lost to Follow-up|1|||
146759233|NCT00359619|529285483|FG004|Overall Study|Lost to Follow-up|1|||
146759234|NCT00359619|529285484|FG005|Overall Study|Lost to Follow-up|5|||
146759235|NCT00359619|529285485|FG006|Overall Study|Lost to Follow-up|0|||
146759236|NCT01419717|529285486|FG000|Overall Study|Protocol-specified Criteria|62|||
146759237|NCT01419717|529285486|FG000|Overall Study|Adverse Event|19|||
146759238|NCT01419717|529285486|FG000|Overall Study|Death|17|||
146759239|NCT01419717|529285486|FG000|Overall Study|Withdrawal by Subject|10|||
146759240|NCT01419717|529285486|FG000|Overall Study|Disease Progression|9|||
146759241|NCT01419717|529285486|FG000|Overall Study|Other|4|||
146522747|NCT05464420|528421820|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
146522748|NCT05464420|528421821|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
146759242|NCT01419717|529285486|FG000|Overall Study|Lost to Follow-up|2|||
146759243|NCT01419717|529285486|FG000|Overall Study|Administrative Decision|1|||
146759244|NCT01419717|529285486|FG000|Overall Study|Noncompliance|1|||
146759245|NCT02857283|529285487|FG000|First Exposure|Withdrawal by Subject|1|||
146759246|NCT02857283|529285488|FG001|First Exposure|Withdrawal by Subject|0|||
146759247|NCT00093795|529285489|FG000|Overall Study|No follow up data|20|||
146759248|NCT00093795|529285490|FG001|Overall Study|No follow up data|16|||
146759249|NCT00093795|529285491|FG002|Overall Study|No follow up data|17|||
146759250|NCT00613301|529285492|FG000|Overall Study|Adverse Event|49|||
146522749|NCT05464420|528421822|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
146759251|NCT00613301|529285492|FG000|Overall Study|Lost to Follow-up|88|||
146759252|NCT00613301|529285492|FG000|Overall Study|Withdrawal by Subject|5|||
146759253|NCT00613301|529285492|FG000|Overall Study|Death|6|||
146759254|NCT00613301|529285492|FG000|Overall Study|Lack of Efficacy|13|||
146625283|NCT03037385|528803848|FG003|Overall Study|Progressive Disease|5|||
146759255|NCT00613301|529285492|FG000|Overall Study|Physician Decision|2|||
146759256|NCT00613301|529285492|FG000|Overall Study|No data was collected|53|||
146759257|NCT00613301|529285492|FG000|Overall Study|Irregularly enrolled patients|12|||
146759258|NCT00587288|529285495|FG000|Overall Study|Adverse Event|0|||
146759259|NCT00587288|529285496|FG001|Overall Study|Adverse Event|1|||
146759260|NCT00587288|529285495|FG000|Overall Study|Lack of Efficacy|2|||
146759261|NCT00587288|529285496|FG001|Overall Study|Lack of Efficacy|8|||
146759262|NCT00587288|529285495|FG000|Overall Study|Protocol Violation|1|||
146759263|NCT00587288|529285496|FG001|Overall Study|Protocol Violation|0|||
146759264|NCT00409708|529285502|FG000|Treatment|Abnormal test procedure result(s)|1|||
146759265|NCT00409708|529285503|FG001|Treatment|Abnormal test procedure result(s)|0|||
146759266|NCT00409708|529285502|FG000|Treatment|Lack of Efficacy|0|||
146759267|NCT00409708|529285503|FG001|Treatment|Lack of Efficacy|1|||
146759268|NCT00409708|529285502|FG000|Treatment|Protocol Violation|6|||
146759269|NCT00409708|529285503|FG001|Treatment|Protocol Violation|2|||
146759270|NCT00409708|529285502|FG000|Treatment|Withdrawal by Subject|3|||
146759271|NCT00409708|529285503|FG001|Treatment|Withdrawal by Subject|8|||
146759272|NCT00409708|529285502|FG000|Treatment|Lost to Follow-up|0|||
146759273|NCT00409708|529285503|FG001|Treatment|Lost to Follow-up|6|||
146759274|NCT00409708|529285502|FG000|Treatment|Administrative problems|5|||
146759275|NCT00409708|529285503|FG001|Treatment|Administrative problems|0|||
146759276|NCT00409708|529285502|FG000|Washout|Lack of Efficacy|9|||
146759277|NCT00409708|529285503|FG001|Washout|Lack of Efficacy|1|||
146759278|NCT00409708|529285502|FG000|Washout|Protocol Violation|0|||
146759279|NCT00409708|529285503|FG001|Washout|Protocol Violation|1|||
146759280|NCT00409708|529285502|FG000|Washout|Withdrawal by Subject|11|||
146759281|NCT00409708|529285503|FG001|Washout|Withdrawal by Subject|5|||
146759282|NCT00409708|529285502|FG000|Washout|Lost to Follow-up|1|||
146759283|NCT00409708|529285503|FG001|Washout|Lost to Follow-up|3|||
146759284|NCT00946114|529285504|FG000|Overall Study|Death|5|||
146759285|NCT00946114|529285505|FG001|Overall Study|Death|2|||
146759286|NCT00946114|529285504|FG000|Overall Study|Other|1|||
146759287|NCT00946114|529285505|FG001|Overall Study|Other|0|||
146759288|NCT00946114|529285504|FG000|Overall Study|Withdrawal by Subject|2|||
146759289|NCT00946114|529285505|FG001|Overall Study|Withdrawal by Subject|0|||
146759290|NCT00723294|529285506|FG000|Overall Study|Lobular histology|2|||
146759291|NCT00723294|529285506|FG000|Overall Study|>25% intraductal component|1|||
146759292|NCT00723294|529285506|FG000|Overall Study|No MRI tumor enhancement|1|||
146759293|NCT00723294|529285506|FG000|Overall Study|1.0-Tesla MRI|1|||
146759294|NCT00723294|529285506|FG000|Overall Study|No cryoabalation|2|||
146759295|NCT00723294|529285506|FG000|Overall Study|Did not undergo surgery|1|||
146759296|NCT00723294|529285506|FG000|Overall Study|Treated prior to registration|1|||
146759297|NCT00723294|529285506|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
146759298|NCT00723294|529285506|FG000|Overall Study|Benign lesion|1|||
146759299|NCT00723294|529285506|FG000|Overall Study|Withdrawal by Subject|1|||
146759300|NCT00723294|529285506|FG000|Overall Study|No treatment due to probe failure|1|||
146759301|NCT01211665|529285507|FG000|Overall Study|Withdrawal by Subject|1|||
146759302|NCT01211665|529285508|FG001|Overall Study|Withdrawal by Subject|0|||
146759303|NCT01211665|529285507|FG000|Overall Study|Death|1|||
146759304|NCT01211665|529285508|FG001|Overall Study|Death|0|||
146759305|NCT05349864|529285511|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
146759306|NCT05349864|529285512|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
146759307|NCT02333630|529285513|FG000|Overall Study|Lost to Follow-up|5|||
146759308|NCT02333630|529285514|FG001|Overall Study|Lost to Follow-up|2|||
146759309|NCT00984282|529285515|FG000|Double Blind Treatment|Adverse Event|40|||
146759310|NCT00984282|529285516|FG001|Double Blind Treatment|Adverse Event|6|||
146759311|NCT00984282|529285515|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
146759312|NCT00984282|529285516|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
146759313|NCT00984282|529285515|FG000|Double Blind Treatment|Physician Decision|1|||
146759314|NCT00984282|529285516|FG001|Double Blind Treatment|Physician Decision|2|||
146759315|NCT00984282|529285515|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
146759316|NCT00984282|529285516|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
146759317|NCT00984282|529285515|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
146759318|NCT00984282|529285516|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
146759319|NCT00984282|529285515|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
146759320|NCT00984282|529285516|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
146759321|NCT00984282|529285515|FG000|Double Blind Treatment|Lost to Follow-up|3|||
146759322|NCT00984282|529285516|FG001|Double Blind Treatment|Lost to Follow-up|0|||
146759323|NCT00984282|529285515|FG000|Double Blind Treatment|Death|8|||
146759324|NCT00984282|529285516|FG001|Double Blind Treatment|Death|4|||
146759325|NCT00984282|529285515|FG000|Double Blind Treatment|Not treated|0|||
146759326|NCT00984282|529285516|FG001|Double Blind Treatment|Not treated|1|||
146759327|NCT00984282|529285515|FG000|Double Blind Treatment|Switched to commercial drug|6|||
146759328|NCT00984282|529285516|FG001|Double Blind Treatment|Switched to commercial drug|1|||
146759329|NCT00984282|529285515|FG000|Double Blind Treatment|protocol driven decision point|1|||
146522750|NCT05464420|528421823|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
146965078|NCT03110107|530033442|FG016|Treatment Period|Death|0|||
146858014|NCT00406653|529650164|FG002|Open-Label Period|Discontinued by Sponsor|0|||
146858015|NCT00406653|529650165|FG003|Open-Label Period|Discontinued by Sponsor|0|||
146858016|NCT00406653|529650166|FG004|Open-Label Period|Discontinued by Sponsor|0|||
146858017|NCT00406653|529650167|FG005|Open-Label Period|Discontinued by Sponsor|0|||
146858018|NCT00406653|529650168|FG006|Open-Label Period|Discontinued by Sponsor|1|||
146858019|NCT00406653|529650162|FG000|Open-Label Period|Refused followup|0|||
146858020|NCT00406653|529650163|FG001|Open-Label Period|Refused followup|0|||
146858021|NCT00406653|529650164|FG002|Open-Label Period|Refused followup|0|||
146858022|NCT00406653|529650165|FG003|Open-Label Period|Refused followup|0|||
146858023|NCT00406653|529650166|FG004|Open-Label Period|Refused followup|0|||
146858024|NCT00406653|529650167|FG005|Open-Label Period|Refused followup|0|||
146858025|NCT00406653|529650168|FG006|Open-Label Period|Refused followup|1|||
146858026|NCT01275131|529650169|FG000|Period 1|Withdrawal by Subject|1|||
146858027|NCT01275131|529650170|FG001|Period 1|Withdrawal by Subject|0|||
146858028|NCT01275131|529650171|FG002|Period 1|Withdrawal by Subject|3|||
146858029|NCT01275131|529650172|FG003|Period 1|Withdrawal by Subject|2|||
146858030|NCT01275131|529650169|FG000|Period 1|Physician Decision|1|||
146858031|NCT01275131|529650170|FG001|Period 1|Physician Decision|0|||
146858032|NCT01275131|529650171|FG002|Period 1|Physician Decision|0|||
146858033|NCT01275131|529650172|FG003|Period 1|Physician Decision|0|||
146858034|NCT01275131|529650169|FG000|Period 2 (Crossover)|Adverse Event|0|||
146858035|NCT01275131|529650170|FG001|Period 2 (Crossover)|Adverse Event|1|||
146858036|NCT01275131|529650171|FG002|Period 2 (Crossover)|Adverse Event|0|||
146858037|NCT01275131|529650172|FG003|Period 2 (Crossover)|Adverse Event|0|||
146858038|NCT01275131|529650169|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
146858039|NCT01275131|529650170|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
146858040|NCT01275131|529650171|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
146858041|NCT01275131|529650172|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
146858042|NCT00816400|529651521|FG000|Overall Study|Death|2|||
146858043|NCT00816400|529651522|FG001|Overall Study|Death|3|||
146858044|NCT00816400|529651523|FG002|Overall Study|Death|3|||
146858045|NCT00816400|529651524|FG003|Overall Study|Death|3|||
146858046|NCT00816400|529651525|FG004|Overall Study|Death|2|||
146858047|NCT00816400|529651526|FG005|Overall Study|Death|3|||
146858048|NCT00816400|529651527|FG006|Overall Study|Death|2|||
146858049|NCT00816400|529651528|FG007|Overall Study|Death|5|||
146858050|NCT00816400|529651529|FG008|Overall Study|Death|6|||
146858051|NCT00816400|529651521|FG000|Overall Study|In hospice care at the end of the study|0|||
146858052|NCT00816400|529651522|FG001|Overall Study|In hospice care at the end of the study|0|||
146858053|NCT00816400|529651523|FG002|Overall Study|In hospice care at the end of the study|2|||
146858054|NCT00816400|529651524|FG003|Overall Study|In hospice care at the end of the study|0|||
146858055|NCT00816400|529651525|FG004|Overall Study|In hospice care at the end of the study|0|||
146858056|NCT00816400|529651526|FG005|Overall Study|In hospice care at the end of the study|0|||
146858057|NCT00816400|529651527|FG006|Overall Study|In hospice care at the end of the study|0|||
146858058|NCT00816400|529651528|FG007|Overall Study|In hospice care at the end of the study|0|||
146858059|NCT00816400|529651529|FG008|Overall Study|In hospice care at the end of the study|0|||
146858060|NCT01786174|529651530|FG000|Overall Study|Discontinued Study Drug|2|||
146858061|NCT01786174|529651531|FG001|Overall Study|Discontinued Study Drug|0|||
146858062|NCT00876694|529651534|FG000|Overall Study|Adverse Event|10|||
146858063|NCT00876694|529651535|FG001|Overall Study|Adverse Event|7|||
146858064|NCT00876694|529651534|FG000|Overall Study|Subject withdrew consent|6|||
146858065|NCT00876694|529651535|FG001|Overall Study|Subject withdrew consent|4|||
146858066|NCT00876694|529651534|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146858067|NCT00876694|529651535|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146858068|NCT00876694|529651534|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146858069|NCT00876694|529651535|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146858070|NCT00876694|529651534|FG000|Overall Study|Administrative problems|1|||
146858071|NCT00876694|529651535|FG001|Overall Study|Administrative problems|1|||
146858072|NCT00876694|529651534|FG000|Overall Study|Death|1|||
146858073|NCT00876694|529651535|FG001|Overall Study|Death|0|||
146858074|NCT01386788|529651540|FG000|Overall Study|Lost to Follow-up|2|||
146858075|NCT00824161|529651541|FG000|Overall Study|Withdrawal by Subject|1|||
146858076|NCT00824161|529651541|FG000|Overall Study|Screen Failure|1|||
146858077|NCT01112306|529651542|FG000|Overall Study|Death|175|||
146858078|NCT01112306|529651542|FG000|Overall Study|Lost to Follow-up|9|||
146858079|NCT01112306|529651542|FG000|Overall Study|Withdrawal by Subject|31|||
146858080|NCT01112306|529651542|FG000|Overall Study|Other|70|||
146858081|NCT00211185|529651551|FG000|Overall Study|Death|2|||
146858082|NCT00211185|529651551|FG000|Overall Study|Disease progression|7|||
146858083|NCT00211185|529651551|FG000|Overall Study|Withdrawal by Subject|6|||
146858084|NCT00211185|529651551|FG000|Overall Study|Physician Decision|5|||
146858085|NCT00842985|529651552|FG000|Screening|Did not meet entrance requirements|27|||
146858086|NCT00842985|529651552|FG000|First Intervention|Withdrawal by Subject|3|||
146858087|NCT00842985|529651552|FG000|First Intervention|Protocol Violation|3|||
146858088|NCT00842985|529651552|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
146858089|NCT00842985|529651552|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
146858090|NCT01037244|529651553|FG000|Overall Study|Adverse Event|3|||
146858091|NCT01037244|529651554|FG001|Overall Study|Adverse Event|2|||
146858092|NCT01037244|529651555|FG002|Overall Study|Adverse Event|6|||
146858093|NCT01037244|529651556|FG003|Overall Study|Adverse Event|3|||
146858094|NCT01037244|529651553|FG000|Overall Study|Lack of Efficacy|1|||
146858095|NCT01037244|529651554|FG001|Overall Study|Lack of Efficacy|1|||
146858096|NCT01037244|529651555|FG002|Overall Study|Lack of Efficacy|0|||
146858097|NCT01037244|529651556|FG003|Overall Study|Lack of Efficacy|1|||
146858098|NCT01037244|529651553|FG000|Overall Study|Lost to Follow-up|3|||
146858099|NCT01037244|529651554|FG001|Overall Study|Lost to Follow-up|3|||
146858100|NCT01037244|529651555|FG002|Overall Study|Lost to Follow-up|4|||
146858101|NCT01037244|529651556|FG003|Overall Study|Lost to Follow-up|4|||
146858102|NCT01037244|529651553|FG000|Overall Study|Withdrawal by Subject|1|||
146858103|NCT01037244|529651554|FG001|Overall Study|Withdrawal by Subject|5|||
146858104|NCT01037244|529651555|FG002|Overall Study|Withdrawal by Subject|3|||
146858105|NCT01037244|529651556|FG003|Overall Study|Withdrawal by Subject|5|||
146858106|NCT01037244|529651553|FG000|Overall Study|Partner Withdrew Consent|2|||
146858107|NCT01037244|529651554|FG001|Overall Study|Partner Withdrew Consent|1|||
146858108|NCT01037244|529651555|FG002|Overall Study|Partner Withdrew Consent|0|||
146858109|NCT01037244|529651556|FG003|Overall Study|Partner Withdrew Consent|0|||
146858110|NCT01037244|529651553|FG000|Overall Study|Various|3|||
146858111|NCT01037244|529651554|FG001|Overall Study|Various|2|||
146858112|NCT01037244|529651555|FG002|Overall Study|Various|1|||
146858113|NCT01037244|529651556|FG003|Overall Study|Various|1|||
146858114|NCT04507126|529651557|FG000|Overall Study|Withdrawal by Subject|1|||
146858115|NCT04507126|529651557|FG000|Overall Study|Protocol Violation|2|||
146858116|NCT04507126|529651557|FG000|Overall Study|Physician Decision|1|||
146858117|NCT02875977|529651559|FG000|Overall Study|Lost to Follow-up|42|||
146858118|NCT02875977|529651560|FG001|Overall Study|Lost to Follow-up|29|||
146858119|NCT02070588|529651561|FG000|Overall Study|Withdrawal by Subject|29|||
146858120|NCT02070588|529651562|FG001|Overall Study|Withdrawal by Subject|1|||
146858121|NCT02070588|529651563|FG002|Overall Study|Withdrawal by Subject|0|||
146858122|NCT02070588|529651561|FG000|Overall Study|Writhdrawal due to early termination|9|||
146858123|NCT02070588|529651562|FG001|Overall Study|Writhdrawal due to early termination|0|||
146858124|NCT02070588|529651563|FG002|Overall Study|Writhdrawal due to early termination|0|||
146858125|NCT02070588|529651561|FG000|Overall Study|Adverse Event|1|||
146858126|NCT02070588|529651562|FG001|Overall Study|Adverse Event|0|||
146858127|NCT02070588|529651563|FG002|Overall Study|Adverse Event|0|||
146858128|NCT00551460|529651567|FG000|Overall Study|Adverse Event|1|||
146858129|NCT00551460|529651567|FG000|Overall Study|Withdrawal by Subject|1|||
146858130|NCT00551460|529651567|FG000|Overall Study|Physician Decision|1|||
146858131|NCT00551460|529651567|FG000|Overall Study|Death|7|||
146858132|NCT00551460|529651567|FG000|Overall Study|Ineligible|4|||
146858133|NCT00551460|529651567|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
146858134|NCT04781387|529651568|FG000|Overall Study|Withdrawal by Subject|1|||
146858135|NCT04781387|529651569|FG001|Overall Study|Withdrawal by Subject|0|||
146858136|NCT04781387|529651570|FG002|Overall Study|Withdrawal by Subject|1|||
146858137|NCT04781387|529651568|FG000|Overall Study|Lost to Follow-up|1|||
146858138|NCT04781387|529651569|FG001|Overall Study|Lost to Follow-up|0|||
146858139|NCT04781387|529651570|FG002|Overall Study|Lost to Follow-up|0|||
146858140|NCT00679627|529651572|FG000|Overall Study|Death|41|||
146858141|NCT00679627|529651573|FG001|Overall Study|Death|29|||
146858142|NCT00679627|529651572|FG000|Overall Study|Adverse Event|43|||
146858143|NCT00679627|529651573|FG001|Overall Study|Adverse Event|53|||
146858144|NCT00679627|529651572|FG000|Overall Study|Withdrawal by Subject|168|||
146858145|NCT00679627|529651573|FG001|Overall Study|Withdrawal by Subject|172|||
146858146|NCT00679627|529651572|FG000|Overall Study|Lost to Follow-up|22|||
146858147|NCT00679627|529651573|FG001|Overall Study|Lost to Follow-up|26|||
146858148|NCT00679627|529651572|FG000|Overall Study|Early Study Closure|425|||
146858149|NCT00679627|529651573|FG001|Overall Study|Early Study Closure|405|||
146858150|NCT00511472|529651574|FG000|Overall Study|Clinical Adverse Event|1|||
146858151|NCT00511472|529651575|FG001|Overall Study|Clinical Adverse Event|2|||
146858152|NCT00511472|529651574|FG000|Overall Study|Laboratory Adverse Event|0|||
146858153|NCT00511472|529651575|FG001|Overall Study|Laboratory Adverse Event|2|||
146858154|NCT00511472|529651574|FG000|Overall Study|Not reported|2|||
146858155|NCT00511472|529651575|FG001|Overall Study|Not reported|2|||
146858156|NCT00446992|529651576|FG000|Overall Study|Adverse Event|11|||
146858157|NCT00446992|529651576|FG000|Overall Study|Lost to Follow-up|5|||
146858158|NCT00818649|529651577|FG000|Overall Study|Declining performance status|2|||
146858159|NCT00818649|529651577|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
146858160|NCT00818649|529651577|FG000|Overall Study|Adverse Event|1|||
146858161|NCT03513588|529651578|FG000|Overall Study|Lost to Follow-up|0|||
146858162|NCT03513588|529651579|FG001|Overall Study|Lost to Follow-up|1|||
146858163|NCT03513588|529651580|FG002|Overall Study|Lost to Follow-up|1|||
146858164|NCT03513588|529651578|FG000|Overall Study|Study dosing paused by sponsor|1|||
146858165|NCT03513588|529651579|FG001|Overall Study|Study dosing paused by sponsor|1|||
146858166|NCT03513588|529651580|FG002|Overall Study|Study dosing paused by sponsor|0|||
146858167|NCT03513588|529651578|FG000|Overall Study|Death|0|||
146759330|NCT00984282|529285516|FG001|Double Blind Treatment|protocol driven decision point|1|||
146759331|NCT00984282|529285515|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
146759332|NCT00984282|529285516|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
146759333|NCT00984282|529285515|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
146759334|NCT00984282|529285516|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
146759335|NCT00984282|529285515|FG000|Open-label Treatment|Adverse Event|20|||
146759336|NCT00984282|529285516|FG001|Open-label Treatment|Adverse Event|30|||
146759337|NCT00984282|529285515|FG000|Open-label Treatment|Withdrawal by Subject|6|||
146759338|NCT00984282|529285516|FG001|Open-label Treatment|Withdrawal by Subject|21|||
146759339|NCT00984282|529285515|FG000|Open-label Treatment|Death|7|||
146759340|NCT00984282|529285516|FG001|Open-label Treatment|Death|15|||
146759341|NCT00984282|529285515|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
146759342|NCT00984282|529285516|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
146759343|NCT00984282|529285515|FG000|Open-label Treatment|Lost to Follow-up|1|||
146759344|NCT00984282|529285516|FG001|Open-label Treatment|Lost to Follow-up|1|||
146759345|NCT00984282|529285515|FG000|Open-label Treatment|Patient convenience|1|||
146759346|NCT00984282|529285516|FG001|Open-label Treatment|Patient convenience|0|||
146759347|NCT00984282|529285515|FG000|Open-label Treatment|Non-compliant with study medication|1|||
146759348|NCT00984282|529285516|FG001|Open-label Treatment|Non-compliant with study medication|0|||
146759349|NCT00984282|529285515|FG000|Open-label Treatment|Target lesion removed|0|||
146759350|NCT00984282|529285516|FG001|Open-label Treatment|Target lesion removed|1|||
146759351|NCT00984282|529285515|FG000|Open-label Treatment|Protocol driven decision point|1|||
146759352|NCT00984282|529285516|FG001|Open-label Treatment|Protocol driven decision point|1|||
146759353|NCT00984282|529285515|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
146759354|NCT00984282|529285516|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
146759355|NCT00984282|529285515|FG000|Open-label Treatment|Switched to commercial drug|6|||
146759356|NCT00984282|529285516|FG001|Open-label Treatment|Switched to commercial drug|7|||
146759357|NCT00984282|529285515|FG000|Open-label Treatment|Physician Decision|1|||
146759358|NCT00984282|529285516|FG001|Open-label Treatment|Physician Decision|0|||
146759359|NCT00984282|529285515|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
146759360|NCT00984282|529285516|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
146759361|NCT00984282|529285515|FG000|Long Term Follow-up|Death|27|||
146759362|NCT00984282|529285516|FG001|Long Term Follow-up|Death|68|||
146759363|NCT00984282|529285515|FG000|Long Term Follow-up|Lost to Follow-up|3|||
146759364|NCT00984282|529285516|FG001|Long Term Follow-up|Lost to Follow-up|6|||
146759365|NCT00984282|529285515|FG000|Long Term Follow-up|Protocol driven decision point|25|||
146759366|NCT00984282|529285516|FG001|Long Term Follow-up|Protocol driven decision point|26|||
146759367|NCT00984282|529285515|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
146759368|NCT00984282|529285516|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
146759369|NCT00984282|529285515|FG000|Long Term Follow-up|Switched to commercial drug|4|||
146759370|NCT00984282|529285516|FG001|Long Term Follow-up|Switched to commercial drug|2|||
146759371|NCT00984282|529285515|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
146759372|NCT00984282|529285516|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
146759373|NCT02223793|529285517|FG000|Overall Study|Lost to Follow-up|10|||
146759374|NCT02223793|529285518|FG001|Overall Study|Lost to Follow-up|1|||
146759375|NCT02223793|529285519|FG002|Overall Study|Lost to Follow-up|2|||
146759376|NCT02223793|529285517|FG000|Overall Study|Withdrawal by Subject|3|||
146759377|NCT02223793|529285518|FG001|Overall Study|Withdrawal by Subject|2|||
146759378|NCT02223793|529285519|FG002|Overall Study|Withdrawal by Subject|3|||
146759379|NCT02223793|529285517|FG000|Overall Study|Moved/studycenter unable to participate|4|||
146759380|NCT02223793|529285518|FG001|Overall Study|Moved/studycenter unable to participate|6|||
146759381|NCT02223793|529285519|FG002|Overall Study|Moved/studycenter unable to participate|8|||
146759382|NCT02359435|529285520|FG000|Overall Study|Lost to Follow-up|4|||
146759383|NCT02359435|529285521|FG001|Overall Study|Lost to Follow-up|4|||
146759384|NCT00315055|529285522|FG000|Overall Study|Protocol Violation|2|||
146759385|NCT00315055|529285523|FG001|Overall Study|Protocol Violation|4|||
146759386|NCT00315055|529285522|FG000|Overall Study|Lost to Follow-up|1|||
146759387|NCT00315055|529285523|FG001|Overall Study|Lost to Follow-up|1|||
146759388|NCT01289119|529285527|FG000|Overall Study|Adverse Event|2|||
146759389|NCT01289119|529285528|FG001|Overall Study|Adverse Event|1|||
146759390|NCT01289119|529285529|FG002|Overall Study|Adverse Event|0|||
146759391|NCT01289119|529285530|FG003|Overall Study|Adverse Event|2|||
146759392|NCT01289119|529285531|FG004|Overall Study|Adverse Event|1|||
146759393|NCT01289119|529285532|FG005|Overall Study|Adverse Event|0|||
146759394|NCT01289119|529285527|FG000|Overall Study|Major Protocol Deviation|2|||
146759395|NCT01289119|529285528|FG001|Overall Study|Major Protocol Deviation|1|||
146759396|NCT01289119|529285529|FG002|Overall Study|Major Protocol Deviation|3|||
146759397|NCT01289119|529285530|FG003|Overall Study|Major Protocol Deviation|0|||
146759398|NCT01289119|529285531|FG004|Overall Study|Major Protocol Deviation|2|||
146759399|NCT01289119|529285532|FG005|Overall Study|Major Protocol Deviation|1|||
146759400|NCT01289119|529285527|FG000|Overall Study|Lost to Follow-up|0|||
146759401|NCT01289119|529285528|FG001|Overall Study|Lost to Follow-up|3|||
146858168|NCT03513588|529651579|FG001|Overall Study|Death|0|||
146858169|NCT03513588|529651580|FG002|Overall Study|Death|1|||
146858170|NCT00505284|529651581|FG000|Overall Study|Adverse Event|3|||
146858171|NCT00505284|529651582|FG001|Overall Study|Adverse Event|7|||
146858172|NCT00505284|529651583|FG002|Overall Study|Adverse Event|9|||
146858173|NCT00505284|529651584|FG003|Overall Study|Adverse Event|14|||
146858174|NCT00505284|529651585|FG004|Overall Study|Adverse Event|22|||
146858175|NCT00505284|529651581|FG000|Overall Study|Protocol Violation|0|||
146858176|NCT00505284|529651582|FG001|Overall Study|Protocol Violation|1|||
146858177|NCT00505284|529651583|FG002|Overall Study|Protocol Violation|1|||
146858178|NCT00505284|529651584|FG003|Overall Study|Protocol Violation|0|||
146858179|NCT00505284|529651585|FG004|Overall Study|Protocol Violation|0|||
146858180|NCT00505284|529651581|FG000|Overall Study|Withdrawal by Subject|2|||
146858181|NCT00505284|529651582|FG001|Overall Study|Withdrawal by Subject|6|||
146858182|NCT00505284|529651583|FG002|Overall Study|Withdrawal by Subject|1|||
146858183|NCT00505284|529651584|FG003|Overall Study|Withdrawal by Subject|0|||
146858184|NCT00505284|529651585|FG004|Overall Study|Withdrawal by Subject|6|||
146858185|NCT00505284|529651581|FG000|Overall Study|Lack of Efficacy|0|||
146858186|NCT00505284|529651582|FG001|Overall Study|Lack of Efficacy|1|||
146858187|NCT00505284|529651583|FG002|Overall Study|Lack of Efficacy|1|||
146858188|NCT00505284|529651584|FG003|Overall Study|Lack of Efficacy|1|||
146858189|NCT00505284|529651585|FG004|Overall Study|Lack of Efficacy|1|||
146858190|NCT00505284|529651581|FG000|Overall Study|Physician Decision|0|||
146858191|NCT00505284|529651582|FG001|Overall Study|Physician Decision|1|||
146858192|NCT00505284|529651583|FG002|Overall Study|Physician Decision|0|||
146858193|NCT00505284|529651584|FG003|Overall Study|Physician Decision|0|||
146858194|NCT00505284|529651585|FG004|Overall Study|Physician Decision|0|||
146858195|NCT00505284|529651581|FG000|Overall Study|Other|5|||
146858196|NCT00505284|529651582|FG001|Overall Study|Other|0|||
146858197|NCT00505284|529651583|FG002|Overall Study|Other|0|||
146858198|NCT00505284|529651584|FG003|Overall Study|Other|4|||
146858199|NCT00505284|529651585|FG004|Overall Study|Other|4|||
146522751|NCT05464420|528421820|FG000|Overall Study|Withdrawal by Subject|4|||
146522752|NCT05464420|528421821|FG001|Overall Study|Withdrawal by Subject|8|||
146522753|NCT05464420|528421822|FG002|Overall Study|Withdrawal by Subject|3|||
146522754|NCT05464420|528421823|FG003|Overall Study|Withdrawal by Subject|1|||
146522755|NCT05464420|528421820|FG000|Overall Study|Protocol Violation|0|||
146522756|NCT05464420|528421821|FG001|Overall Study|Protocol Violation|0|||
146522757|NCT05464420|528421822|FG002|Overall Study|Protocol Violation|1|||
146522758|NCT05464420|528421823|FG003|Overall Study|Protocol Violation|1|||
146759402|NCT01289119|529285529|FG002|Overall Study|Lost to Follow-up|0|||
146759403|NCT01289119|529285530|FG003|Overall Study|Lost to Follow-up|0|||
146759404|NCT01289119|529285531|FG004|Overall Study|Lost to Follow-up|0|||
146759405|NCT01289119|529285532|FG005|Overall Study|Lost to Follow-up|1|||
146759406|NCT01289119|529285527|FG000|Overall Study|Withdrawal by Subject|4|||
146759407|NCT01289119|529285528|FG001|Overall Study|Withdrawal by Subject|2|||
146759408|NCT01289119|529285529|FG002|Overall Study|Withdrawal by Subject|4|||
146759409|NCT01289119|529285530|FG003|Overall Study|Withdrawal by Subject|3|||
146759410|NCT01289119|529285531|FG004|Overall Study|Withdrawal by Subject|1|||
146759411|NCT01289119|529285532|FG005|Overall Study|Withdrawal by Subject|1|||
146759412|NCT01289119|529285527|FG000|Overall Study|Pregnancy|0|||
146759413|NCT01289119|529285528|FG001|Overall Study|Pregnancy|1|||
146759414|NCT01289119|529285529|FG002|Overall Study|Pregnancy|0|||
146759415|NCT01289119|529285530|FG003|Overall Study|Pregnancy|0|||
146759416|NCT01289119|529285531|FG004|Overall Study|Pregnancy|0|||
146759417|NCT01289119|529285532|FG005|Overall Study|Pregnancy|0|||
146759418|NCT01289119|529285527|FG000|Overall Study|Lack of Efficacy|0|||
146759419|NCT01289119|529285528|FG001|Overall Study|Lack of Efficacy|1|||
146759420|NCT01289119|529285529|FG002|Overall Study|Lack of Efficacy|1|||
146759421|NCT01289119|529285530|FG003|Overall Study|Lack of Efficacy|1|||
146759422|NCT01289119|529285531|FG004|Overall Study|Lack of Efficacy|1|||
146759423|NCT01289119|529285532|FG005|Overall Study|Lack of Efficacy|1|||
146759424|NCT01289119|529285527|FG000|Overall Study|Other|1|||
146759425|NCT01289119|529285528|FG001|Overall Study|Other|0|||
146759426|NCT01289119|529285529|FG002|Overall Study|Other|1|||
146759427|NCT01289119|529285530|FG003|Overall Study|Other|0|||
146759428|NCT01289119|529285531|FG004|Overall Study|Other|0|||
146759429|NCT01289119|529285532|FG005|Overall Study|Other|0|||
146858200|NCT00940108|529651586|FG000|Overall Study|Adverse Event|2|||
146858201|NCT00940108|529651587|FG001|Overall Study|Adverse Event|4|||
146858202|NCT00940108|529651588|FG002|Overall Study|Adverse Event|0|||
146858203|NCT00940108|529651589|FG003|Overall Study|Adverse Event|2|||
146858204|NCT00940108|529651586|FG000|Overall Study|Withdrew Consent|2|||
146858205|NCT00940108|529651587|FG001|Overall Study|Withdrew Consent|1|||
146858206|NCT00940108|529651588|FG002|Overall Study|Withdrew Consent|0|||
146858207|NCT00940108|529651589|FG003|Overall Study|Withdrew Consent|1|||
146858208|NCT00940108|529651586|FG000|Overall Study|Dose 2 contraindicated|1|||
146522759|NCT05464420|528421820|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
146759430|NCT01704846|529285533|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146759431|NCT01704846|529285534|FG001|Treatment Period 2|Withdrawal by Subject|1|||
146858209|NCT00940108|529651587|FG001|Overall Study|Dose 2 contraindicated|1|||
146858210|NCT00940108|529651588|FG002|Overall Study|Dose 2 contraindicated|0|||
146858211|NCT00940108|529651589|FG003|Overall Study|Dose 2 contraindicated|1|||
146858212|NCT00940108|529651586|FG000|Overall Study|Declined further vaccination|0|||
146858213|NCT00940108|529651587|FG001|Overall Study|Declined further vaccination|1|||
146858214|NCT00940108|529651588|FG002|Overall Study|Declined further vaccination|3|||
146858215|NCT00940108|529651589|FG003|Overall Study|Declined further vaccination|0|||
146858216|NCT00940108|529651586|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
146858217|NCT00940108|529651587|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
146858218|NCT00940108|529651588|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
146858219|NCT00940108|529651589|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
146858220|NCT00940108|529651586|FG000|Overall Study|Viral illness after Dose 1|0|||
146858221|NCT00940108|529651587|FG001|Overall Study|Viral illness after Dose 1|1|||
146858222|NCT00940108|529651588|FG002|Overall Study|Viral illness after Dose 1|0|||
146858223|NCT00940108|529651589|FG003|Overall Study|Viral illness after Dose 1|0|||
146858224|NCT00940108|529651586|FG000|Overall Study|Diagnosed with H1N1|0|||
146858225|NCT00940108|529651587|FG001|Overall Study|Diagnosed with H1N1|0|||
146858226|NCT00940108|529651588|FG002|Overall Study|Diagnosed with H1N1|0|||
146858227|NCT00940108|529651589|FG003|Overall Study|Diagnosed with H1N1|1|||
146858228|NCT01740323|529651593|FG000|Overall Study|Adverse Event|1|||
146858229|NCT01740323|529651594|FG001|Overall Study|Adverse Event|0|||
146858230|NCT01740323|529651593|FG000|Overall Study|Randomized but did not take study drug|1|||
146858231|NCT01740323|529651594|FG001|Overall Study|Randomized but did not take study drug|0|||
146858232|NCT00953745|529651601|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
146858233|NCT00953745|529651602|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
146858234|NCT00953745|529651601|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
146858235|NCT00953745|529651602|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
146858236|NCT00953745|529651601|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
146858237|NCT00953745|529651602|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
146858238|NCT00953745|529651601|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
146858239|NCT00953745|529651602|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
146858240|NCT00953745|529651601|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
146858241|NCT00953745|529651602|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
146858242|NCT00953745|529651601|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
146858243|NCT00953745|529651602|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
146858244|NCT02427464|529651608|FG000|Overall Study|Adverse Event|6|||
146858245|NCT02427464|529651609|FG001|Overall Study|Adverse Event|1|||
146858246|NCT02427464|529651608|FG000|Overall Study|Lost to Follow-up|16|||
146858247|NCT02427464|529651609|FG001|Overall Study|Lost to Follow-up|5|||
146858248|NCT02427464|529651608|FG000|Overall Study|Physician Decision|2|||
146858249|NCT02427464|529651609|FG001|Overall Study|Physician Decision|0|||
146858250|NCT02427464|529651608|FG000|Overall Study|Withdrawal by Subject|10|||
146858251|NCT02427464|529651609|FG001|Overall Study|Withdrawal by Subject|8|||
146858252|NCT02427464|529651608|FG000|Overall Study|Noncompliance|16|||
146858253|NCT02427464|529651609|FG001|Overall Study|Noncompliance|10|||
146858254|NCT04737187|529651611|FG000|Overall Study|Switched to marketed drug|32|||
146858255|NCT04737187|529651612|FG001|Overall Study|Switched to marketed drug|4|||
146858256|NCT04737187|529651611|FG000|Overall Study|Radiological Progressive Disease|145|||
146858257|NCT04737187|529651612|FG001|Overall Study|Radiological Progressive Disease|146|||
146858258|NCT04737187|529651611|FG000|Overall Study|Clinical Progressive Disease|20|||
146858259|NCT04737187|529651612|FG001|Overall Study|Clinical Progressive Disease|20|||
146858260|NCT04737187|529651611|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
146858261|NCT04737187|529651612|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
146858262|NCT04737187|529651611|FG000|Overall Study|Adverse Event|16|||
146858263|NCT04737187|529651612|FG001|Overall Study|Adverse Event|16|||
146858264|NCT04737187|529651611|FG000|Overall Study|Physician Decision|2|||
146858265|NCT04737187|529651612|FG001|Overall Study|Physician Decision|0|||
146858266|NCT04737187|529651611|FG000|Overall Study|Withdrawal by Subject|5|||
146858267|NCT04737187|529651612|FG001|Overall Study|Withdrawal by Subject|8|||
146858268|NCT03756129|529651613|FG000|Overall Study|Adverse Event|1|||
146858269|NCT03756129|529651614|FG001|Overall Study|Adverse Event|1|||
146858270|NCT03756129|529651615|FG002|Overall Study|Adverse Event|0|||
146858271|NCT03756129|529651616|FG003|Overall Study|Adverse Event|2|||
146858272|NCT03756129|529651617|FG004|Overall Study|Adverse Event|0|||
146858273|NCT03756129|529651618|FG005|Overall Study|Adverse Event|0|||
146858274|NCT03756129|529651613|FG000|Overall Study|Withdrawal by Subject|2|||
146858275|NCT03756129|529651614|FG001|Overall Study|Withdrawal by Subject|1|||
146858276|NCT03756129|529651615|FG002|Overall Study|Withdrawal by Subject|3|||
146858277|NCT03756129|529651616|FG003|Overall Study|Withdrawal by Subject|1|||
146858278|NCT03756129|529651617|FG004|Overall Study|Withdrawal by Subject|1|||
146858279|NCT03756129|529651618|FG005|Overall Study|Withdrawal by Subject|3|||
146858280|NCT03756129|529651613|FG000|Overall Study|Lost to Follow-up|0|||
146858281|NCT03756129|529651614|FG001|Overall Study|Lost to Follow-up|0|||
146858282|NCT03756129|529651615|FG002|Overall Study|Lost to Follow-up|0|||
146858283|NCT03756129|529651616|FG003|Overall Study|Lost to Follow-up|0|||
146858284|NCT03756129|529651617|FG004|Overall Study|Lost to Follow-up|0|||
146858285|NCT03756129|529651618|FG005|Overall Study|Lost to Follow-up|1|||
146858286|NCT03756129|529651613|FG000|Overall Study|Physician Decision|0|||
146858287|NCT03756129|529651614|FG001|Overall Study|Physician Decision|0|||
146858288|NCT03756129|529651615|FG002|Overall Study|Physician Decision|0|||
146858289|NCT03756129|529651616|FG003|Overall Study|Physician Decision|0|||
146858290|NCT03756129|529651617|FG004|Overall Study|Physician Decision|0|||
146858291|NCT03756129|529651618|FG005|Overall Study|Physician Decision|1|||
146858292|NCT03567434|529651619|FG000|Overall Study|Lost to Follow-up|1|||
146858293|NCT03567434|529651620|FG001|Overall Study|Lost to Follow-up|3|||
146858294|NCT01439360|529651621|FG000|Overall Study|Adverse Event|4|||
146858295|NCT01439360|529651622|FG001|Overall Study|Adverse Event|16|||
146858296|NCT01439360|529651621|FG000|Overall Study|Lost to Follow-up|43|||
146858297|NCT01439360|529651622|FG001|Overall Study|Lost to Follow-up|58|||
146858298|NCT01439360|529651621|FG000|Overall Study|Others|10|||
146858299|NCT01439360|529651622|FG001|Overall Study|Others|5|||
146858300|NCT01439360|529651621|FG000|Overall Study|Protocol Violation|1|||
146858301|NCT01439360|529651622|FG001|Overall Study|Protocol Violation|0|||
146858302|NCT01439360|529651621|FG000|Overall Study|Withdrawal by Subject|140|||
146858303|NCT01439360|529651622|FG001|Overall Study|Withdrawal by Subject|129|||
146858304|NCT00345293|529651623|FG000|Overall Study|Unable to access line for sample|1|||
146858305|NCT00345293|529651624|FG001|Overall Study|Unable to access line for sample|0|||
146858306|NCT00345293|529651623|FG000|Overall Study|Withdrawal by Subject|1|||
146858307|NCT00345293|529651624|FG001|Overall Study|Withdrawal by Subject|0|||
146858308|NCT03319849|529651625|FG000|Overall Study|Adverse Event|1|||
146858309|NCT03319849|529651626|FG001|Overall Study|Adverse Event|0|||
146858310|NCT03319849|529651625|FG000|Overall Study|Physician Decision|0|||
146858311|NCT03319849|529651626|FG001|Overall Study|Physician Decision|1|||
146858312|NCT03319849|529651625|FG000|Overall Study|Withdrawal by Subject|0|||
146858313|NCT03319849|529651626|FG001|Overall Study|Withdrawal by Subject|1|||
146858314|NCT03319849|529651625|FG000|Overall Study|COVID-19|0|||
146858315|NCT03319849|529651626|FG001|Overall Study|COVID-19|1|||
146858316|NCT03319849|529651625|FG000|Overall Study|Other|1|||
146858317|NCT03319849|529651626|FG001|Overall Study|Other|2|||
146858318|NCT03319849|529651625|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
146858319|NCT03319849|529651626|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
146858320|NCT03319849|529651625|FG000|Overall Study|Lost to Follow-up|0|||
146858321|NCT03319849|529651626|FG001|Overall Study|Lost to Follow-up|2|||
146858322|NCT01340196|529652720|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
146858323|NCT00604279|529652725|FG000|Overall Study|Lack of Efficacy|22|||
146858324|NCT00604279|529652726|FG001|Overall Study|Lack of Efficacy|9|||
146858325|NCT00604279|529652725|FG000|Overall Study|Lost to Follow-up|9|||
146858326|NCT00604279|529652726|FG001|Overall Study|Lost to Follow-up|14|||
146858327|NCT00604279|529652725|FG000|Overall Study|Pregnancy|2|||
146858328|NCT00604279|529652726|FG001|Overall Study|Pregnancy|0|||
146858329|NCT00604279|529652725|FG000|Overall Study|Protocol Violation|3|||
146858330|NCT00604279|529652726|FG001|Overall Study|Protocol Violation|1|||
146858331|NCT00604279|529652725|FG000|Overall Study|Withdrawal by Subject|16|||
146858332|NCT00604279|529652726|FG001|Overall Study|Withdrawal by Subject|5|||
146858333|NCT00604279|529652725|FG000|Overall Study|Adverse Event|4|||
146858334|NCT00604279|529652726|FG001|Overall Study|Adverse Event|5|||
146858335|NCT00604279|529652725|FG000|Overall Study|Other|8|||
146858336|NCT00604279|529652726|FG001|Overall Study|Other|4|||
146858337|NCT00601419|529652727|FG000|Overall Study|Lost to Follow-up|3|||
146858338|NCT00601419|529652727|FG000|Overall Study|Missed Visits|1|||
146858339|NCT01614197|529652728|FG000|Overall Study|Withdrawal by Subject|0|||
146858340|NCT01614197|529652729|FG001|Overall Study|Withdrawal by Subject|1|||
146858341|NCT01614197|529652730|FG002|Overall Study|Withdrawal by Subject|0|||
146858342|NCT01614197|529652731|FG003|Overall Study|Withdrawal by Subject|0|||
146522760|NCT05464420|528421821|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
146522761|NCT05464420|528421822|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
146858343|NCT03628898|529652733|FG000|Overall Study|Device deficiency|1|||
146858344|NCT01217957|529652734|FG000|Phase 1|Withdrawal by Patient|1|||
146858345|NCT01217957|529652735|FG001|Phase 1|Withdrawal by Patient|0|||
146858346|NCT01217957|529652736|FG002|Phase 1|Withdrawal by Patient|1|||
146522762|NCT05464420|528421823|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
146858347|NCT01217957|529652737|FG003|Phase 1|Withdrawal by Patient|1|||
146858348|NCT01217957|529652738|FG004|Phase 1|Withdrawal by Patient|0|||
146858349|NCT01217957|529652734|FG000|Phase 2|Withdrawal by Patient|0|||
146858350|NCT01217957|529652735|FG001|Phase 2|Withdrawal by Patient|0|||
146858351|NCT01217957|529652736|FG002|Phase 2|Withdrawal by Patient|0|||
146858352|NCT01217957|529652737|FG003|Phase 2|Withdrawal by Patient|0|||
146858353|NCT01217957|529652738|FG004|Phase 2|Withdrawal by Patient|1|||
146522763|NCT01383018|528421824|FG000|Overall Study|Adverse Event|14|||
146858354|NCT00971932|529652739|FG000|Overall Study|Withdrawal by Subject|1|||
146858355|NCT00971932|529652739|FG000|Overall Study|Investigator's decision|2|||
146858356|NCT00971932|529652739|FG000|Overall Study|Ongoing|4|||
146858357|NCT00288509|529652744|FG000|Treatment Cycle 1|Adverse Event|1|||
146858358|NCT00288509|529652744|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
146858359|NCT00288509|529652744|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
146522764|NCT01383018|528421824|FG000|Overall Study|Death|10|||
146522765|NCT01383018|528421824|FG000|Overall Study|Lost to Follow-up|5|||
146522766|NCT01383018|528421824|FG000|Overall Study|Physician Decision|5|||
146522767|NCT01383018|528421824|FG000|Overall Study|Withdrawal by Subject|9|||
146522768|NCT01383018|528421824|FG000|Overall Study|Subject not implanted|76|||
146522769|NCT01383018|528421824|FG000|Overall Study|Missed Visit|247|||
146522770|NCT01383018|528421824|FG000|Overall Study|Site closed early-not compliance related|7|||
146522771|NCT01383018|528421824|FG000|Overall Study|Patient moved away from site|1|||
146522772|NCT01383018|528421824|FG000|Overall Study|Subject Incarcerated|1|||
146522773|NCT00320788|528421825|FG000|Overall Study|Adverse Event|0|||
146522774|NCT00320788|528421826|FG001|Overall Study|Adverse Event|0|||
146522775|NCT00320788|528421827|FG002|Overall Study|Adverse Event|0|||
146522776|NCT00320788|528421828|FG003|Overall Study|Adverse Event|1|||
146522777|NCT00320788|528421829|FG004|Overall Study|Adverse Event|0|||
146522778|NCT00320788|528421825|FG000|Overall Study|Death|0|||
146522779|NCT00320788|528421826|FG001|Overall Study|Death|0|||
146858360|NCT00288509|529652744|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
146858361|NCT00288509|529652744|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
146858362|NCT00288509|529652744|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
146858363|NCT00288509|529652744|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
146858364|NCT00288509|529652744|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
146858365|NCT00288509|529652744|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
146858366|NCT00288509|529652744|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
146858367|NCT00288509|529652744|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
146858368|NCT00288509|529652744|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
146858369|NCT00288509|529652744|FG000|Treatment Cycle 4|Physician Decision|4|||
146858370|NCT00288509|529652744|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
146858371|NCT02382016|529652745|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
146858372|NCT02382016|529652746|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
146858373|NCT02382016|529652745|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
146858374|NCT02382016|529652746|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
146858375|NCT02382016|529652745|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
146858376|NCT02382016|529652746|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
146858377|NCT02382016|529652745|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
146858378|NCT02382016|529652746|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
146858379|NCT02382016|529652745|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
146858380|NCT02382016|529652746|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
146858381|NCT02382016|529652745|FG000|Open-label (OL) Treatment Period|Death|4|||
146858382|NCT02382016|529652746|FG001|Open-label (OL) Treatment Period|Death|0|||
146858383|NCT02382016|529652745|FG000|OL Extension Period|Physician Decision|3|||
146858384|NCT02382016|529652746|FG001|OL Extension Period|Physician Decision|0|||
146858385|NCT02382016|529652745|FG000|OL Extension Period|Death|2|||
146858386|NCT02382016|529652746|FG001|OL Extension Period|Death|0|||
146858387|NCT02382016|529652745|FG000|OL Extension Period|Withdrawal by Subject|1|||
146858388|NCT02382016|529652746|FG001|OL Extension Period|Withdrawal by Subject|0|||
146858389|NCT00084266|529652747|FG000|Overall Study|Death|42|||
146858390|NCT00084266|529652748|FG001|Overall Study|Death|39|||
146858391|NCT00084266|529652747|FG000|Overall Study|Adverse Event|8|||
146858392|NCT00084266|529652748|FG001|Overall Study|Adverse Event|5|||
146858393|NCT00084266|529652747|FG000|Overall Study|Lack of Efficacy|2|||
146858394|NCT00084266|529652748|FG001|Overall Study|Lack of Efficacy|4|||
146858395|NCT00084266|529652747|FG000|Overall Study|Lost to Follow-up|5|||
146858396|NCT00084266|529652748|FG001|Overall Study|Lost to Follow-up|3|||
146858397|NCT00084266|529652747|FG000|Overall Study|Participant not willing to participate|3|||
146858398|NCT00084266|529652748|FG001|Overall Study|Participant not willing to participate|8|||
146858399|NCT00084266|529652747|FG000|Overall Study|Other|360|||
146858400|NCT00084266|529652748|FG001|Overall Study|Other|344|||
146858401|NCT00084266|529652747|FG000|Overall Study|Randomized not treated|21|||
146858402|NCT00084266|529652748|FG001|Overall Study|Randomized not treated|20|||
146858403|NCT05580588|529652753|FG000|Overall Study|Lack of Efficacy|12|||
146858404|NCT00712673|529652756|FG000|Overall Study|Adverse Event|3|||
146858405|NCT00712673|529652757|FG001|Overall Study|Adverse Event|3|||
146858406|NCT00712673|529652758|FG002|Overall Study|Adverse Event|21|||
146858407|NCT00712673|529652759|FG003|Overall Study|Adverse Event|26|||
146522780|NCT00320788|528421827|FG002|Overall Study|Death|1|||
146858408|NCT00712673|529652756|FG000|Overall Study|Lack of Efficacy|2|||
146858409|NCT00712673|529652757|FG001|Overall Study|Lack of Efficacy|8|||
146522781|NCT00320788|528421828|FG003|Overall Study|Death|0|||
146522782|NCT00320788|528421829|FG004|Overall Study|Death|1|||
146858410|NCT00712673|529652758|FG002|Overall Study|Lack of Efficacy|8|||
146858411|NCT00712673|529652759|FG003|Overall Study|Lack of Efficacy|6|||
146858412|NCT00712673|529652756|FG000|Overall Study|Poor Compliance to Protocol|3|||
146522783|NCT00320788|528421825|FG000|Overall Study|Lost to Follow-up|0|||
146522784|NCT00320788|528421826|FG001|Overall Study|Lost to Follow-up|2|||
146522785|NCT00320788|528421827|FG002|Overall Study|Lost to Follow-up|1|||
146759432|NCT00530335|529285538|FG000|Overall Study|Adverse Event|3|||
146759433|NCT00530335|529285538|FG000|Overall Study|Protocol Violation|1|||
146759434|NCT00530335|529285538|FG000|Overall Study|Withdrawal by Subject|1|||
146759435|NCT00530335|529285538|FG000|Overall Study|Physician Decision|1|||
146759436|NCT01244984|529285539|FG000|Overall Study|Adverse Event|2|||
146759437|NCT01244984|529285540|FG001|Overall Study|Adverse Event|11|||
146759438|NCT01244984|529285541|FG002|Overall Study|Adverse Event|2|||
146759439|NCT01244984|529285539|FG000|Overall Study|Protocol Violation|1|||
146759440|NCT01244984|529285540|FG001|Overall Study|Protocol Violation|0|||
146759441|NCT01244984|529285541|FG002|Overall Study|Protocol Violation|0|||
146759442|NCT01244984|529285539|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
146759443|NCT01244984|529285540|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
146759444|NCT01244984|529285541|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
146759445|NCT01244984|529285539|FG000|Overall Study|Withdrawal by Subject|1|||
146759446|NCT01244984|529285540|FG001|Overall Study|Withdrawal by Subject|2|||
146759447|NCT01244984|529285541|FG002|Overall Study|Withdrawal by Subject|2|||
146759448|NCT01360840|529285542|FG000|Overall Study|Ongoing at data cut-off|10|||
146759449|NCT01360840|529285543|FG001|Overall Study|Ongoing at data cut-off|10|||
146759450|NCT01360840|529285544|FG002|Overall Study|Ongoing at data cut-off|9|||
146759451|NCT01928940|529285545|FG000|Overall Study|Adverse Event|0|||
146759452|NCT01928940|529285546|FG001|Overall Study|Adverse Event|1|||
146759453|NCT02954055|529285547|FG000|Overall Study|Did not initiate therapy|6|||
146759454|NCT02954055|529285548|FG001|Overall Study|Did not initiate therapy|1|||
146759455|NCT01352507|529285549|FG000|Treatment Period 1|Adverse Event|3|||
146759456|NCT01352507|529285550|FG001|Treatment Period 1|Adverse Event|0|||
146759457|NCT01352507|529285549|FG000|Treatment Period 1|Lost to Follow-up|3|||
146759458|NCT01352507|529285550|FG001|Treatment Period 1|Lost to Follow-up|4|||
146759459|NCT01352507|529285549|FG000|Treatment Period 1|Withdrawal by Subject|7|||
146759460|NCT01352507|529285550|FG001|Treatment Period 1|Withdrawal by Subject|5|||
146759461|NCT01352507|529285549|FG000|Treatment Period 1|Physician Decision|1|||
146759462|NCT01352507|529285550|FG001|Treatment Period 1|Physician Decision|0|||
146759463|NCT01352507|529285549|FG000|Washout Period|Withdrawal by Subject|0|||
146759464|NCT01352507|529285550|FG001|Washout Period|Withdrawal by Subject|1|||
146759465|NCT01352507|529285549|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
146759466|NCT01352507|529285550|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
146759467|NCT01352507|529285549|FG000|Treatment Period 2|Withdrawal by Subject|4|||
146759468|NCT01352507|529285550|FG001|Treatment Period 2|Withdrawal by Subject|3|||
146759469|NCT01352507|529285549|FG000|Treatment Period 2|Lack of Efficacy|1|||
146759470|NCT01352507|529285550|FG001|Treatment Period 2|Lack of Efficacy|0|||
146759471|NCT02282527|529285554|FG000|Overall Study|Lost to Follow-up|0|||
146759472|NCT02282527|529285555|FG001|Overall Study|Lost to Follow-up|1|||
146759473|NCT02282527|529285554|FG000|Overall Study|Lack of home health aid|1|||
146759474|NCT02282527|529285555|FG001|Overall Study|Lack of home health aid|0|||
146759475|NCT01872611|529285556|FG000|Overall Study|Adverse Event|3|||
146759476|NCT01872611|529285557|FG001|Overall Study|Adverse Event|1|||
146759477|NCT01872611|529285556|FG000|Overall Study|Adverse Event, prior to treatment|0|||
146759478|NCT01872611|529285557|FG001|Overall Study|Adverse Event, prior to treatment|1|||
146759479|NCT01872611|529285556|FG000|Overall Study|Death|0|||
146759480|NCT01872611|529285557|FG001|Overall Study|Death|1|||
146759481|NCT01872611|529285556|FG000|Overall Study|Death, prior to treatment|0|||
146759482|NCT01872611|529285557|FG001|Overall Study|Death, prior to treatment|1|||
146759483|NCT01872611|529285556|FG000|Overall Study|Lost to Follow-up|8|||
146759484|NCT01872611|529285557|FG001|Overall Study|Lost to Follow-up|1|||
146759485|NCT01872611|529285556|FG000|Overall Study|Physician Decision|1|||
146759486|NCT01872611|529285557|FG001|Overall Study|Physician Decision|0|||
146759487|NCT01872611|529285556|FG000|Overall Study|Withdrawal by Subject|6|||
146759488|NCT01872611|529285557|FG001|Overall Study|Withdrawal by Subject|1|||
146759489|NCT01872611|529285556|FG000|Overall Study|Reason not provided|6|||
146759490|NCT01872611|529285557|FG001|Overall Study|Reason not provided|6|||
146759491|NCT03537651|529285558|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
146759492|NCT03537651|529285558|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
146759493|NCT03537651|529285558|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
146759494|NCT03537651|529285558|FG000|Part A (Up to 96 Weeks)|Other|1|||
146759495|NCT03537651|529285558|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
146759496|NCT03537651|529285558|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
146759497|NCT03537651|529285558|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
146759498|NCT03537651|529285558|FG000|Part B (Up to 192 Weeks)|Other|1|||
146759499|NCT02487446|529285572|FG000|Period 1|Physician Decision|0|||
146759500|NCT02487446|529285573|FG001|Period 1|Physician Decision|1|||
146759501|NCT02487446|529285572|FG000|Period 1|Lack of Efficacy|1|||
146759502|NCT02487446|529285573|FG001|Period 1|Lack of Efficacy|0|||
146759503|NCT02487446|529285572|FG000|Period 1|Protocol deviation|3|||
146759504|NCT02487446|529285573|FG001|Period 1|Protocol deviation|2|||
146759505|NCT02487446|529285572|FG000|Period 1|Lost to Follow-up|2|||
146759506|NCT02487446|529285573|FG001|Period 1|Lost to Follow-up|0|||
146759507|NCT02487446|529285572|FG000|Period 1|Withdrawal by Subject|2|||
146759508|NCT02487446|529285573|FG001|Period 1|Withdrawal by Subject|0|||
146522786|NCT00320788|528421828|FG003|Overall Study|Lost to Follow-up|0|||
146522787|NCT00320788|528421829|FG004|Overall Study|Lost to Follow-up|0|||
146522788|NCT00320788|528421825|FG000|Overall Study|Decision by the Sponsor|1|||
146522789|NCT00320788|528421826|FG001|Overall Study|Decision by the Sponsor|1|||
146522790|NCT00320788|528421827|FG002|Overall Study|Decision by the Sponsor|0|||
146522791|NCT00320788|528421828|FG003|Overall Study|Decision by the Sponsor|0|||
146522792|NCT00320788|528421829|FG004|Overall Study|Decision by the Sponsor|1|||
146522793|NCT00320788|528421825|FG000|Overall Study|Other|1|||
146522794|NCT00320788|528421826|FG001|Overall Study|Other|2|||
146522795|NCT00320788|528421827|FG002|Overall Study|Other|1|||
146522796|NCT00320788|528421828|FG003|Overall Study|Other|1|||
146522797|NCT00320788|528421829|FG004|Overall Study|Other|1|||
146522798|NCT00320788|528421825|FG000|Overall Study|Physician Decision|1|||
146522799|NCT00320788|528421826|FG001|Overall Study|Physician Decision|1|||
146522800|NCT00320788|528421827|FG002|Overall Study|Physician Decision|0|||
146522801|NCT00320788|528421828|FG003|Overall Study|Physician Decision|0|||
146522802|NCT00320788|528421829|FG004|Overall Study|Physician Decision|0|||
146522803|NCT00320788|528421825|FG000|Overall Study|Protocol Violation|0|||
146522804|NCT00320788|528421826|FG001|Overall Study|Protocol Violation|0|||
146522805|NCT00320788|528421827|FG002|Overall Study|Protocol Violation|0|||
146522806|NCT00320788|528421828|FG003|Overall Study|Protocol Violation|0|||
146522807|NCT00320788|528421829|FG004|Overall Study|Protocol Violation|1|||
146522808|NCT00320788|528421825|FG000|Overall Study|Withdrawal by Subject|3|||
146522809|NCT00320788|528421826|FG001|Overall Study|Withdrawal by Subject|0|||
146522810|NCT00320788|528421827|FG002|Overall Study|Withdrawal by Subject|0|||
146522811|NCT00320788|528421828|FG003|Overall Study|Withdrawal by Subject|3|||
146522812|NCT00320788|528421829|FG004|Overall Study|Withdrawal by Subject|1|||
146522813|NCT03414229|528421831|FG000|Overall Study|Adverse Event|1|||
146522814|NCT03414229|528421832|FG001|Overall Study|Adverse Event|0|||
146522815|NCT03414229|528421833|FG002|Overall Study|Adverse Event|2|||
146522816|NCT03414229|528421834|FG003|Overall Study|Adverse Event|1|||
146522817|NCT03414229|528421831|FG000|Overall Study|Lack of Efficacy|7|||
146522818|NCT03414229|528421832|FG001|Overall Study|Lack of Efficacy|4|||
146522819|NCT03414229|528421833|FG002|Overall Study|Lack of Efficacy|1|||
146522820|NCT03414229|528421834|FG003|Overall Study|Lack of Efficacy|9|||
146522821|NCT03414229|528421831|FG000|Overall Study|Change in therapy|1|||
146522822|NCT03414229|528421832|FG001|Overall Study|Change in therapy|0|||
146522823|NCT03414229|528421833|FG002|Overall Study|Change in therapy|0|||
146522824|NCT03414229|528421834|FG003|Overall Study|Change in therapy|0|||
146522825|NCT03414229|528421831|FG000|Overall Study|Pregnancy|0|||
146759509|NCT02487446|529285572|FG000|Period 1|Adverse Event|5|||
146759510|NCT02487446|529285573|FG001|Period 1|Adverse Event|5|||
146759511|NCT02487446|529285572|FG000|Washout|Lost to Follow-up|0|||
146759512|NCT02487446|529285573|FG001|Washout|Lost to Follow-up|2|||
146759513|NCT02487446|529285572|FG000|Washout|Withdrawal by Subject|1|||
146759514|NCT02487446|529285573|FG001|Washout|Withdrawal by Subject|4|||
146759515|NCT02487446|529285572|FG000|Washout|Adverse Event|2|||
146759516|NCT02487446|529285573|FG001|Washout|Adverse Event|2|||
146759517|NCT02487446|529285572|FG000|Period 2|Protocol deviation|0|||
146759518|NCT02487446|529285573|FG001|Period 2|Protocol deviation|1|||
146759519|NCT02487446|529285572|FG000|Period 2|Lost to Follow-up|1|||
146759520|NCT02487446|529285573|FG001|Period 2|Lost to Follow-up|1|||
146759521|NCT02487446|529285572|FG000|Period 2|Withdrawal by Subject|1|||
146759522|NCT02487446|529285573|FG001|Period 2|Withdrawal by Subject|1|||
146759523|NCT02487446|529285572|FG000|Period 2|Adverse Event|6|||
146759524|NCT02487446|529285573|FG001|Period 2|Adverse Event|2|||
146759525|NCT01822821|529285574|FG000|Overall Study|Eligible surgery cancelled|1|||
146759526|NCT01822821|529285575|FG001|Overall Study|Eligible surgery cancelled|1|||
146759527|NCT01822821|529285574|FG000|Overall Study|Other reasons|1|||
146759528|NCT01822821|529285575|FG001|Overall Study|Other reasons|0|||
146759529|NCT02320253|529285576|FG000|Overall Study|Withdrawal by Subject|3|||
146759530|NCT02320253|529285577|FG001|Overall Study|Withdrawal by Subject|0|||
146759531|NCT02320253|529285578|FG002|Overall Study|Withdrawal by Subject|0|||
146858413|NCT00712673|529652757|FG001|Overall Study|Poor Compliance to Protocol|3|||
146522826|NCT03414229|528421832|FG001|Overall Study|Pregnancy|0|||
146522827|NCT03414229|528421833|FG002|Overall Study|Pregnancy|1|||
146522828|NCT03414229|528421834|FG003|Overall Study|Pregnancy|0|||
146759532|NCT02320253|529285576|FG000|Overall Study|Lost to Follow-up|2|||
146522829|NCT03414229|528421831|FG000|Overall Study|Withdrawal by Subject|0|||
146522830|NCT03414229|528421832|FG001|Overall Study|Withdrawal by Subject|1|||
146522831|NCT03414229|528421833|FG002|Overall Study|Withdrawal by Subject|1|||
146522832|NCT03414229|528421834|FG003|Overall Study|Withdrawal by Subject|0|||
146522833|NCT05568797|528421841|FG000|Overall Study|Adverse Event|0|||
146522834|NCT05568797|528421842|FG001|Overall Study|Adverse Event|8|||
146522835|NCT05568797|528421841|FG000|Overall Study|Lost to Follow-up|2|||
146522836|NCT05568797|528421842|FG001|Overall Study|Lost to Follow-up|3|||
146759533|NCT02320253|529285577|FG001|Overall Study|Lost to Follow-up|2|||
146759534|NCT02320253|529285578|FG002|Overall Study|Lost to Follow-up|1|||
146522837|NCT05568797|528421841|FG000|Overall Study|Withdrawal by Subject|1|||
146759535|NCT02320253|529285576|FG000|Overall Study|Death|1|||
146759536|NCT02320253|529285577|FG001|Overall Study|Death|0|||
146522838|NCT05568797|528421842|FG001|Overall Study|Withdrawal by Subject|10|||
146522839|NCT05568797|528421841|FG000|Overall Study|Other|2|||
146522840|NCT05568797|528421842|FG001|Overall Study|Other|2|||
146522841|NCT00099632|528421845|FG000|Overall Study|Lost to Follow-up|1|||
146522842|NCT00099632|528421846|FG001|Overall Study|Lost to Follow-up|0|||
146522843|NCT00099632|528421847|FG002|Overall Study|Lost to Follow-up|3|||
146522844|NCT00099632|528421848|FG003|Overall Study|Lost to Follow-up|1|||
146522845|NCT00099632|528421849|FG004|Overall Study|Lost to Follow-up|1|||
146522846|NCT00099632|528421850|FG005|Overall Study|Lost to Follow-up|0|||
146522847|NCT00099632|528421845|FG000|Overall Study|Withdrawal by Subject|0|||
146522848|NCT00099632|528421846|FG001|Overall Study|Withdrawal by Subject|1|||
146522849|NCT00099632|528421847|FG002|Overall Study|Withdrawal by Subject|0|||
146522850|NCT00099632|528421848|FG003|Overall Study|Withdrawal by Subject|0|||
146522851|NCT00099632|528421849|FG004|Overall Study|Withdrawal by Subject|0|||
146522852|NCT00099632|528421850|FG005|Overall Study|Withdrawal by Subject|1|||
146522853|NCT00099632|528421845|FG000|Overall Study|Protocol Violation|0|||
146522854|NCT00099632|528421846|FG001|Overall Study|Protocol Violation|0|||
146759537|NCT02320253|529285578|FG002|Overall Study|Death|1|||
146759538|NCT05750745|529285579|FG000|Overall Study|Adverse Event|1|||
146759539|NCT05750745|529285580|FG001|Overall Study|Adverse Event|0|||
146759540|NCT05750745|529285581|FG002|Overall Study|Adverse Event|0|||
146759541|NCT05750745|529285579|FG000|Overall Study|Protocol Violation|1|||
146759542|NCT05750745|529285580|FG001|Overall Study|Protocol Violation|0|||
146759543|NCT05750745|529285581|FG002|Overall Study|Protocol Violation|0|||
146759544|NCT05750745|529285579|FG000|Overall Study|Withdrawal by Subject|0|||
146759545|NCT05750745|529285580|FG001|Overall Study|Withdrawal by Subject|1|||
146759546|NCT05750745|529285581|FG002|Overall Study|Withdrawal by Subject|0|||
146759547|NCT05780047|529285583|FG000|Overall Study|Did not submit baseline urine test kit|226|||
146759548|NCT05780047|529285583|FG000|Overall Study|Lost to Follow-up|34|||
146759549|NCT05780047|529285583|FG000|Overall Study|Did not submit second urine test kit|124|||
146759550|NCT02698436|529285586|FG000|Overall Study|Adverse Event|1|||
146759551|NCT02698436|529285587|FG001|Overall Study|Adverse Event|0|||
146759552|NCT02698436|529285586|FG000|Overall Study|Withdrawal by Subject|3|||
146759553|NCT02698436|529285587|FG001|Overall Study|Withdrawal by Subject|3|||
146759554|NCT02698436|529285586|FG000|Overall Study|Lost to Follow-up|2|||
146759555|NCT02698436|529285587|FG001|Overall Study|Lost to Follow-up|4|||
146759556|NCT02698436|529285586|FG000|Overall Study|Non-compliance with study regimen|1|||
146759557|NCT02698436|529285587|FG001|Overall Study|Non-compliance with study regimen|0|||
146759558|NCT04949399|529285595|FG000|Overall Study|Lost to Follow-up|11|||
146759559|NCT04949399|529285596|FG001|Overall Study|Lost to Follow-up|6|||
146759560|NCT04949399|529285595|FG000|Overall Study|Withdrawal by Subject|2|||
146759561|NCT04949399|529285596|FG001|Overall Study|Withdrawal by Subject|3|||
146759562|NCT00670540|529285597|FG000|Overall Study|ineligible|17|||
146759563|NCT00670540|529285597|FG000|Overall Study|not living in France|348|||
146759564|NCT00670540|529285597|FG000|Overall Study|refused to participate|189|||
146759565|NCT00670540|529285597|FG000|Overall Study|controls randomised for no follow up|2770|||
146759566|NCT00670540|529285597|FG000|Overall Study|missing information inclusion criteria|1|||
146759567|NCT01866917|529285604|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
146759568|NCT01866917|529285605|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
146759569|NCT01140347|529285606|FG000|Overall Study|Lost to Follow-up|5|||
146759570|NCT01140347|529285607|FG001|Overall Study|Lost to Follow-up|6|||
146759571|NCT01140347|529285606|FG000|Overall Study|Withdrawal by Subject|13|||
146759572|NCT01140347|529285607|FG001|Overall Study|Withdrawal by Subject|8|||
146759573|NCT00901485|529285608|FG000|Overall Study|Lack of Efficacy|0|||
146759574|NCT00901485|529285609|FG001|Overall Study|Lack of Efficacy|2|||
146759575|NCT00901485|529285608|FG000|Overall Study|Withdrawal by Subject|1|||
146759576|NCT00901485|529285609|FG001|Overall Study|Withdrawal by Subject|2|||
146759577|NCT01959880|529285610|FG000|Overall Study|Withdrawal by Subject|11|||
146759578|NCT01959880|529285611|FG001|Overall Study|Withdrawal by Subject|13|||
146759579|NCT01959880|529285612|FG002|Overall Study|Withdrawal by Subject|8|||
146759580|NCT01959880|529285613|FG003|Overall Study|Withdrawal by Subject|7|||
146759581|NCT01959880|529285610|FG000|Overall Study|Death|1|||
146759582|NCT01959880|529285611|FG001|Overall Study|Death|10|||
146759583|NCT01959880|529285612|FG002|Overall Study|Death|1|||
146759584|NCT01959880|529285613|FG003|Overall Study|Death|2|||
146759585|NCT01959880|529285610|FG000|Overall Study|Lost to Follow-up|95|||
146759586|NCT01959880|529285611|FG001|Overall Study|Lost to Follow-up|18|||
146759587|NCT01959880|529285612|FG002|Overall Study|Lost to Follow-up|15|||
146759588|NCT01959880|529285613|FG003|Overall Study|Lost to Follow-up|8|||
146522855|NCT00099632|528421847|FG002|Overall Study|Protocol Violation|0|||
146522856|NCT00099632|528421848|FG003|Overall Study|Protocol Violation|0|||
146522857|NCT00099632|528421849|FG004|Overall Study|Protocol Violation|0|||
146759589|NCT01959880|529285610|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
146759590|NCT01959880|529285611|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
146759591|NCT01959880|529285612|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
146759592|NCT01959880|529285613|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
146759593|NCT01959880|529285610|FG000|Overall Study|Study completed early-FDA approved|1003|||
146858414|NCT00712673|529652758|FG002|Overall Study|Poor Compliance to Protocol|4|||
146858415|NCT00712673|529652759|FG003|Overall Study|Poor Compliance to Protocol|16|||
146858416|NCT00712673|529652756|FG000|Overall Study|Lost to Follow-up|1|||
146858417|NCT00712673|529652757|FG001|Overall Study|Lost to Follow-up|0|||
146858418|NCT00712673|529652758|FG002|Overall Study|Lost to Follow-up|2|||
146858419|NCT00712673|529652759|FG003|Overall Study|Lost to Follow-up|0|||
146858420|NCT00712673|529652756|FG000|Overall Study|Withdrawal by Subject|6|||
146858421|NCT00712673|529652757|FG001|Overall Study|Withdrawal by Subject|7|||
146858422|NCT00712673|529652758|FG002|Overall Study|Withdrawal by Subject|15|||
146858423|NCT00712673|529652759|FG003|Overall Study|Withdrawal by Subject|20|||
146858424|NCT00712673|529652756|FG000|Overall Study|Familial and Personal Reasons|5|||
146858425|NCT00712673|529652757|FG001|Overall Study|Familial and Personal Reasons|0|||
146858426|NCT00712673|529652758|FG002|Overall Study|Familial and Personal Reasons|5|||
146858427|NCT00712673|529652759|FG003|Overall Study|Familial and Personal Reasons|2|||
146858428|NCT00712673|529652756|FG000|Overall Study|Investigator's Decision|1|||
146858429|NCT00712673|529652757|FG001|Overall Study|Investigator's Decision|0|||
146858430|NCT00712673|529652758|FG002|Overall Study|Investigator's Decision|0|||
146858431|NCT00712673|529652759|FG003|Overall Study|Investigator's Decision|0|||
146858432|NCT00712673|529652756|FG000|Overall Study|Protocol Violation|0|||
146858433|NCT00712673|529652757|FG001|Overall Study|Protocol Violation|0|||
146858434|NCT00712673|529652758|FG002|Overall Study|Protocol Violation|2|||
146858435|NCT00712673|529652759|FG003|Overall Study|Protocol Violation|0|||
146858436|NCT03603028|529652760|FG000|Overall Study|Withdrawal by Subject|1|||
146858437|NCT02963610|529652761|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
146858438|NCT00063154|529652762|FG000|Overall Study|Disease progression|27|||
146858439|NCT00063154|529652762|FG000|Overall Study|Adverse Event|2|||
146858440|NCT00063154|529652762|FG000|Overall Study|Physician Decision|10|||
146858441|NCT00063154|529652762|FG000|Overall Study|Death|3|||
146858442|NCT00063154|529652762|FG000|Overall Study|Reason unspecified|1|||
146858443|NCT00063154|529652762|FG000|Overall Study|Did not receive treatment|8|||
146858444|NCT01122862|529652763|FG000|Period 1|Protocol Violation|0|||
146858445|NCT01122862|529652764|FG001|Period 1|Protocol Violation|1|||
146858446|NCT01122862|529652765|FG002|Period 1|Protocol Violation|0|||
146858447|NCT01122862|529652763|FG000|Period 2|Adverse Event|0|||
146858448|NCT01122862|529652764|FG001|Period 2|Adverse Event|0|||
146858449|NCT01122862|529652765|FG002|Period 2|Adverse Event|1|||
146858450|NCT00846391|529652767|FG000|Overall Study|Physician Decision|0|||
146858451|NCT00846391|529652768|FG001|Overall Study|Physician Decision|0|||
146858452|NCT00846391|529652769|FG002|Overall Study|Physician Decision|1|||
146858453|NCT00846391|529652767|FG000|Overall Study|Study Terminated by Sponsor|1|||
146858454|NCT00846391|529652768|FG001|Overall Study|Study Terminated by Sponsor|2|||
146858455|NCT00846391|529652769|FG002|Overall Study|Study Terminated by Sponsor|2|||
146858456|NCT02924064|529652770|FG000|Overall Study|Adverse Event|2|||
146858457|NCT02924064|529652771|FG001|Overall Study|Adverse Event|2|||
146858458|NCT02924064|529652770|FG000|Overall Study|Lost to Follow-up|0|||
146858459|NCT02924064|529652771|FG001|Overall Study|Lost to Follow-up|2|||
146858460|NCT02924064|529652770|FG000|Overall Study|Physician Decision|0|||
146858461|NCT02924064|529652771|FG001|Overall Study|Physician Decision|2|||
146858462|NCT02924064|529652770|FG000|Overall Study|Protocol Violation|1|||
146858463|NCT02924064|529652771|FG001|Overall Study|Protocol Violation|3|||
146858464|NCT02924064|529652770|FG000|Overall Study|Withdrawal by Subject|4|||
146858465|NCT02924064|529652771|FG001|Overall Study|Withdrawal by Subject|5|||
146858466|NCT02924064|529652770|FG000|Overall Study|Other|17|||
146858467|NCT02924064|529652771|FG001|Overall Study|Other|29|||
146858468|NCT02699983|529652772|FG000|Overall Study|Withdrawal by Subject|1|||
146858469|NCT02699983|529652773|FG001|Overall Study|Withdrawal by Subject|0|||
146858470|NCT03575143|529652774|FG000|Overall Study|Lost to Follow-up|0|||
146858471|NCT03575143|529652775|FG001|Overall Study|Lost to Follow-up|0|||
146858472|NCT03575143|529652776|FG002|Overall Study|Lost to Follow-up|4|||
146858473|NCT03575143|529652774|FG000|Overall Study|Withdrawal by Subject|0|||
146858474|NCT03575143|529652775|FG001|Overall Study|Withdrawal by Subject|0|||
146858475|NCT03575143|529652776|FG002|Overall Study|Withdrawal by Subject|5|||
146858476|NCT03575143|529652774|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
146858477|NCT03575143|529652775|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
146858478|NCT03575143|529652776|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
146522858|NCT00099632|528421850|FG005|Overall Study|Protocol Violation|1|||
146522859|NCT02137226|528421873|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
146858479|NCT01790126|529652784|FG000|Overall Study|PSA Progression|12|||
146858480|NCT01790126|529652785|FG001|Overall Study|PSA Progression|16|||
146858481|NCT01790126|529652786|FG002|Overall Study|PSA Progression|16|||
146522860|NCT02137226|528421874|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
146858482|NCT01790126|529652784|FG000|Overall Study|Other|5|||
146858483|NCT01790126|529652785|FG001|Overall Study|Other|4|||
146858484|NCT01790126|529652786|FG002|Overall Study|Other|8|||
146858485|NCT01790126|529652784|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
146858486|NCT01790126|529652785|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
146858487|NCT01790126|529652786|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
146858488|NCT01790126|529652784|FG000|Overall Study|Withdrawal by Physician|1|||
146858489|NCT01790126|529652785|FG001|Overall Study|Withdrawal by Physician|1|||
146858490|NCT01790126|529652786|FG002|Overall Study|Withdrawal by Physician|2|||
146858491|NCT01790126|529652784|FG000|Overall Study|Withdrawal by Subject|3|||
146858492|NCT01790126|529652785|FG001|Overall Study|Withdrawal by Subject|1|||
146858493|NCT01790126|529652786|FG002|Overall Study|Withdrawal by Subject|2|||
146858494|NCT01790126|529652784|FG000|Overall Study|Lost to Follow-up|1|||
146858495|NCT01790126|529652785|FG001|Overall Study|Lost to Follow-up|0|||
146858496|NCT01790126|529652786|FG002|Overall Study|Lost to Follow-up|1|||
146858497|NCT01790126|529652784|FG000|Overall Study|Adverse Event|0|||
146858498|NCT01790126|529652785|FG001|Overall Study|Adverse Event|2|||
146858499|NCT01790126|529652786|FG002|Overall Study|Adverse Event|0|||
146858500|NCT01790126|529652784|FG000|Overall Study|Death|2|||
146858501|NCT01790126|529652785|FG001|Overall Study|Death|0|||
146858502|NCT01790126|529652786|FG002|Overall Study|Death|0|||
146858503|NCT01790126|529652784|FG000|Overall Study|Radiographic Progression|3|||
146858504|NCT01790126|529652785|FG001|Overall Study|Radiographic Progression|1|||
146858505|NCT01790126|529652786|FG002|Overall Study|Radiographic Progression|0|||
146858506|NCT02434939|529652794|FG000|Overall Study|Lack of Efficacy|34|||
146858507|NCT02434939|529652795|FG001|Overall Study|Lack of Efficacy|48|||
146858508|NCT02434939|529652794|FG000|Overall Study|Withdrawal by Subject|3|||
146858509|NCT02434939|529652795|FG001|Overall Study|Withdrawal by Subject|0|||
146858510|NCT02434939|529652794|FG000|Overall Study|Adverse Event|0|||
146858511|NCT02434939|529652795|FG001|Overall Study|Adverse Event|1|||
146858512|NCT06338462|529652796|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
146858513|NCT00069238|529652800|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
146858514|NCT00069238|529652801|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
146858515|NCT00069238|529652802|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
146858516|NCT00069238|529652800|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
146858517|NCT00069238|529652801|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
146858518|NCT00069238|529652802|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
146858519|NCT00069238|529652800|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
146858520|NCT00069238|529652801|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
146858521|NCT00069238|529652802|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
146858522|NCT01668667|529652808|FG000|Overall Study|Adverse Event|3|||
146858523|NCT01668667|529652809|FG001|Overall Study|Adverse Event|6|||
146858524|NCT01668667|529652810|FG002|Overall Study|Adverse Event|4|||
146858525|NCT01668667|529652811|FG003|Overall Study|Adverse Event|4|||
146858526|NCT01668667|529652808|FG000|Overall Study|Lack of Efficacy|3|||
146858527|NCT01668667|529652809|FG001|Overall Study|Lack of Efficacy|2|||
146858528|NCT01668667|529652810|FG002|Overall Study|Lack of Efficacy|2|||
146858529|NCT01668667|529652811|FG003|Overall Study|Lack of Efficacy|3|||
146858530|NCT01668667|529652808|FG000|Overall Study|Protocol Violation|6|||
146858531|NCT01668667|529652809|FG001|Overall Study|Protocol Violation|10|||
146858532|NCT01668667|529652810|FG002|Overall Study|Protocol Violation|12|||
146858533|NCT01668667|529652811|FG003|Overall Study|Protocol Violation|5|||
146858534|NCT01668667|529652808|FG000|Overall Study|Lost to Follow-up|9|||
146858535|NCT01668667|529652809|FG001|Overall Study|Lost to Follow-up|4|||
146858536|NCT01668667|529652810|FG002|Overall Study|Lost to Follow-up|7|||
146858537|NCT01668667|529652811|FG003|Overall Study|Lost to Follow-up|6|||
146858538|NCT01668667|529652808|FG000|Overall Study|Physician Decision|3|||
146858539|NCT01668667|529652809|FG001|Overall Study|Physician Decision|0|||
146858540|NCT01668667|529652810|FG002|Overall Study|Physician Decision|1|||
146858541|NCT01668667|529652811|FG003|Overall Study|Physician Decision|0|||
146858542|NCT01668667|529652808|FG000|Overall Study|Withdrawal by Subject|7|||
146858543|NCT01668667|529652809|FG001|Overall Study|Withdrawal by Subject|4|||
146858544|NCT01668667|529652810|FG002|Overall Study|Withdrawal by Subject|5|||
146858545|NCT01668667|529652811|FG003|Overall Study|Withdrawal by Subject|5|||
146858546|NCT00511901|529652813|FG000|Overall Study|Withdrawal by Subject|1|||
146858547|NCT00511901|529652814|FG001|Overall Study|Withdrawal by Subject|3|||
146858548|NCT04640077|529652818|FG000|Period 1|Withdrawal by Subject|4|||
146858549|NCT04640077|529652819|FG001|Period 1|Withdrawal by Subject|5|||
146858550|NCT04640077|529652820|FG002|Period 1|Withdrawal by Subject|0|||
146858551|NCT04640077|529652818|FG000|Period 1|Adverse Event|1|||
146858552|NCT04640077|529652819|FG001|Period 1|Adverse Event|1|||
146858553|NCT04640077|529652820|FG002|Period 1|Adverse Event|0|||
146858554|NCT04640077|529652818|FG000|Period 1|Screen Failure|2|||
146858555|NCT04640077|529652819|FG001|Period 1|Screen Failure|0|||
146858556|NCT04640077|529652820|FG002|Period 1|Screen Failure|0|||
146858557|NCT04640077|529652818|FG000|Period 2|Withdrawal by Subject|0|||
146858558|NCT04640077|529652819|FG001|Period 2|Withdrawal by Subject|0|||
146858559|NCT04640077|529652820|FG002|Period 2|Withdrawal by Subject|18|||
146858560|NCT04640077|529652818|FG000|Period 2|Adverse Event|0|||
146858561|NCT04640077|529652819|FG001|Period 2|Adverse Event|0|||
146858562|NCT04640077|529652820|FG002|Period 2|Adverse Event|6|||
146522861|NCT02137226|528421875|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
146522862|NCT02137226|528421876|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
146522863|NCT02137226|528421877|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
146522864|NCT02137226|528421873|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
146522865|NCT02137226|528421874|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
146522866|NCT02137226|528421875|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
146522867|NCT02137226|528421876|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
146522868|NCT02137226|528421877|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
146522869|NCT02137226|528421873|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
146522870|NCT02137226|528421874|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
146522871|NCT02137226|528421875|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
146522872|NCT02137226|528421876|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
146522873|NCT02137226|528421877|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
146522874|NCT02137226|528421873|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
146522875|NCT02137226|528421874|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
146522876|NCT02137226|528421875|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
146522877|NCT02137226|528421876|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
146522878|NCT02137226|528421877|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
146522879|NCT02137226|528421873|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
146522880|NCT02137226|528421874|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
146522881|NCT02137226|528421875|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
146522882|NCT02137226|528421876|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
146522883|NCT02137226|528421877|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
146759594|NCT01959880|529285611|FG001|Overall Study|Study completed early-FDA approved|311|||
146759595|NCT01959880|529285612|FG002|Overall Study|Study completed early-FDA approved|179|||
146759596|NCT01959880|529285613|FG003|Overall Study|Study completed early-FDA approved|152|||
146759597|NCT01919619|529285614|FG000|Overall Study|Physician Decision|1|||
146759598|NCT01919619|529285615|FG001|Overall Study|Physician Decision|1|||
146759599|NCT01306331|529286835|FG000|Overall Study|Adverse Event|28|||
146759600|NCT01306331|529286836|FG001|Overall Study|Adverse Event|25|||
146759601|NCT01306331|529286835|FG000|Overall Study|Lost to Follow-up|321|||
146759602|NCT01306331|529286836|FG001|Overall Study|Lost to Follow-up|323|||
146759603|NCT01306331|529286835|FG000|Overall Study|Physician Decision|26|||
146759604|NCT01306331|529286836|FG001|Overall Study|Physician Decision|22|||
146759605|NCT01306331|529286835|FG000|Overall Study|Pregnancy|136|||
146759606|NCT01306331|529286836|FG001|Overall Study|Pregnancy|151|||
146759607|NCT01306331|529286835|FG000|Overall Study|Protocol Violation|154|||
146759608|NCT01306331|529286836|FG001|Overall Study|Protocol Violation|124|||
146759609|NCT01306331|529286835|FG000|Overall Study|Withdrawal by Subject|163|||
146759610|NCT01306331|529286836|FG001|Overall Study|Withdrawal by Subject|152|||
146759611|NCT01306331|529286835|FG000|Overall Study|Not sexually active|29|||
146759612|NCT01306331|529286836|FG001|Overall Study|Not sexually active|28|||
146759613|NCT01306331|529286835|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
146759614|NCT01306331|529286836|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
146759615|NCT01306331|529286835|FG000|Overall Study|Other|34|||
146759616|NCT01306331|529286836|FG001|Overall Study|Other|32|||
146759617|NCT00088465|529286844|FG000|Overall Study|Withdrawal by Subject|290|||
146759618|NCT00088465|529286844|FG000|Overall Study|Adverse Event|77|||
146759619|NCT00088465|529286844|FG000|Overall Study|Lost to Follow-up|57|||
146759620|NCT00088465|529286844|FG000|Overall Study|Physician Decision|45|||
146759621|NCT00088465|529286844|FG000|Overall Study|Sponsor Decision|37|||
146759622|NCT00088465|529286844|FG000|Overall Study|Lack of Efficacy|27|||
146759623|NCT00088465|529286844|FG000|Overall Study|Protocol Violation|17|||
146759624|NCT00088465|529286844|FG000|Overall Study|Death|11|||
146759625|NCT00448864|529286845|FG000|Overall Study|Death|1|||
146759626|NCT00448864|529286846|FG001|Overall Study|Death|0|||
146759627|NCT00448864|529286847|FG002|Overall Study|Death|0|||
146759628|NCT00448864|529286845|FG000|Overall Study|Lost to Follow-up|3|||
146759629|NCT00448864|529286846|FG001|Overall Study|Lost to Follow-up|1|||
146759630|NCT00448864|529286847|FG002|Overall Study|Lost to Follow-up|0|||
146759631|NCT00448864|529286845|FG000|Overall Study|Physician Decision|1|||
146759632|NCT00448864|529286846|FG001|Overall Study|Physician Decision|0|||
146759633|NCT00448864|529286847|FG002|Overall Study|Physician Decision|1|||
146759634|NCT00448864|529286845|FG000|Overall Study|Withdrawal by Subject|0|||
146759635|NCT00448864|529286846|FG001|Overall Study|Withdrawal by Subject|2|||
146759636|NCT00448864|529286847|FG002|Overall Study|Withdrawal by Subject|0|||
146759637|NCT00448864|529286845|FG000|Overall Study|Protocol Violation|0|||
146759638|NCT00448864|529286846|FG001|Overall Study|Protocol Violation|2|||
146759639|NCT00448864|529286847|FG002|Overall Study|Protocol Violation|0|||
146858563|NCT04640077|529652818|FG000|Period 2|Lost to Follow-up|0|||
146858564|NCT04640077|529652819|FG001|Period 2|Lost to Follow-up|0|||
146759640|NCT01390857|529286848|FG000|Overall Study|Protocol Violation|2|||
146759641|NCT01390857|529286848|FG000|Overall Study|Lost to Follow-up|1|||
146759642|NCT01390857|529286848|FG000|Overall Study|No Visit after the First Visit|7|||
146759643|NCT02757885|529286849|FG000|Overall Study|Screen Failures|4|||
146759644|NCT01474538|529286851|FG000|Treatment Period 1|Death|1|||
146759645|NCT01474538|529286852|FG001|Treatment Period 1|Death|0|||
146759646|NCT01474538|529286851|FG000|Treatment Period 1|Physician Decision|1|||
146759647|NCT01474538|529286852|FG001|Treatment Period 1|Physician Decision|0|||
146759648|NCT01474538|529286851|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146759649|NCT01474538|529286852|FG001|Treatment Period 1|Withdrawal by Subject|3|||
146759650|NCT01474538|529286851|FG000|Treatment Period 1|Protocol Violation|0|||
146759651|NCT01474538|529286852|FG001|Treatment Period 1|Protocol Violation|1|||
146759652|NCT01474538|529286851|FG000|Treatment Period 2|Death|1|||
146759653|NCT01474538|529286852|FG001|Treatment Period 2|Death|0|||
146759654|NCT01474538|529286851|FG000|Treatment Period 2|Adverse Event|1|||
146759655|NCT01474538|529286852|FG001|Treatment Period 2|Adverse Event|1|||
146759656|NCT01474538|529286851|FG000|Treatment Period 2|Withdrawal by Subject|2|||
146759657|NCT01474538|529286852|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146759658|NCT01474538|529286851|FG000|Treatment Period 2|Sponsor decision|1|||
146759659|NCT01474538|529286852|FG001|Treatment Period 2|Sponsor decision|0|||
146759660|NCT01474538|529286851|FG000|Treatment Period 2|Physician Decision|0|||
146759661|NCT01474538|529286852|FG001|Treatment Period 2|Physician Decision|1|||
146759662|NCT01474538|529286851|FG000|Treatment Period 2|Protocol Violation|1|||
146759663|NCT01474538|529286852|FG001|Treatment Period 2|Protocol Violation|0|||
146759664|NCT01456780|529286853|FG000|Overall Study|Lost to Follow-up|3|||
146759665|NCT01456780|529286854|FG001|Overall Study|Lost to Follow-up|3|||
146759666|NCT01456780|529286855|FG002|Overall Study|Lost to Follow-up|0|||
146759667|NCT02688621|529286856|FG000|Overall Study|Pregnancy|1|||
146759668|NCT02688621|529286857|FG001|Overall Study|Pregnancy|3|||
146759669|NCT02688621|529286856|FG000|Overall Study|Lost to Follow-up|38|||
146759670|NCT02688621|529286857|FG001|Overall Study|Lost to Follow-up|15|||
146759671|NCT02688621|529286856|FG000|Overall Study|Withdrawal by Subject|1|||
146759672|NCT02688621|529286857|FG001|Overall Study|Withdrawal by Subject|0|||
146759673|NCT04565249|529286862|FG000|Overall Study|Death|0|||
146759674|NCT04565249|529286863|FG001|Overall Study|Death|0|||
146759675|NCT04565249|529286864|FG002|Overall Study|Death|0|||
146759676|NCT04565249|529286865|FG003|Overall Study|Death|1|||
146759677|NCT00886613|529286870|FG000|Overall Study|Protocol deviation (Part B)|1|||
146759678|NCT00886613|529286871|FG001|Overall Study|Protocol deviation (Part B)|0|||
146759679|NCT00886613|529286872|FG002|Overall Study|Protocol deviation (Part B)|0|||
146759680|NCT00886613|529286870|FG000|Overall Study|Lost to follow-up (Part B)|1|||
146759681|NCT00886613|529286871|FG001|Overall Study|Lost to follow-up (Part B)|0|||
146759682|NCT00886613|529286872|FG002|Overall Study|Lost to follow-up (Part B)|1|||
146759683|NCT00886613|529286870|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
146759684|NCT00886613|529286871|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
146759685|NCT00886613|529286872|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
146759686|NCT04577183|529286876|FG000|Overall Study|Death|1|||
146759687|NCT04577183|529286876|FG000|Overall Study|Withdrawal by Subject|3|||
146759688|NCT04577183|529286876|FG000|Overall Study|Early termination|2|||
146759689|NCT02072226|529286877|FG000|Overall Study|Lost to Follow-up|11|||
146759690|NCT02072226|529286878|FG001|Overall Study|Lost to Follow-up|7|||
146759691|NCT02072226|529286877|FG000|Overall Study|Patient Non-compliance|2|||
146759692|NCT02072226|529286878|FG001|Overall Study|Patient Non-compliance|3|||
146759693|NCT02072226|529286877|FG000|Overall Study|Death|1|||
146759694|NCT02072226|529286878|FG001|Overall Study|Death|0|||
146759695|NCT02072226|529286877|FG000|Overall Study|Patient Withdrawal of Consent|1|||
146759696|NCT02072226|529286878|FG001|Overall Study|Patient Withdrawal of Consent|0|||
146759697|NCT03255018|529286881|FG000|Overall Study|Death on study|0|||
146759698|NCT03255018|529286882|FG001|Overall Study|Death on study|5|||
146759699|NCT03255018|529286881|FG000|Overall Study|Withdrawal by Subject|0|||
146759700|NCT03255018|529286882|FG001|Overall Study|Withdrawal by Subject|2|||
146759701|NCT02950545|529286889|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
146759702|NCT02950545|529286890|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
146759703|NCT02950545|529286891|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
146759704|NCT02950545|529286892|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
146759705|NCT02950545|529286893|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
146759706|NCT02950545|529286894|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
146759707|NCT02950545|529286889|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
146759708|NCT02950545|529286890|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
146759709|NCT02950545|529286891|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
146759710|NCT02950545|529286892|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
146759711|NCT02950545|529286893|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
146759712|NCT02950545|529286894|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
146759713|NCT02950545|529286889|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
146759714|NCT02950545|529286890|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
146759715|NCT02950545|529286891|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
146858565|NCT04640077|529652820|FG002|Period 2|Lost to Follow-up|2|||
146858566|NCT04640077|529652818|FG000|Period 2|Death|0|||
146858567|NCT04640077|529652819|FG001|Period 2|Death|0|||
146858568|NCT04640077|529652820|FG002|Period 2|Death|2|||
146858569|NCT04640077|529652818|FG000|Period 2|Progressive Disease|0|||
146858570|NCT04640077|529652819|FG001|Period 2|Progressive Disease|0|||
146858571|NCT04640077|529652820|FG002|Period 2|Progressive Disease|1|||
146858572|NCT04640077|529652818|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
146858573|NCT04640077|529652819|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
146858574|NCT04640077|529652820|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
146858575|NCT01257425|529652821|FG000|Overall Study|Lack of Efficacy|3|||
146858576|NCT01257425|529652822|FG001|Overall Study|Lack of Efficacy|3|||
146858577|NCT01257425|529652821|FG000|Overall Study|Adverse Event|1|||
146858578|NCT01257425|529652822|FG001|Overall Study|Adverse Event|1|||
146858579|NCT01257425|529652821|FG000|Overall Study|Protocol Violation|1|||
146858580|NCT01257425|529652822|FG001|Overall Study|Protocol Violation|1|||
146858581|NCT01257425|529652821|FG000|Overall Study|Withdrawal by Subject|0|||
146858582|NCT01257425|529652822|FG001|Overall Study|Withdrawal by Subject|1|||
146858583|NCT01257425|529652821|FG000|Overall Study|Death|1|||
146858584|NCT01257425|529652822|FG001|Overall Study|Death|0|||
146858585|NCT00368992|529652826|FG000|Overall Study|Ineligible|5|||
146858586|NCT00368992|529652826|FG000|Overall Study|Refused treatment|3|||
146858587|NCT00368992|529652826|FG000|Overall Study|Lack of Efficacy|63|||
146858588|NCT00368992|529652826|FG000|Overall Study|Adverse Event|26|||
146858589|NCT00368992|529652826|FG000|Overall Study|Death|4|||
146858590|NCT00368992|529652826|FG000|Overall Study|Other|9|||
146858591|NCT01013597|529652833|FG000|Overall Study|Withdrawal by Subject|1|||
146858592|NCT00427895|529652834|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
146858593|NCT00427895|529652835|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
146858594|NCT00427895|529652836|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
146858595|NCT00427895|529652837|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
146858596|NCT00427895|529652838|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
146858597|NCT00427895|529652839|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
146858598|NCT00427895|529652840|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
146858599|NCT00427895|529652841|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
146858600|NCT00427895|529652834|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
146858601|NCT00427895|529652835|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
146858602|NCT00427895|529652836|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
146858603|NCT00427895|529652837|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
146858604|NCT00427895|529652838|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
146858605|NCT00427895|529652839|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
146858606|NCT00427895|529652840|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
146858607|NCT00427895|529652841|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
146858608|NCT00427895|529652834|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
146858609|NCT00427895|529652835|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
146858610|NCT00427895|529652836|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
146858611|NCT00427895|529652837|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
146858612|NCT00427895|529652838|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
146858613|NCT00427895|529652839|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
146858614|NCT00427895|529652840|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
146858615|NCT00427895|529652841|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
146858616|NCT00427895|529652834|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
146858617|NCT00427895|529652835|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
146858618|NCT00427895|529652836|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
146858619|NCT00427895|529652837|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
146858620|NCT00427895|529652838|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
146858621|NCT00427895|529652839|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
146858622|NCT00427895|529652840|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
146858623|NCT00427895|529652841|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
146858624|NCT00427895|529652834|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
146858625|NCT00427895|529652835|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
146858626|NCT00427895|529652836|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
146858627|NCT00427895|529652837|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
146858628|NCT00427895|529652838|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
146858629|NCT00427895|529652839|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
146858630|NCT00427895|529652840|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
146858631|NCT00427895|529652841|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
146858632|NCT00427895|529652834|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
146858633|NCT00427895|529652835|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
146858634|NCT00427895|529652836|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
146858635|NCT00427895|529652837|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
146858636|NCT00427895|529652838|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
146858637|NCT00427895|529652839|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
146965079|NCT03110107|530033443|FG017|Treatment Period|Death|0|||
146522884|NCT02137226|528421873|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
146522885|NCT02137226|528421874|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
146522886|NCT02137226|528421875|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
146522887|NCT02137226|528421876|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
146522888|NCT02137226|528421877|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
146522889|NCT02137226|528421873|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
146522890|NCT02137226|528421874|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
146522891|NCT02137226|528421875|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
146522892|NCT02137226|528421876|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
146522893|NCT02137226|528421877|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
146522894|NCT02137226|528421873|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
146522895|NCT02137226|528421874|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
146522896|NCT02137226|528421875|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
146522897|NCT02137226|528421876|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
146522898|NCT02137226|528421877|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
146522899|NCT02137226|528421873|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
146522900|NCT02137226|528421874|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
146522901|NCT02137226|528421875|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
146522902|NCT02137226|528421876|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
146522903|NCT02137226|528421877|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
146522904|NCT02137226|528421873|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
146522905|NCT02137226|528421874|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
146522906|NCT02137226|528421875|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
146522907|NCT02137226|528421876|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
146522908|NCT02137226|528421877|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
146522909|NCT02137226|528421873|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
146522910|NCT02137226|528421874|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
146522911|NCT02137226|528421875|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
146522912|NCT02137226|528421876|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
146522913|NCT02137226|528421877|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
146522914|NCT02137226|528421873|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
146522915|NCT02137226|528421874|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
146522916|NCT02137226|528421875|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
146522917|NCT02137226|528421876|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
146522918|NCT02137226|528421877|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
146522919|NCT02998996|528421878|FG000|Overall Study|Lost to Follow-up|0|||
146522920|NCT02998996|528421879|FG001|Overall Study|Lost to Follow-up|0|||
146522921|NCT02998996|528421880|FG002|Overall Study|Lost to Follow-up|1|||
146522922|NCT02998996|528421881|FG003|Overall Study|Lost to Follow-up|0|||
146522923|NCT02998996|528421882|FG004|Overall Study|Lost to Follow-up|0|||
146522924|NCT02998996|528421883|FG005|Overall Study|Lost to Follow-up|0|||
146522925|NCT02998996|528421878|FG000|Overall Study|Pregnancy|0|||
146522926|NCT02998996|528421879|FG001|Overall Study|Pregnancy|1|||
146522927|NCT02998996|528421880|FG002|Overall Study|Pregnancy|0|||
146522928|NCT02998996|528421881|FG003|Overall Study|Pregnancy|0|||
146522929|NCT02998996|528421882|FG004|Overall Study|Pregnancy|0|||
146522930|NCT02998996|528421883|FG005|Overall Study|Pregnancy|0|||
146522931|NCT02998996|528421878|FG000|Overall Study|Family reasons|0|||
146522932|NCT02998996|528421879|FG001|Overall Study|Family reasons|0|||
146522933|NCT02998996|528421880|FG002|Overall Study|Family reasons|0|||
146759716|NCT02950545|529286892|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
146759717|NCT02950545|529286893|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
146759718|NCT02950545|529286894|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
146759719|NCT02950545|529286889|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
146759720|NCT02950545|529286890|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
146759721|NCT02950545|529286891|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
146759722|NCT02950545|529286892|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
146759723|NCT02950545|529286893|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
146759724|NCT02950545|529286894|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
146759725|NCT02950545|529286889|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
146759726|NCT02950545|529286890|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
146759727|NCT02950545|529286891|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
146759728|NCT02950545|529286892|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
146759729|NCT02950545|529286893|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
146759730|NCT02950545|529286894|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
146858638|NCT00427895|529652840|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
146858639|NCT00427895|529652841|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
146522934|NCT02998996|528421881|FG003|Overall Study|Family reasons|0|||
146522935|NCT02998996|528421882|FG004|Overall Study|Family reasons|1|||
146522936|NCT02998996|528421883|FG005|Overall Study|Family reasons|0|||
146759731|NCT03101592|529286895|FG000|Overall Study|participant files could not be located|111|||
146759732|NCT03101592|529286896|FG001|Overall Study|participant files could not be located|170|||
146858640|NCT00427895|529652834|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
146858641|NCT00427895|529652835|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
146858642|NCT00427895|529652836|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
146858643|NCT00427895|529652837|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
146858644|NCT00427895|529652838|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
146858645|NCT00427895|529652839|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
146858646|NCT00427895|529652840|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
146522937|NCT00003896|528421886|FG000|Overall Study|Adverse Event|16|||
146858647|NCT00427895|529652841|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
146858648|NCT00427895|529652834|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
146858649|NCT00427895|529652835|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
146858650|NCT00427895|529652836|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
146858651|NCT00427895|529652837|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
146858652|NCT00427895|529652838|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
146858653|NCT00427895|529652839|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
146858654|NCT00427895|529652840|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
146858655|NCT00427895|529652841|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
146858656|NCT00427895|529652834|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
146858657|NCT00427895|529652835|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
146858658|NCT00427895|529652836|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
146858659|NCT00427895|529652837|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
146858660|NCT00427895|529652838|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
146858661|NCT00427895|529652839|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
146858662|NCT00427895|529652840|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
146858663|NCT00427895|529652841|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
146858664|NCT00427895|529652834|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
146858665|NCT00427895|529652835|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
146858666|NCT00427895|529652836|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
146858667|NCT00427895|529652837|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
146858668|NCT00427895|529652838|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
146858669|NCT00427895|529652839|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
146858670|NCT00427895|529652840|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
146858671|NCT00427895|529652841|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
146522938|NCT00003896|528421886|FG000|Overall Study|Withdrawal by Subject|1|||
146522939|NCT00003896|528421886|FG000|Overall Study|Lack of Efficacy|1|||
146522940|NCT00003896|528421886|FG000|Overall Study|Death|3|||
146522941|NCT00003896|528421886|FG000|Overall Study|not protocol specified|3|||
146522942|NCT00003896|528421886|FG000|Overall Study|ineligible|5|||
146522943|NCT01398358|528421889|FG000|Overall Study|Lost to Follow-up|11|||
146522944|NCT01398358|528421890|FG001|Overall Study|Lost to Follow-up|21|||
146522945|NCT01398358|528421891|FG002|Overall Study|Lost to Follow-up|18|||
146522946|NCT01398358|528421889|FG000|Overall Study|Withdrawal by Subject|3|||
146522947|NCT01398358|528421890|FG001|Overall Study|Withdrawal by Subject|2|||
146522948|NCT01398358|528421891|FG002|Overall Study|Withdrawal by Subject|2|||
146522949|NCT01398358|528421889|FG000|Overall Study|no longer eligible|1|||
146522950|NCT01398358|528421890|FG001|Overall Study|no longer eligible|0|||
146522951|NCT01398358|528421891|FG002|Overall Study|no longer eligible|1|||
146522952|NCT00985686|528421892|FG000|Overall Study|Lost to Follow-up|1|||
146522953|NCT00985686|528421893|FG001|Overall Study|Lost to Follow-up|1|||
146522954|NCT00985686|528421894|FG002|Overall Study|Lost to Follow-up|0|||
146522955|NCT00985686|528421895|FG003|Overall Study|Lost to Follow-up|2|||
146522956|NCT03134911|528421896|FG000|Overall Study|Screen failure|31|||
146522957|NCT03134911|528421896|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
146522958|NCT01670045|528421897|FG000|Overall Study|Withdrawal by Subject|3|||
146522959|NCT01670045|528421897|FG000|Overall Study|Adverse Event|1|||
146522960|NCT01670045|528421897|FG000|Overall Study|Death|1|||
146522961|NCT01670045|528421897|FG000|Overall Study|Lost to Follow-up|11|||
146522962|NCT00184093|528421900|FG000|Overall Study|Adverse Event|3|||
146522963|NCT00184093|528421900|FG000|Overall Study|Lost to Follow-up|3|||
146522964|NCT00184093|528421900|FG000|Overall Study|Physician Decision|1|||
146522965|NCT00184093|528421900|FG000|Overall Study|Withdrawal by Subject|2|||
146522966|NCT00396383|528421903|FG000|Overall Study|Death|2|||
146522967|NCT00396383|528421903|FG000|Overall Study|Lost to Follow-up|1|||
146522968|NCT03538691|528421904|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
146858672|NCT00427895|529652834|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
146858673|NCT00427895|529652835|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
146522969|NCT03538691|528421905|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
146522970|NCT03538691|528421906|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
146522971|NCT03538691|528421907|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
146522972|NCT03538691|528421904|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
146522973|NCT03538691|528421905|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
146858674|NCT00427895|529652836|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
146858675|NCT00427895|529652837|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
146858676|NCT00427895|529652838|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
146858677|NCT00427895|529652839|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
146858678|NCT00427895|529652840|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
146858679|NCT00427895|529652841|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
146858680|NCT00427895|529652834|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
146858681|NCT00427895|529652835|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
146858682|NCT00427895|529652836|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
146858683|NCT00427895|529652837|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
146858684|NCT00427895|529652838|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
146858685|NCT00427895|529652839|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
146858686|NCT00427895|529652840|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
146858687|NCT00427895|529652841|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
146858688|NCT00427895|529652834|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
146858689|NCT00427895|529652835|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
146858690|NCT00427895|529652836|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
146858691|NCT00427895|529652837|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
146858692|NCT00427895|529652838|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
146858693|NCT00427895|529652839|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
146858694|NCT00427895|529652840|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
146858695|NCT00427895|529652841|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
146858696|NCT00427895|529652834|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
146858697|NCT00427895|529652835|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
146858698|NCT00427895|529652836|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
146858699|NCT00427895|529652837|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
146858700|NCT00427895|529652838|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
146858701|NCT00427895|529652839|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
146858702|NCT00427895|529652840|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
146858703|NCT00427895|529652841|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
146858704|NCT00427895|529652834|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
146858705|NCT00427895|529652835|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
146858706|NCT00427895|529652836|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
146858707|NCT00427895|529652837|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
146858708|NCT00427895|529652838|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
146858709|NCT00427895|529652839|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
146858710|NCT00427895|529652840|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
146858711|NCT00427895|529652841|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
146858712|NCT00427895|529652834|FG000|Vax 1/Year 1 Follow-up|Death|1|||
146858713|NCT00427895|529652835|FG001|Vax 1/Year 1 Follow-up|Death|0|||
146858714|NCT00427895|529652836|FG002|Vax 1/Year 1 Follow-up|Death|0|||
146858715|NCT00427895|529652837|FG003|Vax 1/Year 1 Follow-up|Death|0|||
146858716|NCT00427895|529652838|FG004|Vax 1/Year 1 Follow-up|Death|0|||
146858717|NCT00427895|529652839|FG005|Vax 1/Year 1 Follow-up|Death|0|||
146858718|NCT00427895|529652840|FG006|Vax 1/Year 1 Follow-up|Death|0|||
146858719|NCT00427895|529652841|FG007|Vax 1/Year 1 Follow-up|Death|0|||
146858720|NCT00427895|529652834|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
146858721|NCT00427895|529652835|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
146858722|NCT00427895|529652836|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
146858723|NCT00427895|529652837|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
146858724|NCT00427895|529652838|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
146858725|NCT00427895|529652839|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
146858726|NCT00427895|529652840|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
146858727|NCT00427895|529652841|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
146858728|NCT00427895|529652834|FG000|Vax 1/Year 1 Follow-up|Other|0|||
146858729|NCT00427895|529652835|FG001|Vax 1/Year 1 Follow-up|Other|0|||
146858730|NCT00427895|529652836|FG002|Vax 1/Year 1 Follow-up|Other|0|||
146858731|NCT00427895|529652837|FG003|Vax 1/Year 1 Follow-up|Other|2|||
146858732|NCT00427895|529652838|FG004|Vax 1/Year 1 Follow-up|Other|0|||
146858733|NCT00427895|529652839|FG005|Vax 1/Year 1 Follow-up|Other|0|||
146858734|NCT00427895|529652840|FG006|Vax 1/Year 1 Follow-up|Other|0|||
146858735|NCT00427895|529652841|FG007|Vax 1/Year 1 Follow-up|Other|0|||
146858736|NCT00427895|529652834|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
146858737|NCT00427895|529652835|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
146858738|NCT00427895|529652836|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
146858739|NCT00427895|529652837|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
146858740|NCT00427895|529652838|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
146858741|NCT00427895|529652839|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
146858742|NCT00427895|529652840|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
146858743|NCT00427895|529652841|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
146858744|NCT05437510|529652842|FG000|Overall Study|Adverse Event|2|||
146858745|NCT05437510|529652843|FG001|Overall Study|Adverse Event|1|||
146858746|NCT05437510|529652842|FG000|Overall Study|Protocol Deviation|1|||
146858747|NCT05437510|529652843|FG001|Overall Study|Protocol Deviation|6|||
146522974|NCT03538691|528421906|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
146522975|NCT03538691|528421907|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
146522976|NCT03538691|528421904|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
146522977|NCT03538691|528421905|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
146522978|NCT03538691|528421906|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
146522979|NCT03538691|528421907|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
146522980|NCT03538691|528421904|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
146759733|NCT03101592|529286897|FG002|Overall Study|participant files could not be located|118|||
146759734|NCT03398356|529286898|FG000|Before Treatment|Lost to Follow-up|1|||
146759735|NCT03398356|529286899|FG001|Before Treatment|Lost to Follow-up|2|||
146759736|NCT03398356|529286900|FG002|Before Treatment|Lost to Follow-up|0|||
146759737|NCT03398356|529286898|FG000|Before Treatment|drug intolerance|2|||
146759738|NCT03398356|529286899|FG001|Before Treatment|drug intolerance|1|||
146759739|NCT03398356|529286900|FG002|Before Treatment|drug intolerance|0|||
146759740|NCT03398356|529286898|FG000|Before Treatment|Withdrawal by Subject|0|||
146759741|NCT03398356|529286899|FG001|Before Treatment|Withdrawal by Subject|5|||
146759742|NCT03398356|529286900|FG002|Before Treatment|Withdrawal by Subject|0|||
146759743|NCT03398356|529286898|FG000|Before Treatment|Physician Decision|0|||
146759744|NCT03398356|529286899|FG001|Before Treatment|Physician Decision|0|||
146759745|NCT03398356|529286900|FG002|Before Treatment|Physician Decision|11|||
146759746|NCT03398356|529286898|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
146759747|NCT03398356|529286899|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
146759748|NCT03398356|529286900|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
146759749|NCT00647348|529286902|FG000|Overall Study|Lost to Follow-up|3|||
146759750|NCT00647348|529286903|FG001|Overall Study|Lost to Follow-up|6|||
146759751|NCT00619151|529286904|FG000|Overall Study|Study terminated prior to followup|1|||
146759752|NCT00619151|529286905|FG001|Overall Study|Study terminated prior to followup|0|||
146759753|NCT04889118|529286906|FG000|Overall Study|Death|33|||
146759754|NCT04889118|529286907|FG001|Overall Study|Death|37|||
146759755|NCT04889118|529286906|FG000|Overall Study|Ongoing in Study|31|||
146759756|NCT04889118|529286907|FG001|Overall Study|Ongoing in Study|30|||
146759757|NCT01982760|529286908|FG000|Overall Study|Physician Decision|1|||
146759758|NCT01982760|529286909|FG001|Overall Study|Physician Decision|0|||
146759759|NCT00821236|529286910|FG000|Overall Study|Lost to Follow-up|3|||
146759760|NCT00282438|529286914|FG000|Overall Study|Lack of Efficacy|1|||
146759761|NCT00282438|529286915|FG001|Overall Study|Lack of Efficacy|0|||
146759762|NCT00282438|529286914|FG000|Overall Study|Death|0|||
146759763|NCT00282438|529286915|FG001|Overall Study|Death|1|||
146759764|NCT02397889|529286916|FG000|Overall Study|Physician Decision|1|||
146759765|NCT02397889|529286917|FG001|Overall Study|Physician Decision|0|||
146759766|NCT01119703|529286933|FG000|Overall Study|Adverse Event|0|||
146759767|NCT01119703|529286934|FG001|Overall Study|Adverse Event|1|||
146759768|NCT02095158|529286937|FG000|Overall Study|Adverse Event|14|||
146759769|NCT02095158|529286937|FG000|Overall Study|Lack of Efficacy|3|||
146759770|NCT02095158|529286937|FG000|Overall Study|Pregnancy|1|||
146759771|NCT02095158|529286937|FG000|Overall Study|Lost to Follow-up|20|||
146759772|NCT02095158|529286937|FG000|Overall Study|Personal Reasons|35|||
146759773|NCT02095158|529286937|FG000|Overall Study|Protocol Violation|1|||
146759774|NCT02095158|529286937|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146759775|NCT00941031|529286938|FG000|Induction Period|Lack of Efficacy|2|||
146759776|NCT00941031|529286939|FG001|Induction Period|Lack of Efficacy|1|||
146759777|NCT00941031|529286940|FG002|Induction Period|Lack of Efficacy|0|||
146759778|NCT00941031|529286941|FG003|Induction Period|Lack of Efficacy|5|||
146759779|NCT00941031|529286942|FG004|Induction Period|Lack of Efficacy|0|||
146759780|NCT00941031|529286943|FG005|Induction Period|Lack of Efficacy|0|||
146759781|NCT00941031|529286944|FG006|Induction Period|Lack of Efficacy|0|||
146759782|NCT00941031|529286938|FG000|Induction Period|Withdrawal by Subject|1|||
146759783|NCT00941031|529286939|FG001|Induction Period|Withdrawal by Subject|2|||
146759784|NCT00941031|529286940|FG002|Induction Period|Withdrawal by Subject|2|||
146759785|NCT00941031|529286941|FG003|Induction Period|Withdrawal by Subject|2|||
146759786|NCT00941031|529286942|FG004|Induction Period|Withdrawal by Subject|0|||
146759787|NCT00941031|529286943|FG005|Induction Period|Withdrawal by Subject|0|||
146759788|NCT00941031|529286944|FG006|Induction Period|Withdrawal by Subject|0|||
146759789|NCT00941031|529286938|FG000|Induction Period|Adminstative Problems|1|||
146759790|NCT00941031|529286939|FG001|Induction Period|Adminstative Problems|1|||
146759791|NCT00941031|529286940|FG002|Induction Period|Adminstative Problems|1|||
146522981|NCT03538691|528421905|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
146522982|NCT03538691|528421906|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
146625284|NCT03037385|528803849|FG004|Overall Study|Progressive Disease|2|||
146759792|NCT00941031|529286941|FG003|Induction Period|Adminstative Problems|0|||
146759793|NCT00941031|529286942|FG004|Induction Period|Adminstative Problems|0|||
146759794|NCT00941031|529286943|FG005|Induction Period|Adminstative Problems|0|||
146759795|NCT00941031|529286944|FG006|Induction Period|Adminstative Problems|0|||
146759796|NCT00941031|529286938|FG000|Induction Period|Adverse Event|1|||
146759797|NCT00941031|529286939|FG001|Induction Period|Adverse Event|0|||
146759798|NCT00941031|529286940|FG002|Induction Period|Adverse Event|3|||
146759799|NCT00941031|529286941|FG003|Induction Period|Adverse Event|2|||
146759800|NCT00941031|529286942|FG004|Induction Period|Adverse Event|0|||
146759801|NCT00941031|529286943|FG005|Induction Period|Adverse Event|0|||
146759802|NCT00941031|529286944|FG006|Induction Period|Adverse Event|0|||
146759803|NCT00941031|529286938|FG000|Maintenance Period|Withdrawal by Subject|0|||
146759804|NCT00941031|529286939|FG001|Maintenance Period|Withdrawal by Subject|0|||
146759805|NCT00941031|529286940|FG002|Maintenance Period|Withdrawal by Subject|0|||
146759806|NCT00941031|529286941|FG003|Maintenance Period|Withdrawal by Subject|0|||
146759807|NCT00941031|529286942|FG004|Maintenance Period|Withdrawal by Subject|6|||
146759808|NCT00941031|529286943|FG005|Maintenance Period|Withdrawal by Subject|2|||
146759809|NCT00941031|529286944|FG006|Maintenance Period|Withdrawal by Subject|13|||
146759810|NCT00941031|529286938|FG000|Maintenance Period|Administrative Problems|0|||
146759811|NCT00941031|529286939|FG001|Maintenance Period|Administrative Problems|0|||
146759812|NCT00941031|529286940|FG002|Maintenance Period|Administrative Problems|0|||
146759813|NCT00941031|529286941|FG003|Maintenance Period|Administrative Problems|0|||
146759814|NCT00941031|529286942|FG004|Maintenance Period|Administrative Problems|1|||
146759815|NCT00941031|529286943|FG005|Maintenance Period|Administrative Problems|0|||
146759816|NCT00941031|529286944|FG006|Maintenance Period|Administrative Problems|1|||
146759817|NCT00941031|529286938|FG000|Maintenance Period|Protocol Violation|0|||
146759818|NCT00941031|529286939|FG001|Maintenance Period|Protocol Violation|0|||
146759819|NCT00941031|529286940|FG002|Maintenance Period|Protocol Violation|0|||
146759820|NCT00941031|529286941|FG003|Maintenance Period|Protocol Violation|0|||
146759821|NCT00941031|529286942|FG004|Maintenance Period|Protocol Violation|0|||
146759822|NCT00941031|529286943|FG005|Maintenance Period|Protocol Violation|0|||
146759823|NCT00941031|529286944|FG006|Maintenance Period|Protocol Violation|1|||
146759824|NCT00941031|529286938|FG000|Maintenance Period|Adverse Event|0|||
146759825|NCT00941031|529286939|FG001|Maintenance Period|Adverse Event|0|||
146759826|NCT00941031|529286940|FG002|Maintenance Period|Adverse Event|0|||
146759827|NCT00941031|529286941|FG003|Maintenance Period|Adverse Event|0|||
146759828|NCT00941031|529286942|FG004|Maintenance Period|Adverse Event|0|||
146759829|NCT00941031|529286943|FG005|Maintenance Period|Adverse Event|2|||
146858748|NCT05437510|529652842|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
146522983|NCT03538691|528421907|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
146522984|NCT03538691|528421904|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
146522985|NCT03538691|528421905|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
146522986|NCT03538691|528421906|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
146858749|NCT05437510|529652843|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
146858750|NCT05437510|529652842|FG000|Overall Study|Lost to Follow-up|265|||
146858751|NCT05437510|529652843|FG001|Overall Study|Lost to Follow-up|358|||
146858752|NCT03573401|529652844|FG000|Overall Study|Withdrawal by Subject|2|||
146858753|NCT03573401|529652845|FG001|Overall Study|Withdrawal by Subject|0|||
146858754|NCT03573401|529652844|FG000|Overall Study|Subject non-compliance with study schedule|1|||
146858755|NCT03573401|529652845|FG001|Overall Study|Subject non-compliance with study schedule|0|||
146858756|NCT03573401|529652844|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
146858757|NCT03573401|529652845|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
146858758|NCT03573401|529652844|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
146858759|NCT03573401|529652845|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
146858760|NCT00355056|529654663|FG000|Randomization Period|Early Termination|4|||
146858761|NCT00355056|529654664|FG001|Randomization Period|Early Termination|6|||
146858762|NCT01072877|529654668|FG000|Overall Study|Lost to Follow-up|1|||
146858763|NCT01072877|529654669|FG001|Overall Study|Lost to Follow-up|1|||
146858764|NCT01072877|529654670|FG002|Overall Study|Lost to Follow-up|0|||
146858765|NCT01072877|529654671|FG003|Overall Study|Lost to Follow-up|2|||
146858766|NCT01072877|529654672|FG004|Overall Study|Lost to Follow-up|0|||
146858767|NCT00995020|529654673|FG000|Overall Study|margin analysis not performed|2|||
146858768|NCT00995020|529654674|FG001|Overall Study|margin analysis not performed|5|||
146858769|NCT00995020|529654673|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
146858770|NCT00995020|529654674|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
146858771|NCT02245672|529654675|FG000|Overall Study|Adverse Event|4|||
146858772|NCT02245672|529654676|FG001|Overall Study|Adverse Event|4|||
146858773|NCT02245672|529654677|FG002|Overall Study|Adverse Event|4|||
146858774|NCT02245672|529654675|FG000|Overall Study|Lost to Follow-up|3|||
146858775|NCT02245672|529654676|FG001|Overall Study|Lost to Follow-up|5|||
146858776|NCT02245672|529654677|FG002|Overall Study|Lost to Follow-up|1|||
146858777|NCT02245672|529654675|FG000|Overall Study|Withdrawal by Subject|6|||
146858778|NCT02245672|529654676|FG001|Overall Study|Withdrawal by Subject|3|||
146858779|NCT02245672|529654677|FG002|Overall Study|Withdrawal by Subject|0|||
146858780|NCT02245672|529654675|FG000|Overall Study|Randomized in error (not treated)|0|||
146858781|NCT02245672|529654676|FG001|Overall Study|Randomized in error (not treated)|1|||
146858782|NCT02245672|529654677|FG002|Overall Study|Randomized in error (not treated)|0|||
146858783|NCT01765192|529654679|FG000|Treatment Period 1|Adverse Event|0|||
146858784|NCT01765192|529654680|FG001|Treatment Period 1|Adverse Event|1|||
146858785|NCT01765192|529654679|FG000|Washout Period|Voluntary Withdrawal|1|||
146858786|NCT01765192|529654680|FG001|Washout Period|Voluntary Withdrawal|1|||
146858787|NCT01765192|529654679|FG000|Washout Period|Reason not specified|1|||
146858788|NCT01765192|529654680|FG001|Washout Period|Reason not specified|0|||
146858789|NCT01765192|529654679|FG000|Treatment Period 2|Reason not specified|0|||
146858790|NCT01765192|529654680|FG001|Treatment Period 2|Reason not specified|2|||
146858791|NCT01765192|529654679|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
146858792|NCT01765192|529654680|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
146858793|NCT00730171|529654685|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
146858794|NCT00730171|529654685|FG000|Overall Study|Adverse Event|193|||
146858795|NCT00730171|529654685|FG000|Overall Study|Protocol Violation|48|||
146858796|NCT00730171|529654685|FG000|Overall Study|Withdrawal by Subject|202|||
146858797|NCT00730171|529654685|FG000|Overall Study|Lost to Follow-up|121|||
146858798|NCT00730171|529654685|FG000|Overall Study|Insufficient Therapeutic Response|141|||
146858799|NCT00730171|529654685|FG000|Overall Study|Other|61|||
146858800|NCT01729156|529654686|FG000|Overall Study|Withdrawal by Subject|1|||
146858801|NCT01729156|529654687|FG001|Overall Study|Withdrawal by Subject|0|||
146858802|NCT01729156|529654688|FG002|Overall Study|Withdrawal by Subject|0|||
146858803|NCT01215422|529654689|FG000|Overall Study|Relocation|1|||
146858804|NCT01215422|529654690|FG001|Overall Study|Relocation|0|||
146858805|NCT01215422|529654691|FG002|Overall Study|Relocation|0|||
146858806|NCT01215422|529654692|FG003|Overall Study|Relocation|0|||
146858807|NCT01215422|529654689|FG000|Overall Study|Failed intubations|0|||
146522987|NCT03538691|528421907|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
146522988|NCT03538691|528421904|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
146858808|NCT01215422|529654690|FG001|Overall Study|Failed intubations|0|||
146858809|NCT01215422|529654691|FG002|Overall Study|Failed intubations|3|||
146858810|NCT01215422|529654692|FG003|Overall Study|Failed intubations|8|||
146858811|NCT01215422|529654689|FG000|Overall Study|Did not complete all intubations|7|||
146858812|NCT01215422|529654690|FG001|Overall Study|Did not complete all intubations|0|||
146858813|NCT01215422|529654691|FG002|Overall Study|Did not complete all intubations|0|||
146858814|NCT01215422|529654692|FG003|Overall Study|Did not complete all intubations|0|||
146858815|NCT01256658|529654693|FG000|Period 1|Lost to Follow-up|837|||
146522989|NCT03538691|528421905|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
146522990|NCT03538691|528421906|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
146522991|NCT03538691|528421907|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
146522992|NCT03538691|528421904|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
146522993|NCT03538691|528421905|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
146522994|NCT03538691|528421906|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
146522995|NCT03538691|528421907|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
146522996|NCT03538691|528421904|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
146522997|NCT03538691|528421905|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
146522998|NCT03538691|528421906|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
146522999|NCT03538691|528421907|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
146523000|NCT03538691|528421904|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
146523001|NCT03538691|528421905|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
146523002|NCT03538691|528421906|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
146523003|NCT03538691|528421907|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
146523004|NCT03538691|528421904|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
146523005|NCT03538691|528421905|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
146523006|NCT03538691|528421906|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
146523007|NCT03538691|528421907|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
146523008|NCT03538691|528421904|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
146523009|NCT03538691|528421905|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
146523010|NCT03538691|528421906|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
146523011|NCT03538691|528421907|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
146523012|NCT03538691|528421904|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
146523013|NCT03538691|528421905|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
146523014|NCT03538691|528421906|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
146523015|NCT03538691|528421907|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
146523016|NCT03538691|528421904|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
146523017|NCT03538691|528421905|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
146523018|NCT03538691|528421906|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
146523019|NCT03538691|528421907|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
146523020|NCT03538691|528421904|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
146523021|NCT03538691|528421905|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
146523022|NCT03538691|528421906|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
146523023|NCT03538691|528421907|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
146523024|NCT03538691|528421904|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
146523025|NCT03538691|528421905|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
146523026|NCT03538691|528421906|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
146523027|NCT03538691|528421907|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
146523028|NCT03538691|528421904|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
146523029|NCT03538691|528421905|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
146523030|NCT03538691|528421906|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
146523031|NCT03538691|528421907|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
146523032|NCT03538691|528421904|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
146523033|NCT03538691|528421905|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
146523034|NCT03538691|528421906|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
146523035|NCT03538691|528421907|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
146523036|NCT03538691|528421904|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
146523037|NCT03538691|528421905|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
146523038|NCT03538691|528421906|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
146523039|NCT03538691|528421907|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
146523040|NCT03538691|528421904|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
146523041|NCT03538691|528421905|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
146759830|NCT00941031|529286944|FG006|Maintenance Period|Adverse Event|8|||
146759831|NCT00941031|529286938|FG000|Maintenance Period|Lost to Follow-up|0|||
146759832|NCT00941031|529286939|FG001|Maintenance Period|Lost to Follow-up|0|||
146759833|NCT00941031|529286940|FG002|Maintenance Period|Lost to Follow-up|0|||
146759834|NCT00941031|529286941|FG003|Maintenance Period|Lost to Follow-up|0|||
146759835|NCT00941031|529286942|FG004|Maintenance Period|Lost to Follow-up|2|||
146759836|NCT00941031|529286943|FG005|Maintenance Period|Lost to Follow-up|2|||
146759837|NCT00941031|529286944|FG006|Maintenance Period|Lost to Follow-up|7|||
146759838|NCT00941031|529286938|FG000|Maintenance Period|Lack of Efficacy|0|||
146759839|NCT00941031|529286939|FG001|Maintenance Period|Lack of Efficacy|0|||
146858816|NCT01256658|529654694|FG001|Period 1|Lost to Follow-up|661|||
146858817|NCT01256658|529654693|FG000|Period 1|Withdrawal by Subject|35|||
146858818|NCT01256658|529654694|FG001|Period 1|Withdrawal by Subject|43|||
146858819|NCT01256658|529654693|FG000|Period 1|Death|48|||
146858820|NCT01256658|529654694|FG001|Period 1|Death|44|||
146858821|NCT00719563|529654699|FG000|Overall Study|Adverse Event|16|||
146858822|NCT00719563|529654700|FG001|Overall Study|Adverse Event|13|||
146858823|NCT00719563|529654699|FG000|Overall Study|Medical condition changed|3|||
146523042|NCT03538691|528421906|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
146523043|NCT03538691|528421907|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
146523044|NCT03538691|528421904|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
146858824|NCT00719563|529654700|FG001|Overall Study|Medical condition changed|5|||
146858825|NCT00719563|529654699|FG000|Overall Study|Lack of Efficacy|3|||
146858826|NCT00719563|529654700|FG001|Overall Study|Lack of Efficacy|7|||
146858827|NCT00719563|529654699|FG000|Overall Study|Personal reasons|6|||
146858828|NCT00719563|529654700|FG001|Overall Study|Personal reasons|7|||
146858829|NCT00719563|529654699|FG000|Overall Study|Unknown reasons|4|||
146858830|NCT00719563|529654700|FG001|Overall Study|Unknown reasons|6|||
146858831|NCT00719563|529654699|FG000|Overall Study|Noncompliant|1|||
146858832|NCT00719563|529654700|FG001|Overall Study|Noncompliant|1|||
146858833|NCT00719563|529654699|FG000|Overall Study|Lost to Follow-up|5|||
146858834|NCT00719563|529654700|FG001|Overall Study|Lost to Follow-up|3|||
146858835|NCT00294554|529654701|FG000|Overall Study|Lack of Efficacy|0|||
146858836|NCT00294554|529654702|FG001|Overall Study|Lack of Efficacy|1|||
146858837|NCT00294554|529654701|FG000|Overall Study|Physician Decision|0|||
146523045|NCT03538691|528421905|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
146523046|NCT03538691|528421906|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
146523047|NCT03538691|528421907|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
146523048|NCT03538691|528421904|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
146523049|NCT03538691|528421905|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
146523050|NCT03538691|528421906|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
146523051|NCT03538691|528421907|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
146523052|NCT03538691|528421904|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
146523053|NCT03538691|528421905|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
146523054|NCT03538691|528421906|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
146523055|NCT03538691|528421907|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
146523056|NCT03538691|528421904|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
146523057|NCT03538691|528421905|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
146523058|NCT03538691|528421906|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
146523059|NCT03538691|528421907|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
146523060|NCT03538691|528421904|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
146523061|NCT03538691|528421905|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
146523062|NCT03538691|528421906|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
146523063|NCT03538691|528421907|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
146523064|NCT03538691|528421904|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
146523065|NCT03538691|528421905|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
146523066|NCT03538691|528421906|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
146523067|NCT03538691|528421907|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
146523068|NCT03538691|528421904|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
146523069|NCT03538691|528421905|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
146523070|NCT03538691|528421906|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
146523071|NCT03538691|528421907|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
146523072|NCT03538691|528421904|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
146523073|NCT03538691|528421905|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
146523074|NCT03538691|528421906|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
146523075|NCT03538691|528421907|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
146523076|NCT03538691|528421904|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
146523077|NCT03538691|528421905|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
146523078|NCT03538691|528421906|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
146568716|NCT00328172|528595435|FG004|Overall Study|Withdrawal by Subject|0|||
146858838|NCT00294554|529654702|FG001|Overall Study|Physician Decision|1|||
146858839|NCT00462865|529654703|FG000|Overall Study|Adverse Event|1|||
146858840|NCT02986334|529654704|FG000|Overall Study|Withdrawal by Subject|0|||
146858841|NCT02986334|529654705|FG001|Overall Study|Withdrawal by Subject|1|||
146858842|NCT02986334|529654706|FG002|Overall Study|Withdrawal by Subject|2|||
146858843|NCT02986334|529654704|FG000|Overall Study|Lost to Follow-up|1|||
146858844|NCT02986334|529654705|FG001|Overall Study|Lost to Follow-up|2|||
146523079|NCT03538691|528421907|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
146523080|NCT01366638|528421910|FG000|Overall Study|Withdrawal by Subject|0|||
146523081|NCT01366638|528421911|FG001|Overall Study|Withdrawal by Subject|0|||
146523082|NCT01366638|528421912|FG002|Overall Study|Withdrawal by Subject|6|||
146523083|NCT01366638|528421910|FG000|Overall Study|Other|1|||
146523084|NCT01366638|528421911|FG001|Overall Study|Other|0|||
146523085|NCT01366638|528421912|FG002|Overall Study|Other|0|||
146523086|NCT00636636|528421913|FG000|Overall Study|Other reason|4|||
146523087|NCT00636636|528421914|FG001|Overall Study|Other reason|6|||
146523088|NCT00636636|528421913|FG000|Overall Study|Adverse Event|19|||
146523089|NCT00636636|528421914|FG001|Overall Study|Adverse Event|8|||
146523090|NCT00636636|528421913|FG000|Overall Study|Lack of Efficacy|7|||
146523091|NCT00636636|528421914|FG001|Overall Study|Lack of Efficacy|12|||
146523092|NCT00636636|528421913|FG000|Overall Study|Protocol Violation|2|||
146523093|NCT00636636|528421914|FG001|Overall Study|Protocol Violation|2|||
146523094|NCT00636636|528421913|FG000|Overall Study|Lost to Follow-up|0|||
146523095|NCT00636636|528421914|FG001|Overall Study|Lost to Follow-up|1|||
146523096|NCT00636636|528421913|FG000|Overall Study|Death|0|||
146523097|NCT00636636|528421914|FG001|Overall Study|Death|1|||
146523098|NCT00636636|528421913|FG000|Overall Study|Withdrawal by Subject|4|||
146523099|NCT00636636|528421914|FG001|Overall Study|Withdrawal by Subject|9|||
146523100|NCT03300180|528421915|FG000|Baseline|Withdrawal by Subject|4|||
146523101|NCT03300180|528421916|FG001|Baseline|Withdrawal by Subject|6|||
146523102|NCT03300180|528421917|FG002|Baseline|Withdrawal by Subject|4|||
146523103|NCT03300180|528421915|FG000|6 Month Outcome|Withdrawal by Subject|12|||
146523104|NCT03300180|528421916|FG001|6 Month Outcome|Withdrawal by Subject|12|||
146523105|NCT03300180|528421917|FG002|6 Month Outcome|Withdrawal by Subject|19|||
146523106|NCT03300180|528421915|FG000|6 Month Outcome|Death|2|||
146523107|NCT03300180|528421916|FG001|6 Month Outcome|Death|4|||
146523108|NCT03300180|528421917|FG002|6 Month Outcome|Death|3|||
146523109|NCT03300180|528421915|FG000|6 Month Outcome|Missed Assessment|43|||
146523110|NCT03300180|528421916|FG001|6 Month Outcome|Missed Assessment|52|||
146523111|NCT03300180|528421917|FG002|6 Month Outcome|Missed Assessment|46|||
146523112|NCT03300180|528421915|FG000|12 Month Outcome|Withdrawal by Subject|3|||
146523113|NCT03300180|528421916|FG001|12 Month Outcome|Withdrawal by Subject|6|||
146523114|NCT03300180|528421917|FG002|12 Month Outcome|Withdrawal by Subject|6|||
146523115|NCT03300180|528421915|FG000|12 Month Outcome|Death|9|||
146523116|NCT03300180|528421916|FG001|12 Month Outcome|Death|6|||
146523117|NCT03300180|528421917|FG002|12 Month Outcome|Death|6|||
146523118|NCT03300180|528421915|FG000|12 Month Outcome|Missed Assessment|62|||
146523119|NCT03300180|528421916|FG001|12 Month Outcome|Missed Assessment|59|||
146523120|NCT03300180|528421917|FG002|12 Month Outcome|Missed Assessment|58|||
146523121|NCT03300180|528421915|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
146523122|NCT03300180|528421916|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
146523123|NCT03300180|528421917|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
146523124|NCT03300180|528421915|FG000|18 Month Outcome Assessment|Death|8|||
146523125|NCT03300180|528421916|FG001|18 Month Outcome Assessment|Death|5|||
146523126|NCT03300180|528421917|FG002|18 Month Outcome Assessment|Death|5|||
146523127|NCT03300180|528421915|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
146523128|NCT03300180|528421916|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
146523129|NCT03300180|528421917|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
146523130|NCT03300180|528421915|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
146523131|NCT03300180|528421916|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
146523132|NCT03300180|528421917|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
146523133|NCT03300180|528421915|FG000|24 Month Outcome Assessment|Death|13|||
146523134|NCT03300180|528421916|FG001|24 Month Outcome Assessment|Death|13|||
146858845|NCT02986334|529654706|FG002|Overall Study|Lost to Follow-up|1|||
146858846|NCT02986334|529654704|FG000|Overall Study|Adverse Event|0|||
146858847|NCT02986334|529654705|FG001|Overall Study|Adverse Event|2|||
146858848|NCT02986334|529654706|FG002|Overall Study|Adverse Event|1|||
146858849|NCT02986334|529654704|FG000|Overall Study|non compliance in phone ratings|2|||
146858850|NCT02986334|529654705|FG001|Overall Study|non compliance in phone ratings|1|||
146523135|NCT03300180|528421917|FG002|24 Month Outcome Assessment|Death|3|||
146523136|NCT03300180|528421915|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
146523137|NCT03300180|528421916|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
146858851|NCT02986334|529654706|FG002|Overall Study|non compliance in phone ratings|2|||
146523138|NCT03300180|528421917|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
146523139|NCT01243177|528421918|FG000|Overall Study|Lack of Efficacy|47|||
146523140|NCT01243177|528421919|FG001|Overall Study|Lack of Efficacy|31|||
146523141|NCT01243177|528421918|FG000|Overall Study|Protocol Violation|11|||
146523142|NCT01243177|528421919|FG001|Overall Study|Protocol Violation|10|||
146523143|NCT01243177|528421918|FG000|Overall Study|Lost to Follow-up|15|||
146858852|NCT02986334|529654704|FG000|Overall Study|undisclosed comorbidities|0|||
146858853|NCT02986334|529654705|FG001|Overall Study|undisclosed comorbidities|1|||
146965080|NCT03110107|530033444|FG018|Treatment Period|Death|0|||
146523144|NCT01243177|528421919|FG001|Overall Study|Lost to Follow-up|18|||
146523145|NCT01243177|528421918|FG000|Overall Study|Withdrawal by Subject|46|||
146523146|NCT01243177|528421919|FG001|Overall Study|Withdrawal by Subject|38|||
146858854|NCT02986334|529654706|FG002|Overall Study|undisclosed comorbidities|1|||
146858855|NCT04142450|529654707|FG000|Overall Study|Screen Failure|1|||
146858856|NCT04142450|529654707|FG000|Overall Study|Lost to Follow-up|1|||
146858857|NCT06336603|529654708|FG000|Overall Study|Withdrawal by Subject|1|||
146858858|NCT06336603|529654708|FG000|Overall Study|Lost to Follow-up|2|||
146858859|NCT01146054|529654711|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
146858860|NCT01146054|529654711|FG000|Overall Study|Rapid tumor progression|2|||
146858861|NCT01146054|529654711|FG000|Overall Study|Other illness precluded treatment|2|||
146858862|NCT01146054|529654711|FG000|Overall Study|Lost to Follow-up|1|||
146858863|NCT04335812|529654712|FG000|Overall Study|Withdrawal by Subject|1|||
146858864|NCT04335812|529654713|FG001|Overall Study|Withdrawal by Subject|3|||
146858865|NCT04335812|529654712|FG000|Overall Study|Lost to Follow-up|12|||
146858866|NCT04335812|529654713|FG001|Overall Study|Lost to Follow-up|12|||
146858867|NCT04335812|529654712|FG000|Overall Study|Did not engage in the intervention|22|||
146858868|NCT04335812|529654713|FG001|Overall Study|Did not engage in the intervention|18|||
146858869|NCT02901041|529654719|FG000|Overall Study|Withdrawal by PI|4|||
146858870|NCT02901041|529654720|FG001|Overall Study|Withdrawal by PI|8|||
146858871|NCT02901041|529654719|FG000|Overall Study|Withdrawal by Subject|7|||
146858872|NCT02901041|529654720|FG001|Overall Study|Withdrawal by Subject|3|||
146858873|NCT01480674|529654721|FG000|Overall Study|Death|23|||
146858874|NCT01480674|529654721|FG000|Overall Study|Lost to Follow-up|2|||
146858875|NCT01480674|529654721|FG000|Overall Study|visit not done|10|||
146858876|NCT03249714|529654725|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
146858877|NCT03249714|529654726|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
146858878|NCT03249714|529654725|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
146858879|NCT03249714|529654726|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
146858880|NCT03249714|529654725|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
146858881|NCT03249714|529654726|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
146858882|NCT03249714|529654725|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
146858883|NCT03249714|529654726|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
146858884|NCT00655863|529654734|FG000|Overall Study|Lost to Follow-up|0|||
146858885|NCT00655863|529654735|FG001|Overall Study|Lost to Follow-up|0|||
146858886|NCT00655863|529654736|FG002|Overall Study|Lost to Follow-up|1|||
146858887|NCT03021954|529654739|FG000|Overall Study|Lost to Follow-up|10|||
146858888|NCT03021954|529654740|FG001|Overall Study|Lost to Follow-up|43|||
146858889|NCT03021954|529654739|FG000|Overall Study|Subjects had avulsion trauma|4|||
146858890|NCT03021954|529654740|FG001|Overall Study|Subjects had avulsion trauma|1|||
146858891|NCT01001832|529654741|FG000|Short-term Period|Adverse Event|2|||
146858892|NCT01001832|529654742|FG001|Short-term Period|Adverse Event|3|||
146858893|NCT01001832|529654741|FG000|Long-term Period|Adverse Event|2|||
146858894|NCT01001832|529654742|FG001|Long-term Period|Adverse Event|1|||
146858895|NCT01001832|529654741|FG000|Long-term Period|Withdrawal by Subject|1|||
146858896|NCT01001832|529654742|FG001|Long-term Period|Withdrawal by Subject|0|||
146858897|NCT01001832|529654741|FG000|Long-term Period|Lack of Efficacy|0|||
146858898|NCT01001832|529654742|FG001|Long-term Period|Lack of Efficacy|2|||
146858899|NCT01001832|529654741|FG000|Long-term Period|Other|1|||
146858900|NCT01001832|529654742|FG001|Long-term Period|Other|2|||
146858901|NCT01001832|529654741|FG000|Follow-up Period|Withdrawal by Subject|1|||
146858902|NCT01001832|529654742|FG001|Follow-up Period|Withdrawal by Subject|0|||
146858903|NCT01001832|529654741|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
146858904|NCT01001832|529654742|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
146858905|NCT01001832|529654741|FG000|Follow-up Period|Other|2|||
146858906|NCT01001832|529654742|FG001|Follow-up Period|Other|1|||
146858907|NCT00051363|529654746|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
146858908|NCT00051363|529654747|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
146858909|NCT00051363|529654746|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
146858910|NCT00051363|529654747|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
146858911|NCT00051363|529654746|FG000|Overall Study|Death|2|||
146858912|NCT00051363|529654747|FG001|Overall Study|Death|2|||
146858913|NCT00051363|529654746|FG000|Overall Study|Excluded Pre-Randomization|2|||
146858914|NCT00051363|529654747|FG001|Overall Study|Excluded Pre-Randomization|5|||
146858915|NCT01242800|529654748|FG000|Overall Study|Patient refusal|0|||
146858916|NCT01242800|529654749|FG001|Overall Study|Patient refusal|10|||
146858917|NCT01242800|529654748|FG000|Overall Study|Physician Decision|0|||
146858918|NCT01242800|529654749|FG001|Overall Study|Physician Decision|1|||
146858919|NCT01242800|529654748|FG000|Overall Study|Disease progression|0|||
146858920|NCT01242800|529654749|FG001|Overall Study|Disease progression|3|||
146858921|NCT01242800|529654748|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
146858922|NCT01242800|529654749|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
146858923|NCT01242800|529654748|FG000|Overall Study|Reasons not reported|0|||
146858924|NCT01242800|529654749|FG001|Overall Study|Reasons not reported|4|||
146858925|NCT02640157|529654751|FG000|Overall Study|Adverse Event|2|||
146858926|NCT02640157|529654752|FG001|Overall Study|Adverse Event|2|||
146858927|NCT02640157|529654753|FG002|Overall Study|Adverse Event|1|||
146858928|NCT02640157|529654751|FG000|Overall Study|Withdrew consent|2|||
146858929|NCT02640157|529654752|FG001|Overall Study|Withdrew consent|0|||
146523147|NCT01243177|528421918|FG000|Overall Study|AE, serious fatal|0|||
146523148|NCT01243177|528421919|FG001|Overall Study|AE, serious fatal|1|||
146523149|NCT01243177|528421918|FG000|Overall Study|SAE, non-fatal|7|||
146523150|NCT01243177|528421919|FG001|Overall Study|SAE, non-fatal|9|||
146858930|NCT02640157|529654753|FG002|Overall Study|Withdrew consent|2|||
146858931|NCT02640157|529654751|FG000|Overall Study|Lost to Follow-up|9|||
146858932|NCT02640157|529654752|FG001|Overall Study|Lost to Follow-up|2|||
146858933|NCT02640157|529654753|FG002|Overall Study|Lost to Follow-up|7|||
146858934|NCT02640157|529654751|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
146858935|NCT02640157|529654752|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
146858936|NCT02640157|529654753|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
146858937|NCT00710021|529654754|FG000|Overall Study|Lost to Follow-up|1|||
146858938|NCT00710021|529654755|FG001|Overall Study|Lost to Follow-up|0|||
146858939|NCT00710021|529654756|FG002|Overall Study|Lost to Follow-up|0|||
146858940|NCT00710021|529654754|FG000|Overall Study|Subject's Decision|0|||
146858941|NCT00710021|529654755|FG001|Overall Study|Subject's Decision|1|||
146858942|NCT00710021|529654756|FG002|Overall Study|Subject's Decision|0|||
146858943|NCT00710021|529654754|FG000|Overall Study|Subject misrandomized|0|||
146858944|NCT00710021|529654755|FG001|Overall Study|Subject misrandomized|1|||
146858945|NCT00710021|529654756|FG002|Overall Study|Subject misrandomized|1|||
146858946|NCT00710021|529654754|FG000|Overall Study|Physician Decision|0|||
146858947|NCT00710021|529654755|FG001|Overall Study|Physician Decision|1|||
146858948|NCT00710021|529654756|FG002|Overall Study|Physician Decision|0|||
146858949|NCT01679405|529654757|FG000|Overall Study|Death|2|||
146858950|NCT01679405|529654758|FG001|Overall Study|Death|5|||
146858951|NCT04677179|529654759|FG000|Induction Treatment Period|Adverse Event|1|||
146858952|NCT04677179|529654760|FG001|Induction Treatment Period|Adverse Event|0|||
146858953|NCT04677179|529654761|FG002|Induction Treatment Period|Adverse Event|0|||
146858954|NCT04677179|529654762|FG003|Induction Treatment Period|Adverse Event|0|||
146858955|NCT04677179|529654763|FG004|Induction Treatment Period|Adverse Event|0|||
146858956|NCT04677179|529654764|FG005|Induction Treatment Period|Adverse Event|0|||
146858957|NCT04677179|529654765|FG006|Induction Treatment Period|Adverse Event|0|||
146858958|NCT04677179|529654766|FG007|Induction Treatment Period|Adverse Event|0|||
146858959|NCT04677179|529654767|FG008|Induction Treatment Period|Adverse Event|0|||
146858960|NCT04677179|529654768|FG009|Induction Treatment Period|Adverse Event|0|||
146858961|NCT04677179|529654759|FG000|Induction Treatment Period|Physician Decision|1|||
146858962|NCT04677179|529654760|FG001|Induction Treatment Period|Physician Decision|0|||
146858963|NCT04677179|529654761|FG002|Induction Treatment Period|Physician Decision|1|||
146858964|NCT04677179|529654762|FG003|Induction Treatment Period|Physician Decision|0|||
146858965|NCT04677179|529654763|FG004|Induction Treatment Period|Physician Decision|0|||
146858966|NCT04677179|529654764|FG005|Induction Treatment Period|Physician Decision|0|||
146858967|NCT04677179|529654765|FG006|Induction Treatment Period|Physician Decision|0|||
146858968|NCT04677179|529654766|FG007|Induction Treatment Period|Physician Decision|0|||
146858969|NCT04677179|529654767|FG008|Induction Treatment Period|Physician Decision|0|||
146858970|NCT04677179|529654768|FG009|Induction Treatment Period|Physician Decision|0|||
146858971|NCT04677179|529654759|FG000|Induction Treatment Period|Protocol Violation|0|||
146858972|NCT04677179|529654760|FG001|Induction Treatment Period|Protocol Violation|1|||
146858973|NCT04677179|529654761|FG002|Induction Treatment Period|Protocol Violation|0|||
146858974|NCT04677179|529654762|FG003|Induction Treatment Period|Protocol Violation|0|||
146858975|NCT04677179|529654763|FG004|Induction Treatment Period|Protocol Violation|0|||
146858976|NCT04677179|529654764|FG005|Induction Treatment Period|Protocol Violation|0|||
146858977|NCT04677179|529654765|FG006|Induction Treatment Period|Protocol Violation|0|||
146858978|NCT04677179|529654766|FG007|Induction Treatment Period|Protocol Violation|0|||
146858979|NCT04677179|529654767|FG008|Induction Treatment Period|Protocol Violation|0|||
146858980|NCT04677179|529654768|FG009|Induction Treatment Period|Protocol Violation|0|||
146858981|NCT04677179|529654759|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
146858982|NCT04677179|529654760|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
146858983|NCT04677179|529654761|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
146858984|NCT04677179|529654762|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
146858985|NCT04677179|529654763|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
146858986|NCT04677179|529654764|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
146858987|NCT04677179|529654765|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
146523151|NCT01243177|528421918|FG000|Overall Study|AE, non-serious non-fatal|40|||
146523152|NCT01243177|528421919|FG001|Overall Study|AE, non-serious non-fatal|58|||
146858988|NCT04677179|529654766|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
146858989|NCT04677179|529654767|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
146858990|NCT04677179|529654768|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
146858991|NCT04677179|529654759|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
146858992|NCT04677179|529654760|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
146858993|NCT04677179|529654761|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
146858994|NCT04677179|529654762|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
146858995|NCT04677179|529654763|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
146523153|NCT01243177|528421918|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
146858996|NCT04677179|529654764|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
146858997|NCT04677179|529654765|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
146858998|NCT04677179|529654766|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
146858999|NCT04677179|529654767|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
146859000|NCT04677179|529654768|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
146859001|NCT04677179|529654759|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
146859002|NCT04677179|529654760|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
146859003|NCT04677179|529654761|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
146859004|NCT04677179|529654762|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
146859005|NCT04677179|529654763|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
146859006|NCT04677179|529654764|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
146859007|NCT04677179|529654765|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
146859008|NCT04677179|529654766|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
146859009|NCT04677179|529654767|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
146859010|NCT04677179|529654768|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
146859011|NCT04677179|529654759|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
146859012|NCT04677179|529654760|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
146859013|NCT04677179|529654761|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
146859014|NCT04677179|529654762|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
146859015|NCT04677179|529654763|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
146859016|NCT04677179|529654764|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
146859017|NCT04677179|529654765|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
146859018|NCT04677179|529654766|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
146859019|NCT04677179|529654767|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
146859020|NCT04677179|529654768|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
146859021|NCT04677179|529654759|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
146859022|NCT04677179|529654760|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
146859023|NCT04677179|529654761|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
146859024|NCT04677179|529654762|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
146859025|NCT04677179|529654763|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
146859026|NCT04677179|529654764|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
146859027|NCT04677179|529654765|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
146859028|NCT04677179|529654766|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
146859029|NCT04677179|529654767|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
146859030|NCT04677179|529654768|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
146859031|NCT04677179|529654759|FG000|Extension Treatment Period|Lack of Efficacy|0|||
146859032|NCT04677179|529654760|FG001|Extension Treatment Period|Lack of Efficacy|0|||
146859033|NCT04677179|529654761|FG002|Extension Treatment Period|Lack of Efficacy|0|||
146859034|NCT04677179|529654762|FG003|Extension Treatment Period|Lack of Efficacy|0|||
146859035|NCT04677179|529654763|FG004|Extension Treatment Period|Lack of Efficacy|0|||
146859036|NCT04677179|529654764|FG005|Extension Treatment Period|Lack of Efficacy|0|||
146859037|NCT04677179|529654765|FG006|Extension Treatment Period|Lack of Efficacy|6|||
146859038|NCT04677179|529654766|FG007|Extension Treatment Period|Lack of Efficacy|0|||
146859039|NCT04677179|529654767|FG008|Extension Treatment Period|Lack of Efficacy|0|||
146859040|NCT04677179|529654768|FG009|Extension Treatment Period|Lack of Efficacy|0|||
146859041|NCT04677179|529654759|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
146859042|NCT04677179|529654760|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
146859043|NCT04677179|529654761|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
146859044|NCT04677179|529654762|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
146859045|NCT04677179|529654763|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
146859046|NCT04677179|529654764|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
146859047|NCT04677179|529654765|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
146859048|NCT04677179|529654766|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
146859049|NCT04677179|529654767|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
146859050|NCT04677179|529654768|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
146859051|NCT04677179|529654759|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
146859052|NCT04677179|529654760|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
146859053|NCT04677179|529654761|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
146859054|NCT04677179|529654762|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
146523154|NCT01243177|528421919|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
146523155|NCT01243177|528421918|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
146523156|NCT01243177|528421919|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
146523157|NCT01243177|528421918|FG000|Overall Study|Other Reason|11|||
146523158|NCT01243177|528421919|FG001|Overall Study|Other Reason|12|||
146859055|NCT04677179|529654763|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
146859056|NCT04677179|529654764|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
146859057|NCT04677179|529654765|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
146859058|NCT04677179|529654766|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
146523159|NCT00669318|528423337|FG000|Overall Study|Withdrawal by Subject|2|||
146523160|NCT01971567|528423341|FG000|Overall Study|Withdrawal by Subject|3|||
146523161|NCT01971567|528423342|FG001|Overall Study|Withdrawal by Subject|2|||
146523162|NCT01971567|528423341|FG000|Overall Study|Lost to Follow-up|1|||
146523163|NCT01971567|528423342|FG001|Overall Study|Lost to Follow-up|0|||
146523164|NCT01239394|528423345|FG000|Overall Study|Adverse Event|1|||
146523165|NCT00524771|528423347|FG000|Overall Study|Protocol Violation|220|||
146523166|NCT00524771|528423348|FG001|Overall Study|Protocol Violation|585|||
146523167|NCT01223404|528423349|FG000|First Intervention (1 Day)|Adverse Event|0|||
146523168|NCT01223404|528423350|FG001|First Intervention (1 Day)|Adverse Event|0|||
146523169|NCT01223404|528423351|FG002|First Intervention (1 Day)|Adverse Event|0|||
146523170|NCT01223404|528423352|FG003|First Intervention (1 Day)|Adverse Event|1|||
146523171|NCT01223404|528423353|FG004|First Intervention (1 Day)|Adverse Event|0|||
146523172|NCT01223404|528423354|FG005|First Intervention (1 Day)|Adverse Event|0|||
146523173|NCT01223404|528423349|FG000|Second Intervention (1 Day)|Adverse Event|1|||
146523174|NCT01223404|528423350|FG001|Second Intervention (1 Day)|Adverse Event|0|||
146523175|NCT01223404|528423351|FG002|Second Intervention (1 Day)|Adverse Event|0|||
146523176|NCT01223404|528423352|FG003|Second Intervention (1 Day)|Adverse Event|0|||
146523177|NCT01223404|528423353|FG004|Second Intervention (1 Day)|Adverse Event|0|||
146523178|NCT01223404|528423354|FG005|Second Intervention (1 Day)|Adverse Event|0|||
146523179|NCT01223404|528423349|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
146523180|NCT01223404|528423350|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
146523181|NCT01223404|528423351|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
146523182|NCT01223404|528423352|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
146523183|NCT01223404|528423353|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
146523184|NCT01223404|528423354|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
146523185|NCT00707057|528423355|FG000|Overall Study|Withdrawal by Subject|8|||
146523186|NCT00707057|528423356|FG001|Overall Study|Withdrawal by Subject|3|||
146523187|NCT00707057|528423355|FG000|Overall Study|Dosed incorrectly|0|||
146523188|NCT00707057|528423356|FG001|Overall Study|Dosed incorrectly|1|||
146523189|NCT02492165|528423357|FG000|Overall Study|Withdrawal by Subject|0|||
146523190|NCT02492165|528423358|FG001|Overall Study|Withdrawal by Subject|1|||
146523191|NCT02492165|528423359|FG002|Overall Study|Withdrawal by Subject|0|||
146523192|NCT02492165|528423360|FG003|Overall Study|Withdrawal by Subject|0|||
146523193|NCT01639144|528423363|FG000|Overall Study|Withdrawal by Subject|4|||
146523194|NCT01639144|528423364|FG001|Overall Study|Withdrawal by Subject|2|||
146523195|NCT01639144|528423363|FG000|Overall Study|Physician Decision|2|||
146523196|NCT01639144|528423364|FG001|Overall Study|Physician Decision|0|||
146523197|NCT01639144|528423363|FG000|Overall Study|Met postoperative exclusion criteria|4|||
146523198|NCT01639144|528423364|FG001|Overall Study|Met postoperative exclusion criteria|3|||
146523199|NCT00305227|528423369|FG000|Overall Study|Lost to Follow-up|7|||
146523200|NCT00305227|528423370|FG001|Overall Study|Lost to Follow-up|6|||
146523201|NCT03492437|528423372|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146523202|NCT03492437|528423373|FG001|Treatment Period 2|Withdrawal by Subject|1|||
146523203|NCT02915159|528423374|FG000|Overall Study|Participant no longer meets criteria|2|||
146523204|NCT02915159|528423375|FG001|Overall Study|Participant no longer meets criteria|0|||
146859059|NCT04677179|529654767|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
146859060|NCT04677179|529654768|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
146859061|NCT04677179|529654759|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
146859062|NCT04677179|529654760|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
146859063|NCT04677179|529654761|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
146859064|NCT04677179|529654762|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
146859065|NCT04677179|529654763|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
146859066|NCT04677179|529654764|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
146859067|NCT04677179|529654765|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
146859068|NCT04677179|529654766|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
146859069|NCT04677179|529654767|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
146859070|NCT04677179|529654768|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
146859071|NCT04677179|529654759|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
146859072|NCT04677179|529654760|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
146859073|NCT04677179|529654761|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
146859074|NCT04677179|529654762|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
146523205|NCT02915159|528423374|FG000|Overall Study|poor/non-compliance|1|||
146523206|NCT02915159|528423375|FG001|Overall Study|poor/non-compliance|0|||
146859075|NCT04677179|529654763|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
146523207|NCT02915159|528423374|FG000|Overall Study|Participant withdrew consent|5|||
146523208|NCT02915159|528423375|FG001|Overall Study|Participant withdrew consent|1|||
146523209|NCT02915159|528423374|FG000|Overall Study|Request to discontinue treatment|1|||
146523210|NCT02915159|528423375|FG001|Overall Study|Request to discontinue treatment|2|||
146523211|NCT02915159|528423374|FG000|Overall Study|Adverse Event|2|||
146859076|NCT04677179|529654764|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
146859077|NCT04677179|529654765|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
146859078|NCT04677179|529654766|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
146859079|NCT04677179|529654767|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
146859080|NCT04677179|529654768|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
146859081|NCT04677179|529654759|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146859082|NCT04677179|529654760|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146859083|NCT04677179|529654761|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146859084|NCT04677179|529654762|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146859085|NCT04677179|529654763|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146859086|NCT04677179|529654764|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146859087|NCT04677179|529654765|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146859088|NCT04677179|529654766|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
146859089|NCT04677179|529654767|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146859090|NCT04677179|529654768|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146859091|NCT04677179|529654759|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146859092|NCT04677179|529654760|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146859093|NCT04677179|529654761|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146859094|NCT04677179|529654762|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146859095|NCT04677179|529654763|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146859096|NCT04677179|529654764|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146859097|NCT04677179|529654765|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146859098|NCT04677179|529654766|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
146859099|NCT04677179|529654767|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
146859100|NCT04677179|529654768|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146859101|NCT04677179|529654759|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
146859102|NCT04677179|529654760|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
146859103|NCT04677179|529654761|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
146859104|NCT04677179|529654762|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
146859105|NCT04677179|529654763|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
146859106|NCT04677179|529654764|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
146859107|NCT04677179|529654765|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
146859108|NCT04677179|529654766|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
146859109|NCT04677179|529654767|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
146859110|NCT04677179|529654768|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
146859111|NCT03581825|529654773|FG000|Period 1|Lens Discomfort|1|||
146859112|NCT03581825|529654774|FG001|Period 1|Lens Discomfort|0|||
146859113|NCT03581825|529654773|FG000|Period 2|Unsatisfactory Vision to Test|0|||
146523212|NCT02915159|528423375|FG001|Overall Study|Adverse Event|2|||
146523213|NCT02915159|528423374|FG000|Overall Study|Lack of Efficacy|0|||
146523214|NCT02915159|528423375|FG001|Overall Study|Lack of Efficacy|3|||
146523215|NCT04534517|528423376|FG000|Overall Study|Adverse Event|1|||
146523216|NCT04534517|528423376|FG000|Overall Study|Withdrawal by Subject|1|||
146523217|NCT04534517|528423376|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
146523218|NCT04534517|528423376|FG000|Overall Study|COVID-19 Related|1|||
146523219|NCT03872843|528423377|FG000|Overall Study|Lost to Follow-up|5|||
146523220|NCT03872843|528423378|FG001|Overall Study|Lost to Follow-up|7|||
146523221|NCT05133323|528423379|FG000|Overall Study|Lack of Efficacy|0|||
146523222|NCT05133323|528423380|FG001|Overall Study|Lack of Efficacy|0|||
146523223|NCT05133323|528423381|FG002|Overall Study|Lack of Efficacy|1|||
146523224|NCT05133323|528423379|FG000|Overall Study|Withdrawal by Subject|2|||
146523225|NCT05133323|528423380|FG001|Overall Study|Withdrawal by Subject|1|||
146523226|NCT05133323|528423381|FG002|Overall Study|Withdrawal by Subject|0|||
146523227|NCT02465437|528423390|FG000|Overall Study|Physician Decision|0|||
146523228|NCT02465437|528423391|FG001|Overall Study|Physician Decision|0|||
146523229|NCT02465437|528423392|FG002|Overall Study|Physician Decision|1|||
146523230|NCT02465437|528423393|FG003|Overall Study|Physician Decision|0|||
146523231|NCT02465437|528423390|FG000|Overall Study|Withdrawal by Subject|1|||
146523232|NCT02465437|528423391|FG001|Overall Study|Withdrawal by Subject|0|||
146523233|NCT02465437|528423392|FG002|Overall Study|Withdrawal by Subject|0|||
146523234|NCT02465437|528423393|FG003|Overall Study|Withdrawal by Subject|1|||
146523235|NCT02465437|528423390|FG000|Overall Study|Adverse Event|0|||
146523236|NCT02465437|528423391|FG001|Overall Study|Adverse Event|1|||
146523237|NCT02465437|528423392|FG002|Overall Study|Adverse Event|0|||
146523238|NCT02465437|528423393|FG003|Overall Study|Adverse Event|0|||
146523239|NCT00003483|528423394|FG000|Overall Study|Not evaluable|1|||
146523240|NCT00103662|528423395|FG000|Overall Study|Entered Rescue Procedure|0|||
146523241|NCT00103662|528423396|FG001|Overall Study|Entered Rescue Procedure|7|||
146523242|NCT00103662|528423395|FG000|Overall Study|Death|7|||
146523243|NCT00103662|528423396|FG001|Overall Study|Death|7|||
146859114|NCT03581825|529654774|FG001|Period 2|Unsatisfactory Vision to Test|1|||
146965081|NCT03110107|530033445|FG019|Treatment Period|Death|0|||
146523244|NCT00103662|528423395|FG000|Overall Study|Elective Withdrawal|5|||
146523245|NCT00103662|528423396|FG001|Overall Study|Elective Withdrawal|5|||
146523246|NCT00103662|528423395|FG000|Overall Study|Lost to Follow-up|0|||
146523247|NCT00103662|528423396|FG001|Overall Study|Lost to Follow-up|1|||
146523248|NCT00103662|528423395|FG000|Overall Study|Other|6|||
146859115|NCT03261700|529654775|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
146859116|NCT03261700|529654776|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
146859117|NCT00585195|529654779|FG000|Overall Study|Adverse Event|0|||
146859118|NCT00585195|529654780|FG001|Overall Study|Adverse Event|0|||
146523249|NCT00103662|528423396|FG001|Overall Study|Other|9|||
146523250|NCT00103662|528423395|FG000|Overall Study|Failed mobilization|0|||
146523251|NCT00103662|528423396|FG001|Overall Study|Failed mobilization|4|||
146523252|NCT00103662|528423395|FG000|Overall Study|Intercurrent illness|1|||
146523253|NCT00103662|528423396|FG001|Overall Study|Intercurrent illness|0|||
146523254|NCT00105989|528423397|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
146523255|NCT00105989|528423398|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
146523256|NCT00105989|528423397|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
146523257|NCT00105989|528423398|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
146523258|NCT00105989|528423397|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
146523259|NCT00105989|528423398|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
146523260|NCT00105989|528423397|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
146523261|NCT00105989|528423398|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
146523262|NCT00105989|528423397|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
146523263|NCT00105989|528423398|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
146523264|NCT00105989|528423397|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
146523265|NCT00105989|528423398|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
146523266|NCT00105989|528423397|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
146523267|NCT00105989|528423398|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
146523268|NCT00105989|528423397|FG000|Acute - Open Label: Week 0-10|Death|1|||
146523269|NCT00105989|528423398|FG001|Acute - Open Label: Week 0-10|Death|0|||
146523270|NCT00105989|528423397|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
146523271|NCT00105989|528423398|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
146523272|NCT00105989|528423397|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
146523273|NCT00105989|528423398|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
146523274|NCT00105989|528423397|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
146859119|NCT00585195|529654781|FG002|Overall Study|Adverse Event|0|||
146859120|NCT00585195|529654782|FG003|Overall Study|Adverse Event|0|||
146859121|NCT00585195|529654783|FG004|Overall Study|Adverse Event|2|||
146859122|NCT00585195|529654784|FG005|Overall Study|Adverse Event|1|||
146859123|NCT00585195|529654785|FG006|Overall Study|Adverse Event|0|||
146859124|NCT00585195|529654786|FG007|Overall Study|Adverse Event|1|||
146859125|NCT00585195|529654787|FG008|Overall Study|Adverse Event|0|||
146859126|NCT00585195|529654788|FG009|Overall Study|Adverse Event|0|||
146859127|NCT00585195|529654789|FG010|Overall Study|Adverse Event|3|||
146859128|NCT00585195|529654790|FG011|Overall Study|Adverse Event|0|||
146859129|NCT00585195|529654791|FG012|Overall Study|Adverse Event|8|||
146859130|NCT00585195|529654792|FG013|Overall Study|Adverse Event|6|||
146859131|NCT00585195|529654793|FG014|Overall Study|Adverse Event|4|||
146859132|NCT00585195|529654794|FG015|Overall Study|Adverse Event|1|||
146859133|NCT00585195|529654795|FG016|Overall Study|Adverse Event|14|||
146859134|NCT00585195|529654796|FG017|Overall Study|Adverse Event|9|||
146859135|NCT00585195|529654797|FG018|Overall Study|Adverse Event|2|||
146859136|NCT00585195|529654798|FG019|Overall Study|Adverse Event|3|||
146859137|NCT00585195|529654799|FG020|Overall Study|Adverse Event|1|||
146859138|NCT00585195|529654779|FG000|Overall Study|Progressive Disease|2|||
146859139|NCT00585195|529654780|FG001|Overall Study|Progressive Disease|2|||
146859140|NCT00585195|529654781|FG002|Overall Study|Progressive Disease|5|||
146859141|NCT00585195|529654782|FG003|Overall Study|Progressive Disease|4|||
146859142|NCT00585195|529654783|FG004|Overall Study|Progressive Disease|6|||
146859143|NCT00585195|529654784|FG005|Overall Study|Progressive Disease|4|||
146859144|NCT00585195|529654785|FG006|Overall Study|Progressive Disease|6|||
146859145|NCT00585195|529654786|FG007|Overall Study|Progressive Disease|3|||
146859146|NCT00585195|529654787|FG008|Overall Study|Progressive Disease|0|||
146523275|NCT00105989|528423398|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
146523276|NCT00105989|528423397|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
146523277|NCT00105989|528423398|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
146523278|NCT00105989|528423397|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
146523279|NCT00105989|528423398|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
146523280|NCT00105989|528423397|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
146523281|NCT00105989|528423398|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
146523282|NCT00105989|528423397|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
146859147|NCT00585195|529654788|FG009|Overall Study|Progressive Disease|5|||
146523283|NCT00105989|528423398|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
146523284|NCT00105989|528423397|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
146859148|NCT00585195|529654789|FG010|Overall Study|Progressive Disease|2|||
146859149|NCT00585195|529654790|FG011|Overall Study|Progressive Disease|25|||
146859150|NCT00585195|529654791|FG012|Overall Study|Progressive Disease|29|||
146859151|NCT00585195|529654792|FG013|Overall Study|Progressive Disease|26|||
146859152|NCT00585195|529654793|FG014|Overall Study|Progressive Disease|21|||
146859153|NCT00585195|529654794|FG015|Overall Study|Progressive Disease|12|||
146859154|NCT00585195|529654795|FG016|Overall Study|Progressive Disease|94|||
146859155|NCT00585195|529654796|FG017|Overall Study|Progressive Disease|42|||
146859156|NCT00585195|529654797|FG018|Overall Study|Progressive Disease|4|||
146859157|NCT00585195|529654798|FG019|Overall Study|Progressive Disease|9|||
146859158|NCT00585195|529654799|FG020|Overall Study|Progressive Disease|8|||
146859159|NCT00585195|529654779|FG000|Overall Study|Withdrawal by Subject|1|||
146859160|NCT00585195|529654780|FG001|Overall Study|Withdrawal by Subject|1|||
146859161|NCT00585195|529654781|FG002|Overall Study|Withdrawal by Subject|2|||
146523285|NCT00105989|528423398|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
146523286|NCT00105989|528423397|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
146523287|NCT00105989|528423398|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
146523288|NCT00105989|528423397|FG000|Continuation - Open Label:Week 10-34|Death|0|||
146523289|NCT00105989|528423398|FG001|Continuation - Open Label:Week 10-34|Death|0|||
146523290|NCT00105989|528423397|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
146523291|NCT00105989|528423398|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
146523292|NCT00105989|528423397|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
146523293|NCT00105989|528423398|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
146523294|NCT00105989|528423397|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
146523295|NCT00105989|528423398|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
146523296|NCT00105989|528423397|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
146523297|NCT00105989|528423398|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
146523298|NCT00105989|528423397|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
146523299|NCT00105989|528423398|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
146523300|NCT00105989|528423397|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
146523301|NCT00105989|528423398|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
146523302|NCT00105989|528423397|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
146523303|NCT00105989|528423398|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
146859162|NCT00585195|529654782|FG003|Overall Study|Withdrawal by Subject|2|||
146859163|NCT00585195|529654783|FG004|Overall Study|Withdrawal by Subject|0|||
146859164|NCT00585195|529654784|FG005|Overall Study|Withdrawal by Subject|0|||
146859165|NCT00585195|529654785|FG006|Overall Study|Withdrawal by Subject|0|||
146859166|NCT00585195|529654786|FG007|Overall Study|Withdrawal by Subject|1|||
146859167|NCT00585195|529654787|FG008|Overall Study|Withdrawal by Subject|0|||
146859168|NCT00585195|529654788|FG009|Overall Study|Withdrawal by Subject|0|||
146859169|NCT00585195|529654789|FG010|Overall Study|Withdrawal by Subject|3|||
146859170|NCT00585195|529654790|FG011|Overall Study|Withdrawal by Subject|8|||
146859171|NCT00585195|529654791|FG012|Overall Study|Withdrawal by Subject|15|||
146859172|NCT00585195|529654792|FG013|Overall Study|Withdrawal by Subject|0|||
146859173|NCT00585195|529654793|FG014|Overall Study|Withdrawal by Subject|3|||
146859174|NCT00585195|529654794|FG015|Overall Study|Withdrawal by Subject|0|||
146859175|NCT00585195|529654795|FG016|Overall Study|Withdrawal by Subject|7|||
146859176|NCT00585195|529654796|FG017|Overall Study|Withdrawal by Subject|1|||
146859177|NCT00585195|529654797|FG018|Overall Study|Withdrawal by Subject|2|||
146859178|NCT00585195|529654798|FG019|Overall Study|Withdrawal by Subject|2|||
146859179|NCT00585195|529654799|FG020|Overall Study|Withdrawal by Subject|0|||
146859180|NCT00585195|529654779|FG000|Overall Study|Other|0|||
146859181|NCT00585195|529654780|FG001|Overall Study|Other|1|||
146859182|NCT00585195|529654781|FG002|Overall Study|Other|1|||
146859183|NCT00585195|529654782|FG003|Overall Study|Other|1|||
146859184|NCT00585195|529654783|FG004|Overall Study|Other|0|||
146859185|NCT00585195|529654784|FG005|Overall Study|Other|1|||
146859186|NCT00585195|529654785|FG006|Overall Study|Other|0|||
146859187|NCT00585195|529654786|FG007|Overall Study|Other|0|||
146859188|NCT00585195|529654787|FG008|Overall Study|Other|2|||
146859189|NCT00585195|529654788|FG009|Overall Study|Other|1|||
146859190|NCT00585195|529654789|FG010|Overall Study|Other|0|||
146523304|NCT00105989|528423397|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
146523305|NCT00105989|528423398|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
146859191|NCT00585195|529654790|FG011|Overall Study|Other|19|||
146523306|NCT00105989|528423397|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
146523307|NCT00105989|528423398|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
146568717|NCT00328172|528595431|FG000|Overall Study|Lack of Efficacy|14|||
146859192|NCT00585195|529654791|FG012|Overall Study|Other|24|||
146859193|NCT00585195|529654792|FG013|Overall Study|Other|7|||
146859194|NCT00585195|529654793|FG014|Overall Study|Other|11|||
146859195|NCT00585195|529654794|FG015|Overall Study|Other|3|||
146859196|NCT00585195|529654795|FG016|Overall Study|Other|28|||
146859197|NCT00585195|529654796|FG017|Overall Study|Other|12|||
146859198|NCT00585195|529654797|FG018|Overall Study|Other|10|||
146859199|NCT00585195|529654798|FG019|Overall Study|Other|4|||
146859200|NCT00585195|529654799|FG020|Overall Study|Other|2|||
146859201|NCT00585195|529654779|FG000|Overall Study|Randomized not treated|0|||
146523308|NCT00105989|528423397|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
146523309|NCT00105989|528423398|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
146523310|NCT00105989|528423397|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
146523311|NCT00105989|528423398|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
146523312|NCT00105989|528423397|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
146523313|NCT00105989|528423398|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
146859202|NCT00585195|529654780|FG001|Overall Study|Randomized not treated|0|||
146859203|NCT00585195|529654781|FG002|Overall Study|Randomized not treated|1|||
146523314|NCT01806168|528423399|FG000|Overall Study|Adverse Event|1|||
146523315|NCT01806168|528423400|FG001|Overall Study|Adverse Event|0|||
146523316|NCT01806168|528423401|FG002|Overall Study|Adverse Event|0|||
146523317|NCT01806168|528423399|FG000|Overall Study|Withdrawal by Subject|0|||
146523318|NCT01806168|528423400|FG001|Overall Study|Withdrawal by Subject|1|||
146859204|NCT00585195|529654782|FG003|Overall Study|Randomized not treated|0|||
146859205|NCT00585195|529654783|FG004|Overall Study|Randomized not treated|1|||
146859206|NCT00585195|529654784|FG005|Overall Study|Randomized not treated|0|||
146859207|NCT00585195|529654785|FG006|Overall Study|Randomized not treated|1|||
146859208|NCT00585195|529654786|FG007|Overall Study|Randomized not treated|0|||
146859209|NCT00585195|529654787|FG008|Overall Study|Randomized not treated|0|||
146859210|NCT00585195|529654788|FG009|Overall Study|Randomized not treated|0|||
146859211|NCT00585195|529654789|FG010|Overall Study|Randomized not treated|2|||
146859212|NCT00585195|529654790|FG011|Overall Study|Randomized not treated|0|||
146859213|NCT00585195|529654791|FG012|Overall Study|Randomized not treated|0|||
146859214|NCT00585195|529654792|FG013|Overall Study|Randomized not treated|0|||
146859215|NCT00585195|529654793|FG014|Overall Study|Randomized not treated|0|||
146859216|NCT00585195|529654794|FG015|Overall Study|Randomized not treated|1|||
146859217|NCT00585195|529654795|FG016|Overall Study|Randomized not treated|0|||
146859218|NCT00585195|529654796|FG017|Overall Study|Randomized not treated|1|||
146859219|NCT00585195|529654797|FG018|Overall Study|Randomized not treated|3|||
146859220|NCT00585195|529654798|FG019|Overall Study|Randomized not treated|0|||
146859221|NCT00585195|529654799|FG020|Overall Study|Randomized not treated|2|||
146859222|NCT00585195|529654779|FG000|Overall Study|Death|0|||
146859223|NCT00585195|529654780|FG001|Overall Study|Death|0|||
146859224|NCT00585195|529654781|FG002|Overall Study|Death|0|||
146859225|NCT00585195|529654782|FG003|Overall Study|Death|0|||
146859226|NCT00585195|529654783|FG004|Overall Study|Death|0|||
146859227|NCT00585195|529654784|FG005|Overall Study|Death|0|||
146859228|NCT00585195|529654785|FG006|Overall Study|Death|0|||
146859229|NCT00585195|529654786|FG007|Overall Study|Death|0|||
146859230|NCT00585195|529654787|FG008|Overall Study|Death|1|||
146859231|NCT00585195|529654788|FG009|Overall Study|Death|0|||
146859232|NCT00585195|529654789|FG010|Overall Study|Death|1|||
146859233|NCT00585195|529654790|FG011|Overall Study|Death|1|||
146859234|NCT00585195|529654791|FG012|Overall Study|Death|7|||
146859235|NCT00585195|529654792|FG013|Overall Study|Death|2|||
146859236|NCT00585195|529654793|FG014|Overall Study|Death|8|||
146859237|NCT00585195|529654794|FG015|Overall Study|Death|2|||
146859238|NCT00585195|529654795|FG016|Overall Study|Death|11|||
146859239|NCT00585195|529654796|FG017|Overall Study|Death|0|||
146523319|NCT01806168|528423401|FG002|Overall Study|Withdrawal by Subject|2|||
146523320|NCT01806168|528423399|FG000|Overall Study|Protocol Violation|0|||
146523321|NCT01806168|528423400|FG001|Overall Study|Protocol Violation|0|||
146523322|NCT01806168|528423401|FG002|Overall Study|Protocol Violation|1|||
146523323|NCT01001910|528423402|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
146523324|NCT01462630|528423403|FG000|Overall Study|Did not initiate therapy|3|||
146523325|NCT01462630|528423403|FG000|Overall Study|Death|1|||
146523326|NCT01462630|528423403|FG000|Overall Study|Protocol Violation|2|||
146523327|NCT01462630|528423403|FG000|Overall Study|Adverse Event|1|||
146523328|NCT01048541|528423406|FG000|Overall Study|Withdrawal by Subject|1|||
146523329|NCT01048541|528423407|FG001|Overall Study|Withdrawal by Subject|0|||
146523330|NCT00996034|528423412|FG000|Overall Study|Lost to Follow-up|2|||
146523331|NCT00996034|528423412|FG000|Overall Study|withdrawn by PI|1|||
146859240|NCT00585195|529654797|FG018|Overall Study|Death|0|||
146859241|NCT00585195|529654798|FG019|Overall Study|Death|0|||
146859242|NCT00585195|529654799|FG020|Overall Study|Death|1|||
146523332|NCT01720524|528423413|FG000|Part A|Insufficient Clinical Response|2|||
146523333|NCT01720524|528423414|FG001|Part A|Insufficient Clinical Response|4|||
146859243|NCT00585195|529654779|FG000|Overall Study|Lost to Follow-up|0|||
146859244|NCT00585195|529654780|FG001|Overall Study|Lost to Follow-up|0|||
146859245|NCT00585195|529654781|FG002|Overall Study|Lost to Follow-up|0|||
146859246|NCT00585195|529654782|FG003|Overall Study|Lost to Follow-up|0|||
146523334|NCT01720524|528423413|FG000|Part A|Adverse Event|2|||
146859247|NCT00585195|529654783|FG004|Overall Study|Lost to Follow-up|0|||
146859248|NCT00585195|529654784|FG005|Overall Study|Lost to Follow-up|0|||
146523335|NCT01720524|528423414|FG001|Part A|Adverse Event|2|||
146859249|NCT00585195|529654785|FG006|Overall Study|Lost to Follow-up|0|||
146859250|NCT00585195|529654786|FG007|Overall Study|Lost to Follow-up|0|||
146859251|NCT00585195|529654787|FG008|Overall Study|Lost to Follow-up|0|||
146859252|NCT00585195|529654788|FG009|Overall Study|Lost to Follow-up|0|||
146759840|NCT00941031|529286940|FG002|Maintenance Period|Lack of Efficacy|0|||
146759841|NCT00941031|529286941|FG003|Maintenance Period|Lack of Efficacy|0|||
146759842|NCT00941031|529286942|FG004|Maintenance Period|Lack of Efficacy|0|||
146759843|NCT00941031|529286943|FG005|Maintenance Period|Lack of Efficacy|0|||
146759844|NCT00941031|529286944|FG006|Maintenance Period|Lack of Efficacy|13|||
146759845|NCT00631917|529286945|FG000|Overall Study|Adverse Event|34|||
146759846|NCT00631917|529286946|FG001|Overall Study|Adverse Event|45|||
146759847|NCT00631917|529286945|FG000|Overall Study|Abnormal laboratory value(s)|2|||
146759848|NCT00631917|529286946|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146759849|NCT00631917|529286945|FG000|Overall Study|Abnormal test procedure result(s)|3|||
146759850|NCT00631917|529286946|FG001|Overall Study|Abnormal test procedure result(s)|2|||
146759851|NCT00631917|529286945|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
146759852|NCT00631917|529286946|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
146759853|NCT00631917|529286945|FG000|Overall Study|No longer required study drug|0|||
146759854|NCT00631917|529286946|FG001|Overall Study|No longer required study drug|1|||
146759855|NCT00631917|529286945|FG000|Overall Study|Protocol deviation|6|||
146759856|NCT00631917|529286946|FG001|Overall Study|Protocol deviation|5|||
146759857|NCT00631917|529286945|FG000|Overall Study|Subject withdrew consent|25|||
146759858|NCT00631917|529286946|FG001|Overall Study|Subject withdrew consent|33|||
146759859|NCT00631917|529286945|FG000|Overall Study|Lost to Follow-up|7|||
146759860|NCT00631917|529286946|FG001|Overall Study|Lost to Follow-up|7|||
146759861|NCT00631917|529286945|FG000|Overall Study|Administrative problems|2|||
146759862|NCT00631917|529286946|FG001|Overall Study|Administrative problems|0|||
146759863|NCT00631917|529286945|FG000|Overall Study|Death|1|||
146759864|NCT00631917|529286946|FG001|Overall Study|Death|0|||
146759865|NCT01076335|529286949|FG000|Overall Study|Withdrawal by Subject|3|||
146759866|NCT01076335|529286949|FG000|Overall Study|Withdrawal without treatment|1|||
146759867|NCT02939183|529286950|FG000|Overall Study|Death|0|||
146759868|NCT02939183|529286951|FG001|Overall Study|Death|0|||
146759869|NCT02939183|529286952|FG002|Overall Study|Death|1|||
146759870|NCT02939183|529286953|FG003|Overall Study|Death|0|||
146759871|NCT02939183|529286954|FG004|Overall Study|Death|0|||
146759872|NCT02939183|529286955|FG005|Overall Study|Death|2|||
146759873|NCT02939183|529286956|FG006|Overall Study|Death|1|||
146759874|NCT02939183|529286957|FG007|Overall Study|Death|0|||
146759875|NCT02939183|529286958|FG008|Overall Study|Death|0|||
146759876|NCT02939183|529286950|FG000|Overall Study|Sponsor decision|0|||
146759877|NCT02939183|529286951|FG001|Overall Study|Sponsor decision|1|||
146759878|NCT02939183|529286952|FG002|Overall Study|Sponsor decision|0|||
146759879|NCT02939183|529286953|FG003|Overall Study|Sponsor decision|1|||
146759880|NCT02939183|529286954|FG004|Overall Study|Sponsor decision|2|||
146759881|NCT02939183|529286955|FG005|Overall Study|Sponsor decision|0|||
146759882|NCT02939183|529286956|FG006|Overall Study|Sponsor decision|3|||
146759883|NCT02939183|529286957|FG007|Overall Study|Sponsor decision|1|||
146759884|NCT02939183|529286958|FG008|Overall Study|Sponsor decision|4|||
146759885|NCT02939183|529286950|FG000|Overall Study|Withdrawal by Subject|0|||
146759886|NCT02939183|529286951|FG001|Overall Study|Withdrawal by Subject|2|||
146759887|NCT02939183|529286952|FG002|Overall Study|Withdrawal by Subject|0|||
146759888|NCT02939183|529286953|FG003|Overall Study|Withdrawal by Subject|1|||
146759889|NCT02939183|529286954|FG004|Overall Study|Withdrawal by Subject|0|||
146759890|NCT02939183|529286955|FG005|Overall Study|Withdrawal by Subject|0|||
146759891|NCT02939183|529286956|FG006|Overall Study|Withdrawal by Subject|2|||
146759892|NCT02939183|529286957|FG007|Overall Study|Withdrawal by Subject|2|||
146759893|NCT02939183|529286958|FG008|Overall Study|Withdrawal by Subject|2|||
146759894|NCT02939183|529286950|FG000|Overall Study|Not treated due to adverse event|0|||
146759895|NCT02939183|529286951|FG001|Overall Study|Not treated due to adverse event|0|||
146759896|NCT02939183|529286952|FG002|Overall Study|Not treated due to adverse event|0|||
146759897|NCT02939183|529286953|FG003|Overall Study|Not treated due to adverse event|1|||
146759898|NCT02939183|529286954|FG004|Overall Study|Not treated due to adverse event|0|||
146759899|NCT02939183|529286955|FG005|Overall Study|Not treated due to adverse event|0|||
146759900|NCT02939183|529286956|FG006|Overall Study|Not treated due to adverse event|1|||
146759901|NCT02939183|529286957|FG007|Overall Study|Not treated due to adverse event|0|||
146759902|NCT02939183|529286958|FG008|Overall Study|Not treated due to adverse event|0|||
146759903|NCT01740557|529286959|FG000|Overall Study|Ineligible|1|||
146759904|NCT01740557|529286959|FG000|Overall Study|Screen failure|1|||
146759905|NCT00490555|529286960|FG000|Overall Study|noncompliant with drug administration|0|||
146759906|NCT00490555|529286961|FG001|Overall Study|noncompliant with drug administration|0|||
146759907|NCT00490555|529286962|FG002|Overall Study|noncompliant with drug administration|2|||
146759908|NCT00490555|529286963|FG003|Overall Study|noncompliant with drug administration|0|||
146759909|NCT00603538|529286964|FG000|Overall Study|Adverse Event|0|||
146759910|NCT00603538|529286965|FG001|Overall Study|Adverse Event|4|||
146759911|NCT00603538|529286966|FG002|Overall Study|Adverse Event|2|||
146759912|NCT00603538|529286964|FG000|Overall Study|Objective progression or relapse|3|||
146759913|NCT00603538|529286965|FG001|Overall Study|Objective progression or relapse|0|||
146759914|NCT00603538|529286966|FG002|Overall Study|Objective progression or relapse|0|||
146759915|NCT04794179|529286967|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
146523336|NCT01720524|528423413|FG000|Part A|Death|2|||
146523337|NCT01720524|528423414|FG001|Part A|Death|1|||
146523338|NCT01720524|528423413|FG000|Part A|Lost to Follow-up|0|||
146759916|NCT04794179|529286968|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
146759917|NCT01096056|529286969|FG000|Overall Study|Lost to Follow-up|0|||
146759918|NCT01096056|529286970|FG001|Overall Study|Lost to Follow-up|1|||
146759919|NCT01737268|529286974|FG000|Overall Study|Adverse Event|6|||
146759920|NCT01737268|529286974|FG000|Overall Study|Worsening of Target Disease|2|||
146759921|NCT01737268|529286974|FG000|Overall Study|In consideration of the patient's safety|1|||
146759922|NCT01190176|529286977|FG000|Overall Study|Withdrawal by Subject|1|||
146759923|NCT01190176|529286977|FG000|Overall Study|Lost to Follow-up|1|||
146759924|NCT02909101|529286978|FG000|Overall Study|Lost to Follow-up|1|||
146759925|NCT02909101|529286979|FG001|Overall Study|Lost to Follow-up|1|||
146759926|NCT02189863|529286980|FG000|First 2 Weeks|Motion Sickness|4|||
146759927|NCT02189863|529286981|FG001|First 2 Weeks|Motion Sickness|2|||
146759928|NCT03697460|529286982|FG000|Overall Study|Withdrawal by Subject|3|||
146759929|NCT03369951|529286983|FG000|Overall Study|Withdrawal by Subject|3|||
146759930|NCT03369951|529286983|FG000|Overall Study|Death|1|||
146759931|NCT03369951|529286983|FG000|Overall Study|Lost to Follow-up|1|||
146759932|NCT03369951|529286983|FG000|Overall Study|Protocol Violation|1|||
146759933|NCT00725010|529286993|FG000|Overall Study|Toxicity|9|||
146759934|NCT00725010|529286993|FG000|Overall Study|Tumor Progression|7|||
146759935|NCT00725010|529286993|FG000|Overall Study|Withdrawal by Subject|2|||
146759936|NCT00725010|529286993|FG000|Overall Study|Death|1|||
146759937|NCT00725010|529286993|FG000|Overall Study|Lost to Follow-up|1|||
146759938|NCT00725010|529286993|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
146759939|NCT00725010|529286993|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
146759940|NCT00725010|529286993|FG000|Overall Study|No further documentation|1|||
146759941|NCT00725010|529286993|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
146759942|NCT03499600|529286994|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
146759943|NCT03499600|529286995|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
146759944|NCT00569946|529288658|FG000|Overall Study|Adverse Event|16|||
146759945|NCT00569946|529288658|FG000|Overall Study|Objective Progression or Relapse|42|||
146759946|NCT00569946|529288658|FG000|Overall Study|Global Deterioration of Health Status|1|||
146759947|NCT00797862|529288659|FG000|Overall Study|Adverse Event|86|||
146759948|NCT00797862|529288660|FG001|Overall Study|Adverse Event|44|||
146759949|NCT00797862|529288661|FG002|Overall Study|Adverse Event|58|||
146759950|NCT00797862|529288659|FG000|Overall Study|Abnormal Test Procedure Result|0|||
146759951|NCT00797862|529288660|FG001|Overall Study|Abnormal Test Procedure Result|1|||
146759952|NCT00797862|529288661|FG002|Overall Study|Abnormal Test Procedure Result|1|||
146759953|NCT00797862|529288659|FG000|Overall Study|Lack of Efficacy|1|||
146759954|NCT00797862|529288660|FG001|Overall Study|Lack of Efficacy|7|||
146759955|NCT00797862|529288661|FG002|Overall Study|Lack of Efficacy|6|||
146759956|NCT00797862|529288659|FG000|Overall Study|No longer required study medication|1|||
146759957|NCT00797862|529288660|FG001|Overall Study|No longer required study medication|0|||
146759958|NCT00797862|529288661|FG002|Overall Study|No longer required study medication|0|||
146759959|NCT00797862|529288659|FG000|Overall Study|Withdrawal by Subject|14|||
146759960|NCT00797862|529288660|FG001|Overall Study|Withdrawal by Subject|7|||
146759961|NCT00797862|529288661|FG002|Overall Study|Withdrawal by Subject|7|||
146759962|NCT00797862|529288659|FG000|Overall Study|Lost to Follow-up|11|||
146759963|NCT00797862|529288660|FG001|Overall Study|Lost to Follow-up|0|||
146759964|NCT00797862|529288661|FG002|Overall Study|Lost to Follow-up|5|||
146759965|NCT00797862|529288659|FG000|Overall Study|Administrative Problem|4|||
146759966|NCT00797862|529288660|FG001|Overall Study|Administrative Problem|0|||
146759967|NCT00797862|529288661|FG002|Overall Study|Administrative Problem|0|||
146759968|NCT00797862|529288659|FG000|Overall Study|Protocol Violation|4|||
146759969|NCT00797862|529288660|FG001|Overall Study|Protocol Violation|6|||
146759970|NCT00797862|529288661|FG002|Overall Study|Protocol Violation|8|||
146759971|NCT00797862|529288659|FG000|Overall Study|Mis-randomized|3|||
146759972|NCT00797862|529288660|FG001|Overall Study|Mis-randomized|3|||
146759973|NCT00797862|529288661|FG002|Overall Study|Mis-randomized|1|||
146759974|NCT05074498|529288664|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
146759975|NCT05074498|529288665|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
146759976|NCT05074498|529288666|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
146759977|NCT05074498|529288667|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
146759978|NCT05074498|529288668|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
146523339|NCT01720524|528423414|FG001|Part A|Lost to Follow-up|1|||
146759979|NCT05074498|529288669|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
146759980|NCT05074498|529288664|FG000|Part 1 (Upto Day 104)|Other|1|||
146759981|NCT05074498|529288665|FG001|Part 1 (Upto Day 104)|Other|0|||
146759982|NCT05074498|529288666|FG002|Part 1 (Upto Day 104)|Other|0|||
146759983|NCT05074498|529288667|FG003|Part 1 (Upto Day 104)|Other|0|||
146759984|NCT05074498|529288668|FG004|Part 1 (Upto Day 104)|Other|0|||
146759985|NCT05074498|529288669|FG005|Part 1 (Upto Day 104)|Other|0|||
146759986|NCT05074498|529288664|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
146523340|NCT01720524|528423413|FG000|Part A|Missed 28 day follow-up visit|1|||
146859253|NCT00585195|529654789|FG010|Overall Study|Lost to Follow-up|0|||
146859254|NCT00585195|529654790|FG011|Overall Study|Lost to Follow-up|0|||
146859255|NCT00585195|529654791|FG012|Overall Study|Lost to Follow-up|1|||
146859256|NCT00585195|529654792|FG013|Overall Study|Lost to Follow-up|0|||
146859257|NCT00585195|529654793|FG014|Overall Study|Lost to Follow-up|0|||
146859258|NCT00585195|529654794|FG015|Overall Study|Lost to Follow-up|0|||
146859259|NCT00585195|529654795|FG016|Overall Study|Lost to Follow-up|0|||
146859260|NCT00585195|529654796|FG017|Overall Study|Lost to Follow-up|2|||
146859261|NCT00585195|529654797|FG018|Overall Study|Lost to Follow-up|0|||
146859262|NCT00585195|529654798|FG019|Overall Study|Lost to Follow-up|0|||
146859263|NCT00585195|529654799|FG020|Overall Study|Lost to Follow-up|0|||
146859264|NCT00585195|529654779|FG000|Overall Study|Site Terminated by Sponsor|0|||
146859265|NCT00585195|529654780|FG001|Overall Study|Site Terminated by Sponsor|0|||
146859266|NCT00585195|529654781|FG002|Overall Study|Site Terminated by Sponsor|0|||
146859267|NCT00585195|529654782|FG003|Overall Study|Site Terminated by Sponsor|0|||
146859268|NCT00585195|529654783|FG004|Overall Study|Site Terminated by Sponsor|0|||
146859269|NCT00585195|529654784|FG005|Overall Study|Site Terminated by Sponsor|0|||
146859270|NCT00585195|529654785|FG006|Overall Study|Site Terminated by Sponsor|0|||
146859271|NCT00585195|529654786|FG007|Overall Study|Site Terminated by Sponsor|0|||
146859272|NCT00585195|529654787|FG008|Overall Study|Site Terminated by Sponsor|0|||
146859273|NCT00585195|529654788|FG009|Overall Study|Site Terminated by Sponsor|0|||
146859274|NCT00585195|529654789|FG010|Overall Study|Site Terminated by Sponsor|0|||
146859275|NCT00585195|529654790|FG011|Overall Study|Site Terminated by Sponsor|0|||
146859276|NCT00585195|529654791|FG012|Overall Study|Site Terminated by Sponsor|1|||
146859277|NCT00585195|529654792|FG013|Overall Study|Site Terminated by Sponsor|0|||
146859278|NCT00585195|529654793|FG014|Overall Study|Site Terminated by Sponsor|0|||
146859279|NCT00585195|529654794|FG015|Overall Study|Site Terminated by Sponsor|0|||
146859280|NCT00585195|529654795|FG016|Overall Study|Site Terminated by Sponsor|0|||
146859281|NCT00585195|529654796|FG017|Overall Study|Site Terminated by Sponsor|0|||
146859282|NCT00585195|529654797|FG018|Overall Study|Site Terminated by Sponsor|0|||
146859283|NCT00585195|529654798|FG019|Overall Study|Site Terminated by Sponsor|0|||
146859284|NCT00585195|529654799|FG020|Overall Study|Site Terminated by Sponsor|0|||
146859285|NCT00585195|529654779|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
146859286|NCT00585195|529654780|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
146859287|NCT00585195|529654781|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
146859288|NCT00585195|529654782|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
146859289|NCT00585195|529654783|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
146859290|NCT00585195|529654784|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
146859291|NCT00585195|529654785|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
146859292|NCT00585195|529654786|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
146859293|NCT00585195|529654787|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
146859294|NCT00585195|529654788|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
146859295|NCT00585195|529654789|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
146859296|NCT00585195|529654790|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
146859297|NCT00585195|529654791|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
146859298|NCT00585195|529654792|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
146859299|NCT00585195|529654793|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
146859300|NCT00585195|529654794|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
146859301|NCT00585195|529654795|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
146859302|NCT00585195|529654796|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
146859303|NCT00585195|529654797|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
146859304|NCT00585195|529654798|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
146859305|NCT00585195|529654799|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
146859306|NCT02796560|529654805|FG000|Overall Study|Adverse Event|2|||
146859307|NCT02796560|529654806|FG001|Overall Study|Adverse Event|0|||
146859308|NCT02796560|529654805|FG000|Overall Study|Withdrawal by Subject|2|||
146859309|NCT02796560|529654806|FG001|Overall Study|Withdrawal by Subject|2|||
146859310|NCT02533570|529654807|FG000|Overall Study|Adverse Event|0|||
146859311|NCT02533570|529654808|FG001|Overall Study|Adverse Event|1|||
146859312|NCT02533570|529654809|FG002|Overall Study|Adverse Event|1|||
146859313|NCT00529958|529654810|FG000|2-Year Follow-up|Lost to Follow-up|1|||
146859314|NCT00529958|529654811|FG001|2-Year Follow-up|Lost to Follow-up|2|||
146859315|NCT00529958|529654812|FG002|2-Year Follow-up|Lost to Follow-up|2|||
146859316|NCT00529958|529654810|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
146859317|NCT00529958|529654811|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
146859318|NCT00529958|529654812|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
146859319|NCT00529958|529654810|FG000|5-Year Follow-up|Lost to Follow-up|2|||
146859320|NCT00529958|529654811|FG001|5-Year Follow-up|Lost to Follow-up|3|||
146859321|NCT00529958|529654812|FG002|5-Year Follow-up|Lost to Follow-up|1|||
146859322|NCT00529958|529654810|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
146859323|NCT00529958|529654811|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
146859324|NCT00529958|529654812|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
146859325|NCT03816332|529654813|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
146859326|NCT03816332|529654813|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
146859327|NCT03534284|529654816|FG000|Overall Study|Death|2|||
146859328|NCT03534284|529654817|FG001|Overall Study|Death|3|||
146523341|NCT01720524|528423414|FG001|Part A|Missed 28 day follow-up visit|1|||
146523342|NCT01720524|528423413|FG000|Part A|Withdrawal by Subject|0|||
146523343|NCT01720524|528423414|FG001|Part A|Withdrawal by Subject|1|||
146523344|NCT01720524|528423413|FG000|Part A|Other|0|||
146523345|NCT01720524|528423414|FG001|Part A|Other|1|||
146523346|NCT01720524|528423413|FG000|Part A|Lost to Follow-up|0|||
146523347|NCT01720524|528423414|FG001|Part A|Lost to Follow-up|1|||
146859329|NCT03534284|529654818|FG002|Overall Study|Death|3|||
146859330|NCT03534284|529654816|FG000|Overall Study|Withdrawal by Subject|5|||
146859331|NCT03534284|529654817|FG001|Overall Study|Withdrawal by Subject|0|||
146859332|NCT03534284|529654818|FG002|Overall Study|Withdrawal by Subject|0|||
146859333|NCT03316300|529654819|FG000|Overall Study|Withdrawal by Subject|3|||
146859334|NCT03316300|529654820|FG001|Overall Study|Withdrawal by Subject|2|||
146859335|NCT03316300|529654819|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
146859336|NCT03316300|529654820|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
146859337|NCT03316300|529654819|FG000|Overall Study|Adverse Event|1|||
146859338|NCT03316300|529654820|FG001|Overall Study|Adverse Event|0|||
146859339|NCT03316300|529654819|FG000|Overall Study|COVID-19|0|||
146859340|NCT03316300|529654820|FG001|Overall Study|COVID-19|1|||
146859341|NCT03164564|529654821|FG000|Overall Study|Death|3|||
146859342|NCT03164564|529654822|FG001|Overall Study|Death|0|||
146859343|NCT03164564|529654821|FG000|Overall Study|Withdrawal by Subject|20|||
146859344|NCT03164564|529654822|FG001|Overall Study|Withdrawal by Subject|15|||
146859345|NCT03164564|529654821|FG000|Overall Study|Lost to Follow-up|2|||
146859346|NCT03164564|529654822|FG001|Overall Study|Lost to Follow-up|0|||
146859347|NCT03164564|529654821|FG000|Overall Study|Physician Decision|0|||
146859348|NCT03164564|529654822|FG001|Overall Study|Physician Decision|1|||
146859349|NCT03164564|529654821|FG000|Overall Study|Adverse Event|0|||
146859350|NCT03164564|529654822|FG001|Overall Study|Adverse Event|1|||
146859351|NCT03164564|529654821|FG000|Overall Study|Ongoing|1586|||
146859352|NCT03164564|529654822|FG001|Overall Study|Ongoing|1586|||
146859353|NCT01910181|529654823|FG000|Overall Study|Death|37|||
146859354|NCT01910181|529654823|FG000|Overall Study|Lost to Follow-up|3|||
146859355|NCT01910181|529654823|FG000|Overall Study|Study Terminated by Sponsor|6|||
146859356|NCT02656823|529654824|FG000|Overall Study|Adverse Event|3|||
146859357|NCT02656823|529654824|FG000|Overall Study|Lost to Follow-up|2|||
146859358|NCT01340651|529654828|FG000|Overall Study|Adverse Event|3|||
146859359|NCT01340651|529654828|FG000|Overall Study|Consent Withdrawn|2|||
146859360|NCT01340651|529654828|FG000|Overall Study|Commercial Supply per Sponsor|12|||
146859361|NCT01315353|529654829|FG000|Overall Study|Death|2|||
146859362|NCT01315353|529654830|FG001|Overall Study|Death|1|||
146859363|NCT01315353|529654831|FG002|Overall Study|Death|0|||
146859364|NCT01315353|529654829|FG000|Overall Study|Withdrawal by Subject|2|||
146859365|NCT01315353|529654830|FG001|Overall Study|Withdrawal by Subject|6|||
146859366|NCT01315353|529654831|FG002|Overall Study|Withdrawal by Subject|1|||
146859367|NCT01315353|529654829|FG000|Overall Study|Lost to Follow-up|13|||
146859368|NCT01315353|529654830|FG001|Overall Study|Lost to Follow-up|6|||
146859369|NCT01315353|529654831|FG002|Overall Study|Lost to Follow-up|6|||
146859370|NCT01315353|529654829|FG000|Overall Study|Unwilling to adhere to requirements|5|||
146859371|NCT01315353|529654830|FG001|Overall Study|Unwilling to adhere to requirements|5|||
146859372|NCT01315353|529654831|FG002|Overall Study|Unwilling to adhere to requirements|4|||
146859373|NCT01315353|529654829|FG000|Overall Study|Site closing|7|||
146859374|NCT01315353|529654830|FG001|Overall Study|Site closing|4|||
146859375|NCT01315353|529654831|FG002|Overall Study|Site closing|0|||
146859376|NCT01315353|529654829|FG000|Overall Study|Taken off study by site in error|0|||
146859377|NCT01315353|529654830|FG001|Overall Study|Taken off study by site in error|1|||
146859378|NCT01315353|529654831|FG002|Overall Study|Taken off study by site in error|0|||
146859379|NCT01315353|529654829|FG000|Overall Study|Inadvertent randomization/assignment|0|||
146859380|NCT01315353|529654830|FG001|Overall Study|Inadvertent randomization/assignment|0|||
146859381|NCT01315353|529654831|FG002|Overall Study|Inadvertent randomization/assignment|2|||
146859382|NCT01009580|529654832|FG000|Overall Study|Adverse Event|4|||
146859383|NCT01009580|529654833|FG001|Overall Study|Adverse Event|4|||
146859384|NCT01009580|529654832|FG000|Overall Study|Lack of Efficacy|0|||
146859385|NCT01009580|529654833|FG001|Overall Study|Lack of Efficacy|1|||
146859386|NCT01009580|529654832|FG000|Overall Study|Protocol Violation|2|||
146859387|NCT01009580|529654833|FG001|Overall Study|Protocol Violation|3|||
146859388|NCT01009580|529654832|FG000|Overall Study|Withdrawal Criteria|4|||
146859389|NCT01009580|529654833|FG001|Overall Study|Withdrawal Criteria|6|||
146859390|NCT01009580|529654832|FG000|Overall Study|Unclassified|17|||
146859391|NCT01009580|529654833|FG001|Overall Study|Unclassified|21|||
146523348|NCT01720524|528423413|FG000|Part B|No longer willing to participate in study|1|||
146859392|NCT04469270|529654834|FG000|Overall Study|Adverse Event|2|||
146859393|NCT04469270|529654835|FG001|Overall Study|Adverse Event|0|||
146859394|NCT04469270|529654834|FG000|Overall Study|Lost to Follow-up|4|||
146859395|NCT04469270|529654835|FG001|Overall Study|Lost to Follow-up|3|||
146859396|NCT04469270|529654834|FG000|Overall Study|Withdrawal by Subject|7|||
146859397|NCT04469270|529654835|FG001|Overall Study|Withdrawal by Subject|3|||
146859398|NCT04469270|529654834|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
146523349|NCT01720524|528423414|FG001|Part B|No longer willing to participate in study|4|||
146523350|NCT01720524|528423413|FG000|Part B|Other|2|||
146523351|NCT01720524|528423414|FG001|Part B|Other|0|||
146523352|NCT01720524|528423413|FG000|Part B|Lost to Follow-up|2|||
146523353|NCT01720524|528423414|FG001|Part B|Lost to Follow-up|3|||
146523354|NCT01720524|528423413|FG000|Part B|Death|0|||
146523355|NCT01720524|528423414|FG001|Part B|Death|2|||
146523356|NCT00158262|528423418|FG000|Overall Study|Lost to Follow-up|1|||
146523357|NCT00158262|528423419|FG001|Overall Study|Lost to Follow-up|1|||
146523358|NCT02105285|528423422|FG000|Overall Study|Adverse Event|1|||
146523359|NCT02105285|528423423|FG001|Overall Study|Adverse Event|1|||
146523360|NCT02105285|528423424|FG002|Overall Study|Adverse Event|0|||
146523361|NCT02105285|528423422|FG000|Overall Study|Protocol Violation|0|||
146523362|NCT02105285|528423423|FG001|Overall Study|Protocol Violation|1|||
146523363|NCT02105285|528423424|FG002|Overall Study|Protocol Violation|0|||
146523364|NCT02105285|528423422|FG000|Overall Study|Withdrawal by Subject|1|||
146523365|NCT02105285|528423423|FG001|Overall Study|Withdrawal by Subject|0|||
146523366|NCT02105285|528423424|FG002|Overall Study|Withdrawal by Subject|0|||
146523367|NCT01421641|528423425|FG000|Overall Study|Protocol Violation|2|||
146523368|NCT01421641|528423426|FG001|Overall Study|Protocol Violation|2|||
146523369|NCT02420119|528423427|FG000|Overall Study|insufficient laboratory data|5|||
146523370|NCT03231306|528423428|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
146523371|NCT03231306|528423428|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
146523372|NCT03231306|528423428|FG000|Overall Study|Treatment delay > 21 days|2|||
146523373|NCT03231306|528423428|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
146523374|NCT03231306|528423428|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
146523375|NCT03231306|528423428|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
146523376|NCT03231306|528423428|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
146523377|NCT03231306|528423428|FG000|Overall Study|More than 1 Reason|2|||
146523378|NCT04501952|528423429|FG000|Overall Study|Adverse Event|0|||
146523379|NCT04501952|528423430|FG001|Overall Study|Adverse Event|3|||
146523380|NCT04501952|528423429|FG000|Overall Study|Investigator's Discretion|0|||
146523381|NCT04501952|528423430|FG001|Overall Study|Investigator's Discretion|1|||
146523382|NCT04501952|528423429|FG000|Overall Study|Protocol Violation|1|||
146523383|NCT04501952|528423430|FG001|Overall Study|Protocol Violation|1|||
146523384|NCT04501952|528423429|FG000|Overall Study|Withdrew Consent|5|||
146523385|NCT04501952|528423430|FG001|Overall Study|Withdrew Consent|4|||
146523386|NCT04501952|528423429|FG000|Overall Study|Lost to Follow-up|7|||
146523387|NCT04501952|528423430|FG001|Overall Study|Lost to Follow-up|2|||
146523388|NCT04501952|528423429|FG000|Overall Study|Randomized and Never Treated|13|||
146523389|NCT04501952|528423430|FG001|Overall Study|Randomized and Never Treated|9|||
146523390|NCT02472886|528423435|FG000|Overall Study|Lack of Efficacy|0|||
146523391|NCT02472886|528423436|FG001|Overall Study|Lack of Efficacy|2|||
146523392|NCT02472886|528423437|FG002|Overall Study|Lack of Efficacy|1|||
146523393|NCT04533438|528423438|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
146523394|NCT04533438|528423439|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
146859399|NCT04469270|529654835|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
146859400|NCT04469270|529654834|FG000|Overall Study|missing|1|||
146523395|NCT03131687|528423440|FG000|Overall Study|Adverse Event|0|||
146523396|NCT03131687|528423441|FG001|Overall Study|Adverse Event|1|||
146859401|NCT04469270|529654835|FG001|Overall Study|missing|0|||
146859402|NCT01880528|529654838|FG000|Overall Study|Other|1|||
146859403|NCT01880528|529654839|FG001|Overall Study|Other|1|||
146859404|NCT02254278|529654840|FG000|Overall Study|Protocol Violation|1|||
146859405|NCT02254278|529654841|FG001|Overall Study|Protocol Violation|1|||
146859406|NCT01138007|529656839|FG000|Overall Study|Adverse Event|4|||
146859407|NCT01138007|529656840|FG001|Overall Study|Adverse Event|12|||
146859408|NCT01138007|529656841|FG002|Overall Study|Adverse Event|9|||
146859409|NCT01138007|529656839|FG000|Overall Study|Lack of Efficacy|2|||
146859410|NCT01138007|529656840|FG001|Overall Study|Lack of Efficacy|0|||
146859411|NCT01138007|529656841|FG002|Overall Study|Lack of Efficacy|6|||
146523397|NCT03131687|528423442|FG002|Overall Study|Adverse Event|0|||
146523398|NCT03131687|528423443|FG003|Overall Study|Adverse Event|1|||
146523399|NCT03131687|528423444|FG004|Overall Study|Adverse Event|2|||
146523400|NCT03131687|528423445|FG005|Overall Study|Adverse Event|2|||
146523401|NCT03131687|528423440|FG000|Overall Study|Death|1|||
146523402|NCT03131687|528423441|FG001|Overall Study|Death|0|||
146523403|NCT03131687|528423442|FG002|Overall Study|Death|0|||
146523404|NCT03131687|528423443|FG003|Overall Study|Death|0|||
146523405|NCT03131687|528423444|FG004|Overall Study|Death|0|||
146523406|NCT03131687|528423445|FG005|Overall Study|Death|0|||
146859412|NCT01138007|529656839|FG000|Overall Study|Protocol Violation|2|||
146859413|NCT01138007|529656840|FG001|Overall Study|Protocol Violation|3|||
146859414|NCT01138007|529656841|FG002|Overall Study|Protocol Violation|2|||
146859415|NCT01138007|529656839|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
146859416|NCT01138007|529656840|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
146523407|NCT03131687|528423440|FG000|Overall Study|Withdrawal by Subject|3|||
146859417|NCT01138007|529656841|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
146859418|NCT01138007|529656839|FG000|Overall Study|Lost to Follow-up|3|||
146859419|NCT01138007|529656840|FG001|Overall Study|Lost to Follow-up|3|||
146859420|NCT01138007|529656841|FG002|Overall Study|Lost to Follow-up|5|||
146859421|NCT01138007|529656839|FG000|Overall Study|Physician Decision|0|||
146859422|NCT01138007|529656840|FG001|Overall Study|Physician Decision|5|||
146859423|NCT01138007|529656841|FG002|Overall Study|Physician Decision|3|||
146859424|NCT01138007|529656839|FG000|Overall Study|Withdrawal by Subject|5|||
146859425|NCT01138007|529656840|FG001|Overall Study|Withdrawal by Subject|6|||
146859426|NCT01138007|529656841|FG002|Overall Study|Withdrawal by Subject|15|||
146859427|NCT03548987|529656842|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
146859428|NCT03548987|529656843|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
146859429|NCT03548987|529656842|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
146859430|NCT03548987|529656843|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
146859431|NCT03548987|529656842|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
146859432|NCT03548987|529656843|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
146859433|NCT03548987|529656842|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
146859434|NCT03548987|529656843|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
146859435|NCT03548987|529656842|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
146859436|NCT03548987|529656843|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
146859437|NCT03548987|529656842|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
146859438|NCT03548987|529656843|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
146859439|NCT03548987|529656842|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
146859440|NCT03548987|529656843|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
146859441|NCT03548987|529656842|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
146859442|NCT03548987|529656843|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
146859443|NCT03548987|529656842|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
146859444|NCT03548987|529656843|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
146859445|NCT03548987|529656842|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
146859446|NCT03548987|529656843|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
146859447|NCT03548987|529656842|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
146859448|NCT03548987|529656843|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
146859449|NCT03548987|529656842|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
146859450|NCT03548987|529656843|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
146859451|NCT03548987|529656842|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
146859452|NCT03548987|529656843|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
146859453|NCT03548987|529656842|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
146859454|NCT03548987|529656843|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
146859455|NCT04661878|529656844|FG000|Overall Study|Lost to Follow-up|6|||
146859456|NCT04661878|529656845|FG001|Overall Study|Lost to Follow-up|5|||
146859457|NCT02768870|529656848|FG000|Overall Study|Death|1|||
146859458|NCT02768870|529656848|FG000|Overall Study|Reoperation|6|||
146859459|NCT02768870|529656848|FG000|Overall Study|Lost to Follow-up|1|||
146859460|NCT02768870|529656848|FG000|Overall Study|Exit|4|||
146859461|NCT01774110|529656849|FG000|Overall Study|Lost to Follow-up|7|||
146859462|NCT00640016|529656850|FG000|Overall Study|Withdrawal by Subject|0|||
146859463|NCT00640016|529656851|FG001|Overall Study|Withdrawal by Subject|1|||
146859464|NCT00640016|529656852|FG002|Overall Study|Withdrawal by Subject|0|||
146859465|NCT00640016|529656853|FG003|Overall Study|Withdrawal by Subject|0|||
146859466|NCT00640016|529656850|FG000|Overall Study|Study termination|2|||
146859467|NCT00640016|529656851|FG001|Overall Study|Study termination|1|||
146859468|NCT00640016|529656852|FG002|Overall Study|Study termination|3|||
146859469|NCT00640016|529656853|FG003|Overall Study|Study termination|2|||
146859470|NCT00640016|529656850|FG000|Overall Study|Adverse Event|0|||
146859471|NCT00640016|529656851|FG001|Overall Study|Adverse Event|0|||
146859472|NCT00640016|529656852|FG002|Overall Study|Adverse Event|0|||
146859473|NCT00640016|529656853|FG003|Overall Study|Adverse Event|1|||
146859474|NCT01287065|529656854|FG000|Treatment Period 1|Adverse Event|0|||
146859475|NCT01287065|529656855|FG001|Treatment Period 1|Adverse Event|0|||
146859476|NCT01287065|529656856|FG002|Treatment Period 1|Adverse Event|0|||
146859477|NCT01287065|529656857|FG003|Treatment Period 1|Adverse Event|0|||
146859478|NCT01287065|529656858|FG004|Treatment Period 1|Adverse Event|1|||
146859479|NCT01287065|529656859|FG005|Treatment Period 1|Adverse Event|0|||
146859480|NCT01287065|529656854|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146859481|NCT01287065|529656855|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146859482|NCT01287065|529656856|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146859483|NCT01287065|529656857|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146859484|NCT01287065|529656858|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146859485|NCT01287065|529656859|FG005|Treatment Period 1|Withdrawal by Subject|1|||
146859486|NCT01259726|529656860|FG000|Overall Study|Death|1|||
146859487|NCT01259726|529656861|FG001|Overall Study|Death|0|||
146859488|NCT01259726|529656862|FG002|Overall Study|Death|0|||
146859489|NCT01259726|529656863|FG003|Overall Study|Death|0|||
146859490|NCT01259726|529656860|FG000|Overall Study|Physician Decision|2|||
146523408|NCT03131687|528423441|FG001|Overall Study|Withdrawal by Subject|3|||
146523409|NCT03131687|528423442|FG002|Overall Study|Withdrawal by Subject|3|||
146523410|NCT03131687|528423443|FG003|Overall Study|Withdrawal by Subject|1|||
146523411|NCT03131687|528423444|FG004|Overall Study|Withdrawal by Subject|2|||
146523412|NCT03131687|528423445|FG005|Overall Study|Withdrawal by Subject|1|||
146523413|NCT03131687|528423440|FG000|Overall Study|Lost to Follow-up|1|||
146523414|NCT03131687|528423441|FG001|Overall Study|Lost to Follow-up|4|||
146523415|NCT03131687|528423442|FG002|Overall Study|Lost to Follow-up|0|||
146523416|NCT03131687|528423443|FG003|Overall Study|Lost to Follow-up|1|||
146523417|NCT03131687|528423444|FG004|Overall Study|Lost to Follow-up|4|||
146523418|NCT03131687|528423445|FG005|Overall Study|Lost to Follow-up|2|||
146523419|NCT03131687|528423440|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
146523420|NCT03131687|528423441|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
146523421|NCT03131687|528423442|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
146523422|NCT03131687|528423443|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
146523423|NCT03131687|528423444|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
146523424|NCT03131687|528423445|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
146523425|NCT03131687|528423440|FG000|Overall Study|Principle Investigator Decision|0|||
146523426|NCT03131687|528423441|FG001|Overall Study|Principle Investigator Decision|1|||
146523427|NCT03131687|528423442|FG002|Overall Study|Principle Investigator Decision|0|||
146523428|NCT03131687|528423443|FG003|Overall Study|Principle Investigator Decision|0|||
146523429|NCT03131687|528423444|FG004|Overall Study|Principle Investigator Decision|0|||
146523430|NCT03131687|528423445|FG005|Overall Study|Principle Investigator Decision|0|||
146523431|NCT03131687|528423440|FG000|Overall Study|Inadvertent Enrollment|0|||
146523432|NCT03131687|528423441|FG001|Overall Study|Inadvertent Enrollment|0|||
146523433|NCT03131687|528423442|FG002|Overall Study|Inadvertent Enrollment|0|||
146523434|NCT03131687|528423443|FG003|Overall Study|Inadvertent Enrollment|1|||
146523435|NCT03131687|528423444|FG004|Overall Study|Inadvertent Enrollment|0|||
146523436|NCT03131687|528423445|FG005|Overall Study|Inadvertent Enrollment|0|||
146523437|NCT02797678|528423446|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
146523438|NCT02797678|528423447|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
146523439|NCT02797678|528423448|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
146523440|NCT02797678|528423449|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
146523441|NCT02797678|528423446|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
146523442|NCT02797678|528423447|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
146523443|NCT02797678|528423448|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
146523444|NCT02797678|528423449|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
146523445|NCT02797678|528423446|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
146523446|NCT02797678|528423447|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
146523447|NCT02797678|528423448|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
146523448|NCT02797678|528423449|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
146523449|NCT03046953|528423461|FG000|Overall Study|Relapse/progressive disease|21|||
146523450|NCT03046953|528423461|FG000|Overall Study|Death|2|||
146523451|NCT03046953|528423461|FG000|Overall Study|Withdrawal by Subject|3|||
146523452|NCT02716584|528423464|FG000|Overall Study|Lost to Follow-up|8|||
146523453|NCT02716584|528423465|FG001|Overall Study|Lost to Follow-up|5|||
146523454|NCT00420628|528423466|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
146523455|NCT00420628|528423467|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
146523456|NCT00420628|528423466|FG000|Overall Study|Lost to Follow-up|3|||
146523457|NCT00420628|528423467|FG001|Overall Study|Lost to Follow-up|2|||
146523458|NCT00420628|528423466|FG000|Overall Study|Adverse Event|1|||
146523459|NCT00420628|528423467|FG001|Overall Study|Adverse Event|0|||
146523460|NCT01903993|528423471|FG000|Overall Study|Death|118|||
146523461|NCT01903993|528423472|FG001|Overall Study|Death|121|||
146523462|NCT01903993|528423471|FG000|Overall Study|Withdrawal by Subject|15|||
146523463|NCT01903993|528423472|FG001|Overall Study|Withdrawal by Subject|4|||
146523464|NCT01903993|528423471|FG000|Overall Study|Lost to Follow-up|2|||
146523465|NCT01903993|528423472|FG001|Overall Study|Lost to Follow-up|3|||
146523466|NCT01903993|528423471|FG000|Overall Study|Study Terminated by Sponsor|8|||
146523467|NCT01903993|528423472|FG001|Overall Study|Study Terminated by Sponsor|14|||
146523468|NCT01903993|528423471|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
146523469|NCT01903993|528423472|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
146523470|NCT00805129|528423480|FG000|Overall Study|Not treated|1|||
146523471|NCT01868165|528423481|FG000|Overall Study|Withdrawal by Subject|36|||
146523472|NCT01868165|528423481|FG000|Overall Study|Physician Decision|2|||
146523473|NCT01868165|528423481|FG000|Overall Study|Lost to Follow-up|3|||
146523474|NCT01868165|528423481|FG000|Overall Study|Death|4|||
146523475|NCT00571662|528423482|FG000|Overall Study|Withdrawal by Subject|2|||
146523476|NCT00571662|528423482|FG000|Overall Study|psychiatric instability|1|||
146523477|NCT00571662|528423482|FG000|Overall Study|Adverse Event|5|||
146523478|NCT01429298|528423483|FG000|Overall Study|Protocol Violation|4|||
146523479|NCT01429298|528423484|FG001|Overall Study|Protocol Violation|6|||
146523480|NCT01839916|528423485|FG000|Overall Study|Death|9|||
146523481|NCT01839916|528423485|FG000|Overall Study|Physician Decision|17|||
146523482|NCT01839916|528423485|FG000|Overall Study|Relapse|12|||
146523483|NCT01839916|528423485|FG000|Overall Study|GVHD|2|||
146523484|NCT01839916|528423485|FG000|Overall Study|Graft Failure|1|||
146523485|NCT02385110|528423488|FG000|Overall Study|Early Death|1|||
146523486|NCT02385110|528423489|FG001|Overall Study|Early Death|0|||
146523487|NCT05259163|528425010|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
146523488|NCT05259163|528425011|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
146523489|NCT00823264|528425022|FG000|Overall Study|Protocol Violation|2|||
146523490|NCT00823264|528425023|FG001|Overall Study|Protocol Violation|0|||
146523491|NCT01714544|528425024|FG000|Overall Study|Lost to Follow-up|1|||
146523492|NCT01714544|528425024|FG000|Overall Study|Physician Decision|1|||
146523493|NCT01714544|528425024|FG000|Overall Study|Withdrawal by Subject|1|||
146523494|NCT03373760|528425031|FG000|Overall Study|Adverse Event|8|||
146523495|NCT03373760|528425031|FG000|Overall Study|Disease Progression|46|||
146523496|NCT03373760|528425031|FG000|Overall Study|Death|4|||
146523497|NCT01093586|528425032|FG000|Overall Study|Failed to engraft|3|||
146523498|NCT01968811|528425033|FG000|Overall Study|Protocol Violation|4|||
146523499|NCT01968811|528425033|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
146523500|NCT01716663|528425035|FG000|Overall Study|Withdrawn prior to procedure|4|||
146523501|NCT01716663|528425035|FG000|Overall Study|Treated with non-study catheter|2|||
146523502|NCT00872521|528425036|FG000|Completed PAD Induction|Patient choice|0|||
146523503|NCT00872521|528425037|FG001|Completed PAD Induction|Patient choice|1|||
146523504|NCT00872521|528425038|FG002|Completed PAD Induction|Patient choice|0|||
146523505|NCT00872521|528425036|FG000|Completed PAD Induction|Disease progression|0|||
146523506|NCT00872521|528425037|FG001|Completed PAD Induction|Disease progression|2|||
146523507|NCT00872521|528425038|FG002|Completed PAD Induction|Disease progression|0|||
146523508|NCT00872521|528425036|FG000|Completed PAD Induction|Adverse Event|4|||
146523509|NCT00872521|528425037|FG001|Completed PAD Induction|Adverse Event|0|||
146523510|NCT00872521|528425038|FG002|Completed PAD Induction|Adverse Event|0|||
146523511|NCT00872521|528425036|FG000|Completed PAD Induction|Death|1|||
146523512|NCT00872521|528425037|FG001|Completed PAD Induction|Death|1|||
146523513|NCT00872521|528425038|FG002|Completed PAD Induction|Death|0|||
146523514|NCT00872521|528425036|FG000|Primary Endpoint Analysis|Other|1|||
146523515|NCT00872521|528425037|FG001|Primary Endpoint Analysis|Other|2|||
146523516|NCT00872521|528425038|FG002|Primary Endpoint Analysis|Other|0|||
146523517|NCT00872521|528425036|FG000|Primary Endpoint Analysis|Patient choice|0|||
146523518|NCT00872521|528425037|FG001|Primary Endpoint Analysis|Patient choice|1|||
146523519|NCT00872521|528425038|FG002|Primary Endpoint Analysis|Patient choice|0|||
146523520|NCT00872521|528425036|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
146523521|NCT00872521|528425037|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
146523522|NCT00872521|528425038|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
146523523|NCT00872521|528425036|FG000|Primary Endpoint Analysis|Patient response missing|0|||
146523524|NCT00872521|528425037|FG001|Primary Endpoint Analysis|Patient response missing|0|||
146523525|NCT00872521|528425038|FG002|Primary Endpoint Analysis|Patient response missing|1|||
146523526|NCT00872521|528425036|FG000|Completed 3-month Follow up|Other|0|||
146523527|NCT00872521|528425037|FG001|Completed 3-month Follow up|Other|2|||
146523528|NCT00872521|528425038|FG002|Completed 3-month Follow up|Other|0|||
146523529|NCT00872521|528425036|FG000|Completed 3-month Follow up|Physician Decision|0|||
146523530|NCT00872521|528425037|FG001|Completed 3-month Follow up|Physician Decision|1|||
146523531|NCT00872521|528425038|FG002|Completed 3-month Follow up|Physician Decision|0|||
146523532|NCT00872521|528425036|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
146759987|NCT05074498|529288665|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
146759988|NCT05074498|529288666|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
146759989|NCT05074498|529288667|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
146759990|NCT05074498|529288668|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
146759991|NCT05074498|529288669|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
146759992|NCT05074498|529288664|FG000|Part 2 (Upto Day 104)|Death|0|||
146759993|NCT05074498|529288665|FG001|Part 2 (Upto Day 104)|Death|0|||
146759994|NCT05074498|529288666|FG002|Part 2 (Upto Day 104)|Death|0|||
146759995|NCT05074498|529288667|FG003|Part 2 (Upto Day 104)|Death|0|||
146759996|NCT05074498|529288668|FG004|Part 2 (Upto Day 104)|Death|1|||
146759997|NCT05074498|529288669|FG005|Part 2 (Upto Day 104)|Death|0|||
146759998|NCT05074498|529288664|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
146759999|NCT05074498|529288665|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
146760000|NCT05074498|529288666|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
146523533|NCT00872521|528425037|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
146523534|NCT00872521|528425038|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
146523535|NCT03006562|528425039|FG000|Overall Study|Lost to Follow-up|0|||
146523536|NCT03006562|528425040|FG001|Overall Study|Lost to Follow-up|1|||
146523537|NCT01089127|528425045|FG000|Overall Study|Adverse Event|5|||
146523538|NCT01089127|528425046|FG001|Overall Study|Adverse Event|1|||
146523539|NCT01089127|528425047|FG002|Overall Study|Adverse Event|1|||
146523540|NCT01089127|528425048|FG003|Overall Study|Adverse Event|0|||
146523541|NCT01089127|528425049|FG004|Overall Study|Adverse Event|0|||
146523542|NCT01089127|528425050|FG005|Overall Study|Adverse Event|1|||
146523543|NCT01089127|528425045|FG000|Overall Study|Subject withdrew consent|0|||
146523544|NCT01089127|528425046|FG001|Overall Study|Subject withdrew consent|1|||
146523545|NCT01089127|528425047|FG002|Overall Study|Subject withdrew consent|1|||
146523546|NCT01089127|528425048|FG003|Overall Study|Subject withdrew consent|1|||
146523547|NCT01089127|528425049|FG004|Overall Study|Subject withdrew consent|0|||
146523548|NCT01089127|528425050|FG005|Overall Study|Subject withdrew consent|2|||
146523549|NCT01089127|528425045|FG000|Overall Study|Abnormal test procedure result(s)|2|||
146523550|NCT01089127|528425046|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146523551|NCT01089127|528425047|FG002|Overall Study|Abnormal test procedure result(s)|0|||
146523552|NCT01089127|528425048|FG003|Overall Study|Abnormal test procedure result(s)|0|||
146523553|NCT01089127|528425049|FG004|Overall Study|Abnormal test procedure result(s)|0|||
146523554|NCT01089127|528425050|FG005|Overall Study|Abnormal test procedure result(s)|0|||
146523555|NCT01089127|528425045|FG000|Overall Study|Lost to Follow-up|1|||
146523556|NCT01089127|528425046|FG001|Overall Study|Lost to Follow-up|1|||
146523557|NCT01089127|528425047|FG002|Overall Study|Lost to Follow-up|0|||
146523558|NCT01089127|528425048|FG003|Overall Study|Lost to Follow-up|0|||
146523559|NCT01089127|528425049|FG004|Overall Study|Lost to Follow-up|1|||
146523560|NCT01089127|528425050|FG005|Overall Study|Lost to Follow-up|0|||
146523561|NCT01089127|528425045|FG000|Overall Study|Protocol deviation|0|||
146523562|NCT01089127|528425046|FG001|Overall Study|Protocol deviation|1|||
146523563|NCT01089127|528425047|FG002|Overall Study|Protocol deviation|0|||
146523564|NCT01089127|528425048|FG003|Overall Study|Protocol deviation|0|||
146523565|NCT01089127|528425049|FG004|Overall Study|Protocol deviation|1|||
146523566|NCT01089127|528425050|FG005|Overall Study|Protocol deviation|0|||
146523567|NCT02427841|528425054|FG000|Overall Study|Lack of Efficacy|5|||
146523568|NCT02427841|528425054|FG000|Overall Study|Physician Decision|2|||
146523569|NCT02427841|528425054|FG000|Overall Study|Withdrawal by Subject|1|||
146523570|NCT00511810|528425055|FG000|Overall Study|Lost to Follow-up|1|||
146523571|NCT00511810|528425056|FG001|Overall Study|Lost to Follow-up|2|||
146523572|NCT00511810|528425055|FG000|Overall Study|Lack of Efficacy|0|||
146523573|NCT00511810|528425056|FG001|Overall Study|Lack of Efficacy|2|||
146523574|NCT00511810|528425055|FG000|Overall Study|Refused second scn|0|||
146523575|NCT00511810|528425056|FG001|Overall Study|Refused second scn|1|||
146523576|NCT02592447|528425059|FG000|Overall Study|Lost to Follow-up|1|||
146523577|NCT02592447|528425060|FG001|Overall Study|Lost to Follow-up|0|||
146523578|NCT02592447|528425059|FG000|Overall Study|Ineligible after randomization|1|||
146523579|NCT02592447|528425060|FG001|Overall Study|Ineligible after randomization|0|||
146523580|NCT02592447|528425059|FG000|Overall Study|Withdrawal by Subject|0|||
146523581|NCT02592447|528425060|FG001|Overall Study|Withdrawal by Subject|1|||
146523582|NCT01096160|528425067|FG000|Overall Study|Adverse Event|0|||
146523583|NCT01096160|528425068|FG001|Overall Study|Adverse Event|0|||
146523584|NCT01096160|528425069|FG002|Overall Study|Adverse Event|1|||
146523585|NCT01096160|528425070|FG003|Overall Study|Adverse Event|0|||
146523586|NCT01096160|528425071|FG004|Overall Study|Adverse Event|0|||
146523587|NCT01096160|528425072|FG005|Overall Study|Adverse Event|0|||
146523588|NCT01096160|528425073|FG006|Overall Study|Adverse Event|0|||
146523589|NCT01096160|528425074|FG007|Overall Study|Adverse Event|0|||
146523590|NCT01096160|528425075|FG008|Overall Study|Adverse Event|0|||
146523591|NCT01096160|528425076|FG009|Overall Study|Adverse Event|1|||
146523592|NCT01096160|528425067|FG000|Overall Study|Met stopping criteria per protocol|0|||
146523593|NCT01096160|528425068|FG001|Overall Study|Met stopping criteria per protocol|0|||
146523594|NCT01096160|528425069|FG002|Overall Study|Met stopping criteria per protocol|0|||
146523595|NCT01096160|528425070|FG003|Overall Study|Met stopping criteria per protocol|0|||
146523596|NCT01096160|528425071|FG004|Overall Study|Met stopping criteria per protocol|1|||
146523597|NCT01096160|528425072|FG005|Overall Study|Met stopping criteria per protocol|0|||
146523598|NCT01096160|528425073|FG006|Overall Study|Met stopping criteria per protocol|2|||
146523599|NCT01096160|528425074|FG007|Overall Study|Met stopping criteria per protocol|0|||
146523600|NCT01096160|528425075|FG008|Overall Study|Met stopping criteria per protocol|2|||
146523601|NCT01096160|528425076|FG009|Overall Study|Met stopping criteria per protocol|0|||
146523602|NCT00627497|528425078|FG000|Overall Study|Lost to Follow-up|1|||
146523603|NCT00627497|528425079|FG001|Overall Study|Lost to Follow-up|1|||
146523604|NCT00627497|528425080|FG002|Overall Study|Lost to Follow-up|0|||
146523605|NCT00627497|528425081|FG003|Overall Study|Lost to Follow-up|0|||
146523606|NCT01300247|528425082|FG000|Overall Study|Death|1|||
146523607|NCT01300247|528425083|FG001|Overall Study|Death|1|||
146523608|NCT01300247|528425082|FG000|Overall Study|Lost to Follow-up|2|||
146523609|NCT01300247|528425083|FG001|Overall Study|Lost to Follow-up|0|||
146523610|NCT01300247|528425082|FG000|Overall Study|Withdrawal by Subject|1|||
146523611|NCT01300247|528425083|FG001|Overall Study|Withdrawal by Subject|0|||
146523612|NCT01300247|528425082|FG000|Overall Study|Non-Compliance|0|||
146523613|NCT01300247|528425083|FG001|Overall Study|Non-Compliance|1|||
146523614|NCT00922116|528425084|FG000|Overall Study|Adverse Event|4|||
146523615|NCT00922116|528425084|FG000|Overall Study|Death|1|||
146859491|NCT01259726|529656861|FG001|Overall Study|Physician Decision|0|||
146523616|NCT00922116|528425084|FG000|Overall Study|Lost to Follow-up|1|||
146523617|NCT00922116|528425084|FG000|Overall Study|Withdrawal by Subject|4|||
146523618|NCT00922116|528425084|FG000|Overall Study|Other|5|||
146523619|NCT06060496|528425085|FG000|Overall Study|Withdrawal by Subject|2|||
146523620|NCT06060496|528425085|FG000|Overall Study|Lost to Follow-up|2|||
146523621|NCT02028507|528425086|FG000|Overall Study|Progressive Disease|122|||
146523622|NCT02028507|528425087|FG001|Overall Study|Progressive Disease|90|||
146523623|NCT02028507|528425088|FG002|Overall Study|Progressive Disease|102|||
146523624|NCT02028507|528425089|FG003|Overall Study|Progressive Disease|89|||
146523625|NCT02028507|528425086|FG000|Overall Study|Adverse Event|8|||
146523626|NCT02028507|528425087|FG001|Overall Study|Adverse Event|25|||
146523627|NCT02028507|528425088|FG002|Overall Study|Adverse Event|3|||
146523628|NCT02028507|528425089|FG003|Overall Study|Adverse Event|16|||
146523629|NCT02028507|528425086|FG000|Overall Study|Withdrawal by Subject|6|||
146523630|NCT02028507|528425087|FG001|Overall Study|Withdrawal by Subject|8|||
146523631|NCT02028507|528425088|FG002|Overall Study|Withdrawal by Subject|5|||
146523632|NCT02028507|528425089|FG003|Overall Study|Withdrawal by Subject|9|||
146523633|NCT02028507|528425086|FG000|Overall Study|Protocol Violation|2|||
146523634|NCT02028507|528425087|FG001|Overall Study|Protocol Violation|4|||
146523635|NCT02028507|528425088|FG002|Overall Study|Protocol Violation|1|||
146523636|NCT02028507|528425089|FG003|Overall Study|Protocol Violation|3|||
146523637|NCT02028507|528425086|FG000|Overall Study|Physician Decision|0|||
146523638|NCT02028507|528425087|FG001|Overall Study|Physician Decision|4|||
146523639|NCT02028507|528425088|FG002|Overall Study|Physician Decision|0|||
146523640|NCT02028507|528425089|FG003|Overall Study|Physician Decision|0|||
146523641|NCT02028507|528425086|FG000|Overall Study|Death|1|||
146523642|NCT02028507|528425087|FG001|Overall Study|Death|0|||
146523643|NCT02028507|528425088|FG002|Overall Study|Death|1|||
146523644|NCT02028507|528425089|FG003|Overall Study|Death|3|||
146523645|NCT02028507|528425086|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
146523646|NCT02028507|528425087|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
146523647|NCT02028507|528425088|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
146523648|NCT02028507|528425089|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
146523649|NCT02028507|528425086|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
146523650|NCT02028507|528425087|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
146523651|NCT02028507|528425088|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
146523652|NCT02028507|528425089|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
146523653|NCT02028507|528425086|FG000|Overall Study|Randomized But Not Treated|3|||
146523654|NCT02028507|528425087|FG001|Overall Study|Randomized But Not Treated|6|||
146523655|NCT02028507|528425088|FG002|Overall Study|Randomized But Not Treated|0|||
146523656|NCT02028507|528425089|FG003|Overall Study|Randomized But Not Treated|4|||
146523657|NCT02028507|528425086|FG000|Overall Study|Enzyme defect|0|||
146523658|NCT02028507|528425087|FG001|Overall Study|Enzyme defect|0|||
146523659|NCT02028507|528425088|FG002|Overall Study|Enzyme defect|0|||
146523660|NCT02028507|528425089|FG003|Overall Study|Enzyme defect|1|||
146523661|NCT02028507|528425086|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
146523662|NCT02028507|528425087|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
146523663|NCT02028507|528425088|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
146523664|NCT02028507|528425089|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
146523665|NCT02028507|528425086|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
146523666|NCT02028507|528425087|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
146523667|NCT02028507|528425088|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
146523668|NCT02028507|528425089|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
146523669|NCT02258659|528425090|FG000|Overall Study|Withdrawal by Subject|1|||
146523670|NCT03990051|528425091|FG000|Masked Period|Lost to Follow-up|1|||
146523671|NCT03990051|528425092|FG001|Masked Period|Lost to Follow-up|0|||
146523672|NCT03990051|528425091|FG000|Long Term Period|Death|1|||
146523673|NCT03990051|528425092|FG001|Long Term Period|Death|1|||
146523674|NCT03990051|528425091|FG000|Long Term Period|Lost to Follow-up|7|||
146523675|NCT03990051|528425092|FG001|Long Term Period|Lost to Follow-up|2|||
146523676|NCT00272844|528425093|FG000|Overall Study|Withdrawal by Subject|5|||
146523677|NCT03060291|528425094|FG000|3-month Follow-up|Declined to respond|8|||
146523678|NCT03060291|528425095|FG001|3-month Follow-up|Declined to respond|10|||
146523679|NCT03060291|528425096|FG002|3-month Follow-up|Declined to respond|2|||
146523680|NCT03060291|528425094|FG000|6-month Follow-up|Declined to respond|7|||
146523681|NCT03060291|528425095|FG001|6-month Follow-up|Declined to respond|13|||
146523682|NCT03060291|528425096|FG002|6-month Follow-up|Declined to respond|4|||
146523683|NCT03060291|528425094|FG000|12-month Follow-up|Declined to respond|7|||
146523684|NCT03060291|528425095|FG001|12-month Follow-up|Declined to respond|16|||
146523685|NCT03060291|528425096|FG002|12-month Follow-up|Declined to respond|6|||
146523686|NCT00618826|528425097|FG000|Overall Study|Adverse Event|1|||
146523687|NCT01509664|528425099|FG000|Overall Study|Lost to Follow-up|15|||
146523688|NCT01509664|528425100|FG001|Overall Study|Lost to Follow-up|21|||
146523689|NCT01556932|528425103|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
146523690|NCT01556932|528425104|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
146523691|NCT03743025|528425105|FG000|Overall Study|Surgery was cancelled|2|||
146523692|NCT03743025|528425106|FG001|Overall Study|Surgery was cancelled|1|||
146523693|NCT00791700|528425107|FG000|Overall Study|Insufficient clinical response|1|||
146523694|NCT00791700|528425108|FG001|Overall Study|Insufficient clinical response|4|||
146523695|NCT00791700|528425109|FG002|Overall Study|Insufficient clinical response|1|||
146523696|NCT00791700|528425110|FG003|Overall Study|Insufficient clinical response|8|||
146523697|NCT00791700|528425107|FG000|Overall Study|No longer willing to participate|1|||
146523698|NCT00791700|528425108|FG001|Overall Study|No longer willing to participate|1|||
146523699|NCT00791700|528425109|FG002|Overall Study|No longer willing to participate|0|||
146523700|NCT00791700|528425110|FG003|Overall Study|No longer willing to participate|8|||
146523701|NCT00791700|528425107|FG000|Overall Study|Non-compliance with study treatment|0|||
146523702|NCT00791700|528425108|FG001|Overall Study|Non-compliance with study treatment|2|||
146523703|NCT00791700|528425109|FG002|Overall Study|Non-compliance with study treatment|0|||
146523704|NCT00791700|528425110|FG003|Overall Study|Non-compliance with study treatment|4|||
146523705|NCT00791700|528425107|FG000|Overall Study|Withdrawn due to pregnancy|0|||
146523706|NCT00791700|528425108|FG001|Overall Study|Withdrawn due to pregnancy|0|||
146523707|NCT00791700|528425109|FG002|Overall Study|Withdrawn due to pregnancy|0|||
146523708|NCT00791700|528425110|FG003|Overall Study|Withdrawn due to pregnancy|1|||
146523709|NCT00791700|528425107|FG000|Overall Study|Other|0|||
146523710|NCT00791700|528425108|FG001|Overall Study|Other|1|||
146523711|NCT00791700|528425109|FG002|Overall Study|Other|0|||
146523712|NCT00791700|528425110|FG003|Overall Study|Other|1|||
146523713|NCT00791700|528425107|FG000|Overall Study|Death|0|||
146523714|NCT00791700|528425108|FG001|Overall Study|Death|0|||
146523715|NCT00791700|528425109|FG002|Overall Study|Death|0|||
146523716|NCT00791700|528425110|FG003|Overall Study|Death|1|||
146523717|NCT00791700|528425107|FG000|Overall Study|Lost to Follow-up|4|||
146523718|NCT00791700|528425108|FG001|Overall Study|Lost to Follow-up|3|||
146523719|NCT00791700|528425109|FG002|Overall Study|Lost to Follow-up|4|||
146523720|NCT00791700|528425110|FG003|Overall Study|Lost to Follow-up|6|||
146523721|NCT00791700|528425107|FG000|Overall Study|Adverse Event|0|||
146523722|NCT00791700|528425108|FG001|Overall Study|Adverse Event|0|||
146523723|NCT00791700|528425109|FG002|Overall Study|Adverse Event|1|||
146523724|NCT00791700|528425110|FG003|Overall Study|Adverse Event|1|||
146523725|NCT00527826|528425113|FG000|Overall Study|Adverse Event|10|||
146523726|NCT00527826|528425114|FG001|Overall Study|Adverse Event|10|||
146523727|NCT00527826|528425113|FG000|Overall Study|Lost to Follow-up|3|||
146523728|NCT00527826|528425114|FG001|Overall Study|Lost to Follow-up|2|||
146523729|NCT00527826|528425113|FG000|Overall Study|Withdrawal by Subject|5|||
146523730|NCT00527826|528425114|FG001|Overall Study|Withdrawal by Subject|8|||
146523731|NCT00527826|528425113|FG000|Overall Study|Inclusion Criteria Not Met|3|||
146523732|NCT00527826|528425114|FG001|Overall Study|Inclusion Criteria Not Met|3|||
146523733|NCT00527826|528425113|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
146523734|NCT00527826|528425114|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
146523735|NCT00527826|528425113|FG000|Overall Study|Additional Intake of Viani forte|0|||
146523736|NCT00527826|528425114|FG001|Overall Study|Additional Intake of Viani forte|1|||
146523737|NCT00527826|528425113|FG000|Overall Study|Participant moved away|0|||
146523738|NCT00527826|528425114|FG001|Overall Study|Participant moved away|1|||
146523739|NCT01808261|528425115|FG000|Overall Study|Physician Decision|0|||
146523740|NCT01808261|528425116|FG001|Overall Study|Physician Decision|2|||
146523741|NCT01808261|528425115|FG000|Overall Study|Study Closed/Terminated|25|||
146523742|NCT01808261|528425116|FG001|Overall Study|Study Closed/Terminated|23|||
146523743|NCT01808261|528425115|FG000|Overall Study|Adverse event, non-fatal|2|||
146523744|NCT01808261|528425116|FG001|Overall Study|Adverse event, non-fatal|0|||
146523745|NCT01808261|528425115|FG000|Overall Study|Consent withdrawn by subject|6|||
146523746|NCT01808261|528425116|FG001|Overall Study|Consent withdrawn by subject|7|||
146523747|NCT01808261|528425115|FG000|Overall Study|Lost to Follow-up|3|||
146523748|NCT01808261|528425116|FG001|Overall Study|Lost to Follow-up|1|||
146523749|NCT02080364|528425121|FG000|Baseline Period|Protocol Violation|2|||
146523750|NCT02080364|528425122|FG001|Baseline Period|Protocol Violation|1|||
146523751|NCT02080364|528425123|FG002|Baseline Period|Protocol Violation|0|||
146523752|NCT02080364|528425124|FG003|Baseline Period|Protocol Violation|0|||
146523753|NCT02080364|528425121|FG000|Baseline Period|Other|0|||
146523754|NCT02080364|528425122|FG001|Baseline Period|Other|1|||
146523755|NCT02080364|528425123|FG002|Baseline Period|Other|1|||
146523756|NCT02080364|528425124|FG003|Baseline Period|Other|0|||
146523757|NCT02080364|528425121|FG000|Treatment Period|Adverse Event|10|||
146523758|NCT02080364|528425122|FG001|Treatment Period|Adverse Event|15|||
146523759|NCT02080364|528425123|FG002|Treatment Period|Adverse Event|11|||
146523760|NCT02080364|528425124|FG003|Treatment Period|Adverse Event|14|||
146523761|NCT02080364|528425121|FG000|Treatment Period|Lost to Follow-up|2|||
146523762|NCT02080364|528425122|FG001|Treatment Period|Lost to Follow-up|3|||
146523763|NCT02080364|528425123|FG002|Treatment Period|Lost to Follow-up|5|||
146523764|NCT02080364|528425124|FG003|Treatment Period|Lost to Follow-up|0|||
146523765|NCT02080364|528425121|FG000|Treatment Period|Protocol Violation|5|||
146523766|NCT02080364|528425122|FG001|Treatment Period|Protocol Violation|3|||
146523767|NCT02080364|528425123|FG002|Treatment Period|Protocol Violation|5|||
146523768|NCT02080364|528425124|FG003|Treatment Period|Protocol Violation|1|||
146523769|NCT02080364|528425121|FG000|Treatment Period|Withdrawal by Subject|16|||
146859492|NCT01259726|529656862|FG002|Overall Study|Physician Decision|1|||
146859493|NCT01259726|529656863|FG003|Overall Study|Physician Decision|1|||
146859494|NCT01259726|529656860|FG000|Overall Study|Withdrawal by Subject|1|||
146523770|NCT02080364|528425122|FG001|Treatment Period|Withdrawal by Subject|16|||
146523771|NCT02080364|528425123|FG002|Treatment Period|Withdrawal by Subject|15|||
146523772|NCT02080364|528425124|FG003|Treatment Period|Withdrawal by Subject|10|||
146523773|NCT02080364|528425121|FG000|Treatment Period|Study Terminated by Sponsor|0|||
146523774|NCT02080364|528425122|FG001|Treatment Period|Study Terminated by Sponsor|0|||
146523775|NCT02080364|528425123|FG002|Treatment Period|Study Terminated by Sponsor|180|||
146523776|NCT02080364|528425124|FG003|Treatment Period|Study Terminated by Sponsor|183|||
146523777|NCT02080364|528425121|FG000|Treatment Period|Other|14|||
146523778|NCT02080364|528425122|FG001|Treatment Period|Other|12|||
146523779|NCT02080364|528425123|FG002|Treatment Period|Other|21|||
146523780|NCT02080364|528425124|FG003|Treatment Period|Other|16|||
146523781|NCT00991289|528425125|FG000|Overall Study|Adverse Event|1|||
146523782|NCT00991289|528425125|FG000|Overall Study|Physician Decision|2|||
146523783|NCT00991289|528425125|FG000|Overall Study|Withdrawal by Subject|3|||
146523784|NCT00991289|528425125|FG000|Overall Study|Lost to Follow-up|4|||
146523785|NCT00991289|528425125|FG000|Overall Study|Protocol Violation|2|||
146523786|NCT02256839|528425126|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
146523787|NCT02256839|528425127|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
146523788|NCT01843803|528425128|FG000|Overall Study|not a Veteran, did not see provider|1|||
146523789|NCT01843803|528425129|FG001|Overall Study|not a Veteran, did not see provider|3|||
146523790|NCT05285787|528425131|FG000|Overall Study|Withdrawal by Subject|1|||
146523791|NCT01051817|528425139|FG000|Overall Study|Adverse Event|0|||
146523792|NCT01051817|528425140|FG001|Overall Study|Adverse Event|2|||
146523793|NCT01051817|528425139|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
146523794|NCT01051817|528425140|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
146523795|NCT01051817|528425139|FG000|Overall Study|Withdrawal by Subject|3|||
146523796|NCT01051817|528425140|FG001|Overall Study|Withdrawal by Subject|5|||
146523797|NCT01051817|528425139|FG000|Overall Study|Protocol Violation|0|||
146523798|NCT01051817|528425140|FG001|Overall Study|Protocol Violation|1|||
146523799|NCT04346199|528425141|FG000|Overall Study|Death|8|||
146523800|NCT04346199|528425142|FG001|Overall Study|Death|9|||
146523801|NCT04346199|528425141|FG000|Overall Study|Lost to Follow-up|0|||
146523802|NCT04346199|528425142|FG001|Overall Study|Lost to Follow-up|1|||
146523803|NCT04346199|528425141|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
146523804|NCT04346199|528425142|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
146523805|NCT04346199|528425141|FG000|Overall Study|Withdrawal by Subject|5|||
146523806|NCT04346199|528425142|FG001|Overall Study|Withdrawal by Subject|1|||
146523807|NCT00627926|528425143|FG000|Overall Study|Adverse Event|26|||
146523808|NCT00627926|528425144|FG001|Overall Study|Adverse Event|37|||
146523809|NCT00627926|528425145|FG002|Overall Study|Adverse Event|36|||
146523810|NCT00627926|528425143|FG000|Overall Study|Death|1|||
146523811|NCT00627926|528425144|FG001|Overall Study|Death|0|||
146523812|NCT00627926|528425145|FG002|Overall Study|Death|0|||
146523813|NCT00627926|528425143|FG000|Overall Study|Lost to Follow-up|4|||
146523814|NCT00627926|528425144|FG001|Overall Study|Lost to Follow-up|3|||
146523815|NCT00627926|528425145|FG002|Overall Study|Lost to Follow-up|4|||
146523816|NCT00627926|528425143|FG000|Overall Study|Withdrawal by Subject|2|||
146523817|NCT00627926|528425144|FG001|Overall Study|Withdrawal by Subject|1|||
146523818|NCT00627926|528425145|FG002|Overall Study|Withdrawal by Subject|0|||
146523819|NCT00627926|528425143|FG000|Overall Study|Lack of Efficacy|118|||
146523820|NCT00627926|528425144|FG001|Overall Study|Lack of Efficacy|40|||
146523821|NCT00627926|528425145|FG002|Overall Study|Lack of Efficacy|38|||
146523822|NCT00627926|528425143|FG000|Overall Study|Noncompliance/unspecified|8|||
146523823|NCT00627926|528425144|FG001|Overall Study|Noncompliance/unspecified|23|||
146523824|NCT00627926|528425145|FG002|Overall Study|Noncompliance/unspecified|17|||
146859495|NCT01259726|529656861|FG001|Overall Study|Withdrawal by Subject|3|||
146859496|NCT01259726|529656862|FG002|Overall Study|Withdrawal by Subject|2|||
146859497|NCT01259726|529656863|FG003|Overall Study|Withdrawal by Subject|1|||
146859498|NCT01259726|529656860|FG000|Overall Study|Lost to Follow-up|1|||
146859499|NCT01259726|529656861|FG001|Overall Study|Lost to Follow-up|1|||
146523825|NCT02401035|528425146|FG000|Overall Study|Withdrawal by Subject|1|||
146523826|NCT02401035|528425147|FG001|Overall Study|Withdrawal by Subject|0|||
146523827|NCT00869128|528425148|FG000|Overall Study|lack of Compliance|6|||
146523828|NCT00869128|528425149|FG001|Overall Study|lack of Compliance|6|||
146523829|NCT01118663|528425151|FG000|Overall Study|Adverse Event|2|||
146523830|NCT01118663|528425152|FG001|Overall Study|Adverse Event|1|||
146523831|NCT01118663|528425151|FG000|Overall Study|Withdrawal by Subject|0|||
146523832|NCT01118663|528425152|FG001|Overall Study|Withdrawal by Subject|1|||
146523833|NCT04039204|528425153|FG000|Overall Study|Withdrawal by Subject|0|||
146523834|NCT04039204|528425154|FG001|Overall Study|Withdrawal by Subject|2|||
146523835|NCT01189461|528425155|FG000|Overall Study|Lack of Efficacy|13|||
146523836|NCT01189461|528425155|FG000|Overall Study|Lost to Follow-up|1|||
146859500|NCT01259726|529656862|FG002|Overall Study|Lost to Follow-up|1|||
146859501|NCT01259726|529656863|FG003|Overall Study|Lost to Follow-up|3|||
146523837|NCT01189461|528425155|FG000|Overall Study|Withdrawal by Subject|6|||
146523838|NCT01189461|528425155|FG000|Overall Study|Protocol Violation|1|||
146523839|NCT01189461|528425155|FG000|Overall Study|Adverse Event|2|||
146523840|NCT01189461|528425155|FG000|Overall Study|Did not meet entrance criteria|3|||
146523841|NCT01189461|528425155|FG000|Overall Study|Other|8|||
146523842|NCT00656175|528425156|FG000|Overall Study|Adverse Event|1|||
146523843|NCT00656175|528425157|FG001|Overall Study|Adverse Event|0|||
146523844|NCT00656175|528425156|FG000|Overall Study|Transportation issues|0|||
146523845|NCT00656175|528425157|FG001|Overall Study|Transportation issues|1|||
146523846|NCT03283930|528425160|FG000|Overall Study|Scheduling conflict|8|||
146523847|NCT03283930|528425161|FG001|Overall Study|Scheduling conflict|10|||
146523848|NCT03283930|528425160|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
146523849|NCT03283930|528425161|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
146523850|NCT03283930|528425160|FG000|Overall Study|Technical software issue|2|||
146523851|NCT03283930|528425161|FG001|Overall Study|Technical software issue|2|||
146523852|NCT05251233|528427051|FG000|Overall Study|Disease progression - did not start treatment|0|||
146523853|NCT05251233|528427052|FG001|Overall Study|Disease progression - did not start treatment|0|||
146523854|NCT05251233|528427053|FG002|Overall Study|Disease progression - did not start treatment|5|||
146523855|NCT05251233|528427051|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
146523856|NCT05251233|528427052|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
146523857|NCT05251233|528427053|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
146523858|NCT05251233|528427051|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
146523859|NCT05251233|528427052|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
146523860|NCT05251233|528427053|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
146523861|NCT05251233|528427051|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
146523862|NCT05251233|528427052|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
146523863|NCT05251233|528427053|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
146523864|NCT05251233|528427051|FG000|Overall Study|Death - did not start treatment|3|||
146523865|NCT05251233|528427052|FG001|Overall Study|Death - did not start treatment|0|||
146859502|NCT00887679|529656865|FG000|Overall Study|Withdrawal by Subject|1|||
146523866|NCT05251233|528427053|FG002|Overall Study|Death - did not start treatment|0|||
146859503|NCT00887679|529656865|FG000|Overall Study|Lost to Follow-up|4|||
146859504|NCT00887679|529656865|FG000|Overall Study|Physician Decision|5|||
146859505|NCT02683941|529656866|FG000|Double-blind Phase|Adverse Event|0|||
146859506|NCT02683941|529656867|FG001|Double-blind Phase|Adverse Event|1|||
146859507|NCT02683941|529656866|FG000|Double-blind Phase|Withdrawal by Subject|4|||
146859508|NCT02683941|529656867|FG001|Double-blind Phase|Withdrawal by Subject|2|||
146859509|NCT02683941|529656866|FG000|Double-blind Phase|Lost to Follow-up|1|||
146859510|NCT02683941|529656867|FG001|Double-blind Phase|Lost to Follow-up|0|||
146523867|NCT05251233|528427051|FG000|Overall Study|Withdrawal by Subject|2|||
146523868|NCT05251233|528427052|FG001|Overall Study|Withdrawal by Subject|2|||
146523869|NCT05251233|528427053|FG002|Overall Study|Withdrawal by Subject|0|||
146523870|NCT05251233|528427051|FG000|Overall Study|Other complicating disease|2|||
146523871|NCT05251233|528427052|FG001|Overall Study|Other complicating disease|1|||
146523872|NCT05251233|528427053|FG002|Overall Study|Other complicating disease|0|||
146523873|NCT05251233|528427051|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
146523874|NCT05251233|528427052|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
146523875|NCT05251233|528427053|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
146523876|NCT05251233|528427051|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
146523877|NCT05251233|528427052|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
146523878|NCT05251233|528427053|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
146523879|NCT00103285|528427054|FG000|Induction|Adverse Event|14|||
146523880|NCT00103285|528427055|FG001|Induction|Adverse Event|0|||
146523881|NCT00103285|528427056|FG002|Induction|Adverse Event|0|||
146523882|NCT00103285|528427057|FG003|Induction|Adverse Event|0|||
146523883|NCT00103285|528427058|FG004|Induction|Adverse Event|0|||
146523884|NCT00103285|528427059|FG005|Induction|Adverse Event|0|||
146523885|NCT00103285|528427060|FG006|Induction|Adverse Event|0|||
146523886|NCT00103285|528427061|FG007|Induction|Adverse Event|0|||
146523887|NCT00103285|528427054|FG000|Induction|Death|24|||
146523888|NCT00103285|528427055|FG001|Induction|Death|0|||
146523889|NCT00103285|528427056|FG002|Induction|Death|0|||
146523890|NCT00103285|528427057|FG003|Induction|Death|0|||
146523891|NCT00103285|528427058|FG004|Induction|Death|0|||
146523892|NCT00103285|528427059|FG005|Induction|Death|0|||
146523893|NCT00103285|528427060|FG006|Induction|Death|0|||
146859511|NCT02683941|529656866|FG000|Double-blind Phase|Disease Progression|5|||
146859512|NCT02683941|529656867|FG001|Double-blind Phase|Disease Progression|2|||
146859513|NCT02683941|529656866|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
146859514|NCT02683941|529656867|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
146859515|NCT02683941|529656866|FG000|Open-label Treatment Phase|Disease Progression|1|||
146859516|NCT02683941|529656867|FG001|Open-label Treatment Phase|Disease Progression|2|||
146523894|NCT00103285|528427061|FG007|Induction|Death|0|||
146523895|NCT00103285|528427054|FG000|Induction|Physician Decision|103|||
146523896|NCT00103285|528427055|FG001|Induction|Physician Decision|0|||
146523897|NCT00103285|528427056|FG002|Induction|Physician Decision|0|||
146523898|NCT00103285|528427057|FG003|Induction|Physician Decision|0|||
146523899|NCT00103285|528427058|FG004|Induction|Physician Decision|0|||
146523900|NCT00103285|528427059|FG005|Induction|Physician Decision|0|||
146523901|NCT00103285|528427060|FG006|Induction|Physician Decision|0|||
146523902|NCT00103285|528427061|FG007|Induction|Physician Decision|0|||
146523903|NCT00103285|528427054|FG000|Induction|Withdrawal by Subject|1|||
146523904|NCT00103285|528427055|FG001|Induction|Withdrawal by Subject|0|||
146523905|NCT00103285|528427056|FG002|Induction|Withdrawal by Subject|0|||
146523906|NCT00103285|528427057|FG003|Induction|Withdrawal by Subject|0|||
146523907|NCT00103285|528427058|FG004|Induction|Withdrawal by Subject|0|||
146523908|NCT00103285|528427059|FG005|Induction|Withdrawal by Subject|0|||
146523909|NCT00103285|528427060|FG006|Induction|Withdrawal by Subject|0|||
146523910|NCT00103285|528427061|FG007|Induction|Withdrawal by Subject|0|||
146523911|NCT00103285|528427054|FG000|Induction|Ineligible|43|||
146523912|NCT00103285|528427055|FG001|Induction|Ineligible|0|||
146523913|NCT00103285|528427056|FG002|Induction|Ineligible|0|||
146523914|NCT00103285|528427057|FG003|Induction|Ineligible|0|||
146523915|NCT00103285|528427058|FG004|Induction|Ineligible|0|||
146523916|NCT00103285|528427059|FG005|Induction|Ineligible|0|||
146523917|NCT00103285|528427060|FG006|Induction|Ineligible|0|||
146523918|NCT00103285|528427061|FG007|Induction|Ineligible|0|||
146523919|NCT00103285|528427054|FG000|Induction|Refusal|906|||
146523920|NCT00103285|528427055|FG001|Induction|Refusal|0|||
146523921|NCT00103285|528427056|FG002|Induction|Refusal|0|||
146523922|NCT00103285|528427057|FG003|Induction|Refusal|0|||
146523923|NCT00103285|528427058|FG004|Induction|Refusal|0|||
146523924|NCT00103285|528427059|FG005|Induction|Refusal|0|||
146523925|NCT00103285|528427060|FG006|Induction|Refusal|0|||
146523926|NCT00103285|528427061|FG007|Induction|Refusal|0|||
146523927|NCT00103285|528427054|FG000|Induction|Other|258|||
146523928|NCT00103285|528427055|FG001|Induction|Other|0|||
146523929|NCT00103285|528427056|FG002|Induction|Other|0|||
146523930|NCT00103285|528427057|FG003|Induction|Other|0|||
146523931|NCT00103285|528427058|FG004|Induction|Other|0|||
146523932|NCT00103285|528427059|FG005|Induction|Other|0|||
146523933|NCT00103285|528427060|FG006|Induction|Other|0|||
146523934|NCT00103285|528427061|FG007|Induction|Other|0|||
146523935|NCT00103285|528427054|FG000|Response Assignment|Adverse Event|0|||
146523936|NCT00103285|528427055|FG001|Response Assignment|Adverse Event|8|||
146523937|NCT00103285|528427056|FG002|Response Assignment|Adverse Event|3|||
146523938|NCT00103285|528427057|FG003|Response Assignment|Adverse Event|2|||
146523939|NCT00103285|528427058|FG004|Response Assignment|Adverse Event|3|||
146523940|NCT00103285|528427059|FG005|Response Assignment|Adverse Event|1|||
146523941|NCT00103285|528427060|FG006|Response Assignment|Adverse Event|1|||
146523942|NCT00103285|528427061|FG007|Response Assignment|Adverse Event|2|||
146760001|NCT05074498|529288667|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
146760002|NCT05074498|529288668|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
146760003|NCT05074498|529288669|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
146760004|NCT05074498|529288664|FG000|Part 2 (Upto Day 104)|Other|0|||
146760005|NCT05074498|529288665|FG001|Part 2 (Upto Day 104)|Other|0|||
146760006|NCT05074498|529288666|FG002|Part 2 (Upto Day 104)|Other|0|||
146760007|NCT05074498|529288667|FG003|Part 2 (Upto Day 104)|Other|0|||
146760008|NCT05074498|529288668|FG004|Part 2 (Upto Day 104)|Other|1|||
146760009|NCT05074498|529288669|FG005|Part 2 (Upto Day 104)|Other|0|||
146760010|NCT01240356|529288670|FG000|Overall Study|Withdrawal by Subject|2|||
146760011|NCT01240356|529288671|FG001|Overall Study|Withdrawal by Subject|0|||
146760012|NCT01240356|529288670|FG000|Overall Study|MRI contraindication|1|||
146760013|NCT01240356|529288671|FG001|Overall Study|MRI contraindication|0|||
146760014|NCT04048135|529288675|FG000|Overall Study|Withdrawal by Subject|1|||
146760015|NCT04048135|529288676|FG001|Overall Study|Withdrawal by Subject|1|||
146760016|NCT04048135|529288677|FG002|Overall Study|Withdrawal by Subject|1|||
146760017|NCT04048135|529288678|FG003|Overall Study|Withdrawal by Subject|2|||
146760018|NCT04048135|529288679|FG004|Overall Study|Withdrawal by Subject|0|||
146760019|NCT04048135|529288680|FG005|Overall Study|Withdrawal by Subject|0|||
146760020|NCT04048135|529288681|FG006|Overall Study|Withdrawal by Subject|1|||
146760021|NCT04048135|529288682|FG007|Overall Study|Withdrawal by Subject|1|||
146760022|NCT04048135|529288675|FG000|Overall Study|Adverse Event|0|||
146523943|NCT00103285|528427054|FG000|Response Assignment|Death|0|||
146523944|NCT00103285|528427055|FG001|Response Assignment|Death|5|||
146523945|NCT00103285|528427056|FG002|Response Assignment|Death|2|||
146523946|NCT00103285|528427057|FG003|Response Assignment|Death|2|||
146523947|NCT00103285|528427058|FG004|Response Assignment|Death|3|||
146523948|NCT00103285|528427059|FG005|Response Assignment|Death|1|||
146523949|NCT00103285|528427060|FG006|Response Assignment|Death|0|||
146523950|NCT00103285|528427061|FG007|Response Assignment|Death|8|||
146523951|NCT00103285|528427054|FG000|Response Assignment|Lost to Follow-up|0|||
146523952|NCT00103285|528427055|FG001|Response Assignment|Lost to Follow-up|9|||
146523953|NCT00103285|528427056|FG002|Response Assignment|Lost to Follow-up|5|||
146523954|NCT00103285|528427057|FG003|Response Assignment|Lost to Follow-up|5|||
146523955|NCT00103285|528427058|FG004|Response Assignment|Lost to Follow-up|1|||
146859517|NCT02683941|529656866|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
146859518|NCT02683941|529656867|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
146859519|NCT02683941|529656866|FG000|Open-label Treatment Phase|Other|1|||
146859520|NCT02683941|529656867|FG001|Open-label Treatment Phase|Other|0|||
146859521|NCT02683941|529656866|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
146859522|NCT02683941|529656867|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
146859523|NCT02683941|529656866|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
146859524|NCT02683941|529656867|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
146859525|NCT02683941|529656866|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
146859526|NCT02683941|529656867|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
146859527|NCT02683941|529656866|FG000|Open-label Follow-up Phase|Other|8|||
146859528|NCT02683941|529656867|FG001|Open-label Follow-up Phase|Other|1|||
146859529|NCT00261846|529656868|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
146859530|NCT00261846|529656869|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
146523956|NCT00103285|528427059|FG005|Response Assignment|Lost to Follow-up|2|||
146523957|NCT00103285|528427060|FG006|Response Assignment|Lost to Follow-up|2|||
146523958|NCT00103285|528427061|FG007|Response Assignment|Lost to Follow-up|5|||
146523959|NCT00103285|528427054|FG000|Response Assignment|Physician Decision|0|||
146523960|NCT00103285|528427055|FG001|Response Assignment|Physician Decision|13|||
146523961|NCT00103285|528427056|FG002|Response Assignment|Physician Decision|14|||
146523962|NCT00103285|528427057|FG003|Response Assignment|Physician Decision|9|||
146523963|NCT00103285|528427058|FG004|Response Assignment|Physician Decision|13|||
146523964|NCT00103285|528427059|FG005|Response Assignment|Physician Decision|7|||
146523965|NCT00103285|528427060|FG006|Response Assignment|Physician Decision|4|||
146523966|NCT00103285|528427061|FG007|Response Assignment|Physician Decision|35|||
146523967|NCT00103285|528427054|FG000|Response Assignment|Protocol Violation|0|||
146523968|NCT00103285|528427055|FG001|Response Assignment|Protocol Violation|2|||
146523969|NCT00103285|528427056|FG002|Response Assignment|Protocol Violation|0|||
146523970|NCT00103285|528427057|FG003|Response Assignment|Protocol Violation|0|||
146523971|NCT00103285|528427058|FG004|Response Assignment|Protocol Violation|0|||
146523972|NCT00103285|528427059|FG005|Response Assignment|Protocol Violation|0|||
146523973|NCT00103285|528427060|FG006|Response Assignment|Protocol Violation|0|||
146523974|NCT00103285|528427061|FG007|Response Assignment|Protocol Violation|0|||
146523975|NCT00103285|528427054|FG000|Response Assignment|Withdrawal by Subject|0|||
146523976|NCT00103285|528427055|FG001|Response Assignment|Withdrawal by Subject|4|||
146523977|NCT00103285|528427056|FG002|Response Assignment|Withdrawal by Subject|1|||
146523978|NCT00103285|528427057|FG003|Response Assignment|Withdrawal by Subject|1|||
146523979|NCT00103285|528427058|FG004|Response Assignment|Withdrawal by Subject|2|||
146523980|NCT00103285|528427059|FG005|Response Assignment|Withdrawal by Subject|2|||
146523981|NCT00103285|528427060|FG006|Response Assignment|Withdrawal by Subject|0|||
146523982|NCT00103285|528427061|FG007|Response Assignment|Withdrawal by Subject|2|||
146523983|NCT00103285|528427054|FG000|Response Assignment|Ineligible|0|||
146523984|NCT00103285|528427055|FG001|Response Assignment|Ineligible|8|||
146523985|NCT00103285|528427056|FG002|Response Assignment|Ineligible|6|||
146523986|NCT00103285|528427057|FG003|Response Assignment|Ineligible|2|||
146523987|NCT00103285|528427058|FG004|Response Assignment|Ineligible|0|||
146523988|NCT00103285|528427059|FG005|Response Assignment|Ineligible|3|||
146523989|NCT00103285|528427060|FG006|Response Assignment|Ineligible|1|||
146523990|NCT00103285|528427061|FG007|Response Assignment|Ineligible|5|||
146523991|NCT00103285|528427054|FG000|Response Assignment|Refusal|0|||
146523992|NCT00103285|528427055|FG001|Response Assignment|Refusal|53|||
146523993|NCT00103285|528427056|FG002|Response Assignment|Refusal|5|||
146523994|NCT00103285|528427057|FG003|Response Assignment|Refusal|3|||
146523995|NCT00103285|528427058|FG004|Response Assignment|Refusal|25|||
146523996|NCT00103285|528427059|FG005|Response Assignment|Refusal|15|||
146523997|NCT00103285|528427060|FG006|Response Assignment|Refusal|30|||
146523998|NCT00103285|528427061|FG007|Response Assignment|Refusal|10|||
146523999|NCT00103285|528427054|FG000|Response Assignment|Other|0|||
146524000|NCT00103285|528427055|FG001|Response Assignment|Other|30|||
146524001|NCT00103285|528427056|FG002|Response Assignment|Other|48|||
146524002|NCT00103285|528427057|FG003|Response Assignment|Other|38|||
146524003|NCT00103285|528427058|FG004|Response Assignment|Other|37|||
146524004|NCT00103285|528427059|FG005|Response Assignment|Other|17|||
146524005|NCT00103285|528427060|FG006|Response Assignment|Other|11|||
146524006|NCT00103285|528427061|FG007|Response Assignment|Other|53|||
146524007|NCT00452439|528427062|FG000|Overall Study|Lost to Follow-up|1|||
146859531|NCT00261846|529656870|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
146524008|NCT00452439|528427063|FG001|Overall Study|Lost to Follow-up|1|||
146524009|NCT00452439|528427062|FG000|Overall Study|Refused Treatment|4|||
146524010|NCT00452439|528427063|FG001|Overall Study|Refused Treatment|3|||
146524011|NCT00452439|528427062|FG000|Overall Study|Death|3|||
146524012|NCT00452439|528427063|FG001|Overall Study|Death|1|||
146524013|NCT00452439|528427062|FG000|Overall Study|Bone Marrow Transplant|0|||
146524014|NCT00452439|528427063|FG001|Overall Study|Bone Marrow Transplant|1|||
146524015|NCT00452439|528427062|FG000|Overall Study|Too Ill to Continue|0|||
146524016|NCT00452439|528427063|FG001|Overall Study|Too Ill to Continue|1|||
146524017|NCT00452439|528427062|FG000|Overall Study|Failed to achieve complete response|2|||
146524018|NCT00452439|528427063|FG001|Overall Study|Failed to achieve complete response|0|||
146524019|NCT00452439|528427062|FG000|Overall Study|Relapse|3|||
146524020|NCT00452439|528427063|FG001|Overall Study|Relapse|0|||
146524021|NCT00452439|528427062|FG000|Overall Study|Fracture|1|||
146524022|NCT00452439|528427063|FG001|Overall Study|Fracture|0|||
146524023|NCT01381926|528427064|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
146524024|NCT01381926|528427065|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
146524025|NCT01381926|528427064|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
146524026|NCT01381926|528427065|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
146524027|NCT02624947|528427067|FG000|Maternal Participants|Adverse Event|5|||
146524028|NCT02624947|528427068|FG001|Maternal Participants|Adverse Event|0|||
146524029|NCT02624947|528427067|FG000|Maternal Participants|Investigator Decision|5|||
146524030|NCT02624947|528427068|FG001|Maternal Participants|Investigator Decision|3|||
146524031|NCT02624947|528427067|FG000|Maternal Participants|Lost to Follow-up|54|||
146524032|NCT02624947|528427068|FG001|Maternal Participants|Lost to Follow-up|24|||
146524033|NCT02624947|528427067|FG000|Maternal Participants|Non Compliance|8|||
146524034|NCT02624947|528427068|FG001|Maternal Participants|Non Compliance|5|||
146524035|NCT02624947|528427067|FG000|Maternal Participants|Sponsor Request|1|||
146524036|NCT02624947|528427068|FG001|Maternal Participants|Sponsor Request|1|||
146524037|NCT02624947|528427067|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
146524038|NCT02624947|528427068|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
146524039|NCT02624947|528427067|FG000|Maternal Participants|Miscellaneous|23|||
146524040|NCT02624947|528427068|FG001|Maternal Participants|Miscellaneous|15|||
146524041|NCT02624947|528427067|FG000|Infant Participants|Adverse Event|18|||
146524042|NCT02624947|528427068|FG001|Infant Participants|Adverse Event|11|||
146524043|NCT02624947|528427067|FG000|Infant Participants|Investigator Decision|5|||
146524044|NCT02624947|528427068|FG001|Infant Participants|Investigator Decision|4|||
146524045|NCT02624947|528427067|FG000|Infant Participants|Lost to Follow-up|93|||
146524046|NCT02624947|528427068|FG001|Infant Participants|Lost to Follow-up|58|||
146524047|NCT02624947|528427067|FG000|Infant Participants|Non Compliance|17|||
146524048|NCT02624947|528427068|FG001|Infant Participants|Non Compliance|7|||
146524049|NCT02624947|528427067|FG000|Infant Participants|Sponsor Request|0|||
146524050|NCT02624947|528427068|FG001|Infant Participants|Sponsor Request|1|||
146524051|NCT02624947|528427067|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
146524052|NCT02624947|528427068|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
146524053|NCT02624947|528427067|FG000|Infant Participants|Miscellaneous|50|||
146524054|NCT02624947|528427068|FG001|Infant Participants|Miscellaneous|26|||
146524055|NCT03654729|528427077|FG000|Overall Study|Death|9|||
146524056|NCT03654729|528427078|FG001|Overall Study|Death|9|||
146524057|NCT03654729|528427079|FG002|Overall Study|Death|16|||
146524058|NCT03654729|528427077|FG000|Overall Study|Withdrawal by Subject|8|||
146524059|NCT03654729|528427078|FG001|Overall Study|Withdrawal by Subject|6|||
146524060|NCT03654729|528427079|FG002|Overall Study|Withdrawal by Subject|4|||
146524061|NCT03654729|528427077|FG000|Overall Study|Study terminated by Sponsor|3|||
146524062|NCT03654729|528427078|FG001|Overall Study|Study terminated by Sponsor|5|||
146524063|NCT03654729|528427079|FG002|Overall Study|Study terminated by Sponsor|4|||
146524064|NCT03654729|528427077|FG000|Overall Study|Not reported|2|||
146524065|NCT03654729|528427078|FG001|Overall Study|Not reported|4|||
146524066|NCT03654729|528427079|FG002|Overall Study|Not reported|5|||
146524067|NCT03654729|528427077|FG000|Overall Study|Progressive disease|3|||
146524068|NCT03654729|528427078|FG001|Overall Study|Progressive disease|0|||
146524069|NCT03654729|528427079|FG002|Overall Study|Progressive disease|0|||
146524070|NCT03654729|528427077|FG000|Overall Study|Lost to Follow-up|2|||
146524071|NCT03654729|528427078|FG001|Overall Study|Lost to Follow-up|0|||
146524072|NCT03654729|528427079|FG002|Overall Study|Lost to Follow-up|0|||
146524073|NCT03654729|528427077|FG000|Overall Study|Physician Decision|2|||
146524074|NCT03654729|528427078|FG001|Overall Study|Physician Decision|0|||
146524075|NCT03654729|528427079|FG002|Overall Study|Physician Decision|0|||
146524076|NCT03654729|528427077|FG000|Overall Study|Protocol Violation|1|||
146524077|NCT03654729|528427078|FG001|Overall Study|Protocol Violation|1|||
146524078|NCT03654729|528427079|FG002|Overall Study|Protocol Violation|0|||
146859532|NCT00261846|529656871|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146859533|NCT00261846|529656872|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146859534|NCT00261846|529656873|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146859535|NCT00261846|529656874|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146859536|NCT00261846|529656875|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146859537|NCT00261846|529656876|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146859538|NCT00261846|529656877|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146524079|NCT03654729|528427077|FG000|Overall Study|Non-compliance with study drug|0|||
146524080|NCT03654729|528427078|FG001|Overall Study|Non-compliance with study drug|1|||
146524081|NCT03654729|528427079|FG002|Overall Study|Non-compliance with study drug|0|||
146524082|NCT03654729|528427077|FG000|Overall Study|Site terminated by Sponsor|1|||
146524083|NCT03654729|528427078|FG001|Overall Study|Site terminated by Sponsor|0|||
146524084|NCT03654729|528427079|FG002|Overall Study|Site terminated by Sponsor|0|||
146524085|NCT01919164|528427090|FG000|Overall Study|Adverse Event|6|||
146524086|NCT01919164|528427091|FG001|Overall Study|Adverse Event|4|||
146524087|NCT01919164|528427092|FG002|Overall Study|Adverse Event|9|||
146524088|NCT01919164|528427093|FG003|Overall Study|Adverse Event|3|||
146524089|NCT01919164|528427094|FG004|Overall Study|Adverse Event|2|||
146524090|NCT01919164|528427090|FG000|Overall Study|Lost to Follow-up|2|||
146524091|NCT01919164|528427091|FG001|Overall Study|Lost to Follow-up|2|||
146524092|NCT01919164|528427092|FG002|Overall Study|Lost to Follow-up|2|||
146524093|NCT01919164|528427093|FG003|Overall Study|Lost to Follow-up|0|||
146760023|NCT04048135|529288676|FG001|Overall Study|Adverse Event|0|||
146760024|NCT04048135|529288677|FG002|Overall Study|Adverse Event|0|||
146760025|NCT04048135|529288678|FG003|Overall Study|Adverse Event|1|||
146760026|NCT04048135|529288679|FG004|Overall Study|Adverse Event|1|||
146760027|NCT04048135|529288680|FG005|Overall Study|Adverse Event|0|||
146760028|NCT04048135|529288681|FG006|Overall Study|Adverse Event|0|||
146760029|NCT04048135|529288682|FG007|Overall Study|Adverse Event|0|||
146760030|NCT04048135|529288675|FG000|Overall Study|Protocol Violation|0|||
146760031|NCT04048135|529288676|FG001|Overall Study|Protocol Violation|0|||
146760032|NCT04048135|529288677|FG002|Overall Study|Protocol Violation|0|||
146760033|NCT04048135|529288678|FG003|Overall Study|Protocol Violation|0|||
146760034|NCT04048135|529288679|FG004|Overall Study|Protocol Violation|0|||
146760035|NCT04048135|529288680|FG005|Overall Study|Protocol Violation|1|||
146760036|NCT04048135|529288681|FG006|Overall Study|Protocol Violation|0|||
146760037|NCT04048135|529288682|FG007|Overall Study|Protocol Violation|0|||
146760038|NCT00172185|529288683|FG000|Overall Study|Adverse Event|0|||
146760039|NCT00172185|529288684|FG001|Overall Study|Adverse Event|1|||
146760040|NCT00172185|529288685|FG002|Overall Study|Adverse Event|3|||
146760041|NCT00172185|529288686|FG003|Overall Study|Adverse Event|4|||
146760042|NCT00172185|529288683|FG000|Overall Study|Physician Decision|0|||
146760043|NCT00172185|529288684|FG001|Overall Study|Physician Decision|0|||
146760044|NCT00172185|529288685|FG002|Overall Study|Physician Decision|1|||
146760045|NCT00172185|529288686|FG003|Overall Study|Physician Decision|0|||
146760046|NCT00172185|529288683|FG000|Overall Study|SPONSOR Decision|0|||
146760047|NCT00172185|529288684|FG001|Overall Study|SPONSOR Decision|1|||
146760048|NCT00172185|529288685|FG002|Overall Study|SPONSOR Decision|0|||
146760049|NCT00172185|529288686|FG003|Overall Study|SPONSOR Decision|0|||
146760050|NCT00172185|529288683|FG000|Overall Study|Withdrawal by Subject|0|||
146760051|NCT00172185|529288684|FG001|Overall Study|Withdrawal by Subject|0|||
146760052|NCT00172185|529288685|FG002|Overall Study|Withdrawal by Subject|1|||
146760053|NCT00172185|529288686|FG003|Overall Study|Withdrawal by Subject|0|||
146760054|NCT01677936|529288687|FG000|Overall Study|Lost to Follow-up|4|||
146760055|NCT01677936|529288688|FG001|Overall Study|Lost to Follow-up|1|||
146760056|NCT01677936|529288687|FG000|Overall Study|Protocol Violation|3|||
146760057|NCT01677936|529288688|FG001|Overall Study|Protocol Violation|0|||
146760058|NCT01677936|529288687|FG000|Overall Study|Adverse Event|1|||
146760059|NCT01677936|529288688|FG001|Overall Study|Adverse Event|0|||
146760060|NCT01677936|529288687|FG000|Overall Study|Lost to Follow-up|1|||
146760061|NCT01677936|529288688|FG001|Overall Study|Lost to Follow-up|0|||
146760062|NCT01677936|529288687|FG000|Overall Study|Protocol Violation|0|||
146760063|NCT01677936|529288688|FG001|Overall Study|Protocol Violation|4|||
146760064|NCT03837028|529288689|FG000|Overall Study|Lost to Follow-up|4|||
146760065|NCT03837028|529288690|FG001|Overall Study|Lost to Follow-up|0|||
146760066|NCT03837028|529288691|FG002|Overall Study|Lost to Follow-up|2|||
146760067|NCT03837028|529288692|FG003|Overall Study|Lost to Follow-up|0|||
146760068|NCT03837028|529288689|FG000|Overall Study|Withdrawal by Subject|12|||
146760069|NCT03837028|529288690|FG001|Overall Study|Withdrawal by Subject|11|||
146760070|NCT03837028|529288691|FG002|Overall Study|Withdrawal by Subject|11|||
146760071|NCT03837028|529288692|FG003|Overall Study|Withdrawal by Subject|7|||
146760072|NCT00157014|529288693|FG000|Overall Study|Death|4|||
146760073|NCT00157014|529288694|FG001|Overall Study|Death|2|||
146760074|NCT00157014|529288695|FG002|Overall Study|Death|1|||
146760075|NCT00157014|529288696|FG003|Overall Study|Death|1|||
146760076|NCT00157014|529288693|FG000|Overall Study|Physician Decision|0|||
146760077|NCT00157014|529288694|FG001|Overall Study|Physician Decision|1|||
146760078|NCT00157014|529288695|FG002|Overall Study|Physician Decision|0|||
146760079|NCT00157014|529288696|FG003|Overall Study|Physician Decision|0|||
146760080|NCT00157014|529288693|FG000|Overall Study|Medications withdrawn on family request|0|||
146859539|NCT00261846|529656878|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146760081|NCT00157014|529288694|FG001|Overall Study|Medications withdrawn on family request|1|||
146760082|NCT00157014|529288695|FG002|Overall Study|Medications withdrawn on family request|0|||
146524094|NCT01919164|528427094|FG004|Overall Study|Lost to Follow-up|4|||
146524095|NCT01919164|528427090|FG000|Overall Study|Death|1|||
146524096|NCT01919164|528427091|FG001|Overall Study|Death|0|||
146760083|NCT00157014|529288696|FG003|Overall Study|Medications withdrawn on family request|0|||
146524097|NCT01919164|528427092|FG002|Overall Study|Death|0|||
146760084|NCT00157014|529288693|FG000|Overall Study|Patient withdrawn by investigator|1|||
146760085|NCT00157014|529288694|FG001|Overall Study|Patient withdrawn by investigator|0|||
146760086|NCT00157014|529288695|FG002|Overall Study|Patient withdrawn by investigator|0|||
146760087|NCT00157014|529288696|FG003|Overall Study|Patient withdrawn by investigator|0|||
146760088|NCT00157014|529288693|FG000|Overall Study|Patient unable to return in nursing home|1|||
146524098|NCT01919164|528427093|FG003|Overall Study|Death|0|||
146524099|NCT01919164|528427094|FG004|Overall Study|Death|0|||
146524100|NCT01919164|528427090|FG000|Overall Study|Protocol Violation|6|||
146524101|NCT01919164|528427091|FG001|Overall Study|Protocol Violation|0|||
146524102|NCT01919164|528427092|FG002|Overall Study|Protocol Violation|3|||
146524103|NCT01919164|528427093|FG003|Overall Study|Protocol Violation|2|||
146524104|NCT01919164|528427094|FG004|Overall Study|Protocol Violation|2|||
146524105|NCT01919164|528427090|FG000|Overall Study|Disease progression|2|||
146524106|NCT01919164|528427091|FG001|Overall Study|Disease progression|2|||
146524107|NCT01919164|528427092|FG002|Overall Study|Disease progression|1|||
146524108|NCT01919164|528427093|FG003|Overall Study|Disease progression|2|||
146524109|NCT01919164|528427094|FG004|Overall Study|Disease progression|1|||
146524110|NCT01919164|528427090|FG000|Overall Study|Withdrew consent|13|||
146524111|NCT01919164|528427091|FG001|Overall Study|Withdrew consent|13|||
146524112|NCT01919164|528427092|FG002|Overall Study|Withdrew consent|14|||
146524113|NCT01919164|528427093|FG003|Overall Study|Withdrew consent|14|||
146524114|NCT01919164|528427094|FG004|Overall Study|Withdrew consent|9|||
146524115|NCT01919164|528427090|FG000|Overall Study|Other Un-specified|13|||
146524116|NCT01919164|528427091|FG001|Overall Study|Other Un-specified|9|||
146524117|NCT01919164|528427092|FG002|Overall Study|Other Un-specified|8|||
146524118|NCT01919164|528427093|FG003|Overall Study|Other Un-specified|7|||
146524119|NCT01919164|528427094|FG004|Overall Study|Other Un-specified|15|||
146524120|NCT00588146|528427095|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
146524121|NCT00588146|528427096|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
146524122|NCT02100839|528427097|FG000|Multiple Ascending Dose|Adverse Event|2|||
146524123|NCT02100839|528427098|FG001|Multiple Ascending Dose|Adverse Event|0|||
146524124|NCT02100839|528427097|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
146524125|NCT02100839|528427098|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
146524126|NCT00463801|528427100|FG000|Overall Study|Protocol Violation|1|||
146524127|NCT00463801|528427100|FG000|Overall Study|Lack of Efficacy|2|||
146524128|NCT00463801|528427100|FG000|Overall Study|Adverse Event|4|||
146524129|NCT00463801|528427100|FG000|Overall Study|Lost to Follow-up|5|||
146524130|NCT00463801|528427100|FG000|Overall Study|No longer require therapy|1|||
146524131|NCT03272347|528427101|FG000|Overall Study|Death|0|||
146524132|NCT03272347|528427102|FG001|Overall Study|Death|0|||
146524133|NCT03272347|528427103|FG002|Overall Study|Death|0|||
146524134|NCT03272347|528427104|FG003|Overall Study|Death|1|||
146524135|NCT03272347|528427101|FG000|Overall Study|Lost to Follow-up|1|||
146524136|NCT03272347|528427102|FG001|Overall Study|Lost to Follow-up|3|||
146524137|NCT03272347|528427103|FG002|Overall Study|Lost to Follow-up|5|||
146524138|NCT03272347|528427104|FG003|Overall Study|Lost to Follow-up|1|||
146524139|NCT03272347|528427101|FG000|Overall Study|Physician Decision|4|||
146524140|NCT03272347|528427102|FG001|Overall Study|Physician Decision|2|||
146524141|NCT03272347|528427103|FG002|Overall Study|Physician Decision|5|||
146524142|NCT03272347|528427104|FG003|Overall Study|Physician Decision|4|||
146524143|NCT03272347|528427101|FG000|Overall Study|Screen Failure|1|||
146524144|NCT03272347|528427102|FG001|Overall Study|Screen Failure|0|||
146524145|NCT03272347|528427103|FG002|Overall Study|Screen Failure|0|||
146524146|NCT03272347|528427104|FG003|Overall Study|Screen Failure|0|||
146524147|NCT03272347|528427101|FG000|Overall Study|Withdrawal by Subject|5|||
146524148|NCT03272347|528427102|FG001|Overall Study|Withdrawal by Subject|1|||
146524149|NCT03272347|528427103|FG002|Overall Study|Withdrawal by Subject|2|||
146524150|NCT03272347|528427104|FG003|Overall Study|Withdrawal by Subject|1|||
146524151|NCT00940888|528427105|FG000|Overall Study|Unsuccessful Implant|4|||
146524152|NCT00940888|528427105|FG000|Overall Study|Death|461|||
146524153|NCT00940888|528427105|FG000|Overall Study|Withdrawn - Non-Death|364|||
146524154|NCT00940888|528427105|FG000|Overall Study|Lost to Follow-up|6|||
146524155|NCT00391872|528427109|FG000|Overall Study|Protocol Violation|7|||
146524156|NCT00391872|528427110|FG001|Overall Study|Protocol Violation|2|||
146524157|NCT00391872|528427109|FG000|Overall Study|Withdrawal by Subject|296|||
146524158|NCT00391872|528427110|FG001|Overall Study|Withdrawal by Subject|249|||
146524159|NCT00391872|528427109|FG000|Overall Study|Reason unknown|2|||
146524160|NCT00391872|528427110|FG001|Overall Study|Reason unknown|4|||
146524161|NCT00391872|528427109|FG000|Overall Study|Lost to Follow-up|2|||
146524162|NCT00391872|528427110|FG001|Overall Study|Lost to Follow-up|0|||
146524163|NCT01409915|528427111|FG000|Overall Study|Adverse Event|0|||
146524164|NCT01409915|528427112|FG001|Overall Study|Adverse Event|2|||
146524165|NCT01409915|528427111|FG000|Overall Study|Withdrawal by Subject|0|||
146524166|NCT01409915|528427112|FG001|Overall Study|Withdrawal by Subject|1|||
146524167|NCT01409915|528427111|FG000|Overall Study|Protocol Violation|1|||
146524168|NCT01409915|528427112|FG001|Overall Study|Protocol Violation|0|||
146524169|NCT02250300|528427113|FG000|Expansion Phase|Death|6|||
146524170|NCT02250300|528427114|FG001|Expansion Phase|Death|7|||
146524171|NCT02250300|528427115|FG002|Expansion Phase|Death|0|||
146524172|NCT02250300|528427116|FG003|Expansion Phase|Death|0|||
146524173|NCT00215644|528427117|FG000|Overall Study|Disease Progression|28|||
146524174|NCT00215644|528427118|FG001|Overall Study|Disease Progression|10|||
146524175|NCT00215644|528427117|FG000|Overall Study|Adverse Event|2|||
146524176|NCT00215644|528427118|FG001|Overall Study|Adverse Event|9|||
146524177|NCT00215644|528427117|FG000|Overall Study|Death|1|||
146524178|NCT00215644|528427118|FG001|Overall Study|Death|2|||
146524179|NCT00215644|528427117|FG000|Overall Study|Withdrawal by Subject|1|||
146524180|NCT00215644|528427118|FG001|Overall Study|Withdrawal by Subject|0|||
146524181|NCT00215644|528427117|FG000|Overall Study|Other|3|||
146524182|NCT00215644|528427118|FG001|Overall Study|Other|15|||
146524183|NCT00215644|528427117|FG000|Overall Study|Randomized but Not Treated|1|||
146524184|NCT00215644|528427118|FG001|Overall Study|Randomized but Not Treated|0|||
146524185|NCT03569098|528427120|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
146524186|NCT03569098|528427121|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
146524187|NCT03569098|528427122|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
146524188|NCT03569098|528427120|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
146524189|NCT03569098|528427121|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
146524190|NCT03569098|528427122|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
146524191|NCT03569098|528427120|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
146524192|NCT03569098|528427121|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
146524193|NCT03569098|528427122|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
146524194|NCT03569098|528427120|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
146524195|NCT03569098|528427121|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
146524196|NCT03569098|528427122|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
146524197|NCT03569098|528427120|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
146524198|NCT03569098|528427121|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
146524199|NCT03569098|528427122|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
146524200|NCT03569098|528427120|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
146524201|NCT03569098|528427121|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
146524202|NCT03569098|528427122|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
146524203|NCT03569098|528427120|FG000|Double-Blind Treatment Cycle 1|Other|1|||
146524204|NCT03569098|528427121|FG001|Double-Blind Treatment Cycle 1|Other|0|||
146524205|NCT03569098|528427122|FG002|Double-Blind Treatment Cycle 1|Other|1|||
146524206|NCT03569098|528427120|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
146524207|NCT03569098|528427121|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
146524208|NCT03569098|528427122|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
146524209|NCT03569098|528427120|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
146524210|NCT03569098|528427121|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
146524211|NCT03569098|528427122|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
146524212|NCT03569098|528427120|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
146524213|NCT03569098|528427121|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
146524214|NCT03569098|528427122|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
146524215|NCT03569098|528427120|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
146524216|NCT03569098|528427121|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
146524217|NCT03569098|528427122|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
146524218|NCT03569098|528427120|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
146524219|NCT03569098|528427121|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
146524220|NCT03569098|528427122|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
146524221|NCT03569098|528427120|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
146524222|NCT03569098|528427121|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
146524223|NCT03569098|528427122|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
146859540|NCT00261846|529656879|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146859541|NCT00261846|529656868|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146859542|NCT00261846|529656869|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146859543|NCT00261846|529656870|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146859544|NCT00261846|529656871|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
146859545|NCT00261846|529656872|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146859546|NCT00261846|529656873|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146859547|NCT00261846|529656874|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146859548|NCT00261846|529656875|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146859549|NCT00261846|529656876|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
146859550|NCT00261846|529656877|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146859551|NCT00261846|529656878|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146859552|NCT00261846|529656879|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146859553|NCT00261846|529656868|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
146524224|NCT01516736|528427129|FG000|Overall Study|Withdrawal by Subject|10|||
146524225|NCT01516736|528427130|FG001|Overall Study|Withdrawal by Subject|4|||
146524226|NCT01516736|528427129|FG000|Overall Study|Adverse Event|4|||
146524227|NCT01516736|528427130|FG001|Overall Study|Adverse Event|5|||
146524228|NCT01516736|528427129|FG000|Overall Study|Death|3|||
146524229|NCT01516736|528427130|FG001|Overall Study|Death|1|||
146524230|NCT01516736|528427129|FG000|Overall Study|Physician Decision|2|||
146524231|NCT01516736|528427130|FG001|Overall Study|Physician Decision|1|||
146524232|NCT01516736|528427129|FG000|Overall Study|Lack of Efficacy|1|||
146859554|NCT00261846|529656869|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
146859555|NCT00261846|529656870|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
146859556|NCT00261846|529656871|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
146859557|NCT00261846|529656872|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
146859558|NCT00261846|529656873|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
146859559|NCT00261846|529656874|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
146859560|NCT00261846|529656875|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
146859561|NCT00261846|529656876|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
146859562|NCT00261846|529656877|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
146859563|NCT00261846|529656878|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
146859564|NCT00261846|529656879|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
146859565|NCT00261846|529656868|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
146859566|NCT00261846|529656869|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
146859567|NCT00261846|529656870|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
146859568|NCT00261846|529656871|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
146859569|NCT00261846|529656872|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
146859570|NCT00261846|529656873|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
146859571|NCT00261846|529656874|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
146859572|NCT00261846|529656875|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
146859573|NCT00261846|529656876|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
146859574|NCT00261846|529656877|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
146859575|NCT00261846|529656878|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
146859576|NCT00261846|529656879|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
146859577|NCT00261846|529656868|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
146859578|NCT00261846|529656869|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
146859579|NCT00261846|529656870|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
146524233|NCT01516736|528427130|FG001|Overall Study|Lack of Efficacy|0|||
146524234|NCT01516736|528427129|FG000|Overall Study|Protocol Violation|0|||
146524235|NCT01516736|528427130|FG001|Overall Study|Protocol Violation|1|||
146524236|NCT01516736|528427129|FG000|Overall Study|Other (not specified)|0|||
146524237|NCT01516736|528427130|FG001|Overall Study|Other (not specified)|1|||
146524238|NCT02781818|528427131|FG000|Overall Study|Lost to Follow-up|4|||
146524239|NCT02781818|528427132|FG001|Overall Study|Lost to Follow-up|2|||
146524240|NCT02781818|528427133|FG002|Overall Study|Lost to Follow-up|1|||
146524241|NCT01877668|528427134|FG000|Overall Study|Death|0|||
146524242|NCT01877668|528427135|FG001|Overall Study|Death|0|||
146524243|NCT01877668|528427136|FG002|Overall Study|Death|0|||
146524244|NCT01877668|528427137|FG003|Overall Study|Death|1|||
146524245|NCT01877668|528427138|FG004|Overall Study|Death|0|||
146524246|NCT01877668|528427134|FG000|Overall Study|No longer met study criteria|1|||
146524247|NCT01877668|528427135|FG001|Overall Study|No longer met study criteria|0|||
146524248|NCT01877668|528427136|FG002|Overall Study|No longer met study criteria|1|||
146524249|NCT01877668|528427137|FG003|Overall Study|No longer met study criteria|0|||
146524250|NCT01877668|528427138|FG004|Overall Study|No longer met study criteria|0|||
146524251|NCT01877668|528427134|FG000|Overall Study|Insufficient clinical response|0|||
146524252|NCT01877668|528427135|FG001|Overall Study|Insufficient clinical response|1|||
146524253|NCT01877668|528427136|FG002|Overall Study|Insufficient clinical response|2|||
146524254|NCT01877668|528427137|FG003|Overall Study|Insufficient clinical response|2|||
146524255|NCT01877668|528427138|FG004|Overall Study|Insufficient clinical response|0|||
146524256|NCT01877668|528427134|FG000|Overall Study|Lost to Follow-up|0|||
146524257|NCT01877668|528427135|FG001|Overall Study|Lost to Follow-up|2|||
146524258|NCT01877668|528427136|FG002|Overall Study|Lost to Follow-up|1|||
146524259|NCT01877668|528427137|FG003|Overall Study|Lost to Follow-up|0|||
146524260|NCT01877668|528427138|FG004|Overall Study|Lost to Follow-up|0|||
146524261|NCT01877668|528427134|FG000|Overall Study|Withdrawal by Subject|2|||
146524262|NCT01877668|528427135|FG001|Overall Study|Withdrawal by Subject|0|||
146524263|NCT01877668|528427136|FG002|Overall Study|Withdrawal by Subject|3|||
146524264|NCT01877668|528427137|FG003|Overall Study|Withdrawal by Subject|2|||
146524265|NCT01877668|528427138|FG004|Overall Study|Withdrawal by Subject|2|||
146524266|NCT01877668|528427134|FG000|Overall Study|Other|1|||
146760089|NCT00157014|529288694|FG001|Overall Study|Patient unable to return in nursing home|0|||
146760090|NCT00157014|529288695|FG002|Overall Study|Patient unable to return in nursing home|0|||
146760091|NCT00157014|529288696|FG003|Overall Study|Patient unable to return in nursing home|0|||
146760092|NCT00157014|529288693|FG000|Overall Study|Patient would not receive transplant|0|||
146760093|NCT00157014|529288694|FG001|Overall Study|Patient would not receive transplant|1|||
146760094|NCT00157014|529288695|FG002|Overall Study|Patient would not receive transplant|0|||
146760095|NCT00157014|529288696|FG003|Overall Study|Patient would not receive transplant|0|||
146760096|NCT00157014|529288693|FG000|Overall Study|Withdrawal by Subject|1|||
146760097|NCT00157014|529288694|FG001|Overall Study|Withdrawal by Subject|0|||
146760098|NCT00157014|529288695|FG002|Overall Study|Withdrawal by Subject|0|||
146760099|NCT00157014|529288696|FG003|Overall Study|Withdrawal by Subject|0|||
146760100|NCT01362491|529288697|FG000|Overall Study|Ineligible|1|||
146760101|NCT01362491|529288698|FG001|Overall Study|Ineligible|0|||
146760102|NCT01362491|529288699|FG002|Overall Study|Ineligible|0|||
146760103|NCT01257503|529288700|FG000|Overall Study|Lost to Follow-up|7|||
146760104|NCT01257503|529288701|FG001|Overall Study|Lost to Follow-up|10|||
146760105|NCT01257503|529288700|FG000|Overall Study|Over 5 years old at enrollment|0|||
146760106|NCT01257503|529288701|FG001|Overall Study|Over 5 years old at enrollment|1|||
146760107|NCT01257503|529288700|FG000|Overall Study|strep culture positive at enrollment|1|||
146760108|NCT01257503|529288701|FG001|Overall Study|strep culture positive at enrollment|0|||
146760109|NCT01168401|529288702|FG000|Overall Study|Lost to Follow-up|1|||
146760110|NCT01168401|529288703|FG001|Overall Study|Lost to Follow-up|1|||
146760111|NCT01168401|529288704|FG002|Overall Study|Lost to Follow-up|2|||
146760112|NCT01168401|529288705|FG003|Overall Study|Lost to Follow-up|1|||
146760113|NCT01168401|529288706|FG004|Overall Study|Lost to Follow-up|0|||
146760114|NCT01168401|529288707|FG005|Overall Study|Lost to Follow-up|0|||
146760115|NCT01168401|529288708|FG006|Overall Study|Lost to Follow-up|0|||
146760116|NCT01168401|529288709|FG007|Overall Study|Lost to Follow-up|0|||
146760117|NCT01168401|529288710|FG008|Overall Study|Lost to Follow-up|0|||
146760118|NCT01168401|529288711|FG009|Overall Study|Lost to Follow-up|0|||
146760119|NCT01168401|529288712|FG010|Overall Study|Lost to Follow-up|0|||
146760120|NCT01168401|529288702|FG000|Overall Study|Withdrawal by Subject|0|||
146760121|NCT01168401|529288703|FG001|Overall Study|Withdrawal by Subject|0|||
146760122|NCT01168401|529288704|FG002|Overall Study|Withdrawal by Subject|0|||
146859580|NCT00261846|529656871|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
146760123|NCT01168401|529288705|FG003|Overall Study|Withdrawal by Subject|1|||
146859581|NCT00261846|529656872|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
146859582|NCT00261846|529656873|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
146859583|NCT00261846|529656874|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
146524267|NCT01877668|528427135|FG001|Overall Study|Other|1|||
146524268|NCT01877668|528427136|FG002|Overall Study|Other|1|||
146760124|NCT01168401|529288706|FG004|Overall Study|Withdrawal by Subject|0|||
146859584|NCT00261846|529656875|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
146859585|NCT00261846|529656876|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
146524269|NCT01877668|528427137|FG003|Overall Study|Other|1|||
146524270|NCT01877668|528427138|FG004|Overall Study|Other|3|||
146524271|NCT01877668|528427134|FG000|Overall Study|Protocol Violation|1|||
146524272|NCT01877668|528427135|FG001|Overall Study|Protocol Violation|1|||
146524273|NCT01877668|528427136|FG002|Overall Study|Protocol Violation|0|||
146524274|NCT01877668|528427137|FG003|Overall Study|Protocol Violation|0|||
146524275|NCT01877668|528427138|FG004|Overall Study|Protocol Violation|3|||
146524276|NCT01877668|528427134|FG000|Overall Study|Adverse event related to study drug|2|||
146524277|NCT01877668|528427135|FG001|Overall Study|Adverse event related to study drug|2|||
146524278|NCT01877668|528427136|FG002|Overall Study|Adverse event related to study drug|2|||
146524279|NCT01877668|528427137|FG003|Overall Study|Adverse event related to study drug|2|||
146524280|NCT01877668|528427138|FG004|Overall Study|Adverse event related to study drug|1|||
146524281|NCT01877668|528427134|FG000|Overall Study|Adverse event unrelated to study drug|4|||
146524282|NCT01877668|528427135|FG001|Overall Study|Adverse event unrelated to study drug|1|||
146524283|NCT01877668|528427136|FG002|Overall Study|Adverse event unrelated to study drug|2|||
146524284|NCT01877668|528427137|FG003|Overall Study|Adverse event unrelated to study drug|0|||
146524285|NCT01877668|528427138|FG004|Overall Study|Adverse event unrelated to study drug|1|||
146524286|NCT01697800|528427139|FG000|Overall Study|Death|0|||
146524287|NCT01697800|528427140|FG001|Overall Study|Death|1|||
146524288|NCT01302418|528427141|FG000|Overall Study|Protocol Violation|9|||
146524289|NCT01302418|528427141|FG000|Overall Study|Non-evaluable|9|||
146524290|NCT01957579|528427147|FG000|Overall Study|Withdrawal of concent|0|||
146524291|NCT01957579|528427148|FG001|Overall Study|Withdrawal of concent|1|||
146524292|NCT01957579|528427149|FG002|Overall Study|Withdrawal of concent|0|||
146524293|NCT01957579|528427150|FG003|Overall Study|Withdrawal of concent|0|||
146524294|NCT01957579|528427147|FG000|Overall Study|Death|0|||
146524295|NCT01957579|528427148|FG001|Overall Study|Death|0|||
146524296|NCT01957579|528427149|FG002|Overall Study|Death|2|||
146524297|NCT01957579|528427150|FG003|Overall Study|Death|0|||
146524298|NCT01000974|528427152|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
146524299|NCT01000974|528427153|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
146524300|NCT01000974|528427154|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
146524301|NCT01000974|528427152|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
146524302|NCT01000974|528427153|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
146524303|NCT01000974|528427154|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
146524304|NCT01000974|528427152|FG000|Primary Vaccination Phase|Protocol Violation|40|||
146524305|NCT01000974|528427153|FG001|Primary Vaccination Phase|Protocol Violation|3|||
146524306|NCT01000974|528427154|FG002|Primary Vaccination Phase|Protocol Violation|2|||
146524307|NCT01000974|528427152|FG000|Primary Vaccination Phase|Adverse Event|14|||
146524308|NCT01000974|528427153|FG001|Primary Vaccination Phase|Adverse Event|2|||
146524309|NCT01000974|528427154|FG002|Primary Vaccination Phase|Adverse Event|2|||
146524310|NCT01000974|528427152|FG000|Primary Vaccination Phase|Other|4|||
146524311|NCT01000974|528427153|FG001|Primary Vaccination Phase|Other|9|||
146524312|NCT01000974|528427154|FG002|Primary Vaccination Phase|Other|12|||
146524313|NCT01000974|528427152|FG000|Booster Vaccination Phase|Protocol Violation|0|||
146524314|NCT01000974|528427153|FG001|Booster Vaccination Phase|Protocol Violation|0|||
146859586|NCT00261846|529656877|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
146859587|NCT00261846|529656878|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
146859588|NCT00261846|529656879|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
146859589|NCT00261846|529656868|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
146859590|NCT00261846|529656869|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
146859591|NCT00261846|529656870|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
146859592|NCT00261846|529656871|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
146859593|NCT00261846|529656872|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
146859594|NCT00261846|529656873|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
146859595|NCT00261846|529656874|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
146859596|NCT00261846|529656875|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
146859597|NCT00261846|529656876|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
146524315|NCT01000974|528427154|FG002|Booster Vaccination Phase|Protocol Violation|2|||
146524316|NCT01000974|528427152|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
146524317|NCT01000974|528427153|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
146524318|NCT01000974|528427154|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
146524319|NCT01000974|528427152|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
146524320|NCT01000974|528427153|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
146524321|NCT01000974|528427154|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
146524322|NCT01000974|528427152|FG000|Booster Vaccination Phase|Other|24|||
146524323|NCT01000974|528427153|FG001|Booster Vaccination Phase|Other|6|||
146524324|NCT01000974|528427154|FG002|Booster Vaccination Phase|Other|4|||
146524325|NCT01307891|528427155|FG000|Overall Study|Progressive Disease|3|||
146859598|NCT00261846|529656877|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
146859599|NCT00261846|529656878|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
146524326|NCT01307891|528427156|FG001|Overall Study|Progressive Disease|1|||
146524327|NCT03365934|528427157|FG000|Overall Study|Adverse Event|1|||
146859600|NCT00261846|529656879|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
146524328|NCT03365934|528427157|FG000|Overall Study|Withdrawal by Subject|1|||
146965082|NCT03110107|530033446|FG020|Treatment Period|Death|0|||
146524329|NCT02750332|528427158|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146859601|NCT00261846|529656868|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
146524330|NCT02750332|528427159|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146524331|NCT02937740|528427160|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
146524332|NCT02937740|528427161|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
146524333|NCT02937740|528427160|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
146524334|NCT02937740|528427161|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
146524335|NCT02937740|528427160|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
146524336|NCT02937740|528427161|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
146524337|NCT02937740|528427160|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
146524338|NCT02937740|528427161|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
146524339|NCT02937740|528427160|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
146524340|NCT02937740|528427161|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
146524341|NCT02937740|528427160|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
146524342|NCT02937740|528427161|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
146524343|NCT04194489|528427162|FG000|Overall Study|Withdrawal by Subject|5|||
146524344|NCT04194489|528427162|FG000|Overall Study|Lost to Follow-up|48|||
146524345|NCT02485483|528427168|FG000|Overall Study|Depression at baseline|15|||
146524346|NCT02485483|528427169|FG001|Overall Study|Depression at baseline|0|||
146524347|NCT02485483|528427168|FG000|Overall Study|Discontinued after baseline|39|||
146859602|NCT00261846|529656869|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
146859603|NCT00261846|529656870|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
146859604|NCT00261846|529656871|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
146524348|NCT02485483|528427169|FG001|Overall Study|Discontinued after baseline|0|||
146524349|NCT02291029|528427173|FG000|Overall Study|Withdrawal by Subject|0|||
146524350|NCT02291029|528427174|FG001|Overall Study|Withdrawal by Subject|0|||
146524351|NCT02291029|528427175|FG002|Overall Study|Withdrawal by Subject|1|||
146524352|NCT02291029|528427176|FG003|Overall Study|Withdrawal by Subject|0|||
146524353|NCT02291029|528427177|FG004|Overall Study|Withdrawal by Subject|0|||
146524354|NCT02291029|528427178|FG005|Overall Study|Withdrawal by Subject|0|||
146524355|NCT02291029|528427173|FG000|Overall Study|Adverse Event|0|||
146524356|NCT02291029|528427174|FG001|Overall Study|Adverse Event|1|||
146524357|NCT02291029|528427175|FG002|Overall Study|Adverse Event|0|||
146524358|NCT02291029|528427176|FG003|Overall Study|Adverse Event|0|||
146524359|NCT02291029|528427177|FG004|Overall Study|Adverse Event|0|||
146524360|NCT02291029|528427178|FG005|Overall Study|Adverse Event|0|||
146524361|NCT00377637|528427179|FG000|Induction Phase|Adverse Event|12|||
146524362|NCT00377637|528427180|FG001|Induction Phase|Adverse Event|21|||
146524363|NCT00377637|528427181|FG002|Induction Phase|Adverse Event|0|||
146524364|NCT00377637|528427182|FG003|Induction Phase|Adverse Event|0|||
146524365|NCT00377637|528427179|FG000|Induction Phase|Deterioration/serum creatinine|2|||
146524366|NCT00377637|528427180|FG001|Induction Phase|Deterioration/serum creatinine|0|||
146524367|NCT00377637|528427181|FG002|Induction Phase|Deterioration/serum creatinine|0|||
146524368|NCT00377637|528427182|FG003|Induction Phase|Deterioration/serum creatinine|0|||
146524369|NCT00377637|528427179|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
146524370|NCT00377637|528427180|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
146524371|NCT00377637|528427181|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
146524372|NCT00377637|528427182|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
146524373|NCT00377637|528427179|FG000|Induction Phase|Lost to Follow-up|2|||
146524374|NCT00377637|528427180|FG001|Induction Phase|Lost to Follow-up|1|||
146524375|NCT00377637|528427181|FG002|Induction Phase|Lost to Follow-up|0|||
146524376|NCT00377637|528427182|FG003|Induction Phase|Lost to Follow-up|0|||
146524377|NCT00377637|528427179|FG000|Induction Phase|Death|1|||
146524378|NCT00377637|528427180|FG001|Induction Phase|Death|3|||
146524379|NCT00377637|528427181|FG002|Induction Phase|Death|0|||
146524380|NCT00377637|528427182|FG003|Induction Phase|Death|0|||
146524381|NCT00377637|528427179|FG000|Induction Phase|Withdrawal by Subject|5|||
146524382|NCT00377637|528427180|FG001|Induction Phase|Withdrawal by Subject|6|||
146524383|NCT00377637|528427181|FG002|Induction Phase|Withdrawal by Subject|0|||
146524384|NCT00377637|528427182|FG003|Induction Phase|Withdrawal by Subject|0|||
146524385|NCT00377637|528427179|FG000|Induction Phase|Physician Decision|3|||
146524386|NCT00377637|528427180|FG001|Induction Phase|Physician Decision|1|||
146524387|NCT00377637|528427181|FG002|Induction Phase|Physician Decision|0|||
146524388|NCT00377637|528427182|FG003|Induction Phase|Physician Decision|0|||
146524389|NCT00377637|528427179|FG000|Induction Phase|Sponsor decision|1|||
146524390|NCT00377637|528427180|FG001|Induction Phase|Sponsor decision|2|||
146524391|NCT00377637|528427181|FG002|Induction Phase|Sponsor decision|0|||
146524392|NCT00377637|528427182|FG003|Induction Phase|Sponsor decision|0|||
146524393|NCT00377637|528427179|FG000|Induction Phase|Non-Compliance|1|||
146524394|NCT00377637|528427180|FG001|Induction Phase|Non-Compliance|0|||
146859605|NCT00261846|529656872|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
146524395|NCT00377637|528427181|FG002|Induction Phase|Non-Compliance|0|||
146524396|NCT00377637|528427182|FG003|Induction Phase|Non-Compliance|0|||
146524397|NCT00377637|528427179|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
146524398|NCT00377637|528427180|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
146859606|NCT00261846|529656873|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
146859607|NCT00261846|529656874|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
146859608|NCT00261846|529656875|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
146859609|NCT00261846|529656876|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
146859610|NCT00261846|529656877|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
146859611|NCT00261846|529656878|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
146859612|NCT00261846|529656879|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
146859613|NCT00325039|529656883|FG000|Overall Study|Lost to Follow-up|18|||
146859614|NCT00325039|529656884|FG001|Overall Study|Lost to Follow-up|14|||
146859615|NCT01009203|529656886|FG000|Overall Study|Withdrawal by Subject|1|||
146859616|NCT01009203|529656886|FG000|Overall Study|Adverse Event|5|||
146859617|NCT01009203|529656886|FG000|Overall Study|Treatment-unrelated death|1|||
146859618|NCT01776424|529656887|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
146859619|NCT01776424|529656888|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
146859620|NCT01776424|529656889|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
146859621|NCT01776424|529656887|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
146524399|NCT00377637|528427181|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
146524400|NCT00377637|528427182|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
146859622|NCT01776424|529656888|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
146859623|NCT01776424|529656889|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
146859624|NCT01776424|529656887|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
146859625|NCT01776424|529656888|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
146859626|NCT01776424|529656889|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
146859627|NCT01776424|529656887|FG000|LTOLE Part (Open Label)|Refused|5|||
146859628|NCT01776424|529656888|FG001|LTOLE Part (Open Label)|Refused|2|||
146859629|NCT01776424|529656889|FG002|LTOLE Part (Open Label)|Refused|11|||
146859630|NCT01776424|529656887|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
146859631|NCT01776424|529656888|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
146859632|NCT01776424|529656889|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
146524401|NCT00377637|528427179|FG000|Maintenance Phase|Adverse Event|0|||
146524402|NCT00377637|528427180|FG001|Maintenance Phase|Adverse Event|0|||
146524403|NCT00377637|528427181|FG002|Maintenance Phase|Adverse Event|29|||
146524404|NCT00377637|528427182|FG003|Maintenance Phase|Adverse Event|43|||
146524405|NCT00377637|528427179|FG000|Maintenance Phase|Physician Decision|0|||
146524406|NCT00377637|528427180|FG001|Maintenance Phase|Physician Decision|0|||
146524407|NCT00377637|528427181|FG002|Maintenance Phase|Physician Decision|5|||
146524408|NCT00377637|528427182|FG003|Maintenance Phase|Physician Decision|4|||
146524409|NCT00377637|528427179|FG000|Maintenance Phase|Lost to Follow-up|0|||
146524410|NCT00377637|528427180|FG001|Maintenance Phase|Lost to Follow-up|0|||
146524411|NCT00377637|528427181|FG002|Maintenance Phase|Lost to Follow-up|3|||
146524412|NCT00377637|528427182|FG003|Maintenance Phase|Lost to Follow-up|1|||
146524413|NCT00377637|528427179|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146524414|NCT00377637|528427180|FG001|Maintenance Phase|Withdrawal by Subject|0|||
146524415|NCT00377637|528427181|FG002|Maintenance Phase|Withdrawal by Subject|3|||
146524416|NCT00377637|528427182|FG003|Maintenance Phase|Withdrawal by Subject|3|||
146524417|NCT00377637|528427179|FG000|Maintenance Phase|Sponsor decision|0|||
146524418|NCT00377637|528427180|FG001|Maintenance Phase|Sponsor decision|0|||
146524419|NCT00377637|528427181|FG002|Maintenance Phase|Sponsor decision|2|||
146524420|NCT00377637|528427182|FG003|Maintenance Phase|Sponsor decision|3|||
146524421|NCT00377637|528427179|FG000|Maintenance Phase|Non-compliance|0|||
146524422|NCT00377637|528427180|FG001|Maintenance Phase|Non-compliance|0|||
146524423|NCT00377637|528427181|FG002|Maintenance Phase|Non-compliance|1|||
146524424|NCT00377637|528427182|FG003|Maintenance Phase|Non-compliance|1|||
146524425|NCT00377637|528427179|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
146524426|NCT00377637|528427180|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
146524427|NCT00377637|528427181|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
146524428|NCT00377637|528427182|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
146524429|NCT00377637|528427179|FG000|Maintenance Phase|Death|0|||
146524430|NCT00377637|528427180|FG001|Maintenance Phase|Death|0|||
146524431|NCT00377637|528427181|FG002|Maintenance Phase|Death|0|||
146524432|NCT00377637|528427182|FG003|Maintenance Phase|Death|1|||
146524433|NCT00493012|528427183|FG000|Overall Study|Lost to Follow-up|18|||
146859633|NCT00615836|529656892|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
146859634|NCT00615836|529656893|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
146859635|NCT00615836|529656894|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
146859636|NCT00615836|529656895|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
146859637|NCT00615836|529656896|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
146524434|NCT00493012|528427184|FG001|Overall Study|Lost to Follow-up|17|||
146524435|NCT04147247|528427186|FG000|Overall Study|Progressive disease|3|||
146524436|NCT04147247|528427187|FG001|Overall Study|Progressive disease|3|||
146524437|NCT04147247|528427188|FG002|Overall Study|Progressive disease|4|||
146524438|NCT04147247|528427189|FG003|Overall Study|Progressive disease|4|||
146524439|NCT04147247|528427190|FG004|Overall Study|Progressive disease|3|||
146524440|NCT04147247|528427186|FG000|Overall Study|Physician Decision|0|||
146524441|NCT04147247|528427187|FG001|Overall Study|Physician Decision|1|||
146524442|NCT04147247|528427188|FG002|Overall Study|Physician Decision|0|||
146524443|NCT04147247|528427189|FG003|Overall Study|Physician Decision|0|||
146524444|NCT04147247|528427190|FG004|Overall Study|Physician Decision|0|||
146524445|NCT04147247|528427186|FG000|Overall Study|Clinical Disease Progression|0|||
146524446|NCT04147247|528427187|FG001|Overall Study|Clinical Disease Progression|0|||
146524447|NCT04147247|528427188|FG002|Overall Study|Clinical Disease Progression|0|||
146760125|NCT01168401|529288707|FG005|Overall Study|Withdrawal by Subject|0|||
146760126|NCT01168401|529288708|FG006|Overall Study|Withdrawal by Subject|0|||
146760127|NCT01168401|529288709|FG007|Overall Study|Withdrawal by Subject|0|||
146760128|NCT01168401|529288710|FG008|Overall Study|Withdrawal by Subject|0|||
146760129|NCT01168401|529288711|FG009|Overall Study|Withdrawal by Subject|0|||
146760130|NCT01168401|529288712|FG010|Overall Study|Withdrawal by Subject|0|||
146760131|NCT00672256|529288713|FG000|Overall Study|PI dropped, bad data|44|||
146760132|NCT01801930|529288715|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
146760133|NCT01801930|529288716|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
146760134|NCT01801930|529288717|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
146760135|NCT01801930|529288718|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
146760136|NCT01801930|529288715|FG000|Overall Study|DLT occurs|0|||
146760137|NCT01801930|529288716|FG001|Overall Study|DLT occurs|1|||
146760138|NCT01801930|529288717|FG002|Overall Study|DLT occurs|0|||
146760139|NCT01801930|529288718|FG003|Overall Study|DLT occurs|0|||
146760140|NCT01720043|529288730|FG000|Overall Study|Withdrawal by Subject|1|||
146760141|NCT04381494|529288732|FG000|Overall Study|Early termination of trial|19|||
146760142|NCT04381494|529288732|FG000|Overall Study|Investigator's discretion|1|||
146760143|NCT04381494|529288732|FG000|Overall Study|Withdrawal by Subject|9|||
146760144|NCT04381494|529288732|FG000|Overall Study|NSCLC disease progression|4|||
146760145|NCT04381494|529288732|FG000|Overall Study|Device-Related Adverse Event|2|||
146760146|NCT01941316|529288738|FG000|Overall Study|Adverse Event|0|||
146760147|NCT01941316|529288739|FG001|Overall Study|Adverse Event|1|||
146760148|NCT01941316|529288740|FG002|Overall Study|Adverse Event|0|||
146760149|NCT01941316|529288741|FG003|Overall Study|Adverse Event|7|||
146760150|NCT01941316|529288738|FG000|Overall Study|Progressive Disease|3|||
146760151|NCT01941316|529288739|FG001|Overall Study|Progressive Disease|6|||
146760152|NCT01941316|529288740|FG002|Overall Study|Progressive Disease|2|||
146760153|NCT01941316|529288741|FG003|Overall Study|Progressive Disease|29|||
146760154|NCT01941316|529288738|FG000|Overall Study|Withdrawal by Subject|0|||
146760155|NCT01941316|529288739|FG001|Overall Study|Withdrawal by Subject|2|||
146760156|NCT01941316|529288740|FG002|Overall Study|Withdrawal by Subject|1|||
146760157|NCT01941316|529288741|FG003|Overall Study|Withdrawal by Subject|8|||
146760158|NCT01941316|529288738|FG000|Overall Study|Death|0|||
146760159|NCT01941316|529288739|FG001|Overall Study|Death|0|||
146760160|NCT01941316|529288740|FG002|Overall Study|Death|0|||
146760161|NCT01941316|529288741|FG003|Overall Study|Death|3|||
146760162|NCT01941316|529288738|FG000|Overall Study|Physician Decision|0|||
146760163|NCT01941316|529288739|FG001|Overall Study|Physician Decision|0|||
146760164|NCT01941316|529288740|FG002|Overall Study|Physician Decision|0|||
146760165|NCT01941316|529288741|FG003|Overall Study|Physician Decision|3|||
146760166|NCT01941316|529288738|FG000|Overall Study|Protocol Violation|0|||
146760167|NCT01941316|529288739|FG001|Overall Study|Protocol Violation|0|||
146760168|NCT01941316|529288740|FG002|Overall Study|Protocol Violation|0|||
146760169|NCT01941316|529288741|FG003|Overall Study|Protocol Violation|3|||
146760170|NCT01941316|529288738|FG000|Overall Study|Intercurrent illness|0|||
146760171|NCT01941316|529288739|FG001|Overall Study|Intercurrent illness|0|||
146760172|NCT01941316|529288740|FG002|Overall Study|Intercurrent illness|0|||
146760173|NCT01941316|529288741|FG003|Overall Study|Intercurrent illness|1|||
146760174|NCT01941316|529288738|FG000|Overall Study|Other, not specified|0|||
146760175|NCT01941316|529288739|FG001|Overall Study|Other, not specified|0|||
146760176|NCT01941316|529288740|FG002|Overall Study|Other, not specified|0|||
146760177|NCT01941316|529288741|FG003|Overall Study|Other, not specified|1|||
146760178|NCT02775435|529288742|FG000|Overall Study|Adverse Event|32|||
146760179|NCT02775435|529288743|FG001|Overall Study|Adverse Event|27|||
146760180|NCT02775435|529288742|FG000|Overall Study|Lost to Follow-up|2|||
146760181|NCT02775435|529288743|FG001|Overall Study|Lost to Follow-up|2|||
146760182|NCT02775435|529288742|FG000|Overall Study|Sponsor decision|44|||
146760183|NCT02775435|529288743|FG001|Overall Study|Sponsor decision|19|||
146760184|NCT02775435|529288742|FG000|Overall Study|Withdrawal by Subject|4|||
146760185|NCT02775435|529288743|FG001|Overall Study|Withdrawal by Subject|9|||
146760186|NCT02775435|529288742|FG000|Overall Study|Death|196|||
146760187|NCT02775435|529288743|FG001|Overall Study|Death|224|||
146760188|NCT04555044|529288746|FG000|Overall Study|Adverse Event|0|||
146965083|NCT03110107|530033447|FG021|Treatment Period|Death|0|||
146760189|NCT04555044|529288747|FG001|Overall Study|Adverse Event|1|||
146760190|NCT05487703|529288749|FG000|Overall Study|Other|19|||
146760191|NCT05487703|529288749|FG000|Overall Study|Participant not well|5|||
146760192|NCT05487703|529288749|FG000|Overall Study|Insurance Reasons|6|||
146760193|NCT05487703|529288749|FG000|Overall Study|Physician Decision|19|||
146760194|NCT05487703|529288749|FG000|Overall Study|Lack of Efficacy|60|||
146524448|NCT04147247|528427189|FG003|Overall Study|Clinical Disease Progression|0|||
146524449|NCT04147247|528427190|FG004|Overall Study|Clinical Disease Progression|1|||
146524450|NCT04147247|528427186|FG000|Overall Study|Adverse Event|0|||
146524451|NCT04147247|528427187|FG001|Overall Study|Adverse Event|0|||
146524452|NCT04147247|528427188|FG002|Overall Study|Adverse Event|1|||
146524453|NCT04147247|528427189|FG003|Overall Study|Adverse Event|0|||
146524454|NCT04147247|528427190|FG004|Overall Study|Adverse Event|1|||
146524455|NCT00327340|528427193|FG000|Overall Study|Withdrawal by Subject|1|||
146524456|NCT00327340|528427194|FG001|Overall Study|Withdrawal by Subject|5|||
146524457|NCT00327340|528427193|FG000|Overall Study|Physician Decision|1|||
146524458|NCT00327340|528427194|FG001|Overall Study|Physician Decision|1|||
146524459|NCT00327340|528427193|FG000|Overall Study|Disease Progression|10|||
146524460|NCT00327340|528427194|FG001|Overall Study|Disease Progression|19|||
146524461|NCT00327340|528427193|FG000|Overall Study|Symptomatic Disease|0|||
146524462|NCT00327340|528427194|FG001|Overall Study|Symptomatic Disease|2|||
146524463|NCT00327340|528427193|FG000|Overall Study|Adverse Event|3|||
146524464|NCT00327340|528427194|FG001|Overall Study|Adverse Event|3|||
146524465|NCT00613366|528427195|FG000|Overall Study|Withdrawal by Subject|3|||
146524466|NCT00613366|528427196|FG001|Overall Study|Withdrawal by Subject|2|||
146524467|NCT02282163|528427199|FG000|Overall Study|Protocol Violation|1|||
146524468|NCT03472521|528427200|FG000|Overall Study|Lost to Follow-up|3|||
146524469|NCT03472521|528427201|FG001|Overall Study|Lost to Follow-up|2|||
146524470|NCT03472521|528427200|FG000|Overall Study|Discontinued intervention|3|||
146524471|NCT03472521|528427201|FG001|Overall Study|Discontinued intervention|1|||
146524472|NCT03560869|528427202|FG000|Overall Study|Withdrawal by Subject|3|||
146524473|NCT03560869|528427203|FG001|Overall Study|Withdrawal by Subject|4|||
146524474|NCT03560869|528427202|FG000|Overall Study|Screening failure|4|||
146524475|NCT03560869|528427203|FG001|Overall Study|Screening failure|4|||
146524476|NCT03560869|528427202|FG000|Overall Study|Withdrawal by PI|0|||
146524477|NCT03560869|528427203|FG001|Overall Study|Withdrawal by PI|1|||
146524478|NCT01210482|528427204|FG000|Overall Study|Protocol Violation|1|||
146524479|NCT01210482|528427204|FG000|Overall Study|Case Report Forms were not collected|18|||
146524480|NCT01210482|528427204|FG000|Overall Study|Duplicated|2|||
146524481|NCT01210482|528427204|FG000|Overall Study|No Drug Administration|28|||
146524482|NCT01223937|528427205|FG000|Overall Study|Withdrawal by Subject|3|||
146524483|NCT01223937|528427206|FG001|Overall Study|Withdrawal by Subject|2|||
146524484|NCT01223937|528427205|FG000|Overall Study|Lost to Follow-up|1|||
146524485|NCT01223937|528427206|FG001|Overall Study|Lost to Follow-up|4|||
146524486|NCT01223937|528427205|FG000|Overall Study|Adverse Event|1|||
146524487|NCT01223937|528427206|FG001|Overall Study|Adverse Event|4|||
146524488|NCT01223937|528427205|FG000|Overall Study|Protocol Violation|8|||
146524489|NCT01223937|528427206|FG001|Overall Study|Protocol Violation|7|||
146524490|NCT01223937|528427205|FG000|Overall Study|Other|4|||
146524491|NCT01223937|528427206|FG001|Overall Study|Other|1|||
146524492|NCT00765817|528427207|FG000|Overall Study|Adverse Event|13|||
146524493|NCT00765817|528427208|FG001|Overall Study|Adverse Event|1|||
146524494|NCT00765817|528427207|FG000|Overall Study|Death|0|||
146524495|NCT00765817|528427208|FG001|Overall Study|Death|1|||
146524496|NCT00765817|528427207|FG000|Overall Study|Entry criteria not met|2|||
146524497|NCT00765817|528427208|FG001|Overall Study|Entry criteria not met|2|||
146524498|NCT00765817|528427207|FG000|Overall Study|Loss of glucose control|0|||
146524499|NCT00765817|528427208|FG001|Overall Study|Loss of glucose control|2|||
146524500|NCT00765817|528427207|FG000|Overall Study|Lost to Follow-up|1|||
146524501|NCT00765817|528427208|FG001|Overall Study|Lost to Follow-up|3|||
146524502|NCT00765817|528427207|FG000|Overall Study|Physician Decision|2|||
146524503|NCT00765817|528427208|FG001|Overall Study|Physician Decision|1|||
146524504|NCT00765817|528427207|FG000|Overall Study|Protocol Violation|1|||
146524505|NCT00765817|528427208|FG001|Overall Study|Protocol Violation|1|||
146524506|NCT00765817|528427207|FG000|Overall Study|Subject decision|7|||
146524507|NCT00765817|528427208|FG001|Overall Study|Subject decision|11|||
146524508|NCT06597084|528427209|FG000|Overall Study|Withdrawal by Subject|4|||
146524509|NCT06597084|528427210|FG001|Overall Study|Withdrawal by Subject|9|||
146524510|NCT06597084|528427209|FG000|Overall Study|Consent was not given by the patient until V2|0|||
146760195|NCT02403323|529288750|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
146760196|NCT02403323|529288751|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
146760197|NCT02403323|529288752|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
146524511|NCT06597084|528427210|FG001|Overall Study|Consent was not given by the patient until V2|3|||
146524512|NCT06597084|528427209|FG000|Overall Study|Physician Decision|1|||
146524513|NCT06597084|528427210|FG001|Overall Study|Physician Decision|0|||
146524514|NCT06597084|528427209|FG000|Overall Study|Adverse Event|3|||
146524515|NCT06597084|528427210|FG001|Overall Study|Adverse Event|2|||
146524516|NCT06597084|528427209|FG000|Overall Study|Death|4|||
146524517|NCT06597084|528427210|FG001|Overall Study|Death|0|||
146524518|NCT06597084|528427209|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
146524519|NCT06597084|528427210|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
146760198|NCT02403323|529288750|FG000|Part 1: Open Label Extension Period|Death|3|||
146760199|NCT02403323|529288751|FG001|Part 1: Open Label Extension Period|Death|0|||
146524520|NCT06597084|528427209|FG000|Overall Study|Lost to Follow-up|4|||
146524521|NCT06597084|528427210|FG001|Overall Study|Lost to Follow-up|2|||
146524522|NCT06597084|528427209|FG000|Overall Study|Other. Not specified|1|||
146524523|NCT06597084|528427210|FG001|Overall Study|Other. Not specified|0|||
146524524|NCT04826484|528429119|FG000|Overall Study|Lost to Follow-up|2|||
146524525|NCT04826484|528429120|FG001|Overall Study|Lost to Follow-up|0|||
146524526|NCT03512353|528429124|FG000|Overall Study|Sponsor Decision|3|||
146524527|NCT03512353|528429124|FG000|Overall Study|Death|1|||
146524528|NCT00758498|528429125|FG000|Overall Study|Adverse Event|2|||
146524529|NCT00758498|528429126|FG001|Overall Study|Adverse Event|2|||
146524530|NCT00758498|528429127|FG002|Overall Study|Adverse Event|3|||
146524531|NCT00758498|528429125|FG000|Overall Study|Subject legally detained out of state|1|||
146524532|NCT00758498|528429126|FG001|Overall Study|Subject legally detained out of state|0|||
146524533|NCT00758498|528429127|FG002|Overall Study|Subject legally detained out of state|0|||
146524534|NCT00758498|528429125|FG000|Overall Study|Withdrawal by Subject|0|||
146524535|NCT00758498|528429126|FG001|Overall Study|Withdrawal by Subject|0|||
146524536|NCT00758498|528429127|FG002|Overall Study|Withdrawal by Subject|1|||
146524537|NCT00758498|528429125|FG000|Overall Study|Noncompliance to study procedures|0|||
146524538|NCT00758498|528429126|FG001|Overall Study|Noncompliance to study procedures|0|||
146524539|NCT00758498|528429127|FG002|Overall Study|Noncompliance to study procedures|1|||
146524540|NCT02581488|528429131|FG000|Overall Study|Adverse Event|6|||
146524541|NCT02581488|528429132|FG001|Overall Study|Adverse Event|7|||
146524542|NCT02581488|528429131|FG000|Overall Study|Lost to Follow-up|1|||
146760200|NCT02403323|529288752|FG002|Part 1: Open Label Extension Period|Death|0|||
146760201|NCT02403323|529288750|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
146760202|NCT02403323|529288751|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
146760203|NCT02403323|529288752|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
146760204|NCT02403323|529288750|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
146760205|NCT02403323|529288751|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
146760206|NCT02403323|529288752|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
146760207|NCT02403323|529288750|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
146760208|NCT02403323|529288751|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
146760209|NCT02403323|529288752|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
146760210|NCT02403323|529288750|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
146760211|NCT02403323|529288751|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
146760212|NCT02403323|529288752|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
146760213|NCT02403323|529288750|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
146760214|NCT02403323|529288751|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
146760215|NCT02403323|529288752|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
146760216|NCT02403323|529288750|FG000|Part 1: Open Label Extension Period|Other|1|||
146760217|NCT02403323|529288751|FG001|Part 1: Open Label Extension Period|Other|0|||
146760218|NCT02403323|529288752|FG002|Part 1: Open Label Extension Period|Other|0|||
146760219|NCT02403323|529288750|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
146524543|NCT02581488|528429132|FG001|Overall Study|Lost to Follow-up|0|||
146524544|NCT02581488|528429131|FG000|Overall Study|Withdrawal by Subject|1|||
146524545|NCT02581488|528429132|FG001|Overall Study|Withdrawal by Subject|0|||
146524546|NCT02581488|528429131|FG000|Overall Study|Non-Compliance|1|||
146760220|NCT02403323|529288751|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
146760221|NCT02403323|529288752|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
146524547|NCT02581488|528429132|FG001|Overall Study|Non-Compliance|0|||
146524548|NCT02581488|528429131|FG000|Overall Study|Protocol Violation|0|||
146524549|NCT02581488|528429132|FG001|Overall Study|Protocol Violation|4|||
146524550|NCT00954122|528429133|FG000|Overall Study|Withdrawal by Subject|5|||
146524551|NCT00954122|528429133|FG000|Overall Study|Adverse Event|1|||
146524552|NCT00954122|528429133|FG000|Overall Study|Safety Reason|1|||
146524553|NCT00522548|528429134|FG000|Overall Study|Adverse Event|2|||
146859638|NCT00615836|529656892|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
146859639|NCT00615836|529656893|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
146859640|NCT00615836|529656894|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
146859641|NCT00615836|529656895|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
146859642|NCT00615836|529656896|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
146859643|NCT00615836|529656892|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
146859644|NCT00615836|529656893|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
146859645|NCT00615836|529656894|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
146859646|NCT00615836|529656895|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
146859647|NCT00615836|529656896|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
146859648|NCT00615836|529656892|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
146859649|NCT00615836|529656893|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
146859650|NCT00615836|529656894|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
146859651|NCT00615836|529656895|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
146859652|NCT00615836|529656896|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
146859653|NCT00615836|529656892|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
146859654|NCT00615836|529656893|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
146859655|NCT00615836|529656894|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
146859656|NCT00615836|529656895|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
146859657|NCT00615836|529656896|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
146524554|NCT00522548|528429135|FG001|Overall Study|Adverse Event|2|||
146524555|NCT00522548|528429134|FG000|Overall Study|Withdrawal by Subject|0|||
146524556|NCT00522548|528429135|FG001|Overall Study|Withdrawal by Subject|2|||
146524557|NCT04085601|528429136|FG000|Overall Study|Lost to Follow-up|1|||
146524558|NCT04085601|528429137|FG001|Overall Study|Lost to Follow-up|0|||
146524559|NCT04085601|528429136|FG000|Overall Study|Death|1|||
146524560|NCT04085601|528429137|FG001|Overall Study|Death|1|||
146524561|NCT02121795|528429138|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
146524562|NCT02121795|528429139|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
146524563|NCT02121795|528429138|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
146524564|NCT02121795|528429139|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
146524565|NCT02121795|528429138|FG000|Double-Blind Phase|Lost to Follow-up|7|||
146524566|NCT02121795|528429139|FG001|Double-Blind Phase|Lost to Follow-up|4|||
146524567|NCT02121795|528429138|FG000|Double-Blind Phase|Physician Decision|2|||
146524568|NCT02121795|528429139|FG001|Double-Blind Phase|Physician Decision|5|||
146524569|NCT02121795|528429138|FG000|Double-Blind Phase|Adverse Event|5|||
146524570|NCT02121795|528429139|FG001|Double-Blind Phase|Adverse Event|0|||
146524571|NCT02121795|528429138|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
146524572|NCT02121795|528429139|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
146524573|NCT02121795|528429138|FG000|Double-Blind Phase|Protocol Violation|0|||
146524574|NCT02121795|528429139|FG001|Double-Blind Phase|Protocol Violation|3|||
146524575|NCT02121795|528429138|FG000|Double-Blind Phase|Death|1|||
146524576|NCT02121795|528429139|FG001|Double-Blind Phase|Death|1|||
146524577|NCT02121795|528429138|FG000|Open-Label Phase|Physician Decision|8|||
146524578|NCT02121795|528429139|FG001|Open-Label Phase|Physician Decision|8|||
146524579|NCT02121795|528429138|FG000|Open-Label Phase|Withdrawal by Subject|3|||
146524580|NCT02121795|528429139|FG001|Open-Label Phase|Withdrawal by Subject|2|||
146524581|NCT02121795|528429138|FG000|Open-Label Phase|Lost to Follow-up|1|||
146524582|NCT02121795|528429139|FG001|Open-Label Phase|Lost to Follow-up|0|||
146524583|NCT04155463|528429140|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
146524584|NCT04155463|528429141|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
146524585|NCT00113295|528429142|FG000|Overall Study|Adverse Event|4|||
146524586|NCT00113295|528429143|FG001|Overall Study|Adverse Event|1|||
146524587|NCT00113295|528429142|FG000|Overall Study|Unrelated Medical Illness|1|||
146524588|NCT00113295|528429143|FG001|Overall Study|Unrelated Medical Illness|0|||
146859658|NCT00615836|529656892|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
146524589|NCT00666211|528429144|FG000|Overall Study|Withdrawal by Subject|10|||
146524590|NCT00666211|528429145|FG001|Overall Study|Withdrawal by Subject|13|||
146524591|NCT00666211|528429144|FG000|Overall Study|went off medication, no more pain|1|||
146524592|NCT00666211|528429145|FG001|Overall Study|went off medication, no more pain|0|||
146524593|NCT00666211|528429144|FG000|Overall Study|patient non-compliant|6|||
146524594|NCT00666211|528429145|FG001|Overall Study|patient non-compliant|6|||
146524595|NCT00666211|528429144|FG000|Overall Study|disease progression|1|||
146524596|NCT00666211|528429145|FG001|Overall Study|disease progression|8|||
146524597|NCT00666211|528429144|FG000|Overall Study|Lost to Follow-up|2|||
146524598|NCT00666211|528429145|FG001|Overall Study|Lost to Follow-up|0|||
146524599|NCT00666211|528429144|FG000|Overall Study|toxicity|0|||
146524600|NCT00666211|528429145|FG001|Overall Study|toxicity|2|||
146524601|NCT00666211|528429144|FG000|Overall Study|hospital admission|0|||
146524602|NCT00666211|528429145|FG001|Overall Study|hospital admission|5|||
146524603|NCT00666211|528429144|FG000|Overall Study|Death|0|||
146524604|NCT00666211|528429145|FG001|Overall Study|Death|2|||
146524605|NCT00666211|528429144|FG000|Overall Study|off tx for other complicating disease|0|||
146524606|NCT00666211|528429145|FG001|Overall Study|off tx for other complicating disease|1|||
146524607|NCT00666211|528429144|FG000|Overall Study|Physician Decision|0|||
146524608|NCT00666211|528429145|FG001|Overall Study|Physician Decision|1|||
146524609|NCT02999789|528429148|FG000|Overall Study|Withdrawal by Subject|0|||
146524610|NCT02999789|528429149|FG001|Overall Study|Withdrawal by Subject|1|||
146524611|NCT02999789|528429148|FG000|Overall Study|Became ineligible|1|||
146524612|NCT02999789|528429149|FG001|Overall Study|Became ineligible|2|||
146524613|NCT03334188|528429154|FG000|Overall Study|Withdrawal by Subject|0|||
146524614|NCT03334188|528429155|FG001|Overall Study|Withdrawal by Subject|1|||
146524615|NCT03334188|528429154|FG000|Overall Study|Death|1|||
146524616|NCT03334188|528429155|FG001|Overall Study|Death|0|||
146524617|NCT03334188|528429154|FG000|Overall Study|Never had qualifying clinic visit|7|||
146524618|NCT03334188|528429155|FG001|Overall Study|Never had qualifying clinic visit|7|||
146524619|NCT03442088|528429162|FG000|Overall Study|Adverse Event|1|||
146524620|NCT03442088|528429162|FG000|Overall Study|Lack of Efficacy|2|||
146524621|NCT03442088|528429162|FG000|Overall Study|Lost to Follow-up|2|||
146524622|NCT01001520|528429163|FG000|Medication Period 1|Withdrawal by Subject|2|||
146524623|NCT01001520|528429164|FG001|Medication Period 1|Withdrawal by Subject|2|||
146524624|NCT01001520|528429163|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
146524625|NCT01001520|528429164|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
146524626|NCT01001520|528429163|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
146524627|NCT01001520|528429164|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
146524628|NCT01001520|528429163|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
146524629|NCT01001520|528429164|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
146524630|NCT01001520|528429163|FG000|Washout Period|Withdrawal by Subject|2|||
146524631|NCT01001520|528429164|FG001|Washout Period|Withdrawal by Subject|1|||
146524632|NCT01001520|528429163|FG000|Medication Period 2|Withdrawal by Subject|0|||
146524633|NCT01001520|528429164|FG001|Medication Period 2|Withdrawal by Subject|3|||
146524634|NCT00357877|528429165|FG000|Overall Study|Death|2|||
146524635|NCT00357877|528429166|FG001|Overall Study|Death|1|||
146524636|NCT00357877|528429165|FG000|Overall Study|Lost to Follow-up|20|||
146524637|NCT00357877|528429166|FG001|Overall Study|Lost to Follow-up|23|||
146524638|NCT00357877|528429165|FG000|Overall Study|Withdrawal by Subject|3|||
146524639|NCT00357877|528429166|FG001|Overall Study|Withdrawal by Subject|3|||
146524640|NCT00357877|528429165|FG000|Overall Study|Administrative withdrawal|1|||
146524641|NCT00357877|528429166|FG001|Overall Study|Administrative withdrawal|1|||
146524642|NCT00357877|528429165|FG000|Overall Study|Other|0|||
146524643|NCT00357877|528429166|FG001|Overall Study|Other|2|||
146524644|NCT04668209|528429169|FG000|Overall Study|Withdrawal by Subject|2|||
146524645|NCT04668209|528429170|FG001|Overall Study|Withdrawal by Subject|2|||
146524646|NCT04668209|528429169|FG000|Overall Study|Lost to Follow-up|3|||
146524647|NCT04668209|528429170|FG001|Overall Study|Lost to Follow-up|4|||
146524648|NCT04668209|528429169|FG000|Overall Study|Subject Expired|2|||
146524649|NCT04668209|528429170|FG001|Overall Study|Subject Expired|0|||
146524650|NCT04668209|528429169|FG000|Overall Study|Withdrawn from study|0|||
146524651|NCT04668209|528429170|FG001|Overall Study|Withdrawn from study|1|||
146524652|NCT04668209|528429169|FG000|Overall Study|Adverse Event|0|||
146524653|NCT04668209|528429170|FG001|Overall Study|Adverse Event|1|||
146524654|NCT04878055|528429180|FG000|Overall Study|Patient transferred in another department|0|||
146524655|NCT04878055|528429181|FG001|Overall Study|Patient transferred in another department|2|||
146524656|NCT04878055|528429180|FG000|Overall Study|Physician Decision|1|||
146524657|NCT04878055|528429181|FG001|Overall Study|Physician Decision|1|||
146524658|NCT04878055|528429180|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
146524659|NCT04878055|528429181|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
146524660|NCT04878055|528429180|FG000|Overall Study|Adverse Event|12|||
146524661|NCT04878055|528429181|FG001|Overall Study|Adverse Event|7|||
146524662|NCT04878055|528429180|FG000|Overall Study|Other|5|||
146524663|NCT04878055|528429181|FG001|Overall Study|Other|0|||
146524664|NCT04878055|528429180|FG000|Overall Study|Withdrawal by Subject|7|||
146760222|NCT02403323|529288750|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
146760223|NCT02403323|529288751|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
146760224|NCT02403323|529288752|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
146760225|NCT02403323|529288750|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
146760226|NCT02403323|529288751|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
146760227|NCT02403323|529288752|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
146524665|NCT04878055|528429181|FG001|Overall Study|Withdrawal by Subject|3|||
146524666|NCT04878055|528429180|FG000|Overall Study|Lost to Follow-up|10|||
146760228|NCT02403323|529288750|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
146965084|NCT03110107|530033448|FG022|Treatment Period|Death|0|||
146524667|NCT04878055|528429181|FG001|Overall Study|Lost to Follow-up|1|||
146524668|NCT02907463|528429182|FG000|Overall Study|Lost to Follow-up|17|||
146524669|NCT02907463|528429182|FG000|Overall Study|Death|10|||
146524670|NCT02907463|528429182|FG000|Overall Study|Withdrawal by Subject|4|||
146524671|NCT02907463|528429182|FG000|Overall Study|MIS Approach was not used|2|||
146524672|NCT02907463|528429182|FG000|Overall Study|Not Implanted with Study Device|2|||
146524673|NCT02907463|528429182|FG000|Overall Study|Device Explanted|1|||
146524674|NCT02907463|528429182|FG000|Overall Study|Missing Exit Form|1|||
146524675|NCT05225558|528429188|FG000|Overall Study|Withdrawal by Subject|4|||
146524676|NCT05225558|528429189|FG001|Overall Study|Withdrawal by Subject|3|||
146524677|NCT05225558|528429188|FG000|Overall Study|Adverse Event|1|||
146524678|NCT05225558|528429189|FG001|Overall Study|Adverse Event|0|||
146524679|NCT05225558|528429188|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
146524680|NCT05225558|528429189|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
146524681|NCT05225558|528429188|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
146524682|NCT05225558|528429189|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
146524683|NCT03200548|528429190|FG000|Overall Study|Withdrawal by Subject|5|||
146524684|NCT03200548|528429191|FG001|Overall Study|Withdrawal by Subject|11|||
146524685|NCT03200548|528429192|FG002|Overall Study|Withdrawal by Subject|7|||
146524686|NCT03200548|528429193|FG003|Overall Study|Withdrawal by Subject|6|||
146524687|NCT00875563|528429198|FG000|Overall Study|Death|4|||
146524688|NCT00875563|528429198|FG000|Overall Study|Withdrawal by Subject|7|||
146524689|NCT00875563|528429198|FG000|Overall Study|No long-term (3-5 year) consent|6|||
146524690|NCT00875563|528429198|FG000|Overall Study|Still be eligible for follow-up|7|||
146524691|NCT02896569|528429199|FG000|Overall Study|Lost to Follow-up|2|||
146524692|NCT02896569|528429200|FG001|Overall Study|Lost to Follow-up|1|||
146524693|NCT02896569|528429199|FG000|Overall Study|Physician Decision|1|||
146524694|NCT02896569|528429200|FG001|Overall Study|Physician Decision|3|||
146524695|NCT02896569|528429199|FG000|Overall Study|Adverse Event|0|||
146524696|NCT02896569|528429200|FG001|Overall Study|Adverse Event|1|||
146524697|NCT02896569|528429199|FG000|Overall Study|Withdrawal by Subject|1|||
146524698|NCT02896569|528429200|FG001|Overall Study|Withdrawal by Subject|0|||
146524699|NCT00313846|528429201|FG000|Overall Study|Withdrawal by Subject|2|||
146524700|NCT00313846|528429202|FG001|Overall Study|Withdrawal by Subject|0|||
146524701|NCT00313846|528429201|FG000|Overall Study|Adverse Event|1|||
146524702|NCT00313846|528429202|FG001|Overall Study|Adverse Event|8|||
146524703|NCT00313846|528429201|FG000|Overall Study|Administrative|2|||
146524704|NCT00313846|528429202|FG001|Overall Study|Administrative|3|||
146524705|NCT03257436|528429203|FG000|Overall Study|Withdrawal by Subject|76|||
146524706|NCT03257436|528429203|FG000|Overall Study|Death|19|||
146524707|NCT00970489|528429204|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
146524708|NCT00970489|528429205|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
146524709|NCT02659943|528429206|FG000|Overall Study|Switched to alternative treatment|1|||
146524710|NCT02659943|528429207|FG001|Overall Study|Switched to alternative treatment|1|||
146524711|NCT02659943|528429208|FG002|Overall Study|Switched to alternative treatment|0|||
146524712|NCT02659943|528429209|FG003|Overall Study|Switched to alternative treatment|2|||
146524713|NCT02659943|528429210|FG004|Overall Study|Switched to alternative treatment|1|||
146524714|NCT02659943|528429211|FG005|Overall Study|Switched to alternative treatment|0|||
146524715|NCT02659943|528429212|FG006|Overall Study|Switched to alternative treatment|1|||
146524716|NCT02659943|528429206|FG000|Overall Study|Disease progression on study|0|||
146524717|NCT02659943|528429207|FG001|Overall Study|Disease progression on study|1|||
146524718|NCT02659943|528429208|FG002|Overall Study|Disease progression on study|1|||
146524719|NCT02659943|528429209|FG003|Overall Study|Disease progression on study|1|||
146524720|NCT02659943|528429210|FG004|Overall Study|Disease progression on study|1|||
146524721|NCT02659943|528429211|FG005|Overall Study|Disease progression on study|4|||
146524722|NCT02659943|528429212|FG006|Overall Study|Disease progression on study|0|||
146760229|NCT02403323|529288751|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
146760230|NCT02403323|529288752|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
146760231|NCT02403323|529288750|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
146760232|NCT02403323|529288751|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
146760233|NCT02403323|529288752|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
146760234|NCT02403323|529288750|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
146524723|NCT02659943|528429206|FG000|Overall Study|Patient's condition per principal investigator|0|||
146524724|NCT02659943|528429207|FG001|Overall Study|Patient's condition per principal investigator|0|||
146524725|NCT02659943|528429208|FG002|Overall Study|Patient's condition per principal investigator|0|||
146524726|NCT02659943|528429209|FG003|Overall Study|Patient's condition per principal investigator|0|||
146524727|NCT02659943|528429210|FG004|Overall Study|Patient's condition per principal investigator|0|||
146760235|NCT02403323|529288751|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
146760236|NCT02403323|529288752|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
146760237|NCT02403323|529288750|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
146760238|NCT02403323|529288751|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
146524728|NCT02659943|528429211|FG005|Overall Study|Patient's condition per principal investigator|1|||
146524729|NCT02659943|528429212|FG006|Overall Study|Patient's condition per principal investigator|0|||
146524730|NCT02659943|528429206|FG000|Overall Study|Ineligible|0|||
146524731|NCT02659943|528429207|FG001|Overall Study|Ineligible|0|||
146524732|NCT02659943|528429208|FG002|Overall Study|Ineligible|0|||
146524733|NCT02659943|528429209|FG003|Overall Study|Ineligible|0|||
146524734|NCT02659943|528429210|FG004|Overall Study|Ineligible|0|||
146524735|NCT02659943|528429211|FG005|Overall Study|Ineligible|0|||
146524736|NCT02659943|528429212|FG006|Overall Study|Ineligible|1|||
146524737|NCT02659943|528429206|FG000|Overall Study|No longer meets eligibility|0|||
146524738|NCT02659943|528429207|FG001|Overall Study|No longer meets eligibility|0|||
146524739|NCT02659943|528429208|FG002|Overall Study|No longer meets eligibility|0|||
146524740|NCT02659943|528429209|FG003|Overall Study|No longer meets eligibility|0|||
146524741|NCT02659943|528429210|FG004|Overall Study|No longer meets eligibility|0|||
146524742|NCT02659943|528429211|FG005|Overall Study|No longer meets eligibility|0|||
146524743|NCT02659943|528429212|FG006|Overall Study|No longer meets eligibility|1|||
146524744|NCT02659943|528429206|FG000|Overall Study|No treatment, per protocol|0|||
146524745|NCT02659943|528429207|FG001|Overall Study|No treatment, per protocol|0|||
146524746|NCT02659943|528429208|FG002|Overall Study|No treatment, per protocol|0|||
146524747|NCT02659943|528429209|FG003|Overall Study|No treatment, per protocol|0|||
146524748|NCT02659943|528429210|FG004|Overall Study|No treatment, per protocol|0|||
146524749|NCT02659943|528429211|FG005|Overall Study|No treatment, per protocol|0|||
146524750|NCT02659943|528429212|FG006|Overall Study|No treatment, per protocol|3|||
146524751|NCT01723072|528429217|FG000|Overall Study|Withdrawal by Subject|7|||
146524752|NCT01723072|528429218|FG001|Overall Study|Withdrawal by Subject|13|||
146524753|NCT01723072|528429217|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
146524754|NCT01723072|528429218|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
146524755|NCT01723072|528429217|FG000|Overall Study|Other|4|||
146524756|NCT01723072|528429218|FG001|Overall Study|Other|3|||
146524757|NCT01841970|528429219|FG000|Overall Study|Withdrawal by Subject|1|||
146524758|NCT01841970|528429219|FG000|Overall Study|Physician Decision|2|||
146524759|NCT01841970|528429219|FG000|Overall Study|Lost to Follow-up|8|||
146524760|NCT03478371|528429220|FG000|Overall Study|non-compliance|1|||
146760239|NCT02403323|529288752|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
146760240|NCT02403323|529288750|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
146760241|NCT02403323|529288751|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
146760242|NCT02403323|529288752|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
146760243|NCT02403323|529288750|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
146760244|NCT02403323|529288751|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
146760245|NCT02403323|529288752|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
146760246|NCT02403323|529288750|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
146760247|NCT02403323|529288751|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
146760248|NCT02403323|529288752|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
146760249|NCT00197236|529288756|FG000|Overall Study|Adverse Event|1|||
146760250|NCT00197236|529288757|FG001|Overall Study|Adverse Event|0|||
146760251|NCT00197236|529288758|FG002|Overall Study|Adverse Event|1|||
146760252|NCT00197236|529288756|FG000|Overall Study|Lost to Follow-up|5|||
146760253|NCT00197236|529288757|FG001|Overall Study|Lost to Follow-up|14|||
146760254|NCT00197236|529288758|FG002|Overall Study|Lost to Follow-up|6|||
146760255|NCT00197236|529288756|FG000|Overall Study|Protocol Violation|0|||
146760256|NCT00197236|529288757|FG001|Overall Study|Protocol Violation|0|||
146760257|NCT00197236|529288758|FG002|Overall Study|Protocol Violation|1|||
146760258|NCT00197236|529288756|FG000|Overall Study|Withdrawal by Subject|7|||
146760259|NCT00197236|529288757|FG001|Overall Study|Withdrawal by Subject|3|||
146760260|NCT00197236|529288758|FG002|Overall Study|Withdrawal by Subject|11|||
146760261|NCT00197236|529288756|FG000|Overall Study|Study drug/medication expiration|1|||
146760262|NCT00197236|529288757|FG001|Overall Study|Study drug/medication expiration|0|||
146760263|NCT00197236|529288758|FG002|Overall Study|Study drug/medication expiration|3|||
146965085|NCT03110107|530033449|FG023|Treatment Period|Death|0|||
146524761|NCT03478371|528429220|FG000|Overall Study|Lost to Follow-up|4|||
146524762|NCT03428100|528429221|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
146524763|NCT03428100|528429222|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146524764|NCT03428100|528429223|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
146524765|NCT03428100|528429224|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
146524766|NCT03428100|528429225|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146760264|NCT00197236|529288756|FG000|Overall Study|Returned out of specified time window|0|||
146760265|NCT00197236|529288757|FG001|Overall Study|Returned out of specified time window|0|||
146760266|NCT00197236|529288758|FG002|Overall Study|Returned out of specified time window|1|||
146760267|NCT03885596|529288759|FG000|Overall Study|Withdrawal by Subject|2|||
146760268|NCT03885596|529288760|FG001|Overall Study|Withdrawal by Subject|1|||
146760269|NCT03885596|529288761|FG002|Overall Study|Withdrawal by Subject|0|||
146760270|NCT03885596|529288762|FG003|Overall Study|Withdrawal by Subject|0|||
146760271|NCT01835899|529288764|FG000|Overall Study|Adverse Event|0|||
146760272|NCT01835899|529288765|FG001|Overall Study|Adverse Event|0|||
146859659|NCT00615836|529656893|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
146859660|NCT00615836|529656894|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
146859661|NCT00615836|529656895|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
146859662|NCT00615836|529656896|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
146859663|NCT00615836|529656892|FG000|Extension Study (FE992026 CS31)|Other|10|||
146859664|NCT00615836|529656893|FG001|Extension Study (FE992026 CS31)|Other|7|||
146859665|NCT00615836|529656894|FG002|Extension Study (FE992026 CS31)|Other|8|||
146859666|NCT00615836|529656895|FG003|Extension Study (FE992026 CS31)|Other|8|||
146859667|NCT00615836|529656896|FG004|Extension Study (FE992026 CS31)|Other|0|||
146859668|NCT00615836|529656892|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
146859669|NCT00615836|529656893|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
146859670|NCT00615836|529656894|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
146859671|NCT00615836|529656895|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
146859672|NCT00615836|529656896|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
146859673|NCT00615836|529656892|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
146859674|NCT00615836|529656893|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
146859675|NCT00615836|529656894|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
146859676|NCT00615836|529656895|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
146859677|NCT00615836|529656896|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
146859678|NCT01630434|529656897|FG000|Overall Study|Donor lungs turned down|1|||
146524767|NCT03428100|528429226|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146524768|NCT03428100|528429227|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146524769|NCT03428100|528429228|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146524770|NCT03428100|528429229|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146524771|NCT03428100|528429230|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146524772|NCT03428100|528429231|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146524773|NCT03428100|528429232|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146524774|NCT03428100|528429233|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146524775|NCT03428100|528429234|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146524776|NCT03428100|528429235|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146524777|NCT03428100|528429236|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146524778|NCT03428100|528429237|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146524779|NCT03428100|528429238|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146524780|NCT03428100|528429239|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146524781|NCT03428100|528429221|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
146524782|NCT03428100|528429222|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
146524783|NCT03428100|528429223|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
146524784|NCT03428100|528429224|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
146524785|NCT03428100|528429225|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
146524786|NCT03428100|528429226|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
146524787|NCT03428100|528429227|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
146524788|NCT03428100|528429228|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
146524789|NCT03428100|528429229|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
146524790|NCT03428100|528429230|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
146524791|NCT03428100|528429231|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
146524792|NCT03428100|528429232|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
146524793|NCT03428100|528429233|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
146524794|NCT03428100|528429234|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
146524795|NCT03428100|528429235|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
146524796|NCT03428100|528429236|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
146524797|NCT03428100|528429237|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
146524798|NCT03428100|528429238|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
146524799|NCT03428100|528429239|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
146524800|NCT03428100|528429221|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146524801|NCT03428100|528429222|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
146524802|NCT03428100|528429223|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
146524803|NCT03428100|528429224|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146524804|NCT03428100|528429225|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146524805|NCT03428100|528429226|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146524806|NCT03428100|528429227|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146524807|NCT03428100|528429228|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146859679|NCT01630434|529656898|FG001|Overall Study|Donor lungs turned down|0|||
146859680|NCT01630434|529656897|FG000|Overall Study|Protocol Violation|9|||
146859681|NCT01630434|529656898|FG001|Overall Study|Protocol Violation|4|||
146524808|NCT03428100|528429229|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146524809|NCT03428100|528429230|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146859682|NCT01630434|529656897|FG000|Overall Study|Death|20|||
146859683|NCT01630434|529656898|FG001|Overall Study|Death|26|||
146859684|NCT00687973|529656899|FG000|Overall Study|Adverse Event|18|||
146859685|NCT00687973|529656900|FG001|Overall Study|Adverse Event|28|||
146859686|NCT00687973|529656899|FG000|Overall Study|Lack of Efficacy|2|||
146859687|NCT00687973|529656900|FG001|Overall Study|Lack of Efficacy|3|||
146859688|NCT00687973|529656899|FG000|Overall Study|Protocol Violation|1|||
146859689|NCT00687973|529656900|FG001|Overall Study|Protocol Violation|2|||
146859690|NCT00687973|529656899|FG000|Overall Study|Administrative Reasons|0|||
146859691|NCT00687973|529656900|FG001|Overall Study|Administrative Reasons|2|||
146760273|NCT01835899|529288766|FG002|Overall Study|Adverse Event|1|||
146760274|NCT01835899|529288764|FG000|Overall Study|Other than stated above|0|||
146760275|NCT01835899|529288765|FG001|Overall Study|Other than stated above|1|||
146760276|NCT01835899|529288766|FG002|Overall Study|Other than stated above|0|||
146760277|NCT02616263|529288767|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
146760278|NCT02616263|529288768|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
146760279|NCT02616263|529288767|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
146760280|NCT02616263|529288768|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
146760281|NCT02616263|529288767|FG000|6 Month to 1.5 Year|Death|1|||
146760282|NCT02616263|529288768|FG001|6 Month to 1.5 Year|Death|0|||
146760283|NCT02616263|529288767|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
146760284|NCT02616263|529288768|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
146760285|NCT02616263|529288767|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
146859692|NCT00687973|529656899|FG000|Overall Study|Withdrawal by Subject|3|||
146859693|NCT00687973|529656900|FG001|Overall Study|Withdrawal by Subject|3|||
146859694|NCT02121834|529656902|FG000|Overall Study|Protocol Violation|0|||
146524810|NCT03428100|528429231|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146524811|NCT03428100|528429232|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146524812|NCT03428100|528429233|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146524813|NCT03428100|528429234|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146524814|NCT03428100|528429235|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146524815|NCT03428100|528429236|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146524816|NCT03428100|528429237|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146524817|NCT03428100|528429238|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146524818|NCT03428100|528429239|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146524819|NCT03428100|528429221|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
146524820|NCT03428100|528429222|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524821|NCT03428100|528429223|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146760286|NCT02616263|529288768|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
146760287|NCT02616263|529288767|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
146760288|NCT02616263|529288768|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
146760289|NCT05015478|529288771|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
146760290|NCT05015478|529288772|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
146859695|NCT02121834|529656903|FG001|Overall Study|Protocol Violation|1|||
146859696|NCT02121834|529656904|FG002|Overall Study|Protocol Violation|0|||
146524822|NCT03428100|528429224|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524823|NCT03428100|528429225|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524824|NCT03428100|528429226|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524825|NCT03428100|528429227|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524826|NCT03428100|528429228|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524827|NCT03428100|528429229|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524828|NCT03428100|528429230|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524829|NCT03428100|528429231|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524830|NCT03428100|528429232|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524831|NCT03428100|528429233|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524832|NCT03428100|528429234|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524833|NCT03428100|528429235|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524834|NCT03428100|528429236|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524835|NCT03428100|528429237|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524836|NCT03428100|528429238|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524837|NCT03428100|528429239|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
146524838|NCT03428100|528429221|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524839|NCT03428100|528429222|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
146524840|NCT03428100|528429223|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524841|NCT03428100|528429224|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524842|NCT03428100|528429225|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524843|NCT03428100|528429226|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524844|NCT03428100|528429227|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524845|NCT03428100|528429228|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524846|NCT03428100|528429229|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524847|NCT03428100|528429230|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524848|NCT03428100|528429231|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524849|NCT03428100|528429232|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524850|NCT03428100|528429233|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524851|NCT03428100|528429234|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524852|NCT03428100|528429235|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524853|NCT03428100|528429236|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524854|NCT03428100|528429237|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524855|NCT03428100|528429238|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524856|NCT03428100|528429239|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
146524857|NCT03428100|528429221|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
146524858|NCT03428100|528429222|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
146524859|NCT03428100|528429223|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
146524860|NCT03428100|528429224|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
146524861|NCT03428100|528429225|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
146524862|NCT03428100|528429226|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
146524863|NCT03428100|528429227|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
146524864|NCT03428100|528429228|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
146524865|NCT03428100|528429229|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
146524866|NCT03428100|528429230|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
146524867|NCT03428100|528429231|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
146524868|NCT03428100|528429232|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
146524869|NCT03428100|528429233|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
146524870|NCT03428100|528429234|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
146524871|NCT03428100|528429235|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
146524872|NCT03428100|528429236|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
146524873|NCT03428100|528429237|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
146524874|NCT03428100|528429238|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
146524875|NCT03428100|528429239|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
146524876|NCT03428100|528429221|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
146524877|NCT03428100|528429222|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
146524878|NCT03428100|528429223|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
146524879|NCT03428100|528429224|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
146524880|NCT03428100|528429225|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
146524881|NCT03428100|528429226|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
146524882|NCT03428100|528429227|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
146524883|NCT03428100|528429228|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
146524884|NCT03428100|528429229|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
146524885|NCT03428100|528429230|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
146524886|NCT03428100|528429231|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
146524887|NCT03428100|528429232|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
146524888|NCT03428100|528429233|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
146524889|NCT03428100|528429234|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
146524890|NCT03428100|528429235|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
146524891|NCT03428100|528429236|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
146524892|NCT03428100|528429237|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
146524893|NCT03428100|528429238|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
146524894|NCT03428100|528429239|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
146524895|NCT03428100|528429221|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
146524896|NCT03428100|528429222|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
146524897|NCT03428100|528429223|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
146524898|NCT03428100|528429224|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
146524899|NCT03428100|528429225|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
146524900|NCT03428100|528429226|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
146524901|NCT03428100|528429227|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
146524902|NCT03428100|528429228|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
146524903|NCT03428100|528429229|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
146524904|NCT03428100|528429230|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
146524905|NCT03428100|528429231|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
146524906|NCT03428100|528429232|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
146524907|NCT03428100|528429233|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
146524908|NCT03428100|528429234|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
146524909|NCT03428100|528429235|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
146524910|NCT03428100|528429236|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
146524911|NCT03428100|528429237|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
146524912|NCT03428100|528429238|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
146524913|NCT03428100|528429239|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
146524914|NCT03428100|528429221|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
146524915|NCT03428100|528429222|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
146524916|NCT03428100|528429223|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
146524917|NCT03428100|528429224|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
146524918|NCT03428100|528429225|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
146524919|NCT03428100|528429226|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
146524920|NCT03428100|528429227|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
146524921|NCT03428100|528429228|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
146524922|NCT03428100|528429229|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
146524923|NCT03428100|528429230|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
146524924|NCT03428100|528429231|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
146524925|NCT03428100|528429232|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
146524926|NCT03428100|528429233|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
146524927|NCT03428100|528429234|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
146524928|NCT03428100|528429235|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
146524929|NCT03428100|528429236|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
146524930|NCT03428100|528429237|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
146524931|NCT03428100|528429238|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
146524932|NCT03428100|528429239|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
146524933|NCT03428100|528429221|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
146524934|NCT03428100|528429222|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
146524935|NCT03428100|528429223|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
146524936|NCT03428100|528429224|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
146524937|NCT03428100|528429225|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
146524938|NCT03428100|528429226|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
146524939|NCT03428100|528429227|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
146524940|NCT03428100|528429228|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
146524941|NCT03428100|528429229|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
146524942|NCT03428100|528429230|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
146524943|NCT03428100|528429231|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
146524944|NCT03428100|528429232|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
146524945|NCT03428100|528429233|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
146524946|NCT03428100|528429234|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
146524947|NCT03428100|528429235|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
146524948|NCT03428100|528429236|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
146524949|NCT03428100|528429237|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
146524950|NCT03428100|528429238|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
146524951|NCT03428100|528429239|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
146524952|NCT03428100|528429221|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524953|NCT03428100|528429222|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524954|NCT03428100|528429223|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524955|NCT03428100|528429224|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524956|NCT03428100|528429225|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524957|NCT03428100|528429226|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524958|NCT03428100|528429227|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
146524959|NCT03428100|528429228|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524960|NCT03428100|528429229|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524961|NCT03428100|528429230|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524962|NCT03428100|528429231|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524963|NCT03428100|528429232|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524964|NCT03428100|528429233|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524965|NCT03428100|528429234|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524966|NCT03428100|528429235|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524967|NCT03428100|528429236|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524968|NCT03428100|528429237|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524969|NCT03428100|528429238|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
146524970|NCT03428100|528429239|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
146524971|NCT03428100|528429221|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
146524972|NCT03428100|528429222|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
146524973|NCT03428100|528429223|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
146524974|NCT03428100|528429224|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
146524975|NCT03428100|528429225|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
146524976|NCT03428100|528429226|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
146524977|NCT03428100|528429227|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
146524978|NCT03428100|528429228|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
146524979|NCT03428100|528429229|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
146524980|NCT03428100|528429230|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
146524981|NCT03428100|528429231|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
146524982|NCT03428100|528429232|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
146524983|NCT03428100|528429233|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
146524984|NCT03428100|528429234|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
146524985|NCT03428100|528429235|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
146524986|NCT03428100|528429236|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
146524987|NCT03428100|528429237|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
146524988|NCT03428100|528429238|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
146524989|NCT03428100|528429239|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
146524990|NCT03428100|528429221|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
146524991|NCT03428100|528429222|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
146524992|NCT03428100|528429223|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
146524993|NCT03428100|528429224|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
146524994|NCT03428100|528429225|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
146524995|NCT03428100|528429226|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
146524996|NCT03428100|528429227|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
146524997|NCT03428100|528429228|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
146524998|NCT03428100|528429229|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
146524999|NCT03428100|528429230|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
146525000|NCT03428100|528429231|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
146525001|NCT03428100|528429232|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
146525002|NCT03428100|528429233|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
146525003|NCT03428100|528429234|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
146525004|NCT03428100|528429235|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
146760291|NCT05015478|529288773|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
146760292|NCT05015478|529288774|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
146760293|NCT04939428|529288775|FG000|Overall Study|Death|0|||
146760294|NCT04939428|529288776|FG001|Overall Study|Death|1|||
146760295|NCT04939428|529288777|FG002|Overall Study|Death|0|||
146760296|NCT04939428|529288775|FG000|Overall Study|Lost to Follow-up|0|||
146760297|NCT04939428|529288776|FG001|Overall Study|Lost to Follow-up|5|||
146760298|NCT04939428|529288777|FG002|Overall Study|Lost to Follow-up|0|||
146760299|NCT04939428|529288775|FG000|Overall Study|Physician Decision|1|||
146760300|NCT04939428|529288776|FG001|Overall Study|Physician Decision|0|||
146760301|NCT04939428|529288777|FG002|Overall Study|Physician Decision|0|||
146525005|NCT03428100|528429236|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
146525006|NCT03428100|528429237|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
146525007|NCT03428100|528429238|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
146525008|NCT03428100|528429239|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
146525009|NCT03311841|528429245|FG000|14-day Wash-out|Adverse Event|0|||
146859697|NCT02121834|529656905|FG003|Overall Study|Protocol Violation|0|||
146859698|NCT02121834|529656906|FG004|Overall Study|Protocol Violation|0|||
146859699|NCT02121834|529656907|FG005|Overall Study|Protocol Violation|0|||
146859700|NCT02121834|529656908|FG006|Overall Study|Protocol Violation|0|||
146859701|NCT02121834|529656902|FG000|Overall Study|Withdrawal by Subject|0|||
146859702|NCT02121834|529656903|FG001|Overall Study|Withdrawal by Subject|1|||
146859703|NCT02121834|529656904|FG002|Overall Study|Withdrawal by Subject|1|||
146859704|NCT02121834|529656905|FG003|Overall Study|Withdrawal by Subject|0|||
146859705|NCT02121834|529656906|FG004|Overall Study|Withdrawal by Subject|0|||
146859706|NCT02121834|529656907|FG005|Overall Study|Withdrawal by Subject|0|||
146859707|NCT02121834|529656908|FG006|Overall Study|Withdrawal by Subject|0|||
146859708|NCT02121834|529656902|FG000|Overall Study|Lost to Follow-up|0|||
146859709|NCT02121834|529656903|FG001|Overall Study|Lost to Follow-up|0|||
146859710|NCT02121834|529656904|FG002|Overall Study|Lost to Follow-up|1|||
146859711|NCT02121834|529656905|FG003|Overall Study|Lost to Follow-up|0|||
146859712|NCT02121834|529656906|FG004|Overall Study|Lost to Follow-up|0|||
146859713|NCT02121834|529656907|FG005|Overall Study|Lost to Follow-up|0|||
146859714|NCT02121834|529656908|FG006|Overall Study|Lost to Follow-up|0|||
146859715|NCT02578862|529656909|FG000|Overall Study|Withdrawal by Subject|0|||
146859716|NCT02578862|529656910|FG001|Overall Study|Withdrawal by Subject|1|||
146859717|NCT02578862|529656909|FG000|Overall Study|Unplanned unilateral procedure|0|||
146859718|NCT02578862|529656910|FG001|Overall Study|Unplanned unilateral procedure|1|||
146859719|NCT02075541|529656918|FG000|Overall Study|Serious Adverse Event|1|||
146859720|NCT02075541|529656919|FG001|Overall Study|Serious Adverse Event|4|||
146859721|NCT02075541|529656918|FG000|Overall Study|Protocol Violation|1|||
146859722|NCT02075541|529656919|FG001|Overall Study|Protocol Violation|0|||
146859723|NCT02075541|529656918|FG000|Overall Study|Withdrawal by Subject|1|||
146859724|NCT02075541|529656919|FG001|Overall Study|Withdrawal by Subject|3|||
146859725|NCT02075541|529656918|FG000|Overall Study|Sponsor study termination|0|||
146859726|NCT02075541|529656919|FG001|Overall Study|Sponsor study termination|1|||
146525010|NCT03311841|528429246|FG001|14-day Wash-out|Adverse Event|1|||
146525011|NCT03311841|528429247|FG002|14-day Wash-out|Adverse Event|0|||
146525012|NCT03311841|528429248|FG003|14-day Wash-out|Adverse Event|0|||
146525013|NCT03311841|528429249|FG004|14-day Wash-out|Adverse Event|0|||
146525014|NCT03311841|528429245|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
146525015|NCT03311841|528429246|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
146525016|NCT03311841|528429247|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
146525017|NCT03311841|528429248|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
146525018|NCT03311841|528429249|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
146525019|NCT01026948|528429255|FG000|Overall Study|Physician Decision|8|||
146525020|NCT02989402|528429257|FG000|Overall Study|Adverse event, or serious adverse event|4|||
146525021|NCT02989402|528429257|FG000|Overall Study|Death|2|||
146525022|NCT02989402|528429257|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
146525023|NCT02989402|528429257|FG000|Overall Study|Lost to Follow-up|8|||
146525024|NCT02989402|528429257|FG000|Overall Study|Patient no longer on monotherapy|1|||
146525025|NCT02989402|528429257|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
146525026|NCT02989402|528429257|FG000|Overall Study|Withdrawal by Subject|7|||
146525027|NCT02989402|528429257|FG000|Overall Study|Other|2|||
146525028|NCT02106351|528429271|FG000|Treatment Cycle 1|Adverse Event|2|||
146525029|NCT02106351|528429272|FG001|Treatment Cycle 1|Adverse Event|0|||
146525030|NCT02106351|528429273|FG002|Treatment Cycle 1|Adverse Event|0|||
146525031|NCT02106351|528429271|FG000|Treatment Cycle 1|Consent withdrawn|1|||
146525032|NCT02106351|528429272|FG001|Treatment Cycle 1|Consent withdrawn|0|||
146525033|NCT02106351|528429273|FG002|Treatment Cycle 1|Consent withdrawn|2|||
146525034|NCT02106351|528429271|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
146525035|NCT02106351|528429272|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
146525036|NCT02106351|528429273|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
146525037|NCT02106351|528429271|FG000|Treatment Cycle 1|Other|0|||
146525038|NCT02106351|528429272|FG001|Treatment Cycle 1|Other|3|||
146525039|NCT02106351|528429273|FG002|Treatment Cycle 1|Other|1|||
146525040|NCT02106351|528429271|FG000|Treatment Cycle 1|Randomised but not treated|1|||
146525041|NCT02106351|528429272|FG001|Treatment Cycle 1|Randomised but not treated|0|||
146525042|NCT02106351|528429273|FG002|Treatment Cycle 1|Randomised but not treated|1|||
146525043|NCT02106351|528429271|FG000|Treatment Cycle 2|Adverse Event|0|||
146525044|NCT02106351|528429272|FG001|Treatment Cycle 2|Adverse Event|2|||
146525045|NCT02106351|528429273|FG002|Treatment Cycle 2|Adverse Event|0|||
146525046|NCT02106351|528429271|FG000|Treatment Cycle 2|Consent withdrawn|0|||
146859727|NCT02075541|529656918|FG000|Overall Study|Other- unable to perform study procedure|1|||
146965086|NCT03110107|530033450|FG024|Treatment Period|Death|0|||
146965087|NCT03110107|530033451|FG025|Treatment Period|Death|0|||
146525047|NCT02106351|528429272|FG001|Treatment Cycle 2|Consent withdrawn|1|||
146525048|NCT02106351|528429273|FG002|Treatment Cycle 2|Consent withdrawn|1|||
146525049|NCT02106351|528429271|FG000|Treatment Cycle 2|Other|0|||
146525050|NCT02106351|528429272|FG001|Treatment Cycle 2|Other|2|||
146525051|NCT02106351|528429273|FG002|Treatment Cycle 2|Other|2|||
146525052|NCT02106351|528429271|FG000|Treatment Cycle 3|Adverse Event|0|||
146525053|NCT02106351|528429272|FG001|Treatment Cycle 3|Adverse Event|1|||
146859728|NCT02075541|529656919|FG001|Overall Study|Other- unable to perform study procedure|0|||
146859729|NCT00343252|529656920|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
146859730|NCT00343252|529656921|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
146859731|NCT00343252|529656920|FG000|6 Months (All Treated Participants)|Death|0|||
146859732|NCT00343252|529656921|FG001|6 Months (All Treated Participants)|Death|2|||
146859733|NCT00343252|529656920|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
146525054|NCT02106351|528429273|FG002|Treatment Cycle 3|Adverse Event|0|||
146525055|NCT02106351|528429271|FG000|Treatment Cycle 3|Consent withdrawn|0|||
146525056|NCT02106351|528429272|FG001|Treatment Cycle 3|Consent withdrawn|0|||
146525057|NCT02106351|528429273|FG002|Treatment Cycle 3|Consent withdrawn|2|||
146525058|NCT02106351|528429271|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
146525059|NCT02106351|528429272|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
146525060|NCT02106351|528429273|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
146525061|NCT02106351|528429271|FG000|Treatment Cycle 3|Other|0|||
146525062|NCT02106351|528429272|FG001|Treatment Cycle 3|Other|2|||
146525063|NCT02106351|528429273|FG002|Treatment Cycle 3|Other|3|||
146525064|NCT02106351|528429271|FG000|Treatment Cycle 4|Consent withdrawn|0|||
146859734|NCT00343252|529656921|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
146859735|NCT00343252|529656920|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
146859736|NCT00343252|529656921|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
146859737|NCT00343252|529656920|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
146525065|NCT02106351|528429272|FG001|Treatment Cycle 4|Consent withdrawn|0|||
146859738|NCT00343252|529656921|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
146859739|NCT00343252|529656920|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
146859740|NCT00343252|529656921|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
146859741|NCT00343252|529656920|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
146859742|NCT00343252|529656921|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
146859743|NCT00343252|529656920|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
146859744|NCT00343252|529656921|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
146859745|NCT00343252|529656920|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
146859746|NCT00343252|529656921|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
146859747|NCT00343252|529656920|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
146859748|NCT00343252|529656921|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
146859749|NCT00343252|529656920|FG000|12 Months (All Treated Participants)|Death|3|||
146859750|NCT00343252|529656921|FG001|12 Months (All Treated Participants)|Death|3|||
146525066|NCT02106351|528429273|FG002|Treatment Cycle 4|Consent withdrawn|2|||
146525067|NCT02106351|528429271|FG000|Treatment Cycle 4|Other|0|||
146525068|NCT02106351|528429272|FG001|Treatment Cycle 4|Other|1|||
146525069|NCT02106351|528429273|FG002|Treatment Cycle 4|Other|0|||
146525070|NCT00069823|528429278|FG000|Overall Study|Did not have follow-up diary cards|6|||
146525071|NCT00069823|528429279|FG001|Overall Study|Did not have follow-up diary cards|3|||
146525072|NCT01801111|528429280|FG000|Overall Study|Adverse Event|12|||
146525073|NCT01801111|528429280|FG000|Overall Study|Death|8|||
146525074|NCT01801111|528429280|FG000|Overall Study|Physician Decision|5|||
146525075|NCT01801111|528429280|FG000|Overall Study|Other|1|||
146525076|NCT01801111|528429280|FG000|Overall Study|Withdrawal by Subject|4|||
146525077|NCT01801111|528429280|FG000|Overall Study|Study Terminated by Sponsor|27|||
146525078|NCT01801111|528429280|FG000|Overall Study|Progressive Disease|81|||
146525079|NCT03999749|528429283|FG000|Overall Study|Toxicity|16|||
146525080|NCT03999749|528429283|FG000|Overall Study|Withdrawal by Subject|3|||
146525081|NCT03999749|528429283|FG000|Overall Study|Disease progression|26|||
146525082|NCT03999749|528429283|FG000|Overall Study|Physician Decision|4|||
146525083|NCT03999749|528429283|FG000|Overall Study|Death|5|||
146525084|NCT03999749|528429283|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
146525085|NCT00255164|528429284|FG000|Overall Study|Adverse Event|10|||
146525086|NCT00255164|528429285|FG001|Overall Study|Adverse Event|6|||
146525087|NCT00255164|528429286|FG002|Overall Study|Adverse Event|9|||
146525088|NCT00255164|528429284|FG000|Overall Study|Lost to Follow-up|4|||
146525089|NCT00255164|528429285|FG001|Overall Study|Lost to Follow-up|3|||
146525090|NCT00255164|528429286|FG002|Overall Study|Lost to Follow-up|4|||
146859751|NCT00343252|529656920|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
146859752|NCT00343252|529656921|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
146859753|NCT00343252|529656920|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
146859754|NCT00343252|529656921|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
146859755|NCT00343252|529656920|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
146525091|NCT00255164|528429284|FG000|Overall Study|Withdrawal by Subject|18|||
146525092|NCT00255164|528429285|FG001|Overall Study|Withdrawal by Subject|17|||
146525093|NCT00255164|528429286|FG002|Overall Study|Withdrawal by Subject|8|||
146760302|NCT04939428|529288775|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
146760303|NCT04939428|529288776|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146760304|NCT04939428|529288777|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146760305|NCT04939428|529288775|FG000|Overall Study|Withdrawal by Subject|10|||
146760306|NCT04939428|529288776|FG001|Overall Study|Withdrawal by Subject|11|||
146760307|NCT04939428|529288777|FG002|Overall Study|Withdrawal by Subject|0|||
146760308|NCT04939428|529288775|FG000|Overall Study|Unkown|6|||
146760309|NCT04939428|529288776|FG001|Overall Study|Unkown|3|||
146760310|NCT04939428|529288777|FG002|Overall Study|Unkown|0|||
146760311|NCT04939428|529288775|FG000|Overall Study|Discotinued per protocol|0|||
146760312|NCT04939428|529288776|FG001|Overall Study|Discotinued per protocol|0|||
146760313|NCT04939428|529288777|FG002|Overall Study|Discotinued per protocol|902|||
146760314|NCT04319094|529288780|FG000|Baseline|Lost to Follow-up|4|||
146760315|NCT04319094|529288781|FG001|Baseline|Lost to Follow-up|5|||
146760316|NCT04319094|529288780|FG000|Baseline|Protocol Violation|0|||
146760317|NCT04319094|529288781|FG001|Baseline|Protocol Violation|3|||
146760318|NCT04319094|529288780|FG000|Baseline|Withdrawal by Subject|2|||
146760319|NCT04319094|529288781|FG001|Baseline|Withdrawal by Subject|1|||
146760320|NCT04319094|529288780|FG000|Post-Intervention|Death|0|||
146760321|NCT04319094|529288781|FG001|Post-Intervention|Death|1|||
146760322|NCT04319094|529288780|FG000|Post-Intervention|Lost to Follow-up|4|||
146760323|NCT04319094|529288781|FG001|Post-Intervention|Lost to Follow-up|4|||
146760324|NCT04319094|529288780|FG000|Post-Intervention|Withdrawal by Subject|8|||
146760325|NCT04319094|529288781|FG001|Post-Intervention|Withdrawal by Subject|5|||
146760326|NCT04319094|529288780|FG000|Post-Intervention|Incomplete Data Collection|1|||
146760327|NCT04319094|529288781|FG001|Post-Intervention|Incomplete Data Collection|3|||
146760328|NCT04319094|529288780|FG000|3-month|Death|1|||
146760329|NCT04319094|529288781|FG001|3-month|Death|0|||
146760330|NCT04319094|529288780|FG000|3-month|Lost to Follow-up|2|||
146760331|NCT04319094|529288781|FG001|3-month|Lost to Follow-up|2|||
146760332|NCT04319094|529288780|FG000|3-month|Withdrawal by Subject|0|||
146760333|NCT04319094|529288781|FG001|3-month|Withdrawal by Subject|3|||
146760334|NCT04319094|529288780|FG000|3-month|Incomplete data collection|9|||
146760335|NCT04319094|529288781|FG001|3-month|Incomplete data collection|7|||
146760336|NCT04319094|529288780|FG000|6-month|Lost to Follow-up|1|||
146760337|NCT04319094|529288781|FG001|6-month|Lost to Follow-up|1|||
146760338|NCT04319094|529288780|FG000|6-month|Withdrawal by Subject|0|||
146760339|NCT04319094|529288781|FG001|6-month|Withdrawal by Subject|3|||
146760340|NCT04319094|529288780|FG000|6-month|Incomplete data collection|14|||
146760341|NCT04319094|529288781|FG001|6-month|Incomplete data collection|9|||
146760342|NCT04319094|529288780|FG000|9-month|Lost to Follow-up|8|||
146760343|NCT04319094|529288781|FG001|9-month|Lost to Follow-up|4|||
146760344|NCT04319094|529288780|FG000|9-month|Withdrawal by Subject|0|||
146760345|NCT04319094|529288781|FG001|9-month|Withdrawal by Subject|1|||
146760346|NCT04319094|529288780|FG000|9-month|Incomplete data collection|8|||
146760347|NCT04319094|529288781|FG001|9-month|Incomplete data collection|5|||
146760348|NCT04319094|529288780|FG000|12-month|Lost to Follow-up|11|||
146760349|NCT04319094|529288781|FG001|12-month|Lost to Follow-up|8|||
146760350|NCT00654238|529288784|FG000|Overall Study|Screen Failures|4|||
146760351|NCT00614744|529288785|FG000|Overall Study|Lost to Follow-up|5|||
146760352|NCT00614744|529288786|FG001|Overall Study|Lost to Follow-up|4|||
146760353|NCT00614744|529288785|FG000|Overall Study|Incomplete for Behavior Issues|0|||
146760354|NCT00614744|529288786|FG001|Overall Study|Incomplete for Behavior Issues|2|||
146760355|NCT00877851|529288787|FG000|Overall Study|Lost to Follow-up|5|||
146760356|NCT00877851|529288788|FG001|Overall Study|Lost to Follow-up|5|||
146760357|NCT00877851|529288787|FG000|Overall Study|computer problem|3|||
146760358|NCT00877851|529288788|FG001|Overall Study|computer problem|0|||
146760359|NCT00877851|529288787|FG000|Overall Study|no longer interested in participating|1|||
146760360|NCT00877851|529288788|FG001|Overall Study|no longer interested in participating|0|||
146760361|NCT03424239|529288789|FG000|Overall Study|Withdrawal by Subject|2|||
146760362|NCT01446003|529288790|FG000|Period 1|Protocol Violation|2|||
146760363|NCT01446003|529288791|FG001|Period 1|Protocol Violation|0|||
146760364|NCT01446003|529288790|FG000|Period 2|Adverse Event|1|||
146760365|NCT01446003|529288791|FG001|Period 2|Adverse Event|0|||
146760366|NCT02414828|529288792|FG000|Overall Study|Lost to Follow-up|0|||
146760367|NCT02414828|529288793|FG001|Overall Study|Lost to Follow-up|1|||
146760368|NCT02414828|529288794|FG002|Overall Study|Lost to Follow-up|1|||
146760369|NCT02414828|529288795|FG003|Overall Study|Lost to Follow-up|2|||
146760370|NCT00389519|529288799|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
146760371|NCT00389519|529288800|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
146760372|NCT00389519|529288801|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
146760373|NCT00389519|529288802|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
146760374|NCT00389519|529288799|FG000|Placebo Run-In|Withdrawal by Subject|19|||
146760375|NCT00389519|529288800|FG001|Placebo Run-In|Withdrawal by Subject|0|||
146760376|NCT00389519|529288801|FG002|Placebo Run-In|Withdrawal by Subject|0|||
146760377|NCT00389519|529288802|FG003|Placebo Run-In|Withdrawal by Subject|0|||
146760378|NCT00389519|529288799|FG000|Placebo Run-In|Reason not specified|40|||
146760379|NCT00389519|529288800|FG001|Placebo Run-In|Reason not specified|0|||
146525094|NCT00255164|528429284|FG000|Overall Study|Noncompliance|0|||
146525095|NCT00255164|528429285|FG001|Overall Study|Noncompliance|1|||
146525096|NCT00255164|528429286|FG002|Overall Study|Noncompliance|2|||
146525097|NCT00255164|528429284|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
146525098|NCT00255164|528429285|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
146525099|NCT00255164|528429286|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
146525100|NCT00255164|528429284|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
146525101|NCT00255164|528429285|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
146525102|NCT00255164|528429286|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
146525103|NCT00255164|528429284|FG000|Overall Study|Possible Barrett's Esophagus|1|||
146525104|NCT00255164|528429285|FG001|Overall Study|Possible Barrett's Esophagus|3|||
146525105|NCT00255164|528429286|FG002|Overall Study|Possible Barrett's Esophagus|8|||
146525106|NCT00255164|528429284|FG000|Overall Study|Esophageal Stricture|0|||
146525107|NCT00255164|528429285|FG001|Overall Study|Esophageal Stricture|0|||
146525108|NCT00255164|528429286|FG002|Overall Study|Esophageal Stricture|1|||
146525109|NCT00255164|528429284|FG000|Overall Study|Therapeutic Failure|11|||
146525110|NCT00255164|528429285|FG001|Overall Study|Therapeutic Failure|2|||
146525111|NCT00255164|528429286|FG002|Overall Study|Therapeutic Failure|3|||
146525112|NCT03677869|528429287|FG000|Overall Study|Withdrawal by Subject|1|||
146525113|NCT04587336|528429290|FG000|Overall Study|Lost to Follow-up|1|||
146525114|NCT04587336|528429291|FG001|Overall Study|Lost to Follow-up|0|||
146525115|NCT01845597|528431238|FG000|Overall Study|Death|8|||
146525116|NCT01845597|528431238|FG000|Overall Study|Lost to Follow-up|22|||
146525117|NCT00956839|528431245|FG000|Overall Study|Lost to Follow-up|3|||
146525118|NCT00956839|528431246|FG001|Overall Study|Lost to Follow-up|0|||
146525119|NCT00956839|528431247|FG002|Overall Study|Lost to Follow-up|3|||
146525120|NCT00994110|528431248|FG000|Overall Study|Withdrawal by Subject|9|||
146525121|NCT00994110|528431249|FG001|Overall Study|Withdrawal by Subject|9|||
146525122|NCT00994110|528431248|FG000|Overall Study|Not Treated|4|||
146525123|NCT00994110|528431249|FG001|Overall Study|Not Treated|8|||
146525124|NCT00994110|528431248|FG000|Overall Study|Adverse Event|1|||
146525125|NCT00994110|528431249|FG001|Overall Study|Adverse Event|0|||
146525126|NCT00994110|528431248|FG000|Overall Study|Patient not resected|41|||
146525127|NCT00994110|528431249|FG001|Overall Study|Patient not resected|52|||
146525128|NCT00994110|528431248|FG000|Overall Study|Pt not eligible|10|||
146525129|NCT00994110|528431249|FG001|Overall Study|Pt not eligible|5|||
146525130|NCT01914393|528431250|FG000|Overall Study|Protocol Violation|11|||
146525131|NCT01914393|528431251|FG001|Overall Study|Protocol Violation|3|||
146525132|NCT01914393|528431252|FG002|Overall Study|Protocol Violation|19|||
146525133|NCT01914393|528431250|FG000|Overall Study|Lack of Efficacy|11|||
146525134|NCT01914393|528431251|FG001|Overall Study|Lack of Efficacy|16|||
146525135|NCT01914393|528431252|FG002|Overall Study|Lack of Efficacy|5|||
146525136|NCT01914393|528431250|FG000|Overall Study|no reason given|14|||
146525137|NCT01914393|528431251|FG001|Overall Study|no reason given|8|||
146525138|NCT01914393|528431252|FG002|Overall Study|no reason given|16|||
146525139|NCT01914393|528431250|FG000|Overall Study|Adverse Event|29|||
146525140|NCT01914393|528431251|FG001|Overall Study|Adverse Event|18|||
146525141|NCT01914393|528431252|FG002|Overall Study|Adverse Event|31|||
146525142|NCT01914393|528431250|FG000|Overall Study|Withdrawal by Subject|38|||
146525143|NCT01914393|528431251|FG001|Overall Study|Withdrawal by Subject|20|||
146525144|NCT01914393|528431252|FG002|Overall Study|Withdrawal by Subject|47|||
146525145|NCT01914393|528431250|FG000|Overall Study|Lost to Follow-up|12|||
146525146|NCT01914393|528431251|FG001|Overall Study|Lost to Follow-up|6|||
146525147|NCT01914393|528431252|FG002|Overall Study|Lost to Follow-up|19|||
146525148|NCT01914393|528431250|FG000|Overall Study|subject never dosed|0|||
146525149|NCT01914393|528431251|FG001|Overall Study|subject never dosed|0|||
146859756|NCT00343252|529656921|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
146859757|NCT00343252|529656920|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
146859758|NCT00343252|529656921|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
146859759|NCT00343252|529656920|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
146525150|NCT01914393|528431252|FG002|Overall Study|subject never dosed|1|||
146525151|NCT01111565|528431253|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
146525152|NCT01111565|528431254|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
146525153|NCT01111565|528431255|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
146525154|NCT01111565|528431256|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
146525155|NCT01111565|528431257|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
146525156|NCT01111565|528431253|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
146525157|NCT01111565|528431254|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
146525158|NCT01111565|528431255|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
146525159|NCT01111565|528431256|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
146525160|NCT01111565|528431257|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
146525161|NCT01111565|528431253|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
146525162|NCT01111565|528431254|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
146525163|NCT01111565|528431255|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
146525164|NCT01111565|528431256|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
146525165|NCT01111565|528431257|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
146965088|NCT03110107|530033426|FG000|Treatment Period|Adverse Event|0|||
146525166|NCT01111565|528431253|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
146525167|NCT01111565|528431254|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
146525168|NCT01111565|528431255|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
146525169|NCT01111565|528431256|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
146525170|NCT01111565|528431257|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
146525171|NCT01111565|528431253|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
146525172|NCT01111565|528431254|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
146525173|NCT01111565|528431255|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
146525174|NCT01111565|528431256|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
146525175|NCT01111565|528431257|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
146525176|NCT01111565|528431253|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
146525177|NCT01111565|528431254|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
146525178|NCT01111565|528431255|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
146525179|NCT01111565|528431256|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
146525180|NCT01111565|528431257|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
146525181|NCT01111565|528431253|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
146525182|NCT01111565|528431254|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
146525183|NCT01111565|528431255|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
146525184|NCT01111565|528431256|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
146525185|NCT01111565|528431257|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
146525186|NCT01111565|528431253|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
146525187|NCT01111565|528431254|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
146525188|NCT01111565|528431255|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
146525189|NCT01111565|528431256|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
146525190|NCT01111565|528431257|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
146525191|NCT01111565|528431253|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
146525192|NCT01111565|528431254|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
146525193|NCT01111565|528431255|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
146525194|NCT01111565|528431256|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
146525195|NCT01111565|528431257|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
146525196|NCT01111565|528431253|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
146525197|NCT01111565|528431254|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
146525198|NCT01111565|528431255|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
146525199|NCT01111565|528431256|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
146525200|NCT01111565|528431257|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
146525201|NCT01111565|528431253|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
146525202|NCT01111565|528431254|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
146525203|NCT01111565|528431255|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
146525204|NCT01111565|528431256|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
146525205|NCT01111565|528431257|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
146525206|NCT01111565|528431253|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
146525207|NCT01111565|528431254|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
146525208|NCT01111565|528431255|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
146525209|NCT01111565|528431256|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
146525210|NCT01111565|528431257|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
146525211|NCT02824224|528431258|FG000|Overall Study|Discontinued, IUS expulsion|0|||
146525212|NCT02824224|528431259|FG001|Overall Study|Discontinued, IUS expulsion|1|||
146525213|NCT02824224|528431258|FG000|Overall Study|Did not show up for allocation visit|2|||
146525214|NCT02824224|528431259|FG001|Overall Study|Did not show up for allocation visit|0|||
146525215|NCT02683239|528431260|FG000|Overall Study|Protocol Violation|35|||
146525216|NCT02683239|528431261|FG001|Overall Study|Protocol Violation|23|||
146525217|NCT02683239|528431262|FG002|Overall Study|Protocol Violation|26|||
146525218|NCT02683239|528431263|FG003|Overall Study|Protocol Violation|4|||
146525219|NCT02683239|528431264|FG004|Overall Study|Protocol Violation|35|||
146525220|NCT02683239|528431265|FG005|Overall Study|Protocol Violation|4|||
146525221|NCT02683239|528431266|FG006|Overall Study|Protocol Violation|5|||
146525222|NCT02683239|528431260|FG000|Overall Study|Adverse Event|64|||
146525223|NCT02683239|528431261|FG001|Overall Study|Adverse Event|39|||
146760380|NCT00389519|529288801|FG002|Placebo Run-In|Reason not specified|0|||
146760381|NCT00389519|529288802|FG003|Placebo Run-In|Reason not specified|0|||
146760382|NCT00389519|529288799|FG000|Randomized|Did not receive study drug|2|||
146525224|NCT02683239|528431262|FG002|Overall Study|Adverse Event|42|||
146525225|NCT02683239|528431263|FG003|Overall Study|Adverse Event|16|||
146525226|NCT02683239|528431264|FG004|Overall Study|Adverse Event|189|||
146525227|NCT02683239|528431265|FG005|Overall Study|Adverse Event|9|||
146525228|NCT02683239|528431266|FG006|Overall Study|Adverse Event|9|||
146525229|NCT02683239|528431260|FG000|Overall Study|Physician Decision|38|||
146760383|NCT00389519|529288800|FG001|Randomized|Did not receive study drug|0|||
146525230|NCT02683239|528431261|FG001|Overall Study|Physician Decision|19|||
146525231|NCT02683239|528431262|FG002|Overall Study|Physician Decision|14|||
146525232|NCT02683239|528431263|FG003|Overall Study|Physician Decision|73|||
146525233|NCT02683239|528431264|FG004|Overall Study|Physician Decision|143|||
146525234|NCT02683239|528431265|FG005|Overall Study|Physician Decision|14|||
146525235|NCT02683239|528431266|FG006|Overall Study|Physician Decision|15|||
146525236|NCT02683239|528431260|FG000|Overall Study|Withdrawal by Subject|187|||
146525237|NCT02683239|528431261|FG001|Overall Study|Withdrawal by Subject|99|||
146760384|NCT00389519|529288801|FG002|Randomized|Did not receive study drug|0|||
146760385|NCT00389519|529288802|FG003|Randomized|Did not receive study drug|0|||
146760386|NCT00389519|529288799|FG000|Treated|Adverse Event|1|||
146760387|NCT00389519|529288800|FG001|Treated|Adverse Event|0|||
146760388|NCT00389519|529288801|FG002|Treated|Adverse Event|0|||
146760389|NCT00389519|529288802|FG003|Treated|Adverse Event|2|||
146760390|NCT00389519|529288799|FG000|Treated|Reason not specified|1|||
146760391|NCT00389519|529288800|FG001|Treated|Reason not specified|1|||
146760392|NCT00389519|529288801|FG002|Treated|Reason not specified|0|||
146760393|NCT00389519|529288802|FG003|Treated|Reason not specified|2|||
146760394|NCT02738840|529290938|FG000|Overall Study|MRI Scan not Performed|5|||
146760395|NCT02738840|529290938|FG000|Overall Study|Lost to Follow-up|1|||
146760396|NCT02738840|529290938|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
146760397|NCT02738840|529290938|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
146760398|NCT05526911|529290944|FG000|Overall Study|Adverse Event|2|||
146760399|NCT05025449|529290945|FG000|Overall Study|Withdrawal by Subject|1|||
146760400|NCT05025449|529290945|FG000|Overall Study|Patient emergently taken to operating room|1|||
146760401|NCT00256308|529290946|FG000|Overall Study|Death|2|||
146760402|NCT01537133|529290947|FG000|Overall Study|Withdrawal by Subject|2|||
146760403|NCT01537133|529290948|FG001|Overall Study|Withdrawal by Subject|0|||
146760404|NCT01537133|529290949|FG002|Overall Study|Withdrawal by Subject|0|||
146760405|NCT01537133|529290950|FG003|Overall Study|Withdrawal by Subject|0|||
146760406|NCT01537133|529290947|FG000|Overall Study|Lost to Follow-up|1|||
146760407|NCT01537133|529290948|FG001|Overall Study|Lost to Follow-up|0|||
146760408|NCT01537133|529290949|FG002|Overall Study|Lost to Follow-up|0|||
146760409|NCT01537133|529290950|FG003|Overall Study|Lost to Follow-up|0|||
146760410|NCT00762463|529290952|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
146760411|NCT00762463|529290953|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
146760412|NCT00762463|529290954|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
146760413|NCT00762463|529290955|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
146760414|NCT00762463|529290952|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
146760415|NCT00762463|529290953|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
146760416|NCT00762463|529290954|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
146760417|NCT00762463|529290955|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
146760418|NCT00762463|529290952|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
146760419|NCT00762463|529290953|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
146760420|NCT00762463|529290954|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
146760421|NCT00762463|529290955|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
146760422|NCT00762463|529290952|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
146760423|NCT00762463|529290953|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
146760424|NCT00762463|529290954|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
146760425|NCT00762463|529290955|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
146760426|NCT00762463|529290952|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
146760427|NCT00762463|529290953|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
146760428|NCT00762463|529290954|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
146760429|NCT00762463|529290955|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
146760430|NCT00762463|529290952|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
146760431|NCT00762463|529290953|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
146760432|NCT00762463|529290954|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
146760433|NCT00762463|529290955|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
146760434|NCT00762463|529290952|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
146760435|NCT00762463|529290953|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
146760436|NCT00762463|529290954|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
146760437|NCT00762463|529290955|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
146760438|NCT00762463|529290952|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
146525238|NCT02683239|528431262|FG002|Overall Study|Withdrawal by Subject|91|||
146525239|NCT02683239|528431263|FG003|Overall Study|Withdrawal by Subject|18|||
146760439|NCT00762463|529290953|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
146760440|NCT00762463|529290954|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
146760441|NCT00762463|529290955|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
146760442|NCT00531479|529290956|FG000|Overall Study|Death|68|||
146525240|NCT02683239|528431264|FG004|Overall Study|Withdrawal by Subject|248|||
146525241|NCT02683239|528431265|FG005|Overall Study|Withdrawal by Subject|22|||
146525242|NCT02683239|528431266|FG006|Overall Study|Withdrawal by Subject|28|||
146525243|NCT02683239|528431260|FG000|Overall Study|Lost to Follow-up|77|||
146525244|NCT02683239|528431261|FG001|Overall Study|Lost to Follow-up|24|||
146525245|NCT02683239|528431262|FG002|Overall Study|Lost to Follow-up|25|||
146525246|NCT02683239|528431263|FG003|Overall Study|Lost to Follow-up|7|||
146525247|NCT02683239|528431264|FG004|Overall Study|Lost to Follow-up|88|||
146525248|NCT02683239|528431265|FG005|Overall Study|Lost to Follow-up|8|||
146525249|NCT02683239|528431266|FG006|Overall Study|Lost to Follow-up|11|||
146525250|NCT02683239|528431260|FG000|Overall Study|Death|9|||
146525251|NCT02683239|528431261|FG001|Overall Study|Death|5|||
146525252|NCT02683239|528431262|FG002|Overall Study|Death|8|||
146525253|NCT02683239|528431263|FG003|Overall Study|Death|0|||
146525254|NCT02683239|528431264|FG004|Overall Study|Death|12|||
146525255|NCT02683239|528431265|FG005|Overall Study|Death|1|||
146525256|NCT02683239|528431266|FG006|Overall Study|Death|0|||
146525257|NCT02683239|528431260|FG000|Overall Study|Lack of Efficacy|50|||
146525258|NCT02683239|528431261|FG001|Overall Study|Lack of Efficacy|23|||
146525259|NCT02683239|528431262|FG002|Overall Study|Lack of Efficacy|12|||
146525260|NCT02683239|528431263|FG003|Overall Study|Lack of Efficacy|2|||
146525261|NCT02683239|528431264|FG004|Overall Study|Lack of Efficacy|29|||
146525262|NCT02683239|528431265|FG005|Overall Study|Lack of Efficacy|2|||
146525263|NCT02683239|528431266|FG006|Overall Study|Lack of Efficacy|3|||
146525264|NCT02683239|528431260|FG000|Overall Study|Missing data|0|||
146525265|NCT02683239|528431261|FG001|Overall Study|Missing data|1|||
146525266|NCT02683239|528431262|FG002|Overall Study|Missing data|1|||
146525267|NCT02683239|528431263|FG003|Overall Study|Missing data|0|||
146525268|NCT02683239|528431264|FG004|Overall Study|Missing data|1|||
146525269|NCT02683239|528431265|FG005|Overall Study|Missing data|0|||
146525270|NCT02683239|528431266|FG006|Overall Study|Missing data|0|||
146525271|NCT00368108|528431269|FG000|Overall Study|Adverse Event|38|||
146525272|NCT00368108|528431270|FG001|Overall Study|Adverse Event|26|||
146525273|NCT00368108|528431271|FG002|Overall Study|Adverse Event|44|||
146525274|NCT00368108|528431269|FG000|Overall Study|Abnormal Laboratory Value|0|||
146525275|NCT00368108|528431270|FG001|Overall Study|Abnormal Laboratory Value|0|||
146525276|NCT00368108|528431271|FG002|Overall Study|Abnormal Laboratory Value|3|||
146525277|NCT00368108|528431269|FG000|Overall Study|Protocol Violation|5|||
146525278|NCT00368108|528431270|FG001|Overall Study|Protocol Violation|9|||
146525279|NCT00368108|528431271|FG002|Overall Study|Protocol Violation|9|||
146525280|NCT00368108|528431269|FG000|Overall Study|Withdrawal by Subject|9|||
146525281|NCT00368108|528431270|FG001|Overall Study|Withdrawal by Subject|3|||
146525282|NCT00368108|528431271|FG002|Overall Study|Withdrawal by Subject|5|||
146525283|NCT00368108|528431269|FG000|Overall Study|Lack of Efficacy|7|||
146525284|NCT00368108|528431270|FG001|Overall Study|Lack of Efficacy|8|||
146525285|NCT00368108|528431271|FG002|Overall Study|Lack of Efficacy|5|||
146525286|NCT00368108|528431269|FG000|Overall Study|Physician Decision|2|||
146525287|NCT00368108|528431270|FG001|Overall Study|Physician Decision|0|||
146525288|NCT00368108|528431271|FG002|Overall Study|Physician Decision|1|||
146525289|NCT00368108|528431269|FG000|Overall Study|Other|3|||
146525290|NCT00368108|528431270|FG001|Overall Study|Other|7|||
146525291|NCT00368108|528431271|FG002|Overall Study|Other|1|||
146525292|NCT04131712|528431274|FG000|Overall Study|COVID related|0|||
146525293|NCT04131712|528431275|FG001|Overall Study|COVID related|0|||
146525294|NCT04131712|528431276|FG002|Overall Study|COVID related|2|||
146525295|NCT04131712|528431277|FG003|Overall Study|COVID related|0|||
146525296|NCT04131712|528431274|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
146525297|NCT04131712|528431275|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
146525298|NCT04131712|528431276|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
146525299|NCT04131712|528431277|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
146525300|NCT02299388|528431280|FG000|Overall Study|Withdrawal by Subject|0|||
146525301|NCT02299388|528431281|FG001|Overall Study|Withdrawal by Subject|1|||
146525302|NCT01447407|528431289|FG000|Overall Study|Withdrawal by Subject|2|||
146525303|NCT01447407|528431290|FG001|Overall Study|Withdrawal by Subject|0|||
146525304|NCT01447407|528431291|FG002|Overall Study|Withdrawal by Subject|0|||
146525305|NCT01447407|528431292|FG003|Overall Study|Withdrawal by Subject|1|||
146525306|NCT01447407|528431289|FG000|Overall Study|Physician Decision|0|||
146525307|NCT01447407|528431290|FG001|Overall Study|Physician Decision|0|||
146525308|NCT01447407|528431291|FG002|Overall Study|Physician Decision|1|||
146525309|NCT01447407|528431292|FG003|Overall Study|Physician Decision|1|||
146525310|NCT01719380|528431295|FG000|Overall Study|Adverse Event|0|||
146525311|NCT01719380|528431296|FG001|Overall Study|Adverse Event|0|||
146525312|NCT01719380|528431297|FG002|Overall Study|Adverse Event|1|||
146525313|NCT01719380|528431298|FG003|Overall Study|Adverse Event|2|||
146525314|NCT01719380|528431299|FG004|Overall Study|Adverse Event|0|||
146525315|NCT01719380|528431300|FG005|Overall Study|Adverse Event|1|||
146525316|NCT01719380|528431301|FG006|Overall Study|Adverse Event|0|||
146525317|NCT01719380|528431302|FG007|Overall Study|Adverse Event|1|||
146525318|NCT01719380|528431303|FG008|Overall Study|Adverse Event|4|||
146525319|NCT01719380|528431304|FG009|Overall Study|Adverse Event|3|||
146525320|NCT01719380|528431295|FG000|Overall Study|Death|0|||
146525321|NCT01719380|528431296|FG001|Overall Study|Death|1|||
146525322|NCT01719380|528431297|FG002|Overall Study|Death|0|||
146525323|NCT01719380|528431298|FG003|Overall Study|Death|0|||
146525324|NCT01719380|528431299|FG004|Overall Study|Death|0|||
146859760|NCT00343252|529656921|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
146859761|NCT00343252|529656920|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
146859762|NCT00343252|529656921|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
146859763|NCT00343252|529656920|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
146859764|NCT00343252|529656921|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
146859765|NCT00343252|529656920|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
146859766|NCT00343252|529656921|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
146859767|NCT00343252|529656920|FG000|18 Months (All Treated Participants)|Death|4|||
146859768|NCT00343252|529656921|FG001|18 Months (All Treated Participants)|Death|5|||
146859769|NCT00343252|529656920|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
146859770|NCT00343252|529656921|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
146859771|NCT00343252|529656920|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
146859772|NCT00343252|529656921|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
146859773|NCT00343252|529656920|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
146859774|NCT00343252|529656921|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
146859775|NCT00343252|529656920|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
146859776|NCT00343252|529656921|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
146859777|NCT00343252|529656920|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
146859778|NCT00343252|529656921|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
146859779|NCT00343252|529656920|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
146859780|NCT00343252|529656921|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
146859781|NCT00343252|529656920|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
146859782|NCT00343252|529656921|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
146859783|NCT02076178|529656922|FG000|Oral Phase|Adverse Event|0|||
146859784|NCT02076178|529656923|FG001|Oral Phase|Adverse Event|7|||
146859785|NCT02076178|529656922|FG000|Oral Phase|Withdrawal by Subject|0|||
146859786|NCT02076178|529656923|FG001|Oral Phase|Withdrawal by Subject|4|||
146859787|NCT02076178|529656922|FG000|Oral Phase|Physician Decision|0|||
146859788|NCT02076178|529656923|FG001|Oral Phase|Physician Decision|1|||
146859789|NCT02076178|529656922|FG000|Injection Phase|Protocol defined stopping criteria|1|||
146859790|NCT02076178|529656923|FG001|Injection Phase|Protocol defined stopping criteria|0|||
146859791|NCT02076178|529656922|FG000|Injection Phase|Withdrawal by Subject|0|||
146859792|NCT02076178|529656923|FG001|Injection Phase|Withdrawal by Subject|3|||
146859793|NCT02076178|529656922|FG000|Injection Phase|Physician Decision|0|||
146859794|NCT02076178|529656923|FG001|Injection Phase|Physician Decision|3|||
146859795|NCT02076178|529656922|FG000|Injection Phase|Lost to Follow-up|0|||
146525325|NCT01719380|528431300|FG005|Overall Study|Death|0|||
146859796|NCT02076178|529656923|FG001|Injection Phase|Lost to Follow-up|1|||
146859797|NCT00731120|529656924|FG000|Overall Study|Adverse Event|7|||
146859798|NCT00731120|529656925|FG001|Overall Study|Adverse Event|6|||
146859799|NCT00731120|529656926|FG002|Overall Study|Adverse Event|8|||
146859800|NCT00731120|529656924|FG000|Overall Study|Lack of Efficacy|4|||
146859801|NCT00731120|529656925|FG001|Overall Study|Lack of Efficacy|5|||
146859802|NCT00731120|529656926|FG002|Overall Study|Lack of Efficacy|4|||
146859803|NCT00731120|529656924|FG000|Overall Study|Noncompliance with Study Drug|3|||
146859804|NCT00731120|529656925|FG001|Overall Study|Noncompliance with Study Drug|3|||
146859805|NCT00731120|529656926|FG002|Overall Study|Noncompliance with Study Drug|1|||
146859806|NCT00731120|529656924|FG000|Overall Study|Protocol Deviations|1|||
146859807|NCT00731120|529656925|FG001|Overall Study|Protocol Deviations|6|||
146859808|NCT00731120|529656926|FG002|Overall Study|Protocol Deviations|1|||
146859809|NCT00731120|529656924|FG000|Overall Study|Withdrawal of Consent|13|||
146859810|NCT00731120|529656925|FG001|Overall Study|Withdrawal of Consent|8|||
146859811|NCT00731120|529656926|FG002|Overall Study|Withdrawal of Consent|4|||
146859812|NCT00731120|529656924|FG000|Overall Study|Lost to Follow-up|10|||
146859813|NCT00731120|529656925|FG001|Overall Study|Lost to Follow-up|15|||
146859814|NCT00731120|529656926|FG002|Overall Study|Lost to Follow-up|17|||
146859815|NCT00731120|529656924|FG000|Overall Study|Other|4|||
146859816|NCT00731120|529656925|FG001|Overall Study|Other|0|||
146525326|NCT01719380|528431301|FG006|Overall Study|Death|0|||
146525327|NCT01719380|528431302|FG007|Overall Study|Death|0|||
146525328|NCT01719380|528431303|FG008|Overall Study|Death|3|||
146525329|NCT01719380|528431304|FG009|Overall Study|Death|3|||
146525330|NCT01719380|528431295|FG000|Overall Study|Participant/Guardian Decision|0|||
146859817|NCT00731120|529656926|FG002|Overall Study|Other|1|||
146859818|NCT01142596|529656927|FG000|Overall Study|Withdrawal by Subject|9|||
146859819|NCT01142596|529656928|FG001|Overall Study|Withdrawal by Subject|35|||
146525331|NCT01719380|528431296|FG001|Overall Study|Participant/Guardian Decision|0|||
146525332|NCT01719380|528431297|FG002|Overall Study|Participant/Guardian Decision|1|||
146859820|NCT01142596|529656927|FG000|Overall Study|Adverse Event|8|||
146525333|NCT01719380|528431298|FG003|Overall Study|Participant/Guardian Decision|0|||
146525334|NCT01719380|528431299|FG004|Overall Study|Participant/Guardian Decision|0|||
146525335|NCT01719380|528431300|FG005|Overall Study|Participant/Guardian Decision|0|||
146525336|NCT01719380|528431301|FG006|Overall Study|Participant/Guardian Decision|0|||
146525337|NCT01719380|528431302|FG007|Overall Study|Participant/Guardian Decision|0|||
146525338|NCT01719380|528431303|FG008|Overall Study|Participant/Guardian Decision|2|||
146525339|NCT01719380|528431304|FG009|Overall Study|Participant/Guardian Decision|2|||
146525340|NCT01719380|528431295|FG000|Overall Study|Physician Decision|0|||
146525341|NCT01719380|528431296|FG001|Overall Study|Physician Decision|0|||
146525342|NCT01719380|528431297|FG002|Overall Study|Physician Decision|2|||
146525343|NCT01719380|528431298|FG003|Overall Study|Physician Decision|0|||
146525344|NCT01719380|528431299|FG004|Overall Study|Physician Decision|0|||
146525345|NCT01719380|528431300|FG005|Overall Study|Physician Decision|0|||
146525346|NCT01719380|528431301|FG006|Overall Study|Physician Decision|0|||
146525347|NCT01719380|528431302|FG007|Overall Study|Physician Decision|0|||
146525348|NCT01719380|528431303|FG008|Overall Study|Physician Decision|1|||
146525349|NCT01719380|528431304|FG009|Overall Study|Physician Decision|1|||
146525350|NCT01719380|528431295|FG000|Overall Study|Lack of Efficacy|2|||
146525351|NCT01719380|528431296|FG001|Overall Study|Lack of Efficacy|6|||
146525352|NCT01719380|528431297|FG002|Overall Study|Lack of Efficacy|5|||
146525353|NCT01719380|528431298|FG003|Overall Study|Lack of Efficacy|6|||
146525354|NCT01719380|528431299|FG004|Overall Study|Lack of Efficacy|3|||
146525355|NCT01719380|528431300|FG005|Overall Study|Lack of Efficacy|7|||
146525356|NCT01719380|528431301|FG006|Overall Study|Lack of Efficacy|10|||
146525357|NCT01719380|528431302|FG007|Overall Study|Lack of Efficacy|6|||
146525358|NCT01719380|528431303|FG008|Overall Study|Lack of Efficacy|39|||
146525359|NCT01719380|528431304|FG009|Overall Study|Lack of Efficacy|42|||
146525360|NCT01719380|528431295|FG000|Overall Study|Progressive Disease|0|||
146525361|NCT01719380|528431296|FG001|Overall Study|Progressive Disease|0|||
146525362|NCT01719380|528431297|FG002|Overall Study|Progressive Disease|0|||
146525363|NCT01719380|528431298|FG003|Overall Study|Progressive Disease|0|||
146525364|NCT01719380|528431299|FG004|Overall Study|Progressive Disease|0|||
146525365|NCT01719380|528431300|FG005|Overall Study|Progressive Disease|0|||
146525366|NCT01719380|528431301|FG006|Overall Study|Progressive Disease|0|||
146525367|NCT01719380|528431302|FG007|Overall Study|Progressive Disease|0|||
146525368|NCT01719380|528431303|FG008|Overall Study|Progressive Disease|1|||
146525369|NCT01719380|528431304|FG009|Overall Study|Progressive Disease|0|||
146525370|NCT01064414|528431307|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
146525371|NCT01064414|528431308|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
146525372|NCT01064414|528431309|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
146525373|NCT01064414|528431307|FG000|Core Period: Baseline to Week 26|Death|0|||
146525374|NCT01064414|528431308|FG001|Core Period: Baseline to Week 26|Death|1|||
146525375|NCT01064414|528431309|FG002|Core Period: Baseline to Week 26|Death|0|||
146525376|NCT01064414|528431307|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
146525377|NCT01064414|528431308|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
146525378|NCT01064414|528431309|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
146525379|NCT01064414|528431307|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
146525380|NCT01064414|528431308|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
146525381|NCT01064414|528431309|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
146525382|NCT01064414|528431307|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
146525383|NCT01064414|528431308|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
146525384|NCT01064414|528431309|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
146525385|NCT01064414|528431307|FG000|Core Period: Baseline to Week 26|Other|4|||
146525386|NCT01064414|528431308|FG001|Core Period: Baseline to Week 26|Other|7|||
146525387|NCT01064414|528431309|FG002|Core Period: Baseline to Week 26|Other|2|||
146525388|NCT01064414|528431307|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
146525389|NCT01064414|528431308|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
146525390|NCT01064414|528431309|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
146525391|NCT01064414|528431307|FG000|Extension Period: Week 26 to Week 52|Death|0|||
146525392|NCT01064414|528431308|FG001|Extension Period: Week 26 to Week 52|Death|1|||
146760443|NCT00531479|529290957|FG001|Overall Study|Death|71|||
146760444|NCT00531479|529290956|FG000|Overall Study|Lost to Follow-up|0|||
146760445|NCT00531479|529290957|FG001|Overall Study|Lost to Follow-up|2|||
146760446|NCT00531479|529290956|FG000|Overall Study|Other|0|||
146760447|NCT00531479|529290957|FG001|Overall Study|Other|1|||
146760448|NCT00531479|529290956|FG000|Overall Study|Withdrawal by Subject|6|||
146859821|NCT01142596|529656928|FG001|Overall Study|Adverse Event|35|||
146525393|NCT01064414|528431309|FG002|Extension Period: Week 26 to Week 52|Death|0|||
146525394|NCT01064414|528431307|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
146760449|NCT00531479|529290957|FG001|Overall Study|Withdrawal by Subject|6|||
146760450|NCT00531479|529290956|FG000|Overall Study|Did not receive treatment|2|||
146760451|NCT00531479|529290957|FG001|Overall Study|Did not receive treatment|3|||
146760452|NCT04358549|529290960|FG000|Overall Study|Adverse Event|0|||
146859822|NCT01142596|529656927|FG000|Overall Study|Lack of Efficacy|5|||
146525395|NCT01064414|528431308|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
146525396|NCT01064414|528431309|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
146525397|NCT01064414|528431307|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
146525398|NCT01064414|528431308|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
146525399|NCT01064414|528431309|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
146525400|NCT01064414|528431307|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
146525401|NCT01064414|528431308|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
146525402|NCT01064414|528431309|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
146525403|NCT01064414|528431307|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
146525404|NCT01064414|528431308|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
146525405|NCT01064414|528431309|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
146525406|NCT01064414|528431307|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
146525407|NCT01064414|528431308|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
146525408|NCT01064414|528431309|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
146525409|NCT01064414|528431307|FG000|Extension Period: Week 26 to Week 52|Other|5|||
146525410|NCT01064414|528431308|FG001|Extension Period: Week 26 to Week 52|Other|2|||
146525411|NCT01064414|528431309|FG002|Extension Period: Week 26 to Week 52|Other|1|||
146525412|NCT02532374|528431315|FG000|Overall Study|Withdrawal by Subject|1|||
146525413|NCT02532374|528431315|FG000|Overall Study|Physician Decision|1|||
146525414|NCT00716456|528431316|FG000|Overall Study|Adverse Event|0|||
146525415|NCT00716456|528431317|FG001|Overall Study|Adverse Event|2|||
146525416|NCT00716456|528431318|FG002|Overall Study|Adverse Event|0|||
146525417|NCT00447772|528431319|FG000|Overall Study|Lack of Efficacy|3|||
146525418|NCT00447772|528431319|FG000|Overall Study|Insufficient compliance|6|||
146525419|NCT00447772|528431319|FG000|Overall Study|Discontinuation of drug therapy|1|||
146525420|NCT00447772|528431319|FG000|Overall Study|Lost to Follow-up|9|||
146525421|NCT00447772|528431319|FG000|Overall Study|Withdrawal by Subject|1|||
146525422|NCT00447772|528431319|FG000|Overall Study|Unable to attend all study visits|2|||
146525423|NCT00447772|528431319|FG000|Overall Study|Adverse Event|1|||
146525424|NCT00447772|528431319|FG000|Overall Study|Patient relocated|1|||
146525425|NCT00447772|528431319|FG000|Overall Study|Incomplete documentation at visit 1|1|||
146525426|NCT00447772|528431319|FG000|Overall Study|Chemotherapy for lung cancer|1|||
146525427|NCT00447772|528431319|FG000|Overall Study|Premature re-injection required|1|||
146525428|NCT02849743|528431320|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
146525429|NCT02849743|528431321|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
146525430|NCT02849743|528431320|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
146525431|NCT02849743|528431321|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
146525432|NCT03874013|528431328|FG000|Overall Study|Adverse Event|0|||
146525433|NCT03874013|528431329|FG001|Overall Study|Adverse Event|1|||
146525434|NCT01411852|528431330|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
146525435|NCT01411852|528431331|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
146525436|NCT01411852|528431330|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
146525437|NCT01411852|528431331|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
146525438|NCT01411852|528431330|FG000|Prehospital Intervention Phase|Found to be under age|0|||
146525439|NCT01411852|528431331|FG001|Prehospital Intervention Phase|Found to be under age|1|||
146525440|NCT01411852|528431330|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
146525441|NCT01411852|528431331|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
146525442|NCT01411852|528431330|FG000|Hospital Intervention Phase|Severe head injury|5|||
146525443|NCT01411852|528431331|FG001|Hospital Intervention Phase|Severe head injury|4|||
146525444|NCT01411852|528431330|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
146525445|NCT01411852|528431331|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
146525446|NCT01411852|528431330|FG000|Hospital Intervention Phase|Miscommunication error|1|||
146525447|NCT01411852|528431331|FG001|Hospital Intervention Phase|Miscommunication error|2|||
146525448|NCT01411852|528431330|FG000|Hospital Intervention Phase|CPR administered|3|||
146525449|NCT01411852|528431331|FG001|Hospital Intervention Phase|CPR administered|1|||
146525450|NCT01411852|528431330|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
146525451|NCT01411852|528431331|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
146525452|NCT01411852|528431330|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
146525453|NCT01411852|528431331|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
146525454|NCT01411852|528431330|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
146525455|NCT01411852|528431331|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
146525456|NCT01411852|528431330|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
146525457|NCT01411852|528431331|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
146525458|NCT01411852|528431330|FG000|Hospital Intervention Phase|Other ineligible|2|||
146525459|NCT01411852|528431331|FG001|Hospital Intervention Phase|Other ineligible|2|||
146525460|NCT01411852|528431330|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
146525461|NCT01411852|528431331|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
146625285|NCT03037385|528803850|FG005|Overall Study|Progressive Disease|0|||
146760453|NCT04358549|529290961|FG001|Overall Study|Adverse Event|1|||
146760454|NCT04358549|529290960|FG000|Overall Study|Death|1|||
146760455|NCT04358549|529290961|FG001|Overall Study|Death|0|||
146760456|NCT04358549|529290960|FG000|Overall Study|Lost to Follow-up|2|||
146760457|NCT04358549|529290961|FG001|Overall Study|Lost to Follow-up|1|||
146760458|NCT04358549|529290960|FG000|Overall Study|Withdrawal by Subject|6|||
146760459|NCT04358549|529290961|FG001|Overall Study|Withdrawal by Subject|6|||
146760460|NCT04358549|529290960|FG000|Overall Study|Start remdesivir|1|||
146760461|NCT04358549|529290961|FG001|Overall Study|Start remdesivir|0|||
146760462|NCT04867902|529290965|FG000|Overall Study|Lost to Follow-up|1|||
146760463|NCT04867902|529290965|FG000|Overall Study|Withdrawal by Subject|2|||
146760464|NCT04867902|529290965|FG000|Overall Study|Protocol Violation|1|||
146760465|NCT05355116|529290966|FG000|Overall Study|Withdrawal by Subject|2|||
146760466|NCT02501629|529290967|FG000|Overall Study|Death|0|||
146760467|NCT02501629|529290968|FG001|Overall Study|Death|1|||
146760468|NCT02501629|529290967|FG000|Overall Study|Withdrawn from study by sponsor|1|||
146760469|NCT02501629|529290968|FG001|Overall Study|Withdrawn from study by sponsor|0|||
146760470|NCT02501629|529290967|FG000|Overall Study|Early termination by sponsor|1|||
146760471|NCT02501629|529290968|FG001|Overall Study|Early termination by sponsor|0|||
146760472|NCT02501629|529290967|FG000|Overall Study|Withdrawal by Subject|3|||
146760473|NCT02501629|529290968|FG001|Overall Study|Withdrawal by Subject|5|||
146760474|NCT02501629|529290967|FG000|Overall Study|Subject did not return to site|0|||
146760475|NCT02501629|529290968|FG001|Overall Study|Subject did not return to site|1|||
146760476|NCT00868231|529290971|FG000|Treatment Period 1|Adverse Event|0|||
146760477|NCT00868231|529290972|FG001|Treatment Period 1|Adverse Event|0|||
146760478|NCT00868231|529290973|FG002|Treatment Period 1|Adverse Event|0|||
146760479|NCT00868231|529290974|FG003|Treatment Period 1|Adverse Event|0|||
146760480|NCT00868231|529290975|FG004|Treatment Period 1|Adverse Event|1|||
146760481|NCT00868231|529290976|FG005|Treatment Period 1|Adverse Event|0|||
146760482|NCT00868231|529290971|FG000|Treatment Period 2|Adverse Event|1|||
146760483|NCT00868231|529290972|FG001|Treatment Period 2|Adverse Event|0|||
146760484|NCT00868231|529290973|FG002|Treatment Period 2|Adverse Event|0|||
146760485|NCT00868231|529290974|FG003|Treatment Period 2|Adverse Event|0|||
146760486|NCT00868231|529290975|FG004|Treatment Period 2|Adverse Event|0|||
146760487|NCT00868231|529290976|FG005|Treatment Period 2|Adverse Event|0|||
146760488|NCT00868231|529290971|FG000|Treatment Period 3|Adverse Event|0|||
146760489|NCT00868231|529290972|FG001|Treatment Period 3|Adverse Event|0|||
146760490|NCT00868231|529290973|FG002|Treatment Period 3|Adverse Event|1|||
146760491|NCT00868231|529290974|FG003|Treatment Period 3|Adverse Event|0|||
146760492|NCT00868231|529290975|FG004|Treatment Period 3|Adverse Event|0|||
146760493|NCT00868231|529290976|FG005|Treatment Period 3|Adverse Event|0|||
146760494|NCT03120676|529290977|FG000|Overall Study|Not treated|1|||
146760495|NCT01688973|529290981|FG000|Overall Study|Ineligible|2|||
146760496|NCT01688973|529290982|FG001|Overall Study|Ineligible|3|||
146760497|NCT01124162|529290983|FG000|First Intervention|Adverse Event|2|||
146760498|NCT01124162|529290984|FG001|First Intervention|Adverse Event|0|||
146760499|NCT01124162|529290983|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
146760500|NCT01124162|529290984|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
146760501|NCT01516892|529290988|FG000|Overall Study|Adverse Event|25|||
146760502|NCT01516892|529290988|FG000|Overall Study|Lack of Efficacy|35|||
146760503|NCT01516892|529290988|FG000|Overall Study|Pregnancy|5|||
146760504|NCT01516892|529290988|FG000|Overall Study|Lost to Follow-up|82|||
146760505|NCT01516892|529290988|FG000|Overall Study|Subject Withdrew Consent|92|||
146760506|NCT01516892|529290988|FG000|Overall Study|Protocol Violation|60|||
146760507|NCT01516892|529290988|FG000|Overall Study|Other Miscellaneous Reasons|43|||
146760508|NCT01516892|529290988|FG000|Overall Study|Missing|1|||
146760509|NCT00938340|529290989|FG000|Overall Study|Withdrawal by Subject|3|||
146760510|NCT00938340|529290989|FG000|Overall Study|Protocol Violation|1|||
146760511|NCT00938340|529290989|FG000|Overall Study|Adverse Event|1|||
146760512|NCT03613129|529290990|FG000|Pre-treatment Assessment|Protocol Violation|2|||
146760513|NCT03613129|529290991|FG001|Pre-treatment Assessment|Protocol Violation|0|||
146760514|NCT03613129|529290992|FG002|Pre-treatment Assessment|Protocol Violation|0|||
146760515|NCT03613129|529290993|FG003|Pre-treatment Assessment|Protocol Violation|0|||
146859823|NCT01142596|529656928|FG001|Overall Study|Lack of Efficacy|9|||
146859824|NCT01142596|529656927|FG000|Overall Study|Lost to Follow-up|2|||
146760516|NCT03613129|529290994|FG004|Pre-treatment Assessment|Protocol Violation|0|||
146760517|NCT03613129|529290990|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
146760518|NCT03613129|529290991|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
146760519|NCT03613129|529290992|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
146760520|NCT03613129|529290993|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
146760521|NCT03613129|529290994|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
146760522|NCT00711646|529290995|FG000|Overall Study|Adverse Event|6|||
146760523|NCT00711646|529290996|FG001|Overall Study|Adverse Event|1|||
146760524|NCT00711646|529290995|FG000|Overall Study|Withdrawal by Subject|4|||
146760525|NCT00711646|529290996|FG001|Overall Study|Withdrawal by Subject|0|||
146760526|NCT00711646|529290995|FG000|Overall Study|Protocol Violation|0|||
146760527|NCT00711646|529290996|FG001|Overall Study|Protocol Violation|1|||
146760528|NCT00711646|529290995|FG000|Overall Study|Lost to Follow-up|1|||
146525462|NCT01411852|528431330|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
146525463|NCT01411852|528431331|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
146525464|NCT01411852|528431330|FG000|Hospital Intervention Phase|Vascular access failed|1|||
146525465|NCT01411852|528431331|FG001|Hospital Intervention Phase|Vascular access failed|0|||
146525466|NCT03489343|528431341|FG000|Overall Study|Documented progressive disease|1|||
146525467|NCT03489343|528431342|FG001|Overall Study|Documented progressive disease|0|||
146525468|NCT03489343|528431343|FG002|Overall Study|Documented progressive disease|3|||
146525469|NCT03489343|528431344|FG003|Overall Study|Documented progressive disease|1|||
146525470|NCT03489343|528431345|FG004|Overall Study|Documented progressive disease|3|||
146525471|NCT03489343|528431346|FG005|Overall Study|Documented progressive disease|5|||
146525472|NCT03489343|528431347|FG006|Overall Study|Documented progressive disease|4|||
146525473|NCT03489343|528431341|FG000|Overall Study|Adverse Event|0|||
146525474|NCT03489343|528431342|FG001|Overall Study|Adverse Event|1|||
146525475|NCT03489343|528431343|FG002|Overall Study|Adverse Event|0|||
146525476|NCT03489343|528431344|FG003|Overall Study|Adverse Event|0|||
146525477|NCT03489343|528431345|FG004|Overall Study|Adverse Event|0|||
146525478|NCT03489343|528431346|FG005|Overall Study|Adverse Event|1|||
146525479|NCT03489343|528431347|FG006|Overall Study|Adverse Event|0|||
146525480|NCT03489343|528431341|FG000|Overall Study|Withdrawal by Subject|0|||
146525481|NCT03489343|528431342|FG001|Overall Study|Withdrawal by Subject|0|||
146525482|NCT03489343|528431343|FG002|Overall Study|Withdrawal by Subject|0|||
146525483|NCT03489343|528431344|FG003|Overall Study|Withdrawal by Subject|1|||
146525484|NCT03489343|528431345|FG004|Overall Study|Withdrawal by Subject|0|||
146525485|NCT03489343|528431346|FG005|Overall Study|Withdrawal by Subject|1|||
146525486|NCT03489343|528431347|FG006|Overall Study|Withdrawal by Subject|1|||
146525487|NCT03489343|528431341|FG000|Overall Study|Clinical progression|0|||
146525488|NCT03489343|528431342|FG001|Overall Study|Clinical progression|0|||
146525489|NCT03489343|528431343|FG002|Overall Study|Clinical progression|0|||
146525490|NCT03489343|528431344|FG003|Overall Study|Clinical progression|1|||
146525491|NCT03489343|528431345|FG004|Overall Study|Clinical progression|0|||
146525492|NCT03489343|528431346|FG005|Overall Study|Clinical progression|0|||
146525493|NCT03489343|528431347|FG006|Overall Study|Clinical progression|1|||
146525494|NCT00327717|528431348|FG000|Overall Study|Adverse Event|6|||
146525495|NCT00327717|528431349|FG001|Overall Study|Adverse Event|6|||
146525496|NCT00327717|528431348|FG000|Overall Study|Lack of Efficacy|0|||
146525497|NCT00327717|528431349|FG001|Overall Study|Lack of Efficacy|1|||
146525498|NCT00327717|528431348|FG000|Overall Study|Withdrawal by Subject|3|||
146525499|NCT00327717|528431349|FG001|Overall Study|Withdrawal by Subject|7|||
146525500|NCT01630135|528431351|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
146525501|NCT01630135|528431352|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
146525502|NCT04767373|528431354|FG000|Overall Study|Death|6|||
146525503|NCT04767373|528431355|FG001|Overall Study|Death|3|||
146525504|NCT04767373|528431354|FG000|Overall Study|Lost to Follow-up|67|||
146525505|NCT04767373|528431355|FG001|Overall Study|Lost to Follow-up|35|||
146525506|NCT04767373|528431354|FG000|Overall Study|Physician Decision|15|||
146525507|NCT04767373|528431355|FG001|Overall Study|Physician Decision|4|||
146525508|NCT04767373|528431354|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146525509|NCT04767373|528431355|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
146525510|NCT04767373|528431354|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
146525511|NCT04767373|528431355|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
146525512|NCT04767373|528431354|FG000|Overall Study|Other|1|||
146525513|NCT04767373|528431355|FG001|Overall Study|Other|2|||
146525514|NCT01502033|528431356|FG000|Overall Study|1 participant had scalp discomfort|1|||
146525515|NCT01502033|528431356|FG000|Overall Study|1 participant had worsening depression|1|||
146525516|NCT01502033|528431356|FG000|Overall Study|1 participant went back to school|1|||
146525517|NCT02658669|528431357|FG000|Overall Study|Lost to Follow-up|7|||
146525518|NCT02658669|528431358|FG001|Overall Study|Lost to Follow-up|5|||
146525519|NCT00186485|528431359|FG000|Overall Study|Lost to Follow-up|3|||
146525520|NCT03804268|528431370|FG000|Overall Study|Adverse Event|2|||
146525521|NCT03804268|528431371|FG001|Overall Study|Adverse Event|2|||
146525522|NCT03804268|528431370|FG000|Overall Study|Withdrawal by Subject|2|||
146525523|NCT03804268|528431371|FG001|Overall Study|Withdrawal by Subject|0|||
146525524|NCT03804268|528431370|FG000|Overall Study|Lost to Follow-up|1|||
146525525|NCT03804268|528431371|FG001|Overall Study|Lost to Follow-up|0|||
146525526|NCT03804268|528431370|FG000|Overall Study|Physician Decision|2|||
146525527|NCT03804268|528431371|FG001|Overall Study|Physician Decision|0|||
146525528|NCT00838097|528431372|FG000|Overall Study|Ineligibility determined|6|||
146525529|NCT00838097|528431372|FG000|Overall Study|Adverse Event|2|||
146525530|NCT00838097|528431372|FG000|Overall Study|Withdrawal by Subject|3|||
146525531|NCT00838097|528431372|FG000|Overall Study|Requirement for alternative therapy|2|||
146760529|NCT00711646|529290996|FG001|Overall Study|Lost to Follow-up|0|||
146525532|NCT00838097|528431372|FG000|Overall Study|Physician Decision|4|||
146525533|NCT00838097|528431372|FG000|Overall Study|Lost to Follow-up|11|||
146525534|NCT00838097|528431372|FG000|Overall Study|Death|6|||
146525535|NCT00838097|528431372|FG000|Overall Study|Protocol-specified criteria|142|||
146525536|NCT00672633|528431392|FG000|Overall Study|Withdrawal by Subject|0|||
146859825|NCT01142596|529656928|FG001|Overall Study|Lost to Follow-up|3|||
146859826|NCT01142596|529656927|FG000|Overall Study|Other reason (not specified)|5|||
146859827|NCT01142596|529656928|FG001|Overall Study|Other reason (not specified)|4|||
146859828|NCT03181451|529656931|FG000|Overall Study|Adverse Event|0|||
146859829|NCT03181451|529656932|FG001|Overall Study|Adverse Event|1|||
146859830|NCT03181451|529656933|FG002|Overall Study|Adverse Event|0|||
146859831|NCT03181451|529656931|FG000|Overall Study|Withdrawal by Subject|0|||
146859832|NCT03181451|529656932|FG001|Overall Study|Withdrawal by Subject|1|||
146859833|NCT03181451|529656933|FG002|Overall Study|Withdrawal by Subject|0|||
146859834|NCT01012713|529656936|FG000|Overall Study|Lack of Efficacy|3|||
146859835|NCT01596621|529656938|FG000|Overall Study|Death|4|||
146859836|NCT01596621|529656938|FG000|Overall Study|Withdrawal by Subject|9|||
146859837|NCT01596621|529656938|FG000|Overall Study|Disease Progression|49|||
146859838|NCT01596621|529656938|FG000|Overall Study|Lost to Follow-up|3|||
146859839|NCT01596621|529656938|FG000|Overall Study|Other than specified|13|||
146859840|NCT01536015|529656939|FG000|Overall Study|Adverse Event|1|||
146859841|NCT01536015|529656940|FG001|Overall Study|Adverse Event|4|||
146859842|NCT01536015|529656939|FG000|Overall Study|Lost to Follow-up|0|||
146859843|NCT01536015|529656940|FG001|Overall Study|Lost to Follow-up|1|||
146859844|NCT01536015|529656939|FG000|Overall Study|Inclusion Criterion not met|2|||
146859845|NCT01536015|529656940|FG001|Overall Study|Inclusion Criterion not met|0|||
146859846|NCT01536015|529656939|FG000|Overall Study|Study closure|5|||
146859847|NCT01536015|529656940|FG001|Overall Study|Study closure|5|||
146859848|NCT04508023|529656941|FG000|Overall Study|Withdrawal by Subject|1|||
146859849|NCT04508023|529656942|FG001|Overall Study|Withdrawal by Subject|2|||
146859850|NCT02988622|529656946|FG000|Overall Study|Lost to Follow-up|17|||
146859851|NCT02447172|529656947|FG000|Overall Study|Adverse Event|11|||
146859852|NCT02447172|529656948|FG001|Overall Study|Adverse Event|8|||
146859853|NCT02447172|529656949|FG002|Overall Study|Adverse Event|7|||
146859854|NCT02447172|529656947|FG000|Overall Study|Death|3|||
146859855|NCT02447172|529656948|FG001|Overall Study|Death|1|||
146859856|NCT02447172|529656949|FG002|Overall Study|Death|0|||
146859857|NCT02447172|529656947|FG000|Overall Study|Protocol Violation|2|||
146859858|NCT02447172|529656948|FG001|Overall Study|Protocol Violation|1|||
146859859|NCT02447172|529656949|FG002|Overall Study|Protocol Violation|2|||
146859860|NCT02447172|529656947|FG000|Overall Study|Lost to Follow-up|7|||
146859861|NCT02447172|529656948|FG001|Overall Study|Lost to Follow-up|4|||
146859862|NCT02447172|529656949|FG002|Overall Study|Lost to Follow-up|4|||
146859863|NCT02447172|529656947|FG000|Overall Study|Withdrawal by Subject|5|||
146859864|NCT02447172|529656948|FG001|Overall Study|Withdrawal by Subject|1|||
146859865|NCT02447172|529656949|FG002|Overall Study|Withdrawal by Subject|3|||
146859866|NCT02447172|529656947|FG000|Overall Study|protocol specific treatment unrelated|3|||
146859867|NCT02447172|529656948|FG001|Overall Study|protocol specific treatment unrelated|0|||
146859868|NCT02447172|529656949|FG002|Overall Study|protocol specific treatment unrelated|2|||
146859869|NCT03562247|529656953|FG000|Overall Study|Lost to Follow-up|3|||
146859870|NCT03562247|529656954|FG001|Overall Study|Lost to Follow-up|1|||
146859871|NCT03562247|529656955|FG002|Overall Study|Lost to Follow-up|1|||
146859872|NCT01204398|529656956|FG000|Overall Study|Adverse Event|1|||
146859873|NCT00983931|529656957|FG000|14 Day Washout Period|Physician Decision|1|||
146859874|NCT01723254|529656958|FG000|Overall Study|Conflict with work schedule|0|||
146859875|NCT01723254|529656959|FG001|Overall Study|Conflict with work schedule|0|||
146859876|NCT01723254|529656960|FG002|Overall Study|Conflict with work schedule|0|||
146859877|NCT01723254|529656961|FG003|Overall Study|Conflict with work schedule|0|||
146859878|NCT01723254|529656962|FG004|Overall Study|Conflict with work schedule|0|||
146859879|NCT01723254|529656963|FG005|Overall Study|Conflict with work schedule|0|||
146859880|NCT01723254|529656964|FG006|Overall Study|Conflict with work schedule|0|||
146859881|NCT01723254|529656965|FG007|Overall Study|Conflict with work schedule|1|||
146859882|NCT01723254|529656958|FG000|Overall Study|Personal issues|0|||
146859883|NCT01723254|529656959|FG001|Overall Study|Personal issues|0|||
146859884|NCT01723254|529656960|FG002|Overall Study|Personal issues|0|||
146859885|NCT01723254|529656961|FG003|Overall Study|Personal issues|0|||
146859886|NCT01723254|529656962|FG004|Overall Study|Personal issues|0|||
146859887|NCT01723254|529656963|FG005|Overall Study|Personal issues|1|||
146859888|NCT01723254|529656964|FG006|Overall Study|Personal issues|0|||
146859889|NCT01723254|529656965|FG007|Overall Study|Personal issues|0|||
146859890|NCT01723254|529656958|FG000|Overall Study|No longer have time to participate|0|||
146859891|NCT01723254|529656959|FG001|Overall Study|No longer have time to participate|0|||
146525537|NCT00672633|528431393|FG001|Overall Study|Withdrawal by Subject|1|||
146525538|NCT02824627|528431394|FG000|Overall Study|Adverse Event|1|||
146525539|NCT02824627|528431395|FG001|Overall Study|Adverse Event|2|||
146525540|NCT02824627|528431394|FG000|Overall Study|Lost to Follow-up|2|||
146859892|NCT01723254|529656960|FG002|Overall Study|No longer have time to participate|0|||
146859893|NCT01723254|529656961|FG003|Overall Study|No longer have time to participate|1|||
146859894|NCT01723254|529656962|FG004|Overall Study|No longer have time to participate|0|||
146859895|NCT01723254|529656963|FG005|Overall Study|No longer have time to participate|0|||
146859896|NCT01723254|529656964|FG006|Overall Study|No longer have time to participate|0|||
146965089|NCT03110107|530033427|FG001|Treatment Period|Adverse Event|0|||
146859897|NCT01723254|529656965|FG007|Overall Study|No longer have time to participate|0|||
146859898|NCT01723254|529656958|FG000|Overall Study|Move/Left to another country/city|0|||
146859899|NCT01723254|529656959|FG001|Overall Study|Move/Left to another country/city|0|||
146859900|NCT01723254|529656960|FG002|Overall Study|Move/Left to another country/city|2|||
146859901|NCT01723254|529656961|FG003|Overall Study|Move/Left to another country/city|1|||
146859902|NCT01723254|529656962|FG004|Overall Study|Move/Left to another country/city|1|||
146859903|NCT01723254|529656963|FG005|Overall Study|Move/Left to another country/city|0|||
146859904|NCT01723254|529656964|FG006|Overall Study|Move/Left to another country/city|0|||
146859905|NCT01723254|529656965|FG007|Overall Study|Move/Left to another country/city|0|||
146859906|NCT01723254|529656958|FG000|Overall Study|Protocol Violation|0|||
146859907|NCT01723254|529656959|FG001|Overall Study|Protocol Violation|1|||
146859908|NCT01723254|529656960|FG002|Overall Study|Protocol Violation|0|||
146859909|NCT01723254|529656961|FG003|Overall Study|Protocol Violation|0|||
146859910|NCT01723254|529656962|FG004|Overall Study|Protocol Violation|0|||
146859911|NCT01723254|529656963|FG005|Overall Study|Protocol Violation|0|||
146859912|NCT01723254|529656964|FG006|Overall Study|Protocol Violation|0|||
146859913|NCT01723254|529656965|FG007|Overall Study|Protocol Violation|0|||
146859914|NCT01723254|529656958|FG000|Overall Study|Withdrawal by Subject|1|||
146859915|NCT01723254|529656959|FG001|Overall Study|Withdrawal by Subject|2|||
146859916|NCT01723254|529656960|FG002|Overall Study|Withdrawal by Subject|1|||
146859917|NCT01723254|529656961|FG003|Overall Study|Withdrawal by Subject|0|||
146859918|NCT01723254|529656962|FG004|Overall Study|Withdrawal by Subject|1|||
146859919|NCT01723254|529656963|FG005|Overall Study|Withdrawal by Subject|1|||
146859920|NCT01723254|529656964|FG006|Overall Study|Withdrawal by Subject|1|||
146859921|NCT01723254|529656965|FG007|Overall Study|Withdrawal by Subject|2|||
146859922|NCT02668185|529656966|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
146859923|NCT02668185|529656967|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
146859924|NCT02668185|529656966|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
146859925|NCT02668185|529656967|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
146859926|NCT02668185|529656966|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
146859927|NCT02668185|529656967|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
146859928|NCT02668185|529656966|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
146859929|NCT02668185|529656967|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
146859930|NCT00770341|529656968|FG000|Overall Study|Did not meet eligibility criteria|1|||
146859931|NCT00770341|529656969|FG001|Overall Study|Did not meet eligibility criteria|0|||
146859932|NCT00770341|529656970|FG002|Overall Study|Did not meet eligibility criteria|0|||
146859933|NCT00770341|529656968|FG000|Overall Study|Withdrawal by Subject|0|||
146859934|NCT00770341|529656969|FG001|Overall Study|Withdrawal by Subject|1|||
146859935|NCT00770341|529656970|FG002|Overall Study|Withdrawal by Subject|0|||
146859936|NCT00770341|529656968|FG000|Overall Study|Clinical Adverse Event|3|||
146859937|NCT00770341|529656969|FG001|Overall Study|Clinical Adverse Event|1|||
146859938|NCT00770341|529656970|FG002|Overall Study|Clinical Adverse Event|2|||
146859939|NCT00770341|529656968|FG000|Overall Study|Laboratory adverse event|3|||
146859940|NCT00770341|529656969|FG001|Overall Study|Laboratory adverse event|3|||
146859941|NCT00770341|529656970|FG002|Overall Study|Laboratory adverse event|0|||
146859942|NCT00770341|529656968|FG000|Overall Study|Lack of Efficacy|3|||
146859943|NCT00770341|529656969|FG001|Overall Study|Lack of Efficacy|0|||
146859944|NCT00770341|529656970|FG002|Overall Study|Lack of Efficacy|1|||
146859945|NCT00770341|529656968|FG000|Overall Study|Other|1|||
146859946|NCT00770341|529656969|FG001|Overall Study|Other|0|||
146859947|NCT00770341|529656970|FG002|Overall Study|Other|0|||
146859948|NCT00770341|529656968|FG000|Overall Study|Not treated|1|||
146859949|NCT00770341|529656969|FG001|Overall Study|Not treated|0|||
146859950|NCT00770341|529656970|FG002|Overall Study|Not treated|0|||
146859951|NCT05269355|529656977|FG000|Overall Study|Progressive Disease|104|||
146859952|NCT05269355|529656978|FG001|Overall Study|Progressive Disease|68|||
146965090|NCT03110107|530033428|FG002|Treatment Period|Adverse Event|1|||
146859953|NCT05269355|529656977|FG000|Overall Study|Study Terminated by Sponsor|87|||
146859954|NCT05269355|529656978|FG001|Overall Study|Study Terminated by Sponsor|29|||
146859955|NCT05269355|529656977|FG000|Overall Study|Adverse Event|15|||
146859956|NCT05269355|529656978|FG001|Overall Study|Adverse Event|8|||
146859957|NCT05269355|529656977|FG000|Overall Study|Withdrawal by Subject|18|||
146859958|NCT05269355|529656978|FG001|Overall Study|Withdrawal by Subject|5|||
146859959|NCT05269355|529656977|FG000|Overall Study|Physician Decision|6|||
146859960|NCT05269355|529656978|FG001|Overall Study|Physician Decision|4|||
146859961|NCT05269355|529656977|FG000|Overall Study|Death|3|||
146859962|NCT05269355|529656978|FG001|Overall Study|Death|5|||
146859963|NCT05269355|529656977|FG000|Overall Study|Other Than Specified|5|||
146859964|NCT05269355|529656978|FG001|Overall Study|Other Than Specified|1|||
146859965|NCT05269355|529656977|FG000|Overall Study|Randomized But Not Treated|1|||
146859966|NCT05269355|529656978|FG001|Overall Study|Randomized But Not Treated|0|||
146859967|NCT03705832|529656979|FG000|Overall Study|Physician Decision|0|||
146525541|NCT02824627|528431395|FG001|Overall Study|Lost to Follow-up|1|||
146525542|NCT01938846|528431396|FG000|Overall Study|Progressive disease|26|||
146525543|NCT01938846|528431397|FG001|Overall Study|Progressive disease|18|||
146525544|NCT01938846|528431398|FG002|Overall Study|Progressive disease|16|||
146525545|NCT01938846|528431396|FG000|Overall Study|Adverse Event|8|||
146525546|NCT01938846|528431397|FG001|Overall Study|Adverse Event|4|||
146525547|NCT01938846|528431398|FG002|Overall Study|Adverse Event|3|||
146525548|NCT01938846|528431396|FG000|Overall Study|Withdrawal by Subject|2|||
146525549|NCT01938846|528431397|FG001|Overall Study|Withdrawal by Subject|2|||
146525550|NCT01938846|528431398|FG002|Overall Study|Withdrawal by Subject|1|||
146859968|NCT03705832|529656980|FG001|Overall Study|Physician Decision|1|||
146859969|NCT03705832|529656979|FG000|Overall Study|Withdrawal by Subject|1|||
146859970|NCT03705832|529656980|FG001|Overall Study|Withdrawal by Subject|0|||
146859971|NCT01050790|529656981|FG000|Overall Study|Adverse Event|1|||
146859972|NCT00081497|529656982|FG000|Overall Study|Adverse Event|2|||
146859973|NCT00081497|529656983|FG001|Overall Study|Adverse Event|0|||
146859974|NCT00081497|529656982|FG000|Overall Study|Death|0|||
146859975|NCT00081497|529656983|FG001|Overall Study|Death|1|||
146859976|NCT00081497|529656982|FG000|Overall Study|Withdrawal by Subject|1|||
146859977|NCT00081497|529656983|FG001|Overall Study|Withdrawal by Subject|0|||
146859978|NCT00081497|529656982|FG000|Overall Study|Non-compliance|0|||
146859979|NCT00081497|529656983|FG001|Overall Study|Non-compliance|1|||
146859980|NCT02390245|529656984|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
146859981|NCT02390245|529656985|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
146859982|NCT02390245|529656986|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
146859983|NCT02390245|529656984|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
146859984|NCT02390245|529656985|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
146859985|NCT02390245|529656986|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
146859986|NCT03278106|529658306|FG000|Overall Study|No protocol treatment|1|||
146859987|NCT01137955|529658307|FG000|Overall Study|Withdrawal by Subject|5|||
146859988|NCT01137955|529658308|FG001|Overall Study|Withdrawal by Subject|4|||
146859989|NCT01211197|529658309|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146859990|NCT01211197|529658310|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146859991|NCT01211197|529658311|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
146859992|NCT01211197|529658312|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146859993|NCT01211197|529658313|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146859994|NCT01211197|529658314|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146859995|NCT01211197|529658309|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
146859996|NCT01211197|529658310|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
146859997|NCT01211197|529658311|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
146859998|NCT01211197|529658312|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
146859999|NCT01211197|529658313|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
146860000|NCT01211197|529658314|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
146860001|NCT00892723|529658318|FG000|Overall Study|Lost to Follow-up|1|||
146860002|NCT00892723|529658319|FG001|Overall Study|Lost to Follow-up|3|||
146860003|NCT00892723|529658320|FG002|Overall Study|Lost to Follow-up|1|||
146860004|NCT00892723|529658318|FG000|Overall Study|Withdrawal by Subject|1|||
146860005|NCT00892723|529658319|FG001|Overall Study|Withdrawal by Subject|1|||
146860006|NCT00892723|529658320|FG002|Overall Study|Withdrawal by Subject|1|||
146860007|NCT01026454|529658322|FG000|Second Intervention|Pregnancy|1|||
146860008|NCT01026454|529658323|FG001|Second Intervention|Pregnancy|1|||
146860009|NCT02019927|529658326|FG000|Overall Study|Lost to Follow-up|2|||
146860010|NCT02019927|529658327|FG001|Overall Study|Lost to Follow-up|4|||
146860011|NCT02019927|529658328|FG002|Overall Study|Lost to Follow-up|1|||
146860012|NCT02019927|529658329|FG003|Overall Study|Lost to Follow-up|2|||
146525551|NCT01938846|528431396|FG000|Overall Study|Other than listed|5|||
146525552|NCT01938846|528431397|FG001|Overall Study|Other than listed|1|||
146860013|NCT02019927|529658330|FG004|Overall Study|Lost to Follow-up|3|||
146860014|NCT02019927|529658331|FG005|Overall Study|Lost to Follow-up|1|||
146860015|NCT01054846|529658334|FG000|Overall Study|Lost to Follow-up|76|||
146860016|NCT01054846|529658335|FG001|Overall Study|Lost to Follow-up|17|||
146860017|NCT00394953|529658336|FG000|First Treatment Period|Adverse Event|1|||
146525553|NCT01938846|528431398|FG002|Overall Study|Other than listed|4|||
146525554|NCT02499120|528431399|FG000|Overall Study|Death|52|||
146525555|NCT02499120|528431400|FG001|Overall Study|Death|43|||
146525556|NCT02499120|528431399|FG000|Overall Study|Lost to Follow-up|1|||
146860018|NCT00394953|529658337|FG001|First Treatment Period|Adverse Event|2|||
146525557|NCT02499120|528431400|FG001|Overall Study|Lost to Follow-up|2|||
146525558|NCT02499120|528431399|FG000|Overall Study|Participant refused further follow-up|1|||
146525559|NCT02499120|528431400|FG001|Overall Study|Participant refused further follow-up|0|||
146525560|NCT02499120|528431399|FG000|Overall Study|Withdrawal by Subject|2|||
146525561|NCT02499120|528431400|FG001|Overall Study|Withdrawal by Subject|5|||
146525562|NCT02499120|528431399|FG000|Overall Study|Other|9|||
146525563|NCT02499120|528431400|FG001|Overall Study|Other|10|||
146525564|NCT00964028|528431405|FG000|Overall Study|Withdrawal by Subject|0|||
146525565|NCT00964028|528431406|FG001|Overall Study|Withdrawal by Subject|1|||
146525566|NCT01603407|528431407|FG000|Overall Study|Adverse Event|1|||
146525567|NCT01603407|528431408|FG001|Overall Study|Adverse Event|1|||
146525568|NCT01603407|528431409|FG002|Overall Study|Adverse Event|1|||
146525569|NCT01603407|528431407|FG000|Overall Study|Protocol Violation|2|||
146525570|NCT01603407|528431408|FG001|Overall Study|Protocol Violation|2|||
146525571|NCT01603407|528431409|FG002|Overall Study|Protocol Violation|0|||
146525572|NCT01603407|528431407|FG000|Overall Study|Withdrawal by Subject|8|||
146525573|NCT01603407|528431408|FG001|Overall Study|Withdrawal by Subject|5|||
146525574|NCT01603407|528431409|FG002|Overall Study|Withdrawal by Subject|7|||
146525575|NCT01603407|528431407|FG000|Overall Study|Lost to Follow-up|0|||
146525576|NCT01603407|528431408|FG001|Overall Study|Lost to Follow-up|3|||
146525577|NCT01603407|528431409|FG002|Overall Study|Lost to Follow-up|2|||
146525578|NCT05176717|528431410|FG000|Overall Study|Sponsor Decision|1|||
146525579|NCT05176717|528431411|FG001|Overall Study|Sponsor Decision|2|||
146525580|NCT05176717|528431412|FG002|Overall Study|Sponsor Decision|2|||
146525581|NCT03284853|528431413|FG000|Overall Study|Adverse Event|40|||
146525582|NCT03284853|528431414|FG001|Overall Study|Adverse Event|4|||
146525583|NCT03284853|528431413|FG000|Overall Study|Withdrawal by Subject|5|||
146525584|NCT03284853|528431414|FG001|Overall Study|Withdrawal by Subject|1|||
146525585|NCT03284853|528431413|FG000|Overall Study|Lost to Follow-up|1|||
146525586|NCT03284853|528431414|FG001|Overall Study|Lost to Follow-up|0|||
146525587|NCT03284853|528431413|FG000|Overall Study|Lack of Efficacy|1|||
146525588|NCT03284853|528431414|FG001|Overall Study|Lack of Efficacy|0|||
146525589|NCT03284853|528431413|FG000|Overall Study|Disallowed Concurrent Medication|1|||
146525590|NCT03284853|528431414|FG001|Overall Study|Disallowed Concurrent Medication|1|||
146525591|NCT03284853|528431413|FG000|Overall Study|Protocol Violation|3|||
146525592|NCT03284853|528431414|FG001|Overall Study|Protocol Violation|3|||
146525593|NCT03284853|528431413|FG000|Overall Study|Death|0|||
146525594|NCT03284853|528431414|FG001|Overall Study|Death|1|||
146525595|NCT03284853|528431413|FG000|Overall Study|Other - Reason not reported in CSR|4|||
146525596|NCT03284853|528431414|FG001|Overall Study|Other - Reason not reported in CSR|3|||
146525597|NCT02143024|528431416|FG000|Overall Study|Lost to Follow-up|1|||
146525598|NCT02143024|528431417|FG001|Overall Study|Lost to Follow-up|1|||
146525599|NCT02143024|528431416|FG000|Overall Study|Withdrawal by Subject|1|||
146525600|NCT02143024|528431417|FG001|Overall Study|Withdrawal by Subject|0|||
146525601|NCT02308228|528431418|FG000|Overall Study|Adverse Event|3|||
146525602|NCT02308228|528431419|FG001|Overall Study|Adverse Event|4|||
146525603|NCT02308228|528431418|FG000|Overall Study|Withdrawal by Subject|5|||
146525604|NCT02308228|528431419|FG001|Overall Study|Withdrawal by Subject|3|||
146525605|NCT05219968|528431422|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
146525606|NCT05219968|528431423|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
146860019|NCT00394953|529658336|FG000|First Treatment Period|Death|6|||
146860020|NCT00394953|529658337|FG001|First Treatment Period|Death|7|||
146860021|NCT00394953|529658336|FG000|First Treatment Period|Lack of Efficacy|1|||
146860022|NCT00394953|529658337|FG001|First Treatment Period|Lack of Efficacy|1|||
146525607|NCT05219968|528431424|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
146525608|NCT05219968|528431425|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
146525609|NCT05219968|528431426|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
146525610|NCT05219968|528431422|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
146525611|NCT05219968|528431423|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
146525612|NCT05219968|528431424|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
146525613|NCT05219968|528431425|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
146525614|NCT05219968|528431426|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
146525615|NCT05219968|528431422|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
146525616|NCT05219968|528431423|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
146525617|NCT05219968|528431424|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
146525618|NCT05219968|528431425|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
146525619|NCT05219968|528431426|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
146525620|NCT05219968|528431422|FG000|Week 24 Treatment Period|Adverse Event|3|||
146525621|NCT05219968|528431423|FG001|Week 24 Treatment Period|Adverse Event|0|||
146525622|NCT05219968|528431424|FG002|Week 24 Treatment Period|Adverse Event|0|||
146525623|NCT05219968|528431425|FG003|Week 24 Treatment Period|Adverse Event|0|||
146525624|NCT05219968|528431426|FG004|Week 24 Treatment Period|Adverse Event|0|||
146525625|NCT05219968|528431422|FG000|Week 24 Treatment Period|Physician Decision|0|||
146525626|NCT05219968|528431423|FG001|Week 24 Treatment Period|Physician Decision|1|||
146525627|NCT05219968|528431424|FG002|Week 24 Treatment Period|Physician Decision|0|||
146525628|NCT05219968|528431425|FG003|Week 24 Treatment Period|Physician Decision|0|||
146525629|NCT05219968|528431426|FG004|Week 24 Treatment Period|Physician Decision|0|||
146525630|NCT05219968|528431422|FG000|Week 24 Treatment Period|Other, not specified|3|||
146525631|NCT05219968|528431423|FG001|Week 24 Treatment Period|Other, not specified|0|||
146525632|NCT05219968|528431424|FG002|Week 24 Treatment Period|Other, not specified|0|||
146525633|NCT05219968|528431425|FG003|Week 24 Treatment Period|Other, not specified|0|||
146525634|NCT05219968|528431426|FG004|Week 24 Treatment Period|Other, not specified|0|||
146525635|NCT05219968|528431422|FG000|Safety Extension Period|Treatment administration failure|0|||
146525636|NCT05219968|528431423|FG001|Safety Extension Period|Treatment administration failure|0|||
146525637|NCT05219968|528431424|FG002|Safety Extension Period|Treatment administration failure|0|||
146525638|NCT05219968|528431425|FG003|Safety Extension Period|Treatment administration failure|1|||
146525639|NCT05219968|528431426|FG004|Safety Extension Period|Treatment administration failure|4|||
146525640|NCT05219968|528431422|FG000|Safety Extension Period|Bilateral dislodgement|0|||
146525641|NCT05219968|528431423|FG001|Safety Extension Period|Bilateral dislodgement|0|||
146525642|NCT05219968|528431424|FG002|Safety Extension Period|Bilateral dislodgement|4|||
146525643|NCT05219968|528431425|FG003|Safety Extension Period|Bilateral dislodgement|0|||
146525644|NCT05219968|528431426|FG004|Safety Extension Period|Bilateral dislodgement|1|||
146525645|NCT05219968|528431422|FG000|Safety Extension Period|Withdrawal by Subject|0|||
146525646|NCT05219968|528431423|FG001|Safety Extension Period|Withdrawal by Subject|0|||
146525647|NCT05219968|528431424|FG002|Safety Extension Period|Withdrawal by Subject|2|||
146525648|NCT05219968|528431425|FG003|Safety Extension Period|Withdrawal by Subject|0|||
146760530|NCT00711646|529290995|FG000|Overall Study|administrative decision|0|||
146760531|NCT00711646|529290996|FG001|Overall Study|administrative decision|1|||
146760532|NCT00711646|529290995|FG000|Overall Study|patient non-compliance|1|||
146760533|NCT00711646|529290996|FG001|Overall Study|patient non-compliance|0|||
146760534|NCT03441360|529290997|FG000|Overall Study|Radiological disease progression|5|||
146760535|NCT03441360|529290998|FG001|Overall Study|Radiological disease progression|6|||
146760536|NCT03441360|529290999|FG002|Overall Study|Radiological disease progression|4|||
146760537|NCT03441360|529290997|FG000|Overall Study|Clinical disease progression|2|||
146760538|NCT03441360|529290998|FG001|Overall Study|Clinical disease progression|2|||
146760539|NCT03441360|529290999|FG002|Overall Study|Clinical disease progression|0|||
146760540|NCT03441360|529290997|FG000|Overall Study|Adverse Event|1|||
146760541|NCT03441360|529290998|FG001|Overall Study|Adverse Event|0|||
146760542|NCT03441360|529290999|FG002|Overall Study|Adverse Event|1|||
146760543|NCT00269399|529291000|FG000|Overall Study|Lack of Efficacy|27|||
146760544|NCT00269399|529291001|FG001|Overall Study|Lack of Efficacy|10|||
146760545|NCT00269399|529291000|FG000|Overall Study|Adverse Event|10|||
146760546|NCT00269399|529291001|FG001|Overall Study|Adverse Event|4|||
146760547|NCT00269399|529291000|FG000|Overall Study|Withdrawal by Subject|2|||
146760548|NCT00269399|529291001|FG001|Overall Study|Withdrawal by Subject|5|||
146760549|NCT00269399|529291000|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
146760550|NCT00269399|529291001|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
146760551|NCT00269399|529291000|FG000|Overall Study|Other|0|||
146760552|NCT00269399|529291001|FG001|Overall Study|Other|4|||
146760553|NCT00269399|529291000|FG000|Overall Study|Development of exclusion criteria|0|||
146760554|NCT00269399|529291001|FG001|Overall Study|Development of exclusion criteria|1|||
146760555|NCT03396835|529291002|FG000|Overall Study|Withdrawn prior to completion|1|||
146760556|NCT03396835|529291002|FG000|Overall Study|Did not meet criteria for data analysis|1|||
146760557|NCT03439124|529291003|FG000|Overall Study|Adverse Event|2|||
146760558|NCT03439124|529291004|FG001|Overall Study|Adverse Event|0|||
146760559|NCT03439124|529291003|FG000|Overall Study|Lost to Follow-up|1|||
146760560|NCT03439124|529291004|FG001|Overall Study|Lost to Follow-up|0|||
146760561|NCT03439124|529291003|FG000|Overall Study|Other reasons|1|||
146760562|NCT03439124|529291004|FG001|Overall Study|Other reasons|0|||
146760563|NCT01451814|529291005|FG000|Overall Study|Withdrawal by Subject|1|||
146760564|NCT01451814|529291006|FG001|Overall Study|Withdrawal by Subject|1|||
146760565|NCT01451814|529291005|FG000|Overall Study|Lost to Follow-up|5|||
146525649|NCT05219968|528431426|FG004|Safety Extension Period|Withdrawal by Subject|4|||
146525650|NCT05219968|528431422|FG000|Safety Extension Period|Adverse Event|0|||
146760566|NCT01451814|529291006|FG001|Overall Study|Lost to Follow-up|4|||
146525651|NCT05219968|528431423|FG001|Safety Extension Period|Adverse Event|0|||
146525652|NCT05219968|528431424|FG002|Safety Extension Period|Adverse Event|2|||
146760567|NCT04353037|529291008|FG000|Overall Study|Lost to Follow-up|0|||
146760568|NCT04353037|529291009|FG001|Overall Study|Lost to Follow-up|1|||
146760569|NCT04353037|529291010|FG002|Overall Study|Lost to Follow-up|2|||
146760570|NCT04353037|529291011|FG003|Overall Study|Lost to Follow-up|3|||
146760571|NCT04353037|529291008|FG000|Overall Study|Withdrawal by Subject|0|||
146860023|NCT00394953|529658336|FG000|First Treatment Period|Withdrawal by Subject|6|||
146860024|NCT00394953|529658337|FG001|First Treatment Period|Withdrawal by Subject|3|||
146860025|NCT00394953|529658336|FG000|First Treatment Period|Lost to Follow-up|0|||
146860026|NCT00394953|529658337|FG001|First Treatment Period|Lost to Follow-up|1|||
146860027|NCT00394953|529658336|FG000|First Treatment Period|Renal transplant|11|||
146860028|NCT00394953|529658337|FG001|First Treatment Period|Renal transplant|7|||
146860029|NCT00394953|529658336|FG000|First Treatment Period|Not defined|4|||
146860030|NCT00394953|529658337|FG001|First Treatment Period|Not defined|1|||
146860031|NCT00394953|529658336|FG000|Second Treatment Period|Adverse Event|2|||
146860032|NCT00394953|529658337|FG001|Second Treatment Period|Adverse Event|5|||
146860033|NCT00394953|529658336|FG000|Second Treatment Period|Death|8|||
146860034|NCT00394953|529658337|FG001|Second Treatment Period|Death|4|||
146860035|NCT00394953|529658336|FG000|Second Treatment Period|Lack of Efficacy|9|||
146860036|NCT00394953|529658337|FG001|Second Treatment Period|Lack of Efficacy|47|||
146860037|NCT00394953|529658336|FG000|Second Treatment Period|Withdrawal by Subject|3|||
146860038|NCT00394953|529658337|FG001|Second Treatment Period|Withdrawal by Subject|3|||
146860039|NCT00394953|529658336|FG000|Second Treatment Period|Lost to Follow-up|0|||
146860040|NCT00394953|529658337|FG001|Second Treatment Period|Lost to Follow-up|1|||
146860041|NCT00394953|529658336|FG000|Second Treatment Period|Renal transplant|4|||
146860042|NCT00394953|529658337|FG001|Second Treatment Period|Renal transplant|6|||
146860043|NCT00394953|529658336|FG000|Second Treatment Period|Not defined|3|||
146860044|NCT00394953|529658337|FG001|Second Treatment Period|Not defined|8|||
146860045|NCT00928447|529658346|FG000|Overall Study|Withdrawal by Subject|1|||
146860046|NCT00928447|529658346|FG000|Overall Study|Investigator's decision|1|||
146860047|NCT01259284|529658347|FG000|Overall Study|Study Termination|2|||
146860048|NCT01259284|529658348|FG001|Overall Study|Study Termination|0|||
146860049|NCT01259284|529658349|FG002|Overall Study|Study Termination|0|||
146860050|NCT02196714|529658357|FG000|Overall Study|Protocol Violation|0|||
146860051|NCT02196714|529658358|FG001|Overall Study|Protocol Violation|0|||
146860052|NCT02196714|529658359|FG002|Overall Study|Protocol Violation|1|||
146860053|NCT02196714|529658360|FG003|Overall Study|Protocol Violation|0|||
146860054|NCT01592864|529658362|FG000|Overall Study|Withdrawal by Subject|0|||
146860055|NCT01592864|529658363|FG001|Overall Study|Withdrawal by Subject|1|||
146860056|NCT01326533|529658367|FG000|Overall Study|Lost to Follow-up|2|||
146860057|NCT01326533|529658368|FG001|Overall Study|Lost to Follow-up|0|||
146860058|NCT01326533|529658367|FG000|Overall Study|Withdrawal by Subject|1|||
146860059|NCT01326533|529658368|FG001|Overall Study|Withdrawal by Subject|0|||
146860060|NCT01326533|529658367|FG000|Overall Study|Adverse Event|1|||
146860061|NCT01326533|529658368|FG001|Overall Study|Adverse Event|0|||
146860062|NCT04079803|529658369|FG000|Overall Study|Withdrawal by Subject|0|||
146860063|NCT04079803|529658370|FG001|Overall Study|Withdrawal by Subject|0|||
146860064|NCT04079803|529658371|FG002|Overall Study|Withdrawal by Subject|1|||
146860065|NCT03353350|529658372|FG000|30-week Core Treatment Period|Protocol Violation|1|||
146860066|NCT03353350|529658373|FG001|30-week Core Treatment Period|Protocol Violation|1|||
146860067|NCT03353350|529658374|FG002|30-week Core Treatment Period|Protocol Violation|1|||
146860068|NCT03353350|529658375|FG003|30-week Core Treatment Period|Protocol Violation|0|||
146860069|NCT03353350|529658372|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
146860070|NCT03353350|529658373|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
146860071|NCT03353350|529658374|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
146860072|NCT03353350|529658375|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
146860073|NCT03353350|529658372|FG000|30-week Core Treatment Period|Adverse Event|0|||
146860074|NCT03353350|529658373|FG001|30-week Core Treatment Period|Adverse Event|4|||
146860075|NCT03353350|529658374|FG002|30-week Core Treatment Period|Adverse Event|2|||
146860076|NCT03353350|529658375|FG003|30-week Core Treatment Period|Adverse Event|3|||
146860077|NCT03353350|529658372|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
146860078|NCT03353350|529658373|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
146860079|NCT03353350|529658374|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
146860080|NCT03353350|529658375|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
146860081|NCT03353350|529658372|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
146860082|NCT03353350|529658373|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
146860083|NCT03353350|529658374|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
146525653|NCT05219968|528431425|FG003|Safety Extension Period|Adverse Event|1|||
146525654|NCT05219968|528431426|FG004|Safety Extension Period|Adverse Event|1|||
146860084|NCT03353350|529658375|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
146860085|NCT03353350|529658372|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
146860086|NCT03353350|529658373|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
146860087|NCT03353350|529658374|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
146860088|NCT03353350|529658375|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
146860089|NCT03353350|529658372|FG000|26-week Treatment Extension Period|Adverse Event|1|||
146860090|NCT03353350|529658373|FG001|26-week Treatment Extension Period|Adverse Event|0|||
146860091|NCT03353350|529658374|FG002|26-week Treatment Extension Period|Adverse Event|0|||
146860092|NCT03353350|529658375|FG003|26-week Treatment Extension Period|Adverse Event|1|||
146525655|NCT05219968|528431422|FG000|Safety Extension Period|Lost to Follow-up|0|||
146860093|NCT03353350|529658372|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
146525656|NCT05219968|528431423|FG001|Safety Extension Period|Lost to Follow-up|0|||
146860094|NCT03353350|529658373|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
146860095|NCT03353350|529658374|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
146860096|NCT03353350|529658375|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
146860097|NCT03037619|529658376|FG000|Overall Study|Lost to Follow-up|0|||
146860098|NCT03037619|529658377|FG001|Overall Study|Lost to Follow-up|1|||
146525657|NCT05219968|528431424|FG002|Safety Extension Period|Lost to Follow-up|0|||
146525658|NCT05219968|528431425|FG003|Safety Extension Period|Lost to Follow-up|1|||
146525659|NCT05219968|528431426|FG004|Safety Extension Period|Lost to Follow-up|0|||
146860099|NCT01881750|529658384|FG000|Overall Study|Changes in concomitant therapies|2|||
146860100|NCT01881750|529658385|FG001|Overall Study|Changes in concomitant therapies|3|||
146860101|NCT01881750|529658384|FG000|Overall Study|Lost to Follow-up|0|||
146860102|NCT01881750|529658385|FG001|Overall Study|Lost to Follow-up|1|||
146525660|NCT04547140|528432853|FG000|Overall Study|Adverse Event|0|||
146525661|NCT04547140|528432854|FG001|Overall Study|Adverse Event|1|||
146525662|NCT04547140|528432853|FG000|Overall Study|Withdrawal by Subject|0|||
146525663|NCT04547140|528432854|FG001|Overall Study|Withdrawal by Subject|1|||
146525664|NCT04547140|528432853|FG000|Overall Study|Lost to Follow-up|3|||
146525665|NCT04547140|528432854|FG001|Overall Study|Lost to Follow-up|1|||
146525666|NCT04547140|528432853|FG000|Overall Study|Death|2|||
146525667|NCT04547140|528432854|FG001|Overall Study|Death|1|||
146525668|NCT04547140|528432853|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
146525669|NCT04547140|528432854|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
146525670|NCT04547140|528432853|FG000|Overall Study|Pregnancy|1|||
146525671|NCT04547140|528432854|FG001|Overall Study|Pregnancy|0|||
146525672|NCT04547140|528432853|FG000|Overall Study|Reason Not Specified|4|||
146525673|NCT04547140|528432854|FG001|Overall Study|Reason Not Specified|1|||
146525674|NCT00873730|528432855|FG000|Overall Study|Protocol Deviation|5|||
146525675|NCT00873730|528432856|FG001|Overall Study|Protocol Deviation|2|||
146525676|NCT00873730|528432855|FG000|Overall Study|Adverse Event|0|||
146525677|NCT00873730|528432856|FG001|Overall Study|Adverse Event|2|||
146525678|NCT00873730|528432855|FG000|Overall Study|Withdrawal by Subject|0|||
146525679|NCT00873730|528432856|FG001|Overall Study|Withdrawal by Subject|1|||
146525680|NCT00873730|528432855|FG000|Overall Study|Sponsor decision|1|||
146525681|NCT00873730|528432856|FG001|Overall Study|Sponsor decision|0|||
146525682|NCT04613739|528432857|FG000|Overall Study|Lost to Follow-up|6|||
146525683|NCT04613739|528432858|FG001|Overall Study|Lost to Follow-up|9|||
146525684|NCT04613739|528432857|FG000|Overall Study|potentially duplicative/fraudulent|1|||
146525685|NCT04613739|528432858|FG001|Overall Study|potentially duplicative/fraudulent|3|||
146525686|NCT00003537|528432859|FG000|Overall Study|Not evalauable|1|||
146525687|NCT01051557|528432860|FG000|Overall Study|Physician Decision|1|||
146525688|NCT01051557|528432861|FG001|Overall Study|Physician Decision|0|||
146525689|NCT01051557|528432862|FG002|Overall Study|Physician Decision|0|||
146525690|NCT01051557|528432863|FG003|Overall Study|Physician Decision|0|||
146525691|NCT01051557|528432864|FG004|Overall Study|Physician Decision|0|||
146525692|NCT01051557|528432865|FG005|Overall Study|Physician Decision|0|||
146525693|NCT01051557|528432866|FG006|Overall Study|Physician Decision|0|||
146525694|NCT01051557|528432860|FG000|Overall Study|disease progression|3|||
146525695|NCT01051557|528432861|FG001|Overall Study|disease progression|3|||
146860103|NCT00307125|529658388|FG000|Screening Phase|Adverse Event|1|||
146860104|NCT00307125|529658389|FG001|Screening Phase|Adverse Event|0|||
146860105|NCT00307125|529658390|FG002|Screening Phase|Adverse Event|0|||
146525696|NCT01051557|528432862|FG002|Overall Study|disease progression|5|||
146525697|NCT01051557|528432863|FG003|Overall Study|disease progression|2|||
146525698|NCT01051557|528432864|FG004|Overall Study|disease progression|4|||
146525699|NCT01051557|528432865|FG005|Overall Study|disease progression|3|||
146525700|NCT01051557|528432866|FG006|Overall Study|disease progression|1|||
146525701|NCT01051557|528432860|FG000|Overall Study|Withdrawal by Subject|0|||
146525702|NCT01051557|528432861|FG001|Overall Study|Withdrawal by Subject|0|||
146525703|NCT01051557|528432862|FG002|Overall Study|Withdrawal by Subject|1|||
146525704|NCT01051557|528432863|FG003|Overall Study|Withdrawal by Subject|0|||
146525705|NCT01051557|528432864|FG004|Overall Study|Withdrawal by Subject|2|||
146525706|NCT01051557|528432865|FG005|Overall Study|Withdrawal by Subject|0|||
146525707|NCT01051557|528432866|FG006|Overall Study|Withdrawal by Subject|1|||
146525708|NCT01051557|528432860|FG000|Overall Study|Adverse Event|0|||
146525709|NCT01051557|528432861|FG001|Overall Study|Adverse Event|0|||
146525710|NCT01051557|528432862|FG002|Overall Study|Adverse Event|0|||
146525711|NCT01051557|528432863|FG003|Overall Study|Adverse Event|1|||
146525712|NCT01051557|528432864|FG004|Overall Study|Adverse Event|1|||
146525713|NCT01051557|528432865|FG005|Overall Study|Adverse Event|3|||
146525714|NCT01051557|528432866|FG006|Overall Study|Adverse Event|4|||
146525715|NCT00130689|528432868|FG000|Overall Study|Progressive Disease|29|||
146525716|NCT00130689|528432868|FG000|Overall Study|Death|1|||
146860106|NCT00307125|529658388|FG000|Screening Phase|Protocol Violation|27|||
146860107|NCT00307125|529658389|FG001|Screening Phase|Protocol Violation|0|||
146860108|NCT00307125|529658390|FG002|Screening Phase|Protocol Violation|0|||
146525717|NCT00130689|528432868|FG000|Overall Study|Clinical Deterioration|4|||
146525718|NCT00130689|528432868|FG000|Overall Study|Withdrawal by Subject|3|||
146525719|NCT00130689|528432868|FG000|Overall Study|Ineligible|6|||
146525720|NCT00766597|528432869|FG000|Overall Study|Unexpected closure of study|4|||
146525721|NCT00766597|528432869|FG000|Overall Study|Without CCR5-tropic virus|5|||
146525722|NCT00943397|528432870|FG000|Overall Study|Adverse Event|0|||
146525723|NCT00943397|528432871|FG001|Overall Study|Adverse Event|6|||
146525724|NCT00943397|528432870|FG000|Overall Study|Lost to Follow-up|0|||
146525725|NCT00943397|528432871|FG001|Overall Study|Lost to Follow-up|4|||
146525726|NCT00943397|528432870|FG000|Overall Study|Protocol Violation|2|||
146525727|NCT00943397|528432871|FG001|Overall Study|Protocol Violation|5|||
146525728|NCT00943397|528432870|FG000|Overall Study|Withdrawal by Subject|1|||
146525729|NCT00943397|528432871|FG001|Overall Study|Withdrawal by Subject|1|||
146525730|NCT00943397|528432870|FG000|Overall Study|Site terminated and other|12|||
146525731|NCT00943397|528432871|FG001|Overall Study|Site terminated and other|56|||
146525732|NCT01254656|528432872|FG000|Overall Study|Discontinued due to termination of study|40|||
146525733|NCT01254656|528432873|FG001|Overall Study|Discontinued due to termination of study|39|||
146525734|NCT01254656|528432874|FG002|Overall Study|Discontinued due to termination of study|13|||
146525735|NCT01254656|528432872|FG000|Overall Study|Lack of Efficacy|3|||
146525736|NCT01254656|528432873|FG001|Overall Study|Lack of Efficacy|0|||
146525737|NCT01254656|528432874|FG002|Overall Study|Lack of Efficacy|0|||
146525738|NCT01254656|528432872|FG000|Overall Study|Lost to Follow-up|1|||
146525739|NCT01254656|528432873|FG001|Overall Study|Lost to Follow-up|0|||
146525740|NCT01254656|528432874|FG002|Overall Study|Lost to Follow-up|2|||
146525741|NCT01254656|528432872|FG000|Overall Study|Withdrawal by Subject|2|||
146525742|NCT01254656|528432873|FG001|Overall Study|Withdrawal by Subject|2|||
146525743|NCT01254656|528432874|FG002|Overall Study|Withdrawal by Subject|1|||
146525744|NCT01254656|528432872|FG000|Overall Study|Pregnancy|0|||
146525745|NCT01254656|528432873|FG001|Overall Study|Pregnancy|0|||
146525746|NCT01254656|528432874|FG002|Overall Study|Pregnancy|2|||
146525747|NCT01254656|528432872|FG000|Overall Study|Adverse Event|1|||
146525748|NCT01254656|528432873|FG001|Overall Study|Adverse Event|1|||
146525749|NCT01254656|528432874|FG002|Overall Study|Adverse Event|0|||
146525750|NCT01254656|528432872|FG000|Overall Study|Death|0|||
146525751|NCT01254656|528432873|FG001|Overall Study|Death|1|||
146525752|NCT01254656|528432874|FG002|Overall Study|Death|0|||
146525753|NCT01178125|528432875|FG000|Overall Study|Lost to Follow-up|397|||
146525754|NCT01178125|528432875|FG000|Overall Study|Adverse Event|244|||
146525755|NCT01178125|528432875|FG000|Overall Study|Withdrawal by Subject|209|||
146525756|NCT01178125|528432875|FG000|Overall Study|Noncompliance|184|||
146525757|NCT01178125|528432875|FG000|Overall Study|Pregnancy|55|||
146525758|NCT01178125|528432875|FG000|Overall Study|Other Reason|39|||
146525759|NCT01178125|528432875|FG000|Overall Study|Sponsor Decision|28|||
146525760|NCT01178125|528432875|FG000|Overall Study|Protocol Violation|17|||
146525761|NCT01178125|528432875|FG000|Overall Study|Investigator Decision|5|||
146525762|NCT02948829|528432876|FG000|Overall Study|Lost to Follow-up|2|||
146525763|NCT02948829|528432876|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
146525764|NCT02948829|528432876|FG000|Overall Study|Pregnancy|1|||
146525765|NCT02948829|528432876|FG000|Overall Study|Other: Reason not Specified|8|||
146525766|NCT01004978|528432877|FG000|Overall Study|Disease progression|31|||
146525767|NCT01004978|528432878|FG001|Overall Study|Disease progression|48|||
146525768|NCT01004978|528432877|FG000|Overall Study|Adverse Event|42|||
146525769|NCT01004978|528432878|FG001|Overall Study|Adverse Event|22|||
146525770|NCT01004978|528432877|FG000|Overall Study|Death|3|||
146525771|NCT01004978|528432878|FG001|Overall Study|Death|2|||
146525772|NCT01004978|528432877|FG000|Overall Study|Withdrawal by Subject|16|||
146525773|NCT01004978|528432878|FG001|Overall Study|Withdrawal by Subject|16|||
146525774|NCT01004978|528432877|FG000|Overall Study|Alternative therapy|4|||
146525775|NCT01004978|528432878|FG001|Overall Study|Alternative therapy|8|||
146525776|NCT01004978|528432877|FG000|Overall Study|Physician Decision|6|||
146525777|NCT01004978|528432878|FG001|Overall Study|Physician Decision|3|||
146525778|NCT01004978|528432877|FG000|Overall Study|Other complicating disease|2|||
146525779|NCT01004978|528432878|FG001|Overall Study|Other complicating disease|2|||
146525780|NCT01004978|528432877|FG000|Overall Study|Protocol Violation|2|||
146525781|NCT01004978|528432878|FG001|Overall Study|Protocol Violation|3|||
146525782|NCT01004978|528432877|FG000|Overall Study|Non-compliance|3|||
146525783|NCT01004978|528432878|FG001|Overall Study|Non-compliance|2|||
146525784|NCT01004978|528432877|FG000|Overall Study|Ineligible|1|||
146525785|NCT01004978|528432878|FG001|Overall Study|Ineligible|0|||
146525786|NCT01004978|528432877|FG000|Overall Study|Unblinded|0|||
146525787|NCT01004978|528432878|FG001|Overall Study|Unblinded|1|||
146525788|NCT01004978|528432877|FG000|Overall Study|Performance status worsening|0|||
146525789|NCT01004978|528432878|FG001|Overall Study|Performance status worsening|1|||
146525790|NCT01004978|528432877|FG000|Overall Study|Never started treatment|8|||
146525791|NCT01004978|528432878|FG001|Overall Study|Never started treatment|9|||
146525792|NCT00369915|528432879|FG000|Overall Study|expected side effects|2|||
146525793|NCT00369915|528432880|FG001|Overall Study|expected side effects|1|||
146525794|NCT00369915|528432879|FG000|Overall Study|Withdrawal by Subject|4|||
146525795|NCT00369915|528432880|FG001|Overall Study|Withdrawal by Subject|1|||
146525796|NCT00369915|528432879|FG000|Overall Study|W/drawl by investigators|0|||
146525797|NCT00369915|528432880|FG001|Overall Study|W/drawl by investigators|1|||
146525798|NCT00268983|528432896|FG000|Overall Study|Death|3|||
146860109|NCT00307125|529658388|FG000|Screening Phase|Lost to Follow-up|87|||
146860110|NCT00307125|529658389|FG001|Screening Phase|Lost to Follow-up|0|||
146860111|NCT00307125|529658390|FG002|Screening Phase|Lost to Follow-up|0|||
146860112|NCT00307125|529658388|FG000|Screening Phase|Death|10|||
146860113|NCT00307125|529658389|FG001|Screening Phase|Death|0|||
146860114|NCT00307125|529658390|FG002|Screening Phase|Death|0|||
146860115|NCT00307125|529658388|FG000|Screening Phase|Withdrawal by Subject|77|||
146860116|NCT00307125|529658389|FG001|Screening Phase|Withdrawal by Subject|0|||
146860117|NCT00307125|529658390|FG002|Screening Phase|Withdrawal by Subject|0|||
146860118|NCT00307125|529658388|FG000|Screening Phase|Physician Decision|26|||
146860119|NCT00307125|529658389|FG001|Screening Phase|Physician Decision|0|||
146860120|NCT00307125|529658390|FG002|Screening Phase|Physician Decision|0|||
146860121|NCT00307125|529658388|FG000|Screening Phase|Sponsor Decision|4|||
146860122|NCT00307125|529658389|FG001|Screening Phase|Sponsor Decision|0|||
146860123|NCT00307125|529658390|FG002|Screening Phase|Sponsor Decision|0|||
146860124|NCT00307125|529658388|FG000|Screening Phase|Study Terminated|17|||
146860125|NCT00307125|529658389|FG001|Screening Phase|Study Terminated|0|||
146860126|NCT00307125|529658390|FG002|Screening Phase|Study Terminated|0|||
146860127|NCT00307125|529658388|FG000|Screening Phase|Graft Loss|3|||
146860128|NCT00307125|529658389|FG001|Screening Phase|Graft Loss|0|||
146860129|NCT00307125|529658390|FG002|Screening Phase|Graft Loss|0|||
146860130|NCT00307125|529658388|FG000|Screening Phase|Graft Failure|8|||
146860131|NCT00307125|529658389|FG001|Screening Phase|Graft Failure|0|||
146860132|NCT00307125|529658390|FG002|Screening Phase|Graft Failure|0|||
146860133|NCT00307125|529658388|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
146860134|NCT00307125|529658389|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
146860135|NCT00307125|529658390|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
146860136|NCT00307125|529658388|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
146860137|NCT00307125|529658389|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
146860138|NCT00307125|529658390|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
146860139|NCT00307125|529658388|FG000|Screening Phase|Moved or transferred facilities|34|||
146860140|NCT00307125|529658389|FG001|Screening Phase|Moved or transferred facilities|0|||
146860141|NCT00307125|529658390|FG002|Screening Phase|Moved or transferred facilities|0|||
146860142|NCT00307125|529658388|FG000|Screening Phase|Received Pancreas Transplant|8|||
146860143|NCT00307125|529658389|FG001|Screening Phase|Received Pancreas Transplant|0|||
146860144|NCT00307125|529658390|FG002|Screening Phase|Received Pancreas Transplant|0|||
146525799|NCT00268983|528432897|FG001|Overall Study|Death|0|||
146525800|NCT01348139|528432900|FG000|Period 1|Adverse Event|1|||
146525801|NCT01348139|528432901|FG001|Period 1|Adverse Event|0|||
146525802|NCT01348139|528432902|FG002|Period 1|Adverse Event|0|||
146525803|NCT01348139|528432903|FG003|Period 1|Adverse Event|0|||
146525804|NCT01348139|528432904|FG004|Period 1|Adverse Event|0|||
146525805|NCT01348139|528432905|FG005|Period 1|Adverse Event|0|||
146525806|NCT02762084|528432906|FG000|Overall Study|Withdrawal by Subject|1|||
146525807|NCT02762084|528432907|FG001|Overall Study|Withdrawal by Subject|0|||
146525808|NCT02762084|528432908|FG002|Overall Study|Withdrawal by Subject|0|||
146525809|NCT02762084|528432906|FG000|Overall Study|Adverse Event|0|||
146525810|NCT02762084|528432907|FG001|Overall Study|Adverse Event|0|||
146525811|NCT02762084|528432908|FG002|Overall Study|Adverse Event|1|||
146525812|NCT02254772|528432909|FG000|Overall Study|Ineligible|1|||
146525813|NCT02254772|528432909|FG000|Overall Study|Withdrawal by Subject|1|||
146525814|NCT01765296|528432910|FG000|Overall Study|Protocol Violation|0|||
146525815|NCT01765296|528432911|FG001|Overall Study|Protocol Violation|5|||
146525816|NCT01765296|528432912|FG002|Overall Study|Protocol Violation|4|||
146525817|NCT01765296|528432910|FG000|Overall Study|Withdrawal by Subject|4|||
146525818|NCT01765296|528432911|FG001|Overall Study|Withdrawal by Subject|2|||
146525819|NCT01765296|528432912|FG002|Overall Study|Withdrawal by Subject|2|||
146525820|NCT01765296|528432910|FG000|Overall Study|Adverse Event|1|||
146525821|NCT01765296|528432911|FG001|Overall Study|Adverse Event|13|||
146860145|NCT00307125|529658388|FG000|Screening Phase|Ineligible for pilot|4|||
146860146|NCT00307125|529658389|FG001|Screening Phase|Ineligible for pilot|0|||
146965091|NCT03110107|530033429|FG003|Treatment Period|Adverse Event|0|||
146525822|NCT01765296|528432912|FG002|Overall Study|Adverse Event|5|||
146525823|NCT01765296|528432910|FG000|Overall Study|Lack of Efficacy|0|||
146525824|NCT01765296|528432911|FG001|Overall Study|Lack of Efficacy|0|||
146525825|NCT01765296|528432912|FG002|Overall Study|Lack of Efficacy|2|||
146525826|NCT01619852|528432913|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
146525827|NCT01619852|528432914|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
146525828|NCT01619852|528432913|FG000|3 Month Follow up|Lost to Follow-up|31|||
146860147|NCT00307125|529658390|FG002|Screening Phase|Ineligible for pilot|0|||
146860148|NCT00307125|529658388|FG000|Screening Phase|Try to get pregnant|1|||
146860149|NCT00307125|529658389|FG001|Screening Phase|Try to get pregnant|0|||
146860150|NCT00307125|529658390|FG002|Screening Phase|Try to get pregnant|0|||
146860151|NCT00307125|529658388|FG000|Screening Phase|Developed acute leukemia|1|||
146860152|NCT00307125|529658389|FG001|Screening Phase|Developed acute leukemia|0|||
146525829|NCT01619852|528432914|FG001|3 Month Follow up|Lost to Follow-up|34|||
146525830|NCT04556760|528432915|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
146525831|NCT04556760|528432916|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
146525832|NCT04556760|528432917|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
146525833|NCT04556760|528432918|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
146525834|NCT04556760|528432919|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
146525835|NCT04556760|528432920|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
146525836|NCT04556760|528432915|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
146525837|NCT04556760|528432916|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
146525838|NCT04556760|528432917|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
146525839|NCT04556760|528432918|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
146525840|NCT04556760|528432919|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
146525841|NCT04556760|528432920|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
146525842|NCT03075267|528432926|FG000|Overall Study|Protocol Violation|1|||
146525843|NCT03075267|528432927|FG001|Overall Study|Protocol Violation|0|||
146525844|NCT03075267|528432928|FG002|Overall Study|Protocol Violation|0|||
146525845|NCT02168491|528432929|FG000|Overall Study|Withdrawal by Subject|1|||
146525846|NCT00809445|528432930|FG000|1 Month Follow-up|Lost contact|1|||
146525847|NCT00809445|528432931|FG001|1 Month Follow-up|Lost contact|2|||
146525848|NCT00809445|528432932|FG002|1 Month Follow-up|Lost contact|1|||
146525849|NCT00809445|528432930|FG000|1 Month Follow-up|Withdrew consent|1|||
146525850|NCT00809445|528432931|FG001|1 Month Follow-up|Withdrew consent|1|||
146525851|NCT00809445|528432932|FG002|1 Month Follow-up|Withdrew consent|1|||
146525852|NCT00809445|528432930|FG000|1 Month Follow-up|Death|0|||
146525853|NCT00809445|528432931|FG001|1 Month Follow-up|Death|1|||
146525854|NCT00809445|528432932|FG002|1 Month Follow-up|Death|1|||
146525855|NCT00809445|528432930|FG000|1 Month Follow-up|Incarcerated|0|||
146525856|NCT00809445|528432931|FG001|1 Month Follow-up|Incarcerated|0|||
146525857|NCT00809445|528432932|FG002|1 Month Follow-up|Incarcerated|1|||
146525858|NCT00809445|528432930|FG000|6 Month Follow-up|Lost contact|16|||
146525859|NCT00809445|528432931|FG001|6 Month Follow-up|Lost contact|14|||
146525860|NCT00809445|528432932|FG002|6 Month Follow-up|Lost contact|14|||
146525861|NCT00809445|528432930|FG000|6 Month Follow-up|Death|2|||
146525862|NCT00809445|528432931|FG001|6 Month Follow-up|Death|1|||
146525863|NCT00809445|528432932|FG002|6 Month Follow-up|Death|1|||
146525864|NCT00809445|528432930|FG000|6 Month Follow-up|Incarcerated|6|||
146525865|NCT00809445|528432931|FG001|6 Month Follow-up|Incarcerated|8|||
146525866|NCT00809445|528432932|FG002|6 Month Follow-up|Incarcerated|8|||
146525867|NCT00809445|528432930|FG000|6 Month Follow-up|Withdrew consent|0|||
146525868|NCT00809445|528432931|FG001|6 Month Follow-up|Withdrew consent|0|||
146525869|NCT00809445|528432932|FG002|6 Month Follow-up|Withdrew consent|1|||
146525870|NCT01566604|528432934|FG000|Overall Study|Patient's inability to use the device|1|||
146525871|NCT01566604|528432935|FG001|Overall Study|Patient's inability to use the device|0|||
146525872|NCT01566604|528432934|FG000|Overall Study|Administrative problems|1|||
146525873|NCT01566604|528432935|FG001|Overall Study|Administrative problems|0|||
146525874|NCT01566604|528432934|FG000|Overall Study|Lack of Efficacy|1|||
146525875|NCT01566604|528432935|FG001|Overall Study|Lack of Efficacy|2|||
146525876|NCT01566604|528432934|FG000|Overall Study|Protocol deviation|2|||
146525877|NCT01566604|528432935|FG001|Overall Study|Protocol deviation|0|||
146525878|NCT01566604|528432934|FG000|Overall Study|Abnormal laboratory value|2|||
146525879|NCT01566604|528432935|FG001|Overall Study|Abnormal laboratory value|0|||
146525880|NCT01566604|528432934|FG000|Overall Study|Death|4|||
146525881|NCT01566604|528432935|FG001|Overall Study|Death|1|||
146525882|NCT01566604|528432934|FG000|Overall Study|Adverse Event|4|||
146525883|NCT01566604|528432935|FG001|Overall Study|Adverse Event|2|||
146525884|NCT01566604|528432934|FG000|Overall Study|Withdrawal by Subject|9|||
146525885|NCT01566604|528432935|FG001|Overall Study|Withdrawal by Subject|6|||
146525886|NCT01610037|528432937|FG000|All Patients|Adverse Event|27|||
146525887|NCT01610037|528432938|FG001|All Patients|Adverse Event|22|||
146525888|NCT01610037|528432939|FG002|All Patients|Adverse Event|26|||
146525889|NCT01610037|528432937|FG000|All Patients|Withdrawal by Subject|12|||
146760572|NCT04353037|529291009|FG001|Overall Study|Withdrawal by Subject|2|||
146760573|NCT04353037|529291010|FG002|Overall Study|Withdrawal by Subject|3|||
146760574|NCT04353037|529291011|FG003|Overall Study|Withdrawal by Subject|5|||
146760575|NCT04353037|529291008|FG000|Overall Study|Adverse Event|0|||
146760576|NCT04353037|529291009|FG001|Overall Study|Adverse Event|0|||
146760577|NCT04353037|529291010|FG002|Overall Study|Adverse Event|2|||
146760578|NCT04353037|529291011|FG003|Overall Study|Adverse Event|0|||
146760579|NCT04353037|529291008|FG000|Overall Study|Exposure Change|0|||
146525890|NCT01610037|528432938|FG001|All Patients|Withdrawal by Subject|10|||
146525891|NCT01610037|528432939|FG002|All Patients|Withdrawal by Subject|20|||
146525892|NCT01610037|528432937|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
146760580|NCT04353037|529291009|FG001|Overall Study|Exposure Change|0|||
146760581|NCT04353037|529291010|FG002|Overall Study|Exposure Change|0|||
146760582|NCT04353037|529291011|FG003|Overall Study|Exposure Change|2|||
146525893|NCT01610037|528432938|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
146525894|NCT01610037|528432939|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
146525895|NCT01610037|528432937|FG000|All Patients|Death|4|||
146525896|NCT01610037|528432938|FG001|All Patients|Death|2|||
146525897|NCT01610037|528432939|FG002|All Patients|Death|1|||
146525898|NCT01610037|528432937|FG000|All Patients|Protocol deviation|4|||
146525899|NCT01610037|528432938|FG001|All Patients|Protocol deviation|3|||
146525900|NCT01610037|528432939|FG002|All Patients|Protocol deviation|3|||
146525901|NCT01610037|528432937|FG000|All Patients|Abnormal laboratory value|1|||
146525902|NCT01610037|528432938|FG001|All Patients|Abnormal laboratory value|1|||
146525903|NCT01610037|528432939|FG002|All Patients|Abnormal laboratory value|0|||
146525904|NCT01610037|528432937|FG000|All Patients|Administrative problems|1|||
146525905|NCT01610037|528432938|FG001|All Patients|Administrative problems|4|||
146525906|NCT01610037|528432939|FG002|All Patients|Administrative problems|4|||
146525907|NCT01610037|528432937|FG000|All Patients|Lost to Follow-up|1|||
146525908|NCT01610037|528432938|FG001|All Patients|Lost to Follow-up|0|||
146525909|NCT01610037|528432939|FG002|All Patients|Lost to Follow-up|0|||
146525910|NCT01610037|528432937|FG000|All Patients|Abnormal test procedure result(s)|0|||
146525911|NCT01610037|528432938|FG001|All Patients|Abnormal test procedure result(s)|1|||
146525912|NCT01610037|528432939|FG002|All Patients|Abnormal test procedure result(s)|3|||
146525913|NCT01610037|528432937|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
146525914|NCT01610037|528432938|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
146525915|NCT01610037|528432939|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
146525916|NCT01610037|528432937|FG000|Treatment and Follow up Period|Death|10|||
146525917|NCT01610037|528432938|FG001|Treatment and Follow up Period|Death|5|||
146525918|NCT01610037|528432939|FG002|Treatment and Follow up Period|Death|4|||
146525919|NCT01610037|528432937|FG000|Treatment and Follow up Period|Administrative problems|1|||
146525920|NCT01610037|528432938|FG001|Treatment and Follow up Period|Administrative problems|3|||
146525921|NCT01610037|528432939|FG002|Treatment and Follow up Period|Administrative problems|2|||
146525922|NCT01610037|528432937|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
146525923|NCT01610037|528432938|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
146525924|NCT01610037|528432939|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
146525925|NCT00705757|528432941|FG000|Overall Study|Lack of Efficacy|5|||
146525926|NCT00705757|528432942|FG001|Overall Study|Lack of Efficacy|1|||
146525927|NCT00705757|528432943|FG002|Overall Study|Lack of Efficacy|3|||
146525928|NCT00705757|528432941|FG000|Overall Study|Lost to Follow-up|7|||
146525929|NCT00705757|528432942|FG001|Overall Study|Lost to Follow-up|6|||
146525930|NCT00705757|528432943|FG002|Overall Study|Lost to Follow-up|6|||
146525931|NCT00705757|528432941|FG000|Overall Study|Withdrawal by Subject|1|||
146525932|NCT00705757|528432942|FG001|Overall Study|Withdrawal by Subject|1|||
146525933|NCT00705757|528432943|FG002|Overall Study|Withdrawal by Subject|2|||
146525934|NCT00661089|528432944|FG000|Overall Study|1 subject withdrawal|0|||
146525935|NCT00661089|528432945|FG001|Overall Study|1 subject withdrawal|1|||
146525936|NCT00661089|528432944|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
146525937|NCT00661089|528432945|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
146525938|NCT01443858|528432946|FG000|Overall Study|Withdrawal by Subject|9|||
146525939|NCT01443858|528432947|FG001|Overall Study|Withdrawal by Subject|8|||
146525940|NCT01443858|528432948|FG002|Overall Study|Withdrawal by Subject|5|||
146525941|NCT01443858|528432946|FG000|Overall Study|Lack of Efficacy|1|||
146525942|NCT01443858|528432947|FG001|Overall Study|Lack of Efficacy|0|||
146525943|NCT01443858|528432948|FG002|Overall Study|Lack of Efficacy|0|||
146525944|NCT01443858|528432946|FG000|Overall Study|Lost to Follow-up|5|||
146525945|NCT01443858|528432947|FG001|Overall Study|Lost to Follow-up|5|||
146525946|NCT01443858|528432948|FG002|Overall Study|Lost to Follow-up|2|||
146525947|NCT03361306|528432952|FG000|Overall Study|Death|6|||
146525948|NCT00321906|528432953|FG000|Overall Study|Adverse Event|36|||
146525949|NCT00321906|528432954|FG001|Overall Study|Adverse Event|44|||
146525950|NCT00321906|528432953|FG000|Overall Study|Death|9|||
146525951|NCT00321906|528432954|FG001|Overall Study|Death|6|||
146760583|NCT03710564|529291012|FG000|Overall Study|Study Terminated by Sponsor|104|||
146760584|NCT03710564|529291013|FG001|Overall Study|Study Terminated by Sponsor|55|||
146760585|NCT03710564|529291012|FG000|Overall Study|Withdrawal by Subject|57|||
146760586|NCT03710564|529291013|FG001|Overall Study|Withdrawal by Subject|25|||
146760587|NCT03710564|529291012|FG000|Overall Study|Death|10|||
146760588|NCT03710564|529291013|FG001|Overall Study|Death|4|||
146760589|NCT03710564|529291012|FG000|Overall Study|Lost to Follow-up|5|||
146760590|NCT03710564|529291013|FG001|Overall Study|Lost to Follow-up|4|||
146525952|NCT00321906|528432953|FG000|Overall Study|Lost to Follow-up|1|||
146525953|NCT00321906|528432954|FG001|Overall Study|Lost to Follow-up|2|||
146525954|NCT00321906|528432953|FG000|Overall Study|Withdrawal by Subject|0|||
146525955|NCT00321906|528432954|FG001|Overall Study|Withdrawal by Subject|4|||
146525956|NCT01272908|528432956|FG000|Initial Treatment Period|Adverse Event|1|||
146525957|NCT01272908|528432956|FG000|Initial Treatment Period|Lack of Efficacy|5|||
146525958|NCT01272908|528432956|FG000|Initial Treatment Period|Protocol Violation|1|||
146760591|NCT03710564|529291012|FG000|Overall Study|Protocol Violation|3|||
146760592|NCT03710564|529291013|FG001|Overall Study|Protocol Violation|2|||
146525959|NCT01272908|528432956|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
146525960|NCT01272908|528432956|FG000|Re-Treatment Period|Adverse Event|2|||
146525961|NCT01272908|528432956|FG000|Re-Treatment Period|Lack of Efficacy|3|||
146525962|NCT01272908|528432956|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
146525963|NCT02221648|528432957|FG000|Overall Study|Withdrawal by Subject|3|||
146525964|NCT02221648|528432958|FG001|Overall Study|Withdrawal by Subject|3|||
146525965|NCT00807885|528432959|FG000|Overall Study|Lost to Follow-up|0|||
146525966|NCT00807885|528432960|FG001|Overall Study|Lost to Follow-up|0|||
146525967|NCT00807885|528432961|FG002|Overall Study|Lost to Follow-up|0|||
146525968|NCT00807885|528432962|FG003|Overall Study|Lost to Follow-up|0|||
146525969|NCT00807885|528432963|FG004|Overall Study|Lost to Follow-up|0|||
146525970|NCT00807885|528432964|FG005|Overall Study|Lost to Follow-up|1|||
146525971|NCT00807885|528432965|FG006|Overall Study|Lost to Follow-up|0|||
146525972|NCT00807885|528432966|FG007|Overall Study|Lost to Follow-up|0|||
146525973|NCT00807885|528432967|FG008|Overall Study|Lost to Follow-up|0|||
146525974|NCT00810069|528432968|FG000|Lead-in Period I|Adverse Event|43|||
146525975|NCT00810069|528432969|FG001|Lead-in Period I|Adverse Event|0|||
146525976|NCT00810069|528432970|FG002|Lead-in Period I|Adverse Event|0|||
146525977|NCT00810069|528432968|FG000|Lead-in Period I|Lack of Efficacy|1|||
146525978|NCT00810069|528432969|FG001|Lead-in Period I|Lack of Efficacy|0|||
146525979|NCT00810069|528432970|FG002|Lead-in Period I|Lack of Efficacy|0|||
146525980|NCT00810069|528432968|FG000|Lead-in Period I|Lost to Follow-up|19|||
146525981|NCT00810069|528432969|FG001|Lead-in Period I|Lost to Follow-up|0|||
146525982|NCT00810069|528432970|FG002|Lead-in Period I|Lost to Follow-up|0|||
146525983|NCT00810069|528432968|FG000|Lead-in Period I|Physician Decision|1|||
146525984|NCT00810069|528432969|FG001|Lead-in Period I|Physician Decision|0|||
146525985|NCT00810069|528432970|FG002|Lead-in Period I|Physician Decision|0|||
146525986|NCT00810069|528432968|FG000|Lead-in Period I|Protocol Violation|1|||
146525987|NCT00810069|528432969|FG001|Lead-in Period I|Protocol Violation|0|||
146525988|NCT00810069|528432970|FG002|Lead-in Period I|Protocol Violation|0|||
146525989|NCT00810069|528432968|FG000|Lead-in Period I|Withdrawal by Subject|46|||
146525990|NCT00810069|528432969|FG001|Lead-in Period I|Withdrawal by Subject|0|||
146525991|NCT00810069|528432970|FG002|Lead-in Period I|Withdrawal by Subject|0|||
146525992|NCT00810069|528432968|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
146525993|NCT00810069|528432969|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
146525994|NCT00810069|528432970|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
146525995|NCT00810069|528432968|FG000|Lead-in Period I|Randomization criteria not met|158|||
146525996|NCT00810069|528432969|FG001|Lead-in Period I|Randomization criteria not met|0|||
146525997|NCT00810069|528432970|FG002|Lead-in Period I|Randomization criteria not met|0|||
146525998|NCT00810069|528432968|FG000|Double-Blind Period II|Adverse Event|0|||
146525999|NCT00810069|528432969|FG001|Double-Blind Period II|Adverse Event|9|||
146526000|NCT00810069|528432970|FG002|Double-Blind Period II|Adverse Event|8|||
146526001|NCT00810069|528432968|FG000|Double-Blind Period II|Lack of Efficacy|0|||
146526002|NCT00810069|528432969|FG001|Double-Blind Period II|Lack of Efficacy|7|||
146526003|NCT00810069|528432970|FG002|Double-Blind Period II|Lack of Efficacy|12|||
146526004|NCT00810069|528432968|FG000|Double-Blind Period II|Lost to Follow-up|0|||
146526005|NCT00810069|528432969|FG001|Double-Blind Period II|Lost to Follow-up|9|||
146526006|NCT00810069|528432970|FG002|Double-Blind Period II|Lost to Follow-up|9|||
146526007|NCT00810069|528432968|FG000|Double-Blind Period II|Physician Decision|0|||
146526008|NCT00810069|528432969|FG001|Double-Blind Period II|Physician Decision|0|||
146526009|NCT00810069|528432970|FG002|Double-Blind Period II|Physician Decision|1|||
146526010|NCT00810069|528432968|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
146526011|NCT00810069|528432969|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
146526012|NCT00810069|528432970|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
146526013|NCT00810069|528432968|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
146526014|NCT00810069|528432969|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
146526015|NCT00810069|528432970|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
146526016|NCT00810069|528432968|FG000|Double-Blind Period II|Clinical relapse|0|||
146526017|NCT00810069|528432969|FG001|Double-Blind Period II|Clinical relapse|3|||
146760593|NCT03710564|529291012|FG000|Overall Study|Adverse Event|3|||
146760594|NCT03710564|529291013|FG001|Overall Study|Adverse Event|0|||
146760595|NCT03710564|529291012|FG000|Overall Study|Physician Decision|2|||
146760596|NCT03710564|529291013|FG001|Overall Study|Physician Decision|3|||
146760597|NCT02993471|529291014|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
146760598|NCT02993471|529291014|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
146760599|NCT00770211|529291015|FG000|Overall Study|Lost to Follow-up|1|||
146760600|NCT00770211|529291016|FG001|Overall Study|Lost to Follow-up|0|||
146526018|NCT00810069|528432970|FG002|Double-Blind Period II|Clinical relapse|0|||
146526019|NCT00810069|528432968|FG000|Double-Blind Period II|Protocol Violation|0|||
146526020|NCT00810069|528432969|FG001|Double-Blind Period II|Protocol Violation|7|||
146526021|NCT00810069|528432970|FG002|Double-Blind Period II|Protocol Violation|6|||
146526022|NCT01705977|528432971|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
146526023|NCT01705977|528432972|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
146526024|NCT01705977|528432971|FG000|Treatment Period (Year 1)|Adverse Event|57|||
146760601|NCT00770211|529291015|FG000|Overall Study|Withdrawal by Subject|0|||
146860153|NCT00307125|529658390|FG002|Screening Phase|Developed acute leukemia|0|||
146860154|NCT00307125|529658388|FG000|Screening Phase|Metastatic colon cancer|1|||
146860155|NCT00307125|529658389|FG001|Screening Phase|Metastatic colon cancer|0|||
146860156|NCT00307125|529658390|FG002|Screening Phase|Metastatic colon cancer|0|||
146860157|NCT00307125|529658388|FG000|Screening Phase|Malignancy|1|||
146860158|NCT00307125|529658389|FG001|Screening Phase|Malignancy|0|||
146860159|NCT00307125|529658390|FG002|Screening Phase|Malignancy|0|||
146860160|NCT00307125|529658388|FG000|Screening Phase|PAK|1|||
146526025|NCT01705977|528432972|FG001|Treatment Period (Year 1)|Adverse Event|49|||
146526026|NCT01705977|528432971|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
146526027|NCT01705977|528432972|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
146526028|NCT01705977|528432971|FG000|Treatment Period (Year 1)|Site closure|3|||
146526029|NCT01705977|528432972|FG001|Treatment Period (Year 1)|Site closure|2|||
146526030|NCT01705977|528432971|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
146526031|NCT01705977|528432972|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
146526032|NCT01705977|528432971|FG000|Treatment Period (Year 1)|Physician Decision|48|||
146526033|NCT01705977|528432972|FG001|Treatment Period (Year 1)|Physician Decision|38|||
146526034|NCT01705977|528432971|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
146526035|NCT01705977|528432972|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
146526036|NCT01705977|528432971|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
146526037|NCT01705977|528432972|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
146526038|NCT01705977|528432971|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
146526039|NCT01705977|528432972|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
146526040|NCT01705977|528432971|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
146526041|NCT01705977|528432972|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
146526042|NCT01705977|528432971|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
146526043|NCT01705977|528432972|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
146526044|NCT01705977|528432971|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
146526045|NCT01705977|528432972|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
146526046|NCT02039778|528432975|FG000|Overall Study|Death|2|||
146526047|NCT02039778|528432975|FG000|Overall Study|Withdrawal by Subject|1|||
146526048|NCT02039778|528432975|FG000|Overall Study|Never started the protocol treatment|1|||
146526049|NCT01462110|528432982|FG000|Overall Study|Adverse Event|1|||
146526050|NCT01462110|528432983|FG001|Overall Study|Adverse Event|0|||
146526051|NCT00753675|528432984|FG000|Overall Study|other reason|11|||
146526052|NCT00753675|528432985|FG001|Overall Study|other reason|12|||
146526053|NCT00753675|528432986|FG002|Overall Study|other reason|13|||
146526054|NCT00753675|528432984|FG000|Overall Study|Death|1|||
146526055|NCT00753675|528432985|FG001|Overall Study|Death|2|||
146526056|NCT00753675|528432986|FG002|Overall Study|Death|4|||
146526057|NCT00753675|528432984|FG000|Overall Study|Adverse Event|11|||
146526058|NCT00753675|528432985|FG001|Overall Study|Adverse Event|9|||
146526059|NCT00753675|528432986|FG002|Overall Study|Adverse Event|4|||
146526060|NCT00753675|528432984|FG000|Overall Study|Objective progression of disease|35|||
146526061|NCT00753675|528432985|FG001|Overall Study|Objective progression of disease|35|||
146526062|NCT00753675|528432986|FG002|Overall Study|Objective progression of disease|35|||
146526063|NCT00753675|528432984|FG000|Overall Study|Withdrawal by Subject|0|||
146526064|NCT00753675|528432985|FG001|Overall Study|Withdrawal by Subject|1|||
146526065|NCT00753675|528432986|FG002|Overall Study|Withdrawal by Subject|0|||
146526066|NCT00753675|528432984|FG000|Overall Study|Lost to Follow-up|1|||
146526067|NCT00753675|528432985|FG001|Overall Study|Lost to Follow-up|0|||
146526068|NCT00753675|528432986|FG002|Overall Study|Lost to Follow-up|0|||
146526069|NCT05279131|528432988|FG000|Overall Study|Lost to Follow-up|1|||
146526070|NCT05279131|528432988|FG000|Overall Study|Death|1|||
146526071|NCT05279131|528432988|FG000|Overall Study|Physician Decision|1|||
146526072|NCT02149264|528432994|FG000|Overall Study|Withdrawal by Subject|9|||
146526073|NCT02149264|528432994|FG000|Overall Study|Adverse Event|7|||
146526074|NCT02149264|528432994|FG000|Overall Study|Physician Decision|3|||
146526075|NCT02149264|528432994|FG000|Overall Study|Protocol Violation|1|||
146526076|NCT00520039|528433001|FG000|Overall Study|Exclusion criteria met at first visit|7|||
146526077|NCT00520039|528433002|FG001|Overall Study|Exclusion criteria met at first visit|5|||
146526078|NCT02358031|528434635|FG000|Overall Study|Death|253|||
146526079|NCT02358031|528434636|FG001|Overall Study|Death|237|||
146526080|NCT02358031|528434637|FG002|Overall Study|Death|266|||
146526081|NCT02358031|528434635|FG000|Overall Study|Lost to Follow-up|1|||
146526082|NCT02358031|528434636|FG001|Overall Study|Lost to Follow-up|1|||
146860161|NCT00307125|529658389|FG001|Screening Phase|PAK|0|||
146860162|NCT00307125|529658390|FG002|Screening Phase|PAK|0|||
146860163|NCT00307125|529658388|FG000|Screening Phase|Ineligible|1|||
146526083|NCT02358031|528434637|FG002|Overall Study|Lost to Follow-up|0|||
146526084|NCT02358031|528434635|FG000|Overall Study|Withdrawal by Subject|19|||
146526085|NCT02358031|528434636|FG001|Overall Study|Withdrawal by Subject|14|||
146526086|NCT02358031|528434637|FG002|Overall Study|Withdrawal by Subject|18|||
146860164|NCT00307125|529658389|FG001|Screening Phase|Ineligible|0|||
146860165|NCT00307125|529658390|FG002|Screening Phase|Ineligible|0|||
146860166|NCT00307125|529658388|FG000|Screening Phase|Screen Error|1|||
146860167|NCT00307125|529658389|FG001|Screening Phase|Screen Error|0|||
146526087|NCT02358031|528434635|FG000|Overall Study|Sponsor Decision|26|||
146526088|NCT02358031|528434636|FG001|Overall Study|Sponsor Decision|28|||
146526089|NCT02358031|528434637|FG002|Overall Study|Sponsor Decision|16|||
146526090|NCT01212094|528434638|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
146526091|NCT01212094|528434639|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
146526092|NCT01212094|528434640|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
146526093|NCT01212094|528434638|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
146526094|NCT01212094|528434639|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
146526095|NCT01212094|528434640|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
146526096|NCT01212094|528434638|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
146526097|NCT01212094|528434639|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
146526098|NCT01212094|528434640|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
146526099|NCT01212094|528434638|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
146526100|NCT01212094|528434639|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
146526101|NCT01212094|528434640|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
146526102|NCT01212094|528434638|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
146526103|NCT01212094|528434639|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
146526104|NCT01212094|528434640|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
146526105|NCT01212094|528434638|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
146526106|NCT01212094|528434639|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
146526107|NCT01212094|528434640|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
146526108|NCT05664581|528434642|FG000|Overall Study|Withdrawal by Subject|2|||
146526109|NCT03101150|528434643|FG000|Overall Study|Lost to Follow-up|2|||
146526110|NCT03101150|528434644|FG001|Overall Study|Lost to Follow-up|4|||
146526111|NCT03101150|528434643|FG000|Overall Study|Miscarriage|3|||
146526112|NCT03101150|528434644|FG001|Overall Study|Miscarriage|6|||
146526113|NCT01317641|528434646|FG000|Overall Study|Not treated|0|||
146526114|NCT01317641|528434647|FG001|Overall Study|Not treated|0|||
146526115|NCT01317641|528434648|FG002|Overall Study|Not treated|0|||
146526116|NCT01317641|528434649|FG003|Overall Study|Not treated|0|||
146526117|NCT01317641|528434650|FG004|Overall Study|Not treated|0|||
146526118|NCT01317641|528434651|FG005|Overall Study|Not treated|0|||
146526119|NCT01317641|528434652|FG006|Overall Study|Not treated|0|||
146526120|NCT01317641|528434653|FG007|Overall Study|Not treated|1|||
146526121|NCT01317641|528434654|FG008|Overall Study|Not treated|1|||
146526122|NCT01317641|528434646|FG000|Overall Study|Adverse Event|0|||
146526123|NCT01317641|528434647|FG001|Overall Study|Adverse Event|1|||
146526124|NCT01317641|528434648|FG002|Overall Study|Adverse Event|0|||
146526125|NCT01317641|528434649|FG003|Overall Study|Adverse Event|1|||
146526126|NCT01317641|528434650|FG004|Overall Study|Adverse Event|0|||
146526127|NCT01317641|528434651|FG005|Overall Study|Adverse Event|0|||
146526128|NCT01317641|528434652|FG006|Overall Study|Adverse Event|2|||
146526129|NCT01317641|528434653|FG007|Overall Study|Adverse Event|1|||
146526130|NCT01317641|528434654|FG008|Overall Study|Adverse Event|0|||
146526131|NCT01317641|528434646|FG000|Overall Study|Protocol Violation|1|||
146526132|NCT01317641|528434647|FG001|Overall Study|Protocol Violation|0|||
146526133|NCT01317641|528434648|FG002|Overall Study|Protocol Violation|0|||
146526134|NCT01317641|528434649|FG003|Overall Study|Protocol Violation|0|||
146526135|NCT01317641|528434650|FG004|Overall Study|Protocol Violation|0|||
146526136|NCT01317641|528434651|FG005|Overall Study|Protocol Violation|0|||
146526137|NCT01317641|528434652|FG006|Overall Study|Protocol Violation|0|||
146526138|NCT01317641|528434653|FG007|Overall Study|Protocol Violation|0|||
146526139|NCT01317641|528434654|FG008|Overall Study|Protocol Violation|0|||
146526140|NCT01317641|528434646|FG000|Overall Study|Disease progression|0|||
146526141|NCT01317641|528434647|FG001|Overall Study|Disease progression|0|||
146526142|NCT01317641|528434648|FG002|Overall Study|Disease progression|0|||
146526143|NCT01317641|528434649|FG003|Overall Study|Disease progression|0|||
146526144|NCT01317641|528434650|FG004|Overall Study|Disease progression|0|||
146526145|NCT01317641|528434651|FG005|Overall Study|Disease progression|0|||
146526146|NCT01317641|528434652|FG006|Overall Study|Disease progression|0|||
146760602|NCT00770211|529291016|FG001|Overall Study|Withdrawal by Subject|2|||
146760603|NCT00318656|529291017|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
146760604|NCT00318656|529291018|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
146760605|NCT00318656|529291017|FG000|Overall Study|Did not receive any treatment|0|||
146760606|NCT00318656|529291018|FG001|Overall Study|Did not receive any treatment|1|||
146760607|NCT03905135|529291020|FG000|Dose Escalation|Adverse Event|1|||
146760608|NCT03905135|529291021|FG001|Dose Escalation|Adverse Event|1|||
146760609|NCT03905135|529291020|FG000|Dose Escalation|Progressive disease|3|||
146526147|NCT01317641|528434653|FG007|Overall Study|Disease progression|3|||
146526148|NCT01317641|528434654|FG008|Overall Study|Disease progression|4|||
146526149|NCT01317641|528434646|FG000|Overall Study|Withdrawal by Subject|0|||
146526150|NCT01317641|528434647|FG001|Overall Study|Withdrawal by Subject|0|||
146526151|NCT01317641|528434648|FG002|Overall Study|Withdrawal by Subject|0|||
146526152|NCT01317641|528434649|FG003|Overall Study|Withdrawal by Subject|0|||
146526153|NCT01317641|528434650|FG004|Overall Study|Withdrawal by Subject|0|||
146526154|NCT01317641|528434651|FG005|Overall Study|Withdrawal by Subject|0|||
146526155|NCT01317641|528434652|FG006|Overall Study|Withdrawal by Subject|1|||
146526156|NCT01317641|528434653|FG007|Overall Study|Withdrawal by Subject|0|||
146526157|NCT01317641|528434654|FG008|Overall Study|Withdrawal by Subject|0|||
146526158|NCT00715559|528434655|FG000|Overall Study|medication not tolerated - nausea|1|||
146526159|NCT02019550|528434656|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
146526160|NCT02019550|528434657|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
146526161|NCT02787304|528434660|FG000|Overall Study|Adverse Event|9|||
146526162|NCT02787304|528434661|FG001|Overall Study|Adverse Event|3|||
146526163|NCT02787304|528434662|FG002|Overall Study|Adverse Event|8|||
146526164|NCT02787304|528434663|FG003|Overall Study|Adverse Event|1|||
146526165|NCT02787304|528434660|FG000|Overall Study|Withdrawal by Subject|1|||
146526166|NCT02787304|528434661|FG001|Overall Study|Withdrawal by Subject|4|||
146526167|NCT02787304|528434662|FG002|Overall Study|Withdrawal by Subject|0|||
146526168|NCT02787304|528434663|FG003|Overall Study|Withdrawal by Subject|0|||
146526169|NCT02787304|528434660|FG000|Overall Study|Lost to Follow-up|1|||
146526170|NCT02787304|528434661|FG001|Overall Study|Lost to Follow-up|0|||
146526171|NCT02787304|528434662|FG002|Overall Study|Lost to Follow-up|0|||
146526172|NCT02787304|528434663|FG003|Overall Study|Lost to Follow-up|1|||
146526173|NCT02787304|528434660|FG000|Overall Study|Noncompliance with study drug|0|||
146526174|NCT02787304|528434661|FG001|Overall Study|Noncompliance with study drug|0|||
146526175|NCT02787304|528434662|FG002|Overall Study|Noncompliance with study drug|1|||
146526176|NCT02787304|528434663|FG003|Overall Study|Noncompliance with study drug|0|||
146526177|NCT02787304|528434660|FG000|Overall Study|Physician Decision|0|||
146526178|NCT02787304|528434661|FG001|Overall Study|Physician Decision|0|||
146526179|NCT02787304|528434662|FG002|Overall Study|Physician Decision|1|||
146526180|NCT02787304|528434663|FG003|Overall Study|Physician Decision|0|||
146526181|NCT02787304|528434660|FG000|Overall Study|Study terminated by sponsor|25|||
146526182|NCT02787304|528434661|FG001|Overall Study|Study terminated by sponsor|31|||
146526183|NCT02787304|528434662|FG002|Overall Study|Study terminated by sponsor|31|||
146526184|NCT02787304|528434663|FG003|Overall Study|Study terminated by sponsor|32|||
146526185|NCT04771013|528434664|FG000|Overall Study|Withdrawal by Subject|2|||
146526186|NCT04771013|528434665|FG001|Overall Study|Withdrawal by Subject|0|||
146526187|NCT04771013|528434664|FG000|Overall Study|Death|0|||
146526188|NCT04771013|528434665|FG001|Overall Study|Death|5|||
146526189|NCT04771013|528434664|FG000|Overall Study|Referred to another hospital before day 20|0|||
146526190|NCT04771013|528434665|FG001|Overall Study|Referred to another hospital before day 20|1|||
146526191|NCT00823134|528434667|FG000|Overall Study|Invalid measurement|1|||
146526192|NCT00419757|528434671|FG000|Overall Study|Adverse Event|1|||
146526193|NCT00419757|528434672|FG001|Overall Study|Adverse Event|4|||
146526194|NCT00419757|528434671|FG000|Overall Study|Lost to Follow-up|1|||
146526195|NCT00419757|528434672|FG001|Overall Study|Lost to Follow-up|4|||
146526196|NCT00419757|528434671|FG000|Overall Study|Withdrawal by Subject|7|||
146526197|NCT00419757|528434672|FG001|Overall Study|Withdrawal by Subject|1|||
146526198|NCT00419757|528434671|FG000|Overall Study|Protocol Violation|2|||
146526199|NCT00419757|528434672|FG001|Overall Study|Protocol Violation|3|||
146526200|NCT00419757|528434671|FG000|Overall Study|Study specific discontinuation criteria|4|||
146526201|NCT00419757|528434672|FG001|Overall Study|Study specific discontinuation criteria|8|||
146526202|NCT00419757|528434671|FG000|Overall Study|Multiple reasons|3|||
146526203|NCT00419757|528434672|FG001|Overall Study|Multiple reasons|1|||
146526204|NCT00379834|528434677|FG000|Overall Study|Time constraints|2|||
146526205|NCT01519817|528434678|FG000|Overall Study|Withdrawal by Subject|1|||
146526206|NCT01519817|528434679|FG001|Overall Study|Withdrawal by Subject|0|||
146526207|NCT01519817|528434680|FG002|Overall Study|Withdrawal by Subject|0|||
146526208|NCT01519817|528434681|FG003|Overall Study|Withdrawal by Subject|0|||
146526209|NCT01519817|528434678|FG000|Overall Study|Off study due to infection|0|||
146526210|NCT01519817|528434679|FG001|Overall Study|Off study due to infection|0|||
146526211|NCT01519817|528434680|FG002|Overall Study|Off study due to infection|0|||
146526212|NCT01519817|528434681|FG003|Overall Study|Off study due to infection|1|||
146526213|NCT02922153|528434682|FG000|Overall Study|Death|8|||
146526214|NCT02922153|528434683|FG001|Overall Study|Death|1|||
146526215|NCT02922153|528434682|FG000|Overall Study|Lost to Follow-up|1|||
146526216|NCT02922153|528434683|FG001|Overall Study|Lost to Follow-up|0|||
146526217|NCT02922153|528434682|FG000|Overall Study|Physician Decision|1|||
146526218|NCT02922153|528434683|FG001|Overall Study|Physician Decision|1|||
146526219|NCT01325350|528434688|FG000|Overall Study|Adverse Event|3|||
146526220|NCT01325350|528434689|FG001|Overall Study|Adverse Event|3|||
146526221|NCT01325350|528434690|FG002|Overall Study|Adverse Event|3|||
146526222|NCT01325350|528434691|FG003|Overall Study|Adverse Event|1|||
146526223|NCT01325350|528434692|FG004|Overall Study|Adverse Event|2|||
146526224|NCT01325350|528434688|FG000|Overall Study|Pregnancy|0|||
146526225|NCT01325350|528434689|FG001|Overall Study|Pregnancy|0|||
146526226|NCT01325350|528434690|FG002|Overall Study|Pregnancy|1|||
146526227|NCT01325350|528434691|FG003|Overall Study|Pregnancy|0|||
146526228|NCT01325350|528434692|FG004|Overall Study|Pregnancy|1|||
146526229|NCT01325350|528434688|FG000|Overall Study|Lost to Follow-up|1|||
146526230|NCT01325350|528434689|FG001|Overall Study|Lost to Follow-up|0|||
146526231|NCT01325350|528434690|FG002|Overall Study|Lost to Follow-up|5|||
146526232|NCT01325350|528434691|FG003|Overall Study|Lost to Follow-up|1|||
146526233|NCT01325350|528434692|FG004|Overall Study|Lost to Follow-up|5|||
146526234|NCT01325350|528434688|FG000|Overall Study|Personal Reasons|2|||
146526235|NCT01325350|528434689|FG001|Overall Study|Personal Reasons|1|||
146526236|NCT01325350|528434690|FG002|Overall Study|Personal Reasons|6|||
146526237|NCT01325350|528434691|FG003|Overall Study|Personal Reasons|5|||
146526238|NCT01325350|528434692|FG004|Overall Study|Personal Reasons|3|||
146526239|NCT01325350|528434688|FG000|Overall Study|Protocol Violation|0|||
146526240|NCT01325350|528434689|FG001|Overall Study|Protocol Violation|0|||
146526241|NCT01325350|528434690|FG002|Overall Study|Protocol Violation|0|||
146526242|NCT01325350|528434691|FG003|Overall Study|Protocol Violation|1|||
146526243|NCT01325350|528434692|FG004|Overall Study|Protocol Violation|0|||
146526244|NCT01325350|528434688|FG000|Overall Study|Withdrawal by Subject|0|||
146526245|NCT01325350|528434689|FG001|Overall Study|Withdrawal by Subject|0|||
146526246|NCT01325350|528434690|FG002|Overall Study|Withdrawal by Subject|1|||
146526247|NCT01325350|528434691|FG003|Overall Study|Withdrawal by Subject|1|||
146526248|NCT01325350|528434692|FG004|Overall Study|Withdrawal by Subject|0|||
146526249|NCT01325350|528434688|FG000|Overall Study|Did Not Receive Treatment|0|||
146526250|NCT01325350|528434689|FG001|Overall Study|Did Not Receive Treatment|1|||
146526251|NCT01325350|528434690|FG002|Overall Study|Did Not Receive Treatment|1|||
146526252|NCT01325350|528434691|FG003|Overall Study|Did Not Receive Treatment|0|||
146526253|NCT01325350|528434692|FG004|Overall Study|Did Not Receive Treatment|1|||
146526254|NCT01716806|528434697|FG000|Overall Study|Patient withdrawal of consent|4|||
146526255|NCT01716806|528434698|FG001|Overall Study|Patient withdrawal of consent|2|||
146526256|NCT01716806|528434699|FG002|Overall Study|Patient withdrawal of consent|4|||
146526257|NCT01716806|528434700|FG003|Overall Study|Patient withdrawal of consent|3|||
146526258|NCT01716806|528434701|FG004|Overall Study|Patient withdrawal of consent|2|||
146526259|NCT01716806|528434702|FG005|Overall Study|Patient withdrawal of consent|0|||
146526260|NCT01716806|528434697|FG000|Overall Study|Lost to Follow-up|3|||
146526261|NCT01716806|528434698|FG001|Overall Study|Lost to Follow-up|3|||
146526262|NCT01716806|528434699|FG002|Overall Study|Lost to Follow-up|0|||
146526263|NCT01716806|528434700|FG003|Overall Study|Lost to Follow-up|2|||
146526264|NCT01716806|528434701|FG004|Overall Study|Lost to Follow-up|1|||
146526265|NCT01716806|528434702|FG005|Overall Study|Lost to Follow-up|0|||
146526266|NCT01716806|528434697|FG000|Overall Study|Death|13|||
146526267|NCT01716806|528434698|FG001|Overall Study|Death|9|||
146526268|NCT01716806|528434699|FG002|Overall Study|Death|12|||
146526269|NCT01716806|528434700|FG003|Overall Study|Death|4|||
146526270|NCT01716806|528434701|FG004|Overall Study|Death|10|||
146526271|NCT01716806|528434702|FG005|Overall Study|Death|5|||
146526272|NCT01716806|528434697|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
146526273|NCT01716806|528434698|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
146526274|NCT01716806|528434699|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
146526275|NCT01716806|528434700|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
146526276|NCT01716806|528434701|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
146526277|NCT01716806|528434702|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
146526278|NCT01716806|528434697|FG000|Overall Study|PI decision|0|||
146526279|NCT01716806|528434698|FG001|Overall Study|PI decision|0|||
146526280|NCT01716806|528434699|FG002|Overall Study|PI decision|0|||
146526281|NCT01716806|528434700|FG003|Overall Study|PI decision|0|||
146526282|NCT01716806|528434701|FG004|Overall Study|PI decision|1|||
146526283|NCT01716806|528434702|FG005|Overall Study|PI decision|0|||
146526284|NCT01716806|528434697|FG000|Overall Study|Change in performance status|1|||
146526285|NCT01716806|528434698|FG001|Overall Study|Change in performance status|0|||
146526286|NCT01716806|528434699|FG002|Overall Study|Change in performance status|0|||
146526287|NCT01716806|528434700|FG003|Overall Study|Change in performance status|0|||
146526288|NCT01716806|528434701|FG004|Overall Study|Change in performance status|0|||
146526289|NCT01716806|528434702|FG005|Overall Study|Change in performance status|0|||
146526290|NCT01716806|528434697|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
146526291|NCT01716806|528434698|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
146526292|NCT01716806|528434699|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
146526293|NCT01716806|528434700|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
146526294|NCT01716806|528434701|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
146526295|NCT01716806|528434702|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
146760610|NCT03905135|529291021|FG001|Dose Escalation|Progressive disease|1|||
146760611|NCT03905135|529291020|FG000|Dose Escalation|Intercurrent illness|1|||
146760612|NCT03905135|529291021|FG001|Dose Escalation|Intercurrent illness|0|||
146760613|NCT02042443|529291024|FG000|Overall Study|Adverse Event|2|||
146760614|NCT02042443|529291025|FG001|Overall Study|Adverse Event|1|||
146526296|NCT01716806|528434697|FG000|Overall Study|Sponsor direction|7|||
146526297|NCT01716806|528434698|FG001|Overall Study|Sponsor direction|8|||
146526298|NCT01716806|528434699|FG002|Overall Study|Sponsor direction|5|||
146526299|NCT01716806|528434700|FG003|Overall Study|Sponsor direction|12|||
146526300|NCT01716806|528434701|FG004|Overall Study|Sponsor direction|16|||
146526301|NCT01716806|528434702|FG005|Overall Study|Sponsor direction|1|||
146526302|NCT02692586|528434703|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
146526303|NCT02692586|528434703|FG000|Overall Study|Received adjunctive thrombolytics|2|||
146526304|NCT03506438|528434704|FG000|Overall Study|Lost to Follow-up|8|||
146526305|NCT03506438|528434705|FG001|Overall Study|Lost to Follow-up|7|||
146526306|NCT03506438|528434706|FG002|Overall Study|Lost to Follow-up|8|||
146526307|NCT03506438|528434707|FG003|Overall Study|Lost to Follow-up|7|||
146526308|NCT03506438|528434708|FG004|Overall Study|Lost to Follow-up|0|||
146526309|NCT03506438|528434709|FG005|Overall Study|Lost to Follow-up|0|||
146526310|NCT01128296|528434710|FG000|Overall Study|Physician Decision|0|||
146526311|NCT01128296|528434711|FG001|Overall Study|Physician Decision|0|||
146526312|NCT01128296|528434712|FG002|Overall Study|Physician Decision|0|||
146526313|NCT01128296|528434713|FG003|Overall Study|Physician Decision|0|||
146526314|NCT01128296|528434714|FG004|Overall Study|Physician Decision|0|||
146526315|NCT01128296|528434715|FG005|Overall Study|Physician Decision|3|||
146526316|NCT01128296|528434710|FG000|Overall Study|Withdrawal by Subject|0|||
146526317|NCT01128296|528434711|FG001|Overall Study|Withdrawal by Subject|0|||
146526318|NCT01128296|528434712|FG002|Overall Study|Withdrawal by Subject|0|||
146526319|NCT01128296|528434713|FG003|Overall Study|Withdrawal by Subject|0|||
146526320|NCT01128296|528434714|FG004|Overall Study|Withdrawal by Subject|0|||
146526321|NCT01128296|528434715|FG005|Overall Study|Withdrawal by Subject|2|||
146526322|NCT03316586|528434720|FG000|Overall Study|Adverse Event|2|||
146526323|NCT03316586|528434720|FG000|Overall Study|Physician Decision|3|||
146526324|NCT03316586|528434720|FG000|Overall Study|Lack of Efficacy|10|||
146526325|NCT03316586|528434720|FG000|Overall Study|still on treatment|1|||
146526326|NCT03316586|528434720|FG000|Overall Study|Patient needed radiation therapy|1|||
146526327|NCT03316586|528434720|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
146526328|NCT00521365|528434743|FG000|Overall Study|Adverse Event|3|||
146526329|NCT00521365|528434743|FG000|Overall Study|Lost to Follow-up|6|||
146526330|NCT00521365|528434743|FG000|Overall Study|Protocol deviation|2|||
146526331|NCT00521365|528434743|FG000|Overall Study|Drug compliance|3|||
146526332|NCT00521365|528434743|FG000|Overall Study|Usage of not allowed drugs|6|||
146526333|NCT03150082|528434744|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
146526334|NCT03150082|528434745|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
146526335|NCT02119299|528434746|FG000|Overall Study|Withdrawal by Subject|7|||
146526336|NCT02119299|528434746|FG000|Overall Study|Lack of Efficacy|1|||
146526337|NCT02119299|528434746|FG000|Overall Study|Pregnancy|1|||
146526338|NCT02326272|528434747|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146526339|NCT02326272|528434748|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
146526340|NCT02326272|528434749|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
146526341|NCT02326272|528434750|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146526342|NCT02326272|528434751|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146526343|NCT02326272|528434752|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146526344|NCT02326272|528434753|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146526345|NCT02326272|528434754|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146526346|NCT02326272|528434755|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146526347|NCT02326272|528434756|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146526348|NCT02326272|528434757|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146526349|NCT02326272|528434758|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146526350|NCT02326272|528434759|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146526351|NCT02326272|528434760|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146526352|NCT02326272|528434761|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146526353|NCT02326272|528434747|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
146526354|NCT02326272|528434748|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
146526355|NCT02326272|528434749|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146526356|NCT02326272|528434750|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146526357|NCT02326272|528434751|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146526358|NCT02326272|528434752|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146526359|NCT02326272|528434753|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146526360|NCT02326272|528434754|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146526361|NCT02326272|528434755|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146526362|NCT02326272|528434756|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146526363|NCT02326272|528434757|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146526364|NCT02326272|528434758|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146526365|NCT02326272|528434759|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146526366|NCT02326272|528434760|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146526367|NCT02326272|528434761|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146526368|NCT02326272|528434747|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
146526369|NCT02326272|528434748|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
146526370|NCT02326272|528434749|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
146526371|NCT02326272|528434750|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146526372|NCT02326272|528434751|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146526373|NCT02326272|528434752|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146526374|NCT02326272|528434753|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146526375|NCT02326272|528434754|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146526376|NCT02326272|528434755|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146526377|NCT02326272|528434756|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146526378|NCT02326272|528434757|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146526379|NCT02326272|528434758|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146526380|NCT02326272|528434759|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146526381|NCT02326272|528434760|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146526382|NCT02326272|528434761|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146526383|NCT02326272|528434747|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
146526384|NCT02326272|528434748|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
146526385|NCT02326272|528434749|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
146526386|NCT02326272|528434750|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
146526387|NCT02326272|528434751|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
146526388|NCT02326272|528434752|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
146526389|NCT02326272|528434753|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
146526390|NCT02326272|528434754|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
146526391|NCT02326272|528434755|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
146526392|NCT02326272|528434756|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
146526393|NCT02326272|528434757|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
146526394|NCT02326272|528434758|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
146526395|NCT02326272|528434759|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
146526396|NCT02326272|528434760|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
146526397|NCT02326272|528434761|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
146526398|NCT02326272|528434747|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
146860168|NCT00307125|529658390|FG002|Screening Phase|Screen Error|0|||
146860169|NCT00307125|529658388|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
146860170|NCT00307125|529658389|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
146860171|NCT00307125|529658390|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
146860172|NCT00307125|529658388|FG000|Screening Phase|AMR and treated with rituximab|1|||
146860173|NCT00307125|529658389|FG001|Screening Phase|AMR and treated with rituximab|0|||
146860174|NCT00307125|529658390|FG002|Screening Phase|AMR and treated with rituximab|0|||
146526399|NCT02326272|528434748|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
146860175|NCT00307125|529658388|FG000|Screening Phase|Coronary artery bypass|1|||
146860176|NCT00307125|529658389|FG001|Screening Phase|Coronary artery bypass|0|||
146860177|NCT00307125|529658390|FG002|Screening Phase|Coronary artery bypass|0|||
146860178|NCT00307125|529658388|FG000|Pilot Phase|Lost to Follow-up|0|||
146860179|NCT00307125|529658389|FG001|Pilot Phase|Lost to Follow-up|1|||
146860180|NCT00307125|529658390|FG002|Pilot Phase|Lost to Follow-up|0|||
146860181|NCT00307125|529658388|FG000|Pilot Phase|Withdrawal by Subject|0|||
146860182|NCT00307125|529658389|FG001|Pilot Phase|Withdrawal by Subject|1|||
146860183|NCT00307125|529658390|FG002|Pilot Phase|Withdrawal by Subject|1|||
146860184|NCT00807235|529658391|FG000|Overall Study|Adverse Event|1|||
146860185|NCT00807235|529658392|FG001|Overall Study|Adverse Event|0|||
146860186|NCT00926211|529658393|FG000|Overall Study|Lost to Follow-up|1|||
146860187|NCT01032382|529658396|FG000|Overall Study|Disease dissemination|1|||
146526400|NCT02326272|528434749|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
146526401|NCT02326272|528434750|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
146526402|NCT02326272|528434751|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
146526403|NCT02326272|528434752|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
146526404|NCT02326272|528434753|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
146526405|NCT02326272|528434754|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
146526406|NCT02326272|528434755|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
146526407|NCT02326272|528434756|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
146526408|NCT02326272|528434757|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
146526409|NCT02326272|528434758|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
146526410|NCT02326272|528434759|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
146526411|NCT02326272|528434760|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
146526412|NCT02326272|528434761|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
146526413|NCT02326272|528434747|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
146860188|NCT01032382|529658397|FG001|Overall Study|Disease dissemination|1|||
146860189|NCT01032382|529658396|FG000|Overall Study|Treatment failure|3|||
146860190|NCT01032382|529658397|FG001|Overall Study|Treatment failure|1|||
146860191|NCT01032382|529658396|FG000|Overall Study|Index lesion relapse|1|||
146860192|NCT01032382|529658397|FG001|Overall Study|Index lesion relapse|3|||
146860193|NCT01201265|529658398|FG000|Overall Study|Death|14|||
146860194|NCT01201265|529658398|FG000|Overall Study|Insufficient Therapeutic Response|3|||
146965092|NCT03110107|530033430|FG004|Treatment Period|Adverse Event|0|||
146526414|NCT02326272|528434748|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
146526415|NCT02326272|528434749|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
146526416|NCT02326272|528434750|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
146526417|NCT02326272|528434751|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
146526418|NCT02326272|528434752|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
146526419|NCT02326272|528434753|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
146526420|NCT02326272|528434754|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
146526421|NCT02326272|528434755|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
146526422|NCT02326272|528434756|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
146760615|NCT02042443|529291024|FG000|Overall Study|Withdrawal by Subject|0|||
146760616|NCT02042443|529291025|FG001|Overall Study|Withdrawal by Subject|1|||
146760617|NCT02042443|529291024|FG000|Overall Study|Progression|21|||
146760618|NCT02042443|529291025|FG001|Overall Study|Progression|17|||
146760619|NCT02042443|529291024|FG000|Overall Study|not protocol specified|1|||
146760620|NCT02042443|529291025|FG001|Overall Study|not protocol specified|1|||
146760621|NCT02042443|529291024|FG000|Overall Study|Not eligible/not analyzable|3|||
146760622|NCT02042443|529291025|FG001|Overall Study|Not eligible/not analyzable|6|||
146760623|NCT01007149|529291028|FG000|Overall Study|Administrative problems|0|||
146760624|NCT01007149|529291029|FG001|Overall Study|Administrative problems|1|||
146760625|NCT02784704|529291030|FG000|Overall Study|Adverse Event|4|||
146760626|NCT02784704|529291031|FG001|Overall Study|Adverse Event|2|||
146760627|NCT02784704|529291030|FG000|Overall Study|Lost to Follow-up|6|||
146760628|NCT02784704|529291031|FG001|Overall Study|Lost to Follow-up|4|||
146760629|NCT02784704|529291030|FG000|Overall Study|Withdrawal by Subject|1|||
146760630|NCT02784704|529291031|FG001|Overall Study|Withdrawal by Subject|3|||
146760631|NCT02784704|529291030|FG000|Overall Study|Subject Non Compliance|2|||
146760632|NCT02784704|529291031|FG001|Overall Study|Subject Non Compliance|0|||
146760633|NCT01913340|529291032|FG000|Overall Study|Death|2|||
146760634|NCT01913340|529291033|FG001|Overall Study|Death|5|||
146760635|NCT01913340|529291032|FG000|Overall Study|Lost to Follow-up|1|||
146760636|NCT01913340|529291033|FG001|Overall Study|Lost to Follow-up|1|||
146760637|NCT05096884|529291035|FG000|Overall Study|Excluded based on negative tilt table test|4|||
146760638|NCT03568162|529291036|FG000|Overall Study|Adverse Event|0|||
146760639|NCT03568162|529291037|FG001|Overall Study|Adverse Event|1|||
146760640|NCT03568162|529291038|FG002|Overall Study|Adverse Event|2|||
146760641|NCT03568162|529291039|FG003|Overall Study|Adverse Event|0|||
146760642|NCT03568162|529291040|FG004|Overall Study|Adverse Event|0|||
146760643|NCT03568162|529291041|FG005|Overall Study|Adverse Event|1|||
146760644|NCT03568162|529291036|FG000|Overall Study|Death|0|||
146760645|NCT03568162|529291037|FG001|Overall Study|Death|0|||
146760646|NCT03568162|529291038|FG002|Overall Study|Death|0|||
146760647|NCT03568162|529291039|FG003|Overall Study|Death|0|||
146760648|NCT03568162|529291040|FG004|Overall Study|Death|1|||
146760649|NCT03568162|529291041|FG005|Overall Study|Death|0|||
146760650|NCT03568162|529291036|FG000|Overall Study|Lost to Follow-up|3|||
146760651|NCT03568162|529291037|FG001|Overall Study|Lost to Follow-up|2|||
146760652|NCT03568162|529291038|FG002|Overall Study|Lost to Follow-up|4|||
146760653|NCT03568162|529291039|FG003|Overall Study|Lost to Follow-up|2|||
146760654|NCT03568162|529291040|FG004|Overall Study|Lost to Follow-up|3|||
146760655|NCT03568162|529291041|FG005|Overall Study|Lost to Follow-up|2|||
146760656|NCT03568162|529291036|FG000|Overall Study|Physician Decision|0|||
146760657|NCT03568162|529291037|FG001|Overall Study|Physician Decision|1|||
146760658|NCT03568162|529291038|FG002|Overall Study|Physician Decision|1|||
146760659|NCT03568162|529291039|FG003|Overall Study|Physician Decision|0|||
146760660|NCT03568162|529291040|FG004|Overall Study|Physician Decision|1|||
146760661|NCT03568162|529291041|FG005|Overall Study|Physician Decision|0|||
146760662|NCT03568162|529291036|FG000|Overall Study|Pregnancy|0|||
146760663|NCT03568162|529291037|FG001|Overall Study|Pregnancy|0|||
146760664|NCT03568162|529291038|FG002|Overall Study|Pregnancy|0|||
146760665|NCT03568162|529291039|FG003|Overall Study|Pregnancy|1|||
146760666|NCT03568162|529291040|FG004|Overall Study|Pregnancy|0|||
146760667|NCT03568162|529291041|FG005|Overall Study|Pregnancy|0|||
146760668|NCT03568162|529291036|FG000|Overall Study|Protocol Violation|1|||
146760669|NCT03568162|529291037|FG001|Overall Study|Protocol Violation|0|||
146760670|NCT03568162|529291038|FG002|Overall Study|Protocol Violation|1|||
146760671|NCT03568162|529291039|FG003|Overall Study|Protocol Violation|1|||
146760672|NCT03568162|529291040|FG004|Overall Study|Protocol Violation|1|||
146760673|NCT03568162|529291041|FG005|Overall Study|Protocol Violation|1|||
146760674|NCT03568162|529291036|FG000|Overall Study|Withdrawal by Subject|15|||
146760675|NCT03568162|529291037|FG001|Overall Study|Withdrawal by Subject|15|||
146760676|NCT03568162|529291038|FG002|Overall Study|Withdrawal by Subject|26|||
146760677|NCT03568162|529291039|FG003|Overall Study|Withdrawal by Subject|22|||
146760678|NCT03568162|529291040|FG004|Overall Study|Withdrawal by Subject|6|||
146760679|NCT03568162|529291041|FG005|Overall Study|Withdrawal by Subject|9|||
146760680|NCT03568162|529291036|FG000|Overall Study|Others|3|||
146760681|NCT03568162|529291037|FG001|Overall Study|Others|4|||
146760682|NCT03568162|529291038|FG002|Overall Study|Others|1|||
146526423|NCT02326272|528434757|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
146526424|NCT02326272|528434758|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
146526425|NCT02326272|528434759|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
146526426|NCT02326272|528434760|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
146526427|NCT02326272|528434761|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
146526428|NCT02326272|528434747|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
146526429|NCT02326272|528434748|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
146526430|NCT02326272|528434749|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
146526431|NCT02326272|528434750|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
146526432|NCT02326272|528434751|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
146526433|NCT02326272|528434752|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
146526434|NCT02326272|528434753|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
146526435|NCT02326272|528434754|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
146526436|NCT02326272|528434755|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
146526437|NCT02326272|528434756|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
146526438|NCT02326272|528434757|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
146526439|NCT02326272|528434758|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
146526440|NCT02326272|528434759|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
146526441|NCT02326272|528434760|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
146526442|NCT02326272|528434761|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
146526443|NCT02326272|528434747|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146526444|NCT02326272|528434748|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146526445|NCT02326272|528434749|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146526446|NCT02326272|528434750|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146526447|NCT02326272|528434751|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
146526448|NCT02326272|528434752|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
146526449|NCT02326272|528434753|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
146526450|NCT02326272|528434754|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
146526451|NCT02326272|528434755|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
146526452|NCT02326272|528434756|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146526453|NCT02326272|528434757|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146526454|NCT02326272|528434758|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146526455|NCT02326272|528434759|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146526456|NCT02326272|528434760|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146526457|NCT02326272|528434761|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146526458|NCT02326272|528434747|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146526459|NCT02326272|528434748|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146526460|NCT02326272|528434749|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146526461|NCT02326272|528434750|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146526462|NCT02326272|528434751|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146760683|NCT03568162|529291039|FG003|Overall Study|Others|4|||
146760684|NCT03568162|529291040|FG004|Overall Study|Others|2|||
146760685|NCT03568162|529291041|FG005|Overall Study|Others|1|||
146760686|NCT03781804|529291042|FG000|Overall Study|Adverse Event|2|||
146760687|NCT03781804|529291043|FG001|Overall Study|Adverse Event|2|||
146760688|NCT03781804|529291044|FG002|Overall Study|Adverse Event|3|||
146760689|NCT03781804|529291042|FG000|Overall Study|Lost to Follow-up|1|||
146760690|NCT03781804|529291043|FG001|Overall Study|Lost to Follow-up|1|||
146760691|NCT03781804|529291044|FG002|Overall Study|Lost to Follow-up|2|||
146760692|NCT03781804|529291042|FG000|Overall Study|Lack of Efficacy|4|||
146760693|NCT03781804|529291043|FG001|Overall Study|Lack of Efficacy|2|||
146760694|NCT03781804|529291044|FG002|Overall Study|Lack of Efficacy|9|||
146760695|NCT03781804|529291042|FG000|Overall Study|Protocol Violation|0|||
146760696|NCT03781804|529291043|FG001|Overall Study|Protocol Violation|0|||
146760697|NCT03781804|529291044|FG002|Overall Study|Protocol Violation|1|||
146760698|NCT03781804|529291042|FG000|Overall Study|Withdrawal by Subject|0|||
146760699|NCT03781804|529291043|FG001|Overall Study|Withdrawal by Subject|1|||
146760700|NCT03781804|529291044|FG002|Overall Study|Withdrawal by Subject|1|||
146760701|NCT03781804|529291042|FG000|Overall Study|Reason not provided|2|||
146760702|NCT03781804|529291043|FG001|Overall Study|Reason not provided|2|||
146760703|NCT03781804|529291044|FG002|Overall Study|Reason not provided|0|||
146760704|NCT00768066|529291045|FG000|Overall Study|Did not receive study product injection.|3|||
146760705|NCT00768066|529291046|FG001|Overall Study|Did not receive study product injection.|3|||
146760706|NCT00768066|529291047|FG002|Overall Study|Did not receive study product injection.|0|||
146760707|NCT04831775|529291048|FG000|Overall Study|Lost to Follow-up|11|||
146760708|NCT04831775|529291049|FG001|Overall Study|Lost to Follow-up|13|||
146526463|NCT02326272|528434752|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
146526464|NCT02326272|528434753|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
146526465|NCT02326272|528434754|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146526466|NCT02326272|528434755|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
146526467|NCT02326272|528434756|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
146526468|NCT02326272|528434757|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146526469|NCT02326272|528434758|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146526470|NCT02326272|528434759|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146526471|NCT02326272|528434760|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146526472|NCT02326272|528434761|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146526473|NCT02326272|528434747|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146526474|NCT02326272|528434748|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146526475|NCT02326272|528434749|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146526476|NCT02326272|528434750|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146526477|NCT02326272|528434751|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146526478|NCT02326272|528434752|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
146526479|NCT02326272|528434753|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146526480|NCT02326272|528434754|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
146526481|NCT02326272|528434755|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146526482|NCT02326272|528434756|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146526483|NCT02326272|528434757|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146526484|NCT02326272|528434758|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146526485|NCT02326272|528434759|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146526486|NCT02326272|528434760|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146526487|NCT02326272|528434761|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146526488|NCT02326272|528434747|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146526489|NCT02326272|528434748|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146526490|NCT02326272|528434749|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146526491|NCT02326272|528434750|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146526492|NCT02326272|528434751|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146526493|NCT02326272|528434752|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
146526494|NCT02326272|528434753|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146526495|NCT02326272|528434754|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146526496|NCT02326272|528434755|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146526497|NCT02326272|528434756|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146526498|NCT02326272|528434757|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146526499|NCT02326272|528434758|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146526500|NCT02326272|528434759|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146526501|NCT02326272|528434760|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146526502|NCT02326272|528434761|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146526503|NCT02326272|528434747|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
146526504|NCT02326272|528434748|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
146526505|NCT02326272|528434749|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
146526506|NCT02326272|528434750|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
146526507|NCT02326272|528434751|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
146526508|NCT02326272|528434752|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
146526509|NCT02326272|528434753|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
146526510|NCT02326272|528434754|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
146526511|NCT02326272|528434755|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
146526512|NCT02326272|528434756|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
146526513|NCT02326272|528434757|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
146526514|NCT02326272|528434758|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
146526515|NCT02326272|528434759|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
146526516|NCT02326272|528434760|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
146526517|NCT02326272|528434761|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
146760709|NCT00337818|529291050|FG000|Overall Study|Lost to Follow-up|289|||
146760710|NCT00337818|529291051|FG001|Overall Study|Lost to Follow-up|91|||
146760711|NCT00337818|529291052|FG002|Overall Study|Lost to Follow-up|107|||
146760712|NCT04678830|529291053|FG000|Overall Study|Lack of Efficacy|2|||
146760713|NCT04678830|529291054|FG001|Overall Study|Lack of Efficacy|0|||
146760714|NCT04678830|529291053|FG000|Overall Study|Withdrawal by Subject|0|||
146760715|NCT04678830|529291054|FG001|Overall Study|Withdrawal by Subject|1|||
146760716|NCT05550337|529291055|FG000|Overall Study|Lack of Efficacy|0|||
146760717|NCT05550337|529291056|FG001|Overall Study|Lack of Efficacy|0|||
146526518|NCT02326272|528434747|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146526519|NCT02326272|528434748|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146526520|NCT02326272|528434749|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146526521|NCT02326272|528434750|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146526522|NCT02326272|528434751|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146526523|NCT02326272|528434752|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146526524|NCT02326272|528434753|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
146526525|NCT02326272|528434754|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146860195|NCT01201265|529658398|FG000|Overall Study|Lost to Follow-up|10|||
146860196|NCT01201265|529658398|FG000|Overall Study|Withdrawal by Subject|7|||
146860197|NCT01201265|529658398|FG000|Overall Study|Disease Progression|4|||
146860198|NCT03343301|529658399|FG000|Overall Study|Withdrawal by Subject|1|||
146860199|NCT03343301|529658400|FG001|Overall Study|Withdrawal by Subject|1|||
146860200|NCT03343301|529658399|FG000|Overall Study|Death|0|||
146860201|NCT03343301|529658400|FG001|Overall Study|Death|2|||
146860202|NCT03343301|529658399|FG000|Overall Study|Other|0|||
146860203|NCT03343301|529658400|FG001|Overall Study|Other|6|||
146860204|NCT03343301|529658399|FG000|Overall Study|Missing|2|||
146860205|NCT03343301|529658400|FG001|Overall Study|Missing|0|||
146860206|NCT00723021|529658411|FG000|Intervention Period 4|Adverse Event|0|||
146760718|NCT05550337|529291057|FG002|Overall Study|Lack of Efficacy|1|||
146760719|NCT05550337|529291055|FG000|Overall Study|Adverse Event|1|||
146760720|NCT05550337|529291056|FG001|Overall Study|Adverse Event|5|||
146760721|NCT05550337|529291057|FG002|Overall Study|Adverse Event|0|||
146760722|NCT05550337|529291055|FG000|Overall Study|Withdrawal by Subject|8|||
146760723|NCT05550337|529291056|FG001|Overall Study|Withdrawal by Subject|14|||
146760724|NCT05550337|529291057|FG002|Overall Study|Withdrawal by Subject|10|||
146760725|NCT05550337|529291055|FG000|Overall Study|Pregnancy|0|||
146860207|NCT00723021|529658412|FG001|Intervention Period 4|Adverse Event|0|||
146860208|NCT00723021|529658413|FG002|Intervention Period 4|Adverse Event|0|||
146860209|NCT00723021|529658414|FG003|Intervention Period 4|Adverse Event|0|||
146860210|NCT00723021|529658415|FG004|Intervention Period 4|Adverse Event|1|||
146860211|NCT04002401|529658418|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
146860212|NCT04002401|529658418|FG000|Overall Study|Death|10|||
146860213|NCT04002401|529658418|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
146860214|NCT04002401|529658418|FG000|Overall Study|Enrolled but Never Treated|1|||
146526526|NCT02326272|528434755|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146526527|NCT02326272|528434756|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146526528|NCT02326272|528434757|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146526529|NCT02326272|528434758|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146526530|NCT02326272|528434759|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146526531|NCT02326272|528434760|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146526532|NCT02326272|528434761|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146526533|NCT02326272|528434747|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
146526534|NCT02326272|528434748|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
146526535|NCT02326272|528434749|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
146526536|NCT02326272|528434750|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
146526537|NCT02326272|528434751|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
146526538|NCT02326272|528434752|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
146526539|NCT02326272|528434753|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
146526540|NCT02326272|528434754|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
146526541|NCT02326272|528434755|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
146526542|NCT02326272|528434756|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
146526543|NCT02326272|528434757|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
146526544|NCT02326272|528434758|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
146526545|NCT02326272|528434759|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
146526546|NCT02326272|528434760|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
146526547|NCT02326272|528434761|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
146760726|NCT05550337|529291056|FG001|Overall Study|Pregnancy|0|||
146760727|NCT05550337|529291057|FG002|Overall Study|Pregnancy|1|||
146760728|NCT05550337|529291055|FG000|Overall Study|Protocol Violation|1|||
146760729|NCT05550337|529291056|FG001|Overall Study|Protocol Violation|3|||
146760730|NCT05550337|529291057|FG002|Overall Study|Protocol Violation|4|||
146526548|NCT02326272|528434747|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146526549|NCT02326272|528434748|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146760731|NCT05550337|529291055|FG000|Overall Study|Physician Decision|2|||
146760732|NCT05550337|529291056|FG001|Overall Study|Physician Decision|1|||
146860215|NCT04002401|529658418|FG000|Overall Study|Lost to Follow-up|1|||
146860216|NCT02337751|529658419|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
146860217|NCT02337751|529658420|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
146860218|NCT02337751|529658419|FG000|Overall Study|Voluntary Withdrawal|6|||
146860219|NCT02337751|529658420|FG001|Overall Study|Voluntary Withdrawal|8|||
146760733|NCT05550337|529291057|FG002|Overall Study|Physician Decision|1|||
146860220|NCT02337751|529658419|FG000|Overall Study|Lack of Efficacy|2|||
146860221|NCT02337751|529658420|FG001|Overall Study|Lack of Efficacy|5|||
146860222|NCT02337751|529658419|FG000|Overall Study|Investigator's Judgement|1|||
146860223|NCT02337751|529658420|FG001|Overall Study|Investigator's Judgement|0|||
146860224|NCT02881957|529658425|FG000|Overall Study|Comfort care|0|||
146860225|NCT02881957|529658426|FG001|Overall Study|Comfort care|1|||
146860226|NCT02881957|529658425|FG000|Overall Study|Concurrent trial enrollment|0|||
146860227|NCT02881957|529658426|FG001|Overall Study|Concurrent trial enrollment|1|||
146860228|NCT02881957|529658425|FG000|Overall Study|Discharged within 48 hours|0|||
146860229|NCT02881957|529658426|FG001|Overall Study|Discharged within 48 hours|1|||
146860230|NCT02881957|529658425|FG000|Overall Study|Withdrawal by Subject|2|||
146860231|NCT02881957|529658426|FG001|Overall Study|Withdrawal by Subject|1|||
146860232|NCT02881957|529658425|FG000|Overall Study|Protocol Violation|1|||
146860233|NCT02881957|529658426|FG001|Overall Study|Protocol Violation|0|||
146860234|NCT00959647|529658433|FG000|Overall Study|Adverse Event|2|||
146860235|NCT00959647|529658433|FG000|Overall Study|Progressive disease|6|||
146860236|NCT00959647|529658433|FG000|Overall Study|Study terminated by sponsor|4|||
146526550|NCT02326272|528434749|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146526551|NCT02326272|528434750|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146526552|NCT02326272|528434751|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146526553|NCT02326272|528434752|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
146526554|NCT02326272|528434753|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
146526555|NCT02326272|528434754|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
146526556|NCT02326272|528434755|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
146526557|NCT02326272|528434756|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146526558|NCT02326272|528434757|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146526559|NCT02326272|528434758|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146526560|NCT02326272|528434759|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146526561|NCT02326272|528434760|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146526562|NCT02326272|528434761|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146526563|NCT02326272|528434747|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
146526564|NCT02326272|528434748|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
146526565|NCT02326272|528434749|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
146526566|NCT02326272|528434750|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
146526567|NCT02326272|528434751|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
146526568|NCT02326272|528434752|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
146526569|NCT02326272|528434753|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
146526570|NCT02326272|528434754|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
146526571|NCT02326272|528434755|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
146526572|NCT02326272|528434756|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
146526573|NCT02326272|528434757|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
146526574|NCT02326272|528434758|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
146526575|NCT02326272|528434759|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
146526576|NCT02326272|528434760|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
146526577|NCT02326272|528434761|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
146526578|NCT02326272|528434747|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
146526579|NCT02326272|528434748|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
146526580|NCT02326272|528434749|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
146526581|NCT02326272|528434750|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
146526582|NCT02326272|528434751|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
146526583|NCT02326272|528434752|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
146526584|NCT02326272|528434753|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
146526585|NCT02326272|528434754|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
146526586|NCT02326272|528434755|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
146526587|NCT02326272|528434756|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
146526588|NCT02326272|528434757|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
146526589|NCT02326272|528434758|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
146526590|NCT02326272|528434759|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
146526591|NCT02326272|528434760|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
146568718|NCT00328172|528595432|FG001|Overall Study|Lack of Efficacy|9|||
146860237|NCT00959647|529658433|FG000|Overall Study|Withdrawal by Subject|7|||
146860238|NCT05959629|529658436|FG000|Overall Study|partially necrotic/technical issues|2|||
146860239|NCT05959629|529658437|FG001|Overall Study|partially necrotic/technical issues|2|||
146526592|NCT02326272|528434761|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
146526593|NCT02326272|528434747|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
146526594|NCT02326272|528434748|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
146526595|NCT02326272|528434749|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
146526596|NCT02326272|528434750|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
146526597|NCT02326272|528434751|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
146526598|NCT02326272|528434752|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
146526599|NCT02326272|528434753|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
146526600|NCT02326272|528434754|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
146526601|NCT02326272|528434755|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
146526602|NCT02326272|528434756|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
146526603|NCT02326272|528434757|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
146526604|NCT02326272|528434758|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
146526605|NCT02326272|528434759|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
146526606|NCT02326272|528434760|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
146526607|NCT02326272|528434761|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
146526608|NCT02326272|528434747|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146526609|NCT02326272|528434748|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146526610|NCT02326272|528434749|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146526611|NCT02326272|528434750|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146526612|NCT02326272|528434751|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146526613|NCT02326272|528434752|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146526614|NCT02326272|528434753|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146526615|NCT02326272|528434754|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146526616|NCT02326272|528434755|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146526617|NCT02326272|528434756|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146526618|NCT02326272|528434757|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
146526619|NCT02326272|528434758|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
146526620|NCT02326272|528434759|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
146526621|NCT02326272|528434760|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146526622|NCT02326272|528434761|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
146526623|NCT02326272|528434747|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146526624|NCT02326272|528434748|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146526625|NCT02326272|528434749|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146526626|NCT02326272|528434750|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146526627|NCT02326272|528434751|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146526628|NCT02326272|528434752|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146526629|NCT02326272|528434753|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146526630|NCT02326272|528434754|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146526631|NCT02326272|528434755|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146526632|NCT02326272|528434756|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146526633|NCT02326272|528434757|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
146526634|NCT02326272|528434758|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146526635|NCT02326272|528434759|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
146526636|NCT02326272|528434760|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146526637|NCT02326272|528434761|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146526638|NCT02326272|528434747|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146526639|NCT02326272|528434748|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146526640|NCT02326272|528434749|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146526641|NCT02326272|528434750|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146526642|NCT02326272|528434751|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146526643|NCT02326272|528434752|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146526644|NCT02326272|528434753|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146526645|NCT02326272|528434754|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146526646|NCT02326272|528434755|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146526647|NCT02326272|528434756|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146526648|NCT02326272|528434757|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146526649|NCT02326272|528434758|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
146526650|NCT02326272|528434759|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146526651|NCT02326272|528434760|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146526652|NCT02326272|528434761|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146526653|NCT02326272|528434747|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146526654|NCT02326272|528434748|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146760734|NCT05550337|529291055|FG000|Overall Study|Lost to Follow-up|16|||
146760735|NCT05550337|529291056|FG001|Overall Study|Lost to Follow-up|11|||
146760736|NCT05550337|529291057|FG002|Overall Study|Lost to Follow-up|11|||
146526655|NCT02326272|528434749|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146526656|NCT02326272|528434750|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146526657|NCT02326272|528434751|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146526658|NCT02326272|528434752|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146526659|NCT02326272|528434753|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146526660|NCT02326272|528434754|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146526661|NCT02326272|528434755|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146526662|NCT02326272|528434756|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146526663|NCT02326272|528434757|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
146526664|NCT02326272|528434758|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146526665|NCT02326272|528434759|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
146526666|NCT02326272|528434760|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146526667|NCT02326272|528434761|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
146526668|NCT02326272|528434747|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146526669|NCT02326272|528434748|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146526670|NCT02326272|528434749|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146526671|NCT02326272|528434750|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146526672|NCT02326272|528434751|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146526673|NCT02326272|528434752|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146526674|NCT02326272|528434753|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146526675|NCT02326272|528434754|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146526676|NCT02326272|528434755|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146526677|NCT02326272|528434756|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146526678|NCT02326272|528434757|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146526679|NCT02326272|528434758|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
146526680|NCT02326272|528434759|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146526681|NCT02326272|528434760|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146526682|NCT02326272|528434761|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
146526683|NCT02326272|528434747|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146526684|NCT02326272|528434748|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146526685|NCT02326272|528434749|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146526686|NCT02326272|528434750|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146526687|NCT02326272|528434751|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146526688|NCT02326272|528434752|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146526689|NCT02326272|528434753|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146526690|NCT02326272|528434754|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146526691|NCT02326272|528434755|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146526692|NCT02326272|528434756|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146526693|NCT02326272|528434757|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146526694|NCT02326272|528434758|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
146526695|NCT02326272|528434759|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
146526696|NCT02326272|528434760|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146526697|NCT02326272|528434761|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
146526698|NCT02326272|528434747|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
146526699|NCT02326272|528434748|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
146526700|NCT02326272|528434749|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
146526701|NCT02326272|528434750|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
146526702|NCT02326272|528434751|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
146526703|NCT02326272|528434752|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
146526704|NCT02326272|528434753|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
146526705|NCT02326272|528434754|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
146526706|NCT02326272|528434755|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
146526707|NCT02326272|528434756|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
146526708|NCT02326272|528434757|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
146526709|NCT02326272|528434758|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
146526710|NCT02326272|528434759|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
146526711|NCT02326272|528434760|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
146526712|NCT02326272|528434761|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
146526713|NCT02326272|528434747|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
146526714|NCT02326272|528434748|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
146526715|NCT02326272|528434749|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
146526716|NCT02326272|528434750|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
146568719|NCT00328172|528595433|FG002|Overall Study|Lack of Efficacy|4|||
146568720|NCT00328172|528595434|FG003|Overall Study|Lack of Efficacy|4|||
146526717|NCT02326272|528434751|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
146526718|NCT02326272|528434752|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
146860240|NCT01717989|529659826|FG000|Overall Study|Ineligibility determined|6|||
146526719|NCT02326272|528434753|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
146526720|NCT02326272|528434754|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
146526721|NCT02326272|528434755|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
146526722|NCT02326272|528434756|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
146526723|NCT02326272|528434757|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
146526724|NCT02326272|528434758|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
146526725|NCT02326272|528434759|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
146526726|NCT02326272|528434760|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
146526727|NCT02326272|528434761|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
146526728|NCT00735943|528434768|FG000|Overall Study|Lost to Follow-up|1|||
146526729|NCT00735943|528434768|FG000|Overall Study|Adverse Event|1|||
146526730|NCT01265394|528434769|FG000|Overall Study|Subjects withdrawn|37|||
146526731|NCT02185417|528434770|FG000|Overall Study|Death|448|||
146526732|NCT02185417|528434771|FG001|Overall Study|Death|446|||
146526733|NCT02185417|528434772|FG002|Overall Study|Death|0|||
146526734|NCT02185417|528434770|FG000|Overall Study|Withdrawal by Subject|7|||
146526735|NCT02185417|528434771|FG001|Overall Study|Withdrawal by Subject|12|||
146526736|NCT02185417|528434772|FG002|Overall Study|Withdrawal by Subject|0|||
146526737|NCT03131167|528434775|FG000|Overall Study|Other (Unspecified)|0|||
146526738|NCT03131167|528434776|FG001|Overall Study|Other (Unspecified)|0|||
146526739|NCT03131167|528434777|FG002|Overall Study|Other (Unspecified)|0|||
146526740|NCT03131167|528434778|FG003|Overall Study|Other (Unspecified)|0|||
146526741|NCT03131167|528434779|FG004|Overall Study|Other (Unspecified)|0|||
146526742|NCT03131167|528434780|FG005|Overall Study|Other (Unspecified)|1|||
146526743|NCT03131167|528434781|FG006|Overall Study|Other (Unspecified)|0|||
146526744|NCT03131167|528434782|FG007|Overall Study|Other (Unspecified)|0|||
146526745|NCT03131167|528434783|FG008|Overall Study|Other (Unspecified)|0|||
146526746|NCT03131167|528434784|FG009|Overall Study|Other (Unspecified)|0|||
146526747|NCT03131167|528434785|FG010|Overall Study|Other (Unspecified)|0|||
146526748|NCT03131167|528434786|FG011|Overall Study|Other (Unspecified)|0|||
146526749|NCT03131167|528434787|FG012|Overall Study|Other (Unspecified)|0|||
146526750|NCT01781962|528434788|FG000|Overall Study|Other Miscellaneous Reasons|5|||
146526751|NCT03933449|528434789|FG000|Overall Study|Adverse Event|6|||
146526752|NCT03933449|528434790|FG001|Overall Study|Adverse Event|4|||
146526753|NCT03933449|528434789|FG000|Overall Study|Death|55|||
146526754|NCT03933449|528434790|FG001|Overall Study|Death|57|||
146526755|NCT03933449|528434789|FG000|Overall Study|Sponsor Decision|1|||
146526756|NCT03933449|528434790|FG001|Overall Study|Sponsor Decision|0|||
146526757|NCT00149396|528434799|FG000|Overall Study|Death|15|||
146526758|NCT00149396|528434799|FG000|Overall Study|Withdrawal by Subject|1|||
146526759|NCT00149396|528434799|FG000|Overall Study|Subject noncompliance|2|||
146526760|NCT00149396|528434799|FG000|Overall Study|other treatment|5|||
146526761|NCT01951417|528434802|FG000|Overall Study|Withdrawal by Subject|1|||
146526762|NCT01951417|528434802|FG000|Overall Study|Protocol Violation|2|||
146526763|NCT01951417|528434802|FG000|Overall Study|Lost to Follow-up|6|||
146526764|NCT00977613|528434803|FG000|Overall Study|Lost to Follow-up|16|||
146526765|NCT01598610|528434808|FG000|Overall Study|Adverse Event|1|||
146526766|NCT03360019|528434811|FG000|Overall Study|Withdrawal by Subject|2|||
146526767|NCT03360019|528434812|FG001|Overall Study|Withdrawal by Subject|0|||
146526768|NCT03360019|528434813|FG002|Overall Study|Withdrawal by Subject|0|||
146526769|NCT03360019|528434811|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
146526770|NCT03360019|528434812|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
146526771|NCT03360019|528434813|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
146526772|NCT00325819|528434816|FG000|Overall Study|Study product lost in mail|2|||
146526773|NCT00325819|528434817|FG001|Overall Study|Study product lost in mail|1|||
146526774|NCT00325819|528434816|FG000|Overall Study|Did not take a dose of study product|4|||
146526775|NCT00325819|528434817|FG001|Overall Study|Did not take a dose of study product|9|||
146526776|NCT00325819|528434816|FG000|Overall Study|Lost to Follow-up|3|||
146526777|NCT00325819|528434817|FG001|Overall Study|Lost to Follow-up|3|||
146526778|NCT04754542|528434818|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
146526779|NCT04754542|528434819|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
146526780|NCT03934216|528436248|FG000|Overall Study|Other Reasons|5|||
146526781|NCT03934216|528436249|FG001|Overall Study|Other Reasons|5|||
146526782|NCT03934216|528436248|FG000|Overall Study|Adverse Event|22|||
146526783|NCT03934216|528436249|FG001|Overall Study|Adverse Event|11|||
146526784|NCT03934216|528436248|FG000|Overall Study|Lack of Efficacy|8|||
146526785|NCT03934216|528436249|FG001|Overall Study|Lack of Efficacy|7|||
146526786|NCT03934216|528436248|FG000|Overall Study|Lost to Follow-up|2|||
146526787|NCT03934216|528436249|FG001|Overall Study|Lost to Follow-up|0|||
146526788|NCT03934216|528436248|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146526789|NCT03934216|528436249|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146526790|NCT03934216|528436248|FG000|Overall Study|Pregnancy|1|||
146526791|NCT03934216|528436249|FG001|Overall Study|Pregnancy|0|||
146526792|NCT03934216|528436248|FG000|Overall Study|Withdrawal by Subject|18|||
146526793|NCT03934216|528436249|FG001|Overall Study|Withdrawal by Subject|6|||
146526794|NCT03934216|528436248|FG000|Overall Study|Randomized but not treated|1|||
146526795|NCT03934216|528436249|FG001|Overall Study|Randomized but not treated|1|||
146526796|NCT01053741|528436252|FG000|2nd Study Intervention|Physician Decision|0|||
146526797|NCT01053741|528436253|FG001|2nd Study Intervention|Physician Decision|1|||
146526798|NCT00619827|528436254|FG000|Overall Study|Adverse Event|1|||
146526799|NCT00619827|528436255|FG001|Overall Study|Adverse Event|2|||
146526800|NCT00619827|528436254|FG000|Overall Study|Withdrawal by Subject|2|||
146526801|NCT00619827|528436255|FG001|Overall Study|Withdrawal by Subject|2|||
146526802|NCT01396083|528436256|FG000|Overall Study|Adverse Event|2|||
146526803|NCT01396083|528436257|FG001|Overall Study|Adverse Event|28|||
146526804|NCT01396083|528436256|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146526805|NCT01396083|528436257|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
146526806|NCT01396083|528436256|FG000|Overall Study|Consent withdrawn|4|||
146526807|NCT01396083|528436257|FG001|Overall Study|Consent withdrawn|5|||
146526808|NCT01396083|528436256|FG000|Overall Study|Protocol deviation(s)|0|||
146526809|NCT01396083|528436257|FG001|Overall Study|Protocol deviation(s)|1|||
146526810|NCT01396083|528436256|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146526811|NCT01396083|528436257|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146526812|NCT01396083|528436256|FG000|Overall Study|Administrative problems|1|||
146526813|NCT01396083|528436257|FG001|Overall Study|Administrative problems|0|||
146526814|NCT01396083|528436256|FG000|Overall Study|Lost to Follow-up|1|||
146860241|NCT01717989|529659826|FG000|Overall Study|Protocol deviation|6|||
146860242|NCT01717989|529659826|FG000|Overall Study|Withdrawal by Subject|11|||
146860243|NCT01717989|529659826|FG000|Overall Study|Physician Decision|2|||
146860244|NCT01717989|529659826|FG000|Overall Study|Lost to Follow-up|11|||
146860245|NCT01717989|529659826|FG000|Overall Study|Death|439|||
146860246|NCT01717989|529659826|FG000|Overall Study|Protocol-specified criteria|551|||
146860247|NCT01717989|529659826|FG000|Overall Study|Other|40|||
146860248|NCT03224325|529659827|FG000|Overall Study|Adverse Event|1|||
146860249|NCT03224325|529659828|FG001|Overall Study|Adverse Event|0|||
146860250|NCT03224325|529659829|FG002|Overall Study|Adverse Event|0|||
146860251|NCT03224325|529659830|FG003|Overall Study|Adverse Event|0|||
146860252|NCT03224325|529659831|FG004|Overall Study|Adverse Event|0|||
146860253|NCT03224325|529659832|FG005|Overall Study|Adverse Event|0|||
146860254|NCT03224325|529659833|FG006|Overall Study|Adverse Event|1|||
146860255|NCT03224325|529659827|FG000|Overall Study|Withdrawal by Subject|0|||
146860256|NCT03224325|529659828|FG001|Overall Study|Withdrawal by Subject|0|||
146860257|NCT03224325|529659829|FG002|Overall Study|Withdrawal by Subject|0|||
146860258|NCT03224325|529659830|FG003|Overall Study|Withdrawal by Subject|1|||
146860259|NCT03224325|529659831|FG004|Overall Study|Withdrawal by Subject|0|||
146860260|NCT03224325|529659832|FG005|Overall Study|Withdrawal by Subject|0|||
146860261|NCT03224325|529659833|FG006|Overall Study|Withdrawal by Subject|0|||
146860262|NCT02864381|529659834|FG000|Overall Study|Death|58|||
146860263|NCT02864381|529659835|FG001|Overall Study|Death|61|||
146860264|NCT02864381|529659834|FG000|Overall Study|Withdrew Consent|5|||
146526815|NCT01396083|528436257|FG001|Overall Study|Lost to Follow-up|0|||
146526816|NCT02806713|528436258|FG000|Overall Study|Urethral injury during procedure|1|||
146526817|NCT02806713|528436259|FG001|Overall Study|Urethral injury during procedure|0|||
146526818|NCT02806713|528436258|FG000|Overall Study|cancelled surgery|1|||
146526819|NCT02806713|528436259|FG001|Overall Study|cancelled surgery|2|||
146526820|NCT00735709|528436260|FG000|Overall Study|Adverse Event|2|||
146526821|NCT00735709|528436261|FG001|Overall Study|Adverse Event|3|||
146526822|NCT00735709|528436262|FG002|Overall Study|Adverse Event|1|||
146526823|NCT00735709|528436263|FG003|Overall Study|Adverse Event|5|||
146526824|NCT00735709|528436260|FG000|Overall Study|Lack of Efficacy|8|||
146526825|NCT00735709|528436261|FG001|Overall Study|Lack of Efficacy|4|||
146526826|NCT00735709|528436262|FG002|Overall Study|Lack of Efficacy|2|||
146526827|NCT00735709|528436263|FG003|Overall Study|Lack of Efficacy|3|||
146526828|NCT00735709|528436260|FG000|Overall Study|Noncompliance|0|||
146526829|NCT00735709|528436261|FG001|Overall Study|Noncompliance|0|||
146526830|NCT00735709|528436262|FG002|Overall Study|Noncompliance|1|||
146526831|NCT00735709|528436263|FG003|Overall Study|Noncompliance|0|||
146526832|NCT00735709|528436260|FG000|Overall Study|Protocol deviations|1|||
146526833|NCT00735709|528436261|FG001|Overall Study|Protocol deviations|2|||
146526834|NCT00735709|528436262|FG002|Overall Study|Protocol deviations|1|||
146526835|NCT00735709|528436263|FG003|Overall Study|Protocol deviations|1|||
146860265|NCT02864381|529659835|FG001|Overall Study|Withdrew Consent|6|||
146860266|NCT02864381|529659834|FG000|Overall Study|Reason Unknown|7|||
146860267|NCT02864381|529659835|FG001|Overall Study|Reason Unknown|3|||
146860268|NCT02864381|529659834|FG000|Overall Study|Lost to Follow-up|1|||
146860269|NCT02864381|529659835|FG001|Overall Study|Lost to Follow-up|1|||
146526836|NCT00735709|528436260|FG000|Overall Study|Voluntary Withdrawal|1|||
146526837|NCT00735709|528436261|FG001|Overall Study|Voluntary Withdrawal|3|||
146526838|NCT00735709|528436262|FG002|Overall Study|Voluntary Withdrawal|5|||
146860270|NCT02864381|529659834|FG000|Overall Study|Investigator's Discretion|1|||
146860271|NCT02864381|529659835|FG001|Overall Study|Investigator's Discretion|0|||
146526839|NCT00735709|528436263|FG003|Overall Study|Voluntary Withdrawal|7|||
146526840|NCT00735709|528436260|FG000|Overall Study|Lost to Follow-up|0|||
146526841|NCT00735709|528436261|FG001|Overall Study|Lost to Follow-up|1|||
146526842|NCT00735709|528436262|FG002|Overall Study|Lost to Follow-up|1|||
146526843|NCT00735709|528436263|FG003|Overall Study|Lost to Follow-up|1|||
146526844|NCT00735709|528436260|FG000|Overall Study|Excluded medication|1|||
146526845|NCT00735709|528436261|FG001|Overall Study|Excluded medication|0|||
146526846|NCT00735709|528436262|FG002|Overall Study|Excluded medication|0|||
146526847|NCT00735709|528436263|FG003|Overall Study|Excluded medication|1|||
146526848|NCT01718483|528436264|FG000|Overall Study|Withdrawal by Subject|14|||
146526849|NCT01718483|528436265|FG001|Overall Study|Withdrawal by Subject|12|||
146526850|NCT01718483|528436264|FG000|Overall Study|Adverse Event|5|||
146526851|NCT01718483|528436265|FG001|Overall Study|Adverse Event|12|||
146526852|NCT01718483|528436264|FG000|Overall Study|Lost to Follow-up|8|||
146526853|NCT01718483|528436265|FG001|Overall Study|Lost to Follow-up|3|||
146526854|NCT01718483|528436264|FG000|Overall Study|Protocol Violation|4|||
146526855|NCT01718483|528436265|FG001|Overall Study|Protocol Violation|2|||
146526856|NCT01718483|528436264|FG000|Overall Study|Other|1|||
146526857|NCT01718483|528436265|FG001|Overall Study|Other|4|||
146526858|NCT01718483|528436264|FG000|Overall Study|Pregnancy|1|||
146526859|NCT01718483|528436265|FG001|Overall Study|Pregnancy|1|||
146526860|NCT01718483|528436264|FG000|Overall Study|Lack of Efficacy|1|||
146526861|NCT01718483|528436265|FG001|Overall Study|Lack of Efficacy|0|||
146526862|NCT04110314|528436266|FG000|Overall Study|Did not meet inclusion criteria|35255|||
146526863|NCT04110314|528436267|FG001|Overall Study|Did not meet inclusion criteria|35104|||
146526864|NCT04110314|528436268|FG002|Overall Study|Did not meet inclusion criteria|35636|||
146526865|NCT04110314|528436269|FG003|Overall Study|Did not meet inclusion criteria|35135|||
146526866|NCT04110314|528436270|FG004|Overall Study|Did not meet inclusion criteria|35247|||
146526867|NCT04110314|528436271|FG005|Overall Study|Did not meet inclusion criteria|35727|||
146526868|NCT00115778|528436272|FG000|Overall Study|Withdrawal by Subject|0|||
146526869|NCT00115778|528436273|FG001|Overall Study|Withdrawal by Subject|1|||
146526870|NCT00249873|528436276|FG000|Overall Study|Not treated|7|||
146526871|NCT00249873|528436277|FG001|Overall Study|Not treated|8|||
146526872|NCT00249873|528436276|FG000|Overall Study|Significant thrombocytopenia|9|||
146526873|NCT00249873|528436277|FG001|Overall Study|Significant thrombocytopenia|8|||
146526874|NCT00249873|528436276|FG000|Overall Study|Severe allergic reaction|8|||
146526875|NCT00249873|528436277|FG001|Overall Study|Severe allergic reaction|1|||
146526876|NCT00249873|528436276|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
146526877|NCT00249873|528436277|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
146526878|NCT00249873|528436276|FG000|Overall Study|Other Serious Adverse Event|86|||
146526879|NCT00249873|528436277|FG001|Overall Study|Other Serious Adverse Event|97|||
146526880|NCT00249873|528436276|FG000|Overall Study|Qualifying condition not present|20|||
146526881|NCT00249873|528436277|FG001|Overall Study|Qualifying condition not present|23|||
146526882|NCT00249873|528436276|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
146526883|NCT00249873|528436277|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
146526884|NCT00249873|528436276|FG000|Overall Study|Withdrawal by Subject|504|||
146526885|NCT00249873|528436277|FG001|Overall Study|Withdrawal by Subject|466|||
146526886|NCT00249873|528436276|FG000|Overall Study|Lost to Follow-up|4|||
146526887|NCT00249873|528436277|FG001|Overall Study|Lost to Follow-up|7|||
146526888|NCT00249873|528436276|FG000|Overall Study|Minor bleeding|99|||
146760737|NCT03115346|529291060|FG000|Overall Study|Did not have AAA surgery|28|||
146760738|NCT03115346|529291061|FG001|Overall Study|Did not have AAA surgery|15|||
146760739|NCT03115346|529291060|FG000|Overall Study|Death|3|||
146760740|NCT03115346|529291061|FG001|Overall Study|Death|1|||
146760741|NCT03115346|529291060|FG000|Overall Study|Withdrawal by Subject|0|||
146760742|NCT03115346|529291061|FG001|Overall Study|Withdrawal by Subject|3|||
146760743|NCT03115346|529291060|FG000|Overall Study|Lost to Follow-up|0|||
146760744|NCT03115346|529291061|FG001|Overall Study|Lost to Follow-up|3|||
146760745|NCT03425539|529291065|FG000|Overall Study|Randomized but not treated|0|||
146760746|NCT03425539|529291066|FG001|Overall Study|Randomized but not treated|1|||
146760747|NCT03425539|529291065|FG000|Overall Study|Adverse Event|2|||
146760748|NCT03425539|529291066|FG001|Overall Study|Adverse Event|2|||
146760749|NCT03425539|529291065|FG000|Overall Study|Withdrawal by Subject|3|||
146760750|NCT03425539|529291066|FG001|Overall Study|Withdrawal by Subject|0|||
146760751|NCT03425539|529291065|FG000|Overall Study|Lost to Follow-up|0|||
146760752|NCT03425539|529291066|FG001|Overall Study|Lost to Follow-up|1|||
146760753|NCT00946192|529291067|FG000|Overall Study|Lost to Follow-up|6|||
146526889|NCT00249873|528436277|FG001|Overall Study|Minor bleeding|37|||
146526890|NCT00249873|528436276|FG000|Overall Study|Non-compliance|41|||
146760754|NCT00946192|529291068|FG001|Overall Study|Lost to Follow-up|11|||
146526891|NCT00249873|528436277|FG001|Overall Study|Non-compliance|46|||
146526892|NCT00249873|528436276|FG000|Overall Study|Other non serious Adverse Event|112|||
146526893|NCT00249873|528436277|FG001|Overall Study|Other non serious Adverse Event|108|||
146760755|NCT00946192|529291069|FG002|Overall Study|Lost to Follow-up|9|||
146760756|NCT00946192|529291067|FG000|Overall Study|Withdrawal by Subject|10|||
146760757|NCT00946192|529291068|FG001|Overall Study|Withdrawal by Subject|7|||
146760758|NCT00946192|529291069|FG002|Overall Study|Withdrawal by Subject|3|||
146526894|NCT00249873|528436276|FG000|Overall Study|Other contraindicated medication|1|||
146526895|NCT00249873|528436277|FG001|Overall Study|Other contraindicated medication|0|||
146526896|NCT00249873|528436276|FG000|Overall Study|Patient not wish to continue after May08|3|||
146526897|NCT00249873|528436277|FG001|Overall Study|Patient not wish to continue after May08|4|||
146526898|NCT00249873|528436276|FG000|Overall Study|Physician withdrew consent|59|||
146526899|NCT00249873|528436277|FG001|Overall Study|Physician withdrew consent|60|||
146526900|NCT00249873|528436276|FG000|Overall Study|Open label clopidogrel required|31|||
146526901|NCT00249873|528436277|FG001|Overall Study|Open label clopidogrel required|42|||
146526902|NCT00249873|528436276|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
146526903|NCT00249873|528436277|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
146526904|NCT00249873|528436276|FG000|Overall Study|Oral anticoagulant required|159|||
146526905|NCT00249873|528436277|FG001|Overall Study|Oral anticoagulant required|157|||
146526906|NCT00249873|528436276|FG000|Overall Study|Study drug intolerance|5|||
146526907|NCT00249873|528436277|FG001|Overall Study|Study drug intolerance|0|||
146526908|NCT00249873|528436276|FG000|Overall Study|Surgery/ procedure|9|||
146526909|NCT00249873|528436277|FG001|Overall Study|Surgery/ procedure|9|||
146526910|NCT00249873|528436276|FG000|Overall Study|Event related to cardiac condition|12|||
146526911|NCT00249873|528436277|FG001|Overall Study|Event related to cardiac condition|21|||
146526912|NCT00249873|528436276|FG000|Overall Study|Thromboembolic/outcome event|82|||
146526913|NCT00249873|528436277|FG001|Overall Study|Thromboembolic/outcome event|122|||
146526914|NCT00643201|528436280|FG000|Randomized, Completed 6 Months of Study|Death|20|||
146526915|NCT00643201|528436281|FG001|Randomized, Completed 6 Months of Study|Death|26|||
146526916|NCT00643201|528436280|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
146526917|NCT00643201|528436281|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
146526918|NCT00643201|528436280|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
146526919|NCT00643201|528436281|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
146526920|NCT00643201|528436280|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
146526921|NCT00643201|528436281|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
146526922|NCT00643201|528436280|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
146526923|NCT00643201|528436281|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
146526924|NCT00643201|528436280|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
146526925|NCT00643201|528436281|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
146526926|NCT00643201|528436280|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
146526927|NCT00643201|528436281|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
146526928|NCT00643201|528436280|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
146526929|NCT00643201|528436281|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
146526930|NCT00643201|528436280|FG000|Randomized, Completed 6 Months of Study|Other|107|||
146526931|NCT00643201|528436281|FG001|Randomized, Completed 6 Months of Study|Other|107|||
146526932|NCT00643201|528436280|FG000|Completed Study Follow Up|Death|28|||
146526933|NCT00643201|528436281|FG001|Completed Study Follow Up|Death|34|||
146526934|NCT00643201|528436280|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
146526935|NCT00643201|528436281|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
146526936|NCT00643201|528436280|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
146526937|NCT00643201|528436281|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
146526938|NCT00643201|528436280|FG000|Completed Study Follow Up|non-specified|1|||
146526939|NCT00643201|528436281|FG001|Completed Study Follow Up|non-specified|0|||
146526940|NCT05417412|528436291|FG000|Overall Study|Lost to Follow-up|2|||
146526941|NCT01576575|528436292|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
146526942|NCT01576575|528436292|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
146526943|NCT01576575|528436292|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
146526944|NCT00274742|528436299|FG000|Overall Study|Adverse Event|0|||
146760759|NCT00946192|529291067|FG000|Overall Study|Did not start medication|2|||
146760760|NCT00946192|529291068|FG001|Overall Study|Did not start medication|0|||
146760761|NCT00946192|529291069|FG002|Overall Study|Did not start medication|0|||
146760762|NCT01080131|529291070|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
146760763|NCT01080131|529291071|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
146760764|NCT01080131|529291070|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
146760765|NCT01080131|529291071|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
146760766|NCT01080131|529291070|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
146760767|NCT01080131|529291071|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
146760768|NCT01080131|529291070|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
146760769|NCT01080131|529291071|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
146760770|NCT01080131|529291070|FG000|Core Study (0- 12 Weeks)|Death|1|||
146760771|NCT01080131|529291071|FG001|Core Study (0- 12 Weeks)|Death|0|||
146760772|NCT01080131|529291070|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
146760773|NCT01080131|529291071|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
146760774|NCT01080131|529291070|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
146760775|NCT01080131|529291071|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
146526945|NCT00274742|528436300|FG001|Overall Study|Adverse Event|4|||
146526946|NCT00274742|528436301|FG002|Overall Study|Adverse Event|1|||
146526947|NCT00274742|528436302|FG003|Overall Study|Adverse Event|4|||
146526948|NCT00274742|528436303|FG004|Overall Study|Adverse Event|12|||
146526949|NCT00274742|528436304|FG005|Overall Study|Adverse Event|3|||
146526950|NCT00274742|528436299|FG000|Overall Study|Lost to Follow-up|0|||
146526951|NCT00274742|528436300|FG001|Overall Study|Lost to Follow-up|0|||
146526952|NCT00274742|528436301|FG002|Overall Study|Lost to Follow-up|0|||
146526953|NCT00274742|528436302|FG003|Overall Study|Lost to Follow-up|0|||
146526954|NCT00274742|528436303|FG004|Overall Study|Lost to Follow-up|1|||
146526955|NCT00274742|528436304|FG005|Overall Study|Lost to Follow-up|0|||
146526956|NCT00274742|528436299|FG000|Overall Study|End of Study|0|||
146526957|NCT00274742|528436300|FG001|Overall Study|End of Study|0|||
146526958|NCT00274742|528436301|FG002|Overall Study|End of Study|0|||
146526959|NCT00274742|528436302|FG003|Overall Study|End of Study|1|||
146526960|NCT00274742|528436303|FG004|Overall Study|End of Study|0|||
146526961|NCT00274742|528436304|FG005|Overall Study|End of Study|0|||
146526962|NCT00274742|528436299|FG000|Overall Study|Disease Progression|0|||
146526963|NCT00274742|528436300|FG001|Overall Study|Disease Progression|1|||
146526964|NCT00274742|528436301|FG002|Overall Study|Disease Progression|1|||
146526965|NCT00274742|528436302|FG003|Overall Study|Disease Progression|0|||
146526966|NCT00274742|528436303|FG004|Overall Study|Disease Progression|1|||
146526967|NCT00274742|528436304|FG005|Overall Study|Disease Progression|0|||
146526968|NCT00274742|528436299|FG000|Overall Study|Other|0|||
146526969|NCT00274742|528436300|FG001|Overall Study|Other|3|||
146526970|NCT00274742|528436301|FG002|Overall Study|Other|0|||
146526971|NCT00274742|528436302|FG003|Overall Study|Other|0|||
146526972|NCT00274742|528436303|FG004|Overall Study|Other|2|||
146526973|NCT00274742|528436304|FG005|Overall Study|Other|0|||
146526974|NCT04742673|528436307|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
146526975|NCT04742673|528436308|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
146526976|NCT01158261|528436309|FG000|Overall Study|Lost to Follow-up|9|||
146526977|NCT01158261|528436309|FG000|Overall Study|Death|7|||
146526978|NCT01158261|528436309|FG000|Overall Study|Withdrawal by Subject|1|||
146526979|NCT02899065|528436310|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
146526980|NCT02899065|528436311|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
146526981|NCT02899065|528436310|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
146526982|NCT02899065|528436311|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
146526983|NCT02899065|528436310|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
146526984|NCT02899065|528436311|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
146526985|NCT00971867|528436312|FG000|Overall Study|Adverse Event|4|||
146526986|NCT00971867|528436312|FG000|Overall Study|Participant Withdrew Consent|1|||
146526987|NCT00971867|528436312|FG000|Overall Study|Disease Progression|6|||
146526988|NCT02983045|528436314|FG000|Overall Study|Withdrawal by Subject|0|||
146526989|NCT02983045|528436315|FG001|Overall Study|Withdrawal by Subject|1|||
146526990|NCT02983045|528436316|FG002|Overall Study|Withdrawal by Subject|0|||
146526991|NCT02983045|528436317|FG003|Overall Study|Withdrawal by Subject|5|||
146526992|NCT02983045|528436318|FG004|Overall Study|Withdrawal by Subject|0|||
146526993|NCT02983045|528436319|FG005|Overall Study|Withdrawal by Subject|72|||
146526994|NCT02983045|528436320|FG006|Overall Study|Withdrawal by Subject|0|||
146526995|NCT02983045|528436321|FG007|Overall Study|Withdrawal by Subject|0|||
146526996|NCT02983045|528436322|FG008|Overall Study|Withdrawal by Subject|0|||
146526997|NCT02983045|528436323|FG009|Overall Study|Withdrawal by Subject|2|||
146526998|NCT02983045|528436314|FG000|Overall Study|Lost to Follow-up|0|||
146760776|NCT01080131|529291070|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
146760777|NCT01080131|529291071|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
146760778|NCT01080131|529291070|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
146760779|NCT01080131|529291071|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
146760780|NCT01080131|529291070|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
146760781|NCT01080131|529291071|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
146760782|NCT01080131|529291070|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
146760783|NCT01080131|529291071|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
146760784|NCT01080131|529291070|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
146760785|NCT01080131|529291071|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
146760786|NCT01080131|529291070|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
146760787|NCT01080131|529291071|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
146760788|NCT02014558|529291072|FG000|Overall Study|Never Received Study Drug|0|||
146760789|NCT02014558|529291073|FG001|Overall Study|Never Received Study Drug|0|||
146760790|NCT02014558|529291074|FG002|Overall Study|Never Received Study Drug|0|||
146760791|NCT02014558|529291075|FG003|Overall Study|Never Received Study Drug|0|||
146760792|NCT02014558|529291076|FG004|Overall Study|Never Received Study Drug|1|||
146760793|NCT02014558|529291077|FG005|Overall Study|Never Received Study Drug|0|||
146760794|NCT02014558|529291078|FG006|Overall Study|Never Received Study Drug|1|||
146526999|NCT02983045|528436315|FG001|Overall Study|Lost to Follow-up|0|||
146860272|NCT02864381|529659834|FG000|Overall Study|Protocol Violation|0|||
146527000|NCT02983045|528436316|FG002|Overall Study|Lost to Follow-up|0|||
146527001|NCT02983045|528436317|FG003|Overall Study|Lost to Follow-up|0|||
146527002|NCT02983045|528436318|FG004|Overall Study|Lost to Follow-up|0|||
146527003|NCT02983045|528436319|FG005|Overall Study|Lost to Follow-up|10|||
146527004|NCT02983045|528436320|FG006|Overall Study|Lost to Follow-up|0|||
146527005|NCT02983045|528436321|FG007|Overall Study|Lost to Follow-up|0|||
146527006|NCT02983045|528436322|FG008|Overall Study|Lost to Follow-up|0|||
146527007|NCT02983045|528436323|FG009|Overall Study|Lost to Follow-up|0|||
146527008|NCT00905424|528436324|FG000|Overall Study|Lost to Follow-up|3|||
146527009|NCT00905424|528436325|FG001|Overall Study|Lost to Follow-up|3|||
146527010|NCT00905424|528436324|FG000|Overall Study|Withdrawal by Subject|1|||
146527011|NCT00905424|528436325|FG001|Overall Study|Withdrawal by Subject|2|||
146527012|NCT00905424|528436324|FG000|Overall Study|Adverse Event|4|||
146527013|NCT00905424|528436325|FG001|Overall Study|Adverse Event|2|||
146527014|NCT00905424|528436324|FG000|Overall Study|Non-compliance with study medication|2|||
146527015|NCT00905424|528436325|FG001|Overall Study|Non-compliance with study medication|0|||
146527016|NCT00905424|528436324|FG000|Overall Study|Sponsor decision|1|||
146527017|NCT00905424|528436325|FG001|Overall Study|Sponsor decision|0|||
146527018|NCT00905424|528436324|FG000|Overall Study|Positive urine drug screen|0|||
146527019|NCT00905424|528436325|FG001|Overall Study|Positive urine drug screen|1|||
146527020|NCT00905424|528436324|FG000|Overall Study|Non-adherence to visit schedule|0|||
146527021|NCT00905424|528436325|FG001|Overall Study|Non-adherence to visit schedule|1|||
146527022|NCT00379899|528436328|FG000|Overall Study|Adverse Event|7|||
146527023|NCT00379899|528436329|FG001|Overall Study|Adverse Event|3|||
146527024|NCT00379899|528436328|FG000|Overall Study|Death|10|||
146527025|NCT00379899|528436329|FG001|Overall Study|Death|10|||
146527026|NCT00379899|528436328|FG000|Overall Study|Lost to Follow-up|2|||
146527027|NCT00379899|528436329|FG001|Overall Study|Lost to Follow-up|4|||
146527028|NCT00379899|528436328|FG000|Overall Study|Physician Decision|3|||
146527029|NCT00379899|528436329|FG001|Overall Study|Physician Decision|4|||
146527030|NCT00379899|528436328|FG000|Overall Study|Withdrawal by Subject|5|||
146527031|NCT00379899|528436329|FG001|Overall Study|Withdrawal by Subject|5|||
146527032|NCT00379899|528436328|FG000|Overall Study|Ineligibility determined|0|||
146527033|NCT00379899|528436329|FG001|Overall Study|Ineligibility determined|1|||
146527034|NCT00379899|528436328|FG000|Overall Study|Noncompliance|1|||
146527035|NCT00379899|528436329|FG001|Overall Study|Noncompliance|1|||
146527036|NCT00379899|528436328|FG000|Overall Study|Parathyroidectomy|0|||
146527037|NCT00379899|528436329|FG001|Overall Study|Parathyroidectomy|2|||
146527038|NCT00379899|528436328|FG000|Overall Study|Renal transplantation|5|||
146527039|NCT00379899|528436329|FG001|Overall Study|Renal transplantation|4|||
146527040|NCT00379899|528436328|FG000|Overall Study|Coronary artery bypass graft|1|||
146527041|NCT00379899|528436329|FG001|Overall Study|Coronary artery bypass graft|1|||
146527042|NCT00379899|528436328|FG000|Overall Study|Other protocol-specified criteria|3|||
146527043|NCT00379899|528436329|FG001|Overall Study|Other protocol-specified criteria|4|||
146527044|NCT00379899|528436328|FG000|Overall Study|Other|3|||
146527045|NCT00379899|528436329|FG001|Overall Study|Other|1|||
146527046|NCT01922258|528436330|FG000|Overall Study|Lost to Follow-up|1|||
146760795|NCT02014558|529291079|FG007|Overall Study|Never Received Study Drug|0|||
146760796|NCT02014558|529291080|FG008|Overall Study|Never Received Study Drug|2|||
146760797|NCT02014558|529291081|FG009|Overall Study|Never Received Study Drug|0|||
146760798|NCT02014558|529291082|FG010|Overall Study|Never Received Study Drug|2|||
146760799|NCT02014558|529291083|FG011|Overall Study|Never Received Study Drug|2|||
146760800|NCT02014558|529291084|FG012|Overall Study|Never Received Study Drug|0|||
146760801|NCT02014558|529291072|FG000|Overall Study|Adverse Event|0|||
146760802|NCT02014558|529291073|FG001|Overall Study|Adverse Event|0|||
146760803|NCT02014558|529291074|FG002|Overall Study|Adverse Event|0|||
146760804|NCT02014558|529291075|FG003|Overall Study|Adverse Event|0|||
146760805|NCT02014558|529291076|FG004|Overall Study|Adverse Event|1|||
146760806|NCT02014558|529291077|FG005|Overall Study|Adverse Event|0|||
146760807|NCT02014558|529291078|FG006|Overall Study|Adverse Event|0|||
146760808|NCT02014558|529291079|FG007|Overall Study|Adverse Event|0|||
146760809|NCT02014558|529291080|FG008|Overall Study|Adverse Event|2|||
146760810|NCT02014558|529291081|FG009|Overall Study|Adverse Event|2|||
146760811|NCT02014558|529291082|FG010|Overall Study|Adverse Event|5|||
146760812|NCT02014558|529291083|FG011|Overall Study|Adverse Event|21|||
146860273|NCT02864381|529659835|FG001|Overall Study|Protocol Violation|1|||
146527047|NCT01922258|528436331|FG001|Overall Study|Lost to Follow-up|1|||
146527048|NCT01922258|528436330|FG000|Overall Study|Adverse Event|9|||
146527049|NCT01922258|528436331|FG001|Overall Study|Adverse Event|2|||
146527050|NCT01922258|528436330|FG000|Overall Study|Met Withdrawal Criteria|0|||
146760813|NCT02014558|529291084|FG012|Overall Study|Adverse Event|3|||
146860274|NCT02120625|529659837|FG000|Overall Study|Physician Decision|2|||
146527051|NCT01922258|528436331|FG001|Overall Study|Met Withdrawal Criteria|4|||
146527052|NCT01922258|528436330|FG000|Overall Study|Withdrawn by the Investigator|1|||
146527053|NCT01922258|528436331|FG001|Overall Study|Withdrawn by the Investigator|4|||
146760814|NCT02014558|529291072|FG000|Overall Study|Death|1|||
146760815|NCT02014558|529291073|FG001|Overall Study|Death|0|||
146527054|NCT01922258|528436330|FG000|Overall Study|Withdrawal by participant|5|||
146527055|NCT01922258|528436331|FG001|Overall Study|Withdrawal by participant|5|||
146527056|NCT05225389|528436332|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
146527057|NCT01585246|528436333|FG000|Overall Study|Lost to Follow-up|0|||
146527058|NCT01585246|528436334|FG001|Overall Study|Lost to Follow-up|0|||
146527059|NCT01585246|528436335|FG002|Overall Study|Lost to Follow-up|2|||
146527060|NCT01585246|528436336|FG003|Overall Study|Lost to Follow-up|1|||
146527061|NCT01585246|528436337|FG004|Overall Study|Lost to Follow-up|0|||
146527062|NCT01585246|528436333|FG000|Overall Study|Protocol Violation|0|||
146527063|NCT01585246|528436334|FG001|Overall Study|Protocol Violation|0|||
146527064|NCT01585246|528436335|FG002|Overall Study|Protocol Violation|0|||
146527065|NCT01585246|528436336|FG003|Overall Study|Protocol Violation|0|||
146527066|NCT01585246|528436337|FG004|Overall Study|Protocol Violation|1|||
146527067|NCT01585246|528436333|FG000|Overall Study|Withdrawal by Subject|0|||
146527068|NCT01585246|528436334|FG001|Overall Study|Withdrawal by Subject|0|||
146527069|NCT01585246|528436335|FG002|Overall Study|Withdrawal by Subject|1|||
146527070|NCT01585246|528436336|FG003|Overall Study|Withdrawal by Subject|2|||
146860275|NCT02525861|529659838|FG000|Overall Study|Adverse Event|1|||
146527071|NCT01585246|528436337|FG004|Overall Study|Withdrawal by Subject|1|||
146527072|NCT01585246|528436333|FG000|Overall Study|Other|0|||
146527073|NCT01585246|528436334|FG001|Overall Study|Other|1|||
146527074|NCT01585246|528436335|FG002|Overall Study|Other|1|||
146527075|NCT01585246|528436336|FG003|Overall Study|Other|1|||
146527076|NCT01585246|528436337|FG004|Overall Study|Other|0|||
146527077|NCT04552132|528436338|FG000|Overall Study|Lost to Follow-up|4|||
146527078|NCT04552132|528436339|FG001|Overall Study|Lost to Follow-up|3|||
146527079|NCT04552132|528436338|FG000|Overall Study|Protocol Violation|1|||
146527080|NCT04552132|528436339|FG001|Overall Study|Protocol Violation|0|||
146527081|NCT01657162|528436340|FG000|Overall Study|Adverse Event|26|||
146527082|NCT01657162|528436341|FG001|Overall Study|Adverse Event|36|||
146527083|NCT01657162|528436340|FG000|Overall Study|Withdrawal by Subject|13|||
146527084|NCT01657162|528436341|FG001|Overall Study|Withdrawal by Subject|13|||
146527085|NCT01657162|528436340|FG000|Overall Study|Continuing Significant Deterioration|9|||
146527086|NCT01657162|528436341|FG001|Overall Study|Continuing Significant Deterioration|3|||
146527087|NCT01657162|528436340|FG000|Overall Study|Refusal of Treatment|4|||
146527088|NCT01657162|528436341|FG001|Overall Study|Refusal of Treatment|6|||
146527089|NCT01657162|528436340|FG000|Overall Study|Lost to Follow-up|3|||
146527090|NCT01657162|528436341|FG001|Overall Study|Lost to Follow-up|4|||
146527091|NCT01657162|528436340|FG000|Overall Study|Death|2|||
146527092|NCT01657162|528436341|FG001|Overall Study|Death|3|||
146527093|NCT01657162|528436340|FG000|Overall Study|Inability to Complete Study Procedures|1|||
146527094|NCT01657162|528436341|FG001|Overall Study|Inability to Complete Study Procedures|7|||
146527095|NCT01657162|528436340|FG000|Overall Study|Protocol Violation|1|||
146527096|NCT01657162|528436341|FG001|Overall Study|Protocol Violation|0|||
146527097|NCT01657162|528436340|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
146527098|NCT01657162|528436341|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
146527099|NCT01657162|528436340|FG000|Overall Study|Other than Specified|0|||
146527100|NCT01657162|528436341|FG001|Overall Study|Other than Specified|2|||
146527101|NCT03066830|528436342|FG000|Overall Study|At the Participant's own Request|16|||
146527102|NCT03066830|528436343|FG001|Overall Study|At the Participant's own Request|17|||
146527103|NCT03066830|528436342|FG000|Overall Study|Other|3|||
146527104|NCT03066830|528436343|FG001|Overall Study|Other|0|||
146527105|NCT03066830|528436342|FG000|Overall Study|Poor Compliance to Protocol|1|||
146527106|NCT03066830|528436343|FG001|Overall Study|Poor Compliance to Protocol|0|||
146527107|NCT03066830|528436342|FG000|Overall Study|Adverse Event|2|||
146527108|NCT03066830|528436343|FG001|Overall Study|Adverse Event|2|||
146527109|NCT03066830|528436342|FG000|Overall Study|Lost to Follow-up|11|||
146527110|NCT03066830|528436343|FG001|Overall Study|Lost to Follow-up|3|||
146527111|NCT00096538|528436351|FG000|Overall Study|Withdrawal by Subject|1|||
146527112|NCT02686164|528436353|FG000|Overall Study|Adverse Event|1|||
146527113|NCT02686164|528436353|FG000|Overall Study|Withdrawal of consent|1|||
146527114|NCT02686164|528436353|FG000|Overall Study|Clinical progression|1|||
146527115|NCT01691378|528436354|FG000|Overall Study|Withdrawal by Subject|2|||
146527116|NCT01691378|528436355|FG001|Overall Study|Withdrawal by Subject|0|||
146527117|NCT01691378|528436354|FG000|Overall Study|Lost to Follow-up|5|||
146527118|NCT01691378|528436355|FG001|Overall Study|Lost to Follow-up|2|||
146527119|NCT02329327|528436362|FG000|Overall Study|Death|78|||
146860276|NCT02525861|529659839|FG001|Overall Study|Adverse Event|0|||
146860277|NCT02525861|529659838|FG000|Overall Study|Withdrawal by Subject|0|||
146860278|NCT02525861|529659839|FG001|Overall Study|Withdrawal by Subject|1|||
146527120|NCT02329327|528436363|FG001|Overall Study|Death|0|||
146625286|NCT03037385|528803851|FG006|Overall Study|Progressive Disease|1|||
146860279|NCT02525861|529659838|FG000|Overall Study|Physician Decision|0|||
146527121|NCT02329327|528436362|FG000|Overall Study|Withdrawal by Subject|3|||
146527122|NCT02329327|528436363|FG001|Overall Study|Withdrawal by Subject|0|||
146527123|NCT02329327|528436362|FG000|Overall Study|Lost to Follow-up|4|||
146527124|NCT02329327|528436363|FG001|Overall Study|Lost to Follow-up|0|||
146527125|NCT02493517|528436364|FG000|Overall Study|Protocol Violation|1|||
146527126|NCT02493517|528436365|FG001|Overall Study|Protocol Violation|2|||
146527127|NCT02493517|528436364|FG000|Overall Study|Withdrawal by Subject|1|||
146527128|NCT02493517|528436365|FG001|Overall Study|Withdrawal by Subject|2|||
146527129|NCT02493517|528436364|FG000|Overall Study|Adverse Event|0|||
146527130|NCT02493517|528436365|FG001|Overall Study|Adverse Event|2|||
146527131|NCT02493517|528436364|FG000|Overall Study|Missed study visit|0|||
146527132|NCT02493517|528436365|FG001|Overall Study|Missed study visit|1|||
146527133|NCT03718429|528436366|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
146527134|NCT03718429|528436367|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
146527135|NCT03718429|528436368|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
146527136|NCT03718429|528436369|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
146527137|NCT02058589|528436372|FG000|Overall Study|Serious Adverse Event|1|||
146527138|NCT02058589|528436373|FG001|Overall Study|Serious Adverse Event|1|||
146527139|NCT02058589|528436372|FG000|Overall Study|Non-Serious Adverse Event|1|||
146527140|NCT02058589|528436373|FG001|Overall Study|Non-Serious Adverse Event|0|||
146527141|NCT02058589|528436372|FG000|Overall Study|Withdrawal by Subject|0|||
146527142|NCT02058589|528436373|FG001|Overall Study|Withdrawal by Subject|1|||
146527143|NCT00490971|528436375|FG000|Acute/Continuation|Adverse Event|62|||
146527144|NCT00490971|528436376|FG001|Acute/Continuation|Adverse Event|13|||
146527145|NCT00490971|528436377|FG002|Acute/Continuation|Adverse Event|0|||
146527146|NCT00490971|528436378|FG003|Acute/Continuation|Adverse Event|0|||
146527147|NCT00490971|528436379|FG004|Acute/Continuation|Adverse Event|0|||
146527148|NCT00490971|528436375|FG000|Acute/Continuation|Death|2|||
146527149|NCT00490971|528436376|FG001|Acute/Continuation|Death|0|||
146527150|NCT00490971|528436377|FG002|Acute/Continuation|Death|0|||
146527151|NCT00490971|528436378|FG003|Acute/Continuation|Death|0|||
146860280|NCT02525861|529659839|FG001|Overall Study|Physician Decision|1|||
146860281|NCT01607554|529659841|FG000|Overall Study|Disease progression|2|||
146527152|NCT00490971|528436379|FG004|Acute/Continuation|Death|0|||
146527153|NCT00490971|528436375|FG000|Acute/Continuation|Lack of Efficacy|106|||
146527154|NCT00490971|528436376|FG001|Acute/Continuation|Lack of Efficacy|12|||
146527155|NCT00490971|528436377|FG002|Acute/Continuation|Lack of Efficacy|0|||
146527156|NCT00490971|528436378|FG003|Acute/Continuation|Lack of Efficacy|0|||
146527157|NCT00490971|528436379|FG004|Acute/Continuation|Lack of Efficacy|0|||
146527158|NCT00490971|528436375|FG000|Acute/Continuation|Lost to Follow-up|23|||
146527159|NCT00490971|528436376|FG001|Acute/Continuation|Lost to Follow-up|7|||
146527160|NCT00490971|528436377|FG002|Acute/Continuation|Lost to Follow-up|0|||
146527161|NCT00490971|528436378|FG003|Acute/Continuation|Lost to Follow-up|0|||
146527162|NCT00490971|528436379|FG004|Acute/Continuation|Lost to Follow-up|0|||
146527163|NCT00490971|528436375|FG000|Acute/Continuation|Protocol Violation|10|||
146860282|NCT03952806|529659842|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
146860283|NCT03952806|529659843|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
146860284|NCT03952806|529659842|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
146860285|NCT03952806|529659843|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
146860286|NCT03952806|529659842|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
146860287|NCT03952806|529659843|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
146860288|NCT03952806|529659842|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
146860289|NCT03952806|529659843|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
146527164|NCT00490971|528436376|FG001|Acute/Continuation|Protocol Violation|2|||
146527165|NCT00490971|528436377|FG002|Acute/Continuation|Protocol Violation|0|||
146527166|NCT00490971|528436378|FG003|Acute/Continuation|Protocol Violation|0|||
146527167|NCT00490971|528436379|FG004|Acute/Continuation|Protocol Violation|0|||
146527168|NCT00490971|528436375|FG000|Acute/Continuation|Withdrawal by Subject|92|||
146527169|NCT00490971|528436376|FG001|Acute/Continuation|Withdrawal by Subject|24|||
146527170|NCT00490971|528436377|FG002|Acute/Continuation|Withdrawal by Subject|0|||
146527171|NCT00490971|528436378|FG003|Acute/Continuation|Withdrawal by Subject|0|||
146527172|NCT00490971|528436379|FG004|Acute/Continuation|Withdrawal by Subject|0|||
146527173|NCT00490971|528436375|FG000|Acute/Continuation|Other|11|||
146527174|NCT00490971|528436376|FG001|Acute/Continuation|Other|4|||
146527175|NCT00490971|528436377|FG002|Acute/Continuation|Other|0|||
146527176|NCT00490971|528436378|FG003|Acute/Continuation|Other|0|||
146527177|NCT00490971|528436379|FG004|Acute/Continuation|Other|0|||
146527178|NCT00490971|528436375|FG000|Maintenance|Adverse Event|0|||
146527179|NCT00490971|528436376|FG001|Maintenance|Adverse Event|0|||
146527180|NCT00490971|528436377|FG002|Maintenance|Adverse Event|4|||
146527181|NCT00490971|528436378|FG003|Maintenance|Adverse Event|5|||
146527182|NCT00490971|528436379|FG004|Maintenance|Adverse Event|7|||
146527183|NCT00490971|528436375|FG000|Maintenance|Death|0|||
146527184|NCT00490971|528436376|FG001|Maintenance|Death|0|||
146527185|NCT00490971|528436377|FG002|Maintenance|Death|0|||
146527186|NCT00490971|528436378|FG003|Maintenance|Death|2|||
146527187|NCT00490971|528436379|FG004|Maintenance|Death|0|||
146527188|NCT00490971|528436375|FG000|Maintenance|Lost to Follow-up|0|||
146527189|NCT00490971|528436376|FG001|Maintenance|Lost to Follow-up|0|||
146527190|NCT00490971|528436377|FG002|Maintenance|Lost to Follow-up|5|||
146527191|NCT00490971|528436378|FG003|Maintenance|Lost to Follow-up|8|||
146527192|NCT00490971|528436379|FG004|Maintenance|Lost to Follow-up|10|||
146527193|NCT00490971|528436375|FG000|Maintenance|Pregnancy|0|||
146527194|NCT00490971|528436376|FG001|Maintenance|Pregnancy|0|||
146527195|NCT00490971|528436377|FG002|Maintenance|Pregnancy|1|||
146527196|NCT00490971|528436378|FG003|Maintenance|Pregnancy|0|||
146527197|NCT00490971|528436379|FG004|Maintenance|Pregnancy|0|||
146527198|NCT00490971|528436375|FG000|Maintenance|Protocol Violation|0|||
146527199|NCT00490971|528436376|FG001|Maintenance|Protocol Violation|0|||
146527200|NCT00490971|528436377|FG002|Maintenance|Protocol Violation|4|||
146527201|NCT00490971|528436378|FG003|Maintenance|Protocol Violation|1|||
146527202|NCT00490971|528436379|FG004|Maintenance|Protocol Violation|1|||
146527203|NCT00490971|528436375|FG000|Maintenance|Withdrawal by Subject|0|||
146527204|NCT00490971|528436376|FG001|Maintenance|Withdrawal by Subject|0|||
146527205|NCT00490971|528436377|FG002|Maintenance|Withdrawal by Subject|26|||
146527206|NCT00490971|528436378|FG003|Maintenance|Withdrawal by Subject|28|||
146527207|NCT00490971|528436379|FG004|Maintenance|Withdrawal by Subject|18|||
146527208|NCT00490971|528436375|FG000|Maintenance|Other|0|||
146527209|NCT00490971|528436376|FG001|Maintenance|Other|0|||
146527210|NCT00490971|528436377|FG002|Maintenance|Other|11|||
146527211|NCT00490971|528436378|FG003|Maintenance|Other|9|||
146527212|NCT00490971|528436379|FG004|Maintenance|Other|3|||
146527213|NCT04888494|528436386|FG000|Overall Study|Lost to Follow-up|2|||
146527214|NCT04888494|528436387|FG001|Overall Study|Lost to Follow-up|3|||
146527215|NCT04888494|528436386|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
146527216|NCT04888494|528436387|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
146527217|NCT03430856|528436388|FG000|Overall Study|Adverse Event|0|||
146527218|NCT03430856|528436389|FG001|Overall Study|Adverse Event|1|||
146527219|NCT03430856|528436390|FG002|Overall Study|Adverse Event|0|||
146527220|NCT03430856|528436388|FG000|Overall Study|Rescue criteria|1|||
146527221|NCT03430856|528436389|FG001|Overall Study|Rescue criteria|1|||
146527222|NCT03430856|528436390|FG002|Overall Study|Rescue criteria|0|||
146527223|NCT03430856|528436388|FG000|Overall Study|Voluntary withdrawal of consent|1|||
146527224|NCT03430856|528436389|FG001|Overall Study|Voluntary withdrawal of consent|1|||
146527225|NCT03430856|528436390|FG002|Overall Study|Voluntary withdrawal of consent|1|||
146527226|NCT00565604|528436396|FG000|Overall Study|Failure to treat|2|||
146527227|NCT00565604|528436396|FG000|Overall Study|Lost to Follow-up|2|||
146527228|NCT04980014|528438454|FG000|Overall Study|Participants who are Duplicated|1|||
146527229|NCT04980014|528438454|FG000|Overall Study|Follow-up Failure|13|||
146527230|NCT04980014|528438454|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
146527231|NCT04980014|528438454|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
146527232|NCT04980014|528438454|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
146527233|NCT02317991|528438455|FG000|Overall Study|Adverse Event|12|||
146527234|NCT02317991|528438455|FG000|Overall Study|Death|4|||
146527235|NCT02317991|528438455|FG000|Overall Study|Withdrawal by Subject|8|||
146527236|NCT02317991|528438455|FG000|Overall Study|Progressive Disease|41|||
146527237|NCT00974311|528438459|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
146527238|NCT00974311|528438460|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
146527239|NCT00974311|528438459|FG000|DB Phase (up to 24 Months)|Death|561|||
146527240|NCT00974311|528438460|FG001|DB Phase (up to 24 Months)|Death|298|||
146527241|NCT00974311|528438459|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
146527242|NCT00974311|528438460|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
146527243|NCT00974311|528438459|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
146527244|NCT00974311|528438460|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
146527245|NCT00974311|528438459|FG000|DB Phase (up to 24 Months)|Other|1|||
146527246|NCT00974311|528438460|FG001|DB Phase (up to 24 Months)|Other|0|||
146527247|NCT00974311|528438459|FG000|OLE Phase (up to 77 Months)|Death|14|||
146527248|NCT00974311|528438460|FG001|OLE Phase (up to 77 Months)|Death|21|||
146527249|NCT00974311|528438459|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
146527250|NCT00974311|528438460|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
146527251|NCT00974311|528438459|FG000|OLE Phase (up to 77 Months)|Other|15|||
146527252|NCT00974311|528438460|FG001|OLE Phase (up to 77 Months)|Other|2|||
146527253|NCT00974311|528438459|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
146527254|NCT00974311|528438460|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
146527255|NCT00165503|528438461|FG000|Overall Study|Death|1|||
146527256|NCT00165503|528438461|FG000|Overall Study|Lost to Follow-up|12|||
146527257|NCT00165503|528438461|FG000|Overall Study|Unresectable|3|||
146527258|NCT02976519|528438462|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
146527259|NCT02976519|528438463|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
146527260|NCT02976519|528438464|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
146527261|NCT02976519|528438465|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
146527262|NCT02976519|528438466|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
146527263|NCT02976519|528438467|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
146527264|NCT02976519|528438468|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
146527265|NCT02976519|528438462|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
146527266|NCT02976519|528438463|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
146527267|NCT02976519|528438464|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
146527268|NCT02976519|528438465|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
146527269|NCT02976519|528438466|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
146527270|NCT02976519|528438467|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
146527271|NCT02976519|528438468|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
146527272|NCT02976519|528438462|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
146527273|NCT02976519|528438463|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
146527274|NCT02976519|528438464|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
146527275|NCT02976519|528438465|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
146527276|NCT02976519|528438466|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
146527277|NCT02976519|528438467|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
146527278|NCT02976519|528438468|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
146527279|NCT02976519|528438462|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
146527280|NCT02976519|528438463|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
146527281|NCT02976519|528438464|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
146527282|NCT02976519|528438465|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
146527283|NCT02976519|528438466|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
146527284|NCT02976519|528438467|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
146527285|NCT02976519|528438468|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
146527286|NCT02976519|528438462|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
146527287|NCT02976519|528438463|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
146527288|NCT02976519|528438464|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
146527289|NCT02976519|528438465|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
146527290|NCT02976519|528438466|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
146527291|NCT02976519|528438467|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
146527292|NCT02976519|528438468|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
146527293|NCT02346708|528438469|FG000|Overall Study|Adverse Event|2|||
146527294|NCT02346708|528438470|FG001|Overall Study|Adverse Event|0|||
146527295|NCT02346708|528438469|FG000|Overall Study|Protocol Violation|0|||
146527296|NCT02346708|528438470|FG001|Overall Study|Protocol Violation|1|||
146527297|NCT00928434|528438473|FG000|Overall Study|Adverse Event|14|||
146527298|NCT00928434|528438474|FG001|Overall Study|Adverse Event|5|||
146527299|NCT00928434|528438475|FG002|Overall Study|Adverse Event|18|||
146527300|NCT00928434|528438473|FG000|Overall Study|Protocol Violation|5|||
146527301|NCT00928434|528438474|FG001|Overall Study|Protocol Violation|0|||
146527302|NCT00928434|528438475|FG002|Overall Study|Protocol Violation|8|||
146527303|NCT00928434|528438473|FG000|Overall Study|Physician Decision|2|||
146527304|NCT00928434|528438474|FG001|Overall Study|Physician Decision|0|||
146527305|NCT00928434|528438475|FG002|Overall Study|Physician Decision|3|||
146527306|NCT00928434|528438473|FG000|Overall Study|Lost to Follow-up|1|||
146527307|NCT00928434|528438474|FG001|Overall Study|Lost to Follow-up|0|||
146527308|NCT00928434|528438475|FG002|Overall Study|Lost to Follow-up|3|||
146527309|NCT00928434|528438473|FG000|Overall Study|Withdrawal by Subject|5|||
146527310|NCT00928434|528438474|FG001|Overall Study|Withdrawal by Subject|3|||
146527311|NCT00928434|528438475|FG002|Overall Study|Withdrawal by Subject|2|||
146527312|NCT00928434|528438473|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
146527313|NCT00928434|528438474|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
146527314|NCT00928434|528438475|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
146527315|NCT00928434|528438473|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
146527316|NCT00928434|528438474|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
146527317|NCT00928434|528438475|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
146860290|NCT03952806|529659842|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
146860291|NCT03952806|529659843|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
146860292|NCT03952806|529659842|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
146860293|NCT03952806|529659843|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
146860294|NCT03952806|529659842|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
146860295|NCT03952806|529659843|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
146860296|NCT03952806|529659842|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
146860297|NCT03952806|529659843|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
146860298|NCT03952806|529659842|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
146860299|NCT03952806|529659843|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
146860300|NCT03952806|529659842|FG000|OLE Phase (48 Weeks)|Other|16|||
146860301|NCT03952806|529659843|FG001|OLE Phase (48 Weeks)|Other|13|||
146527318|NCT00928434|528438473|FG000|Overall Study|Other (not meeting above criteria)|5|||
146527319|NCT00928434|528438474|FG001|Overall Study|Other (not meeting above criteria)|1|||
146527320|NCT00928434|528438475|FG002|Overall Study|Other (not meeting above criteria)|2|||
146527321|NCT01278342|528438478|FG000|Overall Study|Physician Decision|0|||
146527322|NCT01278342|528438479|FG001|Overall Study|Physician Decision|1|||
146527323|NCT01278342|528438480|FG002|Overall Study|Physician Decision|0|||
146527324|NCT01278342|528438478|FG000|Overall Study|Lost to Follow-up|1|||
146527325|NCT01278342|528438479|FG001|Overall Study|Lost to Follow-up|0|||
146527326|NCT01278342|528438480|FG002|Overall Study|Lost to Follow-up|0|||
146860302|NCT02168842|529659848|FG000|Overall Study|Withdrawal by Subject|5|||
146965093|NCT03110107|530033431|FG005|Treatment Period|Adverse Event|2|||
146527327|NCT01278342|528438478|FG000|Overall Study|Administrative problems|2|||
146527328|NCT01278342|528438479|FG001|Overall Study|Administrative problems|0|||
146527329|NCT01278342|528438480|FG002|Overall Study|Administrative problems|0|||
146527330|NCT01278342|528438478|FG000|Overall Study|Other|1|||
146527331|NCT01278342|528438479|FG001|Overall Study|Other|0|||
146527332|NCT01278342|528438480|FG002|Overall Study|Other|0|||
146527333|NCT02157519|528438486|FG000|Overall Study|Death|3|||
146527334|NCT02157519|528438487|FG001|Overall Study|Death|1|||
146527335|NCT02157519|528438486|FG000|Overall Study|Withdrawal by Subject|7|||
146527336|NCT02157519|528438487|FG001|Overall Study|Withdrawal by Subject|0|||
146527337|NCT02157519|528438486|FG000|Overall Study|Lost to Follow-up|1|||
146527338|NCT02157519|528438487|FG001|Overall Study|Lost to Follow-up|0|||
146527339|NCT01656395|528438488|FG000|Overall Study|Adverse Event|1|||
146527340|NCT01656395|528438489|FG001|Overall Study|Adverse Event|14|||
146527341|NCT01656395|528438490|FG002|Overall Study|Adverse Event|5|||
146527342|NCT01656395|528438491|FG003|Overall Study|Adverse Event|4|||
146527343|NCT01656395|528438492|FG004|Overall Study|Adverse Event|5|||
146527344|NCT01656395|528438493|FG005|Overall Study|Adverse Event|7|||
146527345|NCT01656395|528438494|FG006|Overall Study|Adverse Event|0|||
146527346|NCT01656395|528438495|FG007|Overall Study|Adverse Event|0|||
146527347|NCT01656395|528438488|FG000|Overall Study|Lack of Efficacy|1|||
146527348|NCT01656395|528438489|FG001|Overall Study|Lack of Efficacy|8|||
146527349|NCT01656395|528438490|FG002|Overall Study|Lack of Efficacy|6|||
146527350|NCT01656395|528438491|FG003|Overall Study|Lack of Efficacy|1|||
146527351|NCT01656395|528438492|FG004|Overall Study|Lack of Efficacy|1|||
146527352|NCT01656395|528438493|FG005|Overall Study|Lack of Efficacy|6|||
146527353|NCT01656395|528438494|FG006|Overall Study|Lack of Efficacy|0|||
146527354|NCT01656395|528438495|FG007|Overall Study|Lack of Efficacy|0|||
146527355|NCT01656395|528438488|FG000|Overall Study|Lost to Follow-up|1|||
146527356|NCT01656395|528438489|FG001|Overall Study|Lost to Follow-up|0|||
146527357|NCT01656395|528438490|FG002|Overall Study|Lost to Follow-up|0|||
146527358|NCT01656395|528438491|FG003|Overall Study|Lost to Follow-up|0|||
146527359|NCT01656395|528438492|FG004|Overall Study|Lost to Follow-up|0|||
146527360|NCT01656395|528438493|FG005|Overall Study|Lost to Follow-up|0|||
146527361|NCT01656395|528438494|FG006|Overall Study|Lost to Follow-up|0|||
146527362|NCT01656395|528438495|FG007|Overall Study|Lost to Follow-up|0|||
146527363|NCT01656395|528438488|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146527364|NCT01656395|528438489|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146527365|NCT01656395|528438490|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146527366|NCT01656395|528438491|FG003|Overall Study|Non-Compliance with Study Drug|0|||
146527367|NCT01656395|528438492|FG004|Overall Study|Non-Compliance with Study Drug|1|||
146527368|NCT01656395|528438493|FG005|Overall Study|Non-Compliance with Study Drug|1|||
146527369|NCT01656395|528438494|FG006|Overall Study|Non-Compliance with Study Drug|0|||
146527370|NCT01656395|528438495|FG007|Overall Study|Non-Compliance with Study Drug|0|||
146527371|NCT01656395|528438488|FG000|Overall Study|Other|0|||
146527372|NCT01656395|528438489|FG001|Overall Study|Other|0|||
146527373|NCT01656395|528438490|FG002|Overall Study|Other|1|||
146527374|NCT01656395|528438491|FG003|Overall Study|Other|0|||
146527375|NCT01656395|528438492|FG004|Overall Study|Other|0|||
146527376|NCT01656395|528438493|FG005|Overall Study|Other|1|||
146527377|NCT01656395|528438494|FG006|Overall Study|Other|0|||
146527378|NCT01656395|528438495|FG007|Overall Study|Other|0|||
146527379|NCT01656395|528438488|FG000|Overall Study|Physician Decision|2|||
146527380|NCT01656395|528438489|FG001|Overall Study|Physician Decision|3|||
146527381|NCT01656395|528438490|FG002|Overall Study|Physician Decision|3|||
146527382|NCT01656395|528438491|FG003|Overall Study|Physician Decision|2|||
146527383|NCT01656395|528438492|FG004|Overall Study|Physician Decision|3|||
146527384|NCT01656395|528438493|FG005|Overall Study|Physician Decision|3|||
146527385|NCT01656395|528438494|FG006|Overall Study|Physician Decision|0|||
146527386|NCT01656395|528438495|FG007|Overall Study|Physician Decision|0|||
146527387|NCT01656395|528438488|FG000|Overall Study|Pregnancy|0|||
146527388|NCT01656395|528438489|FG001|Overall Study|Pregnancy|0|||
146527389|NCT01656395|528438490|FG002|Overall Study|Pregnancy|1|||
146527390|NCT01656395|528438491|FG003|Overall Study|Pregnancy|0|||
146527391|NCT01656395|528438492|FG004|Overall Study|Pregnancy|0|||
146527392|NCT01656395|528438493|FG005|Overall Study|Pregnancy|0|||
146527393|NCT01656395|528438494|FG006|Overall Study|Pregnancy|0|||
146527394|NCT01656395|528438495|FG007|Overall Study|Pregnancy|0|||
146527395|NCT01656395|528438488|FG000|Overall Study|Progressive Disease|0|||
146527396|NCT01656395|528438489|FG001|Overall Study|Progressive Disease|0|||
146527397|NCT01656395|528438490|FG002|Overall Study|Progressive Disease|0|||
146527398|NCT01656395|528438491|FG003|Overall Study|Progressive Disease|0|||
146527399|NCT01656395|528438492|FG004|Overall Study|Progressive Disease|0|||
146527400|NCT01656395|528438493|FG005|Overall Study|Progressive Disease|1|||
146527401|NCT01656395|528438494|FG006|Overall Study|Progressive Disease|0|||
146527402|NCT01656395|528438495|FG007|Overall Study|Progressive Disease|0|||
146527403|NCT01656395|528438488|FG000|Overall Study|Protocol Violation|6|||
146527404|NCT01656395|528438489|FG001|Overall Study|Protocol Violation|6|||
146527405|NCT01656395|528438490|FG002|Overall Study|Protocol Violation|9|||
146527406|NCT01656395|528438491|FG003|Overall Study|Protocol Violation|2|||
146527407|NCT01656395|528438492|FG004|Overall Study|Protocol Violation|4|||
146527408|NCT01656395|528438493|FG005|Overall Study|Protocol Violation|10|||
146527409|NCT01656395|528438494|FG006|Overall Study|Protocol Violation|0|||
146527410|NCT01656395|528438495|FG007|Overall Study|Protocol Violation|0|||
146527411|NCT01656395|528438488|FG000|Overall Study|Screen Failure|2|||
146527412|NCT01656395|528438489|FG001|Overall Study|Screen Failure|1|||
146527413|NCT01656395|528438490|FG002|Overall Study|Screen Failure|7|||
146527414|NCT01656395|528438491|FG003|Overall Study|Screen Failure|1|||
146527415|NCT01656395|528438492|FG004|Overall Study|Screen Failure|0|||
146527416|NCT01656395|528438493|FG005|Overall Study|Screen Failure|8|||
146527417|NCT01656395|528438494|FG006|Overall Study|Screen Failure|0|||
146527418|NCT01656395|528438495|FG007|Overall Study|Screen Failure|0|||
146527419|NCT01656395|528438488|FG000|Overall Study|Withdrawal by Subject|3|||
146760816|NCT02014558|529291074|FG002|Overall Study|Death|0|||
146760817|NCT02014558|529291075|FG003|Overall Study|Death|0|||
146760818|NCT02014558|529291076|FG004|Overall Study|Death|0|||
146760819|NCT02014558|529291077|FG005|Overall Study|Death|0|||
146760820|NCT02014558|529291078|FG006|Overall Study|Death|1|||
146860303|NCT02168842|529659849|FG001|Overall Study|Withdrawal by Subject|3|||
146860304|NCT02168842|529659848|FG000|Overall Study|Lost to Follow-up|0|||
146760821|NCT02014558|529291079|FG007|Overall Study|Death|1|||
146760822|NCT02014558|529291080|FG008|Overall Study|Death|2|||
146760823|NCT02014558|529291081|FG009|Overall Study|Death|5|||
146760824|NCT02014558|529291082|FG010|Overall Study|Death|5|||
146860305|NCT02168842|529659849|FG001|Overall Study|Lost to Follow-up|2|||
146860306|NCT02168842|529659848|FG000|Overall Study|Death|2|||
146860307|NCT02168842|529659849|FG001|Overall Study|Death|1|||
146527420|NCT01656395|528438489|FG001|Overall Study|Withdrawal by Subject|1|||
146527421|NCT01656395|528438490|FG002|Overall Study|Withdrawal by Subject|4|||
146527422|NCT01656395|528438491|FG003|Overall Study|Withdrawal by Subject|2|||
146527423|NCT01656395|528438492|FG004|Overall Study|Withdrawal by Subject|0|||
146527424|NCT01656395|528438493|FG005|Overall Study|Withdrawal by Subject|3|||
146527425|NCT01656395|528438494|FG006|Overall Study|Withdrawal by Subject|0|||
146527426|NCT01656395|528438495|FG007|Overall Study|Withdrawal by Subject|0|||
146527427|NCT02048722|528438502|FG000|2 Cycles of Treatment|Adverse Event|2|||
146527428|NCT02048722|528438502|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
146527429|NCT02048722|528438502|FG000|2 Cycles of Treatment|Progressive Disease|2|||
146860308|NCT02168842|529659848|FG000|Overall Study|Physician Decision|1|||
146860309|NCT02168842|529659849|FG001|Overall Study|Physician Decision|2|||
146860310|NCT02147353|529659850|FG000|Overall Study|Lost to Follow-up|2|||
146527430|NCT02048722|528438502|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
146527431|NCT02048722|528438502|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
146527432|NCT02048722|528438502|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
146527433|NCT04073303|528438504|FG000|Overall Study|Adverse Event|0|||
146527434|NCT04073303|528438505|FG001|Overall Study|Adverse Event|2|||
146527435|NCT04073303|528438504|FG000|Overall Study|Withdrawal by Subject|16|||
146527436|NCT04073303|528438505|FG001|Overall Study|Withdrawal by Subject|36|||
146527437|NCT04073303|528438504|FG000|Overall Study|Lost to Follow-up|6|||
146527438|NCT04073303|528438505|FG001|Overall Study|Lost to Follow-up|1|||
146527439|NCT04073303|528438504|FG000|Overall Study|Protocol Deviation|0|||
146527440|NCT04073303|528438505|FG001|Overall Study|Protocol Deviation|4|||
146527441|NCT04073303|528438504|FG000|Overall Study|Other|1|||
146527442|NCT04073303|528438505|FG001|Overall Study|Other|1|||
146527443|NCT03126786|528438513|FG000|Overall Study|Adverse Event|3|||
146527444|NCT03126786|528438514|FG001|Overall Study|Adverse Event|0|||
146527445|NCT03126786|528438513|FG000|Overall Study|Lost to Follow-up|0|||
146527446|NCT03126786|528438514|FG001|Overall Study|Lost to Follow-up|1|||
146527447|NCT03126786|528438513|FG000|Overall Study|Withdrawal by Subject|3|||
146527448|NCT03126786|528438514|FG001|Overall Study|Withdrawal by Subject|1|||
146527449|NCT00426764|528438515|FG000|Overall Study|Protocol Violation|1|||
146527450|NCT00426764|528438515|FG000|Overall Study|Withdrawal by Subject|4|||
146527451|NCT00426764|528438515|FG000|Overall Study|Physician Decision|6|||
146527452|NCT00426764|528438515|FG000|Overall Study|Compassionate Use|1|||
146527453|NCT00426764|528438515|FG000|Overall Study|Progressive Disease|83|||
146527454|NCT00426764|528438515|FG000|Overall Study|Adverse Event|24|||
146527455|NCT00426764|528438515|FG000|Overall Study|Other|1|||
146760825|NCT02014558|529291083|FG011|Overall Study|Death|19|||
146760826|NCT02014558|529291084|FG012|Overall Study|Death|2|||
146860311|NCT02147353|529659851|FG001|Overall Study|Lost to Follow-up|0|||
146860312|NCT02147353|529659850|FG000|Overall Study|unable to make visits|4|||
146860313|NCT02147353|529659851|FG001|Overall Study|unable to make visits|0|||
146860314|NCT02147353|529659850|FG000|Overall Study|medication noncompliance|3|||
146527456|NCT00426764|528438515|FG000|Overall Study|Death|1|||
146527457|NCT00426764|528438515|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
146527458|NCT00673257|528438516|FG000|Overall Study|Withdrawal by Subject|4|||
146527459|NCT00673257|528438516|FG000|Overall Study|Unable to obtain specimen|1|||
146527460|NCT01166750|528438523|FG000|Overall Study|Lost to Follow-up|1|||
146760827|NCT02014558|529291072|FG000|Overall Study|Lack of Efficacy|1|||
146527461|NCT01166750|528438524|FG001|Overall Study|Lost to Follow-up|0|||
146527462|NCT04396626|528438525|FG000|Overall Study|Premature termination of study|975|||
146527463|NCT02417753|528438526|FG000|Overall Study|Death|1|||
146527464|NCT03113968|528438527|FG000|Overall Study|Withdrawal by Subject|31|||
146527465|NCT03113968|528438528|FG001|Overall Study|Withdrawal by Subject|4|||
146527466|NCT04805671|528438529|FG000|Overall Study|Death|2|||
146527467|NCT04805671|528438530|FG001|Overall Study|Death|7|||
146527468|NCT04805671|528438529|FG000|Overall Study|Lost to Follow-up|1|||
146527469|NCT04805671|528438530|FG001|Overall Study|Lost to Follow-up|0|||
146527470|NCT04805671|528438529|FG000|Overall Study|Withdrawal by Subject|9|||
146527471|NCT04805671|528438530|FG001|Overall Study|Withdrawal by Subject|7|||
146527472|NCT04805671|528438529|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
146527473|NCT04805671|528438530|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
146527474|NCT02111174|528438531|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
146527475|NCT02111174|528438532|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
146527476|NCT02111174|528438531|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
146527477|NCT02111174|528438532|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
146527478|NCT02111174|528438531|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
146527479|NCT02111174|528438532|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
146527480|NCT02111174|528438531|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
146527481|NCT02111174|528438532|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
146527482|NCT00901342|528438533|FG000|Overall Study|Adverse Event|1|||
146527483|NCT00901342|528438533|FG000|Overall Study|Death|4|||
146527484|NCT00901342|528438533|FG000|Overall Study|Disease progression|1|||
146527485|NCT00901342|528438533|FG000|Overall Study|Withdrawal by Subject|9|||
146527486|NCT02849587|528438534|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
146527487|NCT02849587|528438535|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
146527488|NCT02849587|528438536|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
146760828|NCT02014558|529291073|FG001|Overall Study|Lack of Efficacy|2|||
146760829|NCT02014558|529291074|FG002|Overall Study|Lack of Efficacy|1|||
146760830|NCT02014558|529291075|FG003|Overall Study|Lack of Efficacy|1|||
146760831|NCT02014558|529291076|FG004|Overall Study|Lack of Efficacy|0|||
146760832|NCT02014558|529291077|FG005|Overall Study|Lack of Efficacy|0|||
146760833|NCT02014558|529291078|FG006|Overall Study|Lack of Efficacy|1|||
146760834|NCT02014558|529291079|FG007|Overall Study|Lack of Efficacy|3|||
146760835|NCT02014558|529291080|FG008|Overall Study|Lack of Efficacy|3|||
146760836|NCT02014558|529291081|FG009|Overall Study|Lack of Efficacy|3|||
146760837|NCT02014558|529291082|FG010|Overall Study|Lack of Efficacy|16|||
146760838|NCT02014558|529291083|FG011|Overall Study|Lack of Efficacy|8|||
146760839|NCT02014558|529291084|FG012|Overall Study|Lack of Efficacy|5|||
146760840|NCT02014558|529291072|FG000|Overall Study|Lost to Follow-up|0|||
146760841|NCT02014558|529291073|FG001|Overall Study|Lost to Follow-up|0|||
146760842|NCT02014558|529291074|FG002|Overall Study|Lost to Follow-up|0|||
146760843|NCT02014558|529291075|FG003|Overall Study|Lost to Follow-up|0|||
146760844|NCT02014558|529291076|FG004|Overall Study|Lost to Follow-up|0|||
146760845|NCT02014558|529291077|FG005|Overall Study|Lost to Follow-up|0|||
146760846|NCT02014558|529291078|FG006|Overall Study|Lost to Follow-up|0|||
146760847|NCT02014558|529291079|FG007|Overall Study|Lost to Follow-up|0|||
146760848|NCT02014558|529291080|FG008|Overall Study|Lost to Follow-up|0|||
146760849|NCT02014558|529291081|FG009|Overall Study|Lost to Follow-up|0|||
146760850|NCT02014558|529291082|FG010|Overall Study|Lost to Follow-up|1|||
146760851|NCT02014558|529291083|FG011|Overall Study|Lost to Follow-up|0|||
146760852|NCT02014558|529291084|FG012|Overall Study|Lost to Follow-up|0|||
146760853|NCT02014558|529291072|FG000|Overall Study|Progressive Disease|1|||
146760854|NCT02014558|529291073|FG001|Overall Study|Progressive Disease|0|||
146760855|NCT02014558|529291074|FG002|Overall Study|Progressive Disease|1|||
146760856|NCT02014558|529291075|FG003|Overall Study|Progressive Disease|1|||
146760857|NCT02014558|529291076|FG004|Overall Study|Progressive Disease|1|||
146760858|NCT02014558|529291077|FG005|Overall Study|Progressive Disease|2|||
146760859|NCT02014558|529291078|FG006|Overall Study|Progressive Disease|1|||
146760860|NCT02014558|529291079|FG007|Overall Study|Progressive Disease|6|||
146760861|NCT02014558|529291080|FG008|Overall Study|Progressive Disease|5|||
146760862|NCT02014558|529291081|FG009|Overall Study|Progressive Disease|6|||
146760863|NCT02014558|529291082|FG010|Overall Study|Progressive Disease|22|||
146760864|NCT02014558|529291083|FG011|Overall Study|Progressive Disease|31|||
146760865|NCT02014558|529291084|FG012|Overall Study|Progressive Disease|6|||
146760866|NCT02014558|529291072|FG000|Overall Study|Withdrawal by Subject|0|||
146760867|NCT02014558|529291073|FG001|Overall Study|Withdrawal by Subject|0|||
146760868|NCT02014558|529291074|FG002|Overall Study|Withdrawal by Subject|0|||
146760869|NCT02014558|529291075|FG003|Overall Study|Withdrawal by Subject|0|||
146760870|NCT02014558|529291076|FG004|Overall Study|Withdrawal by Subject|1|||
146760871|NCT02014558|529291077|FG005|Overall Study|Withdrawal by Subject|0|||
146760872|NCT02014558|529291078|FG006|Overall Study|Withdrawal by Subject|0|||
146760873|NCT02014558|529291079|FG007|Overall Study|Withdrawal by Subject|0|||
146860315|NCT02147353|529659851|FG001|Overall Study|medication noncompliance|0|||
146527489|NCT02849587|528438534|FG000|Overall Study|Withdrawal by Subject|0|||
146527490|NCT02849587|528438535|FG001|Overall Study|Withdrawal by Subject|1|||
146527491|NCT02849587|528438536|FG002|Overall Study|Withdrawal by Subject|0|||
146527492|NCT03380377|528438539|FG000|Overall Study|Physician Decision|1|||
146527493|NCT03380377|528438539|FG000|Overall Study|Withdrawal by Subject|1|||
146527494|NCT02716779|528438540|FG000|Monotherapy|Adverse Event|0|||
146527495|NCT02716779|528438541|FG001|Monotherapy|Adverse Event|1|||
146527496|NCT02716779|528438542|FG002|Monotherapy|Adverse Event|1|||
146527497|NCT02716779|528438540|FG000|Combination Therapy|Adverse Event|0|||
146527498|NCT02716779|528438541|FG001|Combination Therapy|Adverse Event|2|||
146527499|NCT02716779|528438542|FG002|Combination Therapy|Adverse Event|1|||
146527500|NCT02600923|528438545|FG000|Overall Study|Death|10|||
146527501|NCT02600923|528438545|FG000|Overall Study|Adverse Event|3|||
146527502|NCT02600923|528438545|FG000|Overall Study|Global deterioration of health status|2|||
146527503|NCT02600923|528438545|FG000|Overall Study|Insufficient clinical response|6|||
146527504|NCT02600923|528438545|FG000|Overall Study|Lost to Follow-up|1|||
146527505|NCT02600923|528438545|FG000|Overall Study|Withdrawal by Subject|5|||
146527506|NCT02600923|528438545|FG000|Overall Study|Objective progression or relapse|50|||
146527507|NCT02600923|528438545|FG000|Overall Study|Study terminated by Sponsor|53|||
146527508|NCT02600923|528438545|FG000|Overall Study|Not treated|1|||
146527509|NCT00792909|528438546|FG000|Overall Study|Withdrawal by Subject|0|||
146527510|NCT00792909|528438547|FG001|Overall Study|Withdrawal by Subject|1|||
146527511|NCT00792909|528438548|FG002|Overall Study|Withdrawal by Subject|0|||
146527512|NCT01261390|528438553|FG000|Overall Study|Significant Concurrent Illness|1|||
146527513|NCT01261390|528438554|FG001|Overall Study|Significant Concurrent Illness|0|||
146527514|NCT01261390|528438555|FG002|Overall Study|Significant Concurrent Illness|1|||
146527515|NCT01261390|528438556|FG003|Overall Study|Significant Concurrent Illness|0|||
146527516|NCT01261390|528438553|FG000|Overall Study|Dissatisfaction with Treatment|2|||
146527517|NCT01261390|528438554|FG001|Overall Study|Dissatisfaction with Treatment|1|||
146527518|NCT01261390|528438555|FG002|Overall Study|Dissatisfaction with Treatment|1|||
146527519|NCT01261390|528438556|FG003|Overall Study|Dissatisfaction with Treatment|2|||
146527520|NCT01261390|528438553|FG000|Overall Study|Relocation|0|||
146527521|NCT01261390|528438554|FG001|Overall Study|Relocation|1|||
146527522|NCT01261390|528438555|FG002|Overall Study|Relocation|0|||
146527523|NCT01261390|528438556|FG003|Overall Study|Relocation|0|||
146527524|NCT01261390|528438553|FG000|Overall Study|Loss of Interest in the Study|3|||
146527525|NCT01261390|528438554|FG001|Overall Study|Loss of Interest in the Study|1|||
146760874|NCT02014558|529291080|FG008|Overall Study|Withdrawal by Subject|0|||
146760875|NCT02014558|529291081|FG009|Overall Study|Withdrawal by Subject|2|||
146760876|NCT02014558|529291082|FG010|Overall Study|Withdrawal by Subject|6|||
146760877|NCT02014558|529291083|FG011|Overall Study|Withdrawal by Subject|10|||
146760878|NCT02014558|529291084|FG012|Overall Study|Withdrawal by Subject|0|||
146760879|NCT02014558|529291072|FG000|Overall Study|Miscellaneous|2|||
146760880|NCT02014558|529291073|FG001|Overall Study|Miscellaneous|1|||
146760881|NCT02014558|529291074|FG002|Overall Study|Miscellaneous|1|||
146760882|NCT02014558|529291075|FG003|Overall Study|Miscellaneous|1|||
146760883|NCT02014558|529291076|FG004|Overall Study|Miscellaneous|0|||
146760884|NCT02014558|529291077|FG005|Overall Study|Miscellaneous|1|||
146760885|NCT02014558|529291078|FG006|Overall Study|Miscellaneous|0|||
146760886|NCT02014558|529291079|FG007|Overall Study|Miscellaneous|1|||
146760887|NCT02014558|529291080|FG008|Overall Study|Miscellaneous|1|||
146760888|NCT02014558|529291081|FG009|Overall Study|Miscellaneous|3|||
146760889|NCT02014558|529291082|FG010|Overall Study|Miscellaneous|12|||
146760890|NCT02014558|529291083|FG011|Overall Study|Miscellaneous|11|||
146760891|NCT02014558|529291084|FG012|Overall Study|Miscellaneous|1|||
146760892|NCT00299702|529291087|FG000|Overall Study|Death|1|||
146760893|NCT00299702|529291088|FG001|Overall Study|Death|0|||
146760894|NCT00299702|529291087|FG000|Overall Study|Adverse Event|0|||
146760895|NCT00299702|529291088|FG001|Overall Study|Adverse Event|4|||
146760896|NCT00299702|529291087|FG000|Overall Study|Lost to Follow-up|18|||
146760897|NCT00299702|529291088|FG001|Overall Study|Lost to Follow-up|10|||
146760898|NCT00299702|529291087|FG000|Overall Study|Withdrawal by Subject|25|||
146760899|NCT00299702|529291088|FG001|Overall Study|Withdrawal by Subject|23|||
146760900|NCT00299702|529291087|FG000|Overall Study|Pregnancy|0|||
146760901|NCT00299702|529291088|FG001|Overall Study|Pregnancy|1|||
146760902|NCT00299702|529291087|FG000|Overall Study|Insufficient Response|4|||
146760903|NCT00299702|529291088|FG001|Overall Study|Insufficient Response|3|||
146527526|NCT01261390|528438555|FG002|Overall Study|Loss of Interest in the Study|0|||
146527527|NCT01261390|528438556|FG003|Overall Study|Loss of Interest in the Study|0|||
146527528|NCT01261390|528438553|FG000|Overall Study|Lost to Follow-up|1|||
146527529|NCT01261390|528438554|FG001|Overall Study|Lost to Follow-up|6|||
146527530|NCT01261390|528438555|FG002|Overall Study|Lost to Follow-up|5|||
146760904|NCT00299702|529291087|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
146760905|NCT00299702|529291088|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
146760906|NCT01560949|529291089|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
146760907|NCT01560949|529291089|FG000|Surgery Phase|Physician Decision|3|||
146760908|NCT00751036|529291090|FG000|Overall Study|Disease Progression|28|||
146760909|NCT00751036|529291091|FG001|Overall Study|Disease Progression|29|||
146527531|NCT01261390|528438556|FG003|Overall Study|Lost to Follow-up|6|||
146527532|NCT03421379|528438557|FG000|Period 1|Withdrawal by Subject|0|||
146527533|NCT03421379|528438558|FG001|Period 1|Withdrawal by Subject|1|||
146527534|NCT03421379|528438557|FG000|Period 1|Physician Decision|1|||
146527535|NCT03421379|528438558|FG001|Period 1|Physician Decision|1|||
146527536|NCT03421379|528438557|FG000|Period 1|Did not receive treatment|1|||
146527537|NCT03421379|528438558|FG001|Period 1|Did not receive treatment|2|||
146527538|NCT01497067|528438560|FG000|Overall Study|Lost to Follow-up|56|||
146527539|NCT01497067|528438560|FG000|Overall Study|Adverse Event|3|||
146527540|NCT01497067|528438560|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
146527541|NCT01497067|528438560|FG000|Overall Study|Other|13|||
146527542|NCT03771963|528438561|FG000|Overall Study|Lost to Follow-up|22|||
146527543|NCT03771963|528438561|FG000|Overall Study|Withdrawal of Consent|10|||
146527544|NCT02324361|528438562|FG000|Overall Study|Lost to Follow-up|5|||
146527545|NCT02324361|528438563|FG001|Overall Study|Lost to Follow-up|2|||
146527546|NCT00003471|528438566|FG000|Overall Study|Not evaluable|4|||
146527547|NCT00715403|528438567|FG000|Overall Study|Progressive disease|0|||
146527548|NCT00715403|528438568|FG001|Overall Study|Progressive disease|1|||
146527549|NCT00715403|528438569|FG002|Overall Study|Progressive disease|3|||
146527550|NCT00715403|528438570|FG003|Overall Study|Progressive disease|9|||
146527551|NCT00715403|528438571|FG004|Overall Study|Progressive disease|5|||
146527552|NCT00715403|528438572|FG005|Overall Study|Progressive disease|14|||
146527553|NCT00715403|528438573|FG006|Overall Study|Progressive disease|1|||
146527554|NCT00715403|528438567|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
146527555|NCT00715403|528438568|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
146527556|NCT00715403|528438569|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
146527557|NCT00715403|528438570|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
146527558|NCT00715403|528438571|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
146527559|NCT00715403|528438572|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
146527560|NCT00715403|528438573|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
146527561|NCT00715403|528438567|FG000|Overall Study|Other Adverse Event than DLT|1|||
146527562|NCT00715403|528438568|FG001|Overall Study|Other Adverse Event than DLT|0|||
146527563|NCT00715403|528438569|FG002|Overall Study|Other Adverse Event than DLT|0|||
146527564|NCT00715403|528438570|FG003|Overall Study|Other Adverse Event than DLT|0|||
146527565|NCT00715403|528438571|FG004|Overall Study|Other Adverse Event than DLT|0|||
146527566|NCT00715403|528438572|FG005|Overall Study|Other Adverse Event than DLT|2|||
146527567|NCT00715403|528438573|FG006|Overall Study|Other Adverse Event than DLT|0|||
146527568|NCT00715403|528438567|FG000|Overall Study|Protocol Violation|0|||
146527569|NCT00715403|528438568|FG001|Overall Study|Protocol Violation|0|||
146527570|NCT00715403|528438569|FG002|Overall Study|Protocol Violation|0|||
146527571|NCT00715403|528438570|FG003|Overall Study|Protocol Violation|0|||
146527572|NCT00715403|528438571|FG004|Overall Study|Protocol Violation|0|||
146527573|NCT00715403|528438572|FG005|Overall Study|Protocol Violation|1|||
146527574|NCT00715403|528438573|FG006|Overall Study|Protocol Violation|0|||
146527575|NCT00715403|528438567|FG000|Overall Study|Other reason not defined above|0|||
146527576|NCT00715403|528438568|FG001|Overall Study|Other reason not defined above|0|||
146527577|NCT00715403|528438569|FG002|Overall Study|Other reason not defined above|1|||
146527578|NCT00715403|528438570|FG003|Overall Study|Other reason not defined above|0|||
146527579|NCT00715403|528438571|FG004|Overall Study|Other reason not defined above|1|||
146527580|NCT00715403|528438572|FG005|Overall Study|Other reason not defined above|1|||
146527581|NCT00715403|528438573|FG006|Overall Study|Other reason not defined above|0|||
146527582|NCT04235504|528438577|FG000|Study Phase|Withdrawal by Subject|5|||
146527583|NCT04235504|528438578|FG001|Study Phase|Withdrawal by Subject|2|||
146527584|NCT04235504|528438579|FG002|Study Phase|Withdrawal by Subject|0|||
146527585|NCT04235504|528438580|FG003|Study Phase|Withdrawal by Subject|0|||
146527586|NCT04235504|528438577|FG000|Continuation Phase|Withdrawal by Subject|0|||
146527587|NCT04235504|528438578|FG001|Continuation Phase|Withdrawal by Subject|4|||
146527588|NCT04235504|528438579|FG002|Continuation Phase|Withdrawal by Subject|0|||
146527589|NCT04235504|528438580|FG003|Continuation Phase|Withdrawal by Subject|0|||
146527590|NCT04235504|528438577|FG000|Continuation Phase|Adverse Event|0|||
146527591|NCT04235504|528438578|FG001|Continuation Phase|Adverse Event|1|||
146527592|NCT04235504|528438579|FG002|Continuation Phase|Adverse Event|0|||
146527593|NCT04235504|528438580|FG003|Continuation Phase|Adverse Event|0|||
146527594|NCT04235504|528438577|FG000|Continuation Phase|Physician Decision|1|||
146527595|NCT04235504|528438578|FG001|Continuation Phase|Physician Decision|2|||
146527596|NCT04235504|528438579|FG002|Continuation Phase|Physician Decision|1|||
146527597|NCT04235504|528438580|FG003|Continuation Phase|Physician Decision|0|||
146527598|NCT00101868|528438587|FG000|Overall Study|Death|10|||
146527599|NCT00101868|528438588|FG001|Overall Study|Death|10|||
146527600|NCT00101868|528438587|FG000|Overall Study|Withdrawal by Subject|8|||
146527601|NCT00101868|528438588|FG001|Overall Study|Withdrawal by Subject|9|||
146527602|NCT00101868|528438587|FG000|Overall Study|Protocol Violation|3|||
146527603|NCT00101868|528438588|FG001|Overall Study|Protocol Violation|0|||
146527604|NCT00101868|528438587|FG000|Overall Study|Lost to Follow-up|8|||
146527605|NCT00101868|528438588|FG001|Overall Study|Lost to Follow-up|13|||
146527606|NCT03839394|528438589|FG000|Overall Study|Lost to Follow-up|6|||
146860316|NCT01971203|529659853|FG000|Overall Study|Protocol Violation|3|||
146527607|NCT03839394|528438590|FG001|Overall Study|Lost to Follow-up|8|||
146527608|NCT03839394|528438589|FG000|Overall Study|Withdrawal by Subject|0|||
146527609|NCT03839394|528438590|FG001|Overall Study|Withdrawal by Subject|2|||
146527610|NCT04001803|528438591|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
146527611|NCT04001803|528438591|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
146527612|NCT04001803|528438591|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
146527613|NCT04001803|528438591|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
146527614|NCT04001803|528438591|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
146527615|NCT04001803|528438591|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
146527616|NCT04001803|528438591|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
146527617|NCT04001803|528438591|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
146527618|NCT04001803|528438591|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
146527619|NCT04001803|528438591|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
146527620|NCT01931397|528438592|FG000|Overall Study|Physician Decision|2|||
146527621|NCT01931397|528438592|FG000|Overall Study|Withdrawal by Subject|8|||
146527622|NCT01931397|528438592|FG000|Overall Study|moved out of state|1|||
146527623|NCT01367249|528438596|FG000|Overall Study|Withdrawal by Subject|6|||
146527624|NCT01367249|528438597|FG001|Overall Study|Withdrawal by Subject|6|||
146527625|NCT01367249|528438596|FG000|Overall Study|Other|3|||
146527626|NCT01367249|528438597|FG001|Overall Study|Other|10|||
146527627|NCT05404711|528438598|FG000|Completed Study Visit|Withdrawal by Subject|1|||
146527628|NCT05404711|528438598|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
146527629|NCT05404711|528438598|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
146527630|NCT05404711|528438598|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
146527631|NCT05404711|528438598|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
146527632|NCT05404711|528438598|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
146527633|NCT02346877|528438599|FG000|Overall Study|Adverse Event|1|||
146527634|NCT02346877|528438600|FG001|Overall Study|Adverse Event|0|||
146527635|NCT02346877|528438599|FG000|Overall Study|Administrative Decision|1|||
146527636|NCT02346877|528438600|FG001|Overall Study|Administrative Decision|0|||
146527637|NCT02346877|528438599|FG000|Overall Study|Sponsor Decision|12|||
146527638|NCT02346877|528438600|FG001|Overall Study|Sponsor Decision|0|||
146527639|NCT02346877|528438599|FG000|Overall Study|Missing|5|||
146527640|NCT02346877|528438600|FG001|Overall Study|Missing|0|||
146527641|NCT01817075|528438601|FG000|Overall Study|Adverse Event|7|||
146527642|NCT01817075|528438602|FG001|Overall Study|Adverse Event|5|||
146527643|NCT01817075|528438601|FG000|Overall Study|Physician Decision|9|||
146527644|NCT01817075|528438602|FG001|Overall Study|Physician Decision|12|||
146527645|NCT01817075|528438601|FG000|Overall Study|Withdrawal by Subject|31|||
146527646|NCT01817075|528438602|FG001|Overall Study|Withdrawal by Subject|15|||
146527647|NCT01817075|528438601|FG000|Overall Study|Received Sorafenib after enrollment|0|||
146527648|NCT01817075|528438602|FG001|Overall Study|Received Sorafenib after enrollment|1|||
146527649|NCT01817075|528438601|FG000|Overall Study|Ineligible|0|||
146527650|NCT01817075|528438602|FG001|Overall Study|Ineligible|2|||
146527651|NCT01051921|528440240|FG000|Overall Study|Physician Decision|9|||
146527652|NCT01051921|528440240|FG000|Overall Study|Adverse Event|8|||
146527653|NCT01051921|528440240|FG000|Overall Study|Withdrawal by Subject|7|||
146527654|NCT01051921|528440240|FG000|Overall Study|Lost to Follow-up|4|||
146527655|NCT01051921|528440240|FG000|Overall Study|virological failure|1|||
146527656|NCT01051921|528440240|FG000|Overall Study|patient moved|1|||
146527657|NCT01001429|528440241|FG000|Overall Study|surgery cancelled|0|||
146527658|NCT01001429|528440242|FG001|Overall Study|surgery cancelled|1|||
146527659|NCT01063855|528440243|FG000|Overall Study|Adverse Event|4|||
146527660|NCT01063855|528440244|FG001|Overall Study|Adverse Event|4|||
146527661|NCT01063855|528440243|FG000|Overall Study|Death|0|||
146527662|NCT01063855|528440244|FG001|Overall Study|Death|1|||
146527663|NCT01063855|528440243|FG000|Overall Study|Lost to Follow-up|8|||
146527664|NCT01063855|528440244|FG001|Overall Study|Lost to Follow-up|4|||
146527665|NCT01063855|528440243|FG000|Overall Study|Pregnancy|1|||
146527666|NCT01063855|528440244|FG001|Overall Study|Pregnancy|0|||
146760910|NCT00751036|529291090|FG000|Overall Study|Adverse Event|6|||
146760911|NCT00751036|529291091|FG001|Overall Study|Adverse Event|4|||
146760912|NCT00751036|529291090|FG000|Overall Study|Administrative Problems|3|||
146760913|NCT00751036|529291091|FG001|Overall Study|Administrative Problems|4|||
146527667|NCT01063855|528440243|FG000|Overall Study|Lack of Efficacy|0|||
146527668|NCT01063855|528440244|FG001|Overall Study|Lack of Efficacy|1|||
146527669|NCT01063855|528440243|FG000|Overall Study|Withdrawal by Subject|11|||
146527670|NCT01063855|528440244|FG001|Overall Study|Withdrawal by Subject|8|||
146527671|NCT01063855|528440243|FG000|Overall Study|Reason not specified|13|||
146527672|NCT01063855|528440244|FG001|Overall Study|Reason not specified|11|||
146527673|NCT01165307|528440245|FG000|Overall Study|Lost to Follow-up|11|||
146527674|NCT01165307|528440246|FG001|Overall Study|Lost to Follow-up|3|||
146527675|NCT01165307|528440245|FG000|Overall Study|Withdrawal by Subject|2|||
146527676|NCT01165307|528440246|FG001|Overall Study|Withdrawal by Subject|0|||
146760914|NCT00751036|529291090|FG000|Overall Study|Withdrawal by Subject|5|||
146760915|NCT00751036|529291091|FG001|Overall Study|Withdrawal by Subject|2|||
146527677|NCT01165307|528440245|FG000|Overall Study|Subject not available for contact|1|||
146527678|NCT01165307|528440246|FG001|Overall Study|Subject not available for contact|0|||
146527679|NCT03627832|528440251|FG000|Overall Study|Withdrawal by Subject|10|||
146527680|NCT03627832|528440252|FG001|Overall Study|Withdrawal by Subject|1|||
146527681|NCT00048035|528440258|FG000|Core Period|Early Withdrawals|4|||
146527682|NCT00048035|528440259|FG001|Core Period|Early Withdrawals|2|||
146527683|NCT00048035|528440260|FG002|Core Period|Early Withdrawals|1|||
146527684|NCT00048035|528440261|FG003|Core Period|Early Withdrawals|1|||
146527685|NCT00048035|528440262|FG004|Core Period|Early Withdrawals|1|||
146527686|NCT00048035|528440263|FG005|Core Period|Early Withdrawals|1|||
146527687|NCT00048035|528440264|FG006|Core Period|Early Withdrawals|0|||
146527688|NCT00048035|528440265|FG007|Core Period|Early Withdrawals|0|||
146527689|NCT00048035|528440258|FG000|Extension Year 1|Early Withdrawals|0|||
146527690|NCT00048035|528440259|FG001|Extension Year 1|Early Withdrawals|0|||
146527691|NCT00048035|528440260|FG002|Extension Year 1|Early Withdrawals|0|||
146527692|NCT00048035|528440261|FG003|Extension Year 1|Early Withdrawals|0|||
146527693|NCT00048035|528440262|FG004|Extension Year 1|Early Withdrawals|0|||
146527694|NCT00048035|528440263|FG005|Extension Year 1|Early Withdrawals|0|||
146527695|NCT00048035|528440264|FG006|Extension Year 1|Early Withdrawals|11|||
146527696|NCT00048035|528440265|FG007|Extension Year 1|Early Withdrawals|11|||
146527697|NCT00048035|528440258|FG000|Extension Year 2|Early Withdrawals|0|||
146527698|NCT00048035|528440259|FG001|Extension Year 2|Early Withdrawals|0|||
146527699|NCT00048035|528440260|FG002|Extension Year 2|Early Withdrawals|0|||
146527700|NCT00048035|528440261|FG003|Extension Year 2|Early Withdrawals|0|||
146527701|NCT00048035|528440262|FG004|Extension Year 2|Early Withdrawals|0|||
146527702|NCT00048035|528440263|FG005|Extension Year 2|Early Withdrawals|0|||
146527703|NCT00048035|528440264|FG006|Extension Year 2|Early Withdrawals|3|||
146527704|NCT00048035|528440265|FG007|Extension Year 2|Early Withdrawals|3|||
146527705|NCT05137717|528440266|FG000|Overall Study|Death|2|||
146527706|NCT05137717|528440266|FG000|Overall Study|Withdrawal by Subject|6|||
146527707|NCT02619617|528440267|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
146527708|NCT02619617|528440268|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
146527709|NCT02619617|528440267|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
146527710|NCT02619617|528440268|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
146527711|NCT00509899|528440270|FG000|Overall Study|Progressive disease|1|||
146527712|NCT00509899|528440271|FG001|Overall Study|Progressive disease|3|||
146527713|NCT00509899|528440272|FG002|Overall Study|Progressive disease|5|||
146527714|NCT00509899|528440273|FG003|Overall Study|Progressive disease|1|||
146527715|NCT00509899|528440274|FG004|Overall Study|Progressive disease|0|||
146527716|NCT00509899|528440275|FG005|Overall Study|Progressive disease|1|||
146527717|NCT00509899|528440276|FG006|Overall Study|Progressive disease|0|||
146527718|NCT00509899|528440277|FG007|Overall Study|Progressive disease|0|||
146527719|NCT00509899|528440270|FG000|Overall Study|Unacceptable Toxicity|1|||
146527720|NCT00509899|528440271|FG001|Overall Study|Unacceptable Toxicity|0|||
146527721|NCT00509899|528440272|FG002|Overall Study|Unacceptable Toxicity|0|||
146527722|NCT00509899|528440273|FG003|Overall Study|Unacceptable Toxicity|2|||
146527723|NCT00509899|528440274|FG004|Overall Study|Unacceptable Toxicity|0|||
146527724|NCT00509899|528440275|FG005|Overall Study|Unacceptable Toxicity|0|||
146527725|NCT00509899|528440276|FG006|Overall Study|Unacceptable Toxicity|0|||
146527726|NCT00509899|528440277|FG007|Overall Study|Unacceptable Toxicity|0|||
146527727|NCT00509899|528440270|FG000|Overall Study|Withdrawal by Subject|6|||
146527728|NCT00509899|528440271|FG001|Overall Study|Withdrawal by Subject|2|||
146527729|NCT00509899|528440272|FG002|Overall Study|Withdrawal by Subject|3|||
146527730|NCT00509899|528440273|FG003|Overall Study|Withdrawal by Subject|0|||
146527731|NCT00509899|528440274|FG004|Overall Study|Withdrawal by Subject|3|||
146527732|NCT00509899|528440275|FG005|Overall Study|Withdrawal by Subject|2|||
146527733|NCT00509899|528440276|FG006|Overall Study|Withdrawal by Subject|0|||
146527734|NCT00509899|528440277|FG007|Overall Study|Withdrawal by Subject|0|||
146527735|NCT00509899|528440270|FG000|Overall Study|Physician Decision|4|||
146527736|NCT00509899|528440271|FG001|Overall Study|Physician Decision|2|||
146527737|NCT00509899|528440272|FG002|Overall Study|Physician Decision|7|||
146760916|NCT00751036|529291090|FG000|Overall Study|Death|3|||
146760917|NCT00751036|529291091|FG001|Overall Study|Death|3|||
146760918|NCT00751036|529291090|FG000|Overall Study|Lost to Follow-up|0|||
146760919|NCT00751036|529291091|FG001|Overall Study|Lost to Follow-up|1|||
146760920|NCT00751036|529291090|FG000|Overall Study|Protocol Violation|1|||
146760921|NCT00751036|529291091|FG001|Overall Study|Protocol Violation|0|||
146760922|NCT00751036|529291090|FG000|Overall Study|Missing end of Treatment Page|2|||
146965094|NCT03110107|530033432|FG006|Treatment Period|Adverse Event|0|||
146527738|NCT00509899|528440273|FG003|Overall Study|Physician Decision|0|||
146527739|NCT00509899|528440274|FG004|Overall Study|Physician Decision|1|||
146760923|NCT00751036|529291091|FG001|Overall Study|Missing end of Treatment Page|3|||
146760924|NCT04580407|529291092|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
146527740|NCT00509899|528440275|FG005|Overall Study|Physician Decision|4|||
146527741|NCT00509899|528440276|FG006|Overall Study|Physician Decision|0|||
146527742|NCT00509899|528440277|FG007|Overall Study|Physician Decision|0|||
146760925|NCT01562743|529291100|FG000|Overall Study|Adverse Event|29|||
146760926|NCT01562743|529291100|FG000|Overall Study|Lack of Efficacy|3|||
146760927|NCT01562743|529291100|FG000|Overall Study|Withdrawal by Subject|13|||
146760928|NCT01562743|529291100|FG000|Overall Study|Protocol Violation|1|||
146760929|NCT01562743|529291100|FG000|Overall Study|Discontinuation criteria|2|||
146760930|NCT01562743|529291100|FG000|Overall Study|Lost to Follow-up|2|||
146760931|NCT01562743|529291100|FG000|Overall Study|Physician Decision|2|||
146527743|NCT00509899|528440270|FG000|Overall Study|Intercurrent Illness|1|||
146527744|NCT00509899|528440271|FG001|Overall Study|Intercurrent Illness|0|||
146527745|NCT00509899|528440272|FG002|Overall Study|Intercurrent Illness|0|||
146527746|NCT00509899|528440273|FG003|Overall Study|Intercurrent Illness|1|||
146527747|NCT00509899|528440274|FG004|Overall Study|Intercurrent Illness|0|||
146527748|NCT00509899|528440275|FG005|Overall Study|Intercurrent Illness|1|||
146527749|NCT00509899|528440276|FG006|Overall Study|Intercurrent Illness|0|||
146527750|NCT00509899|528440277|FG007|Overall Study|Intercurrent Illness|0|||
146527751|NCT00509899|528440270|FG000|Overall Study|Death|2|||
146527752|NCT00509899|528440271|FG001|Overall Study|Death|2|||
146527753|NCT00509899|528440272|FG002|Overall Study|Death|3|||
146527754|NCT00509899|528440273|FG003|Overall Study|Death|0|||
146527755|NCT00509899|528440274|FG004|Overall Study|Death|1|||
146527756|NCT00509899|528440275|FG005|Overall Study|Death|1|||
146527757|NCT00509899|528440276|FG006|Overall Study|Death|1|||
146527758|NCT00509899|528440277|FG007|Overall Study|Death|1|||
146527759|NCT00509899|528440270|FG000|Overall Study|Lack of Efficacy|1|||
146527760|NCT00509899|528440271|FG001|Overall Study|Lack of Efficacy|0|||
146527761|NCT00509899|528440272|FG002|Overall Study|Lack of Efficacy|2|||
146527762|NCT00509899|528440273|FG003|Overall Study|Lack of Efficacy|0|||
146527763|NCT00509899|528440274|FG004|Overall Study|Lack of Efficacy|0|||
146527764|NCT00509899|528440275|FG005|Overall Study|Lack of Efficacy|1|||
146527765|NCT00509899|528440276|FG006|Overall Study|Lack of Efficacy|0|||
146527766|NCT00509899|528440277|FG007|Overall Study|Lack of Efficacy|0|||
146527767|NCT01711983|528440282|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
146527768|NCT01711983|528440282|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
146527769|NCT01711983|528440282|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
146527770|NCT01711983|528440282|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
146527771|NCT00737100|528440283|FG000|Overall Study|Adverse Event|6|||
146527772|NCT00737100|528440284|FG001|Overall Study|Adverse Event|5|||
146527773|NCT00737100|528440285|FG002|Overall Study|Adverse Event|3|||
146527774|NCT00737100|528440283|FG000|Overall Study|Lost to Follow-up|0|||
146527775|NCT00737100|528440284|FG001|Overall Study|Lost to Follow-up|1|||
146527776|NCT00737100|528440285|FG002|Overall Study|Lost to Follow-up|0|||
146527777|NCT00737100|528440283|FG000|Overall Study|Withdrawal by Subject|0|||
146527778|NCT00737100|528440284|FG001|Overall Study|Withdrawal by Subject|0|||
146527779|NCT00737100|528440285|FG002|Overall Study|Withdrawal by Subject|3|||
146527780|NCT00737100|528440283|FG000|Overall Study|Reason discontinued not explained above|1|||
146527781|NCT00737100|528440284|FG001|Overall Study|Reason discontinued not explained above|1|||
146527782|NCT00737100|528440285|FG002|Overall Study|Reason discontinued not explained above|1|||
146527783|NCT03713684|528440288|FG000|Overall Study|Adverse Event|1|||
146527784|NCT03713684|528440289|FG001|Overall Study|Adverse Event|3|||
146527785|NCT03713684|528440290|FG002|Overall Study|Adverse Event|1|||
146527786|NCT03713684|528440291|FG003|Overall Study|Adverse Event|0|||
146527787|NCT03713684|528440288|FG000|Overall Study|Poor compliance to protocol|2|||
146527788|NCT03713684|528440289|FG001|Overall Study|Poor compliance to protocol|1|||
146527789|NCT03713684|528440290|FG002|Overall Study|Poor compliance to protocol|0|||
146527790|NCT03713684|528440291|FG003|Overall Study|Poor compliance to protocol|1|||
146527791|NCT03713684|528440288|FG000|Overall Study|Withdrawal by Subject|14|||
146527792|NCT03713684|528440289|FG001|Overall Study|Withdrawal by Subject|6|||
146527793|NCT03713684|528440290|FG002|Overall Study|Withdrawal by Subject|14|||
146527794|NCT03713684|528440291|FG003|Overall Study|Withdrawal by Subject|16|||
146527795|NCT03713684|528440288|FG000|Overall Study|Other than specified|69|||
146527796|NCT03713684|528440289|FG001|Overall Study|Other than specified|77|||
146527797|NCT03713684|528440290|FG002|Overall Study|Other than specified|73|||
146527798|NCT03713684|528440291|FG003|Overall Study|Other than specified|70|||
146760932|NCT04155424|529291102|FG000|Overall Study|Other than specified|3|||
146527799|NCT00528424|528440292|FG000|Overall Study|Lost to Follow-up|13|||
146527800|NCT00528424|528440292|FG000|Overall Study|Withdrew consent|2|||
146527801|NCT00528424|528440292|FG000|Overall Study|Administrative reason|2|||
146527802|NCT00528424|528440292|FG000|Overall Study|Other|12|||
146527803|NCT02595502|528440293|FG000|Period 1|Adverse Event|0|||
146527804|NCT02595502|528440294|FG001|Period 1|Adverse Event|1|||
146527805|NCT02595502|528440293|FG000|Period 1|Withdrawal by Subject|1|||
146760933|NCT04155424|529291102|FG000|Overall Study|Withdrawal by Subject|1|||
146760934|NCT04155424|529291102|FG000|Overall Study|Adverse Event|1|||
146527806|NCT02595502|528440294|FG001|Period 1|Withdrawal by Subject|0|||
146527807|NCT02595502|528440293|FG000|Period 1|Lost to Follow-up|0|||
146527808|NCT02595502|528440294|FG001|Period 1|Lost to Follow-up|1|||
146527809|NCT02595502|528440293|FG000|Period 2|Adverse Event|1|||
146527810|NCT02595502|528440294|FG001|Period 2|Adverse Event|1|||
146527811|NCT02595502|528440293|FG000|Period 2|Received incorrect lens at Period 1|0|||
146527812|NCT02595502|528440294|FG001|Period 2|Received incorrect lens at Period 1|1|||
146527813|NCT02595502|528440293|FG000|Period 3|Protocol Violation|0|||
146527814|NCT02595502|528440294|FG001|Period 3|Protocol Violation|1|||
146527815|NCT02595502|528440293|FG000|Period 3|Lost to Follow-up|1|||
146527816|NCT02595502|528440294|FG001|Period 3|Lost to Follow-up|0|||
146527817|NCT02595502|528440293|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
146527818|NCT02595502|528440294|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
146527819|NCT00458003|528440295|FG000|Overall Study|Non protocol spinal anesthesia|1|||
146527820|NCT00458003|528440296|FG001|Overall Study|Non protocol spinal anesthesia|1|||
146527821|NCT03286218|528440297|FG000|Qualification Phase Period 1|Adverse Event|1|||
146527822|NCT03286218|528440298|FG001|Qualification Phase Period 1|Adverse Event|0|||
146527823|NCT03286218|528440299|FG002|Qualification Phase Period 1|Adverse Event|0|||
146527824|NCT03286218|528440300|FG003|Qualification Phase Period 1|Adverse Event|0|||
146527825|NCT03286218|528440301|FG004|Qualification Phase Period 1|Adverse Event|0|||
146527826|NCT03286218|528440302|FG005|Qualification Phase Period 1|Adverse Event|0|||
146527827|NCT03286218|528440303|FG006|Qualification Phase Period 1|Adverse Event|0|||
146527828|NCT03286218|528440304|FG007|Qualification Phase Period 1|Adverse Event|0|||
146527829|NCT03286218|528440305|FG008|Qualification Phase Period 1|Adverse Event|0|||
146527830|NCT03286218|528440306|FG009|Qualification Phase Period 1|Adverse Event|0|||
146527831|NCT03286218|528440307|FG010|Qualification Phase Period 1|Adverse Event|0|||
146527832|NCT03286218|528440308|FG011|Qualification Phase Period 1|Adverse Event|0|||
146527833|NCT03286218|528440297|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
146527834|NCT03286218|528440298|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
146527835|NCT03286218|528440299|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
146527836|NCT03286218|528440300|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
146527837|NCT03286218|528440301|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
146527838|NCT03286218|528440302|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
146527839|NCT03286218|528440303|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
146527840|NCT03286218|528440304|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
146527841|NCT03286218|528440305|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
146527842|NCT03286218|528440306|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
146527843|NCT03286218|528440307|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
146527844|NCT03286218|528440308|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
146527845|NCT03286218|528440297|FG000|Qualification Phase Period 2|Adverse Event|0|||
146527846|NCT03286218|528440298|FG001|Qualification Phase Period 2|Adverse Event|1|||
146527847|NCT03286218|528440299|FG002|Qualification Phase Period 2|Adverse Event|0|||
146527848|NCT03286218|528440300|FG003|Qualification Phase Period 2|Adverse Event|0|||
146527849|NCT03286218|528440301|FG004|Qualification Phase Period 2|Adverse Event|0|||
146527850|NCT03286218|528440302|FG005|Qualification Phase Period 2|Adverse Event|0|||
146527851|NCT03286218|528440303|FG006|Qualification Phase Period 2|Adverse Event|0|||
146527852|NCT03286218|528440304|FG007|Qualification Phase Period 2|Adverse Event|0|||
146527853|NCT03286218|528440305|FG008|Qualification Phase Period 2|Adverse Event|0|||
146527854|NCT03286218|528440306|FG009|Qualification Phase Period 2|Adverse Event|0|||
146527855|NCT03286218|528440307|FG010|Qualification Phase Period 2|Adverse Event|0|||
146527856|NCT03286218|528440308|FG011|Qualification Phase Period 2|Adverse Event|0|||
146527857|NCT03286218|528440297|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
146527858|NCT03286218|528440298|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
146527859|NCT03286218|528440299|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
146527860|NCT03286218|528440300|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
146527861|NCT03286218|528440301|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
146527862|NCT03286218|528440302|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
146527863|NCT03286218|528440303|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
146527864|NCT03286218|528440304|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
146527865|NCT03286218|528440305|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
146527866|NCT03286218|528440306|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
146527867|NCT03286218|528440307|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
146527868|NCT03286218|528440308|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
146527869|NCT03286218|528440297|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
146527870|NCT03286218|528440298|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
146527871|NCT03286218|528440299|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
146527872|NCT03286218|528440300|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
146527873|NCT03286218|528440301|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
146527874|NCT03286218|528440302|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
146527875|NCT03286218|528440303|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
146527876|NCT03286218|528440304|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
146527877|NCT03286218|528440305|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
146527878|NCT03286218|528440306|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
146527879|NCT03286218|528440307|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
146527880|NCT03286218|528440308|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
146527881|NCT03286218|528440297|FG000|Qualification Phase Period 2|Protocol Violation|2|||
146527882|NCT03286218|528440298|FG001|Qualification Phase Period 2|Protocol Violation|0|||
146527883|NCT03286218|528440299|FG002|Qualification Phase Period 2|Protocol Violation|0|||
146527884|NCT03286218|528440300|FG003|Qualification Phase Period 2|Protocol Violation|0|||
146527885|NCT03286218|528440301|FG004|Qualification Phase Period 2|Protocol Violation|0|||
146527886|NCT03286218|528440302|FG005|Qualification Phase Period 2|Protocol Violation|0|||
146527887|NCT03286218|528440303|FG006|Qualification Phase Period 2|Protocol Violation|0|||
146527888|NCT03286218|528440304|FG007|Qualification Phase Period 2|Protocol Violation|0|||
146527889|NCT03286218|528440305|FG008|Qualification Phase Period 2|Protocol Violation|0|||
146527890|NCT03286218|528440306|FG009|Qualification Phase Period 2|Protocol Violation|0|||
146527891|NCT03286218|528440307|FG010|Qualification Phase Period 2|Protocol Violation|0|||
146527892|NCT03286218|528440308|FG011|Qualification Phase Period 2|Protocol Violation|0|||
146527893|NCT03286218|528440297|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
146527894|NCT03286218|528440298|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
146527895|NCT03286218|528440299|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
146527896|NCT03286218|528440300|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
146527897|NCT03286218|528440301|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
146527898|NCT03286218|528440302|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
146527899|NCT03286218|528440303|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
146527900|NCT03286218|528440304|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
146527901|NCT03286218|528440305|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
146527902|NCT03286218|528440306|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
146527903|NCT03286218|528440307|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
146527904|NCT03286218|528440308|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
146527905|NCT03286218|528440297|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
146527906|NCT03286218|528440298|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
146527907|NCT03286218|528440299|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
146527908|NCT03286218|528440300|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
146527909|NCT03286218|528440301|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
146527910|NCT03286218|528440302|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
146527911|NCT03286218|528440303|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
146527912|NCT03286218|528440304|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
146527913|NCT03286218|528440305|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
146527914|NCT03286218|528440306|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
146527915|NCT03286218|528440307|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
146527916|NCT03286218|528440308|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
146527917|NCT03286218|528440297|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
146527918|NCT03286218|528440298|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
146527919|NCT03286218|528440299|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
146527920|NCT03286218|528440300|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
146527921|NCT03286218|528440301|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
146527922|NCT03286218|528440302|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
146527923|NCT03286218|528440303|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
146527924|NCT03286218|528440304|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
146527925|NCT03286218|528440305|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
146527926|NCT03286218|528440306|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
146527927|NCT03286218|528440307|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
146527928|NCT03286218|528440308|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
146527929|NCT05209880|528440310|FG000|1-Month Follow-up|Spoke with Doctor|5|||
146527930|NCT05209880|528440311|FG001|1-Month Follow-up|Spoke with Doctor|5|||
146527931|NCT05209880|528440310|FG000|1-Month Follow-up|Lost to Follow-up|7|||
146527932|NCT05209880|528440311|FG001|1-Month Follow-up|Lost to Follow-up|9|||
146527933|NCT05209880|528440310|FG000|1-Month Follow-up|Discontinued|0|||
146527934|NCT05209880|528440311|FG001|1-Month Follow-up|Discontinued|1|||
146527935|NCT05209880|528440310|FG000|3-Month Follow-up|Spoke with Doctor|17|||
146527936|NCT05209880|528440311|FG001|3-Month Follow-up|Spoke with Doctor|7|||
146527937|NCT05209880|528440310|FG000|3-Month Follow-up|Lost to Follow-up|8|||
146527938|NCT05209880|528440311|FG001|3-Month Follow-up|Lost to Follow-up|10|||
146527939|NCT05209880|528440310|FG000|3-Month Follow-up|Discontinued|1|||
146527940|NCT05209880|528440311|FG001|3-Month Follow-up|Discontinued|3|||
146527941|NCT05209880|528440310|FG000|6-Month Follow-up|Spoke with Doctor|25|||
146527942|NCT05209880|528440311|FG001|6-Month Follow-up|Spoke with Doctor|14|||
146527943|NCT05209880|528440310|FG000|6-Month Follow-up|Lost to Follow-up|9|||
146527944|NCT05209880|528440311|FG001|6-Month Follow-up|Lost to Follow-up|14|||
146527945|NCT05209880|528440310|FG000|6-Month Follow-up|Discontinued|1|||
146527946|NCT05209880|528440311|FG001|6-Month Follow-up|Discontinued|3|||
146527947|NCT05635045|528440314|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
146527948|NCT05635045|528440315|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
146527949|NCT05635045|528440316|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
146527950|NCT05635045|528440317|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
146527951|NCT03143101|528440323|FG000|Overall Study|Withdrawal by Subject|0|||
146527952|NCT03143101|528440324|FG001|Overall Study|Withdrawal by Subject|1|||
146527953|NCT03143101|528440325|FG002|Overall Study|Withdrawal by Subject|0|||
146527954|NCT03143101|528440323|FG000|Overall Study|Lost to Follow-up|2|||
146527955|NCT03143101|528440324|FG001|Overall Study|Lost to Follow-up|2|||
146527956|NCT03143101|528440325|FG002|Overall Study|Lost to Follow-up|0|||
146527957|NCT05227118|528440326|FG000|Overall Study|Adverse Event|0|||
146527958|NCT05227118|528440327|FG001|Overall Study|Adverse Event|0|||
146527959|NCT05227118|528440328|FG002|Overall Study|Adverse Event|1|||
146527960|NCT05227118|528440329|FG003|Overall Study|Adverse Event|0|||
146527961|NCT05227118|528440326|FG000|Overall Study|Withdrawal by Subject|0|||
146527962|NCT05227118|528440327|FG001|Overall Study|Withdrawal by Subject|0|||
146527963|NCT05227118|528440328|FG002|Overall Study|Withdrawal by Subject|2|||
146527964|NCT05227118|528440329|FG003|Overall Study|Withdrawal by Subject|0|||
146527965|NCT01435759|528440330|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
146527966|NCT01435759|528440331|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
146527967|NCT01435759|528440332|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
146527968|NCT01435759|528440333|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
146527969|NCT01435759|528440334|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
146527970|NCT01435759|528440335|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
146527971|NCT01435759|528440330|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
146527972|NCT01435759|528440331|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
146527973|NCT01435759|528440332|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
146527974|NCT01435759|528440333|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
146527975|NCT01435759|528440334|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
146527976|NCT01435759|528440335|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
146527977|NCT01435759|528440330|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
146527978|NCT01435759|528440331|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
146527979|NCT01435759|528440332|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
146527980|NCT01435759|528440333|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
146527981|NCT01435759|528440334|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
146527982|NCT01435759|528440335|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
146527983|NCT01435759|528440330|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
146527984|NCT01435759|528440331|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
146527985|NCT01435759|528440332|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
146527986|NCT01435759|528440333|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
146527987|NCT01435759|528440334|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
146527988|NCT01435759|528440335|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
146527989|NCT01435759|528440330|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
146527990|NCT01435759|528440331|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
146527991|NCT01435759|528440332|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
146527992|NCT01435759|528440333|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
146527993|NCT01435759|528440334|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
146527994|NCT01435759|528440335|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
146527995|NCT01435759|528440330|FG000|Antidepressant Lead-in Phase|Other|119|||
146527996|NCT01435759|528440331|FG001|Antidepressant Lead-in Phase|Other|0|||
146527997|NCT01435759|528440332|FG002|Antidepressant Lead-in Phase|Other|0|||
146527998|NCT01435759|528440333|FG003|Antidepressant Lead-in Phase|Other|0|||
146527999|NCT01435759|528440334|FG004|Antidepressant Lead-in Phase|Other|0|||
146528000|NCT01435759|528440335|FG005|Antidepressant Lead-in Phase|Other|0|||
146528001|NCT01435759|528440330|FG000|Double-blind Phase|Adverse Event|7|||
146528002|NCT01435759|528440331|FG001|Double-blind Phase|Adverse Event|0|||
146528003|NCT01435759|528440332|FG002|Double-blind Phase|Adverse Event|1|||
146528004|NCT01435759|528440333|FG003|Double-blind Phase|Adverse Event|1|||
146528005|NCT01435759|528440334|FG004|Double-blind Phase|Adverse Event|1|||
146528006|NCT01435759|528440335|FG005|Double-blind Phase|Adverse Event|3|||
146528007|NCT01435759|528440330|FG000|Double-blind Phase|Protocol Violation|2|||
146528008|NCT01435759|528440331|FG001|Double-blind Phase|Protocol Violation|0|||
146528009|NCT01435759|528440332|FG002|Double-blind Phase|Protocol Violation|1|||
146528010|NCT01435759|528440333|FG003|Double-blind Phase|Protocol Violation|2|||
146528011|NCT01435759|528440334|FG004|Double-blind Phase|Protocol Violation|0|||
146528012|NCT01435759|528440335|FG005|Double-blind Phase|Protocol Violation|1|||
146528013|NCT01435759|528440330|FG000|Double-blind Phase|Withdrawal by Subject|17|||
146528014|NCT01435759|528440331|FG001|Double-blind Phase|Withdrawal by Subject|4|||
146528015|NCT01435759|528440332|FG002|Double-blind Phase|Withdrawal by Subject|3|||
146528016|NCT01435759|528440333|FG003|Double-blind Phase|Withdrawal by Subject|4|||
146528017|NCT01435759|528440334|FG004|Double-blind Phase|Withdrawal by Subject|2|||
146528018|NCT01435759|528440335|FG005|Double-blind Phase|Withdrawal by Subject|2|||
146528019|NCT01435759|528440330|FG000|Double-blind Phase|Lost to Follow-up|31|||
146528020|NCT01435759|528440331|FG001|Double-blind Phase|Lost to Follow-up|1|||
146528021|NCT01435759|528440332|FG002|Double-blind Phase|Lost to Follow-up|2|||
146528022|NCT01435759|528440333|FG003|Double-blind Phase|Lost to Follow-up|0|||
146528023|NCT01435759|528440334|FG004|Double-blind Phase|Lost to Follow-up|3|||
146528024|NCT01435759|528440335|FG005|Double-blind Phase|Lost to Follow-up|3|||
146528025|NCT01435759|528440330|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
146528026|NCT01435759|528440331|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
146528027|NCT01435759|528440332|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
146528028|NCT01435759|528440333|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
146528029|NCT01435759|528440334|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
146528030|NCT01435759|528440335|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
146528031|NCT01435759|528440330|FG000|Double-blind Phase|Other|8|||
146528032|NCT01435759|528440331|FG001|Double-blind Phase|Other|2|||
146528033|NCT01435759|528440332|FG002|Double-blind Phase|Other|0|||
146528034|NCT01435759|528440333|FG003|Double-blind Phase|Other|2|||
146528035|NCT01435759|528440334|FG004|Double-blind Phase|Other|0|||
146528036|NCT01435759|528440335|FG005|Double-blind Phase|Other|0|||
146528037|NCT03727841|528440338|FG000|Overall Study|Physician Decision|3|||
146528038|NCT03727841|528440339|FG001|Overall Study|Physician Decision|1|||
146528039|NCT01601496|528440340|FG000|Overall Study|Physician Decision|1|||
146528040|NCT01601496|528440340|FG000|Overall Study|Withdrawal by Subject|1|||
146528041|NCT01601496|528440340|FG000|Overall Study|Lost to Follow-up|6|||
146528042|NCT01601496|528440340|FG000|Overall Study|Death|4|||
146528043|NCT01601496|528440340|FG000|Overall Study|Other: patient refusal to continue|3|||
146528044|NCT03243305|528440341|FG000|Overall Study|Lost to Follow-up|250|||
146528045|NCT03243305|528440341|FG000|Overall Study|Withdrawal by Subject|170|||
146528046|NCT03243305|528440341|FG000|Overall Study|Pregnancy|104|||
146528047|NCT03243305|528440341|FG000|Overall Study|Non-Compliance with Study Drug|38|||
146528048|NCT03243305|528440341|FG000|Overall Study|Adverse Event|23|||
146528049|NCT03243305|528440341|FG000|Overall Study|No sexually active|26|||
146528050|NCT03243305|528440341|FG000|Overall Study|Physician Decision|22|||
146528051|NCT03243305|528440341|FG000|Overall Study|Protocol Violation|22|||
146528052|NCT03243305|528440341|FG000|Overall Study|Study method no longer primary method|12|||
146528053|NCT03243305|528440341|FG000|Overall Study|Study Terminated by Sponsor|1|||
146528054|NCT03243305|528440341|FG000|Overall Study|Early terminations|267|||
146528055|NCT02689804|528440342|FG000|Overall Study|Withdrawal by Subject|2|||
146528056|NCT02689804|528440343|FG001|Overall Study|Withdrawal by Subject|0|||
146528057|NCT00227539|528440344|FG000|Overall Study|Protocol Violation|1|||
146528058|NCT00385918|528440351|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
146528059|NCT00385918|528440352|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
146528060|NCT00385918|528440353|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
146528061|NCT00385918|528440351|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
146528062|NCT00385918|528440352|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
146528063|NCT00385918|528440353|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
146528064|NCT00385918|528440351|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
146528065|NCT00385918|528440352|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
146528066|NCT00385918|528440353|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
146528067|NCT00385918|528440351|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
146528068|NCT00385918|528440352|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
146528069|NCT00385918|528440353|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
146528070|NCT00385918|528440351|FG000|Intervention Phase After Randomization|Physician Decision|1|||
146528071|NCT00385918|528440352|FG001|Intervention Phase After Randomization|Physician Decision|0|||
146528072|NCT00385918|528440353|FG002|Intervention Phase After Randomization|Physician Decision|0|||
146528073|NCT00385918|528440351|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
146528074|NCT00385918|528440352|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
146528075|NCT00385918|528440353|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
146528076|NCT00128661|528440354|FG000|Overall Study|Adverse Event|14|||
146528077|NCT00128661|528440355|FG001|Overall Study|Adverse Event|11|||
146528078|NCT00128661|528440354|FG000|Overall Study|Lost to Follow-up|10|||
146528079|NCT00128661|528440355|FG001|Overall Study|Lost to Follow-up|7|||
146528080|NCT00128661|528440354|FG000|Overall Study|Withdrawal by Subject|243|||
146528081|NCT00128661|528440355|FG001|Overall Study|Withdrawal by Subject|232|||
146528082|NCT00128661|528440354|FG000|Overall Study|Other|7|||
146528083|NCT00128661|528440355|FG001|Overall Study|Other|8|||
146528084|NCT01827592|528440359|FG000|Overall Study|Adverse Event|11|||
146528085|NCT01827592|528440360|FG001|Overall Study|Adverse Event|9|||
146528086|NCT01827592|528440361|FG002|Overall Study|Adverse Event|2|||
146528087|NCT01827592|528440359|FG000|Overall Study|Physician Decision|0|||
146528088|NCT01827592|528440360|FG001|Overall Study|Physician Decision|2|||
146528089|NCT01827592|528440361|FG002|Overall Study|Physician Decision|1|||
146528090|NCT01827592|528440359|FG000|Overall Study|Protocol Violation|2|||
146528091|NCT01827592|528440360|FG001|Overall Study|Protocol Violation|1|||
146528092|NCT01827592|528440361|FG002|Overall Study|Protocol Violation|0|||
146860317|NCT01971203|529659854|FG001|Overall Study|Protocol Violation|2|||
146860318|NCT01971203|529659853|FG000|Overall Study|Withdrawal by Subject|5|||
146528093|NCT01827592|528440359|FG000|Overall Study|Lost to Follow-up|1|||
146528094|NCT01827592|528440360|FG001|Overall Study|Lost to Follow-up|2|||
146528095|NCT01827592|528440361|FG002|Overall Study|Lost to Follow-up|2|||
146528096|NCT01827592|528440359|FG000|Overall Study|Withdrawal by Subject|12|||
146528097|NCT01827592|528440360|FG001|Overall Study|Withdrawal by Subject|11|||
146528098|NCT01827592|528440361|FG002|Overall Study|Withdrawal by Subject|11|||
146528099|NCT01827592|528440359|FG000|Overall Study|Patient's substantial non-compliance|1|||
146528100|NCT01827592|528440360|FG001|Overall Study|Patient's substantial non-compliance|1|||
146528101|NCT01827592|528440361|FG002|Overall Study|Patient's substantial non-compliance|6|||
146528102|NCT01827592|528440359|FG000|Overall Study|Trial terminated by Sponsor|47|||
146528103|NCT01827592|528440360|FG001|Overall Study|Trial terminated by Sponsor|53|||
146528104|NCT01827592|528440361|FG002|Overall Study|Trial terminated by Sponsor|51|||
146528105|NCT01827592|528440359|FG000|Overall Study|Others|0|||
146528106|NCT01827592|528440360|FG001|Overall Study|Others|1|||
146528107|NCT01827592|528440361|FG002|Overall Study|Others|3|||
146528108|NCT00808067|528440364|FG000|Overall Study|Major/minor bleed|30|||
146528109|NCT00808067|528440365|FG001|Overall Study|Major/minor bleed|44|||
146528110|NCT00808067|528440364|FG000|Overall Study|Outcome event - other|33|||
146528111|NCT00808067|528440365|FG001|Overall Study|Outcome event - other|25|||
146528112|NCT00808067|528440364|FG000|Overall Study|Adverse Event|111|||
146528113|NCT00808067|528440365|FG001|Overall Study|Adverse Event|121|||
146528114|NCT00808067|528440364|FG000|Overall Study|Hospitalization (not including surgery)|18|||
146528115|NCT00808067|528440365|FG001|Overall Study|Hospitalization (not including surgery)|17|||
146528116|NCT00808067|528440364|FG000|Overall Study|Hospitalization due to surgery|37|||
146528117|NCT00808067|528440365|FG001|Overall Study|Hospitalization due to surgery|40|||
146528118|NCT00808067|528440364|FG000|Overall Study|Reduced creatinine clearance|53|||
146528119|NCT00808067|528440365|FG001|Overall Study|Reduced creatinine clearance|55|||
146528120|NCT00808067|528440364|FG000|Overall Study|Elevated LFT results|7|||
146528121|NCT00808067|528440365|FG001|Overall Study|Elevated LFT results|3|||
146528122|NCT00808067|528440364|FG000|Overall Study|Patient refused to take study medication|65|||
146528123|NCT00808067|528440365|FG001|Overall Study|Patient refused to take study medication|76|||
146528124|NCT00808067|528440364|FG000|Overall Study|Missing|1|||
146528125|NCT00808067|528440365|FG001|Overall Study|Missing|0|||
146528126|NCT00808067|528440364|FG000|Overall Study|Death|1|||
146528127|NCT00808067|528440365|FG001|Overall Study|Death|1|||
146528128|NCT00808067|528440364|FG000|Overall Study|Procedure|6|||
146528129|NCT00808067|528440365|FG001|Overall Study|Procedure|7|||
146528130|NCT00808067|528440364|FG000|Overall Study|Withdrawal by Subject|21|||
146528131|NCT00808067|528440365|FG001|Overall Study|Withdrawal by Subject|25|||
146528132|NCT00808067|528440364|FG000|Overall Study|Site closed|4|||
146528133|NCT00808067|528440365|FG001|Overall Study|Site closed|3|||
146528134|NCT00808067|528440364|FG000|Overall Study|Physician Decision|47|||
146528135|NCT00808067|528440365|FG001|Overall Study|Physician Decision|38|||
146528136|NCT00808067|528440364|FG000|Overall Study|Protocol Violation|3|||
146528137|NCT00808067|528440365|FG001|Overall Study|Protocol Violation|11|||
146528138|NCT00808067|528440364|FG000|Overall Study|Patient elected|7|||
146528139|NCT00808067|528440365|FG001|Overall Study|Patient elected|9|||
146528140|NCT00808067|528440364|FG000|Overall Study|Site closed for cause|19|||
146528141|NCT00808067|528440365|FG001|Overall Study|Site closed for cause|19|||
146528142|NCT00808067|528440364|FG000|Overall Study|Other reason not defined above|5|||
146528143|NCT00808067|528440365|FG001|Overall Study|Other reason not defined above|5|||
146528144|NCT00808067|528440364|FG000|Overall Study|Excluded from analysis|13|||
146528145|NCT00808067|528440365|FG001|Overall Study|Excluded from analysis|19|||
146528146|NCT00689338|528440366|FG000|Overall Study|Death|65|||
146528147|NCT00689338|528440366|FG000|Overall Study|Adverse Event|13|||
146528148|NCT00689338|528440366|FG000|Overall Study|Insufficient Clinical Response|1|||
146528149|NCT00689338|528440366|FG000|Overall Study|Lack of Efficacy|6|||
146528150|NCT00689338|528440366|FG000|Overall Study|Other|8|||
146528151|NCT00689338|528440366|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
146528152|NCT00689338|528440366|FG000|Overall Study|Lost to Follow-up|5|||
146528153|NCT00689338|528440366|FG000|Overall Study|Withdrawal by Subject|3|||
146528154|NCT00689338|528440366|FG000|Overall Study|Protocol Violation|15|||
146528155|NCT00735007|528440371|FG000|Overall Study|Adverse Event|4|||
146528156|NCT00735007|528440371|FG000|Overall Study|Protocol Violation|1|||
146528157|NCT02104895|528440372|FG000|Overall Study|Withdrawal by Subject|0|||
146528158|NCT02104895|528440373|FG001|Overall Study|Withdrawal by Subject|14|||
146528159|NCT02532283|528440379|FG000|Overall Study|Adverse Event|0|||
146528160|NCT02532283|528440380|FG001|Overall Study|Adverse Event|1|||
146528161|NCT02532283|528440379|FG000|Overall Study|Death|1|||
146528162|NCT02532283|528440380|FG001|Overall Study|Death|0|||
146528163|NCT02532283|528440379|FG000|Overall Study|Lost to Follow-up|0|||
146528164|NCT02532283|528440380|FG001|Overall Study|Lost to Follow-up|1|||
146528165|NCT02532283|528440379|FG000|Overall Study|Withdrawal by Subject|8|||
146528166|NCT02532283|528440380|FG001|Overall Study|Withdrawal by Subject|3|||
146528167|NCT01945944|528440381|FG000|Overall Study|Adverse Event|0|||
146528168|NCT01945944|528440382|FG001|Overall Study|Adverse Event|2|||
146528169|NCT01945944|528440381|FG000|Overall Study|Physician Decision|1|||
146528170|NCT01945944|528440382|FG001|Overall Study|Physician Decision|0|||
146528171|NCT01945944|528440381|FG000|Overall Study|Withdrawal by Subject|0|||
146528172|NCT01945944|528440382|FG001|Overall Study|Withdrawal by Subject|1|||
146528173|NCT04376515|528440383|FG000|Overall Study|Found to have been vaccinated before study start|6|||
146528174|NCT04376515|528440384|FG001|Overall Study|Found to have been vaccinated before study start|6|||
146528175|NCT03811821|528440385|FG000|Overall Study|Adverse Event|1|||
146528176|NCT03811821|528440386|FG001|Overall Study|Adverse Event|1|||
146528177|NCT03811821|528440385|FG000|Overall Study|Withdrawal by Subject|5|||
146528178|NCT03811821|528440386|FG001|Overall Study|Withdrawal by Subject|4|||
146528179|NCT03811821|528440385|FG000|Overall Study|Lost to Follow-up|2|||
146528180|NCT03811821|528440386|FG001|Overall Study|Lost to Follow-up|2|||
146528181|NCT03811821|528440385|FG000|Overall Study|Contraindication for treatment|0|||
146528182|NCT03811821|528440386|FG001|Overall Study|Contraindication for treatment|1|||
146528183|NCT03811821|528440385|FG000|Overall Study|Tolerability|0|||
146528184|NCT03811821|528440386|FG001|Overall Study|Tolerability|3|||
146528185|NCT03811821|528440385|FG000|Overall Study|Comorbidities|0|||
146528186|NCT03811821|528440386|FG001|Overall Study|Comorbidities|2|||
146528187|NCT01683604|528440387|FG000|Overall Study|Adverse Event|2|||
146528188|NCT01683604|528440387|FG000|Overall Study|Lack of Efficacy|1|||
146528189|NCT01683604|528440387|FG000|Overall Study|Other|2|||
146528190|NCT01395810|528440392|FG000|Overall Study|Adverse Event|0|||
146528191|NCT01395810|528440393|FG001|Overall Study|Adverse Event|1|||
146528192|NCT01395810|528440394|FG002|Overall Study|Adverse Event|0|||
146528193|NCT01395810|528440395|FG003|Overall Study|Adverse Event|0|||
146528194|NCT01395810|528440392|FG000|Overall Study|Lack of Efficacy|0|||
146528195|NCT01395810|528440393|FG001|Overall Study|Lack of Efficacy|1|||
146528196|NCT01395810|528440394|FG002|Overall Study|Lack of Efficacy|0|||
146528197|NCT01395810|528440395|FG003|Overall Study|Lack of Efficacy|0|||
146528198|NCT01395810|528440392|FG000|Overall Study|Withdrawal criteria|0|||
146528199|NCT01395810|528440393|FG001|Overall Study|Withdrawal criteria|2|||
146528200|NCT01395810|528440394|FG002|Overall Study|Withdrawal criteria|0|||
146528201|NCT01395810|528440395|FG003|Overall Study|Withdrawal criteria|0|||
146528202|NCT01395810|528440392|FG000|Overall Study|Unclassified|2|||
146528203|NCT01395810|528440393|FG001|Overall Study|Unclassified|0|||
146528204|NCT01395810|528440394|FG002|Overall Study|Unclassified|0|||
146528205|NCT01395810|528440395|FG003|Overall Study|Unclassified|0|||
146528206|NCT05027815|528440398|FG000|Overall Study|Death|2|||
146528207|NCT05027815|528440399|FG001|Overall Study|Death|1|||
146528208|NCT03877224|528440404|FG000|Overall Study|Death|3|||
146528209|NCT03877224|528440405|FG001|Overall Study|Death|2|||
146528210|NCT03877224|528440404|FG000|Overall Study|Withdrawal by Subject|1|||
146528211|NCT03877224|528440405|FG001|Overall Study|Withdrawal by Subject|6|||
146528212|NCT03877224|528440404|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
146528213|NCT03877224|528440405|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
146528214|NCT00447902|528440406|FG000|Overall Study|Adverse Event|0|||
146528215|NCT00447902|528440407|FG001|Overall Study|Adverse Event|3|||
146528216|NCT00447902|528440406|FG000|Overall Study|Protocol Violation|1|||
146528217|NCT00447902|528440407|FG001|Overall Study|Protocol Violation|0|||
146528218|NCT00447902|528440406|FG000|Overall Study|Withdrawal by Subject|0|||
146528219|NCT00447902|528440407|FG001|Overall Study|Withdrawal by Subject|1|||
146528220|NCT00447902|528440406|FG000|Overall Study|included patients who discontinued|1|||
146528221|NCT00447902|528440407|FG001|Overall Study|included patients who discontinued|1|||
146528222|NCT00447902|528440406|FG000|Overall Study|Lack of Efficacy|2|||
146528223|NCT00447902|528440407|FG001|Overall Study|Lack of Efficacy|1|||
146528224|NCT03234036|528442375|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
146528225|NCT03234036|528442376|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
146528226|NCT03234036|528442377|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
146528227|NCT03234036|528442378|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
146528228|NCT02163395|528442379|FG000|Overall Study|Withdrawal by Subject|1|||
146528229|NCT02163395|528442379|FG000|Overall Study|Lost to Follow-up|3|||
146528230|NCT02163395|528442379|FG000|Overall Study|Adverse Event|1|||
146528231|NCT01145482|528442380|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
146528232|NCT01145482|528442381|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
146528233|NCT02735980|528442386|FG000|Overall Study|Adverse Event|0|||
146528234|NCT02735980|528442387|FG001|Overall Study|Adverse Event|4|||
146528235|NCT02735980|528442388|FG002|Overall Study|Adverse Event|1|||
146528236|NCT02735980|528442386|FG000|Overall Study|Death|5|||
146528237|NCT02735980|528442387|FG001|Overall Study|Death|4|||
146528238|NCT02735980|528442388|FG002|Overall Study|Death|0|||
146528239|NCT02735980|528442386|FG000|Overall Study|Physician Decision|3|||
146528240|NCT02735980|528442387|FG001|Overall Study|Physician Decision|1|||
146528241|NCT02735980|528442388|FG002|Overall Study|Physician Decision|0|||
146528242|NCT02735980|528442386|FG000|Overall Study|Screen failure|1|||
146528243|NCT02735980|528442387|FG001|Overall Study|Screen failure|0|||
146528244|NCT02735980|528442388|FG002|Overall Study|Screen failure|0|||
146528245|NCT02735980|528442386|FG000|Overall Study|Withdrawal by Subject|1|||
146528246|NCT02735980|528442387|FG001|Overall Study|Withdrawal by Subject|2|||
146528247|NCT02735980|528442388|FG002|Overall Study|Withdrawal by Subject|0|||
146528248|NCT02515630|528442392|FG000|Overall Study|Withdrawal by Subject|5|||
146528249|NCT02515630|528442392|FG000|Overall Study|Adverse Event|4|||
146528250|NCT02515630|528442392|FG000|Overall Study|Physician Decision|4|||
146528251|NCT02515630|528442392|FG000|Overall Study|Death|2|||
146528252|NCT02515630|528442392|FG000|Overall Study|Disease Progression|1|||
146528253|NCT02154139|528442397|FG000|Overall Study|Injection not administered|2|||
146528254|NCT02154139|528442397|FG000|Overall Study|Other|2|||
146528255|NCT02154139|528442397|FG000|Overall Study|Investigator transferred|3|||
146528256|NCT00473655|528442398|FG000|Overall Study|Lost to Follow-up|9|||
146528257|NCT00473655|528442399|FG001|Overall Study|Lost to Follow-up|5|||
146528258|NCT00473655|528442400|FG002|Overall Study|Lost to Follow-up|8|||
146528259|NCT02087774|528442402|FG000|Overall Study|Were absent day of data collection|8|||
146528260|NCT02087774|528442403|FG001|Overall Study|Were absent day of data collection|20|||
146528261|NCT00243919|528442411|FG000|Overall Study|Death|3|||
146528262|NCT00243919|528442412|FG001|Overall Study|Death|4|||
146528263|NCT00243919|528442413|FG002|Overall Study|Death|6|||
146528264|NCT00243919|528442411|FG000|Overall Study|Withdrawal by Subject|6|||
146528265|NCT00243919|528442412|FG001|Overall Study|Withdrawal by Subject|6|||
146528266|NCT00243919|528442413|FG002|Overall Study|Withdrawal by Subject|2|||
146528267|NCT00243919|528442411|FG000|Overall Study|Lost to Follow-up|6|||
146528268|NCT00243919|528442412|FG001|Overall Study|Lost to Follow-up|7|||
146528269|NCT00243919|528442413|FG002|Overall Study|Lost to Follow-up|3|||
146528270|NCT00243919|528442411|FG000|Overall Study|Administrative Error|1|||
146528271|NCT00243919|528442412|FG001|Overall Study|Administrative Error|0|||
146528272|NCT00243919|528442413|FG002|Overall Study|Administrative Error|0|||
146528273|NCT00243919|528442411|FG000|Overall Study|Physician Decision|1|||
146528274|NCT00243919|528442412|FG001|Overall Study|Physician Decision|1|||
146528275|NCT00243919|528442413|FG002|Overall Study|Physician Decision|0|||
146528276|NCT04176939|528442414|FG000|Overall Study|Withdrawal by Subject|5|||
146528277|NCT04176939|528442414|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
146860319|NCT01971203|529659854|FG001|Overall Study|Withdrawal by Subject|6|||
146860320|NCT01971203|529659853|FG000|Overall Study|Adverse Event|1|||
146860321|NCT01971203|529659854|FG001|Overall Study|Adverse Event|0|||
146860322|NCT01294683|529659855|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
146860323|NCT01294683|529659856|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
146860324|NCT01294683|529659855|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
146860325|NCT01294683|529659856|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
146860326|NCT01294683|529659855|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
146860327|NCT01294683|529659856|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
146528278|NCT04176939|528442414|FG000|Overall Study|Lost to Follow-up|2|||
146528279|NCT04176939|528442414|FG000|Overall Study|Unspecified reason|4|||
146528280|NCT04176939|528442414|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
146528281|NCT04919317|528442415|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
146528282|NCT04919317|528442416|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
146528283|NCT04919317|528442415|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
146528284|NCT04919317|528442416|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
146528285|NCT00230048|528442417|FG000|Overall Study|Lost to Follow-up|13|||
146528286|NCT00230048|528442418|FG001|Overall Study|Lost to Follow-up|18|||
146528287|NCT00676403|528442421|FG000|Overall Study|Adverse Event|1|||
146528288|NCT00676403|528442422|FG001|Overall Study|Adverse Event|2|||
146528289|NCT00676403|528442423|FG002|Overall Study|Adverse Event|0|||
146528290|NCT00676403|528442424|FG003|Overall Study|Adverse Event|5|||
146528291|NCT00676403|528442425|FG004|Overall Study|Adverse Event|1|||
146528292|NCT00676403|528442426|FG005|Overall Study|Adverse Event|2|||
146860328|NCT01294683|529659855|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
146528293|NCT00676403|528442421|FG000|Overall Study|Lost to Follow-up|0|||
146528294|NCT00676403|528442422|FG001|Overall Study|Lost to Follow-up|0|||
146528295|NCT00676403|528442423|FG002|Overall Study|Lost to Follow-up|0|||
146528296|NCT00676403|528442424|FG003|Overall Study|Lost to Follow-up|0|||
146528297|NCT00676403|528442425|FG004|Overall Study|Lost to Follow-up|0|||
146528298|NCT00676403|528442426|FG005|Overall Study|Lost to Follow-up|1|||
146528299|NCT00676403|528442421|FG000|Overall Study|Reason Unspecified|1|||
146528300|NCT00676403|528442422|FG001|Overall Study|Reason Unspecified|0|||
146528301|NCT00676403|528442423|FG002|Overall Study|Reason Unspecified|1|||
146528302|NCT00676403|528442424|FG003|Overall Study|Reason Unspecified|0|||
146528303|NCT00676403|528442425|FG004|Overall Study|Reason Unspecified|0|||
146528304|NCT00676403|528442426|FG005|Overall Study|Reason Unspecified|1|||
146528305|NCT00676403|528442421|FG000|Overall Study|Withdrawal by Subject|0|||
146528306|NCT00676403|528442422|FG001|Overall Study|Withdrawal by Subject|0|||
146528307|NCT00676403|528442423|FG002|Overall Study|Withdrawal by Subject|0|||
146860329|NCT01294683|529659856|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
146860330|NCT01294683|529659855|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
146528308|NCT00676403|528442424|FG003|Overall Study|Withdrawal by Subject|0|||
146528309|NCT00676403|528442425|FG004|Overall Study|Withdrawal by Subject|0|||
146528310|NCT00676403|528442426|FG005|Overall Study|Withdrawal by Subject|1|||
146528311|NCT00297648|528442427|FG000|Overall Study|Adverse Event|13|||
146528312|NCT00297648|528442427|FG000|Overall Study|Lack of Efficacy|18|||
146528313|NCT00297648|528442427|FG000|Overall Study|Lost to Follow-up|1|||
146528314|NCT00297648|528442427|FG000|Overall Study|Withdrawal by Subject|3|||
146528315|NCT00297648|528442427|FG000|Overall Study|Other: Incompliance|1|||
146528316|NCT03225170|528442428|FG000|Overall Study|Lost to Follow-up|4|||
146528317|NCT03225170|528442429|FG001|Overall Study|Lost to Follow-up|4|||
146528318|NCT03225170|528442430|FG002|Overall Study|Lost to Follow-up|0|||
146528319|NCT03225170|528442428|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
146528320|NCT03225170|528442429|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
146528321|NCT03225170|528442430|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
146528322|NCT01529606|528442431|FG000|Overall Study|Lost to Follow-up|21|||
146528323|NCT01529606|528442432|FG001|Overall Study|Lost to Follow-up|18|||
146528324|NCT01746862|528442433|FG000|Overall Study|Withdrawal by Subject|1|||
146528325|NCT01746862|528442434|FG001|Overall Study|Withdrawal by Subject|1|||
146528326|NCT01746862|528442433|FG000|Overall Study|Protocol Violation|1|||
146528327|NCT01746862|528442434|FG001|Overall Study|Protocol Violation|0|||
146528328|NCT01746862|528442433|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
146528329|NCT01746862|528442434|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
146528330|NCT01746862|528442433|FG000|Overall Study|Entered puberty during the study|1|||
146528331|NCT01746862|528442434|FG001|Overall Study|Entered puberty during the study|0|||
146528332|NCT00731822|528442438|FG000|Overall Study|Adverse Event|2|||
146528333|NCT00731822|528442439|FG001|Overall Study|Adverse Event|1|||
146528334|NCT00731822|528442438|FG000|Overall Study|Protocol Violation|1|||
146528335|NCT00731822|528442439|FG001|Overall Study|Protocol Violation|0|||
146528336|NCT00731822|528442438|FG000|Overall Study|Lost to Follow-up|1|||
146528337|NCT00731822|528442439|FG001|Overall Study|Lost to Follow-up|0|||
146528338|NCT04817332|528442440|FG000|Overall Study|Lost to Follow-up|3|||
146528339|NCT04817332|528442441|FG001|Overall Study|Lost to Follow-up|3|||
146528340|NCT04817332|528442440|FG000|Overall Study|Protocol Violation|2|||
146528341|NCT04817332|528442441|FG001|Overall Study|Protocol Violation|0|||
146528342|NCT01867008|528442442|FG000|Overall Study|Withdrawal by Subject|1|||
146528343|NCT00983372|528442443|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
146528344|NCT00983372|528442443|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
146528345|NCT00983372|528442443|FG000|Diltiazem ER Alone|Adverse Event|1|||
146528346|NCT02131064|528442450|FG000|Overall Study|Death|5|||
146528347|NCT02131064|528442451|FG001|Overall Study|Death|6|||
146528348|NCT02131064|528442450|FG000|Overall Study|Lost to Follow-up|4|||
146528349|NCT02131064|528442451|FG001|Overall Study|Lost to Follow-up|8|||
146528350|NCT02131064|528442450|FG000|Overall Study|Withdrawal by Subject|14|||
146528351|NCT02131064|528442451|FG001|Overall Study|Withdrawal by Subject|18|||
146528352|NCT02131064|528442450|FG000|Overall Study|Other|2|||
146528353|NCT02131064|528442451|FG001|Overall Study|Other|2|||
146528354|NCT00570401|528442462|FG000|Overall Study|Adverse Event|2|||
146528355|NCT00871234|528442463|FG000|Overall Study|Adverse Event|2|||
146528356|NCT00871234|528442463|FG000|Overall Study|Lost to Follow-up|3|||
146528357|NCT01710020|528442464|FG000|Period 1|Protocol Violation|1|||
146528358|NCT02782741|528442465|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
146528359|NCT02782741|528442466|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
146528360|NCT02782741|528442467|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
146528361|NCT02782741|528442465|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
146528362|NCT02782741|528442466|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
146528363|NCT02782741|528442467|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
146528364|NCT02782741|528442465|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
146528365|NCT02782741|528442466|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
146528366|NCT02782741|528442467|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
146528367|NCT02782741|528442465|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
146528368|NCT02782741|528442466|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
146528369|NCT02782741|528442467|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
146528370|NCT02782741|528442465|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
146528371|NCT02782741|528442466|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
146528372|NCT02782741|528442467|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
146528373|NCT04157088|528442468|FG000|Overall Study|Study terminated by sponsor|23|||
146528374|NCT04157088|528442468|FG000|Overall Study|Withdrawal by Subject|4|||
146528375|NCT04157088|528442468|FG000|Overall Study|Lost to Follow-up|2|||
146528376|NCT04157088|528442468|FG000|Overall Study|Death|1|||
146760935|NCT04159506|529291103|FG000|Overall Study|Lost to Follow-up|2|||
146760936|NCT04159506|529291104|FG001|Overall Study|Lost to Follow-up|5|||
146760937|NCT02449044|529291105|FG000|Overall Study|Lost to Follow-up|2|||
146760938|NCT02449044|529291105|FG000|Overall Study|Withdrawal by Subject|13|||
146760939|NCT02449044|529291105|FG000|Overall Study|Adverse Event|30|||
146760940|NCT02449044|529291105|FG000|Overall Study|Met Withdrawal Criteria|7|||
146760941|NCT02449044|529291105|FG000|Overall Study|Physician Decision|9|||
146528377|NCT02421419|528442469|FG000|Overall Study|Physician Decision|0|||
146528378|NCT02421419|528442470|FG001|Overall Study|Physician Decision|0|||
146528379|NCT02421419|528442471|FG002|Overall Study|Physician Decision|1|||
146760942|NCT02449044|529291105|FG000|Overall Study|Sponsor Discontinued Trial|3|||
146528380|NCT01676701|528442472|FG000|Overall Study|Protocol Violation|1|||
146528381|NCT01676701|528442473|FG001|Overall Study|Protocol Violation|0|||
146528382|NCT01676701|528442472|FG000|Overall Study|Sponsor Decision|3|||
146528383|NCT01676701|528442473|FG001|Overall Study|Sponsor Decision|4|||
146528384|NCT02115607|528442474|FG000|Overall Study|Withdrawal by Subject|1|||
146528385|NCT00196105|528442478|FG000|Overall Study|Lost to Follow-up|4|||
146528386|NCT00196105|528442479|FG001|Overall Study|Lost to Follow-up|5|||
146528387|NCT00196105|528442480|FG002|Overall Study|Lost to Follow-up|7|||
146528388|NCT04863872|528442481|FG000|Overall Study|Withdrawal by Subject|4|||
146528389|NCT04863872|528442482|FG001|Overall Study|Withdrawal by Subject|15|||
146528390|NCT04863872|528442481|FG000|Overall Study|Death|5|||
146528391|NCT04863872|528442482|FG001|Overall Study|Death|2|||
146528392|NCT04863872|528442481|FG000|Overall Study|Lost to Follow-up|2|||
146528393|NCT04863872|528442482|FG001|Overall Study|Lost to Follow-up|1|||
146528394|NCT04058028|528442486|FG000|Overall Study|Withdrawal of Consent from Study|12|||
146528395|NCT04058028|528442487|FG001|Overall Study|Withdrawal of Consent from Study|8|||
146528396|NCT04058028|528442488|FG002|Overall Study|Withdrawal of Consent from Study|6|||
146528397|NCT04058028|528442489|FG003|Overall Study|Withdrawal of Consent from Study|7|||
146528398|NCT04058028|528442486|FG000|Overall Study|Decision by Sponsor|13|||
146528399|NCT04058028|528442487|FG001|Overall Study|Decision by Sponsor|4|||
146528400|NCT04058028|528442488|FG002|Overall Study|Decision by Sponsor|1|||
146528401|NCT04058028|528442489|FG003|Overall Study|Decision by Sponsor|35|||
146528402|NCT04058028|528442486|FG000|Overall Study|Lost to Follow-up|1|||
146528403|NCT04058028|528442487|FG001|Overall Study|Lost to Follow-up|1|||
146528404|NCT04058028|528442488|FG002|Overall Study|Lost to Follow-up|1|||
146528405|NCT04058028|528442489|FG003|Overall Study|Lost to Follow-up|0|||
146528406|NCT04058028|528442486|FG000|Overall Study|Death|0|||
146528407|NCT04058028|528442487|FG001|Overall Study|Death|1|||
146528408|NCT04058028|528442488|FG002|Overall Study|Death|0|||
146528409|NCT04058028|528442489|FG003|Overall Study|Death|0|||
146528410|NCT04010461|528442490|FG000|Overall Study|COVID based withdrawal|5|||
146528411|NCT04010461|528442490|FG000|Overall Study|Withdrawal by Subject|5|||
146528412|NCT04010461|528442490|FG000|Overall Study|Adverse Event|1|||
146760943|NCT00662909|529291106|FG000|Overall Study|Adverse Event|17|||
146760944|NCT00662909|529291107|FG001|Overall Study|Adverse Event|18|||
146760945|NCT00662909|529291108|FG002|Overall Study|Adverse Event|19|||
146760946|NCT00662909|529291106|FG000|Overall Study|Lack of Efficacy|9|||
146760947|NCT00662909|529291107|FG001|Overall Study|Lack of Efficacy|1|||
146760948|NCT00662909|529291108|FG002|Overall Study|Lack of Efficacy|5|||
146760949|NCT00662909|529291106|FG000|Overall Study|Withdrawal by Subject|29|||
146760950|NCT00662909|529291107|FG001|Overall Study|Withdrawal by Subject|22|||
146760951|NCT00662909|529291108|FG002|Overall Study|Withdrawal by Subject|16|||
146760952|NCT00662909|529291106|FG000|Overall Study|Lost to Follow-up|2|||
146760953|NCT00662909|529291107|FG001|Overall Study|Lost to Follow-up|9|||
146760954|NCT00662909|529291108|FG002|Overall Study|Lost to Follow-up|3|||
146760955|NCT00662909|529291106|FG000|Overall Study|Protocol Violation|7|||
146760956|NCT00662909|529291107|FG001|Overall Study|Protocol Violation|4|||
146760957|NCT00662909|529291108|FG002|Overall Study|Protocol Violation|5|||
146760958|NCT00662909|529291106|FG000|Overall Study|Randomized- never received study drug|1|||
146760959|NCT00662909|529291107|FG001|Overall Study|Randomized- never received study drug|0|||
146760960|NCT00662909|529291108|FG002|Overall Study|Randomized- never received study drug|0|||
146760961|NCT00662909|529291106|FG000|Overall Study|Non-compliance with study procedures|3|||
146760962|NCT00662909|529291107|FG001|Overall Study|Non-compliance with study procedures|3|||
146760963|NCT00662909|529291108|FG002|Overall Study|Non-compliance with study procedures|2|||
146760964|NCT00662909|529291106|FG000|Overall Study|Physician Decision|1|||
146760965|NCT00662909|529291107|FG001|Overall Study|Physician Decision|1|||
146760966|NCT00662909|529291108|FG002|Overall Study|Physician Decision|2|||
146760967|NCT00662909|529291106|FG000|Overall Study|Eligibility criterion not met|0|||
146760968|NCT00662909|529291107|FG001|Overall Study|Eligibility criterion not met|1|||
146760969|NCT00662909|529291108|FG002|Overall Study|Eligibility criterion not met|1|||
146760970|NCT01268891|529292810|FG000|Overall Study|Adverse Event|3|||
146760971|NCT01268891|529292811|FG001|Overall Study|Adverse Event|7|||
146760972|NCT01268891|529292810|FG000|Overall Study|Lack of Efficacy|1|||
146760973|NCT01268891|529292811|FG001|Overall Study|Lack of Efficacy|0|||
146760974|NCT01268891|529292810|FG000|Overall Study|Withdrawal of Consent|3|||
146760975|NCT01268891|529292811|FG001|Overall Study|Withdrawal of Consent|1|||
146528413|NCT04010461|528442490|FG000|Overall Study|No Motor Threshold obtainable|1|||
146528414|NCT04010461|528442490|FG000|Overall Study|Physician Decision|1|||
146528415|NCT02227784|528442491|FG000|Double-Blind Phase|Adverse Event|3|||
146528416|NCT02227784|528442492|FG001|Double-Blind Phase|Adverse Event|2|||
146528417|NCT02227784|528442493|FG002|Double-Blind Phase|Adverse Event|1|||
146528418|NCT02227784|528442494|FG003|Double-Blind Phase|Adverse Event|3|||
146528419|NCT02227784|528442495|FG004|Double-Blind Phase|Adverse Event|0|||
146760976|NCT01268891|529292810|FG000|Overall Study|Administrative or other reason(s)|1|||
146760977|NCT01268891|529292811|FG001|Overall Study|Administrative or other reason(s)|0|||
146760978|NCT00991276|529292812|FG000|First Intervention Period|Adverse Event|0|||
146760979|NCT00991276|529292813|FG001|First Intervention Period|Adverse Event|1|||
146760980|NCT00991276|529292814|FG002|First Intervention Period|Adverse Event|0|||
146760981|NCT00991276|529292815|FG003|First Intervention Period|Adverse Event|1|||
146528420|NCT02227784|528442491|FG000|Double-Blind Phase|Physician Decision|1|||
146528421|NCT02227784|528442492|FG001|Double-Blind Phase|Physician Decision|0|||
146528422|NCT02227784|528442493|FG002|Double-Blind Phase|Physician Decision|0|||
146528423|NCT02227784|528442494|FG003|Double-Blind Phase|Physician Decision|1|||
146528424|NCT02227784|528442495|FG004|Double-Blind Phase|Physician Decision|0|||
146528425|NCT02227784|528442491|FG000|Double-Blind Phase|Protocol Violation|0|||
146528426|NCT02227784|528442492|FG001|Double-Blind Phase|Protocol Violation|0|||
146528427|NCT02227784|528442493|FG002|Double-Blind Phase|Protocol Violation|1|||
146528428|NCT02227784|528442494|FG003|Double-Blind Phase|Protocol Violation|1|||
146528429|NCT02227784|528442495|FG004|Double-Blind Phase|Protocol Violation|0|||
146528430|NCT02227784|528442491|FG000|Double-Blind Phase|Sponsor Decision|34|||
146528431|NCT02227784|528442492|FG001|Double-Blind Phase|Sponsor Decision|15|||
146528432|NCT02227784|528442493|FG002|Double-Blind Phase|Sponsor Decision|14|||
146528433|NCT02227784|528442494|FG003|Double-Blind Phase|Sponsor Decision|32|||
146528434|NCT02227784|528442495|FG004|Double-Blind Phase|Sponsor Decision|0|||
146528435|NCT02227784|528442491|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
146528436|NCT02227784|528442492|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
146528437|NCT02227784|528442493|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
146528438|NCT02227784|528442494|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
146528439|NCT02227784|528442495|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
146528440|NCT02227784|528442491|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
146528441|NCT02227784|528442492|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
146528442|NCT02227784|528442493|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
146528443|NCT02227784|528442494|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
146528444|NCT02227784|528442495|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
146528445|NCT02227784|528442491|FG000|Open-Label Extension Phase (OLE)|Death|0|||
146528446|NCT02227784|528442492|FG001|Open-Label Extension Phase (OLE)|Death|0|||
146528447|NCT02227784|528442493|FG002|Open-Label Extension Phase (OLE)|Death|0|||
146528448|NCT02227784|528442494|FG003|Open-Label Extension Phase (OLE)|Death|0|||
146528449|NCT02227784|528442495|FG004|Open-Label Extension Phase (OLE)|Death|1|||
146528450|NCT02227784|528442491|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
146528451|NCT02227784|528442492|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
146528452|NCT02227784|528442493|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
146528453|NCT02227784|528442494|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
146528454|NCT02227784|528442495|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
146528455|NCT02227784|528442491|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
146528456|NCT02227784|528442492|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
146528457|NCT02227784|528442493|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
146528458|NCT02227784|528442494|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
146528459|NCT02227784|528442495|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
146528460|NCT00102596|528442496|FG000|Part A|Screen failures|6|||
146528461|NCT00102596|528442497|FG001|Part A|Screen failures|0|||
146528462|NCT00102596|528442496|FG000|Part A|Adverse Event|1|||
146528463|NCT00102596|528442497|FG001|Part A|Adverse Event|0|||
146528464|NCT01275144|528442498|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
146528465|NCT01275144|528442499|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
146528466|NCT05607576|528442501|FG000|Overall Study|immediate sensor error|2|||
146528467|NCT05607576|528442501|FG000|Overall Study|Physician Decision|2|||
146528468|NCT00810199|528442502|FG000|Overall Study|Adverse Event|24|||
146528469|NCT00810199|528442503|FG001|Overall Study|Adverse Event|26|||
146528470|NCT00810199|528442502|FG000|Overall Study|Death|4|||
146528471|NCT00810199|528442503|FG001|Overall Study|Death|6|||
146528472|NCT00810199|528442502|FG000|Overall Study|Withdrew consent|9|||
146528473|NCT00810199|528442503|FG001|Overall Study|Withdrew consent|12|||
146528474|NCT00810199|528442502|FG000|Overall Study|Insufficient therapeutic response|5|||
146528475|NCT00810199|528442503|FG001|Overall Study|Insufficient therapeutic response|14|||
146528476|NCT00810199|528442502|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
146528477|NCT00810199|528442503|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
146528478|NCT00810199|528442502|FG000|Overall Study|Administrative/Other|5|||
146528479|NCT00810199|528442503|FG001|Overall Study|Administrative/Other|6|||
146528480|NCT00810199|528442502|FG000|Overall Study|Protocol Violation|2|||
146528481|NCT00810199|528442503|FG001|Overall Study|Protocol Violation|6|||
146528482|NCT00810199|528442502|FG000|Overall Study|Failure to return|1|||
146528483|NCT00810199|528442503|FG001|Overall Study|Failure to return|4|||
146528484|NCT00810199|528442502|FG000|Overall Study|Did not receive study drug|2|||
146528485|NCT00810199|528442503|FG001|Overall Study|Did not receive study drug|1|||
146528486|NCT00992017|528442505|FG000|Overall Study|Lost to Follow-up|2|||
146528487|NCT00992017|528442505|FG000|Overall Study|Withdrawal by Subject|2|||
146528488|NCT00992017|528442505|FG000|Overall Study|Unable to get to clinic|5|||
146528489|NCT00992017|528442505|FG000|Overall Study|Not adhere to study requirements|1|||
146528490|NCT02864407|528442506|FG000|Overall Study|Protocol Violation|3|||
146528491|NCT02864407|528442506|FG000|Overall Study|Lost to Follow-up|115|||
146528492|NCT02864407|528442506|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
146760982|NCT00991276|529292816|FG004|First Intervention Period|Adverse Event|0|||
146528493|NCT02864407|528442506|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
146528494|NCT02864407|528442506|FG000|Overall Study|Consent prior to the contract date|1|||
146528495|NCT02287038|528442516|FG000|Overall Study|Stopped attending appointments|3|||
146528496|NCT02287038|528442517|FG001|Overall Study|Stopped attending appointments|2|||
146528497|NCT02287038|528442516|FG000|Overall Study|Anxiety after starting medication|0|||
146528498|NCT02287038|528442517|FG001|Overall Study|Anxiety after starting medication|1|||
146528499|NCT02287038|528442516|FG000|Overall Study|Nausea after starting medication|1|||
146528500|NCT02287038|528442517|FG001|Overall Study|Nausea after starting medication|0|||
146528501|NCT02287038|528442516|FG000|Overall Study|Abnormal ECG after starting medication|1|||
146528502|NCT02287038|528442517|FG001|Overall Study|Abnormal ECG after starting medication|0|||
146528503|NCT05502302|528442525|FG000|Overall Study|Lost to Follow-up|6|||
146528504|NCT05502302|528442525|FG000|Overall Study|Death|2|||
146528505|NCT02998151|528442529|FG000|Overall Study|Withdrawal by Subject|3|||
146528506|NCT02998151|528442529|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
146528507|NCT02998151|528442529|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
146528508|NCT02155985|528442530|FG000|Overall Study|Withdrawal by Subject|0|||
146528509|NCT02155985|528442531|FG001|Overall Study|Withdrawal by Subject|0|||
146528510|NCT02155985|528442532|FG002|Overall Study|Withdrawal by Subject|1|||
146528511|NCT02155985|528442530|FG000|Overall Study|Lost to Follow-up|1|||
146528512|NCT02155985|528442531|FG001|Overall Study|Lost to Follow-up|0|||
146528513|NCT02155985|528442532|FG002|Overall Study|Lost to Follow-up|0|||
146528514|NCT04414787|528442542|FG000|Overall Study|Patient Death|18|||
146528515|NCT04414787|528442543|FG001|Overall Study|Patient Death|18|||
146528516|NCT04414787|528442544|FG002|Overall Study|Patient Death|15|||
146528517|NCT04414787|528442545|FG003|Overall Study|Patient Death|15|||
146528518|NCT04414787|528442542|FG000|Overall Study|Patient Hospitalization|1|||
146528519|NCT04414787|528442543|FG001|Overall Study|Patient Hospitalization|1|||
146528520|NCT04414787|528442544|FG002|Overall Study|Patient Hospitalization|2|||
146528521|NCT04414787|528442545|FG003|Overall Study|Patient Hospitalization|2|||
146528522|NCT04414787|528442542|FG000|Overall Study|Lost to Follow-up|7|||
146528523|NCT04414787|528442543|FG001|Overall Study|Lost to Follow-up|7|||
146528524|NCT04414787|528442544|FG002|Overall Study|Lost to Follow-up|5|||
146528525|NCT04414787|528442545|FG003|Overall Study|Lost to Follow-up|5|||
146528526|NCT04414787|528442542|FG000|Overall Study|Residence in post-acute care facility|3|||
146528527|NCT04414787|528442543|FG001|Overall Study|Residence in post-acute care facility|3|||
146528528|NCT04414787|528442544|FG002|Overall Study|Residence in post-acute care facility|5|||
146528529|NCT04414787|528442545|FG003|Overall Study|Residence in post-acute care facility|5|||
146528530|NCT02481050|528444444|FG000|Overall Study|Adverse Event|1|||
146528531|NCT02481050|528444444|FG000|Overall Study|Disease Progression|47|||
146528532|NCT02481050|528444444|FG000|Overall Study|Withdrawal by Subject|7|||
146528533|NCT02481050|528444444|FG000|Overall Study|Other|3|||
146528534|NCT01386606|528444445|FG000|Overall Study|Adverse Event|0|||
146528535|NCT01386606|528444446|FG001|Overall Study|Adverse Event|1|||
146528536|NCT01386606|528444447|FG002|Overall Study|Adverse Event|0|||
146528537|NCT01386606|528444448|FG003|Overall Study|Adverse Event|0|||
146528538|NCT01386606|528444445|FG000|Overall Study|Withdrawal by Subject|0|||
146528539|NCT01386606|528444446|FG001|Overall Study|Withdrawal by Subject|1|||
146528540|NCT01386606|528444447|FG002|Overall Study|Withdrawal by Subject|1|||
146528541|NCT01386606|528444448|FG003|Overall Study|Withdrawal by Subject|0|||
146528542|NCT01386606|528444445|FG000|Overall Study|Protocol Violation|1|||
146528543|NCT01386606|528444446|FG001|Overall Study|Protocol Violation|0|||
146528544|NCT01386606|528444447|FG002|Overall Study|Protocol Violation|1|||
146528545|NCT01386606|528444448|FG003|Overall Study|Protocol Violation|1|||
146528546|NCT01386606|528444445|FG000|Overall Study|Lost to Follow-up|2|||
146528547|NCT01386606|528444446|FG001|Overall Study|Lost to Follow-up|0|||
146528548|NCT01386606|528444447|FG002|Overall Study|Lost to Follow-up|0|||
146528549|NCT01386606|528444448|FG003|Overall Study|Lost to Follow-up|0|||
146528550|NCT01386606|528444445|FG000|Overall Study|Subject incarcerated|0|||
146528551|NCT01386606|528444446|FG001|Overall Study|Subject incarcerated|1|||
146528552|NCT01386606|528444447|FG002|Overall Study|Subject incarcerated|0|||
146528553|NCT01386606|528444448|FG003|Overall Study|Subject incarcerated|0|||
146528554|NCT01386606|528444445|FG000|Overall Study|Unable to draw PK|1|||
146528555|NCT01386606|528444446|FG001|Overall Study|Unable to draw PK|0|||
146528556|NCT01386606|528444447|FG002|Overall Study|Unable to draw PK|0|||
146528557|NCT01386606|528444448|FG003|Overall Study|Unable to draw PK|0|||
146528558|NCT01386606|528444445|FG000|Overall Study|T levels too high|0|||
146528559|NCT01386606|528444446|FG001|Overall Study|T levels too high|1|||
146528560|NCT01386606|528444447|FG002|Overall Study|T levels too high|1|||
146528561|NCT01386606|528444448|FG003|Overall Study|T levels too high|0|||
146528562|NCT01228591|528444449|FG000|Baseline|Lack of Efficacy|1|||
146528563|NCT01228591|528444450|FG001|Baseline|Lack of Efficacy|2|||
146528564|NCT01095835|528444451|FG000|Overall Study|Adverse Event|8|||
146528565|NCT01095835|528444452|FG001|Overall Study|Adverse Event|6|||
146528566|NCT01095835|528444453|FG002|Overall Study|Adverse Event|6|||
146528567|NCT01095835|528444451|FG000|Overall Study|Lack of Efficacy|0|||
146528568|NCT01095835|528444452|FG001|Overall Study|Lack of Efficacy|1|||
146528569|NCT01095835|528444453|FG002|Overall Study|Lack of Efficacy|0|||
146528570|NCT01095835|528444451|FG000|Overall Study|Physician Decision|0|||
146528571|NCT01095835|528444452|FG001|Overall Study|Physician Decision|0|||
146528572|NCT01095835|528444453|FG002|Overall Study|Physician Decision|1|||
146528573|NCT01095835|528444451|FG000|Overall Study|Withdrawal by Subject|1|||
146528574|NCT01095835|528444452|FG001|Overall Study|Withdrawal by Subject|3|||
146528575|NCT01095835|528444453|FG002|Overall Study|Withdrawal by Subject|0|||
146528576|NCT01095835|528444451|FG000|Overall Study|Non study compliance|0|||
146528577|NCT01095835|528444452|FG001|Overall Study|Non study compliance|0|||
146528578|NCT01095835|528444453|FG002|Overall Study|Non study compliance|1|||
146528579|NCT01095835|528444451|FG000|Overall Study|Protocol Violation|1|||
146528580|NCT01095835|528444452|FG001|Overall Study|Protocol Violation|2|||
146528581|NCT01095835|528444453|FG002|Overall Study|Protocol Violation|0|||
146528582|NCT03110354|528444454|FG000|Overall Study|Death|1|||
146528583|NCT03110354|528444455|FG001|Overall Study|Death|0|||
146528584|NCT03110354|528444456|FG002|Overall Study|Death|0|||
146528585|NCT03110354|528444457|FG003|Overall Study|Death|1|||
146528586|NCT03110354|528444458|FG004|Overall Study|Death|0|||
146528587|NCT03110354|528444454|FG000|Overall Study|Start of new therapy|0|||
146528588|NCT03110354|528444455|FG001|Overall Study|Start of new therapy|0|||
146528589|NCT03110354|528444456|FG002|Overall Study|Start of new therapy|0|||
146528590|NCT03110354|528444457|FG003|Overall Study|Start of new therapy|0|||
146528591|NCT03110354|528444458|FG004|Overall Study|Start of new therapy|1|||
146528592|NCT03110354|528444454|FG000|Overall Study|Failure to achieve response|2|||
146528593|NCT03110354|528444455|FG001|Overall Study|Failure to achieve response|3|||
146528594|NCT03110354|528444456|FG002|Overall Study|Failure to achieve response|0|||
146528595|NCT03110354|528444457|FG003|Overall Study|Failure to achieve response|2|||
146528596|NCT03110354|528444458|FG004|Overall Study|Failure to achieve response|1|||
146528597|NCT03110354|528444454|FG000|Overall Study|Progressive disease|1|||
146528598|NCT03110354|528444455|FG001|Overall Study|Progressive disease|1|||
146528599|NCT03110354|528444456|FG002|Overall Study|Progressive disease|3|||
146528600|NCT03110354|528444457|FG003|Overall Study|Progressive disease|4|||
146528601|NCT03110354|528444458|FG004|Overall Study|Progressive disease|2|||
146528602|NCT03110354|528444454|FG000|Overall Study|Adverse Event|0|||
146528603|NCT03110354|528444455|FG001|Overall Study|Adverse Event|0|||
146528604|NCT03110354|528444456|FG002|Overall Study|Adverse Event|0|||
146528605|NCT03110354|528444457|FG003|Overall Study|Adverse Event|2|||
146528606|NCT03110354|528444458|FG004|Overall Study|Adverse Event|2|||
146528607|NCT03110354|528444454|FG000|Overall Study|Other|0|||
146528608|NCT03110354|528444455|FG001|Overall Study|Other|0|||
146528609|NCT03110354|528444456|FG002|Overall Study|Other|0|||
146528610|NCT03110354|528444457|FG003|Overall Study|Other|1|||
146528611|NCT03110354|528444458|FG004|Overall Study|Other|1|||
146528612|NCT01298700|528444459|FG000|Overall Study|Adverse Event|50|||
146528613|NCT01298700|528444460|FG001|Overall Study|Adverse Event|51|||
146528614|NCT01298700|528444459|FG000|Overall Study|Lack of Efficacy|9|||
146528615|NCT01298700|528444460|FG001|Overall Study|Lack of Efficacy|14|||
146528616|NCT01298700|528444459|FG000|Overall Study|Lost to Follow-up|5|||
146528617|NCT01298700|528444460|FG001|Overall Study|Lost to Follow-up|2|||
146528618|NCT01298700|528444459|FG000|Overall Study|Withdrawal by Subject|12|||
146528619|NCT01298700|528444460|FG001|Overall Study|Withdrawal by Subject|9|||
146528620|NCT01298700|528444459|FG000|Overall Study|Protocol Violation|6|||
146528621|NCT01298700|528444460|FG001|Overall Study|Protocol Violation|4|||
146528622|NCT01298700|528444459|FG000|Overall Study|Other Miscellaneous Reasons|16|||
146528623|NCT01298700|528444460|FG001|Overall Study|Other Miscellaneous Reasons|15|||
146528624|NCT01298700|528444459|FG000|Overall Study|Did not Receive Study Drug|3|||
146528625|NCT01298700|528444460|FG001|Overall Study|Did not Receive Study Drug|5|||
146528626|NCT04006145|528444461|FG000|Overall Study|Lost to Follow-up|0|||
146528627|NCT04006145|528444462|FG001|Overall Study|Lost to Follow-up|1|||
146528628|NCT04006145|528444461|FG000|Overall Study|Other|1|||
146528629|NCT04006145|528444462|FG001|Overall Study|Other|2|||
146528630|NCT00010257|528444465|FG000|Overall Study|Withdrawal by Subject|1|||
146528631|NCT00010257|528444466|FG001|Overall Study|Withdrawal by Subject|0|||
146528632|NCT02063672|528444467|FG000|Overall Study|Ongoing Follow-up|27|||
146528633|NCT02063672|528444468|FG001|Overall Study|Ongoing Follow-up|14|||
146528634|NCT02063672|528444467|FG000|Overall Study|Death|5|||
146528635|NCT02063672|528444468|FG001|Overall Study|Death|3|||
146528636|NCT02063672|528444467|FG000|Overall Study|Lost to Follow-up|1|||
146528637|NCT02063672|528444468|FG001|Overall Study|Lost to Follow-up|3|||
146528638|NCT02063672|528444467|FG000|Overall Study|Withdrawal by Subject|2|||
146760983|NCT00991276|529292817|FG005|First Intervention Period|Adverse Event|0|||
146528639|NCT02063672|528444468|FG001|Overall Study|Withdrawal by Subject|2|||
146528640|NCT01307787|528444470|FG000|Overall Study|Withdrawal by Subject|2|||
146528641|NCT01307787|528444471|FG001|Overall Study|Withdrawal by Subject|0|||
146528642|NCT01965327|528444472|FG000|Overall Study|Physician Decision|2|||
146528643|NCT02498678|528444473|FG000|Overall Study|interference from the surgical team|0|||
146528644|NCT02498678|528444474|FG001|Overall Study|interference from the surgical team|2|||
146528645|NCT01405560|528444477|FG000|Overall Study|Physician Decision|1|||
146528646|NCT01699750|528444479|FG000|Overall Study|Withdrew Consent|0|||
146760984|NCT00991276|529292812|FG000|First Intervention Period|Protocol Violation|0|||
146528647|NCT01699750|528444480|FG001|Overall Study|Withdrew Consent|1|||
146528648|NCT01699750|528444479|FG000|Overall Study|Other|0|||
146528649|NCT01699750|528444480|FG001|Overall Study|Other|2|||
146528650|NCT01484951|528444482|FG000|Overall Study|Adverse Event|3|||
146528651|NCT01484951|528444482|FG000|Overall Study|Personal Reasons|1|||
146528652|NCT01484951|528444482|FG000|Overall Study|Non-Compliance|1|||
146528653|NCT02452047|528444484|FG000|Overall Study|Adverse Event|0|||
146528654|NCT02452047|528444485|FG001|Overall Study|Adverse Event|1|||
146528655|NCT02452047|528444486|FG002|Overall Study|Adverse Event|1|||
146528656|NCT02452047|528444484|FG000|Overall Study|Death|1|||
146528657|NCT02452047|528444485|FG001|Overall Study|Death|3|||
146528658|NCT02452047|528444486|FG002|Overall Study|Death|1|||
146528659|NCT02452047|528444484|FG000|Overall Study|Physician Decision|1|||
146528660|NCT02452047|528444485|FG001|Overall Study|Physician Decision|0|||
146528661|NCT02452047|528444486|FG002|Overall Study|Physician Decision|0|||
146528662|NCT02452047|528444484|FG000|Overall Study|Lost to Follow-up|1|||
146528663|NCT02452047|528444485|FG001|Overall Study|Lost to Follow-up|1|||
146528664|NCT02452047|528444486|FG002|Overall Study|Lost to Follow-up|0|||
146528665|NCT02452047|528444484|FG000|Overall Study|Withdrawal by Subject|1|||
146528666|NCT02452047|528444485|FG001|Overall Study|Withdrawal by Subject|0|||
146528667|NCT02452047|528444486|FG002|Overall Study|Withdrawal by Subject|0|||
146528668|NCT01868646|528444487|FG000|Overall Study|Do not meet inclusion criteria|3|||
146528669|NCT01868646|528444488|FG001|Overall Study|Do not meet inclusion criteria|5|||
146528670|NCT01831427|528444489|FG000|Overall Study|Adverse Event|0|||
146528671|NCT01831427|528444490|FG001|Overall Study|Adverse Event|1|||
146528672|NCT01831427|528444491|FG002|Overall Study|Adverse Event|0|||
146528673|NCT01831427|528444492|FG003|Overall Study|Adverse Event|0|||
146528674|NCT01831427|528444493|FG004|Overall Study|Adverse Event|0|||
146528675|NCT01831427|528444494|FG005|Overall Study|Adverse Event|1|||
146528676|NCT01831427|528444495|FG006|Overall Study|Adverse Event|0|||
146528677|NCT01831427|528444496|FG007|Overall Study|Adverse Event|1|||
146528678|NCT01831427|528444497|FG008|Overall Study|Adverse Event|0|||
146528679|NCT01831427|528444498|FG009|Overall Study|Adverse Event|0|||
146528680|NCT01831427|528444499|FG010|Overall Study|Adverse Event|2|||
146528681|NCT01831427|528444489|FG000|Overall Study|Investigator's Discretion|0|||
146528682|NCT01831427|528444490|FG001|Overall Study|Investigator's Discretion|0|||
146528683|NCT01831427|528444491|FG002|Overall Study|Investigator's Discretion|0|||
146528684|NCT01831427|528444492|FG003|Overall Study|Investigator's Discretion|1|||
146528685|NCT01831427|528444493|FG004|Overall Study|Investigator's Discretion|0|||
146528686|NCT01831427|528444494|FG005|Overall Study|Investigator's Discretion|0|||
146528687|NCT01831427|528444495|FG006|Overall Study|Investigator's Discretion|0|||
146528688|NCT01831427|528444496|FG007|Overall Study|Investigator's Discretion|0|||
146528689|NCT01831427|528444497|FG008|Overall Study|Investigator's Discretion|0|||
146528690|NCT01831427|528444498|FG009|Overall Study|Investigator's Discretion|0|||
146528691|NCT01831427|528444499|FG010|Overall Study|Investigator's Discretion|0|||
146528692|NCT01831427|528444489|FG000|Overall Study|Withdrew Consent|0|||
146528693|NCT01831427|528444490|FG001|Overall Study|Withdrew Consent|0|||
146528694|NCT01831427|528444491|FG002|Overall Study|Withdrew Consent|0|||
146528695|NCT01831427|528444492|FG003|Overall Study|Withdrew Consent|0|||
146528696|NCT01831427|528444493|FG004|Overall Study|Withdrew Consent|0|||
146528697|NCT01831427|528444494|FG005|Overall Study|Withdrew Consent|0|||
146528698|NCT01831427|528444495|FG006|Overall Study|Withdrew Consent|2|||
146528699|NCT01831427|528444496|FG007|Overall Study|Withdrew Consent|0|||
146528700|NCT01831427|528444497|FG008|Overall Study|Withdrew Consent|0|||
146528701|NCT01831427|528444498|FG009|Overall Study|Withdrew Consent|1|||
146528702|NCT01831427|528444499|FG010|Overall Study|Withdrew Consent|1|||
146528703|NCT02169505|528444500|FG000|Overall Study|Withdrawal by Subject|1|||
146528704|NCT02035553|528444501|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
146528705|NCT02035553|528444502|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
146528706|NCT02035553|528444501|FG000|Overall Study|Adverse Event|10|||
146528707|NCT02035553|528444502|FG001|Overall Study|Adverse Event|6|||
146528708|NCT02035553|528444501|FG000|Overall Study|Physician Decision|3|||
146528709|NCT02035553|528444502|FG001|Overall Study|Physician Decision|2|||
146528710|NCT02035553|528444501|FG000|Overall Study|Lack of Efficacy|1|||
146528711|NCT02035553|528444502|FG001|Overall Study|Lack of Efficacy|1|||
146528712|NCT02035553|528444501|FG000|Overall Study|Withdrawal by Subject|4|||
146528713|NCT02035553|528444502|FG001|Overall Study|Withdrawal by Subject|7|||
146528714|NCT02035553|528444501|FG000|Overall Study|Non-compliance with Study Drug|0|||
146528715|NCT02035553|528444502|FG001|Overall Study|Non-compliance with Study Drug|1|||
146528716|NCT02035553|528444501|FG000|Overall Study|Lost to Follow-up|0|||
146528717|NCT02035553|528444502|FG001|Overall Study|Lost to Follow-up|1|||
146528718|NCT02035553|528444501|FG000|Overall Study|Other Reason|0|||
146528719|NCT02035553|528444502|FG001|Overall Study|Other Reason|4|||
146528720|NCT01854697|528444503|FG000|Overall Study|Adverse Event|1|||
146528721|NCT01854697|528444504|FG001|Overall Study|Adverse Event|0|||
146528722|NCT01854697|528444505|FG002|Overall Study|Adverse Event|0|||
146528723|NCT01854697|528444506|FG003|Overall Study|Adverse Event|0|||
146528724|NCT01854697|528444507|FG004|Overall Study|Adverse Event|1|||
146528725|NCT01854697|528444503|FG000|Overall Study|Lost to Follow-up|4|||
146528726|NCT01854697|528444504|FG001|Overall Study|Lost to Follow-up|1|||
146528727|NCT01854697|528444505|FG002|Overall Study|Lost to Follow-up|1|||
146528728|NCT01854697|528444506|FG003|Overall Study|Lost to Follow-up|2|||
146528729|NCT01854697|528444507|FG004|Overall Study|Lost to Follow-up|0|||
146528730|NCT01854697|528444503|FG000|Overall Study|To enter another AbbVie study|1|||
146528731|NCT01854697|528444504|FG001|Overall Study|To enter another AbbVie study|0|||
146528732|NCT01854697|528444505|FG002|Overall Study|To enter another AbbVie study|0|||
146528733|NCT01854697|528444506|FG003|Overall Study|To enter another AbbVie study|0|||
146528734|NCT01854697|528444507|FG004|Overall Study|To enter another AbbVie study|1|||
146528735|NCT01854697|528444503|FG000|Overall Study|Withdrew Consent|0|||
146528736|NCT01854697|528444504|FG001|Overall Study|Withdrew Consent|1|||
146528737|NCT01854697|528444505|FG002|Overall Study|Withdrew Consent|0|||
146528738|NCT01854697|528444506|FG003|Overall Study|Withdrew Consent|1|||
146528739|NCT01854697|528444507|FG004|Overall Study|Withdrew Consent|0|||
146528740|NCT01854697|528444503|FG000|Overall Study|Other|0|||
146528741|NCT01854697|528444504|FG001|Overall Study|Other|1|||
146528742|NCT01854697|528444505|FG002|Overall Study|Other|1|||
146528743|NCT01854697|528444506|FG003|Overall Study|Other|0|||
146528744|NCT01854697|528444507|FG004|Overall Study|Other|0|||
146528745|NCT00917124|528444508|FG000|Overall Study|Protocol Violation|4|||
146528746|NCT00917124|528444509|FG001|Overall Study|Protocol Violation|6|||
146528747|NCT01607593|528444512|FG000|Overall Study|Adverse Event|15|||
146528748|NCT01607593|528444512|FG000|Overall Study|Lack of Efficacy|16|||
146528749|NCT01607593|528444512|FG000|Overall Study|Lost to Follow-up|25|||
146528750|NCT01607593|528444512|FG000|Overall Study|Continuation|33|||
146528751|NCT01607593|528444512|FG000|Overall Study|Other|4|||
146528752|NCT00483652|528444516|FG000|Double-blind Treatment Period|Protocol Violation|2|||
146528753|NCT00483652|528444517|FG001|Double-blind Treatment Period|Protocol Violation|1|||
146528754|NCT00483652|528444516|FG000|Double-blind Treatment Period|Adverse Event|3|||
146528755|NCT00483652|528444517|FG001|Double-blind Treatment Period|Adverse Event|4|||
146528756|NCT00483652|528444516|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
146528757|NCT00483652|528444517|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
146528758|NCT00483652|528444516|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
146528759|NCT00483652|528444517|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
146528760|NCT00126594|528444518|FG000|Overall Study|Ineligible|2|||
146528761|NCT00126594|528444519|FG001|Overall Study|Ineligible|0|||
146528762|NCT00126594|528444518|FG000|Overall Study|Withdrawal by Subject|0|||
146528763|NCT00126594|528444519|FG001|Overall Study|Withdrawal by Subject|4|||
146528764|NCT00126594|528444518|FG000|Overall Study|Physician Decision|1|||
146528765|NCT00126594|528444519|FG001|Overall Study|Physician Decision|3|||
146528766|NCT00126594|528444518|FG000|Overall Study|Adverse Event|7|||
146528767|NCT00126594|528444519|FG001|Overall Study|Adverse Event|5|||
146528768|NCT00126594|528444518|FG000|Overall Study|Non-compliance|0|||
146528769|NCT00126594|528444519|FG001|Overall Study|Non-compliance|1|||
146528770|NCT00126594|528444518|FG000|Overall Study|Disease Progression|29|||
146528771|NCT00126594|528444519|FG001|Overall Study|Disease Progression|24|||
146528772|NCT00891813|528444524|FG000|Overall Study|Adverse Event|3|||
146528773|NCT00891813|528444524|FG000|Overall Study|Withdrawal by Subject|1|||
146528774|NCT00891813|528444524|FG000|Overall Study|Patient Noncompliance|6|||
146528775|NCT00891813|528444524|FG000|Overall Study|Protocol Violation|2|||
146528776|NCT02513550|528444527|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
146528777|NCT02513550|528444528|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
146528778|NCT02513550|528444529|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
146528779|NCT02513550|528444530|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
146528780|NCT02513550|528444531|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
146528781|NCT02513550|528444532|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
146528782|NCT02513550|528444527|FG000|Double Blind Treatment Period|Adverse Event|5|||
146528783|NCT02513550|528444528|FG001|Double Blind Treatment Period|Adverse Event|13|||
146528784|NCT02513550|528444529|FG002|Double Blind Treatment Period|Adverse Event|17|||
146528785|NCT02513550|528444530|FG003|Double Blind Treatment Period|Adverse Event|0|||
146528786|NCT02513550|528444531|FG004|Double Blind Treatment Period|Adverse Event|1|||
146528787|NCT02513550|528444532|FG005|Double Blind Treatment Period|Adverse Event|0|||
146528788|NCT02513550|528444527|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
146528789|NCT02513550|528444528|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
146528790|NCT02513550|528444529|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
146528791|NCT02513550|528444530|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
146528792|NCT02513550|528444531|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
146528793|NCT02513550|528444532|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
146528794|NCT02513550|528444527|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
146528795|NCT02513550|528444528|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
146528796|NCT02513550|528444529|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
146528797|NCT02513550|528444530|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
146528798|NCT02513550|528444531|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
146528799|NCT02513550|528444532|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
146528800|NCT02513550|528444527|FG000|Double Blind Treatment Period|Protocol Violation|1|||
146528801|NCT02513550|528444528|FG001|Double Blind Treatment Period|Protocol Violation|1|||
146528802|NCT02513550|528444529|FG002|Double Blind Treatment Period|Protocol Violation|4|||
146528803|NCT02513550|528444530|FG003|Double Blind Treatment Period|Protocol Violation|0|||
146528804|NCT02513550|528444531|FG004|Double Blind Treatment Period|Protocol Violation|0|||
146528805|NCT02513550|528444532|FG005|Double Blind Treatment Period|Protocol Violation|0|||
146528806|NCT02513550|528444527|FG000|Double Blind Treatment Period|Physician Decision|2|||
146528807|NCT02513550|528444528|FG001|Double Blind Treatment Period|Physician Decision|0|||
146528808|NCT02513550|528444529|FG002|Double Blind Treatment Period|Physician Decision|4|||
146528809|NCT02513550|528444530|FG003|Double Blind Treatment Period|Physician Decision|0|||
146528810|NCT02513550|528444531|FG004|Double Blind Treatment Period|Physician Decision|0|||
146528811|NCT02513550|528444532|FG005|Double Blind Treatment Period|Physician Decision|0|||
146528812|NCT02513550|528444527|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
146528813|NCT02513550|528444528|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
146528814|NCT02513550|528444529|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
146528815|NCT02513550|528444530|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
146528816|NCT02513550|528444531|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
146528817|NCT02513550|528444532|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
146528818|NCT02513550|528444527|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
146528819|NCT02513550|528444528|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
146528820|NCT02513550|528444529|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
146528821|NCT02513550|528444530|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
146528822|NCT02513550|528444531|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
146528823|NCT02513550|528444532|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
146528824|NCT02513550|528444527|FG000|Double Blind Treatment Period|Due to personal business|2|||
146528825|NCT02513550|528444528|FG001|Double Blind Treatment Period|Due to personal business|0|||
146528826|NCT02513550|528444529|FG002|Double Blind Treatment Period|Due to personal business|1|||
146528827|NCT02513550|528444530|FG003|Double Blind Treatment Period|Due to personal business|0|||
146528828|NCT02513550|528444531|FG004|Double Blind Treatment Period|Due to personal business|0|||
146528829|NCT02513550|528444532|FG005|Double Blind Treatment Period|Due to personal business|0|||
146528830|NCT02513550|528444527|FG000|Double Blind Treatment Period|Death|1|||
146528831|NCT02513550|528444528|FG001|Double Blind Treatment Period|Death|0|||
146528832|NCT02513550|528444529|FG002|Double Blind Treatment Period|Death|2|||
146528833|NCT02513550|528444530|FG003|Double Blind Treatment Period|Death|0|||
146528834|NCT02513550|528444531|FG004|Double Blind Treatment Period|Death|0|||
146528835|NCT02513550|528444532|FG005|Double Blind Treatment Period|Death|0|||
146528836|NCT02513550|528444527|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
146528837|NCT02513550|528444528|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
146528838|NCT02513550|528444529|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
146528839|NCT02513550|528444530|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146528840|NCT02513550|528444531|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146528841|NCT02513550|528444532|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146528842|NCT02513550|528444527|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
146528843|NCT02513550|528444528|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
146528844|NCT02513550|528444529|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
146528845|NCT02513550|528444530|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
146528846|NCT02513550|528444531|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
146528847|NCT02513550|528444532|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
146528848|NCT02513550|528444527|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
146528849|NCT02513550|528444528|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
146528850|NCT02513550|528444529|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
146528851|NCT02513550|528444530|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146528852|NCT02513550|528444531|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146528853|NCT02513550|528444532|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146528854|NCT02513550|528444527|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
146528855|NCT02513550|528444528|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
146528856|NCT02513550|528444529|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
146528857|NCT02513550|528444530|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
146528858|NCT02513550|528444531|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
146528859|NCT02513550|528444532|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
146528860|NCT02513550|528444527|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
146760985|NCT00991276|529292813|FG001|First Intervention Period|Protocol Violation|0|||
146528861|NCT02513550|528444528|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
146528862|NCT02513550|528444529|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
146528863|NCT02513550|528444530|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
146528864|NCT02513550|528444531|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
146528865|NCT02513550|528444532|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
146528866|NCT02513550|528444527|FG000|Post-Treatment Follow-up Period|Death|0|||
146528867|NCT02513550|528444528|FG001|Post-Treatment Follow-up Period|Death|0|||
146528868|NCT02513550|528444529|FG002|Post-Treatment Follow-up Period|Death|1|||
146528869|NCT02513550|528444530|FG003|Post-Treatment Follow-up Period|Death|0|||
146528870|NCT02513550|528444531|FG004|Post-Treatment Follow-up Period|Death|0|||
146528871|NCT02513550|528444532|FG005|Post-Treatment Follow-up Period|Death|0|||
146528872|NCT02513550|528444527|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
146528873|NCT02513550|528444528|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
146528874|NCT02513550|528444529|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
146528875|NCT02513550|528444530|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
146528876|NCT02513550|528444531|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
146528877|NCT02513550|528444532|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
146528878|NCT02513550|528444527|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
146528879|NCT02513550|528444528|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
146528880|NCT02513550|528444529|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
146528881|NCT02513550|528444530|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
146528882|NCT02513550|528444531|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
146528883|NCT02513550|528444532|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
146528884|NCT02513550|528444527|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
146528885|NCT02513550|528444528|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
146760986|NCT00991276|529292814|FG002|First Intervention Period|Protocol Violation|0|||
146528886|NCT02513550|528444529|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
146528887|NCT02513550|528444530|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
146528888|NCT02513550|528444531|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
146528889|NCT02513550|528444532|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
146528890|NCT02869789|528444540|FG000|Overall Study|Disease progression|184|||
146528891|NCT02869789|528444541|FG001|Overall Study|Disease progression|109|||
146528892|NCT02869789|528444542|FG002|Overall Study|Disease progression|260|||
146528893|NCT02869789|528444543|FG003|Overall Study|Disease progression|19|||
146528894|NCT02869789|528444540|FG000|Overall Study|Study drug toxicity|90|||
146528895|NCT02869789|528444541|FG001|Overall Study|Study drug toxicity|32|||
146528896|NCT02869789|528444542|FG002|Overall Study|Study drug toxicity|55|||
146528897|NCT02869789|528444543|FG003|Overall Study|Study drug toxicity|14|||
146528898|NCT02869789|528444540|FG000|Overall Study|Death|7|||
146528899|NCT02869789|528444541|FG001|Overall Study|Death|3|||
146528900|NCT02869789|528444542|FG002|Overall Study|Death|5|||
146528901|NCT02869789|528444543|FG003|Overall Study|Death|1|||
146528902|NCT02869789|528444540|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
146528903|NCT02869789|528444541|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
146528904|NCT02869789|528444542|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
146528905|NCT02869789|528444543|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
146528906|NCT02869789|528444540|FG000|Overall Study|Participant request to discontinue study treatment|10|||
146528907|NCT02869789|528444541|FG001|Overall Study|Participant request to discontinue study treatment|5|||
146528908|NCT02869789|528444542|FG002|Overall Study|Participant request to discontinue study treatment|5|||
146528909|NCT02869789|528444543|FG003|Overall Study|Participant request to discontinue study treatment|3|||
146528910|NCT02869789|528444540|FG000|Overall Study|Withdrawal by Subject|5|||
146528911|NCT02869789|528444541|FG001|Overall Study|Withdrawal by Subject|2|||
146528912|NCT02869789|528444542|FG002|Overall Study|Withdrawal by Subject|7|||
146528913|NCT02869789|528444543|FG003|Overall Study|Withdrawal by Subject|2|||
146528914|NCT02869789|528444540|FG000|Overall Study|Lost to Follow-up|0|||
146528915|NCT02869789|528444541|FG001|Overall Study|Lost to Follow-up|0|||
146528916|NCT02869789|528444542|FG002|Overall Study|Lost to Follow-up|2|||
146528917|NCT02869789|528444543|FG003|Overall Study|Lost to Follow-up|0|||
146528918|NCT02869789|528444540|FG000|Overall Study|Maximum clinical benefit|5|||
146528919|NCT02869789|528444541|FG001|Overall Study|Maximum clinical benefit|2|||
146528920|NCT02869789|528444542|FG002|Overall Study|Maximum clinical benefit|1|||
146760987|NCT00991276|529292815|FG003|First Intervention Period|Protocol Violation|0|||
146760988|NCT00991276|529292816|FG004|First Intervention Period|Protocol Violation|2|||
146760989|NCT00991276|529292817|FG005|First Intervention Period|Protocol Violation|0|||
146760990|NCT00991276|529292812|FG000|First Intervention Period|Insufficient clinical response|0|||
146760991|NCT00991276|529292813|FG001|First Intervention Period|Insufficient clinical response|0|||
146760992|NCT00991276|529292814|FG002|First Intervention Period|Insufficient clinical response|0|||
146760993|NCT00991276|529292815|FG003|First Intervention Period|Insufficient clinical response|0|||
146760994|NCT00991276|529292816|FG004|First Intervention Period|Insufficient clinical response|1|||
146528921|NCT02869789|528444543|FG003|Overall Study|Maximum clinical benefit|0|||
146760995|NCT00991276|529292817|FG005|First Intervention Period|Insufficient clinical response|0|||
146528922|NCT02869789|528444540|FG000|Overall Study|Poor/Non-compliance|0|||
146528923|NCT02869789|528444541|FG001|Overall Study|Poor/Non-compliance|2|||
146528924|NCT02869789|528444542|FG002|Overall Study|Poor/Non-compliance|1|||
146528925|NCT02869789|528444543|FG003|Overall Study|Poor/Non-compliance|0|||
146528926|NCT02869789|528444540|FG000|Overall Study|Participant no longer meets study criteria|0|||
146528927|NCT02869789|528444541|FG001|Overall Study|Participant no longer meets study criteria|1|||
146528928|NCT02869789|528444542|FG002|Overall Study|Participant no longer meets study criteria|1|||
146528929|NCT02869789|528444543|FG003|Overall Study|Participant no longer meets study criteria|0|||
146528930|NCT02869789|528444540|FG000|Overall Study|Administrative reason by sponsor|0|||
146528931|NCT02869789|528444541|FG001|Overall Study|Administrative reason by sponsor|0|||
146528932|NCT02869789|528444542|FG002|Overall Study|Administrative reason by sponsor|1|||
146528933|NCT02869789|528444543|FG003|Overall Study|Administrative reason by sponsor|0|||
146860331|NCT01294683|529659856|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
146860332|NCT01294683|529659855|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
146528934|NCT02869789|528444540|FG000|Overall Study|Other reasons|4|||
146528935|NCT02869789|528444541|FG001|Overall Study|Other reasons|8|||
146528936|NCT02869789|528444542|FG002|Overall Study|Other reasons|6|||
146528937|NCT02869789|528444543|FG003|Overall Study|Other reasons|0|||
146528938|NCT02127658|528444556|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
146528939|NCT02127658|528444557|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
146528940|NCT02127658|528444556|FG000|Overall Study|Withdrawal by Subject|0|||
146528941|NCT02127658|528444557|FG001|Overall Study|Withdrawal by Subject|2|||
146528942|NCT02127658|528444556|FG000|Overall Study|Physician Decision|0|||
146528943|NCT02127658|528444557|FG001|Overall Study|Physician Decision|1|||
146528944|NCT03834493|528444558|FG000|Overall Study|Participants Ongoing|311|||
146528945|NCT03834493|528444559|FG001|Overall Study|Participants Ongoing|324|||
146860333|NCT01294683|529659856|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
146860334|NCT01294683|529659855|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
146860335|NCT01294683|529659856|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
146860336|NCT01294683|529659855|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
146860337|NCT01294683|529659856|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
146860338|NCT01294683|529659855|FG000|Post Crossover (Period III)|Adverse Event|6|||
146860339|NCT01294683|529659856|FG001|Post Crossover (Period III)|Adverse Event|6|||
146860340|NCT01294683|529659855|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
146860341|NCT01294683|529659856|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
146860342|NCT01294683|529659855|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
146860343|NCT01294683|529659856|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
146860344|NCT01294683|529659855|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
146860345|NCT01294683|529659856|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
146860346|NCT01794923|529659857|FG000|Overall Study|Adverse Event|0|||
146860347|NCT01794923|529659858|FG001|Overall Study|Adverse Event|0|||
146860348|NCT01794923|529659859|FG002|Overall Study|Adverse Event|1|||
146860349|NCT02571049|529659862|FG000|Screening|Did not meet entry criteria|2|||
146860350|NCT02571049|529659863|FG001|Screening|Did not meet entry criteria|2|||
146860351|NCT02571049|529659862|FG000|Randomization|No migraine attack|0|||
146528946|NCT03834493|528444558|FG000|Overall Study|Withdrawal by Subject|20|||
146528947|NCT03834493|528444559|FG001|Overall Study|Withdrawal by Subject|17|||
146528948|NCT03834493|528444558|FG000|Overall Study|Physician Decision|1|||
146528949|NCT03834493|528444559|FG001|Overall Study|Physician Decision|0|||
146528950|NCT03834493|528444558|FG000|Overall Study|Death|289|||
146528951|NCT03834493|528444559|FG001|Overall Study|Death|282|||
146528952|NCT04144322|528444561|FG000|Overall Study|Lack of Efficacy|2|||
146528953|NCT04144322|528444562|FG001|Overall Study|Lack of Efficacy|2|||
146528954|NCT02277028|528444563|FG000|Overall Study|Lost to Follow-up|1|||
146528955|NCT02277028|528444564|FG001|Overall Study|Lost to Follow-up|0|||
146528956|NCT02277028|528444563|FG000|Overall Study|Withdrawal by Subject|0|||
146528957|NCT02277028|528444564|FG001|Overall Study|Withdrawal by Subject|1|||
146528958|NCT02718911|528444565|FG000|Overall Study|Adverse Event|0|||
146528959|NCT02718911|528444566|FG001|Overall Study|Adverse Event|0|||
146528960|NCT02718911|528444567|FG002|Overall Study|Adverse Event|0|||
146528961|NCT02718911|528444568|FG003|Overall Study|Adverse Event|0|||
146528962|NCT02718911|528444569|FG004|Overall Study|Adverse Event|0|||
146528963|NCT02718911|528444570|FG005|Overall Study|Adverse Event|0|||
146528964|NCT02718911|528444571|FG006|Overall Study|Adverse Event|0|||
146528965|NCT02718911|528444572|FG007|Overall Study|Adverse Event|0|||
146528966|NCT02718911|528444573|FG008|Overall Study|Adverse Event|0|||
146528967|NCT02718911|528444574|FG009|Overall Study|Adverse Event|2|||
146528968|NCT02718911|528444565|FG000|Overall Study|Death|2|||
146528969|NCT02718911|528444566|FG001|Overall Study|Death|3|||
146860352|NCT02571049|529659863|FG001|Randomization|No migraine attack|1|||
146528970|NCT02718911|528444567|FG002|Overall Study|Death|1|||
146528971|NCT02718911|528444568|FG003|Overall Study|Death|0|||
146860353|NCT02571049|529659862|FG000|Randomization|Adverse Event|0|||
146860354|NCT02571049|529659863|FG001|Randomization|Adverse Event|1|||
146860355|NCT00985153|529659864|FG000|Overall Study|Lost to Follow-up|16|||
146528972|NCT02718911|528444569|FG004|Overall Study|Death|1|||
146528973|NCT02718911|528444570|FG005|Overall Study|Death|3|||
146528974|NCT02718911|528444571|FG006|Overall Study|Death|1|||
146528975|NCT02718911|528444572|FG007|Overall Study|Death|1|||
146528976|NCT02718911|528444573|FG008|Overall Study|Death|4|||
146528977|NCT02718911|528444574|FG009|Overall Study|Death|3|||
146528978|NCT02718911|528444565|FG000|Overall Study|Lost to Follow-up|0|||
146528979|NCT02718911|528444566|FG001|Overall Study|Lost to Follow-up|0|||
146528980|NCT02718911|528444567|FG002|Overall Study|Lost to Follow-up|0|||
146528981|NCT02718911|528444568|FG003|Overall Study|Lost to Follow-up|0|||
146528982|NCT02718911|528444569|FG004|Overall Study|Lost to Follow-up|0|||
146528983|NCT02718911|528444570|FG005|Overall Study|Lost to Follow-up|0|||
146528984|NCT02718911|528444571|FG006|Overall Study|Lost to Follow-up|0|||
146528985|NCT02718911|528444572|FG007|Overall Study|Lost to Follow-up|0|||
146528986|NCT02718911|528444573|FG008|Overall Study|Lost to Follow-up|1|||
146528987|NCT02718911|528444574|FG009|Overall Study|Lost to Follow-up|0|||
146528988|NCT02718911|528444565|FG000|Overall Study|Physician Decision|2|||
146528989|NCT02718911|528444566|FG001|Overall Study|Physician Decision|0|||
146528990|NCT02718911|528444567|FG002|Overall Study|Physician Decision|1|||
146528991|NCT02718911|528444568|FG003|Overall Study|Physician Decision|1|||
146528992|NCT02718911|528444569|FG004|Overall Study|Physician Decision|0|||
146528993|NCT02718911|528444570|FG005|Overall Study|Physician Decision|0|||
146528994|NCT02718911|528444571|FG006|Overall Study|Physician Decision|0|||
146528995|NCT02718911|528444572|FG007|Overall Study|Physician Decision|1|||
146528996|NCT02718911|528444573|FG008|Overall Study|Physician Decision|2|||
146528997|NCT02718911|528444574|FG009|Overall Study|Physician Decision|1|||
146528998|NCT02718911|528444565|FG000|Overall Study|Withdrawal by Subject|0|||
146528999|NCT02718911|528444566|FG001|Overall Study|Withdrawal by Subject|0|||
146529000|NCT02718911|528444567|FG002|Overall Study|Withdrawal by Subject|0|||
146529001|NCT02718911|528444568|FG003|Overall Study|Withdrawal by Subject|0|||
146529002|NCT02718911|528444569|FG004|Overall Study|Withdrawal by Subject|1|||
146529003|NCT02718911|528444570|FG005|Overall Study|Withdrawal by Subject|0|||
146529004|NCT02718911|528444571|FG006|Overall Study|Withdrawal by Subject|0|||
146529005|NCT02718911|528444572|FG007|Overall Study|Withdrawal by Subject|0|||
146529006|NCT02718911|528444573|FG008|Overall Study|Withdrawal by Subject|1|||
146529007|NCT02718911|528444574|FG009|Overall Study|Withdrawal by Subject|4|||
146529008|NCT02718911|528444565|FG000|Overall Study|Reason Not Collected|0|||
146529009|NCT02718911|528444566|FG001|Overall Study|Reason Not Collected|0|||
146529010|NCT02718911|528444567|FG002|Overall Study|Reason Not Collected|1|||
146529011|NCT02718911|528444568|FG003|Overall Study|Reason Not Collected|0|||
146760996|NCT00991276|529292812|FG000|First Intervention Period|Other|0|||
146760997|NCT00991276|529292813|FG001|First Intervention Period|Other|0|||
146760998|NCT00991276|529292814|FG002|First Intervention Period|Other|0|||
146760999|NCT00991276|529292815|FG003|First Intervention Period|Other|1|||
146761000|NCT00991276|529292816|FG004|First Intervention Period|Other|1|||
146761001|NCT00991276|529292817|FG005|First Intervention Period|Other|0|||
146761002|NCT00991276|529292812|FG000|First Intervention Period|Withdrawal by Subject|0|||
146761003|NCT00991276|529292813|FG001|First Intervention Period|Withdrawal by Subject|1|||
146761004|NCT00991276|529292814|FG002|First Intervention Period|Withdrawal by Subject|0|||
146761005|NCT00991276|529292815|FG003|First Intervention Period|Withdrawal by Subject|1|||
146761006|NCT00991276|529292816|FG004|First Intervention Period|Withdrawal by Subject|0|||
146761007|NCT00991276|529292817|FG005|First Intervention Period|Withdrawal by Subject|1|||
146761008|NCT00991276|529292812|FG000|First Intervention Period|Lost to Follow-up|0|||
146761009|NCT00991276|529292813|FG001|First Intervention Period|Lost to Follow-up|1|||
146761010|NCT00991276|529292814|FG002|First Intervention Period|Lost to Follow-up|0|||
146761011|NCT00991276|529292815|FG003|First Intervention Period|Lost to Follow-up|1|||
146761012|NCT00991276|529292816|FG004|First Intervention Period|Lost to Follow-up|0|||
146761013|NCT00991276|529292817|FG005|First Intervention Period|Lost to Follow-up|0|||
146761014|NCT00991276|529292812|FG000|Second Intervention Period|Adverse Event|0|||
146761015|NCT00991276|529292813|FG001|Second Intervention Period|Adverse Event|2|||
146761016|NCT00991276|529292814|FG002|Second Intervention Period|Adverse Event|0|||
146761017|NCT00991276|529292815|FG003|Second Intervention Period|Adverse Event|1|||
146761018|NCT00991276|529292816|FG004|Second Intervention Period|Adverse Event|1|||
146761019|NCT00991276|529292817|FG005|Second Intervention Period|Adverse Event|0|||
146761020|NCT00991276|529292812|FG000|Second Intervention Period|Protocol Violation|1|||
146761021|NCT00991276|529292813|FG001|Second Intervention Period|Protocol Violation|0|||
146761022|NCT00991276|529292814|FG002|Second Intervention Period|Protocol Violation|0|||
146761023|NCT00991276|529292815|FG003|Second Intervention Period|Protocol Violation|0|||
146761024|NCT00991276|529292816|FG004|Second Intervention Period|Protocol Violation|0|||
146761025|NCT00991276|529292817|FG005|Second Intervention Period|Protocol Violation|0|||
146761026|NCT00991276|529292812|FG000|Second Intervention Period|Other|0|||
146761027|NCT00991276|529292813|FG001|Second Intervention Period|Other|0|||
146761028|NCT00991276|529292814|FG002|Second Intervention Period|Other|0|||
146761029|NCT00991276|529292815|FG003|Second Intervention Period|Other|1|||
146761030|NCT00991276|529292816|FG004|Second Intervention Period|Other|0|||
146529012|NCT02718911|528444569|FG004|Overall Study|Reason Not Collected|0|||
146529013|NCT02718911|528444570|FG005|Overall Study|Reason Not Collected|0|||
146529014|NCT02718911|528444571|FG006|Overall Study|Reason Not Collected|2|||
146529015|NCT02718911|528444572|FG007|Overall Study|Reason Not Collected|1|||
146529016|NCT02718911|528444573|FG008|Overall Study|Reason Not Collected|4|||
146529017|NCT02718911|528444574|FG009|Overall Study|Reason Not Collected|9|||
146529018|NCT01764841|528444575|FG000|Overall Study|Logistical Difficulties|0|||
146529019|NCT01764841|528444576|FG001|Overall Study|Logistical Difficulties|1|||
146529020|NCT01764841|528444577|FG002|Overall Study|Logistical Difficulties|0|||
146529021|NCT01764841|528444578|FG003|Overall Study|Logistical Difficulties|0|||
146529022|NCT01764841|528444575|FG000|Overall Study|Death|3|||
146529023|NCT01764841|528444576|FG001|Overall Study|Death|0|||
146529024|NCT01764841|528444577|FG002|Overall Study|Death|1|||
146529025|NCT01764841|528444578|FG003|Overall Study|Death|4|||
146529026|NCT01764841|528444575|FG000|Overall Study|No Follow Up|1|||
146529027|NCT01764841|528444576|FG001|Overall Study|No Follow Up|0|||
146529028|NCT01764841|528444577|FG002|Overall Study|No Follow Up|1|||
146529029|NCT01764841|528444578|FG003|Overall Study|No Follow Up|0|||
146529030|NCT01764841|528444575|FG000|Overall Study|Protocol Violation|0|||
146529031|NCT01764841|528444576|FG001|Overall Study|Protocol Violation|1|||
146529032|NCT01764841|528444577|FG002|Overall Study|Protocol Violation|0|||
146529033|NCT01764841|528444578|FG003|Overall Study|Protocol Violation|0|||
146529034|NCT01764841|528444575|FG000|Overall Study|Withdrawal by Subject|16|||
146529035|NCT01764841|528444576|FG001|Overall Study|Withdrawal by Subject|24|||
146529036|NCT01764841|528444577|FG002|Overall Study|Withdrawal by Subject|11|||
146529037|NCT01764841|528444578|FG003|Overall Study|Withdrawal by Subject|15|||
146529038|NCT01764841|528444575|FG000|Overall Study|Lost to Follow-up|3|||
146529039|NCT01764841|528444576|FG001|Overall Study|Lost to Follow-up|0|||
146529040|NCT01764841|528444577|FG002|Overall Study|Lost to Follow-up|1|||
146529041|NCT01764841|528444578|FG003|Overall Study|Lost to Follow-up|0|||
146529042|NCT00549549|528444579|FG000|Overall Study|Adverse Event|5|||
146529043|NCT00549549|528444580|FG001|Overall Study|Adverse Event|3|||
146529044|NCT00549549|528444581|FG002|Overall Study|Adverse Event|1|||
146529045|NCT00549549|528444582|FG003|Overall Study|Adverse Event|9|||
146529046|NCT00549549|528444579|FG000|Overall Study|Lack of Efficacy|9|||
146529047|NCT00549549|528444580|FG001|Overall Study|Lack of Efficacy|6|||
146529048|NCT00549549|528444581|FG002|Overall Study|Lack of Efficacy|4|||
146529049|NCT00549549|528444582|FG003|Overall Study|Lack of Efficacy|2|||
146529050|NCT00549549|528444579|FG000|Overall Study|Lost to Follow-up|1|||
146529051|NCT00549549|528444580|FG001|Overall Study|Lost to Follow-up|0|||
146529052|NCT00549549|528444581|FG002|Overall Study|Lost to Follow-up|1|||
146529053|NCT00549549|528444582|FG003|Overall Study|Lost to Follow-up|2|||
146529054|NCT00549549|528444579|FG000|Overall Study|Withdrawal by Subject|0|||
146529055|NCT00549549|528444580|FG001|Overall Study|Withdrawal by Subject|4|||
146529056|NCT00549549|528444581|FG002|Overall Study|Withdrawal by Subject|1|||
146529057|NCT00549549|528444582|FG003|Overall Study|Withdrawal by Subject|0|||
146529058|NCT00549549|528444579|FG000|Overall Study|Other|9|||
146529059|NCT00549549|528444580|FG001|Overall Study|Other|9|||
146529060|NCT00549549|528444581|FG002|Overall Study|Other|9|||
146529061|NCT00549549|528444582|FG003|Overall Study|Other|11|||
146529062|NCT00549549|528444579|FG000|Overall Study|Randomized but not treated|0|||
146529063|NCT00549549|528444580|FG001|Overall Study|Randomized but not treated|0|||
146529064|NCT00549549|528444581|FG002|Overall Study|Randomized but not treated|1|||
146529065|NCT00549549|528444582|FG003|Overall Study|Randomized but not treated|1|||
146529066|NCT02155699|528444583|FG000|Overall Study|Withdrawal by Subject|0|||
146529067|NCT02155699|528444584|FG001|Overall Study|Withdrawal by Subject|3|||
146529068|NCT02155699|528444585|FG002|Overall Study|Withdrawal by Subject|6|||
146529069|NCT02155699|528444586|FG003|Overall Study|Withdrawal by Subject|1|||
146529070|NCT02155699|528444583|FG000|Overall Study|Lost to Follow-up|0|||
146529071|NCT02155699|528444584|FG001|Overall Study|Lost to Follow-up|0|||
146529072|NCT02155699|528444585|FG002|Overall Study|Lost to Follow-up|0|||
146529073|NCT02155699|528444586|FG003|Overall Study|Lost to Follow-up|3|||
146529074|NCT02155699|528444583|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
146529075|NCT02155699|528444584|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
146529076|NCT02155699|528444585|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
146529077|NCT02155699|528444586|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
146529078|NCT00485069|528444587|FG000|Overall Study|Adverse Event|10|||
146529079|NCT00485069|528444588|FG001|Overall Study|Adverse Event|4|||
146529080|NCT00485069|528444587|FG000|Overall Study|Lack of Efficacy|2|||
146529081|NCT00485069|528444588|FG001|Overall Study|Lack of Efficacy|1|||
146761031|NCT00991276|529292817|FG005|Second Intervention Period|Other|1|||
146761032|NCT00991276|529292812|FG000|Third Intervention Period|Protocol Violation|1|||
146761033|NCT00991276|529292813|FG001|Third Intervention Period|Protocol Violation|0|||
146761034|NCT00991276|529292814|FG002|Third Intervention Period|Protocol Violation|0|||
146529082|NCT00485069|528444587|FG000|Overall Study|Protocol Violation|0|||
146529083|NCT00485069|528444588|FG001|Overall Study|Protocol Violation|1|||
146529084|NCT00485069|528444587|FG000|Overall Study|Withdrawal by Subject|6|||
146529085|NCT00485069|528444588|FG001|Overall Study|Withdrawal by Subject|6|||
146529086|NCT02688933|528444589|FG000|Overall Study|Adverse Event|3|||
146529087|NCT02688933|528444590|FG001|Overall Study|Adverse Event|1|||
146529088|NCT02688933|528444589|FG000|Overall Study|Lack of Efficacy|2|||
146529089|NCT02688933|528444590|FG001|Overall Study|Lack of Efficacy|2|||
146529090|NCT02688933|528444589|FG000|Overall Study|Poor compliance to protocol|7|||
146529091|NCT02688933|528444590|FG001|Overall Study|Poor compliance to protocol|4|||
146529092|NCT02688933|528444589|FG000|Overall Study|Hypoglycemia|2|||
146529093|NCT02688933|528444590|FG001|Overall Study|Hypoglycemia|0|||
146761035|NCT00991276|529292815|FG003|Third Intervention Period|Protocol Violation|0|||
146761036|NCT00991276|529292816|FG004|Third Intervention Period|Protocol Violation|0|||
146761037|NCT00991276|529292817|FG005|Third Intervention Period|Protocol Violation|0|||
146761038|NCT00991276|529292812|FG000|Third Intervention Period|Other|0|||
146761039|NCT00991276|529292813|FG001|Third Intervention Period|Other|0|||
146761040|NCT00991276|529292814|FG002|Third Intervention Period|Other|0|||
146761041|NCT00991276|529292815|FG003|Third Intervention Period|Other|0|||
146761042|NCT00991276|529292816|FG004|Third Intervention Period|Other|0|||
146761043|NCT00991276|529292817|FG005|Third Intervention Period|Other|1|||
146761044|NCT00991276|529292812|FG000|Third Intervention Period|Adverse Event|0|||
146761045|NCT00991276|529292813|FG001|Third Intervention Period|Adverse Event|0|||
146761046|NCT00991276|529292814|FG002|Third Intervention Period|Adverse Event|1|||
146761047|NCT00991276|529292815|FG003|Third Intervention Period|Adverse Event|0|||
146761048|NCT00991276|529292816|FG004|Third Intervention Period|Adverse Event|0|||
146761049|NCT00991276|529292817|FG005|Third Intervention Period|Adverse Event|0|||
146761050|NCT00991276|529292812|FG000|Third Intervention Period|Withdrawal by Subject|0|||
146761051|NCT00991276|529292813|FG001|Third Intervention Period|Withdrawal by Subject|0|||
146761052|NCT00991276|529292814|FG002|Third Intervention Period|Withdrawal by Subject|0|||
146761053|NCT00991276|529292815|FG003|Third Intervention Period|Withdrawal by Subject|1|||
146761054|NCT00991276|529292816|FG004|Third Intervention Period|Withdrawal by Subject|0|||
146761055|NCT00991276|529292817|FG005|Third Intervention Period|Withdrawal by Subject|0|||
146761056|NCT02534896|529292826|FG000|Overall Study|Adverse Event|2|||
146761057|NCT02534896|529292827|FG001|Overall Study|Adverse Event|1|||
146761058|NCT02534896|529292828|FG002|Overall Study|Adverse Event|1|||
146761059|NCT02534896|529292826|FG000|Overall Study|Insufficient therapeutic response|2|||
146761060|NCT02534896|529292827|FG001|Overall Study|Insufficient therapeutic response|0|||
146761061|NCT02534896|529292828|FG002|Overall Study|Insufficient therapeutic response|0|||
146761062|NCT00920686|529292832|FG000|Overall Study|Lost to Follow-up|2|||
146761063|NCT00920686|529292833|FG001|Overall Study|Lost to Follow-up|3|||
146761064|NCT00920686|529292834|FG002|Overall Study|Lost to Follow-up|1|||
146761065|NCT00920686|529292832|FG000|Overall Study|Study drug dosing criteria not met|17|||
146761066|NCT00920686|529292833|FG001|Overall Study|Study drug dosing criteria not met|19|||
146761067|NCT00920686|529292834|FG002|Overall Study|Study drug dosing criteria not met|12|||
146761068|NCT03006341|529292835|FG000|Overall Study|Not linked in the EMR|25069|||
146761069|NCT03006341|529292836|FG001|Overall Study|Not linked in the EMR|67505|||
146761070|NCT03006341|529292837|FG002|Overall Study|Not linked in the EMR|30993|||
146761071|NCT03006341|529292838|FG003|Overall Study|Not linked in the EMR|10685|||
146761072|NCT00003656|529292839|FG000|Overall Study|Adverse Event|0|||
146761073|NCT00003656|529292840|FG001|Overall Study|Adverse Event|1|||
146761074|NCT00742274|529292843|FG000|Overall Study|Death|1|||
146761075|NCT00742274|529292844|FG001|Overall Study|Death|0|||
146761076|NCT00742274|529292843|FG000|Overall Study|Withdrawal by Subject|1|||
146761077|NCT00742274|529292844|FG001|Overall Study|Withdrawal by Subject|2|||
146761078|NCT00742274|529292843|FG000|Overall Study|Removed for medical reasons|1|||
146761079|NCT00742274|529292844|FG001|Overall Study|Removed for medical reasons|1|||
146761080|NCT02219490|529292848|FG000|Overall Study|Adverse Event|24|||
146761081|NCT02219490|529292848|FG000|Overall Study|Withdrew consent|96|||
146761082|NCT02219490|529292848|FG000|Overall Study|Lost to Follow-up|126|||
146761083|NCT02219490|529292848|FG000|Overall Study|COVID-19 infection|2|||
146761084|NCT02219490|529292848|FG000|Overall Study|COVID-19 logistical restrictions|33|||
146761085|NCT02219490|529292848|FG000|Overall Study|Other, not specified|57|||
146761086|NCT00335556|529292849|FG000|Overall Study|Death|0|||
146761087|NCT00335556|529292850|FG001|Overall Study|Death|5|||
146761088|NCT00335556|529292851|FG002|Overall Study|Death|0|||
146761089|NCT00335556|529292852|FG003|Overall Study|Death|0|||
146761090|NCT00335556|529292853|FG004|Overall Study|Death|1|||
146761091|NCT00335556|529292854|FG005|Overall Study|Death|0|||
146761092|NCT00335556|529292849|FG000|Overall Study|Lack of Efficacy|0|||
146761093|NCT00335556|529292850|FG001|Overall Study|Lack of Efficacy|19|||
146761094|NCT00335556|529292851|FG002|Overall Study|Lack of Efficacy|3|||
146761095|NCT00335556|529292852|FG003|Overall Study|Lack of Efficacy|3|||
146761096|NCT00335556|529292853|FG004|Overall Study|Lack of Efficacy|0|||
146529094|NCT02688933|528444589|FG000|Overall Study|Other than Specified|14|||
146761097|NCT00335556|529292854|FG005|Overall Study|Lack of Efficacy|1|||
146761098|NCT00335556|529292849|FG000|Overall Study|Physician Decision|0|||
146761099|NCT00335556|529292850|FG001|Overall Study|Physician Decision|6|||
146529095|NCT02688933|528444590|FG001|Overall Study|Other than Specified|25|||
146761100|NCT00335556|529292851|FG002|Overall Study|Physician Decision|2|||
146761101|NCT00335556|529292852|FG003|Overall Study|Physician Decision|1|||
146761102|NCT00335556|529292853|FG004|Overall Study|Physician Decision|0|||
146761103|NCT00335556|529292854|FG005|Overall Study|Physician Decision|0|||
146860356|NCT00985153|529659865|FG001|Overall Study|Lost to Follow-up|19|||
146860357|NCT00985153|529659866|FG002|Overall Study|Lost to Follow-up|17|||
146860358|NCT00985153|529659867|FG003|Overall Study|Lost to Follow-up|20|||
146860359|NCT00985153|529659864|FG000|Overall Study|Protocol Violation|3|||
146860360|NCT00985153|529659865|FG001|Overall Study|Protocol Violation|2|||
146860361|NCT00985153|529659866|FG002|Overall Study|Protocol Violation|4|||
146860362|NCT00985153|529659867|FG003|Overall Study|Protocol Violation|3|||
146860363|NCT00985153|529659864|FG000|Overall Study|Withdrawal by Subject|6|||
146860364|NCT00985153|529659865|FG001|Overall Study|Withdrawal by Subject|11|||
146860365|NCT00985153|529659866|FG002|Overall Study|Withdrawal by Subject|11|||
146860366|NCT00985153|529659867|FG003|Overall Study|Withdrawal by Subject|10|||
146860367|NCT00985153|529659864|FG000|Overall Study|Missed One or More Bleeds|7|||
146860368|NCT00985153|529659865|FG001|Overall Study|Missed One or More Bleeds|7|||
146860369|NCT00985153|529659866|FG002|Overall Study|Missed One or More Bleeds|8|||
146860370|NCT00985153|529659867|FG003|Overall Study|Missed One or More Bleeds|10|||
146860371|NCT00985153|529659864|FG000|Overall Study|Incomplete Safety Follow-up|3|||
146860372|NCT00985153|529659865|FG001|Overall Study|Incomplete Safety Follow-up|5|||
146860373|NCT00985153|529659866|FG002|Overall Study|Incomplete Safety Follow-up|4|||
146860374|NCT00985153|529659867|FG003|Overall Study|Incomplete Safety Follow-up|4|||
146860375|NCT01055262|529659870|FG000|Overall Study|Adverse Event|5|||
146860376|NCT01055262|529659870|FG000|Overall Study|Protocol Violation|3|||
146860377|NCT01055262|529659870|FG000|Overall Study|Uncooperativeness|1|||
146529096|NCT02688933|528444589|FG000|Overall Study|Lost to Follow-up|1|||
146529097|NCT02688933|528444590|FG001|Overall Study|Lost to Follow-up|5|||
146529098|NCT00828113|528444593|FG000|Overall Study|Withdrawal by Subject|27|||
146529099|NCT00828113|528444594|FG001|Overall Study|Withdrawal by Subject|26|||
146529100|NCT00828113|528444593|FG000|Overall Study|Lost to Follow-up|3|||
146529101|NCT00828113|528444594|FG001|Overall Study|Lost to Follow-up|5|||
146529102|NCT01365130|528444595|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
146529103|NCT05547386|528444596|FG000|Overall Study|Withdrawal by Subject|7|||
146529104|NCT04622969|528444597|FG000|Overall Study|Withdrawal by Subject|2|||
146529105|NCT04622969|528444598|FG001|Overall Study|Withdrawal by Subject|3|||
146529106|NCT05616013|528444599|FG000|Overall Study|Adverse Event|6|||
146529107|NCT05616013|528444600|FG001|Overall Study|Adverse Event|12|||
146529108|NCT05616013|528444601|FG002|Overall Study|Adverse Event|8|||
146529109|NCT05616013|528444602|FG003|Overall Study|Adverse Event|4|||
146529110|NCT05616013|528444603|FG004|Overall Study|Adverse Event|6|||
146529111|NCT05616013|528444604|FG005|Overall Study|Adverse Event|8|||
146529112|NCT05616013|528444605|FG006|Overall Study|Adverse Event|3|||
146529113|NCT05616013|528444606|FG007|Overall Study|Adverse Event|6|||
146529114|NCT05616013|528444607|FG008|Overall Study|Adverse Event|1|||
146529115|NCT05616013|528444599|FG000|Overall Study|Lost to Follow-up|5|||
146529116|NCT05616013|528444600|FG001|Overall Study|Lost to Follow-up|4|||
146529117|NCT05616013|528444601|FG002|Overall Study|Lost to Follow-up|3|||
146529118|NCT05616013|528444602|FG003|Overall Study|Lost to Follow-up|2|||
146529119|NCT05616013|528444603|FG004|Overall Study|Lost to Follow-up|0|||
146529120|NCT05616013|528444604|FG005|Overall Study|Lost to Follow-up|5|||
146529121|NCT05616013|528444605|FG006|Overall Study|Lost to Follow-up|2|||
146529122|NCT05616013|528444606|FG007|Overall Study|Lost to Follow-up|1|||
146529123|NCT05616013|528444607|FG008|Overall Study|Lost to Follow-up|2|||
146529124|NCT05616013|528444599|FG000|Overall Study|Non-compliance with study requirements|2|||
146529125|NCT05616013|528444600|FG001|Overall Study|Non-compliance with study requirements|2|||
146529126|NCT05616013|528444601|FG002|Overall Study|Non-compliance with study requirements|2|||
146529127|NCT05616013|528444602|FG003|Overall Study|Non-compliance with study requirements|3|||
146529128|NCT05616013|528444603|FG004|Overall Study|Non-compliance with study requirements|0|||
146529129|NCT05616013|528444604|FG005|Overall Study|Non-compliance with study requirements|2|||
146529130|NCT05616013|528444605|FG006|Overall Study|Non-compliance with study requirements|1|||
146529131|NCT05616013|528444606|FG007|Overall Study|Non-compliance with study requirements|1|||
146529132|NCT05616013|528444607|FG008|Overall Study|Non-compliance with study requirements|4|||
146529133|NCT05616013|528444599|FG000|Overall Study|Withdrawal by Subject|11|||
146529134|NCT05616013|528444600|FG001|Overall Study|Withdrawal by Subject|9|||
146529135|NCT05616013|528444601|FG002|Overall Study|Withdrawal by Subject|8|||
146529136|NCT05616013|528444602|FG003|Overall Study|Withdrawal by Subject|6|||
146529137|NCT05616013|528444603|FG004|Overall Study|Withdrawal by Subject|3|||
146529138|NCT05616013|528444604|FG005|Overall Study|Withdrawal by Subject|4|||
146529139|NCT05616013|528444605|FG006|Overall Study|Withdrawal by Subject|6|||
146529140|NCT05616013|528444606|FG007|Overall Study|Withdrawal by Subject|5|||
146529141|NCT05616013|528444607|FG008|Overall Study|Withdrawal by Subject|4|||
146529142|NCT05616013|528444599|FG000|Overall Study|Physician Decision|0|||
146529143|NCT05616013|528444600|FG001|Overall Study|Physician Decision|0|||
146529144|NCT05616013|528444601|FG002|Overall Study|Physician Decision|1|||
146529145|NCT05616013|528444602|FG003|Overall Study|Physician Decision|0|||
146860378|NCT03370471|529659871|FG000|Overall Study|Withdrawal by Subject|6|||
146860379|NCT03370471|529659872|FG001|Overall Study|Withdrawal by Subject|1|||
146965095|NCT03110107|530033433|FG007|Treatment Period|Adverse Event|2|||
146529146|NCT05616013|528444603|FG004|Overall Study|Physician Decision|0|||
146529147|NCT05616013|528444604|FG005|Overall Study|Physician Decision|1|||
146860380|NCT03370471|529659871|FG000|Overall Study|Unable to access veins for blood draw|0|||
146860381|NCT03370471|529659872|FG001|Overall Study|Unable to access veins for blood draw|1|||
146529148|NCT05616013|528444605|FG006|Overall Study|Physician Decision|3|||
146529149|NCT05616013|528444606|FG007|Overall Study|Physician Decision|0|||
146529150|NCT05616013|528444607|FG008|Overall Study|Physician Decision|0|||
146529151|NCT05616013|528444599|FG000|Overall Study|Protocol Violation|0|||
146529152|NCT05616013|528444600|FG001|Overall Study|Protocol Violation|0|||
146529153|NCT05616013|528444601|FG002|Overall Study|Protocol Violation|0|||
146529154|NCT05616013|528444602|FG003|Overall Study|Protocol Violation|0|||
146529155|NCT05616013|528444603|FG004|Overall Study|Protocol Violation|0|||
146529156|NCT05616013|528444604|FG005|Overall Study|Protocol Violation|0|||
146529157|NCT05616013|528444605|FG006|Overall Study|Protocol Violation|1|||
146529158|NCT05616013|528444606|FG007|Overall Study|Protocol Violation|0|||
146529159|NCT05616013|528444607|FG008|Overall Study|Protocol Violation|2|||
146529160|NCT05616013|528444599|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
146529161|NCT05616013|528444600|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
146529162|NCT05616013|528444601|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
146529163|NCT05616013|528444602|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
146529164|NCT05616013|528444603|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
146529165|NCT05616013|528444604|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
146529166|NCT05616013|528444605|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
146529167|NCT05616013|528444606|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
146529168|NCT05616013|528444607|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
146529169|NCT05616013|528444599|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
146529170|NCT05616013|528444600|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
146529171|NCT05616013|528444601|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
146529172|NCT05616013|528444602|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
146529173|NCT05616013|528444603|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
146529174|NCT05616013|528444604|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
146529175|NCT05616013|528444605|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
146529176|NCT05616013|528444606|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
146529177|NCT05616013|528444607|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
146529178|NCT05616013|528444599|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
146529179|NCT05616013|528444600|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
146529180|NCT05616013|528444601|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
146529181|NCT05616013|528444602|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
146529182|NCT05616013|528444603|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
146529183|NCT05616013|528444604|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
146529184|NCT05616013|528444605|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
146529185|NCT05616013|528444606|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
146529186|NCT05616013|528444607|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
146529187|NCT05616013|528444599|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
146529188|NCT05616013|528444600|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
146529189|NCT05616013|528444601|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
146529190|NCT05616013|528444602|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
146529191|NCT05616013|528444603|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
146529192|NCT05616013|528444604|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
146529193|NCT05616013|528444605|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
146529194|NCT05616013|528444606|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
146529195|NCT05616013|528444607|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
146529196|NCT05616013|528444599|FG000|Overall Study|Participant Decision, Time Constraints|0|||
146529197|NCT05616013|528444600|FG001|Overall Study|Participant Decision, Time Constraints|1|||
146529198|NCT05616013|528444601|FG002|Overall Study|Participant Decision, Time Constraints|0|||
146529199|NCT05616013|528444602|FG003|Overall Study|Participant Decision, Time Constraints|0|||
146529200|NCT05616013|528444603|FG004|Overall Study|Participant Decision, Time Constraints|0|||
146529201|NCT05616013|528444604|FG005|Overall Study|Participant Decision, Time Constraints|0|||
146529202|NCT05616013|528444605|FG006|Overall Study|Participant Decision, Time Constraints|0|||
146529203|NCT05616013|528444606|FG007|Overall Study|Participant Decision, Time Constraints|0|||
146529204|NCT05616013|528444607|FG008|Overall Study|Participant Decision, Time Constraints|0|||
146529205|NCT05616013|528444599|FG000|Overall Study|Prohibited Concomitant Medication|0|||
146529206|NCT05616013|528444600|FG001|Overall Study|Prohibited Concomitant Medication|0|||
146860382|NCT03370471|529659871|FG000|Overall Study|Screen fail|1|||
146529207|NCT05616013|528444601|FG002|Overall Study|Prohibited Concomitant Medication|1|||
146860383|NCT03370471|529659872|FG001|Overall Study|Screen fail|0|||
146860384|NCT00561951|529659874|FG000|Overall Study|Adverse Event|11|||
146529208|NCT05616013|528444602|FG003|Overall Study|Prohibited Concomitant Medication|0|||
146529209|NCT05616013|528444603|FG004|Overall Study|Prohibited Concomitant Medication|0|||
146529210|NCT05616013|528444604|FG005|Overall Study|Prohibited Concomitant Medication|0|||
146529211|NCT05616013|528444605|FG006|Overall Study|Prohibited Concomitant Medication|0|||
146529212|NCT05616013|528444606|FG007|Overall Study|Prohibited Concomitant Medication|0|||
146529213|NCT05616013|528444607|FG008|Overall Study|Prohibited Concomitant Medication|0|||
146529214|NCT05616013|528444599|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
146529215|NCT05616013|528444600|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
146529216|NCT05616013|528444601|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
146529217|NCT05616013|528444602|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
146529218|NCT05616013|528444603|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
146529219|NCT05616013|528444604|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
146529220|NCT05616013|528444605|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
146529221|NCT05616013|528444606|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
146529222|NCT05616013|528444607|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
146529223|NCT05616013|528444599|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
146529224|NCT05616013|528444600|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
146529225|NCT05616013|528444601|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
146529226|NCT05616013|528444602|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
146529227|NCT05616013|528444603|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
146529228|NCT05616013|528444604|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
146529229|NCT05616013|528444605|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
146529230|NCT05616013|528444606|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
146529231|NCT05616013|528444607|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
146529232|NCT05616013|528444599|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
146529233|NCT05616013|528444600|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
146529234|NCT05616013|528444601|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
146529235|NCT05616013|528444602|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
146529236|NCT05616013|528444603|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
146529237|NCT05616013|528444604|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
146529238|NCT05616013|528444605|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
146529239|NCT05616013|528444606|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
146529240|NCT05616013|528444607|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
146529241|NCT05616013|528444599|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
146529242|NCT05616013|528444600|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
146529243|NCT05616013|528444601|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
146529244|NCT05616013|528444602|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
146529245|NCT05616013|528444603|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
146529246|NCT05616013|528444604|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
146529247|NCT05616013|528444605|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
146529248|NCT05616013|528444606|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
146529249|NCT05616013|528444607|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
146529250|NCT05616013|528444599|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
146529251|NCT05616013|528444600|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
146529252|NCT05616013|528444601|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
146529253|NCT05616013|528444602|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
146529254|NCT05616013|528444603|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
146529255|NCT05616013|528444604|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
146529256|NCT05616013|528444605|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
146529257|NCT05616013|528444606|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
146529258|NCT05616013|528444607|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
146529259|NCT05116202|528444608|FG000|Overall Study|Study Terminated by Sponsor|21|||
146529260|NCT05116202|528444609|FG001|Overall Study|Study Terminated by Sponsor|38|||
146529261|NCT05116202|528444610|FG002|Overall Study|Study Terminated by Sponsor|17|||
146529262|NCT05116202|528444611|FG003|Overall Study|Study Terminated by Sponsor|18|||
146529263|NCT05116202|528444612|FG004|Overall Study|Study Terminated by Sponsor|0|||
146529264|NCT05116202|528444608|FG000|Overall Study|Withdrawal by Subject|0|||
146529265|NCT05116202|528444609|FG001|Overall Study|Withdrawal by Subject|1|||
146529266|NCT05116202|528444610|FG002|Overall Study|Withdrawal by Subject|1|||
146860385|NCT00561951|529659875|FG001|Overall Study|Adverse Event|14|||
146860386|NCT00561951|529659876|FG002|Overall Study|Adverse Event|14|||
146860387|NCT00561951|529659874|FG000|Overall Study|Lack of Efficacy|5|||
146860388|NCT00561951|529659875|FG001|Overall Study|Lack of Efficacy|3|||
146860389|NCT00561951|529659876|FG002|Overall Study|Lack of Efficacy|2|||
146860390|NCT00561951|529659874|FG000|Overall Study|Lost to Follow-up|1|||
146860391|NCT00561951|529659875|FG001|Overall Study|Lost to Follow-up|1|||
146860392|NCT00561951|529659876|FG002|Overall Study|Lost to Follow-up|0|||
146860393|NCT00561951|529659874|FG000|Overall Study|Withdrawal by Subject|10|||
146860394|NCT00561951|529659875|FG001|Overall Study|Withdrawal by Subject|9|||
146860395|NCT00561951|529659876|FG002|Overall Study|Withdrawal by Subject|10|||
146860396|NCT00561951|529659874|FG000|Overall Study|Protocol Violation|4|||
146860397|NCT00561951|529659875|FG001|Overall Study|Protocol Violation|3|||
146860398|NCT00561951|529659876|FG002|Overall Study|Protocol Violation|4|||
146860399|NCT00561951|529659874|FG000|Overall Study|Physician Decision|1|||
146860400|NCT00561951|529659875|FG001|Overall Study|Physician Decision|0|||
146860401|NCT00561951|529659876|FG002|Overall Study|Physician Decision|0|||
146860402|NCT00561951|529659874|FG000|Overall Study|Pregnancy|0|||
146860403|NCT00561951|529659875|FG001|Overall Study|Pregnancy|1|||
146860404|NCT00561951|529659876|FG002|Overall Study|Pregnancy|0|||
146860405|NCT00561951|529659874|FG000|Overall Study|Meet Withdrawal Criterion|0|||
146860406|NCT00561951|529659875|FG001|Overall Study|Meet Withdrawal Criterion|1|||
146860407|NCT00561951|529659876|FG002|Overall Study|Meet Withdrawal Criterion|1|||
146860408|NCT00561951|529659874|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
146860409|NCT00561951|529659875|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
146860410|NCT00561951|529659876|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
146860411|NCT01765179|529659877|FG000|Overall Study|Adverse Event|3|||
146860412|NCT01765179|529659877|FG000|Overall Study|Lost to Follow-up|5|||
146860413|NCT01765179|529659877|FG000|Overall Study|Non-compliance with study drug|2|||
146860414|NCT01765179|529659877|FG000|Overall Study|Protocol Violation|1|||
146529267|NCT05116202|528444611|FG003|Overall Study|Withdrawal by Subject|1|||
146529268|NCT05116202|528444612|FG004|Overall Study|Withdrawal by Subject|1|||
146529269|NCT05116202|528444608|FG000|Overall Study|Lost to Follow-up|0|||
146529270|NCT05116202|528444609|FG001|Overall Study|Lost to Follow-up|0|||
146529271|NCT05116202|528444610|FG002|Overall Study|Lost to Follow-up|0|||
146529272|NCT05116202|528444611|FG003|Overall Study|Lost to Follow-up|0|||
146529273|NCT05116202|528444612|FG004|Overall Study|Lost to Follow-up|2|||
146529274|NCT05116202|528444608|FG000|Overall Study|Death|1|||
146529275|NCT05116202|528444609|FG001|Overall Study|Death|1|||
146529276|NCT05116202|528444610|FG002|Overall Study|Death|2|||
146529277|NCT05116202|528444611|FG003|Overall Study|Death|1|||
146529278|NCT05116202|528444612|FG004|Overall Study|Death|5|||
146529279|NCT05067972|528444613|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
146529280|NCT05067972|528444614|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
146529281|NCT05067972|528444615|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
146529282|NCT05067972|528444616|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
146529283|NCT05067972|528444617|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
146529284|NCT05067972|528444618|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
146529285|NCT05067972|528444619|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
146529286|NCT05067972|528444613|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
146529287|NCT05067972|528444614|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
146529288|NCT05067972|528444615|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
146529289|NCT05067972|528444616|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
146529290|NCT05067972|528444617|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
146529291|NCT05067972|528444618|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
146529292|NCT05067972|528444619|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
146529293|NCT05067972|528444613|FG000|Part 1: Treatment|Progressive Disease|3|||
146529294|NCT05067972|528444614|FG001|Part 1: Treatment|Progressive Disease|3|||
146529295|NCT05067972|528444615|FG002|Part 1: Treatment|Progressive Disease|4|||
146529296|NCT05067972|528444616|FG003|Part 1: Treatment|Progressive Disease|2|||
146529297|NCT05067972|528444617|FG004|Part 1: Treatment|Progressive Disease|3|||
146529298|NCT05067972|528444618|FG005|Part 1: Treatment|Progressive Disease|0|||
146529299|NCT05067972|528444619|FG006|Part 1: Treatment|Progressive Disease|2|||
146529300|NCT05067972|528444613|FG000|Part 1: Treatment|Physician Decision|0|||
146529301|NCT05067972|528444614|FG001|Part 1: Treatment|Physician Decision|0|||
146529302|NCT05067972|528444615|FG002|Part 1: Treatment|Physician Decision|0|||
146529303|NCT05067972|528444616|FG003|Part 1: Treatment|Physician Decision|1|||
146529304|NCT05067972|528444617|FG004|Part 1: Treatment|Physician Decision|0|||
146860415|NCT01765179|529659877|FG000|Overall Study|Withdrawal by Subject|8|||
146860416|NCT01765179|529659877|FG000|Overall Study|Hematocrit >54%|3|||
146860417|NCT01765179|529659877|FG000|Overall Study|prohibited med|1|||
146860418|NCT01765179|529659877|FG000|Overall Study|Out of country unable to finish study|1|||
146860419|NCT01765179|529659877|FG000|Overall Study|lack of venous access|1|||
146860420|NCT01765179|529659877|FG000|Overall Study|work conflict|1|||
146860421|NCT01765179|529659877|FG000|Overall Study|Ca elevated 10.6|1|||
146860422|NCT00392327|529659891|FG000|Overall Study|Death|1|||
146860423|NCT00392327|529659892|FG001|Overall Study|Death|0|||
146529305|NCT05067972|528444618|FG005|Part 1: Treatment|Physician Decision|0|||
146529306|NCT05067972|528444619|FG006|Part 1: Treatment|Physician Decision|0|||
146529307|NCT05067972|528444613|FG000|Part 1: Treatment|Death|0|||
146529308|NCT05067972|528444614|FG001|Part 1: Treatment|Death|0|||
146860424|NCT00392327|529659893|FG002|Overall Study|Death|1|||
146860425|NCT00392327|529659894|FG003|Overall Study|Death|0|||
146860426|NCT00392327|529659895|FG004|Overall Study|Death|0|||
146860427|NCT00392327|529659896|FG005|Overall Study|Death|0|||
146860428|NCT00392327|529659897|FG006|Overall Study|Death|0|||
146860429|NCT00392327|529659898|FG007|Overall Study|Death|0|||
146860430|NCT00392327|529659891|FG000|Overall Study|Lack of Efficacy|8|||
146860431|NCT00392327|529659892|FG001|Overall Study|Lack of Efficacy|8|||
146860432|NCT00392327|529659893|FG002|Overall Study|Lack of Efficacy|9|||
146860433|NCT00392327|529659894|FG003|Overall Study|Lack of Efficacy|6|||
146860434|NCT00392327|529659895|FG004|Overall Study|Lack of Efficacy|3|||
146860435|NCT00392327|529659896|FG005|Overall Study|Lack of Efficacy|3|||
146860436|NCT00392327|529659897|FG006|Overall Study|Lack of Efficacy|3|||
146860437|NCT00392327|529659898|FG007|Overall Study|Lack of Efficacy|3|||
146860438|NCT00392327|529659891|FG000|Overall Study|Physician Decision|3|||
146860439|NCT00392327|529659892|FG001|Overall Study|Physician Decision|5|||
146860440|NCT00392327|529659893|FG002|Overall Study|Physician Decision|2|||
146860441|NCT00392327|529659894|FG003|Overall Study|Physician Decision|2|||
146860442|NCT00392327|529659895|FG004|Overall Study|Physician Decision|0|||
146860443|NCT00392327|529659896|FG005|Overall Study|Physician Decision|1|||
146860444|NCT00392327|529659897|FG006|Overall Study|Physician Decision|5|||
146860445|NCT00392327|529659898|FG007|Overall Study|Physician Decision|3|||
146860446|NCT00392327|529659891|FG000|Overall Study|Protocol Violation|0|||
146860447|NCT00392327|529659892|FG001|Overall Study|Protocol Violation|0|||
146860448|NCT00392327|529659893|FG002|Overall Study|Protocol Violation|1|||
146860449|NCT00392327|529659894|FG003|Overall Study|Protocol Violation|0|||
146860450|NCT00392327|529659895|FG004|Overall Study|Protocol Violation|0|||
146860451|NCT00392327|529659896|FG005|Overall Study|Protocol Violation|0|||
146860452|NCT00392327|529659897|FG006|Overall Study|Protocol Violation|0|||
146860453|NCT00392327|529659898|FG007|Overall Study|Protocol Violation|0|||
146860454|NCT00392327|529659891|FG000|Overall Study|Withdrawal by Subject|3|||
146860455|NCT00392327|529659892|FG001|Overall Study|Withdrawal by Subject|2|||
146860456|NCT00392327|529659893|FG002|Overall Study|Withdrawal by Subject|4|||
146860457|NCT00392327|529659894|FG003|Overall Study|Withdrawal by Subject|6|||
146860458|NCT00392327|529659895|FG004|Overall Study|Withdrawal by Subject|0|||
146860459|NCT00392327|529659896|FG005|Overall Study|Withdrawal by Subject|1|||
146860460|NCT00392327|529659897|FG006|Overall Study|Withdrawal by Subject|1|||
146860461|NCT00392327|529659898|FG007|Overall Study|Withdrawal by Subject|5|||
146860462|NCT00392327|529659891|FG000|Overall Study|Ineligible|0|||
146860463|NCT00392327|529659892|FG001|Overall Study|Ineligible|4|||
146860464|NCT00392327|529659893|FG002|Overall Study|Ineligible|3|||
146860465|NCT00392327|529659894|FG003|Overall Study|Ineligible|2|||
146860466|NCT00392327|529659895|FG004|Overall Study|Ineligible|0|||
146860467|NCT00392327|529659896|FG005|Overall Study|Ineligible|0|||
146860468|NCT00392327|529659897|FG006|Overall Study|Ineligible|0|||
146860469|NCT00392327|529659898|FG007|Overall Study|Ineligible|0|||
146860470|NCT00986440|529659899|FG000|Overall Study|Progressive disease|27|||
146860471|NCT00986440|529659900|FG001|Overall Study|Progressive disease|37|||
146860472|NCT00986440|529659899|FG000|Overall Study|Serious adverse event or adverse event|9|||
146860473|NCT00986440|529659900|FG001|Overall Study|Serious adverse event or adverse event|2|||
146860474|NCT00986440|529659899|FG000|Overall Study|Withdrawal by Subject|1|||
146860475|NCT00986440|529659900|FG001|Overall Study|Withdrawal by Subject|2|||
146860476|NCT00986440|529659899|FG000|Overall Study|Screen failure (not dosed)|4|||
146860477|NCT00986440|529659900|FG001|Overall Study|Screen failure (not dosed)|2|||
146860478|NCT00178126|529659901|FG000|Overall Study|Lost to Follow-up|21|||
146860479|NCT00178126|529659902|FG001|Overall Study|Lost to Follow-up|21|||
146860480|NCT00178126|529659901|FG000|Overall Study|did not receive intervention|4|||
146860481|NCT00178126|529659902|FG001|Overall Study|did not receive intervention|6|||
146860482|NCT01281969|529659905|FG000|Overall Study|not randomized didn't meet criteria|0|||
146860483|NCT01281969|529659906|FG001|Overall Study|not randomized didn't meet criteria|0|||
146860484|NCT01281969|529659907|FG002|Overall Study|not randomized didn't meet criteria|7|||
146860485|NCT01281969|529659905|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
146860486|NCT01281969|529659906|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
146860487|NCT01281969|529659907|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
146860488|NCT01281969|529659905|FG000|Overall Study|not randomized, child consent not given|0|||
146860489|NCT01281969|529659906|FG001|Overall Study|not randomized, child consent not given|0|||
146860490|NCT01281969|529659907|FG002|Overall Study|not randomized, child consent not given|2|||
146860491|NCT01323634|529659908|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
146860492|NCT01323634|529659909|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
146860493|NCT01323634|529659910|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
146529309|NCT05067972|528444615|FG002|Part 1: Treatment|Death|0|||
146860494|NCT01323634|529659908|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
146860495|NCT01323634|529659909|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
146860496|NCT01323634|529659910|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
146860497|NCT01323634|529659908|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
146860498|NCT01323634|529659909|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
146860499|NCT01323634|529659910|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
146860500|NCT01323634|529659908|FG000|2-week Run-in Period|Physician Decision|5|||
146860501|NCT01323634|529659909|FG001|2-week Run-in Period|Physician Decision|0|||
146860502|NCT01323634|529659910|FG002|2-week Run-in Period|Physician Decision|0|||
146860503|NCT01323634|529659908|FG000|2-week Run-in Period|Protocol Violation|1|||
146860504|NCT01323634|529659909|FG001|2-week Run-in Period|Protocol Violation|0|||
146860505|NCT01323634|529659910|FG002|2-week Run-in Period|Protocol Violation|0|||
146860506|NCT01323634|529659908|FG000|2-week Run-in Period|Adverse Event|1|||
146860507|NCT01323634|529659909|FG001|2-week Run-in Period|Adverse Event|0|||
146860508|NCT01323634|529659910|FG002|2-week Run-in Period|Adverse Event|0|||
146860509|NCT01323634|529659908|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
146860510|NCT01323634|529659909|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
146860511|NCT01323634|529659910|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
146860512|NCT01323634|529659908|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
146860513|NCT01323634|529659909|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
146860514|NCT01323634|529659910|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
146860515|NCT01323634|529659908|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
146860516|NCT01323634|529659909|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
146860517|NCT01323634|529659910|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
146860518|NCT01323634|529659908|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
146860519|NCT01323634|529659909|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
146860520|NCT01323634|529659910|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
146860521|NCT01323634|529659908|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
146860522|NCT01323634|529659909|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
146860523|NCT01323634|529659910|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
146860524|NCT01323634|529659908|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
146860525|NCT01323634|529659909|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
146860526|NCT01323634|529659910|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
146860527|NCT01323634|529659908|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
146529310|NCT05067972|528444616|FG003|Part 1: Treatment|Death|2|||
146529311|NCT05067972|528444617|FG004|Part 1: Treatment|Death|0|||
146529312|NCT05067972|528444618|FG005|Part 1: Treatment|Death|0|||
146529313|NCT05067972|528444619|FG006|Part 1: Treatment|Death|0|||
146529314|NCT05067972|528444613|FG000|Part 1: Treatment|Adverse Event|0|||
146529315|NCT05067972|528444614|FG001|Part 1: Treatment|Adverse Event|0|||
146529316|NCT05067972|528444615|FG002|Part 1: Treatment|Adverse Event|0|||
146529317|NCT05067972|528444616|FG003|Part 1: Treatment|Adverse Event|0|||
146529318|NCT05067972|528444617|FG004|Part 1: Treatment|Adverse Event|0|||
146529319|NCT05067972|528444618|FG005|Part 1: Treatment|Adverse Event|2|||
146529320|NCT05067972|528444619|FG006|Part 1: Treatment|Adverse Event|1|||
146529321|NCT05067972|528444613|FG000|Part 1: Follow-up|Adverse Event|0|||
146529322|NCT05067972|528444614|FG001|Part 1: Follow-up|Adverse Event|0|||
146529323|NCT05067972|528444615|FG002|Part 1: Follow-up|Adverse Event|0|||
146529324|NCT05067972|528444616|FG003|Part 1: Follow-up|Adverse Event|0|||
146529325|NCT05067972|528444617|FG004|Part 1: Follow-up|Adverse Event|0|||
146529326|NCT05067972|528444618|FG005|Part 1: Follow-up|Adverse Event|1|||
146529327|NCT05067972|528444619|FG006|Part 1: Follow-up|Adverse Event|0|||
146529328|NCT05067972|528444613|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
146529329|NCT05067972|528444614|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
146529330|NCT05067972|528444615|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
146529331|NCT05067972|528444616|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
146529332|NCT05067972|528444617|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
146529333|NCT05067972|528444618|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
146529334|NCT05067972|528444619|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
146529335|NCT05067972|528444613|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
146529336|NCT05067972|528444614|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
146529337|NCT05067972|528444615|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
146529338|NCT05067972|528444616|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
146529339|NCT05067972|528444617|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
146529340|NCT05067972|528444618|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
146529341|NCT05067972|528444619|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
146529342|NCT05067972|528444613|FG000|Part 1: Follow-up|Physician Decision|0|||
146529343|NCT05067972|528444614|FG001|Part 1: Follow-up|Physician Decision|0|||
146529344|NCT05067972|528444615|FG002|Part 1: Follow-up|Physician Decision|0|||
146529345|NCT05067972|528444616|FG003|Part 1: Follow-up|Physician Decision|1|||
146529346|NCT05067972|528444617|FG004|Part 1: Follow-up|Physician Decision|0|||
146529347|NCT05067972|528444618|FG005|Part 1: Follow-up|Physician Decision|0|||
146529348|NCT05067972|528444619|FG006|Part 1: Follow-up|Physician Decision|0|||
146529349|NCT05067972|528444613|FG000|Part 1: Follow-up|Death|1|||
146529350|NCT05067972|528444614|FG001|Part 1: Follow-up|Death|2|||
146529351|NCT05067972|528444615|FG002|Part 1: Follow-up|Death|1|||
146529352|NCT05067972|528444616|FG003|Part 1: Follow-up|Death|0|||
146529353|NCT05067972|528444617|FG004|Part 1: Follow-up|Death|1|||
146529354|NCT05067972|528444618|FG005|Part 1: Follow-up|Death|0|||
146529355|NCT05067972|528444619|FG006|Part 1: Follow-up|Death|1|||
146529356|NCT04391842|528444620|FG000|Overall Study|Withdrawal by Subject|2|||
146529357|NCT02573259|528444629|FG000|Overall Study|Death|1|||
146529358|NCT02573259|528444630|FG001|Overall Study|Death|6|||
146529359|NCT02573259|528444631|FG002|Overall Study|Death|5|||
146529360|NCT02573259|528444632|FG003|Overall Study|Death|6|||
146529361|NCT02573259|528444633|FG004|Overall Study|Death|9|||
146529362|NCT02573259|528444634|FG005|Overall Study|Death|32|||
146529363|NCT02573259|528444635|FG006|Overall Study|Death|21|||
146529364|NCT02573259|528444629|FG000|Overall Study|Lost to Follow-up|0|||
146529365|NCT02573259|528444630|FG001|Overall Study|Lost to Follow-up|0|||
146529366|NCT02573259|528444631|FG002|Overall Study|Lost to Follow-up|0|||
146529367|NCT02573259|528444632|FG003|Overall Study|Lost to Follow-up|0|||
146860528|NCT01323634|529659909|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
146860529|NCT01323634|529659910|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
146860530|NCT05056987|529659911|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
146860531|NCT05056987|529659912|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
146529368|NCT02573259|528444633|FG004|Overall Study|Lost to Follow-up|0|||
146529369|NCT02573259|528444634|FG005|Overall Study|Lost to Follow-up|2|||
146529370|NCT02573259|528444635|FG006|Overall Study|Lost to Follow-up|1|||
146529371|NCT02573259|528444629|FG000|Overall Study|Participant refused further follow-up|0|||
146529372|NCT02573259|528444630|FG001|Overall Study|Participant refused further follow-up|2|||
146529373|NCT02573259|528444631|FG002|Overall Study|Participant refused further follow-up|1|||
146529374|NCT02573259|528444632|FG003|Overall Study|Participant refused further follow-up|0|||
146529375|NCT02573259|528444633|FG004|Overall Study|Participant refused further follow-up|3|||
146529376|NCT02573259|528444634|FG005|Overall Study|Participant refused further follow-up|20|||
146529377|NCT02573259|528444635|FG006|Overall Study|Participant refused further follow-up|7|||
146529378|NCT02573259|528444629|FG000|Overall Study|Other|0|||
146529379|NCT02573259|528444630|FG001|Overall Study|Other|0|||
146529380|NCT02573259|528444631|FG002|Overall Study|Other|0|||
146529381|NCT02573259|528444632|FG003|Overall Study|Other|0|||
146529382|NCT02573259|528444633|FG004|Overall Study|Other|1|||
146529383|NCT02573259|528444634|FG005|Overall Study|Other|4|||
146529384|NCT02573259|528444635|FG006|Overall Study|Other|5|||
146529385|NCT00751140|528444636|FG000|Overall Study|benign angioma excluded from analysis|1|||
146529386|NCT02667301|528444637|FG000|Overall Study|Adverse Event|1|||
146529387|NCT02667301|528444637|FG000|Overall Study|Lack of Efficacy|1|||
146529388|NCT01883895|528444641|FG000|Overall Study|Lost to Follow-up|2|||
146529389|NCT02895295|528444642|FG000|Overall Study|Survey Non-response|71|||
146529390|NCT02895295|528444643|FG001|Overall Study|Survey Non-response|94|||
146529391|NCT02895295|528444644|FG002|Overall Study|Survey Non-response|92|||
146529392|NCT00490919|528444645|FG000|Open-label Run-in Period|Adverse Event|239|||
146529393|NCT00490919|528444646|FG001|Open-label Run-in Period|Adverse Event|0|||
146529394|NCT00490919|528444647|FG002|Open-label Run-in Period|Adverse Event|0|||
146529395|NCT00490919|528444645|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
146529396|NCT00490919|528444646|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
146529397|NCT00490919|528444647|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
146529398|NCT00490919|528444645|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
146529399|NCT00490919|528444646|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
146529400|NCT00490919|528444647|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
146529401|NCT00490919|528444645|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
146529402|NCT00490919|528444646|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
146529403|NCT00490919|528444647|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
146529404|NCT00490919|528444645|FG000|Open-label Run-in Period|Administrative|40|||
146529405|NCT00490919|528444646|FG001|Open-label Run-in Period|Administrative|0|||
146529406|NCT00490919|528444647|FG002|Open-label Run-in Period|Administrative|0|||
146529407|NCT00490919|528444645|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
146529408|NCT00490919|528444646|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
146529409|NCT00490919|528444647|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
146529410|NCT00490919|528444645|FG000|Double-blind Phase|Adverse Event|0|||
146529411|NCT00490919|528444646|FG001|Double-blind Phase|Adverse Event|40|||
146529412|NCT00490919|528444647|FG002|Double-blind Phase|Adverse Event|20|||
146860532|NCT05056987|529659911|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
146860533|NCT05056987|529659912|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
146529413|NCT00490919|528444645|FG000|Double-blind Phase|Withdrawal by Subject|0|||
146529414|NCT00490919|528444646|FG001|Double-blind Phase|Withdrawal by Subject|10|||
146529415|NCT00490919|528444647|FG002|Double-blind Phase|Withdrawal by Subject|11|||
146529416|NCT00490919|528444645|FG000|Double-blind Phase|Lost to Follow-up|0|||
146529417|NCT00490919|528444646|FG001|Double-blind Phase|Lost to Follow-up|8|||
146529418|NCT00490919|528444647|FG002|Double-blind Phase|Lost to Follow-up|11|||
146529419|NCT00490919|528444645|FG000|Double-blind Phase|Lack of Efficacy|0|||
146529420|NCT00490919|528444646|FG001|Double-blind Phase|Lack of Efficacy|22|||
146529421|NCT00490919|528444647|FG002|Double-blind Phase|Lack of Efficacy|36|||
146529422|NCT00490919|528444645|FG000|Double-blind Phase|Administrative|0|||
146529423|NCT00490919|528444646|FG001|Double-blind Phase|Administrative|6|||
146529424|NCT00490919|528444647|FG002|Double-blind Phase|Administrative|6|||
146529425|NCT02357459|528446453|FG000|Overall Study|Adverse Event|0|||
146529426|NCT02357459|528446454|FG001|Overall Study|Adverse Event|1|||
146529427|NCT02357459|528446455|FG002|Overall Study|Adverse Event|1|||
146529428|NCT02357459|528446453|FG000|Overall Study|Withdrawal by Subject|5|||
146529429|NCT02357459|528446454|FG001|Overall Study|Withdrawal by Subject|3|||
146529430|NCT02357459|528446455|FG002|Overall Study|Withdrawal by Subject|3|||
146529431|NCT02357459|528446453|FG000|Overall Study|Physician Decision|0|||
146529432|NCT02357459|528446454|FG001|Overall Study|Physician Decision|2|||
146529433|NCT02357459|528446455|FG002|Overall Study|Physician Decision|0|||
146529434|NCT02357459|528446453|FG000|Overall Study|Protocol Violation|1|||
146529435|NCT02357459|528446454|FG001|Overall Study|Protocol Violation|1|||
146529436|NCT02357459|528446455|FG002|Overall Study|Protocol Violation|0|||
146529437|NCT02357459|528446453|FG000|Overall Study|Lost to Follow-up|1|||
146529438|NCT02357459|528446454|FG001|Overall Study|Lost to Follow-up|3|||
146529439|NCT02357459|528446455|FG002|Overall Study|Lost to Follow-up|0|||
146529440|NCT02357459|528446453|FG000|Overall Study|Lack of Efficacy|7|||
146529441|NCT02357459|528446454|FG001|Overall Study|Lack of Efficacy|4|||
146529442|NCT02357459|528446455|FG002|Overall Study|Lack of Efficacy|4|||
146529443|NCT02357459|528446453|FG000|Overall Study|Patient Relocated|2|||
146529444|NCT02357459|528446454|FG001|Overall Study|Patient Relocated|0|||
146529445|NCT02357459|528446455|FG002|Overall Study|Patient Relocated|0|||
146529446|NCT02357459|528446453|FG000|Overall Study|Instruction from PCP|1|||
146529447|NCT02357459|528446454|FG001|Overall Study|Instruction from PCP|0|||
146529448|NCT02357459|528446455|FG002|Overall Study|Instruction from PCP|0|||
146529449|NCT02357459|528446453|FG000|Overall Study|Incarceration|0|||
146529450|NCT02357459|528446454|FG001|Overall Study|Incarceration|0|||
146529451|NCT02357459|528446455|FG002|Overall Study|Incarceration|1|||
146529452|NCT02357459|528446453|FG000|Overall Study|Pre-planned Knee surgery|0|||
146529453|NCT02357459|528446454|FG001|Overall Study|Pre-planned Knee surgery|0|||
146529454|NCT02357459|528446455|FG002|Overall Study|Pre-planned Knee surgery|2|||
146761104|NCT00335556|529292849|FG000|Overall Study|Ineligible|2|||
146529455|NCT02357459|528446453|FG000|Overall Study|Job Commitments|0|||
146529456|NCT02357459|528446454|FG001|Overall Study|Job Commitments|0|||
146529457|NCT02357459|528446455|FG002|Overall Study|Job Commitments|1|||
146529458|NCT03246347|528446456|FG000|Overall Study|On Study|23|||
146529459|NCT01548599|528446457|FG000|Overall Study|Lost to Follow-up|0|||
146529460|NCT01548599|528446458|FG001|Overall Study|Lost to Follow-up|1|||
146529461|NCT01548599|528446457|FG000|Overall Study|Withdrawal by Subject|4|||
146529462|NCT01548599|528446458|FG001|Overall Study|Withdrawal by Subject|0|||
146529463|NCT01548599|528446457|FG000|Overall Study|Death|2|||
146529464|NCT01548599|528446458|FG001|Overall Study|Death|1|||
146529465|NCT02188160|528446459|FG000|Overall Study|Adverse Event|1|||
146529466|NCT02188160|528446460|FG001|Overall Study|Adverse Event|0|||
146529467|NCT02188160|528446459|FG000|Overall Study|Use of an excluded medication|0|||
146529468|NCT02188160|528446460|FG001|Overall Study|Use of an excluded medication|1|||
146529469|NCT04113694|528446461|FG000|Overall Study|Adverse Event|2|||
146529470|NCT04113694|528446461|FG000|Overall Study|Lost to Follow-up|2|||
146529471|NCT04113694|528446461|FG000|Overall Study|Withdrawal by Subject|6|||
146761105|NCT00335556|529292850|FG001|Overall Study|Ineligible|0|||
146761106|NCT00335556|529292851|FG002|Overall Study|Ineligible|0|||
146761107|NCT00335556|529292852|FG003|Overall Study|Ineligible|0|||
146761108|NCT00335556|529292853|FG004|Overall Study|Ineligible|0|||
146761109|NCT00335556|529292854|FG005|Overall Study|Ineligible|0|||
146761110|NCT00335556|529292849|FG000|Overall Study|Refusal of further protocol therapy|0|||
146761111|NCT00335556|529292850|FG001|Overall Study|Refusal of further protocol therapy|4|||
146761112|NCT00335556|529292851|FG002|Overall Study|Refusal of further protocol therapy|0|||
146761113|NCT00335556|529292852|FG003|Overall Study|Refusal of further protocol therapy|1|||
146761114|NCT00335556|529292853|FG004|Overall Study|Refusal of further protocol therapy|0|||
146761115|NCT00335556|529292854|FG005|Overall Study|Refusal of further protocol therapy|0|||
146761116|NCT02365298|529292855|FG000|Period 2|incorrect Rx dispensed|1|||
146761117|NCT02365298|529292856|FG001|Period 2|incorrect Rx dispensed|0|||
146529472|NCT04113694|528446461|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
146529473|NCT00916578|528446464|FG000|Overall Study|Physician Decision|2|||
146529474|NCT00916578|528446464|FG000|Overall Study|Withdrawal by Subject|3|||
146529475|NCT00916578|528446464|FG000|Overall Study|Insurance Denial|2|||
146529476|NCT00754741|528446465|FG000|Overall Study|Died or disenrolled|57|||
146529477|NCT00754741|528446466|FG001|Overall Study|Died or disenrolled|69|||
146529478|NCT00754741|528446467|FG002|Overall Study|Died or disenrolled|54|||
146529479|NCT04152200|528446469|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
146529480|NCT04152200|528446470|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
146761118|NCT02365298|529292855|FG000|Period 2|Discontinued at request of Sponsor|1|||
146761119|NCT02365298|529292856|FG001|Period 2|Discontinued at request of Sponsor|0|||
146761120|NCT02365298|529292855|FG000|Period 2|Test Article longer available|0|||
146529481|NCT04969289|528446471|FG000|Overall Study|Lost to Follow-up|13|||
146761121|NCT02365298|529292856|FG001|Period 2|Test Article longer available|1|||
146529482|NCT04969289|528446472|FG001|Overall Study|Lost to Follow-up|9|||
146529483|NCT00593814|528446473|FG000|Overall Study|Death|7|||
146529484|NCT00593814|528446474|FG001|Overall Study|Death|0|||
146529485|NCT00593814|528446473|FG000|Overall Study|Withdrawal by Subject|7|||
146529486|NCT00593814|528446474|FG001|Overall Study|Withdrawal by Subject|0|||
146529487|NCT00593814|528446473|FG000|Overall Study|Lost to Follow-up|7|||
146529488|NCT00593814|528446474|FG001|Overall Study|Lost to Follow-up|0|||
146529489|NCT00593814|528446473|FG000|Overall Study|Physician Decision|3|||
146529490|NCT00593814|528446474|FG001|Overall Study|Physician Decision|0|||
146529491|NCT02699996|528446475|FG000|Overall Study|Withdrawal by Subject|5|||
146529492|NCT02699996|528446476|FG001|Overall Study|Withdrawal by Subject|2|||
146529493|NCT01921517|528446477|FG000|Overall Study|Lost to Follow-up|5|||
146529494|NCT01921517|528446478|FG001|Overall Study|Lost to Follow-up|0|||
146529495|NCT01921517|528446477|FG000|Overall Study|Newly diagnosed health concern|2|||
146529496|NCT01921517|528446478|FG001|Overall Study|Newly diagnosed health concern|0|||
146529497|NCT01921517|528446477|FG000|Overall Study|Physician Decision|0|||
146529498|NCT01921517|528446478|FG001|Overall Study|Physician Decision|2|||
146529499|NCT01921517|528446477|FG000|Overall Study|Withdrawal by Subject|7|||
146529500|NCT01921517|528446478|FG001|Overall Study|Withdrawal by Subject|3|||
146529501|NCT01921517|528446477|FG000|Overall Study|Subject missed final imaging|1|||
146529502|NCT01921517|528446478|FG001|Overall Study|Subject missed final imaging|4|||
146529503|NCT04069715|528446481|FG000|Overall Study|Lost to Follow-up|1|||
146529504|NCT04069715|528446482|FG001|Overall Study|Lost to Follow-up|1|||
146529505|NCT04069715|528446481|FG000|Overall Study|Physician Decision|1|||
146529506|NCT04069715|528446482|FG001|Overall Study|Physician Decision|1|||
146529507|NCT04069715|528446481|FG000|Overall Study|Withdrawal by Subject|3|||
146529508|NCT04069715|528446482|FG001|Overall Study|Withdrawal by Subject|3|||
146529509|NCT03205150|528446483|FG000|Overall Study|Protocol deviation|1|||
146529510|NCT03205150|528446484|FG001|Overall Study|Protocol deviation|3|||
146529511|NCT03205150|528446485|FG002|Overall Study|Protocol deviation|0|||
146529512|NCT03205150|528446483|FG000|Overall Study|Patient/guardian decision|0|||
146529513|NCT03205150|528446484|FG001|Overall Study|Patient/guardian decision|3|||
146529514|NCT03205150|528446485|FG002|Overall Study|Patient/guardian decision|0|||
146529515|NCT03205150|528446483|FG000|Overall Study|Adverse Event|1|||
146529516|NCT03205150|528446484|FG001|Overall Study|Adverse Event|1|||
146529517|NCT03205150|528446485|FG002|Overall Study|Adverse Event|1|||
146529518|NCT03205150|528446483|FG000|Overall Study|Lost to Follow-up|0|||
146529519|NCT03205150|528446484|FG001|Overall Study|Lost to Follow-up|0|||
146529520|NCT03205150|528446485|FG002|Overall Study|Lost to Follow-up|1|||
146529521|NCT02723188|528446486|FG000|Overall Study|Withdrawal by Subject|1|||
146529522|NCT02723188|528446487|FG001|Overall Study|Withdrawal by Subject|0|||
146529523|NCT02723188|528446488|FG002|Overall Study|Withdrawal by Subject|0|||
146529524|NCT00116688|528446498|FG000|Overall Study|Protocol deviation|1|||
146529525|NCT00116688|528446499|FG001|Overall Study|Protocol deviation|0|||
146529526|NCT00116688|528446498|FG000|Overall Study|Noncompliance|3|||
146529527|NCT00116688|528446499|FG001|Overall Study|Noncompliance|1|||
146529528|NCT00116688|528446498|FG000|Overall Study|Adverse Event|11|||
146529529|NCT00116688|528446499|FG001|Overall Study|Adverse Event|0|||
146529530|NCT00116688|528446498|FG000|Overall Study|Withdrawal by Subject|26|||
146529531|NCT00116688|528446499|FG001|Overall Study|Withdrawal by Subject|2|||
146529532|NCT00116688|528446498|FG000|Overall Study|Requirement for alternative therapy|11|||
146529533|NCT00116688|528446499|FG001|Overall Study|Requirement for alternative therapy|1|||
146529534|NCT00116688|528446498|FG000|Overall Study|Physician Decision|7|||
146529535|NCT00116688|528446499|FG001|Overall Study|Physician Decision|0|||
146529536|NCT00116688|528446498|FG000|Overall Study|Lost to Follow-up|3|||
146529537|NCT00116688|528446499|FG001|Overall Study|Lost to Follow-up|0|||
146529538|NCT00116688|528446498|FG000|Overall Study|Death|15|||
146529539|NCT00116688|528446499|FG001|Overall Study|Death|0|||
146761122|NCT02365298|529292855|FG000|Period 2|Protocol Violation|0|||
146761123|NCT02365298|529292856|FG001|Period 2|Protocol Violation|1|||
146761124|NCT02974010|529292859|FG000|Overall Study|Lost to Follow-up|3|||
146761125|NCT02974010|529292860|FG001|Overall Study|Lost to Follow-up|1|||
146529540|NCT00116688|528446498|FG000|Overall Study|Protocol-specified criteria|3|||
146529541|NCT00116688|528446499|FG001|Overall Study|Protocol-specified criteria|0|||
146529542|NCT00116688|528446498|FG000|Overall Study|Pregnancy|1|||
146529543|NCT00116688|528446499|FG001|Overall Study|Pregnancy|0|||
146529544|NCT00116688|528446498|FG000|Overall Study|Other|11|||
146529545|NCT00116688|528446499|FG001|Overall Study|Other|0|||
146529546|NCT01775670|528446504|FG000|Overall Study|Lost to Follow-up|1|||
146529547|NCT01775670|528446505|FG001|Overall Study|Lost to Follow-up|1|||
146529548|NCT00643760|528446506|FG000|Overall Study|Adverse Event|11|||
146529549|NCT00643760|528446507|FG001|Overall Study|Adverse Event|5|||
146529550|NCT00643760|528446508|FG002|Overall Study|Adverse Event|12|||
146529551|NCT00643760|528446509|FG003|Overall Study|Adverse Event|21|||
146529552|NCT00643760|528446510|FG004|Overall Study|Adverse Event|6|||
146761126|NCT02974010|529292861|FG002|Overall Study|Lost to Follow-up|0|||
146529553|NCT00643760|528446506|FG000|Overall Study|Lack of Efficacy|3|||
146529554|NCT00643760|528446507|FG001|Overall Study|Lack of Efficacy|1|||
146529555|NCT00643760|528446508|FG002|Overall Study|Lack of Efficacy|0|||
146529556|NCT00643760|528446509|FG003|Overall Study|Lack of Efficacy|4|||
146529557|NCT00643760|528446510|FG004|Overall Study|Lack of Efficacy|3|||
146529558|NCT00643760|528446506|FG000|Overall Study|Protocol Violation|7|||
146529559|NCT00643760|528446507|FG001|Overall Study|Protocol Violation|6|||
146529560|NCT00643760|528446508|FG002|Overall Study|Protocol Violation|4|||
146529561|NCT00643760|528446509|FG003|Overall Study|Protocol Violation|4|||
146529562|NCT00643760|528446510|FG004|Overall Study|Protocol Violation|6|||
146529563|NCT00643760|528446506|FG000|Overall Study|Lost to Follow-up|6|||
146529564|NCT00643760|528446507|FG001|Overall Study|Lost to Follow-up|2|||
146529565|NCT00643760|528446508|FG002|Overall Study|Lost to Follow-up|1|||
146761127|NCT02974010|529292862|FG003|Overall Study|Lost to Follow-up|0|||
146761128|NCT02974010|529292859|FG000|Overall Study|Withdrawal by Subject|2|||
146761129|NCT02974010|529292860|FG001|Overall Study|Withdrawal by Subject|1|||
146761130|NCT02974010|529292861|FG002|Overall Study|Withdrawal by Subject|0|||
146761131|NCT02974010|529292862|FG003|Overall Study|Withdrawal by Subject|0|||
146761132|NCT02974010|529292859|FG000|Overall Study|Adverse Event|0|||
146761133|NCT02974010|529292860|FG001|Overall Study|Adverse Event|1|||
146761134|NCT02974010|529292861|FG002|Overall Study|Adverse Event|0|||
146761135|NCT02974010|529292862|FG003|Overall Study|Adverse Event|0|||
146761136|NCT02974010|529292859|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
146761137|NCT02974010|529292860|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
146761138|NCT02974010|529292861|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
146761139|NCT02974010|529292862|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
146761140|NCT02974010|529292859|FG000|Overall Study|Lack of Efficacy|0|||
146761141|NCT02974010|529292860|FG001|Overall Study|Lack of Efficacy|0|||
146761142|NCT02974010|529292861|FG002|Overall Study|Lack of Efficacy|1|||
146761143|NCT02974010|529292862|FG003|Overall Study|Lack of Efficacy|0|||
146761144|NCT04088188|529292865|FG000|Overall Study|Withdrawal by Subject|2|||
146761145|NCT04088188|529292866|FG001|Overall Study|Withdrawal by Subject|0|||
146761146|NCT04088188|529292865|FG000|Overall Study|Adverse Event|2|||
146761147|NCT04088188|529292866|FG001|Overall Study|Adverse Event|0|||
146761148|NCT03124108|529292867|FG000|Overall Study|Adverse Event|0|||
146761149|NCT03124108|529292868|FG001|Overall Study|Adverse Event|1|||
146761150|NCT03124108|529292869|FG002|Overall Study|Adverse Event|0|||
146761151|NCT01670019|529292879|FG000|Overall Study|Adverse Event|3|||
146761152|NCT01670019|529292880|FG001|Overall Study|Adverse Event|0|||
146761153|NCT01670019|529292879|FG000|Overall Study|Withdrawal by Subject|6|||
146761154|NCT01670019|529292880|FG001|Overall Study|Withdrawal by Subject|0|||
146761155|NCT05650333|529292881|FG000|Treatment Period (7 Days)|Adverse Event|1|||
146761156|NCT02524288|529292882|FG000|Overall Study|Adverse Event|115|||
146761157|NCT02524288|529292882|FG000|Overall Study|Lost to Follow-up|216|||
146761158|NCT02524288|529292882|FG000|Overall Study|Non-Compliance With Protocol|32|||
146761159|NCT02524288|529292882|FG000|Overall Study|Non-Compliance With Study Drug|14|||
146761160|NCT02524288|529292882|FG000|Overall Study|Pregnancy Wish|6|||
146761161|NCT02524288|529292882|FG000|Overall Study|Protocol Violation|6|||
146761162|NCT02524288|529292882|FG000|Overall Study|Screen Failure|2|||
146761163|NCT02524288|529292882|FG000|Overall Study|Site Discontinued Study Participation|1|||
146761164|NCT02524288|529292882|FG000|Overall Study|Study Terminated By Sponsor|1417|||
146761165|NCT02524288|529292882|FG000|Overall Study|Subject Moved|32|||
146761166|NCT02524288|529292882|FG000|Overall Study|Withdrawal by Subject|76|||
146761167|NCT02524288|529292882|FG000|Overall Study|Pregnancy|22|||
146761168|NCT02524288|529292882|FG000|Overall Study|Physician Decision|2|||
146761169|NCT00517933|529292884|FG000|Period 1|Death|2|||
146761170|NCT00517933|529292885|FG001|Period 1|Death|1|||
146761171|NCT00517933|529292884|FG000|Period 1|Adverse Event|4|||
146761172|NCT00517933|529292885|FG001|Period 1|Adverse Event|4|||
146761173|NCT00517933|529292884|FG000|Period 1|Lost to Follow-up|2|||
146761174|NCT00517933|529292885|FG001|Period 1|Lost to Follow-up|0|||
146761175|NCT00517933|529292884|FG000|Period 1|Underwent lung transplant|0|||
146761176|NCT00517933|529292885|FG001|Period 1|Underwent lung transplant|1|||
146761177|NCT00517933|529292884|FG000|Period 2|Death|2|||
146761178|NCT00517933|529292885|FG001|Period 2|Death|4|||
146761179|NCT00517933|529292884|FG000|Period 2|Adverse Event|2|||
146761180|NCT00517933|529292885|FG001|Period 2|Adverse Event|4|||
146761181|NCT00517933|529292884|FG000|Period 2|Physician Decision|1|||
146761182|NCT00517933|529292885|FG001|Period 2|Physician Decision|0|||
146761183|NCT00517933|529292884|FG000|Period 2|Withdrawal by Subject|1|||
146761184|NCT00517933|529292885|FG001|Period 2|Withdrawal by Subject|3|||
146761185|NCT00517933|529292884|FG000|Period 2|Underwent lung transplant|0|||
146761186|NCT00517933|529292885|FG001|Period 2|Underwent lung transplant|2|||
146761187|NCT01649427|529292888|FG000|Overall Study|Adverse Event|1|||
146761188|NCT01649427|529292889|FG001|Overall Study|Adverse Event|1|||
146761189|NCT01649427|529292888|FG000|Overall Study|Withdrawal by Subject|8|||
146761190|NCT01649427|529292889|FG001|Overall Study|Withdrawal by Subject|7|||
146761191|NCT01649427|529292888|FG000|Overall Study|Lost to Follow-up|0|||
146529566|NCT00643760|528446509|FG003|Overall Study|Lost to Follow-up|3|||
146529567|NCT00643760|528446510|FG004|Overall Study|Lost to Follow-up|3|||
146529568|NCT00643760|528446506|FG000|Overall Study|Investigator Discretion|0|||
146860534|NCT01575028|529659913|FG000|Overall Study|Physician Decision|0|||
146529569|NCT00643760|528446507|FG001|Overall Study|Investigator Discretion|0|||
146529570|NCT00643760|528446508|FG002|Overall Study|Investigator Discretion|0|||
146529571|NCT00643760|528446509|FG003|Overall Study|Investigator Discretion|2|||
146529572|NCT00643760|528446510|FG004|Overall Study|Investigator Discretion|0|||
146860535|NCT01575028|529659914|FG001|Overall Study|Physician Decision|1|||
146860536|NCT02409368|529659915|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
146860537|NCT02409368|529659916|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
146860538|NCT02409368|529659917|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
146860539|NCT02409368|529659918|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
146860540|NCT02409368|529659915|FG000|ECOG Reclassification|Death|1|||
146860541|NCT02409368|529659916|FG001|ECOG Reclassification|Death|5|||
146860542|NCT02409368|529659917|FG002|ECOG Reclassification|Death|0|||
146860543|NCT02409368|529659918|FG003|ECOG Reclassification|Death|0|||
146860544|NCT02409368|529659915|FG000|ECOG Reclassification|Disease Progression|113|||
146860545|NCT02409368|529659916|FG001|ECOG Reclassification|Disease Progression|382|||
146860546|NCT02409368|529659917|FG002|ECOG Reclassification|Disease Progression|70|||
146860547|NCT02409368|529659918|FG003|ECOG Reclassification|Disease Progression|1|||
146860548|NCT02409368|529659915|FG000|ECOG Reclassification|Lost to Follow-up|1|||
146860549|NCT02409368|529659916|FG001|ECOG Reclassification|Lost to Follow-up|5|||
146860550|NCT02409368|529659917|FG002|ECOG Reclassification|Lost to Follow-up|0|||
146860551|NCT02409368|529659918|FG003|ECOG Reclassification|Lost to Follow-up|0|||
146529573|NCT00643760|528446506|FG000|Overall Study|Withdrawal by Subject|3|||
146529574|NCT00643760|528446507|FG001|Overall Study|Withdrawal by Subject|1|||
146529575|NCT00643760|528446508|FG002|Overall Study|Withdrawal by Subject|2|||
146529576|NCT00643760|528446509|FG003|Overall Study|Withdrawal by Subject|4|||
146529577|NCT00643760|528446510|FG004|Overall Study|Withdrawal by Subject|1|||
146529578|NCT00789321|528446511|FG000|Overall Study|Adverse Event|0|||
146529579|NCT00789321|528446512|FG001|Overall Study|Adverse Event|1|||
146529580|NCT00104052|528446513|FG000|Overall Study|Adverse Event|1|||
146529581|NCT00104052|528446513|FG000|Overall Study|Lack of Efficacy|26|||
146529582|NCT00104052|528446513|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
146529583|NCT03652818|528446516|FG000|Overall Study|Adverse Event|1|||
146529584|NCT03652818|528446517|FG001|Overall Study|Adverse Event|0|||
146529585|NCT03652818|528446518|FG002|Overall Study|Adverse Event|0|||
146529586|NCT03652818|528446519|FG003|Overall Study|Adverse Event|0|||
146529587|NCT03652818|528446520|FG004|Overall Study|Adverse Event|0|||
146529588|NCT03652818|528446516|FG000|Overall Study|Physician Decision|1|||
146529589|NCT03652818|528446517|FG001|Overall Study|Physician Decision|0|||
146529590|NCT03652818|528446518|FG002|Overall Study|Physician Decision|0|||
146529591|NCT03652818|528446519|FG003|Overall Study|Physician Decision|0|||
146529592|NCT03652818|528446520|FG004|Overall Study|Physician Decision|0|||
146529593|NCT03652818|528446516|FG000|Overall Study|Lost to Follow-up|0|||
146529594|NCT03652818|528446517|FG001|Overall Study|Lost to Follow-up|1|||
146529595|NCT03652818|528446518|FG002|Overall Study|Lost to Follow-up|2|||
146529596|NCT03652818|528446519|FG003|Overall Study|Lost to Follow-up|1|||
146529597|NCT03652818|528446520|FG004|Overall Study|Lost to Follow-up|1|||
146529598|NCT03964207|528446521|FG000|First Treatment|Withdrawal by Subject|1|||
146529599|NCT03964207|528446522|FG001|First Treatment|Withdrawal by Subject|2|||
146529600|NCT03964207|528446521|FG000|First Treatment|Protocol Violation|1|||
146529601|NCT03964207|528446522|FG001|First Treatment|Protocol Violation|0|||
146529602|NCT03964207|528446521|FG000|First Treatment|Lost to Follow-up|1|||
146529603|NCT03964207|528446522|FG001|First Treatment|Lost to Follow-up|0|||
146529604|NCT03964207|528446521|FG000|Second Treatment|Lost to Follow-up|0|||
146529605|NCT03964207|528446522|FG001|Second Treatment|Lost to Follow-up|1|||
146529606|NCT03964207|528446521|FG000|Second Treatment|Adverse Event|1|||
146529607|NCT03964207|528446522|FG001|Second Treatment|Adverse Event|2|||
146860552|NCT02409368|529659915|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
146860553|NCT02409368|529659916|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
146860554|NCT02409368|529659917|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
146529608|NCT00830219|528446523|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
146529609|NCT00830219|528446524|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
146860555|NCT02409368|529659918|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
146860556|NCT02409368|529659915|FG000|ECOG Reclassification|Poor/non-compliance|0|||
146860557|NCT02409368|529659916|FG001|ECOG Reclassification|Poor/non-compliance|3|||
146860558|NCT02409368|529659917|FG002|ECOG Reclassification|Poor/non-compliance|2|||
146860559|NCT02409368|529659918|FG003|ECOG Reclassification|Poor/non-compliance|0|||
146529610|NCT01294423|528446529|FG000|Overall Study|Adverse Event|1|||
146529611|NCT01294423|528446530|FG001|Overall Study|Adverse Event|2|||
146529612|NCT01294423|528446531|FG002|Overall Study|Adverse Event|3|||
146529613|NCT01294423|528446529|FG000|Overall Study|Withdrawal by Subject|1|||
146529614|NCT01294423|528446530|FG001|Overall Study|Withdrawal by Subject|2|||
146529615|NCT01294423|528446531|FG002|Overall Study|Withdrawal by Subject|2|||
146529616|NCT01294423|528446529|FG000|Overall Study|subject no longer meets study criteria|2|||
146529617|NCT01294423|528446530|FG001|Overall Study|subject no longer meets study criteria|5|||
146529618|NCT01294423|528446531|FG002|Overall Study|subject no longer meets study criteria|2|||
146529619|NCT01294423|528446529|FG000|Overall Study|poor/non-compliance|1|||
146860560|NCT02409368|529659915|FG000|ECOG Reclassification|Study drug toxicity|17|||
146860561|NCT02409368|529659916|FG001|ECOG Reclassification|Study drug toxicity|42|||
146860562|NCT02409368|529659917|FG002|ECOG Reclassification|Study drug toxicity|7|||
146860563|NCT02409368|529659918|FG003|ECOG Reclassification|Study drug toxicity|0|||
146860564|NCT02409368|529659915|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
146860565|NCT02409368|529659916|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
146860566|NCT02409368|529659917|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
146860567|NCT02409368|529659918|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
146860568|NCT02409368|529659915|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
146860569|NCT02409368|529659916|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
146860570|NCT02409368|529659917|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
146860571|NCT02409368|529659918|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
146860572|NCT02409368|529659915|FG000|ECOG Reclassification|Participant withdrew consent|2|||
146860573|NCT02409368|529659916|FG001|ECOG Reclassification|Participant withdrew consent|3|||
146529620|NCT01294423|528446530|FG001|Overall Study|poor/non-compliance|0|||
146860574|NCT02409368|529659917|FG002|ECOG Reclassification|Participant withdrew consent|4|||
146860575|NCT02409368|529659918|FG003|ECOG Reclassification|Participant withdrew consent|0|||
146860576|NCT02409368|529659915|FG000|ECOG Reclassification|Other Reasons|5|||
146860577|NCT02409368|529659916|FG001|ECOG Reclassification|Other Reasons|26|||
146860578|NCT02409368|529659917|FG002|ECOG Reclassification|Other Reasons|2|||
146860579|NCT02409368|529659918|FG003|ECOG Reclassification|Other Reasons|0|||
146860580|NCT02409368|529659915|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
146860581|NCT02409368|529659916|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
146860582|NCT02409368|529659917|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
146860583|NCT02409368|529659918|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
146860584|NCT01296347|529659919|FG000|Allocation|Withdrawal by Subject|1|||
146860585|NCT01296347|529659920|FG001|Allocation|Withdrawal by Subject|2|||
146860586|NCT01296347|529659919|FG000|Allocation|Lack of Efficacy|1|||
146860587|NCT01296347|529659920|FG001|Allocation|Lack of Efficacy|2|||
146860588|NCT01296347|529659919|FG000|Allocation|not received infusion|1|||
146860589|NCT01296347|529659920|FG001|Allocation|not received infusion|0|||
146860590|NCT01296347|529659919|FG000|6 Week Follow up|Death|0|||
146860591|NCT01296347|529659920|FG001|6 Week Follow up|Death|1|||
146860592|NCT01296347|529659919|FG000|3 Month Follow up|Death|1|||
146860593|NCT01296347|529659920|FG001|3 Month Follow up|Death|0|||
146860594|NCT01296347|529659919|FG000|3 Month Follow up|Lost to Follow-up|0|||
146860595|NCT01296347|529659920|FG001|3 Month Follow up|Lost to Follow-up|1|||
146860596|NCT01296347|529659919|FG000|6 Month Follow up|Death|2|||
146860597|NCT01296347|529659920|FG001|6 Month Follow up|Death|1|||
146860598|NCT01296347|529659919|FG000|6 Month Follow up|Lost to Follow-up|0|||
146860599|NCT01296347|529659920|FG001|6 Month Follow up|Lost to Follow-up|1|||
146860600|NCT01296347|529659919|FG000|12 Month Follow up|Lost to Follow-up|3|||
146860601|NCT01296347|529659920|FG001|12 Month Follow up|Lost to Follow-up|1|||
146860602|NCT01296347|529659919|FG000|12 Month Follow up|Death|1|||
146860603|NCT01296347|529659920|FG001|12 Month Follow up|Death|1|||
146860604|NCT01296347|529659919|FG000|12 Month Follow up|Withdrawal by Subject|0|||
146860605|NCT01296347|529659920|FG001|12 Month Follow up|Withdrawal by Subject|1|||
146860606|NCT01182194|529659921|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
146860607|NCT01182194|529659922|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
146860608|NCT02240693|529659923|FG000|Overall Study|Adverse Event|0|||
146860609|NCT02240693|529659924|FG001|Overall Study|Adverse Event|0|||
146529621|NCT01294423|528446531|FG002|Overall Study|poor/non-compliance|1|||
146529622|NCT01241279|528446532|FG000|Overall Study|Lost to Follow-up|0|||
146529623|NCT01241279|528446533|FG001|Overall Study|Lost to Follow-up|1|||
146529624|NCT00239720|528446537|FG000|Overall Study|Adverse Event|1|||
146529625|NCT00239720|528446538|FG001|Overall Study|Adverse Event|0|||
146529626|NCT00239720|528446537|FG000|Overall Study|Lost to Follow-up|0|||
146529627|NCT00239720|528446538|FG001|Overall Study|Lost to Follow-up|1|||
146529628|NCT01811732|528446539|FG000|Overall Study|Lost to Follow-up|24|||
146529629|NCT01811732|528446540|FG001|Overall Study|Lost to Follow-up|30|||
146529630|NCT01811732|528446539|FG000|Overall Study|Withdrawal by Subject|16|||
146529631|NCT01811732|528446540|FG001|Overall Study|Withdrawal by Subject|10|||
146529632|NCT01811732|528446539|FG000|Overall Study|Adverse Event|3|||
146529633|NCT01811732|528446540|FG001|Overall Study|Adverse Event|9|||
146529634|NCT01811732|528446539|FG000|Overall Study|Lack of Efficacy|3|||
146529635|NCT01811732|528446540|FG001|Overall Study|Lack of Efficacy|1|||
146529636|NCT01811732|528446539|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
146529637|NCT01811732|528446540|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
146860610|NCT02240693|529659925|FG002|Overall Study|Adverse Event|0|||
146860611|NCT02240693|529659926|FG003|Overall Study|Adverse Event|0|||
146860612|NCT02240693|529659927|FG004|Overall Study|Adverse Event|1|||
146860613|NCT02240693|529659923|FG000|Overall Study|Withdrawal by Subject|0|||
146860614|NCT02240693|529659924|FG001|Overall Study|Withdrawal by Subject|0|||
146529638|NCT01811732|528446539|FG000|Overall Study|Physician Decision|2|||
146761192|NCT01649427|529292889|FG001|Overall Study|Lost to Follow-up|1|||
146761193|NCT01649427|529292888|FG000|Overall Study|Graft loss|0|||
146761194|NCT01649427|529292889|FG001|Overall Study|Graft loss|1|||
146761195|NCT01649427|529292888|FG000|Overall Study|Surgical problems during nephrectomy|2|||
146761196|NCT01649427|529292889|FG001|Overall Study|Surgical problems during nephrectomy|2|||
146761197|NCT03717194|529292890|FG000|Overall Study|Withdrawal by Subject|2|||
146761198|NCT03717194|529292891|FG001|Overall Study|Withdrawal by Subject|4|||
146761199|NCT03717194|529292890|FG000|Overall Study|Adverse Event|1|||
146761200|NCT03717194|529292891|FG001|Overall Study|Adverse Event|1|||
146761201|NCT01836458|529292892|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
146761202|NCT01836458|529292893|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146761203|NCT01836458|529292894|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
146761204|NCT01836458|529292895|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
146761205|NCT00561574|529292897|FG000|Overall Study|Adverse Event|21|||
146761206|NCT00561574|529292898|FG001|Overall Study|Adverse Event|24|||
146761207|NCT00561574|529292897|FG000|Overall Study|Lack of Efficacy|11|||
146761208|NCT00561574|529292898|FG001|Overall Study|Lack of Efficacy|21|||
146761209|NCT00561574|529292897|FG000|Overall Study|Withdrawal by Subject|4|||
146761210|NCT00561574|529292898|FG001|Overall Study|Withdrawal by Subject|4|||
146761211|NCT00561574|529292897|FG000|Overall Study|Reason Unrelated to Trial|6|||
146761212|NCT00561574|529292898|FG001|Overall Study|Reason Unrelated to Trial|2|||
146761213|NCT00561574|529292897|FG000|Overall Study|Lost to Follow-up|1|||
146761214|NCT00561574|529292898|FG001|Overall Study|Lost to Follow-up|0|||
146761215|NCT00561574|529292897|FG000|Overall Study|Other|5|||
146761216|NCT00561574|529292898|FG001|Overall Study|Other|7|||
146761217|NCT00445692|529292899|FG000|Overall Study|Adverse Event|11|||
146761218|NCT00445692|529292899|FG000|Overall Study|Lack of Efficacy|5|||
146761219|NCT00430677|529292903|FG000|Short-term Period|Death|1|||
146761220|NCT00430677|529292904|FG001|Short-term Period|Death|1|||
146761221|NCT00430677|529292905|FG002|Short-term Period|Death|5|||
146761222|NCT00430677|529292903|FG000|Short-term Period|Adverse Event|15|||
146761223|NCT00430677|529292904|FG001|Short-term Period|Adverse Event|13|||
146761224|NCT00430677|529292905|FG002|Short-term Period|Adverse Event|9|||
146761225|NCT00430677|529292903|FG000|Short-term Period|Lack of Efficacy|5|||
146761226|NCT00430677|529292904|FG001|Short-term Period|Lack of Efficacy|6|||
146761227|NCT00430677|529292905|FG002|Short-term Period|Lack of Efficacy|4|||
146761228|NCT00430677|529292903|FG000|Short-term Period|Withdrawal by Subject|1|||
146761229|NCT00430677|529292904|FG001|Short-term Period|Withdrawal by Subject|1|||
146761230|NCT00430677|529292905|FG002|Short-term Period|Withdrawal by Subject|2|||
146761231|NCT00430677|529292903|FG000|Short-term Period|Participant no longer met study criteria|1|||
146761232|NCT00430677|529292904|FG001|Short-term Period|Participant no longer met study criteria|1|||
146761233|NCT00430677|529292905|FG002|Short-term Period|Participant no longer met study criteria|2|||
146761234|NCT00430677|529292903|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
146761235|NCT00430677|529292904|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
146761236|NCT00430677|529292905|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
146761237|NCT00430677|529292903|FG000|Short-term Period|Pregnancy|0|||
146761238|NCT00430677|529292904|FG001|Short-term Period|Pregnancy|2|||
146761239|NCT00430677|529292905|FG002|Short-term Period|Pregnancy|0|||
146761240|NCT00430677|529292903|FG000|Long-term Extension Period|Death|1|||
146761241|NCT00430677|529292904|FG001|Long-term Extension Period|Death|0|||
146761242|NCT00430677|529292905|FG002|Long-term Extension Period|Death|0|||
146761243|NCT00430677|529292903|FG000|Long-term Extension Period|Adverse Event|3|||
146761244|NCT00430677|529292904|FG001|Long-term Extension Period|Adverse Event|2|||
146761245|NCT00430677|529292905|FG002|Long-term Extension Period|Adverse Event|5|||
146761246|NCT00430677|529292903|FG000|Long-term Extension Period|Lack of Efficacy|5|||
146761247|NCT00430677|529292904|FG001|Long-term Extension Period|Lack of Efficacy|3|||
146761248|NCT00430677|529292905|FG002|Long-term Extension Period|Lack of Efficacy|8|||
146761249|NCT00430677|529292903|FG000|Long-term Extension Period|Lost to Follow-up|1|||
146761250|NCT00430677|529292904|FG001|Long-term Extension Period|Lost to Follow-up|1|||
146761251|NCT00430677|529292905|FG002|Long-term Extension Period|Lost to Follow-up|1|||
146761252|NCT00430677|529292903|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
146761253|NCT00430677|529292904|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
146761254|NCT00430677|529292905|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
146761255|NCT00430677|529292903|FG000|Long-term Extension Period|Pregnancy|1|||
146761256|NCT00430677|529292904|FG001|Long-term Extension Period|Pregnancy|1|||
146761257|NCT00430677|529292905|FG002|Long-term Extension Period|Pregnancy|0|||
146761258|NCT00430677|529292903|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
146761259|NCT00430677|529292904|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
146761260|NCT00430677|529292905|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
146761261|NCT00430677|529292903|FG000|Long-term Extension Period|Other|2|||
146761262|NCT00430677|529292904|FG001|Long-term Extension Period|Other|1|||
146761263|NCT00430677|529292905|FG002|Long-term Extension Period|Other|1|||
146761264|NCT00430677|529292903|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
146761265|NCT00430677|529292904|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
146761266|NCT00430677|529292905|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
146860615|NCT02240693|529659925|FG002|Overall Study|Withdrawal by Subject|2|||
146529639|NCT01811732|528446540|FG001|Overall Study|Physician Decision|0|||
146529640|NCT01811732|528446539|FG000|Overall Study|Death|1|||
146529641|NCT01811732|528446540|FG001|Overall Study|Death|1|||
146529642|NCT01811732|528446539|FG000|Overall Study|Insufficient venous access|0|||
146529643|NCT01811732|528446540|FG001|Overall Study|Insufficient venous access|1|||
146529644|NCT01811732|528446539|FG000|Overall Study|Protocol Violation|0|||
146529645|NCT01811732|528446540|FG001|Overall Study|Protocol Violation|1|||
146529646|NCT01811732|528446539|FG000|Overall Study|Subject incarcerated|1|||
146529647|NCT01811732|528446540|FG001|Overall Study|Subject incarcerated|2|||
146529648|NCT01811732|528446539|FG000|Overall Study|Admitted to another facility|1|||
146529649|NCT01811732|528446540|FG001|Overall Study|Admitted to another facility|0|||
146860616|NCT02240693|529659926|FG003|Overall Study|Withdrawal by Subject|1|||
146860617|NCT02240693|529659927|FG004|Overall Study|Withdrawal by Subject|0|||
146860618|NCT02240693|529659923|FG000|Overall Study|Other than specified|0|||
146860619|NCT02240693|529659924|FG001|Overall Study|Other than specified|0|||
146860620|NCT02240693|529659925|FG002|Overall Study|Other than specified|2|||
146529650|NCT01811732|528446539|FG000|Overall Study|Correct study drug not available on site|1|||
146529651|NCT01811732|528446540|FG001|Overall Study|Correct study drug not available on site|0|||
146529652|NCT02771275|528446545|FG000|Overall Study|Reoperation|3|||
146529653|NCT02771275|528446545|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
146529654|NCT03191799|528446546|FG000|Overall Study|Withdrawal by Subject|4|||
146529655|NCT03191799|528446546|FG000|Overall Study|Physician Decision|2|||
146529656|NCT03191799|528446546|FG000|Overall Study|Lost to Follow-up|1|||
146529657|NCT03191799|528446546|FG000|Overall Study|Death|2|||
146529658|NCT00468585|528446548|FG000|Overall Study|Patient not treated|1|||
146529659|NCT00468585|528446549|FG001|Overall Study|Patient not treated|0|||
146529660|NCT00468585|528446550|FG002|Overall Study|Patient not treated|1|||
146529661|NCT00468585|528446551|FG003|Overall Study|Patient not treated|0|||
146529662|NCT00468585|528446548|FG000|Overall Study|Patient found to be ineligible|0|||
146529663|NCT00468585|528446549|FG001|Overall Study|Patient found to be ineligible|0|||
146529664|NCT00468585|528446550|FG002|Overall Study|Patient found to be ineligible|1|||
146529665|NCT00468585|528446551|FG003|Overall Study|Patient found to be ineligible|0|||
146529666|NCT00468585|528446548|FG000|Overall Study|Adverse Event|0|||
146529667|NCT00468585|528446549|FG001|Overall Study|Adverse Event|0|||
146529668|NCT00468585|528446550|FG002|Overall Study|Adverse Event|1|||
146529669|NCT00468585|528446551|FG003|Overall Study|Adverse Event|0|||
146529670|NCT00468585|528446548|FG000|Overall Study|Withdrawal by Subject|0|||
146529671|NCT00468585|528446549|FG001|Overall Study|Withdrawal by Subject|0|||
146529672|NCT00468585|528446550|FG002|Overall Study|Withdrawal by Subject|2|||
146529673|NCT00468585|528446551|FG003|Overall Study|Withdrawal by Subject|1|||
146529674|NCT03769649|528446552|FG000|Overall Study|Lost to Follow-up|4|||
146529675|NCT01290718|528446555|FG000|Overall Study|Early termination of the study|4|||
146529676|NCT02456727|528446556|FG000|Overall Study|Lost to Follow-up|63|||
146529677|NCT02456727|528446557|FG001|Overall Study|Lost to Follow-up|65|||
146529678|NCT02456727|528446556|FG000|Overall Study|Death|2|||
146529679|NCT02456727|528446557|FG001|Overall Study|Death|1|||
146529680|NCT02456727|528446556|FG000|Overall Study|Withdrawal by Subject|1|||
146529681|NCT02456727|528446557|FG001|Overall Study|Withdrawal by Subject|10|||
146529682|NCT02456727|528446556|FG000|Overall Study|Never Initiated Treatment|43|||
146529683|NCT02456727|528446557|FG001|Overall Study|Never Initiated Treatment|30|||
146529684|NCT02059239|528446558|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
146529685|NCT02059239|528446559|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
146529686|NCT02059239|528446558|FG000|Overall Study|Physician Decision|1|||
146529687|NCT02059239|528446559|FG001|Overall Study|Physician Decision|0|||
146529688|NCT01268267|528446561|FG000|Overall Study|Protocol Violation|1|||
146529689|NCT01222104|528446562|FG000|Overall Study|Lost to Follow-up|37|||
146529690|NCT01222104|528446562|FG000|Overall Study|Death|10|||
146625287|NCT03037385|528803852|FG007|Overall Study|Progressive Disease|0|||
146761267|NCT02040844|529292908|FG000|Overall Study|Adverse Event|0|||
146761268|NCT02040844|529292909|FG001|Overall Study|Adverse Event|0|||
146761269|NCT02040844|529292910|FG002|Overall Study|Adverse Event|1|||
146761270|NCT02040844|529292908|FG000|Overall Study|Withdrawal by Subject|16|||
146761271|NCT02040844|529292909|FG001|Overall Study|Withdrawal by Subject|22|||
146761272|NCT02040844|529292910|FG002|Overall Study|Withdrawal by Subject|25|||
146761273|NCT02040844|529292908|FG000|Overall Study|Lost to Follow-up|12|||
146761274|NCT02040844|529292909|FG001|Overall Study|Lost to Follow-up|9|||
146761275|NCT02040844|529292910|FG002|Overall Study|Lost to Follow-up|13|||
146761276|NCT02040844|529292908|FG000|Overall Study|Missing|13|||
146761277|NCT02040844|529292909|FG001|Overall Study|Missing|3|||
146761278|NCT02040844|529292910|FG002|Overall Study|Missing|2|||
146860621|NCT02240693|529659926|FG003|Overall Study|Other than specified|0|||
146860622|NCT02240693|529659927|FG004|Overall Study|Other than specified|0|||
146529691|NCT01418339|528446563|FG000|Overall Study|Adverse Event|5|||
146529692|NCT01418339|528446564|FG001|Overall Study|Adverse Event|2|||
146625288|NCT03037385|528803853|FG008|Overall Study|Progressive Disease|0|||
146761279|NCT02040844|529292908|FG000|Overall Study|Non-specified|8|||
146761280|NCT02040844|529292909|FG001|Overall Study|Non-specified|2|||
146529693|NCT01418339|528446563|FG000|Overall Study|Subject Withdrew Consent|1|||
146529694|NCT01418339|528446564|FG001|Overall Study|Subject Withdrew Consent|2|||
146529695|NCT01418339|528446563|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
146529696|NCT01418339|528446564|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
146529697|NCT02204917|528446567|FG000|Overall Study|Protocol Violation|1|||
146529698|NCT00909844|528446568|FG000|Overall Study|Adverse Event|1|||
146529699|NCT00909844|528446568|FG000|Overall Study|Withdrawal by Subject|1|||
146529700|NCT00909844|528446568|FG000|Overall Study|Lost to Follow-up|2|||
146529701|NCT02219685|528446569|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
146529702|NCT02219685|528446570|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
146529703|NCT02219685|528446569|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
146529704|NCT02219685|528446570|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
146529705|NCT00698815|528446571|FG000|Overall Study|Death|1|||
146529706|NCT00698815|528446572|FG001|Overall Study|Death|2|||
146529707|NCT00698815|528446573|FG002|Overall Study|Death|4|||
146529708|NCT00698815|528446571|FG000|Overall Study|Withdrawal by Subject|6|||
146529709|NCT00698815|528446572|FG001|Overall Study|Withdrawal by Subject|3|||
146529710|NCT00698815|528446573|FG002|Overall Study|Withdrawal by Subject|2|||
146529711|NCT00698815|528446571|FG000|Overall Study|MD discretion|2|||
146529712|NCT00698815|528446572|FG001|Overall Study|MD discretion|7|||
146529713|NCT00698815|528446573|FG002|Overall Study|MD discretion|2|||
146529714|NCT00698815|528446571|FG000|Overall Study|Did not receive protocol treatment|1|||
146529715|NCT00698815|528446572|FG001|Overall Study|Did not receive protocol treatment|2|||
146529716|NCT00698815|528446573|FG002|Overall Study|Did not receive protocol treatment|2|||
146529717|NCT00706004|528446574|FG000|Overall Study|Did not meet eligibility criteria|2|||
146860623|NCT01585987|529659928|FG000|Randomized|Withdrawal by Subject|0|||
146860624|NCT01585987|529659929|FG001|Randomized|Withdrawal by Subject|4|||
146860625|NCT01585987|529659928|FG000|Randomized|No longer met criteria|0|||
146860626|NCT01585987|529659929|FG001|Randomized|No longer met criteria|2|||
146860627|NCT01585987|529659928|FG000|Treated|Disease Progression|39|||
146860628|NCT01585987|529659929|FG001|Treated|Disease Progression|36|||
146860629|NCT01585987|529659928|FG000|Treated|Study Drug Toxicity|9|||
146860630|NCT01585987|529659929|FG001|Treated|Study Drug Toxicity|5|||
146860631|NCT01585987|529659928|FG000|Treated|Adverse Event|3|||
146860632|NCT01585987|529659929|FG001|Treated|Adverse Event|0|||
146860633|NCT01585987|529659928|FG000|Treated|Withdrawal by Subject|1|||
146860634|NCT01585987|529659929|FG001|Treated|Withdrawal by Subject|2|||
146860635|NCT01585987|529659928|FG000|Treated|Death|1|||
146860636|NCT01585987|529659929|FG001|Treated|Death|0|||
146860637|NCT01585987|529659928|FG000|Treated|Lost to Follow-up|0|||
146860638|NCT01585987|529659929|FG001|Treated|Lost to Follow-up|1|||
146860639|NCT01585987|529659928|FG000|Treated|Maximum Clinical Benefit|0|||
146860640|NCT01585987|529659929|FG001|Treated|Maximum Clinical Benefit|1|||
146529718|NCT03575702|528446579|FG000|Overall Study|Withdrawal by Subject|1|||
146529719|NCT03575702|528446580|FG001|Overall Study|Withdrawal by Subject|1|||
146529720|NCT03575702|528446579|FG000|Overall Study|Lost to Follow-up|1|||
146529721|NCT03575702|528446580|FG001|Overall Study|Lost to Follow-up|2|||
146529722|NCT03575702|528446579|FG000|Overall Study|Protocol Violation|0|||
146529723|NCT03575702|528446580|FG001|Overall Study|Protocol Violation|1|||
146529724|NCT03575702|528446579|FG000|Overall Study|Patient non compliance|4|||
146529725|NCT03575702|528446580|FG001|Overall Study|Patient non compliance|0|||
146529726|NCT01545388|528446581|FG000|Overall Study|Adverse Event|2|||
146529727|NCT01545388|528446582|FG001|Overall Study|Adverse Event|4|||
146529728|NCT01545388|528446583|FG002|Overall Study|Adverse Event|1|||
146529729|NCT01545388|528446581|FG000|Overall Study|Lack of Efficacy|3|||
146529730|NCT01545388|528446582|FG001|Overall Study|Lack of Efficacy|2|||
146529731|NCT01545388|528446583|FG002|Overall Study|Lack of Efficacy|5|||
146529732|NCT01545388|528446581|FG000|Overall Study|Participant moved or relocated|1|||
146529733|NCT01545388|528446582|FG001|Overall Study|Participant moved or relocated|0|||
146529734|NCT01545388|528446583|FG002|Overall Study|Participant moved or relocated|0|||
146529735|NCT01545388|528446581|FG000|Overall Study|Withdrawal by Subject|1|||
146529736|NCT01545388|528446582|FG001|Overall Study|Withdrawal by Subject|4|||
146529737|NCT01545388|528446583|FG002|Overall Study|Withdrawal by Subject|2|||
146529738|NCT01545388|528446581|FG000|Overall Study|Other|1|||
146529739|NCT01545388|528446582|FG001|Overall Study|Other|1|||
146529740|NCT01545388|528446583|FG002|Overall Study|Other|0|||
146529741|NCT01900444|528446584|FG000|Overall Study|Protocol Violation|2|||
146860641|NCT01585987|529659928|FG000|Treated|Non-Specified|1|||
146860642|NCT01585987|529659929|FG001|Treated|Non-Specified|2|||
146860643|NCT01585987|529659928|FG000|Treated|Subject Request|0|||
146860644|NCT01585987|529659929|FG001|Treated|Subject Request|1|||
146529742|NCT01900444|528446584|FG000|Overall Study|Lost to Follow-up|1|||
146529743|NCT00072384|528446585|FG000|Overall Study|Physician Decision|1|||
146529744|NCT00072384|528446585|FG000|Overall Study|Ineligible|8|||
146529745|NCT01825200|528446586|FG000|Overall Study|Lost to Follow-up|5|||
146529746|NCT01825200|528446587|FG001|Overall Study|Lost to Follow-up|6|||
146529747|NCT01825200|528446586|FG000|Overall Study|Withdrawal by Subject|0|||
146860645|NCT01585987|529659928|FG000|Treated|Poor/Non-Compliance|0|||
146860646|NCT01585987|529659929|FG001|Treated|Poor/Non-Compliance|1|||
146860647|NCT02041520|529659930|FG000|Overall Study|Adverse Event|2|||
146529748|NCT01825200|528446587|FG001|Overall Study|Withdrawal by Subject|1|||
146529749|NCT01255163|528446588|FG000|Overall Study|Withdrawal by Subject|1|||
146529750|NCT01255163|528446589|FG001|Overall Study|Withdrawal by Subject|0|||
146529751|NCT01255163|528446588|FG000|Overall Study|Lost to Follow-up|2|||
146529752|NCT01255163|528446589|FG001|Overall Study|Lost to Follow-up|0|||
146529753|NCT01255163|528446588|FG000|Overall Study|Adverse Event|0|||
146529754|NCT01255163|528446589|FG001|Overall Study|Adverse Event|2|||
146529755|NCT01255163|528446588|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
146529756|NCT01255163|528446589|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
146529757|NCT00791999|528446592|FG000|Overall Study|Protocol planed withdrawal|14|||
146529758|NCT00791999|528446593|FG001|Overall Study|Protocol planed withdrawal|11|||
146529759|NCT00791999|528446594|FG002|Overall Study|Protocol planed withdrawal|11|||
146529760|NCT00791999|528446595|FG003|Overall Study|Protocol planed withdrawal|45|||
146529761|NCT00791999|528446592|FG000|Overall Study|Withdrawal by Subject|0|||
146529762|NCT00791999|528446593|FG001|Overall Study|Withdrawal by Subject|1|||
146529763|NCT00791999|528446594|FG002|Overall Study|Withdrawal by Subject|0|||
146529764|NCT00791999|528446595|FG003|Overall Study|Withdrawal by Subject|2|||
146529765|NCT00791999|528446592|FG000|Overall Study|Protocol Violation|3|||
146529766|NCT00791999|528446593|FG001|Overall Study|Protocol Violation|0|||
146529767|NCT00791999|528446594|FG002|Overall Study|Protocol Violation|1|||
146529768|NCT00791999|528446595|FG003|Overall Study|Protocol Violation|0|||
146529769|NCT00791999|528446592|FG000|Overall Study|Adverse Event|3|||
146529770|NCT00791999|528446593|FG001|Overall Study|Adverse Event|3|||
146529771|NCT00791999|528446594|FG002|Overall Study|Adverse Event|7|||
146529772|NCT00791999|528446595|FG003|Overall Study|Adverse Event|3|||
146529773|NCT00791999|528446592|FG000|Overall Study|Lack of Efficacy|0|||
146529774|NCT00791999|528446593|FG001|Overall Study|Lack of Efficacy|1|||
146529775|NCT00791999|528446594|FG002|Overall Study|Lack of Efficacy|0|||
146529776|NCT00791999|528446595|FG003|Overall Study|Lack of Efficacy|2|||
146529777|NCT00791999|528446592|FG000|Overall Study|Reason other than those above|1|||
146529778|NCT00791999|528446593|FG001|Overall Study|Reason other than those above|0|||
146529779|NCT00791999|528446594|FG002|Overall Study|Reason other than those above|1|||
146529780|NCT00791999|528446595|FG003|Overall Study|Reason other than those above|0|||
146529781|NCT00427908|528446598|FG000|Primary Phase|Lost to Follow-up|4|||
146529782|NCT00427908|528446599|FG001|Primary Phase|Lost to Follow-up|0|||
146761281|NCT02040844|529292910|FG002|Overall Study|Non-specified|5|||
146761282|NCT02040844|529292908|FG000|Overall Study|Concomitant medication|1|||
146761283|NCT02040844|529292909|FG001|Overall Study|Concomitant medication|3|||
146761284|NCT02040844|529292910|FG002|Overall Study|Concomitant medication|1|||
146761285|NCT02068885|529292915|FG000|Overall Study|Withdrew|3|||
146761286|NCT02068885|529292916|FG001|Overall Study|Withdrew|5|||
146761287|NCT02068885|529292917|FG002|Overall Study|Withdrew|8|||
146761288|NCT00681811|529292918|FG000|Overall Study|Adverse Event|1|||
146761289|NCT00681811|529292919|FG001|Overall Study|Adverse Event|1|||
146761290|NCT00681811|529292918|FG000|Overall Study|Withdrawal by Subject|2|||
146761291|NCT00681811|529292919|FG001|Overall Study|Withdrawal by Subject|2|||
146761292|NCT00681811|529292918|FG000|Overall Study|Non-compliance|0|||
146761293|NCT00681811|529292919|FG001|Overall Study|Non-compliance|1|||
146761294|NCT00828919|529292920|FG000|Overall Study|Death|0|||
146761295|NCT00828919|529292921|FG001|Overall Study|Death|1|||
146761296|NCT00828919|529292922|FG002|Overall Study|Death|2|||
146761297|NCT00828919|529292923|FG003|Overall Study|Death|0|||
146761298|NCT00828919|529292924|FG004|Overall Study|Death|0|||
146761299|NCT00828919|529292920|FG000|Overall Study|Adverse Event|2|||
146761300|NCT00828919|529292921|FG001|Overall Study|Adverse Event|2|||
146761301|NCT00828919|529292922|FG002|Overall Study|Adverse Event|2|||
146761302|NCT00828919|529292923|FG003|Overall Study|Adverse Event|1|||
146761303|NCT00828919|529292924|FG004|Overall Study|Adverse Event|3|||
146761304|NCT00828919|529292920|FG000|Overall Study|Objective progression or relapse|4|||
146761305|NCT00828919|529292921|FG001|Overall Study|Objective progression or relapse|4|||
146761306|NCT00828919|529292922|FG002|Overall Study|Objective progression or relapse|11|||
146761307|NCT00828919|529292923|FG003|Overall Study|Objective progression or relapse|0|||
146761308|NCT00828919|529292924|FG004|Overall Study|Objective progression or relapse|5|||
146761309|NCT00828919|529292920|FG000|Overall Study|No longer willing to participate in study|0|||
146761310|NCT00828919|529292921|FG001|Overall Study|No longer willing to participate in study|0|||
146761311|NCT00828919|529292922|FG002|Overall Study|No longer willing to participate in study|2|||
146761312|NCT00828919|529292923|FG003|Overall Study|No longer willing to participate in study|0|||
146761313|NCT00828919|529292924|FG004|Overall Study|No longer willing to participate in study|0|||
146529783|NCT00427908|528446600|FG002|Primary Phase|Lost to Follow-up|2|||
146529784|NCT00427908|528446601|FG003|Primary Phase|Lost to Follow-up|0|||
146529785|NCT00427908|528446598|FG000|Primary Phase|Withdrawal by Subject|1|||
146529786|NCT00427908|528446599|FG001|Primary Phase|Withdrawal by Subject|2|||
146529787|NCT00427908|528446600|FG002|Primary Phase|Withdrawal by Subject|1|||
146529788|NCT00427908|528446601|FG003|Primary Phase|Withdrawal by Subject|0|||
146529789|NCT00427908|528446598|FG000|Primary Phase|Adverse Event|0|||
146761314|NCT00828919|529292920|FG000|Overall Study|Insufficient Clinical Response|0|||
146761315|NCT00828919|529292921|FG001|Overall Study|Insufficient Clinical Response|1|||
146529790|NCT00427908|528446599|FG001|Primary Phase|Adverse Event|1|||
146529791|NCT00427908|528446600|FG002|Primary Phase|Adverse Event|0|||
146529792|NCT00427908|528446601|FG003|Primary Phase|Adverse Event|0|||
146529793|NCT04202497|528446605|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
146529794|NCT04202497|528446606|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
146529795|NCT04202497|528446607|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
146529796|NCT04202497|528446608|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
146529797|NCT04344301|528446609|FG000|Overall Study|Withdrawal by Subject|1|||
146529798|NCT04344301|528446610|FG001|Overall Study|Withdrawal by Subject|0|||
146529799|NCT04344301|528446609|FG000|Overall Study|Death|0|||
146529800|NCT04344301|528446610|FG001|Overall Study|Death|1|||
146529801|NCT00248651|528446611|FG000|Overall Study|Withdrawal by Subject|28|||
146529802|NCT00248651|528446612|FG001|Overall Study|Withdrawal by Subject|40|||
146529803|NCT00248651|528446613|FG002|Overall Study|Withdrawal by Subject|32|||
146529804|NCT01022203|528449026|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
146529805|NCT01022203|528449027|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
146529806|NCT01022203|528449026|FG000|Post Treatment Assessment|Physician Decision|2|||
146529807|NCT01022203|528449027|FG001|Post Treatment Assessment|Physician Decision|0|||
146529808|NCT01022203|528449026|FG000|Post Treatment Assessment|Adverse Event|0|||
146529809|NCT01022203|528449027|FG001|Post Treatment Assessment|Adverse Event|2|||
146529810|NCT01022203|528449026|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
146529811|NCT01022203|528449027|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
146529812|NCT03163446|528449030|FG000|Overall Study|Unable to return for Day 180 visit|2|||
146529813|NCT03163446|528449031|FG001|Overall Study|Unable to return for Day 180 visit|0|||
146529814|NCT03163446|528449030|FG000|Overall Study|Withdrawal by Subject|2|||
146529815|NCT03163446|528449031|FG001|Overall Study|Withdrawal by Subject|6|||
146529816|NCT03163446|528449030|FG000|Overall Study|Death|16|||
146529817|NCT03163446|528449031|FG001|Overall Study|Death|5|||
146529818|NCT03163446|528449030|FG000|Overall Study|Lost to Follow-up|6|||
146529819|NCT03163446|528449031|FG001|Overall Study|Lost to Follow-up|5|||
146529820|NCT03163446|528449030|FG000|Overall Study|Physician Decision|1|||
146529821|NCT03163446|528449031|FG001|Overall Study|Physician Decision|1|||
146529822|NCT03163446|528449030|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
146529823|NCT03163446|528449031|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
146529824|NCT03638128|528449032|FG000|Overall Study|Withdrawal by Subject|1|||
146529825|NCT03638128|528449033|FG001|Overall Study|Withdrawal by Subject|7|||
146529826|NCT03638128|528449034|FG002|Overall Study|Withdrawal by Subject|6|||
146529827|NCT03638128|528449032|FG000|Overall Study|Sponsor Decision|15|||
146529828|NCT03638128|528449033|FG001|Overall Study|Sponsor Decision|12|||
146529829|NCT03638128|528449034|FG002|Overall Study|Sponsor Decision|19|||
146529830|NCT03638128|528449032|FG000|Overall Study|Lost to Follow-up|0|||
146529831|NCT03638128|528449033|FG001|Overall Study|Lost to Follow-up|0|||
146529832|NCT03638128|528449034|FG002|Overall Study|Lost to Follow-up|1|||
146529833|NCT00611806|528449035|FG000|Overall Study|Withdrawal by Subject|8|||
146529834|NCT00611806|528449036|FG001|Overall Study|Withdrawal by Subject|2|||
146529835|NCT00611806|528449035|FG000|Overall Study|Adverse Event|2|||
146529836|NCT00611806|528449036|FG001|Overall Study|Adverse Event|1|||
146529837|NCT00611806|528449035|FG000|Overall Study|Lost to Follow-up|6|||
146529838|NCT00611806|528449036|FG001|Overall Study|Lost to Follow-up|0|||
146529839|NCT00329108|528449038|FG000|Overall Study|Adverse Event|2|||
146529840|NCT00329108|528449039|FG001|Overall Study|Adverse Event|2|||
146860648|NCT02041520|529659931|FG001|Overall Study|Adverse Event|1|||
146860649|NCT02041520|529659930|FG000|Overall Study|Withdrawal by Subject|3|||
146860650|NCT02041520|529659931|FG001|Overall Study|Withdrawal by Subject|4|||
146860651|NCT02041520|529659930|FG000|Overall Study|Protocol Violation|1|||
146860652|NCT02041520|529659931|FG001|Overall Study|Protocol Violation|0|||
146860653|NCT02041520|529659930|FG000|Overall Study|Lost to Follow-up|0|||
146860654|NCT02041520|529659931|FG001|Overall Study|Lost to Follow-up|1|||
146529841|NCT00329108|528449038|FG000|Overall Study|Lack of Efficacy|3|||
146529842|NCT00329108|528449039|FG001|Overall Study|Lack of Efficacy|3|||
146529843|NCT00329108|528449038|FG000|Overall Study|Withdrawal by Subject|0|||
146860655|NCT02041520|529659930|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
146860656|NCT02041520|529659931|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
146860657|NCT00413972|529659932|FG000|Overall Study|Adverse Event|2|||
146860658|NCT00413972|529659933|FG001|Overall Study|Adverse Event|1|||
146860659|NCT00413972|529659934|FG002|Overall Study|Adverse Event|0|||
146860660|NCT00413972|529659935|FG003|Overall Study|Adverse Event|0|||
146529844|NCT00329108|528449039|FG001|Overall Study|Withdrawal by Subject|2|||
146529845|NCT00329108|528449038|FG000|Overall Study|symptomatic deterioration|1|||
146529846|NCT00329108|528449039|FG001|Overall Study|symptomatic deterioration|1|||
146529847|NCT00329108|528449038|FG000|Overall Study|Subject no longer willing to participate|2|||
146860661|NCT00413972|529659932|FG000|Overall Study|Lost to Follow-up|1|||
146860662|NCT00413972|529659933|FG001|Overall Study|Lost to Follow-up|2|||
146860663|NCT00413972|529659934|FG002|Overall Study|Lost to Follow-up|1|||
146860664|NCT00413972|529659935|FG003|Overall Study|Lost to Follow-up|0|||
146965096|NCT03110107|530033434|FG008|Treatment Period|Adverse Event|0|||
146529848|NCT00329108|528449039|FG001|Overall Study|Subject no longer willing to participate|2|||
146529849|NCT00329108|528449038|FG000|Overall Study|study terminated by sponsor|1|||
146529850|NCT00329108|528449039|FG001|Overall Study|study terminated by sponsor|0|||
146529851|NCT00329108|528449038|FG000|Overall Study|withdrew patient after SAE resolved|1|||
146529852|NCT00329108|528449039|FG001|Overall Study|withdrew patient after SAE resolved|0|||
146529853|NCT00329108|528449038|FG000|Overall Study|Protocol Violation|0|||
146529854|NCT00329108|528449039|FG001|Overall Study|Protocol Violation|2|||
146529855|NCT00903201|528449040|FG000|Overall Study|Adverse Event|1|||
146529856|NCT00903201|528449041|FG001|Overall Study|Adverse Event|4|||
146761316|NCT00828919|529292922|FG002|Overall Study|Insufficient Clinical Response|2|||
146761317|NCT00828919|529292923|FG003|Overall Study|Insufficient Clinical Response|0|||
146761318|NCT00828919|529292924|FG004|Overall Study|Insufficient Clinical Response|0|||
146761319|NCT00828919|529292920|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
146761320|NCT00828919|529292921|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
146761321|NCT00828919|529292922|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
146761322|NCT00828919|529292923|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
146761323|NCT00828919|529292924|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
146761324|NCT00828919|529292920|FG000|Overall Study|Other|1|||
146761325|NCT00828919|529292921|FG001|Overall Study|Other|0|||
146761326|NCT00828919|529292922|FG002|Overall Study|Other|1|||
146761327|NCT00828919|529292923|FG003|Overall Study|Other|1|||
146761328|NCT00828919|529292924|FG004|Overall Study|Other|0|||
146761329|NCT00828919|529292920|FG000|Overall Study|Lost to Follow-up|0|||
146761330|NCT00828919|529292921|FG001|Overall Study|Lost to Follow-up|1|||
146761331|NCT00828919|529292922|FG002|Overall Study|Lost to Follow-up|0|||
146761332|NCT00828919|529292923|FG003|Overall Study|Lost to Follow-up|0|||
146761333|NCT00828919|529292924|FG004|Overall Study|Lost to Follow-up|0|||
146761334|NCT05567159|529292925|FG000|Overall Study|Adverse Event|4|||
146761335|NCT05567159|529292925|FG000|Overall Study|Physician Decision|3|||
146761336|NCT05567159|529292925|FG000|Overall Study|Protocol deviation|1|||
146761337|NCT02501811|529292927|FG000|Overall Study|Death|1|||
146761338|NCT02501811|529292928|FG001|Overall Study|Death|3|||
146761339|NCT02501811|529292929|FG002|Overall Study|Death|2|||
146761340|NCT02501811|529292930|FG003|Overall Study|Death|3|||
146761341|NCT02501811|529292927|FG000|Overall Study|Withdrawal by Subject|3|||
146761342|NCT02501811|529292928|FG001|Overall Study|Withdrawal by Subject|3|||
146761343|NCT02501811|529292929|FG002|Overall Study|Withdrawal by Subject|2|||
146761344|NCT02501811|529292930|FG003|Overall Study|Withdrawal by Subject|3|||
146761345|NCT02501811|529292927|FG000|Overall Study|Lost to Follow-up|0|||
146761346|NCT02501811|529292928|FG001|Overall Study|Lost to Follow-up|0|||
146761347|NCT02501811|529292929|FG002|Overall Study|Lost to Follow-up|2|||
146761348|NCT02501811|529292930|FG003|Overall Study|Lost to Follow-up|1|||
146761349|NCT01311648|529295147|FG000|Main Study|Protocol Violation|0|||
146761350|NCT01311648|529295148|FG001|Main Study|Protocol Violation|1|||
146761351|NCT01311648|529295147|FG000|Main Study|Adverse Event|0|||
146761352|NCT01311648|529295148|FG001|Main Study|Adverse Event|1|||
146761353|NCT01311648|529295147|FG000|Main Study|Inhibitor management|0|||
146761354|NCT01311648|529295148|FG001|Main Study|Inhibitor management|17|||
146761355|NCT01311648|529295147|FG000|Main Study|Withdrawal by Subject|0|||
146761356|NCT01311648|529295148|FG001|Main Study|Withdrawal by Subject|2|||
146761357|NCT01311648|529295147|FG000|Extension Study|Physician Decision|0|||
146761358|NCT01311648|529295148|FG001|Extension Study|Physician Decision|1|||
146761359|NCT01311648|529295147|FG000|Extension Study|ITI therapy with marketed product|0|||
146761360|NCT01311648|529295148|FG001|Extension Study|ITI therapy with marketed product|1|||
146761361|NCT01311648|529295147|FG000|Extension Study|Incorrect visit planning|0|||
146761362|NCT01311648|529295148|FG001|Extension Study|Incorrect visit planning|1|||
146761363|NCT01311648|529295147|FG000|Extension Study|Family's decision|0|||
146761364|NCT01311648|529295148|FG001|Extension Study|Family's decision|1|||
146761365|NCT01311648|529295147|FG000|Extension Study|Failure of ITI therapy|0|||
146761366|NCT01311648|529295148|FG001|Extension Study|Failure of ITI therapy|3|||
146761367|NCT01311648|529295147|FG000|Extension Study|Long travel|0|||
146761368|NCT01311648|529295148|FG001|Extension Study|Long travel|1|||
146761369|NCT01311648|529295147|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
146761370|NCT01311648|529295148|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
146761371|NCT01311648|529295147|FG000|Extension Study|Withdrawal by Subject|0|||
146761372|NCT01311648|529295148|FG001|Extension Study|Withdrawal by Subject|1|||
146761373|NCT01311648|529295147|FG000|Extension Study|Inhibitor management|0|||
146761374|NCT01311648|529295148|FG001|Extension Study|Inhibitor management|2|||
146761375|NCT01107626|529295151|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
146761376|NCT01107626|529295152|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
146529857|NCT00903201|528449042|FG002|Overall Study|Adverse Event|0|||
146761377|NCT01107626|529295153|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
146761378|NCT01107626|529295154|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
146761379|NCT01107626|529295151|FG000|Step 1: Induction Therapy|Adverse Event|198|||
146860665|NCT00413972|529659932|FG000|Overall Study|Withdrawal by Subject|4|||
146860666|NCT00413972|529659933|FG001|Overall Study|Withdrawal by Subject|5|||
146860667|NCT00413972|529659934|FG002|Overall Study|Withdrawal by Subject|7|||
146860668|NCT00413972|529659935|FG003|Overall Study|Withdrawal by Subject|2|||
146860669|NCT00413972|529659932|FG000|Overall Study|Protocol Violation|0|||
146860670|NCT00413972|529659933|FG001|Overall Study|Protocol Violation|0|||
146860671|NCT00413972|529659934|FG002|Overall Study|Protocol Violation|2|||
146860672|NCT00413972|529659935|FG003|Overall Study|Protocol Violation|0|||
146860673|NCT00413972|529659932|FG000|Overall Study|Other|0|||
146860674|NCT00413972|529659933|FG001|Overall Study|Other|0|||
146860675|NCT00413972|529659934|FG002|Overall Study|Other|0|||
146860676|NCT00413972|529659935|FG003|Overall Study|Other|1|||
146860677|NCT02520284|529659936|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
146860678|NCT02520284|529659937|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
146860679|NCT02520284|529659938|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
146860680|NCT02520284|529659936|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
146860681|NCT02520284|529659937|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
146860682|NCT02520284|529659938|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
146860683|NCT02520284|529659936|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
146860684|NCT02520284|529659937|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
146860685|NCT02520284|529659938|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
146860686|NCT02520284|529659936|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
146860687|NCT02520284|529659937|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
146860688|NCT02520284|529659938|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
146860689|NCT02520284|529659936|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
146860690|NCT02520284|529659937|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
146860691|NCT02520284|529659938|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
146860692|NCT02520284|529659936|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
146860693|NCT02520284|529659937|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
146860694|NCT02520284|529659938|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
146860695|NCT02520284|529659936|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
146860696|NCT02520284|529659937|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
146860697|NCT02520284|529659938|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
146860698|NCT02520284|529659936|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
146860699|NCT02520284|529659937|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
146860700|NCT02520284|529659938|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
146860701|NCT02520284|529659936|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
146860702|NCT02520284|529659937|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
146860703|NCT02520284|529659938|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
146860704|NCT02520284|529659936|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
146860705|NCT02520284|529659937|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
146860706|NCT02520284|529659938|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
146860707|NCT02520284|529659936|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
146860708|NCT02520284|529659937|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
146860709|NCT02520284|529659938|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
146860710|NCT01898923|529659939|FG000|Overall Study|Lack of Efficacy|5|||
146860711|NCT01898923|529659940|FG001|Overall Study|Lack of Efficacy|6|||
146860712|NCT01898923|529659939|FG000|Overall Study|Adverse Event|3|||
146860713|NCT01898923|529659940|FG001|Overall Study|Adverse Event|1|||
146860714|NCT01898923|529659939|FG000|Overall Study|Lost to Follow-up|0|||
146860715|NCT01898923|529659940|FG001|Overall Study|Lost to Follow-up|1|||
146860716|NCT01898923|529659939|FG000|Overall Study|Withdrawal by Subject|4|||
146860717|NCT01898923|529659940|FG001|Overall Study|Withdrawal by Subject|7|||
146860718|NCT01898923|529659939|FG000|Overall Study|Physician Decision|3|||
146860719|NCT01898923|529659940|FG001|Overall Study|Physician Decision|4|||
146860720|NCT01898923|529659939|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
146860721|NCT01898923|529659940|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
146860722|NCT02678247|529659941|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
146860723|NCT02678247|529659942|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
146860724|NCT02678247|529659941|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
146860725|NCT02678247|529659942|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
146860726|NCT02678247|529659941|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
146860727|NCT02678247|529659942|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
146860728|NCT02678247|529659941|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
146860729|NCT02678247|529659942|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
146860730|NCT02678247|529659941|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
146860731|NCT02678247|529659942|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
146860732|NCT02678247|529659941|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
146860733|NCT02678247|529659942|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
146860734|NCT02739360|529659946|FG000|Overall Study|Adverse Event|1|||
146860735|NCT02739360|529659946|FG000|Overall Study|Study terminated by Sponsor|2|||
146860736|NCT01163916|529659947|FG000|Overall Study|Withdrawal by Subject|2|||
146860737|NCT01163916|529659948|FG001|Overall Study|Withdrawal by Subject|0|||
146860738|NCT01163916|529659949|FG002|Overall Study|Withdrawal by Subject|2|||
146860739|NCT01163916|529659947|FG000|Overall Study|Adverse Event|2|||
146860740|NCT01163916|529659948|FG001|Overall Study|Adverse Event|0|||
146860741|NCT01163916|529659949|FG002|Overall Study|Adverse Event|1|||
146860742|NCT01163916|529659947|FG000|Overall Study|Lack of Efficacy|2|||
146529858|NCT00903201|528449040|FG000|Overall Study|Protocol Violation|2|||
146860743|NCT01163916|529659948|FG001|Overall Study|Lack of Efficacy|0|||
146860744|NCT01163916|529659949|FG002|Overall Study|Lack of Efficacy|1|||
146860745|NCT01163916|529659947|FG000|Overall Study|Other|24|||
146860746|NCT01163916|529659948|FG001|Overall Study|Other|4|||
146860747|NCT01163916|529659949|FG002|Overall Study|Other|16|||
146860748|NCT00026208|529659950|FG000|Overall Study|Complications of auto accident|1|||
146860749|NCT00026208|529659951|FG001|Overall Study|Complications of auto accident|0|||
146860750|NCT00423930|529659953|FG000|Overall Study|Withdrawal by Subject|2|||
146860751|NCT02903368|529659956|FG000|Part 1|Adverse Event|3|||
146860752|NCT02903368|529659957|FG001|Part 1|Adverse Event|0|||
146860753|NCT02903368|529659958|FG002|Part 1|Adverse Event|0|||
146860754|NCT02903368|529659959|FG003|Part 1|Adverse Event|0|||
146860755|NCT02903368|529659956|FG000|Part 1|Withdrawal by Subject|1|||
146860756|NCT02903368|529659957|FG001|Part 1|Withdrawal by Subject|0|||
146860757|NCT02903368|529659958|FG002|Part 1|Withdrawal by Subject|0|||
146860758|NCT02903368|529659959|FG003|Part 1|Withdrawal by Subject|0|||
146860759|NCT02903368|529659956|FG000|Part 2|Adverse Event|0|||
146860760|NCT02903368|529659957|FG001|Part 2|Adverse Event|0|||
146860761|NCT02903368|529659958|FG002|Part 2|Adverse Event|5|||
146860762|NCT02903368|529659959|FG003|Part 2|Adverse Event|0|||
146860763|NCT02903368|529659956|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
146860764|NCT02903368|529659957|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
146860765|NCT02903368|529659958|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
146860766|NCT02903368|529659959|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
146860767|NCT02903368|529659956|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
146860768|NCT02903368|529659957|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
146860769|NCT02903368|529659958|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
146860770|NCT02903368|529659959|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
146860771|NCT02903368|529659956|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
146860772|NCT02903368|529659957|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
146860773|NCT02903368|529659958|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
146860774|NCT02903368|529659959|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
146860775|NCT06515483|529659960|FG000|Overall Study|Subject withdraw due to family issues|1|||
146860776|NCT06515483|529659961|FG001|Overall Study|Subject withdraw due to family issues|0|||
146860777|NCT00147823|529659962|FG000|Overall Study|Lost to Follow-up|6|||
146860778|NCT00147823|529659963|FG001|Overall Study|Lost to Follow-up|12|||
146860779|NCT00147823|529659962|FG000|Overall Study|Physician Decision|1|||
146860780|NCT00147823|529659963|FG001|Overall Study|Physician Decision|0|||
146860781|NCT00147823|529659962|FG000|Overall Study|Withdrawal by Subject|0|||
146860782|NCT00147823|529659963|FG001|Overall Study|Withdrawal by Subject|1|||
146860783|NCT00147823|529659962|FG000|Overall Study|Did not receive vitoss due to infection|6|||
146860784|NCT00147823|529659963|FG001|Overall Study|Did not receive vitoss due to infection|2|||
146860785|NCT05677893|529662436|FG000|Overall Study|Withdrawal by Subject|0|||
146860786|NCT05677893|529662437|FG001|Overall Study|Withdrawal by Subject|0|||
146860787|NCT05677893|529662438|FG002|Overall Study|Withdrawal by Subject|0|||
146860788|NCT05677893|529662439|FG003|Overall Study|Withdrawal by Subject|0|||
146860789|NCT05677893|529662440|FG004|Overall Study|Withdrawal by Subject|1|||
146860790|NCT05677893|529662441|FG005|Overall Study|Withdrawal by Subject|1|||
146860791|NCT05677893|529662442|FG006|Overall Study|Withdrawal by Subject|0|||
146860792|NCT05677893|529662436|FG000|Overall Study|Others|1|||
146529859|NCT00903201|528449041|FG001|Overall Study|Protocol Violation|1|||
146529860|NCT00903201|528449042|FG002|Overall Study|Protocol Violation|0|||
146860793|NCT05677893|529662437|FG001|Overall Study|Others|0|||
146529861|NCT00903201|528449040|FG000|Overall Study|Lost to Follow-up|0|||
146860794|NCT05677893|529662438|FG002|Overall Study|Others|0|||
146860795|NCT05677893|529662439|FG003|Overall Study|Others|0|||
146860796|NCT05677893|529662440|FG004|Overall Study|Others|0|||
146860797|NCT05677893|529662441|FG005|Overall Study|Others|0|||
146860798|NCT05677893|529662442|FG006|Overall Study|Others|0|||
146860799|NCT03217266|529662443|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
146860800|NCT03217266|529662444|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
146860801|NCT03217266|529662445|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
146860802|NCT03217266|529662446|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
146860803|NCT03217266|529662443|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
146860804|NCT03217266|529662444|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
146860805|NCT03217266|529662445|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
146860806|NCT03217266|529662446|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
146860807|NCT03217266|529662443|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
146860808|NCT03217266|529662444|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
146860809|NCT03217266|529662445|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
146860810|NCT03217266|529662446|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
146860811|NCT02101034|529662447|FG000|Overall Study|Enrolled but did not start treatment|0|||
146860812|NCT02101034|529662448|FG001|Overall Study|Enrolled but did not start treatment|0|||
146860813|NCT02101034|529662449|FG002|Overall Study|Enrolled but did not start treatment|1|||
146860814|NCT02101034|529662450|FG003|Overall Study|Enrolled but did not start treatment|0|||
146860815|NCT02101034|529662451|FG004|Overall Study|Enrolled but did not start treatment|0|||
146860816|NCT01390181|529662452|FG000|Overall Study|Lost to Follow-up|1|||
146860817|NCT01390181|529662452|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
146860818|NCT01101477|529662463|FG000|Overall Study|Protocol Violation|5|||
146860819|NCT01101477|529662464|FG001|Overall Study|Protocol Violation|3|||
146860820|NCT01101477|529662465|FG002|Overall Study|Protocol Violation|1|||
146860821|NCT00720941|529662466|FG000|Overall Study|Protocol Violation|1|||
146860822|NCT00720941|529662467|FG001|Overall Study|Protocol Violation|2|||
146860823|NCT00720941|529662466|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
146860824|NCT00720941|529662467|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
146860825|NCT00720941|529662466|FG000|Overall Study|Lost to Follow-up|20|||
146860826|NCT00720941|529662467|FG001|Overall Study|Lost to Follow-up|15|||
146860827|NCT00720941|529662466|FG000|Overall Study|Physician Decision|14|||
146860828|NCT00720941|529662467|FG001|Overall Study|Physician Decision|12|||
146860829|NCT00720941|529662466|FG000|Overall Study|Withdrawal by Subject|29|||
146529862|NCT00903201|528449041|FG001|Overall Study|Lost to Follow-up|1|||
146529863|NCT00903201|528449042|FG002|Overall Study|Lost to Follow-up|0|||
146529864|NCT00903201|528449040|FG000|Overall Study|Physician Decision|1|||
146529865|NCT00903201|528449041|FG001|Overall Study|Physician Decision|0|||
146529866|NCT00903201|528449042|FG002|Overall Study|Physician Decision|1|||
146529867|NCT00903201|528449040|FG000|Overall Study|Withdrawal by Subject|1|||
146529868|NCT00903201|528449041|FG001|Overall Study|Withdrawal by Subject|0|||
146529869|NCT00903201|528449042|FG002|Overall Study|Withdrawal by Subject|1|||
146529870|NCT01094288|528449045|FG000|Overall Study|Adverse Event|0|||
146529871|NCT01094288|528449046|FG001|Overall Study|Adverse Event|3|||
146761380|NCT01107626|529295152|FG001|Step 1: Induction Therapy|Adverse Event|0|||
146761381|NCT01107626|529295153|FG002|Step 1: Induction Therapy|Adverse Event|0|||
146761382|NCT01107626|529295154|FG003|Step 1: Induction Therapy|Adverse Event|0|||
146761383|NCT01107626|529295151|FG000|Step 1: Induction Therapy|Death|62|||
146761384|NCT01107626|529295152|FG001|Step 1: Induction Therapy|Death|0|||
146761385|NCT01107626|529295153|FG002|Step 1: Induction Therapy|Death|0|||
146761386|NCT01107626|529295154|FG003|Step 1: Induction Therapy|Death|0|||
146761387|NCT01107626|529295151|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
146761388|NCT01107626|529295152|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
146761389|NCT01107626|529295153|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
146761390|NCT01107626|529295154|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
146761391|NCT01107626|529295151|FG000|Step 1: Induction Therapy|Complicating disease|13|||
146761392|NCT01107626|529295152|FG001|Step 1: Induction Therapy|Complicating disease|0|||
146761393|NCT01107626|529295153|FG002|Step 1: Induction Therapy|Complicating disease|0|||
146761394|NCT01107626|529295154|FG003|Step 1: Induction Therapy|Complicating disease|0|||
146761395|NCT01107626|529295151|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
146761396|NCT01107626|529295152|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
146761397|NCT01107626|529295153|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
146761398|NCT01107626|529295154|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
146761399|NCT01107626|529295151|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
146761400|NCT01107626|529295152|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
146761401|NCT01107626|529295153|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
146761402|NCT01107626|529295154|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
146860830|NCT00720941|529662467|FG001|Overall Study|Withdrawal by Subject|36|||
146860831|NCT02544217|529662468|FG000|Overall Study|Withdrawal by Subject|1|||
146860832|NCT02544217|529662469|FG001|Overall Study|Withdrawal by Subject|1|||
146529872|NCT01094288|528449047|FG002|Overall Study|Adverse Event|1|||
146761403|NCT01107626|529295151|FG000|Step 1: Induction Therapy|Non-compliance|4|||
146761404|NCT01107626|529295152|FG001|Step 1: Induction Therapy|Non-compliance|0|||
146761405|NCT01107626|529295153|FG002|Step 1: Induction Therapy|Non-compliance|0|||
146529873|NCT01094288|528449048|FG003|Overall Study|Adverse Event|1|||
146529874|NCT01094288|528449049|FG004|Overall Study|Adverse Event|0|||
146529875|NCT01094288|528449050|FG005|Overall Study|Adverse Event|0|||
146529876|NCT01094288|528449051|FG006|Overall Study|Adverse Event|0|||
146529877|NCT01094288|528449052|FG007|Overall Study|Adverse Event|0|||
146529878|NCT01094288|528449045|FG000|Overall Study|Withdrawal by Subject|0|||
146529879|NCT01094288|528449046|FG001|Overall Study|Withdrawal by Subject|1|||
146529880|NCT01094288|528449047|FG002|Overall Study|Withdrawal by Subject|2|||
146529881|NCT01094288|528449048|FG003|Overall Study|Withdrawal by Subject|0|||
146529882|NCT01094288|528449049|FG004|Overall Study|Withdrawal by Subject|0|||
146529883|NCT01094288|528449050|FG005|Overall Study|Withdrawal by Subject|0|||
146529884|NCT01094288|528449051|FG006|Overall Study|Withdrawal by Subject|0|||
146529885|NCT01094288|528449052|FG007|Overall Study|Withdrawal by Subject|2|||
146529886|NCT01094288|528449045|FG000|Overall Study|Initiation of Alternative Therapy|0|||
146529887|NCT01094288|528449046|FG001|Overall Study|Initiation of Alternative Therapy|0|||
146529888|NCT01094288|528449047|FG002|Overall Study|Initiation of Alternative Therapy|1|||
146529889|NCT01094288|528449048|FG003|Overall Study|Initiation of Alternative Therapy|0|||
146529890|NCT01094288|528449049|FG004|Overall Study|Initiation of Alternative Therapy|0|||
146529891|NCT01094288|528449050|FG005|Overall Study|Initiation of Alternative Therapy|0|||
146761406|NCT01107626|529295154|FG003|Step 1: Induction Therapy|Non-compliance|0|||
146761407|NCT01107626|529295151|FG000|Step 1: Induction Therapy|Pain|4|||
146761408|NCT01107626|529295152|FG001|Step 1: Induction Therapy|Pain|0|||
146761409|NCT01107626|529295153|FG002|Step 1: Induction Therapy|Pain|0|||
146761410|NCT01107626|529295154|FG003|Step 1: Induction Therapy|Pain|0|||
146761411|NCT01107626|529295151|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
146761412|NCT01107626|529295152|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
146761413|NCT01107626|529295153|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
146761414|NCT01107626|529295154|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
146761415|NCT01107626|529295151|FG000|Step 1: Induction Therapy|Hospice care|1|||
146761416|NCT01107626|529295152|FG001|Step 1: Induction Therapy|Hospice care|0|||
146761417|NCT01107626|529295153|FG002|Step 1: Induction Therapy|Hospice care|0|||
146761418|NCT01107626|529295154|FG003|Step 1: Induction Therapy|Hospice care|0|||
146761419|NCT01107626|529295151|FG000|Step 1: Induction Therapy|Physician Decision|1|||
146761420|NCT01107626|529295152|FG001|Step 1: Induction Therapy|Physician Decision|0|||
146761421|NCT01107626|529295153|FG002|Step 1: Induction Therapy|Physician Decision|0|||
146761422|NCT01107626|529295154|FG003|Step 1: Induction Therapy|Physician Decision|0|||
146761423|NCT01107626|529295151|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
146761424|NCT01107626|529295152|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
146761425|NCT01107626|529295153|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
146761426|NCT01107626|529295154|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
146761427|NCT01107626|529295151|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
146761428|NCT01107626|529295152|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
146761429|NCT01107626|529295153|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
146761430|NCT01107626|529295154|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
146761431|NCT01107626|529295151|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
146761432|NCT01107626|529295152|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
146761433|NCT01107626|529295153|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
146761434|NCT01107626|529295154|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
146761435|NCT01107626|529295151|FG000|Step 2: Maintenance Therapy|Death|0|||
146761436|NCT01107626|529295152|FG001|Step 2: Maintenance Therapy|Death|8|||
146761437|NCT01107626|529295153|FG002|Step 2: Maintenance Therapy|Death|2|||
146761438|NCT01107626|529295154|FG003|Step 2: Maintenance Therapy|Death|13|||
146761439|NCT01107626|529295151|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
146761440|NCT01107626|529295152|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
146761441|NCT01107626|529295153|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
146761442|NCT01107626|529295154|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
146761443|NCT01107626|529295151|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
146761444|NCT01107626|529295152|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
146761445|NCT01107626|529295153|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
146761446|NCT01107626|529295154|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
146761447|NCT01107626|529295151|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
146761448|NCT01107626|529295152|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
146761449|NCT01107626|529295153|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
146761450|NCT01107626|529295154|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
146761451|NCT01107626|529295151|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
146761452|NCT01107626|529295152|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
146761453|NCT01107626|529295153|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
146761454|NCT01107626|529295154|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
146761455|NCT01107626|529295151|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
146761456|NCT01107626|529295152|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
146761457|NCT01107626|529295153|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
146965097|NCT03110107|530033435|FG009|Treatment Period|Adverse Event|1|||
146529892|NCT01094288|528449051|FG006|Overall Study|Initiation of Alternative Therapy|0|||
146529893|NCT01094288|528449052|FG007|Overall Study|Initiation of Alternative Therapy|0|||
146529894|NCT01094288|528449045|FG000|Overall Study|Reason not Specified|2|||
146860833|NCT02544217|529662470|FG002|Overall Study|Withdrawal by Subject|0|||
146860834|NCT02544217|529662471|FG003|Overall Study|Withdrawal by Subject|0|||
146860835|NCT02544217|529662472|FG004|Overall Study|Withdrawal by Subject|0|||
146860836|NCT02544217|529662473|FG005|Overall Study|Withdrawal by Subject|0|||
146860837|NCT00667355|529662475|FG000|Overall Study|Adverse Event|5|||
146860838|NCT00667355|529662475|FG000|Overall Study|Lost to Follow-up|1|||
146860839|NCT00667355|529662475|FG000|Overall Study|Other reason was not specified|5|||
146860840|NCT00937833|529662476|FG000|Overall Study|Protocol Violation|1|||
146860841|NCT00937833|529662477|FG001|Overall Study|Protocol Violation|2|||
146860842|NCT00937833|529662476|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
146860843|NCT00937833|529662477|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
146860844|NCT00937833|529662476|FG000|Overall Study|Lost to Follow-up|10|||
146860845|NCT00937833|529662477|FG001|Overall Study|Lost to Follow-up|8|||
146860846|NCT00937833|529662476|FG000|Overall Study|Withdrawal by Subject|4|||
146860847|NCT00937833|529662477|FG001|Overall Study|Withdrawal by Subject|6|||
146860848|NCT02175004|529662478|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
146860849|NCT02175004|529662479|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
146860850|NCT02175004|529662478|FG000|Overall Study|Investigator Judgment|1|||
146860851|NCT02175004|529662479|FG001|Overall Study|Investigator Judgment|4|||
146860852|NCT02175004|529662478|FG000|Overall Study|Voluntary Withdrawal|6|||
146860853|NCT02175004|529662479|FG001|Overall Study|Voluntary Withdrawal|19|||
146860854|NCT02175004|529662478|FG000|Overall Study|Liver Transplant|1|||
146860855|NCT02175004|529662479|FG001|Overall Study|Liver Transplant|0|||
146860856|NCT02175004|529662478|FG000|Overall Study|Disease Progression|1|||
146860857|NCT02175004|529662479|FG001|Overall Study|Disease Progression|0|||
146860858|NCT02175004|529662478|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
146860859|NCT02175004|529662479|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
146860860|NCT00162032|529662480|FG000|Overall Study|Lost to Follow-up|4|||
146860861|NCT00162032|529662481|FG001|Overall Study|Lost to Follow-up|2|||
146860862|NCT00162032|529662480|FG000|Overall Study|Reason not specified|1|||
146860863|NCT00162032|529662481|FG001|Overall Study|Reason not specified|0|||
146860864|NCT00818389|529662482|FG000|Overall Study|Death|1|||
146860865|NCT00818389|529662483|FG001|Overall Study|Death|3|||
146860866|NCT00818389|529662482|FG000|Overall Study|ALS Disease Progression|1|||
146860867|NCT00818389|529662483|FG001|Overall Study|ALS Disease Progression|0|||
146860868|NCT00818389|529662482|FG000|Overall Study|Withdrawal by Subject|2|||
146761458|NCT01107626|529295154|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
146761459|NCT01107626|529295151|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
146761460|NCT01107626|529295152|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
146761461|NCT01107626|529295153|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
146761462|NCT01107626|529295154|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
146761463|NCT01107626|529295151|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
146761464|NCT01107626|529295152|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
146761465|NCT01107626|529295153|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
146761466|NCT01107626|529295154|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
146761467|NCT01107626|529295151|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
146761468|NCT01107626|529295152|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
146761469|NCT01107626|529295153|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
146761470|NCT01107626|529295154|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
146761471|NCT01107626|529295151|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
146761472|NCT01107626|529295152|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
146761473|NCT01107626|529295153|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
146761474|NCT01107626|529295154|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
146761475|NCT01107626|529295151|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
146761476|NCT01107626|529295152|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
146761477|NCT01107626|529295153|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
146761478|NCT01107626|529295154|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
146761479|NCT01107626|529295151|FG000|Step 2: Maintenance Therapy|Pain|0|||
146761480|NCT01107626|529295152|FG001|Step 2: Maintenance Therapy|Pain|0|||
146761481|NCT01107626|529295153|FG002|Step 2: Maintenance Therapy|Pain|0|||
146761482|NCT01107626|529295154|FG003|Step 2: Maintenance Therapy|Pain|1|||
146761483|NCT01107626|529295151|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
146761484|NCT01107626|529295152|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
146860869|NCT00818389|529662483|FG001|Overall Study|Withdrawal by Subject|2|||
146860870|NCT00818389|529662482|FG000|Overall Study|Adverse Event|0|||
146860871|NCT00818389|529662483|FG001|Overall Study|Adverse Event|1|||
146529895|NCT01094288|528449046|FG001|Overall Study|Reason not Specified|3|||
146761485|NCT01107626|529295153|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
146761486|NCT01107626|529295154|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
146860872|NCT04263909|529662484|FG000|Overall Study|Physician Decision|1|||
146860873|NCT04263909|529662485|FG001|Overall Study|Physician Decision|0|||
146860874|NCT04263909|529662486|FG002|Overall Study|Physician Decision|0|||
146860875|NCT04263909|529662484|FG000|Overall Study|Adverse Event|3|||
146860876|NCT04263909|529662485|FG001|Overall Study|Adverse Event|0|||
146860877|NCT04263909|529662486|FG002|Overall Study|Adverse Event|0|||
146860878|NCT04263909|529662484|FG000|Overall Study|Protocol Violation|5|||
146860879|NCT04263909|529662485|FG001|Overall Study|Protocol Violation|0|||
146860880|NCT04263909|529662486|FG002|Overall Study|Protocol Violation|0|||
146860881|NCT05193500|529662487|FG000|Overall Study|Withdrawal by Subject|7|||
146860882|NCT05193500|529662488|FG001|Overall Study|Withdrawal by Subject|4|||
146860883|NCT05193500|529662489|FG002|Overall Study|Withdrawal by Subject|3|||
146860884|NCT05193500|529662490|FG003|Overall Study|Withdrawal by Subject|5|||
146860885|NCT03840486|529662491|FG000|Overall Study|Withdrawal by Subject|0|||
146860886|NCT03840486|529662492|FG001|Overall Study|Withdrawal by Subject|1|||
146860887|NCT03840486|529662493|FG002|Overall Study|Withdrawal by Subject|0|||
146860888|NCT03840486|529662494|FG003|Overall Study|Withdrawal by Subject|0|||
146860889|NCT03840486|529662495|FG004|Overall Study|Withdrawal by Subject|0|||
146860890|NCT03840486|529662496|FG005|Overall Study|Withdrawal by Subject|0|||
146860891|NCT03840486|529662497|FG006|Overall Study|Withdrawal by Subject|0|||
146860892|NCT03840486|529662498|FG007|Overall Study|Withdrawal by Subject|0|||
146860893|NCT03840486|529662499|FG008|Overall Study|Withdrawal by Subject|0|||
146860894|NCT03840486|529662500|FG009|Overall Study|Withdrawal by Subject|0|||
146860895|NCT03840486|529662501|FG010|Overall Study|Withdrawal by Subject|0|||
146860896|NCT03840486|529662502|FG011|Overall Study|Withdrawal by Subject|0|||
146860897|NCT04442737|529662505|FG000|Overall Study|Lost to Follow-up|1|||
146860898|NCT04442737|529662506|FG001|Overall Study|Lost to Follow-up|3|||
146860899|NCT04442737|529662505|FG000|Overall Study|Withdrawal by Subject|3|||
146860900|NCT04442737|529662506|FG001|Overall Study|Withdrawal by Subject|2|||
146860901|NCT04442737|529662505|FG000|Overall Study|Adverse Event|3|||
146860902|NCT04442737|529662506|FG001|Overall Study|Adverse Event|2|||
146860903|NCT04442737|529662505|FG000|Overall Study|Death|0|||
146860904|NCT04442737|529662506|FG001|Overall Study|Death|1|||
146860905|NCT04442737|529662505|FG000|Overall Study|Protocol Violation|0|||
146860906|NCT04442737|529662506|FG001|Overall Study|Protocol Violation|2|||
146860907|NCT04442737|529662505|FG000|Overall Study|Other|1|||
146860908|NCT04442737|529662506|FG001|Overall Study|Other|1|||
146860909|NCT02027701|529662510|FG000|Overall Study|Adverse Event|3|||
146860910|NCT02027701|529662510|FG000|Overall Study|Lack of Efficacy|8|||
146860911|NCT02027701|529662510|FG000|Overall Study|Physician Decision|2|||
146860912|NCT02027701|529662510|FG000|Overall Study|Withdrawal by Subject|3|||
146860913|NCT00756470|529662511|FG000|Overall Study|Withdrawal by Subject|1|||
146860914|NCT00756470|529662511|FG000|Overall Study|Adverse Event|4|||
146860915|NCT00820027|529662512|FG000|Overall Study|Adverse Event|15|||
146529896|NCT01094288|528449047|FG002|Overall Study|Reason not Specified|0|||
146529897|NCT01094288|528449048|FG003|Overall Study|Reason not Specified|1|||
146529898|NCT01094288|528449049|FG004|Overall Study|Reason not Specified|0|||
146529899|NCT01094288|528449050|FG005|Overall Study|Reason not Specified|0|||
146529900|NCT01094288|528449051|FG006|Overall Study|Reason not Specified|0|||
146529901|NCT01094288|528449052|FG007|Overall Study|Reason not Specified|0|||
146529902|NCT01094288|528449045|FG000|Overall Study|Ongoing Participants|0|||
146529903|NCT01094288|528449046|FG001|Overall Study|Ongoing Participants|3|||
146529904|NCT01094288|528449047|FG002|Overall Study|Ongoing Participants|0|||
146529905|NCT01094288|528449048|FG003|Overall Study|Ongoing Participants|0|||
146529906|NCT01094288|528449049|FG004|Overall Study|Ongoing Participants|0|||
146529907|NCT01094288|528449050|FG005|Overall Study|Ongoing Participants|0|||
146529908|NCT01094288|528449051|FG006|Overall Study|Ongoing Participants|0|||
146529909|NCT01094288|528449052|FG007|Overall Study|Ongoing Participants|0|||
146529910|NCT02611882|528449053|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
146529911|NCT02611882|528449054|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
146529912|NCT02611882|528449055|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
146529913|NCT01389232|528449056|FG000|Overall Study|Had scaffold removed|15|||
146529914|NCT01389232|528449056|FG000|Overall Study|Personal reasons|2|||
146529915|NCT01389232|528449056|FG000|Overall Study|Adverse Event|1|||
146529916|NCT01389232|528449056|FG000|Overall Study|Death|1|||
146529917|NCT01317940|528449057|FG000|Overall Study|Death|1|||
146529918|NCT01317940|528449058|FG001|Overall Study|Death|0|||
146529919|NCT01317940|528449059|FG002|Overall Study|Death|1|||
146529920|NCT01317940|528449060|FG003|Overall Study|Death|0|||
146529921|NCT01317940|528449061|FG004|Overall Study|Death|0|||
146529922|NCT01317940|528449062|FG005|Overall Study|Death|0|||
146860916|NCT00820027|529662513|FG001|Overall Study|Adverse Event|8|||
146860917|NCT00820027|529662514|FG002|Overall Study|Adverse Event|10|||
146860918|NCT00820027|529662515|FG003|Overall Study|Adverse Event|5|||
146529923|NCT01317940|528449057|FG000|Overall Study|Lost to Follow-up|0|||
146529924|NCT01317940|528449058|FG001|Overall Study|Lost to Follow-up|0|||
146529925|NCT01317940|528449059|FG002|Overall Study|Lost to Follow-up|1|||
146860919|NCT00820027|529662512|FG000|Overall Study|Lack of Efficacy|2|||
146860920|NCT00820027|529662513|FG001|Overall Study|Lack of Efficacy|1|||
146860921|NCT00820027|529662514|FG002|Overall Study|Lack of Efficacy|2|||
146860922|NCT00820027|529662515|FG003|Overall Study|Lack of Efficacy|2|||
146860923|NCT00820027|529662512|FG000|Overall Study|Physician Decision|0|||
146860924|NCT00820027|529662513|FG001|Overall Study|Physician Decision|1|||
146860925|NCT00820027|529662514|FG002|Overall Study|Physician Decision|1|||
146860926|NCT00820027|529662515|FG003|Overall Study|Physician Decision|0|||
146860927|NCT00820027|529662512|FG000|Overall Study|Protocol Violation|3|||
146860928|NCT00820027|529662513|FG001|Overall Study|Protocol Violation|0|||
146860929|NCT00820027|529662514|FG002|Overall Study|Protocol Violation|4|||
146860930|NCT00820027|529662515|FG003|Overall Study|Protocol Violation|0|||
146860931|NCT00820027|529662512|FG000|Overall Study|Withdrawal by Subject|6|||
146860932|NCT00820027|529662513|FG001|Overall Study|Withdrawal by Subject|4|||
146860933|NCT00820027|529662514|FG002|Overall Study|Withdrawal by Subject|4|||
146860934|NCT00820027|529662515|FG003|Overall Study|Withdrawal by Subject|6|||
146860935|NCT02982187|529662516|FG000|Overall Study|Withdrawal by Subject|0|||
146860936|NCT02982187|529662517|FG001|Overall Study|Withdrawal by Subject|0|||
146860937|NCT02982187|529662518|FG002|Overall Study|Withdrawal by Subject|0|||
146860938|NCT02982187|529662519|FG003|Overall Study|Withdrawal by Subject|0|||
146860939|NCT02982187|529662520|FG004|Overall Study|Withdrawal by Subject|0|||
146860940|NCT02982187|529662521|FG005|Overall Study|Withdrawal by Subject|0|||
146860941|NCT02982187|529662522|FG006|Overall Study|Withdrawal by Subject|1|||
146860942|NCT02982187|529662523|FG007|Overall Study|Withdrawal by Subject|0|||
146860943|NCT01978262|529662524|FG000|Overall Study|Withdrawal by Subject|9|||
146860944|NCT01978262|529662524|FG000|Overall Study|Lost to Follow-up|2|||
146860945|NCT02604433|529662525|FG000|Overall Study|Withdrawal by Subject|37|||
146860946|NCT02604433|529662526|FG001|Overall Study|Withdrawal by Subject|16|||
146860947|NCT02604433|529662525|FG000|Overall Study|Adverse Event|4|||
146860948|NCT02604433|529662526|FG001|Overall Study|Adverse Event|0|||
146860949|NCT02604433|529662525|FG000|Overall Study|Other reasons|3|||
146860950|NCT02604433|529662526|FG001|Overall Study|Other reasons|5|||
146860951|NCT02604433|529662525|FG000|Overall Study|Death|4|||
146860952|NCT02604433|529662526|FG001|Overall Study|Death|1|||
146860953|NCT02604433|529662525|FG000|Overall Study|Transition to Rollover Protocol|169|||
146860954|NCT02604433|529662526|FG001|Overall Study|Transition to Rollover Protocol|82|||
146860955|NCT02604433|529662525|FG000|Overall Study|Physician Decision|1|||
146860956|NCT02604433|529662526|FG001|Overall Study|Physician Decision|1|||
146860957|NCT02604433|529662525|FG000|Overall Study|Lack of Efficacy|0|||
146860958|NCT02604433|529662526|FG001|Overall Study|Lack of Efficacy|1|||
146860959|NCT03285178|529662527|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
146860960|NCT03285178|529662528|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
146860961|NCT03285178|529662529|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
146860962|NCT03285178|529662530|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
146860963|NCT03285178|529662531|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
146860964|NCT03285178|529662532|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
146860965|NCT03285178|529662533|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
146860966|NCT03285178|529662527|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
146860967|NCT03285178|529662528|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
146860968|NCT03285178|529662529|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
146860969|NCT03285178|529662530|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
146860970|NCT03285178|529662531|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
146860971|NCT03285178|529662532|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
146860972|NCT03285178|529662533|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
146860973|NCT03285178|529662527|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
146860974|NCT03285178|529662528|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
146860975|NCT03285178|529662529|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
146860976|NCT03285178|529662530|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
146860977|NCT03285178|529662531|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
146860978|NCT03285178|529662532|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
146860979|NCT03285178|529662533|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
146529926|NCT01317940|528449060|FG003|Overall Study|Lost to Follow-up|1|||
146529927|NCT01317940|528449061|FG004|Overall Study|Lost to Follow-up|1|||
146860980|NCT03285178|529662527|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
146860981|NCT03285178|529662528|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
146860982|NCT03285178|529662529|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
146860983|NCT03285178|529662530|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
146529928|NCT01317940|528449062|FG005|Overall Study|Lost to Follow-up|0|||
146860984|NCT03285178|529662531|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
146860985|NCT03285178|529662532|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
146860986|NCT03285178|529662533|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
146860987|NCT03285178|529662527|FG000|Single-Blind Run-In Period|Physician Decision|2|||
146860988|NCT03285178|529662528|FG001|Single-Blind Run-In Period|Physician Decision|0|||
146860989|NCT03285178|529662529|FG002|Single-Blind Run-In Period|Physician Decision|0|||
146860990|NCT03285178|529662530|FG003|Single-Blind Run-In Period|Physician Decision|0|||
146860991|NCT03285178|529662531|FG004|Single-Blind Run-In Period|Physician Decision|0|||
146860992|NCT03285178|529662532|FG005|Single-Blind Run-In Period|Physician Decision|0|||
146860993|NCT03285178|529662533|FG006|Single-Blind Run-In Period|Physician Decision|0|||
146860994|NCT03285178|529662527|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
146860995|NCT03285178|529662528|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
146860996|NCT03285178|529662529|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
146860997|NCT03285178|529662530|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
146860998|NCT03285178|529662531|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
146860999|NCT03285178|529662532|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
146861000|NCT03285178|529662533|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
146861001|NCT03285178|529662527|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146861002|NCT03285178|529662528|FG001|Double-Blind Treatment Period|Adverse Event|0|||
146861003|NCT03285178|529662529|FG002|Double-Blind Treatment Period|Adverse Event|0|||
146861004|NCT03285178|529662530|FG003|Double-Blind Treatment Period|Adverse Event|0|||
146861005|NCT03285178|529662531|FG004|Double-Blind Treatment Period|Adverse Event|0|||
146861006|NCT03285178|529662532|FG005|Double-Blind Treatment Period|Adverse Event|0|||
146861007|NCT03285178|529662533|FG006|Double-Blind Treatment Period|Adverse Event|2|||
146861008|NCT03285178|529662527|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146861009|NCT03285178|529662528|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
146861010|NCT03285178|529662529|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
146861011|NCT03285178|529662530|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
146861012|NCT03285178|529662531|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
146861013|NCT03285178|529662532|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
146861014|NCT03285178|529662533|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
146861015|NCT03285178|529662527|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146861016|NCT03285178|529662528|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146861017|NCT03285178|529662529|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146861018|NCT03285178|529662530|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146861019|NCT03285178|529662531|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146861020|NCT03285178|529662532|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
146861021|NCT03285178|529662533|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146861022|NCT03285178|529662527|FG000|Double-Blind Treatment Period|COVID-19|0|||
146861023|NCT03285178|529662528|FG001|Double-Blind Treatment Period|COVID-19|0|||
146861024|NCT03285178|529662529|FG002|Double-Blind Treatment Period|COVID-19|1|||
146861025|NCT03285178|529662530|FG003|Double-Blind Treatment Period|COVID-19|0|||
146861026|NCT03285178|529662531|FG004|Double-Blind Treatment Period|COVID-19|0|||
146861027|NCT03285178|529662532|FG005|Double-Blind Treatment Period|COVID-19|0|||
146861028|NCT03285178|529662533|FG006|Double-Blind Treatment Period|COVID-19|0|||
146861029|NCT01388790|529662534|FG000|Overall Study|Ongoing at data cut-off date|8|||
146861030|NCT01128894|529662535|FG000|Overall Study|Adverse Event|31|||
146861031|NCT01128894|529662536|FG001|Overall Study|Adverse Event|41|||
146861032|NCT01128894|529662535|FG000|Overall Study|Protocol Violation|2|||
146861033|NCT01128894|529662536|FG001|Overall Study|Protocol Violation|1|||
146861034|NCT01128894|529662535|FG000|Overall Study|Noncompliance|4|||
146861035|NCT01128894|529662536|FG001|Overall Study|Noncompliance|5|||
146861036|NCT01128894|529662535|FG000|Overall Study|Lost to Follow-up|8|||
146861037|NCT01128894|529662536|FG001|Overall Study|Lost to Follow-up|8|||
146861038|NCT01128894|529662535|FG000|Overall Study|Withdrawal by Subject|10|||
146861039|NCT01128894|529662536|FG001|Overall Study|Withdrawal by Subject|12|||
146861040|NCT01128894|529662535|FG000|Overall Study|Physician Decision|2|||
146861041|NCT01128894|529662536|FG001|Overall Study|Physician Decision|1|||
146861042|NCT01128894|529662535|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
146529929|NCT01317940|528449057|FG000|Overall Study|Change in therapy plan|0|||
146529930|NCT01317940|528449058|FG001|Overall Study|Change in therapy plan|0|||
146529931|NCT01317940|528449059|FG002|Overall Study|Change in therapy plan|3|||
146529932|NCT01317940|528449060|FG003|Overall Study|Change in therapy plan|0|||
146861043|NCT01128894|529662536|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
146861044|NCT03437278|529662537|FG000|Overall Study|Adverse Event|0|||
146861045|NCT03437278|529662538|FG001|Overall Study|Adverse Event|0|||
146529933|NCT01317940|528449061|FG004|Overall Study|Change in therapy plan|0|||
146861046|NCT03437278|529662539|FG002|Overall Study|Adverse Event|1|||
146861047|NCT03437278|529662537|FG000|Overall Study|Progressive disease|1|||
146861048|NCT03437278|529662538|FG001|Overall Study|Progressive disease|0|||
146861049|NCT03437278|529662539|FG002|Overall Study|Progressive disease|0|||
146861050|NCT03437278|529662537|FG000|Overall Study|Physician Decision|1|||
146861051|NCT03437278|529662538|FG001|Overall Study|Physician Decision|0|||
146861052|NCT03437278|529662539|FG002|Overall Study|Physician Decision|1|||
146861053|NCT01128738|529662540|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
146861054|NCT01128738|529662541|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
146861055|NCT01128738|529662540|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
146861056|NCT01128738|529662541|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
146861057|NCT01128738|529662540|FG000|Second TP|Lost to Follow-up|0|||
146861058|NCT01128738|529662541|FG001|Second TP|Lost to Follow-up|1|||
146861059|NCT01128738|529662540|FG000|Second TP|Withdrawal by Subject|0|||
146861060|NCT01128738|529662541|FG001|Second TP|Withdrawal by Subject|2|||
146529934|NCT01317940|528449062|FG005|Overall Study|Change in therapy plan|0|||
146529935|NCT00945243|528449064|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
146529936|NCT03256578|528449065|FG000|Overall Study|Excluded Post Randomization|66|||
146529937|NCT03256578|528449066|FG001|Overall Study|Excluded Post Randomization|56|||
146861061|NCT00973362|529662542|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
146861062|NCT00973362|529662543|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
146861063|NCT00973362|529662542|FG000|Baseline Evaluation|No colposcopy visit|62|||
146861064|NCT00973362|529662543|FG001|Baseline Evaluation|No colposcopy visit|0|||
146861065|NCT00973362|529662542|FG000|Baseline Evaluation|Inevaluable|686|||
146861066|NCT00973362|529662543|FG001|Baseline Evaluation|Inevaluable|223|||
146861067|NCT00973362|529662542|FG000|3-Year Follow-up|Lost to Follow-up|17|||
146861068|NCT00973362|529662543|FG001|3-Year Follow-up|Lost to Follow-up|0|||
146861069|NCT05116046|529662544|FG000|Overall Study|Withdrawal by parent/guardian|2|||
146861070|NCT05116046|529662545|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146861071|NCT05116046|529662546|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146861072|NCT05116046|529662544|FG000|Overall Study|Study terminated by sponsor|14|||
146861073|NCT05116046|529662545|FG001|Overall Study|Study terminated by sponsor|16|||
146861074|NCT05116046|529662546|FG002|Overall Study|Study terminated by sponsor|1|||
146861075|NCT02974088|529662547|FG000|Overall Study|Lost to Follow-up|0|||
146861076|NCT02974088|529662548|FG001|Overall Study|Lost to Follow-up|2|||
146861077|NCT02974088|529662547|FG000|Overall Study|Adverse Event|0|||
146861078|NCT02974088|529662548|FG001|Overall Study|Adverse Event|1|||
146861079|NCT00150969|529662549|FG000|24 Month Main Study|Adverse Event|3|||
146861080|NCT00150969|529662550|FG001|24 Month Main Study|Adverse Event|4|||
146861081|NCT00150969|529662549|FG000|24 Month Main Study|Death|1|||
146861082|NCT00150969|529662550|FG001|24 Month Main Study|Death|1|||
146861083|NCT00150969|529662549|FG000|24 Month Main Study|Lack of Efficacy|1|||
146861084|NCT00150969|529662550|FG001|24 Month Main Study|Lack of Efficacy|8|||
146861085|NCT00150969|529662549|FG000|24 Month Main Study|Lost to Follow-up|3|||
146861086|NCT00150969|529662550|FG001|24 Month Main Study|Lost to Follow-up|2|||
146861087|NCT00150969|529662549|FG000|24 Month Main Study|Protocol Violation|4|||
146861088|NCT00150969|529662550|FG001|24 Month Main Study|Protocol Violation|2|||
146861089|NCT00150969|529662549|FG000|24 Month Main Study|Withdrawal by Subject|7|||
146861090|NCT00150969|529662550|FG001|24 Month Main Study|Withdrawal by Subject|4|||
146861091|NCT00150969|529662549|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
146861092|NCT00150969|529662550|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
146861093|NCT00150969|529662549|FG000|24-48 Month Extension|Lack of Efficacy|0|||
146861094|NCT00150969|529662550|FG001|24-48 Month Extension|Lack of Efficacy|1|||
146861095|NCT00150969|529662549|FG000|24-48 Month Extension|Adverse Event|1|||
146861096|NCT00150969|529662550|FG001|24-48 Month Extension|Adverse Event|3|||
146861097|NCT00150969|529662549|FG000|24-48 Month Extension|Other Reason|81|||
146861098|NCT00150969|529662550|FG001|24-48 Month Extension|Other Reason|91|||
146529938|NCT02371616|528449067|FG000|Overall Study|Protocol Violation|2|||
146529939|NCT02371616|528449068|FG001|Overall Study|Protocol Violation|1|||
146529940|NCT02371616|528449067|FG000|Overall Study|Adverse Event|0|||
146529941|NCT02371616|528449068|FG001|Overall Study|Adverse Event|1|||
146529942|NCT02371616|528449067|FG000|Overall Study|Withdrawal of Consent|1|||
146529943|NCT02371616|528449068|FG001|Overall Study|Withdrawal of Consent|0|||
146529944|NCT02371616|528449067|FG000|Overall Study|Other (Not specified)|1|||
146529945|NCT02371616|528449068|FG001|Overall Study|Other (Not specified)|5|||
146529946|NCT02486692|528449071|FG000|Overall Study|did not login for randomization|4|||
146529947|NCT02486692|528449072|FG001|Overall Study|did not login for randomization|7|||
146861099|NCT00146757|529662551|FG000|Overall Study|Death|1|||
146861100|NCT00146757|529662552|FG001|Overall Study|Death|0|||
146861101|NCT00146757|529662551|FG000|Overall Study|Adverse Event|1|||
146529948|NCT03353792|528449090|FG000|Overall Study|Lost to Follow-up|1|||
146861102|NCT00146757|529662552|FG001|Overall Study|Adverse Event|0|||
146861103|NCT02893930|529662558|FG000|Overall Study|Adverse Event|3|||
146861104|NCT02893930|529662558|FG000|Overall Study|Death|1|||
146861105|NCT02893930|529662558|FG000|Overall Study|Disease progression|5|||
146861106|NCT02893930|529662558|FG000|Overall Study|Withdrawal by Subject|2|||
146861107|NCT02893930|529662558|FG000|Overall Study|Physician Decision|1|||
146861108|NCT02893930|529662558|FG000|Overall Study|Ineligible|1|||
146861109|NCT02349360|529662559|FG000|Overall Study|Withdrawal by Subject|0|||
146861110|NCT02349360|529662560|FG001|Overall Study|Withdrawal by Subject|1|||
146861111|NCT01498289|529662569|FG000|Overall Study|Adverse Event|16|||
146861112|NCT01498289|529662570|FG001|Overall Study|Adverse Event|18|||
146861113|NCT01498289|529662569|FG000|Overall Study|Death|6|||
146861114|NCT01498289|529662570|FG001|Overall Study|Death|8|||
146861115|NCT01498289|529662569|FG000|Overall Study|Withdrawal unrelated to AE|16|||
146861116|NCT01498289|529662570|FG001|Overall Study|Withdrawal unrelated to AE|16|||
146861117|NCT01498289|529662569|FG000|Overall Study|Progression/relapse|53|||
146861118|NCT01498289|529662570|FG001|Overall Study|Progression/relapse|59|||
146861119|NCT01498289|529662569|FG000|Overall Study|Not protocol specified|7|||
146861120|NCT01498289|529662570|FG001|Overall Study|Not protocol specified|2|||
146861121|NCT01498289|529662569|FG000|Overall Study|Reason under review|0|||
146861122|NCT01498289|529662570|FG001|Overall Study|Reason under review|1|||
146861123|NCT01423253|529662571|FG000|Overall Study|Adverse Event|2|||
146861124|NCT01423253|529662571|FG000|Overall Study|Lack of Efficacy|2|||
146861125|NCT01423253|529662571|FG000|Overall Study|Lost to Follow-up|1|||
146861126|NCT01423253|529662571|FG000|Overall Study|Protocol Violation|2|||
146861127|NCT01423253|529662571|FG000|Overall Study|Withdrawal by Subject|2|||
146861128|NCT02804178|529662572|FG000|Overall Study|Adverse Event|1|||
146861129|NCT01290601|529662573|FG000|Overall Study|Adverse Event|0|||
146861130|NCT01290601|529662574|FG001|Overall Study|Adverse Event|2|||
146861131|NCT01290601|529662575|FG002|Overall Study|Adverse Event|0|||
146861132|NCT01290601|529662576|FG003|Overall Study|Adverse Event|0|||
146861133|NCT01290601|529662573|FG000|Overall Study|Lack of Efficacy|2|||
146861134|NCT01290601|529662574|FG001|Overall Study|Lack of Efficacy|1|||
146861135|NCT01290601|529662575|FG002|Overall Study|Lack of Efficacy|0|||
146861136|NCT01290601|529662576|FG003|Overall Study|Lack of Efficacy|0|||
146861137|NCT01290601|529662573|FG000|Overall Study|Lost to Follow-up|7|||
146861138|NCT01290601|529662574|FG001|Overall Study|Lost to Follow-up|2|||
146861139|NCT01290601|529662575|FG002|Overall Study|Lost to Follow-up|0|||
146861140|NCT01290601|529662576|FG003|Overall Study|Lost to Follow-up|0|||
146861141|NCT01290601|529662573|FG000|Overall Study|Other|1|||
146861142|NCT01290601|529662574|FG001|Overall Study|Other|0|||
146861143|NCT01290601|529662575|FG002|Overall Study|Other|0|||
146861144|NCT01290601|529662576|FG003|Overall Study|Other|0|||
146861145|NCT01290601|529662573|FG000|Overall Study|Protocol Violation|1|||
146861146|NCT01290601|529662574|FG001|Overall Study|Protocol Violation|0|||
146861147|NCT01290601|529662575|FG002|Overall Study|Protocol Violation|0|||
146861148|NCT01290601|529662576|FG003|Overall Study|Protocol Violation|0|||
146861149|NCT00421707|529662584|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
146861150|NCT00421707|529662585|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
146861151|NCT00421707|529662584|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
146861152|NCT00421707|529662585|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
146861153|NCT00421707|529662584|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
146861154|NCT00421707|529662585|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
146861155|NCT00421707|529662584|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
146861156|NCT00421707|529662585|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
146861157|NCT00421707|529662584|FG000|Period 2: Washout|Adverse Event|1|||
146861158|NCT00421707|529662585|FG001|Period 2: Washout|Adverse Event|1|||
146861159|NCT00421707|529662584|FG000|Period 2: Washout|Withdrawal by Subject|0|||
146861160|NCT00421707|529662585|FG001|Period 2: Washout|Withdrawal by Subject|1|||
146861161|NCT00421707|529662584|FG000|Period 2: Washout|Lost to Follow-up|0|||
146861162|NCT00421707|529662585|FG001|Period 2: Washout|Lost to Follow-up|1|||
146861163|NCT00421707|529662584|FG000|Period 2: Washout|Other: Pregnancy|0|||
146861164|NCT00421707|529662585|FG001|Period 2: Washout|Other: Pregnancy|1|||
146861165|NCT00421707|529662584|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
146529949|NCT03353792|528449091|FG001|Overall Study|Lost to Follow-up|0|||
146529950|NCT03353792|528449090|FG000|Overall Study|Participant Unable to Manage Device|1|||
146529951|NCT03353792|528449091|FG001|Overall Study|Participant Unable to Manage Device|0|||
146529952|NCT00536510|528449094|FG000|Overall Study|Adverse Event|27|||
146529953|NCT00536510|528449095|FG001|Overall Study|Adverse Event|4|||
146529954|NCT00536510|528449094|FG000|Overall Study|Lost to Follow-up|11|||
146529955|NCT00536510|528449095|FG001|Overall Study|Lost to Follow-up|8|||
146861166|NCT00421707|529662585|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
146861167|NCT00421707|529662584|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
146861168|NCT00421707|529662585|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
146529956|NCT00536510|528449094|FG000|Overall Study|Protocol Violation|4|||
146861169|NCT00421707|529662584|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
146861170|NCT00421707|529662585|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
146861171|NCT01948908|529662588|FG000|Overall Study|Protocol Violation|1|||
146861172|NCT01948908|529662589|FG001|Overall Study|Protocol Violation|0|||
146861173|NCT01948908|529662590|FG002|Overall Study|Protocol Violation|2|||
146861174|NCT01759407|529662594|FG000|Overall Study|Protocol Violation|0|||
146861175|NCT01759407|529662595|FG001|Overall Study|Protocol Violation|2|||
146861176|NCT02225353|529662597|FG000|Overall Study|Lost to Follow-up|0|||
146861177|NCT02225353|529662598|FG001|Overall Study|Lost to Follow-up|1|||
146861178|NCT02225353|529662599|FG002|Overall Study|Lost to Follow-up|3|||
146861179|NCT02225353|529662597|FG000|Overall Study|Protocol Violation|4|||
146861180|NCT02225353|529662598|FG001|Overall Study|Protocol Violation|5|||
146861181|NCT02225353|529662599|FG002|Overall Study|Protocol Violation|12|||
146861182|NCT02910739|529662600|FG000|Overall Study|Adverse Event|1|||
146861183|NCT02910739|529662601|FG001|Overall Study|Adverse Event|0|||
146861184|NCT02910739|529662602|FG002|Overall Study|Adverse Event|0|||
146861185|NCT02910739|529662603|FG003|Overall Study|Adverse Event|0|||
146861186|NCT04223856|529662606|FG000|Overall Study|Progressive disease|153|||
146861187|NCT04223856|529662607|FG001|Overall Study|Progressive disease|73|||
146529957|NCT00536510|528449095|FG001|Overall Study|Protocol Violation|5|||
146529958|NCT00536510|528449094|FG000|Overall Study|Withdrawal by Subject|16|||
146529959|NCT00536510|528449095|FG001|Overall Study|Withdrawal by Subject|9|||
146529960|NCT00536510|528449094|FG000|Overall Study|Flushing with Product|20|||
146529961|NCT00536510|528449095|FG001|Overall Study|Flushing with Product|0|||
146529962|NCT00536510|528449094|FG000|Overall Study|Laboratory Adverse Event|2|||
146529963|NCT00536510|528449095|FG001|Overall Study|Laboratory Adverse Event|1|||
146761487|NCT03467724|529295156|FG000|Overall Study|Lost to Follow-up|5|||
146761488|NCT03467724|529295156|FG000|Overall Study|Withdrawal by Subject|1|||
146761489|NCT03467724|529295156|FG000|Overall Study|Protocol Violation|1|||
146761490|NCT03467724|529295156|FG000|Overall Study|Adverse Event|1|||
146761491|NCT04310579|529295163|FG000|Overall Study|Adverse Event|0|||
146761492|NCT04310579|529295164|FG001|Overall Study|Adverse Event|0|||
146761493|NCT04310579|529295165|FG002|Overall Study|Adverse Event|0|||
146761494|NCT04310579|529295166|FG003|Overall Study|Adverse Event|0|||
146761495|NCT04310579|529295167|FG004|Overall Study|Adverse Event|0|||
146761496|NCT04310579|529295168|FG005|Overall Study|Adverse Event|0|||
146761497|NCT04310579|529295169|FG006|Overall Study|Adverse Event|2|||
146761498|NCT04310579|529295170|FG007|Overall Study|Adverse Event|0|||
146761499|NCT04310579|529295171|FG008|Overall Study|Adverse Event|1|||
146761500|NCT04310579|529295172|FG009|Overall Study|Adverse Event|1|||
146761501|NCT04310579|529295173|FG010|Overall Study|Adverse Event|0|||
146761502|NCT04310579|529295163|FG000|Overall Study|Withdrawal by Subject|0|||
146761503|NCT04310579|529295164|FG001|Overall Study|Withdrawal by Subject|0|||
146761504|NCT04310579|529295165|FG002|Overall Study|Withdrawal by Subject|0|||
146761505|NCT04310579|529295166|FG003|Overall Study|Withdrawal by Subject|0|||
146761506|NCT04310579|529295167|FG004|Overall Study|Withdrawal by Subject|0|||
146761507|NCT04310579|529295168|FG005|Overall Study|Withdrawal by Subject|1|||
146761508|NCT04310579|529295169|FG006|Overall Study|Withdrawal by Subject|0|||
146761509|NCT04310579|529295170|FG007|Overall Study|Withdrawal by Subject|0|||
146761510|NCT04310579|529295171|FG008|Overall Study|Withdrawal by Subject|0|||
146761511|NCT04310579|529295172|FG009|Overall Study|Withdrawal by Subject|0|||
146761512|NCT04310579|529295173|FG010|Overall Study|Withdrawal by Subject|0|||
146761513|NCT04310579|529295163|FG000|Overall Study|Positive COVID-19 test|0|||
146761514|NCT04310579|529295164|FG001|Overall Study|Positive COVID-19 test|0|||
146761515|NCT04310579|529295165|FG002|Overall Study|Positive COVID-19 test|0|||
146761516|NCT04310579|529295166|FG003|Overall Study|Positive COVID-19 test|0|||
146761517|NCT04310579|529295167|FG004|Overall Study|Positive COVID-19 test|0|||
146761518|NCT04310579|529295168|FG005|Overall Study|Positive COVID-19 test|0|||
146761519|NCT04310579|529295169|FG006|Overall Study|Positive COVID-19 test|0|||
146761520|NCT04310579|529295170|FG007|Overall Study|Positive COVID-19 test|0|||
146761521|NCT04310579|529295171|FG008|Overall Study|Positive COVID-19 test|0|||
146761522|NCT04310579|529295172|FG009|Overall Study|Positive COVID-19 test|0|||
146761523|NCT04310579|529295173|FG010|Overall Study|Positive COVID-19 test|1|||
146761524|NCT02236559|529295177|FG000|Overall Study|Met Exclusion|3|||
146761525|NCT02236559|529295178|FG001|Overall Study|Met Exclusion|6|||
146761526|NCT02236559|529295177|FG000|Overall Study|Did not Meet Inclusion|3|||
146761527|NCT02236559|529295178|FG001|Overall Study|Did not Meet Inclusion|3|||
146761528|NCT02236559|529295177|FG000|Overall Study|Subject Did Not Consent|4|||
146761529|NCT02236559|529295178|FG001|Overall Study|Subject Did Not Consent|2|||
146761530|NCT02236559|529295177|FG000|Overall Study|Physician Decision|1|||
146761531|NCT02236559|529295178|FG001|Overall Study|Physician Decision|1|||
146529964|NCT00536510|528449094|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
146761532|NCT02236559|529295177|FG000|Overall Study|Withdrawal by Subject|1|||
146761533|NCT02236559|529295178|FG001|Overall Study|Withdrawal by Subject|0|||
146761534|NCT02049866|529295179|FG000|Overall Study|Withdrawal by Subject|1|||
146761535|NCT01117480|529295180|FG000|Overall Study|Protocol Violation|8|||
146761536|NCT01117480|529295180|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
146761537|NCT03721016|529295181|FG000|Overall Study|Adverse Event|0|||
146761538|NCT03721016|529295182|FG001|Overall Study|Adverse Event|1|||
146761539|NCT03721016|529295183|FG002|Overall Study|Adverse Event|1|||
146761540|NCT03721016|529295181|FG000|Overall Study|Withdrawal by Subject|8|||
146761541|NCT03721016|529295182|FG001|Overall Study|Withdrawal by Subject|16|||
146861188|NCT04223856|529662606|FG000|Overall Study|Adverse Event|97|||
146861189|NCT04223856|529662607|FG001|Overall Study|Adverse Event|62|||
146529965|NCT00536510|528449095|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
146529966|NCT01249417|528449096|FG000|Randomised Population|Study treatment not received|0|||
146529967|NCT01249417|528449097|FG001|Randomised Population|Study treatment not received|0|||
146529968|NCT01249417|528449098|FG002|Randomised Population|Study treatment not received|2|||
146529969|NCT01249417|528449096|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
146529970|NCT01249417|528449097|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
146529971|NCT01249417|528449098|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
146529972|NCT01249417|528449096|FG000|Treatment Phase - ITT Population|Other|0|||
146529973|NCT01249417|528449097|FG001|Treatment Phase - ITT Population|Other|0|||
146529974|NCT01249417|528449098|FG002|Treatment Phase - ITT Population|Other|1|||
146529975|NCT01249417|528449096|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
146529976|NCT01249417|528449097|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
146529977|NCT01249417|528449098|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
146529978|NCT01249417|528449096|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
146529979|NCT01249417|528449097|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
146529980|NCT01249417|528449098|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
146529981|NCT01249417|528449096|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
146529982|NCT01249417|528449097|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
146529983|NCT01249417|528449098|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
146761542|NCT03721016|529295183|FG002|Overall Study|Withdrawal by Subject|13|||
146761543|NCT03721016|529295181|FG000|Overall Study|Lost to Follow-up|4|||
146761544|NCT03721016|529295182|FG001|Overall Study|Lost to Follow-up|6|||
146761545|NCT03721016|529295183|FG002|Overall Study|Lost to Follow-up|5|||
146761546|NCT03721016|529295181|FG000|Overall Study|Physician Decision|0|||
146761547|NCT03721016|529295182|FG001|Overall Study|Physician Decision|1|||
146761548|NCT03721016|529295183|FG002|Overall Study|Physician Decision|2|||
146761549|NCT03721016|529295181|FG000|Overall Study|Protocol Violation|0|||
146761550|NCT03721016|529295182|FG001|Overall Study|Protocol Violation|1|||
146761551|NCT03721016|529295183|FG002|Overall Study|Protocol Violation|0|||
146761552|NCT03721016|529295181|FG000|Overall Study|Site terminated by sponsor|3|||
146761553|NCT03721016|529295182|FG001|Overall Study|Site terminated by sponsor|7|||
146761554|NCT03721016|529295183|FG002|Overall Study|Site terminated by sponsor|6|||
146761555|NCT03721016|529295181|FG000|Overall Study|Subject exited early due to COVID-19|1|||
146761556|NCT03721016|529295182|FG001|Overall Study|Subject exited early due to COVID-19|0|||
146761557|NCT03721016|529295183|FG002|Overall Study|Subject exited early due to COVID-19|0|||
146761558|NCT02232178|529295187|FG000|Overall Study|Lost to Follow-up|0|||
146761559|NCT02232178|529295188|FG001|Overall Study|Lost to Follow-up|1|||
146761560|NCT02232178|529295189|FG002|Overall Study|Lost to Follow-up|0|||
146761561|NCT02232178|529295187|FG000|Overall Study|ineligibility|0|||
146761562|NCT02232178|529295188|FG001|Overall Study|ineligibility|0|||
146761563|NCT02232178|529295189|FG002|Overall Study|ineligibility|1|||
146761564|NCT02232178|529295187|FG000|Overall Study|surgical complication|1|||
146761565|NCT02232178|529295188|FG001|Overall Study|surgical complication|0|||
146761566|NCT02232178|529295189|FG002|Overall Study|surgical complication|0|||
146761567|NCT00817635|529295190|FG000|Overall Study|Adverse Event|1|||
146761568|NCT00817635|529295191|FG001|Overall Study|Adverse Event|0|||
146761569|NCT00817635|529295192|FG002|Overall Study|Adverse Event|0|||
146761570|NCT00817635|529295193|FG003|Overall Study|Adverse Event|1|||
146761571|NCT00817635|529295194|FG004|Overall Study|Adverse Event|1|||
146761572|NCT00817635|529295190|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
146761573|NCT00817635|529295191|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
146761574|NCT00817635|529295192|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
146761575|NCT00817635|529295193|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
146761576|NCT00817635|529295194|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
146761577|NCT00817635|529295190|FG000|Overall Study|Withdrawal by Subject|2|||
146761578|NCT00817635|529295191|FG001|Overall Study|Withdrawal by Subject|1|||
146761579|NCT00817635|529295192|FG002|Overall Study|Withdrawal by Subject|0|||
146761580|NCT00817635|529295193|FG003|Overall Study|Withdrawal by Subject|1|||
146761581|NCT00817635|529295194|FG004|Overall Study|Withdrawal by Subject|2|||
146761582|NCT00817635|529295190|FG000|Overall Study|Lost to Follow-up|0|||
146761583|NCT00817635|529295191|FG001|Overall Study|Lost to Follow-up|1|||
146761584|NCT00817635|529295192|FG002|Overall Study|Lost to Follow-up|0|||
146761585|NCT00817635|529295193|FG003|Overall Study|Lost to Follow-up|1|||
146761586|NCT00817635|529295194|FG004|Overall Study|Lost to Follow-up|0|||
146761587|NCT00817635|529295190|FG000|Overall Study|Administrative Problems|0|||
146761588|NCT00817635|529295191|FG001|Overall Study|Administrative Problems|0|||
146761589|NCT00817635|529295192|FG002|Overall Study|Administrative Problems|0|||
146761590|NCT00817635|529295193|FG003|Overall Study|Administrative Problems|0|||
146761591|NCT00817635|529295194|FG004|Overall Study|Administrative Problems|1|||
146761592|NCT00817635|529295190|FG000|Overall Study|Protocol Violation|5|||
146761593|NCT00817635|529295191|FG001|Overall Study|Protocol Violation|1|||
146761594|NCT00817635|529295192|FG002|Overall Study|Protocol Violation|3|||
146761595|NCT00817635|529295193|FG003|Overall Study|Protocol Violation|2|||
146861190|NCT04223856|529662606|FG000|Overall Study|Physician Decision|9|||
146861191|NCT04223856|529662607|FG001|Overall Study|Physician Decision|28|||
146861192|NCT04223856|529662606|FG000|Overall Study|Withdrawal by Subject|22|||
146861193|NCT04223856|529662607|FG001|Overall Study|Withdrawal by Subject|24|||
146861194|NCT04223856|529662606|FG000|Overall Study|Other|7|||
146861195|NCT04223856|529662607|FG001|Overall Study|Other|2|||
146861196|NCT04223856|529662606|FG000|Overall Study|Randomized but not treated|2|||
146861197|NCT04223856|529662607|FG001|Overall Study|Randomized but not treated|11|||
146861198|NCT04223856|529662606|FG000|Overall Study|On-treatment|144|||
146861199|NCT04223856|529662607|FG001|Overall Study|On-treatment|0|||
146861200|NCT03226275|529662608|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
146861201|NCT03226275|529662609|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
146861202|NCT03226275|529662610|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
146529984|NCT01783743|528449099|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
146529985|NCT01783743|528449100|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
146529986|NCT01783743|528449099|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
146529987|NCT01783743|528449100|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
146529988|NCT01783743|528449099|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
146529989|NCT01783743|528449100|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
146529990|NCT05556148|528449101|FG000|Overall Study|Early Termination|29|||
146529991|NCT05556148|528449101|FG000|Overall Study|Baseline Tasks Expired|4|||
146529992|NCT05556148|528449101|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
146529993|NCT05556148|528449101|FG000|Overall Study|No Longer Wished to Participate|1|||
146529994|NCT05556148|528449101|FG000|Overall Study|Bacterial Conjunctivitis|1|||
146529995|NCT00728494|528449114|FG000|Overall Study|Adverse Event|7|||
146529996|NCT00728494|528449115|FG001|Overall Study|Adverse Event|0|||
146529997|NCT00728494|528449114|FG000|Overall Study|Withdrawal by Subject|0|||
146529998|NCT00728494|528449115|FG001|Overall Study|Withdrawal by Subject|2|||
146529999|NCT00728494|528449114|FG000|Overall Study|Lack of Efficacy|2|||
146530000|NCT00728494|528449115|FG001|Overall Study|Lack of Efficacy|4|||
146530001|NCT00728494|528449114|FG000|Overall Study|No data available|0|||
146530002|NCT00728494|528449115|FG001|Overall Study|No data available|1|||
146530003|NCT00853762|528449116|FG000|Overall Study|Premature Termination|16|||
146530004|NCT00853762|528449117|FG001|Overall Study|Premature Termination|15|||
146530005|NCT00853762|528449118|FG002|Overall Study|Premature Termination|14|||
146530006|NCT00853762|528449119|FG003|Overall Study|Premature Termination|21|||
146530007|NCT00853762|528449116|FG000|Overall Study|Protocol Violation|0|||
146530008|NCT00853762|528449117|FG001|Overall Study|Protocol Violation|0|||
146530009|NCT00853762|528449118|FG002|Overall Study|Protocol Violation|0|||
146530010|NCT00853762|528449119|FG003|Overall Study|Protocol Violation|1|||
146530011|NCT00853762|528449116|FG000|Overall Study|Withdrawal by Subject|0|||
146530012|NCT00853762|528449117|FG001|Overall Study|Withdrawal by Subject|0|||
146530013|NCT00853762|528449118|FG002|Overall Study|Withdrawal by Subject|1|||
146530014|NCT00853762|528449119|FG003|Overall Study|Withdrawal by Subject|0|||
146530015|NCT00853762|528449116|FG000|Overall Study|Other|0|||
146530016|NCT00853762|528449117|FG001|Overall Study|Other|2|||
146530017|NCT00853762|528449118|FG002|Overall Study|Other|0|||
146530018|NCT00853762|528449119|FG003|Overall Study|Other|0|||
146530019|NCT00853762|528449116|FG000|Overall Study|Randomised but not Treated|0|||
146530020|NCT00853762|528449117|FG001|Overall Study|Randomised but not Treated|2|||
146530021|NCT00853762|528449118|FG002|Overall Study|Randomised but not Treated|2|||
146530022|NCT00853762|528449119|FG003|Overall Study|Randomised but not Treated|0|||
146530023|NCT00748241|528449121|FG000|Overall Study|Implant failure|1|||
146530024|NCT00748241|528449121|FG000|Overall Study|Lost to Follow-up|5|||
146530025|NCT00748241|528449121|FG000|Overall Study|Death|2|||
146530026|NCT01408706|528449122|FG000|Overall Study|Physician Decision|1|||
146530027|NCT01408706|528449123|FG001|Overall Study|Physician Decision|0|||
146530028|NCT00888654|528449124|FG000|Overall Study|Problems swallowing oral meds.|1|||
146530029|NCT00888654|528449124|FG000|Overall Study|Not enough oral meds before surgery|3|||
146530030|NCT00888654|528449124|FG000|Overall Study|Surgery aborted|2|||
146530031|NCT00888654|528449124|FG000|Overall Study|Withdrawal by Subject|1|||
146530032|NCT00888654|528449124|FG000|Overall Study|Inelig. due to contraindication of med|1|||
146530033|NCT00888654|528449124|FG000|Overall Study|Change in surg date|1|||
146530034|NCT00888654|528449124|FG000|Overall Study|Stopped meds due to headaches|1|||
146530035|NCT02974868|528449125|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
146861203|NCT03226275|529662611|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
146861204|NCT03226275|529662608|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
146861205|NCT03226275|529662609|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
146965098|NCT03110107|530033436|FG010|Treatment Period|Adverse Event|0|||
146530036|NCT02974868|528449126|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
146530037|NCT02974868|528449127|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
146530038|NCT02974868|528449128|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
146530039|NCT02974868|528449125|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
146568721|NCT00328172|528595435|FG004|Overall Study|Lack of Efficacy|3|||
146861206|NCT03226275|529662610|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
146861207|NCT03226275|529662611|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
146861208|NCT03442114|529662612|FG000|Overall Study|Lost to Follow-up|13|||
146861209|NCT03442114|529662613|FG001|Overall Study|Lost to Follow-up|13|||
146861210|NCT03442114|529662612|FG000|Overall Study|Physician Decision|2|||
146861211|NCT03442114|529662613|FG001|Overall Study|Physician Decision|2|||
146861212|NCT03442114|529662612|FG000|Overall Study|Protocol Violation|0|||
146861213|NCT03442114|529662613|FG001|Overall Study|Protocol Violation|2|||
146861214|NCT03442114|529662612|FG000|Overall Study|Withdrawal by Subject|1|||
146861215|NCT03442114|529662613|FG001|Overall Study|Withdrawal by Subject|3|||
146861216|NCT03442114|529662612|FG000|Overall Study|Guardianship Change|0|||
146861217|NCT03442114|529662613|FG001|Overall Study|Guardianship Change|1|||
146861218|NCT00146328|529664593|FG000|Overall Study|Adverse Event|39|||
146861219|NCT00146328|529664594|FG001|Overall Study|Adverse Event|48|||
146861220|NCT00146328|529664595|FG002|Overall Study|Adverse Event|79|||
146861221|NCT00146328|529664593|FG000|Overall Study|Protocol Violation|11|||
146861222|NCT00146328|529664594|FG001|Overall Study|Protocol Violation|6|||
146861223|NCT00146328|529664595|FG002|Overall Study|Protocol Violation|12|||
146861224|NCT00146328|529664593|FG000|Overall Study|Lost to Follow-up|7|||
146861225|NCT00146328|529664594|FG001|Overall Study|Lost to Follow-up|4|||
146530040|NCT02974868|528449126|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
146530041|NCT02974868|528449127|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
146530042|NCT02974868|528449128|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
146530043|NCT02974868|528449125|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
146530044|NCT02974868|528449126|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
146861226|NCT00146328|529664595|FG002|Overall Study|Lost to Follow-up|7|||
146861227|NCT00146328|529664593|FG000|Overall Study|Withdrawal by Subject|16|||
146861228|NCT00146328|529664594|FG001|Overall Study|Withdrawal by Subject|16|||
146861229|NCT00146328|529664595|FG002|Overall Study|Withdrawal by Subject|22|||
146861230|NCT00146328|529664593|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
146861231|NCT00146328|529664594|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
146861232|NCT00146328|529664595|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
146861233|NCT00146328|529664593|FG000|Overall Study|Trial ended/site closed|8|||
146861234|NCT00146328|529664594|FG001|Overall Study|Trial ended/site closed|2|||
146861235|NCT00146328|529664595|FG002|Overall Study|Trial ended/site closed|19|||
146861236|NCT00146328|529664593|FG000|Overall Study|Patient decision to end|0|||
146861237|NCT00146328|529664594|FG001|Overall Study|Patient decision to end|1|||
146861238|NCT00146328|529664595|FG002|Overall Study|Patient decision to end|6|||
146861239|NCT00146328|529664593|FG000|Overall Study|Enroll into other trial|2|||
146861240|NCT00146328|529664594|FG001|Overall Study|Enroll into other trial|4|||
146861241|NCT00146328|529664595|FG002|Overall Study|Enroll into other trial|2|||
146861242|NCT00146328|529664593|FG000|Overall Study|Death|0|||
146861243|NCT00146328|529664594|FG001|Overall Study|Death|1|||
146861244|NCT00146328|529664595|FG002|Overall Study|Death|1|||
146861245|NCT00146328|529664593|FG000|Overall Study|Moved|2|||
146530045|NCT02974868|528449127|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
146530046|NCT02974868|528449128|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
146530047|NCT02974868|528449125|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
146861246|NCT00146328|529664594|FG001|Overall Study|Moved|0|||
146861247|NCT00146328|529664595|FG002|Overall Study|Moved|0|||
146530048|NCT02974868|528449126|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
146530049|NCT02974868|528449127|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
146530050|NCT02974868|528449128|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
146530051|NCT02674516|528449129|FG000|Overall Study|Lost to Follow-up|3|||
146530052|NCT02674516|528449130|FG001|Overall Study|Lost to Follow-up|0|||
146530053|NCT02674516|528449129|FG000|Overall Study|Protocol Violation|0|||
146530054|NCT02674516|528449130|FG001|Overall Study|Protocol Violation|4|||
146530055|NCT02674516|528449129|FG000|Overall Study|Knowledge of study hypothesis|1|||
146530056|NCT02674516|528449130|FG001|Overall Study|Knowledge of study hypothesis|0|||
146530057|NCT01064479|528449131|FG000|Overall Study|Death|10|||
146530058|NCT01064479|528449132|FG001|Overall Study|Death|11|||
146530059|NCT01064479|528449131|FG000|Overall Study|Withdrawal by Subject|2|||
146530060|NCT01064479|528449132|FG001|Overall Study|Withdrawal by Subject|2|||
146530061|NCT01064479|528449131|FG000|Overall Study|Disease progression|1|||
146530062|NCT01064479|528449132|FG001|Overall Study|Disease progression|1|||
146530063|NCT01064479|528449131|FG000|Overall Study|Toxicity|1|||
146861248|NCT00146328|529664593|FG000|Overall Study|Interaction with other medication|2|||
146861249|NCT00146328|529664594|FG001|Overall Study|Interaction with other medication|0|||
146530064|NCT01064479|528449132|FG001|Overall Study|Toxicity|1|||
146530065|NCT01064479|528449131|FG000|Overall Study|Other|1|||
146530066|NCT01064479|528449132|FG001|Overall Study|Other|2|||
146530067|NCT01663402|528449134|FG000|Overall Study|Randomized but not treated|19|||
146530068|NCT01663402|528449135|FG001|Overall Study|Randomized but not treated|11|||
146861250|NCT00146328|529664595|FG002|Overall Study|Interaction with other medication|1|||
146861251|NCT00792805|529664596|FG000|Overall Study|Adverse Event|12|||
146861252|NCT00792805|529664597|FG001|Overall Study|Adverse Event|10|||
146861253|NCT00792805|529664598|FG002|Overall Study|Adverse Event|10|||
146861254|NCT00792805|529664596|FG000|Overall Study|Subject withdrew consent|5|||
146861255|NCT00792805|529664597|FG001|Overall Study|Subject withdrew consent|6|||
146861256|NCT00792805|529664598|FG002|Overall Study|Subject withdrew consent|5|||
146861257|NCT00792805|529664596|FG000|Overall Study|Administrative problems|2|||
146861258|NCT00792805|529664597|FG001|Overall Study|Administrative problems|0|||
146861259|NCT00792805|529664598|FG002|Overall Study|Administrative problems|4|||
146861260|NCT00792805|529664596|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146861261|NCT00792805|529664597|FG001|Overall Study|Abnormal test procedure result(s)|2|||
146861262|NCT00792805|529664598|FG002|Overall Study|Abnormal test procedure result(s)|0|||
146861263|NCT00792805|529664596|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146861264|NCT00792805|529664597|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
146861265|NCT00792805|529664598|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
146861266|NCT00792805|529664596|FG000|Overall Study|Lost to Follow-up|1|||
146861267|NCT00792805|529664597|FG001|Overall Study|Lost to Follow-up|1|||
146861268|NCT00792805|529664598|FG002|Overall Study|Lost to Follow-up|6|||
146861269|NCT00792805|529664596|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146861270|NCT00792805|529664597|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146861271|NCT00792805|529664598|FG002|Overall Study|Abnormal laboratory value(s)|1|||
146861272|NCT00792805|529664596|FG000|Overall Study|Protocol deviation|0|||
146861273|NCT00792805|529664597|FG001|Overall Study|Protocol deviation|1|||
146861274|NCT00792805|529664598|FG002|Overall Study|Protocol deviation|1|||
146861275|NCT02952001|529664604|FG000|Overall Study|Adverse Event|3|||
146861276|NCT02952001|529664605|FG001|Overall Study|Adverse Event|0|||
146861277|NCT02952001|529664604|FG000|Overall Study|Prohibited therapy|10|||
146861278|NCT02952001|529664605|FG001|Overall Study|Prohibited therapy|3|||
146861279|NCT02952001|529664604|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
146861280|NCT02952001|529664605|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
146861281|NCT02276872|529664608|FG000|Overall Study|Adverse Event|1|||
146861282|NCT02276872|529664609|FG001|Overall Study|Adverse Event|0|||
146861283|NCT02276872|529664610|FG002|Overall Study|Adverse Event|0|||
146861284|NCT04356183|529664612|FG000|Overall Study|Lost to Follow-up|1|||
146861285|NCT04356183|529664613|FG001|Overall Study|Lost to Follow-up|0|||
146861286|NCT04356183|529664612|FG000|Overall Study|Withdrawal by Subject|1|||
146861287|NCT04356183|529664613|FG001|Overall Study|Withdrawal by Subject|1|||
146861288|NCT00402363|529664614|FG000|Overall Study|Adverse Event|9|||
146861289|NCT00402363|529664615|FG001|Overall Study|Adverse Event|14|||
146861290|NCT00402363|529664616|FG002|Overall Study|Adverse Event|2|||
146861291|NCT00402363|529664617|FG003|Overall Study|Adverse Event|2|||
146861292|NCT00402363|529664614|FG000|Overall Study|Withdrew Consent|10|||
146861293|NCT00402363|529664615|FG001|Overall Study|Withdrew Consent|5|||
146861294|NCT00402363|529664616|FG002|Overall Study|Withdrew Consent|2|||
146861295|NCT00402363|529664617|FG003|Overall Study|Withdrew Consent|1|||
146861296|NCT00402363|529664614|FG000|Overall Study|Protocol Violation|3|||
146861297|NCT00402363|529664615|FG001|Overall Study|Protocol Violation|5|||
146861298|NCT00402363|529664616|FG002|Overall Study|Protocol Violation|0|||
146861299|NCT00402363|529664617|FG003|Overall Study|Protocol Violation|3|||
146861300|NCT00402363|529664614|FG000|Overall Study|Lost to Follow-up|5|||
146861301|NCT00402363|529664615|FG001|Overall Study|Lost to Follow-up|4|||
146861302|NCT00402363|529664616|FG002|Overall Study|Lost to Follow-up|0|||
146861303|NCT00402363|529664617|FG003|Overall Study|Lost to Follow-up|2|||
146861304|NCT00402363|529664614|FG000|Overall Study|"Captured as Other"|6|||
146861305|NCT00402363|529664615|FG001|Overall Study|"Captured as Other"|2|||
146861306|NCT00402363|529664616|FG002|Overall Study|"Captured as Other"|2|||
146861307|NCT00402363|529664617|FG003|Overall Study|"Captured as Other"|2|||
146861308|NCT00744523|529664626|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
146861309|NCT00744523|529664627|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
146861310|NCT01139021|529664628|FG000|Overall Study|Adverse Event|0|||
146861311|NCT01139021|529664629|FG001|Overall Study|Adverse Event|0|||
146861312|NCT01139021|529664630|FG002|Overall Study|Adverse Event|0|||
146861313|NCT01139021|529664631|FG003|Overall Study|Adverse Event|0|||
146861314|NCT01139021|529664632|FG004|Overall Study|Adverse Event|1|||
146861315|NCT01139021|529664633|FG005|Overall Study|Adverse Event|0|||
146861316|NCT01139021|529664628|FG000|Overall Study|Lost to Follow-up|0|||
146861317|NCT01139021|529664629|FG001|Overall Study|Lost to Follow-up|0|||
146861318|NCT01139021|529664630|FG002|Overall Study|Lost to Follow-up|0|||
146861319|NCT01139021|529664631|FG003|Overall Study|Lost to Follow-up|0|||
146861320|NCT01139021|529664632|FG004|Overall Study|Lost to Follow-up|2|||
146861321|NCT01139021|529664633|FG005|Overall Study|Lost to Follow-up|0|||
146861322|NCT01139021|529664628|FG000|Overall Study|Protocol Violation|1|||
146861323|NCT01139021|529664629|FG001|Overall Study|Protocol Violation|0|||
146861324|NCT01139021|529664630|FG002|Overall Study|Protocol Violation|0|||
146861325|NCT01139021|529664631|FG003|Overall Study|Protocol Violation|0|||
146861326|NCT01139021|529664632|FG004|Overall Study|Protocol Violation|2|||
146861327|NCT01139021|529664633|FG005|Overall Study|Protocol Violation|0|||
146861328|NCT01139021|529664628|FG000|Overall Study|Withdrawal by Subject|0|||
146861329|NCT01139021|529664629|FG001|Overall Study|Withdrawal by Subject|0|||
146861330|NCT01139021|529664630|FG002|Overall Study|Withdrawal by Subject|0|||
146530069|NCT01663402|528449134|FG000|Overall Study|Adverse Event|347|||
146530070|NCT01663402|528449135|FG001|Overall Study|Adverse Event|362|||
146530071|NCT01663402|528449134|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
146530072|NCT01663402|528449135|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
146530073|NCT01663402|528449134|FG000|Overall Study|Poor compliance to protocol|529|||
146530074|NCT01663402|528449135|FG001|Overall Study|Poor compliance to protocol|454|||
146530075|NCT01663402|528449134|FG000|Overall Study|Physician Decision|77|||
146761596|NCT00817635|529295194|FG004|Overall Study|Protocol Violation|3|||
146761597|NCT01167426|529295195|FG000|Overall Study|Lost to Follow-up|6|||
146761598|NCT01167426|529295195|FG000|Overall Study|Protocol Violation|1|||
146761599|NCT01167426|529295195|FG000|Overall Study|Withdrawal by Subject|2|||
146761600|NCT01167426|529295195|FG000|Overall Study|Sponsor Decision|1|||
146761601|NCT04176458|529295197|FG000|Overall Study|Covid 19|4|||
146761602|NCT02131324|529295198|FG000|Overall Study|Withdrawal by Subject|1|||
146761603|NCT02131324|529295199|FG001|Overall Study|Withdrawal by Subject|2|||
146761604|NCT02131324|529295198|FG000|Overall Study|Lost to Follow-up|1|||
146761605|NCT02131324|529295199|FG001|Overall Study|Lost to Follow-up|1|||
146761606|NCT00891618|529295200|FG000|Overall Study|Withdrawal by Subject|1|||
146761607|NCT00763282|529295201|FG000|Overall Study|Withdrawal by Subject|6|||
146761608|NCT00763282|529295202|FG001|Overall Study|Withdrawal by Subject|5|||
146761609|NCT00763282|529295201|FG000|Overall Study|Death|4|||
146761610|NCT00763282|529295202|FG001|Overall Study|Death|3|||
146761611|NCT00763282|529295201|FG000|Overall Study|Lost to Follow-up|22|||
146761612|NCT00763282|529295202|FG001|Overall Study|Lost to Follow-up|26|||
146761613|NCT03736785|529295203|FG000|Overall Study|Adverse Event|1|||
146761614|NCT03736785|529295204|FG001|Overall Study|Adverse Event|1|||
146761615|NCT03736785|529295205|FG002|Overall Study|Adverse Event|1|||
146761616|NCT03736785|529295203|FG000|Overall Study|Death|1|||
146761617|NCT03736785|529295204|FG001|Overall Study|Death|0|||
146761618|NCT03736785|529295205|FG002|Overall Study|Death|1|||
146761619|NCT03736785|529295203|FG000|Overall Study|Lost to Follow-up|0|||
146761620|NCT03736785|529295204|FG001|Overall Study|Lost to Follow-up|2|||
146761621|NCT03736785|529295205|FG002|Overall Study|Lost to Follow-up|3|||
146761622|NCT03736785|529295203|FG000|Overall Study|Non compliance with study drug|1|||
146761623|NCT03736785|529295204|FG001|Overall Study|Non compliance with study drug|1|||
146761624|NCT03736785|529295205|FG002|Overall Study|Non compliance with study drug|0|||
146761625|NCT03736785|529295203|FG000|Overall Study|Physician Decision|0|||
146761626|NCT03736785|529295204|FG001|Overall Study|Physician Decision|1|||
146761627|NCT03736785|529295205|FG002|Overall Study|Physician Decision|1|||
146761628|NCT03736785|529295203|FG000|Overall Study|Protocol Violation|1|||
146761629|NCT03736785|529295204|FG001|Overall Study|Protocol Violation|4|||
146761630|NCT03736785|529295205|FG002|Overall Study|Protocol Violation|3|||
146761631|NCT03736785|529295203|FG000|Overall Study|Sponsor Decision|1|||
146761632|NCT03736785|529295204|FG001|Overall Study|Sponsor Decision|0|||
146761633|NCT03736785|529295205|FG002|Overall Study|Sponsor Decision|0|||
146761634|NCT03736785|529295203|FG000|Overall Study|Unknown/Missing data|3|||
146761635|NCT03736785|529295204|FG001|Overall Study|Unknown/Missing data|2|||
146761636|NCT03736785|529295205|FG002|Overall Study|Unknown/Missing data|1|||
146761637|NCT03736785|529295203|FG000|Overall Study|Withdrawal by Subject|9|||
146761638|NCT03736785|529295204|FG001|Overall Study|Withdrawal by Subject|6|||
146761639|NCT03736785|529295205|FG002|Overall Study|Withdrawal by Subject|4|||
146761640|NCT00320489|529295208|FG000|Overall Study|Adverse Event|26|||
146761641|NCT00320489|529295209|FG001|Overall Study|Adverse Event|25|||
146761642|NCT00320489|529295208|FG000|Overall Study|Clinical Relapse|26|||
146761643|NCT00320489|529295209|FG001|Overall Study|Clinical Relapse|20|||
146761644|NCT00320489|529295208|FG000|Overall Study|Death|0|||
146761645|NCT00320489|529295209|FG001|Overall Study|Death|2|||
146761646|NCT00320489|529295208|FG000|Overall Study|Entry Criteria Exclusion|2|||
146761647|NCT00320489|529295209|FG001|Overall Study|Entry Criteria Exclusion|4|||
146761648|NCT00320489|529295208|FG000|Overall Study|Lack of Efficacy|16|||
146761649|NCT00320489|529295209|FG001|Overall Study|Lack of Efficacy|7|||
146761650|NCT00320489|529295208|FG000|Overall Study|Lost to Follow-up|21|||
146761651|NCT00320489|529295209|FG001|Overall Study|Lost to Follow-up|22|||
146761652|NCT00320489|529295208|FG000|Overall Study|Physician Decision|8|||
146761653|NCT00320489|529295209|FG001|Overall Study|Physician Decision|8|||
146761654|NCT00320489|529295208|FG000|Overall Study|Protocol Violation|4|||
146761655|NCT00320489|529295209|FG001|Overall Study|Protocol Violation|4|||
146761656|NCT00320489|529295208|FG000|Overall Study|Sponsor Decision|3|||
146761657|NCT00320489|529295209|FG001|Overall Study|Sponsor Decision|3|||
146861331|NCT01139021|529664631|FG003|Overall Study|Withdrawal by Subject|1|||
146761658|NCT00320489|529295208|FG000|Overall Study|Withdrawal by Subject|39|||
146761659|NCT00320489|529295209|FG001|Overall Study|Withdrawal by Subject|41|||
146761660|NCT03441984|529295210|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146761661|NCT03441984|529295211|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146761662|NCT03441984|529295212|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
146761663|NCT03441984|529295213|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146861332|NCT01139021|529664632|FG004|Overall Study|Withdrawal by Subject|4|||
146861333|NCT01139021|529664633|FG005|Overall Study|Withdrawal by Subject|0|||
146530076|NCT01663402|528449135|FG001|Overall Study|Physician Decision|62|||
146530077|NCT01663402|528449134|FG000|Overall Study|Site terminated by sponsor|1|||
146530078|NCT01663402|528449135|FG001|Overall Study|Site terminated by sponsor|3|||
146530079|NCT01663402|528449134|FG000|Overall Study|Participant moved|139|||
146530080|NCT01663402|528449135|FG001|Overall Study|Participant moved|104|||
146530081|NCT01663402|528449134|FG000|Overall Study|Withdrawal by Subject|118|||
146530082|NCT01663402|528449135|FG001|Overall Study|Withdrawal by Subject|91|||
146530083|NCT01663402|528449134|FG000|Overall Study|Related to study drug administration|96|||
146530084|NCT01663402|528449135|FG001|Overall Study|Related to study drug administration|105|||
146530085|NCT01663402|528449134|FG000|Overall Study|Lost to Follow-up|17|||
146530086|NCT01663402|528449135|FG001|Overall Study|Lost to Follow-up|15|||
146530087|NCT01663402|528449134|FG000|Overall Study|Other than specified above|172|||
146530088|NCT01663402|528449135|FG001|Overall Study|Other than specified above|147|||
146530089|NCT03903172|528449138|FG000|Overall Study|screen fail|4|||
146530090|NCT03903172|528449139|FG001|Overall Study|screen fail|1|||
146761664|NCT03441984|529295214|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146530091|NCT00490035|528449140|FG000|Overall Study|AE, non-serious non-fatal|3|||
146530092|NCT00490035|528449141|FG001|Overall Study|AE, non-serious non-fatal|4|||
146530093|NCT00490035|528449142|FG002|Overall Study|AE, non-serious non-fatal|4|||
146530094|NCT00490035|528449143|FG003|Overall Study|AE, non-serious non-fatal|5|||
146530095|NCT00490035|528449140|FG000|Overall Study|Lost to Follow-up|2|||
146761665|NCT03441984|529295215|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146761666|NCT03441984|529295216|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146761667|NCT03441984|529295217|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146761668|NCT03441984|529295218|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146761669|NCT03441984|529295219|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146761670|NCT03441984|529295220|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146761671|NCT03441984|529295221|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146761672|NCT02595398|529295225|FG000|Overall Study|Non-compliance|1|||
146761673|NCT02595398|529295226|FG001|Overall Study|Non-compliance|0|||
146761674|NCT02595398|529295225|FG000|Overall Study|Withdrawal by Subject|2|||
146761675|NCT02595398|529295226|FG001|Overall Study|Withdrawal by Subject|1|||
146761676|NCT02595398|529295225|FG000|Overall Study|Lost to Follow-up|1|||
146761677|NCT02595398|529295226|FG001|Overall Study|Lost to Follow-up|0|||
146761678|NCT03601507|529295227|FG000|Overall Study|Adverse Event|1|||
146761679|NCT01664104|529295228|FG000|Overall Study|Adverse Event|6|||
146761680|NCT01664104|529295228|FG000|Overall Study|Lack of Efficacy|2|||
146761681|NCT01664104|529295228|FG000|Overall Study|Withdrawal by Subject|1|||
146761682|NCT01664104|529295228|FG000|Overall Study|Lost to Follow-up|4|||
146761683|NCT01664104|529295228|FG000|Overall Study|Other|1|||
146761684|NCT01664104|529295228|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
146761685|NCT02107014|529295232|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
146761686|NCT03761784|529295233|FG000|Overall Study|Adverse Event|4|||
146761687|NCT03761784|529295234|FG001|Overall Study|Adverse Event|0|||
146761688|NCT03761784|529295233|FG000|Overall Study|Lost to Follow-up|10|||
146761689|NCT03761784|529295234|FG001|Overall Study|Lost to Follow-up|7|||
146761690|NCT03761784|529295233|FG000|Overall Study|Pregnancy|1|||
146761691|NCT03761784|529295234|FG001|Overall Study|Pregnancy|0|||
146761692|NCT03761784|529295233|FG000|Overall Study|Protocol Violation|2|||
146761693|NCT03761784|529295234|FG001|Overall Study|Protocol Violation|0|||
146761694|NCT03761784|529295233|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
146761695|NCT03761784|529295234|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
146761696|NCT03761784|529295233|FG000|Overall Study|Withdrawal by Subject|9|||
146761697|NCT03761784|529295234|FG001|Overall Study|Withdrawal by Subject|4|||
146761698|NCT03761784|529295233|FG000|Overall Study|Physician Decision|1|||
146761699|NCT03761784|529295234|FG001|Overall Study|Physician Decision|0|||
146761700|NCT03761784|529295233|FG000|Overall Study|Other Than Specified|1|||
146761701|NCT03761784|529295234|FG001|Overall Study|Other Than Specified|0|||
146761702|NCT00586339|529295237|FG000|Overall Study|Withdrawal by Subject|1|||
146761703|NCT00586339|529295238|FG001|Overall Study|Withdrawal by Subject|3|||
146761704|NCT00586339|529295239|FG002|Overall Study|Withdrawal by Subject|1|||
146761705|NCT00586339|529295237|FG000|Overall Study|Migrated/moved from study area|3|||
146761706|NCT00586339|529295238|FG001|Overall Study|Migrated/moved from study area|2|||
146761707|NCT00586339|529295239|FG002|Overall Study|Migrated/moved from study area|4|||
146761708|NCT00586339|529295237|FG000|Overall Study|Lost to Follow-up|3|||
146761709|NCT00586339|529295238|FG001|Overall Study|Lost to Follow-up|2|||
146761710|NCT00586339|529295239|FG002|Overall Study|Lost to Follow-up|1|||
146761711|NCT03852433|529295241|FG000|Overall Study|Withdrawal of consent|5|||
146761712|NCT03852433|529295242|FG001|Overall Study|Withdrawal of consent|8|||
146761713|NCT03852433|529295243|FG002|Overall Study|Withdrawal of consent|1|||
146761714|NCT03852433|529295244|FG003|Overall Study|Withdrawal of consent|1|||
146761715|NCT03852433|529295241|FG000|Overall Study|Adverse Event|1|||
146761716|NCT03852433|529295242|FG001|Overall Study|Adverse Event|1|||
146530096|NCT00490035|528449141|FG001|Overall Study|Lost to Follow-up|0|||
146530097|NCT00490035|528449142|FG002|Overall Study|Lost to Follow-up|1|||
146861334|NCT03588728|529664637|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
146861335|NCT03588728|529664638|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
146861336|NCT03588728|529664639|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
146861337|NCT03588728|529664640|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
146861338|NCT03588728|529664637|FG000|Overall Study|Lab shut down due to COVID-19|0|||
146861339|NCT03588728|529664638|FG001|Overall Study|Lab shut down due to COVID-19|0|||
146861340|NCT03588728|529664639|FG002|Overall Study|Lab shut down due to COVID-19|0|||
146861341|NCT03588728|529664640|FG003|Overall Study|Lab shut down due to COVID-19|1|||
146861342|NCT03588728|529664637|FG000|Overall Study|multiple technical issues|1|||
146861343|NCT03588728|529664638|FG001|Overall Study|multiple technical issues|0|||
146861344|NCT03588728|529664639|FG002|Overall Study|multiple technical issues|0|||
146861345|NCT03588728|529664640|FG003|Overall Study|multiple technical issues|0|||
146861346|NCT03588728|529664637|FG000|Overall Study|Hospitalized for COVID|1|||
146861347|NCT03588728|529664638|FG001|Overall Study|Hospitalized for COVID|0|||
146861348|NCT03588728|529664639|FG002|Overall Study|Hospitalized for COVID|0|||
146761717|NCT03852433|529295243|FG002|Overall Study|Adverse Event|1|||
146761718|NCT03852433|529295244|FG003|Overall Study|Adverse Event|1|||
146761719|NCT03852433|529295241|FG000|Overall Study|Lost to Follow-up|0|||
146761720|NCT03852433|529295242|FG001|Overall Study|Lost to Follow-up|1|||
146761721|NCT03852433|529295243|FG002|Overall Study|Lost to Follow-up|0|||
146761722|NCT03852433|529295244|FG003|Overall Study|Lost to Follow-up|1|||
146761723|NCT03852433|529295241|FG000|Overall Study|Pregnancy|0|||
146761724|NCT03852433|529295242|FG001|Overall Study|Pregnancy|1|||
146761725|NCT03852433|529295243|FG002|Overall Study|Pregnancy|1|||
146761726|NCT03852433|529295244|FG003|Overall Study|Pregnancy|0|||
146761727|NCT03852433|529295241|FG000|Overall Study|Protocol Violation|0|||
146761728|NCT03852433|529295242|FG001|Overall Study|Protocol Violation|0|||
146761729|NCT03852433|529295243|FG002|Overall Study|Protocol Violation|1|||
146761730|NCT03852433|529295244|FG003|Overall Study|Protocol Violation|1|||
146761731|NCT03852433|529295241|FG000|Overall Study|Death|0|||
146761732|NCT03852433|529295242|FG001|Overall Study|Death|0|||
146761733|NCT03852433|529295243|FG002|Overall Study|Death|1|||
146761734|NCT03852433|529295244|FG003|Overall Study|Death|0|||
146761735|NCT03852433|529295241|FG000|Overall Study|Lack of Efficacy|0|||
146761736|NCT03852433|529295242|FG001|Overall Study|Lack of Efficacy|1|||
146761737|NCT03852433|529295243|FG002|Overall Study|Lack of Efficacy|0|||
146761738|NCT03852433|529295244|FG003|Overall Study|Lack of Efficacy|0|||
146761739|NCT03852433|529295241|FG000|Overall Study|Non-compliance with study drug|0|||
146761740|NCT03852433|529295242|FG001|Overall Study|Non-compliance with study drug|0|||
146761741|NCT03852433|529295243|FG002|Overall Study|Non-compliance with study drug|0|||
146761742|NCT03852433|529295244|FG003|Overall Study|Non-compliance with study drug|1|||
146761743|NCT03852433|529295241|FG000|Overall Study|Physician Decision|1|||
146761744|NCT03852433|529295242|FG001|Overall Study|Physician Decision|0|||
146761745|NCT03852433|529295243|FG002|Overall Study|Physician Decision|0|||
146761746|NCT03852433|529295244|FG003|Overall Study|Physician Decision|0|||
146761747|NCT03852433|529295241|FG000|Overall Study|Randomized but never treated|1|||
146761748|NCT03852433|529295242|FG001|Overall Study|Randomized but never treated|0|||
146761749|NCT03852433|529295243|FG002|Overall Study|Randomized but never treated|0|||
146761750|NCT03852433|529295244|FG003|Overall Study|Randomized but never treated|0|||
146761751|NCT00746330|529295245|FG000|Period 1|Abnormal test procedure result|0|||
146761752|NCT00746330|529295246|FG001|Period 1|Abnormal test procedure result|0|||
146761753|NCT00746330|529295247|FG002|Period 1|Abnormal test procedure result|1|||
146761754|NCT00746330|529295248|FG003|Period 1|Abnormal test procedure result|0|||
146761755|NCT01981850|529295249|FG000|Main Phase Stage 1|Death|2|||
146761756|NCT01981850|529295250|FG001|Main Phase Stage 1|Death|0|||
146761757|NCT01981850|529295251|FG002|Main Phase Stage 1|Death|0|||
146761758|NCT01981850|529295252|FG003|Main Phase Stage 1|Death|0|||
146761759|NCT01981850|529295253|FG004|Main Phase Stage 1|Death|0|||
146761760|NCT01981850|529295254|FG005|Main Phase Stage 1|Death|0|||
146761761|NCT01981850|529295255|FG006|Main Phase Stage 1|Death|0|||
146761762|NCT01981850|529295256|FG007|Main Phase Stage 1|Death|0|||
146761763|NCT01981850|529295257|FG008|Main Phase Stage 1|Death|0|||
146761764|NCT01981850|529295258|FG009|Main Phase Stage 1|Death|0|||
146761765|NCT01981850|529295249|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
146761766|NCT01981850|529295250|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146761767|NCT01981850|529295251|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146761768|NCT01981850|529295252|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146761769|NCT01981850|529295253|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146761770|NCT01981850|529295254|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146761771|NCT01981850|529295255|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146761772|NCT01981850|529295256|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146761773|NCT01981850|529295257|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146761774|NCT01981850|529295258|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146761775|NCT01981850|529295249|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
146761776|NCT01981850|529295250|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
146530098|NCT00490035|528449143|FG003|Overall Study|Lost to Follow-up|0|||
146861349|NCT03588728|529664640|FG003|Overall Study|Hospitalized for COVID|0|||
146861350|NCT03588728|529664637|FG000|Overall Study|Schedule change unable to attend sessions|1|||
146861351|NCT03588728|529664638|FG001|Overall Study|Schedule change unable to attend sessions|0|||
146861352|NCT03588728|529664639|FG002|Overall Study|Schedule change unable to attend sessions|0|||
146861353|NCT03588728|529664640|FG003|Overall Study|Schedule change unable to attend sessions|0|||
146861354|NCT00195507|529664641|FG000|Overall Study|Adverse Event|24|||
146861355|NCT00195507|529664642|FG001|Overall Study|Adverse Event|13|||
146861356|NCT00195507|529664641|FG000|Overall Study|Death|0|||
146861357|NCT00195507|529664642|FG001|Overall Study|Death|1|||
146861358|NCT00195507|529664641|FG000|Overall Study|Failed to Return|4|||
146861359|NCT00195507|529664642|FG001|Overall Study|Failed to Return|3|||
146861360|NCT00195507|529664641|FG000|Overall Study|Physician Decision|1|||
146861361|NCT00195507|529664642|FG001|Overall Study|Physician Decision|2|||
146861362|NCT00195507|529664641|FG000|Overall Study|Lost to Follow-up|3|||
146861363|NCT00195507|529664642|FG001|Overall Study|Lost to Follow-up|2|||
146861364|NCT00195507|529664641|FG000|Overall Study|Protocol Violation|5|||
146861365|NCT00195507|529664642|FG001|Overall Study|Protocol Violation|4|||
146861366|NCT00195507|529664641|FG000|Overall Study|Lack of Efficacy|40|||
146861367|NCT00195507|529664642|FG001|Overall Study|Lack of Efficacy|67|||
146861368|NCT00195507|529664641|FG000|Overall Study|Withdrawal by Subject|16|||
146861369|NCT00195507|529664642|FG001|Overall Study|Withdrawal by Subject|23|||
146861370|NCT00195507|529664641|FG000|Overall Study|Protocol Deviation|6|||
146861371|NCT00195507|529664642|FG001|Overall Study|Protocol Deviation|3|||
146861372|NCT02202551|529664643|FG000|Overall Study|Adverse Event|8|||
146861373|NCT02202551|529664644|FG001|Overall Study|Adverse Event|19|||
146861374|NCT02202551|529664645|FG002|Overall Study|Adverse Event|5|||
146861375|NCT02202551|529664646|FG003|Overall Study|Adverse Event|9|||
146861376|NCT02202551|529664643|FG000|Overall Study|Death|3|||
146861377|NCT02202551|529664644|FG001|Overall Study|Death|2|||
146861378|NCT02202551|529664645|FG002|Overall Study|Death|1|||
146861379|NCT02202551|529664646|FG003|Overall Study|Death|1|||
146861380|NCT02202551|529664643|FG000|Overall Study|Lost to Follow-up|0|||
146861381|NCT02202551|529664644|FG001|Overall Study|Lost to Follow-up|1|||
146861382|NCT02202551|529664645|FG002|Overall Study|Lost to Follow-up|0|||
146861383|NCT02202551|529664646|FG003|Overall Study|Lost to Follow-up|1|||
146861384|NCT02202551|529664643|FG000|Overall Study|Needed to take excluded medication|0|||
146861385|NCT02202551|529664644|FG001|Overall Study|Needed to take excluded medication|2|||
146861386|NCT02202551|529664645|FG002|Overall Study|Needed to take excluded medication|0|||
146861387|NCT02202551|529664646|FG003|Overall Study|Needed to take excluded medication|1|||
146861388|NCT02202551|529664643|FG000|Overall Study|Subject moved away|0|||
146861389|NCT02202551|529664644|FG001|Overall Study|Subject moved away|1|||
146861390|NCT02202551|529664645|FG002|Overall Study|Subject moved away|0|||
146861391|NCT02202551|529664646|FG003|Overall Study|Subject moved away|0|||
146861392|NCT02202551|529664643|FG000|Overall Study|DBS surgery|3|||
146861393|NCT02202551|529664644|FG001|Overall Study|DBS surgery|0|||
146861394|NCT02202551|529664645|FG002|Overall Study|DBS surgery|0|||
146861395|NCT02202551|529664646|FG003|Overall Study|DBS surgery|0|||
146861396|NCT02202551|529664643|FG000|Overall Study|Dyskinesia upon taper|1|||
146861397|NCT02202551|529664644|FG001|Overall Study|Dyskinesia upon taper|0|||
146861398|NCT02202551|529664645|FG002|Overall Study|Dyskinesia upon taper|0|||
146861399|NCT02202551|529664646|FG003|Overall Study|Dyskinesia upon taper|0|||
146861400|NCT02202551|529664643|FG000|Overall Study|Lack of Efficacy|0|||
146861401|NCT02202551|529664644|FG001|Overall Study|Lack of Efficacy|1|||
146861402|NCT02202551|529664645|FG002|Overall Study|Lack of Efficacy|0|||
146861403|NCT02202551|529664646|FG003|Overall Study|Lack of Efficacy|0|||
146861404|NCT02202551|529664643|FG000|Overall Study|Physician Decision|1|||
146861405|NCT02202551|529664644|FG001|Overall Study|Physician Decision|0|||
146861406|NCT02202551|529664645|FG002|Overall Study|Physician Decision|0|||
146861407|NCT02202551|529664646|FG003|Overall Study|Physician Decision|0|||
146861408|NCT02202551|529664643|FG000|Overall Study|Site closure|3|||
146861409|NCT02202551|529664644|FG001|Overall Study|Site closure|0|||
146861410|NCT02202551|529664645|FG002|Overall Study|Site closure|0|||
146861411|NCT02202551|529664646|FG003|Overall Study|Site closure|1|||
146861412|NCT02202551|529664643|FG000|Overall Study|Unable to complete visits per protocol|1|||
146861413|NCT02202551|529664644|FG001|Overall Study|Unable to complete visits per protocol|0|||
146861414|NCT02202551|529664645|FG002|Overall Study|Unable to complete visits per protocol|0|||
146861415|NCT02202551|529664646|FG003|Overall Study|Unable to complete visits per protocol|0|||
146861416|NCT02202551|529664643|FG000|Overall Study|Worsening Dyskinesia|0|||
146861417|NCT02202551|529664644|FG001|Overall Study|Worsening Dyskinesia|0|||
146861418|NCT02202551|529664645|FG002|Overall Study|Worsening Dyskinesia|0|||
146861419|NCT02202551|529664646|FG003|Overall Study|Worsening Dyskinesia|1|||
146625289|NCT03037385|528803854|FG009|Overall Study|Progressive Disease|30|||
146861420|NCT02202551|529664643|FG000|Overall Study|Protocol Violation|0|||
146861421|NCT02202551|529664644|FG001|Overall Study|Protocol Violation|1|||
146861422|NCT02202551|529664645|FG002|Overall Study|Protocol Violation|0|||
146861423|NCT02202551|529664646|FG003|Overall Study|Protocol Violation|0|||
146861424|NCT02202551|529664643|FG000|Overall Study|Sponsor's decision|2|||
146861425|NCT02202551|529664644|FG001|Overall Study|Sponsor's decision|0|||
146861426|NCT02202551|529664645|FG002|Overall Study|Sponsor's decision|0|||
146761777|NCT01981850|529295251|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
146761778|NCT01981850|529295252|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
146761779|NCT01981850|529295253|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
146761780|NCT01981850|529295254|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
146761781|NCT01981850|529295255|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
146761782|NCT01981850|529295256|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
146761783|NCT01981850|529295257|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
146761784|NCT01981850|529295258|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
146761785|NCT01981850|529295249|FG000|Main Phase Stage 1|Various reasons|0|||
146761786|NCT01981850|529295250|FG001|Main Phase Stage 1|Various reasons|0|||
146761787|NCT01981850|529295251|FG002|Main Phase Stage 1|Various reasons|2|||
146761788|NCT01981850|529295252|FG003|Main Phase Stage 1|Various reasons|0|||
146761789|NCT01981850|529295253|FG004|Main Phase Stage 1|Various reasons|0|||
146761790|NCT01981850|529295254|FG005|Main Phase Stage 1|Various reasons|0|||
146761791|NCT01981850|529295255|FG006|Main Phase Stage 1|Various reasons|0|||
146761792|NCT01981850|529295256|FG007|Main Phase Stage 1|Various reasons|0|||
146761793|NCT01981850|529295257|FG008|Main Phase Stage 1|Various reasons|0|||
146761794|NCT01981850|529295258|FG009|Main Phase Stage 1|Various reasons|0|||
146761795|NCT01981850|529295249|FG000|Main Phase Stage 2|Adverse Event|0|||
146761796|NCT01981850|529295250|FG001|Main Phase Stage 2|Adverse Event|0|||
146761797|NCT01981850|529295251|FG002|Main Phase Stage 2|Adverse Event|0|||
146761798|NCT01981850|529295252|FG003|Main Phase Stage 2|Adverse Event|0|||
146761799|NCT01981850|529295253|FG004|Main Phase Stage 2|Adverse Event|6|||
146761800|NCT01981850|529295254|FG005|Main Phase Stage 2|Adverse Event|5|||
146761801|NCT01981850|529295255|FG006|Main Phase Stage 2|Adverse Event|7|||
146761802|NCT01981850|529295256|FG007|Main Phase Stage 2|Adverse Event|0|||
146761803|NCT01981850|529295257|FG008|Main Phase Stage 2|Adverse Event|0|||
146761804|NCT01981850|529295258|FG009|Main Phase Stage 2|Adverse Event|0|||
146761805|NCT01981850|529295249|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
146761806|NCT01981850|529295250|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
146761807|NCT01981850|529295251|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
146761808|NCT01981850|529295252|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
146761809|NCT01981850|529295253|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
146761810|NCT01981850|529295254|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
146761811|NCT01981850|529295255|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
146761812|NCT01981850|529295256|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
146761813|NCT01981850|529295257|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
146761814|NCT01981850|529295258|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
146761815|NCT01981850|529295249|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
146761816|NCT01981850|529295250|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
146761817|NCT01981850|529295251|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
146761818|NCT01981850|529295252|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
146530099|NCT00490035|528449140|FG000|Overall Study|Withdrawal by Subject|2|||
146530100|NCT00490035|528449141|FG001|Overall Study|Withdrawal by Subject|1|||
146530101|NCT00490035|528449142|FG002|Overall Study|Withdrawal by Subject|1|||
146530102|NCT00490035|528449143|FG003|Overall Study|Withdrawal by Subject|0|||
146530103|NCT00490035|528449140|FG000|Overall Study|Other reason|0|||
146530104|NCT00490035|528449141|FG001|Overall Study|Other reason|1|||
146761819|NCT01981850|529295253|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
146761820|NCT01981850|529295254|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
146761821|NCT01981850|529295255|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
146761822|NCT01981850|529295256|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
146761823|NCT01981850|529295257|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
146761824|NCT01981850|529295258|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
146761825|NCT01981850|529295249|FG000|Main Phase Stage 2|Various reasons|0|||
146761826|NCT01981850|529295250|FG001|Main Phase Stage 2|Various reasons|0|||
146761827|NCT01981850|529295251|FG002|Main Phase Stage 2|Various reasons|0|||
146761828|NCT01981850|529295252|FG003|Main Phase Stage 2|Various reasons|0|||
146761829|NCT01981850|529295253|FG004|Main Phase Stage 2|Various reasons|2|||
146761830|NCT01981850|529295254|FG005|Main Phase Stage 2|Various reasons|0|||
146761831|NCT01981850|529295255|FG006|Main Phase Stage 2|Various reasons|1|||
146761832|NCT01981850|529295256|FG007|Main Phase Stage 2|Various reasons|0|||
146761833|NCT01981850|529295257|FG008|Main Phase Stage 2|Various reasons|0|||
146761834|NCT01981850|529295258|FG009|Main Phase Stage 2|Various reasons|0|||
146530105|NCT00490035|528449142|FG002|Overall Study|Other reason|3|||
146761835|NCT01981850|529295249|FG000|Main Phase Stage 2|Progressive Disease|0|||
146761836|NCT01981850|529295250|FG001|Main Phase Stage 2|Progressive Disease|0|||
146761837|NCT01981850|529295251|FG002|Main Phase Stage 2|Progressive Disease|0|||
146530106|NCT00490035|528449143|FG003|Overall Study|Other reason|1|||
146530107|NCT00490035|528449140|FG000|Overall Study|AE, serious fatal|1|||
146530108|NCT00490035|528449141|FG001|Overall Study|AE, serious fatal|0|||
146761838|NCT01981850|529295252|FG003|Main Phase Stage 2|Progressive Disease|0|||
146761839|NCT01981850|529295253|FG004|Main Phase Stage 2|Progressive Disease|0|||
146761840|NCT01981850|529295254|FG005|Main Phase Stage 2|Progressive Disease|6|||
146761841|NCT01981850|529295255|FG006|Main Phase Stage 2|Progressive Disease|6|||
146761842|NCT01981850|529295256|FG007|Main Phase Stage 2|Progressive Disease|0|||
146861427|NCT02202551|529664646|FG003|Overall Study|Sponsor's decision|0|||
146861428|NCT02202551|529664643|FG000|Overall Study|Subject unwilling to proceed|1|||
146861429|NCT02202551|529664644|FG001|Overall Study|Subject unwilling to proceed|5|||
146861430|NCT02202551|529664645|FG002|Overall Study|Subject unwilling to proceed|3|||
146861431|NCT02202551|529664646|FG003|Overall Study|Subject unwilling to proceed|5|||
146861432|NCT02202551|529664643|FG000|Overall Study|Subject consent withdrawn|0|||
146861433|NCT02202551|529664644|FG001|Overall Study|Subject consent withdrawn|3|||
146861434|NCT02202551|529664645|FG002|Overall Study|Subject consent withdrawn|1|||
146861435|NCT02202551|529664646|FG003|Overall Study|Subject consent withdrawn|2|||
146861436|NCT02202551|529664643|FG000|Overall Study|eGFR<50mL/min/m2|2|||
146861437|NCT02202551|529664644|FG001|Overall Study|eGFR<50mL/min/m2|2|||
146861438|NCT02202551|529664645|FG002|Overall Study|eGFR<50mL/min/m2|0|||
146861439|NCT02202551|529664646|FG003|Overall Study|eGFR<50mL/min/m2|1|||
146861440|NCT02349451|529664647|FG000|Overall Study|Withdrawal by Subject|0|||
146861441|NCT02349451|529664648|FG001|Overall Study|Withdrawal by Subject|1|||
146861442|NCT02349451|529664649|FG002|Overall Study|Withdrawal by Subject|2|||
146861443|NCT02349451|529664650|FG003|Overall Study|Withdrawal by Subject|1|||
146861444|NCT01176773|529664659|FG000|Overall Study|Screen Failure|2|||
146861445|NCT01176773|529664659|FG000|Overall Study|Withdrew consent|1|||
146861446|NCT02446886|529664662|FG000|Overall Study|Adverse Event|1|||
146861447|NCT02446886|529664663|FG001|Overall Study|Adverse Event|3|||
146861448|NCT02446886|529664662|FG000|Overall Study|Withdrawal by Subject|1|||
146861449|NCT02446886|529664663|FG001|Overall Study|Withdrawal by Subject|1|||
146861450|NCT00412971|529664676|FG000|Overall Study|Lost to Follow-up|17|||
146861451|NCT00412971|529664677|FG001|Overall Study|Lost to Follow-up|9|||
146861452|NCT00412971|529664676|FG000|Overall Study|Protocol Violation|13|||
146861453|NCT00412971|529664677|FG001|Overall Study|Protocol Violation|1|||
146861454|NCT01106404|529664678|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
146861455|NCT01106404|529664679|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
146861456|NCT01106404|529664678|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
146861457|NCT01106404|529664679|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
146861458|NCT01106404|529664678|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
146861459|NCT01106404|529664679|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
146861460|NCT01106404|529664678|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
146861461|NCT01106404|529664679|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
146861462|NCT00775450|529664680|FG000|Overall Study|Serious Adverse Event|2|||
146861463|NCT00775450|529664681|FG001|Overall Study|Serious Adverse Event|0|||
146861464|NCT00775450|529664682|FG002|Overall Study|Serious Adverse Event|0|||
146861465|NCT00775450|529664683|FG003|Overall Study|Serious Adverse Event|0|||
146861466|NCT00775450|529664684|FG004|Overall Study|Serious Adverse Event|0|||
146861467|NCT00775450|529664680|FG000|Overall Study|Protocol Violation|0|||
146861468|NCT00775450|529664681|FG001|Overall Study|Protocol Violation|0|||
146861469|NCT00775450|529664682|FG002|Overall Study|Protocol Violation|0|||
146861470|NCT00775450|529664683|FG003|Overall Study|Protocol Violation|0|||
146861471|NCT00775450|529664684|FG004|Overall Study|Protocol Violation|1|||
146861472|NCT00775450|529664680|FG000|Overall Study|Withdrawal by Subject|1|||
146861473|NCT00775450|529664681|FG001|Overall Study|Withdrawal by Subject|0|||
146861474|NCT00775450|529664682|FG002|Overall Study|Withdrawal by Subject|0|||
146861475|NCT00775450|529664683|FG003|Overall Study|Withdrawal by Subject|0|||
146861476|NCT00775450|529664684|FG004|Overall Study|Withdrawal by Subject|1|||
146861477|NCT01749540|529664685|FG000|Overall Study|Protocol Violation|0|||
146861478|NCT01749540|529664686|FG001|Overall Study|Protocol Violation|0|||
146861479|NCT01749540|529664687|FG002|Overall Study|Protocol Violation|0|||
146861480|NCT01749540|529664688|FG003|Overall Study|Protocol Violation|0|||
146861481|NCT01749540|529664689|FG004|Overall Study|Protocol Violation|0|||
146861482|NCT01749540|529664690|FG005|Overall Study|Protocol Violation|1|||
146861483|NCT01749540|529664691|FG006|Overall Study|Protocol Violation|1|||
146861484|NCT01749540|529664685|FG000|Overall Study|Withdrawal by Subject|0|||
146861485|NCT01749540|529664686|FG001|Overall Study|Withdrawal by Subject|0|||
146861486|NCT01749540|529664687|FG002|Overall Study|Withdrawal by Subject|0|||
146861487|NCT01749540|529664688|FG003|Overall Study|Withdrawal by Subject|1|||
146861488|NCT01749540|529664689|FG004|Overall Study|Withdrawal by Subject|0|||
146861489|NCT01749540|529664690|FG005|Overall Study|Withdrawal by Subject|0|||
146861490|NCT01749540|529664691|FG006|Overall Study|Withdrawal by Subject|0|||
146861491|NCT01749540|529664685|FG000|Overall Study|Initiated into extension study A536-06|0|||
146861492|NCT01749540|529664686|FG001|Overall Study|Initiated into extension study A536-06|0|||
146861493|NCT01749540|529664687|FG002|Overall Study|Initiated into extension study A536-06|0|||
146861494|NCT01749540|529664688|FG003|Overall Study|Initiated into extension study A536-06|0|||
146861495|NCT01749540|529664689|FG004|Overall Study|Initiated into extension study A536-06|0|||
146861496|NCT01749540|529664690|FG005|Overall Study|Initiated into extension study A536-06|2|||
146861497|NCT01749540|529664691|FG006|Overall Study|Initiated into extension study A536-06|24|||
146861498|NCT00752622|529664692|FG000|Induction Phase|Adverse Event|3|||
146861499|NCT00752622|529664692|FG000|Induction Phase|Other|3|||
146861500|NCT00752622|529664692|FG000|Induction Phase|Non-responder|14|||
146861501|NCT00752622|529664692|FG000|Induction Phase|Withdrawal by Subject|1|||
146861502|NCT00752622|529664692|FG000|Induction Phase|Premature study termination|14|||
146861503|NCT00752622|529664692|FG000|Observational Phase|Premature Study Termination|36|||
146861504|NCT00752622|529664692|FG000|Observational Phase|Non-responder|2|||
146861505|NCT00752622|529664692|FG000|Observational Phase|Withdrawal by Subject|2|||
146861506|NCT00752622|529664692|FG000|Observational Phase|Adverse Event|1|||
146861507|NCT00752622|529664692|FG000|Observational Phase|Other|2|||
146861508|NCT00752622|529664692|FG000|Interventional Phase|Non-responder|2|||
146861509|NCT00752622|529664692|FG000|Interventional Phase|Physician Decision|1|||
146861510|NCT00752622|529664692|FG000|Interventional Phase|Premature Study Termination|5|||
146861511|NCT00576836|529664693|FG000|Overall Study|Death|0|||
146861512|NCT00576836|529664694|FG001|Overall Study|Death|1|||
146861513|NCT00576836|529664693|FG000|Overall Study|Physician Decision|0|||
146861514|NCT00576836|529664694|FG001|Overall Study|Physician Decision|1|||
146861515|NCT00894686|529664695|FG000|Overall Study|Withdrawal by Subject|50|||
146861516|NCT00894686|529664695|FG000|Overall Study|Physician Decision|1|||
146861517|NCT00894686|529664695|FG000|Overall Study|Other|5|||
146861518|NCT00564018|529664698|FG000|Overall Study|Withdrawal by Subject|2|||
146861519|NCT00564018|529664699|FG001|Overall Study|Withdrawal by Subject|3|||
146861520|NCT00564018|529664700|FG002|Overall Study|Withdrawal by Subject|1|||
146861521|NCT03267940|529664701|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
146861522|NCT03267940|529664702|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
146861523|NCT03267940|529664703|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
146861524|NCT03267940|529664704|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
146761843|NCT01981850|529295257|FG008|Main Phase Stage 2|Progressive Disease|0|||
146761844|NCT01981850|529295258|FG009|Main Phase Stage 2|Progressive Disease|0|||
146761845|NCT01981850|529295249|FG000|Open Label Extension (OLE)|Adverse Event|0|||
146761846|NCT01981850|529295250|FG001|Open Label Extension (OLE)|Adverse Event|0|||
146761847|NCT01981850|529295251|FG002|Open Label Extension (OLE)|Adverse Event|0|||
146761848|NCT01981850|529295252|FG003|Open Label Extension (OLE)|Adverse Event|0|||
146761849|NCT01981850|529295253|FG004|Open Label Extension (OLE)|Adverse Event|0|||
146761850|NCT01981850|529295254|FG005|Open Label Extension (OLE)|Adverse Event|0|||
146761851|NCT01981850|529295255|FG006|Open Label Extension (OLE)|Adverse Event|0|||
146761852|NCT01981850|529295256|FG007|Open Label Extension (OLE)|Adverse Event|2|||
146761853|NCT01981850|529295257|FG008|Open Label Extension (OLE)|Adverse Event|1|||
146761854|NCT01981850|529295258|FG009|Open Label Extension (OLE)|Adverse Event|8|||
146761855|NCT01981850|529295249|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
146761856|NCT01981850|529295250|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
146761857|NCT01981850|529295251|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
146761858|NCT01981850|529295252|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
146761859|NCT01981850|529295253|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
146761860|NCT01981850|529295254|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
146761861|NCT01981850|529295255|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
146761862|NCT01981850|529295256|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
146761863|NCT01981850|529295257|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
146761864|NCT01981850|529295258|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
146761865|NCT01981850|529295249|FG000|Open Label Extension (OLE)|Various reasons|0|||
146761866|NCT01981850|529295250|FG001|Open Label Extension (OLE)|Various reasons|0|||
146761867|NCT01981850|529295251|FG002|Open Label Extension (OLE)|Various reasons|0|||
146761868|NCT01981850|529295252|FG003|Open Label Extension (OLE)|Various reasons|0|||
146761869|NCT01981850|529295253|FG004|Open Label Extension (OLE)|Various reasons|0|||
146761870|NCT01981850|529295254|FG005|Open Label Extension (OLE)|Various reasons|0|||
146761871|NCT01981850|529295255|FG006|Open Label Extension (OLE)|Various reasons|0|||
146761872|NCT01981850|529295256|FG007|Open Label Extension (OLE)|Various reasons|3|||
146761873|NCT01981850|529295257|FG008|Open Label Extension (OLE)|Various reasons|1|||
146761874|NCT01981850|529295258|FG009|Open Label Extension (OLE)|Various reasons|3|||
146761875|NCT01981850|529295249|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
146761876|NCT01981850|529295250|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
146761877|NCT01981850|529295251|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
146761878|NCT01981850|529295252|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
146761879|NCT01981850|529295253|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
146761880|NCT01981850|529295254|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
146761881|NCT01981850|529295255|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
146761882|NCT01981850|529295256|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
146761883|NCT01981850|529295257|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
146761884|NCT01981850|529295258|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
146761885|NCT01981850|529295249|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146761886|NCT01981850|529295250|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146761887|NCT01981850|529295251|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146761888|NCT01981850|529295252|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146861525|NCT03267940|529664705|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
146761889|NCT01981850|529295253|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146761890|NCT01981850|529295254|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146861526|NCT03267940|529664706|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
146861527|NCT03267940|529664701|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
146861528|NCT03267940|529664702|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
146861529|NCT03267940|529664703|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
146861530|NCT03267940|529664704|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
146861531|NCT03267940|529664705|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
146861532|NCT03267940|529664706|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
146861533|NCT03267940|529664701|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
146530109|NCT00490035|528449142|FG002|Overall Study|AE, serious fatal|0|||
146530110|NCT00490035|528449143|FG003|Overall Study|AE, serious fatal|0|||
146530111|NCT00490035|528449140|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
146530112|NCT00490035|528449141|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
146530113|NCT00490035|528449142|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
146761891|NCT01981850|529295255|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146761892|NCT01981850|529295256|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146761893|NCT01981850|529295257|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146761894|NCT01981850|529295258|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
146761895|NCT01981850|529295249|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
146761896|NCT01981850|529295250|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
146761897|NCT01981850|529295251|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
146761898|NCT01981850|529295252|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
146761899|NCT01981850|529295253|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
146761900|NCT01981850|529295254|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
146761901|NCT01981850|529295255|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
146761902|NCT01981850|529295256|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
146761903|NCT01981850|529295257|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
146761904|NCT01981850|529295258|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
146761905|NCT01467700|529295259|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
146761906|NCT01467700|529295260|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
146761907|NCT01467700|529295261|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
146761908|NCT01467700|529295262|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
146761909|NCT01467700|529295259|FG000|Overall Study|Major Protocol Deviation|3|||
146761910|NCT01467700|529295260|FG001|Overall Study|Major Protocol Deviation|3|||
146761911|NCT01467700|529295261|FG002|Overall Study|Major Protocol Deviation|2|||
146761912|NCT01467700|529295262|FG003|Overall Study|Major Protocol Deviation|3|||
146761913|NCT01467700|529295259|FG000|Overall Study|Lost to Follow-up|6|||
146761914|NCT01467700|529295260|FG001|Overall Study|Lost to Follow-up|5|||
146761915|NCT01467700|529295261|FG002|Overall Study|Lost to Follow-up|2|||
146761916|NCT01467700|529295262|FG003|Overall Study|Lost to Follow-up|3|||
146761917|NCT01467700|529295259|FG000|Overall Study|Voluntary Withdrawal|5|||
146761918|NCT01467700|529295260|FG001|Overall Study|Voluntary Withdrawal|7|||
146761919|NCT01467700|529295261|FG002|Overall Study|Voluntary Withdrawal|6|||
146761920|NCT01467700|529295262|FG003|Overall Study|Voluntary Withdrawal|2|||
146761921|NCT01467700|529295259|FG000|Overall Study|Study Termination|6|||
146761922|NCT01467700|529295260|FG001|Overall Study|Study Termination|5|||
146761923|NCT01467700|529295261|FG002|Overall Study|Study Termination|10|||
146761924|NCT01467700|529295262|FG003|Overall Study|Study Termination|7|||
146761925|NCT01467700|529295259|FG000|Overall Study|Pregnancy|0|||
146761926|NCT01467700|529295260|FG001|Overall Study|Pregnancy|1|||
146761927|NCT01467700|529295261|FG002|Overall Study|Pregnancy|1|||
146761928|NCT01467700|529295262|FG003|Overall Study|Pregnancy|0|||
146761929|NCT01467700|529295259|FG000|Overall Study|Lack of Efficacy|2|||
146761930|NCT01467700|529295260|FG001|Overall Study|Lack of Efficacy|0|||
146761931|NCT01467700|529295261|FG002|Overall Study|Lack of Efficacy|2|||
146761932|NCT01467700|529295262|FG003|Overall Study|Lack of Efficacy|1|||
146761933|NCT01467700|529295259|FG000|Overall Study|Reason not Specified|1|||
146761934|NCT01467700|529295260|FG001|Overall Study|Reason not Specified|3|||
146761935|NCT01467700|529295261|FG002|Overall Study|Reason not Specified|2|||
146761936|NCT01467700|529295262|FG003|Overall Study|Reason not Specified|8|||
146761937|NCT03523962|529295263|FG000|Closed Fractures|Death|86|||
146761938|NCT03523962|529295264|FG001|Closed Fractures|Death|71|||
146761939|NCT03523962|529295265|FG002|Closed Fractures|Death|0|||
146761940|NCT03523962|529295266|FG003|Closed Fractures|Death|0|||
146761941|NCT03523962|529295263|FG000|Closed Fractures|Lost to Follow-up|62|||
146761942|NCT03523962|529295264|FG001|Closed Fractures|Lost to Follow-up|36|||
146761943|NCT03523962|529295265|FG002|Closed Fractures|Lost to Follow-up|0|||
146761944|NCT03523962|529295266|FG003|Closed Fractures|Lost to Follow-up|0|||
146761945|NCT03523962|529295263|FG000|Closed Fractures|Withdrawal by Subject|19|||
146761946|NCT03523962|529295264|FG001|Closed Fractures|Withdrawal by Subject|29|||
146761947|NCT03523962|529295265|FG002|Closed Fractures|Withdrawal by Subject|0|||
146761948|NCT03523962|529295266|FG003|Closed Fractures|Withdrawal by Subject|0|||
146761949|NCT03523962|529295263|FG000|Closed Fractures|Incarceration|1|||
146761950|NCT03523962|529295264|FG001|Closed Fractures|Incarceration|4|||
146761951|NCT03523962|529295265|FG002|Closed Fractures|Incarceration|0|||
146861534|NCT03267940|529664702|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
146861535|NCT03267940|529664703|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
146861536|NCT03267940|529664704|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
146861537|NCT03267940|529664705|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
146861538|NCT03267940|529664706|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
146861539|NCT03267940|529664701|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
146861540|NCT03267940|529664702|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
146861541|NCT03267940|529664703|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
146861542|NCT03267940|529664704|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
146861543|NCT03267940|529664705|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
146861544|NCT03267940|529664706|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
146861545|NCT03267940|529664701|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
146861546|NCT03267940|529664702|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
146861547|NCT03267940|529664703|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
146861548|NCT03267940|529664704|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
146861549|NCT03267940|529664705|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
146861550|NCT03267940|529664706|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
146861551|NCT03267940|529664701|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
146861552|NCT03267940|529664702|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
146861553|NCT03267940|529664703|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
146861554|NCT03267940|529664704|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
146861555|NCT03267940|529664705|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
146861556|NCT03267940|529664706|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
146861557|NCT03267940|529664701|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
146861558|NCT03267940|529664702|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
146861559|NCT03267940|529664703|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
146861560|NCT03267940|529664704|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
146861561|NCT03267940|529664705|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
146861562|NCT03267940|529664706|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
146861563|NCT03267940|529664701|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
146861564|NCT03267940|529664702|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
146861565|NCT03267940|529664703|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
146861566|NCT03267940|529664704|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
146861567|NCT03267940|529664705|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
146861568|NCT03267940|529664706|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
146861569|NCT03267940|529664701|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
146861570|NCT03267940|529664702|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
146861571|NCT03267940|529664703|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
146861572|NCT03267940|529664704|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
146861573|NCT03267940|529664705|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
146861574|NCT03267940|529664706|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
146861575|NCT00388154|529664713|FG000|Overall Study|Withdrawal by Subject|1|||
146861576|NCT01074216|529664714|FG000|Overall Study|Physician Decision|1|||
146861577|NCT01074216|529664714|FG000|Overall Study|Not Treated|12|||
146530114|NCT00490035|528449143|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
146530115|NCT00490035|528449140|FG000|Overall Study|AE of unknown type|0|||
146530116|NCT00490035|528449141|FG001|Overall Study|AE of unknown type|0|||
146530117|NCT00490035|528449142|FG002|Overall Study|AE of unknown type|2|||
146530118|NCT00490035|528449143|FG003|Overall Study|AE of unknown type|0|||
146530119|NCT06058390|528449144|FG000|Overall Study|Lost to Follow-up|0|||
146530120|NCT06058390|528449145|FG001|Overall Study|Lost to Follow-up|0|||
146530121|NCT06058390|528449146|FG002|Overall Study|Lost to Follow-up|2|||
146530122|NCT06058390|528449147|FG003|Overall Study|Lost to Follow-up|1|||
146530123|NCT06058390|528449144|FG000|Overall Study|Physician Decision|0|||
146530124|NCT06058390|528449145|FG001|Overall Study|Physician Decision|0|||
146530125|NCT06058390|528449146|FG002|Overall Study|Physician Decision|0|||
146530126|NCT06058390|528449147|FG003|Overall Study|Physician Decision|1|||
146861578|NCT03737474|529664715|FG000|Overall Study|Adverse Event|18|||
146861579|NCT03737474|529664716|FG001|Overall Study|Adverse Event|48|||
146861580|NCT03737474|529664715|FG000|Overall Study|Lack of Efficacy|1|||
146530127|NCT06058390|528449144|FG000|Overall Study|Participants did not receive any study intervention|0|||
146530128|NCT06058390|528449145|FG001|Overall Study|Participants did not receive any study intervention|0|||
146530129|NCT06058390|528449146|FG002|Overall Study|Participants did not receive any study intervention|0|||
146530130|NCT06058390|528449147|FG003|Overall Study|Participants did not receive any study intervention|1|||
146530131|NCT02495389|528449148|FG000|Overall Study|Withdrawal by Subject|40|||
146530132|NCT01802385|528449150|FG000|Overall Study|Death|106|||
146861581|NCT03737474|529664716|FG001|Overall Study|Lack of Efficacy|3|||
146861582|NCT03737474|529664715|FG000|Overall Study|Protocol Violation|0|||
146861583|NCT03737474|529664716|FG001|Overall Study|Protocol Violation|8|||
146861584|NCT03737474|529664715|FG000|Overall Study|Withdrawal by Subject|5|||
146861585|NCT03737474|529664716|FG001|Overall Study|Withdrawal by Subject|20|||
146861586|NCT03737474|529664715|FG000|Overall Study|Non-compliance With Study Drug|0|||
146861587|NCT03737474|529664716|FG001|Overall Study|Non-compliance With Study Drug|1|||
146861588|NCT03737474|529664715|FG000|Overall Study|Physician Decision|1|||
146861589|NCT03737474|529664716|FG001|Overall Study|Physician Decision|4|||
146861590|NCT02370043|529664717|FG000|Overall Study|Withdrawal by Subject|0|||
146861591|NCT02370043|529664718|FG001|Overall Study|Withdrawal by Subject|0|||
146861592|NCT02370043|529664719|FG002|Overall Study|Withdrawal by Subject|0|||
146861593|NCT02370043|529664720|FG003|Overall Study|Withdrawal by Subject|0|||
146861594|NCT02370043|529664721|FG004|Overall Study|Withdrawal by Subject|1|||
146861595|NCT02370043|529664722|FG005|Overall Study|Withdrawal by Subject|1|||
146861596|NCT01231516|529664723|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
146861597|NCT01231516|529664724|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
146861598|NCT01231516|529664723|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
146861599|NCT01231516|529664724|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
146861600|NCT01231516|529664723|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
146861601|NCT01231516|529664724|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
146861602|NCT01231516|529664723|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
146861603|NCT01231516|529664724|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
146861604|NCT01231516|529664723|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
146861605|NCT01231516|529664724|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
146861606|NCT01231516|529664723|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
146861607|NCT01231516|529664724|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
146861608|NCT01231516|529664723|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
146861609|NCT01231516|529664724|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
146861610|NCT01231516|529664723|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
146861611|NCT01231516|529664724|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
146861612|NCT01231516|529664723|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
146861613|NCT01231516|529664724|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
146861614|NCT01231516|529664723|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
146861615|NCT01231516|529664724|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
146861616|NCT01231516|529664723|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
146861617|NCT01231516|529664724|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
146861618|NCT01231516|529664723|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
146861619|NCT01231516|529664724|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
146861620|NCT01231516|529664723|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
146861621|NCT01231516|529664724|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
146861622|NCT01231516|529664723|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
146861623|NCT01231516|529664724|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
146861624|NCT01231516|529664723|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
146861625|NCT01231516|529664724|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
146861626|NCT01231516|529664723|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
146861627|NCT01231516|529664724|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
146861628|NCT05266586|529664725|FG000|Overall Study|Adverse Event|2|||
146861629|NCT05266586|529664726|FG001|Overall Study|Adverse Event|2|||
146861630|NCT05266586|529664727|FG002|Overall Study|Adverse Event|1|||
146861631|NCT05266586|529664725|FG000|Overall Study|Withdrawal by Subject|1|||
146861632|NCT05266586|529664726|FG001|Overall Study|Withdrawal by Subject|0|||
146861633|NCT05266586|529664727|FG002|Overall Study|Withdrawal by Subject|1|||
146861634|NCT05266586|529664725|FG000|Overall Study|Non-compliance with study drug|0|||
146861635|NCT05266586|529664726|FG001|Overall Study|Non-compliance with study drug|1|||
146861636|NCT05266586|529664727|FG002|Overall Study|Non-compliance with study drug|0|||
146861637|NCT05266586|529664725|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
146861638|NCT05266586|529664726|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
146861639|NCT05266586|529664727|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
146530133|NCT01802385|528449151|FG001|Overall Study|Death|120|||
146530134|NCT05559905|528449152|FG000|Overall Study|Withdrawal by Subject|1|||
146530135|NCT05559905|528449153|FG001|Overall Study|Withdrawal by Subject|0|||
146530136|NCT05559905|528449154|FG002|Overall Study|Withdrawal by Subject|0|||
146861640|NCT03707925|529664728|FG000|Overall Study|Inevaluable|1|||
146861641|NCT01117857|529664731|FG000|Overall Study|Lost to Follow-up|4|||
146861642|NCT01117857|529664731|FG000|Overall Study|Withdrawal by Subject|4|||
146861643|NCT01117857|529664731|FG000|Overall Study|Physician Decision|1|||
146861644|NCT02876835|529664732|FG000|Treatment Period (51.1 Month)|Other|1|||
146861645|NCT02876835|529664733|FG001|Treatment Period (51.1 Month)|Other|0|||
146861646|NCT02876835|529664732|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
146861647|NCT02876835|529664733|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
146861648|NCT02876835|529664732|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
146861649|NCT02876835|529664733|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
146861650|NCT02876835|529664732|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
146861651|NCT02876835|529664733|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
146861652|NCT04683731|529664734|FG000|Overall Study|Withdrawal by Subject|1|||
146861653|NCT04683731|529664735|FG001|Overall Study|Withdrawal by Subject|0|||
146861654|NCT04683731|529664736|FG002|Overall Study|Withdrawal by Subject|3|||
146861655|NCT04683731|529664737|FG003|Overall Study|Withdrawal by Subject|2|||
146861656|NCT04683731|529664734|FG000|Overall Study|Determined patient was not eligible|3|||
146861657|NCT04683731|529664735|FG001|Overall Study|Determined patient was not eligible|3|||
146861658|NCT04683731|529664736|FG002|Overall Study|Determined patient was not eligible|12|||
146861659|NCT04683731|529664737|FG003|Overall Study|Determined patient was not eligible|3|||
146861660|NCT00883051|529664739|FG000|Overall Study|Lost to Follow-up|0|||
146861661|NCT00883051|529664740|FG001|Overall Study|Lost to Follow-up|0|||
146861662|NCT00883051|529664741|FG002|Overall Study|Lost to Follow-up|0|||
146861663|NCT00883051|529664742|FG003|Overall Study|Lost to Follow-up|0|||
146861664|NCT00883051|529664743|FG004|Overall Study|Lost to Follow-up|1|||
146861665|NCT00883051|529664739|FG000|Overall Study|Did not use study medication|24|||
146861666|NCT00883051|529664740|FG001|Overall Study|Did not use study medication|22|||
146861667|NCT00883051|529664741|FG002|Overall Study|Did not use study medication|29|||
146861668|NCT00883051|529664742|FG003|Overall Study|Did not use study medication|29|||
146861669|NCT00883051|529664743|FG004|Overall Study|Did not use study medication|17|||
146861670|NCT01411839|529664744|FG000|Overall Study|Lost to Follow-up|4|||
146861671|NCT01411839|529664745|FG001|Overall Study|Lost to Follow-up|3|||
146861672|NCT03282240|529664746|FG000|Overall Study|Adverse Event|2|||
146861673|NCT03282240|529664747|FG001|Overall Study|Adverse Event|2|||
146861674|NCT03282240|529664748|FG002|Overall Study|Adverse Event|0|||
146861675|NCT03282240|529664746|FG000|Overall Study|Lost to Follow-up|3|||
146861676|NCT03282240|529664747|FG001|Overall Study|Lost to Follow-up|0|||
146861677|NCT03282240|529664748|FG002|Overall Study|Lost to Follow-up|0|||
146861678|NCT03282240|529664746|FG000|Overall Study|Protocol Deviation|4|||
146861679|NCT03282240|529664747|FG001|Overall Study|Protocol Deviation|1|||
146861680|NCT03282240|529664748|FG002|Overall Study|Protocol Deviation|2|||
146861681|NCT03282240|529664746|FG000|Overall Study|Withdrawal by Subject|1|||
146530137|NCT05559905|528449152|FG000|Overall Study|Not Reported|1|||
146530138|NCT05559905|528449153|FG001|Overall Study|Not Reported|0|||
146530139|NCT05559905|528449154|FG002|Overall Study|Not Reported|0|||
146530140|NCT04003103|528449155|FG000|Overall Study|Death|1|||
146530141|NCT04003103|528449156|FG001|Overall Study|Death|0|||
146530142|NCT04003103|528449157|FG002|Overall Study|Death|0|||
146530143|NCT04003103|528449155|FG000|Overall Study|Lost to Follow-up|4|||
146530144|NCT04003103|528449156|FG001|Overall Study|Lost to Follow-up|3|||
146861682|NCT03282240|529664747|FG001|Overall Study|Withdrawal by Subject|0|||
146861683|NCT03282240|529664748|FG002|Overall Study|Withdrawal by Subject|1|||
146861684|NCT01675479|529664749|FG000|Overall Study|Lost to Follow-up|11|||
146861685|NCT04751656|529666481|FG000|Overall Study|Lost to Follow-up|1|||
146861686|NCT01485354|529666484|FG000|Overall Study|Withdrawal by Subject|5|||
146861687|NCT03566810|529666485|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
146861688|NCT03566810|529666486|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
146861689|NCT03566810|529666487|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
146861690|NCT03566810|529666488|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
146861691|NCT01103245|529666489|FG000|Overall Study|Withdrawal by Subject|1|||
146861692|NCT01103245|529666490|FG001|Overall Study|Withdrawal by Subject|0|||
146861693|NCT01103245|529666491|FG002|Overall Study|Withdrawal by Subject|3|||
146861694|NCT01103245|529666492|FG003|Overall Study|Withdrawal by Subject|0|||
146861695|NCT01103245|529666489|FG000|Overall Study|Inadequate IV access|1|||
146861696|NCT01103245|529666490|FG001|Overall Study|Inadequate IV access|0|||
146861697|NCT01103245|529666491|FG002|Overall Study|Inadequate IV access|0|||
146861698|NCT01103245|529666492|FG003|Overall Study|Inadequate IV access|0|||
146861699|NCT01103245|529666489|FG000|Overall Study|Adverse Event|0|||
146861700|NCT01103245|529666490|FG001|Overall Study|Adverse Event|2|||
146530145|NCT04003103|528449157|FG002|Overall Study|Lost to Follow-up|2|||
146530146|NCT04003103|528449155|FG000|Overall Study|Withdrawal by Subject|10|||
146861701|NCT01103245|529666491|FG002|Overall Study|Adverse Event|1|||
146861702|NCT01103245|529666492|FG003|Overall Study|Adverse Event|0|||
146861703|NCT01103245|529666489|FG000|Overall Study|Physician Decision|1|||
146861704|NCT01103245|529666490|FG001|Overall Study|Physician Decision|0|||
146861705|NCT01103245|529666491|FG002|Overall Study|Physician Decision|0|||
146861706|NCT01103245|529666492|FG003|Overall Study|Physician Decision|0|||
146861707|NCT00826111|529666493|FG000|Overall Study|Lost to Follow-up|0|||
146861708|NCT00826111|529666494|FG001|Overall Study|Lost to Follow-up|1|||
146861709|NCT00826111|529666493|FG000|Overall Study|Protocol Violation|1|||
146861710|NCT00826111|529666494|FG001|Overall Study|Protocol Violation|0|||
146861711|NCT00826111|529666493|FG000|Overall Study|Withdrawal by Subject|5|||
146530147|NCT04003103|528449156|FG001|Overall Study|Withdrawal by Subject|1|||
146861712|NCT00826111|529666494|FG001|Overall Study|Withdrawal by Subject|0|||
146861713|NCT00826111|529666493|FG000|Overall Study|Physician Decision|1|||
146861714|NCT00826111|529666494|FG001|Overall Study|Physician Decision|1|||
146861715|NCT02805725|529666495|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
146861716|NCT02805725|529666496|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
146861717|NCT02805725|529666497|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
146861718|NCT02805725|529666498|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
146861719|NCT02805725|529666499|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
146861720|NCT02805725|529666495|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
146861721|NCT02805725|529666496|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
146861722|NCT02805725|529666497|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
146861723|NCT02805725|529666498|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
146861724|NCT02805725|529666499|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
146861725|NCT02805725|529666495|FG000|Phase II|Protocol Violation|0|||
146861726|NCT02805725|529666496|FG001|Phase II|Protocol Violation|0|||
146861727|NCT02805725|529666497|FG002|Phase II|Protocol Violation|0|||
146861728|NCT02805725|529666498|FG003|Phase II|Protocol Violation|0|||
146861729|NCT02805725|529666499|FG004|Phase II|Protocol Violation|6|||
146861730|NCT01195545|529666502|FG000|Overall Study|Protocol Violation|4|||
146861731|NCT03511053|529666505|FG000|Overall Study|Withdrawal by Subject|1|||
146861732|NCT02425644|529666506|FG000|Overall Study|Lost to Follow-up|2|||
146861733|NCT02425644|529666507|FG001|Overall Study|Lost to Follow-up|3|||
146861734|NCT02425644|529666506|FG000|Overall Study|Withdrawal by Subject|41|||
146861735|NCT02425644|529666507|FG001|Overall Study|Withdrawal by Subject|36|||
146861736|NCT02425644|529666506|FG000|Overall Study|Lack of Efficacy|3|||
146861737|NCT02425644|529666507|FG001|Overall Study|Lack of Efficacy|10|||
146861738|NCT02425644|529666506|FG000|Overall Study|Adverse Event|13|||
146861739|NCT02425644|529666507|FG001|Overall Study|Adverse Event|3|||
146861740|NCT02425644|529666506|FG000|Overall Study|Death|0|||
146861741|NCT02425644|529666507|FG001|Overall Study|Death|2|||
146861742|NCT02425644|529666506|FG000|Overall Study|Other|18|||
146861743|NCT02425644|529666507|FG001|Overall Study|Other|17|||
146861744|NCT02720536|529666510|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
146861745|NCT02720536|529666510|FG000|Overall Study|PR - pregnancy|2|||
146861746|NCT02720536|529666510|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
146861747|NCT02720536|529666510|FG000|Overall Study|PR - death|1|||
146861748|NCT02720536|529666510|FG000|Overall Study|PR - adverse event|1|||
146861749|NCT02720536|529666510|FG000|Overall Study|PR - abnormal lab value(s)|1|||
146861750|NCT02720536|529666510|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
146861751|NCT01028222|529666511|FG000|Overall Study|Protocol deviation|1|||
146861752|NCT01028222|529666512|FG001|Overall Study|Protocol deviation|0|||
146861753|NCT01028222|529666511|FG000|Overall Study|Disease progression|33|||
146861754|NCT01028222|529666512|FG001|Overall Study|Disease progression|9|||
146861755|NCT01028222|529666511|FG000|Overall Study|Administrative problems|1|||
146861756|NCT01028222|529666512|FG001|Overall Study|Administrative problems|1|||
146861757|NCT01028222|529666511|FG000|Overall Study|Lost to Follow-up|0|||
146861758|NCT01028222|529666512|FG001|Overall Study|Lost to Follow-up|1|||
146861759|NCT01028222|529666511|FG000|Overall Study|Withdrawal by Subject|1|||
146861760|NCT01028222|529666512|FG001|Overall Study|Withdrawal by Subject|0|||
146861761|NCT01028222|529666511|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
146861762|NCT01028222|529666512|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
146861763|NCT01028222|529666511|FG000|Overall Study|Adverse Event|2|||
146861764|NCT01028222|529666512|FG001|Overall Study|Adverse Event|0|||
146861765|NCT00300781|529666513|FG000|Overall Study|Disease Progression|55|||
146861766|NCT00300781|529666514|FG001|Overall Study|Disease Progression|52|||
146861767|NCT00300781|529666513|FG000|Overall Study|Adverse Event|5|||
146861768|NCT00300781|529666514|FG001|Overall Study|Adverse Event|6|||
146861769|NCT00300781|529666513|FG000|Overall Study|Withdrawal by Subject|1|||
146861770|NCT00300781|529666514|FG001|Overall Study|Withdrawal by Subject|2|||
146861771|NCT00300781|529666513|FG000|Overall Study|Physician Decision|1|||
146861772|NCT00300781|529666514|FG001|Overall Study|Physician Decision|0|||
146861773|NCT00300781|529666513|FG000|Overall Study|Not Recorded|0|||
146861774|NCT00300781|529666514|FG001|Overall Study|Not Recorded|1|||
146861775|NCT00300781|529666513|FG000|Overall Study|Symptomatic Deterioration|1|||
146861776|NCT00300781|529666514|FG001|Overall Study|Symptomatic Deterioration|0|||
146861777|NCT00300781|529666513|FG000|Overall Study|Lost to Follow-up|0|||
146861778|NCT00300781|529666514|FG001|Overall Study|Lost to Follow-up|1|||
146861779|NCT00567268|529666515|FG000|Overall Study|Protocol Violation|7|||
146861780|NCT00567268|529666515|FG000|Overall Study|Lost to Follow-up|36|||
146861781|NCT00567268|529666515|FG000|Overall Study|No Visit After First Day of Treatment|2|||
146861782|NCT00567268|529666515|FG000|Overall Study|No Drug Administration|4|||
146861783|NCT00567268|529666515|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
146861784|NCT03236246|529666516|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
146861785|NCT03236246|529666517|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
146861786|NCT03236246|529666516|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
146861787|NCT03236246|529666517|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
146530148|NCT04003103|528449157|FG002|Overall Study|Withdrawal by Subject|1|||
146530149|NCT04003103|528449155|FG000|Overall Study|Status not recorded|0|||
146861788|NCT03236246|529666516|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
146861789|NCT03236246|529666517|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
146861790|NCT03236246|529666516|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
146861791|NCT03236246|529666517|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
146861792|NCT03236246|529666516|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
146861793|NCT03236246|529666517|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
146861794|NCT03236246|529666516|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
146861795|NCT03236246|529666517|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
146861796|NCT03236246|529666516|FG000|24-Week Dose Titration Period|Death|3|||
146861797|NCT03236246|529666517|FG001|24-Week Dose Titration Period|Death|1|||
146861798|NCT03236246|529666516|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
146861799|NCT03236246|529666517|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
146861800|NCT03236246|529666516|FG000|24-Week Dose Titration Period|Adverse Event|7|||
146861801|NCT03236246|529666517|FG001|24-Week Dose Titration Period|Adverse Event|8|||
146861802|NCT03236246|529666516|FG000|24-Week Dose Titration Period|Captured as Other|1|||
146861803|NCT03236246|529666517|FG001|24-Week Dose Titration Period|Captured as Other|2|||
146861804|NCT03236246|529666516|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
146861805|NCT03236246|529666517|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
146861806|NCT03236246|529666516|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
146861807|NCT03236246|529666517|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
146861808|NCT03236246|529666516|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
146861809|NCT03236246|529666517|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
146861810|NCT03236246|529666516|FG000|24-Week Dose Maintenance Period|Death|0|||
146861811|NCT03236246|529666517|FG001|24-Week Dose Maintenance Period|Death|1|||
146861812|NCT03236246|529666516|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
146861813|NCT03236246|529666517|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
146861814|NCT02598557|529666518|FG000|Overall Study|Withdrawal by Subject|1|||
146861815|NCT02598557|529666519|FG001|Overall Study|Withdrawal by Subject|0|||
146861816|NCT02598557|529666520|FG002|Overall Study|Withdrawal by Subject|1|||
146861817|NCT02598557|529666518|FG000|Overall Study|Participant did not start treatment|2|||
146861818|NCT02598557|529666519|FG001|Overall Study|Participant did not start treatment|1|||
146861819|NCT02598557|529666520|FG002|Overall Study|Participant did not start treatment|1|||
146861820|NCT02598557|529666518|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
146861821|NCT02598557|529666519|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
146861822|NCT02598557|529666520|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
146861823|NCT02598557|529666518|FG000|Overall Study|Adverse Event|1|||
146861824|NCT02598557|529666519|FG001|Overall Study|Adverse Event|1|||
146861825|NCT02598557|529666520|FG002|Overall Study|Adverse Event|0|||
146861826|NCT02072434|529666521|FG000|Overall Study|Protocol Violation|10|||
146861827|NCT02072434|529666522|FG001|Overall Study|Protocol Violation|9|||
146861828|NCT02072434|529666521|FG000|Overall Study|Physician Decision|5|||
146861829|NCT02072434|529666522|FG001|Overall Study|Physician Decision|10|||
146861830|NCT02072434|529666521|FG000|Overall Study|Adverse event, serious fatal|1|||
146861831|NCT02072434|529666522|FG001|Overall Study|Adverse event, serious fatal|6|||
146861832|NCT02072434|529666521|FG000|Overall Study|Adverse Event|7|||
146861833|NCT02072434|529666522|FG001|Overall Study|Adverse Event|6|||
146861834|NCT02072434|529666521|FG000|Overall Study|Withdrawal by Subject|17|||
146861835|NCT02072434|529666522|FG001|Overall Study|Withdrawal by Subject|29|||
146861836|NCT02072434|529666521|FG000|Overall Study|Other|14|||
146861837|NCT02072434|529666522|FG001|Overall Study|Other|29|||
146861838|NCT02072434|529666521|FG000|Overall Study|Lost to Follow-up|0|||
146861839|NCT02072434|529666522|FG001|Overall Study|Lost to Follow-up|1|||
146861840|NCT00888433|529666527|FG000|Overall Study|Withdrawal by Subject|1|||
146861841|NCT00888433|529666528|FG001|Overall Study|Withdrawal by Subject|2|||
146530150|NCT04003103|528449156|FG001|Overall Study|Status not recorded|2|||
146530151|NCT04003103|528449157|FG002|Overall Study|Status not recorded|0|||
146530152|NCT05518539|528449160|FG000|Overall Study|Lost to Follow-up|6|||
146530153|NCT03589807|528449163|FG000|Overall Study|Lost to Follow-up|0|||
146530154|NCT03589807|528449164|FG001|Overall Study|Lost to Follow-up|2|||
146530155|NCT03589807|528449165|FG002|Overall Study|Lost to Follow-up|2|||
146530156|NCT03589807|528449166|FG003|Overall Study|Lost to Follow-up|3|||
146861842|NCT00888433|529666527|FG000|Overall Study|Missed Visit|2|||
146861843|NCT00888433|529666528|FG001|Overall Study|Missed Visit|1|||
146861844|NCT01794520|529666529|FG000|Overall Study|Adverse events- related to progression|0|||
146861845|NCT01794520|529666530|FG001|Overall Study|Adverse events- related to progression|0|||
146861846|NCT01794520|529666531|FG002|Overall Study|Adverse events- related to progression|1|||
146861847|NCT01794520|529666532|FG003|Overall Study|Adverse events- related to progression|2|||
146861848|NCT01794520|529666533|FG004|Overall Study|Adverse events- related to progression|0|||
146530157|NCT03589807|528449167|FG004|Overall Study|Lost to Follow-up|1|||
146530158|NCT03589807|528449168|FG005|Overall Study|Lost to Follow-up|1|||
146530159|NCT03589807|528449163|FG000|Overall Study|Withdrawal by Subject|0|||
146530160|NCT03589807|528449164|FG001|Overall Study|Withdrawal by Subject|5|||
146530161|NCT03589807|528449165|FG002|Overall Study|Withdrawal by Subject|0|||
146530162|NCT03589807|528449166|FG003|Overall Study|Withdrawal by Subject|0|||
146761952|NCT03523962|529295266|FG003|Closed Fractures|Incarceration|0|||
146761953|NCT03523962|529295263|FG000|Open Fractures|Death|0|||
146761954|NCT03523962|529295264|FG001|Open Fractures|Death|0|||
146761955|NCT03523962|529295265|FG002|Open Fractures|Death|11|||
146761956|NCT03523962|529295266|FG003|Open Fractures|Death|6|||
146761957|NCT03523962|529295263|FG000|Open Fractures|Lost to Follow-up|0|||
146761958|NCT03523962|529295264|FG001|Open Fractures|Lost to Follow-up|0|||
146761959|NCT03523962|529295265|FG002|Open Fractures|Lost to Follow-up|15|||
146761960|NCT03523962|529295266|FG003|Open Fractures|Lost to Follow-up|8|||
146761961|NCT03523962|529295263|FG000|Open Fractures|Withdrawal by Subject|0|||
146761962|NCT03523962|529295264|FG001|Open Fractures|Withdrawal by Subject|0|||
146761963|NCT03523962|529295265|FG002|Open Fractures|Withdrawal by Subject|6|||
146761964|NCT03523962|529295266|FG003|Open Fractures|Withdrawal by Subject|2|||
146761965|NCT03523962|529295263|FG000|Open Fractures|Incarceration|0|||
146761966|NCT03523962|529295264|FG001|Open Fractures|Incarceration|0|||
146761967|NCT03523962|529295265|FG002|Open Fractures|Incarceration|1|||
146761968|NCT03523962|529295266|FG003|Open Fractures|Incarceration|0|||
146761969|NCT00121199|529295277|FG000|Overall Study|Adverse Event|11|||
146761970|NCT00121199|529295277|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
146761971|NCT00121199|529295277|FG000|Overall Study|Progression/Relapse|1|||
146761972|NCT00121199|529295277|FG000|Overall Study|Death|3|||
146761973|NCT00121199|529295277|FG000|Overall Study|Other - Not Protocol Specified|3|||
146761974|NCT00121199|529295277|FG000|Overall Study|Ineligible|9|||
146761975|NCT03168438|529295278|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
146761976|NCT03168438|529295279|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
146761977|NCT01018511|529295281|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
146761978|NCT01018511|529295282|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
146761979|NCT01018511|529295283|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
146761980|NCT01018511|529295284|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
146761981|NCT01018511|529295281|FG000|Overall Study|Adverse Event|5|||
146761982|NCT01018511|529295282|FG001|Overall Study|Adverse Event|9|||
146761983|NCT01018511|529295283|FG002|Overall Study|Adverse Event|13|||
146761984|NCT01018511|529295284|FG003|Overall Study|Adverse Event|10|||
146761985|NCT01018511|529295281|FG000|Overall Study|Lack of Efficacy|4|||
146761986|NCT01018511|529295282|FG001|Overall Study|Lack of Efficacy|1|||
146761987|NCT01018511|529295283|FG002|Overall Study|Lack of Efficacy|1|||
146761988|NCT01018511|529295284|FG003|Overall Study|Lack of Efficacy|2|||
146761989|NCT01018511|529295281|FG000|Overall Study|Withdrawal by Subject|6|||
146761990|NCT01018511|529295282|FG001|Overall Study|Withdrawal by Subject|5|||
146761991|NCT01018511|529295283|FG002|Overall Study|Withdrawal by Subject|11|||
146761992|NCT01018511|529295284|FG003|Overall Study|Withdrawal by Subject|9|||
146761993|NCT01018511|529295281|FG000|Overall Study|Lost to Follow-up|0|||
146761994|NCT01018511|529295282|FG001|Overall Study|Lost to Follow-up|0|||
146761995|NCT01018511|529295283|FG002|Overall Study|Lost to Follow-up|1|||
146761996|NCT01018511|529295284|FG003|Overall Study|Lost to Follow-up|0|||
146761997|NCT01018511|529295281|FG000|Overall Study|Protocol Violation|5|||
146761998|NCT01018511|529295282|FG001|Overall Study|Protocol Violation|8|||
146761999|NCT01018511|529295283|FG002|Overall Study|Protocol Violation|7|||
146762000|NCT01018511|529295284|FG003|Overall Study|Protocol Violation|9|||
146762001|NCT01018511|529295281|FG000|Overall Study|Miscellaneous|0|||
146762002|NCT01018511|529295282|FG001|Overall Study|Miscellaneous|2|||
146762003|NCT01018511|529295283|FG002|Overall Study|Miscellaneous|0|||
146762004|NCT01018511|529295284|FG003|Overall Study|Miscellaneous|0|||
146762005|NCT04523181|529295285|FG000|Overall Study|Withdrawal by Subject|4|||
146762006|NCT04523181|529295286|FG001|Overall Study|Withdrawal by Subject|5|||
146762007|NCT04523181|529295285|FG000|Overall Study|Lost to Follow-up|2|||
146762008|NCT04523181|529295286|FG001|Overall Study|Lost to Follow-up|3|||
146762009|NCT04523181|529295285|FG000|Overall Study|Physician Decision|1|||
146762010|NCT04523181|529295286|FG001|Overall Study|Physician Decision|0|||
146762011|NCT04523181|529295285|FG000|Overall Study|Transferred to external facility.|1|||
146762012|NCT04523181|529295286|FG001|Overall Study|Transferred to external facility.|1|||
146762013|NCT04305912|529295288|FG000|First Intervention|COVID-19 Suspension|2|||
146762014|NCT04305912|529295289|FG001|First Intervention|COVID-19 Suspension|0|||
146762015|NCT04305912|529295288|FG000|First Intervention|Withdrawal by Subject|0|||
146762016|NCT04305912|529295289|FG001|First Intervention|Withdrawal by Subject|1|||
146762017|NCT04305912|529295288|FG000|Second Intervention|Adverse Event|0|||
146762018|NCT04305912|529295289|FG001|Second Intervention|Adverse Event|1|||
146762019|NCT02138916|529295294|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
146762020|NCT02138916|529295295|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
146762021|NCT02138916|529295296|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
146762022|NCT02138916|529295294|FG000|Overall Study|Death|14|||
146762023|NCT02138916|529295295|FG001|Overall Study|Death|11|||
146530163|NCT03589807|528449167|FG004|Overall Study|Withdrawal by Subject|0|||
146530164|NCT03589807|528449168|FG005|Overall Study|Withdrawal by Subject|0|||
146530165|NCT03589807|528449163|FG000|Overall Study|Protocol Violation|0|||
146762024|NCT02138916|529295296|FG002|Overall Study|Death|12|||
146762025|NCT02138916|529295294|FG000|Overall Study|Withdrawal by Subject|27|||
146762026|NCT02138916|529295295|FG001|Overall Study|Withdrawal by Subject|31|||
146762027|NCT02138916|529295296|FG002|Overall Study|Withdrawal by Subject|32|||
146762028|NCT02138916|529295294|FG000|Overall Study|Study specific withdrawal criteria|0|||
146762029|NCT02138916|529295295|FG001|Overall Study|Study specific withdrawal criteria|0|||
146762030|NCT02138916|529295296|FG002|Overall Study|Study specific withdrawal criteria|1|||
146762031|NCT02138916|529295294|FG000|Overall Study|incorrect enrolment|1|||
146762032|NCT02138916|529295295|FG001|Overall Study|incorrect enrolment|1|||
146762033|NCT02138916|529295296|FG002|Overall Study|incorrect enrolment|0|||
146762034|NCT02138916|529295294|FG000|Overall Study|Severe non-compliance|1|||
146762035|NCT02138916|529295295|FG001|Overall Study|Severe non-compliance|2|||
146762036|NCT02138916|529295296|FG002|Overall Study|Severe non-compliance|1|||
146762037|NCT02138916|529295294|FG000|Overall Study|Lost to Follow-up|4|||
146762038|NCT02138916|529295295|FG001|Overall Study|Lost to Follow-up|2|||
146762039|NCT02138916|529295296|FG002|Overall Study|Lost to Follow-up|3|||
146762040|NCT02138916|529295294|FG000|Overall Study|Adverse Event|4|||
146762041|NCT02138916|529295295|FG001|Overall Study|Adverse Event|4|||
146762042|NCT02138916|529295296|FG002|Overall Study|Adverse Event|3|||
146762043|NCT01348087|529295297|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
146762044|NCT01348087|529295297|FG000|Overall Study|Administrative problems|79|||
146762045|NCT01348087|529295297|FG000|Overall Study|protocol deviation|1|||
146762046|NCT01348087|529295297|FG000|Overall Study|Lost to Follow-up|1|||
146762047|NCT01348087|529295297|FG000|Overall Study|Subject withdrew consent|7|||
146762048|NCT01348087|529295297|FG000|Overall Study|Adverse Event|25|||
146762049|NCT00117988|529295302|FG000|Overall Study|Death|3|||
146762050|NCT00117988|529295302|FG000|Overall Study|Adverse Event|1|||
146762051|NCT02482233|529295309|FG000|Overall Study|Lost to Follow-up|1|||
146762052|NCT02482233|529295310|FG001|Overall Study|Lost to Follow-up|1|||
146762053|NCT04888585|529295311|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
146762054|NCT04888585|529295312|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
146762055|NCT04888585|529295313|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
146762056|NCT04888585|529295314|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
146762057|NCT04888585|529295315|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
146762058|NCT04888585|529295316|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
146762059|NCT04888585|529295317|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
146762060|NCT04888585|529295318|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
146762061|NCT04888585|529295319|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
146762062|NCT04888585|529295320|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
146762063|NCT04888585|529295321|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
146762064|NCT04888585|529295311|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
146762065|NCT04888585|529295312|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
146762066|NCT04888585|529295313|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
146762067|NCT04888585|529295314|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
146762068|NCT04888585|529295315|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
146762069|NCT04888585|529295316|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
146762070|NCT04888585|529295317|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
146762071|NCT04888585|529295318|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
146762072|NCT04888585|529295319|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
146762073|NCT04888585|529295320|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
146762074|NCT04888585|529295321|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
146762075|NCT04888585|529295311|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146762076|NCT04888585|529295312|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146762077|NCT04888585|529295313|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
146762078|NCT04888585|529295314|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146762079|NCT04888585|529295315|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
146762080|NCT04888585|529295316|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146762081|NCT04888585|529295317|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146762082|NCT04888585|529295318|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146762083|NCT04888585|529295319|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146762084|NCT04888585|529295320|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146762085|NCT04888585|529295321|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146762086|NCT04888585|529295311|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
146762087|NCT04888585|529295312|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
146762088|NCT04888585|529295313|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
146762089|NCT04888585|529295314|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
146762090|NCT04888585|529295315|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
146762091|NCT04888585|529295316|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
146861849|NCT01794520|529666534|FG005|Overall Study|Adverse events- related to progression|1|||
146861850|NCT01794520|529666535|FG006|Overall Study|Adverse events- related to progression|0|||
146861851|NCT01794520|529666529|FG000|Overall Study|Adverse event- not related to progression|1|||
146861852|NCT01794520|529666530|FG001|Overall Study|Adverse event- not related to progression|1|||
146861853|NCT01794520|529666531|FG002|Overall Study|Adverse event- not related to progression|0|||
146861854|NCT01794520|529666532|FG003|Overall Study|Adverse event- not related to progression|0|||
146861855|NCT01794520|529666533|FG004|Overall Study|Adverse event- not related to progression|2|||
146861856|NCT01794520|529666534|FG005|Overall Study|Adverse event- not related to progression|0|||
146861857|NCT01794520|529666535|FG006|Overall Study|Adverse event- not related to progression|0|||
146861858|NCT01794520|529666529|FG000|Overall Study|Progressive disease|5|||
146861859|NCT01794520|529666530|FG001|Overall Study|Progressive disease|6|||
146861860|NCT01794520|529666531|FG002|Overall Study|Progressive disease|2|||
146861861|NCT01794520|529666532|FG003|Overall Study|Progressive disease|5|||
146861862|NCT01794520|529666533|FG004|Overall Study|Progressive disease|27|||
146861863|NCT01794520|529666534|FG005|Overall Study|Progressive disease|18|||
146861864|NCT01794520|529666535|FG006|Overall Study|Progressive disease|0|||
146861865|NCT01794520|529666529|FG000|Overall Study|Withdrew consent|0|||
146861866|NCT01794520|529666530|FG001|Overall Study|Withdrew consent|0|||
146861867|NCT01794520|529666531|FG002|Overall Study|Withdrew consent|1|||
146861868|NCT01794520|529666532|FG003|Overall Study|Withdrew consent|1|||
146861869|NCT01794520|529666533|FG004|Overall Study|Withdrew consent|0|||
146861870|NCT01794520|529666534|FG005|Overall Study|Withdrew consent|0|||
146861871|NCT01794520|529666535|FG006|Overall Study|Withdrew consent|0|||
146861872|NCT01794520|529666529|FG000|Overall Study|Lost to Follow-up|0|||
146861873|NCT01794520|529666530|FG001|Overall Study|Lost to Follow-up|0|||
146861874|NCT01794520|529666531|FG002|Overall Study|Lost to Follow-up|0|||
146861875|NCT01794520|529666532|FG003|Overall Study|Lost to Follow-up|0|||
146861876|NCT01794520|529666533|FG004|Overall Study|Lost to Follow-up|1|||
146861877|NCT01794520|529666534|FG005|Overall Study|Lost to Follow-up|0|||
146861878|NCT01794520|529666535|FG006|Overall Study|Lost to Follow-up|0|||
146861879|NCT01794520|529666529|FG000|Overall Study|Toxicity|0|||
146861880|NCT01794520|529666530|FG001|Overall Study|Toxicity|2|||
146861881|NCT01794520|529666531|FG002|Overall Study|Toxicity|0|||
146861882|NCT01794520|529666532|FG003|Overall Study|Toxicity|0|||
146861883|NCT01794520|529666533|FG004|Overall Study|Toxicity|0|||
146861884|NCT01794520|529666534|FG005|Overall Study|Toxicity|0|||
146861885|NCT01794520|529666535|FG006|Overall Study|Toxicity|0|||
146861886|NCT01794520|529666529|FG000|Overall Study|Study terminated by sponsor|0|||
146861887|NCT01794520|529666530|FG001|Overall Study|Study terminated by sponsor|0|||
146861888|NCT01794520|529666531|FG002|Overall Study|Study terminated by sponsor|1|||
146861889|NCT01794520|529666532|FG003|Overall Study|Study terminated by sponsor|0|||
146861890|NCT01794520|529666533|FG004|Overall Study|Study terminated by sponsor|1|||
146861891|NCT01794520|529666534|FG005|Overall Study|Study terminated by sponsor|0|||
146861892|NCT01794520|529666535|FG006|Overall Study|Study terminated by sponsor|7|||
146861893|NCT01794520|529666529|FG000|Overall Study|Death|0|||
146861894|NCT01794520|529666530|FG001|Overall Study|Death|0|||
146861895|NCT01794520|529666531|FG002|Overall Study|Death|0|||
146861896|NCT01794520|529666532|FG003|Overall Study|Death|0|||
146861897|NCT01794520|529666533|FG004|Overall Study|Death|1|||
146861898|NCT01794520|529666534|FG005|Overall Study|Death|0|||
146861899|NCT01794520|529666535|FG006|Overall Study|Death|22|||
146861900|NCT01794520|529666529|FG000|Overall Study|Other, not specified|0|||
146861901|NCT01794520|529666530|FG001|Overall Study|Other, not specified|0|||
146861902|NCT01794520|529666531|FG002|Overall Study|Other, not specified|1|||
146861903|NCT01794520|529666532|FG003|Overall Study|Other, not specified|1|||
146861904|NCT01794520|529666533|FG004|Overall Study|Other, not specified|4|||
146861905|NCT01794520|529666534|FG005|Overall Study|Other, not specified|1|||
146861906|NCT01794520|529666535|FG006|Overall Study|Other, not specified|2|||
146861907|NCT04175808|529666536|FG000|Part A|Miscellaneous|2|||
146861908|NCT04175808|529666537|FG001|Part A|Miscellaneous|0|||
146861909|NCT04175808|529666538|FG002|Part A|Miscellaneous|0|||
146861910|NCT04175808|529666539|FG003|Part A|Miscellaneous|0|||
146861911|NCT04175808|529666540|FG004|Part A|Miscellaneous|0|||
146861912|NCT04175808|529666541|FG005|Part A|Miscellaneous|0|||
146861913|NCT04175808|529666542|FG006|Part A|Miscellaneous|0|||
146861914|NCT02021292|529666544|FG000|Overall Study|Physician Decision|0|||
146530166|NCT03589807|528449164|FG001|Overall Study|Protocol Violation|0|||
146861915|NCT02021292|529666545|FG001|Overall Study|Physician Decision|1|||
146861916|NCT02021292|529666544|FG000|Overall Study|Lost to Follow-up|0|||
146861917|NCT02021292|529666545|FG001|Overall Study|Lost to Follow-up|1|||
146861918|NCT02021292|529666544|FG000|Overall Study|Death|0|||
146861919|NCT02021292|529666545|FG001|Overall Study|Death|1|||
146861920|NCT03291587|529666551|FG000|Overall Study|Lost to Follow-up|62|||
146861921|NCT03291587|529666552|FG001|Overall Study|Lost to Follow-up|43|||
146861922|NCT03291587|529666551|FG000|Overall Study|Refused to Answer|5|||
146861923|NCT03291587|529666552|FG001|Overall Study|Refused to Answer|2|||
146861924|NCT03291587|529666551|FG000|Overall Study|Death|2|||
146861925|NCT03291587|529666552|FG001|Overall Study|Death|4|||
146861926|NCT03291587|529666551|FG000|Overall Study|Not interested in participating|8|||
146861927|NCT03291587|529666552|FG001|Overall Study|Not interested in participating|6|||
146861928|NCT03291587|529666551|FG000|Overall Study|Too busy to participate|4|||
146861929|NCT03291587|529666552|FG001|Overall Study|Too busy to participate|2|||
146861930|NCT00796120|529666553|FG000|Overall Study|Death|3|||
146861931|NCT00796120|529666554|FG001|Overall Study|Death|0|||
146861932|NCT00796120|529666553|FG000|Overall Study|Adverse Event|11|||
146861933|NCT00796120|529666554|FG001|Overall Study|Adverse Event|6|||
146861934|NCT00796120|529666553|FG000|Overall Study|Progressive disease|22|||
146861935|NCT00796120|529666554|FG001|Overall Study|Progressive disease|13|||
146861936|NCT00796120|529666553|FG000|Overall Study|Participant refusal|3|||
146861937|NCT00796120|529666554|FG001|Overall Study|Participant refusal|4|||
146861938|NCT00796120|529666553|FG000|Overall Study|Other|6|||
146861939|NCT00796120|529666554|FG001|Overall Study|Other|17|||
146861940|NCT00796120|529666553|FG000|Overall Study|Physician Decision|16|||
146861941|NCT00796120|529666554|FG001|Overall Study|Physician Decision|17|||
146861942|NCT00796120|529666553|FG000|Overall Study|Randomized but not treated|0|||
146861943|NCT00796120|529666554|FG001|Overall Study|Randomized but not treated|3|||
146861944|NCT02513745|529666560|FG000|Overall Study|Criteria at time of surgery not met.|3|||
146861945|NCT02513745|529666561|FG001|Overall Study|Criteria at time of surgery not met.|3|||
146861946|NCT01209143|529666562|FG000|Overall Study|Adverse Event|2|||
146861947|NCT01209143|529666563|FG001|Overall Study|Adverse Event|1|||
146861948|NCT01209143|529666562|FG000|Overall Study|Death|0|||
146861949|NCT01209143|529666563|FG001|Overall Study|Death|1|||
146861950|NCT01209143|529666562|FG000|Overall Study|Physician Decision|3|||
146861951|NCT01209143|529666563|FG001|Overall Study|Physician Decision|1|||
146861952|NCT01209143|529666562|FG000|Overall Study|Lost to Follow-up|1|||
146861953|NCT01209143|529666563|FG001|Overall Study|Lost to Follow-up|0|||
146861954|NCT01209143|529666562|FG000|Overall Study|Withdrawal by Subject|2|||
146861955|NCT01209143|529666563|FG001|Overall Study|Withdrawal by Subject|1|||
146861956|NCT01209143|529666562|FG000|Overall Study|Disease progression|11|||
146861957|NCT01209143|529666563|FG001|Overall Study|Disease progression|16|||
146861958|NCT00381303|529666566|FG000|Overall Study|Lost to Follow-up|25|||
146861959|NCT00381303|529666567|FG001|Overall Study|Lost to Follow-up|9|||
146861960|NCT00381303|529666566|FG000|Overall Study|AE/HIV-related event|22|||
146861961|NCT00381303|529666567|FG001|Overall Study|AE/HIV-related event|6|||
146861962|NCT00381303|529666566|FG000|Overall Study|Non-Adherence|13|||
146861963|NCT00381303|529666567|FG001|Overall Study|Non-Adherence|6|||
146861964|NCT00381303|529666566|FG000|Overall Study|Withdrawal by Subject|13|||
146861965|NCT00381303|529666567|FG001|Overall Study|Withdrawal by Subject|6|||
146861966|NCT00381303|529666566|FG000|Overall Study|Virologic failure|6|||
146861967|NCT00381303|529666567|FG001|Overall Study|Virologic failure|4|||
146861968|NCT00381303|529666566|FG000|Overall Study|Ineligible to continue the trial|2|||
146861969|NCT00381303|529666567|FG001|Overall Study|Ineligible to continue the trial|1|||
146861970|NCT00381303|529666566|FG000|Overall Study|Pregnancy|2|||
146861971|NCT00381303|529666567|FG001|Overall Study|Pregnancy|0|||
146861972|NCT00381303|529666566|FG000|Overall Study|Physician Decision|1|||
146861973|NCT00381303|529666567|FG001|Overall Study|Physician Decision|0|||
146861974|NCT00381303|529666566|FG000|Overall Study|Physician's decision to close the site|3|||
146861975|NCT00381303|529666567|FG001|Overall Study|Physician's decision to close the site|1|||
146861976|NCT00381303|529666566|FG000|Overall Study|Subject moved out of state|2|||
146861977|NCT00381303|529666567|FG001|Overall Study|Subject moved out of state|0|||
146861978|NCT00381303|529666566|FG000|Overall Study|Subject taking too many different meds|1|||
146861979|NCT00381303|529666567|FG001|Overall Study|Subject taking too many different meds|0|||
146861980|NCT00381303|529666566|FG000|Overall Study|No virologic response by week 12|1|||
146861981|NCT00381303|529666567|FG001|Overall Study|No virologic response by week 12|0|||
146861982|NCT00381303|529666566|FG000|Overall Study|Subject was too busy for appointments|1|||
146861983|NCT00381303|529666567|FG001|Overall Study|Subject was too busy for appointments|0|||
146861984|NCT00381303|529666566|FG000|Overall Study|Subject did not continue visits|1|||
146861985|NCT00381303|529666567|FG001|Overall Study|Subject did not continue visits|0|||
146861986|NCT00381303|529666566|FG000|Overall Study|Subject primary physician's decision|1|||
146861987|NCT00381303|529666567|FG001|Overall Study|Subject primary physician's decision|0|||
146861988|NCT01211522|529666568|FG000|Overall Study|Withdrawal by Subject|3|||
146861989|NCT01211522|529666569|FG001|Overall Study|Withdrawal by Subject|7|||
146861990|NCT01211522|529666570|FG002|Overall Study|Withdrawal by Subject|5|||
146861991|NCT01145755|529666572|FG000|Overall Study|Adverse Event|2|||
146861992|NCT01145755|529666573|FG001|Overall Study|Adverse Event|4|||
146861993|NCT01145755|529666574|FG002|Overall Study|Adverse Event|2|||
146861994|NCT01145755|529666572|FG000|Overall Study|Withdrawal by Subject|2|||
146861995|NCT01145755|529666573|FG001|Overall Study|Withdrawal by Subject|2|||
146861996|NCT01145755|529666574|FG002|Overall Study|Withdrawal by Subject|2|||
146861997|NCT01145755|529666572|FG000|Overall Study|Lost to Follow-up|2|||
146861998|NCT01145755|529666573|FG001|Overall Study|Lost to Follow-up|3|||
146861999|NCT01145755|529666574|FG002|Overall Study|Lost to Follow-up|1|||
146862000|NCT01145755|529666572|FG000|Overall Study|Protocol Violation|0|||
146862001|NCT01145755|529666573|FG001|Overall Study|Protocol Violation|3|||
146862002|NCT01145755|529666574|FG002|Overall Study|Protocol Violation|1|||
146862003|NCT01145755|529666572|FG000|Overall Study|Study Closure|14|||
146862004|NCT01145755|529666573|FG001|Overall Study|Study Closure|14|||
146862005|NCT01145755|529666574|FG002|Overall Study|Study Closure|17|||
146862006|NCT01145755|529666572|FG000|Overall Study|Lack of Efficacy|0|||
146862007|NCT01145755|529666573|FG001|Overall Study|Lack of Efficacy|1|||
146862008|NCT01145755|529666574|FG002|Overall Study|Lack of Efficacy|0|||
146862009|NCT01145755|529666572|FG000|Overall Study|Patient could not swollow medication|0|||
146862010|NCT01145755|529666573|FG001|Overall Study|Patient could not swollow medication|0|||
146862011|NCT01145755|529666574|FG002|Overall Study|Patient could not swollow medication|1|||
146862012|NCT01145755|529666572|FG000|Overall Study|Withdrawal by Subject|0|||
146862013|NCT01145755|529666573|FG001|Overall Study|Withdrawal by Subject|0|||
146862014|NCT01145755|529666574|FG002|Overall Study|Withdrawal by Subject|1|||
146862015|NCT01145755|529666572|FG000|Overall Study|Positive urine ethanol|0|||
146862016|NCT01145755|529666573|FG001|Overall Study|Positive urine ethanol|1|||
146862017|NCT01145755|529666574|FG002|Overall Study|Positive urine ethanol|0|||
146862018|NCT01116882|529666580|FG000|30-day|Lost to Follow-up|50|||
146862019|NCT01116882|529666581|FG001|30-day|Lost to Follow-up|21|||
146862020|NCT01116882|529666580|FG000|30-day|Withdrawal by Subject|2|||
146862021|NCT01116882|529666581|FG001|30-day|Withdrawal by Subject|4|||
146862022|NCT01116882|529666580|FG000|30-day|Other Reasons|16|||
146862023|NCT01116882|529666581|FG001|30-day|Other Reasons|6|||
146862024|NCT01116882|529666580|FG000|12-month|Lost to Follow-up|111|||
146862025|NCT01116882|529666581|FG001|12-month|Lost to Follow-up|42|||
146862026|NCT01116882|529666580|FG000|12-month|Other Reasons|151|||
146862027|NCT01116882|529666581|FG001|12-month|Other Reasons|49|||
146862028|NCT01116882|529666580|FG000|12-month|Withdrawal by Subject|5|||
146862029|NCT01116882|529666581|FG001|12-month|Withdrawal by Subject|8|||
146862030|NCT00547365|529666582|FG000|Overall Study|Physician Decision|1|||
146862031|NCT00547365|529666582|FG000|Overall Study|Lost to Follow-up|1|||
146862032|NCT00547365|529666582|FG000|Overall Study|Protocol Violation|2|||
146862033|NCT00547365|529666582|FG000|Overall Study|death (not related to study)|4|||
146862034|NCT01777269|529666585|FG000|Overall Study|Adverse Event|24|||
146862035|NCT01777269|529666586|FG001|Overall Study|Adverse Event|33|||
146862036|NCT01777269|529666585|FG000|Overall Study|Lack of Efficacy|8|||
146862037|NCT01777269|529666586|FG001|Overall Study|Lack of Efficacy|10|||
146862038|NCT01777269|529666585|FG000|Overall Study|Protocol Violation|4|||
146862039|NCT01777269|529666586|FG001|Overall Study|Protocol Violation|4|||
146862040|NCT01777269|529666585|FG000|Overall Study|Participants reached stopping criteria|1|||
146862041|NCT01777269|529666586|FG001|Overall Study|Participants reached stopping criteria|1|||
146862042|NCT01777269|529666585|FG000|Overall Study|Lost to Follow-up|4|||
146862043|NCT01777269|529666586|FG001|Overall Study|Lost to Follow-up|0|||
146862044|NCT01777269|529666585|FG000|Overall Study|Physician Decision|5|||
146862045|NCT01777269|529666586|FG001|Overall Study|Physician Decision|2|||
146862046|NCT01777269|529666585|FG000|Overall Study|Withdrawal by Subject|9|||
146862047|NCT01777269|529666586|FG001|Overall Study|Withdrawal by Subject|9|||
146862048|NCT00504881|529666587|FG000|Overall Study|Lack of Efficacy|1|||
146862049|NCT00504881|529666588|FG001|Overall Study|Lack of Efficacy|5|||
146862050|NCT00504881|529666587|FG000|Overall Study|Lost to Follow-up|0|||
146862051|NCT00504881|529666588|FG001|Overall Study|Lost to Follow-up|2|||
146862052|NCT00504881|529666587|FG000|Overall Study|Withdrawal by Subject|1|||
146862053|NCT00504881|529666588|FG001|Overall Study|Withdrawal by Subject|4|||
146862054|NCT00504881|529666587|FG000|Overall Study|Non-Compliance|1|||
146862055|NCT00504881|529666588|FG001|Overall Study|Non-Compliance|0|||
146862056|NCT00504881|529666587|FG000|Overall Study|No Birth Control|0|||
146862057|NCT00504881|529666588|FG001|Overall Study|No Birth Control|1|||
146862058|NCT00504881|529666587|FG000|Overall Study|Safety Visit not performed|0|||
146862059|NCT00504881|529666588|FG001|Overall Study|Safety Visit not performed|1|||
146862060|NCT00504881|529666587|FG000|Overall Study|AE, serious fatal|0|||
146862061|NCT00504881|529666588|FG001|Overall Study|AE, serious fatal|1|||
146862062|NCT00504881|529666587|FG000|Overall Study|SAE, non-fatal|2|||
146862063|NCT00504881|529666588|FG001|Overall Study|SAE, non-fatal|6|||
146862064|NCT00504881|529666587|FG000|Overall Study|AE, non-serious non-fatal|4|||
146862065|NCT00504881|529666588|FG001|Overall Study|AE, non-serious non-fatal|14|||
146862066|NCT00504881|529666587|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
146862067|NCT00504881|529666588|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
146862068|NCT00504881|529666587|FG000|Overall Study|AE of unknown type|1|||
146862069|NCT00504881|529666588|FG001|Overall Study|AE of unknown type|0|||
146862070|NCT00753272|529666596|FG000|Overall Study|Adverse Event|878|||
146862071|NCT00753272|529666597|FG001|Overall Study|Adverse Event|869|||
146862072|NCT00753272|529666596|FG000|Overall Study|Protocol Violation|28|||
146862073|NCT00753272|529666597|FG001|Overall Study|Protocol Violation|46|||
146862074|NCT00753272|529666596|FG000|Overall Study|Withdrawal by Subject|2481|||
146862075|NCT00753272|529666597|FG001|Overall Study|Withdrawal by Subject|2407|||
146862076|NCT00753272|529666596|FG000|Overall Study|Lost to Follow-up|491|||
146862077|NCT00753272|529666597|FG001|Overall Study|Lost to Follow-up|497|||
146862078|NCT00753272|529666596|FG000|Overall Study|Other|1104|||
146862079|NCT00753272|529666597|FG001|Overall Study|Other|1088|||
146862080|NCT00803270|529666598|FG000|Overall Study|Lost to Follow-up|1|||
146862081|NCT00803270|529666599|FG001|Overall Study|Lost to Follow-up|2|||
146862082|NCT00971243|529666600|FG000|Double Blind Period|Adverse Event|2|||
146862083|NCT00971243|529666601|FG001|Double Blind Period|Adverse Event|3|||
146862084|NCT00971243|529666602|FG002|Double Blind Period|Adverse Event|2|||
146862085|NCT00971243|529666603|FG003|Double Blind Period|Adverse Event|2|||
146862086|NCT00971243|529666604|FG004|Double Blind Period|Adverse Event|3|||
146862087|NCT00971243|529666600|FG000|Double Blind Period|Lost to Follow-up|0|||
146862088|NCT00971243|529666601|FG001|Double Blind Period|Lost to Follow-up|1|||
146862089|NCT00971243|529666602|FG002|Double Blind Period|Lost to Follow-up|1|||
146862090|NCT00971243|529666603|FG003|Double Blind Period|Lost to Follow-up|0|||
146862091|NCT00971243|529666604|FG004|Double Blind Period|Lost to Follow-up|1|||
146862092|NCT00971243|529666600|FG000|Double Blind Period|Physician Decision|10|||
146862093|NCT00971243|529666601|FG001|Double Blind Period|Physician Decision|6|||
146862094|NCT00971243|529666602|FG002|Double Blind Period|Physician Decision|7|||
146862095|NCT00971243|529666603|FG003|Double Blind Period|Physician Decision|6|||
146862096|NCT00971243|529666604|FG004|Double Blind Period|Physician Decision|7|||
146862097|NCT00971243|529666600|FG000|Double Blind Period|Protocol Violation|2|||
146862098|NCT00971243|529666601|FG001|Double Blind Period|Protocol Violation|0|||
146862099|NCT00971243|529666602|FG002|Double Blind Period|Protocol Violation|3|||
146862100|NCT00971243|529666603|FG003|Double Blind Period|Protocol Violation|2|||
146862101|NCT00971243|529666604|FG004|Double Blind Period|Protocol Violation|2|||
146862102|NCT00971243|529666600|FG000|Double Blind Period|Withdrawal by Subject|4|||
146862103|NCT00971243|529666601|FG001|Double Blind Period|Withdrawal by Subject|1|||
146862104|NCT00971243|529666602|FG002|Double Blind Period|Withdrawal by Subject|4|||
146862105|NCT00971243|529666603|FG003|Double Blind Period|Withdrawal by Subject|4|||
146862106|NCT00971243|529666604|FG004|Double Blind Period|Withdrawal by Subject|4|||
146862107|NCT00971243|529666600|FG000|Double Blind Period|Other reasons|1|||
146862108|NCT00971243|529666601|FG001|Double Blind Period|Other reasons|0|||
146862109|NCT00971243|529666602|FG002|Double Blind Period|Other reasons|2|||
146862110|NCT00971243|529666603|FG003|Double Blind Period|Other reasons|0|||
146862111|NCT00971243|529666604|FG004|Double Blind Period|Other reasons|1|||
146862112|NCT00971243|529666600|FG000|Open-label Period|Adverse Event|1|||
146862113|NCT00971243|529666601|FG001|Open-label Period|Adverse Event|0|||
146862114|NCT00971243|529666602|FG002|Open-label Period|Adverse Event|1|||
146862115|NCT00971243|529666603|FG003|Open-label Period|Adverse Event|1|||
146862116|NCT00971243|529666604|FG004|Open-label Period|Adverse Event|0|||
146862117|NCT00971243|529666600|FG000|Open-label Period|Physician Decision|5|||
146862118|NCT00971243|529666601|FG001|Open-label Period|Physician Decision|9|||
146862119|NCT00971243|529666602|FG002|Open-label Period|Physician Decision|3|||
146862120|NCT00971243|529666603|FG003|Open-label Period|Physician Decision|7|||
146862121|NCT00971243|529666604|FG004|Open-label Period|Physician Decision|2|||
146862122|NCT00971243|529666600|FG000|Open-label Period|Protocol Violation|1|||
146862123|NCT00971243|529666601|FG001|Open-label Period|Protocol Violation|1|||
146862124|NCT00971243|529666602|FG002|Open-label Period|Protocol Violation|1|||
146862125|NCT00971243|529666603|FG003|Open-label Period|Protocol Violation|0|||
146862126|NCT00971243|529666604|FG004|Open-label Period|Protocol Violation|1|||
146862127|NCT00971243|529666600|FG000|Open-label Period|Withdrawal by Subject|1|||
146862128|NCT00971243|529666601|FG001|Open-label Period|Withdrawal by Subject|0|||
146862129|NCT00971243|529666602|FG002|Open-label Period|Withdrawal by Subject|0|||
146862130|NCT00971243|529666603|FG003|Open-label Period|Withdrawal by Subject|2|||
146862131|NCT00971243|529666604|FG004|Open-label Period|Withdrawal by Subject|1|||
146862132|NCT00971243|529666600|FG000|Open-label Period|Other reason|0|||
146862133|NCT00971243|529666601|FG001|Open-label Period|Other reason|0|||
146862134|NCT00971243|529666602|FG002|Open-label Period|Other reason|0|||
146862135|NCT00971243|529666603|FG003|Open-label Period|Other reason|0|||
146862136|NCT00971243|529666604|FG004|Open-label Period|Other reason|2|||
146862137|NCT01966471|529666607|FG000|Overall Study|Death|44|||
146862138|NCT01966471|529666608|FG001|Overall Study|Death|56|||
146862139|NCT01966471|529666607|FG000|Overall Study|Lost to Follow-up|46|||
146862140|NCT01966471|529666608|FG001|Overall Study|Lost to Follow-up|39|||
146862141|NCT01966471|529666607|FG000|Overall Study|Various reasons|4|||
146862142|NCT01966471|529666608|FG001|Overall Study|Various reasons|4|||
146862143|NCT01966471|529666607|FG000|Overall Study|Physician Decision|7|||
146862144|NCT01966471|529666608|FG001|Overall Study|Physician Decision|5|||
146862145|NCT01966471|529666607|FG000|Overall Study|Study Terminated By Sponsor|758|||
146862146|NCT01966471|529666608|FG001|Overall Study|Study Terminated By Sponsor|773|||
146862147|NCT01966471|529666607|FG000|Overall Study|Withdrawal by Subject|59|||
146862148|NCT01966471|529666608|FG001|Overall Study|Withdrawal by Subject|51|||
146862149|NCT02092220|529666610|FG000|Period 1|Unrelated Illness|0|||
146862150|NCT02092220|529666611|FG001|Period 1|Unrelated Illness|2|||
146862151|NCT02092220|529666610|FG000|Period 2|Severe Hypoglycaemia|1|||
146862152|NCT02092220|529666611|FG001|Period 2|Severe Hypoglycaemia|0|||
146862153|NCT02092220|529666610|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
146862154|NCT02092220|529666611|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
146862155|NCT00960531|529666612|FG000|Overall Study|Lack of Efficacy|1|||
146862156|NCT00960531|529666613|FG001|Overall Study|Lack of Efficacy|0|||
146862157|NCT00960531|529666614|FG002|Overall Study|Lack of Efficacy|0|||
146862158|NCT00960531|529666615|FG003|Overall Study|Lack of Efficacy|0|||
146862159|NCT00960531|529666616|FG004|Overall Study|Lack of Efficacy|0|||
146862160|NCT00960531|529666617|FG005|Overall Study|Lack of Efficacy|0|||
146862161|NCT00960531|529666618|FG006|Overall Study|Lack of Efficacy|0|||
146862162|NCT00960531|529666619|FG007|Overall Study|Lack of Efficacy|0|||
146862163|NCT00960531|529666620|FG008|Overall Study|Lack of Efficacy|0|||
146862164|NCT00960531|529666621|FG009|Overall Study|Lack of Efficacy|0|||
146862165|NCT00960531|529666612|FG000|Overall Study|Withdrawal by Subject|1|||
146862166|NCT00960531|529666613|FG001|Overall Study|Withdrawal by Subject|0|||
146862167|NCT00960531|529666614|FG002|Overall Study|Withdrawal by Subject|5|||
146862168|NCT00960531|529666615|FG003|Overall Study|Withdrawal by Subject|2|||
146862169|NCT00960531|529666616|FG004|Overall Study|Withdrawal by Subject|0|||
146862170|NCT00960531|529666617|FG005|Overall Study|Withdrawal by Subject|0|||
146862171|NCT00960531|529666618|FG006|Overall Study|Withdrawal by Subject|2|||
146862172|NCT00960531|529666619|FG007|Overall Study|Withdrawal by Subject|0|||
146862173|NCT00960531|529666620|FG008|Overall Study|Withdrawal by Subject|1|||
146862174|NCT00960531|529666621|FG009|Overall Study|Withdrawal by Subject|0|||
146862175|NCT00960531|529666612|FG000|Overall Study|Caregiver Request|2|||
146862176|NCT00960531|529666613|FG001|Overall Study|Caregiver Request|0|||
146862177|NCT00960531|529666614|FG002|Overall Study|Caregiver Request|6|||
146862178|NCT00960531|529666615|FG003|Overall Study|Caregiver Request|5|||
146862179|NCT00960531|529666616|FG004|Overall Study|Caregiver Request|0|||
146862180|NCT00960531|529666617|FG005|Overall Study|Caregiver Request|2|||
146862181|NCT00960531|529666618|FG006|Overall Study|Caregiver Request|3|||
146862182|NCT00960531|529666619|FG007|Overall Study|Caregiver Request|1|||
146862183|NCT00960531|529666620|FG008|Overall Study|Caregiver Request|3|||
146862184|NCT00960531|529666621|FG009|Overall Study|Caregiver Request|0|||
146862185|NCT00960531|529666612|FG000|Overall Study|Investigator Request|0|||
146862186|NCT00960531|529666613|FG001|Overall Study|Investigator Request|0|||
146862187|NCT00960531|529666614|FG002|Overall Study|Investigator Request|1|||
146862188|NCT00960531|529666615|FG003|Overall Study|Investigator Request|0|||
146862189|NCT00960531|529666616|FG004|Overall Study|Investigator Request|0|||
146862190|NCT00960531|529666617|FG005|Overall Study|Investigator Request|0|||
146862191|NCT00960531|529666618|FG006|Overall Study|Investigator Request|0|||
146862192|NCT00960531|529666619|FG007|Overall Study|Investigator Request|0|||
146862193|NCT00960531|529666620|FG008|Overall Study|Investigator Request|0|||
146862194|NCT00960531|529666621|FG009|Overall Study|Investigator Request|0|||
146862195|NCT00960531|529666612|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
146862196|NCT00960531|529666613|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
146862197|NCT00960531|529666614|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
146862198|NCT00960531|529666615|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
146862199|NCT00960531|529666616|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
146862200|NCT00960531|529666617|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
146862201|NCT00960531|529666618|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
146862202|NCT00960531|529666619|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
146862203|NCT00960531|529666620|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
146862204|NCT00960531|529666621|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
146862205|NCT00960531|529666612|FG000|Overall Study|Lost to Follow-up|0|||
146862206|NCT00960531|529666613|FG001|Overall Study|Lost to Follow-up|0|||
146862207|NCT00960531|529666614|FG002|Overall Study|Lost to Follow-up|1|||
146862208|NCT00960531|529666615|FG003|Overall Study|Lost to Follow-up|0|||
146862209|NCT00960531|529666616|FG004|Overall Study|Lost to Follow-up|0|||
146862210|NCT00960531|529666617|FG005|Overall Study|Lost to Follow-up|0|||
146862211|NCT00960531|529666618|FG006|Overall Study|Lost to Follow-up|1|||
146862212|NCT00960531|529666619|FG007|Overall Study|Lost to Follow-up|0|||
146862213|NCT00960531|529666620|FG008|Overall Study|Lost to Follow-up|0|||
146862214|NCT00960531|529666621|FG009|Overall Study|Lost to Follow-up|0|||
146862215|NCT00960531|529666612|FG000|Overall Study|Failed to Return|2|||
146862216|NCT00960531|529666613|FG001|Overall Study|Failed to Return|0|||
146862217|NCT00960531|529666614|FG002|Overall Study|Failed to Return|0|||
146862218|NCT00960531|529666615|FG003|Overall Study|Failed to Return|0|||
146862219|NCT00960531|529666616|FG004|Overall Study|Failed to Return|0|||
146862220|NCT00960531|529666617|FG005|Overall Study|Failed to Return|0|||
146862221|NCT00960531|529666618|FG006|Overall Study|Failed to Return|0|||
146862222|NCT00960531|529666619|FG007|Overall Study|Failed to Return|2|||
146862223|NCT00960531|529666620|FG008|Overall Study|Failed to Return|0|||
146862224|NCT00960531|529666621|FG009|Overall Study|Failed to Return|0|||
146862225|NCT00960531|529666612|FG000|Overall Study|Adverse Event (AE)|2|||
146862226|NCT00960531|529666613|FG001|Overall Study|Adverse Event (AE)|0|||
146862227|NCT00960531|529666614|FG002|Overall Study|Adverse Event (AE)|0|||
146862228|NCT00960531|529666615|FG003|Overall Study|Adverse Event (AE)|0|||
146862229|NCT00960531|529666616|FG004|Overall Study|Adverse Event (AE)|0|||
146862230|NCT00960531|529666617|FG005|Overall Study|Adverse Event (AE)|1|||
146862231|NCT00960531|529666618|FG006|Overall Study|Adverse Event (AE)|2|||
146862232|NCT00960531|529666619|FG007|Overall Study|Adverse Event (AE)|0|||
146862233|NCT00960531|529666620|FG008|Overall Study|Adverse Event (AE)|2|||
146862234|NCT00960531|529666621|FG009|Overall Study|Adverse Event (AE)|0|||
146862235|NCT00960531|529666612|FG000|Overall Study|Reason not Specified|2|||
146862236|NCT00960531|529666613|FG001|Overall Study|Reason not Specified|1|||
146862237|NCT00960531|529666614|FG002|Overall Study|Reason not Specified|13|||
146862238|NCT00960531|529666615|FG003|Overall Study|Reason not Specified|1|||
146862239|NCT00960531|529666616|FG004|Overall Study|Reason not Specified|2|||
146862240|NCT00960531|529666617|FG005|Overall Study|Reason not Specified|0|||
146862241|NCT00960531|529666618|FG006|Overall Study|Reason not Specified|16|||
146862242|NCT00960531|529666619|FG007|Overall Study|Reason not Specified|0|||
146862243|NCT00960531|529666620|FG008|Overall Study|Reason not Specified|8|||
146862244|NCT00960531|529666621|FG009|Overall Study|Reason not Specified|1|||
146862245|NCT00593957|529666622|FG000|Overall Study|Physician Decision|0|||
146862246|NCT00593957|529666623|FG001|Overall Study|Physician Decision|1|||
146862247|NCT00593957|529666624|FG002|Overall Study|Physician Decision|2|||
146862248|NCT02411578|529666625|FG000|Crossover Trial Phase|Pregnancy|0|||
146862249|NCT02411578|529666626|FG001|Crossover Trial Phase|Pregnancy|1|||
146862250|NCT01193920|529666627|FG000|Overall Study|Withdrawal by Subject|1|||
146862251|NCT01193920|529666628|FG001|Overall Study|Withdrawal by Subject|0|||
146862252|NCT01193920|529666629|FG002|Overall Study|Withdrawal by Subject|5|||
146862253|NCT01193920|529666630|FG003|Overall Study|Withdrawal by Subject|1|||
146862254|NCT01193920|529666631|FG004|Overall Study|Withdrawal by Subject|3|||
146862255|NCT01193920|529666632|FG005|Overall Study|Withdrawal by Subject|1|||
146862256|NCT01193920|529666633|FG006|Overall Study|Withdrawal by Subject|3|||
146862257|NCT01193920|529666634|FG007|Overall Study|Withdrawal by Subject|0|||
146862258|NCT01193920|529666635|FG008|Overall Study|Withdrawal by Subject|1|||
146862259|NCT01193920|529666636|FG009|Overall Study|Withdrawal by Subject|0|||
146862260|NCT01193920|529666627|FG000|Overall Study|Lost to Follow-up|1|||
146862261|NCT01193920|529666628|FG001|Overall Study|Lost to Follow-up|0|||
146862262|NCT01193920|529666629|FG002|Overall Study|Lost to Follow-up|1|||
146862263|NCT01193920|529666630|FG003|Overall Study|Lost to Follow-up|1|||
146862264|NCT01193920|529666631|FG004|Overall Study|Lost to Follow-up|3|||
146862265|NCT01193920|529666632|FG005|Overall Study|Lost to Follow-up|3|||
146862266|NCT01193920|529666633|FG006|Overall Study|Lost to Follow-up|1|||
146862267|NCT01193920|529666634|FG007|Overall Study|Lost to Follow-up|0|||
146862268|NCT01193920|529666635|FG008|Overall Study|Lost to Follow-up|2|||
146862269|NCT01193920|529666636|FG009|Overall Study|Lost to Follow-up|3|||
146862270|NCT01193920|529666627|FG000|Overall Study|Protocol Violation|1|||
146862271|NCT01193920|529666628|FG001|Overall Study|Protocol Violation|0|||
146862272|NCT01193920|529666629|FG002|Overall Study|Protocol Violation|0|||
146862273|NCT01193920|529666630|FG003|Overall Study|Protocol Violation|0|||
146862274|NCT01193920|529666631|FG004|Overall Study|Protocol Violation|0|||
146862275|NCT01193920|529666632|FG005|Overall Study|Protocol Violation|0|||
146862276|NCT01193920|529666633|FG006|Overall Study|Protocol Violation|0|||
146862277|NCT01193920|529666634|FG007|Overall Study|Protocol Violation|0|||
146862278|NCT01193920|529666635|FG008|Overall Study|Protocol Violation|0|||
146862279|NCT01193920|529666636|FG009|Overall Study|Protocol Violation|0|||
146862280|NCT01193920|529666627|FG000|Overall Study|Death|0|||
146862281|NCT01193920|529666628|FG001|Overall Study|Death|0|||
146862282|NCT01193920|529666629|FG002|Overall Study|Death|0|||
146862283|NCT01193920|529666630|FG003|Overall Study|Death|1|||
146862284|NCT01193920|529666631|FG004|Overall Study|Death|0|||
146862285|NCT01193920|529666632|FG005|Overall Study|Death|0|||
146862286|NCT01193920|529666633|FG006|Overall Study|Death|2|||
146862287|NCT01193920|529666634|FG007|Overall Study|Death|3|||
146862288|NCT01193920|529666635|FG008|Overall Study|Death|2|||
146862289|NCT01193920|529666636|FG009|Overall Study|Death|4|||
146862290|NCT01193920|529666627|FG000|Overall Study|Unable to classify|0|||
146862291|NCT01193920|529666628|FG001|Overall Study|Unable to classify|0|||
146862292|NCT01193920|529666629|FG002|Overall Study|Unable to classify|0|||
146862293|NCT01193920|529666630|FG003|Overall Study|Unable to classify|1|||
146862294|NCT01193920|529666631|FG004|Overall Study|Unable to classify|0|||
146862295|NCT01193920|529666632|FG005|Overall Study|Unable to classify|0|||
146862296|NCT01193920|529666633|FG006|Overall Study|Unable to classify|0|||
146862297|NCT01193920|529666634|FG007|Overall Study|Unable to classify|1|||
146862298|NCT01193920|529666635|FG008|Overall Study|Unable to classify|0|||
146862299|NCT01193920|529666636|FG009|Overall Study|Unable to classify|0|||
146862300|NCT00494481|529666637|FG000|Overall Study|Condition under investigation worsened|11|||
146862301|NCT00494481|529666638|FG001|Overall Study|Condition under investigation worsened|13|||
146862302|NCT00494481|529666637|FG000|Overall Study|Adverse Event|15|||
146862303|NCT00494481|529666638|FG001|Overall Study|Adverse Event|11|||
146862304|NCT00494481|529666637|FG000|Overall Study|Other|1|||
146862305|NCT00494481|529666638|FG001|Overall Study|Other|0|||
146862306|NCT00494481|529666637|FG000|Overall Study|Never received IP|2|||
146862307|NCT00494481|529666638|FG001|Overall Study|Never received IP|0|||
146862308|NCT01030198|529666639|FG000|Overall Study|Could not measure efficacy accurately|0|||
146862309|NCT01030198|529666640|FG001|Overall Study|Could not measure efficacy accurately|7|||
146862310|NCT00332189|529666641|FG000|Overall Study|Adverse Event|3|||
146862311|NCT00332189|529666641|FG000|Overall Study|Uncooperative/Noncompliant|3|||
146862312|NCT00332189|529666641|FG000|Overall Study|Withdrawal by Subject|9|||
146862313|NCT00332189|529666641|FG000|Overall Study|Lack of Efficacy|4|||
146862314|NCT00332189|529666641|FG000|Overall Study|Moved out of country|2|||
146862315|NCT05245097|529666642|FG000|Overall Study|Adverse Event|13|||
146862316|NCT05245097|529666643|FG001|Overall Study|Adverse Event|2|||
146862317|NCT05245097|529666642|FG000|Overall Study|Protocol Violation|8|||
146862318|NCT05245097|529666643|FG001|Overall Study|Protocol Violation|6|||
146862319|NCT05245097|529666642|FG000|Overall Study|Withdrawal by Subject|18|||
146862320|NCT05245097|529666643|FG001|Overall Study|Withdrawal by Subject|0|||
146862321|NCT05245097|529666642|FG000|Overall Study|Death|6|||
146862322|NCT05245097|529666643|FG001|Overall Study|Death|7|||
146862323|NCT05245097|529666642|FG000|Overall Study|Physician Decision|6|||
146862324|NCT05245097|529666643|FG001|Overall Study|Physician Decision|0|||
146862325|NCT05245097|529666642|FG000|Overall Study|Relocation|4|||
146862326|NCT05245097|529666643|FG001|Overall Study|Relocation|3|||
146862327|NCT03254485|529666650|FG000|Overall Study|Adverse Event|3|||
146862328|NCT03254485|529666651|FG001|Overall Study|Adverse Event|0|||
146862329|NCT03254485|529666652|FG002|Overall Study|Adverse Event|0|||
146862330|NCT03254485|529666653|FG003|Overall Study|Adverse Event|6|||
146862331|NCT03254485|529666650|FG000|Overall Study|Protocol Violation|6|||
146862332|NCT03254485|529666651|FG001|Overall Study|Protocol Violation|0|||
146862333|NCT03254485|529666652|FG002|Overall Study|Protocol Violation|0|||
146862334|NCT03254485|529666653|FG003|Overall Study|Protocol Violation|2|||
146862335|NCT03254485|529666650|FG000|Overall Study|Withdrawal by Subject|1|||
146862336|NCT03254485|529666651|FG001|Overall Study|Withdrawal by Subject|0|||
146862337|NCT03254485|529666652|FG002|Overall Study|Withdrawal by Subject|0|||
146862338|NCT03254485|529666653|FG003|Overall Study|Withdrawal by Subject|4|||
146862339|NCT03254485|529666650|FG000|Overall Study|Death|0|||
146862340|NCT03254485|529666651|FG001|Overall Study|Death|0|||
146862341|NCT03254485|529666652|FG002|Overall Study|Death|0|||
146862342|NCT03254485|529666653|FG003|Overall Study|Death|1|||
146862343|NCT03254485|529666650|FG000|Overall Study|Lost to Follow-up|1|||
146862344|NCT03254485|529666651|FG001|Overall Study|Lost to Follow-up|0|||
146862345|NCT03254485|529666652|FG002|Overall Study|Lost to Follow-up|0|||
146862346|NCT03254485|529666653|FG003|Overall Study|Lost to Follow-up|0|||
146862347|NCT03254485|529666650|FG000|Overall Study|Other|1|||
146862348|NCT03254485|529666651|FG001|Overall Study|Other|0|||
146862349|NCT03254485|529666652|FG002|Overall Study|Other|0|||
146862350|NCT03254485|529666653|FG003|Overall Study|Other|2|||
146862351|NCT01572922|529666655|FG000|Overall Study|Adverse Event|1|||
146862352|NCT01572922|529666655|FG000|Overall Study|Protocol Violation|1|||
146862353|NCT01572922|529666655|FG000|Overall Study|Death|1|||
146862354|NCT02818920|529666656|FG000|Overall Study|Unresectable|4|||
146862355|NCT02818920|529666656|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
146862356|NCT02818920|529666656|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
146862357|NCT02818920|529666656|FG000|Overall Study|Adverse Event|3|||
146862358|NCT02818920|529666656|FG000|Overall Study|Developed Other Disease|1|||
146862359|NCT02818920|529666656|FG000|Overall Study|Refused Further Treatment|1|||
146862360|NCT01335009|529666657|FG000|Overall Study|Too ill to travel to study sites|1|||
146862361|NCT01335009|529666658|FG001|Overall Study|Too ill to travel to study sites|0|||
146862362|NCT01335009|529666657|FG000|Overall Study|Death|28|||
146862363|NCT01335009|529666658|FG001|Overall Study|Death|32|||
146862364|NCT01335009|529666657|FG000|Overall Study|Withdrawal by Subject|1|||
146862365|NCT01335009|529666658|FG001|Overall Study|Withdrawal by Subject|1|||
146862366|NCT01335009|529666657|FG000|Overall Study|Lost to Follow-up|1|||
146862367|NCT01335009|529666658|FG001|Overall Study|Lost to Follow-up|0|||
146862368|NCT04821869|529666659|FG000|Overall Study|Adverse Event|4|||
146862369|NCT04821869|529666659|FG000|Overall Study|Withdrawal by Subject|2|||
146862370|NCT04821869|529666659|FG000|Overall Study|Did not meet FEV1 criteria|1|||
146862371|NCT00823901|529668242|FG000|Overall Study|Adverse Event|1|||
146862372|NCT00823901|529668243|FG001|Overall Study|Adverse Event|1|||
146862373|NCT00823901|529668242|FG000|Overall Study|Lack of Efficacy|1|||
146862374|NCT00823901|529668243|FG001|Overall Study|Lack of Efficacy|0|||
146862375|NCT00823901|529668242|FG000|Overall Study|Lost to Follow-up|2|||
146862376|NCT00823901|529668243|FG001|Overall Study|Lost to Follow-up|1|||
146862377|NCT01369511|529668244|FG000|Overall Study|Adverse Event|1|||
146862378|NCT01369511|529668245|FG001|Overall Study|Adverse Event|1|||
146862379|NCT01369511|529668246|FG002|Overall Study|Adverse Event|5|||
146862380|NCT01369511|529668247|FG003|Overall Study|Adverse Event|0|||
146862381|NCT01369511|529668244|FG000|Overall Study|Entry criteria not met|2|||
146862382|NCT01369511|529668245|FG001|Overall Study|Entry criteria not met|0|||
146862383|NCT01369511|529668246|FG002|Overall Study|Entry criteria not met|0|||
146862384|NCT01369511|529668247|FG003|Overall Study|Entry criteria not met|1|||
146862385|NCT01369511|529668244|FG000|Overall Study|Lost to Follow-up|0|||
146862386|NCT01369511|529668245|FG001|Overall Study|Lost to Follow-up|1|||
146862387|NCT01369511|529668246|FG002|Overall Study|Lost to Follow-up|1|||
146862388|NCT01369511|529668247|FG003|Overall Study|Lost to Follow-up|2|||
146862389|NCT01369511|529668244|FG000|Overall Study|Protocol Violation|0|||
146862390|NCT01369511|529668245|FG001|Overall Study|Protocol Violation|1|||
146862391|NCT01369511|529668246|FG002|Overall Study|Protocol Violation|0|||
146862392|NCT01369511|529668247|FG003|Overall Study|Protocol Violation|2|||
146862393|NCT01369511|529668244|FG000|Overall Study|Physician Decision|3|||
146862394|NCT01369511|529668245|FG001|Overall Study|Physician Decision|4|||
146862395|NCT01369511|529668246|FG002|Overall Study|Physician Decision|0|||
146862396|NCT01369511|529668247|FG003|Overall Study|Physician Decision|0|||
146862397|NCT01369511|529668244|FG000|Overall Study|Sponsor decision|2|||
146862398|NCT01369511|529668245|FG001|Overall Study|Sponsor decision|0|||
146862399|NCT01369511|529668246|FG002|Overall Study|Sponsor decision|1|||
146862400|NCT01369511|529668247|FG003|Overall Study|Sponsor decision|0|||
146862401|NCT01369511|529668244|FG000|Overall Study|Withdrawal by Subject|5|||
146862402|NCT01369511|529668245|FG001|Overall Study|Withdrawal by Subject|6|||
146862403|NCT01369511|529668246|FG002|Overall Study|Withdrawal by Subject|4|||
146862404|NCT01369511|529668247|FG003|Overall Study|Withdrawal by Subject|6|||
146862405|NCT01180998|529668249|FG000|Overall Study|Poor Vision|0|||
146862406|NCT01180998|529668250|FG001|Overall Study|Poor Vision|2|||
146862407|NCT01180998|529668251|FG002|Overall Study|Poor Vision|2|||
146862408|NCT01180998|529668249|FG000|Overall Study|Lost to Follow-up|0|||
146862409|NCT01180998|529668250|FG001|Overall Study|Lost to Follow-up|0|||
146862410|NCT01180998|529668251|FG002|Overall Study|Lost to Follow-up|1|||
146862411|NCT01180998|529668249|FG000|Overall Study|Protocol Violation|1|||
146862412|NCT01180998|529668250|FG001|Overall Study|Protocol Violation|2|||
146862413|NCT01180998|529668251|FG002|Overall Study|Protocol Violation|0|||
146862414|NCT01180998|529668249|FG000|Overall Study|Withdrawal by Subject|0|||
146862415|NCT01180998|529668250|FG001|Overall Study|Withdrawal by Subject|0|||
146862416|NCT01180998|529668251|FG002|Overall Study|Withdrawal by Subject|1|||
146862417|NCT01180998|529668249|FG000|Overall Study|Poor comfort|3|||
146862418|NCT01180998|529668250|FG001|Overall Study|Poor comfort|0|||
146862419|NCT01180998|529668251|FG002|Overall Study|Poor comfort|4|||
146862420|NCT01180998|529668249|FG000|Overall Study|Poor lens handling|0|||
146862421|NCT01180998|529668250|FG001|Overall Study|Poor lens handling|0|||
146862422|NCT01180998|529668251|FG002|Overall Study|Poor lens handling|2|||
146862423|NCT01376349|529668252|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
146862424|NCT01376349|529668253|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
146862425|NCT01376349|529668254|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
146862426|NCT01376349|529668252|FG000|Raondomized Treatment|Adverse Event|13|||
146862427|NCT01376349|529668253|FG001|Raondomized Treatment|Adverse Event|17|||
146862428|NCT01376349|529668254|FG002|Raondomized Treatment|Adverse Event|14|||
146862429|NCT01376349|529668252|FG000|Raondomized Treatment|Unkown|1|||
146862430|NCT01376349|529668253|FG001|Raondomized Treatment|Unkown|2|||
146862431|NCT01376349|529668254|FG002|Raondomized Treatment|Unkown|1|||
146862432|NCT01376349|529668252|FG000|Raondomized Treatment|Alternative Treatment|0|||
146862433|NCT01376349|529668253|FG001|Raondomized Treatment|Alternative Treatment|0|||
146862434|NCT01376349|529668254|FG002|Raondomized Treatment|Alternative Treatment|1|||
146862435|NCT01176968|529668255|FG000|Overall Study|Adverse Event|10|||
146862436|NCT01176968|529668256|FG001|Overall Study|Adverse Event|11|||
146862437|NCT01176968|529668255|FG000|Overall Study|Death|2|||
146862438|NCT01176968|529668256|FG001|Overall Study|Death|3|||
146862439|NCT01176968|529668255|FG000|Overall Study|Lack of Efficacy|0|||
146862440|NCT01176968|529668256|FG001|Overall Study|Lack of Efficacy|1|||
146862441|NCT01176968|529668255|FG000|Overall Study|Lost to Follow-up|16|||
146862442|NCT01176968|529668256|FG001|Overall Study|Lost to Follow-up|14|||
146862443|NCT01176968|529668255|FG000|Overall Study|Withdrawal by Subject|48|||
146862444|NCT01176968|529668256|FG001|Overall Study|Withdrawal by Subject|48|||
146862445|NCT01176968|529668255|FG000|Overall Study|Protocol Violation|2|||
146862446|NCT01176968|529668256|FG001|Overall Study|Protocol Violation|1|||
146862447|NCT01176968|529668255|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
146862448|NCT01176968|529668256|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
146862449|NCT01176968|529668255|FG000|Overall Study|Study terminated by sponsor|0|||
146862450|NCT01176968|529668256|FG001|Overall Study|Study terminated by sponsor|1|||
146862451|NCT01176968|529668255|FG000|Overall Study|Reason not defined|5|||
146862452|NCT01176968|529668256|FG001|Overall Study|Reason not defined|3|||
146862453|NCT00718640|529668257|FG000|Overall Study|Adverse Event|4|||
146862454|NCT00718640|529668257|FG000|Overall Study|Death|1|||
146862455|NCT00718640|529668257|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
146862456|NCT00068588|529668260|FG000|Overall Study|Adverse Event|0|||
146862457|NCT00068588|529668261|FG001|Overall Study|Adverse Event|0|||
146862458|NCT00068588|529668262|FG002|Overall Study|Adverse Event|2|||
146862459|NCT00068588|529668260|FG000|Overall Study|Withdrawal by Subject|0|||
146862460|NCT00068588|529668261|FG001|Overall Study|Withdrawal by Subject|0|||
146862461|NCT00068588|529668262|FG002|Overall Study|Withdrawal by Subject|1|||
146862462|NCT00068588|529668260|FG000|Overall Study|Poor KPS|0|||
146862463|NCT00068588|529668261|FG001|Overall Study|Poor KPS|0|||
146862464|NCT00068588|529668262|FG002|Overall Study|Poor KPS|1|||
146862465|NCT04098068|529668263|FG000|Overall Study|Disease Progression|7|||
146862466|NCT04098068|529668263|FG000|Overall Study|Withdrawal by Subject|2|||
146862467|NCT04098068|529668263|FG000|Overall Study|New Cancer Diagnosis|1|||
146862468|NCT03694418|529668266|FG000|Overall Study|Lost to Follow-up|115|||
146862469|NCT03694418|529668267|FG001|Overall Study|Lost to Follow-up|23|||
146862470|NCT03694418|529668268|FG002|Overall Study|Lost to Follow-up|12|||
146862471|NCT03694418|529668269|FG003|Overall Study|Lost to Follow-up|12|||
146862472|NCT03694418|529668270|FG004|Overall Study|Lost to Follow-up|13|||
146862473|NCT04485104|529668271|FG000|Overall Study|Physician Decision|2|||
146862474|NCT04485104|529668272|FG001|Overall Study|Physician Decision|0|||
146862475|NCT04485104|529668271|FG000|Overall Study|Decision by sponsor|0|||
146862476|NCT04485104|529668272|FG001|Overall Study|Decision by sponsor|1|||
146862477|NCT05057247|529668277|FG000|Overall Study|Death|4|||
146862478|NCT05057247|529668277|FG000|Overall Study|Physician Decision|3|||
146862479|NCT05057247|529668277|FG000|Overall Study|Progressive Disease|7|||
146862480|NCT05057247|529668277|FG000|Overall Study|Withdrawal by Subject|3|||
146862481|NCT05057247|529668277|FG000|Overall Study|Adverse Event|6|||
146862482|NCT05057247|529668277|FG000|Overall Study|Subject Non-Compliance|1|||
146862483|NCT05057247|529668277|FG000|Overall Study|On treatment|2|||
146862484|NCT05458479|529668278|FG000|Overall Study|Lost to Follow-up|1|||
146862485|NCT01386658|529668282|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
146862486|NCT01386658|529668283|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
146862487|NCT01386658|529668282|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
146862488|NCT01386658|529668283|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
146862489|NCT02465463|529668287|FG000|Overall Study|Lost to Follow-up|2|||
146862490|NCT02465463|529668288|FG001|Overall Study|Lost to Follow-up|1|||
146862491|NCT02465463|529668287|FG000|Overall Study|Death|1|||
146862492|NCT02465463|529668288|FG001|Overall Study|Death|0|||
146862493|NCT02465463|529668287|FG000|Overall Study|Protocol Violation|1|||
146862494|NCT02465463|529668288|FG001|Overall Study|Protocol Violation|0|||
146862495|NCT01067326|529668291|FG000|Overall Study|Adverse Event|0|||
146862496|NCT01067326|529668292|FG001|Overall Study|Adverse Event|2|||
146862497|NCT01067326|529668291|FG000|Overall Study|Withdrawal by Subject|1|||
146862498|NCT01067326|529668292|FG001|Overall Study|Withdrawal by Subject|0|||
146862499|NCT01067326|529668291|FG000|Overall Study|Early Study Termination|1|||
146862500|NCT01067326|529668292|FG001|Overall Study|Early Study Termination|1|||
146862501|NCT00769860|529668293|FG000|Overall Study|Withdrawal by Subject|2|||
146862502|NCT00769860|529668294|FG001|Overall Study|Withdrawal by Subject|0|||
146862503|NCT01139658|529668300|FG000|Overall Study|Adverse Event|10|||
146862504|NCT01139658|529668301|FG001|Overall Study|Adverse Event|27|||
146862505|NCT01139658|529668300|FG000|Overall Study|Lack of Efficacy|15|||
146862506|NCT01139658|529668301|FG001|Overall Study|Lack of Efficacy|7|||
146862507|NCT01139658|529668300|FG000|Overall Study|Withdrawal by Subject|2|||
146862508|NCT01139658|529668301|FG001|Overall Study|Withdrawal by Subject|4|||
146862509|NCT01139658|529668300|FG000|Overall Study|No documentation of treatment|1|||
146862510|NCT01139658|529668301|FG001|Overall Study|No documentation of treatment|0|||
146862511|NCT01139658|529668300|FG000|Overall Study|Other|28|||
146862512|NCT01139658|529668301|FG001|Overall Study|Other|75|||
146862513|NCT01119001|529668305|FG000|Overall Study|Withdrawal by Subject|2|||
146862514|NCT04343248|529668306|FG000|Overall Study|Withdrawal by Subject|5|||
146862515|NCT04343248|529668307|FG001|Overall Study|Withdrawal by Subject|6|||
146862516|NCT04343248|529668306|FG000|Overall Study|Death|1|||
146862517|NCT04343248|529668307|FG001|Overall Study|Death|2|||
146862518|NCT04343248|529668306|FG000|Overall Study|Lost to Follow-up|9|||
146862519|NCT04343248|529668307|FG001|Overall Study|Lost to Follow-up|6|||
146862520|NCT04343248|529668306|FG000|Overall Study|Physician Decision|0|||
146862521|NCT04343248|529668307|FG001|Overall Study|Physician Decision|1|||
146862522|NCT04343248|529668306|FG000|Overall Study|Adverse Event|1|||
146862523|NCT04343248|529668307|FG001|Overall Study|Adverse Event|0|||
146862524|NCT03604523|529668308|FG000|Overall Study|Physician Decision|1|||
146862525|NCT03604523|529668309|FG001|Overall Study|Physician Decision|0|||
146862526|NCT00810394|529668316|FG000|Overall Study|Withdrawal by Subject|3|||
146862527|NCT00467285|529668317|FG000|Overall Study|Lost to Follow-up|4|||
146862528|NCT00467285|529668318|FG001|Overall Study|Lost to Follow-up|4|||
146862529|NCT03891524|529668319|FG000|Overall Study|Death|0|||
146862530|NCT03891524|529668320|FG001|Overall Study|Death|0|||
146862531|NCT03891524|529668321|FG002|Overall Study|Death|0|||
146862532|NCT03891524|529668322|FG003|Overall Study|Death|0|||
146862533|NCT03891524|529668323|FG004|Overall Study|Death|0|||
146862534|NCT03891524|529668324|FG005|Overall Study|Death|0|||
146862535|NCT03891524|529668325|FG006|Overall Study|Death|0|||
146862536|NCT03891524|529668326|FG007|Overall Study|Death|1|||
146862537|NCT03891524|529668319|FG000|Overall Study|Withdrawal by Subject|0|||
146862538|NCT03891524|529668320|FG001|Overall Study|Withdrawal by Subject|1|||
146862539|NCT03891524|529668321|FG002|Overall Study|Withdrawal by Subject|2|||
146862540|NCT03891524|529668322|FG003|Overall Study|Withdrawal by Subject|1|||
146862541|NCT03891524|529668323|FG004|Overall Study|Withdrawal by Subject|2|||
146862542|NCT03891524|529668324|FG005|Overall Study|Withdrawal by Subject|2|||
146862543|NCT03891524|529668325|FG006|Overall Study|Withdrawal by Subject|2|||
146862544|NCT03891524|529668326|FG007|Overall Study|Withdrawal by Subject|1|||
146862545|NCT00475033|529668329|FG000|Infant Series|Failed to return|3|||
146862546|NCT00475033|529668330|FG001|Infant Series|Failed to return|4|||
146862547|NCT00475033|529668329|FG000|Infant Series|Parent or legal guardian request|1|||
146862548|NCT00475033|529668330|FG001|Infant Series|Parent or legal guardian request|5|||
146862549|NCT00475033|529668329|FG000|Infant Series|Protocol Violation|1|||
146862550|NCT00475033|529668330|FG001|Infant Series|Protocol Violation|2|||
146862551|NCT00475033|529668329|FG000|Infant Series|Lost to Follow-up|2|||
146862552|NCT00475033|529668330|FG001|Infant Series|Lost to Follow-up|0|||
146862553|NCT00475033|529668329|FG000|Infant Series|Adverse Event|0|||
146862554|NCT00475033|529668330|FG001|Infant Series|Adverse Event|2|||
146862555|NCT00475033|529668329|FG000|After the Infant Series|Adverse Event|0|||
146862556|NCT00475033|529668330|FG001|After the Infant Series|Adverse Event|4|||
146862557|NCT00475033|529668329|FG000|After the Infant Series|Parent or legal guardian request|2|||
146862558|NCT00475033|529668330|FG001|After the Infant Series|Parent or legal guardian request|2|||
146862559|NCT00475033|529668329|FG000|After the Infant Series|Failed to return|2|||
146862560|NCT00475033|529668330|FG001|After the Infant Series|Failed to return|1|||
146862561|NCT00475033|529668329|FG000|After the Infant Series|Protocol Violation|1|||
146862562|NCT00475033|529668330|FG001|After the Infant Series|Protocol Violation|0|||
146862563|NCT00475033|529668329|FG000|After the Infant Series|Lost to Follow-up|1|||
146862564|NCT00475033|529668330|FG001|After the Infant Series|Lost to Follow-up|0|||
146862565|NCT00475033|529668329|FG000|After the Infant Series|Other|0|||
146862566|NCT00475033|529668330|FG001|After the Infant Series|Other|1|||
146862567|NCT00475033|529668329|FG000|Toddler Dose|Parent or legal guardian request|2|||
146862568|NCT00475033|529668330|FG001|Toddler Dose|Parent or legal guardian request|0|||
146862569|NCT00475033|529668329|FG000|Toddler Dose|Failed to return|1|||
146862570|NCT00475033|529668330|FG001|Toddler Dose|Failed to return|0|||
146862571|NCT00475033|529668329|FG000|Toddler Dose|Lost to Follow-up|1|||
146862572|NCT00475033|529668330|FG001|Toddler Dose|Lost to Follow-up|0|||
146862573|NCT03231943|529668331|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146862574|NCT03231943|529668332|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
146862575|NCT03231943|529668333|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
146862576|NCT03231943|529668334|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146862577|NCT03231943|529668335|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146862578|NCT03231943|529668336|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146862579|NCT03231943|529668337|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146862580|NCT03231943|529668338|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146862581|NCT03231943|529668339|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146862582|NCT03231943|529668340|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146862583|NCT03231943|529668341|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146862584|NCT03231943|529668342|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146862585|NCT03231943|529668343|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146862586|NCT03231943|529668331|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146862587|NCT03231943|529668332|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
146862588|NCT03231943|529668333|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146862589|NCT03231943|529668334|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146862590|NCT03231943|529668335|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146862591|NCT03231943|529668336|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146862592|NCT03231943|529668337|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146862593|NCT03231943|529668338|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146862594|NCT03231943|529668339|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146862595|NCT03231943|529668340|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146862596|NCT03231943|529668341|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146862597|NCT03231943|529668342|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146862598|NCT03231943|529668343|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146862599|NCT03231943|529668331|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
146862600|NCT03231943|529668332|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146862601|NCT03231943|529668333|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146862602|NCT03231943|529668334|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146862603|NCT03231943|529668335|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146862604|NCT03231943|529668336|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146862605|NCT03231943|529668337|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146862606|NCT03231943|529668338|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146862607|NCT03231943|529668339|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146862608|NCT03231943|529668340|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146862609|NCT03231943|529668341|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146862610|NCT03231943|529668342|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146862611|NCT03231943|529668343|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146862612|NCT03231943|529668331|FG000|Part 2|Adverse Event|0|||
146862613|NCT03231943|529668332|FG001|Part 2|Adverse Event|0|||
146862614|NCT03231943|529668333|FG002|Part 2|Adverse Event|0|||
146862615|NCT03231943|529668334|FG003|Part 2|Adverse Event|0|||
146862616|NCT03231943|529668335|FG004|Part 2|Adverse Event|0|||
146862617|NCT03231943|529668336|FG005|Part 2|Adverse Event|0|||
146862618|NCT03231943|529668337|FG006|Part 2|Adverse Event|0|||
146862619|NCT03231943|529668338|FG007|Part 2|Adverse Event|0|||
146862620|NCT03231943|529668339|FG008|Part 2|Adverse Event|0|||
146862621|NCT03231943|529668340|FG009|Part 2|Adverse Event|0|||
146862622|NCT03231943|529668341|FG010|Part 2|Adverse Event|1|||
146862623|NCT03231943|529668342|FG011|Part 2|Adverse Event|0|||
146862624|NCT03231943|529668343|FG012|Part 2|Adverse Event|0|||
146862625|NCT03231943|529668331|FG000|Part 2|Withdrawal by Subject|0|||
146862626|NCT03231943|529668332|FG001|Part 2|Withdrawal by Subject|0|||
146862627|NCT03231943|529668333|FG002|Part 2|Withdrawal by Subject|0|||
146862628|NCT03231943|529668334|FG003|Part 2|Withdrawal by Subject|0|||
146862629|NCT03231943|529668335|FG004|Part 2|Withdrawal by Subject|0|||
146862630|NCT03231943|529668336|FG005|Part 2|Withdrawal by Subject|0|||
146862631|NCT03231943|529668337|FG006|Part 2|Withdrawal by Subject|0|||
146862632|NCT03231943|529668338|FG007|Part 2|Withdrawal by Subject|0|||
146862633|NCT03231943|529668339|FG008|Part 2|Withdrawal by Subject|0|||
146862634|NCT03231943|529668340|FG009|Part 2|Withdrawal by Subject|0|||
146862635|NCT03231943|529668341|FG010|Part 2|Withdrawal by Subject|0|||
146862636|NCT03231943|529668342|FG011|Part 2|Withdrawal by Subject|1|||
146862637|NCT03231943|529668343|FG012|Part 2|Withdrawal by Subject|0|||
146862638|NCT00445068|529668344|FG000|Overall Study|Disease progression|26|||
146862639|NCT00445068|529668344|FG000|Overall Study|Adverse Event|5|||
146862640|NCT00445068|529668344|FG000|Overall Study|Abnormal laboratory value|2|||
146862641|NCT00445068|529668344|FG000|Overall Study|Withdrawal by Subject|2|||
146862642|NCT00445068|529668344|FG000|Overall Study|Death|1|||
146862643|NCT04824521|529668345|FG000|Overall Study|Lost to Follow-up|1|||
146862644|NCT03444324|529668346|FG000|Overall Study|Withdrawal by Subject|0|||
146862645|NCT03444324|529668347|FG001|Overall Study|Withdrawal by Subject|1|||
146862646|NCT03444324|529668346|FG000|Overall Study|Lost to Follow-up|4|||
146862647|NCT03444324|529668347|FG001|Overall Study|Lost to Follow-up|2|||
146862648|NCT03444324|529668346|FG000|Overall Study|Protocol Violation|0|||
146862649|NCT03444324|529668347|FG001|Overall Study|Protocol Violation|1|||
146862650|NCT03444324|529668346|FG000|Overall Study|Lack of Trial Compliance|1|||
146862651|NCT03444324|529668347|FG001|Overall Study|Lack of Trial Compliance|1|||
146862652|NCT03444324|529668346|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
146862653|NCT03444324|529668347|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
146862654|NCT01598311|529668348|FG000|Overall Study|Physician Decision|4|||
146862655|NCT01598311|529668349|FG001|Overall Study|Physician Decision|5|||
146862656|NCT01598311|529668348|FG000|Overall Study|Adverse Event|9|||
146862657|NCT01598311|529668349|FG001|Overall Study|Adverse Event|13|||
146862658|NCT01598311|529668348|FG000|Overall Study|Lost to Follow-up|7|||
146862659|NCT01598311|529668349|FG001|Overall Study|Lost to Follow-up|12|||
146862660|NCT01598311|529668348|FG000|Overall Study|Withdrawal by Subject|9|||
146862661|NCT01598311|529668349|FG001|Overall Study|Withdrawal by Subject|13|||
146862662|NCT01598311|529668348|FG000|Overall Study|No reason provided.|0|||
146862663|NCT01598311|529668349|FG001|Overall Study|No reason provided.|5|||
146862664|NCT01598311|529668348|FG000|Overall Study|Randomized but never treated|8|||
146862665|NCT01598311|529668349|FG001|Overall Study|Randomized but never treated|5|||
146862666|NCT01598311|529668348|FG000|Overall Study|Treated but no confirmed CDAD|9|||
146862667|NCT01598311|529668349|FG001|Overall Study|Treated but no confirmed CDAD|8|||
146862668|NCT01598311|529668348|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
146862669|NCT01598311|529668349|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
146862670|NCT00658684|529668350|FG000|Overall Study|Adverse Event|10|||
146862671|NCT00658684|529668351|FG001|Overall Study|Adverse Event|8|||
146862672|NCT00658684|529668352|FG002|Overall Study|Adverse Event|2|||
146862673|NCT00658684|529668353|FG003|Overall Study|Adverse Event|0|||
146862674|NCT00658684|529668350|FG000|Overall Study|Withdrawal by Subject|6|||
146862675|NCT00658684|529668351|FG001|Overall Study|Withdrawal by Subject|4|||
146862676|NCT00658684|529668352|FG002|Overall Study|Withdrawal by Subject|1|||
146862677|NCT00658684|529668353|FG003|Overall Study|Withdrawal by Subject|1|||
146862678|NCT00658684|529668350|FG000|Overall Study|Lack of Efficacy|1|||
146862679|NCT00658684|529668351|FG001|Overall Study|Lack of Efficacy|1|||
146862680|NCT00658684|529668352|FG002|Overall Study|Lack of Efficacy|0|||
146862681|NCT00658684|529668353|FG003|Overall Study|Lack of Efficacy|0|||
146862682|NCT00658684|529668350|FG000|Overall Study|Protocol Violation|1|||
146862683|NCT00658684|529668351|FG001|Overall Study|Protocol Violation|1|||
146862684|NCT00658684|529668352|FG002|Overall Study|Protocol Violation|0|||
146862685|NCT00658684|529668353|FG003|Overall Study|Protocol Violation|0|||
146862686|NCT00658684|529668350|FG000|Overall Study|Pregnancy|1|||
146862687|NCT00658684|529668351|FG001|Overall Study|Pregnancy|1|||
146862688|NCT00658684|529668352|FG002|Overall Study|Pregnancy|0|||
146862689|NCT00658684|529668353|FG003|Overall Study|Pregnancy|0|||
146862690|NCT00688103|529668354|FG000|Overall Study|Adverse Event|4|||
146862691|NCT00688103|529668355|FG001|Overall Study|Adverse Event|1|||
146862692|NCT00688103|529668354|FG000|Overall Study|Lack of Efficacy|11|||
146862693|NCT00688103|529668355|FG001|Overall Study|Lack of Efficacy|1|||
146862694|NCT00688103|529668354|FG000|Overall Study|Withdrawal by Subject|4|||
146862695|NCT00688103|529668355|FG001|Overall Study|Withdrawal by Subject|2|||
146862696|NCT00688103|529668354|FG000|Overall Study|complex reasons|11|||
146862697|NCT00688103|529668355|FG001|Overall Study|complex reasons|9|||
146862698|NCT03144804|529668357|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
146862699|NCT03769181|529670006|FG000|Overall Study|Adverse Event|1|||
146862700|NCT03769181|529670007|FG001|Overall Study|Adverse Event|0|||
146862701|NCT03769181|529670008|FG002|Overall Study|Adverse Event|2|||
146862702|NCT03769181|529670009|FG003|Overall Study|Adverse Event|4|||
146862703|NCT03769181|529670006|FG000|Overall Study|Withdrawal by Subject|1|||
146862704|NCT03769181|529670007|FG001|Overall Study|Withdrawal by Subject|0|||
146862705|NCT03769181|529670008|FG002|Overall Study|Withdrawal by Subject|2|||
146862706|NCT03769181|529670009|FG003|Overall Study|Withdrawal by Subject|1|||
146862707|NCT03769181|529670006|FG000|Overall Study|Progressive disease|9|||
146862708|NCT03769181|529670007|FG001|Overall Study|Progressive disease|7|||
146862709|NCT03769181|529670008|FG002|Overall Study|Progressive disease|13|||
146862710|NCT03769181|529670009|FG003|Overall Study|Progressive disease|6|||
146862711|NCT03769181|529670006|FG000|Overall Study|Other - Unspecified|2|||
146862712|NCT03769181|529670007|FG001|Overall Study|Other - Unspecified|1|||
146862713|NCT03769181|529670008|FG002|Overall Study|Other - Unspecified|0|||
146862714|NCT03769181|529670009|FG003|Overall Study|Other - Unspecified|0|||
146862715|NCT03971422|529670010|FG000|Overall Study|Lost to Follow-up|0|||
146862716|NCT03971422|529670011|FG001|Overall Study|Lost to Follow-up|1|||
146862717|NCT03971422|529670012|FG002|Overall Study|Lost to Follow-up|0|||
146862718|NCT03971422|529670010|FG000|Overall Study|Lack of Efficacy|5|||
146862719|NCT03971422|529670011|FG001|Overall Study|Lack of Efficacy|1|||
146862720|NCT03971422|529670012|FG002|Overall Study|Lack of Efficacy|1|||
146862721|NCT03971422|529670010|FG000|Overall Study|Adverse event, not fatal|2|||
146862722|NCT03971422|529670011|FG001|Overall Study|Adverse event, not fatal|2|||
146862723|NCT03971422|529670012|FG002|Overall Study|Adverse event, not fatal|5|||
146862724|NCT03971422|529670010|FG000|Overall Study|Worsening of MG Symptoms|1|||
146862725|NCT03971422|529670011|FG001|Overall Study|Worsening of MG Symptoms|4|||
146862726|NCT03971422|529670012|FG002|Overall Study|Worsening of MG Symptoms|2|||
146862727|NCT03971422|529670010|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
146862728|NCT03971422|529670011|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
146862729|NCT03971422|529670012|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
146862730|NCT03971422|529670010|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
146862731|NCT03971422|529670011|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
146862732|NCT03971422|529670012|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
146862733|NCT03971422|529670010|FG000|Overall Study|Due to COVID-19 pandemic|0|||
146862734|NCT03971422|529670011|FG001|Overall Study|Due to COVID-19 pandemic|1|||
146862735|NCT03971422|529670012|FG002|Overall Study|Due to COVID-19 pandemic|1|||
146862736|NCT01444651|529670016|FG000|Overall Study|Adverse Event|3|||
146862737|NCT01444651|529670017|FG001|Overall Study|Adverse Event|2|||
146862738|NCT01444651|529670016|FG000|Overall Study|Lost to Follow-up|5|||
146862739|NCT01444651|529670017|FG001|Overall Study|Lost to Follow-up|5|||
146862740|NCT01444651|529670016|FG000|Overall Study|Non-fasting|2|||
146862741|NCT01444651|529670017|FG001|Overall Study|Non-fasting|1|||
146862742|NCT01444651|529670016|FG000|Overall Study|Missing data|1|||
146862743|NCT01444651|529670017|FG001|Overall Study|Missing data|1|||
146862744|NCT01672788|529670018|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
146862745|NCT01672788|529670019|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
146862746|NCT01672788|529670020|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
146862747|NCT01672788|529670021|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
146862748|NCT03338192|529670022|FG000|Year One to Year Two|High Blood Pressure|7|||
146862749|NCT03338192|529670023|FG001|Year One to Year Two|High Blood Pressure|1|||
146862750|NCT03338192|529670022|FG000|Year One to Year Two|HIV +|1|||
146862751|NCT03338192|529670023|FG001|Year One to Year Two|HIV +|0|||
146862752|NCT03338192|529670022|FG000|Year Two to Year Four|High Blood Pressure|1|||
146862753|NCT03338192|529670023|FG001|Year Two to Year Four|High Blood Pressure|0|||
146862754|NCT03338192|529670022|FG000|Year Two to Year Four|HIV +|2|||
146862755|NCT03338192|529670023|FG001|Year Two to Year Four|HIV +|0|||
146862756|NCT03338192|529670022|FG000|Year Four to Year Six|High Blood Pressure|2|||
146862757|NCT03338192|529670023|FG001|Year Four to Year Six|High Blood Pressure|1|||
146862758|NCT03329196|529670024|FG000|Overall Study|Adverse Event|10|||
146862759|NCT03329196|529670025|FG001|Overall Study|Adverse Event|5|||
146862760|NCT03329196|529670024|FG000|Overall Study|Physician Decision|2|||
146862761|NCT03329196|529670025|FG001|Overall Study|Physician Decision|2|||
146862762|NCT03329196|529670024|FG000|Overall Study|Withdrawal by Subject|11|||
146862763|NCT03329196|529670025|FG001|Overall Study|Withdrawal by Subject|3|||
146862764|NCT03329196|529670024|FG000|Overall Study|Hepatic function abnormalities|0|||
146862765|NCT03329196|529670025|FG001|Overall Study|Hepatic function abnormalities|1|||
146862766|NCT03329196|529670024|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
146862767|NCT03329196|529670025|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
146862768|NCT03329196|529670024|FG000|Overall Study|Difficult to control Hb|2|||
146862769|NCT03329196|529670025|FG001|Overall Study|Difficult to control Hb|3|||
146862770|NCT03329196|529670024|FG000|Overall Study|Dialysis or renal transplant|13|||
146530167|NCT03589807|528449165|FG002|Overall Study|Protocol Violation|0|||
146862771|NCT03329196|529670025|FG001|Overall Study|Dialysis or renal transplant|15|||
146862772|NCT01128361|529670028|FG000|Overall Study|Lost to Follow-up|0|||
146862773|NCT01128361|529670029|FG001|Overall Study|Lost to Follow-up|1|||
146862774|NCT01128361|529670028|FG000|Overall Study|Withdrawal by Subject|5|||
146530168|NCT03589807|528449166|FG003|Overall Study|Protocol Violation|1|||
146862775|NCT01128361|529670029|FG001|Overall Study|Withdrawal by Subject|2|||
146862776|NCT01929980|529670030|FG000|Overall Study|Physician Decision|1|||
146862777|NCT04082429|529670031|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
146862778|NCT04082429|529670032|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
146862779|NCT04082429|529670033|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
146862780|NCT04082429|529670034|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
146862781|NCT04082429|529670035|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
146965099|NCT03110107|530033437|FG011|Treatment Period|Adverse Event|0|||
146862782|NCT04082429|529670036|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
146862783|NCT04082429|529670037|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
146862784|NCT04082429|529670038|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
146862785|NCT04082429|529670039|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
146862786|NCT04082429|529670031|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
146862787|NCT04082429|529670032|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
146862788|NCT04082429|529670033|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
146862789|NCT04082429|529670034|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
146862790|NCT04082429|529670035|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
146862791|NCT04082429|529670036|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
146862792|NCT04082429|529670037|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
146862793|NCT04082429|529670038|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
146862794|NCT04082429|529670039|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
146862795|NCT04082429|529670031|FG000|Main Part (After the Treatment Pause)|Death|0|||
146862796|NCT04082429|529670032|FG001|Main Part (After the Treatment Pause)|Death|0|||
146862797|NCT04082429|529670033|FG002|Main Part (After the Treatment Pause)|Death|0|||
146862798|NCT04082429|529670034|FG003|Main Part (After the Treatment Pause)|Death|0|||
146862799|NCT04082429|529670035|FG004|Main Part (After the Treatment Pause)|Death|1|||
146862800|NCT04082429|529670036|FG005|Main Part (After the Treatment Pause)|Death|0|||
146862801|NCT04082429|529670037|FG006|Main Part (After the Treatment Pause)|Death|0|||
146862802|NCT04082429|529670038|FG007|Main Part (After the Treatment Pause)|Death|0|||
146862803|NCT04082429|529670039|FG008|Main Part (After the Treatment Pause)|Death|0|||
146862804|NCT04082429|529670031|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
146862805|NCT04082429|529670032|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
146862806|NCT04082429|529670033|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
146862807|NCT04082429|529670034|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
146862808|NCT04082429|529670035|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
146862809|NCT04082429|529670036|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
146862810|NCT04082429|529670037|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
146862811|NCT04082429|529670038|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
146862812|NCT04082429|529670039|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
146862813|NCT04082429|529670031|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
146862814|NCT04082429|529670032|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
146862815|NCT04082429|529670033|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
146862816|NCT04082429|529670034|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
146862817|NCT04082429|529670035|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
146862818|NCT04082429|529670036|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
146862819|NCT04082429|529670037|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
146862820|NCT04082429|529670038|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
146862821|NCT04082429|529670039|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
146862822|NCT04082429|529670031|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
146862823|NCT04082429|529670032|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
146862824|NCT04082429|529670033|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
146862825|NCT04082429|529670034|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
146862826|NCT04082429|529670035|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
146862827|NCT04082429|529670036|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
146862828|NCT04082429|529670037|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
146862829|NCT04082429|529670038|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
146862830|NCT04082429|529670039|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
146862831|NCT04082429|529670031|FG000|Extension Part|Ongoing|0|||
146862832|NCT04082429|529670032|FG001|Extension Part|Ongoing|7|||
146862833|NCT04082429|529670033|FG002|Extension Part|Ongoing|17|||
146862834|NCT04082429|529670034|FG003|Extension Part|Ongoing|6|||
146862835|NCT04082429|529670035|FG004|Extension Part|Ongoing|45|||
146862836|NCT04082429|529670036|FG005|Extension Part|Ongoing|0|||
146862837|NCT04082429|529670037|FG006|Extension Part|Ongoing|10|||
146862838|NCT04082429|529670038|FG007|Extension Part|Ongoing|23|||
146862839|NCT04082429|529670039|FG008|Extension Part|Ongoing|25|||
146862840|NCT04796896|529670040|FG000|Overall Study|Adverse Event|1|||
146862841|NCT04796896|529670041|FG001|Overall Study|Adverse Event|0|||
146862842|NCT04796896|529670042|FG002|Overall Study|Adverse Event|0|||
146862843|NCT04796896|529670043|FG003|Overall Study|Adverse Event|0|||
146862844|NCT04796896|529670044|FG004|Overall Study|Adverse Event|0|||
146862845|NCT04796896|529670045|FG005|Overall Study|Adverse Event|1|||
146862846|NCT04796896|529670046|FG006|Overall Study|Adverse Event|1|||
146862847|NCT04796896|529670047|FG007|Overall Study|Adverse Event|0|||
146862848|NCT04796896|529670048|FG008|Overall Study|Adverse Event|1|||
146862849|NCT04796896|529670049|FG009|Overall Study|Adverse Event|1|||
146862850|NCT04796896|529670050|FG010|Overall Study|Adverse Event|1|||
146862851|NCT04796896|529670051|FG011|Overall Study|Adverse Event|0|||
146862852|NCT04796896|529670040|FG000|Overall Study|Lost to Follow-up|24|||
146862853|NCT04796896|529670041|FG001|Overall Study|Lost to Follow-up|15|||
146862854|NCT04796896|529670042|FG002|Overall Study|Lost to Follow-up|6|||
146862855|NCT04796896|529670043|FG003|Overall Study|Lost to Follow-up|4|||
146862856|NCT04796896|529670044|FG004|Overall Study|Lost to Follow-up|21|||
146862857|NCT04796896|529670045|FG005|Overall Study|Lost to Follow-up|55|||
146862858|NCT04796896|529670046|FG006|Overall Study|Lost to Follow-up|237|||
146862859|NCT04796896|529670047|FG007|Overall Study|Lost to Follow-up|52|||
146862860|NCT04796896|529670048|FG008|Overall Study|Lost to Follow-up|221|||
146862861|NCT04796896|529670049|FG009|Overall Study|Lost to Follow-up|43|||
146862862|NCT04796896|529670050|FG010|Overall Study|Lost to Follow-up|142|||
146862863|NCT04796896|529670051|FG011|Overall Study|Lost to Follow-up|18|||
146862864|NCT04796896|529670040|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
146862865|NCT04796896|529670041|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
146862866|NCT04796896|529670042|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
146862867|NCT04796896|529670043|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
146862868|NCT04796896|529670044|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
146862869|NCT04796896|529670045|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
146862870|NCT04796896|529670046|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
146862871|NCT04796896|529670047|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
146862872|NCT04796896|529670048|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
146862873|NCT04796896|529670049|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
146862874|NCT04796896|529670050|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
146862875|NCT04796896|529670051|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
146862876|NCT04796896|529670040|FG000|Overall Study|Physician Decision|1|||
146862877|NCT04796896|529670041|FG001|Overall Study|Physician Decision|0|||
146862878|NCT04796896|529670042|FG002|Overall Study|Physician Decision|0|||
146862879|NCT04796896|529670043|FG003|Overall Study|Physician Decision|0|||
146862880|NCT04796896|529670044|FG004|Overall Study|Physician Decision|0|||
146862881|NCT04796896|529670045|FG005|Overall Study|Physician Decision|3|||
146862882|NCT04796896|529670046|FG006|Overall Study|Physician Decision|18|||
146862883|NCT04796896|529670047|FG007|Overall Study|Physician Decision|1|||
146862884|NCT04796896|529670048|FG008|Overall Study|Physician Decision|7|||
146862885|NCT04796896|529670049|FG009|Overall Study|Physician Decision|0|||
146862886|NCT04796896|529670050|FG010|Overall Study|Physician Decision|5|||
146862887|NCT04796896|529670051|FG011|Overall Study|Physician Decision|0|||
146862888|NCT04796896|529670040|FG000|Overall Study|Withdrawal by Subject|36|||
146862889|NCT04796896|529670041|FG001|Overall Study|Withdrawal by Subject|31|||
146862890|NCT04796896|529670042|FG002|Overall Study|Withdrawal by Subject|11|||
146862891|NCT04796896|529670043|FG003|Overall Study|Withdrawal by Subject|8|||
146862892|NCT04796896|529670044|FG004|Overall Study|Withdrawal by Subject|16|||
146862893|NCT04796896|529670045|FG005|Overall Study|Withdrawal by Subject|162|||
146862894|NCT04796896|529670046|FG006|Overall Study|Withdrawal by Subject|299|||
146862895|NCT04796896|529670047|FG007|Overall Study|Withdrawal by Subject|149|||
146862896|NCT04796896|529670048|FG008|Overall Study|Withdrawal by Subject|303|||
146862897|NCT04796896|529670049|FG009|Overall Study|Withdrawal by Subject|94|||
146862898|NCT04796896|529670050|FG010|Overall Study|Withdrawal by Subject|192|||
146862899|NCT04796896|529670051|FG011|Overall Study|Withdrawal by Subject|16|||
146862900|NCT04796896|529670040|FG000|Overall Study|Other Than Specified|6|||
146862901|NCT04796896|529670041|FG001|Overall Study|Other Than Specified|5|||
146862902|NCT04796896|529670042|FG002|Overall Study|Other Than Specified|3|||
146862903|NCT04796896|529670043|FG003|Overall Study|Other Than Specified|2|||
146862904|NCT04796896|529670044|FG004|Overall Study|Other Than Specified|6|||
146862905|NCT04796896|529670045|FG005|Overall Study|Other Than Specified|31|||
146862906|NCT04796896|529670046|FG006|Overall Study|Other Than Specified|86|||
146862907|NCT04796896|529670047|FG007|Overall Study|Other Than Specified|66|||
146862908|NCT04796896|529670048|FG008|Overall Study|Other Than Specified|388|||
146862909|NCT04796896|529670049|FG009|Overall Study|Other Than Specified|48|||
146862910|NCT04796896|529670050|FG010|Overall Study|Other Than Specified|258|||
146862911|NCT04796896|529670051|FG011|Overall Study|Other Than Specified|4|||
146862912|NCT04796896|529670040|FG000|Overall Study|Protocol Deviation|0|||
146862913|NCT04796896|529670041|FG001|Overall Study|Protocol Deviation|0|||
146862914|NCT04796896|529670042|FG002|Overall Study|Protocol Deviation|0|||
146862915|NCT04796896|529670043|FG003|Overall Study|Protocol Deviation|1|||
146862916|NCT04796896|529670044|FG004|Overall Study|Protocol Deviation|1|||
146862917|NCT04796896|529670045|FG005|Overall Study|Protocol Deviation|2|||
146862918|NCT04796896|529670046|FG006|Overall Study|Protocol Deviation|2|||
146862919|NCT04796896|529670047|FG007|Overall Study|Protocol Deviation|2|||
146862920|NCT04796896|529670048|FG008|Overall Study|Protocol Deviation|2|||
146862921|NCT04796896|529670049|FG009|Overall Study|Protocol Deviation|1|||
146862922|NCT04796896|529670050|FG010|Overall Study|Protocol Deviation|0|||
146862923|NCT04796896|529670051|FG011|Overall Study|Protocol Deviation|0|||
146862924|NCT04796896|529670040|FG000|Overall Study|Missing|0|||
146862925|NCT04796896|529670041|FG001|Overall Study|Missing|0|||
146862926|NCT04796896|529670042|FG002|Overall Study|Missing|0|||
146862927|NCT04796896|529670043|FG003|Overall Study|Missing|0|||
146762092|NCT04888585|529295317|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
146762093|NCT04888585|529295318|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
146762094|NCT04888585|529295319|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
146762095|NCT04888585|529295320|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
146762096|NCT04888585|529295321|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
146762097|NCT04888585|529295311|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
146762098|NCT04888585|529295312|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
146762099|NCT04888585|529295313|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
146762100|NCT04888585|529295314|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
146762101|NCT04888585|529295315|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
146762102|NCT04888585|529295316|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
146762103|NCT04888585|529295317|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
146762104|NCT04888585|529295318|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
146762105|NCT04888585|529295319|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
146762106|NCT04888585|529295320|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
146762107|NCT04888585|529295321|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
146762108|NCT04888585|529295311|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
146762109|NCT04888585|529295312|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
146762110|NCT04888585|529295313|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
146762111|NCT04888585|529295314|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
146762112|NCT04888585|529295315|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
146762113|NCT04888585|529295316|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
146762114|NCT04888585|529295317|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
146762115|NCT04888585|529295318|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
146762116|NCT04888585|529295319|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
146762117|NCT04888585|529295320|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
146762118|NCT04888585|529295321|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
146762119|NCT04888585|529295311|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
146762120|NCT04888585|529295312|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
146762121|NCT04888585|529295313|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
146762122|NCT04888585|529295314|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
146762123|NCT04888585|529295315|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
146762124|NCT04888585|529295316|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
146762125|NCT04888585|529295317|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
146762126|NCT04888585|529295318|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
146762127|NCT04888585|529295319|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
146762128|NCT04888585|529295320|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
146762129|NCT04888585|529295321|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
146762130|NCT04888585|529295311|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
146762131|NCT04888585|529295312|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
146762132|NCT04888585|529295313|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
146762133|NCT04888585|529295314|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
146762134|NCT04888585|529295315|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
146762135|NCT04888585|529295316|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
146762136|NCT04888585|529295317|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
146762137|NCT04888585|529295318|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
146762138|NCT04888585|529295319|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
146762139|NCT04888585|529295320|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
146762140|NCT04888585|529295321|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
146762141|NCT04927975|529295322|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
146762142|NCT04927975|529295323|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
146762143|NCT04927975|529295324|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
146762144|NCT04927975|529295325|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
146762145|NCT04927975|529295326|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
146762146|NCT04927975|529295327|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
146762147|NCT04927975|529295322|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
146762148|NCT04927975|529295323|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
146762149|NCT04927975|529295324|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
146762150|NCT04927975|529295325|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
146762151|NCT04927975|529295326|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
146762152|NCT04927975|529295327|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
146762153|NCT04927975|529295322|FG000|Period 1 (Baseline-Week 24)|Death|0|||
146762154|NCT04927975|529295323|FG001|Period 1 (Baseline-Week 24)|Death|0|||
146762155|NCT04927975|529295324|FG002|Period 1 (Baseline-Week 24)|Death|0|||
146530169|NCT03589807|528449167|FG004|Overall Study|Protocol Violation|0|||
146862928|NCT04796896|529670044|FG004|Overall Study|Missing|0|||
146862929|NCT04796896|529670045|FG005|Overall Study|Missing|0|||
146862930|NCT04796896|529670046|FG006|Overall Study|Missing|2|||
146862931|NCT04796896|529670047|FG007|Overall Study|Missing|1|||
146862932|NCT04796896|529670048|FG008|Overall Study|Missing|2|||
146862933|NCT04796896|529670049|FG009|Overall Study|Missing|1|||
146862934|NCT04796896|529670050|FG010|Overall Study|Missing|1|||
146862935|NCT04796896|529670051|FG011|Overall Study|Missing|0|||
146862936|NCT04796896|529670040|FG000|Overall Study|Death|0|||
146862937|NCT04796896|529670041|FG001|Overall Study|Death|0|||
146862938|NCT04796896|529670042|FG002|Overall Study|Death|0|||
146862939|NCT04796896|529670043|FG003|Overall Study|Death|0|||
146862940|NCT04796896|529670044|FG004|Overall Study|Death|0|||
146862941|NCT04796896|529670045|FG005|Overall Study|Death|0|||
146862942|NCT04796896|529670046|FG006|Overall Study|Death|0|||
146862943|NCT04796896|529670047|FG007|Overall Study|Death|0|||
146862944|NCT04796896|529670048|FG008|Overall Study|Death|1|||
146862945|NCT04796896|529670049|FG009|Overall Study|Death|0|||
146862946|NCT04796896|529670050|FG010|Overall Study|Death|0|||
146862947|NCT04796896|529670051|FG011|Overall Study|Death|0|||
146862948|NCT05972733|529670052|FG000|Overall Study|Lost to Follow-up|2|||
146862949|NCT05972733|529670052|FG000|Overall Study|Withdrawal by Subject|1|||
146862950|NCT01177787|529670055|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
146862951|NCT01177787|529670055|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
146862952|NCT01177787|529670055|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
146862953|NCT01637623|529670058|FG000|Overall Study|Lost to Follow-up|0|||
146862954|NCT01637623|529670059|FG001|Overall Study|Lost to Follow-up|0|||
146862955|NCT01637623|529670060|FG002|Overall Study|Lost to Follow-up|2|||
146862956|NCT01637623|529670058|FG000|Overall Study|Physician Decision|1|||
146862957|NCT01637623|529670059|FG001|Overall Study|Physician Decision|0|||
146862958|NCT01637623|529670060|FG002|Overall Study|Physician Decision|1|||
146862959|NCT02824263|529670065|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
146862960|NCT02824263|529670066|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
146862961|NCT02824263|529670065|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
146862962|NCT02824263|529670066|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
146862963|NCT00568321|529670067|FG000|Overall Study|Adverse Event|1|||
146862964|NCT00568321|529670068|FG001|Overall Study|Adverse Event|0|||
146862965|NCT00568321|529670069|FG002|Overall Study|Adverse Event|0|||
146862966|NCT00568321|529670067|FG000|Overall Study|Lack of Efficacy|8|||
146862967|NCT00568321|529670068|FG001|Overall Study|Lack of Efficacy|5|||
146862968|NCT00568321|529670069|FG002|Overall Study|Lack of Efficacy|6|||
146862969|NCT00568321|529670067|FG000|Overall Study|Lost to Follow-up|0|||
146862970|NCT00568321|529670068|FG001|Overall Study|Lost to Follow-up|0|||
146862971|NCT00568321|529670069|FG002|Overall Study|Lost to Follow-up|1|||
146862972|NCT00568321|529670067|FG000|Overall Study|Withdrawal by Subject|2|||
146862973|NCT00568321|529670068|FG001|Overall Study|Withdrawal by Subject|0|||
146862974|NCT00568321|529670069|FG002|Overall Study|Withdrawal by Subject|0|||
146862975|NCT00568321|529670067|FG000|Overall Study|Protocol Violation|0|||
146862976|NCT00568321|529670068|FG001|Overall Study|Protocol Violation|0|||
146862977|NCT00568321|529670069|FG002|Overall Study|Protocol Violation|1|||
146862978|NCT00568321|529670067|FG000|Overall Study|Randomized, not treated|2|||
146862979|NCT00568321|529670068|FG001|Overall Study|Randomized, not treated|0|||
146862980|NCT00568321|529670069|FG002|Overall Study|Randomized, not treated|1|||
146862981|NCT01676909|529670071|FG000|Overall Study|Withdrawal by Subject|3|||
146862982|NCT01676909|529670072|FG001|Overall Study|Withdrawal by Subject|5|||
146862983|NCT01676909|529670071|FG000|Overall Study|Lost to Follow-up|15|||
146862984|NCT01676909|529670072|FG001|Overall Study|Lost to Follow-up|9|||
146862985|NCT02076113|529670073|FG000|Overall Study|Lost to Follow-up|4|||
146862986|NCT02076113|529670074|FG001|Overall Study|Lost to Follow-up|1|||
146862987|NCT02076113|529670073|FG000|Overall Study|Withdrawal by Subject|2|||
146862988|NCT02076113|529670074|FG001|Overall Study|Withdrawal by Subject|3|||
146862989|NCT02076113|529670073|FG000|Overall Study|Death|1|||
146862990|NCT02076113|529670074|FG001|Overall Study|Death|3|||
146862991|NCT03871829|529670078|FG000|Overall Study|Lost to Follow-up|0|||
146862992|NCT03871829|529670079|FG001|Overall Study|Lost to Follow-up|1|||
146862993|NCT03871829|529670078|FG000|Overall Study|Withdrawal by Subject|1|||
146862994|NCT03871829|529670079|FG001|Overall Study|Withdrawal by Subject|1|||
146862995|NCT03871829|529670078|FG000|Overall Study|Death|12|||
146862996|NCT03871829|529670079|FG001|Overall Study|Death|8|||
146862997|NCT03871829|529670078|FG000|Overall Study|Study terminated by sponsor|31|||
146862998|NCT03871829|529670079|FG001|Overall Study|Study terminated by sponsor|34|||
146862999|NCT02993523|529670080|FG000|Overall Study|Withdrew Consent|0|||
146863000|NCT02993523|529670081|FG001|Overall Study|Withdrew Consent|0|||
146863001|NCT02993523|529670082|FG002|Overall Study|Withdrew Consent|2|||
146863002|NCT02993523|529670083|FG003|Overall Study|Withdrew Consent|9|||
146863003|NCT02993523|529670084|FG004|Overall Study|Withdrew Consent|0|||
146863004|NCT02993523|529670080|FG000|Overall Study|Lost to Follow-up|0|||
146863005|NCT02993523|529670081|FG001|Overall Study|Lost to Follow-up|0|||
146863006|NCT02993523|529670082|FG002|Overall Study|Lost to Follow-up|3|||
146863007|NCT02993523|529670083|FG003|Overall Study|Lost to Follow-up|6|||
146863008|NCT02993523|529670084|FG004|Overall Study|Lost to Follow-up|0|||
146863009|NCT02993523|529670080|FG000|Overall Study|Death|1|||
146863010|NCT02993523|529670081|FG001|Overall Study|Death|1|||
146863011|NCT02993523|529670082|FG002|Overall Study|Death|138|||
146863012|NCT02993523|529670083|FG003|Overall Study|Death|222|||
146863013|NCT02993523|529670084|FG004|Overall Study|Death|6|||
146863014|NCT02993523|529670080|FG000|Overall Study|Reason not Specified|0|||
146863015|NCT02993523|529670081|FG001|Overall Study|Reason not Specified|0|||
146863016|NCT02993523|529670082|FG002|Overall Study|Reason not Specified|1|||
146863017|NCT02993523|529670083|FG003|Overall Study|Reason not Specified|1|||
146863018|NCT02993523|529670084|FG004|Overall Study|Reason not Specified|0|||
146863019|NCT04288778|529670099|FG000|Overall Study|Withdrawal by Subject|2|||
146863020|NCT04288778|529670099|FG000|Overall Study|Adverse Event|5|||
146863021|NCT04288778|529670099|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146863022|NCT04288778|529670099|FG000|Overall Study|Other|1|||
146863023|NCT04288778|529670099|FG000|Overall Study|Started but not treated|2|||
146863024|NCT00784693|529670100|FG000|Overall Study|Lost to Follow-up|0|||
146863025|NCT00784693|529670101|FG001|Overall Study|Lost to Follow-up|1|||
146863026|NCT00784693|529670100|FG000|Overall Study|Lack of Efficacy|1|||
146863027|NCT00784693|529670101|FG001|Overall Study|Lack of Efficacy|1|||
146863028|NCT00784693|529670100|FG000|Overall Study|Withdrawal by Subject|0|||
146863029|NCT00784693|529670101|FG001|Overall Study|Withdrawal by Subject|4|||
146863030|NCT00784693|529670100|FG000|Overall Study|Randomized but not Treated|1|||
146863031|NCT00784693|529670101|FG001|Overall Study|Randomized but not Treated|0|||
146863032|NCT00784693|529670100|FG000|Overall Study|Other|1|||
146863033|NCT00784693|529670101|FG001|Overall Study|Other|0|||
146863034|NCT00528866|529670102|FG000|Overall Study|Protocol Violation|6|||
146863035|NCT00993915|529670103|FG000|Overall Study|Insufficient clinical response|3|||
146863036|NCT00993915|529670103|FG000|Overall Study|Withdrawal by Subject|2|||
146863037|NCT00993915|529670103|FG000|Overall Study|Other|1|||
146863038|NCT00993915|529670103|FG000|Overall Study|Ongoing|3|||
146863039|NCT02430051|529670106|FG000|Overall Study|Withdrawal by Subject|6|||
146863040|NCT02430051|529670107|FG001|Overall Study|Withdrawal by Subject|3|||
146863041|NCT02430051|529670106|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
146863042|NCT02430051|529670107|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
146863043|NCT02430051|529670106|FG000|Overall Study|Protocol Violation|1|||
146863044|NCT02430051|529670107|FG001|Overall Study|Protocol Violation|0|||
146863045|NCT02030405|529670112|FG000|Overall Study|Withdrawal by Subject|1|||
146863046|NCT02030405|529670112|FG000|Overall Study|Lost to Follow-up|1|||
146863047|NCT00132496|529670113|FG000|Overall Study|Withdrawal by Subject|1|||
146863048|NCT00132496|529670114|FG001|Overall Study|Withdrawal by Subject|2|||
146863049|NCT00132496|529670113|FG000|Overall Study|Physician Decision|1|||
146863050|NCT00132496|529670114|FG001|Overall Study|Physician Decision|0|||
146863051|NCT04526197|529670115|FG000|Period 1|Adverse Event|0|||
146863052|NCT04526197|529670116|FG001|Period 1|Adverse Event|1|||
146863053|NCT04526197|529670115|FG000|Period 1|Withdrawal by Subject|1|||
146863054|NCT04526197|529670116|FG001|Period 1|Withdrawal by Subject|0|||
146863055|NCT04526197|529670115|FG000|Period 2|Adverse Event|0|||
146863056|NCT04526197|529670116|FG001|Period 2|Adverse Event|1|||
146863057|NCT04526197|529670115|FG000|Period 2|Withdrawal by Subject|0|||
146863058|NCT04526197|529670116|FG001|Period 2|Withdrawal by Subject|1|||
146863059|NCT01136811|529670117|FG000|Overall Study|Physician Decision|11|||
146863060|NCT00372385|529670118|FG000|Overall Study|Adverse Event|6|||
146863061|NCT00372385|529670119|FG001|Overall Study|Adverse Event|11|||
146863062|NCT00372385|529670120|FG002|Overall Study|Adverse Event|9|||
146863063|NCT00372385|529670121|FG003|Overall Study|Adverse Event|7|||
146863064|NCT00372385|529670118|FG000|Overall Study|Noncompliance|0|||
146863065|NCT00372385|529670119|FG001|Overall Study|Noncompliance|1|||
146863066|NCT00372385|529670120|FG002|Overall Study|Noncompliance|1|||
146863067|NCT00372385|529670121|FG003|Overall Study|Noncompliance|1|||
146863068|NCT00372385|529670118|FG000|Overall Study|Physician Decision|1|||
146863069|NCT00372385|529670119|FG001|Overall Study|Physician Decision|0|||
146863070|NCT00372385|529670120|FG002|Overall Study|Physician Decision|0|||
146863071|NCT00372385|529670121|FG003|Overall Study|Physician Decision|0|||
146863072|NCT00372385|529670118|FG000|Overall Study|Lost to Follow-up|2|||
146863073|NCT00372385|529670119|FG001|Overall Study|Lost to Follow-up|0|||
146863074|NCT00372385|529670120|FG002|Overall Study|Lost to Follow-up|0|||
146863075|NCT00372385|529670121|FG003|Overall Study|Lost to Follow-up|0|||
146863076|NCT00372385|529670118|FG000|Overall Study|Withdrawal by Subject|2|||
146863077|NCT00372385|529670119|FG001|Overall Study|Withdrawal by Subject|1|||
146863078|NCT00372385|529670120|FG002|Overall Study|Withdrawal by Subject|0|||
146863079|NCT00372385|529670121|FG003|Overall Study|Withdrawal by Subject|0|||
146863080|NCT00372385|529670118|FG000|Overall Study|Refusal of Treatment|3|||
146863081|NCT00372385|529670119|FG001|Overall Study|Refusal of Treatment|6|||
146863082|NCT00372385|529670120|FG002|Overall Study|Refusal of Treatment|0|||
146863083|NCT00372385|529670121|FG003|Overall Study|Refusal of Treatment|0|||
146863084|NCT00372385|529670118|FG000|Overall Study|No Response|1|||
146863085|NCT00372385|529670119|FG001|Overall Study|No Response|1|||
146863086|NCT00372385|529670120|FG002|Overall Study|No Response|0|||
146863087|NCT00372385|529670121|FG003|Overall Study|No Response|0|||
146863088|NCT00372385|529670118|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
146863089|NCT00372385|529670119|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
146863090|NCT00372385|529670120|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
146863091|NCT00372385|529670121|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
146863092|NCT00372385|529670118|FG000|Overall Study|Virologic Stopping Rule|17|||
146863093|NCT00372385|529670119|FG001|Overall Study|Virologic Stopping Rule|0|||
146863094|NCT00372385|529670120|FG002|Overall Study|Virologic Stopping Rule|0|||
146863095|NCT00372385|529670121|FG003|Overall Study|Virologic Stopping Rule|0|||
146863096|NCT03170154|529670123|FG000|Overall Study|Lost to Follow-up|4|||
146863097|NCT03170154|529670123|FG000|Overall Study|Death|2|||
146863098|NCT03170154|529670123|FG000|Overall Study|Withdrawal by Subject|2|||
146863099|NCT02279862|529670124|FG000|Overall Study|Study drug toxicity|3|||
146863100|NCT02279862|529670125|FG001|Overall Study|Study drug toxicity|6|||
146863101|NCT02279862|529670124|FG000|Overall Study|No longer meets criteria|0|||
146863102|NCT02279862|529670125|FG001|Overall Study|No longer meets criteria|1|||
146863103|NCT02279862|529670124|FG000|Overall Study|Administrative reason by sponsor|0|||
146863104|NCT02279862|529670125|FG001|Overall Study|Administrative reason by sponsor|1|||
146863105|NCT02279862|529670124|FG000|Overall Study|Disease progression|5|||
146863106|NCT02279862|529670125|FG001|Overall Study|Disease progression|2|||
146863107|NCT02279862|529670124|FG000|Overall Study|Study closed by sponsor|16|||
146863108|NCT02279862|529670125|FG001|Overall Study|Study closed by sponsor|13|||
146863109|NCT02279862|529670124|FG000|Overall Study|Other|1|||
146863110|NCT02279862|529670125|FG001|Overall Study|Other|2|||
146863111|NCT02279862|529670124|FG000|Overall Study|Withdrawal by Subject|1|||
146530170|NCT03589807|528449168|FG005|Overall Study|Protocol Violation|0|||
146762156|NCT04927975|529295325|FG003|Period 1 (Baseline-Week 24)|Death|0|||
146762157|NCT04927975|529295326|FG004|Period 1 (Baseline-Week 24)|Death|0|||
146762158|NCT04927975|529295327|FG005|Period 1 (Baseline-Week 24)|Death|1|||
146762159|NCT04927975|529295322|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
146762160|NCT04927975|529295323|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
146762161|NCT04927975|529295324|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
146762162|NCT04927975|529295325|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
146762163|NCT04927975|529295326|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
146762164|NCT04927975|529295327|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
146762165|NCT04927975|529295322|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
146762166|NCT04927975|529295323|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
146762167|NCT04927975|529295324|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
146762168|NCT04927975|529295325|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
146762169|NCT04927975|529295326|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
146762170|NCT04927975|529295327|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
146762171|NCT03822351|529295328|FG000|Overall Study|Death|27|||
146762172|NCT03822351|529295329|FG001|Overall Study|Death|23|||
146762173|NCT03822351|529295330|FG002|Overall Study|Death|24|||
146762174|NCT03822351|529295328|FG000|Overall Study|Lost to Follow-up|6|||
146762175|NCT03822351|529295329|FG001|Overall Study|Lost to Follow-up|2|||
146762176|NCT03822351|529295330|FG002|Overall Study|Lost to Follow-up|1|||
146762177|NCT03822351|529295328|FG000|Overall Study|Withdrawal by Subject|10|||
146762178|NCT03822351|529295329|FG001|Overall Study|Withdrawal by Subject|4|||
146762179|NCT03822351|529295330|FG002|Overall Study|Withdrawal by Subject|6|||
146762180|NCT03822351|529295328|FG000|Overall Study|Progressive Disease|2|||
146762181|NCT03822351|529295329|FG001|Overall Study|Progressive Disease|1|||
146762182|NCT03822351|529295330|FG002|Overall Study|Progressive Disease|0|||
146762183|NCT03822351|529295328|FG000|Overall Study|Not Treated|1|||
146762184|NCT03822351|529295329|FG001|Overall Study|Not Treated|1|||
146762185|NCT03822351|529295330|FG002|Overall Study|Not Treated|1|||
146762186|NCT00630864|529295331|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
146762187|NCT00630864|529295331|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
146762188|NCT01645111|529296943|FG000|Overall Study|Did not require Clevidipine|15|||
146762189|NCT04057196|529296944|FG000|Overall Study|Withdrawal by Subject|3|||
146762190|NCT04057196|529296944|FG000|Overall Study|Death|3|||
146762191|NCT01118377|529296945|FG000|Overall Study|Did Not Receive Study Medication|1|||
146762192|NCT01118377|529296945|FG000|Overall Study|Death|38|||
146762193|NCT01118377|529296945|FG000|Overall Study|Failure to Return|3|||
146762194|NCT00739102|529296950|FG000|Overall Study|Death|5|||
146762195|NCT00739102|529296950|FG000|Overall Study|Withdrawal by Subject|10|||
146762196|NCT01062126|529296951|FG000|Overall Study|Death|209|||
146863112|NCT02279862|529670125|FG001|Overall Study|Withdrawal by Subject|0|||
146863113|NCT03431857|529670128|FG000|Overall Study|Death|6|||
146863114|NCT03431857|529670128|FG000|Overall Study|Lost to Follow-up|41|||
146863115|NCT03431857|529670128|FG000|Overall Study|Adverse Event|6|||
146762197|NCT01062126|529296951|FG000|Overall Study|All Withdrawals|324|||
146762198|NCT00646451|529296952|FG000|Overall Study|Adverse Event|3|||
146762199|NCT00646451|529296953|FG001|Overall Study|Adverse Event|0|||
146762200|NCT00646451|529296952|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
146762201|NCT00646451|529296953|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
146863116|NCT03431857|529670128|FG000|Overall Study|Withdrawal by Subject|1|||
146863117|NCT01323621|529670129|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
146863118|NCT01323621|529670130|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
146863119|NCT01323621|529670131|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
146863120|NCT01323621|529670129|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
146863121|NCT01323621|529670130|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
146863122|NCT01323621|529670131|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
146863123|NCT01323621|529670129|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
146863124|NCT01323621|529670130|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
146863125|NCT01323621|529670131|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
146863126|NCT01323621|529670129|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
146863127|NCT01323621|529670130|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
146863128|NCT01323621|529670131|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
146863129|NCT01323621|529670129|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
146863130|NCT01323621|529670130|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
146863131|NCT01323621|529670131|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
146863132|NCT01323621|529670129|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
146762202|NCT01149681|529296954|FG000|Overall Study|Withdrawal by Subject|7|||
146762203|NCT01149681|529296954|FG000|Overall Study|Progressive disease|1|||
146762204|NCT01149681|529296954|FG000|Overall Study|Physician Decision|2|||
146762205|NCT01149681|529296954|FG000|Overall Study|adverse events nonrelated study drug|2|||
146762206|NCT01876511|529296955|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
146762207|NCT01876511|529296956|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
146762208|NCT01876511|529296957|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
146762209|NCT01876511|529296955|FG000|Overall Study|Death (unrelated)|3|||
146762210|NCT01876511|529296956|FG001|Overall Study|Death (unrelated)|0|||
146762211|NCT01876511|529296957|FG002|Overall Study|Death (unrelated)|2|||
146762212|NCT01876511|529296955|FG000|Overall Study|Drug-related Toxicity|5|||
146762213|NCT01876511|529296956|FG001|Overall Study|Drug-related Toxicity|1|||
146762214|NCT01876511|529296957|FG002|Overall Study|Drug-related Toxicity|6|||
146762215|NCT01876511|529296955|FG000|Overall Study|Patient Decision|3|||
146762216|NCT01876511|529296956|FG001|Overall Study|Patient Decision|0|||
146762217|NCT01876511|529296957|FG002|Overall Study|Patient Decision|6|||
146762218|NCT01876511|529296955|FG000|Overall Study|Physician Decision|1|||
146762219|NCT01876511|529296956|FG001|Overall Study|Physician Decision|0|||
146762220|NCT01876511|529296957|FG002|Overall Study|Physician Decision|1|||
146762221|NCT04582877|529296958|FG000|Overall Study|Did not use device measurement|5|||
146762222|NCT04582877|529296958|FG000|Overall Study|No fractional flow reserve test results|2|||
146863133|NCT01323621|529670130|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
146863134|NCT01323621|529670131|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
146863135|NCT01323621|529670129|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
146863136|NCT01323621|529670130|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
146863137|NCT01323621|529670131|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
146863138|NCT01323621|529670129|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
146863139|NCT01323621|529670130|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
146863140|NCT01323621|529670131|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
146863141|NCT01323621|529670129|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
146863142|NCT01323621|529670130|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
146863143|NCT01323621|529670131|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
146863144|NCT01323621|529670129|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146863145|NCT01323621|529670130|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
146863146|NCT01323621|529670131|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146863147|NCT01323621|529670129|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
146863148|NCT01323621|529670130|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
146863149|NCT01323621|529670131|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
146863150|NCT01323621|529670129|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
146863151|NCT01323621|529670130|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
146863152|NCT01323621|529670131|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
146863153|NCT00651157|529670132|FG000|Overall Study|Death|1|||
146863154|NCT00651157|529670132|FG000|Overall Study|Protocol Violation|1|||
146863155|NCT01163721|529670137|FG000|Overall Study|Adverse Event|5|||
146863156|NCT01163721|529670138|FG001|Overall Study|Adverse Event|6|||
146863157|NCT01163721|529670137|FG000|Overall Study|Withdrawal by Subject|3|||
146863158|NCT01163721|529670138|FG001|Overall Study|Withdrawal by Subject|4|||
146863159|NCT01163721|529670137|FG000|Overall Study|Lost to Follow-up|0|||
146762223|NCT04582877|529296958|FG000|Overall Study|Protocol Violation|1|||
146762224|NCT04304534|529296959|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
146863160|NCT01163721|529670138|FG001|Overall Study|Lost to Follow-up|1|||
146762225|NCT04304534|529296960|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
146762226|NCT04304534|529296961|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
146762227|NCT04304534|529296962|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
146863161|NCT01163721|529670137|FG000|Overall Study|Physician Decision|0|||
146863162|NCT01163721|529670138|FG001|Overall Study|Physician Decision|1|||
146863163|NCT00688181|529670139|FG000|Overall Study|Lost to Follow-up|17|||
146863164|NCT00688181|529670139|FG000|Overall Study|Unknown Reason|4|||
146863165|NCT00688181|529670139|FG000|Overall Study|Non-clinical Reason|2|||
146863166|NCT01050205|529670140|FG000|Overall Study|Lost to Follow-up|7|||
146863167|NCT01050205|529670141|FG001|Overall Study|Lost to Follow-up|1|||
146863168|NCT01050205|529670140|FG000|Overall Study|Withdrawal by Subject|1|||
146863169|NCT01050205|529670141|FG001|Overall Study|Withdrawal by Subject|1|||
146863170|NCT01050205|529670140|FG000|Overall Study|Relocated from area|1|||
146863171|NCT01050205|529670141|FG001|Overall Study|Relocated from area|2|||
146863172|NCT01050205|529670140|FG000|Overall Study|Discontinued Intervention|2|||
146863173|NCT01050205|529670141|FG001|Overall Study|Discontinued Intervention|0|||
146863174|NCT01295281|529670144|FG000|First Intervention (7 Days)|Death|0|||
146863175|NCT01295281|529670145|FG001|First Intervention (7 Days)|Death|1|||
146863176|NCT00292461|529670146|FG000|Overall Study|Adverse Event|4|||
146863177|NCT00292461|529670147|FG001|Overall Study|Adverse Event|2|||
146863178|NCT00292461|529670146|FG000|Overall Study|Lack of Efficacy|1|||
146863179|NCT00292461|529670147|FG001|Overall Study|Lack of Efficacy|0|||
146863180|NCT00292461|529670146|FG000|Overall Study|Withdrawal by Subject|0|||
146863181|NCT00292461|529670147|FG001|Overall Study|Withdrawal by Subject|1|||
146863182|NCT00292461|529670146|FG000|Overall Study|Protocol Violation|4|||
146863183|NCT00292461|529670147|FG001|Overall Study|Protocol Violation|3|||
146863184|NCT00292461|529670146|FG000|Overall Study|Lost to Follow-up|1|||
146863185|NCT00292461|529670147|FG001|Overall Study|Lost to Follow-up|0|||
146863186|NCT00954421|529670148|FG000|Screening|screen failures|3|||
146863187|NCT00954421|529670148|FG000|6 Months of DBS|Withdrawal by Subject|1|||
146863188|NCT00954421|529670148|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
146863189|NCT01891721|529670149|FG000|Overall Study|Lost to Follow-up|10|||
146762228|NCT04304534|529296959|FG000|Overall Study|Non-Compliance with study drug|0|||
146762229|NCT04304534|529296960|FG001|Overall Study|Non-Compliance with study drug|1|||
146762230|NCT04304534|529296961|FG002|Overall Study|Non-Compliance with study drug|1|||
146762231|NCT04304534|529296962|FG003|Overall Study|Non-Compliance with study drug|1|||
146762232|NCT04304534|529296959|FG000|Overall Study|Lost to Follow-up|0|||
146762233|NCT04304534|529296960|FG001|Overall Study|Lost to Follow-up|1|||
146762234|NCT04304534|529296961|FG002|Overall Study|Lost to Follow-up|2|||
146762235|NCT04304534|529296962|FG003|Overall Study|Lost to Follow-up|3|||
146762236|NCT04304534|529296959|FG000|Overall Study|Unspecific|4|||
146762237|NCT04304534|529296960|FG001|Overall Study|Unspecific|2|||
146762238|NCT04304534|529296961|FG002|Overall Study|Unspecific|2|||
146762239|NCT04304534|529296962|FG003|Overall Study|Unspecific|2|||
146762240|NCT04304534|529296959|FG000|Overall Study|Technical Problems|2|||
146762241|NCT04304534|529296960|FG001|Overall Study|Technical Problems|2|||
146762242|NCT04304534|529296961|FG002|Overall Study|Technical Problems|3|||
146762243|NCT04304534|529296962|FG003|Overall Study|Technical Problems|4|||
146762244|NCT04304534|529296959|FG000|Overall Study|Death|7|||
146762245|NCT04304534|529296960|FG001|Overall Study|Death|2|||
146762246|NCT04304534|529296961|FG002|Overall Study|Death|4|||
146762247|NCT04304534|529296962|FG003|Overall Study|Death|3|||
146762248|NCT04304534|529296959|FG000|Overall Study|Withdrawal by Subject|7|||
146762249|NCT04304534|529296960|FG001|Overall Study|Withdrawal by Subject|2|||
146762250|NCT04304534|529296961|FG002|Overall Study|Withdrawal by Subject|7|||
146762251|NCT04304534|529296962|FG003|Overall Study|Withdrawal by Subject|4|||
146762252|NCT04304534|529296959|FG000|Overall Study|Physician Decision|4|||
146762253|NCT04304534|529296960|FG001|Overall Study|Physician Decision|9|||
146762254|NCT04304534|529296961|FG002|Overall Study|Physician Decision|9|||
146762255|NCT04304534|529296962|FG003|Overall Study|Physician Decision|5|||
146762256|NCT04304534|529296959|FG000|Overall Study|Subject Decision|34|||
146762257|NCT04304534|529296960|FG001|Overall Study|Subject Decision|25|||
146762258|NCT04304534|529296961|FG002|Overall Study|Subject Decision|25|||
146762259|NCT04304534|529296962|FG003|Overall Study|Subject Decision|26|||
146762260|NCT04304534|529296959|FG000|Overall Study|Adverse Event|35|||
146762261|NCT04304534|529296960|FG001|Overall Study|Adverse Event|40|||
146762262|NCT04304534|529296961|FG002|Overall Study|Adverse Event|39|||
146762263|NCT04304534|529296962|FG003|Overall Study|Adverse Event|44|||
146762264|NCT00464672|529296963|FG000|Overall Study|withdrawal of consent|0|||
146762265|NCT00464672|529296964|FG001|Overall Study|withdrawal of consent|0|||
146762266|NCT00464672|529296965|FG002|Overall Study|withdrawal of consent|0|||
146762267|NCT00464672|529296966|FG003|Overall Study|withdrawal of consent|1|||
146863190|NCT01891721|529670150|FG001|Overall Study|Lost to Follow-up|5|||
146863191|NCT01891721|529670151|FG002|Overall Study|Lost to Follow-up|1|||
146762268|NCT00464672|529296967|FG004|Overall Study|withdrawal of consent|9|||
146762269|NCT00464672|529296968|FG005|Overall Study|withdrawal of consent|4|||
146762270|NCT00464672|529296963|FG000|Overall Study|Lost to Follow-up|25|||
146863192|NCT00633061|529670152|FG000|Overall Study|Study closed|86|||
146863193|NCT00633061|529670153|FG001|Overall Study|Study closed|0|||
146863194|NCT02708095|529670156|FG000|Overall Study|Adverse Event|4|||
146863195|NCT02708095|529670157|FG001|Overall Study|Adverse Event|10|||
146863196|NCT02708095|529670158|FG002|Overall Study|Adverse Event|11|||
146863197|NCT02708095|529670156|FG000|Overall Study|Lack of Efficacy|9|||
146863198|NCT02708095|529670157|FG001|Overall Study|Lack of Efficacy|3|||
146863199|NCT02708095|529670158|FG002|Overall Study|Lack of Efficacy|0|||
146863200|NCT02708095|529670156|FG000|Overall Study|Lost to Follow-up|2|||
146863201|NCT02708095|529670157|FG001|Overall Study|Lost to Follow-up|0|||
146863202|NCT02708095|529670158|FG002|Overall Study|Lost to Follow-up|0|||
146863203|NCT02708095|529670156|FG000|Overall Study|Physician Decision|2|||
146863204|NCT02708095|529670157|FG001|Overall Study|Physician Decision|3|||
146863205|NCT02708095|529670158|FG002|Overall Study|Physician Decision|2|||
146863206|NCT02708095|529670156|FG000|Overall Study|Protocol Violation|0|||
146863207|NCT02708095|529670157|FG001|Overall Study|Protocol Violation|0|||
146863208|NCT02708095|529670158|FG002|Overall Study|Protocol Violation|1|||
146863209|NCT02708095|529670156|FG000|Overall Study|Withdrawal by Subject|5|||
146863210|NCT02708095|529670157|FG001|Overall Study|Withdrawal by Subject|3|||
146863211|NCT02708095|529670158|FG002|Overall Study|Withdrawal by Subject|4|||
146863212|NCT05066724|529670171|FG000|Overall Study|Adverse Event|1|||
146863213|NCT05066724|529670171|FG000|Overall Study|Non-Compliance With Study Drug|5|||
146863214|NCT05066724|529670171|FG000|Overall Study|Withdrawal by Subject|6|||
146863215|NCT05066724|529670171|FG000|Overall Study|Physician Decision|2|||
146863216|NCT01696942|529670186|FG000|Overall Study|Withdrawal by Subject|1|||
146863217|NCT01696942|529670187|FG001|Overall Study|Withdrawal by Subject|0|||
146863218|NCT01696942|529670186|FG000|Overall Study|Protocol Violation|1|||
146863219|NCT01696942|529670187|FG001|Overall Study|Protocol Violation|2|||
146863220|NCT01696942|529670186|FG000|Overall Study|screen failure|0|||
146863221|NCT01696942|529670187|FG001|Overall Study|screen failure|1|||
146863222|NCT03078907|529671362|FG000|Overall Study|Adverse Event|2|||
146863223|NCT03078907|529671363|FG001|Overall Study|Adverse Event|0|||
146863224|NCT03078907|529671362|FG000|Overall Study|Other|1|||
146863225|NCT03078907|529671363|FG001|Overall Study|Other|0|||
146863226|NCT03078907|529671362|FG000|Overall Study|Protocol Violation|0|||
146863227|NCT03078907|529671363|FG001|Overall Study|Protocol Violation|1|||
146863228|NCT01955122|529671364|FG000|Overall Study|Physician Decision|5|||
146863229|NCT01955122|529671365|FG001|Overall Study|Physician Decision|5|||
146863230|NCT00985166|529671366|FG000|Overall Study|Lost to Follow-up|3|||
146863231|NCT00985166|529671367|FG001|Overall Study|Lost to Follow-up|2|||
146863232|NCT00985166|529671368|FG002|Overall Study|Lost to Follow-up|2|||
146863233|NCT00985166|529671366|FG000|Overall Study|Withdrawal by Subject|3|||
146863234|NCT00985166|529671367|FG001|Overall Study|Withdrawal by Subject|2|||
146863235|NCT00985166|529671368|FG002|Overall Study|Withdrawal by Subject|0|||
146863236|NCT00985166|529671366|FG000|Overall Study|Test not done|2|||
146863237|NCT00985166|529671367|FG001|Overall Study|Test not done|0|||
146863238|NCT00985166|529671368|FG002|Overall Study|Test not done|4|||
146863239|NCT00985166|529671366|FG000|Overall Study|Other|1|||
146863240|NCT00985166|529671367|FG001|Overall Study|Other|0|||
146863241|NCT00985166|529671368|FG002|Overall Study|Other|1|||
146863242|NCT02464228|529671369|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
146863243|NCT02464228|529671370|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
146965100|NCT03110107|530033438|FG012|Treatment Period|Adverse Event|0|||
146530171|NCT03589807|528449163|FG000|Overall Study|Enrolled but treatment not administered|0|||
146530172|NCT03589807|528449164|FG001|Overall Study|Enrolled but treatment not administered|0|||
146530173|NCT03589807|528449165|FG002|Overall Study|Enrolled but treatment not administered|0|||
146530174|NCT03589807|528449166|FG003|Overall Study|Enrolled but treatment not administered|0|||
146530175|NCT03589807|528449167|FG004|Overall Study|Enrolled but treatment not administered|1|||
146762271|NCT00464672|529296964|FG001|Overall Study|Lost to Follow-up|10|||
146762272|NCT00464672|529296965|FG002|Overall Study|Lost to Follow-up|0|||
146762273|NCT00464672|529296966|FG003|Overall Study|Lost to Follow-up|0|||
146762274|NCT00464672|529296967|FG004|Overall Study|Lost to Follow-up|1|||
146762275|NCT00464672|529296968|FG005|Overall Study|Lost to Follow-up|0|||
146762276|NCT02299635|529296969|FG000|Overall Study|Adverse Event|2|||
146762277|NCT02299635|529296969|FG000|Overall Study|Death|1|||
146762278|NCT02299635|529296969|FG000|Overall Study|Global deterioration of health status|1|||
146762279|NCT02299635|529296969|FG000|Overall Study|Objective progression or relapse|10|||
146762280|NCT02299635|529296969|FG000|Overall Study|Withdrawal by Subject|2|||
146762281|NCT02299635|529296969|FG000|Overall Study|Other|3|||
146762282|NCT00601640|529296970|FG000|Overall Study|Withdrawal by Subject|3|||
146762283|NCT00601640|529296971|FG001|Overall Study|Withdrawal by Subject|0|||
146762284|NCT00601640|529296972|FG002|Overall Study|Withdrawal by Subject|7|||
146762285|NCT00601640|529296970|FG000|Overall Study|Death|1|||
146762286|NCT00601640|529296971|FG001|Overall Study|Death|0|||
146762287|NCT00601640|529296972|FG002|Overall Study|Death|0|||
146762288|NCT00601640|529296970|FG000|Overall Study|Adverse Event|0|||
146762289|NCT00601640|529296971|FG001|Overall Study|Adverse Event|4|||
146762290|NCT00601640|529296972|FG002|Overall Study|Adverse Event|2|||
146762291|NCT00601640|529296970|FG000|Overall Study|intercurrent illness|1|||
146762292|NCT00601640|529296971|FG001|Overall Study|intercurrent illness|0|||
146762293|NCT00601640|529296972|FG002|Overall Study|intercurrent illness|0|||
146863244|NCT02464228|529671371|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
146863245|NCT02464228|529671372|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
146863246|NCT02464228|529671369|FG000|Overall Study|Physician Decision|2|||
146863247|NCT02464228|529671370|FG001|Overall Study|Physician Decision|0|||
146863248|NCT02464228|529671371|FG002|Overall Study|Physician Decision|1|||
146863249|NCT02464228|529671372|FG003|Overall Study|Physician Decision|0|||
146863250|NCT02464228|529671369|FG000|Overall Study|Miscellaneous|1|||
146863251|NCT02464228|529671370|FG001|Overall Study|Miscellaneous|0|||
146863252|NCT02464228|529671371|FG002|Overall Study|Miscellaneous|1|||
146863253|NCT02464228|529671372|FG003|Overall Study|Miscellaneous|0|||
146863254|NCT02464228|529671369|FG000|Overall Study|Adverse Event|9|||
146863255|NCT02464228|529671370|FG001|Overall Study|Adverse Event|0|||
146863256|NCT02464228|529671371|FG002|Overall Study|Adverse Event|3|||
146863257|NCT02464228|529671372|FG003|Overall Study|Adverse Event|0|||
146863258|NCT02464228|529671369|FG000|Overall Study|Withdrawal by Subject|1|||
146863259|NCT02464228|529671370|FG001|Overall Study|Withdrawal by Subject|1|||
146863260|NCT02464228|529671371|FG002|Overall Study|Withdrawal by Subject|1|||
146863261|NCT02464228|529671372|FG003|Overall Study|Withdrawal by Subject|0|||
146863262|NCT02464228|529671369|FG000|Overall Study|Disease Progression|22|||
146863263|NCT02464228|529671370|FG001|Overall Study|Disease Progression|12|||
146863264|NCT02464228|529671371|FG002|Overall Study|Disease Progression|5|||
146863265|NCT02464228|529671372|FG003|Overall Study|Disease Progression|2|||
146863266|NCT01117454|529671375|FG000|Overall Study|Pregnancy|0|||
146863267|NCT01117454|529671376|FG001|Overall Study|Pregnancy|1|||
146863268|NCT02973048|529671388|FG000|Overall Study|Epidural catheter insertion failure|1|||
146863269|NCT02973048|529671389|FG001|Overall Study|Epidural catheter insertion failure|0|||
146863270|NCT02973048|529671388|FG000|Overall Study|Withdrawal by Subject|0|||
146863271|NCT02973048|529671389|FG001|Overall Study|Withdrawal by Subject|3|||
146863272|NCT01906346|529671393|FG000|Overall Study|AEs|1|||
146863273|NCT00364156|529671396|FG000|Overall Study|Withdrawal by Subject|73|||
146863274|NCT00364156|529671397|FG001|Overall Study|Withdrawal by Subject|80|||
146863275|NCT00364156|529671396|FG000|Overall Study|Protocol Violation|6|||
146863276|NCT00364156|529671397|FG001|Overall Study|Protocol Violation|1|||
146863277|NCT02511678|529671398|FG000|Overall Study|Withdrawal by Subject|2|||
146863278|NCT02511678|529671398|FG000|Overall Study|Lost to Follow-up|4|||
146863279|NCT02511678|529671398|FG000|Overall Study|Death|19|||
146863280|NCT02511678|529671398|FG000|Overall Study|Adverse Event|1|||
146863281|NCT02511678|529671398|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
146863282|NCT02511678|529671398|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
146863283|NCT02511678|529671398|FG000|Overall Study|Required Radiofrequency Ablation|1|||
146863284|NCT02511678|529671398|FG000|Overall Study|Biopsy was Negative|1|||
146863285|NCT02511678|529671398|FG000|Overall Study|Protocol Violation|1|||
146863286|NCT02511678|529671398|FG000|Overall Study|Received Radiation Treatment|1|||
146863287|NCT05125679|529671404|FG000|Overall Study|Study Terminated by Sponsor|2|||
146863288|NCT05125679|529671405|FG001|Overall Study|Study Terminated by Sponsor|5|||
146863289|NCT04908189|529671410|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
146863290|NCT04908189|529671411|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
146863291|NCT04908189|529671412|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
146863292|NCT04908189|529671410|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
146863293|NCT04908189|529671411|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
146863294|NCT04908189|529671412|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
146863295|NCT04908189|529671410|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
146863296|NCT04908189|529671411|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
146863297|NCT04908189|529671412|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
146863298|NCT04908189|529671410|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
146863299|NCT04908189|529671411|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
146863300|NCT04908189|529671412|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
146863301|NCT04908189|529671410|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
146863302|NCT04908189|529671411|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
146863303|NCT04908189|529671412|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
146863304|NCT04908189|529671410|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
146863305|NCT04908189|529671411|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
146863306|NCT04908189|529671412|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
146863307|NCT04908189|529671410|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
146863308|NCT04908189|529671411|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
146863309|NCT04908189|529671412|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
146863310|NCT04908189|529671410|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
146863311|NCT04908189|529671411|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
146863312|NCT04908189|529671412|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
146863313|NCT04908189|529671410|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
146863314|NCT04908189|529671411|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
146863315|NCT04908189|529671412|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
146863316|NCT04908189|529671410|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
146863317|NCT04908189|529671411|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
146863318|NCT04908189|529671412|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
146863319|NCT04908189|529671410|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
146863320|NCT04908189|529671411|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
146863321|NCT04908189|529671412|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
146863322|NCT04908189|529671410|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
146863323|NCT04908189|529671411|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
146863324|NCT04908189|529671412|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
146863325|NCT00607022|529671414|FG000|Overall Study|Withdrawal by Subject|1|||
146863326|NCT00607022|529671415|FG001|Overall Study|Withdrawal by Subject|0|||
146863327|NCT00607022|529671416|FG002|Overall Study|Withdrawal by Subject|0|||
146863328|NCT00458341|529671417|FG000|Cycle 1|Adverse Event|1|||
146863329|NCT00458341|529671418|FG001|Cycle 1|Adverse Event|0|||
146863330|NCT04540133|529671419|FG000|Overall Study|Lost to Follow-up|1|||
146863331|NCT04540133|529671420|FG001|Overall Study|Lost to Follow-up|0|||
146863332|NCT05461794|529671421|FG000|Overall Study|Withdrawal by Subject|1|||
146863333|NCT05461794|529671422|FG001|Overall Study|Withdrawal by Subject|1|||
146863334|NCT05461794|529671423|FG002|Overall Study|Withdrawal by Subject|3|||
146863335|NCT05461794|529671421|FG000|Overall Study|Study Terminated By Sponsor|18|||
146863336|NCT05461794|529671422|FG001|Overall Study|Study Terminated By Sponsor|13|||
146863337|NCT05461794|529671423|FG002|Overall Study|Study Terminated By Sponsor|16|||
146863338|NCT05461794|529671421|FG000|Overall Study|Death|20|||
146863339|NCT05461794|529671422|FG001|Overall Study|Death|5|||
146863340|NCT05461794|529671423|FG002|Overall Study|Death|19|||
146863341|NCT02730598|529671428|FG000|Overall Study|Withdrawal by Subject|3|||
146863342|NCT02730598|529671429|FG001|Overall Study|Withdrawal by Subject|3|||
146863343|NCT02730598|529671428|FG000|Overall Study|Protocol Violation|0|||
146863344|NCT02730598|529671429|FG001|Overall Study|Protocol Violation|1|||
146863345|NCT02730598|529671428|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
146863346|NCT02730598|529671429|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
146863347|NCT01210118|529671435|FG000|Overall Study|Lost to Follow-up|1|||
146863348|NCT01210118|529671436|FG001|Overall Study|Lost to Follow-up|1|||
146863349|NCT01210118|529671435|FG000|Overall Study|Protocol Violation|1|||
146863350|NCT01210118|529671436|FG001|Overall Study|Protocol Violation|1|||
146863351|NCT01210118|529671435|FG000|Overall Study|Spontaneous abortion|1|||
146863352|NCT01210118|529671436|FG001|Overall Study|Spontaneous abortion|3|||
146863353|NCT02958267|529671437|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
146863354|NCT02958267|529671438|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
146863355|NCT02958267|529671437|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
146863356|NCT02958267|529671438|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
146863357|NCT02958267|529671437|FG000|Follow-up Visits|Additional treatment pursued|2|||
146863358|NCT02958267|529671438|FG001|Follow-up Visits|Additional treatment pursued|1|||
146863359|NCT00777946|529671439|FG000|Overall Study|Adverse Event|11|||
146863360|NCT00777946|529671440|FG001|Overall Study|Adverse Event|1|||
146863361|NCT00777946|529671441|FG002|Overall Study|Adverse Event|3|||
146863362|NCT00777946|529671439|FG000|Overall Study|Lack of Efficacy|0|||
146863363|NCT00777946|529671440|FG001|Overall Study|Lack of Efficacy|0|||
146863364|NCT00777946|529671441|FG002|Overall Study|Lack of Efficacy|9|||
146863365|NCT00777946|529671439|FG000|Overall Study|Condition no longer required study drug|1|||
146863366|NCT00777946|529671440|FG001|Overall Study|Condition no longer required study drug|0|||
146863367|NCT00777946|529671441|FG002|Overall Study|Condition no longer required study drug|0|||
146863368|NCT00777946|529671439|FG000|Overall Study|Patient withdrew consent|3|||
146863369|NCT00777946|529671440|FG001|Overall Study|Patient withdrew consent|2|||
146863370|NCT00777946|529671441|FG002|Overall Study|Patient withdrew consent|3|||
146863371|NCT00777946|529671439|FG000|Overall Study|Lost to Follow-up|3|||
146863372|NCT00777946|529671440|FG001|Overall Study|Lost to Follow-up|1|||
146863373|NCT00777946|529671441|FG002|Overall Study|Lost to Follow-up|0|||
146863374|NCT00777946|529671439|FG000|Overall Study|Protocol deviation|2|||
146863375|NCT00777946|529671440|FG001|Overall Study|Protocol deviation|1|||
146863376|NCT00777946|529671441|FG002|Overall Study|Protocol deviation|1|||
146863377|NCT00777946|529671439|FG000|Overall Study|Randomized in error|1|||
146863378|NCT00777946|529671440|FG001|Overall Study|Randomized in error|1|||
146863379|NCT00777946|529671441|FG002|Overall Study|Randomized in error|0|||
146863380|NCT01422850|529671447|FG000|Overall Study|Physician Decision|3|||
146863381|NCT04484831|529671448|FG000|Overall Study|Withdrawal by Subject|1|||
146863382|NCT04484831|529671449|FG001|Overall Study|Withdrawal by Subject|0|||
146863383|NCT02244996|529671451|FG000|Overall Study|Lack of Efficacy|2|||
146863384|NCT02244996|529671452|FG001|Overall Study|Lack of Efficacy|6|||
146863385|NCT00174265|529671453|FG000|Overall Study|Adverse Event|7|||
146863386|NCT00174265|529671454|FG001|Overall Study|Adverse Event|4|||
146863387|NCT00174265|529671453|FG000|Overall Study|Lack of Efficacy|2|||
146863388|NCT00174265|529671454|FG001|Overall Study|Lack of Efficacy|2|||
146863389|NCT00174265|529671453|FG000|Overall Study|Withdrawal by Subject|3|||
146863390|NCT00174265|529671454|FG001|Overall Study|Withdrawal by Subject|5|||
146863391|NCT00174265|529671453|FG000|Overall Study|Lost to Follow-up|1|||
146863392|NCT00174265|529671454|FG001|Overall Study|Lost to Follow-up|0|||
146863393|NCT00174265|529671453|FG000|Overall Study|Other (Not specified)|16|||
146863394|NCT00174265|529671454|FG001|Overall Study|Other (Not specified)|10|||
146863395|NCT03471871|529671456|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
146863396|NCT03471871|529671457|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
146863397|NCT03471871|529671458|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
146863398|NCT03471871|529671459|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
146863399|NCT03471871|529671460|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
146863400|NCT03471871|529671456|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
146863401|NCT03471871|529671457|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
146863402|NCT03471871|529671458|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
146863403|NCT03471871|529671459|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
146863404|NCT03471871|529671460|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
146863405|NCT03471871|529671456|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
146863406|NCT03471871|529671457|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
146863407|NCT03471871|529671458|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
146863408|NCT03471871|529671459|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
146863409|NCT03471871|529671460|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
146863410|NCT03471871|529671456|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
146863411|NCT03471871|529671457|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
146863412|NCT03471871|529671458|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
146863413|NCT03471871|529671459|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
146863414|NCT03471871|529671460|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
146863415|NCT03471871|529671456|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
146863416|NCT03471871|529671457|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
146863417|NCT03471871|529671458|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
146863418|NCT03471871|529671459|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
146863419|NCT03471871|529671460|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
146863420|NCT00047320|529671461|FG000|Overall Study|Lack of Efficacy|8|||
146863421|NCT00047320|529671461|FG000|Overall Study|Lost to Follow-up|1|||
146863422|NCT00047320|529671461|FG000|Overall Study|Physician Decision|8|||
146863423|NCT00047320|529671461|FG000|Overall Study|Withdrawal by Subject|9|||
146863424|NCT00047320|529671461|FG000|Overall Study|Ineligible|2|||
146863425|NCT03040622|529671463|FG000|Overall Study|unable to implant device|3|||
146863426|NCT02673619|529671464|FG000|Overall Study|Lost to Follow-up|1|||
146863427|NCT02673619|529671465|FG001|Overall Study|Lost to Follow-up|0|||
146863428|NCT02673619|529671466|FG002|Overall Study|Lost to Follow-up|0|||
146863429|NCT02673619|529671467|FG003|Overall Study|Lost to Follow-up|0|||
146863430|NCT02673619|529671464|FG000|Overall Study|Withdrawal by Subject|1|||
146863431|NCT02673619|529671465|FG001|Overall Study|Withdrawal by Subject|1|||
146863432|NCT02673619|529671466|FG002|Overall Study|Withdrawal by Subject|1|||
146863433|NCT02673619|529671467|FG003|Overall Study|Withdrawal by Subject|0|||
146863434|NCT02673619|529671464|FG000|Overall Study|Adverse Event|0|||
146863435|NCT02673619|529671465|FG001|Overall Study|Adverse Event|0|||
146863436|NCT02673619|529671466|FG002|Overall Study|Adverse Event|1|||
146863437|NCT02673619|529671467|FG003|Overall Study|Adverse Event|0|||
146863438|NCT02673619|529671464|FG000|Overall Study|Lack of Efficacy|0|||
146863439|NCT02673619|529671465|FG001|Overall Study|Lack of Efficacy|0|||
146863440|NCT02673619|529671466|FG002|Overall Study|Lack of Efficacy|1|||
146863441|NCT02673619|529671467|FG003|Overall Study|Lack of Efficacy|0|||
146863442|NCT01313117|529671469|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
146863443|NCT01313117|529671469|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
146863444|NCT03602261|529671474|FG000|Overall Study|Adverse Event|5|||
146863445|NCT03602261|529671475|FG001|Overall Study|Adverse Event|1|||
146863446|NCT03602261|529671474|FG000|Overall Study|Physician Decision|1|||
146863447|NCT03602261|529671475|FG001|Overall Study|Physician Decision|0|||
146863448|NCT03602261|529671474|FG000|Overall Study|Withdrawal by Subject|1|||
146863449|NCT03602261|529671475|FG001|Overall Study|Withdrawal by Subject|1|||
146863450|NCT03602261|529671474|FG000|Overall Study|Lack of Efficacy|0|||
146863451|NCT03602261|529671475|FG001|Overall Study|Lack of Efficacy|1|||
146863452|NCT03602261|529671474|FG000|Overall Study|Subject moving out of state|1|||
146863453|NCT03602261|529671475|FG001|Overall Study|Subject moving out of state|0|||
146863454|NCT00909792|529672853|FG000|Period 1|Did not meet inclusion criteria|0|||
146863455|NCT00909792|529672854|FG001|Period 1|Did not meet inclusion criteria|1|||
146863456|NCT00909792|529672853|FG000|Period 2|Biomicroscopy|1|||
146863457|NCT00909792|529672854|FG001|Period 2|Biomicroscopy|0|||
146863458|NCT00909792|529672853|FG000|Period 2|Lost to Follow-up|0|||
146863459|NCT00909792|529672854|FG001|Period 2|Lost to Follow-up|1|||
146863460|NCT03434353|529672855|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
146863461|NCT03434353|529672856|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
146863462|NCT03434353|529672857|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
146863463|NCT03434353|529672858|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
146863464|NCT03434353|529672859|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
146863465|NCT03434353|529672855|FG000|Overall Study|Withdrew consent|1|||
146863466|NCT03434353|529672856|FG001|Overall Study|Withdrew consent|0|||
146863467|NCT03434353|529672857|FG002|Overall Study|Withdrew consent|3|||
146863468|NCT03434353|529672858|FG003|Overall Study|Withdrew consent|0|||
146863469|NCT03434353|529672859|FG004|Overall Study|Withdrew consent|0|||
146863470|NCT03434353|529672855|FG000|Overall Study|Adverse Event|1|||
146863471|NCT03434353|529672856|FG001|Overall Study|Adverse Event|0|||
146863472|NCT03434353|529672857|FG002|Overall Study|Adverse Event|0|||
146863473|NCT03434353|529672858|FG003|Overall Study|Adverse Event|0|||
146863474|NCT03434353|529672859|FG004|Overall Study|Adverse Event|1|||
146863475|NCT03434353|529672855|FG000|Overall Study|Lost to Follow-up|2|||
146863476|NCT03434353|529672856|FG001|Overall Study|Lost to Follow-up|0|||
146863477|NCT03434353|529672857|FG002|Overall Study|Lost to Follow-up|0|||
146863478|NCT03434353|529672858|FG003|Overall Study|Lost to Follow-up|0|||
146863479|NCT03434353|529672859|FG004|Overall Study|Lost to Follow-up|0|||
146863480|NCT01990534|529672860|FG000|Overall Study|Death|22|||
146863481|NCT01990534|529672860|FG000|Overall Study|Progressive disease|3|||
146863482|NCT01990534|529672860|FG000|Overall Study|Protocol Violation|1|||
146863483|NCT01990534|529672860|FG000|Overall Study|Withdrawal of Informed Consent|2|||
146863484|NCT01990534|529672860|FG000|Overall Study|Symptomatic Deterioration|1|||
146863485|NCT01990534|529672860|FG000|Overall Study|Withdrawal by Subject|3|||
146863486|NCT01990534|529672860|FG000|Overall Study|Reason not Specified|2|||
146863487|NCT01990534|529672860|FG000|Overall Study|Lost to Follow-up|1|||
146863488|NCT00234494|529672861|FG000|Overall Study|Protocol Violation|2|||
146863489|NCT01831544|529672864|FG000|Overall Study|Death|1|||
146863490|NCT01831544|529672864|FG000|Overall Study|Still on original MVAD device|2|||
146863491|NCT01681628|529672867|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
146863492|NCT01681628|529672868|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
146863493|NCT01681628|529672867|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
146863494|NCT01681628|529672868|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
146863495|NCT01681628|529672867|FG000|19 Months Follow-up|Death|1|||
146863496|NCT01681628|529672868|FG001|19 Months Follow-up|Death|0|||
146863497|NCT01681628|529672867|FG000|19 Months Follow-up|Lost to Follow-up|61|||
146863498|NCT01681628|529672868|FG001|19 Months Follow-up|Lost to Follow-up|43|||
146863499|NCT01521897|529672869|FG000|Overall Study|Protocol Violation|18|||
146863500|NCT01521897|529672869|FG000|Overall Study|Lost to Follow-up|5|||
146863501|NCT02194062|529672871|FG000|Overall Study|Lost to Follow-up|2|||
146863502|NCT02194062|529672872|FG001|Overall Study|Lost to Follow-up|2|||
146863503|NCT02194062|529672873|FG002|Overall Study|Lost to Follow-up|5|||
146863504|NCT03422172|529672877|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
146863505|NCT03422172|529672877|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
146863506|NCT03422172|529672877|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
146863507|NCT05736211|529672879|FG000|Overall Study|Lost to Follow-up|6|||
146863508|NCT05736211|529672880|FG001|Overall Study|Lost to Follow-up|0|||
146863509|NCT00293722|529672881|FG000|Overall Study|Other|427|||
146863510|NCT02634346|529672887|FG000|Overall Study|Withdrawal by Subject|8|||
146863511|NCT02634346|529672888|FG001|Overall Study|Withdrawal by Subject|9|||
146863512|NCT02634346|529672889|FG002|Overall Study|Withdrawal by Subject|8|||
146863513|NCT02634346|529672887|FG000|Overall Study|Adverse Event|2|||
146863514|NCT02634346|529672888|FG001|Overall Study|Adverse Event|2|||
146863515|NCT02634346|529672889|FG002|Overall Study|Adverse Event|7|||
146863516|NCT02634346|529672887|FG000|Overall Study|Lack of Efficacy|1|||
146863517|NCT02634346|529672888|FG001|Overall Study|Lack of Efficacy|2|||
146863518|NCT02634346|529672889|FG002|Overall Study|Lack of Efficacy|8|||
146863519|NCT02634346|529672887|FG000|Overall Study|Lost to Follow-up|1|||
146863520|NCT02634346|529672888|FG001|Overall Study|Lost to Follow-up|0|||
146863521|NCT02634346|529672889|FG002|Overall Study|Lost to Follow-up|0|||
146863522|NCT02634346|529672887|FG000|Overall Study|Protocol Violation|0|||
146863523|NCT02634346|529672888|FG001|Overall Study|Protocol Violation|1|||
146863524|NCT02634346|529672889|FG002|Overall Study|Protocol Violation|0|||
146863525|NCT00992511|529672891|FG000|Overall Study|Migrated/moved from study area|1|||
146863526|NCT00992511|529672892|FG001|Overall Study|Migrated/moved from study area|0|||
146863527|NCT00992511|529672893|FG002|Overall Study|Migrated/moved from study area|1|||
146863528|NCT00992511|529672894|FG003|Overall Study|Migrated/moved from study area|2|||
146863529|NCT00992511|529672891|FG000|Overall Study|Lost to Follow-up|1|||
146863530|NCT00992511|529672892|FG001|Overall Study|Lost to Follow-up|0|||
146863531|NCT00992511|529672893|FG002|Overall Study|Lost to Follow-up|0|||
146863532|NCT00992511|529672894|FG003|Overall Study|Lost to Follow-up|2|||
146863533|NCT00992511|529672891|FG000|Overall Study|Withdrawal by Subject|0|||
146863534|NCT00992511|529672892|FG001|Overall Study|Withdrawal by Subject|0|||
146863535|NCT00992511|529672893|FG002|Overall Study|Withdrawal by Subject|1|||
146863536|NCT00992511|529672894|FG003|Overall Study|Withdrawal by Subject|1|||
146863537|NCT04498169|529672895|FG000|Study Completion|Adverse Event|1|||
146762294|NCT00601640|529296970|FG000|Overall Study|change in eligibility status|0|||
146762295|NCT00601640|529296971|FG001|Overall Study|change in eligibility status|1|||
146762296|NCT00601640|529296972|FG002|Overall Study|change in eligibility status|1|||
146762297|NCT00015457|529296976|FG000|First Intervention|Adverse Event|0|||
146762298|NCT00015457|529296977|FG001|First Intervention|Adverse Event|2|||
146762299|NCT00015457|529296976|FG000|First Intervention|Lack of Efficacy|0|||
146762300|NCT00015457|529296977|FG001|First Intervention|Lack of Efficacy|1|||
146762301|NCT00015457|529296976|FG000|Second Intervention|Withdrawal by Subject|1|||
146762302|NCT00015457|529296977|FG001|Second Intervention|Withdrawal by Subject|0|||
146762303|NCT01190150|529296979|FG000|First Treatment|Withdrawal by Subject|1|||
146762304|NCT01190150|529296980|FG001|First Treatment|Withdrawal by Subject|0|||
146762305|NCT01190150|529296979|FG000|Washout|Withdrawal by Subject|0|||
146762306|NCT01190150|529296980|FG001|Washout|Withdrawal by Subject|1|||
146762307|NCT01190150|529296979|FG000|Washout|Difficulty in adherence|0|||
146762308|NCT01190150|529296980|FG001|Washout|Difficulty in adherence|1|||
146762309|NCT01081145|529296982|FG000|Open-Label Phase|Lack of Efficacy|56|||
146762310|NCT01081145|529296983|FG001|Open-Label Phase|Lack of Efficacy|0|||
146762311|NCT01081145|529296982|FG000|Open-Label Phase|Response criteria not met|46|||
146762312|NCT01081145|529296983|FG001|Open-Label Phase|Response criteria not met|0|||
146762313|NCT01081145|529296982|FG000|Open-Label Phase|Adverse Event|42|||
146762314|NCT01081145|529296983|FG001|Open-Label Phase|Adverse Event|0|||
146762315|NCT01081145|529296982|FG000|Open-Label Phase|Withdrawal by Subject|41|||
146762316|NCT01081145|529296983|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146762317|NCT01081145|529296982|FG000|Open-Label Phase|Other|12|||
146762318|NCT01081145|529296983|FG001|Open-Label Phase|Other|0|||
146762319|NCT01081145|529296982|FG000|Open-Label Phase|Lost to Follow-up|11|||
146762320|NCT01081145|529296983|FG001|Open-Label Phase|Lost to Follow-up|0|||
146762321|NCT01081145|529296982|FG000|Open-Label Phase|Protocol Violation|4|||
146762322|NCT01081145|529296983|FG001|Open-Label Phase|Protocol Violation|0|||
146762323|NCT01081145|529296982|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
146762324|NCT01081145|529296983|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
146762325|NCT01081145|529296982|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
146762326|NCT01081145|529296983|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
146762327|NCT01081145|529296982|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
146762328|NCT01081145|529296983|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
146762329|NCT01081145|529296982|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
146762330|NCT01081145|529296983|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
146762331|NCT01081145|529296982|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
146762332|NCT01081145|529296983|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
146762333|NCT01081145|529296982|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
146762334|NCT01081145|529296983|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
146762335|NCT01081145|529296982|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
146762336|NCT01081145|529296983|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
146762337|NCT03235349|529296988|FG000|Overall Study|Adverse Event|1|||
146762338|NCT03235349|529296988|FG000|Overall Study|Other|1|||
146762339|NCT03394027|529296989|FG000|Overall Study|Ineligible|3|||
146762340|NCT03394027|529296990|FG001|Overall Study|Ineligible|1|||
146762341|NCT03394027|529296991|FG002|Overall Study|Ineligible|3|||
146762342|NCT03394027|529296989|FG000|Overall Study|Participant declined to participate before treatment started|0|||
146762343|NCT03394027|529296990|FG001|Overall Study|Participant declined to participate before treatment started|0|||
146762344|NCT03394027|529296991|FG002|Overall Study|Participant declined to participate before treatment started|1|||
146762345|NCT01268566|529297001|FG000|Overall Study|Lost to Follow-up|1|||
146762346|NCT01268566|529297001|FG000|Overall Study|Withdrawal by Subject|12|||
146762347|NCT01268566|529297001|FG000|Overall Study|Death|30|||
146762348|NCT03563053|529297010|FG000|Overall Study|Withdrawal by Subject|17|||
146762349|NCT03563053|529297010|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
146762350|NCT03563053|529297010|FG000|Overall Study|Adverse Event|3|||
146762351|NCT03563053|529297010|FG000|Overall Study|Physician Decision|1|||
146762352|NCT03563053|529297010|FG000|Overall Study|study terminated by sponsor|71|||
146762353|NCT02081391|529297011|FG000|12-hour Treatment|Withdrawal by Subject|3|||
146762354|NCT02081391|529297012|FG001|12-hour Treatment|Withdrawal by Subject|2|||
146762355|NCT02081391|529297013|FG002|12-hour Treatment|Withdrawal by Subject|0|||
146762356|NCT02081391|529297014|FG003|12-hour Treatment|Withdrawal by Subject|0|||
146762357|NCT02081391|529297011|FG000|12-hour Treatment|Physician Decision|4|||
146762358|NCT02081391|529297012|FG001|12-hour Treatment|Physician Decision|1|||
146762359|NCT02081391|529297013|FG002|12-hour Treatment|Physician Decision|0|||
146762360|NCT02081391|529297014|FG003|12-hour Treatment|Physician Decision|0|||
146762361|NCT02081391|529297011|FG000|12-hour Treatment|Lack of Efficacy|3|||
146762362|NCT02081391|529297012|FG001|12-hour Treatment|Lack of Efficacy|0|||
146762363|NCT02081391|529297013|FG002|12-hour Treatment|Lack of Efficacy|0|||
146762364|NCT02081391|529297014|FG003|12-hour Treatment|Lack of Efficacy|0|||
146762365|NCT02081391|529297011|FG000|12-hour Treatment|Adverse Event|4|||
146762366|NCT02081391|529297012|FG001|12-hour Treatment|Adverse Event|2|||
146863538|NCT04498169|529672896|FG001|Study Completion|Adverse Event|1|||
146863539|NCT04615247|529672897|FG000|Overall Study|Adverse Event|0|||
146863540|NCT04615247|529672898|FG001|Overall Study|Adverse Event|2|||
146863541|NCT04615247|529672897|FG000|Overall Study|Withdrawal by Subject|1|||
146863542|NCT04615247|529672898|FG001|Overall Study|Withdrawal by Subject|1|||
146863543|NCT04658186|529672903|FG000|Overall Study|Adverse Event|4|||
146863544|NCT04658186|529672904|FG001|Overall Study|Adverse Event|18|||
146863545|NCT04658186|529672905|FG002|Overall Study|Adverse Event|15|||
146863546|NCT04658186|529672903|FG000|Overall Study|Lack of Efficacy|1|||
146863547|NCT04658186|529672904|FG001|Overall Study|Lack of Efficacy|1|||
146863548|NCT04658186|529672905|FG002|Overall Study|Lack of Efficacy|0|||
146863549|NCT04658186|529672903|FG000|Overall Study|Protocol Violation|0|||
146863550|NCT04658186|529672904|FG001|Overall Study|Protocol Violation|0|||
146863551|NCT04658186|529672905|FG002|Overall Study|Protocol Violation|1|||
146863552|NCT04658186|529672903|FG000|Overall Study|Lost to Follow-up|0|||
146863553|NCT04658186|529672904|FG001|Overall Study|Lost to Follow-up|0|||
146863554|NCT04658186|529672905|FG002|Overall Study|Lost to Follow-up|2|||
146863555|NCT04658186|529672903|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
146863556|NCT04658186|529672904|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
146863557|NCT04658186|529672905|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
146863558|NCT04658186|529672903|FG000|Overall Study|Participant is Moving in Another Province|0|||
146863559|NCT04658186|529672904|FG001|Overall Study|Participant is Moving in Another Province|1|||
146863560|NCT04658186|529672905|FG002|Overall Study|Participant is Moving in Another Province|0|||
146863561|NCT04658186|529672903|FG000|Overall Study|Non-Compliance|0|||
146863562|NCT04658186|529672904|FG001|Overall Study|Non-Compliance|1|||
146863563|NCT04658186|529672905|FG002|Overall Study|Non-Compliance|1|||
146863564|NCT04658186|529672903|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
146863565|NCT04658186|529672904|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
146863566|NCT04658186|529672905|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
146863567|NCT04658186|529672903|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
146863568|NCT04658186|529672904|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
146863569|NCT04658186|529672905|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
146863570|NCT04658186|529672903|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
146863571|NCT04658186|529672904|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
146863572|NCT04658186|529672905|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
146863573|NCT04658186|529672903|FG000|Overall Study|PI Decision due to Participant Safety|0|||
146863574|NCT04658186|529672904|FG001|Overall Study|PI Decision due to Participant Safety|0|||
146863575|NCT04658186|529672905|FG002|Overall Study|PI Decision due to Participant Safety|1|||
146863576|NCT04658186|529672903|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
146863577|NCT04658186|529672904|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
146863578|NCT04658186|529672905|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
146863579|NCT00954174|529672906|FG000|Overall Study|Adverse Event|28|||
146863580|NCT00954174|529672907|FG001|Overall Study|Adverse Event|23|||
146863581|NCT00954174|529672908|FG002|Overall Study|Adverse Event|4|||
146863582|NCT00954174|529672909|FG003|Overall Study|Adverse Event|9|||
146863583|NCT00954174|529672906|FG000|Overall Study|Death|4|||
146863584|NCT00954174|529672907|FG001|Overall Study|Death|2|||
146863585|NCT00954174|529672908|FG002|Overall Study|Death|0|||
146863586|NCT00954174|529672909|FG003|Overall Study|Death|0|||
146863587|NCT00954174|529672906|FG000|Overall Study|Lack of Efficacy|32|||
146863588|NCT00954174|529672907|FG001|Overall Study|Lack of Efficacy|22|||
146863589|NCT00954174|529672908|FG002|Overall Study|Lack of Efficacy|8|||
146863590|NCT00954174|529672909|FG003|Overall Study|Lack of Efficacy|6|||
146863591|NCT00954174|529672906|FG000|Overall Study|Withdrawal by Subject|14|||
146863592|NCT00954174|529672907|FG001|Overall Study|Withdrawal by Subject|10|||
146863593|NCT00954174|529672908|FG002|Overall Study|Withdrawal by Subject|4|||
146863594|NCT00954174|529672909|FG003|Overall Study|Withdrawal by Subject|3|||
146863595|NCT00954174|529672906|FG000|Overall Study|Medical Reason|4|||
146863596|NCT00954174|529672907|FG001|Overall Study|Medical Reason|2|||
146863597|NCT00954174|529672908|FG002|Overall Study|Medical Reason|1|||
146863598|NCT00954174|529672909|FG003|Overall Study|Medical Reason|0|||
146863599|NCT00954174|529672906|FG000|Overall Study|Ineligible|40|||
146863600|NCT00954174|529672907|FG001|Overall Study|Ineligible|47|||
146863601|NCT00954174|529672908|FG002|Overall Study|Ineligible|7|||
146863602|NCT00954174|529672909|FG003|Overall Study|Ineligible|4|||
146863603|NCT00954174|529672906|FG000|Overall Study|Never Treated|4|||
146863604|NCT00954174|529672907|FG001|Overall Study|Never Treated|17|||
146863605|NCT00954174|529672908|FG002|Overall Study|Never Treated|0|||
146863606|NCT00954174|529672909|FG003|Overall Study|Never Treated|3|||
146863607|NCT02234323|529672910|FG000|All Enrolled|Not Treated: Completed study in database|2|||
146863608|NCT02234323|529672910|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
146863609|NCT02234323|529672910|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
146863610|NCT02234323|529672910|FG000|All Treated|Death|1|||
146863611|NCT02234323|529672910|FG000|All Treated|Physician Decision|5|||
146863612|NCT02234323|529672910|FG000|All Treated|Lack of Efficacy|3|||
146863613|NCT02234323|529672910|FG000|All Treated|Exceeded lab value limit|2|||
146863614|NCT02234323|529672910|FG000|All Treated|Other|7|||
146863615|NCT02249767|529672911|FG000|Overall Study|Did not use medication|8|||
146863616|NCT02249767|529672912|FG001|Overall Study|Did not use medication|9|||
146863617|NCT02249767|529672913|FG002|Overall Study|Did not use medication|8|||
146863618|NCT00867113|529672914|FG000|Treatment Period|Adverse Event|15|||
146863619|NCT00867113|529672914|FG000|Treatment Period|Death|2|||
146863620|NCT00867113|529672914|FG000|Treatment Period|Withdrawal by Subject|19|||
146863621|NCT00867113|529672914|FG000|Treatment Period|Lost to Follow-up|3|||
146863622|NCT00867113|529672914|FG000|Treatment Period|Administrative problems|1|||
146863623|NCT00867113|529672914|FG000|Treatment Period|Disease progression/relapse|1|||
146863624|NCT00867113|529672914|FG000|Treatment Period|Protocol Violation|4|||
146863625|NCT00867113|529672914|FG000|Post Treatment After Survival Follow-up|Death|1|||
146863626|NCT00867113|529672914|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
146863627|NCT00867113|529672914|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
146863628|NCT00867113|529672914|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
146863629|NCT04585646|529672915|FG000|First Intervention|Physician Decision|1|||
146863630|NCT04585646|529672916|FG001|First Intervention|Physician Decision|0|||
146863631|NCT04585646|529672915|FG000|First Intervention|Lost to Follow-up|0|||
146863632|NCT04585646|529672916|FG001|First Intervention|Lost to Follow-up|3|||
146863633|NCT04585646|529672915|FG000|First Intervention|Withdrawal by Subject|0|||
146863634|NCT04585646|529672916|FG001|First Intervention|Withdrawal by Subject|1|||
146863635|NCT01886313|529672917|FG000|Overall Study|Adverse Event|1|||
146863636|NCT01886313|529672918|FG001|Overall Study|Adverse Event|1|||
146863637|NCT04614662|529672919|FG000|Overall Study|Withdrawal by Subject|0|||
146863638|NCT04614662|529672920|FG001|Overall Study|Withdrawal by Subject|1|||
146863639|NCT01230788|529672923|FG000|Overall Study|Prescribed exclusion drug|1|||
146863640|NCT01774084|529672925|FG000|Overall Study|Personal reasons|1|||
146863641|NCT01774084|529672926|FG001|Overall Study|Personal reasons|0|||
146863642|NCT04226833|529672927|FG000|Overall Study|Death|0|||
146863643|NCT04226833|529672928|FG001|Overall Study|Death|0|||
146863644|NCT04226833|529672929|FG002|Overall Study|Death|1|||
146863645|NCT04226833|529672930|FG003|Overall Study|Death|0|||
146863646|NCT01472380|529672931|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
146863647|NCT01472380|529672931|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
146863648|NCT03049735|529672932|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
146863649|NCT03049735|529672933|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
146863650|NCT03049735|529672934|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
146863651|NCT03049735|529672932|FG000|Overall Study|Other|5|||
146863652|NCT03049735|529672933|FG001|Overall Study|Other|3|||
146863653|NCT03049735|529672934|FG002|Overall Study|Other|1|||
146863654|NCT03049735|529672932|FG000|Overall Study|Lack of Efficacy|4|||
146863655|NCT03049735|529672933|FG001|Overall Study|Lack of Efficacy|0|||
146863656|NCT03049735|529672934|FG002|Overall Study|Lack of Efficacy|3|||
146863657|NCT03049735|529672932|FG000|Overall Study|Protocol deviation|1|||
146863658|NCT03049735|529672933|FG001|Overall Study|Protocol deviation|0|||
146863659|NCT03049735|529672934|FG002|Overall Study|Protocol deviation|0|||
146863660|NCT03049735|529672932|FG000|Overall Study|Pregnancy|0|||
146863661|NCT03049735|529672933|FG001|Overall Study|Pregnancy|0|||
146863662|NCT03049735|529672934|FG002|Overall Study|Pregnancy|1|||
146863663|NCT03049735|529672932|FG000|Overall Study|Adverse Event|7|||
146863664|NCT03049735|529672933|FG001|Overall Study|Adverse Event|18|||
146863665|NCT03049735|529672934|FG002|Overall Study|Adverse Event|5|||
146863666|NCT03049735|529672932|FG000|Overall Study|Withdrawal by Subject|10|||
146863667|NCT03049735|529672933|FG001|Overall Study|Withdrawal by Subject|3|||
146863668|NCT03049735|529672934|FG002|Overall Study|Withdrawal by Subject|7|||
146863669|NCT03049735|529672932|FG000|Overall Study|Lost to Follow-up|1|||
146863670|NCT03049735|529672933|FG001|Overall Study|Lost to Follow-up|5|||
146863671|NCT03049735|529672934|FG002|Overall Study|Lost to Follow-up|5|||
146863672|NCT02146326|529672935|FG000|Overall Study|Lost to Follow-up|3|||
146863673|NCT02146326|529672936|FG001|Overall Study|Lost to Follow-up|3|||
146863674|NCT02146326|529672937|FG002|Overall Study|Lost to Follow-up|11|||
146863675|NCT02146326|529672938|FG003|Overall Study|Lost to Follow-up|19|||
146863676|NCT02146326|529672935|FG000|Overall Study|Withdrawal by Subject|2|||
146863677|NCT02146326|529672936|FG001|Overall Study|Withdrawal by Subject|1|||
146863678|NCT02146326|529672937|FG002|Overall Study|Withdrawal by Subject|15|||
146863679|NCT02146326|529672938|FG003|Overall Study|Withdrawal by Subject|11|||
146863680|NCT02146326|529672935|FG000|Overall Study|Separated from mental health center|23|||
146863681|NCT02146326|529672936|FG001|Overall Study|Separated from mental health center|33|||
146863682|NCT02146326|529672937|FG002|Overall Study|Separated from mental health center|0|||
146863683|NCT02146326|529672938|FG003|Overall Study|Separated from mental health center|0|||
146863684|NCT02146326|529672935|FG000|Overall Study|Incarcerated|0|||
146863685|NCT02146326|529672936|FG001|Overall Study|Incarcerated|0|||
146863686|NCT02146326|529672937|FG002|Overall Study|Incarcerated|3|||
146863687|NCT02146326|529672938|FG003|Overall Study|Incarcerated|8|||
146863688|NCT02146326|529672935|FG000|Overall Study|Death|0|||
146863689|NCT02146326|529672936|FG001|Overall Study|Death|0|||
146863690|NCT02146326|529672937|FG002|Overall Study|Death|4|||
146863691|NCT02146326|529672938|FG003|Overall Study|Death|4|||
146863692|NCT02146326|529672935|FG000|Overall Study|Unable to complete interview|0|||
146863693|NCT02146326|529672936|FG001|Overall Study|Unable to complete interview|0|||
146863694|NCT02146326|529672937|FG002|Overall Study|Unable to complete interview|10|||
146863695|NCT02146326|529672938|FG003|Overall Study|Unable to complete interview|6|||
146863696|NCT03153111|529672939|FG000|Overall Study|Death|2|||
146863697|NCT03153111|529672940|FG001|Overall Study|Death|5|||
146863698|NCT03153111|529672939|FG000|Overall Study|Lost to Follow-up|1|||
146863699|NCT03153111|529672940|FG001|Overall Study|Lost to Follow-up|0|||
146863700|NCT03153111|529672939|FG000|Overall Study|Physician Decision|5|||
146863701|NCT03153111|529672940|FG001|Overall Study|Physician Decision|1|||
146863702|NCT03153111|529672939|FG000|Overall Study|Withdrawal by Subject|3|||
146863703|NCT03153111|529672940|FG001|Overall Study|Withdrawal by Subject|3|||
146863704|NCT01079130|529672943|FG000|Overall Study|Adverse Event|1|||
146863705|NCT01079130|529672944|FG001|Overall Study|Adverse Event|1|||
146863706|NCT01079130|529672945|FG002|Overall Study|Adverse Event|0|||
146863707|NCT01079130|529672946|FG003|Overall Study|Adverse Event|1|||
146863708|NCT01079130|529672947|FG004|Overall Study|Adverse Event|5|||
146863709|NCT01079130|529672948|FG005|Overall Study|Adverse Event|1|||
146863710|NCT01079130|529672943|FG000|Overall Study|Administrative problems|1|||
146863711|NCT01079130|529672944|FG001|Overall Study|Administrative problems|3|||
146863712|NCT01079130|529672945|FG002|Overall Study|Administrative problems|0|||
146863713|NCT01079130|529672946|FG003|Overall Study|Administrative problems|0|||
146863714|NCT01079130|529672947|FG004|Overall Study|Administrative problems|0|||
146863715|NCT01079130|529672948|FG005|Overall Study|Administrative problems|1|||
146863716|NCT01079130|529672943|FG000|Overall Study|Withdrawal by Subject|0|||
146863717|NCT01079130|529672944|FG001|Overall Study|Withdrawal by Subject|1|||
146863718|NCT01079130|529672945|FG002|Overall Study|Withdrawal by Subject|0|||
146863719|NCT01079130|529672946|FG003|Overall Study|Withdrawal by Subject|0|||
146863720|NCT01079130|529672947|FG004|Overall Study|Withdrawal by Subject|1|||
146863721|NCT01079130|529672948|FG005|Overall Study|Withdrawal by Subject|3|||
146863722|NCT01079130|529672943|FG000|Overall Study|Protocol deviation|0|||
146863723|NCT01079130|529672944|FG001|Overall Study|Protocol deviation|2|||
146863724|NCT01079130|529672945|FG002|Overall Study|Protocol deviation|1|||
146863725|NCT01079130|529672946|FG003|Overall Study|Protocol deviation|2|||
146863726|NCT01079130|529672947|FG004|Overall Study|Protocol deviation|0|||
146863727|NCT01079130|529672948|FG005|Overall Study|Protocol deviation|0|||
146863728|NCT01079130|529672943|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146863729|NCT01079130|529672944|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146863730|NCT01079130|529672945|FG002|Overall Study|Abnormal test procedure result(s)|0|||
146863731|NCT01079130|529672946|FG003|Overall Study|Abnormal test procedure result(s)|0|||
146863732|NCT01079130|529672947|FG004|Overall Study|Abnormal test procedure result(s)|1|||
146863733|NCT01079130|529672948|FG005|Overall Study|Abnormal test procedure result(s)|0|||
146863734|NCT01079130|529672943|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146863735|NCT01079130|529672944|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146863736|NCT01079130|529672945|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146863737|NCT01079130|529672946|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
146863738|NCT01079130|529672947|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
146863739|NCT01079130|529672948|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
146863740|NCT01079130|529672943|FG000|Overall Study|Lost to Follow-up|0|||
146863741|NCT01079130|529672944|FG001|Overall Study|Lost to Follow-up|0|||
146863742|NCT01079130|529672945|FG002|Overall Study|Lost to Follow-up|0|||
146863743|NCT01079130|529672946|FG003|Overall Study|Lost to Follow-up|0|||
146863744|NCT01079130|529672947|FG004|Overall Study|Lost to Follow-up|1|||
146863745|NCT01079130|529672948|FG005|Overall Study|Lost to Follow-up|0|||
146863746|NCT01853982|529672949|FG000|Overall Study|Withdrawal by Subject|1|||
146863747|NCT01853982|529672950|FG001|Overall Study|Withdrawal by Subject|0|||
146863748|NCT01853982|529672949|FG000|Overall Study|Death|1|||
146863749|NCT01853982|529672950|FG001|Overall Study|Death|0|||
146863750|NCT01853982|529672949|FG000|Overall Study|Lost to Follow-up|0|||
146863751|NCT01853982|529672950|FG001|Overall Study|Lost to Follow-up|1|||
146863752|NCT00390910|529672951|FG000|Overall Study|Adverse Event|1|||
146863753|NCT00390910|529672952|FG001|Overall Study|Adverse Event|0|||
146863754|NCT00390910|529672953|FG002|Overall Study|Adverse Event|0|||
146863755|NCT00390910|529672951|FG000|Overall Study|Lost to Follow-up|0|||
146863756|NCT00390910|529672952|FG001|Overall Study|Lost to Follow-up|1|||
146863757|NCT00390910|529672953|FG002|Overall Study|Lost to Follow-up|5|||
146863758|NCT00390910|529672951|FG000|Overall Study|Withdrawal by Subject|1|||
146863759|NCT00390910|529672952|FG001|Overall Study|Withdrawal by Subject|3|||
146863760|NCT00390910|529672953|FG002|Overall Study|Withdrawal by Subject|2|||
146863761|NCT00390910|529672951|FG000|Overall Study|Migrated/moved from study area|0|||
146863762|NCT00390910|529672952|FG001|Overall Study|Migrated/moved from study area|0|||
146863763|NCT00390910|529672953|FG002|Overall Study|Migrated/moved from study area|3|||
146863764|NCT01839487|529672954|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
146863765|NCT01839487|529672955|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
146863766|NCT01839487|529672956|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
146863767|NCT01839487|529672957|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
146863768|NCT01839487|529672958|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
146863769|NCT01839487|529672959|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
146863770|NCT01839487|529672954|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
146863771|NCT01839487|529672955|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
146863772|NCT01839487|529672956|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
146863773|NCT01839487|529672957|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
146863774|NCT01839487|529672958|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
146863775|NCT01839487|529672959|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
146863776|NCT01839487|529672954|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
146863777|NCT01839487|529672955|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
146863778|NCT01839487|529672956|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
146863779|NCT01839487|529672957|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
146863780|NCT01839487|529672958|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
146863781|NCT01839487|529672959|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
146863782|NCT01839487|529672954|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
146863783|NCT01839487|529672955|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
146863784|NCT01839487|529672956|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
146863785|NCT01839487|529672957|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
146863786|NCT01839487|529672958|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
146863787|NCT01839487|529672959|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
146863788|NCT01839487|529672954|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
146863789|NCT01839487|529672955|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
146863790|NCT01839487|529672956|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
146863791|NCT01839487|529672957|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
146863792|NCT01839487|529672958|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
146863793|NCT01839487|529672959|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
146863794|NCT01839487|529672954|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
146863795|NCT01839487|529672955|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
146863796|NCT01839487|529672956|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
146863797|NCT01839487|529672957|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
146863798|NCT01839487|529672958|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
146863799|NCT01839487|529672959|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
146863800|NCT01839487|529672954|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
146863801|NCT01839487|529672955|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
146863802|NCT01839487|529672956|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
146863803|NCT01839487|529672957|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
146863804|NCT01839487|529672958|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
146863805|NCT01839487|529672959|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
146863806|NCT01839487|529672954|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
146863807|NCT01839487|529672955|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
146863808|NCT01839487|529672956|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
146863809|NCT01839487|529672957|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
146863810|NCT01839487|529672958|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
146863811|NCT01839487|529672959|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
146863812|NCT01839487|529672954|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
146863813|NCT01839487|529672955|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
146863814|NCT01839487|529672956|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
146863815|NCT01839487|529672957|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
146863816|NCT01839487|529672958|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
146863817|NCT01839487|529672959|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
146863818|NCT01658826|529672965|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
146863819|NCT01658826|529672966|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
146863820|NCT01658826|529672965|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
146863821|NCT01658826|529672966|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
146863822|NCT01658826|529672965|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
146863823|NCT01658826|529672966|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
146863824|NCT01658826|529672965|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
146863825|NCT01658826|529672966|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
146863826|NCT01658826|529672965|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
146863827|NCT01658826|529672966|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
146863828|NCT01658826|529672965|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
146863829|NCT01658826|529672966|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
146863830|NCT01658826|529672965|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
146863831|NCT01658826|529672966|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
146863832|NCT01658826|529672965|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
146863833|NCT01658826|529672966|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
146863834|NCT01658826|529672965|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
146863835|NCT01658826|529672966|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
146863836|NCT06071754|529672969|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
146863837|NCT02170389|529675098|FG000|Overall Study|Study terminated prior to start of treat|1|||
146863838|NCT01008696|529675099|FG000|Overall Study|Participant's evasion of hospital visit|5|||
146863839|NCT01008696|529675100|FG001|Overall Study|Participant's evasion of hospital visit|4|||
146863840|NCT01008696|529675099|FG000|Overall Study|Withdrawal by Subject|2|||
146863841|NCT01008696|529675100|FG001|Overall Study|Withdrawal by Subject|4|||
146863842|NCT01008696|529675099|FG000|Overall Study|Physician Decision|5|||
146863843|NCT01008696|529675100|FG001|Overall Study|Physician Decision|1|||
146863844|NCT01008696|529675099|FG000|Overall Study|Adverse Event|1|||
146863845|NCT01008696|529675100|FG001|Overall Study|Adverse Event|0|||
146863846|NCT01008696|529675099|FG000|Overall Study|Participants' non-cooperation|2|||
146863847|NCT01008696|529675100|FG001|Overall Study|Participants' non-cooperation|3|||
146863848|NCT01008696|529675099|FG000|Overall Study|Other|2|||
146863849|NCT01008696|529675100|FG001|Overall Study|Other|3|||
146863850|NCT01008696|529675099|FG000|Overall Study|Other|0|||
146863851|NCT01008696|529675100|FG001|Overall Study|Other|2|||
146863852|NCT02366728|529675101|FG000|Overall Study|Death|0|||
146863853|NCT02366728|529675102|FG001|Overall Study|Death|0|||
146863854|NCT02366728|529675103|FG002|Overall Study|Death|1|||
146863855|NCT02366728|529675101|FG000|Overall Study|Adverse Event|1|||
146863856|NCT02366728|529675102|FG001|Overall Study|Adverse Event|0|||
146863857|NCT02366728|529675103|FG002|Overall Study|Adverse Event|0|||
146863858|NCT02366728|529675101|FG000|Overall Study|Screen Failure|2|||
146863859|NCT02366728|529675102|FG001|Overall Study|Screen Failure|1|||
146863860|NCT02366728|529675103|FG002|Overall Study|Screen Failure|0|||
146863861|NCT02366728|529675101|FG000|Overall Study|Only yielded 2 vaccines|1|||
146863862|NCT02366728|529675102|FG001|Overall Study|Only yielded 2 vaccines|0|||
146863863|NCT02366728|529675103|FG002|Overall Study|Only yielded 2 vaccines|0|||
146863864|NCT02960854|529675104|FG000|Overall Study|Not Disclosed|2|||
146863865|NCT02960854|529675105|FG001|Overall Study|Not Disclosed|2|||
146863866|NCT02960854|529675104|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
146863867|NCT02960854|529675105|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
146863868|NCT02960854|529675104|FG000|Overall Study|Subject Withdrew Consent|0|||
146863869|NCT02960854|529675105|FG001|Overall Study|Subject Withdrew Consent|1|||
146863870|NCT02960854|529675104|FG000|Overall Study|Death|4|||
146863871|NCT02960854|529675105|FG001|Overall Study|Death|6|||
146863872|NCT00221195|529675106|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
146863873|NCT00221195|529675107|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
146863874|NCT00221195|529675106|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
146863875|NCT00221195|529675107|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
146863876|NCT00221195|529675106|FG000|Washout Period (Months 7-9)|Death|0|||
146863877|NCT00221195|529675107|FG001|Washout Period (Months 7-9)|Death|1|||
146863878|NCT00221195|529675106|FG000|Therapy 2 (Months 10-15)|Death|1|||
146863879|NCT00221195|529675107|FG001|Therapy 2 (Months 10-15)|Death|0|||
146863880|NCT00221195|529675106|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
146863881|NCT00221195|529675107|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
146863882|NCT00833911|529675109|FG000|Titration|Adverse Event|18|||
146863883|NCT00833911|529675109|FG000|Titration|Withdrawal by Subject|3|||
146863884|NCT00833911|529675109|FG000|Maintenance Phase I|Adverse Event|73|||
146863885|NCT00833911|529675109|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
146863886|NCT00833911|529675109|FG000|Maintenance Phase I|Physician Decision|10|||
146863887|NCT00833911|529675109|FG000|Maintenance Phase I|Lack of Efficacy|4|||
146863888|NCT00833911|529675109|FG000|Maintenance Phase II|Adverse Event|6|||
146863889|NCT00833911|529675109|FG000|Maintenance Phase II|Physician Decision|2|||
146863890|NCT00833911|529675109|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
146863891|NCT00833911|529675109|FG000|Maintenance Phase II|Lack of Efficacy|1|||
146863892|NCT01383161|529675110|FG000|Overall Study|Adverse Event|5|||
146863893|NCT01383161|529675111|FG001|Overall Study|Adverse Event|1|||
146863894|NCT01383161|529675110|FG000|Overall Study|Withdrawal by Subject|0|||
146863895|NCT01383161|529675111|FG001|Overall Study|Withdrawal by Subject|2|||
146863896|NCT01383161|529675110|FG000|Overall Study|Lack of Efficacy|0|||
146863897|NCT01383161|529675111|FG001|Overall Study|Lack of Efficacy|1|||
146863898|NCT03942406|529675120|FG000|Overall Study|Lost to Follow-up|4|||
146863899|NCT03942406|529675121|FG001|Overall Study|Lost to Follow-up|5|||
146863900|NCT03942406|529675122|FG002|Overall Study|Lost to Follow-up|3|||
146863901|NCT03942406|529675123|FG003|Overall Study|Lost to Follow-up|7|||
146863902|NCT03942406|529675124|FG004|Overall Study|Lost to Follow-up|1|||
146863903|NCT03942406|529675125|FG005|Overall Study|Lost to Follow-up|0|||
146863904|NCT03942406|529675126|FG006|Overall Study|Lost to Follow-up|0|||
146530176|NCT03589807|528449168|FG005|Overall Study|Enrolled but treatment not administered|0|||
146530177|NCT01534273|528449169|FG000|Period 1|Physician Decision|0|||
146530178|NCT01534273|528449170|FG001|Period 1|Physician Decision|0|||
146530179|NCT01534273|528449171|FG002|Period 1|Physician Decision|0|||
146530180|NCT01534273|528449172|FG003|Period 1|Physician Decision|1|||
146530181|NCT01534273|528449173|FG004|Period 1|Physician Decision|0|||
146530182|NCT01534273|528449174|FG005|Period 1|Physician Decision|0|||
146530183|NCT01534273|528449175|FG006|Period 1|Physician Decision|0|||
146530184|NCT01619865|528449176|FG000|Overall Study|Adverse Event|1|||
146530185|NCT01619865|528449176|FG000|Overall Study|Death|2|||
146530186|NCT01619865|528449176|FG000|Overall Study|subject not able to comply|1|||
146530187|NCT03586050|528449177|FG000|Overall Study|Death|3|||
146530188|NCT03586050|528449177|FG000|Overall Study|Withdrawal by Subject|2|||
146530189|NCT01494818|528449178|FG000|Overall Study|Relocation|1|||
146530190|NCT01494818|528449179|FG001|Overall Study|Relocation|2|||
146530191|NCT01494818|528449178|FG000|Overall Study|Lost to Follow-up|1|||
146530192|NCT01494818|528449179|FG001|Overall Study|Lost to Follow-up|0|||
146530193|NCT00593918|528449180|FG000|Overall Study|Withdrawal by Subject|5|||
146530194|NCT00593918|528449181|FG001|Overall Study|Withdrawal by Subject|24|||
146530195|NCT01211145|528449184|FG000|Overall Study|Reason not specified|3|||
146530196|NCT01211145|528449185|FG001|Overall Study|Reason not specified|2|||
146863905|NCT03942406|529675120|FG000|Overall Study|Withdrawal by Subject|3|||
146863906|NCT03942406|529675121|FG001|Overall Study|Withdrawal by Subject|1|||
146863907|NCT03942406|529675122|FG002|Overall Study|Withdrawal by Subject|1|||
146863908|NCT03942406|529675123|FG003|Overall Study|Withdrawal by Subject|3|||
146863909|NCT03942406|529675124|FG004|Overall Study|Withdrawal by Subject|0|||
146863910|NCT03942406|529675125|FG005|Overall Study|Withdrawal by Subject|0|||
146863911|NCT03942406|529675126|FG006|Overall Study|Withdrawal by Subject|0|||
146863912|NCT03942406|529675120|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
146863913|NCT03942406|529675121|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
146863914|NCT03942406|529675122|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
146863915|NCT03942406|529675123|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
146863916|NCT03942406|529675124|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
146863917|NCT03942406|529675125|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
146863918|NCT03942406|529675126|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
146863919|NCT01207596|529675127|FG000|Overall Study|Physician Decision|4|||
146863920|NCT01207596|529675127|FG000|Overall Study|Lack of Efficacy|1|||
146863921|NCT01207596|529675127|FG000|Overall Study|Adverse Event|3|||
146863922|NCT01207596|529675127|FG000|Overall Study|Withdrawal by Subject|1|||
146863923|NCT00216203|529675128|FG000|Overall Study|Withdrawal by Subject|2|||
146863924|NCT02596620|529675131|FG000|Overall Study|Lost to Follow-up|1|||
146863925|NCT02596620|529675132|FG001|Overall Study|Lost to Follow-up|1|||
146863926|NCT01054144|529675133|FG000|Overall Study|Death|2|||
146863927|NCT02748018|529675134|FG000|Study Period|Adverse Event|1|||
146863928|NCT02748018|529675135|FG001|Study Period|Adverse Event|3|||
146863929|NCT02748018|529675136|FG002|Study Period|Adverse Event|4|||
146863930|NCT02748018|529675137|FG003|Study Period|Adverse Event|0|||
146863931|NCT02748018|529675138|FG004|Study Period|Adverse Event|3|||
146863932|NCT02748018|529675139|FG005|Study Period|Adverse Event|3|||
146863933|NCT02748018|529675134|FG000|Study Period|Withdrawal by Subject|7|||
146863934|NCT02748018|529675135|FG001|Study Period|Withdrawal by Subject|4|||
146863935|NCT02748018|529675136|FG002|Study Period|Withdrawal by Subject|4|||
146863936|NCT02748018|529675137|FG003|Study Period|Withdrawal by Subject|11|||
146863937|NCT02748018|529675138|FG004|Study Period|Withdrawal by Subject|12|||
146863938|NCT02748018|529675139|FG005|Study Period|Withdrawal by Subject|10|||
146863939|NCT02748018|529675134|FG000|Study Period|Pregnancy|0|||
146863940|NCT02748018|529675135|FG001|Study Period|Pregnancy|1|||
146863941|NCT02748018|529675136|FG002|Study Period|Pregnancy|0|||
146863942|NCT02748018|529675137|FG003|Study Period|Pregnancy|0|||
146863943|NCT02748018|529675138|FG004|Study Period|Pregnancy|1|||
146863944|NCT02748018|529675139|FG005|Study Period|Pregnancy|0|||
146863945|NCT02748018|529675134|FG000|Study Period|Physician Decision|2|||
146863946|NCT02748018|529675135|FG001|Study Period|Physician Decision|2|||
146863947|NCT02748018|529675136|FG002|Study Period|Physician Decision|1|||
146863948|NCT02748018|529675137|FG003|Study Period|Physician Decision|0|||
146530197|NCT01211145|528449186|FG002|Overall Study|Reason not specified|2|||
146530198|NCT01211145|528449187|FG003|Overall Study|Reason not specified|1|||
146530199|NCT01211145|528449184|FG000|Overall Study|Lost to Follow-up|3|||
146530200|NCT01211145|528449185|FG001|Overall Study|Lost to Follow-up|2|||
146863949|NCT02748018|529675138|FG004|Study Period|Physician Decision|2|||
146863950|NCT02748018|529675139|FG005|Study Period|Physician Decision|0|||
146863951|NCT02748018|529675134|FG000|Study Period|Lost to Follow-up|0|||
146863952|NCT02748018|529675135|FG001|Study Period|Lost to Follow-up|0|||
146863953|NCT02748018|529675136|FG002|Study Period|Lost to Follow-up|0|||
146863954|NCT02748018|529675137|FG003|Study Period|Lost to Follow-up|2|||
146863955|NCT02748018|529675138|FG004|Study Period|Lost to Follow-up|0|||
146863956|NCT02748018|529675139|FG005|Study Period|Lost to Follow-up|1|||
146863957|NCT02748018|529675134|FG000|Continuation Period|Adverse Event|2|||
146530201|NCT01211145|528449186|FG002|Overall Study|Lost to Follow-up|1|||
146530202|NCT01211145|528449187|FG003|Overall Study|Lost to Follow-up|2|||
146530203|NCT01211145|528449184|FG000|Overall Study|Study-specific withdrawal criteria|1|||
146530204|NCT01211145|528449185|FG001|Overall Study|Study-specific withdrawal criteria|0|||
146530205|NCT01211145|528449186|FG002|Overall Study|Study-specific withdrawal criteria|0|||
146530206|NCT01211145|528449187|FG003|Overall Study|Study-specific withdrawal criteria|0|||
146530207|NCT01211145|528449184|FG000|Overall Study|Severe noncompliance to protocol|1|||
146530208|NCT01211145|528449185|FG001|Overall Study|Severe noncompliance to protocol|0|||
146530209|NCT01211145|528449186|FG002|Overall Study|Severe noncompliance to protocol|0|||
146530210|NCT01211145|528449187|FG003|Overall Study|Severe noncompliance to protocol|0|||
146530211|NCT01211145|528449184|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
146530212|NCT01211145|528449185|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
146530213|NCT01211145|528449186|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
146530214|NCT01211145|528449187|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
146530215|NCT01211145|528449184|FG000|Overall Study|Patient decision|2|||
146530216|NCT01211145|528449185|FG001|Overall Study|Patient decision|1|||
146530217|NCT01211145|528449186|FG002|Overall Study|Patient decision|0|||
146530218|NCT01211145|528449187|FG003|Overall Study|Patient decision|2|||
146530219|NCT00617357|528449188|FG000|Overall Study|Lost to Follow-up|7|||
146530220|NCT00617357|528449188|FG000|Overall Study|Death|5|||
146530221|NCT00617357|528449188|FG000|Overall Study|insurance concerns|2|||
146530222|NCT00617357|528449188|FG000|Overall Study|Withdrawal by Subject|1|||
146530223|NCT00617357|528449188|FG000|Overall Study|Physician Decision|1|||
146530224|NCT01747499|528449189|FG000|Overall Study|Steroid refractory aGvHD|1|||
146530225|NCT01747499|528449190|FG001|Overall Study|Steroid refractory aGvHD|0|||
146530226|NCT01747499|528449191|FG002|Overall Study|Steroid refractory aGvHD|0|||
146530227|NCT01747499|528449192|FG003|Overall Study|Steroid refractory aGvHD|1|||
146530228|NCT01747499|528449193|FG004|Overall Study|Steroid refractory aGvHD|4|||
146530229|NCT01747499|528449189|FG000|Overall Study|Physician Decision|0|||
146530230|NCT01747499|528449190|FG001|Overall Study|Physician Decision|1|||
146530231|NCT01747499|528449191|FG002|Overall Study|Physician Decision|0|||
146530232|NCT01747499|528449192|FG003|Overall Study|Physician Decision|0|||
146530233|NCT01747499|528449193|FG004|Overall Study|Physician Decision|2|||
146530234|NCT01747499|528449189|FG000|Overall Study|Death|0|||
146530235|NCT01747499|528449190|FG001|Overall Study|Death|0|||
146530236|NCT01747499|528449191|FG002|Overall Study|Death|0|||
146530237|NCT01747499|528449192|FG003|Overall Study|Death|1|||
146530238|NCT01747499|528449193|FG004|Overall Study|Death|1|||
146530239|NCT01747499|528449189|FG000|Overall Study|Withdrawal by Subject|0|||
146530240|NCT01747499|528449190|FG001|Overall Study|Withdrawal by Subject|0|||
146530241|NCT01747499|528449191|FG002|Overall Study|Withdrawal by Subject|0|||
146530242|NCT01747499|528449192|FG003|Overall Study|Withdrawal by Subject|0|||
146530243|NCT01747499|528449193|FG004|Overall Study|Withdrawal by Subject|6|||
146530244|NCT01747499|528449189|FG000|Overall Study|Developed AML and death|0|||
146530245|NCT01747499|528449190|FG001|Overall Study|Developed AML and death|0|||
146530246|NCT01747499|528449191|FG002|Overall Study|Developed AML and death|0|||
146530247|NCT01747499|528449192|FG003|Overall Study|Developed AML and death|0|||
146530248|NCT01747499|528449193|FG004|Overall Study|Developed AML and death|1|||
146530249|NCT01747499|528449189|FG000|Overall Study|Determined not to be eligible|0|||
146530250|NCT01747499|528449190|FG001|Overall Study|Determined not to be eligible|0|||
146530251|NCT01747499|528449191|FG002|Overall Study|Determined not to be eligible|0|||
146530252|NCT01747499|528449192|FG003|Overall Study|Determined not to be eligible|0|||
146530253|NCT01747499|528449193|FG004|Overall Study|Determined not to be eligible|1|||
146530254|NCT00072410|528449194|FG000|Overall Study|Progressive disease|0|||
146530255|NCT00072410|528449195|FG001|Overall Study|Progressive disease|3|||
146530256|NCT03834506|528449200|FG000|Overall Study|Death|336|||
146530257|NCT03834506|528449201|FG001|Overall Study|Death|326|||
146530258|NCT03834506|528449200|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146530259|NCT03834506|528449201|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146530260|NCT03834506|528449200|FG000|Overall Study|Withdrawal by Subject|10|||
146530261|NCT03834506|528449201|FG001|Overall Study|Withdrawal by Subject|8|||
146530262|NCT03834506|528449200|FG000|Overall Study|Sponsor decision|165|||
146530263|NCT03834506|528449201|FG001|Overall Study|Sponsor decision|178|||
146530264|NCT03834506|528449200|FG000|Overall Study|Physician Decision|3|||
146863958|NCT02748018|529675135|FG001|Continuation Period|Adverse Event|0|||
146530265|NCT03834506|528449201|FG001|Overall Study|Physician Decision|1|||
146530266|NCT03834506|528449200|FG000|Overall Study|Lost to Follow-up|0|||
146530267|NCT03834506|528449201|FG001|Overall Study|Lost to Follow-up|1|||
146530268|NCT01939314|528449204|FG000|Overall Study|Withdrawal by Subject|3|||
146530269|NCT01939314|528449205|FG001|Overall Study|Withdrawal by Subject|1|||
146530270|NCT01939314|528449204|FG000|Overall Study|Protocol Violation|1|||
146530271|NCT01939314|528449205|FG001|Overall Study|Protocol Violation|0|||
146530272|NCT01939314|528449204|FG000|Overall Study|Pregnancy|0|||
146530273|NCT01939314|528449205|FG001|Overall Study|Pregnancy|1|||
146530274|NCT01939314|528449204|FG000|Overall Study|Lost to Follow-up|5|||
146530275|NCT01939314|528449205|FG001|Overall Study|Lost to Follow-up|6|||
146530276|NCT01107925|528449211|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
146530277|NCT01107925|528449212|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
146530278|NCT01107925|528449213|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
146530279|NCT01107925|528449214|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
146530280|NCT01107925|528449215|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
146530281|NCT01107925|528449216|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
146530282|NCT01107925|528449211|FG000|Period 2|Withdrawal by Subject|0|||
146530283|NCT01107925|528449212|FG001|Period 2|Withdrawal by Subject|1|||
146530284|NCT01107925|528449213|FG002|Period 2|Withdrawal by Subject|0|||
146530285|NCT01107925|528449214|FG003|Period 2|Withdrawal by Subject|0|||
146530286|NCT01107925|528449215|FG004|Period 2|Withdrawal by Subject|0|||
146530287|NCT01107925|528449216|FG005|Period 2|Withdrawal by Subject|1|||
146530288|NCT01949142|528449217|FG000|Overall Study|Withdrawal of consent|1|||
146530289|NCT01949142|528449218|FG001|Overall Study|Withdrawal of consent|0|||
146530290|NCT01949142|528449217|FG000|Overall Study|Lost to Follow-up|1|||
146530291|NCT01949142|528449218|FG001|Overall Study|Lost to Follow-up|1|||
146530292|NCT01949142|528449217|FG000|Overall Study|Parent changed their mind|1|||
146530293|NCT01949142|528449218|FG001|Overall Study|Parent changed their mind|0|||
146530294|NCT02007720|528449219|FG000|Overall Study|Withdrawal by Subject|9|||
146530295|NCT02007720|528449220|FG001|Overall Study|Withdrawal by Subject|11|||
146530296|NCT02007720|528449219|FG000|Overall Study|study terminated by sponsor|58|||
146530297|NCT02007720|528449220|FG001|Overall Study|study terminated by sponsor|54|||
146530298|NCT02007720|528449219|FG000|Overall Study|technical problem|4|||
146530299|NCT02007720|528449220|FG001|Overall Study|technical problem|2|||
146530300|NCT02007720|528449219|FG000|Overall Study|patient followd less than 165 days|11|||
146530301|NCT02007720|528449220|FG001|Overall Study|patient followd less than 165 days|5|||
146530302|NCT03028142|528451288|FG000|Overall Study|Adverse Event|1|||
146530303|NCT03028142|528451289|FG001|Overall Study|Adverse Event|1|||
146530304|NCT03028142|528451290|FG002|Overall Study|Adverse Event|0|||
146530305|NCT03028142|528451291|FG003|Overall Study|Adverse Event|0|||
146530306|NCT03028142|528451292|FG004|Overall Study|Adverse Event|0|||
146530307|NCT03028142|528451293|FG005|Overall Study|Adverse Event|1|||
146530308|NCT03028142|528451288|FG000|Overall Study|Withdrawal by Subject|0|||
146530309|NCT03028142|528451289|FG001|Overall Study|Withdrawal by Subject|0|||
146530310|NCT03028142|528451290|FG002|Overall Study|Withdrawal by Subject|0|||
146530311|NCT03028142|528451291|FG003|Overall Study|Withdrawal by Subject|0|||
146530312|NCT03028142|528451292|FG004|Overall Study|Withdrawal by Subject|1|||
146530313|NCT03028142|528451293|FG005|Overall Study|Withdrawal by Subject|0|||
146530314|NCT01198002|528451294|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
146530315|NCT01198002|528451295|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
146530316|NCT01198002|528451296|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
146530317|NCT01198002|528451294|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
146530318|NCT01198002|528451295|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
146530319|NCT01198002|528451296|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
146530320|NCT01198002|528451294|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
146530321|NCT01198002|528451295|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
146530322|NCT01198002|528451296|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
146530323|NCT01198002|528451294|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
146530324|NCT01198002|528451295|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
146530325|NCT01198002|528451296|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
146530326|NCT01198002|528451294|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
146530327|NCT01198002|528451295|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
146530328|NCT01198002|528451296|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
146530329|NCT01198002|528451294|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
146530330|NCT01198002|528451295|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
146530331|NCT01198002|528451296|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
146530332|NCT01198002|528451294|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
146530333|NCT01198002|528451295|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
146530334|NCT01198002|528451296|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
146530335|NCT01198002|528451294|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
146530336|NCT01198002|528451295|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
146530337|NCT01198002|528451296|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
146530338|NCT01198002|528451294|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
146530339|NCT01198002|528451295|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
146530340|NCT01198002|528451296|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
146530341|NCT01198002|528451294|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
146530342|NCT01198002|528451295|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
146530343|NCT01198002|528451296|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
146530344|NCT01198002|528451294|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
146863959|NCT02748018|529675136|FG002|Continuation Period|Adverse Event|1|||
146530345|NCT01198002|528451295|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
146530346|NCT01198002|528451296|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
146530347|NCT01198002|528451294|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
146530348|NCT01198002|528451295|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
146530349|NCT01198002|528451296|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
146530350|NCT01198002|528451294|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
146530351|NCT01198002|528451295|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
146530352|NCT01198002|528451296|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
146530353|NCT01198002|528451294|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
146530354|NCT01198002|528451295|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
146530355|NCT01198002|528451296|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
146530356|NCT01198002|528451294|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
146530357|NCT01198002|528451295|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
146530358|NCT01198002|528451296|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
146530359|NCT03102762|528451297|FG000|Overall Study|Lost to Follow-up|1|||
146530360|NCT03102762|528451298|FG001|Overall Study|Lost to Follow-up|0|||
146530361|NCT01232790|528451305|FG000|Randomization|Withdrawal by Subject|2|||
146530362|NCT01232790|528451306|FG001|Randomization|Withdrawal by Subject|0|||
146530363|NCT01232790|528451305|FG000|Randomization|Protocol Violation|0|||
146530364|NCT01232790|528451306|FG001|Randomization|Protocol Violation|1|||
146530365|NCT01232790|528451305|FG000|Randomization|Physician Decision|0|||
146530366|NCT01232790|528451306|FG001|Randomization|Physician Decision|1|||
146530367|NCT01232790|528451305|FG000|Initial Assessment|Withdrawal by Subject|0|||
146530368|NCT01232790|528451306|FG001|Initial Assessment|Withdrawal by Subject|1|||
146530369|NCT01232790|528451305|FG000|First Crossover|Withdrawal by Subject|1|||
146530370|NCT01232790|528451306|FG001|First Crossover|Withdrawal by Subject|0|||
146530371|NCT01232790|528451305|FG000|Second Crossover|Withdrawal by Subject|1|||
146530372|NCT01232790|528451306|FG001|Second Crossover|Withdrawal by Subject|2|||
146530373|NCT03322293|528451307|FG000|Overall Study|Lost to Follow-up|0|||
146530374|NCT03322293|528451308|FG001|Overall Study|Lost to Follow-up|0|||
146863960|NCT02748018|529675137|FG003|Continuation Period|Adverse Event|1|||
146863961|NCT02748018|529675138|FG004|Continuation Period|Adverse Event|1|||
146863962|NCT02748018|529675139|FG005|Continuation Period|Adverse Event|4|||
146863963|NCT02748018|529675134|FG000|Continuation Period|Withdrawal by Subject|3|||
146863964|NCT02748018|529675135|FG001|Continuation Period|Withdrawal by Subject|5|||
146863965|NCT02748018|529675136|FG002|Continuation Period|Withdrawal by Subject|3|||
146863966|NCT02748018|529675137|FG003|Continuation Period|Withdrawal by Subject|9|||
146863967|NCT02748018|529675138|FG004|Continuation Period|Withdrawal by Subject|11|||
146863968|NCT02748018|529675139|FG005|Continuation Period|Withdrawal by Subject|1|||
146863969|NCT02748018|529675134|FG000|Continuation Period|Lost to Follow-up|0|||
146863970|NCT02748018|529675135|FG001|Continuation Period|Lost to Follow-up|2|||
146863971|NCT02748018|529675136|FG002|Continuation Period|Lost to Follow-up|1|||
146863972|NCT02748018|529675137|FG003|Continuation Period|Lost to Follow-up|0|||
146863973|NCT02748018|529675138|FG004|Continuation Period|Lost to Follow-up|1|||
146863974|NCT02748018|529675139|FG005|Continuation Period|Lost to Follow-up|0|||
146863975|NCT02748018|529675134|FG000|Continuation Period|Pregnancy|1|||
146863976|NCT02748018|529675135|FG001|Continuation Period|Pregnancy|2|||
146863977|NCT02748018|529675136|FG002|Continuation Period|Pregnancy|0|||
146863978|NCT02748018|529675137|FG003|Continuation Period|Pregnancy|0|||
146863979|NCT02748018|529675138|FG004|Continuation Period|Pregnancy|0|||
146863980|NCT02748018|529675139|FG005|Continuation Period|Pregnancy|0|||
146863981|NCT02748018|529675134|FG000|Continuation Period|Physician Decision|0|||
146863982|NCT02748018|529675135|FG001|Continuation Period|Physician Decision|1|||
146863983|NCT02748018|529675136|FG002|Continuation Period|Physician Decision|2|||
146863984|NCT02748018|529675137|FG003|Continuation Period|Physician Decision|0|||
146863985|NCT02748018|529675138|FG004|Continuation Period|Physician Decision|2|||
146863986|NCT02748018|529675139|FG005|Continuation Period|Physician Decision|1|||
146863987|NCT02748018|529675134|FG000|Continuation Period|Protocol Violation|0|||
146863988|NCT02748018|529675135|FG001|Continuation Period|Protocol Violation|1|||
146863989|NCT02748018|529675136|FG002|Continuation Period|Protocol Violation|0|||
146863990|NCT02748018|529675137|FG003|Continuation Period|Protocol Violation|0|||
146863991|NCT02748018|529675138|FG004|Continuation Period|Protocol Violation|0|||
146863992|NCT02748018|529675139|FG005|Continuation Period|Protocol Violation|0|||
146863993|NCT06069778|529675140|FG000|Overall Study|Withdrawal by Subject|1|||
146863994|NCT02856893|529675141|FG000|Overall Study|Lack of Efficacy|27|||
146530375|NCT03322293|528451309|FG002|Overall Study|Lost to Follow-up|1|||
146530376|NCT00083915|528451310|FG000|Overall Study|Death|6|||
146530377|NCT00083915|528451311|FG001|Overall Study|Death|3|||
146530378|NCT00083915|528451310|FG000|Overall Study|Physician Decision|11|||
146530379|NCT00083915|528451311|FG001|Overall Study|Physician Decision|6|||
146530380|NCT00083915|528451310|FG000|Overall Study|Withdrawal by Subject|8|||
146530381|NCT00083915|528451311|FG001|Overall Study|Withdrawal by Subject|3|||
146530382|NCT00083915|528451310|FG000|Overall Study|disease progression|18|||
146530383|NCT00083915|528451311|FG001|Overall Study|disease progression|23|||
146863995|NCT02856893|529675142|FG001|Overall Study|Lack of Efficacy|15|||
146863996|NCT02856893|529675143|FG002|Overall Study|Lack of Efficacy|19|||
146863997|NCT02856893|529675141|FG000|Overall Study|Death|1|||
146863998|NCT02856893|529675142|FG001|Overall Study|Death|0|||
146530384|NCT00083915|528451310|FG000|Overall Study|Failure to collect|3|||
146863999|NCT02856893|529675143|FG002|Overall Study|Death|0|||
146864000|NCT02856893|529675141|FG000|Overall Study|Adverse Event|2|||
146864001|NCT02856893|529675142|FG001|Overall Study|Adverse Event|0|||
146864002|NCT02856893|529675143|FG002|Overall Study|Adverse Event|0|||
146864003|NCT02856893|529675141|FG000|Overall Study|Physician Decision|0|||
146864004|NCT02856893|529675142|FG001|Overall Study|Physician Decision|2|||
146864005|NCT02856893|529675143|FG002|Overall Study|Physician Decision|3|||
146864006|NCT02856893|529675141|FG000|Overall Study|Withdrawal by Subject|1|||
146864007|NCT02856893|529675142|FG001|Overall Study|Withdrawal by Subject|1|||
146864008|NCT02856893|529675143|FG002|Overall Study|Withdrawal by Subject|0|||
146864009|NCT02856893|529675141|FG000|Overall Study|Other reasons|2|||
146864010|NCT02856893|529675142|FG001|Overall Study|Other reasons|1|||
146864011|NCT02856893|529675143|FG002|Overall Study|Other reasons|2|||
146864012|NCT03801902|529675144|FG000|Overall Study|Did not receive protocol treatment.|1|||
146864013|NCT03801902|529675145|FG001|Overall Study|Did not receive protocol treatment.|0|||
146864014|NCT03801902|529675146|FG002|Overall Study|Did not receive protocol treatment.|0|||
146864015|NCT03801902|529675147|FG003|Overall Study|Did not receive protocol treatment.|0|||
146864016|NCT02310672|529675148|FG000|Overall Study|Death|1|||
146864017|NCT02310672|529675148|FG000|Overall Study|Lost to Follow-up|1|||
146864018|NCT02310672|529675148|FG000|Overall Study|Withdrawal by Subject|1|||
146864019|NCT02310672|529675148|FG000|Overall Study|Sponsor's decision|12|||
146864020|NCT04704336|529675152|FG000|Overall Study|Death|2|||
146864021|NCT04704336|529675153|FG001|Overall Study|Death|2|||
146864022|NCT04704336|529675152|FG000|Overall Study|Lost to Follow-up|33|||
146864023|NCT04704336|529675153|FG001|Overall Study|Lost to Follow-up|40|||
146864024|NCT03118674|529675161|FG000|Overall Study|Lost to Follow-up|2|||
146864025|NCT03118674|529675161|FG000|Overall Study|Screen Faliure|8|||
146864026|NCT03118674|529675161|FG000|Overall Study|Withdrawal by Subject|5|||
146864027|NCT01324323|529675162|FG000|Overall Study|Withdrawal by Subject|1|||
146864028|NCT00537485|529675163|FG000|Overall Study|Adverse Event|10|||
146864029|NCT00537485|529675164|FG001|Overall Study|Adverse Event|5|||
146864030|NCT00537485|529675163|FG000|Overall Study|Withdrawal by Subject|3|||
146864031|NCT00537485|529675164|FG001|Overall Study|Withdrawal by Subject|2|||
146864032|NCT00537485|529675163|FG000|Overall Study|Withdrawal by Subject|1|||
146864033|NCT00537485|529675164|FG001|Overall Study|Withdrawal by Subject|3|||
146864034|NCT00537485|529675163|FG000|Overall Study|Physician Decision|1|||
146864035|NCT00537485|529675164|FG001|Overall Study|Physician Decision|0|||
146864036|NCT00908232|529675165|FG000|Cycle 1 to 4|Death|5|||
146864037|NCT00908232|529675166|FG001|Cycle 1 to 4|Death|0|||
146864038|NCT00908232|529675167|FG002|Cycle 1 to 4|Death|0|||
146864039|NCT00908232|529675168|FG003|Cycle 1 to 4|Death|0|||
146864040|NCT00908232|529675165|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
146864041|NCT00908232|529675166|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
146864042|NCT00908232|529675167|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
146864043|NCT00908232|529675168|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
146864044|NCT00908232|529675165|FG000|Cycle 1 to 4|Progressive Disease|6|||
146864045|NCT00908232|529675166|FG001|Cycle 1 to 4|Progressive Disease|0|||
146864046|NCT00908232|529675167|FG002|Cycle 1 to 4|Progressive Disease|0|||
146864047|NCT00908232|529675168|FG003|Cycle 1 to 4|Progressive Disease|0|||
146864048|NCT00908232|529675165|FG000|Cycle 1 to 4|Adverse Event|12|||
146864049|NCT00908232|529675166|FG001|Cycle 1 to 4|Adverse Event|0|||
146864050|NCT00908232|529675167|FG002|Cycle 1 to 4|Adverse Event|0|||
146864051|NCT00908232|529675168|FG003|Cycle 1 to 4|Adverse Event|0|||
146864052|NCT00908232|529675165|FG000|Cycle 1 to 4|Other|1|||
146864053|NCT00908232|529675166|FG001|Cycle 1 to 4|Other|0|||
146864054|NCT00908232|529675167|FG002|Cycle 1 to 4|Other|0|||
146864055|NCT00908232|529675168|FG003|Cycle 1 to 4|Other|0|||
146864056|NCT00908232|529675165|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
146864057|NCT00908232|529675166|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
146864058|NCT00908232|529675167|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
146864059|NCT00908232|529675168|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
146864060|NCT00908232|529675165|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
146864061|NCT00908232|529675166|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
146864062|NCT00908232|529675167|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
146864063|NCT00908232|529675168|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
146864064|NCT00908232|529675165|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
146864065|NCT00908232|529675166|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
146864066|NCT00908232|529675167|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
146864067|NCT00908232|529675168|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
146864068|NCT00908232|529675165|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
146864069|NCT00908232|529675166|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
146864070|NCT00908232|529675167|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
146864071|NCT00908232|529675168|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
146864072|NCT00908232|529675165|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
146864073|NCT00908232|529675166|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
146864074|NCT00908232|529675167|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
146530385|NCT00083915|528451311|FG001|Overall Study|Failure to collect|0|||
146530386|NCT00083915|528451310|FG000|Overall Study|No response|3|||
146530387|NCT00083915|528451311|FG001|Overall Study|No response|1|||
146530388|NCT00083915|528451310|FG000|Overall Study|Insurance issues|1|||
146530389|NCT00083915|528451311|FG001|Overall Study|Insurance issues|1|||
146530390|NCT01239797|528451312|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
146530391|NCT01239797|528451313|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
146530392|NCT01239797|528451312|FG000|Randomized Participants|Participant withdrew consent|1|||
146530393|NCT01239797|528451313|FG001|Randomized Participants|Participant withdrew consent|7|||
146530394|NCT01239797|528451312|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
146530395|NCT01239797|528451313|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
146530396|NCT01239797|528451312|FG000|Treated Participants|Disease progression|185|||
146762367|NCT02081391|529297013|FG002|12-hour Treatment|Adverse Event|0|||
146762368|NCT02081391|529297014|FG003|12-hour Treatment|Adverse Event|0|||
146762369|NCT02081391|529297011|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
146762370|NCT02081391|529297012|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
146762371|NCT02081391|529297013|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
146762372|NCT02081391|529297014|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
146762373|NCT02081391|529297011|FG000|12-hour Treatment|Further reasons|2|||
146762374|NCT02081391|529297012|FG001|12-hour Treatment|Further reasons|1|||
146762375|NCT02081391|529297013|FG002|12-hour Treatment|Further reasons|0|||
146762376|NCT02081391|529297014|FG003|12-hour Treatment|Further reasons|0|||
146762377|NCT02081391|529297011|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
146762378|NCT02081391|529297012|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
146762379|NCT02081391|529297013|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
146762380|NCT02081391|529297014|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
146762381|NCT02081391|529297011|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
146762382|NCT02081391|529297012|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
146762383|NCT02081391|529297013|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
146762384|NCT02081391|529297014|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
146762385|NCT02081391|529297011|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
146762386|NCT02081391|529297012|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
146762387|NCT02081391|529297013|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
146762388|NCT02081391|529297014|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
146762389|NCT02081391|529297011|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
146762390|NCT02081391|529297012|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
146762391|NCT02081391|529297013|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
146762392|NCT02081391|529297014|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
146762393|NCT02081391|529297011|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
146762394|NCT02081391|529297012|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
146762395|NCT02081391|529297013|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
146762396|NCT02081391|529297014|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
146762397|NCT02081391|529297011|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
146762398|NCT02081391|529297012|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
146762399|NCT02081391|529297013|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
146762400|NCT02081391|529297014|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
146762401|NCT01458275|529297015|FG000|Overall Study|Adverse Event|3|||
146762402|NCT01458275|529297016|FG001|Overall Study|Adverse Event|4|||
146762403|NCT01458275|529297017|FG002|Overall Study|Adverse Event|1|||
146762404|NCT01458275|529297015|FG000|Overall Study|Lost to Follow-up|3|||
146762405|NCT01458275|529297016|FG001|Overall Study|Lost to Follow-up|2|||
146762406|NCT01458275|529297017|FG002|Overall Study|Lost to Follow-up|5|||
146762407|NCT01458275|529297015|FG000|Overall Study|Protocol Violation|5|||
146762408|NCT01458275|529297016|FG001|Overall Study|Protocol Violation|5|||
146762409|NCT01458275|529297017|FG002|Overall Study|Protocol Violation|2|||
146762410|NCT01458275|529297015|FG000|Overall Study|Withdrawal by Subject|3|||
146762411|NCT01458275|529297016|FG001|Overall Study|Withdrawal by Subject|2|||
146762412|NCT01458275|529297017|FG002|Overall Study|Withdrawal by Subject|1|||
146762413|NCT00813488|529297018|FG000|Titration Period 1|Adverse Event|6|||
146762414|NCT00813488|529297019|FG001|Titration Period 1|Adverse Event|1|||
146762415|NCT00813488|529297018|FG000|Titration Period 1|Lack of Efficacy|9|||
146762416|NCT00813488|529297019|FG001|Titration Period 1|Lack of Efficacy|7|||
146762417|NCT00813488|529297018|FG000|Titration Period 1|Withdrawal by Subject|2|||
146762418|NCT00813488|529297019|FG001|Titration Period 1|Withdrawal by Subject|2|||
146762419|NCT00813488|529297018|FG000|Titration Period 1|Protocol Violation|4|||
146762420|NCT00813488|529297019|FG001|Titration Period 1|Protocol Violation|3|||
146762421|NCT00813488|529297018|FG000|Titration Period 1|Non-compliance to study medication|4|||
146530397|NCT01239797|528451313|FG001|Treated Participants|Disease progression|185|||
146530398|NCT01239797|528451312|FG000|Treated Participants|Study drug toxicity|39|||
146762422|NCT00813488|529297019|FG001|Titration Period 1|Non-compliance to study medication|1|||
146965101|NCT03110107|530033439|FG013|Treatment Period|Adverse Event|0|||
146864075|NCT00908232|529675168|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
146864076|NCT00908232|529675165|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
146864077|NCT00908232|529675166|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
146864078|NCT00908232|529675167|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
146864079|NCT00908232|529675168|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
146864080|NCT00908232|529675165|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
146864081|NCT00908232|529675166|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
146864082|NCT00908232|529675167|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
146864083|NCT00908232|529675168|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
146864084|NCT00908232|529675165|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
146864085|NCT00908232|529675166|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
146864086|NCT00908232|529675167|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
146864087|NCT00908232|529675168|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
146864088|NCT03153137|529675169|FG000|Overall Study|Lost to Follow-up|1|||
146864089|NCT03153137|529675170|FG001|Overall Study|Lost to Follow-up|0|||
146864090|NCT03153137|529675169|FG000|Overall Study|Withdrawal by Subject|2|||
146864091|NCT03153137|529675170|FG001|Overall Study|Withdrawal by Subject|1|||
146864092|NCT03153137|529675169|FG000|Overall Study|Physician Decision|0|||
146864093|NCT03153137|529675170|FG001|Overall Study|Physician Decision|3|||
146530399|NCT01239797|528451313|FG001|Treated Participants|Study drug toxicity|45|||
146530400|NCT01239797|528451312|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
146864094|NCT02260882|529675174|FG000|Overall Study|Protocol Violation|0|||
146864095|NCT02260882|529675175|FG001|Overall Study|Protocol Violation|1|||
146864096|NCT02119325|529675176|FG000|Washout Period 1|Adverse Event|0|||
146864097|NCT02119325|529675177|FG001|Washout Period 1|Adverse Event|1|||
146864098|NCT01601847|529675178|FG000|Overall Study|Death|1|||
146864099|NCT01601847|529675179|FG001|Overall Study|Death|0|||
146864100|NCT01601847|529675178|FG000|Overall Study|Withdrawal by Subject|11|||
146864101|NCT01601847|529675179|FG001|Overall Study|Withdrawal by Subject|7|||
146864102|NCT01601847|529675178|FG000|Overall Study|Lost to Follow-up|1|||
146864103|NCT01601847|529675179|FG001|Overall Study|Lost to Follow-up|3|||
146864104|NCT01284062|529675191|FG000|Overall Study|Adverse Event|4|||
146864105|NCT01284062|529675192|FG001|Overall Study|Adverse Event|5|||
146864106|NCT01284062|529675193|FG002|Overall Study|Adverse Event|0|||
146864107|NCT01284062|529675194|FG003|Overall Study|Adverse Event|5|||
146864108|NCT01284062|529675191|FG000|Overall Study|Lack of Efficacy|3|||
146864109|NCT01284062|529675192|FG001|Overall Study|Lack of Efficacy|2|||
146864110|NCT01284062|529675193|FG002|Overall Study|Lack of Efficacy|2|||
146864111|NCT01284062|529675194|FG003|Overall Study|Lack of Efficacy|1|||
146864112|NCT01284062|529675191|FG000|Overall Study|Medication error without adverse event|0|||
146864113|NCT01284062|529675192|FG001|Overall Study|Medication error without adverse event|0|||
146864114|NCT01284062|529675193|FG002|Overall Study|Medication error without adverse event|1|||
146864115|NCT01284062|529675194|FG003|Overall Study|Medication error without adverse event|0|||
146864116|NCT01284062|529675191|FG000|Overall Study|Protocol Violation|1|||
146864117|NCT01284062|529675192|FG001|Overall Study|Protocol Violation|0|||
146864118|NCT01284062|529675193|FG002|Overall Study|Protocol Violation|0|||
146864119|NCT01284062|529675194|FG003|Overall Study|Protocol Violation|2|||
146864120|NCT01284062|529675191|FG000|Overall Study|Withdrawal by Subject|3|||
146864121|NCT01284062|529675192|FG001|Overall Study|Withdrawal by Subject|1|||
146864122|NCT01284062|529675193|FG002|Overall Study|Withdrawal by Subject|2|||
146864123|NCT01284062|529675194|FG003|Overall Study|Withdrawal by Subject|5|||
146530401|NCT01239797|528451313|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
146530402|NCT01239797|528451312|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
146530403|NCT01239797|528451313|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
146530404|NCT01239797|528451312|FG000|Treated Participants|Administrative reason by sponsor|13|||
146530405|NCT01239797|528451313|FG001|Treated Participants|Administrative reason by sponsor|4|||
146530406|NCT01239797|528451312|FG000|Treated Participants|Other reasons|14|||
146530407|NCT01239797|528451313|FG001|Treated Participants|Other reasons|14|||
146530408|NCT01239797|528451312|FG000|Treated Participants|Participant withdrew consent|6|||
146530409|NCT01239797|528451313|FG001|Treated Participants|Participant withdrew consent|11|||
146530410|NCT01239797|528451312|FG000|Treated Participants|Death|1|||
146530411|NCT01239797|528451313|FG001|Treated Participants|Death|1|||
146530412|NCT01239797|528451312|FG000|Treated Participants|Participant no longer meets study criteria|1|||
146530413|NCT01239797|528451313|FG001|Treated Participants|Participant no longer meets study criteria|1|||
146530414|NCT01239797|528451312|FG000|Treated Participants|Poor/non-compliance|0|||
146864124|NCT01284062|529675191|FG000|Overall Study|Other|0|||
146864125|NCT01284062|529675192|FG001|Overall Study|Other|0|||
146864126|NCT01284062|529675193|FG002|Overall Study|Other|0|||
146864127|NCT01284062|529675194|FG003|Overall Study|Other|1|||
146864128|NCT01284062|529675191|FG000|Overall Study|Site Closed|0|||
146864129|NCT01284062|529675192|FG001|Overall Study|Site Closed|0|||
146864130|NCT01284062|529675193|FG002|Overall Study|Site Closed|1|||
146864131|NCT01284062|529675194|FG003|Overall Study|Site Closed|0|||
146864132|NCT00559585|529675197|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
146965102|NCT03110107|530033440|FG014|Treatment Period|Adverse Event|0|||
146530415|NCT01239797|528451313|FG001|Treated Participants|Poor/non-compliance|1|||
146530416|NCT02000921|528451314|FG000|Overall Study|Withdrawal by Subject|3|||
146530417|NCT02000921|528451315|FG001|Overall Study|Withdrawal by Subject|10|||
146530418|NCT02000921|528451316|FG002|Overall Study|Withdrawal by Subject|5|||
146530419|NCT02000921|528451314|FG000|Overall Study|Lost to Follow-up|2|||
146530420|NCT02000921|528451315|FG001|Overall Study|Lost to Follow-up|4|||
146530421|NCT02000921|528451316|FG002|Overall Study|Lost to Follow-up|5|||
146530422|NCT02000921|528451314|FG000|Overall Study|Physician Decision|0|||
146530423|NCT02000921|528451315|FG001|Overall Study|Physician Decision|2|||
146530424|NCT02000921|528451316|FG002|Overall Study|Physician Decision|0|||
146530425|NCT02914834|528451321|FG000|Overall Study|Study halted due to COVID|1|||
146530426|NCT02914834|528451322|FG001|Overall Study|Study halted due to COVID|1|||
146530427|NCT02914834|528451321|FG000|Overall Study|1 subject withdrew|0|||
146530428|NCT02914834|528451322|FG001|Overall Study|1 subject withdrew|1|||
146530429|NCT02631941|528451327|FG000|Overall Study|Physician Decision|0|||
146530430|NCT02631941|528451328|FG001|Overall Study|Physician Decision|1|||
146530431|NCT02631941|528451329|FG002|Overall Study|Physician Decision|0|||
146864133|NCT00559585|529675198|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
146864134|NCT00559585|529675197|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
146864135|NCT00559585|529675198|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
146864136|NCT00559585|529675197|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
146864137|NCT00559585|529675198|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
146530432|NCT02631941|528451330|FG003|Overall Study|Physician Decision|0|||
146530433|NCT02631941|528451331|FG004|Overall Study|Physician Decision|0|||
146530434|NCT02631941|528451332|FG005|Overall Study|Physician Decision|0|||
146762423|NCT00813488|529297018|FG000|Titration Period 1|Non-compliance to study procedures|2|||
146762424|NCT00813488|529297019|FG001|Titration Period 1|Non-compliance to study procedures|2|||
146762425|NCT00813488|529297018|FG000|Titration Period 1|Technical Difficulties|0|||
146762426|NCT00813488|529297019|FG001|Titration Period 1|Technical Difficulties|1|||
146762427|NCT00813488|529297018|FG000|Titration Period 2|Adverse Event|2|||
146762428|NCT00813488|529297019|FG001|Titration Period 2|Adverse Event|3|||
146762429|NCT00813488|529297018|FG000|Titration Period 2|Lack of Efficacy|8|||
146762430|NCT00813488|529297019|FG001|Titration Period 2|Lack of Efficacy|4|||
146762431|NCT00813488|529297018|FG000|Titration Period 2|Protocol Violation|3|||
146762432|NCT00813488|529297019|FG001|Titration Period 2|Protocol Violation|2|||
146762433|NCT00813488|529297018|FG000|Titration Period 2|Lost to Follow-up|1|||
146762434|NCT00813488|529297019|FG001|Titration Period 2|Lost to Follow-up|0|||
146762435|NCT00813488|529297018|FG000|Titration Period 2|Non-compliance with study procedures|2|||
146762436|NCT00813488|529297019|FG001|Titration Period 2|Non-compliance with study procedures|1|||
146762437|NCT00813488|529297018|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
146762438|NCT00813488|529297019|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
146762439|NCT00813488|529297018|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
146762440|NCT00813488|529297019|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
146762441|NCT00813488|529297018|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
146762442|NCT00813488|529297019|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
146762443|NCT00813488|529297018|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
146762444|NCT00813488|529297019|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
146762445|NCT00813488|529297018|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
146762446|NCT00813488|529297019|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
146762447|NCT00813488|529297018|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
146762448|NCT00813488|529297019|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
146762449|NCT00813488|529297018|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
146762450|NCT00813488|529297019|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
146762451|NCT00813488|529297018|FG000|Double-blind Treatment Period 2|Other|1|||
146762452|NCT00813488|529297019|FG001|Double-blind Treatment Period 2|Other|0|||
146762453|NCT00813488|529297018|FG000|Open-label Extension|Adverse Event|1|||
146762454|NCT00813488|529297019|FG001|Open-label Extension|Adverse Event|2|||
146762455|NCT00813488|529297018|FG000|Open-label Extension|Lack of Efficacy|3|||
146762456|NCT00813488|529297019|FG001|Open-label Extension|Lack of Efficacy|0|||
146762457|NCT00813488|529297018|FG000|Open-label Extension|Withdrawal by Subject|0|||
146762458|NCT00813488|529297019|FG001|Open-label Extension|Withdrawal by Subject|2|||
146762459|NCT00813488|529297018|FG000|Open-label Extension|Protocol Violation|1|||
146762460|NCT00813488|529297019|FG001|Open-label Extension|Protocol Violation|2|||
146762461|NCT00813488|529297018|FG000|Open-label Extension|Non-compliance study medication|4|||
146762462|NCT00813488|529297019|FG001|Open-label Extension|Non-compliance study medication|0|||
146762463|NCT00813488|529297018|FG000|Open-label Extension|Non-compliance study procedures|2|||
146762464|NCT00813488|529297019|FG001|Open-label Extension|Non-compliance study procedures|1|||
146530435|NCT02631941|528451333|FG006|Overall Study|Physician Decision|0|||
146530436|NCT02631941|528451334|FG007|Overall Study|Physician Decision|0|||
146530437|NCT02631941|528451335|FG008|Overall Study|Physician Decision|0|||
146530438|NCT02631941|528451336|FG009|Overall Study|Physician Decision|0|||
146530439|NCT02631941|528451327|FG000|Overall Study|Adverse Event|0|||
146762465|NCT00813488|529297018|FG000|Open-label Extension|Other|1|||
146864138|NCT00559585|529675197|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
146864139|NCT00559585|529675198|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
146864140|NCT00559585|529675197|FG000|Double Blind ST Period Main Study|Death|1|||
146864141|NCT00559585|529675198|FG001|Double Blind ST Period Main Study|Death|1|||
146864142|NCT00559585|529675197|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
146864143|NCT00559585|529675198|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
146864144|NCT00559585|529675197|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
146530440|NCT02631941|528451328|FG001|Overall Study|Adverse Event|1|||
146530441|NCT02631941|528451329|FG002|Overall Study|Adverse Event|0|||
146530442|NCT02631941|528451330|FG003|Overall Study|Adverse Event|0|||
146530443|NCT02631941|528451331|FG004|Overall Study|Adverse Event|0|||
146530444|NCT02631941|528451332|FG005|Overall Study|Adverse Event|0|||
146530445|NCT02631941|528451333|FG006|Overall Study|Adverse Event|0|||
146530446|NCT02631941|528451334|FG007|Overall Study|Adverse Event|0|||
146530447|NCT02631941|528451335|FG008|Overall Study|Adverse Event|0|||
146530448|NCT02631941|528451336|FG009|Overall Study|Adverse Event|0|||
146530449|NCT02631941|528451327|FG000|Overall Study|Withdrawal by Subject|0|||
146530450|NCT02631941|528451328|FG001|Overall Study|Withdrawal by Subject|0|||
146530451|NCT02631941|528451329|FG002|Overall Study|Withdrawal by Subject|0|||
146530452|NCT02631941|528451330|FG003|Overall Study|Withdrawal by Subject|0|||
146530453|NCT02631941|528451331|FG004|Overall Study|Withdrawal by Subject|1|||
146530454|NCT02631941|528451332|FG005|Overall Study|Withdrawal by Subject|0|||
146530455|NCT02631941|528451333|FG006|Overall Study|Withdrawal by Subject|0|||
146530456|NCT02631941|528451334|FG007|Overall Study|Withdrawal by Subject|1|||
146530457|NCT02631941|528451335|FG008|Overall Study|Withdrawal by Subject|0|||
146530458|NCT02631941|528451336|FG009|Overall Study|Withdrawal by Subject|0|||
146530459|NCT02631941|528451327|FG000|Overall Study|Lost to Follow-up|0|||
146530460|NCT02631941|528451328|FG001|Overall Study|Lost to Follow-up|0|||
146530461|NCT02631941|528451329|FG002|Overall Study|Lost to Follow-up|0|||
146530462|NCT02631941|528451330|FG003|Overall Study|Lost to Follow-up|0|||
146530463|NCT02631941|528451331|FG004|Overall Study|Lost to Follow-up|0|||
146530464|NCT02631941|528451332|FG005|Overall Study|Lost to Follow-up|0|||
146530465|NCT02631941|528451333|FG006|Overall Study|Lost to Follow-up|0|||
146530466|NCT02631941|528451334|FG007|Overall Study|Lost to Follow-up|0|||
146530467|NCT02631941|528451335|FG008|Overall Study|Lost to Follow-up|1|||
146530468|NCT02631941|528451336|FG009|Overall Study|Lost to Follow-up|0|||
146530469|NCT04456686|528451339|FG000|Overall Study|Adverse Event|2|||
146530470|NCT04456686|528451340|FG001|Overall Study|Adverse Event|1|||
146530471|NCT04456686|528451339|FG000|Overall Study|Lack of Efficacy|3|||
146530472|NCT04456686|528451340|FG001|Overall Study|Lack of Efficacy|1|||
146530473|NCT04456686|528451339|FG000|Overall Study|Withdrew consent|3|||
146530474|NCT04456686|528451340|FG001|Overall Study|Withdrew consent|1|||
146530475|NCT04456686|528451339|FG000|Overall Study|Physician Decision|2|||
146530476|NCT04456686|528451340|FG001|Overall Study|Physician Decision|2|||
146530477|NCT04456686|528451339|FG000|Overall Study|Withdrawal by Subject|5|||
146530478|NCT04456686|528451340|FG001|Overall Study|Withdrawal by Subject|1|||
146530479|NCT04456686|528451339|FG000|Overall Study|Protocol Violation|0|||
146530480|NCT04456686|528451340|FG001|Overall Study|Protocol Violation|1|||
146530481|NCT02858401|528451346|FG000|Overall Study|Withdrew Consent|0|||
146530482|NCT02858401|528451347|FG001|Overall Study|Withdrew Consent|0|||
146530483|NCT02858401|528451348|FG002|Overall Study|Withdrew Consent|0|||
146530484|NCT02858401|528451349|FG003|Overall Study|Withdrew Consent|0|||
146530485|NCT02858401|528451350|FG004|Overall Study|Withdrew Consent|0|||
146530486|NCT02858401|528451351|FG005|Overall Study|Withdrew Consent|1|||
146530487|NCT02858401|528451352|FG006|Overall Study|Withdrew Consent|0|||
146530488|NCT02858401|528451346|FG000|Overall Study|Lost to Follow-up|0|||
146530489|NCT02858401|528451347|FG001|Overall Study|Lost to Follow-up|1|||
146530490|NCT02858401|528451348|FG002|Overall Study|Lost to Follow-up|0|||
146530491|NCT02858401|528451349|FG003|Overall Study|Lost to Follow-up|0|||
146530492|NCT02858401|528451350|FG004|Overall Study|Lost to Follow-up|0|||
146530493|NCT02858401|528451351|FG005|Overall Study|Lost to Follow-up|0|||
146530494|NCT02858401|528451352|FG006|Overall Study|Lost to Follow-up|0|||
146530495|NCT03722576|528451353|FG000|Overall Study|Withdrawal by Subject|3|||
146530496|NCT03722576|528451353|FG000|Overall Study|Adverse Event|2|||
146530497|NCT03722576|528451353|FG000|Overall Study|Physician Decision|1|||
146530498|NCT03722576|528451353|FG000|Overall Study|Lost to Follow-up|1|||
146530499|NCT01240382|528451354|FG000|Overall Study|Adverse Event|2|||
146530500|NCT01240382|528451355|FG001|Overall Study|Adverse Event|1|||
146530501|NCT01240382|528451354|FG000|Overall Study|Lack of Efficacy|0|||
146530502|NCT01240382|528451355|FG001|Overall Study|Lack of Efficacy|2|||
146530503|NCT01240382|528451354|FG000|Overall Study|Fear of adverse events|0|||
146530504|NCT01240382|528451355|FG001|Overall Study|Fear of adverse events|1|||
146530505|NCT03885908|528451356|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
146530506|NCT03885908|528451357|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
146530507|NCT03885908|528451356|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
146530508|NCT03885908|528451357|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
146530509|NCT03885908|528451356|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
146530510|NCT03885908|528451357|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
146530511|NCT03885908|528451356|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
146530512|NCT03885908|528451357|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
146762466|NCT00813488|529297019|FG001|Open-label Extension|Other|0|||
146762467|NCT02926937|529297020|FG000|Overall Study|Adverse Event|0|||
146762468|NCT02926937|529297021|FG001|Overall Study|Adverse Event|1|||
146762469|NCT02926937|529297022|FG002|Overall Study|Adverse Event|1|||
146762470|NCT02926937|529297020|FG000|Overall Study|Poor Compliance to Protocol|1|||
146762471|NCT02926937|529297021|FG001|Overall Study|Poor Compliance to Protocol|0|||
146762472|NCT02926937|529297022|FG002|Overall Study|Poor Compliance to Protocol|0|||
146762473|NCT02926937|529297020|FG000|Overall Study|Lost to Follow-up|4|||
146762474|NCT02926937|529297021|FG001|Overall Study|Lost to Follow-up|5|||
146762475|NCT02926937|529297022|FG002|Overall Study|Lost to Follow-up|0|||
146762476|NCT02926937|529297020|FG000|Overall Study|At the Participant's own Request|11|||
146762477|NCT02926937|529297021|FG001|Overall Study|At the Participant's own Request|5|||
146762478|NCT02926937|529297022|FG002|Overall Study|At the Participant's own Request|8|||
146762479|NCT02926937|529297020|FG000|Overall Study|Reason not Specified|3|||
146762480|NCT02926937|529297021|FG001|Overall Study|Reason not Specified|4|||
146762481|NCT02926937|529297022|FG002|Overall Study|Reason not Specified|2|||
146762482|NCT01559090|529297023|FG000|Stage I|Withdrawal by Subject|2|||
146762483|NCT01559090|529297024|FG001|Stage I|Withdrawal by Subject|2|||
146762484|NCT01559090|529297025|FG002|Stage I|Withdrawal by Subject|3|||
146762485|NCT01559090|529297023|FG000|Stage II|Withdrawal by Subject|1|||
146762486|NCT01559090|529297024|FG001|Stage II|Withdrawal by Subject|0|||
146762487|NCT01559090|529297025|FG002|Stage II|Withdrawal by Subject|0|||
146762488|NCT03677375|529297027|FG000|Overall Study|Incomplete procedure|8|||
146762489|NCT03677375|529297027|FG000|Overall Study|Adverse Event|3|||
146762490|NCT03677375|529297027|FG000|Overall Study|Physician Decision|1|||
146762491|NCT03971357|529297030|FG000|Overall Study|Lack of Efficacy|0|||
146762492|NCT03971357|529297031|FG001|Overall Study|Lack of Efficacy|1|||
146762493|NCT01729871|529297032|FG000|Overall Study|Adverse Event|7|||
146762494|NCT01729871|529297033|FG001|Overall Study|Adverse Event|7|||
146762495|NCT01729871|529297032|FG000|Overall Study|Death|0|||
146762496|NCT01729871|529297033|FG001|Overall Study|Death|1|||
146762497|NCT01729871|529297032|FG000|Overall Study|Lack of Efficacy|0|||
146762498|NCT01729871|529297033|FG001|Overall Study|Lack of Efficacy|1|||
146762499|NCT01729871|529297032|FG000|Overall Study|Physician Decision|0|||
146762500|NCT01729871|529297033|FG001|Overall Study|Physician Decision|2|||
146762501|NCT01729871|529297032|FG000|Overall Study|Protocol Violation|1|||
146762502|NCT01729871|529297033|FG001|Overall Study|Protocol Violation|0|||
146762503|NCT01729871|529297032|FG000|Overall Study|Withdrawal by Subject|0|||
146762504|NCT01729871|529297033|FG001|Overall Study|Withdrawal by Subject|3|||
146762505|NCT01729871|529297032|FG000|Overall Study|Other|4|||
146762506|NCT01729871|529297033|FG001|Overall Study|Other|9|||
146762507|NCT01143077|529297034|FG000|Overall Study|Lack of Efficacy|0|||
146762508|NCT01143077|529297035|FG001|Overall Study|Lack of Efficacy|2|||
146762509|NCT01143077|529297036|FG002|Overall Study|Lack of Efficacy|1|||
146762510|NCT01143077|529297034|FG000|Overall Study|Adverse Event|5|||
146762511|NCT01143077|529297035|FG001|Overall Study|Adverse Event|6|||
146762512|NCT01143077|529297036|FG002|Overall Study|Adverse Event|5|||
146762513|NCT01143077|529297034|FG000|Overall Study|Lost to Follow-up|2|||
146762514|NCT01143077|529297035|FG001|Overall Study|Lost to Follow-up|3|||
146762515|NCT01143077|529297036|FG002|Overall Study|Lost to Follow-up|4|||
146762516|NCT01143077|529297034|FG000|Overall Study|Protocol Violation|2|||
146762517|NCT01143077|529297035|FG001|Overall Study|Protocol Violation|0|||
146762518|NCT01143077|529297036|FG002|Overall Study|Protocol Violation|0|||
146762519|NCT01143077|529297034|FG000|Overall Study|Withdrawal by Subject|4|||
146762520|NCT01143077|529297035|FG001|Overall Study|Withdrawal by Subject|3|||
146762521|NCT01143077|529297036|FG002|Overall Study|Withdrawal by Subject|3|||
146762522|NCT01143077|529297034|FG000|Overall Study|Non-compliance with study drug|0|||
146762523|NCT01143077|529297035|FG001|Overall Study|Non-compliance with study drug|1|||
146762524|NCT01143077|529297036|FG002|Overall Study|Non-compliance with study drug|1|||
146762525|NCT01143077|529297034|FG000|Overall Study|Administrative|1|||
146762526|NCT01143077|529297035|FG001|Overall Study|Administrative|0|||
146762527|NCT01143077|529297036|FG002|Overall Study|Administrative|0|||
146762528|NCT01143077|529297034|FG000|Overall Study|Principal Investigator Decision|2|||
146762529|NCT01143077|529297035|FG001|Overall Study|Principal Investigator Decision|0|||
146762530|NCT01143077|529297036|FG002|Overall Study|Principal Investigator Decision|1|||
146762531|NCT00124982|529297037|FG000|Short-term Period|Death|1|||
146762532|NCT00124982|529297038|FG001|Short-term Period|Death|1|||
146762533|NCT00124982|529297039|FG002|Short-term Period|Death|0|||
146762534|NCT00124982|529297037|FG000|Short-term Period|Adverse Event|17|||
146762535|NCT00124982|529297038|FG001|Short-term Period|Adverse Event|22|||
146762536|NCT00124982|529297039|FG002|Short-term Period|Adverse Event|0|||
146762537|NCT00124982|529297037|FG000|Short-term Period|Lack of Efficacy|32|||
146762538|NCT00124982|529297038|FG001|Short-term Period|Lack of Efficacy|73|||
146864145|NCT00559585|529675198|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
146864146|NCT00559585|529675197|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
146864147|NCT00559585|529675198|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
146864148|NCT00559585|529675197|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
146864149|NCT00559585|529675198|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
146864150|NCT00559585|529675197|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
146864151|NCT00559585|529675198|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
146864152|NCT00559585|529675197|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
146864153|NCT00559585|529675198|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
146864154|NCT00559585|529675197|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
146864155|NCT00559585|529675198|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
146864156|NCT00559585|529675197|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
146864157|NCT00559585|529675198|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
146864158|NCT00559585|529675197|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
146864159|NCT00559585|529675198|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
146864160|NCT00559585|529675197|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
146864161|NCT00559585|529675198|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
146864162|NCT00559585|529675197|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
146864163|NCT00559585|529675198|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
146864164|NCT00559585|529675197|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
146864165|NCT00559585|529675198|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
146864166|NCT00559585|529675197|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
146864167|NCT00559585|529675198|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
146864168|NCT00559585|529675197|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
146864169|NCT00559585|529675198|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
146864170|NCT00559585|529675197|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
146864171|NCT00559585|529675198|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
146864172|NCT00559585|529675197|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
146864173|NCT00559585|529675198|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
146864174|NCT00559585|529675197|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
146864175|NCT00559585|529675198|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
146864176|NCT00559585|529675197|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
146864177|NCT00559585|529675198|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
146864178|NCT00559585|529675197|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
146864179|NCT00559585|529675198|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
146864180|NCT00559585|529675197|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
146864181|NCT00559585|529675198|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
146864182|NCT00559585|529675197|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
146864183|NCT00559585|529675198|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
146864184|NCT00559585|529675197|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
146864185|NCT00559585|529675198|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
146864186|NCT00559585|529675197|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
146864187|NCT00559585|529675198|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
146864188|NCT04209621|529675199|FG000|Overall Study|Death|1|||
146864189|NCT04209621|529675199|FG000|Overall Study|Study Terminated Early|2|||
146864190|NCT01372410|529675200|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
146864191|NCT01372410|529675201|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
146864192|NCT01372410|529675202|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
146864193|NCT01372410|529675203|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
146864194|NCT01372410|529675204|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
146864195|NCT01372410|529675205|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
146864196|NCT01372410|529675206|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
146864197|NCT01372410|529675207|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
146864198|NCT01372410|529675200|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
146864199|NCT01372410|529675201|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
146864200|NCT01372410|529675202|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
146864201|NCT01372410|529675203|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
146864202|NCT01372410|529675204|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
146864203|NCT01372410|529675205|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
146864204|NCT01372410|529675206|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
146864205|NCT01372410|529675207|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
146530513|NCT03669549|528451358|FG000|Overall Study|Adverse Event|4|||
146530514|NCT03669549|528451358|FG000|Overall Study|Withdrawal by Subject|1|||
146530515|NCT03669549|528451358|FG000|Overall Study|Study terminated by the Sponsor|1|||
146530516|NCT03585270|528451364|FG000|Overall Study|Withdrawal by Subject|2|||
146530517|NCT03585270|528451365|FG001|Overall Study|Withdrawal by Subject|6|||
146864206|NCT01372410|529675200|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146965103|NCT03110107|530033441|FG015|Treatment Period|Adverse Event|2|||
146530518|NCT03585270|528451364|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
146530519|NCT03585270|528451365|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
146530520|NCT03585270|528451364|FG000|Overall Study|Adverse Event|5|||
146530521|NCT03585270|528451365|FG001|Overall Study|Adverse Event|2|||
146530522|NCT03585270|528451364|FG000|Overall Study|Lost to Follow-up|1|||
146530523|NCT03585270|528451365|FG001|Overall Study|Lost to Follow-up|4|||
146530524|NCT03585270|528451364|FG000|Overall Study|Death|5|||
146530525|NCT03585270|528451365|FG001|Overall Study|Death|3|||
146530526|NCT03585270|528451364|FG000|Overall Study|Other reasons|2|||
146530527|NCT03585270|528451365|FG001|Overall Study|Other reasons|2|||
146530528|NCT02053493|528451366|FG000|Overall Study|Withdrawal by Subject|1|||
146530529|NCT02053493|528451367|FG001|Overall Study|Withdrawal by Subject|1|||
146530530|NCT00338741|528451368|FG000|Overall Study|Lost to Follow-up|2|||
146530531|NCT00338741|528451369|FG001|Overall Study|Lost to Follow-up|0|||
146530532|NCT01791985|528451372|FG000|Overall Study|Adverse Event|7|||
146530533|NCT01791985|528451372|FG000|Overall Study|Withdrawal by Subject|1|||
146530534|NCT03217591|528451383|FG000|Overall Study|Adverse Event|1|||
146530535|NCT03217591|528451384|FG001|Overall Study|Adverse Event|2|||
146530536|NCT03217591|528451385|FG002|Overall Study|Adverse Event|6|||
146530537|NCT03217591|528451383|FG000|Overall Study|Withdrawal by Subject|0|||
146530538|NCT03217591|528451384|FG001|Overall Study|Withdrawal by Subject|1|||
146530539|NCT03217591|528451385|FG002|Overall Study|Withdrawal by Subject|3|||
146530540|NCT03217591|528451383|FG000|Overall Study|Lost to Follow-up|1|||
146530541|NCT03217591|528451384|FG001|Overall Study|Lost to Follow-up|0|||
146530542|NCT03217591|528451385|FG002|Overall Study|Lost to Follow-up|0|||
146530543|NCT03217591|528451383|FG000|Overall Study|Protocol Violation|1|||
146530544|NCT03217591|528451384|FG001|Overall Study|Protocol Violation|0|||
146530545|NCT03217591|528451385|FG002|Overall Study|Protocol Violation|1|||
146530546|NCT04467515|528451388|FG000|Overall Study|Lost to Follow-up|1|||
146530547|NCT04467515|528451389|FG001|Overall Study|Lost to Follow-up|0|||
146530548|NCT04467515|528451390|FG002|Overall Study|Lost to Follow-up|0|||
146530549|NCT04467515|528451388|FG000|Overall Study|Withdrawal by Subject|1|||
146530550|NCT04467515|528451389|FG001|Overall Study|Withdrawal by Subject|0|||
146530551|NCT04467515|528451390|FG002|Overall Study|Withdrawal by Subject|1|||
146530552|NCT04467515|528451388|FG000|Overall Study|Progressive Disease|0|||
146530553|NCT04467515|528451389|FG001|Overall Study|Progressive Disease|1|||
146530554|NCT04467515|528451390|FG002|Overall Study|Progressive Disease|3|||
146530555|NCT04467515|528451388|FG000|Overall Study|Death|0|||
146530556|NCT04467515|528451389|FG001|Overall Study|Death|1|||
146530557|NCT04467515|528451390|FG002|Overall Study|Death|0|||
146530558|NCT03014206|528451393|FG000|Overall Study|Registration Violation|12|||
146530559|NCT01091246|528451394|FG000|Overall Study|Lost to Follow-up|23|||
146530560|NCT01091246|528451395|FG001|Overall Study|Lost to Follow-up|11|||
146530561|NCT01091246|528451396|FG002|Overall Study|Lost to Follow-up|7|||
146762539|NCT00124982|529297039|FG002|Short-term Period|Lack of Efficacy|0|||
146762540|NCT00124982|529297037|FG000|Short-term Period|Lost to Follow-up|8|||
146762541|NCT00124982|529297038|FG001|Short-term Period|Lost to Follow-up|5|||
146762542|NCT00124982|529297039|FG002|Short-term Period|Lost to Follow-up|0|||
146762543|NCT00124982|529297037|FG000|Short-term Period|Withdrawal of Consent|7|||
146762544|NCT00124982|529297038|FG001|Short-term Period|Withdrawal of Consent|9|||
146762545|NCT00124982|529297039|FG002|Short-term Period|Withdrawal of Consent|0|||
146762546|NCT00124982|529297037|FG000|Short-term Period|Poor/Non-compliance|3|||
146762547|NCT00124982|529297038|FG001|Short-term Period|Poor/Non-compliance|1|||
146762548|NCT00124982|529297039|FG002|Short-term Period|Poor/Non-compliance|0|||
146762549|NCT00124982|529297037|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
146762550|NCT00124982|529297038|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
146762551|NCT00124982|529297039|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
146762552|NCT00124982|529297037|FG000|Short-term Period|Participant Decision|1|||
146762553|NCT00124982|529297038|FG001|Short-term Period|Participant Decision|0|||
146762554|NCT00124982|529297039|FG002|Short-term Period|Participant Decision|0|||
146762555|NCT00124982|529297037|FG000|Short-term Period|Participant Chose Own Doctor|0|||
146762556|NCT00124982|529297038|FG001|Short-term Period|Participant Chose Own Doctor|1|||
146762557|NCT00124982|529297039|FG002|Short-term Period|Participant Chose Own Doctor|0|||
146762558|NCT00124982|529297037|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
146762559|NCT00124982|529297038|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
146762560|NCT00124982|529297039|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
146762561|NCT00124982|529297037|FG000|Short-term Period|Participant Had Lymphopenia|1|||
146762562|NCT00124982|529297038|FG001|Short-term Period|Participant Had Lymphopenia|0|||
146762563|NCT00124982|529297039|FG002|Short-term Period|Participant Had Lymphopenia|0|||
146762564|NCT00124982|529297037|FG000|Long-term Period|Death|0|||
146762565|NCT00124982|529297038|FG001|Long-term Period|Death|0|||
146762566|NCT00124982|529297039|FG002|Long-term Period|Death|1|||
146762567|NCT00124982|529297037|FG000|Long-term Period|Adverse Event|0|||
146762568|NCT00124982|529297038|FG001|Long-term Period|Adverse Event|0|||
146762569|NCT00124982|529297039|FG002|Long-term Period|Adverse Event|17|||
146530562|NCT01091246|528451394|FG000|Overall Study|Adverse Event|1|||
146530563|NCT01091246|528451395|FG001|Overall Study|Adverse Event|0|||
146864207|NCT01372410|529675201|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146864208|NCT01372410|529675202|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146864209|NCT01372410|529675203|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146864210|NCT01372410|529675204|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
146864211|NCT01372410|529675205|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146864212|NCT01372410|529675206|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146864213|NCT01372410|529675207|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146864214|NCT01372410|529675200|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
146864215|NCT01372410|529675201|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
146864216|NCT01372410|529675202|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
146864217|NCT01372410|529675203|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
146864218|NCT01372410|529675204|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
146864219|NCT01372410|529675205|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
146864220|NCT01372410|529675206|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
146864221|NCT01372410|529675207|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
146864222|NCT01372410|529675200|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
146864223|NCT01372410|529675201|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
146864224|NCT01372410|529675202|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
146864225|NCT01372410|529675203|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
146864226|NCT01372410|529675204|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
146864227|NCT01372410|529675205|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
146864228|NCT01372410|529675206|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
146864229|NCT01372410|529675207|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
146864230|NCT01372410|529675200|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
146864231|NCT01372410|529675201|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
146864232|NCT01372410|529675202|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
146864233|NCT01372410|529675203|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
146864234|NCT01372410|529675204|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
146864235|NCT01372410|529675205|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
146864236|NCT01372410|529675206|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
146864237|NCT01372410|529675207|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
146864238|NCT01372410|529675200|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
146864239|NCT01372410|529675201|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
146864240|NCT01372410|529675202|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
146864241|NCT01372410|529675203|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
146864242|NCT01372410|529675204|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
146864243|NCT01372410|529675205|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
146864244|NCT01372410|529675206|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
146864245|NCT01372410|529675207|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
146864246|NCT01372410|529675200|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
146864247|NCT01372410|529675201|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
146864248|NCT01372410|529675202|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
146864249|NCT01372410|529675203|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
146864250|NCT01372410|529675204|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
146864251|NCT01372410|529675205|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
146864252|NCT01372410|529675206|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
146864253|NCT01372410|529675207|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
146864254|NCT01372410|529675200|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
146864255|NCT01372410|529675201|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
146864256|NCT01372410|529675202|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
146864257|NCT01372410|529675203|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
146864258|NCT01372410|529675204|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
146864259|NCT01372410|529675205|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
146864260|NCT01372410|529675206|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
146864261|NCT01372410|529675207|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
146864262|NCT01372410|529675200|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
146530564|NCT01091246|528451396|FG002|Overall Study|Adverse Event|1|||
146864263|NCT01372410|529675201|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
146864264|NCT01372410|529675202|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
146530565|NCT01091246|528451394|FG000|Overall Study|Withdrawal by Subject|9|||
146530566|NCT01091246|528451395|FG001|Overall Study|Withdrawal by Subject|5|||
146530567|NCT01091246|528451396|FG002|Overall Study|Withdrawal by Subject|4|||
146530568|NCT01091246|528451394|FG000|Overall Study|Subject not dosed|2|||
146530569|NCT01091246|528451395|FG001|Overall Study|Subject not dosed|0|||
146530570|NCT01091246|528451396|FG002|Overall Study|Subject not dosed|1|||
146864265|NCT01372410|529675203|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
146864266|NCT01372410|529675204|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
146864267|NCT01372410|529675205|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
146965104|NCT03110107|530033442|FG016|Treatment Period|Adverse Event|0|||
146530571|NCT04577794|528451397|FG000|Overall Study|Adverse Event|1|||
146530572|NCT04577794|528451398|FG001|Overall Study|Adverse Event|1|||
146530573|NCT01676012|528451400|FG000|Overall Study|Adverse Event|2|||
146530574|NCT01676012|528451400|FG000|Overall Study|incomplete set of videos|1|||
146530575|NCT02849080|528451404|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
146530576|NCT02849080|528451405|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
146530577|NCT02849080|528451406|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
146530578|NCT02849080|528451407|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
146530579|NCT02849080|528451404|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
146530580|NCT02849080|528451405|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
146864268|NCT01372410|529675206|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
146864269|NCT01372410|529675207|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
146864270|NCT02644941|529675208|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
146864271|NCT02644941|529675209|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
146864272|NCT01145495|529675210|FG000|Overall Study|Adverse Event|6|||
146864273|NCT01145495|529675210|FG000|Overall Study|Withdrawal by Subject|6|||
146864274|NCT01145495|529675210|FG000|Overall Study|Disease progression after respone|2|||
146864275|NCT01717768|529675223|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146864276|NCT01717768|529675224|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
146864277|NCT01717768|529675225|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146864278|NCT01717768|529675226|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146864279|NCT01717768|529675227|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146864280|NCT01717768|529675228|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146864281|NCT01717768|529675229|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146864282|NCT01717768|529675230|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146864283|NCT01717768|529675231|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146864284|NCT01717768|529675232|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146864285|NCT01717768|529675233|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146864286|NCT01717768|529675234|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146864287|NCT01717768|529675223|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146864288|NCT01717768|529675224|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146864289|NCT01717768|529675225|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146864290|NCT01717768|529675226|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146864291|NCT01717768|529675227|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146864292|NCT01717768|529675228|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146864293|NCT01717768|529675229|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146864294|NCT01717768|529675230|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146864295|NCT01717768|529675231|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146864296|NCT01717768|529675232|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146864297|NCT01717768|529675233|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146864298|NCT01717768|529675234|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
146864299|NCT01717768|529675223|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146864300|NCT01717768|529675224|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146864301|NCT01717768|529675225|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146864302|NCT01717768|529675226|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146864303|NCT01717768|529675227|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146864304|NCT01717768|529675228|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146864305|NCT01717768|529675229|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146864306|NCT01717768|529675230|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
146864307|NCT01717768|529675231|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146864308|NCT01717768|529675232|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146864309|NCT01717768|529675233|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146864310|NCT01717768|529675234|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146864311|NCT01717768|529675223|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146864312|NCT01717768|529675224|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146864313|NCT01717768|529675225|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146864314|NCT01717768|529675226|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146864315|NCT01717768|529675227|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146864316|NCT01717768|529675228|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146530581|NCT02849080|528451406|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
146530582|NCT02849080|528451407|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
146530583|NCT02849080|528451404|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
146530584|NCT02849080|528451405|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
146864317|NCT01717768|529675229|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146864318|NCT01717768|529675230|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146864319|NCT01717768|529675231|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146530585|NCT02849080|528451406|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
146530586|NCT02849080|528451407|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
146530587|NCT02849080|528451404|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
146530588|NCT02849080|528451405|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
146530589|NCT02849080|528451406|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
146530590|NCT02849080|528451407|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
146530591|NCT02849080|528451404|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
146530592|NCT02849080|528451405|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
146530593|NCT02849080|528451406|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
146530594|NCT02849080|528451407|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
146530595|NCT02849080|528451404|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
146530596|NCT02849080|528451405|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
146762570|NCT00124982|529297037|FG000|Long-term Period|Lack of Efficacy|0|||
146762571|NCT00124982|529297038|FG001|Long-term Period|Lack of Efficacy|0|||
146762572|NCT00124982|529297039|FG002|Long-term Period|Lack of Efficacy|46|||
146762573|NCT00124982|529297037|FG000|Long-term Period|Lost to Follow-up|0|||
146762574|NCT00124982|529297038|FG001|Long-term Period|Lost to Follow-up|0|||
146762575|NCT00124982|529297039|FG002|Long-term Period|Lost to Follow-up|4|||
146762576|NCT00124982|529297037|FG000|Long-term Period|Withdrawal by Subject|0|||
146762577|NCT00124982|529297038|FG001|Long-term Period|Withdrawal by Subject|0|||
146762578|NCT00124982|529297039|FG002|Long-term Period|Withdrawal by Subject|16|||
146762579|NCT00124982|529297037|FG000|Long-term Period|Pregnancy|0|||
146762580|NCT00124982|529297038|FG001|Long-term Period|Pregnancy|0|||
146762581|NCT00124982|529297039|FG002|Long-term Period|Pregnancy|1|||
146762582|NCT00124982|529297037|FG000|Long-term Period|Poor/Non-compliance|0|||
146762583|NCT00124982|529297038|FG001|Long-term Period|Poor/Non-compliance|0|||
146762584|NCT00124982|529297039|FG002|Long-term Period|Poor/Non-compliance|2|||
146762585|NCT00124982|529297037|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
146762586|NCT00124982|529297038|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
146762587|NCT00124982|529297039|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
146762588|NCT00124982|529297037|FG000|Long-term Period|Neurologist Recommendation|0|||
146762589|NCT00124982|529297038|FG001|Long-term Period|Neurologist Recommendation|0|||
146762590|NCT00124982|529297039|FG002|Long-term Period|Neurologist Recommendation|1|||
146762591|NCT01555762|529297040|FG000|Overall Study|No information on Bevacizumab intake|11|||
146762592|NCT01555762|529297040|FG000|Overall Study|Missing start date of infusion|8|||
146762593|NCT01555762|529297040|FG000|Overall Study|75 years old or more ticked No|1|||
146762594|NCT01555762|529297040|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
146762595|NCT01555762|529297040|FG000|Overall Study|Death linked to progression of disease|165|||
146762596|NCT01555762|529297040|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
146762597|NCT01555762|529297040|FG000|Overall Study|Investigator's decision|10|||
146762598|NCT01555762|529297040|FG000|Overall Study|Participant not wishing to continue|5|||
146762599|NCT01555762|529297040|FG000|Overall Study|Missing data|1|||
146762600|NCT01555762|529297040|FG000|Overall Study|Death linked to an adverse event|14|||
146762601|NCT01333514|529297041|FG000|Overall Study|Withdrawal by Subject|1|||
146762602|NCT01333514|529297042|FG001|Overall Study|Withdrawal by Subject|0|||
146762603|NCT00819910|529297043|FG000|Overall Study|Adverse Event|0|||
146762604|NCT00819910|529297044|FG001|Overall Study|Adverse Event|0|||
146762605|NCT00819910|529297045|FG002|Overall Study|Adverse Event|2|||
146762606|NCT00819910|529297046|FG003|Overall Study|Adverse Event|1|||
146762607|NCT00819910|529297043|FG000|Overall Study|Withdrawal by Subject|1|||
146762608|NCT00819910|529297044|FG001|Overall Study|Withdrawal by Subject|1|||
146762609|NCT00819910|529297045|FG002|Overall Study|Withdrawal by Subject|1|||
146762610|NCT00819910|529297046|FG003|Overall Study|Withdrawal by Subject|0|||
146762611|NCT00819910|529297043|FG000|Overall Study|Lost to Follow-up|1|||
146762612|NCT00819910|529297044|FG001|Overall Study|Lost to Follow-up|0|||
146762613|NCT00819910|529297045|FG002|Overall Study|Lost to Follow-up|0|||
146762614|NCT00819910|529297046|FG003|Overall Study|Lost to Follow-up|0|||
146762615|NCT00836810|529297049|FG000|Overall Study|New diagnosis|1|||
146762616|NCT00836810|529297050|FG001|Overall Study|New diagnosis|0|||
146762617|NCT00871429|529297052|FG000|Overall Study|Lost to Follow-up|6|||
146762618|NCT00871429|529297052|FG000|Overall Study|Withdrawal by Subject|17|||
146762619|NCT00871429|529297052|FG000|Overall Study|Questionnaire not completed|1|||
146762620|NCT03102242|529297053|FG000|Overall Study|Adverse Event|2|||
146762621|NCT01137292|529297054|FG000|Overall Study|Death|30|||
146762622|NCT01137292|529297054|FG000|Overall Study|Adverse Event|3|||
146762623|NCT01137292|529297054|FG000|Overall Study|Lack of Efficacy|13|||
146762624|NCT01137292|529297054|FG000|Overall Study|Lost to Follow-up|1|||
146762625|NCT01137292|529297054|FG000|Overall Study|Other|7|||
146762626|NCT01772719|529297055|FG000|Overall Study|Withdrawal by Subject|3|||
146762627|NCT01772719|529297055|FG000|Overall Study|Adverse Event|2|||
146762628|NCT01772719|529297055|FG000|Overall Study|Protocol Violation|1|||
146762629|NCT01772719|529297055|FG000|Overall Study|Lost to Follow-up|1|||
146762630|NCT01311713|529297062|FG000|Overall Study|Death|0|||
146762631|NCT01311713|529297063|FG001|Overall Study|Death|0|||
146762632|NCT01311713|529297064|FG002|Overall Study|Death|1|||
146762633|NCT01311713|529297065|FG003|Overall Study|Death|1|||
146864320|NCT01717768|529675232|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
146864321|NCT01717768|529675233|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146864322|NCT01717768|529675234|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146864323|NCT01699789|529675237|FG000|Overall Study|Withdrawal by Subject|18|||
146864324|NCT01699789|529675238|FG001|Overall Study|Withdrawal by Subject|23|||
146864325|NCT01699789|529675237|FG000|Overall Study|Death|1|||
146864326|NCT01699789|529675238|FG001|Overall Study|Death|2|||
146864327|NCT01699789|529675237|FG000|Overall Study|Lost to Follow-up|83|||
146864328|NCT01699789|529675238|FG001|Overall Study|Lost to Follow-up|101|||
146864329|NCT02554903|529675239|FG000|Overall Study|Death|1|||
146864330|NCT02554903|529675240|FG001|Overall Study|Death|1|||
146864331|NCT02554903|529675239|FG000|Overall Study|Physician Decision|2|||
146864332|NCT02554903|529675240|FG001|Overall Study|Physician Decision|2|||
146864333|NCT02554903|529675239|FG000|Overall Study|Heart Transplant|1|||
146864334|NCT02554903|529675240|FG001|Overall Study|Heart Transplant|2|||
146864335|NCT00639223|529675245|FG000|Overall Study|Lost to Follow-up|0|||
146864336|NCT00639223|529675246|FG001|Overall Study|Lost to Follow-up|2|||
146864337|NCT02540538|529675249|FG000|Overall Study|Pregnancy|0|||
146864338|NCT02540538|529675250|FG001|Overall Study|Pregnancy|1|||
146864339|NCT02540538|529675251|FG002|Overall Study|Pregnancy|0|||
146864340|NCT01557348|529675255|FG000|Overall Study|Adverse Event|6|||
146864341|NCT01557348|529675256|FG001|Overall Study|Adverse Event|16|||
146864342|NCT01557348|529675255|FG000|Overall Study|Infusion reaction event|5|||
146864343|NCT01557348|529675256|FG001|Overall Study|Infusion reaction event|5|||
146864344|NCT01557348|529675255|FG000|Overall Study|Death|7|||
146864345|NCT01557348|529675256|FG001|Overall Study|Death|4|||
146864346|NCT01557348|529675255|FG000|Overall Study|Insufficient Therapeutic Response|13|||
146864347|NCT01557348|529675256|FG001|Overall Study|Insufficient Therapeutic Response|28|||
146864348|NCT01557348|529675255|FG000|Overall Study|Withdrawal by Subject|5|||
146864349|NCT01557348|529675256|FG001|Overall Study|Withdrawal by Subject|4|||
146864350|NCT01557348|529675255|FG000|Overall Study|Lost to Follow-up|26|||
146864351|NCT01557348|529675256|FG001|Overall Study|Lost to Follow-up|22|||
146864352|NCT01557348|529675255|FG000|Overall Study|Administrative|18|||
146530597|NCT02849080|528451406|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
146864353|NCT01557348|529675256|FG001|Overall Study|Administrative|11|||
146864354|NCT00403754|529675257|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
146864355|NCT00403754|529675258|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
146864356|NCT00403754|529675259|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
146864357|NCT00403754|529675260|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
146864358|NCT00403754|529675257|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
146864359|NCT00403754|529675258|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
146864360|NCT00403754|529675259|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
146864361|NCT00403754|529675260|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
146864362|NCT02000427|529675261|FG000|Overall Study|Death|22|||
146864363|NCT03829319|529675262|FG000|Overall Study|Sponsor's Decision|4|||
146864364|NCT03829319|529675263|FG001|Overall Study|Sponsor's Decision|90|||
146864365|NCT03829319|529675264|FG002|Overall Study|Sponsor's Decision|102|||
146864366|NCT03829319|529675262|FG000|Overall Study|Withdrawal by Subject|1|||
146864367|NCT03829319|529675263|FG001|Overall Study|Withdrawal by Subject|5|||
146864368|NCT03829319|529675264|FG002|Overall Study|Withdrawal by Subject|4|||
146864369|NCT03829319|529675262|FG000|Overall Study|Physician Decision|0|||
146864370|NCT03829319|529675263|FG001|Overall Study|Physician Decision|3|||
146864371|NCT03829319|529675264|FG002|Overall Study|Physician Decision|0|||
146864372|NCT03829319|529675262|FG000|Overall Study|Lost to Follow-up|0|||
146864373|NCT03829319|529675263|FG001|Overall Study|Lost to Follow-up|0|||
146864374|NCT03829319|529675264|FG002|Overall Study|Lost to Follow-up|1|||
146530598|NCT02849080|528451407|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
146530599|NCT01819727|528451411|FG000|Overall Study|Adverse Event|8|||
146530600|NCT01819727|528451412|FG001|Overall Study|Adverse Event|9|||
146530601|NCT01819727|528451411|FG000|Overall Study|Death|1|||
146864375|NCT03829319|529675262|FG000|Overall Study|Death|8|||
146864376|NCT03829319|529675263|FG001|Overall Study|Death|277|||
146864377|NCT03829319|529675264|FG002|Overall Study|Death|266|||
146864378|NCT02846532|529675265|FG000|Overall Study|Lost to Follow-up|0|||
146864379|NCT02846532|529675266|FG001|Overall Study|Lost to Follow-up|1|||
146864380|NCT02846532|529675267|FG002|Overall Study|Lost to Follow-up|1|||
146864381|NCT02846532|529675265|FG000|Overall Study|Withdrawal by Subject|1|||
146864382|NCT02846532|529675266|FG001|Overall Study|Withdrawal by Subject|2|||
146864383|NCT02846532|529675267|FG002|Overall Study|Withdrawal by Subject|0|||
146864384|NCT04484259|529675268|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
146864385|NCT04484259|529675269|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
146864386|NCT04484259|529675270|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
146864387|NCT04484259|529675271|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
146864388|NCT04484259|529675272|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
146864389|NCT04484259|529675268|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
146864390|NCT04484259|529675269|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
146965105|NCT03110107|530033443|FG017|Treatment Period|Adverse Event|1|||
146864391|NCT04484259|529675270|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
146864392|NCT04484259|529675271|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
146864393|NCT04484259|529675272|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
146864394|NCT04484259|529675268|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
146864395|NCT04484259|529675269|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
146864396|NCT04484259|529675270|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
146864397|NCT04484259|529675271|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
146864398|NCT04484259|529675272|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
146864399|NCT04484259|529675268|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
146864400|NCT04484259|529675269|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
146864401|NCT04484259|529675270|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
146864402|NCT04484259|529675271|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
146864403|NCT04484259|529675272|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
146864404|NCT04484259|529675268|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
146864405|NCT04484259|529675269|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
146864406|NCT04484259|529675270|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
146864407|NCT04484259|529675271|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
146864408|NCT04484259|529675272|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
146864409|NCT04484259|529675268|FG000|Randomized Treatment|Withdrawal by Subject|1|||
146864410|NCT04484259|529675269|FG001|Randomized Treatment|Withdrawal by Subject|0|||
146864411|NCT04484259|529675270|FG002|Randomized Treatment|Withdrawal by Subject|0|||
146864412|NCT04484259|529675271|FG003|Randomized Treatment|Withdrawal by Subject|0|||
146864413|NCT04484259|529675272|FG004|Randomized Treatment|Withdrawal by Subject|0|||
146864414|NCT03951220|529675273|FG000|Overall Study|Withdrawal by Subject|9|||
146864415|NCT03951220|529675274|FG001|Overall Study|Withdrawal by Subject|2|||
146864416|NCT03951220|529675275|FG002|Overall Study|Withdrawal by Subject|0|||
146864417|NCT04498832|529675276|FG000|Overall Study|Adverse Event|1|||
146864418|NCT04498832|529675277|FG001|Overall Study|Adverse Event|3|||
146864419|NCT04498832|529675276|FG000|Overall Study|Withdrawal by Subject|0|||
146864420|NCT04498832|529675277|FG001|Overall Study|Withdrawal by Subject|1|||
146864421|NCT05359003|529675278|FG000|Overall Study|Withdrawal by Subject|1|||
146864422|NCT05359003|529675279|FG001|Overall Study|Withdrawal by Subject|3|||
146864423|NCT06268288|529675282|FG000|Overall Study|Withdrawal by Subject|1|||
146864424|NCT06268288|529675283|FG001|Overall Study|Withdrawal by Subject|2|||
146864425|NCT02684357|529675284|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
146864426|NCT02684357|529675285|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
146864427|NCT02684357|529675286|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
146864428|NCT02684357|529675287|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
146864429|NCT02684357|529675288|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
146864430|NCT02684357|529675289|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
146864431|NCT02684357|529675284|FG000|Part A|Lost to Follow-up|0|||
146864432|NCT02684357|529675285|FG001|Part A|Lost to Follow-up|2|||
146864433|NCT02684357|529675286|FG002|Part A|Lost to Follow-up|2|||
146864434|NCT02684357|529675287|FG003|Part A|Lost to Follow-up|0|||
146864435|NCT02684357|529675288|FG004|Part A|Lost to Follow-up|0|||
146864436|NCT02684357|529675289|FG005|Part A|Lost to Follow-up|0|||
146864437|NCT02684357|529675284|FG000|Part A|Withdrawal by Subject|3|||
146864438|NCT02684357|529675285|FG001|Part A|Withdrawal by Subject|0|||
146864439|NCT02684357|529675286|FG002|Part A|Withdrawal by Subject|0|||
146864440|NCT02684357|529675287|FG003|Part A|Withdrawal by Subject|0|||
146864441|NCT02684357|529675288|FG004|Part A|Withdrawal by Subject|0|||
146864442|NCT02684357|529675289|FG005|Part A|Withdrawal by Subject|0|||
146864443|NCT02684357|529675284|FG000|Part A|Other|0|||
146864444|NCT02684357|529675285|FG001|Part A|Other|1|||
146864445|NCT02684357|529675286|FG002|Part A|Other|0|||
146864446|NCT02684357|529675287|FG003|Part A|Other|0|||
146864447|NCT02684357|529675288|FG004|Part A|Other|0|||
146864448|NCT02684357|529675289|FG005|Part A|Other|0|||
146864449|NCT02684357|529675284|FG000|Part B|Adverse Event (Other)|0|||
146864450|NCT02684357|529675285|FG001|Part B|Adverse Event (Other)|0|||
146864451|NCT02684357|529675286|FG002|Part B|Adverse Event (Other)|0|||
146864452|NCT02684357|529675287|FG003|Part B|Adverse Event (Other)|1|||
146864453|NCT02684357|529675288|FG004|Part B|Adverse Event (Other)|1|||
146864454|NCT02684357|529675289|FG005|Part B|Adverse Event (Other)|1|||
146864455|NCT02684357|529675284|FG000|Part B|Lost to Follow-up|0|||
146864456|NCT02684357|529675285|FG001|Part B|Lost to Follow-up|0|||
146864457|NCT02684357|529675286|FG002|Part B|Lost to Follow-up|0|||
146864458|NCT02684357|529675287|FG003|Part B|Lost to Follow-up|1|||
146864459|NCT02684357|529675288|FG004|Part B|Lost to Follow-up|1|||
146864460|NCT02684357|529675289|FG005|Part B|Lost to Follow-up|7|||
146864461|NCT02684357|529675284|FG000|Part B|Withdrawal by Subject|0|||
146864462|NCT02684357|529675285|FG001|Part B|Withdrawal by Subject|0|||
146864463|NCT02684357|529675286|FG002|Part B|Withdrawal by Subject|0|||
146864464|NCT02684357|529675287|FG003|Part B|Withdrawal by Subject|0|||
146864465|NCT02684357|529675288|FG004|Part B|Withdrawal by Subject|2|||
146530602|NCT01819727|528451412|FG001|Overall Study|Death|0|||
146530603|NCT01819727|528451411|FG000|Overall Study|Lost to Follow-up|1|||
146530604|NCT01819727|528451412|FG001|Overall Study|Lost to Follow-up|1|||
146530605|NCT01819727|528451411|FG000|Overall Study|Physician Decision|3|||
146530606|NCT01819727|528451412|FG001|Overall Study|Physician Decision|2|||
146530607|NCT01819727|528451411|FG000|Overall Study|Pregnancy|1|||
146530608|NCT01819727|528451412|FG001|Overall Study|Pregnancy|0|||
146530609|NCT01819727|528451411|FG000|Overall Study|Protocol Violation|0|||
146530610|NCT01819727|528451412|FG001|Overall Study|Protocol Violation|2|||
146530611|NCT01819727|528451411|FG000|Overall Study|Study Terminated by Sponsor|0|||
146864466|NCT02684357|529675289|FG005|Part B|Withdrawal by Subject|4|||
146864467|NCT02684357|529675284|FG000|Part B|Other|0|||
146864468|NCT02684357|529675285|FG001|Part B|Other|0|||
146864469|NCT02684357|529675286|FG002|Part B|Other|0|||
146864470|NCT02684357|529675287|FG003|Part B|Other|1|||
146864471|NCT02684357|529675288|FG004|Part B|Other|0|||
146864472|NCT02684357|529675289|FG005|Part B|Other|1|||
146864473|NCT04567615|529675290|FG000|Randomization|Participant withdrew consent|1|||
146864474|NCT04567615|529675291|FG001|Randomization|Participant withdrew consent|0|||
146864475|NCT04567615|529675292|FG002|Randomization|Participant withdrew consent|0|||
146864476|NCT04567615|529675290|FG000|Randomization|Adverse event unrelated to study drug|0|||
146864477|NCT04567615|529675291|FG001|Randomization|Adverse event unrelated to study drug|1|||
146864478|NCT04567615|529675292|FG002|Randomization|Adverse event unrelated to study drug|0|||
146864479|NCT04567615|529675290|FG000|Treatment Period|Participant Withdrew Consent|2|||
146864480|NCT04567615|529675291|FG001|Treatment Period|Participant Withdrew Consent|5|||
146864481|NCT04567615|529675292|FG002|Treatment Period|Participant Withdrew Consent|1|||
146864482|NCT04567615|529675290|FG000|Treatment Period|Death|1|||
146864483|NCT04567615|529675291|FG001|Treatment Period|Death|2|||
146864484|NCT04567615|529675292|FG002|Treatment Period|Death|0|||
146864485|NCT04567615|529675290|FG000|Treatment Period|Lost to Follow-up|0|||
146864486|NCT04567615|529675291|FG001|Treatment Period|Lost to Follow-up|1|||
146864487|NCT04567615|529675292|FG002|Treatment Period|Lost to Follow-up|0|||
146864488|NCT04567615|529675290|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
146864489|NCT04567615|529675291|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
146864490|NCT04567615|529675292|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
146530612|NCT01819727|528451412|FG001|Overall Study|Study Terminated by Sponsor|1|||
146762634|NCT01311713|529297066|FG004|Overall Study|Death|0|||
146762635|NCT01311713|529297067|FG005|Overall Study|Death|1|||
146762636|NCT01311713|529297068|FG006|Overall Study|Death|0|||
146762637|NCT01311713|529297062|FG000|Overall Study|Adverse Event|0|||
146762638|NCT01311713|529297063|FG001|Overall Study|Adverse Event|1|||
146762639|NCT01311713|529297064|FG002|Overall Study|Adverse Event|0|||
146762640|NCT01311713|529297065|FG003|Overall Study|Adverse Event|2|||
146762641|NCT01311713|529297066|FG004|Overall Study|Adverse Event|0|||
146762642|NCT01311713|529297067|FG005|Overall Study|Adverse Event|0|||
146762643|NCT01311713|529297068|FG006|Overall Study|Adverse Event|2|||
146762644|NCT01311713|529297062|FG000|Overall Study|Withdrawal by Subject|0|||
146762645|NCT01311713|529297063|FG001|Overall Study|Withdrawal by Subject|1|||
146762646|NCT01311713|529297064|FG002|Overall Study|Withdrawal by Subject|1|||
146762647|NCT01311713|529297065|FG003|Overall Study|Withdrawal by Subject|0|||
146762648|NCT01311713|529297066|FG004|Overall Study|Withdrawal by Subject|0|||
146762649|NCT01311713|529297067|FG005|Overall Study|Withdrawal by Subject|1|||
146762650|NCT01311713|529297068|FG006|Overall Study|Withdrawal by Subject|2|||
146762651|NCT01311713|529297062|FG000|Overall Study|Disease progression|3|||
146762652|NCT01311713|529297063|FG001|Overall Study|Disease progression|4|||
146762653|NCT01311713|529297064|FG002|Overall Study|Disease progression|3|||
146762654|NCT01311713|529297065|FG003|Overall Study|Disease progression|2|||
146762655|NCT01311713|529297066|FG004|Overall Study|Disease progression|4|||
146762656|NCT01311713|529297067|FG005|Overall Study|Disease progression|4|||
146762657|NCT01311713|529297068|FG006|Overall Study|Disease progression|5|||
146762658|NCT01311713|529297062|FG000|Overall Study|Lost to Follow-up|0|||
146762659|NCT01311713|529297063|FG001|Overall Study|Lost to Follow-up|0|||
146762660|NCT01311713|529297064|FG002|Overall Study|Lost to Follow-up|1|||
146762661|NCT01311713|529297065|FG003|Overall Study|Lost to Follow-up|0|||
146762662|NCT01311713|529297066|FG004|Overall Study|Lost to Follow-up|0|||
146762663|NCT01311713|529297067|FG005|Overall Study|Lost to Follow-up|0|||
146762664|NCT01311713|529297068|FG006|Overall Study|Lost to Follow-up|0|||
146762665|NCT01311713|529297062|FG000|Overall Study|Stopped taking study medication|0|||
146762666|NCT01311713|529297063|FG001|Overall Study|Stopped taking study medication|0|||
146762667|NCT01311713|529297064|FG002|Overall Study|Stopped taking study medication|0|||
146762668|NCT01311713|529297065|FG003|Overall Study|Stopped taking study medication|1|||
146762669|NCT01311713|529297066|FG004|Overall Study|Stopped taking study medication|1|||
146762670|NCT01311713|529297067|FG005|Overall Study|Stopped taking study medication|0|||
146762671|NCT01311713|529297068|FG006|Overall Study|Stopped taking study medication|0|||
146762672|NCT01311713|529297062|FG000|Overall Study|Enrolled but not treated|0|||
146762673|NCT01311713|529297063|FG001|Overall Study|Enrolled but not treated|0|||
146864491|NCT04567615|529675290|FG000|Treatment Period|Disease Progression|85|||
146864492|NCT04567615|529675291|FG001|Treatment Period|Disease Progression|63|||
146864493|NCT04567615|529675292|FG002|Treatment Period|Disease Progression|16|||
146530613|NCT01819727|528451411|FG000|Overall Study|Withdrawal by Subject|6|||
146530614|NCT01819727|528451412|FG001|Overall Study|Withdrawal by Subject|11|||
146530615|NCT01819727|528451411|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
146530616|NCT01819727|528451412|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
146864494|NCT04567615|529675290|FG000|Treatment Period|Study Drug Toxicity|3|||
146864495|NCT04567615|529675291|FG001|Treatment Period|Study Drug Toxicity|10|||
146864496|NCT04567615|529675292|FG002|Treatment Period|Study Drug Toxicity|4|||
146864497|NCT04567615|529675290|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
146530617|NCT01819727|528451411|FG000|Overall Study|Quit due to lack of health benifits|0|||
146530618|NCT01819727|528451412|FG001|Overall Study|Quit due to lack of health benifits|1|||
146530619|NCT04460326|528451417|FG000|Completed at Least 4 Meals|Early discharge|5|||
146530620|NCT04460326|528451418|FG001|Completed at Least 4 Meals|Early discharge|5|||
146530621|NCT04460326|528451417|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
146530622|NCT04460326|528451418|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
146530623|NCT04460326|528451417|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
146530624|NCT04460326|528451418|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
146530625|NCT04460326|528451417|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
146530626|NCT04460326|528451418|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
146530627|NCT04460326|528451417|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
146530628|NCT04460326|528451418|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
146530629|NCT04460326|528451417|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
146530630|NCT04460326|528451418|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
146530631|NCT03160716|528451419|FG000|Overall Study|Lost to Follow-up|1|||
146530632|NCT01628848|528451420|FG000|Overall Study|Adverse Event|9|||
146530633|NCT01628848|528451421|FG001|Overall Study|Adverse Event|7|||
146530634|NCT01628848|528451420|FG000|Overall Study|Lack of Efficacy|0|||
146530635|NCT01628848|528451421|FG001|Overall Study|Lack of Efficacy|4|||
146530636|NCT01628848|528451420|FG000|Overall Study|Withdrawal by Subject|0|||
146530637|NCT01628848|528451421|FG001|Overall Study|Withdrawal by Subject|2|||
146530638|NCT01628848|528451420|FG000|Overall Study|Physician Decision|3|||
146530639|NCT01628848|528451421|FG001|Overall Study|Physician Decision|1|||
146530640|NCT04794751|528451425|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
146530641|NCT04794751|528451426|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
146530642|NCT04794751|528451425|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
146530643|NCT04794751|528451426|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
146530644|NCT04794751|528451425|FG000|Period 1|Protocol Violation|0|||
146530645|NCT04794751|528451426|FG001|Period 1|Protocol Violation|2|||
146530646|NCT04794751|528451425|FG000|Period 1|Withdrawal by Subject|0|||
146530647|NCT04794751|528451426|FG001|Period 1|Withdrawal by Subject|1|||
146530648|NCT04794751|528451425|FG000|Period 2|Withdrawal by Subject|0|||
146530649|NCT04794751|528451426|FG001|Period 2|Withdrawal by Subject|1|||
146530650|NCT04794751|528451425|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
146530651|NCT04794751|528451426|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
146530652|NCT04794751|528451425|FG000|Period 2|Protocol Violation|1|||
146530653|NCT04794751|528451426|FG001|Period 2|Protocol Violation|0|||
146530654|NCT03644017|528451429|FG000|Overall Study|Access Abandonment|5|||
146530655|NCT03644017|528451429|FG000|Overall Study|Kidney Transplant|2|||
146530656|NCT02700048|528451430|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
146530657|NCT02700048|528451431|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
146530658|NCT02175225|528451432|FG000|Overall Study|Withdrawal by Subject|1|||
146530659|NCT02175225|528451433|FG001|Overall Study|Withdrawal by Subject|2|||
146530660|NCT02175225|528451432|FG000|Overall Study|Lost to Follow-up|6|||
146530661|NCT02175225|528451433|FG001|Overall Study|Lost to Follow-up|7|||
146530662|NCT02175225|528451432|FG000|Overall Study|Study drug not administered|1|||
146530663|NCT02175225|528451433|FG001|Overall Study|Study drug not administered|2|||
146530664|NCT02340000|528451434|FG000|Time Period 1|Withdrawal by Subject|6|||
146530665|NCT02340000|528451435|FG001|Time Period 1|Withdrawal by Subject|8|||
146864498|NCT04567615|529675291|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
146864499|NCT04567615|529675292|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
146530666|NCT02340000|528451434|FG000|Time Period 1|Lost to Follow-up|6|||
146530667|NCT02340000|528451435|FG001|Time Period 1|Lost to Follow-up|7|||
146530668|NCT02340000|528451434|FG000|Time Period 2|Withdrawal by Subject|9|||
146530669|NCT02340000|528451435|FG001|Time Period 2|Withdrawal by Subject|7|||
146864500|NCT04567615|529675290|FG000|Treatment Period|Other Reasons|1|||
146864501|NCT04567615|529675291|FG001|Treatment Period|Other Reasons|2|||
146864502|NCT04567615|529675292|FG002|Treatment Period|Other Reasons|0|||
146530670|NCT02340000|528451434|FG000|Time Period 2|Lost to Follow-up|10|||
146864503|NCT04567615|529675290|FG000|Treatment Period|Still On-going Treatment|21|||
146864504|NCT04567615|529675291|FG001|Treatment Period|Still On-going Treatment|22|||
146530671|NCT02340000|528451435|FG001|Time Period 2|Lost to Follow-up|8|||
146530672|NCT00969228|528451436|FG000|Overall Study|Adverse Event|1|||
146530673|NCT00969228|528451437|FG001|Overall Study|Adverse Event|0|||
146530674|NCT00969228|528451436|FG000|Overall Study|Withdrawal by Subject|4|||
146530675|NCT00969228|528451437|FG001|Overall Study|Withdrawal by Subject|0|||
146530676|NCT00969228|528451436|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
146530677|NCT00969228|528451437|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
146530678|NCT03311945|528451438|FG000|Overall Study|Adverse Event|2|||
146530679|NCT03311945|528451438|FG000|Overall Study|Lack of Efficacy|1|||
146530680|NCT04877990|528451439|FG000|Treatment|Other reasons|3|||
146530681|NCT04877990|528451440|FG001|Treatment|Other reasons|1|||
146530682|NCT04877990|528451439|FG000|Treatment|Administrative reasons by sponsor|17|||
146530683|NCT04877990|528451440|FG001|Treatment|Administrative reasons by sponsor|33|||
146530684|NCT04877990|528451439|FG000|Treatment|Withdrawal by Subject|2|||
146530685|NCT04877990|528451440|FG001|Treatment|Withdrawal by Subject|6|||
146530686|NCT04877990|528451439|FG000|Treatment|Adverse Event|2|||
146530687|NCT04877990|528451440|FG001|Treatment|Adverse Event|1|||
146530688|NCT01619878|528451441|FG000|6 Week Follow-up Phase|Adverse Event|1|||
146530689|NCT01619878|528451441|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
146530690|NCT01619878|528451441|FG000|Follow-up at 12 Months of Age|Death|2|||
146530691|NCT01305564|528451444|FG000|Overall Study|Death|21|||
146530692|NCT01305564|528451444|FG000|Overall Study|Lost to Follow-up|12|||
146530693|NCT01305564|528451444|FG000|Overall Study|Withdrawal by Subject|1|||
146530694|NCT01305564|528451444|FG000|Overall Study|Physician Decision|3|||
146530695|NCT00919633|528451457|FG000|Overall Study|Adverse Event|1|||
146530696|NCT00919633|528451458|FG001|Overall Study|Adverse Event|9|||
146530697|NCT00919633|528451459|FG002|Overall Study|Adverse Event|12|||
146530698|NCT00919633|528451460|FG003|Overall Study|Adverse Event|10|||
146530699|NCT00919633|528451457|FG000|Overall Study|Death|0|||
146530700|NCT00919633|528451458|FG001|Overall Study|Death|0|||
146530701|NCT00919633|528451459|FG002|Overall Study|Death|2|||
146530702|NCT00919633|528451460|FG003|Overall Study|Death|0|||
146530703|NCT00919633|528451457|FG000|Overall Study|Lack of Efficacy|17|||
146530704|NCT00919633|528451458|FG001|Overall Study|Lack of Efficacy|3|||
146530705|NCT00919633|528451459|FG002|Overall Study|Lack of Efficacy|2|||
146530706|NCT00919633|528451460|FG003|Overall Study|Lack of Efficacy|3|||
146530707|NCT00919633|528451457|FG000|Overall Study|Withdrawal by Subject|1|||
146530708|NCT00919633|528451458|FG001|Overall Study|Withdrawal by Subject|2|||
146530709|NCT00919633|528451459|FG002|Overall Study|Withdrawal by Subject|4|||
146530710|NCT00919633|528451460|FG003|Overall Study|Withdrawal by Subject|3|||
146530711|NCT00919633|528451457|FG000|Overall Study|Lost to Follow-up|3|||
146530712|NCT00919633|528451458|FG001|Overall Study|Lost to Follow-up|1|||
146530713|NCT00919633|528451459|FG002|Overall Study|Lost to Follow-up|0|||
146530714|NCT00919633|528451460|FG003|Overall Study|Lost to Follow-up|2|||
146530715|NCT00919633|528451457|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
146530716|NCT00919633|528451458|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
146530717|NCT00919633|528451459|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
146530718|NCT00919633|528451460|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
146530719|NCT00919633|528451457|FG000|Overall Study|Protocol Violation|0|||
146530720|NCT00919633|528451458|FG001|Overall Study|Protocol Violation|0|||
146530721|NCT00919633|528451459|FG002|Overall Study|Protocol Violation|0|||
146530722|NCT00919633|528451460|FG003|Overall Study|Protocol Violation|1|||
146530723|NCT00919633|528451457|FG000|Overall Study|Physician Decision|0|||
146530724|NCT00919633|528451458|FG001|Overall Study|Physician Decision|0|||
146530725|NCT00919633|528451459|FG002|Overall Study|Physician Decision|0|||
146530726|NCT00919633|528451460|FG003|Overall Study|Physician Decision|1|||
146530727|NCT00919633|528451457|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
146530728|NCT00919633|528451458|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
146530729|NCT00919633|528451459|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
146530730|NCT00919633|528451460|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
146530731|NCT00919633|528451457|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
146530732|NCT00919633|528451458|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
146530733|NCT00919633|528451459|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
146530734|NCT00919633|528451460|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
146530735|NCT00960804|528451461|FG000|Overall Study|Adverse Event|1|||
146530736|NCT00960804|528451462|FG001|Overall Study|Adverse Event|0|||
146530737|NCT00960804|528451463|FG002|Overall Study|Adverse Event|0|||
146530738|NCT00960804|528451461|FG000|Overall Study|Withdrawal by Subject|1|||
146530739|NCT00960804|528451462|FG001|Overall Study|Withdrawal by Subject|0|||
146530740|NCT00960804|528451463|FG002|Overall Study|Withdrawal by Subject|0|||
146530741|NCT00960804|528451461|FG000|Overall Study|Study terminated by the sponsor|5|||
146530742|NCT00960804|528451462|FG001|Overall Study|Study terminated by the sponsor|4|||
146530743|NCT00960804|528451463|FG002|Overall Study|Study terminated by the sponsor|10|||
146530744|NCT05630196|528452860|FG000|Overall Study|Adverse Event|2|||
146965106|NCT03110107|530033444|FG018|Treatment Period|Adverse Event|2|||
146530745|NCT05630196|528452861|FG001|Overall Study|Adverse Event|1|||
146530746|NCT05630196|528452860|FG000|Overall Study|Lost to Follow-up|1|||
146864505|NCT04567615|529675292|FG002|Treatment Period|Still On-going Treatment|2|||
146864506|NCT05028517|529675293|FG000|Overall Study|Lost to Follow-up|13|||
146864507|NCT05028517|529675294|FG001|Overall Study|Lost to Follow-up|20|||
146864508|NCT05028517|529675295|FG002|Overall Study|Lost to Follow-up|12|||
146864509|NCT05028517|529675293|FG000|Overall Study|Withdrawal by Subject|0|||
146864510|NCT05028517|529675294|FG001|Overall Study|Withdrawal by Subject|0|||
146864511|NCT05028517|529675295|FG002|Overall Study|Withdrawal by Subject|1|||
146864512|NCT01306890|529676751|FG000|Overall Study|Adverse Event|2|||
146864513|NCT01306890|529676751|FG000|Overall Study|Death|1223|||
146864514|NCT01306890|529676751|FG000|Overall Study|Lost to Follow-up|58|||
146864515|NCT01306890|529676751|FG000|Overall Study|Withdrawal by Subject|88|||
146864516|NCT01306890|529676751|FG000|Overall Study|Unspecified reasons|104|||
146864517|NCT01306890|529676751|FG000|Overall Study|Study Termination|3|||
146864518|NCT01306890|529676751|FG000|Overall Study|No discontinuation documentation|41|||
146864519|NCT02217436|529676752|FG000|Overall Study|Protocol Violation|1|||
146864520|NCT02217436|529676753|FG001|Overall Study|Protocol Violation|1|||
146530747|NCT05630196|528452861|FG001|Overall Study|Lost to Follow-up|1|||
146530748|NCT05630196|528452860|FG000|Overall Study|Protocol Violation|2|||
146530749|NCT05630196|528452861|FG001|Overall Study|Protocol Violation|3|||
146530750|NCT05630196|528452860|FG000|Overall Study|Physician Decision|1|||
146530751|NCT05630196|528452861|FG001|Overall Study|Physician Decision|0|||
146530752|NCT05630196|528452860|FG000|Overall Study|Withdrawal by Subject|3|||
146530753|NCT05630196|528452861|FG001|Overall Study|Withdrawal by Subject|4|||
146530754|NCT01655901|528452865|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
146530755|NCT01655901|528452866|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
146530756|NCT01655901|528452867|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
146530757|NCT01655901|528452868|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
146530758|NCT01655901|528452869|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
146530759|NCT01655901|528452870|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
146530760|NCT00352118|528452871|FG000|Overall Study|Physician Decision|4|||
146530761|NCT00870727|528452872|FG000|Overall Study|Lost to Follow-up|0|||
146530762|NCT00870727|528452873|FG001|Overall Study|Lost to Follow-up|1|||
146530763|NCT00870727|528452872|FG000|Overall Study|Lack of Efficacy|1|||
146530764|NCT00870727|528452873|FG001|Overall Study|Lack of Efficacy|3|||
146530765|NCT00870727|528452872|FG000|Overall Study|Adverse Event|0|||
146530766|NCT00870727|528452873|FG001|Overall Study|Adverse Event|1|||
146530767|NCT01712516|528452874|FG000|Overall Study|Technical problems|0|||
146530768|NCT01712516|528452875|FG001|Overall Study|Technical problems|0|||
146530769|NCT01712516|528452876|FG002|Overall Study|Technical problems|0|||
146530770|NCT01712516|528452877|FG003|Overall Study|Technical problems|2|||
146530771|NCT01712516|528452874|FG000|Overall Study|Lost to Follow-up|0|||
146530772|NCT01712516|528452875|FG001|Overall Study|Lost to Follow-up|0|||
146530773|NCT01712516|528452876|FG002|Overall Study|Lost to Follow-up|2|||
146530774|NCT01712516|528452877|FG003|Overall Study|Lost to Follow-up|1|||
146530775|NCT01712516|528452874|FG000|Overall Study|Death|0|||
146530776|NCT01712516|528452875|FG001|Overall Study|Death|1|||
146530777|NCT01712516|528452876|FG002|Overall Study|Death|0|||
146530778|NCT01712516|528452877|FG003|Overall Study|Death|0|||
146530779|NCT01712516|528452874|FG000|Overall Study|Protocol deviation|1|||
146530780|NCT01712516|528452875|FG001|Overall Study|Protocol deviation|0|||
146530781|NCT01712516|528452876|FG002|Overall Study|Protocol deviation|1|||
146530782|NCT01712516|528452877|FG003|Overall Study|Protocol deviation|0|||
146530783|NCT01712516|528452874|FG000|Overall Study|Physician Decision|2|||
146530784|NCT01712516|528452875|FG001|Overall Study|Physician Decision|0|||
146530785|NCT01712516|528452876|FG002|Overall Study|Physician Decision|0|||
146530786|NCT01712516|528452877|FG003|Overall Study|Physician Decision|1|||
146530787|NCT01712516|528452874|FG000|Overall Study|Withdrawal by Subject|3|||
146530788|NCT01712516|528452875|FG001|Overall Study|Withdrawal by Subject|9|||
146530789|NCT01712516|528452876|FG002|Overall Study|Withdrawal by Subject|3|||
146530790|NCT01712516|528452877|FG003|Overall Study|Withdrawal by Subject|9|||
146530791|NCT01251952|528452878|FG000|Overall Study|Adverse Event|1|||
146530792|NCT00496769|528452879|FG000|Double Blind|>=1 reason assigned per patient|558|||
146530793|NCT00496769|528452880|FG001|Double Blind|>=1 reason assigned per patient|649|||
146530794|NCT00496769|528452881|FG002|Double Blind|>=1 reason assigned per patient|0|||
146530795|NCT00496769|528452879|FG000|Open Label|>=1 reason assigned per patient|0|||
146530796|NCT00496769|528452880|FG001|Open Label|>=1 reason assigned per patient|0|||
146864521|NCT02217436|529676752|FG000|Overall Study|Incomplete data|0|||
146864522|NCT02217436|529676753|FG001|Overall Study|Incomplete data|1|||
146864523|NCT03739762|529676754|FG000|Overall Study|Lost to Follow-up|1|||
146864524|NCT03739762|529676755|FG001|Overall Study|Lost to Follow-up|1|||
146864525|NCT03739762|529676754|FG000|Overall Study|Withdrawal by Subject|2|||
146530797|NCT00496769|528452881|FG002|Open Label|>=1 reason assigned per patient|1011|||
146530798|NCT02810418|528452885|FG000|Arm A Dose Escalation|Adverse Event|2|||
146864526|NCT03739762|529676755|FG001|Overall Study|Withdrawal by Subject|6|||
146530799|NCT02810418|528452886|FG001|Arm A Dose Escalation|Adverse Event|1|||
146530800|NCT02810418|528452887|FG002|Arm A Dose Escalation|Adverse Event|0|||
146530801|NCT02810418|528452888|FG003|Arm A Dose Escalation|Adverse Event|0|||
146864527|NCT00607880|529676756|FG000|Overall Study|Unable to place port due to occlusion|1|||
146530802|NCT02810418|528452889|FG004|Arm A Dose Escalation|Adverse Event|0|||
146530803|NCT02810418|528452890|FG005|Arm A Dose Escalation|Adverse Event|0|||
146530804|NCT02810418|528452891|FG006|Arm A Dose Escalation|Adverse Event|0|||
146530805|NCT02810418|528452885|FG000|Dose Expansion|Adverse Event|0|||
146530806|NCT02810418|528452886|FG001|Dose Expansion|Adverse Event|1|||
146530807|NCT02810418|528452887|FG002|Dose Expansion|Adverse Event|1|||
146530808|NCT02810418|528452888|FG003|Dose Expansion|Adverse Event|0|||
146530809|NCT02810418|528452889|FG004|Dose Expansion|Adverse Event|0|||
146530810|NCT02810418|528452890|FG005|Dose Expansion|Adverse Event|0|||
146530811|NCT02810418|528452891|FG006|Dose Expansion|Adverse Event|0|||
146530812|NCT02810418|528452885|FG000|Dose Expansion|Physician Decision|0|||
146530813|NCT02810418|528452886|FG001|Dose Expansion|Physician Decision|0|||
146530814|NCT02810418|528452887|FG002|Dose Expansion|Physician Decision|2|||
146530815|NCT02810418|528452888|FG003|Dose Expansion|Physician Decision|0|||
146530816|NCT02810418|528452889|FG004|Dose Expansion|Physician Decision|0|||
146530817|NCT02810418|528452890|FG005|Dose Expansion|Physician Decision|0|||
146530818|NCT02810418|528452891|FG006|Dose Expansion|Physician Decision|0|||
146530819|NCT02810418|528452885|FG000|Arm B Dose Escalation|Adverse Event|0|||
146530820|NCT02810418|528452886|FG001|Arm B Dose Escalation|Adverse Event|0|||
146530821|NCT02810418|528452887|FG002|Arm B Dose Escalation|Adverse Event|0|||
146530822|NCT02810418|528452888|FG003|Arm B Dose Escalation|Adverse Event|0|||
146530823|NCT02810418|528452889|FG004|Arm B Dose Escalation|Adverse Event|1|||
146530824|NCT02810418|528452890|FG005|Arm B Dose Escalation|Adverse Event|2|||
146530825|NCT02810418|528452891|FG006|Arm B Dose Escalation|Adverse Event|0|||
146530826|NCT02224625|528452892|FG000|Irritation|Adverse Event|6|||
146530827|NCT02224625|528452892|FG000|Sensitization|Adverse Event|55|||
146530828|NCT01573000|528452893|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
146530829|NCT01573000|528452894|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
146530830|NCT01573000|528452893|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
146530831|NCT01573000|528452894|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
146530832|NCT01573000|528452893|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
146530833|NCT01573000|528452894|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
146530834|NCT01573000|528452893|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
146530835|NCT01573000|528452894|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
146530836|NCT01573000|528452893|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
146530837|NCT01573000|528452894|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
146530838|NCT01573000|528452893|FG000|Crossover Phase|Lack of Efficacy|0|||
146530839|NCT01573000|528452894|FG001|Crossover Phase|Lack of Efficacy|13|||
146530840|NCT01573000|528452893|FG000|Crossover Phase|Lost to Follow-up|0|||
146530841|NCT01573000|528452894|FG001|Crossover Phase|Lost to Follow-up|2|||
146530842|NCT01573000|528452893|FG000|Crossover Phase|Death|0|||
146530843|NCT01573000|528452894|FG001|Crossover Phase|Death|3|||
146530844|NCT01573000|528452893|FG000|Long-Term Follow-Up|Death|3|||
146530845|NCT01573000|528452894|FG001|Long-Term Follow-Up|Death|0|||
146530846|NCT01573000|528452893|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
146530847|NCT01573000|528452894|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
146530848|NCT01100853|528452900|FG000|Overall Study|Lost to Follow-up|11|||
146530849|NCT01100853|528452901|FG001|Overall Study|Lost to Follow-up|6|||
146530850|NCT01100853|528452900|FG000|Overall Study|Received <4 study injections|10|||
146530851|NCT01100853|528452901|FG001|Overall Study|Received <4 study injections|13|||
146530852|NCT01100853|528452900|FG000|Overall Study|Withdrawal by Subject|6|||
146530853|NCT01100853|528452901|FG001|Overall Study|Withdrawal by Subject|4|||
146530854|NCT01384877|528452902|FG000|Treatment 2|Lost to Follow-up|2|||
146530855|NCT01384877|528452903|FG001|Treatment 2|Lost to Follow-up|2|||
146530856|NCT04161391|528452904|FG000|Overall Study|Adverse Event|0|||
146530857|NCT04161391|528452905|FG001|Overall Study|Adverse Event|1|||
146530858|NCT04161391|528452906|FG002|Overall Study|Adverse Event|0|||
146530859|NCT04161391|528452907|FG003|Overall Study|Adverse Event|1|||
146530860|NCT04161391|528452908|FG004|Overall Study|Adverse Event|0|||
146530861|NCT04161391|528452909|FG005|Overall Study|Adverse Event|0|||
146530862|NCT04161391|528452910|FG006|Overall Study|Adverse Event|0|||
146530863|NCT04161391|528452911|FG007|Overall Study|Adverse Event|3|||
146530864|NCT04161391|528452912|FG008|Overall Study|Adverse Event|0|||
146762674|NCT01311713|529297064|FG002|Overall Study|Enrolled but not treated|1|||
146762675|NCT01311713|529297065|FG003|Overall Study|Enrolled but not treated|0|||
146762676|NCT01311713|529297066|FG004|Overall Study|Enrolled but not treated|0|||
146762677|NCT01311713|529297067|FG005|Overall Study|Enrolled but not treated|0|||
146762678|NCT01311713|529297068|FG006|Overall Study|Enrolled but not treated|0|||
146762679|NCT01311713|529297062|FG000|Overall Study|Other than specified|0|||
146762680|NCT01311713|529297063|FG001|Overall Study|Other than specified|1|||
146762681|NCT01311713|529297064|FG002|Overall Study|Other than specified|2|||
146762682|NCT01311713|529297065|FG003|Overall Study|Other than specified|0|||
146762683|NCT01311713|529297066|FG004|Overall Study|Other than specified|0|||
146762684|NCT01311713|529297067|FG005|Overall Study|Other than specified|0|||
146762685|NCT01311713|529297068|FG006|Overall Study|Other than specified|0|||
146762686|NCT00477412|529297069|FG000|Overall Study|Death|0|||
146530865|NCT04161391|528452904|FG000|Overall Study|Death|0|||
146864528|NCT00607880|529676757|FG001|Overall Study|Unable to place port due to occlusion|0|||
146864529|NCT00323297|529676758|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
146864530|NCT00323297|529676759|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
146864531|NCT00323297|529676758|FG000|Part A (Double Blind Randomized)|Death|0|||
146864532|NCT00323297|529676759|FG001|Part A (Double Blind Randomized)|Death|1|||
146864533|NCT00323297|529676758|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
146864534|NCT00323297|529676759|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
146864535|NCT00323297|529676758|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
146864536|NCT00323297|529676759|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
146864537|NCT00323297|529676758|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
146864538|NCT00323297|529676759|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
146864539|NCT00323297|529676758|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
146864540|NCT00323297|529676759|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
146864541|NCT00323297|529676758|FG000|Part B (Open-label)|Death|0|||
146864542|NCT00323297|529676759|FG001|Part B (Open-label)|Death|1|||
146864543|NCT00323297|529676758|FG000|Part B (Open-label)|Reason unspecified|0|||
146864544|NCT00323297|529676759|FG001|Part B (Open-label)|Reason unspecified|1|||
146864545|NCT00323297|529676758|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
146864546|NCT00323297|529676759|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
146864547|NCT00323297|529676758|FG000|Part B (Open-label)|Lack of Efficacy|3|||
146864548|NCT00323297|529676759|FG001|Part B (Open-label)|Lack of Efficacy|1|||
146864549|NCT00323297|529676758|FG000|Part B (Open-label)|Adverse Event|5|||
146864550|NCT00323297|529676759|FG001|Part B (Open-label)|Adverse Event|5|||
146530866|NCT04161391|528452905|FG001|Overall Study|Death|0|||
146530867|NCT04161391|528452906|FG002|Overall Study|Death|0|||
146530868|NCT04161391|528452907|FG003|Overall Study|Death|0|||
146530869|NCT04161391|528452908|FG004|Overall Study|Death|0|||
146530870|NCT04161391|528452909|FG005|Overall Study|Death|0|||
146530871|NCT04161391|528452910|FG006|Overall Study|Death|0|||
146530872|NCT04161391|528452911|FG007|Overall Study|Death|1|||
146530873|NCT04161391|528452912|FG008|Overall Study|Death|0|||
146530874|NCT04161391|528452904|FG000|Overall Study|Physician Decision|0|||
146530875|NCT04161391|528452905|FG001|Overall Study|Physician Decision|0|||
146530876|NCT04161391|528452906|FG002|Overall Study|Physician Decision|1|||
146530877|NCT04161391|528452907|FG003|Overall Study|Physician Decision|2|||
146530878|NCT04161391|528452908|FG004|Overall Study|Physician Decision|0|||
146530879|NCT04161391|528452909|FG005|Overall Study|Physician Decision|0|||
146530880|NCT04161391|528452910|FG006|Overall Study|Physician Decision|2|||
146530881|NCT04161391|528452911|FG007|Overall Study|Physician Decision|0|||
146530882|NCT04161391|528452912|FG008|Overall Study|Physician Decision|0|||
146530883|NCT04161391|528452904|FG000|Overall Study|Progressive Disease|4|||
146530884|NCT04161391|528452905|FG001|Overall Study|Progressive Disease|3|||
146530885|NCT04161391|528452906|FG002|Overall Study|Progressive Disease|3|||
146530886|NCT04161391|528452907|FG003|Overall Study|Progressive Disease|5|||
146530887|NCT04161391|528452908|FG004|Overall Study|Progressive Disease|3|||
146530888|NCT04161391|528452909|FG005|Overall Study|Progressive Disease|3|||
146530889|NCT04161391|528452910|FG006|Overall Study|Progressive Disease|5|||
146530890|NCT04161391|528452911|FG007|Overall Study|Progressive Disease|2|||
146530891|NCT04161391|528452912|FG008|Overall Study|Progressive Disease|2|||
146530892|NCT01162343|528452915|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
146530893|NCT01162343|528452915|FG000|Overall Study|Refused psychiatrist assessment|12|||
146530894|NCT01130272|528452916|FG000|Overall Study|Adverse Event|2|||
146530895|NCT01130272|528452917|FG001|Overall Study|Adverse Event|5|||
146530896|NCT01130272|528452918|FG002|Overall Study|Adverse Event|6|||
146530897|NCT01130272|528452919|FG003|Overall Study|Adverse Event|22|||
146530898|NCT01130272|528452920|FG004|Overall Study|Adverse Event|7|||
146530899|NCT01130272|528452916|FG000|Overall Study|IVRS-confirmed constipation|0|||
146530900|NCT01130272|528452917|FG001|Overall Study|IVRS-confirmed constipation|1|||
146530901|NCT01130272|528452918|FG002|Overall Study|IVRS-confirmed constipation|1|||
146530902|NCT01130272|528452919|FG003|Overall Study|IVRS-confirmed constipation|2|||
146864551|NCT00323297|529676758|FG000|Part B (Open-label)|Protocol Violation|0|||
146864552|NCT00323297|529676759|FG001|Part B (Open-label)|Protocol Violation|1|||
146864553|NCT01603082|529676761|FG000|Overall Study|Adverse Event|0|||
146530903|NCT01130272|528452920|FG004|Overall Study|IVRS-confirmed constipation|0|||
146530904|NCT01130272|528452916|FG000|Overall Study|Rescue medications due to diarrhea|3|||
146530905|NCT01130272|528452917|FG001|Overall Study|Rescue medications due to diarrhea|5|||
146530906|NCT01130272|528452918|FG002|Overall Study|Rescue medications due to diarrhea|8|||
146530907|NCT01130272|528452919|FG003|Overall Study|Rescue medications due to diarrhea|8|||
146530908|NCT01130272|528452920|FG004|Overall Study|Rescue medications due to diarrhea|6|||
146530909|NCT01130272|528452916|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
146530910|NCT01130272|528452917|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
146530911|NCT01130272|528452918|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
146530912|NCT01130272|528452919|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
146530913|NCT01130272|528452920|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
146864554|NCT01603082|529676762|FG001|Overall Study|Adverse Event|1|||
146864555|NCT01603082|529676761|FG000|Overall Study|Withdrawal by Subject|1|||
146864556|NCT01603082|529676762|FG001|Overall Study|Withdrawal by Subject|0|||
146864557|NCT01603082|529676761|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
146864558|NCT01603082|529676762|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
146864559|NCT00634010|529676768|FG000|Overall Study|Adverse Event|2|||
146864560|NCT00634010|529676769|FG001|Overall Study|Adverse Event|5|||
146864561|NCT00634010|529676768|FG000|Overall Study|Withdrawal by Subject|5|||
146864562|NCT00634010|529676769|FG001|Overall Study|Withdrawal by Subject|6|||
146864563|NCT00634010|529676768|FG000|Overall Study|Physician Decision|1|||
146864564|NCT00634010|529676769|FG001|Overall Study|Physician Decision|1|||
146864565|NCT00634010|529676768|FG000|Overall Study|Disease Progression|1|||
146864566|NCT00634010|529676769|FG001|Overall Study|Disease Progression|1|||
146864567|NCT00634010|529676768|FG000|Overall Study|Non-Compliant|1|||
146864568|NCT00634010|529676769|FG001|Overall Study|Non-Compliant|1|||
146864569|NCT01026142|529676770|FG000|Overall Study|Death|136|||
146864570|NCT01026142|529676771|FG001|Overall Study|Death|134|||
146864571|NCT01026142|529676770|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
146864572|NCT01026142|529676771|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
146864573|NCT01862640|529676775|FG000|Overall Study|Adverse Event|4|||
146864574|NCT01862640|529676776|FG001|Overall Study|Adverse Event|10|||
146864575|NCT01862640|529676777|FG002|Overall Study|Adverse Event|6|||
146864576|NCT01862640|529676778|FG003|Overall Study|Adverse Event|8|||
146864577|NCT01862640|529676775|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
146864578|NCT01862640|529676776|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
146864579|NCT01862640|529676777|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
146864580|NCT01862640|529676778|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
146864581|NCT01862640|529676775|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
146864582|NCT01862640|529676776|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
146864583|NCT01862640|529676777|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
146864584|NCT01862640|529676778|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
146864585|NCT01862640|529676775|FG000|Overall Study|Withdrawal by Subject|2|||
146864586|NCT01862640|529676776|FG001|Overall Study|Withdrawal by Subject|4|||
146864587|NCT01862640|529676777|FG002|Overall Study|Withdrawal by Subject|8|||
146864588|NCT01862640|529676778|FG003|Overall Study|Withdrawal by Subject|5|||
146864589|NCT01862640|529676775|FG000|Overall Study|Protocol Deviation|0|||
146864590|NCT01862640|529676776|FG001|Overall Study|Protocol Deviation|0|||
146864591|NCT01862640|529676777|FG002|Overall Study|Protocol Deviation|1|||
146864592|NCT01862640|529676778|FG003|Overall Study|Protocol Deviation|0|||
146864593|NCT01019317|529676779|FG000|Overall Study|Not Eligible|4|||
146864594|NCT02178553|529676780|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
146864595|NCT02178553|529676781|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
146864596|NCT02178553|529676780|FG000|Overall Study|Physician Decision|0|||
146864597|NCT02178553|529676781|FG001|Overall Study|Physician Decision|4|||
146864598|NCT02178553|529676780|FG000|Overall Study|Technical problem with injection|1|||
146864599|NCT02178553|529676781|FG001|Overall Study|Technical problem with injection|3|||
146864600|NCT05085665|529676782|FG000|Overall Study|Physician Decision|2|||
146530914|NCT01130272|528452916|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
146530915|NCT01130272|528452917|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
146530916|NCT01130272|528452918|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
146530917|NCT01130272|528452919|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
146530918|NCT01130272|528452920|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
146530919|NCT01130272|528452916|FG000|Overall Study|Protocol Violation|0|||
146530920|NCT01130272|528452917|FG001|Overall Study|Protocol Violation|0|||
146530921|NCT01130272|528452918|FG002|Overall Study|Protocol Violation|3|||
146530922|NCT01130272|528452919|FG003|Overall Study|Protocol Violation|5|||
146530923|NCT01130272|528452920|FG004|Overall Study|Protocol Violation|5|||
146530924|NCT01130272|528452916|FG000|Overall Study|Lost to Follow-up|4|||
146530925|NCT01130272|528452917|FG001|Overall Study|Lost to Follow-up|3|||
146530926|NCT01130272|528452918|FG002|Overall Study|Lost to Follow-up|4|||
146530927|NCT01130272|528452919|FG003|Overall Study|Lost to Follow-up|7|||
146530928|NCT01130272|528452920|FG004|Overall Study|Lost to Follow-up|6|||
146530929|NCT01130272|528452916|FG000|Overall Study|Withdrawal by Subject|4|||
146864601|NCT01641809|529676784|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
146864602|NCT01641809|529676785|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
146864603|NCT01641809|529676786|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
146864604|NCT01641809|529676787|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
146864605|NCT01641809|529676784|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
146864606|NCT01641809|529676785|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
146864607|NCT01641809|529676786|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
146864608|NCT01641809|529676787|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
146864609|NCT01641809|529676784|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
146530930|NCT01130272|528452917|FG001|Overall Study|Withdrawal by Subject|11|||
146530931|NCT01130272|528452918|FG002|Overall Study|Withdrawal by Subject|10|||
146864610|NCT01641809|529676785|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
146864611|NCT01641809|529676786|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
146864612|NCT01641809|529676787|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
146864613|NCT01641809|529676784|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
146864614|NCT01641809|529676785|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
146864615|NCT01641809|529676786|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
146864616|NCT01641809|529676787|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
146864617|NCT01641809|529676784|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
146864618|NCT01641809|529676785|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
146864619|NCT01641809|529676786|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
146864620|NCT01641809|529676787|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
146864621|NCT01641809|529676784|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
146864622|NCT01641809|529676785|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
146864623|NCT01641809|529676786|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
146864624|NCT01641809|529676787|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
146864625|NCT01641809|529676784|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
146864626|NCT01641809|529676785|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
146864627|NCT01641809|529676786|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
146864628|NCT01641809|529676787|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
146864629|NCT01641809|529676784|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
146864630|NCT01641809|529676785|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
146864631|NCT01641809|529676786|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
146864632|NCT01641809|529676787|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
146864633|NCT01641809|529676784|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
146864634|NCT01641809|529676785|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
146864635|NCT01641809|529676786|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
146864636|NCT01641809|529676787|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
146864637|NCT01641809|529676784|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
146864638|NCT01641809|529676785|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
146864639|NCT01641809|529676786|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
146864640|NCT01641809|529676787|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
146864641|NCT01641809|529676784|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
146864642|NCT01641809|529676785|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
146864643|NCT01641809|529676786|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
146864644|NCT01641809|529676787|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
146864645|NCT01641809|529676784|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
146864646|NCT01641809|529676785|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
146864647|NCT01641809|529676786|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
146864648|NCT01641809|529676787|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
146864649|NCT01641809|529676784|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
146530932|NCT01130272|528452919|FG003|Overall Study|Withdrawal by Subject|9|||
146530933|NCT01130272|528452920|FG004|Overall Study|Withdrawal by Subject|8|||
146530934|NCT01130272|528452916|FG000|Overall Study|Physician Decision|1|||
146530935|NCT01130272|528452917|FG001|Overall Study|Physician Decision|1|||
146530936|NCT01130272|528452918|FG002|Overall Study|Physician Decision|0|||
146530937|NCT01130272|528452919|FG003|Overall Study|Physician Decision|1|||
146530938|NCT01130272|528452920|FG004|Overall Study|Physician Decision|2|||
146530939|NCT01130272|528452916|FG000|Overall Study|Sponsor decision|6|||
146530940|NCT01130272|528452917|FG001|Overall Study|Sponsor decision|15|||
146530941|NCT01130272|528452918|FG002|Overall Study|Sponsor decision|16|||
146530942|NCT01130272|528452919|FG003|Overall Study|Sponsor decision|13|||
146530943|NCT01130272|528452920|FG004|Overall Study|Sponsor decision|16|||
146530944|NCT01130272|528452916|FG000|Overall Study|Study arm discontinued|38|||
146530945|NCT01130272|528452917|FG001|Overall Study|Study arm discontinued|0|||
146530946|NCT01130272|528452918|FG002|Overall Study|Study arm discontinued|0|||
146530947|NCT01130272|528452919|FG003|Overall Study|Study arm discontinued|0|||
146530948|NCT01130272|528452920|FG004|Overall Study|Study arm discontinued|0|||
146864650|NCT01641809|529676785|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
146530949|NCT01548404|528452921|FG000|Overall Study|Adverse Event|3|||
146864651|NCT01641809|529676786|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
146864652|NCT01641809|529676787|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
146864653|NCT01641809|529676784|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
146864654|NCT01641809|529676785|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
146864655|NCT01641809|529676786|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
146530950|NCT01548404|528452922|FG001|Overall Study|Adverse Event|1|||
146530951|NCT01548404|528452921|FG000|Overall Study|Physician Decision|2|||
146530952|NCT01548404|528452922|FG001|Overall Study|Physician Decision|1|||
146530953|NCT01548404|528452921|FG000|Overall Study|Inadequate response to study treatment|23|||
146864656|NCT01641809|529676787|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
146864657|NCT01641809|529676784|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
146864658|NCT01641809|529676785|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
146864659|NCT01641809|529676786|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
146864660|NCT01641809|529676787|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
146864661|NCT01641809|529676784|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
146864662|NCT01641809|529676785|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
146864663|NCT01641809|529676786|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
146864664|NCT01641809|529676787|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
146864665|NCT01641809|529676784|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
146864666|NCT01641809|529676785|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
146864667|NCT01641809|529676786|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
146864668|NCT01641809|529676787|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
146864669|NCT01641809|529676784|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
146864670|NCT01641809|529676785|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
146864671|NCT01641809|529676786|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
146864672|NCT01641809|529676787|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
146864673|NCT03294109|529676788|FG000|Overall Study|Withdrawal by Subject|6|||
146864674|NCT03294109|529676789|FG001|Overall Study|Withdrawal by Subject|5|||
146864675|NCT03690141|529676792|FG000|Overall Study|Adverse Event|5|||
146864676|NCT03690141|529676792|FG000|Overall Study|Withdrawal by Subject|3|||
146864677|NCT03690141|529676792|FG000|Overall Study|Physician Decision|4|||
146864678|NCT03690141|529676792|FG000|Overall Study|Disease progression|4|||
146864679|NCT04744285|529676793|FG000|Overall Study|Withdrawal by Subject|1|||
146864680|NCT04744285|529676794|FG001|Overall Study|Withdrawal by Subject|1|||
146864681|NCT04744285|529676795|FG002|Overall Study|Withdrawal by Subject|2|||
146864682|NCT04744285|529676796|FG003|Overall Study|Withdrawal by Subject|1|||
146864683|NCT00448435|529676797|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
146864684|NCT00448435|529676798|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
146864685|NCT04195581|529676801|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
146864686|NCT04195581|529676801|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
146864687|NCT04195581|529676801|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
146864688|NCT04195581|529676801|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
146864689|NCT04195581|529676801|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
146864690|NCT04195581|529676801|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
146864691|NCT00821431|529676802|FG000|Overall Study|Adverse Event|6|||
146864692|NCT00821431|529676803|FG001|Overall Study|Adverse Event|3|||
146530954|NCT01548404|528452922|FG001|Overall Study|Inadequate response to study treatment|7|||
146530955|NCT01548404|528452921|FG000|Overall Study|Lost to Follow-up|2|||
146530956|NCT01548404|528452922|FG001|Overall Study|Lost to Follow-up|0|||
146530957|NCT01548404|528452921|FG000|Overall Study|Withdrawal by Subject|0|||
146530958|NCT01548404|528452922|FG001|Overall Study|Withdrawal by Subject|3|||
146530959|NCT01548404|528452921|FG000|Overall Study|Other than specified above|0|||
146530960|NCT01548404|528452922|FG001|Overall Study|Other than specified above|2|||
146530961|NCT00641056|528452923|FG000|Overall Study|Adverse Event|12|||
146530962|NCT00641056|528452924|FG001|Overall Study|Adverse Event|2|||
146530963|NCT00641056|528452923|FG000|Overall Study|Lost to Follow-up|2|||
146530964|NCT00641056|528452924|FG001|Overall Study|Lost to Follow-up|1|||
146530965|NCT00641056|528452923|FG000|Overall Study|Physician Decision|3|||
146530966|NCT00641056|528452924|FG001|Overall Study|Physician Decision|1|||
146530967|NCT00641056|528452923|FG000|Overall Study|Protocol Violation|2|||
146530968|NCT00641056|528452924|FG001|Overall Study|Protocol Violation|0|||
146530969|NCT00641056|528452923|FG000|Overall Study|Entry Criteria Not Met|3|||
146530970|NCT00641056|528452924|FG001|Overall Study|Entry Criteria Not Met|0|||
146530971|NCT00641056|528452923|FG000|Overall Study|Subject Decision|6|||
146530972|NCT00641056|528452924|FG001|Overall Study|Subject Decision|19|||
146530973|NCT00641056|528452923|FG000|Overall Study|Sponsor Decision|1|||
146530974|NCT00641056|528452924|FG001|Overall Study|Sponsor Decision|2|||
146864693|NCT00821431|529676802|FG000|Overall Study|Withdrawal by Subject|5|||
146864694|NCT00821431|529676803|FG001|Overall Study|Withdrawal by Subject|0|||
146864695|NCT00821431|529676802|FG000|Overall Study|Lost to Follow-up|1|||
146530975|NCT00896493|528452927|FG000|Overall Study|Early disease relapse|3|||
146530976|NCT02026141|528452930|FG000|Overall Study|Protocol Violation|0|||
146530977|NCT02026141|528452931|FG001|Overall Study|Protocol Violation|1|||
146530978|NCT03074695|528452938|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
146530979|NCT03074695|528452939|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
146530980|NCT03074695|528452938|FG000|Overall Study|Research staff not available|1|||
146530981|NCT03074695|528452939|FG001|Overall Study|Research staff not available|2|||
146530982|NCT03074695|528452938|FG000|Overall Study|Did not receive neuraxial block|2|||
146530983|NCT03074695|528452939|FG001|Overall Study|Did not receive neuraxial block|2|||
146864696|NCT00821431|529676803|FG001|Overall Study|Lost to Follow-up|0|||
146864697|NCT00821431|529676802|FG000|Overall Study|Protocol Violation|3|||
146864698|NCT00821431|529676803|FG001|Overall Study|Protocol Violation|1|||
146864699|NCT00821431|529676802|FG000|Overall Study|Physician Decision|0|||
146864700|NCT00821431|529676803|FG001|Overall Study|Physician Decision|1|||
146864701|NCT01387230|529676804|FG000|Overall Study|Adverse Event|0|||
146864702|NCT01387230|529676805|FG001|Overall Study|Adverse Event|1|||
146864703|NCT01387230|529676806|FG002|Overall Study|Adverse Event|3|||
146864704|NCT01387230|529676804|FG000|Overall Study|Lack of Efficacy|8|||
146864705|NCT01387230|529676805|FG001|Overall Study|Lack of Efficacy|5|||
146864706|NCT01387230|529676806|FG002|Overall Study|Lack of Efficacy|4|||
146864707|NCT01387230|529676804|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
146864708|NCT01387230|529676805|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
146864709|NCT01387230|529676806|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
146864710|NCT01387230|529676804|FG000|Overall Study|Lost to Follow-up|0|||
146864711|NCT01387230|529676805|FG001|Overall Study|Lost to Follow-up|0|||
146530984|NCT01774981|528452940|FG000|Overall Study|Adverse Event|0|||
146530985|NCT01774981|528452941|FG001|Overall Study|Adverse Event|0|||
146530986|NCT01774981|528452942|FG002|Overall Study|Adverse Event|0|||
146530987|NCT01774981|528452943|FG003|Overall Study|Adverse Event|0|||
146530988|NCT01774981|528452944|FG004|Overall Study|Adverse Event|0|||
146530989|NCT01774981|528452945|FG005|Overall Study|Adverse Event|1|||
146530990|NCT01774981|528452946|FG006|Overall Study|Adverse Event|0|||
146530991|NCT01774981|528452947|FG007|Overall Study|Adverse Event|0|||
146530992|NCT01774981|528452940|FG000|Overall Study|Withdrawal by Subject|0|||
146530993|NCT01774981|528452941|FG001|Overall Study|Withdrawal by Subject|0|||
146530994|NCT01774981|528452942|FG002|Overall Study|Withdrawal by Subject|0|||
146530995|NCT01774981|528452943|FG003|Overall Study|Withdrawal by Subject|0|||
146530996|NCT01774981|528452944|FG004|Overall Study|Withdrawal by Subject|0|||
146530997|NCT01774981|528452945|FG005|Overall Study|Withdrawal by Subject|0|||
146530998|NCT01774981|528452946|FG006|Overall Study|Withdrawal by Subject|0|||
146530999|NCT01774981|528452947|FG007|Overall Study|Withdrawal by Subject|1|||
146531000|NCT01774981|528452940|FG000|Overall Study|Death|0|||
146531001|NCT01774981|528452941|FG001|Overall Study|Death|0|||
146531002|NCT01774981|528452942|FG002|Overall Study|Death|0|||
146531003|NCT01774981|528452943|FG003|Overall Study|Death|0|||
146531004|NCT01774981|528452944|FG004|Overall Study|Death|1|||
146531005|NCT01774981|528452945|FG005|Overall Study|Death|0|||
146531006|NCT01774981|528452946|FG006|Overall Study|Death|0|||
146531007|NCT01774981|528452947|FG007|Overall Study|Death|0|||
146531008|NCT00902577|528452948|FG000|Overall Study|Withdrawal by Subject|6|||
146531009|NCT00902577|528452948|FG000|Overall Study|FMISO production failure|2|||
146531010|NCT00719901|528452949|FG000|Overall Study|Adverse Event|5|||
146531011|NCT00719901|528452949|FG000|Overall Study|Withdrawal by Subject|1|||
146531012|NCT00719901|528452949|FG000|Overall Study|Alternate Treatment|1|||
146531013|NCT00719901|528452949|FG000|Overall Study|Disease Progression|3|||
146531014|NCT00719901|528452949|FG000|Overall Study|Availability of Study Drug|1|||
146531015|NCT02643693|528452950|FG000|Overall Study|Physician Decision|0|||
146531016|NCT02643693|528452951|FG001|Overall Study|Physician Decision|1|||
146531017|NCT02643693|528452952|FG002|Overall Study|Physician Decision|0|||
146531018|NCT02643693|528452953|FG003|Overall Study|Physician Decision|0|||
146531019|NCT02643693|528452954|FG004|Overall Study|Physician Decision|0|||
146531020|NCT02643693|528452955|FG005|Overall Study|Physician Decision|0|||
146531021|NCT02643693|528452950|FG000|Overall Study|Withdrawal by Subject|0|||
146531022|NCT02643693|528452951|FG001|Overall Study|Withdrawal by Subject|1|||
146531023|NCT02643693|528452952|FG002|Overall Study|Withdrawal by Subject|0|||
146531024|NCT02643693|528452953|FG003|Overall Study|Withdrawal by Subject|0|||
146531025|NCT02643693|528452954|FG004|Overall Study|Withdrawal by Subject|0|||
146531026|NCT02643693|528452955|FG005|Overall Study|Withdrawal by Subject|0|||
146531027|NCT02643693|528452950|FG000|Overall Study|Protocol Adherence Issues|2|||
146531028|NCT02643693|528452951|FG001|Overall Study|Protocol Adherence Issues|0|||
146531029|NCT02643693|528452952|FG002|Overall Study|Protocol Adherence Issues|1|||
146531030|NCT02643693|528452953|FG003|Overall Study|Protocol Adherence Issues|0|||
146531031|NCT02643693|528452954|FG004|Overall Study|Protocol Adherence Issues|0|||
146531032|NCT02643693|528452955|FG005|Overall Study|Protocol Adherence Issues|1|||
146531033|NCT00492297|528452956|FG000|Treatment|Death|2|||
146864712|NCT01387230|529676806|FG002|Overall Study|Lost to Follow-up|1|||
146864713|NCT01387230|529676804|FG000|Overall Study|Withdrawal by Subject|4|||
146864714|NCT01387230|529676805|FG001|Overall Study|Withdrawal by Subject|1|||
146864715|NCT01387230|529676806|FG002|Overall Study|Withdrawal by Subject|0|||
146531034|NCT00492297|528452956|FG000|Treatment|Study terminated by sponsor|3|||
146531035|NCT00492297|528452956|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
146531036|NCT00492297|528452956|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
146531037|NCT00492297|528452956|FG000|Survival Only Follow-up|Death|46|||
146531038|NCT00492297|528452956|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
146531039|NCT00492297|528452956|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
146864716|NCT03026127|529676809|FG000|CRISP R61|Adverse Event|5|||
146531040|NCT05002972|528452963|FG000|Overall Study|Withdrawal by Subject|2|||
146531041|NCT01664091|528452964|FG000|Overall Study|Death|1|||
146531042|NCT01664091|528452964|FG000|Overall Study|Disease Progression|2|||
146531043|NCT01664091|528452964|FG000|Overall Study|Lost to Follow-up|2|||
146531044|NCT01664091|528452964|FG000|Overall Study|Withdrawal by Subject|1|||
146864717|NCT03026127|529676810|FG001|CRISP R61|Adverse Event|0|||
146531045|NCT01172873|528452965|FG000|Overall Study|Withdrawal by Subject|3|||
146531046|NCT01172873|528452966|FG001|Overall Study|Withdrawal by Subject|2|||
146531047|NCT01076543|528452967|FG000|Overall Study|Withdrawal by Subject|2|||
146531048|NCT01076543|528452968|FG001|Overall Study|Withdrawal by Subject|0|||
146531049|NCT01076543|528452969|FG002|Overall Study|Withdrawal by Subject|0|||
146531050|NCT01076543|528452970|FG003|Overall Study|Withdrawal by Subject|0|||
146531051|NCT01076543|528452971|FG004|Overall Study|Withdrawal by Subject|0|||
146531052|NCT01076543|528452972|FG005|Overall Study|Withdrawal by Subject|0|||
146531053|NCT02144701|528452973|FG000|Overall Study|development of relapse, GVHD or death|9|||
146531054|NCT02144701|528452974|FG001|Overall Study|development of relapse, GVHD or death|3|||
146531055|NCT01103323|528452975|FG000|Without/Before Drug Switch|Adverse Event|50|||
146531056|NCT01103323|528452976|FG001|Without/Before Drug Switch|Adverse Event|7|||
146531057|NCT01103323|528452975|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
146531058|NCT01103323|528452976|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
146531059|NCT01103323|528452975|FG000|Without/Before Drug Switch|Protocol Violation|2|||
146531060|NCT01103323|528452976|FG001|Without/Before Drug Switch|Protocol Violation|0|||
146531061|NCT01103323|528452975|FG000|Without/Before Drug Switch|Physician Decision|2|||
146531062|NCT01103323|528452976|FG001|Without/Before Drug Switch|Physician Decision|0|||
146531063|NCT01103323|528452975|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
146531064|NCT01103323|528452976|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
146531065|NCT01103323|528452975|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
146531066|NCT01103323|528452976|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
146531067|NCT01103323|528452975|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
146531068|NCT01103323|528452976|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
146531069|NCT00372424|528452977|FG000|Overall Study|Adverse Event|2|||
146531070|NCT00372424|528452977|FG000|Overall Study|Withdrawal by Subject|1|||
146531071|NCT00372424|528452977|FG000|Overall Study|Death|1|||
146531072|NCT00372424|528452977|FG000|Overall Study|Objective Progression or Relapse|14|||
146531073|NCT00372424|528452977|FG000|Overall Study|Other|7|||
146531074|NCT00372424|528452977|FG000|Overall Study|Enrolled, Not Treated|1|||
146531075|NCT05214118|528452982|FG000|Overall Study|Lost to Follow-up|0|||
146531076|NCT05214118|528452983|FG001|Overall Study|Lost to Follow-up|2|||
146531077|NCT05214118|528452982|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
146531078|NCT05214118|528452983|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
146531079|NCT05214118|528452982|FG000|Overall Study|moved|1|||
146531080|NCT05214118|528452983|FG001|Overall Study|moved|0|||
146531081|NCT03797898|528452984|FG000|Overall Study|Lost to Follow-up|60|||
146531082|NCT03797898|528452985|FG001|Overall Study|Lost to Follow-up|69|||
146531083|NCT03797898|528452984|FG000|Overall Study|Withdrawal by Subject|9|||
146531084|NCT03797898|528452985|FG001|Overall Study|Withdrawal by Subject|7|||
146531085|NCT03797898|528452984|FG000|Overall Study|Became ineligible|5|||
146531086|NCT03797898|528452985|FG001|Overall Study|Became ineligible|2|||
146531087|NCT02314728|528452986|FG000|Overall Study|Protocol Violation|1|||
146531088|NCT02314728|528452987|FG001|Overall Study|Protocol Violation|0|||
146531089|NCT02314728|528452986|FG000|Overall Study|Lost to Follow-up|0|||
146531090|NCT02314728|528452987|FG001|Overall Study|Lost to Follow-up|1|||
146531091|NCT00086190|528452988|FG000|Overall Study|Adverse Event|6|||
146531092|NCT00086190|528452989|FG001|Overall Study|Adverse Event|2|||
146531093|NCT00086190|528452990|FG002|Overall Study|Adverse Event|2|||
146531094|NCT00086190|528452988|FG000|Overall Study|Withdrawal by Subject|0|||
146531095|NCT00086190|528452989|FG001|Overall Study|Withdrawal by Subject|2|||
146531096|NCT00086190|528452990|FG002|Overall Study|Withdrawal by Subject|2|||
146531097|NCT00086190|528452988|FG000|Overall Study|Protocol Violation|1|||
146531098|NCT00086190|528452989|FG001|Overall Study|Protocol Violation|0|||
146531099|NCT00086190|528452990|FG002|Overall Study|Protocol Violation|0|||
146531100|NCT00086190|528452988|FG000|Overall Study|Moved|1|||
146531101|NCT00086190|528452989|FG001|Overall Study|Moved|0|||
146531102|NCT00086190|528452990|FG002|Overall Study|Moved|0|||
146531103|NCT00086190|528452988|FG000|Overall Study|Worsening depression|0|||
146531104|NCT00086190|528452989|FG001|Overall Study|Worsening depression|0|||
146531105|NCT00086190|528452990|FG002|Overall Study|Worsening depression|2|||
146531106|NCT03902613|528452994|FG000|Overall Study|Physician Decision|1|||
146531107|NCT02283658|528452995|FG000|Overall Study|Withdrawal by Subject|1|||
146531108|NCT03528551|528452997|FG000|Overall Study|Lost to Follow-up|0|||
146531109|NCT03528551|528452998|FG001|Overall Study|Lost to Follow-up|1|||
146531110|NCT03528551|528452999|FG002|Overall Study|Lost to Follow-up|0|||
146531111|NCT03528551|528452997|FG000|Overall Study|Transferred to other arm/group|2|||
146531112|NCT03528551|528452998|FG001|Overall Study|Transferred to other arm/group|3|||
146531113|NCT03528551|528452999|FG002|Overall Study|Transferred to other arm/group|0|||
146531114|NCT03528551|528452997|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146531115|NCT03528551|528452998|FG001|Overall Study|Withdrawal by parent/guardian|5|||
146531116|NCT03528551|528452999|FG002|Overall Study|Withdrawal by parent/guardian|0|||
146531117|NCT03528551|528452997|FG000|Overall Study|Protocol Violation|0|||
146531118|NCT03528551|528452998|FG001|Overall Study|Protocol Violation|3|||
146864718|NCT03026127|529676811|FG002|CRISP R61|Adverse Event|0|||
146864719|NCT03026127|529676809|FG000|CRISP R61|Lost to Follow-up|2|||
146531119|NCT03528551|528452999|FG002|Overall Study|Protocol Violation|0|||
146531120|NCT03528551|528452997|FG000|Overall Study|Withdrawal by Subject|0|||
146531121|NCT03528551|528452998|FG001|Overall Study|Withdrawal by Subject|7|||
146531122|NCT03528551|528452999|FG002|Overall Study|Withdrawal by Subject|0|||
146531123|NCT01789047|528453000|FG000|Overall Study|Adverse Event|3|||
146531124|NCT01789047|528453001|FG001|Overall Study|Adverse Event|2|||
146531125|NCT01789047|528453000|FG000|Overall Study|Withdrawal by Subject|1|||
146531126|NCT01789047|528453001|FG001|Overall Study|Withdrawal by Subject|2|||
146531127|NCT02668640|528453002|FG000|Overall Study|Lost to Follow-up|13|||
146531128|NCT02668640|528453002|FG000|Overall Study|Other, not specified|1|||
146531129|NCT02322749|528453003|FG000|Period 2|Adverse Event|0|||
146531130|NCT02322749|528453004|FG001|Period 2|Adverse Event|0|||
146531131|NCT02322749|528453005|FG002|Period 2|Adverse Event|0|||
146531132|NCT02322749|528453006|FG003|Period 2|Adverse Event|1|||
146531133|NCT02322749|528453007|FG004|Period 2|Adverse Event|0|||
146531134|NCT02322749|528453008|FG005|Period 2|Adverse Event|0|||
146531135|NCT02322749|528453003|FG000|Period 2|Withdrawal by Subject|0|||
146531136|NCT02322749|528453004|FG001|Period 2|Withdrawal by Subject|0|||
146531137|NCT02322749|528453005|FG002|Period 2|Withdrawal by Subject|0|||
146531138|NCT02322749|528453006|FG003|Period 2|Withdrawal by Subject|1|||
146531139|NCT02322749|528453007|FG004|Period 2|Withdrawal by Subject|0|||
146531140|NCT02322749|528453008|FG005|Period 2|Withdrawal by Subject|0|||
146531141|NCT02322749|528453003|FG000|Period 3|Withdrawal by Subject|0|||
146531142|NCT02322749|528453004|FG001|Period 3|Withdrawal by Subject|0|||
146531143|NCT02322749|528453005|FG002|Period 3|Withdrawal by Subject|1|||
146531144|NCT02322749|528453006|FG003|Period 3|Withdrawal by Subject|0|||
146531145|NCT02322749|528453007|FG004|Period 3|Withdrawal by Subject|0|||
146531146|NCT02322749|528453008|FG005|Period 3|Withdrawal by Subject|0|||
146531147|NCT00073918|528453009|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
146531148|NCT00073918|528453009|FG000|Overall Study|Rapid disease progression|2|||
146531149|NCT00073918|528453009|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
146531150|NCT01190813|528453010|FG000|Overall Study|Lost to Follow-up|1|||
146531151|NCT01190813|528453011|FG001|Overall Study|Lost to Follow-up|2|||
146531152|NCT01190813|528453010|FG000|Overall Study|Withdrawal by Subject|2|||
146531153|NCT01190813|528453011|FG001|Overall Study|Withdrawal by Subject|1|||
146531154|NCT01190813|528453010|FG000|Overall Study|Refused study treatment after randomized|1|||
146531155|NCT01190813|528453011|FG001|Overall Study|Refused study treatment after randomized|0|||
146531156|NCT01190813|528453010|FG000|Overall Study|Adverse Event|0|||
146531157|NCT01190813|528453011|FG001|Overall Study|Adverse Event|1|||
146531158|NCT04821830|528453014|FG000|Overall Study|Withdrawal by Subject|1|||
146531159|NCT04821830|528453015|FG001|Overall Study|Withdrawal by Subject|0|||
146531160|NCT00557466|528454181|FG000|Overall Study|Adverse Event|3|||
146531161|NCT00557466|528454182|FG001|Overall Study|Adverse Event|1|||
146531162|NCT00557466|528454183|FG002|Overall Study|Adverse Event|4|||
146531163|NCT00557466|528454184|FG003|Overall Study|Adverse Event|1|||
146531164|NCT00557466|528454185|FG004|Overall Study|Adverse Event|2|||
146531165|NCT00557466|528454186|FG005|Overall Study|Adverse Event|4|||
146531166|NCT00557466|528454181|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146531167|NCT00557466|528454182|FG001|Overall Study|Abnormal laboratory value(s)|2|||
146531168|NCT00557466|528454183|FG002|Overall Study|Abnormal laboratory value(s)|0|||
146531169|NCT00557466|528454184|FG003|Overall Study|Abnormal laboratory value(s)|0|||
146531170|NCT00557466|528454185|FG004|Overall Study|Abnormal laboratory value(s)|0|||
146531171|NCT00557466|528454186|FG005|Overall Study|Abnormal laboratory value(s)|0|||
146531172|NCT00557466|528454181|FG000|Overall Study|Protocol deviation|0|||
146531173|NCT00557466|528454182|FG001|Overall Study|Protocol deviation|1|||
146531174|NCT00557466|528454183|FG002|Overall Study|Protocol deviation|0|||
146531175|NCT00557466|528454184|FG003|Overall Study|Protocol deviation|2|||
146531176|NCT00557466|528454185|FG004|Overall Study|Protocol deviation|0|||
146531177|NCT00557466|528454186|FG005|Overall Study|Protocol deviation|0|||
146531178|NCT00557466|528454181|FG000|Overall Study|Subject withdrew consent|0|||
146531179|NCT00557466|528454182|FG001|Overall Study|Subject withdrew consent|0|||
146531180|NCT00557466|528454183|FG002|Overall Study|Subject withdrew consent|0|||
146531181|NCT00557466|528454184|FG003|Overall Study|Subject withdrew consent|0|||
146531182|NCT00557466|528454185|FG004|Overall Study|Subject withdrew consent|1|||
146531183|NCT00557466|528454186|FG005|Overall Study|Subject withdrew consent|2|||
146531184|NCT00557466|528454181|FG000|Overall Study|Administrative problems|0|||
146531185|NCT00557466|528454182|FG001|Overall Study|Administrative problems|1|||
146531186|NCT00557466|528454183|FG002|Overall Study|Administrative problems|1|||
146531187|NCT00557466|528454184|FG003|Overall Study|Administrative problems|0|||
146531188|NCT00557466|528454185|FG004|Overall Study|Administrative problems|0|||
146531189|NCT00557466|528454186|FG005|Overall Study|Administrative problems|0|||
146531190|NCT00557466|528454181|FG000|Overall Study|Abnormal test procedure results|0|||
146531191|NCT00557466|528454182|FG001|Overall Study|Abnormal test procedure results|0|||
146531192|NCT00557466|528454183|FG002|Overall Study|Abnormal test procedure results|1|||
146531193|NCT00557466|528454184|FG003|Overall Study|Abnormal test procedure results|0|||
146531194|NCT00557466|528454185|FG004|Overall Study|Abnormal test procedure results|0|||
146531195|NCT00557466|528454186|FG005|Overall Study|Abnormal test procedure results|0|||
146531196|NCT00557466|528454181|FG000|Overall Study|Lost to Follow-up|0|||
146531197|NCT00557466|528454182|FG001|Overall Study|Lost to Follow-up|0|||
146531198|NCT00557466|528454183|FG002|Overall Study|Lost to Follow-up|0|||
146531199|NCT00557466|528454184|FG003|Overall Study|Lost to Follow-up|1|||
146531200|NCT00557466|528454185|FG004|Overall Study|Lost to Follow-up|0|||
146531201|NCT00557466|528454186|FG005|Overall Study|Lost to Follow-up|0|||
146531202|NCT02308046|528454189|FG000|Overall Study|Negative yeast culture at Baseline|32|||
146531203|NCT02308046|528454190|FG001|Overall Study|Negative yeast culture at Baseline|33|||
146531204|NCT02308046|528454189|FG000|Overall Study|Positive for STD at Baseline|1|||
146531205|NCT02308046|528454190|FG001|Overall Study|Positive for STD at Baseline|2|||
146531206|NCT02308046|528454189|FG000|Overall Study|Lost to Follow-up|1|||
146531207|NCT02308046|528454190|FG001|Overall Study|Lost to Follow-up|3|||
146531208|NCT01181167|528454193|FG000|Overall Study|Adverse Event|11|||
146531209|NCT01181167|528454194|FG001|Overall Study|Adverse Event|21|||
146531210|NCT01181167|528454193|FG000|Overall Study|Lost to Follow-up|1|||
146531211|NCT01181167|528454194|FG001|Overall Study|Lost to Follow-up|0|||
146531212|NCT01181167|528454193|FG000|Overall Study|Physician Decision|2|||
146531213|NCT01181167|528454194|FG001|Overall Study|Physician Decision|3|||
146531214|NCT01181167|528454193|FG000|Overall Study|Protocol Violation|3|||
146531215|NCT01181167|528454194|FG001|Overall Study|Protocol Violation|0|||
146531216|NCT01181167|528454193|FG000|Overall Study|Withdrawal by Subject|6|||
146531217|NCT01181167|528454194|FG001|Overall Study|Withdrawal by Subject|8|||
146531218|NCT00301834|528454195|FG000|Overall Study|Death|1|||
146531219|NCT02870868|528454196|FG000|Overall Study|Withdrawal by Subject|2|||
146531220|NCT02870868|528454197|FG001|Overall Study|Withdrawal by Subject|1|||
146531221|NCT04040439|528454198|FG000|Overall Study|Invalid registration|11|||
146531222|NCT04040439|528454198|FG000|Overall Study|No IC* on publication of study results|2|||
146531223|NCT01117870|528454203|FG000|Overall Study|Inability to place needle|1|||
146531224|NCT01117870|528454204|FG001|Overall Study|Inability to place needle|0|||
146531225|NCT01309386|528454205|FG000|Overall Study|Other|2|||
146531226|NCT01309386|528454206|FG001|Overall Study|Other|0|||
146531227|NCT01309386|528454205|FG000|Overall Study|Withdrawal by Subject|2|||
146531228|NCT01309386|528454206|FG001|Overall Study|Withdrawal by Subject|0|||
146531229|NCT01309386|528454205|FG000|Overall Study|Progressive disease|9|||
146531230|NCT01309386|528454206|FG001|Overall Study|Progressive disease|11|||
146531231|NCT01309386|528454205|FG000|Overall Study|Physician Decision|1|||
146531232|NCT01309386|528454206|FG001|Overall Study|Physician Decision|1|||
146531233|NCT01309386|528454205|FG000|Overall Study|Lack of Efficacy|3|||
146531234|NCT01309386|528454206|FG001|Overall Study|Lack of Efficacy|1|||
146531235|NCT01309386|528454205|FG000|Overall Study|Adverse Event|5|||
146531236|NCT01309386|528454206|FG001|Overall Study|Adverse Event|8|||
146531237|NCT00723229|528454207|FG000|First Intervention|Lost to Follow-up|7|||
146531238|NCT00723229|528454208|FG001|First Intervention|Lost to Follow-up|3|||
146864720|NCT03026127|529676810|FG001|CRISP R61|Lost to Follow-up|0|||
146864721|NCT03026127|529676811|FG002|CRISP R61|Lost to Follow-up|0|||
146864722|NCT03026127|529676809|FG000|CRISP R61|Dropped before therapy|5|||
146864723|NCT03026127|529676810|FG001|CRISP R61|Dropped before therapy|0|||
146864724|NCT03026127|529676811|FG002|CRISP R61|Dropped before therapy|0|||
146864725|NCT03026127|529676809|FG000|CRISP R33|Lost to Follow-up|0|||
146864726|NCT03026127|529676810|FG001|CRISP R33|Lost to Follow-up|5|||
146864727|NCT03026127|529676811|FG002|CRISP R33|Lost to Follow-up|4|||
146864728|NCT03026127|529676809|FG000|CRISP R33|Adverse Event|0|||
146864729|NCT03026127|529676810|FG001|CRISP R33|Adverse Event|9|||
146864730|NCT03026127|529676811|FG002|CRISP R33|Adverse Event|5|||
146864731|NCT03026127|529676809|FG000|CRISP R33|Withdrawal by Subject|0|||
146864732|NCT03026127|529676810|FG001|CRISP R33|Withdrawal by Subject|9|||
146864733|NCT03026127|529676811|FG002|CRISP R33|Withdrawal by Subject|1|||
146864734|NCT03026127|529676809|FG000|CRISP R33|Lack of Efficacy|0|||
146531239|NCT01674725|528454209|FG000|Overall Study|Adverse Event|1|||
146531240|NCT01674725|528454210|FG001|Overall Study|Adverse Event|0|||
146531241|NCT01674725|528454209|FG000|Overall Study|Did not receive study drug|1|||
146531242|NCT01674725|528454210|FG001|Overall Study|Did not receive study drug|0|||
146531243|NCT01674725|528454209|FG000|Overall Study|Withdrawal by Subject|1|||
146531244|NCT01674725|528454210|FG001|Overall Study|Withdrawal by Subject|0|||
146531245|NCT01674725|528454209|FG000|Overall Study|Lost to Follow-up|0|||
146531246|NCT01674725|528454210|FG001|Overall Study|Lost to Follow-up|1|||
146531247|NCT00960193|528454211|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
146531248|NCT01324102|528454212|FG000|Overall Study|illness|1|||
146531249|NCT01324102|528454213|FG001|Overall Study|illness|6|||
146531250|NCT03238417|528454214|FG000|Overall|non-response|955|||
146531251|NCT03238417|528454215|FG001|Overall|non-response|1920|||
146531252|NCT03238417|528454214|FG000|Overall|partial completion|48|||
146531253|NCT03238417|528454215|FG001|Overall|partial completion|68|||
146864735|NCT03026127|529676810|FG001|CRISP R33|Lack of Efficacy|3|||
146864736|NCT03026127|529676811|FG002|CRISP R33|Lack of Efficacy|2|||
146864737|NCT03026127|529676809|FG000|CRISP R33|Physician Decision|0|||
146864738|NCT03026127|529676810|FG001|CRISP R33|Physician Decision|3|||
146864739|NCT03026127|529676811|FG002|CRISP R33|Physician Decision|1|||
146864740|NCT03026127|529676809|FG000|CRISP R33|Transportation|0|||
146864741|NCT03026127|529676810|FG001|CRISP R33|Transportation|2|||
146864742|NCT03026127|529676811|FG002|CRISP R33|Transportation|1|||
146864743|NCT01182766|529676815|FG000|Overall Study|Lost to Follow-up|32|||
146864744|NCT01182766|529676816|FG001|Overall Study|Lost to Follow-up|36|||
146864745|NCT01182766|529676817|FG002|Overall Study|Lost to Follow-up|29|||
146864746|NCT01182766|529676815|FG000|Overall Study|Withdrawal by Subject|14|||
146864747|NCT01182766|529676816|FG001|Overall Study|Withdrawal by Subject|3|||
146864748|NCT01182766|529676817|FG002|Overall Study|Withdrawal by Subject|6|||
146864749|NCT01182766|529676815|FG000|Overall Study|Physician Decision|1|||
146864750|NCT01182766|529676816|FG001|Overall Study|Physician Decision|0|||
146864751|NCT01182766|529676817|FG002|Overall Study|Physician Decision|0|||
146864752|NCT01182766|529676815|FG000|Overall Study|Non-compliance|1|||
146864753|NCT01182766|529676816|FG001|Overall Study|Non-compliance|1|||
146864754|NCT01182766|529676817|FG002|Overall Study|Non-compliance|1|||
146864755|NCT03027557|529676818|FG000|Overall Study|Adverse Event|1|||
146864756|NCT03027557|529676819|FG001|Overall Study|Adverse Event|0|||
146864757|NCT03027557|529676820|FG002|Overall Study|Adverse Event|0|||
146864758|NCT02510560|529676821|FG000|Overall Study|Discontinued from Treatment|27|||
146864759|NCT02510560|529676822|FG001|Overall Study|Discontinued from Treatment|18|||
146864760|NCT02510560|529676823|FG002|Overall Study|Discontinued from Treatment|19|||
146531254|NCT03238417|528454214|FG000|Baseline|Partial completion|17|||
146531255|NCT03238417|528454215|FG001|Baseline|Partial completion|48|||
146531256|NCT03238417|528454214|FG000|Baseline|non-response|372|||
146531257|NCT03238417|528454215|FG001|Baseline|non-response|669|||
146531258|NCT03238417|528454214|FG000|12-month|non-response|296|||
146531259|NCT03238417|528454215|FG001|12-month|non-response|669|||
146531260|NCT03238417|528454214|FG000|12-month|partial completion|23|||
146531261|NCT03238417|528454215|FG001|12-month|partial completion|37|||
146531262|NCT03238417|528454214|FG000|24-month|non-response|287|||
146531263|NCT03238417|528454215|FG001|24-month|non-response|594|||
146531264|NCT03238417|528454214|FG000|24-month|partial completion|8|||
146531265|NCT03238417|528454215|FG001|24-month|partial completion|31|||
146531266|NCT01249131|528454216|FG000|Washout Period of 10 Days|Adverse Event|0|||
146531267|NCT01249131|528454217|FG001|Washout Period of 10 Days|Adverse Event|0|||
146531268|NCT01249131|528454218|FG002|Washout Period of 10 Days|Adverse Event|0|||
146531269|NCT01249131|528454219|FG003|Washout Period of 10 Days|Adverse Event|0|||
146531270|NCT01249131|528454220|FG004|Washout Period of 10 Days|Adverse Event|1|||
146531271|NCT01249131|528454221|FG005|Washout Period of 10 Days|Adverse Event|0|||
146531272|NCT00192114|528454222|FG000|Overall Study|Objective Tumor Progression|19|||
146531273|NCT00192114|528454222|FG000|Overall Study|Adverse Event|2|||
146531274|NCT00192114|528454222|FG000|Overall Study|Clinical Progression|2|||
146531275|NCT00192114|528454222|FG000|Overall Study|Death|1|||
146531276|NCT00113607|528454223|FG000|Overall Study|Adverse Event|40|||
146531277|NCT00113607|528454224|FG001|Overall Study|Adverse Event|71|||
146531278|NCT00113607|528454223|FG000|Overall Study|Death|8|||
146531279|NCT00113607|528454224|FG001|Overall Study|Death|8|||
146531280|NCT00113607|528454223|FG000|Overall Study|Withdrawal by Subject|50|||
146531281|NCT00113607|528454224|FG001|Overall Study|Withdrawal by Subject|58|||
146531282|NCT00113607|528454223|FG000|Overall Study|Lost to Follow-up|0|||
146531283|NCT00113607|528454224|FG001|Overall Study|Lost to Follow-up|2|||
146531284|NCT00113607|528454223|FG000|Overall Study|Disease Progression|180|||
146531285|NCT00113607|528454224|FG001|Overall Study|Disease Progression|142|||
146531286|NCT00113607|528454223|FG000|Overall Study|Complete Response (Confirmed)|14|||
146531287|NCT00113607|528454224|FG001|Overall Study|Complete Response (Confirmed)|24|||
146531288|NCT00113607|528454223|FG000|Overall Study|Other|43|||
146531289|NCT00113607|528454224|FG001|Overall Study|Other|32|||
146531290|NCT00749398|528454226|FG000|Overall Study|Lack of Efficacy|7|||
146531291|NCT00749398|528454226|FG000|Overall Study|Adverse Event|4|||
146531292|NCT00749398|528454226|FG000|Overall Study|Serious adverse event|11|||
146531293|NCT00749398|528454226|FG000|Overall Study|Withdrawal by Subject|17|||
146531294|NCT00749398|528454226|FG000|Overall Study|Lost to Follow-up|11|||
146531295|NCT00749398|528454226|FG000|Overall Study|Reason not specified|2|||
146531296|NCT00749398|528454226|FG000|Overall Study|Unknown reason|1|||
146531297|NCT04613518|528454235|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
146531298|NCT04613518|528454236|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
146864761|NCT02510560|529676821|FG000|Overall Study|Other|4|||
146864762|NCT02510560|529676822|FG001|Overall Study|Other|4|||
146864763|NCT02510560|529676823|FG002|Overall Study|Other|3|||
146864764|NCT04427501|529676824|FG000|Overall Study|Death|0|||
146864765|NCT04427501|529676825|FG001|Overall Study|Death|0|||
146531299|NCT04613518|528454237|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
146531300|NCT04613518|528454235|FG000|Double-Blind Treatment Period|Adverse Event|2|||
146531301|NCT04613518|528454236|FG001|Double-Blind Treatment Period|Adverse Event|0|||
146531302|NCT04613518|528454237|FG002|Double-Blind Treatment Period|Adverse Event|1|||
146531303|NCT04613518|528454235|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
146864766|NCT04427501|529676826|FG002|Overall Study|Death|0|||
146531304|NCT04613518|528454236|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
146531305|NCT04613518|528454237|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
146864767|NCT04427501|529676827|FG003|Overall Study|Death|0|||
146864768|NCT04427501|529676828|FG004|Overall Study|Death|0|||
146864769|NCT04427501|529676829|FG005|Overall Study|Death|15|||
146864770|NCT04427501|529676830|FG006|Overall Study|Death|0|||
146864771|NCT04427501|529676831|FG007|Overall Study|Death|0|||
146864772|NCT04427501|529676832|FG008|Overall Study|Death|0|||
146864773|NCT04427501|529676833|FG009|Overall Study|Death|0|||
146531306|NCT04613518|528454235|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
146531307|NCT04613518|528454236|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
146531308|NCT04613518|528454237|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
146531309|NCT04613518|528454235|FG000|Double-Blind Treatment Period|Other Reasons|2|||
146531310|NCT04613518|528454236|FG001|Double-Blind Treatment Period|Other Reasons|0|||
146531311|NCT04613518|528454237|FG002|Double-Blind Treatment Period|Other Reasons|0|||
146531312|NCT04613518|528454235|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
146531313|NCT04613518|528454236|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
146531314|NCT04613518|528454237|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
146531315|NCT04613518|528454235|FG000|Open-Label Treatment Period|Adverse Event|1|||
146531316|NCT04613518|528454236|FG001|Open-Label Treatment Period|Adverse Event|0|||
146531317|NCT04613518|528454237|FG002|Open-Label Treatment Period|Adverse Event|3|||
146531318|NCT04613518|528454235|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
146531319|NCT04613518|528454236|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
146531320|NCT04613518|528454237|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
146531321|NCT04613518|528454235|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
146531322|NCT04613518|528454236|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
146531323|NCT04613518|528454237|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
146531324|NCT04613518|528454235|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
146531325|NCT04613518|528454236|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
146531326|NCT04613518|528454237|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
146531327|NCT04613518|528454235|FG000|Open-Label Treatment Period|Other reasons|1|||
146531328|NCT04613518|528454236|FG001|Open-Label Treatment Period|Other reasons|0|||
146531329|NCT04613518|528454237|FG002|Open-Label Treatment Period|Other reasons|0|||
146531330|NCT01077323|528454239|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
146531331|NCT01077323|528454240|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
146531332|NCT01077323|528454241|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
146531333|NCT01077323|528454239|FG000|Overall Study|Dispensing of drug in baseline period|0|||
146531334|NCT01077323|528454240|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
146531335|NCT01077323|528454241|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
146531336|NCT01077323|528454239|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
146531337|NCT01077323|528454240|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
146531338|NCT01077323|528454241|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
146531339|NCT02984982|528454244|FG000|Overall Study|Adverse Event|2|||
146531340|NCT02984982|528454245|FG001|Overall Study|Adverse Event|5|||
146531341|NCT02984982|528454244|FG000|Overall Study|Poor Compliance to Protocol|4|||
146531342|NCT02984982|528454245|FG001|Overall Study|Poor Compliance to Protocol|4|||
146531343|NCT02984982|528454244|FG000|Overall Study|Withdrawal by Subject|2|||
146531344|NCT02984982|528454245|FG001|Overall Study|Withdrawal by Subject|0|||
146531345|NCT02984982|528454244|FG000|Overall Study|Randomized but not treated|0|||
146531346|NCT02984982|528454245|FG001|Overall Study|Randomized but not treated|1|||
146531347|NCT02153918|528454246|FG000|Overall Study|Refused further treatment|1|||
146531348|NCT02616783|528454247|FG000|Overall Study|Randomized but Not Treated|1|||
146531349|NCT02616783|528454248|FG001|Overall Study|Randomized but Not Treated|0|||
146531350|NCT02616783|528454247|FG000|Overall Study|Adverse Event|1|||
146531351|NCT02616783|528454248|FG001|Overall Study|Adverse Event|0|||
146531352|NCT02616783|528454247|FG000|Overall Study|Death|1|||
146531353|NCT02616783|528454248|FG001|Overall Study|Death|0|||
146531354|NCT02616783|528454247|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146531355|NCT02616783|528454248|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146531356|NCT02616783|528454247|FG000|Overall Study|Protocol Violation|1|||
146531357|NCT02616783|528454248|FG001|Overall Study|Protocol Violation|1|||
146531358|NCT02616783|528454247|FG000|Overall Study|Withdrew Consent|1|||
146531359|NCT02616783|528454248|FG001|Overall Study|Withdrew Consent|1|||
146531360|NCT01614470|528454254|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
146864774|NCT04427501|529676834|FG010|Overall Study|Death|0|||
146531361|NCT01614470|528454255|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
146531362|NCT01614470|528454256|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
146531363|NCT01614470|528454254|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
146531364|NCT01614470|528454255|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
146531365|NCT01614470|528454256|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
146531366|NCT00249834|528454257|FG000|Overall Study|Ovarian stimulation failed|1|||
146531367|NCT00249834|528454258|FG001|Overall Study|Ovarian stimulation failed|0|||
146531368|NCT00249834|528454259|FG002|Overall Study|Ovarian stimulation failed|0|||
146864775|NCT04427501|529676835|FG011|Overall Study|Death|0|||
146864776|NCT04427501|529676824|FG000|Overall Study|Lost to Follow-up|5|||
146531369|NCT00249834|528454260|FG003|Overall Study|Ovarian stimulation failed|0|||
146531370|NCT00249834|528454261|FG004|Overall Study|Ovarian stimulation failed|0|||
146531371|NCT00249834|528454262|FG005|Overall Study|Ovarian stimulation failed|0|||
146531372|NCT00249834|528454263|FG006|Overall Study|Ovarian stimulation failed|0|||
146531373|NCT00249834|528454264|FG007|Overall Study|Ovarian stimulation failed|0|||
146531374|NCT00249834|528454257|FG000|Overall Study|Failure of down-regulation|0|||
146531375|NCT00249834|528454258|FG001|Overall Study|Failure of down-regulation|0|||
146531376|NCT00249834|528454259|FG002|Overall Study|Failure of down-regulation|0|||
146531377|NCT00249834|528454260|FG003|Overall Study|Failure of down-regulation|0|||
146531378|NCT00249834|528454261|FG004|Overall Study|Failure of down-regulation|0|||
146531379|NCT00249834|528454262|FG005|Overall Study|Failure of down-regulation|0|||
146531380|NCT00249834|528454263|FG006|Overall Study|Failure of down-regulation|1|||
146531381|NCT00249834|528454264|FG007|Overall Study|Failure of down-regulation|0|||
146531382|NCT00249834|528454257|FG000|Overall Study|Protocol Violation|0|||
146531383|NCT00249834|528454258|FG001|Overall Study|Protocol Violation|19|||
146531384|NCT00249834|528454259|FG002|Overall Study|Protocol Violation|14|||
146531385|NCT00249834|528454260|FG003|Overall Study|Protocol Violation|8|||
146531386|NCT00249834|528454261|FG004|Overall Study|Protocol Violation|5|||
146864777|NCT04427501|529676825|FG001|Overall Study|Lost to Follow-up|1|||
146864778|NCT04427501|529676826|FG002|Overall Study|Lost to Follow-up|2|||
146864779|NCT04427501|529676827|FG003|Overall Study|Lost to Follow-up|0|||
146531387|NCT00249834|528454262|FG005|Overall Study|Protocol Violation|2|||
146531388|NCT00249834|528454263|FG006|Overall Study|Protocol Violation|0|||
146531389|NCT00249834|528454264|FG007|Overall Study|Protocol Violation|0|||
146531390|NCT00069264|528454267|FG000|Overall Study|Adverse Event|3|||
146531391|NCT00069264|528454267|FG000|Overall Study|Progressive Disease|23|||
146531392|NCT00069264|528454267|FG000|Overall Study|Withdrawal by Subject|3|||
146531393|NCT00069264|528454267|FG000|Overall Study|Discon Therapy|3|||
146531394|NCT02848664|528454270|FG000|Overall Study|Withdrawal by Subject|2|||
146531395|NCT02848664|528454270|FG000|Overall Study|Adverse Event|1|||
146531396|NCT02848664|528454270|FG000|Overall Study|no assistance for device training|1|||
146531397|NCT00732069|528454271|FG000|Washout After First Study Drug|Adverse Event|1|||
146531398|NCT00732069|528454272|FG001|Washout After First Study Drug|Adverse Event|0|||
146531399|NCT00732069|528454273|FG002|Washout After First Study Drug|Adverse Event|0|||
146531400|NCT00732069|528454274|FG003|Washout After First Study Drug|Adverse Event|0|||
146531401|NCT00732069|528454275|FG004|Washout After First Study Drug|Adverse Event|0|||
146531402|NCT00732069|528454276|FG005|Washout After First Study Drug|Adverse Event|0|||
146531403|NCT00577317|528454277|FG000|Overall Study|Study Terminated|0|||
146531404|NCT00577317|528454278|FG001|Overall Study|Study Terminated|2|||
146531405|NCT01405898|528454282|FG000|Overall Study|Withdrawal by Subject|2|||
146531406|NCT01405898|528454283|FG001|Overall Study|Withdrawal by Subject|2|||
146531407|NCT01687218|528454285|FG000|Overall Study|Withdrawal by Subject|2|||
146531408|NCT01687218|528454286|FG001|Overall Study|Withdrawal by Subject|3|||
146531409|NCT01687218|528454287|FG002|Overall Study|Withdrawal by Subject|0|||
146531410|NCT01687218|528454288|FG003|Overall Study|Withdrawal by Subject|1|||
146531411|NCT01687218|528454289|FG004|Overall Study|Withdrawal by Subject|1|||
146531412|NCT01687218|528454290|FG005|Overall Study|Withdrawal by Subject|0|||
146531413|NCT01687218|528454285|FG000|Overall Study|Relocated, no follow-up planned|1|||
146531414|NCT01687218|528454286|FG001|Overall Study|Relocated, no follow-up planned|0|||
146531415|NCT01687218|528454287|FG002|Overall Study|Relocated, no follow-up planned|1|||
146531416|NCT01687218|528454288|FG003|Overall Study|Relocated, no follow-up planned|1|||
146531417|NCT01687218|528454289|FG004|Overall Study|Relocated, no follow-up planned|0|||
146531418|NCT01687218|528454290|FG005|Overall Study|Relocated, no follow-up planned|0|||
146531419|NCT00875810|528454297|FG000|Overall Study|Withdrawal by Subject|1|||
146531420|NCT00875810|528454297|FG000|Overall Study|Physician Decision|3|||
146531421|NCT00875810|528454297|FG000|Overall Study|Lost to Follow-up|39|||
146531422|NCT00875810|528454297|FG000|Overall Study|Patient enroled but not implanted|2|||
146531423|NCT00875810|528454297|FG000|Overall Study|Device explanted|1|||
146531424|NCT00780975|528454298|FG000|Overall Study|Progressive disease|3|||
146864780|NCT04427501|529676828|FG004|Overall Study|Lost to Follow-up|2|||
146864781|NCT04427501|529676829|FG005|Overall Study|Lost to Follow-up|11|||
146531425|NCT00780975|528454298|FG000|Overall Study|Toxicity|5|||
146531426|NCT03106077|528454299|FG000|Overall Study|Screen Failure|94|||
146531427|NCT03106077|528454300|FG001|Overall Study|Screen Failure|0|||
146864782|NCT04427501|529676830|FG006|Overall Study|Lost to Follow-up|10|||
146531428|NCT01274533|528454301|FG000|Overall Study|Withdrawal by Subject|1|||
146531429|NCT01274533|528454301|FG000|Overall Study|Non-compliance|1|||
146531430|NCT01274533|528454301|FG000|Overall Study|Disease progression|2|||
146531431|NCT03669588|528454302|FG000|Overall Study|Adverse Event|1|||
146531432|NCT03669588|528454303|FG001|Overall Study|Adverse Event|0|||
146531433|NCT03669588|528454302|FG000|Overall Study|Physician Decision|0|||
146531434|NCT03669588|528454303|FG001|Overall Study|Physician Decision|1|||
146531435|NCT03669588|528454302|FG000|Overall Study|Protocol Violation|1|||
146531436|NCT03669588|528454303|FG001|Overall Study|Protocol Violation|0|||
146531437|NCT03669588|528454302|FG000|Overall Study|Sponsor Decision|1|||
146531438|NCT03669588|528454303|FG001|Overall Study|Sponsor Decision|1|||
146531439|NCT03669588|528454302|FG000|Overall Study|Withdrawal by Subject|1|||
146531440|NCT03669588|528454303|FG001|Overall Study|Withdrawal by Subject|4|||
146531441|NCT03669588|528454302|FG000|Overall Study|Rescue Therapy Needed|0|||
146531442|NCT03669588|528454303|FG001|Overall Study|Rescue Therapy Needed|1|||
146531443|NCT02008526|528454304|FG000|Overall Study|Death|0|||
146531444|NCT02008526|528454305|FG001|Overall Study|Death|2|||
146531445|NCT02008526|528454306|FG002|Overall Study|Death|1|||
146531446|NCT02008526|528454304|FG000|Overall Study|Withdrawal by Subject|3|||
146531447|NCT02008526|528454305|FG001|Overall Study|Withdrawal by Subject|3|||
146531448|NCT02008526|528454306|FG002|Overall Study|Withdrawal by Subject|2|||
146531449|NCT02008526|528454304|FG000|Overall Study|Lost to Follow-up|5|||
146531450|NCT02008526|528454305|FG001|Overall Study|Lost to Follow-up|9|||
146531451|NCT02008526|528454306|FG002|Overall Study|Lost to Follow-up|6|||
146531452|NCT00492726|528454307|FG000|Overall Study|Adverse Event|10|||
146531453|NCT00492726|528454308|FG001|Overall Study|Adverse Event|6|||
146531454|NCT00492726|528454307|FG000|Overall Study|Death|7|||
146531455|NCT00492726|528454308|FG001|Overall Study|Death|2|||
146531456|NCT00492726|528454307|FG000|Overall Study|Lack of Efficacy|0|||
146531457|NCT00492726|528454308|FG001|Overall Study|Lack of Efficacy|2|||
146531458|NCT00492726|528454307|FG000|Overall Study|Lost to Follow-up|27|||
146531459|NCT00492726|528454308|FG001|Overall Study|Lost to Follow-up|19|||
146531460|NCT00492726|528454307|FG000|Overall Study|Physician Decision|0|||
146531461|NCT00492726|528454308|FG001|Overall Study|Physician Decision|1|||
146531462|NCT00492726|528454307|FG000|Overall Study|Withdrawal by Subject|6|||
146531463|NCT00492726|528454308|FG001|Overall Study|Withdrawal by Subject|3|||
146531464|NCT00492726|528454307|FG000|Overall Study|Non compliant with study medication|0|||
146531465|NCT00492726|528454308|FG001|Overall Study|Non compliant with study medication|3|||
146531466|NCT04386902|528454309|FG000|Overall Study|Withdrawal by Subject|5|||
146531467|NCT04386902|528454309|FG000|Overall Study|Technical problems in the recording|5|||
146531468|NCT01100502|528454310|FG000|Overall Study|Withdrawal by Subject|18|||
146531469|NCT01100502|528454311|FG001|Overall Study|Withdrawal by Subject|25|||
146531470|NCT01100502|528454310|FG000|Overall Study|Lost to Follow-up|13|||
146531471|NCT01100502|528454311|FG001|Overall Study|Lost to Follow-up|28|||
146531472|NCT01100502|528454310|FG000|Overall Study|Site request to end participation in study|0|||
146531473|NCT01100502|528454311|FG001|Overall Study|Site request to end participation in study|1|||
146531474|NCT01100502|528454310|FG000|Overall Study|Death|45|||
146531475|NCT01100502|528454311|FG001|Overall Study|Death|40|||
146531476|NCT00721799|528454312|FG000|Overall Study|Withdrawal by Subject|7|||
146531477|NCT00721799|528454312|FG000|Overall Study|withdraw by subject after scan 1|1|||
146531478|NCT05158140|528454314|FG000|Overall Study|Death|0|||
146531479|NCT05158140|528454315|FG001|Overall Study|Death|0|||
146531480|NCT05158140|528454316|FG002|Overall Study|Death|0|||
146531481|NCT05158140|528454317|FG003|Overall Study|Death|1|||
146531482|NCT05158140|528454314|FG000|Overall Study|Lost to Follow-up|3|||
146531483|NCT05158140|528454315|FG001|Overall Study|Lost to Follow-up|6|||
146531484|NCT05158140|528454316|FG002|Overall Study|Lost to Follow-up|4|||
146531485|NCT05158140|528454317|FG003|Overall Study|Lost to Follow-up|3|||
146531486|NCT05158140|528454314|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146531487|NCT05158140|528454315|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146531488|NCT05158140|528454316|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
146531489|NCT05158140|528454317|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
146531490|NCT05158140|528454314|FG000|Overall Study|Withdrawal by Subject|3|||
146531491|NCT05158140|528454315|FG001|Overall Study|Withdrawal by Subject|7|||
146531492|NCT05158140|528454316|FG002|Overall Study|Withdrawal by Subject|3|||
146531493|NCT05158140|528454317|FG003|Overall Study|Withdrawal by Subject|7|||
146531494|NCT00807365|528454321|FG000|Overall Study|Study Terminated|5|||
146531495|NCT01526785|528454323|FG000|Overall Study|Study Terminated by Sponsor|8|||
146531496|NCT01526785|528454323|FG000|Overall Study|Death|2|||
146531497|NCT01526785|528454323|FG000|Overall Study|Physician Decision|1|||
146531498|NCT01526785|528454323|FG000|Overall Study|Withdrawal by Subject|2|||
146531499|NCT01121263|528454326|FG000|Overall Study|Death|3|||
146531500|NCT01121263|528454327|FG001|Overall Study|Death|2|||
146531501|NCT01121263|528454326|FG000|Overall Study|Lost to Follow-up|22|||
146965107|NCT03110107|530033445|FG019|Treatment Period|Adverse Event|1|||
146965108|NCT03110107|530033446|FG020|Treatment Period|Adverse Event|4|||
146965109|NCT03110107|530033447|FG021|Treatment Period|Adverse Event|2|||
146965110|NCT03110107|530033448|FG022|Treatment Period|Adverse Event|2|||
146965111|NCT03110107|530033449|FG023|Treatment Period|Adverse Event|2|||
146965112|NCT03110107|530033450|FG024|Treatment Period|Adverse Event|2|||
146965113|NCT03110107|530033451|FG025|Treatment Period|Adverse Event|4|||
146965114|NCT03110107|530033426|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
146965115|NCT03110107|530033427|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
146531502|NCT01121263|528454327|FG001|Overall Study|Lost to Follow-up|12|||
146531503|NCT01121263|528454326|FG000|Overall Study|Withdrawal by Subject|0|||
146531504|NCT01121263|528454327|FG001|Overall Study|Withdrawal by Subject|1|||
146531505|NCT04350827|528454332|FG000|Overall Study|Lost to Follow-up|1|||
146531506|NCT04350827|528454333|FG001|Overall Study|Lost to Follow-up|2|||
146531507|NCT04265261|528454334|FG000|Overall Study|Adverse Event|2|||
146965116|NCT03110107|530033428|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
146965117|NCT03110107|530033429|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
146965118|NCT03110107|530033430|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
146965119|NCT03110107|530033431|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
146965120|NCT03110107|530033432|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
146965121|NCT03110107|530033433|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
146965122|NCT03110107|530033434|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
146965123|NCT03110107|530033435|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
146965124|NCT03110107|530033436|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
146965125|NCT03110107|530033437|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
146965126|NCT03110107|530033438|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
146965127|NCT03110107|530033439|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
146965128|NCT03110107|530033440|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
146965129|NCT03110107|530033441|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
146965130|NCT03110107|530033442|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
146965131|NCT03110107|530033443|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
146965132|NCT03110107|530033444|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
146965133|NCT03110107|530033445|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
146965134|NCT03110107|530033446|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
146965135|NCT03110107|530033447|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
146965136|NCT03110107|530033448|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
146965137|NCT03110107|530033449|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
146965138|NCT03110107|530033450|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
146965139|NCT03110107|530033451|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
146965140|NCT03110107|530033426|FG000|Treatment Period|Participant withdrew consent|0|||
146965141|NCT03110107|530033427|FG001|Treatment Period|Participant withdrew consent|0|||
146965142|NCT03110107|530033428|FG002|Treatment Period|Participant withdrew consent|1|||
146965143|NCT03110107|530033429|FG003|Treatment Period|Participant withdrew consent|0|||
146965144|NCT03110107|530033430|FG004|Treatment Period|Participant withdrew consent|4|||
146965145|NCT03110107|530033431|FG005|Treatment Period|Participant withdrew consent|3|||
146965146|NCT03110107|530033432|FG006|Treatment Period|Participant withdrew consent|0|||
146965147|NCT03110107|530033433|FG007|Treatment Period|Participant withdrew consent|0|||
146965148|NCT03110107|530033434|FG008|Treatment Period|Participant withdrew consent|0|||
146965149|NCT03110107|530033435|FG009|Treatment Period|Participant withdrew consent|1|||
146965150|NCT03110107|530033436|FG010|Treatment Period|Participant withdrew consent|0|||
146965151|NCT03110107|530033437|FG011|Treatment Period|Participant withdrew consent|0|||
146965152|NCT03110107|530033438|FG012|Treatment Period|Participant withdrew consent|0|||
146965153|NCT03110107|530033439|FG013|Treatment Period|Participant withdrew consent|0|||
146965154|NCT03110107|530033440|FG014|Treatment Period|Participant withdrew consent|0|||
146965155|NCT03110107|530033441|FG015|Treatment Period|Participant withdrew consent|0|||
146965156|NCT03110107|530033442|FG016|Treatment Period|Participant withdrew consent|0|||
146965157|NCT03110107|530033443|FG017|Treatment Period|Participant withdrew consent|0|||
146965158|NCT03110107|530033444|FG018|Treatment Period|Participant withdrew consent|0|||
146965159|NCT03110107|530033445|FG019|Treatment Period|Participant withdrew consent|1|||
146965160|NCT03110107|530033446|FG020|Treatment Period|Participant withdrew consent|0|||
146965161|NCT03110107|530033447|FG021|Treatment Period|Participant withdrew consent|2|||
146965162|NCT03110107|530033448|FG022|Treatment Period|Participant withdrew consent|0|||
146965163|NCT03110107|530033449|FG023|Treatment Period|Participant withdrew consent|0|||
146965164|NCT03110107|530033450|FG024|Treatment Period|Participant withdrew consent|0|||
146965165|NCT03110107|530033451|FG025|Treatment Period|Participant withdrew consent|2|||
146965166|NCT03110107|530033426|FG000|Treatment Period|Participants no longer meets study criteria|0|||
146965167|NCT03110107|530033427|FG001|Treatment Period|Participants no longer meets study criteria|0|||
146965168|NCT03110107|530033428|FG002|Treatment Period|Participants no longer meets study criteria|0|||
146531508|NCT04265261|528454335|FG001|Overall Study|Adverse Event|0|||
146531509|NCT04265261|528454336|FG002|Overall Study|Adverse Event|0|||
146762687|NCT00477412|529297070|FG001|Overall Study|Death|0|||
146531510|NCT04265261|528454334|FG000|Overall Study|Death|1|||
146762688|NCT00477412|529297071|FG002|Overall Study|Death|0|||
146762689|NCT00477412|529297072|FG003|Overall Study|Death|4|||
146762690|NCT00477412|529297069|FG000|Overall Study|Lost to Follow-up|0|||
146762691|NCT00477412|529297070|FG001|Overall Study|Lost to Follow-up|0|||
146762692|NCT00477412|529297071|FG002|Overall Study|Lost to Follow-up|0|||
146762693|NCT00477412|529297072|FG003|Overall Study|Lost to Follow-up|1|||
146762694|NCT00477412|529297069|FG000|Overall Study|Withdrawal by Subject|0|||
146762695|NCT00477412|529297070|FG001|Overall Study|Withdrawal by Subject|0|||
146762696|NCT00477412|529297071|FG002|Overall Study|Withdrawal by Subject|0|||
146965169|NCT03110107|530033429|FG003|Treatment Period|Participants no longer meets study criteria|0|||
146965170|NCT03110107|530033430|FG004|Treatment Period|Participants no longer meets study criteria|0|||
146965171|NCT03110107|530033431|FG005|Treatment Period|Participants no longer meets study criteria|0|||
146965172|NCT03110107|530033432|FG006|Treatment Period|Participants no longer meets study criteria|0|||
146864783|NCT04427501|529676831|FG007|Overall Study|Lost to Follow-up|10|||
146864784|NCT04427501|529676832|FG008|Overall Study|Lost to Follow-up|2|||
146864785|NCT04427501|529676833|FG009|Overall Study|Lost to Follow-up|5|||
146864786|NCT04427501|529676834|FG010|Overall Study|Lost to Follow-up|2|||
146864787|NCT04427501|529676835|FG011|Overall Study|Lost to Follow-up|0|||
146864788|NCT04427501|529676824|FG000|Overall Study|Physician Decision|0|||
146864789|NCT04427501|529676825|FG001|Overall Study|Physician Decision|3|||
146864790|NCT04427501|529676826|FG002|Overall Study|Physician Decision|0|||
146864791|NCT04427501|529676827|FG003|Overall Study|Physician Decision|0|||
146864792|NCT04427501|529676828|FG004|Overall Study|Physician Decision|0|||
146965173|NCT03110107|530033433|FG007|Treatment Period|Participants no longer meets study criteria|0|||
146965174|NCT03110107|530033434|FG008|Treatment Period|Participants no longer meets study criteria|0|||
146965175|NCT03110107|530033435|FG009|Treatment Period|Participants no longer meets study criteria|0|||
146965176|NCT03110107|530033436|FG010|Treatment Period|Participants no longer meets study criteria|0|||
146965177|NCT03110107|530033437|FG011|Treatment Period|Participants no longer meets study criteria|0|||
146965178|NCT03110107|530033438|FG012|Treatment Period|Participants no longer meets study criteria|0|||
146965179|NCT03110107|530033439|FG013|Treatment Period|Participants no longer meets study criteria|0|||
146965180|NCT03110107|530033440|FG014|Treatment Period|Participants no longer meets study criteria|0|||
146965181|NCT03110107|530033441|FG015|Treatment Period|Participants no longer meets study criteria|0|||
146965182|NCT03110107|530033442|FG016|Treatment Period|Participants no longer meets study criteria|0|||
146965183|NCT03110107|530033443|FG017|Treatment Period|Participants no longer meets study criteria|0|||
146965184|NCT03110107|530033444|FG018|Treatment Period|Participants no longer meets study criteria|0|||
146965185|NCT03110107|530033445|FG019|Treatment Period|Participants no longer meets study criteria|0|||
146965186|NCT03110107|530033446|FG020|Treatment Period|Participants no longer meets study criteria|0|||
146965187|NCT03110107|530033447|FG021|Treatment Period|Participants no longer meets study criteria|0|||
146965188|NCT03110107|530033448|FG022|Treatment Period|Participants no longer meets study criteria|0|||
146965189|NCT03110107|530033449|FG023|Treatment Period|Participants no longer meets study criteria|1|||
146965190|NCT03110107|530033450|FG024|Treatment Period|Participants no longer meets study criteria|0|||
146965191|NCT03110107|530033451|FG025|Treatment Period|Participants no longer meets study criteria|0|||
146965192|NCT03110107|530033426|FG000|Treatment Period|Other Reasons|0|||
146965193|NCT03110107|530033427|FG001|Treatment Period|Other Reasons|0|||
146965194|NCT03110107|530033428|FG002|Treatment Period|Other Reasons|1|||
146965195|NCT03110107|530033429|FG003|Treatment Period|Other Reasons|1|||
146965196|NCT03110107|530033430|FG004|Treatment Period|Other Reasons|0|||
146965197|NCT03110107|530033431|FG005|Treatment Period|Other Reasons|1|||
146965198|NCT03110107|530033432|FG006|Treatment Period|Other Reasons|0|||
146965199|NCT03110107|530033433|FG007|Treatment Period|Other Reasons|0|||
146965200|NCT03110107|530033434|FG008|Treatment Period|Other Reasons|0|||
146965201|NCT03110107|530033435|FG009|Treatment Period|Other Reasons|0|||
146965202|NCT03110107|530033436|FG010|Treatment Period|Other Reasons|0|||
146965203|NCT03110107|530033437|FG011|Treatment Period|Other Reasons|0|||
146965204|NCT03110107|530033438|FG012|Treatment Period|Other Reasons|0|||
146965205|NCT03110107|530033439|FG013|Treatment Period|Other Reasons|0|||
146965206|NCT03110107|530033440|FG014|Treatment Period|Other Reasons|0|||
146965207|NCT03110107|530033441|FG015|Treatment Period|Other Reasons|0|||
146965208|NCT03110107|530033442|FG016|Treatment Period|Other Reasons|0|||
146965209|NCT03110107|530033443|FG017|Treatment Period|Other Reasons|0|||
146965210|NCT03110107|530033444|FG018|Treatment Period|Other Reasons|0|||
146965211|NCT03110107|530033445|FG019|Treatment Period|Other Reasons|0|||
146965212|NCT03110107|530033446|FG020|Treatment Period|Other Reasons|0|||
146965213|NCT03110107|530033447|FG021|Treatment Period|Other Reasons|0|||
146965214|NCT03110107|530033448|FG022|Treatment Period|Other Reasons|0|||
146965215|NCT03110107|530033449|FG023|Treatment Period|Other Reasons|0|||
146965216|NCT03110107|530033450|FG024|Treatment Period|Other Reasons|1|||
146864793|NCT04427501|529676829|FG005|Overall Study|Physician Decision|0|||
146864794|NCT04427501|529676830|FG006|Overall Study|Physician Decision|2|||
146864795|NCT04427501|529676831|FG007|Overall Study|Physician Decision|0|||
146965217|NCT03110107|530033451|FG025|Treatment Period|Other Reasons|0|||
146965218|NCT03985982|530033452|FG000|Double-Blind Phase|Lost to Follow-up|4|||
146965219|NCT03985982|530033453|FG001|Double-Blind Phase|Lost to Follow-up|3|||
146965220|NCT03985982|530033454|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146965221|NCT03985982|530033452|FG000|Double-Blind Phase|Physician Decision|1|||
146864796|NCT04427501|529676832|FG008|Overall Study|Physician Decision|0|||
146864797|NCT04427501|529676833|FG009|Overall Study|Physician Decision|0|||
146965222|NCT03985982|530033453|FG001|Double-Blind Phase|Physician Decision|0|||
146965223|NCT03985982|530033454|FG002|Double-Blind Phase|Physician Decision|0|||
146864798|NCT04427501|529676834|FG010|Overall Study|Physician Decision|0|||
146864799|NCT04427501|529676835|FG011|Overall Study|Physician Decision|0|||
146864800|NCT04427501|529676824|FG000|Overall Study|Withdrawal by Subject|9|||
146531511|NCT04265261|528454335|FG001|Overall Study|Death|0|||
146762697|NCT00477412|529297072|FG003|Overall Study|Withdrawal by Subject|2|||
146762698|NCT00477412|529297069|FG000|Overall Study|Second Malignancy|0|||
146762699|NCT00477412|529297070|FG001|Overall Study|Second Malignancy|0|||
146762700|NCT00477412|529297071|FG002|Overall Study|Second Malignancy|0|||
146762701|NCT00477412|529297072|FG003|Overall Study|Second Malignancy|1|||
146762702|NCT00477412|529297069|FG000|Overall Study|Adverse Event|1|||
146762703|NCT00477412|529297070|FG001|Overall Study|Adverse Event|0|||
146762704|NCT00477412|529297071|FG002|Overall Study|Adverse Event|1|||
146762705|NCT00477412|529297072|FG003|Overall Study|Adverse Event|0|||
146762706|NCT02931396|529297074|FG000|Overall Study|Lost to Follow-up|3|||
146762707|NCT02931396|529297075|FG001|Overall Study|Lost to Follow-up|0|||
146762708|NCT02931396|529297074|FG000|Overall Study|Withdrawal by Subject|2|||
146762709|NCT02931396|529297075|FG001|Overall Study|Withdrawal by Subject|0|||
146762710|NCT05460663|529297076|FG000|Overall Study|Withdrawal by Subject|2|||
146762711|NCT05460663|529297077|FG001|Overall Study|Withdrawal by Subject|5|||
146762712|NCT03068468|529299254|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
146762713|NCT03068468|529299255|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
146762714|NCT03068468|529299256|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
146762715|NCT03068468|529299257|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
146762716|NCT03068468|529299254|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
146762717|NCT03068468|529299255|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
146762718|NCT03068468|529299256|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
146762719|NCT03068468|529299257|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
146762720|NCT03068468|529299254|FG000|Placebo-Controlled Period|Adverse Event|16|||
146762721|NCT03068468|529299255|FG001|Placebo-Controlled Period|Adverse Event|21|||
146762722|NCT03068468|529299256|FG002|Placebo-Controlled Period|Adverse Event|0|||
146762723|NCT03068468|529299257|FG003|Placebo-Controlled Period|Adverse Event|0|||
146762724|NCT03068468|529299254|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
146762725|NCT03068468|529299255|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
146762726|NCT03068468|529299256|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
146762727|NCT03068468|529299257|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
146762728|NCT03068468|529299254|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
146762729|NCT03068468|529299255|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
146762730|NCT03068468|529299256|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146762731|NCT03068468|529299257|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146762732|NCT03068468|529299254|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
146762733|NCT03068468|529299255|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
146762734|NCT03068468|529299256|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
146762735|NCT03068468|529299257|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
146762736|NCT03068468|529299254|FG000|Placebo-Controlled Period|Death|0|||
146762737|NCT03068468|529299255|FG001|Placebo-Controlled Period|Death|1|||
146762738|NCT03068468|529299256|FG002|Placebo-Controlled Period|Death|0|||
146762739|NCT03068468|529299257|FG003|Placebo-Controlled Period|Death|0|||
146762740|NCT03068468|529299254|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
146762741|NCT03068468|529299255|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
146762742|NCT03068468|529299256|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
146762743|NCT03068468|529299257|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
146762744|NCT03068468|529299254|FG000|Open-Label Extension Period|Adverse Event|0|||
146762745|NCT03068468|529299255|FG001|Open-Label Extension Period|Adverse Event|0|||
146762746|NCT03068468|529299256|FG002|Open-Label Extension Period|Adverse Event|13|||
146762747|NCT03068468|529299257|FG003|Open-Label Extension Period|Adverse Event|17|||
146762748|NCT03068468|529299254|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
146762749|NCT03068468|529299255|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
146762750|NCT03068468|529299256|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
146762751|NCT03068468|529299257|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
146762752|NCT03068468|529299254|FG000|Open-Label Extension Period|Death|0|||
146762753|NCT03068468|529299255|FG001|Open-Label Extension Period|Death|0|||
146864801|NCT04427501|529676825|FG001|Overall Study|Withdrawal by Subject|2|||
146864802|NCT04427501|529676826|FG002|Overall Study|Withdrawal by Subject|2|||
146864803|NCT04427501|529676827|FG003|Overall Study|Withdrawal by Subject|3|||
146864804|NCT04427501|529676828|FG004|Overall Study|Withdrawal by Subject|7|||
146864805|NCT04427501|529676829|FG005|Overall Study|Withdrawal by Subject|25|||
146864806|NCT04427501|529676830|FG006|Overall Study|Withdrawal by Subject|15|||
146864807|NCT04427501|529676831|FG007|Overall Study|Withdrawal by Subject|7|||
146864808|NCT04427501|529676832|FG008|Overall Study|Withdrawal by Subject|4|||
146864809|NCT04427501|529676833|FG009|Overall Study|Withdrawal by Subject|1|||
146864810|NCT04427501|529676834|FG010|Overall Study|Withdrawal by Subject|4|||
146864811|NCT04427501|529676835|FG011|Overall Study|Withdrawal by Subject|0|||
146864812|NCT04427501|529676824|FG000|Overall Study|Other - as reported by the investigator|1|||
146864813|NCT04427501|529676825|FG001|Overall Study|Other - as reported by the investigator|0|||
146864814|NCT04427501|529676826|FG002|Overall Study|Other - as reported by the investigator|0|||
146864815|NCT04427501|529676827|FG003|Overall Study|Other - as reported by the investigator|0|||
146864816|NCT04427501|529676828|FG004|Overall Study|Other - as reported by the investigator|0|||
146864817|NCT04427501|529676829|FG005|Overall Study|Other - as reported by the investigator|6|||
146531512|NCT04265261|528454336|FG002|Overall Study|Death|0|||
146864818|NCT04427501|529676830|FG006|Overall Study|Other - as reported by the investigator|6|||
146864819|NCT04427501|529676831|FG007|Overall Study|Other - as reported by the investigator|0|||
146864820|NCT04427501|529676832|FG008|Overall Study|Other - as reported by the investigator|0|||
146864821|NCT04427501|529676833|FG009|Overall Study|Other - as reported by the investigator|0|||
146864822|NCT04427501|529676834|FG010|Overall Study|Other - as reported by the investigator|0|||
146864823|NCT04427501|529676835|FG011|Overall Study|Other - as reported by the investigator|0|||
146864824|NCT04427501|529676824|FG000|Overall Study|Other|0|||
146864825|NCT04427501|529676825|FG001|Overall Study|Other|0|||
146864826|NCT04427501|529676826|FG002|Overall Study|Other|0|||
146864827|NCT04427501|529676827|FG003|Overall Study|Other|0|||
146864828|NCT04427501|529676828|FG004|Overall Study|Other|0|||
146864829|NCT04427501|529676829|FG005|Overall Study|Other|0|||
146864830|NCT04427501|529676830|FG006|Overall Study|Other|0|||
146864831|NCT04427501|529676831|FG007|Overall Study|Other|0|||
146864832|NCT04427501|529676832|FG008|Overall Study|Other|0|||
146864833|NCT04427501|529676833|FG009|Overall Study|Other|0|||
146864834|NCT04427501|529676834|FG010|Overall Study|Other|0|||
146864835|NCT04427501|529676835|FG011|Overall Study|Other|1|||
146864836|NCT04936841|529676836|FG000|Overall Study|Death|1|||
146864837|NCT04598477|529676841|FG000|Overall Study|Adverse Event|2|||
146864838|NCT04598477|529676842|FG001|Overall Study|Adverse Event|0|||
146864839|NCT04598477|529676841|FG000|Overall Study|Death|0|||
146864840|NCT04598477|529676842|FG001|Overall Study|Death|1|||
146864841|NCT04598477|529676841|FG000|Overall Study|Lost to Follow-up|1|||
146864842|NCT04598477|529676842|FG001|Overall Study|Lost to Follow-up|0|||
146864843|NCT04598477|529676841|FG000|Overall Study|Physician Decision|7|||
146864844|NCT04598477|529676842|FG001|Overall Study|Physician Decision|2|||
146864845|NCT04598477|529676841|FG000|Overall Study|Pregnancy|0|||
146864846|NCT04598477|529676842|FG001|Overall Study|Pregnancy|1|||
146864847|NCT04598477|529676841|FG000|Overall Study|Requires Prohibited Medication|0|||
146864848|NCT04598477|529676842|FG001|Overall Study|Requires Prohibited Medication|1|||
146864849|NCT04598477|529676841|FG000|Overall Study|Study Terminated by Sponsor|18|||
146864850|NCT04598477|529676842|FG001|Overall Study|Study Terminated by Sponsor|12|||
146864851|NCT04598477|529676841|FG000|Overall Study|Withdrawal by Subject|16|||
146864852|NCT04598477|529676842|FG001|Overall Study|Withdrawal by Subject|12|||
146864853|NCT04598477|529676841|FG000|Overall Study|Other|15|||
146864854|NCT04598477|529676842|FG001|Overall Study|Other|8|||
146864855|NCT05579990|529676843|FG000|Overall Study|Lost to Follow-up|3|||
146864856|NCT05118204|529676844|FG000|Overall Study|Lost to Follow-up|3|||
146864857|NCT05118204|529676845|FG001|Overall Study|Lost to Follow-up|2|||
146864858|NCT05118204|529676844|FG000|Overall Study|Withdrawal by Subject|0|||
146864859|NCT05118204|529676845|FG001|Overall Study|Withdrawal by Subject|2|||
146864860|NCT01313650|529676847|FG000|Overall Study|Adverse Event|9|||
146864861|NCT01313650|529676848|FG001|Overall Study|Adverse Event|34|||
146864862|NCT01313650|529676849|FG002|Overall Study|Adverse Event|24|||
146864863|NCT01313650|529676850|FG003|Overall Study|Adverse Event|23|||
146864864|NCT01313650|529676847|FG000|Overall Study|Lack of Efficacy|37|||
146864865|NCT01313650|529676848|FG001|Overall Study|Lack of Efficacy|20|||
146864866|NCT01313650|529676849|FG002|Overall Study|Lack of Efficacy|32|||
146864867|NCT01313650|529676850|FG003|Overall Study|Lack of Efficacy|20|||
146864868|NCT01313650|529676847|FG000|Overall Study|Lost to Follow-up|1|||
146864869|NCT01313650|529676848|FG001|Overall Study|Lost to Follow-up|0|||
146864870|NCT01313650|529676849|FG002|Overall Study|Lost to Follow-up|3|||
146864871|NCT01313650|529676850|FG003|Overall Study|Lost to Follow-up|2|||
146864872|NCT01313650|529676847|FG000|Overall Study|Withdrawal by Subject|16|||
146864873|NCT01313650|529676848|FG001|Overall Study|Withdrawal by Subject|20|||
146864874|NCT01313650|529676849|FG002|Overall Study|Withdrawal by Subject|15|||
146864875|NCT01313650|529676850|FG003|Overall Study|Withdrawal by Subject|15|||
146864876|NCT01313650|529676847|FG000|Overall Study|Protocol Violation|4|||
146864877|NCT01313650|529676848|FG001|Overall Study|Protocol Violation|7|||
146864878|NCT01313650|529676849|FG002|Overall Study|Protocol Violation|5|||
146864879|NCT01313650|529676850|FG003|Overall Study|Protocol Violation|6|||
146864880|NCT01313650|529676847|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
146864881|NCT01313650|529676848|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
146864882|NCT01313650|529676849|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
146864883|NCT01313650|529676850|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
146864884|NCT05393037|529676853|FG000|Part A|Death|1|||
146864885|NCT05393037|529676854|FG001|Part A|Death|0|||
146864886|NCT05393037|529676853|FG000|Part A|Lost to Follow-up|1|||
146864887|NCT05393037|529676854|FG001|Part A|Lost to Follow-up|1|||
146864888|NCT05393037|529676853|FG000|Part A|Withdrawal by Subject|2|||
146864889|NCT05393037|529676854|FG001|Part A|Withdrawal by Subject|4|||
146864890|NCT05393037|529676853|FG000|Part B|Lost to Follow-up|1|||
146864891|NCT05393037|529676854|FG001|Part B|Lost to Follow-up|0|||
146864892|NCT01012739|529676855|FG000|Treatment Period 1|Adverse Event|0|||
146965224|NCT03985982|530033452|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
146965225|NCT03985982|530033453|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
146965226|NCT03985982|530033454|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
146965227|NCT03985982|530033452|FG000|Double-Blind Phase|COVID-19|1|||
146965228|NCT03985982|530033453|FG001|Double-Blind Phase|COVID-19|0|||
146965229|NCT03985982|530033454|FG002|Double-Blind Phase|COVID-19|0|||
146965230|NCT03985982|530033452|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
146965231|NCT03985982|530033453|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
146965232|NCT03985982|530033454|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
146965233|NCT03985982|530033452|FG000|Open-Label Phase|Lost to Follow-up|0|||
146965234|NCT03985982|530033453|FG001|Open-Label Phase|Lost to Follow-up|0|||
146965235|NCT03985982|530033454|FG002|Open-Label Phase|Lost to Follow-up|13|||
146965236|NCT03985982|530033452|FG000|Open-Label Phase|Physician Decision|0|||
146965237|NCT03985982|530033453|FG001|Open-Label Phase|Physician Decision|0|||
146965238|NCT03985982|530033454|FG002|Open-Label Phase|Physician Decision|2|||
146965239|NCT03985982|530033452|FG000|Open-Label Phase|Withdrawal by Subject|0|||
146965240|NCT03985982|530033453|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146531513|NCT04265261|528454334|FG000|Overall Study|Lost to Follow-up|4|||
146531514|NCT04265261|528454335|FG001|Overall Study|Lost to Follow-up|1|||
146531515|NCT04265261|528454336|FG002|Overall Study|Lost to Follow-up|3|||
146531516|NCT04265261|528454334|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146531517|NCT04265261|528454335|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146531518|NCT04265261|528454336|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146531519|NCT04265261|528454334|FG000|Overall Study|Physician Decision|0|||
146531520|NCT04265261|528454335|FG001|Overall Study|Physician Decision|0|||
146531521|NCT04265261|528454336|FG002|Overall Study|Physician Decision|1|||
146531522|NCT04265261|528454334|FG000|Overall Study|Protocol Deviation|0|||
146864893|NCT01012739|529676856|FG001|Treatment Period 1|Adverse Event|0|||
146864894|NCT01012739|529676857|FG002|Treatment Period 1|Adverse Event|0|||
146531523|NCT04265261|528454335|FG001|Overall Study|Protocol Deviation|2|||
146531524|NCT04265261|528454336|FG002|Overall Study|Protocol Deviation|0|||
146531525|NCT04265261|528454334|FG000|Overall Study|Withdrawal by Subject|2|||
146531526|NCT04265261|528454335|FG001|Overall Study|Withdrawal by Subject|1|||
146531527|NCT04265261|528454336|FG002|Overall Study|Withdrawal by Subject|4|||
146531528|NCT02990000|528456159|FG000|Overall Study|Failed to provide data beyond baseline|36|||
146531529|NCT02990000|528456160|FG001|Overall Study|Failed to provide data beyond baseline|34|||
146531530|NCT00922636|528456161|FG000|Overall Study|Adverse Event|3|||
146531531|NCT00922636|528456162|FG001|Overall Study|Adverse Event|3|||
146531532|NCT00922636|528456163|FG002|Overall Study|Adverse Event|2|||
146531533|NCT00922636|528456164|FG003|Overall Study|Adverse Event|3|||
146531534|NCT00922636|528456165|FG004|Overall Study|Adverse Event|2|||
146531535|NCT00922636|528456161|FG000|Overall Study|Lack of Efficacy|1|||
146531536|NCT00922636|528456162|FG001|Overall Study|Lack of Efficacy|7|||
146531537|NCT00922636|528456163|FG002|Overall Study|Lack of Efficacy|3|||
146531538|NCT00922636|528456164|FG003|Overall Study|Lack of Efficacy|2|||
146531539|NCT00922636|528456165|FG004|Overall Study|Lack of Efficacy|4|||
146531540|NCT00922636|528456161|FG000|Overall Study|Sponsor Decision|0|||
146531541|NCT00922636|528456162|FG001|Overall Study|Sponsor Decision|0|||
146531542|NCT00922636|528456163|FG002|Overall Study|Sponsor Decision|2|||
146531543|NCT00922636|528456164|FG003|Overall Study|Sponsor Decision|0|||
146531544|NCT00922636|528456165|FG004|Overall Study|Sponsor Decision|0|||
146531545|NCT00922636|528456161|FG000|Overall Study|Withdrawal by Subject|0|||
146531546|NCT00922636|528456162|FG001|Overall Study|Withdrawal by Subject|0|||
146864895|NCT01012739|529676858|FG003|Treatment Period 1|Adverse Event|1|||
146864896|NCT01012739|529676855|FG000|Treatment Period 2|Abnormal test procedure results|0|||
146864897|NCT01012739|529676856|FG001|Treatment Period 2|Abnormal test procedure results|0|||
146864898|NCT01012739|529676857|FG002|Treatment Period 2|Abnormal test procedure results|0|||
146864899|NCT01012739|529676858|FG003|Treatment Period 2|Abnormal test procedure results|1|||
146864900|NCT02593786|529676863|FG000|Overall Study|Disease progression|12|||
146864901|NCT02593786|529676864|FG001|Overall Study|Disease progression|16|||
146864902|NCT02593786|529676865|FG002|Overall Study|Disease progression|10|||
146531547|NCT00922636|528456163|FG002|Overall Study|Withdrawal by Subject|5|||
146531548|NCT00922636|528456164|FG003|Overall Study|Withdrawal by Subject|2|||
146965241|NCT03985982|530033454|FG002|Open-Label Phase|Withdrawal by Subject|11|||
146965242|NCT01298362|530033455|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
146531549|NCT00922636|528456165|FG004|Overall Study|Withdrawal by Subject|4|||
146864903|NCT02593786|529676866|FG003|Overall Study|Disease progression|7|||
146531550|NCT00922636|528456161|FG000|Overall Study|Protocol Violation|0|||
146531551|NCT00922636|528456162|FG001|Overall Study|Protocol Violation|0|||
146531552|NCT00922636|528456163|FG002|Overall Study|Protocol Violation|2|||
146864904|NCT02593786|529676863|FG000|Overall Study|Study drug toxicity|1|||
146864905|NCT02593786|529676864|FG001|Overall Study|Study drug toxicity|0|||
146864906|NCT02593786|529676865|FG002|Overall Study|Study drug toxicity|0|||
146531553|NCT00922636|528456164|FG003|Overall Study|Protocol Violation|2|||
146531554|NCT00922636|528456165|FG004|Overall Study|Protocol Violation|0|||
146531555|NCT00922636|528456161|FG000|Overall Study|Entry Criteria Not Met|0|||
146531556|NCT00922636|528456162|FG001|Overall Study|Entry Criteria Not Met|0|||
146531557|NCT00922636|528456163|FG002|Overall Study|Entry Criteria Not Met|1|||
146531558|NCT00922636|528456164|FG003|Overall Study|Entry Criteria Not Met|1|||
146531559|NCT00922636|528456165|FG004|Overall Study|Entry Criteria Not Met|0|||
146531560|NCT00922636|528456161|FG000|Overall Study|Parent/Caregiver Decision|2|||
146531561|NCT00922636|528456162|FG001|Overall Study|Parent/Caregiver Decision|4|||
146531562|NCT00922636|528456163|FG002|Overall Study|Parent/Caregiver Decision|3|||
146531563|NCT00922636|528456164|FG003|Overall Study|Parent/Caregiver Decision|5|||
146531564|NCT00922636|528456165|FG004|Overall Study|Parent/Caregiver Decision|2|||
146531565|NCT00922636|528456161|FG000|Overall Study|Lost to Follow-up|1|||
146531566|NCT00922636|528456162|FG001|Overall Study|Lost to Follow-up|2|||
146531567|NCT00922636|528456163|FG002|Overall Study|Lost to Follow-up|2|||
146531568|NCT00922636|528456164|FG003|Overall Study|Lost to Follow-up|2|||
146531569|NCT00922636|528456165|FG004|Overall Study|Lost to Follow-up|4|||
146531570|NCT02812186|528456166|FG000|Period 1|Post randomization screen failure|5|||
146531571|NCT02812186|528456167|FG001|Period 1|Post randomization screen failure|9|||
146965243|NCT01298362|530033456|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
146965244|NCT01283009|530033462|FG000|Overall Study|Death|83|||
146965245|NCT01283009|530033463|FG001|Overall Study|Death|78|||
146965246|NCT01283009|530033462|FG000|Overall Study|Study ended early|23|||
146965247|NCT01283009|530033463|FG001|Overall Study|Study ended early|26|||
146965248|NCT01283009|530033462|FG000|Overall Study|Withdrawal by Subject|10|||
146965249|NCT01283009|530033463|FG001|Overall Study|Withdrawal by Subject|8|||
146965250|NCT01283009|530033462|FG000|Overall Study|Physician Decision|1|||
146965251|NCT01283009|530033463|FG001|Overall Study|Physician Decision|1|||
146965252|NCT01283009|530033462|FG000|Overall Study|Lost to Follow-up|1|||
146965253|NCT01283009|530033463|FG001|Overall Study|Lost to Follow-up|0|||
146965254|NCT01283009|530033462|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
146965255|NCT01283009|530033463|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
146965256|NCT00505765|530033472|FG000|Overall Study|Withdrawal by Subject|1|||
146965257|NCT00505765|530033473|FG001|Overall Study|Withdrawal by Subject|0|||
146965258|NCT00505765|530033474|FG002|Overall Study|Withdrawal by Subject|0|||
146965259|NCT00505765|530033472|FG000|Overall Study|Adverse Event|1|||
146965260|NCT00505765|530033473|FG001|Overall Study|Adverse Event|2|||
146531572|NCT02812186|528456166|FG000|Period 1|nonevaluable data sets|6|||
146531573|NCT02812186|528456167|FG001|Period 1|nonevaluable data sets|6|||
146531574|NCT00161213|528456168|FG000|Overall Study|Withdrawal by Subject|1|||
146531575|NCT00161213|528456168|FG000|Overall Study|Evaluable for toxicity but not response|1|||
146531576|NCT03103503|528456169|FG000|Overall Study|Death|64|||
146531577|NCT03103503|528456169|FG000|Overall Study|Physician Decision|57|||
146531578|NCT03103503|528456169|FG000|Overall Study|Withdrawal by Subject|10|||
146531579|NCT03103503|528456169|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
146531580|NCT03103503|528456169|FG000|Overall Study|Lost to Follow-up|3|||
146531581|NCT03103503|528456169|FG000|Overall Study|Study Closure|757|||
146531582|NCT03342001|528456172|FG000|Overall Study|Adverse Event|1|||
146864907|NCT02593786|529676866|FG003|Overall Study|Study drug toxicity|0|||
146864908|NCT02593786|529676863|FG000|Overall Study|Adverse event unrelated to study drug|1|||
146965261|NCT00505765|530033474|FG002|Overall Study|Adverse Event|0|||
146965262|NCT00505765|530033472|FG000|Overall Study|Noncompliance|0|||
146965263|NCT00505765|530033473|FG001|Overall Study|Noncompliance|1|||
146965264|NCT00505765|530033474|FG002|Overall Study|Noncompliance|3|||
146965265|NCT02743117|530033475|FG000|Overall Study|Lost to Follow-up|0|||
146965266|NCT02743117|530033476|FG001|Overall Study|Lost to Follow-up|1|||
146864909|NCT02593786|529676864|FG001|Overall Study|Adverse event unrelated to study drug|1|||
146864910|NCT02593786|529676865|FG002|Overall Study|Adverse event unrelated to study drug|1|||
146864911|NCT02593786|529676866|FG003|Overall Study|Adverse event unrelated to study drug|0|||
146864912|NCT02593786|529676863|FG000|Overall Study|Participant request to discontinue study therapy|0|||
146864913|NCT02593786|529676864|FG001|Overall Study|Participant request to discontinue study therapy|2|||
146864914|NCT02593786|529676865|FG002|Overall Study|Participant request to discontinue study therapy|0|||
146864915|NCT02593786|529676866|FG003|Overall Study|Participant request to discontinue study therapy|0|||
146864916|NCT02593786|529676863|FG000|Overall Study|Other reasons|1|||
146965267|NCT02743117|530033475|FG000|Overall Study|Other|1|||
146965268|NCT02743117|530033476|FG001|Overall Study|Other|0|||
146965269|NCT01207219|530033478|FG000|Overall Study|changed diagnosis during study period|5|||
146965270|NCT01207219|530033479|FG001|Overall Study|changed diagnosis during study period|3|||
146965271|NCT01207219|530033480|FG002|Overall Study|changed diagnosis during study period|1|||
146965272|NCT01207219|530033478|FG000|Overall Study|Lost to Follow-up|6|||
146965273|NCT01207219|530033479|FG001|Overall Study|Lost to Follow-up|8|||
146965274|NCT01207219|530033480|FG002|Overall Study|Lost to Follow-up|6|||
146531583|NCT03342001|528456172|FG000|Overall Study|Lost to Follow-up|1|||
146531584|NCT01433159|528456174|FG000|Overall Study|Adverse Event|1|||
146531585|NCT01433159|528456175|FG001|Overall Study|Adverse Event|0|||
146531586|NCT01433159|528456174|FG000|Overall Study|Physician Decision|1|||
146965275|NCT01453296|530033481|FG000|Treatment Period 1|Adverse Event|0|||
146965276|NCT01453296|530033482|FG001|Treatment Period 1|Adverse Event|1|||
146965277|NCT01453296|530033481|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
146965278|NCT01453296|530033482|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
146531587|NCT01433159|528456175|FG001|Overall Study|Physician Decision|0|||
146531588|NCT01433159|528456174|FG000|Overall Study|Protocol Violation|0|||
146531589|NCT01433159|528456175|FG001|Overall Study|Protocol Violation|1|||
146531590|NCT01930539|528456191|FG000|Overall Study|Withdrawal by Subject|2|||
146531591|NCT01930539|528456192|FG001|Overall Study|Withdrawal by Subject|2|||
146531592|NCT02579629|528456193|FG000|Overall Study|Withdrawal by Subject|0|||
146531593|NCT02579629|528456194|FG001|Overall Study|Withdrawal by Subject|1|||
146531594|NCT02579629|528456195|FG002|Overall Study|Withdrawal by Subject|0|||
146531595|NCT02579629|528456193|FG000|Overall Study|Screen Failure|2|||
146531596|NCT02579629|528456194|FG001|Overall Study|Screen Failure|0|||
146531597|NCT02579629|528456195|FG002|Overall Study|Screen Failure|2|||
146531598|NCT01190891|528456196|FG000|Overall Study|Protocol Violation|1|||
146531599|NCT01190891|528456197|FG001|Overall Study|Protocol Violation|0|||
146531600|NCT01190891|528456196|FG000|Overall Study|Withdrawal by Subject|5|||
146531601|NCT01190891|528456197|FG001|Overall Study|Withdrawal by Subject|0|||
146531602|NCT01926028|528456198|FG000|Overall Study|Lost to Follow-up|7|||
146531603|NCT01926028|528456199|FG001|Overall Study|Lost to Follow-up|6|||
146531604|NCT01926028|528456200|FG002|Overall Study|Lost to Follow-up|0|||
146531605|NCT01926028|528456198|FG000|Overall Study|Physician Decision|1|||
146531606|NCT01926028|528456199|FG001|Overall Study|Physician Decision|5|||
146531607|NCT01926028|528456200|FG002|Overall Study|Physician Decision|0|||
146531608|NCT01926028|528456198|FG000|Overall Study|Withdrawal by Subject|9|||
146531609|NCT01926028|528456199|FG001|Overall Study|Withdrawal by Subject|9|||
146531610|NCT01926028|528456200|FG002|Overall Study|Withdrawal by Subject|2|||
146531611|NCT01926028|528456198|FG000|Overall Study|Non compliance or other reasons|4|||
146531612|NCT01926028|528456199|FG001|Overall Study|Non compliance or other reasons|2|||
146531613|NCT01926028|528456200|FG002|Overall Study|Non compliance or other reasons|0|||
146531614|NCT00737048|528456201|FG000|Overall Study|Physician Decision|0|||
146531615|NCT00737048|528456202|FG001|Overall Study|Physician Decision|0|||
146531616|NCT00737048|528456203|FG002|Overall Study|Physician Decision|1|||
146531617|NCT00737048|528456201|FG000|Overall Study|Adverse Event|0|||
146531618|NCT00737048|528456202|FG001|Overall Study|Adverse Event|1|||
146531619|NCT00737048|528456203|FG002|Overall Study|Adverse Event|0|||
146531620|NCT00737048|528456201|FG000|Overall Study|Worsening of the symptoms|3|||
146531621|NCT00737048|528456202|FG001|Overall Study|Worsening of the symptoms|5|||
146965279|NCT01453296|530033481|FG000|Treatment Period 2|Adverse Event|1|||
146965280|NCT01453296|530033482|FG001|Treatment Period 2|Adverse Event|0|||
146965281|NCT01453296|530033481|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146965282|NCT01453296|530033482|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146965283|NCT00620776|530033483|FG000|Overall Study|Did not receive treatment|3|||
146965284|NCT00620776|530033484|FG001|Overall Study|Did not receive treatment|5|||
146965285|NCT00620776|530033483|FG000|Overall Study|Adverse Event|2|||
146965286|NCT00620776|530033484|FG001|Overall Study|Adverse Event|3|||
146965287|NCT00620776|530033483|FG000|Overall Study|Lack of Efficacy|2|||
146965288|NCT00620776|530033484|FG001|Overall Study|Lack of Efficacy|1|||
146965289|NCT00620776|530033483|FG000|Overall Study|Lost to Follow-up|2|||
146965290|NCT00620776|530033484|FG001|Overall Study|Lost to Follow-up|5|||
146965291|NCT00620776|530033483|FG000|Overall Study|Withdrawal by Subject|3|||
146965292|NCT00620776|530033484|FG001|Overall Study|Withdrawal by Subject|2|||
146965293|NCT00183170|530033489|FG000|First Intervention|Did not complete study|1|||
146965294|NCT00183170|530033490|FG001|First Intervention|Did not complete study|0|||
146965295|NCT00183170|530033489|FG000|First Intervention|Did not meet targeted BrAC|1|||
146965296|NCT00183170|530033490|FG001|First Intervention|Did not meet targeted BrAC|0|||
146965297|NCT00183170|530033489|FG000|Washout 1 Week|Did not complete study|6|||
146965298|NCT00183170|530033490|FG001|Washout 1 Week|Did not complete study|8|||
146965299|NCT00183170|530033489|FG000|Second Intervention|Did not complete study|1|||
146965300|NCT00183170|530033490|FG001|Second Intervention|Did not complete study|0|||
146965301|NCT00183170|530033489|FG000|Second Intervention|Did not meet targeted BrAC|0|||
146965302|NCT00183170|530033490|FG001|Second Intervention|Did not meet targeted BrAC|2|||
146965303|NCT00924820|530033491|FG000|Overall Study|Death|2|||
146965304|NCT00924820|530033491|FG000|Overall Study|Ineligible, Screen Failure|5|||
146965305|NCT04983589|530033492|FG000|Overall Study|Withdrawal by Subject|0|||
146965306|NCT04983589|530033493|FG001|Overall Study|Withdrawal by Subject|3|||
146965307|NCT04983589|530033492|FG000|Overall Study|COVID-19 Infection|1|||
146531622|NCT00737048|528456203|FG002|Overall Study|Worsening of the symptoms|3|||
146531623|NCT04635839|528456204|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
146531624|NCT04635839|528456205|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
146531625|NCT02737358|528456206|FG000|Overall Study|Withdrawal by Subject|7|||
146531626|NCT02737358|528456207|FG001|Overall Study|Withdrawal by Subject|12|||
146531627|NCT02737358|528456206|FG000|Overall Study|Lost to Follow-up|2|||
146531628|NCT02737358|528456207|FG001|Overall Study|Lost to Follow-up|3|||
146965308|NCT04983589|530033493|FG001|Overall Study|COVID-19 Infection|0|||
146965309|NCT04983589|530033492|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
146965310|NCT04983589|530033493|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
146531629|NCT00744939|528456209|FG000|Overall Study|Withdrawal by Subject|9|||
146531630|NCT00744939|528456209|FG000|Overall Study|Protocol Violation|13|||
146531631|NCT00744939|528456209|FG000|Overall Study|Death|24|||
146531632|NCT00744939|528456209|FG000|Overall Study|distance|4|||
146531633|NCT00744939|528456209|FG000|Overall Study|Lost to Follow-up|12|||
146531634|NCT00744939|528456209|FG000|Overall Study|Medical history exclusionary|1|||
146531635|NCT00744939|528456209|FG000|Overall Study|Did not receive Magnevist|7|||
146531636|NCT00744939|528456209|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
146531637|NCT00744939|528456209|FG000|Overall Study|coma|1|||
146531638|NCT00744939|528456209|FG000|Overall Study|incorrect race|1|||
146531639|NCT01248455|528456212|FG000|Overall Study|switched to alternate treatment|1|||
146531640|NCT00426270|528456213|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
146531641|NCT00426270|528456213|FG000|Overall Study|Adverse Event|5|||
146531642|NCT01587885|528456214|FG000|Treatment Period 1|Failure to Return|0|||
146762754|NCT03068468|529299256|FG002|Open-Label Extension Period|Death|0|||
146762755|NCT03068468|529299257|FG003|Open-Label Extension Period|Death|1|||
146762756|NCT03068468|529299254|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
146762757|NCT03068468|529299255|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
146762758|NCT03068468|529299256|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
146762759|NCT03068468|529299257|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
146762760|NCT03068468|529299254|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
146762761|NCT03068468|529299255|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
146762762|NCT03068468|529299256|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
146762763|NCT03068468|529299257|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
146762764|NCT03068468|529299254|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
146762765|NCT03068468|529299255|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
146762766|NCT03068468|529299256|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
146762767|NCT03068468|529299257|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
146762768|NCT03068468|529299254|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
146762769|NCT03068468|529299255|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
146762770|NCT03068468|529299256|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
146762771|NCT03068468|529299257|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
146762772|NCT03068468|529299254|FG000|Open-Label Extension Period|Reason not Specified|0|||
146762773|NCT03068468|529299255|FG001|Open-Label Extension Period|Reason not Specified|0|||
146762774|NCT03068468|529299256|FG002|Open-Label Extension Period|Reason not Specified|1|||
146762775|NCT03068468|529299257|FG003|Open-Label Extension Period|Reason not Specified|4|||
146762776|NCT02466516|529299259|FG000|Overall Study|Adverse Event|1|||
146762777|NCT02466516|529299260|FG001|Overall Study|Adverse Event|1|||
146762778|NCT02466516|529299261|FG002|Overall Study|Adverse Event|0|||
146762779|NCT02466516|529299262|FG003|Overall Study|Adverse Event|0|||
146762780|NCT02466516|529299263|FG004|Overall Study|Adverse Event|0|||
146762781|NCT02466516|529299259|FG000|Overall Study|Withdrew Consent|1|||
146762782|NCT02466516|529299260|FG001|Overall Study|Withdrew Consent|0|||
146762783|NCT02466516|529299261|FG002|Overall Study|Withdrew Consent|0|||
146762784|NCT02466516|529299262|FG003|Overall Study|Withdrew Consent|0|||
146762785|NCT02466516|529299263|FG004|Overall Study|Withdrew Consent|0|||
146762786|NCT02466516|529299259|FG000|Overall Study|Lost to Follow-up|2|||
146762787|NCT02466516|529299260|FG001|Overall Study|Lost to Follow-up|0|||
146762788|NCT02466516|529299261|FG002|Overall Study|Lost to Follow-up|1|||
146762789|NCT02466516|529299262|FG003|Overall Study|Lost to Follow-up|0|||
146762790|NCT02466516|529299263|FG004|Overall Study|Lost to Follow-up|0|||
146762791|NCT03712930|529299264|FG000|Overall Study|Death|7|||
146762792|NCT03712930|529299264|FG000|Overall Study|Physician Decision|1|||
146762793|NCT03712930|529299264|FG000|Overall Study|Study Terminated by Sponsor|3|||
146762794|NCT03712930|529299264|FG000|Overall Study|Progressive Disease|2|||
146762795|NCT03895034|529299265|FG000|Overall Study|Lost to Follow-up|2|||
146762796|NCT03784963|529299266|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
146762797|NCT03784963|529299267|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
146762798|NCT03784963|529299268|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
146762799|NCT03784963|529299269|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
146762800|NCT01510912|529299270|FG000|Overall Study|Adverse Event|99|||
146762801|NCT01510912|529299270|FG000|Overall Study|Lack of Efficacy|12|||
146762802|NCT01510912|529299270|FG000|Overall Study|Non-compliance with trial drug|23|||
146762803|NCT01510912|529299270|FG000|Overall Study|Withdrawal by Subject|49|||
146762804|NCT01510912|529299270|FG000|Overall Study|Physician Decision|1|||
146762805|NCT01510912|529299270|FG000|Overall Study|Protocol Violation|27|||
146762806|NCT01510912|529299270|FG000|Overall Study|Lost to Follow-up|26|||
146762807|NCT01510912|529299270|FG000|Overall Study|Other, including joint replacement|5|||
146762808|NCT03181958|529299271|FG000|Overall Study|Lost to Follow-up|17|||
146762809|NCT03181958|529299272|FG001|Overall Study|Lost to Follow-up|21|||
146864917|NCT02593786|529676864|FG001|Overall Study|Other reasons|1|||
146864918|NCT02593786|529676865|FG002|Overall Study|Other reasons|0|||
146864919|NCT02593786|529676866|FG003|Overall Study|Other reasons|5|||
146864920|NCT03901053|529676874|FG000|Overall Study|Lost to Follow-up|6|||
146864921|NCT03901053|529676875|FG001|Overall Study|Lost to Follow-up|2|||
146864922|NCT03901053|529676874|FG000|Overall Study|Withdrawal by Subject|4|||
146864923|NCT03901053|529676875|FG001|Overall Study|Withdrawal by Subject|3|||
146864924|NCT03901053|529676874|FG000|Overall Study|Unsatisfactory Device|1|||
146864925|NCT03901053|529676875|FG001|Overall Study|Unsatisfactory Device|2|||
146864926|NCT03901053|529676874|FG000|Overall Study|No longer meets study criteria|1|||
146864927|NCT03901053|529676875|FG001|Overall Study|No longer meets study criteria|3|||
146864928|NCT03901053|529676874|FG000|Overall Study|Subject's Medical Status|0|||
146864929|NCT03901053|529676875|FG001|Overall Study|Subject's Medical Status|1|||
146864930|NCT03901053|529676874|FG000|Overall Study|Screening Failure|1|||
146864931|NCT03901053|529676875|FG001|Overall Study|Screening Failure|0|||
146864932|NCT02408861|529676876|FG000|Overall Study|Death|0|||
146864933|NCT02408861|529676877|FG001|Overall Study|Death|3|||
146864934|NCT02408861|529676878|FG002|Overall Study|Death|1|||
146864935|NCT02408861|529676879|FG003|Overall Study|Death|2|||
146864936|NCT02408861|529676880|FG004|Overall Study|Death|4|||
146864937|NCT02408861|529676881|FG005|Overall Study|Death|1|||
146864938|NCT02408861|529676882|FG006|Overall Study|Death|0|||
146864939|NCT02408861|529676876|FG000|Overall Study|Lost to Follow-up|0|||
146864940|NCT02408861|529676877|FG001|Overall Study|Lost to Follow-up|0|||
146864941|NCT02408861|529676878|FG002|Overall Study|Lost to Follow-up|1|||
146864942|NCT02408861|529676879|FG003|Overall Study|Lost to Follow-up|1|||
146864943|NCT02408861|529676880|FG004|Overall Study|Lost to Follow-up|4|||
146864944|NCT02408861|529676881|FG005|Overall Study|Lost to Follow-up|2|||
146864945|NCT02408861|529676882|FG006|Overall Study|Lost to Follow-up|1|||
146864946|NCT02408861|529676876|FG000|Overall Study|Disease Progression|0|||
146864947|NCT02408861|529676877|FG001|Overall Study|Disease Progression|0|||
146864948|NCT02408861|529676878|FG002|Overall Study|Disease Progression|1|||
146864949|NCT02408861|529676879|FG003|Overall Study|Disease Progression|0|||
146864950|NCT02408861|529676880|FG004|Overall Study|Disease Progression|3|||
146864951|NCT02408861|529676881|FG005|Overall Study|Disease Progression|1|||
146864952|NCT02408861|529676882|FG006|Overall Study|Disease Progression|1|||
146864953|NCT02408861|529676876|FG000|Overall Study|Adverse Event|1|||
146864954|NCT02408861|529676877|FG001|Overall Study|Adverse Event|0|||
146864955|NCT02408861|529676878|FG002|Overall Study|Adverse Event|1|||
146864956|NCT02408861|529676879|FG003|Overall Study|Adverse Event|0|||
146864957|NCT02408861|529676880|FG004|Overall Study|Adverse Event|2|||
146864958|NCT02408861|529676881|FG005|Overall Study|Adverse Event|0|||
146864959|NCT02408861|529676882|FG006|Overall Study|Adverse Event|0|||
146864960|NCT02408861|529676876|FG000|Overall Study|Physician Decision|1|||
146864961|NCT02408861|529676877|FG001|Overall Study|Physician Decision|1|||
146864962|NCT02408861|529676878|FG002|Overall Study|Physician Decision|1|||
146864963|NCT02408861|529676879|FG003|Overall Study|Physician Decision|0|||
146864964|NCT02408861|529676880|FG004|Overall Study|Physician Decision|0|||
146864965|NCT02408861|529676881|FG005|Overall Study|Physician Decision|1|||
146864966|NCT02408861|529676882|FG006|Overall Study|Physician Decision|0|||
146864967|NCT02408861|529676876|FG000|Overall Study|Protocol Violation|1|||
146864968|NCT02408861|529676877|FG001|Overall Study|Protocol Violation|0|||
146864969|NCT02408861|529676878|FG002|Overall Study|Protocol Violation|0|||
146864970|NCT02408861|529676879|FG003|Overall Study|Protocol Violation|0|||
146864971|NCT02408861|529676880|FG004|Overall Study|Protocol Violation|0|||
146864972|NCT02408861|529676881|FG005|Overall Study|Protocol Violation|0|||
146864973|NCT02408861|529676882|FG006|Overall Study|Protocol Violation|0|||
146864974|NCT02408861|529676876|FG000|Overall Study|Withdrawal by Subject|0|||
146864975|NCT02408861|529676877|FG001|Overall Study|Withdrawal by Subject|0|||
146864976|NCT02408861|529676878|FG002|Overall Study|Withdrawal by Subject|0|||
146864977|NCT02408861|529676879|FG003|Overall Study|Withdrawal by Subject|0|||
146864978|NCT02408861|529676880|FG004|Overall Study|Withdrawal by Subject|1|||
146864979|NCT02408861|529676881|FG005|Overall Study|Withdrawal by Subject|1|||
146864980|NCT02408861|529676882|FG006|Overall Study|Withdrawal by Subject|0|||
146864981|NCT02408861|529676876|FG000|Overall Study|Other Treatment|0|||
146864982|NCT02408861|529676877|FG001|Overall Study|Other Treatment|0|||
146864983|NCT02408861|529676878|FG002|Overall Study|Other Treatment|0|||
146864984|NCT02408861|529676879|FG003|Overall Study|Other Treatment|0|||
146864985|NCT02408861|529676880|FG004|Overall Study|Other Treatment|0|||
146864986|NCT02408861|529676881|FG005|Overall Study|Other Treatment|1|||
146864987|NCT02408861|529676882|FG006|Overall Study|Other Treatment|1|||
146531643|NCT01587885|528456215|FG001|Treatment Period 1|Failure to Return|1|||
146531644|NCT01587885|528456214|FG000|Treatment Period 1|Protocol Violation|0|||
146531645|NCT01587885|528456215|FG001|Treatment Period 1|Protocol Violation|2|||
146531646|NCT02062437|528456217|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
146531647|NCT02062437|528456217|FG000|Overall Study|Patient not available for the 2y visit|18|||
146531648|NCT02062437|528456217|FG000|Overall Study|Death|2|||
146865002|NCT01890148|529678265|FG000|Overall Study|Adverse Event|1|||
146865003|NCT01215175|529678266|FG000|Overall Study|Lost to Follow-up|0|||
146865004|NCT01215175|529678267|FG001|Overall Study|Lost to Follow-up|1|||
146865005|NCT01215175|529678268|FG002|Overall Study|Lost to Follow-up|0|||
146865006|NCT01215175|529678269|FG003|Overall Study|Lost to Follow-up|1|||
146865007|NCT01215175|529678270|FG004|Overall Study|Lost to Follow-up|0|||
146865008|NCT01678209|529678271|FG000|Overall Study|could not scan twice|1|||
146865009|NCT01678209|529678272|FG001|Overall Study|could not scan twice|1|||
146865010|NCT01678209|529678273|FG002|Overall Study|could not scan twice|1|||
146865011|NCT01678209|529678271|FG000|Overall Study|scheduling conflicts|0|||
146865012|NCT01678209|529678272|FG001|Overall Study|scheduling conflicts|0|||
146865013|NCT01678209|529678273|FG002|Overall Study|scheduling conflicts|1|||
146865014|NCT01678209|529678271|FG000|Overall Study|screen fail|16|||
146865015|NCT01678209|529678272|FG001|Overall Study|screen fail|17|||
146865016|NCT01678209|529678273|FG002|Overall Study|screen fail|16|||
146865017|NCT03756350|529678274|FG000|Overall Study|Lost to Follow-up|1|||
146865018|NCT01096342|529678275|FG000|Overall Study|Protocol Violation|1|||
146865019|NCT05104476|529678280|FG000|Overall Study|Randomized But Not Treated|1|||
146865020|NCT05104476|529678281|FG001|Overall Study|Randomized But Not Treated|2|||
146865021|NCT05104476|529678280|FG000|Overall Study|Adverse Event|2|||
146865022|NCT05104476|529678281|FG001|Overall Study|Adverse Event|2|||
146865023|NCT05104476|529678280|FG000|Overall Study|Withdrawal by Subject|3|||
146865024|NCT05104476|529678281|FG001|Overall Study|Withdrawal by Subject|3|||
146865025|NCT05104476|529678280|FG000|Overall Study|Other Than Specified|0|||
146865026|NCT05104476|529678281|FG001|Overall Study|Other Than Specified|3|||
146865027|NCT04964960|529678282|FG000|Overall Study|Withdrawal by Subject|1|||
146865028|NCT04964960|529678282|FG000|Overall Study|Did not complete cycles|1|||
146865029|NCT01423812|529678283|FG000|Overall Study|Lost to Follow-up|2|||
146865030|NCT01423812|529678284|FG001|Overall Study|Lost to Follow-up|2|||
146865031|NCT01423812|529678283|FG000|Overall Study|Withdrawal by Subject|1|||
146865032|NCT01423812|529678284|FG001|Overall Study|Withdrawal by Subject|2|||
146865033|NCT03155373|529678285|FG000|Overall Study|No longer required surgery|1|||
146865034|NCT03155373|529678285|FG000|Overall Study|Protocol Violation|1|||
146865035|NCT03155373|529678285|FG000|Overall Study|Death|2|||
146865036|NCT03155373|529678285|FG000|Overall Study|Withdrawal by Subject|3|||
146865037|NCT02616614|529678286|FG000|Overall Study|Withdrawal by Subject|10|||
146865038|NCT02616614|529678287|FG001|Overall Study|Withdrawal by Subject|5|||
146865039|NCT02616614|529678288|FG002|Overall Study|Withdrawal by Subject|6|||
146865040|NCT02616614|529678286|FG000|Overall Study|Physician Decision|2|||
146865041|NCT02616614|529678287|FG001|Overall Study|Physician Decision|1|||
146865042|NCT02616614|529678288|FG002|Overall Study|Physician Decision|0|||
146865043|NCT02616614|529678286|FG000|Overall Study|Adverse Event|1|||
146865044|NCT02616614|529678287|FG001|Overall Study|Adverse Event|4|||
146865045|NCT02616614|529678288|FG002|Overall Study|Adverse Event|1|||
146865046|NCT02616614|529678286|FG000|Overall Study|Protocol Violation|0|||
146865047|NCT02616614|529678287|FG001|Overall Study|Protocol Violation|3|||
146865048|NCT02616614|529678288|FG002|Overall Study|Protocol Violation|1|||
146865049|NCT02616614|529678286|FG000|Overall Study|Prohibited Medication|12|||
146865050|NCT02616614|529678287|FG001|Overall Study|Prohibited Medication|9|||
146865051|NCT02616614|529678288|FG002|Overall Study|Prohibited Medication|5|||
146865052|NCT02616614|529678286|FG000|Overall Study|More than 3 applications missed|6|||
146865053|NCT02616614|529678287|FG001|Overall Study|More than 3 applications missed|8|||
146865054|NCT02616614|529678288|FG002|Overall Study|More than 3 applications missed|1|||
146865055|NCT02616614|529678286|FG000|Overall Study|Lost to Follow-up|31|||
146865056|NCT02616614|529678287|FG001|Overall Study|Lost to Follow-up|28|||
146865057|NCT02616614|529678288|FG002|Overall Study|Lost to Follow-up|13|||
146865058|NCT02616614|529678286|FG000|Overall Study|Pregnancy|2|||
146865059|NCT02616614|529678287|FG001|Overall Study|Pregnancy|0|||
146865060|NCT02616614|529678288|FG002|Overall Study|Pregnancy|1|||
146865061|NCT02616614|529678286|FG000|Overall Study|Other|1|||
146865062|NCT02616614|529678287|FG001|Overall Study|Other|2|||
146865063|NCT02616614|529678288|FG002|Overall Study|Other|1|||
146865064|NCT01233869|529678291|FG000|Initial Treatment Period (24 Months)|Death|1|||
146865065|NCT01233869|529678292|FG001|Initial Treatment Period (24 Months)|Death|0|||
146865066|NCT01233869|529678293|FG002|Initial Treatment Period (24 Months)|Death|0|||
146531649|NCT02062437|528456217|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
146865067|NCT01233869|529678294|FG003|Initial Treatment Period (24 Months)|Death|0|||
146865068|NCT01233869|529678291|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
146865069|NCT01233869|529678292|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
146865070|NCT01233869|529678293|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
146865071|NCT01233869|529678294|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
146865072|NCT01233869|529678291|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
146865073|NCT01233869|529678292|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
146865074|NCT01233869|529678293|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
146865075|NCT01233869|529678294|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
146865076|NCT01233869|529678291|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
146865077|NCT01233869|529678292|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
146865078|NCT01233869|529678293|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
146865079|NCT01233869|529678294|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
146965311|NCT00585468|530033494|FG000|First Intervention|Withdrawal by Subject|1|||
146965312|NCT00585468|530033495|FG001|First Intervention|Withdrawal by Subject|1|||
146965313|NCT00978120|530033500|FG000|Overall Study|Death|0|||
146965314|NCT00978120|530033501|FG001|Overall Study|Death|0|||
146965315|NCT00978120|530033502|FG002|Overall Study|Death|0|||
146965316|NCT00978120|530033503|FG003|Overall Study|Death|1|||
146965317|NCT00978120|530033500|FG000|Overall Study|Lost to Follow-up|0|||
146965318|NCT00978120|530033501|FG001|Overall Study|Lost to Follow-up|0|||
146965319|NCT00978120|530033502|FG002|Overall Study|Lost to Follow-up|3|||
146965320|NCT00978120|530033503|FG003|Overall Study|Lost to Follow-up|0|||
146965321|NCT00978120|530033500|FG000|Overall Study|Withdrawal by Subject|2|||
146965322|NCT00978120|530033501|FG001|Overall Study|Withdrawal by Subject|0|||
146965323|NCT00978120|530033502|FG002|Overall Study|Withdrawal by Subject|0|||
146965324|NCT00978120|530033503|FG003|Overall Study|Withdrawal by Subject|0|||
146965325|NCT00978120|530033500|FG000|Overall Study|Moved out of state|0|||
146965326|NCT00978120|530033501|FG001|Overall Study|Moved out of state|0|||
146965327|NCT00978120|530033502|FG002|Overall Study|Moved out of state|0|||
146965328|NCT00978120|530033503|FG003|Overall Study|Moved out of state|1|||
146965329|NCT00762073|530033504|FG000|Overall Study|Lack of Efficacy|1|||
146965330|NCT00762073|530033505|FG001|Overall Study|Lack of Efficacy|1|||
146965331|NCT00762073|530033506|FG002|Overall Study|Lack of Efficacy|0|||
146965332|NCT00762073|530033507|FG003|Overall Study|Lack of Efficacy|0|||
146965333|NCT00762073|530033504|FG000|Overall Study|Adverse Event|1|||
146965334|NCT00762073|530033505|FG001|Overall Study|Adverse Event|0|||
146965335|NCT00762073|530033506|FG002|Overall Study|Adverse Event|1|||
146965336|NCT00762073|530033507|FG003|Overall Study|Adverse Event|1|||
146965337|NCT00762073|530033504|FG000|Overall Study|Significant Subject Noncompliance|0|||
146965338|NCT00762073|530033505|FG001|Overall Study|Significant Subject Noncompliance|1|||
146965339|NCT00762073|530033506|FG002|Overall Study|Significant Subject Noncompliance|0|||
146965340|NCT00762073|530033507|FG003|Overall Study|Significant Subject Noncompliance|1|||
146965341|NCT00762073|530033504|FG000|Overall Study|Withdrawal by Subject|1|||
146965342|NCT00762073|530033505|FG001|Overall Study|Withdrawal by Subject|2|||
146965343|NCT00762073|530033506|FG002|Overall Study|Withdrawal by Subject|1|||
146965344|NCT00762073|530033507|FG003|Overall Study|Withdrawal by Subject|1|||
146965345|NCT00762073|530033504|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
146965346|NCT00762073|530033505|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
146965347|NCT00762073|530033506|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
146965348|NCT00762073|530033507|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
146965349|NCT03155269|530033514|FG000|Overall Study|Withdrawal by Subject|4|||
146965350|NCT03155269|530033515|FG001|Overall Study|Withdrawal by Subject|5|||
146965351|NCT03155269|530033514|FG000|Overall Study|Lost to Follow-up|1|||
146965352|NCT03155269|530033515|FG001|Overall Study|Lost to Follow-up|2|||
146965353|NCT02369874|530033518|FG000|Overall Study|Lost to Follow-up|2|||
146965354|NCT02369874|530033519|FG001|Overall Study|Lost to Follow-up|2|||
146965355|NCT02369874|530033520|FG002|Overall Study|Lost to Follow-up|2|||
146965356|NCT02369874|530033518|FG000|Overall Study|Withdrawal by Subject|7|||
146865080|NCT01233869|529678291|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
146865081|NCT01233869|529678292|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
146865082|NCT01233869|529678293|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
146965357|NCT02369874|530033519|FG001|Overall Study|Withdrawal by Subject|9|||
146965358|NCT02369874|530033520|FG002|Overall Study|Withdrawal by Subject|27|||
146531650|NCT02900352|528456218|FG000|Overall Study|Lost to Follow-up|28|||
146965359|NCT02369874|530033518|FG000|Overall Study|Miscellaneous|1|||
146965360|NCT02369874|530033519|FG001|Overall Study|Miscellaneous|1|||
146965361|NCT02369874|530033520|FG002|Overall Study|Miscellaneous|0|||
146965362|NCT02369874|530033518|FG000|Overall Study|On Treatment/Off Study|34|||
146965363|NCT02369874|530033519|FG001|Overall Study|On Treatment/Off Study|45|||
146965364|NCT02369874|530033520|FG002|Overall Study|On Treatment/Off Study|32|||
146965365|NCT00596466|530033521|FG000|Overall Study|Lack of Efficacy|5|||
146965366|NCT00596466|530033521|FG000|Overall Study|Adverse Event|4|||
146965367|NCT00596466|530033521|FG000|Overall Study|Withdrawal by Subject|2|||
146965368|NCT00596466|530033521|FG000|Overall Study|Protocol Violation|2|||
146965369|NCT00596466|530033521|FG000|Overall Study|Unpecified|2|||
146965370|NCT00596466|530033521|FG000|Overall Study|Enrolled, not treated|2|||
146965371|NCT00145795|530033522|FG000|Overall Study|Adverse Event|1|||
146965372|NCT00145795|530033523|FG001|Overall Study|Adverse Event|0|||
146965373|NCT01891669|530033524|FG000|Overall Study|Death|0|||
146965374|NCT01891669|530033525|FG001|Overall Study|Death|0|||
146965375|NCT01891669|530033526|FG002|Overall Study|Death|0|||
146965376|NCT01891669|530033527|FG003|Overall Study|Death|0|||
146965377|NCT01891669|530033528|FG004|Overall Study|Death|0|||
146965378|NCT01891669|530033529|FG005|Overall Study|Death|0|||
146965379|NCT01891669|530033530|FG006|Overall Study|Death|0|||
146965380|NCT01891669|530033531|FG007|Overall Study|Death|1|||
146965381|NCT01891669|530033532|FG008|Overall Study|Death|0|||
146965382|NCT01891669|530033533|FG009|Overall Study|Death|1|||
146965383|NCT01891669|530033524|FG000|Overall Study|Withdrawal by Subject|1|||
146965384|NCT01891669|530033525|FG001|Overall Study|Withdrawal by Subject|1|||
146965385|NCT01891669|530033526|FG002|Overall Study|Withdrawal by Subject|0|||
146965386|NCT01891669|530033527|FG003|Overall Study|Withdrawal by Subject|0|||
146965387|NCT01891669|530033528|FG004|Overall Study|Withdrawal by Subject|0|||
146965388|NCT01891669|530033529|FG005|Overall Study|Withdrawal by Subject|0|||
146965389|NCT01891669|530033530|FG006|Overall Study|Withdrawal by Subject|1|||
146965390|NCT01891669|530033531|FG007|Overall Study|Withdrawal by Subject|2|||
146965391|NCT01891669|530033532|FG008|Overall Study|Withdrawal by Subject|1|||
146965392|NCT01891669|530033533|FG009|Overall Study|Withdrawal by Subject|1|||
146965393|NCT01891669|530033524|FG000|Overall Study|Other|1|||
146965394|NCT01891669|530033525|FG001|Overall Study|Other|0|||
146965395|NCT01891669|530033526|FG002|Overall Study|Other|0|||
146965396|NCT01891669|530033527|FG003|Overall Study|Other|0|||
146965397|NCT01891669|530033528|FG004|Overall Study|Other|0|||
146965398|NCT01891669|530033529|FG005|Overall Study|Other|0|||
146965399|NCT01891669|530033530|FG006|Overall Study|Other|0|||
146965400|NCT01891669|530033531|FG007|Overall Study|Other|1|||
146965401|NCT01891669|530033532|FG008|Overall Study|Other|0|||
146965402|NCT01891669|530033533|FG009|Overall Study|Other|0|||
146762810|NCT03181958|529299273|FG002|Overall Study|Lost to Follow-up|15|||
146762811|NCT00349908|529299277|FG000|Overall Study|Withdrawal by Subject|0|||
146762812|NCT00349908|529299278|FG001|Overall Study|Withdrawal by Subject|4|||
146762813|NCT00151996|529299281|FG000|Overall Study|Adverse Event|3|||
146762814|NCT00151996|529299282|FG001|Overall Study|Adverse Event|2|||
146762815|NCT00151996|529299281|FG000|Overall Study|Withdrawal by Subject|1|||
146762816|NCT00151996|529299282|FG001|Overall Study|Withdrawal by Subject|1|||
146762817|NCT00151996|529299281|FG000|Overall Study|Protocol Violation|1|||
146762818|NCT00151996|529299282|FG001|Overall Study|Protocol Violation|2|||
146762819|NCT00151996|529299281|FG000|Overall Study|Sponsor's decision|0|||
146762820|NCT00151996|529299282|FG001|Overall Study|Sponsor's decision|2|||
146762821|NCT00109967|529299285|FG000|Overall Study|Cancel Prior to Treatment|2|||
146762822|NCT00109967|529299286|FG001|Overall Study|Cancel Prior to Treatment|0|||
146762823|NCT00109967|529299285|FG000|Overall Study|Adverse Event|12|||
146762824|NCT00109967|529299286|FG001|Overall Study|Adverse Event|1|||
146762825|NCT00109967|529299285|FG000|Overall Study|Withdrawal by Subject|5|||
146762826|NCT00109967|529299286|FG001|Overall Study|Withdrawal by Subject|0|||
146762827|NCT00109967|529299285|FG000|Overall Study|Physician Decision|1|||
146762828|NCT00109967|529299286|FG001|Overall Study|Physician Decision|3|||
146762829|NCT00109967|529299285|FG000|Overall Study|Death|0|||
146762830|NCT00109967|529299286|FG001|Overall Study|Death|2|||
146762831|NCT01977612|529299289|FG000|Overall Study|Lost to Follow-up|1|||
146762832|NCT01977612|529299290|FG001|Overall Study|Lost to Follow-up|1|||
146762833|NCT02715258|529299291|FG000|Overall Study|Withdrawal by Subject|6|||
146762834|NCT02715258|529299292|FG001|Overall Study|Withdrawal by Subject|1|||
146762835|NCT02715258|529299291|FG000|Overall Study|Lost to Follow-up|7|||
146762836|NCT02715258|529299292|FG001|Overall Study|Lost to Follow-up|1|||
146762837|NCT02715258|529299291|FG000|Overall Study|Terminated by Sponsor|0|||
146762838|NCT02715258|529299292|FG001|Overall Study|Terminated by Sponsor|1|||
146762839|NCT02715258|529299291|FG000|Overall Study|Death|0|||
146762840|NCT02715258|529299292|FG001|Overall Study|Death|1|||
146762841|NCT02715258|529299291|FG000|Overall Study|Subject non-compliant|1|||
146762842|NCT02715258|529299292|FG001|Overall Study|Subject non-compliant|1|||
146762843|NCT02715258|529299291|FG000|Overall Study|GCP violation|2|||
146762844|NCT02715258|529299292|FG001|Overall Study|GCP violation|1|||
146762845|NCT02955069|529299294|FG000|Overall Study|Adverse Event|7|||
146762846|NCT02955069|529299295|FG001|Overall Study|Adverse Event|2|||
146762847|NCT02955069|529299294|FG000|Overall Study|Death|7|||
146762848|NCT02955069|529299295|FG001|Overall Study|Death|3|||
146762849|NCT02955069|529299294|FG000|Overall Study|Physician Decision|10|||
146762850|NCT02955069|529299295|FG001|Overall Study|Physician Decision|2|||
146762851|NCT02955069|529299294|FG000|Overall Study|Progressive disease|64|||
146531651|NCT02900352|528456219|FG001|Overall Study|Lost to Follow-up|17|||
146762852|NCT02955069|529299295|FG001|Overall Study|Progressive disease|13|||
146762853|NCT02955069|529299294|FG000|Overall Study|Study terminated by sponsor|4|||
146965403|NCT00480077|530033534|FG000|Overall Study|Death|19|||
146865083|NCT01233869|529678294|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
146865084|NCT01233869|529678291|FG000|Extended Treatment Period (46 Months)|Other|3|||
146865085|NCT01233869|529678292|FG001|Extended Treatment Period (46 Months)|Other|0|||
146865086|NCT01233869|529678293|FG002|Extended Treatment Period (46 Months)|Other|0|||
146865087|NCT01233869|529678294|FG003|Extended Treatment Period (46 Months)|Other|3|||
146865088|NCT01233869|529678291|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
146865089|NCT01233869|529678292|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
146865090|NCT01233869|529678293|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
146865091|NCT01233869|529678294|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
146531652|NCT02089347|528456220|FG000|Overall Study|Protocol Violation|1|||
146531653|NCT02089347|528456221|FG001|Overall Study|Protocol Violation|0|||
146531654|NCT00001566|528456222|FG000|Overall Study|patients' choice to discontinue protocol|3|||
146531655|NCT00001566|528456222|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
146531656|NCT00001566|528456222|FG000|Overall Study|Death|13|||
146531657|NCT00001566|528456222|FG000|Overall Study|Lost to Follow-up|1|||
146531658|NCT00001566|528456222|FG000|Overall Study|unable to complete initial apheresis|1|||
146531659|NCT03439137|528456227|FG000|Overall Study|Adverse Event|16|||
146531660|NCT03439137|528456228|FG001|Overall Study|Adverse Event|12|||
146531661|NCT03439137|528456227|FG000|Overall Study|Physician Decision|0|||
146531662|NCT03439137|528456228|FG001|Overall Study|Physician Decision|5|||
146531663|NCT03439137|528456227|FG000|Overall Study|Withdrawal by Subject|14|||
146531664|NCT03439137|528456228|FG001|Overall Study|Withdrawal by Subject|4|||
146531665|NCT03439137|528456227|FG000|Overall Study|Conducting rescue therapy|2|||
146531666|NCT03439137|528456228|FG001|Overall Study|Conducting rescue therapy|1|||
146531667|NCT03439137|528456227|FG000|Overall Study|Difficult to control Hb|10|||
146531668|NCT03439137|528456228|FG001|Overall Study|Difficult to control Hb|2|||
146531669|NCT03439137|528456227|FG000|Overall Study|Initiation of a renal transplant|0|||
146531670|NCT03439137|528456228|FG001|Overall Study|Initiation of a renal transplant|2|||
146531671|NCT01225549|528456233|FG000|Period 4 - Washout|Disallowed medication|0|||
146531672|NCT01225549|528456234|FG001|Period 4 - Washout|Disallowed medication|1|||
146531673|NCT01225549|528456235|FG002|Period 4 - Washout|Disallowed medication|0|||
146531674|NCT01225549|528456236|FG003|Period 4 - Washout|Disallowed medication|0|||
146531675|NCT01225549|528456237|FG004|Period 4 - Washout|Disallowed medication|0|||
146531676|NCT01225549|528456238|FG005|Period 4 - Washout|Disallowed medication|0|||
146531677|NCT01225549|528456239|FG006|Period 4 - Washout|Disallowed medication|0|||
146531678|NCT01225549|528456240|FG007|Period 4 - Washout|Disallowed medication|0|||
146531679|NCT01225549|528456241|FG008|Period 4 - Washout|Disallowed medication|0|||
146531680|NCT01225549|528456242|FG009|Period 4 - Washout|Disallowed medication|0|||
146531681|NCT01225549|528456233|FG000|Period 6 - Washout|Disallowed medication|0|||
146531682|NCT01225549|528456234|FG001|Period 6 - Washout|Disallowed medication|0|||
146531683|NCT01225549|528456235|FG002|Period 6 - Washout|Disallowed medication|0|||
146865092|NCT02378220|529678296|FG000|Overall Study|Death|6|||
146865093|NCT02378220|529678297|FG001|Overall Study|Death|1|||
146865094|NCT00866723|529678298|FG000|Overall Study|Withdrawal by Subject|1|||
146865095|NCT00866723|529678298|FG000|Overall Study|Disease Progression|4|||
146865096|NCT01975428|529678302|FG000|Overall Study|Lost to Follow-up|17|||
146865097|NCT01975428|529678303|FG001|Overall Study|Lost to Follow-up|4|||
146865098|NCT01975428|529678302|FG000|Overall Study|Withdrawal by Subject|3|||
146865099|NCT01975428|529678303|FG001|Overall Study|Withdrawal by Subject|10|||
146865100|NCT00628251|529678304|FG000|Randomised Part|Withdrawal by Subject|0|||
146865101|NCT00628251|529678305|FG001|Randomised Part|Withdrawal by Subject|0|||
146865102|NCT00628251|529678306|FG002|Randomised Part|Withdrawal by Subject|1|||
146865103|NCT00628251|529678304|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
146865104|NCT00628251|529678305|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
146865105|NCT00628251|529678306|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
146865106|NCT00628251|529678304|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
146865107|NCT00628251|529678305|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
146865108|NCT00628251|529678306|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
146865109|NCT00628251|529678304|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
146865110|NCT00628251|529678305|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
146865111|NCT00628251|529678306|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
146865112|NCT00628251|529678304|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
146865113|NCT00628251|529678305|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
146865114|NCT00628251|529678306|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
146865115|NCT00628251|529678304|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
146865116|NCT00628251|529678305|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
146865117|NCT00628251|529678306|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
146865118|NCT02066051|529678309|FG000|Overall Study|Subject developed active GVHD|1|||
146865119|NCT02401412|529678310|FG000|Overall Study|Lost to Follow-up|1|||
146865120|NCT02401412|529678311|FG001|Overall Study|Lost to Follow-up|0|||
146865121|NCT02401412|529678310|FG000|Overall Study|Discontinued Intervention|15|||
146865122|NCT02401412|529678311|FG001|Overall Study|Discontinued Intervention|21|||
146865123|NCT02401412|529678310|FG000|Overall Study|Withdrawal by Subject|4|||
146865124|NCT02401412|529678311|FG001|Overall Study|Withdrawal by Subject|4|||
146865125|NCT02401412|529678310|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
146865126|NCT02401412|529678311|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
146865127|NCT02401412|529678310|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
146865128|NCT02401412|529678311|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
146865129|NCT00882310|529678316|FG000|Overall Study|Screen Failure|10|||
146865130|NCT00882310|529678316|FG000|Overall Study|Never received treatment|1|||
146865131|NCT00882310|529678316|FG000|Overall Study|Death|6|||
146865132|NCT00882310|529678316|FG000|Overall Study|Progression of disease|4|||
146865133|NCT00882310|529678316|FG000|Overall Study|Adverse Event|1|||
146865134|NCT01093625|529678317|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
146865135|NCT01093625|529678318|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
146865136|NCT01093625|529678317|FG000|2-Week Visit|Withdrawal by Subject|1|||
146865137|NCT01093625|529678318|FG001|2-Week Visit|Withdrawal by Subject|0|||
146865138|NCT01093625|529678317|FG000|1-Month Visit|Lost to Follow-up|2|||
146865139|NCT01093625|529678318|FG001|1-Month Visit|Lost to Follow-up|0|||
146865140|NCT01093625|529678317|FG000|3-Month Visit|Lost to Follow-up|2|||
146865141|NCT01093625|529678318|FG001|3-Month Visit|Lost to Follow-up|0|||
146865142|NCT01093625|529678317|FG000|6-Month Visit|Withdrawal by Subject|6|||
146865143|NCT01093625|529678318|FG001|6-Month Visit|Withdrawal by Subject|7|||
146865144|NCT01093625|529678317|FG000|6-Month Visit|Lost to Follow-up|2|||
146865145|NCT01093625|529678318|FG001|6-Month Visit|Lost to Follow-up|2|||
146865146|NCT01093625|529678317|FG000|1-Year Visit|Lost to Follow-up|5|||
146865147|NCT01093625|529678318|FG001|1-Year Visit|Lost to Follow-up|3|||
146865148|NCT04233164|529678325|FG000|Overall Study|Unable to obtain specimen|0|||
146865149|NCT04233164|529678326|FG001|Overall Study|Unable to obtain specimen|1|||
146865150|NCT01843218|529678331|FG000|Overall Study|Withdrawal by Subject|5|||
146865151|NCT01431534|529678332|FG000|Treatment Phase|Adverse Event|0|||
146531684|NCT01225549|528456236|FG003|Period 6 - Washout|Disallowed medication|1|||
146965404|NCT00480077|530033535|FG001|Overall Study|Death|15|||
146865152|NCT01431534|529678333|FG001|Treatment Phase|Adverse Event|0|||
146865153|NCT01431534|529678334|FG002|Treatment Phase|Adverse Event|1|||
146865154|NCT01431534|529678332|FG000|Treatment Phase|Progressive Disease|4|||
146965405|NCT00480077|530033534|FG000|Overall Study|early exit|12|||
146965406|NCT00480077|530033535|FG001|Overall Study|early exit|11|||
146965407|NCT04527380|530033538|FG000|Overall Study|Lack of Efficacy|0|||
146965408|NCT04527380|530033539|FG001|Overall Study|Lack of Efficacy|1|||
146965409|NCT04527380|530033538|FG000|Overall Study|Withdrawal by Subject|1|||
146965410|NCT04527380|530033539|FG001|Overall Study|Withdrawal by Subject|0|||
146965411|NCT00938366|530033540|FG000|Overall Study|Withdrawal by Subject|1|||
146965412|NCT00938366|530033541|FG001|Overall Study|Withdrawal by Subject|0|||
146965413|NCT01215968|530033544|FG000|Overall Study|Adverse Event|0|||
146965414|NCT01215968|530033545|FG001|Overall Study|Adverse Event|2|||
146965415|NCT01215968|530033544|FG000|Overall Study|Protocol Violation|2|||
146965416|NCT01215968|530033545|FG001|Overall Study|Protocol Violation|4|||
146965417|NCT01215968|530033544|FG000|Overall Study|Not received study drug|0|||
146965418|NCT01215968|530033545|FG001|Overall Study|Not received study drug|1|||
146965419|NCT03759340|530033550|FG000|Overall Study|Adverse Event|2|||
146965420|NCT03759340|530033550|FG000|Overall Study|Lost to Follow-up|1|||
146965421|NCT03759340|530033550|FG000|Overall Study|Withdrawal by Subject|15|||
146965422|NCT03759340|530033550|FG000|Overall Study|Study Terminated by Sponsor|38|||
146965423|NCT03795233|530033551|FG000|Overall Study|Withdrawal by Subject|2|||
146965424|NCT03795233|530033552|FG001|Overall Study|Withdrawal by Subject|1|||
146965425|NCT03795233|530033551|FG000|Overall Study|Lost to Follow-up|1|||
146965426|NCT03795233|530033552|FG001|Overall Study|Lost to Follow-up|0|||
146965427|NCT03795233|530033551|FG000|Overall Study|Death|1|||
146531685|NCT01225549|528456237|FG004|Period 6 - Washout|Disallowed medication|0|||
146531686|NCT01225549|528456238|FG005|Period 6 - Washout|Disallowed medication|0|||
146531687|NCT01225549|528456239|FG006|Period 6 - Washout|Disallowed medication|0|||
146531688|NCT01225549|528456240|FG007|Period 6 - Washout|Disallowed medication|0|||
146965428|NCT03795233|530033552|FG001|Overall Study|Death|0|||
146965429|NCT01054443|530033553|FG000|Overall Study|Withdrawal by Subject|0|||
146965430|NCT01054443|530033554|FG001|Overall Study|Withdrawal by Subject|0|||
146965431|NCT01054443|530033555|FG002|Overall Study|Withdrawal by Subject|0|||
146965432|NCT01054443|530033556|FG003|Overall Study|Withdrawal by Subject|1|||
146865155|NCT01431534|529678333|FG001|Treatment Phase|Progressive Disease|3|||
146865156|NCT01431534|529678334|FG002|Treatment Phase|Progressive Disease|10|||
146865157|NCT01009554|529678335|FG000|Overall Study|Adverse Event|1|||
146865158|NCT01009554|529678336|FG001|Overall Study|Adverse Event|1|||
146865159|NCT01009554|529678335|FG000|Overall Study|Withdrawal by Subject|1|||
146965433|NCT00985114|530033558|FG000|Overall Study|Adverse Event|1|||
146531689|NCT01225549|528456241|FG008|Period 6 - Washout|Disallowed medication|0|||
146865160|NCT01009554|529678336|FG001|Overall Study|Withdrawal by Subject|3|||
146965434|NCT00985114|530033559|FG001|Overall Study|Adverse Event|0|||
146865161|NCT01009554|529678335|FG000|Overall Study|Noncompliant with Study Product|0|||
146965435|NCT00985114|530033558|FG000|Overall Study|Withdrawal by Subject|0|||
146965436|NCT00985114|530033559|FG001|Overall Study|Withdrawal by Subject|2|||
146865162|NCT01009554|529678336|FG001|Overall Study|Noncompliant with Study Product|3|||
146965437|NCT02950831|530033560|FG000|Overall Study|Lost to Follow-up|1|||
146965438|NCT02950831|530033560|FG000|Overall Study|Withdrawal by Subject|3|||
146965439|NCT02950831|530033560|FG000|Overall Study|stimulation trail failure|5|||
146965440|NCT01119118|530033561|FG000|Overall Study|Adverse Event|1|||
146965441|NCT01676818|530033565|FG000|Overall Study|Physician Decision|1|||
146965442|NCT01676818|530033565|FG000|Overall Study|Withdrawal by Subject|1|||
146965443|NCT04075656|530033572|FG000|Overall Study|Withdrawal by Subject|5|||
146965444|NCT04075656|530033573|FG001|Overall Study|Withdrawal by Subject|5|||
146965445|NCT00563706|530035119|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
146965446|NCT00563706|530035120|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
146965447|NCT00563706|530035121|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
146965448|NCT00563706|530035122|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
146965449|NCT00563706|530035123|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
146965450|NCT00563706|530035124|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
146965451|NCT00563706|530035125|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
146965452|NCT00563706|530035126|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
146965453|NCT00563706|530035127|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
146965454|NCT00563706|530035119|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
146965455|NCT00563706|530035120|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
146965456|NCT00563706|530035121|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
146965457|NCT00563706|530035122|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
146965458|NCT00563706|530035123|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
146965459|NCT00563706|530035124|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
146965460|NCT00563706|530035125|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
146965461|NCT00563706|530035126|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
146965462|NCT00563706|530035127|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
146965463|NCT00563706|530035119|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
146865163|NCT01605253|529678337|FG000|Overall Study|Physician Decision|3|||
146865164|NCT01605253|529678338|FG001|Overall Study|Physician Decision|2|||
146865165|NCT01605253|529678337|FG000|Overall Study|Lost to Follow-up|3|||
146865166|NCT01605253|529678338|FG001|Overall Study|Lost to Follow-up|1|||
146865167|NCT04029480|529678348|FG000|Overall Study|Physician Decision|0|||
146865168|NCT04029480|529678349|FG001|Overall Study|Physician Decision|0|||
146865169|NCT04029480|529678350|FG002|Overall Study|Physician Decision|2|||
146965464|NCT00563706|530035120|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
146965465|NCT00563706|530035121|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
146965466|NCT00563706|530035122|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
146965467|NCT00563706|530035123|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
146965468|NCT00563706|530035124|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
146965469|NCT00563706|530035125|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
146965470|NCT00563706|530035126|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
146965471|NCT00563706|530035127|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
146965472|NCT00563706|530035119|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
146965473|NCT00563706|530035120|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
146965474|NCT00563706|530035121|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
146965475|NCT00563706|530035122|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
146965476|NCT00563706|530035123|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
146965477|NCT00563706|530035124|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
146965478|NCT00563706|530035125|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
146965479|NCT00563706|530035126|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
146965480|NCT00563706|530035127|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
146965481|NCT00563706|530035119|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
146965482|NCT00563706|530035120|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
146965483|NCT00563706|530035121|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
146965484|NCT00563706|530035122|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
146965485|NCT00563706|530035123|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
146965486|NCT00563706|530035124|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
146965487|NCT00563706|530035125|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
146965488|NCT00563706|530035126|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
146965489|NCT00563706|530035127|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
146865170|NCT04029480|529678351|FG003|Overall Study|Physician Decision|1|||
146865171|NCT04029480|529678348|FG000|Overall Study|Withdrawal by Subject|2|||
146865172|NCT04029480|529678349|FG001|Overall Study|Withdrawal by Subject|0|||
146865173|NCT04029480|529678350|FG002|Overall Study|Withdrawal by Subject|1|||
146865174|NCT04029480|529678351|FG003|Overall Study|Withdrawal by Subject|1|||
146865175|NCT04786119|529678352|FG000|Overall Study|Withdrawal by Subject|4|||
146865176|NCT04786119|529678353|FG001|Overall Study|Withdrawal by Subject|5|||
146865177|NCT04786119|529678352|FG000|Overall Study|Lost to Follow-up|5|||
146865178|NCT04786119|529678353|FG001|Overall Study|Lost to Follow-up|5|||
146865179|NCT04786119|529678352|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
146865180|NCT04786119|529678353|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
146865181|NCT00835120|529678356|FG000|Overall Study|Lack of Efficacy|1|||
146865182|NCT00835120|529678356|FG000|Overall Study|Lost to Follow-up|3|||
146865183|NCT00835120|529678356|FG000|Overall Study|Adverse Event|2|||
146865184|NCT00835120|529678356|FG000|Overall Study|Withdrawal by Subject|2|||
146865185|NCT01019980|529678360|FG000|Overall Study|Drug not available.|2|||
146865186|NCT01019980|529678361|FG001|Overall Study|Drug not available.|0|||
146865187|NCT00708175|529678367|FG000|Overall Study|Adverse Event|4|||
146865188|NCT00708175|529678368|FG001|Overall Study|Adverse Event|5|||
146865189|NCT00708175|529678367|FG000|Overall Study|Protocol Violation|2|||
146865190|NCT00708175|529678368|FG001|Overall Study|Protocol Violation|3|||
146865191|NCT00708175|529678367|FG000|Overall Study|Lost to Follow-up|5|||
146865192|NCT00708175|529678368|FG001|Overall Study|Lost to Follow-up|3|||
146865193|NCT00708175|529678367|FG000|Overall Study|Withdrawal by Subject|5|||
146865194|NCT00708175|529678368|FG001|Overall Study|Withdrawal by Subject|7|||
146865195|NCT00708175|529678367|FG000|Overall Study|BMD loss >7%|2|||
146865196|NCT00708175|529678368|FG001|Overall Study|BMD loss >7%|3|||
146865197|NCT02038920|529678370|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
146865198|NCT02038920|529678371|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
146865199|NCT02038920|529678372|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
146865200|NCT02038920|529678373|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
146865201|NCT02038920|529678374|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
146865202|NCT02038920|529678375|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
146865203|NCT02038920|529678370|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
146865204|NCT02038920|529678371|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
146865205|NCT02038920|529678372|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
146865206|NCT02038920|529678373|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
146865207|NCT02038920|529678374|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
146865208|NCT02038920|529678375|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
146865209|NCT02038920|529678370|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
146865210|NCT02038920|529678371|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
146865211|NCT02038920|529678372|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
146865212|NCT02038920|529678373|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
146865213|NCT02038920|529678374|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
146865214|NCT02038920|529678375|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
146865215|NCT02038920|529678370|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
146865216|NCT02038920|529678371|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
146865217|NCT02038920|529678372|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
146865218|NCT02038920|529678373|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
146865219|NCT02038920|529678374|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
146865220|NCT02038920|529678375|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
146865221|NCT02038920|529678370|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
146865222|NCT02038920|529678371|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
146865223|NCT02038920|529678372|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
146865224|NCT02038920|529678373|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
146865225|NCT02038920|529678374|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
146865226|NCT02038920|529678375|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
146865227|NCT02038920|529678370|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
146865228|NCT02038920|529678371|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
146865229|NCT02038920|529678372|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
146865230|NCT02038920|529678373|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
146865231|NCT02038920|529678374|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
146865232|NCT02038920|529678375|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
146865233|NCT02038920|529678370|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
146865234|NCT02038920|529678371|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
146865235|NCT02038920|529678372|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
146865236|NCT02038920|529678373|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
146865237|NCT02038920|529678374|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
146865238|NCT02038920|529678375|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
146865239|NCT02038920|529678370|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
146865240|NCT02038920|529678371|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
146865241|NCT02038920|529678372|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
146865242|NCT02038920|529678373|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
146762854|NCT02955069|529299295|FG001|Overall Study|Study terminated by sponsor|0|||
146762855|NCT02955069|529299294|FG000|Overall Study|Subject/Guardian decision|3|||
146762856|NCT02955069|529299295|FG001|Overall Study|Subject/Guardian decision|1|||
146762857|NCT00943605|529299296|FG000|Overall Study|Study termination|30|||
146762858|NCT00943605|529299297|FG001|Overall Study|Study termination|30|||
146762859|NCT04148937|529299298|FG000|Overall Study|Withdrawal by Subject|0|||
146762860|NCT04148937|529299299|FG001|Overall Study|Withdrawal by Subject|0|||
146762861|NCT04148937|529299300|FG002|Overall Study|Withdrawal by Subject|0|||
146762862|NCT04148937|529299301|FG003|Overall Study|Withdrawal by Subject|1|||
146762863|NCT04148937|529299302|FG004|Overall Study|Withdrawal by Subject|0|||
146762864|NCT04148937|529299303|FG005|Overall Study|Withdrawal by Subject|1|||
146762865|NCT04148937|529299304|FG006|Overall Study|Withdrawal by Subject|1|||
146762866|NCT04148937|529299305|FG007|Overall Study|Withdrawal by Subject|0|||
146762867|NCT04148937|529299298|FG000|Overall Study|Lost to Follow-up|0|||
146762868|NCT04148937|529299299|FG001|Overall Study|Lost to Follow-up|0|||
146762869|NCT04148937|529299300|FG002|Overall Study|Lost to Follow-up|1|||
146762870|NCT04148937|529299301|FG003|Overall Study|Lost to Follow-up|0|||
146762871|NCT04148937|529299302|FG004|Overall Study|Lost to Follow-up|0|||
146762872|NCT04148937|529299303|FG005|Overall Study|Lost to Follow-up|2|||
146762873|NCT04148937|529299304|FG006|Overall Study|Lost to Follow-up|0|||
146762874|NCT04148937|529299305|FG007|Overall Study|Lost to Follow-up|0|||
146762875|NCT03107611|529299307|FG000|Overall Study|Adverse Event|1|||
146762876|NCT03107611|529299308|FG001|Overall Study|Adverse Event|0|||
146762877|NCT03107611|529299309|FG002|Overall Study|Adverse Event|2|||
146762878|NCT03107611|529299307|FG000|Overall Study|Lost to Follow-up|3|||
146762879|NCT03107611|529299308|FG001|Overall Study|Lost to Follow-up|3|||
146762880|NCT03107611|529299309|FG002|Overall Study|Lost to Follow-up|3|||
146762881|NCT03107611|529299307|FG000|Overall Study|Protocol Violation|0|||
146762882|NCT03107611|529299308|FG001|Overall Study|Protocol Violation|0|||
146762883|NCT03107611|529299309|FG002|Overall Study|Protocol Violation|1|||
146865243|NCT02038920|529678374|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
146865244|NCT02038920|529678375|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
146865245|NCT02038920|529678370|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
146865246|NCT02038920|529678371|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
146865247|NCT02038920|529678372|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
146865248|NCT02038920|529678373|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
146865249|NCT02038920|529678374|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
146865250|NCT02038920|529678375|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
146865251|NCT02038920|529678370|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
146865252|NCT02038920|529678371|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
146865253|NCT02038920|529678372|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
146865254|NCT02038920|529678373|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
146865255|NCT02038920|529678374|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
146865256|NCT02038920|529678375|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
146865257|NCT02038920|529678370|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
146865258|NCT02038920|529678371|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
146865259|NCT02038920|529678372|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
146865260|NCT02038920|529678373|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
146865261|NCT02038920|529678374|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
146865262|NCT02038920|529678375|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
146865263|NCT02038920|529678370|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
146865264|NCT02038920|529678371|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
146865265|NCT02038920|529678372|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
146865266|NCT02038920|529678373|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
146865267|NCT02038920|529678374|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
146865268|NCT02038920|529678375|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
146865269|NCT02383589|529678376|FG000|Treatment Period|Adverse Event|1|||
146865270|NCT02383589|529678377|FG001|Treatment Period|Adverse Event|3|||
146865271|NCT02383589|529678376|FG000|Treatment Period|Lost to Follow-up|0|||
146865272|NCT02383589|529678377|FG001|Treatment Period|Lost to Follow-up|1|||
146865273|NCT02383589|529678376|FG000|Treatment Period|Withdrawal by Subject|0|||
146865274|NCT02383589|529678377|FG001|Treatment Period|Withdrawal by Subject|5|||
146865275|NCT02383589|529678376|FG000|Treatment Period|Non-compliance with study drug|0|||
146865276|NCT02383589|529678377|FG001|Treatment Period|Non-compliance with study drug|1|||
146531690|NCT01225549|528456242|FG009|Period 6 - Washout|Disallowed medication|0|||
146762884|NCT03107611|529299307|FG000|Overall Study|Withdrawal by Subject|1|||
146762885|NCT03107611|529299308|FG001|Overall Study|Withdrawal by Subject|0|||
146762886|NCT03107611|529299309|FG002|Overall Study|Withdrawal by Subject|1|||
146762887|NCT03107611|529299307|FG000|Overall Study|Worsening signs/symptoms|2|||
146762888|NCT03107611|529299308|FG001|Overall Study|Worsening signs/symptoms|1|||
146865277|NCT02383589|529678376|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
146865278|NCT02383589|529678377|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
146865279|NCT02383589|529678376|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
146865280|NCT02383589|529678377|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
146865281|NCT02383589|529678376|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
146865282|NCT02383589|529678377|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
146865283|NCT00866697|529678378|FG000|Overall Study|Study closed/terminated|156|||
146865284|NCT00866697|529678379|FG001|Overall Study|Study closed/terminated|138|||
146865285|NCT00866697|529678378|FG000|Overall Study|Lost to Follow-up|22|||
146865286|NCT00866697|529678379|FG001|Overall Study|Lost to Follow-up|28|||
146865287|NCT00866697|529678378|FG000|Overall Study|Physician Decision|3|||
146865288|NCT00866697|529678379|FG001|Overall Study|Physician Decision|5|||
146865289|NCT00866697|529678378|FG000|Overall Study|Withdrawal by Subject|33|||
146865290|NCT00866697|529678379|FG001|Overall Study|Withdrawal by Subject|57|||
146865291|NCT02906787|529678383|FG000|Overall Study|Withdrawal by Subject|12|||
146865292|NCT02906787|529678384|FG001|Overall Study|Withdrawal by Subject|10|||
146865293|NCT02906787|529678383|FG000|Overall Study|Missed|24|||
146865294|NCT02906787|529678384|FG001|Overall Study|Missed|22|||
146865295|NCT04275297|529678385|FG000|Overall Study|Lost to Follow-up|1|||
146865296|NCT04275297|529678386|FG001|Overall Study|Lost to Follow-up|1|||
146865297|NCT00447382|529678389|FG000|Overall Study|Adverse Event|1|||
146865298|NCT00447382|529678390|FG001|Overall Study|Adverse Event|1|||
146865299|NCT00447382|529678389|FG000|Overall Study|Lack of Efficacy|1|||
146865300|NCT00447382|529678390|FG001|Overall Study|Lack of Efficacy|0|||
146865301|NCT00447382|529678389|FG000|Overall Study|Protocol Violation|2|||
146865302|NCT00447382|529678390|FG001|Overall Study|Protocol Violation|0|||
146865303|NCT00447382|529678389|FG000|Overall Study|Unclassified|2|||
146865304|NCT00447382|529678390|FG001|Overall Study|Unclassified|5|||
146865305|NCT04600336|529678395|FG000|Initial Treatment|Withdrawal by Subject|1|||
146865306|NCT04600336|529678396|FG001|Initial Treatment|Withdrawal by Subject|2|||
146865307|NCT04600336|529678397|FG002|Initial Treatment|Withdrawal by Subject|0|||
146865308|NCT04600336|529678398|FG003|Initial Treatment|Withdrawal by Subject|0|||
146865309|NCT04600336|529678395|FG000|Initial Treatment|Adverse Event|0|||
146865310|NCT04600336|529678396|FG001|Initial Treatment|Adverse Event|2|||
146865311|NCT04600336|529678397|FG002|Initial Treatment|Adverse Event|0|||
146865312|NCT04600336|529678398|FG003|Initial Treatment|Adverse Event|0|||
146865313|NCT04600336|529678395|FG000|Initial Treatment|Other complicating disease|0|||
146865314|NCT04600336|529678396|FG001|Initial Treatment|Other complicating disease|0|||
146865315|NCT04600336|529678397|FG002|Initial Treatment|Other complicating disease|1|||
146865316|NCT04600336|529678398|FG003|Initial Treatment|Other complicating disease|0|||
146865317|NCT04600336|529678395|FG000|Crossover Treatment|Withdrawal by Subject|0|||
146865318|NCT04600336|529678396|FG001|Crossover Treatment|Withdrawal by Subject|0|||
146865319|NCT04600336|529678397|FG002|Crossover Treatment|Withdrawal by Subject|2|||
146865320|NCT04600336|529678398|FG003|Crossover Treatment|Withdrawal by Subject|1|||
146865321|NCT04600336|529678395|FG000|Crossover Treatment|Adverse Event|0|||
146865322|NCT04600336|529678396|FG001|Crossover Treatment|Adverse Event|0|||
146865323|NCT04600336|529678397|FG002|Crossover Treatment|Adverse Event|1|||
146865324|NCT04600336|529678398|FG003|Crossover Treatment|Adverse Event|1|||
146865349|NCT04225806|529678403|FG000|Overall Study|Trial termination|15|||
146865350|NCT04890054|529680283|FG000|Overall Study|Lost to Follow-up|202|||
146865351|NCT04890054|529680284|FG001|Overall Study|Lost to Follow-up|219|||
146865352|NCT02113579|529680288|FG000|Overall Study|Adverse Event|1|||
146865353|NCT02113579|529680289|FG001|Overall Study|Adverse Event|0|||
146865354|NCT02113579|529680288|FG000|Overall Study|Withdrawal by Subject|3|||
146965490|NCT01361308|530035132|FG000|Overall Study|Withdrawal by Subject|9|||
146965491|NCT01361308|530035133|FG001|Overall Study|Withdrawal by Subject|13|||
146965492|NCT01361308|530035132|FG000|Overall Study|Physician Decision|3|||
146965493|NCT01361308|530035133|FG001|Overall Study|Physician Decision|3|||
146965494|NCT01361308|530035132|FG000|Overall Study|Lack of Efficacy|2|||
146965495|NCT01361308|530035133|FG001|Overall Study|Lack of Efficacy|0|||
146965496|NCT01361308|530035132|FG000|Overall Study|Protocol Violation|1|||
146965497|NCT01361308|530035133|FG001|Overall Study|Protocol Violation|0|||
146965498|NCT01361308|530035132|FG000|Overall Study|Lost to Follow-up|5|||
146965499|NCT01361308|530035133|FG001|Overall Study|Lost to Follow-up|4|||
146965500|NCT01361308|530035132|FG000|Overall Study|Adverse Event|8|||
146965501|NCT01361308|530035133|FG001|Overall Study|Adverse Event|4|||
146965502|NCT01361308|530035132|FG000|Overall Study|Eligibility Criteria Not Met|2|||
146965503|NCT01361308|530035133|FG001|Overall Study|Eligibility Criteria Not Met|3|||
146965504|NCT01361308|530035132|FG000|Overall Study|Failed C-SSRS|5|||
146965505|NCT01361308|530035133|FG001|Overall Study|Failed C-SSRS|2|||
146965506|NCT01361308|530035132|FG000|Overall Study|Other|0|||
146965507|NCT01361308|530035133|FG001|Overall Study|Other|1|||
146965508|NCT03839693|530035138|FG000|Overall Study|Lost to Follow-up|0|||
146965509|NCT03839693|530035139|FG001|Overall Study|Lost to Follow-up|2|||
146965510|NCT03839693|530035140|FG002|Overall Study|Lost to Follow-up|2|||
146965511|NCT03839693|530035138|FG000|Overall Study|Withdrawal by Subject|1|||
146965512|NCT03839693|530035139|FG001|Overall Study|Withdrawal by Subject|0|||
146965513|NCT03839693|530035140|FG002|Overall Study|Withdrawal by Subject|2|||
146965514|NCT03839693|530035138|FG000|Overall Study|subject moved out of the area|1|||
146965515|NCT03839693|530035139|FG001|Overall Study|subject moved out of the area|0|||
146965516|NCT03839693|530035140|FG002|Overall Study|subject moved out of the area|0|||
146965517|NCT00700115|530035149|FG000|Overall Study|Withdrawal by Subject|1|||
146531691|NCT00473083|528456245|FG000|Overall Study|Adverse Event|1|||
146531692|NCT00473083|528456246|FG001|Overall Study|Adverse Event|0|||
146531693|NCT00473083|528456247|FG002|Overall Study|Adverse Event|0|||
146531694|NCT02915835|528456248|FG000|Overall Study|Physician Decision|1|||
146531695|NCT02915835|528456249|FG001|Overall Study|Physician Decision|0|||
146531696|NCT02915835|528456248|FG000|Overall Study|Withdrawal by Subject|0|||
146531697|NCT02915835|528456249|FG001|Overall Study|Withdrawal by Subject|1|||
146531698|NCT01184872|528456250|FG000|Overall Study|Adverse Event|3|||
146531699|NCT01184872|528456251|FG001|Overall Study|Adverse Event|4|||
146531700|NCT01184872|528456250|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
146531701|NCT01184872|528456251|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146531702|NCT01184872|528456250|FG000|Overall Study|Withdrawal by Subject|2|||
146531703|NCT01184872|528456251|FG001|Overall Study|Withdrawal by Subject|0|||
146531704|NCT01184872|528456250|FG000|Overall Study|Lost to Follow-up|0|||
146531705|NCT01184872|528456251|FG001|Overall Study|Lost to Follow-up|1|||
146531706|NCT01184872|528456250|FG000|Overall Study|Administrative problems|1|||
146531707|NCT01184872|528456251|FG001|Overall Study|Administrative problems|1|||
146531708|NCT01184872|528456250|FG000|Overall Study|Protocol deviation|1|||
146531709|NCT01184872|528456251|FG001|Overall Study|Protocol deviation|0|||
146531710|NCT03426345|528456252|FG000|Overall Study|Adverse Event|4|||
146531711|NCT03426345|528456253|FG001|Overall Study|Adverse Event|4|||
146531712|NCT03426345|528456252|FG000|Overall Study|Lack of Efficacy|1|||
146531713|NCT03426345|528456253|FG001|Overall Study|Lack of Efficacy|0|||
146531714|NCT03426345|528456252|FG000|Overall Study|Withdrawal by Subject|5|||
146965518|NCT00700115|530035150|FG001|Overall Study|Withdrawal by Subject|0|||
146965519|NCT00700115|530035149|FG000|Overall Study|Lost to Follow-up|0|||
146965520|NCT00700115|530035150|FG001|Overall Study|Lost to Follow-up|1|||
146965521|NCT02503215|530035151|FG000|Overall Study|Unable to wear compression stockings|1|||
146965522|NCT02503215|530035151|FG000|Overall Study|Unable to use positive airway pressure|2|||
146965523|NCT03433482|530035152|FG000|Overall Study|Lost to Follow-up|1|||
146965524|NCT03433482|530035153|FG001|Overall Study|Lost to Follow-up|0|||
146965525|NCT03433482|530035154|FG002|Overall Study|Lost to Follow-up|1|||
146965526|NCT03433482|530035155|FG003|Overall Study|Lost to Follow-up|1|||
146965527|NCT03433482|530035152|FG000|Overall Study|Withdrawal by Subject|0|||
146965528|NCT03433482|530035153|FG001|Overall Study|Withdrawal by Subject|0|||
146965529|NCT03433482|530035154|FG002|Overall Study|Withdrawal by Subject|1|||
146965530|NCT03433482|530035155|FG003|Overall Study|Withdrawal by Subject|0|||
146965531|NCT03433482|530035152|FG000|Overall Study|Unknown reason|0|||
146965532|NCT03433482|530035153|FG001|Overall Study|Unknown reason|0|||
146965533|NCT03433482|530035154|FG002|Overall Study|Unknown reason|2|||
146965534|NCT03433482|530035155|FG003|Overall Study|Unknown reason|0|||
146965535|NCT01646268|530035156|FG000|Overall Study|Adverse Event|6|||
146965536|NCT01646268|530035157|FG001|Overall Study|Adverse Event|7|||
146965537|NCT01646268|530035156|FG000|Overall Study|Lack of Efficacy|1|||
146965538|NCT01646268|530035157|FG001|Overall Study|Lack of Efficacy|3|||
146531715|NCT03426345|528456253|FG001|Overall Study|Withdrawal by Subject|6|||
146965539|NCT01646268|530035156|FG000|Overall Study|Protocol Violation|0|||
146965540|NCT01646268|530035157|FG001|Overall Study|Protocol Violation|1|||
146965541|NCT01646268|530035156|FG000|Overall Study|Withdrawal by Subject|2|||
146965542|NCT01646268|530035157|FG001|Overall Study|Withdrawal by Subject|5|||
146965543|NCT01646268|530035156|FG000|Overall Study|Other|2|||
146965544|NCT01646268|530035157|FG001|Overall Study|Other|0|||
146965545|NCT00968539|530035160|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
146965546|NCT00968539|530035161|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
146965547|NCT00326118|530035162|FG000|Active Phase|Withdrawal by Subject|4|||
146965548|NCT00326118|530035163|FG001|Active Phase|Withdrawal by Subject|1|||
146965549|NCT00122954|530035164|FG000|Overall Study|Withdrawal by Subject|2|||
146965550|NCT00122954|530035165|FG001|Overall Study|Withdrawal by Subject|2|||
146965551|NCT00122954|530035164|FG000|Overall Study|Protocol Violation|0|||
146965552|NCT00122954|530035165|FG001|Overall Study|Protocol Violation|1|||
146965553|NCT04341727|530035173|FG000|Overall Study|Withdrawal by Subject|0|||
146965554|NCT04341727|530035174|FG001|Overall Study|Withdrawal by Subject|0|||
146965555|NCT04341727|530035175|FG002|Overall Study|Withdrawal by Subject|1|||
146965556|NCT04341727|530035176|FG003|Overall Study|Withdrawal by Subject|0|||
146965557|NCT04341727|530035173|FG000|Overall Study|Lost to Follow-up|0|||
146965558|NCT04341727|530035174|FG001|Overall Study|Lost to Follow-up|0|||
146965559|NCT04341727|530035175|FG002|Overall Study|Lost to Follow-up|0|||
146965560|NCT04341727|530035176|FG003|Overall Study|Lost to Follow-up|1|||
146965561|NCT02074982|530035177|FG000|Overall Study|Adverse Event|15|||
146965562|NCT02074982|530035178|FG001|Overall Study|Adverse Event|7|||
146965563|NCT02074982|530035177|FG000|Overall Study|Lack of Efficacy|6|||
146965564|NCT02074982|530035178|FG001|Overall Study|Lack of Efficacy|1|||
146965565|NCT02074982|530035177|FG000|Overall Study|Lost to Follow-up|9|||
146965566|NCT02074982|530035178|FG001|Overall Study|Lost to Follow-up|10|||
146965567|NCT02074982|530035177|FG000|Overall Study|Non-compliance with study treatment|0|||
146965568|NCT02074982|530035178|FG001|Overall Study|Non-compliance with study treatment|2|||
146865355|NCT02113579|529680289|FG001|Overall Study|Withdrawal by Subject|2|||
146865356|NCT02113579|529680288|FG000|Overall Study|Lost to Follow-up|6|||
146965569|NCT02074982|530035177|FG000|Overall Study|Physician Decision|1|||
146965570|NCT02074982|530035178|FG001|Overall Study|Physician Decision|1|||
146965571|NCT02074982|530035177|FG000|Overall Study|Pregnancy|1|||
146965572|NCT02074982|530035178|FG001|Overall Study|Pregnancy|2|||
146965573|NCT02074982|530035177|FG000|Overall Study|Protocol deviation|4|||
146965574|NCT02074982|530035178|FG001|Overall Study|Protocol deviation|3|||
146965575|NCT02074982|530035177|FG000|Overall Study|Technical problems|0|||
146965576|NCT02074982|530035178|FG001|Overall Study|Technical problems|2|||
146965577|NCT02074982|530035177|FG000|Overall Study|Subject/guardian decision|15|||
146965578|NCT02074982|530035178|FG001|Overall Study|Subject/guardian decision|24|||
146965579|NCT02074982|530035177|FG000|Overall Study|Death|0|||
146965580|NCT02074982|530035178|FG001|Overall Study|Death|2|||
146965581|NCT01817764|530035179|FG000|Overall Study|Adverse Event|7|||
146965582|NCT01817764|530035180|FG001|Overall Study|Adverse Event|10|||
146965583|NCT01817764|530035179|FG000|Overall Study|Lack of Efficacy|9|||
146965584|NCT01817764|530035180|FG001|Overall Study|Lack of Efficacy|7|||
146965585|NCT01817764|530035179|FG000|Overall Study|Protocol Violation|7|||
146965586|NCT01817764|530035180|FG001|Overall Study|Protocol Violation|5|||
146531716|NCT03426345|528456252|FG000|Overall Study|Lost to Follow-up|3|||
146531717|NCT03426345|528456253|FG001|Overall Study|Lost to Follow-up|1|||
146531718|NCT03426345|528456252|FG000|Overall Study|Protocol Deviation|3|||
146531719|NCT03426345|528456253|FG001|Overall Study|Protocol Deviation|4|||
146531720|NCT03426345|528456252|FG000|Overall Study|Reason Not Specified|1|||
146865357|NCT02113579|529680289|FG001|Overall Study|Lost to Follow-up|2|||
146865358|NCT03808688|529680290|FG000|Overall Study|Adverse Event|13|||
146865359|NCT03808688|529680291|FG001|Overall Study|Adverse Event|17|||
146865360|NCT03808688|529680290|FG000|Overall Study|Lack of Efficacy|2|||
146865361|NCT03808688|529680291|FG001|Overall Study|Lack of Efficacy|0|||
146865362|NCT03808688|529680290|FG000|Overall Study|Lost to Follow-up|0|||
146865363|NCT03808688|529680291|FG001|Overall Study|Lost to Follow-up|2|||
146531721|NCT03426345|528456253|FG001|Overall Study|Reason Not Specified|2|||
146531722|NCT03426345|528456252|FG000|Overall Study|Missing Completion Status|1|||
146531723|NCT03426345|528456253|FG001|Overall Study|Missing Completion Status|0|||
146531724|NCT00433836|528456254|FG000|Overall Study|Adverse Event|7|||
146865364|NCT03808688|529680290|FG000|Overall Study|Withdrawal by Subject|1|||
146531725|NCT00433836|528456255|FG001|Overall Study|Adverse Event|0|||
146531726|NCT00433836|528456254|FG000|Overall Study|Lost to Follow-up|3|||
146531727|NCT00433836|528456255|FG001|Overall Study|Lost to Follow-up|0|||
146531728|NCT00433836|528456254|FG000|Overall Study|Withdrawal by Subject|2|||
146865365|NCT03808688|529680291|FG001|Overall Study|Withdrawal by Subject|0|||
146865366|NCT03808688|529680290|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
146865367|NCT03808688|529680291|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
146865368|NCT03808688|529680290|FG000|Overall Study|IOP Too High|1|||
146865369|NCT03808688|529680291|FG001|Overall Study|IOP Too High|1|||
146965587|NCT01817764|530035179|FG000|Overall Study|Lost to Follow-up|1|||
146965588|NCT01817764|530035180|FG001|Overall Study|Lost to Follow-up|4|||
146965589|NCT01817764|530035179|FG000|Overall Study|Withdrawal by Subject|10|||
146965590|NCT01817764|530035180|FG001|Overall Study|Withdrawal by Subject|12|||
146965591|NCT05279807|530035185|FG000|Overall Study|Withdrawal by Subject|1|||
146965592|NCT05279807|530035186|FG001|Overall Study|Withdrawal by Subject|0|||
146965593|NCT05279807|530035185|FG000|Overall Study|Adverse Event|0|||
146865370|NCT03808688|529680290|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
146865371|NCT03808688|529680291|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
146865372|NCT03808688|529680290|FG000|Overall Study|Visit Out of Window|0|||
146865373|NCT03808688|529680291|FG001|Overall Study|Visit Out of Window|1|||
146531729|NCT00433836|528456255|FG001|Overall Study|Withdrawal by Subject|1|||
146531730|NCT00433836|528456254|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146965594|NCT05279807|530035186|FG001|Overall Study|Adverse Event|1|||
146965595|NCT05279807|530035185|FG000|Overall Study|Laboratory Abnormal Results|1|||
146965596|NCT05279807|530035186|FG001|Overall Study|Laboratory Abnormal Results|0|||
146965597|NCT04242446|530035191|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
146965598|NCT04242446|530035192|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
146965599|NCT04242446|530035193|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
146965600|NCT04242446|530035194|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
146965601|NCT04242446|530035195|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
146965602|NCT04242446|530035196|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
146965603|NCT04242446|530035197|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
146531731|NCT00433836|528456255|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146531732|NCT00433836|528456254|FG000|Overall Study|Protocol Violation|0|||
146531733|NCT00433836|528456255|FG001|Overall Study|Protocol Violation|2|||
146531734|NCT00433836|528456254|FG000|Overall Study|Condition no longer requires study drug|0|||
146531735|NCT00433836|528456255|FG001|Overall Study|Condition no longer requires study drug|1|||
146531736|NCT00433836|528456254|FG000|Overall Study|Abnormal laboratory values|0|||
146531737|NCT00433836|528456255|FG001|Overall Study|Abnormal laboratory values|1|||
146531738|NCT02446691|528456256|FG000|Overall Study|Withdrawal by Subject|2|||
146531739|NCT02446691|528456256|FG000|Overall Study|Lost to Follow-up|8|||
146531740|NCT02446691|528456256|FG000|Overall Study|Protocol Violation|1|||
146531741|NCT01474486|528456257|FG000|Overall Study|Death|2|||
146531742|NCT01474486|528456257|FG000|Overall Study|Withdrawal by Subject|4|||
146531743|NCT01474486|528456257|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
146531744|NCT03863353|528456258|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
146531745|NCT03863353|528456259|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
146531746|NCT04079790|528456260|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
146531747|NCT04079790|528456261|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
146531748|NCT04079790|528456262|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
146531749|NCT04079790|528456263|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
146531750|NCT04079790|528456260|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
146531751|NCT04079790|528456261|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
146531752|NCT04079790|528456262|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
146531753|NCT04079790|528456263|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
146531754|NCT04079790|528456260|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
146531755|NCT04079790|528456261|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
146531756|NCT04079790|528456262|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
146531757|NCT04079790|528456263|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
146531758|NCT05817669|528456264|FG000|Overall Study|Prohibited medication used|1|||
146531759|NCT05817669|528456265|FG001|Overall Study|Prohibited medication used|2|||
146531760|NCT05817669|528456264|FG000|Overall Study|Adverse Event|1|||
146531761|NCT05817669|528456265|FG001|Overall Study|Adverse Event|0|||
146531762|NCT05817669|528456264|FG000|Overall Study|Withdrawal by Subject|1|||
146531763|NCT05817669|528456265|FG001|Overall Study|Withdrawal by Subject|2|||
146531764|NCT03810183|528456268|FG000|Overall Study|Study terminated by Sponsor|2|||
146531765|NCT03810183|528456269|FG001|Overall Study|Study terminated by Sponsor|1|||
146531766|NCT00323063|528456270|FG000|Overall Study|Adverse Event|1|||
146531767|NCT00323063|528456271|FG001|Overall Study|Adverse Event|0|||
146531768|NCT00323063|528456270|FG000|Overall Study|brain mets discovered prior to treatment|1|||
146531769|NCT00323063|528456271|FG001|Overall Study|brain mets discovered prior to treatment|0|||
146531770|NCT04275336|528456272|FG000|Overall Study|First venipuncture failed|4|||
146531771|NCT04275336|528456273|FG001|Overall Study|First venipuncture failed|6|||
146531772|NCT04275336|528456274|FG002|Overall Study|First venipuncture failed|5|||
146531773|NCT04275336|528456272|FG000|Overall Study|Unscheduled venipuncture|9|||
146865374|NCT03808688|529680290|FG000|Overall Study|Medication Non-Compliance|0|||
146965604|NCT04242446|530035191|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146965605|NCT04242446|530035192|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
146865375|NCT03808688|529680291|FG001|Overall Study|Medication Non-Compliance|1|||
146865376|NCT01940354|529680305|FG000|Overall Study|Withdrawal by Subject|4|||
146865377|NCT01940354|529680306|FG001|Overall Study|Withdrawal by Subject|2|||
146865378|NCT03872453|529680307|FG000|Overall Study|Adverse Event|1|||
146965606|NCT04242446|530035193|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
146965607|NCT04242446|530035194|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146965608|NCT04242446|530035195|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146965609|NCT04242446|530035196|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146965610|NCT04242446|530035197|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146965611|NCT04242446|530035191|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
146965612|NCT04242446|530035192|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
146965613|NCT04242446|530035193|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
146865379|NCT03872453|529680308|FG001|Overall Study|Adverse Event|1|||
146865380|NCT03872453|529680309|FG002|Overall Study|Adverse Event|0|||
146865381|NCT03872453|529680310|FG003|Overall Study|Adverse Event|0|||
146865382|NCT03872453|529680307|FG000|Overall Study|Lost to Follow-up|8|||
146865383|NCT03872453|529680308|FG001|Overall Study|Lost to Follow-up|7|||
146865384|NCT03872453|529680309|FG002|Overall Study|Lost to Follow-up|4|||
146865385|NCT03872453|529680310|FG003|Overall Study|Lost to Follow-up|4|||
146865386|NCT03872453|529680307|FG000|Overall Study|Never Treated Migraine|19|||
146865387|NCT03872453|529680308|FG001|Overall Study|Never Treated Migraine|17|||
146865388|NCT03872453|529680309|FG002|Overall Study|Never Treated Migraine|13|||
146865389|NCT03872453|529680310|FG003|Overall Study|Never Treated Migraine|12|||
146865390|NCT03872453|529680307|FG000|Overall Study|Pregnancy|1|||
146865391|NCT03872453|529680308|FG001|Overall Study|Pregnancy|0|||
146865392|NCT03872453|529680309|FG002|Overall Study|Pregnancy|0|||
146865393|NCT03872453|529680310|FG003|Overall Study|Pregnancy|0|||
146865394|NCT03872453|529680307|FG000|Overall Study|Protocol Deviation|2|||
146865395|NCT03872453|529680308|FG001|Overall Study|Protocol Deviation|0|||
146865396|NCT03872453|529680309|FG002|Overall Study|Protocol Deviation|0|||
146865397|NCT03872453|529680310|FG003|Overall Study|Protocol Deviation|2|||
146865398|NCT03872453|529680307|FG000|Overall Study|Withdrawal by Subject|0|||
146865399|NCT03872453|529680308|FG001|Overall Study|Withdrawal by Subject|1|||
146865400|NCT03872453|529680309|FG002|Overall Study|Withdrawal by Subject|2|||
146865401|NCT03872453|529680310|FG003|Overall Study|Withdrawal by Subject|0|||
146865402|NCT03872453|529680307|FG000|Overall Study|Other Than Specified|1|||
146865403|NCT03872453|529680308|FG001|Overall Study|Other Than Specified|0|||
146865404|NCT03872453|529680309|FG002|Overall Study|Other Than Specified|0|||
146865405|NCT03872453|529680310|FG003|Overall Study|Other Than Specified|0|||
146865406|NCT00929656|529680313|FG000|Overall Study|Lost to Follow-up|0|||
146865407|NCT00929656|529680314|FG001|Overall Study|Lost to Follow-up|1|||
146865408|NCT03308942|529680315|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
146865409|NCT03308942|529680316|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
146865410|NCT03308942|529680317|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
146865411|NCT03308942|529680318|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
146865412|NCT03308942|529680319|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
146865413|NCT03308942|529680315|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
146865414|NCT03308942|529680316|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
146865415|NCT03308942|529680317|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
146865416|NCT03308942|529680318|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
146865417|NCT03308942|529680319|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
146865418|NCT03308942|529680315|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
146865419|NCT03308942|529680316|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
146865420|NCT03308942|529680317|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
146865421|NCT03308942|529680318|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
146865422|NCT03308942|529680319|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
146865423|NCT03308942|529680315|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
146865424|NCT03308942|529680316|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
146865425|NCT03308942|529680317|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
146865426|NCT03308942|529680318|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
146865427|NCT03308942|529680319|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
146865428|NCT03308942|529680315|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
146865429|NCT03308942|529680316|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
146865430|NCT03308942|529680317|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
146865431|NCT03308942|529680318|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
146865432|NCT03308942|529680319|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
146865433|NCT03308942|529680315|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
146865434|NCT03308942|529680316|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
146865435|NCT03308942|529680317|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
146865436|NCT03308942|529680318|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
146865437|NCT03308942|529680319|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
146865438|NCT03308942|529680315|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
146865439|NCT03308942|529680316|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
146865440|NCT03308942|529680317|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
146865441|NCT03308942|529680318|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
146865442|NCT03308942|529680319|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
146865443|NCT01131351|529680320|FG000|Overall Study|Adverse Event|0|||
146865444|NCT01131351|529680321|FG001|Overall Study|Adverse Event|2|||
146531774|NCT04275336|528456273|FG001|Overall Study|Unscheduled venipuncture|13|||
146531775|NCT04275336|528456274|FG002|Overall Study|Unscheduled venipuncture|7|||
146531776|NCT04275336|528456272|FG000|Overall Study|Failed specimen of saliva|4|||
146531777|NCT04275336|528456273|FG001|Overall Study|Failed specimen of saliva|3|||
146531778|NCT04275336|528456274|FG002|Overall Study|Failed specimen of saliva|4|||
146531779|NCT03055936|528456275|FG000|Overall Study|Adverse Event|0|||
146531780|NCT03055936|528456276|FG001|Overall Study|Adverse Event|1|||
146531781|NCT03055936|528456277|FG002|Overall Study|Adverse Event|1|||
146531782|NCT03055936|528456278|FG003|Overall Study|Adverse Event|1|||
146531783|NCT03055936|528456275|FG000|Overall Study|Personal reason|2|||
146531784|NCT03055936|528456276|FG001|Overall Study|Personal reason|0|||
146531785|NCT03055936|528456277|FG002|Overall Study|Personal reason|1|||
146531786|NCT03055936|528456278|FG003|Overall Study|Personal reason|0|||
146531787|NCT03167242|528456282|FG000|Overall Study|Patient/Guardian Decision|0|||
146531788|NCT03167242|528456283|FG001|Overall Study|Patient/Guardian Decision|1|||
146531789|NCT03167242|528456284|FG002|Overall Study|Patient/Guardian Decision|2|||
146531790|NCT03167242|528456285|FG003|Overall Study|Patient/Guardian Decision|1|||
146531791|NCT03167242|528456286|FG004|Overall Study|Patient/Guardian Decision|1|||
146531792|NCT03167242|528456287|FG005|Overall Study|Patient/Guardian Decision|1|||
146531793|NCT03167242|528456288|FG006|Overall Study|Patient/Guardian Decision|0|||
146531794|NCT03167242|528456289|FG007|Overall Study|Patient/Guardian Decision|0|||
146531795|NCT03167242|528456290|FG008|Overall Study|Patient/Guardian Decision|0|||
146531796|NCT03167242|528456291|FG009|Overall Study|Patient/Guardian Decision|0|||
146531797|NCT03167242|528456292|FG010|Overall Study|Patient/Guardian Decision|1|||
146531798|NCT03167242|528456293|FG011|Overall Study|Patient/Guardian Decision|0|||
146531799|NCT03167242|528456282|FG000|Overall Study|Lost to Follow-up|0|||
146531800|NCT03167242|528456283|FG001|Overall Study|Lost to Follow-up|0|||
146531801|NCT03167242|528456284|FG002|Overall Study|Lost to Follow-up|1|||
146531802|NCT03167242|528456285|FG003|Overall Study|Lost to Follow-up|0|||
146531803|NCT03167242|528456286|FG004|Overall Study|Lost to Follow-up|0|||
146531804|NCT03167242|528456287|FG005|Overall Study|Lost to Follow-up|1|||
146531805|NCT03167242|528456288|FG006|Overall Study|Lost to Follow-up|2|||
146531806|NCT03167242|528456289|FG007|Overall Study|Lost to Follow-up|1|||
146531807|NCT03167242|528456290|FG008|Overall Study|Lost to Follow-up|0|||
146531808|NCT03167242|528456291|FG009|Overall Study|Lost to Follow-up|0|||
146531809|NCT03167242|528456292|FG010|Overall Study|Lost to Follow-up|1|||
146531810|NCT03167242|528456293|FG011|Overall Study|Lost to Follow-up|1|||
146531811|NCT03167242|528456282|FG000|Overall Study|Reason not provided|0|||
146531812|NCT03167242|528456283|FG001|Overall Study|Reason not provided|0|||
146531813|NCT03167242|528456284|FG002|Overall Study|Reason not provided|0|||
146531814|NCT03167242|528456285|FG003|Overall Study|Reason not provided|0|||
146531815|NCT03167242|528456286|FG004|Overall Study|Reason not provided|0|||
146531816|NCT03167242|528456287|FG005|Overall Study|Reason not provided|0|||
146531817|NCT03167242|528456288|FG006|Overall Study|Reason not provided|0|||
146531818|NCT03167242|528456289|FG007|Overall Study|Reason not provided|0|||
146531819|NCT03167242|528456290|FG008|Overall Study|Reason not provided|1|||
146531820|NCT03167242|528456291|FG009|Overall Study|Reason not provided|0|||
146531821|NCT03167242|528456292|FG010|Overall Study|Reason not provided|0|||
146531822|NCT03167242|528456293|FG011|Overall Study|Reason not provided|0|||
146531823|NCT01038687|528456297|FG000|Overall Study|Adverse Event|0|||
146531824|NCT01038687|528456298|FG001|Overall Study|Adverse Event|2|||
146531825|NCT01038687|528456299|FG002|Overall Study|Adverse Event|1|||
146531826|NCT05222880|528456300|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
146531827|NCT05222880|528456300|FG000|Overall Study|Withdrew Consent during Study|1|||
146531828|NCT05222880|528456300|FG000|Overall Study|COVID-19 Related|1|||
146531829|NCT05401565|528456301|FG000|Overall Study|Lost to Follow-up|1|||
146531830|NCT05401565|528456302|FG001|Overall Study|Lost to Follow-up|0|||
146762889|NCT03107611|529299309|FG002|Overall Study|Worsening signs/symptoms|2|||
146762890|NCT04464421|529299312|FG000|Overall Study|Lost to Follow-up|2|||
146762891|NCT04464421|529299313|FG001|Overall Study|Lost to Follow-up|2|||
146762892|NCT01020838|529299314|FG000|Overall Study|Death|90|||
146762893|NCT01020838|529299314|FG000|Overall Study|Adverse Event|1|||
146762894|NCT01020838|529299314|FG000|Overall Study|Withdrawal by Subject|9|||
146762895|NCT01020838|529299314|FG000|Overall Study|Lost to Follow-up|6|||
146762896|NCT01020838|529299314|FG000|Overall Study|Most common: Study ended by sponsor|77|||
146531831|NCT05401565|528456301|FG000|Overall Study|Adverse Event|2|||
146531832|NCT05401565|528456302|FG001|Overall Study|Adverse Event|0|||
146531833|NCT03327324|528456307|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
146531834|NCT03327324|528456308|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
146531835|NCT03327324|528456309|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
146531836|NCT03327324|528456310|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
146531837|NCT03327324|528456311|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
146762897|NCT01908634|529299317|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
146865445|NCT01131351|529680320|FG000|Overall Study|Protocol Deviation|0|||
146865446|NCT01131351|529680321|FG001|Overall Study|Protocol Deviation|1|||
146865447|NCT04147234|529680322|FG000|Overall Study|Clinical deterioration|0|||
146865448|NCT04147234|529680323|FG001|Overall Study|Clinical deterioration|0|||
146865449|NCT04147234|529680324|FG002|Overall Study|Clinical deterioration|1|||
146531838|NCT03327324|528456312|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
146531839|NCT03327324|528456307|FG000|Baseline (Month 0-Month 3)|Refused|0|||
146531840|NCT03327324|528456308|FG001|Baseline (Month 0-Month 3)|Refused|0|||
146531841|NCT03327324|528456309|FG002|Baseline (Month 0-Month 3)|Refused|0|||
146531842|NCT03327324|528456310|FG003|Baseline (Month 0-Month 3)|Refused|0|||
146531843|NCT03327324|528456311|FG004|Baseline (Month 0-Month 3)|Refused|1|||
146531844|NCT03327324|528456312|FG005|Baseline (Month 0-Month 3)|Refused|0|||
146531845|NCT03327324|528456307|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
146531846|NCT03327324|528456308|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
146531847|NCT03327324|528456309|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
146531848|NCT03327324|528456310|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
146531849|NCT03327324|528456311|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
146531850|NCT03327324|528456312|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
146531851|NCT03327324|528456307|FG000|Baseline (Month 0-Month 3)|Death|0|||
146531852|NCT03327324|528456308|FG001|Baseline (Month 0-Month 3)|Death|0|||
146531853|NCT03327324|528456309|FG002|Baseline (Month 0-Month 3)|Death|0|||
146531854|NCT03327324|528456310|FG003|Baseline (Month 0-Month 3)|Death|0|||
146531855|NCT03327324|528456311|FG004|Baseline (Month 0-Month 3)|Death|1|||
146531856|NCT03327324|528456312|FG005|Baseline (Month 0-Month 3)|Death|0|||
146531857|NCT03327324|528456307|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
146531858|NCT03327324|528456308|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
146531859|NCT03327324|528456309|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
146531860|NCT03327324|528456310|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
146531861|NCT03327324|528456311|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
146531862|NCT03327324|528456312|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
146531863|NCT03327324|528456307|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
146531864|NCT03327324|528456308|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
146531865|NCT03327324|528456309|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
146531866|NCT03327324|528456310|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
146531867|NCT03327324|528456311|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
146531868|NCT03327324|528456312|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
146531869|NCT03327324|528456307|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
146531870|NCT03327324|528456308|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
146531871|NCT03327324|528456309|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
146531872|NCT03327324|528456310|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
146531873|NCT03327324|528456311|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
146531874|NCT03327324|528456312|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
146531875|NCT03327324|528456307|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
146531876|NCT03327324|528456308|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
146531877|NCT03327324|528456309|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
146531878|NCT03327324|528456310|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
146531879|NCT03327324|528456311|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
146531880|NCT03327324|528456312|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
146531881|NCT03327324|528456307|FG000|Intervention (Month 3-Month 6)|Death|1|||
146531882|NCT03327324|528456308|FG001|Intervention (Month 3-Month 6)|Death|0|||
146531883|NCT03327324|528456309|FG002|Intervention (Month 3-Month 6)|Death|1|||
146531884|NCT03327324|528456310|FG003|Intervention (Month 3-Month 6)|Death|1|||
146531885|NCT03327324|528456311|FG004|Intervention (Month 3-Month 6)|Death|1|||
146531886|NCT03327324|528456312|FG005|Intervention (Month 3-Month 6)|Death|0|||
146531887|NCT03327324|528456307|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
146531888|NCT03327324|528456308|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
146531889|NCT03327324|528456309|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
146531890|NCT03327324|528456310|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
146531891|NCT03327324|528456311|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
146865450|NCT04147234|529680325|FG003|Overall Study|Clinical deterioration|0|||
146865451|NCT04147234|529680326|FG004|Overall Study|Clinical deterioration|0|||
146865452|NCT04147234|529680327|FG005|Overall Study|Clinical deterioration|0|||
146865453|NCT04147234|529680328|FG006|Overall Study|Clinical deterioration|0|||
146865454|NCT04147234|529680322|FG000|Overall Study|Withdrawal by Subject|0|||
146865455|NCT04147234|529680323|FG001|Overall Study|Withdrawal by Subject|1|||
146865456|NCT04147234|529680324|FG002|Overall Study|Withdrawal by Subject|1|||
146865457|NCT04147234|529680325|FG003|Overall Study|Withdrawal by Subject|0|||
146865458|NCT04147234|529680326|FG004|Overall Study|Withdrawal by Subject|0|||
146865459|NCT04147234|529680327|FG005|Overall Study|Withdrawal by Subject|0|||
146865460|NCT04147234|529680328|FG006|Overall Study|Withdrawal by Subject|0|||
146531892|NCT03327324|528456312|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
146531893|NCT03327324|528456307|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
146531894|NCT03327324|528456308|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
146531895|NCT03327324|528456309|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
146531896|NCT03327324|528456310|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
146531897|NCT03327324|528456311|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
146531898|NCT03327324|528456312|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
146531899|NCT03327324|528456307|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
146531900|NCT03327324|528456308|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
146531901|NCT03327324|528456309|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
146531902|NCT03327324|528456310|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
146531903|NCT03327324|528456311|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
146531904|NCT03327324|528456312|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
146531905|NCT03327324|528456307|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
146531906|NCT03327324|528456308|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
146531907|NCT03327324|528456309|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
146531908|NCT03327324|528456310|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
146531909|NCT03327324|528456311|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
146531910|NCT03327324|528456312|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
146531911|NCT03327324|528456307|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
146531912|NCT03327324|528456308|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
146531913|NCT03327324|528456309|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
146531914|NCT03327324|528456310|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
146531915|NCT03327324|528456311|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
146531916|NCT03327324|528456312|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
146531917|NCT03327324|528456307|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
146531918|NCT03327324|528456308|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
146531919|NCT03327324|528456309|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
146531920|NCT03327324|528456310|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
146531921|NCT03327324|528456311|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
146531922|NCT03327324|528456312|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
146531923|NCT03327324|528456307|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
146531924|NCT03327324|528456308|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
146531925|NCT03327324|528456309|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
146531926|NCT03327324|528456310|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
146531927|NCT03327324|528456311|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
146531928|NCT03327324|528456312|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
146531929|NCT03177148|528456323|FG000|Overall Study|Lost to Follow-up|50|||
146531930|NCT03177148|528456324|FG001|Overall Study|Lost to Follow-up|1|||
146531931|NCT03177148|528456323|FG000|Overall Study|Death|1|||
146531932|NCT03177148|528456324|FG001|Overall Study|Death|0|||
146531933|NCT00846586|528456325|FG000|Overall Study|Adverse Event|20|||
146531934|NCT00846586|528456326|FG001|Overall Study|Adverse Event|10|||
146531935|NCT00846586|528456325|FG000|Overall Study|Subject withdrew consent|8|||
146531936|NCT00846586|528456326|FG001|Overall Study|Subject withdrew consent|10|||
146531937|NCT00846586|528456325|FG000|Overall Study|Administrative problems|5|||
146531938|NCT00846586|528456326|FG001|Overall Study|Administrative problems|4|||
146531939|NCT00846586|528456325|FG000|Overall Study|Death|2|||
146531940|NCT00846586|528456326|FG001|Overall Study|Death|0|||
146531941|NCT00846586|528456325|FG000|Overall Study|Protocol deviation|2|||
146531942|NCT00846586|528456326|FG001|Overall Study|Protocol deviation|6|||
146531943|NCT00846586|528456325|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146865461|NCT04147234|529680322|FG000|Overall Study|Clinical disease progression|1|||
146865462|NCT04147234|529680323|FG001|Overall Study|Clinical disease progression|3|||
146865463|NCT04147234|529680324|FG002|Overall Study|Clinical disease progression|1|||
146865464|NCT04147234|529680325|FG003|Overall Study|Clinical disease progression|1|||
146865465|NCT04147234|529680326|FG004|Overall Study|Clinical disease progression|0|||
146865466|NCT04147234|529680327|FG005|Overall Study|Clinical disease progression|1|||
146865467|NCT04147234|529680328|FG006|Overall Study|Clinical disease progression|0|||
146865468|NCT04147234|529680322|FG000|Overall Study|Objective disease progression|6|||
146865469|NCT04147234|529680323|FG001|Overall Study|Objective disease progression|4|||
146865470|NCT04147234|529680324|FG002|Overall Study|Objective disease progression|3|||
146865471|NCT04147234|529680325|FG003|Overall Study|Objective disease progression|3|||
146865472|NCT04147234|529680326|FG004|Overall Study|Objective disease progression|5|||
146865473|NCT04147234|529680327|FG005|Overall Study|Objective disease progression|2|||
146865474|NCT04147234|529680328|FG006|Overall Study|Objective disease progression|3|||
146865475|NCT04147234|529680322|FG000|Overall Study|Adverse Event|0|||
146865476|NCT04147234|529680323|FG001|Overall Study|Adverse Event|0|||
146865477|NCT04147234|529680324|FG002|Overall Study|Adverse Event|0|||
146865478|NCT04147234|529680325|FG003|Overall Study|Adverse Event|0|||
146865479|NCT04147234|529680326|FG004|Overall Study|Adverse Event|1|||
146865480|NCT04147234|529680327|FG005|Overall Study|Adverse Event|0|||
146865481|NCT04147234|529680328|FG006|Overall Study|Adverse Event|0|||
146865482|NCT01524133|529680331|FG000|Treatment Phase|Withdrawal by Subject|13|||
146865483|NCT01524133|529680332|FG001|Treatment Phase|Withdrawal by Subject|28|||
146865484|NCT01524133|529680333|FG002|Treatment Phase|Withdrawal by Subject|31|||
146865485|NCT01524133|529680331|FG000|Treatment Phase|Physician Decision|6|||
146865486|NCT01524133|529680332|FG001|Treatment Phase|Physician Decision|3|||
146865487|NCT01524133|529680333|FG002|Treatment Phase|Physician Decision|3|||
146865488|NCT01524133|529680331|FG000|Treatment Phase|Lost to Follow-up|0|||
146865489|NCT01524133|529680332|FG001|Treatment Phase|Lost to Follow-up|1|||
146865490|NCT01524133|529680333|FG002|Treatment Phase|Lost to Follow-up|2|||
146865491|NCT01524133|529680331|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
146865492|NCT01524133|529680332|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
146865493|NCT01524133|529680333|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
146865494|NCT01524133|529680331|FG000|Overall Study 52 Weeks|Physician Decision|1|||
146865495|NCT01524133|529680332|FG001|Overall Study 52 Weeks|Physician Decision|0|||
146865496|NCT01524133|529680333|FG002|Overall Study 52 Weeks|Physician Decision|2|||
146865497|NCT01524133|529680331|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
146865498|NCT01524133|529680332|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
146865499|NCT01524133|529680333|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
146865500|NCT04606771|529680334|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
146865501|NCT04606771|529680335|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
146865502|NCT04606771|529680334|FG000|Overall Study|Death|5|||
146865503|NCT04606771|529680335|FG001|Overall Study|Death|6|||
146865504|NCT04606771|529680334|FG000|Overall Study|Wrong randomisation|0|||
146865505|NCT04606771|529680335|FG001|Overall Study|Wrong randomisation|1|||
146865506|NCT01214187|529680339|FG000|Overall Study|Adverse Event|6|||
146531944|NCT00846586|528456326|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146531945|NCT00846586|528456325|FG000|Overall Study|Lost to Follow-up|1|||
146531946|NCT00846586|528456326|FG001|Overall Study|Lost to Follow-up|4|||
146531947|NCT00846586|528456325|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146531948|NCT00846586|528456326|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146531949|NCT01061606|528456327|FG000|Overall Study|Adverse Event|1|||
146531950|NCT01061606|528456327|FG000|Overall Study|Death|1|||
146531951|NCT01061606|528456327|FG000|Overall Study|Disease Progression|4|||
146531952|NCT01061606|528456327|FG000|Overall Study|alternative therapy|2|||
146531953|NCT01204671|528456328|FG000|Overall Study|Adverse Event|4|||
146531954|NCT01204671|528456329|FG001|Overall Study|Adverse Event|3|||
146531955|NCT01204671|528456330|FG002|Overall Study|Adverse Event|3|||
146531956|NCT01204671|528456331|FG003|Overall Study|Adverse Event|3|||
146531957|NCT01204671|528456332|FG004|Overall Study|Adverse Event|1|||
146531958|NCT01204671|528456328|FG000|Overall Study|Withdrawal by Subject|2|||
146531959|NCT01204671|528456329|FG001|Overall Study|Withdrawal by Subject|3|||
146531960|NCT01204671|528456330|FG002|Overall Study|Withdrawal by Subject|4|||
146531961|NCT01204671|528456331|FG003|Overall Study|Withdrawal by Subject|5|||
146865507|NCT01214187|529680340|FG001|Overall Study|Adverse Event|2|||
146865508|NCT01214187|529680339|FG000|Overall Study|Death|1|||
146865509|NCT01214187|529680340|FG001|Overall Study|Death|1|||
146865510|NCT01214187|529680339|FG000|Overall Study|Withdrawal by Subject|0|||
146865511|NCT01214187|529680340|FG001|Overall Study|Withdrawal by Subject|3|||
146865512|NCT04464265|529680342|FG000|Overall Study|Physician Decision|2|||
146531962|NCT01204671|528456332|FG004|Overall Study|Withdrawal by Subject|3|||
146531963|NCT01204671|528456328|FG000|Overall Study|Lost to Follow-up|7|||
146531964|NCT01204671|528456329|FG001|Overall Study|Lost to Follow-up|8|||
146531965|NCT01204671|528456330|FG002|Overall Study|Lost to Follow-up|6|||
146865513|NCT01438151|529680345|FG000|Overall Study|study terminated|8|||
146865514|NCT02459769|529680349|FG000|Overall Study|Withdrawal by Subject|7|||
146865515|NCT02459769|529680350|FG001|Overall Study|Withdrawal by Subject|4|||
146531966|NCT01204671|528456331|FG003|Overall Study|Lost to Follow-up|4|||
146531967|NCT01204671|528456332|FG004|Overall Study|Lost to Follow-up|0|||
146531968|NCT01204671|528456328|FG000|Overall Study|Unknown Completion Status|1|||
146531969|NCT01204671|528456329|FG001|Overall Study|Unknown Completion Status|1|||
146531970|NCT01204671|528456330|FG002|Overall Study|Unknown Completion Status|0|||
146865516|NCT02459769|529680351|FG002|Overall Study|Withdrawal by Subject|8|||
146865517|NCT02459769|529680352|FG003|Overall Study|Withdrawal by Subject|5|||
146865518|NCT02459769|529680349|FG000|Overall Study|Lost to Follow-up|1|||
146865519|NCT02459769|529680350|FG001|Overall Study|Lost to Follow-up|0|||
146865520|NCT02459769|529680351|FG002|Overall Study|Lost to Follow-up|1|||
146865521|NCT02459769|529680352|FG003|Overall Study|Lost to Follow-up|0|||
146865522|NCT00312221|529680353|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
146865523|NCT00312221|529680354|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
146865524|NCT00312221|529680355|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
146865525|NCT00312221|529680356|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
146865526|NCT00312221|529680353|FG000|Open-label Run-in Period|Adverse Event|74|||
146865527|NCT00312221|529680354|FG001|Open-label Run-in Period|Adverse Event|0|||
146865528|NCT00312221|529680355|FG002|Open-label Run-in Period|Adverse Event|0|||
146865529|NCT00312221|529680356|FG003|Open-label Run-in Period|Adverse Event|0|||
146865530|NCT00312221|529680353|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
146865531|NCT00312221|529680354|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
146865532|NCT00312221|529680355|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
146865533|NCT00312221|529680356|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
146865534|NCT00312221|529680353|FG000|Open-label Run-in Period|Administrative|42|||
146865535|NCT00312221|529680354|FG001|Open-label Run-in Period|Administrative|0|||
146531971|NCT01204671|528456331|FG003|Overall Study|Unknown Completion Status|0|||
146531972|NCT01204671|528456332|FG004|Overall Study|Unknown Completion Status|0|||
146531973|NCT01204671|528456328|FG000|Overall Study|Physician Decision|0|||
146531974|NCT01204671|528456329|FG001|Overall Study|Physician Decision|0|||
146531975|NCT01204671|528456330|FG002|Overall Study|Physician Decision|0|||
146531976|NCT01204671|528456331|FG003|Overall Study|Physician Decision|1|||
146531977|NCT01204671|528456332|FG004|Overall Study|Physician Decision|0|||
146531978|NCT02033759|528456338|FG000|Overall Study|Withdrawal by Subject|2|||
146531979|NCT02033759|528456339|FG001|Overall Study|Withdrawal by Subject|1|||
146531980|NCT02033759|528456338|FG000|Overall Study|Protocol Violation|1|||
146531981|NCT02033759|528456339|FG001|Overall Study|Protocol Violation|1|||
146531982|NCT03810456|528456340|FG000|Treatment|Urgent Family Matters|3|||
146531983|NCT03810456|528456341|FG001|Treatment|Urgent Family Matters|0|||
146531984|NCT03810456|528456342|FG002|Treatment|Urgent Family Matters|0|||
146531985|NCT03810456|528456340|FG000|Treatment|Scheduling Conflicts|0|||
146531986|NCT03810456|528456341|FG001|Treatment|Scheduling Conflicts|11|||
146531987|NCT03810456|528456342|FG002|Treatment|Scheduling Conflicts|0|||
146531988|NCT03810456|528456340|FG000|Treatment|No Longer Interested|0|||
146531989|NCT03810456|528456341|FG001|Treatment|No Longer Interested|12|||
146531990|NCT03810456|528456342|FG002|Treatment|No Longer Interested|0|||
146531991|NCT03810456|528456340|FG000|Treatment|Transportation Issues|0|||
146531992|NCT03810456|528456341|FG001|Treatment|Transportation Issues|1|||
146531993|NCT03810456|528456342|FG002|Treatment|Transportation Issues|0|||
146531994|NCT03810456|528456340|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
146531995|NCT03810456|528456341|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
146531996|NCT03810456|528456342|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
146531997|NCT03810456|528456340|FG000|1 Month Follow-Up|Relocated to Different State|1|||
146531998|NCT03810456|528456341|FG001|1 Month Follow-Up|Relocated to Different State|0|||
146531999|NCT03810456|528456342|FG002|1 Month Follow-Up|Relocated to Different State|1|||
146532000|NCT03810456|528456340|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
146532001|NCT03810456|528456341|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
146532002|NCT03810456|528456342|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
146532003|NCT03810456|528456340|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
146865536|NCT00312221|529680355|FG002|Open-label Run-in Period|Administrative|0|||
146865537|NCT00312221|529680356|FG003|Open-label Run-in Period|Administrative|0|||
146532004|NCT03810456|528456341|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
146532005|NCT03810456|528456342|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
146532006|NCT03810456|528456340|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
146532007|NCT03810456|528456341|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
146532008|NCT03810456|528456342|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
146532009|NCT03810456|528456340|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
146532010|NCT03810456|528456341|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
146532011|NCT03810456|528456342|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
146532012|NCT03810456|528456340|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
146865538|NCT00312221|529680353|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
146865539|NCT00312221|529680354|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
146865540|NCT00312221|529680355|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
146865541|NCT00312221|529680356|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
146865542|NCT00312221|529680353|FG000|Open-label Run-in Period|Did not qualify|5|||
146865543|NCT00312221|529680354|FG001|Open-label Run-in Period|Did not qualify|0|||
146532013|NCT03810456|528456341|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
146532014|NCT03810456|528456342|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
146532015|NCT02100124|528456347|FG000|Overall Study|Lost to Follow-up|5|||
146532016|NCT02100124|528456348|FG001|Overall Study|Lost to Follow-up|11|||
146532017|NCT02100124|528456349|FG002|Overall Study|Lost to Follow-up|3|||
146532018|NCT02100124|528456347|FG000|Overall Study|Withdrawal by Subject|1|||
146532019|NCT02100124|528456348|FG001|Overall Study|Withdrawal by Subject|0|||
146532020|NCT02100124|528456349|FG002|Overall Study|Withdrawal by Subject|0|||
146532021|NCT02997163|528458456|FG000|Overall Study|Adverse Event|1|||
146532022|NCT02997163|528458457|FG001|Overall Study|Adverse Event|0|||
146532023|NCT02997163|528458458|FG002|Overall Study|Adverse Event|0|||
146532024|NCT02997163|528458459|FG003|Overall Study|Adverse Event|1|||
146532025|NCT02337764|528458460|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
146532026|NCT02337764|528458460|FG000|Overall Study|Voluntary Withdrawal|12|||
146532027|NCT02337764|528458460|FG000|Overall Study|Lack of Efficacy|2|||
146532028|NCT01739335|528458470|FG000|Overall Study|Lost to Follow-up|7|||
146532029|NCT01739335|528458471|FG001|Overall Study|Lost to Follow-up|4|||
146532030|NCT01739335|528458470|FG000|Overall Study|Ineligible patient randomized|0|||
146532031|NCT01739335|528458471|FG001|Overall Study|Ineligible patient randomized|1|||
146532032|NCT00288912|528458472|FG000|Overall Study|Developed exclusion criterion|4|||
146532033|NCT00288912|528458473|FG001|Overall Study|Developed exclusion criterion|6|||
146532034|NCT00288912|528458474|FG002|Overall Study|Developed exclusion criterion|7|||
146532035|NCT00288912|528458472|FG000|Overall Study|Lost to Follow-up|9|||
146532036|NCT00288912|528458473|FG001|Overall Study|Lost to Follow-up|6|||
146532037|NCT00288912|528458474|FG002|Overall Study|Lost to Follow-up|9|||
146532038|NCT00288912|528458472|FG000|Overall Study|Withdrawal by Subject|4|||
146532039|NCT00288912|528458473|FG001|Overall Study|Withdrawal by Subject|5|||
146532040|NCT00288912|528458474|FG002|Overall Study|Withdrawal by Subject|12|||
146532041|NCT00183430|528458477|FG000|Overall Study|Adverse Event|1|||
146532042|NCT00183430|528458478|FG001|Overall Study|Adverse Event|0|||
146532043|NCT00183430|528458477|FG000|Overall Study|Lost to Follow-up|3|||
146532044|NCT00183430|528458478|FG001|Overall Study|Lost to Follow-up|0|||
146532045|NCT00183430|528458477|FG000|Overall Study|did not meet inclusion criteria|1|||
146532046|NCT00183430|528458478|FG001|Overall Study|did not meet inclusion criteria|0|||
146532047|NCT00183430|528458477|FG000|Overall Study|Withdrawal by Subject|1|||
146532048|NCT00183430|528458478|FG001|Overall Study|Withdrawal by Subject|0|||
146532049|NCT00883181|528458489|FG000|Overall Study|Hematological Adverse Event|26|||
146532050|NCT00883181|528458489|FG000|Overall Study|Non-hematological Adverse Event|55|||
146532051|NCT00883181|528458489|FG000|Overall Study|Disease Progression|94|||
146532052|NCT00883181|528458489|FG000|Overall Study|Administrative Reason|24|||
146532053|NCT00883181|528458489|FG000|Overall Study|Withdrawal by Subject|4|||
146532054|NCT00883181|528458489|FG000|Overall Study|Death|31|||
146532055|NCT00883181|528458489|FG000|Overall Study|Other|38|||
146532056|NCT00883181|528458489|FG000|Overall Study|Protocol Deviation|3|||
146532057|NCT00883181|528458489|FG000|Overall Study|Noncompliance|3|||
146532058|NCT01218308|528458490|FG000|Overall Study|Adverse Event|1|||
146532059|NCT01218308|528458491|FG001|Overall Study|Adverse Event|2|||
146532060|NCT01218308|528458490|FG000|Overall Study|Protocol Violation|0|||
146532061|NCT01218308|528458491|FG001|Overall Study|Protocol Violation|2|||
146532062|NCT01218308|528458490|FG000|Overall Study|Withdrawal by Subject|61|||
146532063|NCT01218308|528458491|FG001|Overall Study|Withdrawal by Subject|64|||
146532064|NCT01218308|528458490|FG000|Overall Study|Lost to Follow-up|27|||
146532065|NCT01218308|528458491|FG001|Overall Study|Lost to Follow-up|31|||
146532066|NCT01218308|528458490|FG000|Overall Study|Other|14|||
146532067|NCT01218308|528458491|FG001|Overall Study|Other|21|||
146532068|NCT02709746|528458492|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
146532069|NCT02709746|528458493|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
146532070|NCT02709746|528458494|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
146532071|NCT02709746|528458495|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
146762898|NCT01908634|529299317|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
146762899|NCT01072357|529299318|FG000|Overall Study|Lost to Follow-up|0|||
146762900|NCT01072357|529299319|FG001|Overall Study|Lost to Follow-up|1|||
146762901|NCT01570751|529299320|FG000|Period A (16 Weeks)|Protocol Violation|1|||
146762902|NCT01570751|529299321|FG001|Period A (16 Weeks)|Protocol Violation|1|||
146762903|NCT01570751|529299320|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
146762904|NCT01570751|529299321|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
146762905|NCT01570751|529299320|FG000|Period A (16 Weeks)|Unclassified|2|||
146762906|NCT01570751|529299321|FG001|Period A (16 Weeks)|Unclassified|3|||
146762907|NCT01570751|529299320|FG000|Period B (16 Weeks)|Adverse Event|1|||
146762908|NCT01570751|529299321|FG001|Period B (16 Weeks)|Adverse Event|0|||
146762909|NCT01570751|529299320|FG000|Period B (16 Weeks)|Protocol Violation|0|||
146762910|NCT01570751|529299321|FG001|Period B (16 Weeks)|Protocol Violation|1|||
146762911|NCT01048788|529299326|FG000|Overall Study|Adverse Event|5|||
146762912|NCT01048788|529299327|FG001|Overall Study|Adverse Event|1|||
146762913|NCT01048788|529299328|FG002|Overall Study|Adverse Event|1|||
146762914|NCT01048788|529299326|FG000|Overall Study|Lack of Efficacy|0|||
146762915|NCT01048788|529299327|FG001|Overall Study|Lack of Efficacy|0|||
146762916|NCT01048788|529299328|FG002|Overall Study|Lack of Efficacy|1|||
146762917|NCT01048788|529299326|FG000|Overall Study|Withdrawal by Subject|0|||
146532072|NCT02709746|528458496|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
146532073|NCT02709746|528458492|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
146532074|NCT02709746|528458493|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
146532075|NCT02709746|528458494|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
146532076|NCT02709746|528458495|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
146865544|NCT00312221|529680355|FG002|Open-label Run-in Period|Did not qualify|0|||
146865545|NCT00312221|529680356|FG003|Open-label Run-in Period|Did not qualify|0|||
146865546|NCT00312221|529680353|FG000|Double-blind Phase|Withdrawal by Subject|0|||
146532077|NCT02709746|528458496|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
146532078|NCT02709746|528458492|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
146532079|NCT02709746|528458493|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
146532080|NCT02709746|528458494|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
146532081|NCT02709746|528458495|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
146532082|NCT02709746|528458496|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
146532083|NCT02709746|528458492|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
146532084|NCT02709746|528458493|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
146532085|NCT02709746|528458494|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
146532086|NCT02709746|528458495|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
146532087|NCT02709746|528458496|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
146532088|NCT02709746|528458492|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
146532089|NCT02709746|528458493|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
146532090|NCT02709746|528458494|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
146532091|NCT02709746|528458495|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
146532092|NCT02709746|528458496|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
146532093|NCT02709746|528458492|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
146532094|NCT02709746|528458493|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
146532095|NCT02709746|528458494|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
146532096|NCT02709746|528458495|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
146532097|NCT02709746|528458496|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
146532098|NCT02709746|528458492|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
146532099|NCT02709746|528458493|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
146532100|NCT02709746|528458494|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
146532101|NCT02709746|528458495|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
146532102|NCT02709746|528458496|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
146532103|NCT02709746|528458492|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
146532104|NCT02709746|528458493|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
146532105|NCT02709746|528458494|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
146532106|NCT02709746|528458495|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
146532107|NCT02709746|528458496|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
146532108|NCT02709746|528458492|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
146532109|NCT02709746|528458493|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
146532110|NCT02709746|528458494|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
146532111|NCT02709746|528458495|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
146532112|NCT02709746|528458496|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
146532113|NCT02709746|528458492|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
146532114|NCT02709746|528458493|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
146532115|NCT02709746|528458494|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
146532116|NCT02709746|528458495|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
146532117|NCT02709746|528458496|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
146532118|NCT02709746|528458492|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
146532119|NCT02709746|528458493|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
146532120|NCT02709746|528458494|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
146865547|NCT00312221|529680354|FG001|Double-blind Phase|Withdrawal by Subject|6|||
146865548|NCT00312221|529680355|FG002|Double-blind Phase|Withdrawal by Subject|8|||
146865549|NCT00312221|529680356|FG003|Double-blind Phase|Withdrawal by Subject|7|||
146865550|NCT00312221|529680353|FG000|Double-blind Phase|Adverse Event|0|||
146865551|NCT00312221|529680354|FG001|Double-blind Phase|Adverse Event|10|||
146865552|NCT00312221|529680355|FG002|Double-blind Phase|Adverse Event|19|||
146865553|NCT00312221|529680356|FG003|Double-blind Phase|Adverse Event|18|||
146865554|NCT00312221|529680353|FG000|Double-blind Phase|Lost to Follow-up|0|||
146865555|NCT00312221|529680354|FG001|Double-blind Phase|Lost to Follow-up|0|||
146865556|NCT00312221|529680355|FG002|Double-blind Phase|Lost to Follow-up|2|||
146865557|NCT00312221|529680356|FG003|Double-blind Phase|Lost to Follow-up|2|||
146532121|NCT02709746|528458495|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
146865558|NCT00312221|529680353|FG000|Double-blind Phase|Administrative|0|||
146865559|NCT00312221|529680354|FG001|Double-blind Phase|Administrative|26|||
146865560|NCT00312221|529680355|FG002|Double-blind Phase|Administrative|37|||
146865561|NCT00312221|529680356|FG003|Double-blind Phase|Administrative|33|||
146865562|NCT00312221|529680353|FG000|Double-blind Phase|Lack of Efficacy|0|||
146865563|NCT00312221|529680354|FG001|Double-blind Phase|Lack of Efficacy|17|||
146865564|NCT00312221|529680355|FG002|Double-blind Phase|Lack of Efficacy|6|||
146865565|NCT00312221|529680356|FG003|Double-blind Phase|Lack of Efficacy|10|||
146865566|NCT02060721|529680357|FG000|Overall Study|Lost to Follow-up|1|||
146865567|NCT02060721|529680357|FG000|Overall Study|Physician Decision|2|||
146532122|NCT02709746|528458496|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
146532123|NCT02709746|528458492|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
146532124|NCT02709746|528458493|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
146532125|NCT02709746|528458494|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
146532126|NCT02709746|528458495|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
146532127|NCT02709746|528458496|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
146532128|NCT02709746|528458492|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
146532129|NCT02709746|528458493|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
146532130|NCT02709746|528458494|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
146532131|NCT02709746|528458495|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
146532132|NCT02709746|528458496|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
146532133|NCT02709746|528458492|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
146532134|NCT02709746|528458493|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
146532135|NCT02709746|528458494|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
146532136|NCT02709746|528458495|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
146532137|NCT02709746|528458496|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
146532138|NCT02709746|528458492|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
146532139|NCT02709746|528458493|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
146532140|NCT02709746|528458494|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
146532141|NCT02709746|528458495|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
146532142|NCT02709746|528458496|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
146532143|NCT02709746|528458492|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
146532144|NCT02709746|528458493|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
146532145|NCT02709746|528458494|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
146532146|NCT02709746|528458495|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
146532147|NCT02709746|528458496|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
146532148|NCT02709746|528458492|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
146532149|NCT02709746|528458493|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
146532150|NCT02709746|528458494|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
146532151|NCT02709746|528458495|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
146532152|NCT02709746|528458496|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
146532153|NCT00752089|528458497|FG000|Overall Study|Adverse Event|1|||
146532154|NCT00752089|528458497|FG000|Overall Study|Protocol Deviation|2|||
146532155|NCT00752089|528458497|FG000|Overall Study|Could not attend visit 9|1|||
146532156|NCT00752089|528458497|FG000|Overall Study|Not capable of wearing partial denture|1|||
146532157|NCT00752089|528458497|FG000|Overall Study|Cannot continue the study|1|||
146532158|NCT00386334|528458500|FG000|Double Blind Period|Adverse Event|9|||
146532159|NCT00386334|528458501|FG001|Double Blind Period|Adverse Event|14|||
146532160|NCT00386334|528458500|FG000|Double Blind Period|Protocol Violation|1|||
146532161|NCT00386334|528458501|FG001|Double Blind Period|Protocol Violation|1|||
146532162|NCT00386334|528458500|FG000|Double Blind Period|Withdrawal by Subject|9|||
146532163|NCT00386334|528458501|FG001|Double Blind Period|Withdrawal by Subject|13|||
146532164|NCT00386334|528458500|FG000|Double Blind Period|Lack of Efficacy|20|||
146532165|NCT00386334|528458501|FG001|Double Blind Period|Lack of Efficacy|11|||
146532166|NCT00386334|528458500|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
146532167|NCT00386334|528458501|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
146532168|NCT00386334|528458500|FG000|Double Blind Period|Other|3|||
146532169|NCT00386334|528458501|FG001|Double Blind Period|Other|3|||
146532170|NCT00386334|528458500|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
146532171|NCT00386334|528458501|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
146532172|NCT00975416|528458506|FG000|Overall Study|early discharge from tx|3|||
146532173|NCT00975416|528458507|FG001|Overall Study|early discharge from tx|5|||
146532174|NCT00106002|528458508|FG000|Overall Study|Did not take any study drug|1|||
146532175|NCT00106002|528458508|FG000|Overall Study|Ineligible after Registration|1|||
146532176|NCT01245101|528458510|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
146532177|NCT01245101|528458511|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
146532178|NCT01245101|528458510|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
146865568|NCT02060721|529680357|FG000|Overall Study|Death|14|||
146865569|NCT02060721|529680357|FG000|Overall Study|Withdrawal by Subject|2|||
146865570|NCT02060721|529680357|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
146865571|NCT05105789|529680358|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
146865572|NCT01271803|529680359|FG000|Overall Study|Progressive disease|0|||
146865573|NCT01271803|529680360|FG001|Overall Study|Progressive disease|0|||
146865574|NCT01271803|529680361|FG002|Overall Study|Progressive disease|2|||
146865575|NCT01271803|529680359|FG000|Overall Study|Death|53|||
146865576|NCT01271803|529680360|FG001|Overall Study|Death|34|||
146865577|NCT01271803|529680361|FG002|Overall Study|Death|0|||
146865578|NCT01271803|529680359|FG000|Overall Study|Withdrawal by Subject|1|||
146865579|NCT01271803|529680360|FG001|Overall Study|Withdrawal by Subject|5|||
146865580|NCT01271803|529680361|FG002|Overall Study|Withdrawal by Subject|0|||
146865581|NCT01271803|529680359|FG000|Overall Study|Lost to Follow-up|1|||
146532179|NCT01245101|528458511|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
146532180|NCT01245101|528458510|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
146532181|NCT01245101|528458511|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
146532182|NCT01122173|528458512|FG000|Overall Study|Lost to Follow-up|3|||
146532183|NCT01122173|528458512|FG000|Overall Study|Withdrawal by Subject|3|||
146532184|NCT01122173|528458512|FG000|Overall Study|Left study for other reasons|3|||
146532185|NCT02133508|528458513|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
146532186|NCT02133508|528458513|FG000|Overall Study|Death|12|||
146532187|NCT02133508|528458513|FG000|Overall Study|Lost to Follow-up|2|||
146532188|NCT03093181|528458516|FG000|Overall Study|Withdrawal by Subject|2|||
146532189|NCT03093181|528458517|FG001|Overall Study|Withdrawal by Subject|1|||
146532190|NCT03093181|528458518|FG002|Overall Study|Withdrawal by Subject|2|||
146532191|NCT03093181|528458516|FG000|Overall Study|Other (Not specified)|1|||
146532192|NCT03093181|528458517|FG001|Overall Study|Other (Not specified)|0|||
146532193|NCT03093181|528458518|FG002|Overall Study|Other (Not specified)|0|||
146532194|NCT03093181|528458516|FG000|Overall Study|Adverse Event|0|||
146532195|NCT03093181|528458517|FG001|Overall Study|Adverse Event|1|||
146532196|NCT03093181|528458518|FG002|Overall Study|Adverse Event|0|||
146532197|NCT03093181|528458516|FG000|Overall Study|Other (Protocol violation)|0|||
146532198|NCT03093181|528458517|FG001|Overall Study|Other (Protocol violation)|0|||
146532199|NCT03093181|528458518|FG002|Overall Study|Other (Protocol violation)|1|||
146532200|NCT04210986|528458521|FG000|Overall Study|Lost to Follow-up|5|||
146532201|NCT04210986|528458522|FG001|Overall Study|Lost to Follow-up|2|||
146532202|NCT04210986|528458521|FG000|Overall Study|Withdrawal by Subject|3|||
146532203|NCT04210986|528458522|FG001|Overall Study|Withdrawal by Subject|1|||
146532204|NCT04210986|528458521|FG000|Overall Study|Protocol Violation|1|||
146532205|NCT04210986|528458522|FG001|Overall Study|Protocol Violation|1|||
146532206|NCT04210986|528458521|FG000|Overall Study|Physician Decision|0|||
146532207|NCT04210986|528458522|FG001|Overall Study|Physician Decision|1|||
146532208|NCT02378662|528458523|FG000|Overall Study|Early Discontinuation|2|||
146532209|NCT02378662|528458524|FG001|Overall Study|Early Discontinuation|0|||
146532210|NCT01159574|528458525|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
146532211|NCT01159574|528458525|FG000|Treatment Phase|Adverse Event|3|||
146532212|NCT01159574|528458525|FG000|Treatment Phase|Death|6|||
146532213|NCT01159574|528458525|FG000|Treatment Phase|Physician Decision|2|||
146532214|NCT01159574|528458525|FG000|Treatment Phase|Withdrawal by Subject|7|||
146532215|NCT01159574|528458525|FG000|Treatment Phase|still on treatment|2|||
146532216|NCT01159574|528458525|FG000|Follow Up Phase|Lost to Follow-up|2|||
146532217|NCT01159574|528458525|FG000|Follow Up Phase|still being followed for overall surviva|18|||
146532218|NCT03555149|528458528|FG000|Overall Study|Death|18|||
146532219|NCT03555149|528458529|FG001|Overall Study|Death|15|||
146532220|NCT03555149|528458530|FG002|Overall Study|Death|15|||
146532221|NCT03555149|528458531|FG003|Overall Study|Death|4|||
146532222|NCT03555149|528458532|FG004|Overall Study|Death|4|||
146532223|NCT03555149|528458533|FG005|Overall Study|Death|11|||
146532224|NCT03555149|528458534|FG006|Overall Study|Death|12|||
146532225|NCT03555149|528458535|FG007|Overall Study|Death|1|||
146532226|NCT03555149|528458528|FG000|Overall Study|Lost to Follow-up|1|||
146532227|NCT03555149|528458529|FG001|Overall Study|Lost to Follow-up|0|||
146532228|NCT03555149|528458530|FG002|Overall Study|Lost to Follow-up|0|||
146532229|NCT03555149|528458531|FG003|Overall Study|Lost to Follow-up|0|||
146532230|NCT03555149|528458532|FG004|Overall Study|Lost to Follow-up|0|||
146532231|NCT03555149|528458533|FG005|Overall Study|Lost to Follow-up|1|||
146532232|NCT03555149|528458534|FG006|Overall Study|Lost to Follow-up|0|||
146532233|NCT03555149|528458535|FG007|Overall Study|Lost to Follow-up|0|||
146532234|NCT03555149|528458528|FG000|Overall Study|Physician Decision|1|||
146532235|NCT03555149|528458529|FG001|Overall Study|Physician Decision|0|||
146532236|NCT03555149|528458530|FG002|Overall Study|Physician Decision|0|||
146532237|NCT03555149|528458531|FG003|Overall Study|Physician Decision|0|||
146865582|NCT01271803|529680360|FG001|Overall Study|Lost to Follow-up|0|||
146865583|NCT01271803|529680361|FG002|Overall Study|Lost to Follow-up|0|||
146532238|NCT03555149|528458532|FG004|Overall Study|Physician Decision|0|||
146532239|NCT03555149|528458533|FG005|Overall Study|Physician Decision|0|||
146532240|NCT03555149|528458534|FG006|Overall Study|Physician Decision|0|||
146532241|NCT03555149|528458535|FG007|Overall Study|Physician Decision|0|||
146532242|NCT03555149|528458528|FG000|Overall Study|Study Terminated By Sponsor|1|||
146532243|NCT03555149|528458529|FG001|Overall Study|Study Terminated By Sponsor|0|||
146865584|NCT04178967|529680362|FG000|Induction Period|Adverse Event|4|||
146532244|NCT03555149|528458530|FG002|Overall Study|Study Terminated By Sponsor|0|||
146532245|NCT03555149|528458531|FG003|Overall Study|Study Terminated By Sponsor|0|||
146532246|NCT03555149|528458532|FG004|Overall Study|Study Terminated By Sponsor|0|||
146532247|NCT03555149|528458533|FG005|Overall Study|Study Terminated By Sponsor|2|||
146532248|NCT03555149|528458534|FG006|Overall Study|Study Terminated By Sponsor|3|||
146532249|NCT03555149|528458535|FG007|Overall Study|Study Terminated By Sponsor|1|||
146532250|NCT03555149|528458528|FG000|Overall Study|Withdrawal by Subject|3|||
146532251|NCT03555149|528458529|FG001|Overall Study|Withdrawal by Subject|0|||
146532252|NCT03555149|528458530|FG002|Overall Study|Withdrawal by Subject|0|||
146532253|NCT03555149|528458531|FG003|Overall Study|Withdrawal by Subject|2|||
146532254|NCT03555149|528458532|FG004|Overall Study|Withdrawal by Subject|0|||
146532255|NCT03555149|528458533|FG005|Overall Study|Withdrawal by Subject|1|||
146532256|NCT03555149|528458534|FG006|Overall Study|Withdrawal by Subject|0|||
146532257|NCT03555149|528458535|FG007|Overall Study|Withdrawal by Subject|0|||
146532258|NCT02666222|528458541|FG000|Overall Study|Death|2|||
146532259|NCT02295644|528458554|FG000|Overall Study|Did not meet inclusion criterion|0|||
146532260|NCT02295644|528458555|FG001|Overall Study|Did not meet inclusion criterion|0|||
146532261|NCT02295644|528458556|FG002|Overall Study|Did not meet inclusion criterion|1|||
146532262|NCT02295644|528458557|FG003|Overall Study|Did not meet inclusion criterion|2|||
146532263|NCT03504917|528458558|FG000|Blinded Treatment Period|Protocol Violation|1|||
146532264|NCT03504917|528458559|FG001|Blinded Treatment Period|Protocol Violation|0|||
146532265|NCT03504917|528458558|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
146532266|NCT03504917|528458559|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
146532267|NCT03504917|528458558|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
146532268|NCT03504917|528458559|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
146532269|NCT03504917|528458558|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
146532270|NCT03504917|528458559|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
146532271|NCT03504917|528458558|FG000|Blinded Treatment Period|Adverse Event|4|||
146532272|NCT03504917|528458559|FG001|Blinded Treatment Period|Adverse Event|4|||
146532273|NCT03504917|528458558|FG000|Blinded Treatment Period|Physician Decision|1|||
146532274|NCT03504917|528458559|FG001|Blinded Treatment Period|Physician Decision|0|||
146865585|NCT04178967|529680363|FG001|Induction Period|Adverse Event|6|||
146532275|NCT03504917|528458558|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
146532276|NCT03504917|528458559|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
146532277|NCT03504917|528458558|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
146532278|NCT03504917|528458559|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
146865586|NCT04178967|529680364|FG002|Induction Period|Adverse Event|0|||
146865587|NCT04178967|529680365|FG003|Induction Period|Adverse Event|0|||
146865588|NCT04178967|529680366|FG004|Induction Period|Adverse Event|0|||
146865589|NCT04178967|529680367|FG005|Induction Period|Adverse Event|0|||
146865590|NCT04178967|529680368|FG006|Induction Period|Adverse Event|0|||
146865591|NCT04178967|529680369|FG007|Induction Period|Adverse Event|0|||
146532279|NCT03504917|528458558|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
146532280|NCT03504917|528458559|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
146532281|NCT03504917|528458558|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
146532282|NCT03504917|528458559|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
146532283|NCT03504917|528458558|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
146532284|NCT03504917|528458559|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
146532285|NCT03504917|528458558|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
146532286|NCT03504917|528458559|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
146532287|NCT03504917|528458558|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
146532288|NCT03504917|528458559|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
146532289|NCT03504917|528458558|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
146532290|NCT03504917|528458559|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
146532291|NCT03504917|528458558|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
146865592|NCT04178967|529680370|FG008|Induction Period|Adverse Event|0|||
146865593|NCT04178967|529680371|FG009|Induction Period|Adverse Event|0|||
146865594|NCT04178967|529680372|FG010|Induction Period|Adverse Event|0|||
146865595|NCT04178967|529680362|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
146865596|NCT04178967|529680363|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
146865597|NCT04178967|529680364|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
146865598|NCT04178967|529680365|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
146865599|NCT04178967|529680366|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
146865600|NCT04178967|529680367|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
146865601|NCT04178967|529680368|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
146865602|NCT04178967|529680369|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
146865603|NCT04178967|529680370|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
146865604|NCT04178967|529680371|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
146865605|NCT04178967|529680372|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
146865606|NCT04178967|529680362|FG000|Induction Period|Lack of Efficacy|4|||
146865607|NCT04178967|529680363|FG001|Induction Period|Lack of Efficacy|1|||
146532292|NCT03504917|528458559|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
146532293|NCT03504917|528458558|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
146532294|NCT03504917|528458559|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
146532295|NCT04219189|528458560|FG000|Overall Study|Withdrawal by Subject|1|||
146532296|NCT04219189|528458561|FG001|Overall Study|Withdrawal by Subject|2|||
146532297|NCT04219189|528458560|FG000|Overall Study|Protocol Violation|0|||
146532298|NCT04219189|528458561|FG001|Overall Study|Protocol Violation|1|||
146532299|NCT04219189|528458560|FG000|Overall Study|Lost to Follow-up|0|||
146532300|NCT04219189|528458561|FG001|Overall Study|Lost to Follow-up|1|||
146532301|NCT04219189|528458560|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
146532302|NCT04219189|528458561|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
146532303|NCT01299584|528458562|FG000|Overall Study|Protocol Violation|9|||
146532304|NCT00324155|528458563|FG000|Enrolled and Randomized|No longer met study criteria|3|||
146532305|NCT00324155|528458564|FG001|Enrolled and Randomized|No longer met study criteria|0|||
146532306|NCT00324155|528458563|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
146532307|NCT00324155|528458564|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
146532308|NCT00324155|528458563|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
146532309|NCT00324155|528458564|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
146532310|NCT00324155|528458563|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
146532311|NCT00324155|528458564|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
146532312|NCT00324155|528458563|FG000|Received Treatment in Induction Phase|Death|8|||
146532313|NCT00324155|528458564|FG001|Received Treatment in Induction Phase|Death|15|||
146532314|NCT00324155|528458563|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
146532315|NCT00324155|528458564|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
146532316|NCT00324155|528458563|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
146532317|NCT00324155|528458564|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
146532318|NCT00324155|528458563|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
146532319|NCT00324155|528458564|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
146532320|NCT00324155|528458563|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
146532321|NCT00324155|528458564|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
146532322|NCT00324155|528458563|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
146532323|NCT00324155|528458564|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
146532324|NCT00324155|528458563|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
146532325|NCT00324155|528458564|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
146532326|NCT00324155|528458563|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
146532327|NCT00324155|528458564|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
146532328|NCT00324155|528458563|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
146532329|NCT00324155|528458564|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
146532330|NCT00324155|528458563|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
146532331|NCT00324155|528458564|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
146532332|NCT00324155|528458563|FG000|Follow-up Phase|On-going participants still on drug|11|||
146532333|NCT00324155|528458564|FG001|Follow-up Phase|On-going participants still on drug|6|||
146532334|NCT01253161|528458565|FG000|Overall Study|Adverse Event|1|||
146532335|NCT01909804|528458566|FG000|Overall Study|Randomized but Never Treated|0|||
146532336|NCT01909804|528458567|FG001|Overall Study|Randomized but Never Treated|0|||
146532337|NCT01909804|528458568|FG002|Overall Study|Randomized but Never Treated|0|||
146532338|NCT01909804|528458569|FG003|Overall Study|Randomized but Never Treated|0|||
146532339|NCT01909804|528458570|FG004|Overall Study|Randomized but Never Treated|0|||
146532340|NCT01909804|528458571|FG005|Overall Study|Randomized but Never Treated|0|||
146532341|NCT01909804|528458572|FG006|Overall Study|Randomized but Never Treated|1|||
146532342|NCT01909804|528458573|FG007|Overall Study|Randomized but Never Treated|0|||
146532343|NCT01909804|528458574|FG008|Overall Study|Randomized but Never Treated|0|||
146532344|NCT01909804|528458575|FG009|Overall Study|Randomized but Never Treated|0|||
146532345|NCT01909804|528458576|FG010|Overall Study|Randomized but Never Treated|0|||
146532346|NCT01909804|528458577|FG011|Overall Study|Randomized but Never Treated|1|||
146532347|NCT01909804|528458566|FG000|Overall Study|Death|0|||
146532348|NCT01909804|528458567|FG001|Overall Study|Death|0|||
146532349|NCT01909804|528458568|FG002|Overall Study|Death|0|||
146532350|NCT01909804|528458569|FG003|Overall Study|Death|0|||
146532351|NCT01909804|528458570|FG004|Overall Study|Death|0|||
146532352|NCT01909804|528458571|FG005|Overall Study|Death|0|||
146532353|NCT01909804|528458572|FG006|Overall Study|Death|0|||
146532354|NCT01909804|528458573|FG007|Overall Study|Death|0|||
146532355|NCT01909804|528458574|FG008|Overall Study|Death|0|||
146532356|NCT01909804|528458575|FG009|Overall Study|Death|0|||
146532357|NCT01909804|528458576|FG010|Overall Study|Death|1|||
146532358|NCT01909804|528458577|FG011|Overall Study|Death|0|||
146532359|NCT01909804|528458566|FG000|Overall Study|Lack of Efficacy|4|||
146532360|NCT01909804|528458567|FG001|Overall Study|Lack of Efficacy|1|||
146532361|NCT01909804|528458568|FG002|Overall Study|Lack of Efficacy|0|||
146865608|NCT04178967|529680364|FG002|Induction Period|Lack of Efficacy|0|||
146865609|NCT04178967|529680365|FG003|Induction Period|Lack of Efficacy|0|||
146865610|NCT04178967|529680366|FG004|Induction Period|Lack of Efficacy|0|||
146865611|NCT04178967|529680367|FG005|Induction Period|Lack of Efficacy|0|||
146865612|NCT04178967|529680368|FG006|Induction Period|Lack of Efficacy|0|||
146865613|NCT04178967|529680369|FG007|Induction Period|Lack of Efficacy|0|||
146865614|NCT04178967|529680370|FG008|Induction Period|Lack of Efficacy|0|||
146865615|NCT04178967|529680371|FG009|Induction Period|Lack of Efficacy|0|||
146865616|NCT04178967|529680372|FG010|Induction Period|Lack of Efficacy|0|||
146865617|NCT04178967|529680362|FG000|Induction Period|Protocol Violation|0|||
146865618|NCT04178967|529680363|FG001|Induction Period|Protocol Violation|6|||
146532362|NCT01909804|528458569|FG003|Overall Study|Lack of Efficacy|0|||
146532363|NCT01909804|528458570|FG004|Overall Study|Lack of Efficacy|7|||
146532364|NCT01909804|528458571|FG005|Overall Study|Lack of Efficacy|3|||
146532365|NCT01909804|528458572|FG006|Overall Study|Lack of Efficacy|1|||
146532366|NCT01909804|528458573|FG007|Overall Study|Lack of Efficacy|1|||
146532367|NCT01909804|528458574|FG008|Overall Study|Lack of Efficacy|0|||
146532368|NCT01909804|528458575|FG009|Overall Study|Lack of Efficacy|1|||
146532369|NCT01909804|528458576|FG010|Overall Study|Lack of Efficacy|0|||
146532370|NCT01909804|528458577|FG011|Overall Study|Lack of Efficacy|1|||
146532371|NCT01909804|528458566|FG000|Overall Study|Withdrew Consent|0|||
146532372|NCT01909804|528458567|FG001|Overall Study|Withdrew Consent|0|||
146532373|NCT01909804|528458568|FG002|Overall Study|Withdrew Consent|0|||
146532374|NCT01909804|528458569|FG003|Overall Study|Withdrew Consent|0|||
146532375|NCT01909804|528458570|FG004|Overall Study|Withdrew Consent|1|||
146532376|NCT01909804|528458571|FG005|Overall Study|Withdrew Consent|1|||
146532377|NCT01909804|528458572|FG006|Overall Study|Withdrew Consent|0|||
146532378|NCT01909804|528458573|FG007|Overall Study|Withdrew Consent|0|||
146532379|NCT01909804|528458574|FG008|Overall Study|Withdrew Consent|0|||
146532380|NCT01909804|528458575|FG009|Overall Study|Withdrew Consent|0|||
146532381|NCT01909804|528458576|FG010|Overall Study|Withdrew Consent|0|||
146532382|NCT01909804|528458577|FG011|Overall Study|Withdrew Consent|0|||
146532383|NCT01909804|528458566|FG000|Overall Study|Protocol Violation|0|||
146532384|NCT01909804|528458567|FG001|Overall Study|Protocol Violation|0|||
146532385|NCT01909804|528458568|FG002|Overall Study|Protocol Violation|0|||
146532386|NCT01909804|528458569|FG003|Overall Study|Protocol Violation|0|||
146532387|NCT01909804|528458570|FG004|Overall Study|Protocol Violation|0|||
146532388|NCT01909804|528458571|FG005|Overall Study|Protocol Violation|0|||
146532389|NCT01909804|528458572|FG006|Overall Study|Protocol Violation|0|||
146532390|NCT01909804|528458573|FG007|Overall Study|Protocol Violation|0|||
146532391|NCT01909804|528458574|FG008|Overall Study|Protocol Violation|0|||
146532392|NCT01909804|528458575|FG009|Overall Study|Protocol Violation|0|||
146532393|NCT01909804|528458576|FG010|Overall Study|Protocol Violation|0|||
146532394|NCT01909804|528458577|FG011|Overall Study|Protocol Violation|1|||
146532395|NCT02895347|528458578|FG000|Overall Study|Withdrawal by Subject|3|||
146532396|NCT02895347|528458579|FG001|Overall Study|Withdrawal by Subject|1|||
146532397|NCT01673178|528458580|FG000|Overall Study|Lost to Follow-up|0|||
146532398|NCT01673178|528458581|FG001|Overall Study|Lost to Follow-up|1|||
146532399|NCT01673178|528458582|FG002|Overall Study|Lost to Follow-up|0|||
146532400|NCT01673178|528458583|FG003|Overall Study|Lost to Follow-up|0|||
146532401|NCT01673178|528458584|FG004|Overall Study|Lost to Follow-up|0|||
146532402|NCT01673178|528458580|FG000|Overall Study|Withdrawal by Subject|0|||
146532403|NCT01673178|528458581|FG001|Overall Study|Withdrawal by Subject|0|||
146532404|NCT01673178|528458582|FG002|Overall Study|Withdrawal by Subject|1|||
146532405|NCT01673178|528458583|FG003|Overall Study|Withdrawal by Subject|4|||
146532406|NCT01673178|528458584|FG004|Overall Study|Withdrawal by Subject|2|||
146532407|NCT01673178|528458580|FG000|Overall Study|Protocol Violation|1|||
146532408|NCT01673178|528458581|FG001|Overall Study|Protocol Violation|1|||
146532409|NCT01673178|528458582|FG002|Overall Study|Protocol Violation|0|||
146532410|NCT01673178|528458583|FG003|Overall Study|Protocol Violation|1|||
146532411|NCT01673178|528458584|FG004|Overall Study|Protocol Violation|0|||
146532412|NCT01673178|528458580|FG000|Overall Study|Adverse Event|1|||
146532413|NCT01673178|528458581|FG001|Overall Study|Adverse Event|0|||
146532414|NCT01673178|528458582|FG002|Overall Study|Adverse Event|0|||
146532415|NCT01673178|528458583|FG003|Overall Study|Adverse Event|2|||
146532416|NCT01673178|528458584|FG004|Overall Study|Adverse Event|0|||
146532417|NCT01673178|528458580|FG000|Overall Study|Other|1|||
146532418|NCT01673178|528458581|FG001|Overall Study|Other|0|||
146532419|NCT01673178|528458582|FG002|Overall Study|Other|2|||
146532420|NCT01673178|528458583|FG003|Overall Study|Other|1|||
146532421|NCT01673178|528458584|FG004|Overall Study|Other|0|||
146532422|NCT02563899|528458601|FG000|Overall Study|Protocol Violation|1|||
146532423|NCT02563899|528458602|FG001|Overall Study|Protocol Violation|0|||
146532424|NCT02563899|528458603|FG002|Overall Study|Protocol Violation|0|||
146532425|NCT02563899|528458604|FG003|Overall Study|Protocol Violation|0|||
146532426|NCT02563899|528458601|FG000|Overall Study|Withdrawal by Subject|0|||
146532427|NCT02563899|528458602|FG001|Overall Study|Withdrawal by Subject|0|||
146532428|NCT02563899|528458603|FG002|Overall Study|Withdrawal by Subject|1|||
146532429|NCT02563899|528458604|FG003|Overall Study|Withdrawal by Subject|0|||
146865619|NCT04178967|529680364|FG002|Induction Period|Protocol Violation|0|||
146532430|NCT01026493|528460702|FG000|Overall Study|Protocol Violation|0|||
146532431|NCT01026493|528460703|FG001|Overall Study|Protocol Violation|1|||
146532432|NCT01026493|528460704|FG002|Overall Study|Protocol Violation|0|||
146532433|NCT01026493|528460705|FG003|Overall Study|Protocol Violation|0|||
146532434|NCT01026493|528460706|FG004|Overall Study|Protocol Violation|2|||
146532435|NCT01026493|528460707|FG005|Overall Study|Protocol Violation|3|||
146532436|NCT01026493|528460708|FG006|Overall Study|Protocol Violation|4|||
146532437|NCT01026493|528460709|FG007|Overall Study|Protocol Violation|1|||
146532438|NCT03154086|528460713|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
146532439|NCT03154086|528460714|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
146532440|NCT03154086|528460715|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
146532441|NCT03154086|528460716|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
146532442|NCT03154086|528460717|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
146532443|NCT03154086|528460718|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
146532444|NCT03154086|528460719|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
146532445|NCT03154086|528460720|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
146532446|NCT03154086|528460721|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
146532447|NCT03154086|528460722|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
146532448|NCT03154086|528460723|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
146532449|NCT03154086|528460724|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
146532450|NCT03154086|528460725|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
146532451|NCT03154086|528460726|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
146532452|NCT03154086|528460727|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
146532453|NCT03154086|528460713|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
146532454|NCT03154086|528460714|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
146532455|NCT03154086|528460715|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
146532456|NCT03154086|528460716|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
146532457|NCT03154086|528460717|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
146532458|NCT03154086|528460718|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
146532459|NCT03154086|528460719|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
146532460|NCT03154086|528460720|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
146532461|NCT03154086|528460721|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
146532462|NCT03154086|528460722|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
146532463|NCT03154086|528460723|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
146532464|NCT03154086|528460724|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
146532465|NCT03154086|528460725|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
146532466|NCT03154086|528460726|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
146532467|NCT03154086|528460727|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
146532468|NCT03154086|528460713|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
146532469|NCT03154086|528460714|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
146532470|NCT03154086|528460715|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
146532471|NCT03154086|528460716|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
146532472|NCT03154086|528460717|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
146532473|NCT03154086|528460718|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
146532474|NCT03154086|528460719|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
146532475|NCT03154086|528460720|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
146532476|NCT03154086|528460721|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
146532477|NCT03154086|528460722|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
146532478|NCT03154086|528460723|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
146532479|NCT03154086|528460724|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
146532480|NCT03154086|528460725|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
146532481|NCT03154086|528460726|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
146532482|NCT03154086|528460727|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
146532483|NCT03154086|528460713|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
146532484|NCT03154086|528460714|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
146532485|NCT03154086|528460715|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
146532486|NCT03154086|528460716|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
146762918|NCT01048788|529299327|FG001|Overall Study|Withdrawal by Subject|1|||
146762919|NCT01048788|529299328|FG002|Overall Study|Withdrawal by Subject|0|||
146762920|NCT02145182|529299330|FG000|Overall Study|Adverse Event|4|||
146762921|NCT02145182|529299331|FG001|Overall Study|Adverse Event|1|||
146762922|NCT02145182|529299330|FG000|Overall Study|Death|7|||
146762923|NCT02145182|529299331|FG001|Overall Study|Death|7|||
146762924|NCT02145182|529299330|FG000|Overall Study|Lost to Follow-up|2|||
146762925|NCT02145182|529299331|FG001|Overall Study|Lost to Follow-up|2|||
146762926|NCT02145182|529299330|FG000|Overall Study|Pre-transplant Withdrawal|0|||
146762927|NCT02145182|529299331|FG001|Overall Study|Pre-transplant Withdrawal|2|||
146865620|NCT04178967|529680365|FG003|Induction Period|Protocol Violation|0|||
146865621|NCT04178967|529680366|FG004|Induction Period|Protocol Violation|0|||
146865622|NCT04178967|529680367|FG005|Induction Period|Protocol Violation|0|||
146865623|NCT04178967|529680368|FG006|Induction Period|Protocol Violation|0|||
146865624|NCT04178967|529680369|FG007|Induction Period|Protocol Violation|0|||
146865625|NCT04178967|529680370|FG008|Induction Period|Protocol Violation|0|||
146865626|NCT04178967|529680371|FG009|Induction Period|Protocol Violation|0|||
146865627|NCT04178967|529680372|FG010|Induction Period|Protocol Violation|0|||
146865628|NCT04178967|529680362|FG000|Induction Period|Withdrawal by Subject|6|||
146865629|NCT04178967|529680363|FG001|Induction Period|Withdrawal by Subject|4|||
146865630|NCT04178967|529680364|FG002|Induction Period|Withdrawal by Subject|0|||
146865631|NCT04178967|529680365|FG003|Induction Period|Withdrawal by Subject|0|||
146865632|NCT04178967|529680366|FG004|Induction Period|Withdrawal by Subject|0|||
146865633|NCT04178967|529680367|FG005|Induction Period|Withdrawal by Subject|0|||
146865634|NCT04178967|529680368|FG006|Induction Period|Withdrawal by Subject|0|||
146865635|NCT04178967|529680369|FG007|Induction Period|Withdrawal by Subject|0|||
146865636|NCT04178967|529680370|FG008|Induction Period|Withdrawal by Subject|0|||
146865637|NCT04178967|529680371|FG009|Induction Period|Withdrawal by Subject|0|||
146865638|NCT04178967|529680372|FG010|Induction Period|Withdrawal by Subject|0|||
146865639|NCT04178967|529680362|FG000|Induction Period|Lost to Follow-up|2|||
146865640|NCT04178967|529680363|FG001|Induction Period|Lost to Follow-up|0|||
146865641|NCT04178967|529680364|FG002|Induction Period|Lost to Follow-up|0|||
146865642|NCT04178967|529680365|FG003|Induction Period|Lost to Follow-up|0|||
146865643|NCT04178967|529680366|FG004|Induction Period|Lost to Follow-up|0|||
146865644|NCT04178967|529680367|FG005|Induction Period|Lost to Follow-up|0|||
146865645|NCT04178967|529680368|FG006|Induction Period|Lost to Follow-up|0|||
146865646|NCT04178967|529680369|FG007|Induction Period|Lost to Follow-up|0|||
146865647|NCT04178967|529680370|FG008|Induction Period|Lost to Follow-up|0|||
146865648|NCT04178967|529680371|FG009|Induction Period|Lost to Follow-up|0|||
146865649|NCT04178967|529680372|FG010|Induction Period|Lost to Follow-up|0|||
146865650|NCT04178967|529680362|FG000|Induction Period|Participant Missed Study Visits|0|||
146865651|NCT04178967|529680363|FG001|Induction Period|Participant Missed Study Visits|1|||
146865652|NCT04178967|529680364|FG002|Induction Period|Participant Missed Study Visits|0|||
146865653|NCT04178967|529680365|FG003|Induction Period|Participant Missed Study Visits|0|||
146865654|NCT04178967|529680366|FG004|Induction Period|Participant Missed Study Visits|0|||
146865655|NCT04178967|529680367|FG005|Induction Period|Participant Missed Study Visits|0|||
146865656|NCT04178967|529680368|FG006|Induction Period|Participant Missed Study Visits|0|||
146865657|NCT04178967|529680369|FG007|Induction Period|Participant Missed Study Visits|0|||
146865658|NCT04178967|529680370|FG008|Induction Period|Participant Missed Study Visits|0|||
146865659|NCT04178967|529680371|FG009|Induction Period|Participant Missed Study Visits|0|||
146865660|NCT04178967|529680372|FG010|Induction Period|Participant Missed Study Visits|0|||
146865661|NCT04178967|529680362|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
146865662|NCT04178967|529680363|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
146865663|NCT04178967|529680364|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
146865664|NCT04178967|529680365|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
146865665|NCT04178967|529680366|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
146865666|NCT04178967|529680367|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
146865667|NCT04178967|529680368|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
146865668|NCT04178967|529680369|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
146865669|NCT04178967|529680370|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
146865670|NCT04178967|529680371|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
146865671|NCT04178967|529680372|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
146865672|NCT04178967|529680362|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146865673|NCT04178967|529680363|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146865674|NCT04178967|529680364|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146865675|NCT04178967|529680365|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146865676|NCT04178967|529680366|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146865677|NCT04178967|529680367|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
146865678|NCT04178967|529680368|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146865679|NCT04178967|529680369|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146865680|NCT04178967|529680370|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146865681|NCT04178967|529680371|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146865682|NCT04178967|529680372|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146865683|NCT04178967|529680362|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146865684|NCT04178967|529680363|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146865685|NCT04178967|529680364|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146865686|NCT04178967|529680365|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
146865687|NCT04178967|529680366|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146865688|NCT04178967|529680367|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146865689|NCT04178967|529680368|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146865690|NCT04178967|529680369|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146532487|NCT03154086|528460717|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
146532488|NCT03154086|528460718|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
146532489|NCT03154086|528460719|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
146532490|NCT03154086|528460720|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
146532491|NCT03154086|528460721|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
146532492|NCT03154086|528460722|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
146532493|NCT03154086|528460723|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
146532494|NCT03154086|528460724|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
146532495|NCT03154086|528460725|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
146762928|NCT02145182|529299330|FG000|Overall Study|Withdrawal by Subject|5|||
146762929|NCT02145182|529299331|FG001|Overall Study|Withdrawal by Subject|4|||
146762930|NCT01196988|529299333|FG000|Overall Study|Adverse Event|1|||
146762931|NCT01196988|529299334|FG001|Overall Study|Adverse Event|2|||
146762932|NCT01196988|529299335|FG002|Overall Study|Adverse Event|0|||
146762933|NCT01196988|529299336|FG003|Overall Study|Adverse Event|0|||
146762934|NCT01196988|529299333|FG000|Overall Study|Withdrawal by Subject|5|||
146762935|NCT01196988|529299334|FG001|Overall Study|Withdrawal by Subject|1|||
146762936|NCT01196988|529299335|FG002|Overall Study|Withdrawal by Subject|4|||
146762937|NCT01196988|529299336|FG003|Overall Study|Withdrawal by Subject|0|||
146762938|NCT01196988|529299333|FG000|Overall Study|Lost to Follow-up|16|||
146762939|NCT01196988|529299334|FG001|Overall Study|Lost to Follow-up|29|||
146762940|NCT01196988|529299335|FG002|Overall Study|Lost to Follow-up|21|||
146762941|NCT01196988|529299336|FG003|Overall Study|Lost to Follow-up|1|||
146762942|NCT01196988|529299333|FG000|Overall Study|Other|2|||
146762943|NCT01196988|529299334|FG001|Overall Study|Other|0|||
146762944|NCT01196988|529299335|FG002|Overall Study|Other|0|||
146762945|NCT01196988|529299336|FG003|Overall Study|Other|0|||
146762946|NCT05419557|529299337|FG000|Overall Study|Lost to Follow-up|11|||
146762947|NCT05419557|529299338|FG001|Overall Study|Lost to Follow-up|4|||
146762948|NCT00588666|529299339|FG000|Overall Study|Adverse Event|4|||
146762949|NCT01233050|529299340|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
146762950|NCT01233050|529299341|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
146762951|NCT03999554|529299344|FG000|Overall Study|Lost to Follow-up|4|||
146762952|NCT03999554|529299345|FG001|Overall Study|Lost to Follow-up|5|||
146762953|NCT03999554|529299346|FG002|Overall Study|Lost to Follow-up|4|||
146762954|NCT03999554|529299347|FG003|Overall Study|Lost to Follow-up|5|||
146762955|NCT03999554|529299348|FG004|Overall Study|Lost to Follow-up|8|||
146762956|NCT03999554|529299344|FG000|Overall Study|Protocol Violation|0|||
146762957|NCT03999554|529299345|FG001|Overall Study|Protocol Violation|0|||
146762958|NCT03999554|529299346|FG002|Overall Study|Protocol Violation|5|||
146762959|NCT03999554|529299347|FG003|Overall Study|Protocol Violation|0|||
146762960|NCT03999554|529299348|FG004|Overall Study|Protocol Violation|0|||
146762961|NCT03999554|529299344|FG000|Overall Study|Pregnancy|0|||
146762962|NCT03999554|529299345|FG001|Overall Study|Pregnancy|0|||
146762963|NCT03999554|529299346|FG002|Overall Study|Pregnancy|1|||
146762964|NCT03999554|529299347|FG003|Overall Study|Pregnancy|0|||
146762965|NCT03999554|529299348|FG004|Overall Study|Pregnancy|0|||
146762966|NCT03999554|529299344|FG000|Overall Study|Withdrawal by Subject|2|||
146762967|NCT03999554|529299345|FG001|Overall Study|Withdrawal by Subject|2|||
146762968|NCT03999554|529299346|FG002|Overall Study|Withdrawal by Subject|2|||
146762969|NCT03999554|529299347|FG003|Overall Study|Withdrawal by Subject|1|||
146762970|NCT03999554|529299348|FG004|Overall Study|Withdrawal by Subject|1|||
146762971|NCT03999554|529299344|FG000|Overall Study|failure to comply with protocol requirements|0|||
146762972|NCT03999554|529299345|FG001|Overall Study|failure to comply with protocol requirements|0|||
146762973|NCT03999554|529299346|FG002|Overall Study|failure to comply with protocol requirements|0|||
146762974|NCT03999554|529299347|FG003|Overall Study|failure to comply with protocol requirements|1|||
146762975|NCT03999554|529299348|FG004|Overall Study|failure to comply with protocol requirements|0|||
146762976|NCT01710514|529299355|FG000|Overall Study|Adverse Event|6|||
146762977|NCT01710514|529299356|FG001|Overall Study|Adverse Event|7|||
146762978|NCT01710514|529299355|FG000|Overall Study|Withdrawal by Subject|1|||
146762979|NCT01710514|529299356|FG001|Overall Study|Withdrawal by Subject|0|||
146762980|NCT03404843|529299357|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
146762981|NCT03404843|529299358|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
146762982|NCT02701361|529299359|FG000|Overall Study|Lost to Follow-up|5|||
146762983|NCT02701361|529299360|FG001|Overall Study|Lost to Follow-up|2|||
146762984|NCT02701361|529299361|FG002|Overall Study|Lost to Follow-up|1|||
146762985|NCT02701361|529299359|FG000|Overall Study|Withdrawal by Subject|4|||
146762986|NCT02701361|529299360|FG001|Overall Study|Withdrawal by Subject|0|||
146762987|NCT02701361|529299361|FG002|Overall Study|Withdrawal by Subject|0|||
146762988|NCT02701361|529299359|FG000|Overall Study|timed out in rehab center|0|||
146762989|NCT02701361|529299360|FG001|Overall Study|timed out in rehab center|1|||
146762990|NCT02701361|529299361|FG002|Overall Study|timed out in rehab center|0|||
146762991|NCT02701361|529299359|FG000|Overall Study|incarceration|0|||
146762992|NCT02701361|529299360|FG001|Overall Study|incarceration|0|||
146762993|NCT02701361|529299361|FG002|Overall Study|incarceration|1|||
146762994|NCT02430532|529299370|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
146865691|NCT04178967|529680370|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146865692|NCT04178967|529680371|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146865693|NCT04178967|529680372|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146865694|NCT04178967|529680362|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
146865695|NCT04178967|529680363|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
146865696|NCT04178967|529680364|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
146865697|NCT04178967|529680365|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
146865698|NCT04178967|529680366|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
146865699|NCT04178967|529680367|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
146865700|NCT04178967|529680368|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
146865701|NCT04178967|529680369|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
146865702|NCT04178967|529680370|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
146865703|NCT04178967|529680371|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
146865704|NCT04178967|529680372|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
146865705|NCT04178967|529680362|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
146865706|NCT04178967|529680363|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
146865707|NCT04178967|529680364|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
146865708|NCT04178967|529680365|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
146865709|NCT04178967|529680366|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
146865710|NCT04178967|529680367|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
146865711|NCT04178967|529680368|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
146865712|NCT04178967|529680369|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
146865713|NCT04178967|529680370|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
146865714|NCT04178967|529680371|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
146865715|NCT04178967|529680372|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
146865716|NCT04178967|529680362|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
146865717|NCT04178967|529680363|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
146865718|NCT04178967|529680364|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
146865719|NCT04178967|529680365|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
146865720|NCT04178967|529680366|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
146865721|NCT04178967|529680367|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
146865722|NCT04178967|529680368|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
146865723|NCT04178967|529680369|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
146865724|NCT04178967|529680370|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
146865725|NCT04178967|529680371|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
146865726|NCT04178967|529680372|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
146865727|NCT04178967|529680362|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
146865728|NCT04178967|529680363|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
146865729|NCT04178967|529680364|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
146865730|NCT04178967|529680365|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
146865731|NCT04178967|529680366|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
146865732|NCT04178967|529680367|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
146865733|NCT04178967|529680368|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
146865734|NCT04178967|529680369|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
146865735|NCT04178967|529680370|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
146865736|NCT04178967|529680371|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
146865737|NCT04178967|529680372|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
146865738|NCT04178967|529680362|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
146865739|NCT04178967|529680363|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
146865740|NCT04178967|529680364|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
146865741|NCT04178967|529680365|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
146865742|NCT04178967|529680366|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
146865743|NCT04178967|529680367|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
146762995|NCT02430532|529299371|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
146762996|NCT02430532|529299370|FG000|Overall Study|Consent Withdrawn|0|||
146762997|NCT02430532|529299371|FG001|Overall Study|Consent Withdrawn|2|||
146762998|NCT02430532|529299370|FG000|Overall Study|Adverse Event|0|||
146762999|NCT02430532|529299371|FG001|Overall Study|Adverse Event|1|||
146763000|NCT02750709|529299374|FG000|Treatment Period 1|Adverse Event|0|||
146763001|NCT02750709|529299375|FG001|Treatment Period 1|Adverse Event|0|||
146763002|NCT02750709|529299376|FG002|Treatment Period 1|Adverse Event|0|||
146763003|NCT02750709|529299377|FG003|Treatment Period 1|Adverse Event|0|||
146763004|NCT02750709|529299378|FG004|Treatment Period 1|Adverse Event|0|||
146763005|NCT02750709|529299379|FG005|Treatment Period 1|Adverse Event|1|||
146763006|NCT03256344|529299380|FG000|Overall Study|Death|6|||
146763007|NCT03256344|529299381|FG001|Overall Study|Death|22|||
146763008|NCT03256344|529299380|FG000|Overall Study|Withdrawal by Subject|3|||
146763009|NCT03256344|529299381|FG001|Overall Study|Withdrawal by Subject|3|||
146865744|NCT04178967|529680368|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
146865745|NCT04178967|529680369|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
146865746|NCT04178967|529680370|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
146865747|NCT04178967|529680371|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
146865748|NCT04178967|529680372|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
146865749|NCT04178967|529680362|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146865750|NCT04178967|529680363|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146865751|NCT04178967|529680364|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146865752|NCT04178967|529680365|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146865753|NCT04178967|529680366|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146865754|NCT04178967|529680367|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146865755|NCT04178967|529680368|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146865756|NCT04178967|529680369|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146865757|NCT04178967|529680370|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
146865758|NCT04178967|529680371|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
146865759|NCT04178967|529680372|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
146865760|NCT04178967|529680362|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146865761|NCT04178967|529680363|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146865762|NCT04178967|529680364|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146865763|NCT04178967|529680365|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146865764|NCT04178967|529680366|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146865765|NCT04178967|529680367|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146865766|NCT04178967|529680368|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146865767|NCT04178967|529680369|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146865768|NCT04178967|529680370|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146865769|NCT04178967|529680371|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
146865770|NCT04178967|529680372|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146865771|NCT04178967|529680362|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146865772|NCT04178967|529680363|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146865773|NCT04178967|529680364|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146865774|NCT04178967|529680365|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146865775|NCT04178967|529680366|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146865776|NCT04178967|529680367|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146865777|NCT04178967|529680368|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146865778|NCT04178967|529680369|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146865779|NCT04178967|529680370|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
146865780|NCT04178967|529680371|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
146865781|NCT04178967|529680372|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
146865782|NCT04178967|529680362|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146865783|NCT04178967|529680363|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146865784|NCT04178967|529680364|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146865785|NCT04178967|529680365|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146865786|NCT04178967|529680366|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146865787|NCT04178967|529680367|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146865788|NCT04178967|529680368|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146865789|NCT04178967|529680369|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146865790|NCT04178967|529680370|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146865791|NCT04178967|529680371|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
146865792|NCT04178967|529680372|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146865793|NCT04178967|529680362|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146865794|NCT04178967|529680363|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146865795|NCT04178967|529680364|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146865796|NCT04178967|529680365|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146865797|NCT04178967|529680366|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146865798|NCT04178967|529680367|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146865799|NCT04178967|529680368|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146865800|NCT04178967|529680369|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146865801|NCT04178967|529680370|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146865802|NCT04178967|529680371|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
146865803|NCT04178967|529680372|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146865804|NCT02545322|529680373|FG000|Overall Study|Withdrawal by Subject|3|||
146865805|NCT01251120|529680375|FG000|Overall Study|Lack of Efficacy|0|||
146865806|NCT01251120|529680376|FG001|Overall Study|Lack of Efficacy|1|||
146865807|NCT01822522|529680377|FG000|Overall Study|Adverse Event|1|||
146865808|NCT01822522|529680378|FG001|Overall Study|Adverse Event|1|||
146865809|NCT01822522|529680379|FG002|Overall Study|Adverse Event|1|||
146865810|NCT01822522|529680380|FG003|Overall Study|Adverse Event|0|||
146865811|NCT01822522|529680381|FG004|Overall Study|Adverse Event|0|||
146865812|NCT01822522|529680382|FG005|Overall Study|Adverse Event|1|||
146865813|NCT01822522|529680377|FG000|Overall Study|Death|3|||
146865814|NCT01822522|529680378|FG001|Overall Study|Death|0|||
146865815|NCT01822522|529680379|FG002|Overall Study|Death|2|||
146865816|NCT01822522|529680380|FG003|Overall Study|Death|0|||
146865817|NCT01822522|529680381|FG004|Overall Study|Death|0|||
146865818|NCT01822522|529680382|FG005|Overall Study|Death|0|||
146865819|NCT01822522|529680377|FG000|Overall Study|Lost to Follow-up|0|||
146865820|NCT01822522|529680378|FG001|Overall Study|Lost to Follow-up|0|||
146865821|NCT01822522|529680379|FG002|Overall Study|Lost to Follow-up|1|||
146865822|NCT01822522|529680380|FG003|Overall Study|Lost to Follow-up|1|||
146865823|NCT01822522|529680381|FG004|Overall Study|Lost to Follow-up|0|||
146865824|NCT01822522|529680382|FG005|Overall Study|Lost to Follow-up|1|||
146865825|NCT01822522|529680377|FG000|Overall Study|Withdrawal by Subject|0|||
146865826|NCT01822522|529680378|FG001|Overall Study|Withdrawal by Subject|0|||
146865827|NCT01822522|529680379|FG002|Overall Study|Withdrawal by Subject|0|||
146865828|NCT01822522|529680380|FG003|Overall Study|Withdrawal by Subject|1|||
146865829|NCT01822522|529680381|FG004|Overall Study|Withdrawal by Subject|0|||
146532496|NCT03154086|528460726|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
146865830|NCT01822522|529680382|FG005|Overall Study|Withdrawal by Subject|0|||
146865831|NCT01822522|529680377|FG000|Overall Study|Lack of Efficacy|0|||
146865832|NCT01822522|529680378|FG001|Overall Study|Lack of Efficacy|0|||
146865833|NCT01822522|529680379|FG002|Overall Study|Lack of Efficacy|0|||
146865834|NCT01822522|529680380|FG003|Overall Study|Lack of Efficacy|0|||
146865835|NCT01822522|529680381|FG004|Overall Study|Lack of Efficacy|0|||
146865836|NCT01822522|529680382|FG005|Overall Study|Lack of Efficacy|2|||
146865837|NCT01807923|529680383|FG000|Overall Study|Adverse Event|2|||
146865838|NCT01807923|529680384|FG001|Overall Study|Adverse Event|1|||
146865839|NCT01807923|529680385|FG002|Overall Study|Adverse Event|2|||
146865840|NCT01807923|529680383|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
146865841|NCT01807923|529680384|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
146865842|NCT01807923|529680385|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
146865843|NCT01807923|529680383|FG000|Overall Study|Physician Decision|0|||
146865844|NCT01807923|529680384|FG001|Overall Study|Physician Decision|0|||
146865845|NCT01807923|529680385|FG002|Overall Study|Physician Decision|1|||
146865846|NCT01807923|529680383|FG000|Overall Study|Not Eligible (Genotype)|0|||
146865847|NCT01807923|529680384|FG001|Overall Study|Not Eligible (Genotype)|0|||
146865848|NCT01807923|529680385|FG002|Overall Study|Not Eligible (Genotype)|1|||
146865849|NCT01807923|529680383|FG000|Overall Study|Randomized But Not Treated|3|||
146865850|NCT01807923|529680384|FG001|Overall Study|Randomized But Not Treated|2|||
146865851|NCT01807923|529680385|FG002|Overall Study|Randomized But Not Treated|5|||
146865852|NCT02558231|529680387|FG000|Overall Study|Death|4|||
146865853|NCT02558231|529680388|FG001|Overall Study|Death|12|||
146865854|NCT02558231|529680387|FG000|Overall Study|Lost to Follow-up|7|||
146865855|NCT02558231|529680388|FG001|Overall Study|Lost to Follow-up|4|||
146865856|NCT02558231|529680387|FG000|Overall Study|Withdrawal by Subject|7|||
146865857|NCT02558231|529680388|FG001|Overall Study|Withdrawal by Subject|4|||
146865858|NCT02558231|529680387|FG000|Overall Study|Physician Decision|7|||
146865859|NCT02558231|529680388|FG001|Overall Study|Physician Decision|5|||
146865860|NCT02558231|529680387|FG000|Overall Study|Sponsor Decision|0|||
146865861|NCT02558231|529680388|FG001|Overall Study|Sponsor Decision|1|||
146865862|NCT00995007|529680389|FG000|Overall Study|Withdrew consent|1|||
146865863|NCT00995007|529680390|FG001|Overall Study|Withdrew consent|0|||
146865864|NCT00995007|529680389|FG000|Overall Study|Refused further treatment|8|||
146865865|NCT00995007|529680390|FG001|Overall Study|Refused further treatment|2|||
146865866|NCT00995007|529680389|FG000|Overall Study|Toxicity|8|||
146865867|NCT00995007|529680390|FG001|Overall Study|Toxicity|0|||
146532497|NCT03154086|528460727|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
146532498|NCT03154086|528460713|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
146532499|NCT03154086|528460714|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
146532500|NCT03154086|528460715|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
146532501|NCT03154086|528460716|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
146865868|NCT03933397|529680391|FG000|Overall Study|No emergency department visit|65|||
146865869|NCT03933397|529680392|FG001|Overall Study|No emergency department visit|71|||
146865870|NCT03933397|529680391|FG000|Overall Study|Missed emergency department visit|25|||
146865871|NCT03933397|529680392|FG001|Overall Study|Missed emergency department visit|30|||
146865872|NCT03933397|529680391|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
146865873|NCT03933397|529680392|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
146865874|NCT03933397|529680391|FG000|Overall Study|Withdrawal by Subject|1|||
146865875|NCT03933397|529680392|FG001|Overall Study|Withdrawal by Subject|0|||
146865876|NCT03933397|529680391|FG000|Overall Study|Physician Decision|1|||
146865877|NCT03933397|529680392|FG001|Overall Study|Physician Decision|1|||
146865878|NCT03933397|529680391|FG000|Overall Study|missing pain score|1|||
146865879|NCT03933397|529680392|FG001|Overall Study|missing pain score|1|||
146532502|NCT03154086|528460717|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
146532503|NCT03154086|528460718|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
146532504|NCT03154086|528460719|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
146532505|NCT03154086|528460720|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
146532506|NCT03154086|528460721|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
146532507|NCT03154086|528460722|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
146532508|NCT03154086|528460723|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
146532509|NCT03154086|528460724|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
146532510|NCT03154086|528460725|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
146532511|NCT03154086|528460726|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
146865880|NCT03933397|529680391|FG000|Overall Study|Confirmed COVID-19|1|||
146865881|NCT03933397|529680392|FG001|Overall Study|Confirmed COVID-19|2|||
146865882|NCT01237340|529680399|FG000|Overall Study|Adverse Event|3|||
146865883|NCT01237340|529680399|FG000|Overall Study|Withdrawal by Subject|1|||
146865884|NCT01237340|529680399|FG000|Overall Study|Early termination of the trial|36|||
146865885|NCT01610687|529680400|FG000|Overall Study|Lack of Efficacy|26|||
146865886|NCT01610687|529680400|FG000|Overall Study|Adverse Event|18|||
146865887|NCT01610687|529680400|FG000|Overall Study|Moved out of area|6|||
146865888|NCT01610687|529680400|FG000|Overall Study|Withdrawal by Subject|7|||
146865889|NCT01610687|529680400|FG000|Overall Study|Lost to Follow-up|4|||
146865890|NCT01610687|529680400|FG000|Overall Study|Symptom control without study medication|2|||
146532512|NCT03154086|528460727|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
146763010|NCT03256344|529299380|FG000|Overall Study|Sponsor Decision|1|||
146763011|NCT03256344|529299381|FG001|Overall Study|Sponsor Decision|0|||
146763012|NCT00853827|529299385|FG000|Single Blind Period (1 Week)|Other|4|||
146763013|NCT00853827|529299386|FG001|Single Blind Period (1 Week)|Other|0|||
146763014|NCT00853827|529299385|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
146763015|NCT00853827|529299386|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
146763016|NCT00853827|529299385|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
146763017|NCT00853827|529299386|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
146763018|NCT00853827|529299385|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
146763019|NCT00853827|529299386|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
146763020|NCT00853827|529299385|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
146763021|NCT00853827|529299386|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
146763022|NCT00853827|529299385|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
146763023|NCT00853827|529299386|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
146763024|NCT00853827|529299385|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
146763025|NCT00853827|529299386|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
146763026|NCT00853827|529299385|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
146763027|NCT00853827|529299386|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
146763028|NCT00853827|529299385|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
146763029|NCT00853827|529299386|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
146763030|NCT00853827|529299385|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
146763031|NCT00853827|529299386|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
146763032|NCT00853827|529299385|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
146763033|NCT00853827|529299386|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
146763034|NCT00853827|529299385|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
146763035|NCT00853827|529299386|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
146763036|NCT00853827|529299385|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
146763037|NCT00853827|529299386|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
146763038|NCT00853827|529299385|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
146763039|NCT00853827|529299386|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
146763040|NCT00853827|529299385|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
146763041|NCT00853827|529299386|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
146763042|NCT00853827|529299385|FG000|Double Blind Period (103 Weeks)|Death|1|||
146763043|NCT00853827|529299386|FG001|Double Blind Period (103 Weeks)|Death|6|||
146763044|NCT00290732|529299394|FG000|Overall Study|Inability to instill drug intraductally.|0|||
146763045|NCT00290732|529299395|FG001|Overall Study|Inability to instill drug intraductally.|1|||
146763046|NCT00290732|529299396|FG002|Overall Study|Inability to instill drug intraductally.|1|||
146763047|NCT00290732|529299397|FG003|Overall Study|Inability to instill drug intraductally.|0|||
146763048|NCT00290732|529299398|FG004|Overall Study|Inability to instill drug intraductally.|0|||
146763049|NCT00580801|529299399|FG000|Overall Study|Physician Decision|1|||
146763050|NCT00580801|529299400|FG001|Overall Study|Physician Decision|0|||
146763051|NCT00580801|529299401|FG002|Overall Study|Physician Decision|0|||
146763052|NCT00580801|529299399|FG000|Overall Study|Adverse Event|2|||
146763053|NCT00580801|529299400|FG001|Overall Study|Adverse Event|0|||
146763054|NCT00580801|529299401|FG002|Overall Study|Adverse Event|0|||
146763055|NCT00580801|529299399|FG000|Overall Study|Lost to Follow-up|2|||
146865891|NCT01610687|529680400|FG000|Overall Study|Unable to make journey|1|||
146532513|NCT03154086|528460713|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
146532514|NCT03154086|528460714|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
146532515|NCT03154086|528460715|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
146532516|NCT03154086|528460716|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
146532517|NCT03154086|528460717|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
146532518|NCT03154086|528460718|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
146532519|NCT03154086|528460719|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
146532520|NCT03154086|528460720|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
146532521|NCT03154086|528460721|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
146532522|NCT03154086|528460722|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
146532523|NCT03154086|528460723|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
146532524|NCT03154086|528460724|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
146532525|NCT03154086|528460725|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
146532526|NCT03154086|528460726|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
146763056|NCT00580801|529299400|FG001|Overall Study|Lost to Follow-up|0|||
146763057|NCT00580801|529299401|FG002|Overall Study|Lost to Follow-up|0|||
146532527|NCT03154086|528460727|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
146532528|NCT03154086|528460713|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
146532529|NCT03154086|528460714|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
146532530|NCT03154086|528460715|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
146532531|NCT03154086|528460716|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
146532532|NCT03154086|528460717|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
146532533|NCT03154086|528460718|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
146532534|NCT03154086|528460719|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
146532535|NCT03154086|528460720|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
146532536|NCT03154086|528460721|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
146532537|NCT03154086|528460722|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
146532538|NCT03154086|528460723|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
146532539|NCT03154086|528460724|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
146532540|NCT03154086|528460725|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
146532541|NCT03154086|528460726|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
146532542|NCT03154086|528460727|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
146532543|NCT04076917|528460728|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
146532544|NCT04076917|528460728|FG000|Overall Study|Study closure|13|||
146532545|NCT04076917|528460728|FG000|Overall Study|Physician Decision|3|||
146532546|NCT04076917|528460728|FG000|Overall Study|Death|1|||
146532547|NCT04076917|528460728|FG000|Overall Study|Lost to Follow-up|1|||
146532548|NCT04076917|528460728|FG000|Overall Study|Withdrawal by Subject|1|||
146532549|NCT04076917|528460728|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
146532550|NCT01701245|528460731|FG000|Overall Study|Protocol Violation|1|||
146532551|NCT01701245|528460732|FG001|Overall Study|Protocol Violation|3|||
146532552|NCT01701245|528460731|FG000|Overall Study|Did not complete the open label period|11|||
146532553|NCT01701245|528460732|FG001|Overall Study|Did not complete the open label period|12|||
146532554|NCT01774591|528460733|FG000|Overall Study|Physician Decision|1|||
146532555|NCT01774591|528460734|FG001|Overall Study|Physician Decision|1|||
146532556|NCT01774591|528460733|FG000|Overall Study|Withdrawal by Subject|0|||
146532557|NCT01774591|528460734|FG001|Overall Study|Withdrawal by Subject|1|||
146532558|NCT01774591|528460733|FG000|Overall Study|Adverse Event|0|||
146532559|NCT01774591|528460734|FG001|Overall Study|Adverse Event|2|||
146532560|NCT00630916|528460736|FG000|Overall Study|Death|110|||
146532561|NCT00630916|528460736|FG000|Overall Study|Explant|8|||
146763058|NCT00580801|529299399|FG000|Overall Study|Reached a virologic endpoint|0|||
146532562|NCT00630916|528460736|FG000|Overall Study|Lost to Follow-up|5|||
146532563|NCT00630916|528460736|FG000|Overall Study|Withdrawal by Subject|30|||
146532564|NCT00630916|528460736|FG000|Overall Study|Protocol Violation|7|||
146532565|NCT00630916|528460736|FG000|Overall Study|Physician Decision|47|||
146532566|NCT00630916|528460736|FG000|Overall Study|Lack of Efficacy|3|||
146532567|NCT02147626|528460737|FG000|Overall Study|Lost to Follow-up|4|||
146532568|NCT02147626|528460738|FG001|Overall Study|Lost to Follow-up|4|||
146532569|NCT02147626|528460737|FG000|Overall Study|Pregnancy|1|||
146532570|NCT02147626|528460738|FG001|Overall Study|Pregnancy|2|||
146532571|NCT02147626|528460737|FG000|Overall Study|Withdrawal by Subject|0|||
146532572|NCT02147626|528460738|FG001|Overall Study|Withdrawal by Subject|1|||
146532573|NCT00572832|528460739|FG000|Overall Study|Lost to Follow-up|0|||
146532574|NCT00572832|528460740|FG001|Overall Study|Lost to Follow-up|11|||
146532575|NCT00572832|528460739|FG000|Overall Study|Pregnancy|0|||
146532576|NCT00572832|528460740|FG001|Overall Study|Pregnancy|1|||
146532577|NCT00390689|528460744|FG000|Overall Study|Adverse Event|2|||
146532578|NCT00390689|528460745|FG001|Overall Study|Adverse Event|5|||
146532579|NCT00390689|528460746|FG002|Overall Study|Adverse Event|2|||
146532580|NCT00390689|528460744|FG000|Overall Study|Lack of Efficacy|0|||
146532581|NCT00390689|528460745|FG001|Overall Study|Lack of Efficacy|0|||
146532582|NCT00390689|528460746|FG002|Overall Study|Lack of Efficacy|1|||
146763059|NCT00580801|529299400|FG001|Overall Study|Reached a virologic endpoint|1|||
146865892|NCT01610687|529680400|FG000|Overall Study|Death|1|||
146532583|NCT00390689|528460744|FG000|Overall Study|Protocol Violation|1|||
146532584|NCT00390689|528460745|FG001|Overall Study|Protocol Violation|0|||
146532585|NCT00390689|528460746|FG002|Overall Study|Protocol Violation|0|||
146532586|NCT00390689|528460744|FG000|Overall Study|Investigator's judgement|2|||
146532587|NCT00390689|528460745|FG001|Overall Study|Investigator's judgement|0|||
146532588|NCT00390689|528460746|FG002|Overall Study|Investigator's judgement|0|||
146532589|NCT03101020|528460748|FG000|Overall Study|Lack of time to participate|1|||
146532590|NCT03101020|528460749|FG001|Overall Study|Lack of time to participate|0|||
146532591|NCT03101020|528460748|FG000|Overall Study|Ran over by a car|0|||
146532592|NCT03101020|528460749|FG001|Overall Study|Ran over by a car|1|||
146532593|NCT03101020|528460748|FG000|Overall Study|Withdrawal by Subject|0|||
146532594|NCT03101020|528460749|FG001|Overall Study|Withdrawal by Subject|2|||
146532595|NCT01924533|528460750|FG000|Overall Study|Death|181|||
146532596|NCT01924533|528460751|FG001|Overall Study|Death|200|||
146532597|NCT01924533|528460750|FG000|Overall Study|Lost to Follow-up|0|||
146532598|NCT01924533|528460751|FG001|Overall Study|Lost to Follow-up|1|||
146532599|NCT01924533|528460750|FG000|Overall Study|Withdrawal by Subject|7|||
146532600|NCT01924533|528460751|FG001|Overall Study|Withdrawal by Subject|3|||
146532601|NCT01924533|528460750|FG000|Overall Study|Other Eligibility criteria|1|||
146532602|NCT01924533|528460751|FG001|Overall Study|Other Eligibility criteria|1|||
146532603|NCT04233879|528460752|FG000|Overall Study|Death|2|||
146532604|NCT04233879|528460753|FG001|Overall Study|Death|0|||
146532605|NCT04233879|528460752|FG000|Overall Study|Lost to Follow-up|3|||
146532606|NCT04233879|528460753|FG001|Overall Study|Lost to Follow-up|8|||
146532607|NCT04233879|528460752|FG000|Overall Study|Physician Decision|4|||
146532608|NCT04233879|528460753|FG001|Overall Study|Physician Decision|4|||
146532609|NCT04233879|528460752|FG000|Overall Study|Withdrawal by Subject|7|||
146532610|NCT04233879|528460753|FG001|Overall Study|Withdrawal by Subject|10|||
146532611|NCT04233879|528460752|FG000|Overall Study|Other|281|||
146532612|NCT04233879|528460753|FG001|Overall Study|Other|279|||
146532613|NCT03292016|528460754|FG000|Second Washout|Adverse Event|0|||
146532614|NCT03292016|528460755|FG001|Second Washout|Adverse Event|1|||
146532615|NCT03292016|528460756|FG002|Second Washout|Adverse Event|0|||
146532616|NCT03292016|528460757|FG003|Second Washout|Adverse Event|0|||
146532617|NCT03292016|528460758|FG004|Second Washout|Adverse Event|0|||
146532618|NCT03292016|528460759|FG005|Second Washout|Adverse Event|0|||
146532619|NCT04249427|528460762|FG000|Overall Study|Adverse Event|3|||
146532620|NCT04249427|528460763|FG001|Overall Study|Adverse Event|1|||
146532621|NCT04249427|528460762|FG000|Overall Study|Lack of Efficacy|0|||
146532622|NCT04249427|528460763|FG001|Overall Study|Lack of Efficacy|1|||
146532623|NCT04249427|528460762|FG000|Overall Study|Withdrawal by Subject|1|||
146532624|NCT04249427|528460763|FG001|Overall Study|Withdrawal by Subject|2|||
146532625|NCT03886272|528460764|FG000|Period 1|Withdrawal by Subject|0|||
146532626|NCT03886272|528460765|FG001|Period 1|Withdrawal by Subject|0|||
146532627|NCT03886272|528460766|FG002|Period 1|Withdrawal by Subject|0|||
146532628|NCT03886272|528460767|FG003|Period 1|Withdrawal by Subject|0|||
146532629|NCT03886272|528460768|FG004|Period 1|Withdrawal by Subject|0|||
146532630|NCT03886272|528460769|FG005|Period 1|Withdrawal by Subject|1|||
146532631|NCT03886272|528460770|FG006|Period 1|Withdrawal by Subject|0|||
146532632|NCT02557399|528460776|FG000|Overall Study|Adverse Event|6|||
146532633|NCT02557399|528460777|FG001|Overall Study|Adverse Event|5|||
146532634|NCT02557399|528460776|FG000|Overall Study|Protocol Violation|0|||
146532635|NCT02557399|528460777|FG001|Overall Study|Protocol Violation|1|||
146532636|NCT02557399|528460776|FG000|Overall Study|Protocol-defined stopping criteria|0|||
146532637|NCT02557399|528460777|FG001|Overall Study|Protocol-defined stopping criteria|1|||
146532638|NCT02557399|528460776|FG000|Overall Study|Withdrawal by Subject|1|||
146532639|NCT02557399|528460777|FG001|Overall Study|Withdrawal by Subject|1|||
146532640|NCT00931632|528460779|FG000|Overall Study|Withdrawal by Subject|2|||
146532641|NCT00931632|528460780|FG001|Overall Study|Withdrawal by Subject|3|||
146532642|NCT00931632|528460779|FG000|Overall Study|Adverse Event|19|||
146532643|NCT00931632|528460780|FG001|Overall Study|Adverse Event|15|||
146532644|NCT01419314|528460781|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
146532645|NCT01419314|528460782|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
146532646|NCT01419314|528460781|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
146532647|NCT01419314|528460782|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
146532648|NCT01419314|528460781|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
146532649|NCT01419314|528460782|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
146532650|NCT00402727|528460786|FG000|Overall Study|Adverse Event|10|||
146532651|NCT00402727|528460787|FG001|Overall Study|Adverse Event|6|||
146532652|NCT00402727|528460786|FG000|Overall Study|Death|1|||
146532653|NCT00402727|528460787|FG001|Overall Study|Death|0|||
146532654|NCT00402727|528460786|FG000|Overall Study|Lack of Efficacy|1|||
146532655|NCT00402727|528460787|FG001|Overall Study|Lack of Efficacy|3|||
146532656|NCT00402727|528460786|FG000|Overall Study|Lost to Follow-up|24|||
146532657|NCT00402727|528460787|FG001|Overall Study|Lost to Follow-up|11|||
146532658|NCT00402727|528460786|FG000|Overall Study|Physician Decision|1|||
146532659|NCT00402727|528460787|FG001|Overall Study|Physician Decision|1|||
146532660|NCT00402727|528460786|FG000|Overall Study|Protocol Violation|0|||
146532661|NCT00402727|528460787|FG001|Overall Study|Protocol Violation|4|||
146532662|NCT00402727|528460786|FG000|Overall Study|Withdrawal by Subject|3|||
146532663|NCT00402727|528460787|FG001|Overall Study|Withdrawal by Subject|7|||
146532664|NCT00402727|528460786|FG000|Overall Study|supply problems|2|||
146865893|NCT01610687|529680400|FG000|Overall Study|Cannabis affecting job|1|||
146865894|NCT01610687|529680400|FG000|Overall Study|Felt more alter without study medication|1|||
146532665|NCT00402727|528460787|FG001|Overall Study|supply problems|1|||
146532666|NCT00402727|528460786|FG000|Overall Study|non-compliance|0|||
146532667|NCT00402727|528460787|FG001|Overall Study|non-compliance|1|||
146532668|NCT03372798|528460788|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
146532669|NCT03372798|528460789|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
146532670|NCT03372798|528460788|FG000|Overall Study|Failure of imaging probe|0|||
146532671|NCT03372798|528460789|FG001|Overall Study|Failure of imaging probe|1|||
146532672|NCT03608826|528460790|FG000|Overall Study|Death|3|||
146532673|NCT03608826|528460790|FG000|Overall Study|Heart Transplant|3|||
146532674|NCT03608826|528460790|FG000|Overall Study|Physician Decision|4|||
146532675|NCT03139552|528460791|FG000|Overall Study|unable to attend tasting due to schedule|3|||
146532676|NCT00887484|528460804|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
146532677|NCT00887484|528460804|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
146532678|NCT00887484|528460804|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
146532679|NCT03044314|528460810|FG000|Overall Study|Physician Decision|2|||
146532680|NCT03044314|528460810|FG000|Overall Study|Withdrawal by Subject|1|||
146532681|NCT03044314|528460810|FG000|Overall Study|Connector tubing not available|1|||
146532682|NCT03122171|528460811|FG000|Overall Study|Withdrawal by Subject|1|||
146532683|NCT01316224|528460812|FG000|Overall Study|Protocol Violation|3|||
146532684|NCT01316224|528460812|FG000|Overall Study|Adverse Event|3|||
146532685|NCT01316224|528460812|FG000|Overall Study|Lack of Efficacy|1|||
146532686|NCT01316224|528460812|FG000|Overall Study|Withdrawal by Subject|1|||
146532687|NCT01316224|528460812|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
146532688|NCT01316224|528460812|FG000|Overall Study|Other|1|||
146532689|NCT00264147|528460813|FG000|Treatment I Period|Adverse Event|3|||
146532690|NCT00264147|528460814|FG001|Treatment I Period|Adverse Event|6|||
146532691|NCT00264147|528460815|FG002|Treatment I Period|Adverse Event|3|||
146532692|NCT00264147|528460816|FG003|Treatment I Period|Adverse Event|5|||
146532693|NCT00264147|528460817|FG004|Treatment I Period|Adverse Event|7|||
146532694|NCT00264147|528460818|FG005|Treatment I Period|Adverse Event|0|||
146532695|NCT00264147|528460813|FG000|Treatment I Period|Laboratory Adverse Event|0|||
146532696|NCT00264147|528460814|FG001|Treatment I Period|Laboratory Adverse Event|0|||
146532697|NCT00264147|528460815|FG002|Treatment I Period|Laboratory Adverse Event|0|||
146532698|NCT00264147|528460816|FG003|Treatment I Period|Laboratory Adverse Event|1|||
146532699|NCT00264147|528460817|FG004|Treatment I Period|Laboratory Adverse Event|0|||
146532700|NCT00264147|528460818|FG005|Treatment I Period|Laboratory Adverse Event|0|||
146532701|NCT00264147|528460813|FG000|Treatment I Period|Lack of Efficacy|6|||
146532702|NCT00264147|528460814|FG001|Treatment I Period|Lack of Efficacy|2|||
146532703|NCT00264147|528460815|FG002|Treatment I Period|Lack of Efficacy|8|||
146532704|NCT00264147|528460816|FG003|Treatment I Period|Lack of Efficacy|0|||
146532705|NCT00264147|528460817|FG004|Treatment I Period|Lack of Efficacy|1|||
146532706|NCT00264147|528460818|FG005|Treatment I Period|Lack of Efficacy|0|||
146532707|NCT00264147|528460813|FG000|Treatment I Period|Lost to Follow-up|1|||
146532708|NCT00264147|528460814|FG001|Treatment I Period|Lost to Follow-up|0|||
146532709|NCT00264147|528460815|FG002|Treatment I Period|Lost to Follow-up|0|||
146532710|NCT00264147|528460816|FG003|Treatment I Period|Lost to Follow-up|1|||
146532711|NCT00264147|528460817|FG004|Treatment I Period|Lost to Follow-up|1|||
146532712|NCT00264147|528460818|FG005|Treatment I Period|Lost to Follow-up|0|||
146532713|NCT00264147|528460813|FG000|Treatment I Period|Protocol Violation|2|||
146532714|NCT00264147|528460814|FG001|Treatment I Period|Protocol Violation|2|||
146532715|NCT00264147|528460815|FG002|Treatment I Period|Protocol Violation|0|||
146532716|NCT00264147|528460816|FG003|Treatment I Period|Protocol Violation|0|||
146532717|NCT00264147|528460817|FG004|Treatment I Period|Protocol Violation|0|||
146532718|NCT00264147|528460818|FG005|Treatment I Period|Protocol Violation|0|||
146532719|NCT00264147|528460813|FG000|Treatment I Period|Withdrawal by Subject|2|||
146532720|NCT00264147|528460814|FG001|Treatment I Period|Withdrawal by Subject|0|||
146532721|NCT00264147|528460815|FG002|Treatment I Period|Withdrawal by Subject|0|||
146532722|NCT00264147|528460816|FG003|Treatment I Period|Withdrawal by Subject|2|||
146532723|NCT00264147|528460817|FG004|Treatment I Period|Withdrawal by Subject|2|||
146532724|NCT00264147|528460818|FG005|Treatment I Period|Withdrawal by Subject|0|||
146532725|NCT00264147|528460813|FG000|Treatment I Period|Patient out of town for an extended time|0|||
146532726|NCT00264147|528460814|FG001|Treatment I Period|Patient out of town for an extended time|1|||
146532727|NCT00264147|528460815|FG002|Treatment I Period|Patient out of town for an extended time|0|||
146532728|NCT00264147|528460816|FG003|Treatment I Period|Patient out of town for an extended time|0|||
146532729|NCT00264147|528460817|FG004|Treatment I Period|Patient out of town for an extended time|0|||
146532730|NCT00264147|528460818|FG005|Treatment I Period|Patient out of town for an extended time|0|||
146532731|NCT00264147|528460813|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
146532732|NCT00264147|528460814|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
146532733|NCT00264147|528460815|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
146532734|NCT00264147|528460816|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
146532735|NCT00264147|528460817|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
146532736|NCT00264147|528460818|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
146763060|NCT00580801|529299401|FG002|Overall Study|Reached a virologic endpoint|2|||
146763061|NCT00580801|529299399|FG000|Overall Study|Participant non-compliant|0|||
146763062|NCT00580801|529299400|FG001|Overall Study|Participant non-compliant|0|||
146763063|NCT00580801|529299401|FG002|Overall Study|Participant non-compliant|1|||
146763064|NCT00580801|529299399|FG000|Overall Study|Travel|1|||
146763065|NCT00580801|529299400|FG001|Overall Study|Travel|0|||
146763066|NCT00580801|529299401|FG002|Overall Study|Travel|0|||
146763067|NCT00502593|529299402|FG000|Overall Study|Withdrawn unspecified reason|1|||
146763068|NCT00502593|529299403|FG001|Overall Study|Withdrawn unspecified reason|1|||
146763069|NCT00502593|529299404|FG002|Overall Study|Withdrawn unspecified reason|3|||
146763070|NCT00502593|529299405|FG003|Overall Study|Withdrawn unspecified reason|1|||
146763071|NCT00502593|529299406|FG004|Overall Study|Withdrawn unspecified reason|2|||
146763072|NCT00502593|529299407|FG005|Overall Study|Withdrawn unspecified reason|0|||
146763073|NCT00502593|529299408|FG006|Overall Study|Withdrawn unspecified reason|2|||
146763074|NCT00502593|529299409|FG007|Overall Study|Withdrawn unspecified reason|0|||
146763075|NCT00502593|529299410|FG008|Overall Study|Withdrawn unspecified reason|0|||
146763076|NCT00502593|529299411|FG009|Overall Study|Withdrawn unspecified reason|0|||
146763077|NCT00502593|529299412|FG010|Overall Study|Withdrawn unspecified reason|0|||
146865895|NCT03836807|529680401|FG000|Overall Study|Physician Decision|1|||
146865896|NCT03836807|529680402|FG001|Overall Study|Physician Decision|0|||
146865897|NCT00685685|529680403|FG000|Washout Period of 7 Days|Adverse Event|2|||
146865898|NCT00685685|529680404|FG001|Washout Period of 7 Days|Adverse Event|0|||
146865899|NCT00685685|529680403|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
146865900|NCT00685685|529680404|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
146865901|NCT04029116|529680405|FG000|Overall Study|Adverse Event|0|||
146865902|NCT04029116|529680406|FG001|Overall Study|Adverse Event|2|||
146865903|NCT04029116|529680405|FG000|Overall Study|Lost to Follow-up|3|||
146865904|NCT04029116|529680406|FG001|Overall Study|Lost to Follow-up|5|||
146865905|NCT04029116|529680405|FG000|Overall Study|Physician Decision|2|||
146865906|NCT04029116|529680406|FG001|Overall Study|Physician Decision|0|||
146865907|NCT04029116|529680405|FG000|Overall Study|Pregnancy|1|||
146865908|NCT04029116|529680406|FG001|Overall Study|Pregnancy|2|||
146865909|NCT04029116|529680405|FG000|Overall Study|Withdrawal by Subject|4|||
146865910|NCT04029116|529680406|FG001|Overall Study|Withdrawal by Subject|6|||
146865911|NCT04029116|529680405|FG000|Overall Study|Other|2|||
146865912|NCT04029116|529680406|FG001|Overall Study|Other|1|||
146865913|NCT01272947|529680407|FG000|Overall Study|Abnormal Laboratory Value|2|||
146865914|NCT01272947|529680408|FG001|Overall Study|Abnormal Laboratory Value|2|||
146865915|NCT02019420|529680411|FG000|Overall Study|Did not receive study drug|2|||
146865916|NCT02019420|529680412|FG001|Overall Study|Did not receive study drug|2|||
146865917|NCT02019420|529680411|FG000|Overall Study|Withdrawal by Subject|1|||
146865918|NCT02019420|529680412|FG001|Overall Study|Withdrawal by Subject|3|||
146865919|NCT02019420|529680411|FG000|Overall Study|At request of sponsor or investigator|0|||
146865920|NCT02019420|529680412|FG001|Overall Study|At request of sponsor or investigator|1|||
146865921|NCT02019420|529680411|FG000|Overall Study|Death|104|||
146865922|NCT02019420|529680412|FG001|Overall Study|Death|99|||
146865923|NCT02019420|529680411|FG000|Overall Study|Transferred to other care facility|1|||
146865924|NCT02019420|529680412|FG001|Overall Study|Transferred to other care facility|1|||
146865925|NCT02469896|529680413|FG000|Overall Study|Withdrawal by Subject|2|||
146865926|NCT02469896|529680414|FG001|Overall Study|Withdrawal by Subject|0|||
146865927|NCT04201821|529680417|FG000|Overall Study|Withdrawal by Subject|2|||
146865928|NCT04409353|529680419|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
146865929|NCT04409353|529680420|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
146865930|NCT04409353|529680421|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
146865931|NCT04409353|529680419|FG000|Overall Study|Lost to Follow-up|6|||
146865932|NCT04409353|529680420|FG001|Overall Study|Lost to Follow-up|8|||
146865933|NCT04409353|529680421|FG002|Overall Study|Lost to Follow-up|7|||
146865934|NCT04409353|529680419|FG000|Overall Study|Major surgery during participation window|4|||
146865935|NCT04409353|529680420|FG001|Overall Study|Major surgery during participation window|3|||
146865936|NCT04409353|529680421|FG002|Overall Study|Major surgery during participation window|3|||
146865937|NCT04409353|529680419|FG000|Overall Study|Life event occurred during participation window|3|||
146865938|NCT04409353|529680420|FG001|Overall Study|Life event occurred during participation window|2|||
146532737|NCT00264147|528460813|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
146532738|NCT00264147|528460814|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
146532739|NCT00264147|528460815|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
146532740|NCT00264147|528460816|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
146532741|NCT00264147|528460817|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
146532742|NCT00264147|528460818|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
146532743|NCT00264147|528460813|FG000|Treatment II Period|Adverse Event|0|||
146532744|NCT00264147|528460814|FG001|Treatment II Period|Adverse Event|0|||
146532745|NCT00264147|528460815|FG002|Treatment II Period|Adverse Event|0|||
146532746|NCT00264147|528460816|FG003|Treatment II Period|Adverse Event|0|||
146865939|NCT04409353|529680421|FG002|Overall Study|Life event occurred during participation window|4|||
146865940|NCT04409353|529680419|FG000|Overall Study|Lack of Efficacy|4|||
146865941|NCT04409353|529680420|FG001|Overall Study|Lack of Efficacy|1|||
146865942|NCT04409353|529680421|FG002|Overall Study|Lack of Efficacy|3|||
146865943|NCT04409353|529680419|FG000|Overall Study|Adverse Event|2|||
146865944|NCT04409353|529680420|FG001|Overall Study|Adverse Event|1|||
146865945|NCT04409353|529680421|FG002|Overall Study|Adverse Event|1|||
146532747|NCT00264147|528460817|FG004|Treatment II Period|Adverse Event|9|||
146532748|NCT00264147|528460818|FG005|Treatment II Period|Adverse Event|9|||
146532749|NCT00264147|528460813|FG000|Treatment II Period|Laboratory Adverse Event|0|||
146532750|NCT00264147|528460814|FG001|Treatment II Period|Laboratory Adverse Event|0|||
146532751|NCT00264147|528460815|FG002|Treatment II Period|Laboratory Adverse Event|0|||
146532752|NCT00264147|528460816|FG003|Treatment II Period|Laboratory Adverse Event|0|||
146532753|NCT00264147|528460817|FG004|Treatment II Period|Laboratory Adverse Event|0|||
146865946|NCT04409353|529680419|FG000|Overall Study|Disease burden - unable to participate|0|||
146865947|NCT04409353|529680420|FG001|Overall Study|Disease burden - unable to participate|1|||
146865948|NCT04409353|529680421|FG002|Overall Study|Disease burden - unable to participate|1|||
146865949|NCT04409353|529680419|FG000|Overall Study|Intervention too complicated|1|||
146865950|NCT04409353|529680420|FG001|Overall Study|Intervention too complicated|0|||
146865951|NCT04409353|529680421|FG002|Overall Study|Intervention too complicated|1|||
146865952|NCT02499770|529680424|FG000|Overall Study|Death|17|||
146865953|NCT02499770|529680425|FG001|Overall Study|Death|56|||
146865954|NCT02499770|529680424|FG000|Overall Study|Study completion|1|||
146865955|NCT02499770|529680425|FG001|Overall Study|Study completion|10|||
146865956|NCT02499770|529680424|FG000|Overall Study|Withdrawal by Subject|0|||
146865957|NCT02499770|529680425|FG001|Overall Study|Withdrawal by Subject|7|||
146865958|NCT02499770|529680424|FG000|Overall Study|Lost to Follow-up|0|||
146865959|NCT02499770|529680425|FG001|Overall Study|Lost to Follow-up|2|||
146532754|NCT00264147|528460818|FG005|Treatment II Period|Laboratory Adverse Event|1|||
146532755|NCT00264147|528460813|FG000|Treatment II Period|Lack of Efficacy|0|||
146532756|NCT00264147|528460814|FG001|Treatment II Period|Lack of Efficacy|0|||
146532757|NCT00264147|528460815|FG002|Treatment II Period|Lack of Efficacy|0|||
146532758|NCT00264147|528460816|FG003|Treatment II Period|Lack of Efficacy|0|||
146532759|NCT00264147|528460817|FG004|Treatment II Period|Lack of Efficacy|20|||
146532760|NCT00264147|528460818|FG005|Treatment II Period|Lack of Efficacy|19|||
146532761|NCT00264147|528460813|FG000|Treatment II Period|Lost to Follow-up|0|||
146532762|NCT00264147|528460814|FG001|Treatment II Period|Lost to Follow-up|0|||
146532763|NCT00264147|528460815|FG002|Treatment II Period|Lost to Follow-up|0|||
146532764|NCT00264147|528460816|FG003|Treatment II Period|Lost to Follow-up|0|||
146532765|NCT00264147|528460817|FG004|Treatment II Period|Lost to Follow-up|1|||
146532766|NCT00264147|528460818|FG005|Treatment II Period|Lost to Follow-up|1|||
146532767|NCT00264147|528460813|FG000|Treatment II Period|Withdrawal by Subject|0|||
146532768|NCT00264147|528460814|FG001|Treatment II Period|Withdrawal by Subject|0|||
146532769|NCT00264147|528460815|FG002|Treatment II Period|Withdrawal by Subject|0|||
146532770|NCT00264147|528460816|FG003|Treatment II Period|Withdrawal by Subject|0|||
146532771|NCT00264147|528460817|FG004|Treatment II Period|Withdrawal by Subject|3|||
146532772|NCT00264147|528460818|FG005|Treatment II Period|Withdrawal by Subject|2|||
146532773|NCT00264147|528460813|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
146532774|NCT00264147|528460814|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
146532775|NCT00264147|528460815|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
146532776|NCT00264147|528460816|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
146532777|NCT00264147|528460817|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
146532778|NCT00264147|528460818|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
146532779|NCT03234465|528460819|FG000|Overall Study|Adverse Event|4|||
146532780|NCT03234465|528460820|FG001|Overall Study|Adverse Event|2|||
146532781|NCT03234465|528460819|FG000|Overall Study|Death|0|||
146532782|NCT03234465|528460820|FG001|Overall Study|Death|1|||
146532783|NCT03234465|528460819|FG000|Overall Study|Lost to Follow-up|1|||
146532784|NCT03234465|528460820|FG001|Overall Study|Lost to Follow-up|1|||
146532785|NCT03234465|528460819|FG000|Overall Study|Withdrawal by Subject|12|||
146532786|NCT03234465|528460820|FG001|Overall Study|Withdrawal by Subject|27|||
146532787|NCT03234465|528460819|FG000|Overall Study|Symptomatic deterioration|0|||
146532788|NCT03234465|528460820|FG001|Overall Study|Symptomatic deterioration|1|||
146532789|NCT03234465|528460819|FG000|Overall Study|Non-compliance|2|||
146532790|NCT03234465|528460820|FG001|Overall Study|Non-compliance|0|||
146532791|NCT03234465|528460819|FG000|Overall Study|Other|14|||
146532792|NCT03234465|528460820|FG001|Overall Study|Other|8|||
146532793|NCT00449163|528460821|FG000|Overall Study|Physician Decision|3|||
146532794|NCT00606307|528460826|FG000|Overall Study|Adverse Event|2|||
146532795|NCT00606307|528460826|FG000|Overall Study|Withdrawal by Subject|2|||
146532796|NCT00606307|528460826|FG000|Overall Study|Disease progression|6|||
146532797|NCT00606307|528460826|FG000|Overall Study|QTc prolongation|1|||
146532798|NCT03368807|528460827|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
146532799|NCT03368807|528460827|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
146532800|NCT03368807|528460827|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
146532801|NCT03368807|528460827|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
146532802|NCT01677741|528460853|FG000|Overall Study|Death|0|||
146532803|NCT01677741|528460854|FG001|Overall Study|Death|0|||
146532804|NCT01677741|528460855|FG002|Overall Study|Death|0|||
146532805|NCT01677741|528460856|FG003|Overall Study|Death|1|||
146532806|NCT01677741|528460857|FG004|Overall Study|Death|0|||
146532807|NCT01677741|528460858|FG005|Overall Study|Death|1|||
146532808|NCT01677741|528460859|FG006|Overall Study|Death|0|||
146532809|NCT01677741|528460860|FG007|Overall Study|Death|0|||
146532810|NCT01677741|528460853|FG000|Overall Study|Withdrawal by Subject|2|||
146865960|NCT02499770|529680424|FG000|Overall Study|Subject declined further treatment|1|||
146532811|NCT01677741|528460854|FG001|Overall Study|Withdrawal by Subject|7|||
146532812|NCT01677741|528460855|FG002|Overall Study|Withdrawal by Subject|5|||
146532813|NCT01677741|528460856|FG003|Overall Study|Withdrawal by Subject|4|||
146865961|NCT02499770|529680425|FG001|Overall Study|Subject declined further treatment|0|||
146532814|NCT01677741|528460857|FG004|Overall Study|Withdrawal by Subject|11|||
146532815|NCT01677741|528460858|FG005|Overall Study|Withdrawal by Subject|20|||
146532816|NCT01677741|528460859|FG006|Overall Study|Withdrawal by Subject|4|||
146532817|NCT01677741|528460860|FG007|Overall Study|Withdrawal by Subject|2|||
146865962|NCT02499770|529680424|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
146865963|NCT02499770|529680425|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
146532818|NCT01677741|528460853|FG000|Overall Study|Enrolled in a rollover study|0|||
146532819|NCT01677741|528460854|FG001|Overall Study|Enrolled in a rollover study|3|||
146532820|NCT01677741|528460855|FG002|Overall Study|Enrolled in a rollover study|2|||
146532821|NCT01677741|528460856|FG003|Overall Study|Enrolled in a rollover study|1|||
146532822|NCT01677741|528460857|FG004|Overall Study|Enrolled in a rollover study|6|||
146532823|NCT01677741|528460858|FG005|Overall Study|Enrolled in a rollover study|6|||
146532824|NCT01677741|528460859|FG006|Overall Study|Enrolled in a rollover study|7|||
146532825|NCT01677741|528460860|FG007|Overall Study|Enrolled in a rollover study|0|||
146532826|NCT01677741|528460853|FG000|Overall Study|Progressive disease|1|||
146532827|NCT01677741|528460854|FG001|Overall Study|Progressive disease|0|||
146532828|NCT01677741|528460855|FG002|Overall Study|Progressive disease|1|||
146532829|NCT01677741|528460856|FG003|Overall Study|Progressive disease|0|||
146532830|NCT01677741|528460857|FG004|Overall Study|Progressive disease|0|||
146532831|NCT01677741|528460858|FG005|Overall Study|Progressive disease|1|||
146532832|NCT01677741|528460859|FG006|Overall Study|Progressive disease|0|||
146532833|NCT01677741|528460860|FG007|Overall Study|Progressive disease|0|||
146532834|NCT02949947|528460861|FG000|Overall Study|Non Compliance|0|||
146532835|NCT02949947|528460862|FG001|Overall Study|Non Compliance|1|||
146532836|NCT02949947|528460861|FG000|Overall Study|Insurance change|1|||
146532837|NCT02949947|528460862|FG001|Overall Study|Insurance change|0|||
146532838|NCT00720499|528460863|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
146532839|NCT00720499|528460864|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
146532840|NCT00720499|528460863|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
146532841|NCT00720499|528460864|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
146532842|NCT00720499|528460863|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
146532843|NCT00720499|528460864|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
146532844|NCT01973218|528460865|FG000|Overall Study|Adverse Event|1|||
146532845|NCT01973218|528460866|FG001|Overall Study|Adverse Event|0|||
146532846|NCT01973218|528460865|FG000|Overall Study|Withdrawal by Subject|1|||
146532847|NCT01973218|528460866|FG001|Overall Study|Withdrawal by Subject|0|||
146532848|NCT02247466|528460867|FG000|Overall Study|Procedure changed to open surgery|0|||
146532849|NCT02247466|528460868|FG001|Overall Study|Procedure changed to open surgery|3|||
146532850|NCT02230891|528460873|FG000|Baseline|Did not meet inclusion|0|||
146532851|NCT02230891|528460874|FG001|Baseline|Did not meet inclusion|1|||
146532852|NCT02230891|528460875|FG002|Baseline|Did not meet inclusion|1|||
146532853|NCT02230891|528460873|FG000|2 Week|Withdrawal by Subject|2|||
146532854|NCT02230891|528460874|FG001|2 Week|Withdrawal by Subject|2|||
146532855|NCT02230891|528460875|FG002|2 Week|Withdrawal by Subject|0|||
146532856|NCT02230891|528460873|FG000|2 Week|Consent withdrawn|1|||
146532857|NCT02230891|528460874|FG001|2 Week|Consent withdrawn|0|||
146532858|NCT02230891|528460875|FG002|2 Week|Consent withdrawn|0|||
146532859|NCT02230891|528460873|FG000|6 Month|Withdrawal by Subject|1|||
146532860|NCT02230891|528460874|FG001|6 Month|Withdrawal by Subject|1|||
146532861|NCT02230891|528460875|FG002|6 Month|Withdrawal by Subject|1|||
146532862|NCT02230891|528460873|FG000|6 Month|Physician Decision|0|||
146532863|NCT02230891|528460874|FG001|6 Month|Physician Decision|2|||
146532864|NCT02230891|528460875|FG002|6 Month|Physician Decision|0|||
146532865|NCT02230891|528460873|FG000|12 Month|Death|1|||
146532866|NCT02230891|528460874|FG001|12 Month|Death|0|||
146532867|NCT02230891|528460875|FG002|12 Month|Death|0|||
146532868|NCT02230891|528460873|FG000|12 Month|Lost to Follow-up|0|||
146532869|NCT02230891|528460874|FG001|12 Month|Lost to Follow-up|1|||
146763078|NCT00502593|529299413|FG011|Overall Study|Withdrawn unspecified reason|0|||
146763079|NCT00502593|529299402|FG000|Overall Study|Withdrawal by Subject|0|||
146763080|NCT00502593|529299403|FG001|Overall Study|Withdrawal by Subject|0|||
146763081|NCT00502593|529299404|FG002|Overall Study|Withdrawal by Subject|6|||
146763082|NCT00502593|529299405|FG003|Overall Study|Withdrawal by Subject|2|||
146763083|NCT00502593|529299406|FG004|Overall Study|Withdrawal by Subject|2|||
146763084|NCT00502593|529299407|FG005|Overall Study|Withdrawal by Subject|0|||
146763085|NCT00502593|529299408|FG006|Overall Study|Withdrawal by Subject|3|||
146763086|NCT00502593|529299409|FG007|Overall Study|Withdrawal by Subject|0|||
146763087|NCT00502593|529299410|FG008|Overall Study|Withdrawal by Subject|3|||
146763088|NCT00502593|529299411|FG009|Overall Study|Withdrawal by Subject|0|||
146763089|NCT00502593|529299412|FG010|Overall Study|Withdrawal by Subject|1|||
146763090|NCT00502593|529299413|FG011|Overall Study|Withdrawal by Subject|0|||
146763091|NCT00502593|529299402|FG000|Overall Study|Lost to Follow-up|2|||
146763092|NCT00502593|529299403|FG001|Overall Study|Lost to Follow-up|1|||
146763093|NCT00502593|529299404|FG002|Overall Study|Lost to Follow-up|1|||
146865964|NCT02499770|529680424|FG000|Overall Study|Randomized but not enrolled|0|||
146532870|NCT02230891|528460875|FG002|12 Month|Lost to Follow-up|0|||
146532871|NCT02230891|528460873|FG000|12 Month|Withdrawal by Subject|0|||
146532872|NCT02230891|528460874|FG001|12 Month|Withdrawal by Subject|2|||
146532873|NCT02230891|528460875|FG002|12 Month|Withdrawal by Subject|0|||
146532874|NCT02230891|528460873|FG000|18 Month End of Study|Death|0|||
146532875|NCT02230891|528460874|FG001|18 Month End of Study|Death|0|||
146532876|NCT02230891|528460875|FG002|18 Month End of Study|Death|1|||
146763094|NCT00502593|529299405|FG003|Overall Study|Lost to Follow-up|1|||
146763095|NCT00502593|529299406|FG004|Overall Study|Lost to Follow-up|0|||
146532877|NCT02230891|528460873|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
146532878|NCT02230891|528460874|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
146532879|NCT02230891|528460875|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
146532880|NCT04356937|528460876|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
146532881|NCT04356937|528460877|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
146763096|NCT00502593|529299407|FG005|Overall Study|Lost to Follow-up|0|||
146763097|NCT00502593|529299408|FG006|Overall Study|Lost to Follow-up|0|||
146763098|NCT00502593|529299409|FG007|Overall Study|Lost to Follow-up|0|||
146763099|NCT00502593|529299410|FG008|Overall Study|Lost to Follow-up|3|||
146763100|NCT00502593|529299411|FG009|Overall Study|Lost to Follow-up|0|||
146763101|NCT00502593|529299412|FG010|Overall Study|Lost to Follow-up|1|||
146763102|NCT00502593|529299413|FG011|Overall Study|Lost to Follow-up|0|||
146763103|NCT00843193|529299414|FG000|Overall Study|Adverse Event|2|||
146763104|NCT00843193|529299415|FG001|Overall Study|Adverse Event|4|||
146763105|NCT00843193|529299414|FG000|Overall Study|Lack of Efficacy|1|||
146763106|NCT00843193|529299415|FG001|Overall Study|Lack of Efficacy|1|||
146763107|NCT00843193|529299414|FG000|Overall Study|Protocol Violation|1|||
146763108|NCT00843193|529299415|FG001|Overall Study|Protocol Violation|2|||
146763109|NCT00843193|529299414|FG000|Overall Study|Lost to Follow-up|1|||
146763110|NCT00843193|529299415|FG001|Overall Study|Lost to Follow-up|0|||
146763111|NCT00843193|529299414|FG000|Overall Study|Physician Decision|0|||
146763112|NCT00843193|529299415|FG001|Overall Study|Physician Decision|1|||
146763113|NCT00843193|529299414|FG000|Overall Study|Withdrawal by Subject|3|||
146763114|NCT00843193|529299415|FG001|Overall Study|Withdrawal by Subject|3|||
146763115|NCT00542386|529299416|FG000|Overall Study|Adverse Event|1|||
146763116|NCT00542386|529299417|FG001|Overall Study|Adverse Event|7|||
146763117|NCT00542386|529299418|FG002|Overall Study|Adverse Event|7|||
146763118|NCT00542386|529299419|FG003|Overall Study|Adverse Event|8|||
146763119|NCT00542386|529299420|FG004|Overall Study|Adverse Event|13|||
146763120|NCT00542386|529299421|FG005|Overall Study|Adverse Event|4|||
146763121|NCT00542386|529299416|FG000|Overall Study|Death|0|||
146763122|NCT00542386|529299417|FG001|Overall Study|Death|0|||
146763123|NCT00542386|529299418|FG002|Overall Study|Death|1|||
146763124|NCT00542386|529299419|FG003|Overall Study|Death|2|||
146763125|NCT00542386|529299420|FG004|Overall Study|Death|1|||
146763126|NCT00542386|529299421|FG005|Overall Study|Death|2|||
146763127|NCT00542386|529299416|FG000|Overall Study|Lack of Efficacy|32|||
146763128|NCT00542386|529299417|FG001|Overall Study|Lack of Efficacy|12|||
146763129|NCT00542386|529299418|FG002|Overall Study|Lack of Efficacy|10|||
146763130|NCT00542386|529299419|FG003|Overall Study|Lack of Efficacy|13|||
146763131|NCT00542386|529299420|FG004|Overall Study|Lack of Efficacy|7|||
146763132|NCT00542386|529299421|FG005|Overall Study|Lack of Efficacy|31|||
146763133|NCT00542386|529299416|FG000|Overall Study|Physician Decision|1|||
146763134|NCT00542386|529299417|FG001|Overall Study|Physician Decision|0|||
146763135|NCT00542386|529299418|FG002|Overall Study|Physician Decision|0|||
146763136|NCT00542386|529299419|FG003|Overall Study|Physician Decision|1|||
146763137|NCT00542386|529299420|FG004|Overall Study|Physician Decision|0|||
146763138|NCT00542386|529299421|FG005|Overall Study|Physician Decision|0|||
146763139|NCT00542386|529299416|FG000|Overall Study|Protocol Violation|0|||
146763140|NCT00542386|529299417|FG001|Overall Study|Protocol Violation|0|||
146763141|NCT00542386|529299418|FG002|Overall Study|Protocol Violation|1|||
146763142|NCT00542386|529299419|FG003|Overall Study|Protocol Violation|0|||
146763143|NCT00542386|529299420|FG004|Overall Study|Protocol Violation|0|||
146763144|NCT00542386|529299421|FG005|Overall Study|Protocol Violation|4|||
146763145|NCT00542386|529299416|FG000|Overall Study|Withdrawal by Subject|5|||
146763146|NCT00542386|529299417|FG001|Overall Study|Withdrawal by Subject|8|||
146763147|NCT00542386|529299418|FG002|Overall Study|Withdrawal by Subject|10|||
146763148|NCT00542386|529299419|FG003|Overall Study|Withdrawal by Subject|11|||
146763149|NCT00542386|529299420|FG004|Overall Study|Withdrawal by Subject|15|||
146763150|NCT00542386|529299421|FG005|Overall Study|Withdrawal by Subject|7|||
146763151|NCT00542386|529299416|FG000|Overall Study|Other Reasons|4|||
146763152|NCT00542386|529299417|FG001|Overall Study|Other Reasons|1|||
146763153|NCT00542386|529299418|FG002|Overall Study|Other Reasons|4|||
146763154|NCT00542386|529299419|FG003|Overall Study|Other Reasons|3|||
146763155|NCT00542386|529299420|FG004|Overall Study|Other Reasons|4|||
146763156|NCT00542386|529299421|FG005|Overall Study|Other Reasons|2|||
146763157|NCT00880906|529299423|FG000|Overall Study|Lost to Follow-up|0|||
146763158|NCT00880906|529299424|FG001|Overall Study|Lost to Follow-up|1|||
146763159|NCT00880906|529299423|FG000|Overall Study|Did not meet criteria following patholog|12|||
146763160|NCT00880906|529299424|FG001|Overall Study|Did not meet criteria following patholog|6|||
146763161|NCT00544440|529299427|FG000|Overall Study|Other|1|||
146763162|NCT00544440|529299427|FG000|Overall Study|Adverse Event|1|||
146763163|NCT00544440|529299427|FG000|Overall Study|Withdrawal by Subject|2|||
146763164|NCT00544440|529299427|FG000|Overall Study|Subject Non-compliance|1|||
146763165|NCT00544440|529299427|FG000|Overall Study|Progressive Disease|47|||
146763166|NCT00544440|529299427|FG000|Overall Study|Other|5|||
146763167|NCT01460342|529299428|FG000|Overall Study|Adverse Event|5|||
146763168|NCT01460342|529299429|FG001|Overall Study|Adverse Event|4|||
146763169|NCT01460342|529299428|FG000|Overall Study|Lost to Follow-up|1|||
146532882|NCT04158219|528460878|FG000|Overall Study|Lost to Follow-up|1|||
146532883|NCT01814007|528460879|FG000|Overall Study|Withdrawal by Subject|1|||
146532884|NCT01324947|528460881|FG000|Overall Study|Adverse Event|7|||
146532885|NCT01324947|528460881|FG000|Overall Study|Death|10|||
146532886|NCT01324947|528460881|FG000|Overall Study|Other|3|||
146532887|NCT01324947|528460881|FG000|Overall Study|Progressive Disease|50|||
146532888|NCT01324947|528460881|FG000|Overall Study|Withdrawal by Subject|3|||
146532889|NCT01324947|528460881|FG000|Overall Study|1 discontinued before starting drug|1|||
146532890|NCT04194814|528460882|FG000|Overall Study|Physician Decision|3|||
146532891|NCT04194814|528460883|FG001|Overall Study|Physician Decision|0|||
146532892|NCT04194814|528460882|FG000|Overall Study|Withdrawal by Subject|0|||
146532893|NCT04194814|528460883|FG001|Overall Study|Withdrawal by Subject|2|||
146532894|NCT00434252|528462640|FG000|Overall Study|Lack of Efficacy|50|||
146532895|NCT00434252|528462641|FG001|Overall Study|Lack of Efficacy|100|||
146532896|NCT00434252|528462640|FG000|Overall Study|Adverse Event|6|||
146532897|NCT00434252|528462641|FG001|Overall Study|Adverse Event|13|||
146532898|NCT00434252|528462640|FG000|Overall Study|Death|1|||
146532899|NCT00434252|528462641|FG001|Overall Study|Death|2|||
146532900|NCT00434252|528462640|FG000|Overall Study|Lost to Follow-up|0|||
146532901|NCT00434252|528462641|FG001|Overall Study|Lost to Follow-up|1|||
146532902|NCT00434252|528462640|FG000|Overall Study|Physician Decision|4|||
146532903|NCT00434252|528462641|FG001|Overall Study|Physician Decision|8|||
146532904|NCT00434252|528462640|FG000|Overall Study|Withdrawal by Subject|3|||
146532905|NCT00434252|528462641|FG001|Overall Study|Withdrawal by Subject|7|||
146532906|NCT00720278|528462659|FG000|Overall Study|Adverse Event|5|||
146532907|NCT00720278|528462660|FG001|Overall Study|Adverse Event|3|||
146532908|NCT00720278|528462661|FG002|Overall Study|Adverse Event|4|||
146532909|NCT00720278|528462659|FG000|Overall Study|Withdrawal by Subject|0|||
146532910|NCT00720278|528462660|FG001|Overall Study|Withdrawal by Subject|1|||
146532911|NCT00720278|528462661|FG002|Overall Study|Withdrawal by Subject|0|||
146532912|NCT00720278|528462659|FG000|Overall Study|Lost to Follow-up|0|||
146532913|NCT00720278|528462660|FG001|Overall Study|Lost to Follow-up|0|||
146532914|NCT00720278|528462661|FG002|Overall Study|Lost to Follow-up|1|||
146532915|NCT00720278|528462659|FG000|Overall Study|Non-compliance|1|||
146532916|NCT00720278|528462660|FG001|Overall Study|Non-compliance|0|||
146532917|NCT00720278|528462661|FG002|Overall Study|Non-compliance|0|||
146532918|NCT00720278|528462659|FG000|Overall Study|eligibility criteria violation|1|||
146532919|NCT00720278|528462660|FG001|Overall Study|eligibility criteria violation|0|||
146532920|NCT00720278|528462661|FG002|Overall Study|eligibility criteria violation|1|||
146532921|NCT03630393|528462667|FG000|Overall Study|Death|1|||
146532922|NCT03630393|528462668|FG001|Overall Study|Death|0|||
146532923|NCT00408499|528462669|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
146532924|NCT00408499|528462670|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
146532925|NCT00408499|528462671|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
146532926|NCT00408499|528462672|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
146532927|NCT00408499|528462673|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
146532928|NCT00408499|528462669|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
146532929|NCT00408499|528462670|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
146532930|NCT00408499|528462671|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
146532931|NCT00408499|528462672|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
146532932|NCT00408499|528462673|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
146532933|NCT00408499|528462669|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
146532934|NCT00408499|528462670|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
146532935|NCT00408499|528462671|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
146532936|NCT00408499|528462672|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
146532937|NCT00408499|528462673|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
146532938|NCT00408499|528462669|FG000|Phase II- MTD Expansion|Adverse Event|0|||
146532939|NCT00408499|528462670|FG001|Phase II- MTD Expansion|Adverse Event|0|||
146532940|NCT00408499|528462671|FG002|Phase II- MTD Expansion|Adverse Event|0|||
146532941|NCT00408499|528462672|FG003|Phase II- MTD Expansion|Adverse Event|0|||
146763170|NCT01460342|529299429|FG001|Overall Study|Lost to Follow-up|2|||
146532942|NCT00408499|528462673|FG004|Phase II- MTD Expansion|Adverse Event|9|||
146532943|NCT00408499|528462669|FG000|Phase II- MTD Expansion|Death|0|||
146532944|NCT00408499|528462670|FG001|Phase II- MTD Expansion|Death|0|||
146532945|NCT00408499|528462671|FG002|Phase II- MTD Expansion|Death|0|||
146532946|NCT00408499|528462672|FG003|Phase II- MTD Expansion|Death|0|||
146532947|NCT00408499|528462673|FG004|Phase II- MTD Expansion|Death|2|||
146532948|NCT00408499|528462669|FG000|Phase II- MTD Expansion|Physician Decision|0|||
146532949|NCT00408499|528462670|FG001|Phase II- MTD Expansion|Physician Decision|0|||
146763171|NCT01460342|529299428|FG000|Overall Study|Protocol Violation|0|||
146763172|NCT01460342|529299429|FG001|Overall Study|Protocol Violation|1|||
146532950|NCT00408499|528462671|FG002|Phase II- MTD Expansion|Physician Decision|0|||
146532951|NCT00408499|528462672|FG003|Phase II- MTD Expansion|Physician Decision|0|||
146532952|NCT00408499|528462673|FG004|Phase II- MTD Expansion|Physician Decision|1|||
146532953|NCT00408499|528462669|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
146532954|NCT00408499|528462670|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
146865965|NCT02499770|529680425|FG001|Overall Study|Randomized but not enrolled|1|||
146865966|NCT00671554|529680432|FG000|Overall Study|Disease progression|3|||
146865967|NCT07052682|529680433|FG000|Overall Study|Withdrawal by Subject|4|||
146865968|NCT04667247|529680434|FG000|Overall Study|Withdrawal by Subject|0|||
146865969|NCT04667247|529680435|FG001|Overall Study|Withdrawal by Subject|1|||
146865970|NCT04124614|529680436|FG000|Placebo Run-in Period|Not Randomized|34|||
146865971|NCT04124614|529680437|FG001|Placebo Run-in Period|Not Randomized|0|||
146865972|NCT04124614|529680438|FG002|Placebo Run-in Period|Not Randomized|0|||
146865973|NCT04124614|529680436|FG000|Double Blind Treatment Period|Adverse Event|0|||
146865974|NCT04124614|529680437|FG001|Double Blind Treatment Period|Adverse Event|7|||
146865975|NCT04124614|529680438|FG002|Double Blind Treatment Period|Adverse Event|22|||
146865976|NCT04124614|529680436|FG000|Double Blind Treatment Period|Death|0|||
146865977|NCT04124614|529680437|FG001|Double Blind Treatment Period|Death|0|||
146865978|NCT04124614|529680438|FG002|Double Blind Treatment Period|Death|1|||
146865979|NCT04124614|529680436|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
146865980|NCT04124614|529680437|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
146865981|NCT04124614|529680438|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
146865982|NCT04124614|529680436|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
146865983|NCT04124614|529680437|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
146865984|NCT04124614|529680438|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
146865985|NCT04124614|529680436|FG000|Double Blind Treatment Period|Physician Decision|0|||
146865986|NCT04124614|529680437|FG001|Double Blind Treatment Period|Physician Decision|0|||
146865987|NCT04124614|529680438|FG002|Double Blind Treatment Period|Physician Decision|3|||
146865988|NCT04124614|529680436|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
146865989|NCT04124614|529680437|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
146865990|NCT04124614|529680438|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
146865991|NCT04124614|529680436|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
146865992|NCT04124614|529680437|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
146865993|NCT04124614|529680438|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
146865994|NCT04124614|529680436|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
146865995|NCT04124614|529680437|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
146865996|NCT04124614|529680438|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
146865997|NCT04313153|529682642|FG000|Overall Study|Adverse Event (includes Death)|14|||
146532955|NCT00408499|528462671|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
146532956|NCT00408499|528462672|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
146532957|NCT00408499|528462673|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
146532958|NCT00408499|528462669|FG000|Phase II- MTD Expansion|treatment delay|0|||
146532959|NCT00408499|528462670|FG001|Phase II- MTD Expansion|treatment delay|0|||
146532960|NCT00408499|528462671|FG002|Phase II- MTD Expansion|treatment delay|0|||
146532961|NCT00408499|528462672|FG003|Phase II- MTD Expansion|treatment delay|0|||
146532962|NCT00408499|528462673|FG004|Phase II- MTD Expansion|treatment delay|3|||
146532963|NCT01586195|528462675|FG000|Overall Study|Death|11|||
146532964|NCT01586195|528462675|FG000|Overall Study|Withdrawal of Consent|5|||
146532965|NCT01586195|528462675|FG000|Overall Study|Started new anti-melanoma therapy|1|||
146532966|NCT01586195|528462675|FG000|Overall Study|Reason not specified|9|||
146532967|NCT00997334|528462678|FG000|Overall Study|still on therapy|12|||
146865998|NCT04313153|529682643|FG001|Overall Study|Adverse Event (includes Death)|19|||
146865999|NCT04313153|529682644|FG002|Overall Study|Adverse Event (includes Death)|10|||
146866000|NCT04313153|529682642|FG000|Overall Study|Physician Decision|4|||
146866001|NCT04313153|529682643|FG001|Overall Study|Physician Decision|2|||
146866002|NCT04313153|529682644|FG002|Overall Study|Physician Decision|1|||
146866003|NCT04313153|529682642|FG000|Overall Study|Withdrawal by Subject|7|||
146866004|NCT04313153|529682643|FG001|Overall Study|Withdrawal by Subject|6|||
146866005|NCT04313153|529682644|FG002|Overall Study|Withdrawal by Subject|2|||
146866006|NCT04313153|529682642|FG000|Overall Study|Lack of Efficacy|3|||
146866007|NCT04313153|529682643|FG001|Overall Study|Lack of Efficacy|3|||
146866008|NCT04313153|529682644|FG002|Overall Study|Lack of Efficacy|0|||
146866009|NCT04313153|529682642|FG000|Overall Study|Lost to Follow-up|1|||
146866010|NCT04313153|529682643|FG001|Overall Study|Lost to Follow-up|0|||
146866011|NCT04313153|529682644|FG002|Overall Study|Lost to Follow-up|2|||
146866012|NCT04313153|529682642|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
146866013|NCT04313153|529682643|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
146866014|NCT04313153|529682644|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
146866015|NCT04313153|529682642|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
146866016|NCT04313153|529682643|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
146866017|NCT04313153|529682644|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
146866018|NCT04313153|529682642|FG000|Overall Study|Change in Dialysis Modality|0|||
146866019|NCT04313153|529682643|FG001|Overall Study|Change in Dialysis Modality|1|||
146866020|NCT04313153|529682644|FG002|Overall Study|Change in Dialysis Modality|2|||
146532968|NCT00997334|528462678|FG000|Overall Study|Adverse Event|3|||
146532969|NCT00997334|528462678|FG000|Overall Study|Patient non-compliance|1|||
146866021|NCT04313153|529682642|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
146866022|NCT04313153|529682643|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
146866023|NCT04313153|529682644|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
146866024|NCT04313153|529682642|FG000|Overall Study|Other|5|||
146866025|NCT04313153|529682643|FG001|Overall Study|Other|3|||
146866026|NCT04313153|529682644|FG002|Overall Study|Other|2|||
146866027|NCT04752475|529682645|FG000|Overall Study|Withdrawal by Subject|1|||
146866028|NCT04752475|529682646|FG001|Overall Study|Withdrawal by Subject|1|||
146866029|NCT00523718|529682647|FG000|Overall Study|Withdrawal by Subject|1|||
146866030|NCT00523718|529682648|FG001|Overall Study|Withdrawal by Subject|0|||
146866031|NCT00523718|529682647|FG000|Overall Study|Protocol Violation|2|||
146866032|NCT00523718|529682648|FG001|Overall Study|Protocol Violation|0|||
146866033|NCT01436071|529682649|FG000|Overall Study|Adverse Event|1|||
146866034|NCT01436071|529682650|FG001|Overall Study|Adverse Event|0|||
146866035|NCT01436071|529682649|FG000|Overall Study|Lack of Efficacy|16|||
146866036|NCT01436071|529682650|FG001|Overall Study|Lack of Efficacy|7|||
146866037|NCT01436071|529682649|FG000|Overall Study|Protocol Violation|0|||
146866038|NCT01436071|529682650|FG001|Overall Study|Protocol Violation|1|||
146866039|NCT01436071|529682649|FG000|Overall Study|Lost to Follow-up|3|||
146866040|NCT01436071|529682650|FG001|Overall Study|Lost to Follow-up|1|||
146866041|NCT01436071|529682649|FG000|Overall Study|Physician Decision|1|||
146866042|NCT01436071|529682650|FG001|Overall Study|Physician Decision|0|||
146866043|NCT01436071|529682649|FG000|Overall Study|Withdrawal by Subject|2|||
146866044|NCT01436071|529682650|FG001|Overall Study|Withdrawal by Subject|2|||
146866045|NCT01436071|529682649|FG000|Overall Study|Did Not Receive Trial Medication|3|||
146866046|NCT01436071|529682650|FG001|Overall Study|Did Not Receive Trial Medication|3|||
146866047|NCT00726622|529682653|FG000|Overall Study|Withdrawal by Subject|16|||
146866048|NCT00726622|529682654|FG001|Overall Study|Withdrawal by Subject|2|||
146866049|NCT00726622|529682653|FG000|Overall Study|Physician Decision|0|||
146866050|NCT00726622|529682654|FG001|Overall Study|Physician Decision|1|||
146866051|NCT00726622|529682653|FG000|Overall Study|Metastasis|2|||
146866052|NCT00726622|529682654|FG001|Overall Study|Metastasis|0|||
146866053|NCT04641299|529682657|FG000|Overall Study|Adverse Event|0|||
146866054|NCT04641299|529682658|FG001|Overall Study|Adverse Event|0|||
146866055|NCT04641299|529682659|FG002|Overall Study|Adverse Event|2|||
146866056|NCT04641299|529682660|FG003|Overall Study|Adverse Event|0|||
146866057|NCT04641299|529682657|FG000|Overall Study|Lost to Follow-up|0|||
146866058|NCT04641299|529682658|FG001|Overall Study|Lost to Follow-up|1|||
146866059|NCT04641299|529682659|FG002|Overall Study|Lost to Follow-up|0|||
146866060|NCT04641299|529682660|FG003|Overall Study|Lost to Follow-up|0|||
146866061|NCT04641299|529682657|FG000|Overall Study|Withdrawal by Subject|1|||
146866062|NCT04641299|529682658|FG001|Overall Study|Withdrawal by Subject|0|||
146866063|NCT04641299|529682659|FG002|Overall Study|Withdrawal by Subject|0|||
146866064|NCT04641299|529682660|FG003|Overall Study|Withdrawal by Subject|0|||
146866065|NCT04641299|529682657|FG000|Overall Study|Reason not given|1|||
146866066|NCT04641299|529682658|FG001|Overall Study|Reason not given|0|||
146866067|NCT04641299|529682659|FG002|Overall Study|Reason not given|0|||
146866068|NCT04641299|529682660|FG003|Overall Study|Reason not given|0|||
146866069|NCT01016964|529682667|FG000|Overall Study|Lost to Follow-up|3|||
146866070|NCT01016964|529682668|FG001|Overall Study|Lost to Follow-up|3|||
146866071|NCT00352885|529682669|FG000|Overall Study|Withdrawal by Subject|0|||
146866072|NCT00352885|529682670|FG001|Overall Study|Withdrawal by Subject|3|||
146866073|NCT00352885|529682669|FG000|Overall Study|Development of major depression|0|||
146866074|NCT00352885|529682670|FG001|Overall Study|Development of major depression|1|||
146866075|NCT00352885|529682669|FG000|Overall Study|Progression of metastatic melanoma|5|||
146866076|NCT00352885|529682670|FG001|Overall Study|Progression of metastatic melanoma|3|||
146866077|NCT00352885|529682669|FG000|Overall Study|Side effects of IL-2 administration|1|||
146866078|NCT00352885|529682670|FG001|Overall Study|Side effects of IL-2 administration|0|||
146866079|NCT03873493|529682671|FG000|Overall Study|Withdrawal by Subject|1|||
146866080|NCT03873493|529682671|FG000|Overall Study|Death|9|||
146866081|NCT03873493|529682671|FG000|Overall Study|Lost to Follow-up|1|||
146866082|NCT03873493|529682671|FG000|Overall Study|Study Terminated by Sponsor|1|||
146866083|NCT03873493|529682671|FG000|Overall Study|Other|2|||
146866084|NCT00702845|529682673|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
146866085|NCT00702845|529682674|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
146866086|NCT00702845|529682673|FG000|Overall Study|Too high ovarian response|5|||
146866087|NCT00702845|529682674|FG001|Overall Study|Too high ovarian response|1|||
146866088|NCT00702845|529682673|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
146866089|NCT00702845|529682674|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
146866090|NCT00702845|529682673|FG000|Overall Study|Insufficient ovarian response|1|||
146866091|NCT00702845|529682674|FG001|Overall Study|Insufficient ovarian response|0|||
146866092|NCT00702845|529682673|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
146866093|NCT00702845|529682674|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
146866094|NCT00702845|529682673|FG000|Overall Study|No or abnormal fertilization|4|||
146866095|NCT00702845|529682674|FG001|Overall Study|No or abnormal fertilization|2|||
146866096|NCT00702845|529682673|FG000|Overall Study|Patient's decision|2|||
146866097|NCT00702845|529682674|FG001|Overall Study|Patient's decision|1|||
146866098|NCT00702845|529682673|FG000|Overall Study|Not randomized|0|||
146866099|NCT00702845|529682674|FG001|Overall Study|Not randomized|1|||
146866100|NCT00440700|529682675|FG000|Overall Study|Withdrawal by Subject|8|||
146866101|NCT00440700|529682676|FG001|Overall Study|Withdrawal by Subject|8|||
146866102|NCT00440700|529682677|FG002|Overall Study|Withdrawal by Subject|4|||
146866103|NCT00928564|529682681|FG000|Overall Study|Lost to Follow-up|6|||
146866104|NCT00928564|529682682|FG001|Overall Study|Lost to Follow-up|0|||
146866105|NCT02973425|529682684|FG000|Overall Study|Lost to Follow-up|49|||
146866106|NCT02973425|529682685|FG001|Overall Study|Lost to Follow-up|53|||
146866107|NCT04906616|529682688|FG000|Overall Study|Divorce|3|||
146866108|NCT04906616|529682689|FG001|Overall Study|Divorce|2|||
146866109|NCT00385203|529682692|FG000|Overall Study|Adverse Event|5|||
146866110|NCT00385203|529682693|FG001|Overall Study|Adverse Event|4|||
146866111|NCT00385203|529682692|FG000|Overall Study|Death|1|||
146866112|NCT00385203|529682693|FG001|Overall Study|Death|0|||
146866113|NCT00385203|529682692|FG000|Overall Study|Condition under investigation worsened|18|||
146866114|NCT00385203|529682693|FG001|Overall Study|Condition under investigation worsened|3|||
146866115|NCT00385203|529682692|FG000|Overall Study|Incorrect enrollment|2|||
146866116|NCT00385203|529682693|FG001|Overall Study|Incorrect enrollment|0|||
146866117|NCT03842163|529682702|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
146866118|NCT03842163|529682702|FG000|Overall Study|Scintigraphy was not performed|44|||
146866119|NCT00698451|529682703|FG000|Overall Study|Adverse Event|22|||
146866120|NCT00698451|529682703|FG000|Overall Study|Physician Decision|2|||
146866121|NCT00698451|529682703|FG000|Overall Study|Protocol Violation|6|||
146866122|NCT00698451|529682703|FG000|Overall Study|Withdrawal by Subject|6|||
146866123|NCT00698451|529682703|FG000|Overall Study|Disease progression|3|||
146866124|NCT03083847|529682704|FG000|Main|Physician Decision|0|||
146866125|NCT03083847|529682705|FG001|Main|Physician Decision|0|||
146866126|NCT03083847|529682706|FG002|Main|Physician Decision|0|||
146866127|NCT03083847|529682707|FG003|Main|Physician Decision|0|||
146866128|NCT03083847|529682708|FG004|Main|Physician Decision|0|||
146866129|NCT03083847|529682709|FG005|Main|Physician Decision|1|||
146866130|NCT03083847|529682710|FG006|Main|Physician Decision|0|||
146866131|NCT03083847|529682711|FG007|Main|Physician Decision|0|||
146866132|NCT03083847|529682712|FG008|Main|Physician Decision|0|||
146866133|NCT03083847|529682713|FG009|Main|Physician Decision|0|||
146866134|NCT03083847|529682704|FG000|Main|Pregnancy|0|||
146866135|NCT03083847|529682705|FG001|Main|Pregnancy|0|||
146866136|NCT03083847|529682706|FG002|Main|Pregnancy|0|||
146866137|NCT03083847|529682707|FG003|Main|Pregnancy|0|||
146866138|NCT03083847|529682708|FG004|Main|Pregnancy|0|||
146866139|NCT03083847|529682709|FG005|Main|Pregnancy|0|||
146866140|NCT03083847|529682710|FG006|Main|Pregnancy|0|||
146866141|NCT03083847|529682711|FG007|Main|Pregnancy|1|||
146866142|NCT03083847|529682712|FG008|Main|Pregnancy|0|||
146866143|NCT03083847|529682713|FG009|Main|Pregnancy|0|||
146866144|NCT03083847|529682704|FG000|Main|Adverse Event|0|||
146866145|NCT03083847|529682705|FG001|Main|Adverse Event|0|||
146866146|NCT03083847|529682706|FG002|Main|Adverse Event|0|||
146866147|NCT03083847|529682707|FG003|Main|Adverse Event|0|||
146866148|NCT03083847|529682708|FG004|Main|Adverse Event|0|||
146866149|NCT03083847|529682709|FG005|Main|Adverse Event|0|||
146866150|NCT03083847|529682710|FG006|Main|Adverse Event|0|||
146866151|NCT03083847|529682711|FG007|Main|Adverse Event|2|||
146866152|NCT03083847|529682712|FG008|Main|Adverse Event|0|||
146866153|NCT03083847|529682713|FG009|Main|Adverse Event|0|||
146866154|NCT03083847|529682704|FG000|Main|Withdrawal by Subject|0|||
146866155|NCT03083847|529682705|FG001|Main|Withdrawal by Subject|0|||
146866156|NCT03083847|529682706|FG002|Main|Withdrawal by Subject|0|||
146866157|NCT03083847|529682707|FG003|Main|Withdrawal by Subject|0|||
146866158|NCT03083847|529682708|FG004|Main|Withdrawal by Subject|0|||
146866159|NCT03083847|529682709|FG005|Main|Withdrawal by Subject|0|||
146866160|NCT03083847|529682710|FG006|Main|Withdrawal by Subject|1|||
146866161|NCT03083847|529682711|FG007|Main|Withdrawal by Subject|1|||
146866162|NCT03083847|529682712|FG008|Main|Withdrawal by Subject|0|||
146866163|NCT03083847|529682713|FG009|Main|Withdrawal by Subject|0|||
146866164|NCT01187550|529682716|FG000|Overall Study|Protocol Violation|3|||
146866165|NCT01187550|529682717|FG001|Overall Study|Protocol Violation|1|||
146866166|NCT01187550|529682716|FG000|Overall Study|Other|3|||
146866167|NCT01187550|529682717|FG001|Overall Study|Other|0|||
146866168|NCT01187550|529682716|FG000|Overall Study|Randomized but not treated|8|||
146866169|NCT01187550|529682717|FG001|Overall Study|Randomized but not treated|0|||
146866170|NCT00733304|529682718|FG000|Overall Study|Adverse Event|3|||
146866171|NCT00733304|529682719|FG001|Overall Study|Adverse Event|0|||
146866172|NCT00733304|529682720|FG002|Overall Study|Adverse Event|0|||
146866173|NCT00733304|529682718|FG000|Overall Study|Lack of Efficacy|0|||
146866174|NCT00733304|529682719|FG001|Overall Study|Lack of Efficacy|0|||
146866175|NCT00733304|529682720|FG002|Overall Study|Lack of Efficacy|2|||
146866176|NCT00733304|529682718|FG000|Overall Study|Lost to Follow-up|0|||
146866177|NCT00733304|529682719|FG001|Overall Study|Lost to Follow-up|1|||
146866178|NCT00733304|529682720|FG002|Overall Study|Lost to Follow-up|0|||
146866179|NCT00733304|529682718|FG000|Overall Study|Physician Decision|3|||
146532970|NCT00997334|528462678|FG000|Overall Study|Withdrawal by Subject|3|||
146532971|NCT00997334|528462678|FG000|Overall Study|Death|2|||
146532972|NCT00997334|528462678|FG000|Overall Study|Urgent Palliative Care|2|||
146532973|NCT00997334|528462678|FG000|Overall Study|No lesion amenable|1|||
146532974|NCT00997334|528462678|FG000|Overall Study|Ineligible|1|||
146532975|NCT01863771|528462683|FG000|Induction Phase|Adverse Event|9|||
146532976|NCT01863771|528462684|FG001|Induction Phase|Adverse Event|0|||
146532977|NCT01863771|528462685|FG002|Induction Phase|Adverse Event|0|||
146532978|NCT01863771|528462686|FG003|Induction Phase|Adverse Event|0|||
146532979|NCT01863771|528462683|FG000|Induction Phase|Lack of Efficacy|10|||
146532980|NCT01863771|528462684|FG001|Induction Phase|Lack of Efficacy|0|||
146532981|NCT01863771|528462685|FG002|Induction Phase|Lack of Efficacy|0|||
146532982|NCT01863771|528462686|FG003|Induction Phase|Lack of Efficacy|0|||
146532983|NCT01863771|528462683|FG000|Induction Phase|Withdrawal by Subject|2|||
146532984|NCT01863771|528462684|FG001|Induction Phase|Withdrawal by Subject|0|||
146532985|NCT01863771|528462685|FG002|Induction Phase|Withdrawal by Subject|0|||
146532986|NCT01863771|528462686|FG003|Induction Phase|Withdrawal by Subject|0|||
146532987|NCT01863771|528462683|FG000|Maintenance Phase|Adverse Event|0|||
146532988|NCT01863771|528462684|FG001|Maintenance Phase|Adverse Event|0|||
146532989|NCT01863771|528462685|FG002|Maintenance Phase|Adverse Event|1|||
146532990|NCT01863771|528462686|FG003|Maintenance Phase|Adverse Event|1|||
146532991|NCT01863771|528462683|FG000|Maintenance Phase|Lack of Efficacy|0|||
146532992|NCT01863771|528462684|FG001|Maintenance Phase|Lack of Efficacy|3|||
146532993|NCT01863771|528462685|FG002|Maintenance Phase|Lack of Efficacy|7|||
146532994|NCT01863771|528462686|FG003|Maintenance Phase|Lack of Efficacy|38|||
146532995|NCT01863771|528462683|FG000|Maintenance Phase|Physician Decision|0|||
146532996|NCT01863771|528462684|FG001|Maintenance Phase|Physician Decision|0|||
146532997|NCT01863771|528462685|FG002|Maintenance Phase|Physician Decision|2|||
146532998|NCT01863771|528462686|FG003|Maintenance Phase|Physician Decision|1|||
146532999|NCT01863771|528462683|FG000|Maintenance Phase|Pregnancy|0|||
146533000|NCT01863771|528462684|FG001|Maintenance Phase|Pregnancy|1|||
146533001|NCT01863771|528462685|FG002|Maintenance Phase|Pregnancy|0|||
146533002|NCT01863771|528462686|FG003|Maintenance Phase|Pregnancy|0|||
146533003|NCT01863771|528462683|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146533004|NCT01863771|528462684|FG001|Maintenance Phase|Withdrawal by Subject|1|||
146533005|NCT01863771|528462685|FG002|Maintenance Phase|Withdrawal by Subject|2|||
146533006|NCT01863771|528462686|FG003|Maintenance Phase|Withdrawal by Subject|3|||
146533007|NCT03499795|528462687|FG000|Overall Study|Adverse Event|1|||
146533008|NCT03499795|528462687|FG000|Overall Study|Lost to Follow-up|1|||
146533009|NCT03636256|528462688|FG000|Overall Study|Lost to Follow-up|3|||
146533010|NCT03636256|528462689|FG001|Overall Study|Lost to Follow-up|0|||
146533011|NCT03636256|528462690|FG002|Overall Study|Lost to Follow-up|2|||
146533012|NCT03636256|528462691|FG003|Overall Study|Lost to Follow-up|1|||
146533013|NCT03636256|528462692|FG004|Overall Study|Lost to Follow-up|0|||
146533014|NCT03636256|528462693|FG005|Overall Study|Lost to Follow-up|4|||
146533015|NCT03636256|528462694|FG006|Overall Study|Lost to Follow-up|2|||
146533016|NCT03636256|528462695|FG007|Overall Study|Lost to Follow-up|0|||
146533017|NCT03636256|528462696|FG008|Overall Study|Lost to Follow-up|4|||
146533018|NCT03636256|528462688|FG000|Overall Study|Withdrawal by Subject|0|||
146533019|NCT03636256|528462689|FG001|Overall Study|Withdrawal by Subject|0|||
146533020|NCT03636256|528462690|FG002|Overall Study|Withdrawal by Subject|0|||
146533021|NCT03636256|528462691|FG003|Overall Study|Withdrawal by Subject|0|||
146533022|NCT03636256|528462692|FG004|Overall Study|Withdrawal by Subject|0|||
146533023|NCT03636256|528462693|FG005|Overall Study|Withdrawal by Subject|0|||
146533024|NCT03636256|528462694|FG006|Overall Study|Withdrawal by Subject|0|||
146533025|NCT03636256|528462695|FG007|Overall Study|Withdrawal by Subject|0|||
146533026|NCT03636256|528462696|FG008|Overall Study|Withdrawal by Subject|1|||
146533027|NCT02426684|528462697|FG000|Overall Study|Physician Decision|1|||
146533028|NCT04748718|528462700|FG000|Overall Study|Lost to Follow-up|50|||
146533029|NCT01450813|528462701|FG000|Overall Study|Physician Decision|1|||
146533030|NCT01450813|528462702|FG001|Overall Study|Physician Decision|1|||
146533031|NCT01450813|528462703|FG002|Overall Study|Physician Decision|0|||
146533032|NCT01450813|528462704|FG003|Overall Study|Physician Decision|3|||
146533033|NCT01118299|528462705|FG000|Overall Study|Death|7|||
146533034|NCT01118299|528462706|FG001|Overall Study|Death|5|||
146533035|NCT01118299|528462705|FG000|Overall Study|Withdrawal by Subject|8|||
146763173|NCT01460342|529299428|FG000|Overall Study|Withdrawal by Subject|3|||
146763174|NCT01460342|529299429|FG001|Overall Study|Withdrawal by Subject|4|||
146763175|NCT01460342|529299428|FG000|Overall Study|Physician Decision|1|||
146763176|NCT01460342|529299429|FG001|Overall Study|Physician Decision|3|||
146763177|NCT01460342|529299428|FG000|Overall Study|Lack of Efficacy|1|||
146763178|NCT01460342|529299429|FG001|Overall Study|Lack of Efficacy|0|||
146763179|NCT00591838|529299430|FG000|Overall Study|Withdrawal by Subject|0|||
146763180|NCT00591838|529299431|FG001|Overall Study|Withdrawal by Subject|0|||
146533036|NCT01118299|528462706|FG001|Overall Study|Withdrawal by Subject|8|||
146533037|NCT01118299|528462705|FG000|Overall Study|Lost to Follow-up|2|||
146763181|NCT00591838|529299432|FG002|Overall Study|Withdrawal by Subject|0|||
146763182|NCT00591838|529299433|FG003|Overall Study|Withdrawal by Subject|1|||
146533038|NCT01118299|528462706|FG001|Overall Study|Lost to Follow-up|1|||
146533039|NCT01118299|528462705|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
146866180|NCT00733304|529682719|FG001|Overall Study|Physician Decision|1|||
146866181|NCT00733304|529682720|FG002|Overall Study|Physician Decision|3|||
146866182|NCT00733304|529682718|FG000|Overall Study|Withdrawal by Subject|1|||
146866183|NCT00733304|529682719|FG001|Overall Study|Withdrawal by Subject|1|||
146866184|NCT00733304|529682720|FG002|Overall Study|Withdrawal by Subject|0|||
146866185|NCT00129623|529682721|FG000|Overall Study|Adverse Event|3|||
146866186|NCT00129623|529682722|FG001|Overall Study|Adverse Event|7|||
146866187|NCT00129623|529682721|FG000|Overall Study|Refused Treatment|5|||
146866188|NCT00129623|529682722|FG001|Overall Study|Refused Treatment|3|||
146866189|NCT00129623|529682721|FG000|Overall Study|Failure to Return|1|||
146866190|NCT00129623|529682722|FG001|Overall Study|Failure to Return|1|||
146866191|NCT00129623|529682721|FG000|Overall Study|Relocated job out of state|1|||
146866192|NCT00129623|529682722|FG001|Overall Study|Relocated job out of state|0|||
146866193|NCT00129623|529682721|FG000|Overall Study|Uncertainty to return|0|||
146866194|NCT00129623|529682722|FG001|Overall Study|Uncertainty to return|1|||
146866195|NCT02445755|529682732|FG000|Overall Study|Withdrawal by Subject|2|||
146866196|NCT02445755|529682732|FG000|Overall Study|Protocol Violation|6|||
146866197|NCT02445755|529682732|FG000|Overall Study|Screen Failure|5|||
146866198|NCT05352048|529682733|FG000|Overall Study|Lost to Follow-up|1|||
146866199|NCT05352048|529682733|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
146866200|NCT02308007|529682743|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
146866201|NCT02308007|529682744|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
146866202|NCT02308007|529682745|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
146866203|NCT02308007|529682743|FG000|Overall Study|Positive for STD at Baseline|7|||
146866204|NCT02308007|529682744|FG001|Overall Study|Positive for STD at Baseline|11|||
146866205|NCT02308007|529682745|FG002|Overall Study|Positive for STD at Baseline|7|||
146866206|NCT02308007|529682743|FG000|Overall Study|Lost to Follow-up|3|||
146866207|NCT02308007|529682744|FG001|Overall Study|Lost to Follow-up|0|||
146866208|NCT02308007|529682745|FG002|Overall Study|Lost to Follow-up|1|||
146866209|NCT00528567|529682751|FG000|Overall Study|Death|4|||
146866210|NCT00528567|529682752|FG001|Overall Study|Death|5|||
146866211|NCT00528567|529682751|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
146866212|NCT00528567|529682752|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
146866213|NCT00528567|529682751|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
146866214|NCT00528567|529682752|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
146866215|NCT00528567|529682751|FG000|Overall Study|Violation Criteria at Entry|3|||
146866216|NCT00528567|529682752|FG001|Overall Study|Violation Criteria at Entry|17|||
146866217|NCT00528567|529682751|FG000|Overall Study|Withdrew Consent|59|||
146866218|NCT00528567|529682752|FG001|Overall Study|Withdrew Consent|55|||
146866219|NCT00528567|529682751|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
146866220|NCT00528567|529682752|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
146866221|NCT00528567|529682751|FG000|Overall Study|Failure to Return|1|||
146866222|NCT00528567|529682752|FG001|Overall Study|Failure to Return|4|||
146866223|NCT00528567|529682751|FG000|Overall Study|Other Protocol Violation|5|||
146866224|NCT00528567|529682752|FG001|Overall Study|Other Protocol Violation|21|||
146866225|NCT00528567|529682751|FG000|Overall Study|Administrative/Other|22|||
146866226|NCT00528567|529682752|FG001|Overall Study|Administrative/Other|75|||
146866227|NCT03085758|529682755|FG000|Overall Study|Death|26|||
146866228|NCT03085758|529682756|FG001|Overall Study|Death|24|||
146866229|NCT03085758|529682757|FG002|Overall Study|Death|53|||
146866230|NCT03085758|529682755|FG000|Overall Study|Lost to Follow-up|1|||
146866231|NCT03085758|529682756|FG001|Overall Study|Lost to Follow-up|1|||
146866232|NCT03085758|529682757|FG002|Overall Study|Lost to Follow-up|1|||
146866233|NCT03085758|529682755|FG000|Overall Study|Withdrawal by Subject|2|||
146866234|NCT03085758|529682756|FG001|Overall Study|Withdrawal by Subject|2|||
146866235|NCT03085758|529682757|FG002|Overall Study|Withdrawal by Subject|1|||
146866236|NCT03085758|529682755|FG000|Overall Study|Refusal to recall it up to day 90|0|||
146866237|NCT03085758|529682756|FG001|Overall Study|Refusal to recall it up to day 90|0|||
146866238|NCT03085758|529682757|FG002|Overall Study|Refusal to recall it up to day 90|1|||
146866239|NCT03085758|529682755|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
146866240|NCT03085758|529682756|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
146866241|NCT03085758|529682757|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
146866242|NCT00631189|529682760|FG000|Initial Phase|Protocol Violation|347|||
146866243|NCT00631189|529682761|FG001|Initial Phase|Protocol Violation|0|||
146866244|NCT00631189|529682762|FG002|Initial Phase|Protocol Violation|0|||
146866245|NCT00631189|529682763|FG003|Initial Phase|Protocol Violation|0|||
146866246|NCT00631189|529682760|FG000|Initial Phase|Withdrawal by Subject|4|||
146866247|NCT00631189|529682761|FG001|Initial Phase|Withdrawal by Subject|0|||
146866248|NCT00631189|529682762|FG002|Initial Phase|Withdrawal by Subject|0|||
146866249|NCT00631189|529682763|FG003|Initial Phase|Withdrawal by Subject|0|||
146866250|NCT00631189|529682760|FG000|Treatment Phase|Withdrawal by Subject|0|||
146866251|NCT00631189|529682761|FG001|Treatment Phase|Withdrawal by Subject|2|||
146533040|NCT01118299|528462706|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
146866252|NCT00631189|529682762|FG002|Treatment Phase|Withdrawal by Subject|1|||
146866253|NCT00631189|529682763|FG003|Treatment Phase|Withdrawal by Subject|1|||
146866254|NCT00631189|529682760|FG000|Treatment Phase|Protocol Violation|0|||
146866255|NCT00631189|529682761|FG001|Treatment Phase|Protocol Violation|1|||
146866256|NCT00631189|529682762|FG002|Treatment Phase|Protocol Violation|6|||
146866257|NCT00631189|529682763|FG003|Treatment Phase|Protocol Violation|2|||
146866258|NCT00631189|529682760|FG000|Treatment Phase|Adverse Event|0|||
146866259|NCT00631189|529682761|FG001|Treatment Phase|Adverse Event|3|||
146866260|NCT00631189|529682762|FG002|Treatment Phase|Adverse Event|2|||
146866261|NCT00631189|529682763|FG003|Treatment Phase|Adverse Event|4|||
146866262|NCT00631189|529682760|FG000|Treatment Phase|Lost to Follow-up|0|||
146866263|NCT00631189|529682761|FG001|Treatment Phase|Lost to Follow-up|1|||
146866264|NCT00631189|529682762|FG002|Treatment Phase|Lost to Follow-up|0|||
146866265|NCT00631189|529682763|FG003|Treatment Phase|Lost to Follow-up|0|||
146866266|NCT00631189|529682760|FG000|Treatment Phase|Pregnancy|0|||
146866267|NCT00631189|529682761|FG001|Treatment Phase|Pregnancy|0|||
146866268|NCT00631189|529682762|FG002|Treatment Phase|Pregnancy|1|||
146866269|NCT00631189|529682763|FG003|Treatment Phase|Pregnancy|0|||
146866270|NCT00631189|529682760|FG000|Treatment Phase|patient did not take pravastatin|0|||
146866271|NCT00631189|529682761|FG001|Treatment Phase|patient did not take pravastatin|0|||
146866272|NCT00631189|529682762|FG002|Treatment Phase|patient did not take pravastatin|1|||
146866273|NCT00631189|529682763|FG003|Treatment Phase|patient did not take pravastatin|0|||
146866274|NCT00974090|529682764|FG000|Period 1: Double Blind Period|Adverse Event|2|||
146866275|NCT00974090|529682765|FG001|Period 1: Double Blind Period|Adverse Event|1|||
146866276|NCT00974090|529682764|FG000|Period 1: Double Blind Period|Physician Decision|1|||
146866277|NCT00974090|529682765|FG001|Period 1: Double Blind Period|Physician Decision|0|||
146866278|NCT00974090|529682764|FG000|Period 2: Open-label Period|Adverse Event|4|||
146866279|NCT00974090|529682765|FG001|Period 2: Open-label Period|Adverse Event|6|||
146866280|NCT00974090|529682764|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
146866281|NCT00974090|529682765|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
146866282|NCT00974090|529682764|FG000|Period 2: Open-label Period|Physician Decision|0|||
146866283|NCT00974090|529682765|FG001|Period 2: Open-label Period|Physician Decision|3|||
146866284|NCT00974090|529682764|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
146866285|NCT00974090|529682765|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
146866286|NCT03189862|529682766|FG000|Overall Study|Withdrawal by Subject|1|||
146866287|NCT03189862|529682767|FG001|Overall Study|Withdrawal by Subject|0|||
146866288|NCT03189862|529682766|FG000|Overall Study|Lost to Follow-up|54|||
146866289|NCT03189862|529682767|FG001|Overall Study|Lost to Follow-up|62|||
146866290|NCT00056862|529682768|FG000|Overall Study|Protocol Violation|1|||
146866291|NCT00056862|529682769|FG001|Overall Study|Protocol Violation|0|||
146866292|NCT01122576|529682770|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
146866293|NCT01122576|529682771|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
146866294|NCT01122576|529682772|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
146866295|NCT01122576|529682770|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
146866296|NCT01122576|529682771|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
146866297|NCT01122576|529682772|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
146866298|NCT01122576|529682770|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
146866299|NCT01122576|529682771|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
146866300|NCT01122576|529682772|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
146866301|NCT05696236|529682773|FG000|Overall Study|Lost to Follow-up|1|||
146866302|NCT05696236|529682774|FG001|Overall Study|Lost to Follow-up|0|||
146866303|NCT05696236|529682773|FG000|Overall Study|Later determined to not be eligible for participation|0|||
146866304|NCT05696236|529682774|FG001|Overall Study|Later determined to not be eligible for participation|1|||
146866305|NCT05696236|529682773|FG000|Overall Study|Withdrawal by Subject|2|||
146866306|NCT05696236|529682774|FG001|Overall Study|Withdrawal by Subject|2|||
146866307|NCT01829360|529682775|FG000|Overall Study|Protocol Violation|0|||
146866308|NCT01829360|529682776|FG001|Overall Study|Protocol Violation|0|||
146866309|NCT01829360|529682777|FG002|Overall Study|Protocol Violation|1|||
146866310|NCT01829360|529682778|FG003|Overall Study|Protocol Violation|0|||
146866311|NCT00578786|529682779|FG000|Overall Study|Adverse Event|27|||
146866312|NCT00578786|529682780|FG001|Overall Study|Adverse Event|37|||
146866313|NCT00578786|529682781|FG002|Overall Study|Adverse Event|17|||
146866314|NCT00578786|529682779|FG000|Overall Study|Lack of Efficacy|2|||
146866315|NCT00578786|529682780|FG001|Overall Study|Lack of Efficacy|5|||
146866316|NCT00578786|529682781|FG002|Overall Study|Lack of Efficacy|2|||
146866317|NCT00578786|529682779|FG000|Overall Study|Early Escape from Prior Study|2|||
146866318|NCT00578786|529682780|FG001|Overall Study|Early Escape from Prior Study|1|||
146866319|NCT00578786|529682781|FG002|Overall Study|Early Escape from Prior Study|2|||
146866320|NCT00578786|529682779|FG000|Overall Study|Withdrawal by Subject|7|||
146866321|NCT00578786|529682780|FG001|Overall Study|Withdrawal by Subject|8|||
146866322|NCT00578786|529682781|FG002|Overall Study|Withdrawal by Subject|5|||
146866323|NCT00578786|529682779|FG000|Overall Study|Protocol Violation|0|||
146866324|NCT00578786|529682780|FG001|Overall Study|Protocol Violation|3|||
146866325|NCT00578786|529682781|FG002|Overall Study|Protocol Violation|1|||
146866326|NCT00578786|529682779|FG000|Overall Study|Physician Decision|1|||
146533041|NCT01935089|528462708|FG000|Overall Study|Adverse Event|2|||
146533042|NCT01935089|528462708|FG000|Overall Study|Withdrawal by Subject|1|||
146533043|NCT02932943|528462709|FG000|Overall Study|Lost to Follow-up|0|||
146533044|NCT02932943|528462710|FG001|Overall Study|Lost to Follow-up|2|||
146533045|NCT02932943|528462709|FG000|Overall Study|Adverse Event|2|||
146533046|NCT02932943|528462710|FG001|Overall Study|Adverse Event|2|||
146533047|NCT02932943|528462709|FG000|Overall Study|Withdrawal by Subject|3|||
146533048|NCT02932943|528462710|FG001|Overall Study|Withdrawal by Subject|3|||
146533049|NCT02337491|528462711|FG000|Overall Study|Death|1|||
146533050|NCT02337491|528462712|FG001|Overall Study|Death|1|||
146533051|NCT02337491|528462711|FG000|Overall Study|Adverse Event|0|||
146533052|NCT02337491|528462712|FG001|Overall Study|Adverse Event|1|||
146533053|NCT02337491|528462711|FG000|Overall Study|Withdrawal by Subject|3|||
146533054|NCT02337491|528462712|FG001|Overall Study|Withdrawal by Subject|0|||
146533055|NCT02337491|528462711|FG000|Overall Study|Progressive Disease|44|||
146533056|NCT02337491|528462712|FG001|Overall Study|Progressive Disease|28|||
146533057|NCT02337491|528462711|FG000|Overall Study|On Treatment|2|||
146533058|NCT02337491|528462712|FG001|Overall Study|On Treatment|0|||
146533059|NCT01483118|528462713|FG000|Overall Study|Lost to Follow-up|12|||
146533060|NCT01483118|528462714|FG001|Overall Study|Lost to Follow-up|16|||
146533061|NCT00785356|528462715|FG000|Overall Study|Study prematurely terminated|8|||
146533062|NCT01079780|528462716|FG000|Overall Study|Disease progression|43|||
146533063|NCT01079780|528462717|FG001|Overall Study|Disease progression|7|||
146533064|NCT01079780|528462718|FG002|Overall Study|Disease progression|31|||
146533065|NCT01079780|528462716|FG000|Overall Study|Adverse Event|13|||
146533066|NCT01079780|528462717|FG001|Overall Study|Adverse Event|5|||
146533067|NCT01079780|528462718|FG002|Overall Study|Adverse Event|7|||
146533068|NCT01079780|528462716|FG000|Overall Study|Death|2|||
146533069|NCT01079780|528462717|FG001|Overall Study|Death|0|||
146533070|NCT01079780|528462718|FG002|Overall Study|Death|2|||
146533071|NCT01079780|528462716|FG000|Overall Study|Withdrawal by Subject|6|||
146533072|NCT01079780|528462717|FG001|Overall Study|Withdrawal by Subject|4|||
146533073|NCT01079780|528462718|FG002|Overall Study|Withdrawal by Subject|4|||
146533074|NCT01079780|528462716|FG000|Overall Study|Alternative therapy|2|||
146533075|NCT01079780|528462717|FG001|Overall Study|Alternative therapy|0|||
146533076|NCT01079780|528462718|FG002|Overall Study|Alternative therapy|2|||
146533077|NCT01079780|528462716|FG000|Overall Study|Physician Decision|1|||
146533078|NCT01079780|528462717|FG001|Overall Study|Physician Decision|0|||
146533079|NCT01079780|528462718|FG002|Overall Study|Physician Decision|1|||
146866327|NCT00578786|529682780|FG001|Overall Study|Physician Decision|0|||
146866328|NCT00578786|529682781|FG002|Overall Study|Physician Decision|1|||
146533080|NCT01079780|528462716|FG000|Overall Study|Error made in lesion measurement|1|||
146533081|NCT01079780|528462717|FG001|Overall Study|Error made in lesion measurement|0|||
146533082|NCT01079780|528462718|FG002|Overall Study|Error made in lesion measurement|0|||
146533083|NCT01079780|528462716|FG000|Overall Study|Patient had surgery|1|||
146533084|NCT01079780|528462717|FG001|Overall Study|Patient had surgery|0|||
146533085|NCT01079780|528462718|FG002|Overall Study|Patient had surgery|0|||
146533086|NCT01079780|528462716|FG000|Overall Study|Treatment cycle delay|0|||
146533087|NCT01079780|528462717|FG001|Overall Study|Treatment cycle delay|0|||
146533088|NCT01079780|528462718|FG002|Overall Study|Treatment cycle delay|1|||
146533089|NCT01079780|528462716|FG000|Overall Study|Never started treatment|1|||
146533090|NCT01079780|528462717|FG001|Overall Study|Never started treatment|0|||
146533091|NCT01079780|528462718|FG002|Overall Study|Never started treatment|2|||
146533092|NCT01178294|528462724|FG000|Overall Study|Adverse Event|4|||
146533093|NCT01178294|528462724|FG000|Overall Study|Lost to Follow-up|2|||
146533094|NCT01178294|528462724|FG000|Overall Study|Lack of Efficacy|1|||
146533095|NCT01178294|528462724|FG000|Overall Study|Death|1|||
146533096|NCT01178294|528462724|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
146533097|NCT01178294|528462724|FG000|Overall Study|Subject status is terminal|1|||
146533098|NCT01178294|528462724|FG000|Overall Study|Completion status could not be verified|1|||
146533099|NCT02783066|528462725|FG000|Overall Study|Withdrawal by Subject|13|||
146533100|NCT00551369|528462726|FG000|Overall Study|Protocol Violation|5|||
146533101|NCT00551369|528462726|FG000|Overall Study|Withdrawal by Subject|1|||
146533102|NCT00551369|528462726|FG000|Overall Study|Not treated per protocol and re|1|||
146533103|NCT02051296|528462727|FG000|Overall Study|Lost to Follow-up|1|||
146533104|NCT02051296|528462728|FG001|Overall Study|Lost to Follow-up|2|||
146866329|NCT00578786|529682779|FG000|Overall Study|Sponsor Decision|0|||
146533105|NCT02051296|528462727|FG000|Overall Study|withdraw prior to treatment|7|||
146533106|NCT02051296|528462728|FG001|Overall Study|withdraw prior to treatment|7|||
146533107|NCT05379920|528462729|FG000|Overall Study|Lost to Follow-up|0|||
146533108|NCT05379920|528462730|FG001|Overall Study|Lost to Follow-up|5|||
146533109|NCT05379920|528462731|FG002|Overall Study|Lost to Follow-up|0|||
146533110|NCT05379920|528462732|FG003|Overall Study|Lost to Follow-up|0|||
146533111|NCT03176771|528462735|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
146533112|NCT03176771|528462736|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
146533113|NCT03176771|528462737|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
146533114|NCT03176771|528462738|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
146866330|NCT00578786|529682780|FG001|Overall Study|Sponsor Decision|0|||
146866331|NCT00578786|529682781|FG002|Overall Study|Sponsor Decision|1|||
146866332|NCT00578786|529682779|FG000|Overall Study|Lost to Follow-up|0|||
146866333|NCT00578786|529682780|FG001|Overall Study|Lost to Follow-up|4|||
146866334|NCT00578786|529682781|FG002|Overall Study|Lost to Follow-up|0|||
146866335|NCT00578786|529682779|FG000|Overall Study|Pregnancy|0|||
146866336|NCT00578786|529682780|FG001|Overall Study|Pregnancy|1|||
146866337|NCT00578786|529682781|FG002|Overall Study|Pregnancy|0|||
146866338|NCT00578786|529682779|FG000|Overall Study|Not Otherwise Specified|0|||
146866339|NCT00578786|529682780|FG001|Overall Study|Not Otherwise Specified|4|||
146866340|NCT00578786|529682781|FG002|Overall Study|Not Otherwise Specified|1|||
146866341|NCT00578786|529682779|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
146866342|NCT00578786|529682780|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
146866343|NCT00578786|529682781|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
146866344|NCT00728481|529682785|FG000|Overall Study|Withdrawal by Subject|0|||
146866345|NCT00728481|529682786|FG001|Overall Study|Withdrawal by Subject|1|||
146866346|NCT00728481|529682785|FG000|Overall Study|Adverse Event|0|||
146866347|NCT00728481|529682786|FG001|Overall Study|Adverse Event|1|||
146866348|NCT00728481|529682785|FG000|Overall Study|Study medication non-compliance|0|||
146866349|NCT00728481|529682786|FG001|Overall Study|Study medication non-compliance|2|||
146866350|NCT00728481|529682785|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
146866351|NCT00728481|529682786|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
146866352|NCT00041067|529682787|FG000|Overall Study|Adverse Event|20|||
146866353|NCT00041067|529682787|FG000|Overall Study|Progression|19|||
146866354|NCT00041067|529682787|FG000|Overall Study|Patient refusal|12|||
146866355|NCT00041067|529682787|FG000|Overall Study|Other reasons|23|||
146866356|NCT00041067|529682787|FG000|Overall Study|Ineligible|2|||
146866357|NCT00778622|529682788|FG000|Overall Study|Adverse Event|5|||
146866358|NCT00778622|529682789|FG001|Overall Study|Adverse Event|4|||
146866359|NCT00778622|529682790|FG002|Overall Study|Adverse Event|7|||
146866360|NCT00778622|529682788|FG000|Overall Study|Withdrawal by Subject|4|||
146866361|NCT00778622|529682789|FG001|Overall Study|Withdrawal by Subject|5|||
146866362|NCT00778622|529682790|FG002|Overall Study|Withdrawal by Subject|5|||
146866363|NCT00778622|529682788|FG000|Overall Study|Lost to Follow-up|3|||
146866364|NCT00778622|529682789|FG001|Overall Study|Lost to Follow-up|3|||
146866365|NCT00778622|529682790|FG002|Overall Study|Lost to Follow-up|2|||
146866366|NCT00778622|529682788|FG000|Overall Study|Protocol Violation|0|||
146866367|NCT00778622|529682789|FG001|Overall Study|Protocol Violation|3|||
146866368|NCT00778622|529682790|FG002|Overall Study|Protocol Violation|0|||
146866369|NCT00778622|529682788|FG000|Overall Study|Lack of Efficacy|2|||
146866370|NCT00778622|529682789|FG001|Overall Study|Lack of Efficacy|0|||
146866371|NCT00778622|529682790|FG002|Overall Study|Lack of Efficacy|0|||
146866372|NCT00778622|529682788|FG000|Overall Study|immigration|1|||
146866373|NCT00778622|529682789|FG001|Overall Study|immigration|0|||
146866374|NCT00778622|529682790|FG002|Overall Study|immigration|0|||
146866375|NCT00778622|529682788|FG000|Overall Study|Other|1|||
146866376|NCT00778622|529682789|FG001|Overall Study|Other|0|||
146866377|NCT00778622|529682790|FG002|Overall Study|Other|1|||
146866378|NCT01968070|529682791|FG000|Period 1|Withdrawal by Subject|0|||
146866379|NCT01968070|529682792|FG001|Period 1|Withdrawal by Subject|1|||
146866380|NCT01968070|529682793|FG002|Period 1|Withdrawal by Subject|0|||
146866381|NCT01968070|529682794|FG003|Period 1|Withdrawal by Subject|0|||
146866382|NCT01968070|529682795|FG004|Period 1|Withdrawal by Subject|0|||
146866383|NCT01968070|529682796|FG005|Period 1|Withdrawal by Subject|0|||
146866384|NCT01968070|529682797|FG006|Period 1|Withdrawal by Subject|1|||
146866385|NCT01968070|529682798|FG007|Period 1|Withdrawal by Subject|0|||
146866386|NCT01968070|529682799|FG008|Period 1|Withdrawal by Subject|0|||
146866387|NCT01968070|529682800|FG009|Period 1|Withdrawal by Subject|0|||
146866388|NCT01968070|529682801|FG010|Period 1|Withdrawal by Subject|0|||
146866389|NCT01968070|529682802|FG011|Period 1|Withdrawal by Subject|0|||
146866390|NCT01968070|529682803|FG012|Period 1|Withdrawal by Subject|0|||
146866391|NCT01968070|529682804|FG013|Period 1|Withdrawal by Subject|0|||
146866392|NCT01968070|529682805|FG014|Period 1|Withdrawal by Subject|0|||
146866393|NCT01968070|529682806|FG015|Period 1|Withdrawal by Subject|1|||
146866394|NCT01968070|529682807|FG016|Period 1|Withdrawal by Subject|0|||
146866395|NCT01968070|529682808|FG017|Period 1|Withdrawal by Subject|0|||
146866396|NCT01968070|529682791|FG000|Period 1|Protocol Violation|0|||
146866397|NCT01968070|529682792|FG001|Period 1|Protocol Violation|0|||
146866398|NCT01968070|529682793|FG002|Period 1|Protocol Violation|0|||
146866399|NCT01968070|529682794|FG003|Period 1|Protocol Violation|1|||
146866400|NCT01968070|529682795|FG004|Period 1|Protocol Violation|1|||
146866401|NCT01968070|529682796|FG005|Period 1|Protocol Violation|0|||
146866402|NCT01968070|529682797|FG006|Period 1|Protocol Violation|0|||
146866403|NCT01968070|529682798|FG007|Period 1|Protocol Violation|0|||
146866404|NCT01968070|529682799|FG008|Period 1|Protocol Violation|0|||
146866405|NCT01968070|529682800|FG009|Period 1|Protocol Violation|0|||
146866406|NCT01968070|529682801|FG010|Period 1|Protocol Violation|0|||
146866407|NCT01968070|529682802|FG011|Period 1|Protocol Violation|0|||
146866408|NCT01968070|529682803|FG012|Period 1|Protocol Violation|0|||
146866409|NCT01968070|529682804|FG013|Period 1|Protocol Violation|0|||
146866410|NCT01968070|529682805|FG014|Period 1|Protocol Violation|0|||
146533115|NCT03176771|528462739|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
146533116|NCT03176771|528462735|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
146533117|NCT03176771|528462736|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
146533118|NCT03176771|528462737|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
146533119|NCT03176771|528462738|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
146533120|NCT03176771|528462739|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
146533121|NCT03176771|528462735|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
146533122|NCT03176771|528462736|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
146533123|NCT03176771|528462737|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
146533124|NCT03176771|528462738|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
146533125|NCT03176771|528462739|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
146533126|NCT03176771|528462735|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
146533127|NCT03176771|528462736|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
146533128|NCT03176771|528462737|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
146533129|NCT03176771|528462738|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
146533130|NCT03176771|528462739|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
146533131|NCT03176771|528462735|FG000|Double-Blind Extension Period|Adverse Event|0|||
146533132|NCT03176771|528462736|FG001|Double-Blind Extension Period|Adverse Event|0|||
146533133|NCT03176771|528462737|FG002|Double-Blind Extension Period|Adverse Event|0|||
146533134|NCT03176771|528462738|FG003|Double-Blind Extension Period|Adverse Event|15|||
146533135|NCT03176771|528462739|FG004|Double-Blind Extension Period|Adverse Event|18|||
146533136|NCT03176771|528462735|FG000|Double-Blind Extension Period|Death|0|||
146533137|NCT03176771|528462736|FG001|Double-Blind Extension Period|Death|0|||
146533138|NCT03176771|528462737|FG002|Double-Blind Extension Period|Death|0|||
146533139|NCT03176771|528462738|FG003|Double-Blind Extension Period|Death|3|||
146533140|NCT03176771|528462739|FG004|Double-Blind Extension Period|Death|4|||
146533141|NCT03176771|528462735|FG000|Double-Blind Extension Period|Physician Decision|0|||
146533142|NCT03176771|528462736|FG001|Double-Blind Extension Period|Physician Decision|0|||
146533143|NCT03176771|528462737|FG002|Double-Blind Extension Period|Physician Decision|0|||
146533144|NCT03176771|528462738|FG003|Double-Blind Extension Period|Physician Decision|3|||
146533145|NCT03176771|528462739|FG004|Double-Blind Extension Period|Physician Decision|1|||
146533146|NCT03176771|528462735|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
146533147|NCT03176771|528462736|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
146533148|NCT03176771|528462737|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
146533149|NCT03176771|528462738|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
146533150|NCT03176771|528462739|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
146533151|NCT02251275|528462740|FG000|Overall Study|Adverse Event|23|||
146533152|NCT02251275|528462741|FG001|Overall Study|Adverse Event|60|||
146533153|NCT02251275|528462742|FG002|Overall Study|Adverse Event|28|||
146533154|NCT02251275|528462743|FG003|Overall Study|Adverse Event|0|||
146533155|NCT02251275|528462744|FG004|Overall Study|Adverse Event|0|||
146533156|NCT02251275|528462740|FG000|Overall Study|Lost to Follow-up|5|||
146533157|NCT02251275|528462741|FG001|Overall Study|Lost to Follow-up|6|||
146533158|NCT02251275|528462742|FG002|Overall Study|Lost to Follow-up|4|||
146533159|NCT02251275|528462743|FG003|Overall Study|Lost to Follow-up|0|||
146533160|NCT02251275|528462744|FG004|Overall Study|Lost to Follow-up|0|||
146533161|NCT02251275|528462740|FG000|Overall Study|Physician Decision|19|||
146533162|NCT02251275|528462741|FG001|Overall Study|Physician Decision|30|||
146533163|NCT02251275|528462742|FG002|Overall Study|Physician Decision|26|||
146533164|NCT02251275|528462743|FG003|Overall Study|Physician Decision|0|||
146533165|NCT02251275|528462744|FG004|Overall Study|Physician Decision|1|||
146533166|NCT02251275|528462740|FG000|Overall Study|Protocol Deviation|0|||
146533167|NCT02251275|528462741|FG001|Overall Study|Protocol Deviation|0|||
146533168|NCT02251275|528462742|FG002|Overall Study|Protocol Deviation|1|||
146533169|NCT02251275|528462743|FG003|Overall Study|Protocol Deviation|0|||
146533170|NCT02251275|528462744|FG004|Overall Study|Protocol Deviation|0|||
146533171|NCT02251275|528462740|FG000|Overall Study|Withdrawal by Subject|25|||
146533172|NCT02251275|528462741|FG001|Overall Study|Withdrawal by Subject|51|||
146533173|NCT02251275|528462742|FG002|Overall Study|Withdrawal by Subject|35|||
146533174|NCT02251275|528462743|FG003|Overall Study|Withdrawal by Subject|1|||
146533175|NCT02251275|528462744|FG004|Overall Study|Withdrawal by Subject|0|||
146763183|NCT00591838|529299434|FG004|Overall Study|Withdrawal by Subject|0|||
146533176|NCT02265510|528462746|FG000|Overall Study|Withdrawal by Subject|1|||
146533177|NCT02265510|528462747|FG001|Overall Study|Withdrawal by Subject|1|||
146763184|NCT03586167|529299435|FG000|Overall Study|Other|1|||
146763185|NCT03586167|529299436|FG001|Overall Study|Other|0|||
146763186|NCT02982213|529299437|FG000|Overall Study|Did not complete follow up questionnaire|5|||
146763187|NCT02982213|529299438|FG001|Overall Study|Did not complete follow up questionnaire|1|||
146763188|NCT02512042|529299440|FG000|Overall Study|Adverse Event|0|||
146763189|NCT02512042|529299441|FG001|Overall Study|Adverse Event|4|||
146763190|NCT02512042|529299440|FG000|Overall Study|Withdrawal by Subject|6|||
146866411|NCT01968070|529682806|FG015|Period 1|Protocol Violation|0|||
146866412|NCT01968070|529682807|FG016|Period 1|Protocol Violation|0|||
146866413|NCT01968070|529682808|FG017|Period 1|Protocol Violation|0|||
146866414|NCT01968070|529682791|FG000|Period 1|Lost to Follow-up|0|||
146866415|NCT01968070|529682792|FG001|Period 1|Lost to Follow-up|0|||
146866416|NCT01968070|529682793|FG002|Period 1|Lost to Follow-up|0|||
146866417|NCT01968070|529682794|FG003|Period 1|Lost to Follow-up|1|||
146866418|NCT01968070|529682795|FG004|Period 1|Lost to Follow-up|0|||
146866419|NCT01968070|529682796|FG005|Period 1|Lost to Follow-up|0|||
146533178|NCT02265510|528462748|FG002|Overall Study|Withdrawal by Subject|2|||
146533179|NCT02265510|528462749|FG003|Overall Study|Withdrawal by Subject|1|||
146533180|NCT02265510|528462750|FG004|Overall Study|Withdrawal by Subject|0|||
146533181|NCT02265510|528462751|FG005|Overall Study|Withdrawal by Subject|2|||
146533182|NCT02265510|528462752|FG006|Overall Study|Withdrawal by Subject|0|||
146533183|NCT02265510|528462753|FG007|Overall Study|Withdrawal by Subject|2|||
146533184|NCT02265510|528462754|FG008|Overall Study|Withdrawal by Subject|0|||
146533185|NCT02265510|528462755|FG009|Overall Study|Withdrawal by Subject|0|||
146533186|NCT02265510|528462756|FG010|Overall Study|Withdrawal by Subject|0|||
146533187|NCT02265510|528462757|FG011|Overall Study|Withdrawal by Subject|0|||
146533188|NCT02265510|528462758|FG012|Overall Study|Withdrawal by Subject|1|||
146533189|NCT02265510|528462759|FG013|Overall Study|Withdrawal by Subject|0|||
146533190|NCT02265510|528462746|FG000|Overall Study|Disease Progression|0|||
146533191|NCT02265510|528462747|FG001|Overall Study|Disease Progression|1|||
146533192|NCT02265510|528462748|FG002|Overall Study|Disease Progression|2|||
146533193|NCT02265510|528462749|FG003|Overall Study|Disease Progression|1|||
146533194|NCT02265510|528462750|FG004|Overall Study|Disease Progression|1|||
146533195|NCT02265510|528462751|FG005|Overall Study|Disease Progression|0|||
146533196|NCT02265510|528462752|FG006|Overall Study|Disease Progression|0|||
146533197|NCT02265510|528462753|FG007|Overall Study|Disease Progression|0|||
146533198|NCT02265510|528462754|FG008|Overall Study|Disease Progression|0|||
146533199|NCT02265510|528462755|FG009|Overall Study|Disease Progression|0|||
146533200|NCT02265510|528462756|FG010|Overall Study|Disease Progression|0|||
146533201|NCT02265510|528462757|FG011|Overall Study|Disease Progression|0|||
146533202|NCT02265510|528462758|FG012|Overall Study|Disease Progression|0|||
146533203|NCT02265510|528462759|FG013|Overall Study|Disease Progression|0|||
146533204|NCT02265510|528462746|FG000|Overall Study|Death|2|||
146533205|NCT02265510|528462747|FG001|Overall Study|Death|0|||
146533206|NCT02265510|528462748|FG002|Overall Study|Death|2|||
146533207|NCT02265510|528462749|FG003|Overall Study|Death|2|||
146533208|NCT02265510|528462750|FG004|Overall Study|Death|1|||
146533209|NCT02265510|528462751|FG005|Overall Study|Death|3|||
146533210|NCT02265510|528462752|FG006|Overall Study|Death|2|||
146533211|NCT02265510|528462753|FG007|Overall Study|Death|1|||
146533212|NCT02265510|528462754|FG008|Overall Study|Death|3|||
146533213|NCT02265510|528462755|FG009|Overall Study|Death|3|||
146533214|NCT02265510|528462756|FG010|Overall Study|Death|4|||
146533215|NCT02265510|528462757|FG011|Overall Study|Death|12|||
146533216|NCT02265510|528462758|FG012|Overall Study|Death|7|||
146533217|NCT02265510|528462759|FG013|Overall Study|Death|6|||
146533218|NCT02265510|528462746|FG000|Overall Study|Lost to Follow-up|0|||
146533219|NCT02265510|528462747|FG001|Overall Study|Lost to Follow-up|0|||
146533220|NCT02265510|528462748|FG002|Overall Study|Lost to Follow-up|0|||
146533221|NCT02265510|528462749|FG003|Overall Study|Lost to Follow-up|0|||
146533222|NCT02265510|528462750|FG004|Overall Study|Lost to Follow-up|1|||
146533223|NCT02265510|528462751|FG005|Overall Study|Lost to Follow-up|0|||
146533224|NCT02265510|528462752|FG006|Overall Study|Lost to Follow-up|0|||
146533225|NCT02265510|528462753|FG007|Overall Study|Lost to Follow-up|0|||
146533226|NCT02265510|528462754|FG008|Overall Study|Lost to Follow-up|0|||
146533227|NCT02265510|528462755|FG009|Overall Study|Lost to Follow-up|2|||
146533228|NCT02265510|528462756|FG010|Overall Study|Lost to Follow-up|0|||
146533229|NCT02265510|528462757|FG011|Overall Study|Lost to Follow-up|0|||
146533230|NCT02265510|528462758|FG012|Overall Study|Lost to Follow-up|0|||
146533231|NCT02265510|528462759|FG013|Overall Study|Lost to Follow-up|2|||
146533232|NCT02265510|528462746|FG000|Overall Study|Other|0|||
146866420|NCT01968070|529682797|FG006|Period 1|Lost to Follow-up|0|||
146866421|NCT01968070|529682798|FG007|Period 1|Lost to Follow-up|0|||
146866422|NCT01968070|529682799|FG008|Period 1|Lost to Follow-up|0|||
146866423|NCT01968070|529682800|FG009|Period 1|Lost to Follow-up|0|||
146533233|NCT02265510|528462747|FG001|Overall Study|Other|1|||
146533234|NCT02265510|528462748|FG002|Overall Study|Other|0|||
146533235|NCT02265510|528462749|FG003|Overall Study|Other|0|||
146533236|NCT02265510|528462750|FG004|Overall Study|Other|0|||
146533237|NCT02265510|528462751|FG005|Overall Study|Other|0|||
146533238|NCT02265510|528462752|FG006|Overall Study|Other|0|||
146533239|NCT02265510|528462753|FG007|Overall Study|Other|0|||
146533240|NCT02265510|528462754|FG008|Overall Study|Other|0|||
146533241|NCT02265510|528462755|FG009|Overall Study|Other|0|||
146533242|NCT02265510|528462756|FG010|Overall Study|Other|0|||
146533243|NCT02265510|528462757|FG011|Overall Study|Other|0|||
146533244|NCT02265510|528462758|FG012|Overall Study|Other|0|||
146866424|NCT01968070|529682801|FG010|Period 1|Lost to Follow-up|0|||
146866425|NCT01968070|529682802|FG011|Period 1|Lost to Follow-up|0|||
146866426|NCT01968070|529682803|FG012|Period 1|Lost to Follow-up|0|||
146866427|NCT01968070|529682804|FG013|Period 1|Lost to Follow-up|0|||
146866428|NCT01968070|529682805|FG014|Period 1|Lost to Follow-up|0|||
146866429|NCT01968070|529682806|FG015|Period 1|Lost to Follow-up|0|||
146866430|NCT01968070|529682807|FG016|Period 1|Lost to Follow-up|0|||
146866431|NCT01968070|529682808|FG017|Period 1|Lost to Follow-up|0|||
146866432|NCT01968070|529682791|FG000|Period 1|Adverse Event|0|||
146866433|NCT01968070|529682792|FG001|Period 1|Adverse Event|0|||
146866434|NCT01968070|529682793|FG002|Period 1|Adverse Event|0|||
146866435|NCT01968070|529682794|FG003|Period 1|Adverse Event|0|||
146866436|NCT01968070|529682795|FG004|Period 1|Adverse Event|0|||
146866437|NCT01968070|529682796|FG005|Period 1|Adverse Event|0|||
146866438|NCT01968070|529682797|FG006|Period 1|Adverse Event|1|||
146866439|NCT01968070|529682798|FG007|Period 1|Adverse Event|0|||
146866440|NCT01968070|529682799|FG008|Period 1|Adverse Event|0|||
146866441|NCT01968070|529682800|FG009|Period 1|Adverse Event|0|||
146866442|NCT01968070|529682801|FG010|Period 1|Adverse Event|0|||
146866443|NCT01968070|529682802|FG011|Period 1|Adverse Event|0|||
146866444|NCT01968070|529682803|FG012|Period 1|Adverse Event|0|||
146866445|NCT01968070|529682804|FG013|Period 1|Adverse Event|0|||
146866446|NCT01968070|529682805|FG014|Period 1|Adverse Event|0|||
146866447|NCT01968070|529682806|FG015|Period 1|Adverse Event|0|||
146866448|NCT01968070|529682807|FG016|Period 1|Adverse Event|0|||
146866449|NCT01968070|529682808|FG017|Period 1|Adverse Event|0|||
146866450|NCT01968070|529682791|FG000|Period 1|Physician Decision|0|||
146866451|NCT01968070|529682792|FG001|Period 1|Physician Decision|0|||
146866452|NCT01968070|529682793|FG002|Period 1|Physician Decision|0|||
146866453|NCT01968070|529682794|FG003|Period 1|Physician Decision|0|||
146866454|NCT01968070|529682795|FG004|Period 1|Physician Decision|0|||
146866455|NCT01968070|529682796|FG005|Period 1|Physician Decision|0|||
146866456|NCT01968070|529682797|FG006|Period 1|Physician Decision|0|||
146866457|NCT01968070|529682798|FG007|Period 1|Physician Decision|0|||
146866458|NCT01968070|529682799|FG008|Period 1|Physician Decision|0|||
146866459|NCT01968070|529682800|FG009|Period 1|Physician Decision|0|||
146866460|NCT01968070|529682801|FG010|Period 1|Physician Decision|0|||
146866461|NCT01968070|529682802|FG011|Period 1|Physician Decision|1|||
146866462|NCT01968070|529682803|FG012|Period 1|Physician Decision|0|||
146866463|NCT01968070|529682804|FG013|Period 1|Physician Decision|0|||
146866464|NCT01968070|529682805|FG014|Period 1|Physician Decision|0|||
146866465|NCT01968070|529682806|FG015|Period 1|Physician Decision|0|||
146866466|NCT01968070|529682807|FG016|Period 1|Physician Decision|0|||
146866467|NCT01968070|529682808|FG017|Period 1|Physician Decision|0|||
146866468|NCT01968070|529682791|FG000|Period 2|Withdrawal by Subject|0|||
146533245|NCT02265510|528462759|FG013|Overall Study|Other|0|||
146533246|NCT02265510|528462746|FG000|Overall Study|Study Terminated by Sponsor|0|||
146533247|NCT02265510|528462747|FG001|Overall Study|Study Terminated by Sponsor|0|||
146533248|NCT02265510|528462748|FG002|Overall Study|Study Terminated by Sponsor|0|||
146866469|NCT01968070|529682792|FG001|Period 2|Withdrawal by Subject|0|||
146866470|NCT01968070|529682793|FG002|Period 2|Withdrawal by Subject|0|||
146866471|NCT01968070|529682794|FG003|Period 2|Withdrawal by Subject|0|||
146866472|NCT01968070|529682795|FG004|Period 2|Withdrawal by Subject|1|||
146866473|NCT01968070|529682796|FG005|Period 2|Withdrawal by Subject|0|||
146866474|NCT01968070|529682797|FG006|Period 2|Withdrawal by Subject|0|||
146533249|NCT02265510|528462749|FG003|Overall Study|Study Terminated by Sponsor|0|||
146533250|NCT02265510|528462750|FG004|Overall Study|Study Terminated by Sponsor|0|||
146533251|NCT02265510|528462751|FG005|Overall Study|Study Terminated by Sponsor|1|||
146533252|NCT02265510|528462752|FG006|Overall Study|Study Terminated by Sponsor|1|||
146533253|NCT02265510|528462753|FG007|Overall Study|Study Terminated by Sponsor|1|||
146533254|NCT02265510|528462754|FG008|Overall Study|Study Terminated by Sponsor|1|||
146533255|NCT02265510|528462755|FG009|Overall Study|Study Terminated by Sponsor|2|||
146866475|NCT01968070|529682798|FG007|Period 2|Withdrawal by Subject|0|||
146866476|NCT01968070|529682799|FG008|Period 2|Withdrawal by Subject|0|||
146866477|NCT01968070|529682800|FG009|Period 2|Withdrawal by Subject|0|||
146866478|NCT01968070|529682801|FG010|Period 2|Withdrawal by Subject|0|||
146866479|NCT01968070|529682802|FG011|Period 2|Withdrawal by Subject|0|||
146866480|NCT01968070|529682803|FG012|Period 2|Withdrawal by Subject|0|||
146866481|NCT01968070|529682804|FG013|Period 2|Withdrawal by Subject|0|||
146866482|NCT01968070|529682805|FG014|Period 2|Withdrawal by Subject|0|||
146866483|NCT01968070|529682806|FG015|Period 2|Withdrawal by Subject|0|||
146866484|NCT01968070|529682807|FG016|Period 2|Withdrawal by Subject|0|||
146866485|NCT01968070|529682808|FG017|Period 2|Withdrawal by Subject|0|||
146533256|NCT02265510|528462756|FG010|Overall Study|Study Terminated by Sponsor|1|||
146866486|NCT00890929|529682811|FG000|Overall Study|Death before treatment|2|||
146866487|NCT00890929|529682811|FG000|Overall Study|Withdrawal by Subject|3|||
146866488|NCT00890929|529682811|FG000|Overall Study|Physician Decision|1|||
146866489|NCT00108069|529682812|FG000|Overall Study|Never rec'd study drug|0|||
146866490|NCT00108069|529682813|FG001|Overall Study|Never rec'd study drug|1|||
146866491|NCT00108069|529682812|FG000|Overall Study|Adverse Event|1|||
146866492|NCT00108069|529682813|FG001|Overall Study|Adverse Event|1|||
146866493|NCT00108069|529682812|FG000|Overall Study|Withdrawal by Subject|1|||
146866494|NCT00108069|529682813|FG001|Overall Study|Withdrawal by Subject|0|||
146866495|NCT00108069|529682812|FG000|Overall Study|Death|1|||
146866496|NCT00108069|529682813|FG001|Overall Study|Death|0|||
146866497|NCT00108069|529682812|FG000|Overall Study|Progessive disease|27|||
146866498|NCT00108069|529682813|FG001|Overall Study|Progessive disease|11|||
146866499|NCT02014740|529682814|FG000|Overall Study|Lost to Follow-up|4|||
146866500|NCT02014740|529682815|FG001|Overall Study|Lost to Follow-up|4|||
146533257|NCT02265510|528462757|FG011|Overall Study|Study Terminated by Sponsor|4|||
146533258|NCT02265510|528462758|FG012|Overall Study|Study Terminated by Sponsor|1|||
146533259|NCT02265510|528462759|FG013|Overall Study|Study Terminated by Sponsor|2|||
146533260|NCT01004614|528462760|FG000|Washout|Withdrawal by Subject|0|||
146533261|NCT01004614|528462761|FG001|Washout|Withdrawal by Subject|1|||
146533262|NCT01004614|528462762|FG002|Washout|Withdrawal by Subject|0|||
146533263|NCT01004614|528462763|FG003|Washout|Withdrawal by Subject|0|||
146533264|NCT02530385|528462764|FG000|Overall Study|Withdrawal by Subject|0|||
146533265|NCT02530385|528462765|FG001|Overall Study|Withdrawal by Subject|1|||
146533266|NCT01569022|528462767|FG000|First Intervention|Lost to Follow-up|2|||
146533267|NCT01569022|528462768|FG001|First Intervention|Lost to Follow-up|1|||
146533268|NCT01569022|528462767|FG000|Second Intervention|Lost to Follow-up|2|||
146533269|NCT01569022|528462768|FG001|Second Intervention|Lost to Follow-up|2|||
146533270|NCT02111083|528462773|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
146533271|NCT02111083|528462774|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
146533272|NCT00116142|528462775|FG000|Overall Study|Adverse Event|8|||
146533273|NCT00116142|528462776|FG001|Overall Study|Adverse Event|7|||
146533274|NCT00116142|528462775|FG000|Overall Study|Protocol Violation|2|||
146533275|NCT00116142|528462776|FG001|Overall Study|Protocol Violation|1|||
146533276|NCT00116142|528462775|FG000|Overall Study|Withdrawal by Subject|5|||
146533277|NCT00116142|528462776|FG001|Overall Study|Withdrawal by Subject|5|||
146533278|NCT00116142|528462775|FG000|Overall Study|Physician Decision|3|||
146533279|NCT00116142|528462776|FG001|Overall Study|Physician Decision|1|||
146533280|NCT00116142|528462775|FG000|Overall Study|Delayed Radiation Therapy|1|||
146533281|NCT00116142|528462776|FG001|Overall Study|Delayed Radiation Therapy|0|||
146533282|NCT00116142|528462775|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
146533283|NCT00116142|528462776|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
146533284|NCT00116142|528462775|FG000|Overall Study|Patient stopped due to depression|0|||
146533285|NCT00116142|528462776|FG001|Overall Study|Patient stopped due to depression|1|||
146533286|NCT00116142|528462775|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
146533287|NCT00116142|528462776|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
146533288|NCT00116142|528462775|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
146533289|NCT00116142|528462776|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
146533290|NCT00116142|528462775|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
146533291|NCT00116142|528462776|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
146533292|NCT00644059|528462777|FG000|Overall Study|Lost to Follow-up|37|||
146533293|NCT00644059|528462778|FG001|Overall Study|Lost to Follow-up|34|||
146533294|NCT00644059|528462779|FG002|Overall Study|Lost to Follow-up|16|||
146533295|NCT00644059|528462777|FG000|Overall Study|Withdrawal by Subject|52|||
146533296|NCT00644059|528462778|FG001|Overall Study|Withdrawal by Subject|60|||
146533297|NCT00644059|528462779|FG002|Overall Study|Withdrawal by Subject|30|||
146533298|NCT00644059|528462777|FG000|Overall Study|Adverse Event|8|||
146533299|NCT00644059|528462778|FG001|Overall Study|Adverse Event|5|||
146533300|NCT00644059|528462779|FG002|Overall Study|Adverse Event|1|||
146533301|NCT00644059|528462777|FG000|Overall Study|Inappropriate Enrollment|1|||
146533302|NCT00644059|528462778|FG001|Overall Study|Inappropriate Enrollment|3|||
146533303|NCT00644059|528462779|FG002|Overall Study|Inappropriate Enrollment|0|||
146533304|NCT00644059|528462777|FG000|Overall Study|Protocol Deviation/violation|20|||
146533305|NCT00644059|528462778|FG001|Overall Study|Protocol Deviation/violation|19|||
146533306|NCT00644059|528462779|FG002|Overall Study|Protocol Deviation/violation|15|||
146533307|NCT00644059|528462777|FG000|Overall Study|Unable to classify|6|||
146533308|NCT00644059|528462778|FG001|Overall Study|Unable to classify|2|||
146533309|NCT00644059|528462779|FG002|Overall Study|Unable to classify|3|||
146533310|NCT02152007|528462780|FG000|Overall Study|Withdrawal by Subject|1|||
146533311|NCT01302899|528462785|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
146533312|NCT01302899|528462786|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
146533313|NCT01302899|528462785|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
146533314|NCT01302899|528462786|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
146866501|NCT02014740|529682814|FG000|Overall Study|Withdrawal by Subject|2|||
146533315|NCT02497469|528462787|FG000|Overall Study|Randomized but not Treated|0|||
146533316|NCT02497469|528462788|FG001|Overall Study|Randomized but not Treated|2|||
146533317|NCT02497469|528462787|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
146533318|NCT02497469|528462788|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
146533319|NCT02497469|528462787|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
146533320|NCT02497469|528462788|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
146533321|NCT02497469|528462787|FG000|Overall Study|Significant Protocol Deviation|4|||
146533322|NCT02497469|528462788|FG001|Overall Study|Significant Protocol Deviation|5|||
146533323|NCT02497469|528462787|FG000|Overall Study|Lost to Follow-up|14|||
146866502|NCT02014740|529682815|FG001|Overall Study|Withdrawal by Subject|1|||
146866503|NCT02608879|529682816|FG000|Overall Study|Lost to Follow-up|1|||
146866504|NCT02608879|529682817|FG001|Overall Study|Lost to Follow-up|0|||
146866505|NCT02608879|529682818|FG002|Overall Study|Lost to Follow-up|0|||
146866506|NCT02608879|529682816|FG000|Overall Study|Did not meet continuation criteria|0|||
146866507|NCT02608879|529682817|FG001|Overall Study|Did not meet continuation criteria|0|||
146866508|NCT02608879|529682818|FG002|Overall Study|Did not meet continuation criteria|3|||
146866509|NCT03684642|529682819|FG000|Overall Study|Adverse Event|6|||
146866510|NCT03684642|529682820|FG001|Overall Study|Adverse Event|15|||
146866511|NCT03684642|529682821|FG002|Overall Study|Adverse Event|11|||
146866512|NCT03684642|529682819|FG000|Overall Study|Withdrawal by Subject|35|||
146866513|NCT03684642|529682820|FG001|Overall Study|Withdrawal by Subject|53|||
146866514|NCT03684642|529682821|FG002|Overall Study|Withdrawal by Subject|23|||
146866515|NCT03684642|529682819|FG000|Overall Study|Lack of Efficacy|0|||
146866516|NCT03684642|529682820|FG001|Overall Study|Lack of Efficacy|0|||
146533324|NCT02497469|528462788|FG001|Overall Study|Lost to Follow-up|4|||
146533325|NCT02497469|528462787|FG000|Overall Study|Voluntary Withdrawal|39|||
146866517|NCT03684642|529682821|FG002|Overall Study|Lack of Efficacy|1|||
146866518|NCT03684642|529682819|FG000|Overall Study|Poor compliance to protocol|0|||
146866519|NCT03684642|529682820|FG001|Overall Study|Poor compliance to protocol|4|||
146533326|NCT02497469|528462788|FG001|Overall Study|Voluntary Withdrawal|41|||
146533327|NCT02497469|528462787|FG000|Overall Study|Pregnancy|1|||
146533328|NCT02497469|528462788|FG001|Overall Study|Pregnancy|1|||
146533329|NCT02497469|528462787|FG000|Overall Study|Lack of Efficacy|86|||
146533330|NCT02497469|528462788|FG001|Overall Study|Lack of Efficacy|40|||
146533331|NCT02497469|528462787|FG000|Overall Study|Reason not Specified|6|||
146533332|NCT02497469|528462788|FG001|Overall Study|Reason not Specified|6|||
146533333|NCT03558516|528462789|FG000|Overall Study|Protocol Violation|2|||
146533334|NCT03558516|528462790|FG001|Overall Study|Protocol Violation|2|||
146533335|NCT00472420|528462791|FG000|Induction Treatment Period|Physician Decision|9|||
146533336|NCT00472420|528462791|FG000|Induction Treatment Period|Adverse Event|3|||
146533337|NCT00472420|528462791|FG000|Induction Treatment Period|Non-compliance|1|||
146533338|NCT00472420|528462791|FG000|Induction Treatment Period|Death|3|||
146533339|NCT00472420|528462791|FG000|Follow-up Period|Death|5|||
146533340|NCT00472420|528462791|FG000|Follow-up Period|Physician Decision|9|||
146533341|NCT00472420|528462791|FG000|Follow-up Period|Lost to Follow-up|2|||
146533342|NCT00472420|528462791|FG000|Follow-up Period|Protocol Violation|1|||
146533343|NCT01462942|528462796|FG000|Overall Study|Adverse Event|7|||
146533344|NCT01462942|528462797|FG001|Overall Study|Adverse Event|12|||
146533345|NCT01462942|528462798|FG002|Overall Study|Adverse Event|10|||
146533346|NCT01462942|528462799|FG003|Overall Study|Adverse Event|11|||
146533347|NCT01462942|528462800|FG004|Overall Study|Adverse Event|11|||
146533348|NCT01462942|528462796|FG000|Overall Study|Other, including COPD exacerbation|3|||
146533349|NCT01462942|528462797|FG001|Overall Study|Other, including COPD exacerbation|5|||
146533350|NCT01462942|528462798|FG002|Overall Study|Other, including COPD exacerbation|2|||
146533351|NCT01462942|528462799|FG003|Overall Study|Other, including COPD exacerbation|8|||
146533352|NCT01462942|528462800|FG004|Overall Study|Other, including COPD exacerbation|5|||
146533353|NCT01462942|528462796|FG000|Overall Study|Withdrawal by Subject|14|||
146533354|NCT01462942|528462797|FG001|Overall Study|Withdrawal by Subject|10|||
146533355|NCT01462942|528462798|FG002|Overall Study|Withdrawal by Subject|14|||
146533356|NCT01462942|528462799|FG003|Overall Study|Withdrawal by Subject|16|||
146533357|NCT01462942|528462800|FG004|Overall Study|Withdrawal by Subject|19|||
146533358|NCT01462942|528462796|FG000|Overall Study|Lack of Efficacy|6|||
146533359|NCT01462942|528462797|FG001|Overall Study|Lack of Efficacy|0|||
146533360|NCT01462942|528462798|FG002|Overall Study|Lack of Efficacy|4|||
146533361|NCT01462942|528462799|FG003|Overall Study|Lack of Efficacy|5|||
146533362|NCT01462942|528462800|FG004|Overall Study|Lack of Efficacy|3|||
146533363|NCT01462942|528462796|FG000|Overall Study|Lost to Follow-up|0|||
146533364|NCT01462942|528462797|FG001|Overall Study|Lost to Follow-up|1|||
146533365|NCT01462942|528462798|FG002|Overall Study|Lost to Follow-up|1|||
146533366|NCT01462942|528462799|FG003|Overall Study|Lost to Follow-up|1|||
146533367|NCT01462942|528462800|FG004|Overall Study|Lost to Follow-up|1|||
146533368|NCT01462942|528462796|FG000|Overall Study|Protocol Violation|4|||
146866520|NCT03684642|529682821|FG002|Overall Study|Poor compliance to protocol|1|||
146866521|NCT03684642|529682819|FG000|Overall Study|Other than specified|62|||
146866522|NCT03684642|529682820|FG001|Overall Study|Other than specified|60|||
146866523|NCT03684642|529682821|FG002|Overall Study|Other than specified|67|||
146866524|NCT03684642|529682819|FG000|Overall Study|Randomized and not treated|0|||
146866525|NCT03684642|529682820|FG001|Overall Study|Randomized and not treated|0|||
146533369|NCT01462942|528462797|FG001|Overall Study|Protocol Violation|6|||
146866526|NCT03684642|529682821|FG002|Overall Study|Randomized and not treated|1|||
146866527|NCT03684642|529682819|FG000|Overall Study|Missing completion status but alive at last contact|0|||
146866528|NCT03684642|529682820|FG001|Overall Study|Missing completion status but alive at last contact|1|||
146866529|NCT03684642|529682821|FG002|Overall Study|Missing completion status but alive at last contact|2|||
146866530|NCT02742766|529682822|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146533370|NCT01462942|528462798|FG002|Overall Study|Protocol Violation|9|||
146533371|NCT01462942|528462799|FG003|Overall Study|Protocol Violation|9|||
146533372|NCT01462942|528462800|FG004|Overall Study|Protocol Violation|6|||
146533373|NCT02737722|528462803|FG000|Overall Study|Physician Decision|0|||
146866531|NCT02742766|529682823|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866532|NCT02742766|529682824|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866533|NCT02742766|529682825|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866534|NCT02742766|529682826|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866535|NCT02742766|529682827|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866536|NCT02742766|529682828|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866537|NCT02742766|529682829|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866538|NCT02742766|529682830|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866539|NCT02742766|529682831|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866540|NCT02742766|529682832|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866541|NCT02742766|529682833|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866542|NCT02742766|529682834|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866543|NCT02742766|529682835|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
146866544|NCT02742766|529682836|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866545|NCT02742766|529682837|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866546|NCT02742766|529682838|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866547|NCT02742766|529682839|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866548|NCT02742766|529682840|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146866549|NCT02742766|529682822|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
146866550|NCT02742766|529682823|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
146866551|NCT02742766|529682824|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
146866552|NCT02742766|529682825|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
146866553|NCT02742766|529682826|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
146866554|NCT02742766|529682827|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
146866555|NCT02742766|529682828|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
146866556|NCT02742766|529682829|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
146866557|NCT02742766|529682830|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
146866558|NCT02742766|529682831|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
146866559|NCT02742766|529682832|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
146866560|NCT02742766|529682833|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
146866561|NCT02742766|529682834|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
146866562|NCT02742766|529682835|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
146866563|NCT02742766|529682836|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
146866564|NCT02742766|529682837|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
146866565|NCT02742766|529682838|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
146866566|NCT02742766|529682839|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
146866567|NCT02742766|529682840|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
146866568|NCT01840605|529682843|FG000|Overall Study|Adverse Event|0|||
146866569|NCT01840605|529682844|FG001|Overall Study|Adverse Event|1|||
146866570|NCT01840605|529682843|FG000|Overall Study|Physician Decision|2|||
146866571|NCT01840605|529682844|FG001|Overall Study|Physician Decision|1|||
146866572|NCT03739437|529682845|FG000|Overall Study|Lost to Follow-up|2|||
146866573|NCT03739437|529682846|FG001|Overall Study|Lost to Follow-up|5|||
146866574|NCT01351623|529682847|FG000|Overall Study|Protocol Violation|2|||
146866575|NCT01351623|529682847|FG000|Overall Study|Adverse Event|4|||
146866576|NCT01351623|529682847|FG000|Overall Study|Withdrawal by Subject|1|||
146866577|NCT01351623|529682847|FG000|Overall Study|Death|2|||
146866578|NCT01130974|529682849|FG000|Overall Study|Protocol Violation|10|||
146866579|NCT01130974|529682850|FG001|Overall Study|Protocol Violation|10|||
146866580|NCT01130974|529682849|FG000|Overall Study|Withdrawal by Subject|0|||
146533374|NCT02737722|528462804|FG001|Overall Study|Physician Decision|0|||
146533375|NCT02737722|528462805|FG002|Overall Study|Physician Decision|1|||
146533376|NCT02737722|528462806|FG003|Overall Study|Physician Decision|0|||
146533377|NCT02662569|528462807|FG000|Overall Study|Withdrawal by Subject|6|||
146533378|NCT02662569|528462808|FG001|Overall Study|Withdrawal by Subject|1|||
146533379|NCT02662569|528462809|FG002|Overall Study|Withdrawal by Subject|6|||
146533380|NCT02662569|528462810|FG003|Overall Study|Withdrawal by Subject|4|||
146533381|NCT02662569|528462807|FG000|Overall Study|Lost to Follow-up|1|||
146533382|NCT02662569|528462808|FG001|Overall Study|Lost to Follow-up|0|||
146533383|NCT02662569|528462809|FG002|Overall Study|Lost to Follow-up|0|||
146533384|NCT02662569|528462810|FG003|Overall Study|Lost to Follow-up|0|||
146866581|NCT01130974|529682850|FG001|Overall Study|Withdrawal by Subject|1|||
146866582|NCT01130974|529682849|FG000|Overall Study|Ineligibility criteria|5|||
146866583|NCT01130974|529682850|FG001|Overall Study|Ineligibility criteria|2|||
146866584|NCT01395316|529682851|FG000|Overall Study|Lost to Follow-up|2|||
146866585|NCT01395316|529682851|FG000|Overall Study|poor MRI quality|1|||
146866586|NCT03359590|529682852|FG000|First Intervention|Withdrawal by Subject|1|||
146866587|NCT03359590|529682853|FG001|First Intervention|Withdrawal by Subject|1|||
146866588|NCT03359590|529682852|FG000|First Intervention|Protocol Violation|0|||
146533385|NCT02785939|528462818|FG000|Overall Study|Progression|25|||
146533386|NCT02785939|528462819|FG001|Overall Study|Progression|8|||
146533387|NCT02785939|528462818|FG000|Overall Study|Adverse Event|3|||
146533388|NCT02785939|528462819|FG001|Overall Study|Adverse Event|1|||
146866589|NCT03359590|529682853|FG001|First Intervention|Protocol Violation|1|||
146866590|NCT06132425|529682854|FG000|Overall Study|Withdrawal by Subject|3|||
146866591|NCT06132425|529682855|FG001|Overall Study|Withdrawal by Subject|0|||
146533389|NCT02785939|528462818|FG000|Overall Study|Death|1|||
146533390|NCT02785939|528462819|FG001|Overall Study|Death|0|||
146533391|NCT02785939|528462818|FG000|Overall Study|Refusal|1|||
146533392|NCT02785939|528462819|FG001|Overall Study|Refusal|0|||
146533393|NCT02785939|528462818|FG000|Overall Study|Deteriorating health|1|||
146533394|NCT02785939|528462819|FG001|Overall Study|Deteriorating health|0|||
146533395|NCT02785939|528462818|FG000|Overall Study|Not protocol specified|0|||
146533396|NCT02785939|528462819|FG001|Overall Study|Not protocol specified|1|||
146533397|NCT03786380|528462824|FG000|Overall Study|Adverse Event|1|||
146533398|NCT03786380|528462825|FG001|Overall Study|Adverse Event|0|||
146533399|NCT03786380|528462826|FG002|Overall Study|Adverse Event|0|||
146533400|NCT03786380|528462827|FG003|Overall Study|Adverse Event|3|||
146533401|NCT03786380|528462828|FG004|Overall Study|Adverse Event|1|||
146533402|NCT03786380|528462824|FG000|Overall Study|Lack of Efficacy|0|||
146533403|NCT03786380|528462825|FG001|Overall Study|Lack of Efficacy|0|||
146533404|NCT03786380|528462826|FG002|Overall Study|Lack of Efficacy|0|||
146533405|NCT03786380|528462827|FG003|Overall Study|Lack of Efficacy|0|||
146533406|NCT03786380|528462828|FG004|Overall Study|Lack of Efficacy|1|||
146533407|NCT03786380|528462824|FG000|Overall Study|Withdrawal by Subject|1|||
146533408|NCT03786380|528462825|FG001|Overall Study|Withdrawal by Subject|2|||
146533409|NCT03786380|528462826|FG002|Overall Study|Withdrawal by Subject|2|||
146533410|NCT03786380|528462827|FG003|Overall Study|Withdrawal by Subject|1|||
146533411|NCT03786380|528462828|FG004|Overall Study|Withdrawal by Subject|2|||
146533412|NCT03786380|528462824|FG000|Overall Study|Lost to Follow-up|3|||
146533413|NCT03786380|528462825|FG001|Overall Study|Lost to Follow-up|0|||
146533414|NCT03786380|528462826|FG002|Overall Study|Lost to Follow-up|1|||
146533415|NCT03786380|528462827|FG003|Overall Study|Lost to Follow-up|2|||
146533416|NCT03786380|528462828|FG004|Overall Study|Lost to Follow-up|0|||
146533417|NCT03786380|528462824|FG000|Overall Study|Physician Decision|0|||
146533418|NCT03786380|528462825|FG001|Overall Study|Physician Decision|0|||
146533419|NCT03786380|528462826|FG002|Overall Study|Physician Decision|1|||
146533420|NCT03786380|528462827|FG003|Overall Study|Physician Decision|0|||
146533421|NCT03786380|528462828|FG004|Overall Study|Physician Decision|0|||
146533422|NCT03786380|528462824|FG000|Overall Study|Study Terminated by the Sponsor|30|||
146533423|NCT03786380|528462825|FG001|Overall Study|Study Terminated by the Sponsor|20|||
146533424|NCT03786380|528462826|FG002|Overall Study|Study Terminated by the Sponsor|50|||
146533425|NCT03786380|528462827|FG003|Overall Study|Study Terminated by the Sponsor|57|||
146533426|NCT03786380|528462828|FG004|Overall Study|Study Terminated by the Sponsor|23|||
146533427|NCT03786380|528462824|FG000|Overall Study|Reason Not Specified|0|||
146533428|NCT03786380|528462825|FG001|Overall Study|Reason Not Specified|0|||
146533429|NCT03786380|528462826|FG002|Overall Study|Reason Not Specified|0|||
146533430|NCT03786380|528462827|FG003|Overall Study|Reason Not Specified|0|||
146533431|NCT03786380|528462828|FG004|Overall Study|Reason Not Specified|1|||
146533432|NCT00423046|528462833|FG000|Overall Study|Other|340|||
146533433|NCT00423046|528462834|FG001|Overall Study|Other|345|||
146533434|NCT01791595|528462837|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
146533435|NCT01791595|528462838|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
146533436|NCT01791595|528462839|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
146533437|NCT01791595|528462840|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
146533438|NCT01791595|528462841|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
146533439|NCT01791595|528462842|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
146533440|NCT01791595|528462843|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
146533441|NCT01791595|528462837|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
146533442|NCT01791595|528462838|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
146533443|NCT01791595|528462839|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
146533444|NCT01791595|528462840|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
146533445|NCT01791595|528462841|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
146533446|NCT01791595|528462842|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
146533447|NCT01791595|528462843|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
146533448|NCT01791595|528462837|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
146533449|NCT01791595|528462838|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
146533450|NCT01791595|528462839|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
146533451|NCT01791595|528462840|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
146533452|NCT01791595|528462841|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
146533453|NCT01791595|528462842|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
146533454|NCT01791595|528462843|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
146533455|NCT01791595|528462837|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
146533456|NCT01791595|528462838|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
146533457|NCT01791595|528462839|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
146533458|NCT01791595|528462840|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
146533459|NCT01791595|528462841|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
146533460|NCT01791595|528462842|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
146533461|NCT01791595|528462843|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
146866592|NCT06132425|529682854|FG000|Overall Study|Did not follow study instructions|0|||
146866593|NCT06132425|529682855|FG001|Overall Study|Did not follow study instructions|2|||
146866594|NCT06132425|529682854|FG000|Overall Study|Lost to Follow-up|3|||
146866595|NCT06132425|529682855|FG001|Overall Study|Lost to Follow-up|5|||
146866596|NCT06308666|529682856|FG000|Overall Study|Withdrawal by Subject|1|||
146866597|NCT06308666|529682856|FG000|Overall Study|Protocol Violation|2|||
146866598|NCT04376060|529682857|FG000|Overall Study|Physician Decision|1|||
146866599|NCT00977574|529682858|FG000|Overall Study|Never Treated|4|||
146866600|NCT00977574|529682859|FG001|Overall Study|Never Treated|2|||
146866601|NCT00977574|529682860|FG002|Overall Study|Never Treated|4|||
146866602|NCT05460273|529682861|FG000|Overall Study|Death|43|||
146866603|NCT05460273|529682862|FG001|Overall Study|Death|9|||
146866604|NCT05460273|529682861|FG000|Overall Study|Lost to Follow-up|7|||
146866605|NCT05460273|529682862|FG001|Overall Study|Lost to Follow-up|0|||
146866606|NCT05460273|529682861|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
146866607|NCT05460273|529682862|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
146866608|NCT05749952|529682863|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
146866609|NCT06950879|529682864|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
146866610|NCT05586269|529684569|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
146866611|NCT05586269|529684570|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
146866612|NCT05586269|529684571|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
146866613|NCT05586269|529684572|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
146866614|NCT05586269|529684569|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
146866615|NCT05586269|529684570|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
146866616|NCT05586269|529684571|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
146533462|NCT01791595|528462837|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
146533463|NCT01791595|528462838|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
146533464|NCT01791595|528462839|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
146533465|NCT01791595|528462840|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
146533466|NCT01791595|528462841|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
146533467|NCT01791595|528462842|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
146533468|NCT01791595|528462843|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
146533469|NCT01791595|528462837|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
146866617|NCT05586269|529684572|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
146866618|NCT01310803|529684578|FG000|Overall Study|Subject terminated by Sponsor|1|||
146866619|NCT01310803|529684579|FG001|Overall Study|Subject terminated by Sponsor|0|||
146866620|NCT00332839|529684580|FG000|Core (Months 0 - 12)|Administrative problems|1|||
146866621|NCT00332839|529684581|FG001|Core (Months 0 - 12)|Administrative problems|1|||
146866622|NCT00332839|529684580|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
146866623|NCT00332839|529684581|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
146866624|NCT00332839|529684580|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
146866625|NCT00332839|529684581|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
146866626|NCT00332839|529684580|FG000|Core (Months 0 - 12)|Adverse Event|5|||
146866627|NCT00332839|529684581|FG001|Core (Months 0 - 12)|Adverse Event|15|||
146866628|NCT00332839|529684580|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
146866629|NCT00332839|529684581|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
146866630|NCT00332839|529684580|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
146866631|NCT00332839|529684581|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
146866632|NCT00332839|529684580|FG000|Follow-up (Months 12 - 60)|Death|1|||
146866633|NCT00332839|529684581|FG001|Follow-up (Months 12 - 60)|Death|1|||
146866634|NCT03047551|529684585|FG000|Overall Study|Did not receive TAS|1|||
146533470|NCT01791595|528462838|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
146533471|NCT01791595|528462839|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
146866635|NCT03047551|529684586|FG001|Overall Study|Did not receive TAS|0|||
146866636|NCT03047551|529684585|FG000|Overall Study|Physician Decision|1|||
146866637|NCT03047551|529684586|FG001|Overall Study|Physician Decision|0|||
146866638|NCT03047551|529684585|FG000|Overall Study|Withdrawal by Subject|0|||
146866639|NCT03047551|529684586|FG001|Overall Study|Withdrawal by Subject|1|||
146866640|NCT03047551|529684585|FG000|Overall Study|Probe malfunction|0|||
146866641|NCT03047551|529684586|FG001|Overall Study|Probe malfunction|1|||
146866642|NCT03047551|529684585|FG000|Overall Study|Ineligible|0|||
146866643|NCT03047551|529684586|FG001|Overall Study|Ineligible|1|||
146866644|NCT00594516|529684588|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
146866645|NCT00594516|529684589|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
146533472|NCT01791595|528462840|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
146866646|NCT00594516|529684590|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
146866647|NCT00594516|529684588|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
146866648|NCT00594516|529684589|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
146866649|NCT00594516|529684590|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
146866650|NCT00594516|529684588|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
146866651|NCT00594516|529684589|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
146866652|NCT00594516|529684590|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
146866653|NCT00594516|529684588|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
146866654|NCT00594516|529684589|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
146866655|NCT00594516|529684590|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
146866656|NCT00594516|529684588|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
146866657|NCT00594516|529684589|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
146866658|NCT00594516|529684590|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
146866659|NCT00594516|529684588|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
146866660|NCT00594516|529684589|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
146866661|NCT00594516|529684590|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
146866662|NCT00594516|529684588|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
146866663|NCT00594516|529684589|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
146866664|NCT00594516|529684590|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
146866665|NCT00594516|529684588|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
146866666|NCT00594516|529684589|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
146866667|NCT00594516|529684590|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
146866668|NCT00594516|529684588|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
146866669|NCT00594516|529684589|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
146866670|NCT00594516|529684590|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
146866671|NCT02462928|529684591|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
146866672|NCT02462928|529684592|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
146866673|NCT02462928|529684593|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
146866674|NCT02462928|529684591|FG000|Overall Study|Adverse Event|47|||
146866675|NCT02462928|529684592|FG001|Overall Study|Adverse Event|51|||
146866676|NCT02462928|529684593|FG002|Overall Study|Adverse Event|25|||
146866677|NCT02462928|529684591|FG000|Overall Study|Lack of Efficacy|3|||
146866678|NCT02462928|529684592|FG001|Overall Study|Lack of Efficacy|8|||
146866679|NCT02462928|529684593|FG002|Overall Study|Lack of Efficacy|3|||
146866680|NCT02462928|529684591|FG000|Overall Study|Lost to Follow-up|4|||
146866681|NCT02462928|529684592|FG001|Overall Study|Lost to Follow-up|4|||
146866682|NCT02462928|529684593|FG002|Overall Study|Lost to Follow-up|1|||
146866683|NCT02462928|529684591|FG000|Overall Study|Withdrawal by Patient|31|||
146866684|NCT02462928|529684592|FG001|Overall Study|Withdrawal by Patient|21|||
146866685|NCT02462928|529684593|FG002|Overall Study|Withdrawal by Patient|21|||
146866686|NCT02462928|529684591|FG000|Overall Study|Protocol Violation|0|||
146866687|NCT02462928|529684592|FG001|Overall Study|Protocol Violation|1|||
146866688|NCT02462928|529684593|FG002|Overall Study|Protocol Violation|0|||
146866689|NCT02462928|529684591|FG000|Overall Study|Reason not Specified|4|||
146866690|NCT02462928|529684592|FG001|Overall Study|Reason not Specified|6|||
146866691|NCT02462928|529684593|FG002|Overall Study|Reason not Specified|5|||
146866692|NCT01493557|529684594|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
146866693|NCT01493557|529684595|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
146866694|NCT01493557|529684596|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
146866695|NCT01493557|529684594|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
146866696|NCT01493557|529684595|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
146866697|NCT01493557|529684596|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
146866698|NCT01493557|529684594|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
146866699|NCT01493557|529684595|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
146866700|NCT01493557|529684596|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
146866701|NCT01493557|529684594|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
146866702|NCT01493557|529684595|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
146866703|NCT01493557|529684596|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
146866704|NCT01493557|529684594|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
146866705|NCT01493557|529684595|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
146866706|NCT01493557|529684596|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
146866707|NCT01493557|529684594|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
146866708|NCT01493557|529684595|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
146866709|NCT01493557|529684596|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
146866710|NCT01493557|529684594|FG000|Not Randomized to Management Strategies|Early termination|0|||
146866711|NCT01493557|529684595|FG001|Not Randomized to Management Strategies|Early termination|0|||
146866712|NCT01493557|529684596|FG002|Not Randomized to Management Strategies|Early termination|34|||
146866713|NCT01493557|529684594|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
146866714|NCT01493557|529684595|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
146866715|NCT01493557|529684596|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
146866716|NCT01493557|529684594|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
146866717|NCT01493557|529684595|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
146866718|NCT01493557|529684596|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
146533473|NCT01791595|528462841|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
146533474|NCT01791595|528462842|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
146533475|NCT01791595|528462843|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
146533476|NCT01791595|528462837|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
146533477|NCT01791595|528462838|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
146533478|NCT01791595|528462839|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
146533479|NCT01791595|528462840|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
146533480|NCT01791595|528462841|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
146533481|NCT01791595|528462842|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
146533482|NCT01791595|528462843|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
146533483|NCT01791595|528462837|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
146533484|NCT01791595|528462838|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
146533485|NCT01791595|528462839|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
146533486|NCT01791595|528462840|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
146533487|NCT01791595|528462841|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
146533488|NCT01791595|528462842|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
146533489|NCT01791595|528462843|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
146533490|NCT01791595|528462837|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
146533491|NCT01791595|528462838|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
146533492|NCT01791595|528462839|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
146533493|NCT01791595|528462840|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
146533494|NCT01791595|528462841|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
146533495|NCT01791595|528462842|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
146533496|NCT01791595|528462843|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
146533497|NCT01791595|528462837|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
146533498|NCT01791595|528462838|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
146533499|NCT01791595|528462839|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
146533500|NCT01791595|528462840|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
146533501|NCT01791595|528462841|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
146533502|NCT01791595|528462842|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
146533503|NCT01791595|528462843|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
146533504|NCT01791595|528462837|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
146533505|NCT01791595|528462838|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
146533506|NCT01791595|528462839|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
146533507|NCT01791595|528462840|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
146533508|NCT01791595|528462841|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
146533509|NCT01791595|528462842|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
146533510|NCT01791595|528462843|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
146533511|NCT01791595|528462837|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
146533512|NCT01791595|528462838|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
146533513|NCT01791595|528462839|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
146533514|NCT01791595|528462840|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
146533515|NCT01791595|528462841|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
146533516|NCT01791595|528462842|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
146533517|NCT01791595|528462843|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
146533518|NCT01791595|528462837|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
146533519|NCT01791595|528462838|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
146533520|NCT01791595|528462839|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
146533521|NCT01791595|528462840|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
146533522|NCT01791595|528462841|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
146533523|NCT01791595|528462842|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
146533524|NCT01791595|528462843|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
146533525|NCT01791595|528462837|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
146533526|NCT01791595|528462838|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
146533527|NCT01791595|528462839|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
146533528|NCT01791595|528462840|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
146533529|NCT01791595|528462841|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
146866719|NCT01493557|529684594|FG000|Randomized to Management Strategies|Other adverse event|8|||
146866720|NCT01493557|529684595|FG001|Randomized to Management Strategies|Other adverse event|5|||
146866721|NCT01493557|529684596|FG002|Randomized to Management Strategies|Other adverse event|0|||
146866722|NCT01493557|529684594|FG000|Randomized to Management Strategies|Protocol Violation|3|||
146866723|NCT01493557|529684595|FG001|Randomized to Management Strategies|Protocol Violation|0|||
146866724|NCT01493557|529684596|FG002|Randomized to Management Strategies|Protocol Violation|0|||
146866725|NCT01493557|529684594|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
146866726|NCT01493557|529684595|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
146866727|NCT01493557|529684596|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
146866728|NCT01493557|529684594|FG000|Randomized to Management Strategies|Other than stated above|1|||
146533530|NCT01791595|528462842|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
146533531|NCT01791595|528462843|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
146533532|NCT01791595|528462837|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
146533533|NCT01791595|528462838|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
146533534|NCT01791595|528462839|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
146533535|NCT01791595|528462840|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
146533536|NCT01791595|528462841|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
146533537|NCT01791595|528462842|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
146533538|NCT01791595|528462843|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
146533539|NCT01791595|528462837|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
146533540|NCT01791595|528462838|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
146533541|NCT01791595|528462839|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
146533542|NCT01791595|528462840|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
146533543|NCT01791595|528462841|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
146533544|NCT01791595|528462842|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
146533545|NCT01791595|528462843|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
146533546|NCT01791595|528462837|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
146533547|NCT01791595|528462838|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
146533548|NCT01791595|528462839|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
146533549|NCT01791595|528462840|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
146533550|NCT01791595|528462841|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
146533551|NCT01791595|528462842|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
146533552|NCT01791595|528462843|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
146533553|NCT01791595|528462837|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
146533554|NCT01791595|528462838|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
146533555|NCT01791595|528462839|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
146533556|NCT01791595|528462840|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
146533557|NCT01791595|528462841|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
146533558|NCT01791595|528462842|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
146533559|NCT01791595|528462843|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
146533560|NCT03118934|528462844|FG000|Overall Study|Adverse Event|0|||
146533561|NCT03118934|528462845|FG001|Overall Study|Adverse Event|0|||
146533562|NCT03118934|528462846|FG002|Overall Study|Adverse Event|0|||
146533563|NCT03118934|528462847|FG003|Overall Study|Adverse Event|0|||
146533564|NCT03118934|528462848|FG004|Overall Study|Adverse Event|0|||
146533565|NCT03118934|528462849|FG005|Overall Study|Adverse Event|1|||
146533566|NCT03118934|528462844|FG000|Overall Study|Physician Decision|0|||
146533567|NCT03118934|528462845|FG001|Overall Study|Physician Decision|0|||
146533568|NCT03118934|528462846|FG002|Overall Study|Physician Decision|0|||
146533569|NCT03118934|528462847|FG003|Overall Study|Physician Decision|0|||
146533570|NCT03118934|528462848|FG004|Overall Study|Physician Decision|0|||
146533571|NCT03118934|528462849|FG005|Overall Study|Physician Decision|1|||
146533572|NCT03118934|528462844|FG000|Overall Study|Discontinued prior to exposure|0|||
146533573|NCT03118934|528462845|FG001|Overall Study|Discontinued prior to exposure|1|||
146533574|NCT03118934|528462846|FG002|Overall Study|Discontinued prior to exposure|1|||
146533575|NCT03118934|528462847|FG003|Overall Study|Discontinued prior to exposure|1|||
146533576|NCT03118934|528462848|FG004|Overall Study|Discontinued prior to exposure|2|||
146533577|NCT03118934|528462849|FG005|Overall Study|Discontinued prior to exposure|0|||
146533578|NCT03080935|528462850|FG000|Overall Study|Death|34|||
146533579|NCT03080935|528462851|FG001|Overall Study|Death|50|||
146533580|NCT03080935|528462850|FG000|Overall Study|Lost to Follow-up|5|||
146533581|NCT03080935|528462851|FG001|Overall Study|Lost to Follow-up|4|||
146533582|NCT03080935|528462850|FG000|Overall Study|Withdrawal by Subject|11|||
146533583|NCT03080935|528462851|FG001|Overall Study|Withdrawal by Subject|15|||
146533584|NCT02175121|528462853|FG000|Overall Study|Lack of Efficacy|1|||
146533585|NCT02175121|528462854|FG001|Overall Study|Lack of Efficacy|0|||
146533586|NCT02175121|528462855|FG002|Overall Study|Lack of Efficacy|0|||
146533587|NCT02175121|528462856|FG003|Overall Study|Lack of Efficacy|0|||
146533588|NCT02175121|528462857|FG004|Overall Study|Lack of Efficacy|0|||
146533589|NCT02175121|528462853|FG000|Overall Study|Lost to Follow-up|0|||
146533590|NCT02175121|528462854|FG001|Overall Study|Lost to Follow-up|1|||
146533591|NCT02175121|528462855|FG002|Overall Study|Lost to Follow-up|0|||
146533592|NCT02175121|528462856|FG003|Overall Study|Lost to Follow-up|1|||
146533593|NCT02175121|528462857|FG004|Overall Study|Lost to Follow-up|0|||
146533594|NCT02175121|528462853|FG000|Overall Study|Personal emergency|0|||
146533595|NCT02175121|528462854|FG001|Overall Study|Personal emergency|0|||
146533596|NCT02175121|528462855|FG002|Overall Study|Personal emergency|0|||
146533597|NCT02175121|528462856|FG003|Overall Study|Personal emergency|0|||
146533598|NCT02175121|528462857|FG004|Overall Study|Personal emergency|1|||
146533599|NCT02175121|528462853|FG000|Overall Study|Schedule conflict|0|||
146533600|NCT02175121|528462854|FG001|Overall Study|Schedule conflict|0|||
146533601|NCT02175121|528462855|FG002|Overall Study|Schedule conflict|1|||
146533602|NCT02175121|528462856|FG003|Overall Study|Schedule conflict|0|||
146533603|NCT02175121|528462857|FG004|Overall Study|Schedule conflict|0|||
146533604|NCT02175121|528462853|FG000|Overall Study|Time issues|0|||
146533605|NCT02175121|528462854|FG001|Overall Study|Time issues|0|||
146533606|NCT02175121|528462855|FG002|Overall Study|Time issues|1|||
146533607|NCT02175121|528462856|FG003|Overall Study|Time issues|0|||
146533608|NCT02175121|528462857|FG004|Overall Study|Time issues|0|||
146533609|NCT02027025|528462862|FG000|Overall Study|Adverse Event|0|||
146533610|NCT02027025|528462863|FG001|Overall Study|Adverse Event|1|||
146533611|NCT02027025|528462864|FG002|Overall Study|Adverse Event|1|||
146533612|NCT02027025|528462862|FG000|Overall Study|Protocol Violation|1|||
146533613|NCT02027025|528462863|FG001|Overall Study|Protocol Violation|0|||
146533614|NCT02027025|528462864|FG002|Overall Study|Protocol Violation|0|||
146533615|NCT02027025|528462862|FG000|Overall Study|Lost to Follow-up|0|||
146533616|NCT02027025|528462863|FG001|Overall Study|Lost to Follow-up|2|||
146533617|NCT02027025|528462864|FG002|Overall Study|Lost to Follow-up|0|||
146533618|NCT02027025|528462862|FG000|Overall Study|Withdrawal by Subject|0|||
146533619|NCT02027025|528462863|FG001|Overall Study|Withdrawal by Subject|1|||
146533620|NCT02027025|528462864|FG002|Overall Study|Withdrawal by Subject|0|||
146533621|NCT02027025|528462862|FG000|Overall Study|Sponsor's decision|0|||
146533622|NCT02027025|528462863|FG001|Overall Study|Sponsor's decision|1|||
146533623|NCT02027025|528462864|FG002|Overall Study|Sponsor's decision|0|||
146533624|NCT01118052|528462867|FG000|Overall Study|Never treated|2|||
146533625|NCT02873689|528464578|FG000|Overall Study|Lack of Efficacy|1|||
146533626|NCT02873689|528464579|FG001|Overall Study|Lack of Efficacy|0|||
146533627|NCT02873689|528464578|FG000|Overall Study|Withdrawal by Subject|2|||
146533628|NCT02873689|528464579|FG001|Overall Study|Withdrawal by Subject|2|||
146533629|NCT02873689|528464578|FG000|Overall Study|Protocol Violation|1|||
146533630|NCT02873689|528464579|FG001|Overall Study|Protocol Violation|0|||
146533631|NCT02873689|528464578|FG000|Overall Study|Adverse Event|2|||
146533632|NCT02873689|528464579|FG001|Overall Study|Adverse Event|2|||
146533633|NCT02873689|528464578|FG000|Overall Study|Randomized but not Treated|1|||
146533634|NCT02873689|528464579|FG001|Overall Study|Randomized but not Treated|1|||
146533635|NCT00350545|528464580|FG000|Overall Study|Withdrawal by Subject|2|||
146533636|NCT00266708|528464591|FG000|Overall Study|No renal function|1|||
146533637|NCT00266708|528464592|FG001|Overall Study|No renal function|1|||
146533638|NCT00266708|528464591|FG000|Overall Study|Refused biopsy|3|||
146533639|NCT00266708|528464592|FG001|Overall Study|Refused biopsy|6|||
146533640|NCT00266708|528464591|FG000|Overall Study|Asthma|0|||
146533641|NCT00266708|528464592|FG001|Overall Study|Asthma|2|||
146533642|NCT02791269|528464593|FG000|Overall Study|Lost to Follow-up|0|||
146533643|NCT02791269|528464594|FG001|Overall Study|Lost to Follow-up|1|||
146533644|NCT02351934|528464595|FG000|Allocation|POD weight<pre-op weight|3|||
146533645|NCT02351934|528464596|FG001|Allocation|POD weight<pre-op weight|0|||
146533646|NCT02351934|528464595|FG000|Allocation|Hypotension preventing administration|2|||
146533647|NCT02351934|528464596|FG001|Allocation|Hypotension preventing administration|0|||
146533648|NCT02351934|528464595|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
146533649|NCT02351934|528464596|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
146533650|NCT02351934|528464595|FG000|Follow-Up|POD weight<pre-op weight|3|||
146533651|NCT02351934|528464596|FG001|Follow-Up|POD weight<pre-op weight|0|||
146533652|NCT02351934|528464595|FG000|Follow-Up|Acute Kidney Injury|1|||
146533653|NCT02351934|528464596|FG001|Follow-Up|Acute Kidney Injury|0|||
146533654|NCT02351934|528464595|FG000|Follow-Up|Early dismissal|3|||
146533655|NCT02351934|528464596|FG001|Follow-Up|Early dismissal|0|||
146533656|NCT02351934|528464595|FG000|Follow-Up|Hypotension|3|||
146533657|NCT02351934|528464596|FG001|Follow-Up|Hypotension|0|||
146533658|NCT02351934|528464595|FG000|Follow-Up|No documentation|2|||
146533659|NCT02351934|528464596|FG001|Follow-Up|No documentation|0|||
146533660|NCT02351934|528464595|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
146533661|NCT02351934|528464596|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
146533662|NCT02351934|528464595|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
146533663|NCT02351934|528464596|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
146533664|NCT02683109|528464597|FG000|Overall Study|Adverse Event|1|||
146533665|NCT02683109|528464598|FG001|Overall Study|Adverse Event|0|||
146533666|NCT00368251|528464599|FG000|Overall Study|SAE, non-fatal|1|||
146533667|NCT00368251|528464600|FG001|Overall Study|SAE, non-fatal|0|||
146533668|NCT00368251|528464601|FG002|Overall Study|SAE, non-fatal|0|||
146533669|NCT00368251|528464599|FG000|Overall Study|AE, non-serious non-fatal|0|||
146866729|NCT01493557|529684595|FG001|Randomized to Management Strategies|Other than stated above|3|||
146533670|NCT00368251|528464600|FG001|Overall Study|AE, non-serious non-fatal|0|||
146533671|NCT00368251|528464601|FG002|Overall Study|AE, non-serious non-fatal|1|||
146533672|NCT01373164|528464603|FG000|Overall Study|Lost to Follow-up|0|||
146533673|NCT01373164|528464604|FG001|Overall Study|Lost to Follow-up|0|||
146533674|NCT01373164|528464605|FG002|Overall Study|Lost to Follow-up|1|||
146533675|NCT01373164|528464606|FG003|Overall Study|Lost to Follow-up|2|||
146866730|NCT01493557|529684596|FG002|Randomized to Management Strategies|Other than stated above|0|||
146866731|NCT01493557|529684594|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
146866732|NCT01493557|529684595|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
146866733|NCT01493557|529684596|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
146866734|NCT01493557|529684594|FG000|Adding the Second Strategy|Other adverse event|1|||
146866735|NCT01493557|529684595|FG001|Adding the Second Strategy|Other adverse event|2|||
146866736|NCT01493557|529684596|FG002|Adding the Second Strategy|Other adverse event|0|||
146866737|NCT01493557|529684594|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
146866738|NCT01493557|529684595|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
146866739|NCT01493557|529684596|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
146866740|NCT03335163|529684603|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
146866741|NCT03335163|529684603|FG000|Overall Study|Withdrawal by Subject|18|||
146866742|NCT02020863|529684605|FG000|Overall Study|Discovery of Metastatic disease|4|||
146866743|NCT02020863|529684605|FG000|Overall Study|Team chose not to place an a line|1|||
146866744|NCT01920594|529684606|FG000|Overall Study|Adverse Event|4|||
146866745|NCT01920594|529684607|FG001|Overall Study|Adverse Event|2|||
146866746|NCT01920594|529684606|FG000|Overall Study|Lost to Follow-up|1|||
146866747|NCT01920594|529684607|FG001|Overall Study|Lost to Follow-up|0|||
146866748|NCT01920594|529684606|FG000|Overall Study|Recovery|2|||
146866749|NCT01920594|529684607|FG001|Overall Study|Recovery|0|||
146866750|NCT01920594|529684606|FG000|Overall Study|Investigator discretion|0|||
146866751|NCT01920594|529684607|FG001|Overall Study|Investigator discretion|1|||
146866752|NCT01448213|529684612|FG000|Overall Study|Lost to Follow-up|12|||
146866753|NCT01448213|529684613|FG001|Overall Study|Lost to Follow-up|10|||
146866754|NCT01448213|529684612|FG000|Overall Study|Adverse Event|4|||
146866755|NCT01448213|529684613|FG001|Overall Study|Adverse Event|10|||
146866756|NCT01448213|529684612|FG000|Overall Study|Protocol Violation|1|||
146866757|NCT01448213|529684613|FG001|Overall Study|Protocol Violation|2|||
146866758|NCT03503513|529684614|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
146866759|NCT03503513|529684614|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
146866760|NCT03503513|529684614|FG000|Overall Study|Physician Decision|3|||
146866761|NCT03503513|529684614|FG000|Overall Study|Withdrawal by Subject|2|||
146866762|NCT03503513|529684614|FG000|Overall Study|Lost to Follow-up|1|||
146866763|NCT00059839|529684620|FG000|Overall Study|Death|1|||
146866764|NCT00059839|529684621|FG001|Overall Study|Death|1|||
146866765|NCT00059839|529684620|FG000|Overall Study|Lack of Efficacy|6|||
146866766|NCT00059839|529684621|FG001|Overall Study|Lack of Efficacy|5|||
146866767|NCT00059839|529684620|FG000|Overall Study|Lost to Follow-up|2|||
146866768|NCT00059839|529684621|FG001|Overall Study|Lost to Follow-up|0|||
146866769|NCT00059839|529684620|FG000|Overall Study|Physician Decision|1|||
146866770|NCT00059839|529684621|FG001|Overall Study|Physician Decision|2|||
146866771|NCT00059839|529684620|FG000|Overall Study|Withdrawal by Subject|1|||
146866772|NCT00059839|529684621|FG001|Overall Study|Withdrawal by Subject|6|||
146866773|NCT00059839|529684620|FG000|Overall Study|Ineligible|1|||
146866774|NCT00059839|529684621|FG001|Overall Study|Ineligible|3|||
146866775|NCT03829241|529684622|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
146866776|NCT03829241|529684623|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
146866777|NCT03829241|529684622|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
146866778|NCT03829241|529684623|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
146866779|NCT03829241|529684622|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
146866780|NCT03829241|529684623|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
146866781|NCT03829241|529684622|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
146866782|NCT03829241|529684623|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
146866783|NCT03829241|529684622|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
146866784|NCT03829241|529684623|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
146866785|NCT03829241|529684622|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
146533676|NCT01373164|528464607|FG004|Overall Study|Lost to Follow-up|0|||
146866786|NCT03829241|529684623|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
146866787|NCT03829241|529684622|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
146866788|NCT03829241|529684623|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
146866789|NCT03829241|529684622|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
146866790|NCT03829241|529684623|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
146866791|NCT03829241|529684622|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
146866792|NCT03829241|529684623|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
146866793|NCT03829241|529684622|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
146866794|NCT03829241|529684623|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
146866795|NCT03829241|529684622|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
146866796|NCT03829241|529684623|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
146866797|NCT03829241|529684622|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
146866798|NCT03829241|529684623|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
146533677|NCT01373164|528464603|FG000|Overall Study|Withdrawal by Subject|0|||
146866799|NCT03829241|529684622|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
146866800|NCT03829241|529684623|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
146866801|NCT03829241|529684622|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
146866802|NCT03829241|529684623|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
146866803|NCT02224599|529684624|FG000|Overall Study|Physician Decision|1|||
146866804|NCT02224599|529684624|FG000|Overall Study|Progression of Disease|1|||
146866805|NCT01330914|529684627|FG000|Overall Study|Withdrawal by Subject|4|||
146866806|NCT01330914|529684627|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
146866807|NCT03974334|529684635|FG000|Overall Study|Lost to Follow-up|1|||
146866808|NCT00931944|529684636|FG000|Overall Study|Adverse Event|4|||
146866809|NCT00931944|529684636|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
146866810|NCT00931944|529684636|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
146866811|NCT00931944|529684636|FG000|Overall Study|Death|28|||
146866812|NCT00931944|529684636|FG000|Overall Study|Other|2|||
146866813|NCT01109173|529684637|FG000|Overall Study|Adverse Event|15|||
146866814|NCT01109173|529684638|FG001|Overall Study|Adverse Event|17|||
146866815|NCT01109173|529684639|FG002|Overall Study|Adverse Event|9|||
146866816|NCT01109173|529684640|FG003|Overall Study|Adverse Event|6|||
146866817|NCT01109173|529684637|FG000|Overall Study|Lost to Follow-up|0|||
146866818|NCT01109173|529684638|FG001|Overall Study|Lost to Follow-up|1|||
146866819|NCT01109173|529684639|FG002|Overall Study|Lost to Follow-up|0|||
146866820|NCT01109173|529684640|FG003|Overall Study|Lost to Follow-up|0|||
146866821|NCT01109173|529684637|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
146866822|NCT01109173|529684638|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
146866823|NCT01109173|529684639|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
146866824|NCT01109173|529684640|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
146866825|NCT01109173|529684637|FG000|Overall Study|Noncompliance|0|||
146866826|NCT01109173|529684638|FG001|Overall Study|Noncompliance|1|||
146866827|NCT01109173|529684639|FG002|Overall Study|Noncompliance|0|||
146866828|NCT01109173|529684640|FG003|Overall Study|Noncompliance|0|||
146866829|NCT01109173|529684637|FG000|Overall Study|Treatment Failure|25|||
146866830|NCT01109173|529684638|FG001|Overall Study|Treatment Failure|32|||
146866831|NCT01109173|529684639|FG002|Overall Study|Treatment Failure|69|||
146866832|NCT01109173|529684640|FG003|Overall Study|Treatment Failure|64|||
146866833|NCT01109173|529684637|FG000|Overall Study|Protocol Violation|4|||
146866834|NCT01109173|529684638|FG001|Overall Study|Protocol Violation|5|||
146866835|NCT01109173|529684639|FG002|Overall Study|Protocol Violation|1|||
146866836|NCT01109173|529684640|FG003|Overall Study|Protocol Violation|2|||
146866837|NCT01109173|529684637|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
146866838|NCT01109173|529684638|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
146866839|NCT01109173|529684639|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
146866840|NCT01109173|529684640|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
146866841|NCT01109173|529684637|FG000|Overall Study|Not Specifiied|5|||
146866842|NCT01109173|529684638|FG001|Overall Study|Not Specifiied|4|||
146866843|NCT01109173|529684639|FG002|Overall Study|Not Specifiied|9|||
146866844|NCT01109173|529684640|FG003|Overall Study|Not Specifiied|14|||
146866845|NCT01132612|529684641|FG000|Overall Study|Death|0|||
146866846|NCT01132612|529684642|FG001|Overall Study|Death|0|||
146866847|NCT01132612|529684643|FG002|Overall Study|Death|1|||
146866848|NCT01132612|529684641|FG000|Overall Study|Protocol deviation|0|||
146866849|NCT01132612|529684642|FG001|Overall Study|Protocol deviation|0|||
146866850|NCT01132612|529684643|FG002|Overall Study|Protocol deviation|3|||
146866851|NCT01132612|529684641|FG000|Overall Study|Lost to Follow-up|2|||
146866852|NCT01132612|529684642|FG001|Overall Study|Lost to Follow-up|2|||
146866853|NCT01132612|529684643|FG002|Overall Study|Lost to Follow-up|7|||
146866854|NCT01132612|529684641|FG000|Overall Study|Adverse Event|5|||
146866855|NCT01132612|529684642|FG001|Overall Study|Adverse Event|2|||
146866856|NCT01132612|529684643|FG002|Overall Study|Adverse Event|15|||
146866857|NCT01132612|529684641|FG000|Overall Study|Withdrawal by Subject|5|||
146866858|NCT01132612|529684642|FG001|Overall Study|Withdrawal by Subject|8|||
146866859|NCT01132612|529684643|FG002|Overall Study|Withdrawal by Subject|19|||
146866860|NCT01132612|529684641|FG000|Overall Study|Administrative problems|5|||
146866861|NCT01132612|529684642|FG001|Overall Study|Administrative problems|1|||
146866862|NCT01132612|529684643|FG002|Overall Study|Administrative problems|52|||
146866863|NCT01132612|529684641|FG000|Overall Study|Lack of Efficacy|23|||
146866864|NCT01132612|529684642|FG001|Overall Study|Lack of Efficacy|22|||
146866865|NCT01132612|529684643|FG002|Overall Study|Lack of Efficacy|73|||
146866866|NCT02252536|529684647|FG000|Overall Study|Lost to Follow-up|5|||
146866867|NCT02252536|529684648|FG001|Overall Study|Lost to Follow-up|3|||
146866868|NCT00006392|529684654|FG000|Overall Study|Ineligible|11|||
146866869|NCT00006392|529684655|FG001|Overall Study|Ineligible|3|||
146866870|NCT00006392|529684656|FG002|Overall Study|Ineligible|5|||
146866871|NCT00006392|529684657|FG003|Overall Study|Ineligible|5|||
146866872|NCT00006392|529684654|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
146866873|NCT00006392|529684655|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
146866874|NCT00006392|529684656|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
146866875|NCT00006392|529684657|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
146866876|NCT01186796|529684658|FG000|Overall Study|Adverse Event|3|||
146866877|NCT01186796|529684659|FG001|Overall Study|Adverse Event|0|||
146866878|NCT01186796|529684658|FG000|Overall Study|Withdrawal by Subject|1|||
146866879|NCT01186796|529684659|FG001|Overall Study|Withdrawal by Subject|1|||
146866880|NCT01186796|529684658|FG000|Overall Study|Protocol Violation|0|||
146866881|NCT01186796|529684659|FG001|Overall Study|Protocol Violation|1|||
146866882|NCT03838198|529684660|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
146866883|NCT03838198|529684661|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
146866884|NCT03838198|529684662|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
146866885|NCT03838198|529684663|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
146866886|NCT03838198|529684660|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
146866887|NCT03838198|529684661|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
146866888|NCT03838198|529684662|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
146866889|NCT03838198|529684663|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
146866890|NCT03606980|529684664|FG000|Overall Study|Lost to Follow-up|3|||
146866891|NCT03606980|529684665|FG001|Overall Study|Lost to Follow-up|2|||
146866892|NCT03606980|529684666|FG002|Overall Study|Lost to Follow-up|3|||
146866893|NCT03606980|529684664|FG000|Overall Study|Withdrawal by Subject|1|||
146866894|NCT03606980|529684665|FG001|Overall Study|Withdrawal by Subject|0|||
146866895|NCT03606980|529684666|FG002|Overall Study|Withdrawal by Subject|4|||
146866896|NCT01294150|529684669|FG000|Overall Study|Physician Decision|2|||
146866897|NCT01294150|529684670|FG001|Overall Study|Physician Decision|2|||
146866898|NCT03675776|529684671|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
146866899|NCT03675776|529684672|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
146866900|NCT03675776|529684673|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
146866901|NCT03675776|529684671|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
146866902|NCT03675776|529684672|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
146866903|NCT03675776|529684673|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
146866904|NCT04513665|529684674|FG000|Overall Study|Adverse Event|2|||
146866905|NCT04513665|529684675|FG001|Overall Study|Adverse Event|0|||
146866906|NCT04513665|529684674|FG000|Overall Study|Lack of Efficacy|14|||
146866907|NCT04513665|529684675|FG001|Overall Study|Lack of Efficacy|0|||
146866908|NCT00999713|529684679|FG000|Overall Study|Physician Decision|2|||
146866909|NCT00999713|529684680|FG001|Overall Study|Physician Decision|0|||
146866910|NCT05390580|529684688|FG000|Overall Study|Physician Decision|3|||
146866911|NCT05390580|529684689|FG001|Overall Study|Physician Decision|2|||
146866912|NCT04014361|529684690|FG000|Period 2|Physician Decision|0|||
146866913|NCT04014361|529684691|FG001|Period 2|Physician Decision|0|||
146866914|NCT04014361|529684692|FG002|Period 2|Physician Decision|0|||
146866915|NCT04014361|529684693|FG003|Period 2|Physician Decision|1|||
146866916|NCT04014361|529684694|FG004|Period 2|Physician Decision|0|||
146866917|NCT04014361|529684695|FG005|Period 2|Physician Decision|0|||
146866918|NCT04014361|529684696|FG006|Period 2|Physician Decision|0|||
146866919|NCT04014361|529684697|FG007|Period 2|Physician Decision|0|||
146866920|NCT01130051|529684699|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
146866921|NCT01130051|529684700|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
146866922|NCT01130051|529684699|FG000|Washout Period of 14 Days|Protocol Violation|1|||
146866923|NCT01130051|529684700|FG001|Washout Period of 14 Days|Protocol Violation|1|||
146866924|NCT01298518|529684706|FG000|Overall Study|Withdrawal by Subject|0|||
146866925|NCT01298518|529684707|FG001|Overall Study|Withdrawal by Subject|0|||
146866926|NCT01298518|529684708|FG002|Overall Study|Withdrawal by Subject|1|||
146866927|NCT03610165|529684709|FG000|Overall Study|Device didn't work|0|||
146866928|NCT03610165|529684710|FG001|Overall Study|Device didn't work|1|||
146866929|NCT02129205|529684711|FG000|Overall Study|Withdrawal by Subject|0|||
146866930|NCT02129205|529684712|FG001|Overall Study|Withdrawal by Subject|0|||
146866931|NCT02129205|529684713|FG002|Overall Study|Withdrawal by Subject|0|||
146866932|NCT02129205|529684714|FG003|Overall Study|Withdrawal by Subject|0|||
146866933|NCT02129205|529684715|FG004|Overall Study|Withdrawal by Subject|1|||
146866934|NCT02129205|529684716|FG005|Overall Study|Withdrawal by Subject|1|||
146866935|NCT02129205|529684717|FG006|Overall Study|Withdrawal by Subject|1|||
146866936|NCT02129205|529684718|FG007|Overall Study|Withdrawal by Subject|0|||
146866937|NCT02129205|529684719|FG008|Overall Study|Withdrawal by Subject|1|||
146866938|NCT02129205|529684720|FG009|Overall Study|Withdrawal by Subject|0|||
146866939|NCT02129205|529684711|FG000|Overall Study|Other|1|||
146866940|NCT02129205|529684712|FG001|Overall Study|Other|0|||
146866941|NCT02129205|529684713|FG002|Overall Study|Other|0|||
146866942|NCT02129205|529684714|FG003|Overall Study|Other|0|||
146866943|NCT02129205|529684715|FG004|Overall Study|Other|2|||
146866944|NCT02129205|529684716|FG005|Overall Study|Other|3|||
146866945|NCT02129205|529684717|FG006|Overall Study|Other|3|||
146866946|NCT02129205|529684718|FG007|Overall Study|Other|2|||
146866947|NCT02129205|529684719|FG008|Overall Study|Other|1|||
146866948|NCT02129205|529684720|FG009|Overall Study|Other|0|||
146866949|NCT04435782|529684724|FG000|Overall Study|Study terminated by sponsor|4|||
146866950|NCT03876171|529685986|FG000|Overall Study|Withdrawal by Subject|3|||
146866951|NCT03876171|529685987|FG001|Overall Study|Withdrawal by Subject|3|||
146866952|NCT03876171|529685986|FG000|Overall Study|Re-arrest|0|||
146866953|NCT03876171|529685987|FG001|Overall Study|Re-arrest|4|||
146866954|NCT02012296|529685988|FG000|Overall Study|Lack of Efficacy|0|||
146866955|NCT02012296|529685989|FG001|Overall Study|Lack of Efficacy|0|||
146866956|NCT02012296|529685990|FG002|Overall Study|Lack of Efficacy|15|||
146866957|NCT02012296|529685988|FG000|Overall Study|Adverse Event|0|||
146866958|NCT02012296|529685989|FG001|Overall Study|Adverse Event|0|||
146866959|NCT02012296|529685990|FG002|Overall Study|Adverse Event|2|||
146866960|NCT02012296|529685988|FG000|Overall Study|Early study closure|0|||
146866961|NCT02012296|529685989|FG001|Overall Study|Early study closure|0|||
146866962|NCT02012296|529685990|FG002|Overall Study|Early study closure|5|||
146866963|NCT02012296|529685988|FG000|Overall Study|Protocol Violation|0|||
146866964|NCT02012296|529685989|FG001|Overall Study|Protocol Violation|1|||
146866965|NCT02012296|529685990|FG002|Overall Study|Protocol Violation|0|||
146866966|NCT01170039|529685993|FG000|Overall Study|Withdrawal by Subject|5|||
146866967|NCT01170039|529685994|FG001|Overall Study|Withdrawal by Subject|3|||
146866968|NCT01170039|529685993|FG000|Overall Study|Lack of funding, drug not available|3|||
146533678|NCT01373164|528464604|FG001|Overall Study|Withdrawal by Subject|1|||
146533679|NCT01373164|528464605|FG002|Overall Study|Withdrawal by Subject|0|||
146533680|NCT01373164|528464606|FG003|Overall Study|Withdrawal by Subject|10|||
146533681|NCT01373164|528464607|FG004|Overall Study|Withdrawal by Subject|2|||
146533682|NCT02669849|528464608|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
146533683|NCT02669849|528464609|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
146533684|NCT02669849|528464610|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
146533685|NCT02669849|528464608|FG000|Overall Study|Lost to Follow-up|1|||
146533686|NCT02669849|528464609|FG001|Overall Study|Lost to Follow-up|0|||
146533687|NCT02669849|528464610|FG002|Overall Study|Lost to Follow-up|3|||
146533688|NCT02669849|528464608|FG000|Overall Study|Death|1|||
146533689|NCT02669849|528464609|FG001|Overall Study|Death|1|||
146533690|NCT02669849|528464610|FG002|Overall Study|Death|2|||
146533691|NCT02669849|528464608|FG000|Overall Study|Study terminated by sponsor|16|||
146533692|NCT02669849|528464609|FG001|Overall Study|Study terminated by sponsor|1|||
146533693|NCT02669849|528464610|FG002|Overall Study|Study terminated by sponsor|14|||
146533694|NCT02669849|528464608|FG000|Overall Study|Other|0|||
146533695|NCT02669849|528464609|FG001|Overall Study|Other|0|||
146533696|NCT02669849|528464610|FG002|Overall Study|Other|2|||
146533697|NCT03408899|528464613|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
146533698|NCT04745351|528464614|FG000|Overall Study|Death|51|||
146533699|NCT04745351|528464615|FG001|Overall Study|Death|25|||
146533700|NCT04745351|528464614|FG000|Overall Study|Lost to Follow-up|9|||
146533701|NCT04745351|528464615|FG001|Overall Study|Lost to Follow-up|3|||
146533702|NCT04745351|528464614|FG000|Overall Study|Randomized but Never Treated|3|||
146533703|NCT04745351|528464615|FG001|Overall Study|Randomized but Never Treated|3|||
146533704|NCT04745351|528464614|FG000|Overall Study|Adverse Event|4|||
146533705|NCT04745351|528464615|FG001|Overall Study|Adverse Event|0|||
146533706|NCT04745351|528464614|FG000|Overall Study|Withdrew Consent|1|||
146533707|NCT04745351|528464615|FG001|Overall Study|Withdrew Consent|2|||
146533708|NCT04745351|528464614|FG000|Overall Study|Investigator's Discretion|2|||
146533709|NCT04745351|528464615|FG001|Overall Study|Investigator's Discretion|0|||
146533710|NCT04745351|528464614|FG000|Overall Study|Protocol Violation|1|||
146533711|NCT04745351|528464615|FG001|Overall Study|Protocol Violation|0|||
146533712|NCT01787552|528464617|FG000|Overall Study|Withdrawal by Subject|2|||
146533713|NCT01787552|528464618|FG001|Overall Study|Withdrawal by Subject|0|||
146533714|NCT01787552|528464619|FG002|Overall Study|Withdrawal by Subject|0|||
146533715|NCT01787552|528464620|FG003|Overall Study|Withdrawal by Subject|4|||
146533716|NCT01787552|528464617|FG000|Overall Study|Physician Decision|2|||
146533717|NCT01787552|528464618|FG001|Overall Study|Physician Decision|2|||
146533718|NCT01787552|528464619|FG002|Overall Study|Physician Decision|1|||
146533719|NCT01787552|528464620|FG003|Overall Study|Physician Decision|2|||
146533720|NCT01787552|528464617|FG000|Overall Study|Death|0|||
146533721|NCT01787552|528464618|FG001|Overall Study|Death|0|||
146533722|NCT01787552|528464619|FG002|Overall Study|Death|0|||
146866969|NCT01170039|529685994|FG001|Overall Study|Lack of funding, drug not available|3|||
146866970|NCT00908583|529685995|FG000|Phase 1|Withdrawal by Subject|1|||
146533723|NCT01787552|528464620|FG003|Overall Study|Death|1|||
146533724|NCT01787552|528464617|FG000|Overall Study|Adverse Event|2|||
146866971|NCT00908583|529685995|FG000|Phase 1|Adverse Event|4|||
146866972|NCT00908583|529685995|FG000|Phase 2|Physician Decision|1|||
146866973|NCT00908583|529685995|FG000|Phase 2|Adverse Event|1|||
146866974|NCT00908583|529685995|FG000|Phase 3|Adverse Event|2|||
146866975|NCT00908583|529685995|FG000|Phase 4|Adverse Event|1|||
146866976|NCT00908583|529685995|FG000|Phase 4|Physician Decision|1|||
146533725|NCT01787552|528464618|FG001|Overall Study|Adverse Event|5|||
146533726|NCT01787552|528464619|FG002|Overall Study|Adverse Event|2|||
146533727|NCT01787552|528464620|FG003|Overall Study|Adverse Event|16|||
146533728|NCT01787552|528464617|FG000|Overall Study|Study terminated by Sponsor|0|||
146866977|NCT00908583|529685995|FG000|Phase 5|Adverse Event|3|||
146533729|NCT01787552|528464618|FG001|Overall Study|Study terminated by Sponsor|0|||
146533730|NCT01787552|528464619|FG002|Overall Study|Study terminated by Sponsor|1|||
146533731|NCT01787552|528464620|FG003|Overall Study|Study terminated by Sponsor|3|||
146533732|NCT01787552|528464617|FG000|Overall Study|Progressive Disease|2|||
146533733|NCT01787552|528464618|FG001|Overall Study|Progressive Disease|2|||
146533734|NCT01787552|528464619|FG002|Overall Study|Progressive Disease|1|||
146533735|NCT01787552|528464620|FG003|Overall Study|Progressive Disease|1|||
146533736|NCT05412134|528464622|FG000|Overall Study|Lost to Follow-up|2|||
146533737|NCT05412134|528464623|FG001|Overall Study|Lost to Follow-up|0|||
146533738|NCT03329885|528464625|FG000|Overall Study|Sponsor discontinued the study early|0|||
146533739|NCT03329885|528464626|FG001|Overall Study|Sponsor discontinued the study early|0|||
146533740|NCT03329885|528464627|FG002|Overall Study|Sponsor discontinued the study early|0|||
146533741|NCT03329885|528464628|FG003|Overall Study|Sponsor discontinued the study early|0|||
146533742|NCT03329885|528464629|FG004|Overall Study|Sponsor discontinued the study early|0|||
146533743|NCT03329885|528464630|FG005|Overall Study|Sponsor discontinued the study early|0|||
146533744|NCT03329885|528464631|FG006|Overall Study|Sponsor discontinued the study early|1|||
146533745|NCT03329885|528464632|FG007|Overall Study|Sponsor discontinued the study early|1|||
146533746|NCT03329885|528464633|FG008|Overall Study|Sponsor discontinued the study early|0|||
146533747|NCT00843492|528464639|FG000|Overall Study|Adverse Event|0|||
146533748|NCT00843492|528464640|FG001|Overall Study|Adverse Event|3|||
146533749|NCT00843492|528464639|FG000|Overall Study|Lost to Follow-up|4|||
146533750|NCT00843492|528464640|FG001|Overall Study|Lost to Follow-up|4|||
146533751|NCT00843492|528464639|FG000|Overall Study|Withdrawal by Subject|0|||
146533752|NCT00843492|528464640|FG001|Overall Study|Withdrawal by Subject|4|||
146533753|NCT00843492|528464639|FG000|Overall Study|Immobilization Stopped|1|||
146533754|NCT00843492|528464640|FG001|Overall Study|Immobilization Stopped|0|||
146533755|NCT00843492|528464639|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
146533756|NCT00843492|528464640|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
146533757|NCT00843492|528464639|FG000|Overall Study|Orthopedic Surgery|0|||
146533758|NCT00843492|528464640|FG001|Overall Study|Orthopedic Surgery|2|||
146533759|NCT00843492|528464639|FG000|Overall Study|Visit Not Performed|1|||
146533760|NCT00843492|528464640|FG001|Overall Study|Visit Not Performed|0|||
146533761|NCT00843492|528464639|FG000|Overall Study|Deep-vein Thrombosis|1|||
146533762|NCT00843492|528464640|FG001|Overall Study|Deep-vein Thrombosis|0|||
146533763|NCT00369343|528464641|FG000|Double-blind Phase|Adverse Event|19|||
146533764|NCT00369343|528464642|FG001|Double-blind Phase|Adverse Event|4|||
146533765|NCT00369343|528464641|FG000|Double-blind Phase|Failed to return|2|||
146533766|NCT00369343|528464642|FG001|Double-blind Phase|Failed to return|0|||
146533767|NCT00369343|528464641|FG000|Double-blind Phase|Lost to Follow-up|9|||
146533768|NCT00369343|528464642|FG001|Double-blind Phase|Lost to Follow-up|2|||
146533769|NCT00369343|528464641|FG000|Double-blind Phase|Protocol Violation|2|||
146533770|NCT00369343|528464642|FG001|Double-blind Phase|Protocol Violation|0|||
146533771|NCT00369343|528464641|FG000|Double-blind Phase|Withdrawal by Subject|8|||
146533772|NCT00369343|528464642|FG001|Double-blind Phase|Withdrawal by Subject|6|||
146533773|NCT00369343|528464641|FG000|Double-blind Phase|Lack of Efficacy|0|||
146533774|NCT00369343|528464642|FG001|Double-blind Phase|Lack of Efficacy|4|||
146533775|NCT00369343|528464641|FG000|Double-blind Phase|Protocol deviation|4|||
146533776|NCT00369343|528464642|FG001|Double-blind Phase|Protocol deviation|0|||
146533777|NCT00369343|528464641|FG000|Open-label Phase|Adverse Event|19|||
146533778|NCT00369343|528464642|FG001|Open-label Phase|Adverse Event|7|||
146533779|NCT00369343|528464641|FG000|Open-label Phase|Failed to return|4|||
146533780|NCT00369343|528464642|FG001|Open-label Phase|Failed to return|0|||
146533781|NCT00369343|528464641|FG000|Open-label Phase|Physician Decision|2|||
146533782|NCT00369343|528464642|FG001|Open-label Phase|Physician Decision|0|||
146533783|NCT00369343|528464641|FG000|Open-label Phase|Lost to Follow-up|5|||
146533784|NCT00369343|528464642|FG001|Open-label Phase|Lost to Follow-up|3|||
146533785|NCT00369343|528464641|FG000|Open-label Phase|inadvertently reported study completers|3|||
146533786|NCT00369343|528464642|FG001|Open-label Phase|inadvertently reported study completers|2|||
146533787|NCT00369343|528464641|FG000|Open-label Phase|Protocol Violation|1|||
146533788|NCT00369343|528464642|FG001|Open-label Phase|Protocol Violation|3|||
146533789|NCT00369343|528464641|FG000|Open-label Phase|Withdrawal by Subject|15|||
146533790|NCT00369343|528464642|FG001|Open-label Phase|Withdrawal by Subject|6|||
146533791|NCT00369343|528464641|FG000|Open-label Phase|Lack of Efficacy|4|||
146533792|NCT00369343|528464642|FG001|Open-label Phase|Lack of Efficacy|3|||
146533793|NCT00369343|528464641|FG000|Open-label Phase|Lack of continuance tolerability|3|||
146533794|NCT00369343|528464642|FG001|Open-label Phase|Lack of continuance tolerability|4|||
146533795|NCT00369343|528464641|FG000|Open-label Phase|did not take study drug|1|||
146533796|NCT00369343|528464642|FG001|Open-label Phase|did not take study drug|2|||
146533797|NCT00794664|528464643|FG000|Treatment Period|Withdrawal by Subject|0|||
146533798|NCT00794664|528464644|FG001|Treatment Period|Withdrawal by Subject|2|||
146533799|NCT00794664|528464643|FG000|Treatment Period|Protocol non-compliance|0|||
146533800|NCT00794664|528464644|FG001|Treatment Period|Protocol non-compliance|1|||
146533801|NCT00794664|528464643|FG000|Treatment Period|Other|0|||
146533802|NCT00794664|528464644|FG001|Treatment Period|Other|1|||
146533803|NCT00794664|528464643|FG000|Treatment Period|Adverse Event|1|||
146533804|NCT00794664|528464644|FG001|Treatment Period|Adverse Event|8|||
146866978|NCT00993954|529685996|FG000|Overall Study|Protocol Violation|21|||
146866979|NCT00993954|529685997|FG001|Overall Study|Protocol Violation|2|||
146866980|NCT00860951|529685998|FG000|Overall Study|Withdrawal by Subject|2|||
146866981|NCT00860951|529685998|FG000|Overall Study|Lost to Follow-up|5|||
146866982|NCT00727649|529685999|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
146866983|NCT00727649|529686000|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
146866984|NCT00727649|529685999|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
146866985|NCT00727649|529686000|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
146866986|NCT00727649|529685999|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
146866987|NCT00727649|529686000|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
146866988|NCT00727649|529685999|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
146866989|NCT00727649|529686000|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
146866990|NCT00727649|529685999|FG000|Second Intervention (4-weeks)|Death|1|||
146533805|NCT00794664|528464643|FG000|Follow-up Period|Other|1|||
146533806|NCT00794664|528464644|FG001|Follow-up Period|Other|2|||
146533807|NCT00794664|528464643|FG000|Follow-up Period|Withdrawal by Subject|0|||
146533808|NCT00794664|528464644|FG001|Follow-up Period|Withdrawal by Subject|2|||
146533809|NCT00794664|528464643|FG000|Follow-up Period|Protocol non-compliance|0|||
146533810|NCT00794664|528464644|FG001|Follow-up Period|Protocol non-compliance|1|||
146533811|NCT00828711|528464648|FG000|Overall Study|Lost to Follow-up|1|||
146533812|NCT00828711|528464649|FG001|Overall Study|Lost to Follow-up|0|||
146533813|NCT00828711|528464650|FG002|Overall Study|Lost to Follow-up|0|||
146533814|NCT01618968|528464651|FG000|Overall Study|Adverse Event|1|||
146533815|NCT01618968|528464652|FG001|Overall Study|Adverse Event|0|||
146533816|NCT01618968|528464653|FG002|Overall Study|Adverse Event|0|||
146533817|NCT01618968|528464654|FG003|Overall Study|Adverse Event|0|||
146533818|NCT01618968|528464651|FG000|Overall Study|Death|0|||
146533819|NCT01618968|528464652|FG001|Overall Study|Death|0|||
146533820|NCT01618968|528464653|FG002|Overall Study|Death|0|||
146533821|NCT01618968|528464654|FG003|Overall Study|Death|1|||
146533822|NCT03883386|528464655|FG000|First Assignment|Lost to Follow-up|1|||
146533823|NCT03883386|528464656|FG001|First Assignment|Lost to Follow-up|0|||
146533824|NCT03883386|528464655|FG000|First Assignment|Withdrawal by Subject|1|||
146533825|NCT03883386|528464656|FG001|First Assignment|Withdrawal by Subject|1|||
146533826|NCT01326871|528464657|FG000|Overall Study|Major surgery|0|||
146533827|NCT01326871|528464658|FG001|Overall Study|Major surgery|1|||
146533828|NCT01326871|528464659|FG002|Overall Study|Major surgery|0|||
146533829|NCT01326871|528464657|FG000|Overall Study|SAE and death|0|||
146533830|NCT01326871|528464658|FG001|Overall Study|SAE and death|2|||
146533831|NCT01326871|528464659|FG002|Overall Study|SAE and death|0|||
146533832|NCT01326871|528464657|FG000|Overall Study|Physician decision and decreased performance status|0|||
146533833|NCT01326871|528464658|FG001|Overall Study|Physician decision and decreased performance status|1|||
146533834|NCT01326871|528464659|FG002|Overall Study|Physician decision and decreased performance status|0|||
146533835|NCT01326871|528464657|FG000|Overall Study|Disease progression|0|||
146533836|NCT01326871|528464658|FG001|Overall Study|Disease progression|11|||
146533837|NCT01326871|528464659|FG002|Overall Study|Disease progression|5|||
146533838|NCT01326871|528464657|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
146533839|NCT01326871|528464658|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
146533840|NCT01326871|528464659|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
146533841|NCT01326871|528464657|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
146533842|NCT01326871|528464658|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
146533843|NCT01326871|528464659|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
146533844|NCT01326871|528464657|FG000|Overall Study|Withdrawal by Subject|0|||
146533845|NCT01326871|528464658|FG001|Overall Study|Withdrawal by Subject|1|||
146533846|NCT01326871|528464659|FG002|Overall Study|Withdrawal by Subject|0|||
146533847|NCT01326871|528464657|FG000|Overall Study|DLT|0|||
146533848|NCT01326871|528464658|FG001|Overall Study|DLT|2|||
146533849|NCT01326871|528464659|FG002|Overall Study|DLT|0|||
146533850|NCT01326871|528464657|FG000|Overall Study|SAE, disease progression and subject decision|0|||
146533851|NCT01326871|528464658|FG001|Overall Study|SAE, disease progression and subject decision|1|||
146533852|NCT01326871|528464659|FG002|Overall Study|SAE, disease progression and subject decision|0|||
146533853|NCT01326871|528464657|FG000|Overall Study|Death|0|||
146533854|NCT01326871|528464658|FG001|Overall Study|Death|1|||
146533855|NCT01326871|528464659|FG002|Overall Study|Death|0|||
146533856|NCT01326871|528464657|FG000|Overall Study|Other|0|||
146533857|NCT01326871|528464658|FG001|Overall Study|Other|3|||
146533858|NCT01326871|528464659|FG002|Overall Study|Other|0|||
146866991|NCT00727649|529686000|FG001|Second Intervention (4-weeks)|Death|0|||
146533859|NCT01326871|528464657|FG000|Overall Study|SAE and disease progression|0|||
146533860|NCT01326871|528464658|FG001|Overall Study|SAE and disease progression|0|||
146533861|NCT01326871|528464659|FG002|Overall Study|SAE and disease progression|1|||
146533862|NCT01326871|528464657|FG000|Overall Study|SAE and physician decision|0|||
146533863|NCT01326871|528464658|FG001|Overall Study|SAE and physician decision|0|||
146533864|NCT01326871|528464659|FG002|Overall Study|SAE and physician decision|1|||
146533865|NCT01326871|528464657|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
146866992|NCT00727649|529685999|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
146866993|NCT00727649|529686000|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
146866994|NCT00727649|529685999|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
146866995|NCT00727649|529686000|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
146866996|NCT02953639|529686003|FG000|Overall Study|Adverse Event|2|||
146866997|NCT02953639|529686004|FG001|Overall Study|Adverse Event|0|||
146866998|NCT02953639|529686005|FG002|Overall Study|Adverse Event|1|||
146866999|NCT02953639|529686003|FG000|Overall Study|Lost to Follow-up|8|||
146867000|NCT02953639|529686004|FG001|Overall Study|Lost to Follow-up|4|||
146867001|NCT02953639|529686005|FG002|Overall Study|Lost to Follow-up|3|||
146867002|NCT02953639|529686003|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146867003|NCT02953639|529686004|FG001|Overall Study|Non-Compliance With Study Drug|2|||
146867004|NCT02953639|529686005|FG002|Overall Study|Non-Compliance With Study Drug|1|||
146867005|NCT02953639|529686003|FG000|Overall Study|Multiple Reasons|1|||
146867006|NCT02953639|529686004|FG001|Overall Study|Multiple Reasons|0|||
146867007|NCT02953639|529686005|FG002|Overall Study|Multiple Reasons|1|||
146867008|NCT02953639|529686003|FG000|Overall Study|Physician Decision|1|||
146867009|NCT02953639|529686004|FG001|Overall Study|Physician Decision|0|||
146867010|NCT02953639|529686005|FG002|Overall Study|Physician Decision|0|||
146867011|NCT02953639|529686003|FG000|Overall Study|Withdrawal by Subject|7|||
146867012|NCT02953639|529686004|FG001|Overall Study|Withdrawal by Subject|8|||
146867013|NCT02953639|529686005|FG002|Overall Study|Withdrawal by Subject|10|||
146867014|NCT02953639|529686003|FG000|Overall Study|Completed or Discontinued information is missing|1|||
146867015|NCT02953639|529686004|FG001|Overall Study|Completed or Discontinued information is missing|0|||
146867016|NCT02953639|529686005|FG002|Overall Study|Completed or Discontinued information is missing|0|||
146867017|NCT01830855|529686006|FG000|Overall Study|Other|7|||
146867018|NCT01830855|529686007|FG001|Overall Study|Other|1|||
146867019|NCT01830855|529686008|FG002|Overall Study|Other|4|||
146867020|NCT01830855|529686009|FG003|Overall Study|Other|4|||
146867021|NCT01830855|529686006|FG000|Overall Study|Medication error without associated AE|1|||
146867022|NCT01830855|529686007|FG001|Overall Study|Medication error without associated AE|0|||
146867023|NCT01830855|529686008|FG002|Overall Study|Medication error without associated AE|0|||
146867024|NCT01830855|529686009|FG003|Overall Study|Medication error without associated AE|1|||
146867025|NCT01830855|529686006|FG000|Overall Study|Pregnancy|3|||
146867026|NCT01830855|529686007|FG001|Overall Study|Pregnancy|1|||
146867027|NCT01830855|529686008|FG002|Overall Study|Pregnancy|2|||
146867028|NCT01830855|529686009|FG003|Overall Study|Pregnancy|1|||
146867029|NCT01830855|529686006|FG000|Overall Study|No longer meets eligibility criteria|11|||
146867030|NCT01830855|529686007|FG001|Overall Study|No longer meets eligibility criteria|2|||
146867031|NCT01830855|529686008|FG002|Overall Study|No longer meets eligibility criteria|3|||
146867032|NCT01830855|529686009|FG003|Overall Study|No longer meets eligibility criteria|5|||
146867033|NCT01830855|529686006|FG000|Overall Study|Adverse Event|11|||
146867034|NCT01830855|529686007|FG001|Overall Study|Adverse Event|5|||
146867035|NCT01830855|529686008|FG002|Overall Study|Adverse Event|6|||
146867036|NCT01830855|529686009|FG003|Overall Study|Adverse Event|3|||
146867037|NCT01830855|529686006|FG000|Overall Study|Protocol deviation|10|||
146867038|NCT01830855|529686007|FG001|Overall Study|Protocol deviation|5|||
146867039|NCT01830855|529686008|FG002|Overall Study|Protocol deviation|6|||
146867040|NCT01830855|529686009|FG003|Overall Study|Protocol deviation|6|||
146867041|NCT01830855|529686006|FG000|Overall Study|Withdrawal by Subject|33|||
146867042|NCT01830855|529686007|FG001|Overall Study|Withdrawal by Subject|14|||
146867043|NCT01830855|529686008|FG002|Overall Study|Withdrawal by Subject|10|||
146867044|NCT01830855|529686009|FG003|Overall Study|Withdrawal by Subject|12|||
146867045|NCT01830855|529686006|FG000|Overall Study|No longer willing to participate|32|||
146867046|NCT01830855|529686007|FG001|Overall Study|No longer willing to participate|13|||
146867047|NCT01830855|529686008|FG002|Overall Study|No longer willing to participate|12|||
146867048|NCT01830855|529686009|FG003|Overall Study|No longer willing to participate|17|||
146533866|NCT01326871|528464658|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
146533867|NCT01326871|528464659|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
146533868|NCT01326871|528464657|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
146533869|NCT01326871|528464658|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
146533870|NCT01326871|528464659|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
146533871|NCT01326871|528464657|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
146867049|NCT01830855|529686006|FG000|Overall Study|Lost to Follow-up|47|||
146533872|NCT01326871|528464658|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
146867050|NCT01830855|529686007|FG001|Overall Study|Lost to Follow-up|20|||
146867051|NCT01830855|529686008|FG002|Overall Study|Lost to Follow-up|23|||
146867052|NCT01830855|529686009|FG003|Overall Study|Lost to Follow-up|33|||
146867053|NCT01667081|529686010|FG000|Overall Study|Death|43|||
146867054|NCT01667081|529686011|FG001|Overall Study|Death|3|||
146867055|NCT01667081|529686010|FG000|Overall Study|Lost to Follow-up|99|||
146867056|NCT01667081|529686011|FG001|Overall Study|Lost to Follow-up|48|||
146867057|NCT01667081|529686010|FG000|Overall Study|Physician Decision|16|||
146867058|NCT01667081|529686011|FG001|Overall Study|Physician Decision|2|||
146867059|NCT01667081|529686010|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
146867060|NCT01667081|529686011|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
146867061|NCT01667081|529686010|FG000|Overall Study|Withdrawal by Subject|90|||
146867062|NCT01667081|529686011|FG001|Overall Study|Withdrawal by Subject|35|||
146867063|NCT03034460|529686012|FG000|Overall Study|Adverse Event|0|||
146867064|NCT03034460|529686013|FG001|Overall Study|Adverse Event|1|||
146867065|NCT03034460|529686012|FG000|Overall Study|Withdrawal by Subject|2|||
146867066|NCT03034460|529686013|FG001|Overall Study|Withdrawal by Subject|2|||
146867067|NCT03034460|529686012|FG000|Overall Study|Personal Reasons|1|||
146867068|NCT03034460|529686013|FG001|Overall Study|Personal Reasons|0|||
146867069|NCT00295633|529686016|FG000|Overall Study|Lack of Efficacy|19|||
146867070|NCT00295633|529686017|FG001|Overall Study|Lack of Efficacy|7|||
146867071|NCT00295633|529686018|FG002|Overall Study|Lack of Efficacy|16|||
146867072|NCT00295633|529686016|FG000|Overall Study|Withdrawal of consent by subject|16|||
146867073|NCT00295633|529686017|FG001|Overall Study|Withdrawal of consent by subject|16|||
146867074|NCT00295633|529686018|FG002|Overall Study|Withdrawal of consent by subject|26|||
146867075|NCT00295633|529686016|FG000|Overall Study|Adverse Event|9|||
146867076|NCT00295633|529686017|FG001|Overall Study|Adverse Event|17|||
146867077|NCT00295633|529686018|FG002|Overall Study|Adverse Event|9|||
146867078|NCT00295633|529686016|FG000|Overall Study|Lost to Follow-up|6|||
146867079|NCT00295633|529686017|FG001|Overall Study|Lost to Follow-up|11|||
146867080|NCT00295633|529686018|FG002|Overall Study|Lost to Follow-up|7|||
146867081|NCT00295633|529686016|FG000|Overall Study|Physician Decision|9|||
146867082|NCT00295633|529686017|FG001|Overall Study|Physician Decision|10|||
146867083|NCT00295633|529686018|FG002|Overall Study|Physician Decision|8|||
146867084|NCT00295633|529686016|FG000|Overall Study|Poor/Noncompliance|2|||
146867085|NCT00295633|529686017|FG001|Overall Study|Poor/Noncompliance|2|||
146867086|NCT00295633|529686018|FG002|Overall Study|Poor/Noncompliance|6|||
146533873|NCT01326871|528464659|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
146533874|NCT01326871|528464657|FG000|Overall Study|Physician Decision|0|||
146533875|NCT01326871|528464658|FG001|Overall Study|Physician Decision|0|||
146533876|NCT01326871|528464659|FG002|Overall Study|Physician Decision|1|||
146533877|NCT01326871|528464657|FG000|Overall Study|SAE|0|||
146533878|NCT01326871|528464658|FG001|Overall Study|SAE|0|||
146533879|NCT01326871|528464659|FG002|Overall Study|SAE|1|||
146533880|NCT01326871|528464657|FG000|Overall Study|Disease progression and death|0|||
146533881|NCT01326871|528464658|FG001|Overall Study|Disease progression and death|0|||
146533882|NCT01326871|528464659|FG002|Overall Study|Disease progression and death|1|||
146533883|NCT01326871|528464657|FG000|Overall Study|Subject decision|0|||
146533884|NCT01326871|528464658|FG001|Overall Study|Subject decision|0|||
146533885|NCT01326871|528464659|FG002|Overall Study|Subject decision|1|||
146533886|NCT00251758|528464661|FG000|Overall Study|Adverse Event|7|||
146533887|NCT00251758|528464662|FG001|Overall Study|Adverse Event|9|||
146533888|NCT00251758|528464663|FG002|Overall Study|Adverse Event|11|||
146533889|NCT00251758|528464661|FG000|Overall Study|Lost to Follow-up|4|||
146533890|NCT00251758|528464662|FG001|Overall Study|Lost to Follow-up|2|||
146533891|NCT00251758|528464663|FG002|Overall Study|Lost to Follow-up|5|||
146533892|NCT00251758|528464661|FG000|Overall Study|Withdrawal by Subject|13|||
146533893|NCT00251758|528464662|FG001|Overall Study|Withdrawal by Subject|7|||
146533894|NCT00251758|528464663|FG002|Overall Study|Withdrawal by Subject|3|||
146533895|NCT00251758|528464661|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
146533896|NCT00251758|528464662|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
146533897|NCT00251758|528464663|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
146533898|NCT00251758|528464661|FG000|Overall Study|Lack of Efficacy|3|||
146533899|NCT00251758|528464662|FG001|Overall Study|Lack of Efficacy|0|||
146533900|NCT00251758|528464663|FG002|Overall Study|Lack of Efficacy|0|||
146533901|NCT00251758|528464661|FG000|Overall Study|Noncompliant|0|||
146533902|NCT00251758|528464662|FG001|Overall Study|Noncompliant|2|||
146533903|NCT00251758|528464663|FG002|Overall Study|Noncompliant|2|||
146533904|NCT00251758|528464661|FG000|Overall Study|Pregnancy|0|||
146533905|NCT00251758|528464662|FG001|Overall Study|Pregnancy|1|||
146533906|NCT00251758|528464663|FG002|Overall Study|Pregnancy|0|||
146533907|NCT00251758|528464661|FG000|Overall Study|Per Subject Request|0|||
146533908|NCT00251758|528464662|FG001|Overall Study|Per Subject Request|0|||
146533909|NCT00251758|528464663|FG002|Overall Study|Per Subject Request|1|||
146533910|NCT00251758|528464661|FG000|Overall Study|Per Investigator Request|1|||
146533911|NCT00251758|528464662|FG001|Overall Study|Per Investigator Request|0|||
146867087|NCT00295633|529686016|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
146867088|NCT00295633|529686017|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
146533912|NCT00251758|528464663|FG002|Overall Study|Per Investigator Request|0|||
146533913|NCT01387269|528464668|FG000|Overall Study|Death|38|||
146533914|NCT01387269|528464669|FG001|Overall Study|Death|20|||
146533915|NCT01387269|528464668|FG000|Overall Study|Other|8|||
146533916|NCT01387269|528464669|FG001|Overall Study|Other|7|||
146867089|NCT00295633|529686018|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
146867090|NCT00295633|529686016|FG000|Overall Study|Death|1|||
146867091|NCT00295633|529686017|FG001|Overall Study|Death|1|||
146867092|NCT00295633|529686018|FG002|Overall Study|Death|0|||
146867093|NCT00295633|529686016|FG000|Overall Study|Administrative reason by sponsor|0|||
146867094|NCT00295633|529686017|FG001|Overall Study|Administrative reason by sponsor|0|||
146867095|NCT00295633|529686018|FG002|Overall Study|Administrative reason by sponsor|1|||
146867096|NCT02294682|529686019|FG000|Overall Study|Could not swallow pills|1|||
146867097|NCT02294682|529686020|FG001|Overall Study|Could not swallow pills|0|||
146867098|NCT01516970|529686021|FG000|Overall Study|Lost to Follow-up|7|||
146867099|NCT01516970|529686022|FG001|Overall Study|Lost to Follow-up|8|||
146533917|NCT01387269|528464668|FG000|Overall Study|Unrelated AE|12|||
146533918|NCT01387269|528464669|FG001|Overall Study|Unrelated AE|3|||
146533919|NCT01387269|528464668|FG000|Overall Study|Withdrawal by patient|32|||
146533920|NCT01387269|528464669|FG001|Overall Study|Withdrawal by patient|10|||
146533921|NCT01387269|528464668|FG000|Overall Study|Study drug-related AE|1|||
146533922|NCT01387269|528464669|FG001|Overall Study|Study drug-related AE|0|||
146533923|NCT01387269|528464668|FG000|Overall Study|Lost to Follow-up|1|||
146533924|NCT01387269|528464669|FG001|Overall Study|Lost to Follow-up|0|||
146533925|NCT01200329|528464670|FG000|Overall Study|Lack of financial coverage|2|||
146533926|NCT01200329|528464670|FG000|Overall Study|Progressive disease|1|||
146533927|NCT03641508|528464673|FG000|First Injection|Lost to Follow-up|2|||
146533928|NCT03641508|528464674|FG001|First Injection|Lost to Follow-up|0|||
146533929|NCT02404545|528464675|FG000|Overall Study|Sponsor Termination|6|||
146533930|NCT02404545|528464676|FG001|Overall Study|Sponsor Termination|6|||
146867100|NCT01516970|529686021|FG000|Overall Study|Adverse Event|1|||
146867101|NCT01516970|529686022|FG001|Overall Study|Adverse Event|5|||
146867102|NCT01516970|529686021|FG000|Overall Study|Withdrawal by Subject|1|||
146867103|NCT01516970|529686022|FG001|Overall Study|Withdrawal by Subject|1|||
146867104|NCT01516970|529686021|FG000|Overall Study|Other|9|||
146867105|NCT01516970|529686022|FG001|Overall Study|Other|7|||
146867106|NCT00434421|529686023|FG000|Overall Study|Withdrawal by Subject|1|||
146867107|NCT00434421|529686023|FG000|Overall Study|Non-compliance with study treatment|1|||
146867108|NCT01205438|529686024|FG000|Overall Study|Adverse Event|19|||
146867109|NCT01205438|529686025|FG001|Overall Study|Adverse Event|17|||
146867110|NCT01205438|529686026|FG002|Overall Study|Adverse Event|24|||
146867111|NCT01205438|529686024|FG000|Overall Study|Death|1|||
146867112|NCT01205438|529686025|FG001|Overall Study|Death|1|||
146867113|NCT01205438|529686026|FG002|Overall Study|Death|3|||
146867114|NCT01205438|529686024|FG000|Overall Study|Entry Criteria Not Met|16|||
146867115|NCT01205438|529686025|FG001|Overall Study|Entry Criteria Not Met|15|||
146867116|NCT01205438|529686026|FG002|Overall Study|Entry Criteria Not Met|13|||
146867117|NCT01205438|529686024|FG000|Overall Study|Lack of Efficacy|14|||
146867118|NCT01205438|529686025|FG001|Overall Study|Lack of Efficacy|11|||
146867119|NCT01205438|529686026|FG002|Overall Study|Lack of Efficacy|14|||
146867120|NCT01205438|529686024|FG000|Overall Study|Lost to Follow-up|6|||
146867121|NCT01205438|529686025|FG001|Overall Study|Lost to Follow-up|7|||
146867122|NCT01205438|529686026|FG002|Overall Study|Lost to Follow-up|8|||
146867123|NCT01205438|529686024|FG000|Overall Study|Withdrawal by Subject|19|||
146867124|NCT01205438|529686025|FG001|Overall Study|Withdrawal by Subject|25|||
146867125|NCT01205438|529686026|FG002|Overall Study|Withdrawal by Subject|19|||
146867126|NCT01205438|529686024|FG000|Overall Study|Physician Decision|0|||
146867127|NCT01205438|529686025|FG001|Overall Study|Physician Decision|3|||
146867128|NCT01205438|529686026|FG002|Overall Study|Physician Decision|2|||
146867129|NCT01205438|529686024|FG000|Overall Study|Protocol Violation|2|||
146867130|NCT01205438|529686025|FG001|Overall Study|Protocol Violation|7|||
146867131|NCT01205438|529686026|FG002|Overall Study|Protocol Violation|4|||
146867132|NCT01205438|529686024|FG000|Overall Study|Sponsor Decision|0|||
146867133|NCT01205438|529686025|FG001|Overall Study|Sponsor Decision|1|||
146867134|NCT01205438|529686026|FG002|Overall Study|Sponsor Decision|1|||
146867135|NCT03823404|529686027|FG000|Overall Study|Lost to Follow-up|1|||
146867136|NCT03823404|529686028|FG001|Overall Study|Lost to Follow-up|2|||
146867137|NCT03823404|529686029|FG002|Overall Study|Lost to Follow-up|3|||
146867138|NCT03823404|529686027|FG000|Overall Study|Protocol Violation|2|||
146867139|NCT03823404|529686028|FG001|Overall Study|Protocol Violation|0|||
146867140|NCT03823404|529686029|FG002|Overall Study|Protocol Violation|2|||
146867141|NCT03823404|529686027|FG000|Overall Study|Adverse Event|35|||
146867142|NCT03823404|529686028|FG001|Overall Study|Adverse Event|38|||
146867143|NCT03823404|529686029|FG002|Overall Study|Adverse Event|8|||
146867144|NCT03823404|529686027|FG000|Overall Study|Withdrawal by Subject|38|||
146867145|NCT03823404|529686028|FG001|Overall Study|Withdrawal by Subject|40|||
146867146|NCT03823404|529686029|FG002|Overall Study|Withdrawal by Subject|35|||
146867147|NCT03823404|529686027|FG000|Overall Study|Death|4|||
146867148|NCT03823404|529686028|FG001|Overall Study|Death|0|||
146867149|NCT03823404|529686029|FG002|Overall Study|Death|0|||
146533931|NCT03087058|528464678|FG000|Overall Study|Withdrawal by Subject|2|||
146533932|NCT03087058|528464679|FG001|Overall Study|Withdrawal by Subject|0|||
146533933|NCT03087058|528464680|FG002|Overall Study|Withdrawal by Subject|0|||
146867150|NCT03823404|529686027|FG000|Overall Study|Other: Various reasons provided|5|||
146867151|NCT03823404|529686028|FG001|Overall Study|Other: Various reasons provided|5|||
146867152|NCT03823404|529686029|FG002|Overall Study|Other: Various reasons provided|6|||
146867153|NCT00892177|529686034|FG000|Phase II|Ineligible|0|||
146533934|NCT02577029|528464683|FG000|Overall Study|Adverse Event|1|||
146533935|NCT02577029|528464684|FG001|Overall Study|Adverse Event|0|||
146533936|NCT02577029|528464685|FG002|Overall Study|Adverse Event|2|||
146533937|NCT02577029|528464686|FG003|Overall Study|Adverse Event|0|||
146533938|NCT02577029|528464687|FG004|Overall Study|Adverse Event|1|||
146533939|NCT02577029|528464688|FG005|Overall Study|Adverse Event|0|||
146533940|NCT02577029|528464689|FG006|Overall Study|Adverse Event|0|||
146533941|NCT02577029|528464690|FG007|Overall Study|Adverse Event|0|||
146533942|NCT02577029|528464683|FG000|Overall Study|Withdrawal by Subject|0|||
146533943|NCT02577029|528464684|FG001|Overall Study|Withdrawal by Subject|0|||
146533944|NCT02577029|528464685|FG002|Overall Study|Withdrawal by Subject|0|||
146533945|NCT02577029|528464686|FG003|Overall Study|Withdrawal by Subject|0|||
146533946|NCT02577029|528464687|FG004|Overall Study|Withdrawal by Subject|0|||
146533947|NCT02577029|528464688|FG005|Overall Study|Withdrawal by Subject|1|||
146533948|NCT02577029|528464689|FG006|Overall Study|Withdrawal by Subject|0|||
146533949|NCT02577029|528464690|FG007|Overall Study|Withdrawal by Subject|0|||
146533950|NCT02577029|528464683|FG000|Overall Study|Sponsor Termination of the Study|9|||
146533951|NCT02577029|528464684|FG001|Overall Study|Sponsor Termination of the Study|2|||
146533952|NCT02577029|528464685|FG002|Overall Study|Sponsor Termination of the Study|5|||
146533953|NCT02577029|528464686|FG003|Overall Study|Sponsor Termination of the Study|12|||
146533954|NCT02577029|528464687|FG004|Overall Study|Sponsor Termination of the Study|10|||
146533955|NCT02577029|528464688|FG005|Overall Study|Sponsor Termination of the Study|12|||
146533956|NCT02577029|528464689|FG006|Overall Study|Sponsor Termination of the Study|12|||
146533957|NCT02577029|528464690|FG007|Overall Study|Sponsor Termination of the Study|12|||
146533958|NCT02078817|528464691|FG000|Overall Study|Withdrawal by Subject|1|||
146533959|NCT00855218|528464692|FG000|Overall Study|Adverse Event|43|||
146533960|NCT00855218|528464693|FG001|Overall Study|Adverse Event|27|||
146533961|NCT00855218|528464692|FG000|Overall Study|Withdrawal by Subject|10|||
146533962|NCT00855218|528464693|FG001|Overall Study|Withdrawal by Subject|6|||
146533963|NCT00855218|528464692|FG000|Overall Study|Physician Decision|18|||
146533964|NCT00855218|528464693|FG001|Overall Study|Physician Decision|11|||
146533965|NCT00855218|528464692|FG000|Overall Study|Lost to Follow-up|0|||
146533966|NCT00855218|528464693|FG001|Overall Study|Lost to Follow-up|1|||
146533967|NCT00855218|528464692|FG000|Overall Study|Protocol Violation|5|||
146533968|NCT00855218|528464693|FG001|Overall Study|Protocol Violation|9|||
146533969|NCT00855218|528464692|FG000|Overall Study|non-compliant with study drug|3|||
146533970|NCT00855218|528464693|FG001|Overall Study|non-compliant with study drug|1|||
146533971|NCT00855218|528464692|FG000|Overall Study|patient convenience|2|||
146533972|NCT00855218|528464693|FG001|Overall Study|patient convenience|0|||
146533973|NCT00855218|528464692|FG000|Overall Study|technical problems|2|||
146533974|NCT00855218|528464693|FG001|Overall Study|technical problems|1|||
146533975|NCT00855218|528464692|FG000|Overall Study|Still treated with study medication|0|||
146533976|NCT00855218|528464693|FG001|Overall Study|Still treated with study medication|1|||
146533977|NCT00855218|528464692|FG000|Overall Study|Untreatable disease progression|54|||
146763191|NCT02512042|529299441|FG001|Overall Study|Withdrawal by Subject|6|||
146763192|NCT02512042|529299440|FG000|Overall Study|Non-compliance with study drug|1|||
146763193|NCT02512042|529299441|FG001|Overall Study|Non-compliance with study drug|2|||
146763194|NCT02512042|529299440|FG000|Overall Study|Lost to Follow-up|5|||
146763195|NCT02512042|529299441|FG001|Overall Study|Lost to Follow-up|2|||
146763196|NCT02512042|529299440|FG000|Overall Study|Other|11|||
146763197|NCT02512042|529299441|FG001|Overall Study|Other|11|||
146763198|NCT04163458|529299444|FG000|Overall Study|Protocol Deviation|7|||
146763199|NCT04163458|529299445|FG001|Overall Study|Protocol Deviation|13|||
146763200|NCT04163458|529299444|FG000|Overall Study|Adverse Event|5|||
146763201|NCT04163458|529299445|FG001|Overall Study|Adverse Event|8|||
146763202|NCT04163458|529299444|FG000|Overall Study|Due to COVID-19 pandemic|4|||
146763203|NCT04163458|529299445|FG001|Overall Study|Due to COVID-19 pandemic|2|||
146763204|NCT04163458|529299444|FG000|Overall Study|Participant withdrew consent|2|||
146763205|NCT04163458|529299445|FG001|Overall Study|Participant withdrew consent|3|||
146763206|NCT04163458|529299444|FG000|Overall Study|Randomization failure|2|||
146763207|NCT04163458|529299445|FG001|Overall Study|Randomization failure|2|||
146763208|NCT04163458|529299444|FG000|Overall Study|Other|4|||
146763209|NCT04163458|529299445|FG001|Overall Study|Other|2|||
146763210|NCT04109118|529299450|FG000|Overall Study|Lost to Follow-up|3|||
146763211|NCT05273801|529299451|FG000|Overall Study|Physician Decision|1|||
146763212|NCT04257058|529301282|FG000|Overall Study|Lost to Follow-up|31|||
146763213|NCT02030028|529301286|FG000|Overall Study|Withdrawal by Subject|4|||
146763214|NCT02030028|529301286|FG000|Overall Study|lack of transportation|1|||
146763215|NCT01249092|529301289|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
146533978|NCT00855218|528464693|FG001|Overall Study|Untreatable disease progression|67|||
146533979|NCT00855218|528464692|FG000|Overall Study|Second malignancy|0|||
146533980|NCT00855218|528464693|FG001|Overall Study|Second malignancy|1|||
146533981|NCT00855218|528464692|FG000|Overall Study|Progression measurement proven|7|||
146763216|NCT01249092|529301289|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
146763217|NCT02001623|529301296|FG000|Overall Study|Disease Progression|2|||
146763218|NCT02001623|529301297|FG001|Overall Study|Disease Progression|2|||
146763219|NCT02001623|529301298|FG002|Overall Study|Disease Progression|3|||
146867154|NCT00892177|529686035|FG001|Phase II|Ineligible|0|||
146763220|NCT02001623|529301299|FG003|Overall Study|Disease Progression|2|||
146763221|NCT02001623|529301300|FG004|Overall Study|Disease Progression|3|||
146763222|NCT02001623|529301301|FG005|Overall Study|Disease Progression|2|||
146763223|NCT02001623|529301302|FG006|Overall Study|Disease Progression|3|||
146763224|NCT02001623|529301303|FG007|Overall Study|Disease Progression|3|||
146763225|NCT02001623|529301304|FG008|Overall Study|Disease Progression|7|||
146763226|NCT02001623|529301305|FG009|Overall Study|Disease Progression|40|||
146763227|NCT02001623|529301306|FG010|Overall Study|Disease Progression|5|||
146763228|NCT02001623|529301307|FG011|Overall Study|Disease Progression|9|||
146763229|NCT02001623|529301308|FG012|Overall Study|Disease Progression|9|||
146763230|NCT02001623|529301309|FG013|Overall Study|Disease Progression|20|||
146763231|NCT02001623|529301310|FG014|Overall Study|Disease Progression|9|||
146763232|NCT02001623|529301296|FG000|Overall Study|Physician Decision|0|||
146763233|NCT02001623|529301297|FG001|Overall Study|Physician Decision|0|||
146763234|NCT02001623|529301298|FG002|Overall Study|Physician Decision|0|||
146763235|NCT02001623|529301299|FG003|Overall Study|Physician Decision|0|||
146763236|NCT02001623|529301300|FG004|Overall Study|Physician Decision|0|||
146763237|NCT02001623|529301301|FG005|Overall Study|Physician Decision|0|||
146763238|NCT02001623|529301302|FG006|Overall Study|Physician Decision|0|||
146763239|NCT02001623|529301303|FG007|Overall Study|Physician Decision|0|||
146763240|NCT02001623|529301304|FG008|Overall Study|Physician Decision|3|||
146763241|NCT02001623|529301305|FG009|Overall Study|Physician Decision|2|||
146763242|NCT02001623|529301306|FG010|Overall Study|Physician Decision|3|||
146763243|NCT02001623|529301307|FG011|Overall Study|Physician Decision|3|||
146763244|NCT02001623|529301308|FG012|Overall Study|Physician Decision|1|||
146763245|NCT02001623|529301309|FG013|Overall Study|Physician Decision|2|||
146763246|NCT02001623|529301310|FG014|Overall Study|Physician Decision|1|||
146763247|NCT02001623|529301296|FG000|Overall Study|Death|0|||
146763248|NCT02001623|529301297|FG001|Overall Study|Death|1|||
146763249|NCT02001623|529301298|FG002|Overall Study|Death|0|||
146763250|NCT02001623|529301299|FG003|Overall Study|Death|0|||
146763251|NCT02001623|529301300|FG004|Overall Study|Death|0|||
146763252|NCT02001623|529301301|FG005|Overall Study|Death|0|||
146763253|NCT02001623|529301302|FG006|Overall Study|Death|0|||
146763254|NCT02001623|529301303|FG007|Overall Study|Death|0|||
146763255|NCT02001623|529301304|FG008|Overall Study|Death|0|||
146763256|NCT02001623|529301305|FG009|Overall Study|Death|0|||
146763257|NCT02001623|529301306|FG010|Overall Study|Death|0|||
146763258|NCT02001623|529301307|FG011|Overall Study|Death|0|||
146763259|NCT02001623|529301308|FG012|Overall Study|Death|0|||
146763260|NCT02001623|529301309|FG013|Overall Study|Death|0|||
146763261|NCT02001623|529301310|FG014|Overall Study|Death|0|||
146763262|NCT02001623|529301296|FG000|Overall Study|Adverse Event|0|||
146763263|NCT02001623|529301297|FG001|Overall Study|Adverse Event|0|||
146763264|NCT02001623|529301298|FG002|Overall Study|Adverse Event|0|||
146763265|NCT02001623|529301299|FG003|Overall Study|Adverse Event|0|||
146763266|NCT02001623|529301300|FG004|Overall Study|Adverse Event|0|||
146763267|NCT02001623|529301301|FG005|Overall Study|Adverse Event|1|||
146763268|NCT02001623|529301302|FG006|Overall Study|Adverse Event|0|||
146763269|NCT02001623|529301303|FG007|Overall Study|Adverse Event|3|||
146763270|NCT02001623|529301304|FG008|Overall Study|Adverse Event|4|||
146763271|NCT02001623|529301305|FG009|Overall Study|Adverse Event|6|||
146763272|NCT02001623|529301306|FG010|Overall Study|Adverse Event|4|||
146763273|NCT02001623|529301307|FG011|Overall Study|Adverse Event|0|||
146763274|NCT02001623|529301308|FG012|Overall Study|Adverse Event|3|||
146763275|NCT02001623|529301309|FG013|Overall Study|Adverse Event|5|||
146763276|NCT02001623|529301310|FG014|Overall Study|Adverse Event|6|||
146763277|NCT02001623|529301296|FG000|Overall Study|Other - Miscellaneous|0|||
146763278|NCT02001623|529301297|FG001|Overall Study|Other - Miscellaneous|0|||
146763279|NCT02001623|529301298|FG002|Overall Study|Other - Miscellaneous|0|||
146763280|NCT02001623|529301299|FG003|Overall Study|Other - Miscellaneous|0|||
146763281|NCT02001623|529301300|FG004|Overall Study|Other - Miscellaneous|0|||
146763282|NCT02001623|529301301|FG005|Overall Study|Other - Miscellaneous|0|||
146763283|NCT02001623|529301302|FG006|Overall Study|Other - Miscellaneous|0|||
146763284|NCT02001623|529301303|FG007|Overall Study|Other - Miscellaneous|0|||
146763285|NCT02001623|529301304|FG008|Overall Study|Other - Miscellaneous|0|||
146763286|NCT02001623|529301305|FG009|Overall Study|Other - Miscellaneous|1|||
146763287|NCT02001623|529301306|FG010|Overall Study|Other - Miscellaneous|0|||
146763288|NCT02001623|529301307|FG011|Overall Study|Other - Miscellaneous|0|||
146763289|NCT02001623|529301308|FG012|Overall Study|Other - Miscellaneous|0|||
146763290|NCT02001623|529301309|FG013|Overall Study|Other - Miscellaneous|1|||
146763291|NCT02001623|529301310|FG014|Overall Study|Other - Miscellaneous|0|||
146763292|NCT02001623|529301296|FG000|Overall Study|Withdrawal by Subject|1|||
146763293|NCT02001623|529301297|FG001|Overall Study|Withdrawal by Subject|0|||
146763294|NCT02001623|529301298|FG002|Overall Study|Withdrawal by Subject|0|||
146763295|NCT02001623|529301299|FG003|Overall Study|Withdrawal by Subject|0|||
146763296|NCT02001623|529301300|FG004|Overall Study|Withdrawal by Subject|0|||
146763297|NCT02001623|529301301|FG005|Overall Study|Withdrawal by Subject|0|||
146763298|NCT02001623|529301302|FG006|Overall Study|Withdrawal by Subject|0|||
146763299|NCT02001623|529301303|FG007|Overall Study|Withdrawal by Subject|0|||
146867155|NCT00892177|529686036|FG002|Phase II|Ineligible|0|||
146867156|NCT00892177|529686037|FG003|Phase II|Ineligible|0|||
146533982|NCT00855218|528464693|FG001|Overall Study|Progression measurement proven|15|||
146533983|NCT00855218|528464692|FG000|Overall Study|Clinical endpoint reached|10|||
146533984|NCT00855218|528464693|FG001|Overall Study|Clinical endpoint reached|13|||
146533985|NCT00769561|528464699|FG000|Overall Study|Withdrawal by Subject|2|||
146533986|NCT00769561|528464700|FG001|Overall Study|Withdrawal by Subject|2|||
146533987|NCT00769561|528464699|FG000|Overall Study|Lost to Follow-up|1|||
146533988|NCT00769561|528464700|FG001|Overall Study|Lost to Follow-up|3|||
146533989|NCT03824561|528464708|FG000|Overall Study|Protocol Violation|19|||
146533990|NCT03191552|528464709|FG000|Overall Study|Lost to Follow-up|1|||
146533991|NCT03191552|528464710|FG001|Overall Study|Lost to Follow-up|0|||
146533992|NCT03191552|528464711|FG002|Overall Study|Lost to Follow-up|0|||
146533993|NCT03191552|528464709|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
146533994|NCT03191552|528464710|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
146533995|NCT03191552|528464711|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
146533996|NCT01441973|528464712|FG000|Overall Study|Disease progression|8|||
146533997|NCT01441973|528464713|FG001|Overall Study|Disease progression|6|||
146533998|NCT01441973|528464712|FG000|Overall Study|Adverse event unrelated to study drug|3|||
146533999|NCT01441973|528464713|FG001|Overall Study|Adverse event unrelated to study drug|2|||
146534000|NCT01441973|528464712|FG000|Overall Study|Participant request to discontinue|1|||
146534001|NCT01441973|528464713|FG001|Overall Study|Participant request to discontinue|1|||
146534002|NCT01441973|528464712|FG000|Overall Study|Poor compliance/noncompliance|0|||
146534003|NCT01441973|528464713|FG001|Overall Study|Poor compliance/noncompliance|1|||
146534004|NCT01441973|528464712|FG000|Overall Study|Administrative reason by sponsor|3|||
146534005|NCT01441973|528464713|FG001|Overall Study|Administrative reason by sponsor|5|||
146534006|NCT01441973|528464712|FG000|Overall Study|Participant withdrew consent|0|||
146534007|NCT01441973|528464713|FG001|Overall Study|Participant withdrew consent|1|||
146534008|NCT02370511|528464714|FG000|Overall Study|Death|10|||
146534009|NCT02370511|528464715|FG001|Overall Study|Death|7|||
146534010|NCT02370511|528464716|FG002|Overall Study|Death|1|||
146534011|NCT02370511|528464714|FG000|Overall Study|Withdrawal by Subject|2|||
146534012|NCT02370511|528464715|FG001|Overall Study|Withdrawal by Subject|0|||
146534013|NCT02370511|528464716|FG002|Overall Study|Withdrawal by Subject|0|||
146534014|NCT02370511|528464714|FG000|Overall Study|Lost to Follow-up|0|||
146534015|NCT02370511|528464715|FG001|Overall Study|Lost to Follow-up|4|||
146534016|NCT02370511|528464716|FG002|Overall Study|Lost to Follow-up|0|||
146534017|NCT01149655|528464717|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
146534018|NCT01149655|528464718|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
146534019|NCT01149655|528464719|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
146534020|NCT01149655|528464720|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
146534021|NCT01149655|528464717|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
146534022|NCT01149655|528464718|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
146534023|NCT01149655|528464719|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
146534024|NCT01149655|528464720|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
146534025|NCT01149655|528464717|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
146534026|NCT01149655|528464718|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
146534027|NCT01149655|528464719|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
146534028|NCT01149655|528464720|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
146534029|NCT01149655|528464717|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
146534030|NCT01149655|528464718|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
146534031|NCT01149655|528464719|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
146534032|NCT01149655|528464720|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
146534033|NCT01149655|528464717|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
146534034|NCT01149655|528464718|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
146534035|NCT01149655|528464719|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
146534036|NCT01149655|528464720|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
146534037|NCT01149655|528464717|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
146534038|NCT01149655|528464718|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
146534039|NCT01149655|528464719|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
146534040|NCT01149655|528464720|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
146534041|NCT01149655|528464717|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
146534042|NCT01149655|528464718|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
146534043|NCT01149655|528464719|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
146534044|NCT01149655|528464720|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
146534045|NCT01149655|528464717|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
146534046|NCT01149655|528464718|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
146867157|NCT00892177|529686038|FG004|Phase II|Ineligible|1|||
146867158|NCT00892177|529686039|FG005|Phase II|Ineligible|1|||
146867159|NCT00892177|529686034|FG000|Phase II|Withdrawal by Subject|0|||
146867160|NCT00892177|529686035|FG001|Phase II|Withdrawal by Subject|0|||
146867161|NCT00892177|529686036|FG002|Phase II|Withdrawal by Subject|0|||
146867162|NCT00892177|529686037|FG003|Phase II|Withdrawal by Subject|0|||
146867163|NCT00892177|529686038|FG004|Phase II|Withdrawal by Subject|4|||
146867164|NCT00892177|529686039|FG005|Phase II|Withdrawal by Subject|1|||
146867165|NCT00404066|529686045|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
146867166|NCT00404066|529686045|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
146867167|NCT01754857|529686046|FG000|Overall Study|Adverse Event|7|||
146867168|NCT01754857|529686046|FG000|Overall Study|Disease progression|3|||
146867169|NCT01754857|529686046|FG000|Overall Study|Physician Decision|2|||
146867170|NCT01754857|529686046|FG000|Overall Study|Withdrawal by Subject|3|||
146867171|NCT01754857|529686046|FG000|Overall Study|other complicating disease|1|||
146867172|NCT01754857|529686046|FG000|Overall Study|ineligible to continue onto maintenance|1|||
146867173|NCT01754857|529686046|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
146867174|NCT01754857|529686046|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
146867175|NCT01399190|529686047|FG000|Overall Study|Not Eligible for Final Analysis|5|||
146867176|NCT01399190|529686047|FG000|Overall Study|Adverse Event|8|||
146867177|NCT01399190|529686047|FG000|Overall Study|Participant's Request|5|||
146867178|NCT01399190|529686047|FG000|Overall Study|Physician Decision|2|||
146867179|NCT00596934|529686049|FG000|Overall Study|Protocol Violation|1|||
146867180|NCT00596934|529686049|FG000|Overall Study|Withdrawal by Subject|1|||
146867181|NCT02315898|529686050|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
146867182|NCT02315898|529686051|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
146867183|NCT02315898|529686052|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
146867184|NCT02315898|529686053|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
146867185|NCT03239483|529686054|FG000|Overall Study|Lost to Follow-up|1|||
146867186|NCT03239483|529686055|FG001|Overall Study|Lost to Follow-up|0|||
146867187|NCT03239483|529686054|FG000|Overall Study|Withdrawal by Subject|1|||
146867188|NCT03239483|529686055|FG001|Overall Study|Withdrawal by Subject|0|||
146867189|NCT01296035|529686056|FG000|Overall Study|Withdrawal by Subject|1|||
146867190|NCT05395104|529686061|FG000|Overall Study|Met Liver Stopping Criteria|1|||
146867191|NCT05395104|529686061|FG000|Overall Study|Withdrawal by Subject|1|||
146867192|NCT00381563|529686062|FG000|Overall Study|Withdrawal by Subject|5|||
146867193|NCT00381563|529686063|FG001|Overall Study|Withdrawal by Subject|5|||
146867194|NCT00381563|529686062|FG000|Overall Study|Lost to Follow-up|2|||
146867195|NCT00381563|529686063|FG001|Overall Study|Lost to Follow-up|0|||
146867196|NCT00381563|529686062|FG000|Overall Study|Protocol Violation|0|||
146867197|NCT00381563|529686063|FG001|Overall Study|Protocol Violation|1|||
146867198|NCT05372653|529686064|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
146867199|NCT05372653|529686065|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
146867200|NCT05372653|529686064|FG000|Overall Study|Adverse Event|0|||
146867201|NCT05372653|529686065|FG001|Overall Study|Adverse Event|1|||
146867202|NCT01003990|529686068|FG000|Overall Study|Adverse Event|8|||
146867203|NCT01003990|529686069|FG001|Overall Study|Adverse Event|5|||
146867204|NCT01003990|529686070|FG002|Overall Study|Adverse Event|11|||
146867205|NCT01003990|529686068|FG000|Overall Study|Death|0|||
146867206|NCT01003990|529686069|FG001|Overall Study|Death|8|||
146867207|NCT01003990|529686070|FG002|Overall Study|Death|1|||
146867208|NCT01003990|529686068|FG000|Overall Study|Lack of Efficacy|10|||
146867209|NCT01003990|529686069|FG001|Overall Study|Lack of Efficacy|2|||
146867210|NCT01003990|529686070|FG002|Overall Study|Lack of Efficacy|3|||
146867211|NCT01003990|529686068|FG000|Overall Study|Lost to Follow-up|30|||
146867212|NCT01003990|529686069|FG001|Overall Study|Lost to Follow-up|12|||
146867213|NCT01003990|529686070|FG002|Overall Study|Lost to Follow-up|7|||
146867214|NCT01003990|529686068|FG000|Overall Study|Reasons Not Identified|14|||
146867215|NCT01003990|529686069|FG001|Overall Study|Reasons Not Identified|13|||
146867216|NCT01003990|529686070|FG002|Overall Study|Reasons Not Identified|8|||
146867217|NCT01003990|529686068|FG000|Overall Study|Poor/Non-compliance|4|||
146867218|NCT01003990|529686069|FG001|Overall Study|Poor/Non-compliance|3|||
146867219|NCT01003990|529686070|FG002|Overall Study|Poor/Non-compliance|2|||
146867220|NCT01003990|529686068|FG000|Overall Study|Pregnancy|10|||
146867221|NCT01003990|529686069|FG001|Overall Study|Pregnancy|2|||
146867222|NCT01003990|529686070|FG002|Overall Study|Pregnancy|4|||
146867223|NCT01003990|529686068|FG000|Overall Study|No Longer Met Study Criteria|4|||
146867224|NCT01003990|529686069|FG001|Overall Study|No Longer Met Study Criteria|1|||
146867225|NCT01003990|529686070|FG002|Overall Study|No Longer Met Study Criteria|0|||
146867226|NCT01003990|529686068|FG000|Overall Study|Subject Withdrew Consent|12|||
146867227|NCT01003990|529686069|FG001|Overall Study|Subject Withdrew Consent|5|||
146867228|NCT01003990|529686070|FG002|Overall Study|Subject Withdrew Consent|7|||
146867229|NCT01829425|529686071|FG000|Overall Study|Withdrawal by Subject|4|||
146867230|NCT01829425|529686072|FG001|Overall Study|Withdrawal by Subject|3|||
146867231|NCT01829425|529686071|FG000|Overall Study|Lost to Follow-up|2|||
146867232|NCT01829425|529686072|FG001|Overall Study|Lost to Follow-up|1|||
146867233|NCT05211739|529686073|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
146867234|NCT05211739|529686074|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
146914646|NCT03303339|529850043|FG001|Overall Study|Study Terminated by Sponsor|0|||
146867235|NCT05211739|529686073|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
146867236|NCT05211739|529686074|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
146867237|NCT05211739|529686073|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
146867238|NCT05211739|529686074|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
146867239|NCT05211739|529686073|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
146867240|NCT05211739|529686074|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
146867241|NCT01505010|529686075|FG000|Overall Study|Protocol Violation|0|||
146867242|NCT01505010|529686076|FG001|Overall Study|Protocol Violation|1|||
146867243|NCT01505010|529686075|FG000|Overall Study|Lost to Follow-up|0|||
146867244|NCT01505010|529686076|FG001|Overall Study|Lost to Follow-up|1|||
146867245|NCT01006265|529686085|FG000|Overall Study|Lost to Follow-up|1|||
146867246|NCT01006265|529686086|FG001|Overall Study|Lost to Follow-up|0|||
146867247|NCT01006265|529686087|FG002|Overall Study|Lost to Follow-up|1|||
146867248|NCT01006265|529686088|FG003|Overall Study|Lost to Follow-up|0|||
146867249|NCT01006265|529686085|FG000|Overall Study|Withdrawal by Subject|4|||
146867250|NCT01006265|529686086|FG001|Overall Study|Withdrawal by Subject|7|||
146867251|NCT01006265|529686087|FG002|Overall Study|Withdrawal by Subject|5|||
146867252|NCT01006265|529686088|FG003|Overall Study|Withdrawal by Subject|5|||
146867253|NCT01006265|529686085|FG000|Overall Study|Administrative reason|1|||
146867254|NCT01006265|529686086|FG001|Overall Study|Administrative reason|2|||
146867255|NCT01006265|529686087|FG002|Overall Study|Administrative reason|3|||
146867256|NCT01006265|529686088|FG003|Overall Study|Administrative reason|0|||
146867257|NCT00698932|529686089|FG000|Overall Study|Adverse Event|0|||
146867258|NCT00698932|529686090|FG001|Overall Study|Adverse Event|2|||
146867259|NCT00698932|529686089|FG000|Overall Study|Incorrect enrollment|0|||
146867260|NCT00698932|529686090|FG001|Overall Study|Incorrect enrollment|2|||
146867261|NCT00698932|529686089|FG000|Overall Study|Study specific discontinuation criteria|3|||
146867262|NCT00698932|529686090|FG001|Overall Study|Study specific discontinuation criteria|4|||
146867263|NCT00698932|529686089|FG000|Overall Study|Withdrawal by Subject|11|||
146867264|NCT00698932|529686090|FG001|Overall Study|Withdrawal by Subject|23|||
146867265|NCT00698932|529686089|FG000|Overall Study|Lost to Follow-up|6|||
146867266|NCT00698932|529686090|FG001|Overall Study|Lost to Follow-up|1|||
146867267|NCT00698932|529686089|FG000|Overall Study|Severe non-compliance to protocol|1|||
146867268|NCT00698932|529686090|FG001|Overall Study|Severe non-compliance to protocol|2|||
146867269|NCT00698932|529686089|FG000|Overall Study|Safety reasons|0|||
146867270|NCT00698932|529686090|FG001|Overall Study|Safety reasons|2|||
146867271|NCT00698932|529686089|FG000|Overall Study|Death|1|||
146867272|NCT00698932|529686090|FG001|Overall Study|Death|0|||
146867273|NCT00757003|529686091|FG000|Overall Study|Death|33|||
146867274|NCT00757003|529686091|FG000|Overall Study|Lost to Follow-up|9|||
146867275|NCT00757003|529686091|FG000|Overall Study|Withdrawal by Subject|4|||
146867276|NCT00757003|529686091|FG000|Overall Study|Surgically explanted|2|||
146867277|NCT00757003|529686091|FG000|Overall Study|Not implanted|1|||
146867278|NCT02966223|529686092|FG000|Overall Study|Physician Decision|3|||
146867279|NCT02966223|529686092|FG000|Overall Study|Withdrawal by Subject|11|||
146867280|NCT02966223|529686092|FG000|Overall Study|Lost to Follow-up|1|||
146867281|NCT01326728|529686093|FG000|Overall Study|Death|13|||
146867282|NCT01326728|529686094|FG001|Overall Study|Death|0|||
146867283|NCT01326728|529686093|FG000|Overall Study|Early closure of study|34|||
146867284|NCT01326728|529686094|FG001|Overall Study|Early closure of study|9|||
146867285|NCT01184053|529686095|FG000|Overall Study|progression while on treatment|3|||
146867286|NCT03785678|529686096|FG000|Overall Study|Death|44|||
146867287|NCT03785678|529686097|FG001|Overall Study|Death|42|||
146867288|NCT03785678|529686096|FG000|Overall Study|Lost to Follow-up|4|||
146867289|NCT03785678|529686097|FG001|Overall Study|Lost to Follow-up|2|||
146867290|NCT03785678|529686096|FG000|Overall Study|Physician Decision|0|||
146867291|NCT03785678|529686097|FG001|Overall Study|Physician Decision|2|||
146867292|NCT03785678|529686096|FG000|Overall Study|Withdrawal by Subject|5|||
146867293|NCT03785678|529686097|FG001|Overall Study|Withdrawal by Subject|3|||
146867294|NCT00375219|529686098|FG000|Overall Study|Failure to achieve a response|16|||
146867295|NCT00375219|529686099|FG001|Overall Study|Failure to achieve a response|2|||
146867296|NCT00375219|529686100|FG002|Overall Study|Failure to achieve a response|0|||
146867297|NCT00375219|529686098|FG000|Overall Study|Adverse Event|8|||
146867298|NCT00375219|529686099|FG001|Overall Study|Adverse Event|2|||
146867299|NCT00375219|529686100|FG002|Overall Study|Adverse Event|1|||
146867300|NCT00375219|529686098|FG000|Overall Study|Protocol Violation|1|||
146867301|NCT00375219|529686099|FG001|Overall Study|Protocol Violation|0|||
146867302|NCT00375219|529686100|FG002|Overall Study|Protocol Violation|1|||
146867303|NCT00375219|529686098|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
146867304|NCT00375219|529686099|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
146867305|NCT00375219|529686100|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
146867306|NCT00375219|529686098|FG000|Overall Study|Lost to Follow-up|1|||
146867307|NCT00375219|529686099|FG001|Overall Study|Lost to Follow-up|1|||
146867308|NCT00375219|529686100|FG002|Overall Study|Lost to Follow-up|0|||
146867309|NCT00375219|529686098|FG000|Overall Study|Disease progression|18|||
146867310|NCT00375219|529686099|FG001|Overall Study|Disease progression|9|||
146867311|NCT00375219|529686100|FG002|Overall Study|Disease progression|12|||
146867312|NCT00375219|529686098|FG000|Overall Study|Death|4|||
146867313|NCT00375219|529686099|FG001|Overall Study|Death|3|||
146867314|NCT00375219|529686100|FG002|Overall Study|Death|7|||
146867315|NCT00375219|529686098|FG000|Overall Study|Hematologic resistance|1|||
146867316|NCT00375219|529686099|FG001|Overall Study|Hematologic resistance|0|||
146867317|NCT00375219|529686100|FG002|Overall Study|Hematologic resistance|0|||
146867318|NCT00375219|529686098|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
146867319|NCT00375219|529686099|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
146867320|NCT00375219|529686100|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
146867321|NCT00375219|529686098|FG000|Overall Study|Allograft|2|||
146867322|NCT00375219|529686099|FG001|Overall Study|Allograft|0|||
146867323|NCT00375219|529686100|FG002|Overall Study|Allograft|0|||
146867324|NCT00375219|529686098|FG000|Overall Study|Cord blood transplantation|1|||
146867325|NCT00375219|529686099|FG001|Overall Study|Cord blood transplantation|0|||
146867326|NCT00375219|529686100|FG002|Overall Study|Cord blood transplantation|0|||
146867327|NCT00375219|529686098|FG000|Overall Study|Withdrawal by Subject|1|||
146867328|NCT00375219|529686099|FG001|Overall Study|Withdrawal by Subject|0|||
146867329|NCT00375219|529686100|FG002|Overall Study|Withdrawal by Subject|0|||
146867330|NCT01667107|529686101|FG000|Overall Study|Adverse Event|4|||
146867331|NCT01667107|529686102|FG001|Overall Study|Adverse Event|3|||
146867332|NCT01667107|529686101|FG000|Overall Study|Tolerability issues|0|||
146867333|NCT01667107|529686102|FG001|Overall Study|Tolerability issues|2|||
146867334|NCT01667107|529686101|FG000|Overall Study|Protocol Violation|0|||
146867335|NCT01667107|529686102|FG001|Overall Study|Protocol Violation|1|||
146867336|NCT01667107|529686101|FG000|Overall Study|Lack of Efficacy|0|||
146867337|NCT01667107|529686102|FG001|Overall Study|Lack of Efficacy|1|||
146867338|NCT03427125|529686103|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
146867339|NCT03427125|529686104|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
146867340|NCT03427125|529686105|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
146867341|NCT04252287|529686106|FG000|Overall Study|Death|5|||
146534047|NCT01149655|528464719|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
146534048|NCT01149655|528464720|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
146534049|NCT01149655|528464717|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
146534050|NCT01149655|528464718|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
146534051|NCT01149655|528464719|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
146534052|NCT01149655|528464720|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
146534053|NCT01149655|528464717|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
146534054|NCT01149655|528464718|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
146534055|NCT01149655|528464719|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
146534056|NCT01149655|528464720|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
146534057|NCT01149655|528464717|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
146534058|NCT01149655|528464718|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
146534059|NCT01149655|528464719|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
146534060|NCT01149655|528464720|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
146534061|NCT01149655|528464717|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
146534062|NCT01149655|528464718|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
146534063|NCT01149655|528464719|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
146534064|NCT01149655|528464720|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
146534065|NCT01149655|528464717|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
146534066|NCT01149655|528464718|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
146534067|NCT01149655|528464719|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
146534068|NCT01149655|528464720|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
146534069|NCT01149655|528464717|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
146534070|NCT01149655|528464718|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
146534071|NCT01149655|528464719|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
146534072|NCT01149655|528464720|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
146534073|NCT01149655|528464717|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
146534074|NCT01149655|528464718|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
146534075|NCT01149655|528464719|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
146534076|NCT01149655|528464720|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
146867342|NCT04252287|529686107|FG001|Overall Study|Death|3|||
146867343|NCT04252287|529686106|FG000|Overall Study|Lost to Follow-up|4|||
146867344|NCT04252287|529686107|FG001|Overall Study|Lost to Follow-up|6|||
146534077|NCT01149655|528464717|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
146534078|NCT01149655|528464718|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
146534079|NCT01149655|528464719|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
146534080|NCT01149655|528464720|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
146534081|NCT01265498|528464723|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
146867345|NCT04252287|529686106|FG000|Overall Study|Withdrawal by Subject|19|||
146867346|NCT04252287|529686107|FG001|Overall Study|Withdrawal by Subject|16|||
146534082|NCT01265498|528464724|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
146534083|NCT00617279|528464729|FG000|Overall Study|Study terminated by Sponsor|10|||
146534084|NCT00617279|528464730|FG001|Overall Study|Study terminated by Sponsor|15|||
146534085|NCT00617279|528464729|FG000|Overall Study|Graft abandonment|2|||
146534086|NCT00617279|528464730|FG001|Overall Study|Graft abandonment|0|||
146534087|NCT00617279|528464729|FG000|Overall Study|Lost to Follow-up|1|||
146534088|NCT00617279|528464730|FG001|Overall Study|Lost to Follow-up|0|||
146534089|NCT00617279|528464729|FG000|Overall Study|Death|1|||
146534090|NCT00617279|528464730|FG001|Overall Study|Death|2|||
146534091|NCT00921024|528464733|FG000|Overall Study|Lost to Follow-up|2|||
146534092|NCT00921024|528464734|FG001|Overall Study|Lost to Follow-up|0|||
146534093|NCT00921024|528464733|FG000|Overall Study|Received concomittant therapy|2|||
146534094|NCT00921024|528464734|FG001|Overall Study|Received concomittant therapy|0|||
146534095|NCT00921024|528464733|FG000|Overall Study|Withdrawal by Subject|0|||
146534096|NCT00921024|528464734|FG001|Overall Study|Withdrawal by Subject|3|||
146534097|NCT02003144|528464741|FG000|Open Label Maintenance Phase|Other than specified|2|||
146534098|NCT02003144|528464742|FG001|Open Label Maintenance Phase|Other than specified|4|||
146534099|NCT02003144|528464741|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
146534100|NCT02003144|528464742|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
146534101|NCT02003144|528464741|FG000|Open Label Maintenance Phase|Pregnancy|0|||
146534102|NCT02003144|528464742|FG001|Open Label Maintenance Phase|Pregnancy|2|||
146534103|NCT02003144|528464741|FG000|Open Label Maintenance Phase|Physician Decision|1|||
146534104|NCT02003144|528464742|FG001|Open Label Maintenance Phase|Physician Decision|1|||
146534105|NCT02003144|528464741|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
146534106|NCT02003144|528464742|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
146534107|NCT02003144|528464741|FG000|Open Label Maintenance Phase|Adverse Event|2|||
146534108|NCT02003144|528464742|FG001|Open Label Maintenance Phase|Adverse Event|1|||
146534109|NCT01855958|528466644|FG000|Overall Study|Withdrawal by Subject|1|||
146534110|NCT01855958|528466645|FG001|Overall Study|Withdrawal by Subject|0|||
146534111|NCT00499122|528466646|FG000|Overall Study|Withdrawal by Subject|2|||
146534112|NCT03312738|528466647|FG000|Overall Study|Progressive disease|58|||
146534113|NCT03312738|528466648|FG001|Overall Study|Progressive disease|67|||
146534114|NCT03312738|528466647|FG000|Overall Study|Patient/guardian decision|13|||
146534115|NCT03312738|528466648|FG001|Overall Study|Patient/guardian decision|5|||
146534116|NCT03312738|528466647|FG000|Overall Study|Adverse Event|5|||
146534117|NCT03312738|528466648|FG001|Overall Study|Adverse Event|3|||
146534118|NCT03312738|528466647|FG000|Overall Study|Protocol deviation|2|||
146534119|NCT03312738|528466648|FG001|Overall Study|Protocol deviation|0|||
146534120|NCT03312738|528466647|FG000|Overall Study|Technical problems|0|||
146534121|NCT03312738|528466648|FG001|Overall Study|Technical problems|1|||
146534122|NCT03312738|528466647|FG000|Overall Study|Physician Decision|2|||
146534123|NCT03312738|528466648|FG001|Overall Study|Physician Decision|3|||
146534124|NCT02466399|528466655|FG000|Overall Study|Adverse Event|1|||
146534125|NCT02466399|528466656|FG001|Overall Study|Adverse Event|0|||
146534126|NCT02466399|528466655|FG000|Overall Study|Early exit due to family emergency|1|||
146534127|NCT02466399|528466656|FG001|Overall Study|Early exit due to family emergency|0|||
146534128|NCT04539275|528466657|FG000|Overall Study|Death|2|||
146534129|NCT04539275|528466658|FG001|Overall Study|Death|4|||
146534130|NCT04539275|528466657|FG000|Overall Study|Lost to Follow-up|1|||
146867347|NCT04252287|529686106|FG000|Overall Study|Protocol Violation|3|||
146867348|NCT04252287|529686107|FG001|Overall Study|Protocol Violation|4|||
146867349|NCT03672461|529686109|FG000|Overall Study|COVID Related|4|||
146867350|NCT03672461|529686110|FG001|Overall Study|COVID Related|2|||
146867351|NCT03672461|529686109|FG000|Overall Study|Adverse Event|2|||
146867352|NCT03672461|529686110|FG001|Overall Study|Adverse Event|0|||
146867353|NCT03672461|529686109|FG000|Overall Study|Serious Adverse Event|0|||
146867354|NCT03672461|529686110|FG001|Overall Study|Serious Adverse Event|1|||
146867355|NCT03672461|529686109|FG000|Overall Study|Too Busy|3|||
146867356|NCT03672461|529686110|FG001|Overall Study|Too Busy|1|||
146867357|NCT03672461|529686109|FG000|Overall Study|Lost to Follow-up|1|||
146867358|NCT03672461|529686110|FG001|Overall Study|Lost to Follow-up|2|||
146867359|NCT03672461|529686109|FG000|Overall Study|Family|2|||
146867360|NCT03672461|529686110|FG001|Overall Study|Family|2|||
146534131|NCT04539275|528466658|FG001|Overall Study|Lost to Follow-up|1|||
146534132|NCT04539275|528466657|FG000|Overall Study|Withdrawal by Subject|3|||
146534133|NCT04539275|528466658|FG001|Overall Study|Withdrawal by Subject|0|||
146534134|NCT00607893|528466659|FG000|Overall Study|Lost to Follow-up|4|||
146867361|NCT03672461|529686109|FG000|Overall Study|No remote technology access|0|||
146867362|NCT03672461|529686110|FG001|Overall Study|No remote technology access|1|||
146867363|NCT03672461|529686109|FG000|Overall Study|Withdrawal by Subject|1|||
146534135|NCT00607893|528466660|FG001|Overall Study|Lost to Follow-up|0|||
146534136|NCT00607893|528466659|FG000|Overall Study|withdrew due to loss of interest|0|||
146534137|NCT00607893|528466660|FG001|Overall Study|withdrew due to loss of interest|1|||
146534138|NCT00607893|528466659|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
146534139|NCT00607893|528466660|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
146534140|NCT00607893|528466659|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
146867364|NCT03672461|529686110|FG001|Overall Study|Withdrawal by Subject|0|||
146867365|NCT03672461|529686109|FG000|Overall Study|Cannot tolerate intervention|1|||
146867366|NCT03672461|529686110|FG001|Overall Study|Cannot tolerate intervention|0|||
146867367|NCT03672461|529686109|FG000|Overall Study|Incomplete outcome data|6|||
146867368|NCT03672461|529686110|FG001|Overall Study|Incomplete outcome data|1|||
146867369|NCT04223791|529686111|FG000|Overall Study|Lost to Follow-up|0|||
146867370|NCT04223791|529686112|FG001|Overall Study|Lost to Follow-up|4|||
146867371|NCT04223791|529686111|FG000|Overall Study|Physician Decision|5|||
146867372|NCT04223791|529686112|FG001|Overall Study|Physician Decision|1|||
146867373|NCT04223791|529686111|FG000|Overall Study|Protocol Violation|1|||
146867374|NCT04223791|529686112|FG001|Overall Study|Protocol Violation|1|||
146867375|NCT04223791|529686111|FG000|Overall Study|Withdrawal by Subject|10|||
146867376|NCT04223791|529686112|FG001|Overall Study|Withdrawal by Subject|12|||
146867377|NCT04223791|529686111|FG000|Overall Study|Pregnancy|1|||
146867378|NCT04223791|529686112|FG001|Overall Study|Pregnancy|1|||
146867379|NCT04223791|529686111|FG000|Overall Study|Ongoing in Study|305|||
146867380|NCT04223791|529686112|FG001|Overall Study|Ongoing in Study|302|||
146867381|NCT00395863|529687458|FG000|Overall Study|Patients did not complete both exams|2|||
146867382|NCT00395863|529687459|FG001|Overall Study|Patients did not complete both exams|3|||
146867383|NCT02592551|529687460|FG000|Overall Study|Not evaluable|1|||
146867384|NCT02592551|529687461|FG001|Overall Study|Not evaluable|3|||
146867385|NCT02592551|529687462|FG002|Overall Study|Not evaluable|0|||
146867386|NCT01876251|529687465|FG000|Overall Study|Clinical progression|1|||
146867387|NCT01876251|529687466|FG001|Overall Study|Clinical progression|0|||
146867388|NCT01876251|529687467|FG002|Overall Study|Clinical progression|0|||
146867389|NCT01876251|529687465|FG000|Overall Study|Death|2|||
146867390|NCT01876251|529687466|FG001|Overall Study|Death|0|||
146867391|NCT01876251|529687467|FG002|Overall Study|Death|1|||
146867392|NCT01876251|529687465|FG000|Overall Study|Participant started new treatment|1|||
146867393|NCT01876251|529687466|FG001|Overall Study|Participant started new treatment|0|||
146867394|NCT01876251|529687467|FG002|Overall Study|Participant started new treatment|1|||
146867395|NCT01876251|529687465|FG000|Overall Study|Participant refused further follow-up|0|||
146534141|NCT00607893|528466660|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
146534142|NCT00607893|528466659|FG000|Overall Study|Declined to be treated|1|||
146534143|NCT00607893|528466660|FG001|Overall Study|Declined to be treated|0|||
146534144|NCT00607893|528466659|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
146534145|NCT00607893|528466660|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
146534146|NCT01799941|528466661|FG000|Overall Study|Adverse Event|34|||
146534147|NCT01799941|528466661|FG000|Overall Study|Withdrawal by Subject|21|||
146534148|NCT01799941|528466661|FG000|Overall Study|Death|2|||
146534149|NCT01799941|528466661|FG000|Overall Study|Investigator Decision|4|||
146534150|NCT01799941|528466661|FG000|Overall Study|Lack of Efficacy|3|||
146534151|NCT01799941|528466661|FG000|Overall Study|Lost to Follow-up|17|||
146534152|NCT01799941|528466661|FG000|Overall Study|Other|15|||
146867396|NCT01876251|529687466|FG001|Overall Study|Participant refused further follow-up|0|||
146867397|NCT01876251|529687467|FG002|Overall Study|Participant refused further follow-up|1|||
146867398|NCT01876251|529687465|FG000|Overall Study|Study terminated|1|||
146867399|NCT01876251|529687466|FG001|Overall Study|Study terminated|0|||
146867400|NCT01876251|529687467|FG002|Overall Study|Study terminated|0|||
146867401|NCT01876251|529687465|FG000|Overall Study|Objective progression or relapse|10|||
146867402|NCT01876251|529687466|FG001|Overall Study|Objective progression or relapse|3|||
146867403|NCT01876251|529687467|FG002|Overall Study|Objective progression or relapse|8|||
146867404|NCT01798992|529687470|FG000|Overall Study|Administrative withdrawal|0|||
146867405|NCT01798992|529687471|FG001|Overall Study|Administrative withdrawal|1|||
146867406|NCT01798992|529687472|FG002|Overall Study|Administrative withdrawal|0|||
146867407|NCT01798992|529687473|FG003|Overall Study|Administrative withdrawal|1|||
146867408|NCT01798992|529687470|FG000|Overall Study|Lost to Follow-up|0|||
146867409|NCT01798992|529687471|FG001|Overall Study|Lost to Follow-up|1|||
146867410|NCT01798992|529687472|FG002|Overall Study|Lost to Follow-up|1|||
146867411|NCT01798992|529687473|FG003|Overall Study|Lost to Follow-up|0|||
146867412|NCT01798992|529687470|FG000|Overall Study|Insufficient biopsy tissue|0|||
146867413|NCT01798992|529687471|FG001|Overall Study|Insufficient biopsy tissue|0|||
146867414|NCT01798992|529687472|FG002|Overall Study|Insufficient biopsy tissue|1|||
146867415|NCT01798992|529687473|FG003|Overall Study|Insufficient biopsy tissue|0|||
146867416|NCT03631667|529687476|FG000|Overall Study|Withdrawal by Subject|3|||
146867417|NCT01674712|529687481|FG000|Overall Study|Adverse Event|5|||
146867418|NCT01674712|529687482|FG001|Overall Study|Adverse Event|6|||
146867419|NCT01674712|529687483|FG002|Overall Study|Adverse Event|3|||
146867420|NCT01674712|529687484|FG003|Overall Study|Adverse Event|4|||
146867421|NCT01674712|529687485|FG004|Overall Study|Adverse Event|6|||
146867422|NCT01674712|529687481|FG000|Overall Study|Lost to Follow-up|1|||
146867423|NCT01674712|529687482|FG001|Overall Study|Lost to Follow-up|0|||
146867424|NCT01674712|529687483|FG002|Overall Study|Lost to Follow-up|0|||
146867425|NCT01674712|529687484|FG003|Overall Study|Lost to Follow-up|0|||
146867426|NCT01674712|529687485|FG004|Overall Study|Lost to Follow-up|0|||
146867427|NCT01674712|529687481|FG000|Overall Study|Protocol Violation|2|||
146867428|NCT01674712|529687482|FG001|Overall Study|Protocol Violation|0|||
146867429|NCT01674712|529687483|FG002|Overall Study|Protocol Violation|0|||
146867430|NCT01674712|529687484|FG003|Overall Study|Protocol Violation|0|||
146867431|NCT01674712|529687485|FG004|Overall Study|Protocol Violation|0|||
146867432|NCT01674712|529687481|FG000|Overall Study|Withdrawal by Subject|2|||
146867433|NCT01674712|529687482|FG001|Overall Study|Withdrawal by Subject|2|||
146867434|NCT01674712|529687483|FG002|Overall Study|Withdrawal by Subject|5|||
146867435|NCT01674712|529687484|FG003|Overall Study|Withdrawal by Subject|4|||
146867436|NCT01674712|529687485|FG004|Overall Study|Withdrawal by Subject|3|||
146867437|NCT01674712|529687481|FG000|Overall Study|Administrative|0|||
146867438|NCT01674712|529687482|FG001|Overall Study|Administrative|1|||
146867439|NCT01674712|529687483|FG002|Overall Study|Administrative|0|||
146867440|NCT01674712|529687484|FG003|Overall Study|Administrative|0|||
146867441|NCT01674712|529687485|FG004|Overall Study|Administrative|1|||
146867442|NCT01674712|529687481|FG000|Overall Study|Lack of Efficacy|0|||
146867443|NCT01674712|529687482|FG001|Overall Study|Lack of Efficacy|0|||
146867444|NCT01674712|529687483|FG002|Overall Study|Lack of Efficacy|1|||
146867445|NCT01674712|529687484|FG003|Overall Study|Lack of Efficacy|0|||
146867446|NCT01674712|529687485|FG004|Overall Study|Lack of Efficacy|1|||
146867447|NCT01287364|529687489|FG000|Overall Study|Adverse Event|0|||
146867448|NCT01287364|529687490|FG001|Overall Study|Adverse Event|3|||
146867449|NCT01287364|529687489|FG000|Overall Study|Protocol Violation|5|||
146867450|NCT01287364|529687490|FG001|Overall Study|Protocol Violation|5|||
146867451|NCT01287364|529687489|FG000|Overall Study|Other Reason|4|||
146867452|NCT01287364|529687490|FG001|Overall Study|Other Reason|2|||
146867453|NCT00770770|529687500|FG000|Overall Study|Lost to Follow-up|1|||
146867454|NCT00770770|529687501|FG001|Overall Study|Lost to Follow-up|0|||
146867455|NCT00770770|529687500|FG000|Overall Study|Withdrawal by Subject|1|||
146867456|NCT00770770|529687501|FG001|Overall Study|Withdrawal by Subject|0|||
146867457|NCT00770770|529687500|FG000|Overall Study|Death|0|||
146867458|NCT00770770|529687501|FG001|Overall Study|Death|1|||
146867459|NCT00770770|529687500|FG000|Overall Study|Study Terminated|8|||
146867460|NCT00770770|529687501|FG001|Overall Study|Study Terminated|0|||
146867461|NCT00117507|529687506|FG000|Overall Study|Adverse Event|4|||
146867462|NCT00117507|529687506|FG000|Overall Study|Abnormal laboratory values|3|||
146867463|NCT00117507|529687506|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146867464|NCT00117507|529687506|FG000|Overall Study|Patient withdrew consent|4|||
146867465|NCT00117507|529687506|FG000|Overall Study|Death|3|||
146867466|NCT00800436|529687507|FG000|Overall Study|Withdrawal by Subject|0|||
146867467|NCT00800436|529687508|FG001|Overall Study|Withdrawal by Subject|0|||
146867468|NCT00800436|529687509|FG002|Overall Study|Withdrawal by Subject|1|||
146867469|NCT00800436|529687510|FG003|Overall Study|Withdrawal by Subject|1|||
146867470|NCT00800436|529687511|FG004|Overall Study|Withdrawal by Subject|0|||
146867471|NCT00800436|529687512|FG005|Overall Study|Withdrawal by Subject|0|||
146867472|NCT00800436|529687513|FG006|Overall Study|Withdrawal by Subject|0|||
146867473|NCT00711529|529687520|FG000|Overall Study|Protocol Violation|2|||
146867474|NCT00711529|529687521|FG001|Overall Study|Protocol Violation|0|||
146867475|NCT00711529|529687520|FG000|Overall Study|Withdrawal by Subject|2|||
146867476|NCT00711529|529687521|FG001|Overall Study|Withdrawal by Subject|6|||
146867477|NCT03740997|529687524|FG000|Overall Study|Withdrawal by Subject|1|||
146867478|NCT03740997|529687525|FG001|Overall Study|Withdrawal by Subject|0|||
146867479|NCT03740997|529687524|FG000|Overall Study|Participant was unable to complete study procedures|1|||
146867480|NCT03740997|529687525|FG001|Overall Study|Participant was unable to complete study procedures|0|||
146867481|NCT03681951|529687529|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
146867482|NCT03681951|529687530|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
146867483|NCT03681951|529687531|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
146867484|NCT03681951|529687532|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
146867485|NCT03681951|529687533|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
146867486|NCT03681951|529687534|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
146867487|NCT03681951|529687535|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
146867488|NCT03681951|529687536|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
146867489|NCT03681951|529687529|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
146867490|NCT03681951|529687530|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
146867491|NCT03681951|529687531|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
146867492|NCT03681951|529687532|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
146867493|NCT03681951|529687533|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
146867494|NCT03681951|529687534|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
146867495|NCT03681951|529687535|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
146867496|NCT03681951|529687536|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
146867497|NCT03681951|529687529|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
146867498|NCT03681951|529687530|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
146867499|NCT03681951|529687531|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
146867500|NCT03681951|529687532|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
146867501|NCT03681951|529687533|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
146867502|NCT03681951|529687534|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
146867503|NCT03681951|529687535|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
146867504|NCT03681951|529687536|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
146867505|NCT02187809|529687537|FG000|Overall Study|The study was terminated|3|||
146867506|NCT01020448|529687538|FG000|Pre-assignment|Adverse Event|6|||
146867507|NCT01020448|529687538|FG000|Pre-assignment|Withdrawal by Subject|5|||
146867508|NCT01020448|529687538|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
146867509|NCT01020448|529687538|FG000|Treatment|Adverse Event|11|||
146867510|NCT01020448|529687538|FG000|Treatment|Consent Withdrawn|3|||
146867511|NCT01020448|529687538|FG000|Treatment|Disease Progression|2|||
146867512|NCT01020448|529687538|FG000|Treatment|Lack of Efficacy|8|||
146867513|NCT01020448|529687538|FG000|Treatment|Lost to Follow-up|2|||
146867514|NCT00601705|529687539|FG000|Overall Study|Withdrawal by Subject|1|||
146867515|NCT02146599|529687543|FG000|Overall Study|Failed to meet inclusion criteria|5|||
146867516|NCT02101021|529687547|FG000|Overall Study|Death|4|||
146867517|NCT02101021|529687548|FG001|Overall Study|Death|3|||
146867518|NCT02101021|529687549|FG002|Overall Study|Death|6|||
146867519|NCT02101021|529687550|FG003|Overall Study|Death|0|||
146867520|NCT02101021|529687551|FG004|Overall Study|Death|3|||
146867521|NCT02101021|529687547|FG000|Overall Study|Withdrew Consent from study|1|||
146867522|NCT02101021|529687548|FG001|Overall Study|Withdrew Consent from study|1|||
146867523|NCT02101021|529687549|FG002|Overall Study|Withdrew Consent from study|0|||
146867524|NCT02101021|529687550|FG003|Overall Study|Withdrew Consent from study|2|||
146867525|NCT02101021|529687551|FG004|Overall Study|Withdrew Consent from study|0|||
146867526|NCT02101021|529687547|FG000|Overall Study|Lost to Follow-up|1|||
146867527|NCT02101021|529687548|FG001|Overall Study|Lost to Follow-up|0|||
146867528|NCT02101021|529687549|FG002|Overall Study|Lost to Follow-up|0|||
146867529|NCT02101021|529687550|FG003|Overall Study|Lost to Follow-up|0|||
146867530|NCT02101021|529687551|FG004|Overall Study|Lost to Follow-up|0|||
146867531|NCT02101021|529687547|FG000|Overall Study|Study Terminated by Sponsor|1|||
146867532|NCT02101021|529687548|FG001|Overall Study|Study Terminated by Sponsor|0|||
146867533|NCT02101021|529687549|FG002|Overall Study|Study Terminated by Sponsor|1|||
146867534|NCT02101021|529687550|FG003|Overall Study|Study Terminated by Sponsor|1|||
146867535|NCT02101021|529687551|FG004|Overall Study|Study Terminated by Sponsor|1|||
146867536|NCT00387764|529687552|FG000|Overall Study|Adverse Event|12|||
146867537|NCT00387764|529687552|FG000|Overall Study|Withdrawal by Subject|8|||
146867538|NCT00387764|529687552|FG000|Overall Study|Sponsor Terminated Study|1|||
146534153|NCT00606008|528466669|FG000|Overall Study|Adverse Event|1|||
146534154|NCT00606008|528466669|FG000|Overall Study|Withdrawal by Subject|4|||
146534155|NCT02014272|528466675|FG000|Intervention Period 1|Withdrawal by Subject|1|||
146534156|NCT02014272|528466676|FG001|Intervention Period 1|Withdrawal by Subject|0|||
146534157|NCT02014272|528466675|FG000|Intervention Period 1|Adverse Event|0|||
146534158|NCT02014272|528466676|FG001|Intervention Period 1|Adverse Event|1|||
146534159|NCT00547339|528466677|FG000|Overall Study|Physician Decision|0|||
146534160|NCT00547339|528466678|FG001|Overall Study|Physician Decision|0|||
146534161|NCT00547339|528466679|FG002|Overall Study|Physician Decision|1|||
146534162|NCT00547339|528466680|FG003|Overall Study|Physician Decision|0|||
146534163|NCT02369653|528466681|FG000|Overall Study|Lost to Follow-up|0|||
146534164|NCT02369653|528466682|FG001|Overall Study|Lost to Follow-up|1|||
146867539|NCT00387764|529687552|FG000|Overall Study|Physician Decision|1|||
146867540|NCT00387764|529687552|FG000|Overall Study|Other|2|||
146867541|NCT00387764|529687552|FG000|Overall Study|Death|7|||
146867542|NCT04399122|529687553|FG000|Overall Study|Lost to Follow-up|2|||
146867543|NCT04399122|529687554|FG001|Overall Study|Lost to Follow-up|0|||
146867544|NCT04399122|529687553|FG000|Overall Study|Withdrawal by Subject|1|||
146534165|NCT02369653|528466681|FG000|Overall Study|Administrative reason by sponsor|0|||
146867545|NCT04399122|529687554|FG001|Overall Study|Withdrawal by Subject|0|||
146867546|NCT02536755|529687559|FG000|Overall Study|Adverse Event|4|||
146867547|NCT01174238|529687560|FG000|Overall Study|Lost to Follow-up|2|||
146867548|NCT02301936|529687561|FG000|Overall Study|Lost to Follow-up|1|||
146867549|NCT02301936|529687562|FG001|Overall Study|Lost to Follow-up|0|||
146867550|NCT02322229|529687564|FG000|Overall Study|Physician Decision|2|||
146867551|NCT01102803|529687565|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
146867552|NCT01102803|529687566|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
146534166|NCT02369653|528466682|FG001|Overall Study|Administrative reason by sponsor|1|||
146534167|NCT02369653|528466681|FG000|Overall Study|Death|1|||
146534168|NCT02369653|528466682|FG001|Overall Study|Death|2|||
146534169|NCT02369653|528466681|FG000|Overall Study|Participant withdrew consent|13|||
146534170|NCT02369653|528466682|FG001|Overall Study|Participant withdrew consent|3|||
146534171|NCT01458587|528466683|FG000|Overall Study|Withdrawal by Subject|1|||
146534172|NCT01458587|528466684|FG001|Overall Study|Withdrawal by Subject|0|||
146534173|NCT01603602|528466685|FG000|Overall Study|Adverse Event|1|||
146534174|NCT01603602|528466686|FG001|Overall Study|Adverse Event|0|||
146534175|NCT01603602|528466687|FG002|Overall Study|Adverse Event|0|||
146534176|NCT01603602|528466685|FG000|Overall Study|Personal Reasons|1|||
146534177|NCT01603602|528466686|FG001|Overall Study|Personal Reasons|0|||
146534178|NCT01603602|528466687|FG002|Overall Study|Personal Reasons|1|||
146534179|NCT00958074|528466689|FG000|Overall Study|Withdrawal by Subject|0|||
146534180|NCT00958074|528466690|FG001|Overall Study|Withdrawal by Subject|1|||
146534181|NCT03712280|528466693|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
146534182|NCT03712280|528466694|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
146534183|NCT03712280|528466695|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
146534184|NCT03712280|528466696|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
146534185|NCT03712280|528466693|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
146534186|NCT03712280|528466694|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
146534187|NCT03712280|528466695|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
146534188|NCT03712280|528466696|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
146534189|NCT03712280|528466693|FG000|Overall Study|Adverse Event|0|||
146534190|NCT03712280|528466694|FG001|Overall Study|Adverse Event|0|||
146534191|NCT03712280|528466695|FG002|Overall Study|Adverse Event|1|||
146534192|NCT03712280|528466696|FG003|Overall Study|Adverse Event|0|||
146534193|NCT03530293|528466700|FG000|Pre-randomization|Adverse Event|12|||
146534194|NCT03530293|528466701|FG001|Pre-randomization|Adverse Event|0|||
146534195|NCT03530293|528466702|FG002|Pre-randomization|Adverse Event|0|||
146534196|NCT03530293|528466700|FG000|Pre-randomization|Protocol Violation|2|||
146534197|NCT03530293|528466701|FG001|Pre-randomization|Protocol Violation|0|||
146534198|NCT03530293|528466702|FG002|Pre-randomization|Protocol Violation|0|||
146534199|NCT03530293|528466700|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
146534200|NCT03530293|528466701|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
146534201|NCT03530293|528466702|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
146534202|NCT03530293|528466700|FG000|Pre-randomization|Withdrawal by Subject|5|||
146534203|NCT03530293|528466701|FG001|Pre-randomization|Withdrawal by Subject|0|||
146534204|NCT03530293|528466702|FG002|Pre-randomization|Withdrawal by Subject|0|||
146534205|NCT03530293|528466700|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
146534206|NCT03530293|528466701|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
146534207|NCT03530293|528466702|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
146534208|NCT03530293|528466700|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
146534209|NCT03530293|528466701|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
146534210|NCT03530293|528466702|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
146534211|NCT03530293|528466700|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
146534212|NCT03530293|528466701|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
146534213|NCT03530293|528466702|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
146534214|NCT03530293|528466700|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
146534215|NCT03530293|528466701|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
146534216|NCT03530293|528466702|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
146534217|NCT03530293|528466700|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
146534218|NCT03530293|528466701|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
146534219|NCT03530293|528466702|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
146534220|NCT01663623|528466703|FG000|Overall Study|Adverse Event|3|||
146534221|NCT01663623|528466704|FG001|Overall Study|Adverse Event|7|||
146534222|NCT01663623|528466703|FG000|Overall Study|Lack of Efficacy|5|||
146534223|NCT01663623|528466704|FG001|Overall Study|Lack of Efficacy|6|||
146867553|NCT01102803|529687565|FG000|Post to Follow-Up|Lost to Follow-up|1|||
146534224|NCT01663623|528466703|FG000|Overall Study|Protocol Violation|0|||
146534225|NCT01663623|528466704|FG001|Overall Study|Protocol Violation|1|||
146534226|NCT01663623|528466703|FG000|Overall Study|Other-Study closed/terminated|1|||
146534227|NCT01663623|528466704|FG001|Overall Study|Other-Study closed/terminated|1|||
146867554|NCT01102803|529687566|FG001|Post to Follow-Up|Lost to Follow-up|3|||
146867555|NCT00705432|529687567|FG000|Treatment Period|Adverse Event|45|||
146867556|NCT00705432|529687568|FG001|Treatment Period|Adverse Event|37|||
146867557|NCT00705432|529687569|FG002|Treatment Period|Adverse Event|51|||
146867558|NCT00705432|529687570|FG003|Treatment Period|Adverse Event|12|||
146867559|NCT00705432|529687571|FG004|Treatment Period|Adverse Event|8|||
146867560|NCT00705432|529687572|FG005|Treatment Period|Adverse Event|9|||
146867561|NCT00705432|529687567|FG000|Treatment Period|Treatment failure|92|||
146867562|NCT00705432|529687568|FG001|Treatment Period|Treatment failure|42|||
146867563|NCT00705432|529687569|FG002|Treatment Period|Treatment failure|33|||
146867564|NCT00705432|529687570|FG003|Treatment Period|Treatment failure|25|||
146867565|NCT00705432|529687571|FG004|Treatment Period|Treatment failure|13|||
146867566|NCT00705432|529687572|FG005|Treatment Period|Treatment failure|14|||
146867567|NCT00705432|529687567|FG000|Treatment Period|Non medical reason|26|||
146867568|NCT00705432|529687568|FG001|Treatment Period|Non medical reason|32|||
146867569|NCT00705432|529687569|FG002|Treatment Period|Non medical reason|37|||
146867570|NCT00705432|529687570|FG003|Treatment Period|Non medical reason|4|||
146867571|NCT00705432|529687571|FG004|Treatment Period|Non medical reason|7|||
146867572|NCT00705432|529687572|FG005|Treatment Period|Non medical reason|7|||
146867573|NCT00705432|529687567|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
146867574|NCT00705432|529687568|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
146867575|NCT00705432|529687569|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
146867576|NCT00705432|529687570|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
146867577|NCT00705432|529687571|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
146867578|NCT00705432|529687572|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
146867579|NCT00705432|529687567|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
146867580|NCT00705432|529687568|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
146867581|NCT00705432|529687569|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
146867582|NCT00705432|529687570|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
146867583|NCT00705432|529687571|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
146867584|NCT00705432|529687572|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
146867585|NCT00521053|529687573|FG000|Observation Phase|Disease Progression|55|||
146867586|NCT00521053|529687573|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
146867587|NCT00521053|529687573|FG000|Observation Phase|Death|2|||
146867588|NCT00521053|529687573|FG000|Observation Phase|Adverse Event|1|||
146867589|NCT00521053|529687573|FG000|Observation Phase|Other non-study melanoma treatment|1|||
146867590|NCT00521053|529687573|FG000|Observation Phase|Physician Decision|1|||
146867591|NCT02281357|529687576|FG000|Overall Study|Adverse Event|2|||
146867592|NCT02281357|529687577|FG001|Overall Study|Adverse Event|1|||
146867593|NCT02281357|529687576|FG000|Overall Study|Lost to Follow-up|1|||
146867594|NCT02281357|529687577|FG001|Overall Study|Lost to Follow-up|0|||
146867595|NCT02281357|529687576|FG000|Overall Study|Withdrawal by Subject|4|||
146867596|NCT02281357|529687577|FG001|Overall Study|Withdrawal by Subject|3|||
146867597|NCT02684279|529687578|FG000|Overall Study|Adverse Event|87|||
146867598|NCT02684279|529687578|FG000|Overall Study|Lack of Efficacy|4|||
146867599|NCT02684279|529687578|FG000|Overall Study|Lost to Follow-up|61|||
146867600|NCT02684279|529687578|FG000|Overall Study|Protocol Violation|6|||
146867601|NCT02684279|529687578|FG000|Overall Study|Pregnancy|8|||
146867602|NCT02684279|529687578|FG000|Overall Study|Withdrawal by Subject|92|||
146867603|NCT02684279|529687578|FG000|Overall Study|non-compliance with study drug|9|||
146867604|NCT02684279|529687578|FG000|Overall Study|non compliance with study visits|2|||
146867605|NCT02684279|529687578|FG000|Overall Study|subject to have surgery|1|||
146867606|NCT02684279|529687578|FG000|Overall Study|family emergency|1|||
146867607|NCT02684279|529687578|FG000|Overall Study|Site closures|7|||
146867608|NCT02684279|529687578|FG000|Overall Study|Physician Decision|1|||
146534228|NCT01663623|528466703|FG000|Overall Study|Physician Decision|1|||
146867609|NCT01162239|529687579|FG000|Treatment Phase|Withdrawal by Subject|1|||
146867610|NCT01162239|529687580|FG001|Treatment Phase|Withdrawal by Subject|3|||
146867611|NCT01162239|529687581|FG002|Treatment Phase|Withdrawal by Subject|2|||
146867612|NCT01162239|529687582|FG003|Treatment Phase|Withdrawal by Subject|3|||
146867613|NCT01162239|529687579|FG000|Treatment Phase|Death|0|||
146867614|NCT01162239|529687580|FG001|Treatment Phase|Death|0|||
146867615|NCT01162239|529687581|FG002|Treatment Phase|Death|0|||
146867616|NCT01162239|529687582|FG003|Treatment Phase|Death|1|||
146867617|NCT01162239|529687579|FG000|Treatment Phase|Lost to Follow-up|5|||
146867618|NCT01162239|529687580|FG001|Treatment Phase|Lost to Follow-up|4|||
146867619|NCT01162239|529687581|FG002|Treatment Phase|Lost to Follow-up|2|||
146867620|NCT01162239|529687582|FG003|Treatment Phase|Lost to Follow-up|1|||
146534229|NCT01663623|528466704|FG001|Overall Study|Physician Decision|4|||
146867621|NCT01162239|529687579|FG000|Extended Follow-up|Lost to Follow-up|8|||
146867622|NCT01162239|529687580|FG001|Extended Follow-up|Lost to Follow-up|13|||
146867623|NCT01162239|529687581|FG002|Extended Follow-up|Lost to Follow-up|8|||
146867624|NCT01162239|529687582|FG003|Extended Follow-up|Lost to Follow-up|6|||
146867625|NCT04448756|529687585|FG000|Overall Study|Adverse Event|0|||
146867626|NCT04448756|529687586|FG001|Overall Study|Adverse Event|1|||
146867627|NCT04448756|529687587|FG002|Overall Study|Adverse Event|0|||
146867628|NCT04448756|529687585|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
146867629|NCT04448756|529687586|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
146867630|NCT04448756|529687587|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
146867631|NCT04448756|529687585|FG000|Overall Study|Withdrawal by Subject|0|||
146867632|NCT04448756|529687586|FG001|Overall Study|Withdrawal by Subject|3|||
146867633|NCT04448756|529687587|FG002|Overall Study|Withdrawal by Subject|1|||
146867634|NCT04448756|529687585|FG000|Overall Study|Death|2|||
146867635|NCT04448756|529687586|FG001|Overall Study|Death|1|||
146534230|NCT01663623|528466703|FG000|Overall Study|Withdrawal by Subject|2|||
146534231|NCT01663623|528466704|FG001|Overall Study|Withdrawal by Subject|1|||
146534232|NCT00686972|528466705|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
146534233|NCT04465422|528466718|FG000|Overall Study|Lost to Follow-up|0|||
146534234|NCT04465422|528466719|FG001|Overall Study|Lost to Follow-up|2|||
146534235|NCT03307174|528466723|FG000|Overall Study|Unplanned ICU Administrion|5|||
146534236|NCT03307174|528466724|FG001|Overall Study|Unplanned ICU Administrion|3|||
146534237|NCT03307174|528466723|FG000|Overall Study|Aborted Surgery|1|||
146534238|NCT03307174|528466724|FG001|Overall Study|Aborted Surgery|2|||
146534239|NCT03307174|528466723|FG000|Overall Study|Hypotension|6|||
146534240|NCT03307174|528466724|FG001|Overall Study|Hypotension|0|||
146534241|NCT03307174|528466723|FG000|Overall Study|Nonfunctional epidural|1|||
146534242|NCT03307174|528466724|FG001|Overall Study|Nonfunctional epidural|1|||
146534243|NCT03307174|528466723|FG000|Overall Study|Planned epidural removal|1|||
146534244|NCT03307174|528466724|FG001|Overall Study|Planned epidural removal|0|||
146534245|NCT03307174|528466723|FG000|Overall Study|Intrathecal catheter placement|0|||
146534246|NCT03307174|528466724|FG001|Overall Study|Intrathecal catheter placement|1|||
146534247|NCT01192815|528466725|FG000|Overall Study|Withdrawal by Subject|1|||
146534248|NCT01192815|528466725|FG000|Overall Study|Lack of Efficacy|1|||
146534249|NCT03444584|528466726|FG000|Overall Study|Withdrawal by Subject|0|||
146534250|NCT03444584|528466727|FG001|Overall Study|Withdrawal by Subject|1|||
146534251|NCT03444584|528466726|FG000|Overall Study|Other|0|||
146534252|NCT03444584|528466727|FG001|Overall Study|Other|1|||
146534253|NCT00863707|528466728|FG000|Overall Study|Randomized, but drug not received|4|||
146534254|NCT00863707|528466729|FG001|Overall Study|Randomized, but drug not received|3|||
146534255|NCT01142336|528466730|FG000|Overall Study|Adverse Event|1|||
146534256|NCT01142336|528466731|FG001|Overall Study|Adverse Event|1|||
146534257|NCT01142336|528466730|FG000|Overall Study|Lost to Follow-up|0|||
146534258|NCT01142336|528466731|FG001|Overall Study|Lost to Follow-up|1|||
146534259|NCT01704261|528466732|FG000|Overall Study|Withdrawal by Subject|12|||
146534260|NCT01704261|528466733|FG001|Overall Study|Withdrawal by Subject|15|||
146534261|NCT01704261|528466732|FG000|Overall Study|Lost to Follow-up|1|||
146534262|NCT01704261|528466733|FG001|Overall Study|Lost to Follow-up|0|||
146534263|NCT02722967|528466734|FG000|Overall Study|Adverse Event|1|||
146534264|NCT02722967|528466735|FG001|Overall Study|Adverse Event|0|||
146534265|NCT02722967|528466736|FG002|Overall Study|Adverse Event|0|||
146534266|NCT02722967|528466734|FG000|Overall Study|Lost to Follow-up|0|||
146534267|NCT02722967|528466735|FG001|Overall Study|Lost to Follow-up|1|||
146534268|NCT02722967|528466736|FG002|Overall Study|Lost to Follow-up|0|||
146534269|NCT02722967|528466734|FG000|Overall Study|Non-compliance with patch wearing|2|||
146534270|NCT02722967|528466735|FG001|Overall Study|Non-compliance with patch wearing|1|||
146534271|NCT02722967|528466736|FG002|Overall Study|Non-compliance with patch wearing|1|||
146534272|NCT02722967|528466734|FG000|Overall Study|Withdrawal by Subject|1|||
146534273|NCT02722967|528466735|FG001|Overall Study|Withdrawal by Subject|0|||
146534274|NCT02722967|528466736|FG002|Overall Study|Withdrawal by Subject|1|||
146534275|NCT02722967|528466734|FG000|Overall Study|Physician Decision|1|||
146534276|NCT02722967|528466735|FG001|Overall Study|Physician Decision|0|||
146534277|NCT02722967|528466736|FG002|Overall Study|Physician Decision|0|||
146534278|NCT02722967|528466734|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
146534279|NCT02722967|528466735|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
146534280|NCT02722967|528466736|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
146534281|NCT01286129|528466740|FG000|Overall Study|Withdrawal by Subject|4|||
146534282|NCT01286129|528466741|FG001|Overall Study|Withdrawal by Subject|1|||
146534283|NCT01286129|528466740|FG000|Overall Study|Could not comply with study requirements|4|||
146534284|NCT01286129|528466741|FG001|Overall Study|Could not comply with study requirements|4|||
146534285|NCT04142242|528466742|FG000|Stage I|Non-compliance with the protocol|1|||
146534286|NCT04142242|528466743|FG001|Stage I|Non-compliance with the protocol|0|||
146534287|NCT04142242|528466744|FG002|Stage I|Non-compliance with the protocol|0|||
146534288|NCT04142242|528466745|FG003|Stage I|Non-compliance with the protocol|0|||
146534289|NCT04142242|528466746|FG004|Stage I|Non-compliance with the protocol|0|||
146534290|NCT04142242|528466747|FG005|Stage I|Non-compliance with the protocol|1|||
146534291|NCT04142242|528466742|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
146867636|NCT04448756|529687587|FG002|Overall Study|Death|0|||
146534292|NCT04142242|528466743|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
146534293|NCT04142242|528466744|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
146867637|NCT02733185|529687588|FG000|Overall Study|Withdrawal by Subject|12|||
146867638|NCT02733185|529687589|FG001|Overall Study|Withdrawal by Subject|10|||
146867639|NCT02733185|529687590|FG002|Overall Study|Withdrawal by Subject|17|||
146867640|NCT02733185|529687591|FG003|Overall Study|Withdrawal by Subject|21|||
146867641|NCT02733185|529687588|FG000|Overall Study|Death|46|||
146534294|NCT04142242|528466745|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
146534295|NCT04142242|528466746|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
146534296|NCT04142242|528466747|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
146534297|NCT04142242|528466742|FG000|Stage II|Non-compliance with the protocol|0|||
146534298|NCT04142242|528466743|FG001|Stage II|Non-compliance with the protocol|0|||
146534299|NCT04142242|528466744|FG002|Stage II|Non-compliance with the protocol|0|||
146534300|NCT04142242|528466745|FG003|Stage II|Non-compliance with the protocol|2|||
146534301|NCT04142242|528466746|FG004|Stage II|Non-compliance with the protocol|0|||
146534302|NCT04142242|528466747|FG005|Stage II|Non-compliance with the protocol|0|||
146534303|NCT04142242|528466742|FG000|Stage II|Lost to Follow-up|0|||
146534304|NCT04142242|528466743|FG001|Stage II|Lost to Follow-up|0|||
146534305|NCT04142242|528466744|FG002|Stage II|Lost to Follow-up|1|||
146534306|NCT04142242|528466745|FG003|Stage II|Lost to Follow-up|2|||
146534307|NCT04142242|528466746|FG004|Stage II|Lost to Follow-up|0|||
146534308|NCT04142242|528466747|FG005|Stage II|Lost to Follow-up|0|||
146534309|NCT04142242|528466742|FG000|Stage II|Withdrawal by Subject|0|||
146534310|NCT04142242|528466743|FG001|Stage II|Withdrawal by Subject|0|||
146534311|NCT04142242|528466744|FG002|Stage II|Withdrawal by Subject|5|||
146534312|NCT04142242|528466745|FG003|Stage II|Withdrawal by Subject|9|||
146534313|NCT04142242|528466746|FG004|Stage II|Withdrawal by Subject|0|||
146534314|NCT04142242|528466747|FG005|Stage II|Withdrawal by Subject|0|||
146867642|NCT02733185|529687589|FG001|Overall Study|Death|34|||
146867643|NCT02733185|529687590|FG002|Overall Study|Death|35|||
146867644|NCT02733185|529687591|FG003|Overall Study|Death|43|||
146867645|NCT02733185|529687588|FG000|Overall Study|Lost to Follow-up|17|||
146867646|NCT02733185|529687589|FG001|Overall Study|Lost to Follow-up|18|||
146867647|NCT02733185|529687590|FG002|Overall Study|Lost to Follow-up|16|||
146867648|NCT02733185|529687591|FG003|Overall Study|Lost to Follow-up|11|||
146867649|NCT02877927|529687592|FG000|Overall Study|Adverse Event|1|||
146867650|NCT02877927|529687593|FG001|Overall Study|Adverse Event|0|||
146867651|NCT02877927|529687592|FG000|Overall Study|Lost to Follow-up|37|||
146867652|NCT02877927|529687593|FG001|Overall Study|Lost to Follow-up|38|||
146867653|NCT02877927|529687592|FG000|Overall Study|Withdrawal by Subject|11|||
146867654|NCT02877927|529687593|FG001|Overall Study|Withdrawal by Subject|12|||
146867655|NCT02877927|529687592|FG000|Overall Study|Physician Decision|0|||
146867656|NCT02877927|529687593|FG001|Overall Study|Physician Decision|1|||
146867657|NCT02877927|529687592|FG000|Overall Study|Missed EOT/PTE Visit|5|||
146867658|NCT02877927|529687593|FG001|Overall Study|Missed EOT/PTE Visit|6|||
146867659|NCT00601250|529687594|FG000|Overall Study|Adverse Event|3|||
146867660|NCT00601250|529687595|FG001|Overall Study|Adverse Event|9|||
146867661|NCT00601250|529687594|FG000|Overall Study|Protocol Violation|3|||
146867662|NCT00601250|529687595|FG001|Overall Study|Protocol Violation|2|||
146867663|NCT00601250|529687594|FG000|Overall Study|Lost to Follow-up|2|||
146867664|NCT00601250|529687595|FG001|Overall Study|Lost to Follow-up|6|||
146867665|NCT00601250|529687594|FG000|Overall Study|Withdrawal by Subject|4|||
146867666|NCT00601250|529687595|FG001|Overall Study|Withdrawal by Subject|13|||
146867667|NCT00601250|529687594|FG000|Overall Study|Other incl. lack of efficacy|2|||
146867668|NCT00601250|529687595|FG001|Overall Study|Other incl. lack of efficacy|9|||
146867669|NCT01810016|529687596|FG000|Overall Study|Progressive disease|1|||
146867670|NCT01810016|529687597|FG001|Overall Study|Progressive disease|1|||
146867671|NCT01810016|529687598|FG002|Overall Study|Progressive disease|0|||
146867672|NCT01810016|529687596|FG000|Overall Study|Death|0|||
146867673|NCT01810016|529687597|FG001|Overall Study|Death|0|||
146867674|NCT01810016|529687598|FG002|Overall Study|Death|1|||
146867675|NCT01791803|529687603|FG000|Overall Study|Withdrawal by Subject|0|||
146867676|NCT01791803|529687604|FG001|Overall Study|Withdrawal by Subject|0|||
146867677|NCT01791803|529687605|FG002|Overall Study|Withdrawal by Subject|0|||
146867678|NCT01791803|529687606|FG003|Overall Study|Withdrawal by Subject|2|||
146867679|NCT01791803|529687603|FG000|Overall Study|Physician Decision|0|||
146867680|NCT01791803|529687604|FG001|Overall Study|Physician Decision|2|||
146534315|NCT00846053|528466748|FG000|Overall Study|Physician Decision|3|||
146534316|NCT00846053|528466749|FG001|Overall Study|Physician Decision|0|||
146534317|NCT02783911|528466750|FG000|Overall Study|Lost to Follow-up|3|||
146534318|NCT02783911|528466751|FG001|Overall Study|Lost to Follow-up|32|||
146534319|NCT00467519|528466754|FG000|Overall Study|Protocol Violation|8|||
146534320|NCT00467519|528466755|FG001|Overall Study|Protocol Violation|4|||
146534321|NCT00467519|528466754|FG000|Overall Study|Lost to Follow-up|2|||
146534322|NCT00467519|528466755|FG001|Overall Study|Lost to Follow-up|9|||
146867681|NCT01791803|529687605|FG002|Overall Study|Physician Decision|0|||
146867682|NCT01791803|529687606|FG003|Overall Study|Physician Decision|1|||
146867683|NCT01791803|529687603|FG000|Overall Study|Death|0|||
146867684|NCT01791803|529687604|FG001|Overall Study|Death|0|||
146867685|NCT01791803|529687605|FG002|Overall Study|Death|2|||
146867686|NCT01791803|529687606|FG003|Overall Study|Death|2|||
146867687|NCT04572854|529687607|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
146867688|NCT04572854|529687608|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
146867689|NCT04572854|529687609|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
146867690|NCT04572854|529687610|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
146867691|NCT04572854|529687607|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
146867692|NCT04572854|529687608|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
146867693|NCT04572854|529687609|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
146867694|NCT04572854|529687610|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
146867695|NCT00972777|529687611|FG000|Overall Study|Adverse Event|3|||
146867696|NCT00972777|529687612|FG001|Overall Study|Adverse Event|2|||
146867697|NCT00972777|529687611|FG000|Overall Study|Lost to Follow-up|0|||
146867698|NCT00972777|529687612|FG001|Overall Study|Lost to Follow-up|4|||
146867699|NCT00972777|529687611|FG000|Overall Study|Withdrawal by Subject|4|||
146867700|NCT00972777|529687612|FG001|Overall Study|Withdrawal by Subject|5|||
146867701|NCT00972777|529687611|FG000|Overall Study|Physician Decision|4|||
146867702|NCT00972777|529687612|FG001|Overall Study|Physician Decision|0|||
146867703|NCT00972777|529687611|FG000|Overall Study|Protocol Violation|0|||
146867704|NCT00972777|529687612|FG001|Overall Study|Protocol Violation|2|||
146534323|NCT00467519|528466754|FG000|Overall Study|Withdrawal by Subject|4|||
146534324|NCT00467519|528466755|FG001|Overall Study|Withdrawal by Subject|10|||
146534325|NCT01218802|528466759|FG000|Overall Study|Lost to Follow-up|5|||
146534326|NCT01218802|528466760|FG001|Overall Study|Lost to Follow-up|6|||
146534327|NCT01218802|528466759|FG000|Overall Study|Withdrawal by Subject|3|||
146534328|NCT01218802|528466760|FG001|Overall Study|Withdrawal by Subject|10|||
146534329|NCT01218802|528466759|FG000|Overall Study|Adverse Event|0|||
146534330|NCT01218802|528466760|FG001|Overall Study|Adverse Event|2|||
146534331|NCT01218802|528466759|FG000|Overall Study|Incarcerated|2|||
146534332|NCT01218802|528466760|FG001|Overall Study|Incarcerated|0|||
146534333|NCT01123655|528466763|FG000|Overall Study|Medication for RA had to be changed|1|||
146534334|NCT01123655|528466764|FG001|Overall Study|Medication for RA had to be changed|0|||
146534335|NCT01123655|528466765|FG002|Overall Study|Medication for RA had to be changed|0|||
146534336|NCT01123655|528466763|FG000|Overall Study|new illness|0|||
146534337|NCT01123655|528466764|FG001|Overall Study|new illness|1|||
146534338|NCT01123655|528466765|FG002|Overall Study|new illness|0|||
146534339|NCT01123655|528466763|FG000|Overall Study|began prohibitive drug|0|||
146534340|NCT01123655|528466764|FG001|Overall Study|began prohibitive drug|0|||
146534341|NCT01123655|528466765|FG002|Overall Study|began prohibitive drug|1|||
146534342|NCT01776554|528466771|FG000|Overall Study|Adverse Event|1|||
146534343|NCT01776554|528466772|FG001|Overall Study|Adverse Event|0|||
146534344|NCT01776554|528466771|FG000|Overall Study|Withdrawal by Subject|3|||
146534345|NCT01776554|528466772|FG001|Overall Study|Withdrawal by Subject|8|||
146534346|NCT01776554|528466771|FG000|Overall Study|Lost to Follow-up|6|||
146534347|NCT01776554|528466772|FG001|Overall Study|Lost to Follow-up|9|||
146534348|NCT01776554|528466771|FG000|Overall Study|Administrative Reason|2|||
146534349|NCT01776554|528466772|FG001|Overall Study|Administrative Reason|5|||
146534350|NCT01776554|528466771|FG000|Overall Study|Protocol Violation|1|||
146534351|NCT01776554|528466772|FG001|Overall Study|Protocol Violation|0|||
146534352|NCT01776554|528466771|FG000|Overall Study|Unclassified|4|||
146534353|NCT01776554|528466772|FG001|Overall Study|Unclassified|1|||
146534354|NCT01041859|528466773|FG000|Open-Label Titration|Adverse Event|69|||
146534355|NCT01041859|528466774|FG001|Open-Label Titration|Adverse Event|0|||
146534356|NCT01041859|528466775|FG002|Open-Label Titration|Adverse Event|0|||
146534357|NCT01041859|528466773|FG000|Open-Label Titration|Lack of Efficacy|3|||
146534358|NCT01041859|528466774|FG001|Open-Label Titration|Lack of Efficacy|0|||
146534359|NCT01041859|528466775|FG002|Open-Label Titration|Lack of Efficacy|0|||
146534360|NCT01041859|528466773|FG000|Open-Label Titration|Lost to Follow-up|1|||
146534361|NCT01041859|528466774|FG001|Open-Label Titration|Lost to Follow-up|0|||
146534362|NCT01041859|528466775|FG002|Open-Label Titration|Lost to Follow-up|0|||
146534363|NCT01041859|528466773|FG000|Open-Label Titration|Physician Decision|1|||
146534364|NCT01041859|528466774|FG001|Open-Label Titration|Physician Decision|0|||
146534365|NCT01041859|528466775|FG002|Open-Label Titration|Physician Decision|0|||
146534366|NCT01041859|528466773|FG000|Open-Label Titration|Protocol Violation|1|||
146534367|NCT01041859|528466774|FG001|Open-Label Titration|Protocol Violation|0|||
146534368|NCT01041859|528466775|FG002|Open-Label Titration|Protocol Violation|0|||
146534369|NCT01041859|528466773|FG000|Open-Label Titration|Other|7|||
146534370|NCT01041859|528466774|FG001|Open-Label Titration|Other|0|||
146534371|NCT01041859|528466775|FG002|Open-Label Titration|Other|0|||
146534372|NCT01041859|528466773|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
146867705|NCT00972777|529687611|FG000|Overall Study|Screening Failure|2|||
146534373|NCT01041859|528466774|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
146534374|NCT01041859|528466775|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
146534375|NCT01041859|528466773|FG000|Open-Label Titration|Withdrawal by Subject|11|||
146534376|NCT01041859|528466774|FG001|Open-Label Titration|Withdrawal by Subject|0|||
146534377|NCT01041859|528466775|FG002|Open-Label Titration|Withdrawal by Subject|0|||
146534378|NCT01041859|528466773|FG000|Double-Blind Maintenance|Adverse Event|0|||
146534379|NCT01041859|528466774|FG001|Double-Blind Maintenance|Adverse Event|23|||
146867706|NCT00972777|529687612|FG001|Overall Study|Screening Failure|1|||
146867707|NCT00972777|529687611|FG000|Overall Study|Missed visit|1|||
146534380|NCT01041859|528466775|FG002|Double-Blind Maintenance|Adverse Event|13|||
146534381|NCT01041859|528466773|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
146534382|NCT01041859|528466774|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
146534383|NCT01041859|528466775|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
146534384|NCT01041859|528466773|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
146534385|NCT01041859|528466774|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
146534386|NCT01041859|528466775|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
146534387|NCT01041859|528466773|FG000|Double-Blind Maintenance|Physician Decision|0|||
146534388|NCT01041859|528466774|FG001|Double-Blind Maintenance|Physician Decision|2|||
146534389|NCT01041859|528466775|FG002|Double-Blind Maintenance|Physician Decision|1|||
146534390|NCT01041859|528466773|FG000|Double-Blind Maintenance|Protocol Violation|0|||
146534391|NCT01041859|528466774|FG001|Double-Blind Maintenance|Protocol Violation|1|||
146867708|NCT00972777|529687612|FG001|Overall Study|Missed visit|0|||
146867709|NCT01093326|529687613|FG000|Overall Study|Death|0|||
146867710|NCT01093326|529687614|FG001|Overall Study|Death|1|||
146867711|NCT01093326|529687615|FG002|Overall Study|Death|0|||
146534392|NCT01041859|528466775|FG002|Double-Blind Maintenance|Protocol Violation|3|||
146534393|NCT01041859|528466773|FG000|Double-Blind Maintenance|Other|0|||
146534394|NCT01041859|528466774|FG001|Double-Blind Maintenance|Other|6|||
146534395|NCT01041859|528466775|FG002|Double-Blind Maintenance|Other|2|||
146534396|NCT01041859|528466773|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
146534397|NCT01041859|528466774|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
146534398|NCT01041859|528466775|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
146534399|NCT01041859|528466773|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
146534400|NCT01041859|528466774|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
146534401|NCT01041859|528466775|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
146534402|NCT01991795|528466778|FG000|Overall Study|Lost to Follow-up|6|||
146534403|NCT01991795|528466779|FG001|Overall Study|Lost to Follow-up|4|||
146534404|NCT01991795|528466778|FG000|Overall Study|Withdrawal by Subject|117|||
146534405|NCT01991795|528466779|FG001|Overall Study|Withdrawal by Subject|94|||
146534406|NCT01991795|528466778|FG000|Overall Study|Site prematurely closed by sponsor|26|||
146534407|NCT01991795|528466779|FG001|Overall Study|Site prematurely closed by sponsor|25|||
146534408|NCT00885118|528466780|FG000|Overall Study|Adverse Event|1|||
146534409|NCT00885118|528466781|FG001|Overall Study|Adverse Event|0|||
146534410|NCT00885118|528466782|FG002|Overall Study|Adverse Event|0|||
146534411|NCT00885118|528466783|FG003|Overall Study|Adverse Event|0|||
146534412|NCT00885118|528466784|FG004|Overall Study|Adverse Event|0|||
146534413|NCT00885118|528466780|FG000|Overall Study|Withdrawal by Subject|0|||
146534414|NCT00885118|528466781|FG001|Overall Study|Withdrawal by Subject|0|||
146534415|NCT00885118|528466782|FG002|Overall Study|Withdrawal by Subject|0|||
146534416|NCT00885118|528466783|FG003|Overall Study|Withdrawal by Subject|0|||
146534417|NCT00885118|528466784|FG004|Overall Study|Withdrawal by Subject|1|||
146534418|NCT00885118|528466780|FG000|Overall Study|Other reason not defined above|0|||
146534419|NCT00885118|528466781|FG001|Overall Study|Other reason not defined above|0|||
146534420|NCT00885118|528466782|FG002|Overall Study|Other reason not defined above|1|||
146534421|NCT00885118|528466783|FG003|Overall Study|Other reason not defined above|0|||
146534422|NCT00885118|528466784|FG004|Overall Study|Other reason not defined above|0|||
146534423|NCT00094445|528466785|FG000|Overall Study|Withdrawal by Subject|3|||
146534424|NCT00094445|528466785|FG000|Overall Study|Lost to Follow-up|1|||
146534425|NCT00094445|528466785|FG000|Overall Study|Progressive Disease|2|||
146534426|NCT03092752|528466788|FG000|Overall Study|Aged <40 years|14209|||
146867712|NCT01093326|529687613|FG000|Overall Study|Lack of Efficacy|7|||
146867713|NCT01093326|529687614|FG001|Overall Study|Lack of Efficacy|6|||
146867714|NCT01093326|529687615|FG002|Overall Study|Lack of Efficacy|3|||
146867715|NCT01093326|529687613|FG000|Overall Study|Lost to Follow-up|2|||
146867716|NCT01093326|529687614|FG001|Overall Study|Lost to Follow-up|5|||
146867717|NCT01093326|529687615|FG002|Overall Study|Lost to Follow-up|4|||
146534427|NCT03092752|528466788|FG000|Overall Study|At least one claim with T2DM|61299|||
146534428|NCT03092752|528466788|FG000|Overall Study|Having no claim of study drugs|29282|||
146534429|NCT03092752|528466788|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
146534430|NCT03092752|528466788|FG000|Overall Study|<6 month history|245900|||
146534431|NCT06996301|528466789|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
146534432|NCT06996301|528466790|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
146534433|NCT06996301|528466789|FG000|Overall Study|Patients with discordant diagnostic results|107|||
146534434|NCT06996301|528466790|FG001|Overall Study|Patients with discordant diagnostic results|90|||
146534435|NCT06996301|528466789|FG000|Overall Study|Lost to Follow-up|31|||
146534436|NCT06996301|528466790|FG001|Overall Study|Lost to Follow-up|56|||
146534437|NCT06996301|528466789|FG000|Overall Study|Withdrawal by Subject|12|||
146534438|NCT06996301|528466790|FG001|Overall Study|Withdrawal by Subject|7|||
146534439|NCT04030598|528466791|FG000|Overall Study|Voluntary Withdrawal|0|||
146534440|NCT04030598|528466792|FG001|Overall Study|Voluntary Withdrawal|1|||
146534441|NCT04030598|528466793|FG002|Overall Study|Voluntary Withdrawal|0|||
146534442|NCT03141359|528466794|FG000|Overall Study|Death|32|||
146534443|NCT03141359|528466794|FG000|Overall Study|Still On Study (in follow up)|29|||
146867718|NCT01093326|529687613|FG000|Overall Study|Physician Decision|3|||
146867719|NCT01093326|529687614|FG001|Overall Study|Physician Decision|1|||
146867720|NCT01093326|529687615|FG002|Overall Study|Physician Decision|3|||
146867721|NCT01093326|529687613|FG000|Overall Study|Withdrawal by Subject|30|||
146534444|NCT01296412|528466799|FG000|Overall Study|Adverse Event|8|||
146534445|NCT01296412|528466800|FG001|Overall Study|Adverse Event|29|||
146534446|NCT01296412|528466799|FG000|Overall Study|Lack of Efficacy|1|||
146534447|NCT01296412|528466800|FG001|Overall Study|Lack of Efficacy|0|||
146534448|NCT01296412|528466799|FG000|Overall Study|Lost to Follow-up|10|||
146534449|NCT01296412|528466800|FG001|Overall Study|Lost to Follow-up|7|||
146534450|NCT01296412|528466799|FG000|Overall Study|Non-compliance with study drug|1|||
146534451|NCT01296412|528466800|FG001|Overall Study|Non-compliance with study drug|2|||
146534452|NCT01296412|528466799|FG000|Overall Study|Other reason not specified|20|||
146534453|NCT01296412|528466800|FG001|Overall Study|Other reason not specified|15|||
146534454|NCT01296412|528466799|FG000|Overall Study|Physician Decision|1|||
146534455|NCT01296412|528466800|FG001|Overall Study|Physician Decision|3|||
146534456|NCT01296412|528466799|FG000|Overall Study|Pregnancy|0|||
146534457|NCT01296412|528466800|FG001|Overall Study|Pregnancy|1|||
146534458|NCT01296412|528466799|FG000|Overall Study|Withdrawal by Subject|10|||
146534459|NCT01296412|528466800|FG001|Overall Study|Withdrawal by Subject|13|||
146534460|NCT02160626|528466801|FG000|Overall Study|Adverse Event|1|||
146534461|NCT02160626|528466802|FG001|Overall Study|Adverse Event|0|||
146534462|NCT02160626|528466803|FG002|Overall Study|Adverse Event|0|||
146534463|NCT02160626|528466801|FG000|Overall Study|Schedule not conducive to study visits|0|||
146534464|NCT02160626|528466802|FG001|Overall Study|Schedule not conducive to study visits|0|||
146534465|NCT02160626|528466803|FG002|Overall Study|Schedule not conducive to study visits|1|||
146534466|NCT02160626|528466801|FG000|Overall Study|Withdrawal by Subject|0|||
146534467|NCT02160626|528466802|FG001|Overall Study|Withdrawal by Subject|1|||
146534468|NCT02160626|528466803|FG002|Overall Study|Withdrawal by Subject|0|||
146534469|NCT02034006|528468754|FG000|Overall Study|Withdrawal by Subject|7|||
146534470|NCT02034006|528468754|FG000|Overall Study|Lost to Follow-up|5|||
146534471|NCT02034006|528468754|FG000|Overall Study|Death|1|||
146534472|NCT02034006|528468754|FG000|Overall Study|Pregnancy|1|||
146534473|NCT01898078|528468761|FG000|Overall Study|Progressive Disease|1|||
146534474|NCT01898078|528468762|FG001|Overall Study|Progressive Disease|5|||
146534475|NCT01898078|528468761|FG000|Overall Study|Adverse Event|2|||
146534476|NCT01898078|528468762|FG001|Overall Study|Adverse Event|1|||
146534477|NCT01898078|528468761|FG000|Overall Study|Withdrawal by Subject|1|||
146534478|NCT01898078|528468762|FG001|Overall Study|Withdrawal by Subject|1|||
146534479|NCT01898078|528468761|FG000|Overall Study|Symptomatic Deterioration|2|||
146534480|NCT01898078|528468762|FG001|Overall Study|Symptomatic Deterioration|0|||
146534481|NCT01898078|528468761|FG000|Overall Study|Reason not Specified|0|||
146534482|NCT01898078|528468762|FG001|Overall Study|Reason not Specified|1|||
146534483|NCT01075048|528468763|FG000|Overall Study|Death|4|||
146534484|NCT01075048|528468764|FG001|Overall Study|Death|17|||
146534485|NCT01075048|528468765|FG002|Overall Study|Death|12|||
146534486|NCT01075048|528468763|FG000|Overall Study|Start of other or new therapy|4|||
146534487|NCT01075048|528468764|FG001|Overall Study|Start of other or new therapy|36|||
146534488|NCT01075048|528468765|FG002|Overall Study|Start of other or new therapy|46|||
146534489|NCT01075048|528468763|FG000|Overall Study|Withdrawal by Subject|1|||
146534490|NCT01075048|528468764|FG001|Overall Study|Withdrawal by Subject|6|||
146534491|NCT01075048|528468765|FG002|Overall Study|Withdrawal by Subject|3|||
146534492|NCT01075048|528468763|FG000|Overall Study|Lost to Follow-up|0|||
146534493|NCT01075048|528468764|FG001|Overall Study|Lost to Follow-up|1|||
146534494|NCT01075048|528468765|FG002|Overall Study|Lost to Follow-up|1|||
146534495|NCT00761319|528468771|FG000|Overall Study|Protocol Violation|21|||
146534496|NCT00761319|528468772|FG001|Overall Study|Protocol Violation|14|||
146534497|NCT00761319|528468771|FG000|Overall Study|Adverse Event|11|||
146534498|NCT00761319|528468772|FG001|Overall Study|Adverse Event|7|||
146534499|NCT00761319|528468771|FG000|Overall Study|Withdrawal by Subject|8|||
146534500|NCT00761319|528468772|FG001|Overall Study|Withdrawal by Subject|7|||
146534501|NCT00761319|528468771|FG000|Overall Study|Noncompliance|4|||
146867722|NCT01093326|529687614|FG001|Overall Study|Withdrawal by Subject|27|||
146867723|NCT01093326|529687615|FG002|Overall Study|Withdrawal by Subject|26|||
146867724|NCT01093326|529687613|FG000|Overall Study|Adverse Event|2|||
146867725|NCT01093326|529687614|FG001|Overall Study|Adverse Event|1|||
146534502|NCT00761319|528468772|FG001|Overall Study|Noncompliance|3|||
146534503|NCT00761319|528468771|FG000|Overall Study|Lost to Follow-up|1|||
146534504|NCT00761319|528468772|FG001|Overall Study|Lost to Follow-up|1|||
146534505|NCT00761319|528468771|FG000|Overall Study|Nonspecified|2|||
146534506|NCT00761319|528468772|FG001|Overall Study|Nonspecified|2|||
146867726|NCT01093326|529687615|FG002|Overall Study|Adverse Event|4|||
146534507|NCT00761319|528468771|FG000|Overall Study|Missing|1|||
146534508|NCT00761319|528468772|FG001|Overall Study|Missing|0|||
146534509|NCT01715831|528468777|FG000|Overall Study|Adverse Event|1|||
146534510|NCT00900562|528468780|FG000|Overall Study|Progressive disease|9|||
146534511|NCT00900562|528468781|FG001|Overall Study|Progressive disease|5|||
146534512|NCT00900562|528468780|FG000|Overall Study|Toxicity|1|||
146534513|NCT00900562|528468781|FG001|Overall Study|Toxicity|0|||
146867727|NCT01093326|529687613|FG000|Overall Study|Other|0|||
146867728|NCT01093326|529687614|FG001|Overall Study|Other|0|||
146867729|NCT01093326|529687615|FG002|Overall Study|Other|1|||
146867730|NCT05162027|529689564|FG000|Overall Study|Adverse Event|1|||
146867731|NCT05162027|529689565|FG001|Overall Study|Adverse Event|0|||
146867732|NCT02553265|529689566|FG000|Enrollment|Death|0|||
146867733|NCT02553265|529689567|FG001|Enrollment|Death|0|||
146867734|NCT02553265|529689568|FG002|Enrollment|Death|1|||
146867735|NCT02553265|529689566|FG000|First Intervention (28 Days)|Adverse Event|1|||
146867736|NCT02553265|529689567|FG001|First Intervention (28 Days)|Adverse Event|0|||
146867737|NCT02553265|529689568|FG002|First Intervention (28 Days)|Adverse Event|0|||
146867738|NCT02553265|529689566|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
146867739|NCT02553265|529689567|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
146867740|NCT02553265|529689568|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
146867741|NCT02553265|529689566|FG000|Second Intervention (28 Days)|Adverse Event|1|||
146867742|NCT02553265|529689567|FG001|Second Intervention (28 Days)|Adverse Event|0|||
146867743|NCT02553265|529689568|FG002|Second Intervention (28 Days)|Adverse Event|0|||
146867744|NCT02553265|529689566|FG000|Third Intervention (28 Days)|Adverse Event|1|||
146867745|NCT02553265|529689567|FG001|Third Intervention (28 Days)|Adverse Event|0|||
146867746|NCT02553265|529689568|FG002|Third Intervention (28 Days)|Adverse Event|0|||
146867747|NCT02553265|529689566|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
146867748|NCT02553265|529689567|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
146867749|NCT02553265|529689568|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
146867750|NCT02460497|529689571|FG000|Overall Study|Participant Requested Withdrawal|4|||
146867751|NCT02460497|529689571|FG000|Overall Study|Non-Compliance|1|||
146867752|NCT02460497|529689571|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
146867753|NCT02460497|529689571|FG000|Overall Study|Lost to Follow-up|2|||
146867754|NCT02460497|529689571|FG000|Overall Study|Investigator Decision|1|||
146867755|NCT01650285|529689575|FG000|Overall Study|Adverse Event|1|||
146867756|NCT00659529|529689576|FG000|Overall Study|Withdrawal by Subject|4|||
146867757|NCT00659529|529689576|FG000|Overall Study|Protocol Violation|3|||
146867758|NCT00659529|529689576|FG000|Overall Study|Screen failure|9|||
146867759|NCT00283049|529689582|FG000|Overall Study|Adverse Event|6|||
146867760|NCT00283049|529689583|FG001|Overall Study|Adverse Event|1|||
146867761|NCT00283049|529689584|FG002|Overall Study|Adverse Event|4|||
146867762|NCT00283049|529689582|FG000|Overall Study|Protocol Violation|3|||
146867763|NCT00283049|529689583|FG001|Overall Study|Protocol Violation|0|||
146867764|NCT00283049|529689584|FG002|Overall Study|Protocol Violation|3|||
146867765|NCT00283049|529689582|FG000|Overall Study|Death|1|||
146867766|NCT00283049|529689583|FG001|Overall Study|Death|1|||
146867767|NCT00283049|529689584|FG002|Overall Study|Death|1|||
146867768|NCT00283049|529689582|FG000|Overall Study|Lack of Efficacy|0|||
146867769|NCT00283049|529689583|FG001|Overall Study|Lack of Efficacy|1|||
146867770|NCT00283049|529689584|FG002|Overall Study|Lack of Efficacy|1|||
146867771|NCT00283049|529689582|FG000|Overall Study|Lost to Follow-up|4|||
146867772|NCT00283049|529689583|FG001|Overall Study|Lost to Follow-up|2|||
146867773|NCT00283049|529689584|FG002|Overall Study|Lost to Follow-up|5|||
146867774|NCT00283049|529689582|FG000|Overall Study|Withdrawal by Subject|26|||
146867775|NCT00283049|529689583|FG001|Overall Study|Withdrawal by Subject|24|||
146867776|NCT00283049|529689584|FG002|Overall Study|Withdrawal by Subject|19|||
146867777|NCT00283049|529689582|FG000|Overall Study|Discontinuation of Study|18|||
146867778|NCT00283049|529689583|FG001|Overall Study|Discontinuation of Study|16|||
146867779|NCT00283049|529689584|FG002|Overall Study|Discontinuation of Study|20|||
146867780|NCT00283049|529689582|FG000|Overall Study|No longer requires study treatment|0|||
146867781|NCT00283049|529689583|FG001|Overall Study|No longer requires study treatment|0|||
146867782|NCT00283049|529689584|FG002|Overall Study|No longer requires study treatment|1|||
146867783|NCT01086410|529689585|FG000|Overall Study|Adverse Event|1|||
146867784|NCT01086410|529689586|FG001|Overall Study|Adverse Event|0|||
146867785|NCT01086410|529689587|FG002|Overall Study|Adverse Event|0|||
146867786|NCT01086410|529689588|FG003|Overall Study|Adverse Event|2|||
146867787|NCT01086410|529689585|FG000|Overall Study|Lack of Efficacy|1|||
146867788|NCT01086410|529689586|FG001|Overall Study|Lack of Efficacy|1|||
146867789|NCT01086410|529689587|FG002|Overall Study|Lack of Efficacy|0|||
146867790|NCT01086410|529689588|FG003|Overall Study|Lack of Efficacy|0|||
146867791|NCT01086410|529689585|FG000|Overall Study|Protocol Violation|1|||
146867792|NCT01086410|529689586|FG001|Overall Study|Protocol Violation|1|||
146867793|NCT01086410|529689587|FG002|Overall Study|Protocol Violation|0|||
146867794|NCT01086410|529689588|FG003|Overall Study|Protocol Violation|0|||
146867795|NCT01086410|529689585|FG000|Overall Study|Lost to Follow-up|0|||
146867796|NCT01086410|529689586|FG001|Overall Study|Lost to Follow-up|0|||
146867797|NCT01086410|529689587|FG002|Overall Study|Lost to Follow-up|1|||
146867798|NCT01086410|529689588|FG003|Overall Study|Lost to Follow-up|0|||
146867799|NCT04196803|529689589|FG000|Overall Study|Withdrawal by Subject|1|||
146867800|NCT04196803|529689590|FG001|Overall Study|Withdrawal by Subject|3|||
146867801|NCT04196803|529689589|FG000|Overall Study|Adverse Event|4|||
146867802|NCT04196803|529689590|FG001|Overall Study|Adverse Event|2|||
146867803|NCT04196803|529689589|FG000|Overall Study|Lost to Follow-up|0|||
146867804|NCT04196803|529689590|FG001|Overall Study|Lost to Follow-up|1|||
146867805|NCT01022996|529689591|FG000|Overall Study|Adverse Event|14|||
146867806|NCT01022996|529689591|FG000|Overall Study|Withdrawal by Subject|3|||
146867807|NCT01022996|529689591|FG000|Overall Study|Lost to Follow-up|1|||
146534514|NCT00900562|528468780|FG000|Overall Study|Death|1|||
146534515|NCT00900562|528468781|FG001|Overall Study|Death|1|||
146534516|NCT00900562|528468780|FG000|Overall Study|Withdrawal by Subject|0|||
146534517|NCT00900562|528468781|FG001|Overall Study|Withdrawal by Subject|1|||
146534518|NCT00900562|528468780|FG000|Overall Study|Unrelated adverse event|1|||
146534519|NCT00900562|528468781|FG001|Overall Study|Unrelated adverse event|0|||
146534520|NCT01516216|528468782|FG000|Overall Study|Adverse Event|2|||
146534521|NCT01516216|528468783|FG001|Overall Study|Adverse Event|4|||
146534522|NCT01516216|528468782|FG000|Overall Study|Disease Progression|38|||
146534523|NCT01516216|528468783|FG001|Overall Study|Disease Progression|34|||
146534524|NCT01516216|528468782|FG000|Overall Study|Withdrawal by Subject|9|||
146534525|NCT01516216|528468783|FG001|Overall Study|Withdrawal by Subject|11|||
146534526|NCT01516216|528468782|FG000|Overall Study|Potentially Curative Resection|6|||
146534527|NCT01516216|528468783|FG001|Overall Study|Potentially Curative Resection|12|||
146534528|NCT01516216|528468782|FG000|Overall Study|Nonadherence|2|||
146534529|NCT01516216|528468783|FG001|Overall Study|Nonadherence|3|||
146534530|NCT01516216|528468782|FG000|Overall Study|Physician Decision|6|||
146534531|NCT01516216|528468783|FG001|Overall Study|Physician Decision|3|||
146534532|NCT01516216|528468782|FG000|Overall Study|Prolonged Treatment Delay|5|||
146534533|NCT01516216|528468783|FG001|Overall Study|Prolonged Treatment Delay|1|||
146534534|NCT01516216|528468782|FG000|Overall Study|Intercurrent Illness|1|||
146534535|NCT01516216|528468783|FG001|Overall Study|Intercurrent Illness|0|||
146534536|NCT01516216|528468782|FG000|Overall Study|Death|1|||
146534537|NCT01516216|528468783|FG001|Overall Study|Death|1|||
146534538|NCT03098979|528468784|FG000|Overall Study|Adverse Event|1|||
146534539|NCT03098979|528468785|FG001|Overall Study|Adverse Event|0|||
146534540|NCT03098979|528468786|FG002|Overall Study|Adverse Event|1|||
146534541|NCT03098979|528468787|FG003|Overall Study|Adverse Event|4|||
146534542|NCT03098979|528468788|FG004|Overall Study|Adverse Event|6|||
146534543|NCT03098979|528468789|FG005|Overall Study|Adverse Event|1|||
146534544|NCT03098979|528468784|FG000|Overall Study|Withdrawal by Subject|2|||
146534545|NCT03098979|528468785|FG001|Overall Study|Withdrawal by Subject|1|||
146534546|NCT03098979|528468786|FG002|Overall Study|Withdrawal by Subject|1|||
146534547|NCT03098979|528468787|FG003|Overall Study|Withdrawal by Subject|1|||
146534548|NCT03098979|528468788|FG004|Overall Study|Withdrawal by Subject|2|||
146534549|NCT03098979|528468789|FG005|Overall Study|Withdrawal by Subject|1|||
146534550|NCT03098979|528468784|FG000|Overall Study|Death|1|||
146534551|NCT03098979|528468785|FG001|Overall Study|Death|0|||
146534552|NCT03098979|528468786|FG002|Overall Study|Death|2|||
146534553|NCT03098979|528468787|FG003|Overall Study|Death|0|||
146534554|NCT03098979|528468788|FG004|Overall Study|Death|1|||
146534555|NCT03098979|528468789|FG005|Overall Study|Death|0|||
146534556|NCT03098979|528468784|FG000|Overall Study|Physician Decision|2|||
146867808|NCT01022996|529689591|FG000|Overall Study|Administrative problems|6|||
146534557|NCT03098979|528468785|FG001|Overall Study|Physician Decision|1|||
146534558|NCT03098979|528468786|FG002|Overall Study|Physician Decision|0|||
146534559|NCT03098979|528468787|FG003|Overall Study|Physician Decision|0|||
146534560|NCT03098979|528468788|FG004|Overall Study|Physician Decision|0|||
146534561|NCT03098979|528468789|FG005|Overall Study|Physician Decision|0|||
146534562|NCT03098979|528468784|FG000|Overall Study|Non-compliance|0|||
146867809|NCT01022996|529689591|FG000|Overall Study|Disease Progression|32|||
146867810|NCT01022996|529689591|FG000|Overall Study|Protocol Violation|1|||
146867811|NCT01950247|529689593|FG000|Overall Study|Withdrawal by Subject|28|||
146534563|NCT03098979|528468785|FG001|Overall Study|Non-compliance|0|||
146867812|NCT01950247|529689594|FG001|Overall Study|Withdrawal by Subject|13|||
146534564|NCT03098979|528468786|FG002|Overall Study|Non-compliance|0|||
146534565|NCT03098979|528468787|FG003|Overall Study|Non-compliance|0|||
146534566|NCT03098979|528468788|FG004|Overall Study|Non-compliance|0|||
146534567|NCT03098979|528468789|FG005|Overall Study|Non-compliance|1|||
146534568|NCT03098979|528468784|FG000|Overall Study|Protocol Violation|0|||
146534569|NCT03098979|528468785|FG001|Overall Study|Protocol Violation|0|||
146534570|NCT03098979|528468786|FG002|Overall Study|Protocol Violation|0|||
146534571|NCT03098979|528468787|FG003|Overall Study|Protocol Violation|0|||
146534572|NCT03098979|528468788|FG004|Overall Study|Protocol Violation|0|||
146867813|NCT01950247|529689593|FG000|Overall Study|Lost to Follow-up|18|||
146534573|NCT03098979|528468789|FG005|Overall Study|Protocol Violation|1|||
146534574|NCT03736967|528468790|FG000|Overall Study|Withdrawal by Subject|26|||
146534575|NCT03736967|528468791|FG001|Overall Study|Withdrawal by Subject|25|||
146534576|NCT03736967|528468792|FG002|Overall Study|Withdrawal by Subject|23|||
146867814|NCT01950247|529689594|FG001|Overall Study|Lost to Follow-up|16|||
146867815|NCT01950247|529689593|FG000|Overall Study|Physician Decision|3|||
146867816|NCT01950247|529689594|FG001|Overall Study|Physician Decision|4|||
146867817|NCT01950247|529689593|FG000|Overall Study|Adverse Event|3|||
146867818|NCT01950247|529689594|FG001|Overall Study|Adverse Event|2|||
146867819|NCT01950247|529689593|FG000|Overall Study|Death|1|||
146867820|NCT01950247|529689594|FG001|Overall Study|Death|1|||
146867821|NCT01950247|529689593|FG000|Overall Study|Not Defined|4|||
146867822|NCT01950247|529689594|FG001|Overall Study|Not Defined|10|||
146867823|NCT00763971|529689595|FG000|Overall Study|Adverse Event|5|||
146867824|NCT00763971|529689596|FG001|Overall Study|Adverse Event|2|||
146867825|NCT00763971|529689597|FG002|Overall Study|Adverse Event|4|||
146867826|NCT00763971|529689595|FG000|Overall Study|Protocol Violation|3|||
146867827|NCT00763971|529689596|FG001|Overall Study|Protocol Violation|3|||
146867828|NCT00763971|529689597|FG002|Overall Study|Protocol Violation|2|||
146867829|NCT00763971|529689595|FG000|Overall Study|Withdrawal by Subject|4|||
146867830|NCT00763971|529689596|FG001|Overall Study|Withdrawal by Subject|5|||
146534577|NCT03736967|528468793|FG003|Overall Study|Withdrawal by Subject|26|||
146534578|NCT03736967|528468790|FG000|Overall Study|Lost to Follow-up|3|||
146534579|NCT03736967|528468791|FG001|Overall Study|Lost to Follow-up|2|||
146534580|NCT03736967|528468792|FG002|Overall Study|Lost to Follow-up|1|||
146534581|NCT03736967|528468793|FG003|Overall Study|Lost to Follow-up|1|||
146534582|NCT03736967|528468790|FG000|Overall Study|Physician Decision|1|||
146534583|NCT03736967|528468791|FG001|Overall Study|Physician Decision|0|||
146534584|NCT03736967|528468792|FG002|Overall Study|Physician Decision|0|||
146534585|NCT03736967|528468793|FG003|Overall Study|Physician Decision|1|||
146534586|NCT03736967|528468790|FG000|Overall Study|Adverse Event|0|||
146534587|NCT03736967|528468791|FG001|Overall Study|Adverse Event|1|||
146534588|NCT03736967|528468792|FG002|Overall Study|Adverse Event|0|||
146534589|NCT03736967|528468793|FG003|Overall Study|Adverse Event|1|||
146534590|NCT03736967|528468790|FG000|Overall Study|Death|0|||
146534591|NCT03736967|528468791|FG001|Overall Study|Death|0|||
146534592|NCT03736967|528468792|FG002|Overall Study|Death|0|||
146534593|NCT03736967|528468793|FG003|Overall Study|Death|1|||
146534594|NCT03736967|528468790|FG000|Overall Study|Randomized but never treated|1|||
146534595|NCT03736967|528468791|FG001|Overall Study|Randomized but never treated|0|||
146534596|NCT03736967|528468792|FG002|Overall Study|Randomized but never treated|0|||
146534597|NCT03736967|528468793|FG003|Overall Study|Randomized but never treated|0|||
146534598|NCT02419807|528468794|FG000|Overall Study|Withdrawal by Subject|4|||
146534599|NCT02419807|528468794|FG000|Overall Study|Physician Decision|1|||
146534600|NCT02419807|528468794|FG000|Overall Study|Protocol Violation|5|||
146534601|NCT03587636|528468795|FG000|Overall Study|Lost to Follow-up|2|||
146534602|NCT03587636|528468796|FG001|Overall Study|Lost to Follow-up|5|||
146534603|NCT01006629|528468797|FG000|Overall Study|Adverse Event|1|||
146534604|NCT01006629|528468797|FG000|Overall Study|Parent refused to continue participation|1|||
146534605|NCT01006629|528468797|FG000|Overall Study|Parent unable to perform site visit|4|||
146534606|NCT00316004|528468798|FG000|Overall Study|Subject was not given study fluid.|14|||
146534607|NCT00316004|528468799|FG001|Overall Study|Subject was not given study fluid.|14|||
146534608|NCT00316004|528468800|FG002|Overall Study|Subject was not given study fluid.|21|||
146534609|NCT01065818|528468801|FG000|Overall Study|Withdrawal by Subject|1|||
146534610|NCT01065818|528468801|FG000|Overall Study|Not a candidate for surgery|1|||
146534611|NCT04459338|528468804|FG000|Overall Study|Loss of IV during study|1|||
146534612|NCT04459338|528468805|FG001|Overall Study|Loss of IV during study|0|||
146534613|NCT03157089|528468806|FG000|Overall Study|Treated only with pembrolizumab|1|||
146534614|NCT03157089|528468807|FG001|Overall Study|Treated only with pembrolizumab|0|||
146534615|NCT03157089|528468806|FG000|Overall Study|Adverse Event|5|||
146534616|NCT03157089|528468807|FG001|Overall Study|Adverse Event|4|||
146534617|NCT03157089|528468806|FG000|Overall Study|Progressive disease|6|||
146534618|NCT03157089|528468807|FG001|Overall Study|Progressive disease|8|||
146534619|NCT02665117|528468810|FG000|Overall Study|Physician Decision|1|||
146534620|NCT02665117|528468811|FG001|Overall Study|Physician Decision|0|||
146534621|NCT00977197|528468814|FG000|Overall Study|Withdrawal by Subject|3|||
146534622|NCT00977197|528468815|FG001|Overall Study|Withdrawal by Subject|4|||
146534623|NCT00977197|528468814|FG000|Overall Study|Adverse Event|3|||
146534624|NCT00977197|528468815|FG001|Overall Study|Adverse Event|1|||
146534625|NCT00977197|528468814|FG000|Overall Study|Lack of Efficacy|1|||
146534626|NCT00977197|528468815|FG001|Overall Study|Lack of Efficacy|0|||
146534627|NCT00977197|528468814|FG000|Overall Study|Lost to Follow-up|1|||
146534628|NCT00977197|528468815|FG001|Overall Study|Lost to Follow-up|3|||
146534629|NCT00977197|528468814|FG000|Overall Study|Nonadherence|1|||
146867831|NCT00763971|529689597|FG002|Overall Study|Withdrawal by Subject|5|||
146534630|NCT00977197|528468815|FG001|Overall Study|Nonadherence|1|||
146534631|NCT00784875|528468816|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
146534632|NCT00784875|528468817|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
146534633|NCT00784875|528468818|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
146534634|NCT00784875|528468819|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
146534635|NCT00784875|528468816|FG000|Period A - Baseline|Adverse Event|0|||
146867832|NCT00763971|529689595|FG000|Overall Study|Lost to Follow-up|0|||
146867833|NCT00763971|529689596|FG001|Overall Study|Lost to Follow-up|1|||
146867834|NCT00763971|529689597|FG002|Overall Study|Lost to Follow-up|0|||
146867835|NCT00763971|529689595|FG000|Overall Study|Lack of Efficacy|11|||
146867836|NCT00763971|529689596|FG001|Overall Study|Lack of Efficacy|22|||
146867837|NCT00763971|529689597|FG002|Overall Study|Lack of Efficacy|54|||
146867838|NCT00763971|529689595|FG000|Overall Study|Unable to swallow capsule|2|||
146867839|NCT00763971|529689596|FG001|Overall Study|Unable to swallow capsule|1|||
146867840|NCT00763971|529689597|FG002|Overall Study|Unable to swallow capsule|1|||
146867841|NCT00763971|529689595|FG000|Overall Study|Personal reason|3|||
146867842|NCT00763971|529689596|FG001|Overall Study|Personal reason|0|||
146867843|NCT00763971|529689597|FG002|Overall Study|Personal reason|0|||
146867844|NCT00763971|529689595|FG000|Overall Study|Exclusion criteria met|1|||
146867845|NCT00763971|529689596|FG001|Overall Study|Exclusion criteria met|0|||
146867846|NCT00763971|529689597|FG002|Overall Study|Exclusion criteria met|0|||
146867847|NCT00763971|529689595|FG000|Overall Study|Sponsor decision|1|||
146867848|NCT00763971|529689596|FG001|Overall Study|Sponsor decision|0|||
146867849|NCT00763971|529689597|FG002|Overall Study|Sponsor decision|0|||
146867850|NCT00763971|529689595|FG000|Overall Study|Due to holiday season|2|||
146867851|NCT00763971|529689596|FG001|Overall Study|Due to holiday season|0|||
146867852|NCT00763971|529689597|FG002|Overall Study|Due to holiday season|1|||
146867853|NCT00763971|529689595|FG000|Overall Study|Randomization error|0|||
146867854|NCT00763971|529689596|FG001|Overall Study|Randomization error|0|||
146867855|NCT00763971|529689597|FG002|Overall Study|Randomization error|1|||
146867856|NCT00763971|529689595|FG000|Overall Study|Medical monitor decision|0|||
146867857|NCT00763971|529689596|FG001|Overall Study|Medical monitor decision|0|||
146867858|NCT00763971|529689597|FG002|Overall Study|Medical monitor decision|1|||
146867859|NCT00763971|529689595|FG000|Overall Study|Moved to another country|0|||
146867860|NCT00763971|529689596|FG001|Overall Study|Moved to another country|1|||
146867861|NCT00763971|529689597|FG002|Overall Study|Moved to another country|0|||
146867862|NCT00763971|529689595|FG000|Overall Study|Subject wanted dose reduction|0|||
146867863|NCT00763971|529689596|FG001|Overall Study|Subject wanted dose reduction|1|||
146867864|NCT00763971|529689597|FG002|Overall Study|Subject wanted dose reduction|0|||
146867865|NCT00763971|529689595|FG000|Overall Study|Lack of availability|0|||
146867866|NCT00763971|529689596|FG001|Overall Study|Lack of availability|1|||
146867867|NCT00763971|529689597|FG002|Overall Study|Lack of availability|0|||
146867868|NCT00763971|529689595|FG000|Overall Study|Performed final visit on phone|0|||
146867869|NCT00763971|529689596|FG001|Overall Study|Performed final visit on phone|1|||
146867870|NCT00763971|529689597|FG002|Overall Study|Performed final visit on phone|0|||
146867871|NCT00763971|529689595|FG000|Overall Study|Participation in 489-326 required|1|||
146867872|NCT00763971|529689596|FG001|Overall Study|Participation in 489-326 required|0|||
146867873|NCT00763971|529689597|FG002|Overall Study|Participation in 489-326 required|0|||
146867874|NCT00710879|529689598|FG000|Overall Study|Lost to Follow-up|2|||
146867875|NCT00710879|529689599|FG001|Overall Study|Lost to Follow-up|1|||
146867876|NCT00710879|529689598|FG000|Overall Study|Protocol Violation|0|||
146867877|NCT00710879|529689599|FG001|Overall Study|Protocol Violation|3|||
146867878|NCT03383289|529689602|FG000|Overall Study|Death|83|||
146534636|NCT00784875|528468817|FG001|Period A - Baseline|Adverse Event|0|||
146534637|NCT00784875|528468818|FG002|Period A - Baseline|Adverse Event|0|||
146534638|NCT00784875|528468819|FG003|Period A - Baseline|Adverse Event|8|||
146534639|NCT00784875|528468816|FG000|Period A - Baseline|Protocol Violation|0|||
146534640|NCT00784875|528468817|FG001|Period A - Baseline|Protocol Violation|0|||
146534641|NCT00784875|528468818|FG002|Period A - Baseline|Protocol Violation|0|||
146534642|NCT00784875|528468819|FG003|Period A - Baseline|Protocol Violation|25|||
146534643|NCT00784875|528468816|FG000|Period A - Baseline|Withdrawal by Subject|0|||
146534644|NCT00784875|528468817|FG001|Period A - Baseline|Withdrawal by Subject|0|||
146534645|NCT00784875|528468818|FG002|Period A - Baseline|Withdrawal by Subject|0|||
146534646|NCT00784875|528468819|FG003|Period A - Baseline|Withdrawal by Subject|27|||
146534647|NCT00784875|528468816|FG000|Period A - Baseline|Physician Decision|0|||
146534648|NCT00784875|528468817|FG001|Period A - Baseline|Physician Decision|0|||
146534649|NCT00784875|528468818|FG002|Period A - Baseline|Physician Decision|0|||
146534650|NCT00784875|528468819|FG003|Period A - Baseline|Physician Decision|2|||
146534651|NCT00784875|528468816|FG000|Period A - Baseline|Sponsor Decision|0|||
146534652|NCT00784875|528468817|FG001|Period A - Baseline|Sponsor Decision|0|||
146534653|NCT00784875|528468818|FG002|Period A - Baseline|Sponsor Decision|0|||
146534654|NCT00784875|528468819|FG003|Period A - Baseline|Sponsor Decision|113|||
146534655|NCT00784875|528468816|FG000|Period A - Baseline|Lost to Follow-up|0|||
146534656|NCT00784875|528468817|FG001|Period A - Baseline|Lost to Follow-up|0|||
146867879|NCT03383289|529689603|FG001|Overall Study|Death|78|||
146867880|NCT03383289|529689602|FG000|Overall Study|discharge from facility|84|||
146867881|NCT03383289|529689603|FG001|Overall Study|discharge from facility|84|||
146867882|NCT03383289|529689602|FG000|Overall Study|Withdrawal by Subject|4|||
146867883|NCT03383289|529689603|FG001|Overall Study|Withdrawal by Subject|1|||
146867884|NCT00884325|529689604|FG000|Overall Study|Lost to Follow-up|1|||
146867885|NCT00884325|529689605|FG001|Overall Study|Lost to Follow-up|2|||
146867886|NCT00884325|529689604|FG000|Overall Study|Lack of Efficacy|0|||
146867887|NCT00884325|529689605|FG001|Overall Study|Lack of Efficacy|1|||
146867888|NCT00884325|529689604|FG000|Overall Study|Withdrawal by Subject|1|||
146867889|NCT00884325|529689605|FG001|Overall Study|Withdrawal by Subject|1|||
146867890|NCT00884325|529689604|FG000|Overall Study|Not provided|1|||
146867891|NCT00884325|529689605|FG001|Overall Study|Not provided|0|||
146867892|NCT00832117|529689606|FG000|Overall Study|Death|1|||
146867893|NCT00832117|529689606|FG000|Overall Study|Disease Progression|11|||
146867894|NCT04439071|529689607|FG000|Overall Study|Lost to Follow-up|0|||
146867895|NCT04439071|529689608|FG001|Overall Study|Lost to Follow-up|3|||
146867896|NCT04439071|529689607|FG000|Overall Study|Withdrawal by Subject|3|||
146867897|NCT04439071|529689608|FG001|Overall Study|Withdrawal by Subject|8|||
146867898|NCT04439071|529689607|FG000|Overall Study|Death|6|||
146867899|NCT04439071|529689608|FG001|Overall Study|Death|4|||
146867900|NCT04439071|529689607|FG000|Overall Study|Other than specified|3|||
146867901|NCT04439071|529689608|FG001|Overall Study|Other than specified|3|||
146867902|NCT04439071|529689607|FG000|Overall Study|Randomized but not treated|2|||
146867903|NCT04439071|529689608|FG001|Overall Study|Randomized but not treated|0|||
146867904|NCT01446016|529689609|FG000|Overall Study|Lost to Follow-up|3|||
146867905|NCT01446016|529689609|FG000|Overall Study|Withdrawal by Subject|1|||
146867906|NCT01446016|529689609|FG000|Overall Study|Toxicity|3|||
146867907|NCT01087957|529689616|FG000|Overall Study|Death|2|||
146867908|NCT01087957|529689617|FG001|Overall Study|Death|2|||
146867909|NCT01087957|529689616|FG000|Overall Study|Lost to Follow-up|3|||
146867910|NCT01087957|529689617|FG001|Overall Study|Lost to Follow-up|4|||
146867911|NCT01087957|529689616|FG000|Overall Study|Protocol Violation|13|||
146867912|NCT01087957|529689617|FG001|Overall Study|Protocol Violation|25|||
146867913|NCT01087957|529689616|FG000|Overall Study|Withdrawal by Subject|18|||
146534657|NCT00784875|528468818|FG002|Period A - Baseline|Lost to Follow-up|0|||
146534658|NCT00784875|528468819|FG003|Period A - Baseline|Lost to Follow-up|2|||
146534659|NCT00784875|528468816|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
146534660|NCT00784875|528468817|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
146867914|NCT01087957|529689617|FG001|Overall Study|Withdrawal by Subject|15|||
146867915|NCT01087957|529689616|FG000|Overall Study|Physician Decision|5|||
146867916|NCT01087957|529689617|FG001|Overall Study|Physician Decision|9|||
146867917|NCT01186939|529689618|FG000|Overall Study|Death|7|||
146867918|NCT01186939|529689618|FG000|Overall Study|Withdrawal by Subject|2|||
146867919|NCT01186939|529689618|FG000|Overall Study|No longer receiving clinical benefit|17|||
146867920|NCT01186939|529689618|FG000|Overall Study|Program closed|5|||
146867921|NCT01186939|529689618|FG000|Overall Study|Sponsor decision|4|||
146867922|NCT01186939|529689618|FG000|Overall Study|Started additional treatment|1|||
146867923|NCT01186939|529689618|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
146867924|NCT01186939|529689618|FG000|Overall Study|Myocardial infarction|1|||
146867925|NCT01186939|529689618|FG000|Overall Study|Bone marrow transplant|1|||
146867926|NCT01186939|529689618|FG000|Overall Study|Transformation to AML|1|||
146867927|NCT03945591|529689623|FG000|Overall Study|Participant not transplanted|1|||
146867928|NCT03945591|529689623|FG000|Overall Study|Change in treatment plan|3|||
146867929|NCT03945591|529689623|FG000|Overall Study|Adverse Event|1|||
146867930|NCT00698204|529689626|FG000|Overall Study|Withdrawal by Subject|1|||
146867931|NCT00698204|529689627|FG001|Overall Study|Withdrawal by Subject|0|||
146867932|NCT01179672|529689628|FG000|Overall Study|Adverse Event|17|||
146867933|NCT01179672|529689629|FG001|Overall Study|Adverse Event|8|||
146867934|NCT01179672|529689628|FG000|Overall Study|Withdrawal by Subject|10|||
146867935|NCT01179672|529689629|FG001|Overall Study|Withdrawal by Subject|12|||
146867936|NCT01179672|529689628|FG000|Overall Study|Entry Criteria Not Met|0|||
146867937|NCT01179672|529689629|FG001|Overall Study|Entry Criteria Not Met|2|||
146867938|NCT01179672|529689628|FG000|Overall Study|Lost to Follow-up|0|||
146867939|NCT01179672|529689629|FG001|Overall Study|Lost to Follow-up|1|||
146867940|NCT01179672|529689628|FG000|Overall Study|Protocol Violation|2|||
146867941|NCT01179672|529689629|FG001|Overall Study|Protocol Violation|2|||
146867942|NCT01179672|529689628|FG000|Overall Study|Physician Decision|1|||
146867943|NCT01179672|529689629|FG001|Overall Study|Physician Decision|1|||
146867944|NCT00314249|529689631|FG000|Overall Study|Adverse Event|73|||
146867945|NCT00314249|529689632|FG001|Overall Study|Adverse Event|94|||
146867946|NCT00314249|529689631|FG000|Overall Study|Lack of Efficacy|33|||
146867947|NCT00314249|529689632|FG001|Overall Study|Lack of Efficacy|24|||
146867948|NCT00314249|529689631|FG000|Overall Study|Withdrawal by Subject|21|||
146534661|NCT00784875|528468818|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
146534662|NCT00784875|528468819|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
146867949|NCT00314249|529689632|FG001|Overall Study|Withdrawal by Subject|28|||
146867950|NCT00314249|529689631|FG000|Overall Study|Lost to Follow-up|15|||
146867951|NCT00314249|529689632|FG001|Overall Study|Lost to Follow-up|9|||
146867952|NCT00314249|529689631|FG000|Overall Study|Physician Decision|1|||
146867953|NCT00314249|529689632|FG001|Overall Study|Physician Decision|1|||
146867954|NCT00314249|529689631|FG000|Overall Study|Withdrawn for other reasons|4|||
146867955|NCT00314249|529689632|FG001|Overall Study|Withdrawn for other reasons|1|||
146867956|NCT00314249|529689631|FG000|Overall Study|Non-Compliant|5|||
146867957|NCT00314249|529689632|FG001|Overall Study|Non-Compliant|6|||
146867958|NCT01949155|529689633|FG000|Overall Study|Lost to Follow-up|1|||
146867959|NCT01949155|529689634|FG001|Overall Study|Lost to Follow-up|0|||
146867960|NCT01949155|529689633|FG000|Overall Study|Protocol Violation|1|||
146867961|NCT01949155|529689634|FG001|Overall Study|Protocol Violation|0|||
146867962|NCT00210184|529689635|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
146867963|NCT02316340|529689636|FG000|First Progression|Clinical progression|2|||
146867964|NCT02316340|529689637|FG001|First Progression|Clinical progression|1|||
146867965|NCT02316340|529689636|FG000|First Progression|Withdrawal by Subject|1|||
146867966|NCT02316340|529689637|FG001|First Progression|Withdrawal by Subject|0|||
146867967|NCT01835015|529689638|FG000|Overall Study|Adverse Event|0|||
146867968|NCT01835015|529689639|FG001|Overall Study|Adverse Event|0|||
146867969|NCT01835015|529689640|FG002|Overall Study|Adverse Event|1|||
146867970|NCT01835015|529689641|FG003|Overall Study|Adverse Event|0|||
146867971|NCT01835015|529689642|FG004|Overall Study|Adverse Event|0|||
146867972|NCT01118325|529689647|FG000|Overall Study|Adverse Event|1|||
146867973|NCT01118325|529689648|FG001|Overall Study|Adverse Event|0|||
146867974|NCT01118325|529689649|FG002|Overall Study|Adverse Event|1|||
146867975|NCT03334409|529689653|FG000|Overall Study|Did not meet inclusion criteria|1|||
146867976|NCT03334409|529689654|FG001|Overall Study|Did not meet inclusion criteria|0|||
146867977|NCT03678103|529689655|FG000|Overall Study|Withdrawn prior to completion|4|||
146867978|NCT00975715|529689656|FG000|Titration Period|Adverse Event|6|||
146867979|NCT00975715|529689657|FG001|Titration Period|Adverse Event|0|||
146867980|NCT00975715|529689656|FG000|Titration Period|Protocol Violation|1|||
146867981|NCT00975715|529689657|FG001|Titration Period|Protocol Violation|0|||
146867982|NCT00975715|529689656|FG000|Maintenance Period|Adverse Event|2|||
146867983|NCT00975715|529689657|FG001|Maintenance Period|Adverse Event|1|||
146867984|NCT01241552|529689666|FG000|Overall Study|Lack of Efficacy|1|||
146867985|NCT01241552|529689667|FG001|Overall Study|Lack of Efficacy|0|||
146867986|NCT01241552|529689668|FG002|Overall Study|Lack of Efficacy|0|||
146867987|NCT01241552|529689669|FG003|Overall Study|Lack of Efficacy|0|||
146867988|NCT01241552|529689666|FG000|Overall Study|Death|26|||
146867989|NCT01241552|529689667|FG001|Overall Study|Death|30|||
146867990|NCT01241552|529689668|FG002|Overall Study|Death|20|||
146867991|NCT01241552|529689669|FG003|Overall Study|Death|25|||
146867992|NCT01241552|529689666|FG000|Overall Study|Adverse Event|1|||
146867993|NCT01241552|529689667|FG001|Overall Study|Adverse Event|1|||
146867994|NCT01241552|529689668|FG002|Overall Study|Adverse Event|0|||
146867995|NCT01241552|529689669|FG003|Overall Study|Adverse Event|0|||
146867996|NCT01241552|529689666|FG000|Overall Study|Technical Problems|2|||
146867997|NCT01241552|529689667|FG001|Overall Study|Technical Problems|0|||
146867998|NCT01241552|529689668|FG002|Overall Study|Technical Problems|2|||
146867999|NCT01241552|529689669|FG003|Overall Study|Technical Problems|2|||
146868000|NCT01241552|529689666|FG000|Overall Study|Progressive Disease|0|||
146868001|NCT01241552|529689667|FG001|Overall Study|Progressive Disease|0|||
146868002|NCT01241552|529689668|FG002|Overall Study|Progressive Disease|1|||
146868003|NCT01241552|529689669|FG003|Overall Study|Progressive Disease|2|||
146868004|NCT01241552|529689666|FG000|Overall Study|Protocol Violation|0|||
146868005|NCT01241552|529689667|FG001|Overall Study|Protocol Violation|2|||
146868006|NCT01241552|529689668|FG002|Overall Study|Protocol Violation|6|||
146868007|NCT01241552|529689669|FG003|Overall Study|Protocol Violation|1|||
146868008|NCT01241552|529689666|FG000|Overall Study|Withdrawal by Subject|7|||
146868009|NCT01241552|529689667|FG001|Overall Study|Withdrawal by Subject|15|||
146868010|NCT01241552|529689668|FG002|Overall Study|Withdrawal by Subject|14|||
146868011|NCT01241552|529689669|FG003|Overall Study|Withdrawal by Subject|15|||
146868012|NCT01241552|529689666|FG000|Overall Study|Physician Decision|2|||
146868013|NCT01241552|529689667|FG001|Overall Study|Physician Decision|4|||
146868014|NCT01241552|529689668|FG002|Overall Study|Physician Decision|2|||
146868015|NCT01241552|529689669|FG003|Overall Study|Physician Decision|3|||
146868016|NCT01241552|529689666|FG000|Overall Study|Lost to Follow-up|2|||
146868017|NCT01241552|529689667|FG001|Overall Study|Lost to Follow-up|11|||
146868018|NCT01241552|529689668|FG002|Overall Study|Lost to Follow-up|15|||
146868019|NCT01241552|529689669|FG003|Overall Study|Lost to Follow-up|16|||
146868020|NCT02606461|529689670|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
146868021|NCT02606461|529689671|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
146868022|NCT02606461|529689672|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
146868023|NCT02606461|529689673|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
146868024|NCT02606461|529689674|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
146868025|NCT02606461|529689675|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
146868026|NCT02092350|529689680|FG000|Overall Study|Adverse Event|0|||
146868027|NCT02092350|529689681|FG001|Overall Study|Adverse Event|3|||
146868028|NCT02092350|529689680|FG000|Overall Study|Death|2|||
146868029|NCT02092350|529689681|FG001|Overall Study|Death|5|||
146868030|NCT02092350|529689680|FG000|Overall Study|Lost to Follow-up|3|||
146868031|NCT02092350|529689681|FG001|Overall Study|Lost to Follow-up|1|||
146868032|NCT02092350|529689680|FG000|Overall Study|Protocol Violation|1|||
146868033|NCT02092350|529689681|FG001|Overall Study|Protocol Violation|0|||
146868034|NCT02092350|529689680|FG000|Overall Study|Physician Decision|1|||
146868035|NCT02092350|529689681|FG001|Overall Study|Physician Decision|1|||
146868036|NCT02092350|529689680|FG000|Overall Study|Screen Failure|1|||
146868037|NCT02092350|529689681|FG001|Overall Study|Screen Failure|0|||
146868038|NCT02092350|529689680|FG000|Overall Study|Withdrawal by Subject|2|||
146868039|NCT02092350|529689681|FG001|Overall Study|Withdrawal by Subject|2|||
146868040|NCT00024167|529689682|FG000|Overall Study|Death|53|||
146868041|NCT00024167|529689683|FG001|Overall Study|Death|47|||
146868042|NCT00307333|529689697|FG000|Overall Study|Lost to Follow-up|11|||
146868043|NCT00307333|529689698|FG001|Overall Study|Lost to Follow-up|3|||
146868044|NCT01245387|529689699|FG000|Overall Study|Lost to Follow-up|106|||
146868045|NCT01245387|529689699|FG000|Overall Study|Lack of Efficacy|195|||
146868046|NCT01245387|529689699|FG000|Overall Study|Adverse Event|9|||
146868047|NCT01245387|529689699|FG000|Overall Study|Death|3|||
146868048|NCT01245387|529689699|FG000|Overall Study|Other|131|||
146868049|NCT01245387|529689699|FG000|Overall Study|Missing discontinuation status|369|||
146868050|NCT04246801|529689700|FG000|Overall Study|Adverse Event|1|||
146868051|NCT04246801|529689701|FG001|Overall Study|Adverse Event|1|||
146868052|NCT04246801|529689700|FG000|Overall Study|Protocol Violation|1|||
146868053|NCT04246801|529689701|FG001|Overall Study|Protocol Violation|1|||
146868054|NCT04246801|529689700|FG000|Overall Study|Lack of Efficacy|0|||
146868055|NCT04246801|529689701|FG001|Overall Study|Lack of Efficacy|2|||
146868056|NCT04246801|529689700|FG000|Overall Study|Lost to Follow-up|1|||
146868057|NCT04246801|529689701|FG001|Overall Study|Lost to Follow-up|1|||
146534663|NCT00784875|528468816|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
146868058|NCT04246801|529689700|FG000|Overall Study|Withdrawal by Subject|2|||
146868059|NCT04246801|529689701|FG001|Overall Study|Withdrawal by Subject|1|||
146868060|NCT01621542|529689702|FG000|Overall Study|Adverse Event|0|||
146868061|NCT01621542|529689703|FG001|Overall Study|Adverse Event|0|||
146868062|NCT01621542|529689704|FG002|Overall Study|Adverse Event|1|||
146868063|NCT01621542|529689705|FG003|Overall Study|Adverse Event|3|||
146868064|NCT01621542|529689706|FG004|Overall Study|Adverse Event|0|||
146868065|NCT01621542|529689707|FG005|Overall Study|Adverse Event|0|||
146868066|NCT01621542|529689702|FG000|Overall Study|Death|0|||
146868067|NCT01621542|529689703|FG001|Overall Study|Death|1|||
146868068|NCT01621542|529689704|FG002|Overall Study|Death|0|||
146868069|NCT01621542|529689705|FG003|Overall Study|Death|0|||
146868070|NCT01621542|529689706|FG004|Overall Study|Death|0|||
146868071|NCT01621542|529689707|FG005|Overall Study|Death|0|||
146868072|NCT01621542|529689702|FG000|Overall Study|Physician Decision|1|||
146868073|NCT01621542|529689703|FG001|Overall Study|Physician Decision|0|||
146868074|NCT01621542|529689704|FG002|Overall Study|Physician Decision|1|||
146868075|NCT01621542|529689705|FG003|Overall Study|Physician Decision|13|||
146868076|NCT01621542|529689706|FG004|Overall Study|Physician Decision|3|||
146868077|NCT01621542|529689707|FG005|Overall Study|Physician Decision|1|||
146868078|NCT01621542|529689702|FG000|Overall Study|Withdrawal by Subject|2|||
146868079|NCT01621542|529689703|FG001|Overall Study|Withdrawal by Subject|0|||
146868080|NCT01621542|529689704|FG002|Overall Study|Withdrawal by Subject|1|||
146868081|NCT01621542|529689705|FG003|Overall Study|Withdrawal by Subject|3|||
146868082|NCT01621542|529689706|FG004|Overall Study|Withdrawal by Subject|3|||
146868083|NCT01621542|529689707|FG005|Overall Study|Withdrawal by Subject|3|||
146868084|NCT01621542|529689702|FG000|Overall Study|progression/treatment failure|2|||
146868085|NCT01621542|529689703|FG001|Overall Study|progression/treatment failure|4|||
146868086|NCT01621542|529689704|FG002|Overall Study|progression/treatment failure|3|||
146868087|NCT01621542|529689705|FG003|Overall Study|progression/treatment failure|7|||
146534664|NCT00784875|528468817|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
146534665|NCT00784875|528468818|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
146534666|NCT00784875|528468819|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
146534667|NCT00784875|528468816|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
146534668|NCT00784875|528468817|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
146534669|NCT00784875|528468818|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
146534670|NCT00784875|528468819|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
146534671|NCT00784875|528468816|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
146534672|NCT00784875|528468817|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
146534673|NCT00784875|528468818|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
146534674|NCT00784875|528468819|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
146534675|NCT00784875|528468816|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
146868088|NCT01621542|529689706|FG004|Overall Study|progression/treatment failure|3|||
146868089|NCT01621542|529689707|FG005|Overall Study|progression/treatment failure|5|||
146868090|NCT01621542|529689702|FG000|Overall Study|Protocol Violation|0|||
146868091|NCT01621542|529689703|FG001|Overall Study|Protocol Violation|0|||
146868092|NCT01621542|529689704|FG002|Overall Study|Protocol Violation|0|||
146868093|NCT01621542|529689705|FG003|Overall Study|Protocol Violation|1|||
146868094|NCT01621542|529689706|FG004|Overall Study|Protocol Violation|0|||
146868095|NCT01621542|529689707|FG005|Overall Study|Protocol Violation|0|||
146868096|NCT01621542|529689702|FG000|Overall Study|study stopped by sponsor|0|||
146868097|NCT01621542|529689703|FG001|Overall Study|study stopped by sponsor|0|||
146868098|NCT01621542|529689704|FG002|Overall Study|study stopped by sponsor|0|||
146868099|NCT01621542|529689705|FG003|Overall Study|study stopped by sponsor|1|||
146868100|NCT01621542|529689706|FG004|Overall Study|study stopped by sponsor|0|||
146868101|NCT01621542|529689707|FG005|Overall Study|study stopped by sponsor|0|||
146868102|NCT01368042|529689708|FG000|Overall Study|Death|14|||
146868103|NCT01368042|529689708|FG000|Overall Study|Protocol Violation|11|||
146868104|NCT01368042|529689708|FG000|Overall Study|Lost to Follow-up|4|||
146868105|NCT01368042|529689708|FG000|Overall Study|Transplanted|1|||
146868106|NCT02632721|529689712|FG000|Overall Study|Adverse Event|0|||
146868107|NCT02632721|529689713|FG001|Overall Study|Adverse Event|0|||
146868108|NCT02632721|529689714|FG002|Overall Study|Adverse Event|2|||
146868109|NCT02632721|529689715|FG003|Overall Study|Adverse Event|5|||
146868110|NCT02632721|529689716|FG004|Overall Study|Adverse Event|3|||
146868111|NCT02632721|529689712|FG000|Overall Study|Dose limiting toxicity|0|||
146868112|NCT02632721|529689713|FG001|Overall Study|Dose limiting toxicity|0|||
146868113|NCT02632721|529689714|FG002|Overall Study|Dose limiting toxicity|0|||
146868114|NCT02632721|529689715|FG003|Overall Study|Dose limiting toxicity|1|||
146868115|NCT02632721|529689716|FG004|Overall Study|Dose limiting toxicity|0|||
146868116|NCT02632721|529689712|FG000|Overall Study|Progressive disease|3|||
146868117|NCT02632721|529689713|FG001|Overall Study|Progressive disease|0|||
146868118|NCT02632721|529689714|FG002|Overall Study|Progressive disease|4|||
146868119|NCT02632721|529689715|FG003|Overall Study|Progressive disease|6|||
146868120|NCT02632721|529689716|FG004|Overall Study|Progressive disease|5|||
146868121|NCT02632721|529689712|FG000|Overall Study|Refused to continue taking trial medication|0|||
146868122|NCT02632721|529689713|FG001|Overall Study|Refused to continue taking trial medication|1|||
146868123|NCT02632721|529689714|FG002|Overall Study|Refused to continue taking trial medication|1|||
146868124|NCT02632721|529689715|FG003|Overall Study|Refused to continue taking trial medication|1|||
146868125|NCT02632721|529689716|FG004|Overall Study|Refused to continue taking trial medication|2|||
146868126|NCT02632721|529689712|FG000|Overall Study|Inadequate clinical condition|0|||
146868127|NCT02632721|529689713|FG001|Overall Study|Inadequate clinical condition|0|||
146868128|NCT02632721|529689714|FG002|Overall Study|Inadequate clinical condition|0|||
146868129|NCT02632721|529689715|FG003|Overall Study|Inadequate clinical condition|0|||
146868130|NCT02632721|529689716|FG004|Overall Study|Inadequate clinical condition|1|||
146868131|NCT02632721|529689712|FG000|Overall Study|No meet eligibility|0|||
146868132|NCT02632721|529689713|FG001|Overall Study|No meet eligibility|0|||
146868133|NCT02632721|529689714|FG002|Overall Study|No meet eligibility|0|||
146868134|NCT02632721|529689715|FG003|Overall Study|No meet eligibility|0|||
146868135|NCT02632721|529689716|FG004|Overall Study|No meet eligibility|1|||
146868136|NCT02632721|529689712|FG000|Overall Study|Allergic reaction|0|||
146868137|NCT02632721|529689713|FG001|Overall Study|Allergic reaction|0|||
146868138|NCT02632721|529689714|FG002|Overall Study|Allergic reaction|0|||
146534676|NCT00784875|528468817|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
146534677|NCT00784875|528468818|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
146868139|NCT02632721|529689715|FG003|Overall Study|Allergic reaction|1|||
146868140|NCT02632721|529689716|FG004|Overall Study|Allergic reaction|0|||
146868141|NCT02632721|529689712|FG000|Overall Study|Receiving Decitabine locally|0|||
146868142|NCT02632721|529689713|FG001|Overall Study|Receiving Decitabine locally|0|||
146868143|NCT02632721|529689714|FG002|Overall Study|Receiving Decitabine locally|1|||
146868144|NCT02632721|529689715|FG003|Overall Study|Receiving Decitabine locally|0|||
146868145|NCT02632721|529689716|FG004|Overall Study|Receiving Decitabine locally|0|||
146868146|NCT02632721|529689712|FG000|Overall Study|No benefit from study treatment|1|||
146868147|NCT02632721|529689713|FG001|Overall Study|No benefit from study treatment|1|||
146868148|NCT02632721|529689714|FG002|Overall Study|No benefit from study treatment|0|||
146868149|NCT02632721|529689715|FG003|Overall Study|No benefit from study treatment|0|||
146868150|NCT02632721|529689716|FG004|Overall Study|No benefit from study treatment|1|||
146868151|NCT02632721|529689712|FG000|Overall Study|Patient wish for other treatment|0|||
146868152|NCT02632721|529689713|FG001|Overall Study|Patient wish for other treatment|1|||
146868153|NCT02632721|529689714|FG002|Overall Study|Patient wish for other treatment|0|||
146868154|NCT02632721|529689715|FG003|Overall Study|Patient wish for other treatment|0|||
146534678|NCT00784875|528468819|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
146868155|NCT02632721|529689716|FG004|Overall Study|Patient wish for other treatment|0|||
146868156|NCT02632721|529689712|FG000|Overall Study|Relapsed Pneumonia|0|||
146868157|NCT02632721|529689713|FG001|Overall Study|Relapsed Pneumonia|0|||
146868158|NCT02632721|529689714|FG002|Overall Study|Relapsed Pneumonia|0|||
146868159|NCT02632721|529689715|FG003|Overall Study|Relapsed Pneumonia|0|||
146868160|NCT02632721|529689716|FG004|Overall Study|Relapsed Pneumonia|1|||
146868161|NCT02632721|529689712|FG000|Overall Study|Therapy refractory AML|0|||
146868162|NCT02632721|529689713|FG001|Overall Study|Therapy refractory AML|0|||
146868163|NCT02632721|529689714|FG002|Overall Study|Therapy refractory AML|0|||
146868164|NCT02632721|529689715|FG003|Overall Study|Therapy refractory AML|0|||
146868165|NCT02632721|529689716|FG004|Overall Study|Therapy refractory AML|1|||
146868166|NCT02632721|529689712|FG000|Overall Study|Increase of white blood cell count|0|||
146868167|NCT02632721|529689713|FG001|Overall Study|Increase of white blood cell count|0|||
146868168|NCT02632721|529689714|FG002|Overall Study|Increase of white blood cell count|0|||
146868169|NCT02632721|529689715|FG003|Overall Study|Increase of white blood cell count|0|||
146868170|NCT02632721|529689716|FG004|Overall Study|Increase of white blood cell count|1|||
146868171|NCT02632721|529689712|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
146868172|NCT02632721|529689713|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
146868173|NCT02632721|529689714|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
146868174|NCT02632721|529689715|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
146868175|NCT02632721|529689716|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
146868176|NCT00544648|529689720|FG000|Overall Study|Withdrawal by Subject|1|||
146868177|NCT00544648|529689721|FG001|Overall Study|Withdrawal by Subject|0|||
146868178|NCT00544648|529689720|FG000|Overall Study|Adverse Event|1|||
146868179|NCT00544648|529689721|FG001|Overall Study|Adverse Event|1|||
146868180|NCT00544648|529689720|FG000|Overall Study|progression of disease|1|||
146868181|NCT00544648|529689721|FG001|Overall Study|progression of disease|0|||
146868182|NCT01572675|529689722|FG000|Overall Study|End of prescribed treatment|140|||
146868183|NCT01572675|529689723|FG001|Overall Study|End of prescribed treatment|118|||
146868184|NCT01572675|529689722|FG000|Overall Study|Recovery|16|||
146868185|NCT01572675|529689723|FG001|Overall Study|Recovery|23|||
146868186|NCT01572675|529689722|FG000|Overall Study|Lack of Efficacy|31|||
146868187|NCT01572675|529689723|FG001|Overall Study|Lack of Efficacy|31|||
146868188|NCT01572675|529689722|FG000|Overall Study|Intolerance|6|||
146868189|NCT01572675|529689723|FG001|Overall Study|Intolerance|5|||
146868190|NCT01572675|529689722|FG000|Overall Study|Improved symptoms|8|||
146868191|NCT01572675|529689723|FG001|Overall Study|Improved symptoms|2|||
146868192|NCT01572675|529689722|FG000|Overall Study|Surgical intervention|3|||
146868193|NCT01572675|529689723|FG001|Overall Study|Surgical intervention|6|||
146868194|NCT01572675|529689722|FG000|Overall Study|Withdrawal by Subject|5|||
146868195|NCT01572675|529689723|FG001|Overall Study|Withdrawal by Subject|1|||
146868196|NCT01572675|529689722|FG000|Overall Study|Physician Decision|2|||
146868197|NCT01572675|529689723|FG001|Overall Study|Physician Decision|2|||
146868198|NCT01572675|529689722|FG000|Overall Study|Death unrelated to coxibs|1|||
146868199|NCT01572675|529689723|FG001|Overall Study|Death unrelated to coxibs|1|||
146868200|NCT01572675|529689722|FG000|Overall Study|Other disease detected|1|||
146868201|NCT01572675|529689723|FG001|Overall Study|Other disease detected|1|||
146868202|NCT01572675|529689722|FG000|Overall Study|Unknown reason|1|||
146868203|NCT01572675|529689723|FG001|Overall Study|Unknown reason|1|||
146868204|NCT01572675|529689722|FG000|Overall Study|Rheumatologist new evaluation|0|||
146868205|NCT01572675|529689723|FG001|Overall Study|Rheumatologist new evaluation|1|||
146868206|NCT01572675|529689722|FG000|Overall Study|Missing data|1|||
146868207|NCT01572675|529689723|FG001|Overall Study|Missing data|4|||
146868208|NCT01572675|529689722|FG000|Overall Study|Lost to Follow-up|22|||
146868209|NCT01572675|529689723|FG001|Overall Study|Lost to Follow-up|27|||
146868210|NCT03346057|529689725|FG000|Overall Study|Death|1|||
146868211|NCT03346057|529689726|FG001|Overall Study|Death|2|||
146868212|NCT03346057|529689727|FG002|Overall Study|Death|0|||
146868213|NCT03346057|529689728|FG003|Overall Study|Death|0|||
146868214|NCT03346057|529689725|FG000|Overall Study|Lost to Follow-up|0|||
146868215|NCT03346057|529689726|FG001|Overall Study|Lost to Follow-up|2|||
146868216|NCT03346057|529689727|FG002|Overall Study|Lost to Follow-up|1|||
146868217|NCT03346057|529689728|FG003|Overall Study|Lost to Follow-up|0|||
146868218|NCT03346057|529689725|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
146868219|NCT03346057|529689726|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
146868220|NCT03346057|529689727|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
146868221|NCT03346057|529689728|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
146868222|NCT03346057|529689725|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
146868223|NCT03346057|529689726|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
146868224|NCT03346057|529689727|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
146868225|NCT03346057|529689728|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
146868226|NCT03346057|529689725|FG000|Overall Study|Physician Decision|3|||
146868227|NCT03346057|529689726|FG001|Overall Study|Physician Decision|2|||
146868228|NCT03346057|529689727|FG002|Overall Study|Physician Decision|0|||
146868229|NCT03346057|529689728|FG003|Overall Study|Physician Decision|2|||
146868230|NCT03346057|529689725|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
146868231|NCT03346057|529689726|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
146868232|NCT03346057|529689727|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
146868233|NCT03346057|529689728|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
146868234|NCT03346057|529689725|FG000|Overall Study|Withdrawal by Subject|1|||
146868235|NCT03346057|529689726|FG001|Overall Study|Withdrawal by Subject|0|||
146868236|NCT03346057|529689727|FG002|Overall Study|Withdrawal by Subject|0|||
146868237|NCT03346057|529689728|FG003|Overall Study|Withdrawal by Subject|0|||
146868238|NCT03044886|529689729|FG000|Overall Study|Lost to Follow-up|15|||
146868239|NCT03044886|529689730|FG001|Overall Study|Lost to Follow-up|10|||
146868240|NCT03044886|529689731|FG002|Overall Study|Lost to Follow-up|12|||
146868241|NCT02921269|529689732|FG000|Overall Study|Did not complete DLT period|1|||
146868242|NCT03065023|529689733|FG000|Overall Study|Progressive Disease|0|||
146868243|NCT03065023|529689734|FG001|Overall Study|Progressive Disease|1|||
146868244|NCT03065023|529689735|FG002|Overall Study|Progressive Disease|0|||
146868245|NCT03065023|529689736|FG003|Overall Study|Progressive Disease|0|||
146868246|NCT03065023|529689737|FG004|Overall Study|Progressive Disease|0|||
146868247|NCT03065023|529689733|FG000|Overall Study|Death|2|||
146868248|NCT03065023|529689734|FG001|Overall Study|Death|0|||
146868249|NCT03065023|529689735|FG002|Overall Study|Death|1|||
146868250|NCT03065023|529689736|FG003|Overall Study|Death|1|||
146868251|NCT03065023|529689737|FG004|Overall Study|Death|0|||
146868252|NCT03065023|529689733|FG000|Overall Study|Lost to Follow-up|0|||
146868253|NCT03065023|529689734|FG001|Overall Study|Lost to Follow-up|1|||
146868254|NCT03065023|529689735|FG002|Overall Study|Lost to Follow-up|0|||
146868255|NCT03065023|529689736|FG003|Overall Study|Lost to Follow-up|0|||
146868256|NCT03065023|529689737|FG004|Overall Study|Lost to Follow-up|0|||
146868257|NCT03065023|529689733|FG000|Overall Study|Participant Decision|0|||
146868258|NCT03065023|529689734|FG001|Overall Study|Participant Decision|0|||
146868259|NCT03065023|529689735|FG002|Overall Study|Participant Decision|0|||
146868260|NCT03065023|529689736|FG003|Overall Study|Participant Decision|1|||
146868261|NCT03065023|529689737|FG004|Overall Study|Participant Decision|0|||
146868262|NCT03065023|529689733|FG000|Overall Study|Withdrawal by Subject|0|||
146868263|NCT03065023|529689734|FG001|Overall Study|Withdrawal by Subject|0|||
146868264|NCT03065023|529689735|FG002|Overall Study|Withdrawal by Subject|0|||
146868265|NCT03065023|529689736|FG003|Overall Study|Withdrawal by Subject|1|||
146868266|NCT03065023|529689737|FG004|Overall Study|Withdrawal by Subject|0|||
146868267|NCT00228566|529689738|FG000|Overall Study|Adverse Event|31|||
146868268|NCT00228566|529689738|FG000|Overall Study|Lack of Efficacy|14|||
146868269|NCT00228566|529689738|FG000|Overall Study|Lost to Follow-up|16|||
146868270|NCT00228566|529689738|FG000|Overall Study|Physician Decision|5|||
146868271|NCT00228566|529689738|FG000|Overall Study|Withdrawal by Subject|4|||
146868272|NCT00228566|529689738|FG000|Overall Study|Miscellaneous|1|||
146868273|NCT05975840|529689739|FG000|Overall Study|Other|1|||
146868274|NCT05975840|529689740|FG001|Overall Study|Other|0|||
146868275|NCT05975840|529689741|FG002|Overall Study|Other|0|||
146868276|NCT05975840|529689742|FG003|Overall Study|Other|0|||
146868277|NCT05975840|529689743|FG004|Overall Study|Other|1|||
146868278|NCT05975840|529689744|FG005|Overall Study|Other|0|||
146868279|NCT05975840|529689745|FG006|Overall Study|Other|0|||
146868280|NCT05975840|529689746|FG007|Overall Study|Other|0|||
146868281|NCT05975840|529689739|FG000|Overall Study|Lost to Follow-up|3|||
146868282|NCT05975840|529689740|FG001|Overall Study|Lost to Follow-up|6|||
146868283|NCT05975840|529689741|FG002|Overall Study|Lost to Follow-up|3|||
146868284|NCT05975840|529689742|FG003|Overall Study|Lost to Follow-up|1|||
146868285|NCT05975840|529689743|FG004|Overall Study|Lost to Follow-up|4|||
146868286|NCT05975840|529689744|FG005|Overall Study|Lost to Follow-up|1|||
146868287|NCT05975840|529689745|FG006|Overall Study|Lost to Follow-up|2|||
146868288|NCT05975840|529689746|FG007|Overall Study|Lost to Follow-up|4|||
146868289|NCT05975840|529689739|FG000|Overall Study|Migrated/moved from the study area|1|||
146868290|NCT05975840|529689740|FG001|Overall Study|Migrated/moved from the study area|0|||
146868291|NCT05975840|529689741|FG002|Overall Study|Migrated/moved from the study area|0|||
146868292|NCT05975840|529689742|FG003|Overall Study|Migrated/moved from the study area|0|||
146534679|NCT00784875|528468816|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
146534680|NCT00784875|528468817|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
146534681|NCT00784875|528468818|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
146534682|NCT00784875|528468819|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
146534683|NCT00784875|528468816|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
146534684|NCT00784875|528468817|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
146534685|NCT00784875|528468818|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
146534686|NCT00784875|528468819|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
146868293|NCT05975840|529689743|FG004|Overall Study|Migrated/moved from the study area|0|||
146868294|NCT05975840|529689744|FG005|Overall Study|Migrated/moved from the study area|0|||
146868295|NCT05975840|529689745|FG006|Overall Study|Migrated/moved from the study area|0|||
146534687|NCT00784875|528468816|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
146534688|NCT00784875|528468817|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
146534689|NCT00784875|528468818|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
146868296|NCT05975840|529689746|FG007|Overall Study|Migrated/moved from the study area|0|||
146868297|NCT05975840|529689739|FG000|Overall Study|Withdrawal by Subject|0|||
146868298|NCT05975840|529689740|FG001|Overall Study|Withdrawal by Subject|5|||
146868299|NCT05975840|529689741|FG002|Overall Study|Withdrawal by Subject|2|||
146868300|NCT05975840|529689742|FG003|Overall Study|Withdrawal by Subject|2|||
146868301|NCT05975840|529689743|FG004|Overall Study|Withdrawal by Subject|0|||
146868302|NCT05975840|529689744|FG005|Overall Study|Withdrawal by Subject|2|||
146868303|NCT05975840|529689745|FG006|Overall Study|Withdrawal by Subject|2|||
146868304|NCT05975840|529689746|FG007|Overall Study|Withdrawal by Subject|1|||
146868305|NCT05975840|529689739|FG000|Overall Study|Protocol Violation|0|||
146868306|NCT05975840|529689740|FG001|Overall Study|Protocol Violation|1|||
146868307|NCT05975840|529689741|FG002|Overall Study|Protocol Violation|0|||
146868308|NCT05975840|529689742|FG003|Overall Study|Protocol Violation|0|||
146868309|NCT05975840|529689743|FG004|Overall Study|Protocol Violation|0|||
146868310|NCT05975840|529689744|FG005|Overall Study|Protocol Violation|0|||
146868311|NCT05975840|529689745|FG006|Overall Study|Protocol Violation|0|||
146868312|NCT05975840|529689746|FG007|Overall Study|Protocol Violation|0|||
146534690|NCT00784875|528468819|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
146534691|NCT00784875|528468816|FG000|Period C|Adverse Event|1|||
146534692|NCT00784875|528468817|FG001|Period C|Adverse Event|0|||
146534693|NCT00784875|528468818|FG002|Period C|Adverse Event|4|||
146534694|NCT00784875|528468819|FG003|Period C|Adverse Event|2|||
146534695|NCT00784875|528468816|FG000|Period C|Protocol Violation|0|||
146534696|NCT00784875|528468817|FG001|Period C|Protocol Violation|0|||
146534697|NCT00784875|528468818|FG002|Period C|Protocol Violation|1|||
146534698|NCT00784875|528468819|FG003|Period C|Protocol Violation|2|||
146534699|NCT00784875|528468816|FG000|Period C|Lack of Efficacy|0|||
146534700|NCT00784875|528468817|FG001|Period C|Lack of Efficacy|0|||
146534701|NCT00784875|528468818|FG002|Period C|Lack of Efficacy|1|||
146534702|NCT00784875|528468819|FG003|Period C|Lack of Efficacy|0|||
146534703|NCT00784875|528468816|FG000|Period C|Withdrawal by Subject|1|||
146534704|NCT00784875|528468817|FG001|Period C|Withdrawal by Subject|1|||
146534705|NCT00784875|528468818|FG002|Period C|Withdrawal by Subject|2|||
146763300|NCT02001623|529301304|FG008|Overall Study|Withdrawal by Subject|1|||
146763301|NCT02001623|529301305|FG009|Overall Study|Withdrawal by Subject|3|||
146868313|NCT05975840|529689739|FG000|Overall Study|Adverse Event|0|||
146868314|NCT05975840|529689740|FG001|Overall Study|Adverse Event|0|||
146868315|NCT05975840|529689741|FG002|Overall Study|Adverse Event|0|||
146868316|NCT05975840|529689742|FG003|Overall Study|Adverse Event|1|||
146868317|NCT05975840|529689743|FG004|Overall Study|Adverse Event|0|||
146868318|NCT05975840|529689744|FG005|Overall Study|Adverse Event|0|||
146868319|NCT05975840|529689745|FG006|Overall Study|Adverse Event|0|||
146868320|NCT05975840|529689746|FG007|Overall Study|Adverse Event|0|||
146868321|NCT05975840|529689739|FG000|Overall Study|Death|0|||
146868322|NCT05975840|529689740|FG001|Overall Study|Death|1|||
146868323|NCT05975840|529689741|FG002|Overall Study|Death|0|||
146868324|NCT05975840|529689742|FG003|Overall Study|Death|0|||
146868325|NCT05975840|529689743|FG004|Overall Study|Death|0|||
146868326|NCT05975840|529689744|FG005|Overall Study|Death|0|||
146868327|NCT05975840|529689745|FG006|Overall Study|Death|0|||
146868328|NCT05975840|529689746|FG007|Overall Study|Death|1|||
146868329|NCT02246582|529691254|FG000|Overall Study|Withdrawal by Subject|3|||
146868330|NCT02246582|529691255|FG001|Overall Study|Withdrawal by Subject|4|||
146868331|NCT02229539|529691256|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
146868332|NCT02229539|529691257|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
146868333|NCT02229539|529691258|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
146868334|NCT02229539|529691256|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
146868335|NCT02229539|529691257|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
146534706|NCT00784875|528468819|FG003|Period C|Withdrawal by Subject|0|||
146534707|NCT00784875|528468816|FG000|Period C|Physician Decision|0|||
146534708|NCT00784875|528468817|FG001|Period C|Physician Decision|0|||
146534709|NCT00784875|528468818|FG002|Period C|Physician Decision|1|||
146763302|NCT02001623|529301306|FG010|Overall Study|Withdrawal by Subject|2|||
146763303|NCT02001623|529301307|FG011|Overall Study|Withdrawal by Subject|2|||
146763304|NCT02001623|529301308|FG012|Overall Study|Withdrawal by Subject|1|||
146763305|NCT02001623|529301309|FG013|Overall Study|Withdrawal by Subject|5|||
146763306|NCT02001623|529301310|FG014|Overall Study|Withdrawal by Subject|2|||
146763307|NCT02001623|529301296|FG000|Overall Study|Lost to Follow-up|0|||
146763308|NCT02001623|529301297|FG001|Overall Study|Lost to Follow-up|0|||
146763309|NCT02001623|529301298|FG002|Overall Study|Lost to Follow-up|0|||
146763310|NCT02001623|529301299|FG003|Overall Study|Lost to Follow-up|0|||
146763311|NCT02001623|529301300|FG004|Overall Study|Lost to Follow-up|0|||
146763312|NCT02001623|529301301|FG005|Overall Study|Lost to Follow-up|0|||
146763313|NCT02001623|529301302|FG006|Overall Study|Lost to Follow-up|0|||
146763314|NCT02001623|529301303|FG007|Overall Study|Lost to Follow-up|0|||
146763315|NCT02001623|529301304|FG008|Overall Study|Lost to Follow-up|0|||
146763316|NCT02001623|529301305|FG009|Overall Study|Lost to Follow-up|1|||
146763317|NCT02001623|529301306|FG010|Overall Study|Lost to Follow-up|0|||
146763318|NCT02001623|529301307|FG011|Overall Study|Lost to Follow-up|0|||
146763319|NCT02001623|529301308|FG012|Overall Study|Lost to Follow-up|0|||
146763320|NCT02001623|529301309|FG013|Overall Study|Lost to Follow-up|0|||
146763321|NCT02001623|529301310|FG014|Overall Study|Lost to Follow-up|0|||
146763322|NCT02001623|529301296|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
146763323|NCT02001623|529301297|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
146763324|NCT02001623|529301298|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
146534710|NCT00784875|528468819|FG003|Period C|Physician Decision|1|||
146868336|NCT02229539|529691258|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
146868337|NCT02229539|529691256|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
146868338|NCT02229539|529691257|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
146868339|NCT02229539|529691258|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
146868340|NCT02229539|529691256|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
146868341|NCT02229539|529691257|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
146868342|NCT02229539|529691258|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
146534711|NCT00784875|528468816|FG000|Period C|Sponsor Decision|5|||
146534712|NCT00784875|528468817|FG001|Period C|Sponsor Decision|5|||
146534713|NCT00784875|528468818|FG002|Period C|Sponsor Decision|4|||
146534714|NCT00784875|528468819|FG003|Period C|Sponsor Decision|2|||
146534715|NCT00784875|528468816|FG000|Period D|Adverse Event|0|||
146534716|NCT00784875|528468817|FG001|Period D|Adverse Event|2|||
146534717|NCT00784875|528468818|FG002|Period D|Adverse Event|2|||
146534718|NCT00784875|528468819|FG003|Period D|Adverse Event|0|||
146534719|NCT00784875|528468816|FG000|Period D|Protocol Violation|1|||
146868343|NCT02229539|529691256|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
146868344|NCT02229539|529691257|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
146868345|NCT02229539|529691258|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
146868346|NCT02229539|529691256|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
146868347|NCT02229539|529691257|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
146868348|NCT02229539|529691258|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
146534720|NCT00784875|528468817|FG001|Period D|Protocol Violation|0|||
146534721|NCT00784875|528468818|FG002|Period D|Protocol Violation|0|||
146534722|NCT00784875|528468819|FG003|Period D|Protocol Violation|0|||
146534723|NCT00784875|528468816|FG000|Period D|Withdrawal by Subject|2|||
146534724|NCT00784875|528468817|FG001|Period D|Withdrawal by Subject|0|||
146534725|NCT00784875|528468818|FG002|Period D|Withdrawal by Subject|2|||
146534726|NCT00784875|528468819|FG003|Period D|Withdrawal by Subject|0|||
146534727|NCT00784875|528468816|FG000|Period D|Physician Decision|0|||
146868349|NCT02060383|529691260|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
146868350|NCT02060383|529691261|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
146868351|NCT02060383|529691262|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
146868352|NCT02060383|529691263|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
146868353|NCT02060383|529691264|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
146868354|NCT02060383|529691260|FG000|Core Phase|Adverse Event|2|||
146868355|NCT02060383|529691261|FG001|Core Phase|Adverse Event|0|||
146868356|NCT02060383|529691262|FG002|Core Phase|Adverse Event|0|||
146868357|NCT02060383|529691263|FG003|Core Phase|Adverse Event|2|||
146868358|NCT02060383|529691264|FG004|Core Phase|Adverse Event|6|||
146868359|NCT02060383|529691260|FG000|Core Phase|Administrative problems|0|||
146868360|NCT02060383|529691261|FG001|Core Phase|Administrative problems|1|||
146868361|NCT02060383|529691262|FG002|Core Phase|Administrative problems|0|||
146868362|NCT02060383|529691263|FG003|Core Phase|Administrative problems|0|||
146868363|NCT02060383|529691264|FG004|Core Phase|Administrative problems|0|||
146868364|NCT02060383|529691260|FG000|Core Phase|Protocol Violation|0|||
146868365|NCT02060383|529691261|FG001|Core Phase|Protocol Violation|0|||
146868366|NCT02060383|529691262|FG002|Core Phase|Protocol Violation|0|||
146868367|NCT02060383|529691263|FG003|Core Phase|Protocol Violation|1|||
146868368|NCT02060383|529691264|FG004|Core Phase|Protocol Violation|0|||
146868369|NCT02060383|529691260|FG000|Core Phase|Withdrawal by Subject|0|||
146868370|NCT02060383|529691261|FG001|Core Phase|Withdrawal by Subject|0|||
146534728|NCT00784875|528468817|FG001|Period D|Physician Decision|1|||
146534729|NCT00784875|528468818|FG002|Period D|Physician Decision|0|||
146868371|NCT02060383|529691262|FG002|Core Phase|Withdrawal by Subject|0|||
146868372|NCT02060383|529691263|FG003|Core Phase|Withdrawal by Subject|4|||
146868373|NCT02060383|529691264|FG004|Core Phase|Withdrawal by Subject|2|||
146868374|NCT02060383|529691260|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
146868375|NCT02060383|529691261|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
146868376|NCT02060383|529691262|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
146868377|NCT02060383|529691263|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
146868378|NCT02060383|529691264|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
146868379|NCT02060383|529691260|FG000|Extension Phase|Adverse Event|1|||
146534730|NCT00784875|528468819|FG003|Period D|Physician Decision|0|||
146534731|NCT00784875|528468816|FG000|Period D|Sponsor Decision|1|||
146868380|NCT02060383|529691261|FG001|Extension Phase|Adverse Event|1|||
146868381|NCT02060383|529691262|FG002|Extension Phase|Adverse Event|2|||
146868382|NCT02060383|529691263|FG003|Extension Phase|Adverse Event|0|||
146534732|NCT00784875|528468817|FG001|Period D|Sponsor Decision|1|||
146534733|NCT00784875|528468818|FG002|Period D|Sponsor Decision|1|||
146534734|NCT00784875|528468819|FG003|Period D|Sponsor Decision|0|||
146534735|NCT00784875|528468816|FG000|Period D|Lost to Follow-up|1|||
146534736|NCT00784875|528468817|FG001|Period D|Lost to Follow-up|0|||
146534737|NCT00784875|528468818|FG002|Period D|Lost to Follow-up|1|||
146534738|NCT00784875|528468819|FG003|Period D|Lost to Follow-up|1|||
146534739|NCT01432951|528468820|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
146868383|NCT02060383|529691264|FG004|Extension Phase|Adverse Event|1|||
146868384|NCT02060383|529691260|FG000|Extension Phase|Withdrawal by Subject|0|||
146868385|NCT02060383|529691261|FG001|Extension Phase|Withdrawal by Subject|1|||
146868386|NCT02060383|529691262|FG002|Extension Phase|Withdrawal by Subject|0|||
146868387|NCT02060383|529691263|FG003|Extension Phase|Withdrawal by Subject|0|||
146868388|NCT02060383|529691264|FG004|Extension Phase|Withdrawal by Subject|2|||
146868389|NCT02060383|529691260|FG000|Extension Phase|Administrative problems|1|||
146868390|NCT02060383|529691261|FG001|Extension Phase|Administrative problems|0|||
146868391|NCT02060383|529691262|FG002|Extension Phase|Administrative problems|0|||
146868392|NCT02060383|529691263|FG003|Extension Phase|Administrative problems|0|||
146868393|NCT02060383|529691264|FG004|Extension Phase|Administrative problems|0|||
146868394|NCT02060383|529691260|FG000|Extension Phase|Death|0|||
146868395|NCT02060383|529691261|FG001|Extension Phase|Death|0|||
146868396|NCT02060383|529691262|FG002|Extension Phase|Death|1|||
146868397|NCT02060383|529691263|FG003|Extension Phase|Death|0|||
146868398|NCT02060383|529691264|FG004|Extension Phase|Death|1|||
146868399|NCT02060383|529691260|FG000|Extension Phase|Protocol Violation|0|||
146868400|NCT02060383|529691261|FG001|Extension Phase|Protocol Violation|0|||
146868401|NCT02060383|529691262|FG002|Extension Phase|Protocol Violation|0|||
146868402|NCT02060383|529691263|FG003|Extension Phase|Protocol Violation|0|||
146868403|NCT02060383|529691264|FG004|Extension Phase|Protocol Violation|1|||
146868404|NCT03441334|529691265|FG000|Overall Study|Withdrawal by Subject|1|||
146868405|NCT03441334|529691266|FG001|Overall Study|Withdrawal by Subject|0|||
146868406|NCT03627767|529691279|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
146868407|NCT03627767|529691280|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
146868408|NCT03627767|529691281|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
146868409|NCT03627767|529691282|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
146868410|NCT03627767|529691283|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
146868411|NCT03627767|529691279|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
146868412|NCT03627767|529691280|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
146534740|NCT00853385|528468821|FG000|Overall Study|Death|0|||
146534741|NCT00853385|528468822|FG001|Overall Study|Death|0|||
146868413|NCT03627767|529691281|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
146868414|NCT03627767|529691282|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
146868415|NCT03627767|529691283|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
146868416|NCT03627767|529691279|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
146868417|NCT03627767|529691280|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
146868418|NCT03627767|529691281|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
146868419|NCT03627767|529691282|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
146868420|NCT03627767|529691283|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
146534742|NCT00853385|528468823|FG002|Overall Study|Death|0|||
146534743|NCT00853385|528468824|FG003|Overall Study|Death|0|||
146534744|NCT00853385|528468825|FG004|Overall Study|Death|1|||
146534745|NCT00853385|528468821|FG000|Overall Study|Adverse Event|24|||
146868421|NCT03627767|529691279|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
146868422|NCT03627767|529691280|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
146868423|NCT03627767|529691281|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
146868424|NCT03627767|529691282|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
146868425|NCT03627767|529691283|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
146868426|NCT03627767|529691279|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
146868427|NCT03627767|529691280|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
146868428|NCT03627767|529691281|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
146868429|NCT03627767|529691282|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
146868430|NCT03627767|529691283|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
146868431|NCT03627767|529691279|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
146868432|NCT03627767|529691280|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
146868433|NCT03627767|529691281|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
146868434|NCT03627767|529691282|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
146868435|NCT03627767|529691283|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
146534746|NCT00853385|528468822|FG001|Overall Study|Adverse Event|24|||
146534747|NCT00853385|528468823|FG002|Overall Study|Adverse Event|2|||
146868436|NCT03627767|529691279|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
146868437|NCT03627767|529691280|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
146914647|NCT03303339|529850044|FG002|Overall Study|Study Terminated by Sponsor|0|||
146534748|NCT00853385|528468824|FG003|Overall Study|Adverse Event|5|||
146534749|NCT00853385|528468825|FG004|Overall Study|Adverse Event|22|||
146534750|NCT00853385|528468821|FG000|Overall Study|Lack of Efficacy|6|||
146534751|NCT00853385|528468822|FG001|Overall Study|Lack of Efficacy|7|||
146534752|NCT00853385|528468823|FG002|Overall Study|Lack of Efficacy|3|||
146534753|NCT00853385|528468824|FG003|Overall Study|Lack of Efficacy|3|||
146534754|NCT00853385|528468825|FG004|Overall Study|Lack of Efficacy|6|||
146534755|NCT00853385|528468821|FG000|Overall Study|Lost to Follow-up|2|||
146534756|NCT00853385|528468822|FG001|Overall Study|Lost to Follow-up|1|||
146534757|NCT00853385|528468823|FG002|Overall Study|Lost to Follow-up|0|||
146534758|NCT00853385|528468824|FG003|Overall Study|Lost to Follow-up|0|||
146868438|NCT03627767|529691281|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
146868439|NCT03627767|529691282|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
146868440|NCT03627767|529691283|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
146868441|NCT03627767|529691279|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
146868442|NCT03627767|529691280|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
146868443|NCT03627767|529691281|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
146868444|NCT03627767|529691282|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
146868445|NCT03627767|529691283|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
146868446|NCT03627767|529691279|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
146868447|NCT03627767|529691280|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
146868448|NCT03627767|529691281|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
146868449|NCT03627767|529691282|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
146868450|NCT03627767|529691283|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
146868451|NCT03627767|529691279|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
146534759|NCT00853385|528468825|FG004|Overall Study|Lost to Follow-up|0|||
146868452|NCT03627767|529691280|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
146868453|NCT03627767|529691281|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
146868454|NCT03627767|529691282|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
146868455|NCT03627767|529691283|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
146868456|NCT03627767|529691279|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
146868457|NCT03627767|529691280|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
146868458|NCT03627767|529691281|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
146868459|NCT03627767|529691282|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
146868460|NCT03627767|529691283|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
146868461|NCT03627767|529691279|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
146868462|NCT03627767|529691280|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
146868463|NCT03627767|529691281|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
146868464|NCT03627767|529691282|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
146868465|NCT03627767|529691283|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
146868466|NCT03627767|529691279|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
146868467|NCT03627767|529691280|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
146868468|NCT03627767|529691281|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
146868469|NCT03627767|529691282|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
146868470|NCT03627767|529691283|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
146868471|NCT03627767|529691279|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
146868472|NCT03627767|529691280|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
146868473|NCT03627767|529691281|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
146868474|NCT03627767|529691282|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
146868475|NCT03627767|529691283|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
146868476|NCT03627767|529691279|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
146868477|NCT03627767|529691280|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
146868478|NCT03627767|529691281|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
146868479|NCT03627767|529691282|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
146868480|NCT03627767|529691283|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
146868481|NCT03627767|529691279|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
146868482|NCT03627767|529691280|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
146868483|NCT03627767|529691281|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
146868484|NCT03627767|529691282|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
146868485|NCT03627767|529691283|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
146868486|NCT03627767|529691279|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
146868487|NCT03627767|529691280|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
146868488|NCT03627767|529691281|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
146868489|NCT03627767|529691282|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
146868490|NCT03627767|529691283|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
146868491|NCT03627767|529691279|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
146868492|NCT03627767|529691280|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
146868493|NCT03627767|529691281|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
146868494|NCT03627767|529691282|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
146534760|NCT00853385|528468821|FG000|Overall Study|Withdrawal by Subject|4|||
146868495|NCT03627767|529691283|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
146868496|NCT03627767|529691279|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
146868497|NCT03627767|529691280|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
146868498|NCT03627767|529691281|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
146868499|NCT03627767|529691282|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
146868500|NCT03627767|529691283|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
146868501|NCT03627767|529691279|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
146868502|NCT03627767|529691280|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
146868503|NCT03627767|529691281|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
146868504|NCT03627767|529691282|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
146868505|NCT03627767|529691283|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
146868506|NCT00907257|529691284|FG000|Overall Study|Adverse Event|0|||
146868507|NCT00907257|529691285|FG001|Overall Study|Adverse Event|4|||
146868508|NCT00907257|529691284|FG000|Overall Study|Protocol Violation|1|||
146868509|NCT00907257|529691285|FG001|Overall Study|Protocol Violation|2|||
146868510|NCT00907257|529691284|FG000|Overall Study|Lost to Follow-up|3|||
146868511|NCT00907257|529691285|FG001|Overall Study|Lost to Follow-up|3|||
146868512|NCT00907257|529691284|FG000|Overall Study|Withdrawal by Subject|1|||
146868513|NCT00907257|529691285|FG001|Overall Study|Withdrawal by Subject|2|||
146868514|NCT00907257|529691284|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
146868515|NCT00907257|529691285|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
146868516|NCT00907257|529691284|FG000|Overall Study|Moved|1|||
146868517|NCT00907257|529691285|FG001|Overall Study|Moved|0|||
146868518|NCT00907257|529691284|FG000|Overall Study|Personal Reasons|6|||
146868519|NCT00907257|529691285|FG001|Overall Study|Personal Reasons|1|||
146868520|NCT04163900|529691286|FG000|Overall Study|Radiological disease progression|112|||
146868521|NCT04163900|529691287|FG001|Overall Study|Radiological disease progression|127|||
146868522|NCT04163900|529691286|FG000|Overall Study|Study closure|98|||
146868523|NCT04163900|529691287|FG001|Overall Study|Study closure|133|||
146868524|NCT04163900|529691286|FG000|Overall Study|Adverse Event|78|||
146868525|NCT04163900|529691287|FG001|Overall Study|Adverse Event|32|||
146868526|NCT04163900|529691286|FG000|Overall Study|Withdrawal by Subject|37|||
146868527|NCT04163900|529691287|FG001|Overall Study|Withdrawal by Subject|34|||
146868528|NCT04163900|529691286|FG000|Overall Study|Death|29|||
146868529|NCT04163900|529691287|FG001|Overall Study|Death|16|||
146868530|NCT04163900|529691286|FG000|Overall Study|Physician Decision|17|||
146868531|NCT04163900|529691287|FG001|Overall Study|Physician Decision|25|||
146868532|NCT04163900|529691286|FG000|Overall Study|Clinical disease progression|14|||
146868533|NCT04163900|529691287|FG001|Overall Study|Clinical disease progression|13|||
146868534|NCT04163900|529691286|FG000|Overall Study|Protocol Violation|3|||
146868535|NCT04163900|529691287|FG001|Overall Study|Protocol Violation|4|||
146868536|NCT04163900|529691286|FG000|Overall Study|Lost to Follow-up|0|||
146868537|NCT04163900|529691287|FG001|Overall Study|Lost to Follow-up|1|||
146868538|NCT01873417|529691288|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
146868539|NCT01873417|529691288|FG000|Overall Study|Adverse Event|24|||
146868540|NCT01873417|529691288|FG000|Overall Study|Lost to Follow-up|2|||
146868541|NCT01873417|529691288|FG000|Overall Study|Withdrawal by Subject|2|||
146868542|NCT01873417|529691288|FG000|Overall Study|Physician Decision|3|||
146868543|NCT00785044|529691289|FG000|Overall Study|Dosed at non-participating sites|152|||
146868544|NCT00785044|529691289|FG000|Overall Study|Death|77|||
146868545|NCT00785044|529691289|FG000|Overall Study|Lost to Follow-up|266|||
146868546|NCT00785044|529691289|FG000|Overall Study|Withdrawal by Subject|1|||
146868547|NCT01628107|529691290|FG000|Overall Study|Withdrawal by Subject|17|||
146868548|NCT01628107|529691290|FG000|Overall Study|Lost to Follow-up|4|||
146868549|NCT01628107|529691290|FG000|Overall Study|Adverse Event|33|||
146868550|NCT01628107|529691290|FG000|Overall Study|Physician Decision|2|||
146868551|NCT01628107|529691290|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
146868552|NCT01628107|529691290|FG000|Overall Study|Non-compliant with Study Procedures|10|||
146868553|NCT01628107|529691290|FG000|Overall Study|Not Treated|8|||
146868554|NCT01628107|529691290|FG000|Overall Study|Sponsor Decision|11|||
146868555|NCT01628107|529691290|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
146868556|NCT01628107|529691290|FG000|Overall Study|Relocated|8|||
146868557|NCT01628107|529691290|FG000|Overall Study|Kidney Transplant|9|||
146868558|NCT01628107|529691290|FG000|Overall Study|Use of Standard of Care|9|||
146868559|NCT00930722|529691291|FG000|Overall Study|Lost to Follow-up|16|||
146868560|NCT00930722|529691291|FG000|Overall Study|No longer willing to participate|9|||
146868561|NCT00930722|529691291|FG000|Overall Study|Study terminated by sponsor|2|||
146868562|NCT03523728|529691292|FG000|Stage 1 (24 Months)|Adverse Event|2|||
146868563|NCT03523728|529691293|FG001|Stage 1 (24 Months)|Adverse Event|2|||
146868564|NCT03523728|529691294|FG002|Stage 1 (24 Months)|Adverse Event|4|||
146868565|NCT03523728|529691295|FG003|Stage 1 (24 Months)|Adverse Event|0|||
146868566|NCT03523728|529691296|FG004|Stage 1 (24 Months)|Adverse Event|0|||
146868567|NCT03523728|529691292|FG000|Stage 1 (24 Months)|Progressive disease|0|||
146868568|NCT03523728|529691293|FG001|Stage 1 (24 Months)|Progressive disease|0|||
146868569|NCT03523728|529691294|FG002|Stage 1 (24 Months)|Progressive disease|1|||
146868570|NCT03523728|529691295|FG003|Stage 1 (24 Months)|Progressive disease|0|||
146868571|NCT03523728|529691296|FG004|Stage 1 (24 Months)|Progressive disease|0|||
146868572|NCT03523728|529691292|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
146868573|NCT03523728|529691293|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
146868574|NCT03523728|529691294|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
146868575|NCT03523728|529691295|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
146868576|NCT03523728|529691296|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
146868577|NCT03523728|529691292|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
146868578|NCT03523728|529691293|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
146868579|NCT03523728|529691294|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
146868580|NCT03523728|529691295|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
146868581|NCT03523728|529691296|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
146868582|NCT03523728|529691292|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
146868583|NCT03523728|529691293|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
146868584|NCT03523728|529691294|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
146868585|NCT03523728|529691295|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
146868586|NCT03523728|529691296|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
146868587|NCT03523728|529691292|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
146868588|NCT03523728|529691293|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
146868589|NCT03523728|529691294|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
146868590|NCT03523728|529691295|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
146868591|NCT03523728|529691296|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
146868592|NCT03523728|529691292|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
146534761|NCT00853385|528468822|FG001|Overall Study|Withdrawal by Subject|2|||
146534762|NCT00853385|528468823|FG002|Overall Study|Withdrawal by Subject|0|||
146534763|NCT00853385|528468824|FG003|Overall Study|Withdrawal by Subject|1|||
146534764|NCT00853385|528468825|FG004|Overall Study|Withdrawal by Subject|1|||
146868593|NCT03523728|529691293|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
146534765|NCT00853385|528468821|FG000|Overall Study|Other|18|||
146534766|NCT00853385|528468822|FG001|Overall Study|Other|9|||
146534767|NCT00853385|528468823|FG002|Overall Study|Other|4|||
146534768|NCT00853385|528468824|FG003|Overall Study|Other|4|||
146868594|NCT03523728|529691294|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
146868595|NCT03523728|529691295|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
146868596|NCT03523728|529691296|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
146868597|NCT03523728|529691292|FG000|Stage 2 (24 Months)|Adverse Event|0|||
146534769|NCT00853385|528468825|FG004|Overall Study|Other|12|||
146534770|NCT00941928|528468832|FG000|Overall Study|Withdrawal by Subject|1|||
146534771|NCT00941928|528468832|FG000|Overall Study|Disease Progression|1|||
146534772|NCT02300610|528468835|FG000|Overall Study|Withdrawal by Subject|1|||
146534773|NCT02300610|528468836|FG001|Overall Study|Withdrawal by Subject|0|||
146868598|NCT03523728|529691293|FG001|Stage 2 (24 Months)|Adverse Event|0|||
146868599|NCT03523728|529691294|FG002|Stage 2 (24 Months)|Adverse Event|0|||
146868600|NCT03523728|529691295|FG003|Stage 2 (24 Months)|Adverse Event|1|||
146868601|NCT03523728|529691296|FG004|Stage 2 (24 Months)|Adverse Event|2|||
146868602|NCT03523728|529691292|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
146868603|NCT03523728|529691293|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
146868604|NCT03523728|529691294|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
146868605|NCT03523728|529691295|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
146868606|NCT03523728|529691296|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
146868607|NCT03523728|529691292|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
146868608|NCT03523728|529691293|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
146868609|NCT03523728|529691294|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
146868610|NCT03523728|529691295|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
146868611|NCT03523728|529691296|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
146868612|NCT03523728|529691292|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
146868613|NCT03523728|529691293|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
146868614|NCT03523728|529691294|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
146868615|NCT03523728|529691295|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
146868616|NCT03523728|529691296|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
146868617|NCT03523728|529691292|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
146868618|NCT03523728|529691293|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
146868619|NCT03523728|529691294|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
146868620|NCT03523728|529691295|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
146868621|NCT03523728|529691296|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
146868622|NCT00621751|529691297|FG000|Overall Study|Adverse Event|0|||
146868623|NCT00621751|529691298|FG001|Overall Study|Adverse Event|1|||
146868624|NCT00419120|529691299|FG000|Long Term Follow up Period|study ongoing|10|||
146868625|NCT01069120|529691300|FG000|Overall Study|Study prematurely terminated|27|||
146868626|NCT01809132|529691301|FG000|Overall Study|Withdrawal by Subject|0|||
146868627|NCT01809132|529691302|FG001|Overall Study|Withdrawal by Subject|0|||
146868628|NCT01809132|529691303|FG002|Overall Study|Withdrawal by Subject|1|||
146868629|NCT03349775|529691304|FG000|Overall Study|Side Effects|1|||
146868630|NCT03349775|529691305|FG001|Overall Study|Side Effects|2|||
146868631|NCT03349775|529691304|FG000|Overall Study|Withdrawal by Subject|1|||
146868632|NCT03349775|529691305|FG001|Overall Study|Withdrawal by Subject|1|||
146868633|NCT03349775|529691304|FG000|Overall Study|No primary outcome measurements|0|||
146868634|NCT03349775|529691305|FG001|Overall Study|No primary outcome measurements|1|||
146868635|NCT03583450|529691307|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
146868636|NCT03583450|529691308|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
146868637|NCT00791258|529691311|FG000|Overall Study|Adverse Event|87|||
146868638|NCT00791258|529691311|FG000|Overall Study|Lost to Follow-up|18|||
146868639|NCT00791258|529691311|FG000|Overall Study|Protocol Violation|109|||
146868640|NCT00791258|529691311|FG000|Overall Study|Withdrawal by Subject|40|||
146868641|NCT00791258|529691311|FG000|Overall Study|Did not take medication for >3 days|1|||
146868642|NCT00791258|529691311|FG000|Overall Study|subject left area|2|||
146868643|NCT00791258|529691311|FG000|Overall Study|non-compliance|3|||
146868644|NCT00791258|529691311|FG000|Overall Study|Subject incarcerated|1|||
146868645|NCT00791258|529691311|FG000|Overall Study|Subject required restricted medication|1|||
146868646|NCT00791258|529691311|FG000|Overall Study|Lack of Efficacy|1|||
146868647|NCT04667377|529691312|FG000|Dose Escalation Period|Other not specified below|3|||
146868648|NCT04667377|529691313|FG001|Dose Escalation Period|Other not specified below|3|||
146868649|NCT04667377|529691314|FG002|Dose Escalation Period|Other not specified below|2|||
146868650|NCT04667377|529691315|FG003|Dose Escalation Period|Other not specified below|1|||
146868651|NCT04667377|529691316|FG004|Dose Escalation Period|Other not specified below|3|||
146868652|NCT04667377|529691312|FG000|Dose Escalation Period|Protocol Violation|2|||
146868653|NCT04667377|529691313|FG001|Dose Escalation Period|Protocol Violation|2|||
146868654|NCT04667377|529691314|FG002|Dose Escalation Period|Protocol Violation|0|||
146868655|NCT04667377|529691315|FG003|Dose Escalation Period|Protocol Violation|2|||
146868656|NCT04667377|529691316|FG004|Dose Escalation Period|Protocol Violation|1|||
146868657|NCT04667377|529691312|FG000|Dose Escalation Period|Burden of study procedures|2|||
146868658|NCT04667377|529691313|FG001|Dose Escalation Period|Burden of study procedures|1|||
146868659|NCT04667377|529691314|FG002|Dose Escalation Period|Burden of study procedures|1|||
146868660|NCT04667377|529691315|FG003|Dose Escalation Period|Burden of study procedures|1|||
146534774|NCT02300610|528468837|FG002|Overall Study|Withdrawal by Subject|1|||
146868661|NCT04667377|529691316|FG004|Dose Escalation Period|Burden of study procedures|5|||
146868662|NCT04667377|529691312|FG000|Dose Escalation Period|Change of residence|0|||
146868663|NCT04667377|529691313|FG001|Dose Escalation Period|Change of residence|0|||
146868664|NCT04667377|529691314|FG002|Dose Escalation Period|Change of residence|1|||
146534775|NCT00095979|528468838|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
146868665|NCT04667377|529691315|FG003|Dose Escalation Period|Change of residence|0|||
146868666|NCT04667377|529691316|FG004|Dose Escalation Period|Change of residence|0|||
146868667|NCT04667377|529691312|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
146868668|NCT04667377|529691313|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
146868669|NCT04667377|529691314|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
146868670|NCT04667377|529691315|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
146868671|NCT04667377|529691316|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
146868672|NCT04667377|529691312|FG000|Dose Escalation Period|Adverse Event|9|||
146868673|NCT04667377|529691313|FG001|Dose Escalation Period|Adverse Event|10|||
146868674|NCT04667377|529691314|FG002|Dose Escalation Period|Adverse Event|12|||
146868675|NCT04667377|529691315|FG003|Dose Escalation Period|Adverse Event|17|||
146868676|NCT04667377|529691316|FG004|Dose Escalation Period|Adverse Event|3|||
146868677|NCT04667377|529691312|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
146868678|NCT04667377|529691313|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
146868679|NCT04667377|529691314|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
146868680|NCT04667377|529691315|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
146868681|NCT04667377|529691316|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
146868682|NCT04667377|529691312|FG000|Dose Escalation Period|Not treated|1|||
146868683|NCT04667377|529691313|FG001|Dose Escalation Period|Not treated|0|||
146868684|NCT04667377|529691314|FG002|Dose Escalation Period|Not treated|0|||
146868685|NCT04667377|529691315|FG003|Dose Escalation Period|Not treated|0|||
146868686|NCT04667377|529691316|FG004|Dose Escalation Period|Not treated|0|||
146868687|NCT04667377|529691312|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
146868688|NCT04667377|529691313|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
146868689|NCT04667377|529691314|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
146868690|NCT04667377|529691315|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
146868691|NCT04667377|529691316|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
146868692|NCT04667377|529691312|FG000|Dose Escalation Period|Lost to Follow-up|0|||
146868693|NCT04667377|529691313|FG001|Dose Escalation Period|Lost to Follow-up|1|||
146868694|NCT04667377|529691314|FG002|Dose Escalation Period|Lost to Follow-up|0|||
146868695|NCT04667377|529691315|FG003|Dose Escalation Period|Lost to Follow-up|0|||
146868696|NCT04667377|529691316|FG004|Dose Escalation Period|Lost to Follow-up|0|||
146868697|NCT04667377|529691312|FG000|Maintenance Period|Perceived lack of efficacy|0|||
146868698|NCT04667377|529691313|FG001|Maintenance Period|Perceived lack of efficacy|2|||
146868699|NCT04667377|529691314|FG002|Maintenance Period|Perceived lack of efficacy|1|||
146868700|NCT04667377|529691315|FG003|Maintenance Period|Perceived lack of efficacy|0|||
146868701|NCT04667377|529691316|FG004|Maintenance Period|Perceived lack of efficacy|1|||
146868702|NCT04667377|529691312|FG000|Maintenance Period|Adverse Event|2|||
146868703|NCT04667377|529691313|FG001|Maintenance Period|Adverse Event|8|||
146868704|NCT04667377|529691314|FG002|Maintenance Period|Adverse Event|5|||
146868705|NCT04667377|529691315|FG003|Maintenance Period|Adverse Event|4|||
146868706|NCT04667377|529691316|FG004|Maintenance Period|Adverse Event|1|||
146868707|NCT04667377|529691312|FG000|Maintenance Period|Adverse event: COVID infection|0|||
146868708|NCT04667377|529691313|FG001|Maintenance Period|Adverse event: COVID infection|1|||
146868709|NCT04667377|529691314|FG002|Maintenance Period|Adverse event: COVID infection|0|||
146868710|NCT04667377|529691315|FG003|Maintenance Period|Adverse event: COVID infection|0|||
146868711|NCT04667377|529691316|FG004|Maintenance Period|Adverse event: COVID infection|0|||
146868712|NCT04667377|529691312|FG000|Maintenance Period|COVID-related|0|||
146868713|NCT04667377|529691313|FG001|Maintenance Period|COVID-related|0|||
146868714|NCT04667377|529691314|FG002|Maintenance Period|COVID-related|1|||
146868715|NCT04667377|529691315|FG003|Maintenance Period|COVID-related|1|||
146868716|NCT04667377|529691316|FG004|Maintenance Period|COVID-related|0|||
146868717|NCT04667377|529691312|FG000|Maintenance Period|Protocol Violation|1|||
146868718|NCT04667377|529691313|FG001|Maintenance Period|Protocol Violation|0|||
146868719|NCT04667377|529691314|FG002|Maintenance Period|Protocol Violation|0|||
146868720|NCT04667377|529691315|FG003|Maintenance Period|Protocol Violation|0|||
146868721|NCT04667377|529691316|FG004|Maintenance Period|Protocol Violation|1|||
146868722|NCT04667377|529691312|FG000|Maintenance Period|Burden of study procedures|1|||
146868723|NCT04667377|529691313|FG001|Maintenance Period|Burden of study procedures|2|||
146868724|NCT04667377|529691314|FG002|Maintenance Period|Burden of study procedures|0|||
146868725|NCT04667377|529691315|FG003|Maintenance Period|Burden of study procedures|1|||
146868726|NCT04667377|529691316|FG004|Maintenance Period|Burden of study procedures|0|||
146868727|NCT04667377|529691312|FG000|Maintenance Period|Change of residence|0|||
146868728|NCT04667377|529691313|FG001|Maintenance Period|Change of residence|1|||
146868729|NCT04667377|529691314|FG002|Maintenance Period|Change of residence|0|||
146868730|NCT04667377|529691315|FG003|Maintenance Period|Change of residence|0|||
146868731|NCT04667377|529691316|FG004|Maintenance Period|Change of residence|1|||
146868732|NCT04667377|529691312|FG000|Maintenance Period|Missing|1|||
146868733|NCT04667377|529691313|FG001|Maintenance Period|Missing|0|||
146868734|NCT04667377|529691314|FG002|Maintenance Period|Missing|0|||
146868735|NCT04667377|529691315|FG003|Maintenance Period|Missing|0|||
146868736|NCT04667377|529691316|FG004|Maintenance Period|Missing|0|||
146868737|NCT04667377|529691312|FG000|Maintenance Period|Other than listed above|2|||
146868738|NCT04667377|529691313|FG001|Maintenance Period|Other than listed above|0|||
146868739|NCT04667377|529691314|FG002|Maintenance Period|Other than listed above|3|||
146868740|NCT04667377|529691315|FG003|Maintenance Period|Other than listed above|2|||
146868741|NCT04667377|529691316|FG004|Maintenance Period|Other than listed above|6|||
146868742|NCT04667377|529691312|FG000|Maintenance Period|Withdrawal by Subject|0|||
146868743|NCT04667377|529691313|FG001|Maintenance Period|Withdrawal by Subject|1|||
146868744|NCT04667377|529691314|FG002|Maintenance Period|Withdrawal by Subject|0|||
146868745|NCT04667377|529691315|FG003|Maintenance Period|Withdrawal by Subject|0|||
146868746|NCT04667377|529691316|FG004|Maintenance Period|Withdrawal by Subject|0|||
146868747|NCT04667377|529691312|FG000|Maintenance Period|Lost to Follow-up|1|||
146868748|NCT04667377|529691313|FG001|Maintenance Period|Lost to Follow-up|0|||
146868749|NCT04667377|529691314|FG002|Maintenance Period|Lost to Follow-up|1|||
146868750|NCT04667377|529691315|FG003|Maintenance Period|Lost to Follow-up|0|||
146868751|NCT04667377|529691316|FG004|Maintenance Period|Lost to Follow-up|1|||
146868752|NCT04004429|529691319|FG000|Overall Study|Protocol Violation|1|||
146868753|NCT04004429|529691320|FG001|Overall Study|Protocol Violation|0|||
146868754|NCT04004429|529691321|FG002|Overall Study|Protocol Violation|0|||
146868755|NCT04004429|529691319|FG000|Overall Study|Physician Decision|0|||
146868756|NCT04004429|529691320|FG001|Overall Study|Physician Decision|1|||
146868757|NCT04004429|529691321|FG002|Overall Study|Physician Decision|1|||
146868758|NCT04004429|529691319|FG000|Overall Study|Withdrawal by Subject|1|||
146868759|NCT04004429|529691320|FG001|Overall Study|Withdrawal by Subject|1|||
146868760|NCT04004429|529691321|FG002|Overall Study|Withdrawal by Subject|1|||
146868761|NCT05215262|529691322|FG000|Overall Study|Lost to Follow-up|12|||
146868762|NCT05215262|529691323|FG001|Overall Study|Lost to Follow-up|0|||
146868763|NCT00239226|529691325|FG000|Overall Study|permAF during stabilization period|0|||
146868764|NCT00239226|529691326|FG001|Overall Study|permAF during stabilization period|0|||
146868765|NCT00239226|529691327|FG002|Overall Study|permAF during stabilization period|0|||
146868766|NCT00239226|529691328|FG003|Overall Study|permAF during stabilization period|3|||
146868767|NCT00239226|529691325|FG000|Overall Study|Lost to Follow-up|1|||
146868768|NCT00239226|529691326|FG001|Overall Study|Lost to Follow-up|0|||
146868769|NCT00239226|529691327|FG002|Overall Study|Lost to Follow-up|1|||
146868770|NCT00239226|529691328|FG003|Overall Study|Lost to Follow-up|0|||
146868771|NCT00646906|529691329|FG000|Crossover Period 1|Withdrawal by Subject|1|||
146868772|NCT00646906|529691330|FG001|Crossover Period 1|Withdrawal by Subject|0|||
146868773|NCT00646906|529691331|FG002|Crossover Period 1|Withdrawal by Subject|0|||
146868774|NCT00646906|529691332|FG003|Crossover Period 1|Withdrawal by Subject|0|||
146868775|NCT00646906|529691333|FG004|Crossover Period 1|Withdrawal by Subject|0|||
146868776|NCT00646906|529691334|FG005|Crossover Period 1|Withdrawal by Subject|1|||
146868777|NCT00646906|529691335|FG006|Crossover Period 1|Withdrawal by Subject|0|||
146868778|NCT00646906|529691329|FG000|Crossover Period 2|Withdrawal by Subject|0|||
146868779|NCT00646906|529691330|FG001|Crossover Period 2|Withdrawal by Subject|1|||
146868780|NCT00646906|529691331|FG002|Crossover Period 2|Withdrawal by Subject|2|||
146868781|NCT00646906|529691332|FG003|Crossover Period 2|Withdrawal by Subject|1|||
146868782|NCT00646906|529691333|FG004|Crossover Period 2|Withdrawal by Subject|0|||
146868783|NCT00646906|529691334|FG005|Crossover Period 2|Withdrawal by Subject|0|||
146868784|NCT00646906|529691335|FG006|Crossover Period 2|Withdrawal by Subject|0|||
146868785|NCT00646906|529691329|FG000|Crossover Period 2|Physician Decision|0|||
146763325|NCT02001623|529301299|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
146763326|NCT02001623|529301300|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
146763327|NCT02001623|529301301|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
146763328|NCT02001623|529301302|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
146763329|NCT02001623|529301303|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
146763330|NCT02001623|529301304|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
146763331|NCT02001623|529301305|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
146763332|NCT02001623|529301306|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
146763333|NCT02001623|529301307|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
146763334|NCT02001623|529301308|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
146763335|NCT02001623|529301309|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
146763336|NCT02001623|529301310|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
146763337|NCT02001623|529301296|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
146763338|NCT02001623|529301297|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
146763339|NCT02001623|529301298|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
146763340|NCT02001623|529301299|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
146868786|NCT00646906|529691330|FG001|Crossover Period 2|Physician Decision|0|||
146868787|NCT00646906|529691331|FG002|Crossover Period 2|Physician Decision|0|||
146868788|NCT00646906|529691332|FG003|Crossover Period 2|Physician Decision|0|||
146868789|NCT00646906|529691333|FG004|Crossover Period 2|Physician Decision|0|||
146868790|NCT00646906|529691334|FG005|Crossover Period 2|Physician Decision|0|||
146868791|NCT00646906|529691335|FG006|Crossover Period 2|Physician Decision|1|||
146868792|NCT02448225|529691337|FG000|Overall Study|Withdrawal by Subject|1|||
146868793|NCT02448225|529691337|FG000|Overall Study|Did not get FSPG scan|18|||
146868794|NCT02448225|529691337|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
146868795|NCT04060563|529691338|FG000|Overall Study|Lost to Follow-up|1|||
146868796|NCT04060563|529691339|FG001|Overall Study|Lost to Follow-up|1|||
146868797|NCT04060563|529691338|FG000|Overall Study|Physician Decision|0|||
146868798|NCT04060563|529691339|FG001|Overall Study|Physician Decision|1|||
146868799|NCT00851682|529691342|FG000|Overall Study|screen failure|5|||
146868800|NCT00851682|529691343|FG001|Overall Study|screen failure|0|||
146868801|NCT01379573|529691348|FG000|Overall Study|Lost to Follow-up|1|||
146868802|NCT01379573|529691348|FG000|Overall Study|Screen Failure|10|||
146868803|NCT00962390|529691349|FG000|Overall Study|Adverse Event|0|||
146868804|NCT00962390|529691350|FG001|Overall Study|Adverse Event|0|||
146868805|NCT00962390|529691351|FG002|Overall Study|Adverse Event|3|||
146868806|NCT00962390|529691352|FG003|Overall Study|Adverse Event|1|||
146868807|NCT00962390|529691349|FG000|Overall Study|Lost to Follow-up|2|||
146868808|NCT00962390|529691350|FG001|Overall Study|Lost to Follow-up|2|||
146868809|NCT00962390|529691351|FG002|Overall Study|Lost to Follow-up|0|||
146868810|NCT00962390|529691352|FG003|Overall Study|Lost to Follow-up|0|||
146868811|NCT00962390|529691349|FG000|Overall Study|Protocol Violation|1|||
146868812|NCT00962390|529691350|FG001|Overall Study|Protocol Violation|0|||
146868813|NCT00962390|529691351|FG002|Overall Study|Protocol Violation|0|||
146868814|NCT00962390|529691352|FG003|Overall Study|Protocol Violation|0|||
146868815|NCT00962390|529691349|FG000|Overall Study|Withdrawal by Subject|1|||
146868816|NCT00962390|529691350|FG001|Overall Study|Withdrawal by Subject|1|||
146868817|NCT00962390|529691351|FG002|Overall Study|Withdrawal by Subject|1|||
146868818|NCT00962390|529691352|FG003|Overall Study|Withdrawal by Subject|0|||
146868819|NCT02613884|529691353|FG000|Overall Study|Death|1|||
146868820|NCT02613884|529691353|FG000|Overall Study|Lost to Follow-up|1|||
146868821|NCT04422990|529691354|FG000|Overall Study|Withdrawal by Subject|0|||
146868822|NCT04422990|529691355|FG001|Overall Study|Withdrawal by Subject|1|||
146868823|NCT04422990|529691354|FG000|Overall Study|Travel|3|||
146868824|NCT04422990|529691355|FG001|Overall Study|Travel|0|||
146868825|NCT02844920|529691358|FG000|Overall Study|Lost to Follow-up|2|||
146868826|NCT02486653|529691361|FG000|Overall Study|Withdrawal by Subject|1|||
146868827|NCT02486653|529691362|FG001|Overall Study|Withdrawal by Subject|3|||
146868828|NCT02486653|529691361|FG000|Overall Study|Protocol Violation|1|||
146868829|NCT02486653|529691362|FG001|Overall Study|Protocol Violation|0|||
146868830|NCT02486653|529691361|FG000|Overall Study|surgery cancelled|4|||
146868831|NCT02486653|529691362|FG001|Overall Study|surgery cancelled|1|||
146868832|NCT00131469|529691369|FG000|Overall Study|Withdrawal by Subject|3|||
146868833|NCT00131469|529691370|FG001|Overall Study|Withdrawal by Subject|4|||
146868834|NCT00131469|529691369|FG000|Overall Study|Protocol Violation|3|||
146868835|NCT00131469|529691370|FG001|Overall Study|Protocol Violation|1|||
146868836|NCT00131469|529691369|FG000|Overall Study|Death|0|||
146868837|NCT00131469|529691370|FG001|Overall Study|Death|1|||
146868838|NCT00131469|529691369|FG000|Overall Study|Lost to Follow-up|0|||
146868839|NCT00131469|529691370|FG001|Overall Study|Lost to Follow-up|1|||
146868840|NCT00131469|529691369|FG000|Overall Study|scan not analyzable|3|||
146868841|NCT00131469|529691370|FG001|Overall Study|scan not analyzable|6|||
146868842|NCT02871778|529691371|FG000|Part A: Treatment Period 1|Adverse Event|1|||
146868843|NCT02871778|529691372|FG001|Part A: Treatment Period 1|Adverse Event|1|||
146868844|NCT02871778|529691373|FG002|Part A: Treatment Period 1|Adverse Event|1|||
146868845|NCT02871778|529691374|FG003|Part A: Treatment Period 1|Adverse Event|0|||
146868846|NCT02871778|529691375|FG004|Part A: Treatment Period 1|Adverse Event|0|||
146868847|NCT02871778|529691376|FG005|Part A: Treatment Period 1|Adverse Event|0|||
146868848|NCT02871778|529691377|FG006|Part A: Treatment Period 1|Adverse Event|0|||
146868849|NCT02871778|529691378|FG007|Part A: Treatment Period 1|Adverse Event|0|||
146868850|NCT02871778|529691371|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
146868851|NCT02871778|529691372|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
146868852|NCT02871778|529691373|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
146868853|NCT02871778|529691374|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
146868854|NCT02871778|529691375|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
146868855|NCT02871778|529691376|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
146868856|NCT02871778|529691377|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
146868857|NCT02871778|529691378|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
146868858|NCT02871778|529691371|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
146868859|NCT02871778|529691372|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
146868860|NCT02871778|529691373|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
146868861|NCT02871778|529691374|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
146534776|NCT01829347|528468839|FG000|VTI-210|Death|5|||
146534777|NCT01829347|528468840|FG001|VTI-210|Death|3|||
146534778|NCT01829347|528468839|FG000|VTI-210|Withdrawal by Subject|1|||
146534779|NCT01829347|528468840|FG001|VTI-210|Withdrawal by Subject|0|||
146763341|NCT02001623|529301300|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
146763342|NCT02001623|529301301|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
146763343|NCT02001623|529301302|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
146763344|NCT02001623|529301303|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
146763345|NCT02001623|529301304|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
146763346|NCT02001623|529301305|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
146763347|NCT02001623|529301306|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
146763348|NCT02001623|529301307|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
146763349|NCT02001623|529301308|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
146763350|NCT02001623|529301309|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
146763351|NCT02001623|529301310|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
146763352|NCT01063036|529301319|FG000|Participants Treated With Study Drug|Adverse Event|1|||
146534780|NCT01829347|528468839|FG000|VTI-210E|Death|2|||
146534781|NCT01829347|528468840|FG001|VTI-210E|Death|1|||
146534782|NCT01829347|528468839|FG000|VTI-210E|Study terminated prematurely|1|||
146534783|NCT01829347|528468840|FG001|VTI-210E|Study terminated prematurely|5|||
146534784|NCT04018066|528468841|FG000|Overall Study|participants started taking medications during the study period|3|||
146534785|NCT04018066|528468841|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
146534786|NCT02732639|528468847|FG000|Overall Study|Lost to Follow-up|1|||
146534787|NCT01668797|528468848|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
146534788|NCT01668797|528468849|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
146534789|NCT01668797|528468850|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
146534790|NCT01668797|528468851|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
146534791|NCT01668797|528468848|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
146534792|NCT01668797|528468849|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
146534793|NCT01668797|528468850|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
146868862|NCT02871778|529691375|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
146868863|NCT02871778|529691376|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
146868864|NCT02871778|529691377|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
146868865|NCT02871778|529691378|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
146868866|NCT02871778|529691371|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
146868867|NCT02871778|529691372|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
146868868|NCT02871778|529691373|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
146868869|NCT02871778|529691374|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
146868870|NCT02871778|529691375|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
146868871|NCT02871778|529691376|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
146868872|NCT02871778|529691377|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
146868873|NCT02871778|529691378|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
146868874|NCT02871778|529691371|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
146868875|NCT02871778|529691372|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
146868876|NCT02871778|529691373|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
146868877|NCT02871778|529691374|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
146868878|NCT02871778|529691375|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
146868879|NCT02871778|529691376|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
146868880|NCT02871778|529691377|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
146868881|NCT02871778|529691378|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
146868882|NCT02871778|529691371|FG000|Part A: Treatment Period 2|Adverse Event|2|||
146868883|NCT02871778|529691372|FG001|Part A: Treatment Period 2|Adverse Event|2|||
146868884|NCT02871778|529691373|FG002|Part A: Treatment Period 2|Adverse Event|0|||
146868885|NCT02871778|529691374|FG003|Part A: Treatment Period 2|Adverse Event|0|||
146868886|NCT02871778|529691375|FG004|Part A: Treatment Period 2|Adverse Event|0|||
146868887|NCT02871778|529691376|FG005|Part A: Treatment Period 2|Adverse Event|0|||
146868888|NCT02871778|529691377|FG006|Part A: Treatment Period 2|Adverse Event|0|||
146868889|NCT02871778|529691378|FG007|Part A: Treatment Period 2|Adverse Event|0|||
146868890|NCT02871778|529691371|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
146868891|NCT02871778|529691372|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
146868892|NCT02871778|529691373|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
146868893|NCT02871778|529691374|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
146868894|NCT02871778|529691375|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
146868895|NCT02871778|529691376|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
146868896|NCT02871778|529691377|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
146868897|NCT02871778|529691378|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
146868898|NCT02871778|529691371|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
146868899|NCT02871778|529691372|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
146868900|NCT02871778|529691373|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
146868901|NCT02871778|529691374|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
146868902|NCT02871778|529691375|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
146868903|NCT02871778|529691376|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
146868904|NCT02871778|529691377|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
146868905|NCT02871778|529691378|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
146868906|NCT02871778|529691371|FG000|Part B: Treatment Period 3|Adverse Event|0|||
146868907|NCT02871778|529691372|FG001|Part B: Treatment Period 3|Adverse Event|0|||
146868908|NCT02871778|529691373|FG002|Part B: Treatment Period 3|Adverse Event|0|||
146868909|NCT02871778|529691374|FG003|Part B: Treatment Period 3|Adverse Event|0|||
146868910|NCT02871778|529691375|FG004|Part B: Treatment Period 3|Adverse Event|1|||
146868911|NCT02871778|529691376|FG005|Part B: Treatment Period 3|Adverse Event|1|||
146868912|NCT02871778|529691377|FG006|Part B: Treatment Period 3|Adverse Event|1|||
146868913|NCT02871778|529691378|FG007|Part B: Treatment Period 3|Adverse Event|0|||
146868914|NCT01230554|529691379|FG000|Overall Study|Lost to Follow-up|2|||
146868915|NCT01230554|529691379|FG000|Overall Study|Inability to maintain visit schedule|1|||
146868916|NCT02663271|529691380|FG000|Overall Study|Withdrawal by Subject|5|||
146868917|NCT02663271|529691380|FG000|Overall Study|Lack of Efficacy|1|||
146914648|NCT03303339|529850045|FG003|Overall Study|Study Terminated by Sponsor|0|||
146868918|NCT04166383|529691381|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
146868919|NCT04166383|529691381|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
146868920|NCT04166383|529691381|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
146868921|NCT01624259|529691391|FG000|Overall Study|Adverse Event|18|||
146868922|NCT01624259|529691392|FG001|Overall Study|Adverse Event|18|||
146868923|NCT01624259|529691391|FG000|Overall Study|Protocol Violation|1|||
146868924|NCT01624259|529691392|FG001|Overall Study|Protocol Violation|2|||
146868925|NCT01624259|529691391|FG000|Overall Study|Withdrawal by Subject|5|||
146868926|NCT01624259|529691392|FG001|Overall Study|Withdrawal by Subject|7|||
146868927|NCT01624259|529691391|FG000|Overall Study|Physician Decision|1|||
146868928|NCT01624259|529691392|FG001|Overall Study|Physician Decision|1|||
146868929|NCT01624259|529691391|FG000|Overall Study|Lost to Follow-up|2|||
146868930|NCT01624259|529691392|FG001|Overall Study|Lost to Follow-up|3|||
146868931|NCT01624259|529691391|FG000|Overall Study|Abnormal laboratory measure|3|||
146868932|NCT01624259|529691392|FG001|Overall Study|Abnormal laboratory measure|0|||
146868933|NCT00088907|529692199|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
146868934|NCT00088907|529692200|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
146868935|NCT00088907|529692199|FG000|Randomized Study (Step 1)|Adverse Event|14|||
146868936|NCT00088907|529692200|FG001|Randomized Study (Step 1)|Adverse Event|19|||
146868937|NCT00088907|529692199|FG000|Randomized Study (Step 1)|Death|11|||
146868938|NCT00088907|529692200|FG001|Randomized Study (Step 1)|Death|12|||
146868939|NCT00088907|529692199|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
146868940|NCT00088907|529692200|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
146868941|NCT00088907|529692199|FG000|Randomized Study (Step 1)|complicating disease|3|||
146868942|NCT00088907|529692200|FG001|Randomized Study (Step 1)|complicating disease|1|||
146868943|NCT00088907|529692199|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
146868944|NCT00088907|529692200|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
146868945|NCT00088907|529692199|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
146868946|NCT00088907|529692200|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
146868947|NCT00088907|529692199|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
146868948|NCT00088907|529692200|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
146868949|NCT00088907|529692199|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
146868950|NCT00088907|529692200|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
146868951|NCT00088907|529692199|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
146868952|NCT00088907|529692200|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
146868953|NCT00088907|529692199|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
146868954|NCT00088907|529692200|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
146868955|NCT03426787|529692201|FG000|Overall Study|Withdrawal by Subject|6|||
146868956|NCT03426787|529692201|FG000|Overall Study|Lost to Follow-up|7|||
146868957|NCT03426787|529692201|FG000|Overall Study|Unrelated to intervention death|1|||
146868958|NCT04050670|529692202|FG000|Period 3|Physician Decision|0|||
146868959|NCT04050670|529692203|FG001|Period 3|Physician Decision|1|||
146868960|NCT04050670|529692204|FG002|Period 3|Physician Decision|0|||
146868961|NCT00880555|529692206|FG000|Overall Study|Physician Decision|0|||
146868962|NCT00880555|529692207|FG001|Overall Study|Physician Decision|8|||
146868963|NCT00880555|529692208|FG002|Overall Study|Physician Decision|0|||
146868964|NCT00880555|529692209|FG003|Overall Study|Physician Decision|2|||
146868965|NCT00880555|529692210|FG004|Overall Study|Physician Decision|1|||
146868966|NCT00880555|529692211|FG005|Overall Study|Physician Decision|0|||
146868967|NCT00880555|529692206|FG000|Overall Study|Withdrawal by Subject|1|||
146868968|NCT00880555|529692207|FG001|Overall Study|Withdrawal by Subject|1|||
146868969|NCT00880555|529692208|FG002|Overall Study|Withdrawal by Subject|0|||
146868970|NCT00880555|529692209|FG003|Overall Study|Withdrawal by Subject|0|||
146868971|NCT00880555|529692210|FG004|Overall Study|Withdrawal by Subject|0|||
146868972|NCT00880555|529692211|FG005|Overall Study|Withdrawal by Subject|0|||
146868973|NCT00880555|529692206|FG000|Overall Study|Lack of resources (hired rater)|9|||
146868974|NCT00880555|529692207|FG001|Overall Study|Lack of resources (hired rater)|7|||
146868975|NCT00880555|529692208|FG002|Overall Study|Lack of resources (hired rater)|5|||
146868976|NCT00880555|529692209|FG003|Overall Study|Lack of resources (hired rater)|0|||
146868977|NCT00880555|529692210|FG004|Overall Study|Lack of resources (hired rater)|0|||
146868978|NCT00880555|529692211|FG005|Overall Study|Lack of resources (hired rater)|0|||
146868979|NCT00880555|529692206|FG000|Overall Study|Death|0|||
146868980|NCT00880555|529692207|FG001|Overall Study|Death|0|||
146868981|NCT00880555|529692208|FG002|Overall Study|Death|0|||
146868982|NCT00880555|529692209|FG003|Overall Study|Death|0|||
146868983|NCT00880555|529692210|FG004|Overall Study|Death|0|||
146868984|NCT00880555|529692211|FG005|Overall Study|Death|1|||
146868985|NCT00880555|529692206|FG000|Overall Study|Lost to Follow-up|0|||
146868986|NCT00880555|529692207|FG001|Overall Study|Lost to Follow-up|1|||
146868987|NCT00880555|529692208|FG002|Overall Study|Lost to Follow-up|0|||
146868988|NCT00880555|529692209|FG003|Overall Study|Lost to Follow-up|0|||
146868989|NCT00880555|529692210|FG004|Overall Study|Lost to Follow-up|0|||
146868990|NCT00880555|529692211|FG005|Overall Study|Lost to Follow-up|0|||
146868991|NCT02767323|529692213|FG000|Overall Study|Withdrawal by Subject|17|||
146868992|NCT02767323|529692214|FG001|Overall Study|Withdrawal by Subject|5|||
146868993|NCT02767323|529692215|FG002|Overall Study|Withdrawal by Subject|13|||
146868994|NCT02767323|529692216|FG003|Overall Study|Withdrawal by Subject|0|||
146868995|NCT02767323|529692213|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
146868996|NCT02767323|529692214|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
146868997|NCT02767323|529692215|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
146868998|NCT02767323|529692216|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
146868999|NCT02230254|529692217|FG000|Overall Study|Lost to Follow-up|3|||
146869000|NCT02023242|529692218|FG000|Overall Study|Lost to Follow-up|3|||
146869001|NCT02023242|529692219|FG001|Overall Study|Lost to Follow-up|1|||
146869002|NCT02023242|529692218|FG000|Overall Study|Death|0|||
146869003|NCT02023242|529692219|FG001|Overall Study|Death|1|||
146869004|NCT04854434|529692227|FG000|Overall Study|Death|1|||
146869005|NCT04854434|529692228|FG001|Overall Study|Death|3|||
146869006|NCT04854434|529692229|FG002|Overall Study|Death|4|||
146869007|NCT04854434|529692227|FG000|Overall Study|Study Terminated by Sponsor|2|||
146869008|NCT04854434|529692228|FG001|Overall Study|Study Terminated by Sponsor|0|||
146869009|NCT04854434|529692229|FG002|Overall Study|Study Terminated by Sponsor|0|||
146869010|NCT04854434|529692227|FG000|Overall Study|Other|1|||
146869011|NCT04854434|529692228|FG001|Overall Study|Other|1|||
146869012|NCT04854434|529692229|FG002|Overall Study|Other|0|||
146869013|NCT02667275|529692230|FG000|Overall Study|Protocol Violation|11|||
146869014|NCT02667275|529692231|FG001|Overall Study|Protocol Violation|7|||
146869015|NCT02667275|529692230|FG000|Overall Study|Lost to Follow-up|0|||
146869016|NCT02667275|529692231|FG001|Overall Study|Lost to Follow-up|2|||
146869017|NCT02667275|529692230|FG000|Overall Study|Withdrawal by Subject|0|||
146869018|NCT02667275|529692231|FG001|Overall Study|Withdrawal by Subject|5|||
146869019|NCT02667275|529692230|FG000|Overall Study|Discontinued early without completing|0|||
146869020|NCT02667275|529692231|FG001|Overall Study|Discontinued early without completing|1|||
146869021|NCT01756040|529692232|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
146869022|NCT01756040|529692232|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
146869023|NCT01756040|529692232|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
146869024|NCT01274715|529692233|FG000|Overall Study|Lost to Follow-up|1|||
146869025|NCT01274715|529692233|FG000|Overall Study|After consent, met exclusion criteria.|1|||
146869026|NCT01274715|529692233|FG000|Overall Study|After consent, met exclusion criteria.|1|||
146869027|NCT01274715|529692233|FG000|Overall Study|After consent, met exclusion criteria.|1|||
146869028|NCT04479436|529692234|FG000|Overall Study|Progressive disease|26|||
146869029|NCT04479436|529692235|FG001|Overall Study|Progressive disease|1|||
146869030|NCT04479436|529692234|FG000|Overall Study|Adverse Event|6|||
146869031|NCT04479436|529692235|FG001|Overall Study|Adverse Event|0|||
146869032|NCT04479436|529692234|FG000|Overall Study|Withdrawal by Subject|5|||
146534794|NCT01668797|528468851|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
146869033|NCT04479436|529692235|FG001|Overall Study|Withdrawal by Subject|0|||
146869034|NCT04479436|529692234|FG000|Overall Study|Clinical progression|1|||
146869035|NCT04479436|529692235|FG001|Overall Study|Clinical progression|0|||
146869036|NCT04479436|529692234|FG000|Overall Study|Physician Decision|1|||
146869037|NCT04479436|529692235|FG001|Overall Study|Physician Decision|0|||
146869038|NCT02713542|529692236|FG000|Overall Study|Use of prohibited medication|14|||
146869039|NCT02713542|529692237|FG001|Overall Study|Use of prohibited medication|5|||
146869040|NCT02713542|529692236|FG000|Overall Study|Withdrawal by Subject|4|||
146869041|NCT02713542|529692237|FG001|Overall Study|Withdrawal by Subject|1|||
146869042|NCT02357134|529692238|FG000|Overall Study|Lost to Follow-up|1|||
146869043|NCT02357134|529692239|FG001|Overall Study|Lost to Follow-up|0|||
146869044|NCT02357134|529692240|FG002|Overall Study|Lost to Follow-up|0|||
146869045|NCT02357134|529692241|FG003|Overall Study|Lost to Follow-up|0|||
146869046|NCT05097716|529692242|FG000|Period 1|Adverse Event|1|||
146869047|NCT05097716|529692242|FG000|Period 1|Close contact with highly-transmissible infection|1|||
146869048|NCT02653300|529692243|FG000|Overall Study|Withdrawal by Subject|2|||
146869049|NCT01910116|529692244|FG000|Overall Study|Adverse Event|0|||
146869050|NCT01910116|529692245|FG001|Overall Study|Adverse Event|3|||
146869051|NCT01910116|529692244|FG000|Overall Study|Lack of Efficacy|3|||
146869052|NCT01910116|529692245|FG001|Overall Study|Lack of Efficacy|4|||
146869053|NCT01910116|529692244|FG000|Overall Study|Lost to Follow-up|1|||
146869054|NCT01910116|529692245|FG001|Overall Study|Lost to Follow-up|0|||
146869055|NCT01910116|529692244|FG000|Overall Study|Protocol Violation|1|||
146869056|NCT01910116|529692245|FG001|Overall Study|Protocol Violation|2|||
146869057|NCT01910116|529692244|FG000|Overall Study|Withdrawal by Subject|8|||
146869058|NCT01910116|529692245|FG001|Overall Study|Withdrawal by Subject|3|||
146869059|NCT01910116|529692244|FG000|Overall Study|uncertain allocation|1|||
146869060|NCT01910116|529692245|FG001|Overall Study|uncertain allocation|3|||
146869061|NCT01910116|529692244|FG000|Overall Study|incomplete data|0|||
146869062|NCT01910116|529692245|FG001|Overall Study|incomplete data|1|||
146869063|NCT01849497|529692246|FG000|Overall Study|Withdrawal by Subject|1|||
146869064|NCT01849497|529692247|FG001|Overall Study|Withdrawal by Subject|2|||
146869065|NCT01849497|529692246|FG000|Overall Study|Sponsor Decision|0|||
146869066|NCT01849497|529692247|FG001|Overall Study|Sponsor Decision|1|||
146869067|NCT01849497|529692246|FG000|Overall Study|Lost to Follow-up|0|||
146869068|NCT01849497|529692247|FG001|Overall Study|Lost to Follow-up|1|||
146869069|NCT00911625|529692248|FG000|Overall Study|Lost to Follow-up|7|||
146869070|NCT00911625|529692249|FG001|Overall Study|Lost to Follow-up|0|||
146869071|NCT01289821|529692250|FG000|Treatment Period|Withdrawal by Subject|1|||
146869072|NCT01289821|529692250|FG000|Treatment Period|Physician Decision|3|||
146869073|NCT01289821|529692250|FG000|Treatment Period|Adverse Event|4|||
146869074|NCT01289821|529692250|FG000|Treatment Period|Radiological Progression|43|||
146869075|NCT01289821|529692250|FG000|Treatment Period|Clinical Progression|2|||
146869076|NCT01289821|529692250|FG000|Treatment Period|Therapeutic procedure required|1|||
146869077|NCT01289821|529692250|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
146869078|NCT01289821|529692250|FG000|Safety Follow-up Period|Protocol Violation|3|||
146869079|NCT01289821|529692250|FG000|Safety Follow-up Period|Unspecified reason|1|||
146869080|NCT01289821|529692250|FG000|Survival Follow-up Period|Protocol Violation|1|||
146869081|NCT01289821|529692250|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
146869082|NCT01289821|529692250|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
146869083|NCT02729740|529692253|FG000|Overall Study|Early Termination|130|||
146869084|NCT02729740|529692253|FG000|Overall Study|Other|1|||
146869085|NCT03061175|529692270|FG000|Baseline|Participant was deemed ineligible|1|||
146869086|NCT03061175|529692271|FG001|Baseline|Participant was deemed ineligible|0|||
146869087|NCT03061175|529692270|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
146869088|NCT03061175|529692271|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
146869089|NCT03061175|529692270|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
146869090|NCT03061175|529692271|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
146869091|NCT03061175|529692270|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
146869092|NCT03061175|529692271|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
146869093|NCT03044249|529692272|FG000|Overall Study|Adverse Event|4|||
146869094|NCT03044249|529692273|FG001|Overall Study|Adverse Event|9|||
146869095|NCT03044249|529692272|FG000|Overall Study|Lost to Follow-up|1|||
146869096|NCT03044249|529692273|FG001|Overall Study|Lost to Follow-up|0|||
146869097|NCT03044249|529692272|FG000|Overall Study|Non-compliance with Study Drug|1|||
146869098|NCT03044249|529692273|FG001|Overall Study|Non-compliance with Study Drug|0|||
146869099|NCT03044249|529692272|FG000|Overall Study|Study Terminated by Sponsor|2|||
146869100|NCT03044249|529692273|FG001|Overall Study|Study Terminated by Sponsor|0|||
146869101|NCT03044249|529692272|FG000|Overall Study|Withdrawal by Subject|2|||
146869102|NCT03044249|529692273|FG001|Overall Study|Withdrawal by Subject|5|||
146869103|NCT00760669|529692274|FG000|Overall Study|Not assessed for overall improvement|18|||
146869104|NCT00760669|529692274|FG000|Overall Study|Participants missing efficacy assessment|6|||
146869105|NCT00760669|529692274|FG000|Overall Study|Participants with overlapping cases|1|||
146869106|NCT00760669|529692274|FG000|Overall Study|Took drug before entering in contract|5|||
146869107|NCT00504153|529692280|FG000|Overall Study|Withdrawal by Subject|1|||
146869108|NCT00504153|529692280|FG000|Overall Study|Adverse Event|4|||
146869109|NCT00504153|529692280|FG000|Overall Study|Death|1|||
146869110|NCT00732251|529692283|FG000|Overall Study|Lost to Follow-up|3|||
146869111|NCT00732251|529692283|FG000|Overall Study|Withdrawal by Subject|3|||
146869112|NCT00732251|529692283|FG000|Overall Study|Early Term due to Site Closure|1|||
146869113|NCT00805025|529692284|FG000|Overall Study|Screened but not enrolled/treated|42|||
146869114|NCT00805025|529692284|FG000|Overall Study|Adverse Event|4|||
146869115|NCT00805025|529692284|FG000|Overall Study|Withdrawal by Subject|2|||
146869116|NCT00805025|529692284|FG000|Overall Study|Physician Decision|1|||
146869117|NCT04029961|529692285|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
146869118|NCT04029961|529692286|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
146869119|NCT04029961|529692285|FG000|Overall Study|Change in Treatment Course|0|||
146869120|NCT04029961|529692286|FG001|Overall Study|Change in Treatment Course|1|||
146869121|NCT03007979|529692290|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
146869122|NCT00232141|529692291|FG000|Overall Study|Adverse Event|9|||
146869123|NCT00232141|529692292|FG001|Overall Study|Adverse Event|4|||
146869124|NCT00232141|529692291|FG000|Overall Study|Lack of Efficacy|0|||
146869125|NCT00232141|529692292|FG001|Overall Study|Lack of Efficacy|3|||
146869126|NCT00232141|529692291|FG000|Overall Study|Lost to Follow-up|9|||
146869127|NCT00232141|529692292|FG001|Overall Study|Lost to Follow-up|6|||
146869128|NCT00232141|529692291|FG000|Overall Study|Other|8|||
146869129|NCT00232141|529692292|FG001|Overall Study|Other|10|||
146869130|NCT00232141|529692291|FG000|Overall Study|Withdrawal by Subject|5|||
146869131|NCT00232141|529692292|FG001|Overall Study|Withdrawal by Subject|3|||
146869132|NCT02273726|529692293|FG000|Overall Study|Death|70|||
146869133|NCT02273726|529692294|FG001|Overall Study|Death|62|||
146869134|NCT02273726|529692293|FG000|Overall Study|Withdrawal by Subject|41|||
146869135|NCT02273726|529692294|FG001|Overall Study|Withdrawal by Subject|29|||
146869136|NCT02273726|529692293|FG000|Overall Study|Kidney transplant|31|||
146869137|NCT02273726|529692294|FG001|Overall Study|Kidney transplant|39|||
146869138|NCT02273726|529692293|FG000|Overall Study|Physician Decision|30|||
146869139|NCT02273726|529692294|FG001|Overall Study|Physician Decision|15|||
146869140|NCT02273726|529692293|FG000|Overall Study|Adverse Event|27|||
146869141|NCT02273726|529692294|FG001|Overall Study|Adverse Event|9|||
146869142|NCT02273726|529692293|FG000|Overall Study|Lost to Follow-up|6|||
146869143|NCT02273726|529692294|FG001|Overall Study|Lost to Follow-up|3|||
146869144|NCT02273726|529692293|FG000|Overall Study|Lack of Efficacy|6|||
146869145|NCT02273726|529692294|FG001|Overall Study|Lack of Efficacy|1|||
146869146|NCT02273726|529692293|FG000|Overall Study|Protocol Violation|4|||
146869147|NCT02273726|529692294|FG001|Overall Study|Protocol Violation|0|||
146869148|NCT02273726|529692293|FG000|Overall Study|Other than specified|28|||
146869149|NCT02273726|529692294|FG001|Overall Study|Other than specified|30|||
146869150|NCT01479829|529692295|FG000|Overall Study|Withdrawal by Subject|8|||
146869151|NCT01479829|529692296|FG001|Overall Study|Withdrawal by Subject|10|||
146869152|NCT04263896|529692298|FG000|Overall Study|Withdrawal by Subject|2|||
146869153|NCT04263896|529692299|FG001|Overall Study|Withdrawal by Subject|4|||
146869154|NCT04263896|529692298|FG000|Overall Study|converted to open procedure|0|||
146869155|NCT04263896|529692299|FG001|Overall Study|converted to open procedure|1|||
146869156|NCT04263896|529692298|FG000|Overall Study|Lost to Follow-up|9|||
146869157|NCT04263896|529692299|FG001|Overall Study|Lost to Follow-up|11|||
146869158|NCT04263896|529692298|FG000|Overall Study|surveys lost in mail|5|||
146869159|NCT04263896|529692299|FG001|Overall Study|surveys lost in mail|3|||
146869160|NCT04263896|529692298|FG000|Overall Study|excluded from analysis|1|||
146869161|NCT04263896|529692299|FG001|Overall Study|excluded from analysis|0|||
146869162|NCT00682448|529694414|FG000|Overall Study|Adverse Event|1|||
146869163|NCT00682448|529694415|FG001|Overall Study|Adverse Event|2|||
146869164|NCT00682448|529694414|FG000|Overall Study|Lack of Efficacy|1|||
146869165|NCT00682448|529694415|FG001|Overall Study|Lack of Efficacy|0|||
146869166|NCT00682448|529694414|FG000|Overall Study|Lost to Follow-up|1|||
146869167|NCT00682448|529694415|FG001|Overall Study|Lost to Follow-up|3|||
146869168|NCT00682448|529694414|FG000|Overall Study|Pregnancy|0|||
146869169|NCT00682448|529694415|FG001|Overall Study|Pregnancy|1|||
146869170|NCT00682448|529694414|FG000|Overall Study|Withdrawal by Subject|2|||
146869171|NCT00682448|529694415|FG001|Overall Study|Withdrawal by Subject|0|||
146869172|NCT00761306|529694418|FG000|Overall Study|Adverse Event|5|||
146869173|NCT00761306|529694418|FG000|Overall Study|Lack of Efficacy|4|||
146869174|NCT00761306|529694418|FG000|Overall Study|Protocol Violation|2|||
146869175|NCT00761306|529694418|FG000|Overall Study|Withdrawal of Consent|3|||
146869176|NCT00761306|529694418|FG000|Overall Study|Lost to Follow-up|1|||
146869177|NCT00761306|529694418|FG000|Overall Study|Administrative or Other Reasons|5|||
146869178|NCT00268437|529694419|FG000|Overall Study|Ineligible|1|||
146869179|NCT00525044|529694420|FG000|Overall Study|Lost to Follow-up|0|||
146869180|NCT00525044|529694421|FG001|Overall Study|Lost to Follow-up|1|||
146869181|NCT02982239|529694424|FG000|Overall Study|Lost to Follow-up|3|||
146869182|NCT02982239|529694425|FG001|Overall Study|Lost to Follow-up|2|||
146869183|NCT00467779|529694428|FG000|Stage 1|Adverse Event|1|||
146869184|NCT00467779|529694429|FG001|Stage 1|Adverse Event|0|||
146763353|NCT01063036|529301319|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
146534795|NCT01668797|528468848|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
146534796|NCT01668797|528468849|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
146534797|NCT01668797|528468850|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
146534798|NCT01668797|528468851|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
146534799|NCT01668797|528468848|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
146534800|NCT01668797|528468849|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
146763354|NCT01063036|529301319|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
146763355|NCT01063036|529301319|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
146763356|NCT01063036|529301319|FG000|Participants Treated With Study Drug|Pregnancy|1|||
146763357|NCT01063036|529301319|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
146763358|NCT01063036|529301319|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
146763359|NCT01063036|529301319|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
146763360|NCT01259102|529301320|FG000|Overall Study|Adverse Event|1|||
146763361|NCT01259102|529301321|FG001|Overall Study|Adverse Event|0|||
146763362|NCT01259102|529301322|FG002|Overall Study|Adverse Event|1|||
146763363|NCT01259102|529301323|FG003|Overall Study|Adverse Event|1|||
146763364|NCT01259102|529301324|FG004|Overall Study|Adverse Event|0|||
146763365|NCT01259102|529301320|FG000|Overall Study|Other|0|||
146763366|NCT01259102|529301321|FG001|Overall Study|Other|0|||
146763367|NCT01259102|529301322|FG002|Overall Study|Other|1|||
146763368|NCT01259102|529301323|FG003|Overall Study|Other|1|||
146763369|NCT01259102|529301324|FG004|Overall Study|Other|1|||
146763370|NCT00918957|529301325|FG000|Overall Study|Adverse Event|2|||
146763371|NCT00918957|529301326|FG001|Overall Study|Adverse Event|0|||
146763372|NCT00918957|529301325|FG000|Overall Study|Withdrawal by Subject|1|||
146763373|NCT00918957|529301326|FG001|Overall Study|Withdrawal by Subject|0|||
146763374|NCT01720446|529301327|FG000|Overall Study|Lost to Follow-up|12|||
146763375|NCT01720446|529301328|FG001|Overall Study|Lost to Follow-up|6|||
146763376|NCT01720446|529301329|FG002|Overall Study|Lost to Follow-up|16|||
146763377|NCT01720446|529301330|FG003|Overall Study|Lost to Follow-up|16|||
146763378|NCT01720446|529301327|FG000|Overall Study|Withdrawal by Subject|2|||
146763379|NCT01720446|529301328|FG001|Overall Study|Withdrawal by Subject|5|||
146763380|NCT01720446|529301329|FG002|Overall Study|Withdrawal by Subject|4|||
146763381|NCT01720446|529301330|FG003|Overall Study|Withdrawal by Subject|4|||
146763382|NCT01956669|529301331|FG000|Overall Study|Disease Progression|12|||
146763383|NCT01956669|529301332|FG001|Overall Study|Disease Progression|7|||
146763384|NCT01956669|529301333|FG002|Overall Study|Disease Progression|7|||
146763385|NCT01956669|529301334|FG003|Overall Study|Disease Progression|8|||
146763386|NCT01956669|529301335|FG004|Overall Study|Disease Progression|4|||
146763387|NCT01956669|529301336|FG005|Overall Study|Disease Progression|3|||
146763388|NCT01956669|529301337|FG006|Overall Study|Disease Progression|5|||
146763389|NCT01956669|529301331|FG000|Overall Study|Adverse Event|0|||
146763390|NCT01956669|529301332|FG001|Overall Study|Adverse Event|2|||
146763391|NCT01956669|529301333|FG002|Overall Study|Adverse Event|2|||
146763392|NCT01956669|529301334|FG003|Overall Study|Adverse Event|1|||
146763393|NCT01956669|529301335|FG004|Overall Study|Adverse Event|0|||
146763394|NCT01956669|529301336|FG005|Overall Study|Adverse Event|0|||
146534801|NCT01668797|528468850|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
146763395|NCT01956669|529301337|FG006|Overall Study|Adverse Event|0|||
146763396|NCT01956669|529301331|FG000|Overall Study|Physician Decision|0|||
146763397|NCT01956669|529301332|FG001|Overall Study|Physician Decision|2|||
146763398|NCT01956669|529301333|FG002|Overall Study|Physician Decision|0|||
146763399|NCT01956669|529301334|FG003|Overall Study|Physician Decision|0|||
146763400|NCT01956669|529301335|FG004|Overall Study|Physician Decision|0|||
146763401|NCT01956669|529301336|FG005|Overall Study|Physician Decision|1|||
146869185|NCT00467779|529694430|FG002|Stage 1|Adverse Event|0|||
146869186|NCT00467779|529694431|FG003|Stage 1|Adverse Event|0|||
146869187|NCT00467779|529694432|FG004|Stage 1|Adverse Event|0|||
146869188|NCT00467779|529694433|FG005|Stage 1|Adverse Event|1|||
146869189|NCT00467779|529694434|FG006|Stage 1|Adverse Event|2|||
146869190|NCT00467779|529694435|FG007|Stage 1|Adverse Event|1|||
146869191|NCT00467779|529694436|FG008|Stage 1|Adverse Event|0|||
146869192|NCT00467779|529694437|FG009|Stage 1|Adverse Event|0|||
146869193|NCT00467779|529694438|FG010|Stage 1|Adverse Event|0|||
146869194|NCT00467779|529694439|FG011|Stage 1|Adverse Event|0|||
146869195|NCT00467779|529694440|FG012|Stage 1|Adverse Event|0|||
146869196|NCT00467779|529694441|FG013|Stage 1|Adverse Event|0|||
146869197|NCT00467779|529694442|FG014|Stage 1|Adverse Event|0|||
146869198|NCT00467779|529694428|FG000|Stage 1|Disease Progression|2|||
146869199|NCT00467779|529694429|FG001|Stage 1|Disease Progression|2|||
146869200|NCT00467779|529694430|FG002|Stage 1|Disease Progression|2|||
146869201|NCT00467779|529694431|FG003|Stage 1|Disease Progression|3|||
146869202|NCT00467779|529694432|FG004|Stage 1|Disease Progression|2|||
146869203|NCT00467779|529694433|FG005|Stage 1|Disease Progression|2|||
146869204|NCT00467779|529694434|FG006|Stage 1|Disease Progression|4|||
146869205|NCT00467779|529694435|FG007|Stage 1|Disease Progression|5|||
146869206|NCT00467779|529694436|FG008|Stage 1|Disease Progression|0|||
146869207|NCT00467779|529694437|FG009|Stage 1|Disease Progression|0|||
146869208|NCT00467779|529694438|FG010|Stage 1|Disease Progression|0|||
146869209|NCT00467779|529694439|FG011|Stage 1|Disease Progression|0|||
146869210|NCT00467779|529694440|FG012|Stage 1|Disease Progression|0|||
146869211|NCT00467779|529694441|FG013|Stage 1|Disease Progression|0|||
146869212|NCT00467779|529694442|FG014|Stage 1|Disease Progression|0|||
146869213|NCT00467779|529694428|FG000|Stage 1|Unspecified Reason|1|||
146869214|NCT00467779|529694429|FG001|Stage 1|Unspecified Reason|0|||
146869215|NCT00467779|529694430|FG002|Stage 1|Unspecified Reason|1|||
146869216|NCT00467779|529694431|FG003|Stage 1|Unspecified Reason|0|||
146869217|NCT00467779|529694432|FG004|Stage 1|Unspecified Reason|1|||
146869218|NCT00467779|529694433|FG005|Stage 1|Unspecified Reason|2|||
146869219|NCT00467779|529694434|FG006|Stage 1|Unspecified Reason|0|||
146869220|NCT00467779|529694435|FG007|Stage 1|Unspecified Reason|0|||
146869221|NCT00467779|529694436|FG008|Stage 1|Unspecified Reason|0|||
146869222|NCT00467779|529694437|FG009|Stage 1|Unspecified Reason|0|||
146869223|NCT00467779|529694438|FG010|Stage 1|Unspecified Reason|0|||
146869224|NCT00467779|529694439|FG011|Stage 1|Unspecified Reason|0|||
146869225|NCT00467779|529694440|FG012|Stage 1|Unspecified Reason|0|||
146869226|NCT00467779|529694441|FG013|Stage 1|Unspecified Reason|0|||
146869227|NCT00467779|529694442|FG014|Stage 1|Unspecified Reason|0|||
146869228|NCT00467779|529694428|FG000|Stage 1|Physician Decision|0|||
146869229|NCT00467779|529694429|FG001|Stage 1|Physician Decision|1|||
146869230|NCT00467779|529694430|FG002|Stage 1|Physician Decision|0|||
146869231|NCT00467779|529694431|FG003|Stage 1|Physician Decision|0|||
146869232|NCT00467779|529694432|FG004|Stage 1|Physician Decision|0|||
146534802|NCT01668797|528468851|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
146869233|NCT00467779|529694433|FG005|Stage 1|Physician Decision|0|||
146869234|NCT00467779|529694434|FG006|Stage 1|Physician Decision|0|||
146869235|NCT00467779|529694435|FG007|Stage 1|Physician Decision|0|||
146869236|NCT00467779|529694436|FG008|Stage 1|Physician Decision|0|||
146869237|NCT00467779|529694437|FG009|Stage 1|Physician Decision|0|||
146869238|NCT00467779|529694438|FG010|Stage 1|Physician Decision|0|||
146869239|NCT00467779|529694439|FG011|Stage 1|Physician Decision|0|||
146869240|NCT00467779|529694440|FG012|Stage 1|Physician Decision|0|||
146869241|NCT00467779|529694441|FG013|Stage 1|Physician Decision|0|||
146869242|NCT00467779|529694442|FG014|Stage 1|Physician Decision|0|||
146534803|NCT01668797|528468848|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
146534804|NCT01668797|528468849|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
146869243|NCT00467779|529694428|FG000|Stage 1|Withdrawal by Subject|0|||
146869244|NCT00467779|529694429|FG001|Stage 1|Withdrawal by Subject|0|||
146869245|NCT00467779|529694430|FG002|Stage 1|Withdrawal by Subject|0|||
146869246|NCT00467779|529694431|FG003|Stage 1|Withdrawal by Subject|0|||
146534805|NCT01668797|528468850|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
146869247|NCT00467779|529694432|FG004|Stage 1|Withdrawal by Subject|0|||
146869248|NCT00467779|529694433|FG005|Stage 1|Withdrawal by Subject|0|||
146869249|NCT00467779|529694434|FG006|Stage 1|Withdrawal by Subject|1|||
146869250|NCT00467779|529694435|FG007|Stage 1|Withdrawal by Subject|1|||
146869251|NCT00467779|529694436|FG008|Stage 1|Withdrawal by Subject|0|||
146869252|NCT00467779|529694437|FG009|Stage 1|Withdrawal by Subject|0|||
146869253|NCT00467779|529694438|FG010|Stage 1|Withdrawal by Subject|0|||
146869254|NCT00467779|529694439|FG011|Stage 1|Withdrawal by Subject|0|||
146869255|NCT00467779|529694440|FG012|Stage 1|Withdrawal by Subject|0|||
146869256|NCT00467779|529694441|FG013|Stage 1|Withdrawal by Subject|0|||
146534806|NCT01668797|528468851|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
146534807|NCT01668797|528468848|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
146534808|NCT01668797|528468849|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
146534809|NCT01668797|528468850|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
146534810|NCT01668797|528468851|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
146534811|NCT01668797|528468848|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
146534812|NCT01668797|528468849|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
146534813|NCT01668797|528468850|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
146534814|NCT01668797|528468851|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
146534815|NCT01668797|528468848|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
146534816|NCT01668797|528468849|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
146534817|NCT01668797|528468850|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
146763402|NCT01956669|529301337|FG006|Overall Study|Physician Decision|0|||
146763403|NCT01956669|529301331|FG000|Overall Study|Withdrawal by Subject|0|||
146869257|NCT00467779|529694442|FG014|Stage 1|Withdrawal by Subject|0|||
146763404|NCT01956669|529301332|FG001|Overall Study|Withdrawal by Subject|0|||
146763405|NCT01956669|529301333|FG002|Overall Study|Withdrawal by Subject|1|||
146763406|NCT01956669|529301334|FG003|Overall Study|Withdrawal by Subject|1|||
146763407|NCT01956669|529301335|FG004|Overall Study|Withdrawal by Subject|0|||
146763408|NCT01956669|529301336|FG005|Overall Study|Withdrawal by Subject|0|||
146763409|NCT01956669|529301337|FG006|Overall Study|Withdrawal by Subject|1|||
146763410|NCT00930813|529301338|FG000|Overall Study|Death|4|||
146763411|NCT00930813|529301339|FG001|Overall Study|Death|5|||
146763412|NCT00930813|529301338|FG000|Overall Study|Withdrawal by Subject|2|||
146763413|NCT00930813|529301339|FG001|Overall Study|Withdrawal by Subject|5|||
146763414|NCT00930813|529301338|FG000|Overall Study|Lost to Follow-up|2|||
146763415|NCT00930813|529301339|FG001|Overall Study|Lost to Follow-up|4|||
146763416|NCT05790408|529301340|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
146763417|NCT01131494|529301341|FG000|Overall Study|Withdrawal by Subject|2|||
146763418|NCT04012853|529301342|FG000|Overall Study|Withdrawal by Subject|1|||
146763419|NCT04012853|529301343|FG001|Overall Study|Withdrawal by Subject|1|||
146763420|NCT04012853|529301342|FG000|Overall Study|Protocol Violation|1|||
146763421|NCT04012853|529301343|FG001|Overall Study|Protocol Violation|0|||
146763422|NCT04012853|529301342|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
146763423|NCT04012853|529301343|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
146763424|NCT01313182|529301344|FG000|Overall Study|Protocol Violation|66|||
146763425|NCT01313182|529301345|FG001|Overall Study|Protocol Violation|92|||
146763426|NCT01695317|529301346|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
146763427|NCT01695317|529301347|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
146763428|NCT01695317|529301346|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
146763429|NCT01695317|529301347|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
146763430|NCT03055767|529301348|FG000|Open-Label Period|Lost to Follow-up|0|||
146763431|NCT03055767|529301349|FG001|Open-Label Period|Lost to Follow-up|0|||
146763432|NCT03055767|529301350|FG002|Open-Label Period|Lost to Follow-up|2|||
146763433|NCT03055767|529301351|FG003|Open-Label Period|Lost to Follow-up|0|||
146763434|NCT03055767|529301348|FG000|Open-Label Period|Withdrawal by Subject|0|||
146763435|NCT03055767|529301349|FG001|Open-Label Period|Withdrawal by Subject|0|||
146763436|NCT03055767|529301350|FG002|Open-Label Period|Withdrawal by Subject|0|||
146763437|NCT03055767|529301351|FG003|Open-Label Period|Withdrawal by Subject|1|||
146763438|NCT02759731|529301354|FG000|Overall Study|Did not complete treatment.|8|||
146763439|NCT01466881|529301356|FG000|Overall Study|Ineligible|5|||
146763440|NCT01466881|529301356|FG000|Overall Study|Adverse Event|6|||
146763441|NCT01466881|529301356|FG000|Overall Study|Progression/relapse|20|||
146763442|NCT01466881|529301356|FG000|Overall Study|Death|4|||
146763443|NCT01466881|529301356|FG000|Overall Study|Other reason not protocol specified|5|||
146763444|NCT00606580|529301357|FG000|Overall Study|Lost to Follow-up|1|||
146763445|NCT00606580|529301358|FG001|Overall Study|Lost to Follow-up|1|||
146763446|NCT00606580|529301359|FG002|Overall Study|Lost to Follow-up|4|||
146763447|NCT00606580|529301357|FG000|Overall Study|Clinical failures|1|||
146763448|NCT00606580|529301358|FG001|Overall Study|Clinical failures|0|||
146763449|NCT00606580|529301359|FG002|Overall Study|Clinical failures|12|||
146763450|NCT00606580|529301357|FG000|Overall Study|Withdrawal by investigator|0|||
146763451|NCT00606580|529301358|FG001|Overall Study|Withdrawal by investigator|1|||
146763452|NCT00606580|529301359|FG002|Overall Study|Withdrawal by investigator|6|||
146763453|NCT00606580|529301357|FG000|Overall Study|Withdrawal by Subject|0|||
146763454|NCT00606580|529301358|FG001|Overall Study|Withdrawal by Subject|1|||
146763455|NCT00606580|529301359|FG002|Overall Study|Withdrawal by Subject|0|||
146763456|NCT01101165|529301360|FG000|Period 1|Adverse Event|1|||
146763457|NCT01101165|529301361|FG001|Period 1|Adverse Event|2|||
146763458|NCT01101165|529301360|FG000|Period 1|Withdrawal by Subject|0|||
146763459|NCT01101165|529301361|FG001|Period 1|Withdrawal by Subject|2|||
146763460|NCT01101165|529301360|FG000|Period 1|Positive Drug Screen|0|||
146763461|NCT01101165|529301361|FG001|Period 1|Positive Drug Screen|1|||
146763462|NCT01101165|529301360|FG000|Period 1|Lost to Follow-up|1|||
146869258|NCT00467779|529694428|FG000|Stage 1A|Adverse Event|0|||
146869259|NCT00467779|529694429|FG001|Stage 1A|Adverse Event|0|||
146869260|NCT00467779|529694430|FG002|Stage 1A|Adverse Event|0|||
146869261|NCT00467779|529694431|FG003|Stage 1A|Adverse Event|0|||
146869262|NCT00467779|529694432|FG004|Stage 1A|Adverse Event|0|||
146869263|NCT00467779|529694433|FG005|Stage 1A|Adverse Event|0|||
146869264|NCT00467779|529694434|FG006|Stage 1A|Adverse Event|0|||
146869265|NCT00467779|529694435|FG007|Stage 1A|Adverse Event|0|||
146869266|NCT00467779|529694436|FG008|Stage 1A|Adverse Event|0|||
146869267|NCT00467779|529694437|FG009|Stage 1A|Adverse Event|0|||
146869268|NCT00467779|529694438|FG010|Stage 1A|Adverse Event|0|||
146869269|NCT00467779|529694439|FG011|Stage 1A|Adverse Event|0|||
146869270|NCT00467779|529694440|FG012|Stage 1A|Adverse Event|1|||
146869271|NCT00467779|529694441|FG013|Stage 1A|Adverse Event|0|||
146869272|NCT00467779|529694442|FG014|Stage 1A|Adverse Event|0|||
146763463|NCT01101165|529301361|FG001|Period 1|Lost to Follow-up|0|||
146763464|NCT01101165|529301360|FG000|Period 2|Withdrawal by Subject|3|||
146763465|NCT01101165|529301361|FG001|Period 2|Withdrawal by Subject|1|||
146763466|NCT01101165|529301360|FG000|Period 2|Adverse Event|1|||
146763467|NCT01101165|529301361|FG001|Period 2|Adverse Event|0|||
146763468|NCT04580303|529301362|FG000|Overall Study|Adverse Event|0|||
146763469|NCT04580303|529301363|FG001|Overall Study|Adverse Event|1|||
146763470|NCT04580303|529301364|FG002|Overall Study|Adverse Event|0|||
146763471|NCT04580303|529301365|FG003|Overall Study|Adverse Event|0|||
146763472|NCT04580303|529301362|FG000|Overall Study|Withdrawal by Subject|0|||
146763473|NCT04580303|529301363|FG001|Overall Study|Withdrawal by Subject|0|||
146763474|NCT04580303|529301364|FG002|Overall Study|Withdrawal by Subject|1|||
146763475|NCT04580303|529301365|FG003|Overall Study|Withdrawal by Subject|0|||
146763476|NCT00927823|529301369|FG000|Continuous Dosing Period|Death|0|||
146763477|NCT00927823|529301370|FG001|Continuous Dosing Period|Death|0|||
146763478|NCT00927823|529301371|FG002|Continuous Dosing Period|Death|6|||
146763479|NCT00927823|529301372|FG003|Continuous Dosing Period|Death|0|||
146763480|NCT00927823|529301369|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
146763481|NCT00927823|529301370|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
146763482|NCT00927823|529301371|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
146763483|NCT00927823|529301372|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
146763484|NCT00927823|529301369|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
146763485|NCT00927823|529301370|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
146763486|NCT00927823|529301371|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
146763487|NCT00927823|529301372|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
146869273|NCT00467779|529694428|FG000|Stage 1A|Death|0|||
146869274|NCT00467779|529694429|FG001|Stage 1A|Death|0|||
146869275|NCT00467779|529694430|FG002|Stage 1A|Death|0|||
146869276|NCT00467779|529694431|FG003|Stage 1A|Death|0|||
146869277|NCT00467779|529694432|FG004|Stage 1A|Death|0|||
146869278|NCT00467779|529694433|FG005|Stage 1A|Death|0|||
146869279|NCT00467779|529694434|FG006|Stage 1A|Death|0|||
146869280|NCT00467779|529694435|FG007|Stage 1A|Death|0|||
146869281|NCT00467779|529694436|FG008|Stage 1A|Death|0|||
146869282|NCT00467779|529694437|FG009|Stage 1A|Death|0|||
146869283|NCT00467779|529694438|FG010|Stage 1A|Death|0|||
146869284|NCT00467779|529694439|FG011|Stage 1A|Death|1|||
146869285|NCT00467779|529694440|FG012|Stage 1A|Death|1|||
146869286|NCT00467779|529694441|FG013|Stage 1A|Death|0|||
146869287|NCT00467779|529694442|FG014|Stage 1A|Death|0|||
146869288|NCT00467779|529694428|FG000|Stage 1A|Disease Progression|0|||
146869289|NCT00467779|529694429|FG001|Stage 1A|Disease Progression|0|||
146869290|NCT00467779|529694430|FG002|Stage 1A|Disease Progression|0|||
146869291|NCT00467779|529694431|FG003|Stage 1A|Disease Progression|0|||
146869292|NCT00467779|529694432|FG004|Stage 1A|Disease Progression|0|||
146869293|NCT00467779|529694433|FG005|Stage 1A|Disease Progression|0|||
146869294|NCT00467779|529694434|FG006|Stage 1A|Disease Progression|0|||
146869295|NCT00467779|529694435|FG007|Stage 1A|Disease Progression|0|||
146869296|NCT00467779|529694436|FG008|Stage 1A|Disease Progression|0|||
146869297|NCT00467779|529694437|FG009|Stage 1A|Disease Progression|2|||
146869298|NCT00467779|529694438|FG010|Stage 1A|Disease Progression|2|||
146869299|NCT00467779|529694439|FG011|Stage 1A|Disease Progression|5|||
146869300|NCT00467779|529694440|FG012|Stage 1A|Disease Progression|2|||
146869301|NCT00467779|529694441|FG013|Stage 1A|Disease Progression|0|||
146869302|NCT00467779|529694442|FG014|Stage 1A|Disease Progression|0|||
146869303|NCT00467779|529694428|FG000|Stage 1A|Physician Decision|0|||
146869304|NCT00467779|529694429|FG001|Stage 1A|Physician Decision|0|||
146869305|NCT00467779|529694430|FG002|Stage 1A|Physician Decision|0|||
146869306|NCT00467779|529694431|FG003|Stage 1A|Physician Decision|0|||
146869307|NCT00467779|529694432|FG004|Stage 1A|Physician Decision|0|||
146869308|NCT00467779|529694433|FG005|Stage 1A|Physician Decision|0|||
146869309|NCT00467779|529694434|FG006|Stage 1A|Physician Decision|0|||
146869310|NCT00467779|529694435|FG007|Stage 1A|Physician Decision|0|||
146869311|NCT00467779|529694436|FG008|Stage 1A|Physician Decision|0|||
146869312|NCT00467779|529694437|FG009|Stage 1A|Physician Decision|1|||
146869313|NCT00467779|529694438|FG010|Stage 1A|Physician Decision|0|||
146869314|NCT00467779|529694439|FG011|Stage 1A|Physician Decision|0|||
146869315|NCT00467779|529694440|FG012|Stage 1A|Physician Decision|0|||
146869316|NCT00467779|529694441|FG013|Stage 1A|Physician Decision|0|||
146869317|NCT00467779|529694442|FG014|Stage 1A|Physician Decision|0|||
146869318|NCT00467779|529694428|FG000|Stage 1A|Withdrawal by Subject|0|||
146869319|NCT00467779|529694429|FG001|Stage 1A|Withdrawal by Subject|0|||
146869320|NCT00467779|529694430|FG002|Stage 1A|Withdrawal by Subject|0|||
146869321|NCT00467779|529694431|FG003|Stage 1A|Withdrawal by Subject|0|||
146869322|NCT00467779|529694432|FG004|Stage 1A|Withdrawal by Subject|0|||
146534818|NCT01668797|528468851|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
146869323|NCT00467779|529694433|FG005|Stage 1A|Withdrawal by Subject|0|||
146869324|NCT00467779|529694434|FG006|Stage 1A|Withdrawal by Subject|0|||
146869325|NCT00467779|529694435|FG007|Stage 1A|Withdrawal by Subject|0|||
146869326|NCT00467779|529694436|FG008|Stage 1A|Withdrawal by Subject|0|||
146534819|NCT01668797|528468848|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
146534820|NCT01668797|528468849|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
146869327|NCT00467779|529694437|FG009|Stage 1A|Withdrawal by Subject|0|||
146869328|NCT00467779|529694438|FG010|Stage 1A|Withdrawal by Subject|1|||
146869329|NCT00467779|529694439|FG011|Stage 1A|Withdrawal by Subject|1|||
146869330|NCT00467779|529694440|FG012|Stage 1A|Withdrawal by Subject|1|||
146869331|NCT00467779|529694441|FG013|Stage 1A|Withdrawal by Subject|0|||
146869332|NCT00467779|529694442|FG014|Stage 1A|Withdrawal by Subject|0|||
146869333|NCT00467779|529694428|FG000|Stage 1A|Unspecified Reason|0|||
146869334|NCT00467779|529694429|FG001|Stage 1A|Unspecified Reason|0|||
146869335|NCT00467779|529694430|FG002|Stage 1A|Unspecified Reason|0|||
146869336|NCT00467779|529694431|FG003|Stage 1A|Unspecified Reason|0|||
146869337|NCT00467779|529694432|FG004|Stage 1A|Unspecified Reason|0|||
146869338|NCT00467779|529694433|FG005|Stage 1A|Unspecified Reason|0|||
146869339|NCT00467779|529694434|FG006|Stage 1A|Unspecified Reason|0|||
146869340|NCT00467779|529694435|FG007|Stage 1A|Unspecified Reason|0|||
146869341|NCT00467779|529694436|FG008|Stage 1A|Unspecified Reason|0|||
146869342|NCT00467779|529694437|FG009|Stage 1A|Unspecified Reason|0|||
146869343|NCT00467779|529694438|FG010|Stage 1A|Unspecified Reason|0|||
146869344|NCT00467779|529694439|FG011|Stage 1A|Unspecified Reason|1|||
146869345|NCT00467779|529694440|FG012|Stage 1A|Unspecified Reason|1|||
146869346|NCT00467779|529694441|FG013|Stage 1A|Unspecified Reason|0|||
146869347|NCT00467779|529694442|FG014|Stage 1A|Unspecified Reason|0|||
146869348|NCT00467779|529694428|FG000|Stage 2|Adverse Event|0|||
146869349|NCT00467779|529694429|FG001|Stage 2|Adverse Event|0|||
146869350|NCT00467779|529694430|FG002|Stage 2|Adverse Event|0|||
146869351|NCT00467779|529694431|FG003|Stage 2|Adverse Event|0|||
146869352|NCT00467779|529694432|FG004|Stage 2|Adverse Event|0|||
146869353|NCT00467779|529694433|FG005|Stage 2|Adverse Event|0|||
146869354|NCT00467779|529694434|FG006|Stage 2|Adverse Event|0|||
146869355|NCT00467779|529694435|FG007|Stage 2|Adverse Event|0|||
146869356|NCT00467779|529694436|FG008|Stage 2|Adverse Event|1|||
146869357|NCT00467779|529694437|FG009|Stage 2|Adverse Event|0|||
146869358|NCT00467779|529694438|FG010|Stage 2|Adverse Event|0|||
146869359|NCT00467779|529694439|FG011|Stage 2|Adverse Event|0|||
146869360|NCT00467779|529694440|FG012|Stage 2|Adverse Event|0|||
146869361|NCT00467779|529694441|FG013|Stage 2|Adverse Event|0|||
146869362|NCT00467779|529694442|FG014|Stage 2|Adverse Event|0|||
146869363|NCT00467779|529694428|FG000|Stage 2|Death|0|||
146869364|NCT00467779|529694429|FG001|Stage 2|Death|0|||
146869365|NCT00467779|529694430|FG002|Stage 2|Death|0|||
146869366|NCT00467779|529694431|FG003|Stage 2|Death|0|||
146869367|NCT00467779|529694432|FG004|Stage 2|Death|0|||
146534821|NCT01668797|528468850|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
146534822|NCT01668797|528468851|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
146534823|NCT01668797|528468848|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
146534824|NCT01668797|528468849|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
146869368|NCT00467779|529694433|FG005|Stage 2|Death|0|||
146869369|NCT00467779|529694434|FG006|Stage 2|Death|0|||
146869370|NCT00467779|529694435|FG007|Stage 2|Death|0|||
146869371|NCT00467779|529694436|FG008|Stage 2|Death|1|||
146869372|NCT00467779|529694437|FG009|Stage 2|Death|0|||
146869373|NCT00467779|529694438|FG010|Stage 2|Death|0|||
146869374|NCT00467779|529694439|FG011|Stage 2|Death|0|||
146869375|NCT00467779|529694440|FG012|Stage 2|Death|0|||
146869376|NCT00467779|529694441|FG013|Stage 2|Death|0|||
146869377|NCT00467779|529694442|FG014|Stage 2|Death|0|||
146869378|NCT00467779|529694428|FG000|Stage 2|Disease Progression|0|||
146534825|NCT01668797|528468850|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
146534826|NCT01668797|528468851|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
146869379|NCT00467779|529694429|FG001|Stage 2|Disease Progression|0|||
146869380|NCT00467779|529694430|FG002|Stage 2|Disease Progression|0|||
146869381|NCT00467779|529694431|FG003|Stage 2|Disease Progression|0|||
146869382|NCT00467779|529694432|FG004|Stage 2|Disease Progression|0|||
146869383|NCT00467779|529694433|FG005|Stage 2|Disease Progression|0|||
146869384|NCT00467779|529694434|FG006|Stage 2|Disease Progression|0|||
146869385|NCT00467779|529694435|FG007|Stage 2|Disease Progression|0|||
146869386|NCT00467779|529694436|FG008|Stage 2|Disease Progression|16|||
146869387|NCT00467779|529694437|FG009|Stage 2|Disease Progression|0|||
146869388|NCT00467779|529694438|FG010|Stage 2|Disease Progression|0|||
146869389|NCT00467779|529694439|FG011|Stage 2|Disease Progression|0|||
146869390|NCT00467779|529694440|FG012|Stage 2|Disease Progression|0|||
146869391|NCT00467779|529694441|FG013|Stage 2|Disease Progression|0|||
146869392|NCT00467779|529694442|FG014|Stage 2|Disease Progression|0|||
146869393|NCT00467779|529694428|FG000|Stage 2|Unspecified Reason|0|||
146869394|NCT00467779|529694429|FG001|Stage 2|Unspecified Reason|0|||
146869395|NCT00467779|529694430|FG002|Stage 2|Unspecified Reason|0|||
146869396|NCT00467779|529694431|FG003|Stage 2|Unspecified Reason|0|||
146869397|NCT00467779|529694432|FG004|Stage 2|Unspecified Reason|0|||
146869398|NCT00467779|529694433|FG005|Stage 2|Unspecified Reason|0|||
146869399|NCT00467779|529694434|FG006|Stage 2|Unspecified Reason|0|||
146869400|NCT00467779|529694435|FG007|Stage 2|Unspecified Reason|0|||
146869401|NCT00467779|529694436|FG008|Stage 2|Unspecified Reason|3|||
146869402|NCT00467779|529694437|FG009|Stage 2|Unspecified Reason|0|||
146869403|NCT00467779|529694438|FG010|Stage 2|Unspecified Reason|0|||
146869404|NCT00467779|529694439|FG011|Stage 2|Unspecified Reason|0|||
146869405|NCT00467779|529694440|FG012|Stage 2|Unspecified Reason|0|||
146869406|NCT00467779|529694441|FG013|Stage 2|Unspecified Reason|0|||
146869407|NCT00467779|529694442|FG014|Stage 2|Unspecified Reason|0|||
146869408|NCT00467779|529694428|FG000|Stage 2A|Adverse Event|0|||
146869409|NCT00467779|529694429|FG001|Stage 2A|Adverse Event|0|||
146869410|NCT00467779|529694430|FG002|Stage 2A|Adverse Event|0|||
146869411|NCT00467779|529694431|FG003|Stage 2A|Adverse Event|0|||
146869412|NCT00467779|529694432|FG004|Stage 2A|Adverse Event|0|||
146869413|NCT00467779|529694433|FG005|Stage 2A|Adverse Event|0|||
146869414|NCT00467779|529694434|FG006|Stage 2A|Adverse Event|0|||
146869415|NCT00467779|529694435|FG007|Stage 2A|Adverse Event|0|||
146869416|NCT00467779|529694436|FG008|Stage 2A|Adverse Event|0|||
146869417|NCT00467779|529694437|FG009|Stage 2A|Adverse Event|0|||
146869418|NCT00467779|529694438|FG010|Stage 2A|Adverse Event|0|||
146869419|NCT00467779|529694439|FG011|Stage 2A|Adverse Event|0|||
146869420|NCT00467779|529694440|FG012|Stage 2A|Adverse Event|0|||
146869421|NCT00467779|529694441|FG013|Stage 2A|Adverse Event|2|||
146869422|NCT00467779|529694442|FG014|Stage 2A|Adverse Event|0|||
146869423|NCT00467779|529694428|FG000|Stage 2A|Death|0|||
146869424|NCT00467779|529694429|FG001|Stage 2A|Death|0|||
146869425|NCT00467779|529694430|FG002|Stage 2A|Death|0|||
146869426|NCT00467779|529694431|FG003|Stage 2A|Death|0|||
146869427|NCT00467779|529694432|FG004|Stage 2A|Death|0|||
146869428|NCT00467779|529694433|FG005|Stage 2A|Death|0|||
146869429|NCT00467779|529694434|FG006|Stage 2A|Death|0|||
146869430|NCT00467779|529694435|FG007|Stage 2A|Death|0|||
146869431|NCT00467779|529694436|FG008|Stage 2A|Death|0|||
146869432|NCT00467779|529694437|FG009|Stage 2A|Death|0|||
146869433|NCT00467779|529694438|FG010|Stage 2A|Death|0|||
146869434|NCT00467779|529694439|FG011|Stage 2A|Death|0|||
146869435|NCT00467779|529694440|FG012|Stage 2A|Death|0|||
146869436|NCT00467779|529694441|FG013|Stage 2A|Death|1|||
146869437|NCT00467779|529694442|FG014|Stage 2A|Death|0|||
146869438|NCT00467779|529694428|FG000|Stage 2A|Disease Progression|0|||
146869439|NCT00467779|529694429|FG001|Stage 2A|Disease Progression|0|||
146869440|NCT00467779|529694430|FG002|Stage 2A|Disease Progression|0|||
146869441|NCT00467779|529694431|FG003|Stage 2A|Disease Progression|0|||
146869442|NCT00467779|529694432|FG004|Stage 2A|Disease Progression|0|||
146869443|NCT00467779|529694433|FG005|Stage 2A|Disease Progression|0|||
146869444|NCT00467779|529694434|FG006|Stage 2A|Disease Progression|0|||
146869445|NCT00467779|529694435|FG007|Stage 2A|Disease Progression|0|||
146869446|NCT00467779|529694436|FG008|Stage 2A|Disease Progression|0|||
146869447|NCT00467779|529694437|FG009|Stage 2A|Disease Progression|0|||
146869448|NCT00467779|529694438|FG010|Stage 2A|Disease Progression|0|||
146869449|NCT00467779|529694439|FG011|Stage 2A|Disease Progression|0|||
146869450|NCT00467779|529694440|FG012|Stage 2A|Disease Progression|0|||
146869451|NCT00467779|529694441|FG013|Stage 2A|Disease Progression|10|||
146869452|NCT00467779|529694442|FG014|Stage 2A|Disease Progression|0|||
146869453|NCT00467779|529694428|FG000|Stage 2A|Unspecified Reason|0|||
146869454|NCT00467779|529694429|FG001|Stage 2A|Unspecified Reason|0|||
146869455|NCT00467779|529694430|FG002|Stage 2A|Unspecified Reason|0|||
146869456|NCT00467779|529694431|FG003|Stage 2A|Unspecified Reason|0|||
146869457|NCT00467779|529694432|FG004|Stage 2A|Unspecified Reason|0|||
146869458|NCT00467779|529694433|FG005|Stage 2A|Unspecified Reason|0|||
146869459|NCT00467779|529694434|FG006|Stage 2A|Unspecified Reason|0|||
146869460|NCT00467779|529694435|FG007|Stage 2A|Unspecified Reason|0|||
146869461|NCT00467779|529694436|FG008|Stage 2A|Unspecified Reason|0|||
146869462|NCT00467779|529694437|FG009|Stage 2A|Unspecified Reason|0|||
146869463|NCT00467779|529694438|FG010|Stage 2A|Unspecified Reason|0|||
146869464|NCT00467779|529694439|FG011|Stage 2A|Unspecified Reason|0|||
146869465|NCT00467779|529694440|FG012|Stage 2A|Unspecified Reason|0|||
146869466|NCT00467779|529694441|FG013|Stage 2A|Unspecified Reason|7|||
146534827|NCT01668797|528468848|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
146534828|NCT01668797|528468849|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
146534829|NCT01668797|528468850|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
146534830|NCT01668797|528468851|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
146534831|NCT01668797|528468848|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
146534832|NCT01668797|528468849|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
146534833|NCT01668797|528468850|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
146534834|NCT01668797|528468851|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
146534835|NCT01668797|528468848|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
146534836|NCT01668797|528468849|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
146534837|NCT01668797|528468850|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
146534838|NCT01668797|528468851|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
146534839|NCT01668797|528468848|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
146534840|NCT01668797|528468849|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
146534841|NCT01668797|528468850|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
146534842|NCT01668797|528468851|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
146534843|NCT01668797|528468848|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
146534844|NCT01668797|528468849|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
146534845|NCT01668797|528468850|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
146763488|NCT00927823|529301369|FG000|Continuous Dosing Period|Other|1|||
146763489|NCT00927823|529301370|FG001|Continuous Dosing Period|Other|2|||
146763490|NCT00927823|529301371|FG002|Continuous Dosing Period|Other|9|||
146763491|NCT00927823|529301372|FG003|Continuous Dosing Period|Other|3|||
146763492|NCT01456936|529301378|FG000|Overall Study|Other reason|41|||
146763493|NCT01456936|529301379|FG001|Overall Study|Other reason|30|||
146763494|NCT01456936|529301380|FG002|Overall Study|Other reason|36|||
146763495|NCT01456936|529301381|FG003|Overall Study|Other reason|33|||
146763496|NCT01456936|529301378|FG000|Overall Study|No longer meets eligibility criteria|4|||
146763497|NCT01456936|529301379|FG001|Overall Study|No longer meets eligibility criteria|8|||
146763498|NCT01456936|529301380|FG002|Overall Study|No longer meets eligibility criteria|6|||
146763499|NCT01456936|529301381|FG003|Overall Study|No longer meets eligibility criteria|5|||
146763500|NCT01456936|529301378|FG000|Overall Study|Protocol Violation|4|||
146763501|NCT01456936|529301379|FG001|Overall Study|Protocol Violation|2|||
146763502|NCT01456936|529301380|FG002|Overall Study|Protocol Violation|5|||
146763503|NCT01456936|529301381|FG003|Overall Study|Protocol Violation|5|||
146763504|NCT01456936|529301378|FG000|Overall Study|Pregnancy|1|||
146763505|NCT01456936|529301379|FG001|Overall Study|Pregnancy|0|||
146763506|NCT01456936|529301380|FG002|Overall Study|Pregnancy|0|||
146763507|NCT01456936|529301381|FG003|Overall Study|Pregnancy|1|||
146763508|NCT01456936|529301378|FG000|Overall Study|Insufficient clinical response|4|||
146763509|NCT01456936|529301379|FG001|Overall Study|Insufficient clinical response|4|||
146763510|NCT01456936|529301380|FG002|Overall Study|Insufficient clinical response|14|||
146763511|NCT01456936|529301381|FG003|Overall Study|Insufficient clinical response|13|||
146763512|NCT01456936|529301378|FG000|Overall Study|No longer willing to participate|195|||
146763513|NCT01456936|529301379|FG001|Overall Study|No longer willing to participate|218|||
146763514|NCT01456936|529301380|FG002|Overall Study|No longer willing to participate|224|||
146763515|NCT01456936|529301381|FG003|Overall Study|No longer willing to participate|248|||
146763516|NCT01456936|529301378|FG000|Overall Study|Lost to Follow-up|135|||
146763517|NCT01456936|529301379|FG001|Overall Study|Lost to Follow-up|126|||
146763518|NCT01456936|529301380|FG002|Overall Study|Lost to Follow-up|144|||
146869467|NCT00467779|529694442|FG014|Stage 2A|Unspecified Reason|0|||
146869468|NCT00467779|529694428|FG000|Stage 2A|Withdrawal by Subject|0|||
146869469|NCT00467779|529694429|FG001|Stage 2A|Withdrawal by Subject|0|||
146869470|NCT00467779|529694430|FG002|Stage 2A|Withdrawal by Subject|0|||
146869471|NCT00467779|529694431|FG003|Stage 2A|Withdrawal by Subject|0|||
146869472|NCT00467779|529694432|FG004|Stage 2A|Withdrawal by Subject|0|||
146869473|NCT00467779|529694433|FG005|Stage 2A|Withdrawal by Subject|0|||
146869474|NCT00467779|529694434|FG006|Stage 2A|Withdrawal by Subject|0|||
146869475|NCT00467779|529694435|FG007|Stage 2A|Withdrawal by Subject|0|||
146869476|NCT00467779|529694436|FG008|Stage 2A|Withdrawal by Subject|0|||
146869477|NCT00467779|529694437|FG009|Stage 2A|Withdrawal by Subject|0|||
146869478|NCT00467779|529694438|FG010|Stage 2A|Withdrawal by Subject|0|||
146869479|NCT00467779|529694439|FG011|Stage 2A|Withdrawal by Subject|0|||
146869480|NCT00467779|529694440|FG012|Stage 2A|Withdrawal by Subject|0|||
146869481|NCT00467779|529694441|FG013|Stage 2A|Withdrawal by Subject|1|||
146869482|NCT00467779|529694442|FG014|Stage 2A|Withdrawal by Subject|0|||
146869483|NCT00467779|529694428|FG000|Stage 3|Adverse Event|0|||
146869484|NCT00467779|529694429|FG001|Stage 3|Adverse Event|0|||
146869485|NCT00467779|529694430|FG002|Stage 3|Adverse Event|0|||
146869486|NCT00467779|529694431|FG003|Stage 3|Adverse Event|0|||
146869487|NCT00467779|529694432|FG004|Stage 3|Adverse Event|0|||
146869488|NCT00467779|529694433|FG005|Stage 3|Adverse Event|0|||
146869489|NCT00467779|529694434|FG006|Stage 3|Adverse Event|0|||
146869490|NCT00467779|529694435|FG007|Stage 3|Adverse Event|0|||
146869491|NCT00467779|529694436|FG008|Stage 3|Adverse Event|0|||
146869492|NCT00467779|529694437|FG009|Stage 3|Adverse Event|0|||
146869493|NCT00467779|529694438|FG010|Stage 3|Adverse Event|0|||
146869494|NCT00467779|529694439|FG011|Stage 3|Adverse Event|0|||
146869495|NCT00467779|529694440|FG012|Stage 3|Adverse Event|0|||
146869496|NCT00467779|529694441|FG013|Stage 3|Adverse Event|0|||
146869497|NCT00467779|529694442|FG014|Stage 3|Adverse Event|2|||
146869498|NCT00467779|529694428|FG000|Stage 3|Death|0|||
146869499|NCT00467779|529694429|FG001|Stage 3|Death|0|||
146869500|NCT00467779|529694430|FG002|Stage 3|Death|0|||
146869501|NCT00467779|529694431|FG003|Stage 3|Death|0|||
146869502|NCT00467779|529694432|FG004|Stage 3|Death|0|||
146869503|NCT00467779|529694433|FG005|Stage 3|Death|0|||
146869504|NCT00467779|529694434|FG006|Stage 3|Death|0|||
146869505|NCT00467779|529694435|FG007|Stage 3|Death|0|||
146869506|NCT00467779|529694436|FG008|Stage 3|Death|0|||
146869507|NCT00467779|529694437|FG009|Stage 3|Death|0|||
146869508|NCT00467779|529694438|FG010|Stage 3|Death|0|||
146869509|NCT00467779|529694439|FG011|Stage 3|Death|0|||
146869510|NCT00467779|529694440|FG012|Stage 3|Death|0|||
146869511|NCT00467779|529694441|FG013|Stage 3|Death|0|||
146869512|NCT00467779|529694442|FG014|Stage 3|Death|1|||
146869513|NCT00467779|529694428|FG000|Stage 3|Disease Progression|0|||
146869514|NCT00467779|529694429|FG001|Stage 3|Disease Progression|0|||
146869515|NCT00467779|529694430|FG002|Stage 3|Disease Progression|0|||
146869516|NCT00467779|529694431|FG003|Stage 3|Disease Progression|0|||
146869517|NCT00467779|529694432|FG004|Stage 3|Disease Progression|0|||
146869518|NCT00467779|529694433|FG005|Stage 3|Disease Progression|0|||
146869519|NCT00467779|529694434|FG006|Stage 3|Disease Progression|0|||
146869520|NCT00467779|529694435|FG007|Stage 3|Disease Progression|0|||
146869521|NCT00467779|529694436|FG008|Stage 3|Disease Progression|0|||
146869522|NCT00467779|529694437|FG009|Stage 3|Disease Progression|0|||
146869523|NCT00467779|529694438|FG010|Stage 3|Disease Progression|0|||
146869524|NCT00467779|529694439|FG011|Stage 3|Disease Progression|0|||
146869525|NCT00467779|529694440|FG012|Stage 3|Disease Progression|0|||
146869526|NCT00467779|529694441|FG013|Stage 3|Disease Progression|0|||
146869527|NCT00467779|529694442|FG014|Stage 3|Disease Progression|9|||
146869528|NCT00467779|529694428|FG000|Stage 3|Unspecified Reason|0|||
146869529|NCT00467779|529694429|FG001|Stage 3|Unspecified Reason|0|||
146869530|NCT00467779|529694430|FG002|Stage 3|Unspecified Reason|0|||
146869531|NCT00467779|529694431|FG003|Stage 3|Unspecified Reason|0|||
146869532|NCT00467779|529694432|FG004|Stage 3|Unspecified Reason|0|||
146869533|NCT00467779|529694433|FG005|Stage 3|Unspecified Reason|0|||
146869534|NCT00467779|529694434|FG006|Stage 3|Unspecified Reason|0|||
146869535|NCT00467779|529694435|FG007|Stage 3|Unspecified Reason|0|||
146869536|NCT00467779|529694436|FG008|Stage 3|Unspecified Reason|0|||
146869537|NCT00467779|529694437|FG009|Stage 3|Unspecified Reason|0|||
146869538|NCT00467779|529694438|FG010|Stage 3|Unspecified Reason|0|||
146869539|NCT00467779|529694439|FG011|Stage 3|Unspecified Reason|0|||
146869540|NCT00467779|529694440|FG012|Stage 3|Unspecified Reason|0|||
146869541|NCT00467779|529694441|FG013|Stage 3|Unspecified Reason|0|||
146534846|NCT01668797|528468851|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
146534847|NCT01668797|528468848|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
146534848|NCT01668797|528468849|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
146534849|NCT01668797|528468850|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
146534850|NCT01668797|528468851|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
146763519|NCT01456936|529301381|FG003|Overall Study|Lost to Follow-up|127|||
146763520|NCT01456936|529301378|FG000|Overall Study|Medication error|0|||
146869542|NCT00467779|529694442|FG014|Stage 3|Unspecified Reason|5|||
146869543|NCT01509079|529694443|FG000|Overall Study|Lack of Efficacy|0|||
146869544|NCT01509079|529694444|FG001|Overall Study|Lack of Efficacy|2|||
146869545|NCT01509079|529694443|FG000|Overall Study|started an excluded medication|0|||
146869546|NCT01509079|529694444|FG001|Overall Study|started an excluded medication|1|||
146869547|NCT05111041|529694445|FG000|Overall Study|Lost to Follow-up|6|||
146869548|NCT05111041|529694446|FG001|Overall Study|Lost to Follow-up|7|||
146869549|NCT05111041|529694445|FG000|Overall Study|Withdrawal by Subject|1|||
146869550|NCT05111041|529694446|FG001|Overall Study|Withdrawal by Subject|0|||
146965614|NCT04242446|530035194|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146763521|NCT01456936|529301379|FG001|Overall Study|Medication error|1|||
146763522|NCT01456936|529301380|FG002|Overall Study|Medication error|0|||
146763523|NCT01456936|529301381|FG003|Overall Study|Medication error|1|||
146763524|NCT01456936|529301378|FG000|Overall Study|Adverse event (study drug)|25|||
146763525|NCT01456936|529301379|FG001|Overall Study|Adverse event (study drug)|21|||
146763526|NCT01456936|529301380|FG002|Overall Study|Adverse event (study drug)|26|||
146763527|NCT01456936|529301381|FG003|Overall Study|Adverse event (study drug)|17|||
146763528|NCT01456936|529301378|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
146763529|NCT01456936|529301379|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
146763530|NCT01456936|529301380|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
146763531|NCT01456936|529301381|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
146763532|NCT01456936|529301378|FG000|Overall Study|Death|0|||
146763533|NCT01456936|529301379|FG001|Overall Study|Death|3|||
146763534|NCT01456936|529301380|FG002|Overall Study|Death|1|||
146869551|NCT00041080|529694447|FG000|Overall Study|Adverse Event|21|||
146869552|NCT00041080|529694448|FG001|Overall Study|Adverse Event|1|||
146869553|NCT00041080|529694447|FG000|Overall Study|Withdrawal by Subject|6|||
146869554|NCT00041080|529694448|FG001|Overall Study|Withdrawal by Subject|6|||
146869555|NCT00041080|529694447|FG000|Overall Study|Concommitant Illness/Other|1|||
146869556|NCT00041080|529694448|FG001|Overall Study|Concommitant Illness/Other|2|||
146869557|NCT00041080|529694447|FG000|Overall Study|Did not start therapy|1|||
146869558|NCT00041080|529694448|FG001|Overall Study|Did not start therapy|1|||
146869559|NCT00041080|529694447|FG000|Overall Study|Ineligible|1|||
146869560|NCT00041080|529694448|FG001|Overall Study|Ineligible|0|||
146869561|NCT00436618|529694449|FG000|Overall Study|Withdrawal by Subject|5|||
146869562|NCT00436618|529694450|FG001|Overall Study|Withdrawal by Subject|8|||
146869563|NCT00436618|529694451|FG002|Overall Study|Withdrawal by Subject|11|||
146869564|NCT00436618|529694449|FG000|Overall Study|Adverse Event|8|||
146869565|NCT00436618|529694450|FG001|Overall Study|Adverse Event|8|||
146869566|NCT00436618|529694451|FG002|Overall Study|Adverse Event|9|||
146869567|NCT00436618|529694449|FG000|Overall Study|Alternate Treatment|3|||
146869568|NCT00436618|529694450|FG001|Overall Study|Alternate Treatment|4|||
146869569|NCT00436618|529694451|FG002|Overall Study|Alternate Treatment|12|||
146869570|NCT00436618|529694449|FG000|Overall Study|Other Medical Problems|3|||
146869571|NCT00436618|529694450|FG001|Overall Study|Other Medical Problems|1|||
146869572|NCT00436618|529694451|FG002|Overall Study|Other Medical Problems|7|||
146869573|NCT00436618|529694449|FG000|Overall Study|Death|4|||
146869574|NCT00436618|529694450|FG001|Overall Study|Death|2|||
146869575|NCT00436618|529694451|FG002|Overall Study|Death|3|||
146869576|NCT00436618|529694449|FG000|Overall Study|New Primary or Other Reasons|6|||
146869577|NCT00436618|529694450|FG001|Overall Study|New Primary or Other Reasons|2|||
146869578|NCT00436618|529694451|FG002|Overall Study|New Primary or Other Reasons|12|||
146869579|NCT00436618|529694449|FG000|Overall Study|Still on treatment|1|||
146869580|NCT00436618|529694450|FG001|Overall Study|Still on treatment|2|||
146869581|NCT00436618|529694451|FG002|Overall Study|Still on treatment|7|||
146869582|NCT01011439|529694452|FG000|Overall Study|Death|37|||
146869583|NCT01011439|529694452|FG000|Overall Study|Lost to Follow-up|4|||
146869584|NCT01011439|529694452|FG000|Overall Study|Withdrawal by Subject|1|||
146869585|NCT01011439|529694452|FG000|Overall Study|Sponsor's decision|15|||
146869586|NCT05418673|529694453|FG000|Overall Study|Study Terminated by Sponsor|2|||
146869587|NCT05418673|529694454|FG001|Overall Study|Study Terminated by Sponsor|4|||
146869588|NCT05418673|529694453|FG000|Overall Study|Lost to Follow-up|1|||
146869589|NCT05418673|529694454|FG001|Overall Study|Lost to Follow-up|0|||
146869590|NCT01986920|529694455|FG000|A- 101 25%|Withdrawal by Subject|1|||
146869591|NCT01986920|529694456|FG001|A- 101 25%|Withdrawal by Subject|0|||
146869592|NCT01986920|529694457|FG002|A- 101 25%|Withdrawal by Subject|0|||
146869593|NCT01986920|529694458|FG003|A- 101 25%|Withdrawal by Subject|0|||
146869594|NCT01986920|529694455|FG000|A-101 32.5%|Withdrawal by Subject|0|||
146869595|NCT01986920|529694456|FG001|A-101 32.5%|Withdrawal by Subject|1|||
146869596|NCT01986920|529694457|FG002|A-101 32.5%|Withdrawal by Subject|0|||
146869597|NCT01986920|529694458|FG003|A-101 32.5%|Withdrawal by Subject|0|||
146869598|NCT01986920|529694455|FG000|A-101 40%|Withdrawal by Subject|0|||
146869599|NCT01986920|529694456|FG001|A-101 40%|Withdrawal by Subject|0|||
146869600|NCT01986920|529694457|FG002|A-101 40%|Withdrawal by Subject|1|||
146869601|NCT01986920|529694458|FG003|A-101 40%|Withdrawal by Subject|0|||
146869602|NCT01986920|529694455|FG000|Placebo|Withdrawal by Subject|0|||
146869603|NCT01986920|529694456|FG001|Placebo|Withdrawal by Subject|0|||
146869604|NCT01986920|529694457|FG002|Placebo|Withdrawal by Subject|0|||
146869605|NCT01986920|529694458|FG003|Placebo|Withdrawal by Subject|1|||
146869606|NCT00874770|529694462|FG000|Overall Study|Lack of Efficacy|2|||
146869607|NCT00874770|529694463|FG001|Overall Study|Lack of Efficacy|0|||
146869608|NCT00874770|529694464|FG002|Overall Study|Lack of Efficacy|0|||
146869609|NCT00874770|529694465|FG003|Overall Study|Lack of Efficacy|2|||
146869610|NCT00874770|529694462|FG000|Overall Study|Adverse Event|1|||
146869611|NCT00874770|529694463|FG001|Overall Study|Adverse Event|1|||
146869612|NCT00874770|529694464|FG002|Overall Study|Adverse Event|4|||
146869613|NCT00874770|529694465|FG003|Overall Study|Adverse Event|2|||
146869614|NCT00874770|529694462|FG000|Overall Study|Lost to Follow-up|1|||
146869615|NCT00874770|529694463|FG001|Overall Study|Lost to Follow-up|0|||
146869616|NCT00874770|529694464|FG002|Overall Study|Lost to Follow-up|0|||
146869617|NCT00874770|529694465|FG003|Overall Study|Lost to Follow-up|1|||
146869618|NCT00874770|529694462|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
146869619|NCT00874770|529694463|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
146869620|NCT00874770|529694464|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
146869621|NCT00874770|529694465|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
146869622|NCT04880447|529694467|FG000|Overall Study|No vaccination information|1|||
146869623|NCT04880447|529694467|FG000|Overall Study|No adverse event information (missing information)|1|||
146869624|NCT04880447|529694467|FG000|Overall Study|Disease not covered in this study|35|||
146869625|NCT00718549|529694468|FG000|Induction Phase|Disease Progression|1|||
146869626|NCT00718549|529694469|FG001|Induction Phase|Disease Progression|0|||
146869627|NCT00718549|529694470|FG002|Induction Phase|Disease Progression|0|||
146869628|NCT00718549|529694468|FG000|Induction Phase|Eligibility Criteria Violation|2|||
146869629|NCT00718549|529694469|FG001|Induction Phase|Eligibility Criteria Violation|0|||
146534851|NCT01668797|528468848|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
146534852|NCT01668797|528468849|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
146534853|NCT01668797|528468850|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
146534854|NCT01668797|528468851|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
146534855|NCT01668797|528468848|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
146534856|NCT01668797|528468849|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
146534857|NCT01668797|528468850|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
146534858|NCT01668797|528468851|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
146534859|NCT01668797|528468848|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
146534860|NCT01668797|528468849|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
146534861|NCT01668797|528468850|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
146534862|NCT01668797|528468851|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
146534863|NCT01668797|528468848|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
146534864|NCT01668797|528468849|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
146763535|NCT01456936|529301381|FG003|Overall Study|Death|3|||
146763536|NCT01456936|529301378|FG000|Overall Study|Randomized but not treated|21|||
146763537|NCT01456936|529301379|FG001|Overall Study|Randomized but not treated|28|||
146763538|NCT01456936|529301380|FG002|Overall Study|Randomized but not treated|16|||
146763539|NCT01456936|529301381|FG003|Overall Study|Randomized but not treated|21|||
146763540|NCT02317705|529301382|FG000|Overall Study|Withdrawal by Subject|3|||
146763541|NCT02317705|529301382|FG000|Overall Study|Physician Decision|1|||
146763542|NCT02317705|529301382|FG000|Overall Study|Drug not usable|1|||
146763543|NCT03095508|529301383|FG000|Overall Study|Adverse Event|0|||
146763544|NCT03095508|529301384|FG001|Overall Study|Adverse Event|1|||
146763545|NCT01674569|529301385|FG000|Overall Study|Adverse Event|0|||
146763546|NCT01674569|529301386|FG001|Overall Study|Adverse Event|2|||
146763547|NCT01674569|529301387|FG002|Overall Study|Adverse Event|0|||
146763548|NCT01674569|529301388|FG003|Overall Study|Adverse Event|1|||
146763549|NCT01674569|529301389|FG004|Overall Study|Adverse Event|2|||
146763550|NCT01674569|529301390|FG005|Overall Study|Adverse Event|2|||
146534865|NCT01668797|528468850|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
146534866|NCT01668797|528468851|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
146534867|NCT01668797|528468848|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
146534868|NCT01668797|528468849|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
146534869|NCT01668797|528468850|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
146534870|NCT01668797|528468851|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
146534871|NCT01668797|528468848|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
146534872|NCT01668797|528468849|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
146534873|NCT01668797|528468850|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
146534874|NCT01668797|528468851|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
146534875|NCT01668797|528468848|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
146534876|NCT01668797|528468849|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
146534877|NCT01668797|528468850|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
146534878|NCT01668797|528468851|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
146534879|NCT01668797|528468848|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
146534880|NCT01668797|528468849|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
146763551|NCT01674569|529301385|FG000|Overall Study|Protocol Violation|0|||
146763552|NCT01674569|529301386|FG001|Overall Study|Protocol Violation|1|||
146763553|NCT01674569|529301387|FG002|Overall Study|Protocol Violation|1|||
146763554|NCT01674569|529301388|FG003|Overall Study|Protocol Violation|0|||
146763555|NCT01674569|529301389|FG004|Overall Study|Protocol Violation|0|||
146763556|NCT01674569|529301390|FG005|Overall Study|Protocol Violation|0|||
146763557|NCT01674569|529301385|FG000|Overall Study|Withdrawal by Subject|0|||
146763558|NCT01674569|529301386|FG001|Overall Study|Withdrawal by Subject|0|||
146763559|NCT01674569|529301387|FG002|Overall Study|Withdrawal by Subject|1|||
146763560|NCT01674569|529301388|FG003|Overall Study|Withdrawal by Subject|0|||
146763561|NCT01674569|529301389|FG004|Overall Study|Withdrawal by Subject|0|||
146763562|NCT01674569|529301390|FG005|Overall Study|Withdrawal by Subject|0|||
146763563|NCT01599325|529301391|FG000|Primary Parent Phase|Adverse Event|5|||
146763564|NCT01599325|529301391|FG000|Primary Parent Phase|Disease Progression|7|||
146763565|NCT01599325|529301391|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
146763566|NCT01599325|529301391|FG000|Primary Parent Phase|Death|13|||
146763567|NCT01599325|529301391|FG000|Primary Parent Phase|Protocol Violation|1|||
146763568|NCT01599325|529301391|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
146763569|NCT01599325|529301391|FG000|Primary Parent Phase|Other|2|||
146763570|NCT01599325|529301391|FG000|Extension Phase|Study Closure|1|||
146763571|NCT01599325|529301391|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
146763572|NCT01599325|529301391|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
146763573|NCT01599325|529301391|FG000|Extension Phase|Disease Progression|1|||
146763574|NCT01599325|529301391|FG000|Extension Phase|Withdrawal by Subject|8|||
146763575|NCT01878890|529301392|FG000|Overall Study|Protocol Violation|0|||
146763576|NCT01878890|529301393|FG001|Overall Study|Protocol Violation|1|||
146763577|NCT01878890|529301394|FG002|Overall Study|Protocol Violation|0|||
146763578|NCT01878890|529301395|FG003|Overall Study|Protocol Violation|0|||
146763579|NCT00567164|529301403|FG000|Overall Study|Withdrawal by Subject|171|||
146763580|NCT00567164|529301404|FG001|Overall Study|Withdrawal by Subject|21|||
146763581|NCT00567164|529301405|FG002|Overall Study|Withdrawal by Subject|17|||
146763582|NCT00567164|529301403|FG000|Overall Study|Protocol Violation|23|||
146763583|NCT00567164|529301404|FG001|Overall Study|Protocol Violation|4|||
146763584|NCT00567164|529301405|FG002|Overall Study|Protocol Violation|2|||
146763585|NCT00567164|529301403|FG000|Overall Study|Adverse Event|92|||
146763586|NCT00567164|529301404|FG001|Overall Study|Adverse Event|13|||
146763587|NCT00567164|529301405|FG002|Overall Study|Adverse Event|9|||
146763588|NCT00567164|529301403|FG000|Overall Study|Death|0|||
146763589|NCT00567164|529301404|FG001|Overall Study|Death|0|||
146763590|NCT00567164|529301405|FG002|Overall Study|Death|1|||
146763591|NCT00567164|529301403|FG000|Overall Study|Lost to Follow-up|202|||
146763592|NCT00567164|529301404|FG001|Overall Study|Lost to Follow-up|23|||
146763593|NCT00567164|529301405|FG002|Overall Study|Lost to Follow-up|21|||
146763594|NCT00567164|529301403|FG000|Overall Study|Pregnancy|20|||
146763595|NCT00567164|529301404|FG001|Overall Study|Pregnancy|4|||
146763596|NCT00567164|529301405|FG002|Overall Study|Pregnancy|6|||
146763597|NCT00567164|529301403|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
146763598|NCT00567164|529301404|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
146763599|NCT00567164|529301405|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
146763600|NCT00567164|529301403|FG000|Overall Study|Missing|1|||
146763601|NCT00567164|529301404|FG001|Overall Study|Missing|0|||
146763602|NCT00567164|529301405|FG002|Overall Study|Missing|0|||
146763603|NCT04044664|529301406|FG000|Stage 1|Adverse Event|3|||
146763604|NCT04044664|529301407|FG001|Stage 1|Adverse Event|3|||
146763605|NCT04044664|529301408|FG002|Stage 1|Adverse Event|1|||
146763606|NCT04044664|529301406|FG000|Stage 1|Lost to Follow-up|3|||
146763607|NCT04044664|529301407|FG001|Stage 1|Lost to Follow-up|2|||
146534881|NCT01668797|528468850|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
146534882|NCT01668797|528468851|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
146534883|NCT01668797|528468848|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
146534884|NCT01668797|528468849|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
146534885|NCT01668797|528468850|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
146534886|NCT01668797|528468851|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
146534887|NCT02515227|528468852|FG000|Overall Study|Adverse Event|0|||
146534888|NCT02515227|528468853|FG001|Overall Study|Adverse Event|2|||
146534889|NCT02515227|528468852|FG000|Overall Study|Progressive disease|2|||
146534890|NCT02515227|528468853|FG001|Overall Study|Progressive disease|9|||
146534891|NCT00929669|528468857|FG000|Overall Study|elevated glucose levels|1|||
146534892|NCT02714153|528468858|FG000|Overall Study|Death|1|||
146534893|NCT01901185|528468859|FG000|Overall Study|Withdrawal by Subject|2|||
146534894|NCT03502798|528468860|FG000|Overall Study|equipment failure|0|||
146534895|NCT03502798|528468861|FG001|Overall Study|equipment failure|7|||
146534896|NCT00296335|528468863|FG000|Overall Study|Recurrence|3|||
146534897|NCT00296335|528468864|FG001|Overall Study|Recurrence|51|||
146534898|NCT00296335|528468863|FG000|Overall Study|Adverse Event|17|||
146534899|NCT00296335|528468864|FG001|Overall Study|Adverse Event|27|||
146534900|NCT00296335|528468863|FG000|Overall Study|Lost to Follow-up|7|||
146534901|NCT00296335|528468864|FG001|Overall Study|Lost to Follow-up|33|||
146534902|NCT00296335|528468863|FG000|Overall Study|Physician Decision|3|||
146869630|NCT00718549|529694470|FG002|Induction Phase|Eligibility Criteria Violation|0|||
146869631|NCT00718549|529694468|FG000|Induction Phase|Early Termination - No Additional Info|59|||
146534903|NCT00296335|528468864|FG001|Overall Study|Physician Decision|11|||
146534904|NCT01027845|528468865|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
146534905|NCT01027845|528468866|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
146869632|NCT00718549|529694469|FG001|Induction Phase|Early Termination - No Additional Info|0|||
146869633|NCT00718549|529694470|FG002|Induction Phase|Early Termination - No Additional Info|0|||
146869634|NCT00718549|529694468|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
146869635|NCT00718549|529694469|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
146869636|NCT00718549|529694470|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
146869637|NCT00718549|529694468|FG000|Maintenance/ Observation Phase|Death|0|||
146869638|NCT00718549|529694469|FG001|Maintenance/ Observation Phase|Death|1|||
146869639|NCT00718549|529694470|FG002|Maintenance/ Observation Phase|Death|2|||
146869640|NCT00718549|529694468|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
146869641|NCT00718549|529694469|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
146869642|NCT00718549|529694470|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
146869643|NCT00718549|529694468|FG000|Maintenance/ Observation Phase|Progression|0|||
146869644|NCT00718549|529694469|FG001|Maintenance/ Observation Phase|Progression|5|||
146869645|NCT00718549|529694470|FG002|Maintenance/ Observation Phase|Progression|14|||
146869646|NCT00718549|529694468|FG000|Maintenance/ Observation Phase|Relapse|0|||
146869647|NCT00718549|529694469|FG001|Maintenance/ Observation Phase|Relapse|3|||
146869648|NCT00718549|529694470|FG002|Maintenance/ Observation Phase|Relapse|2|||
146869649|NCT01353508|529694471|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
146869650|NCT01353508|529694472|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
146869651|NCT01353508|529694473|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
146869652|NCT01353508|529694474|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
146869653|NCT01353508|529694471|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
146869654|NCT01353508|529694472|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
146869655|NCT01353508|529694473|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
146869656|NCT01353508|529694474|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
146869657|NCT01576172|529694475|FG000|Overall Study|Ineligible|2|||
146869658|NCT01576172|529694476|FG001|Overall Study|Ineligible|1|||
146869659|NCT01576172|529694475|FG000|Overall Study|Withdrawal by Subject|2|||
146869660|NCT01576172|529694476|FG001|Overall Study|Withdrawal by Subject|0|||
146869661|NCT01576172|529694475|FG000|Overall Study|Insurance issue|1|||
146869662|NCT01576172|529694476|FG001|Overall Study|Insurance issue|0|||
146869663|NCT01303965|529694477|FG000|Overall Study|Adverse Event|1|||
146869664|NCT01303965|529694478|FG001|Overall Study|Adverse Event|1|||
146869665|NCT01303965|529694477|FG000|Overall Study|Death|0|||
146869666|NCT01303965|529694478|FG001|Overall Study|Death|3|||
146869667|NCT01303965|529694477|FG000|Overall Study|Withdrawal by Subject|1|||
146869668|NCT01303965|529694478|FG001|Overall Study|Withdrawal by Subject|0|||
146869669|NCT01303965|529694477|FG000|Overall Study|Disease Progression|1|||
146869670|NCT01303965|529694478|FG001|Overall Study|Disease Progression|6|||
146869671|NCT00433914|529694480|FG000|Overall Study|Withdrawal by Subject|0|||
146869672|NCT00433914|529694481|FG001|Overall Study|Withdrawal by Subject|2|||
146869673|NCT00433914|529694480|FG000|Overall Study|Lost to Follow-up|0|||
146869674|NCT00433914|529694481|FG001|Overall Study|Lost to Follow-up|1|||
146869675|NCT04534491|529694482|FG000|Overall Study|Not completed end-of-study interview|24|||
146869676|NCT04534491|529694482|FG000|Overall Study|Non-users|70|||
146869677|NCT04534491|529694482|FG000|Overall Study|Non-verifiable users|58|||
146534906|NCT01027845|528468867|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
146534907|NCT01027845|528468868|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
146534908|NCT01027845|528468865|FG000|Primary Vaccination Phase|Adverse Event|1|||
146534909|NCT01027845|528468866|FG001|Primary Vaccination Phase|Adverse Event|0|||
146534910|NCT01027845|528468867|FG002|Primary Vaccination Phase|Adverse Event|0|||
146534911|NCT01027845|528468868|FG003|Primary Vaccination Phase|Adverse Event|0|||
146534912|NCT01027845|528468865|FG000|Primary Vaccination Phase|Protocol Violation|1|||
146534913|NCT01027845|528468866|FG001|Primary Vaccination Phase|Protocol Violation|0|||
146534914|NCT01027845|528468867|FG002|Primary Vaccination Phase|Protocol Violation|0|||
146534915|NCT01027845|528468868|FG003|Primary Vaccination Phase|Protocol Violation|0|||
146534916|NCT01027845|528468865|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
146534917|NCT01027845|528468866|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
146534918|NCT01027845|528468867|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
146869678|NCT00766090|529694485|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146869679|NCT00766090|529694486|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146869680|NCT00766090|529694487|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146869681|NCT00766090|529694488|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146869682|NCT00766090|529694489|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146869683|NCT00766090|529694490|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146534919|NCT01027845|528468868|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
146534920|NCT01027845|528468865|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
146534921|NCT01027845|528468866|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
146869684|NCT00766090|529694491|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146869685|NCT00766090|529694492|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146869686|NCT00766090|529694493|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
146869687|NCT00766090|529694494|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146869688|NCT00766090|529694495|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146869689|NCT00766090|529694496|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146869690|NCT00766090|529694485|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
146869691|NCT00766090|529694486|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146869692|NCT00766090|529694487|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146869693|NCT00766090|529694488|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146869694|NCT00766090|529694489|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146869695|NCT00766090|529694490|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146869696|NCT00766090|529694491|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146869697|NCT00766090|529694492|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146869698|NCT00766090|529694493|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146869699|NCT00766090|529694494|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146869700|NCT00766090|529694495|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146869701|NCT00766090|529694496|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146869702|NCT00766090|529694485|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
146763608|NCT04044664|529301408|FG002|Stage 1|Lost to Follow-up|2|||
146763609|NCT04044664|529301406|FG000|Stage 1|Withdrawal by Subject|9|||
146763610|NCT04044664|529301407|FG001|Stage 1|Withdrawal by Subject|1|||
146763611|NCT04044664|529301408|FG002|Stage 1|Withdrawal by Subject|0|||
146763612|NCT04044664|529301406|FG000|Stage 1|noncompliance, personal reason|2|||
146763613|NCT04044664|529301407|FG001|Stage 1|noncompliance, personal reason|0|||
146763614|NCT04044664|529301408|FG002|Stage 1|noncompliance, personal reason|0|||
146763615|NCT04044664|529301406|FG000|Stage 1|randomization error|0|||
146763616|NCT04044664|529301407|FG001|Stage 1|randomization error|1|||
146763617|NCT04044664|529301408|FG002|Stage 1|randomization error|0|||
146763618|NCT04044664|529301406|FG000|Stage 2|Adverse Event|2|||
146763619|NCT04044664|529301407|FG001|Stage 2|Adverse Event|0|||
146763620|NCT04044664|529301408|FG002|Stage 2|Adverse Event|0|||
146763621|NCT04044664|529301406|FG000|Stage 2|Lost to Follow-up|3|||
146763622|NCT04044664|529301407|FG001|Stage 2|Lost to Follow-up|2|||
146763623|NCT04044664|529301408|FG002|Stage 2|Lost to Follow-up|1|||
146763624|NCT04044664|529301406|FG000|Stage 2|Withdrawal by Subject|3|||
146763625|NCT04044664|529301407|FG001|Stage 2|Withdrawal by Subject|0|||
146763626|NCT04044664|529301408|FG002|Stage 2|Withdrawal by Subject|0|||
146763627|NCT04044664|529301406|FG000|Stage 2|protocol deviation|1|||
146763628|NCT04044664|529301407|FG001|Stage 2|protocol deviation|0|||
146763629|NCT04044664|529301408|FG002|Stage 2|protocol deviation|0|||
146763630|NCT01744691|529301415|FG000|Overall Study|Progressive Disease|18|||
146763631|NCT01744691|529301415|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
146763632|NCT01744691|529301415|FG000|Overall Study|Withdrawal of consent for treatment|3|||
146763633|NCT01744691|529301415|FG000|Overall Study|Physician Decision|4|||
146763634|NCT04588480|529301417|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
146763635|NCT04588480|529301418|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
146763636|NCT04588480|529301419|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
146763637|NCT04588480|529301417|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
146763638|NCT04588480|529301418|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
146763639|NCT04588480|529301419|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
146763640|NCT03247543|529301420|FG000|Overall Study|Adverse Event|3|||
146763641|NCT03247543|529301421|FG001|Overall Study|Adverse Event|6|||
146763642|NCT03247543|529301422|FG002|Overall Study|Adverse Event|4|||
146763643|NCT03247543|529301420|FG000|Overall Study|Lost to Follow-up|10|||
146763644|NCT03247543|529301421|FG001|Overall Study|Lost to Follow-up|7|||
146763645|NCT03247543|529301422|FG002|Overall Study|Lost to Follow-up|8|||
146763646|NCT03247543|529301420|FG000|Overall Study|Consent withdrawn by caregiver|2|||
146763647|NCT03247543|529301421|FG001|Overall Study|Consent withdrawn by caregiver|2|||
146763648|NCT03247543|529301422|FG002|Overall Study|Consent withdrawn by caregiver|9|||
146763649|NCT03247543|529301420|FG000|Overall Study|Withdrawal by Subject|0|||
146763650|NCT03247543|529301421|FG001|Overall Study|Withdrawal by Subject|0|||
146763651|NCT03247543|529301422|FG002|Overall Study|Withdrawal by Subject|1|||
146763652|NCT03247543|529301420|FG000|Overall Study|Failure to Follow study procedures|1|||
146763653|NCT03247543|529301421|FG001|Overall Study|Failure to Follow study procedures|3|||
146763654|NCT03247543|529301422|FG002|Overall Study|Failure to Follow study procedures|1|||
146763655|NCT03247543|529301420|FG000|Overall Study|Lack of Efficacy|1|||
146763656|NCT03247543|529301421|FG001|Overall Study|Lack of Efficacy|0|||
146763657|NCT03247543|529301422|FG002|Overall Study|Lack of Efficacy|0|||
146763658|NCT03247543|529301420|FG000|Overall Study|Non-compliance with study visits|0|||
146763659|NCT03247543|529301421|FG001|Overall Study|Non-compliance with study visits|1|||
146763660|NCT03247543|529301422|FG002|Overall Study|Non-compliance with study visits|0|||
146763661|NCT02059980|529301426|FG000|Overall Study|Lost to Follow-up|2|||
146763662|NCT02059980|529301427|FG001|Overall Study|Lost to Follow-up|1|||
146763663|NCT01104415|529301428|FG000|Core Phase|Consent withdrawn by subjects|1|||
146763664|NCT01104415|529301429|FG001|Core Phase|Consent withdrawn by subjects|0|||
146763665|NCT01104415|529301428|FG000|Extension Period|Progressive disease|0|||
146763666|NCT01104415|529301429|FG001|Extension Period|Progressive disease|4|||
146869703|NCT00766090|529694486|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146869704|NCT00766090|529694487|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146869705|NCT00766090|529694488|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
146869706|NCT00766090|529694489|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146869707|NCT00766090|529694490|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146869708|NCT00766090|529694491|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146869709|NCT00766090|529694492|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146869710|NCT00766090|529694493|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146869711|NCT00766090|529694494|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146869712|NCT00766090|529694495|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146869713|NCT00766090|529694496|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146869714|NCT00766090|529694485|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
146869715|NCT00766090|529694486|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
146869716|NCT00766090|529694487|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
146869717|NCT00766090|529694488|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
146869718|NCT00766090|529694489|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
146869719|NCT00766090|529694490|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
146869720|NCT00766090|529694491|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
146869721|NCT00766090|529694492|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
146869722|NCT00766090|529694493|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
146869723|NCT00766090|529694494|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
146869724|NCT00766090|529694495|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
146869725|NCT00766090|529694496|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
146869726|NCT00766090|529694485|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146869727|NCT00766090|529694486|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146869728|NCT00766090|529694487|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146869729|NCT00766090|529694488|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146869730|NCT00766090|529694489|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
146869731|NCT00766090|529694490|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146869732|NCT00766090|529694491|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146869733|NCT00766090|529694492|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146869734|NCT00766090|529694493|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146869735|NCT00766090|529694494|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146869736|NCT00766090|529694495|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146534922|NCT01027845|528468867|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
146534923|NCT01027845|528468868|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
146534924|NCT01027845|528468865|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
146534925|NCT01027845|528468866|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
146534926|NCT01027845|528468867|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
146534927|NCT01027845|528468868|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
146534928|NCT01670292|528468870|FG000|Overall Study|Lost to Follow-up|14|||
146534929|NCT01603277|528468873|FG000|Overall Study|Adverse Event|1|||
146534930|NCT01603277|528468874|FG001|Overall Study|Adverse Event|2|||
146534931|NCT01603277|528468873|FG000|Overall Study|Physician Decision|0|||
146534932|NCT01603277|528468874|FG001|Overall Study|Physician Decision|1|||
146534933|NCT01603277|528468873|FG000|Overall Study|Protocol Violation|6|||
146534934|NCT01603277|528468874|FG001|Overall Study|Protocol Violation|10|||
146534935|NCT01603277|528468873|FG000|Overall Study|Withdrawal by Subject|5|||
146534936|NCT01603277|528468874|FG001|Overall Study|Withdrawal by Subject|4|||
146534937|NCT01603277|528468873|FG000|Overall Study|Non-Compliance|2|||
146534938|NCT01603277|528468874|FG001|Overall Study|Non-Compliance|1|||
146534939|NCT04494646|528468875|FG000|Overall Study|Adverse Event|0|||
146534940|NCT04494646|528468876|FG001|Overall Study|Adverse Event|1|||
146534941|NCT04494646|528468875|FG000|Overall Study|Withdrawal by Subject|0|||
146534942|NCT04494646|528468876|FG001|Overall Study|Withdrawal by Subject|1|||
146534943|NCT01692119|528468877|FG000|Overall Study|Protocol Violation|3|||
146534944|NCT01692119|528468878|FG001|Overall Study|Protocol Violation|1|||
146534945|NCT01692119|528468877|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
146534946|NCT01692119|528468878|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
146534947|NCT00112957|528468885|FG000|Overall Study|Progressive disease|18|||
146534948|NCT00112957|528468885|FG000|Overall Study|Physician Decision|1|||
146534949|NCT03451045|528468888|FG000|Overall Study|Lack of Efficacy|3|||
146534950|NCT03451045|528468889|FG001|Overall Study|Lack of Efficacy|2|||
146869737|NCT00766090|529694496|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146869738|NCT00766090|529694485|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146869739|NCT00766090|529694486|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146534951|NCT03451045|528468890|FG002|Overall Study|Lack of Efficacy|2|||
146534952|NCT03451045|528468888|FG000|Overall Study|Physician Decision|1|||
146534953|NCT03451045|528468889|FG001|Overall Study|Physician Decision|1|||
146534954|NCT03451045|528468890|FG002|Overall Study|Physician Decision|1|||
146534955|NCT03451045|528468888|FG000|Overall Study|Withdrawal by Subject|4|||
146869740|NCT00766090|529694487|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
146869741|NCT00766090|529694488|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146869742|NCT00766090|529694489|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146869743|NCT00766090|529694490|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146869744|NCT00766090|529694491|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146869745|NCT00766090|529694492|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146869746|NCT00766090|529694493|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146869747|NCT00766090|529694494|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146869748|NCT00766090|529694495|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146869749|NCT00766090|529694496|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146869750|NCT00766090|529694485|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
146869751|NCT00766090|529694486|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
146869752|NCT00766090|529694487|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
146869753|NCT00766090|529694488|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
146869754|NCT00766090|529694489|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
146869755|NCT00766090|529694490|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
146869756|NCT00766090|529694491|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
146869757|NCT00766090|529694492|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
146869758|NCT00766090|529694493|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
146869759|NCT00766090|529694494|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
146869760|NCT00766090|529694495|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
146869761|NCT00766090|529694496|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
146869762|NCT00766090|529694485|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146869763|NCT00766090|529694486|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146869764|NCT00766090|529694487|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146869765|NCT00766090|529694488|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146869766|NCT00766090|529694489|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146869767|NCT00766090|529694490|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
146869768|NCT00766090|529694491|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146869769|NCT00766090|529694492|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146869770|NCT00766090|529694493|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146869771|NCT00766090|529694494|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146869772|NCT00766090|529694495|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146869773|NCT00766090|529694496|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146869774|NCT00766090|529694485|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146869775|NCT00766090|529694486|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
146869776|NCT00766090|529694487|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146869777|NCT00766090|529694488|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
146869778|NCT00766090|529694489|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146869779|NCT00766090|529694490|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146869780|NCT00766090|529694491|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146869781|NCT00766090|529694492|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146869782|NCT00766090|529694493|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146534956|NCT03451045|528468889|FG001|Overall Study|Withdrawal by Subject|0|||
146534957|NCT03451045|528468890|FG002|Overall Study|Withdrawal by Subject|5|||
146534958|NCT03451045|528468888|FG000|Overall Study|Pregnancy|0|||
146534959|NCT03451045|528468889|FG001|Overall Study|Pregnancy|0|||
146534960|NCT03451045|528468890|FG002|Overall Study|Pregnancy|2|||
146534961|NCT03451045|528468888|FG000|Overall Study|Adverse Event|7|||
146534962|NCT03451045|528468889|FG001|Overall Study|Adverse Event|1|||
146534963|NCT03451045|528468890|FG002|Overall Study|Adverse Event|3|||
146763667|NCT01104415|529301428|FG000|Extension Period|Death|0|||
146763668|NCT01104415|529301429|FG001|Extension Period|Death|1|||
146763669|NCT01104415|529301428|FG000|Extension Period|Physician Decision|0|||
146763670|NCT01104415|529301429|FG001|Extension Period|Physician Decision|1|||
146763671|NCT01104415|529301428|FG000|Extension Period|Transition to Study LX1606.302|0|||
146763672|NCT01104415|529301429|FG001|Extension Period|Transition to Study LX1606.302|4|||
146763673|NCT01104415|529301428|FG000|Extension Period|Heart surgery/feeling miserable|0|||
146763674|NCT01104415|529301429|FG001|Extension Period|Heart surgery/feeling miserable|1|||
146763675|NCT03227757|529302865|FG000|Overall Study|Death|25|||
146763676|NCT03227757|529302865|FG000|Overall Study|Withdrawal|10|||
146763677|NCT03227757|529302865|FG000|Overall Study|Missed visits|1|||
146763678|NCT03227757|529302865|FG000|Overall Study|Lost to Follow-up|2|||
146763679|NCT01144468|529302867|FG000|Overall Study|Lost to Follow-up|4|||
146763680|NCT01144468|529302868|FG001|Overall Study|Lost to Follow-up|7|||
146763681|NCT01144468|529302867|FG000|Overall Study|Adverse Event|3|||
146763682|NCT01144468|529302868|FG001|Overall Study|Adverse Event|2|||
146763683|NCT01144468|529302867|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
146763684|NCT01144468|529302868|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
146763685|NCT02960659|529302869|FG000|Overall Study|Withdrawal by Subject|1|||
146763686|NCT02960659|529302870|FG001|Overall Study|Withdrawal by Subject|0|||
146763687|NCT02960659|529302869|FG000|Overall Study|Poor compliance|0|||
146763688|NCT02960659|529302870|FG001|Overall Study|Poor compliance|1|||
146763689|NCT04199728|529302871|FG000|Overall Study|Adverse Event|1|||
146763690|NCT04199728|529302872|FG001|Overall Study|Adverse Event|0|||
146763691|NCT04199728|529302871|FG000|Overall Study|Withdrawal by Subject|8|||
146763692|NCT04199728|529302872|FG001|Overall Study|Withdrawal by Subject|3|||
146763693|NCT04199728|529302871|FG000|Overall Study|Screen fail after consent|0|||
146763694|NCT04199728|529302872|FG001|Overall Study|Screen fail after consent|1|||
146763695|NCT04199728|529302871|FG000|Overall Study|Early withdraw criteria met|0|||
146763696|NCT04199728|529302872|FG001|Overall Study|Early withdraw criteria met|1|||
146763697|NCT04199728|529302871|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
146763698|NCT04199728|529302872|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
146763699|NCT01331824|529302875|FG000|Overall Study|Adverse Event|2|||
146763700|NCT01331824|529302875|FG000|Overall Study|Death|1|||
146763701|NCT01331824|529302875|FG000|Overall Study|Disease Progression|9|||
146763702|NCT01331824|529302875|FG000|Overall Study|Withdrawal by Subject|1|||
146763703|NCT01091454|529302878|FG000|Overall Study|Ineligible|1|||
146763704|NCT03179787|529302882|FG000|Overall Study|Lost to Follow-up|15|||
146534964|NCT03451045|528468888|FG000|Overall Study|Non-compliance with study|2|||
146534965|NCT03451045|528468889|FG001|Overall Study|Non-compliance with study|0|||
146534966|NCT03451045|528468890|FG002|Overall Study|Non-compliance with study|1|||
146534967|NCT03451045|528468888|FG000|Overall Study|any other reason|10|||
146534968|NCT03451045|528468889|FG001|Overall Study|any other reason|2|||
146534969|NCT03451045|528468890|FG002|Overall Study|any other reason|13|||
146534970|NCT02391337|528468891|FG000|6 Months Follow-up|Death|5|||
146534971|NCT02391337|528468892|FG001|6 Months Follow-up|Death|4|||
146534972|NCT02391337|528468891|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
146534973|NCT02391337|528468892|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
146534974|NCT02391337|528468891|FG000|12 Months Follow-up|Death|2|||
146534975|NCT02391337|528468892|FG001|12 Months Follow-up|Death|0|||
146534976|NCT02391337|528468891|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
146534977|NCT02391337|528468892|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
146534978|NCT02391337|528468891|FG000|12 Months Follow-up|Lost to Follow-up|0|||
146534979|NCT02391337|528468892|FG001|12 Months Follow-up|Lost to Follow-up|2|||
146534980|NCT00830128|528468893|FG000|Overall Study|Adverse Event|5|||
146534981|NCT00830128|528468893|FG000|Overall Study|Lack of Efficacy|7|||
146534982|NCT00830128|528468893|FG000|Overall Study|Protocol Violation|1|||
146534983|NCT00830128|528468893|FG000|Overall Study|Withdrawal by Subject|2|||
146534984|NCT00830128|528468893|FG000|Overall Study|Family obligation|1|||
146534985|NCT00830128|528468893|FG000|Overall Study|Relocation|1|||
146534986|NCT00830128|528468893|FG000|Overall Study|Work obligation|1|||
146869783|NCT00766090|529694494|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146869784|NCT00766090|529694495|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146869785|NCT00766090|529694496|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
146534987|NCT00830128|528468893|FG000|Overall Study|Operating a vehicle|1|||
146534988|NCT00111761|528468900|FG000|Part 1|Physician Decision|0|||
146534989|NCT00111761|528468901|FG001|Part 1|Physician Decision|1|||
146534990|NCT00111761|528468900|FG000|Part 1|Death|0|||
146534991|NCT00111761|528468901|FG001|Part 1|Death|2|||
146534992|NCT00111761|528468900|FG000|Part 1|Other|0|||
146534993|NCT00111761|528468901|FG001|Part 1|Other|1|||
146534994|NCT00111761|528468900|FG000|Part 1|Withdrawal by Subject|0|||
146534995|NCT00111761|528468901|FG001|Part 1|Withdrawal by Subject|1|||
146534996|NCT00111761|528468900|FG000|Part 2|Adverse Event|1|||
146534997|NCT00111761|528468901|FG001|Part 2|Adverse Event|0|||
146534998|NCT00111761|528468900|FG000|Part 2|Physician Decision|1|||
146534999|NCT00111761|528468901|FG001|Part 2|Physician Decision|0|||
146535000|NCT00111761|528468900|FG000|Part 2|Death|1|||
146535001|NCT00111761|528468901|FG001|Part 2|Death|0|||
146535002|NCT00111761|528468900|FG000|Part 2|Disease progression|3|||
146535003|NCT00111761|528468901|FG001|Part 2|Disease progression|0|||
146535004|NCT00111761|528468900|FG000|Part 2|Protocol-specified criteria|1|||
146535005|NCT00111761|528468901|FG001|Part 2|Protocol-specified criteria|0|||
146535006|NCT00111761|528468900|FG000|Part 2|Other|1|||
146535007|NCT00111761|528468901|FG001|Part 2|Other|0|||
146535008|NCT00062166|528468908|FG000|Overall Study|Withdrawal by Subject|6|||
146535009|NCT02475369|528468909|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
146535010|NCT02475369|528468910|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
146535011|NCT04798027|528468913|FG000|Overall Study|Protocol Violation|0|||
146535012|NCT04798027|528468914|FG001|Overall Study|Protocol Violation|0|||
146535013|NCT04798027|528468915|FG002|Overall Study|Protocol Violation|0|||
146535014|NCT04798027|528468916|FG003|Overall Study|Protocol Violation|0|||
146869786|NCT00766090|529694485|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146869787|NCT00766090|529694486|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146869788|NCT00766090|529694487|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146869789|NCT00766090|529694488|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146869790|NCT00766090|529694489|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
146869791|NCT00766090|529694490|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146869792|NCT00766090|529694491|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146869793|NCT00766090|529694492|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146869794|NCT00766090|529694493|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146535015|NCT04798027|528468917|FG004|Overall Study|Protocol Violation|1|||
146535016|NCT04798027|528468918|FG005|Overall Study|Protocol Violation|0|||
146535017|NCT04798027|528468919|FG006|Overall Study|Protocol Violation|0|||
146535018|NCT04798027|528468920|FG007|Overall Study|Protocol Violation|1|||
146535019|NCT04798027|528468921|FG008|Overall Study|Protocol Violation|0|||
146535020|NCT04798027|528468913|FG000|Overall Study|Withdrawal by Subject|1|||
146535021|NCT04798027|528468914|FG001|Overall Study|Withdrawal by Subject|0|||
146869795|NCT00766090|529694494|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146869796|NCT00766090|529694495|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146535022|NCT04798027|528468915|FG002|Overall Study|Withdrawal by Subject|1|||
146535023|NCT04798027|528468916|FG003|Overall Study|Withdrawal by Subject|1|||
146535024|NCT04798027|528468917|FG004|Overall Study|Withdrawal by Subject|1|||
146535025|NCT04798027|528468918|FG005|Overall Study|Withdrawal by Subject|1|||
146535026|NCT04798027|528468919|FG006|Overall Study|Withdrawal by Subject|3|||
146535027|NCT04798027|528468920|FG007|Overall Study|Withdrawal by Subject|2|||
146869797|NCT00766090|529694496|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146869798|NCT03024970|529694501|FG000|First Intervention|Adverse Event|1|||
146869799|NCT03024970|529694502|FG001|First Intervention|Adverse Event|0|||
146869800|NCT03024970|529694501|FG000|Second Intervention|Lost to Follow-up|1|||
146869801|NCT03024970|529694502|FG001|Second Intervention|Lost to Follow-up|0|||
146869802|NCT02289352|529694512|FG000|Overall Study|Withdrawal by Subject|1|||
146869803|NCT02289352|529694513|FG001|Overall Study|Withdrawal by Subject|1|||
146869804|NCT02289352|529694514|FG002|Overall Study|Withdrawal by Subject|0|||
146869805|NCT01390272|529694515|FG000|Overall Study|Death|3|||
146869806|NCT01390272|529694516|FG001|Overall Study|Death|2|||
146869807|NCT01390272|529694515|FG000|Overall Study|Withdrawal by Subject|9|||
146869808|NCT01390272|529694516|FG001|Overall Study|Withdrawal by Subject|5|||
146869809|NCT01390272|529694515|FG000|Overall Study|Patient moved, no longer eligible|5|||
146869810|NCT01390272|529694516|FG001|Overall Study|Patient moved, no longer eligible|8|||
146869811|NCT01177384|529694517|FG000|Overall Study|Adverse Event|6|||
146869812|NCT01177384|529694518|FG001|Overall Study|Adverse Event|4|||
146869813|NCT01177384|529694517|FG000|Overall Study|Lack of Efficacy|0|||
146869814|NCT01177384|529694518|FG001|Overall Study|Lack of Efficacy|1|||
146869815|NCT01177384|529694517|FG000|Overall Study|Lost to Follow-up|3|||
146869816|NCT01177384|529694518|FG001|Overall Study|Lost to Follow-up|4|||
146869817|NCT01177384|529694517|FG000|Overall Study|Physician Decision|0|||
146869818|NCT01177384|529694518|FG001|Overall Study|Physician Decision|3|||
146869819|NCT01177384|529694517|FG000|Overall Study|Protocol Violation|0|||
146869820|NCT01177384|529694518|FG001|Overall Study|Protocol Violation|2|||
146869821|NCT01177384|529694517|FG000|Overall Study|Withdrawal by Subject|5|||
146869822|NCT01177384|529694518|FG001|Overall Study|Withdrawal by Subject|12|||
146869823|NCT00590044|529694548|FG000|Overall Study|Withdrawal by Subject|2|||
146869824|NCT00590044|529694549|FG001|Overall Study|Withdrawal by Subject|2|||
146869825|NCT00590044|529694548|FG000|Overall Study|wrong insulin arm assigned|1|||
146869826|NCT00590044|529694549|FG001|Overall Study|wrong insulin arm assigned|0|||
146869827|NCT00590044|529694548|FG000|Overall Study|Protocol Violation|1|||
146869828|NCT00590044|529694549|FG001|Overall Study|Protocol Violation|0|||
146869829|NCT00175877|529694553|FG000|Overall Study|Adverse Event|136|||
146869830|NCT00175877|529694553|FG000|Overall Study|Withdrawal by Subject|141|||
146869831|NCT00175877|529694553|FG000|Overall Study|Lost to Follow-up|9|||
146869832|NCT00175877|529694553|FG000|Overall Study|Lack of Efficacy|26|||
146869833|NCT00175877|529694553|FG000|Overall Study|Protocol Violation|15|||
146869834|NCT00175877|529694553|FG000|Overall Study|Other Reason|20|||
146869835|NCT00175877|529694553|FG000|Overall Study|AE & Other|1|||
146869836|NCT00175877|529694553|FG000|Overall Study|Withdrawal by subject & Other|1|||
146869837|NCT00955279|529694556|FG000|Overall Study|Other|0|||
146869838|NCT00955279|529694557|FG001|Overall Study|Other|0|||
146869839|NCT00955279|529694558|FG002|Overall Study|Other|3|||
146869840|NCT00955279|529694556|FG000|Overall Study|Death|1|||
146869841|NCT00955279|529694557|FG001|Overall Study|Death|1|||
146869842|NCT00955279|529694558|FG002|Overall Study|Death|1|||
146869843|NCT00955279|529694556|FG000|Overall Study|Lost to Follow-up|0|||
146869844|NCT00955279|529694557|FG001|Overall Study|Lost to Follow-up|3|||
146869845|NCT00955279|529694558|FG002|Overall Study|Lost to Follow-up|1|||
146869846|NCT00955279|529694556|FG000|Overall Study|Withdrawal by Subject|2|||
146869847|NCT00955279|529694557|FG001|Overall Study|Withdrawal by Subject|0|||
146869848|NCT00955279|529694558|FG002|Overall Study|Withdrawal by Subject|3|||
146869849|NCT01235793|529694559|FG000|Overall Study|Death|6|||
146869850|NCT01159912|529694560|FG000|Overall Study|Adverse Event|2|||
146869851|NCT01159912|529694561|FG001|Overall Study|Adverse Event|2|||
146869852|NCT01159912|529694562|FG002|Overall Study|Adverse Event|3|||
146869853|NCT01159912|529694560|FG000|Overall Study|Lack of Efficacy|23|||
146869854|NCT01159912|529694561|FG001|Overall Study|Lack of Efficacy|15|||
146869855|NCT01159912|529694562|FG002|Overall Study|Lack of Efficacy|14|||
146869856|NCT01159912|529694560|FG000|Overall Study|Protocol Violation|1|||
146869857|NCT01159912|529694561|FG001|Overall Study|Protocol Violation|2|||
146869858|NCT01159912|529694562|FG002|Overall Study|Protocol Violation|3|||
146535028|NCT04798027|528468921|FG008|Overall Study|Withdrawal by Subject|2|||
146869859|NCT01159912|529694560|FG000|Overall Study|Lost to Follow-up|4|||
146869860|NCT01159912|529694561|FG001|Overall Study|Lost to Follow-up|0|||
146869861|NCT01159912|529694562|FG002|Overall Study|Lost to Follow-up|0|||
146869862|NCT01159912|529694560|FG000|Overall Study|Physician Decision|0|||
146869863|NCT01159912|529694561|FG001|Overall Study|Physician Decision|0|||
146869864|NCT01159912|529694562|FG002|Overall Study|Physician Decision|3|||
146869865|NCT01159912|529694560|FG000|Overall Study|Withdrawal by Subject|10|||
146869866|NCT01159912|529694561|FG001|Overall Study|Withdrawal by Subject|3|||
146535029|NCT04798027|528468913|FG000|Overall Study|Lost to Follow-up|1|||
146535030|NCT04798027|528468914|FG001|Overall Study|Lost to Follow-up|3|||
146869867|NCT01159912|529694562|FG002|Overall Study|Withdrawal by Subject|3|||
146869868|NCT02456662|529694565|FG000|Overall Study|Lost to Follow-up|2|||
146869869|NCT02456662|529694566|FG001|Overall Study|Lost to Follow-up|1|||
146869870|NCT02374021|529694569|FG000|Overall Study|Adverse Event|1|||
146869871|NCT02374021|529694570|FG001|Overall Study|Adverse Event|0|||
146869872|NCT02374021|529694569|FG000|Overall Study|Lost to Follow-up|3|||
146869873|NCT02374021|529694570|FG001|Overall Study|Lost to Follow-up|2|||
146869874|NCT02374021|529694569|FG000|Overall Study|Physician Decision|0|||
146869875|NCT02374021|529694570|FG001|Overall Study|Physician Decision|3|||
146869876|NCT02374021|529694569|FG000|Overall Study|Withdrawal by Subject|6|||
146869877|NCT02374021|529694570|FG001|Overall Study|Withdrawal by Subject|5|||
146869878|NCT02374021|529694569|FG000|Overall Study|Poor Adherence|0|||
146869879|NCT02374021|529694570|FG001|Overall Study|Poor Adherence|1|||
146869880|NCT02374021|529694569|FG000|Overall Study|Scan protocol not followed|0|||
146869881|NCT02374021|529694570|FG001|Overall Study|Scan protocol not followed|1|||
146869882|NCT02374021|529694569|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
146869883|NCT02374021|529694570|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
146869884|NCT04411628|529694572|FG000|Overall Study|Withdrawal by Subject|1|||
146869885|NCT04411628|529694573|FG001|Overall Study|Withdrawal by Subject|1|||
146869886|NCT04411628|529694574|FG002|Overall Study|Withdrawal by Subject|2|||
146869887|NCT04411628|529694575|FG003|Overall Study|Withdrawal by Subject|0|||
146869888|NCT04411628|529694572|FG000|Overall Study|Lost to Follow-up|0|||
146869889|NCT04411628|529694573|FG001|Overall Study|Lost to Follow-up|1|||
146869890|NCT04411628|529694574|FG002|Overall Study|Lost to Follow-up|0|||
146869891|NCT04411628|529694575|FG003|Overall Study|Lost to Follow-up|0|||
146869892|NCT03828292|529694576|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
146869893|NCT03828292|529694577|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
146869894|NCT03828292|529694578|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
146869895|NCT03828292|529694579|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
146869896|NCT03828292|529694580|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
146869897|NCT03828292|529694581|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
146869898|NCT03828292|529694576|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
146869899|NCT03828292|529694577|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
146869900|NCT03828292|529694578|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
146869901|NCT03828292|529694579|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
146869902|NCT03828292|529694580|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
146869903|NCT03828292|529694581|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
146869904|NCT03828292|529694576|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
146869905|NCT03828292|529694577|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
146869906|NCT03828292|529694578|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
146869907|NCT03828292|529694579|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
146869908|NCT03828292|529694580|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
146869909|NCT03828292|529694581|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
146869910|NCT03828292|529694576|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
146869911|NCT03828292|529694577|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
146869912|NCT03828292|529694578|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
146869913|NCT03828292|529694579|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
146869914|NCT03828292|529694580|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
146869915|NCT03828292|529694581|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
146869916|NCT03828292|529694576|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
146869917|NCT03828292|529694577|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
146869918|NCT03828292|529694578|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
146869919|NCT03828292|529694579|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
146869920|NCT03828292|529694580|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
146869921|NCT03828292|529694581|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
146869922|NCT01444456|529694582|FG000|Overall Study|Withdrawal by Subject|21|||
146869923|NCT01444456|529694582|FG000|Overall Study|Physician Decision|9|||
146869924|NCT01444456|529694582|FG000|Overall Study|Lost to Follow-up|37|||
146869925|NCT01444456|529694582|FG000|Overall Study|Death|73|||
146869926|NCT01444456|529694582|FG000|Overall Study|Ineligibility determined|23|||
146869927|NCT01444456|529694582|FG000|Overall Study|Other|18|||
146869928|NCT01444456|529694582|FG000|Overall Study|Not treated|104|||
146869929|NCT04376827|529694586|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
146869930|NCT04376827|529694587|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
146869931|NCT04376827|529694586|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
146869932|NCT04376827|529694587|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
146869933|NCT04376827|529694586|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
146869934|NCT04376827|529694587|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
146869935|NCT04376827|529694586|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
146869936|NCT04376827|529694587|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
146869937|NCT04376827|529694586|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
146869938|NCT04376827|529694587|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
146869939|NCT02142738|529696215|FG000|Overall Study|Adverse Event|13|||
146869940|NCT02142738|529696216|FG001|Overall Study|Adverse Event|9|||
146869941|NCT02142738|529696215|FG000|Overall Study|Death|92|||
146869942|NCT02142738|529696216|FG001|Overall Study|Death|112|||
146869943|NCT02142738|529696215|FG000|Overall Study|Lost to Follow-up|0|||
146869944|NCT02142738|529696216|FG001|Overall Study|Lost to Follow-up|3|||
146869945|NCT02142738|529696215|FG000|Overall Study|Withdrawal by Subject|6|||
146869946|NCT02142738|529696216|FG001|Overall Study|Withdrawal by Subject|7|||
146869947|NCT02142738|529696215|FG000|Overall Study|Follow up ended by sponsor|43|||
146869948|NCT02142738|529696216|FG001|Overall Study|Follow up ended by sponsor|20|||
146869949|NCT03688880|529696217|FG000|Overall Study|Withdrawal by Subject|0|||
146869950|NCT03688880|529696218|FG001|Overall Study|Withdrawal by Subject|2|||
146869951|NCT03688880|529696217|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
146869952|NCT03688880|529696218|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
146869953|NCT03688880|529696217|FG000|Overall Study|Lost to Follow-up|4|||
146869954|NCT03688880|529696218|FG001|Overall Study|Lost to Follow-up|7|||
146869955|NCT03688880|529696217|FG000|Overall Study|Adverse Event|0|||
146869956|NCT03688880|529696218|FG001|Overall Study|Adverse Event|2|||
146869957|NCT03688880|529696217|FG000|Overall Study|Device deficiencies|0|||
146869958|NCT03688880|529696218|FG001|Overall Study|Device deficiencies|2|||
146869959|NCT03688880|529696217|FG000|Overall Study|Other|10|||
146869960|NCT03688880|529696218|FG001|Overall Study|Other|16|||
146869961|NCT01704287|529696219|FG000|Initial Treatment Period|Death|139|||
146869962|NCT01704287|529696220|FG001|Initial Treatment Period|Death|129|||
146869963|NCT01704287|529696221|FG002|Initial Treatment Period|Death|71|||
146869964|NCT01704287|529696222|FG003|Initial Treatment Period|Death|0|||
146869965|NCT01704287|529696223|FG004|Initial Treatment Period|Death|0|||
146869966|NCT01704287|529696219|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
146869967|NCT01704287|529696220|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
146869968|NCT01704287|529696221|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
146869969|NCT01704287|529696222|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
146869970|NCT01704287|529696223|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
146869971|NCT01704287|529696219|FG000|Initial Treatment Period|Lost to Follow-up|5|||
146869972|NCT01704287|529696220|FG001|Initial Treatment Period|Lost to Follow-up|3|||
146869973|NCT01704287|529696221|FG002|Initial Treatment Period|Lost to Follow-up|0|||
146869974|NCT01704287|529696222|FG003|Initial Treatment Period|Lost to Follow-up|0|||
146869975|NCT01704287|529696223|FG004|Initial Treatment Period|Lost to Follow-up|0|||
146869976|NCT01704287|529696219|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
146869977|NCT01704287|529696220|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
146869978|NCT01704287|529696221|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
146869979|NCT01704287|529696222|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
146869980|NCT01704287|529696223|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
146869981|NCT01704287|529696219|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
146869982|NCT01704287|529696220|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
146869983|NCT01704287|529696221|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
146869984|NCT01704287|529696222|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
146869985|NCT01704287|529696223|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
146869986|NCT01704287|529696219|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
146869987|NCT01704287|529696220|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
146869988|NCT01704287|529696221|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
146869989|NCT01704287|529696222|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
146869990|NCT01704287|529696223|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
146869991|NCT01704287|529696219|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
146869992|NCT01704287|529696220|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
146869993|NCT01704287|529696221|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
146869994|NCT01704287|529696222|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
146869995|NCT01704287|529696223|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
146869996|NCT03713034|529696224|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
146869997|NCT03713034|529696225|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
146869998|NCT02615470|529696226|FG000|Overall Study|Lost to Follow-up|21|||
146869999|NCT02615470|529696227|FG001|Overall Study|Lost to Follow-up|32|||
146870000|NCT04024228|529696233|FG000|Overall Study|Adverse Event|1|||
146535031|NCT04798027|528468915|FG002|Overall Study|Lost to Follow-up|0|||
146535032|NCT04798027|528468916|FG003|Overall Study|Lost to Follow-up|0|||
146535033|NCT04798027|528468917|FG004|Overall Study|Lost to Follow-up|0|||
146535034|NCT04798027|528468918|FG005|Overall Study|Lost to Follow-up|1|||
146535035|NCT04798027|528468919|FG006|Overall Study|Lost to Follow-up|0|||
146535036|NCT04798027|528468920|FG007|Overall Study|Lost to Follow-up|0|||
146535037|NCT04798027|528468921|FG008|Overall Study|Lost to Follow-up|1|||
146535038|NCT04798027|528468913|FG000|Overall Study|Withdrawal by Sponsor|8|||
146535039|NCT04798027|528468914|FG001|Overall Study|Withdrawal by Sponsor|22|||
146535040|NCT04798027|528468915|FG002|Overall Study|Withdrawal by Sponsor|9|||
146870001|NCT04024228|529696234|FG001|Overall Study|Adverse Event|0|||
146535041|NCT04798027|528468916|FG003|Overall Study|Withdrawal by Sponsor|26|||
146870002|NCT04024228|529696233|FG000|Overall Study|Protocol Deviation|0|||
146535042|NCT04798027|528468917|FG004|Overall Study|Withdrawal by Sponsor|24|||
146870003|NCT04024228|529696234|FG001|Overall Study|Protocol Deviation|2|||
146870004|NCT04024228|529696233|FG000|Overall Study|Withdrawal by Subject|3|||
146870005|NCT04024228|529696234|FG001|Overall Study|Withdrawal by Subject|4|||
146870006|NCT02982590|529696235|FG000|Overall Study|Lost to Follow-up|0|||
146870007|NCT02982590|529696236|FG001|Overall Study|Lost to Follow-up|1|||
146870008|NCT02982590|529696235|FG000|Overall Study|Death|4|||
146870009|NCT02982590|529696236|FG001|Overall Study|Death|0|||
146870010|NCT01168973|529696240|FG000|Overall Study|Progressive Disease|341|||
146870011|NCT01168973|529696241|FG001|Overall Study|Progressive Disease|429|||
146870012|NCT01168973|529696240|FG000|Overall Study|Adverse Event|94|||
146870013|NCT01168973|529696241|FG001|Overall Study|Adverse Event|55|||
146870014|NCT01168973|529696240|FG000|Overall Study|Withdrawal by Subject|90|||
146870015|NCT01168973|529696241|FG001|Overall Study|Withdrawal by Subject|53|||
146870016|NCT01168973|529696240|FG000|Overall Study|Death|42|||
146870017|NCT01168973|529696241|FG001|Overall Study|Death|45|||
146870018|NCT01168973|529696240|FG000|Overall Study|Physician Decision|37|||
146870019|NCT01168973|529696241|FG001|Overall Study|Physician Decision|19|||
146870020|NCT01168973|529696240|FG000|Overall Study|Sponsor Decision|2|||
146870021|NCT01168973|529696241|FG001|Overall Study|Sponsor Decision|1|||
146870022|NCT01168973|529696240|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
146870023|NCT01168973|529696241|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
146870024|NCT00709111|529696266|FG000|Overall Study|Withdrawal by Subject|1|||
146870025|NCT00709111|529696266|FG000|Overall Study|Unable to attend clinic visits|1|||
146870026|NCT01301456|529696271|FG000|Stage 1|Withdrawal by Subject|0|||
146870027|NCT01301456|529696272|FG001|Stage 1|Withdrawal by Subject|0|||
146870028|NCT01301456|529696273|FG002|Stage 1|Withdrawal by Subject|1|||
146870029|NCT01301456|529696274|FG003|Stage 1|Withdrawal by Subject|0|||
146870030|NCT01301456|529696275|FG004|Stage 1|Withdrawal by Subject|1|||
146870031|NCT01301456|529696276|FG005|Stage 1|Withdrawal by Subject|0|||
146870032|NCT01301456|529696277|FG006|Stage 1|Withdrawal by Subject|0|||
146870033|NCT01301456|529696278|FG007|Stage 1|Withdrawal by Subject|0|||
146870034|NCT01301456|529696279|FG008|Stage 1|Withdrawal by Subject|0|||
146870035|NCT01301456|529696280|FG009|Stage 1|Withdrawal by Subject|0|||
146870036|NCT01301456|529696281|FG010|Stage 1|Withdrawal by Subject|0|||
146870037|NCT01301456|529696282|FG011|Stage 1|Withdrawal by Subject|0|||
146870038|NCT01301456|529696271|FG000|Stage 1|Randomized but not treated|0|||
146870039|NCT01301456|529696272|FG001|Stage 1|Randomized but not treated|0|||
146870040|NCT01301456|529696273|FG002|Stage 1|Randomized but not treated|0|||
146870041|NCT01301456|529696274|FG003|Stage 1|Randomized but not treated|0|||
146870042|NCT01301456|529696275|FG004|Stage 1|Randomized but not treated|0|||
146870043|NCT01301456|529696276|FG005|Stage 1|Randomized but not treated|0|||
146870044|NCT01301456|529696277|FG006|Stage 1|Randomized but not treated|1|||
146870045|NCT01301456|529696278|FG007|Stage 1|Randomized but not treated|0|||
146870046|NCT01301456|529696279|FG008|Stage 1|Randomized but not treated|0|||
146870047|NCT01301456|529696280|FG009|Stage 1|Randomized but not treated|0|||
146870048|NCT01301456|529696281|FG010|Stage 1|Randomized but not treated|0|||
146870049|NCT01301456|529696282|FG011|Stage 1|Randomized but not treated|0|||
146870050|NCT01301456|529696271|FG000|Stage 2|Adverse Event|0|||
146870051|NCT01301456|529696272|FG001|Stage 2|Adverse Event|0|||
146870052|NCT01301456|529696273|FG002|Stage 2|Adverse Event|0|||
146870053|NCT01301456|529696274|FG003|Stage 2|Adverse Event|0|||
146870054|NCT01301456|529696275|FG004|Stage 2|Adverse Event|0|||
146870055|NCT01301456|529696276|FG005|Stage 2|Adverse Event|0|||
146870056|NCT01301456|529696277|FG006|Stage 2|Adverse Event|0|||
146870057|NCT01301456|529696278|FG007|Stage 2|Adverse Event|0|||
146870058|NCT01301456|529696279|FG008|Stage 2|Adverse Event|0|||
146870059|NCT01301456|529696280|FG009|Stage 2|Adverse Event|0|||
146870060|NCT01301456|529696281|FG010|Stage 2|Adverse Event|1|||
146870061|NCT01301456|529696282|FG011|Stage 2|Adverse Event|0|||
146870062|NCT01383096|529696283|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
146870063|NCT01383096|529696284|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
146870064|NCT01383096|529696285|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
146870065|NCT01383096|529696283|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
146870066|NCT01383096|529696284|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
146870067|NCT01383096|529696285|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
146870068|NCT01383096|529696283|FG000|Third Intervention (8 Days)|Elevated AST|0|||
146870069|NCT01383096|529696284|FG001|Third Intervention (8 Days)|Elevated AST|1|||
146870070|NCT01383096|529696285|FG002|Third Intervention (8 Days)|Elevated AST|0|||
146870071|NCT01383096|529696283|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
146870072|NCT01383096|529696284|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
146870073|NCT01383096|529696285|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
146870074|NCT01383096|529696283|FG000|Third Intervention (8 Days)|Adverse Event|1|||
146870075|NCT01383096|529696284|FG001|Third Intervention (8 Days)|Adverse Event|0|||
146870076|NCT01383096|529696285|FG002|Third Intervention (8 Days)|Adverse Event|0|||
146870077|NCT01383096|529696283|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
146870078|NCT01383096|529696284|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
146763705|NCT03179787|529302882|FG000|Overall Study|Case report failures|2|||
146763706|NCT03179787|529302882|FG000|Overall Study|Treatment not administered|1|||
146535043|NCT04798027|528468918|FG005|Overall Study|Withdrawal by Sponsor|11|||
146535044|NCT04798027|528468919|FG006|Overall Study|Withdrawal by Sponsor|25|||
146535045|NCT04798027|528468920|FG007|Overall Study|Withdrawal by Sponsor|26|||
146535046|NCT04798027|528468921|FG008|Overall Study|Withdrawal by Sponsor|11|||
146535047|NCT03642990|528468922|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
146535048|NCT03642990|528468922|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
146535049|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
146535050|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
146535051|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
146535052|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
146535053|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
146535054|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
146535055|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
146535056|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
146535057|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
146535058|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
146535059|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
146535060|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
146535061|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
146535062|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
146535063|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
146535064|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
146535065|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
146535066|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
146535067|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
146535068|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
146535069|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
146535070|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
146535071|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
146535072|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
146535073|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
146535074|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
146535075|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
146535076|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
146535077|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
146535078|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
146535079|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
146535080|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
146535081|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
146535082|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
146535083|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
146535084|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
146535085|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
146535086|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
146535087|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
146535088|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
146535089|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
146535090|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
146535091|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
146535092|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
146535093|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
146535094|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
146763707|NCT00661778|529302883|FG000|Overall Study|Disease Progression|23|||
146763708|NCT00661778|529302883|FG000|Overall Study|Adverse Event|18|||
146763709|NCT00661778|529302883|FG000|Overall Study|Reason not Specified|6|||
146763710|NCT00661778|529302883|FG000|Overall Study|Protocol Violation|2|||
146763711|NCT00661778|529302883|FG000|Overall Study|Withdrawal of Consent|1|||
146763712|NCT01090024|529302888|FG000|Period 1|Met exclusion criteria|0|||
146763713|NCT01090024|529302889|FG001|Period 1|Met exclusion criteria|0|||
146763714|NCT01090024|529302890|FG002|Period 1|Met exclusion criteria|0|||
146763715|NCT01090024|529302891|FG003|Period 1|Met exclusion criteria|0|||
146763716|NCT01090024|529302892|FG004|Period 1|Met exclusion criteria|0|||
146763717|NCT01090024|529302893|FG005|Period 1|Met exclusion criteria|0|||
146763718|NCT01090024|529302894|FG006|Period 1|Met exclusion criteria|0|||
146535095|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
146535096|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
146535097|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
146535098|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
146535099|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
146535100|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
146535101|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
146535102|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
146535103|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
146535104|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
146535105|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
146535106|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
146535107|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
146535108|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
146535109|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
146535110|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
146535111|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
146535112|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
146535113|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
146535114|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
146535115|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
146535116|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
146535117|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
146535118|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
146535119|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
146535120|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
146535121|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
146535122|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
146535123|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
146535124|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
146535125|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
146535126|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
146535127|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
146535128|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
146535129|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
146535130|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
146535131|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
146535132|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
146535133|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
146535134|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
146535135|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
146535136|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
146535137|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
146535138|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
146535139|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
146535140|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
146535141|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
146535142|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
146535143|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
146535144|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
146535145|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
146535146|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
146535147|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
146535148|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
146535149|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
146535150|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
146535151|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
146535152|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
146535153|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
146535154|NCT02717195|528468923|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
146763719|NCT01090024|529302895|FG007|Period 1|Met exclusion criteria|0|||
146763720|NCT01090024|529302896|FG008|Period 1|Met exclusion criteria|0|||
146870079|NCT01383096|529696285|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
146870080|NCT01383096|529696283|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
146870081|NCT01383096|529696284|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
146870082|NCT01383096|529696285|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
146870083|NCT01383096|529696283|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
146870084|NCT01383096|529696284|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
146870085|NCT01383096|529696285|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
146870086|NCT01383096|529696283|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
146870087|NCT01383096|529696284|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
146870088|NCT01383096|529696285|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
146870089|NCT01383096|529696283|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
146870090|NCT01383096|529696284|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
146870091|NCT01383096|529696285|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
146870092|NCT01383096|529696283|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
146870093|NCT01383096|529696284|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
146870094|NCT01383096|529696285|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
146870095|NCT00616434|529696290|FG000|Overall Study|Adverse Event|5|||
146870096|NCT00616434|529696291|FG001|Overall Study|Adverse Event|2|||
146870097|NCT00616434|529696290|FG000|Overall Study|Physician Decision|0|||
146870098|NCT00616434|529696291|FG001|Overall Study|Physician Decision|4|||
146870099|NCT00616434|529696290|FG000|Overall Study|Withdrawal by Subject|1|||
146870100|NCT00616434|529696291|FG001|Overall Study|Withdrawal by Subject|1|||
146870101|NCT00616434|529696290|FG000|Overall Study|Protocol deviation|0|||
146870102|NCT00616434|529696291|FG001|Overall Study|Protocol deviation|1|||
146870103|NCT01994382|529696295|FG000|Overall Study|Informed consent withdrawn|0|||
146870104|NCT01994382|529696296|FG001|Overall Study|Informed consent withdrawn|0|||
146870105|NCT01994382|529696297|FG002|Overall Study|Informed consent withdrawn|0|||
146870106|NCT01994382|529696298|FG003|Overall Study|Informed consent withdrawn|0|||
146870107|NCT01994382|529696299|FG004|Overall Study|Informed consent withdrawn|0|||
146870108|NCT01994382|529696300|FG005|Overall Study|Informed consent withdrawn|0|||
146870109|NCT01994382|529696301|FG006|Overall Study|Informed consent withdrawn|1|||
146870110|NCT01994382|529696302|FG007|Overall Study|Informed consent withdrawn|0|||
146870111|NCT01994382|529696303|FG008|Overall Study|Informed consent withdrawn|0|||
146870112|NCT01994382|529696304|FG009|Overall Study|Informed consent withdrawn|0|||
146870113|NCT01994382|529696305|FG010|Overall Study|Informed consent withdrawn|0|||
146870114|NCT01994382|529696306|FG011|Overall Study|Informed consent withdrawn|0|||
146870115|NCT01994382|529696307|FG012|Overall Study|Informed consent withdrawn|0|||
146870116|NCT01994382|529696308|FG013|Overall Study|Informed consent withdrawn|0|||
146870117|NCT01994382|529696309|FG014|Overall Study|Informed consent withdrawn|0|||
146870118|NCT01994382|529696310|FG015|Overall Study|Informed consent withdrawn|0|||
146870119|NCT01994382|529696311|FG016|Overall Study|Informed consent withdrawn|0|||
146870120|NCT01994382|529696295|FG000|Overall Study|Progressive disease|3|||
146870121|NCT01994382|529696296|FG001|Overall Study|Progressive disease|4|||
146870122|NCT01994382|529696297|FG002|Overall Study|Progressive disease|4|||
146870123|NCT01994382|529696298|FG003|Overall Study|Progressive disease|3|||
146870124|NCT01994382|529696299|FG004|Overall Study|Progressive disease|2|||
146870125|NCT01994382|529696300|FG005|Overall Study|Progressive disease|3|||
146870126|NCT01994382|529696301|FG006|Overall Study|Progressive disease|3|||
146870127|NCT01994382|529696302|FG007|Overall Study|Progressive disease|6|||
146870128|NCT01994382|529696303|FG008|Overall Study|Progressive disease|2|||
146870129|NCT01994382|529696304|FG009|Overall Study|Progressive disease|2|||
146870130|NCT01994382|529696305|FG010|Overall Study|Progressive disease|13|||
146870131|NCT01994382|529696306|FG011|Overall Study|Progressive disease|8|||
146870132|NCT01994382|529696307|FG012|Overall Study|Progressive disease|7|||
146870133|NCT01994382|529696308|FG013|Overall Study|Progressive disease|3|||
146870134|NCT01994382|529696309|FG014|Overall Study|Progressive disease|6|||
146870135|NCT01994382|529696310|FG015|Overall Study|Progressive disease|44|||
146870136|NCT01994382|529696311|FG016|Overall Study|Progressive disease|28|||
146870137|NCT01994382|529696295|FG000|Overall Study|Physician Decision|0|||
146870138|NCT01994382|529696296|FG001|Overall Study|Physician Decision|1|||
146870139|NCT01994382|529696297|FG002|Overall Study|Physician Decision|0|||
146870140|NCT01994382|529696298|FG003|Overall Study|Physician Decision|0|||
146870141|NCT01994382|529696299|FG004|Overall Study|Physician Decision|0|||
146870142|NCT01994382|529696300|FG005|Overall Study|Physician Decision|0|||
146870143|NCT01994382|529696301|FG006|Overall Study|Physician Decision|0|||
146870144|NCT01994382|529696302|FG007|Overall Study|Physician Decision|0|||
146870145|NCT01994382|529696303|FG008|Overall Study|Physician Decision|0|||
146870146|NCT01994382|529696304|FG009|Overall Study|Physician Decision|0|||
146870147|NCT01994382|529696305|FG010|Overall Study|Physician Decision|3|||
146870148|NCT01994382|529696306|FG011|Overall Study|Physician Decision|1|||
146870149|NCT01994382|529696307|FG012|Overall Study|Physician Decision|1|||
146870150|NCT01994382|529696308|FG013|Overall Study|Physician Decision|0|||
146870151|NCT01994382|529696309|FG014|Overall Study|Physician Decision|1|||
146870152|NCT01994382|529696310|FG015|Overall Study|Physician Decision|4|||
146870153|NCT01994382|529696311|FG016|Overall Study|Physician Decision|2|||
146870154|NCT01994382|529696295|FG000|Overall Study|Death|0|||
146535155|NCT02717195|528468924|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
146535156|NCT02717195|528468925|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
146535157|NCT02717195|528468926|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
146535158|NCT02717195|528468927|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
146535159|NCT02717195|528468923|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
146535160|NCT02717195|528468924|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
146535161|NCT02717195|528468925|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
146535162|NCT02717195|528468926|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
146535163|NCT02717195|528468927|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
146535164|NCT02717195|528468923|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
146535165|NCT02717195|528468924|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
146535166|NCT02717195|528468925|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
146535167|NCT02717195|528468926|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
146535168|NCT02717195|528468927|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
146535169|NCT02717195|528468923|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
146535170|NCT02717195|528468924|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
146535171|NCT02717195|528468925|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
146535172|NCT02717195|528468926|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
146535173|NCT02717195|528468927|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
146535174|NCT02717195|528468923|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
146535175|NCT02717195|528468924|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
146535176|NCT02717195|528468925|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
146535177|NCT02717195|528468926|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
146535178|NCT02717195|528468927|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
146535179|NCT02717195|528468923|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
146535180|NCT02717195|528468924|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
146535181|NCT02717195|528468925|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
146535182|NCT02717195|528468926|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
146535183|NCT02717195|528468927|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
146535184|NCT02717195|528468923|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
146535185|NCT02717195|528468924|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
146535186|NCT02717195|528468925|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
146535187|NCT02717195|528468926|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
146535188|NCT02717195|528468927|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
146535189|NCT02717195|528468923|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
146535190|NCT02717195|528468924|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
146535191|NCT02717195|528468925|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
146535192|NCT02717195|528468926|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
146535193|NCT02717195|528468927|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
146535194|NCT02717195|528468923|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
146535195|NCT02717195|528468924|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
146535196|NCT02717195|528468925|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
146535197|NCT02717195|528468926|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
146535198|NCT02717195|528468927|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
146535199|NCT02717195|528468923|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
146535200|NCT02717195|528468924|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
146535201|NCT02717195|528468925|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
146535202|NCT02717195|528468926|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
146535203|NCT02717195|528468927|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
146535204|NCT02717195|528468923|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
146535205|NCT02717195|528468924|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
146535206|NCT02717195|528468925|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
146535207|NCT02717195|528468926|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
146535208|NCT02717195|528468927|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
146535209|NCT02717195|528468923|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
146535210|NCT02717195|528468924|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
146535211|NCT02717195|528468925|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
146535212|NCT02717195|528468926|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
146535213|NCT02717195|528468927|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
146535214|NCT02717195|528468923|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
146535215|NCT02717195|528468924|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
146535216|NCT02717195|528468925|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
146535217|NCT02717195|528468926|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
146535218|NCT02717195|528468927|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
146535219|NCT02717195|528468923|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
146535220|NCT02717195|528468924|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
146535221|NCT02717195|528468925|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
146535222|NCT02717195|528468926|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
146535223|NCT02717195|528468927|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
146535224|NCT02717195|528468923|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
146535225|NCT02717195|528468924|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
146535226|NCT02717195|528468925|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
146535227|NCT02717195|528468926|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
146535228|NCT02717195|528468927|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
146535229|NCT03882918|528468928|FG000|Overall Study|Study terminated by sponsor|98|||
146870155|NCT01994382|529696296|FG001|Overall Study|Death|0|||
146870156|NCT01994382|529696297|FG002|Overall Study|Death|0|||
146870157|NCT01994382|529696298|FG003|Overall Study|Death|0|||
146870158|NCT01994382|529696299|FG004|Overall Study|Death|1|||
146870159|NCT01994382|529696300|FG005|Overall Study|Death|0|||
146870160|NCT01994382|529696301|FG006|Overall Study|Death|0|||
146870161|NCT01994382|529696302|FG007|Overall Study|Death|0|||
146870162|NCT01994382|529696303|FG008|Overall Study|Death|1|||
146870163|NCT01994382|529696304|FG009|Overall Study|Death|1|||
146870164|NCT01994382|529696305|FG010|Overall Study|Death|0|||
146870165|NCT01994382|529696306|FG011|Overall Study|Death|0|||
146870166|NCT01994382|529696307|FG012|Overall Study|Death|0|||
146870167|NCT01994382|529696308|FG013|Overall Study|Death|0|||
146870168|NCT01994382|529696309|FG014|Overall Study|Death|0|||
146870169|NCT01994382|529696310|FG015|Overall Study|Death|1|||
146870170|NCT01994382|529696311|FG016|Overall Study|Death|0|||
146870171|NCT01994382|529696295|FG000|Overall Study|Adverse Event|0|||
146870172|NCT01994382|529696296|FG001|Overall Study|Adverse Event|1|||
146870173|NCT01994382|529696297|FG002|Overall Study|Adverse Event|2|||
146870174|NCT01994382|529696298|FG003|Overall Study|Adverse Event|0|||
146870175|NCT01994382|529696299|FG004|Overall Study|Adverse Event|0|||
146870176|NCT01994382|529696300|FG005|Overall Study|Adverse Event|0|||
146870177|NCT01994382|529696301|FG006|Overall Study|Adverse Event|0|||
146870178|NCT01994382|529696302|FG007|Overall Study|Adverse Event|0|||
146535230|NCT03882918|528468928|FG000|Overall Study|Protocol Violation|1|||
146535231|NCT03882918|528468928|FG000|Overall Study|Other|9|||
146535232|NCT03882918|528468928|FG000|Overall Study|Lack of Efficacy|14|||
146535233|NCT03882918|528468928|FG000|Overall Study|Adverse Event|13|||
146535234|NCT03882918|528468928|FG000|Overall Study|Withdrawal by Subject|5|||
146535235|NCT04239924|528468931|FG000|Overall Study|Lost to Follow-up|2|||
146535236|NCT00666237|528468932|FG000|Overall Study|Death|5|||
146535237|NCT00666237|528468933|FG001|Overall Study|Death|5|||
146535238|NCT00666237|528468932|FG000|Overall Study|Lost to Follow-up|29|||
146535239|NCT00666237|528468933|FG001|Overall Study|Lost to Follow-up|25|||
146535240|NCT00750269|528470581|FG000|Overall Study|Protocol Violation|0|||
146535241|NCT00750269|528470582|FG001|Overall Study|Protocol Violation|1|||
146535242|NCT00750269|528470583|FG002|Overall Study|Protocol Violation|1|||
146535243|NCT00750269|528470584|FG003|Overall Study|Protocol Violation|2|||
146535244|NCT00750269|528470585|FG004|Overall Study|Protocol Violation|4|||
146535245|NCT00750269|528470581|FG000|Overall Study|Withdrawal by Subject|0|||
146535246|NCT00750269|528470582|FG001|Overall Study|Withdrawal by Subject|0|||
146535247|NCT00750269|528470583|FG002|Overall Study|Withdrawal by Subject|2|||
146535248|NCT00750269|528470584|FG003|Overall Study|Withdrawal by Subject|2|||
146535249|NCT00750269|528470585|FG004|Overall Study|Withdrawal by Subject|2|||
146535250|NCT00750269|528470581|FG000|Overall Study|Physician Decision|0|||
146535251|NCT00750269|528470582|FG001|Overall Study|Physician Decision|0|||
146535252|NCT00750269|528470583|FG002|Overall Study|Physician Decision|0|||
146535253|NCT00750269|528470584|FG003|Overall Study|Physician Decision|0|||
146535254|NCT00750269|528470585|FG004|Overall Study|Physician Decision|2|||
146535255|NCT00750269|528470581|FG000|Overall Study|Patient too large for positioning|0|||
146535256|NCT00750269|528470582|FG001|Overall Study|Patient too large for positioning|0|||
146535257|NCT00750269|528470583|FG002|Overall Study|Patient too large for positioning|1|||
146870179|NCT01994382|529696303|FG008|Overall Study|Adverse Event|0|||
146870180|NCT01994382|529696304|FG009|Overall Study|Adverse Event|0|||
146870181|NCT01994382|529696305|FG010|Overall Study|Adverse Event|15|||
146870182|NCT01994382|529696306|FG011|Overall Study|Adverse Event|2|||
146870183|NCT01994382|529696307|FG012|Overall Study|Adverse Event|7|||
146870184|NCT01994382|529696308|FG013|Overall Study|Adverse Event|3|||
146870185|NCT01994382|529696309|FG014|Overall Study|Adverse Event|17|||
146870186|NCT01994382|529696310|FG015|Overall Study|Adverse Event|6|||
146870187|NCT01994382|529696311|FG016|Overall Study|Adverse Event|3|||
146870188|NCT01994382|529696295|FG000|Overall Study|Other than specified|0|||
146535258|NCT00750269|528470584|FG003|Overall Study|Patient too large for positioning|0|||
146535259|NCT00750269|528470585|FG004|Overall Study|Patient too large for positioning|0|||
146535260|NCT00750269|528470581|FG000|Overall Study|Site error|0|||
146535261|NCT00750269|528470582|FG001|Overall Study|Site error|0|||
146535262|NCT00750269|528470583|FG002|Overall Study|Site error|0|||
146870189|NCT01994382|529696296|FG001|Overall Study|Other than specified|0|||
146870190|NCT01994382|529696297|FG002|Overall Study|Other than specified|0|||
146870191|NCT01994382|529696298|FG003|Overall Study|Other than specified|0|||
146870192|NCT01994382|529696299|FG004|Overall Study|Other than specified|0|||
146870193|NCT01994382|529696300|FG005|Overall Study|Other than specified|0|||
146870194|NCT01994382|529696301|FG006|Overall Study|Other than specified|0|||
146870195|NCT01994382|529696302|FG007|Overall Study|Other than specified|0|||
146870196|NCT01994382|529696303|FG008|Overall Study|Other than specified|0|||
146870197|NCT01994382|529696304|FG009|Overall Study|Other than specified|0|||
146870198|NCT01994382|529696305|FG010|Overall Study|Other than specified|2|||
146870199|NCT01994382|529696306|FG011|Overall Study|Other than specified|0|||
146870200|NCT01994382|529696307|FG012|Overall Study|Other than specified|2|||
146870201|NCT01994382|529696308|FG013|Overall Study|Other than specified|0|||
146870202|NCT01994382|529696309|FG014|Overall Study|Other than specified|0|||
146870203|NCT01994382|529696310|FG015|Overall Study|Other than specified|4|||
146870204|NCT01994382|529696311|FG016|Overall Study|Other than specified|4|||
146870205|NCT01994382|529696295|FG000|Overall Study|Withdrawal by Subject|0|||
146870206|NCT01994382|529696296|FG001|Overall Study|Withdrawal by Subject|0|||
146870207|NCT01994382|529696297|FG002|Overall Study|Withdrawal by Subject|0|||
146870208|NCT01994382|529696298|FG003|Overall Study|Withdrawal by Subject|0|||
146870209|NCT01994382|529696299|FG004|Overall Study|Withdrawal by Subject|0|||
146870210|NCT01994382|529696300|FG005|Overall Study|Withdrawal by Subject|0|||
146870211|NCT01994382|529696301|FG006|Overall Study|Withdrawal by Subject|0|||
146870212|NCT01994382|529696302|FG007|Overall Study|Withdrawal by Subject|0|||
146870213|NCT01994382|529696303|FG008|Overall Study|Withdrawal by Subject|0|||
146870214|NCT01994382|529696304|FG009|Overall Study|Withdrawal by Subject|0|||
146870215|NCT01994382|529696305|FG010|Overall Study|Withdrawal by Subject|6|||
146870216|NCT01994382|529696306|FG011|Overall Study|Withdrawal by Subject|0|||
146870217|NCT01994382|529696307|FG012|Overall Study|Withdrawal by Subject|2|||
146870218|NCT01994382|529696308|FG013|Overall Study|Withdrawal by Subject|0|||
146870219|NCT01994382|529696309|FG014|Overall Study|Withdrawal by Subject|4|||
146870220|NCT01994382|529696310|FG015|Overall Study|Withdrawal by Subject|3|||
146870221|NCT01994382|529696311|FG016|Overall Study|Withdrawal by Subject|0|||
146870222|NCT01994382|529696295|FG000|Overall Study|Lost to Follow-up|0|||
146870223|NCT01994382|529696296|FG001|Overall Study|Lost to Follow-up|0|||
146870224|NCT01994382|529696297|FG002|Overall Study|Lost to Follow-up|0|||
146870225|NCT01994382|529696298|FG003|Overall Study|Lost to Follow-up|0|||
146870226|NCT01994382|529696299|FG004|Overall Study|Lost to Follow-up|0|||
146870227|NCT01994382|529696300|FG005|Overall Study|Lost to Follow-up|0|||
146870228|NCT01994382|529696301|FG006|Overall Study|Lost to Follow-up|0|||
146870229|NCT01994382|529696302|FG007|Overall Study|Lost to Follow-up|0|||
146870230|NCT01994382|529696303|FG008|Overall Study|Lost to Follow-up|0|||
146870231|NCT01994382|529696304|FG009|Overall Study|Lost to Follow-up|0|||
146870232|NCT01994382|529696305|FG010|Overall Study|Lost to Follow-up|1|||
146870233|NCT01994382|529696306|FG011|Overall Study|Lost to Follow-up|0|||
146870234|NCT01994382|529696307|FG012|Overall Study|Lost to Follow-up|0|||
146870235|NCT01994382|529696308|FG013|Overall Study|Lost to Follow-up|0|||
146870236|NCT01994382|529696309|FG014|Overall Study|Lost to Follow-up|0|||
146870237|NCT01994382|529696310|FG015|Overall Study|Lost to Follow-up|0|||
146870238|NCT01994382|529696311|FG016|Overall Study|Lost to Follow-up|0|||
146870239|NCT01994382|529696295|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146870240|NCT01994382|529696296|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146870241|NCT01994382|529696297|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146870242|NCT01994382|529696298|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146870243|NCT01994382|529696299|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146870244|NCT01994382|529696300|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146870245|NCT01994382|529696301|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146870246|NCT01994382|529696302|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146870247|NCT01994382|529696303|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146870248|NCT01994382|529696304|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146870249|NCT01994382|529696305|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
146870250|NCT01994382|529696306|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146870251|NCT01994382|529696307|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
146870252|NCT01994382|529696308|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146870253|NCT01994382|529696309|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146870254|NCT01994382|529696310|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
146870255|NCT01994382|529696311|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
146870256|NCT01994382|529696295|FG000|Overall Study|Protocol violation/noncompliance|0|||
146870257|NCT01994382|529696296|FG001|Overall Study|Protocol violation/noncompliance|0|||
146870258|NCT01994382|529696297|FG002|Overall Study|Protocol violation/noncompliance|0|||
146535263|NCT00750269|528470584|FG003|Overall Study|Site error|1|||
146535264|NCT00750269|528470585|FG004|Overall Study|Site error|0|||
146535265|NCT00750269|528470581|FG000|Overall Study|SBRT plan could not be drawn|0|||
146535266|NCT00750269|528470582|FG001|Overall Study|SBRT plan could not be drawn|0|||
146535267|NCT00750269|528470583|FG002|Overall Study|SBRT plan could not be drawn|0|||
146535268|NCT00750269|528470584|FG003|Overall Study|SBRT plan could not be drawn|0|||
146535269|NCT00750269|528470585|FG004|Overall Study|SBRT plan could not be drawn|1|||
146535270|NCT00750269|528470581|FG000|Overall Study|Fiducials could not be placed|0|||
146535271|NCT00750269|528470582|FG001|Overall Study|Fiducials could not be placed|0|||
146535272|NCT00750269|528470583|FG002|Overall Study|Fiducials could not be placed|0|||
146535273|NCT00750269|528470584|FG003|Overall Study|Fiducials could not be placed|0|||
146535274|NCT00750269|528470585|FG004|Overall Study|Fiducials could not be placed|1|||
146535275|NCT02934178|528470586|FG000|Received Vaccination 2|Death|0|||
146535276|NCT02934178|528470587|FG001|Received Vaccination 2|Death|1|||
146535277|NCT02934178|528470586|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
146535278|NCT02934178|528470587|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
146535279|NCT00296244|528470590|FG000|Overall Study|Underwent retransplant|0|||
146535280|NCT00296244|528470591|FG001|Overall Study|Underwent retransplant|1|||
146535281|NCT01125930|528470592|FG000|Overall Study|Adverse Event|0|||
146535282|NCT01125930|528470593|FG001|Overall Study|Adverse Event|1|||
146535283|NCT01125930|528470592|FG000|Overall Study|Withdrawal by Subject|1|||
146535284|NCT01125930|528470593|FG001|Overall Study|Withdrawal by Subject|6|||
146535285|NCT01125930|528470592|FG000|Overall Study|Protocol Violation|0|||
146535286|NCT01125930|528470593|FG001|Overall Study|Protocol Violation|1|||
146535287|NCT01125930|528470592|FG000|Overall Study|Lost to Follow-up|0|||
146535288|NCT01125930|528470593|FG001|Overall Study|Lost to Follow-up|2|||
146535289|NCT03617588|528470594|FG000|Overall Study|Withdrawal by Subject|1|||
146535290|NCT03617588|528470595|FG001|Overall Study|Withdrawal by Subject|0|||
146535291|NCT03261401|528470596|FG000|Overall Study|Withdrawal by Subject|0|||
146535292|NCT03261401|528470597|FG001|Overall Study|Withdrawal by Subject|0|||
146535293|NCT03261401|528470598|FG002|Overall Study|Withdrawal by Subject|0|||
146535294|NCT03261401|528470599|FG003|Overall Study|Withdrawal by Subject|0|||
146535295|NCT03261401|528470600|FG004|Overall Study|Withdrawal by Subject|0|||
146535296|NCT03261401|528470601|FG005|Overall Study|Withdrawal by Subject|1|||
146535297|NCT03261401|528470602|FG006|Overall Study|Withdrawal by Subject|0|||
146535298|NCT03261401|528470603|FG007|Overall Study|Withdrawal by Subject|0|||
146535299|NCT03261401|528470604|FG008|Overall Study|Withdrawal by Subject|0|||
146535300|NCT03261401|528470605|FG009|Overall Study|Withdrawal by Subject|0|||
146535301|NCT03261401|528470606|FG010|Overall Study|Withdrawal by Subject|0|||
146535302|NCT03261401|528470607|FG011|Overall Study|Withdrawal by Subject|0|||
146535303|NCT03261401|528470608|FG012|Overall Study|Withdrawal by Subject|0|||
146535304|NCT03261401|528470596|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
146535305|NCT03261401|528470597|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
146535306|NCT03261401|528470598|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
146535307|NCT03261401|528470599|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
146535308|NCT03261401|528470600|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
146535309|NCT03261401|528470601|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
146535310|NCT03261401|528470602|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
146535311|NCT03261401|528470603|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
146535312|NCT03261401|528470604|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
146535313|NCT03261401|528470605|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
146535314|NCT03261401|528470606|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
146535315|NCT03261401|528470607|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
146535316|NCT03261401|528470608|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
146535317|NCT00856180|528470609|FG000|Overall Study|Adverse Event|4|||
146535318|NCT00856180|528470609|FG000|Overall Study|Progressive Disease|16|||
146535319|NCT03451071|528470612|FG000|First Vaccine|Withdrawal by Subject|1|||
146535320|NCT03451071|528470612|FG000|Second Vaccine|Lost to Follow-up|19|||
146535321|NCT03451071|528470612|FG000|Third Vaccine|Lost to Follow-up|22|||
146535322|NCT03451071|528470612|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
146535323|NCT02834975|528470613|FG000|Overall Study|Physician Decision|2|||
146870259|NCT01994382|529696298|FG003|Overall Study|Protocol violation/noncompliance|0|||
146870260|NCT01994382|529696299|FG004|Overall Study|Protocol violation/noncompliance|0|||
146870261|NCT01994382|529696300|FG005|Overall Study|Protocol violation/noncompliance|0|||
146870262|NCT01994382|529696301|FG006|Overall Study|Protocol violation/noncompliance|0|||
146870263|NCT01994382|529696302|FG007|Overall Study|Protocol violation/noncompliance|0|||
146870264|NCT01994382|529696303|FG008|Overall Study|Protocol violation/noncompliance|0|||
146535324|NCT02834975|528470613|FG000|Overall Study|Adverse Event|1|||
146535325|NCT02834975|528470613|FG000|Overall Study|Withdrawal by Subject|1|||
146870265|NCT01994382|529696304|FG009|Overall Study|Protocol violation/noncompliance|0|||
146870266|NCT01994382|529696305|FG010|Overall Study|Protocol violation/noncompliance|0|||
146870267|NCT01994382|529696306|FG011|Overall Study|Protocol violation/noncompliance|1|||
146535326|NCT02834975|528470613|FG000|Overall Study|Lack of Efficacy|1|||
146870268|NCT01994382|529696307|FG012|Overall Study|Protocol violation/noncompliance|0|||
146870269|NCT01994382|529696308|FG013|Overall Study|Protocol violation/noncompliance|0|||
146870270|NCT01994382|529696309|FG014|Overall Study|Protocol violation/noncompliance|0|||
146870271|NCT01994382|529696310|FG015|Overall Study|Protocol violation/noncompliance|0|||
146870272|NCT01994382|529696311|FG016|Overall Study|Protocol violation/noncompliance|2|||
146870273|NCT01994382|529696295|FG000|Overall Study|Rolled over to Phase 2a|0|||
146870274|NCT01994382|529696296|FG001|Overall Study|Rolled over to Phase 2a|0|||
146870275|NCT01994382|529696297|FG002|Overall Study|Rolled over to Phase 2a|1|||
146870276|NCT01994382|529696298|FG003|Overall Study|Rolled over to Phase 2a|0|||
146870277|NCT01994382|529696299|FG004|Overall Study|Rolled over to Phase 2a|0|||
146870278|NCT01994382|529696300|FG005|Overall Study|Rolled over to Phase 2a|0|||
146870279|NCT01994382|529696301|FG006|Overall Study|Rolled over to Phase 2a|0|||
146870280|NCT01994382|529696302|FG007|Overall Study|Rolled over to Phase 2a|0|||
146870281|NCT01994382|529696303|FG008|Overall Study|Rolled over to Phase 2a|0|||
146870282|NCT01994382|529696304|FG009|Overall Study|Rolled over to Phase 2a|2|||
146870283|NCT01994382|529696305|FG010|Overall Study|Rolled over to Phase 2a|0|||
146870284|NCT01994382|529696306|FG011|Overall Study|Rolled over to Phase 2a|0|||
146870285|NCT01994382|529696307|FG012|Overall Study|Rolled over to Phase 2a|0|||
146870286|NCT01994382|529696308|FG013|Overall Study|Rolled over to Phase 2a|0|||
146870287|NCT01994382|529696309|FG014|Overall Study|Rolled over to Phase 2a|0|||
146870288|NCT01994382|529696310|FG015|Overall Study|Rolled over to Phase 2a|0|||
146870289|NCT01994382|529696311|FG016|Overall Study|Rolled over to Phase 2a|0|||
146870290|NCT02428855|529696312|FG000|Overall Study|Withdrawal by Subject|2|||
146870291|NCT00359021|529696313|FG000|Overall Study|Adverse Event|26|||
146870292|NCT00359021|529696314|FG001|Overall Study|Adverse Event|8|||
146870293|NCT00359021|529696313|FG000|Overall Study|Subject Non-Compliant|1|||
146870294|NCT00359021|529696314|FG001|Overall Study|Subject Non-Compliant|2|||
146870295|NCT00359021|529696313|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
146870296|NCT00359021|529696314|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
146870297|NCT00359021|529696313|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
146870298|NCT00359021|529696314|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
146870299|NCT00359021|529696313|FG000|Overall Study|Withdrawal by Subject|2|||
146870300|NCT00359021|529696314|FG001|Overall Study|Withdrawal by Subject|9|||
146870301|NCT00359021|529696313|FG000|Overall Study|Lost to Follow-up|1|||
146870302|NCT00359021|529696314|FG001|Overall Study|Lost to Follow-up|0|||
146870303|NCT00359021|529696313|FG000|Overall Study|Other|4|||
146870304|NCT00359021|529696314|FG001|Overall Study|Other|1|||
146535327|NCT03363906|528470619|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
146535328|NCT03363906|528470620|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
146535329|NCT03363906|528470619|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
146870305|NCT00359021|529696313|FG000|Overall Study|Pregnancy|1|||
146870306|NCT00359021|529696314|FG001|Overall Study|Pregnancy|0|||
146870307|NCT02066311|529696315|FG000|Overall Study|Adverse Event|4|||
146870308|NCT02066311|529696315|FG000|Overall Study|Withdrawal by Subject|1|||
146870309|NCT04353596|529696318|FG000|Overall Study|Protocol Violation|4|||
146870310|NCT04353596|529696319|FG001|Overall Study|Protocol Violation|4|||
146870311|NCT04353596|529696318|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
146870312|NCT04353596|529696319|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
146870313|NCT03023059|529696322|FG000|Overall Study|Withdrawal by Subject|5|||
146870314|NCT03781323|529696323|FG000|Overall Study|Withdrawal by Subject|1|||
146870315|NCT01338415|529696324|FG000|Core + Extension|Adverse Event|8|||
146870316|NCT01338415|529696325|FG001|Core + Extension|Adverse Event|6|||
146870317|NCT01338415|529696326|FG002|Core + Extension|Adverse Event|0|||
146870318|NCT01338415|529696324|FG000|Core + Extension|Withdrawal by Subject|1|||
146870319|NCT01338415|529696325|FG001|Core + Extension|Withdrawal by Subject|1|||
146870320|NCT01338415|529696326|FG002|Core + Extension|Withdrawal by Subject|0|||
146870321|NCT01338415|529696324|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
146870322|NCT01338415|529696325|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
146870323|NCT01338415|529696326|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
146870324|NCT01338415|529696324|FG000|Core + Extension|Other (administrative reason)|1|||
146870325|NCT01338415|529696325|FG001|Core + Extension|Other (administrative reason)|0|||
146870326|NCT01338415|529696326|FG002|Core + Extension|Other (administrative reason)|0|||
146870327|NCT01338415|529696324|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
146870328|NCT01338415|529696325|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
146870329|NCT01338415|529696326|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
146870330|NCT01338415|529696324|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
146870331|NCT01338415|529696325|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
146870332|NCT01338415|529696326|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
146870333|NCT01338415|529696324|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
146535330|NCT03363906|528470620|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
146870334|NCT01338415|529696325|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
146870335|NCT01338415|529696326|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
146870336|NCT01338415|529696324|FG000|Exceptional Use Treatment Period|Death|0|||
146870337|NCT01338415|529696325|FG001|Exceptional Use Treatment Period|Death|0|||
146870338|NCT01338415|529696326|FG002|Exceptional Use Treatment Period|Death|1|||
146870339|NCT00233363|529696329|FG000|Overall Study|Adverse Event|1|||
146870340|NCT00233363|529696330|FG001|Overall Study|Adverse Event|2|||
146870341|NCT00233363|529696329|FG000|Overall Study|Lack of Efficacy|0|||
146870342|NCT00233363|529696330|FG001|Overall Study|Lack of Efficacy|2|||
146870343|NCT00233363|529696329|FG000|Overall Study|Withdrawal by Subject|1|||
146870344|NCT00233363|529696330|FG001|Overall Study|Withdrawal by Subject|1|||
146870345|NCT00233363|529696329|FG000|Overall Study|Aggravation of complication|1|||
146870346|NCT00233363|529696330|FG001|Overall Study|Aggravation of complication|0|||
146870347|NCT01526551|529696331|FG000|Overall Study|Lack of returned parental consent form|424|||
146870348|NCT01106027|529696347|FG000|Overall Study|Lost graft early, discontinued|1|||
146870349|NCT02170779|529696348|FG000|Overall Study|Withdrawal by Subject|1|||
146870350|NCT02170779|529696349|FG001|Overall Study|Withdrawal by Subject|0|||
146870351|NCT02170779|529696348|FG000|Overall Study|Lost to Follow-up|0|||
146870352|NCT02170779|529696349|FG001|Overall Study|Lost to Follow-up|1|||
146870353|NCT00369785|529696350|FG000|Overall Study|Physician Decision|3|||
146870354|NCT00369785|529696351|FG001|Overall Study|Physician Decision|2|||
146870355|NCT00369785|529696350|FG000|Overall Study|Death|1|||
146870356|NCT00369785|529696351|FG001|Overall Study|Death|2|||
146870357|NCT00369785|529696350|FG000|Overall Study|Withdrawal by Subject|7|||
146870358|NCT00369785|529696351|FG001|Overall Study|Withdrawal by Subject|6|||
146870359|NCT00369785|529696350|FG000|Overall Study|Toxicity|6|||
146870360|NCT00369785|529696351|FG001|Overall Study|Toxicity|4|||
146870361|NCT00369785|529696350|FG000|Overall Study|Never started|0|||
146870362|NCT00369785|529696351|FG001|Overall Study|Never started|2|||
146870363|NCT00369785|529696350|FG000|Overall Study|Progression|4|||
146870364|NCT00369785|529696351|FG001|Overall Study|Progression|4|||
146870365|NCT00369785|529696350|FG000|Overall Study|Multiple reasons|6|||
146870366|NCT00369785|529696351|FG001|Overall Study|Multiple reasons|5|||
146870367|NCT00800683|529696352|FG000|Overall Study|Adverse Event|11|||
146870368|NCT00800683|529696353|FG001|Overall Study|Adverse Event|8|||
146870369|NCT00800683|529696352|FG000|Overall Study|Lost to Follow-up|3|||
146535331|NCT03363906|528470619|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
146535332|NCT03363906|528470620|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
146535333|NCT03363906|528470619|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
146535334|NCT03363906|528470620|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
146535335|NCT00250588|528470623|FG000|Overall Study|Withdrawal by Subject|3|||
146535336|NCT00250588|528470624|FG001|Overall Study|Withdrawal by Subject|6|||
146535337|NCT00250588|528470625|FG002|Overall Study|Withdrawal by Subject|0|||
146535338|NCT00250588|528470623|FG000|Overall Study|Lost to Follow-up|6|||
146535339|NCT00250588|528470624|FG001|Overall Study|Lost to Follow-up|13|||
146535340|NCT00250588|528470625|FG002|Overall Study|Lost to Follow-up|13|||
146535341|NCT00485303|528470628|FG000|Overall Study|Adverse Event|5|||
146535342|NCT00485303|528470628|FG000|Overall Study|Progressive Disease|44|||
146535343|NCT00485303|528470628|FG000|Overall Study|Other|3|||
146535344|NCT00485303|528470628|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
146535345|NCT00485303|528470628|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
146535346|NCT00087178|528470634|FG000|Overall Study|No follow up data|5|||
146535347|NCT00087178|528470635|FG001|Overall Study|No follow up data|15|||
146535348|NCT00087178|528470634|FG000|Overall Study|No clinical assessment|1|||
146535349|NCT00087178|528470635|FG001|Overall Study|No clinical assessment|2|||
146535350|NCT00087178|528470634|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
146535351|NCT00087178|528470635|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
146535352|NCT03704064|528470641|FG000|Overall Study|Lost to Follow-up|8|||
146535353|NCT03704064|528470642|FG001|Overall Study|Lost to Follow-up|4|||
146535354|NCT03704064|528470641|FG000|Overall Study|Withdrawal by Subject|1|||
146535355|NCT03704064|528470642|FG001|Overall Study|Withdrawal by Subject|1|||
146535356|NCT03704064|528470641|FG000|Overall Study|No longer available for study visits|0|||
146535357|NCT03704064|528470642|FG001|Overall Study|No longer available for study visits|1|||
146535358|NCT03704064|528470641|FG000|Overall Study|Censoring event|1|||
146535359|NCT03704064|528470642|FG001|Overall Study|Censoring event|0|||
146535360|NCT01604785|528470643|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
146535361|NCT01604785|528470644|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
146535362|NCT02908347|528470646|FG000|Overall Study|Adverse Event|0|||
146870370|NCT00800683|529696353|FG001|Overall Study|Lost to Follow-up|1|||
146870371|NCT00800683|529696352|FG000|Overall Study|Withdrawal by Subject|1|||
146870372|NCT00800683|529696353|FG001|Overall Study|Withdrawal by Subject|7|||
146870373|NCT00800683|529696352|FG000|Overall Study|Lack of Efficacy|1|||
146870374|NCT00800683|529696353|FG001|Overall Study|Lack of Efficacy|1|||
146535363|NCT02908347|528470647|FG001|Overall Study|Adverse Event|1|||
146535364|NCT02908347|528470646|FG000|Overall Study|Lost to Follow-up|1|||
146535365|NCT02908347|528470647|FG001|Overall Study|Lost to Follow-up|0|||
146535366|NCT03104374|528470648|FG000|Period 1|Adverse Event|7|||
146535367|NCT03104374|528470649|FG001|Period 1|Adverse Event|7|||
146535368|NCT03104374|528470650|FG002|Period 1|Adverse Event|12|||
146870375|NCT00800683|529696352|FG000|Overall Study|Other|1|||
146870376|NCT00800683|529696353|FG001|Overall Study|Other|2|||
146870377|NCT00356889|529696354|FG000|Overall Study|Protocol Violation|2|||
146870378|NCT00356889|529696354|FG000|Overall Study|Adverse Event|1|||
146870379|NCT02678416|529696355|FG000|Part 1|Withdrawal by Subject|1|||
146870380|NCT02678416|529696355|FG000|Part 2|Adverse Event|2|||
146870381|NCT02678416|529696355|FG000|Part 2|Withdrawal by Subject|1|||
146870382|NCT01848353|529696356|FG000|Phase 1|Withdrawal by Subject|3|||
146870383|NCT01848353|529696357|FG001|Phase 1|Withdrawal by Subject|1|||
146870384|NCT01848353|529696358|FG002|Phase 1|Withdrawal by Subject|0|||
146870385|NCT01848353|529696359|FG003|Phase 1|Withdrawal by Subject|0|||
146870386|NCT01848353|529696356|FG000|Phase 2|Withdrawal by Subject|3|||
146870387|NCT01848353|529696357|FG001|Phase 2|Withdrawal by Subject|2|||
146870388|NCT01848353|529696358|FG002|Phase 2|Withdrawal by Subject|0|||
146870389|NCT01848353|529696359|FG003|Phase 2|Withdrawal by Subject|0|||
146870390|NCT01848353|529696356|FG000|Phase 3|Withdrawal by Subject|1|||
146870391|NCT01848353|529696357|FG001|Phase 3|Withdrawal by Subject|1|||
146870392|NCT01848353|529696358|FG002|Phase 3|Withdrawal by Subject|0|||
146870393|NCT01848353|529696359|FG003|Phase 3|Withdrawal by Subject|0|||
146870394|NCT00935272|529696362|FG000|Overall Study|Lost to Follow-up|10|||
146870395|NCT00935272|529696363|FG001|Overall Study|Lost to Follow-up|3|||
146870396|NCT00935272|529696362|FG000|Overall Study|Withdrawal by Subject|8|||
146870397|NCT00935272|529696363|FG001|Overall Study|Withdrawal by Subject|2|||
146870398|NCT00935272|529696362|FG000|Overall Study|Physician Decision|1|||
146870399|NCT00935272|529696363|FG001|Overall Study|Physician Decision|0|||
146870400|NCT00935272|529696362|FG000|Overall Study|Protocol Violation|0|||
146870401|NCT00935272|529696363|FG001|Overall Study|Protocol Violation|1|||
146870402|NCT03492554|529696371|FG000|Overall Study|Protocol Violation|0|||
146870403|NCT03492554|529696372|FG001|Overall Study|Protocol Violation|14|||
146870404|NCT00736034|529696375|FG000|Overall Study|Adverse Event|2|||
146870405|NCT01478360|529696376|FG000|Overall Study|Lost to Follow-up|1|||
146870406|NCT01478360|529696377|FG001|Overall Study|Lost to Follow-up|0|||
146870407|NCT01478360|529696376|FG000|Overall Study|Adverse Event|0|||
146870408|NCT01478360|529696377|FG001|Overall Study|Adverse Event|1|||
146870409|NCT01478360|529696376|FG000|Overall Study|Administrative problems|1|||
146870410|NCT01478360|529696377|FG001|Overall Study|Administrative problems|2|||
146870411|NCT01514136|529696382|FG000|Test Period 1; Test A|Protocol Violation|1|||
146870412|NCT01514136|529696383|FG001|Test Period 1; Test A|Protocol Violation|0|||
146870413|NCT01514136|529696384|FG002|Test Period 1; Test A|Protocol Violation|0|||
146870414|NCT01514136|529696385|FG003|Test Period 1; Test A|Protocol Violation|0|||
146870415|NCT01514136|529696386|FG004|Test Period 1; Test A|Protocol Violation|0|||
146870416|NCT01514136|529696387|FG005|Test Period 1; Test A|Protocol Violation|0|||
146870417|NCT01514136|529696388|FG006|Test Period 1; Test A|Protocol Violation|0|||
146870418|NCT01514136|529696389|FG007|Test Period 1; Test A|Protocol Violation|0|||
146870419|NCT01514136|529696382|FG000|Test Period 1; Test A|Break from study holiday|2|||
146870420|NCT01514136|529696383|FG001|Test Period 1; Test A|Break from study holiday|0|||
146870421|NCT01514136|529696384|FG002|Test Period 1; Test A|Break from study holiday|0|||
146870422|NCT01514136|529696385|FG003|Test Period 1; Test A|Break from study holiday|0|||
146870423|NCT01514136|529696386|FG004|Test Period 1; Test A|Break from study holiday|0|||
146870424|NCT01514136|529696387|FG005|Test Period 1; Test A|Break from study holiday|0|||
146870425|NCT01514136|529696388|FG006|Test Period 1; Test A|Break from study holiday|0|||
146870426|NCT01514136|529696389|FG007|Test Period 1; Test A|Break from study holiday|0|||
146870427|NCT01514136|529696382|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
146870428|NCT01514136|529696383|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
146870429|NCT01514136|529696384|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
146870430|NCT01514136|529696385|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
146870431|NCT01514136|529696386|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
146870432|NCT01514136|529696387|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
146870433|NCT01514136|529696388|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
146870434|NCT01514136|529696389|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
146870435|NCT01514136|529696382|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
146535369|NCT03104374|528470651|FG003|Period 1|Adverse Event|14|||
146870436|NCT01514136|529696383|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
146870437|NCT01514136|529696384|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
146870438|NCT01514136|529696385|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
146870439|NCT01514136|529696386|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
146870440|NCT01514136|529696387|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
146535370|NCT03104374|528470648|FG000|Period 1|Withdrawal by Subject|18|||
146535371|NCT03104374|528470649|FG001|Period 1|Withdrawal by Subject|9|||
146535372|NCT03104374|528470650|FG002|Period 1|Withdrawal by Subject|10|||
146535373|NCT03104374|528470651|FG003|Period 1|Withdrawal by Subject|17|||
146870441|NCT01514136|529696388|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
146870442|NCT01514136|529696389|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
146870443|NCT01514136|529696382|FG000|Test Period 2; Test A*|Adverse Event|0|||
146870444|NCT01514136|529696383|FG001|Test Period 2; Test A*|Adverse Event|0|||
146535374|NCT03104374|528470648|FG000|Period 1|Lost to Follow-up|4|||
146535375|NCT03104374|528470649|FG001|Period 1|Lost to Follow-up|4|||
146535376|NCT03104374|528470650|FG002|Period 1|Lost to Follow-up|6|||
146535377|NCT03104374|528470651|FG003|Period 1|Lost to Follow-up|8|||
146535378|NCT03104374|528470648|FG000|Period 1|Lack of Efficacy|6|||
146535379|NCT03104374|528470649|FG001|Period 1|Lack of Efficacy|7|||
146535380|NCT03104374|528470650|FG002|Period 1|Lack of Efficacy|12|||
146535381|NCT03104374|528470651|FG003|Period 1|Lack of Efficacy|6|||
146535382|NCT03104374|528470648|FG000|Period 1|Other|2|||
146535383|NCT03104374|528470649|FG001|Period 1|Other|2|||
146535384|NCT03104374|528470650|FG002|Period 1|Other|4|||
146535385|NCT03104374|528470651|FG003|Period 1|Other|7|||
146535386|NCT03104374|528470648|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
146535387|NCT03104374|528470649|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
146535388|NCT03104374|528470650|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
146535389|NCT03104374|528470651|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
146535390|NCT03104374|528470648|FG000|Period 2|Adverse Event|4|||
146535391|NCT03104374|528470649|FG001|Period 2|Adverse Event|7|||
146535392|NCT03104374|528470650|FG002|Period 2|Adverse Event|10|||
146535393|NCT03104374|528470651|FG003|Period 2|Adverse Event|10|||
146535394|NCT03104374|528470648|FG000|Period 2|Withdrawal by Subject|3|||
146535395|NCT03104374|528470649|FG001|Period 2|Withdrawal by Subject|7|||
146535396|NCT03104374|528470650|FG002|Period 2|Withdrawal by Subject|13|||
146535397|NCT03104374|528470651|FG003|Period 2|Withdrawal by Subject|16|||
146535398|NCT03104374|528470648|FG000|Period 2|Lost to Follow-up|2|||
146535399|NCT03104374|528470649|FG001|Period 2|Lost to Follow-up|2|||
146535400|NCT03104374|528470650|FG002|Period 2|Lost to Follow-up|3|||
146535401|NCT03104374|528470651|FG003|Period 2|Lost to Follow-up|5|||
146535402|NCT03104374|528470648|FG000|Period 2|Lack of Efficacy|2|||
146535403|NCT03104374|528470649|FG001|Period 2|Lack of Efficacy|4|||
146535404|NCT03104374|528470650|FG002|Period 2|Lack of Efficacy|7|||
146535405|NCT03104374|528470651|FG003|Period 2|Lack of Efficacy|4|||
146535406|NCT03104374|528470648|FG000|Period 2|COVID-19 Infection|0|||
146535407|NCT03104374|528470649|FG001|Period 2|COVID-19 Infection|0|||
146535408|NCT03104374|528470650|FG002|Period 2|COVID-19 Infection|1|||
146535409|NCT03104374|528470651|FG003|Period 2|COVID-19 Infection|0|||
146535410|NCT03104374|528470648|FG000|Period 2|Other|3|||
146535411|NCT03104374|528470649|FG001|Period 2|Other|2|||
146535412|NCT03104374|528470650|FG002|Period 2|Other|2|||
146535413|NCT03104374|528470651|FG003|Period 2|Other|4|||
146535414|NCT02121210|528470652|FG000|Overall Study|Adverse Event|5|||
146535415|NCT02121210|528470653|FG001|Overall Study|Adverse Event|7|||
146535416|NCT02121210|528470652|FG000|Overall Study|Lack of Efficacy|2|||
146535417|NCT02121210|528470653|FG001|Overall Study|Lack of Efficacy|0|||
146535418|NCT02121210|528470652|FG000|Overall Study|Other than specified above|0|||
146535419|NCT02121210|528470653|FG001|Overall Study|Other than specified above|2|||
146535420|NCT04609514|528470654|FG000|Overall Study|Lost to Follow-up|5|||
146870445|NCT01514136|529696384|FG002|Test Period 2; Test A*|Adverse Event|0|||
146870446|NCT01514136|529696385|FG003|Test Period 2; Test A*|Adverse Event|0|||
146870447|NCT01514136|529696386|FG004|Test Period 2; Test A*|Adverse Event|1|||
146870448|NCT01514136|529696387|FG005|Test Period 2; Test A*|Adverse Event|0|||
146870449|NCT01514136|529696388|FG006|Test Period 2; Test A*|Adverse Event|0|||
146870450|NCT01514136|529696389|FG007|Test Period 2; Test A*|Adverse Event|0|||
146870451|NCT01514136|529696382|FG000|Test Period 2; Test A*|Holiday|0|||
146870452|NCT01514136|529696383|FG001|Test Period 2; Test A*|Holiday|0|||
146870453|NCT01514136|529696384|FG002|Test Period 2; Test A*|Holiday|0|||
146535421|NCT04609514|528470655|FG001|Overall Study|Lost to Follow-up|4|||
146535422|NCT04609514|528470654|FG000|Overall Study|Withdrawal by PI|0|||
146535423|NCT04609514|528470655|FG001|Overall Study|Withdrawal by PI|2|||
146535424|NCT00909870|528470656|FG000|Overall Study|Adverse Event|13|||
146535425|NCT00909870|528470657|FG001|Overall Study|Adverse Event|7|||
146535426|NCT00909870|528470656|FG000|Overall Study|Protocol Violation|1|||
146535427|NCT00909870|528470657|FG001|Overall Study|Protocol Violation|2|||
146535428|NCT00909870|528470656|FG000|Overall Study|Withdrawal by Subject|5|||
146535429|NCT00909870|528470657|FG001|Overall Study|Withdrawal by Subject|8|||
146763721|NCT01090024|529302897|FG009|Period 1|Met exclusion criteria|0|||
146763722|NCT01090024|529302898|FG010|Period 1|Met exclusion criteria|0|||
146763723|NCT01090024|529302899|FG011|Period 1|Met exclusion criteria|0|||
146763724|NCT01090024|529302900|FG012|Period 1|Met exclusion criteria|0|||
146763725|NCT01090024|529302901|FG013|Period 1|Met exclusion criteria|0|||
146763726|NCT01090024|529302902|FG014|Period 1|Met exclusion criteria|1|||
146763727|NCT01090024|529302903|FG015|Period 1|Met exclusion criteria|0|||
146763728|NCT01090024|529302904|FG016|Period 1|Met exclusion criteria|0|||
146763729|NCT01090024|529302905|FG017|Period 1|Met exclusion criteria|0|||
146763730|NCT01090024|529302888|FG000|Period 1|Adverse Event|0|||
146763731|NCT01090024|529302889|FG001|Period 1|Adverse Event|0|||
146763732|NCT01090024|529302890|FG002|Period 1|Adverse Event|0|||
146763733|NCT01090024|529302891|FG003|Period 1|Adverse Event|0|||
146763734|NCT01090024|529302892|FG004|Period 1|Adverse Event|0|||
146763735|NCT01090024|529302893|FG005|Period 1|Adverse Event|0|||
146763736|NCT01090024|529302894|FG006|Period 1|Adverse Event|0|||
146870454|NCT01514136|529696385|FG003|Test Period 2; Test A*|Holiday|0|||
146870455|NCT01514136|529696386|FG004|Test Period 2; Test A*|Holiday|1|||
146870456|NCT01514136|529696387|FG005|Test Period 2; Test A*|Holiday|0|||
146870457|NCT01514136|529696388|FG006|Test Period 2; Test A*|Holiday|0|||
146870458|NCT01514136|529696389|FG007|Test Period 2; Test A*|Holiday|0|||
146870459|NCT01514136|529696382|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
146870460|NCT01514136|529696383|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
146870461|NCT01514136|529696384|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
146870462|NCT01514136|529696385|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
146870463|NCT01514136|529696386|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
146870464|NCT01514136|529696387|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
146870465|NCT01514136|529696388|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
146870466|NCT01514136|529696389|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
146870467|NCT01514136|529696382|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
146535430|NCT00909870|528470656|FG000|Overall Study|Lost to Follow-up|3|||
146535431|NCT00909870|528470657|FG001|Overall Study|Lost to Follow-up|3|||
146535432|NCT00909870|528470656|FG000|Overall Study|Physician Decision|0|||
146870468|NCT01514136|529696383|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
146535433|NCT00909870|528470657|FG001|Overall Study|Physician Decision|2|||
146535434|NCT00909870|528470656|FG000|Overall Study|Other|1|||
146535435|NCT00909870|528470657|FG001|Overall Study|Other|5|||
146535436|NCT03054428|528470663|FG000|Overall Study|Physician Decision|0|||
146535437|NCT03054428|528470664|FG001|Overall Study|Physician Decision|1|||
146535438|NCT03054428|528470665|FG002|Overall Study|Physician Decision|1|||
146535439|NCT03054428|528470663|FG000|Overall Study|Lack of Efficacy|3|||
146535440|NCT03054428|528470664|FG001|Overall Study|Lack of Efficacy|1|||
146535441|NCT03054428|528470665|FG002|Overall Study|Lack of Efficacy|0|||
146535442|NCT03054428|528470663|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
146535443|NCT03054428|528470664|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
146535444|NCT03054428|528470665|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
146870469|NCT01514136|529696384|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
146870470|NCT01514136|529696385|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
146870471|NCT01514136|529696386|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
146870472|NCT01514136|529696387|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
146870473|NCT01514136|529696388|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
146870474|NCT01514136|529696389|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
146870475|NCT01514136|529696382|FG000|Test Period 2; Test C*|holiday|0|||
146870476|NCT01514136|529696383|FG001|Test Period 2; Test C*|holiday|0|||
146870477|NCT01514136|529696384|FG002|Test Period 2; Test C*|holiday|0|||
146870478|NCT01514136|529696385|FG003|Test Period 2; Test C*|holiday|0|||
146870479|NCT01514136|529696386|FG004|Test Period 2; Test C*|holiday|0|||
146870480|NCT01514136|529696387|FG005|Test Period 2; Test C*|holiday|0|||
146870481|NCT01514136|529696388|FG006|Test Period 2; Test C*|holiday|1|||
146870482|NCT01514136|529696389|FG007|Test Period 2; Test C*|holiday|0|||
146870483|NCT01514136|529696382|FG000|Test Period 2; Test C*|Protocol Violation|0|||
146870484|NCT01514136|529696383|FG001|Test Period 2; Test C*|Protocol Violation|0|||
146870485|NCT01514136|529696384|FG002|Test Period 2; Test C*|Protocol Violation|0|||
146870486|NCT01514136|529696385|FG003|Test Period 2; Test C*|Protocol Violation|0|||
146870487|NCT01514136|529696386|FG004|Test Period 2; Test C*|Protocol Violation|0|||
146870488|NCT01514136|529696387|FG005|Test Period 2; Test C*|Protocol Violation|0|||
146870489|NCT01514136|529696388|FG006|Test Period 2; Test C*|Protocol Violation|1|||
146870490|NCT01514136|529696389|FG007|Test Period 2; Test C*|Protocol Violation|0|||
146870491|NCT01010633|529696390|FG000|Overall Study|Adverse Event|1|||
146870492|NCT01010633|529696391|FG001|Overall Study|Adverse Event|1|||
146870493|NCT01010633|529696390|FG000|Overall Study|Protocol Violation|1|||
146870494|NCT01010633|529696391|FG001|Overall Study|Protocol Violation|2|||
146870495|NCT01010633|529696390|FG000|Overall Study|Withdrawal by Subject|2|||
146870496|NCT01010633|529696391|FG001|Overall Study|Withdrawal by Subject|1|||
146870497|NCT01010633|529696390|FG000|Overall Study|Investigator decision|0|||
146870498|NCT01010633|529696391|FG001|Overall Study|Investigator decision|1|||
146870499|NCT00888381|529696393|FG000|Overall Study|Lost to Follow-up|0|||
146870500|NCT00888381|529696394|FG001|Overall Study|Lost to Follow-up|1|||
146535445|NCT03054428|528470663|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
146535446|NCT03054428|528470664|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
146535447|NCT03054428|528470665|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
146535448|NCT03054428|528470663|FG000|Overall Study|Transitioned to OLE study|76|||
146535449|NCT03054428|528470664|FG001|Overall Study|Transitioned to OLE study|76|||
146535450|NCT03054428|528470665|FG002|Overall Study|Transitioned to OLE study|73|||
146535451|NCT03054428|528470663|FG000|Overall Study|Withdrawal by Subject|3|||
146535452|NCT03054428|528470664|FG001|Overall Study|Withdrawal by Subject|2|||
146870501|NCT00257166|529698088|FG000|Overall Study|Adverse Event|18|||
146870502|NCT00257166|529698089|FG001|Overall Study|Adverse Event|13|||
146870503|NCT00257166|529698088|FG000|Overall Study|Laboratory abnormality|1|||
146870504|NCT00257166|529698089|FG001|Overall Study|Laboratory abnormality|0|||
146870505|NCT00257166|529698088|FG000|Overall Study|Lost to Follow-up|8|||
146870506|NCT00257166|529698089|FG001|Overall Study|Lost to Follow-up|1|||
146870507|NCT00257166|529698088|FG000|Overall Study|Withdrawal by Subject|9|||
146870508|NCT00257166|529698089|FG001|Overall Study|Withdrawal by Subject|2|||
146870509|NCT00257166|529698088|FG000|Overall Study|Other|16|||
146870510|NCT00257166|529698089|FG001|Overall Study|Other|21|||
146870511|NCT00257166|529698088|FG000|Overall Study|Randomized, but not treated|1|||
146870512|NCT00257166|529698089|FG001|Overall Study|Randomized, but not treated|0|||
146870513|NCT02163187|529698092|FG000|Overall Study|Device removed|1|||
146870514|NCT02163187|529698093|FG001|Overall Study|Device removed|0|||
146870515|NCT02163187|529698092|FG000|Overall Study|Progressive disease|1|||
146870516|NCT02163187|529698093|FG001|Overall Study|Progressive disease|0|||
146870517|NCT03281668|529698094|FG000|Overall Study|Physician Decision|1|||
146870518|NCT03281668|529698094|FG000|Overall Study|scheduling conflict, family circumstance|2|||
146870519|NCT03281668|529698094|FG000|Overall Study|Withdrawal by Subject|4|||
146870520|NCT03281668|529698094|FG000|Overall Study|Lost to Follow-up|1|||
146870521|NCT00762892|529698098|FG000|Overall Study|Lost to Follow-up|2|||
146870522|NCT00762892|529698099|FG001|Overall Study|Lost to Follow-up|5|||
146870523|NCT00762892|529698098|FG000|Overall Study|Withdrawal by Subject|0|||
146870524|NCT00762892|529698099|FG001|Overall Study|Withdrawal by Subject|1|||
146870525|NCT00762892|529698098|FG000|Overall Study|Death|1|||
146870526|NCT00762892|529698099|FG001|Overall Study|Death|0|||
146870527|NCT00762892|529698098|FG000|Overall Study|Pregnancy|1|||
146870528|NCT00762892|529698099|FG001|Overall Study|Pregnancy|0|||
146870529|NCT00762892|529698098|FG000|Overall Study|Incarceration|1|||
146870530|NCT00762892|529698099|FG001|Overall Study|Incarceration|0|||
146870531|NCT01641237|529698109|FG000|Period II|Withdrawal by Subject|1|||
146870532|NCT01641237|529698110|FG001|Period II|Withdrawal by Subject|0|||
146870533|NCT01641237|529698111|FG002|Period II|Withdrawal by Subject|0|||
146870534|NCT01641237|529698112|FG003|Period II|Withdrawal by Subject|0|||
146870535|NCT01641237|529698109|FG000|Period III|Lost to Follow-up|1|||
146870536|NCT01641237|529698110|FG001|Period III|Lost to Follow-up|0|||
146870537|NCT01641237|529698111|FG002|Period III|Lost to Follow-up|0|||
146870538|NCT01641237|529698112|FG003|Period III|Lost to Follow-up|0|||
146870539|NCT02716675|529698113|FG000|Overall Study|Death|2|||
146870540|NCT02716675|529698114|FG001|Overall Study|Death|3|||
146870541|NCT02716675|529698115|FG002|Overall Study|Death|0|||
146870542|NCT02716675|529698113|FG000|Overall Study|Physician Decision|2|||
146870543|NCT02716675|529698114|FG001|Overall Study|Physician Decision|1|||
146870544|NCT02716675|529698115|FG002|Overall Study|Physician Decision|1|||
146870545|NCT02716675|529698113|FG000|Overall Study|Lost to Follow-up|100|||
146535453|NCT03054428|528470665|FG002|Overall Study|Withdrawal by Subject|3|||
146535454|NCT03054428|528470663|FG000|Overall Study|Lost to Follow-up|0|||
146535455|NCT03054428|528470664|FG001|Overall Study|Lost to Follow-up|0|||
146535456|NCT03054428|528470665|FG002|Overall Study|Lost to Follow-up|1|||
146535457|NCT01652690|528470666|FG000|Overall Study|Withdrawal by Subject|16|||
146535458|NCT01652690|528470667|FG001|Overall Study|Withdrawal by Subject|4|||
146535459|NCT01652690|528470666|FG000|Overall Study|Other|8|||
146535460|NCT01652690|528470667|FG001|Overall Study|Other|9|||
146535461|NCT01652690|528470666|FG000|Overall Study|Lost to Follow-up|6|||
146535462|NCT01652690|528470667|FG001|Overall Study|Lost to Follow-up|6|||
146535463|NCT01652690|528470666|FG000|Overall Study|Death|5|||
146535464|NCT01652690|528470667|FG001|Overall Study|Death|2|||
146535465|NCT03225287|528470668|FG000|Overall Study|Adverse Event|0|||
146535466|NCT03225287|528470669|FG001|Overall Study|Adverse Event|0|||
146535467|NCT03225287|528470670|FG002|Overall Study|Adverse Event|1|||
146535468|NCT03225287|528470668|FG000|Overall Study|Protocol non-compliance|0|||
146535469|NCT03225287|528470669|FG001|Overall Study|Protocol non-compliance|0|||
146535470|NCT03225287|528470670|FG002|Overall Study|Protocol non-compliance|1|||
146535471|NCT03225287|528470668|FG000|Overall Study|Subject withdraws consent|3|||
146535472|NCT03225287|528470669|FG001|Overall Study|Subject withdraws consent|0|||
146535473|NCT03225287|528470670|FG002|Overall Study|Subject withdraws consent|0|||
146535474|NCT03225287|528470668|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
146535475|NCT03225287|528470669|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
146535476|NCT03225287|528470670|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
146535477|NCT03225287|528470668|FG000|Overall Study|Trial drug not effective|0|||
146535478|NCT03225287|528470669|FG001|Overall Study|Trial drug not effective|1|||
146535479|NCT03225287|528470670|FG002|Overall Study|Trial drug not effective|0|||
146535480|NCT03225287|528470668|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
146535481|NCT03225287|528470669|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
146535482|NCT03225287|528470670|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
146535483|NCT03225287|528470668|FG000|Overall Study|Stem cell transplantation|0|||
146870546|NCT02716675|529698114|FG001|Overall Study|Lost to Follow-up|87|||
146870547|NCT02716675|529698115|FG002|Overall Study|Lost to Follow-up|99|||
146870548|NCT02716675|529698113|FG000|Overall Study|Withdrawal by Subject|22|||
146870549|NCT02716675|529698114|FG001|Overall Study|Withdrawal by Subject|25|||
146870550|NCT02716675|529698115|FG002|Overall Study|Withdrawal by Subject|20|||
146870551|NCT02716675|529698113|FG000|Overall Study|Protocol Violation|0|||
146870552|NCT02716675|529698114|FG001|Overall Study|Protocol Violation|3|||
146870553|NCT02716675|529698115|FG002|Overall Study|Protocol Violation|1|||
146870554|NCT02716675|529698113|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
146870555|NCT02716675|529698114|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
146870556|NCT02716675|529698115|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
146870557|NCT02716675|529698113|FG000|Overall Study|Other|38|||
146870558|NCT02716675|529698114|FG001|Overall Study|Other|47|||
146870559|NCT02716675|529698115|FG002|Overall Study|Other|48|||
146870560|NCT00290290|529698118|FG000|Overall Study|Death|3|||
146870561|NCT00290290|529698119|FG001|Overall Study|Death|4|||
146870562|NCT00290290|529698118|FG000|Overall Study|Withdrawal by Subject|2|||
146870563|NCT00290290|529698119|FG001|Overall Study|Withdrawal by Subject|2|||
146870564|NCT00290290|529698118|FG000|Overall Study|Underwent clean surgical procedure|13|||
146870565|NCT00290290|529698119|FG001|Overall Study|Underwent clean surgical procedure|12|||
146870566|NCT00915772|529698120|FG000|Overall Study|Adverse Event|12|||
146870567|NCT00915772|529698121|FG001|Overall Study|Adverse Event|13|||
146870568|NCT00915772|529698122|FG002|Overall Study|Adverse Event|11|||
146870569|NCT00915772|529698120|FG000|Overall Study|Protocol Violation|4|||
146535484|NCT03225287|528470669|FG001|Overall Study|Stem cell transplantation|1|||
146535485|NCT03225287|528470670|FG002|Overall Study|Stem cell transplantation|0|||
146535486|NCT01499810|528470672|FG000|Overall Study|Lost to Follow-up|10|||
146535487|NCT01499810|528470672|FG000|Overall Study|Protocol Violation|1|||
146535488|NCT01499810|528470672|FG000|Overall Study|Withdrawal by Subject|1|||
146535489|NCT05117060|528470675|FG000|Overall Study|Adverse Event|3|||
146535490|NCT05117060|528470676|FG001|Overall Study|Adverse Event|5|||
146535491|NCT05117060|528470677|FG002|Overall Study|Adverse Event|6|||
146535492|NCT05117060|528470678|FG003|Overall Study|Adverse Event|1|||
146535493|NCT05117060|528470675|FG000|Overall Study|Lost to Follow-up|0|||
146535494|NCT05117060|528470676|FG001|Overall Study|Lost to Follow-up|0|||
146535495|NCT05117060|528470677|FG002|Overall Study|Lost to Follow-up|0|||
146535496|NCT05117060|528470678|FG003|Overall Study|Lost to Follow-up|1|||
146870570|NCT00915772|529698121|FG001|Overall Study|Protocol Violation|1|||
146870571|NCT00915772|529698122|FG002|Overall Study|Protocol Violation|2|||
146870572|NCT00915772|529698120|FG000|Overall Study|Lost to Follow-up|1|||
146870573|NCT00915772|529698121|FG001|Overall Study|Lost to Follow-up|2|||
146870574|NCT00915772|529698122|FG002|Overall Study|Lost to Follow-up|2|||
146870575|NCT00915772|529698120|FG000|Overall Study|Lack of Efficacy|9|||
146870576|NCT00915772|529698121|FG001|Overall Study|Lack of Efficacy|15|||
146870577|NCT00915772|529698122|FG002|Overall Study|Lack of Efficacy|3|||
146870578|NCT00915772|529698120|FG000|Overall Study|Refused to continue trial medication|6|||
146870579|NCT00915772|529698121|FG001|Overall Study|Refused to continue trial medication|8|||
146870580|NCT00915772|529698122|FG002|Overall Study|Refused to continue trial medication|4|||
146870581|NCT00915772|529698120|FG000|Overall Study|Any other reason|4|||
146870582|NCT00915772|529698121|FG001|Overall Study|Any other reason|7|||
146870583|NCT00915772|529698122|FG002|Overall Study|Any other reason|7|||
146870584|NCT03374995|529698123|FG000|Overall Study|Withdrawal by Subject|0|||
146870585|NCT03374995|529698124|FG001|Overall Study|Withdrawal by Subject|1|||
146870586|NCT01211535|529698127|FG000|Overall Study|Adverse Event|0|||
146870587|NCT01211535|529698128|FG001|Overall Study|Adverse Event|1|||
146870588|NCT00549939|529698134|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
146870589|NCT00549939|529698135|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
146870590|NCT00549939|529698136|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
146870591|NCT00549939|529698134|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
146870592|NCT00549939|529698135|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
146870593|NCT00549939|529698136|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
146870594|NCT00549939|529698134|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
146870595|NCT00549939|529698135|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
146870596|NCT00549939|529698136|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
146870597|NCT00549939|529698134|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
146870598|NCT00549939|529698135|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
146870599|NCT00549939|529698136|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
146870600|NCT00549939|529698134|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
146870601|NCT00549939|529698135|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
146870602|NCT00549939|529698136|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
146870603|NCT00549939|529698134|FG000|40-week Open Label Treatment Period|Other|0|||
146870604|NCT00549939|529698135|FG001|40-week Open Label Treatment Period|Other|1|||
146870605|NCT00549939|529698136|FG002|40-week Open Label Treatment Period|Other|4|||
146870606|NCT03593850|529698137|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
146535497|NCT05117060|528470675|FG000|Overall Study|Lack of Efficacy|4|||
146535498|NCT05117060|528470676|FG001|Overall Study|Lack of Efficacy|5|||
146535499|NCT05117060|528470677|FG002|Overall Study|Lack of Efficacy|2|||
146535500|NCT05117060|528470678|FG003|Overall Study|Lack of Efficacy|6|||
146914649|NCT03303339|529850046|FG004|Overall Study|Study Terminated by Sponsor|0|||
146535501|NCT05117060|528470675|FG000|Overall Study|Withdrawal by Subject|8|||
146535502|NCT05117060|528470676|FG001|Overall Study|Withdrawal by Subject|5|||
146535503|NCT05117060|528470677|FG002|Overall Study|Withdrawal by Subject|5|||
146535504|NCT05117060|528470678|FG003|Overall Study|Withdrawal by Subject|6|||
146535505|NCT05117060|528470675|FG000|Overall Study|Other|2|||
146535506|NCT05117060|528470676|FG001|Overall Study|Other|1|||
146535507|NCT05117060|528470677|FG002|Overall Study|Other|3|||
146535508|NCT05117060|528470678|FG003|Overall Study|Other|1|||
146535509|NCT05079321|528470679|FG000|Overall Study|Withdrawal by Subject|2|||
146535510|NCT05079321|528470680|FG001|Overall Study|Withdrawal by Subject|2|||
146535511|NCT05079321|528470679|FG000|Overall Study|Lost to Follow-up|0|||
146535512|NCT05079321|528470680|FG001|Overall Study|Lost to Follow-up|1|||
146535513|NCT01884597|528470681|FG000|Overall Study|Adverse Event|0|||
146535514|NCT01884597|528470682|FG001|Overall Study|Adverse Event|0|||
146535515|NCT01884597|528470683|FG002|Overall Study|Adverse Event|1|||
146535516|NCT01884597|528470681|FG000|Overall Study|Lack of Efficacy|1|||
146535517|NCT01884597|528470682|FG001|Overall Study|Lack of Efficacy|0|||
146535518|NCT01884597|528470683|FG002|Overall Study|Lack of Efficacy|0|||
146535519|NCT01884597|528470681|FG000|Overall Study|Death|0|||
146535520|NCT01884597|528470682|FG001|Overall Study|Death|1|||
146535521|NCT01884597|528470683|FG002|Overall Study|Death|0|||
146535522|NCT02097823|528470684|FG000|Overall Study|Withdrawal by Subject|1|||
146535523|NCT02097823|528470685|FG001|Overall Study|Withdrawal by Subject|1|||
146535524|NCT01081626|528470686|FG000|Overall Study|Dosing error|1|||
146535525|NCT01081626|528470687|FG001|Overall Study|Dosing error|1|||
146535526|NCT01081626|528470686|FG000|Overall Study|Missing Estradiol|25|||
146535527|NCT01081626|528470687|FG001|Overall Study|Missing Estradiol|28|||
146535528|NCT01081626|528470686|FG000|Overall Study|Low antral follicle count|1|||
146535529|NCT01081626|528470687|FG001|Overall Study|Low antral follicle count|0|||
146535530|NCT01081626|528470686|FG000|Overall Study|Overstimulation|0|||
146535531|NCT01081626|528470687|FG001|Overall Study|Overstimulation|1|||
146535532|NCT01081626|528470686|FG000|Overall Study|Lost to Follow-up|0|||
146535533|NCT01081626|528470687|FG001|Overall Study|Lost to Follow-up|1|||
146535534|NCT01081626|528470686|FG000|Overall Study|Other|33|||
146535535|NCT01081626|528470687|FG001|Overall Study|Other|30|||
146535536|NCT01419535|528470689|FG000|Overall Study|could not maintain iv line|1|||
146535537|NCT01419535|528470690|FG001|Overall Study|could not maintain iv line|1|||
146535538|NCT01419535|528470689|FG000|Overall Study|Withdrawal by Subject|0|||
146535539|NCT01419535|528470690|FG001|Overall Study|Withdrawal by Subject|1|||
146535540|NCT05965752|528470693|FG000|Overall Study|Adverse Event|0|||
146535541|NCT05965752|528470694|FG001|Overall Study|Adverse Event|1|||
146535542|NCT05965752|528470695|FG002|Overall Study|Adverse Event|0|||
146535543|NCT05965752|528470696|FG003|Overall Study|Adverse Event|1|||
146535544|NCT05965752|528470697|FG004|Overall Study|Adverse Event|3|||
146535545|NCT05965752|528470693|FG000|Overall Study|Lost to Follow-up|2|||
146535546|NCT05965752|528470694|FG001|Overall Study|Lost to Follow-up|0|||
146535547|NCT05965752|528470695|FG002|Overall Study|Lost to Follow-up|1|||
146535548|NCT05965752|528470696|FG003|Overall Study|Lost to Follow-up|1|||
146535549|NCT05965752|528470697|FG004|Overall Study|Lost to Follow-up|1|||
146535550|NCT05965752|528470693|FG000|Overall Study|Withdrawal by Subject|2|||
146535551|NCT05965752|528470694|FG001|Overall Study|Withdrawal by Subject|2|||
146870607|NCT03593850|529698138|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
146535552|NCT05965752|528470695|FG002|Overall Study|Withdrawal by Subject|1|||
146535553|NCT05965752|528470696|FG003|Overall Study|Withdrawal by Subject|5|||
146535554|NCT05965752|528470697|FG004|Overall Study|Withdrawal by Subject|0|||
146535555|NCT05965752|528470693|FG000|Overall Study|Disease Relapse|1|||
146870608|NCT00003895|529698139|FG000|Overall Study|Adverse Event|4|||
146870609|NCT00003895|529698140|FG001|Overall Study|Adverse Event|0|||
146870610|NCT00003895|529698139|FG000|Overall Study|Lack of Efficacy|1|||
146535556|NCT05965752|528470694|FG001|Overall Study|Disease Relapse|0|||
146535557|NCT05965752|528470695|FG002|Overall Study|Disease Relapse|1|||
146535558|NCT05965752|528470696|FG003|Overall Study|Disease Relapse|0|||
146535559|NCT05965752|528470697|FG004|Overall Study|Disease Relapse|0|||
146870611|NCT00003895|529698140|FG001|Overall Study|Lack of Efficacy|1|||
146870612|NCT00003895|529698139|FG000|Overall Study|Patient Vacation|2|||
146870613|NCT00003895|529698140|FG001|Overall Study|Patient Vacation|0|||
146870614|NCT00003895|529698139|FG000|Overall Study|Withdrawal by Subject|0|||
146870615|NCT00003895|529698140|FG001|Overall Study|Withdrawal by Subject|3|||
146870616|NCT01735279|529698141|FG000|Overall Study|Lost to Follow-up|11|||
146870617|NCT01735279|529698142|FG001|Overall Study|Lost to Follow-up|8|||
146870618|NCT02490475|529698143|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
146535560|NCT05965752|528470693|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
146535561|NCT05965752|528470694|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
146535562|NCT05965752|528470695|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
146535563|NCT05965752|528470696|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
146535564|NCT05965752|528470697|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
146535565|NCT05965752|528470693|FG000|Overall Study|Unable to Return for Study Visits|0|||
146535566|NCT05965752|528470694|FG001|Overall Study|Unable to Return for Study Visits|1|||
146535567|NCT05965752|528470695|FG002|Overall Study|Unable to Return for Study Visits|0|||
146535568|NCT05965752|528470696|FG003|Overall Study|Unable to Return for Study Visits|3|||
146535569|NCT05965752|528470697|FG004|Overall Study|Unable to Return for Study Visits|1|||
146535570|NCT05965752|528470693|FG000|Overall Study|Early Termination|0|||
146535571|NCT05965752|528470694|FG001|Overall Study|Early Termination|0|||
146535572|NCT05965752|528470695|FG002|Overall Study|Early Termination|1|||
146535573|NCT05965752|528470696|FG003|Overall Study|Early Termination|0|||
146535574|NCT05965752|528470697|FG004|Overall Study|Early Termination|0|||
146535575|NCT05965752|528470693|FG000|Overall Study|Reported Unwanted Symptoms|0|||
146535576|NCT05965752|528470694|FG001|Overall Study|Reported Unwanted Symptoms|0|||
146535577|NCT05965752|528470695|FG002|Overall Study|Reported Unwanted Symptoms|0|||
146535578|NCT05965752|528470696|FG003|Overall Study|Reported Unwanted Symptoms|0|||
146535579|NCT05965752|528470697|FG004|Overall Study|Reported Unwanted Symptoms|1|||
146535580|NCT05965752|528470693|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
146535581|NCT05965752|528470694|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
146535582|NCT05965752|528470695|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
146535583|NCT05965752|528470696|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
146535584|NCT05965752|528470697|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
146535585|NCT01274351|528470699|FG000|Overall Study|Lost to Follow-up|1|||
146535586|NCT01274351|528470699|FG000|Overall Study|patient not compliant with the protocol|1|||
146870619|NCT02490475|529698144|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
146870620|NCT02490475|529698145|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
146870621|NCT02490475|529698146|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
146870622|NCT02490475|529698143|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
146870623|NCT02490475|529698144|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
146870624|NCT02490475|529698145|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
146870625|NCT02490475|529698146|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
146870626|NCT02490475|529698143|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
146870627|NCT02490475|529698144|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
146870628|NCT02490475|529698145|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
146870629|NCT02490475|529698146|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
146870630|NCT02490475|529698143|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
146870631|NCT02490475|529698144|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
146870632|NCT02490475|529698145|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
146870633|NCT02490475|529698146|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
146870634|NCT02490475|529698143|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
146870635|NCT02490475|529698144|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
146870636|NCT02490475|529698145|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
146870637|NCT02490475|529698146|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
146870638|NCT02490475|529698143|FG000|Period 2: Extension Phase|Refused Treatment|0|||
146870639|NCT02490475|529698144|FG001|Period 2: Extension Phase|Refused Treatment|0|||
146870640|NCT02490475|529698145|FG002|Period 2: Extension Phase|Refused Treatment|0|||
146870641|NCT02490475|529698146|FG003|Period 2: Extension Phase|Refused Treatment|1|||
146870642|NCT02490475|529698143|FG000|Period 2: Extension Phase|Adverse Event|0|||
146870643|NCT02490475|529698144|FG001|Period 2: Extension Phase|Adverse Event|0|||
146870644|NCT02490475|529698145|FG002|Period 2: Extension Phase|Adverse Event|1|||
146870645|NCT02490475|529698146|FG003|Period 2: Extension Phase|Adverse Event|0|||
146870646|NCT01195090|529698149|FG000|Overall Study|Adverse Event|1|||
146870647|NCT01195090|529698150|FG001|Overall Study|Adverse Event|2|||
146870648|NCT01195090|529698149|FG000|Overall Study|Lost to Follow-up|2|||
146870649|NCT01195090|529698150|FG001|Overall Study|Lost to Follow-up|2|||
146870650|NCT01195090|529698149|FG000|Overall Study|Protocol Violation|3|||
146870651|NCT01195090|529698150|FG001|Overall Study|Protocol Violation|4|||
146870652|NCT04912245|529698151|FG000|Overall Study|Withdrawal by Subject|21|||
146870653|NCT04912245|529698152|FG001|Overall Study|Withdrawal by Subject|4|||
146870654|NCT04912245|529698151|FG000|Overall Study|Lost to Follow-up|5|||
146870655|NCT04912245|529698152|FG001|Overall Study|Lost to Follow-up|11|||
146870656|NCT01205230|529698153|FG000|Overall Study|Adverse Event|4|||
146870657|NCT01205230|529698154|FG001|Overall Study|Adverse Event|0|||
146870658|NCT01205230|529698153|FG000|Overall Study|Physician Decision|1|||
146870659|NCT01205230|529698154|FG001|Overall Study|Physician Decision|0|||
146870660|NCT00058552|529698155|FG000|Overall Study|Died prior to receiving treatment|4|||
146870661|NCT00058552|529698156|FG001|Overall Study|Died prior to receiving treatment|2|||
146870662|NCT00058552|529698155|FG000|Overall Study|Disease progression|52|||
146870663|NCT00058552|529698156|FG001|Overall Study|Disease progression|44|||
146870664|NCT00058552|529698155|FG000|Overall Study|Adverse Event|4|||
146870665|NCT00058552|529698156|FG001|Overall Study|Adverse Event|2|||
146870666|NCT00058552|529698155|FG000|Overall Study|Withdrawal by Subject|3|||
146870667|NCT00058552|529698156|FG001|Overall Study|Withdrawal by Subject|5|||
146535587|NCT01274351|528470699|FG000|Overall Study|Pregnancy|1|||
146870668|NCT00058552|529698155|FG000|Overall Study|Physician Decision|2|||
146535588|NCT01274351|528470699|FG000|Overall Study|Death|2|||
146535589|NCT01274351|528470699|FG000|Overall Study|Withdrawal by Subject|3|||
146870669|NCT00058552|529698156|FG001|Overall Study|Physician Decision|5|||
146535590|NCT01274351|528470699|FG000|Overall Study|Adverse Event|8|||
146535591|NCT01274351|528470699|FG000|Overall Study|progression of disease|3|||
146535592|NCT01274351|528470699|FG000|Overall Study|hospitalization|1|||
146535593|NCT05399680|528472318|FG000|Overall Study|Lost to Follow-up|1|||
146535594|NCT05399680|528472319|FG001|Overall Study|Lost to Follow-up|0|||
146535595|NCT05399680|528472318|FG000|Overall Study|Death|0|||
146535596|NCT05399680|528472319|FG001|Overall Study|Death|1|||
146535597|NCT02659865|528472320|FG000|Period 1|Withdrawal by Subject|1|||
146535598|NCT02659865|528472321|FG001|Period 1|Withdrawal by Subject|0|||
146535599|NCT02659865|528472322|FG002|Period 1|Withdrawal by Subject|0|||
146535600|NCT02659865|528472323|FG003|Period 1|Withdrawal by Subject|0|||
146535601|NCT02659865|528472324|FG004|Period 1|Withdrawal by Subject|0|||
146535602|NCT02659865|528472320|FG000|Period 1|Adverse Event|0|||
146535603|NCT02659865|528472321|FG001|Period 1|Adverse Event|0|||
146535604|NCT02659865|528472322|FG002|Period 1|Adverse Event|0|||
146535605|NCT02659865|528472323|FG003|Period 1|Adverse Event|0|||
146535606|NCT02659865|528472324|FG004|Period 1|Adverse Event|1|||
146535607|NCT03370172|528472325|FG000|Overall Study|Withdrawal by Subject|0|||
146535608|NCT03370172|528472326|FG001|Overall Study|Withdrawal by Subject|1|||
146535609|NCT00753519|528472328|FG000|Overall Study|Withdrawal by Subject|0|||
146535610|NCT00753519|528472329|FG001|Overall Study|Withdrawal by Subject|2|||
146535611|NCT00959751|528472330|FG000|Overall Study|Lost to Follow-up|2|||
146535612|NCT00959751|528472331|FG001|Overall Study|Lost to Follow-up|3|||
146535613|NCT00959751|528472330|FG000|Overall Study|Consent Withdrawn|0|||
146535614|NCT00959751|528472331|FG001|Overall Study|Consent Withdrawn|1|||
146535615|NCT00959751|528472330|FG000|Overall Study|Non-compliance to Study Procedures|0|||
146535616|NCT00959751|528472331|FG001|Overall Study|Non-compliance to Study Procedures|1|||
146535617|NCT00959751|528472330|FG000|Overall Study|No migraine headache without aura|7|||
146535618|NCT00959751|528472331|FG001|Overall Study|No migraine headache without aura|7|||
146535619|NCT01113749|528472332|FG000|Overall Study|Lost to Follow-up|1|||
146535620|NCT01113749|528472333|FG001|Overall Study|Lost to Follow-up|2|||
146535621|NCT03427892|528472334|FG000|Overall Study|Lost to Follow-up|2|||
146535622|NCT03255187|528472335|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
146535623|NCT03255187|528472336|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
146535624|NCT03255187|528472335|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
146535625|NCT03255187|528472336|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
146535626|NCT00703534|528472337|FG000|Overall Study|Adverse Event|14|||
146535627|NCT00703534|528472338|FG001|Overall Study|Adverse Event|3|||
146535628|NCT00703534|528472337|FG000|Overall Study|Withdrawal by Subject|8|||
146535629|NCT00703534|528472338|FG001|Overall Study|Withdrawal by Subject|7|||
146535630|NCT00703534|528472337|FG000|Overall Study|Incorrect Enrollment|6|||
146535631|NCT00703534|528472338|FG001|Overall Study|Incorrect Enrollment|6|||
146535632|NCT00703534|528472337|FG000|Overall Study|Lost to Follow-up|1|||
146535633|NCT00703534|528472338|FG001|Overall Study|Lost to Follow-up|4|||
146535634|NCT00703534|528472337|FG000|Overall Study|Severe Non Compliance|1|||
146535635|NCT00703534|528472338|FG001|Overall Study|Severe Non Compliance|5|||
146535636|NCT01715298|528472339|FG000|Overall Study|Lost to Follow-up|0|||
146535637|NCT01715298|528472340|FG001|Overall Study|Lost to Follow-up|2|||
146535638|NCT01715298|528472339|FG000|Overall Study|Patient/guardian decision|7|||
146535639|NCT01715298|528472340|FG001|Overall Study|Patient/guardian decision|9|||
146535640|NCT03248037|528472344|FG000|Overall Study|Withdrawal by Subject|6|||
146535641|NCT03248037|528472345|FG001|Overall Study|Withdrawal by Subject|9|||
146535642|NCT03248037|528472344|FG000|Overall Study|Adverse Event|15|||
146535643|NCT03248037|528472345|FG001|Overall Study|Adverse Event|0|||
146535644|NCT02897349|528472349|FG000|Overall Study|Lost to Follow-up|2|||
146535645|NCT02897349|528472350|FG001|Overall Study|Lost to Follow-up|2|||
146535646|NCT02897349|528472349|FG000|Overall Study|Adverse Event|3|||
146535647|NCT02897349|528472350|FG001|Overall Study|Adverse Event|3|||
146535648|NCT02897349|528472349|FG000|Overall Study|Other than listed above|0|||
146535649|NCT02897349|528472350|FG001|Overall Study|Other than listed above|1|||
146535650|NCT03435055|528472353|FG000|Screening|Physician Decision|2|||
146535651|NCT03435055|528472353|FG000|Received Intervention|Did not complete nitrous administration|3|||
146535652|NCT01027949|528472359|FG000|Overall Study|Death|174|||
146535653|NCT01027949|528472359|FG000|Overall Study|Progressive Disease|163|||
146535654|NCT01027949|528472359|FG000|Overall Study|Adverse Event|172|||
146535655|NCT01027949|528472359|FG000|Overall Study|Withdrawal by Subject|113|||
146870670|NCT00058552|529698155|FG000|Overall Study|Clinical disease progression|0|||
146870671|NCT00058552|529698156|FG001|Overall Study|Clinical disease progression|4|||
146870672|NCT03861936|529698157|FG000|Overall Study|Withdrawal by Subject|4|||
146535656|NCT01027949|528472359|FG000|Overall Study|Lost to Follow-up|17|||
146535657|NCT01027949|528472359|FG000|Overall Study|Protocol Violation|13|||
146535658|NCT01027949|528472359|FG000|Overall Study|PI Decision|8|||
146535659|NCT01027949|528472359|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
146870673|NCT03861936|529698158|FG001|Overall Study|Withdrawal by Subject|1|||
146535660|NCT01027949|528472359|FG000|Overall Study|Non-compliance with Study Procedures|7|||
146535661|NCT01027949|528472359|FG000|Overall Study|Lung Transplant|5|||
146535662|NCT01027949|528472359|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
146535663|NCT01027949|528472359|FG000|Overall Study|Use of Excluded Medication|2|||
146535664|NCT01027949|528472359|FG000|Overall Study|Patient Self-discontinuation|1|||
146535665|NCT01027949|528472359|FG000|Overall Study|Pregnancy|1|||
146535666|NCT01027949|528472359|FG000|Overall Study|Surgery|1|||
146535667|NCT02765035|528472362|FG000|First Intervention (90 Days)|Adverse Event|1|||
146535668|NCT02765035|528472363|FG001|First Intervention (90 Days)|Adverse Event|1|||
146535669|NCT02765035|528472362|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
146535670|NCT02765035|528472363|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
146535671|NCT00671749|528472367|FG000|Overall Study|Adverse Event|2|||
146535672|NCT00671749|528472367|FG000|Overall Study|Withdrawal by Subject|4|||
146535673|NCT00671749|528472367|FG000|Overall Study|Protocol Violation|1|||
146535674|NCT00671749|528472367|FG000|Overall Study|Lost to Follow-up|1|||
146535675|NCT01259245|528472373|FG000|Overall Study|Withdrawal by Subject|27|||
146535676|NCT01259245|528472374|FG001|Overall Study|Withdrawal by Subject|24|||
146535677|NCT01259245|528472373|FG000|Overall Study|Death|1|||
146535678|NCT01259245|528472374|FG001|Overall Study|Death|2|||
146535679|NCT03937778|528472375|FG000|Overall Study|Withdrawal by Subject|1|||
146535680|NCT03937778|528472375|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
146870674|NCT03861936|529698159|FG002|Overall Study|Withdrawal by Subject|3|||
146870675|NCT03861936|529698157|FG000|Overall Study|Lost to Follow-up|5|||
146870676|NCT03861936|529698158|FG001|Overall Study|Lost to Follow-up|3|||
146535681|NCT02065557|528472376|FG000|Induction Period|Withdrawal by Subject|2|||
146535682|NCT02065557|528472377|FG001|Induction Period|Withdrawal by Subject|1|||
146535683|NCT02065557|528472378|FG002|Induction Period|Withdrawal by Subject|0|||
146535684|NCT02065557|528472379|FG003|Induction Period|Withdrawal by Subject|0|||
146535685|NCT02065557|528472380|FG004|Induction Period|Withdrawal by Subject|0|||
146535686|NCT02065557|528472381|FG005|Induction Period|Withdrawal by Subject|0|||
146535687|NCT02065557|528472376|FG000|Induction Period|Lack of Efficacy|2|||
146535688|NCT02065557|528472377|FG001|Induction Period|Lack of Efficacy|1|||
146535689|NCT02065557|528472378|FG002|Induction Period|Lack of Efficacy|1|||
146535690|NCT02065557|528472379|FG003|Induction Period|Lack of Efficacy|0|||
146535691|NCT02065557|528472380|FG004|Induction Period|Lack of Efficacy|0|||
146535692|NCT02065557|528472381|FG005|Induction Period|Lack of Efficacy|0|||
146535693|NCT02065557|528472376|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
146535694|NCT02065557|528472377|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
146535695|NCT02065557|528472378|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
146535696|NCT02065557|528472379|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
146535697|NCT02065557|528472380|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
146535698|NCT02065557|528472381|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
146535699|NCT02065557|528472376|FG000|Induction Period|Non-Responder at Week 8|4|||
146535700|NCT02065557|528472377|FG001|Induction Period|Non-Responder at Week 8|4|||
146535701|NCT02065557|528472378|FG002|Induction Period|Non-Responder at Week 8|0|||
146535702|NCT02065557|528472379|FG003|Induction Period|Non-Responder at Week 8|0|||
146535703|NCT02065557|528472380|FG004|Induction Period|Non-Responder at Week 8|0|||
146535704|NCT02065557|528472381|FG005|Induction Period|Non-Responder at Week 8|0|||
146535705|NCT02065557|528472376|FG000|Induction Period|Adverse Event|1|||
146535706|NCT02065557|528472377|FG001|Induction Period|Adverse Event|1|||
146535707|NCT02065557|528472378|FG002|Induction Period|Adverse Event|0|||
146535708|NCT02065557|528472379|FG003|Induction Period|Adverse Event|0|||
146535709|NCT02065557|528472380|FG004|Induction Period|Adverse Event|0|||
146535710|NCT02065557|528472381|FG005|Induction Period|Adverse Event|0|||
146535711|NCT02065557|528472376|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
146535712|NCT02065557|528472377|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
146535713|NCT02065557|528472378|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
146535714|NCT02065557|528472379|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
146535715|NCT02065557|528472380|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
146535716|NCT02065557|528472381|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
146535717|NCT02065557|528472376|FG000|Maintenance Period|Withdrawal by Subject|0|||
146535718|NCT02065557|528472377|FG001|Maintenance Period|Withdrawal by Subject|0|||
146535719|NCT02065557|528472378|FG002|Maintenance Period|Withdrawal by Subject|0|||
146535720|NCT02065557|528472379|FG003|Maintenance Period|Withdrawal by Subject|0|||
146870677|NCT03861936|529698159|FG002|Overall Study|Lost to Follow-up|3|||
146870678|NCT03861936|529698157|FG000|Overall Study|Physician Decision|0|||
146870679|NCT03861936|529698158|FG001|Overall Study|Physician Decision|1|||
146535721|NCT02065557|528472380|FG004|Maintenance Period|Withdrawal by Subject|2|||
146535722|NCT02065557|528472381|FG005|Maintenance Period|Withdrawal by Subject|1|||
146535723|NCT02065557|528472376|FG000|Maintenance Period|Lack of Efficacy|0|||
146535724|NCT02065557|528472377|FG001|Maintenance Period|Lack of Efficacy|0|||
146870680|NCT03861936|529698159|FG002|Overall Study|Physician Decision|0|||
146535725|NCT02065557|528472378|FG002|Maintenance Period|Lack of Efficacy|0|||
146535726|NCT02065557|528472379|FG003|Maintenance Period|Lack of Efficacy|0|||
146535727|NCT02065557|528472380|FG004|Maintenance Period|Lack of Efficacy|5|||
146535728|NCT02065557|528472381|FG005|Maintenance Period|Lack of Efficacy|2|||
146535729|NCT02065557|528472376|FG000|Maintenance Period|Subject Non-Compliance|0|||
146870681|NCT03861936|529698157|FG000|Overall Study|Protocol Deviation|0|||
146870682|NCT03861936|529698158|FG001|Overall Study|Protocol Deviation|0|||
146535730|NCT02065557|528472377|FG001|Maintenance Period|Subject Non-Compliance|0|||
146535731|NCT02065557|528472378|FG002|Maintenance Period|Subject Non-Compliance|0|||
146535732|NCT02065557|528472379|FG003|Maintenance Period|Subject Non-Compliance|0|||
146535733|NCT02065557|528472380|FG004|Maintenance Period|Subject Non-Compliance|0|||
146535734|NCT02065557|528472381|FG005|Maintenance Period|Subject Non-Compliance|1|||
146535735|NCT01200355|528472382|FG000|Overall Study|Death|7|||
146763737|NCT01090024|529302895|FG007|Period 1|Adverse Event|0|||
146763738|NCT01090024|529302896|FG008|Period 1|Adverse Event|0|||
146763739|NCT01090024|529302897|FG009|Period 1|Adverse Event|1|||
146763740|NCT01090024|529302898|FG010|Period 1|Adverse Event|0|||
146763741|NCT01090024|529302899|FG011|Period 1|Adverse Event|1|||
146763742|NCT01090024|529302900|FG012|Period 1|Adverse Event|0|||
146763743|NCT01090024|529302901|FG013|Period 1|Adverse Event|0|||
146763744|NCT01090024|529302902|FG014|Period 1|Adverse Event|0|||
146763745|NCT01090024|529302903|FG015|Period 1|Adverse Event|0|||
146763746|NCT01090024|529302904|FG016|Period 1|Adverse Event|0|||
146763747|NCT01090024|529302905|FG017|Period 1|Adverse Event|1|||
146763748|NCT01090024|529302888|FG000|Period 1|Withdrawal by Subject|0|||
146763749|NCT01090024|529302889|FG001|Period 1|Withdrawal by Subject|0|||
146763750|NCT01090024|529302890|FG002|Period 1|Withdrawal by Subject|0|||
146763751|NCT01090024|529302891|FG003|Period 1|Withdrawal by Subject|1|||
146763752|NCT01090024|529302892|FG004|Period 1|Withdrawal by Subject|0|||
146763753|NCT01090024|529302893|FG005|Period 1|Withdrawal by Subject|0|||
146763754|NCT01090024|529302894|FG006|Period 1|Withdrawal by Subject|0|||
146763755|NCT01090024|529302895|FG007|Period 1|Withdrawal by Subject|0|||
146763756|NCT01090024|529302896|FG008|Period 1|Withdrawal by Subject|0|||
146763757|NCT01090024|529302897|FG009|Period 1|Withdrawal by Subject|0|||
146763758|NCT01090024|529302898|FG010|Period 1|Withdrawal by Subject|0|||
146763759|NCT01090024|529302899|FG011|Period 1|Withdrawal by Subject|0|||
146763760|NCT01090024|529302900|FG012|Period 1|Withdrawal by Subject|0|||
146763761|NCT01090024|529302901|FG013|Period 1|Withdrawal by Subject|0|||
146763762|NCT01090024|529302902|FG014|Period 1|Withdrawal by Subject|0|||
146763763|NCT01090024|529302903|FG015|Period 1|Withdrawal by Subject|0|||
146763764|NCT01090024|529302904|FG016|Period 1|Withdrawal by Subject|0|||
146763765|NCT01090024|529302905|FG017|Period 1|Withdrawal by Subject|0|||
146763766|NCT01090024|529302888|FG000|Period 1|Lost to Follow-up|0|||
146763767|NCT01090024|529302889|FG001|Period 1|Lost to Follow-up|1|||
146763768|NCT01090024|529302890|FG002|Period 1|Lost to Follow-up|0|||
146763769|NCT01090024|529302891|FG003|Period 1|Lost to Follow-up|0|||
146763770|NCT01090024|529302892|FG004|Period 1|Lost to Follow-up|0|||
146763771|NCT01090024|529302893|FG005|Period 1|Lost to Follow-up|0|||
146763772|NCT01090024|529302894|FG006|Period 1|Lost to Follow-up|0|||
146763773|NCT01090024|529302895|FG007|Period 1|Lost to Follow-up|0|||
146763774|NCT01090024|529302896|FG008|Period 1|Lost to Follow-up|0|||
146763775|NCT01090024|529302897|FG009|Period 1|Lost to Follow-up|0|||
146763776|NCT01090024|529302898|FG010|Period 1|Lost to Follow-up|0|||
146763777|NCT01090024|529302899|FG011|Period 1|Lost to Follow-up|0|||
146763778|NCT01090024|529302900|FG012|Period 1|Lost to Follow-up|0|||
146763779|NCT01090024|529302901|FG013|Period 1|Lost to Follow-up|0|||
146763780|NCT01090024|529302902|FG014|Period 1|Lost to Follow-up|0|||
146763781|NCT01090024|529302903|FG015|Period 1|Lost to Follow-up|0|||
146763782|NCT01090024|529302904|FG016|Period 1|Lost to Follow-up|0|||
146763783|NCT01090024|529302905|FG017|Period 1|Lost to Follow-up|0|||
146763784|NCT01090024|529302888|FG000|Period 2|Lost to Follow-up|0|||
146763785|NCT01090024|529302889|FG001|Period 2|Lost to Follow-up|0|||
146763786|NCT01090024|529302890|FG002|Period 2|Lost to Follow-up|0|||
146763787|NCT01090024|529302891|FG003|Period 2|Lost to Follow-up|1|||
146763788|NCT01090024|529302892|FG004|Period 2|Lost to Follow-up|0|||
146763789|NCT01090024|529302893|FG005|Period 2|Lost to Follow-up|0|||
146763790|NCT01090024|529302894|FG006|Period 2|Lost to Follow-up|0|||
146763791|NCT01090024|529302895|FG007|Period 2|Lost to Follow-up|0|||
146763792|NCT01090024|529302896|FG008|Period 2|Lost to Follow-up|0|||
146763793|NCT01090024|529302897|FG009|Period 2|Lost to Follow-up|0|||
146763794|NCT01090024|529302898|FG010|Period 2|Lost to Follow-up|0|||
146763795|NCT01090024|529302899|FG011|Period 2|Lost to Follow-up|0|||
146763796|NCT01090024|529302900|FG012|Period 2|Lost to Follow-up|0|||
146763797|NCT01090024|529302901|FG013|Period 2|Lost to Follow-up|0|||
146763798|NCT01090024|529302902|FG014|Period 2|Lost to Follow-up|0|||
146763799|NCT01090024|529302903|FG015|Period 2|Lost to Follow-up|0|||
146763800|NCT01090024|529302904|FG016|Period 2|Lost to Follow-up|0|||
146763801|NCT01090024|529302905|FG017|Period 2|Lost to Follow-up|0|||
146763802|NCT01090024|529302888|FG000|Period 2|Adverse Event|1|||
146763803|NCT01090024|529302889|FG001|Period 2|Adverse Event|0|||
146763804|NCT01090024|529302890|FG002|Period 2|Adverse Event|0|||
146763805|NCT01090024|529302891|FG003|Period 2|Adverse Event|0|||
146763806|NCT01090024|529302892|FG004|Period 2|Adverse Event|0|||
146763807|NCT01090024|529302893|FG005|Period 2|Adverse Event|0|||
146763808|NCT01090024|529302894|FG006|Period 2|Adverse Event|0|||
146763809|NCT01090024|529302895|FG007|Period 2|Adverse Event|0|||
146763810|NCT01090024|529302896|FG008|Period 2|Adverse Event|0|||
146763811|NCT01090024|529302897|FG009|Period 2|Adverse Event|0|||
146763812|NCT01090024|529302898|FG010|Period 2|Adverse Event|0|||
146535736|NCT01200355|528472383|FG001|Overall Study|Death|2|||
146535737|NCT00706797|528472384|FG000|Overall Study|Lack of Efficacy|3|||
146535738|NCT00706797|528472385|FG001|Overall Study|Lack of Efficacy|0|||
146535739|NCT00706797|528472384|FG000|Overall Study|Adverse Event|0|||
146535740|NCT00706797|528472385|FG001|Overall Study|Adverse Event|3|||
146535741|NCT00706797|528472384|FG000|Overall Study|Withdrawal by Subject|8|||
146535742|NCT00706797|528472385|FG001|Overall Study|Withdrawal by Subject|1|||
146535743|NCT00706797|528472384|FG000|Overall Study|Death|1|||
146535744|NCT00706797|528472385|FG001|Overall Study|Death|0|||
146535745|NCT00706797|528472384|FG000|Overall Study|Discontinuation of study by sponsor|52|||
146535746|NCT00706797|528472385|FG001|Overall Study|Discontinuation of study by sponsor|63|||
146535747|NCT00706797|528472384|FG000|Overall Study|Protocol Violation|3|||
146535748|NCT00706797|528472385|FG001|Overall Study|Protocol Violation|2|||
146535749|NCT00706797|528472384|FG000|Overall Study|Lost to Follow-up|1|||
146535750|NCT00706797|528472385|FG001|Overall Study|Lost to Follow-up|2|||
146535751|NCT00706797|528472384|FG000|Overall Study|Other|1|||
146535752|NCT00706797|528472385|FG001|Overall Study|Other|0|||
146535753|NCT01401322|528472387|FG000|Overall Study|Withdrawal by Subject|1|||
146535754|NCT01401322|528472387|FG000|Overall Study|Physician Decision|1|||
146535755|NCT00486044|528472388|FG000|Overall Study|Withdrawal by Subject|2|||
146535756|NCT00486044|528472389|FG001|Overall Study|Withdrawal by Subject|1|||
146535757|NCT00486044|528472388|FG000|Overall Study|Adverse Event|0|||
146535758|NCT00486044|528472389|FG001|Overall Study|Adverse Event|1|||
146535759|NCT00486044|528472388|FG000|Overall Study|Lost to Follow-up|0|||
146535760|NCT00486044|528472389|FG001|Overall Study|Lost to Follow-up|1|||
146535761|NCT02309359|528472390|FG000|Overall Study|Adverse Event|4|||
146535762|NCT02309359|528472391|FG001|Overall Study|Adverse Event|5|||
146535763|NCT02309359|528472392|FG002|Overall Study|Adverse Event|5|||
146535764|NCT02309359|528472393|FG003|Overall Study|Adverse Event|4|||
146535765|NCT02309359|528472394|FG004|Overall Study|Adverse Event|4|||
146535766|NCT02309359|528472390|FG000|Overall Study|Death|1|||
146535767|NCT02309359|528472391|FG001|Overall Study|Death|0|||
146535768|NCT02309359|528472392|FG002|Overall Study|Death|0|||
146535769|NCT02309359|528472393|FG003|Overall Study|Death|0|||
146535770|NCT02309359|528472394|FG004|Overall Study|Death|0|||
146535771|NCT02309359|528472390|FG000|Overall Study|Withdrawal by Subject|2|||
146535772|NCT02309359|528472391|FG001|Overall Study|Withdrawal by Subject|2|||
146535773|NCT02309359|528472392|FG002|Overall Study|Withdrawal by Subject|4|||
146535774|NCT02309359|528472393|FG003|Overall Study|Withdrawal by Subject|4|||
146535775|NCT02309359|528472394|FG004|Overall Study|Withdrawal by Subject|0|||
146535776|NCT02309359|528472390|FG000|Overall Study|Lack of Efficacy|3|||
146535777|NCT02309359|528472391|FG001|Overall Study|Lack of Efficacy|1|||
146535778|NCT02309359|528472392|FG002|Overall Study|Lack of Efficacy|0|||
146535779|NCT02309359|528472393|FG003|Overall Study|Lack of Efficacy|0|||
146535780|NCT02309359|528472394|FG004|Overall Study|Lack of Efficacy|3|||
146535781|NCT02309359|528472390|FG000|Overall Study|Lost to Follow-up|0|||
146535782|NCT02309359|528472391|FG001|Overall Study|Lost to Follow-up|0|||
146535783|NCT02309359|528472392|FG002|Overall Study|Lost to Follow-up|0|||
146535784|NCT02309359|528472393|FG003|Overall Study|Lost to Follow-up|1|||
146535785|NCT02309359|528472394|FG004|Overall Study|Lost to Follow-up|0|||
146535786|NCT02309359|528472390|FG000|Overall Study|Other|2|||
146535787|NCT02309359|528472391|FG001|Overall Study|Other|0|||
146535788|NCT02309359|528472392|FG002|Overall Study|Other|2|||
146535789|NCT02309359|528472393|FG003|Overall Study|Other|3|||
146535790|NCT02309359|528472394|FG004|Overall Study|Other|2|||
146535791|NCT04759131|528472395|FG000|Overall Study|Investigator's discretion|1|||
146535792|NCT04759131|528472396|FG001|Overall Study|Investigator's discretion|0|||
146535793|NCT04759131|528472395|FG000|Overall Study|Subject withdrawal|1|||
146535794|NCT04759131|528472396|FG001|Overall Study|Subject withdrawal|0|||
146535795|NCT05144945|528472397|FG000|Overall Study|Withdrawal by Subject|1|||
146535796|NCT05144945|528472398|FG001|Overall Study|Withdrawal by Subject|0|||
146535797|NCT05853120|528472399|FG000|Overall Study|Lost to Follow-up|4|||
146535798|NCT05853120|528472400|FG001|Overall Study|Lost to Follow-up|4|||
146535799|NCT05853120|528472399|FG000|Overall Study|Physician Decision|3|||
146535800|NCT05853120|528472400|FG001|Overall Study|Physician Decision|0|||
146535801|NCT05853120|528472399|FG000|Overall Study|Withdrawal by Subject|5|||
146535802|NCT05853120|528472400|FG001|Overall Study|Withdrawal by Subject|2|||
146535803|NCT02592824|528472402|FG000|Overall Study|Protocol Violation|5|||
146535804|NCT02592824|528472403|FG001|Overall Study|Protocol Violation|3|||
146870683|NCT03861936|529698159|FG002|Overall Study|Protocol Deviation|1|||
146535805|NCT02592824|528472402|FG000|Overall Study|Lost to Follow-up|2|||
146535806|NCT02592824|528472403|FG001|Overall Study|Lost to Follow-up|1|||
146535807|NCT00465517|528472404|FG000|Overall Study|Adverse Event|7|||
146535808|NCT00465517|528472405|FG001|Overall Study|Adverse Event|3|||
146535809|NCT00465517|528472404|FG000|Overall Study|Lost to Follow-up|1|||
146535810|NCT00465517|528472405|FG001|Overall Study|Lost to Follow-up|0|||
146535811|NCT00465517|528472404|FG000|Overall Study|Withdrawal by Subject|4|||
146535812|NCT00465517|528472405|FG001|Overall Study|Withdrawal by Subject|1|||
146535813|NCT00289276|528472408|FG000|Second Part of FAST Study (Expansion)|Death|0|||
146535814|NCT00289276|528472409|FG001|Second Part of FAST Study (Expansion)|Death|2|||
146535815|NCT00289276|528472408|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
146535816|NCT00289276|528472409|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
146535817|NCT00869960|528472410|FG000|Overall Study|Lost to Follow-up|2|||
146535818|NCT00726609|528472413|FG000|Overall Study|Adverse Event|10|||
146535819|NCT00726609|528472413|FG000|Overall Study|Withdrawal by Subject|2|||
146535820|NCT00726609|528472413|FG000|Overall Study|Lack of Efficacy|25|||
146535821|NCT00726609|528472413|FG000|Overall Study|Other|16|||
146870684|NCT03861936|529698157|FG000|Overall Study|Reason not Specified|5|||
146870685|NCT03861936|529698158|FG001|Overall Study|Reason not Specified|5|||
146870686|NCT03861936|529698159|FG002|Overall Study|Reason not Specified|3|||
146870687|NCT02319668|529698160|FG000|Overall Study|Other (Not specified)|0|||
146870688|NCT02319668|529698161|FG001|Overall Study|Other (Not specified)|2|||
146870689|NCT01372150|529698166|FG000|Overall Study|Lack of Efficacy|3|||
146870690|NCT01372150|529698167|FG001|Overall Study|Lack of Efficacy|0|||
146870691|NCT01372150|529698168|FG002|Overall Study|Lack of Efficacy|1|||
146870692|NCT01372150|529698166|FG000|Overall Study|Lost to Follow-up|4|||
146870693|NCT01372150|529698167|FG001|Overall Study|Lost to Follow-up|5|||
146870694|NCT01372150|529698168|FG002|Overall Study|Lost to Follow-up|6|||
146870695|NCT01372150|529698166|FG000|Overall Study|Protocol Violation|1|||
146870696|NCT01372150|529698167|FG001|Overall Study|Protocol Violation|0|||
146870697|NCT01372150|529698168|FG002|Overall Study|Protocol Violation|3|||
146870698|NCT01372150|529698166|FG000|Overall Study|Withdrawal by Subject|2|||
146870699|NCT01372150|529698167|FG001|Overall Study|Withdrawal by Subject|7|||
146870700|NCT01372150|529698168|FG002|Overall Study|Withdrawal by Subject|2|||
146870701|NCT01372150|529698166|FG000|Overall Study|Other|1|||
146870702|NCT01372150|529698167|FG001|Overall Study|Other|0|||
146870703|NCT01372150|529698168|FG002|Overall Study|Other|2|||
146870704|NCT01372150|529698166|FG000|Overall Study|Adverse Event|2|||
146870705|NCT01372150|529698167|FG001|Overall Study|Adverse Event|1|||
146870706|NCT01372150|529698168|FG002|Overall Study|Adverse Event|2|||
146870707|NCT01372150|529698166|FG000|Overall Study|Randomized but not treated|0|||
146870708|NCT01372150|529698167|FG001|Overall Study|Randomized but not treated|1|||
146870709|NCT01372150|529698168|FG002|Overall Study|Randomized but not treated|0|||
146870710|NCT03198520|529698169|FG000|Overall Study|Physician Decision|2|||
146870711|NCT03198520|529698169|FG000|Overall Study|Protocol Violation|2|||
146870712|NCT03198520|529698169|FG000|Overall Study|Withdrawal by Subject|1|||
146870713|NCT03198520|529698169|FG000|Overall Study|Study Ended|1|||
146870714|NCT01670539|529698170|FG000|Overall Study|Death|3|||
146870715|NCT01670539|529698171|FG001|Overall Study|Death|5|||
146870716|NCT01670539|529698170|FG000|Overall Study|Withdrawal by Subject|3|||
146870717|NCT01670539|529698171|FG001|Overall Study|Withdrawal by Subject|0|||
146870718|NCT01236573|529698172|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
146870719|NCT01236573|529698173|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
146870720|NCT01236573|529698174|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
146870721|NCT01236573|529698175|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
146870722|NCT01236573|529698176|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
146870723|NCT01236573|529698177|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
146870724|NCT01236573|529698178|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
146870725|NCT01236573|529698179|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
146870726|NCT01236573|529698180|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
146870727|NCT01236573|529698181|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
146870728|NCT01236573|529698182|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
146870729|NCT01236573|529698172|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146870730|NCT01236573|529698173|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146870731|NCT01236573|529698174|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146870732|NCT01236573|529698175|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146870733|NCT01236573|529698176|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146870734|NCT01236573|529698177|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146870735|NCT01236573|529698178|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146870736|NCT01236573|529698179|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146870737|NCT01236573|529698180|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
146870738|NCT01236573|529698181|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146870739|NCT01236573|529698182|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146870740|NCT01236573|529698172|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146870741|NCT01236573|529698173|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146870742|NCT01236573|529698174|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146870743|NCT01236573|529698175|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146870744|NCT01236573|529698176|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146870745|NCT01236573|529698177|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146870746|NCT01236573|529698178|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146870747|NCT01236573|529698179|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146870748|NCT01236573|529698180|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146535822|NCT00726609|528472413|FG000|Overall Study|Missing|42|||
146870749|NCT01236573|529698181|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146870750|NCT01236573|529698182|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
146870751|NCT00823823|529698183|FG000|Overall Study|Lost to Follow-up|3|||
146535823|NCT00726609|528472413|FG000|Overall Study|Other|3|||
146535824|NCT00746551|528472417|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
146535825|NCT00746551|528472418|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
146535826|NCT00746551|528472417|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
146535827|NCT00746551|528472418|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
146535828|NCT00746551|528472417|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
146535829|NCT00746551|528472418|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
146535830|NCT02029417|528472419|FG000|Overall Study|Death|1|||
146535831|NCT02029417|528472419|FG000|Overall Study|Adverse Event|1|||
146535832|NCT03040726|528472420|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
146535833|NCT03040726|528472421|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
146535834|NCT03040726|528472420|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
146535835|NCT03040726|528472421|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
146535836|NCT03040726|528472420|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
146535837|NCT03040726|528472421|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
146535838|NCT03040726|528472420|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
146535839|NCT03040726|528472421|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
146535840|NCT03040726|528472420|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
146535841|NCT03040726|528472421|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
146535842|NCT00171249|528472423|FG000|Overall Study|Withdrawal by Subject|2|||
146535843|NCT00171249|528472424|FG001|Overall Study|Withdrawal by Subject|0|||
146535844|NCT00171249|528472425|FG002|Overall Study|Withdrawal by Subject|0|||
146535845|NCT00171249|528472426|FG003|Overall Study|Withdrawal by Subject|6|||
146535846|NCT00171249|528472427|FG004|Overall Study|Withdrawal by Subject|0|||
146535847|NCT00171249|528472428|FG005|Overall Study|Withdrawal by Subject|0|||
146535848|NCT00171249|528472429|FG006|Overall Study|Withdrawal by Subject|0|||
146535849|NCT00171249|528472423|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
146535850|NCT00171249|528472424|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
146535851|NCT00171249|528472425|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
146535852|NCT00171249|528472426|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
146535853|NCT00171249|528472427|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
146535854|NCT00171249|528472428|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
146535855|NCT00171249|528472429|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
146535856|NCT00171249|528472423|FG000|Overall Study|Death|7|||
146535857|NCT00171249|528472424|FG001|Overall Study|Death|1|||
146535858|NCT00171249|528472425|FG002|Overall Study|Death|0|||
146535859|NCT00171249|528472426|FG003|Overall Study|Death|4|||
146535860|NCT00171249|528472427|FG004|Overall Study|Death|0|||
146535861|NCT00171249|528472428|FG005|Overall Study|Death|3|||
146535862|NCT00171249|528472429|FG006|Overall Study|Death|1|||
146535863|NCT00171249|528472423|FG000|Overall Study|Other|10|||
146535864|NCT00171249|528472424|FG001|Overall Study|Other|0|||
146535865|NCT00171249|528472425|FG002|Overall Study|Other|0|||
146535866|NCT00171249|528472426|FG003|Overall Study|Other|43|||
146535867|NCT00171249|528472427|FG004|Overall Study|Other|0|||
146535868|NCT00171249|528472428|FG005|Overall Study|Other|2|||
146535869|NCT00171249|528472429|FG006|Overall Study|Other|0|||
146870752|NCT00823823|529698184|FG001|Overall Study|Lost to Follow-up|1|||
146870753|NCT00823823|529698183|FG000|Overall Study|Protocol Violation|5|||
146870754|NCT00823823|529698184|FG001|Overall Study|Protocol Violation|5|||
146870755|NCT00536809|529698185|FG000|Phase II|Adverse Event|1|||
146870756|NCT00536809|529698185|FG000|Phase II|Referred for surgical resection|1|||
146870757|NCT00113074|529698195|FG000|Overall Study|Lost to Follow-up|10|||
146870758|NCT00113074|529698196|FG001|Overall Study|Lost to Follow-up|10|||
146535870|NCT00171249|528472423|FG000|Overall Study|No Longer Requires Study Drug|4|||
146870759|NCT00113074|529698197|FG002|Overall Study|Lost to Follow-up|14|||
146870760|NCT02941926|529698199|FG000|Core Phase|Progressive disease|1109|||
146870761|NCT02941926|529698199|FG000|Core Phase|Adverse Event|504|||
146535871|NCT00171249|528472424|FG001|Overall Study|No Longer Requires Study Drug|0|||
146870762|NCT02941926|529698199|FG000|Core Phase|Subject/guardian decision|127|||
146535872|NCT00171249|528472425|FG002|Overall Study|No Longer Requires Study Drug|0|||
146535873|NCT00171249|528472426|FG003|Overall Study|No Longer Requires Study Drug|3|||
146535874|NCT00171249|528472427|FG004|Overall Study|No Longer Requires Study Drug|0|||
146535875|NCT00171249|528472428|FG005|Overall Study|No Longer Requires Study Drug|5|||
146535876|NCT00171249|528472429|FG006|Overall Study|No Longer Requires Study Drug|0|||
146535877|NCT00171249|528472423|FG000|Overall Study|Administrative Problems|1|||
146535878|NCT00171249|528472424|FG001|Overall Study|Administrative Problems|0|||
146870763|NCT02941926|529698199|FG000|Core Phase|Physician Decision|112|||
146870764|NCT02941926|529698199|FG000|Core Phase|Death|46|||
146870765|NCT02941926|529698199|FG000|Core Phase|Protocol deviation|34|||
146870766|NCT02941926|529698199|FG000|Core Phase|Lost to Follow-up|8|||
146870767|NCT02941926|529698199|FG000|Core Phase|Technical problems|5|||
146870768|NCT02941926|529698199|FG000|Extension Phase|Physician Decision|155|||
146870769|NCT02941926|529698199|FG000|Extension Phase|Progressive disease|115|||
146870770|NCT02941926|529698199|FG000|Extension Phase|Adverse Event|13|||
146870771|NCT02941926|529698199|FG000|Extension Phase|Subject/Guardian decision|12|||
146870772|NCT02941926|529698199|FG000|Extension Phase|Death|6|||
146870773|NCT00097773|529698200|FG000|Overall Study|Lost to Follow-up|2|||
146870774|NCT00097773|529698201|FG001|Overall Study|Lost to Follow-up|2|||
146870775|NCT00097773|529698202|FG002|Overall Study|Lost to Follow-up|0|||
146870776|NCT00097773|529698203|FG003|Overall Study|Lost to Follow-up|1|||
146870777|NCT00097773|529698200|FG000|Overall Study|Physician Decision|2|||
146870778|NCT00097773|529698201|FG001|Overall Study|Physician Decision|2|||
146870779|NCT00097773|529698202|FG002|Overall Study|Physician Decision|3|||
146870780|NCT00097773|529698203|FG003|Overall Study|Physician Decision|1|||
146870781|NCT00097773|529698200|FG000|Overall Study|Withdrawal by Subject|3|||
146870782|NCT00097773|529698201|FG001|Overall Study|Withdrawal by Subject|3|||
146870783|NCT00097773|529698202|FG002|Overall Study|Withdrawal by Subject|3|||
146870784|NCT00097773|529698203|FG003|Overall Study|Withdrawal by Subject|1|||
146870785|NCT00097773|529698200|FG000|Overall Study|Adverse Event|0|||
146870786|NCT00097773|529698201|FG001|Overall Study|Adverse Event|1|||
146870787|NCT00097773|529698202|FG002|Overall Study|Adverse Event|0|||
146870788|NCT00097773|529698203|FG003|Overall Study|Adverse Event|0|||
146870789|NCT00097773|529698200|FG000|Overall Study|Other|1|||
146870790|NCT00097773|529698201|FG001|Overall Study|Other|0|||
146870791|NCT00097773|529698202|FG002|Overall Study|Other|2|||
146870792|NCT00097773|529698203|FG003|Overall Study|Other|0|||
146870793|NCT04305275|529698204|FG000|Overall Study|Adverse Event|4|||
146870794|NCT04305275|529698205|FG001|Overall Study|Adverse Event|0|||
146870795|NCT04305275|529698204|FG000|Overall Study|Lost to Follow-up|1|||
146870796|NCT04305275|529698205|FG001|Overall Study|Lost to Follow-up|1|||
146870797|NCT04305275|529698204|FG000|Overall Study|Withdrawal by Participant|8|||
146870798|NCT04305275|529698205|FG001|Overall Study|Withdrawal by Participant|1|||
146870799|NCT02243865|529698206|FG000|Overall Study|Protocol Violation|1|||
146870800|NCT02243865|529698207|FG001|Overall Study|Protocol Violation|3|||
146870801|NCT02243865|529698206|FG000|Overall Study|Lost to Follow-up|1|||
146870802|NCT02243865|529698207|FG001|Overall Study|Lost to Follow-up|1|||
146870803|NCT02243865|529698206|FG000|Overall Study|Withdrawal by Subject|1|||
146870804|NCT02243865|529698207|FG001|Overall Study|Withdrawal by Subject|0|||
146870805|NCT02243865|529698206|FG000|Overall Study|Adverse Event|1|||
146870806|NCT02243865|529698207|FG001|Overall Study|Adverse Event|1|||
146870807|NCT02003014|529698213|FG000|Overall Study|Case report forms uncollected|9|||
146870808|NCT02003014|529698213|FG000|Overall Study|Treatment started after contract period|1|||
146870809|NCT02003014|529698213|FG000|Overall Study|Patient did not visit the study site|5|||
146870810|NCT02003014|529698213|FG000|Overall Study|Investigator's transfer|4|||
146870811|NCT01660451|529698214|FG000|Overall Study|Protocol Violation|0|||
146870812|NCT01660451|529698215|FG001|Overall Study|Protocol Violation|1|||
146870813|NCT01660451|529698216|FG002|Overall Study|Protocol Violation|1|||
146870814|NCT01660451|529698214|FG000|Overall Study|AE not associated with clinical disease progression|13|||
146870815|NCT01660451|529698215|FG001|Overall Study|AE not associated with clinical disease progression|10|||
146870816|NCT01660451|529698216|FG002|Overall Study|AE not associated with clinical disease progression|40|||
146870817|NCT01660451|529698214|FG000|Overall Study|AE associated with clinical disease progression|1|||
146870818|NCT01660451|529698215|FG001|Overall Study|AE associated with clinical disease progression|3|||
146870819|NCT01660451|529698216|FG002|Overall Study|AE associated with clinical disease progression|11|||
146870820|NCT01660451|529698214|FG000|Overall Study|Sponsor Decision|0|||
146870821|NCT01660451|529698215|FG001|Overall Study|Sponsor Decision|0|||
146870822|NCT01660451|529698216|FG002|Overall Study|Sponsor Decision|1|||
146870823|NCT01660451|529698214|FG000|Overall Study|Protocol Deviation|0|||
146870824|NCT01660451|529698215|FG001|Overall Study|Protocol Deviation|0|||
146870825|NCT01660451|529698216|FG002|Overall Study|Protocol Deviation|1|||
146870826|NCT01660451|529698214|FG000|Overall Study|Physician Decision|1|||
146870827|NCT01660451|529698215|FG001|Overall Study|Physician Decision|2|||
146870828|NCT01660451|529698216|FG002|Overall Study|Physician Decision|5|||
146870829|NCT01660451|529698214|FG000|Overall Study|Withdrawal by Subject|1|||
146870830|NCT01660451|529698215|FG001|Overall Study|Withdrawal by Subject|1|||
146870831|NCT01660451|529698216|FG002|Overall Study|Withdrawal by Subject|20|||
146870832|NCT01660451|529698214|FG000|Overall Study|Trial closure.|0|||
146870833|NCT01660451|529698215|FG001|Overall Study|Trial closure.|0|||
146870834|NCT01660451|529698216|FG002|Overall Study|Trial closure.|1|||
146870835|NCT01660451|529698214|FG000|Overall Study|Switching to other therapy|0|||
146870836|NCT01660451|529698215|FG001|Overall Study|Switching to other therapy|1|||
146870837|NCT01660451|529698216|FG002|Overall Study|Switching to other therapy|1|||
146870838|NCT01660451|529698214|FG000|Overall Study|Progressive disease - clinical progression|4|||
146870839|NCT01660451|529698215|FG001|Overall Study|Progressive disease - clinical progression|10|||
146870840|NCT01660451|529698216|FG002|Overall Study|Progressive disease - clinical progression|9|||
146870841|NCT01660451|529698214|FG000|Overall Study|Progressive disease - radiological progression|12|||
146870842|NCT01660451|529698215|FG001|Overall Study|Progressive disease - radiological progression|23|||
146870843|NCT01660451|529698216|FG002|Overall Study|Progressive disease - radiological progression|50|||
146870844|NCT01660451|529698214|FG000|Overall Study|Death|1|||
146870845|NCT01660451|529698215|FG001|Overall Study|Death|0|||
146870846|NCT01660451|529698216|FG002|Overall Study|Death|1|||
146870847|NCT01660451|529698214|FG000|Overall Study|Other|0|||
146870848|NCT01660451|529698215|FG001|Overall Study|Other|0|||
146870849|NCT01660451|529698216|FG002|Overall Study|Other|1|||
146870850|NCT05093322|529698217|FG000|Overall Study|Death|6|||
146870851|NCT05093322|529698218|FG001|Overall Study|Death|2|||
146870852|NCT05093322|529698217|FG000|Overall Study|Other|4|||
146870853|NCT05093322|529698218|FG001|Overall Study|Other|1|||
146870854|NCT00074581|529698220|FG000|Overall Study|Death|15|||
146870855|NCT00074581|529698221|FG001|Overall Study|Death|16|||
146870856|NCT00074581|529698220|FG000|Overall Study|Withdrawal by Subject|50|||
146870857|NCT00074581|529698221|FG001|Overall Study|Withdrawal by Subject|49|||
146870858|NCT00074581|529698220|FG000|Overall Study|Unable to adhere to visit schedule|13|||
146870859|NCT00074581|529698221|FG001|Overall Study|Unable to adhere to visit schedule|14|||
146870860|NCT00074581|529698220|FG000|Overall Study|Relocated|14|||
146870861|NCT00074581|529698221|FG001|Overall Study|Relocated|9|||
146870862|NCT00074581|529698220|FG000|Overall Study|Were withdrawn by investigator|5|||
146870863|NCT00074581|529698221|FG001|Overall Study|Were withdrawn by investigator|2|||
146870864|NCT00074581|529698220|FG000|Overall Study|Lost to Follow-up|16|||
146870865|NCT00074581|529698221|FG001|Overall Study|Lost to Follow-up|11|||
146870866|NCT00074581|529698220|FG000|Overall Study|Ended relationship w. index participant|117|||
146870867|NCT00074581|529698221|FG001|Overall Study|Ended relationship w. index participant|106|||
146870868|NCT00074581|529698220|FG000|Overall Study|Other|14|||
146870869|NCT00074581|529698221|FG001|Overall Study|Other|19|||
146870870|NCT05293743|529698229|FG000|Overall Study|Withdrawal by Subject|1|||
146870871|NCT05293743|529698230|FG001|Overall Study|Withdrawal by Subject|0|||
146870872|NCT02064920|529698231|FG000|Overall Study|Adverse Event|0|||
146870873|NCT02064920|529698232|FG001|Overall Study|Adverse Event|4|||
146870874|NCT02064920|529698231|FG000|Overall Study|Physician Decision|0|||
146870875|NCT02064920|529698232|FG001|Overall Study|Physician Decision|1|||
146870876|NCT02064920|529698231|FG000|Overall Study|Technical Problems|0|||
146870877|NCT02064920|529698232|FG001|Overall Study|Technical Problems|1|||
146870878|NCT02064920|529698231|FG000|Overall Study|Withdrawal by Subject|1|||
146870879|NCT02064920|529698232|FG001|Overall Study|Withdrawal by Subject|3|||
146870880|NCT00916279|529698233|FG000|Overall Study|Death|2|||
146870881|NCT00916279|529698233|FG000|Overall Study|Lost to Follow-up|2|||
146870882|NCT00310804|529698234|FG000|Overall Study|Lost to Follow-up|2|||
146870883|NCT00310804|529698235|FG001|Overall Study|Lost to Follow-up|0|||
146870884|NCT00310804|529698234|FG000|Overall Study|Withdrawal by Subject|3|||
146870885|NCT00310804|529698235|FG001|Overall Study|Withdrawal by Subject|0|||
146870886|NCT00688155|529698240|FG000|Overall Study|Withdrawal by Subject|2|||
146870887|NCT00688155|529698241|FG001|Overall Study|Withdrawal by Subject|2|||
146870888|NCT00688155|529698242|FG002|Overall Study|Withdrawal by Subject|1|||
146870889|NCT00688155|529698243|FG003|Overall Study|Withdrawal by Subject|1|||
146870890|NCT03734016|529698248|FG000|Overall Study|Sponsor Ended Study|225|||
146870891|NCT03734016|529698249|FG001|Overall Study|Sponsor Ended Study|200|||
146870892|NCT03734016|529698248|FG000|Overall Study|Death|69|||
146870893|NCT03734016|529698249|FG001|Overall Study|Death|83|||
146870894|NCT03734016|529698248|FG000|Overall Study|Withdrawal by Subject|21|||
146870895|NCT03734016|529698249|FG001|Overall Study|Withdrawal by Subject|27|||
146870896|NCT03734016|529698248|FG000|Overall Study|Physician Decision|1|||
146870897|NCT03734016|529698249|FG001|Overall Study|Physician Decision|12|||
146870898|NCT03734016|529698248|FG000|Overall Study|Lost to Follow-up|6|||
146870899|NCT03734016|529698249|FG001|Overall Study|Lost to Follow-up|2|||
146870900|NCT03734016|529698248|FG000|Overall Study|Miscellaneous|5|||
146870901|NCT03734016|529698249|FG001|Overall Study|Miscellaneous|1|||
146870902|NCT01979835|529698250|FG000|Primary Outcome SA Measurment|failed insertion|18|||
146870903|NCT01979835|529698250|FG000|Follow-up|Lost to Follow-up|32|||
146870904|NCT01428661|529698253|FG000|Double-Masked Phase|Protocol Violation|9|||
146870905|NCT01428661|529698254|FG001|Double-Masked Phase|Protocol Violation|4|||
146870906|NCT01428661|529698255|FG002|Double-Masked Phase|Protocol Violation|0|||
146870907|NCT01428661|529698253|FG000|Double-Masked Phase|Adverse Event|13|||
146870908|NCT01428661|529698254|FG001|Double-Masked Phase|Adverse Event|4|||
146870909|NCT01428661|529698255|FG002|Double-Masked Phase|Adverse Event|0|||
146870910|NCT01428661|529698253|FG000|Double-Masked Phase|Lost to Follow-up|14|||
146870911|NCT01428661|529698254|FG001|Double-Masked Phase|Lost to Follow-up|14|||
146870912|NCT01428661|529698255|FG002|Double-Masked Phase|Lost to Follow-up|0|||
146870913|NCT01428661|529698253|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
146870914|NCT01428661|529698254|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
146870915|NCT01428661|529698255|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
146870916|NCT01428661|529698253|FG000|Double-Masked Phase|Lack of Efficacy|2|||
146535879|NCT00171249|528472425|FG002|Overall Study|Administrative Problems|0|||
146535880|NCT00171249|528472426|FG003|Overall Study|Administrative Problems|2|||
146535881|NCT00171249|528472427|FG004|Overall Study|Administrative Problems|0|||
146535882|NCT00171249|528472428|FG005|Overall Study|Administrative Problems|0|||
146535883|NCT00171249|528472429|FG006|Overall Study|Administrative Problems|0|||
146535884|NCT00171249|528472423|FG000|Overall Study|Adverse Event|3|||
146535885|NCT00171249|528472424|FG001|Overall Study|Adverse Event|1|||
146535886|NCT00171249|528472425|FG002|Overall Study|Adverse Event|0|||
146535887|NCT00171249|528472426|FG003|Overall Study|Adverse Event|15|||
146535888|NCT00171249|528472427|FG004|Overall Study|Adverse Event|0|||
146535889|NCT00171249|528472428|FG005|Overall Study|Adverse Event|2|||
146535890|NCT00171249|528472429|FG006|Overall Study|Adverse Event|0|||
146535891|NCT00171249|528472423|FG000|Overall Study|Lost to Follow-up|5|||
146535892|NCT00171249|528472424|FG001|Overall Study|Lost to Follow-up|0|||
146535893|NCT00171249|528472425|FG002|Overall Study|Lost to Follow-up|0|||
146535894|NCT00171249|528472426|FG003|Overall Study|Lost to Follow-up|9|||
146535895|NCT00171249|528472427|FG004|Overall Study|Lost to Follow-up|0|||
146535896|NCT00171249|528472428|FG005|Overall Study|Lost to Follow-up|0|||
146535897|NCT00171249|528472429|FG006|Overall Study|Lost to Follow-up|0|||
146535898|NCT01232283|528472432|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
146535899|NCT01232283|528472433|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
146535900|NCT01232283|528472434|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
146535901|NCT01232283|528472435|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
146535902|NCT01232283|528472436|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
146535903|NCT01232283|528472437|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
146535904|NCT01232283|528472438|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
146535905|NCT01232283|528472439|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
146535906|NCT01232283|528472440|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
146535907|NCT01232283|528472441|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
146535908|NCT01232283|528472432|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
146535909|NCT01232283|528472433|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
146535910|NCT01232283|528472434|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
146535911|NCT01232283|528472435|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
146535912|NCT01232283|528472436|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
146535913|NCT01232283|528472437|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
146535914|NCT01232283|528472438|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
146535915|NCT01232283|528472439|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
146535916|NCT01232283|528472440|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
146535917|NCT01232283|528472441|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
146535918|NCT01232283|528472432|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
146535919|NCT01232283|528472433|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
146535920|NCT01232283|528472434|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
146535921|NCT01232283|528472435|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
146535922|NCT01232283|528472436|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
146535923|NCT01232283|528472437|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
146763813|NCT01090024|529302899|FG011|Period 2|Adverse Event|0|||
146763814|NCT01090024|529302900|FG012|Period 2|Adverse Event|0|||
146763815|NCT01090024|529302901|FG013|Period 2|Adverse Event|0|||
146763816|NCT01090024|529302902|FG014|Period 2|Adverse Event|0|||
146763817|NCT01090024|529302903|FG015|Period 2|Adverse Event|0|||
146763818|NCT01090024|529302904|FG016|Period 2|Adverse Event|0|||
146763819|NCT01090024|529302905|FG017|Period 2|Adverse Event|0|||
146763820|NCT01090024|529302888|FG000|Period 3|Withdrawal by Subject|0|||
146763821|NCT01090024|529302889|FG001|Period 3|Withdrawal by Subject|0|||
146763822|NCT01090024|529302890|FG002|Period 3|Withdrawal by Subject|0|||
146763823|NCT01090024|529302891|FG003|Period 3|Withdrawal by Subject|0|||
146763824|NCT01090024|529302892|FG004|Period 3|Withdrawal by Subject|0|||
146763825|NCT01090024|529302893|FG005|Period 3|Withdrawal by Subject|0|||
146763826|NCT01090024|529302894|FG006|Period 3|Withdrawal by Subject|0|||
146763827|NCT01090024|529302895|FG007|Period 3|Withdrawal by Subject|0|||
146763828|NCT01090024|529302896|FG008|Period 3|Withdrawal by Subject|0|||
146763829|NCT01090024|529302897|FG009|Period 3|Withdrawal by Subject|0|||
146763830|NCT01090024|529302898|FG010|Period 3|Withdrawal by Subject|0|||
146763831|NCT01090024|529302899|FG011|Period 3|Withdrawal by Subject|0|||
146763832|NCT01090024|529302900|FG012|Period 3|Withdrawal by Subject|0|||
146763833|NCT01090024|529302901|FG013|Period 3|Withdrawal by Subject|0|||
146763834|NCT01090024|529302902|FG014|Period 3|Withdrawal by Subject|0|||
146763835|NCT01090024|529302903|FG015|Period 3|Withdrawal by Subject|1|||
146763836|NCT01090024|529302904|FG016|Period 3|Withdrawal by Subject|0|||
146763837|NCT01090024|529302905|FG017|Period 3|Withdrawal by Subject|0|||
146763838|NCT01090024|529302888|FG000|Period 3|Protocol Violation|0|||
146763839|NCT01090024|529302889|FG001|Period 3|Protocol Violation|0|||
146870917|NCT01428661|529698254|FG001|Double-Masked Phase|Lack of Efficacy|1|||
146870918|NCT01428661|529698255|FG002|Double-Masked Phase|Lack of Efficacy|0|||
146870919|NCT01428661|529698253|FG000|Double-Masked Phase|*Various|1|||
146535924|NCT01232283|528472438|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
146535925|NCT01232283|528472439|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
146535926|NCT01232283|528472440|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
146535927|NCT01232283|528472441|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
146535928|NCT01232283|528472432|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
146535929|NCT01232283|528472433|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
146535930|NCT01232283|528472434|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
146535931|NCT01232283|528472435|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
146535932|NCT01232283|528472436|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
146535933|NCT01232283|528472437|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
146535934|NCT01232283|528472438|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
146535935|NCT01232283|528472439|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
146535936|NCT01232283|528472440|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
146535937|NCT01232283|528472441|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
146535938|NCT01232283|528472432|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
146535939|NCT01232283|528472433|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
146535940|NCT01232283|528472434|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
146535941|NCT01232283|528472435|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
146535942|NCT01232283|528472436|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
146535943|NCT01232283|528472437|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
146535944|NCT01232283|528472438|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
146535945|NCT01232283|528472439|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
146535946|NCT01232283|528472440|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
146535947|NCT01232283|528472441|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
146535948|NCT01232283|528472432|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
146535949|NCT01232283|528472433|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
146535950|NCT01232283|528472434|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
146535951|NCT01232283|528472435|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
146535952|NCT01232283|528472436|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
146535953|NCT01232283|528472437|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
146535954|NCT01232283|528472438|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
146535955|NCT01232283|528472439|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
146535956|NCT01232283|528472440|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
146535957|NCT01232283|528472441|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
146535958|NCT01232283|528472432|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
146535959|NCT01232283|528472433|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
146535960|NCT01232283|528472434|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
146535961|NCT01232283|528472435|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
146535962|NCT01232283|528472436|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
146535963|NCT01232283|528472437|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
146535964|NCT01232283|528472438|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
146535965|NCT01232283|528472439|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
146535966|NCT01232283|528472440|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
146535967|NCT01232283|528472441|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
146535968|NCT01232283|528472432|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
146535969|NCT01232283|528472433|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
146535970|NCT01232283|528472434|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
146535971|NCT01232283|528472435|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
146535972|NCT01232283|528472436|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
146535973|NCT01232283|528472437|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
146535974|NCT01232283|528472438|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
146535975|NCT01232283|528472439|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
146535976|NCT01232283|528472440|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
146535977|NCT01232283|528472441|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
146535978|NCT01232283|528472432|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
146535979|NCT01232283|528472433|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
146535980|NCT01232283|528472434|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
146535981|NCT01232283|528472435|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
146535982|NCT01232283|528472436|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
146535983|NCT01232283|528472437|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
146870920|NCT01428661|529698254|FG001|Double-Masked Phase|*Various|6|||
146535984|NCT01232283|528472438|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
146535985|NCT01232283|528472439|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
146535986|NCT01232283|528472440|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
146535987|NCT01232283|528472441|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
146535988|NCT01232283|528472432|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
146535989|NCT01232283|528472433|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
146535990|NCT01232283|528472434|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
146535991|NCT01232283|528472435|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
146535992|NCT01232283|528472436|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
146535993|NCT01232283|528472437|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
146535994|NCT01232283|528472438|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
146535995|NCT01232283|528472439|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
146535996|NCT01232283|528472440|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
146535997|NCT01232283|528472441|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
146535998|NCT01232283|528472432|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
146535999|NCT01232283|528472433|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
146536000|NCT01232283|528472434|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
146536001|NCT01232283|528472435|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
146536002|NCT01232283|528472436|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
146536003|NCT01232283|528472437|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
146536004|NCT01232283|528472438|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
146536005|NCT01232283|528472439|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
146536006|NCT01232283|528472440|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
146536007|NCT01232283|528472441|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
146536008|NCT01232283|528472432|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
146536009|NCT01232283|528472433|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
146536010|NCT01232283|528472434|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
146536011|NCT01232283|528472435|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
146536012|NCT01232283|528472436|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
146536013|NCT01232283|528472437|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
146536014|NCT01232283|528472438|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
146536015|NCT01232283|528472439|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
146536016|NCT01232283|528472440|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
146536017|NCT01232283|528472441|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
146536018|NCT01232283|528472432|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
146536019|NCT01232283|528472433|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
146536020|NCT01232283|528472434|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
146536021|NCT01232283|528472435|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
146536022|NCT01232283|528472436|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
146536023|NCT01232283|528472437|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
146536024|NCT01232283|528472438|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
146536025|NCT01232283|528472439|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
146536026|NCT01232283|528472440|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
146536027|NCT01232283|528472441|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
146536028|NCT01232283|528472432|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
146536029|NCT01232283|528472433|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
146536030|NCT01232283|528472434|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
146536031|NCT01232283|528472435|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
146536032|NCT01232283|528472436|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
146536033|NCT01232283|528472437|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
146536034|NCT01232283|528472438|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
146536035|NCT01232283|528472439|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
146536036|NCT01232283|528472440|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
146536037|NCT01232283|528472441|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
146536038|NCT01232283|528472432|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
146536039|NCT01232283|528472433|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
146536040|NCT01232283|528472434|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
146536041|NCT01232283|528472435|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
146536042|NCT01232283|528472436|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
146536043|NCT01232283|528472437|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
146536044|NCT01232283|528472438|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
146536045|NCT01232283|528472439|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
146536046|NCT01232283|528472440|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
146536047|NCT01232283|528472441|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
146536048|NCT01232283|528472432|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
146536049|NCT01232283|528472433|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
146536050|NCT01232283|528472434|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
146536051|NCT01232283|528472435|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
146536052|NCT01232283|528472436|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
146763840|NCT01090024|529302890|FG002|Period 3|Protocol Violation|0|||
146536053|NCT01232283|528472437|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
146536054|NCT01232283|528472438|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
146536055|NCT01232283|528472439|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
146536056|NCT01232283|528472440|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
146536057|NCT01232283|528472441|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
146536058|NCT01232283|528472432|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
146536059|NCT01232283|528472433|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
146536060|NCT01232283|528472434|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
146536061|NCT01232283|528472435|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
146536062|NCT01232283|528472436|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
146536063|NCT01232283|528472437|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
146536064|NCT01232283|528472438|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
146536065|NCT01232283|528472439|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
146536066|NCT01232283|528472440|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
146536067|NCT01232283|528472441|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
146536068|NCT01232283|528472432|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
146536069|NCT01232283|528472433|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
146536070|NCT01232283|528472434|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
146536071|NCT01232283|528472435|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
146536072|NCT01232283|528472436|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
146536073|NCT01232283|528472437|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
146536074|NCT01232283|528472438|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
146536075|NCT01232283|528472439|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
146536076|NCT01232283|528472440|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
146536077|NCT01232283|528472441|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
146536078|NCT01232283|528472432|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
146536079|NCT01232283|528472433|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
146536080|NCT01232283|528472434|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
146536081|NCT01232283|528472435|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
146536082|NCT01232283|528472436|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
146536083|NCT01232283|528472437|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
146536084|NCT01232283|528472438|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
146536085|NCT01232283|528472439|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
146536086|NCT01232283|528472440|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
146536087|NCT01232283|528472441|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
146536088|NCT01232283|528472432|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
146536089|NCT01232283|528472433|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
146536090|NCT01232283|528472434|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
146536091|NCT01232283|528472435|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
146536092|NCT01232283|528472436|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
146536093|NCT01232283|528472437|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
146536094|NCT01232283|528472438|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
146536095|NCT01232283|528472439|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
146536096|NCT01232283|528472440|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
146536097|NCT01232283|528472441|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
146536098|NCT01232283|528472432|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
146536099|NCT01232283|528472433|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
146536100|NCT01232283|528472434|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
146536101|NCT01232283|528472435|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
146536102|NCT01232283|528472436|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
146536103|NCT01232283|528472437|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
146536104|NCT01232283|528472438|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
146536105|NCT01232283|528472439|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
146536106|NCT01232283|528472440|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
146536107|NCT01232283|528472441|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
146536108|NCT01232283|528472432|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
146536109|NCT01232283|528472433|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
146536110|NCT01232283|528472434|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
146536111|NCT01232283|528472435|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
146536112|NCT01232283|528472436|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
146536113|NCT01232283|528472437|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
146536114|NCT01232283|528472438|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
146870921|NCT01428661|529698255|FG002|Double-Masked Phase|*Various|0|||
146870922|NCT01428661|529698253|FG000|Open Label Extension|Protocol Violation|0|||
146870923|NCT01428661|529698254|FG001|Open Label Extension|Protocol Violation|0|||
146870924|NCT01428661|529698255|FG002|Open Label Extension|Protocol Violation|9|||
146536115|NCT01232283|528472439|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
146536116|NCT01232283|528472440|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
146536117|NCT01232283|528472441|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
146536118|NCT01232283|528472432|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
146536119|NCT01232283|528472433|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
146536120|NCT01232283|528472434|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
146536121|NCT01232283|528472435|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
146536122|NCT01232283|528472436|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
146536123|NCT01232283|528472437|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
146536124|NCT01232283|528472438|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
146536125|NCT01232283|528472439|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
146536126|NCT01232283|528472440|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
146536127|NCT01232283|528472441|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
146536128|NCT01232283|528472432|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
146536129|NCT01232283|528472433|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
146536130|NCT01232283|528472434|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
146536131|NCT01232283|528472435|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
146536132|NCT01232283|528472436|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
146536133|NCT01232283|528472437|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
146536134|NCT01232283|528472438|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
146536135|NCT01232283|528472439|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
146536136|NCT01232283|528472440|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
146536137|NCT01232283|528472441|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
146536138|NCT01232283|528472432|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
146536139|NCT01232283|528472433|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
146536140|NCT01232283|528472434|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
146536141|NCT01232283|528472435|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
146536142|NCT01232283|528472436|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
146536143|NCT01232283|528472437|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
146536144|NCT01232283|528472438|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
146536145|NCT01232283|528472439|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
146536146|NCT01232283|528472440|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
146536147|NCT01232283|528472441|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
146536148|NCT01232283|528472432|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
146536149|NCT01232283|528472433|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
146536150|NCT01232283|528472434|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
146536151|NCT01232283|528472435|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
146536152|NCT01232283|528472436|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
146536153|NCT01232283|528472437|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
146536154|NCT01232283|528472438|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
146536155|NCT01232283|528472439|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
146536156|NCT01232283|528472440|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
146536157|NCT01232283|528472441|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
146536158|NCT01232283|528472432|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
146536159|NCT01232283|528472433|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
146536160|NCT01232283|528472434|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
146536161|NCT01232283|528472435|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
146536162|NCT01232283|528472436|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
146536163|NCT01232283|528472437|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
146536164|NCT01232283|528472438|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
146536165|NCT01232283|528472439|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
146536166|NCT01232283|528472440|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
146536167|NCT01232283|528472441|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
146536168|NCT01232283|528472432|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
146536169|NCT01232283|528472433|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
146763841|NCT01090024|529302891|FG003|Period 3|Protocol Violation|0|||
146763842|NCT01090024|529302892|FG004|Period 3|Protocol Violation|0|||
146763843|NCT01090024|529302893|FG005|Period 3|Protocol Violation|0|||
146763844|NCT01090024|529302894|FG006|Period 3|Protocol Violation|0|||
146763845|NCT01090024|529302895|FG007|Period 3|Protocol Violation|0|||
146763846|NCT01090024|529302896|FG008|Period 3|Protocol Violation|1|||
146763847|NCT01090024|529302897|FG009|Period 3|Protocol Violation|0|||
146763848|NCT01090024|529302898|FG010|Period 3|Protocol Violation|0|||
146763849|NCT01090024|529302899|FG011|Period 3|Protocol Violation|0|||
146763850|NCT01090024|529302900|FG012|Period 3|Protocol Violation|0|||
146763851|NCT01090024|529302901|FG013|Period 3|Protocol Violation|0|||
146536170|NCT01232283|528472434|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
146536171|NCT01232283|528472435|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
146536172|NCT01232283|528472436|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
146536173|NCT01232283|528472437|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
146536174|NCT01232283|528472438|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
146536175|NCT01232283|528472439|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
146536176|NCT01232283|528472440|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
146536177|NCT01232283|528472441|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
146536178|NCT01981616|528472442|FG000|Overall Study|Adverse Event|0|||
146536179|NCT01981616|528472443|FG001|Overall Study|Adverse Event|1|||
146536180|NCT01981616|528472442|FG000|Overall Study|Protocol Violation|1|||
146536181|NCT01981616|528472443|FG001|Overall Study|Protocol Violation|0|||
146536182|NCT01420536|528472444|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
146536183|NCT01420536|528472445|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
146536184|NCT00764790|528472446|FG000|Overall Study|Protocol Violation|0|||
146536185|NCT00764790|528472447|FG001|Overall Study|Protocol Violation|0|||
146536186|NCT00764790|528472448|FG002|Overall Study|Protocol Violation|1|||
146536187|NCT00764790|528472446|FG000|Overall Study|Withdrawal by Subject|10|||
146536188|NCT00764790|528472447|FG001|Overall Study|Withdrawal by Subject|12|||
146536189|NCT00764790|528472448|FG002|Overall Study|Withdrawal by Subject|6|||
146536190|NCT00764790|528472446|FG000|Overall Study|Lost to Follow-up|28|||
146536191|NCT00764790|528472447|FG001|Overall Study|Lost to Follow-up|29|||
146536192|NCT00764790|528472448|FG002|Overall Study|Lost to Follow-up|23|||
146536193|NCT01773928|528472449|FG000|Overall Study|Adverse Event|0|||
146536194|NCT01773928|528472450|FG001|Overall Study|Adverse Event|0|||
146536195|NCT01773928|528472451|FG002|Overall Study|Adverse Event|0|||
146536196|NCT01773928|528472452|FG003|Overall Study|Adverse Event|0|||
146536197|NCT01773928|528472453|FG004|Overall Study|Adverse Event|0|||
146536198|NCT01773928|528472454|FG005|Overall Study|Adverse Event|0|||
146536199|NCT01773928|528472455|FG006|Overall Study|Adverse Event|0|||
146536200|NCT01773928|528472456|FG007|Overall Study|Adverse Event|1|||
146536201|NCT01773928|528472457|FG008|Overall Study|Adverse Event|0|||
146536202|NCT01773928|528472449|FG000|Overall Study|Physician Decision|0|||
146536203|NCT01773928|528472450|FG001|Overall Study|Physician Decision|0|||
146536204|NCT01773928|528472451|FG002|Overall Study|Physician Decision|0|||
146536205|NCT01773928|528472452|FG003|Overall Study|Physician Decision|1|||
146536206|NCT01773928|528472453|FG004|Overall Study|Physician Decision|0|||
146536207|NCT01773928|528472454|FG005|Overall Study|Physician Decision|0|||
146536208|NCT01773928|528472455|FG006|Overall Study|Physician Decision|0|||
146536209|NCT01773928|528472456|FG007|Overall Study|Physician Decision|0|||
146536210|NCT01773928|528472457|FG008|Overall Study|Physician Decision|0|||
146536211|NCT01773928|528472449|FG000|Overall Study|Withdrawal by Subject|5|||
146536212|NCT01773928|528472450|FG001|Overall Study|Withdrawal by Subject|4|||
146536213|NCT01773928|528472451|FG002|Overall Study|Withdrawal by Subject|4|||
146536214|NCT01773928|528472452|FG003|Overall Study|Withdrawal by Subject|4|||
146536215|NCT01773928|528472453|FG004|Overall Study|Withdrawal by Subject|7|||
146536216|NCT01773928|528472454|FG005|Overall Study|Withdrawal by Subject|1|||
146536217|NCT01773928|528472455|FG006|Overall Study|Withdrawal by Subject|0|||
146536218|NCT01773928|528472456|FG007|Overall Study|Withdrawal by Subject|0|||
146536219|NCT01773928|528472457|FG008|Overall Study|Withdrawal by Subject|1|||
146536220|NCT01773928|528472449|FG000|Overall Study|Lost to Follow-up|0|||
146536221|NCT01773928|528472450|FG001|Overall Study|Lost to Follow-up|0|||
146536222|NCT01773928|528472451|FG002|Overall Study|Lost to Follow-up|0|||
146536223|NCT01773928|528472452|FG003|Overall Study|Lost to Follow-up|0|||
146536224|NCT01773928|528472453|FG004|Overall Study|Lost to Follow-up|0|||
146536225|NCT01773928|528472454|FG005|Overall Study|Lost to Follow-up|1|||
146536226|NCT01773928|528472455|FG006|Overall Study|Lost to Follow-up|0|||
146536227|NCT01773928|528472456|FG007|Overall Study|Lost to Follow-up|0|||
146536228|NCT01773928|528472457|FG008|Overall Study|Lost to Follow-up|0|||
146536229|NCT01773928|528472449|FG000|Overall Study|Subject misrepresented age|0|||
146536230|NCT01773928|528472450|FG001|Overall Study|Subject misrepresented age|1|||
146536231|NCT01773928|528472451|FG002|Overall Study|Subject misrepresented age|0|||
146536232|NCT01773928|528472452|FG003|Overall Study|Subject misrepresented age|0|||
146536233|NCT01773928|528472453|FG004|Overall Study|Subject misrepresented age|0|||
146536234|NCT01773928|528472454|FG005|Overall Study|Subject misrepresented age|0|||
146536235|NCT01773928|528472455|FG006|Overall Study|Subject misrepresented age|0|||
146536236|NCT01773928|528472456|FG007|Overall Study|Subject misrepresented age|0|||
146763852|NCT01090024|529302902|FG014|Period 3|Protocol Violation|0|||
146763853|NCT01090024|529302903|FG015|Period 3|Protocol Violation|0|||
146763854|NCT01090024|529302904|FG016|Period 3|Protocol Violation|0|||
146763855|NCT01090024|529302905|FG017|Period 3|Protocol Violation|0|||
146763856|NCT01090024|529302888|FG000|Period 3|Adverse Event|0|||
146763857|NCT01090024|529302889|FG001|Period 3|Adverse Event|0|||
146763858|NCT01090024|529302890|FG002|Period 3|Adverse Event|0|||
146763859|NCT01090024|529302891|FG003|Period 3|Adverse Event|0|||
146763860|NCT01090024|529302892|FG004|Period 3|Adverse Event|0|||
146763861|NCT01090024|529302893|FG005|Period 3|Adverse Event|1|||
146763862|NCT01090024|529302894|FG006|Period 3|Adverse Event|0|||
146536237|NCT01773928|528472457|FG008|Overall Study|Subject misrepresented age|0|||
146536238|NCT01773928|528472449|FG000|Overall Study|Subject met exclusion criteria|0|||
146536239|NCT01773928|528472450|FG001|Overall Study|Subject met exclusion criteria|0|||
146536240|NCT01773928|528472451|FG002|Overall Study|Subject met exclusion criteria|0|||
146536241|NCT01773928|528472452|FG003|Overall Study|Subject met exclusion criteria|0|||
146536242|NCT01773928|528472453|FG004|Overall Study|Subject met exclusion criteria|0|||
146536243|NCT01773928|528472454|FG005|Overall Study|Subject met exclusion criteria|0|||
146536244|NCT01773928|528472455|FG006|Overall Study|Subject met exclusion criteria|0|||
146536245|NCT01773928|528472456|FG007|Overall Study|Subject met exclusion criteria|0|||
146536246|NCT01773928|528472457|FG008|Overall Study|Subject met exclusion criteria|1|||
146536247|NCT01773928|528472449|FG000|Overall Study|Randomized, had to leave, never returned|0|||
146536248|NCT01773928|528472450|FG001|Overall Study|Randomized, had to leave, never returned|0|||
146536249|NCT01773928|528472451|FG002|Overall Study|Randomized, had to leave, never returned|0|||
146536250|NCT01773928|528472452|FG003|Overall Study|Randomized, had to leave, never returned|1|||
146536251|NCT01773928|528472453|FG004|Overall Study|Randomized, had to leave, never returned|0|||
146536252|NCT01773928|528472454|FG005|Overall Study|Randomized, had to leave, never returned|0|||
146536253|NCT01773928|528472455|FG006|Overall Study|Randomized, had to leave, never returned|0|||
146536254|NCT01773928|528472456|FG007|Overall Study|Randomized, had to leave, never returned|0|||
146536255|NCT01773928|528472457|FG008|Overall Study|Randomized, had to leave, never returned|0|||
146536256|NCT01773928|528472449|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
146536257|NCT01773928|528472450|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
146536258|NCT01773928|528472451|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
146536259|NCT01773928|528472452|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
146536260|NCT01773928|528472453|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
146536261|NCT01773928|528472454|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
146536262|NCT01773928|528472455|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
146536263|NCT01773928|528472456|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
146536264|NCT01773928|528472457|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
146536265|NCT03533751|528472458|FG000|Overall Study|Withdrawal by Subject|12|||
146536266|NCT03533751|528472459|FG001|Overall Study|Withdrawal by Subject|6|||
146536267|NCT03533751|528472460|FG002|Overall Study|Withdrawal by Subject|11|||
146536268|NCT03533751|528472461|FG003|Overall Study|Withdrawal by Subject|9|||
146536269|NCT03533751|528472462|FG004|Overall Study|Withdrawal by Subject|10|||
146536270|NCT03533751|528472458|FG000|Overall Study|Adverse Event|4|||
146536271|NCT03533751|528472459|FG001|Overall Study|Adverse Event|7|||
146536272|NCT03533751|528472460|FG002|Overall Study|Adverse Event|2|||
146536273|NCT03533751|528472461|FG003|Overall Study|Adverse Event|4|||
146536274|NCT03533751|528472462|FG004|Overall Study|Adverse Event|5|||
146536275|NCT03533751|528472458|FG000|Overall Study|Physician Decision|0|||
146536276|NCT03533751|528472459|FG001|Overall Study|Physician Decision|2|||
146536277|NCT03533751|528472460|FG002|Overall Study|Physician Decision|1|||
146536278|NCT03533751|528472461|FG003|Overall Study|Physician Decision|2|||
146536279|NCT03533751|528472462|FG004|Overall Study|Physician Decision|1|||
146536280|NCT03533751|528472458|FG000|Overall Study|Sponsor Decision|0|||
146536281|NCT03533751|528472459|FG001|Overall Study|Sponsor Decision|0|||
146536282|NCT03533751|528472460|FG002|Overall Study|Sponsor Decision|1|||
146536283|NCT03533751|528472461|FG003|Overall Study|Sponsor Decision|1|||
146536284|NCT03533751|528472462|FG004|Overall Study|Sponsor Decision|0|||
146536285|NCT03533751|528472458|FG000|Overall Study|Lost to Follow-up|3|||
146536286|NCT03533751|528472459|FG001|Overall Study|Lost to Follow-up|7|||
146536287|NCT03533751|528472460|FG002|Overall Study|Lost to Follow-up|6|||
146536288|NCT03533751|528472461|FG003|Overall Study|Lost to Follow-up|4|||
146536289|NCT03533751|528472462|FG004|Overall Study|Lost to Follow-up|3|||
146536290|NCT03533751|528472458|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
146536291|NCT03533751|528472459|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
146536292|NCT03533751|528472460|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
146536293|NCT03533751|528472461|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
146536294|NCT03533751|528472462|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
146536295|NCT03533751|528472458|FG000|Overall Study|Other|0|||
146536296|NCT03533751|528472459|FG001|Overall Study|Other|2|||
146536297|NCT03533751|528472460|FG002|Overall Study|Other|1|||
146536298|NCT03533751|528472461|FG003|Overall Study|Other|0|||
146536299|NCT03533751|528472462|FG004|Overall Study|Other|3|||
146536300|NCT02074514|528472465|FG000|Overall Study|Lack of Efficacy|3|||
146536301|NCT02074514|528472466|FG001|Overall Study|Lack of Efficacy|2|||
146536302|NCT02074514|528472465|FG000|Overall Study|Lost to Follow-up|0|||
146536303|NCT02074514|528472466|FG001|Overall Study|Lost to Follow-up|1|||
146536304|NCT02074514|528472465|FG000|Overall Study|Withdrew Consent|0|||
146536305|NCT02074514|528472466|FG001|Overall Study|Withdrew Consent|1|||
146536306|NCT03082729|528472467|FG000|Overall Study|Lost to Follow-up|7|||
146870925|NCT01428661|529698253|FG000|Open Label Extension|Adverse Event|0|||
146870926|NCT01428661|529698254|FG001|Open Label Extension|Adverse Event|0|||
146536307|NCT03082729|528472467|FG000|Overall Study|Physician Decision|2|||
146536308|NCT03082729|528472467|FG000|Overall Study|Withdrawal by Subject|1|||
146536309|NCT03082729|528472467|FG000|Overall Study|Lack of Efficacy|9|||
146870927|NCT01428661|529698255|FG002|Open Label Extension|Adverse Event|15|||
146870928|NCT01428661|529698253|FG000|Open Label Extension|Lost to Follow-up|0|||
146870929|NCT01428661|529698254|FG001|Open Label Extension|Lost to Follow-up|0|||
146870930|NCT01428661|529698255|FG002|Open Label Extension|Lost to Follow-up|38|||
146870931|NCT01428661|529698253|FG000|Open Label Extension|Withdrawal by Subject|0|||
146870932|NCT01428661|529698254|FG001|Open Label Extension|Withdrawal by Subject|0|||
146870933|NCT01428661|529698255|FG002|Open Label Extension|Withdrawal by Subject|49|||
146870934|NCT01428661|529698253|FG000|Open Label Extension|Lack of Efficacy|0|||
146870935|NCT01428661|529698254|FG001|Open Label Extension|Lack of Efficacy|0|||
146870936|NCT01428661|529698255|FG002|Open Label Extension|Lack of Efficacy|24|||
146870937|NCT01428661|529698253|FG000|Open Label Extension|**Various|0|||
146870938|NCT01428661|529698254|FG001|Open Label Extension|**Various|0|||
146870939|NCT01428661|529698255|FG002|Open Label Extension|**Various|185|||
146870940|NCT00382720|529699724|FG000|Overall Study|Adverse Event|21|||
146870941|NCT00382720|529699725|FG001|Overall Study|Adverse Event|23|||
146870942|NCT00382720|529699726|FG002|Overall Study|Adverse Event|15|||
146870943|NCT00382720|529699724|FG000|Overall Study|Protocol Violation|2|||
146870944|NCT00382720|529699725|FG001|Overall Study|Protocol Violation|5|||
146870945|NCT00382720|529699726|FG002|Overall Study|Protocol Violation|1|||
146870946|NCT00382720|529699724|FG000|Overall Study|Death|0|||
146870947|NCT00382720|529699725|FG001|Overall Study|Death|1|||
146870948|NCT00382720|529699726|FG002|Overall Study|Death|2|||
146870949|NCT00382720|529699724|FG000|Overall Study|Progressive disease|37|||
146870950|NCT00382720|529699725|FG001|Overall Study|Progressive disease|28|||
146870951|NCT00382720|529699726|FG002|Overall Study|Progressive disease|38|||
146870952|NCT00382720|529699724|FG000|Overall Study|Withdrew consent|1|||
146870953|NCT00382720|529699725|FG001|Overall Study|Withdrew consent|1|||
146870954|NCT00382720|529699726|FG002|Overall Study|Withdrew consent|2|||
146870955|NCT00382720|529699724|FG000|Overall Study|Withdrawal by Subject|11|||
146870956|NCT00382720|529699725|FG001|Overall Study|Withdrawal by Subject|20|||
146870957|NCT00382720|529699726|FG002|Overall Study|Withdrawal by Subject|12|||
146870958|NCT00382720|529699724|FG000|Overall Study|Surgery|1|||
146870959|NCT00382720|529699725|FG001|Overall Study|Surgery|1|||
146870960|NCT00382720|529699726|FG002|Overall Study|Surgery|4|||
146870961|NCT00382720|529699724|FG000|Overall Study|Patient did not receive study medication|1|||
146870962|NCT00382720|529699725|FG001|Overall Study|Patient did not receive study medication|1|||
146870963|NCT00382720|529699726|FG002|Overall Study|Patient did not receive study medication|4|||
146870964|NCT00382720|529699724|FG000|Overall Study|Clinically progressive disease|0|||
146870965|NCT00382720|529699725|FG001|Overall Study|Clinically progressive disease|1|||
146870966|NCT00382720|529699726|FG002|Overall Study|Clinically progressive disease|0|||
146870967|NCT00382720|529699724|FG000|Overall Study|Good prognosis|0|||
146870968|NCT00382720|529699725|FG001|Overall Study|Good prognosis|1|||
146870969|NCT00382720|529699726|FG002|Overall Study|Good prognosis|0|||
146870970|NCT00382720|529699724|FG000|Overall Study|Investigator/Clinical decision|5|||
146870971|NCT00382720|529699725|FG001|Overall Study|Investigator/Clinical decision|6|||
146870972|NCT00382720|529699726|FG002|Overall Study|Investigator/Clinical decision|6|||
146870973|NCT00382720|529699724|FG000|Overall Study|Discontinued at end of study|0|||
146536310|NCT03082729|528472467|FG000|Overall Study|Adverse Event|4|||
146536311|NCT03082729|528472467|FG000|Overall Study|Protocol Violation|6|||
146536312|NCT03082729|528472467|FG000|Overall Study|Fear of study procedure|1|||
146536313|NCT03082729|528472467|FG000|Overall Study|Scheduling conflict|1|||
146536314|NCT01171534|528474360|FG000|Overall Study|Lost to Follow-up|0|||
146536315|NCT01171534|528474361|FG001|Overall Study|Lost to Follow-up|2|||
146870974|NCT00382720|529699725|FG001|Overall Study|Discontinued at end of study|1|||
146870975|NCT00382720|529699726|FG002|Overall Study|Discontinued at end of study|2|||
146870976|NCT02737852|529699729|FG000|Overall Study|Withdrawal by Subject|2|||
146870977|NCT01183143|529699730|FG000|Overall Study|Protocol Violation|115|||
146870978|NCT01183143|529699730|FG000|Overall Study|Withdrawal by Subject|19|||
146870979|NCT01183143|529699730|FG000|Overall Study|Subject Questionnaires not returned|5|||
146870980|NCT01183143|529699730|FG000|Overall Study|Subjects enrolled, but not treated|11|||
146870981|NCT04042740|529699732|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
146536316|NCT01171534|528474360|FG000|Overall Study|screen failure|0|||
146536317|NCT01171534|528474361|FG001|Overall Study|screen failure|1|||
146870982|NCT04042740|529699732|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
146870983|NCT01717287|529699733|FG000|Overall Study|Lost to Follow-up|0|||
146870984|NCT01717287|529699734|FG001|Overall Study|Lost to Follow-up|2|||
146870985|NCT01717287|529699733|FG000|Overall Study|Protocol Violation|0|||
146870986|NCT01717287|529699734|FG001|Overall Study|Protocol Violation|1|||
146870987|NCT04490395|529699735|FG000|Overall Study|Lost to Follow-up|0|||
146870988|NCT04490395|529699736|FG001|Overall Study|Lost to Follow-up|1|||
146870989|NCT00388505|529699738|FG000|Overall Study|Adverse Event or Death|43|||
146870990|NCT00388505|529699739|FG001|Overall Study|Adverse Event or Death|17|||
146870991|NCT00388505|529699738|FG000|Overall Study|Withdrawal by Subject|24|||
146870992|NCT00388505|529699739|FG001|Overall Study|Withdrawal by Subject|9|||
146536318|NCT03861039|528474362|FG000|Overall Study|Adverse Event|2|||
146536319|NCT03861039|528474363|FG001|Overall Study|Adverse Event|5|||
146870993|NCT00388505|529699738|FG000|Overall Study|Lost to Follow-up|5|||
146870994|NCT00388505|529699739|FG001|Overall Study|Lost to Follow-up|3|||
146870995|NCT00388505|529699738|FG000|Overall Study|Inappropriate Enrollment|0|||
146870996|NCT00388505|529699739|FG001|Overall Study|Inappropriate Enrollment|1|||
146870997|NCT00388505|529699738|FG000|Overall Study|Administrative Reason|1|||
146536320|NCT03861039|528474364|FG002|Overall Study|Adverse Event|11|||
146536321|NCT03861039|528474362|FG000|Overall Study|Withdrawal by Subject|1|||
146536322|NCT03861039|528474363|FG001|Overall Study|Withdrawal by Subject|3|||
146536323|NCT03861039|528474364|FG002|Overall Study|Withdrawal by Subject|4|||
146536324|NCT00548327|528474366|FG000|Overall Study|Adverse Event|0|||
146536325|NCT00548327|528474367|FG001|Overall Study|Adverse Event|1|||
146536326|NCT01673386|528474368|FG000|Overall Study|Study terminated by sponsor|16|||
146536327|NCT01673386|528474369|FG001|Overall Study|Study terminated by sponsor|22|||
146536328|NCT01673386|528474368|FG000|Overall Study|Adverse Event|5|||
146536329|NCT01673386|528474369|FG001|Overall Study|Adverse Event|2|||
146536330|NCT01673386|528474368|FG000|Overall Study|Progressive disease|4|||
146536331|NCT01673386|528474369|FG001|Overall Study|Progressive disease|1|||
146536332|NCT01673386|528474368|FG000|Overall Study|Withdrawal by Subject|0|||
146536333|NCT01673386|528474369|FG001|Overall Study|Withdrawal by Subject|2|||
146536334|NCT00109343|528474370|FG000|Overall Study|Adverse Event|1|||
146536335|NCT00109343|528474371|FG001|Overall Study|Adverse Event|0|||
146536336|NCT00109343|528474372|FG002|Overall Study|Adverse Event|2|||
146536337|NCT00109343|528474370|FG000|Overall Study|Lack of Efficacy|1|||
146536338|NCT00109343|528474371|FG001|Overall Study|Lack of Efficacy|0|||
146536339|NCT00109343|528474372|FG002|Overall Study|Lack of Efficacy|0|||
146536340|NCT00109343|528474370|FG000|Overall Study|Lost to Follow-up|35|||
146536341|NCT00109343|528474371|FG001|Overall Study|Lost to Follow-up|20|||
146536342|NCT00109343|528474372|FG002|Overall Study|Lost to Follow-up|14|||
146536343|NCT00109343|528474370|FG000|Overall Study|Protocol Violation|1|||
146536344|NCT00109343|528474371|FG001|Overall Study|Protocol Violation|2|||
146536345|NCT00109343|528474372|FG002|Overall Study|Protocol Violation|2|||
146536346|NCT00109343|528474370|FG000|Overall Study|Withdrawal by Subject|15|||
146536347|NCT00109343|528474371|FG001|Overall Study|Withdrawal by Subject|11|||
146536348|NCT00109343|528474372|FG002|Overall Study|Withdrawal by Subject|10|||
146536349|NCT00109343|528474370|FG000|Overall Study|Subject Moved|6|||
146536350|NCT00109343|528474371|FG001|Overall Study|Subject Moved|2|||
146536351|NCT00109343|528474372|FG002|Overall Study|Subject Moved|1|||
146536352|NCT00109343|528474370|FG000|Overall Study|Other|5|||
146536353|NCT00109343|528474371|FG001|Overall Study|Other|2|||
146536354|NCT00109343|528474372|FG002|Overall Study|Other|1|||
146536355|NCT02100631|528474373|FG000|Overall Study|Withdrawal by Subject|1|||
146536356|NCT02100631|528474374|FG001|Overall Study|Withdrawal by Subject|0|||
146536357|NCT02100631|528474375|FG002|Overall Study|Withdrawal by Subject|0|||
146536358|NCT02100631|528474373|FG000|Overall Study|Lost to Follow-up|3|||
146536359|NCT02100631|528474374|FG001|Overall Study|Lost to Follow-up|4|||
146536360|NCT02100631|528474375|FG002|Overall Study|Lost to Follow-up|0|||
146536361|NCT02100631|528474373|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
146536362|NCT02100631|528474374|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
146536363|NCT02100631|528474375|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
146536364|NCT03944616|528474376|FG000|Overall Study|Lost to Follow-up|0|||
146536365|NCT03944616|528474377|FG001|Overall Study|Lost to Follow-up|2|||
146536366|NCT01287936|528474378|FG000|Overall Study|Lost to Follow-up|0|||
146536367|NCT01287936|528474379|FG001|Overall Study|Lost to Follow-up|1|||
146536368|NCT01287936|528474380|FG002|Overall Study|Lost to Follow-up|1|||
146536369|NCT00427934|528474381|FG000|Overall Study|Adverse Event|1|||
146536370|NCT00427934|528474382|FG001|Overall Study|Adverse Event|0|||
146536371|NCT00427934|528474383|FG002|Overall Study|Adverse Event|5|||
146536372|NCT00427934|528474384|FG003|Overall Study|Adverse Event|4|||
146536373|NCT00427934|528474381|FG000|Overall Study|Lack of Efficacy|0|||
146536374|NCT00427934|528474382|FG001|Overall Study|Lack of Efficacy|0|||
146536375|NCT00427934|528474383|FG002|Overall Study|Lack of Efficacy|5|||
146870998|NCT00388505|529699739|FG001|Overall Study|Administrative Reason|0|||
146870999|NCT00388505|529699738|FG000|Overall Study|Protocol Violation|6|||
146871000|NCT00388505|529699739|FG001|Overall Study|Protocol Violation|5|||
146871001|NCT00388505|529699738|FG000|Overall Study|Unable to classify|4|||
146536376|NCT00427934|528474384|FG003|Overall Study|Lack of Efficacy|2|||
146536377|NCT00427934|528474381|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
146536378|NCT00427934|528474382|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
146536379|NCT00427934|528474383|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
146536380|NCT00427934|528474384|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
146871002|NCT00388505|529699739|FG001|Overall Study|Unable to classify|3|||
146871003|NCT02248259|529699741|FG000|Treatment Period 1|Adverse Event|0|||
146536381|NCT00427934|528474381|FG000|Overall Study|Other|0|||
146536382|NCT00427934|528474382|FG001|Overall Study|Other|0|||
146536383|NCT00427934|528474383|FG002|Overall Study|Other|11|||
146536384|NCT00427934|528474384|FG003|Overall Study|Other|5|||
146536385|NCT00427934|528474381|FG000|Overall Study|Withdrawal by Subject|0|||
146536386|NCT00427934|528474382|FG001|Overall Study|Withdrawal by Subject|0|||
146536387|NCT00427934|528474383|FG002|Overall Study|Withdrawal by Subject|1|||
146536388|NCT00427934|528474384|FG003|Overall Study|Withdrawal by Subject|3|||
146536389|NCT01649765|528474385|FG000|Overall Study|Adverse Event|5|||
146536390|NCT01649765|528474386|FG001|Overall Study|Adverse Event|3|||
146536391|NCT01649765|528474385|FG000|Overall Study|Lack of Efficacy|1|||
146536392|NCT01649765|528474386|FG001|Overall Study|Lack of Efficacy|1|||
146536393|NCT01649765|528474385|FG000|Overall Study|Physician Decision|0|||
146536394|NCT01649765|528474386|FG001|Overall Study|Physician Decision|3|||
146536395|NCT01649765|528474385|FG000|Overall Study|Protocol Violation|1|||
146536396|NCT01649765|528474386|FG001|Overall Study|Protocol Violation|0|||
146536397|NCT01649765|528474385|FG000|Overall Study|Withdrawal by Subject|2|||
146871004|NCT02248259|529699742|FG001|Treatment Period 1|Adverse Event|0|||
146871005|NCT02248259|529699743|FG002|Treatment Period 1|Adverse Event|1|||
146871006|NCT02248259|529699744|FG003|Treatment Period 1|Adverse Event|0|||
146871007|NCT02369848|529699749|FG000|Overall Study|Death|1|||
146536398|NCT01649765|528474386|FG001|Overall Study|Withdrawal by Subject|1|||
146536399|NCT02194465|528474387|FG000|Overall Study|Adverse Event|6|||
146536400|NCT02194465|528474388|FG001|Overall Study|Adverse Event|1|||
146536401|NCT02194465|528474389|FG002|Overall Study|Adverse Event|4|||
146536402|NCT02194465|528474390|FG003|Overall Study|Adverse Event|4|||
146536403|NCT02194465|528474391|FG004|Overall Study|Adverse Event|4|||
146536404|NCT02194465|528474392|FG005|Overall Study|Adverse Event|2|||
146536405|NCT02194465|528474393|FG006|Overall Study|Adverse Event|0|||
146536406|NCT02194465|528474387|FG000|Overall Study|Lost to Follow-up|0|||
146536407|NCT02194465|528474388|FG001|Overall Study|Lost to Follow-up|0|||
146536408|NCT02194465|528474389|FG002|Overall Study|Lost to Follow-up|0|||
146536409|NCT02194465|528474390|FG003|Overall Study|Lost to Follow-up|1|||
146536410|NCT02194465|528474391|FG004|Overall Study|Lost to Follow-up|0|||
146536411|NCT02194465|528474392|FG005|Overall Study|Lost to Follow-up|1|||
146536412|NCT02194465|528474393|FG006|Overall Study|Lost to Follow-up|0|||
146536413|NCT02194465|528474387|FG000|Overall Study|Physician Decision|1|||
146536414|NCT02194465|528474388|FG001|Overall Study|Physician Decision|0|||
146536415|NCT02194465|528474389|FG002|Overall Study|Physician Decision|0|||
146536416|NCT02194465|528474390|FG003|Overall Study|Physician Decision|0|||
146536417|NCT02194465|528474391|FG004|Overall Study|Physician Decision|0|||
146536418|NCT02194465|528474392|FG005|Overall Study|Physician Decision|0|||
146536419|NCT02194465|528474393|FG006|Overall Study|Physician Decision|0|||
146536420|NCT02194465|528474387|FG000|Overall Study|Protocol Violation|1|||
146536421|NCT02194465|528474388|FG001|Overall Study|Protocol Violation|1|||
146536422|NCT02194465|528474389|FG002|Overall Study|Protocol Violation|2|||
146536423|NCT02194465|528474390|FG003|Overall Study|Protocol Violation|1|||
146536424|NCT02194465|528474391|FG004|Overall Study|Protocol Violation|1|||
146536425|NCT02194465|528474392|FG005|Overall Study|Protocol Violation|0|||
146536426|NCT02194465|528474393|FG006|Overall Study|Protocol Violation|0|||
146536427|NCT02194465|528474387|FG000|Overall Study|Withdrawal by Subject|1|||
146536428|NCT02194465|528474388|FG001|Overall Study|Withdrawal by Subject|3|||
146536429|NCT02194465|528474389|FG002|Overall Study|Withdrawal by Subject|1|||
146536430|NCT02194465|528474390|FG003|Overall Study|Withdrawal by Subject|2|||
146536431|NCT02194465|528474391|FG004|Overall Study|Withdrawal by Subject|2|||
146536432|NCT02194465|528474392|FG005|Overall Study|Withdrawal by Subject|1|||
146536433|NCT02194465|528474393|FG006|Overall Study|Withdrawal by Subject|2|||
146536434|NCT02194465|528474387|FG000|Overall Study|Discontinued follow-up period|0|||
146536435|NCT02194465|528474388|FG001|Overall Study|Discontinued follow-up period|2|||
146536436|NCT02194465|528474389|FG002|Overall Study|Discontinued follow-up period|1|||
146536437|NCT02194465|528474390|FG003|Overall Study|Discontinued follow-up period|0|||
146536438|NCT02194465|528474391|FG004|Overall Study|Discontinued follow-up period|2|||
146536439|NCT02194465|528474392|FG005|Overall Study|Discontinued follow-up period|0|||
146536440|NCT02194465|528474393|FG006|Overall Study|Discontinued follow-up period|0|||
146536441|NCT00961064|528474394|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
146536442|NCT00961064|528474394|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
146536443|NCT00961064|528474394|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
146536444|NCT00961064|528474394|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
146536445|NCT00961064|528474394|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
146536446|NCT00961064|528474394|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
146536447|NCT00961064|528474394|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
146536448|NCT00961064|528474394|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
146536449|NCT01408641|528474395|FG000|Overall Study|Physician Decision|1|||
146536450|NCT01408641|528474396|FG001|Overall Study|Physician Decision|0|||
146536451|NCT01648764|528474397|FG000|Overall Study|Progressive Disease|0|||
146536452|NCT01648764|528474398|FG001|Overall Study|Progressive Disease|1|||
146536453|NCT01648764|528474399|FG002|Overall Study|Progressive Disease|0|||
146536454|NCT01648764|528474400|FG003|Overall Study|Progressive Disease|0|||
146536455|NCT01648764|528474401|FG004|Overall Study|Progressive Disease|0|||
146536456|NCT01648764|528474402|FG005|Overall Study|Progressive Disease|1|||
146536457|NCT01648764|528474403|FG006|Overall Study|Progressive Disease|1|||
146871008|NCT02369848|529699749|FG000|Overall Study|Withdrawal by Subject|2|||
146871009|NCT02369848|529699749|FG000|Overall Study|Lost to Follow-up|1|||
146871010|NCT02573870|529699752|FG000|Overall Study|Adverse Event|0|||
146871011|NCT02573870|529699753|FG001|Overall Study|Adverse Event|2|||
146871012|NCT02573870|529699752|FG000|Overall Study|Lack of Efficacy|0|||
146871013|NCT02573870|529699753|FG001|Overall Study|Lack of Efficacy|1|||
146871014|NCT02573870|529699752|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
146871015|NCT02573870|529699753|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
146871016|NCT02573870|529699752|FG000|Overall Study|Lost to Follow-up|0|||
146871017|NCT02573870|529699753|FG001|Overall Study|Lost to Follow-up|1|||
146871018|NCT02573870|529699752|FG000|Overall Study|Other: Fail to Meet Visit|0|||
146871019|NCT02573870|529699753|FG001|Overall Study|Other: Fail to Meet Visit|2|||
146871020|NCT03785925|529699754|FG000|Overall Study|Withdrawal by Subject|15|||
146871021|NCT03785925|529699754|FG000|Overall Study|Lost to Follow-up|1|||
146871022|NCT00957528|529699756|FG000|Overall Study|Protocol Violation|0|||
146871023|NCT00957528|529699757|FG001|Overall Study|Protocol Violation|1|||
146871024|NCT00957528|529699758|FG002|Overall Study|Protocol Violation|0|||
146871025|NCT00957528|529699756|FG000|Overall Study|Withdrawal by Subject|0|||
146871026|NCT00957528|529699757|FG001|Overall Study|Withdrawal by Subject|0|||
146871027|NCT00957528|529699758|FG002|Overall Study|Withdrawal by Subject|1|||
146871028|NCT01841749|529699761|FG000|Overall Study|Protocol Violation|1|||
146871029|NCT00677820|529699762|FG000|Overall Study|Lost to Follow-up|1|||
146871030|NCT00677820|529699763|FG001|Overall Study|Lost to Follow-up|0|||
146871031|NCT01480284|529699769|FG000|Overall Study|Withdrawal by Subject|2|||
146871032|NCT01480284|529699770|FG001|Overall Study|Withdrawal by Subject|0|||
146871033|NCT01480284|529699769|FG000|Overall Study|Adverse Event|1|||
146871034|NCT01480284|529699770|FG001|Overall Study|Adverse Event|0|||
146871035|NCT01480284|529699769|FG000|Overall Study|Study closed/terminated|3|||
146871036|NCT01480284|529699770|FG001|Overall Study|Study closed/terminated|0|||
146871037|NCT01480284|529699769|FG000|Overall Study|Lost to Follow-up|1|||
146871038|NCT01480284|529699770|FG001|Overall Study|Lost to Follow-up|0|||
146871039|NCT01480284|529699769|FG000|Overall Study|Physician Decision|1|||
146871040|NCT01480284|529699770|FG001|Overall Study|Physician Decision|0|||
146871041|NCT00066742|529699771|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
146871042|NCT00066742|529699771|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
146871043|NCT00066742|529699771|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
146871044|NCT00066742|529699771|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
146871045|NCT00066742|529699771|FG000|Induction Chemoradiotherapy|Ineligible|3|||
146536458|NCT01648764|528474404|FG007|Overall Study|Progressive Disease|0|||
146536459|NCT01648764|528474405|FG008|Overall Study|Progressive Disease|0|||
146536460|NCT01648764|528474406|FG009|Overall Study|Progressive Disease|2|||
146536461|NCT01648764|528474407|FG010|Overall Study|Progressive Disease|0|||
146536462|NCT01648764|528474408|FG011|Overall Study|Progressive Disease|1|||
146536463|NCT01648764|528474409|FG012|Overall Study|Progressive Disease|2|||
146536464|NCT01648764|528474410|FG013|Overall Study|Progressive Disease|1|||
146536465|NCT01648764|528474397|FG000|Overall Study|Adverse Event|0|||
146536466|NCT01648764|528474398|FG001|Overall Study|Adverse Event|0|||
146536467|NCT01648764|528474399|FG002|Overall Study|Adverse Event|0|||
146536468|NCT01648764|528474400|FG003|Overall Study|Adverse Event|0|||
146536469|NCT01648764|528474401|FG004|Overall Study|Adverse Event|0|||
146536470|NCT01648764|528474402|FG005|Overall Study|Adverse Event|1|||
146536471|NCT01648764|528474403|FG006|Overall Study|Adverse Event|0|||
146536472|NCT01648764|528474404|FG007|Overall Study|Adverse Event|0|||
146536473|NCT01648764|528474405|FG008|Overall Study|Adverse Event|0|||
146536474|NCT01648764|528474406|FG009|Overall Study|Adverse Event|1|||
146536475|NCT01648764|528474407|FG010|Overall Study|Adverse Event|0|||
146536476|NCT01648764|528474408|FG011|Overall Study|Adverse Event|3|||
146536477|NCT01648764|528474409|FG012|Overall Study|Adverse Event|1|||
146536478|NCT01648764|528474410|FG013|Overall Study|Adverse Event|1|||
146536479|NCT01648764|528474397|FG000|Overall Study|Death|0|||
146536480|NCT01648764|528474398|FG001|Overall Study|Death|0|||
146871046|NCT00066742|529699771|FG000|Consolidation Chemotherapy|not protocol specified|1|||
146871047|NCT00066742|529699771|FG000|Consolidation Chemotherapy|Ineligible|2|||
146871048|NCT01380730|529699778|FG000|Overall Study|Death|0|||
146536481|NCT01648764|528474399|FG002|Overall Study|Death|0|||
146871049|NCT01380730|529699779|FG001|Overall Study|Death|0|||
146871050|NCT01380730|529699780|FG002|Overall Study|Death|0|||
146536482|NCT01648764|528474400|FG003|Overall Study|Death|0|||
146536483|NCT01648764|528474401|FG004|Overall Study|Death|0|||
146536484|NCT01648764|528474402|FG005|Overall Study|Death|0|||
146536485|NCT01648764|528474403|FG006|Overall Study|Death|1|||
146871051|NCT01380730|529699781|FG003|Overall Study|Death|0|||
146871052|NCT01380730|529699782|FG004|Overall Study|Death|1|||
146871053|NCT01380730|529699783|FG005|Overall Study|Death|0|||
146871054|NCT01380730|529699784|FG006|Overall Study|Death|0|||
146871055|NCT01380730|529699785|FG007|Overall Study|Death|0|||
146536486|NCT01648764|528474404|FG007|Overall Study|Death|0|||
146871056|NCT04784897|529699789|FG000|Overall Study|Death|4|||
146871057|NCT04784897|529699790|FG001|Overall Study|Death|2|||
146536487|NCT01648764|528474405|FG008|Overall Study|Death|0|||
146536488|NCT01648764|528474406|FG009|Overall Study|Death|0|||
146871058|NCT04784897|529699791|FG002|Overall Study|Death|1|||
146871059|NCT04784897|529699789|FG000|Overall Study|Withdrawal by Subject|0|||
146871060|NCT04784897|529699790|FG001|Overall Study|Withdrawal by Subject|0|||
146536489|NCT01648764|528474407|FG010|Overall Study|Death|0|||
146536490|NCT01648764|528474408|FG011|Overall Study|Death|0|||
146536491|NCT01648764|528474409|FG012|Overall Study|Death|0|||
146536492|NCT01648764|528474410|FG013|Overall Study|Death|1|||
146536493|NCT01648764|528474397|FG000|Overall Study|Withdrawal by Subject|0|||
146536494|NCT01648764|528474398|FG001|Overall Study|Withdrawal by Subject|0|||
146536495|NCT01648764|528474399|FG002|Overall Study|Withdrawal by Subject|0|||
146536496|NCT01648764|528474400|FG003|Overall Study|Withdrawal by Subject|0|||
146536497|NCT01648764|528474401|FG004|Overall Study|Withdrawal by Subject|0|||
146536498|NCT01648764|528474402|FG005|Overall Study|Withdrawal by Subject|0|||
146536499|NCT01648764|528474403|FG006|Overall Study|Withdrawal by Subject|2|||
146536500|NCT01648764|528474404|FG007|Overall Study|Withdrawal by Subject|0|||
146536501|NCT01648764|528474405|FG008|Overall Study|Withdrawal by Subject|0|||
146536502|NCT01648764|528474406|FG009|Overall Study|Withdrawal by Subject|0|||
146536503|NCT01648764|528474407|FG010|Overall Study|Withdrawal by Subject|0|||
146536504|NCT01648764|528474408|FG011|Overall Study|Withdrawal by Subject|0|||
146536505|NCT01648764|528474409|FG012|Overall Study|Withdrawal by Subject|1|||
146536506|NCT01648764|528474410|FG013|Overall Study|Withdrawal by Subject|0|||
146536507|NCT01648764|528474397|FG000|Overall Study|Investigator Decision|0|||
146536508|NCT01648764|528474398|FG001|Overall Study|Investigator Decision|0|||
146536509|NCT01648764|528474399|FG002|Overall Study|Investigator Decision|0|||
146536510|NCT01648764|528474400|FG003|Overall Study|Investigator Decision|0|||
146536511|NCT01648764|528474401|FG004|Overall Study|Investigator Decision|0|||
146536512|NCT01648764|528474402|FG005|Overall Study|Investigator Decision|0|||
146536513|NCT01648764|528474403|FG006|Overall Study|Investigator Decision|1|||
146536514|NCT01648764|528474404|FG007|Overall Study|Investigator Decision|0|||
146536515|NCT01648764|528474405|FG008|Overall Study|Investigator Decision|0|||
146536516|NCT01648764|528474406|FG009|Overall Study|Investigator Decision|0|||
146536517|NCT01648764|528474407|FG010|Overall Study|Investigator Decision|0|||
146536518|NCT01648764|528474408|FG011|Overall Study|Investigator Decision|1|||
146536519|NCT01648764|528474409|FG012|Overall Study|Investigator Decision|0|||
146536520|NCT01648764|528474410|FG013|Overall Study|Investigator Decision|0|||
146536521|NCT00715208|528474411|FG000|Overall Study|Withdrawal by Subject|1|||
146536522|NCT00715208|528474412|FG001|Overall Study|Withdrawal by Subject|1|||
146536523|NCT00715208|528474411|FG000|Overall Study|Adverse Event|0|||
146536524|NCT00715208|528474412|FG001|Overall Study|Adverse Event|6|||
146536525|NCT00715208|528474411|FG000|Overall Study|Lack of Efficacy|0|||
146536526|NCT00715208|528474412|FG001|Overall Study|Lack of Efficacy|2|||
146536527|NCT00076570|528474413|FG000|Overall Study|Drug intolerance|8|||
146536528|NCT00076570|528474414|FG001|Overall Study|Drug intolerance|8|||
146536529|NCT01294046|528474415|FG000|Overall Study|Infection and surgical explant|1|||
146536530|NCT01294046|528474415|FG000|Overall Study|Eligibility criteria expanded|1|||
146536531|NCT01294046|528474415|FG000|Overall Study|Stimulation response inadqequate|1|||
146536532|NCT02058095|528474418|FG000|Overall Study|Adverse Event|1|||
146536533|NCT02058095|528474419|FG001|Overall Study|Adverse Event|0|||
146536534|NCT01499511|528474420|FG000|Overall Study|Death|1|||
146536535|NCT01499511|528474421|FG001|Overall Study|Death|0|||
146536536|NCT00998946|528474422|FG000|Overall Study|Lost to Follow-up|1|||
146536537|NCT00998946|528474422|FG000|Overall Study|Withdrawal by Subject|1|||
146536538|NCT00998946|528474422|FG000|Overall Study|Death|2|||
146536539|NCT00998946|528474422|FG000|Overall Study|Reason Unspecified|3|||
146536540|NCT00998946|528474422|FG000|Overall Study|Enrolled but not Dosed|2|||
146536541|NCT01588509|528474426|FG000|Overall Study|Lost to Follow-up|1|||
146536542|NCT01588509|528474427|FG001|Overall Study|Lost to Follow-up|0|||
146536543|NCT01454284|528474428|FG000|Overall Study|Adverse Event|20|||
146536544|NCT01454284|528474429|FG001|Overall Study|Adverse Event|7|||
146536545|NCT01454284|528474428|FG000|Overall Study|Death|0|||
146536546|NCT01454284|528474429|FG001|Overall Study|Death|3|||
146536547|NCT01454284|528474428|FG000|Overall Study|Lost to Follow-up|13|||
146536548|NCT01454284|528474429|FG001|Overall Study|Lost to Follow-up|8|||
146536549|NCT01454284|528474428|FG000|Overall Study|Protocol Violation|9|||
146536550|NCT01454284|528474429|FG001|Overall Study|Protocol Violation|6|||
146536551|NCT01454284|528474428|FG000|Overall Study|Withdrawal by Subject|58|||
146536552|NCT01454284|528474429|FG001|Overall Study|Withdrawal by Subject|36|||
146536553|NCT01454284|528474428|FG000|Overall Study|Physician Decision|16|||
146536554|NCT01454284|528474429|FG001|Overall Study|Physician Decision|11|||
146536555|NCT01454284|528474428|FG000|Overall Study|Sponsor Decision|0|||
146536556|NCT01454284|528474429|FG001|Overall Study|Sponsor Decision|2|||
146536557|NCT00393367|528474430|FG000|Overall Study|Protocol Violation|2|||
146536558|NCT00393367|528474431|FG001|Overall Study|Protocol Violation|5|||
146536559|NCT00393367|528474430|FG000|Overall Study|Withdrawal by Subject|0|||
146536560|NCT00393367|528474431|FG001|Overall Study|Withdrawal by Subject|2|||
146536561|NCT02842866|528474434|FG000|Overall Study|Serious Adverse Event|0|||
146536562|NCT02842866|528474435|FG001|Overall Study|Serious Adverse Event|1|||
146536563|NCT02842866|528474434|FG000|Overall Study|Protocol Violation|4|||
146536564|NCT02842866|528474435|FG001|Overall Study|Protocol Violation|2|||
146536565|NCT02842866|528474434|FG000|Overall Study|Lost to Follow-up|2|||
146536566|NCT02842866|528474435|FG001|Overall Study|Lost to Follow-up|0|||
146536567|NCT02842866|528474434|FG000|Overall Study|Withdrawal by Subject|1|||
146536568|NCT02842866|528474435|FG001|Overall Study|Withdrawal by Subject|0|||
146536569|NCT00915525|528474436|FG000|Overall Study|Protocol Violation|9|||
146536570|NCT00915525|528474437|FG001|Overall Study|Protocol Violation|4|||
146536571|NCT00915525|528474436|FG000|Overall Study|Withdrawal by Subject|59|||
146536572|NCT00915525|528474437|FG001|Overall Study|Withdrawal by Subject|21|||
146536573|NCT00915525|528474436|FG000|Overall Study|Lost to Follow-up|27|||
146536574|NCT00915525|528474437|FG001|Overall Study|Lost to Follow-up|16|||
146536575|NCT00915525|528474436|FG000|Overall Study|Pregnancy|2|||
146536576|NCT00915525|528474437|FG001|Overall Study|Pregnancy|0|||
146536577|NCT00915525|528474436|FG000|Overall Study|Lack of Efficacy|15|||
146536578|NCT00915525|528474437|FG001|Overall Study|Lack of Efficacy|32|||
146536579|NCT00915525|528474436|FG000|Overall Study|Adverse Event|29|||
146536580|NCT00915525|528474437|FG001|Overall Study|Adverse Event|13|||
146536581|NCT00915525|528474436|FG000|Overall Study|Missing|12|||
146536582|NCT00915525|528474437|FG001|Overall Study|Missing|1|||
146536583|NCT00915525|528474436|FG000|Overall Study|Other Reason|35|||
146536584|NCT00915525|528474437|FG001|Overall Study|Other Reason|12|||
146536585|NCT00915525|528474436|FG000|Overall Study|Site Closed|27|||
146536586|NCT00915525|528474437|FG001|Overall Study|Site Closed|9|||
146536587|NCT00915525|528474436|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
146536588|NCT00915525|528474437|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
146536589|NCT00915525|528474436|FG000|Overall Study|Study Burden|28|||
146536590|NCT00915525|528474437|FG001|Overall Study|Study Burden|12|||
146536591|NCT00915525|528474436|FG000|Overall Study|Non-Compliance|3|||
146536592|NCT00915525|528474437|FG001|Overall Study|Non-Compliance|1|||
146536593|NCT00915525|528474436|FG000|Overall Study|Patient Moved|15|||
146536594|NCT00915525|528474437|FG001|Overall Study|Patient Moved|9|||
146536595|NCT01432327|528474438|FG000|Posttest 3 Months|depression|3|||
146536596|NCT01432327|528474439|FG001|Posttest 3 Months|depression|0|||
146536597|NCT01432327|528474440|FG002|Posttest 3 Months|depression|0|||
146536598|NCT01432327|528474441|FG003|Posttest 3 Months|depression|0|||
146536599|NCT01432327|528474438|FG000|Posttest 3 Months|Lost to Follow-up|1|||
146536600|NCT01432327|528474439|FG001|Posttest 3 Months|Lost to Follow-up|0|||
146536601|NCT01432327|528474440|FG002|Posttest 3 Months|Lost to Follow-up|2|||
146536602|NCT01432327|528474441|FG003|Posttest 3 Months|Lost to Follow-up|1|||
146536603|NCT01432327|528474438|FG000|Posttest 3 Months|Allergic reaction|0|||
146536604|NCT01432327|528474439|FG001|Posttest 3 Months|Allergic reaction|2|||
146536605|NCT01432327|528474440|FG002|Posttest 3 Months|Allergic reaction|0|||
146536606|NCT01432327|528474441|FG003|Posttest 3 Months|Allergic reaction|0|||
146536607|NCT01432327|528474438|FG000|Posttest 6 Months|Lost to Follow-up|0|||
146536608|NCT01432327|528474439|FG001|Posttest 6 Months|Lost to Follow-up|0|||
146536609|NCT01432327|528474440|FG002|Posttest 6 Months|Lost to Follow-up|3|||
146536610|NCT01432327|528474441|FG003|Posttest 6 Months|Lost to Follow-up|2|||
146536611|NCT01432327|528474438|FG000|Posttest 6 Months|Allergic reaction|0|||
146536612|NCT01432327|528474439|FG001|Posttest 6 Months|Allergic reaction|0|||
146536613|NCT01432327|528474440|FG002|Posttest 6 Months|Allergic reaction|1|||
146536614|NCT01432327|528474441|FG003|Posttest 6 Months|Allergic reaction|0|||
146536615|NCT01432327|528474438|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
146536616|NCT01432327|528474439|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
146536617|NCT01432327|528474440|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
146536618|NCT01432327|528474441|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
146536619|NCT01432327|528474438|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
146536620|NCT01432327|528474439|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
146536621|NCT01432327|528474440|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
146536622|NCT01432327|528474441|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
146536623|NCT01432327|528474438|FG000|Posttest 1 Year|Lost to Follow-up|0|||
146536624|NCT01432327|528474439|FG001|Posttest 1 Year|Lost to Follow-up|0|||
146536625|NCT01432327|528474440|FG002|Posttest 1 Year|Lost to Follow-up|4|||
146536626|NCT01432327|528474441|FG003|Posttest 1 Year|Lost to Follow-up|2|||
146536627|NCT01432327|528474438|FG000|Posttest 1 Year|Allergic reaction|0|||
146536628|NCT01432327|528474439|FG001|Posttest 1 Year|Allergic reaction|0|||
146536629|NCT01432327|528474440|FG002|Posttest 1 Year|Allergic reaction|1|||
146536630|NCT01432327|528474441|FG003|Posttest 1 Year|Allergic reaction|1|||
146536631|NCT00577408|528474442|FG000|Overall Study|Stopped attending study visits|9|||
146536632|NCT00577408|528474443|FG001|Overall Study|Stopped attending study visits|11|||
146536633|NCT00577408|528474442|FG000|Overall Study|Continued opioid use|3|||
146536634|NCT00577408|528474443|FG001|Overall Study|Continued opioid use|2|||
146536635|NCT00577408|528474442|FG000|Overall Study|Non-compliance with study meds|0|||
146536636|NCT00577408|528474443|FG001|Overall Study|Non-compliance with study meds|3|||
146536637|NCT00577408|528474442|FG000|Overall Study|Refused Oral Naltrexone|0|||
146536638|NCT00577408|528474443|FG001|Overall Study|Refused Oral Naltrexone|1|||
146536639|NCT00577408|528474442|FG000|Overall Study|Moved out of state|0|||
146536640|NCT00577408|528474443|FG001|Overall Study|Moved out of state|1|||
146536641|NCT00577408|528474442|FG000|Overall Study|Scheduling Issues|0|||
146536642|NCT00577408|528474443|FG001|Overall Study|Scheduling Issues|3|||
146536643|NCT00577408|528474442|FG000|Overall Study|Death|0|||
146536644|NCT00577408|528474443|FG001|Overall Study|Death|1|||
146625290|NCT03037385|528803845|FG000|Overall Study|Withdrawal by Subject|0|||
146625291|NCT03037385|528803846|FG001|Overall Study|Withdrawal by Subject|0|||
146625292|NCT03037385|528803847|FG002|Overall Study|Withdrawal by Subject|1|||
146625293|NCT03037385|528803848|FG003|Overall Study|Withdrawal by Subject|2|||
146625294|NCT03037385|528803849|FG004|Overall Study|Withdrawal by Subject|1|||
146625295|NCT03037385|528803850|FG005|Overall Study|Withdrawal by Subject|3|||
146625296|NCT03037385|528803851|FG006|Overall Study|Withdrawal by Subject|0|||
146536645|NCT00577408|528474442|FG000|Overall Study|Psychiatric hospitalization|0|||
146536646|NCT00577408|528474443|FG001|Overall Study|Psychiatric hospitalization|1|||
146536647|NCT03817528|528474446|FG000|Overall Study|Withdrawal by Subject|1|||
146536648|NCT03817528|528474446|FG000|Overall Study|Adverse Event|2|||
146536649|NCT01712178|528474453|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
146625297|NCT03037385|528803852|FG007|Overall Study|Withdrawal by Subject|0|||
146625298|NCT03037385|528803853|FG008|Overall Study|Withdrawal by Subject|0|||
146625299|NCT03037385|528803854|FG009|Overall Study|Withdrawal by Subject|52|||
146625300|NCT03037385|528803845|FG000|Overall Study|Reason Not Specified|0|||
146625301|NCT03037385|528803846|FG001|Overall Study|Reason Not Specified|1|||
146536650|NCT01712178|528474454|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
146536651|NCT01712178|528474453|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
146536652|NCT01712178|528474454|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
146536653|NCT01712178|528474453|FG000|Overall Study|Lost to Follow-up|0|||
146536654|NCT01712178|528474454|FG001|Overall Study|Lost to Follow-up|1|||
146536655|NCT00827567|528474455|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
146536656|NCT03482024|528474460|FG000|Overall Study|Physician Decision|1|||
146536657|NCT03482024|528474461|FG001|Overall Study|Physician Decision|0|||
146536658|NCT03482024|528474462|FG002|Overall Study|Physician Decision|0|||
146536659|NCT03482024|528474463|FG003|Overall Study|Physician Decision|0|||
146536660|NCT03482024|528474464|FG004|Overall Study|Physician Decision|0|||
146536661|NCT00676143|528474467|FG000|Overall Study|Adverse Event|34|||
146536662|NCT00676143|528474468|FG001|Overall Study|Adverse Event|60|||
146536663|NCT00676143|528474467|FG000|Overall Study|Death|4|||
146536664|NCT00676143|528474468|FG001|Overall Study|Death|4|||
146536665|NCT00676143|528474467|FG000|Overall Study|Lack of Efficacy|0|||
146536666|NCT00676143|528474468|FG001|Overall Study|Lack of Efficacy|6|||
146536667|NCT00676143|528474467|FG000|Overall Study|Lost to Follow-up|0|||
146536668|NCT00676143|528474468|FG001|Overall Study|Lost to Follow-up|13|||
146536669|NCT00676143|528474467|FG000|Overall Study|Physician Decision|5|||
146536670|NCT00676143|528474468|FG001|Overall Study|Physician Decision|8|||
146536671|NCT00676143|528474467|FG000|Overall Study|Protocol Violation|4|||
146536672|NCT00676143|528474468|FG001|Overall Study|Protocol Violation|8|||
146536673|NCT00676143|528474467|FG000|Overall Study|Withdrawal by Subject|24|||
146536674|NCT00676143|528474468|FG001|Overall Study|Withdrawal by Subject|42|||
146536675|NCT00676143|528474467|FG000|Overall Study|Discontinuation of study by sponsor|65|||
146536676|NCT00676143|528474468|FG001|Overall Study|Discontinuation of study by sponsor|88|||
146536677|NCT00676143|528474467|FG000|Overall Study|Failed to return|2|||
146536678|NCT00676143|528474468|FG001|Overall Study|Failed to return|1|||
146536679|NCT00676143|528474467|FG000|Overall Study|Loss of caregiver|5|||
146536680|NCT00676143|528474468|FG001|Overall Study|Loss of caregiver|3|||
146536681|NCT00676143|528474467|FG000|Overall Study|Other|11|||
146536682|NCT00676143|528474468|FG001|Overall Study|Other|20|||
146536683|NCT00676143|528474467|FG000|Overall Study|Participant participation unknown|1|||
146536684|NCT00676143|528474468|FG001|Overall Study|Participant participation unknown|4|||
146536685|NCT00676143|528474467|FG000|Overall Study|Vasogenic edema recurrence|1|||
146536686|NCT00676143|528474468|FG001|Overall Study|Vasogenic edema recurrence|3|||
146536687|NCT04810962|528474473|FG000|Overall Study|Adverse Event|0|||
146536688|NCT04810962|528474474|FG001|Overall Study|Adverse Event|1|||
146536689|NCT04810962|528474473|FG000|Overall Study|Lost to Follow-up|2|||
146536690|NCT04810962|528474474|FG001|Overall Study|Lost to Follow-up|1|||
146536691|NCT04810962|528474473|FG000|Overall Study|Physician Decision|1|||
146536692|NCT04810962|528474474|FG001|Overall Study|Physician Decision|0|||
146536693|NCT04810962|528474473|FG000|Overall Study|Withdrawal by Subject|1|||
146625302|NCT03037385|528803847|FG002|Overall Study|Reason Not Specified|0|||
146536694|NCT04810962|528474474|FG001|Overall Study|Withdrawal by Subject|3|||
146536695|NCT04810962|528474473|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
146536696|NCT04810962|528474474|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
146536697|NCT02412657|528474478|FG000|Overall Study|Lost to Follow-up|1|||
146536698|NCT02412657|528474479|FG001|Overall Study|Lost to Follow-up|0|||
146536699|NCT02412657|528474480|FG002|Overall Study|Lost to Follow-up|0|||
146536700|NCT02412657|528474478|FG000|Overall Study|Protocol Violation|0|||
146536701|NCT02412657|528474479|FG001|Overall Study|Protocol Violation|2|||
146536702|NCT02412657|528474480|FG002|Overall Study|Protocol Violation|3|||
146536703|NCT01281306|528474482|FG000|Overall Study|Lack of Efficacy|0|||
146536704|NCT01281306|528474483|FG001|Overall Study|Lack of Efficacy|1|||
146536705|NCT01281306|528474484|FG002|Overall Study|Lack of Efficacy|3|||
146536706|NCT01281306|528474485|FG003|Overall Study|Lack of Efficacy|0|||
146536707|NCT01281306|528474486|FG004|Overall Study|Lack of Efficacy|2|||
146536708|NCT01281306|528474487|FG005|Overall Study|Lack of Efficacy|0|||
146536709|NCT01281306|528474488|FG006|Overall Study|Lack of Efficacy|1|||
146536710|NCT01281306|528474482|FG000|Overall Study|Withdrawal by Subject|1|||
146536711|NCT01281306|528474483|FG001|Overall Study|Withdrawal by Subject|0|||
146536712|NCT01281306|528474484|FG002|Overall Study|Withdrawal by Subject|2|||
146536713|NCT01281306|528474485|FG003|Overall Study|Withdrawal by Subject|4|||
146536714|NCT01281306|528474486|FG004|Overall Study|Withdrawal by Subject|1|||
146536715|NCT01281306|528474487|FG005|Overall Study|Withdrawal by Subject|3|||
146536716|NCT01281306|528474488|FG006|Overall Study|Withdrawal by Subject|1|||
146536717|NCT01281306|528474482|FG000|Overall Study|Protocol deviation|0|||
146536718|NCT01281306|528474483|FG001|Overall Study|Protocol deviation|1|||
146536719|NCT01281306|528474484|FG002|Overall Study|Protocol deviation|1|||
146536720|NCT01281306|528474485|FG003|Overall Study|Protocol deviation|1|||
146536721|NCT01281306|528474486|FG004|Overall Study|Protocol deviation|1|||
146536722|NCT01281306|528474487|FG005|Overall Study|Protocol deviation|0|||
146536723|NCT01281306|528474488|FG006|Overall Study|Protocol deviation|0|||
146536724|NCT01281306|528474482|FG000|Overall Study|Condition no longer requires study drug|1|||
146536725|NCT01281306|528474483|FG001|Overall Study|Condition no longer requires study drug|0|||
146536726|NCT01281306|528474484|FG002|Overall Study|Condition no longer requires study drug|0|||
146536727|NCT01281306|528474485|FG003|Overall Study|Condition no longer requires study drug|0|||
146536728|NCT01281306|528474486|FG004|Overall Study|Condition no longer requires study drug|0|||
146536729|NCT01281306|528474487|FG005|Overall Study|Condition no longer requires study drug|1|||
146536730|NCT01281306|528474488|FG006|Overall Study|Condition no longer requires study drug|1|||
146536731|NCT01281306|528474482|FG000|Overall Study|Lost to Follow-up|1|||
146536732|NCT01281306|528474483|FG001|Overall Study|Lost to Follow-up|0|||
146536733|NCT01281306|528474484|FG002|Overall Study|Lost to Follow-up|0|||
146536734|NCT01281306|528474485|FG003|Overall Study|Lost to Follow-up|2|||
146536735|NCT01281306|528474486|FG004|Overall Study|Lost to Follow-up|0|||
146536736|NCT01281306|528474487|FG005|Overall Study|Lost to Follow-up|0|||
146536737|NCT01281306|528474488|FG006|Overall Study|Lost to Follow-up|1|||
146536738|NCT01281306|528474482|FG000|Overall Study|Death|1|||
146536739|NCT01281306|528474483|FG001|Overall Study|Death|0|||
146536740|NCT01281306|528474484|FG002|Overall Study|Death|0|||
146536741|NCT01281306|528474485|FG003|Overall Study|Death|0|||
146536742|NCT01281306|528474486|FG004|Overall Study|Death|0|||
146536743|NCT01281306|528474487|FG005|Overall Study|Death|0|||
146536744|NCT01281306|528474488|FG006|Overall Study|Death|0|||
146536745|NCT01281306|528474482|FG000|Overall Study|Adverse Event|3|||
146536746|NCT01281306|528474483|FG001|Overall Study|Adverse Event|2|||
146536747|NCT01281306|528474484|FG002|Overall Study|Adverse Event|2|||
146536748|NCT01281306|528474485|FG003|Overall Study|Adverse Event|3|||
146536749|NCT01281306|528474486|FG004|Overall Study|Adverse Event|5|||
146536750|NCT01281306|528474487|FG005|Overall Study|Adverse Event|3|||
146536751|NCT01281306|528474488|FG006|Overall Study|Adverse Event|3|||
146536752|NCT01281306|528474482|FG000|Overall Study|Randomized in error|1|||
146536753|NCT01281306|528474483|FG001|Overall Study|Randomized in error|0|||
146536754|NCT01281306|528474484|FG002|Overall Study|Randomized in error|0|||
146536755|NCT01281306|528474485|FG003|Overall Study|Randomized in error|1|||
146536756|NCT01281306|528474486|FG004|Overall Study|Randomized in error|0|||
146536757|NCT01281306|528474487|FG005|Overall Study|Randomized in error|0|||
146536758|NCT01281306|528474488|FG006|Overall Study|Randomized in error|0|||
146536759|NCT00368550|528474489|FG000|Overall Study|Adverse Event|7|||
146536760|NCT00368550|528474490|FG001|Overall Study|Adverse Event|4|||
146536761|NCT00368550|528474489|FG000|Overall Study|Lack of Efficacy|4|||
146536762|NCT00368550|528474490|FG001|Overall Study|Lack of Efficacy|9|||
146536763|NCT00368550|528474489|FG000|Overall Study|Withdrawal by Subject|17|||
146536764|NCT00368550|528474490|FG001|Overall Study|Withdrawal by Subject|10|||
146536765|NCT02410629|528474491|FG000|Overall Study|Family cannot commit to the study|2|||
146536766|NCT02410629|528474492|FG001|Overall Study|Family cannot commit to the study|1|||
146536767|NCT02410629|528474491|FG000|Overall Study|Subject returned to work|1|||
146536768|NCT02410629|528474492|FG001|Overall Study|Subject returned to work|0|||
146536769|NCT02410629|528474491|FG000|Overall Study|Subject moved back to home country|0|||
146536770|NCT02410629|528474492|FG001|Overall Study|Subject moved back to home country|1|||
146536771|NCT02410629|528474491|FG000|Overall Study|Subject underwent heart surgery|0|||
146536772|NCT02410629|528474492|FG001|Overall Study|Subject underwent heart surgery|1|||
146536773|NCT01206764|528474493|FG000|Overall Study|Adverse Event|20|||
146536774|NCT01206764|528474493|FG000|Overall Study|Abnormal laboratory value|2|||
146536775|NCT01206764|528474493|FG000|Overall Study|Abnormal test procedure result|1|||
146536776|NCT01206764|528474493|FG000|Overall Study|Patient withdrew consent|5|||
146536777|NCT01206764|528474493|FG000|Overall Study|Lost to Follow-up|6|||
146536778|NCT01206764|528474493|FG000|Overall Study|Death|11|||
146536779|NCT01206764|528474493|FG000|Overall Study|New cancer therapy|2|||
146536780|NCT01206764|528474493|FG000|Overall Study|Disease progression|88|||
146536781|NCT01206764|528474493|FG000|Overall Study|Protocol deviation|3|||
146536782|NCT00997893|528474494|FG000|Overall Study|Adverse Event|1|||
146536783|NCT00997893|528474495|FG001|Overall Study|Adverse Event|0|||
146536784|NCT00997893|528474496|FG002|Overall Study|Adverse Event|0|||
146536785|NCT00997893|528474494|FG000|Overall Study|Unable to meet study timelines|1|||
146536786|NCT00997893|528474495|FG001|Overall Study|Unable to meet study timelines|0|||
146536787|NCT00997893|528474496|FG002|Overall Study|Unable to meet study timelines|0|||
146536788|NCT00997893|528474494|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
146536789|NCT00997893|528474495|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
146536790|NCT00997893|528474496|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
146536791|NCT00226655|528474497|FG000|Overall Study|Death|13|||
146536792|NCT00226655|528474497|FG000|Overall Study|Withdrawal by Subject|15|||
146536793|NCT00226655|528474497|FG000|Overall Study|Adverse Event|35|||
146536794|NCT00226655|528474497|FG000|Overall Study|Physician Decision|6|||
146536795|NCT00226655|528474497|FG000|Overall Study|Clinical deterioration|10|||
146536796|NCT00701363|528474498|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
146536797|NCT00701363|528474499|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
146536798|NCT00701363|528474500|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
146536799|NCT00701363|528474501|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
146536800|NCT00701363|528474498|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
146536801|NCT00701363|528474499|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
146536802|NCT00701363|528474500|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
146536803|NCT00701363|528474501|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
146536804|NCT00701363|528474498|FG000|Treatment Phase 1|Adverse Event|7|||
146536805|NCT00701363|528474499|FG001|Treatment Phase 1|Adverse Event|0|||
146536806|NCT00701363|528474500|FG002|Treatment Phase 1|Adverse Event|0|||
146536807|NCT00701363|528474501|FG003|Treatment Phase 1|Adverse Event|0|||
146536808|NCT00701363|528474498|FG000|Treatment Phase 1|Protocol Violation|1|||
146536809|NCT00701363|528474499|FG001|Treatment Phase 1|Protocol Violation|0|||
146536810|NCT00701363|528474500|FG002|Treatment Phase 1|Protocol Violation|0|||
146536811|NCT00701363|528474501|FG003|Treatment Phase 1|Protocol Violation|0|||
146536812|NCT00701363|528474498|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
146536813|NCT00701363|528474499|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
146536814|NCT00701363|528474500|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
146536815|NCT00701363|528474501|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
146536816|NCT00701363|528474498|FG000|Treatment Phase 1|Lack of Efficacy|1|||
146536817|NCT00701363|528474499|FG001|Treatment Phase 1|Lack of Efficacy|0|||
146536818|NCT00701363|528474500|FG002|Treatment Phase 1|Lack of Efficacy|0|||
146536819|NCT00701363|528474501|FG003|Treatment Phase 1|Lack of Efficacy|0|||
146536820|NCT00701363|528474498|FG000|Treatment Phase 2|Adverse Event|0|||
146536821|NCT00701363|528474499|FG001|Treatment Phase 2|Adverse Event|0|||
146536822|NCT00701363|528474500|FG002|Treatment Phase 2|Adverse Event|1|||
146536823|NCT00701363|528474501|FG003|Treatment Phase 2|Adverse Event|0|||
146536824|NCT00701363|528474498|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
146536825|NCT00701363|528474499|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
146536826|NCT00701363|528474500|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
146536827|NCT00701363|528474501|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
146536828|NCT00465179|528474504|FG000|Overall Study|Adverse Event|4|||
146536829|NCT00465179|528474504|FG000|Overall Study|Withdrawal by Subject|2|||
146536830|NCT00465179|528474504|FG000|Overall Study|Progression of Disease|47|||
146536831|NCT00833755|528474508|FG000|Overall Study|Physician Decision|4|||
146536832|NCT00833755|528474509|FG001|Overall Study|Physician Decision|4|||
146536833|NCT00833755|528474510|FG002|Overall Study|Physician Decision|2|||
146536834|NCT00833755|528474511|FG003|Overall Study|Physician Decision|6|||
146536835|NCT00833755|528474508|FG000|Overall Study|Subject had scheduling issues|0|||
146536836|NCT00833755|528474509|FG001|Overall Study|Subject had scheduling issues|1|||
146536837|NCT00833755|528474510|FG002|Overall Study|Subject had scheduling issues|0|||
146536838|NCT00833755|528474511|FG003|Overall Study|Subject had scheduling issues|0|||
146536839|NCT00262925|528474512|FG000|Overall Study|Lack of Efficacy|3|||
146536840|NCT00262925|528474512|FG000|Overall Study|Adverse Event|4|||
146871061|NCT04784897|529699791|FG002|Overall Study|Withdrawal by Subject|1|||
146536841|NCT00262925|528474512|FG000|Overall Study|Death|2|||
146536842|NCT00262925|528474512|FG000|Overall Study|alternative therapy|1|||
146536843|NCT00262925|528474512|FG000|Overall Study|Other|1|||
146536844|NCT04682301|528474514|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
146536845|NCT04682301|528474514|FG000|Overall Study|Death|2|||
146536846|NCT00560404|528474515|FG000|Overall Study|Adverse Event|2|||
146536847|NCT00560404|528474516|FG001|Overall Study|Adverse Event|3|||
146536848|NCT00560404|528474515|FG000|Overall Study|Death|3|||
146536849|NCT00560404|528474516|FG001|Overall Study|Death|3|||
146536850|NCT00560404|528474515|FG000|Overall Study|Protocol Violation|12|||
146536851|NCT00560404|528474516|FG001|Overall Study|Protocol Violation|7|||
146536852|NCT00560404|528474515|FG000|Overall Study|Administrative Reasons|1|||
146536853|NCT00560404|528474516|FG001|Overall Study|Administrative Reasons|1|||
146536854|NCT00560404|528474515|FG000|Overall Study|Withdrew Consent|4|||
146536855|NCT00560404|528474516|FG001|Overall Study|Withdrew Consent|0|||
146536856|NCT00560404|528474515|FG000|Overall Study|Failure to return|1|||
146536857|NCT00560404|528474516|FG001|Overall Study|Failure to return|2|||
146536858|NCT00560404|528474515|FG000|Overall Study|Other withdrawal reason|13|||
146536859|NCT00560404|528474516|FG001|Overall Study|Other withdrawal reason|5|||
146536860|NCT05219162|528474517|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
146536861|NCT05219162|528474517|FG000|Overall Study|Withdrawal by Subject|23|||
146536862|NCT02187783|528474526|FG000|Overall Study|Adverse Event|8|||
146536863|NCT02187783|528474526|FG000|Overall Study|Death|3|||
146536864|NCT02187783|528474526|FG000|Overall Study|Progressive disease|80|||
146536865|NCT02187783|528474526|FG000|Overall Study|Protocol Violation|3|||
146536866|NCT02187783|528474526|FG000|Overall Study|Physician Decision|2|||
146536867|NCT02187783|528474526|FG000|Overall Study|Withdrawal by Subject|9|||
146536868|NCT02187783|528474526|FG000|Overall Study|Study terminated by sponsor|1|||
146536869|NCT00471497|528474527|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
146536870|NCT00471497|528474528|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
146536871|NCT00471497|528474529|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
146536872|NCT00471497|528474527|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
146536873|NCT00471497|528474528|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
146536874|NCT00471497|528474529|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
146536875|NCT00471497|528474527|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
146536876|NCT00471497|528474528|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
146536877|NCT00471497|528474529|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
146536878|NCT00471497|528474527|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
146536879|NCT00471497|528474528|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
146536880|NCT00471497|528474529|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
146536881|NCT00471497|528474527|FG000|Core Treatment Phase|Lost to Follow-up|6|||
146536882|NCT00471497|528474528|FG001|Core Treatment Phase|Lost to Follow-up|6|||
146536883|NCT00471497|528474529|FG002|Core Treatment Phase|Lost to Follow-up|3|||
146536884|NCT00471497|528474527|FG000|Core Treatment Phase|Death|3|||
146536885|NCT00471497|528474528|FG001|Core Treatment Phase|Death|9|||
146536886|NCT00471497|528474529|FG002|Core Treatment Phase|Death|3|||
146536887|NCT00471497|528474527|FG000|Core Treatment Phase|Disease Progression|10|||
146536888|NCT00471497|528474528|FG001|Core Treatment Phase|Disease Progression|2|||
146536889|NCT00471497|528474529|FG002|Core Treatment Phase|Disease Progression|4|||
146536890|NCT00471497|528474527|FG000|Core Treatment Phase|Protocol Violation|6|||
146536891|NCT00471497|528474528|FG001|Core Treatment Phase|Protocol Violation|15|||
146536892|NCT00471497|528474529|FG002|Core Treatment Phase|Protocol Violation|11|||
146536893|NCT00471497|528474527|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
146536894|NCT00471497|528474528|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
146536895|NCT00471497|528474529|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
146536896|NCT00471497|528474527|FG000|Core Treatment Phase|Administrative problems|14|||
146536897|NCT00471497|528474528|FG001|Core Treatment Phase|Administrative problems|14|||
146536898|NCT00471497|528474529|FG002|Core Treatment Phase|Administrative problems|12|||
146536899|NCT00471497|528474527|FG000|Core Treatment Phase|Adverse Event|43|||
146536900|NCT00471497|528474528|FG001|Core Treatment Phase|Adverse Event|53|||
146536901|NCT00471497|528474529|FG002|Core Treatment Phase|Adverse Event|89|||
146536902|NCT00471497|528474527|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
146536903|NCT00471497|528474528|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
146536904|NCT00471497|528474529|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
146536905|NCT00471497|528474527|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
146536906|NCT00471497|528474528|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
146536907|NCT00471497|528474529|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
146536908|NCT00471497|528474527|FG000|Extension Phase|Adverse Event|9|||
146536909|NCT00471497|528474528|FG001|Extension Phase|Adverse Event|5|||
146536910|NCT00471497|528474529|FG002|Extension Phase|Adverse Event|1|||
146536911|NCT00471497|528474527|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
146536912|NCT00471497|528474528|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
146536913|NCT00471497|528474529|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
146763863|NCT01090024|529302895|FG007|Period 3|Adverse Event|0|||
146536914|NCT00471497|528474527|FG000|Extension Phase|Withdrawal by Subject|3|||
146536915|NCT00471497|528474528|FG001|Extension Phase|Withdrawal by Subject|1|||
146536916|NCT00471497|528474529|FG002|Extension Phase|Withdrawal by Subject|0|||
146536917|NCT00471497|528474527|FG000|Extension Phase|Lost to Follow-up|2|||
146536918|NCT00471497|528474528|FG001|Extension Phase|Lost to Follow-up|0|||
146536919|NCT00471497|528474529|FG002|Extension Phase|Lost to Follow-up|0|||
146536920|NCT00471497|528474527|FG000|Extension Phase|Death|1|||
146536921|NCT00471497|528474528|FG001|Extension Phase|Death|0|||
146536922|NCT00471497|528474529|FG002|Extension Phase|Death|0|||
146763864|NCT01090024|529302896|FG008|Period 3|Adverse Event|0|||
146536923|NCT00471497|528474527|FG000|Extension Phase|Disease progression|2|||
146536924|NCT00471497|528474528|FG001|Extension Phase|Disease progression|0|||
146536925|NCT00471497|528474529|FG002|Extension Phase|Disease progression|0|||
146536926|NCT00471497|528474527|FG000|Extension Phase|Protocol Violation|2|||
146536927|NCT00471497|528474528|FG001|Extension Phase|Protocol Violation|2|||
146536928|NCT00471497|528474529|FG002|Extension Phase|Protocol Violation|0|||
146536929|NCT00392223|528474530|FG000|Overall Study|Adverse Event|5|||
146536930|NCT00392223|528474531|FG001|Overall Study|Adverse Event|4|||
146536931|NCT00392223|528474530|FG000|Overall Study|Lost to Follow-up|1|||
146536932|NCT00392223|528474531|FG001|Overall Study|Lost to Follow-up|4|||
146536933|NCT00392223|528474530|FG000|Overall Study|Protocol Violation|0|||
146536934|NCT00392223|528474531|FG001|Overall Study|Protocol Violation|3|||
146625303|NCT03037385|528803848|FG003|Overall Study|Reason Not Specified|4|||
146625304|NCT03037385|528803849|FG004|Overall Study|Reason Not Specified|3|||
146625305|NCT03037385|528803850|FG005|Overall Study|Reason Not Specified|6|||
146625306|NCT03037385|528803851|FG006|Overall Study|Reason Not Specified|2|||
146625307|NCT03037385|528803852|FG007|Overall Study|Reason Not Specified|0|||
146625308|NCT03037385|528803853|FG008|Overall Study|Reason Not Specified|1|||
146536935|NCT00392223|528474530|FG000|Overall Study|Withdrawal by Subject|3|||
146536936|NCT00392223|528474531|FG001|Overall Study|Withdrawal by Subject|2|||
146536937|NCT03344757|528474533|FG000|Overall Study|Withdrawal by Subject|18|||
146763865|NCT01090024|529302897|FG009|Period 3|Adverse Event|0|||
146763866|NCT01090024|529302898|FG010|Period 3|Adverse Event|0|||
146625309|NCT03037385|528803854|FG009|Overall Study|Reason Not Specified|181|||
146625310|NCT04515771|528803855|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
146625311|NCT04515771|528803856|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
146625312|NCT04515771|528803855|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
146625313|NCT04515771|528803856|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
146625314|NCT04515771|528803855|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
146625315|NCT04515771|528803856|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
146625316|NCT01021020|528803858|FG000|Period I|Protocol Violation|1|||
146625317|NCT01021020|528803858|FG000|Period I|Withdrawal by Subject|1|||
146625318|NCT01021020|528803858|FG000|14 Day Washout Period A|Physician Decision|1|||
146625319|NCT00948246|528803861|FG000|Overall Study|Lost to Follow-up|11|||
146625320|NCT00948246|528803861|FG000|Overall Study|Adverse Event|11|||
146625321|NCT00948246|528803861|FG000|Overall Study|Death|1|||
146625322|NCT00948246|528803861|FG000|Overall Study|Withdrawal by Subject|1|||
146625323|NCT00148317|528803862|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
146625324|NCT00148317|528803862|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
146625325|NCT00148317|528803862|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
146625326|NCT03924622|528803863|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
146625327|NCT03924622|528803864|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
146625328|NCT03924622|528803865|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
146536938|NCT03344757|528474534|FG001|Overall Study|Withdrawal by Subject|16|||
146536939|NCT03344757|528474533|FG000|Overall Study|Lost to Follow-up|0|||
146536940|NCT03344757|528474534|FG001|Overall Study|Lost to Follow-up|2|||
146536941|NCT00269152|528474537|FG000|Overall Study|Adverse Event|9|||
146536942|NCT00269152|528474538|FG001|Overall Study|Adverse Event|3|||
146536943|NCT00269152|528474537|FG000|Overall Study|Withdrawal by Subject|7|||
146536944|NCT00269152|528474538|FG001|Overall Study|Withdrawal by Subject|3|||
146536945|NCT00269152|528474537|FG000|Overall Study|Physician Decision|2|||
146536946|NCT00269152|528474538|FG001|Overall Study|Physician Decision|3|||
146536947|NCT00269152|528474537|FG000|Overall Study|Protocol Violation|0|||
146536948|NCT00269152|528474538|FG001|Overall Study|Protocol Violation|1|||
146536949|NCT04530630|528476381|FG000|Overall Study|Physician Decision|1|||
146536950|NCT03675308|528476384|FG000|Overall Study|Adverse Event|3|||
146536951|NCT03675308|528476385|FG001|Overall Study|Adverse Event|2|||
146536952|NCT03675308|528476384|FG000|Overall Study|Withdrawal by Subject|6|||
146536953|NCT03675308|528476385|FG001|Overall Study|Withdrawal by Subject|4|||
146536954|NCT03675308|528476384|FG000|Overall Study|Lost to Follow-up|3|||
146536955|NCT03675308|528476385|FG001|Overall Study|Lost to Follow-up|0|||
146536956|NCT03675308|528476384|FG000|Overall Study|Lack of Efficacy|1|||
146536957|NCT03675308|528476385|FG001|Overall Study|Lack of Efficacy|1|||
146536958|NCT03675308|528476384|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
146536959|NCT03675308|528476385|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
146536960|NCT03675308|528476384|FG000|Overall Study|Other|0|||
146536961|NCT03675308|528476385|FG001|Overall Study|Other|1|||
146536962|NCT04006457|528476390|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
146536963|NCT04006457|528476391|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
146536964|NCT04006457|528476392|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
146536965|NCT04006457|528476390|FG000|Main Study: Treatment Period 1|Death|1|||
146536966|NCT04006457|528476391|FG001|Main Study: Treatment Period 1|Death|1|||
146536967|NCT04006457|528476392|FG002|Main Study: Treatment Period 1|Death|0|||
146536968|NCT04006457|528476390|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
146536969|NCT04006457|528476391|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
146536970|NCT04006457|528476392|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
146536971|NCT04006457|528476390|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
146536972|NCT04006457|528476391|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
146536973|NCT04006457|528476392|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
146536974|NCT04006457|528476390|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
146536975|NCT04006457|528476391|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
146536976|NCT04006457|528476392|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
146536977|NCT04006457|528476390|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
146536978|NCT04006457|528476391|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
146536979|NCT04006457|528476392|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
146536980|NCT04006457|528476390|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
146536981|NCT04006457|528476391|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
146536982|NCT04006457|528476392|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
146536983|NCT04006457|528476390|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
146536984|NCT04006457|528476391|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
146536985|NCT04006457|528476392|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
146625329|NCT03924622|528803866|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
146625330|NCT03924622|528803867|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
146625331|NCT03924622|528803868|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
146625332|NCT02766023|528803869|FG000|Overall Study|Lost to Follow-up|23|||
146625333|NCT02766023|528803870|FG001|Overall Study|Lost to Follow-up|11|||
146625334|NCT02766023|528803869|FG000|Overall Study|Pregnancy|1|||
146625335|NCT02766023|528803870|FG001|Overall Study|Pregnancy|0|||
146625336|NCT02766023|528803869|FG000|Overall Study|Adverse Event|1|||
146625337|NCT02766023|528803870|FG001|Overall Study|Adverse Event|0|||
146625338|NCT02766023|528803869|FG000|Overall Study|Withdrawal by Subject|4|||
146625339|NCT02766023|528803870|FG001|Overall Study|Withdrawal by Subject|5|||
146625340|NCT02766023|528803869|FG000|Overall Study|Physician Decision|1|||
146625341|NCT02766023|528803870|FG001|Overall Study|Physician Decision|0|||
146625342|NCT02766023|528803869|FG000|Overall Study|Not Eligible at Enrollment|0|||
146625343|NCT02766023|528803870|FG001|Overall Study|Not Eligible at Enrollment|1|||
146625344|NCT00286468|528803871|FG000|Overall Study|Hyperglycemic Rescue|28|||
146625345|NCT00286468|528803872|FG001|Overall Study|Hyperglycemic Rescue|30|||
146625346|NCT00286468|528803873|FG002|Overall Study|Hyperglycemic Rescue|31|||
146625347|NCT00286468|528803871|FG000|Overall Study|Adverse Event|2|||
146625348|NCT00286468|528803872|FG001|Overall Study|Adverse Event|6|||
146536986|NCT04006457|528476390|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
146536987|NCT04006457|528476391|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
146536988|NCT04006457|528476392|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
146536989|NCT04006457|528476390|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
146536990|NCT04006457|528476391|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
146536991|NCT04006457|528476392|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
146536992|NCT04006457|528476390|FG000|Main Study: Treatment Period 1|Other|10|||
146536993|NCT04006457|528476391|FG001|Main Study: Treatment Period 1|Other|4|||
146536994|NCT04006457|528476392|FG002|Main Study: Treatment Period 1|Other|0|||
146536995|NCT04006457|528476390|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
146536996|NCT04006457|528476391|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
146536997|NCT04006457|528476392|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
146536998|NCT04006457|528476390|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
146536999|NCT04006457|528476391|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
146537000|NCT04006457|528476392|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
146537001|NCT04006457|528476390|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
146537002|NCT04006457|528476391|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
146537003|NCT04006457|528476392|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
146537004|NCT04006457|528476390|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
146537005|NCT04006457|528476391|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
146537006|NCT04006457|528476392|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
146537007|NCT04006457|528476390|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
146537008|NCT04006457|528476391|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
146537009|NCT04006457|528476392|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
146537010|NCT04006457|528476390|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
146537011|NCT04006457|528476391|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
146537012|NCT04006457|528476392|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
146537013|NCT04006457|528476390|FG000|Main Study: Treatment Period 2|Other|2|||
146537014|NCT04006457|528476391|FG001|Main Study: Treatment Period 2|Other|3|||
146537015|NCT04006457|528476392|FG002|Main Study: Treatment Period 2|Other|0|||
146537016|NCT04006457|528476390|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
146537017|NCT04006457|528476391|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
146537018|NCT04006457|528476392|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
146537019|NCT04006457|528476390|FG000|Main Study: Treatment Period 2|Ongoing|86|||
146537020|NCT04006457|528476391|FG001|Main Study: Treatment Period 2|Ongoing|96|||
146537021|NCT04006457|528476392|FG002|Main Study: Treatment Period 2|Ongoing|0|||
146537022|NCT04006457|528476390|FG000|Main Study Observation Period|Adverse Event|1|||
146537023|NCT04006457|528476391|FG001|Main Study Observation Period|Adverse Event|1|||
146537024|NCT04006457|528476392|FG002|Main Study Observation Period|Adverse Event|0|||
146537025|NCT04006457|528476390|FG000|Main Study Observation Period|Lost to Follow-up|0|||
146537026|NCT04006457|528476391|FG001|Main Study Observation Period|Lost to Follow-up|1|||
146537027|NCT04006457|528476392|FG002|Main Study Observation Period|Lost to Follow-up|0|||
146537028|NCT04006457|528476390|FG000|Main Study Observation Period|Pregnancy|1|||
146537029|NCT04006457|528476391|FG001|Main Study Observation Period|Pregnancy|0|||
146537030|NCT04006457|528476392|FG002|Main Study Observation Period|Pregnancy|0|||
146537031|NCT04006457|528476390|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
146537032|NCT04006457|528476391|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
146537033|NCT04006457|528476392|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
146537034|NCT04006457|528476390|FG000|Main Study Observation Period|Other|8|||
146625349|NCT00286468|528803873|FG002|Overall Study|Adverse Event|4|||
146625350|NCT00286468|528803871|FG000|Overall Study|Protocol Violation|0|||
146625351|NCT00286468|528803872|FG001|Overall Study|Protocol Violation|3|||
146625352|NCT00286468|528803873|FG002|Overall Study|Protocol Violation|1|||
146537035|NCT04006457|528476391|FG001|Main Study Observation Period|Other|16|||
146537036|NCT04006457|528476392|FG002|Main Study Observation Period|Other|0|||
146537037|NCT04006457|528476390|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
146537038|NCT04006457|528476391|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
146537039|NCT04006457|528476392|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
146537040|NCT04006457|528476390|FG000|Main Study Observation Period|Ongoing|2|||
146537041|NCT04006457|528476391|FG001|Main Study Observation Period|Ongoing|1|||
146537042|NCT04006457|528476392|FG002|Main Study Observation Period|Ongoing|0|||
146537043|NCT04006457|528476390|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
146537044|NCT04006457|528476391|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
146537045|NCT04006457|528476392|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
146537046|NCT01721798|528476396|FG000|Overall Study|Death|0|||
146537047|NCT01721798|528476397|FG001|Overall Study|Death|0|||
146537048|NCT01721798|528476398|FG002|Overall Study|Death|1|||
146537049|NCT01721798|528476399|FG003|Overall Study|Death|1|||
146537050|NCT01721798|528476396|FG000|Overall Study|Lost to Follow-up|2|||
146537051|NCT01721798|528476397|FG001|Overall Study|Lost to Follow-up|2|||
146537052|NCT01721798|528476398|FG002|Overall Study|Lost to Follow-up|9|||
146537053|NCT01721798|528476399|FG003|Overall Study|Lost to Follow-up|9|||
146537054|NCT01721798|528476396|FG000|Overall Study|Pregnancy|0|||
146537055|NCT01721798|528476397|FG001|Overall Study|Pregnancy|0|||
146537056|NCT01721798|528476398|FG002|Overall Study|Pregnancy|1|||
146537057|NCT01721798|528476399|FG003|Overall Study|Pregnancy|1|||
146537058|NCT01721798|528476396|FG000|Overall Study|Withdrawal by Subject|1|||
146537059|NCT01721798|528476397|FG001|Overall Study|Withdrawal by Subject|0|||
146537060|NCT01721798|528476398|FG002|Overall Study|Withdrawal by Subject|2|||
146537061|NCT01721798|528476399|FG003|Overall Study|Withdrawal by Subject|1|||
146537062|NCT01721798|528476396|FG000|Overall Study|Not eligible for 24 month visit|1|||
146537063|NCT01721798|528476397|FG001|Overall Study|Not eligible for 24 month visit|0|||
146537064|NCT01721798|528476398|FG002|Overall Study|Not eligible for 24 month visit|8|||
146537065|NCT01721798|528476399|FG003|Overall Study|Not eligible for 24 month visit|7|||
146537066|NCT00420745|528476400|FG000|Overall Study|Adverse Event|2|||
146537067|NCT00420745|528476401|FG001|Overall Study|Adverse Event|2|||
146537068|NCT00420745|528476400|FG000|Overall Study|Lost to Follow-up|10|||
146537069|NCT00420745|528476401|FG001|Overall Study|Lost to Follow-up|2|||
146537070|NCT00420745|528476400|FG000|Overall Study|Protocol Violation|1|||
146537071|NCT00420745|528476401|FG001|Overall Study|Protocol Violation|0|||
146537072|NCT00420745|528476400|FG000|Overall Study|Physician Decision|1|||
146537073|NCT00420745|528476401|FG001|Overall Study|Physician Decision|1|||
146537074|NCT00420745|528476400|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
146537075|NCT00420745|528476401|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
146537076|NCT00420745|528476400|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
146537077|NCT00420745|528476401|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
146537078|NCT00819039|528476402|FG000|Overall Study|Physician Decision|1|||
146537079|NCT00819039|528476403|FG001|Overall Study|Physician Decision|0|||
146537080|NCT00819039|528476404|FG002|Overall Study|Physician Decision|1|||
146537081|NCT00819039|528476402|FG000|Overall Study|Protocol Violation|1|||
146537082|NCT00819039|528476403|FG001|Overall Study|Protocol Violation|0|||
146537083|NCT00819039|528476404|FG002|Overall Study|Protocol Violation|0|||
146537084|NCT04796415|528476405|FG000|Overall Study|not interested|12|||
146537085|NCT04796415|528476405|FG000|Overall Study|health issue|8|||
146537086|NCT04796415|528476405|FG000|Overall Study|Other|4|||
146537087|NCT04796415|528476405|FG000|Overall Study|discharged from home health service|3|||
146537088|NCT04796415|528476405|FG000|Overall Study|re-hospitalization|2|||
146537089|NCT04796415|528476405|FG000|Overall Study|moving to nursing home|1|||
146537090|NCT04796415|528476405|FG000|Overall Study|lost contact|1|||
146537091|NCT03185208|528476409|FG000|Overall Study|Did not start study medication|0|||
146537092|NCT03185208|528476410|FG001|Overall Study|Did not start study medication|3|||
146537093|NCT03834350|528476411|FG000|Overall Study|Withdrawal by Subject|1|||
146537094|NCT02701634|528476412|FG000|Overall Study|Adverse Event|2|||
146537095|NCT02701634|528476413|FG001|Overall Study|Adverse Event|3|||
146537096|NCT02701634|528476412|FG000|Overall Study|Death|1|||
146537097|NCT02701634|528476413|FG001|Overall Study|Death|0|||
146537098|NCT02701634|528476412|FG000|Overall Study|Investigator's Discretion|7|||
146537099|NCT02701634|528476413|FG001|Overall Study|Investigator's Discretion|4|||
146537100|NCT02701634|528476412|FG000|Overall Study|Study terminated by Sponsor|15|||
146537101|NCT02701634|528476413|FG001|Overall Study|Study terminated by Sponsor|17|||
146537102|NCT02701634|528476412|FG000|Overall Study|Withdrew Consent|6|||
146537103|NCT02701634|528476413|FG001|Overall Study|Withdrew Consent|7|||
146537104|NCT02701634|528476412|FG000|Overall Study|Randomized but not treated|1|||
146537105|NCT02701634|528476413|FG001|Overall Study|Randomized but not treated|0|||
146537106|NCT00961415|528476418|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
146537107|NCT00961415|528476419|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
146537108|NCT00961415|528476420|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
146871062|NCT02665052|529699792|FG000|Overall Study|Lost to Follow-up|1|||
146537109|NCT00961415|528476418|FG000|Induction Treatment Phase|Death|77|||
146537110|NCT00961415|528476419|FG001|Induction Treatment Phase|Death|0|||
146537111|NCT00961415|528476420|FG002|Induction Treatment Phase|Death|0|||
146537112|NCT00961415|528476418|FG000|Induction Treatment Phase|Protocol Violation|1|||
146537113|NCT00961415|528476419|FG001|Induction Treatment Phase|Protocol Violation|0|||
146537114|NCT00961415|528476420|FG002|Induction Treatment Phase|Protocol Violation|0|||
146537115|NCT00961415|528476418|FG000|Induction Treatment Phase|Physician Decision|2|||
146537116|NCT00961415|528476419|FG001|Induction Treatment Phase|Physician Decision|0|||
146537117|NCT00961415|528476420|FG002|Induction Treatment Phase|Physician Decision|0|||
146537118|NCT00961415|528476418|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
146537119|NCT00961415|528476419|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
146537120|NCT00961415|528476420|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
146537121|NCT00961415|528476418|FG000|Induction Treatment Phase|Other Reason|5|||
146537122|NCT00961415|528476419|FG001|Induction Treatment Phase|Other Reason|0|||
146537123|NCT00961415|528476420|FG002|Induction Treatment Phase|Other Reason|0|||
146537124|NCT00961415|528476418|FG000|Maintenance Treatment Phase|Death|0|||
146537125|NCT00961415|528476419|FG001|Maintenance Treatment Phase|Death|42|||
146537126|NCT00961415|528476420|FG002|Maintenance Treatment Phase|Death|34|||
146537127|NCT00961415|528476418|FG000|Maintenance Treatment Phase|Investigators decision|0|||
146537128|NCT00961415|528476419|FG001|Maintenance Treatment Phase|Investigators decision|2|||
146537129|NCT00961415|528476420|FG002|Maintenance Treatment Phase|Investigators decision|0|||
146537130|NCT00961415|528476418|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146537131|NCT00961415|528476419|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
146537132|NCT00961415|528476420|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
146537133|NCT00961415|528476418|FG000|Maintenance Treatment Phase|Other reason|0|||
146537134|NCT00961415|528476419|FG001|Maintenance Treatment Phase|Other reason|1|||
146537135|NCT00961415|528476420|FG002|Maintenance Treatment Phase|Other reason|3|||
146537136|NCT01311661|528476423|FG000|Overall Study|Adverse Event|2|||
146537137|NCT01311661|528476423|FG000|Overall Study|Protocol Violation|3|||
146537138|NCT01311661|528476423|FG000|Overall Study|Withdrawal by Subject|2|||
146537139|NCT00284856|528476424|FG000|Overall Study|Adverse Event|3|||
146537140|NCT00284856|528476425|FG001|Overall Study|Adverse Event|3|||
146537141|NCT00284856|528476426|FG002|Overall Study|Adverse Event|3|||
146537142|NCT00284856|528476424|FG000|Overall Study|Lack of Efficacy|2|||
146537143|NCT00284856|528476425|FG001|Overall Study|Lack of Efficacy|1|||
146537144|NCT00284856|528476426|FG002|Overall Study|Lack of Efficacy|8|||
146537145|NCT00284856|528476424|FG000|Overall Study|Lost to Follow-up|25|||
146537146|NCT00284856|528476425|FG001|Overall Study|Lost to Follow-up|21|||
146537147|NCT00284856|528476426|FG002|Overall Study|Lost to Follow-up|22|||
146537148|NCT00284856|528476424|FG000|Overall Study|Protocol Violation|5|||
146537149|NCT00284856|528476425|FG001|Overall Study|Protocol Violation|4|||
146537150|NCT00284856|528476426|FG002|Overall Study|Protocol Violation|5|||
146537151|NCT00284856|528476424|FG000|Overall Study|Withdrawal by Subject|12|||
146537152|NCT00284856|528476425|FG001|Overall Study|Withdrawal by Subject|16|||
146537153|NCT00284856|528476426|FG002|Overall Study|Withdrawal by Subject|18|||
146537154|NCT00284856|528476424|FG000|Overall Study|Other|4|||
146537155|NCT00284856|528476425|FG001|Overall Study|Other|5|||
146537156|NCT00284856|528476426|FG002|Overall Study|Other|4|||
146537157|NCT03692949|528476427|FG000|Overall Study|Lost to Follow-up|0|||
146537158|NCT03692949|528476428|FG001|Overall Study|Lost to Follow-up|0|||
146537159|NCT03692949|528476429|FG002|Overall Study|Lost to Follow-up|0|||
146537160|NCT03692949|528476430|FG003|Overall Study|Lost to Follow-up|0|||
146537161|NCT03692949|528476431|FG004|Overall Study|Lost to Follow-up|0|||
146537162|NCT03692949|528476432|FG005|Overall Study|Lost to Follow-up|0|||
146537163|NCT03692949|528476433|FG006|Overall Study|Lost to Follow-up|0|||
146537164|NCT03692949|528476434|FG007|Overall Study|Lost to Follow-up|1|||
146537165|NCT03426878|528476442|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
146537166|NCT03426878|528476442|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
146537167|NCT03426878|528476442|FG000|Overall Study|Declined to receive results|3|||
146537168|NCT03426878|528476442|FG000|Overall Study|Received negative results by mailed letter|65|||
146537169|NCT03426878|528476442|FG000|Overall Study|Lost to Follow-up|177|||
146537170|NCT02855268|528476443|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
146537171|NCT02855268|528476444|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
146537172|NCT02855268|528476443|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
146537173|NCT02855268|528476444|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
146537174|NCT02855268|528476443|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
146537175|NCT02855268|528476444|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
146537176|NCT02855268|528476443|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
146537177|NCT02855268|528476444|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
146537178|NCT02855268|528476443|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
146537179|NCT02855268|528476444|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
146537180|NCT02855268|528476443|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
146537181|NCT02855268|528476444|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
146537182|NCT01316575|528476449|FG000|Overall Study|Withdrawal by Subject|2|||
146537183|NCT01316575|528476450|FG001|Overall Study|Withdrawal by Subject|0|||
146871063|NCT02665052|529699793|FG001|Overall Study|Lost to Follow-up|0|||
146871064|NCT02665052|529699794|FG002|Overall Study|Lost to Follow-up|0|||
146537184|NCT01316575|528476449|FG000|Overall Study|Required alternate treatment|0|||
146537185|NCT01316575|528476450|FG001|Overall Study|Required alternate treatment|1|||
146537186|NCT00402831|528476451|FG000|Overall Study|Lost to Follow-up|1|||
146537187|NCT00402831|528476452|FG001|Overall Study|Lost to Follow-up|2|||
146537188|NCT00402831|528476451|FG000|Overall Study|Non-compliance with protocol|0|||
146625353|NCT00286468|528803871|FG000|Overall Study|Lost to Follow-up|1|||
146625354|NCT00286468|528803872|FG001|Overall Study|Lost to Follow-up|1|||
146625355|NCT00286468|528803873|FG002|Overall Study|Lost to Follow-up|2|||
146625356|NCT00286468|528803871|FG000|Overall Study|Withdrawal by Subject|3|||
146625357|NCT00286468|528803872|FG001|Overall Study|Withdrawal by Subject|8|||
146625358|NCT00286468|528803873|FG002|Overall Study|Withdrawal by Subject|11|||
146625359|NCT00286468|528803871|FG000|Overall Study|Physician Decision|3|||
146625360|NCT00286468|528803872|FG001|Overall Study|Physician Decision|2|||
146625361|NCT00286468|528803873|FG002|Overall Study|Physician Decision|1|||
146625362|NCT02923726|528803875|FG000|Overall Study|Death|196|||
146625363|NCT02923726|528803876|FG001|Overall Study|Death|175|||
146625364|NCT02923726|528803875|FG000|Overall Study|Withdrawal by Subject|337|||
146625365|NCT02923726|528803876|FG001|Overall Study|Withdrawal by Subject|307|||
146625366|NCT03617172|528803888|FG000|Overall Study|Lost to Follow-up|1|||
146625367|NCT03617172|528803889|FG001|Overall Study|Lost to Follow-up|0|||
146625368|NCT02587221|528803892|FG000|Overall Study|Adverse Event|3|||
146625369|NCT02587221|528803893|FG001|Overall Study|Adverse Event|3|||
146625370|NCT02587221|528803892|FG000|Overall Study|Death|33|||
146625371|NCT02587221|528803893|FG001|Overall Study|Death|34|||
146625372|NCT02587221|528803892|FG000|Overall Study|Withdrawal by Subject|66|||
146625373|NCT02587221|528803893|FG001|Overall Study|Withdrawal by Subject|61|||
146625374|NCT02587221|528803892|FG000|Overall Study|Lost to Follow-up|21|||
146625375|NCT02587221|528803893|FG001|Overall Study|Lost to Follow-up|19|||
146625376|NCT02587221|528803892|FG000|Overall Study|Protocol Violation|6|||
146625377|NCT02587221|528803893|FG001|Overall Study|Protocol Violation|5|||
146625378|NCT02587221|528803892|FG000|Overall Study|Other Reason or Unspecified|2|||
146625379|NCT02587221|528803893|FG001|Overall Study|Other Reason or Unspecified|1|||
146625380|NCT01176032|528803897|FG000|Overall Study|Adverse Event|1|||
146625381|NCT01176032|528803898|FG001|Overall Study|Adverse Event|0|||
146625382|NCT01176032|528803897|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146625383|NCT01176032|528803898|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146625384|NCT01176032|528803897|FG000|Overall Study|Protocol Violation|1|||
146625385|NCT01176032|528803898|FG001|Overall Study|Protocol Violation|0|||
146625386|NCT01176032|528803897|FG000|Overall Study|Informed consent withdrawn|3|||
146625387|NCT01176032|528803898|FG001|Overall Study|Informed consent withdrawn|0|||
146625388|NCT01176032|528803897|FG000|Overall Study|Other|1|||
146625389|NCT01176032|528803898|FG001|Overall Study|Other|0|||
146625390|NCT01469221|528803899|FG000|Double Blind Phase|Protocol Violation|1|||
146625391|NCT01469221|528803900|FG001|Double Blind Phase|Protocol Violation|0|||
146625392|NCT01469221|528803901|FG002|Double Blind Phase|Protocol Violation|0|||
146625393|NCT01469221|528803899|FG000|Double Blind Phase|Physician Decision|1|||
146625394|NCT01469221|528803900|FG001|Double Blind Phase|Physician Decision|1|||
146537189|NCT00402831|528476452|FG001|Overall Study|Non-compliance with protocol|1|||
146537190|NCT00671788|528476455|FG000|Overall Study|Adverse Event|8|||
146537191|NCT00671788|528476455|FG000|Overall Study|Refused further treatment|3|||
146537192|NCT00671788|528476455|FG000|Overall Study|Ineligible|1|||
146537193|NCT00671788|528476455|FG000|Overall Study|MD Decision|1|||
146537194|NCT00671788|528476455|FG000|Overall Study|Other|1|||
146537195|NCT02792504|528476458|FG000|Overall Study|Lost to Follow-up|24|||
146537196|NCT02792504|528476458|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
146537197|NCT01035138|528476465|FG000|Overall Study|Adverse Event|4|||
146537198|NCT01035138|528476466|FG001|Overall Study|Adverse Event|0|||
146537199|NCT01035138|528476467|FG002|Overall Study|Adverse Event|2|||
146537200|NCT01035138|528476465|FG000|Overall Study|Caregiver Decision|2|||
146537201|NCT01035138|528476466|FG001|Overall Study|Caregiver Decision|0|||
146537202|NCT01035138|528476467|FG002|Overall Study|Caregiver Decision|1|||
146537203|NCT01035138|528476465|FG000|Overall Study|Withdrawal by Subject|1|||
146537204|NCT01035138|528476466|FG001|Overall Study|Withdrawal by Subject|0|||
146537205|NCT01035138|528476467|FG002|Overall Study|Withdrawal by Subject|0|||
146763867|NCT01090024|529302899|FG011|Period 3|Adverse Event|0|||
146625395|NCT01469221|528803901|FG002|Double Blind Phase|Physician Decision|0|||
146625396|NCT01469221|528803899|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
146537206|NCT01035138|528476465|FG000|Overall Study|Physician Decision|0|||
146537207|NCT01035138|528476466|FG001|Overall Study|Physician Decision|0|||
146537208|NCT01035138|528476467|FG002|Overall Study|Physician Decision|1|||
146537209|NCT01035138|528476465|FG000|Overall Study|Sponsor Decision|66|||
146625397|NCT01469221|528803900|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
146625398|NCT01469221|528803901|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
146625399|NCT01149096|528803904|FG000|Overall Study|Lost to Follow-up|0|||
146537210|NCT01035138|528476466|FG001|Overall Study|Sponsor Decision|60|||
146625400|NCT01149096|528803905|FG001|Overall Study|Lost to Follow-up|1|||
146625401|NCT04914364|528803906|FG000|Overall Study|No longer eligible for study|1|||
146625402|NCT04914364|528803906|FG000|Overall Study|Lost to Follow-up|2|||
146763868|NCT01090024|529302900|FG012|Period 3|Adverse Event|0|||
146625403|NCT02358473|528803907|FG000|Overall Study|Disease Progession|6|||
146625404|NCT02358473|528803907|FG000|Overall Study|Adverse Event|3|||
146625405|NCT02358473|528803907|FG000|Overall Study|Withdrawal by Subject|2|||
146625406|NCT02358473|528803907|FG000|Overall Study|Physician Decision|2|||
146625407|NCT04819945|528803922|FG000|Overall Study|Lost to Follow-up|1|||
146625408|NCT00703014|528803923|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
146625409|NCT00703014|528803924|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
146625410|NCT00703014|528803925|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
146625411|NCT00703014|528803926|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
146625412|NCT00703014|528803923|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
146625413|NCT00703014|528803924|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
146625414|NCT00703014|528803925|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
146625415|NCT00703014|528803926|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
146625416|NCT02004236|528803927|FG000|Overall Study|Lack of Efficacy|0|||
146625417|NCT02004236|528803928|FG001|Overall Study|Lack of Efficacy|0|||
146625418|NCT02004236|528803929|FG002|Overall Study|Lack of Efficacy|16|||
146625419|NCT00918281|528803934|FG000|Overall Study|Physician Decision|29|||
146625420|NCT01446159|528803935|FG000|Overall Study|Withdrawal by Subject|1|||
146625421|NCT01446159|528803936|FG001|Overall Study|Withdrawal by Subject|0|||
146625422|NCT01446159|528803937|FG002|Overall Study|Withdrawal by Subject|14|||
146625423|NCT01446159|528803938|FG003|Overall Study|Withdrawal by Subject|11|||
146625424|NCT01446159|528803935|FG000|Overall Study|Lost to Follow-up|0|||
146625425|NCT01446159|528803936|FG001|Overall Study|Lost to Follow-up|0|||
146625426|NCT01446159|528803937|FG002|Overall Study|Lost to Follow-up|1|||
146625427|NCT01446159|528803938|FG003|Overall Study|Lost to Follow-up|2|||
146625428|NCT01446159|528803935|FG000|Overall Study|Death|2|||
146625429|NCT01446159|528803936|FG001|Overall Study|Death|3|||
146625430|NCT01446159|528803937|FG002|Overall Study|Death|43|||
146625431|NCT01446159|528803938|FG003|Overall Study|Death|36|||
146625432|NCT01446159|528803935|FG000|Overall Study|Other|0|||
146625433|NCT01446159|528803936|FG001|Overall Study|Other|0|||
146625434|NCT01446159|528803937|FG002|Overall Study|Other|13|||
146625435|NCT01446159|528803938|FG003|Overall Study|Other|13|||
146625436|NCT01283139|528803939|FG000|Overall Study|Lost to Follow-up|5|||
146625437|NCT01283139|528803940|FG001|Overall Study|Lost to Follow-up|2|||
146625438|NCT01283139|528803941|FG002|Overall Study|Lost to Follow-up|3|||
146625439|NCT01283139|528803942|FG003|Overall Study|Lost to Follow-up|1|||
146625440|NCT01283139|528803939|FG000|Overall Study|Withdrawal by Subject|8|||
146625441|NCT01283139|528803940|FG001|Overall Study|Withdrawal by Subject|8|||
146625442|NCT01283139|528803941|FG002|Overall Study|Withdrawal by Subject|6|||
146625443|NCT01283139|528803942|FG003|Overall Study|Withdrawal by Subject|8|||
146625444|NCT01283139|528803939|FG000|Overall Study|Death|2|||
146625445|NCT01283139|528803940|FG001|Overall Study|Death|0|||
146625446|NCT01283139|528803941|FG002|Overall Study|Death|2|||
146625447|NCT01283139|528803942|FG003|Overall Study|Death|2|||
146625448|NCT01283139|528803939|FG000|Overall Study|Lack of Efficacy|1|||
146625449|NCT01283139|528803940|FG001|Overall Study|Lack of Efficacy|2|||
146625450|NCT01283139|528803941|FG002|Overall Study|Lack of Efficacy|2|||
146625451|NCT01283139|528803942|FG003|Overall Study|Lack of Efficacy|1|||
146625452|NCT01283139|528803939|FG000|Overall Study|Early termination due to AE/SAE|1|||
146625453|NCT01283139|528803940|FG001|Overall Study|Early termination due to AE/SAE|1|||
146625454|NCT01283139|528803941|FG002|Overall Study|Early termination due to AE/SAE|0|||
146625455|NCT01283139|528803942|FG003|Overall Study|Early termination due to AE/SAE|0|||
146625456|NCT01283139|528803939|FG000|Overall Study|Participant's refusal to continue|0|||
146625457|NCT01283139|528803940|FG001|Overall Study|Participant's refusal to continue|3|||
146625458|NCT01283139|528803941|FG002|Overall Study|Participant's refusal to continue|1|||
146625459|NCT01283139|528803942|FG003|Overall Study|Participant's refusal to continue|1|||
146625460|NCT01283139|528803939|FG000|Overall Study|Pregnancy|0|||
146625461|NCT01283139|528803940|FG001|Overall Study|Pregnancy|1|||
146625462|NCT01283139|528803941|FG002|Overall Study|Pregnancy|1|||
146625463|NCT01283139|528803942|FG003|Overall Study|Pregnancy|0|||
146625464|NCT01283139|528803939|FG000|Overall Study|Missed follow-up visit|0|||
146625465|NCT01283139|528803940|FG001|Overall Study|Missed follow-up visit|1|||
146625466|NCT01283139|528803941|FG002|Overall Study|Missed follow-up visit|2|||
146625467|NCT01283139|528803942|FG003|Overall Study|Missed follow-up visit|2|||
146625468|NCT01283139|528803939|FG000|Overall Study|Participant randomized in error|0|||
146625469|NCT01283139|528803940|FG001|Overall Study|Participant randomized in error|0|||
146625470|NCT01283139|528803941|FG002|Overall Study|Participant randomized in error|1|||
146625471|NCT01283139|528803942|FG003|Overall Study|Participant randomized in error|0|||
146625472|NCT00004563|528803943|FG000|Overall Study|Withdrawal by Subject|20|||
146625473|NCT00004563|528803944|FG001|Overall Study|Withdrawal by Subject|16|||
146625474|NCT00004563|528803943|FG000|Overall Study|Lack of Efficacy|3|||
146625475|NCT00004563|528803944|FG001|Overall Study|Lack of Efficacy|5|||
146625476|NCT00004563|528803943|FG000|Overall Study|Death|2|||
146625477|NCT00004563|528803944|FG001|Overall Study|Death|3|||
146625478|NCT00762164|528803946|FG000|Overall Study|Lost to Follow-up|1|||
146625479|NCT00762164|528803947|FG001|Overall Study|Lost to Follow-up|1|||
146625480|NCT00762164|528803946|FG000|Overall Study|Discontinued medication|2|||
146625481|NCT00762164|528803947|FG001|Overall Study|Discontinued medication|0|||
146625482|NCT00762164|528803946|FG000|Overall Study|Withdrawal by Subject|0|||
146625483|NCT00762164|528803947|FG001|Overall Study|Withdrawal by Subject|1|||
146625484|NCT00321789|528803952|FG000|Overall Study|Lost to Follow-up|4|||
146625485|NCT00321789|528803953|FG001|Overall Study|Lost to Follow-up|7|||
146625486|NCT00321789|528803952|FG000|Overall Study|Withdrawal by Subject|6|||
146625487|NCT00321789|528803953|FG001|Overall Study|Withdrawal by Subject|6|||
146625488|NCT00321789|528803952|FG000|Overall Study|Protocol Violation|5|||
146625489|NCT00321789|528803953|FG001|Overall Study|Protocol Violation|3|||
146625490|NCT02025179|528803954|FG000|Overall Study|Lost to Follow-up|0|||
146625491|NCT02025179|528803955|FG001|Overall Study|Lost to Follow-up|0|||
146625492|NCT02025179|528803956|FG002|Overall Study|Lost to Follow-up|1|||
146625493|NCT02362724|528803957|FG000|Overall Study|Withdrawal by Subject|3|||
146625494|NCT02362724|528803958|FG001|Overall Study|Withdrawal by Subject|1|||
146625495|NCT02362724|528803957|FG000|Overall Study|Adverse Event|3|||
146625496|NCT02362724|528803958|FG001|Overall Study|Adverse Event|0|||
146625497|NCT01927497|528803961|FG000|Overall Study|Death|0|||
146625498|NCT01927497|528803962|FG001|Overall Study|Death|1|||
146625499|NCT01927497|528803961|FG000|Overall Study|Protocol Violation|2|||
146625500|NCT01927497|528803962|FG001|Overall Study|Protocol Violation|0|||
146625501|NCT00517296|528803963|FG000|Overall Study|Withdrawal by Subject|1|||
146625502|NCT00517296|528803964|FG001|Overall Study|Withdrawal by Subject|0|||
146625503|NCT03137992|528803967|FG000|Washout Period 1|Adverse Event|1|||
146625504|NCT03137992|528803968|FG001|Washout Period 1|Adverse Event|1|||
146625505|NCT03137992|528803969|FG002|Washout Period 1|Adverse Event|0|||
146625506|NCT03137992|528803970|FG003|Washout Period 1|Adverse Event|0|||
146625507|NCT03137992|528803971|FG004|Washout Period 1|Adverse Event|0|||
146625508|NCT03137992|528803972|FG005|Washout Period 1|Adverse Event|1|||
146625509|NCT03137992|528803967|FG000|Washout Period 1|Withdrawal by Subject|0|||
146625510|NCT03137992|528803968|FG001|Washout Period 1|Withdrawal by Subject|1|||
146625511|NCT03137992|528803969|FG002|Washout Period 1|Withdrawal by Subject|1|||
146625512|NCT03137992|528803970|FG003|Washout Period 1|Withdrawal by Subject|0|||
146625513|NCT03137992|528803971|FG004|Washout Period 1|Withdrawal by Subject|0|||
146625514|NCT03137992|528803972|FG005|Washout Period 1|Withdrawal by Subject|0|||
146625515|NCT03137992|528803967|FG000|Washout Period 1|Principal Investigator Discretion|0|||
146625516|NCT03137992|528803968|FG001|Washout Period 1|Principal Investigator Discretion|1|||
146625517|NCT03137992|528803969|FG002|Washout Period 1|Principal Investigator Discretion|0|||
146625518|NCT03137992|528803970|FG003|Washout Period 1|Principal Investigator Discretion|0|||
146625519|NCT03137992|528803971|FG004|Washout Period 1|Principal Investigator Discretion|0|||
146625520|NCT03137992|528803972|FG005|Washout Period 1|Principal Investigator Discretion|0|||
146625521|NCT03137992|528803967|FG000|Washout Period 1|COPD Exacerbation|1|||
146625522|NCT03137992|528803968|FG001|Washout Period 1|COPD Exacerbation|1|||
146625523|NCT03137992|528803969|FG002|Washout Period 1|COPD Exacerbation|1|||
146625524|NCT03137992|528803970|FG003|Washout Period 1|COPD Exacerbation|0|||
146625525|NCT03137992|528803971|FG004|Washout Period 1|COPD Exacerbation|1|||
146625526|NCT03137992|528803972|FG005|Washout Period 1|COPD Exacerbation|1|||
146625527|NCT03137992|528803967|FG000|Washout Period 1|Subject Noncompliance|1|||
146625528|NCT03137992|528803968|FG001|Washout Period 1|Subject Noncompliance|0|||
146625529|NCT03137992|528803969|FG002|Washout Period 1|Subject Noncompliance|0|||
146625530|NCT03137992|528803970|FG003|Washout Period 1|Subject Noncompliance|0|||
146625531|NCT03137992|528803971|FG004|Washout Period 1|Subject Noncompliance|1|||
146625532|NCT03137992|528803972|FG005|Washout Period 1|Subject Noncompliance|0|||
146625533|NCT03137992|528803967|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
146625534|NCT03137992|528803968|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
146625535|NCT03137992|528803969|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
146625536|NCT03137992|528803970|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
146625537|NCT03137992|528803971|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
146625538|NCT03137992|528803972|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
146625539|NCT03137992|528803967|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
146625540|NCT03137992|528803968|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
146625541|NCT03137992|528803969|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
146625542|NCT03137992|528803970|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
146625543|NCT03137992|528803971|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
146625544|NCT03137992|528803972|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
146625545|NCT03137992|528803967|FG000|Period 2 (Visit 3)|Adverse Event|0|||
146625546|NCT03137992|528803968|FG001|Period 2 (Visit 3)|Adverse Event|1|||
146625547|NCT03137992|528803969|FG002|Period 2 (Visit 3)|Adverse Event|0|||
146625548|NCT03137992|528803970|FG003|Period 2 (Visit 3)|Adverse Event|0|||
146625549|NCT03137992|528803971|FG004|Period 2 (Visit 3)|Adverse Event|0|||
146625550|NCT03137992|528803972|FG005|Period 2 (Visit 3)|Adverse Event|0|||
146625551|NCT03137992|528803967|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
146625552|NCT03137992|528803968|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
146625553|NCT03137992|528803969|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
146625554|NCT03137992|528803970|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
146625555|NCT03137992|528803971|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
146625556|NCT03137992|528803972|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
146625557|NCT03137992|528803967|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
146625558|NCT03137992|528803968|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
146625559|NCT03137992|528803969|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
146625560|NCT03137992|528803970|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
146625561|NCT03137992|528803971|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
146625562|NCT03137992|528803972|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
146625563|NCT03137992|528803967|FG000|Washout Period 2|COPD Exacerbation|1|||
146625564|NCT03137992|528803968|FG001|Washout Period 2|COPD Exacerbation|1|||
146625565|NCT03137992|528803969|FG002|Washout Period 2|COPD Exacerbation|0|||
146625566|NCT03137992|528803970|FG003|Washout Period 2|COPD Exacerbation|0|||
146625567|NCT03137992|528803971|FG004|Washout Period 2|COPD Exacerbation|1|||
146625568|NCT03137992|528803972|FG005|Washout Period 2|COPD Exacerbation|0|||
146625569|NCT03137992|528803967|FG000|Washout Period 2|Subject Non-compliance|0|||
146625570|NCT03137992|528803968|FG001|Washout Period 2|Subject Non-compliance|1|||
146625571|NCT03137992|528803969|FG002|Washout Period 2|Subject Non-compliance|0|||
146625572|NCT03137992|528803970|FG003|Washout Period 2|Subject Non-compliance|0|||
146625573|NCT03137992|528803971|FG004|Washout Period 2|Subject Non-compliance|0|||
146625574|NCT03137992|528803972|FG005|Washout Period 2|Subject Non-compliance|0|||
146625575|NCT03137992|528803967|FG000|Washout Period 2|Adverse Event|0|||
146625576|NCT03137992|528803968|FG001|Washout Period 2|Adverse Event|0|||
146625577|NCT03137992|528803969|FG002|Washout Period 2|Adverse Event|0|||
146625578|NCT03137992|528803970|FG003|Washout Period 2|Adverse Event|1|||
146625579|NCT03137992|528803971|FG004|Washout Period 2|Adverse Event|1|||
146625580|NCT03137992|528803972|FG005|Washout Period 2|Adverse Event|0|||
146625581|NCT03137992|528803967|FG000|Washout Period 2|Withdrawal by Subject|1|||
146625582|NCT03137992|528803968|FG001|Washout Period 2|Withdrawal by Subject|0|||
146625583|NCT03137992|528803969|FG002|Washout Period 2|Withdrawal by Subject|0|||
146625584|NCT03137992|528803970|FG003|Washout Period 2|Withdrawal by Subject|0|||
146625585|NCT03137992|528803971|FG004|Washout Period 2|Withdrawal by Subject|1|||
146625586|NCT03137992|528803972|FG005|Washout Period 2|Withdrawal by Subject|0|||
146625587|NCT03137992|528803967|FG000|Washout Period 2|Sponsor Decision|0|||
146625588|NCT03137992|528803968|FG001|Washout Period 2|Sponsor Decision|0|||
146625589|NCT03137992|528803969|FG002|Washout Period 2|Sponsor Decision|0|||
146625590|NCT03137992|528803970|FG003|Washout Period 2|Sponsor Decision|0|||
146625591|NCT03137992|528803971|FG004|Washout Period 2|Sponsor Decision|0|||
146625592|NCT03137992|528803972|FG005|Washout Period 2|Sponsor Decision|1|||
146625593|NCT03137992|528803967|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
146625594|NCT03137992|528803968|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
146625595|NCT03137992|528803969|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
146625596|NCT03137992|528803970|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
146625597|NCT03137992|528803971|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
146625598|NCT03137992|528803972|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
146625599|NCT03137992|528803967|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
146625600|NCT03137992|528803968|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
146625601|NCT03137992|528803969|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
146537211|NCT01035138|528476467|FG002|Overall Study|Sponsor Decision|42|||
146537212|NCT01035138|528476465|FG000|Overall Study|Lost to Follow-up|0|||
146537213|NCT01035138|528476466|FG001|Overall Study|Lost to Follow-up|0|||
146537214|NCT01035138|528476467|FG002|Overall Study|Lost to Follow-up|1|||
146537215|NCT00848497|528476468|FG000|Overall Study|Screen failure|2|||
146537216|NCT00848497|528476469|FG001|Overall Study|Screen failure|0|||
146537217|NCT00848497|528476468|FG000|Overall Study|Withdrawal by Subject|0|||
146537218|NCT00848497|528476469|FG001|Overall Study|Withdrawal by Subject|1|||
146625602|NCT03137992|528803970|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
146625603|NCT03137992|528803971|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
146625604|NCT03137992|528803972|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
146625605|NCT03137992|528803967|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
146625606|NCT03137992|528803968|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
146625607|NCT03137992|528803969|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
146625608|NCT03137992|528803970|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
146625609|NCT03137992|528803971|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
146537219|NCT01832766|528476470|FG000|Washout|Lost to Follow-up|0|||
146763869|NCT01090024|529302901|FG013|Period 3|Adverse Event|0|||
146537220|NCT01832766|528476471|FG001|Washout|Lost to Follow-up|1|||
146537221|NCT01114724|528476474|FG000|Overall Study|Death|8|||
146625610|NCT03137992|528803972|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
146625611|NCT03137992|528803967|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
146763870|NCT01090024|529302902|FG014|Period 3|Adverse Event|0|||
146625612|NCT03137992|528803968|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
146625613|NCT03137992|528803969|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
146625614|NCT03137992|528803970|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
146625615|NCT03137992|528803971|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
146625616|NCT03137992|528803972|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
146625617|NCT03137992|528803967|FG000|Part 2 (Open-label Extension)|Per study team|1|||
146625618|NCT03137992|528803968|FG001|Part 2 (Open-label Extension)|Per study team|0|||
146625619|NCT03137992|528803969|FG002|Part 2 (Open-label Extension)|Per study team|0|||
146625620|NCT03137992|528803970|FG003|Part 2 (Open-label Extension)|Per study team|0|||
146625621|NCT03137992|528803971|FG004|Part 2 (Open-label Extension)|Per study team|0|||
146625622|NCT03137992|528803972|FG005|Part 2 (Open-label Extension)|Per study team|0|||
146625623|NCT03137992|528803967|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
146625624|NCT03137992|528803968|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
146625625|NCT03137992|528803969|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
146625626|NCT03137992|528803970|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
146625627|NCT03137992|528803971|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
146625628|NCT03137992|528803972|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
146625629|NCT03077542|528803975|FG000|Overall Study|Death|4|||
146625630|NCT03077542|528803976|FG001|Overall Study|Death|0|||
146625631|NCT03077542|528803975|FG000|Overall Study|Physician Decision|6|||
146625632|NCT03077542|528803976|FG001|Overall Study|Physician Decision|1|||
146625633|NCT03077542|528803975|FG000|Overall Study|Withdrawal by Subject|0|||
146625634|NCT03077542|528803976|FG001|Overall Study|Withdrawal by Subject|1|||
146625635|NCT00795704|528803979|FG000|Overall Study|Withdrawal by Subject|3|||
146625636|NCT00795704|528803980|FG001|Overall Study|Withdrawal by Subject|2|||
146625637|NCT00795704|528803979|FG000|Overall Study|Adverse Event|1|||
146625638|NCT00795704|528803980|FG001|Overall Study|Adverse Event|1|||
146625639|NCT01300728|528803981|FG000|Overall Study|Withdrawal by Subject|1|||
146625640|NCT01300728|528803982|FG001|Overall Study|Withdrawal by Subject|1|||
146625641|NCT01300728|528803981|FG000|Overall Study|Physician Decision|1|||
146625642|NCT01300728|528803982|FG001|Overall Study|Physician Decision|0|||
146625643|NCT01247324|528803983|FG000|Overall Study|Death|6|||
146625644|NCT01247324|528803984|FG001|Overall Study|Death|10|||
146625645|NCT01247324|528803983|FG000|Overall Study|Physician Decision|2|||
146625646|NCT01247324|528803984|FG001|Overall Study|Physician Decision|3|||
146625647|NCT01247324|528803983|FG000|Overall Study|Non-compliance with study drug|3|||
146625648|NCT01247324|528803984|FG001|Overall Study|Non-compliance with study drug|0|||
146625649|NCT01247324|528803983|FG000|Overall Study|Lack of Efficacy|24|||
146625650|NCT01247324|528803984|FG001|Overall Study|Lack of Efficacy|14|||
146625651|NCT01247324|528803983|FG000|Overall Study|Non-compliance|3|||
146625652|NCT01247324|528803984|FG001|Overall Study|Non-compliance|2|||
146625653|NCT01247324|528803983|FG000|Overall Study|Pregnancy|5|||
146625654|NCT01247324|528803984|FG001|Overall Study|Pregnancy|10|||
146625655|NCT01247324|528803983|FG000|Overall Study|Protocol Violation|1|||
146625656|NCT01247324|528803984|FG001|Overall Study|Protocol Violation|1|||
146871065|NCT02665052|529699795|FG003|Overall Study|Lost to Follow-up|0|||
146871066|NCT02665052|529699792|FG000|Overall Study|Withdrawal by Subject|1|||
146871067|NCT02665052|529699793|FG001|Overall Study|Withdrawal by Subject|1|||
146537222|NCT01114724|528476474|FG000|Overall Study|Lost to Follow-up|1|||
146537223|NCT01114724|528476474|FG000|Overall Study|Withdrawal by Subject|1|||
146537224|NCT02966834|528476475|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
146537225|NCT02966834|528476476|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
146537226|NCT02966834|528476477|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
146537227|NCT02966834|528476478|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
146537228|NCT02966834|528476479|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
146537229|NCT02966834|528476480|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
146537230|NCT02966834|528476475|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
146537231|NCT02966834|528476476|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
146537232|NCT02966834|528476477|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
146537233|NCT02966834|528476478|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
146537234|NCT02966834|528476479|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
146537235|NCT02966834|528476480|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
146537236|NCT02966834|528476475|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
146537237|NCT02966834|528476476|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
146625657|NCT01247324|528803983|FG000|Overall Study|Reason not specified|42|||
146625658|NCT01247324|528803984|FG001|Overall Study|Reason not specified|32|||
146625659|NCT01247324|528803983|FG000|Overall Study|Consent withdrawn by participant|41|||
146625660|NCT01247324|528803984|FG001|Overall Study|Consent withdrawn by participant|56|||
146625661|NCT01247324|528803983|FG000|Overall Study|Adverse Event|49|||
146625662|NCT01247324|528803984|FG001|Overall Study|Adverse Event|35|||
146625663|NCT01247324|528803983|FG000|Overall Study|Lost to Follow-up|3|||
146625664|NCT01247324|528803984|FG001|Overall Study|Lost to Follow-up|6|||
146871068|NCT02665052|529699794|FG002|Overall Study|Withdrawal by Subject|0|||
146537238|NCT02966834|528476477|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
146537239|NCT02966834|528476478|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
146537240|NCT02966834|528476479|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
146537241|NCT02966834|528476480|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
146537242|NCT02966834|528476475|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
146537243|NCT02966834|528476476|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
146537244|NCT02966834|528476477|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
146537245|NCT02966834|528476478|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
146537246|NCT02966834|528476479|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
146537247|NCT02966834|528476480|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
146537248|NCT02966834|528476475|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
146537249|NCT02966834|528476476|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
146537250|NCT02966834|528476477|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
146537251|NCT02966834|528476478|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
146537252|NCT02966834|528476479|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
146537253|NCT02966834|528476480|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
146537254|NCT02966834|528476475|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
146537255|NCT02966834|528476476|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
146537256|NCT02966834|528476477|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
146537257|NCT02966834|528476478|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
146537258|NCT02966834|528476479|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
146537259|NCT02966834|528476480|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
146537260|NCT02814526|528476483|FG000|Overall Study|Adverse Event|4|||
146537261|NCT02814526|528476484|FG001|Overall Study|Adverse Event|3|||
146537262|NCT02814526|528476483|FG000|Overall Study|Death|1|||
146537263|NCT02814526|528476484|FG001|Overall Study|Death|1|||
146537264|NCT02814526|528476483|FG000|Overall Study|Lost to Follow-up|3|||
146537265|NCT02814526|528476484|FG001|Overall Study|Lost to Follow-up|4|||
146537266|NCT02814526|528476483|FG000|Overall Study|non site physician decision|1|||
146537267|NCT02814526|528476484|FG001|Overall Study|non site physician decision|0|||
146537268|NCT02814526|528476483|FG000|Overall Study|participant noncompliance|1|||
146537269|NCT02814526|528476484|FG001|Overall Study|participant noncompliance|1|||
146537270|NCT02814526|528476483|FG000|Overall Study|Withdrawal by Subject|20|||
146537271|NCT02814526|528476484|FG001|Overall Study|Withdrawal by Subject|14|||
146537272|NCT02814526|528476483|FG000|Overall Study|safety risk|2|||
146537273|NCT02814526|528476484|FG001|Overall Study|safety risk|1|||
146537274|NCT02814526|528476483|FG000|Overall Study|early termination-study terminated|1|||
146537275|NCT02814526|528476484|FG001|Overall Study|early termination-study terminated|2|||
146537276|NCT02814526|528476483|FG000|Overall Study|Other|0|||
146537277|NCT02814526|528476484|FG001|Overall Study|Other|4|||
146537278|NCT04711005|528476492|FG000|Overall Study|Withdrawal by Subject|0|||
146537279|NCT04711005|528476493|FG001|Overall Study|Withdrawal by Subject|0|||
146537280|NCT04711005|528476494|FG002|Overall Study|Withdrawal by Subject|0|||
146537281|NCT04711005|528476495|FG003|Overall Study|Withdrawal by Subject|0|||
146537282|NCT04711005|528476496|FG004|Overall Study|Withdrawal by Subject|0|||
146537283|NCT04711005|528476497|FG005|Overall Study|Withdrawal by Subject|0|||
146537284|NCT04711005|528476498|FG006|Overall Study|Withdrawal by Subject|0|||
146537285|NCT04711005|528476499|FG007|Overall Study|Withdrawal by Subject|1|||
146537286|NCT04711005|528476500|FG008|Overall Study|Withdrawal by Subject|0|||
146537287|NCT04711005|528476501|FG009|Overall Study|Withdrawal by Subject|0|||
146537288|NCT04711005|528476492|FG000|Overall Study|Physician Decision|0|||
146537289|NCT04711005|528476493|FG001|Overall Study|Physician Decision|0|||
146537290|NCT04711005|528476494|FG002|Overall Study|Physician Decision|0|||
146537291|NCT04711005|528476495|FG003|Overall Study|Physician Decision|0|||
146537292|NCT04711005|528476496|FG004|Overall Study|Physician Decision|0|||
146537293|NCT04711005|528476497|FG005|Overall Study|Physician Decision|0|||
146537294|NCT04711005|528476498|FG006|Overall Study|Physician Decision|0|||
146537295|NCT04711005|528476499|FG007|Overall Study|Physician Decision|2|||
146537296|NCT04711005|528476500|FG008|Overall Study|Physician Decision|1|||
146537297|NCT04711005|528476501|FG009|Overall Study|Physician Decision|0|||
146537298|NCT03415178|528476508|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
146537299|NCT03415178|528476509|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
146537300|NCT03415178|528476508|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
146537301|NCT03415178|528476509|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
146537302|NCT02781324|528476510|FG000|Overall Study|Withdrawal by Subject|1|||
146537303|NCT02781324|528476511|FG001|Overall Study|Withdrawal by Subject|0|||
146537304|NCT02781324|528476510|FG000|Overall Study|Physician Decision|1|||
146537305|NCT02781324|528476511|FG001|Overall Study|Physician Decision|2|||
146537306|NCT00834041|528476512|FG000|Overall Study|Withdrawal by Subject|1|||
146537307|NCT00834041|528476513|FG001|Overall Study|Withdrawal by Subject|0|||
146537308|NCT00834041|528476512|FG000|Overall Study|Lost to Follow-up|0|||
146537309|NCT00834041|528476513|FG001|Overall Study|Lost to Follow-up|1|||
146537310|NCT03074500|528476514|FG000|Overall Study|Lost to Follow-up|1|||
146537311|NCT03074500|528476515|FG001|Overall Study|Lost to Follow-up|0|||
146625665|NCT01247324|528803983|FG000|Overall Study|Study Terminated by Sponsor|4|||
146625666|NCT01247324|528803984|FG001|Overall Study|Study Terminated by Sponsor|1|||
146625667|NCT01247324|528803983|FG000|Overall Study|Missing|2|||
146625668|NCT01247324|528803984|FG001|Overall Study|Missing|1|||
146625669|NCT00301808|528803986|FG000|Overall Study|Adverse Event|5|||
146625670|NCT00301808|528803986|FG000|Overall Study|Death|3|||
146625671|NCT00301808|528803986|FG000|Overall Study|Lack of Efficacy|4|||
146625672|NCT01607957|528803987|FG000|Overall Study|Not treated|1|||
146625673|NCT01607957|528803988|FG001|Overall Study|Not treated|1|||
146625674|NCT01607957|528803987|FG000|Overall Study|Death|367|||
146625675|NCT01607957|528803988|FG001|Overall Study|Death|211|||
146625676|NCT01607957|528803987|FG000|Overall Study|Lost to Follow-up|3|||
146625677|NCT01607957|528803988|FG001|Overall Study|Lost to Follow-up|3|||
146625678|NCT01607957|528803987|FG000|Overall Study|Participant refusal|1|||
146625679|NCT01607957|528803988|FG001|Overall Study|Participant refusal|0|||
146625680|NCT04972786|528803991|FG000|First Intervention (1 Day)|Adverse Event|1|||
146625681|NCT04972786|528803992|FG001|First Intervention (1 Day)|Adverse Event|0|||
146625682|NCT03905096|528803993|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
146625683|NCT03905096|528803994|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
146625684|NCT02016781|528803996|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
146625685|NCT02016781|528803997|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
146625686|NCT02016781|528803996|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
146625687|NCT02016781|528803997|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
146625688|NCT02016781|528803996|FG000|Final Database Lock|Withdrawal by Subject|2|||
146625689|NCT02016781|528803997|FG001|Final Database Lock|Withdrawal by Subject|1|||
146625690|NCT02016781|528803996|FG000|Final Database Lock|Lost to Follow-up|11|||
146625691|NCT02016781|528803997|FG001|Final Database Lock|Lost to Follow-up|4|||
146625692|NCT02016781|528803996|FG000|Final Database Lock|Missing data|0|||
146625693|NCT02016781|528803997|FG001|Final Database Lock|Missing data|3|||
146625694|NCT02994108|528806028|FG000|Intervention Messages|Withdrawal by Subject|2|||
146625695|NCT02994108|528806029|FG001|Intervention Messages|Withdrawal by Subject|0|||
146625696|NCT02994108|528806028|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
146625697|NCT02994108|528806029|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
146625698|NCT02994108|528806028|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
146625699|NCT02994108|528806029|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
146625700|NCT02994108|528806028|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
146625701|NCT02994108|528806029|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
146625702|NCT02118584|528806038|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
146625703|NCT02118584|528806039|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
146625704|NCT02118584|528806040|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
146625705|NCT02118584|528806038|FG000|Part 1: Open Label Extension Period|Death|9|||
146625706|NCT02118584|528806039|FG001|Part 1: Open Label Extension Period|Death|0|||
146625707|NCT02118584|528806040|FG002|Part 1: Open Label Extension Period|Death|0|||
146625708|NCT02118584|528806038|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
146625709|NCT02118584|528806039|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
146625710|NCT02118584|528806040|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
146625711|NCT02118584|528806038|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
146625712|NCT02118584|528806039|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
146625713|NCT02118584|528806040|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
146625714|NCT02118584|528806038|FG000|Part 1: Open Label Extension Period|Other|135|||
146625715|NCT02118584|528806039|FG001|Part 1: Open Label Extension Period|Other|0|||
146625716|NCT02118584|528806040|FG002|Part 1: Open Label Extension Period|Other|0|||
146625717|NCT02118584|528806038|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
146625718|NCT02118584|528806039|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
146625719|NCT02118584|528806040|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
146625720|NCT02118584|528806038|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
146625721|NCT02118584|528806039|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
146625722|NCT02118584|528806040|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
146625723|NCT02118584|528806038|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
146625724|NCT02118584|528806039|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
146625725|NCT02118584|528806040|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
146625726|NCT02118584|528806038|FG000|Part 1: Open Label Extension Period|Other|3|||
146625727|NCT02118584|528806039|FG001|Part 1: Open Label Extension Period|Other|0|||
146625728|NCT02118584|528806040|FG002|Part 1: Open Label Extension Period|Other|0|||
146625729|NCT02118584|528806038|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
146625730|NCT02118584|528806039|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
146625731|NCT02118584|528806040|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
146625732|NCT02118584|528806038|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
146625733|NCT02118584|528806039|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
146625734|NCT02118584|528806040|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
146625735|NCT02118584|528806038|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
146625736|NCT02118584|528806039|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
146625737|NCT02118584|528806040|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
146625738|NCT02118584|528806038|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
146625739|NCT02118584|528806039|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
146625740|NCT02118584|528806040|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
146625741|NCT02118584|528806038|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
146625742|NCT02118584|528806039|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
146625743|NCT02118584|528806040|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
146625744|NCT02118584|528806038|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
146625745|NCT02118584|528806039|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
146625746|NCT02118584|528806040|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
146625747|NCT02118584|528806038|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
146625748|NCT02118584|528806039|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
146537312|NCT03074500|528476516|FG002|Overall Study|Lost to Follow-up|0|||
146537313|NCT03074500|528476514|FG000|Overall Study|Lack of Efficacy|0|||
146537314|NCT03074500|528476515|FG001|Overall Study|Lack of Efficacy|1|||
146537315|NCT03074500|528476516|FG002|Overall Study|Lack of Efficacy|0|||
146537316|NCT03074500|528476514|FG000|Overall Study|Adverse Event|0|||
146537317|NCT03074500|528476515|FG001|Overall Study|Adverse Event|0|||
146537318|NCT03074500|528476516|FG002|Overall Study|Adverse Event|1|||
146537319|NCT03321721|528476517|FG000|Overall Study|Lost to Follow-up|4|||
146537320|NCT03321721|528476518|FG001|Overall Study|Lost to Follow-up|8|||
146537321|NCT03321721|528476519|FG002|Overall Study|Lost to Follow-up|11|||
146537322|NCT01416571|528476522|FG000|Overall Study|Lost to Follow-up|2|||
146537323|NCT03608163|528476523|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
146537324|NCT03608163|528476524|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
146537325|NCT03353220|528476525|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
146537326|NCT03353220|528476526|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
146537327|NCT00661388|528476529|FG000|Overall Study|Adverse Event|14|||
146537328|NCT00661388|528476529|FG000|Overall Study|Protocol Violation|7|||
146537329|NCT00661388|528476529|FG000|Overall Study|Renal transplantation|1|||
146537330|NCT00661388|528476529|FG000|Overall Study|Dialysis initiation|1|||
146537331|NCT00661388|528476529|FG000|Overall Study|Administrative reasons|1|||
146537332|NCT03729362|528478025|FG000|Overall Study|Withdrawal by Subject|2|||
146537333|NCT03729362|528478026|FG001|Overall Study|Withdrawal by Subject|0|||
146537334|NCT03729362|528478025|FG000|Overall Study|Physician Decision|1|||
146537335|NCT03729362|528478026|FG001|Overall Study|Physician Decision|0|||
146537336|NCT03729362|528478025|FG000|Overall Study|COVID-19 Pandemic|1|||
146537337|NCT03729362|528478026|FG001|Overall Study|COVID-19 Pandemic|0|||
146537338|NCT03729362|528478025|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
146537339|NCT03729362|528478026|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
146537340|NCT03729362|528478025|FG000|Overall Study|Adverse Event|0|||
146537341|NCT03729362|528478026|FG001|Overall Study|Adverse Event|1|||
146537342|NCT03729362|528478025|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
146537343|NCT03729362|528478026|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
146537344|NCT02807259|528478027|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
146537345|NCT02807259|528478028|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
146537346|NCT02807259|528478027|FG000|Midline (3 Months)|migration, refusal, not available|30|||
146537347|NCT02807259|528478028|FG001|Midline (3 Months)|migration, refusal, not available|34|||
146537348|NCT02807259|528478027|FG000|Endline (3 Months)|migration, refusal, not available|35|||
146537349|NCT02807259|528478028|FG001|Endline (3 Months)|migration, refusal, not available|87|||
146537350|NCT00849056|528478029|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
146537351|NCT00849056|528478030|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
146537352|NCT00849056|528478029|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
146537353|NCT00849056|528478030|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
146537354|NCT00849056|528478029|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
146537355|NCT00849056|528478030|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
146537356|NCT00849056|528478029|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
146537357|NCT00849056|528478030|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
146537358|NCT00849056|528478029|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
146537359|NCT00849056|528478030|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
146537360|NCT00849056|528478029|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
146537361|NCT00849056|528478030|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
146537362|NCT00849056|528478029|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
146537363|NCT00849056|528478030|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
146537364|NCT00849056|528478029|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
146537365|NCT00849056|528478030|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
146625749|NCT02118584|528806040|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
146625750|NCT02118584|528806038|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
146537366|NCT00849056|528478029|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
146625751|NCT02118584|528806039|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
146625752|NCT02118584|528806040|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
146625753|NCT02118584|528806038|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
146625754|NCT02118584|528806039|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
146625755|NCT02118584|528806040|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
146625756|NCT00671658|528806045|FG000|Overall Study|Physician Decision|5|||
146625757|NCT01680341|528806049|FG000|Overall Study|Adverse Event|3|||
146625758|NCT01680341|528806050|FG001|Overall Study|Adverse Event|2|||
146625759|NCT01680341|528806049|FG000|Overall Study|Unclassified|18|||
146625760|NCT01680341|528806050|FG001|Overall Study|Unclassified|15|||
146625761|NCT00499486|528806051|FG000|Overall Study|Withdrawal by Subject|16|||
146625762|NCT03796728|528806053|FG000|Overall Study|Lost to Follow-up|8|||
146625763|NCT03796728|528806053|FG000|Overall Study|Reason not Specified|16|||
146625764|NCT02476617|528806055|FG000|Overall Study|Adverse Event|1|||
146625765|NCT02476617|528806055|FG000|Overall Study|Lost to Follow-up|1|||
146625766|NCT01383928|528806056|FG000|Overall Study|Initiation of ASCT|2|||
146625767|NCT01383928|528806057|FG001|Overall Study|Initiation of ASCT|1|||
146625768|NCT01383928|528806058|FG002|Overall Study|Initiation of ASCT|18|||
146625769|NCT01383928|528806056|FG000|Overall Study|Adverse Event|1|||
146625770|NCT01383928|528806057|FG001|Overall Study|Adverse Event|2|||
146625771|NCT01383928|528806058|FG002|Overall Study|Adverse Event|8|||
146625772|NCT01383928|528806056|FG000|Overall Study|Other|1|||
146625773|NCT01383928|528806057|FG001|Overall Study|Other|3|||
146625774|NCT01383928|528806058|FG002|Overall Study|Other|4|||
146625775|NCT01383928|528806056|FG000|Overall Study|Progressive Disease|1|||
146625776|NCT01383928|528806057|FG001|Overall Study|Progressive Disease|1|||
146625777|NCT01383928|528806058|FG002|Overall Study|Progressive Disease|5|||
146625778|NCT01383928|528806056|FG000|Overall Study|Withdrawal by Subject|0|||
146625779|NCT01383928|528806057|FG001|Overall Study|Withdrawal by Subject|0|||
146625780|NCT01383928|528806058|FG002|Overall Study|Withdrawal by Subject|4|||
146625781|NCT01383928|528806056|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
146625782|NCT01383928|528806057|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
146625783|NCT01383928|528806058|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
146625784|NCT01263769|528806061|FG000|Overall Study|Non-Compliant with treatment|1|||
146625785|NCT01346358|528806062|FG000|Overall Study|Withdrawal by Subject|1|||
146625786|NCT01346358|528806063|FG001|Overall Study|Withdrawal by Subject|0|||
146625787|NCT01346358|528806064|FG002|Overall Study|Withdrawal by Subject|1|||
146625788|NCT01346358|528806065|FG003|Overall Study|Withdrawal by Subject|1|||
146625789|NCT01346358|528806066|FG004|Overall Study|Withdrawal by Subject|0|||
146625790|NCT01346358|528806067|FG005|Overall Study|Withdrawal by Subject|2|||
146625791|NCT01346358|528806068|FG006|Overall Study|Withdrawal by Subject|1|||
146625792|NCT01346358|528806069|FG007|Overall Study|Withdrawal by Subject|1|||
146625793|NCT01346358|528806070|FG008|Overall Study|Withdrawal by Subject|1|||
146625794|NCT01346358|528806062|FG000|Overall Study|Adverse Event|1|||
146625795|NCT01346358|528806063|FG001|Overall Study|Adverse Event|0|||
146625796|NCT01346358|528806064|FG002|Overall Study|Adverse Event|0|||
146625797|NCT01346358|528806065|FG003|Overall Study|Adverse Event|0|||
146625798|NCT01346358|528806066|FG004|Overall Study|Adverse Event|1|||
146625799|NCT01346358|528806067|FG005|Overall Study|Adverse Event|0|||
146625800|NCT01346358|528806068|FG006|Overall Study|Adverse Event|0|||
146625801|NCT01346358|528806069|FG007|Overall Study|Adverse Event|0|||
146625802|NCT01346358|528806070|FG008|Overall Study|Adverse Event|1|||
146625803|NCT01346358|528806062|FG000|Overall Study|Non-Compliance|0|||
146625804|NCT01346358|528806063|FG001|Overall Study|Non-Compliance|0|||
146625805|NCT01346358|528806064|FG002|Overall Study|Non-Compliance|0|||
146625806|NCT01346358|528806065|FG003|Overall Study|Non-Compliance|0|||
146625807|NCT01346358|528806066|FG004|Overall Study|Non-Compliance|0|||
146625808|NCT01346358|528806067|FG005|Overall Study|Non-Compliance|0|||
146625809|NCT01346358|528806068|FG006|Overall Study|Non-Compliance|0|||
146625810|NCT01346358|528806069|FG007|Overall Study|Non-Compliance|2|||
146625811|NCT01346358|528806070|FG008|Overall Study|Non-Compliance|0|||
146625812|NCT01346358|528806062|FG000|Overall Study|Physician Decision|0|||
146625813|NCT01346358|528806063|FG001|Overall Study|Physician Decision|1|||
146625814|NCT01346358|528806064|FG002|Overall Study|Physician Decision|0|||
146625815|NCT01346358|528806065|FG003|Overall Study|Physician Decision|0|||
146625816|NCT01346358|528806066|FG004|Overall Study|Physician Decision|0|||
146625817|NCT01346358|528806067|FG005|Overall Study|Physician Decision|0|||
146625818|NCT01346358|528806068|FG006|Overall Study|Physician Decision|0|||
146625819|NCT01346358|528806069|FG007|Overall Study|Physician Decision|1|||
146625820|NCT01346358|528806070|FG008|Overall Study|Physician Decision|1|||
146625821|NCT05058365|528806071|FG000|Overall Study|Migration|1|||
146625822|NCT05058365|528806072|FG001|Overall Study|Migration|1|||
146625823|NCT00702702|528806075|FG000|Overall Study|Study prematurely terminated|56|||
146625824|NCT00551759|528806076|FG000|Overall Study|Adverse Event|7|||
146625825|NCT00551759|528806076|FG000|Overall Study|Death|5|||
146625826|NCT00551759|528806076|FG000|Overall Study|Ineligible|1|||
146625827|NCT01667900|528806077|FG000|Part B|Death|0|||
146625828|NCT01667900|528806078|FG001|Part B|Death|0|||
146625829|NCT01667900|528806079|FG002|Part B|Death|0|||
146537367|NCT00849056|528478030|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
146537368|NCT00849056|528478029|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
146537369|NCT00849056|528478030|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
146537370|NCT00849056|528478029|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
146537371|NCT00849056|528478030|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
146537372|NCT00849056|528478029|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
146537373|NCT00849056|528478030|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
146537374|NCT00849056|528478029|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
146537375|NCT00849056|528478030|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
146537376|NCT00849056|528478029|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
146537377|NCT00849056|528478030|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
146537378|NCT00849056|528478029|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
146537379|NCT00849056|528478030|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
146537380|NCT00849056|528478029|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
146537381|NCT00849056|528478030|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
146537382|NCT00274456|528478031|FG000|Overall Study|Still on treatment|2|||
146537383|NCT00274456|528478032|FG001|Overall Study|Still on treatment|3|||
146537384|NCT00274456|528478033|FG002|Overall Study|Still on treatment|5|||
146537385|NCT00274456|528478034|FG003|Overall Study|Still on treatment|1|||
146537386|NCT00274456|528478031|FG000|Overall Study|Unacceptable toxicity|10|||
146537387|NCT00274456|528478032|FG001|Overall Study|Unacceptable toxicity|5|||
146537388|NCT00274456|528478033|FG002|Overall Study|Unacceptable toxicity|12|||
146537389|NCT00274456|528478034|FG003|Overall Study|Unacceptable toxicity|16|||
146537390|NCT00274456|528478031|FG000|Overall Study|Adverse Event|0|||
146537391|NCT00274456|528478032|FG001|Overall Study|Adverse Event|1|||
146537392|NCT00274456|528478033|FG002|Overall Study|Adverse Event|2|||
146537393|NCT00274456|528478034|FG003|Overall Study|Adverse Event|2|||
146537394|NCT00274456|528478031|FG000|Overall Study|Physician Decision|7|||
146537395|NCT00274456|528478032|FG001|Overall Study|Physician Decision|5|||
146537396|NCT00274456|528478033|FG002|Overall Study|Physician Decision|6|||
146537397|NCT00274456|528478034|FG003|Overall Study|Physician Decision|13|||
146537398|NCT00274456|528478031|FG000|Overall Study|Lost to Follow-up|0|||
146537399|NCT00274456|528478032|FG001|Overall Study|Lost to Follow-up|0|||
146537400|NCT00274456|528478033|FG002|Overall Study|Lost to Follow-up|1|||
146537401|NCT00274456|528478034|FG003|Overall Study|Lost to Follow-up|0|||
146537402|NCT00274456|528478031|FG000|Overall Study|Withdrawal by Subject|18|||
146537403|NCT00274456|528478032|FG001|Overall Study|Withdrawal by Subject|13|||
146537404|NCT00274456|528478033|FG002|Overall Study|Withdrawal by Subject|9|||
146537405|NCT00274456|528478034|FG003|Overall Study|Withdrawal by Subject|13|||
146537406|NCT00375752|528478038|FG000|Overall Study|Lack of Efficacy|4|||
146537407|NCT00375752|528478039|FG001|Overall Study|Lack of Efficacy|4|||
146537408|NCT00375752|528478038|FG000|Overall Study|Adverse Event|1|||
146537409|NCT00375752|528478039|FG001|Overall Study|Adverse Event|6|||
146537410|NCT00375752|528478038|FG000|Overall Study|Withdrawal by Subject|6|||
146537411|NCT00375752|528478039|FG001|Overall Study|Withdrawal by Subject|1|||
146537412|NCT00375752|528478038|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
146537413|NCT00375752|528478039|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
146537414|NCT00375752|528478038|FG000|Overall Study|Protocol Violation|0|||
146871069|NCT02665052|529699795|FG003|Overall Study|Withdrawal by Subject|5|||
146871070|NCT02665052|529699792|FG000|Overall Study|Adverse Event|1|||
146871071|NCT02665052|529699793|FG001|Overall Study|Adverse Event|1|||
146871072|NCT02665052|529699794|FG002|Overall Study|Adverse Event|0|||
146871073|NCT02665052|529699795|FG003|Overall Study|Adverse Event|0|||
146871074|NCT02234284|529699796|FG000|Overall Study|Death|4|||
146871075|NCT02234284|529699797|FG001|Overall Study|Death|2|||
146625830|NCT01667900|528806080|FG003|Part B|Death|0|||
146625831|NCT01667900|528806081|FG004|Part B|Death|0|||
146625832|NCT01667900|528806082|FG005|Part B|Death|0|||
146625833|NCT01667900|528806083|FG006|Part B|Death|0|||
146625834|NCT01667900|528806084|FG007|Part B|Death|0|||
146625835|NCT01667900|528806085|FG008|Part B|Death|0|||
146871076|NCT02234284|529699796|FG000|Overall Study|Withdrawal by Subject|1|||
146625836|NCT01667900|528806086|FG009|Part B|Death|0|||
146625837|NCT01667900|528806087|FG010|Part B|Death|0|||
146871077|NCT02234284|529699797|FG001|Overall Study|Withdrawal by Subject|0|||
146871078|NCT02234284|529699796|FG000|Overall Study|Lost to Follow-up|20|||
146871079|NCT02234284|529699797|FG001|Overall Study|Lost to Follow-up|7|||
146871080|NCT04754802|529699799|FG000|Overall Study|Lost to Follow-up|0|||
146871081|NCT04754802|529699800|FG001|Overall Study|Lost to Follow-up|2|||
146871082|NCT04754802|529699799|FG000|Overall Study|Withdrawal by Subject|2|||
146871083|NCT04754802|529699800|FG001|Overall Study|Withdrawal by Subject|0|||
146871084|NCT04569032|529699801|FG000|Overall Study|Death|10|||
146871085|NCT04569032|529699802|FG001|Overall Study|Death|13|||
146871086|NCT04569032|529699801|FG000|Overall Study|Withdrawal by Subject|2|||
146871087|NCT04569032|529699802|FG001|Overall Study|Withdrawal by Subject|0|||
146871088|NCT04569032|529699801|FG000|Overall Study|Lost to Follow-up|0|||
146871089|NCT04569032|529699802|FG001|Overall Study|Lost to Follow-up|1|||
146871090|NCT04569032|529699801|FG000|Overall Study|In long term follow up|22|||
146871091|NCT04569032|529699802|FG001|Overall Study|In long term follow up|34|||
146871092|NCT00873366|529699803|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
146871093|NCT00873366|529699803|FG000|Overall Study|Off tamoxifen due to side effects|2|||
146871094|NCT00873366|529699803|FG000|Overall Study|Refused to continue DM-BT testing|3|||
146871095|NCT01970488|529699804|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
146871096|NCT01970488|529699805|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
146871097|NCT01970488|529699806|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
146871098|NCT01970488|529699807|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
146871099|NCT01970488|529699808|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
146871100|NCT01970488|529699804|FG000|Part 1: Through Week 16|Protocol Violation|1|||
146871101|NCT01970488|529699805|FG001|Part 1: Through Week 16|Protocol Violation|2|||
146871102|NCT01970488|529699806|FG002|Part 1: Through Week 16|Protocol Violation|0|||
146871103|NCT01970488|529699807|FG003|Part 1: Through Week 16|Protocol Violation|0|||
146871104|NCT01970488|529699808|FG004|Part 1: Through Week 16|Protocol Violation|0|||
146871105|NCT01970488|529699804|FG000|Part 1: Through Week 16|Adverse Event|6|||
146871106|NCT01970488|529699805|FG001|Part 1: Through Week 16|Adverse Event|5|||
146871107|NCT01970488|529699806|FG002|Part 1: Through Week 16|Adverse Event|0|||
146871108|NCT01970488|529699807|FG003|Part 1: Through Week 16|Adverse Event|0|||
146871109|NCT01970488|529699808|FG004|Part 1: Through Week 16|Adverse Event|0|||
146871110|NCT01970488|529699804|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
146871111|NCT01970488|529699805|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
146871112|NCT01970488|529699806|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
146871113|NCT01970488|529699807|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
146871114|NCT01970488|529699808|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
146871115|NCT01970488|529699804|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
146871116|NCT01970488|529699805|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
146871117|NCT01970488|529699806|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
146871118|NCT01970488|529699807|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
146871119|NCT01970488|529699808|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
146871120|NCT01970488|529699804|FG000|Part 2: Post Week 16|Physician Decision|0|||
146871121|NCT01970488|529699805|FG001|Part 2: Post Week 16|Physician Decision|0|||
146871122|NCT01970488|529699806|FG002|Part 2: Post Week 16|Physician Decision|0|||
146871123|NCT01970488|529699807|FG003|Part 2: Post Week 16|Physician Decision|0|||
146871124|NCT01970488|529699808|FG004|Part 2: Post Week 16|Physician Decision|1|||
146871125|NCT01970488|529699804|FG000|Part 2: Post Week 16|Non-compliance|0|||
146871126|NCT01970488|529699805|FG001|Part 2: Post Week 16|Non-compliance|0|||
146871127|NCT01970488|529699806|FG002|Part 2: Post Week 16|Non-compliance|1|||
146625838|NCT01667900|528806088|FG011|Part B|Death|0|||
146871128|NCT01970488|529699807|FG003|Part 2: Post Week 16|Non-compliance|0|||
146625839|NCT01667900|528806089|FG012|Part B|Death|0|||
146625840|NCT01667900|528806090|FG013|Part B|Death|0|||
146871129|NCT01970488|529699808|FG004|Part 2: Post Week 16|Non-compliance|0|||
146871130|NCT01970488|529699804|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
146625841|NCT01667900|528806091|FG014|Part B|Death|0|||
146625842|NCT01667900|528806092|FG015|Part B|Death|0|||
146625843|NCT01667900|528806093|FG016|Part B|Death|1|||
146625844|NCT01667900|528806094|FG017|Part B|Death|0|||
146871131|NCT01970488|529699805|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
146871132|NCT01970488|529699806|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
146871133|NCT01970488|529699807|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
146871134|NCT01970488|529699808|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
146871135|NCT01970488|529699804|FG000|Part 2: Post Week 16|Adverse Event|0|||
146871136|NCT01970488|529699805|FG001|Part 2: Post Week 16|Adverse Event|0|||
146625845|NCT01667900|528806095|FG018|Part B|Death|0|||
146625846|NCT01667900|528806096|FG019|Part B|Death|0|||
146871137|NCT01970488|529699806|FG002|Part 2: Post Week 16|Adverse Event|5|||
146871138|NCT01970488|529699807|FG003|Part 2: Post Week 16|Adverse Event|1|||
146871139|NCT01970488|529699808|FG004|Part 2: Post Week 16|Adverse Event|1|||
146871140|NCT01970488|529699804|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
146871141|NCT01970488|529699805|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
146871142|NCT01970488|529699806|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
146871143|NCT01970488|529699807|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
146871144|NCT01970488|529699808|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
146871145|NCT01970488|529699804|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
146871146|NCT01970488|529699805|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
146871147|NCT01970488|529699806|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
146871148|NCT01970488|529699807|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
146871149|NCT01970488|529699808|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
146871150|NCT01490814|529699814|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
146871151|NCT01490814|529699815|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
146871152|NCT01490814|529699814|FG000|Overall Study|Physician Decision|1|||
146871153|NCT01490814|529699815|FG001|Overall Study|Physician Decision|0|||
146871154|NCT01490814|529699814|FG000|Overall Study|Withdrawal by Subject|0|||
146871155|NCT01490814|529699815|FG001|Overall Study|Withdrawal by Subject|5|||
146871156|NCT00496730|529699816|FG000|Overall Study|Lost to Follow-up|4|||
146871157|NCT00496730|529699817|FG001|Overall Study|Lost to Follow-up|3|||
146871158|NCT00496730|529699816|FG000|Overall Study|Withdrawal by Subject|2|||
146871159|NCT00496730|529699817|FG001|Overall Study|Withdrawal by Subject|2|||
146871160|NCT03716050|529699825|FG000|Overall Study|Lost to Follow-up|0|||
146871161|NCT03716050|529699826|FG001|Overall Study|Lost to Follow-up|0|||
146871162|NCT03716050|529699827|FG002|Overall Study|Lost to Follow-up|1|||
146871163|NCT03716050|529699828|FG003|Overall Study|Lost to Follow-up|0|||
146871164|NCT03716050|529699829|FG004|Overall Study|Lost to Follow-up|0|||
146871165|NCT03716050|529699830|FG005|Overall Study|Lost to Follow-up|0|||
146871166|NCT03716050|529699831|FG006|Overall Study|Lost to Follow-up|0|||
146871167|NCT03716050|529699832|FG007|Overall Study|Lost to Follow-up|0|||
146871168|NCT03716050|529699825|FG000|Overall Study|Physician Decision|0|||
146871169|NCT03716050|529699826|FG001|Overall Study|Physician Decision|0|||
146871170|NCT03716050|529699827|FG002|Overall Study|Physician Decision|0|||
146871171|NCT03716050|529699828|FG003|Overall Study|Physician Decision|1|||
146871172|NCT03716050|529699829|FG004|Overall Study|Physician Decision|0|||
146871173|NCT03716050|529699830|FG005|Overall Study|Physician Decision|0|||
146871174|NCT03716050|529699831|FG006|Overall Study|Physician Decision|0|||
146871175|NCT03716050|529699832|FG007|Overall Study|Physician Decision|0|||
146871176|NCT03716050|529699825|FG000|Overall Study|Protocol Violation|0|||
146871177|NCT03716050|529699826|FG001|Overall Study|Protocol Violation|0|||
146871178|NCT03716050|529699827|FG002|Overall Study|Protocol Violation|0|||
146871179|NCT03716050|529699828|FG003|Overall Study|Protocol Violation|1|||
146871180|NCT03716050|529699829|FG004|Overall Study|Protocol Violation|0|||
146871181|NCT03716050|529699830|FG005|Overall Study|Protocol Violation|0|||
146871182|NCT03716050|529699831|FG006|Overall Study|Protocol Violation|0|||
146871183|NCT03716050|529699832|FG007|Overall Study|Protocol Violation|2|||
146871184|NCT03123250|529699833|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
146871185|NCT04340557|529699834|FG000|Overall Study|Transferred to ICU and/or death|1|||
146871186|NCT04340557|529699835|FG001|Overall Study|Transferred to ICU and/or death|2|||
146871187|NCT01221727|529699836|FG000|Overall Study|Physician Decision|2|||
146871188|NCT01221727|529699837|FG001|Overall Study|Physician Decision|0|||
146871189|NCT01221727|529699836|FG000|Overall Study|Withdrawal by Subject|1|||
146871190|NCT01221727|529699837|FG001|Overall Study|Withdrawal by Subject|1|||
146871191|NCT00529451|529699838|FG000|Overall Study|Subject withdrew consent|16|||
146871192|NCT00529451|529699839|FG001|Overall Study|Subject withdrew consent|21|||
146871193|NCT00529451|529699840|FG002|Overall Study|Subject withdrew consent|13|||
146871194|NCT00529451|529699841|FG003|Overall Study|Subject withdrew consent|12|||
146871195|NCT00529451|529699838|FG000|Overall Study|Adverse Event|9|||
146871196|NCT00529451|529699839|FG001|Overall Study|Adverse Event|16|||
146871197|NCT00529451|529699840|FG002|Overall Study|Adverse Event|14|||
146871198|NCT00529451|529699841|FG003|Overall Study|Adverse Event|8|||
146871199|NCT00529451|529699838|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
146871200|NCT00529451|529699839|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
146871201|NCT00529451|529699840|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
146871202|NCT00529451|529699841|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
146871203|NCT00529451|529699838|FG000|Overall Study|Lost to Follow-up|4|||
146871204|NCT00529451|529699839|FG001|Overall Study|Lost to Follow-up|7|||
146871205|NCT00529451|529699840|FG002|Overall Study|Lost to Follow-up|4|||
146871206|NCT00529451|529699841|FG003|Overall Study|Lost to Follow-up|4|||
146871207|NCT00529451|529699838|FG000|Overall Study|Protocol deviation|1|||
146871208|NCT00529451|529699839|FG001|Overall Study|Protocol deviation|1|||
146871209|NCT00529451|529699840|FG002|Overall Study|Protocol deviation|4|||
146871210|NCT00529451|529699841|FG003|Overall Study|Protocol deviation|1|||
146871211|NCT00529451|529699838|FG000|Overall Study|Administrative problems|1|||
146871212|NCT00529451|529699839|FG001|Overall Study|Administrative problems|1|||
146871213|NCT00529451|529699840|FG002|Overall Study|Administrative problems|0|||
146625847|NCT02954536|528806099|FG000|Overall Study|Adverse Event|2|||
146625848|NCT02954536|528806099|FG000|Overall Study|Death|12|||
146625849|NCT00685165|528806104|FG000|Washout Period of 14 Days|Adverse Event|1|||
146625850|NCT00685165|528806105|FG001|Washout Period of 14 Days|Adverse Event|0|||
146625851|NCT04576988|528806112|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
146625852|NCT04576988|528806113|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
146625853|NCT04576988|528806112|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
146625854|NCT04576988|528806113|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
146625855|NCT04576988|528806112|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
146625856|NCT04576988|528806113|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
146625857|NCT04576988|528806112|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
146625858|NCT04576988|528806113|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
146625859|NCT04576988|528806112|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
146625860|NCT04576988|528806113|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
146625861|NCT04576988|528806112|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
146625862|NCT04576988|528806113|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
146625863|NCT04576988|528806112|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
146625864|NCT04576988|528806113|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
146625865|NCT04576988|528806112|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
146625866|NCT04576988|528806113|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
146625867|NCT04576988|528806112|FG000|Long Term Double Blind (LTDB)|Death|2|||
146625868|NCT04576988|528806113|FG001|Long Term Double Blind (LTDB)|Death|1|||
146625869|NCT04576988|528806112|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
146625870|NCT04576988|528806113|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
146625871|NCT01576341|528806116|FG000|Overall Study|Withdrawal by Subject|24|||
146625872|NCT01576341|528806116|FG000|Overall Study|Adverse Event|10|||
146625873|NCT01576341|528806116|FG000|Overall Study|Death|21|||
146625874|NCT01576341|528806116|FG000|Overall Study|Physician Decision|2|||
146625875|NCT01576341|528806116|FG000|Overall Study|Lost to Follow-up|2|||
146625876|NCT01576341|528806116|FG000|Overall Study|Kidney transplantation|10|||
146625877|NCT01576341|528806116|FG000|Overall Study|Protocol Violation|12|||
146625878|NCT01576341|528806116|FG000|Overall Study|Other|12|||
146537415|NCT00375752|528478039|FG001|Overall Study|Protocol Violation|2|||
146537416|NCT00375752|528478038|FG000|Overall Study|Administrative Problems|0|||
146537417|NCT00375752|528478039|FG001|Overall Study|Administrative Problems|1|||
146537418|NCT01140906|528478046|FG000|Overall Study|Adverse Event|7|||
146537419|NCT01140906|528478047|FG001|Overall Study|Adverse Event|10|||
146537420|NCT01140906|528478048|FG002|Overall Study|Adverse Event|17|||
146537421|NCT01140906|528478049|FG003|Overall Study|Adverse Event|7|||
146537422|NCT01140906|528478046|FG000|Overall Study|Lack of Efficacy|6|||
146537423|NCT01140906|528478047|FG001|Overall Study|Lack of Efficacy|8|||
146537424|NCT01140906|528478048|FG002|Overall Study|Lack of Efficacy|2|||
146537425|NCT01140906|528478049|FG003|Overall Study|Lack of Efficacy|1|||
146537426|NCT01140906|528478046|FG000|Overall Study|Non-compliance|0|||
146537427|NCT01140906|528478047|FG001|Overall Study|Non-compliance|1|||
146537428|NCT01140906|528478048|FG002|Overall Study|Non-compliance|0|||
146537429|NCT01140906|528478049|FG003|Overall Study|Non-compliance|1|||
146537430|NCT01140906|528478046|FG000|Overall Study|Protocol Violation|5|||
146537431|NCT01140906|528478047|FG001|Overall Study|Protocol Violation|3|||
146537432|NCT01140906|528478048|FG002|Overall Study|Protocol Violation|2|||
146537433|NCT01140906|528478049|FG003|Overall Study|Protocol Violation|1|||
146537434|NCT01140906|528478046|FG000|Overall Study|Withdrawal of consent|6|||
146625879|NCT01844765|528806117|FG000|Overall Study|Adverse Event|6|||
146625880|NCT01844765|528806118|FG001|Overall Study|Adverse Event|8|||
146625881|NCT01844765|528806117|FG000|Overall Study|Withdrawal by Subject|2|||
146625882|NCT01844765|528806118|FG001|Overall Study|Withdrawal by Subject|3|||
146625883|NCT01844765|528806117|FG000|Overall Study|Disease progression|1|||
146763871|NCT01090024|529302903|FG015|Period 3|Adverse Event|0|||
146763872|NCT01090024|529302904|FG016|Period 3|Adverse Event|0|||
146763873|NCT01090024|529302905|FG017|Period 3|Adverse Event|0|||
146537435|NCT01140906|528478047|FG001|Overall Study|Withdrawal of consent|6|||
146537436|NCT01140906|528478048|FG002|Overall Study|Withdrawal of consent|2|||
146537437|NCT01140906|528478049|FG003|Overall Study|Withdrawal of consent|2|||
146763874|NCT00149630|529302908|FG000|Overall Study|Incarceration|2|||
146763875|NCT00149630|529302909|FG001|Overall Study|Incarceration|0|||
146763876|NCT00149630|529302908|FG000|Overall Study|Treatment Programs|4|||
146763877|NCT00149630|529302909|FG001|Overall Study|Treatment Programs|5|||
146763878|NCT00149630|529302908|FG000|Overall Study|Adverse Event|2|||
146763879|NCT00149630|529302909|FG001|Overall Study|Adverse Event|0|||
146763880|NCT00567879|529302913|FG000|Overall Study|Adverse Event|2|||
146763881|NCT00567879|529302914|FG001|Overall Study|Adverse Event|0|||
146763882|NCT00567879|529302915|FG002|Overall Study|Adverse Event|1|||
146763883|NCT00567879|529302916|FG003|Overall Study|Adverse Event|0|||
146763884|NCT00567879|529302917|FG004|Overall Study|Adverse Event|1|||
146763885|NCT00567879|529302918|FG005|Overall Study|Adverse Event|0|||
146763886|NCT00567879|529302913|FG000|Overall Study|Abnormal test procedure(s)|0|||
146625884|NCT01844765|528806118|FG001|Overall Study|Disease progression|0|||
146625885|NCT01844765|528806117|FG000|Overall Study|Administrative problems|3|||
146625886|NCT01844765|528806118|FG001|Overall Study|Administrative problems|4|||
146625887|NCT01844765|528806117|FG000|Overall Study|Protocol deviation|2|||
146625888|NCT01844765|528806118|FG001|Overall Study|Protocol deviation|0|||
146625889|NCT01844765|528806117|FG000|Overall Study|Untreated|1|||
146625890|NCT01844765|528806118|FG001|Overall Study|Untreated|0|||
146625891|NCT00556075|528806127|FG000|Overall Study|Lost to Follow-up|3|||
146625892|NCT00556075|528806128|FG001|Overall Study|Lost to Follow-up|0|||
146625893|NCT00556075|528806129|FG002|Overall Study|Lost to Follow-up|3|||
146625894|NCT00556075|528806127|FG000|Overall Study|Withdrawal by Subject|3|||
146625895|NCT00556075|528806128|FG001|Overall Study|Withdrawal by Subject|3|||
146625896|NCT00556075|528806129|FG002|Overall Study|Withdrawal by Subject|0|||
146625897|NCT00556075|528806127|FG000|Overall Study|Protocol Violation|1|||
146625898|NCT00556075|528806128|FG001|Overall Study|Protocol Violation|1|||
146625899|NCT00556075|528806129|FG002|Overall Study|Protocol Violation|3|||
146625900|NCT00556075|528806127|FG000|Overall Study|Not eligible|1|||
146625901|NCT00556075|528806128|FG001|Overall Study|Not eligible|1|||
146625902|NCT00556075|528806129|FG002|Overall Study|Not eligible|2|||
146625903|NCT00556075|528806127|FG000|Overall Study|Adverse Event|1|||
146625904|NCT00556075|528806128|FG001|Overall Study|Adverse Event|2|||
146625905|NCT00556075|528806129|FG002|Overall Study|Adverse Event|0|||
146625906|NCT00556075|528806127|FG000|Overall Study|Personal issues|4|||
146625907|NCT00556075|528806128|FG001|Overall Study|Personal issues|1|||
146625908|NCT00556075|528806129|FG002|Overall Study|Personal issues|0|||
146625909|NCT00556075|528806127|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
146625910|NCT00556075|528806128|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
146625911|NCT00556075|528806129|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
146625912|NCT00395746|528806130|FG000|Overall Study|Adverse Event|5|||
146625913|NCT00395746|528806131|FG001|Overall Study|Adverse Event|2|||
146537438|NCT01140906|528478046|FG000|Overall Study|Lost to Follow-up|1|||
146537439|NCT01140906|528478047|FG001|Overall Study|Lost to Follow-up|1|||
146537440|NCT01140906|528478048|FG002|Overall Study|Lost to Follow-up|0|||
146537441|NCT01140906|528478049|FG003|Overall Study|Lost to Follow-up|2|||
146537442|NCT01140906|528478046|FG000|Overall Study|Administrative or other reason|0|||
146537443|NCT01140906|528478047|FG001|Overall Study|Administrative or other reason|5|||
146537444|NCT01140906|528478048|FG002|Overall Study|Administrative or other reason|3|||
146537445|NCT01140906|528478049|FG003|Overall Study|Administrative or other reason|2|||
146537446|NCT00336544|528478050|FG000|Overall Study|Lack of Efficacy|8|||
146537447|NCT00336544|528478051|FG001|Overall Study|Lack of Efficacy|5|||
146537448|NCT00336544|528478050|FG000|Overall Study|Adverse Event|4|||
146537449|NCT00336544|528478051|FG001|Overall Study|Adverse Event|9|||
146537450|NCT00336544|528478050|FG000|Overall Study|Withdrawal by Subject|4|||
146537451|NCT00336544|528478051|FG001|Overall Study|Withdrawal by Subject|3|||
146537452|NCT00336544|528478050|FG000|Overall Study|Other|3|||
146537453|NCT00336544|528478051|FG001|Overall Study|Other|5|||
146537454|NCT00576758|528478052|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
146537455|NCT00576758|528478053|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
146537456|NCT00576758|528478052|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
146537457|NCT00576758|528478053|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
146537458|NCT00576758|528478052|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
146537459|NCT00576758|528478053|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
146537460|NCT00576758|528478052|FG000|Induction Treatment Period|Death|1|||
146537461|NCT00576758|528478053|FG001|Induction Treatment Period|Death|0|||
146537462|NCT00576758|528478052|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
146537463|NCT00576758|528478053|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
146537464|NCT00576758|528478052|FG000|Induction Treatment Period|Withdrew consent|1|||
146537465|NCT00576758|528478053|FG001|Induction Treatment Period|Withdrew consent|0|||
146537466|NCT00576758|528478052|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
146537467|NCT00576758|528478053|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
146537468|NCT00576758|528478052|FG000|Extension Treatment Period|Death|1|||
146537469|NCT00576758|528478053|FG001|Extension Treatment Period|Death|1|||
146537470|NCT00576758|528478052|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
146537471|NCT00576758|528478053|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
146537472|NCT00576758|528478052|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
146537473|NCT00576758|528478053|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
146537474|NCT00576758|528478052|FG000|Extension Treatment Period|Administrative/Other|3|||
146537475|NCT00576758|528478053|FG001|Extension Treatment Period|Administrative/Other|1|||
146537476|NCT00576758|528478052|FG000|Follow-up Period|Administrative/Other|6|||
146537477|NCT00576758|528478053|FG001|Follow-up Period|Administrative/Other|8|||
146537478|NCT00576758|528478052|FG000|Follow-up Period|Death|3|||
146537479|NCT00576758|528478053|FG001|Follow-up Period|Death|3|||
146537480|NCT00576758|528478052|FG000|Follow-up Period|Insufficient therapeutic response|16|||
146537481|NCT00576758|528478053|FG001|Follow-up Period|Insufficient therapeutic response|5|||
146537482|NCT00576758|528478052|FG000|Follow-up Period|Withdrew consent|2|||
146537483|NCT00576758|528478053|FG001|Follow-up Period|Withdrew consent|1|||
146537484|NCT01316614|528478054|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
146537485|NCT01316614|528478054|FG000|Overall Study|Cytology slides not available for review|4|||
146537486|NCT01316614|528478054|FG000|Overall Study|Cystic lesion|5|||
146537487|NCT01316614|528478054|FG000|Overall Study|Inadequate number of passes|2|||
146537488|NCT01316614|528478054|FG000|Overall Study|Medically unstable|1|||
146537489|NCT03427411|528478055|FG000|Overall Study|Screen failure - platelets too low|0|||
146537490|NCT03427411|528478056|FG001|Overall Study|Screen failure - platelets too low|1|||
146537491|NCT00903968|528478057|FG000|Overall Study|Adverse Event|0|||
146537492|NCT00903968|528478058|FG001|Overall Study|Adverse Event|0|||
146537493|NCT00903968|528478059|FG002|Overall Study|Adverse Event|0|||
146537494|NCT00903968|528478060|FG003|Overall Study|Adverse Event|0|||
146625914|NCT00395746|528806132|FG002|Overall Study|Adverse Event|2|||
146625915|NCT00395746|528806130|FG000|Overall Study|Protocol Violation|0|||
146537495|NCT00903968|528478061|FG004|Overall Study|Adverse Event|0|||
146537496|NCT00903968|528478062|FG005|Overall Study|Adverse Event|0|||
146537497|NCT00903968|528478063|FG006|Overall Study|Adverse Event|1|||
146537498|NCT00903968|528478064|FG007|Overall Study|Adverse Event|8|||
146537499|NCT00903968|528478057|FG000|Overall Study|DLT|0|||
146625916|NCT00395746|528806131|FG001|Overall Study|Protocol Violation|1|||
146537500|NCT00903968|528478058|FG001|Overall Study|DLT|0|||
146537501|NCT00903968|528478059|FG002|Overall Study|DLT|0|||
146537502|NCT00903968|528478060|FG003|Overall Study|DLT|0|||
146537503|NCT00903968|528478061|FG004|Overall Study|DLT|0|||
146537504|NCT00903968|528478062|FG005|Overall Study|DLT|0|||
146537505|NCT00903968|528478063|FG006|Overall Study|DLT|2|||
146537506|NCT00903968|528478064|FG007|Overall Study|DLT|0|||
146537507|NCT00903968|528478057|FG000|Overall Study|Withdrawal by Subject|1|||
146625917|NCT00395746|528806132|FG002|Overall Study|Protocol Violation|0|||
146537508|NCT00903968|528478058|FG001|Overall Study|Withdrawal by Subject|0|||
146537509|NCT00903968|528478059|FG002|Overall Study|Withdrawal by Subject|1|||
146537510|NCT00903968|528478060|FG003|Overall Study|Withdrawal by Subject|0|||
146537511|NCT00903968|528478061|FG004|Overall Study|Withdrawal by Subject|1|||
146537512|NCT00903968|528478062|FG005|Overall Study|Withdrawal by Subject|1|||
146537513|NCT00903968|528478063|FG006|Overall Study|Withdrawal by Subject|0|||
146537514|NCT00903968|528478064|FG007|Overall Study|Withdrawal by Subject|4|||
146537515|NCT00903968|528478057|FG000|Overall Study|Non-Compliance|0|||
146537516|NCT00903968|528478058|FG001|Overall Study|Non-Compliance|0|||
146537517|NCT00903968|528478059|FG002|Overall Study|Non-Compliance|0|||
146537518|NCT00903968|528478060|FG003|Overall Study|Non-Compliance|0|||
146537519|NCT00903968|528478061|FG004|Overall Study|Non-Compliance|0|||
146537520|NCT00903968|528478062|FG005|Overall Study|Non-Compliance|1|||
146537521|NCT00903968|528478063|FG006|Overall Study|Non-Compliance|0|||
146537522|NCT00903968|528478064|FG007|Overall Study|Non-Compliance|0|||
146537523|NCT00903968|528478057|FG000|Overall Study|Physician Decision|0|||
146537524|NCT00903968|528478058|FG001|Overall Study|Physician Decision|0|||
146537525|NCT00903968|528478059|FG002|Overall Study|Physician Decision|0|||
146537526|NCT00903968|528478060|FG003|Overall Study|Physician Decision|0|||
146537527|NCT00903968|528478061|FG004|Overall Study|Physician Decision|0|||
146537528|NCT00903968|528478062|FG005|Overall Study|Physician Decision|1|||
146537529|NCT00903968|528478063|FG006|Overall Study|Physician Decision|0|||
146537530|NCT00903968|528478064|FG007|Overall Study|Physician Decision|0|||
146537531|NCT00903968|528478057|FG000|Overall Study|Progressive Disease|2|||
146537532|NCT00903968|528478058|FG001|Overall Study|Progressive Disease|3|||
146537533|NCT00903968|528478059|FG002|Overall Study|Progressive Disease|2|||
146537534|NCT00903968|528478060|FG003|Overall Study|Progressive Disease|3|||
146537535|NCT00903968|528478061|FG004|Overall Study|Progressive Disease|3|||
146537536|NCT00903968|528478062|FG005|Overall Study|Progressive Disease|3|||
146537537|NCT00903968|528478063|FG006|Overall Study|Progressive Disease|0|||
146537538|NCT00903968|528478064|FG007|Overall Study|Progressive Disease|18|||
146537539|NCT00903968|528478057|FG000|Overall Study|Lack of Efficacy|0|||
146537540|NCT00903968|528478058|FG001|Overall Study|Lack of Efficacy|0|||
146537541|NCT00903968|528478059|FG002|Overall Study|Lack of Efficacy|0|||
146537542|NCT00903968|528478060|FG003|Overall Study|Lack of Efficacy|0|||
146537543|NCT00903968|528478061|FG004|Overall Study|Lack of Efficacy|0|||
146537544|NCT00903968|528478062|FG005|Overall Study|Lack of Efficacy|0|||
146537545|NCT00903968|528478063|FG006|Overall Study|Lack of Efficacy|0|||
146537546|NCT00903968|528478064|FG007|Overall Study|Lack of Efficacy|3|||
146537547|NCT03979313|528478065|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
146537548|NCT03979313|528478066|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
146537549|NCT03979313|528478065|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
146537550|NCT03979313|528478066|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
146537551|NCT03979313|528478065|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
146537552|NCT03979313|528478066|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
146537553|NCT03979313|528478065|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
146537554|NCT03979313|528478066|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
146537555|NCT03979313|528478065|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
146537556|NCT03979313|528478066|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
146537557|NCT03979313|528478065|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
146537558|NCT03979313|528478066|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
146537559|NCT03979313|528478065|FG000|All Subjects|Any Other Reason|16|||
146537560|NCT03979313|528478066|FG001|All Subjects|Any Other Reason|23|||
146537561|NCT03979313|528478065|FG000|All Subjects|Covid-19|1|||
146537562|NCT03979313|528478066|FG001|All Subjects|Covid-19|3|||
146537563|NCT03979313|528478065|FG000|All Subjects|Withdrawal by Subject|35|||
146537564|NCT03979313|528478066|FG001|All Subjects|Withdrawal by Subject|44|||
146537565|NCT03979313|528478065|FG000|All Subjects|Death|0|||
146537566|NCT03979313|528478066|FG001|All Subjects|Death|5|||
146537567|NCT03979313|528478065|FG000|All Subjects|Lost to Follow-up|28|||
146537568|NCT03979313|528478066|FG001|All Subjects|Lost to Follow-up|61|||
146537569|NCT00089648|528478067|FG000|Overall Study|Adverse Event|7|||
146537570|NCT00089648|528478067|FG000|Overall Study|Withdrawal by Subject|1|||
146537571|NCT00089648|528478067|FG000|Overall Study|Lack of Efficacy|33|||
146537572|NCT00423605|528478068|FG000|Overall Study|Adverse Event|129|||
146537573|NCT00423605|528478068|FG000|Overall Study|Withdrawal by Subject|36|||
146625918|NCT00395746|528806130|FG000|Overall Study|Lack of Efficacy|2|||
146537574|NCT00423605|528478068|FG000|Overall Study|Lost to Follow-up|15|||
146537575|NCT00423605|528478068|FG000|Overall Study|Lack of Efficacy|38|||
146537576|NCT00423605|528478068|FG000|Overall Study|Sponsor Decision|3|||
146537577|NCT00423605|528478068|FG000|Overall Study|Physician Decision|8|||
146537578|NCT00423605|528478068|FG000|Overall Study|Protocol Violation|7|||
146537579|NCT00423605|528478068|FG000|Overall Study|Not one of the pre-specified options|5|||
146537580|NCT04889040|528478072|FG000|Overall Study|Withdrawal by Subject|3|||
146537581|NCT04889040|528478073|FG001|Overall Study|Withdrawal by Subject|3|||
146537582|NCT04889040|528478072|FG000|Overall Study|Lost to Follow-up|0|||
146537583|NCT04889040|528478073|FG001|Overall Study|Lost to Follow-up|1|||
146537584|NCT04889040|528478072|FG000|Overall Study|Adverse Event|2|||
146537585|NCT04889040|528478073|FG001|Overall Study|Adverse Event|1|||
146537586|NCT03183908|528478074|FG000|Overall Study|Missing Symptom Diary Data|0|||
146537587|NCT03183908|528478075|FG001|Overall Study|Missing Symptom Diary Data|2|||
146537588|NCT03738696|528478076|FG000|Overall Study|Withdrawal by Subject|0|||
146537589|NCT03738696|528478077|FG001|Overall Study|Withdrawal by Subject|1|||
146537590|NCT03738696|528478076|FG000|Overall Study|Lost to Follow-up|8|||
146537591|NCT03738696|528478077|FG001|Overall Study|Lost to Follow-up|14|||
146537592|NCT00726453|528478083|FG000|Primary Enrollment Group|Death|18|||
146537593|NCT00726453|528478084|FG001|Primary Enrollment Group|Death|0|||
146537594|NCT00726453|528478083|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
146537595|NCT00726453|528478084|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
146537596|NCT00726453|528478083|FG000|38 mm Length Group|Death|0|||
146537597|NCT00726453|528478084|FG001|38 mm Length Group|Death|3|||
146537598|NCT02690727|528478085|FG000|Overall Study|Adverse Event|2|||
146537599|NCT02690727|528478086|FG001|Overall Study|Adverse Event|2|||
146537600|NCT01983930|528478088|FG000|Overall Study|Withdrawal by Subject|9|||
146537601|NCT01983930|528478089|FG001|Overall Study|Withdrawal by Subject|8|||
146537602|NCT01983930|528478088|FG000|Overall Study|Adverse Event|0|||
146537603|NCT01983930|528478089|FG001|Overall Study|Adverse Event|1|||
146537604|NCT00656617|528478090|FG000|Overall Study|Adverse Event|1|||
146537605|NCT00656617|528478090|FG000|Overall Study|Death|2|||
146537606|NCT00656617|528478090|FG000|Overall Study|Insurance Issues|2|||
146537607|NCT00656617|528478090|FG000|Overall Study|Move to different clinical trial|2|||
146537608|NCT02030600|528478091|FG000|Treatment Period 1|Adverse Event|5|||
146537609|NCT02030600|528478092|FG001|Treatment Period 1|Adverse Event|7|||
146537610|NCT02030600|528478091|FG000|Treatment Period 1|Lack of Efficacy|0|||
146537611|NCT02030600|528478092|FG001|Treatment Period 1|Lack of Efficacy|1|||
146537612|NCT02030600|528478091|FG000|Treatment Period 1|Lost to Follow-up|11|||
146537613|NCT02030600|528478092|FG001|Treatment Period 1|Lost to Follow-up|3|||
146537614|NCT02030600|528478091|FG000|Treatment Period 1|Protocol Violation|22|||
146537615|NCT02030600|528478092|FG001|Treatment Period 1|Protocol Violation|17|||
146537616|NCT02030600|528478091|FG000|Treatment Period 1|Withdrawal by Subject|13|||
146537617|NCT02030600|528478092|FG001|Treatment Period 1|Withdrawal by Subject|17|||
146537618|NCT02030600|528478091|FG000|Treatment Period 1|Casebook Unsigned|1|||
146537619|NCT02030600|528478092|FG001|Treatment Period 1|Casebook Unsigned|0|||
146537620|NCT02030600|528478091|FG000|Treatment Period 1|Unclassified|1|||
146537621|NCT02030600|528478092|FG001|Treatment Period 1|Unclassified|0|||
146537622|NCT02030600|528478091|FG000|Treatment Period 2|Adverse Event|4|||
146537623|NCT02030600|528478092|FG001|Treatment Period 2|Adverse Event|4|||
146537624|NCT02030600|528478091|FG000|Treatment Period 2|Lack of Efficacy|2|||
146537625|NCT02030600|528478092|FG001|Treatment Period 2|Lack of Efficacy|1|||
146537626|NCT02030600|528478091|FG000|Treatment Period 2|Lost to Follow-up|4|||
146537627|NCT02030600|528478092|FG001|Treatment Period 2|Lost to Follow-up|2|||
146537628|NCT02030600|528478091|FG000|Treatment Period 2|Protocol Violation|1|||
146537629|NCT02030600|528478092|FG001|Treatment Period 2|Protocol Violation|2|||
146537630|NCT02030600|528478091|FG000|Treatment Period 2|Withdrawal by Subject|13|||
146537631|NCT02030600|528478092|FG001|Treatment Period 2|Withdrawal by Subject|9|||
146537632|NCT02030600|528478091|FG000|Treatment Period 2|Unclassified|1|||
146537633|NCT02030600|528478092|FG001|Treatment Period 2|Unclassified|0|||
146537634|NCT00091819|528478093|FG000|Overall Study|Adverse Event|1|||
146537635|NCT00091819|528478094|FG001|Overall Study|Adverse Event|1|||
146537636|NCT00091819|528478093|FG000|Overall Study|Death|4|||
146537637|NCT00091819|528478094|FG001|Overall Study|Death|5|||
146537638|NCT00091819|528478093|FG000|Overall Study|Lost to Follow-up|26|||
146537639|NCT00091819|528478094|FG001|Overall Study|Lost to Follow-up|23|||
146537640|NCT00091819|528478093|FG000|Overall Study|Withdrawal by Subject|5|||
146537641|NCT00091819|528478094|FG001|Overall Study|Withdrawal by Subject|8|||
146537642|NCT00091819|528478093|FG000|Overall Study|Protocol Violation|1|||
146537643|NCT00091819|528478094|FG001|Overall Study|Protocol Violation|2|||
146537644|NCT00091819|528478093|FG000|Overall Study|Other|2|||
146537645|NCT00091819|528478094|FG001|Overall Study|Other|3|||
146537646|NCT00091819|528478093|FG000|Overall Study|Never received study treatment|3|||
146537647|NCT00091819|528478094|FG001|Overall Study|Never received study treatment|4|||
146537648|NCT05001620|528478095|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
146537649|NCT05001620|528478096|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
146537650|NCT02736617|528478097|FG000|Treatment|Adverse Event|1|||
146537651|NCT02736617|528478097|FG000|Treatment|Lack of Efficacy|1|||
146537652|NCT02736617|528478097|FG000|Treatment|Withdrawal by Subject|1|||
146537653|NCT02736617|528478097|FG000|Maintenance|Lack of Efficacy|4|||
146537654|NCT02736617|528478097|FG000|Maintenance|Physician Decision|1|||
146537655|NCT00481676|528478100|FG000|Overall Study|Adverse Event|0|||
146537656|NCT00481676|528478101|FG001|Overall Study|Adverse Event|1|||
146537657|NCT00481676|528478100|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146537658|NCT00481676|528478101|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
146537659|NCT00481676|528478100|FG000|Overall Study|Administrative problem|1|||
146537660|NCT00481676|528478101|FG001|Overall Study|Administrative problem|0|||
146537661|NCT02911116|528478102|FG000|Overall Study|Insufficient Therapeutic Response|1|||
146625919|NCT00395746|528806131|FG001|Overall Study|Lack of Efficacy|0|||
146625920|NCT00395746|528806132|FG002|Overall Study|Lack of Efficacy|17|||
146625921|NCT00395746|528806130|FG000|Overall Study|Hypoglycaemia|2|||
146625922|NCT00395746|528806131|FG001|Overall Study|Hypoglycaemia|1|||
146625923|NCT00395746|528806132|FG002|Overall Study|Hypoglycaemia|0|||
146625924|NCT00395746|528806130|FG000|Overall Study|Subject decision|0|||
146625925|NCT00395746|528806131|FG001|Overall Study|Subject decision|0|||
146625926|NCT00395746|528806132|FG002|Overall Study|Subject decision|1|||
146625927|NCT00395746|528806130|FG000|Overall Study|Withdrawal of consent|0|||
146625928|NCT00395746|528806131|FG001|Overall Study|Withdrawal of consent|0|||
146625929|NCT00395746|528806132|FG002|Overall Study|Withdrawal of consent|1|||
146625930|NCT00395746|528806130|FG000|Overall Study|Difficultulty in use of device|0|||
146625931|NCT00395746|528806131|FG001|Overall Study|Difficultulty in use of device|0|||
146625932|NCT00395746|528806132|FG002|Overall Study|Difficultulty in use of device|1|||
146625933|NCT00395746|528806130|FG000|Overall Study|Unable to visit site on schedule|1|||
146625934|NCT00395746|528806131|FG001|Overall Study|Unable to visit site on schedule|0|||
146625935|NCT00395746|528806132|FG002|Overall Study|Unable to visit site on schedule|0|||
146625936|NCT04528641|528806133|FG000|Overall Study|Withdrawal by Subject|0|||
146625937|NCT04528641|528806134|FG001|Overall Study|Withdrawal by Subject|0|||
146625938|NCT04528641|528806135|FG002|Overall Study|Withdrawal by Subject|0|||
146625939|NCT04528641|528806136|FG003|Overall Study|Withdrawal by Subject|1|||
146625940|NCT04528641|528806137|FG004|Overall Study|Withdrawal by Subject|0|||
146625941|NCT04528641|528806138|FG005|Overall Study|Withdrawal by Subject|1|||
146625942|NCT03914417|528806139|FG000|Overall Study|Withdrawal by Subject|2|||
146625943|NCT03836625|528806142|FG000|Overall Study|Lost to Follow-up|9|||
146625944|NCT03836625|528806143|FG001|Overall Study|Lost to Follow-up|9|||
146625945|NCT03836625|528806142|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
146625946|NCT03836625|528806143|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
146625947|NCT03836625|528806142|FG000|Overall Study|Death|0|||
146625948|NCT03836625|528806143|FG001|Overall Study|Death|1|||
146625949|NCT03836625|528806142|FG000|Overall Study|Refused follow-up|0|||
146625950|NCT03836625|528806143|FG001|Overall Study|Refused follow-up|1|||
146625951|NCT03361137|528806146|FG000|Overall Study|Reason not specified|1|||
146625952|NCT03361137|528806147|FG001|Overall Study|Reason not specified|0|||
146625953|NCT03361137|528806148|FG002|Overall Study|Reason not specified|0|||
146625954|NCT03361137|528806149|FG003|Overall Study|Reason not specified|0|||
146625955|NCT03361137|528806150|FG004|Overall Study|Reason not specified|0|||
146625956|NCT00791934|528806151|FG000|Overall Study|Withdrawal by Subject|2|||
146625957|NCT00791934|528806151|FG000|Overall Study|Did not consent for extended follow-up|13|||
146625958|NCT03413891|528806153|FG000|Overall Study|Lost to Follow-up|2|||
146625959|NCT03413891|528806154|FG001|Overall Study|Lost to Follow-up|1|||
146625960|NCT03413891|528806153|FG000|Overall Study|Protocol Violation|0|||
146625961|NCT03413891|528806154|FG001|Overall Study|Protocol Violation|1|||
146625962|NCT04905134|528806155|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
146625963|NCT04905134|528806155|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
146625964|NCT03009058|528806156|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
146625965|NCT03221556|528806157|FG000|Allocation|post-randomization exclusion|0|||
146625966|NCT03221556|528806158|FG001|Allocation|post-randomization exclusion|1|||
146625967|NCT03221556|528806157|FG000|Follow-Up|Withdrawal by Subject|0|||
146625968|NCT03221556|528806158|FG001|Follow-Up|Withdrawal by Subject|1|||
146625971|NCT01486966|528806163|FG000|Overall Study|Adverse Event|0|||
146625972|NCT01486966|528806164|FG001|Overall Study|Adverse Event|1|||
146625973|NCT01486966|528806163|FG000|Overall Study|Withdrawal by Subject|0|||
146625974|NCT01486966|528806164|FG001|Overall Study|Withdrawal by Subject|1|||
146625975|NCT02234843|528806165|FG000|Overall Study|Death|1|||
146625976|NCT02234843|528806166|FG001|Overall Study|Death|0|||
146625977|NCT02234843|528806167|FG002|Overall Study|Death|0|||
146625978|NCT02234843|528806168|FG003|Overall Study|Death|0|||
146625979|NCT02234843|528806169|FG004|Overall Study|Death|0|||
146625980|NCT02234843|528806170|FG005|Overall Study|Death|0|||
146625981|NCT02234843|528806171|FG006|Overall Study|Death|0|||
146625982|NCT02234843|528806172|FG007|Overall Study|Death|0|||
146625983|NCT02234843|528806173|FG008|Overall Study|Death|0|||
146625984|NCT02234843|528806174|FG009|Overall Study|Death|0|||
146625985|NCT02234843|528806165|FG000|Overall Study|Protocol Violation|1|||
146625986|NCT02234843|528806166|FG001|Overall Study|Protocol Violation|0|||
146625987|NCT02234843|528806167|FG002|Overall Study|Protocol Violation|1|||
146625988|NCT02234843|528806168|FG003|Overall Study|Protocol Violation|0|||
146625989|NCT02234843|528806169|FG004|Overall Study|Protocol Violation|0|||
146625990|NCT02234843|528806170|FG005|Overall Study|Protocol Violation|0|||
146625991|NCT02234843|528806171|FG006|Overall Study|Protocol Violation|0|||
146625992|NCT02234843|528806172|FG007|Overall Study|Protocol Violation|0|||
146625993|NCT02234843|528806173|FG008|Overall Study|Protocol Violation|0|||
146625994|NCT02234843|528806174|FG009|Overall Study|Protocol Violation|0|||
146625995|NCT02234843|528806165|FG000|Overall Study|Efficacy outcome reached|2|||
146625996|NCT02234843|528806166|FG001|Overall Study|Efficacy outcome reached|0|||
146625997|NCT02234843|528806167|FG002|Overall Study|Efficacy outcome reached|0|||
146625998|NCT02234843|528806168|FG003|Overall Study|Efficacy outcome reached|0|||
146625999|NCT02234843|528806169|FG004|Overall Study|Efficacy outcome reached|0|||
146537662|NCT02911116|528478103|FG001|Overall Study|Insufficient Therapeutic Response|0|||
146537663|NCT02911116|528478102|FG000|Overall Study|Lost to Follow-up|0|||
146537664|NCT02911116|528478103|FG001|Overall Study|Lost to Follow-up|1|||
146537665|NCT01240694|528478104|FG000|Overall Study|Adverse Event|9|||
146537666|NCT01240694|528478104|FG000|Overall Study|Lack of Efficacy|6|||
146537667|NCT01240694|528478104|FG000|Overall Study|Withdrawal by Subject|6|||
146537668|NCT01240694|528478104|FG000|Overall Study|Protocol Violation|2|||
146537669|NCT01240694|528478104|FG000|Overall Study|Lost to Follow-up|2|||
146537670|NCT01240694|528478104|FG000|Overall Study|Other than specified|3|||
146537671|NCT01240694|528478104|FG000|Overall Study|Withdrawn due to early study termination|107|||
146537672|NCT01513590|528478105|FG000|Overall Study|Adverse Event|2|||
146537673|NCT01513590|528478106|FG001|Overall Study|Adverse Event|3|||
146537674|NCT01513590|528478105|FG000|Overall Study|Withdrawal Criteria|3|||
146537675|NCT01513590|528478106|FG001|Overall Study|Withdrawal Criteria|0|||
146537676|NCT01513590|528478105|FG000|Overall Study|Unclassified|5|||
146537677|NCT01513590|528478106|FG001|Overall Study|Unclassified|10|||
146537678|NCT01056276|528478107|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
146537679|NCT01056276|528478108|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
146537680|NCT01056276|528478107|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
146537681|NCT01056276|528478108|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
146537682|NCT01056276|528478107|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
146537683|NCT01056276|528478108|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
146537684|NCT01056276|528478107|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
146537685|NCT01056276|528478108|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
146537686|NCT01056276|528478107|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
146537687|NCT01056276|528478108|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
146537688|NCT01056276|528478107|FG000|Treatment Period-Cycles 1-8|Death|3|||
146537689|NCT01056276|528478108|FG001|Treatment Period-Cycles 1-8|Death|1|||
146537690|NCT01056276|528478107|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
146537691|NCT01056276|528478108|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
146537692|NCT01056276|528478107|FG000|Maintenance Therapy|Toxicity|0|||
146626000|NCT02234843|528806170|FG005|Overall Study|Efficacy outcome reached|2|||
146537693|NCT01056276|528478108|FG001|Maintenance Therapy|Toxicity|2|||
146537694|NCT01056276|528478107|FG000|Maintenance Therapy|Progressive Disease|0|||
146537695|NCT01056276|528478108|FG001|Maintenance Therapy|Progressive Disease|9|||
146537696|NCT01056276|528478107|FG000|Maintenance Therapy|Physician Decision|0|||
146537697|NCT01056276|528478108|FG001|Maintenance Therapy|Physician Decision|1|||
146537698|NCT01056276|528478107|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
146626001|NCT02234843|528806171|FG006|Overall Study|Efficacy outcome reached|0|||
146626002|NCT02234843|528806172|FG007|Overall Study|Efficacy outcome reached|0|||
146626003|NCT02234843|528806173|FG008|Overall Study|Efficacy outcome reached|0|||
146626004|NCT02234843|528806174|FG009|Overall Study|Efficacy outcome reached|0|||
146626005|NCT02234843|528806165|FG000|Overall Study|Patient convenience|2|||
146626006|NCT02234843|528806166|FG001|Overall Study|Patient convenience|0|||
146626007|NCT02234843|528806167|FG002|Overall Study|Patient convenience|0|||
146626008|NCT02234843|528806168|FG003|Overall Study|Patient convenience|0|||
146626009|NCT02234843|528806169|FG004|Overall Study|Patient convenience|0|||
146626010|NCT02234843|528806170|FG005|Overall Study|Patient convenience|1|||
146537699|NCT01056276|528478108|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
146537700|NCT01056276|528478107|FG000|Maintenance Therapy|Intercurrent Illness|0|||
146537701|NCT01056276|528478108|FG001|Maintenance Therapy|Intercurrent Illness|1|||
146626011|NCT02234843|528806171|FG006|Overall Study|Patient convenience|0|||
146626012|NCT02234843|528806172|FG007|Overall Study|Patient convenience|0|||
146626013|NCT02234843|528806173|FG008|Overall Study|Patient convenience|0|||
146626014|NCT02234843|528806174|FG009|Overall Study|Patient convenience|0|||
146626015|NCT02234843|528806165|FG000|Overall Study|Withdrawal by Subject|5|||
146626016|NCT02234843|528806166|FG001|Overall Study|Withdrawal by Subject|1|||
146626017|NCT02234843|528806167|FG002|Overall Study|Withdrawal by Subject|1|||
146626018|NCT02234843|528806168|FG003|Overall Study|Withdrawal by Subject|0|||
146626019|NCT02234843|528806169|FG004|Overall Study|Withdrawal by Subject|0|||
146626020|NCT02234843|528806170|FG005|Overall Study|Withdrawal by Subject|7|||
146626021|NCT02234843|528806171|FG006|Overall Study|Withdrawal by Subject|0|||
146626022|NCT02234843|528806172|FG007|Overall Study|Withdrawal by Subject|0|||
146626023|NCT02234843|528806173|FG008|Overall Study|Withdrawal by Subject|0|||
146626024|NCT02234843|528806174|FG009|Overall Study|Withdrawal by Subject|0|||
146626025|NCT02234843|528806165|FG000|Overall Study|Recovery|1|||
146626026|NCT02234843|528806166|FG001|Overall Study|Recovery|0|||
146626027|NCT02234843|528806167|FG002|Overall Study|Recovery|0|||
146626028|NCT02234843|528806168|FG003|Overall Study|Recovery|0|||
146537702|NCT01056276|528478107|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
146537703|NCT01056276|528478108|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
146537704|NCT01881425|528478109|FG000|Overall Study|Death|5|||
146537705|NCT01881425|528478110|FG001|Overall Study|Death|1|||
146537706|NCT01881425|528478109|FG000|Overall Study|Withdrawal by Subject|8|||
146537707|NCT01881425|528478110|FG001|Overall Study|Withdrawal by Subject|3|||
146537708|NCT01881425|528478109|FG000|Overall Study|Physician Decision|2|||
146537709|NCT01881425|528478110|FG001|Overall Study|Physician Decision|1|||
146537710|NCT01881425|528478109|FG000|Overall Study|Adverse Event|3|||
146537711|NCT01881425|528478110|FG001|Overall Study|Adverse Event|0|||
146537712|NCT01881425|528478109|FG000|Overall Study|General Anesthesia panic attack|0|||
146537713|NCT01881425|528478110|FG001|Overall Study|General Anesthesia panic attack|1|||
146537714|NCT01881425|528478109|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
146537715|NCT01881425|528478110|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
146537716|NCT01881425|528478109|FG000|Overall Study|Lost to Follow-up|7|||
146537717|NCT01881425|528478110|FG001|Overall Study|Lost to Follow-up|2|||
146537718|NCT04154956|528478111|FG000|Overall Study|Death|109|||
146537719|NCT04154956|528478112|FG001|Overall Study|Death|110|||
146537720|NCT04154956|528478111|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
146537721|NCT04154956|528478112|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
146537722|NCT04154956|528478111|FG000|Overall Study|Withdrawal by Subject|1|||
146537723|NCT04154956|528478112|FG001|Overall Study|Withdrawal by Subject|7|||
146537724|NCT04154956|528478111|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
146537725|NCT04154956|528478112|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
146537726|NCT00147238|528478113|FG000|Overall Study|Inevaluable|8|||
146537727|NCT04424901|528478114|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
146537728|NCT04424901|528478115|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
146537729|NCT01348269|528478116|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
146537730|NCT01348269|528478117|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
146537731|NCT01348269|528478116|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
146537732|NCT01348269|528478117|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
146537733|NCT01348269|528478116|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
146537734|NCT01348269|528478117|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
146537735|NCT00805532|528478118|FG000|Overall Study|invalid data|0|||
146537736|NCT00805532|528478119|FG001|Overall Study|invalid data|1|||
146537737|NCT01859741|528478120|FG000|Overall Study|Death|3|||
146537738|NCT01859741|528478121|FG001|Overall Study|Death|2|||
146537739|NCT01859741|528478122|FG002|Overall Study|Death|4|||
146537740|NCT01859741|528478123|FG003|Overall Study|Death|3|||
146537741|NCT01859741|528478124|FG004|Overall Study|Death|5|||
146537742|NCT01859741|528478125|FG005|Overall Study|Death|4|||
146763887|NCT00567879|529302914|FG001|Overall Study|Abnormal test procedure(s)|0|||
146537743|NCT01859741|528478126|FG006|Overall Study|Death|51|||
146537744|NCT01859741|528478127|FG007|Overall Study|Death|51|||
146537745|NCT01859741|528478120|FG000|Overall Study|Lost to Follow-up|0|||
146537746|NCT01859741|528478121|FG001|Overall Study|Lost to Follow-up|0|||
146537747|NCT01859741|528478122|FG002|Overall Study|Lost to Follow-up|0|||
146537748|NCT01859741|528478123|FG003|Overall Study|Lost to Follow-up|0|||
146626029|NCT02234843|528806169|FG004|Overall Study|Recovery|0|||
146626030|NCT02234843|528806170|FG005|Overall Study|Recovery|0|||
146626031|NCT02234843|528806171|FG006|Overall Study|Recovery|0|||
146626032|NCT02234843|528806172|FG007|Overall Study|Recovery|0|||
146626033|NCT02234843|528806173|FG008|Overall Study|Recovery|0|||
146626034|NCT02234843|528806174|FG009|Overall Study|Recovery|0|||
146763888|NCT00567879|529302915|FG002|Overall Study|Abnormal test procedure(s)|1|||
146537749|NCT01859741|528478124|FG004|Overall Study|Lost to Follow-up|0|||
146537750|NCT01859741|528478125|FG005|Overall Study|Lost to Follow-up|1|||
146537751|NCT01859741|528478126|FG006|Overall Study|Lost to Follow-up|0|||
146537752|NCT01859741|528478127|FG007|Overall Study|Lost to Follow-up|4|||
146537753|NCT01859741|528478120|FG000|Overall Study|Withdrawal by Subject|0|||
146537754|NCT01859741|528478121|FG001|Overall Study|Withdrawal by Subject|1|||
146537755|NCT01859741|528478122|FG002|Overall Study|Withdrawal by Subject|2|||
146537756|NCT01859741|528478123|FG003|Overall Study|Withdrawal by Subject|0|||
146537757|NCT01859741|528478124|FG004|Overall Study|Withdrawal by Subject|0|||
146537758|NCT01859741|528478125|FG005|Overall Study|Withdrawal by Subject|1|||
146537759|NCT01859741|528478126|FG006|Overall Study|Withdrawal by Subject|1|||
146537760|NCT01859741|528478127|FG007|Overall Study|Withdrawal by Subject|1|||
146537761|NCT01859741|528478120|FG000|Overall Study|Study Terminated by Sponsor|0|||
146537762|NCT01859741|528478121|FG001|Overall Study|Study Terminated by Sponsor|0|||
146537763|NCT01859741|528478122|FG002|Overall Study|Study Terminated by Sponsor|0|||
146537764|NCT01859741|528478123|FG003|Overall Study|Study Terminated by Sponsor|0|||
146537765|NCT01859741|528478124|FG004|Overall Study|Study Terminated by Sponsor|1|||
146537766|NCT01859741|528478125|FG005|Overall Study|Study Terminated by Sponsor|0|||
146537767|NCT01859741|528478126|FG006|Overall Study|Study Terminated by Sponsor|16|||
146537768|NCT01859741|528478127|FG007|Overall Study|Study Terminated by Sponsor|14|||
146537769|NCT01859741|528478120|FG000|Overall Study|Other|0|||
146537770|NCT01859741|528478121|FG001|Overall Study|Other|0|||
146537771|NCT01859741|528478122|FG002|Overall Study|Other|0|||
146537772|NCT01859741|528478123|FG003|Overall Study|Other|0|||
146537773|NCT01859741|528478124|FG004|Overall Study|Other|0|||
146537774|NCT01859741|528478125|FG005|Overall Study|Other|0|||
146537775|NCT01859741|528478126|FG006|Overall Study|Other|2|||
146537776|NCT01859741|528478127|FG007|Overall Study|Other|0|||
146537777|NCT02606253|528478128|FG000|Overall Study|Adverse Event|2|||
146537778|NCT02606253|528478129|FG001|Overall Study|Adverse Event|0|||
146537779|NCT02606253|528478130|FG002|Overall Study|Adverse Event|0|||
146626035|NCT02234843|528806165|FG000|Overall Study|Other|0|||
146626036|NCT02234843|528806166|FG001|Overall Study|Other|2|||
146626037|NCT02234843|528806167|FG002|Overall Study|Other|0|||
146537780|NCT02606253|528478128|FG000|Overall Study|Protocol Violation|2|||
146537781|NCT02606253|528478129|FG001|Overall Study|Protocol Violation|1|||
146537782|NCT02606253|528478130|FG002|Overall Study|Protocol Violation|0|||
146537783|NCT02606253|528478128|FG000|Overall Study|Physician Decision|1|||
146537784|NCT02606253|528478129|FG001|Overall Study|Physician Decision|1|||
146537785|NCT02606253|528478130|FG002|Overall Study|Physician Decision|0|||
146537786|NCT02567188|528478131|FG000|Overall Study|Death|10|||
146537787|NCT02567188|528478131|FG000|Overall Study|Terminated Mircera Treatment|9|||
146537788|NCT02567188|528478131|FG000|Overall Study|Lost to Follow-up|5|||
146537789|NCT02567188|528478131|FG000|Overall Study|Adverse Event|1|||
146537790|NCT02567188|528478131|FG000|Overall Study|Withdrawal by Subject|1|||
146537791|NCT02567188|528478131|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
146537792|NCT02567188|528478131|FG000|Overall Study|Moved and Changed Clinic|1|||
146537793|NCT02567188|528478131|FG000|Overall Study|Started Hemodialysis|2|||
146537794|NCT02567188|528478131|FG000|Overall Study|Protocol Violation|5|||
146537795|NCT01189266|528478136|FG000|Overall Study|Adverse Event|1|||
146537796|NCT01189266|528478137|FG001|Overall Study|Adverse Event|0|||
146537797|NCT01189266|528478138|FG002|Overall Study|Adverse Event|5|||
146537798|NCT01189266|528478136|FG000|Overall Study|Death|0|||
146537799|NCT01189266|528478137|FG001|Overall Study|Death|0|||
146537800|NCT01189266|528478138|FG002|Overall Study|Death|5|||
146537801|NCT01189266|528478136|FG000|Overall Study|Lack of Efficacy|4|||
146537802|NCT01189266|528478137|FG001|Overall Study|Lack of Efficacy|5|||
146537803|NCT01189266|528478138|FG002|Overall Study|Lack of Efficacy|44|||
146537804|NCT01189266|528478136|FG000|Overall Study|Physician Decision|0|||
146537805|NCT01189266|528478137|FG001|Overall Study|Physician Decision|0|||
146537806|NCT01189266|528478138|FG002|Overall Study|Physician Decision|1|||
146537807|NCT01189266|528478136|FG000|Overall Study|Protocol Violation|0|||
146537808|NCT01189266|528478137|FG001|Overall Study|Protocol Violation|1|||
146537809|NCT01189266|528478138|FG002|Overall Study|Protocol Violation|1|||
146626038|NCT02234843|528806168|FG003|Overall Study|Other|1|||
146626039|NCT02234843|528806169|FG004|Overall Study|Other|0|||
146626040|NCT02234843|528806170|FG005|Overall Study|Other|1|||
146763889|NCT00567879|529302916|FG003|Overall Study|Abnormal test procedure(s)|0|||
146537810|NCT01189266|528478136|FG000|Overall Study|Withdrawal by Subject|0|||
146537811|NCT01189266|528478137|FG001|Overall Study|Withdrawal by Subject|0|||
146537812|NCT01189266|528478138|FG002|Overall Study|Withdrawal by Subject|1|||
146537813|NCT01189266|528478136|FG000|Overall Study|Patient refuses further therapy|1|||
146537814|NCT01189266|528478137|FG001|Overall Study|Patient refuses further therapy|0|||
146626041|NCT02234843|528806171|FG006|Overall Study|Other|0|||
146626042|NCT02234843|528806172|FG007|Overall Study|Other|1|||
146626043|NCT02234843|528806173|FG008|Overall Study|Other|0|||
146763890|NCT00567879|529302917|FG004|Overall Study|Abnormal test procedure(s)|0|||
146763891|NCT00567879|529302918|FG005|Overall Study|Abnormal test procedure(s)|0|||
146763892|NCT00567879|529302913|FG000|Overall Study|Withdrawal by Subject|0|||
146763893|NCT00567879|529302914|FG001|Overall Study|Withdrawal by Subject|0|||
146537815|NCT01189266|528478138|FG002|Overall Study|Patient refuses further therapy|7|||
146537816|NCT01189266|528478136|FG000|Overall Study|No treatment|0|||
146537817|NCT01189266|528478137|FG001|Overall Study|No treatment|0|||
146537818|NCT01189266|528478138|FG002|Overall Study|No treatment|1|||
146537819|NCT00537277|528478139|FG000|Overall Study|Adverse Event|1|||
146537820|NCT00537277|528478139|FG000|Overall Study|Lack of Efficacy|2|||
146537821|NCT00537277|528478139|FG000|Overall Study|Lost to Follow-up|12|||
146537822|NCT00537277|528478139|FG000|Overall Study|Protocol Violation|11|||
146537823|NCT00537277|528478139|FG000|Overall Study|Unclassified|4|||
146537824|NCT00537277|528478139|FG000|Overall Study|Inability to tolerate trial medication|4|||
146537825|NCT00537277|528478139|FG000|Overall Study|Non-compliance with trial procedures|15|||
146537826|NCT03620162|528478140|FG000|Overall Study|Physician Decision|4|||
146537827|NCT03620162|528478141|FG001|Overall Study|Physician Decision|0|||
146537828|NCT03620162|528478142|FG002|Overall Study|Physician Decision|1|||
146537829|NCT03620162|528478143|FG003|Overall Study|Physician Decision|0|||
146537830|NCT03620162|528478144|FG004|Overall Study|Physician Decision|2|||
146537831|NCT03620162|528478140|FG000|Overall Study|Lost to Follow-up|2|||
146537832|NCT03620162|528478141|FG001|Overall Study|Lost to Follow-up|6|||
146537833|NCT03620162|528478142|FG002|Overall Study|Lost to Follow-up|7|||
146537834|NCT03620162|528478143|FG003|Overall Study|Lost to Follow-up|3|||
146537835|NCT03620162|528478144|FG004|Overall Study|Lost to Follow-up|2|||
146537836|NCT03620162|528478140|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
146537837|NCT03620162|528478141|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
146537838|NCT03620162|528478142|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
146537839|NCT03620162|528478143|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
146537840|NCT03620162|528478144|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
146537841|NCT04009837|528478146|FG000|Overall Study|Withdrawal by Subject|5|||
146537842|NCT04009837|528478147|FG001|Overall Study|Withdrawal by Subject|4|||
146537843|NCT04009837|528478146|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
146537844|NCT04009837|528478147|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
146537845|NCT00071981|528478149|FG000|Overall Study|Lack of Efficacy|37|||
146537846|NCT00071981|528478150|FG001|Overall Study|Lack of Efficacy|29|||
146537847|NCT00071981|528478151|FG002|Overall Study|Lack of Efficacy|30|||
146537848|NCT00071981|528478152|FG003|Overall Study|Lack of Efficacy|43|||
146537849|NCT00071981|528478149|FG000|Overall Study|Adverse Event|4|||
146537850|NCT00071981|528478150|FG001|Overall Study|Adverse Event|4|||
146537851|NCT00071981|528478151|FG002|Overall Study|Adverse Event|3|||
146537852|NCT00071981|528478152|FG003|Overall Study|Adverse Event|1|||
146537853|NCT00071981|528478149|FG000|Overall Study|Death|0|||
146537854|NCT00071981|528478150|FG001|Overall Study|Death|0|||
146537855|NCT00071981|528478151|FG002|Overall Study|Death|1|||
146537856|NCT00071981|528478152|FG003|Overall Study|Death|1|||
146537857|NCT00071981|528478149|FG000|Overall Study|Withdrawal by Subject|3|||
146537858|NCT00071981|528478150|FG001|Overall Study|Withdrawal by Subject|1|||
146537859|NCT00071981|528478151|FG002|Overall Study|Withdrawal by Subject|0|||
146537860|NCT00071981|528478152|FG003|Overall Study|Withdrawal by Subject|0|||
146537861|NCT00071981|528478149|FG000|Overall Study|No protocol therapy|2|||
146537862|NCT00071981|528478150|FG001|Overall Study|No protocol therapy|5|||
146537863|NCT00071981|528478151|FG002|Overall Study|No protocol therapy|1|||
146537864|NCT00071981|528478152|FG003|Overall Study|No protocol therapy|0|||
146537865|NCT00071981|528478149|FG000|Overall Study|others (not specified in the study)|0|||
146537866|NCT00071981|528478150|FG001|Overall Study|others (not specified in the study)|2|||
146537867|NCT00071981|528478151|FG002|Overall Study|others (not specified in the study)|2|||
146537868|NCT00071981|528478152|FG003|Overall Study|others (not specified in the study)|0|||
146537869|NCT01933594|528478154|FG000|Overall Study|Lost to Follow-up|1|||
146537870|NCT01933594|528478155|FG001|Overall Study|Lost to Follow-up|0|||
146537871|NCT01933594|528478156|FG002|Overall Study|Lost to Follow-up|0|||
146537872|NCT01933594|528478157|FG003|Overall Study|Lost to Follow-up|0|||
146537873|NCT01933594|528478158|FG004|Overall Study|Lost to Follow-up|1|||
146537874|NCT01933594|528478159|FG005|Overall Study|Lost to Follow-up|0|||
146537875|NCT01933594|528478154|FG000|Overall Study|Ineligible for subsequent study step|0|||
146537876|NCT01933594|528478155|FG001|Overall Study|Ineligible for subsequent study step|0|||
146537877|NCT01933594|528478156|FG002|Overall Study|Ineligible for subsequent study step|0|||
146537878|NCT01933594|528478157|FG003|Overall Study|Ineligible for subsequent study step|0|||
146537879|NCT01933594|528478158|FG004|Overall Study|Ineligible for subsequent study step|1|||
146537880|NCT01933594|528478159|FG005|Overall Study|Ineligible for subsequent study step|0|||
146537881|NCT04513366|528478160|FG000|Treatment Phase|Withdrawal by Subject|6|||
146763894|NCT00567879|529302915|FG002|Overall Study|Withdrawal by Subject|3|||
146537882|NCT04513366|528478161|FG001|Treatment Phase|Withdrawal by Subject|8|||
146537883|NCT04513366|528478162|FG002|Treatment Phase|Withdrawal by Subject|3|||
146537884|NCT04513366|528478160|FG000|Treatment Phase|Lost to Follow-up|1|||
146537885|NCT04513366|528478161|FG001|Treatment Phase|Lost to Follow-up|2|||
146537886|NCT04513366|528478162|FG002|Treatment Phase|Lost to Follow-up|5|||
146537887|NCT04513366|528478160|FG000|Treatment Phase|Other than Specified|1|||
146537888|NCT04513366|528478161|FG001|Treatment Phase|Other than Specified|0|||
146537889|NCT04513366|528478162|FG002|Treatment Phase|Other than Specified|2|||
146537890|NCT04513366|528478160|FG000|Treatment Phase|Physician Decision|2|||
146537891|NCT04513366|528478161|FG001|Treatment Phase|Physician Decision|0|||
146537892|NCT04513366|528478162|FG002|Treatment Phase|Physician Decision|0|||
146537893|NCT04513366|528478160|FG000|Treatment Phase|Adverse Event|0|||
146537894|NCT04513366|528478161|FG001|Treatment Phase|Adverse Event|1|||
146537895|NCT04513366|528478162|FG002|Treatment Phase|Adverse Event|1|||
146537896|NCT04513366|528478160|FG000|Extension Phase|Withdrawal by Subject|3|||
146537897|NCT04513366|528478161|FG001|Extension Phase|Withdrawal by Subject|1|||
146537898|NCT04513366|528478162|FG002|Extension Phase|Withdrawal by Subject|1|||
146537899|NCT04513366|528478160|FG000|Extension Phase|Other than Specified|4|||
146537900|NCT04513366|528478161|FG001|Extension Phase|Other than Specified|0|||
146537901|NCT04513366|528478162|FG002|Extension Phase|Other than Specified|1|||
146537902|NCT04513366|528478160|FG000|Extension Phase|Lost to Follow-up|1|||
146537903|NCT04513366|528478161|FG001|Extension Phase|Lost to Follow-up|1|||
146537904|NCT04513366|528478162|FG002|Extension Phase|Lost to Follow-up|1|||
146537905|NCT04513366|528478160|FG000|Extension Phase|Sponsor Decision|0|||
146537906|NCT04513366|528478161|FG001|Extension Phase|Sponsor Decision|1|||
146537907|NCT04513366|528478162|FG002|Extension Phase|Sponsor Decision|0|||
146537908|NCT04513366|528478160|FG000|Extension Phase|Death|0|||
146537909|NCT04513366|528478161|FG001|Extension Phase|Death|1|||
146537910|NCT04513366|528478162|FG002|Extension Phase|Death|0|||
146537911|NCT04513366|528478160|FG000|Extension Phase|Adverse Event|0|||
146537912|NCT04513366|528478161|FG001|Extension Phase|Adverse Event|0|||
146537913|NCT04513366|528478162|FG002|Extension Phase|Adverse Event|1|||
146537914|NCT00655889|528478166|FG000|Overall Study|Inadequate cell growth|1|||
146537915|NCT00655889|528478166|FG000|Overall Study|Protocol Violation|1|||
146537916|NCT04585893|528478167|FG000|Overall Study|Death|1|||
146537917|NCT04585893|528478168|FG001|Overall Study|Death|0|||
146537918|NCT01366092|528478169|FG000|Overall Study|Progressive cGVHD|2|||
146537919|NCT01366092|528478169|FG000|Overall Study|Physician Decision|1|||
146537920|NCT01366092|528478169|FG000|Overall Study|Withdrawal by Subject|1|||
146537921|NCT02273167|528478171|FG000|Overall Study|Adverse Event|1|||
146537922|NCT02273167|528478172|FG001|Overall Study|Adverse Event|0|||
146537923|NCT02273167|528478173|FG002|Overall Study|Adverse Event|0|||
146537924|NCT02273167|528478171|FG000|Overall Study|Protocol Violation|3|||
146537925|NCT02273167|528478172|FG001|Overall Study|Protocol Violation|1|||
146537926|NCT02273167|528478173|FG002|Overall Study|Protocol Violation|1|||
146537927|NCT02273167|528478171|FG000|Overall Study|Lost to Follow-up|0|||
146537928|NCT02273167|528478172|FG001|Overall Study|Lost to Follow-up|1|||
146537929|NCT02273167|528478173|FG002|Overall Study|Lost to Follow-up|1|||
146537930|NCT02273167|528478171|FG000|Overall Study|Withdrawal by Subject|10|||
146537931|NCT02273167|528478172|FG001|Overall Study|Withdrawal by Subject|12|||
146537932|NCT02273167|528478173|FG002|Overall Study|Withdrawal by Subject|11|||
146537933|NCT02273167|528478171|FG000|Overall Study|Various|10|||
146537934|NCT02273167|528478172|FG001|Overall Study|Various|9|||
146537935|NCT02273167|528478173|FG002|Overall Study|Various|8|||
146537936|NCT01093846|528478174|FG000|Overall Study|Adverse Event|0|||
146537937|NCT01093846|528478175|FG001|Overall Study|Adverse Event|0|||
146537938|NCT01093846|528478176|FG002|Overall Study|Adverse Event|1|||
146537939|NCT01093846|528478174|FG000|Overall Study|Lack of Efficacy|0|||
146537940|NCT01093846|528478175|FG001|Overall Study|Lack of Efficacy|0|||
146537941|NCT01093846|528478176|FG002|Overall Study|Lack of Efficacy|4|||
146537942|NCT01093846|528478174|FG000|Overall Study|Condition no longer required study drug|1|||
146537943|NCT01093846|528478175|FG001|Overall Study|Condition no longer required study drug|1|||
146537944|NCT01093846|528478176|FG002|Overall Study|Condition no longer required study drug|1|||
146537945|NCT01093846|528478174|FG000|Overall Study|Administrative Problems|18|||
146537946|NCT01093846|528478175|FG001|Overall Study|Administrative Problems|17|||
146537947|NCT01093846|528478176|FG002|Overall Study|Administrative Problems|15|||
146537948|NCT03454555|528479539|FG000|Overall Study|Death|6|||
146537949|NCT03454555|528479540|FG001|Overall Study|Death|6|||
146537950|NCT03454555|528479539|FG000|Overall Study|Lost to Follow-up|31|||
146537951|NCT03454555|528479540|FG001|Overall Study|Lost to Follow-up|12|||
146537952|NCT03454555|528479539|FG000|Overall Study|Physician Decision|2|||
146537953|NCT03454555|528479540|FG001|Overall Study|Physician Decision|6|||
146537954|NCT03454555|528479539|FG000|Overall Study|Withdrawal by Subject|34|||
146537955|NCT03454555|528479540|FG001|Overall Study|Withdrawal by Subject|5|||
146537956|NCT03454555|528479539|FG000|Overall Study|Ineligible|1|||
146537957|NCT03454555|528479540|FG001|Overall Study|Ineligible|5|||
146537958|NCT01288430|528479544|FG000|Part 1|Progressive disease|2|||
146537959|NCT01288430|528479545|FG001|Part 1|Progressive disease|1|||
146537960|NCT01288430|528479546|FG002|Part 1|Progressive disease|1|||
146537961|NCT01288430|528479547|FG003|Part 1|Progressive disease|6|||
146537962|NCT01288430|528479548|FG004|Part 1|Progressive disease|2|||
146537963|NCT01288430|528479549|FG005|Part 1|Progressive disease|4|||
146537964|NCT01288430|528479550|FG006|Part 1|Progressive disease|2|||
146537965|NCT01288430|528479551|FG007|Part 1|Progressive disease|0|||
146537966|NCT01288430|528479552|FG008|Part 1|Progressive disease|0|||
146537967|NCT01288430|528479553|FG009|Part 1|Progressive disease|0|||
146537968|NCT01288430|528479544|FG000|Part 1|Clinical disease progression|0|||
146537969|NCT01288430|528479545|FG001|Part 1|Clinical disease progression|0|||
146537970|NCT01288430|528479546|FG002|Part 1|Clinical disease progression|1|||
146537971|NCT01288430|528479547|FG003|Part 1|Clinical disease progression|0|||
146626044|NCT02234843|528806174|FG009|Overall Study|Other|0|||
146626045|NCT02234843|528806165|FG000|Overall Study|Physician Decision|4|||
146626046|NCT02234843|528806166|FG001|Overall Study|Physician Decision|1|||
146626047|NCT02234843|528806167|FG002|Overall Study|Physician Decision|0|||
146626048|NCT02234843|528806168|FG003|Overall Study|Physician Decision|1|||
146626049|NCT02234843|528806169|FG004|Overall Study|Physician Decision|0|||
146626050|NCT02234843|528806170|FG005|Overall Study|Physician Decision|0|||
146626051|NCT02234843|528806171|FG006|Overall Study|Physician Decision|0|||
146626052|NCT02234843|528806172|FG007|Overall Study|Physician Decision|1|||
146626053|NCT02234843|528806173|FG008|Overall Study|Physician Decision|0|||
146626054|NCT02234843|528806174|FG009|Overall Study|Physician Decision|0|||
146626055|NCT02234843|528806165|FG000|Overall Study|Adverse Event|5|||
146626056|NCT02234843|528806166|FG001|Overall Study|Adverse Event|1|||
146626057|NCT02234843|528806167|FG002|Overall Study|Adverse Event|1|||
146626058|NCT02234843|528806168|FG003|Overall Study|Adverse Event|3|||
146626059|NCT02234843|528806169|FG004|Overall Study|Adverse Event|2|||
146626060|NCT02234843|528806170|FG005|Overall Study|Adverse Event|1|||
146763895|NCT00567879|529302916|FG003|Overall Study|Withdrawal by Subject|1|||
146537972|NCT01288430|528479548|FG004|Part 1|Clinical disease progression|0|||
146537973|NCT01288430|528479549|FG005|Part 1|Clinical disease progression|2|||
146537974|NCT01288430|528479550|FG006|Part 1|Clinical disease progression|2|||
146537975|NCT01288430|528479551|FG007|Part 1|Clinical disease progression|0|||
146537976|NCT01288430|528479552|FG008|Part 1|Clinical disease progression|0|||
146537977|NCT01288430|528479553|FG009|Part 1|Clinical disease progression|0|||
146537978|NCT01288430|528479544|FG000|Part 1|Death due to disease progression|0|||
146537979|NCT01288430|528479545|FG001|Part 1|Death due to disease progression|0|||
146537980|NCT01288430|528479546|FG002|Part 1|Death due to disease progression|0|||
146537981|NCT01288430|528479547|FG003|Part 1|Death due to disease progression|0|||
146537982|NCT01288430|528479548|FG004|Part 1|Death due to disease progression|1|||
146537983|NCT01288430|528479549|FG005|Part 1|Death due to disease progression|0|||
146537984|NCT01288430|528479550|FG006|Part 1|Death due to disease progression|0|||
146537985|NCT01288430|528479551|FG007|Part 1|Death due to disease progression|0|||
146537986|NCT01288430|528479552|FG008|Part 1|Death due to disease progression|0|||
146537987|NCT01288430|528479553|FG009|Part 1|Death due to disease progression|0|||
146537988|NCT01288430|528479544|FG000|Part 1|Adverse Event|0|||
146537989|NCT01288430|528479545|FG001|Part 1|Adverse Event|0|||
146537990|NCT01288430|528479546|FG002|Part 1|Adverse Event|3|||
146537991|NCT01288430|528479547|FG003|Part 1|Adverse Event|1|||
146537992|NCT01288430|528479548|FG004|Part 1|Adverse Event|0|||
146537993|NCT01288430|528479549|FG005|Part 1|Adverse Event|0|||
146537994|NCT01288430|528479550|FG006|Part 1|Adverse Event|2|||
146537995|NCT01288430|528479551|FG007|Part 1|Adverse Event|0|||
146537996|NCT01288430|528479552|FG008|Part 1|Adverse Event|0|||
146537997|NCT01288430|528479553|FG009|Part 1|Adverse Event|0|||
146537998|NCT01288430|528479544|FG000|Part 1|Other|0|||
146537999|NCT01288430|528479545|FG001|Part 1|Other|2|||
146538000|NCT01288430|528479546|FG002|Part 1|Other|0|||
146538001|NCT01288430|528479547|FG003|Part 1|Other|0|||
146538002|NCT01288430|528479548|FG004|Part 1|Other|0|||
146538003|NCT01288430|528479549|FG005|Part 1|Other|0|||
146538004|NCT01288430|528479550|FG006|Part 1|Other|1|||
146538005|NCT01288430|528479551|FG007|Part 1|Other|0|||
146538006|NCT01288430|528479552|FG008|Part 1|Other|0|||
146538007|NCT01288430|528479553|FG009|Part 1|Other|0|||
146538008|NCT01288430|528479544|FG000|Part 2|Progressive disease|0|||
146538009|NCT01288430|528479545|FG001|Part 2|Progressive disease|0|||
146538010|NCT01288430|528479546|FG002|Part 2|Progressive disease|0|||
146538011|NCT01288430|528479547|FG003|Part 2|Progressive disease|0|||
146538012|NCT01288430|528479548|FG004|Part 2|Progressive disease|0|||
146538013|NCT01288430|528479549|FG005|Part 2|Progressive disease|0|||
146538014|NCT01288430|528479550|FG006|Part 2|Progressive disease|0|||
146538015|NCT01288430|528479551|FG007|Part 2|Progressive disease|8|||
146538016|NCT01288430|528479552|FG008|Part 2|Progressive disease|7|||
146538017|NCT01288430|528479553|FG009|Part 2|Progressive disease|2|||
146538018|NCT01288430|528479544|FG000|Part 2|Clinical disease progression|0|||
146538019|NCT01288430|528479545|FG001|Part 2|Clinical disease progression|0|||
146538020|NCT01288430|528479546|FG002|Part 2|Clinical disease progression|0|||
146538021|NCT01288430|528479547|FG003|Part 2|Clinical disease progression|0|||
146538022|NCT01288430|528479548|FG004|Part 2|Clinical disease progression|0|||
146538023|NCT01288430|528479549|FG005|Part 2|Clinical disease progression|0|||
146538024|NCT01288430|528479550|FG006|Part 2|Clinical disease progression|0|||
146538025|NCT01288430|528479551|FG007|Part 2|Clinical disease progression|2|||
146626061|NCT02234843|528806171|FG006|Overall Study|Adverse Event|0|||
146626062|NCT02234843|528806172|FG007|Overall Study|Adverse Event|0|||
146626063|NCT02234843|528806173|FG008|Overall Study|Adverse Event|1|||
146626064|NCT02234843|528806174|FG009|Overall Study|Adverse Event|0|||
146626065|NCT02234843|528806165|FG000|Overall Study|Non-compliance with study drug|1|||
146626066|NCT02234843|528806166|FG001|Overall Study|Non-compliance with study drug|0|||
146538026|NCT01288430|528479552|FG008|Part 2|Clinical disease progression|0|||
146538027|NCT01288430|528479553|FG009|Part 2|Clinical disease progression|0|||
146538028|NCT01288430|528479544|FG000|Part 2|Withdrawal by Subject|0|||
146538029|NCT01288430|528479545|FG001|Part 2|Withdrawal by Subject|0|||
146538030|NCT01288430|528479546|FG002|Part 2|Withdrawal by Subject|0|||
146538031|NCT01288430|528479547|FG003|Part 2|Withdrawal by Subject|0|||
146538032|NCT01288430|528479548|FG004|Part 2|Withdrawal by Subject|0|||
146538033|NCT01288430|528479549|FG005|Part 2|Withdrawal by Subject|0|||
146538034|NCT01288430|528479550|FG006|Part 2|Withdrawal by Subject|0|||
146538035|NCT01288430|528479551|FG007|Part 2|Withdrawal by Subject|1|||
146538036|NCT01288430|528479552|FG008|Part 2|Withdrawal by Subject|4|||
146538037|NCT01288430|528479553|FG009|Part 2|Withdrawal by Subject|0|||
146538038|NCT01288430|528479544|FG000|Part 2|Adverse Event|0|||
146538039|NCT01288430|528479545|FG001|Part 2|Adverse Event|0|||
146538040|NCT01288430|528479546|FG002|Part 2|Adverse Event|0|||
146538041|NCT01288430|528479547|FG003|Part 2|Adverse Event|0|||
146538042|NCT01288430|528479548|FG004|Part 2|Adverse Event|0|||
146538043|NCT01288430|528479549|FG005|Part 2|Adverse Event|0|||
146538044|NCT01288430|528479550|FG006|Part 2|Adverse Event|0|||
146538045|NCT01288430|528479551|FG007|Part 2|Adverse Event|1|||
146538046|NCT01288430|528479552|FG008|Part 2|Adverse Event|1|||
146538047|NCT01288430|528479553|FG009|Part 2|Adverse Event|0|||
146538048|NCT01288430|528479544|FG000|Part 2|Other|0|||
146538049|NCT01288430|528479545|FG001|Part 2|Other|0|||
146538050|NCT01288430|528479546|FG002|Part 2|Other|0|||
146538051|NCT01288430|528479547|FG003|Part 2|Other|0|||
146538052|NCT01288430|528479548|FG004|Part 2|Other|0|||
146538053|NCT01288430|528479549|FG005|Part 2|Other|0|||
146538054|NCT01288430|528479550|FG006|Part 2|Other|0|||
146538055|NCT01288430|528479551|FG007|Part 2|Other|0|||
146538056|NCT01288430|528479552|FG008|Part 2|Other|0|||
146538057|NCT01288430|528479553|FG009|Part 2|Other|1|||
146538058|NCT06125964|528479554|FG000|Overall Study|Lost to Follow-up|0|||
146538059|NCT06125964|528479555|FG001|Overall Study|Lost to Follow-up|1|||
146538060|NCT06125964|528479556|FG002|Overall Study|Lost to Follow-up|0|||
146538061|NCT06125964|528479557|FG003|Overall Study|Lost to Follow-up|0|||
146538062|NCT03405870|528479558|FG000|Overall Study|Withdrawal|1|||
146538063|NCT03405870|528479559|FG001|Overall Study|Withdrawal|0|||
146538064|NCT03405870|528479560|FG002|Overall Study|Withdrawal|1|||
146538065|NCT03405870|528479561|FG003|Overall Study|Withdrawal|0|||
146538066|NCT03405870|528479562|FG004|Overall Study|Withdrawal|0|||
146538067|NCT03405870|528479563|FG005|Overall Study|Withdrawal|0|||
146538068|NCT03405870|528479564|FG006|Overall Study|Withdrawal|1|||
146538069|NCT03405870|528479565|FG007|Overall Study|Withdrawal|0|||
146538070|NCT05172609|528479566|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
146538071|NCT05172609|528479567|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
146538072|NCT05172609|528479566|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
146538073|NCT05172609|528479567|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
146538074|NCT05172609|528479566|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
146538075|NCT05172609|528479567|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
146538076|NCT03737994|528479568|FG000|Overall Study|Withdrawal by Subject|0|||
146538077|NCT03737994|528479569|FG001|Overall Study|Withdrawal by Subject|0|||
146538078|NCT03737994|528479570|FG002|Overall Study|Withdrawal by Subject|0|||
146538079|NCT03737994|528479571|FG003|Overall Study|Withdrawal by Subject|0|||
146538080|NCT03737994|528479572|FG004|Overall Study|Withdrawal by Subject|0|||
146538081|NCT03737994|528479573|FG005|Overall Study|Withdrawal by Subject|0|||
146538082|NCT03737994|528479574|FG006|Overall Study|Withdrawal by Subject|1|||
146538083|NCT00300053|528479589|FG000|Overall Study|Patient/Caregiver Preference|2|||
146538084|NCT00300053|528479590|FG001|Overall Study|Patient/Caregiver Preference|2|||
146538085|NCT00300053|528479591|FG002|Overall Study|Patient/Caregiver Preference|3|||
146538086|NCT00300053|528479589|FG000|Overall Study|Death|0|||
146538087|NCT00300053|528479590|FG001|Overall Study|Death|0|||
146538088|NCT00300053|528479591|FG002|Overall Study|Death|3|||
146538089|NCT00300053|528479589|FG000|Overall Study|Lost to Follow-up|0|||
146538090|NCT00300053|528479590|FG001|Overall Study|Lost to Follow-up|1|||
146538091|NCT00300053|528479591|FG002|Overall Study|Lost to Follow-up|0|||
146538092|NCT01963611|528479592|FG000|Overall Study|Adverse Event|1|||
146538093|NCT01963611|528479593|FG001|Overall Study|Adverse Event|1|||
146538094|NCT01963611|528479594|FG002|Overall Study|Adverse Event|3|||
146538095|NCT01963611|528479595|FG003|Overall Study|Adverse Event|4|||
146538096|NCT01963611|528479596|FG004|Overall Study|Adverse Event|3|||
146538097|NCT01963611|528479592|FG000|Overall Study|Protocol Violation|0|||
146538098|NCT01963611|528479593|FG001|Overall Study|Protocol Violation|0|||
146538099|NCT01963611|528479594|FG002|Overall Study|Protocol Violation|0|||
146538100|NCT01963611|528479595|FG003|Overall Study|Protocol Violation|1|||
146538101|NCT01963611|528479596|FG004|Overall Study|Protocol Violation|0|||
146538102|NCT01963611|528479592|FG000|Overall Study|Lack of Efficacy|0|||
146538103|NCT01963611|528479593|FG001|Overall Study|Lack of Efficacy|0|||
146538104|NCT01963611|528479594|FG002|Overall Study|Lack of Efficacy|0|||
146538105|NCT01963611|528479595|FG003|Overall Study|Lack of Efficacy|1|||
146538106|NCT01963611|528479596|FG004|Overall Study|Lack of Efficacy|0|||
146538107|NCT01963611|528479592|FG000|Overall Study|Withdrawal by Subject|3|||
146538108|NCT01963611|528479593|FG001|Overall Study|Withdrawal by Subject|2|||
146538109|NCT01963611|528479594|FG002|Overall Study|Withdrawal by Subject|1|||
146538110|NCT01963611|528479595|FG003|Overall Study|Withdrawal by Subject|1|||
146871214|NCT00529451|529699841|FG003|Overall Study|Administrative problems|2|||
146871215|NCT00773136|529699842|FG000|Overall Study|Physician Decision|2|||
146871216|NCT02463071|529699845|FG000|Overall Study|Adverse Event|3|||
146871217|NCT02463071|529699846|FG001|Overall Study|Adverse Event|5|||
146871218|NCT02463071|529699847|FG002|Overall Study|Adverse Event|1|||
146871219|NCT02463071|529699845|FG000|Overall Study|Death|1|||
146871220|NCT02463071|529699846|FG001|Overall Study|Death|0|||
146871221|NCT02463071|529699847|FG002|Overall Study|Death|0|||
146871222|NCT02463071|529699845|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
146871223|NCT02463071|529699846|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146871224|NCT02463071|529699847|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
146871225|NCT02463071|529699845|FG000|Overall Study|Reason not specified|7|||
146871226|NCT02463071|529699846|FG001|Overall Study|Reason not specified|9|||
146871227|NCT02463071|529699847|FG002|Overall Study|Reason not specified|4|||
146871228|NCT02463071|529699845|FG000|Overall Study|Protocol Violation|0|||
146871229|NCT02463071|529699846|FG001|Overall Study|Protocol Violation|2|||
146626067|NCT02234843|528806167|FG002|Overall Study|Non-compliance with study drug|0|||
146626068|NCT02234843|528806168|FG003|Overall Study|Non-compliance with study drug|0|||
146871230|NCT02463071|529699847|FG002|Overall Study|Protocol Violation|0|||
146871231|NCT02463071|529699845|FG000|Overall Study|Lost to Follow-up|0|||
146871232|NCT02463071|529699846|FG001|Overall Study|Lost to Follow-up|0|||
146871233|NCT02463071|529699847|FG002|Overall Study|Lost to Follow-up|1|||
146871234|NCT01009034|529699848|FG000|Overall Study|Lost to Follow-up|2|||
146871235|NCT01009034|529699848|FG000|Overall Study|Withdrawal by Subject|2|||
146871236|NCT01494350|529699849|FG000|Overall Study|Worsening of lesion|1|||
146871237|NCT00199836|529699851|FG000|Overall Study|Progressive Disease|5|||
146871238|NCT00199836|529699851|FG000|Overall Study|Death|1|||
146871239|NCT03098836|529699857|FG000|Overall Study|Adverse Event|1|||
146871240|NCT03098836|529699858|FG001|Overall Study|Adverse Event|3|||
146871241|NCT03098836|529699857|FG000|Overall Study|Lack of Efficacy|30|||
146626069|NCT02234843|528806169|FG004|Overall Study|Non-compliance with study drug|0|||
146626070|NCT02234843|528806170|FG005|Overall Study|Non-compliance with study drug|1|||
146626071|NCT02234843|528806171|FG006|Overall Study|Non-compliance with study drug|1|||
146626072|NCT02234843|528806172|FG007|Overall Study|Non-compliance with study drug|0|||
146626073|NCT02234843|528806173|FG008|Overall Study|Non-compliance with study drug|0|||
146626074|NCT02234843|528806174|FG009|Overall Study|Non-compliance with study drug|0|||
146626075|NCT02234843|528806165|FG000|Overall Study|Lost to Follow-up|0|||
146626076|NCT02234843|528806166|FG001|Overall Study|Lost to Follow-up|1|||
146626077|NCT02234843|528806167|FG002|Overall Study|Lost to Follow-up|0|||
146871242|NCT03098836|529699858|FG001|Overall Study|Lack of Efficacy|15|||
146871243|NCT03098836|529699857|FG000|Overall Study|Physician Decision|2|||
146871244|NCT03098836|529699858|FG001|Overall Study|Physician Decision|1|||
146871245|NCT03098836|529699857|FG000|Overall Study|Withdrawal by Subject|3|||
146871246|NCT03098836|529699858|FG001|Overall Study|Withdrawal by Subject|2|||
146871247|NCT03986866|529699859|FG000|Overall Study|Withdrawal by Subject|0|||
146871248|NCT03986866|529699860|FG001|Overall Study|Withdrawal by Subject|3|||
146871249|NCT03986866|529699859|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
146871250|NCT03986866|529699860|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
146871251|NCT00898443|529699861|FG000|Overall Study|Withdrawal by Subject|1|||
146538111|NCT01963611|528479596|FG004|Overall Study|Withdrawal by Subject|3|||
146538112|NCT01963611|528479592|FG000|Overall Study|Other|47|||
146538113|NCT01963611|528479593|FG001|Overall Study|Other|46|||
146538114|NCT01963611|528479594|FG002|Overall Study|Other|48|||
146538115|NCT01963611|528479595|FG003|Overall Study|Other|45|||
146538116|NCT01963611|528479596|FG004|Overall Study|Other|45|||
146538117|NCT03801252|528479597|FG000|Overall Study|Protocol Violation|1|||
146538118|NCT03801252|528479598|FG001|Overall Study|Protocol Violation|2|||
146538119|NCT02471183|528479599|FG000|Main Treatment Period|Adverse Event|1|||
146538120|NCT02471183|528479599|FG000|Main Treatment Period|Withdrawal by Subject|1|||
146626078|NCT02234843|528806168|FG003|Overall Study|Lost to Follow-up|0|||
146626079|NCT02234843|528806169|FG004|Overall Study|Lost to Follow-up|0|||
146871252|NCT00898443|529699862|FG001|Overall Study|Withdrawal by Subject|0|||
146871253|NCT00617604|529699864|FG000|Overall Study|Death|2|||
146871254|NCT00617604|529699865|FG001|Overall Study|Death|1|||
146538121|NCT02471183|528479599|FG000|Extended Treatment Period|Lack of Efficacy|1|||
146626080|NCT02234843|528806170|FG005|Overall Study|Lost to Follow-up|0|||
146626081|NCT02234843|528806171|FG006|Overall Study|Lost to Follow-up|1|||
146871255|NCT00617604|529699864|FG000|Overall Study|Lost to Follow-up|1|||
146871256|NCT00617604|529699865|FG001|Overall Study|Lost to Follow-up|0|||
146871257|NCT00617604|529699864|FG000|Overall Study|Miscellaneous Reasons|8|||
146871258|NCT00617604|529699865|FG001|Overall Study|Miscellaneous Reasons|10|||
146871259|NCT00617604|529699864|FG000|Overall Study|Withdrawal by Subject|4|||
146538122|NCT02328105|528479603|FG000|Overall Study|Death|6|||
146871260|NCT00617604|529699865|FG001|Overall Study|Withdrawal by Subject|6|||
146538123|NCT02328105|528479603|FG000|Overall Study|Withdrawal by Subject|1|||
146538124|NCT02328105|528479603|FG000|Overall Study|Still On Study in Follow-Up|4|||
146538125|NCT00614393|528479604|FG000|Overall Study|Adverse Event|20|||
146538126|NCT00614393|528479605|FG001|Overall Study|Adverse Event|2|||
146538127|NCT00614393|528479606|FG002|Overall Study|Adverse Event|3|||
146538128|NCT00614393|528479607|FG003|Overall Study|Adverse Event|13|||
146538129|NCT00614393|528479608|FG004|Overall Study|Adverse Event|21|||
146538130|NCT00614393|528479604|FG000|Overall Study|Lost to Follow-up|0|||
146538131|NCT00614393|528479605|FG001|Overall Study|Lost to Follow-up|0|||
146538132|NCT00614393|528479606|FG002|Overall Study|Lost to Follow-up|0|||
146538133|NCT00614393|528479607|FG003|Overall Study|Lost to Follow-up|1|||
146538134|NCT00614393|528479608|FG004|Overall Study|Lost to Follow-up|2|||
146538135|NCT00614393|528479604|FG000|Overall Study|Physician Decision|17|||
146538136|NCT00614393|528479605|FG001|Overall Study|Physician Decision|0|||
146538137|NCT00614393|528479606|FG002|Overall Study|Physician Decision|1|||
146538138|NCT00614393|528479607|FG003|Overall Study|Physician Decision|8|||
146538139|NCT00614393|528479608|FG004|Overall Study|Physician Decision|9|||
146538140|NCT00614393|528479604|FG000|Overall Study|Progressive Disease|118|||
146538141|NCT00614393|528479605|FG001|Overall Study|Progressive Disease|5|||
146538142|NCT00614393|528479606|FG002|Overall Study|Progressive Disease|5|||
146538143|NCT00614393|528479607|FG003|Overall Study|Progressive Disease|138|||
146538144|NCT00614393|528479608|FG004|Overall Study|Progressive Disease|130|||
146538145|NCT00614393|528479604|FG000|Overall Study|Protocol Violation|1|||
146538146|NCT00614393|528479605|FG001|Overall Study|Protocol Violation|0|||
146538147|NCT00614393|528479606|FG002|Overall Study|Protocol Violation|0|||
146538148|NCT00614393|528479607|FG003|Overall Study|Protocol Violation|0|||
146538149|NCT00614393|528479608|FG004|Overall Study|Protocol Violation|0|||
146538150|NCT00614393|528479604|FG000|Overall Study|Terminated by Sponsor|0|||
146538151|NCT00614393|528479605|FG001|Overall Study|Terminated by Sponsor|0|||
146538152|NCT00614393|528479606|FG002|Overall Study|Terminated by Sponsor|0|||
146538153|NCT00614393|528479607|FG003|Overall Study|Terminated by Sponsor|0|||
146538154|NCT00614393|528479608|FG004|Overall Study|Terminated by Sponsor|1|||
146538155|NCT00614393|528479604|FG000|Overall Study|Withdrawal by Subject|20|||
146538156|NCT00614393|528479605|FG001|Overall Study|Withdrawal by Subject|1|||
146538157|NCT00614393|528479606|FG002|Overall Study|Withdrawal by Subject|1|||
146538158|NCT00614393|528479607|FG003|Overall Study|Withdrawal by Subject|16|||
146538159|NCT00614393|528479608|FG004|Overall Study|Withdrawal by Subject|13|||
146538160|NCT00614393|528479604|FG000|Overall Study|Other|4|||
146538161|NCT00614393|528479605|FG001|Overall Study|Other|0|||
146538162|NCT00614393|528479606|FG002|Overall Study|Other|0|||
146538163|NCT00614393|528479607|FG003|Overall Study|Other|4|||
146538164|NCT00614393|528479608|FG004|Overall Study|Other|2|||
146538165|NCT00614393|528479604|FG000|Overall Study|Not Treated|0|||
146538166|NCT00614393|528479605|FG001|Overall Study|Not Treated|0|||
146538167|NCT00614393|528479606|FG002|Overall Study|Not Treated|0|||
146538168|NCT00614393|528479607|FG003|Overall Study|Not Treated|0|||
146538169|NCT00614393|528479608|FG004|Overall Study|Not Treated|2|||
146538170|NCT00855582|528479612|FG000|Overall Study|Adverse Event|2|||
146538171|NCT00855582|528479613|FG001|Overall Study|Adverse Event|6|||
146538172|NCT00855582|528479614|FG002|Overall Study|Adverse Event|3|||
146538173|NCT00855582|528479612|FG000|Overall Study|Death|1|||
146538174|NCT00855582|528479613|FG001|Overall Study|Death|0|||
146538175|NCT00855582|528479614|FG002|Overall Study|Death|0|||
146538176|NCT00855582|528479612|FG000|Overall Study|Lack of Efficacy|1|||
146538177|NCT00855582|528479613|FG001|Overall Study|Lack of Efficacy|3|||
146538178|NCT00855582|528479614|FG002|Overall Study|Lack of Efficacy|8|||
146538179|NCT00855582|528479612|FG000|Overall Study|Lost to Follow-up|1|||
146538180|NCT00855582|528479613|FG001|Overall Study|Lost to Follow-up|3|||
146538181|NCT00855582|528479614|FG002|Overall Study|Lost to Follow-up|1|||
146538182|NCT00855582|528479612|FG000|Overall Study|Physician Decision|0|||
146538183|NCT00855582|528479613|FG001|Overall Study|Physician Decision|0|||
146538184|NCT00855582|528479614|FG002|Overall Study|Physician Decision|1|||
146538185|NCT00855582|528479612|FG000|Overall Study|Protocol Violation|6|||
146538186|NCT00855582|528479613|FG001|Overall Study|Protocol Violation|2|||
146538187|NCT00855582|528479614|FG002|Overall Study|Protocol Violation|6|||
146538188|NCT00855582|528479612|FG000|Overall Study|Entry Criteria Not Met|8|||
146538189|NCT00855582|528479613|FG001|Overall Study|Entry Criteria Not Met|6|||
146538190|NCT00855582|528479614|FG002|Overall Study|Entry Criteria Not Met|3|||
146538191|NCT00855582|528479612|FG000|Overall Study|Withdrawal by Subject|7|||
146538192|NCT00855582|528479613|FG001|Overall Study|Withdrawal by Subject|4|||
146538193|NCT00855582|528479614|FG002|Overall Study|Withdrawal by Subject|8|||
146538194|NCT03286504|528479620|FG000|Overall Study|Lost to Follow-up|19|||
146538195|NCT03286504|528479621|FG001|Overall Study|Lost to Follow-up|16|||
146538196|NCT00851591|528479628|FG000|Overall Study|Withdrawal by Subject|2|||
146538197|NCT00851591|528479629|FG001|Overall Study|Withdrawal by Subject|0|||
146538198|NCT00634504|528479630|FG000|Overall Study|Protocol Violation|1|||
146538199|NCT00634504|528479631|FG001|Overall Study|Protocol Violation|0|||
146538200|NCT02110693|528479632|FG000|Overall Study|Withdrawal by Subject|6|||
146538201|NCT02110693|528479633|FG001|Overall Study|Withdrawal by Subject|7|||
146538202|NCT02110693|528479632|FG000|Overall Study|skipped assessment|15|||
146626082|NCT02234843|528806172|FG007|Overall Study|Lost to Follow-up|0|||
146626083|NCT02234843|528806173|FG008|Overall Study|Lost to Follow-up|0|||
146626084|NCT02234843|528806174|FG009|Overall Study|Lost to Follow-up|0|||
146626085|NCT00506350|528806177|FG000|Overall Study|Serious Adverse Event|1|||
146626086|NCT00506350|528806178|FG001|Overall Study|Serious Adverse Event|0|||
146626087|NCT00506350|528806179|FG002|Overall Study|Serious Adverse Event|0|||
146626088|NCT00506350|528806180|FG003|Overall Study|Serious Adverse Event|0|||
146626089|NCT00506350|528806181|FG004|Overall Study|Serious Adverse Event|0|||
146626090|NCT00506350|528806182|FG005|Overall Study|Serious Adverse Event|0|||
146626091|NCT00506350|528806183|FG006|Overall Study|Serious Adverse Event|0|||
146626092|NCT00506350|528806184|FG007|Overall Study|Serious Adverse Event|0|||
146626093|NCT00506350|528806185|FG008|Overall Study|Serious Adverse Event|0|||
146626094|NCT00506350|528806177|FG000|Overall Study|Adverse Event|0|||
146626095|NCT00506350|528806178|FG001|Overall Study|Adverse Event|0|||
146626096|NCT00506350|528806179|FG002|Overall Study|Adverse Event|0|||
146538203|NCT02110693|528479633|FG001|Overall Study|skipped assessment|18|||
146538204|NCT02110693|528479632|FG000|Overall Study|technical difficulties|6|||
146538205|NCT02110693|528479633|FG001|Overall Study|technical difficulties|4|||
146538206|NCT02110693|528479632|FG000|Overall Study|Other|1|||
146538207|NCT02110693|528479633|FG001|Overall Study|Other|0|||
146538208|NCT02765165|528479641|FG000|Treatment Period|Progressive disease|3|||
146538209|NCT02765165|528479642|FG001|Treatment Period|Progressive disease|2|||
146538210|NCT02765165|528479643|FG002|Treatment Period|Progressive disease|3|||
146538211|NCT02765165|528479644|FG003|Treatment Period|Progressive disease|3|||
146538212|NCT02765165|528479645|FG004|Treatment Period|Progressive disease|4|||
146538213|NCT02765165|528479646|FG005|Treatment Period|Progressive disease|2|||
146538214|NCT02765165|528479647|FG006|Treatment Period|Progressive disease|2|||
146538215|NCT02765165|528479641|FG000|Treatment Period|Physician Decision|0|||
146538216|NCT02765165|528479642|FG001|Treatment Period|Physician Decision|1|||
146538217|NCT02765165|528479643|FG002|Treatment Period|Physician Decision|0|||
146538218|NCT02765165|528479644|FG003|Treatment Period|Physician Decision|0|||
146538219|NCT02765165|528479645|FG004|Treatment Period|Physician Decision|0|||
146538220|NCT02765165|528479646|FG005|Treatment Period|Physician Decision|0|||
146538221|NCT02765165|528479647|FG006|Treatment Period|Physician Decision|0|||
146538222|NCT02765165|528479641|FG000|Treatment Period|Adverse Event|0|||
146538223|NCT02765165|528479642|FG001|Treatment Period|Adverse Event|1|||
146538224|NCT02765165|528479643|FG002|Treatment Period|Adverse Event|0|||
146538225|NCT02765165|528479644|FG003|Treatment Period|Adverse Event|0|||
146538226|NCT02765165|528479645|FG004|Treatment Period|Adverse Event|0|||
146538227|NCT02765165|528479646|FG005|Treatment Period|Adverse Event|0|||
146538228|NCT02765165|528479647|FG006|Treatment Period|Adverse Event|0|||
146538229|NCT02765165|528479641|FG000|Treatment Period|Withdrawal by Subject|0|||
146538230|NCT02765165|528479642|FG001|Treatment Period|Withdrawal by Subject|0|||
146538231|NCT02765165|528479643|FG002|Treatment Period|Withdrawal by Subject|0|||
146538232|NCT02765165|528479644|FG003|Treatment Period|Withdrawal by Subject|0|||
146538233|NCT02765165|528479645|FG004|Treatment Period|Withdrawal by Subject|2|||
146538234|NCT02765165|528479646|FG005|Treatment Period|Withdrawal by Subject|0|||
146538235|NCT02765165|528479647|FG006|Treatment Period|Withdrawal by Subject|0|||
146538236|NCT02765165|528479641|FG000|Treatment Period|Study terminated|0|||
146538237|NCT02765165|528479642|FG001|Treatment Period|Study terminated|0|||
146538238|NCT02765165|528479643|FG002|Treatment Period|Study terminated|0|||
146538239|NCT02765165|528479644|FG003|Treatment Period|Study terminated|0|||
146538240|NCT02765165|528479645|FG004|Treatment Period|Study terminated|0|||
146538241|NCT02765165|528479646|FG005|Treatment Period|Study terminated|1|||
146538242|NCT02765165|528479647|FG006|Treatment Period|Study terminated|2|||
146538243|NCT02765165|528479641|FG000|Post-treatment Follow-up|Death|1|||
146538244|NCT02765165|528479642|FG001|Post-treatment Follow-up|Death|2|||
146538245|NCT02765165|528479643|FG002|Post-treatment Follow-up|Death|1|||
146538246|NCT02765165|528479644|FG003|Post-treatment Follow-up|Death|1|||
146538247|NCT02765165|528479645|FG004|Post-treatment Follow-up|Death|1|||
146538248|NCT02765165|528479646|FG005|Post-treatment Follow-up|Death|1|||
146538249|NCT02765165|528479647|FG006|Post-treatment Follow-up|Death|0|||
146538250|NCT02765165|528479641|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
146626097|NCT00506350|528806180|FG003|Overall Study|Adverse Event|0|||
146626098|NCT00506350|528806181|FG004|Overall Study|Adverse Event|0|||
146965615|NCT04242446|530035195|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146538251|NCT02765165|528479642|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
146538252|NCT02765165|528479643|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
146538253|NCT02765165|528479644|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
146538254|NCT02765165|528479645|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
146538255|NCT02765165|528479646|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
146538256|NCT02765165|528479647|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
146626099|NCT00506350|528806182|FG005|Overall Study|Adverse Event|0|||
146626100|NCT00506350|528806183|FG006|Overall Study|Adverse Event|0|||
146626101|NCT00506350|528806184|FG007|Overall Study|Adverse Event|1|||
146626102|NCT00506350|528806185|FG008|Overall Study|Adverse Event|1|||
146538257|NCT02765165|528479641|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
146538258|NCT02765165|528479642|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
146538259|NCT02765165|528479643|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
146538260|NCT02765165|528479644|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
146538261|NCT02765165|528479645|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
146538262|NCT02765165|528479646|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
146538263|NCT02765165|528479647|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
146538264|NCT02765165|528479641|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
146538265|NCT02765165|528479642|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
146538266|NCT02765165|528479643|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
146538267|NCT02765165|528479644|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
146538268|NCT02765165|528479645|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
146538269|NCT02765165|528479646|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
146538270|NCT02765165|528479647|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
146538271|NCT02765165|528479641|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
146538272|NCT02765165|528479642|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
146626103|NCT00506350|528806177|FG000|Overall Study|Protocol Violation|0|||
146626104|NCT00506350|528806178|FG001|Overall Study|Protocol Violation|0|||
146626105|NCT00506350|528806179|FG002|Overall Study|Protocol Violation|1|||
146626106|NCT00506350|528806180|FG003|Overall Study|Protocol Violation|0|||
146626107|NCT00506350|528806181|FG004|Overall Study|Protocol Violation|0|||
146626108|NCT00506350|528806182|FG005|Overall Study|Protocol Violation|0|||
146626109|NCT00506350|528806183|FG006|Overall Study|Protocol Violation|1|||
146626110|NCT00506350|528806184|FG007|Overall Study|Protocol Violation|0|||
146626111|NCT00506350|528806185|FG008|Overall Study|Protocol Violation|0|||
146626112|NCT00506350|528806177|FG000|Overall Study|Withdrawal by Subject|0|||
146626113|NCT00506350|528806178|FG001|Overall Study|Withdrawal by Subject|1|||
146626114|NCT00506350|528806179|FG002|Overall Study|Withdrawal by Subject|1|||
146626115|NCT00506350|528806180|FG003|Overall Study|Withdrawal by Subject|1|||
146626116|NCT00506350|528806181|FG004|Overall Study|Withdrawal by Subject|4|||
146626117|NCT00506350|528806182|FG005|Overall Study|Withdrawal by Subject|1|||
146626118|NCT00506350|528806183|FG006|Overall Study|Withdrawal by Subject|1|||
146626119|NCT00506350|528806184|FG007|Overall Study|Withdrawal by Subject|2|||
146626120|NCT00506350|528806185|FG008|Overall Study|Withdrawal by Subject|0|||
146626121|NCT00506350|528806177|FG000|Overall Study|Lost to Follow-up|1|||
146626122|NCT00506350|528806178|FG001|Overall Study|Lost to Follow-up|1|||
146626123|NCT00506350|528806179|FG002|Overall Study|Lost to Follow-up|1|||
146626124|NCT00506350|528806180|FG003|Overall Study|Lost to Follow-up|1|||
146626125|NCT00506350|528806181|FG004|Overall Study|Lost to Follow-up|2|||
146626126|NCT00506350|528806182|FG005|Overall Study|Lost to Follow-up|1|||
146626127|NCT00506350|528806183|FG006|Overall Study|Lost to Follow-up|0|||
146626128|NCT00506350|528806184|FG007|Overall Study|Lost to Follow-up|0|||
146626129|NCT00506350|528806185|FG008|Overall Study|Lost to Follow-up|2|||
146626130|NCT00506350|528806177|FG000|Overall Study|Medical Reason|0|||
146626131|NCT00506350|528806178|FG001|Overall Study|Medical Reason|0|||
146626132|NCT00506350|528806179|FG002|Overall Study|Medical Reason|0|||
146626133|NCT00506350|528806180|FG003|Overall Study|Medical Reason|0|||
146626134|NCT00506350|528806181|FG004|Overall Study|Medical Reason|1|||
146626135|NCT00506350|528806182|FG005|Overall Study|Medical Reason|0|||
146626136|NCT00506350|528806183|FG006|Overall Study|Medical Reason|0|||
146626137|NCT00506350|528806184|FG007|Overall Study|Medical Reason|0|||
146626138|NCT00506350|528806185|FG008|Overall Study|Medical Reason|0|||
146626139|NCT00506350|528806177|FG000|Overall Study|Other|1|||
146626140|NCT00506350|528806178|FG001|Overall Study|Other|1|||
146626141|NCT00506350|528806179|FG002|Overall Study|Other|3|||
146626142|NCT00506350|528806180|FG003|Overall Study|Other|0|||
146626143|NCT00506350|528806181|FG004|Overall Study|Other|3|||
146626144|NCT00506350|528806182|FG005|Overall Study|Other|0|||
146626145|NCT00506350|528806183|FG006|Overall Study|Other|0|||
146626146|NCT00506350|528806184|FG007|Overall Study|Other|2|||
146871261|NCT00617604|529699864|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
146626147|NCT00506350|528806185|FG008|Overall Study|Other|2|||
146626148|NCT03474588|528806186|FG000|Overall Study|Withdrawal by Subject|4|||
146626149|NCT03474588|528806187|FG001|Overall Study|Withdrawal by Subject|3|||
146626150|NCT03474588|528806186|FG000|Overall Study|Death|0|||
146626151|NCT03474588|528806187|FG001|Overall Study|Death|1|||
146626152|NCT01691794|528806189|FG000|Overall Study|Poor/Non-Compliance|1|||
146626153|NCT01691794|528806190|FG001|Overall Study|Poor/Non-Compliance|4|||
146626154|NCT01691794|528806191|FG002|Overall Study|Poor/Non-Compliance|1|||
146626155|NCT01691794|528806189|FG000|Overall Study|Death|0|||
146626156|NCT01691794|528806190|FG001|Overall Study|Death|0|||
146626157|NCT01691794|528806191|FG002|Overall Study|Death|1|||
146626158|NCT01691794|528806189|FG000|Overall Study|Lack of Efficacy|0|||
146626159|NCT01691794|528806190|FG001|Overall Study|Lack of Efficacy|7|||
146626160|NCT01691794|528806191|FG002|Overall Study|Lack of Efficacy|1|||
146626161|NCT01691794|528806189|FG000|Overall Study|Participant request to discontinue|0|||
146626162|NCT01691794|528806190|FG001|Overall Study|Participant request to discontinue|1|||
146626163|NCT01691794|528806191|FG002|Overall Study|Participant request to discontinue|0|||
146538273|NCT02765165|528479643|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
146538274|NCT02765165|528479644|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
146538275|NCT02765165|528479645|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
146538276|NCT02765165|528479646|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
146538277|NCT02765165|528479647|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
146538278|NCT02765165|528479641|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
146538279|NCT02765165|528479642|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
146538280|NCT02765165|528479643|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
146538281|NCT02765165|528479644|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
146538282|NCT02765165|528479645|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
146538283|NCT02765165|528479646|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
146538284|NCT02765165|528479647|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
146626164|NCT01691794|528806189|FG000|Overall Study|Adverse Event|0|||
146538285|NCT01186770|528479648|FG000|Overall Study|Ineligibility|0|||
146538286|NCT01186770|528479649|FG001|Overall Study|Ineligibility|0|||
146538287|NCT01186770|528479650|FG002|Overall Study|Ineligibility|2|||
146538288|NCT01186770|528479651|FG003|Overall Study|Ineligibility|0|||
146538289|NCT01186770|528479648|FG000|Overall Study|Protocol Violation|7|||
146538290|NCT01186770|528479649|FG001|Overall Study|Protocol Violation|9|||
146538291|NCT01186770|528479650|FG002|Overall Study|Protocol Violation|12|||
146538292|NCT01186770|528479651|FG003|Overall Study|Protocol Violation|14|||
146538293|NCT01186770|528479648|FG000|Overall Study|Adverse Event|2|||
146538294|NCT01186770|528479649|FG001|Overall Study|Adverse Event|9|||
146538295|NCT01186770|528479650|FG002|Overall Study|Adverse Event|7|||
146538296|NCT01186770|528479651|FG003|Overall Study|Adverse Event|9|||
146538297|NCT01186770|528479648|FG000|Overall Study|Withdrawal by Subject|15|||
146538298|NCT01186770|528479649|FG001|Overall Study|Withdrawal by Subject|13|||
146538299|NCT01186770|528479650|FG002|Overall Study|Withdrawal by Subject|11|||
146538300|NCT01186770|528479651|FG003|Overall Study|Withdrawal by Subject|17|||
146538301|NCT01186770|528479648|FG000|Overall Study|Lost to Follow-up|10|||
146538302|NCT01186770|528479649|FG001|Overall Study|Lost to Follow-up|6|||
146538303|NCT01186770|528479650|FG002|Overall Study|Lost to Follow-up|14|||
146538304|NCT01186770|528479651|FG003|Overall Study|Lost to Follow-up|9|||
146538305|NCT01186770|528479648|FG000|Overall Study|Insufficient response to treatment|7|||
146538306|NCT01186770|528479649|FG001|Overall Study|Insufficient response to treatment|8|||
146538307|NCT01186770|528479650|FG002|Overall Study|Insufficient response to treatment|5|||
146538308|NCT01186770|528479651|FG003|Overall Study|Insufficient response to treatment|7|||
146538309|NCT01186770|528479648|FG000|Overall Study|Other than specified|0|||
146538310|NCT01186770|528479649|FG001|Overall Study|Other than specified|1|||
146538311|NCT01186770|528479650|FG002|Overall Study|Other than specified|1|||
146538312|NCT01186770|528479651|FG003|Overall Study|Other than specified|2|||
146538313|NCT00410163|528479654|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
146538314|NCT00410163|528479655|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
146538315|NCT00410163|528479654|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
146538316|NCT00410163|528479655|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
146538317|NCT00410163|528479654|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
146538318|NCT00410163|528479655|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
146538319|NCT00410163|528479654|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
146538320|NCT00410163|528479655|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
146538321|NCT00410163|528479654|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
146538322|NCT00410163|528479655|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
146538323|NCT00410163|528479654|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
146538324|NCT00410163|528479655|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
146538325|NCT00410163|528479654|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
146538326|NCT00410163|528479655|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
146538327|NCT00410163|528479654|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
146538328|NCT00410163|528479655|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
146538329|NCT00410163|528479654|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
146538330|NCT00410163|528479655|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
146538331|NCT00410163|528479654|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
146538332|NCT00410163|528479655|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
146538333|NCT00410163|528479654|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
146538334|NCT00410163|528479655|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
146626165|NCT01691794|528806190|FG001|Overall Study|Adverse Event|1|||
146626166|NCT01691794|528806191|FG002|Overall Study|Adverse Event|1|||
146538335|NCT00410163|528479654|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
146538336|NCT00410163|528479655|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
146538337|NCT00410163|528479654|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
146626167|NCT01691794|528806189|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
146626168|NCT01691794|528806190|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
146626169|NCT01691794|528806191|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
146626170|NCT01691794|528806189|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
146626171|NCT01691794|528806190|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
146626172|NCT01691794|528806191|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
146626173|NCT00844844|528806194|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
146626174|NCT00844844|528806194|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
146626175|NCT00844844|528806194|FG000|Extension Treatment Period|Adverse Event|2|||
146626176|NCT00844844|528806194|FG000|Post Treatment Period|Withdrawal by Subject|1|||
146626177|NCT00945009|528806195|FG000|Overall Study|Lack of Efficacy|10|||
146626178|NCT00945009|528806196|FG001|Overall Study|Lack of Efficacy|0|||
146626179|NCT00945009|528806197|FG002|Overall Study|Lack of Efficacy|0|||
146626180|NCT00945009|528806195|FG000|Overall Study|Physician Decision|21|||
146626181|NCT00945009|528806196|FG001|Overall Study|Physician Decision|4|||
146626182|NCT00945009|528806197|FG002|Overall Study|Physician Decision|3|||
146626183|NCT00945009|528806195|FG000|Overall Study|Protocol Violation|6|||
146626184|NCT00945009|528806196|FG001|Overall Study|Protocol Violation|1|||
146626185|NCT00945009|528806197|FG002|Overall Study|Protocol Violation|0|||
146626186|NCT00945009|528806195|FG000|Overall Study|Withdrawal by Subject|1|||
146626187|NCT00945009|528806196|FG001|Overall Study|Withdrawal by Subject|0|||
146626188|NCT00945009|528806197|FG002|Overall Study|Withdrawal by Subject|0|||
146626189|NCT00945009|528806195|FG000|Overall Study|Ineligible|6|||
146626190|NCT00945009|528806196|FG001|Overall Study|Ineligible|1|||
146626191|NCT00945009|528806197|FG002|Overall Study|Ineligible|0|||
146626192|NCT00945009|528806195|FG000|Overall Study|Inevaluable|0|||
146626193|NCT00945009|528806196|FG001|Overall Study|Inevaluable|1|||
146626194|NCT00945009|528806197|FG002|Overall Study|Inevaluable|0|||
146626195|NCT00945009|528806195|FG000|Overall Study|Refusal of further protocol|1|||
146626196|NCT00945009|528806196|FG001|Overall Study|Refusal of further protocol|0|||
146626197|NCT00945009|528806197|FG002|Overall Study|Refusal of further protocol|0|||
146626198|NCT04886154|528806198|FG000|Overall Study|Adverse Event|0|||
146626199|NCT04886154|528806199|FG001|Overall Study|Adverse Event|0|||
146626200|NCT04886154|528806200|FG002|Overall Study|Adverse Event|0|||
146626201|NCT04886154|528806201|FG003|Overall Study|Adverse Event|0|||
146626202|NCT04886154|528806202|FG004|Overall Study|Adverse Event|1|||
146626203|NCT04886154|528806203|FG005|Overall Study|Adverse Event|0|||
146626204|NCT04886154|528806204|FG006|Overall Study|Adverse Event|0|||
146626205|NCT04886154|528806205|FG007|Overall Study|Adverse Event|1|||
146626206|NCT04886154|528806206|FG008|Overall Study|Adverse Event|1|||
146626207|NCT04886154|528806207|FG009|Overall Study|Adverse Event|0|||
146626208|NCT04886154|528806208|FG010|Overall Study|Adverse Event|0|||
146626209|NCT04886154|528806209|FG011|Overall Study|Adverse Event|1|||
146626210|NCT04886154|528806210|FG012|Overall Study|Adverse Event|0|||
146626211|NCT04886154|528806211|FG013|Overall Study|Adverse Event|0|||
146626212|NCT04886154|528806212|FG014|Overall Study|Adverse Event|3|||
146626213|NCT04886154|528806198|FG000|Overall Study|Lost to Follow-up|1|||
146626214|NCT04886154|528806199|FG001|Overall Study|Lost to Follow-up|0|||
146626215|NCT04886154|528806200|FG002|Overall Study|Lost to Follow-up|2|||
146626216|NCT04886154|528806201|FG003|Overall Study|Lost to Follow-up|0|||
146626217|NCT04886154|528806202|FG004|Overall Study|Lost to Follow-up|17|||
146626218|NCT04886154|528806203|FG005|Overall Study|Lost to Follow-up|7|||
146626219|NCT04886154|528806204|FG006|Overall Study|Lost to Follow-up|8|||
146626220|NCT04886154|528806205|FG007|Overall Study|Lost to Follow-up|7|||
146626221|NCT04886154|528806206|FG008|Overall Study|Lost to Follow-up|8|||
146626222|NCT04886154|528806207|FG009|Overall Study|Lost to Follow-up|0|||
146626223|NCT04886154|528806208|FG010|Overall Study|Lost to Follow-up|2|||
146626224|NCT04886154|528806209|FG011|Overall Study|Lost to Follow-up|0|||
146626225|NCT04886154|528806210|FG012|Overall Study|Lost to Follow-up|0|||
146626226|NCT04886154|528806211|FG013|Overall Study|Lost to Follow-up|0|||
146626227|NCT04886154|528806212|FG014|Overall Study|Lost to Follow-up|0|||
146626228|NCT04886154|528806198|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146626229|NCT04886154|528806199|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146626230|NCT04886154|528806200|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146626231|NCT04886154|528806201|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146626232|NCT04886154|528806202|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146626233|NCT04886154|528806203|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146626234|NCT04886154|528806204|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
146626235|NCT04886154|528806205|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146626236|NCT04886154|528806206|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146626237|NCT04886154|528806207|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146626238|NCT04886154|528806208|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146626239|NCT04886154|528806209|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146626240|NCT04886154|528806210|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146626241|NCT04886154|528806211|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146626242|NCT04886154|528806212|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146626243|NCT04886154|528806198|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146538338|NCT00410163|528479655|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
146538339|NCT00410163|528479654|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
146538340|NCT00410163|528479655|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
146538341|NCT01394276|528479656|FG000|Overall Study|Related Adverse event (AEs)|15|||
146538342|NCT01394276|528479656|FG000|Overall Study|Not related AEs|9|||
146538343|NCT01394276|528479656|FG000|Overall Study|Remission of disease|2|||
146538344|NCT01394276|528479656|FG000|Overall Study|Insufficient therapeutic effect|17|||
146538345|NCT01394276|528479656|FG000|Overall Study|Insufficient compliance|9|||
146538346|NCT01394276|528479656|FG000|Overall Study|Lost to Follow-up|5|||
146538347|NCT01394276|528479656|FG000|Overall Study|Participant moved to another site|1|||
146538348|NCT01394276|528479656|FG000|Overall Study|Pregnancy|1|||
146538349|NCT01394276|528479656|FG000|Overall Study|unavailability of drug at the Hospital|2|||
146538350|NCT01394276|528479656|FG000|Overall Study|Symptoms of concurrent diseases|1|||
146538351|NCT03573297|528479657|FG000|Open Label Treatment Period|Adverse Event|67|||
146538352|NCT03573297|528479658|FG001|Open Label Treatment Period|Adverse Event|0|||
146538353|NCT03573297|528479659|FG002|Open Label Treatment Period|Adverse Event|0|||
146538354|NCT03573297|528479660|FG003|Open Label Treatment Period|Adverse Event|0|||
146538355|NCT03573297|528479657|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
146538356|NCT03573297|528479658|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
146538357|NCT03573297|528479659|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
146538358|NCT03573297|528479660|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
146538359|NCT03573297|528479657|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
146538360|NCT03573297|528479658|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
146538361|NCT03573297|528479659|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
146538362|NCT03573297|528479660|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
146538363|NCT03573297|528479657|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
146538364|NCT03573297|528479658|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
146538365|NCT03573297|528479659|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
146538366|NCT03573297|528479660|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
146538367|NCT03573297|528479657|FG000|Open Label Treatment Period|Pregnancy|1|||
146538368|NCT03573297|528479658|FG001|Open Label Treatment Period|Pregnancy|0|||
146538369|NCT03573297|528479659|FG002|Open Label Treatment Period|Pregnancy|0|||
146538370|NCT03573297|528479660|FG003|Open Label Treatment Period|Pregnancy|0|||
146538371|NCT03573297|528479657|FG000|Open Label Treatment Period|Protocol Violation|17|||
146538372|NCT03573297|528479658|FG001|Open Label Treatment Period|Protocol Violation|0|||
146538373|NCT03573297|528479659|FG002|Open Label Treatment Period|Protocol Violation|0|||
146538374|NCT03573297|528479660|FG003|Open Label Treatment Period|Protocol Violation|0|||
146538375|NCT03573297|528479657|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
146538376|NCT03573297|528479658|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
146538377|NCT03573297|528479659|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
146538378|NCT03573297|528479660|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
146538379|NCT03573297|528479657|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
146538380|NCT03573297|528479658|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
146538381|NCT03573297|528479659|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
146538382|NCT03573297|528479660|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
146538383|NCT03573297|528479657|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
146538384|NCT03573297|528479658|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
146538385|NCT03573297|528479659|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
146538386|NCT03573297|528479660|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
146538387|NCT03573297|528479657|FG000|Open Label Treatment Period|Other, Not Specified|7|||
146538388|NCT03573297|528479658|FG001|Open Label Treatment Period|Other, Not Specified|0|||
146538389|NCT03573297|528479659|FG002|Open Label Treatment Period|Other, Not Specified|0|||
146538390|NCT03573297|528479660|FG003|Open Label Treatment Period|Other, Not Specified|0|||
146538391|NCT03573297|528479657|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
146538392|NCT03573297|528479658|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
146538393|NCT03573297|528479659|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
146538394|NCT03573297|528479660|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
146538395|NCT03573297|528479657|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146871262|NCT00617604|529699865|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
146871263|NCT03250832|529699866|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
146871264|NCT03250832|529699867|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
146871265|NCT03250832|529699868|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
146538396|NCT03573297|528479658|FG001|Double-Blind Treatment Period|Adverse Event|1|||
146538397|NCT03573297|528479659|FG002|Double-Blind Treatment Period|Adverse Event|5|||
146538398|NCT03573297|528479660|FG003|Double-Blind Treatment Period|Adverse Event|1|||
146538399|NCT03573297|528479657|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
146538400|NCT03573297|528479658|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
146871266|NCT03250832|529699869|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
146626244|NCT04886154|528806199|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146626245|NCT04886154|528806200|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146626246|NCT04886154|528806201|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146626247|NCT04886154|528806202|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146626248|NCT04886154|528806203|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146626249|NCT04886154|528806204|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
146626250|NCT04886154|528806205|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146626251|NCT04886154|528806206|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146626252|NCT04886154|528806207|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146626253|NCT04886154|528806208|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146626254|NCT04886154|528806209|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146626255|NCT04886154|528806210|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146626256|NCT04886154|528806211|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146626257|NCT04886154|528806212|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146626258|NCT04886154|528806198|FG000|Overall Study|Other, Not Specified|0|||
146626259|NCT04886154|528806199|FG001|Overall Study|Other, Not Specified|0|||
146626260|NCT04886154|528806200|FG002|Overall Study|Other, Not Specified|0|||
146626261|NCT04886154|528806201|FG003|Overall Study|Other, Not Specified|0|||
146626262|NCT04886154|528806202|FG004|Overall Study|Other, Not Specified|11|||
146626263|NCT04886154|528806203|FG005|Overall Study|Other, Not Specified|8|||
146626264|NCT04886154|528806204|FG006|Overall Study|Other, Not Specified|9|||
146626265|NCT04886154|528806205|FG007|Overall Study|Other, Not Specified|10|||
146626266|NCT04886154|528806206|FG008|Overall Study|Other, Not Specified|6|||
146626267|NCT04886154|528806207|FG009|Overall Study|Other, Not Specified|1|||
146626268|NCT04886154|528806208|FG010|Overall Study|Other, Not Specified|1|||
146626269|NCT04886154|528806209|FG011|Overall Study|Other, Not Specified|2|||
146626270|NCT04886154|528806210|FG012|Overall Study|Other, Not Specified|1|||
146626271|NCT04886154|528806211|FG013|Overall Study|Other, Not Specified|2|||
146626272|NCT04886154|528806212|FG014|Overall Study|Other, Not Specified|3|||
146626273|NCT03919773|528806221|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
146626274|NCT03919773|528806222|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
146626275|NCT03919773|528806221|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
146626276|NCT03919773|528806222|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
146626277|NCT04659044|528806223|FG000|Induction|Physician Decision|1|||
146626278|NCT04659044|528806223|FG000|Induction|Adverse Event|2|||
146626279|NCT04966013|528806224|FG000|Overall Study|Withdrawal by Subject|0|||
146626280|NCT04966013|528806225|FG001|Overall Study|Withdrawal by Subject|2|||
146626281|NCT04966013|528806226|FG002|Overall Study|Withdrawal by Subject|1|||
146626282|NCT04966013|528806224|FG000|Overall Study|Adverse Event|2|||
146626283|NCT04966013|528806225|FG001|Overall Study|Adverse Event|1|||
146626284|NCT04966013|528806226|FG002|Overall Study|Adverse Event|1|||
146626285|NCT02336282|528806230|FG000|Overall Study|Unrelated illness|1|||
146626286|NCT02336282|528806230|FG000|Overall Study|Uncomfortable with technology|1|||
146626287|NCT02336282|528806230|FG000|Overall Study|Lost to Follow-up|1|||
146626288|NCT02336282|528806230|FG000|Overall Study|Not enough time to complete sessions|2|||
146626289|NCT04875975|528806246|FG000|Overall Study|Adverse Event|1|||
146626290|NCT04875975|528806247|FG001|Overall Study|Adverse Event|2|||
146626291|NCT04875975|528806246|FG000|Overall Study|Lack of Efficacy|2|||
146626292|NCT04875975|528806247|FG001|Overall Study|Lack of Efficacy|2|||
146626293|NCT04875975|528806246|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
146626294|NCT04875975|528806247|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
146626295|NCT04875975|528806246|FG000|Overall Study|Relapse With Insults|0|||
146626296|NCT04875975|528806247|FG001|Overall Study|Relapse With Insults|1|||
146626297|NCT04875975|528806246|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
146626298|NCT04875975|528806247|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
146626299|NCT00904969|528807595|FG000|Overall Study|Lost to Follow-up|4|||
146626300|NCT00904969|528807595|FG000|Overall Study|Withdrawal by Subject|3|||
146626301|NCT00904969|528807595|FG000|Overall Study|Additional Treatments|11|||
146626302|NCT00904969|528807595|FG000|Overall Study|Case Aborted; Subject Exited|1|||
146626303|NCT00755183|528807603|FG000|Overall Study|Adverse Event|5|||
146626304|NCT00755183|528807604|FG001|Overall Study|Adverse Event|2|||
146626305|NCT00755183|528807603|FG000|Overall Study|Protocol Violation|0|||
146626306|NCT00755183|528807604|FG001|Overall Study|Protocol Violation|1|||
146626307|NCT00755183|528807603|FG000|Overall Study|Withdrawal by Subject|0|||
146626308|NCT00755183|528807604|FG001|Overall Study|Withdrawal by Subject|2|||
146626309|NCT00755183|528807603|FG000|Overall Study|Administrative|2|||
146626310|NCT00755183|528807604|FG001|Overall Study|Administrative|1|||
146626311|NCT00804908|528807606|FG000|Overall Study|Other|115|||
146626312|NCT00804908|528807607|FG001|Overall Study|Other|116|||
146626313|NCT00804908|528807608|FG002|Overall Study|Other|114|||
146626314|NCT02177695|528807609|FG000|ITT Analysis|Ineligible|5|||
146626315|NCT02177695|528807610|FG001|ITT Analysis|Ineligible|5|||
146626316|NCT02177695|528807609|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
146626317|NCT02177695|528807610|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
146538401|NCT03573297|528479659|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
146538402|NCT03573297|528479660|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
146538403|NCT03573297|528479657|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146538404|NCT03573297|528479658|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
146538405|NCT03573297|528479659|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
146538406|NCT03573297|528479660|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
146538407|NCT03573297|528479657|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146538408|NCT03573297|528479658|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
146538409|NCT03573297|528479659|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
146538410|NCT03573297|528479660|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
146538411|NCT03573297|528479657|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
146538412|NCT03573297|528479658|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
146538413|NCT03573297|528479659|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
146538414|NCT03573297|528479660|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
146538415|NCT03573297|528479657|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
146538416|NCT03573297|528479658|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
146538417|NCT03573297|528479659|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
146538418|NCT03573297|528479660|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
146538419|NCT03573297|528479657|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
146538420|NCT03573297|528479658|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
146538421|NCT03573297|528479659|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
146538422|NCT03573297|528479660|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
146538423|NCT01277861|528479662|FG000|Overall Study|Physician Decision|2|||
146538424|NCT01277861|528479663|FG001|Overall Study|Physician Decision|2|||
146538425|NCT02696798|528479664|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
146538426|NCT02696798|528479665|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
146538427|NCT02696798|528479666|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
146538428|NCT02696798|528479664|FG000|Blinded Treatment Dosing Period|Death|0|||
146538429|NCT02696798|528479665|FG001|Blinded Treatment Dosing Period|Death|0|||
146538430|NCT02696798|528479666|FG002|Blinded Treatment Dosing Period|Death|1|||
146538431|NCT02696798|528479664|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
146538432|NCT02696798|528479665|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
146538433|NCT02696798|528479666|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
146538434|NCT02696798|528479664|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
146538435|NCT02696798|528479665|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
146538436|NCT02696798|528479666|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
146538437|NCT02696798|528479664|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
146538438|NCT02696798|528479665|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
146538439|NCT02696798|528479666|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
146538440|NCT02696798|528479664|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
146538441|NCT02696798|528479665|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
146538442|NCT02696798|528479666|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
146538443|NCT02696798|528479664|FG000|Extended Treatment Period|Adverse Event|1|||
146538444|NCT02696798|528479665|FG001|Extended Treatment Period|Adverse Event|4|||
146538445|NCT02696798|528479666|FG002|Extended Treatment Period|Adverse Event|5|||
146538446|NCT02696798|528479664|FG000|Extended Treatment Period|Lack of Efficacy|7|||
146538447|NCT02696798|528479665|FG001|Extended Treatment Period|Lack of Efficacy|2|||
146538448|NCT02696798|528479666|FG002|Extended Treatment Period|Lack of Efficacy|2|||
146538449|NCT02696798|528479664|FG000|Extended Treatment Period|Lost to Follow-up|1|||
146538450|NCT02696798|528479665|FG001|Extended Treatment Period|Lost to Follow-up|0|||
146538451|NCT02696798|528479666|FG002|Extended Treatment Period|Lost to Follow-up|0|||
146538452|NCT02696798|528479664|FG000|Extended Treatment Period|Physician Decision|0|||
146538453|NCT02696798|528479665|FG001|Extended Treatment Period|Physician Decision|1|||
146538454|NCT02696798|528479666|FG002|Extended Treatment Period|Physician Decision|0|||
146538455|NCT02696798|528479664|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
146538456|NCT02696798|528479665|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
146538457|NCT02696798|528479666|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
146538458|NCT02696798|528479664|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
146538459|NCT02696798|528479665|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
146538460|NCT02696798|528479666|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
146538461|NCT02696798|528479664|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
146538462|NCT02696798|528479665|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
146538463|NCT02696798|528479666|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
146538464|NCT02696798|528479664|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
146538465|NCT02696798|528479665|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
146538466|NCT02696798|528479666|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
146538467|NCT02696798|528479664|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
146538468|NCT02696798|528479665|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
146626318|NCT02177695|528807609|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
146538469|NCT02696798|528479666|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
146538470|NCT02696798|528479664|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
146538471|NCT02696798|528479665|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
146538472|NCT02696798|528479666|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
146538473|NCT02696798|528479664|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
146538474|NCT02696798|528479665|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
146538475|NCT02696798|528479666|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
146538476|NCT01157845|528479669|FG000|Overall Study|Lost to Follow-up|5|||
146538477|NCT01157845|528479669|FG000|Overall Study|Withdrawal by Subject|12|||
146538478|NCT01157845|528479669|FG000|Overall Study|Physician Decision|3|||
146538479|NCT01157845|528479669|FG000|Overall Study|Protocol Violation|13|||
146538480|NCT01157845|528479669|FG000|Overall Study|Study was ended|1|||
146538481|NCT01157845|528479669|FG000|Overall Study|Device malfunction|1|||
146538482|NCT03311555|528479670|FG000|Overall Study|Adverse Event|1|||
146568722|NCT00328172|528595431|FG000|Overall Study|Other reason (not specified)|3|||
146568723|NCT00328172|528595432|FG001|Overall Study|Other reason (not specified)|0|||
146568724|NCT00328172|528595433|FG002|Overall Study|Other reason (not specified)|1|||
146568725|NCT00328172|528595434|FG003|Overall Study|Other reason (not specified)|0|||
146568726|NCT00328172|528595435|FG004|Overall Study|Other reason (not specified)|0|||
146568727|NCT00558636|528595436|FG000|Treatment|Adverse Event|9|||
146568728|NCT00558636|528595437|FG001|Treatment|Adverse Event|2|||
146568729|NCT00558636|528595436|FG000|Treatment|Withdrawal by Subject|2|||
146568730|NCT00558636|528595437|FG001|Treatment|Withdrawal by Subject|0|||
146568731|NCT00558636|528595436|FG000|Treatment|Premature termination of the study|35|||
146568732|NCT00558636|528595437|FG001|Treatment|Premature termination of the study|37|||
146568733|NCT00558636|528595436|FG000|Treatment|Disease progression|1|||
146568734|NCT00558636|528595437|FG001|Treatment|Disease progression|5|||
146568735|NCT00558636|528595436|FG000|Follow-up|Premature termination of the study|12|||
146568736|NCT00558636|528595437|FG001|Follow-up|Premature termination of the study|7|||
146568737|NCT01990742|528595438|FG000|Overall Study|Withdrawal by facility|407|||
146568738|NCT01990742|528595439|FG001|Overall Study|Withdrawal by facility|1083|||
146568739|NCT01990742|528595438|FG000|Overall Study|Facility closed|0|||
146568740|NCT01990742|528595439|FG001|Overall Study|Facility closed|270|||
146568741|NCT03443687|528595440|FG000|Overall Study|Lost to Follow-up|3|||
146568742|NCT03443687|528595441|FG001|Overall Study|Lost to Follow-up|5|||
146568743|NCT03443687|528595440|FG000|Overall Study|Withdrawal by Subject|1|||
146568744|NCT03443687|528595441|FG001|Overall Study|Withdrawal by Subject|0|||
146568745|NCT03443687|528595440|FG000|Overall Study|Discontinued intervention|1|||
146568746|NCT03443687|528595441|FG001|Overall Study|Discontinued intervention|1|||
146568747|NCT01331681|528595448|FG000|Overall Study|Adverse Event|10|||
146568748|NCT01331681|528595449|FG001|Overall Study|Adverse Event|13|||
146568749|NCT01331681|528595450|FG002|Overall Study|Adverse Event|10|||
146568750|NCT01331681|528595448|FG000|Overall Study|Death|6|||
146568751|NCT01331681|528595449|FG001|Overall Study|Death|6|||
146568752|NCT01331681|528595450|FG002|Overall Study|Death|2|||
146568753|NCT01331681|528595448|FG000|Overall Study|Lack of Efficacy|0|||
146568754|NCT01331681|528595449|FG001|Overall Study|Lack of Efficacy|1|||
146568755|NCT01331681|528595450|FG002|Overall Study|Lack of Efficacy|0|||
146568756|NCT01331681|528595448|FG000|Overall Study|Withdrawal by Subject|12|||
146568757|NCT01331681|528595449|FG001|Overall Study|Withdrawal by Subject|8|||
146568758|NCT01331681|528595450|FG002|Overall Study|Withdrawal by Subject|15|||
146568759|NCT01331681|528595448|FG000|Overall Study|Protocol Violation|1|||
146568760|NCT01331681|528595449|FG001|Overall Study|Protocol Violation|1|||
146568761|NCT01331681|528595450|FG002|Overall Study|Protocol Violation|0|||
146568762|NCT01331681|528595448|FG000|Overall Study|Lost to Follow-up|2|||
146568763|NCT01331681|528595449|FG001|Overall Study|Lost to Follow-up|4|||
146568764|NCT01331681|528595450|FG002|Overall Study|Lost to Follow-up|1|||
146568765|NCT01331681|528595448|FG000|Overall Study|Physician Decision|2|||
146626319|NCT02177695|528807610|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
146626320|NCT02177695|528807609|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
146626321|NCT02177695|528807610|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
146568766|NCT01331681|528595449|FG001|Overall Study|Physician Decision|0|||
146568767|NCT01331681|528595450|FG002|Overall Study|Physician Decision|4|||
146568768|NCT01331681|528595448|FG000|Overall Study|Therapeutic procedure required|1|||
146568769|NCT01331681|528595449|FG001|Overall Study|Therapeutic procedure required|0|||
146568770|NCT01331681|528595450|FG002|Overall Study|Therapeutic procedure required|0|||
146568771|NCT01331681|528595448|FG000|Overall Study|Sponsor decision|1|||
146568772|NCT01331681|528595449|FG001|Overall Study|Sponsor decision|1|||
146568773|NCT01331681|528595450|FG002|Overall Study|Sponsor decision|0|||
146568774|NCT01331681|528595448|FG000|Overall Study|Switching to other therapy|0|||
146568775|NCT01331681|528595449|FG001|Overall Study|Switching to other therapy|0|||
146568776|NCT01331681|528595450|FG002|Overall Study|Switching to other therapy|1|||
146568777|NCT01331681|528595448|FG000|Overall Study|Not Received Study Treatment|0|||
146568778|NCT01331681|528595449|FG001|Overall Study|Not Received Study Treatment|0|||
146568779|NCT01331681|528595450|FG002|Overall Study|Not Received Study Treatment|2|||
146626322|NCT00248625|528807613|FG000|Overall Study|Withdrawal by Subject|0|||
146626323|NCT00248625|528807614|FG001|Overall Study|Withdrawal by Subject|2|||
146626324|NCT05176314|528807621|FG000|Overall Study|Lost to Follow-up|2|||
146626325|NCT05176314|528807621|FG000|Overall Study|Physician Decision|1|||
146626326|NCT05176314|528807621|FG000|Overall Study|Adverse Event|1|||
146626327|NCT03103542|528807626|FG000|Overall Study|Physician Decision|2|||
146626328|NCT03103542|528807626|FG000|Overall Study|Adverse Event|2|||
146626329|NCT03103542|528807626|FG000|Overall Study|Other|2|||
146626330|NCT03103542|528807626|FG000|Overall Study|Withdrawal by Subject|1|||
146626331|NCT02939287|528807630|FG000|Overall Study|met exclusion criteria|1|||
146626332|NCT02939287|528807631|FG001|Overall Study|met exclusion criteria|1|||
146626333|NCT02939287|528807632|FG002|Overall Study|met exclusion criteria|1|||
146626334|NCT02939287|528807630|FG000|Overall Study|Did not complete survey|2|||
146626335|NCT02939287|528807631|FG001|Overall Study|Did not complete survey|2|||
146626336|NCT02939287|528807632|FG002|Overall Study|Did not complete survey|0|||
146626337|NCT02939287|528807630|FG000|Overall Study|Withdrawal by Subject|1|||
146626338|NCT02939287|528807631|FG001|Overall Study|Withdrawal by Subject|1|||
146626339|NCT02939287|528807632|FG002|Overall Study|Withdrawal by Subject|0|||
146626340|NCT00333775|528807635|FG000|Overall Study|Death|144|||
146626341|NCT00333775|528807636|FG001|Overall Study|Death|149|||
146626342|NCT00333775|528807637|FG002|Overall Study|Death|143|||
146626343|NCT00333775|528807635|FG000|Overall Study|In Follow-up When Study Stopped|87|||
146626344|NCT00333775|528807636|FG001|Overall Study|In Follow-up When Study Stopped|92|||
146626345|NCT00333775|528807637|FG002|Overall Study|In Follow-up When Study Stopped|96|||
146626346|NCT00333775|528807635|FG000|Overall Study|Lost to Follow-up|10|||
146626347|NCT00333775|528807636|FG001|Overall Study|Lost to Follow-up|7|||
146626348|NCT00333775|528807637|FG002|Overall Study|Lost to Follow-up|8|||
146626349|NCT02491684|528807641|FG000|Treatment Phase|Adverse Event|2|||
146626350|NCT02491684|528807642|FG001|Treatment Phase|Adverse Event|2|||
146626351|NCT02491684|528807641|FG000|Treatment Phase|Incorrect randomisation|1|||
146626352|NCT02491684|528807642|FG001|Treatment Phase|Incorrect randomisation|0|||
146626353|NCT02491684|528807641|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
146626354|NCT02491684|528807642|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
146626355|NCT04739982|528807644|FG000|Overall Study|Lost to Follow-up|176|||
146626356|NCT04739982|528807645|FG001|Overall Study|Lost to Follow-up|65|||
146626357|NCT04739982|528807644|FG000|Overall Study|Withdrawal by Subject|19|||
146626358|NCT04739982|528807645|FG001|Overall Study|Withdrawal by Subject|0|||
146626359|NCT04739982|528807644|FG000|Overall Study|Protocol Violation|0|||
146626360|NCT04739982|528807645|FG001|Overall Study|Protocol Violation|5|||
146626361|NCT03651765|528807646|FG000|Overall Study|Adverse Event|6|||
146626362|NCT03651765|528807646|FG000|Overall Study|Lack of Efficacy|18|||
146626363|NCT03651765|528807646|FG000|Overall Study|Lost to Follow-up|5|||
146626364|NCT03651765|528807646|FG000|Overall Study|Non-Compliance with Study Drug|4|||
146626365|NCT03651765|528807646|FG000|Overall Study|Physician Decision|6|||
146626366|NCT03651765|528807646|FG000|Overall Study|Pregnancy|1|||
146626367|NCT03651765|528807646|FG000|Overall Study|Discontinued by Sponsor|40|||
146626368|NCT03651765|528807646|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
146626369|NCT03651765|528807646|FG000|Overall Study|Withdrawal by Subject|24|||
146626370|NCT03651765|528807646|FG000|Overall Study|Miscellaneous|6|||
146626371|NCT03279081|528807652|FG000|Overall Study|Withdrawal by Subject|12|||
146626372|NCT03279081|528807653|FG001|Overall Study|Withdrawal by Subject|20|||
146626373|NCT03279081|528807652|FG000|Overall Study|Physician Decision|4|||
146626374|NCT03279081|528807653|FG001|Overall Study|Physician Decision|1|||
146626375|NCT03279081|528807652|FG000|Overall Study|Lost to Follow-up|8|||
146538483|NCT05493111|528481470|FG000|Overall Study|Adverse Event|3|||
146538484|NCT05493111|528481471|FG001|Overall Study|Adverse Event|4|||
146538485|NCT05493111|528481470|FG000|Overall Study|Withdrawal of Consent|19|||
146538486|NCT05493111|528481471|FG001|Overall Study|Withdrawal of Consent|10|||
146538487|NCT05493111|528481470|FG000|Overall Study|Non-compliance|1|||
146538488|NCT05493111|528481471|FG001|Overall Study|Non-compliance|1|||
146538489|NCT05493111|528481470|FG000|Overall Study|Lost to Follow-up|8|||
146538490|NCT05493111|528481471|FG001|Overall Study|Lost to Follow-up|1|||
146538491|NCT05493111|528481470|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
146538492|NCT05493111|528481471|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
146538493|NCT05493111|528481470|FG000|Overall Study|Withdrawal by Subject|1|||
146626376|NCT03279081|528807653|FG001|Overall Study|Lost to Follow-up|8|||
146626377|NCT03279081|528807652|FG000|Overall Study|Death|0|||
146626378|NCT03279081|528807653|FG001|Overall Study|Death|1|||
146626379|NCT03279081|528807652|FG000|Overall Study|Adverse Event|1|||
146626380|NCT03279081|528807653|FG001|Overall Study|Adverse Event|0|||
146626381|NCT03279081|528807652|FG000|Overall Study|Reason not Specified|14|||
146626382|NCT03279081|528807653|FG001|Overall Study|Reason not Specified|4|||
146626383|NCT03521570|528807654|FG000|Overall Study|Not eligible|11|||
146626384|NCT00322881|528807655|FG000|Overall Study|Death|2|||
146626385|NCT00322881|528807655|FG000|Overall Study|Adverse Event|1|||
146626386|NCT00322881|528807655|FG000|Overall Study|Disease Progression|2|||
146626387|NCT00771914|528807659|FG000|Overall Study|Physician Decision|0|||
146626388|NCT00771914|528807660|FG001|Overall Study|Physician Decision|0|||
146538494|NCT05493111|528481471|FG001|Overall Study|Withdrawal by Subject|1|||
146538495|NCT03836053|528481472|FG000|Overall Study|Protocol-specified criteria|0|||
146538496|NCT03836053|528481473|FG001|Overall Study|Protocol-specified criteria|2|||
146538497|NCT03836053|528481474|FG002|Overall Study|Protocol-specified criteria|1|||
146538498|NCT03836053|528481472|FG000|Overall Study|Death|1|||
146538499|NCT03836053|528481473|FG001|Overall Study|Death|6|||
146538500|NCT03836053|528481474|FG002|Overall Study|Death|4|||
146538501|NCT03836053|528481472|FG000|Overall Study|Withdrawal of consent from study|0|||
146538502|NCT03836053|528481473|FG001|Overall Study|Withdrawal of consent from study|0|||
146538503|NCT03836053|528481474|FG002|Overall Study|Withdrawal of consent from study|1|||
146538504|NCT03836053|528481472|FG000|Overall Study|Decision by sponsor|0|||
146538505|NCT03836053|528481473|FG001|Overall Study|Decision by sponsor|2|||
146538506|NCT03836053|528481474|FG002|Overall Study|Decision by sponsor|4|||
146538507|NCT00788671|528481475|FG000|Overall Study|Death|2|||
146538508|NCT00788671|528481475|FG000|Overall Study|Unable to biopsy|1|||
146538509|NCT00788671|528481475|FG000|Overall Study|Withdrawal by Subject|4|||
146538510|NCT00788671|528481475|FG000|Overall Study|IUD expulsed|1|||
146538511|NCT00788671|528481475|FG000|Overall Study|Lost to follow up|2|||
146538512|NCT04486716|528481476|FG000|Core Phase|Subject decision|6|||
146538513|NCT04486716|528481476|FG000|Core Phase|Adverse Event|5|||
146538514|NCT04486716|528481476|FG000|Core Phase|Lost to Follow-up|1|||
146538515|NCT04486716|528481476|FG000|Core Phase|Physician Decision|1|||
146538516|NCT04486716|528481476|FG000|Core Phase|Enrolled subjects not treated|9|||
146538517|NCT03846479|528481477|FG000|Overall Study|Death|8|||
146538518|NCT03846479|528481477|FG000|Overall Study|Lost to Follow-up|1|||
146538519|NCT02332707|528481478|FG000|Overall Study|Adverse Event|0|||
146538520|NCT02332707|528481479|FG001|Overall Study|Adverse Event|0|||
146538521|NCT02332707|528481480|FG002|Overall Study|Adverse Event|0|||
146538522|NCT02332707|528481481|FG003|Overall Study|Adverse Event|0|||
146538523|NCT02332707|528481482|FG004|Overall Study|Adverse Event|0|||
146538524|NCT02332707|528481483|FG005|Overall Study|Adverse Event|0|||
146538525|NCT02332707|528481484|FG006|Overall Study|Adverse Event|0|||
146538526|NCT02332707|528481485|FG007|Overall Study|Adverse Event|0|||
146538527|NCT02332707|528481486|FG008|Overall Study|Adverse Event|0|||
146538528|NCT02332707|528481487|FG009|Overall Study|Adverse Event|0|||
146538529|NCT02332707|528481488|FG010|Overall Study|Adverse Event|0|||
146538530|NCT02332707|528481489|FG011|Overall Study|Adverse Event|0|||
146538531|NCT02332707|528481490|FG012|Overall Study|Adverse Event|1|||
146538532|NCT02332707|528481491|FG013|Overall Study|Adverse Event|0|||
146538533|NCT02332707|528481492|FG014|Overall Study|Adverse Event|0|||
146538534|NCT02332707|528481493|FG015|Overall Study|Adverse Event|0|||
146538535|NCT02332707|528481494|FG016|Overall Study|Adverse Event|0|||
146538536|NCT02332707|528481495|FG017|Overall Study|Adverse Event|0|||
146538537|NCT02332707|528481478|FG000|Overall Study|Lost to Follow-up|0|||
146538538|NCT02332707|528481479|FG001|Overall Study|Lost to Follow-up|0|||
146538539|NCT02332707|528481480|FG002|Overall Study|Lost to Follow-up|0|||
146538540|NCT02332707|528481481|FG003|Overall Study|Lost to Follow-up|0|||
146538541|NCT02332707|528481482|FG004|Overall Study|Lost to Follow-up|0|||
146538542|NCT02332707|528481483|FG005|Overall Study|Lost to Follow-up|1|||
146538543|NCT02332707|528481484|FG006|Overall Study|Lost to Follow-up|0|||
146538544|NCT02332707|528481485|FG007|Overall Study|Lost to Follow-up|0|||
146538545|NCT02332707|528481486|FG008|Overall Study|Lost to Follow-up|0|||
146538546|NCT02332707|528481487|FG009|Overall Study|Lost to Follow-up|0|||
146538547|NCT02332707|528481488|FG010|Overall Study|Lost to Follow-up|2|||
146538548|NCT02332707|528481489|FG011|Overall Study|Lost to Follow-up|0|||
146538549|NCT02332707|528481490|FG012|Overall Study|Lost to Follow-up|3|||
146538550|NCT02332707|528481491|FG013|Overall Study|Lost to Follow-up|0|||
146538551|NCT02332707|528481492|FG014|Overall Study|Lost to Follow-up|0|||
146538552|NCT02332707|528481493|FG015|Overall Study|Lost to Follow-up|0|||
146538553|NCT02332707|528481494|FG016|Overall Study|Lost to Follow-up|0|||
146538554|NCT02332707|528481495|FG017|Overall Study|Lost to Follow-up|0|||
146538555|NCT02332707|528481478|FG000|Overall Study|Physician Decision|0|||
146538556|NCT02332707|528481479|FG001|Overall Study|Physician Decision|0|||
146538557|NCT02332707|528481480|FG002|Overall Study|Physician Decision|0|||
146538558|NCT02332707|528481481|FG003|Overall Study|Physician Decision|1|||
146538559|NCT02332707|528481482|FG004|Overall Study|Physician Decision|0|||
146538560|NCT02332707|528481483|FG005|Overall Study|Physician Decision|0|||
146538561|NCT02332707|528481484|FG006|Overall Study|Physician Decision|0|||
146538562|NCT02332707|528481485|FG007|Overall Study|Physician Decision|0|||
146538563|NCT02332707|528481486|FG008|Overall Study|Physician Decision|0|||
146538564|NCT02332707|528481487|FG009|Overall Study|Physician Decision|0|||
146538565|NCT02332707|528481488|FG010|Overall Study|Physician Decision|0|||
146538566|NCT02332707|528481489|FG011|Overall Study|Physician Decision|0|||
146538567|NCT02332707|528481490|FG012|Overall Study|Physician Decision|1|||
146538568|NCT02332707|528481491|FG013|Overall Study|Physician Decision|0|||
146538569|NCT02332707|528481492|FG014|Overall Study|Physician Decision|0|||
146538570|NCT02332707|528481493|FG015|Overall Study|Physician Decision|0|||
146538571|NCT02332707|528481494|FG016|Overall Study|Physician Decision|0|||
146538572|NCT02332707|528481495|FG017|Overall Study|Physician Decision|0|||
146538573|NCT02332707|528481478|FG000|Overall Study|Withdrawal by Subject|0|||
146538574|NCT02332707|528481479|FG001|Overall Study|Withdrawal by Subject|0|||
146538575|NCT02332707|528481480|FG002|Overall Study|Withdrawal by Subject|1|||
146538576|NCT02332707|528481481|FG003|Overall Study|Withdrawal by Subject|0|||
146538577|NCT02332707|528481482|FG004|Overall Study|Withdrawal by Subject|0|||
146538578|NCT02332707|528481483|FG005|Overall Study|Withdrawal by Subject|0|||
146538579|NCT02332707|528481484|FG006|Overall Study|Withdrawal by Subject|0|||
146538580|NCT02332707|528481485|FG007|Overall Study|Withdrawal by Subject|0|||
146538581|NCT02332707|528481486|FG008|Overall Study|Withdrawal by Subject|0|||
146538582|NCT02332707|528481487|FG009|Overall Study|Withdrawal by Subject|3|||
146538583|NCT02332707|528481488|FG010|Overall Study|Withdrawal by Subject|0|||
146538584|NCT02332707|528481489|FG011|Overall Study|Withdrawal by Subject|0|||
146538585|NCT02332707|528481490|FG012|Overall Study|Withdrawal by Subject|0|||
146538586|NCT02332707|528481491|FG013|Overall Study|Withdrawal by Subject|0|||
146538587|NCT02332707|528481492|FG014|Overall Study|Withdrawal by Subject|0|||
146538588|NCT02332707|528481493|FG015|Overall Study|Withdrawal by Subject|0|||
146538589|NCT02332707|528481494|FG016|Overall Study|Withdrawal by Subject|0|||
146538590|NCT02332707|528481495|FG017|Overall Study|Withdrawal by Subject|0|||
146538591|NCT01473134|528481496|FG000|Overall Study|Lost to Follow-up|21|||
146538592|NCT01473134|528481497|FG001|Overall Study|Lost to Follow-up|13|||
146538593|NCT01473134|528481496|FG000|Overall Study|Protocol Violation|32|||
146538594|NCT01473134|528481497|FG001|Overall Study|Protocol Violation|19|||
146538595|NCT01473134|528481496|FG000|Overall Study|Withdrawal by Subject|1|||
146538596|NCT01473134|528481497|FG001|Overall Study|Withdrawal by Subject|2|||
146538597|NCT01473134|528481496|FG000|Overall Study|Death|0|||
146538598|NCT01473134|528481497|FG001|Overall Study|Death|1|||
146538599|NCT01473134|528481496|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
146538600|NCT01473134|528481497|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
146538601|NCT04761822|528481498|FG000|Overall Study|Adverse Event|3|||
146538602|NCT04761822|528481499|FG001|Overall Study|Adverse Event|1|||
146538603|NCT04761822|528481500|FG002|Overall Study|Adverse Event|1|||
146538604|NCT04761822|528481501|FG003|Overall Study|Adverse Event|3|||
146538605|NCT04761822|528481498|FG000|Overall Study|Lost to Follow-up|1|||
146538606|NCT04761822|528481499|FG001|Overall Study|Lost to Follow-up|0|||
146538607|NCT04761822|528481500|FG002|Overall Study|Lost to Follow-up|2|||
146538608|NCT04761822|528481501|FG003|Overall Study|Lost to Follow-up|3|||
146538609|NCT04761822|528481498|FG000|Overall Study|Physician Decision|0|||
146538610|NCT04761822|528481499|FG001|Overall Study|Physician Decision|1|||
146538611|NCT04761822|528481500|FG002|Overall Study|Physician Decision|0|||
146538612|NCT04761822|528481501|FG003|Overall Study|Physician Decision|0|||
146538613|NCT04761822|528481498|FG000|Overall Study|Withdrawal by Subject|3|||
146538614|NCT04761822|528481499|FG001|Overall Study|Withdrawal by Subject|8|||
146538615|NCT04761822|528481500|FG002|Overall Study|Withdrawal by Subject|1|||
146538616|NCT04761822|528481501|FG003|Overall Study|Withdrawal by Subject|11|||
146538617|NCT04761822|528481498|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
146538618|NCT04761822|528481499|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
146538619|NCT04761822|528481500|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
146538620|NCT04761822|528481501|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
146538621|NCT04761822|528481498|FG000|Overall Study|Participant requested unblinding|0|||
146538622|NCT04761822|528481499|FG001|Overall Study|Participant requested unblinding|0|||
146538623|NCT04761822|528481500|FG002|Overall Study|Participant requested unblinding|0|||
146538624|NCT04761822|528481501|FG003|Overall Study|Participant requested unblinding|1|||
146538625|NCT00362232|528481502|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
146538626|NCT00362232|528481503|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
146538627|NCT00362232|528481502|FG000|Treatment (12 +/- 2 Days)|Death|1|||
146538628|NCT00362232|528481503|FG001|Treatment (12 +/- 2 Days)|Death|3|||
146538629|NCT00362232|528481502|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
146538630|NCT00362232|528481503|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
146538631|NCT00362232|528481502|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
146538632|NCT00362232|528481503|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
146538633|NCT00362232|528481502|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
146538634|NCT00362232|528481503|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
146538635|NCT00362232|528481502|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
146538636|NCT00362232|528481503|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
146538637|NCT00362232|528481502|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
146538638|NCT00362232|528481503|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
146538639|NCT00362232|528481502|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
146538640|NCT00362232|528481503|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
146538641|NCT00362232|528481502|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
146538642|NCT00362232|528481503|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
146538643|NCT00362232|528481502|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
146538644|NCT00362232|528481503|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
146538645|NCT00362232|528481502|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
146538646|NCT00362232|528481503|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
146538647|NCT00362232|528481502|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
146538648|NCT00362232|528481503|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
146626389|NCT00771914|528807661|FG002|Overall Study|Physician Decision|0|||
146626390|NCT00771914|528807662|FG003|Overall Study|Physician Decision|1|||
146626391|NCT00771914|528807659|FG000|Overall Study|Lost to Follow-up|0|||
146538649|NCT00362232|528481502|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
146538650|NCT00362232|528481503|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
146538651|NCT05020015|528481510|FG000|Overall Study|Ongoing on study|1|||
146626392|NCT00771914|528807660|FG001|Overall Study|Lost to Follow-up|0|||
146626393|NCT00771914|528807661|FG002|Overall Study|Lost to Follow-up|0|||
146626394|NCT00771914|528807662|FG003|Overall Study|Lost to Follow-up|1|||
146626395|NCT00468169|528807664|FG000|Overall Study|Withdrawal by Subject|1|||
146626396|NCT00468169|528807665|FG001|Overall Study|Withdrawal by Subject|0|||
146626397|NCT01521117|528807670|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
146538652|NCT05020015|528481511|FG001|Overall Study|Ongoing on study|3|||
146538653|NCT05020015|528481512|FG002|Overall Study|Ongoing on study|4|||
146538654|NCT05020015|528481513|FG003|Overall Study|Ongoing on study|7|||
146538655|NCT05020015|528481510|FG000|Overall Study|Death|2|||
146538656|NCT05020015|528481511|FG001|Overall Study|Death|3|||
146538657|NCT05020015|528481512|FG002|Overall Study|Death|4|||
146538658|NCT05020015|528481513|FG003|Overall Study|Death|0|||
146538659|NCT05020015|528481510|FG000|Overall Study|Withdrawal by Subject|0|||
146538660|NCT05020015|528481511|FG001|Overall Study|Withdrawal by Subject|0|||
146538661|NCT05020015|528481512|FG002|Overall Study|Withdrawal by Subject|1|||
146538662|NCT05020015|528481513|FG003|Overall Study|Withdrawal by Subject|0|||
146538663|NCT05020015|528481510|FG000|Overall Study|Reason Not Specified|0|||
146538664|NCT05020015|528481511|FG001|Overall Study|Reason Not Specified|0|||
146538665|NCT05020015|528481512|FG002|Overall Study|Reason Not Specified|2|||
146538666|NCT05020015|528481513|FG003|Overall Study|Reason Not Specified|0|||
146538667|NCT02233413|528481514|FG000|Overall Study|Lost to Follow-up|7|||
146538668|NCT02233413|528481515|FG001|Overall Study|Lost to Follow-up|9|||
146538669|NCT02233413|528481514|FG000|Overall Study|Withdrawal by Subject|4|||
146538670|NCT02233413|528481515|FG001|Overall Study|Withdrawal by Subject|5|||
146538671|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
146538672|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
146538673|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
146538674|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
146538675|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
146538676|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
146538677|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
146538678|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
146538679|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
146538680|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
146538681|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
146538682|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
146538683|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
146538684|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
146538685|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
146538686|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
146538687|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
146538688|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
146538689|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
146538690|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
146538691|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
146538692|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
146538693|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
146538694|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
146538695|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
146538696|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
146538697|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
146538698|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
146538699|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
146538700|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
146538701|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
146626398|NCT01521117|528807671|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
146538702|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
146626399|NCT01521117|528807670|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
146626400|NCT01521117|528807671|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
146626401|NCT01521117|528807670|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
146626402|NCT01521117|528807671|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
146626403|NCT00784563|528807672|FG000|Years 1 & 2|Withdrawal by Subject|3|||
146626404|NCT00784563|528807673|FG001|Years 1 & 2|Withdrawal by Subject|2|||
146626405|NCT00784563|528807674|FG002|Years 1 & 2|Withdrawal by Subject|0|||
146538703|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
146538704|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
146538705|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
146538706|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
146538707|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
146538708|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
146538709|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
146538710|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
146538711|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
146538712|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
146538713|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
146538714|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
146538715|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
146538716|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
146538717|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
146538718|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
146538719|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
146538720|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
146538721|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
146538722|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
146538723|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
146538724|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
146538725|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
146538726|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
146538727|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
146538728|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
146538729|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
146538730|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
146538731|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
146538732|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
146538733|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
146538734|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
146538735|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
146538736|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
146538737|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
146538738|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
146538739|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
146538740|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
146538741|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
146538742|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
146538743|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
146538744|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
146538745|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
146538746|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
146538747|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
146538748|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
146538749|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
146538750|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
146538751|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
146538752|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
146538753|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
146538754|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
146538755|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
146538756|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
146538757|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
146626406|NCT00784563|528807672|FG000|Years 1 & 2|Adverse Event|0|||
146626407|NCT00784563|528807673|FG001|Years 1 & 2|Adverse Event|3|||
146626408|NCT00784563|528807674|FG002|Years 1 & 2|Adverse Event|0|||
146626409|NCT00784563|528807672|FG000|Year 3|Withdrawal by Subject|0|||
146626410|NCT00784563|528807673|FG001|Year 3|Withdrawal by Subject|0|||
146626411|NCT00784563|528807674|FG002|Year 3|Withdrawal by Subject|2|||
146626412|NCT00784563|528807672|FG000|Year 3|Adverse Event|0|||
146626413|NCT00784563|528807673|FG001|Year 3|Adverse Event|0|||
146626414|NCT00784563|528807674|FG002|Year 3|Adverse Event|1|||
146626415|NCT01668784|528807675|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
146626416|NCT01668784|528807676|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
146626417|NCT01668784|528807675|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
146626418|NCT01668784|528807676|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
146626419|NCT01668784|528807675|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
146626420|NCT01668784|528807676|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
146626421|NCT01668784|528807675|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
146626422|NCT01668784|528807676|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
146626423|NCT01668784|528807675|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
146626424|NCT01668784|528807676|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
146626425|NCT01668784|528807675|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
146626426|NCT01668784|528807676|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
146626427|NCT01668784|528807675|FG000|Treatment Period|Disease Progression|316|||
146626428|NCT01668784|528807676|FG001|Treatment Period|Disease Progression|293|||
146626429|NCT01668784|528807675|FG000|Treatment Period|Study Drug Toxicity|46|||
146626430|NCT01668784|528807676|FG001|Treatment Period|Study Drug Toxicity|53|||
146626431|NCT01668784|528807675|FG000|Treatment Period|Death|1|||
146626432|NCT01668784|528807676|FG001|Treatment Period|Death|1|||
146626433|NCT01668784|528807675|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
146626434|NCT01668784|528807676|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
146626435|NCT01668784|528807675|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
146626436|NCT01668784|528807676|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
146626437|NCT01668784|528807675|FG000|Treatment Period|Withdrawal by Subject|5|||
146626438|NCT01668784|528807676|FG001|Treatment Period|Withdrawal by Subject|3|||
146626439|NCT01668784|528807675|FG000|Treatment Period|Maximal Clinical Benefit|3|||
146626440|NCT01668784|528807676|FG001|Treatment Period|Maximal Clinical Benefit|3|||
146626441|NCT01668784|528807675|FG000|Treatment Period|Other|2|||
146626442|NCT01668784|528807676|FG001|Treatment Period|Other|8|||
146626443|NCT01668784|528807675|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
146626444|NCT01668784|528807676|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
146626445|NCT05135871|528807679|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
146626446|NCT05135871|528807680|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
146626447|NCT05135871|528807681|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
146626448|NCT05135871|528807682|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
146626449|NCT00374140|528807687|FG000|Overall Study|Lost to Follow-up|1|||
146626450|NCT00374140|528807687|FG000|Overall Study|Protocol Violation|1|||
146626451|NCT00617734|528807688|FG000|Overall Study|Withdrew Consent|2|||
146626452|NCT00617734|528807689|FG001|Overall Study|Withdrew Consent|0|||
146626453|NCT00617734|528807688|FG000|Overall Study|Adverse Event|4|||
146626454|NCT00617734|528807689|FG001|Overall Study|Adverse Event|1|||
146626455|NCT00617734|528807688|FG000|Overall Study|Protocol Violation|1|||
146626456|NCT00617734|528807689|FG001|Overall Study|Protocol Violation|0|||
146763896|NCT00567879|529302917|FG004|Overall Study|Withdrawal by Subject|0|||
146538758|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
146538759|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
146538760|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
146538761|NCT00090103|528481516|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
146538762|NCT00090103|528481517|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
146538763|NCT00090103|528481518|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
146538764|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
146538765|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
146538766|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
146538767|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
146538768|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
146538769|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
146626457|NCT00617734|528807688|FG000|Overall Study|Found Ineligible After Randomization|1|||
146626458|NCT00617734|528807689|FG001|Overall Study|Found Ineligible After Randomization|4|||
146626459|NCT00617734|528807688|FG000|Overall Study|Lost to Follow-up|0|||
146626460|NCT00617734|528807689|FG001|Overall Study|Lost to Follow-up|1|||
146626461|NCT02485691|528807690|FG000|Overall Study|Adverse Event|25|||
146626462|NCT02485691|528807691|FG001|Overall Study|Adverse Event|11|||
146626463|NCT02485691|528807690|FG000|Overall Study|Poor compliance to protocol|0|||
146626464|NCT02485691|528807691|FG001|Overall Study|Poor compliance to protocol|1|||
146626465|NCT02485691|528807690|FG000|Overall Study|Disease progression|57|||
146626466|NCT02485691|528807691|FG001|Overall Study|Disease progression|92|||
146626467|NCT02485691|528807690|FG000|Overall Study|Investigator's decision|23|||
146626468|NCT02485691|528807691|FG001|Overall Study|Investigator's decision|5|||
146538770|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
146538771|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
146538772|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
146538773|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
146538774|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
146538775|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
146538776|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
146538777|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
146538778|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
146538779|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
146538780|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
146538781|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
146538782|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
146538783|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
146538784|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
146538785|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
146538786|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
146538787|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
146538788|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
146538789|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
146538790|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
146538791|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
146538792|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
146538793|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
146538794|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
146538795|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
146538796|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
146538797|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
146538798|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
146538799|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
146538800|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
146538801|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
146538802|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
146538803|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
146538804|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
146538805|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
146538806|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
146538807|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
146538808|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
146538809|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
146538810|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
146538811|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
146538812|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Death|1|||
146538813|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Death|0|||
146538814|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Death|1|||
146538815|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
146538816|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
146538817|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
146538818|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
146538819|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
146538820|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
146538821|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
146538822|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
146538823|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
146538824|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
146538825|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
146538826|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
146538827|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
146538828|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
146538829|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
146538830|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
146538831|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
146538832|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
146538833|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
146965616|NCT04242446|530035196|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146626469|NCT02485691|528807690|FG000|Overall Study|Participant's request|13|||
146626470|NCT02485691|528807691|FG001|Overall Study|Participant's request|6|||
146626471|NCT02485691|528807690|FG000|Overall Study|Other reason|8|||
146626472|NCT02485691|528807691|FG001|Overall Study|Other reason|9|||
146626473|NCT02485691|528807690|FG000|Overall Study|Randomized and not treated|3|||
146626474|NCT02485691|528807691|FG001|Overall Study|Randomized and not treated|2|||
146626475|NCT00604565|528807692|FG000|Overall Study|Study terminated|0|||
146626476|NCT00604565|528807693|FG001|Overall Study|Study terminated|3|||
146626477|NCT04292535|528807695|FG000|Overall Study|Withdrawal by Subject|0|||
146626478|NCT04292535|528807696|FG001|Overall Study|Withdrawal by Subject|0|||
146626479|NCT04292535|528807697|FG002|Overall Study|Withdrawal by Subject|0|||
146626480|NCT04292535|528807698|FG003|Overall Study|Withdrawal by Subject|0|||
146626481|NCT04292535|528807699|FG004|Overall Study|Withdrawal by Subject|0|||
146626482|NCT04292535|528807700|FG005|Overall Study|Withdrawal by Subject|0|||
146626483|NCT04292535|528807701|FG006|Overall Study|Withdrawal by Subject|0|||
146626484|NCT04292535|528807702|FG007|Overall Study|Withdrawal by Subject|1|||
146626485|NCT04292535|528807703|FG008|Overall Study|Withdrawal by Subject|0|||
146626486|NCT04292535|528807704|FG009|Overall Study|Withdrawal by Subject|0|||
146626487|NCT04292535|528807705|FG010|Overall Study|Withdrawal by Subject|0|||
146626488|NCT04292535|528807706|FG011|Overall Study|Withdrawal by Subject|0|||
146626489|NCT04292535|528807707|FG012|Overall Study|Withdrawal by Subject|0|||
146626490|NCT04292535|528807708|FG013|Overall Study|Withdrawal by Subject|0|||
146626491|NCT04292535|528807695|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146626492|NCT04292535|528807696|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146626493|NCT04292535|528807697|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146626494|NCT04292535|528807698|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146626495|NCT04292535|528807699|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146626496|NCT04292535|528807700|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146626497|NCT04292535|528807701|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146626498|NCT04292535|528807702|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
146626499|NCT04292535|528807703|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146626500|NCT04292535|528807704|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146626501|NCT04292535|528807705|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146626502|NCT04292535|528807706|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146626503|NCT04292535|528807707|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
146626504|NCT04292535|528807708|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
146626505|NCT04292535|528807695|FG000|Overall Study|Report of Dizziness|0|||
146626506|NCT04292535|528807696|FG001|Overall Study|Report of Dizziness|0|||
146626507|NCT04292535|528807697|FG002|Overall Study|Report of Dizziness|0|||
146626508|NCT04292535|528807698|FG003|Overall Study|Report of Dizziness|0|||
146626509|NCT04292535|528807699|FG004|Overall Study|Report of Dizziness|0|||
146626510|NCT04292535|528807700|FG005|Overall Study|Report of Dizziness|0|||
146626511|NCT04292535|528807701|FG006|Overall Study|Report of Dizziness|0|||
146626512|NCT04292535|528807702|FG007|Overall Study|Report of Dizziness|0|||
146626513|NCT04292535|528807703|FG008|Overall Study|Report of Dizziness|0|||
146626514|NCT04292535|528807704|FG009|Overall Study|Report of Dizziness|0|||
146626515|NCT04292535|528807705|FG010|Overall Study|Report of Dizziness|0|||
146626516|NCT04292535|528807706|FG011|Overall Study|Report of Dizziness|0|||
146626517|NCT04292535|528807707|FG012|Overall Study|Report of Dizziness|0|||
146626518|NCT04292535|528807708|FG013|Overall Study|Report of Dizziness|1|||
146626519|NCT04292535|528807695|FG000|Overall Study|Equipment Failure|0|||
146626520|NCT04292535|528807696|FG001|Overall Study|Equipment Failure|0|||
146626521|NCT04292535|528807697|FG002|Overall Study|Equipment Failure|0|||
146626522|NCT04292535|528807698|FG003|Overall Study|Equipment Failure|0|||
146871267|NCT03250832|529699870|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
146871268|NCT03250832|529699871|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
146626523|NCT04292535|528807699|FG004|Overall Study|Equipment Failure|0|||
146626524|NCT04292535|528807700|FG005|Overall Study|Equipment Failure|0|||
146626525|NCT04292535|528807701|FG006|Overall Study|Equipment Failure|0|||
146626526|NCT04292535|528807702|FG007|Overall Study|Equipment Failure|0|||
146626527|NCT04292535|528807703|FG008|Overall Study|Equipment Failure|0|||
146626528|NCT04292535|528807704|FG009|Overall Study|Equipment Failure|0|||
146626529|NCT04292535|528807705|FG010|Overall Study|Equipment Failure|0|||
146626530|NCT04292535|528807706|FG011|Overall Study|Equipment Failure|1|||
146626531|NCT04292535|528807707|FG012|Overall Study|Equipment Failure|0|||
146626532|NCT04292535|528807708|FG013|Overall Study|Equipment Failure|0|||
146626533|NCT01420861|528807713|FG000|Overall Study|Adverse Event|2|||
146626534|NCT01420861|528807713|FG000|Overall Study|Study terminated by Sponsor|7|||
146626535|NCT01420861|528807713|FG000|Overall Study|Screen failure|7|||
146626536|NCT01420861|528807713|FG000|Overall Study|Randomized not Treated|2|||
146626537|NCT05472090|528807724|FG000|Overall Study|Adverse Event|2|||
146626538|NCT05472090|528807725|FG001|Overall Study|Adverse Event|3|||
146626539|NCT05472090|528807724|FG000|Overall Study|Lack of Efficacy|1|||
146626540|NCT05472090|528807725|FG001|Overall Study|Lack of Efficacy|0|||
146626541|NCT05472090|528807724|FG000|Overall Study|Physician Decision|1|||
146626542|NCT05472090|528807725|FG001|Overall Study|Physician Decision|0|||
146626543|NCT05472090|528807724|FG000|Overall Study|Withdrawal by Subject|2|||
146626544|NCT05472090|528807725|FG001|Overall Study|Withdrawal by Subject|0|||
146626545|NCT05472090|528807724|FG000|Overall Study|Lost to Follow-up|0|||
146626546|NCT05472090|528807725|FG001|Overall Study|Lost to Follow-up|3|||
146626547|NCT03414983|528809359|FG000|Pre-Treatment|Other reasons|1|||
146626548|NCT03414983|528809360|FG001|Pre-Treatment|Other reasons|0|||
146626549|NCT03414983|528809359|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
146626550|NCT03414983|528809360|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
146626551|NCT03414983|528809359|FG000|Pre-Treatment|Participant withdrew consent|1|||
146626552|NCT03414983|528809360|FG001|Pre-Treatment|Participant withdrew consent|3|||
146626553|NCT03414983|528809359|FG000|Treatment|Participant withdrew consent|4|||
146626554|NCT03414983|528809360|FG001|Treatment|Participant withdrew consent|3|||
146626555|NCT03414983|528809359|FG000|Treatment|Participant request to discontinue study treatment|8|||
146626556|NCT03414983|528809360|FG001|Treatment|Participant request to discontinue study treatment|10|||
146626557|NCT03414983|528809359|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
146626558|NCT03414983|528809360|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
146626559|NCT03414983|528809359|FG000|Treatment|Death|0|||
146871269|NCT03250832|529699872|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
146871270|NCT03250832|529699873|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
146871271|NCT03250832|529699874|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
146871272|NCT03250832|529699875|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
146871273|NCT03250832|529699876|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
146871274|NCT03250832|529699877|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
146871275|NCT03250832|529699866|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
146626560|NCT03414983|528809360|FG001|Treatment|Death|1|||
146626561|NCT03414983|528809359|FG000|Treatment|Study Drug Toxicity|10|||
146626562|NCT03414983|528809360|FG001|Treatment|Study Drug Toxicity|5|||
146626563|NCT03414983|528809359|FG000|Treatment|Disease Progression|75|||
146626564|NCT03414983|528809360|FG001|Treatment|Disease Progression|29|||
146871276|NCT03250832|529699867|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
146871277|NCT03250832|529699868|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
146871278|NCT03250832|529699869|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
146871279|NCT03250832|529699870|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
146871280|NCT03250832|529699871|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
146871281|NCT03250832|529699872|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
146871282|NCT03250832|529699873|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
146871283|NCT03250832|529699874|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
146871284|NCT03250832|529699875|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
146871285|NCT03250832|529699876|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
146871286|NCT03250832|529699877|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
146871287|NCT03250832|529699866|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146538834|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
146538835|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
146538836|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Depression|0|||
146538837|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Depression|1|||
146538838|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Depression|0|||
146538839|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
146538840|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
146538841|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
146538842|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Jailed|0|||
146538843|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Jailed|1|||
146538844|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Jailed|0|||
146538845|NCT00090103|528481516|FG000|16-Week Safety Follow-up Period|Other|0|||
146538846|NCT00090103|528481517|FG001|16-Week Safety Follow-up Period|Other|1|||
146538847|NCT00090103|528481518|FG002|16-Week Safety Follow-up Period|Other|0|||
146538848|NCT01799889|528481521|FG000|Overall Study|Adverse Event|4|||
146538849|NCT01799889|528481522|FG001|Overall Study|Adverse Event|4|||
146538850|NCT01799889|528481523|FG002|Overall Study|Adverse Event|5|||
146538851|NCT01799889|528481524|FG003|Overall Study|Adverse Event|1|||
146538852|NCT01799889|528481525|FG004|Overall Study|Adverse Event|11|||
146538853|NCT01799889|528481526|FG005|Overall Study|Adverse Event|1|||
146538854|NCT01799889|528481527|FG006|Overall Study|Adverse Event|5|||
146538855|NCT01799889|528481528|FG007|Overall Study|Adverse Event|2|||
146538856|NCT01799889|528481529|FG008|Overall Study|Adverse Event|3|||
146538857|NCT01799889|528481530|FG009|Overall Study|Adverse Event|1|||
146626565|NCT03414983|528809359|FG000|Treatment|Not reported|1|||
146626566|NCT03414983|528809360|FG001|Treatment|Not reported|0|||
146626567|NCT03414983|528809359|FG000|Treatment|Other reasons|3|||
146626568|NCT03414983|528809360|FG001|Treatment|Other reasons|2|||
146626569|NCT03414983|528809359|FG000|Treatment|Poor/non-compliance|2|||
146626570|NCT03414983|528809360|FG001|Treatment|Poor/non-compliance|0|||
146538858|NCT01799889|528481531|FG010|Overall Study|Adverse Event|1|||
146538859|NCT01799889|528481532|FG011|Overall Study|Adverse Event|0|||
146538860|NCT01799889|528481521|FG000|Overall Study|Death|1|||
146538861|NCT01799889|528481522|FG001|Overall Study|Death|0|||
146538862|NCT01799889|528481523|FG002|Overall Study|Death|5|||
146538863|NCT01799889|528481524|FG003|Overall Study|Death|3|||
146538864|NCT01799889|528481525|FG004|Overall Study|Death|1|||
146626571|NCT03414983|528809359|FG000|Treatment|Maximum clinical benefit|5|||
146626572|NCT03414983|528809360|FG001|Treatment|Maximum clinical benefit|9|||
146626573|NCT03414983|528809359|FG000|Treatment|Lost to Follow-up|0|||
146626574|NCT03414983|528809360|FG001|Treatment|Lost to Follow-up|1|||
146626575|NCT03414983|528809359|FG000|Treatment|Administrative reasons by sponsor|1|||
146626576|NCT03414983|528809360|FG001|Treatment|Administrative reasons by sponsor|0|||
146626577|NCT02608684|528809361|FG000|Overall Study|Physician Decision|2|||
146626578|NCT02608684|528809361|FG000|Overall Study|Withdrawal by Subject|1|||
146626579|NCT00751296|528809362|FG000|Overall Study|Adverse Event|2|||
146626580|NCT01775501|528809367|FG000|Overall Study|Discontinued prior to treatment|1|||
146626581|NCT02318706|528809368|FG000|Double-blind Phase|Adverse Event|7|||
146626582|NCT02318706|528809369|FG001|Double-blind Phase|Adverse Event|4|||
146626583|NCT02318706|528809370|FG002|Double-blind Phase|Adverse Event|3|||
146626584|NCT02318706|528809371|FG003|Double-blind Phase|Adverse Event|10|||
146626585|NCT02318706|528809372|FG004|Double-blind Phase|Adverse Event|0|||
146626586|NCT02318706|528809368|FG000|Double-blind Phase|Lost to Follow-up|1|||
146626587|NCT02318706|528809369|FG001|Double-blind Phase|Lost to Follow-up|0|||
146626588|NCT02318706|528809370|FG002|Double-blind Phase|Lost to Follow-up|0|||
146626589|NCT02318706|528809371|FG003|Double-blind Phase|Lost to Follow-up|0|||
146626590|NCT02318706|528809372|FG004|Double-blind Phase|Lost to Follow-up|0|||
146626591|NCT02318706|528809368|FG000|Double-blind Phase|Protocol Violation|4|||
146626592|NCT02318706|528809369|FG001|Double-blind Phase|Protocol Violation|2|||
146626593|NCT02318706|528809370|FG002|Double-blind Phase|Protocol Violation|4|||
146626594|NCT02318706|528809371|FG003|Double-blind Phase|Protocol Violation|3|||
146626595|NCT02318706|528809372|FG004|Double-blind Phase|Protocol Violation|0|||
146626596|NCT02318706|528809368|FG000|Double-blind Phase|Withdrawal by Subject|9|||
146626597|NCT02318706|528809369|FG001|Double-blind Phase|Withdrawal by Subject|5|||
146626598|NCT02318706|528809370|FG002|Double-blind Phase|Withdrawal by Subject|7|||
146626599|NCT02318706|528809371|FG003|Double-blind Phase|Withdrawal by Subject|10|||
146626600|NCT02318706|528809372|FG004|Double-blind Phase|Withdrawal by Subject|0|||
146626601|NCT02318706|528809368|FG000|Double-blind Phase|Other|4|||
146626602|NCT02318706|528809369|FG001|Double-blind Phase|Other|1|||
146626603|NCT02318706|528809370|FG002|Double-blind Phase|Other|2|||
146626604|NCT02318706|528809371|FG003|Double-blind Phase|Other|1|||
146626605|NCT02318706|528809372|FG004|Double-blind Phase|Other|0|||
146626606|NCT02318706|528809368|FG000|Double-blind Phase|Death|0|||
146626607|NCT02318706|528809369|FG001|Double-blind Phase|Death|0|||
146538865|NCT01799889|528481526|FG005|Overall Study|Death|0|||
146538866|NCT01799889|528481527|FG006|Overall Study|Death|0|||
146626608|NCT02318706|528809370|FG002|Double-blind Phase|Death|2|||
146626609|NCT02318706|528809371|FG003|Double-blind Phase|Death|0|||
146871288|NCT03250832|529699867|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146538867|NCT01799889|528481528|FG007|Overall Study|Death|0|||
146538868|NCT01799889|528481529|FG008|Overall Study|Death|1|||
146538869|NCT01799889|528481530|FG009|Overall Study|Death|0|||
146538870|NCT01799889|528481531|FG010|Overall Study|Death|1|||
146538871|NCT01799889|528481532|FG011|Overall Study|Death|0|||
146538872|NCT01799889|528481521|FG000|Overall Study|Lack of Efficacy|1|||
146538873|NCT01799889|528481522|FG001|Overall Study|Lack of Efficacy|1|||
146538874|NCT01799889|528481523|FG002|Overall Study|Lack of Efficacy|0|||
146538875|NCT01799889|528481524|FG003|Overall Study|Lack of Efficacy|1|||
146538876|NCT01799889|528481525|FG004|Overall Study|Lack of Efficacy|2|||
146538877|NCT01799889|528481526|FG005|Overall Study|Lack of Efficacy|2|||
146538878|NCT01799889|528481527|FG006|Overall Study|Lack of Efficacy|0|||
146538879|NCT01799889|528481528|FG007|Overall Study|Lack of Efficacy|0|||
146538880|NCT01799889|528481529|FG008|Overall Study|Lack of Efficacy|2|||
146538881|NCT01799889|528481530|FG009|Overall Study|Lack of Efficacy|0|||
146871289|NCT03250832|529699868|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
146538882|NCT01799889|528481531|FG010|Overall Study|Lack of Efficacy|1|||
146538883|NCT01799889|528481532|FG011|Overall Study|Lack of Efficacy|0|||
146538884|NCT01799889|528481521|FG000|Overall Study|Lost to Follow-up|0|||
146538885|NCT01799889|528481522|FG001|Overall Study|Lost to Follow-up|1|||
146626610|NCT02318706|528809372|FG004|Double-blind Phase|Death|0|||
146626611|NCT02318706|528809368|FG000|Open-label Extension Phase|Adverse Event|0|||
146626612|NCT02318706|528809369|FG001|Open-label Extension Phase|Adverse Event|0|||
146626613|NCT02318706|528809370|FG002|Open-label Extension Phase|Adverse Event|0|||
146626614|NCT02318706|528809371|FG003|Open-label Extension Phase|Adverse Event|0|||
146626615|NCT02318706|528809372|FG004|Open-label Extension Phase|Adverse Event|21|||
146626616|NCT02318706|528809368|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
146538886|NCT01799889|528481523|FG002|Overall Study|Lost to Follow-up|0|||
146538887|NCT01799889|528481524|FG003|Overall Study|Lost to Follow-up|0|||
146871290|NCT03250832|529699869|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146538888|NCT01799889|528481525|FG004|Overall Study|Lost to Follow-up|0|||
146538889|NCT01799889|528481526|FG005|Overall Study|Lost to Follow-up|0|||
146626617|NCT02318706|528809369|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
146626618|NCT02318706|528809370|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
146626619|NCT02318706|528809371|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
146626620|NCT02318706|528809372|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
146626621|NCT02318706|528809368|FG000|Open-label Extension Phase|Death|0|||
146626622|NCT02318706|528809369|FG001|Open-label Extension Phase|Death|0|||
146538890|NCT01799889|528481527|FG006|Overall Study|Lost to Follow-up|0|||
146538891|NCT01799889|528481528|FG007|Overall Study|Lost to Follow-up|0|||
146538892|NCT01799889|528481529|FG008|Overall Study|Lost to Follow-up|0|||
146538893|NCT01799889|528481530|FG009|Overall Study|Lost to Follow-up|0|||
146538894|NCT01799889|528481531|FG010|Overall Study|Lost to Follow-up|0|||
146538895|NCT01799889|528481532|FG011|Overall Study|Lost to Follow-up|0|||
146538896|NCT01799889|528481521|FG000|Overall Study|Physician Decision|3|||
146538897|NCT01799889|528481522|FG001|Overall Study|Physician Decision|2|||
146538898|NCT01799889|528481523|FG002|Overall Study|Physician Decision|4|||
146538899|NCT01799889|528481524|FG003|Overall Study|Physician Decision|4|||
146538900|NCT01799889|528481525|FG004|Overall Study|Physician Decision|5|||
146538901|NCT01799889|528481526|FG005|Overall Study|Physician Decision|5|||
146538902|NCT01799889|528481527|FG006|Overall Study|Physician Decision|5|||
146538903|NCT01799889|528481528|FG007|Overall Study|Physician Decision|2|||
146538904|NCT01799889|528481529|FG008|Overall Study|Physician Decision|6|||
146538905|NCT01799889|528481530|FG009|Overall Study|Physician Decision|0|||
146538906|NCT01799889|528481531|FG010|Overall Study|Physician Decision|0|||
146538907|NCT01799889|528481532|FG011|Overall Study|Physician Decision|1|||
146538908|NCT01799889|528481521|FG000|Overall Study|Progressive Disease|30|||
146538909|NCT01799889|528481522|FG001|Overall Study|Progressive Disease|26|||
146538910|NCT01799889|528481523|FG002|Overall Study|Progressive Disease|25|||
146538911|NCT01799889|528481524|FG003|Overall Study|Progressive Disease|30|||
146538912|NCT01799889|528481525|FG004|Overall Study|Progressive Disease|23|||
146538913|NCT01799889|528481526|FG005|Overall Study|Progressive Disease|9|||
146538914|NCT01799889|528481527|FG006|Overall Study|Progressive Disease|8|||
146538915|NCT01799889|528481528|FG007|Overall Study|Progressive Disease|13|||
146538916|NCT01799889|528481529|FG008|Overall Study|Progressive Disease|18|||
146538917|NCT01799889|528481530|FG009|Overall Study|Progressive Disease|5|||
146538918|NCT01799889|528481531|FG010|Overall Study|Progressive Disease|3|||
146538919|NCT01799889|528481532|FG011|Overall Study|Progressive Disease|1|||
146538920|NCT01799889|528481521|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
146538921|NCT01799889|528481522|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
146538922|NCT01799889|528481523|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
146538923|NCT01799889|528481524|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
146538924|NCT01799889|528481525|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
146538925|NCT01799889|528481526|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
146538926|NCT01799889|528481527|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
146538927|NCT01799889|528481528|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
146538928|NCT01799889|528481529|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
146538929|NCT01799889|528481530|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
146538930|NCT01799889|528481531|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
146538931|NCT01799889|528481532|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
146538932|NCT01799889|528481521|FG000|Overall Study|Study Terminated By Sponsor|1|||
146538933|NCT01799889|528481522|FG001|Overall Study|Study Terminated By Sponsor|0|||
146538934|NCT01799889|528481523|FG002|Overall Study|Study Terminated By Sponsor|0|||
146538935|NCT01799889|528481524|FG003|Overall Study|Study Terminated By Sponsor|0|||
146538936|NCT01799889|528481525|FG004|Overall Study|Study Terminated By Sponsor|2|||
146538937|NCT01799889|528481526|FG005|Overall Study|Study Terminated By Sponsor|1|||
146538938|NCT01799889|528481527|FG006|Overall Study|Study Terminated By Sponsor|0|||
146538939|NCT01799889|528481528|FG007|Overall Study|Study Terminated By Sponsor|2|||
146538940|NCT01799889|528481529|FG008|Overall Study|Study Terminated By Sponsor|1|||
146538941|NCT01799889|528481530|FG009|Overall Study|Study Terminated By Sponsor|1|||
146538942|NCT01799889|528481531|FG010|Overall Study|Study Terminated By Sponsor|0|||
146538943|NCT01799889|528481532|FG011|Overall Study|Study Terminated By Sponsor|0|||
146538944|NCT01799889|528481521|FG000|Overall Study|Withdrawal by Subject|1|||
146626623|NCT02318706|528809370|FG002|Open-label Extension Phase|Death|0|||
146626624|NCT02318706|528809371|FG003|Open-label Extension Phase|Death|0|||
146626625|NCT02318706|528809372|FG004|Open-label Extension Phase|Death|1|||
146626626|NCT02318706|528809368|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
146763897|NCT00567879|529302918|FG005|Overall Study|Withdrawal by Subject|0|||
146538945|NCT01799889|528481522|FG001|Overall Study|Withdrawal by Subject|6|||
146538946|NCT01799889|528481523|FG002|Overall Study|Withdrawal by Subject|4|||
146538947|NCT01799889|528481524|FG003|Overall Study|Withdrawal by Subject|0|||
146538948|NCT01799889|528481525|FG004|Overall Study|Withdrawal by Subject|5|||
146538949|NCT01799889|528481526|FG005|Overall Study|Withdrawal by Subject|1|||
146538950|NCT01799889|528481527|FG006|Overall Study|Withdrawal by Subject|3|||
146538951|NCT01799889|528481528|FG007|Overall Study|Withdrawal by Subject|1|||
146538952|NCT01799889|528481529|FG008|Overall Study|Withdrawal by Subject|2|||
146763898|NCT00567879|529302913|FG000|Overall Study|New cancer therapy|0|||
146626627|NCT02318706|528809369|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
146626628|NCT02318706|528809370|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
146626629|NCT02318706|528809371|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
146626630|NCT02318706|528809372|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
146626631|NCT01702311|528809373|FG000|Overall Study|Withdrawal by Subject|3|||
146626632|NCT01702311|528809374|FG001|Overall Study|Withdrawal by Subject|2|||
146626633|NCT01702311|528809373|FG000|Overall Study|Discharge less than 24 hours|10|||
146626634|NCT01702311|528809374|FG001|Overall Study|Discharge less than 24 hours|7|||
146626635|NCT01702311|528809373|FG000|Overall Study|Physician Decision|3|||
146626636|NCT01702311|528809374|FG001|Overall Study|Physician Decision|4|||
146626637|NCT03714672|528809379|FG000|Overall Study|Adverse Event|0|||
146626638|NCT03714672|528809380|FG001|Overall Study|Adverse Event|0|||
146626639|NCT03714672|528809381|FG002|Overall Study|Adverse Event|3|||
146626640|NCT03714672|528809382|FG003|Overall Study|Adverse Event|0|||
146626641|NCT03714672|528809379|FG000|Overall Study|Physician Decision|0|||
146626642|NCT03714672|528809380|FG001|Overall Study|Physician Decision|1|||
146626643|NCT03714672|528809381|FG002|Overall Study|Physician Decision|0|||
146626644|NCT03714672|528809382|FG003|Overall Study|Physician Decision|0|||
146626645|NCT03714672|528809379|FG000|Overall Study|Other Reason|1|||
146626646|NCT03714672|528809380|FG001|Overall Study|Other Reason|2|||
146626647|NCT03714672|528809381|FG002|Overall Study|Other Reason|1|||
146626648|NCT03714672|528809382|FG003|Overall Study|Other Reason|1|||
146626649|NCT03714672|528809379|FG000|Overall Study|Lost to Follow-up|1|||
146626650|NCT03714672|528809380|FG001|Overall Study|Lost to Follow-up|1|||
146626651|NCT03714672|528809381|FG002|Overall Study|Lost to Follow-up|0|||
146626652|NCT03714672|528809382|FG003|Overall Study|Lost to Follow-up|0|||
146626653|NCT01054885|528809384|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
146626654|NCT01054885|528809385|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146626655|NCT01054885|528809386|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146626656|NCT01054885|528809387|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146626657|NCT01054885|528809388|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146626658|NCT01054885|528809389|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146626659|NCT01054885|528809390|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146626660|NCT01054885|528809384|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
146626661|NCT01054885|528809385|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
146626662|NCT01054885|528809386|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
146626663|NCT01054885|528809387|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
146626664|NCT01054885|528809388|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
146626665|NCT01054885|528809389|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
146626666|NCT01054885|528809390|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
146626667|NCT01054885|528809384|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
146626668|NCT01054885|528809385|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146626669|NCT01054885|528809386|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146626670|NCT01054885|528809387|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146626671|NCT01054885|528809388|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146626672|NCT01054885|528809389|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146626673|NCT01054885|528809390|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146626674|NCT01054885|528809384|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
146626675|NCT01054885|528809385|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146626676|NCT01054885|528809386|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146626677|NCT01054885|528809387|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146626678|NCT01054885|528809388|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146626679|NCT01054885|528809389|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146626680|NCT01054885|528809390|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146626681|NCT01054885|528809384|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
146626682|NCT01054885|528809385|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
146626683|NCT01054885|528809386|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
146626684|NCT01054885|528809387|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
146626685|NCT01054885|528809388|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
146626686|NCT01054885|528809389|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
146626687|NCT01054885|528809390|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
146965617|NCT04242446|530035197|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146626688|NCT01054885|528809384|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
146626689|NCT01054885|528809385|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146626690|NCT01054885|528809386|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146626691|NCT01054885|528809387|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146763899|NCT00567879|529302914|FG001|Overall Study|New cancer therapy|0|||
146763900|NCT00567879|529302915|FG002|Overall Study|New cancer therapy|1|||
146763901|NCT00567879|529302916|FG003|Overall Study|New cancer therapy|0|||
146626692|NCT01054885|528809388|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146626693|NCT01054885|528809389|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146626694|NCT01054885|528809390|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146626695|NCT01054885|528809384|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
146626696|NCT01054885|528809385|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
146626697|NCT01054885|528809386|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
146626698|NCT01054885|528809387|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
146626699|NCT01054885|528809388|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
146626700|NCT01054885|528809389|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
146626701|NCT01054885|528809390|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
146626702|NCT01054885|528809384|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146626703|NCT01054885|528809385|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146626704|NCT01054885|528809386|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
146626705|NCT01054885|528809387|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
146626706|NCT01054885|528809388|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146626707|NCT01054885|528809389|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
146626708|NCT01054885|528809390|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146626709|NCT01054885|528809384|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
146626710|NCT01054885|528809385|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
146626711|NCT01054885|528809386|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
146626712|NCT01054885|528809387|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
146626713|NCT01054885|528809388|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
146626714|NCT01054885|528809389|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
146626715|NCT01054885|528809390|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
146626716|NCT01054885|528809384|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
146626717|NCT01054885|528809385|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
146626718|NCT01054885|528809386|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
146626719|NCT01054885|528809387|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
146626720|NCT01054885|528809388|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
146626721|NCT01054885|528809389|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
146626722|NCT01054885|528809390|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
146626723|NCT01054885|528809384|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
146626724|NCT01054885|528809385|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
146626725|NCT01054885|528809386|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
146626726|NCT01054885|528809387|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
146626727|NCT01054885|528809388|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
146626728|NCT01054885|528809389|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
146626729|NCT01054885|528809390|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
146626730|NCT01054885|528809384|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
146626731|NCT01054885|528809385|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
146626732|NCT01054885|528809386|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
146626733|NCT01054885|528809387|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
146626734|NCT01054885|528809388|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
146626735|NCT01054885|528809389|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
146626736|NCT01054885|528809390|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
146626737|NCT01054885|528809384|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146626738|NCT01054885|528809385|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
146626739|NCT01054885|528809386|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
146626740|NCT01054885|528809387|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146626741|NCT01054885|528809388|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146626742|NCT01054885|528809389|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
146626743|NCT01054885|528809390|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
146626744|NCT01054885|528809384|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
146626745|NCT01054885|528809385|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
146626746|NCT01054885|528809386|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
146626747|NCT01054885|528809387|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
146626748|NCT01054885|528809388|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
146626749|NCT01054885|528809389|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
146626750|NCT01054885|528809390|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
146626751|NCT01054885|528809384|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
146626752|NCT01054885|528809385|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
146763902|NCT00567879|529302917|FG004|Overall Study|New cancer therapy|0|||
146626753|NCT01054885|528809386|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
146626754|NCT01054885|528809387|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
146626755|NCT01054885|528809388|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
146626756|NCT01054885|528809389|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
146626757|NCT01054885|528809390|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
146626758|NCT01280903|528809391|FG000|Overall Study|Lost to Follow-up|23|||
146626759|NCT01280903|528809392|FG001|Overall Study|Lost to Follow-up|16|||
146626760|NCT03453164|528809393|FG000|Overall Study|Lack of Efficacy|16|||
146626761|NCT03453164|528809393|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
146626762|NCT01074502|528809396|FG000|Overall Study|Withdrawal by Subject|1|||
146626763|NCT02220920|528809404|FG000|Overall Study|Adverse Event|1|||
146626764|NCT02220920|528809405|FG001|Overall Study|Adverse Event|0|||
146626765|NCT02220920|528809404|FG000|Overall Study|Lack of Efficacy|0|||
146626766|NCT02220920|528809405|FG001|Overall Study|Lack of Efficacy|1|||
146626767|NCT02220920|528809404|FG000|Overall Study|Withdrawal by Subject|1|||
146626768|NCT02220920|528809405|FG001|Overall Study|Withdrawal by Subject|0|||
146626769|NCT02220920|528809404|FG000|Overall Study|Conflict with the stopping criteria|1|||
146626770|NCT02220920|528809405|FG001|Overall Study|Conflict with the stopping criteria|2|||
146626771|NCT04945733|528809406|FG000|Overall Study|Physician Decision|1|||
146626772|NCT04945733|528809407|FG001|Overall Study|Physician Decision|3|||
146626773|NCT04945733|528809408|FG002|Overall Study|Physician Decision|0|||
146626774|NCT04945733|528809406|FG000|Overall Study|Withdrawal by Subject|3|||
146626775|NCT04945733|528809407|FG001|Overall Study|Withdrawal by Subject|3|||
146626776|NCT04945733|528809408|FG002|Overall Study|Withdrawal by Subject|0|||
146626777|NCT00726063|528809409|FG000|Overall Study|Adverse Event|9|||
146626778|NCT00726063|528809410|FG001|Overall Study|Adverse Event|7|||
146626779|NCT02007096|528809411|FG000|Overall Study|medication not available|2|||
146626780|NCT02007096|528809412|FG001|Overall Study|medication not available|0|||
146626781|NCT02007096|528809411|FG000|Overall Study|did not inject saline|0|||
146538953|NCT01799889|528481530|FG009|Overall Study|Withdrawal by Subject|1|||
146538954|NCT01799889|528481531|FG010|Overall Study|Withdrawal by Subject|1|||
146538955|NCT01799889|528481532|FG011|Overall Study|Withdrawal by Subject|1|||
146538956|NCT01799889|528481521|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146538957|NCT01799889|528481522|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146538958|NCT01799889|528481523|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146538959|NCT01799889|528481524|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146538960|NCT01799889|528481525|FG004|Overall Study|Non-Compliance With Study Drug|0|||
146538961|NCT01799889|528481526|FG005|Overall Study|Non-Compliance With Study Drug|1|||
146538962|NCT01799889|528481527|FG006|Overall Study|Non-Compliance With Study Drug|0|||
146538963|NCT01799889|528481528|FG007|Overall Study|Non-Compliance With Study Drug|0|||
146538964|NCT01799889|528481529|FG008|Overall Study|Non-Compliance With Study Drug|0|||
146538965|NCT01799889|528481530|FG009|Overall Study|Non-Compliance With Study Drug|0|||
146538966|NCT01799889|528481531|FG010|Overall Study|Non-Compliance With Study Drug|0|||
146538967|NCT01799889|528481532|FG011|Overall Study|Non-Compliance With Study Drug|0|||
146538968|NCT04476043|528481533|FG000|Overall Study|Withdrawal by Subject|1|||
146538969|NCT04476043|528481534|FG001|Overall Study|Withdrawal by Subject|3|||
146538970|NCT04476043|528481535|FG002|Overall Study|Withdrawal by Subject|4|||
146538971|NCT04476043|528481536|FG003|Overall Study|Withdrawal by Subject|1|||
146538972|NCT04476043|528481533|FG000|Overall Study|Lost to Follow-up|1|||
146538973|NCT04476043|528481534|FG001|Overall Study|Lost to Follow-up|1|||
146538974|NCT04476043|528481535|FG002|Overall Study|Lost to Follow-up|2|||
146538975|NCT04476043|528481536|FG003|Overall Study|Lost to Follow-up|1|||
146538976|NCT04476043|528481533|FG000|Overall Study|Adverse Event|2|||
146538977|NCT04476043|528481534|FG001|Overall Study|Adverse Event|0|||
146538978|NCT04476043|528481535|FG002|Overall Study|Adverse Event|1|||
146538979|NCT04476043|528481536|FG003|Overall Study|Adverse Event|0|||
146538980|NCT04476043|528481533|FG000|Overall Study|Protocol Violation|0|||
146538981|NCT04476043|528481534|FG001|Overall Study|Protocol Violation|1|||
146538982|NCT04476043|528481535|FG002|Overall Study|Protocol Violation|0|||
146538983|NCT04476043|528481536|FG003|Overall Study|Protocol Violation|0|||
146538984|NCT06217380|528481537|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
146538985|NCT06217380|528481537|FG000|Overall Study|Physician Decision|1|||
146538986|NCT06217380|528481537|FG000|Overall Study|Withdrawal by Subject|2|||
146538987|NCT06633965|528481538|FG000|Overall Study|Withdrawal by Subject|0|||
146626782|NCT02007096|528809412|FG001|Overall Study|did not inject saline|3|||
146626783|NCT02007096|528809411|FG000|Overall Study|did not follow postoperative protocol|8|||
146626784|NCT02007096|528809412|FG001|Overall Study|did not follow postoperative protocol|11|||
146626785|NCT02007096|528809411|FG000|Overall Study|converted to open surgery|1|||
146538988|NCT06633965|528481539|FG001|Overall Study|Withdrawal by Subject|1|||
146538989|NCT02469233|528481540|FG000|Overall Study|Death|1|||
146538990|NCT02469233|528481541|FG001|Overall Study|Death|1|||
146538991|NCT02469233|528481540|FG000|Overall Study|Lost to post or 6 month follow up|7|||
146538992|NCT02469233|528481541|FG001|Overall Study|Lost to post or 6 month follow up|2|||
146626786|NCT02007096|528809412|FG001|Overall Study|converted to open surgery|1|||
146626787|NCT02007096|528809411|FG000|Overall Study|no mesh placed|0|||
146626788|NCT02007096|528809412|FG001|Overall Study|no mesh placed|1|||
146626789|NCT01231984|528809413|FG000|Study Period 1|Withdrawal by Subject|0|||
146626790|NCT01231984|528809414|FG001|Study Period 1|Withdrawal by Subject|0|||
146626791|NCT01231984|528809415|FG002|Study Period 1|Withdrawal by Subject|0|||
146626792|NCT01231984|528809416|FG003|Study Period 1|Withdrawal by Subject|1|||
146626793|NCT01231984|528809413|FG000|Study Period 1|Lost to Follow-up|1|||
146538993|NCT00947544|528481542|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
146538994|NCT00947544|528481543|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
146538995|NCT02566005|528481549|FG000|Overall Study|vaginal bleeding|0|||
146538996|NCT02566005|528481550|FG001|Overall Study|vaginal bleeding|1|||
146538997|NCT02566005|528481549|FG000|Overall Study|received foley|8|||
146538998|NCT02566005|528481550|FG001|Overall Study|received foley|0|||
146538999|NCT02566005|528481549|FG000|Overall Study|did not receive foley|0|||
146539000|NCT02566005|528481550|FG001|Overall Study|did not receive foley|1|||
146539001|NCT02566005|528481549|FG000|Overall Study|labor after randomization|0|||
146539002|NCT02566005|528481550|FG001|Overall Study|labor after randomization|4|||
146539003|NCT03345004|528481551|FG000|Overall Study|Physician Decision|1|||
146539004|NCT03345004|528481552|FG001|Overall Study|Physician Decision|0|||
146539005|NCT03345004|528481551|FG000|Overall Study|Withdrawal by Subject|0|||
146539006|NCT03345004|528481552|FG001|Overall Study|Withdrawal by Subject|1|||
146539007|NCT01013753|528481555|FG000|Overall Study|Adverse Event|8|||
146539008|NCT01013753|528481555|FG000|Overall Study|Protocol Violation|3|||
146539009|NCT01013753|528481555|FG000|Overall Study|Lost to Follow-up|1|||
146539010|NCT01013753|528481555|FG000|Overall Study|Withdrawal by Subject|2|||
146539011|NCT01013753|528481555|FG000|Overall Study|Other|2|||
146539012|NCT04757636|528481556|FG000|Overall Study|Adverse Event|25|||
146539013|NCT04757636|528481557|FG001|Overall Study|Adverse Event|8|||
146539014|NCT04757636|528481558|FG002|Overall Study|Adverse Event|11|||
146539015|NCT04757636|528481556|FG000|Overall Study|Death|9|||
146539016|NCT04757636|528481557|FG001|Overall Study|Death|12|||
146539017|NCT04757636|528481558|FG002|Overall Study|Death|6|||
146871291|NCT03250832|529699870|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146871292|NCT03250832|529699871|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146871293|NCT03250832|529699872|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146871294|NCT03250832|529699873|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146871295|NCT03250832|529699874|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146871296|NCT03250832|529699875|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146871297|NCT03250832|529699876|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146871298|NCT03250832|529699877|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146871299|NCT03250832|529699866|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
146871300|NCT03250832|529699867|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
146871301|NCT03250832|529699868|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
146871302|NCT03250832|529699869|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
146871303|NCT03250832|529699870|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
146871304|NCT03250832|529699871|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
146871305|NCT03250832|529699872|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
146871306|NCT03250832|529699873|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
146871307|NCT03250832|529699874|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
146871308|NCT03250832|529699875|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
146871309|NCT03250832|529699876|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
146871310|NCT03250832|529699877|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
146871311|NCT03250832|529699866|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146539018|NCT04757636|528481556|FG000|Overall Study|Lack of Efficacy|2|||
146539019|NCT04757636|528481557|FG001|Overall Study|Lack of Efficacy|0|||
146539020|NCT04757636|528481558|FG002|Overall Study|Lack of Efficacy|0|||
146539021|NCT04757636|528481556|FG000|Overall Study|Lost to Follow-up|1|||
146539022|NCT04757636|528481557|FG001|Overall Study|Lost to Follow-up|6|||
146539023|NCT04757636|528481558|FG002|Overall Study|Lost to Follow-up|7|||
146539024|NCT04757636|528481556|FG000|Overall Study|Physician Decision|1|||
146539025|NCT04757636|528481557|FG001|Overall Study|Physician Decision|3|||
146539026|NCT04757636|528481558|FG002|Overall Study|Physician Decision|4|||
146539027|NCT04757636|528481556|FG000|Overall Study|Withdrawal by Subject|20|||
146539028|NCT04757636|528481557|FG001|Overall Study|Withdrawal by Subject|23|||
146539029|NCT04757636|528481558|FG002|Overall Study|Withdrawal by Subject|18|||
146626794|NCT01231984|528809414|FG001|Study Period 1|Lost to Follow-up|1|||
146626795|NCT01231984|528809415|FG002|Study Period 1|Lost to Follow-up|1|||
146539030|NCT04757636|528481556|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
146626796|NCT01231984|528809416|FG003|Study Period 1|Lost to Follow-up|0|||
146539031|NCT04757636|528481557|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
146626797|NCT01231984|528809413|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
146871312|NCT03250832|529699867|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146965618|NCT04242446|530035191|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
146626798|NCT01231984|528809414|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
146626799|NCT01231984|528809415|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
146626800|NCT01231984|528809416|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
146626801|NCT01231984|528809413|FG000|Study Period 1|Screen Failure|0|||
146626802|NCT01231984|528809414|FG001|Study Period 1|Screen Failure|0|||
146626803|NCT01231984|528809415|FG002|Study Period 1|Screen Failure|0|||
146626804|NCT01231984|528809416|FG003|Study Period 1|Screen Failure|1|||
146626805|NCT01231984|528809413|FG000|Study Period 1|Non-compliance with study requirements|5|||
146626806|NCT01231984|528809414|FG001|Study Period 1|Non-compliance with study requirements|0|||
146626807|NCT01231984|528809415|FG002|Study Period 1|Non-compliance with study requirements|2|||
146626808|NCT01231984|528809416|FG003|Study Period 1|Non-compliance with study requirements|1|||
146626809|NCT01231984|528809413|FG000|Study Period 1|Protocol Violation|3|||
146626810|NCT01231984|528809414|FG001|Study Period 1|Protocol Violation|4|||
146626811|NCT01231984|528809415|FG002|Study Period 1|Protocol Violation|2|||
146626812|NCT01231984|528809416|FG003|Study Period 1|Protocol Violation|3|||
146626813|NCT01231984|528809413|FG000|Study Period 1|Adverse Event|1|||
146626814|NCT01231984|528809414|FG001|Study Period 1|Adverse Event|0|||
146626815|NCT01231984|528809415|FG002|Study Period 1|Adverse Event|0|||
146626816|NCT01231984|528809416|FG003|Study Period 1|Adverse Event|0|||
146626817|NCT01231984|528809413|FG000|Study Period 1|Other|0|||
146626818|NCT01231984|528809414|FG001|Study Period 1|Other|0|||
146626819|NCT01231984|528809415|FG002|Study Period 1|Other|0|||
146626820|NCT01231984|528809416|FG003|Study Period 1|Other|1|||
146626821|NCT01231984|528809413|FG000|Study Period 2|Withdrawal by Subject|1|||
146626822|NCT01231984|528809414|FG001|Study Period 2|Withdrawal by Subject|1|||
146626823|NCT01231984|528809415|FG002|Study Period 2|Withdrawal by Subject|0|||
146626824|NCT01231984|528809416|FG003|Study Period 2|Withdrawal by Subject|0|||
146626825|NCT01231984|528809413|FG000|Study Period 2|Lost to Follow-up|1|||
146626826|NCT01231984|528809414|FG001|Study Period 2|Lost to Follow-up|0|||
146626827|NCT01231984|528809415|FG002|Study Period 2|Lost to Follow-up|0|||
146626828|NCT01231984|528809416|FG003|Study Period 2|Lost to Follow-up|3|||
146626829|NCT01231984|528809413|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
146626830|NCT01231984|528809414|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
146626831|NCT01231984|528809415|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
146626832|NCT01231984|528809416|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
146626833|NCT02182895|528809419|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
146626834|NCT02182895|528809420|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
146626835|NCT03566511|528809422|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
146626836|NCT03566511|528809423|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
146626837|NCT04026113|528809424|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
146626838|NCT04026113|528809425|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
146626839|NCT04026113|528809426|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
146539032|NCT04757636|528481558|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
146539033|NCT04757636|528481556|FG000|Overall Study|Study Terminated by Sponsor|103|||
146539034|NCT04757636|528481557|FG001|Overall Study|Study Terminated by Sponsor|104|||
146539035|NCT04757636|528481558|FG002|Overall Study|Study Terminated by Sponsor|114|||
146626840|NCT04026113|528809427|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
146626841|NCT04026113|528809424|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
146626842|NCT04026113|528809425|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
146626843|NCT04026113|528809426|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
146626844|NCT04026113|528809427|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
146626845|NCT04026113|528809424|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
146626846|NCT04026113|528809425|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146626847|NCT04026113|528809426|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
146626848|NCT04026113|528809427|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146539036|NCT04757636|528481556|FG000|Overall Study|Sponsor Decision|0|||
146539037|NCT04757636|528481557|FG001|Overall Study|Sponsor Decision|0|||
146539038|NCT04757636|528481558|FG002|Overall Study|Sponsor Decision|1|||
146539039|NCT04757636|528481556|FG000|Overall Study|Randomized in Error|0|||
146539040|NCT04757636|528481557|FG001|Overall Study|Randomized in Error|0|||
146539041|NCT04757636|528481558|FG002|Overall Study|Randomized in Error|2|||
146539042|NCT02349386|528481559|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
146539043|NCT02349386|528481560|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
146539044|NCT02349386|528481561|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
146626849|NCT04026113|528809424|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
146626850|NCT04026113|528809425|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
146539045|NCT02349386|528481562|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
146539046|NCT02349386|528481559|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
146626851|NCT04026113|528809426|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
146626852|NCT04026113|528809427|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
146763903|NCT00567879|529302918|FG005|Overall Study|New cancer therapy|0|||
146763904|NCT00567879|529302913|FG000|Overall Study|Disease progression|5|||
146539047|NCT02349386|528481560|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
146626853|NCT04026113|528809424|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
146626854|NCT04026113|528809425|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
146626855|NCT04026113|528809426|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
146539048|NCT02349386|528481561|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
146539049|NCT02349386|528481562|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
146539050|NCT02349386|528481559|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
146539051|NCT02349386|528481560|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
146539052|NCT02349386|528481561|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
146539053|NCT02349386|528481562|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
146539054|NCT02349386|528481559|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
146539055|NCT02349386|528481560|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
146539056|NCT02349386|528481561|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
146539057|NCT02349386|528481562|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
146539058|NCT02349386|528481559|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
146539059|NCT02349386|528481560|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
146539060|NCT02349386|528481561|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
146539061|NCT02349386|528481562|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
146539062|NCT02349386|528481559|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
146539063|NCT02349386|528481560|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
146539064|NCT02349386|528481561|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
146539065|NCT02349386|528481562|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
146539066|NCT00984867|528481563|FG000|Overall Study|Adverse Event|3|||
146539067|NCT00984867|528481564|FG001|Overall Study|Adverse Event|7|||
146539068|NCT00984867|528481563|FG000|Overall Study|Death|1|||
146539069|NCT00984867|528481564|FG001|Overall Study|Death|0|||
146539070|NCT00984867|528481563|FG000|Overall Study|Withdrawal by Subject|13|||
146539071|NCT00984867|528481564|FG001|Overall Study|Withdrawal by Subject|4|||
146539072|NCT00984867|528481563|FG000|Overall Study|Lost to Follow-up|3|||
146539073|NCT00984867|528481564|FG001|Overall Study|Lost to Follow-up|4|||
146539074|NCT00984867|528481563|FG000|Overall Study|Poor/non-compliance|0|||
146539075|NCT00984867|528481564|FG001|Overall Study|Poor/non-compliance|1|||
146539076|NCT00984867|528481563|FG000|Overall Study|Subject no longer meets study criteria|1|||
146539077|NCT00984867|528481564|FG001|Overall Study|Subject no longer meets study criteria|1|||
146539078|NCT00984867|528481563|FG000|Overall Study|site closing|1|||
146539079|NCT00984867|528481564|FG001|Overall Study|site closing|0|||
146539080|NCT00984867|528481563|FG000|Overall Study|lack of efficacy and subject compliance|1|||
146539081|NCT00984867|528481564|FG001|Overall Study|lack of efficacy and subject compliance|0|||
146539082|NCT06057064|528481565|FG000|Overall Study|Death|2|||
146539083|NCT06057064|528481566|FG001|Overall Study|Death|0|||
146539084|NCT06057064|528481565|FG000|Overall Study|Physician Decision|1|||
146539085|NCT06057064|528481566|FG001|Overall Study|Physician Decision|0|||
146539086|NCT06057064|528481565|FG000|Overall Study|Withdrawal by Subject|1|||
146539087|NCT06057064|528481566|FG001|Overall Study|Withdrawal by Subject|1|||
146539088|NCT01155141|528481574|FG000|Overall Study|Withdrawal by Subject|1|||
146539089|NCT01155141|528481574|FG000|Overall Study|Screen Failure|1|||
146539090|NCT00785629|528481576|FG000|Overall Study|Adverse Event|2|||
146539091|NCT00785629|528481577|FG001|Overall Study|Adverse Event|1|||
146539092|NCT00785629|528481578|FG002|Overall Study|Adverse Event|1|||
146539093|NCT00785629|528481579|FG003|Overall Study|Adverse Event|5|||
146539094|NCT00785629|528481576|FG000|Overall Study|Protocol Violation|1|||
146539095|NCT00785629|528481577|FG001|Overall Study|Protocol Violation|2|||
146539096|NCT00785629|528481578|FG002|Overall Study|Protocol Violation|4|||
146539097|NCT00785629|528481579|FG003|Overall Study|Protocol Violation|5|||
146539098|NCT00785629|528481576|FG000|Overall Study|administrative decision|5|||
146539099|NCT00785629|528481577|FG001|Overall Study|administrative decision|1|||
146539100|NCT00785629|528481578|FG002|Overall Study|administrative decision|3|||
146539101|NCT00785629|528481579|FG003|Overall Study|administrative decision|4|||
146626856|NCT04026113|528809427|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
146626857|NCT04026113|528809424|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
146626858|NCT04026113|528809425|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
146626859|NCT04026113|528809426|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
146539102|NCT00785629|528481576|FG000|Overall Study|Withdrawal by Subject|0|||
146539103|NCT00785629|528481577|FG001|Overall Study|Withdrawal by Subject|1|||
146539104|NCT00785629|528481578|FG002|Overall Study|Withdrawal by Subject|2|||
146539105|NCT00785629|528481579|FG003|Overall Study|Withdrawal by Subject|2|||
146539106|NCT01898130|528481583|FG000|Treatment|Withdrawal by Subject|2|||
146539107|NCT01898130|528481583|FG000|Treatment|Progressive Disease|4|||
146539108|NCT01898130|528481583|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
146539109|NCT00920816|528481584|FG000|Overall Study|Death|116|||
146626860|NCT04026113|528809427|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
146626861|NCT04026113|528809424|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
146626862|NCT04026113|528809425|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
146626863|NCT04026113|528809426|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
146626864|NCT04026113|528809427|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
146626865|NCT04026113|528809424|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
146626866|NCT04026113|528809425|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
146626867|NCT04026113|528809426|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
146626868|NCT04026113|528809427|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
146626869|NCT04026113|528809424|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
146626870|NCT04026113|528809425|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
146539110|NCT00920816|528481585|FG001|Overall Study|Death|63|||
146539111|NCT00920816|528481586|FG002|Overall Study|Death|8|||
146539112|NCT00920816|528481587|FG003|Overall Study|Death|3|||
146539113|NCT00920816|528481584|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
146539114|NCT00920816|528481585|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
146539115|NCT00920816|528481586|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
146539116|NCT00920816|528481587|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
146539117|NCT00920816|528481584|FG000|Overall Study|Global deterioration of health status|2|||
146539118|NCT00920816|528481585|FG001|Overall Study|Global deterioration of health status|0|||
146539119|NCT00920816|528481586|FG002|Overall Study|Global deterioration of health status|0|||
146539120|NCT00920816|528481587|FG003|Overall Study|Global deterioration of health status|0|||
146539121|NCT00920816|528481584|FG000|Overall Study|Objective progression or relapse|6|||
146539122|NCT00920816|528481585|FG001|Overall Study|Objective progression or relapse|2|||
146539123|NCT00920816|528481586|FG002|Overall Study|Objective progression or relapse|0|||
146539124|NCT00920816|528481587|FG003|Overall Study|Objective progression or relapse|0|||
146539125|NCT00920816|528481584|FG000|Overall Study|Other|26|||
146539126|NCT00920816|528481585|FG001|Overall Study|Other|15|||
146539127|NCT00920816|528481586|FG002|Overall Study|Other|1|||
146539128|NCT00920816|528481587|FG003|Overall Study|Other|2|||
146539129|NCT00920816|528481584|FG000|Overall Study|Lost to Follow-up|11|||
146539130|NCT00920816|528481585|FG001|Overall Study|Lost to Follow-up|2|||
146539131|NCT00920816|528481586|FG002|Overall Study|Lost to Follow-up|0|||
146539132|NCT00920816|528481587|FG003|Overall Study|Lost to Follow-up|0|||
146539133|NCT00920816|528481584|FG000|Overall Study|Adverse Event|1|||
146539134|NCT00920816|528481585|FG001|Overall Study|Adverse Event|1|||
146539135|NCT00920816|528481586|FG002|Overall Study|Adverse Event|1|||
146539136|NCT00920816|528481587|FG003|Overall Study|Adverse Event|0|||
146539137|NCT00920816|528481584|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
146539138|NCT00920816|528481585|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
146539139|NCT00920816|528481586|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
146539140|NCT00920816|528481587|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
146539141|NCT00920816|528481584|FG000|Overall Study|Randomized but not treated|3|||
146539142|NCT00920816|528481585|FG001|Overall Study|Randomized but not treated|0|||
146539143|NCT00920816|528481586|FG002|Overall Study|Randomized but not treated|0|||
146539144|NCT00920816|528481587|FG003|Overall Study|Randomized but not treated|0|||
146539145|NCT01572792|528481590|FG000|Lead-in Study|Lost to Follow-up|5|||
146539146|NCT01572792|528481591|FG001|Lead-in Study|Lost to Follow-up|9|||
146539147|NCT01572792|528481592|FG002|Lead-in Study|Lost to Follow-up|4|||
146539148|NCT01572792|528481593|FG003|Lead-in Study|Lost to Follow-up|2|||
146539149|NCT01572792|528481594|FG004|Lead-in Study|Lost to Follow-up|4|||
146539150|NCT01572792|528481590|FG000|Lead-in Study|Withdrawal by Subject|22|||
146539151|NCT01572792|528481591|FG001|Lead-in Study|Withdrawal by Subject|11|||
146539152|NCT01572792|528481592|FG002|Lead-in Study|Withdrawal by Subject|12|||
146539153|NCT01572792|528481593|FG003|Lead-in Study|Withdrawal by Subject|24|||
146539154|NCT01572792|528481594|FG004|Lead-in Study|Withdrawal by Subject|11|||
146539155|NCT01572792|528481590|FG000|Lead-in Study|Protocol Violation|19|||
146539156|NCT01572792|528481591|FG001|Lead-in Study|Protocol Violation|10|||
146539157|NCT01572792|528481592|FG002|Lead-in Study|Protocol Violation|12|||
146539158|NCT01572792|528481593|FG003|Lead-in Study|Protocol Violation|13|||
146539159|NCT01572792|528481594|FG004|Lead-in Study|Protocol Violation|21|||
146539160|NCT01572792|528481590|FG000|Lead-in Study|Lack of Efficacy|20|||
146539161|NCT01572792|528481591|FG001|Lead-in Study|Lack of Efficacy|5|||
146539162|NCT01572792|528481592|FG002|Lead-in Study|Lack of Efficacy|4|||
146539163|NCT01572792|528481593|FG003|Lead-in Study|Lack of Efficacy|8|||
146539164|NCT01572792|528481594|FG004|Lead-in Study|Lack of Efficacy|10|||
146539165|NCT01572792|528481590|FG000|Lead-in Study|Adverse Event|21|||
146539166|NCT01572792|528481591|FG001|Lead-in Study|Adverse Event|21|||
146539167|NCT01572792|528481592|FG002|Lead-in Study|Adverse Event|22|||
146539168|NCT01572792|528481593|FG003|Lead-in Study|Adverse Event|16|||
146539169|NCT01572792|528481594|FG004|Lead-in Study|Adverse Event|14|||
146539170|NCT01572792|528481590|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
146539171|NCT01572792|528481591|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
146539172|NCT01572792|528481592|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
146539173|NCT01572792|528481593|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
146539174|NCT01572792|528481594|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
146539175|NCT01572792|528481590|FG000|Extension Study|Lost to Follow-up|6|||
146539176|NCT01572792|528481591|FG001|Extension Study|Lost to Follow-up|2|||
146539177|NCT01572792|528481592|FG002|Extension Study|Lost to Follow-up|0|||
146539178|NCT01572792|528481593|FG003|Extension Study|Lost to Follow-up|3|||
146539179|NCT01572792|528481594|FG004|Extension Study|Lost to Follow-up|3|||
146539180|NCT01572792|528481590|FG000|Extension Study|Withdrawal by Subject|7|||
146539181|NCT01572792|528481591|FG001|Extension Study|Withdrawal by Subject|6|||
146539182|NCT01572792|528481592|FG002|Extension Study|Withdrawal by Subject|11|||
146539183|NCT01572792|528481593|FG003|Extension Study|Withdrawal by Subject|8|||
146539184|NCT01572792|528481594|FG004|Extension Study|Withdrawal by Subject|14|||
146539185|NCT01572792|528481590|FG000|Extension Study|Protocol Violation|0|||
146539186|NCT01572792|528481591|FG001|Extension Study|Protocol Violation|4|||
146539187|NCT01572792|528481592|FG002|Extension Study|Protocol Violation|3|||
146539188|NCT01572792|528481593|FG003|Extension Study|Protocol Violation|4|||
146539189|NCT01572792|528481594|FG004|Extension Study|Protocol Violation|3|||
146539190|NCT01572792|528481590|FG000|Extension Study|Lack of Efficacy|2|||
146539191|NCT01572792|528481591|FG001|Extension Study|Lack of Efficacy|3|||
146539192|NCT01572792|528481592|FG002|Extension Study|Lack of Efficacy|3|||
146539193|NCT01572792|528481593|FG003|Extension Study|Lack of Efficacy|2|||
146539194|NCT01572792|528481594|FG004|Extension Study|Lack of Efficacy|2|||
146539195|NCT01572792|528481590|FG000|Extension Study|Adverse Event|7|||
146539196|NCT01572792|528481591|FG001|Extension Study|Adverse Event|6|||
146539197|NCT01572792|528481592|FG002|Extension Study|Adverse Event|5|||
146539198|NCT01572792|528481593|FG003|Extension Study|Adverse Event|6|||
146539199|NCT01572792|528481594|FG004|Extension Study|Adverse Event|4|||
146539200|NCT01572792|528481590|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
146539201|NCT01572792|528481591|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
146539202|NCT01572792|528481592|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
146539203|NCT01572792|528481593|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
146539204|NCT01572792|528481594|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
146539205|NCT02472353|528481595|FG000|Overall Study|Lost to Follow-up|1|||
146539206|NCT02472353|528481596|FG001|Overall Study|Lost to Follow-up|1|||
146539207|NCT02472353|528481595|FG000|Overall Study|Withdrawal by Subject|2|||
146539208|NCT02472353|528481596|FG001|Overall Study|Withdrawal by Subject|1|||
146539209|NCT02472353|528481595|FG000|Overall Study|Study Termination|1|||
146539210|NCT02472353|528481596|FG001|Overall Study|Study Termination|4|||
146539211|NCT00797563|528481597|FG000|Overall Study|Adverse Event|1|||
146539212|NCT03416179|528481598|FG000|Overall Study|Death|90|||
146539213|NCT03416179|528481599|FG001|Overall Study|Death|87|||
146539214|NCT03416179|528481600|FG002|Overall Study|Death|117|||
146539215|NCT03416179|528481601|FG003|Overall Study|Death|113|||
146539216|NCT03416179|528481598|FG000|Overall Study|Withdrawal by Subject|15|||
146539217|NCT03416179|528481599|FG001|Overall Study|Withdrawal by Subject|20|||
146539218|NCT03416179|528481600|FG002|Overall Study|Withdrawal by Subject|6|||
146539219|NCT03416179|528481601|FG003|Overall Study|Withdrawal by Subject|9|||
146539220|NCT03416179|528481598|FG000|Overall Study|Lost to Follow-up|1|||
146539221|NCT03416179|528481599|FG001|Overall Study|Lost to Follow-up|1|||
146539222|NCT03416179|528481600|FG002|Overall Study|Lost to Follow-up|0|||
146539223|NCT03416179|528481601|FG003|Overall Study|Lost to Follow-up|3|||
146539224|NCT03416179|528481598|FG000|Overall Study|Study participation terminated by Sponsor|93|||
146539225|NCT03416179|528481599|FG001|Overall Study|Study participation terminated by Sponsor|91|||
146539226|NCT03416179|528481600|FG002|Overall Study|Study participation terminated by Sponsor|26|||
146539227|NCT03416179|528481601|FG003|Overall Study|Study participation terminated by Sponsor|31|||
146539228|NCT03416179|528481598|FG000|Overall Study|Other|2|||
146539229|NCT03416179|528481599|FG001|Overall Study|Other|3|||
146539230|NCT03416179|528481600|FG002|Overall Study|Other|1|||
146539231|NCT03416179|528481601|FG003|Overall Study|Other|0|||
146539232|NCT00688597|528481603|FG000|Overall Study|Adverse Event|2|||
146539233|NCT00688597|528481604|FG001|Overall Study|Adverse Event|0|||
146539234|NCT00688597|528481605|FG002|Overall Study|Adverse Event|0|||
146539235|NCT00688597|528481603|FG000|Overall Study|Physician Decision|1|||
146539236|NCT00688597|528481604|FG001|Overall Study|Physician Decision|0|||
146539237|NCT00688597|528481605|FG002|Overall Study|Physician Decision|0|||
146539238|NCT06438601|528481606|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
146539239|NCT06438601|528481607|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
146539240|NCT06438601|528481606|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
146539241|NCT06438601|528481607|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
146539242|NCT05233761|528481610|FG000|Treatment Period A|Withdrawal by Subject|12|||
146539243|NCT05233761|528481611|FG001|Treatment Period A|Withdrawal by Subject|10|||
146539244|NCT05233761|528481610|FG000|Treatment Period A|Lost to Follow-up|6|||
146539245|NCT05233761|528481611|FG001|Treatment Period A|Lost to Follow-up|12|||
146539246|NCT05233761|528481610|FG000|Treatment Period A|Protocol Violation|8|||
146539247|NCT05233761|528481611|FG001|Treatment Period A|Protocol Violation|15|||
146539248|NCT04058717|528481616|FG000|Randomization Period|Lost to Follow-up|2|||
146539249|NCT04058717|528481617|FG001|Randomization Period|Lost to Follow-up|3|||
146539250|NCT04058717|528481618|FG002|Randomization Period|Lost to Follow-up|4|||
146539251|NCT04058717|528481619|FG003|Randomization Period|Lost to Follow-up|4|||
146539252|NCT04058717|528481616|FG000|Randomization Period|Withdrawal by Subject|1|||
146539253|NCT04058717|528481617|FG001|Randomization Period|Withdrawal by Subject|3|||
146539254|NCT04058717|528481618|FG002|Randomization Period|Withdrawal by Subject|3|||
146539255|NCT04058717|528481619|FG003|Randomization Period|Withdrawal by Subject|3|||
146539256|NCT04058717|528481616|FG000|Randomization Period|PI decision|0|||
146539257|NCT04058717|528481617|FG001|Randomization Period|PI decision|1|||
146539258|NCT04058717|528481618|FG002|Randomization Period|PI decision|0|||
146539259|NCT04058717|528481619|FG003|Randomization Period|PI decision|0|||
146539260|NCT01925417|528481620|FG000|Overall Study|Withdrawal by Subject|2|||
146539261|NCT01925417|528481620|FG000|Overall Study|Death|1|||
146539262|NCT01047319|528481621|FG000|Overall Study|Teva requested participant withdrawal|3|||
146539263|NCT01047319|528481622|FG001|Overall Study|Teva requested participant withdrawal|0|||
146539264|NCT01047319|528481623|FG002|Overall Study|Teva requested participant withdrawal|1|||
146539265|NCT01047319|528481621|FG000|Overall Study|Protocol Violation|3|||
146539266|NCT01047319|528481622|FG001|Overall Study|Protocol Violation|2|||
146539267|NCT01047319|528481623|FG002|Overall Study|Protocol Violation|4|||
146539268|NCT01047319|528481621|FG000|Overall Study|Lack of Efficacy|4|||
146539269|NCT01047319|528481622|FG001|Overall Study|Lack of Efficacy|3|||
146539270|NCT01047319|528481623|FG002|Overall Study|Lack of Efficacy|3|||
146539271|NCT01047319|528481621|FG000|Overall Study|Death|5|||
146539272|NCT01047319|528481622|FG001|Overall Study|Death|1|||
146539273|NCT01047319|528481623|FG002|Overall Study|Death|5|||
146539274|NCT01047319|528481621|FG000|Overall Study|Pregnancy|13|||
146539275|NCT01047319|528481622|FG001|Overall Study|Pregnancy|8|||
146539276|NCT01047319|528481623|FG002|Overall Study|Pregnancy|8|||
146539277|NCT01047319|528481621|FG000|Overall Study|Physician Decision|12|||
146539278|NCT01047319|528481622|FG001|Overall Study|Physician Decision|9|||
146539279|NCT01047319|528481623|FG002|Overall Study|Physician Decision|10|||
146539280|NCT01047319|528481621|FG000|Overall Study|Lost to Follow-up|14|||
146539281|NCT01047319|528481622|FG001|Overall Study|Lost to Follow-up|10|||
146539282|NCT01047319|528481623|FG002|Overall Study|Lost to Follow-up|10|||
146539283|NCT01047319|528481621|FG000|Overall Study|Adverse Event|16|||
146539284|NCT01047319|528481622|FG001|Overall Study|Adverse Event|27|||
146539285|NCT01047319|528481623|FG002|Overall Study|Adverse Event|21|||
146539286|NCT01047319|528481621|FG000|Overall Study|Withdrawal by Subject|77|||
146539287|NCT01047319|528481622|FG001|Overall Study|Withdrawal by Subject|75|||
146539288|NCT01047319|528481623|FG002|Overall Study|Withdrawal by Subject|87|||
146539289|NCT01047319|528481621|FG000|Overall Study|Study terminated by Sponsor|198|||
146539290|NCT01047319|528481622|FG001|Overall Study|Study terminated by Sponsor|215|||
146539291|NCT01047319|528481623|FG002|Overall Study|Study terminated by Sponsor|203|||
146539292|NCT03095287|528483357|FG000|Overall Study|Treatment Failure|1|||
146539293|NCT03095287|528483357|FG000|Overall Study|Adverse Event|1|||
146539294|NCT01294514|528483360|FG000|Overall Study|Excluded due to Arrhythmia|1|||
146539295|NCT02394275|528483361|FG000|Overall Study|Adverse Event|22|||
146539296|NCT02394275|528483361|FG000|Overall Study|Lost to Follow-up|7|||
146539297|NCT00782067|528483362|FG000|Overall Study|Adverse Event|35|||
146539298|NCT00782067|528483362|FG000|Overall Study|Subject withdrew consent|11|||
146539299|NCT00782067|528483362|FG000|Overall Study|Lost to Follow-up|2|||
146539300|NCT00782067|528483362|FG000|Overall Study|Administrative problems|14|||
146539301|NCT00782067|528483362|FG000|Overall Study|Death|9|||
146539302|NCT00782067|528483362|FG000|Overall Study|Disease progression|43|||
146539303|NCT00782067|528483362|FG000|Overall Study|Protocol deviation|2|||
146539304|NCT00141921|528483365|FG000|Overall Study|Remain on Study|28|||
146539305|NCT00141921|528483365|FG000|Overall Study|Withdrawal by Subject|42|||
146539306|NCT00141921|528483365|FG000|Overall Study|Lost to Follow-up|19|||
146539307|NCT00141921|528483365|FG000|Overall Study|Noncompliance|17|||
146539308|NCT00141921|528483365|FG000|Overall Study|Disease Progression|7|||
146539309|NCT00141921|528483365|FG000|Overall Study|Protocol Deviation|7|||
146539310|NCT00141921|528483365|FG000|Overall Study|Adverse Event|5|||
146539311|NCT00141921|528483365|FG000|Overall Study|Administrative Decision|2|||
146539312|NCT00141921|528483365|FG000|Overall Study|Pregnancy|4|||
146539313|NCT00141921|528483365|FG000|Overall Study|Ineligibility Determined|2|||
146539314|NCT00141921|528483365|FG000|Overall Study|Other|8|||
146539315|NCT03813654|528483368|FG000|Overall Study|Protocol Violation|0|||
146539316|NCT03813654|528483369|FG001|Overall Study|Protocol Violation|1|||
146539317|NCT03813654|528483370|FG002|Overall Study|Protocol Violation|2|||
146539318|NCT03813654|528483368|FG000|Overall Study|Withdrawal by Subject|1|||
146539319|NCT03813654|528483369|FG001|Overall Study|Withdrawal by Subject|0|||
146539320|NCT03813654|528483370|FG002|Overall Study|Withdrawal by Subject|0|||
146539321|NCT01732692|528483372|FG000|Overall Study|Adverse Event|0|||
146539322|NCT01732692|528483373|FG001|Overall Study|Adverse Event|1|||
146539323|NCT01155323|528483374|FG000|First Intervention|exclusion criteria|1|||
146539324|NCT01155323|528483375|FG001|First Intervention|exclusion criteria|1|||
146539325|NCT01155323|528483374|FG000|Second Intervention|Lost to Follow-up|1|||
146965619|NCT04242446|530035192|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
146539326|NCT01155323|528483375|FG001|Second Intervention|Lost to Follow-up|1|||
146539327|NCT01208051|528483391|FG000|Total Enrollment|Withdrawal by Subject|0|||
146539328|NCT01208051|528483392|FG001|Total Enrollment|Withdrawal by Subject|1|||
146539329|NCT01208051|528483393|FG002|Total Enrollment|Withdrawal by Subject|0|||
146539330|NCT01208051|528483394|FG003|Total Enrollment|Withdrawal by Subject|0|||
146539331|NCT01208051|528483395|FG004|Total Enrollment|Withdrawal by Subject|2|||
146539332|NCT01208051|528483391|FG000|Total Enrollment|Brain metastases|0|||
146539333|NCT01208051|528483392|FG001|Total Enrollment|Brain metastases|0|||
146539334|NCT01208051|528483393|FG002|Total Enrollment|Brain metastases|1|||
146539335|NCT01208051|528483394|FG003|Total Enrollment|Brain metastases|0|||
146539336|NCT01208051|528483395|FG004|Total Enrollment|Brain metastases|0|||
146539337|NCT00973973|528483397|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
146539338|NCT00973973|528483398|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
146539339|NCT00973973|528483397|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
146539340|NCT00973973|528483398|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
146539341|NCT00973973|528483397|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
146539342|NCT00973973|528483398|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
146539343|NCT00973973|528483397|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
146539344|NCT00973973|528483398|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
146539345|NCT00973973|528483397|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
146539346|NCT00973973|528483398|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
146539347|NCT00973973|528483397|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
146539348|NCT00973973|528483398|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
146539349|NCT00973973|528483397|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
146539350|NCT00973973|528483398|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
146539351|NCT00973973|528483397|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
146539352|NCT00973973|528483398|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
146539353|NCT00973973|528483397|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
146539354|NCT00973973|528483398|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
146539355|NCT00973973|528483397|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
146539356|NCT00973973|528483398|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
146539357|NCT00973973|528483397|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
146539358|NCT00973973|528483398|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
146539359|NCT00973973|528483397|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
146539360|NCT00973973|528483398|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
146539361|NCT02471339|528483399|FG000|Overall Study|Did not provide follow-up data|2|||
146539362|NCT02471339|528483400|FG001|Overall Study|Did not provide follow-up data|0|||
146539363|NCT01541748|528483401|FG000|Overall Study|Lost to Follow-up|17|||
146539364|NCT01541748|528483401|FG000|Overall Study|Moved out of state|1|||
146539365|NCT01541748|528483401|FG000|Overall Study|Withdrawal by Subject|7|||
146539366|NCT01541748|528483401|FG000|Overall Study|Screen failure|5|||
146539367|NCT01541748|528483401|FG000|Overall Study|Did not receive study device|1|||
146539368|NCT00626639|528483402|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
146539369|NCT00626639|528483403|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
146539370|NCT01461551|528483404|FG000|Overall Study|Physician Decision|2|||
146539371|NCT01461551|528483405|FG001|Overall Study|Physician Decision|1|||
146539372|NCT01461551|528483406|FG002|Overall Study|Physician Decision|2|||
146539373|NCT03473197|528483407|FG000|Overall Study|Adverse Event|4|||
146539374|NCT03473197|528483407|FG000|Overall Study|Lost to Follow-up|1|||
146539375|NCT03473197|528483407|FG000|Overall Study|Withdrawal by Subject|5|||
146539376|NCT02326883|528483410|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
146539377|NCT02326883|528483411|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
146539378|NCT02326883|528483412|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
146539379|NCT02107898|528483414|FG000|Overall Study|Adverse Event|4|||
146539380|NCT02107898|528483415|FG001|Overall Study|Adverse Event|7|||
146539381|NCT02107898|528483414|FG000|Overall Study|Poor compliance to protocol|0|||
146539382|NCT02107898|528483415|FG001|Overall Study|Poor compliance to protocol|1|||
146539383|NCT02107898|528483414|FG000|Overall Study|Participant moved|0|||
146539384|NCT02107898|528483415|FG001|Overall Study|Participant moved|2|||
146539385|NCT02107898|528483414|FG000|Overall Study|Consent withdrawn by participant|2|||
146539386|NCT02107898|528483415|FG001|Overall Study|Consent withdrawn by participant|1|||
146539387|NCT02107898|528483414|FG000|Overall Study|Randomized but not treated|0|||
146539388|NCT02107898|528483415|FG001|Overall Study|Randomized but not treated|1|||
146626871|NCT04026113|528809426|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
146626872|NCT04026113|528809427|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
146626873|NCT04613362|528809428|FG000|3 Month Follow-up|Lost to Follow-up|1|||
146626874|NCT04613362|528809429|FG001|3 Month Follow-up|Lost to Follow-up|2|||
146626875|NCT04613362|528809428|FG000|6 Month Follow-up|Lost to Follow-up|0|||
146626876|NCT04613362|528809429|FG001|6 Month Follow-up|Lost to Follow-up|1|||
146626877|NCT02218372|528809430|FG000|Overall Study|Adverse Event|1|||
146626878|NCT02218372|528809431|FG001|Overall Study|Adverse Event|1|||
146626879|NCT02218372|528809430|FG000|Overall Study|Miscellaneous|2|||
146626880|NCT02218372|528809431|FG001|Overall Study|Miscellaneous|1|||
146626881|NCT02218372|528809430|FG000|Overall Study|Randomized but did not receive treatment|2|||
146626882|NCT02218372|528809431|FG001|Overall Study|Randomized but did not receive treatment|3|||
146626883|NCT02218372|528809430|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146626884|NCT02218372|528809431|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146626885|NCT03406780|528809432|FG000|Overall Study|Withdrawal by Subject|1|||
146626886|NCT03406780|528809433|FG001|Overall Study|Withdrawal by Subject|1|||
146626887|NCT03406780|528809432|FG000|Overall Study|Other|0|||
146626888|NCT03406780|528809433|FG001|Overall Study|Other|2|||
146626889|NCT01488045|528809435|FG000|Overall Study|Withdrawal by Subject|6|||
146626890|NCT01488045|528809436|FG001|Overall Study|Withdrawal by Subject|11|||
146626891|NCT01488045|528809435|FG000|Overall Study|Failure to present for colonoscopy|3|||
146626892|NCT01488045|528809436|FG001|Overall Study|Failure to present for colonoscopy|6|||
146626893|NCT01488045|528809435|FG000|Overall Study|Failure to report exclusion criteria|0|||
146626894|NCT01488045|528809436|FG001|Overall Study|Failure to report exclusion criteria|1|||
146626895|NCT05365217|528809438|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146626896|NCT05365217|528809439|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146626897|NCT01527149|528809440|FG000|Overall Study|Death|2|||
146626898|NCT02230410|528809441|FG000|Overall Study|Screen Failure|3|||
146626899|NCT04558125|528809445|FG000|Overall Study|Death|1|||
146626900|NCT03199976|528809446|FG000|Overall Study|Lack of Efficacy|3|||
146626901|NCT03199976|528809447|FG001|Overall Study|Lack of Efficacy|6|||
146626902|NCT03199976|528809448|FG002|Overall Study|Lack of Efficacy|13|||
146626903|NCT03199976|528809446|FG000|Overall Study|Withdrawal by Subject|1|||
146626904|NCT03199976|528809447|FG001|Overall Study|Withdrawal by Subject|0|||
146626905|NCT03199976|528809448|FG002|Overall Study|Withdrawal by Subject|0|||
146626906|NCT03199976|528809446|FG000|Overall Study|Lost to Follow-up|0|||
146626907|NCT03199976|528809447|FG001|Overall Study|Lost to Follow-up|1|||
146626908|NCT03199976|528809448|FG002|Overall Study|Lost to Follow-up|1|||
146626909|NCT01761877|528809449|FG000|Overall Study|Adverse Event|7|||
146626910|NCT01761877|528809450|FG001|Overall Study|Adverse Event|0|||
146626911|NCT01761877|528809449|FG000|Overall Study|Withdrawal by Subject|6|||
146626912|NCT01761877|528809450|FG001|Overall Study|Withdrawal by Subject|4|||
146626913|NCT01761877|528809449|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
146626914|NCT01761877|528809450|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
146626915|NCT01761877|528809449|FG000|Overall Study|Death|0|||
146626916|NCT01761877|528809450|FG001|Overall Study|Death|1|||
146626917|NCT01761877|528809449|FG000|Overall Study|MRI intolerant|1|||
146626918|NCT01761877|528809450|FG001|Overall Study|MRI intolerant|6|||
146626919|NCT04842747|528809452|FG000|Overall Study|Withdrawal by Subject|6|||
146626920|NCT04842747|528809453|FG001|Overall Study|Withdrawal by Subject|2|||
146626921|NCT04842747|528809452|FG000|Overall Study|Lost to Follow-up|1|||
146626922|NCT04842747|528809453|FG001|Overall Study|Lost to Follow-up|2|||
146626923|NCT04842747|528809452|FG000|Overall Study|Physician Decision|1|||
146626924|NCT04842747|528809453|FG001|Overall Study|Physician Decision|0|||
146626925|NCT04842747|528809452|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
146626926|NCT04842747|528809453|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
146626927|NCT01126749|528809456|FG000|Phase 1b|Other|0|||
146626928|NCT01126749|528809457|FG001|Phase 1b|Other|1|||
146626929|NCT01126749|528809458|FG002|Phase 1b|Other|0|||
146626930|NCT01126749|528809459|FG003|Phase 1b|Other|0|||
146626931|NCT01126749|528809456|FG000|Phase 1b|Withdrawal by Subject|0|||
146626932|NCT01126749|528809457|FG001|Phase 1b|Withdrawal by Subject|1|||
146626933|NCT01126749|528809458|FG002|Phase 1b|Withdrawal by Subject|0|||
146626934|NCT01126749|528809459|FG003|Phase 1b|Withdrawal by Subject|0|||
146626935|NCT01126749|528809456|FG000|Phase 1b|Death|3|||
146626936|NCT01126749|528809457|FG001|Phase 1b|Death|4|||
146626937|NCT01126749|528809458|FG002|Phase 1b|Death|0|||
146626938|NCT01126749|528809459|FG003|Phase 1b|Death|0|||
146626939|NCT01126749|528809456|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
146626940|NCT01126749|528809457|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
146626941|NCT01126749|528809458|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
146626942|NCT01126749|528809459|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
146626943|NCT01126749|528809456|FG000|Phase 2|Study Termination by Sponsor|0|||
146626944|NCT01126749|528809457|FG001|Phase 2|Study Termination by Sponsor|0|||
146626945|NCT01126749|528809458|FG002|Phase 2|Study Termination by Sponsor|12|||
146626946|NCT01126749|528809459|FG003|Phase 2|Study Termination by Sponsor|6|||
146626947|NCT01126749|528809456|FG000|Phase 2|Other|0|||
146626948|NCT01126749|528809457|FG001|Phase 2|Other|0|||
146626949|NCT01126749|528809458|FG002|Phase 2|Other|4|||
146626950|NCT01126749|528809459|FG003|Phase 2|Other|2|||
146626951|NCT01126749|528809456|FG000|Phase 2|Withdrawal by Subject|0|||
146626952|NCT01126749|528809457|FG001|Phase 2|Withdrawal by Subject|0|||
146626953|NCT01126749|528809458|FG002|Phase 2|Withdrawal by Subject|0|||
146626954|NCT01126749|528809459|FG003|Phase 2|Withdrawal by Subject|2|||
146626955|NCT01126749|528809456|FG000|Phase 2|Lost to Follow-up|0|||
146626956|NCT01126749|528809457|FG001|Phase 2|Lost to Follow-up|0|||
146626957|NCT01126749|528809458|FG002|Phase 2|Lost to Follow-up|0|||
146626958|NCT01126749|528809459|FG003|Phase 2|Lost to Follow-up|1|||
146626959|NCT01126749|528809456|FG000|Phase 2|Death|0|||
146626960|NCT01126749|528809457|FG001|Phase 2|Death|0|||
146626961|NCT01126749|528809458|FG002|Phase 2|Death|22|||
146626962|NCT01126749|528809459|FG003|Phase 2|Death|22|||
146626963|NCT01126749|528809456|FG000|Phase 2|Adverse Event|0|||
146626964|NCT01126749|528809457|FG001|Phase 2|Adverse Event|0|||
146626965|NCT01126749|528809458|FG002|Phase 2|Adverse Event|0|||
146626966|NCT01126749|528809459|FG003|Phase 2|Adverse Event|1|||
146626967|NCT00976274|528809461|FG000|Overall Study|Lost to Follow-up|5|||
146626968|NCT00976274|528809462|FG001|Overall Study|Lost to Follow-up|5|||
146626969|NCT00976274|528809461|FG000|Overall Study|Withdrawal by Subject|1|||
146626970|NCT00976274|528809462|FG001|Overall Study|Withdrawal by Subject|1|||
146626971|NCT00976274|528809461|FG000|Overall Study|Physician Decision|1|||
146626972|NCT00976274|528809462|FG001|Overall Study|Physician Decision|2|||
146626973|NCT02183675|528809463|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
146626974|NCT02183675|528809464|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
146626975|NCT02183675|528809465|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
146626976|NCT02183675|528809466|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
146626977|NCT02183675|528809467|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
146626978|NCT02183675|528809468|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
146626979|NCT00627393|528809469|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
146626980|NCT00627393|528809470|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
146626981|NCT00627393|528809469|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
146626982|NCT00627393|528809470|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
146626983|NCT00627393|528809469|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
146626984|NCT00627393|528809470|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
146626985|NCT00627393|528809469|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
146626986|NCT00627393|528809470|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
146626987|NCT03337308|528809471|FG000|Overall Study|Adverse Event|2|||
146626988|NCT03337308|528809472|FG001|Overall Study|Adverse Event|3|||
146626989|NCT03337308|528809473|FG002|Overall Study|Adverse Event|3|||
146626990|NCT03337308|528809474|FG003|Overall Study|Adverse Event|1|||
146626991|NCT03337308|528809471|FG000|Overall Study|Lost to Follow-up|1|||
146626992|NCT03337308|528809472|FG001|Overall Study|Lost to Follow-up|2|||
146626993|NCT03337308|528809473|FG002|Overall Study|Lost to Follow-up|0|||
146626994|NCT03337308|528809474|FG003|Overall Study|Lost to Follow-up|0|||
146626995|NCT03337308|528809471|FG000|Overall Study|Withdrawal by Subject|2|||
146626996|NCT03337308|528809472|FG001|Overall Study|Withdrawal by Subject|1|||
146626997|NCT03337308|528809473|FG002|Overall Study|Withdrawal by Subject|2|||
146626998|NCT03337308|528809474|FG003|Overall Study|Withdrawal by Subject|1|||
146626999|NCT03337308|528809471|FG000|Overall Study|Protocol Violation|0|||
146627000|NCT03337308|528809472|FG001|Overall Study|Protocol Violation|1|||
146627001|NCT03337308|528809473|FG002|Overall Study|Protocol Violation|0|||
146627002|NCT03337308|528809474|FG003|Overall Study|Protocol Violation|0|||
146627003|NCT01056822|528809475|FG000|Overall Study|Adverse Event|0|||
146627004|NCT01056822|528809476|FG001|Overall Study|Adverse Event|1|||
146627005|NCT01056822|528809475|FG000|Overall Study|Protocol Violation|6|||
146871313|NCT03250832|529699868|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146627006|NCT01056822|528809476|FG001|Overall Study|Protocol Violation|5|||
146627007|NCT01056822|528809475|FG000|Overall Study|Withdrawal by Subject|1|||
146627008|NCT01056822|528809476|FG001|Overall Study|Withdrawal by Subject|1|||
146627009|NCT01056822|528809475|FG000|Overall Study|Lost to Follow-up|1|||
146627010|NCT01056822|528809476|FG001|Overall Study|Lost to Follow-up|0|||
146627011|NCT01614249|528809480|FG000|Overall Study|Lost to Follow-up|11|||
146627012|NCT01614249|528809481|FG001|Overall Study|Lost to Follow-up|23|||
146627013|NCT02946580|528809493|FG000|Overall Study|Withdrawal by Subject|1|||
146627014|NCT02946580|528809494|FG001|Overall Study|Withdrawal by Subject|2|||
146627015|NCT02946580|528809493|FG000|Overall Study|Adverse Event|0|||
146627016|NCT02946580|528809494|FG001|Overall Study|Adverse Event|2|||
146627017|NCT02946580|528809493|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
146627018|NCT02946580|528809494|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
146627019|NCT02761330|528809495|FG000|Treatment Week 1|Withdrawal by Subject|0|||
146627020|NCT02761330|528809496|FG001|Treatment Week 1|Withdrawal by Subject|0|||
146627021|NCT02761330|528809497|FG002|Treatment Week 1|Withdrawal by Subject|0|||
146627022|NCT02761330|528809498|FG003|Treatment Week 1|Withdrawal by Subject|1|||
146627023|NCT02761330|528809499|FG004|Treatment Week 1|Withdrawal by Subject|0|||
146627024|NCT02761330|528809500|FG005|Treatment Week 1|Withdrawal by Subject|1|||
146627025|NCT00888134|528809501|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
146627026|NCT00888134|528809501|FG000|Follow-up|being followed for long-term survival|1|||
146627027|NCT03043313|528809502|FG000|Overall Study|Withdrawal by Subject|5|||
146627028|NCT03043313|528809503|FG001|Overall Study|Withdrawal by Subject|1|||
146627029|NCT03043313|528809504|FG002|Overall Study|Withdrawal by Subject|1|||
146627030|NCT03043313|528809502|FG000|Overall Study|Lost to Follow-up|1|||
146627031|NCT03043313|528809503|FG001|Overall Study|Lost to Follow-up|1|||
146627032|NCT03043313|528809504|FG002|Overall Study|Lost to Follow-up|0|||
146627033|NCT03043313|528809502|FG000|Overall Study|Death|28|||
146627034|NCT03043313|528809503|FG001|Overall Study|Death|26|||
146627035|NCT03043313|528809504|FG002|Overall Study|Death|17|||
146627036|NCT03043313|528809502|FG000|Overall Study|Participation terminated by sponsor|11|||
146627037|NCT03043313|528809503|FG001|Overall Study|Participation terminated by sponsor|13|||
146763905|NCT00567879|529302914|FG001|Overall Study|Disease progression|7|||
146539389|NCT03329989|528483416|FG000|Overall Study|Withdrawal by Subject|9|||
146539390|NCT03329989|528483416|FG000|Overall Study|Lost to Follow-up|8|||
146539391|NCT03329989|528483416|FG000|Overall Study|Adverse Event|5|||
146539392|NCT03329989|528483416|FG000|Overall Study|Protocol Violation|1|||
146539393|NCT01283386|528483417|FG000|Overall Study|Death|2|||
146539394|NCT01283386|528483418|FG001|Overall Study|Death|0|||
146539395|NCT01283386|528483417|FG000|Overall Study|Withdrawal by Subject|2|||
146539396|NCT01283386|528483418|FG001|Overall Study|Withdrawal by Subject|1|||
146539397|NCT01283386|528483417|FG000|Overall Study|Relapse of underlying disease|1|||
146539398|NCT01283386|528483418|FG001|Overall Study|Relapse of underlying disease|3|||
146539399|NCT01283386|528483417|FG000|Overall Study|Progression of underlying disease|2|||
146539400|NCT01283386|528483418|FG001|Overall Study|Progression of underlying disease|7|||
146539401|NCT01283386|528483417|FG000|Overall Study|Reason not specified|1|||
146539402|NCT01283386|528483418|FG001|Overall Study|Reason not specified|0|||
146539403|NCT01283386|528483417|FG000|Overall Study|Protocol Violation|0|||
146539404|NCT01283386|528483418|FG001|Overall Study|Protocol Violation|1|||
146539405|NCT02469857|528483419|FG000|Overall Study|Death|24|||
146539406|NCT02469857|528483420|FG001|Overall Study|Death|29|||
146539407|NCT02469857|528483419|FG000|Overall Study|Discontinuation|1|||
146539408|NCT02469857|528483420|FG001|Overall Study|Discontinuation|3|||
146539409|NCT00937950|528483421|FG000|Overall Study|Withdrawal by Subject|23|||
146539410|NCT00937950|528483421|FG000|Overall Study|Migrated/moved from study area|27|||
146539411|NCT00937950|528483421|FG000|Overall Study|Lost to Follow-up|144|||
146539412|NCT00937950|528483421|FG000|Overall Study|Missing confirmed|4|||
146539413|NCT00937950|528483421|FG000|Overall Study|Other|18|||
146539414|NCT03483103|528483424|FG000|Pre-Treatment Phase|Other reasons|1|||
146539415|NCT03483103|528483424|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
146539416|NCT03483103|528483424|FG000|Pre-Treatment Phase|Disease-related complications|1|||
146539417|NCT03483103|528483424|FG000|Pre-Treatment Phase|Death|5|||
146539418|NCT03483103|528483424|FG000|Treatment Phase|Withdrawal by Subject|7|||
146539419|NCT03483103|528483424|FG000|Treatment Phase|Other reasons|1|||
146539420|NCT03483103|528483424|FG000|Treatment Phase|Death|23|||
146539421|NCT03483103|528483424|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
146539422|NCT03483103|528483424|FG000|Treatment Phase|Received nonconforming product|1|||
146539423|NCT02378181|528483425|FG000|Overall Study|Lost to Follow-up|2|||
146539424|NCT02378181|528483426|FG001|Overall Study|Lost to Follow-up|5|||
146539425|NCT02378181|528483425|FG000|Overall Study|Withdrawal by Subject|1|||
146539426|NCT02378181|528483426|FG001|Overall Study|Withdrawal by Subject|1|||
146539427|NCT02378181|528483425|FG000|Overall Study|Incarcerated|0|||
146539428|NCT02378181|528483426|FG001|Overall Study|Incarcerated|1|||
146539429|NCT00297167|528483428|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
146539430|NCT00297167|528483429|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
146539431|NCT00297167|528483430|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
146539432|NCT00297167|528483428|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
146539433|NCT00297167|528483429|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
146539434|NCT00297167|528483430|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
146539435|NCT04167462|528483433|FG000|Overall Study|Other reasons|3|||
146539436|NCT04167462|528483434|FG001|Overall Study|Other reasons|2|||
146539437|NCT04167462|528483433|FG000|Overall Study|Withdrawal by Subject|6|||
146539438|NCT04167462|528483434|FG001|Overall Study|Withdrawal by Subject|7|||
146539439|NCT04167462|528483433|FG000|Overall Study|Adverse Event|4|||
146539440|NCT04167462|528483434|FG001|Overall Study|Adverse Event|0|||
146539441|NCT04167462|528483433|FG000|Overall Study|Pregnancy|1|||
146627038|NCT03043313|528809504|FG002|Overall Study|Participation terminated by sponsor|13|||
146627039|NCT02657889|528809505|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
146627040|NCT02657889|528809506|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
146627041|NCT02657889|528809507|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
146627042|NCT02657889|528809508|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
146763906|NCT00567879|529302915|FG002|Overall Study|Disease progression|15|||
146763907|NCT00567879|529302916|FG003|Overall Study|Disease progression|5|||
146627043|NCT02657889|528809505|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
146627044|NCT02657889|528809506|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
146627045|NCT02657889|528809507|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
146627046|NCT02657889|528809508|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
146627047|NCT02657889|528809505|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
146627048|NCT02657889|528809506|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
146627049|NCT02657889|528809507|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
146627050|NCT02657889|528809508|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
146627051|NCT02657889|528809505|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
146627052|NCT02657889|528809506|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
146627053|NCT02657889|528809507|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
146627054|NCT02657889|528809508|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
146627055|NCT02657889|528809505|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
146627056|NCT02657889|528809506|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
146627057|NCT02657889|528809507|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
146627058|NCT02657889|528809508|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
146627059|NCT02657889|528809505|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
146627060|NCT02657889|528809506|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
146627061|NCT02657889|528809507|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
146627062|NCT02657889|528809508|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
146539442|NCT04167462|528483434|FG001|Overall Study|Pregnancy|0|||
146539443|NCT04167462|528483433|FG000|Overall Study|Lack of Efficacy|0|||
146627063|NCT02657889|528809505|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
146627064|NCT02657889|528809506|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
146627065|NCT02657889|528809507|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
146539444|NCT04167462|528483434|FG001|Overall Study|Lack of Efficacy|1|||
146539445|NCT03331562|528483435|FG000|Overall Study|Adverse Event|2|||
146539446|NCT03331562|528483436|FG001|Overall Study|Adverse Event|0|||
146539447|NCT03331562|528483435|FG000|Overall Study|Death|1|||
146539448|NCT03331562|528483436|FG001|Overall Study|Death|0|||
146539449|NCT00505921|528483437|FG000|Overall Study|Ineligible|1|||
146539450|NCT00505921|528483437|FG000|Overall Study|Failed to Mobilize|8|||
146539451|NCT01033136|528483438|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
146539452|NCT01033136|528483439|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
146539453|NCT00142415|528483440|FG000|Overall Study|Physician Decision|0|||
146539454|NCT00142415|528483441|FG001|Overall Study|Physician Decision|0|||
146539455|NCT00142415|528483442|FG002|Overall Study|Physician Decision|0|||
146539456|NCT00142415|528483443|FG003|Overall Study|Physician Decision|0|||
146539457|NCT00142415|528483444|FG004|Overall Study|Physician Decision|1|||
146539458|NCT00142415|528483445|FG005|Overall Study|Physician Decision|2|||
146539459|NCT03530696|528483447|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
146539460|NCT03530696|528483448|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
146539461|NCT01129128|528483449|FG000|Overall Study|Lost to Follow-up|2|||
146539462|NCT01129128|528483450|FG001|Overall Study|Lost to Follow-up|2|||
146539463|NCT01129128|528483451|FG002|Overall Study|Lost to Follow-up|1|||
146539464|NCT01129128|528483449|FG000|Overall Study|Protocol Violation|0|||
146627066|NCT02657889|528809508|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
146627067|NCT02657889|528809505|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
146627068|NCT02657889|528809506|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
146627069|NCT02657889|528809507|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
146627070|NCT02657889|528809508|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
146627071|NCT02657889|528809505|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
146627072|NCT02657889|528809506|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
146627073|NCT02657889|528809507|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
146627074|NCT02657889|528809508|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
146539465|NCT01129128|528483450|FG001|Overall Study|Protocol Violation|1|||
146539466|NCT01129128|528483451|FG002|Overall Study|Protocol Violation|0|||
146539467|NCT01129128|528483449|FG000|Overall Study|Withdrawal by Subject|0|||
146539468|NCT01129128|528483450|FG001|Overall Study|Withdrawal by Subject|1|||
146539469|NCT01129128|528483451|FG002|Overall Study|Withdrawal by Subject|3|||
146539470|NCT01129128|528483449|FG000|Overall Study|Physician Decision|1|||
146539471|NCT01129128|528483450|FG001|Overall Study|Physician Decision|0|||
146539472|NCT01129128|528483451|FG002|Overall Study|Physician Decision|0|||
146539473|NCT00844519|528483452|FG000|Overall Study|Withdrawal by Subject|1|||
146539474|NCT00844519|528483453|FG001|Overall Study|Withdrawal by Subject|1|||
146539475|NCT00844519|528483452|FG000|Overall Study|Adverse Event|1|||
146539476|NCT00844519|528483453|FG001|Overall Study|Adverse Event|0|||
146627075|NCT02657889|528809505|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
146763908|NCT00567879|529302917|FG004|Overall Study|Disease progression|11|||
146627076|NCT02657889|528809506|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
146627077|NCT02657889|528809507|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
146627078|NCT02657889|528809508|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
146627079|NCT02657889|528809505|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
146627080|NCT02657889|528809506|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
146627081|NCT02657889|528809507|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
146627082|NCT02657889|528809508|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
146627083|NCT02657889|528809505|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
146627084|NCT02657889|528809506|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
146627085|NCT02657889|528809507|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
146627086|NCT02657889|528809508|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
146627087|NCT00795535|528809509|FG000|Overall Study|incomplete data and technical problems|20|||
146627088|NCT03341299|528809510|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
146627089|NCT03341299|528809511|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
146627090|NCT03341299|528809512|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
146627091|NCT03341299|528809513|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
146627092|NCT02702492|528809514|FG000|Overall Study|Disease progression|3|||
146627093|NCT02702492|528809515|FG001|Overall Study|Disease progression|3|||
146627094|NCT02702492|528809516|FG002|Overall Study|Disease progression|2|||
146627095|NCT02702492|528809517|FG003|Overall Study|Disease progression|4|||
146627096|NCT02702492|528809518|FG004|Overall Study|Disease progression|4|||
146627097|NCT02702492|528809519|FG005|Overall Study|Disease progression|1|||
146627098|NCT02702492|528809520|FG006|Overall Study|Disease progression|2|||
146627099|NCT02702492|528809521|FG007|Overall Study|Disease progression|8|||
146627100|NCT02702492|528809522|FG008|Overall Study|Disease progression|5|||
146627101|NCT02702492|528809523|FG009|Overall Study|Disease progression|1|||
146627102|NCT02702492|528809524|FG010|Overall Study|Disease progression|0|||
146627103|NCT02702492|528809525|FG011|Overall Study|Disease progression|3|||
146627104|NCT02702492|528809526|FG012|Overall Study|Disease progression|2|||
146627105|NCT02702492|528809514|FG000|Overall Study|Clinical progression|0|||
146627106|NCT02702492|528809515|FG001|Overall Study|Clinical progression|0|||
146627107|NCT02702492|528809516|FG002|Overall Study|Clinical progression|2|||
146627108|NCT02702492|528809517|FG003|Overall Study|Clinical progression|1|||
146627109|NCT02702492|528809518|FG004|Overall Study|Clinical progression|0|||
146627110|NCT02702492|528809519|FG005|Overall Study|Clinical progression|2|||
146627111|NCT02702492|528809520|FG006|Overall Study|Clinical progression|1|||
146627112|NCT02702492|528809521|FG007|Overall Study|Clinical progression|4|||
146627113|NCT02702492|528809522|FG008|Overall Study|Clinical progression|0|||
146627114|NCT02702492|528809523|FG009|Overall Study|Clinical progression|0|||
146627115|NCT02702492|528809524|FG010|Overall Study|Clinical progression|1|||
146627116|NCT02702492|528809525|FG011|Overall Study|Clinical progression|2|||
146627117|NCT02702492|528809526|FG012|Overall Study|Clinical progression|0|||
146627118|NCT02702492|528809514|FG000|Overall Study|Adverse Event|0|||
146627119|NCT02702492|528809515|FG001|Overall Study|Adverse Event|0|||
146627120|NCT02702492|528809516|FG002|Overall Study|Adverse Event|1|||
146627121|NCT02702492|528809517|FG003|Overall Study|Adverse Event|2|||
146627122|NCT02702492|528809518|FG004|Overall Study|Adverse Event|1|||
146627123|NCT02702492|528809519|FG005|Overall Study|Adverse Event|0|||
146627124|NCT02702492|528809520|FG006|Overall Study|Adverse Event|1|||
146627125|NCT02702492|528809521|FG007|Overall Study|Adverse Event|0|||
146627126|NCT02702492|528809522|FG008|Overall Study|Adverse Event|2|||
146627127|NCT02702492|528809523|FG009|Overall Study|Adverse Event|0|||
146627128|NCT02702492|528809524|FG010|Overall Study|Adverse Event|0|||
146627129|NCT02702492|528809525|FG011|Overall Study|Adverse Event|0|||
146627130|NCT02702492|528809526|FG012|Overall Study|Adverse Event|1|||
146627131|NCT02702492|528809514|FG000|Overall Study|Other|0|||
146627132|NCT02702492|528809515|FG001|Overall Study|Other|0|||
146627133|NCT02702492|528809516|FG002|Overall Study|Other|0|||
146627134|NCT02702492|528809517|FG003|Overall Study|Other|0|||
146627135|NCT02702492|528809518|FG004|Overall Study|Other|0|||
146627136|NCT02702492|528809519|FG005|Overall Study|Other|0|||
146627137|NCT02702492|528809520|FG006|Overall Study|Other|0|||
146627138|NCT02702492|528809521|FG007|Overall Study|Other|0|||
146627139|NCT02702492|528809522|FG008|Overall Study|Other|0|||
146627140|NCT02702492|528809523|FG009|Overall Study|Other|0|||
146627141|NCT02702492|528809524|FG010|Overall Study|Other|0|||
146627142|NCT02702492|528809525|FG011|Overall Study|Other|0|||
146627143|NCT02702492|528809526|FG012|Overall Study|Other|1|||
146627144|NCT00781768|528811669|FG000|Overall Study|Not transplanted.|0|||
146627145|NCT00781768|528811670|FG001|Overall Study|Not transplanted.|2|||
146627146|NCT02458313|528811679|FG000|Overall Study|Withdrawal by Subject|6|||
146627147|NCT02458313|528811680|FG001|Overall Study|Withdrawal by Subject|8|||
146627148|NCT02458313|528811679|FG000|Overall Study|Excluded for motion during MRI|1|||
146627149|NCT02458313|528811680|FG001|Overall Study|Excluded for motion during MRI|2|||
146627150|NCT00199381|528811681|FG000|Overall Study|Withdrawal by Subject|38|||
146627151|NCT00199381|528811681|FG000|Overall Study|Adverse Event|73|||
146627152|NCT00199381|528811681|FG000|Overall Study|Protocol Violation|6|||
146627153|NCT00199381|528811681|FG000|Overall Study|Lack of Efficacy|27|||
146627154|NCT00199381|528811681|FG000|Overall Study|Not including due to early termination|37|||
146627155|NCT00199381|528811681|FG000|Overall Study|Study termination by Sponsor|323|||
146627156|NCT02892344|528811683|FG000|Overall Study|Protocol deviation|3|||
146627157|NCT02892344|528811684|FG001|Overall Study|Protocol deviation|4|||
146627158|NCT02892344|528811683|FG000|Overall Study|Adverse Event|1|||
146627159|NCT02892344|528811684|FG001|Overall Study|Adverse Event|8|||
146627160|NCT02892344|528811683|FG000|Overall Study|Lost to Follow-up|0|||
146627161|NCT02892344|528811684|FG001|Overall Study|Lost to Follow-up|1|||
146627162|NCT02892344|528811683|FG000|Overall Study|Non-compliance with study treatment|0|||
146627163|NCT02892344|528811684|FG001|Overall Study|Non-compliance with study treatment|1|||
146627164|NCT02892344|528811683|FG000|Overall Study|Physician Decision|0|||
146627165|NCT02892344|528811684|FG001|Overall Study|Physician Decision|2|||
146627166|NCT02892344|528811683|FG000|Overall Study|Subject/guardian decision|0|||
146627167|NCT02892344|528811684|FG001|Overall Study|Subject/guardian decision|4|||
146627168|NCT02892344|528811683|FG000|Overall Study|Technical problems|0|||
146627169|NCT02892344|528811684|FG001|Overall Study|Technical problems|1|||
146627170|NCT01295814|528811685|FG000|Overall Study|Lack of Efficacy|0|||
146627171|NCT01295814|528811686|FG001|Overall Study|Lack of Efficacy|2|||
146627172|NCT01295814|528811685|FG000|Overall Study|Withdrawal by Subject|2|||
146627173|NCT01295814|528811686|FG001|Overall Study|Withdrawal by Subject|0|||
146627174|NCT04106557|528811692|FG000|Overall Study|Physician Decision|0|||
146627175|NCT04106557|528811693|FG001|Overall Study|Physician Decision|1|||
146627176|NCT04106557|528811694|FG002|Overall Study|Physician Decision|0|||
146627177|NCT04106557|528811692|FG000|Overall Study|Protocol Violation|0|||
146627178|NCT04106557|528811693|FG001|Overall Study|Protocol Violation|1|||
146627179|NCT04106557|528811694|FG002|Overall Study|Protocol Violation|0|||
146627180|NCT02326155|528811695|FG000|Overall Study|Adverse Event|21|||
146627181|NCT02326155|528811696|FG001|Overall Study|Adverse Event|5|||
146627182|NCT02326155|528811695|FG000|Overall Study|Death|3|||
146627183|NCT02326155|528811696|FG001|Overall Study|Death|0|||
146627184|NCT02326155|528811695|FG000|Overall Study|Lack of Efficacy|49|||
146627185|NCT02326155|528811696|FG001|Overall Study|Lack of Efficacy|5|||
146627186|NCT02326155|528811695|FG000|Overall Study|Lost to Follow-up|14|||
146627187|NCT02326155|528811696|FG001|Overall Study|Lost to Follow-up|3|||
146627188|NCT02326155|528811695|FG000|Overall Study|Protocol Violation|2|||
146627189|NCT02326155|528811696|FG001|Overall Study|Protocol Violation|0|||
146627190|NCT02326155|528811695|FG000|Overall Study|Withdrawal by Subject|34|||
146627191|NCT02326155|528811696|FG001|Overall Study|Withdrawal by Subject|11|||
146627192|NCT02326155|528811695|FG000|Overall Study|Disease progression|37|||
146627193|NCT02326155|528811696|FG001|Overall Study|Disease progression|4|||
146627194|NCT02326155|528811695|FG000|Overall Study|Study close|188|||
146627195|NCT02326155|528811696|FG001|Overall Study|Study close|21|||
146627196|NCT02326155|528811695|FG000|Overall Study|except for study close|46|||
146627197|NCT02326155|528811696|FG001|Overall Study|except for study close|13|||
146627198|NCT05024032|528811697|FG000|Overall Study|Withdrawal by Subject|0|||
146627199|NCT05024032|528811698|FG001|Overall Study|Withdrawal by Subject|3|||
146627200|NCT05024032|528811699|FG002|Overall Study|Withdrawal by Subject|4|||
146627201|NCT05024032|528811697|FG000|Overall Study|Adverse Event|0|||
146627202|NCT05024032|528811698|FG001|Overall Study|Adverse Event|1|||
146627203|NCT05024032|528811699|FG002|Overall Study|Adverse Event|0|||
146627204|NCT05024032|528811697|FG000|Overall Study|Protocol Deviation|1|||
146627205|NCT05024032|528811698|FG001|Overall Study|Protocol Deviation|0|||
146627206|NCT05024032|528811699|FG002|Overall Study|Protocol Deviation|0|||
146627207|NCT01209689|528811700|FG000|Overall Study|Insufficient Therapeutic Response|7|||
146627208|NCT01209689|528811701|FG001|Overall Study|Insufficient Therapeutic Response|2|||
146627209|NCT01209689|528811700|FG000|Overall Study|Refused Treatment|8|||
146627210|NCT01209689|528811701|FG001|Overall Study|Refused Treatment|3|||
146627211|NCT01209689|528811700|FG000|Overall Study|Adverse Event|4|||
146627212|NCT01209689|528811701|FG001|Overall Study|Adverse Event|0|||
146975321|NCT00736333|530073531|FG000|Overall Study|Withdrawal by Subject|10|||
146627213|NCT01209689|528811700|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
146627214|NCT01209689|528811701|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
146627215|NCT01209689|528811700|FG000|Overall Study|Failure to Return|3|||
146627216|NCT01209689|528811701|FG001|Overall Study|Failure to Return|0|||
146627217|NCT01209689|528811700|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
146627218|NCT01209689|528811701|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
146627219|NCT03780244|528811702|FG000|Overall Study|Lost to Follow-up|1|||
146627220|NCT03780244|528811703|FG001|Overall Study|Lost to Follow-up|0|||
146627221|NCT03175367|528811704|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
146627222|NCT03175367|528811705|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
146627223|NCT03175367|528811706|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
146627224|NCT03175367|528811707|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
146627225|NCT03175367|528811708|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
146627226|NCT03175367|528811709|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
146627227|NCT03175367|528811710|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
146627228|NCT03175367|528811704|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
146627229|NCT03175367|528811705|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
146627230|NCT03175367|528811706|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
146627231|NCT03175367|528811707|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
146627232|NCT03175367|528811708|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
146627233|NCT03175367|528811709|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
146627234|NCT03175367|528811710|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
146627235|NCT03175367|528811704|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
146627236|NCT03175367|528811705|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
146627237|NCT03175367|528811706|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
146627238|NCT03175367|528811707|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
146627239|NCT03175367|528811708|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
146539477|NCT01900314|528483454|FG000|Overall Study|Lost to Follow-up|1|||
146539478|NCT01900314|528483455|FG001|Overall Study|Lost to Follow-up|0|||
146539479|NCT01900314|528483454|FG000|Overall Study|Protocol Violation|0|||
146539480|NCT01900314|528483455|FG001|Overall Study|Protocol Violation|1|||
146539481|NCT01900314|528483454|FG000|Overall Study|Withdrawal by Subject|3|||
146539482|NCT01900314|528483455|FG001|Overall Study|Withdrawal by Subject|3|||
146539483|NCT03282097|528483456|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
146539484|NCT03282097|528483457|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
146539485|NCT03282097|528483456|FG000|Intervention Visit Complete|Patient Death|13|||
146539486|NCT03282097|528483457|FG001|Intervention Visit Complete|Patient Death|15|||
146539487|NCT03282097|528483456|FG000|Intervention Visit Complete|Caregiver Death|0|||
146539488|NCT03282097|528483457|FG001|Intervention Visit Complete|Caregiver Death|3|||
146539489|NCT03282097|528483456|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
146539490|NCT03282097|528483457|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
146539491|NCT03282097|528483456|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
146539492|NCT03282097|528483457|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
146539493|NCT03282097|528483456|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
146539494|NCT03282097|528483457|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
146539495|NCT03282097|528483456|FG000|Primary Outcome Data Collection Complete|Missing|2|||
146539496|NCT03282097|528483457|FG001|Primary Outcome Data Collection Complete|Missing|3|||
146539497|NCT03282097|528483456|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
146539498|NCT03282097|528483457|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
146539499|NCT03282097|528483456|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
146539500|NCT03282097|528483457|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
146539501|NCT03282097|528483456|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
146539502|NCT03282097|528483457|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
146539503|NCT01056536|528483460|FG000|Overall Study|Lost to Follow-up|202|||
146539504|NCT01056536|528483461|FG001|Overall Study|Lost to Follow-up|116|||
146539505|NCT01056536|528483462|FG002|Overall Study|Lost to Follow-up|248|||
146539506|NCT01551173|528483467|FG000|Overall Study|Withdrawal by Subject|11|||
146539507|NCT01551173|528483468|FG001|Overall Study|Withdrawal by Subject|16|||
146539508|NCT01551173|528483467|FG000|Overall Study|Adverse Event|7|||
146539509|NCT01551173|528483468|FG001|Overall Study|Adverse Event|6|||
146539510|NCT01551173|528483467|FG000|Overall Study|Lost to Follow-up|5|||
146539511|NCT01551173|528483468|FG001|Overall Study|Lost to Follow-up|7|||
146539512|NCT01551173|528483467|FG000|Overall Study|Other|5|||
146539513|NCT01551173|528483468|FG001|Overall Study|Other|3|||
146539514|NCT04530344|528483469|FG000|Overall Study|Lost to Follow-up|3|||
146539515|NCT04530344|528483470|FG001|Overall Study|Lost to Follow-up|3|||
146539516|NCT04530344|528483471|FG002|Overall Study|Lost to Follow-up|3|||
146539517|NCT04530344|528483472|FG003|Overall Study|Lost to Follow-up|10|||
146539518|NCT04530344|528483469|FG000|Overall Study|Withdrawal by Subject|14|||
146539519|NCT04530344|528483470|FG001|Overall Study|Withdrawal by Subject|5|||
146539520|NCT04530344|528483471|FG002|Overall Study|Withdrawal by Subject|18|||
146627240|NCT03175367|528811709|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
146627241|NCT03175367|528811710|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
146627242|NCT03175367|528811704|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
146627243|NCT03175367|528811705|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
146627244|NCT03175367|528811706|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
146627245|NCT03175367|528811707|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
146627246|NCT03175367|528811708|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
146627247|NCT03175367|528811709|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
146627248|NCT03175367|528811710|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
146627249|NCT03175367|528811704|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146763909|NCT00567879|529302918|FG005|Overall Study|Disease progression|3|||
146539521|NCT04530344|528483472|FG003|Overall Study|Withdrawal by Subject|33|||
146539522|NCT04530344|528483469|FG000|Overall Study|Adverse Event|0|||
146539523|NCT04530344|528483470|FG001|Overall Study|Adverse Event|0|||
146539524|NCT04530344|528483471|FG002|Overall Study|Adverse Event|0|||
146627250|NCT03175367|528811705|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146627251|NCT03175367|528811706|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
146627252|NCT03175367|528811707|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146627253|NCT03175367|528811708|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
146627254|NCT03175367|528811709|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146627255|NCT03175367|528811710|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146627256|NCT03175367|528811704|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
146627257|NCT03175367|528811705|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
146627258|NCT03175367|528811706|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
146627259|NCT03175367|528811707|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
146627260|NCT03175367|528811708|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
146627261|NCT03175367|528811709|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
146627262|NCT03175367|528811710|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
146627263|NCT03175367|528811704|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146627264|NCT03175367|528811705|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146627265|NCT03175367|528811706|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146627266|NCT03175367|528811707|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146627267|NCT03175367|528811708|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146627268|NCT03175367|528811709|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
146627269|NCT03175367|528811710|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
146627270|NCT03085095|528811715|FG000|Overall Study|Adverse Event|23|||
146627271|NCT03085095|528811716|FG001|Overall Study|Adverse Event|8|||
146627272|NCT03085095|528811715|FG000|Overall Study|Protocol Violation|0|||
146627273|NCT03085095|528811716|FG001|Overall Study|Protocol Violation|1|||
146627274|NCT03085095|528811715|FG000|Overall Study|Lost to Follow-up|2|||
146627275|NCT03085095|528811716|FG001|Overall Study|Lost to Follow-up|1|||
146627276|NCT03085095|528811715|FG000|Overall Study|Withdrawal by Subject|17|||
146627277|NCT03085095|528811716|FG001|Overall Study|Withdrawal by Subject|6|||
146627278|NCT03085095|528811715|FG000|Overall Study|Physician Decision|9|||
146627279|NCT03085095|528811716|FG001|Overall Study|Physician Decision|3|||
146627280|NCT03085095|528811715|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
146627281|NCT03085095|528811716|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
146627282|NCT03085095|528811715|FG000|Overall Study|Did not Receive Study Drug|2|||
146627283|NCT03085095|528811716|FG001|Overall Study|Did not Receive Study Drug|2|||
146627284|NCT03085095|528811715|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
146627285|NCT03085095|528811716|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
146627286|NCT03459079|528811718|FG000|Overall Study|Adverse Event|4|||
146627287|NCT03459079|528811719|FG001|Overall Study|Adverse Event|2|||
146627288|NCT03459079|528811720|FG002|Overall Study|Adverse Event|0|||
146627289|NCT03459079|528811718|FG000|Overall Study|Withdrawal by Subject|2|||
146627290|NCT03459079|528811719|FG001|Overall Study|Withdrawal by Subject|2|||
146627291|NCT03459079|528811720|FG002|Overall Study|Withdrawal by Subject|0|||
146627292|NCT00674817|528811721|FG000|Period 1|Withdrawal by Subject|2|||
146627293|NCT00674817|528811721|FG000|Period 1|Protocol Violation|1|||
146627294|NCT00674817|528811721|FG000|Period 3|Adverse Event|1|||
146627295|NCT00674817|528811721|FG000|Period 3|Protocol Violation|1|||
146627296|NCT00674817|528811721|FG000|Period 4|Adverse Event|1|||
146627297|NCT02379728|528811722|FG000|Overall Study|Lost to Follow-up|1|||
146627298|NCT02379728|528811723|FG001|Overall Study|Lost to Follow-up|0|||
146627299|NCT02379728|528811724|FG002|Overall Study|Lost to Follow-up|3|||
146539525|NCT04530344|528483472|FG003|Overall Study|Adverse Event|1|||
146539526|NCT04530344|528483469|FG000|Overall Study|Lack of Efficacy|0|||
146539527|NCT04530344|528483470|FG001|Overall Study|Lack of Efficacy|0|||
146539528|NCT04530344|528483471|FG002|Overall Study|Lack of Efficacy|0|||
146539529|NCT04530344|528483472|FG003|Overall Study|Lack of Efficacy|1|||
146539530|NCT04530344|528483469|FG000|Overall Study|Physician Decision|0|||
146539531|NCT04530344|528483470|FG001|Overall Study|Physician Decision|0|||
146539532|NCT04530344|528483471|FG002|Overall Study|Physician Decision|1|||
146627300|NCT02379728|528811725|FG003|Overall Study|Lost to Follow-up|0|||
146627301|NCT02379728|528811722|FG000|Overall Study|Withdrawal by Subject|5|||
146627302|NCT02379728|528811723|FG001|Overall Study|Withdrawal by Subject|0|||
146627303|NCT02379728|528811724|FG002|Overall Study|Withdrawal by Subject|5|||
146627304|NCT02379728|528811725|FG003|Overall Study|Withdrawal by Subject|3|||
146539533|NCT04530344|528483472|FG003|Overall Study|Physician Decision|1|||
146539534|NCT04530344|528483469|FG000|Overall Study|Pregnancy|0|||
146539535|NCT04530344|528483470|FG001|Overall Study|Pregnancy|0|||
146539536|NCT04530344|528483471|FG002|Overall Study|Pregnancy|2|||
146627305|NCT02379728|528811722|FG000|Overall Study|Protocol Violation|0|||
146627306|NCT02379728|528811723|FG001|Overall Study|Protocol Violation|0|||
146627307|NCT02379728|528811724|FG002|Overall Study|Protocol Violation|2|||
146627308|NCT02379728|528811725|FG003|Overall Study|Protocol Violation|0|||
146627309|NCT01112917|528811726|FG000|Overall Study|Death|2|||
146539537|NCT04530344|528483472|FG003|Overall Study|Pregnancy|1|||
146539538|NCT04530344|528483469|FG000|Overall Study|Protocol Violation|0|||
146627310|NCT01112917|528811727|FG001|Overall Study|Death|11|||
146627311|NCT01112917|528811726|FG000|Overall Study|Lost to Follow-up|1|||
146627312|NCT01112917|528811727|FG001|Overall Study|Lost to Follow-up|1|||
146627313|NCT01112917|528811726|FG000|Overall Study|Withdrawal by Subject|1|||
146627314|NCT01112917|528811727|FG001|Overall Study|Withdrawal by Subject|3|||
146627315|NCT01112917|528811726|FG000|Overall Study|Unable to Convert Filter|3|||
146627316|NCT01112917|528811727|FG001|Overall Study|Unable to Convert Filter|0|||
146627317|NCT05101122|528811728|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
146627318|NCT05101122|528811728|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
146627319|NCT05101122|528811728|FG000|AD313 80/5|Withdrawal by Subject|1|||
146627320|NCT05101122|528811728|FG000|AD313 80/10|Physician Decision|1|||
146627321|NCT03363841|528811729|FG000|Overall Study|Adverse Event|1|||
146627322|NCT03363841|528811729|FG000|Overall Study|Withdrawal by Subject|1|||
146627323|NCT03363841|528811729|FG000|Overall Study|Death|7|||
146627324|NCT03363841|528811729|FG000|Overall Study|Physician Decision|1|||
146627325|NCT02156076|528811732|FG000|Treatment Period|no longer meets study criteria|0|||
146627326|NCT02156076|528811733|FG001|Treatment Period|no longer meets study criteria|0|||
146627327|NCT02156076|528811734|FG002|Treatment Period|no longer meets study criteria|1|||
146627328|NCT02156076|528811735|FG003|Treatment Period|no longer meets study criteria|0|||
146627329|NCT02156076|528811732|FG000|Treatment Period|Poor/non-compliance|0|||
146627330|NCT02156076|528811733|FG001|Treatment Period|Poor/non-compliance|1|||
146627331|NCT02156076|528811734|FG002|Treatment Period|Poor/non-compliance|0|||
146627332|NCT02156076|528811735|FG003|Treatment Period|Poor/non-compliance|0|||
146627333|NCT02156076|528811732|FG000|Treatment Period|Lost to Follow-up|0|||
146627334|NCT02156076|528811733|FG001|Treatment Period|Lost to Follow-up|0|||
146627335|NCT02156076|528811734|FG002|Treatment Period|Lost to Follow-up|0|||
146627336|NCT02156076|528811735|FG003|Treatment Period|Lost to Follow-up|1|||
146627337|NCT02156076|528811732|FG000|Treatment Period|Withdrawal by Subject|0|||
146627338|NCT02156076|528811733|FG001|Treatment Period|Withdrawal by Subject|0|||
146627339|NCT02156076|528811734|FG002|Treatment Period|Withdrawal by Subject|1|||
146627340|NCT02156076|528811735|FG003|Treatment Period|Withdrawal by Subject|0|||
146627341|NCT02156076|528811732|FG000|Treatment Period|Subject request to discontinue treatment|0|||
146627342|NCT02156076|528811733|FG001|Treatment Period|Subject request to discontinue treatment|1|||
146627343|NCT02156076|528811734|FG002|Treatment Period|Subject request to discontinue treatment|0|||
146627344|NCT02156076|528811735|FG003|Treatment Period|Subject request to discontinue treatment|0|||
146627345|NCT02156076|528811732|FG000|Treatment Period|Adverse Event|0|||
146627346|NCT02156076|528811733|FG001|Treatment Period|Adverse Event|0|||
146627347|NCT02156076|528811734|FG002|Treatment Period|Adverse Event|0|||
146627348|NCT02156076|528811735|FG003|Treatment Period|Adverse Event|1|||
146627349|NCT02156076|528811732|FG000|Follow-up Period|Withdrawal by Subject|1|||
146627350|NCT02156076|528811733|FG001|Follow-up Period|Withdrawal by Subject|0|||
146627351|NCT02156076|528811734|FG002|Follow-up Period|Withdrawal by Subject|0|||
146627352|NCT02156076|528811735|FG003|Follow-up Period|Withdrawal by Subject|0|||
146627353|NCT06271993|528811736|FG000|Overall Study|Not reactive to histamine|5|||
146627354|NCT06271993|528811737|FG001|Overall Study|Not reactive to histamine|5|||
146627355|NCT06271993|528811738|FG002|Overall Study|Not reactive to histamine|5|||
146627356|NCT00687596|528811739|FG000|Overall Study|Adverse Event (AE)|10|||
146627357|NCT00687596|528811740|FG001|Overall Study|Adverse Event (AE)|3|||
146627358|NCT00687596|528811739|FG000|Overall Study|Radiological Disease Progression|6|||
146627359|NCT00687596|528811740|FG001|Overall Study|Radiological Disease Progression|2|||
146627360|NCT00687596|528811739|FG000|Overall Study|Clinical Disease Progression|1|||
146627361|NCT00687596|528811740|FG001|Overall Study|Clinical Disease Progression|3|||
146627362|NCT00687596|528811739|FG000|Overall Study|Investigator Discretion|3|||
146627363|NCT00687596|528811740|FG001|Overall Study|Investigator Discretion|1|||
146627364|NCT00687596|528811739|FG000|Overall Study|Sponsor Terminated Study|6|||
146627365|NCT00687596|528811740|FG001|Overall Study|Sponsor Terminated Study|17|||
146627366|NCT03331315|528811745|FG000|Overall Study|Physician Decision|18|||
146627367|NCT03331315|528811746|FG001|Overall Study|Physician Decision|14|||
146627368|NCT02558894|528811749|FG000|Overall Study|Death; any cause, entire study duration|28|||
146627369|NCT02558894|528811750|FG001|Overall Study|Death; any cause, entire study duration|31|||
146627370|NCT02558894|528811749|FG000|Overall Study|Withdrawal by Subject|2|||
146627371|NCT02558894|528811750|FG001|Overall Study|Withdrawal by Subject|1|||
146627372|NCT02558894|528811749|FG000|Overall Study|Closure of Part A|2|||
146627373|NCT02558894|528811750|FG001|Overall Study|Closure of Part A|1|||
146965620|NCT04242446|530035193|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
146627374|NCT02992288|528811751|FG000|Overall Study|Adverse Event|8|||
146627375|NCT02992288|528811752|FG001|Overall Study|Adverse Event|2|||
146627376|NCT02992288|528811753|FG002|Overall Study|Adverse Event|2|||
146627377|NCT02992288|528811754|FG003|Overall Study|Adverse Event|2|||
146627378|NCT02992288|528811755|FG004|Overall Study|Adverse Event|2|||
146627379|NCT02992288|528811756|FG005|Overall Study|Adverse Event|7|||
146627380|NCT02992288|528811751|FG000|Overall Study|Non-compliance with study drug|0|||
146627381|NCT02992288|528811752|FG001|Overall Study|Non-compliance with study drug|1|||
146627382|NCT02992288|528811753|FG002|Overall Study|Non-compliance with study drug|1|||
146627383|NCT02992288|528811754|FG003|Overall Study|Non-compliance with study drug|0|||
146627384|NCT02992288|528811755|FG004|Overall Study|Non-compliance with study drug|1|||
146627385|NCT02992288|528811756|FG005|Overall Study|Non-compliance with study drug|0|||
146627386|NCT02992288|528811751|FG000|Overall Study|Physician Decision|3|||
146627387|NCT02992288|528811752|FG001|Overall Study|Physician Decision|0|||
146627388|NCT02992288|528811753|FG002|Overall Study|Physician Decision|1|||
146627389|NCT02992288|528811754|FG003|Overall Study|Physician Decision|0|||
146627390|NCT02992288|528811755|FG004|Overall Study|Physician Decision|0|||
146627391|NCT02992288|528811756|FG005|Overall Study|Physician Decision|1|||
146627392|NCT02992288|528811751|FG000|Overall Study|Death|2|||
146627393|NCT02992288|528811752|FG001|Overall Study|Death|0|||
146627394|NCT02992288|528811753|FG002|Overall Study|Death|2|||
146627395|NCT02992288|528811754|FG003|Overall Study|Death|1|||
146627396|NCT02992288|528811755|FG004|Overall Study|Death|2|||
146627397|NCT02992288|528811756|FG005|Overall Study|Death|0|||
146627398|NCT02992288|528811751|FG000|Overall Study|Lost to Follow-up|0|||
146627399|NCT02992288|528811752|FG001|Overall Study|Lost to Follow-up|0|||
146627400|NCT02992288|528811753|FG002|Overall Study|Lost to Follow-up|0|||
146871314|NCT03250832|529699869|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146539539|NCT04530344|528483470|FG001|Overall Study|Protocol Violation|0|||
146539540|NCT04530344|528483471|FG002|Overall Study|Protocol Violation|0|||
146539541|NCT04530344|528483472|FG003|Overall Study|Protocol Violation|1|||
146539542|NCT04530344|528483469|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
146539543|NCT04530344|528483470|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
146539544|NCT04530344|528483471|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
146539545|NCT04530344|528483472|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
146539546|NCT04530344|528483469|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
146539547|NCT04530344|528483470|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
146539548|NCT04530344|528483471|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
146539549|NCT04530344|528483472|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
146539550|NCT04530344|528483469|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
146539551|NCT04530344|528483470|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
146539552|NCT04530344|528483471|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
146539553|NCT04530344|528483472|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
146539554|NCT04530344|528483469|FG000|Overall Study|Personal Reasons|0|||
146539555|NCT04530344|528483470|FG001|Overall Study|Personal Reasons|0|||
146539556|NCT04530344|528483471|FG002|Overall Study|Personal Reasons|0|||
146539557|NCT04530344|528483472|FG003|Overall Study|Personal Reasons|1|||
146539558|NCT04530344|528483469|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
146539559|NCT04530344|528483470|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
146539560|NCT04530344|528483471|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
146539561|NCT04530344|528483472|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
146539562|NCT01654276|528483481|FG000|Overall Study|Lack of Efficacy|1|||
146539563|NCT01654276|528483481|FG000|Overall Study|Lost to Follow-up|4|||
146539564|NCT01654276|528483481|FG000|Overall Study|Withdrawal by Subject|1|||
146539565|NCT04478266|528483482|FG000|Overall Study|Adverse Event|20|||
146539566|NCT04478266|528483483|FG001|Overall Study|Adverse Event|21|||
146539567|NCT04478266|528483482|FG000|Overall Study|Progressive disease|146|||
146539568|NCT04478266|528483483|FG001|Overall Study|Progressive disease|168|||
146539569|NCT04478266|528483482|FG000|Overall Study|Poor compliance to protocol|1|||
146539570|NCT04478266|528483483|FG001|Overall Study|Poor compliance to protocol|0|||
146539571|NCT04478266|528483482|FG000|Overall Study|Withdrawal by Subject|19|||
146539572|NCT04478266|528483483|FG001|Overall Study|Withdrawal by Subject|16|||
146539573|NCT04478266|528483482|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
146539574|NCT04478266|528483483|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
146539575|NCT04478266|528483482|FG000|Overall Study|Study terminated by sponsor|33|||
146539576|NCT04478266|528483483|FG001|Overall Study|Study terminated by sponsor|35|||
146539577|NCT04478266|528483482|FG000|Overall Study|Other: unspecified|5|||
146539578|NCT04478266|528483483|FG001|Overall Study|Other: unspecified|7|||
146539579|NCT04478266|528483482|FG000|Overall Study|Randomized but not treated|1|||
146871315|NCT03250832|529699870|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146871316|NCT03250832|529699871|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146975322|NCT00736333|530073531|FG000|Overall Study|Death|7|||
146539580|NCT04478266|528483483|FG001|Overall Study|Randomized but not treated|1|||
146539581|NCT01977846|528483486|FG000|Total Study - Prospective|Death|0|||
146539582|NCT01977846|528483487|FG001|Total Study - Prospective|Death|1|||
146539583|NCT01977846|528483486|FG000|Total Study - Prospective|Lost to Follow-up|0|||
146539584|NCT01977846|528483487|FG001|Total Study - Prospective|Lost to Follow-up|8|||
146539585|NCT01977846|528483486|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
146539586|NCT01977846|528483487|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
146627401|NCT02992288|528811754|FG003|Overall Study|Lost to Follow-up|1|||
146627402|NCT02992288|528811755|FG004|Overall Study|Lost to Follow-up|0|||
146627403|NCT02992288|528811756|FG005|Overall Study|Lost to Follow-up|0|||
146627404|NCT02992288|528811751|FG000|Overall Study|Protocol Violation|0|||
146627405|NCT02992288|528811752|FG001|Overall Study|Protocol Violation|0|||
146627406|NCT02992288|528811753|FG002|Overall Study|Protocol Violation|0|||
146627407|NCT02992288|528811754|FG003|Overall Study|Protocol Violation|0|||
146627408|NCT02992288|528811755|FG004|Overall Study|Protocol Violation|0|||
146627409|NCT02992288|528811756|FG005|Overall Study|Protocol Violation|1|||
146627410|NCT02992288|528811751|FG000|Overall Study|Withdrawal by Subject|4|||
146627411|NCT02992288|528811752|FG001|Overall Study|Withdrawal by Subject|2|||
146627412|NCT02992288|528811753|FG002|Overall Study|Withdrawal by Subject|1|||
146627413|NCT02992288|528811754|FG003|Overall Study|Withdrawal by Subject|5|||
146627414|NCT02992288|528811755|FG004|Overall Study|Withdrawal by Subject|3|||
146627415|NCT02992288|528811756|FG005|Overall Study|Withdrawal by Subject|4|||
146627416|NCT00656513|528811757|FG000|Overall Study|Protocol Violation|1|||
146627417|NCT00656513|528811758|FG001|Overall Study|Protocol Violation|0|||
146627418|NCT00656513|528811759|FG002|Overall Study|Protocol Violation|2|||
146627419|NCT00656513|528811757|FG000|Overall Study|Withdrawal by Subject|0|||
146627420|NCT00656513|528811758|FG001|Overall Study|Withdrawal by Subject|11|||
146627421|NCT00656513|528811759|FG002|Overall Study|Withdrawal by Subject|4|||
146627422|NCT00656513|528811757|FG000|Overall Study|Death|0|||
146627423|NCT00656513|528811758|FG001|Overall Study|Death|0|||
146627424|NCT00656513|528811759|FG002|Overall Study|Death|1|||
146627425|NCT00656513|528811757|FG000|Overall Study|Missing data|0|||
146627426|NCT00656513|528811758|FG001|Overall Study|Missing data|11|||
146627427|NCT00656513|528811759|FG002|Overall Study|Missing data|9|||
146627428|NCT00656513|528811757|FG000|Overall Study|Incomplete treatment|3|||
146627429|NCT00656513|528811758|FG001|Overall Study|Incomplete treatment|0|||
146627430|NCT00656513|528811759|FG002|Overall Study|Incomplete treatment|0|||
146627431|NCT00656513|528811757|FG000|Overall Study|Treatment completed outside of timeframe|0|||
146627432|NCT00656513|528811758|FG001|Overall Study|Treatment completed outside of timeframe|3|||
146627433|NCT00656513|528811759|FG002|Overall Study|Treatment completed outside of timeframe|1|||
146627434|NCT00656513|528811757|FG000|Overall Study|Missing baseline form|0|||
146627435|NCT00656513|528811758|FG001|Overall Study|Missing baseline form|5|||
146627436|NCT00656513|528811759|FG002|Overall Study|Missing baseline form|5|||
146627437|NCT03379818|528811760|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
146627438|NCT03379818|528811761|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
146627439|NCT03379818|528811760|FG000|Overall Study|Withdrawal by Subject|2|||
146627440|NCT03379818|528811761|FG001|Overall Study|Withdrawal by Subject|3|||
146627441|NCT03379818|528811760|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
146539587|NCT01977846|528483486|FG000|Total Study - Prospective|Not available at time of visit|0|||
146539588|NCT01977846|528483487|FG001|Total Study - Prospective|Not available at time of visit|5|||
146539589|NCT01977846|528483486|FG000|Total Study - Prospective|No show|0|||
146539590|NCT01977846|528483487|FG001|Total Study - Prospective|No show|1|||
146627442|NCT03379818|528811761|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
146627443|NCT01867671|528811765|FG000|Overall Study|Adverse Event|5|||
146627444|NCT01867671|528811766|FG001|Overall Study|Adverse Event|3|||
146539591|NCT01977846|528483486|FG000|Total Study - Prospective|Protocol Violation|0|||
146539592|NCT01977846|528483487|FG001|Total Study - Prospective|Protocol Violation|1|||
146539593|NCT00596635|528483489|FG000|Overall Study|Lost to Follow-up|0|||
146539594|NCT00596635|528483490|FG001|Overall Study|Lost to Follow-up|2|||
146539595|NCT00596635|528483491|FG002|Overall Study|Lost to Follow-up|0|||
146539596|NCT00596635|528483489|FG000|Overall Study|Treatment for symptomatic UTI|4|||
146539597|NCT00596635|528483490|FG001|Overall Study|Treatment for symptomatic UTI|6|||
146539598|NCT00596635|528483491|FG002|Overall Study|Treatment for symptomatic UTI|3|||
146539599|NCT00596635|528483489|FG000|Overall Study|Hip fracture|2|||
146539600|NCT00596635|528483490|FG001|Overall Study|Hip fracture|3|||
146539601|NCT00596635|528483491|FG002|Overall Study|Hip fracture|3|||
146539602|NCT00596635|528483489|FG000|Overall Study|Could not provide urine specimen|1|||
146539603|NCT00596635|528483490|FG001|Overall Study|Could not provide urine specimen|2|||
146539604|NCT00596635|528483491|FG002|Overall Study|Could not provide urine specimen|2|||
146627445|NCT01867671|528811765|FG000|Overall Study|Anaphylaxis|0|||
146627446|NCT01867671|528811766|FG001|Overall Study|Anaphylaxis|1|||
146627447|NCT01867671|528811765|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
146627448|NCT01867671|528811766|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
146627449|NCT01867671|528811765|FG000|Overall Study|Lost to Follow-up|0|||
146627450|NCT01867671|528811766|FG001|Overall Study|Lost to Follow-up|1|||
146627451|NCT01867671|528811765|FG000|Overall Study|Non-compliance with Study Drug|1|||
146627452|NCT01867671|528811766|FG001|Overall Study|Non-compliance with Study Drug|2|||
146627453|NCT01867671|528811765|FG000|Overall Study|Withdrawal by Subject|21|||
146627454|NCT01867671|528811766|FG001|Overall Study|Withdrawal by Subject|21|||
146627455|NCT05236270|528811769|FG000|Overall Study|Lost to Follow-up|3|||
146627456|NCT05236270|528811770|FG001|Overall Study|Lost to Follow-up|2|||
146627457|NCT05236270|528811771|FG002|Overall Study|Lost to Follow-up|0|||
146539605|NCT00127803|528483494|FG000|Overall Study|Adverse Event|2|||
146627458|NCT05236270|528811772|FG003|Overall Study|Lost to Follow-up|0|||
146627459|NCT05236270|528811773|FG004|Overall Study|Lost to Follow-up|2|||
146871317|NCT03250832|529699872|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146627460|NCT05236270|528811774|FG005|Overall Study|Lost to Follow-up|0|||
146627461|NCT05236270|528811775|FG006|Overall Study|Lost to Follow-up|1|||
146539606|NCT00127803|528483495|FG001|Overall Study|Adverse Event|0|||
146539607|NCT00127803|528483496|FG002|Overall Study|Adverse Event|0|||
146539608|NCT00127803|528483497|FG003|Overall Study|Adverse Event|0|||
146539609|NCT00127803|528483494|FG000|Overall Study|Withdrawal by Subject|1|||
146539610|NCT00127803|528483495|FG001|Overall Study|Withdrawal by Subject|0|||
146539611|NCT00127803|528483496|FG002|Overall Study|Withdrawal by Subject|0|||
146539612|NCT00127803|528483497|FG003|Overall Study|Withdrawal by Subject|0|||
146539613|NCT00127803|528483494|FG000|Overall Study|Lost to Follow-up|0|||
146539614|NCT00127803|528483495|FG001|Overall Study|Lost to Follow-up|0|||
146539615|NCT00127803|528483496|FG002|Overall Study|Lost to Follow-up|0|||
146539616|NCT00127803|528483497|FG003|Overall Study|Lost to Follow-up|1|||
146539617|NCT01020123|528483498|FG000|Main Period|Withdrawal by Subject|6|||
146539618|NCT01020123|528483499|FG001|Main Period|Withdrawal by Subject|5|||
146539619|NCT01020123|528483500|FG002|Main Period|Withdrawal by Subject|3|||
146539620|NCT01020123|528483501|FG003|Main Period|Withdrawal by Subject|1|||
146539621|NCT01020123|528483502|FG004|Main Period|Withdrawal by Subject|6|||
146539622|NCT01020123|528483503|FG005|Main Period|Withdrawal by Subject|3|||
146539623|NCT01020123|528483504|FG006|Main Period|Withdrawal by Subject|2|||
146539624|NCT01020123|528483498|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
146539625|NCT01020123|528483499|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
146539626|NCT01020123|528483500|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
146539627|NCT01020123|528483501|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
146539628|NCT01020123|528483502|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
146539629|NCT01020123|528483503|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
146539630|NCT01020123|528483504|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
146539631|NCT01020123|528483498|FG000|Main Period|Adverse Event|5|||
146539632|NCT01020123|528483499|FG001|Main Period|Adverse Event|2|||
146539633|NCT01020123|528483500|FG002|Main Period|Adverse Event|2|||
146539634|NCT01020123|528483501|FG003|Main Period|Adverse Event|1|||
146539635|NCT01020123|528483502|FG004|Main Period|Adverse Event|1|||
146539636|NCT01020123|528483503|FG005|Main Period|Adverse Event|2|||
146539637|NCT01020123|528483504|FG006|Main Period|Adverse Event|1|||
146539638|NCT01020123|528483498|FG000|Main Period|Protocol Violation|4|||
146539639|NCT01020123|528483499|FG001|Main Period|Protocol Violation|4|||
146539640|NCT01020123|528483500|FG002|Main Period|Protocol Violation|2|||
146539641|NCT01020123|528483501|FG003|Main Period|Protocol Violation|5|||
146539642|NCT01020123|528483502|FG004|Main Period|Protocol Violation|2|||
146539643|NCT01020123|528483503|FG005|Main Period|Protocol Violation|3|||
146539644|NCT01020123|528483504|FG006|Main Period|Protocol Violation|2|||
146539645|NCT01020123|528483498|FG000|Main Period|Lost to Follow-up|0|||
146539646|NCT01020123|528483499|FG001|Main Period|Lost to Follow-up|2|||
146539647|NCT01020123|528483500|FG002|Main Period|Lost to Follow-up|0|||
146539648|NCT01020123|528483501|FG003|Main Period|Lost to Follow-up|0|||
146539649|NCT01020123|528483502|FG004|Main Period|Lost to Follow-up|0|||
146539650|NCT01020123|528483503|FG005|Main Period|Lost to Follow-up|0|||
146539651|NCT01020123|528483504|FG006|Main Period|Lost to Follow-up|0|||
146539652|NCT01020123|528483498|FG000|Main Period|Unclasified|2|||
146539653|NCT01020123|528483499|FG001|Main Period|Unclasified|0|||
146539654|NCT01020123|528483500|FG002|Main Period|Unclasified|1|||
146539655|NCT01020123|528483501|FG003|Main Period|Unclasified|0|||
146539656|NCT01020123|528483502|FG004|Main Period|Unclasified|1|||
146539657|NCT01020123|528483503|FG005|Main Period|Unclasified|3|||
146539658|NCT01020123|528483504|FG006|Main Period|Unclasified|6|||
146539659|NCT01020123|528483498|FG000|Extention Period|Withdrawal by Subject|2|||
146539660|NCT01020123|528483499|FG001|Extention Period|Withdrawal by Subject|1|||
146539661|NCT01020123|528483500|FG002|Extention Period|Withdrawal by Subject|1|||
146539662|NCT01020123|528483501|FG003|Extention Period|Withdrawal by Subject|0|||
146539663|NCT01020123|528483502|FG004|Extention Period|Withdrawal by Subject|0|||
146539664|NCT01020123|528483503|FG005|Extention Period|Withdrawal by Subject|0|||
146539665|NCT01020123|528483504|FG006|Extention Period|Withdrawal by Subject|0|||
146539666|NCT01020123|528483498|FG000|Extention Period|Adverse Event|0|||
146539667|NCT01020123|528483499|FG001|Extention Period|Adverse Event|0|||
146539668|NCT01020123|528483500|FG002|Extention Period|Adverse Event|0|||
146539669|NCT01020123|528483501|FG003|Extention Period|Adverse Event|1|||
146539670|NCT01020123|528483502|FG004|Extention Period|Adverse Event|0|||
146539671|NCT01020123|528483503|FG005|Extention Period|Adverse Event|0|||
146539672|NCT01020123|528483504|FG006|Extention Period|Adverse Event|0|||
146539673|NCT01020123|528483498|FG000|Extention Period|Protocol Violation|1|||
146539674|NCT01020123|528483499|FG001|Extention Period|Protocol Violation|1|||
146763910|NCT00777556|529302921|FG000|Overall Study|Inappropriate self-selection|34|||
146539675|NCT01020123|528483500|FG002|Extention Period|Protocol Violation|1|||
146539676|NCT01020123|528483501|FG003|Extention Period|Protocol Violation|0|||
146539677|NCT01020123|528483502|FG004|Extention Period|Protocol Violation|0|||
146539678|NCT01020123|528483503|FG005|Extention Period|Protocol Violation|0|||
146539679|NCT01020123|528483504|FG006|Extention Period|Protocol Violation|1|||
146539680|NCT01020123|528483498|FG000|Extention Period|Lost to Follow-up|0|||
146539681|NCT01020123|528483499|FG001|Extention Period|Lost to Follow-up|0|||
146539682|NCT01020123|528483500|FG002|Extention Period|Lost to Follow-up|0|||
146539683|NCT01020123|528483501|FG003|Extention Period|Lost to Follow-up|0|||
146871318|NCT03250832|529699873|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
146871319|NCT03250832|529699874|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146871320|NCT03250832|529699875|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146871321|NCT03250832|529699876|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146871322|NCT03250832|529699877|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146871323|NCT03250832|529699866|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146871324|NCT03250832|529699867|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146871325|NCT03250832|529699868|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146871326|NCT03250832|529699869|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146871327|NCT03250832|529699870|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146871328|NCT03250832|529699871|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146871329|NCT03250832|529699872|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146871330|NCT03250832|529699873|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
146871331|NCT03250832|529699874|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146871332|NCT03250832|529699875|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146871333|NCT03250832|529699876|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146871334|NCT03250832|529699877|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146871335|NCT03250832|529699866|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146871336|NCT03250832|529699867|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146871337|NCT03250832|529699868|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146871338|NCT03250832|529699869|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146871339|NCT03250832|529699870|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146871340|NCT03250832|529699871|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146871341|NCT03250832|529699872|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146871342|NCT03250832|529699873|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
146871343|NCT03250832|529699874|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146871344|NCT03250832|529699875|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146871345|NCT03250832|529699876|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146871346|NCT03250832|529699877|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146871347|NCT03250832|529699866|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
146871348|NCT03250832|529699867|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
146871349|NCT03250832|529699868|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
146871350|NCT03250832|529699869|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
146871351|NCT03250832|529699870|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
146871352|NCT03250832|529699871|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
146871353|NCT03250832|529699872|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
146871354|NCT03250832|529699873|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
146871355|NCT03250832|529699874|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
146871356|NCT03250832|529699875|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
146871357|NCT03250832|529699876|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
146871358|NCT03250832|529699877|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
146871359|NCT03250832|529699866|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
146871360|NCT03250832|529699867|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
146871361|NCT03250832|529699868|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
146871362|NCT03250832|529699869|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
146871363|NCT03250832|529699870|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
146539684|NCT01020123|528483502|FG004|Extention Period|Lost to Follow-up|0|||
146539685|NCT01020123|528483503|FG005|Extention Period|Lost to Follow-up|2|||
146539686|NCT01020123|528483504|FG006|Extention Period|Lost to Follow-up|0|||
146871364|NCT03250832|529699871|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
146871365|NCT03250832|529699872|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
146871366|NCT03250832|529699873|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
146871367|NCT03250832|529699874|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
146871368|NCT03250832|529699875|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
146871369|NCT03250832|529699876|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
146871370|NCT03250832|529699877|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
146871371|NCT03250832|529699866|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146871372|NCT03250832|529699867|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146871373|NCT03250832|529699868|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146871374|NCT03250832|529699869|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146871375|NCT03250832|529699870|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146871376|NCT03250832|529699871|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146871377|NCT03250832|529699872|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146539687|NCT00846365|528483505|FG000|Overall Study|Adverse Event|20|||
146539688|NCT00846365|528483506|FG001|Overall Study|Adverse Event|30|||
146539689|NCT00846365|528483507|FG002|Overall Study|Adverse Event|11|||
146539690|NCT00846365|528483505|FG000|Overall Study|Protocol Violation|5|||
146871378|NCT03250832|529699873|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146871379|NCT03250832|529699874|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
146871380|NCT03250832|529699875|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
146871381|NCT03250832|529699876|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146871382|NCT03250832|529699877|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146871383|NCT03250832|529699866|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146871384|NCT03250832|529699867|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146871385|NCT03250832|529699868|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146871386|NCT03250832|529699869|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146627462|NCT05236270|528811776|FG007|Overall Study|Lost to Follow-up|3|||
146627463|NCT04711850|528811777|FG000|Overall Study|Graft loss|2|||
146871387|NCT03250832|529699870|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146871388|NCT03250832|529699871|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146871389|NCT03250832|529699872|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146871390|NCT03250832|529699873|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146871391|NCT03250832|529699874|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
146871392|NCT03250832|529699875|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
146871393|NCT03250832|529699876|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146871394|NCT03250832|529699877|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146871395|NCT03250832|529699866|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146871396|NCT03250832|529699867|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146871397|NCT03250832|529699868|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146871398|NCT03250832|529699869|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146871399|NCT03250832|529699870|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146871400|NCT03250832|529699871|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146871401|NCT03250832|529699872|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146871402|NCT03250832|529699873|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146539691|NCT00846365|528483506|FG001|Overall Study|Protocol Violation|4|||
146539692|NCT00846365|528483507|FG002|Overall Study|Protocol Violation|0|||
146539693|NCT00846365|528483505|FG000|Overall Study|Lost to Follow-up|8|||
146539694|NCT00846365|528483506|FG001|Overall Study|Lost to Follow-up|2|||
146539695|NCT00846365|528483507|FG002|Overall Study|Lost to Follow-up|5|||
146539696|NCT00846365|528483505|FG000|Overall Study|Withdrawal by Subject|11|||
146539697|NCT00846365|528483506|FG001|Overall Study|Withdrawal by Subject|11|||
146539698|NCT00846365|528483507|FG002|Overall Study|Withdrawal by Subject|9|||
146539699|NCT00846365|528483505|FG000|Overall Study|Pregnancy|1|||
146539700|NCT00846365|528483506|FG001|Overall Study|Pregnancy|0|||
146871403|NCT03250832|529699874|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146871404|NCT03250832|529699875|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146871405|NCT03250832|529699876|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146871406|NCT03250832|529699877|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
146871407|NCT02303704|529699878|FG000|Overall Study|Protocol Violation|5|||
146871408|NCT02303704|529699879|FG001|Overall Study|Protocol Violation|9|||
146871409|NCT01034540|529699882|FG000|Overall Study|Adverse Event|0|||
146871410|NCT01034540|529699883|FG001|Overall Study|Adverse Event|1|||
146871411|NCT00932425|529699884|FG000|Overall Study|Lost to Follow-up|0|||
146871412|NCT00932425|529699885|FG001|Overall Study|Lost to Follow-up|1|||
146871413|NCT00932425|529699884|FG000|Overall Study|Withdrawal by Subject|0|||
146871414|NCT00932425|529699885|FG001|Overall Study|Withdrawal by Subject|1|||
146871415|NCT01721876|529699889|FG000|Overall Study|Not treated|1|||
146871416|NCT01721876|529699890|FG001|Overall Study|Not treated|4|||
146871417|NCT01721876|529699889|FG000|Overall Study|Disease progression / relapse|123|||
146871418|NCT01721876|529699890|FG001|Overall Study|Disease progression / relapse|156|||
146871419|NCT01721876|529699889|FG000|Overall Study|Death|6|||
146871420|NCT01721876|529699890|FG001|Overall Study|Death|13|||
146871421|NCT01721876|529699889|FG000|Overall Study|Adverse Event|41|||
146871422|NCT01721876|529699890|FG001|Overall Study|Adverse Event|165|||
146871423|NCT01721876|529699889|FG000|Overall Study|Protocol Violation|2|||
146871424|NCT01721876|529699890|FG001|Overall Study|Protocol Violation|1|||
146871425|NCT01721876|529699889|FG000|Overall Study|Withdrawal by Subject|15|||
146871426|NCT01721876|529699890|FG001|Overall Study|Withdrawal by Subject|38|||
146871427|NCT01721876|529699889|FG000|Overall Study|Reason not listed|34|||
146871428|NCT01721876|529699890|FG001|Overall Study|Reason not listed|63|||
146871429|NCT01721876|529699889|FG000|Overall Study|Sponsor terminated trial|0|||
146539701|NCT00846365|528483507|FG002|Overall Study|Pregnancy|0|||
146539702|NCT00846365|528483505|FG000|Overall Study|Lack of Efficacy|1|||
146871430|NCT01721876|529699890|FG001|Overall Study|Sponsor terminated trial|4|||
146871431|NCT02109562|529699891|FG000|Overall Study|Insufficient clinical response|2|||
146871432|NCT02109562|529699892|FG001|Overall Study|Insufficient clinical response|0|||
146871433|NCT02109562|529699893|FG002|Overall Study|Insufficient clinical response|4|||
146539703|NCT00846365|528483506|FG001|Overall Study|Lack of Efficacy|1|||
146627464|NCT04711850|528811778|FG001|Overall Study|Graft loss|1|||
146539704|NCT00846365|528483507|FG002|Overall Study|Lack of Efficacy|2|||
146871434|NCT02109562|529699891|FG000|Overall Study|Adverse Event|0|||
146871435|NCT02109562|529699892|FG001|Overall Study|Adverse Event|2|||
146871436|NCT02109562|529699893|FG002|Overall Study|Adverse Event|3|||
146871437|NCT02109562|529699891|FG000|Overall Study|Lost to Follow-up|1|||
146871438|NCT02109562|529699892|FG001|Overall Study|Lost to Follow-up|0|||
146871439|NCT02109562|529699893|FG002|Overall Study|Lost to Follow-up|1|||
146871440|NCT02109562|529699891|FG000|Overall Study|Protocol Violation|0|||
146871441|NCT02109562|529699892|FG001|Overall Study|Protocol Violation|3|||
146871442|NCT02109562|529699893|FG002|Overall Study|Protocol Violation|1|||
146871443|NCT02109562|529699891|FG000|Overall Study|Withdrawal by Subject|20|||
146871444|NCT02109562|529699892|FG001|Overall Study|Withdrawal by Subject|25|||
146871445|NCT02109562|529699893|FG002|Overall Study|Withdrawal by Subject|21|||
146871446|NCT02109562|529699891|FG000|Overall Study|Physician Decision|3|||
146871447|NCT02109562|529699892|FG001|Overall Study|Physician Decision|4|||
146871448|NCT02109562|529699893|FG002|Overall Study|Physician Decision|5|||
146871449|NCT03697720|529701364|FG000|Overall Study|Lost to Follow-up|7|||
146871450|NCT04096274|529701365|FG000|Phase I|Lost to Follow-up|5|||
146871451|NCT04096274|529701366|FG001|Phase I|Lost to Follow-up|5|||
146871452|NCT04096274|529701365|FG000|Phase II|Lost to Follow-up|11|||
146871453|NCT04096274|529701366|FG001|Phase II|Lost to Follow-up|11|||
146871454|NCT05092919|529701368|FG000|Overall Study|Lost to Follow-up|7|||
146871455|NCT05092919|529701368|FG000|Overall Study|Withdrawal by Subject|2|||
146871456|NCT01942148|529701369|FG000|Overall Study|Adverse Event|4|||
146871457|NCT01942148|529701369|FG000|Overall Study|Lack of Efficacy|2|||
146871458|NCT01942148|529701369|FG000|Overall Study|Physician Decision|11|||
146871459|NCT01942148|529701369|FG000|Overall Study|Protocol Violation|1|||
146871460|NCT01942148|529701369|FG000|Overall Study|Withdrawal by Subject|8|||
146871461|NCT01942148|529701369|FG000|Overall Study|Use of the prohibition medicine|1|||
146871462|NCT02807480|529701370|FG000|Overall Study|Withdrawal by Subject|14|||
146871463|NCT02807480|529701371|FG001|Overall Study|Withdrawal by Subject|10|||
146871464|NCT00096785|529701373|FG000|Overall Study|Lost to Follow-up|1|||
146871465|NCT00096785|529701374|FG001|Overall Study|Lost to Follow-up|0|||
146871466|NCT00096785|529701373|FG000|Overall Study|Withdrawal by Subject|0|||
146871467|NCT00096785|529701374|FG001|Overall Study|Withdrawal by Subject|1|||
146871468|NCT00096785|529701373|FG000|Overall Study|Relocated|1|||
146871469|NCT00096785|529701374|FG001|Overall Study|Relocated|0|||
146871470|NCT00257725|529701375|FG000|Overall Study|Adverse Event|3|||
146871471|NCT01858532|529701376|FG000|Overall Study|Adverse Event|58|||
146871472|NCT01858532|529701377|FG001|Overall Study|Adverse Event|50|||
146871473|NCT01858532|529701378|FG002|Overall Study|Adverse Event|23|||
146871474|NCT01858532|529701379|FG003|Overall Study|Adverse Event|28|||
146871475|NCT01858532|529701376|FG000|Overall Study|Withdrew consent|71|||
146871476|NCT01858532|529701377|FG001|Overall Study|Withdrew consent|93|||
146871477|NCT01858532|529701378|FG002|Overall Study|Withdrew consent|46|||
146871478|NCT01858532|529701379|FG003|Overall Study|Withdrew consent|27|||
146871479|NCT01858532|529701376|FG000|Overall Study|Lost to Follow-up|17|||
146871480|NCT01858532|529701377|FG001|Overall Study|Lost to Follow-up|26|||
146871481|NCT01858532|529701378|FG002|Overall Study|Lost to Follow-up|11|||
146871482|NCT01858532|529701379|FG003|Overall Study|Lost to Follow-up|14|||
146871483|NCT01858532|529701376|FG000|Overall Study|Deterioration of medical status|3|||
146871484|NCT01858532|529701377|FG001|Overall Study|Deterioration of medical status|4|||
146871485|NCT01858532|529701378|FG002|Overall Study|Deterioration of medical status|3|||
146871486|NCT01858532|529701379|FG003|Overall Study|Deterioration of medical status|7|||
146871487|NCT01858532|529701376|FG000|Overall Study|Investigator request|3|||
146871488|NCT01858532|529701377|FG001|Overall Study|Investigator request|4|||
146871489|NCT01858532|529701378|FG002|Overall Study|Investigator request|2|||
146871490|NCT01858532|529701379|FG003|Overall Study|Investigator request|6|||
146871491|NCT01858532|529701376|FG000|Overall Study|Other, not specified|29|||
146871492|NCT01858532|529701377|FG001|Overall Study|Other, not specified|15|||
146539705|NCT00846365|528483505|FG000|Overall Study|Other|9|||
146539706|NCT00846365|528483506|FG001|Overall Study|Other|1|||
146871493|NCT01858532|529701378|FG002|Overall Study|Other, not specified|13|||
146871494|NCT01858532|529701379|FG003|Overall Study|Other, not specified|11|||
146871495|NCT00514514|529701380|FG000|Pre-phase|Death|10|||
146871496|NCT00514514|529701381|FG001|Pre-phase|Death|0|||
146871497|NCT00514514|529701382|FG002|Pre-phase|Death|0|||
146871498|NCT00514514|529701380|FG000|Pre-phase|administrative problems|2|||
146871499|NCT00514514|529701381|FG001|Pre-phase|administrative problems|0|||
146871500|NCT00514514|529701382|FG002|Pre-phase|administrative problems|0|||
146871501|NCT00514514|529701380|FG000|Pre-phase|Protocol Violation|6|||
146871502|NCT00514514|529701381|FG001|Pre-phase|Protocol Violation|0|||
146871503|NCT00514514|529701382|FG002|Pre-phase|Protocol Violation|0|||
146871504|NCT00514514|529701380|FG000|Pre-phase|condition no longer requires study drug|7|||
146871505|NCT00514514|529701381|FG001|Pre-phase|condition no longer requires study drug|0|||
146871506|NCT00514514|529701382|FG002|Pre-phase|condition no longer requires study drug|0|||
146871507|NCT00514514|529701380|FG000|Pre-phase|abnormal test procedure results|15|||
146871508|NCT00514514|529701381|FG001|Pre-phase|abnormal test procedure results|0|||
146871509|NCT00514514|529701382|FG002|Pre-phase|abnormal test procedure results|0|||
146627465|NCT04711850|528811777|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
146627466|NCT04711850|528811778|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
146627467|NCT04711850|528811777|FG000|Overall Study|Study terminated by sponsor|5|||
146627468|NCT04711850|528811778|FG001|Overall Study|Study terminated by sponsor|3|||
146627469|NCT04711850|528811777|FG000|Overall Study|Sponsor decision|0|||
146627470|NCT04711850|528811778|FG001|Overall Study|Sponsor decision|2|||
146627471|NCT04531176|528811796|FG000|Overall Study|Study was stopped early|24|||
146627472|NCT04531176|528811797|FG001|Overall Study|Study was stopped early|26|||
146627473|NCT04531176|528811798|FG002|Overall Study|Study was stopped early|24|||
146627474|NCT00561652|528811803|FG000|Overall Study|Withdrawal by Subject|0|||
146627475|NCT00561652|528811804|FG001|Overall Study|Withdrawal by Subject|1|||
146627476|NCT01743469|528811805|FG000|Active Treatment Phase|Adverse Event|10|||
146627477|NCT01743469|528811806|FG001|Active Treatment Phase|Adverse Event|5|||
146627478|NCT01743469|528811807|FG002|Active Treatment Phase|Adverse Event|8|||
146627479|NCT01743469|528811808|FG003|Active Treatment Phase|Adverse Event|1|||
146627480|NCT01743469|528811805|FG000|Active Treatment Phase|Disease Progression|40|||
146627481|NCT01743469|528811806|FG001|Active Treatment Phase|Disease Progression|47|||
146627482|NCT01743469|528811807|FG002|Active Treatment Phase|Disease Progression|30|||
146627483|NCT01743469|528811808|FG003|Active Treatment Phase|Disease Progression|20|||
146627484|NCT01743469|528811805|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
146627485|NCT01743469|528811806|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
146627486|NCT01743469|528811807|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
146627487|NCT01743469|528811808|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
146627488|NCT01743469|528811805|FG000|Active Treatment Phase|Missing|1|||
146627489|NCT01743469|528811806|FG001|Active Treatment Phase|Missing|0|||
146627490|NCT01743469|528811807|FG002|Active Treatment Phase|Missing|0|||
146627491|NCT01743469|528811808|FG003|Active Treatment Phase|Missing|0|||
146627492|NCT01743469|528811805|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
146627493|NCT01743469|528811806|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
146627494|NCT01743469|528811807|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
146627495|NCT01743469|528811808|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
146627496|NCT01743469|528811805|FG000|Follow-up Period - Post-Treatment|Death|43|||
146627497|NCT01743469|528811806|FG001|Follow-up Period - Post-Treatment|Death|47|||
146627498|NCT01743469|528811807|FG002|Follow-up Period - Post-Treatment|Death|22|||
146627499|NCT01743469|528811808|FG003|Follow-up Period - Post-Treatment|Death|16|||
146627500|NCT01743469|528811805|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
146627501|NCT01743469|528811806|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
146627502|NCT01743469|528811807|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
146627503|NCT01743469|528811808|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
146627504|NCT00317473|528811809|FG000|Overall Study|Withdrawal by Subject|2|||
146627505|NCT00317473|528811810|FG001|Overall Study|Withdrawal by Subject|1|||
146627506|NCT00317473|528811811|FG002|Overall Study|Withdrawal by Subject|2|||
146627507|NCT00317473|528811812|FG003|Overall Study|Withdrawal by Subject|1|||
146627508|NCT00317473|528811813|FG004|Overall Study|Withdrawal by Subject|3|||
146627509|NCT00317473|528811814|FG005|Overall Study|Withdrawal by Subject|1|||
146627510|NCT00317473|528811809|FG000|Overall Study|Relocation|1|||
146871510|NCT00514514|529701380|FG000|Pre-phase|Lost to Follow-up|2|||
146871511|NCT00514514|529701381|FG001|Pre-phase|Lost to Follow-up|0|||
146627511|NCT00317473|528811810|FG001|Overall Study|Relocation|0|||
146627512|NCT00317473|528811811|FG002|Overall Study|Relocation|1|||
146627513|NCT00317473|528811812|FG003|Overall Study|Relocation|1|||
146627514|NCT00317473|528811813|FG004|Overall Study|Relocation|5|||
146627515|NCT00317473|528811814|FG005|Overall Study|Relocation|2|||
146539707|NCT00846365|528483507|FG002|Overall Study|Other|6|||
146539708|NCT00671060|528485120|FG000|Overall Study|Protocol Violation|1|||
146539709|NCT00671060|528485121|FG001|Overall Study|Protocol Violation|0|||
146539710|NCT00671060|528485120|FG000|Overall Study|Physician Decision|0|||
146539711|NCT00671060|528485121|FG001|Overall Study|Physician Decision|1|||
146539712|NCT00303186|528485122|FG000|Overall Study|Other|52|||
146539713|NCT02020941|528485123|FG000|Overall Study|Adverse Event|1|||
146539714|NCT02020941|528485123|FG000|Overall Study|Physician Decision|2|||
146539715|NCT02020941|528485123|FG000|Overall Study|Withdrawal by Subject|1|||
146539716|NCT02020941|528485123|FG000|Overall Study|Disease Progression|4|||
146539717|NCT02832037|528485124|FG000|Overall Study|Administrative reasons|0|||
146539718|NCT02832037|528485125|FG001|Overall Study|Administrative reasons|0|||
146539719|NCT02832037|528485126|FG002|Overall Study|Administrative reasons|1|||
146539720|NCT02832037|528485127|FG003|Overall Study|Administrative reasons|0|||
146539721|NCT02832037|528485128|FG004|Overall Study|Administrative reasons|0|||
146539722|NCT02832037|528485124|FG000|Overall Study|Protocol Violation|3|||
146539723|NCT02832037|528485125|FG001|Overall Study|Protocol Violation|0|||
146539724|NCT02832037|528485126|FG002|Overall Study|Protocol Violation|4|||
146539725|NCT02832037|528485127|FG003|Overall Study|Protocol Violation|1|||
146539726|NCT02832037|528485128|FG004|Overall Study|Protocol Violation|2|||
146539727|NCT02832037|528485124|FG000|Overall Study|Lost to Follow-up|2|||
146539728|NCT02832037|528485125|FG001|Overall Study|Lost to Follow-up|0|||
146539729|NCT02832037|528485126|FG002|Overall Study|Lost to Follow-up|3|||
146539730|NCT02832037|528485127|FG003|Overall Study|Lost to Follow-up|0|||
146539731|NCT02832037|528485128|FG004|Overall Study|Lost to Follow-up|5|||
146539732|NCT02832037|528485124|FG000|Overall Study|Withdrawal by Subject|9|||
146539733|NCT02832037|528485125|FG001|Overall Study|Withdrawal by Subject|8|||
146539734|NCT02832037|528485126|FG002|Overall Study|Withdrawal by Subject|0|||
146539735|NCT02832037|528485127|FG003|Overall Study|Withdrawal by Subject|4|||
146539736|NCT02832037|528485128|FG004|Overall Study|Withdrawal by Subject|8|||
146539737|NCT02832037|528485124|FG000|Overall Study|Adverse Event|5|||
146539738|NCT02832037|528485125|FG001|Overall Study|Adverse Event|4|||
146539739|NCT02832037|528485126|FG002|Overall Study|Adverse Event|0|||
146539740|NCT02832037|528485127|FG003|Overall Study|Adverse Event|2|||
146539741|NCT02832037|528485128|FG004|Overall Study|Adverse Event|4|||
146539742|NCT01531153|528485135|FG000|Overall Study|Withdrawal by Subject|10|||
146539743|NCT01531153|528485136|FG001|Overall Study|Withdrawal by Subject|9|||
146539744|NCT01531153|528485137|FG002|Overall Study|Withdrawal by Subject|15|||
146539745|NCT00435942|528485138|FG000|Overall Study|Death|17|||
146539746|NCT00435942|528485139|FG001|Overall Study|Death|10|||
146539747|NCT00435942|528485138|FG000|Overall Study|Withdrawal by Subject|2|||
146539748|NCT00435942|528485139|FG001|Overall Study|Withdrawal by Subject|0|||
146539749|NCT00435942|528485138|FG000|Overall Study|Lost to Follow-up|0|||
146539750|NCT00435942|528485139|FG001|Overall Study|Lost to Follow-up|16|||
146539751|NCT00435942|528485138|FG000|Overall Study|Conversion to Open Repair|1|||
146539752|NCT00435942|528485139|FG001|Overall Study|Conversion to Open Repair|0|||
146539753|NCT00435942|528485138|FG000|Overall Study|Technical Failure|3|||
146539754|NCT00435942|528485139|FG001|Overall Study|Technical Failure|0|||
146539755|NCT00435942|528485138|FG000|Overall Study|Other|0|||
146539756|NCT00435942|528485139|FG001|Overall Study|Other|1|||
146539757|NCT01180777|528485140|FG000|Overall Study|Protocol Violation|6|||
146539758|NCT01180777|528485140|FG000|Overall Study|Poor lens fit|4|||
146539759|NCT01180777|528485140|FG000|Overall Study|Lost to Follow-up|1|||
146539760|NCT01180777|528485140|FG000|Overall Study|Adverse Event|1|||
146539761|NCT04491994|528485141|FG000|Overall Study|Withdrawal by Subject|10|||
146539762|NCT04491994|528485142|FG001|Overall Study|Withdrawal by Subject|5|||
146539763|NCT04491994|528485141|FG000|Overall Study|developed fever > 3 days|4|||
146539764|NCT04491994|528485142|FG001|Overall Study|developed fever > 3 days|1|||
146539765|NCT04491994|528485141|FG000|Overall Study|Protocol Violation|11|||
146965621|NCT04242446|530035194|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
146539766|NCT04491994|528485142|FG001|Overall Study|Protocol Violation|2|||
146539767|NCT04491994|528485141|FG000|Overall Study|Lost to Follow-up|4|||
146539768|NCT04491994|528485142|FG001|Overall Study|Lost to Follow-up|3|||
146965622|NCT04242446|530035195|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
146965623|NCT04242446|530035196|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
146965624|NCT04242446|530035197|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
146539769|NCT02320396|528485143|FG000|Overall Study|Adverse Event|2|||
146539770|NCT02320396|528485144|FG001|Overall Study|Adverse Event|2|||
146539771|NCT02320396|528485143|FG000|Overall Study|Pregnancy|0|||
146539772|NCT02320396|528485144|FG001|Overall Study|Pregnancy|1|||
146539773|NCT02320396|528485143|FG000|Overall Study|Protocol Violation|0|||
146965625|NCT04242446|530035191|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
146965626|NCT04242446|530035192|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
146965627|NCT04242446|530035193|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
146965628|NCT04242446|530035194|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
146965629|NCT04242446|530035195|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
146965630|NCT04242446|530035196|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
146965631|NCT04242446|530035197|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
146965632|NCT04242446|530035191|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
146965633|NCT04242446|530035192|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
146965634|NCT04242446|530035193|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
146539774|NCT02320396|528485144|FG001|Overall Study|Protocol Violation|1|||
146539775|NCT02320396|528485143|FG000|Overall Study|Withdrawal by Subject|2|||
146539776|NCT02320396|528485144|FG001|Overall Study|Withdrawal by Subject|0|||
146539777|NCT03718000|528485145|FG000|Overall Study|Relocation|2|||
146539778|NCT03718000|528485146|FG001|Overall Study|Relocation|4|||
146539779|NCT03718000|528485145|FG000|Overall Study|Pregnancy|0|||
146539780|NCT03718000|528485146|FG001|Overall Study|Pregnancy|1|||
146539781|NCT02475213|528485149|FG000|Overall Study|Adverse Event|2|||
146539782|NCT02475213|528485150|FG001|Overall Study|Adverse Event|0|||
146539783|NCT02475213|528485151|FG002|Overall Study|Adverse Event|0|||
146539784|NCT02475213|528485152|FG003|Overall Study|Adverse Event|1|||
146539785|NCT02475213|528485153|FG004|Overall Study|Adverse Event|1|||
146539786|NCT02475213|528485154|FG005|Overall Study|Adverse Event|4|||
146539787|NCT02475213|528485155|FG006|Overall Study|Adverse Event|6|||
146763911|NCT00777556|529302921|FG000|Overall Study|Dispensed but did not use product|12|||
146763912|NCT00777556|529302921|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
146763913|NCT05298111|529302923|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
146763914|NCT05298111|529302924|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
146763915|NCT02380742|529302925|FG000|Overall Study|Withdrawal by Subject|1|||
146763916|NCT02380742|529302926|FG001|Overall Study|Withdrawal by Subject|0|||
146763917|NCT03518112|529302928|FG000|Overall Study|Withdrawal by Subject|1|||
146763918|NCT01729819|529302931|FG000|Overall Study|Adverse Event|2|||
146763919|NCT01729819|529302932|FG001|Overall Study|Adverse Event|4|||
146763920|NCT01729819|529302931|FG000|Overall Study|Lack of Efficacy|1|||
146763921|NCT01729819|529302932|FG001|Overall Study|Lack of Efficacy|0|||
146763922|NCT01729819|529302931|FG000|Overall Study|Lost to Follow-up|2|||
146763923|NCT01729819|529302932|FG001|Overall Study|Lost to Follow-up|0|||
146763924|NCT01729819|529302931|FG000|Overall Study|Other reason|1|||
146763925|NCT01729819|529302932|FG001|Overall Study|Other reason|0|||
146763926|NCT01729819|529302931|FG000|Overall Study|Protocol Violation|0|||
146763927|NCT01729819|529302932|FG001|Overall Study|Protocol Violation|1|||
146763928|NCT01729819|529302931|FG000|Overall Study|Withdrawal by Subject|0|||
146763929|NCT01729819|529302932|FG001|Overall Study|Withdrawal by Subject|2|||
146763930|NCT02987543|529302933|FG000|Overall Study|Ongoing study at data cut off|49|||
146763931|NCT02987543|529302934|FG001|Overall Study|Ongoing study at data cut off|21|||
146763932|NCT02987543|529302935|FG002|Overall Study|Ongoing study at data cut off|19|||
146763933|NCT02987543|529302936|FG003|Overall Study|Ongoing study at data cut off|12|||
146763934|NCT02987543|529302933|FG000|Overall Study|Death|88|||
146763935|NCT02987543|529302934|FG001|Overall Study|Death|54|||
146763936|NCT02987543|529302935|FG002|Overall Study|Death|67|||
146763937|NCT02987543|529302936|FG003|Overall Study|Death|28|||
146763938|NCT02987543|529302933|FG000|Overall Study|Lost to Follow-up|3|||
146763939|NCT02987543|529302934|FG001|Overall Study|Lost to Follow-up|0|||
146763940|NCT02987543|529302935|FG002|Overall Study|Lost to Follow-up|1|||
146763941|NCT02987543|529302936|FG003|Overall Study|Lost to Follow-up|0|||
146763942|NCT02987543|529302933|FG000|Overall Study|Screen failure|0|||
146763943|NCT02987543|529302934|FG001|Overall Study|Screen failure|0|||
146763944|NCT02987543|529302935|FG002|Overall Study|Screen failure|0|||
146763945|NCT02987543|529302936|FG003|Overall Study|Screen failure|1|||
146763946|NCT02987543|529302933|FG000|Overall Study|Withdrawal by Subject|21|||
146763947|NCT02987543|529302934|FG001|Overall Study|Withdrawal by Subject|7|||
146763948|NCT02987543|529302935|FG002|Overall Study|Withdrawal by Subject|7|||
146763949|NCT02987543|529302936|FG003|Overall Study|Withdrawal by Subject|6|||
146763950|NCT02987543|529302933|FG000|Overall Study|Study terminated by sponsor|1|||
146763951|NCT02987543|529302934|FG001|Overall Study|Study terminated by sponsor|0|||
146763952|NCT02987543|529302935|FG002|Overall Study|Study terminated by sponsor|0|||
146763953|NCT02987543|529302936|FG003|Overall Study|Study terminated by sponsor|0|||
146763954|NCT02987543|529302933|FG000|Overall Study|Investigator decision|0|||
146763955|NCT02987543|529302934|FG001|Overall Study|Investigator decision|1|||
146763956|NCT02987543|529302935|FG002|Overall Study|Investigator decision|0|||
146763957|NCT02987543|529302936|FG003|Overall Study|Investigator decision|0|||
146763958|NCT02987543|529302933|FG000|Overall Study|Disease progression|0|||
146763959|NCT02987543|529302934|FG001|Overall Study|Disease progression|0|||
146763960|NCT02987543|529302935|FG002|Overall Study|Disease progression|0|||
146763961|NCT02987543|529302936|FG003|Overall Study|Disease progression|1|||
146763962|NCT02263508|529302937|FG000|Overall Study|Withdrawal by Subject|1|||
146627516|NCT00317473|528811809|FG000|Overall Study|Death|1|||
146627517|NCT00317473|528811810|FG001|Overall Study|Death|0|||
146627518|NCT00317473|528811811|FG002|Overall Study|Death|0|||
146627519|NCT00317473|528811812|FG003|Overall Study|Death|0|||
146627520|NCT00317473|528811813|FG004|Overall Study|Death|0|||
146627521|NCT00317473|528811814|FG005|Overall Study|Death|0|||
146627522|NCT00317473|528811809|FG000|Overall Study|Other|0|||
146627523|NCT00317473|528811810|FG001|Overall Study|Other|2|||
146627524|NCT00317473|528811811|FG002|Overall Study|Other|0|||
146627525|NCT00317473|528811812|FG003|Overall Study|Other|0|||
146627526|NCT00317473|528811813|FG004|Overall Study|Other|0|||
146627527|NCT00317473|528811814|FG005|Overall Study|Other|0|||
146627528|NCT02718898|528811819|FG000|Blinded Treatment Period|Adverse Event|5|||
146627529|NCT02718898|528811820|FG001|Blinded Treatment Period|Adverse Event|1|||
146627530|NCT02718898|528811821|FG002|Blinded Treatment Period|Adverse Event|0|||
146627531|NCT02718898|528811822|FG003|Blinded Treatment Period|Adverse Event|0|||
146627532|NCT02718898|528811823|FG004|Blinded Treatment Period|Adverse Event|0|||
146627533|NCT02718898|528811824|FG005|Blinded Treatment Period|Adverse Event|0|||
146627534|NCT02718898|528811825|FG006|Blinded Treatment Period|Adverse Event|0|||
146871512|NCT00514514|529701382|FG002|Pre-phase|Lost to Follow-up|0|||
146871513|NCT00514514|529701380|FG000|Pre-phase|abnormal lab values|23|||
146871514|NCT00514514|529701381|FG001|Pre-phase|abnormal lab values|0|||
146871515|NCT00514514|529701382|FG002|Pre-phase|abnormal lab values|0|||
146871516|NCT00514514|529701380|FG000|Pre-phase|Lack of Efficacy|35|||
146871517|NCT00514514|529701381|FG001|Pre-phase|Lack of Efficacy|0|||
146871518|NCT00514514|529701382|FG002|Pre-phase|Lack of Efficacy|0|||
146871519|NCT00514514|529701380|FG000|Pre-phase|Adverse Event|137|||
146871520|NCT00514514|529701381|FG001|Pre-phase|Adverse Event|0|||
146871521|NCT00514514|529701382|FG002|Pre-phase|Adverse Event|0|||
146871522|NCT00514514|529701380|FG000|Pre-phase|Withdrawal by Subject|66|||
146871523|NCT00514514|529701381|FG001|Pre-phase|Withdrawal by Subject|0|||
146871524|NCT00514514|529701382|FG002|Pre-phase|Withdrawal by Subject|0|||
146871525|NCT00514514|529701380|FG000|Randomized - 9 Month|Death|3|||
146871526|NCT00514514|529701381|FG001|Randomized - 9 Month|Death|2|||
146871527|NCT00514514|529701382|FG002|Randomized - 9 Month|Death|2|||
146871528|NCT00514514|529701380|FG000|Randomized - 9 Month|Administrative problems|1|||
146871529|NCT00514514|529701381|FG001|Randomized - 9 Month|Administrative problems|1|||
146871530|NCT00514514|529701382|FG002|Randomized - 9 Month|Administrative problems|2|||
146871531|NCT00514514|529701380|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
146627535|NCT02718898|528811819|FG000|Blinded Treatment Period|Physician Decision|1|||
146627536|NCT02718898|528811820|FG001|Blinded Treatment Period|Physician Decision|0|||
146627537|NCT02718898|528811821|FG002|Blinded Treatment Period|Physician Decision|0|||
146627538|NCT02718898|528811822|FG003|Blinded Treatment Period|Physician Decision|0|||
146627539|NCT02718898|528811823|FG004|Blinded Treatment Period|Physician Decision|0|||
146627540|NCT02718898|528811824|FG005|Blinded Treatment Period|Physician Decision|0|||
146627541|NCT02718898|528811825|FG006|Blinded Treatment Period|Physician Decision|0|||
146627542|NCT02718898|528811819|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
146627543|NCT02718898|528811820|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
146627544|NCT02718898|528811821|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
146627545|NCT02718898|528811822|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
146627546|NCT02718898|528811823|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
146627547|NCT02718898|528811824|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
146627548|NCT02718898|528811825|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
146627549|NCT02718898|528811819|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
146627550|NCT02718898|528811820|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
146627551|NCT02718898|528811821|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
146627552|NCT02718898|528811822|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
146627553|NCT02718898|528811823|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
146627554|NCT02718898|528811824|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
146871532|NCT00514514|529701381|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
146871533|NCT00514514|529701382|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
146871534|NCT00514514|529701380|FG000|Randomized - 9 Month|Protocol Violation|1|||
146871535|NCT00514514|529701381|FG001|Randomized - 9 Month|Protocol Violation|1|||
146871536|NCT00514514|529701382|FG002|Randomized - 9 Month|Protocol Violation|0|||
146975323|NCT00736333|530073531|FG000|Overall Study|Other|4|||
146539788|NCT02475213|528485156|FG007|Overall Study|Adverse Event|2|||
146539789|NCT02475213|528485149|FG000|Overall Study|Physician Decision|1|||
146539790|NCT02475213|528485150|FG001|Overall Study|Physician Decision|1|||
146539791|NCT02475213|528485151|FG002|Overall Study|Physician Decision|1|||
146539792|NCT02475213|528485152|FG003|Overall Study|Physician Decision|0|||
146539793|NCT02475213|528485153|FG004|Overall Study|Physician Decision|0|||
146539794|NCT02475213|528485154|FG005|Overall Study|Physician Decision|1|||
146539795|NCT02475213|528485155|FG006|Overall Study|Physician Decision|4|||
146539796|NCT02475213|528485156|FG007|Overall Study|Physician Decision|0|||
146539797|NCT02475213|528485149|FG000|Overall Study|Progressive Disease|3|||
146539798|NCT02475213|528485150|FG001|Overall Study|Progressive Disease|2|||
146539799|NCT02475213|528485151|FG002|Overall Study|Progressive Disease|2|||
146539800|NCT02475213|528485152|FG003|Overall Study|Progressive Disease|13|||
146965635|NCT04242446|530035194|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
146965636|NCT04242446|530035195|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
146871537|NCT00514514|529701380|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
146871538|NCT00514514|529701381|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
146871539|NCT00514514|529701382|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
146871540|NCT00514514|529701380|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
146871541|NCT00514514|529701381|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
146871542|NCT00514514|529701382|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
146871543|NCT00514514|529701380|FG000|Randomized - 9 Month|Adverse Event|25|||
146871544|NCT00514514|529701381|FG001|Randomized - 9 Month|Adverse Event|44|||
146871545|NCT00514514|529701382|FG002|Randomized - 9 Month|Adverse Event|27|||
146871546|NCT00514514|529701380|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
146871547|NCT00514514|529701381|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
146871548|NCT00514514|529701382|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
146871549|NCT00514514|529701380|FG000|Extension - 4 Years|Lost to Follow-up|12|||
146871550|NCT00514514|529701381|FG001|Extension - 4 Years|Lost to Follow-up|10|||
146871551|NCT00514514|529701382|FG002|Extension - 4 Years|Lost to Follow-up|9|||
146871552|NCT00514514|529701380|FG000|Extension - 4 Years|Administrative problems|3|||
146871553|NCT00514514|529701381|FG001|Extension - 4 Years|Administrative problems|1|||
146871554|NCT00514514|529701382|FG002|Extension - 4 Years|Administrative problems|1|||
146871555|NCT00514514|529701380|FG000|Extension - 4 Years|Death|8|||
146539801|NCT02475213|528485153|FG004|Overall Study|Progressive Disease|15|||
146539802|NCT02475213|528485154|FG005|Overall Study|Progressive Disease|25|||
146871556|NCT00514514|529701381|FG001|Extension - 4 Years|Death|3|||
146871557|NCT00514514|529701382|FG002|Extension - 4 Years|Death|6|||
146871558|NCT00514514|529701380|FG000|Extension - 4 Years|Adverse Event|9|||
146871559|NCT00514514|529701381|FG001|Extension - 4 Years|Adverse Event|6|||
146871560|NCT00514514|529701382|FG002|Extension - 4 Years|Adverse Event|3|||
146871561|NCT02081534|529701389|FG000|Overall Study|Adverse Event|5|||
146871562|NCT02081534|529701390|FG001|Overall Study|Adverse Event|4|||
146871563|NCT02081534|529701391|FG002|Overall Study|Adverse Event|3|||
146871564|NCT02081534|529701392|FG003|Overall Study|Adverse Event|10|||
146871565|NCT02081534|529701393|FG004|Overall Study|Adverse Event|2|||
146871566|NCT02081534|529701394|FG005|Overall Study|Adverse Event|8|||
146871567|NCT02081534|529701395|FG006|Overall Study|Adverse Event|2|||
146871568|NCT02081534|529701389|FG000|Overall Study|Withdrawal by Subject|0|||
146871569|NCT02081534|529701390|FG001|Overall Study|Withdrawal by Subject|1|||
146871570|NCT02081534|529701391|FG002|Overall Study|Withdrawal by Subject|1|||
146871571|NCT02081534|529701392|FG003|Overall Study|Withdrawal by Subject|1|||
146871572|NCT02081534|529701393|FG004|Overall Study|Withdrawal by Subject|1|||
146871573|NCT02081534|529701394|FG005|Overall Study|Withdrawal by Subject|0|||
146871574|NCT02081534|529701395|FG006|Overall Study|Withdrawal by Subject|1|||
146871575|NCT02081534|529701389|FG000|Overall Study|Protocol Violation|0|||
146871576|NCT02081534|529701390|FG001|Overall Study|Protocol Violation|3|||
146871577|NCT02081534|529701391|FG002|Overall Study|Protocol Violation|0|||
146871578|NCT02081534|529701392|FG003|Overall Study|Protocol Violation|0|||
146871579|NCT02081534|529701393|FG004|Overall Study|Protocol Violation|0|||
146871580|NCT02081534|529701394|FG005|Overall Study|Protocol Violation|0|||
146871581|NCT02081534|529701395|FG006|Overall Study|Protocol Violation|1|||
146871582|NCT02081534|529701389|FG000|Overall Study|Lost to Follow-up|0|||
146871583|NCT02081534|529701390|FG001|Overall Study|Lost to Follow-up|0|||
146871584|NCT02081534|529701391|FG002|Overall Study|Lost to Follow-up|0|||
146871585|NCT02081534|529701392|FG003|Overall Study|Lost to Follow-up|2|||
146871586|NCT02081534|529701393|FG004|Overall Study|Lost to Follow-up|1|||
146871587|NCT02081534|529701394|FG005|Overall Study|Lost to Follow-up|1|||
146965637|NCT04242446|530035196|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
146965638|NCT04242446|530035197|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
146965639|NCT04242446|530035191|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
146965640|NCT04242446|530035192|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
146965641|NCT04242446|530035193|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
146965642|NCT04242446|530035194|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
146965643|NCT04242446|530035195|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
146965644|NCT04242446|530035196|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
146965645|NCT04242446|530035197|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
146965646|NCT04242446|530035191|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146965647|NCT04242446|530035192|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
146965648|NCT04242446|530035193|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
146965649|NCT04242446|530035194|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146965650|NCT04242446|530035195|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146965651|NCT04242446|530035196|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146965652|NCT04242446|530035197|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146965653|NCT04242446|530035191|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
146975324|NCT00572156|530073539|FG000|Overall Study|Adverse Event|3|||
146539803|NCT02475213|528485155|FG006|Overall Study|Progressive Disease|30|||
146539804|NCT02475213|528485156|FG007|Overall Study|Progressive Disease|10|||
146539805|NCT02475213|528485149|FG000|Overall Study|Death|0|||
146539806|NCT02475213|528485150|FG001|Overall Study|Death|0|||
146871588|NCT02081534|529701395|FG006|Overall Study|Lost to Follow-up|0|||
146871589|NCT02234479|529701396|FG000|Overall Study|Withdrawal by Subject|1|||
146871590|NCT02234479|529701397|FG001|Overall Study|Withdrawal by Subject|3|||
146871591|NCT01848288|529701399|FG000|Overall Study|Death|1|||
146871592|NCT01848288|529701399|FG000|Overall Study|Protocol Violation|1|||
146871593|NCT01848288|529701399|FG000|Overall Study|Withdrawal by Subject|1|||
146871594|NCT02285920|529701400|FG000|Overall Study|Kidney transplantation|2|||
146871595|NCT02285920|529701401|FG001|Overall Study|Kidney transplantation|2|||
146871596|NCT02285920|529701402|FG002|Overall Study|Kidney transplantation|2|||
146871597|NCT02285920|529701403|FG003|Overall Study|Kidney transplantation|0|||
146871598|NCT02285920|529701400|FG000|Overall Study|Change to peritoneal dialysis|0|||
146871599|NCT02285920|529701401|FG001|Overall Study|Change to peritoneal dialysis|0|||
146871600|NCT02285920|529701402|FG002|Overall Study|Change to peritoneal dialysis|1|||
146871601|NCT02285920|529701403|FG003|Overall Study|Change to peritoneal dialysis|0|||
146871602|NCT02285920|529701400|FG000|Overall Study|Transfer to non-participating unit|0|||
146871603|NCT02285920|529701401|FG001|Overall Study|Transfer to non-participating unit|1|||
146871604|NCT02285920|529701402|FG002|Overall Study|Transfer to non-participating unit|0|||
146871605|NCT02285920|529701403|FG003|Overall Study|Transfer to non-participating unit|0|||
146871606|NCT02285920|529701400|FG000|Overall Study|Dialysis discontinuation|0|||
146871607|NCT02285920|529701401|FG001|Overall Study|Dialysis discontinuation|1|||
146871608|NCT02285920|529701402|FG002|Overall Study|Dialysis discontinuation|0|||
146871609|NCT02285920|529701403|FG003|Overall Study|Dialysis discontinuation|0|||
146871610|NCT02285920|529701400|FG000|Overall Study|Death|2|||
146871611|NCT02285920|529701401|FG001|Overall Study|Death|0|||
146871612|NCT02285920|529701402|FG002|Overall Study|Death|2|||
146871613|NCT02285920|529701403|FG003|Overall Study|Death|1|||
146871614|NCT00922480|529701404|FG000|Main Study|Protocol Violation|3|||
146871615|NCT00922480|529701405|FG001|Main Study|Protocol Violation|6|||
146871616|NCT00922480|529701404|FG000|Main Study|Adverse Event|6|||
146871617|NCT00922480|529701405|FG001|Main Study|Adverse Event|7|||
146871618|NCT00922480|529701404|FG000|Main Study|Lack of Efficacy|3|||
146871619|NCT00922480|529701405|FG001|Main Study|Lack of Efficacy|0|||
146871620|NCT00922480|529701404|FG000|Main Study|Withdrawal by Subject|20|||
146871621|NCT00922480|529701405|FG001|Main Study|Withdrawal by Subject|15|||
146871622|NCT00922480|529701404|FG000|Main Study|Lost to Follow-up|5|||
146871623|NCT00922480|529701405|FG001|Main Study|Lost to Follow-up|0|||
146871624|NCT00922480|529701404|FG000|Main Study|Physician Decision|0|||
146871625|NCT00922480|529701405|FG001|Main Study|Physician Decision|1|||
146871626|NCT00922480|529701404|FG000|Extension Study|Protocol Violation|3|||
146871627|NCT00922480|529701405|FG001|Extension Study|Protocol Violation|0|||
146871628|NCT00922480|529701404|FG000|Extension Study|Adverse Event|1|||
146871629|NCT00922480|529701405|FG001|Extension Study|Adverse Event|1|||
146871630|NCT00922480|529701404|FG000|Extension Study|Withdrawal by Subject|1|||
146871631|NCT00922480|529701405|FG001|Extension Study|Withdrawal by Subject|1|||
146871632|NCT00922480|529701404|FG000|Extension Study|Others|0|||
146539807|NCT02475213|528485151|FG002|Overall Study|Death|0|||
146871633|NCT00922480|529701405|FG001|Extension Study|Others|1|||
146871634|NCT01537198|529701406|FG000|Overall Study|RSV infection|2|||
146871635|NCT01537198|529701406|FG000|Overall Study|Adverse Event|4|||
146871636|NCT01537198|529701406|FG000|Overall Study|No Further Visits to the Clinic|37|||
146871637|NCT01537198|529701406|FG000|Overall Study|Other|111|||
146871638|NCT00574288|529701407|FG000|Overall Study|Adverse Event|2|||
146871639|NCT00574288|529701408|FG001|Overall Study|Adverse Event|0|||
146871640|NCT00574288|529701409|FG002|Overall Study|Adverse Event|0|||
146871641|NCT00574288|529701410|FG003|Overall Study|Adverse Event|0|||
146871642|NCT00574288|529701411|FG004|Overall Study|Adverse Event|1|||
146871643|NCT00574288|529701412|FG005|Overall Study|Adverse Event|0|||
146871644|NCT00574288|529701413|FG006|Overall Study|Adverse Event|0|||
146871645|NCT00574288|529701407|FG000|Overall Study|Death|0|||
146871646|NCT00574288|529701408|FG001|Overall Study|Death|0|||
146871647|NCT00574288|529701409|FG002|Overall Study|Death|0|||
146871648|NCT00574288|529701410|FG003|Overall Study|Death|0|||
146871649|NCT00574288|529701411|FG004|Overall Study|Death|0|||
146871650|NCT00574288|529701412|FG005|Overall Study|Death|25|||
146539808|NCT02475213|528485152|FG003|Overall Study|Death|0|||
146539809|NCT02475213|528485153|FG004|Overall Study|Death|0|||
146539810|NCT02475213|528485154|FG005|Overall Study|Death|4|||
146539811|NCT02475213|528485155|FG006|Overall Study|Death|1|||
146539812|NCT02475213|528485156|FG007|Overall Study|Death|0|||
146539813|NCT02475213|528485149|FG000|Overall Study|Protocol Violation|0|||
146539814|NCT02475213|528485150|FG001|Overall Study|Protocol Violation|0|||
146539815|NCT02475213|528485151|FG002|Overall Study|Protocol Violation|0|||
146763963|NCT02263508|529302938|FG001|Overall Study|Withdrawal by Subject|23|||
146763964|NCT02263508|529302939|FG002|Overall Study|Withdrawal by Subject|17|||
146539816|NCT02475213|528485152|FG003|Overall Study|Protocol Violation|0|||
146763965|NCT02263508|529302937|FG000|Overall Study|Sponsor Decision|12|||
146763966|NCT02263508|529302938|FG001|Overall Study|Sponsor Decision|165|||
146763967|NCT02263508|529302939|FG002|Overall Study|Sponsor Decision|182|||
146763968|NCT02263508|529302937|FG000|Overall Study|Lost to Follow-up|2|||
146763969|NCT02263508|529302938|FG001|Overall Study|Lost to Follow-up|7|||
146763970|NCT02263508|529302939|FG002|Overall Study|Lost to Follow-up|7|||
146763971|NCT02263508|529302937|FG000|Overall Study|Death|6|||
146763972|NCT02263508|529302938|FG001|Overall Study|Death|151|||
146763973|NCT02263508|529302939|FG002|Overall Study|Death|140|||
146763974|NCT01280591|529302940|FG000|Overall Study|Withdrawal by Subject|0|||
146763975|NCT01280591|529302941|FG001|Overall Study|Withdrawal by Subject|0|||
146763976|NCT01280591|529302942|FG002|Overall Study|Withdrawal by Subject|0|||
146763977|NCT01280591|529302943|FG003|Overall Study|Withdrawal by Subject|2|||
146763978|NCT01280591|529302940|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
146763979|NCT01280591|529302941|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
146763980|NCT01280591|529302942|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
146763981|NCT01280591|529302943|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
146763982|NCT03265210|529302946|FG000|Overall Study|Withdrawal by Subject|7|||
146763983|NCT03265210|529302947|FG001|Overall Study|Withdrawal by Subject|9|||
146763984|NCT03265210|529302946|FG000|Overall Study|Lost to Follow-up|2|||
146763985|NCT03265210|529302947|FG001|Overall Study|Lost to Follow-up|0|||
146763986|NCT03265210|529302946|FG000|Overall Study|Physician Decision|2|||
146763987|NCT03265210|529302947|FG001|Overall Study|Physician Decision|0|||
146763988|NCT03265210|529302946|FG000|Overall Study|Adverse Event|1|||
146763989|NCT03265210|529302947|FG001|Overall Study|Adverse Event|0|||
146763990|NCT03357341|529302950|FG000|Overall Study|Withdrawal by Subject|3|||
146763991|NCT03357341|529302951|FG001|Overall Study|Withdrawal by Subject|6|||
146763992|NCT03357341|529302950|FG000|Overall Study|Lost to Follow-up|4|||
146763993|NCT03357341|529302951|FG001|Overall Study|Lost to Follow-up|5|||
146763994|NCT03357341|529302950|FG000|Overall Study|Death|0|||
146763995|NCT03357341|529302951|FG001|Overall Study|Death|1|||
146763996|NCT00686517|529302952|FG000|Treatment|Serious Adverse Event|1|||
146763997|NCT00686517|529302953|FG001|Treatment|Serious Adverse Event|2|||
146763998|NCT00686517|529302954|FG002|Treatment|Serious Adverse Event|1|||
146763999|NCT00686517|529302952|FG000|Treatment|Adverse Event|2|||
146764000|NCT00686517|529302953|FG001|Treatment|Adverse Event|0|||
146764001|NCT00686517|529302954|FG002|Treatment|Adverse Event|0|||
146764002|NCT00686517|529302952|FG000|Treatment|Poor Protocol Compliance|1|||
146764003|NCT00686517|529302953|FG001|Treatment|Poor Protocol Compliance|0|||
146764004|NCT00686517|529302954|FG002|Treatment|Poor Protocol Compliance|0|||
146764005|NCT00686517|529302952|FG000|Treatment|Protocol Violation|2|||
146764006|NCT00686517|529302953|FG001|Treatment|Protocol Violation|1|||
146764007|NCT00686517|529302954|FG002|Treatment|Protocol Violation|0|||
146764008|NCT01803646|529302957|FG000|Overall Study|Protocol Violation|1|||
146764009|NCT01803646|529302958|FG001|Overall Study|Protocol Violation|0|||
146764010|NCT01803646|529302957|FG000|Overall Study|Adverse Event|1|||
146764011|NCT01803646|529302958|FG001|Overall Study|Adverse Event|1|||
146764012|NCT01803646|529302957|FG000|Overall Study|Withdrawal by Subject|9|||
146764013|NCT01803646|529302958|FG001|Overall Study|Withdrawal by Subject|6|||
146764014|NCT01803646|529302957|FG000|Overall Study|Randomization error|1|||
146764015|NCT01803646|529302958|FG001|Overall Study|Randomization error|2|||
146764016|NCT01803646|529302957|FG000|Overall Study|Lost to Follow-up|5|||
146764017|NCT01803646|529302958|FG001|Overall Study|Lost to Follow-up|1|||
146764018|NCT01693614|529302960|FG000|Overall Study|Adverse Event|7|||
146764019|NCT01693614|529302961|FG001|Overall Study|Adverse Event|11|||
146764020|NCT01693614|529302962|FG002|Overall Study|Adverse Event|5|||
146764021|NCT01693614|529302960|FG000|Overall Study|Disease progression|11|||
146764022|NCT01693614|529302961|FG001|Overall Study|Disease progression|8|||
146764023|NCT01693614|529302962|FG002|Overall Study|Disease progression|7|||
146764024|NCT01693614|529302960|FG000|Overall Study|Protocol Violation|5|||
146764025|NCT01693614|529302961|FG001|Overall Study|Protocol Violation|2|||
146764026|NCT01693614|529302962|FG002|Overall Study|Protocol Violation|1|||
146764027|NCT01693614|529302960|FG000|Overall Study|Death|1|||
146764028|NCT01693614|529302961|FG001|Overall Study|Death|0|||
146871651|NCT00574288|529701413|FG006|Overall Study|Death|21|||
146871652|NCT00574288|529701407|FG000|Overall Study|Lost to Follow-up|0|||
146871653|NCT00574288|529701408|FG001|Overall Study|Lost to Follow-up|0|||
146871654|NCT00574288|529701409|FG002|Overall Study|Lost to Follow-up|0|||
146871655|NCT00574288|529701410|FG003|Overall Study|Lost to Follow-up|0|||
146871656|NCT00574288|529701411|FG004|Overall Study|Lost to Follow-up|0|||
146871657|NCT00574288|529701412|FG005|Overall Study|Lost to Follow-up|1|||
146871658|NCT00574288|529701413|FG006|Overall Study|Lost to Follow-up|2|||
146871659|NCT00574288|529701407|FG000|Overall Study|Study Terminated By Sponsor|0|||
146871660|NCT00574288|529701408|FG001|Overall Study|Study Terminated By Sponsor|0|||
146871661|NCT00574288|529701409|FG002|Overall Study|Study Terminated By Sponsor|0|||
146871662|NCT00574288|529701410|FG003|Overall Study|Study Terminated By Sponsor|0|||
146871663|NCT00574288|529701411|FG004|Overall Study|Study Terminated By Sponsor|0|||
146871664|NCT00574288|529701412|FG005|Overall Study|Study Terminated By Sponsor|0|||
146871665|NCT00574288|529701413|FG006|Overall Study|Study Terminated By Sponsor|5|||
146871666|NCT00574288|529701407|FG000|Overall Study|Progressive Disease|17|||
146871667|NCT00574288|529701408|FG001|Overall Study|Progressive Disease|2|||
146871668|NCT00574288|529701409|FG002|Overall Study|Progressive Disease|3|||
146871669|NCT00574288|529701410|FG003|Overall Study|Progressive Disease|2|||
146871670|NCT00574288|529701411|FG004|Overall Study|Progressive Disease|1|||
146871671|NCT00574288|529701412|FG005|Overall Study|Progressive Disease|0|||
146871672|NCT00574288|529701413|FG006|Overall Study|Progressive Disease|0|||
146965654|NCT04242446|530035192|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
146965655|NCT04242446|530035193|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
146965656|NCT04242446|530035194|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
146965657|NCT04242446|530035195|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
146965658|NCT04242446|530035196|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
146965659|NCT04242446|530035197|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
146871673|NCT00574288|529701407|FG000|Overall Study|Other|1|||
146871674|NCT00574288|529701408|FG001|Overall Study|Other|1|||
146965660|NCT04242446|530035191|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
146871675|NCT00574288|529701409|FG002|Overall Study|Other|0|||
146871676|NCT00574288|529701410|FG003|Overall Study|Other|0|||
146871677|NCT00574288|529701411|FG004|Overall Study|Other|0|||
146871678|NCT00574288|529701412|FG005|Overall Study|Other|0|||
146871679|NCT00574288|529701413|FG006|Overall Study|Other|0|||
146871680|NCT02247960|529701414|FG000|Patient Consent and Randomization|Physician Decision|2|||
146871681|NCT02247960|529701415|FG001|Patient Consent and Randomization|Physician Decision|2|||
146871682|NCT02247960|529701414|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
146871683|NCT02247960|529701415|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
146871684|NCT02247960|529701414|FG000|Catheter Removed|Lost to Follow-up|7|||
146871685|NCT02247960|529701415|FG001|Catheter Removed|Lost to Follow-up|10|||
146871686|NCT02361944|529701418|FG000|Overall Study|surgery cancellation|0|||
146871687|NCT02361944|529701419|FG001|Overall Study|surgery cancellation|1|||
146871688|NCT03086057|529701421|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
146871689|NCT03086057|529701422|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
146871690|NCT03086057|529701423|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
146871691|NCT03086057|529701424|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
146871692|NCT03086057|529701421|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
146871693|NCT03086057|529701422|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
146871694|NCT03086057|529701423|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
146871695|NCT03086057|529701424|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
146871696|NCT03086057|529701421|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
146871697|NCT03086057|529701422|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
146871698|NCT03086057|529701423|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
146871699|NCT03086057|529701424|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
146871700|NCT03086057|529701421|FG000|Stage 1: PrEP Uptake|Death|1|||
146871701|NCT03086057|529701422|FG001|Stage 1: PrEP Uptake|Death|0|||
146871702|NCT03086057|529701423|FG002|Stage 1: PrEP Uptake|Death|0|||
146871703|NCT03086057|529701424|FG003|Stage 1: PrEP Uptake|Death|0|||
146871704|NCT03086057|529701421|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
146871705|NCT03086057|529701422|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
146871706|NCT03086057|529701423|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
146871707|NCT03086057|529701424|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
146871708|NCT03086057|529701421|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
146871709|NCT03086057|529701422|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
146871710|NCT03086057|529701423|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
146871711|NCT03086057|529701424|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
146871712|NCT03086057|529701421|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
146871713|NCT03086057|529701422|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
146871714|NCT03086057|529701423|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
146871715|NCT03086057|529701424|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
146871716|NCT01786603|529701425|FG000|Overall Study|Death|5|||
146871717|NCT01786603|529701426|FG001|Overall Study|Death|1|||
146871718|NCT01786603|529701425|FG000|Overall Study|Adverse Event|6|||
146871719|NCT01786603|529701426|FG001|Overall Study|Adverse Event|2|||
146871720|NCT01786603|529701425|FG000|Overall Study|Physician decision to withdraw|6|||
146871721|NCT01786603|529701426|FG001|Overall Study|Physician decision to withdraw|7|||
146871722|NCT01786603|529701425|FG000|Overall Study|Lost to Follow-up|1|||
146871723|NCT01786603|529701426|FG001|Overall Study|Lost to Follow-up|2|||
146871724|NCT03700320|529701427|FG000|Overall Study|Adverse Event|5|||
146871725|NCT03700320|529701428|FG001|Overall Study|Adverse Event|31|||
146871726|NCT03700320|529701427|FG000|Overall Study|Lack of Efficacy|2|||
146871727|NCT03700320|529701428|FG001|Overall Study|Lack of Efficacy|5|||
146871728|NCT03700320|529701427|FG000|Overall Study|Withdrawal by Subject|29|||
146871729|NCT03700320|529701428|FG001|Overall Study|Withdrawal by Subject|75|||
146871730|NCT03700320|529701427|FG000|Overall Study|Lost to Follow-up|16|||
146871731|NCT03700320|529701428|FG001|Overall Study|Lost to Follow-up|23|||
146871732|NCT03700320|529701427|FG000|Overall Study|Pregnancy|2|||
146871733|NCT03700320|529701428|FG001|Overall Study|Pregnancy|4|||
146871734|NCT03700320|529701427|FG000|Overall Study|Protocol Deviation|7|||
146871735|NCT03700320|529701428|FG001|Overall Study|Protocol Deviation|31|||
146871736|NCT03700320|529701427|FG000|Overall Study|Non-compliance with Study Drug|1|||
146871737|NCT03700320|529701428|FG001|Overall Study|Non-compliance with Study Drug|3|||
146871738|NCT03700320|529701427|FG000|Overall Study|Reason not Specified|0|||
146871739|NCT03700320|529701428|FG001|Overall Study|Reason not Specified|1|||
146871740|NCT01770912|529701433|FG000|Overall Study|Lost to Follow-up|2|||
146871741|NCT01770912|529701434|FG001|Overall Study|Lost to Follow-up|0|||
146871742|NCT00430482|529701438|FG000|Completed Treatment|Insufficient Treatment|7|||
146871743|NCT00430482|529701439|FG001|Completed Treatment|Insufficient Treatment|11|||
146871744|NCT00545402|529701440|FG000|Overall Study|Discontinuation of treatment|17|||
146871745|NCT00545402|529701441|FG001|Overall Study|Discontinuation of treatment|9|||
146871746|NCT00545402|529701440|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
146871747|NCT00545402|529701441|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
146539817|NCT02475213|528485153|FG004|Overall Study|Protocol Violation|1|||
146871748|NCT00545402|529701440|FG000|Overall Study|Death|5|||
146871749|NCT00545402|529701441|FG001|Overall Study|Death|7|||
146539818|NCT02475213|528485154|FG005|Overall Study|Protocol Violation|0|||
146539819|NCT02475213|528485155|FG006|Overall Study|Protocol Violation|0|||
146539820|NCT02475213|528485156|FG007|Overall Study|Protocol Violation|0|||
146627555|NCT02718898|528811825|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
146627556|NCT02718898|528811819|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
146627557|NCT02718898|528811820|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
146627558|NCT02718898|528811821|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
146627559|NCT02718898|528811822|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
146627560|NCT02718898|528811823|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
146627561|NCT02718898|528811824|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
146627562|NCT02718898|528811825|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
146627563|NCT02718898|528811819|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
146627564|NCT02718898|528811820|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
146627565|NCT02718898|528811821|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
146627566|NCT02718898|528811822|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
146627567|NCT02718898|528811823|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
146627568|NCT02718898|528811824|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
146627569|NCT02718898|528811825|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
146627570|NCT02718898|528811819|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146764029|NCT01693614|529302962|FG002|Overall Study|Death|0|||
146764030|NCT01693614|529302960|FG000|Overall Study|Physician Decision|1|||
146764031|NCT01693614|529302961|FG001|Overall Study|Physician Decision|1|||
146764032|NCT01693614|529302962|FG002|Overall Study|Physician Decision|4|||
146764033|NCT01693614|529302960|FG000|Overall Study|Withdrawal by subject/guardian|0|||
146764034|NCT01693614|529302961|FG001|Overall Study|Withdrawal by subject/guardian|0|||
146764035|NCT01693614|529302962|FG002|Overall Study|Withdrawal by subject/guardian|2|||
146764036|NCT01693614|529302960|FG000|Overall Study|Withdrawal by Subject|1|||
146764037|NCT01693614|529302961|FG001|Overall Study|Withdrawal by Subject|0|||
146764038|NCT01693614|529302962|FG002|Overall Study|Withdrawal by Subject|5|||
146764039|NCT00420316|529302965|FG000|Overall Study|Withdrawal by Subject|0|||
146764040|NCT00420316|529302966|FG001|Overall Study|Withdrawal by Subject|1|||
146764041|NCT00420316|529302965|FG000|Overall Study|Lost to Follow-up|12|||
146764042|NCT00420316|529302966|FG001|Overall Study|Lost to Follow-up|8|||
146764043|NCT02281318|529302967|FG000|Overall Study|Adverse Event|2|||
146764044|NCT02281318|529302968|FG001|Overall Study|Adverse Event|2|||
146764045|NCT02281318|529302967|FG000|Overall Study|Lack of Efficacy|2|||
146764046|NCT02281318|529302968|FG001|Overall Study|Lack of Efficacy|0|||
146764047|NCT02281318|529302967|FG000|Overall Study|Lost to Follow-up|2|||
146764048|NCT02281318|529302968|FG001|Overall Study|Lost to Follow-up|1|||
146764049|NCT02281318|529302967|FG000|Overall Study|Physician Decision|2|||
146764050|NCT02281318|529302968|FG001|Overall Study|Physician Decision|0|||
146764051|NCT02281318|529302967|FG000|Overall Study|Withdrawal by Subject|6|||
146764052|NCT02281318|529302968|FG001|Overall Study|Withdrawal by Subject|2|||
146764053|NCT01064817|529302969|FG000|Study Completion|Physician Decision|1|||
146764054|NCT01064817|529302970|FG001|Study Completion|Physician Decision|0|||
146764055|NCT01064817|529302969|FG000|Study Completion|Withdrawal by Subject|1|||
146764056|NCT01064817|529302970|FG001|Study Completion|Withdrawal by Subject|0|||
146764057|NCT02274493|529302971|FG000|Overall Study|Withdrawal by Subject|1|||
146764058|NCT00558363|529302972|FG000|Overall Study|Physician Decision|18|||
146764059|NCT00558363|529302973|FG001|Overall Study|Physician Decision|4|||
146764060|NCT00558363|529302972|FG000|Overall Study|Withdrawal by Subject|11|||
146764061|NCT00558363|529302973|FG001|Overall Study|Withdrawal by Subject|4|||
146764062|NCT00558363|529302972|FG000|Overall Study|Adverse Event|5|||
146764063|NCT00558363|529302973|FG001|Overall Study|Adverse Event|5|||
146764064|NCT00558363|529302972|FG000|Overall Study|Lack of Efficacy|2|||
146764065|NCT00558363|529302973|FG001|Overall Study|Lack of Efficacy|2|||
146764066|NCT00558363|529302972|FG000|Overall Study|Protocol Violation|2|||
146764067|NCT00558363|529302973|FG001|Overall Study|Protocol Violation|1|||
146764068|NCT00558363|529302972|FG000|Overall Study|Lost to Follow-up|0|||
146764069|NCT00558363|529302973|FG001|Overall Study|Lost to Follow-up|1|||
146764070|NCT00558363|529302972|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
146764071|NCT00558363|529302973|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
146764072|NCT00558363|529302972|FG000|Overall Study|Randomized in Error|1|||
146764073|NCT00558363|529302973|FG001|Overall Study|Randomized in Error|2|||
146764074|NCT00558363|529302972|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
146764075|NCT00558363|529302973|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
146764076|NCT03102710|529302974|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
146764077|NCT03102710|529302975|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
146764078|NCT03102710|529302976|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
146764079|NCT03102710|529302974|FG000|Overall Study|Technical issues during final MRI scan|0|||
146764080|NCT03102710|529302975|FG001|Overall Study|Technical issues during final MRI scan|1|||
146764081|NCT03102710|529302976|FG002|Overall Study|Technical issues during final MRI scan|0|||
146764082|NCT03102710|529302974|FG000|Overall Study|Nausea during MRI scan|0|||
146764083|NCT03102710|529302975|FG001|Overall Study|Nausea during MRI scan|1|||
146627571|NCT02718898|528811820|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146627572|NCT02718898|528811821|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
146871750|NCT00545402|529701440|FG000|Overall Study|Graft loss|2|||
146871751|NCT00545402|529701441|FG001|Overall Study|Graft loss|4|||
146871752|NCT00545402|529701440|FG000|Overall Study|Withdrawal by Subject|0|||
146764084|NCT03102710|529302976|FG002|Overall Study|Nausea during MRI scan|0|||
146539821|NCT02475213|528485149|FG000|Overall Study|Withdrawal by Subject|0|||
146539822|NCT02475213|528485150|FG001|Overall Study|Withdrawal by Subject|0|||
146539823|NCT02475213|528485151|FG002|Overall Study|Withdrawal by Subject|0|||
146539824|NCT02475213|528485152|FG003|Overall Study|Withdrawal by Subject|1|||
146539825|NCT02475213|528485153|FG004|Overall Study|Withdrawal by Subject|0|||
146539826|NCT02475213|528485154|FG005|Overall Study|Withdrawal by Subject|2|||
146871753|NCT00545402|529701441|FG001|Overall Study|Withdrawal by Subject|1|||
146871754|NCT00545402|529701440|FG000|Overall Study|Protocol Violation|1|||
146871755|NCT00545402|529701441|FG001|Overall Study|Protocol Violation|0|||
146871756|NCT00545402|529701440|FG000|Overall Study|Reason not specified|1|||
146871757|NCT00545402|529701441|FG001|Overall Study|Reason not specified|1|||
146871758|NCT00555477|529701442|FG000|Overall Study|Adverse Event|0|||
146871759|NCT00555477|529701443|FG001|Overall Study|Adverse Event|9|||
146871760|NCT00555477|529701442|FG000|Overall Study|Withdrawal by Subject|1|||
146871761|NCT00555477|529701443|FG001|Overall Study|Withdrawal by Subject|2|||
146871762|NCT00555477|529701442|FG000|Overall Study|Physician Decision|1|||
146871763|NCT00555477|529701443|FG001|Overall Study|Physician Decision|2|||
146871764|NCT00397033|529701444|FG000|Overall Study|Adverse Event|7|||
146871765|NCT00397033|529701445|FG001|Overall Study|Adverse Event|10|||
146871766|NCT00397033|529701446|FG002|Overall Study|Adverse Event|4|||
146764085|NCT03102710|529302974|FG000|Overall Study|Subject unable to attend final session|0|||
146764086|NCT03102710|529302975|FG001|Overall Study|Subject unable to attend final session|1|||
146764087|NCT03102710|529302976|FG002|Overall Study|Subject unable to attend final session|0|||
146764088|NCT01368406|529302977|FG000|Overall Study|Lost to Follow-up|8|||
146764089|NCT01368406|529302978|FG001|Overall Study|Lost to Follow-up|4|||
146764090|NCT01368406|529302977|FG000|Overall Study|Withdrawal by Subject|8|||
146764091|NCT01368406|529302978|FG001|Overall Study|Withdrawal by Subject|4|||
146764092|NCT01368406|529302977|FG000|Overall Study|relapse of the disease|3|||
146764093|NCT01368406|529302978|FG001|Overall Study|relapse of the disease|2|||
146764094|NCT01368406|529302977|FG000|Overall Study|started working|2|||
146764095|NCT01368406|529302978|FG001|Overall Study|started working|3|||
146764096|NCT00957229|529302979|FG000|Study Start|Adverse Event|0|||
146764097|NCT00957229|529302980|FG001|Study Start|Adverse Event|3|||
146764098|NCT00957229|529302979|FG000|Study Start|Disease Progression|1|||
146965661|NCT04242446|530035192|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
146965662|NCT04242446|530035193|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
146965663|NCT04242446|530035194|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
146539827|NCT02475213|528485155|FG006|Overall Study|Withdrawal by Subject|2|||
146539828|NCT02475213|528485156|FG007|Overall Study|Withdrawal by Subject|0|||
146764099|NCT00957229|529302980|FG001|Study Start|Disease Progression|0|||
146764100|NCT00957229|529302979|FG000|Reallocated to or Continued Vismodegib|Death|1|||
146764101|NCT00957229|529302980|FG001|Reallocated to or Continued Vismodegib|Death|1|||
146764102|NCT00957229|529302979|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
146764103|NCT00957229|529302980|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
146764104|NCT01833065|529302981|FG000|Overall Study|Adverse Event|6|||
146764105|NCT01833065|529302982|FG001|Overall Study|Adverse Event|1|||
146764106|NCT01833065|529302983|FG002|Overall Study|Adverse Event|0|||
146764107|NCT01833065|529302984|FG003|Overall Study|Adverse Event|2|||
146764108|NCT01833065|529302985|FG004|Overall Study|Adverse Event|3|||
146764109|NCT01833065|529302981|FG000|Overall Study|Protocol Violation|1|||
146764110|NCT01833065|529302982|FG001|Overall Study|Protocol Violation|0|||
146965664|NCT04242446|530035195|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
146965665|NCT04242446|530035196|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
146965666|NCT04242446|530035197|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
146965667|NCT04242446|530035191|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
146965668|NCT04242446|530035192|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
146965669|NCT04242446|530035193|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
146965670|NCT04242446|530035194|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
146965671|NCT04242446|530035195|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
146965672|NCT04242446|530035196|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
146965673|NCT04242446|530035197|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
146965674|NCT04242446|530035191|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
146965675|NCT04242446|530035192|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
146965676|NCT04242446|530035193|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
146965677|NCT04242446|530035194|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
146965678|NCT04242446|530035195|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
146965679|NCT04242446|530035196|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
146871767|NCT00397033|529701444|FG000|Overall Study|Lack of Efficacy|22|||
146871768|NCT00397033|529701445|FG001|Overall Study|Lack of Efficacy|12|||
146871769|NCT00397033|529701446|FG002|Overall Study|Lack of Efficacy|9|||
146871770|NCT00397033|529701444|FG000|Overall Study|Lost to Follow-up|3|||
146871771|NCT00397033|529701445|FG001|Overall Study|Lost to Follow-up|3|||
146871772|NCT00397033|529701446|FG002|Overall Study|Lost to Follow-up|3|||
146965680|NCT04242446|530035197|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
146965681|NCT04242446|530035191|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
146965682|NCT04242446|530035192|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
146965683|NCT04242446|530035193|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
146965684|NCT04242446|530035194|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
146965685|NCT04242446|530035195|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
146965686|NCT04242446|530035196|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
146965687|NCT04242446|530035197|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
146965688|NCT04242446|530035191|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
146965689|NCT04242446|530035192|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
146965690|NCT04242446|530035193|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
146965691|NCT04242446|530035194|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
146965692|NCT04242446|530035195|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
146965693|NCT04242446|530035196|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
146965694|NCT04242446|530035197|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
146965695|NCT04242446|530035191|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
146965696|NCT04242446|530035192|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
146965697|NCT04242446|530035193|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
146965698|NCT04242446|530035194|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
146965699|NCT04242446|530035195|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
146965700|NCT04242446|530035196|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
146965701|NCT04242446|530035197|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
146965702|NCT04242446|530035191|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
146965703|NCT04242446|530035192|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
146965704|NCT04242446|530035193|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
146965705|NCT04242446|530035194|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
146965706|NCT04242446|530035195|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
146965707|NCT04242446|530035196|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
146965708|NCT04242446|530035197|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
146965709|NCT04242446|530035191|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
146965710|NCT04242446|530035192|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
146965711|NCT04242446|530035193|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
146965712|NCT04242446|530035194|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
146965713|NCT04242446|530035195|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
146965714|NCT04242446|530035196|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
146965715|NCT04242446|530035197|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
146965716|NCT04242446|530035191|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
146965717|NCT04242446|530035192|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
146965718|NCT04242446|530035193|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
146965719|NCT04242446|530035194|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
146965720|NCT04242446|530035195|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
146965721|NCT04242446|530035196|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
146539829|NCT02475213|528485149|FG000|Overall Study|Other|0|||
146539830|NCT02475213|528485150|FG001|Overall Study|Other|0|||
146539831|NCT02475213|528485151|FG002|Overall Study|Other|0|||
146539832|NCT02475213|528485152|FG003|Overall Study|Other|1|||
146871773|NCT00397033|529701444|FG000|Overall Study|Withdrawal by Subject|12|||
146871774|NCT00397033|529701445|FG001|Overall Study|Withdrawal by Subject|7|||
146871775|NCT00397033|529701446|FG002|Overall Study|Withdrawal by Subject|5|||
146871776|NCT00397033|529701444|FG000|Overall Study|Other|0|||
146627573|NCT02718898|528811822|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
146627574|NCT02718898|528811823|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146627575|NCT02718898|528811824|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146627576|NCT02718898|528811825|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146627577|NCT02718898|528811819|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
146627578|NCT02718898|528811820|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
146627579|NCT02718898|528811821|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
146627580|NCT02718898|528811822|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
146627581|NCT02718898|528811823|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
146627582|NCT02718898|528811824|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
146627583|NCT02718898|528811825|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
146627584|NCT02718898|528811819|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
146627585|NCT02718898|528811820|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
146627586|NCT02718898|528811821|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
146627587|NCT02718898|528811822|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
146627588|NCT02718898|528811823|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
146627589|NCT02718898|528811824|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
146627590|NCT02718898|528811825|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
146627591|NCT02718898|528811819|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
146627592|NCT02718898|528811820|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
146627593|NCT02718898|528811821|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
146627594|NCT02718898|528811822|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
146627595|NCT02718898|528811823|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
146627596|NCT02718898|528811824|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
146627597|NCT02718898|528811825|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
146627598|NCT02718898|528811819|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
146627599|NCT02718898|528811820|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
146627600|NCT02718898|528811821|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
146627601|NCT02718898|528811822|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
146627602|NCT02718898|528811823|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
146627603|NCT02718898|528811824|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
146627604|NCT02718898|528811825|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
146627605|NCT02718898|528811819|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
146627606|NCT02718898|528811820|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
146627607|NCT02718898|528811821|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
146627608|NCT02718898|528811822|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
146627609|NCT02718898|528811823|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
146871777|NCT00397033|529701445|FG001|Overall Study|Other|5|||
146871778|NCT00397033|529701446|FG002|Overall Study|Other|2|||
146871779|NCT03519867|529701447|FG000|Overall Study|Adverse Event|1|||
146539833|NCT02475213|528485153|FG004|Overall Study|Other|3|||
146539834|NCT02475213|528485154|FG005|Overall Study|Other|1|||
146539835|NCT02475213|528485155|FG006|Overall Study|Other|0|||
146539836|NCT02475213|528485156|FG007|Overall Study|Other|0|||
146539837|NCT02441283|528485157|FG000|Overall Study|Withdrew consent|15|||
146539838|NCT02441283|528485157|FG000|Overall Study|Lost to Follow-up|42|||
146539839|NCT02441283|528485157|FG000|Overall Study|Death|1|||
146539840|NCT02441283|528485157|FG000|Overall Study|Other, not specified|32|||
146539841|NCT00630292|528485158|FG000|Overall Study|Withdrawal by Subject|1|||
146539842|NCT02382939|528485159|FG000|Overall Study|Adverse Event|1|||
146539843|NCT02382939|528485160|FG001|Overall Study|Adverse Event|1|||
146539844|NCT02382939|528485159|FG000|Overall Study|Withdrawal by Subject|2|||
146539845|NCT02382939|528485160|FG001|Overall Study|Withdrawal by Subject|2|||
146539846|NCT05383209|528485163|FG000|Overall Study|Adverse Event: Non-ocular|0|||
146539847|NCT05383209|528485164|FG001|Overall Study|Adverse Event: Non-ocular|1|||
146539848|NCT05383209|528485165|FG002|Overall Study|Adverse Event: Non-ocular|0|||
146627610|NCT02718898|528811824|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
146871780|NCT03519867|529701448|FG001|Overall Study|Adverse Event|1|||
146871781|NCT03519867|529701449|FG002|Overall Study|Adverse Event|0|||
146871782|NCT03519867|529701450|FG003|Overall Study|Adverse Event|0|||
146871783|NCT03519867|529701451|FG004|Overall Study|Adverse Event|0|||
146539849|NCT05383209|528485163|FG000|Overall Study|Lost to Follow-up|2|||
146539850|NCT05383209|528485164|FG001|Overall Study|Lost to Follow-up|1|||
146539851|NCT05383209|528485165|FG002|Overall Study|Lost to Follow-up|4|||
146539852|NCT05383209|528485163|FG000|Overall Study|Withdrawal by Subject|2|||
146539853|NCT05383209|528485164|FG001|Overall Study|Withdrawal by Subject|0|||
146539854|NCT05383209|528485165|FG002|Overall Study|Withdrawal by Subject|1|||
146539855|NCT05383209|528485163|FG000|Overall Study|Death|1|||
146539856|NCT05383209|528485164|FG001|Overall Study|Death|0|||
146539857|NCT05383209|528485165|FG002|Overall Study|Death|0|||
146539858|NCT05383209|528485163|FG000|Overall Study|Other|0|||
146539859|NCT05383209|528485164|FG001|Overall Study|Other|1|||
146539860|NCT05383209|528485165|FG002|Overall Study|Other|0|||
146871784|NCT03519867|529701452|FG005|Overall Study|Adverse Event|0|||
146871785|NCT03519867|529701453|FG006|Overall Study|Adverse Event|0|||
146871786|NCT03519867|529701454|FG007|Overall Study|Adverse Event|0|||
146871787|NCT03519867|529701455|FG008|Overall Study|Adverse Event|0|||
146871788|NCT03519867|529701456|FG009|Overall Study|Adverse Event|0|||
146871789|NCT03519867|529701447|FG000|Overall Study|Protocol Violation|0|||
146871790|NCT03519867|529701448|FG001|Overall Study|Protocol Violation|0|||
146871791|NCT03519867|529701449|FG002|Overall Study|Protocol Violation|0|||
146871792|NCT03519867|529701450|FG003|Overall Study|Protocol Violation|0|||
146871793|NCT03519867|529701451|FG004|Overall Study|Protocol Violation|0|||
146871794|NCT03519867|529701452|FG005|Overall Study|Protocol Violation|1|||
146871795|NCT03519867|529701453|FG006|Overall Study|Protocol Violation|0|||
146871796|NCT03519867|529701454|FG007|Overall Study|Protocol Violation|0|||
146871797|NCT03519867|529701455|FG008|Overall Study|Protocol Violation|0|||
146871798|NCT03519867|529701456|FG009|Overall Study|Protocol Violation|0|||
146871799|NCT03519867|529701447|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146871800|NCT03519867|529701448|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146871801|NCT03519867|529701449|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146871802|NCT03519867|529701450|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146871803|NCT03519867|529701451|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146871804|NCT03519867|529701452|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146871805|NCT03519867|529701453|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
146871806|NCT03519867|529701454|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146871807|NCT03519867|529701455|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146871808|NCT03519867|529701456|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146871809|NCT03519867|529701447|FG000|Overall Study|Admin. of other reversal agent|1|||
146871810|NCT03519867|529701448|FG001|Overall Study|Admin. of other reversal agent|1|||
146871811|NCT03519867|529701449|FG002|Overall Study|Admin. of other reversal agent|0|||
146871812|NCT03519867|529701450|FG003|Overall Study|Admin. of other reversal agent|0|||
146871813|NCT03519867|529701451|FG004|Overall Study|Admin. of other reversal agent|0|||
146871814|NCT03519867|529701452|FG005|Overall Study|Admin. of other reversal agent|1|||
146871815|NCT03519867|529701453|FG006|Overall Study|Admin. of other reversal agent|0|||
146539861|NCT00321763|528485167|FG000|Overall Study|Adverse Event|1|||
146539862|NCT00321763|528485168|FG001|Overall Study|Adverse Event|1|||
146539863|NCT00321763|528485169|FG002|Overall Study|Adverse Event|0|||
146539864|NCT00321763|528485170|FG003|Overall Study|Adverse Event|1|||
146539865|NCT00321763|528485167|FG000|Overall Study|Withdrawal by Subject|2|||
146539866|NCT00321763|528485168|FG001|Overall Study|Withdrawal by Subject|0|||
146539867|NCT00321763|528485169|FG002|Overall Study|Withdrawal by Subject|1|||
146539868|NCT00321763|528485170|FG003|Overall Study|Withdrawal by Subject|0|||
146539869|NCT00321763|528485167|FG000|Overall Study|Lost to Follow-up|3|||
146539870|NCT00321763|528485168|FG001|Overall Study|Lost to Follow-up|1|||
146539871|NCT00321763|528485169|FG002|Overall Study|Lost to Follow-up|5|||
146539872|NCT00321763|528485170|FG003|Overall Study|Lost to Follow-up|4|||
146539873|NCT00717886|528485171|FG000|Overall Study|Withdrawal by Subject|3|||
146965722|NCT04242446|530035197|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
146871816|NCT03519867|529701454|FG007|Overall Study|Admin. of other reversal agent|0|||
146871817|NCT03519867|529701455|FG008|Overall Study|Admin. of other reversal agent|0|||
146871818|NCT03519867|529701456|FG009|Overall Study|Admin. of other reversal agent|0|||
146871819|NCT03519867|529701447|FG000|Overall Study|Reason not provided|1|||
146965723|NCT04242446|530035191|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
146965724|NCT04242446|530035192|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
146965725|NCT04242446|530035193|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
146965726|NCT04242446|530035194|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
146965727|NCT04242446|530035195|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
146965728|NCT04242446|530035196|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
146965729|NCT04242446|530035197|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
146965730|NCT04242446|530035191|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
146539874|NCT00717886|528485171|FG000|Overall Study|Treatment Failure|1|||
146539875|NCT01553851|528485172|FG000|Overall Study|Adverse Event|2|||
146539876|NCT01553851|528485172|FG000|Overall Study|constipation|1|||
146539877|NCT02101294|528485173|FG000|Overall Study|Withdrawal by Subject|5|||
146539878|NCT02101294|528485173|FG000|Overall Study|Lost to Follow-up|6|||
146539879|NCT03822416|528485176|FG000|Overall Study|Lost to Follow-up|1|||
146539880|NCT03822416|528485177|FG001|Overall Study|Lost to Follow-up|0|||
146539881|NCT03822416|528485176|FG000|Overall Study|Withdrawal by Subject|0|||
146627611|NCT02718898|528811825|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
146627612|NCT02718898|528811819|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146627613|NCT02718898|528811820|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146627614|NCT02718898|528811821|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146539882|NCT03822416|528485177|FG001|Overall Study|Withdrawal by Subject|1|||
146539883|NCT01303419|528485178|FG000|Overall Study|Discontinuation of study|60|||
146539884|NCT01303419|528485178|FG000|Overall Study|Did not complete both imaging methods|5|||
146539885|NCT01303419|528485178|FG000|Overall Study|Did not meet all I/E after screening|31|||
146539886|NCT02709369|528485179|FG000|Overall Study|Lost to Follow-up|15|||
146539887|NCT02709369|528485179|FG000|Overall Study|Withdrawal by Subject|10|||
146539888|NCT02709369|528485179|FG000|Overall Study|Did not received intervention|2|||
146539889|NCT01104766|528485180|FG000|Overall Study|Did not meet inc/exc criteria|1|||
146539890|NCT01104766|528485181|FG001|Overall Study|Did not meet inc/exc criteria|0|||
146539891|NCT01104766|528485182|FG002|Overall Study|Did not meet inc/exc criteria|0|||
146539892|NCT01104766|528485183|FG003|Overall Study|Did not meet inc/exc criteria|0|||
146539893|NCT01104766|528485180|FG000|Overall Study|Adverse Event|17|||
146539894|NCT01104766|528485181|FG001|Overall Study|Adverse Event|15|||
146539895|NCT01104766|528485182|FG002|Overall Study|Adverse Event|20|||
146539896|NCT01104766|528485183|FG003|Overall Study|Adverse Event|14|||
146539897|NCT01104766|528485180|FG000|Overall Study|Lack of Efficacy|20|||
146539898|NCT01104766|528485181|FG001|Overall Study|Lack of Efficacy|15|||
146539899|NCT01104766|528485182|FG002|Overall Study|Lack of Efficacy|14|||
146539900|NCT01104766|528485183|FG003|Overall Study|Lack of Efficacy|8|||
146539901|NCT01104766|528485180|FG000|Overall Study|Protocol Violation|2|||
146539902|NCT01104766|528485181|FG001|Overall Study|Protocol Violation|0|||
146539903|NCT01104766|528485182|FG002|Overall Study|Protocol Violation|0|||
146539904|NCT01104766|528485183|FG003|Overall Study|Protocol Violation|0|||
146539905|NCT01104766|528485180|FG000|Overall Study|Withdrawal by Subject|17|||
146539906|NCT01104766|528485181|FG001|Overall Study|Withdrawal by Subject|19|||
146539907|NCT01104766|528485182|FG002|Overall Study|Withdrawal by Subject|25|||
146539908|NCT01104766|528485183|FG003|Overall Study|Withdrawal by Subject|15|||
146539909|NCT01104766|528485180|FG000|Overall Study|Lost to Follow-up|1|||
146539910|NCT01104766|528485181|FG001|Overall Study|Lost to Follow-up|2|||
146539911|NCT01104766|528485182|FG002|Overall Study|Lost to Follow-up|1|||
146539912|NCT01104766|528485183|FG003|Overall Study|Lost to Follow-up|1|||
146627615|NCT02718898|528811822|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146627616|NCT02718898|528811823|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146539913|NCT01136915|528485185|FG000|Overall Study|Lost to Follow-up|2|||
146627617|NCT02718898|528811824|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
146627618|NCT02718898|528811825|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
146539914|NCT01136915|528485186|FG001|Overall Study|Lost to Follow-up|0|||
146539915|NCT01136915|528485185|FG000|Overall Study|Exclusion criterion met|0|||
146871820|NCT03519867|529701448|FG001|Overall Study|Reason not provided|1|||
146871821|NCT03519867|529701449|FG002|Overall Study|Reason not provided|1|||
146871822|NCT03519867|529701450|FG003|Overall Study|Reason not provided|1|||
146871823|NCT03519867|529701451|FG004|Overall Study|Reason not provided|0|||
146871824|NCT03519867|529701452|FG005|Overall Study|Reason not provided|1|||
146871825|NCT03519867|529701453|FG006|Overall Study|Reason not provided|0|||
146871826|NCT03519867|529701454|FG007|Overall Study|Reason not provided|1|||
146871827|NCT03519867|529701455|FG008|Overall Study|Reason not provided|1|||
146871828|NCT03519867|529701456|FG009|Overall Study|Reason not provided|0|||
146871829|NCT01252810|529701457|FG000|Overall Study|Withdrawal by Subject|4|||
146871830|NCT01252810|529701458|FG001|Overall Study|Withdrawal by Subject|1|||
146871831|NCT01252810|529701457|FG000|Overall Study|Lost to Follow-up|0|||
146871832|NCT01252810|529701458|FG001|Overall Study|Lost to Follow-up|1|||
146871833|NCT01252810|529701457|FG000|Overall Study|Physician Decision|2|||
146871834|NCT01252810|529701458|FG001|Overall Study|Physician Decision|1|||
146871835|NCT01252810|529701457|FG000|Overall Study|Various reasons|8|||
146871836|NCT01252810|529701458|FG001|Overall Study|Various reasons|0|||
146871837|NCT01721057|529701459|FG000|Treatment Period|Withdrawal by Subject|11|||
146871838|NCT01721057|529701460|FG001|Treatment Period|Withdrawal by Subject|5|||
146539916|NCT01136915|528485186|FG001|Overall Study|Exclusion criterion met|1|||
146539917|NCT02755090|528485190|FG000|Overall Study|equipment malfunction|1|||
146871839|NCT01721057|529701461|FG002|Treatment Period|Withdrawal by Subject|8|||
146871840|NCT01721057|529701462|FG003|Treatment Period|Withdrawal by Subject|0|||
146871841|NCT01721057|529701463|FG004|Treatment Period|Withdrawal by Subject|0|||
146871842|NCT01721057|529701464|FG005|Treatment Period|Withdrawal by Subject|0|||
146871843|NCT01721057|529701465|FG006|Treatment Period|Withdrawal by Subject|0|||
146871844|NCT01721057|529701459|FG000|Treatment Period|Adverse Event|7|||
146871845|NCT01721057|529701460|FG001|Treatment Period|Adverse Event|10|||
146539918|NCT02755090|528485191|FG001|Overall Study|equipment malfunction|0|||
146539919|NCT01564407|528485193|FG000|Overall Study|Lost to Follow-up|0|||
146871846|NCT01721057|529701461|FG002|Treatment Period|Adverse Event|12|||
146965731|NCT04242446|530035192|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
146965732|NCT04242446|530035193|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
146965733|NCT04242446|530035194|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
146965734|NCT04242446|530035195|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
146965735|NCT04242446|530035196|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
146965736|NCT04242446|530035197|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
146965737|NCT04242446|530035191|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
146965738|NCT04242446|530035192|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
146965739|NCT04242446|530035193|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
146965740|NCT04242446|530035194|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
146965741|NCT04242446|530035195|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
146965742|NCT04242446|530035196|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
146965743|NCT04242446|530035197|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
146965744|NCT04242446|530035191|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
146965745|NCT04242446|530035192|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
146965746|NCT04242446|530035193|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
146965747|NCT04242446|530035194|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
146965748|NCT04242446|530035195|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
146965749|NCT04242446|530035196|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
146965750|NCT04242446|530035197|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
146965751|NCT04242446|530035191|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
146965752|NCT04242446|530035192|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
146965753|NCT04242446|530035193|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
146965754|NCT04242446|530035194|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
146965755|NCT04242446|530035195|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
146965756|NCT04242446|530035196|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
146965757|NCT04242446|530035197|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
146965758|NCT04242446|530035191|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
146627619|NCT01451606|528811826|FG000|Overall Study|Withdrawal by Subject|4|||
146627620|NCT01451606|528811827|FG001|Overall Study|Withdrawal by Subject|3|||
146627621|NCT02559622|528811831|FG000|Overall Study|Progressive disease|0|||
146764111|NCT01833065|529302983|FG002|Overall Study|Protocol Violation|0|||
146764112|NCT01833065|529302984|FG003|Overall Study|Protocol Violation|0|||
146764113|NCT01833065|529302985|FG004|Overall Study|Protocol Violation|2|||
146764114|NCT01833065|529302981|FG000|Overall Study|Lost to Follow-up|1|||
146764115|NCT01833065|529302982|FG001|Overall Study|Lost to Follow-up|0|||
146764116|NCT01833065|529302983|FG002|Overall Study|Lost to Follow-up|0|||
146764117|NCT01833065|529302984|FG003|Overall Study|Lost to Follow-up|0|||
146764118|NCT01833065|529302985|FG004|Overall Study|Lost to Follow-up|3|||
146764119|NCT01833065|529302981|FG000|Overall Study|Withdrawal by Subject|6|||
146764120|NCT01833065|529302982|FG001|Overall Study|Withdrawal by Subject|2|||
146764121|NCT01833065|529302983|FG002|Overall Study|Withdrawal by Subject|4|||
146764122|NCT01833065|529302984|FG003|Overall Study|Withdrawal by Subject|3|||
146764123|NCT01833065|529302985|FG004|Overall Study|Withdrawal by Subject|11|||
146764124|NCT01833065|529302981|FG000|Overall Study|Subject's substantial non-compliance|0|||
146764125|NCT01833065|529302982|FG001|Overall Study|Subject's substantial non-compliance|1|||
146539920|NCT01564407|528485194|FG001|Overall Study|Lost to Follow-up|1|||
146871847|NCT01721057|529701462|FG003|Treatment Period|Adverse Event|0|||
146871848|NCT01721057|529701463|FG004|Treatment Period|Adverse Event|0|||
146871849|NCT01721057|529701464|FG005|Treatment Period|Adverse Event|0|||
146871850|NCT01721057|529701465|FG006|Treatment Period|Adverse Event|0|||
146871851|NCT01721057|529701459|FG000|Treatment Period|Lack of Efficacy|7|||
146871852|NCT01721057|529701460|FG001|Treatment Period|Lack of Efficacy|3|||
146871853|NCT01721057|529701461|FG002|Treatment Period|Lack of Efficacy|0|||
146871854|NCT01721057|529701462|FG003|Treatment Period|Lack of Efficacy|0|||
146871855|NCT01721057|529701463|FG004|Treatment Period|Lack of Efficacy|0|||
146871856|NCT01721057|529701464|FG005|Treatment Period|Lack of Efficacy|0|||
146871857|NCT01721057|529701465|FG006|Treatment Period|Lack of Efficacy|0|||
146871858|NCT01721057|529701459|FG000|Treatment Period|Lost to Follow-up|1|||
146871859|NCT01721057|529701460|FG001|Treatment Period|Lost to Follow-up|0|||
146871860|NCT01721057|529701461|FG002|Treatment Period|Lost to Follow-up|0|||
146871861|NCT01721057|529701462|FG003|Treatment Period|Lost to Follow-up|0|||
146871862|NCT01721057|529701463|FG004|Treatment Period|Lost to Follow-up|0|||
146871863|NCT01721057|529701464|FG005|Treatment Period|Lost to Follow-up|0|||
146871864|NCT01721057|529701465|FG006|Treatment Period|Lost to Follow-up|0|||
146871865|NCT01721057|529701459|FG000|Treatment Period|Physician Decision|0|||
146871866|NCT01721057|529701460|FG001|Treatment Period|Physician Decision|1|||
146871867|NCT01721057|529701461|FG002|Treatment Period|Physician Decision|3|||
146871868|NCT01721057|529701462|FG003|Treatment Period|Physician Decision|0|||
146871869|NCT01721057|529701463|FG004|Treatment Period|Physician Decision|0|||
146871870|NCT01721057|529701464|FG005|Treatment Period|Physician Decision|0|||
146871871|NCT01721057|529701465|FG006|Treatment Period|Physician Decision|0|||
146871872|NCT01721057|529701459|FG000|Treatment Period|Death|2|||
146871873|NCT01721057|529701460|FG001|Treatment Period|Death|0|||
146871874|NCT01721057|529701461|FG002|Treatment Period|Death|0|||
146871875|NCT01721057|529701462|FG003|Treatment Period|Death|0|||
146965759|NCT04242446|530035192|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
146965760|NCT04242446|530035193|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
146965761|NCT04242446|530035194|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
146965762|NCT04242446|530035195|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
146965763|NCT04242446|530035196|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
146965764|NCT04242446|530035197|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
146965765|NCT03587116|530035198|FG000|Overall Study|Lost to Follow-up|0|||
146965766|NCT03587116|530035199|FG001|Overall Study|Lost to Follow-up|1|||
146965767|NCT03587116|530035198|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
146965768|NCT03587116|530035199|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
146965769|NCT03587116|530035198|FG000|Overall Study|Withdrawal by Subject|4|||
146965770|NCT03587116|530035199|FG001|Overall Study|Withdrawal by Subject|0|||
146965771|NCT03526549|530035206|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
146965772|NCT03526549|530035207|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
146965773|NCT03526549|530035206|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
146965774|NCT03526549|530035207|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
146965775|NCT03526549|530035206|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
146965776|NCT03526549|530035207|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
146965777|NCT03526549|530035206|FG000|Open-label Phase|Adverse Event|4|||
146965778|NCT03526549|530035207|FG001|Open-label Phase|Adverse Event|0|||
146965779|NCT03526549|530035206|FG000|Open-label Phase|Withdrawal by Subject|54|||
146965780|NCT03526549|530035207|FG001|Open-label Phase|Withdrawal by Subject|0|||
146965781|NCT03526549|530035206|FG000|Open-label Phase|Lost to Follow-up|35|||
146965782|NCT03526549|530035207|FG001|Open-label Phase|Lost to Follow-up|0|||
146965783|NCT03526549|530035206|FG000|Open-label Phase|Other than Specified|5|||
146965784|NCT03526549|530035207|FG001|Open-label Phase|Other than Specified|0|||
146965785|NCT05981365|530035208|FG000|Period 1|Adverse Event|1|||
146965786|NCT05981365|530035209|FG001|Period 1|Adverse Event|0|||
146965787|NCT03927989|530035213|FG000|Overall Study|Withdrawal by Subject|0|||
146965788|NCT03927989|530035214|FG001|Overall Study|Withdrawal by Subject|1|||
146965789|NCT02593175|530035215|FG000|Overall Study|Adverse Event|5|||
146965790|NCT02593175|530035215|FG000|Overall Study|Disease progression|4|||
146965791|NCT00478933|530035219|FG000|Overall Study|Protocol Violation|22|||
146965792|NCT00478933|530035219|FG000|Overall Study|Informed consent not verified|3|||
146965793|NCT00478933|530035219|FG000|Overall Study|Inadequate data available|53|||
146539921|NCT01564407|528485195|FG002|Overall Study|Lost to Follow-up|0|||
146871876|NCT01721057|529701463|FG004|Treatment Period|Death|0|||
146871877|NCT01721057|529701464|FG005|Treatment Period|Death|0|||
146871878|NCT01721057|529701465|FG006|Treatment Period|Death|0|||
146627622|NCT02559622|528811832|FG001|Overall Study|Progressive disease|1|||
146627623|NCT02559622|528811833|FG002|Overall Study|Progressive disease|0|||
146627624|NCT02559622|528811834|FG003|Overall Study|Progressive disease|0|||
146627625|NCT02559622|528811831|FG000|Overall Study|Adverse Event|0|||
146627626|NCT02559622|528811832|FG001|Overall Study|Adverse Event|2|||
146627627|NCT02559622|528811833|FG002|Overall Study|Adverse Event|2|||
146627628|NCT02559622|528811834|FG003|Overall Study|Adverse Event|2|||
146627629|NCT02559622|528811831|FG000|Overall Study|Patient/guardian decision|1|||
146871879|NCT01721057|529701459|FG000|Rescue Period|Adverse Event|0|||
146871880|NCT01721057|529701460|FG001|Rescue Period|Adverse Event|0|||
146871881|NCT01721057|529701461|FG002|Rescue Period|Adverse Event|0|||
146871882|NCT01721057|529701462|FG003|Rescue Period|Adverse Event|1|||
146871883|NCT01721057|529701463|FG004|Rescue Period|Adverse Event|0|||
146871884|NCT01721057|529701464|FG005|Rescue Period|Adverse Event|0|||
146871885|NCT01721057|529701465|FG006|Rescue Period|Adverse Event|0|||
146871886|NCT01721057|529701459|FG000|Rescue Period|Lack of Efficacy|0|||
146627630|NCT02559622|528811832|FG001|Overall Study|Patient/guardian decision|2|||
146627631|NCT02559622|528811833|FG002|Overall Study|Patient/guardian decision|0|||
146627632|NCT02559622|528811834|FG003|Overall Study|Patient/guardian decision|1|||
146627633|NCT02163538|528811835|FG000|Overall Study|Protocol Violation|1|||
146871887|NCT01721057|529701460|FG001|Rescue Period|Lack of Efficacy|0|||
146965794|NCT00643006|530035221|FG000|Overall Study|Lost to Follow-up|5|||
146965795|NCT00643006|530035222|FG001|Overall Study|Lost to Follow-up|4|||
146965796|NCT03772574|530035223|FG000|Overall Study|Protocol Violation|2|||
146965797|NCT03772574|530035224|FG001|Overall Study|Protocol Violation|0|||
146965798|NCT03772574|530035225|FG002|Overall Study|Protocol Violation|0|||
146965799|NCT03772574|530035223|FG000|Overall Study|Discomfort|0|||
146965800|NCT03772574|530035224|FG001|Overall Study|Discomfort|5|||
146965801|NCT03772574|530035225|FG002|Overall Study|Discomfort|4|||
146965802|NCT03586427|530035231|FG000|Overall Study|Lost to Follow-up|0|||
146965803|NCT03586427|530035232|FG001|Overall Study|Lost to Follow-up|3|||
146965804|NCT03586427|530035233|FG002|Overall Study|Lost to Follow-up|1|||
146965805|NCT03586427|530035234|FG003|Overall Study|Lost to Follow-up|3|||
146965806|NCT03586427|530035235|FG004|Overall Study|Lost to Follow-up|3|||
146965807|NCT03586427|530035231|FG000|Overall Study|Withdrawal by Subject|0|||
146965808|NCT03586427|530035232|FG001|Overall Study|Withdrawal by Subject|1|||
146965809|NCT03586427|530035233|FG002|Overall Study|Withdrawal by Subject|2|||
146965810|NCT03586427|530035234|FG003|Overall Study|Withdrawal by Subject|1|||
146965811|NCT03586427|530035235|FG004|Overall Study|Withdrawal by Subject|1|||
146965812|NCT03586427|530035231|FG000|Overall Study|Adverse Event|0|||
146965813|NCT03586427|530035232|FG001|Overall Study|Adverse Event|0|||
146965814|NCT03586427|530035233|FG002|Overall Study|Adverse Event|1|||
146965815|NCT03586427|530035234|FG003|Overall Study|Adverse Event|0|||
146965816|NCT03586427|530035235|FG004|Overall Study|Adverse Event|0|||
146965817|NCT03586427|530035231|FG000|Overall Study|Protocol Violation|0|||
146965818|NCT03586427|530035232|FG001|Overall Study|Protocol Violation|0|||
146965819|NCT03586427|530035233|FG002|Overall Study|Protocol Violation|1|||
146965820|NCT03586427|530035234|FG003|Overall Study|Protocol Violation|0|||
146965821|NCT03586427|530035235|FG004|Overall Study|Protocol Violation|1|||
146965822|NCT03586427|530035231|FG000|Overall Study|Noncompliance with study drug|0|||
146965823|NCT03586427|530035232|FG001|Overall Study|Noncompliance with study drug|0|||
146965824|NCT03586427|530035233|FG002|Overall Study|Noncompliance with study drug|1|||
146965825|NCT03586427|530035234|FG003|Overall Study|Noncompliance with study drug|0|||
146965826|NCT03586427|530035235|FG004|Overall Study|Noncompliance with study drug|0|||
146965827|NCT00593385|530035240|FG000|Overall Study|Death|14|||
146965828|NCT00593385|530035240|FG000|Overall Study|Lost to Follow-up|17|||
146965829|NCT00593385|530035240|FG000|Overall Study|Withdrawal by Subject|9|||
146965830|NCT01471197|530035241|FG000|Overall Study|Disease Progression|4|||
146965831|NCT01471197|530035242|FG001|Overall Study|Disease Progression|2|||
146764126|NCT01833065|529302983|FG002|Overall Study|Subject's substantial non-compliance|0|||
146871888|NCT01721057|529701461|FG002|Rescue Period|Lack of Efficacy|0|||
146627634|NCT02163538|528811836|FG001|Overall Study|Protocol Violation|0|||
146871889|NCT01721057|529701462|FG003|Rescue Period|Lack of Efficacy|2|||
146871890|NCT01721057|529701463|FG004|Rescue Period|Lack of Efficacy|0|||
146871891|NCT01721057|529701464|FG005|Rescue Period|Lack of Efficacy|0|||
146871892|NCT01721057|529701465|FG006|Rescue Period|Lack of Efficacy|0|||
146871893|NCT01202279|529701468|FG000|Overall Study|Adverse Event|8|||
146871894|NCT01202279|529701469|FG001|Overall Study|Adverse Event|6|||
146871895|NCT01202279|529701468|FG000|Overall Study|Withdrawal by Subject|13|||
146871896|NCT01202279|529701469|FG001|Overall Study|Withdrawal by Subject|10|||
146871897|NCT01202279|529701468|FG000|Overall Study|Physician Decision|0|||
146871898|NCT01202279|529701469|FG001|Overall Study|Physician Decision|1|||
146871899|NCT01202279|529701468|FG000|Overall Study|Lost to Follow-up|10|||
146871900|NCT01202279|529701469|FG001|Overall Study|Lost to Follow-up|7|||
146871901|NCT01202279|529701468|FG000|Overall Study|Protocol Violation|1|||
146871902|NCT01202279|529701469|FG001|Overall Study|Protocol Violation|1|||
146871903|NCT01202279|529701468|FG000|Overall Study|study compliance|5|||
146871904|NCT01202279|529701469|FG001|Overall Study|study compliance|2|||
146871905|NCT03805750|529701470|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
146871906|NCT03805750|529701471|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
146871907|NCT01984164|529701472|FG000|Overall Study|Withdrawal by Subject|4|||
146871908|NCT01984164|529701473|FG001|Overall Study|Withdrawal by Subject|3|||
146871909|NCT01984164|529701472|FG000|Overall Study|Adverse Event|5|||
146871910|NCT01984164|529701473|FG001|Overall Study|Adverse Event|19|||
146965832|NCT01471197|530035241|FG000|Overall Study|Death|1|||
146965833|NCT01471197|530035242|FG001|Overall Study|Death|0|||
146965834|NCT01471197|530035241|FG000|Overall Study|Study Drug Toxicity|1|||
146539922|NCT01564407|528485196|FG003|Overall Study|Lost to Follow-up|0|||
146539923|NCT01564407|528485197|FG004|Overall Study|Lost to Follow-up|0|||
146539924|NCT01564407|528485193|FG000|Overall Study|Withdrawal by Subject|0|||
146539925|NCT01564407|528485194|FG001|Overall Study|Withdrawal by Subject|1|||
146539926|NCT01564407|528485195|FG002|Overall Study|Withdrawal by Subject|0|||
146539927|NCT01564407|528485196|FG003|Overall Study|Withdrawal by Subject|0|||
146965835|NCT01471197|530035242|FG001|Overall Study|Study Drug Toxicity|0|||
146965836|NCT00924313|530035245|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
146965837|NCT00455923|530035253|FG000|Overall Study|Pregnancy|0|||
146965838|NCT00455923|530035254|FG001|Overall Study|Pregnancy|2|||
146965839|NCT00455923|530035253|FG000|Overall Study|Other|3|||
146965840|NCT00455923|530035254|FG001|Overall Study|Other|1|||
146965841|NCT02686749|530035256|FG000|Overall Study|terminated for poor enrollment|2|||
146965842|NCT02686749|530035257|FG001|Overall Study|terminated for poor enrollment|2|||
146965843|NCT00145119|530035262|FG000|Overall Study|Death|45|||
146965844|NCT04478994|530036484|FG000|Overall Study|Withdrawal by Subject|1|||
146965845|NCT04478994|530036485|FG001|Overall Study|Withdrawal by Subject|1|||
146965846|NCT01100073|530036486|FG000|Overall Study|Lack of Efficacy|4|||
146965847|NCT01100073|530036486|FG000|Overall Study|Insufficient Tolerability|21|||
146965848|NCT01100073|530036486|FG000|Overall Study|Withdrawal by Subject|13|||
146965849|NCT01100073|530036486|FG000|Overall Study|Lost to Follow-up|39|||
146965850|NCT01100073|530036486|FG000|Overall Study|Lack of effect + patient's wish|2|||
146965851|NCT01100073|530036486|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
146965852|NCT01100073|530036486|FG000|Overall Study|Other|8|||
146965853|NCT01100073|530036486|FG000|Overall Study|Missing|5|||
146965854|NCT00299546|530036487|FG000|Overall Study|Death|3|||
146965855|NCT00299546|530036488|FG001|Overall Study|Death|2|||
146965856|NCT00299546|530036489|FG002|Overall Study|Death|0|||
146965857|NCT00299546|530036487|FG000|Overall Study|Lost to Follow-up|2|||
146965858|NCT00299546|530036488|FG001|Overall Study|Lost to Follow-up|2|||
146965859|NCT00299546|530036489|FG002|Overall Study|Lost to Follow-up|5|||
146965860|NCT00299546|530036487|FG000|Overall Study|Adverse Event|37|||
146965861|NCT00299546|530036488|FG001|Overall Study|Adverse Event|22|||
146965862|NCT00299546|530036489|FG002|Overall Study|Adverse Event|27|||
146539928|NCT01564407|528485197|FG004|Overall Study|Withdrawal by Subject|0|||
146965863|NCT00299546|530036487|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
146965864|NCT00299546|530036488|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
146965865|NCT00299546|530036489|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
146965866|NCT00299546|530036487|FG000|Overall Study|Other|24|||
146965867|NCT00299546|530036488|FG001|Overall Study|Other|26|||
146965868|NCT00299546|530036489|FG002|Overall Study|Other|19|||
146965869|NCT00299546|530036487|FG000|Overall Study|Not treated|0|||
146965870|NCT00299546|530036488|FG001|Overall Study|Not treated|1|||
146965871|NCT00299546|530036489|FG002|Overall Study|Not treated|1|||
146965872|NCT03099265|530036490|FG000|Overall Study|Adverse Event|1|||
146965873|NCT01741259|530036494|FG000|Overall Study|Protocol Violation|6|||
146965874|NCT01741259|530036495|FG001|Overall Study|Protocol Violation|4|||
146965875|NCT01741259|530036494|FG000|Overall Study|Withdrawal by Subject|0|||
146965876|NCT01741259|530036495|FG001|Overall Study|Withdrawal by Subject|2|||
146965877|NCT02094573|530036498|FG000|Overall Study|Adverse Event|4|||
146965878|NCT02094573|530036499|FG001|Overall Study|Adverse Event|14|||
146965879|NCT02094573|530036498|FG000|Overall Study|Clinical Progressive Disease|9|||
146965880|NCT02094573|530036499|FG001|Overall Study|Clinical Progressive Disease|13|||
146965881|NCT02094573|530036498|FG000|Overall Study|Death|11|||
146965882|NCT02094573|530036499|FG001|Overall Study|Death|3|||
146965883|NCT02094573|530036498|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
146965884|NCT02094573|530036499|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
146965885|NCT02094573|530036498|FG000|Overall Study|Non-compliance with Study Drug|1|||
146965886|NCT02094573|530036499|FG001|Overall Study|Non-compliance with Study Drug|1|||
146965887|NCT02094573|530036498|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
146965888|NCT02094573|530036499|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
146965889|NCT02094573|530036498|FG000|Overall Study|Physician Decision|4|||
146965890|NCT02094573|530036499|FG001|Overall Study|Physician Decision|4|||
146539929|NCT01564407|528485193|FG000|Overall Study|funding lost, study ended|0|||
146539930|NCT01564407|528485194|FG001|Overall Study|funding lost, study ended|0|||
146539931|NCT01564407|528485195|FG002|Overall Study|funding lost, study ended|0|||
146539932|NCT01564407|528485196|FG003|Overall Study|funding lost, study ended|1|||
146539933|NCT01564407|528485197|FG004|Overall Study|funding lost, study ended|0|||
146965891|NCT02094573|530036498|FG000|Overall Study|Site Terminated by Sponsor|10|||
146965892|NCT02094573|530036499|FG001|Overall Study|Site Terminated by Sponsor|17|||
146965893|NCT02094573|530036498|FG000|Overall Study|Withdrawal by Subject|6|||
146965894|NCT02094573|530036499|FG001|Overall Study|Withdrawal by Subject|8|||
146965895|NCT02094573|530036498|FG000|Overall Study|Randomized but not Treated|3|||
146965896|NCT02094573|530036499|FG001|Overall Study|Randomized but not Treated|0|||
146965897|NCT02411110|530036500|FG000|Treatment Period 1|Adverse Event|4|||
146871911|NCT01984164|529701472|FG000|Overall Study|Lost to Follow-up|1|||
146871912|NCT01984164|529701473|FG001|Overall Study|Lost to Follow-up|3|||
146871913|NCT02811549|529701474|FG000|Overall Study|Lost to Follow-up|1|||
146871914|NCT02811549|529701474|FG000|Overall Study|Withdrawal by Subject|3|||
146871915|NCT02811549|529701474|FG000|Overall Study|Subject screen failed|4|||
146871916|NCT02811549|529701474|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
146871917|NCT03472924|529701475|FG000|Overall Study|Adverse Event|1|||
146871918|NCT03472924|529701476|FG001|Overall Study|Adverse Event|0|||
146871919|NCT02546765|529701480|FG000|Overall Study|Withdrawal by Subject|0|||
146871920|NCT02546765|529701481|FG001|Overall Study|Withdrawal by Subject|1|||
146871921|NCT02546765|529701482|FG002|Overall Study|Withdrawal by Subject|0|||
146871922|NCT02546765|529701483|FG003|Overall Study|Withdrawal by Subject|0|||
146871923|NCT00698997|529701484|FG000|Overall Study|Lost to Follow-up|3|||
146871924|NCT00698997|529701485|FG001|Overall Study|Lost to Follow-up|0|||
146871925|NCT00698997|529701484|FG000|Overall Study|Withdrawal by Subject|7|||
146871926|NCT00698997|529701485|FG001|Overall Study|Withdrawal by Subject|27|||
146871927|NCT00475722|529701486|FG000|Overall Study|Withdrawal by Subject|12|||
146871928|NCT00475722|529701487|FG001|Overall Study|Withdrawal by Subject|12|||
146871929|NCT00475722|529701486|FG000|Overall Study|Protocol Violation|3|||
146871930|NCT00475722|529701487|FG001|Overall Study|Protocol Violation|0|||
146871931|NCT00493220|529701488|FG000|Third Intervention|Withdrawal by Subject|1|||
146871932|NCT00493220|529701489|FG001|Third Intervention|Withdrawal by Subject|0|||
146871933|NCT00493220|529701490|FG002|Third Intervention|Withdrawal by Subject|0|||
146871934|NCT00493220|529701491|FG003|Third Intervention|Withdrawal by Subject|0|||
146871935|NCT00493220|529701492|FG004|Third Intervention|Withdrawal by Subject|0|||
146871936|NCT00493220|529701493|FG005|Third Intervention|Withdrawal by Subject|0|||
146871937|NCT01889238|529701496|FG000|Overall Study|Death|1|||
146871938|NCT01889238|529701496|FG000|Overall Study|Withdrawal by Subject|1|||
146871939|NCT01889238|529701496|FG000|Overall Study|Adverse Event|6|||
146871940|NCT01889238|529701496|FG000|Overall Study|Disease Progression|104|||
146871941|NCT01889238|529701496|FG000|Overall Study|Other|6|||
146871942|NCT04136184|529701497|FG000|Overall Study|Lost to Follow-up|0|||
146871943|NCT04136184|529701498|FG001|Overall Study|Lost to Follow-up|3|||
146871944|NCT04136184|529701497|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
146871945|NCT04136184|529701498|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
146871946|NCT03318978|529701502|FG000|Overall Study|Withdrawal by Subject|1|||
146871947|NCT02844816|529701503|FG000|Overall Study|No protocol treatment received|5|||
146871948|NCT02844816|529701504|FG001|Overall Study|No protocol treatment received|1|||
146871949|NCT02844816|529701503|FG000|Overall Study|Ineligible|22|||
146871950|NCT02844816|529701504|FG001|Overall Study|Ineligible|15|||
146871951|NCT02844816|529701503|FG000|Overall Study|Participant refusal|5|||
146871952|NCT02844816|529701504|FG001|Overall Study|Participant refusal|5|||
146871953|NCT02844816|529701503|FG000|Overall Study|Adverse Event|5|||
146871954|NCT02844816|529701504|FG001|Overall Study|Adverse Event|4|||
146871955|NCT02844816|529701503|FG000|Overall Study|Death|0|||
146871956|NCT02844816|529701504|FG001|Overall Study|Death|1|||
146871957|NCT02844816|529701503|FG000|Overall Study|Disease progression/recurrence|50|||
146871958|NCT02844816|529701504|FG001|Overall Study|Disease progression/recurrence|24|||
146871959|NCT02844816|529701503|FG000|Overall Study|Physician Decision|1|||
146871960|NCT02844816|529701504|FG001|Overall Study|Physician Decision|1|||
146871961|NCT02717754|529701508|FG000|Overall Study|Incorrect Infusion Duration|0|||
146871962|NCT02717754|529701509|FG001|Overall Study|Incorrect Infusion Duration|0|||
146871963|NCT02717754|529701510|FG002|Overall Study|Incorrect Infusion Duration|0|||
146871964|NCT02717754|529701511|FG003|Overall Study|Incorrect Infusion Duration|10|||
146871965|NCT02717754|529701512|FG004|Overall Study|Incorrect Infusion Duration|20|||
146871966|NCT02717754|529701513|FG005|Overall Study|Incorrect Infusion Duration|20|||
146871967|NCT01200238|529701514|FG000|Overall Study|Adverse Event|2|||
146871968|NCT01200238|529701515|FG001|Overall Study|Adverse Event|1|||
146871969|NCT01200238|529701514|FG000|Overall Study|Progressive Disease|5|||
146871970|NCT01200238|529701515|FG001|Overall Study|Progressive Disease|8|||
146871971|NCT01200238|529701514|FG000|Overall Study|Withdrawal by Subject|0|||
146871972|NCT01200238|529701515|FG001|Overall Study|Withdrawal by Subject|1|||
146764127|NCT01833065|529302984|FG003|Overall Study|Subject's substantial non-compliance|0|||
146764128|NCT01833065|529302985|FG004|Overall Study|Subject's substantial non-compliance|0|||
146965898|NCT02411110|530036501|FG001|Treatment Period 1|Adverse Event|2|||
146539934|NCT05049122|528485198|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
146539935|NCT05049122|528485198|FG000|Overall Study|Participant moved|1|||
146539936|NCT05049122|528485198|FG000|Overall Study|At the direction of the doctor|1|||
146539937|NCT03636477|528485202|FG000|Overall Study|Adverse Event|0|||
146539938|NCT03636477|528485203|FG001|Overall Study|Adverse Event|0|||
146539939|NCT03636477|528485204|FG002|Overall Study|Adverse Event|1|||
146539940|NCT05168800|528485205|FG000|Time 1 Survey|Did not start T1 survey|182|||
146539941|NCT05168800|528485206|FG001|Time 1 Survey|Did not start T1 survey|150|||
146965899|NCT02411110|530036500|FG000|Treatment Period 1|Lost to Follow-up|1|||
146965900|NCT02411110|530036501|FG001|Treatment Period 1|Lost to Follow-up|0|||
146965901|NCT02411110|530036500|FG000|Treatment Period 1|Personal Reasons|2|||
146539942|NCT05168800|528485207|FG002|Time 1 Survey|Did not start T1 survey|140|||
146965902|NCT02411110|530036501|FG001|Treatment Period 1|Personal Reasons|5|||
146965903|NCT02411110|530036500|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
146965904|NCT02411110|530036501|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
146965905|NCT02411110|530036500|FG000|Treatment Period 2|Adverse Event|1|||
146965906|NCT02411110|530036501|FG001|Treatment Period 2|Adverse Event|0|||
146965907|NCT02411110|530036500|FG000|Treatment Period 2|Lost to Follow-up|0|||
146965908|NCT02411110|530036501|FG001|Treatment Period 2|Lost to Follow-up|2|||
146965909|NCT02411110|530036500|FG000|Treatment Period 2|Personal Reasons|0|||
146965910|NCT02411110|530036501|FG001|Treatment Period 2|Personal Reasons|2|||
146965911|NCT00526162|530036502|FG000|Overall Study|Device not implanted|3|||
146965912|NCT03193996|530036504|FG000|Overall Study|Withdrawal by Subject|4|||
146965913|NCT03193996|530036504|FG000|Overall Study|Lost to Follow-up|4|||
146965914|NCT03193996|530036504|FG000|Overall Study|Physician Decision|2|||
146965915|NCT03193996|530036504|FG000|Overall Study|Pregnancy|1|||
146965916|NCT03193996|530036504|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
146965917|NCT03193996|530036504|FG000|Overall Study|Complicating disease|1|||
146965918|NCT01353586|530036505|FG000|Overall Study|Procedure terminated prior to ablation|3|||
146965919|NCT01353586|530036506|FG001|Overall Study|Procedure terminated prior to ablation|0|||
146965920|NCT01353586|530036505|FG000|Overall Study|Never had insertion of study catheter|4|||
146965921|NCT01353586|530036506|FG001|Overall Study|Never had insertion of study catheter|1|||
146965922|NCT01353586|530036505|FG000|Overall Study|Neurological exam not done|0|||
146965923|NCT01353586|530036506|FG001|Overall Study|Neurological exam not done|1|||
146965924|NCT05027958|530036507|FG000|Overall Study|Lost to Follow-up|1|||
146965925|NCT05027958|530036508|FG001|Overall Study|Lost to Follow-up|1|||
146965926|NCT05027958|530036507|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
146539943|NCT05168800|528485205|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
146965927|NCT05027958|530036508|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
146965928|NCT05027958|530036507|FG000|Overall Study|Physician Decision|1|||
146965929|NCT05027958|530036508|FG001|Overall Study|Physician Decision|4|||
146965930|NCT05027958|530036507|FG000|Overall Study|Adverse Event|0|||
146965931|NCT05027958|530036508|FG001|Overall Study|Adverse Event|1|||
146965932|NCT00491322|530036510|FG000|Overall Study|Protocol Violation|1|||
146965933|NCT00491322|530036511|FG001|Overall Study|Protocol Violation|0|||
146965934|NCT00491322|530036510|FG000|Overall Study|Pregnancy|0|||
146965935|NCT00491322|530036511|FG001|Overall Study|Pregnancy|1|||
146965936|NCT00807040|530036514|FG000|Overall Study|Death|24|||
146965937|NCT00807040|530036515|FG001|Overall Study|Death|29|||
146965938|NCT00807040|530036514|FG000|Overall Study|Withdrawal by Subject|8|||
146965939|NCT00807040|530036515|FG001|Overall Study|Withdrawal by Subject|6|||
146539944|NCT05168800|528485206|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
146539945|NCT05168800|528485207|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
146965940|NCT00807040|530036514|FG000|Overall Study|Lost to Follow-up|4|||
146965941|NCT00807040|530036515|FG001|Overall Study|Lost to Follow-up|6|||
146965942|NCT00890409|530036520|FG000|Overall Study|Lost to Follow-up|20|||
146965943|NCT00890409|530036521|FG001|Overall Study|Lost to Follow-up|21|||
146539946|NCT05168800|528485205|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
146539947|NCT05168800|528485206|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
146539948|NCT05168800|528485207|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
146539949|NCT05168800|528485205|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
146539950|NCT05168800|528485206|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
146539951|NCT05168800|528485207|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
146539952|NCT05168800|528485205|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
146539953|NCT05168800|528485206|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
146539954|NCT05168800|528485207|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
146539955|NCT05168800|528485205|FG000|Time 1 Survey|Withdrawal by Subject|6|||
146539956|NCT05168800|528485206|FG001|Time 1 Survey|Withdrawal by Subject|3|||
146539957|NCT05168800|528485207|FG002|Time 1 Survey|Withdrawal by Subject|2|||
146539958|NCT05168800|528485205|FG000|Time 2 Survey|Already excluded at Time 1|228|||
146539959|NCT05168800|528485206|FG001|Time 2 Survey|Already excluded at Time 1|202|||
146539960|NCT05168800|528485207|FG002|Time 2 Survey|Already excluded at Time 1|173|||
146539961|NCT05168800|528485205|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
146539962|NCT05168800|528485206|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
146539963|NCT05168800|528485207|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
146539964|NCT05168800|528485205|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
146539965|NCT05168800|528485206|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
146539966|NCT05168800|528485207|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
146539967|NCT05168800|528485205|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
146539968|NCT05168800|528485206|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
146539969|NCT05168800|528485207|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
146539970|NCT05168800|528485205|FG000|Time 2 Survey|Withdrawal by Subject|1|||
146539971|NCT05168800|528485206|FG001|Time 2 Survey|Withdrawal by Subject|0|||
146539972|NCT05168800|528485207|FG002|Time 2 Survey|Withdrawal by Subject|1|||
146539973|NCT05168800|528485205|FG000|Time 3 Survey|Already excluded at Time 1|228|||
146539974|NCT05168800|528485206|FG001|Time 3 Survey|Already excluded at Time 1|200|||
146539975|NCT05168800|528485207|FG002|Time 3 Survey|Already excluded at Time 1|173|||
146539976|NCT05168800|528485205|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
146539977|NCT05168800|528485206|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
146539978|NCT05168800|528485207|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
146539979|NCT05168800|528485205|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
146539980|NCT05168800|528485206|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
146539981|NCT05168800|528485207|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
146539982|NCT05168800|528485205|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
146539983|NCT05168800|528485206|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
146539984|NCT05168800|528485207|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
146539985|NCT05722015|528485212|FG000|Overall Study|Death|57|||
146539986|NCT05722015|528485213|FG001|Overall Study|Death|37|||
146539987|NCT05722015|528485212|FG000|Overall Study|Lost to Follow-up|1|||
146539988|NCT05722015|528485213|FG001|Overall Study|Lost to Follow-up|0|||
146539989|NCT05722015|528485212|FG000|Overall Study|Withdrawal by Subject|5|||
146539990|NCT05722015|528485213|FG001|Overall Study|Withdrawal by Subject|1|||
146539991|NCT05722015|528485212|FG000|Overall Study|Participants Ongoing|188|||
146539992|NCT05722015|528485213|FG001|Overall Study|Participants Ongoing|88|||
146539993|NCT05352399|528485214|FG000|Overall Study|Discontinued intervention|6|||
146539994|NCT02657551|528485215|FG000|Overall Study|Adverse Event|2|||
146539995|NCT02657551|528485215|FG000|Overall Study|Withdrawal by Subject|1|||
146539996|NCT02657551|528485215|FG000|Overall Study|Non-Compliance|1|||
146764129|NCT01833065|529302981|FG000|Overall Study|Trial terminated by sponsor|8|||
146764130|NCT01833065|529302982|FG001|Overall Study|Trial terminated by sponsor|8|||
146764131|NCT01833065|529302983|FG002|Overall Study|Trial terminated by sponsor|7|||
146539997|NCT02657551|528485215|FG000|Overall Study|Progression / Relapse|4|||
146764132|NCT01833065|529302984|FG003|Overall Study|Trial terminated by sponsor|3|||
146764133|NCT01833065|529302985|FG004|Overall Study|Trial terminated by sponsor|13|||
146764134|NCT01833065|529302981|FG000|Overall Study|Others|2|||
146764135|NCT01833065|529302982|FG001|Overall Study|Others|1|||
146764136|NCT01833065|529302983|FG002|Overall Study|Others|1|||
146764137|NCT01833065|529302984|FG003|Overall Study|Others|1|||
146764138|NCT01833065|529302985|FG004|Overall Study|Others|4|||
146539998|NCT02340949|528485216|FG000|Overall Study|Adverse Event|4|||
146539999|NCT02340949|528485217|FG001|Overall Study|Adverse Event|2|||
146540000|NCT02340949|528485216|FG000|Overall Study|Withdrawal by Subject|2|||
146540001|NCT02340949|528485217|FG001|Overall Study|Withdrawal by Subject|0|||
146965944|NCT02353572|530036522|FG000|Overall Study|Withdrawal by Subject|1|||
146965945|NCT02353572|530036522|FG000|Overall Study|Study terminated|2|||
146965946|NCT01870921|530036530|FG000|Overall Study|Subject decision|80|||
146975325|NCT00572156|530073540|FG001|Overall Study|Adverse Event|1|||
146871973|NCT00482703|529701516|FG000|Overall Study|Poor compliance|1|||
146540002|NCT02340949|528485216|FG000|Overall Study|Progression disease|6|||
146871974|NCT00482703|529701517|FG001|Overall Study|Poor compliance|0|||
146871975|NCT00667823|529701519|FG000|Overall Study|Lost to Follow-up|5|||
146871976|NCT00667823|529701519|FG000|Overall Study|Adverse Event|7|||
146871977|NCT00667823|529701519|FG000|Overall Study|Death|182|||
146871978|NCT00667823|529701519|FG000|Overall Study|Withdrawal by Subject|12|||
146540003|NCT02340949|528485217|FG001|Overall Study|Progression disease|2|||
146540004|NCT02340949|528485216|FG000|Overall Study|Death|3|||
146540005|NCT02340949|528485217|FG001|Overall Study|Death|0|||
146540006|NCT02340949|528485216|FG000|Overall Study|Physician Decision|1|||
146764139|NCT00828672|529302986|FG000|Study Treatment|Lost to Follow-up|1|||
146764140|NCT00828672|529302987|FG001|Study Treatment|Lost to Follow-up|0|||
146764141|NCT00828672|529302986|FG000|Study Treatment|Adverse Event|0|||
146764142|NCT00828672|529302987|FG001|Study Treatment|Adverse Event|1|||
146764143|NCT00828672|529302986|FG000|Study Treatment|Complete response, no surgery|1|||
146764144|NCT00828672|529302987|FG001|Study Treatment|Complete response, no surgery|1|||
146764145|NCT00828672|529302986|FG000|Post-surgery (<30 Days)|No central review materials|0|||
146764146|NCT00828672|529302987|FG001|Post-surgery (<30 Days)|No central review materials|1|||
146764147|NCT00906698|529302988|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
146764148|NCT00906698|529302989|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
146764149|NCT00906698|529302990|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
146764150|NCT00906698|529302991|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
146871979|NCT00667823|529701519|FG000|Overall Study|Other|8|||
146871980|NCT00667823|529701519|FG000|Overall Study|Missing (completion page missing)|2|||
146540007|NCT02340949|528485217|FG001|Overall Study|Physician Decision|0|||
146540008|NCT00296517|528485218|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
146871981|NCT02592018|529701521|FG000|Overall Study|Adverse Event|1|||
146871982|NCT02592018|529701521|FG000|Overall Study|Lost to Follow-up|1|||
146871983|NCT06156215|529701524|FG000|Overall Study|Withdrawal by Subject|2|||
146871984|NCT06156215|529701525|FG001|Overall Study|Withdrawal by Subject|4|||
146871985|NCT06156215|529701526|FG002|Overall Study|Withdrawal by Subject|4|||
146871986|NCT06156215|529701527|FG003|Overall Study|Withdrawal by Subject|0|||
146871987|NCT06156215|529701528|FG004|Overall Study|Withdrawal by Subject|2|||
146871988|NCT06156215|529701529|FG005|Overall Study|Withdrawal by Subject|2|||
146871989|NCT06156215|529701524|FG000|Overall Study|Left ED without completing study|9|||
146871990|NCT06156215|529701525|FG001|Overall Study|Left ED without completing study|3|||
146965947|NCT01870921|530036530|FG000|Overall Study|Severe non-compliance to protocol|7|||
146965948|NCT01870921|530036530|FG000|Overall Study|Subject Lost to Follow up|2|||
146540009|NCT00296517|528485219|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
146540010|NCT00296517|528485218|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
146540011|NCT00296517|528485219|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
146540012|NCT00296517|528485218|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
146540013|NCT00296517|528485219|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
146540014|NCT00296517|528485218|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
146540015|NCT00296517|528485219|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
146540016|NCT00296517|528485218|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
146540017|NCT00296517|528485219|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
146540018|NCT00296517|528485218|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
146540019|NCT00296517|528485219|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
146540020|NCT00296517|528485218|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
146540021|NCT00296517|528485219|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
146540022|NCT00296517|528485218|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
146540023|NCT00296517|528485219|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
146540024|NCT00296517|528485218|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
146540025|NCT00296517|528485219|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
146965949|NCT01870921|530036530|FG000|Overall Study|Other|1|||
146965950|NCT03075826|530036531|FG000|Overall Study|Withdrawal by Subject|1|||
146965951|NCT03075826|530036531|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
146965952|NCT03707145|530036532|FG000|Overall Study|Lost to Follow-up|0|||
146965953|NCT03707145|530036533|FG001|Overall Study|Lost to Follow-up|1|||
146965954|NCT03707145|530036534|FG002|Overall Study|Lost to Follow-up|1|||
146965955|NCT03707145|530036535|FG003|Overall Study|Lost to Follow-up|0|||
146965956|NCT04221477|530036536|FG000|Overall Study|Adverse Event|1|||
146965957|NCT04221477|530036537|FG001|Overall Study|Adverse Event|1|||
146965958|NCT04221477|530036536|FG000|Overall Study|Death|5|||
146965959|NCT04221477|530036537|FG001|Overall Study|Death|4|||
146965960|NCT04221477|530036536|FG000|Overall Study|Lack of Efficacy|1|||
146965961|NCT04221477|530036537|FG001|Overall Study|Lack of Efficacy|2|||
146965962|NCT04221477|530036536|FG000|Overall Study|Lost to Follow-up|1|||
146965963|NCT04221477|530036537|FG001|Overall Study|Lost to Follow-up|2|||
146965964|NCT04221477|530036536|FG000|Overall Study|Non-compliance with Study Drug|1|||
146965965|NCT04221477|530036537|FG001|Overall Study|Non-compliance with Study Drug|0|||
146965966|NCT04221477|530036536|FG000|Overall Study|Reason not Specified|0|||
146965967|NCT04221477|530036537|FG001|Overall Study|Reason not Specified|5|||
146965968|NCT04221477|530036536|FG000|Overall Study|Physician Decision|0|||
146540026|NCT01143324|528485227|FG000|Overall Study|Lost to Follow-up|11|||
146965969|NCT04221477|530036537|FG001|Overall Study|Physician Decision|6|||
146965970|NCT04221477|530036536|FG000|Overall Study|Withdrawal by Subject|10|||
146965971|NCT04221477|530036537|FG001|Overall Study|Withdrawal by Subject|14|||
146965972|NCT04221477|530036536|FG000|Overall Study|Ongoing in the Study|116|||
146965973|NCT04221477|530036537|FG001|Overall Study|Ongoing in the Study|102|||
146965974|NCT02242942|530036538|FG000|Overall Study|Death|17|||
146965975|NCT02242942|530036539|FG001|Overall Study|Death|20|||
146965976|NCT02242942|530036540|FG002|Overall Study|Death|2|||
146965977|NCT02242942|530036538|FG000|Overall Study|Physician Decision|1|||
146965978|NCT02242942|530036539|FG001|Overall Study|Physician Decision|0|||
146965979|NCT02242942|530036540|FG002|Overall Study|Physician Decision|0|||
146965980|NCT02242942|530036538|FG000|Overall Study|Withdrawal by Subject|8|||
146965981|NCT02242942|530036539|FG001|Overall Study|Withdrawal by Subject|10|||
146965982|NCT02242942|530036540|FG002|Overall Study|Withdrawal by Subject|0|||
146965983|NCT02242942|530036538|FG000|Overall Study|On-going in Study|190|||
146540027|NCT01143324|528485227|FG000|Overall Study|Withdrawal by Subject|4|||
146540028|NCT01143324|528485227|FG000|Overall Study|Explant of the device|4|||
146871991|NCT06156215|529701526|FG002|Overall Study|Left ED without completing study|9|||
146965984|NCT02242942|530036539|FG001|Overall Study|On-going in Study|186|||
146965985|NCT02242942|530036540|FG002|Overall Study|On-going in Study|11|||
146965986|NCT04882085|530036541|FG000|Overall Study|Death|6|||
146965987|NCT04882085|530036542|FG001|Overall Study|Death|9|||
146965988|NCT04882085|530036541|FG000|Overall Study|Withdrawal by Subject|0|||
146965989|NCT04882085|530036542|FG001|Overall Study|Withdrawal by Subject|3|||
146965990|NCT04882085|530036541|FG000|Overall Study|Randomized not treated|1|||
146965991|NCT04882085|530036542|FG001|Overall Study|Randomized not treated|0|||
146965992|NCT05681715|530036550|FG000|Training Period (6-weeks)|Adverse Event|3|||
146965993|NCT05681715|530036551|FG001|Training Period (6-weeks)|Adverse Event|0|||
146965994|NCT05681715|530036552|FG002|Training Period (6-weeks)|Adverse Event|0|||
146965995|NCT05681715|530036550|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
146965996|NCT05681715|530036551|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
146965997|NCT05681715|530036552|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
146965998|NCT05681715|530036550|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
146965999|NCT05681715|530036551|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
146966000|NCT05681715|530036552|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
146966001|NCT05681715|530036550|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
146966002|NCT05681715|530036551|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
146966003|NCT05681715|530036552|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
146966004|NCT05681715|530036550|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
146966005|NCT05681715|530036551|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
146966006|NCT05681715|530036552|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
146966007|NCT05681715|530036550|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
146966008|NCT05681715|530036551|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
146966009|NCT05681715|530036552|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
146966010|NCT05681715|530036550|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
146966011|NCT05681715|530036551|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
146966012|NCT05681715|530036552|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
146966013|NCT05681715|530036550|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
146966014|NCT05681715|530036551|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
146966015|NCT05681715|530036552|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
146966016|NCT02268214|530036553|FG000|Overall Study|Subject no longer meets study criteria|0|||
146966017|NCT02268214|530036554|FG001|Overall Study|Subject no longer meets study criteria|2|||
146966018|NCT02268214|530036555|FG002|Overall Study|Subject no longer meets study criteria|0|||
146966019|NCT02268214|530036553|FG000|Overall Study|Pregnancy|2|||
146966020|NCT02268214|530036554|FG001|Overall Study|Pregnancy|2|||
146966021|NCT02268214|530036555|FG002|Overall Study|Pregnancy|1|||
146966022|NCT02268214|530036553|FG000|Overall Study|Lost to Follow-up|3|||
146966023|NCT02268214|530036554|FG001|Overall Study|Lost to Follow-up|3|||
146966024|NCT02268214|530036555|FG002|Overall Study|Lost to Follow-up|4|||
146966025|NCT02268214|530036553|FG000|Overall Study|Lack of Efficacy|1|||
146966026|NCT02268214|530036554|FG001|Overall Study|Lack of Efficacy|0|||
146966027|NCT02268214|530036555|FG002|Overall Study|Lack of Efficacy|2|||
146966028|NCT02268214|530036553|FG000|Overall Study|Adverse Event|11|||
146966029|NCT02268214|530036554|FG001|Overall Study|Adverse Event|14|||
146966030|NCT02268214|530036555|FG002|Overall Study|Adverse Event|9|||
146966031|NCT02268214|530036553|FG000|Overall Study|Withdrawal by Subject|4|||
146966032|NCT02268214|530036554|FG001|Overall Study|Withdrawal by Subject|5|||
146966033|NCT02268214|530036555|FG002|Overall Study|Withdrawal by Subject|10|||
146966034|NCT02268214|530036553|FG000|Overall Study|Subject request to discontinue treatment|10|||
146966035|NCT02268214|530036554|FG001|Overall Study|Subject request to discontinue treatment|8|||
146966036|NCT02268214|530036555|FG002|Overall Study|Subject request to discontinue treatment|6|||
146966037|NCT02268214|530036553|FG000|Overall Study|Poor/non-compliance|2|||
146966038|NCT02268214|530036554|FG001|Overall Study|Poor/non-compliance|1|||
146966039|NCT02268214|530036555|FG002|Overall Study|Poor/non-compliance|2|||
146966040|NCT02268214|530036553|FG000|Overall Study|Other reasons|7|||
146966041|NCT02268214|530036554|FG001|Overall Study|Other reasons|3|||
146966042|NCT02268214|530036555|FG002|Overall Study|Other reasons|3|||
146966043|NCT02268214|530036553|FG000|Overall Study|Not entering long-term period|2|||
146966044|NCT02268214|530036554|FG001|Overall Study|Not entering long-term period|3|||
146966045|NCT02268214|530036555|FG002|Overall Study|Not entering long-term period|5|||
146966046|NCT02951130|530036556|FG000|Overall Study|Protocol Violation|1|||
146966047|NCT02951130|530036557|FG001|Overall Study|Protocol Violation|1|||
146966048|NCT03743571|530036558|FG000|Overall Study|Withdrawal by Subject|1|||
146966049|NCT03743571|530036559|FG001|Overall Study|Withdrawal by Subject|1|||
146966050|NCT03743571|530036558|FG000|Overall Study|Lost to Follow-up|1|||
146540029|NCT01101178|528485230|FG000|Period 1|Withdrawal by Subject|1|||
146540030|NCT01101178|528485231|FG001|Period 1|Withdrawal by Subject|2|||
146540031|NCT01101178|528485230|FG000|Period 1|Positive drug screen|1|||
146764151|NCT00906698|529302992|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
146966051|NCT03743571|530036559|FG001|Overall Study|Lost to Follow-up|2|||
146966052|NCT05403502|530036560|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
146966053|NCT05403502|530036560|FG000|Humalog Lead-In Period|Physician Decision|2|||
146764152|NCT00906698|529302993|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
146966054|NCT05403502|530036560|FG000|Humalog Lead-In Period|Protocol Violation|1|||
146966055|NCT05403502|530036560|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
146966056|NCT05403502|530036560|FG000|Lyumjev Treatment Period|Physician Decision|2|||
146966057|NCT02756182|530036561|FG000|Overall Study|StudyTechnical Difficulties|4|||
146966058|NCT01003691|530036562|FG000|Overall Study|Adverse Event|0|||
146764153|NCT00906698|529302988|FG000|Overall Study|Adverse Event|0|||
146764154|NCT00906698|529302989|FG001|Overall Study|Adverse Event|0|||
146764155|NCT00906698|529302990|FG002|Overall Study|Adverse Event|2|||
146966059|NCT01003691|530036563|FG001|Overall Study|Adverse Event|0|||
146966060|NCT01003691|530036564|FG002|Overall Study|Adverse Event|0|||
146966061|NCT01003691|530036565|FG003|Overall Study|Adverse Event|1|||
146966062|NCT00828009|530036570|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
146966063|NCT00828009|530036570|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
146540032|NCT01101178|528485231|FG001|Period 1|Positive drug screen|1|||
146966064|NCT00828009|530036570|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
146966065|NCT00828009|530036570|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
146966066|NCT00828009|530036570|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
146966067|NCT00828009|530036570|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
146966068|NCT00828009|530036570|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
146966069|NCT00828009|530036570|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
146966070|NCT00828009|530036570|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
146540033|NCT01101178|528485230|FG000|Period 1|Adverse Event|2|||
146540034|NCT01101178|528485231|FG001|Period 1|Adverse Event|1|||
146540035|NCT01101178|528485230|FG000|Period 2|Withdrawal by Subject|0|||
146540036|NCT01101178|528485231|FG001|Period 2|Withdrawal by Subject|1|||
146540037|NCT01850641|528485232|FG000|Overall Study|Physician Decision|1|||
146540038|NCT01850641|528485232|FG000|Overall Study|Decrease in serum phosphorus|1|||
146540039|NCT01850641|528485232|FG000|Overall Study|Decrease in serum calcium|2|||
146540040|NCT01850641|528485232|FG000|Overall Study|Increase in serum ferritin|1|||
146540041|NCT03479905|528485252|FG000|Overall Study|Other airway method used|4|||
146540042|NCT03479905|528485253|FG001|Overall Study|Other airway method used|5|||
146540043|NCT03479905|528485254|FG002|Overall Study|Other airway method used|5|||
146540044|NCT00862992|528485255|FG000|Overall Study|Adverse Event|2|||
146540045|NCT00862992|528485256|FG001|Overall Study|Adverse Event|1|||
146540046|NCT00862992|528485257|FG002|Overall Study|Adverse Event|1|||
146966071|NCT00828009|530036570|FG000|Step 2 - Maintenance Therapy|Death|1|||
146540047|NCT00862992|528485255|FG000|Overall Study|Physician Decision|1|||
146540048|NCT00862992|528485256|FG001|Overall Study|Physician Decision|0|||
146975326|NCT00572156|530073541|FG002|Overall Study|Adverse Event|5|||
146540049|NCT00862992|528485257|FG002|Overall Study|Physician Decision|0|||
146871992|NCT06156215|529701527|FG003|Overall Study|Left ED without completing study|0|||
146871993|NCT06156215|529701528|FG004|Overall Study|Left ED without completing study|8|||
146871994|NCT06156215|529701529|FG005|Overall Study|Left ED without completing study|16|||
146871995|NCT06156215|529701524|FG000|Overall Study|Physician Decision|1|||
146540050|NCT00862992|528485255|FG000|Overall Study|Withdrawal by Subject|0|||
146540051|NCT00862992|528485256|FG001|Overall Study|Withdrawal by Subject|0|||
146540052|NCT00862992|528485257|FG002|Overall Study|Withdrawal by Subject|2|||
146540053|NCT00720759|528485258|FG000|Overall Study|Lost to Follow-up|0|||
146540054|NCT00720759|528485259|FG001|Overall Study|Lost to Follow-up|1|||
146540055|NCT00720759|528485260|FG002|Overall Study|Lost to Follow-up|1|||
146540056|NCT00720759|528485261|FG003|Overall Study|Lost to Follow-up|0|||
146540057|NCT02318940|528485262|FG000|Overall Study|lost the record|1|||
146540058|NCT02318940|528485263|FG001|Overall Study|lost the record|0|||
146540059|NCT05032196|528485276|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
146540060|NCT05032196|528485277|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
146540061|NCT05032196|528485278|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
146540062|NCT05032196|528485279|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
146540063|NCT05032196|528485280|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
146540064|NCT05032196|528485281|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
146540065|NCT05032196|528485276|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
146540066|NCT05032196|528485277|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
146540067|NCT05032196|528485278|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
146540068|NCT05032196|528485279|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
146540069|NCT05032196|528485280|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
146540070|NCT05032196|528485281|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
146540071|NCT05032196|528485276|FG000|Period 2 (Multidose)|Physician Decision|0|||
146540072|NCT05032196|528485277|FG001|Period 2 (Multidose)|Physician Decision|0|||
146540073|NCT05032196|528485278|FG002|Period 2 (Multidose)|Physician Decision|0|||
146871996|NCT06156215|529701525|FG001|Overall Study|Physician Decision|0|||
146871997|NCT06156215|529701526|FG002|Overall Study|Physician Decision|0|||
146871998|NCT06156215|529701527|FG003|Overall Study|Physician Decision|0|||
146871999|NCT06156215|529701528|FG004|Overall Study|Physician Decision|0|||
146872000|NCT06156215|529701529|FG005|Overall Study|Physician Decision|0|||
146872001|NCT06156215|529701524|FG000|Overall Study|Became or found ineligible|2|||
146872002|NCT06156215|529701525|FG001|Overall Study|Became or found ineligible|0|||
146872003|NCT06156215|529701526|FG002|Overall Study|Became or found ineligible|2|||
146975327|NCT00572156|530073542|FG003|Overall Study|Adverse Event|1|||
146540074|NCT05032196|528485279|FG003|Period 2 (Multidose)|Physician Decision|0|||
146540075|NCT05032196|528485280|FG004|Period 2 (Multidose)|Physician Decision|1|||
146764156|NCT00906698|529302991|FG003|Overall Study|Adverse Event|0|||
146540076|NCT05032196|528485281|FG005|Period 2 (Multidose)|Physician Decision|0|||
146764157|NCT00906698|529302992|FG004|Overall Study|Adverse Event|4|||
146540077|NCT00857389|528485282|FG000|Overall Study|Did not proceed to transplant|2|||
146540078|NCT05260008|528485283|FG000|Overall Study|Physician Decision|0|||
146540079|NCT05260008|528485284|FG001|Overall Study|Physician Decision|1|||
146540080|NCT05260008|528485285|FG002|Overall Study|Physician Decision|0|||
146540081|NCT05260008|528485286|FG003|Overall Study|Physician Decision|0|||
146540082|NCT04584788|528485288|FG000|Overall Study|Physician Decision|8|||
146540083|NCT04584788|528485288|FG000|Overall Study|Withdrawal by Subject|1|||
146540084|NCT04584788|528485288|FG000|Overall Study|Adverse Event|3|||
146540085|NCT02472405|528487519|FG000|Overall Study|Lost to Follow-up|9|||
146540086|NCT02472405|528487519|FG000|Overall Study|Adverse Event|1|||
146540087|NCT01134042|528487520|FG000|Overall Study|Adverse Event|3|||
146540088|NCT01134042|528487521|FG001|Overall Study|Adverse Event|7|||
146540089|NCT01134042|528487522|FG002|Overall Study|Adverse Event|2|||
146540090|NCT01134042|528487520|FG000|Overall Study|Lack of Efficacy|21|||
146540091|NCT01134042|528487521|FG001|Overall Study|Lack of Efficacy|6|||
146540092|NCT01134042|528487522|FG002|Overall Study|Lack of Efficacy|18|||
146540093|NCT01134042|528487520|FG000|Overall Study|Protocol Violation|5|||
146540094|NCT01134042|528487521|FG001|Overall Study|Protocol Violation|3|||
146540095|NCT01134042|528487522|FG002|Overall Study|Protocol Violation|5|||
146540096|NCT01134042|528487520|FG000|Overall Study|Lost to Follow-up|2|||
146540097|NCT01134042|528487521|FG001|Overall Study|Lost to Follow-up|0|||
146540098|NCT01134042|528487522|FG002|Overall Study|Lost to Follow-up|1|||
146540099|NCT01134042|528487520|FG000|Overall Study|Physician Decision|4|||
146540100|NCT01134042|528487521|FG001|Overall Study|Physician Decision|8|||
146540101|NCT01134042|528487522|FG002|Overall Study|Physician Decision|1|||
146540102|NCT01134042|528487520|FG000|Overall Study|Withdrawal by Subject|13|||
146540103|NCT01134042|528487521|FG001|Overall Study|Withdrawal by Subject|4|||
146540104|NCT01134042|528487522|FG002|Overall Study|Withdrawal by Subject|7|||
146540105|NCT05350423|528487525|FG000|Overall Study|Lost to Follow-up|3|||
146540106|NCT05350423|528487526|FG001|Overall Study|Lost to Follow-up|3|||
146540107|NCT05350423|528487525|FG000|Overall Study|screen failure|5|||
146540108|NCT05350423|528487526|FG001|Overall Study|screen failure|6|||
146540109|NCT02097277|528487531|FG000|Overall Study|Subject no longer meets study criteria|0|||
146540110|NCT02097277|528487532|FG001|Overall Study|Subject no longer meets study criteria|1|||
146540111|NCT02097277|528487533|FG002|Overall Study|Subject no longer meets study criteria|0|||
146764158|NCT00906698|529302993|FG005|Overall Study|Adverse Event|1|||
146540112|NCT02097277|528487534|FG003|Overall Study|Subject no longer meets study criteria|1|||
146540113|NCT02097277|528487535|FG004|Overall Study|Subject no longer meets study criteria|0|||
146540114|NCT02097277|528487531|FG000|Overall Study|Subject request to discontinue treatment|0|||
146540115|NCT02097277|528487532|FG001|Overall Study|Subject request to discontinue treatment|0|||
146540116|NCT02097277|528487533|FG002|Overall Study|Subject request to discontinue treatment|0|||
146540117|NCT02097277|528487534|FG003|Overall Study|Subject request to discontinue treatment|0|||
146540118|NCT02097277|528487535|FG004|Overall Study|Subject request to discontinue treatment|1|||
146540119|NCT02097277|528487531|FG000|Overall Study|Lost to Follow-up|0|||
146540120|NCT02097277|528487532|FG001|Overall Study|Lost to Follow-up|1|||
146540121|NCT02097277|528487533|FG002|Overall Study|Lost to Follow-up|1|||
146540122|NCT02097277|528487534|FG003|Overall Study|Lost to Follow-up|0|||
146540123|NCT02097277|528487535|FG004|Overall Study|Lost to Follow-up|0|||
146764159|NCT00906698|529302988|FG000|Overall Study|Disease progression|3|||
146764160|NCT00906698|529302989|FG001|Overall Study|Disease progression|12|||
146764161|NCT00906698|529302990|FG002|Overall Study|Disease progression|4|||
146764162|NCT00906698|529302991|FG003|Overall Study|Disease progression|4|||
146540124|NCT02097277|528487531|FG000|Overall Study|Withdrawal by Subject|2|||
146540125|NCT02097277|528487532|FG001|Overall Study|Withdrawal by Subject|1|||
146540126|NCT02097277|528487533|FG002|Overall Study|Withdrawal by Subject|0|||
146540127|NCT02097277|528487534|FG003|Overall Study|Withdrawal by Subject|1|||
146540128|NCT02097277|528487535|FG004|Overall Study|Withdrawal by Subject|0|||
146540129|NCT02097277|528487531|FG000|Overall Study|Adverse Event|0|||
146540130|NCT02097277|528487532|FG001|Overall Study|Adverse Event|0|||
146540131|NCT02097277|528487533|FG002|Overall Study|Adverse Event|1|||
146540132|NCT02097277|528487534|FG003|Overall Study|Adverse Event|2|||
146540133|NCT02097277|528487535|FG004|Overall Study|Adverse Event|0|||
146540134|NCT01091259|528487539|FG000|Overall Study|Adverse Event|3|||
146540135|NCT01091259|528487539|FG000|Overall Study|Lack of Efficacy|2|||
146540136|NCT03320369|528487540|FG000|Overall Study|Adverse Event|1|||
146540137|NCT03320369|528487540|FG000|Overall Study|Withdrawal by Subject|2|||
146540138|NCT01137786|528487543|FG000|Overall Study|Lost to Follow-up|0|||
146540139|NCT01137786|528487544|FG001|Overall Study|Lost to Follow-up|2|||
146540140|NCT01137786|528487543|FG000|Overall Study|Withdrawal by Subject|1|||
146540141|NCT01137786|528487544|FG001|Overall Study|Withdrawal by Subject|1|||
146540142|NCT00770367|528487545|FG000|First Intervention|Withdrawal by Subject|0|||
146540143|NCT00770367|528487546|FG001|First Intervention|Withdrawal by Subject|2|||
146540144|NCT00770367|528487545|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
146764163|NCT00906698|529302992|FG004|Overall Study|Disease progression|12|||
146540145|NCT00770367|528487546|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
146764164|NCT00906698|529302993|FG005|Overall Study|Disease progression|4|||
146764165|NCT00906698|529302988|FG000|Overall Study|Withdrawal by Subject|0|||
146540146|NCT00770367|528487545|FG000|Second Intervention|Lost to Follow-up|2|||
146540147|NCT00770367|528487546|FG001|Second Intervention|Lost to Follow-up|0|||
146540148|NCT04727749|528487547|FG000|Overall Study|Lost to Follow-up|10|||
146540149|NCT04727749|528487548|FG001|Overall Study|Lost to Follow-up|3|||
146540150|NCT00716417|528487550|FG000|Overall Study|Adverse Event|0|||
146540151|NCT00716417|528487551|FG001|Overall Study|Adverse Event|0|||
146872004|NCT06156215|529701527|FG003|Overall Study|Became or found ineligible|0|||
146872005|NCT06156215|529701528|FG004|Overall Study|Became or found ineligible|1|||
146872006|NCT06156215|529701529|FG005|Overall Study|Became or found ineligible|2|||
146872007|NCT05050318|529703104|FG000|Overall Study|Protocol Deviation|1|||
146872008|NCT05050318|529703105|FG001|Overall Study|Protocol Deviation|0|||
146872009|NCT05050318|529703106|FG002|Overall Study|Protocol Deviation|0|||
146872010|NCT00574145|529703112|FG000|Overall Study|Withdrawal by Subject|2|||
146872011|NCT00574145|529703113|FG001|Overall Study|Withdrawal by Subject|1|||
146872012|NCT03227471|529703114|FG000|Overall Study|Withdrawal by Subject|0|||
146540152|NCT00716417|528487552|FG002|Overall Study|Adverse Event|2|||
146540153|NCT00716417|528487553|FG003|Overall Study|Adverse Event|1|||
146540154|NCT00716417|528487554|FG004|Overall Study|Adverse Event|0|||
146540155|NCT00716417|528487555|FG005|Overall Study|Adverse Event|0|||
146540156|NCT00716417|528487556|FG006|Overall Study|Adverse Event|3|||
146872013|NCT03227471|529703115|FG001|Overall Study|Withdrawal by Subject|0|||
146872014|NCT03227471|529703116|FG002|Overall Study|Withdrawal by Subject|0|||
146872015|NCT03227471|529703117|FG003|Overall Study|Withdrawal by Subject|0|||
146872016|NCT03227471|529703118|FG004|Overall Study|Withdrawal by Subject|1|||
146872017|NCT03227471|529703119|FG005|Overall Study|Withdrawal by Subject|0|||
146540157|NCT00716417|528487557|FG007|Overall Study|Adverse Event|1|||
146540158|NCT00716417|528487558|FG008|Overall Study|Adverse Event|0|||
146872018|NCT03227471|529703120|FG006|Overall Study|Withdrawal by Subject|0|||
146872019|NCT03227471|529703121|FG007|Overall Study|Withdrawal by Subject|0|||
146872020|NCT03227471|529703122|FG008|Overall Study|Withdrawal by Subject|0|||
146872021|NCT03227471|529703123|FG009|Overall Study|Withdrawal by Subject|0|||
146540159|NCT00716417|528487559|FG009|Overall Study|Adverse Event|3|||
146540160|NCT00716417|528487550|FG000|Overall Study|Withdrawal by Subject|0|||
146540161|NCT00716417|528487551|FG001|Overall Study|Withdrawal by Subject|1|||
146540162|NCT00716417|528487552|FG002|Overall Study|Withdrawal by Subject|0|||
146540163|NCT00716417|528487553|FG003|Overall Study|Withdrawal by Subject|2|||
146540164|NCT00716417|528487554|FG004|Overall Study|Withdrawal by Subject|0|||
146540165|NCT00716417|528487555|FG005|Overall Study|Withdrawal by Subject|0|||
146540166|NCT00716417|528487556|FG006|Overall Study|Withdrawal by Subject|1|||
146540167|NCT00716417|528487557|FG007|Overall Study|Withdrawal by Subject|0|||
146540168|NCT00716417|528487558|FG008|Overall Study|Withdrawal by Subject|0|||
146540169|NCT00716417|528487559|FG009|Overall Study|Withdrawal by Subject|0|||
146540170|NCT00716417|528487550|FG000|Overall Study|Progressive disease|3|||
146540171|NCT00716417|528487551|FG001|Overall Study|Progressive disease|5|||
146540172|NCT00716417|528487552|FG002|Overall Study|Progressive disease|3|||
146540173|NCT00716417|528487553|FG003|Overall Study|Progressive disease|8|||
146540174|NCT00716417|528487554|FG004|Overall Study|Progressive disease|0|||
146540175|NCT00716417|528487555|FG005|Overall Study|Progressive disease|3|||
146540176|NCT00716417|528487556|FG006|Overall Study|Progressive disease|3|||
146540177|NCT00716417|528487557|FG007|Overall Study|Progressive disease|1|||
146540178|NCT00716417|528487558|FG008|Overall Study|Progressive disease|5|||
146540179|NCT00716417|528487559|FG009|Overall Study|Progressive disease|0|||
146540180|NCT00716417|528487550|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
146540181|NCT00716417|528487551|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
146540182|NCT00716417|528487552|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
146540183|NCT00716417|528487553|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
146540184|NCT00716417|528487554|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
146540185|NCT00716417|528487555|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
146540186|NCT00716417|528487556|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
146540187|NCT00716417|528487557|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
146540188|NCT00716417|528487558|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
146540189|NCT00716417|528487559|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
146540190|NCT00716417|528487550|FG000|Overall Study|On patient request due to toxicities|0|||
146540191|NCT00716417|528487551|FG001|Overall Study|On patient request due to toxicities|0|||
146540192|NCT00716417|528487552|FG002|Overall Study|On patient request due to toxicities|0|||
146540193|NCT00716417|528487553|FG003|Overall Study|On patient request due to toxicities|0|||
146540194|NCT00716417|528487554|FG004|Overall Study|On patient request due to toxicities|0|||
146540195|NCT00716417|528487555|FG005|Overall Study|On patient request due to toxicities|0|||
146540196|NCT00716417|528487556|FG006|Overall Study|On patient request due to toxicities|0|||
146540197|NCT00716417|528487557|FG007|Overall Study|On patient request due to toxicities|1|||
146540198|NCT00716417|528487558|FG008|Overall Study|On patient request due to toxicities|0|||
146540199|NCT00716417|528487559|FG009|Overall Study|On patient request due to toxicities|0|||
146540200|NCT01138046|528487562|FG000|Overall Study|Withdrawal due to death|6|||
146540201|NCT03839641|528487566|FG000|Overall Study|Withdrawal by Subject|1|||
146540202|NCT03839641|528487567|FG001|Overall Study|Withdrawal by Subject|1|||
146540203|NCT04221490|528487568|FG000|At 30 Days Follow-up|Death|7|||
146540204|NCT04221490|528487568|FG000|At 30 Days Follow-up|Missed Visit|4|||
146540205|NCT04221490|528487568|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
146540206|NCT04221490|528487568|FG000|At 6 Months Follow-up|Death|9|||
146540207|NCT04221490|528487568|FG000|At 6 Months Follow-up|Physician Decision|1|||
146540208|NCT04221490|528487568|FG000|At 6 Months Follow-up|Missed Visit|8|||
146540209|NCT04221490|528487568|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
146540210|NCT03765073|528487569|FG000|Stage 1|Lost to Follow-up|1|||
146540211|NCT03765073|528487570|FG001|Stage 1|Lost to Follow-up|0|||
146540212|NCT03765073|528487571|FG002|Stage 1|Lost to Follow-up|0|||
146540213|NCT03765073|528487572|FG003|Stage 1|Lost to Follow-up|0|||
146540214|NCT03765073|528487573|FG004|Stage 1|Lost to Follow-up|0|||
146540215|NCT03765073|528487574|FG005|Stage 1|Lost to Follow-up|0|||
146540216|NCT03765073|528487575|FG006|Stage 1|Lost to Follow-up|0|||
146540217|NCT03765073|528487576|FG007|Stage 1|Lost to Follow-up|0|||
146540218|NCT03765073|528487577|FG008|Stage 1|Lost to Follow-up|0|||
146540219|NCT03765073|528487578|FG009|Stage 1|Lost to Follow-up|0|||
146540220|NCT03765073|528487579|FG010|Stage 1|Lost to Follow-up|0|||
146540221|NCT03765073|528487580|FG011|Stage 1|Lost to Follow-up|0|||
146872022|NCT03227471|529703124|FG010|Overall Study|Withdrawal by Subject|0|||
146872023|NCT03227471|529703125|FG011|Overall Study|Withdrawal by Subject|0|||
146872024|NCT03227471|529703126|FG012|Overall Study|Withdrawal by Subject|1|||
146872025|NCT03227471|529703127|FG013|Overall Study|Withdrawal by Subject|0|||
146540222|NCT03765073|528487581|FG012|Stage 1|Lost to Follow-up|0|||
146540223|NCT03765073|528487582|FG013|Stage 1|Lost to Follow-up|0|||
146540224|NCT03765073|528487583|FG014|Stage 1|Lost to Follow-up|0|||
146540225|NCT03765073|528487584|FG015|Stage 1|Lost to Follow-up|0|||
146540226|NCT03765073|528487585|FG016|Stage 1|Lost to Follow-up|0|||
146872026|NCT03227471|529703128|FG014|Overall Study|Withdrawal by Subject|0|||
146540227|NCT03765073|528487586|FG017|Stage 1|Lost to Follow-up|0|||
146540228|NCT03765073|528487587|FG018|Stage 1|Lost to Follow-up|0|||
146540229|NCT03765073|528487588|FG019|Stage 1|Lost to Follow-up|0|||
146872027|NCT03227471|529703114|FG000|Overall Study|Randomized, Never Dosed|0|||
146627635|NCT02163538|528811835|FG000|Overall Study|Physician Decision|0|||
146627636|NCT02163538|528811836|FG001|Overall Study|Physician Decision|1|||
146627637|NCT04484961|528811839|FG000|Overall Study|Lost to Follow-up|9|||
146627638|NCT04484961|528811840|FG001|Overall Study|Lost to Follow-up|9|||
146627639|NCT00388349|528811841|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
146627640|NCT00388349|528811842|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
146627641|NCT01345240|528811846|FG000|Overall Study|Adverse Event|3|||
146627642|NCT01345240|528811847|FG001|Overall Study|Adverse Event|5|||
146627643|NCT01345240|528811848|FG002|Overall Study|Adverse Event|4|||
146627644|NCT01345240|528811849|FG003|Overall Study|Adverse Event|2|||
146627645|NCT01345240|528811850|FG004|Overall Study|Adverse Event|1|||
146627646|NCT01345240|528811846|FG000|Overall Study|Lost to Follow-up|8|||
146627647|NCT01345240|528811847|FG001|Overall Study|Lost to Follow-up|9|||
146627648|NCT01345240|528811848|FG002|Overall Study|Lost to Follow-up|14|||
146627649|NCT01345240|528811849|FG003|Overall Study|Lost to Follow-up|7|||
146627650|NCT01345240|528811850|FG004|Overall Study|Lost to Follow-up|9|||
146627651|NCT04011540|528811851|FG000|Overall Study|Lost to Follow-up|9|||
146627652|NCT04011540|528811852|FG001|Overall Study|Lost to Follow-up|6|||
146627653|NCT01502293|528811853|FG000|Overall Study|Progressive Disease|20|||
146627654|NCT01502293|528811854|FG001|Overall Study|Progressive Disease|12|||
146627655|NCT01502293|528811855|FG002|Overall Study|Progressive Disease|2|||
146627656|NCT01502293|528811853|FG000|Overall Study|Withdrawal by Subject|3|||
146627657|NCT01502293|528811854|FG001|Overall Study|Withdrawal by Subject|3|||
146627658|NCT01502293|528811855|FG002|Overall Study|Withdrawal by Subject|1|||
146627659|NCT01502293|528811853|FG000|Overall Study|Adverse Event|0|||
146627660|NCT01502293|528811854|FG001|Overall Study|Adverse Event|2|||
146627661|NCT01502293|528811855|FG002|Overall Study|Adverse Event|0|||
146627662|NCT01502293|528811853|FG000|Overall Study|Reason Not Specified|2|||
146627663|NCT01502293|528811854|FG001|Overall Study|Reason Not Specified|0|||
146627664|NCT01502293|528811855|FG002|Overall Study|Reason Not Specified|0|||
146627665|NCT01502293|528811853|FG000|Overall Study|Physician Decision|0|||
146627666|NCT01502293|528811854|FG001|Overall Study|Physician Decision|0|||
146627667|NCT01502293|528811855|FG002|Overall Study|Physician Decision|1|||
146627668|NCT01339832|528811861|FG000|Overall Study|Lost to Follow-up|3|||
146627669|NCT01339832|528811861|FG000|Overall Study|Death|11|||
146627670|NCT00231816|528811862|FG000|Overall Study|Adverse Event|1|||
146627671|NCT00231816|528811863|FG001|Overall Study|Adverse Event|0|||
146627672|NCT00231816|528811862|FG000|Overall Study|Lost to Follow-up|8|||
146627673|NCT00231816|528811863|FG001|Overall Study|Lost to Follow-up|5|||
146627674|NCT00231816|528811862|FG000|Overall Study|Protocol Violation|2|||
146627675|NCT00231816|528811863|FG001|Overall Study|Protocol Violation|3|||
146627676|NCT00231816|528811862|FG000|Overall Study|Withdrawal by Subject|3|||
146627677|NCT00231816|528811863|FG001|Overall Study|Withdrawal by Subject|3|||
146627678|NCT00231816|528811862|FG000|Overall Study|Other|2|||
146627679|NCT00231816|528811863|FG001|Overall Study|Other|1|||
146627680|NCT00774046|528811864|FG000|Screening|Not eligible|56|||
146627681|NCT00774046|528811864|FG000|Enrollment|Desired other therapy/refused|28|||
146627682|NCT00774046|528811864|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
146627683|NCT05498649|528811865|FG000|Overall Study|Lost to Follow-up|1|||
146627684|NCT04609319|528811866|FG000|Overall Study|Death|64|||
146627685|NCT04609319|528811867|FG001|Overall Study|Death|49|||
146627686|NCT04609319|528811868|FG002|Overall Study|Death|1|||
146627687|NCT04609319|528811866|FG000|Overall Study|Withdrawal of consent|15|||
146627688|NCT04609319|528811867|FG001|Overall Study|Withdrawal of consent|3|||
146627689|NCT04609319|528811868|FG002|Overall Study|Withdrawal of consent|0|||
146627690|NCT04609319|528811866|FG000|Overall Study|Lost to Follow-up|20|||
146627691|NCT04609319|528811867|FG001|Overall Study|Lost to Follow-up|33|||
146627692|NCT04609319|528811868|FG002|Overall Study|Lost to Follow-up|0|||
146627693|NCT04609319|528811866|FG000|Overall Study|Alive until end of follow-up|60|||
146627694|NCT04609319|528811867|FG001|Overall Study|Alive until end of follow-up|53|||
146627695|NCT04609319|528811868|FG002|Overall Study|Alive until end of follow-up|1|||
146627696|NCT03804528|528811869|FG000|Overall Study|Time Commitment|18|||
146627697|NCT03804528|528811869|FG000|Overall Study|Health Reasons|5|||
146627698|NCT04607005|528811870|FG000|Overall Study|Adverse Event|0|||
146627699|NCT04607005|528811871|FG001|Overall Study|Adverse Event|1|||
146627700|NCT04607005|528811870|FG000|Overall Study|Lack of Efficacy|1|||
146627701|NCT04607005|528811871|FG001|Overall Study|Lack of Efficacy|6|||
146627702|NCT04607005|528811870|FG000|Overall Study|Withdrawal by Subject|4|||
146627703|NCT04607005|528811871|FG001|Overall Study|Withdrawal by Subject|9|||
146627704|NCT04607005|528811870|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
146627705|NCT04607005|528811871|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
146627706|NCT00668148|528811872|FG000|Overall Study|Adverse Event|5|||
146627707|NCT00668148|528811872|FG000|Overall Study|Subject Non-compliance|1|||
146627708|NCT00668148|528811872|FG000|Overall Study|Progressive Disease Before Treatment|2|||
146627709|NCT00668148|528811872|FG000|Overall Study|Withdrawal of Consent|2|||
146627710|NCT04944992|528813444|FG000|Overall Study|Lost to Follow-up|1|||
146627711|NCT04944992|528813445|FG001|Overall Study|Lost to Follow-up|1|||
146627712|NCT04944992|528813444|FG000|Overall Study|Physician Decision|1|||
146540230|NCT03765073|528487589|FG020|Stage 1|Lost to Follow-up|0|||
146540231|NCT03765073|528487569|FG000|Stage 1|Withdrawal by participant|0|||
146540232|NCT03765073|528487570|FG001|Stage 1|Withdrawal by participant|1|||
146540233|NCT03765073|528487571|FG002|Stage 1|Withdrawal by participant|0|||
146540234|NCT03765073|528487572|FG003|Stage 1|Withdrawal by participant|0|||
146540235|NCT03765073|528487573|FG004|Stage 1|Withdrawal by participant|0|||
146540236|NCT03765073|528487574|FG005|Stage 1|Withdrawal by participant|0|||
146540237|NCT03765073|528487575|FG006|Stage 1|Withdrawal by participant|0|||
146540238|NCT03765073|528487576|FG007|Stage 1|Withdrawal by participant|0|||
146540239|NCT03765073|528487577|FG008|Stage 1|Withdrawal by participant|0|||
146540240|NCT03765073|528487578|FG009|Stage 1|Withdrawal by participant|0|||
146540241|NCT03765073|528487579|FG010|Stage 1|Withdrawal by participant|0|||
146540242|NCT03765073|528487580|FG011|Stage 1|Withdrawal by participant|0|||
146540243|NCT03765073|528487581|FG012|Stage 1|Withdrawal by participant|0|||
146540244|NCT03765073|528487582|FG013|Stage 1|Withdrawal by participant|0|||
146540245|NCT03765073|528487583|FG014|Stage 1|Withdrawal by participant|0|||
146540246|NCT03765073|528487584|FG015|Stage 1|Withdrawal by participant|0|||
146540247|NCT03765073|528487585|FG016|Stage 1|Withdrawal by participant|0|||
146540248|NCT03765073|528487586|FG017|Stage 1|Withdrawal by participant|0|||
146540249|NCT03765073|528487587|FG018|Stage 1|Withdrawal by participant|0|||
146540250|NCT03765073|528487588|FG019|Stage 1|Withdrawal by participant|0|||
146540251|NCT03765073|528487589|FG020|Stage 1|Withdrawal by participant|0|||
146540252|NCT03765073|528487569|FG000|Stage 2|Death|0|||
146540253|NCT03765073|528487570|FG001|Stage 2|Death|0|||
146540254|NCT03765073|528487571|FG002|Stage 2|Death|0|||
146540255|NCT03765073|528487572|FG003|Stage 2|Death|0|||
146540256|NCT03765073|528487573|FG004|Stage 2|Death|0|||
146540257|NCT03765073|528487574|FG005|Stage 2|Death|0|||
146540258|NCT03765073|528487575|FG006|Stage 2|Death|0|||
146540259|NCT03765073|528487576|FG007|Stage 2|Death|0|||
146540260|NCT03765073|528487577|FG008|Stage 2|Death|0|||
146540261|NCT03765073|528487578|FG009|Stage 2|Death|1|||
146540262|NCT03765073|528487579|FG010|Stage 2|Death|0|||
146540263|NCT03765073|528487580|FG011|Stage 2|Death|1|||
146540264|NCT03765073|528487581|FG012|Stage 2|Death|0|||
146540265|NCT03765073|528487582|FG013|Stage 2|Death|0|||
146540266|NCT03765073|528487583|FG014|Stage 2|Death|0|||
146540267|NCT03765073|528487584|FG015|Stage 2|Death|0|||
146540268|NCT03765073|528487585|FG016|Stage 2|Death|2|||
146540269|NCT03765073|528487586|FG017|Stage 2|Death|0|||
146540270|NCT03765073|528487587|FG018|Stage 2|Death|0|||
146540271|NCT03765073|528487588|FG019|Stage 2|Death|0|||
146540272|NCT03765073|528487589|FG020|Stage 2|Death|0|||
146540273|NCT03765073|528487569|FG000|Stage 2|Lost to Follow-up|0|||
146540274|NCT03765073|528487570|FG001|Stage 2|Lost to Follow-up|0|||
146540275|NCT03765073|528487571|FG002|Stage 2|Lost to Follow-up|0|||
146540276|NCT03765073|528487572|FG003|Stage 2|Lost to Follow-up|5|||
146540277|NCT03765073|528487573|FG004|Stage 2|Lost to Follow-up|1|||
146540278|NCT03765073|528487574|FG005|Stage 2|Lost to Follow-up|0|||
146966072|NCT00828009|530036570|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
146966073|NCT00828009|530036570|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
146966074|NCT00828009|530036570|FG000|Step 2 - Maintenance Therapy|Other|1|||
146966075|NCT04814654|530036573|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
146966076|NCT04814654|530036574|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
146966077|NCT04814654|530036575|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
146966078|NCT02207413|530036578|FG000|Overall Study|Withdrawal by Subject|1|||
146966079|NCT02207413|530036579|FG001|Overall Study|Withdrawal by Subject|0|||
146966080|NCT02207413|530036580|FG002|Overall Study|Withdrawal by Subject|0|||
146966081|NCT02207413|530036581|FG003|Overall Study|Withdrawal by Subject|0|||
146966082|NCT02207413|530036582|FG004|Overall Study|Withdrawal by Subject|3|||
146966083|NCT02207413|530036583|FG005|Overall Study|Withdrawal by Subject|7|||
146966084|NCT02207413|530036578|FG000|Overall Study|Lost to Follow-up|0|||
146966085|NCT02207413|530036579|FG001|Overall Study|Lost to Follow-up|0|||
146966086|NCT02207413|530036580|FG002|Overall Study|Lost to Follow-up|0|||
146966087|NCT02207413|530036581|FG003|Overall Study|Lost to Follow-up|1|||
146966088|NCT02207413|530036582|FG004|Overall Study|Lost to Follow-up|1|||
146966089|NCT02207413|530036583|FG005|Overall Study|Lost to Follow-up|5|||
146966090|NCT02207413|530036578|FG000|Overall Study|Adverse Event|0|||
146966091|NCT02207413|530036579|FG001|Overall Study|Adverse Event|0|||
146966092|NCT02207413|530036580|FG002|Overall Study|Adverse Event|0|||
146966093|NCT02207413|530036581|FG003|Overall Study|Adverse Event|0|||
146966094|NCT02207413|530036582|FG004|Overall Study|Adverse Event|2|||
146540279|NCT03765073|528487575|FG006|Stage 2|Lost to Follow-up|3|||
146540280|NCT03765073|528487576|FG007|Stage 2|Lost to Follow-up|3|||
146540281|NCT03765073|528487577|FG008|Stage 2|Lost to Follow-up|1|||
146540282|NCT03765073|528487578|FG009|Stage 2|Lost to Follow-up|6|||
146627713|NCT04944992|528813445|FG001|Overall Study|Physician Decision|0|||
146540283|NCT03765073|528487579|FG010|Stage 2|Lost to Follow-up|5|||
146540284|NCT03765073|528487580|FG011|Stage 2|Lost to Follow-up|1|||
146540285|NCT03765073|528487581|FG012|Stage 2|Lost to Follow-up|1|||
146540286|NCT03765073|528487582|FG013|Stage 2|Lost to Follow-up|3|||
146540287|NCT03765073|528487583|FG014|Stage 2|Lost to Follow-up|3|||
146627714|NCT04944992|528813444|FG000|Overall Study|Withdrawal by Subject|6|||
146627715|NCT04944992|528813445|FG001|Overall Study|Withdrawal by Subject|1|||
146627716|NCT00303069|528813446|FG000|Overall Study|Lost to Follow-up|1|||
146627717|NCT00303069|528813447|FG001|Overall Study|Lost to Follow-up|0|||
146627718|NCT00303069|528813448|FG002|Overall Study|Lost to Follow-up|0|||
146627719|NCT00303069|528813449|FG003|Overall Study|Lost to Follow-up|2|||
146627720|NCT00303069|528813446|FG000|Overall Study|subject moved|1|||
146627721|NCT00303069|528813447|FG001|Overall Study|subject moved|0|||
146627722|NCT00303069|528813448|FG002|Overall Study|subject moved|0|||
146627723|NCT00303069|528813449|FG003|Overall Study|subject moved|0|||
146627724|NCT00303069|528813446|FG000|Overall Study|Recruitment into Army Reserves|0|||
146627725|NCT00303069|528813447|FG001|Overall Study|Recruitment into Army Reserves|0|||
146627726|NCT00303069|528813448|FG002|Overall Study|Recruitment into Army Reserves|1|||
146627727|NCT00303069|528813449|FG003|Overall Study|Recruitment into Army Reserves|0|||
146627728|NCT01972217|528813452|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
146627729|NCT01972217|528813453|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
146627730|NCT01972217|528813454|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
146627731|NCT01972217|528813455|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
146627732|NCT01972217|528813452|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
146627733|NCT01972217|528813453|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
146627734|NCT01972217|528813454|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
146627735|NCT01972217|528813455|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
146627736|NCT01972217|528813452|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
146627737|NCT01972217|528813453|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
146627738|NCT01972217|528813454|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
146627739|NCT01972217|528813455|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
146627740|NCT01972217|528813452|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
146627741|NCT01972217|528813453|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
146627742|NCT01972217|528813454|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
146627743|NCT01972217|528813455|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
146627744|NCT01972217|528813452|FG000|Part B Double-blind, Randomised Period|Death|0|||
146627745|NCT01972217|528813453|FG001|Part B Double-blind, Randomised Period|Death|0|||
146627746|NCT01972217|528813454|FG002|Part B Double-blind, Randomised Period|Death|43|||
146627747|NCT01972217|528813455|FG003|Part B Double-blind, Randomised Period|Death|44|||
146627748|NCT01972217|528813452|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
146627749|NCT01972217|528813453|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
146627750|NCT01972217|528813454|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
146627751|NCT01972217|528813455|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
146627752|NCT01972217|528813452|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
146627753|NCT01972217|528813453|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
146627754|NCT01972217|528813454|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
146627755|NCT01972217|528813455|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
146627756|NCT01972217|528813452|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
146627757|NCT01972217|528813453|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
146627758|NCT01972217|528813454|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
146627759|NCT01972217|528813455|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
146627760|NCT01972217|528813452|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
146627761|NCT01972217|528813453|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
146627762|NCT01972217|528813454|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
146627763|NCT01972217|528813455|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
146627764|NCT04328077|528813457|FG000|Overall Study|Lost to Follow-up|0|||
146627765|NCT04328077|528813458|FG001|Overall Study|Lost to Follow-up|1|||
146627766|NCT04328077|528813459|FG002|Overall Study|Lost to Follow-up|0|||
146627767|NCT04328077|528813460|FG003|Overall Study|Lost to Follow-up|0|||
146627768|NCT04328077|528813457|FG000|Overall Study|Withdrawal by Subject|0|||
146627769|NCT04328077|528813458|FG001|Overall Study|Withdrawal by Subject|1|||
146627770|NCT04328077|528813459|FG002|Overall Study|Withdrawal by Subject|1|||
146627771|NCT04328077|528813460|FG003|Overall Study|Withdrawal by Subject|3|||
146627772|NCT01456039|528813461|FG000|Phase 1 (First Step)|Disease Progression|1|||
146627773|NCT01456039|528813462|FG001|Phase 1 (First Step)|Disease Progression|1|||
146627774|NCT01456039|528813463|FG002|Phase 1 (First Step)|Disease Progression|0|||
146627775|NCT01456039|528813461|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
146627776|NCT01456039|528813462|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
146627777|NCT01456039|528813463|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
146627778|NCT01456039|528813461|FG000|Phase 1 (First Step)|Adverse Event|0|||
146627779|NCT01456039|528813462|FG001|Phase 1 (First Step)|Adverse Event|3|||
146627780|NCT01456039|528813463|FG002|Phase 1 (First Step)|Adverse Event|0|||
146627781|NCT01456039|528813461|FG000|Phase 1 (First Step)|Other|0|||
146627782|NCT01456039|528813462|FG001|Phase 1 (First Step)|Other|1|||
146627783|NCT01456039|528813463|FG002|Phase 1 (First Step)|Other|0|||
146627784|NCT01456039|528813461|FG000|Phase 2 (Second Step)|Disease Progression|0|||
146627785|NCT01456039|528813462|FG001|Phase 2 (Second Step)|Disease Progression|0|||
146627786|NCT01456039|528813463|FG002|Phase 2 (Second Step)|Disease Progression|17|||
146627787|NCT01456039|528813461|FG000|Phase 2 (Second Step)|Adverse Event|0|||
146627788|NCT01456039|528813462|FG001|Phase 2 (Second Step)|Adverse Event|0|||
146627789|NCT01456039|528813463|FG002|Phase 2 (Second Step)|Adverse Event|10|||
146627790|NCT01456039|528813461|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
146627791|NCT01456039|528813462|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
146627792|NCT01456039|528813463|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
146966095|NCT02207413|530036583|FG005|Overall Study|Adverse Event|1|||
146966096|NCT02207413|530036578|FG000|Overall Study|Migrated/moved from study area|0|||
146966097|NCT02207413|530036579|FG001|Overall Study|Migrated/moved from study area|0|||
146966098|NCT02207413|530036580|FG002|Overall Study|Migrated/moved from study area|0|||
146966099|NCT02207413|530036581|FG003|Overall Study|Migrated/moved from study area|0|||
146966100|NCT02207413|530036582|FG004|Overall Study|Migrated/moved from study area|1|||
146966101|NCT02207413|530036583|FG005|Overall Study|Migrated/moved from study area|0|||
146966102|NCT05102162|530038751|FG000|Overall Study|Withdrawal by Subject|3|||
146966103|NCT05102162|530038752|FG001|Overall Study|Withdrawal by Subject|0|||
146966104|NCT05102162|530038751|FG000|Overall Study|Baseline cultures negative|4|||
146966105|NCT05102162|530038752|FG001|Overall Study|Baseline cultures negative|2|||
146966106|NCT05102162|530038751|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
146966107|NCT05102162|530038752|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
146966108|NCT05102162|530038751|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
146627793|NCT01456039|528813461|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
146627794|NCT01456039|528813462|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
146627795|NCT01456039|528813463|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
146627796|NCT01456039|528813461|FG000|Phase 2 (Second Step)|Other|0|||
146627797|NCT01456039|528813462|FG001|Phase 2 (Second Step)|Other|0|||
146627798|NCT01456039|528813463|FG002|Phase 2 (Second Step)|Other|1|||
146627799|NCT00335777|528813466|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
146627800|NCT00335777|528813466|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
146627801|NCT00335777|528813466|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
146627802|NCT00335777|528813466|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
146627803|NCT00335777|528813466|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
146627804|NCT00939393|528813474|FG000|Overall Study|Withdrawal by Subject|1|||
146627805|NCT00939393|528813475|FG001|Overall Study|Withdrawal by Subject|0|||
146966109|NCT05102162|530038752|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
146966110|NCT02871921|530038755|FG000|Overall Study|Withdrawal by Subject|34|||
146966111|NCT02871921|530038756|FG001|Overall Study|Withdrawal by Subject|27|||
146966112|NCT02871921|530038757|FG002|Overall Study|Withdrawal by Subject|27|||
146966113|NCT02871921|530038758|FG003|Overall Study|Withdrawal by Subject|30|||
146966114|NCT00320801|530038759|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
146966115|NCT00320801|530038760|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
146966116|NCT00320801|530038761|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
146966117|NCT00320801|530038762|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
146966118|NCT00320801|530038759|FG000|Open-label Run-in Period|Adverse Event|33|||
146966119|NCT00320801|530038760|FG001|Open-label Run-in Period|Adverse Event|0|||
146966120|NCT00320801|530038761|FG002|Open-label Run-in Period|Adverse Event|0|||
146966121|NCT00320801|530038762|FG003|Open-label Run-in Period|Adverse Event|0|||
146966122|NCT00320801|530038759|FG000|Open-label Run-in Period|Administrative|10|||
146966123|NCT00320801|530038760|FG001|Open-label Run-in Period|Administrative|0|||
146966124|NCT00320801|530038761|FG002|Open-label Run-in Period|Administrative|0|||
146966125|NCT00320801|530038762|FG003|Open-label Run-in Period|Administrative|0|||
146966126|NCT00320801|530038759|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
146966127|NCT00320801|530038760|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
146966128|NCT00320801|530038761|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
146540288|NCT03765073|528487584|FG015|Stage 2|Lost to Follow-up|1|||
146540289|NCT03765073|528487585|FG016|Stage 2|Lost to Follow-up|6|||
146540290|NCT03765073|528487586|FG017|Stage 2|Lost to Follow-up|0|||
146540291|NCT03765073|528487587|FG018|Stage 2|Lost to Follow-up|0|||
146540292|NCT03765073|528487588|FG019|Stage 2|Lost to Follow-up|0|||
146540293|NCT03765073|528487589|FG020|Stage 2|Lost to Follow-up|0|||
146540294|NCT03765073|528487569|FG000|Stage 2|Other|0|||
146540295|NCT03765073|528487570|FG001|Stage 2|Other|0|||
146540296|NCT03765073|528487571|FG002|Stage 2|Other|0|||
146540297|NCT03765073|528487572|FG003|Stage 2|Other|0|||
146540298|NCT03765073|528487573|FG004|Stage 2|Other|0|||
146540299|NCT03765073|528487574|FG005|Stage 2|Other|0|||
146540300|NCT03765073|528487575|FG006|Stage 2|Other|0|||
146540301|NCT03765073|528487576|FG007|Stage 2|Other|1|||
146540302|NCT03765073|528487577|FG008|Stage 2|Other|1|||
146540303|NCT03765073|528487578|FG009|Stage 2|Other|3|||
146540304|NCT03765073|528487579|FG010|Stage 2|Other|0|||
146540305|NCT03765073|528487580|FG011|Stage 2|Other|0|||
146540306|NCT03765073|528487581|FG012|Stage 2|Other|0|||
146966129|NCT00320801|530038762|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
146966130|NCT00320801|530038759|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
146966131|NCT00320801|530038760|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
146966132|NCT00320801|530038761|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
146966133|NCT00320801|530038762|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
146540307|NCT03765073|528487582|FG013|Stage 2|Other|0|||
146540308|NCT03765073|528487583|FG014|Stage 2|Other|0|||
146540309|NCT03765073|528487584|FG015|Stage 2|Other|1|||
146540310|NCT03765073|528487585|FG016|Stage 2|Other|2|||
146966134|NCT00320801|530038759|FG000|Open-label Run-in Period|Did not qualify|1|||
146966135|NCT00320801|530038760|FG001|Open-label Run-in Period|Did not qualify|0|||
146966136|NCT00320801|530038761|FG002|Open-label Run-in Period|Did not qualify|0|||
146966137|NCT00320801|530038762|FG003|Open-label Run-in Period|Did not qualify|0|||
146966138|NCT00320801|530038759|FG000|Double-blind Phase|Withdrawal by Subject|0|||
146966139|NCT00320801|530038760|FG001|Double-blind Phase|Withdrawal by Subject|0|||
146966140|NCT00320801|530038761|FG002|Double-blind Phase|Withdrawal by Subject|1|||
146966141|NCT00320801|530038762|FG003|Double-blind Phase|Withdrawal by Subject|0|||
146966142|NCT00320801|530038759|FG000|Double-blind Phase|Adverse Event|0|||
146966143|NCT00320801|530038760|FG001|Double-blind Phase|Adverse Event|2|||
146966144|NCT00320801|530038761|FG002|Double-blind Phase|Adverse Event|8|||
146966145|NCT00320801|530038762|FG003|Double-blind Phase|Adverse Event|0|||
146966146|NCT00320801|530038759|FG000|Double-blind Phase|Administrative|0|||
146966147|NCT00320801|530038760|FG001|Double-blind Phase|Administrative|0|||
146966148|NCT00320801|530038761|FG002|Double-blind Phase|Administrative|4|||
146966149|NCT00320801|530038762|FG003|Double-blind Phase|Administrative|0|||
146540311|NCT03765073|528487586|FG017|Stage 2|Other|0|||
146540312|NCT03765073|528487587|FG018|Stage 2|Other|0|||
146540313|NCT03765073|528487588|FG019|Stage 2|Other|0|||
146540314|NCT03765073|528487589|FG020|Stage 2|Other|0|||
146540315|NCT03765073|528487569|FG000|Stage 2|Withdrawal by parent/guardian|0|||
146540316|NCT03765073|528487570|FG001|Stage 2|Withdrawal by parent/guardian|0|||
146540317|NCT03765073|528487571|FG002|Stage 2|Withdrawal by parent/guardian|0|||
146540318|NCT03765073|528487572|FG003|Stage 2|Withdrawal by parent/guardian|0|||
146540319|NCT03765073|528487573|FG004|Stage 2|Withdrawal by parent/guardian|0|||
146540320|NCT03765073|528487574|FG005|Stage 2|Withdrawal by parent/guardian|0|||
146540321|NCT03765073|528487575|FG006|Stage 2|Withdrawal by parent/guardian|0|||
146540322|NCT03765073|528487576|FG007|Stage 2|Withdrawal by parent/guardian|0|||
146540323|NCT03765073|528487577|FG008|Stage 2|Withdrawal by parent/guardian|0|||
146540324|NCT03765073|528487578|FG009|Stage 2|Withdrawal by parent/guardian|0|||
146540325|NCT03765073|528487579|FG010|Stage 2|Withdrawal by parent/guardian|3|||
146540326|NCT03765073|528487580|FG011|Stage 2|Withdrawal by parent/guardian|3|||
146540327|NCT03765073|528487581|FG012|Stage 2|Withdrawal by parent/guardian|3|||
146540328|NCT03765073|528487582|FG013|Stage 2|Withdrawal by parent/guardian|1|||
146540329|NCT03765073|528487583|FG014|Stage 2|Withdrawal by parent/guardian|1|||
146540330|NCT03765073|528487584|FG015|Stage 2|Withdrawal by parent/guardian|0|||
146540331|NCT03765073|528487585|FG016|Stage 2|Withdrawal by parent/guardian|3|||
146540332|NCT03765073|528487586|FG017|Stage 2|Withdrawal by parent/guardian|0|||
146540333|NCT03765073|528487587|FG018|Stage 2|Withdrawal by parent/guardian|0|||
146540334|NCT03765073|528487588|FG019|Stage 2|Withdrawal by parent/guardian|0|||
146540335|NCT03765073|528487589|FG020|Stage 2|Withdrawal by parent/guardian|0|||
146540336|NCT03765073|528487569|FG000|Stage 2|Withdrawal by Subject|0|||
146540337|NCT03765073|528487570|FG001|Stage 2|Withdrawal by Subject|0|||
146540338|NCT03765073|528487571|FG002|Stage 2|Withdrawal by Subject|0|||
146540339|NCT03765073|528487572|FG003|Stage 2|Withdrawal by Subject|3|||
146540340|NCT03765073|528487573|FG004|Stage 2|Withdrawal by Subject|3|||
146540341|NCT03765073|528487574|FG005|Stage 2|Withdrawal by Subject|3|||
146540342|NCT03765073|528487575|FG006|Stage 2|Withdrawal by Subject|0|||
146540343|NCT03765073|528487576|FG007|Stage 2|Withdrawal by Subject|1|||
146540344|NCT03765073|528487577|FG008|Stage 2|Withdrawal by Subject|0|||
146627806|NCT00939393|528813474|FG000|Overall Study|Lost to Follow-up|3|||
146627807|NCT00939393|528813475|FG001|Overall Study|Lost to Follow-up|0|||
146966150|NCT00320801|530038759|FG000|Double-blind Phase|Lack of Efficacy|0|||
146966151|NCT00320801|530038760|FG001|Double-blind Phase|Lack of Efficacy|9|||
146966152|NCT00320801|530038761|FG002|Double-blind Phase|Lack of Efficacy|1|||
146966153|NCT00320801|530038762|FG003|Double-blind Phase|Lack of Efficacy|0|||
146966154|NCT00320801|530038759|FG000|Extension Phase|Withdrawal by Subject|0|||
146966155|NCT00320801|530038760|FG001|Extension Phase|Withdrawal by Subject|0|||
146966156|NCT00320801|530038761|FG002|Extension Phase|Withdrawal by Subject|0|||
146966157|NCT00320801|530038762|FG003|Extension Phase|Withdrawal by Subject|6|||
146627808|NCT02851615|528813476|FG000|Overall Study|Cognitive Issue|1|||
146966158|NCT00320801|530038759|FG000|Extension Phase|Adverse Event|0|||
146966159|NCT00320801|530038760|FG001|Extension Phase|Adverse Event|0|||
146627809|NCT02851615|528813477|FG001|Overall Study|Cognitive Issue|0|||
146540345|NCT03765073|528487578|FG009|Stage 2|Withdrawal by Subject|5|||
146540346|NCT03765073|528487579|FG010|Stage 2|Withdrawal by Subject|0|||
146540347|NCT03765073|528487580|FG011|Stage 2|Withdrawal by Subject|0|||
146540348|NCT03765073|528487581|FG012|Stage 2|Withdrawal by Subject|0|||
146540349|NCT03765073|528487582|FG013|Stage 2|Withdrawal by Subject|0|||
146540350|NCT03765073|528487583|FG014|Stage 2|Withdrawal by Subject|0|||
146966160|NCT00320801|530038761|FG002|Extension Phase|Adverse Event|0|||
146966161|NCT00320801|530038762|FG003|Extension Phase|Adverse Event|8|||
146966162|NCT00320801|530038759|FG000|Extension Phase|Administrative|0|||
146966163|NCT00320801|530038760|FG001|Extension Phase|Administrative|0|||
146966164|NCT00320801|530038761|FG002|Extension Phase|Administrative|0|||
146966165|NCT00320801|530038762|FG003|Extension Phase|Administrative|29|||
146966166|NCT00320801|530038759|FG000|Extension Phase|Lack of Efficacy|0|||
146966167|NCT00320801|530038760|FG001|Extension Phase|Lack of Efficacy|0|||
146966168|NCT00320801|530038761|FG002|Extension Phase|Lack of Efficacy|0|||
146966169|NCT00320801|530038762|FG003|Extension Phase|Lack of Efficacy|2|||
146966170|NCT00320801|530038759|FG000|Extension Phase|Lost to Follow-up|0|||
146966171|NCT00320801|530038760|FG001|Extension Phase|Lost to Follow-up|0|||
146966172|NCT00320801|530038761|FG002|Extension Phase|Lost to Follow-up|0|||
146966173|NCT00320801|530038762|FG003|Extension Phase|Lost to Follow-up|3|||
146966174|NCT02060188|530038763|FG000|Overall Study|Disease Progression|36|||
146966175|NCT02060188|530038764|FG001|Overall Study|Disease Progression|42|||
146966176|NCT02060188|530038765|FG002|Overall Study|Disease Progression|8|||
146966177|NCT02060188|530038766|FG003|Overall Study|Disease Progression|5|||
146966178|NCT02060188|530038767|FG004|Overall Study|Disease Progression|6|||
146966179|NCT02060188|530038768|FG005|Overall Study|Disease Progression|3|||
146966180|NCT02060188|530038769|FG006|Overall Study|Disease Progression|23|||
146966181|NCT02060188|530038770|FG007|Overall Study|Disease Progression|20|||
146966182|NCT02060188|530038771|FG008|Overall Study|Disease Progression|43|||
146966183|NCT02060188|530038763|FG000|Overall Study|Study Drug Toxicity|10|||
146966184|NCT02060188|530038764|FG001|Overall Study|Study Drug Toxicity|18|||
146966185|NCT02060188|530038765|FG002|Overall Study|Study Drug Toxicity|7|||
146966186|NCT02060188|530038766|FG003|Overall Study|Study Drug Toxicity|4|||
146966187|NCT02060188|530038767|FG004|Overall Study|Study Drug Toxicity|3|||
146966188|NCT02060188|530038768|FG005|Overall Study|Study Drug Toxicity|0|||
146966189|NCT02060188|530038769|FG006|Overall Study|Study Drug Toxicity|2|||
146966190|NCT02060188|530038770|FG007|Overall Study|Study Drug Toxicity|5|||
146966191|NCT02060188|530038771|FG008|Overall Study|Study Drug Toxicity|0|||
146966192|NCT02060188|530038763|FG000|Overall Study|Adverse event unrelated to study drug|2|||
146966193|NCT02060188|530038764|FG001|Overall Study|Adverse event unrelated to study drug|5|||
146966194|NCT02060188|530038765|FG002|Overall Study|Adverse event unrelated to study drug|6|||
146966195|NCT02060188|530038766|FG003|Overall Study|Adverse event unrelated to study drug|0|||
146966196|NCT02060188|530038767|FG004|Overall Study|Adverse event unrelated to study drug|1|||
146966197|NCT02060188|530038768|FG005|Overall Study|Adverse event unrelated to study drug|0|||
146966198|NCT02060188|530038769|FG006|Overall Study|Adverse event unrelated to study drug|4|||
146966199|NCT02060188|530038770|FG007|Overall Study|Adverse event unrelated to study drug|4|||
146966200|NCT02060188|530038771|FG008|Overall Study|Adverse event unrelated to study drug|1|||
146966201|NCT02060188|530038763|FG000|Overall Study|Participant request to discontinue study treatment|7|||
146966202|NCT02060188|530038764|FG001|Overall Study|Participant request to discontinue study treatment|7|||
146966203|NCT02060188|530038765|FG002|Overall Study|Participant request to discontinue study treatment|4|||
146966204|NCT02060188|530038766|FG003|Overall Study|Participant request to discontinue study treatment|0|||
146966205|NCT02060188|530038767|FG004|Overall Study|Participant request to discontinue study treatment|0|||
146966206|NCT02060188|530038768|FG005|Overall Study|Participant request to discontinue study treatment|0|||
146966207|NCT02060188|530038769|FG006|Overall Study|Participant request to discontinue study treatment|1|||
146966208|NCT02060188|530038770|FG007|Overall Study|Participant request to discontinue study treatment|1|||
146966209|NCT02060188|530038771|FG008|Overall Study|Participant request to discontinue study treatment|0|||
146966210|NCT02060188|530038763|FG000|Overall Study|Participant withdrew consent|3|||
146966211|NCT02060188|530038764|FG001|Overall Study|Participant withdrew consent|0|||
146540351|NCT03765073|528487584|FG015|Stage 2|Withdrawal by Subject|0|||
146540352|NCT03765073|528487585|FG016|Stage 2|Withdrawal by Subject|0|||
146540353|NCT03765073|528487586|FG017|Stage 2|Withdrawal by Subject|0|||
146540354|NCT03765073|528487587|FG018|Stage 2|Withdrawal by Subject|0|||
146966212|NCT02060188|530038765|FG002|Overall Study|Participant withdrew consent|0|||
146966213|NCT02060188|530038766|FG003|Overall Study|Participant withdrew consent|0|||
146966214|NCT02060188|530038767|FG004|Overall Study|Participant withdrew consent|0|||
146966215|NCT02060188|530038768|FG005|Overall Study|Participant withdrew consent|0|||
146966216|NCT02060188|530038769|FG006|Overall Study|Participant withdrew consent|0|||
146966217|NCT02060188|530038770|FG007|Overall Study|Participant withdrew consent|0|||
146966218|NCT02060188|530038771|FG008|Overall Study|Participant withdrew consent|0|||
146966219|NCT02060188|530038763|FG000|Overall Study|Maximum clinical benefit|13|||
146966220|NCT02060188|530038764|FG001|Overall Study|Maximum clinical benefit|38|||
146966221|NCT02060188|530038765|FG002|Overall Study|Maximum clinical benefit|19|||
146966222|NCT02060188|530038766|FG003|Overall Study|Maximum clinical benefit|0|||
146966223|NCT02060188|530038767|FG004|Overall Study|Maximum clinical benefit|0|||
146966224|NCT02060188|530038768|FG005|Overall Study|Maximum clinical benefit|0|||
146966225|NCT02060188|530038769|FG006|Overall Study|Maximum clinical benefit|0|||
146966226|NCT02060188|530038770|FG007|Overall Study|Maximum clinical benefit|10|||
146540355|NCT03765073|528487588|FG019|Stage 2|Withdrawal by Subject|0|||
146966227|NCT02060188|530038771|FG008|Overall Study|Maximum clinical benefit|0|||
146966228|NCT02060188|530038763|FG000|Overall Study|Other reason|3|||
146872028|NCT03227471|529703115|FG001|Overall Study|Randomized, Never Dosed|0|||
146872029|NCT03227471|529703116|FG002|Overall Study|Randomized, Never Dosed|0|||
146872030|NCT03227471|529703117|FG003|Overall Study|Randomized, Never Dosed|0|||
146872031|NCT03227471|529703118|FG004|Overall Study|Randomized, Never Dosed|0|||
146872032|NCT03227471|529703119|FG005|Overall Study|Randomized, Never Dosed|0|||
146872033|NCT03227471|529703120|FG006|Overall Study|Randomized, Never Dosed|0|||
146872034|NCT03227471|529703121|FG007|Overall Study|Randomized, Never Dosed|0|||
146872035|NCT03227471|529703122|FG008|Overall Study|Randomized, Never Dosed|0|||
146872036|NCT03227471|529703123|FG009|Overall Study|Randomized, Never Dosed|0|||
146872037|NCT03227471|529703124|FG010|Overall Study|Randomized, Never Dosed|0|||
146872038|NCT03227471|529703125|FG011|Overall Study|Randomized, Never Dosed|0|||
146872039|NCT03227471|529703126|FG012|Overall Study|Randomized, Never Dosed|0|||
146872040|NCT03227471|529703127|FG013|Overall Study|Randomized, Never Dosed|0|||
146872041|NCT03227471|529703128|FG014|Overall Study|Randomized, Never Dosed|1|||
146872042|NCT02322125|529703129|FG000|Overall Study|Withdrawal by Subject|2|||
146872043|NCT01007032|529703137|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
146872044|NCT01007032|529703138|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
146872045|NCT01007032|529703139|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
146966229|NCT02060188|530038764|FG001|Overall Study|Other reason|7|||
146966230|NCT02060188|530038765|FG002|Overall Study|Other reason|0|||
146966231|NCT02060188|530038766|FG003|Overall Study|Other reason|1|||
146966232|NCT02060188|530038767|FG004|Overall Study|Other reason|0|||
146966233|NCT02060188|530038768|FG005|Overall Study|Other reason|0|||
146966234|NCT02060188|530038769|FG006|Overall Study|Other reason|0|||
146966235|NCT02060188|530038770|FG007|Overall Study|Other reason|9|||
146966236|NCT02060188|530038771|FG008|Overall Study|Other reason|0|||
146966237|NCT02060188|530038763|FG000|Overall Study|Death|0|||
146966238|NCT02060188|530038764|FG001|Overall Study|Death|1|||
146966239|NCT02060188|530038765|FG002|Overall Study|Death|0|||
146966240|NCT02060188|530038766|FG003|Overall Study|Death|0|||
146966241|NCT02060188|530038767|FG004|Overall Study|Death|0|||
146966242|NCT02060188|530038768|FG005|Overall Study|Death|0|||
146966243|NCT02060188|530038769|FG006|Overall Study|Death|0|||
146966244|NCT02060188|530038770|FG007|Overall Study|Death|1|||
146966245|NCT02060188|530038771|FG008|Overall Study|Death|0|||
146966246|NCT02060188|530038763|FG000|Overall Study|Administrative reasons by sponsor|0|||
146966247|NCT02060188|530038764|FG001|Overall Study|Administrative reasons by sponsor|1|||
146966248|NCT02060188|530038765|FG002|Overall Study|Administrative reasons by sponsor|0|||
146966249|NCT02060188|530038766|FG003|Overall Study|Administrative reasons by sponsor|0|||
146966250|NCT02060188|530038767|FG004|Overall Study|Administrative reasons by sponsor|0|||
146966251|NCT02060188|530038768|FG005|Overall Study|Administrative reasons by sponsor|0|||
146966252|NCT02060188|530038769|FG006|Overall Study|Administrative reasons by sponsor|0|||
146966253|NCT02060188|530038770|FG007|Overall Study|Administrative reasons by sponsor|0|||
146966254|NCT02060188|530038771|FG008|Overall Study|Administrative reasons by sponsor|0|||
146966255|NCT02060188|530038763|FG000|Overall Study|Lost to Follow-up|0|||
146966256|NCT02060188|530038764|FG001|Overall Study|Lost to Follow-up|0|||
146966257|NCT02060188|530038765|FG002|Overall Study|Lost to Follow-up|1|||
146966258|NCT02060188|530038766|FG003|Overall Study|Lost to Follow-up|0|||
146966259|NCT02060188|530038767|FG004|Overall Study|Lost to Follow-up|0|||
146966260|NCT02060188|530038768|FG005|Overall Study|Lost to Follow-up|0|||
146966261|NCT02060188|530038769|FG006|Overall Study|Lost to Follow-up|0|||
146966262|NCT02060188|530038770|FG007|Overall Study|Lost to Follow-up|0|||
146966263|NCT02060188|530038771|FG008|Overall Study|Lost to Follow-up|0|||
146966264|NCT03426995|530038772|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966265|NCT03426995|530038773|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966266|NCT03426995|530038774|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
146966267|NCT03426995|530038775|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966268|NCT03426995|530038776|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966269|NCT03426995|530038777|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966270|NCT03426995|530038778|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966271|NCT03426995|530038779|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966272|NCT03426995|530038780|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966273|NCT03426995|530038781|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966274|NCT03426995|530038782|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966275|NCT03426995|530038783|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966276|NCT03426995|530038784|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966277|NCT03426995|530038785|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966278|NCT03426995|530038786|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966279|NCT03426995|530038787|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146872046|NCT01007032|529703140|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
146872047|NCT01007032|529703137|FG000|Overall Study|Withdrawal by Subject|0|||
146872048|NCT01007032|529703138|FG001|Overall Study|Withdrawal by Subject|0|||
146627810|NCT02851615|528813476|FG000|Overall Study|Lost to Follow-up|0|||
146627811|NCT02851615|528813477|FG001|Overall Study|Lost to Follow-up|4|||
146627812|NCT00313014|528813478|FG000|Overall Study|Withdrawal by Subject|11|||
146627813|NCT00313014|528813479|FG001|Overall Study|Withdrawal by Subject|7|||
146627814|NCT00313014|528813480|FG002|Overall Study|Withdrawal by Subject|5|||
146627815|NCT00313014|528813478|FG000|Overall Study|Adverse Event|14|||
146627816|NCT00313014|528813479|FG001|Overall Study|Adverse Event|29|||
146627817|NCT00313014|528813480|FG002|Overall Study|Adverse Event|16|||
146627818|NCT00313014|528813478|FG000|Overall Study|Lost to Follow-up|7|||
146627819|NCT00313014|528813479|FG001|Overall Study|Lost to Follow-up|6|||
146627820|NCT00313014|528813480|FG002|Overall Study|Lost to Follow-up|10|||
146627821|NCT00313014|528813478|FG000|Overall Study|Administrative|9|||
146627822|NCT00313014|528813479|FG001|Overall Study|Administrative|6|||
146627823|NCT00313014|528813480|FG002|Overall Study|Administrative|14|||
146627824|NCT00313014|528813478|FG000|Overall Study|Lack of Efficacy|52|||
146627825|NCT00313014|528813479|FG001|Overall Study|Lack of Efficacy|25|||
146627826|NCT00313014|528813480|FG002|Overall Study|Lack of Efficacy|16|||
146627827|NCT00371150|528813482|FG000|Overall Study|Lost to Follow-up|3|||
146627828|NCT00371150|528813483|FG001|Overall Study|Lost to Follow-up|2|||
146627829|NCT02345070|528813484|FG000|Overall Study|Adverse Event|12|||
146627830|NCT02345070|528813485|FG001|Overall Study|Adverse Event|8|||
146627831|NCT02345070|528813486|FG002|Overall Study|Adverse Event|16|||
146627832|NCT02345070|528813484|FG000|Overall Study|Poor compliance to protocol|2|||
146627833|NCT02345070|528813485|FG001|Overall Study|Poor compliance to protocol|0|||
146627834|NCT02345070|528813486|FG002|Overall Study|Poor compliance to protocol|0|||
146627835|NCT02345070|528813484|FG000|Overall Study|Other than specified above|6|||
146627836|NCT02345070|528813485|FG001|Overall Study|Other than specified above|3|||
146627837|NCT02345070|528813486|FG002|Overall Study|Other than specified above|7|||
146627838|NCT00473564|528813489|FG000|Overall Study|robot surgery aborted in OR|23|||
146627839|NCT03131219|528813490|FG000|Initial Evaluation Period|Adverse Event|2|||
146627840|NCT03131219|528813491|FG001|Initial Evaluation Period|Adverse Event|0|||
146627841|NCT03131219|528813490|FG000|Initial Evaluation Period|Protocol Violation|1|||
146627842|NCT03131219|528813491|FG001|Initial Evaluation Period|Protocol Violation|0|||
146627843|NCT03131219|528813490|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
146627844|NCT03131219|528813491|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
146627845|NCT03131219|528813490|FG000|Initial Evaluation Period|Physician Decision|1|||
146627846|NCT03131219|528813491|FG001|Initial Evaluation Period|Physician Decision|0|||
146627847|NCT03131219|528813490|FG000|Extension Period|Physician Decision|1|||
146627848|NCT03131219|528813491|FG001|Extension Period|Physician Decision|0|||
146627849|NCT00616759|528813492|FG000|Overall Study|Physician Decision|2|||
146627850|NCT00616759|528813493|FG001|Overall Study|Physician Decision|0|||
146627851|NCT00616759|528813492|FG000|Overall Study|Withdrawal by Subject|1|||
146627852|NCT00616759|528813493|FG001|Overall Study|Withdrawal by Subject|2|||
146627853|NCT00981656|528813507|FG000|Overall Study|Protocol Violation|1|||
146627854|NCT00981656|528813507|FG000|Overall Study|Did not start protocol treatment|2|||
146627855|NCT02903771|528813508|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
146627856|NCT02903771|528813509|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
146627857|NCT02903771|528813510|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
146627858|NCT02903771|528813511|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
146627859|NCT02903771|528813512|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
146627860|NCT02903771|528813513|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
146627861|NCT02903771|528813514|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
146627862|NCT02903771|528813508|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
146627863|NCT02903771|528813509|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
146627864|NCT02903771|528813510|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
146627865|NCT02903771|528813511|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
146627866|NCT02903771|528813512|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
146627867|NCT02903771|528813513|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
146627868|NCT02903771|528813514|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
146627869|NCT02903771|528813508|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
146627870|NCT02903771|528813509|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
146764166|NCT00906698|529302989|FG001|Overall Study|Withdrawal by Subject|0|||
146627871|NCT02903771|528813510|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
146627872|NCT02903771|528813511|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
146627873|NCT02903771|528813512|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
146627874|NCT02903771|528813513|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
146627875|NCT02903771|528813514|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
146627876|NCT02903771|528813508|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
146627877|NCT02903771|528813509|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
146764167|NCT00906698|529302990|FG002|Overall Study|Withdrawal by Subject|0|||
146764168|NCT00906698|529302991|FG003|Overall Study|Withdrawal by Subject|0|||
146764169|NCT00906698|529302992|FG004|Overall Study|Withdrawal by Subject|1|||
146627878|NCT02903771|528813510|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
146872049|NCT01007032|529703139|FG002|Overall Study|Withdrawal by Subject|0|||
146872050|NCT01007032|529703140|FG003|Overall Study|Withdrawal by Subject|1|||
146872051|NCT01101438|529703141|FG000|Overall Study|Withdrawal by Subject|8|||
146872052|NCT01101438|529703142|FG001|Overall Study|Withdrawal by Subject|9|||
146872053|NCT03677596|529703147|FG000|Overall Study|Adverse Event|0|||
146872054|NCT03677596|529703148|FG001|Overall Study|Adverse Event|1|||
146872055|NCT03677596|529703147|FG000|Overall Study|Death|10|||
146872056|NCT03677596|529703148|FG001|Overall Study|Death|6|||
146872057|NCT03677596|529703147|FG000|Overall Study|Lost to Follow-up|0|||
146872058|NCT03677596|529703148|FG001|Overall Study|Lost to Follow-up|1|||
146872059|NCT03677596|529703147|FG000|Overall Study|Progressive Disease|8|||
146872060|NCT03677596|529703148|FG001|Overall Study|Progressive Disease|8|||
146872061|NCT03677596|529703147|FG000|Overall Study|Withdrawal by Subject|3|||
146872062|NCT03677596|529703148|FG001|Overall Study|Withdrawal by Subject|0|||
146872063|NCT03677596|529703147|FG000|Overall Study|Disease Relapse|2|||
146872064|NCT03677596|529703148|FG001|Overall Study|Disease Relapse|2|||
146872065|NCT03677596|529703147|FG000|Overall Study|Other|0|||
146872066|NCT03677596|529703148|FG001|Overall Study|Other|1|||
146872067|NCT03794583|529703149|FG000|Overall Study|Death|8|||
146872068|NCT03794583|529703149|FG000|Overall Study|Study Terminated by Sponsor|24|||
146872069|NCT03794583|529703149|FG000|Overall Study|Withdrawal by Subject|9|||
146872070|NCT00806195|529703150|FG000|Overall Study|Death|6|||
146872071|NCT00806195|529703151|FG001|Overall Study|Death|0|||
146872072|NCT00806195|529703152|FG002|Overall Study|Death|1|||
146872073|NCT00806195|529703153|FG003|Overall Study|Death|0|||
146872074|NCT00806195|529703150|FG000|Overall Study|Adverse Event|25|||
146872075|NCT00806195|529703151|FG001|Overall Study|Adverse Event|5|||
146872076|NCT00806195|529703152|FG002|Overall Study|Adverse Event|11|||
146872077|NCT00806195|529703153|FG003|Overall Study|Adverse Event|2|||
146872078|NCT00806195|529703150|FG000|Overall Study|Withdrawal by Subject|119|||
146872079|NCT00806195|529703151|FG001|Overall Study|Withdrawal by Subject|31|||
146872080|NCT00806195|529703152|FG002|Overall Study|Withdrawal by Subject|76|||
146872081|NCT00806195|529703153|FG003|Overall Study|Withdrawal by Subject|35|||
146872082|NCT00806195|529703150|FG000|Overall Study|Lost to Follow-up|217|||
146872083|NCT00806195|529703151|FG001|Overall Study|Lost to Follow-up|66|||
146872084|NCT00806195|529703152|FG002|Overall Study|Lost to Follow-up|90|||
146872085|NCT00806195|529703153|FG003|Overall Study|Lost to Follow-up|34|||
146872086|NCT00806195|529703150|FG000|Overall Study|Inappropriate Enrollment|0|||
146872087|NCT00806195|529703151|FG001|Overall Study|Inappropriate Enrollment|1|||
146872088|NCT00806195|529703152|FG002|Overall Study|Inappropriate Enrollment|0|||
146872089|NCT00806195|529703153|FG003|Overall Study|Inappropriate Enrollment|0|||
146872090|NCT00806195|529703150|FG000|Overall Study|Administrative Reason|113|||
146872091|NCT00806195|529703151|FG001|Overall Study|Administrative Reason|35|||
146872092|NCT00806195|529703152|FG002|Overall Study|Administrative Reason|66|||
146872093|NCT00806195|529703153|FG003|Overall Study|Administrative Reason|26|||
146872094|NCT00806195|529703150|FG000|Overall Study|Protocol Violation|34|||
146872095|NCT00806195|529703151|FG001|Overall Study|Protocol Violation|24|||
146872096|NCT00806195|529703152|FG002|Overall Study|Protocol Violation|26|||
146872097|NCT00806195|529703153|FG003|Overall Study|Protocol Violation|9|||
146872098|NCT02752035|529703156|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
146872099|NCT02752035|529703157|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
146872100|NCT02752035|529703158|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
146872101|NCT02752035|529703159|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
146872102|NCT02752035|529703156|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
146872103|NCT02752035|529703157|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
146872104|NCT02752035|529703158|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
146872105|NCT02752035|529703159|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
146872106|NCT02752035|529703156|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
146872107|NCT02752035|529703157|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
146872108|NCT02752035|529703158|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
146872109|NCT02752035|529703159|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
146872110|NCT02752035|529703156|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
146872111|NCT02752035|529703157|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
146872112|NCT02752035|529703158|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
146872113|NCT02752035|529703159|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
146872114|NCT02752035|529703156|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
146872115|NCT02752035|529703157|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
146872116|NCT02752035|529703158|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
146872117|NCT02752035|529703159|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
146872118|NCT02752035|529703156|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
146872119|NCT02752035|529703157|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
146872120|NCT02752035|529703158|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
146975328|NCT00572156|530073539|FG000|Overall Study|Lost to Follow-up|1|||
146627879|NCT02903771|528813511|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
146627880|NCT02903771|528813512|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
146627881|NCT02903771|528813513|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
146627882|NCT02903771|528813514|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
146627883|NCT02903771|528813508|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
146627884|NCT02903771|528813509|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
146627885|NCT02903771|528813510|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
146627886|NCT02903771|528813511|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
146627887|NCT02903771|528813512|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
146627888|NCT02903771|528813513|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
146627889|NCT02903771|528813514|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
146872121|NCT02752035|529703159|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
146872122|NCT02752035|529703156|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
146872123|NCT02752035|529703157|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
146872124|NCT02752035|529703158|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
146872125|NCT02752035|529703159|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
146872126|NCT02752035|529703156|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
146627890|NCT02903771|528813508|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
146627891|NCT02903771|528813509|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
146627892|NCT02903771|528813510|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
146627893|NCT02903771|528813511|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
146627894|NCT02903771|528813512|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
146627895|NCT02903771|528813513|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
146627896|NCT02903771|528813514|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
146627897|NCT02903771|528813508|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
146627898|NCT02903771|528813509|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
146627899|NCT02903771|528813510|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
146627900|NCT02903771|528813511|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
146627901|NCT02903771|528813512|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
146627902|NCT02903771|528813513|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
146627903|NCT02903771|528813514|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
146627904|NCT02903771|528813508|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
146627905|NCT02903771|528813509|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
146627906|NCT02903771|528813510|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
146627907|NCT02903771|528813511|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
146627908|NCT02903771|528813512|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
146627909|NCT02903771|528813513|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
146627910|NCT02903771|528813514|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
146627911|NCT02903771|528813508|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
146627912|NCT02903771|528813509|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
146627913|NCT02903771|528813510|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
146627914|NCT02903771|528813511|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
146627915|NCT02903771|528813512|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
146627916|NCT02903771|528813513|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
146627917|NCT02903771|528813514|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
146627918|NCT02903771|528813508|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
146627919|NCT02903771|528813509|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
146627920|NCT02903771|528813510|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
146627921|NCT02903771|528813511|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
146627922|NCT02903771|528813512|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
146627923|NCT02903771|528813513|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
146627924|NCT02903771|528813514|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
146627925|NCT02903771|528813508|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
146627926|NCT02903771|528813509|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
146627927|NCT02903771|528813510|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
146627928|NCT02903771|528813511|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
146627929|NCT02903771|528813512|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
146627930|NCT02903771|528813513|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
146627931|NCT02903771|528813514|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
146627932|NCT01709721|528813518|FG000|Open Label Phase|Withdrawal by Subject|0|||
146627933|NCT01709721|528813519|FG001|Open Label Phase|Withdrawal by Subject|0|||
146627934|NCT01709721|528813520|FG002|Open Label Phase|Withdrawal by Subject|5|||
146872127|NCT02752035|529703157|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
146872128|NCT02752035|529703158|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
146872129|NCT02752035|529703159|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
146872130|NCT02752035|529703156|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
146627935|NCT01709721|528813518|FG000|Open Label Phase|Adverse Event|0|||
146627936|NCT01709721|528813519|FG001|Open Label Phase|Adverse Event|0|||
146627937|NCT01709721|528813520|FG002|Open Label Phase|Adverse Event|8|||
146627938|NCT01709721|528813518|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
146627939|NCT01709721|528813519|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
146627940|NCT01709721|528813520|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
146627941|NCT01709721|528813518|FG000|Open Label Phase|Investigator Decision|0|||
146627942|NCT01709721|528813519|FG001|Open Label Phase|Investigator Decision|0|||
146627943|NCT01709721|528813520|FG002|Open Label Phase|Investigator Decision|1|||
146627944|NCT01709721|528813518|FG000|Open Label Phase|Sponsor Decision|0|||
146627945|NCT01709721|528813519|FG001|Open Label Phase|Sponsor Decision|0|||
146627946|NCT01709721|528813520|FG002|Open Label Phase|Sponsor Decision|2|||
146627947|NCT01709721|528813518|FG000|Open Label Phase|Protocol Violation|0|||
146627948|NCT01709721|528813519|FG001|Open Label Phase|Protocol Violation|0|||
146627949|NCT01709721|528813520|FG002|Open Label Phase|Protocol Violation|1|||
146627950|NCT01709721|528813518|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
146627951|NCT01709721|528813519|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
146627952|NCT01709721|528813520|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
146627953|NCT01709721|528813518|FG000|Open Label Phase|Inadequate Pain Control|0|||
146627954|NCT01709721|528813519|FG001|Open Label Phase|Inadequate Pain Control|0|||
146627955|NCT01709721|528813520|FG002|Open Label Phase|Inadequate Pain Control|37|||
146627956|NCT01709721|528813518|FG000|Open Label Phase|Other, Specify in text field in database|0|||
146627957|NCT01709721|528813519|FG001|Open Label Phase|Other, Specify in text field in database|0|||
146627958|NCT01709721|528813520|FG002|Open Label Phase|Other, Specify in text field in database|14|||
146627959|NCT01709721|528813518|FG000|Randomized Phase|Adverse Event|0|||
146627960|NCT01709721|528813519|FG001|Randomized Phase|Adverse Event|1|||
146627961|NCT01709721|528813520|FG002|Randomized Phase|Adverse Event|0|||
146627962|NCT01709721|528813518|FG000|Randomized Phase|Lost to Follow-up|1|||
146627963|NCT01709721|528813519|FG001|Randomized Phase|Lost to Follow-up|0|||
146627964|NCT01709721|528813520|FG002|Randomized Phase|Lost to Follow-up|0|||
146627965|NCT01709721|528813518|FG000|Randomized Phase|Inadequate Pain Control|1|||
146627966|NCT01709721|528813519|FG001|Randomized Phase|Inadequate Pain Control|2|||
146627967|NCT01709721|528813520|FG002|Randomized Phase|Inadequate Pain Control|0|||
146627968|NCT01709721|528813518|FG000|Randomized Phase|Other, Specify text field in database|1|||
146627969|NCT01709721|528813519|FG001|Randomized Phase|Other, Specify text field in database|3|||
146627970|NCT01709721|528813520|FG002|Randomized Phase|Other, Specify text field in database|0|||
146627971|NCT01435382|528813523|FG000|Overall Study|Lost to Follow-up|1|||
146627972|NCT01435382|528813524|FG001|Overall Study|Lost to Follow-up|0|||
146627973|NCT01435382|528813525|FG002|Overall Study|Lost to Follow-up|1|||
146627974|NCT01435382|528813526|FG003|Overall Study|Lost to Follow-up|0|||
146627975|NCT01435382|528813523|FG000|Overall Study|Withdrawal by Subject|0|||
146627976|NCT01435382|528813524|FG001|Overall Study|Withdrawal by Subject|2|||
146627977|NCT01435382|528813525|FG002|Overall Study|Withdrawal by Subject|0|||
146627978|NCT01435382|528813526|FG003|Overall Study|Withdrawal by Subject|1|||
146627979|NCT00423579|528813528|FG000|Overall Study|Lost to Follow-up|3|||
146627980|NCT00423579|528813529|FG001|Overall Study|Lost to Follow-up|0|||
146627981|NCT00423579|528813528|FG000|Overall Study|Protocol Violation|1|||
146627982|NCT00423579|528813529|FG001|Overall Study|Protocol Violation|3|||
146627983|NCT00423579|528813528|FG000|Overall Study|Diagnosis of diabetes|0|||
146627984|NCT00423579|528813529|FG001|Overall Study|Diagnosis of diabetes|1|||
146627985|NCT01310777|528813534|FG000|Overall Study|Adverse Event|23|||
146627986|NCT01310777|528813535|FG001|Overall Study|Adverse Event|1|||
146627987|NCT01310777|528813536|FG002|Overall Study|Adverse Event|15|||
146627988|NCT01310777|528813534|FG000|Overall Study|Lost to Follow-up|0|||
146627989|NCT01310777|528813535|FG001|Overall Study|Lost to Follow-up|4|||
146627990|NCT01310777|528813536|FG002|Overall Study|Lost to Follow-up|1|||
146627991|NCT01310777|528813534|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
146627992|NCT01310777|528813535|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
146627993|NCT01310777|528813536|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
146627994|NCT01310777|528813534|FG000|Overall Study|Inadequate Control of IOP|5|||
146627995|NCT01310777|528813535|FG001|Overall Study|Inadequate Control of IOP|7|||
146627996|NCT01310777|528813536|FG002|Overall Study|Inadequate Control of IOP|10|||
146627997|NCT01310777|528813534|FG000|Overall Study|Other|4|||
146627998|NCT01310777|528813535|FG001|Overall Study|Other|1|||
146627999|NCT01310777|528813536|FG002|Overall Study|Other|2|||
146872131|NCT02752035|529703157|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
146628000|NCT03962491|528813537|FG000|Overall Study|Lost to Follow-up|4|||
146628001|NCT03962491|528813538|FG001|Overall Study|Lost to Follow-up|5|||
146628002|NCT03697252|528813545|FG000|Overall Study|Adverse Event|3|||
146628003|NCT03697252|528813546|FG001|Overall Study|Adverse Event|2|||
146872132|NCT02752035|529703158|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
146628004|NCT03697252|528813545|FG000|Overall Study|Withdrawal by Subject|14|||
146628005|NCT03697252|528813546|FG001|Overall Study|Withdrawal by Subject|14|||
146872133|NCT02752035|529703159|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
146966280|NCT03426995|530038788|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966281|NCT03426995|530038789|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966282|NCT03426995|530038790|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146966283|NCT03426995|530038772|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966284|NCT03426995|530038773|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966285|NCT03426995|530038774|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966286|NCT03426995|530038775|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966287|NCT03426995|530038776|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966288|NCT03426995|530038777|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
146966289|NCT03426995|530038778|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966290|NCT03426995|530038779|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966291|NCT03426995|530038780|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966292|NCT03426995|530038781|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966293|NCT03426995|530038782|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966294|NCT03426995|530038783|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966295|NCT03426995|530038784|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966296|NCT03426995|530038785|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966297|NCT03426995|530038786|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966298|NCT03426995|530038787|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966299|NCT03426995|530038788|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966300|NCT03426995|530038789|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966301|NCT03426995|530038790|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146966302|NCT03426995|530038772|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966303|NCT03426995|530038773|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966304|NCT03426995|530038774|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966305|NCT03426995|530038775|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966306|NCT03426995|530038776|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
146966307|NCT03426995|530038777|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
146966308|NCT03426995|530038778|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966309|NCT03426995|530038779|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966310|NCT03426995|530038780|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966311|NCT03426995|530038781|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966312|NCT03426995|530038782|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966313|NCT03426995|530038783|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966314|NCT03426995|530038784|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966315|NCT03426995|530038785|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966316|NCT03426995|530038786|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966317|NCT03426995|530038787|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966318|NCT03426995|530038788|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966319|NCT03426995|530038789|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966320|NCT03426995|530038790|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146966321|NCT03426995|530038772|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966322|NCT03426995|530038773|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966323|NCT03426995|530038774|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966324|NCT03426995|530038775|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966325|NCT03426995|530038776|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966326|NCT03426995|530038777|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966327|NCT03426995|530038778|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966328|NCT03426995|530038779|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966329|NCT03426995|530038780|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966330|NCT03426995|530038781|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966331|NCT03426995|530038782|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
146966332|NCT03426995|530038783|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966333|NCT03426995|530038784|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966334|NCT03426995|530038785|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966335|NCT03426995|530038786|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966336|NCT03426995|530038787|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966337|NCT03426995|530038788|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966338|NCT03426995|530038789|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146966339|NCT03426995|530038790|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146540356|NCT03765073|528487589|FG020|Stage 2|Withdrawal by Subject|0|||
146540357|NCT03765073|528487569|FG000|Stage 3|Adverse Event|0|||
146540358|NCT03765073|528487570|FG001|Stage 3|Adverse Event|0|||
146540359|NCT03765073|528487571|FG002|Stage 3|Adverse Event|0|||
146540360|NCT03765073|528487572|FG003|Stage 3|Adverse Event|0|||
146540361|NCT03765073|528487573|FG004|Stage 3|Adverse Event|0|||
146540362|NCT03765073|528487574|FG005|Stage 3|Adverse Event|0|||
146540363|NCT03765073|528487575|FG006|Stage 3|Adverse Event|0|||
146872134|NCT02752035|529703156|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
146872135|NCT02752035|529703157|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
146872136|NCT02752035|529703158|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
146872137|NCT02752035|529703159|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
146872138|NCT02752035|529703156|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
146872139|NCT02752035|529703157|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
146872140|NCT02752035|529703158|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
146872141|NCT02752035|529703159|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
146872142|NCT02752035|529703156|FG000|Randomization: Approximately 3 Years|Death|0|||
146872143|NCT02752035|529703157|FG001|Randomization: Approximately 3 Years|Death|25|||
146872144|NCT02752035|529703158|FG002|Randomization: Approximately 3 Years|Death|13|||
146872145|NCT02752035|529703159|FG003|Randomization: Approximately 3 Years|Death|4|||
146872146|NCT02752035|529703156|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
146872147|NCT02752035|529703157|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
146872148|NCT02752035|529703158|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
146872149|NCT02752035|529703159|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
146872150|NCT02752035|529703156|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
146872151|NCT02752035|529703157|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
146872152|NCT02752035|529703158|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
146966340|NCT03426995|530038772|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146966341|NCT03426995|530038773|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146872153|NCT02752035|529703159|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
146872154|NCT02752035|529703156|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
146872155|NCT02752035|529703157|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
146975329|NCT00572156|530073540|FG001|Overall Study|Lost to Follow-up|1|||
146872156|NCT02752035|529703158|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
146540364|NCT03765073|528487576|FG007|Stage 3|Adverse Event|0|||
146540365|NCT03765073|528487577|FG008|Stage 3|Adverse Event|0|||
146540366|NCT03765073|528487578|FG009|Stage 3|Adverse Event|0|||
146540367|NCT03765073|528487579|FG010|Stage 3|Adverse Event|0|||
146540368|NCT03765073|528487580|FG011|Stage 3|Adverse Event|0|||
146540369|NCT03765073|528487581|FG012|Stage 3|Adverse Event|0|||
146540370|NCT03765073|528487582|FG013|Stage 3|Adverse Event|0|||
146540371|NCT03765073|528487583|FG014|Stage 3|Adverse Event|0|||
146540372|NCT03765073|528487584|FG015|Stage 3|Adverse Event|0|||
146540373|NCT03765073|528487585|FG016|Stage 3|Adverse Event|0|||
146540374|NCT03765073|528487586|FG017|Stage 3|Adverse Event|0|||
146540375|NCT03765073|528487587|FG018|Stage 3|Adverse Event|1|||
146540376|NCT03765073|528487588|FG019|Stage 3|Adverse Event|0|||
146540377|NCT03765073|528487589|FG020|Stage 3|Adverse Event|0|||
146872157|NCT02752035|529703159|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
146872158|NCT02752035|529703156|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
146872159|NCT02752035|529703157|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
146872160|NCT02752035|529703158|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
146872161|NCT02752035|529703159|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
146872162|NCT02752035|529703156|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
146872163|NCT02752035|529703157|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
146872164|NCT02752035|529703158|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
146872165|NCT02752035|529703159|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
146872166|NCT01519934|529703160|FG000|Overall Study|Lost to Follow-up|3|||
146872167|NCT01161043|529703161|FG000|Overall Study|Withdrawal by Subject|3|||
146872168|NCT02161575|529703163|FG000|Overall Study|Protocol Violation|8|||
146872169|NCT02161575|529703163|FG000|Overall Study|Lack of Efficacy|1|||
146872170|NCT02161575|529703163|FG000|Overall Study|Adverse Event|2|||
146872171|NCT00701090|529703172|FG000|Overall Study|Adverse Event|11|||
146872172|NCT00701090|529703173|FG001|Overall Study|Adverse Event|2|||
146872173|NCT00701090|529703172|FG000|Overall Study|Death|0|||
146872174|NCT00701090|529703173|FG001|Overall Study|Death|1|||
146872175|NCT00701090|529703172|FG000|Overall Study|Lack of Efficacy|5|||
146872176|NCT00701090|529703173|FG001|Overall Study|Lack of Efficacy|4|||
146872177|NCT00701090|529703172|FG000|Overall Study|Lost to Follow-up|9|||
146872178|NCT00701090|529703173|FG001|Overall Study|Lost to Follow-up|9|||
146872179|NCT00701090|529703172|FG000|Overall Study|Physician Decision|3|||
146872180|NCT00701090|529703173|FG001|Overall Study|Physician Decision|4|||
146872181|NCT00701090|529703172|FG000|Overall Study|Protocol Violation|2|||
146872182|NCT00701090|529703173|FG001|Overall Study|Protocol Violation|3|||
146872183|NCT00701090|529703172|FG000|Overall Study|Withdrawal by Subject|11|||
146872184|NCT00701090|529703173|FG001|Overall Study|Withdrawal by Subject|16|||
146872185|NCT00701090|529703172|FG000|Overall Study|Other|7|||
146872186|NCT00701090|529703173|FG001|Overall Study|Other|12|||
146872187|NCT01231659|529703178|FG000|Overall Study|Adverse Event|9|||
146872188|NCT01231659|529703178|FG000|Overall Study|Disease Progression|48|||
146872189|NCT01231659|529703178|FG000|Overall Study|Death|2|||
146872190|NCT01231659|529703178|FG000|Overall Study|Patient refused to complete study visit|1|||
146872191|NCT01231659|529703178|FG000|Overall Study|Other protocol defined criteria|12|||
146872192|NCT01299376|529703179|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
146872193|NCT01299376|529703180|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
146872194|NCT01299376|529703179|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
146872195|NCT01299376|529703180|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
146872196|NCT01299376|529703179|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
146872197|NCT01299376|529703180|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
146872198|NCT01299376|529703179|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
146872199|NCT01299376|529703180|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
146872200|NCT01299376|529703179|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
146872201|NCT01299376|529703180|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
146872202|NCT01299376|529703179|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
146872203|NCT01299376|529703180|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
146872204|NCT01299376|529703179|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
146975330|NCT00572156|530073541|FG002|Overall Study|Lost to Follow-up|1|||
146540378|NCT03765073|528487569|FG000|Stage 3|Death|0|||
146540379|NCT03765073|528487570|FG001|Stage 3|Death|0|||
146540380|NCT03765073|528487571|FG002|Stage 3|Death|0|||
146540381|NCT03765073|528487572|FG003|Stage 3|Death|0|||
146540382|NCT03765073|528487573|FG004|Stage 3|Death|0|||
146966342|NCT03426995|530038774|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146966343|NCT03426995|530038775|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146966344|NCT03426995|530038776|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146966345|NCT03426995|530038777|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146966346|NCT03426995|530038778|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146966347|NCT03426995|530038779|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
146966348|NCT03426995|530038780|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146966349|NCT03426995|530038781|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146966350|NCT03426995|530038782|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146966351|NCT03426995|530038783|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146966352|NCT03426995|530038784|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146540383|NCT03765073|528487574|FG005|Stage 3|Death|0|||
146540384|NCT03765073|528487575|FG006|Stage 3|Death|0|||
146540385|NCT03765073|528487576|FG007|Stage 3|Death|0|||
146540386|NCT03765073|528487577|FG008|Stage 3|Death|0|||
146540387|NCT03765073|528487578|FG009|Stage 3|Death|0|||
146540388|NCT03765073|528487579|FG010|Stage 3|Death|0|||
146540389|NCT03765073|528487580|FG011|Stage 3|Death|0|||
146540390|NCT03765073|528487581|FG012|Stage 3|Death|0|||
146540391|NCT03765073|528487582|FG013|Stage 3|Death|0|||
146540392|NCT03765073|528487583|FG014|Stage 3|Death|0|||
146540393|NCT03765073|528487584|FG015|Stage 3|Death|0|||
146540394|NCT03765073|528487585|FG016|Stage 3|Death|0|||
146540395|NCT03765073|528487586|FG017|Stage 3|Death|0|||
146540396|NCT03765073|528487587|FG018|Stage 3|Death|0|||
146540397|NCT03765073|528487588|FG019|Stage 3|Death|3|||
146540398|NCT03765073|528487589|FG020|Stage 3|Death|2|||
146540399|NCT03765073|528487569|FG000|Stage 3|Lost to Follow-up|0|||
146540400|NCT03765073|528487570|FG001|Stage 3|Lost to Follow-up|0|||
146540401|NCT03765073|528487571|FG002|Stage 3|Lost to Follow-up|0|||
146540402|NCT03765073|528487572|FG003|Stage 3|Lost to Follow-up|0|||
146540403|NCT03765073|528487573|FG004|Stage 3|Lost to Follow-up|0|||
146540404|NCT03765073|528487574|FG005|Stage 3|Lost to Follow-up|0|||
146540405|NCT03765073|528487575|FG006|Stage 3|Lost to Follow-up|0|||
146540406|NCT03765073|528487576|FG007|Stage 3|Lost to Follow-up|0|||
146540407|NCT03765073|528487577|FG008|Stage 3|Lost to Follow-up|0|||
146540408|NCT03765073|528487578|FG009|Stage 3|Lost to Follow-up|0|||
146540409|NCT03765073|528487579|FG010|Stage 3|Lost to Follow-up|0|||
146540410|NCT03765073|528487580|FG011|Stage 3|Lost to Follow-up|0|||
146540411|NCT03765073|528487581|FG012|Stage 3|Lost to Follow-up|0|||
146540412|NCT03765073|528487582|FG013|Stage 3|Lost to Follow-up|0|||
146540413|NCT03765073|528487583|FG014|Stage 3|Lost to Follow-up|0|||
146540414|NCT03765073|528487584|FG015|Stage 3|Lost to Follow-up|0|||
146540415|NCT03765073|528487585|FG016|Stage 3|Lost to Follow-up|0|||
146540416|NCT03765073|528487586|FG017|Stage 3|Lost to Follow-up|8|||
146540417|NCT03765073|528487587|FG018|Stage 3|Lost to Follow-up|5|||
146540418|NCT03765073|528487588|FG019|Stage 3|Lost to Follow-up|7|||
146540419|NCT03765073|528487589|FG020|Stage 3|Lost to Follow-up|4|||
146540420|NCT03765073|528487569|FG000|Stage 3|No longer meets eligibility criteria|0|||
146540421|NCT03765073|528487570|FG001|Stage 3|No longer meets eligibility criteria|0|||
146540422|NCT03765073|528487571|FG002|Stage 3|No longer meets eligibility criteria|0|||
146540423|NCT03765073|528487572|FG003|Stage 3|No longer meets eligibility criteria|0|||
146540424|NCT03765073|528487573|FG004|Stage 3|No longer meets eligibility criteria|0|||
146540425|NCT03765073|528487574|FG005|Stage 3|No longer meets eligibility criteria|0|||
146540426|NCT03765073|528487575|FG006|Stage 3|No longer meets eligibility criteria|0|||
146540427|NCT03765073|528487576|FG007|Stage 3|No longer meets eligibility criteria|0|||
146540428|NCT03765073|528487577|FG008|Stage 3|No longer meets eligibility criteria|0|||
146540429|NCT03765073|528487578|FG009|Stage 3|No longer meets eligibility criteria|0|||
146540430|NCT03765073|528487579|FG010|Stage 3|No longer meets eligibility criteria|0|||
146540431|NCT03765073|528487580|FG011|Stage 3|No longer meets eligibility criteria|0|||
146540432|NCT03765073|528487581|FG012|Stage 3|No longer meets eligibility criteria|0|||
146540433|NCT03765073|528487582|FG013|Stage 3|No longer meets eligibility criteria|0|||
146540434|NCT03765073|528487583|FG014|Stage 3|No longer meets eligibility criteria|0|||
146540435|NCT03765073|528487584|FG015|Stage 3|No longer meets eligibility criteria|0|||
146540436|NCT03765073|528487585|FG016|Stage 3|No longer meets eligibility criteria|0|||
146540437|NCT03765073|528487586|FG017|Stage 3|No longer meets eligibility criteria|0|||
146540438|NCT03765073|528487587|FG018|Stage 3|No longer meets eligibility criteria|1|||
146540439|NCT03765073|528487588|FG019|Stage 3|No longer meets eligibility criteria|0|||
146540440|NCT03765073|528487589|FG020|Stage 3|No longer meets eligibility criteria|1|||
146540441|NCT03765073|528487569|FG000|Stage 3|Other|0|||
146540442|NCT03765073|528487570|FG001|Stage 3|Other|0|||
146540443|NCT03765073|528487571|FG002|Stage 3|Other|0|||
146540444|NCT03765073|528487572|FG003|Stage 3|Other|0|||
146540445|NCT03765073|528487573|FG004|Stage 3|Other|0|||
146540446|NCT03765073|528487574|FG005|Stage 3|Other|0|||
146540447|NCT03765073|528487575|FG006|Stage 3|Other|0|||
146540448|NCT03765073|528487576|FG007|Stage 3|Other|0|||
146540449|NCT03765073|528487577|FG008|Stage 3|Other|0|||
146540450|NCT03765073|528487578|FG009|Stage 3|Other|0|||
146540451|NCT03765073|528487579|FG010|Stage 3|Other|0|||
146540452|NCT03765073|528487580|FG011|Stage 3|Other|0|||
146540453|NCT03765073|528487581|FG012|Stage 3|Other|0|||
146540454|NCT03765073|528487582|FG013|Stage 3|Other|0|||
146540455|NCT03765073|528487583|FG014|Stage 3|Other|0|||
146540456|NCT03765073|528487584|FG015|Stage 3|Other|0|||
146966353|NCT03426995|530038785|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146966354|NCT03426995|530038786|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146966355|NCT03426995|530038787|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146966356|NCT03426995|530038788|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146966357|NCT03426995|530038789|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146966358|NCT03426995|530038790|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146966359|NCT03426995|530038772|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146966360|NCT03426995|530038773|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146966361|NCT03426995|530038774|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146966362|NCT03426995|530038775|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146540457|NCT03765073|528487585|FG016|Stage 3|Other|0|||
146540458|NCT03765073|528487586|FG017|Stage 3|Other|1|||
146540459|NCT03765073|528487587|FG018|Stage 3|Other|2|||
146540460|NCT03765073|528487588|FG019|Stage 3|Other|2|||
146540461|NCT03765073|528487589|FG020|Stage 3|Other|2|||
146540462|NCT03765073|528487569|FG000|Stage 3|Withdrawal by parent/guardian|0|||
146540463|NCT03765073|528487570|FG001|Stage 3|Withdrawal by parent/guardian|0|||
146540464|NCT03765073|528487571|FG002|Stage 3|Withdrawal by parent/guardian|0|||
146540465|NCT03765073|528487572|FG003|Stage 3|Withdrawal by parent/guardian|0|||
146540466|NCT03765073|528487573|FG004|Stage 3|Withdrawal by parent/guardian|0|||
146540467|NCT03765073|528487574|FG005|Stage 3|Withdrawal by parent/guardian|0|||
146540468|NCT03765073|528487575|FG006|Stage 3|Withdrawal by parent/guardian|0|||
146540469|NCT03765073|528487576|FG007|Stage 3|Withdrawal by parent/guardian|0|||
146540470|NCT03765073|528487577|FG008|Stage 3|Withdrawal by parent/guardian|0|||
146540471|NCT03765073|528487578|FG009|Stage 3|Withdrawal by parent/guardian|0|||
146872205|NCT01299376|529703180|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
146872206|NCT01299376|529703179|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
146872207|NCT01299376|529703180|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
146872208|NCT01299376|529703179|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
146872209|NCT01299376|529703180|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
146872210|NCT01299376|529703179|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
146872211|NCT01299376|529703180|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
146872212|NCT01299376|529703179|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
146872213|NCT01299376|529703180|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
146872214|NCT03680911|529703181|FG000|At Home Treatment|Study Termination|3|||
146872215|NCT03680911|529703182|FG001|At Home Treatment|Study Termination|0|||
146872216|NCT03680911|529703181|FG000|At Home Treatment|Lost to Follow-up|0|||
146872217|NCT03680911|529703182|FG001|At Home Treatment|Lost to Follow-up|1|||
146872218|NCT03680911|529703181|FG000|At Home Treatment|Withdrawal by Subject|0|||
146872219|NCT03680911|529703182|FG001|At Home Treatment|Withdrawal by Subject|2|||
146872220|NCT03680911|529703181|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
146872221|NCT03680911|529703182|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
146872222|NCT03962738|529703183|FG000|Overall Study|Protocol Deviation|3|||
146872223|NCT03962738|529703184|FG001|Overall Study|Protocol Deviation|0|||
146872224|NCT03962738|529703185|FG002|Overall Study|Protocol Deviation|1|||
146872225|NCT03962738|529703186|FG003|Overall Study|Protocol Deviation|1|||
146872226|NCT03962738|529703183|FG000|Overall Study|Withdrawal by Subject|4|||
146872227|NCT03962738|529703184|FG001|Overall Study|Withdrawal by Subject|0|||
146872228|NCT03962738|529703185|FG002|Overall Study|Withdrawal by Subject|0|||
146540472|NCT03765073|528487579|FG010|Stage 3|Withdrawal by parent/guardian|0|||
146540473|NCT03765073|528487580|FG011|Stage 3|Withdrawal by parent/guardian|0|||
146540474|NCT03765073|528487581|FG012|Stage 3|Withdrawal by parent/guardian|0|||
146540475|NCT03765073|528487582|FG013|Stage 3|Withdrawal by parent/guardian|0|||
146872229|NCT03962738|529703186|FG003|Overall Study|Withdrawal by Subject|0|||
146872230|NCT03962738|529703183|FG000|Overall Study|Lost to Follow-up|0|||
146872231|NCT03962738|529703184|FG001|Overall Study|Lost to Follow-up|0|||
146872232|NCT03962738|529703185|FG002|Overall Study|Lost to Follow-up|1|||
146966363|NCT03426995|530038776|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146540476|NCT03765073|528487583|FG014|Stage 3|Withdrawal by parent/guardian|0|||
146540477|NCT03765073|528487584|FG015|Stage 3|Withdrawal by parent/guardian|0|||
146540478|NCT03765073|528487585|FG016|Stage 3|Withdrawal by parent/guardian|0|||
146966364|NCT03426995|530038777|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146966365|NCT03426995|530038778|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146966366|NCT03426995|530038779|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146966367|NCT03426995|530038780|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146966368|NCT03426995|530038781|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146975331|NCT00572156|530073542|FG003|Overall Study|Lost to Follow-up|0|||
146540479|NCT03765073|528487586|FG017|Stage 3|Withdrawal by parent/guardian|0|||
146540480|NCT03765073|528487587|FG018|Stage 3|Withdrawal by parent/guardian|0|||
146872233|NCT03962738|529703186|FG003|Overall Study|Lost to Follow-up|0|||
146540481|NCT03765073|528487588|FG019|Stage 3|Withdrawal by parent/guardian|6|||
146966369|NCT03426995|530038782|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146966370|NCT03426995|530038783|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146966371|NCT03426995|530038784|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146966372|NCT03426995|530038785|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146966373|NCT03426995|530038786|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
146966374|NCT03426995|530038787|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
146966375|NCT03426995|530038788|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146966376|NCT03426995|530038789|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146966377|NCT03426995|530038790|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146966378|NCT03426995|530038772|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966379|NCT03426995|530038773|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966380|NCT03426995|530038774|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966381|NCT03426995|530038775|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966382|NCT03426995|530038776|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966383|NCT03426995|530038777|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966384|NCT03426995|530038778|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966385|NCT03426995|530038779|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966386|NCT03426995|530038780|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966387|NCT03426995|530038781|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966388|NCT03426995|530038782|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966389|NCT03426995|530038783|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966390|NCT03426995|530038784|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966391|NCT03426995|530038785|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966392|NCT03426995|530038786|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
146966393|NCT03426995|530038787|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
146966394|NCT03426995|530038788|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966395|NCT03426995|530038789|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966396|NCT03426995|530038790|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146966397|NCT02335411|530038791|FG000|Overall Study|Death|223|||
146966398|NCT02335411|530038792|FG001|Overall Study|Death|22|||
146966399|NCT02335411|530038793|FG002|Overall Study|Death|26|||
146966400|NCT02335411|530038791|FG000|Overall Study|Physician Decision|3|||
146966401|NCT02335411|530038792|FG001|Overall Study|Physician Decision|0|||
146966402|NCT02335411|530038793|FG002|Overall Study|Physician Decision|0|||
146966403|NCT02335411|530038791|FG000|Overall Study|Protocol Violation|1|||
146966404|NCT02335411|530038792|FG001|Overall Study|Protocol Violation|0|||
146966405|NCT02335411|530038793|FG002|Overall Study|Protocol Violation|0|||
146966406|NCT02335411|530038791|FG000|Overall Study|Withdrawal by Subject|11|||
146966407|NCT02335411|530038792|FG001|Overall Study|Withdrawal by Subject|0|||
146966408|NCT02335411|530038793|FG002|Overall Study|Withdrawal by Subject|3|||
146966409|NCT02335411|530038791|FG000|Overall Study|Sponsor Decision|12|||
146966410|NCT02335411|530038792|FG001|Overall Study|Sponsor Decision|3|||
146966411|NCT02335411|530038793|FG002|Overall Study|Sponsor Decision|2|||
146966412|NCT02335411|530038791|FG000|Overall Study|Adverse Event|9|||
146966413|NCT02335411|530038792|FG001|Overall Study|Adverse Event|0|||
146966414|NCT02335411|530038793|FG002|Overall Study|Adverse Event|0|||
146966415|NCT04150107|530038797|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
146966416|NCT04150107|530038798|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
146966417|NCT04150107|530038797|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
146966418|NCT04150107|530038798|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
146966419|NCT00650806|530038799|FG000|Overall Study|Adverse Event|0|||
146966420|NCT00650806|530038800|FG001|Overall Study|Adverse Event|5|||
146966421|NCT00650806|530038801|FG002|Overall Study|Adverse Event|3|||
146966422|NCT00650806|530038802|FG003|Overall Study|Adverse Event|4|||
146966423|NCT00650806|530038799|FG000|Overall Study|Lost to Follow-up|7|||
146966424|NCT00650806|530038800|FG001|Overall Study|Lost to Follow-up|6|||
146966425|NCT00650806|530038801|FG002|Overall Study|Lost to Follow-up|11|||
146966426|NCT00650806|530038802|FG003|Overall Study|Lost to Follow-up|10|||
146628006|NCT03697252|528813545|FG000|Overall Study|Lost to Follow-up|0|||
146764170|NCT00906698|529302993|FG005|Overall Study|Withdrawal by Subject|0|||
146764171|NCT00906698|529302988|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
146966427|NCT00650806|530038799|FG000|Overall Study|Protocol Violation|0|||
146966428|NCT00650806|530038800|FG001|Overall Study|Protocol Violation|0|||
146966429|NCT00650806|530038801|FG002|Overall Study|Protocol Violation|0|||
146966430|NCT00650806|530038802|FG003|Overall Study|Protocol Violation|1|||
146966431|NCT00650806|530038799|FG000|Overall Study|Pregnancy|0|||
146966432|NCT00650806|530038800|FG001|Overall Study|Pregnancy|0|||
146966433|NCT00650806|530038801|FG002|Overall Study|Pregnancy|0|||
146966434|NCT00650806|530038802|FG003|Overall Study|Pregnancy|1|||
146966435|NCT00650806|530038799|FG000|Overall Study|Withdrawal by Subject|7|||
146966436|NCT00650806|530038800|FG001|Overall Study|Withdrawal by Subject|5|||
146966437|NCT00650806|530038801|FG002|Overall Study|Withdrawal by Subject|8|||
146975332|NCT00572156|530073539|FG000|Overall Study|Protocol Violation|1|||
146540482|NCT03765073|528487589|FG020|Stage 3|Withdrawal by parent/guardian|9|||
146540483|NCT03765073|528487569|FG000|Stage 3|Withdrawal by Subject|0|||
146540484|NCT03765073|528487570|FG001|Stage 3|Withdrawal by Subject|0|||
146540485|NCT03765073|528487571|FG002|Stage 3|Withdrawal by Subject|0|||
146540486|NCT03765073|528487572|FG003|Stage 3|Withdrawal by Subject|0|||
146540487|NCT03765073|528487573|FG004|Stage 3|Withdrawal by Subject|0|||
146540488|NCT03765073|528487574|FG005|Stage 3|Withdrawal by Subject|0|||
146540489|NCT03765073|528487575|FG006|Stage 3|Withdrawal by Subject|0|||
146540490|NCT03765073|528487576|FG007|Stage 3|Withdrawal by Subject|0|||
146540491|NCT03765073|528487577|FG008|Stage 3|Withdrawal by Subject|0|||
146540492|NCT03765073|528487578|FG009|Stage 3|Withdrawal by Subject|0|||
146540493|NCT03765073|528487579|FG010|Stage 3|Withdrawal by Subject|0|||
146540494|NCT03765073|528487580|FG011|Stage 3|Withdrawal by Subject|0|||
146540495|NCT03765073|528487581|FG012|Stage 3|Withdrawal by Subject|0|||
146540496|NCT03765073|528487582|FG013|Stage 3|Withdrawal by Subject|0|||
146540497|NCT03765073|528487583|FG014|Stage 3|Withdrawal by Subject|0|||
146540498|NCT03765073|528487584|FG015|Stage 3|Withdrawal by Subject|0|||
146540499|NCT03765073|528487585|FG016|Stage 3|Withdrawal by Subject|0|||
146540500|NCT03765073|528487586|FG017|Stage 3|Withdrawal by Subject|8|||
146540501|NCT03765073|528487587|FG018|Stage 3|Withdrawal by Subject|11|||
146540502|NCT03765073|528487588|FG019|Stage 3|Withdrawal by Subject|0|||
146540503|NCT03765073|528487589|FG020|Stage 3|Withdrawal by Subject|0|||
146540504|NCT03188822|528487596|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
146540505|NCT03188822|528487596|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
146540506|NCT04537299|528487597|FG000|Overall Study|Withdrawal by Subject|2|||
146540507|NCT04537299|528487598|FG001|Overall Study|Withdrawal by Subject|0|||
146540508|NCT04537299|528487597|FG000|Overall Study|Protocol Violation|1|||
146540509|NCT04537299|528487598|FG001|Overall Study|Protocol Violation|1|||
146540510|NCT03034967|528487603|FG000|Overall Study|Withdrawal by Subject|9|||
146540511|NCT03034967|528487604|FG001|Overall Study|Withdrawal by Subject|2|||
146540512|NCT03034967|528487605|FG002|Overall Study|Withdrawal by Subject|6|||
146540513|NCT03034967|528487606|FG003|Overall Study|Withdrawal by Subject|6|||
146540514|NCT03034967|528487607|FG004|Overall Study|Withdrawal by Subject|9|||
146540515|NCT03034967|528487608|FG005|Overall Study|Withdrawal by Subject|2|||
146540516|NCT03034967|528487603|FG000|Overall Study|Physician Decision|1|||
146540517|NCT03034967|528487604|FG001|Overall Study|Physician Decision|0|||
146540518|NCT03034967|528487605|FG002|Overall Study|Physician Decision|1|||
146872234|NCT00702325|529703198|FG000|Overall Study|Adverse Event|1|||
146872235|NCT00702325|529703199|FG001|Overall Study|Adverse Event|0|||
146872236|NCT00702325|529703198|FG000|Overall Study|Withdrawal by Subject|7|||
146872237|NCT00702325|529703199|FG001|Overall Study|Withdrawal by Subject|7|||
146872238|NCT00702325|529703198|FG000|Overall Study|Lost to Follow-up|3|||
146872239|NCT00702325|529703199|FG001|Overall Study|Lost to Follow-up|4|||
146872240|NCT00702325|529703198|FG000|Overall Study|Incorrect enrollment|5|||
146872241|NCT00702325|529703199|FG001|Overall Study|Incorrect enrollment|7|||
146872242|NCT00702325|529703198|FG000|Overall Study|Developed study discontinuation criteria|18|||
146872243|NCT00702325|529703199|FG001|Overall Study|Developed study discontinuation criteria|28|||
146872244|NCT00702325|529703198|FG000|Overall Study|Severe noncompliance to protocol|3|||
146872245|NCT00702325|529703199|FG001|Overall Study|Severe noncompliance to protocol|3|||
146872246|NCT00702325|529703198|FG000|Overall Study|Termination due to lab results|1|||
146872247|NCT00702325|529703199|FG001|Overall Study|Termination due to lab results|0|||
146872248|NCT00702325|529703198|FG000|Overall Study|Didn't follow study medication dosage|0|||
146872249|NCT00702325|529703199|FG001|Overall Study|Didn't follow study medication dosage|2|||
146872250|NCT00702325|529703198|FG000|Overall Study|Withdrew consent|0|||
146872251|NCT00702325|529703199|FG001|Overall Study|Withdrew consent|1|||
146872252|NCT00702325|529703198|FG000|Overall Study|Incorrectly Discontinued|0|||
146872253|NCT00702325|529703199|FG001|Overall Study|Incorrectly Discontinued|1|||
146872254|NCT04556136|529703203|FG000|Overall Study|Lost to Follow-up|6|||
146872255|NCT04556136|529703204|FG001|Overall Study|Lost to Follow-up|6|||
146872256|NCT04556136|529703203|FG000|Overall Study|Physician Decision|2|||
146872257|NCT04556136|529703204|FG001|Overall Study|Physician Decision|1|||
146872258|NCT04556136|529703203|FG000|Overall Study|Withdrawal by Subject|2|||
146872259|NCT04556136|529703204|FG001|Overall Study|Withdrawal by Subject|1|||
146872260|NCT01022502|529703207|FG000|Overall Study|Adverse Event|1|||
146872261|NCT01022502|529703207|FG000|Overall Study|employment related reasons|1|||
146872262|NCT01022502|529703207|FG000|Overall Study|Withdrawal by Subject|1|||
146872263|NCT02566577|529703209|FG000|Overall Study|Withdrawal by Subject|1|||
146872264|NCT02566577|529703210|FG001|Overall Study|Withdrawal by Subject|1|||
146872265|NCT02566577|529703209|FG000|Overall Study|Equipment failure|1|||
146872266|NCT02566577|529703210|FG001|Overall Study|Equipment failure|1|||
146872267|NCT02566577|529703209|FG000|Overall Study|Physical limitation|1|||
146872268|NCT02566577|529703210|FG001|Overall Study|Physical limitation|0|||
146872269|NCT00073528|529703219|FG000|Overall Study|Death|488|||
146540519|NCT03034967|528487606|FG003|Overall Study|Physician Decision|1|||
146540520|NCT03034967|528487607|FG004|Overall Study|Physician Decision|1|||
146540521|NCT03034967|528487608|FG005|Overall Study|Physician Decision|0|||
146872270|NCT00073528|529703220|FG001|Overall Study|Death|473|||
146540522|NCT03034967|528487603|FG000|Overall Study|Lost to Follow-up|0|||
146540523|NCT03034967|528487604|FG001|Overall Study|Lost to Follow-up|0|||
146540524|NCT03034967|528487605|FG002|Overall Study|Lost to Follow-up|0|||
146540525|NCT03034967|528487606|FG003|Overall Study|Lost to Follow-up|1|||
146540526|NCT03034967|528487607|FG004|Overall Study|Lost to Follow-up|0|||
146540527|NCT03034967|528487608|FG005|Overall Study|Lost to Follow-up|2|||
146540528|NCT03034967|528487603|FG000|Overall Study|Liver function test abnormality|0|||
146540529|NCT03034967|528487604|FG001|Overall Study|Liver function test abnormality|0|||
146540530|NCT03034967|528487605|FG002|Overall Study|Liver function test abnormality|1|||
146540531|NCT03034967|528487606|FG003|Overall Study|Liver function test abnormality|0|||
146540532|NCT03034967|528487607|FG004|Overall Study|Liver function test abnormality|0|||
146540533|NCT03034967|528487608|FG005|Overall Study|Liver function test abnormality|0|||
146540534|NCT03034967|528487603|FG000|Overall Study|Protocol Violation|1|||
146540535|NCT03034967|528487604|FG001|Overall Study|Protocol Violation|0|||
146540536|NCT03034967|528487605|FG002|Overall Study|Protocol Violation|0|||
146540537|NCT03034967|528487606|FG003|Overall Study|Protocol Violation|0|||
146540538|NCT03034967|528487607|FG004|Overall Study|Protocol Violation|0|||
146540539|NCT03034967|528487608|FG005|Overall Study|Protocol Violation|2|||
146540540|NCT03034967|528487603|FG000|Overall Study|Lack of Efficacy|0|||
146540541|NCT03034967|528487604|FG001|Overall Study|Lack of Efficacy|1|||
146540542|NCT03034967|528487605|FG002|Overall Study|Lack of Efficacy|2|||
146540543|NCT03034967|528487606|FG003|Overall Study|Lack of Efficacy|1|||
146540544|NCT03034967|528487607|FG004|Overall Study|Lack of Efficacy|1|||
146540545|NCT03034967|528487608|FG005|Overall Study|Lack of Efficacy|0|||
146540546|NCT03034967|528487603|FG000|Overall Study|Adverse Event, non-fatal|3|||
146540547|NCT03034967|528487604|FG001|Overall Study|Adverse Event, non-fatal|1|||
146540548|NCT03034967|528487605|FG002|Overall Study|Adverse Event, non-fatal|2|||
146540549|NCT03034967|528487606|FG003|Overall Study|Adverse Event, non-fatal|0|||
146540550|NCT03034967|528487607|FG004|Overall Study|Adverse Event, non-fatal|2|||
146540551|NCT03034967|528487608|FG005|Overall Study|Adverse Event, non-fatal|8|||
146540552|NCT03034967|528487603|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
146540553|NCT03034967|528487604|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
146540554|NCT03034967|528487605|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
146540555|NCT03034967|528487606|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
146540556|NCT03034967|528487607|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
146540557|NCT03034967|528487608|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
146540558|NCT03806296|528487609|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
146540559|NCT03806296|528487610|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
146540560|NCT03806296|528487611|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
146540561|NCT03806296|528487609|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
146540562|NCT03806296|528487610|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
146540563|NCT03806296|528487611|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
146540564|NCT03806296|528487609|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
146540565|NCT03806296|528487610|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
146540566|NCT03806296|528487611|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
146540567|NCT00790036|528487631|FG000|Overall Study|Abnormal lab values|3|||
146540568|NCT00790036|528487632|FG001|Overall Study|Abnormal lab values|2|||
146540569|NCT00790036|528487631|FG000|Overall Study|Administrative problems|5|||
146540570|NCT00790036|528487632|FG001|Overall Study|Administrative problems|9|||
146540571|NCT00790036|528487631|FG000|Overall Study|Adverse Event|113|||
146540572|NCT00790036|528487632|FG001|Overall Study|Adverse Event|44|||
146540573|NCT00790036|528487631|FG000|Overall Study|Death|1|||
146540574|NCT00790036|528487632|FG001|Overall Study|Death|0|||
146540575|NCT00790036|528487631|FG000|Overall Study|Disease progression|24|||
146540576|NCT00790036|528487632|FG001|Overall Study|Disease progression|48|||
146540577|NCT00790036|528487631|FG000|Overall Study|Lost to Follow-up|1|||
146540578|NCT00790036|528487632|FG001|Overall Study|Lost to Follow-up|2|||
146540579|NCT00790036|528487631|FG000|Overall Study|Protocol Violation|10|||
146540580|NCT00790036|528487632|FG001|Overall Study|Protocol Violation|2|||
146540581|NCT00790036|528487631|FG000|Overall Study|Withdrawal by Subject|18|||
146540582|NCT00790036|528487632|FG001|Overall Study|Withdrawal by Subject|7|||
146540583|NCT00790036|528487631|FG000|Overall Study|Subject/guardian decision|20|||
146540584|NCT00790036|528487632|FG001|Overall Study|Subject/guardian decision|7|||
146540585|NCT02442349|528487635|FG000|Overall Study|Death|95|||
146540586|NCT02442349|528487635|FG000|Overall Study|Withdrawal by Subject|27|||
146540587|NCT02442349|528487635|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
146628007|NCT03697252|528813546|FG001|Overall Study|Lost to Follow-up|1|||
146540588|NCT02442349|528487635|FG000|Overall Study|Lost to Follow-up|1|||
146540589|NCT00879658|528487636|FG000|Overall Study|Abnormal laboratory value(s)|3|||
146540590|NCT00879658|528487637|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146540591|NCT00879658|528487638|FG002|Overall Study|Abnormal laboratory value(s)|0|||
146628008|NCT03697252|528813545|FG000|Overall Study|Physician Decision|1|||
146540592|NCT00879658|528487639|FG003|Overall Study|Abnormal laboratory value(s)|1|||
146540593|NCT00879658|528487640|FG004|Overall Study|Abnormal laboratory value(s)|0|||
146628009|NCT03697252|528813546|FG001|Overall Study|Physician Decision|1|||
146540594|NCT00879658|528487641|FG005|Overall Study|Abnormal laboratory value(s)|0|||
146540595|NCT00879658|528487642|FG006|Overall Study|Abnormal laboratory value(s)|0|||
146540596|NCT00879658|528487636|FG000|Overall Study|Administrative problems|2|||
146540597|NCT00879658|528487637|FG001|Overall Study|Administrative problems|1|||
146540598|NCT00879658|528487638|FG002|Overall Study|Administrative problems|0|||
146540599|NCT00879658|528487639|FG003|Overall Study|Administrative problems|1|||
146540600|NCT00879658|528487640|FG004|Overall Study|Administrative problems|0|||
146540601|NCT00879658|528487641|FG005|Overall Study|Administrative problems|0|||
146540602|NCT00879658|528487642|FG006|Overall Study|Administrative problems|0|||
146540603|NCT00879658|528487636|FG000|Overall Study|Adverse Event|6|||
146540604|NCT00879658|528487637|FG001|Overall Study|Adverse Event|4|||
146540605|NCT00879658|528487638|FG002|Overall Study|Adverse Event|3|||
146540606|NCT00879658|528487639|FG003|Overall Study|Adverse Event|1|||
146540607|NCT00879658|528487640|FG004|Overall Study|Adverse Event|2|||
146540608|NCT00879658|528487641|FG005|Overall Study|Adverse Event|0|||
146540609|NCT00879658|528487642|FG006|Overall Study|Adverse Event|0|||
146540610|NCT00879658|528487636|FG000|Overall Study|Protocol Violation|1|||
146540611|NCT00879658|528487637|FG001|Overall Study|Protocol Violation|0|||
146540612|NCT00879658|528487638|FG002|Overall Study|Protocol Violation|0|||
146540613|NCT00879658|528487639|FG003|Overall Study|Protocol Violation|0|||
146540614|NCT00879658|528487640|FG004|Overall Study|Protocol Violation|0|||
146540615|NCT00879658|528487641|FG005|Overall Study|Protocol Violation|0|||
146540616|NCT00879658|528487642|FG006|Overall Study|Protocol Violation|0|||
146540617|NCT00879658|528487636|FG000|Overall Study|Withdrawal by Subject|3|||
146540618|NCT00879658|528487637|FG001|Overall Study|Withdrawal by Subject|0|||
146540619|NCT00879658|528487638|FG002|Overall Study|Withdrawal by Subject|2|||
146540620|NCT00879658|528487639|FG003|Overall Study|Withdrawal by Subject|0|||
146540621|NCT00879658|528487640|FG004|Overall Study|Withdrawal by Subject|0|||
146540622|NCT00879658|528487641|FG005|Overall Study|Withdrawal by Subject|1|||
146872271|NCT00073528|529703219|FG000|Overall Study|Lost to Follow-up|52|||
146872272|NCT00073528|529703220|FG001|Overall Study|Lost to Follow-up|45|||
146872273|NCT00073528|529703219|FG000|Overall Study|Withdrawal by Subject|50|||
146872274|NCT00073528|529703220|FG001|Overall Study|Withdrawal by Subject|45|||
146540623|NCT00879658|528487642|FG006|Overall Study|Withdrawal by Subject|0|||
146872275|NCT00073528|529703219|FG000|Overall Study|Study terminated by Sponsor|10|||
146540624|NCT00879658|528487636|FG000|Overall Study|Lack of Efficacy|0|||
146540625|NCT00879658|528487637|FG001|Overall Study|Lack of Efficacy|0|||
146540626|NCT00879658|528487638|FG002|Overall Study|Lack of Efficacy|2|||
146540627|NCT00879658|528487639|FG003|Overall Study|Lack of Efficacy|0|||
146540628|NCT00879658|528487640|FG004|Overall Study|Lack of Efficacy|0|||
146540629|NCT00879658|528487641|FG005|Overall Study|Lack of Efficacy|0|||
146540630|NCT00879658|528487642|FG006|Overall Study|Lack of Efficacy|0|||
146540631|NCT00879658|528487636|FG000|Overall Study|misrandomized (never received study med)|0|||
146540632|NCT00879658|528487637|FG001|Overall Study|misrandomized (never received study med)|0|||
146540633|NCT00879658|528487638|FG002|Overall Study|misrandomized (never received study med)|0|||
146540634|NCT00879658|528487639|FG003|Overall Study|misrandomized (never received study med)|1|||
146872276|NCT00073528|529703220|FG001|Overall Study|Study terminated by Sponsor|29|||
146872277|NCT00073528|529703219|FG000|Overall Study|Other|18|||
146540635|NCT00879658|528487640|FG004|Overall Study|misrandomized (never received study med)|0|||
146540636|NCT00879658|528487641|FG005|Overall Study|misrandomized (never received study med)|0|||
146540637|NCT00879658|528487642|FG006|Overall Study|misrandomized (never received study med)|0|||
146540638|NCT00639509|528487645|FG000|Overall Study|Death|1|||
146540639|NCT00294658|528487646|FG000|Overall Study|Death|0|||
146540640|NCT00294658|528487647|FG001|Overall Study|Death|1|||
146540641|NCT00294658|528487646|FG000|Overall Study|Lost to Follow-up|4|||
146540642|NCT00294658|528487647|FG001|Overall Study|Lost to Follow-up|0|||
146540643|NCT00294658|528487646|FG000|Overall Study|Physician Decision|1|||
146540644|NCT00294658|528487647|FG001|Overall Study|Physician Decision|2|||
146540645|NCT00294658|528487646|FG000|Overall Study|Pregnancy|0|||
146540646|NCT00294658|528487647|FG001|Overall Study|Pregnancy|1|||
146540647|NCT00294658|528487646|FG000|Overall Study|Withdrawal by Subject|0|||
146540648|NCT00294658|528487647|FG001|Overall Study|Withdrawal by Subject|4|||
146540649|NCT00294658|528487646|FG000|Overall Study|Found to have invasive thymoma|1|||
146540650|NCT00294658|528487647|FG001|Overall Study|Found to have invasive thymoma|0|||
146540651|NCT00294658|528487646|FG000|Overall Study|Patient and family were not satisfied|0|||
146540652|NCT00294658|528487647|FG001|Overall Study|Patient and family were not satisfied|1|||
146540653|NCT01402700|528487648|FG000|Overall Study|Death|3|||
146540654|NCT01402700|528487648|FG000|Overall Study|Withdrawal by Subject|3|||
146540655|NCT01402700|528487648|FG000|Overall Study|Missed Visit|1|||
146540656|NCT03507790|528487649|FG000|Overall Study|Adverse Event|0|||
146540657|NCT03507790|528487650|FG001|Overall Study|Adverse Event|11|||
146540658|NCT03507790|528487651|FG002|Overall Study|Adverse Event|3|||
146540659|NCT03507790|528487649|FG000|Overall Study|Withdrawal by Subject|2|||
146540660|NCT03507790|528487650|FG001|Overall Study|Withdrawal by Subject|0|||
146540661|NCT03507790|528487651|FG002|Overall Study|Withdrawal by Subject|0|||
146540662|NCT03507790|528487649|FG000|Overall Study|Subject moved to another location|1|||
146540663|NCT03507790|528487650|FG001|Overall Study|Subject moved to another location|2|||
146540664|NCT03507790|528487651|FG002|Overall Study|Subject moved to another location|0|||
146540665|NCT03507790|528487649|FG000|Overall Study|Non-compliance with study drug|0|||
146540666|NCT03507790|528487650|FG001|Overall Study|Non-compliance with study drug|0|||
146540667|NCT03507790|528487651|FG002|Overall Study|Non-compliance with study drug|1|||
146540668|NCT03507790|528487649|FG000|Overall Study|COVID 19 Pandemic|0|||
146540669|NCT03507790|528487650|FG001|Overall Study|COVID 19 Pandemic|1|||
146540670|NCT03507790|528487651|FG002|Overall Study|COVID 19 Pandemic|0|||
146540671|NCT03507790|528487649|FG000|Overall Study|Lost to Follow-up|0|||
146540672|NCT03507790|528487650|FG001|Overall Study|Lost to Follow-up|1|||
146540673|NCT03507790|528487651|FG002|Overall Study|Lost to Follow-up|0|||
146540674|NCT03507790|528487649|FG000|Overall Study|Discontinuation of the trial at the site|1|||
146540675|NCT03507790|528487650|FG001|Overall Study|Discontinuation of the trial at the site|1|||
146540676|NCT03507790|528487651|FG002|Overall Study|Discontinuation of the trial at the site|0|||
146540677|NCT03507790|528487649|FG000|Overall Study|Randomized in error|0|||
146540678|NCT03507790|528487650|FG001|Overall Study|Randomized in error|0|||
146540679|NCT03507790|528487651|FG002|Overall Study|Randomized in error|1|||
146540680|NCT00157755|528487653|FG000|Overall Study|Death|2|||
146540681|NCT00157755|528487654|FG001|Overall Study|Death|3|||
146540682|NCT00157755|528487655|FG002|Overall Study|Death|3|||
146540683|NCT00157755|528487656|FG003|Overall Study|Death|2|||
146540684|NCT00157755|528487657|FG004|Overall Study|Death|0|||
146540685|NCT00157755|528487658|FG005|Overall Study|Death|0|||
146540686|NCT00157755|528487653|FG000|Overall Study|Lost to Follow-up|0|||
146540687|NCT00157755|528487654|FG001|Overall Study|Lost to Follow-up|0|||
146540688|NCT00157755|528487655|FG002|Overall Study|Lost to Follow-up|1|||
146540689|NCT00157755|528487656|FG003|Overall Study|Lost to Follow-up|0|||
146540690|NCT00157755|528487657|FG004|Overall Study|Lost to Follow-up|0|||
146540691|NCT00157755|528487658|FG005|Overall Study|Lost to Follow-up|0|||
146540692|NCT00157755|528487653|FG000|Overall Study|Withdrawal by Subject|0|||
146540693|NCT00157755|528487654|FG001|Overall Study|Withdrawal by Subject|0|||
146540694|NCT00157755|528487655|FG002|Overall Study|Withdrawal by Subject|1|||
146540695|NCT00157755|528487656|FG003|Overall Study|Withdrawal by Subject|1|||
146540696|NCT00157755|528487657|FG004|Overall Study|Withdrawal by Subject|1|||
146540697|NCT00157755|528487658|FG005|Overall Study|Withdrawal by Subject|2|||
146540698|NCT00157755|528487653|FG000|Overall Study|Explant due to infection|0|||
146540699|NCT00157755|528487654|FG001|Overall Study|Explant due to infection|0|||
146540700|NCT00157755|528487655|FG002|Overall Study|Explant due to infection|1|||
146540701|NCT00157755|528487656|FG003|Overall Study|Explant due to infection|0|||
146540702|NCT00157755|528487657|FG004|Overall Study|Explant due to infection|0|||
146540703|NCT00157755|528487658|FG005|Overall Study|Explant due to infection|0|||
146540704|NCT00157755|528487653|FG000|Overall Study|Medical reason|0|||
146540705|NCT00157755|528487654|FG001|Overall Study|Medical reason|0|||
146540706|NCT00157755|528487655|FG002|Overall Study|Medical reason|1|||
146540707|NCT00157755|528487656|FG003|Overall Study|Medical reason|1|||
146540708|NCT00157755|528487657|FG004|Overall Study|Medical reason|0|||
146540709|NCT00157755|528487658|FG005|Overall Study|Medical reason|0|||
146540710|NCT00157755|528487653|FG000|Overall Study|Study site closure|0|||
146540711|NCT00157755|528487654|FG001|Overall Study|Study site closure|1|||
146540712|NCT00157755|528487655|FG002|Overall Study|Study site closure|0|||
146872278|NCT00073528|529703220|FG001|Overall Study|Other|19|||
146628010|NCT03697252|528813545|FG000|Overall Study|Other|0|||
146540713|NCT00157755|528487656|FG003|Overall Study|Study site closure|0|||
146540714|NCT00157755|528487657|FG004|Overall Study|Study site closure|0|||
146540715|NCT00157755|528487658|FG005|Overall Study|Study site closure|0|||
146540716|NCT00157755|528487653|FG000|Overall Study|Subject non-compliance|0|||
146540717|NCT00157755|528487654|FG001|Overall Study|Subject non-compliance|0|||
146540718|NCT00157755|528487655|FG002|Overall Study|Subject non-compliance|0|||
146540719|NCT00157755|528487656|FG003|Overall Study|Subject non-compliance|0|||
146540720|NCT00157755|528487657|FG004|Overall Study|Subject non-compliance|0|||
146540721|NCT00157755|528487658|FG005|Overall Study|Subject non-compliance|1|||
146540722|NCT00157755|528487653|FG000|Overall Study|Study completion|0|||
146540723|NCT00157755|528487654|FG001|Overall Study|Study completion|0|||
146540724|NCT00157755|528487655|FG002|Overall Study|Study completion|0|||
146540725|NCT00157755|528487656|FG003|Overall Study|Study completion|0|||
146540726|NCT00157755|528487657|FG004|Overall Study|Study completion|1|||
146540727|NCT00157755|528487658|FG005|Overall Study|Study completion|2|||
146540728|NCT03314935|528487666|FG000|Phase 1|Death|4|||
146540729|NCT03314935|528487667|FG001|Phase 1|Death|2|||
146540730|NCT03314935|528487668|FG002|Phase 1|Death|5|||
146540731|NCT03314935|528487669|FG003|Phase 1|Death|4|||
146540732|NCT03314935|528487670|FG004|Phase 1|Death|3|||
146540733|NCT03314935|528487671|FG005|Phase 1|Death|4|||
146540734|NCT03314935|528487672|FG006|Phase 1|Death|5|||
146540735|NCT03314935|528487673|FG007|Phase 1|Death|4|||
146540736|NCT03314935|528487674|FG008|Phase 1|Death|3|||
146540737|NCT03314935|528487675|FG009|Phase 1|Death|0|||
146540738|NCT03314935|528487676|FG010|Phase 1|Death|0|||
146540739|NCT03314935|528487677|FG011|Phase 1|Death|0|||
146540740|NCT03314935|528487678|FG012|Phase 1|Death|0|||
146540741|NCT03314935|528487679|FG013|Phase 1|Death|0|||
146540742|NCT03314935|528487680|FG014|Phase 1|Death|0|||
146540743|NCT03314935|528487666|FG000|Phase 1|Withdrawal by Subject|2|||
146540744|NCT03314935|528487667|FG001|Phase 1|Withdrawal by Subject|1|||
146540745|NCT03314935|528487668|FG002|Phase 1|Withdrawal by Subject|1|||
146540746|NCT03314935|528487669|FG003|Phase 1|Withdrawal by Subject|2|||
146540747|NCT03314935|528487670|FG004|Phase 1|Withdrawal by Subject|1|||
146540748|NCT03314935|528487671|FG005|Phase 1|Withdrawal by Subject|0|||
146540749|NCT03314935|528487672|FG006|Phase 1|Withdrawal by Subject|1|||
146540750|NCT03314935|528487673|FG007|Phase 1|Withdrawal by Subject|0|||
146540751|NCT03314935|528487674|FG008|Phase 1|Withdrawal by Subject|1|||
146540752|NCT03314935|528487675|FG009|Phase 1|Withdrawal by Subject|0|||
146540753|NCT03314935|528487676|FG010|Phase 1|Withdrawal by Subject|0|||
146540754|NCT03314935|528487677|FG011|Phase 1|Withdrawal by Subject|0|||
146540755|NCT03314935|528487678|FG012|Phase 1|Withdrawal by Subject|0|||
146540756|NCT03314935|528487679|FG013|Phase 1|Withdrawal by Subject|0|||
146540757|NCT03314935|528487680|FG014|Phase 1|Withdrawal by Subject|0|||
146540758|NCT03314935|528487666|FG000|Phase 1|Progressive Disease|2|||
146540759|NCT03314935|528487667|FG001|Phase 1|Progressive Disease|0|||
146540760|NCT03314935|528487668|FG002|Phase 1|Progressive Disease|0|||
146540761|NCT03314935|528487669|FG003|Phase 1|Progressive Disease|1|||
146540762|NCT03314935|528487670|FG004|Phase 1|Progressive Disease|0|||
146540763|NCT03314935|528487671|FG005|Phase 1|Progressive Disease|0|||
146540764|NCT03314935|528487672|FG006|Phase 1|Progressive Disease|0|||
146540765|NCT03314935|528487673|FG007|Phase 1|Progressive Disease|0|||
146540766|NCT03314935|528487674|FG008|Phase 1|Progressive Disease|0|||
146540767|NCT03314935|528487675|FG009|Phase 1|Progressive Disease|0|||
146540768|NCT03314935|528487676|FG010|Phase 1|Progressive Disease|0|||
146540769|NCT03314935|528487677|FG011|Phase 1|Progressive Disease|0|||
146540770|NCT03314935|528487678|FG012|Phase 1|Progressive Disease|0|||
146540771|NCT03314935|528487679|FG013|Phase 1|Progressive Disease|0|||
146540772|NCT03314935|528487680|FG014|Phase 1|Progressive Disease|0|||
146540773|NCT03314935|528487666|FG000|Phase 1|Study Terminated by Sponsor|0|||
146540774|NCT03314935|528487667|FG001|Phase 1|Study Terminated by Sponsor|1|||
146540775|NCT03314935|528487668|FG002|Phase 1|Study Terminated by Sponsor|0|||
146540776|NCT03314935|528487669|FG003|Phase 1|Study Terminated by Sponsor|0|||
146540777|NCT03314935|528487670|FG004|Phase 1|Study Terminated by Sponsor|0|||
146540778|NCT03314935|528487671|FG005|Phase 1|Study Terminated by Sponsor|0|||
146540779|NCT03314935|528487672|FG006|Phase 1|Study Terminated by Sponsor|0|||
146540780|NCT03314935|528487673|FG007|Phase 1|Study Terminated by Sponsor|0|||
146540781|NCT03314935|528487674|FG008|Phase 1|Study Terminated by Sponsor|1|||
146540782|NCT03314935|528487675|FG009|Phase 1|Study Terminated by Sponsor|0|||
146540783|NCT03314935|528487676|FG010|Phase 1|Study Terminated by Sponsor|0|||
146540784|NCT03314935|528487677|FG011|Phase 1|Study Terminated by Sponsor|0|||
146540785|NCT03314935|528487678|FG012|Phase 1|Study Terminated by Sponsor|0|||
146540786|NCT03314935|528487679|FG013|Phase 1|Study Terminated by Sponsor|0|||
146540787|NCT03314935|528487680|FG014|Phase 1|Study Terminated by Sponsor|0|||
146540788|NCT03314935|528487666|FG000|Phase 1|"Captured as Other in Database"|0|||
146540789|NCT03314935|528487667|FG001|Phase 1|"Captured as Other in Database"|2|||
146540790|NCT03314935|528487668|FG002|Phase 1|"Captured as Other in Database"|0|||
146540791|NCT03314935|528487669|FG003|Phase 1|"Captured as Other in Database"|0|||
146540792|NCT03314935|528487670|FG004|Phase 1|"Captured as Other in Database"|0|||
146540793|NCT03314935|528487671|FG005|Phase 1|"Captured as Other in Database"|0|||
146540794|NCT03314935|528487672|FG006|Phase 1|"Captured as Other in Database"|1|||
146540795|NCT03314935|528487673|FG007|Phase 1|"Captured as Other in Database"|1|||
146540796|NCT03314935|528487674|FG008|Phase 1|"Captured as Other in Database"|1|||
146628011|NCT03697252|528813546|FG001|Overall Study|Other|1|||
146628012|NCT00106704|528813547|FG000|Overall Study|Adverse Event|10|||
146540797|NCT03314935|528487675|FG009|Phase 1|"Captured as Other in Database"|0|||
146540798|NCT03314935|528487676|FG010|Phase 1|"Captured as Other in Database"|0|||
146540799|NCT03314935|528487677|FG011|Phase 1|"Captured as Other in Database"|0|||
146540800|NCT03314935|528487678|FG012|Phase 1|"Captured as Other in Database"|0|||
146540801|NCT03314935|528487679|FG013|Phase 1|"Captured as Other in Database"|0|||
146540802|NCT03314935|528487680|FG014|Phase 1|"Captured as Other in Database"|0|||
146540803|NCT03314935|528487666|FG000|Phase 1|Lost to Follow-up|0|||
146540804|NCT03314935|528487667|FG001|Phase 1|Lost to Follow-up|0|||
146540805|NCT03314935|528487668|FG002|Phase 1|Lost to Follow-up|0|||
146540806|NCT03314935|528487669|FG003|Phase 1|Lost to Follow-up|0|||
146540807|NCT03314935|528487670|FG004|Phase 1|Lost to Follow-up|0|||
146540808|NCT03314935|528487671|FG005|Phase 1|Lost to Follow-up|0|||
146540809|NCT03314935|528487672|FG006|Phase 1|Lost to Follow-up|0|||
146540810|NCT03314935|528487673|FG007|Phase 1|Lost to Follow-up|0|||
146540811|NCT03314935|528487674|FG008|Phase 1|Lost to Follow-up|1|||
146540812|NCT03314935|528487675|FG009|Phase 1|Lost to Follow-up|0|||
146540813|NCT03314935|528487676|FG010|Phase 1|Lost to Follow-up|0|||
146540814|NCT03314935|528487677|FG011|Phase 1|Lost to Follow-up|0|||
146540815|NCT03314935|528487678|FG012|Phase 1|Lost to Follow-up|0|||
146540816|NCT03314935|528487679|FG013|Phase 1|Lost to Follow-up|0|||
146540817|NCT03314935|528487680|FG014|Phase 1|Lost to Follow-up|0|||
146540818|NCT03314935|528487666|FG000|Phase 2|Death|0|||
146540819|NCT03314935|528487667|FG001|Phase 2|Death|0|||
146540820|NCT03314935|528487668|FG002|Phase 2|Death|0|||
146540821|NCT03314935|528487669|FG003|Phase 2|Death|0|||
146540822|NCT03314935|528487670|FG004|Phase 2|Death|0|||
146540823|NCT03314935|528487671|FG005|Phase 2|Death|0|||
146540824|NCT03314935|528487672|FG006|Phase 2|Death|0|||
146540825|NCT03314935|528487673|FG007|Phase 2|Death|0|||
146540826|NCT03314935|528487674|FG008|Phase 2|Death|0|||
146540827|NCT03314935|528487675|FG009|Phase 2|Death|5|||
146540828|NCT03314935|528487676|FG010|Phase 2|Death|20|||
146540829|NCT03314935|528487677|FG011|Phase 2|Death|6|||
146540830|NCT03314935|528487678|FG012|Phase 2|Death|7|||
146540831|NCT03314935|528487679|FG013|Phase 2|Death|6|||
146540832|NCT03314935|528487680|FG014|Phase 2|Death|17|||
146540833|NCT03314935|528487666|FG000|Phase 2|Withdrawal by Subject|0|||
146540834|NCT03314935|528487667|FG001|Phase 2|Withdrawal by Subject|0|||
146540835|NCT03314935|528487668|FG002|Phase 2|Withdrawal by Subject|0|||
146540836|NCT03314935|528487669|FG003|Phase 2|Withdrawal by Subject|0|||
146540837|NCT03314935|528487670|FG004|Phase 2|Withdrawal by Subject|0|||
146540838|NCT03314935|528487671|FG005|Phase 2|Withdrawal by Subject|0|||
146540839|NCT03314935|528487672|FG006|Phase 2|Withdrawal by Subject|0|||
146540840|NCT03314935|528487673|FG007|Phase 2|Withdrawal by Subject|0|||
146540841|NCT03314935|528487674|FG008|Phase 2|Withdrawal by Subject|0|||
146540842|NCT03314935|528487675|FG009|Phase 2|Withdrawal by Subject|1|||
146540843|NCT03314935|528487676|FG010|Phase 2|Withdrawal by Subject|4|||
146540844|NCT03314935|528487677|FG011|Phase 2|Withdrawal by Subject|0|||
146540845|NCT03314935|528487678|FG012|Phase 2|Withdrawal by Subject|1|||
146540846|NCT03314935|528487679|FG013|Phase 2|Withdrawal by Subject|0|||
146540847|NCT03314935|528487680|FG014|Phase 2|Withdrawal by Subject|1|||
146540848|NCT03314935|528487666|FG000|Phase 2|Progressive Disease|0|||
146540849|NCT03314935|528487667|FG001|Phase 2|Progressive Disease|0|||
146540850|NCT03314935|528487668|FG002|Phase 2|Progressive Disease|0|||
146540851|NCT03314935|528487669|FG003|Phase 2|Progressive Disease|0|||
146540852|NCT03314935|528487670|FG004|Phase 2|Progressive Disease|0|||
146540853|NCT03314935|528487671|FG005|Phase 2|Progressive Disease|0|||
146540854|NCT03314935|528487672|FG006|Phase 2|Progressive Disease|0|||
146540855|NCT03314935|528487673|FG007|Phase 2|Progressive Disease|0|||
146540856|NCT03314935|528487674|FG008|Phase 2|Progressive Disease|0|||
146540857|NCT03314935|528487675|FG009|Phase 2|Progressive Disease|1|||
146872279|NCT00073528|529703219|FG000|Overall Study|Other|9|||
146872280|NCT00073528|529703220|FG001|Overall Study|Other|12|||
146540858|NCT03314935|528487676|FG010|Phase 2|Progressive Disease|1|||
146540859|NCT03314935|528487677|FG011|Phase 2|Progressive Disease|1|||
146540860|NCT03314935|528487678|FG012|Phase 2|Progressive Disease|2|||
146540861|NCT03314935|528487679|FG013|Phase 2|Progressive Disease|0|||
146540862|NCT03314935|528487680|FG014|Phase 2|Progressive Disease|1|||
146540863|NCT03314935|528487666|FG000|Phase 2|Study Terminated by Sponsor|0|||
146540864|NCT03314935|528487667|FG001|Phase 2|Study Terminated by Sponsor|0|||
146540865|NCT03314935|528487668|FG002|Phase 2|Study Terminated by Sponsor|0|||
146540866|NCT03314935|528487669|FG003|Phase 2|Study Terminated by Sponsor|0|||
146540867|NCT03314935|528487670|FG004|Phase 2|Study Terminated by Sponsor|0|||
146540868|NCT03314935|528487671|FG005|Phase 2|Study Terminated by Sponsor|0|||
146540869|NCT03314935|528487672|FG006|Phase 2|Study Terminated by Sponsor|0|||
146540870|NCT03314935|528487673|FG007|Phase 2|Study Terminated by Sponsor|0|||
146540871|NCT03314935|528487674|FG008|Phase 2|Study Terminated by Sponsor|0|||
146540872|NCT03314935|528487675|FG009|Phase 2|Study Terminated by Sponsor|0|||
146540873|NCT03314935|528487676|FG010|Phase 2|Study Terminated by Sponsor|7|||
146540874|NCT03314935|528487677|FG011|Phase 2|Study Terminated by Sponsor|2|||
146540875|NCT03314935|528487678|FG012|Phase 2|Study Terminated by Sponsor|1|||
146540876|NCT03314935|528487679|FG013|Phase 2|Study Terminated by Sponsor|4|||
146540877|NCT03314935|528487680|FG014|Phase 2|Study Terminated by Sponsor|4|||
146540878|NCT03314935|528487666|FG000|Phase 2|Lost to Follow-up|0|||
146540879|NCT03314935|528487667|FG001|Phase 2|Lost to Follow-up|0|||
146540880|NCT03314935|528487668|FG002|Phase 2|Lost to Follow-up|0|||
146540881|NCT03314935|528487669|FG003|Phase 2|Lost to Follow-up|0|||
146540882|NCT03314935|528487670|FG004|Phase 2|Lost to Follow-up|0|||
146540883|NCT03314935|528487671|FG005|Phase 2|Lost to Follow-up|0|||
146540884|NCT03314935|528487672|FG006|Phase 2|Lost to Follow-up|0|||
146540885|NCT03314935|528487673|FG007|Phase 2|Lost to Follow-up|0|||
146540886|NCT03314935|528487674|FG008|Phase 2|Lost to Follow-up|0|||
146540887|NCT03314935|528487675|FG009|Phase 2|Lost to Follow-up|1|||
146540888|NCT03314935|528487676|FG010|Phase 2|Lost to Follow-up|0|||
146540889|NCT03314935|528487677|FG011|Phase 2|Lost to Follow-up|0|||
146540890|NCT03314935|528487678|FG012|Phase 2|Lost to Follow-up|0|||
146540891|NCT03314935|528487679|FG013|Phase 2|Lost to Follow-up|0|||
146540892|NCT03314935|528487680|FG014|Phase 2|Lost to Follow-up|1|||
146540893|NCT03314935|528487666|FG000|Phase 2|Physician Decision|0|||
146540894|NCT03314935|528487667|FG001|Phase 2|Physician Decision|0|||
146540895|NCT03314935|528487668|FG002|Phase 2|Physician Decision|0|||
146540896|NCT03314935|528487669|FG003|Phase 2|Physician Decision|0|||
146540897|NCT03314935|528487670|FG004|Phase 2|Physician Decision|0|||
146540898|NCT03314935|528487671|FG005|Phase 2|Physician Decision|0|||
146540899|NCT03314935|528487672|FG006|Phase 2|Physician Decision|0|||
146540900|NCT03314935|528487673|FG007|Phase 2|Physician Decision|0|||
146540901|NCT03314935|528487674|FG008|Phase 2|Physician Decision|0|||
146540902|NCT03314935|528487675|FG009|Phase 2|Physician Decision|0|||
146540903|NCT03314935|528487676|FG010|Phase 2|Physician Decision|1|||
146540904|NCT03314935|528487677|FG011|Phase 2|Physician Decision|0|||
146540905|NCT03314935|528487678|FG012|Phase 2|Physician Decision|0|||
146540906|NCT03314935|528487679|FG013|Phase 2|Physician Decision|0|||
146540907|NCT03314935|528487680|FG014|Phase 2|Physician Decision|0|||
146540908|NCT01910441|528487681|FG000|Overall Study|Sponsor decision|0|||
146540909|NCT01910441|528487682|FG001|Overall Study|Sponsor decision|2|||
146540910|NCT01910441|528487681|FG000|Overall Study|Lost to Follow-up|6|||
146540911|NCT01910441|528487682|FG001|Overall Study|Lost to Follow-up|5|||
146540912|NCT01910441|528487681|FG000|Overall Study|Withdrawal by Subject|0|||
146540913|NCT01910441|528487682|FG001|Overall Study|Withdrawal by Subject|1|||
146540914|NCT01910441|528487681|FG000|Overall Study|Non-compliance|0|||
146540915|NCT01910441|528487682|FG001|Overall Study|Non-compliance|1|||
146540916|NCT01910441|528487681|FG000|Overall Study|Adverse Event|1|||
146540917|NCT01910441|528487682|FG001|Overall Study|Adverse Event|0|||
146540918|NCT01910441|528487681|FG000|Overall Study|Physician Decision|0|||
146540919|NCT01910441|528487682|FG001|Overall Study|Physician Decision|1|||
146540920|NCT05845619|528487683|FG000|Overall Study|duplicate enrollment|2|||
146540921|NCT05845619|528487684|FG001|Overall Study|duplicate enrollment|2|||
146540922|NCT05845619|528487685|FG002|Overall Study|duplicate enrollment|1|||
146540923|NCT04958707|528487686|FG000|Post Intervention|Withdrawal by Subject|1|||
146540924|NCT04958707|528487687|FG001|Post Intervention|Withdrawal by Subject|0|||
146540925|NCT04958707|528487688|FG002|Post Intervention|Withdrawal by Subject|0|||
146540926|NCT04958707|528487686|FG000|3 Months Follow- up|Lost to Follow-up|0|||
146540927|NCT04958707|528487687|FG001|3 Months Follow- up|Lost to Follow-up|3|||
146540928|NCT04958707|528487688|FG002|3 Months Follow- up|Lost to Follow-up|0|||
146540929|NCT04958707|528487686|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
146540930|NCT04958707|528487687|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
146540931|NCT04958707|528487688|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
146540932|NCT05523297|528487692|FG000|Overall Study|Death|7|||
146540933|NCT05523297|528487693|FG001|Overall Study|Death|8|||
146540934|NCT05523297|528487692|FG000|Overall Study|Lost to Follow-up|2|||
146540935|NCT05523297|528487693|FG001|Overall Study|Lost to Follow-up|1|||
146540936|NCT01299909|528487696|FG000|Overall Study|Lost to Follow-up|22|||
146540937|NCT01299909|528487697|FG001|Overall Study|Lost to Follow-up|18|||
146540938|NCT01299909|528487698|FG002|Overall Study|Lost to Follow-up|17|||
146540939|NCT01192178|528487699|FG000|Overall Study|Withdrawal by Subject|6|||
146540940|NCT01192178|528487700|FG001|Overall Study|Withdrawal by Subject|10|||
146540941|NCT01192178|528487699|FG000|Overall Study|Protocol Violation|10|||
146540942|NCT01192178|528487700|FG001|Overall Study|Protocol Violation|3|||
146540943|NCT01192178|528487699|FG000|Overall Study|Physician Decision|2|||
146540944|NCT01192178|528487700|FG001|Overall Study|Physician Decision|4|||
146540945|NCT01192178|528487699|FG000|Overall Study|Lost to Follow-up|3|||
146540946|NCT01192178|528487700|FG001|Overall Study|Lost to Follow-up|3|||
146540947|NCT01192178|528487699|FG000|Overall Study|Adverse Event|2|||
146540948|NCT01192178|528487700|FG001|Overall Study|Adverse Event|1|||
146540949|NCT01192178|528487699|FG000|Overall Study|Lack of Efficacy|1|||
146540950|NCT01192178|528487700|FG001|Overall Study|Lack of Efficacy|2|||
146540951|NCT02460289|528487701|FG000|Overall Study|Adverse Event|1|||
146540952|NCT02460289|528487701|FG000|Overall Study|Withdrawal by Subject|8|||
146540953|NCT02460289|528487701|FG000|Overall Study|Lost to Follow-up|1|||
146540954|NCT02164916|528487702|FG000|Overall Study|Adverse Event|3|||
146540955|NCT02164916|528487703|FG001|Overall Study|Adverse Event|8|||
146540956|NCT02164916|528487702|FG000|Overall Study|Death|1|||
146540957|NCT02164916|528487703|FG001|Overall Study|Death|1|||
146540958|NCT02164916|528487702|FG000|Overall Study|Refusal unrelated to adverse event|3|||
146540959|NCT02164916|528487703|FG001|Overall Study|Refusal unrelated to adverse event|7|||
146540960|NCT02164916|528487702|FG000|Overall Study|Progression|37|||
146540961|NCT02164916|528487703|FG001|Overall Study|Progression|26|||
146540962|NCT02164916|528487702|FG000|Overall Study|Not protocol specified|5|||
146540963|NCT02164916|528487703|FG001|Overall Study|Not protocol specified|1|||
146540964|NCT02164916|528487702|FG000|Overall Study|Reason under review|1|||
146540965|NCT02164916|528487703|FG001|Overall Study|Reason under review|6|||
146540966|NCT02164916|528487702|FG000|Overall Study|Not eligible|2|||
146540967|NCT02164916|528487703|FG001|Overall Study|Not eligible|5|||
146540968|NCT01155570|528487704|FG000|Overall Study|Adverse Event|39|||
146540969|NCT01155570|528487704|FG000|Overall Study|Lack of Efficacy|46|||
146540970|NCT01155570|528487704|FG000|Overall Study|Participant's Economic Reasons|17|||
146540971|NCT01155570|528487704|FG000|Overall Study|No Hospital Visits|7|||
146540972|NCT01155570|528487704|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
146540973|NCT01155570|528487704|FG000|Overall Study|Adverse Event + Other Reasons|7|||
146540974|NCT01155570|528487704|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
146540975|NCT01155570|528487704|FG000|Overall Study|Other Reasons|23|||
146540976|NCT00964782|528487707|FG000|Overall Study|Lost to Follow-up|1|||
146540977|NCT00964782|528487708|FG001|Overall Study|Lost to Follow-up|0|||
146540978|NCT00141817|528487709|FG000|Overall Study|Protocol Violation|0|||
146540979|NCT00141817|528487710|FG001|Overall Study|Protocol Violation|0|||
146540980|NCT00141817|528487711|FG002|Overall Study|Protocol Violation|1|||
146540981|NCT00141817|528487712|FG003|Overall Study|Protocol Violation|0|||
146540982|NCT00141817|528487709|FG000|Overall Study|Parent request|1|||
146540983|NCT00141817|528487710|FG001|Overall Study|Parent request|0|||
146540984|NCT00141817|528487711|FG002|Overall Study|Parent request|0|||
146540985|NCT00141817|528487712|FG003|Overall Study|Parent request|0|||
146540986|NCT02774889|528487713|FG000|Overall Study|Lost to Follow-up|2|||
146540987|NCT02774889|528487714|FG001|Overall Study|Lost to Follow-up|1|||
146872281|NCT00073528|529703219|FG000|Overall Study|Protocol Violation|3|||
146540988|NCT01349595|528487717|FG000|Overall Study|Lack of funding|2|||
146540989|NCT01349595|528487718|FG001|Overall Study|Lack of funding|2|||
146540990|NCT04817410|528489610|FG000|Overall Study|Withdrawal by Subject|5|||
146872282|NCT00073528|529703220|FG001|Overall Study|Protocol Violation|5|||
146540991|NCT04817410|528489610|FG000|Overall Study|Physician Decision|3|||
146540992|NCT00549055|528489611|FG000|Overall Study|Adverse Event|4|||
146540993|NCT00549055|528489611|FG000|Overall Study|Lack of Efficacy|18|||
146540994|NCT00549055|528489611|FG000|Overall Study|Stabilization|5|||
146540995|NCT00549055|528489611|FG000|Overall Study|Progression to fibrosis|2|||
146540996|NCT00549055|528489611|FG000|Overall Study|Decrease of size|1|||
146540997|NCT00549055|528489611|FG000|Overall Study|Active choroidal neovascula increased|1|||
146540998|NCT00549055|528489611|FG000|Overall Study|Vitreous hemorrhage|1|||
146540999|NCT00549055|528489611|FG000|Overall Study|Growth choroidal neovascularisation|1|||
146541000|NCT00549055|528489611|FG000|Overall Study|Choroidal neovascularization|1|||
146541001|NCT00549055|528489611|FG000|Overall Study|Very low visual acuity (VA)|1|||
146541002|NCT01431976|528489612|FG000|Overall Study|Adverse Event|6|||
146541003|NCT01431976|528489612|FG000|Overall Study|Lack of Efficacy|2|||
146541004|NCT01431976|528489612|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
146541005|NCT01431976|528489612|FG000|Overall Study|Physician Decision|1|||
146541006|NCT01431976|528489612|FG000|Overall Study|Withdrawal by Subject|1|||
146541007|NCT00460798|528489616|FG000|Overall Study|Death|59|||
146541008|NCT00460798|528489616|FG000|Overall Study|Adverse Event|27|||
146541009|NCT00460798|528489616|FG000|Overall Study|Lost to Follow-up|19|||
146541010|NCT00460798|528489616|FG000|Overall Study|Progressive Disease|99|||
146541011|NCT00460798|528489616|FG000|Overall Study|Other|27|||
146541012|NCT00460798|528489616|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
146541013|NCT00460798|528489616|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
146541014|NCT03881371|528489625|FG000|Overall Study|Adverse Event|8|||
146541015|NCT03881371|528489626|FG001|Overall Study|Adverse Event|9|||
146541016|NCT03881371|528489625|FG000|Overall Study|Death|1|||
146872283|NCT00003702|529703223|FG000|Overall Study|Ineligible cell types|2|||
146872284|NCT00003702|529703224|FG001|Overall Study|Ineligible cell types|2|||
146541017|NCT03881371|528489626|FG001|Overall Study|Death|0|||
146541018|NCT03881371|528489625|FG000|Overall Study|Lost to Follow-up|1|||
146541019|NCT03881371|528489626|FG001|Overall Study|Lost to Follow-up|0|||
146541020|NCT03881371|528489625|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146541021|NCT03881371|528489626|FG001|Overall Study|Non-Compliance with Study Drug|2|||
146872285|NCT00003702|529703223|FG000|Overall Study|Did not meet criteria for persistence|8|||
146872286|NCT00003702|529703224|FG001|Overall Study|Did not meet criteria for persistence|5|||
146872287|NCT00003702|529703223|FG000|Overall Study|WHO score > 6|2|||
146541022|NCT03881371|528489625|FG000|Overall Study|Physician Decision|3|||
146541023|NCT03881371|528489626|FG001|Overall Study|Physician Decision|3|||
146541024|NCT03881371|528489625|FG000|Overall Study|Withdrawal by Subject|2|||
146541025|NCT03881371|528489626|FG001|Overall Study|Withdrawal by Subject|10|||
146541026|NCT03881371|528489625|FG000|Overall Study|Discontinuation from Study|1|||
146541027|NCT03881371|528489626|FG001|Overall Study|Discontinuation from Study|0|||
146541028|NCT04666298|528489633|FG000|Overall Study|Subject decision|1|||
146541029|NCT04666298|528489634|FG001|Overall Study|Subject decision|0|||
146541030|NCT04666298|528489635|FG002|Overall Study|Subject decision|0|||
146541031|NCT04666298|528489636|FG003|Overall Study|Subject decision|2|||
146872288|NCT00003702|529703224|FG001|Overall Study|WHO score > 6|1|||
146541032|NCT04666298|528489633|FG000|Overall Study|Death|1|||
146541033|NCT04666298|528489634|FG001|Overall Study|Death|0|||
146541034|NCT04666298|528489635|FG002|Overall Study|Death|0|||
146541035|NCT04666298|528489636|FG003|Overall Study|Death|0|||
146541036|NCT04666298|528489633|FG000|Overall Study|Lost to Follow-up|0|||
146541037|NCT04666298|528489634|FG001|Overall Study|Lost to Follow-up|0|||
146541038|NCT04666298|528489635|FG002|Overall Study|Lost to Follow-up|0|||
146541039|NCT04666298|528489636|FG003|Overall Study|Lost to Follow-up|1|||
146541040|NCT04666298|528489633|FG000|Overall Study|Physician Decision|0|||
146541041|NCT04666298|528489634|FG001|Overall Study|Physician Decision|0|||
146541042|NCT04666298|528489635|FG002|Overall Study|Physician Decision|0|||
146541043|NCT04666298|528489636|FG003|Overall Study|Physician Decision|1|||
146541044|NCT04666298|528489633|FG000|Overall Study|Protocol deviation|0|||
146541045|NCT04666298|528489634|FG001|Overall Study|Protocol deviation|0|||
146541046|NCT04666298|528489635|FG002|Overall Study|Protocol deviation|1|||
146541047|NCT04666298|528489636|FG003|Overall Study|Protocol deviation|0|||
146541048|NCT02178956|528489641|FG000|Overall Study|Lost to Follow-up|4|||
146541049|NCT02178956|528489642|FG001|Overall Study|Lost to Follow-up|4|||
146541050|NCT02178956|528489641|FG000|Overall Study|Sponsor terminated study|49|||
146541051|NCT02178956|528489642|FG001|Overall Study|Sponsor terminated study|58|||
146541052|NCT02178956|528489641|FG000|Overall Study|Withdrawal by Subject|15|||
146541053|NCT02178956|528489642|FG001|Overall Study|Withdrawal by Subject|11|||
146541054|NCT02178956|528489641|FG000|Overall Study|Various Reasons|3|||
146541055|NCT02178956|528489642|FG001|Overall Study|Various Reasons|5|||
146541056|NCT01756235|528489643|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
146541057|NCT05376358|528489644|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
146541058|NCT05376358|528489645|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
146541059|NCT05376358|528489644|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
146541060|NCT05376358|528489645|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
146541061|NCT05376358|528489644|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
146541062|NCT05376358|528489645|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
146541063|NCT05376358|528489644|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
146541064|NCT05376358|528489645|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
146541065|NCT05376358|528489644|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
146541066|NCT05376358|528489645|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
146541067|NCT05376358|528489644|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
146541068|NCT05376358|528489645|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
146541069|NCT04225832|528489646|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
146541070|NCT04225832|528489647|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
146541071|NCT04225832|528489646|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
146541072|NCT04225832|528489647|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
146541073|NCT03323502|528489648|FG000|Overall Study|Resident could not be linked to CMS data|594|||
146541074|NCT03323502|528489649|FG001|Overall Study|Resident could not be linked to CMS data|435|||
146541075|NCT03323502|528489648|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
146541076|NCT03323502|528489649|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
146541077|NCT03323502|528489648|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
146541078|NCT03323502|528489649|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
146541079|NCT03323502|528489648|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
146541080|NCT03323502|528489649|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
146541081|NCT03323502|528489648|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
146541082|NCT03323502|528489649|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
146541083|NCT02327078|528489650|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
146541084|NCT02327078|528489651|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
146541085|NCT02327078|528489652|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
146541086|NCT02327078|528489653|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
146541087|NCT02327078|528489654|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
146541088|NCT02327078|528489655|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
146541089|NCT02327078|528489656|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
146541090|NCT02327078|528489657|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
146541091|NCT02327078|528489658|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
146541092|NCT02327078|528489650|FG000|Overall Study|Death|2|||
146541093|NCT02327078|528489651|FG001|Overall Study|Death|4|||
146541094|NCT02327078|528489652|FG002|Overall Study|Death|10|||
146541095|NCT02327078|528489653|FG003|Overall Study|Death|6|||
146541096|NCT02327078|528489654|FG004|Overall Study|Death|4|||
146541097|NCT02327078|528489655|FG005|Overall Study|Death|3|||
146541098|NCT02327078|528489656|FG006|Overall Study|Death|2|||
146541099|NCT02327078|528489657|FG007|Overall Study|Death|51|||
146541100|NCT02327078|528489658|FG008|Overall Study|Death|97|||
146541101|NCT02327078|528489650|FG000|Overall Study|Lost to Follow-up|0|||
146541102|NCT02327078|528489651|FG001|Overall Study|Lost to Follow-up|1|||
146541103|NCT02327078|528489652|FG002|Overall Study|Lost to Follow-up|1|||
146541104|NCT02327078|528489653|FG003|Overall Study|Lost to Follow-up|0|||
146541105|NCT02327078|528489654|FG004|Overall Study|Lost to Follow-up|0|||
146541106|NCT02327078|528489655|FG005|Overall Study|Lost to Follow-up|0|||
146541107|NCT02327078|528489656|FG006|Overall Study|Lost to Follow-up|0|||
146541108|NCT02327078|528489657|FG007|Overall Study|Lost to Follow-up|2|||
146541109|NCT02327078|528489658|FG008|Overall Study|Lost to Follow-up|5|||
146541110|NCT02327078|528489650|FG000|Overall Study|Site Terminated by Sponsor|1|||
146541111|NCT02327078|528489651|FG001|Overall Study|Site Terminated by Sponsor|0|||
146541112|NCT02327078|528489652|FG002|Overall Study|Site Terminated by Sponsor|1|||
146541113|NCT02327078|528489653|FG003|Overall Study|Site Terminated by Sponsor|4|||
146541114|NCT02327078|528489654|FG004|Overall Study|Site Terminated by Sponsor|0|||
146541115|NCT02327078|528489655|FG005|Overall Study|Site Terminated by Sponsor|0|||
146541116|NCT02327078|528489656|FG006|Overall Study|Site Terminated by Sponsor|0|||
146541117|NCT02327078|528489657|FG007|Overall Study|Site Terminated by Sponsor|11|||
146541118|NCT02327078|528489658|FG008|Overall Study|Site Terminated by Sponsor|25|||
146541119|NCT02327078|528489650|FG000|Overall Study|Physician Decision|0|||
146541120|NCT02327078|528489651|FG001|Overall Study|Physician Decision|0|||
146541121|NCT02327078|528489652|FG002|Overall Study|Physician Decision|0|||
146541122|NCT02327078|528489653|FG003|Overall Study|Physician Decision|1|||
146541123|NCT02327078|528489654|FG004|Overall Study|Physician Decision|0|||
146628013|NCT00106704|528813548|FG001|Overall Study|Adverse Event|7|||
146872289|NCT00003702|529703223|FG000|Overall Study|Inadequate documentation of disease|1|||
146872290|NCT00003702|529703224|FG001|Overall Study|Inadequate documentation of disease|3|||
146872291|NCT02790138|529703227|FG000|Overall Study|Adverse Event|5|||
146872292|NCT02790138|529703228|FG001|Overall Study|Adverse Event|2|||
146872293|NCT02790138|529703227|FG000|Overall Study|Significant Protocol Deviation|0|||
146872294|NCT02790138|529703228|FG001|Overall Study|Significant Protocol Deviation|1|||
146872295|NCT02790138|529703227|FG000|Overall Study|Lost to Follow-up|1|||
146872296|NCT02790138|529703228|FG001|Overall Study|Lost to Follow-up|0|||
146541124|NCT02327078|528489655|FG005|Overall Study|Physician Decision|0|||
146541125|NCT02327078|528489656|FG006|Overall Study|Physician Decision|0|||
146541126|NCT02327078|528489657|FG007|Overall Study|Physician Decision|0|||
146541127|NCT02327078|528489658|FG008|Overall Study|Physician Decision|1|||
146541128|NCT02327078|528489650|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
146541129|NCT02327078|528489651|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
146541130|NCT02327078|528489652|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
146541131|NCT02327078|528489653|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
146541132|NCT02327078|528489654|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
146541133|NCT02327078|528489655|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
146541134|NCT02327078|528489656|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
146541135|NCT02327078|528489657|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
146541136|NCT02327078|528489658|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
146541137|NCT02327078|528489650|FG000|Overall Study|Reason not Specified|0|||
146541138|NCT02327078|528489651|FG001|Overall Study|Reason not Specified|0|||
146541139|NCT02327078|528489652|FG002|Overall Study|Reason not Specified|0|||
146541140|NCT02327078|528489653|FG003|Overall Study|Reason not Specified|0|||
146541141|NCT02327078|528489654|FG004|Overall Study|Reason not Specified|0|||
146541142|NCT02327078|528489655|FG005|Overall Study|Reason not Specified|0|||
146541143|NCT02327078|528489656|FG006|Overall Study|Reason not Specified|0|||
146541144|NCT02327078|528489657|FG007|Overall Study|Reason not Specified|5|||
146541145|NCT02327078|528489658|FG008|Overall Study|Reason not Specified|12|||
146541146|NCT04797169|528489661|FG000|Overall Study|Lost to Follow-up|84|||
146541147|NCT04797169|528489662|FG001|Overall Study|Lost to Follow-up|67|||
146541148|NCT04797169|528489661|FG000|Overall Study|Pregnancy|1|||
146541149|NCT04797169|528489662|FG001|Overall Study|Pregnancy|3|||
146541150|NCT04797169|528489661|FG000|Overall Study|Withdrawal by Subject|27|||
146541151|NCT04797169|528489662|FG001|Overall Study|Withdrawal by Subject|35|||
146541152|NCT02337829|528489663|FG000|Overall Study|Death|0|||
146541153|NCT02337829|528489664|FG001|Overall Study|Death|1|||
146541154|NCT02337829|528489665|FG002|Overall Study|Death|0|||
146541155|NCT02337829|528489666|FG003|Overall Study|Death|0|||
146541156|NCT02337829|528489663|FG000|Overall Study|Study terminated by sponsor|12|||
146764172|NCT00906698|529302989|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
146764173|NCT00906698|529302990|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
146541157|NCT02337829|528489664|FG001|Overall Study|Study terminated by sponsor|10|||
146541158|NCT02337829|528489665|FG002|Overall Study|Study terminated by sponsor|5|||
146541159|NCT02337829|528489666|FG003|Overall Study|Study terminated by sponsor|6|||
146541160|NCT02337829|528489663|FG000|Overall Study|discontinued for other reasons|6|||
146541161|NCT02337829|528489664|FG001|Overall Study|discontinued for other reasons|3|||
146628014|NCT00106704|528813547|FG000|Overall Study|Death|2|||
146764174|NCT00906698|529302991|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
146764175|NCT00906698|529302992|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
146764176|NCT00906698|529302993|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
146764177|NCT00001575|529303001|FG000|Overall Study|Screening failures-Ph I portion|22|||
146764178|NCT00001575|529303001|FG000|Overall Study|Withdrawn/deaths|23|||
146764179|NCT00831792|529303002|FG000|Overall Study|Not Eligible|3|||
146764180|NCT00831792|529303002|FG000|Overall Study|Adverse Event|1|||
146764181|NCT00831792|529303002|FG000|Overall Study|Death|1|||
146764182|NCT00831792|529303002|FG000|Overall Study|Lack of Efficacy|1|||
146764183|NCT01242085|529303003|FG000|Overall Study|Withdrawal by Subject|4|||
146764184|NCT01242085|529303004|FG001|Overall Study|Withdrawal by Subject|2|||
146541162|NCT02337829|528489665|FG002|Overall Study|discontinued for other reasons|1|||
146541163|NCT02337829|528489666|FG003|Overall Study|discontinued for other reasons|4|||
146541164|NCT02550795|528489670|FG000|Overall Study|Physician Decision|0|||
146541165|NCT02550795|528489671|FG001|Overall Study|Physician Decision|1|||
146541166|NCT02550795|528489672|FG002|Overall Study|Physician Decision|0|||
146541167|NCT02802228|528489674|FG000|Overall Study|Withdrawal by Subject|2|||
146541168|NCT02802228|528489675|FG001|Overall Study|Withdrawal by Subject|0|||
146541169|NCT02802228|528489674|FG000|Overall Study|Lost to Follow-up|1|||
146541170|NCT02802228|528489675|FG001|Overall Study|Lost to Follow-up|0|||
146541171|NCT02802228|528489674|FG000|Overall Study|Adverse Event|1|||
146541172|NCT02802228|528489675|FG001|Overall Study|Adverse Event|0|||
146541173|NCT02802228|528489674|FG000|Overall Study|Physician Decision|1|||
146541174|NCT02802228|528489675|FG001|Overall Study|Physician Decision|0|||
146541175|NCT00695019|528489676|FG000|Overall Study|Withdrawal by Subject|8|||
146541176|NCT00695019|528489677|FG001|Overall Study|Withdrawal by Subject|6|||
146541177|NCT00695019|528489678|FG002|Overall Study|Withdrawal by Subject|4|||
146541178|NCT00695019|528489676|FG000|Overall Study|Protocol Violation|1|||
146541179|NCT00695019|528489677|FG001|Overall Study|Protocol Violation|3|||
146541180|NCT00695019|528489678|FG002|Overall Study|Protocol Violation|1|||
146541181|NCT00695019|528489676|FG000|Overall Study|Lack of Efficacy|0|||
146541182|NCT00695019|528489677|FG001|Overall Study|Lack of Efficacy|0|||
146541183|NCT00695019|528489678|FG002|Overall Study|Lack of Efficacy|1|||
146541184|NCT00695019|528489676|FG000|Overall Study|Various|4|||
146541185|NCT00695019|528489677|FG001|Overall Study|Various|5|||
146541186|NCT00695019|528489678|FG002|Overall Study|Various|4|||
146541187|NCT02763566|528489679|FG000|Overall Study|Lost to Follow-up|1|||
146541188|NCT02763566|528489680|FG001|Overall Study|Lost to Follow-up|4|||
146541189|NCT02763566|528489681|FG002|Overall Study|Lost to Follow-up|0|||
146541190|NCT02763566|528489682|FG003|Overall Study|Lost to Follow-up|1|||
146541191|NCT02763566|528489679|FG000|Overall Study|On study treatment at study conclusion|114|||
146541192|NCT02763566|528489680|FG001|Overall Study|On study treatment at study conclusion|34|||
146541193|NCT02763566|528489681|FG002|Overall Study|On study treatment at study conclusion|54|||
146541194|NCT02763566|528489682|FG003|Overall Study|On study treatment at study conclusion|13|||
146541195|NCT02763566|528489679|FG000|Overall Study|Withdrawal by Subject|3|||
146541196|NCT02763566|528489680|FG001|Overall Study|Withdrawal by Subject|1|||
146541197|NCT02763566|528489681|FG002|Overall Study|Withdrawal by Subject|0|||
146541198|NCT02763566|528489682|FG003|Overall Study|Withdrawal by Subject|0|||
146541199|NCT04896385|528489683|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
146541200|NCT04896385|528489684|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
146541201|NCT04896385|528489685|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
146541202|NCT04896385|528489686|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
146541203|NCT04896385|528489683|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
146541204|NCT04896385|528489684|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
146541205|NCT04896385|528489685|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
146541206|NCT04896385|528489686|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
146541207|NCT04896385|528489683|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
146541208|NCT04896385|528489684|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
146541209|NCT04896385|528489685|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
146541210|NCT04896385|528489686|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
146541211|NCT04896385|528489683|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
146541212|NCT04896385|528489684|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
146541213|NCT04896385|528489685|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
146541214|NCT04896385|528489686|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
146541215|NCT04896385|528489683|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
146541216|NCT04896385|528489684|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
146541217|NCT04896385|528489685|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
146541218|NCT04896385|528489686|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
146541219|NCT04896385|528489683|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
146541220|NCT04896385|528489684|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
146541221|NCT04896385|528489685|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
146541222|NCT04896385|528489686|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
146541223|NCT01901562|528489688|FG000|Overall Study|Protocol Violation|5|||
146541224|NCT01901562|528489688|FG000|Overall Study|Excluded intraoperatively|4|||
146541225|NCT01925794|528489689|FG000|180 Days|Death|2|||
146541226|NCT01925794|528489689|FG000|180 Days|Withdrawal by Subject|2|||
146541227|NCT01925794|528489689|FG000|270 Days|Death|2|||
146541228|NCT01925794|528489689|FG000|270 Days|Protocol Violation|3|||
146541229|NCT02612155|528489690|FG000|Overall Study|Death|1|||
146541230|NCT02612155|528489691|FG001|Overall Study|Death|1|||
146541231|NCT02612155|528489690|FG000|Overall Study|Lost to Follow-up|2|||
146541232|NCT02612155|528489691|FG001|Overall Study|Lost to Follow-up|2|||
146541233|NCT03197129|528489692|FG000|Overall Study|did not answer the VPT: shyness|4|||
146541234|NCT03197129|528489693|FG001|Overall Study|did not answer the VPT: shyness|5|||
146764185|NCT01242085|529303005|FG002|Overall Study|Withdrawal by Subject|0|||
146975333|NCT00572156|530073540|FG001|Overall Study|Protocol Violation|2|||
146872297|NCT02790138|529703227|FG000|Overall Study|Voluntary Withdrawal|8|||
146872298|NCT02790138|529703228|FG001|Overall Study|Voluntary Withdrawal|9|||
146872299|NCT02790138|529703227|FG000|Overall Study|Lack of Efficacy|6|||
146872300|NCT02790138|529703228|FG001|Overall Study|Lack of Efficacy|7|||
146872301|NCT02790138|529703227|FG000|Overall Study|Reason not Specified|1|||
146975334|NCT00572156|530073541|FG002|Overall Study|Protocol Violation|0|||
146541235|NCT03126110|528489695|FG000|Phase 1|Death|2|||
146541236|NCT03126110|528489696|FG001|Phase 1|Death|2|||
146541237|NCT03126110|528489697|FG002|Phase 1|Death|4|||
146541238|NCT03126110|528489698|FG003|Phase 1|Death|3|||
146541239|NCT03126110|528489699|FG004|Phase 1|Death|4|||
146541240|NCT03126110|528489700|FG005|Phase 1|Death|4|||
146541241|NCT03126110|528489701|FG006|Phase 1|Death|3|||
146541242|NCT03126110|528489702|FG007|Phase 1|Death|4|||
146541243|NCT03126110|528489703|FG008|Phase 1|Death|5|||
146541244|NCT03126110|528489704|FG009|Phase 1|Death|2|||
146541245|NCT03126110|528489705|FG010|Phase 1|Death|6|||
146541246|NCT03126110|528489706|FG011|Phase 1|Death|0|||
146541247|NCT03126110|528489707|FG012|Phase 1|Death|0|||
146541248|NCT03126110|528489708|FG013|Phase 1|Death|0|||
146541249|NCT03126110|528489709|FG014|Phase 1|Death|0|||
146541250|NCT03126110|528489710|FG015|Phase 1|Death|0|||
146541251|NCT03126110|528489711|FG016|Phase 1|Death|0|||
146541252|NCT03126110|528489695|FG000|Phase 1|Lost to Follow-up|0|||
146541253|NCT03126110|528489696|FG001|Phase 1|Lost to Follow-up|1|||
146541254|NCT03126110|528489697|FG002|Phase 1|Lost to Follow-up|0|||
146541255|NCT03126110|528489698|FG003|Phase 1|Lost to Follow-up|0|||
146541256|NCT03126110|528489699|FG004|Phase 1|Lost to Follow-up|0|||
146541257|NCT03126110|528489700|FG005|Phase 1|Lost to Follow-up|0|||
146541258|NCT03126110|528489701|FG006|Phase 1|Lost to Follow-up|0|||
146541259|NCT03126110|528489702|FG007|Phase 1|Lost to Follow-up|0|||
146541260|NCT03126110|528489703|FG008|Phase 1|Lost to Follow-up|1|||
146541261|NCT03126110|528489704|FG009|Phase 1|Lost to Follow-up|0|||
146541262|NCT03126110|528489705|FG010|Phase 1|Lost to Follow-up|0|||
146541263|NCT03126110|528489706|FG011|Phase 1|Lost to Follow-up|0|||
146541264|NCT03126110|528489707|FG012|Phase 1|Lost to Follow-up|0|||
146541265|NCT03126110|528489708|FG013|Phase 1|Lost to Follow-up|0|||
146541266|NCT03126110|528489709|FG014|Phase 1|Lost to Follow-up|0|||
146541267|NCT03126110|528489710|FG015|Phase 1|Lost to Follow-up|0|||
146541268|NCT03126110|528489711|FG016|Phase 1|Lost to Follow-up|0|||
146541269|NCT03126110|528489695|FG000|Phase 1|Withdrawal by Subject|1|||
146541270|NCT03126110|528489696|FG001|Phase 1|Withdrawal by Subject|0|||
146541271|NCT03126110|528489697|FG002|Phase 1|Withdrawal by Subject|0|||
146541272|NCT03126110|528489698|FG003|Phase 1|Withdrawal by Subject|1|||
146541273|NCT03126110|528489699|FG004|Phase 1|Withdrawal by Subject|1|||
146541274|NCT03126110|528489700|FG005|Phase 1|Withdrawal by Subject|0|||
146541275|NCT03126110|528489701|FG006|Phase 1|Withdrawal by Subject|0|||
146541276|NCT03126110|528489702|FG007|Phase 1|Withdrawal by Subject|0|||
146541277|NCT03126110|528489703|FG008|Phase 1|Withdrawal by Subject|2|||
146541278|NCT03126110|528489704|FG009|Phase 1|Withdrawal by Subject|1|||
146541279|NCT03126110|528489705|FG010|Phase 1|Withdrawal by Subject|0|||
146541280|NCT03126110|528489706|FG011|Phase 1|Withdrawal by Subject|0|||
146541281|NCT03126110|528489707|FG012|Phase 1|Withdrawal by Subject|0|||
146541282|NCT03126110|528489708|FG013|Phase 1|Withdrawal by Subject|0|||
146541283|NCT03126110|528489709|FG014|Phase 1|Withdrawal by Subject|0|||
146541284|NCT03126110|528489710|FG015|Phase 1|Withdrawal by Subject|0|||
146541285|NCT03126110|528489711|FG016|Phase 1|Withdrawal by Subject|0|||
146541286|NCT03126110|528489695|FG000|Phase 1|Safety follow-up no longer necessary|1|||
146541287|NCT03126110|528489696|FG001|Phase 1|Safety follow-up no longer necessary|0|||
146541288|NCT03126110|528489697|FG002|Phase 1|Safety follow-up no longer necessary|0|||
146541289|NCT03126110|528489698|FG003|Phase 1|Safety follow-up no longer necessary|0|||
146541290|NCT03126110|528489699|FG004|Phase 1|Safety follow-up no longer necessary|0|||
146541291|NCT03126110|528489700|FG005|Phase 1|Safety follow-up no longer necessary|0|||
146541292|NCT03126110|528489701|FG006|Phase 1|Safety follow-up no longer necessary|0|||
146541293|NCT03126110|528489702|FG007|Phase 1|Safety follow-up no longer necessary|0|||
146541294|NCT03126110|528489703|FG008|Phase 1|Safety follow-up no longer necessary|0|||
146541295|NCT03126110|528489704|FG009|Phase 1|Safety follow-up no longer necessary|0|||
146541296|NCT03126110|528489705|FG010|Phase 1|Safety follow-up no longer necessary|0|||
146541297|NCT03126110|528489706|FG011|Phase 1|Safety follow-up no longer necessary|0|||
146541298|NCT03126110|528489707|FG012|Phase 1|Safety follow-up no longer necessary|0|||
146541299|NCT03126110|528489708|FG013|Phase 1|Safety follow-up no longer necessary|0|||
146541300|NCT03126110|528489709|FG014|Phase 1|Safety follow-up no longer necessary|0|||
146541301|NCT03126110|528489710|FG015|Phase 1|Safety follow-up no longer necessary|0|||
146541302|NCT03126110|528489711|FG016|Phase 1|Safety follow-up no longer necessary|0|||
146541303|NCT03126110|528489695|FG000|Phase 1|Survival follow-up no longer necessary|0|||
146541304|NCT03126110|528489696|FG001|Phase 1|Survival follow-up no longer necessary|0|||
146541305|NCT03126110|528489697|FG002|Phase 1|Survival follow-up no longer necessary|1|||
146541306|NCT03126110|528489698|FG003|Phase 1|Survival follow-up no longer necessary|0|||
146541307|NCT03126110|528489699|FG004|Phase 1|Survival follow-up no longer necessary|0|||
146541308|NCT03126110|528489700|FG005|Phase 1|Survival follow-up no longer necessary|0|||
146541309|NCT03126110|528489701|FG006|Phase 1|Survival follow-up no longer necessary|0|||
146541310|NCT03126110|528489702|FG007|Phase 1|Survival follow-up no longer necessary|0|||
146541311|NCT03126110|528489703|FG008|Phase 1|Survival follow-up no longer necessary|0|||
146541312|NCT03126110|528489704|FG009|Phase 1|Survival follow-up no longer necessary|0|||
146541313|NCT03126110|528489705|FG010|Phase 1|Survival follow-up no longer necessary|0|||
146541314|NCT03126110|528489706|FG011|Phase 1|Survival follow-up no longer necessary|0|||
146541315|NCT03126110|528489707|FG012|Phase 1|Survival follow-up no longer necessary|0|||
146541316|NCT03126110|528489708|FG013|Phase 1|Survival follow-up no longer necessary|0|||
146541317|NCT03126110|528489709|FG014|Phase 1|Survival follow-up no longer necessary|0|||
146541318|NCT03126110|528489710|FG015|Phase 1|Survival follow-up no longer necessary|0|||
146541319|NCT03126110|528489711|FG016|Phase 1|Survival follow-up no longer necessary|0|||
146541320|NCT03126110|528489695|FG000|Phase 2|Study terminated by the sponsor|0|||
146541321|NCT03126110|528489696|FG001|Phase 2|Study terminated by the sponsor|0|||
146541322|NCT03126110|528489697|FG002|Phase 2|Study terminated by the sponsor|0|||
146541323|NCT03126110|528489698|FG003|Phase 2|Study terminated by the sponsor|0|||
146541324|NCT03126110|528489699|FG004|Phase 2|Study terminated by the sponsor|0|||
146541325|NCT03126110|528489700|FG005|Phase 2|Study terminated by the sponsor|0|||
146541326|NCT03126110|528489701|FG006|Phase 2|Study terminated by the sponsor|0|||
146541327|NCT03126110|528489702|FG007|Phase 2|Study terminated by the sponsor|0|||
146541328|NCT03126110|528489703|FG008|Phase 2|Study terminated by the sponsor|0|||
146541329|NCT03126110|528489704|FG009|Phase 2|Study terminated by the sponsor|0|||
146541330|NCT03126110|528489705|FG010|Phase 2|Study terminated by the sponsor|0|||
146541331|NCT03126110|528489706|FG011|Phase 2|Study terminated by the sponsor|0|||
146541332|NCT03126110|528489707|FG012|Phase 2|Study terminated by the sponsor|0|||
146541333|NCT03126110|528489708|FG013|Phase 2|Study terminated by the sponsor|4|||
146541334|NCT03126110|528489709|FG014|Phase 2|Study terminated by the sponsor|0|||
146541335|NCT03126110|528489710|FG015|Phase 2|Study terminated by the sponsor|0|||
146541336|NCT03126110|528489711|FG016|Phase 2|Study terminated by the sponsor|0|||
146541337|NCT03126110|528489695|FG000|Phase 2|Withdrawal by Subject|0|||
146541338|NCT03126110|528489696|FG001|Phase 2|Withdrawal by Subject|0|||
146541339|NCT03126110|528489697|FG002|Phase 2|Withdrawal by Subject|0|||
146541340|NCT03126110|528489698|FG003|Phase 2|Withdrawal by Subject|0|||
146541341|NCT03126110|528489699|FG004|Phase 2|Withdrawal by Subject|0|||
146541342|NCT03126110|528489700|FG005|Phase 2|Withdrawal by Subject|0|||
146541343|NCT03126110|528489701|FG006|Phase 2|Withdrawal by Subject|0|||
146541344|NCT03126110|528489702|FG007|Phase 2|Withdrawal by Subject|0|||
146541345|NCT03126110|528489703|FG008|Phase 2|Withdrawal by Subject|0|||
146541346|NCT03126110|528489704|FG009|Phase 2|Withdrawal by Subject|0|||
146541347|NCT03126110|528489705|FG010|Phase 2|Withdrawal by Subject|0|||
146541348|NCT03126110|528489706|FG011|Phase 2|Withdrawal by Subject|1|||
146541349|NCT03126110|528489707|FG012|Phase 2|Withdrawal by Subject|3|||
146764186|NCT01242085|529303003|FG000|Overall Study|medically unable to have surgery|4|||
146764187|NCT01242085|529303004|FG001|Overall Study|medically unable to have surgery|5|||
146764188|NCT01242085|529303005|FG002|Overall Study|medically unable to have surgery|0|||
146764189|NCT01178762|529303006|FG000|Overall Study|Lost to Follow-up|15|||
146541350|NCT03126110|528489708|FG013|Phase 2|Withdrawal by Subject|3|||
146541351|NCT03126110|528489709|FG014|Phase 2|Withdrawal by Subject|2|||
146541352|NCT03126110|528489710|FG015|Phase 2|Withdrawal by Subject|1|||
146872302|NCT02790138|529703228|FG001|Overall Study|Reason not Specified|0|||
146872303|NCT03199040|529703229|FG000|Overall Study|Lack of Efficacy|2|||
146872304|NCT03199040|529703230|FG001|Overall Study|Lack of Efficacy|0|||
146872305|NCT03199040|529703229|FG000|Overall Study|Withdrawal by Subject|2|||
146872306|NCT03199040|529703230|FG001|Overall Study|Withdrawal by Subject|0|||
146872307|NCT03199040|529703229|FG000|Overall Study|Adverse Event|0|||
146872308|NCT03199040|529703230|FG001|Overall Study|Adverse Event|1|||
146872309|NCT03199040|529703229|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
146872310|NCT03199040|529703230|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
146872311|NCT01226459|529703231|FG000|Overall Study|Adverse Event|2|||
146541353|NCT03126110|528489711|FG016|Phase 2|Withdrawal by Subject|0|||
146541354|NCT03126110|528489695|FG000|Phase 2|Lost to Follow-up|0|||
146541355|NCT03126110|528489696|FG001|Phase 2|Lost to Follow-up|0|||
146541356|NCT03126110|528489697|FG002|Phase 2|Lost to Follow-up|0|||
146541357|NCT03126110|528489698|FG003|Phase 2|Lost to Follow-up|0|||
146541358|NCT03126110|528489699|FG004|Phase 2|Lost to Follow-up|0|||
146541359|NCT03126110|528489700|FG005|Phase 2|Lost to Follow-up|0|||
146541360|NCT03126110|528489701|FG006|Phase 2|Lost to Follow-up|0|||
146541361|NCT03126110|528489702|FG007|Phase 2|Lost to Follow-up|0|||
146541362|NCT03126110|528489703|FG008|Phase 2|Lost to Follow-up|0|||
146541363|NCT03126110|528489704|FG009|Phase 2|Lost to Follow-up|0|||
146541364|NCT03126110|528489705|FG010|Phase 2|Lost to Follow-up|0|||
146541365|NCT03126110|528489706|FG011|Phase 2|Lost to Follow-up|1|||
146541366|NCT03126110|528489707|FG012|Phase 2|Lost to Follow-up|1|||
146541367|NCT03126110|528489708|FG013|Phase 2|Lost to Follow-up|1|||
146541368|NCT03126110|528489709|FG014|Phase 2|Lost to Follow-up|2|||
146541369|NCT03126110|528489710|FG015|Phase 2|Lost to Follow-up|0|||
146541370|NCT03126110|528489711|FG016|Phase 2|Lost to Follow-up|0|||
146541371|NCT03126110|528489695|FG000|Phase 2|Death|0|||
146541372|NCT03126110|528489696|FG001|Phase 2|Death|0|||
146541373|NCT03126110|528489697|FG002|Phase 2|Death|0|||
146541374|NCT03126110|528489698|FG003|Phase 2|Death|0|||
146541375|NCT03126110|528489699|FG004|Phase 2|Death|0|||
146541376|NCT03126110|528489700|FG005|Phase 2|Death|0|||
146541377|NCT03126110|528489701|FG006|Phase 2|Death|0|||
146541378|NCT03126110|528489702|FG007|Phase 2|Death|0|||
146541379|NCT03126110|528489703|FG008|Phase 2|Death|0|||
146541380|NCT03126110|528489704|FG009|Phase 2|Death|0|||
146541381|NCT03126110|528489705|FG010|Phase 2|Death|0|||
146541382|NCT03126110|528489706|FG011|Phase 2|Death|6|||
146541383|NCT03126110|528489707|FG012|Phase 2|Death|12|||
146541384|NCT03126110|528489708|FG013|Phase 2|Death|25|||
146541385|NCT03126110|528489709|FG014|Phase 2|Death|11|||
146541386|NCT03126110|528489710|FG015|Phase 2|Death|3|||
146541387|NCT03126110|528489711|FG016|Phase 2|Death|2|||
146541388|NCT03126110|528489695|FG000|Phase 2|Progressive Disease|0|||
146541389|NCT03126110|528489696|FG001|Phase 2|Progressive Disease|0|||
146541390|NCT03126110|528489697|FG002|Phase 2|Progressive Disease|0|||
146541391|NCT03126110|528489698|FG003|Phase 2|Progressive Disease|0|||
146541392|NCT03126110|528489699|FG004|Phase 2|Progressive Disease|0|||
146541393|NCT03126110|528489700|FG005|Phase 2|Progressive Disease|0|||
146541394|NCT03126110|528489701|FG006|Phase 2|Progressive Disease|0|||
146872312|NCT01226459|529703232|FG001|Overall Study|Adverse Event|8|||
146872313|NCT01226459|529703231|FG000|Overall Study|Protocol Violation|4|||
146872314|NCT01226459|529703232|FG001|Overall Study|Protocol Violation|3|||
146872315|NCT01226459|529703231|FG000|Overall Study|Withdrawal by Subject|10|||
146541395|NCT03126110|528489702|FG007|Phase 2|Progressive Disease|0|||
146541396|NCT03126110|528489703|FG008|Phase 2|Progressive Disease|0|||
146541397|NCT03126110|528489704|FG009|Phase 2|Progressive Disease|0|||
146541398|NCT03126110|528489705|FG010|Phase 2|Progressive Disease|0|||
146541399|NCT03126110|528489706|FG011|Phase 2|Progressive Disease|0|||
146541400|NCT03126110|528489707|FG012|Phase 2|Progressive Disease|0|||
146541401|NCT03126110|528489708|FG013|Phase 2|Progressive Disease|1|||
146541402|NCT03126110|528489709|FG014|Phase 2|Progressive Disease|0|||
146541403|NCT03126110|528489710|FG015|Phase 2|Progressive Disease|0|||
146541404|NCT03126110|528489711|FG016|Phase 2|Progressive Disease|0|||
146541405|NCT03126110|528489695|FG000|Phase 2|Started new treatment|0|||
146541406|NCT03126110|528489696|FG001|Phase 2|Started new treatment|0|||
146541407|NCT03126110|528489697|FG002|Phase 2|Started new treatment|0|||
146541408|NCT03126110|528489698|FG003|Phase 2|Started new treatment|0|||
146541409|NCT03126110|528489699|FG004|Phase 2|Started new treatment|0|||
146541410|NCT03126110|528489700|FG005|Phase 2|Started new treatment|0|||
146541411|NCT03126110|528489701|FG006|Phase 2|Started new treatment|0|||
146541412|NCT03126110|528489702|FG007|Phase 2|Started new treatment|0|||
146628015|NCT00106704|528813548|FG001|Overall Study|Death|1|||
146872316|NCT01226459|529703232|FG001|Overall Study|Withdrawal by Subject|13|||
146541413|NCT03126110|528489703|FG008|Phase 2|Started new treatment|0|||
146541414|NCT03126110|528489704|FG009|Phase 2|Started new treatment|0|||
146541415|NCT03126110|528489705|FG010|Phase 2|Started new treatment|0|||
146541416|NCT03126110|528489706|FG011|Phase 2|Started new treatment|0|||
146541417|NCT03126110|528489707|FG012|Phase 2|Started new treatment|0|||
146541418|NCT03126110|528489708|FG013|Phase 2|Started new treatment|0|||
146541419|NCT03126110|528489709|FG014|Phase 2|Started new treatment|1|||
146541420|NCT03126110|528489710|FG015|Phase 2|Started new treatment|0|||
146872317|NCT01226459|529703231|FG000|Overall Study|Lost to Follow-up|4|||
146541421|NCT03126110|528489711|FG016|Phase 2|Started new treatment|0|||
146541422|NCT01285518|528489712|FG000|Overall Study|Lost to Follow-up|0|||
146541423|NCT01285518|528489713|FG001|Overall Study|Lost to Follow-up|0|||
146541424|NCT01285518|528489714|FG002|Overall Study|Lost to Follow-up|0|||
146541425|NCT01285518|528489715|FG003|Overall Study|Lost to Follow-up|0|||
146541426|NCT01285518|528489716|FG004|Overall Study|Lost to Follow-up|0|||
146541427|NCT01285518|528489717|FG005|Overall Study|Lost to Follow-up|1|||
146541428|NCT01285518|528489718|FG006|Overall Study|Lost to Follow-up|0|||
146541429|NCT01285518|528489719|FG007|Overall Study|Lost to Follow-up|0|||
146541430|NCT00580840|528489720|FG000|Run-in|Adverse Event|17|||
146541431|NCT00580840|528489721|FG001|Run-in|Adverse Event|0|||
146541432|NCT00580840|528489722|FG002|Run-in|Adverse Event|0|||
146541433|NCT00580840|528489723|FG003|Run-in|Adverse Event|0|||
146541434|NCT00580840|528489720|FG000|Run-in|Lack of Efficacy|93|||
146541435|NCT00580840|528489721|FG001|Run-in|Lack of Efficacy|0|||
146541436|NCT00580840|528489722|FG002|Run-in|Lack of Efficacy|0|||
146541437|NCT00580840|528489723|FG003|Run-in|Lack of Efficacy|0|||
146541438|NCT00580840|528489720|FG000|Run-in|Loss of Efficacy|1|||
146541439|NCT00580840|528489721|FG001|Run-in|Loss of Efficacy|0|||
146541440|NCT00580840|528489722|FG002|Run-in|Loss of Efficacy|0|||
146541441|NCT00580840|528489723|FG003|Run-in|Loss of Efficacy|0|||
146872318|NCT01226459|529703232|FG001|Overall Study|Lost to Follow-up|8|||
146872319|NCT01226459|529703231|FG000|Overall Study|Pregnancy|1|||
146872320|NCT01226459|529703232|FG001|Overall Study|Pregnancy|0|||
146872321|NCT00474708|529703233|FG000|Overall Study|Lack of Efficacy|11|||
146872322|NCT00474708|529703234|FG001|Overall Study|Lack of Efficacy|5|||
146872323|NCT00474708|529703233|FG000|Overall Study|Suicide ideation/behavior|0|||
146872324|NCT00474708|529703234|FG001|Overall Study|Suicide ideation/behavior|1|||
146872325|NCT00474708|529703233|FG000|Overall Study|Withdrawal by Subject|7|||
146541442|NCT00580840|528489720|FG000|Run-in|Lost to Follow-up|4|||
146541443|NCT00580840|528489721|FG001|Run-in|Lost to Follow-up|0|||
146541444|NCT00580840|528489722|FG002|Run-in|Lost to Follow-up|0|||
146541445|NCT00580840|528489723|FG003|Run-in|Lost to Follow-up|0|||
146541446|NCT00580840|528489720|FG000|Run-in|Withdrawal by Subject|5|||
146541447|NCT00580840|528489721|FG001|Run-in|Withdrawal by Subject|0|||
146541448|NCT00580840|528489722|FG002|Run-in|Withdrawal by Subject|0|||
146541449|NCT00580840|528489723|FG003|Run-in|Withdrawal by Subject|0|||
146541450|NCT00580840|528489720|FG000|Run-in|Other: Per Sponsor Request|2|||
146541451|NCT00580840|528489721|FG001|Run-in|Other: Per Sponsor Request|0|||
146541452|NCT00580840|528489722|FG002|Run-in|Other: Per Sponsor Request|0|||
146541453|NCT00580840|528489723|FG003|Run-in|Other: Per Sponsor Request|0|||
146541454|NCT00580840|528489720|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
146541455|NCT00580840|528489721|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
146541456|NCT00580840|528489722|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
146541457|NCT00580840|528489723|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
146541458|NCT00580840|528489720|FG000|Run-in|Other: Exclusionary Lab Value|1|||
146541459|NCT00580840|528489721|FG001|Run-in|Other: Exclusionary Lab Value|0|||
146541460|NCT00580840|528489722|FG002|Run-in|Other: Exclusionary Lab Value|0|||
146541461|NCT00580840|528489723|FG003|Run-in|Other: Exclusionary Lab Value|0|||
146541462|NCT00580840|528489720|FG000|Double-Blind|Adverse Event|0|||
146541463|NCT00580840|528489721|FG001|Double-Blind|Adverse Event|3|||
146541464|NCT00580840|528489722|FG002|Double-Blind|Adverse Event|4|||
146541465|NCT00580840|528489723|FG003|Double-Blind|Adverse Event|1|||
146541466|NCT00580840|528489720|FG000|Double-Blind|Loss of Efficacy|0|||
146541467|NCT00580840|528489721|FG001|Double-Blind|Loss of Efficacy|1|||
146541468|NCT00580840|528489722|FG002|Double-Blind|Loss of Efficacy|2|||
146541469|NCT00580840|528489723|FG003|Double-Blind|Loss of Efficacy|10|||
146541470|NCT00580840|528489720|FG000|Double-Blind|Lost to Follow-up|0|||
146541471|NCT00580840|528489721|FG001|Double-Blind|Lost to Follow-up|1|||
146541472|NCT00580840|528489722|FG002|Double-Blind|Lost to Follow-up|0|||
146541473|NCT00580840|528489723|FG003|Double-Blind|Lost to Follow-up|2|||
146541474|NCT00580840|528489720|FG000|Double-Blind|Withdrawal by Subject|0|||
146541475|NCT00580840|528489721|FG001|Double-Blind|Withdrawal by Subject|1|||
146541476|NCT00580840|528489722|FG002|Double-Blind|Withdrawal by Subject|2|||
146541477|NCT00580840|528489723|FG003|Double-Blind|Withdrawal by Subject|2|||
146541478|NCT00580840|528489720|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
146872326|NCT00474708|529703234|FG001|Overall Study|Withdrawal by Subject|0|||
146541479|NCT00580840|528489721|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
146541480|NCT00580840|528489722|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
146628016|NCT00106704|528813547|FG000|Overall Study|Lack of Efficacy|67|||
146872327|NCT00474708|529703233|FG000|Overall Study|Lack of compliance|12|||
146541481|NCT00580840|528489723|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
146541482|NCT00580840|528489720|FG000|Double-Blind|Other: Forbidden Medication|0|||
146541483|NCT00580840|528489721|FG001|Double-Blind|Other: Forbidden Medication|0|||
146541484|NCT00580840|528489722|FG002|Double-Blind|Other: Forbidden Medication|1|||
146541485|NCT00580840|528489723|FG003|Double-Blind|Other: Forbidden Medication|0|||
146541486|NCT01160614|528489725|FG000|Overall Study|Withdrawal by Subject|0|||
146541487|NCT01160614|528489726|FG001|Overall Study|Withdrawal by Subject|2|||
146541488|NCT03805841|528489727|FG000|Overall Study|Clinical Progression|2|||
146541489|NCT03805841|528489728|FG001|Overall Study|Clinical Progression|0|||
146541490|NCT03805841|528489729|FG002|Overall Study|Clinical Progression|0|||
146541491|NCT03805841|528489727|FG000|Overall Study|Death|0|||
146541492|NCT03805841|528489728|FG001|Overall Study|Death|3|||
146541493|NCT03805841|528489729|FG002|Overall Study|Death|1|||
146541494|NCT03805841|528489727|FG000|Overall Study|Lost to Follow-up|0|||
146541495|NCT03805841|528489728|FG001|Overall Study|Lost to Follow-up|0|||
146541496|NCT03805841|528489729|FG002|Overall Study|Lost to Follow-up|1|||
146541497|NCT03805841|528489727|FG000|Overall Study|Withdrawal by Subject|2|||
146541498|NCT03805841|528489728|FG001|Overall Study|Withdrawal by Subject|3|||
146541499|NCT03805841|528489729|FG002|Overall Study|Withdrawal by Subject|0|||
146541500|NCT03805841|528489727|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
146541501|NCT03805841|528489728|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
146541502|NCT03805841|528489729|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
146541503|NCT02382380|528489731|FG000|Overall Study|Withdrawal by Subject|2|||
146541504|NCT02382380|528489732|FG001|Overall Study|Withdrawal by Subject|2|||
146541505|NCT02382380|528489731|FG000|Overall Study|Lost to Follow-up|0|||
146541506|NCT02382380|528489732|FG001|Overall Study|Lost to Follow-up|1|||
146541507|NCT04279522|528489733|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
146541508|NCT04279522|528489734|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
146541509|NCT04279522|528489733|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
146541510|NCT04279522|528489734|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
146541511|NCT04279522|528489733|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
146541512|NCT04279522|528489734|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
146541513|NCT04279522|528489733|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
146541514|NCT04279522|528489734|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
146541515|NCT04279522|528489733|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
146541516|NCT04279522|528489734|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
146541517|NCT04279522|528489733|FG000|Period 2: Open Label Phase|Physician Decision|0|||
146541518|NCT04279522|528489734|FG001|Period 2: Open Label Phase|Physician Decision|3|||
146541519|NCT04279522|528489733|FG000|Period 2: Open Label Phase|Adverse Event|0|||
146541520|NCT04279522|528489734|FG001|Period 2: Open Label Phase|Adverse Event|1|||
146541521|NCT04279522|528489733|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
146541522|NCT04279522|528489734|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
146541523|NCT02629159|528489735|FG000|Overall Study|Adverse Event|17|||
146541524|NCT02629159|528489736|FG001|Overall Study|Adverse Event|20|||
146541525|NCT02629159|528489737|FG002|Overall Study|Adverse Event|22|||
146541526|NCT02629159|528489735|FG000|Overall Study|Withdrawal by Subject|22|||
146541527|NCT02629159|528489736|FG001|Overall Study|Withdrawal by Subject|11|||
146541528|NCT02629159|528489737|FG002|Overall Study|Withdrawal by Subject|15|||
146541529|NCT02629159|528489735|FG000|Overall Study|Lost to Follow-up|7|||
146541530|NCT02629159|528489736|FG001|Overall Study|Lost to Follow-up|4|||
146541531|NCT02629159|528489737|FG002|Overall Study|Lost to Follow-up|5|||
146541532|NCT02629159|528489735|FG000|Overall Study|Lack of Efficacy|4|||
146541533|NCT02629159|528489736|FG001|Overall Study|Lack of Efficacy|0|||
146541534|NCT02629159|528489737|FG002|Overall Study|Lack of Efficacy|1|||
146541535|NCT02629159|528489735|FG000|Overall Study|Other|6|||
146541536|NCT02629159|528489736|FG001|Overall Study|Other|4|||
146541537|NCT02629159|528489737|FG002|Overall Study|Other|8|||
146541538|NCT01802281|528489742|FG000|Overall Study|Death|1|||
146541539|NCT01802281|528489743|FG001|Overall Study|Death|2|||
146541540|NCT01802281|528489742|FG000|Overall Study|Withdrawal by Subject|2|||
146541541|NCT01802281|528489743|FG001|Overall Study|Withdrawal by Subject|1|||
146541542|NCT01802281|528489742|FG000|Overall Study|Ineligible|5|||
146541543|NCT01802281|528489743|FG001|Overall Study|Ineligible|3|||
146541544|NCT02401230|528489744|FG000|Overall Study|Adverse Event|3|||
146541545|NCT02401230|528489745|FG001|Overall Study|Adverse Event|2|||
146541546|NCT02401230|528489746|FG002|Overall Study|Adverse Event|0|||
146541547|NCT02401230|528489744|FG000|Overall Study|Withdrawal by Subject|2|||
146541548|NCT02401230|528489745|FG001|Overall Study|Withdrawal by Subject|1|||
146541549|NCT02401230|528489746|FG002|Overall Study|Withdrawal by Subject|1|||
146541550|NCT02401230|528489744|FG000|Overall Study|Lost to Follow-up|1|||
146541551|NCT02401230|528489745|FG001|Overall Study|Lost to Follow-up|3|||
146541552|NCT02401230|528489746|FG002|Overall Study|Lost to Follow-up|3|||
146541553|NCT00831844|528489747|FG000|Overall Study|Adverse Event|2|||
146541554|NCT00831844|528489748|FG001|Overall Study|Adverse Event|0|||
146541555|NCT00831844|528489749|FG002|Overall Study|Adverse Event|0|||
146541556|NCT00831844|528489750|FG003|Overall Study|Adverse Event|0|||
146541557|NCT00831844|528489751|FG004|Overall Study|Adverse Event|1|||
146541558|NCT00831844|528489752|FG005|Overall Study|Adverse Event|1|||
146541559|NCT00831844|528489753|FG006|Overall Study|Adverse Event|2|||
146541560|NCT00831844|528489754|FG007|Overall Study|Adverse Event|0|||
146541561|NCT00831844|528489755|FG008|Overall Study|Adverse Event|0|||
146541562|NCT00831844|528489756|FG009|Overall Study|Adverse Event|0|||
146541563|NCT00831844|528489747|FG000|Overall Study|Death|0|||
146541564|NCT00831844|528489748|FG001|Overall Study|Death|0|||
146541565|NCT00831844|528489749|FG002|Overall Study|Death|0|||
146541566|NCT00831844|528489750|FG003|Overall Study|Death|1|||
146541567|NCT00831844|528489751|FG004|Overall Study|Death|0|||
146541568|NCT00831844|528489752|FG005|Overall Study|Death|0|||
146541569|NCT00831844|528489753|FG006|Overall Study|Death|0|||
146541570|NCT00831844|528489754|FG007|Overall Study|Death|0|||
146541571|NCT00831844|528489755|FG008|Overall Study|Death|0|||
146541572|NCT00831844|528489756|FG009|Overall Study|Death|0|||
146541573|NCT00831844|528489747|FG000|Overall Study|Lack of Efficacy|8|||
146541574|NCT00831844|528489748|FG001|Overall Study|Lack of Efficacy|10|||
146541575|NCT00831844|528489749|FG002|Overall Study|Lack of Efficacy|15|||
146541576|NCT00831844|528489750|FG003|Overall Study|Lack of Efficacy|8|||
146541577|NCT00831844|528489751|FG004|Overall Study|Lack of Efficacy|11|||
146541578|NCT00831844|528489752|FG005|Overall Study|Lack of Efficacy|17|||
146541579|NCT00831844|528489753|FG006|Overall Study|Lack of Efficacy|8|||
146541580|NCT00831844|528489754|FG007|Overall Study|Lack of Efficacy|9|||
146541581|NCT00831844|528489755|FG008|Overall Study|Lack of Efficacy|7|||
146541582|NCT00831844|528489756|FG009|Overall Study|Lack of Efficacy|0|||
146541583|NCT00831844|528489747|FG000|Overall Study|Physician Decision|0|||
146541584|NCT00831844|528489748|FG001|Overall Study|Physician Decision|1|||
146541585|NCT00831844|528489749|FG002|Overall Study|Physician Decision|3|||
146541586|NCT00831844|528489750|FG003|Overall Study|Physician Decision|1|||
146541587|NCT00831844|528489751|FG004|Overall Study|Physician Decision|1|||
146541588|NCT00831844|528489752|FG005|Overall Study|Physician Decision|1|||
146541589|NCT00831844|528489753|FG006|Overall Study|Physician Decision|0|||
146541590|NCT00831844|528489754|FG007|Overall Study|Physician Decision|0|||
146541591|NCT00831844|528489755|FG008|Overall Study|Physician Decision|1|||
146541592|NCT00831844|528489756|FG009|Overall Study|Physician Decision|0|||
146541593|NCT00831844|528489747|FG000|Overall Study|Withdrawal by Subject|0|||
146541594|NCT00831844|528489748|FG001|Overall Study|Withdrawal by Subject|0|||
146541595|NCT00831844|528489749|FG002|Overall Study|Withdrawal by Subject|1|||
146541596|NCT00831844|528489750|FG003|Overall Study|Withdrawal by Subject|0|||
146541597|NCT00831844|528489751|FG004|Overall Study|Withdrawal by Subject|0|||
146541598|NCT00831844|528489752|FG005|Overall Study|Withdrawal by Subject|0|||
146541599|NCT00831844|528489753|FG006|Overall Study|Withdrawal by Subject|0|||
146541600|NCT00831844|528489754|FG007|Overall Study|Withdrawal by Subject|1|||
146541601|NCT00831844|528489755|FG008|Overall Study|Withdrawal by Subject|1|||
146541602|NCT00831844|528489756|FG009|Overall Study|Withdrawal by Subject|0|||
146541603|NCT00831844|528489747|FG000|Overall Study|Ineligible|0|||
146541604|NCT00831844|528489748|FG001|Overall Study|Ineligible|1|||
146541605|NCT00831844|528489749|FG002|Overall Study|Ineligible|1|||
146541606|NCT00831844|528489750|FG003|Overall Study|Ineligible|0|||
146541607|NCT00831844|528489751|FG004|Overall Study|Ineligible|1|||
146541608|NCT00831844|528489752|FG005|Overall Study|Ineligible|0|||
146541609|NCT00831844|528489753|FG006|Overall Study|Ineligible|0|||
146541610|NCT00831844|528489754|FG007|Overall Study|Ineligible|0|||
146541611|NCT00831844|528489755|FG008|Overall Study|Ineligible|0|||
146541612|NCT00831844|528489756|FG009|Overall Study|Ineligible|0|||
146541613|NCT00830765|528489757|FG000|Overall Study|Protocol Violation|3|||
146541614|NCT00830765|528489758|FG001|Overall Study|Protocol Violation|2|||
146541615|NCT00315445|528489759|FG000|Overall Study|Adverse Event|7|||
146541616|NCT00315445|528489760|FG001|Overall Study|Adverse Event|12|||
146541617|NCT00315445|528489761|FG002|Overall Study|Adverse Event|15|||
146541618|NCT00315445|528489759|FG000|Overall Study|Lack of Efficacy|16|||
146541619|NCT00315445|528489760|FG001|Overall Study|Lack of Efficacy|1|||
146541620|NCT00315445|528489761|FG002|Overall Study|Lack of Efficacy|7|||
146541621|NCT00315445|528489759|FG000|Overall Study|Lost to Follow-up|1|||
146541622|NCT00315445|528489760|FG001|Overall Study|Lost to Follow-up|0|||
146541623|NCT00315445|528489761|FG002|Overall Study|Lost to Follow-up|1|||
146541624|NCT00315445|528489759|FG000|Overall Study|Protocol Violation|2|||
146541625|NCT00315445|528489760|FG001|Overall Study|Protocol Violation|0|||
146541626|NCT00315445|528489761|FG002|Overall Study|Protocol Violation|1|||
146541627|NCT00315445|528489759|FG000|Overall Study|Other|1|||
146541628|NCT00315445|528489760|FG001|Overall Study|Other|3|||
146541629|NCT00315445|528489761|FG002|Overall Study|Other|0|||
146541630|NCT00858988|528489768|FG000|Analysis|Lactulose unable to be detected in urine|2|||
146541631|NCT00858988|528489769|FG001|Analysis|Lactulose unable to be detected in urine|1|||
146541632|NCT01787838|528491458|FG000|Overall Study|refused|1413|||
146541633|NCT01240746|528491459|FG000|Overall Study|Adverse Event|2|||
146541634|NCT01240746|528491460|FG001|Overall Study|Adverse Event|0|||
146541635|NCT01240746|528491461|FG002|Overall Study|Adverse Event|10|||
146541636|NCT01240746|528491459|FG000|Overall Study|Lost to Follow-up|23|||
146541637|NCT01240746|528491460|FG001|Overall Study|Lost to Follow-up|20|||
146541638|NCT01240746|528491461|FG002|Overall Study|Lost to Follow-up|102|||
146541639|NCT01240746|528491459|FG000|Overall Study|Protocol Violation|24|||
146541640|NCT01240746|528491460|FG001|Overall Study|Protocol Violation|15|||
146541641|NCT01240746|528491461|FG002|Overall Study|Protocol Violation|72|||
146541642|NCT01240746|528491459|FG000|Overall Study|Withdrawal by Subject|10|||
146541643|NCT01240746|528491460|FG001|Overall Study|Withdrawal by Subject|13|||
146541644|NCT01240746|528491461|FG002|Overall Study|Withdrawal by Subject|59|||
146541645|NCT01126424|528491466|FG000|Overall Study|Adverse Event|0|||
146541646|NCT01126424|528491467|FG001|Overall Study|Adverse Event|0|||
146541647|NCT01126424|528491468|FG002|Overall Study|Adverse Event|0|||
146541648|NCT01126424|528491469|FG003|Overall Study|Adverse Event|0|||
146541649|NCT01126424|528491470|FG004|Overall Study|Adverse Event|1|||
146541650|NCT01126424|528491471|FG005|Overall Study|Adverse Event|0|||
146541651|NCT01126424|528491466|FG000|Overall Study|Withdrawal by Subject|0|||
146541652|NCT01126424|528491467|FG001|Overall Study|Withdrawal by Subject|0|||
146541653|NCT01126424|528491468|FG002|Overall Study|Withdrawal by Subject|1|||
146541654|NCT01126424|528491469|FG003|Overall Study|Withdrawal by Subject|3|||
146541655|NCT01126424|528491470|FG004|Overall Study|Withdrawal by Subject|1|||
146541656|NCT01126424|528491471|FG005|Overall Study|Withdrawal by Subject|0|||
146541657|NCT02127671|528491472|FG000|Overall Study|Death|2|||
146541658|NCT02127671|528491473|FG001|Overall Study|Death|2|||
146541659|NCT02127671|528491472|FG000|Overall Study|Lost to Follow-up|4|||
146541660|NCT02127671|528491473|FG001|Overall Study|Lost to Follow-up|2|||
146541661|NCT02127671|528491472|FG000|Overall Study|Physician Decision|1|||
146541662|NCT02127671|528491473|FG001|Overall Study|Physician Decision|0|||
146541663|NCT02127671|528491472|FG000|Overall Study|incarceration|0|||
146541664|NCT02127671|528491473|FG001|Overall Study|incarceration|1|||
146872328|NCT00474708|529703234|FG001|Overall Study|Lack of compliance|4|||
146541665|NCT02127671|528491472|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
146872329|NCT00474708|529703233|FG000|Overall Study|Lost to Follow-up|18|||
146541666|NCT02127671|528491473|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
146872330|NCT00474708|529703234|FG001|Overall Study|Lost to Follow-up|9|||
146872331|NCT00474708|529703233|FG000|Overall Study|Physician Decision|9|||
146872332|NCT00474708|529703234|FG001|Overall Study|Physician Decision|6|||
146872333|NCT01092143|529703235|FG000|Overall Study|Adverse Event|10|||
146872334|NCT01092143|529703236|FG001|Overall Study|Adverse Event|5|||
146872335|NCT01092143|529703237|FG002|Overall Study|Adverse Event|1|||
146872336|NCT01092143|529703238|FG003|Overall Study|Adverse Event|4|||
146872337|NCT01092143|529703239|FG004|Overall Study|Adverse Event|3|||
146872338|NCT01092143|529703235|FG000|Overall Study|Lost to Follow-up|1|||
146872339|NCT01092143|529703236|FG001|Overall Study|Lost to Follow-up|0|||
146872340|NCT01092143|529703237|FG002|Overall Study|Lost to Follow-up|1|||
146872341|NCT01092143|529703238|FG003|Overall Study|Lost to Follow-up|0|||
146872342|NCT01092143|529703239|FG004|Overall Study|Lost to Follow-up|0|||
146872343|NCT01092143|529703235|FG000|Overall Study|Consent withdrawn|2|||
146872344|NCT01092143|529703236|FG001|Overall Study|Consent withdrawn|1|||
146872345|NCT01092143|529703237|FG002|Overall Study|Consent withdrawn|0|||
146872346|NCT01092143|529703238|FG003|Overall Study|Consent withdrawn|1|||
146872347|NCT01092143|529703239|FG004|Overall Study|Consent withdrawn|3|||
146872348|NCT01092143|529703235|FG000|Overall Study|Not treated|0|||
146872349|NCT01092143|529703236|FG001|Overall Study|Not treated|0|||
146872350|NCT01092143|529703237|FG002|Overall Study|Not treated|1|||
146872351|NCT01092143|529703238|FG003|Overall Study|Not treated|0|||
146872352|NCT01092143|529703239|FG004|Overall Study|Not treated|0|||
146872353|NCT01092143|529703235|FG000|Overall Study|did not reversibility criteria|0|||
146872354|NCT01092143|529703236|FG001|Overall Study|did not reversibility criteria|0|||
146872355|NCT01092143|529703237|FG002|Overall Study|did not reversibility criteria|1|||
146872356|NCT01092143|529703238|FG003|Overall Study|did not reversibility criteria|0|||
146872357|NCT01092143|529703239|FG004|Overall Study|did not reversibility criteria|0|||
146872358|NCT01092143|529703235|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
146541667|NCT00764517|528491477|FG000|Overall Study|Adverse Event|9|||
146541668|NCT00764517|528491478|FG001|Overall Study|Adverse Event|3|||
146541669|NCT00764517|528491477|FG000|Overall Study|Death|3|||
146872359|NCT01092143|529703236|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
146872360|NCT01092143|529703237|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
146872361|NCT01092143|529703238|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
146872362|NCT01092143|529703239|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
146872363|NCT01092143|529703235|FG000|Overall Study|Ineligible patient|1|||
146872364|NCT01092143|529703236|FG001|Overall Study|Ineligible patient|0|||
146872365|NCT01092143|529703237|FG002|Overall Study|Ineligible patient|0|||
146872366|NCT01092143|529703238|FG003|Overall Study|Ineligible patient|0|||
146541670|NCT00764517|528491478|FG001|Overall Study|Death|11|||
146872367|NCT01092143|529703239|FG004|Overall Study|Ineligible patient|0|||
146872368|NCT01092143|529703235|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
146872369|NCT01092143|529703236|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
146872370|NCT01092143|529703237|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
146872371|NCT01092143|529703238|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
146872372|NCT01092143|529703239|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
146872373|NCT01092143|529703235|FG000|Overall Study|Patient travel|0|||
146541671|NCT00764517|528491477|FG000|Overall Study|Physician Decision|3|||
146541672|NCT00764517|528491478|FG001|Overall Study|Physician Decision|0|||
146541673|NCT02239328|528491484|FG000|Overall Study|Benign disease noted at time of surgery|6|||
146541674|NCT02239328|528491484|FG000|Overall Study|Equipment or website malfunction|2|||
146541675|NCT04115059|528491487|FG000|Overall Study|Withdrawal by Subject|1|||
146541676|NCT04115059|528491487|FG000|Overall Study|Lack of Efficacy|2|||
146541677|NCT03517137|528491490|FG000|Overall Study|Lack of Efficacy|1|||
146541678|NCT03517137|528491490|FG000|Overall Study|Adverse Event|2|||
146541679|NCT03517137|528491490|FG000|Overall Study|Withdrawal by Subject|2|||
146541680|NCT03517137|528491490|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
146541681|NCT01838876|528491497|FG000|Overall Study|Adverse Event|49|||
146541682|NCT01838876|528491497|FG000|Overall Study|Insufficient Therapeutic Response|10|||
146541683|NCT01838876|528491497|FG000|Overall Study|Protocol Violation|34|||
146541684|NCT01838876|528491497|FG000|Overall Study|Withdrawal of Consent|33|||
146541685|NCT01838876|528491497|FG000|Overall Study|Lost to Follow-up|21|||
146541686|NCT01838876|528491497|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
146541687|NCT01838876|528491497|FG000|Overall Study|Reason not Specified|7|||
146541688|NCT01838876|528491497|FG000|Overall Study|Did not meet eligibility criteria|78|||
146872374|NCT01092143|529703236|FG001|Overall Study|Patient travel|0|||
146872375|NCT01092143|529703237|FG002|Overall Study|Patient travel|0|||
146872376|NCT01092143|529703238|FG003|Overall Study|Patient travel|0|||
146872377|NCT01092143|529703239|FG004|Overall Study|Patient travel|1|||
146872378|NCT01092143|529703235|FG000|Overall Study|Non compliance with study medication|0|||
146872379|NCT01092143|529703236|FG001|Overall Study|Non compliance with study medication|0|||
146872380|NCT01092143|529703237|FG002|Overall Study|Non compliance with study medication|0|||
146872381|NCT01092143|529703238|FG003|Overall Study|Non compliance with study medication|0|||
146872382|NCT01092143|529703239|FG004|Overall Study|Non compliance with study medication|1|||
146872383|NCT01092143|529703235|FG000|Overall Study|Randomized by mistake|0|||
146872384|NCT01092143|529703236|FG001|Overall Study|Randomized by mistake|0|||
146872385|NCT01092143|529703237|FG002|Overall Study|Randomized by mistake|0|||
146872386|NCT01092143|529703238|FG003|Overall Study|Randomized by mistake|1|||
146872387|NCT01092143|529703239|FG004|Overall Study|Randomized by mistake|0|||
146872388|NCT01092143|529703235|FG000|Overall Study|Pregnancy|0|||
146872389|NCT01092143|529703236|FG001|Overall Study|Pregnancy|0|||
146872390|NCT01092143|529703237|FG002|Overall Study|Pregnancy|0|||
146872391|NCT01092143|529703238|FG003|Overall Study|Pregnancy|1|||
146872392|NCT01092143|529703239|FG004|Overall Study|Pregnancy|0|||
146872393|NCT00117598|529703245|FG000|Prior to Treatment Cross Over|Death|40|||
146872394|NCT00117598|529703246|FG001|Prior to Treatment Cross Over|Death|41|||
146872395|NCT00117598|529703247|FG002|Prior to Treatment Cross Over|Death|37|||
146872396|NCT00117598|529703248|FG003|Prior to Treatment Cross Over|Death|0|||
146872397|NCT00117598|529703249|FG004|Prior to Treatment Cross Over|Death|0|||
146872398|NCT00117598|529703245|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
146872399|NCT00117598|529703246|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
146872400|NCT00117598|529703247|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
146872401|NCT00117598|529703248|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
146872402|NCT00117598|529703249|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
146872403|NCT00117598|529703245|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
146872404|NCT00117598|529703246|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
146872405|NCT00117598|529703247|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
146872406|NCT00117598|529703248|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
146872407|NCT00117598|529703249|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
146872408|NCT00117598|529703245|FG000|Prior to Treatment Cross Over|Other|15|||
146872409|NCT00117598|529703246|FG001|Prior to Treatment Cross Over|Other|9|||
146872410|NCT00117598|529703247|FG002|Prior to Treatment Cross Over|Other|9|||
146872411|NCT00117598|529703248|FG003|Prior to Treatment Cross Over|Other|0|||
146872412|NCT00117598|529703249|FG004|Prior to Treatment Cross Over|Other|0|||
146872413|NCT00117598|529703245|FG000|After Treament Cross Over|Death|0|||
146872414|NCT00117598|529703246|FG001|After Treament Cross Over|Death|0|||
146872415|NCT00117598|529703247|FG002|After Treament Cross Over|Death|0|||
146872416|NCT00117598|529703248|FG003|After Treament Cross Over|Death|1|||
146872417|NCT00117598|529703249|FG004|After Treament Cross Over|Death|2|||
146541689|NCT02313155|528491498|FG000|Overall Study|Lost to Follow-up|0|||
146541690|NCT02313155|528491499|FG001|Overall Study|Lost to Follow-up|1|||
146541691|NCT01682031|528491500|FG000|Overall Study|Withdrawal by Subject|0|||
146541692|NCT01682031|528491501|FG001|Overall Study|Withdrawal by Subject|1|||
146541693|NCT01682031|528491500|FG000|Overall Study|Adverse Event|0|||
146541694|NCT01682031|528491501|FG001|Overall Study|Adverse Event|2|||
146541695|NCT01682031|528491500|FG000|Overall Study|MRI results indicate increased nodul|0|||
146541696|NCT01682031|528491501|FG001|Overall Study|MRI results indicate increased nodul|1|||
146541697|NCT01682031|528491500|FG000|Overall Study|Patient could not swallow tablets|1|||
146541698|NCT01682031|528491501|FG001|Overall Study|Patient could not swallow tablets|0|||
146541699|NCT01682031|528491500|FG000|Overall Study|Patient stopped selenium on his own|0|||
146541700|NCT01682031|528491501|FG001|Overall Study|Patient stopped selenium on his own|1|||
146541701|NCT00933933|528491504|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
146541702|NCT00933933|528491505|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
146541703|NCT00933933|528491506|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
146764190|NCT02377362|529303007|FG000|Part A Second Treatment|Protocol Violation|0|||
146764191|NCT02377362|529303008|FG001|Part A Second Treatment|Protocol Violation|0|||
146568780|NCT00658541|528595451|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
146975335|NCT00572156|530073542|FG003|Overall Study|Protocol Violation|2|||
146541704|NCT00933933|528491504|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
146541705|NCT00933933|528491505|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
146541706|NCT00933933|528491506|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
146541707|NCT01995201|528491507|FG000|From Baseline Until Week 24|Adverse Event|4|||
146541708|NCT01995201|528491508|FG001|From Baseline Until Week 24|Adverse Event|15|||
146541709|NCT01995201|528491509|FG002|From Baseline Until Week 24|Adverse Event|0|||
146541710|NCT01995201|528491510|FG003|From Baseline Until Week 24|Adverse Event|0|||
146541711|NCT01995201|528491511|FG004|From Baseline Until Week 24|Adverse Event|0|||
146541712|NCT01995201|528491512|FG005|From Baseline Until Week 24|Adverse Event|0|||
146541713|NCT01995201|528491513|FG006|From Baseline Until Week 24|Adverse Event|0|||
146541714|NCT01995201|528491507|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
146541715|NCT01995201|528491508|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
146541716|NCT01995201|528491509|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
146541717|NCT01995201|528491510|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
146541718|NCT01995201|528491511|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
146541719|NCT01995201|528491512|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
146541720|NCT01995201|528491513|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
146541721|NCT01995201|528491507|FG000|From Baseline Until Week 24|Death|0|||
146541722|NCT01995201|528491508|FG001|From Baseline Until Week 24|Death|1|||
146541723|NCT01995201|528491509|FG002|From Baseline Until Week 24|Death|0|||
146541724|NCT01995201|528491510|FG003|From Baseline Until Week 24|Death|0|||
146541725|NCT01995201|528491511|FG004|From Baseline Until Week 24|Death|0|||
146541726|NCT01995201|528491512|FG005|From Baseline Until Week 24|Death|0|||
146541727|NCT01995201|528491513|FG006|From Baseline Until Week 24|Death|0|||
146541728|NCT01995201|528491507|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
146541729|NCT01995201|528491508|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
146541730|NCT01995201|528491509|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
146541731|NCT01995201|528491510|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
146541732|NCT01995201|528491511|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
146541733|NCT01995201|528491512|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
146541734|NCT01995201|528491513|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
146541735|NCT01995201|528491507|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
146541736|NCT01995201|528491508|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
146541737|NCT01995201|528491509|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
146541738|NCT01995201|528491510|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
146541739|NCT01995201|528491511|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
146541740|NCT01995201|528491512|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
146541741|NCT01995201|528491513|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
146541742|NCT01995201|528491507|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
146541743|NCT01995201|528491508|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
146541744|NCT01995201|528491509|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
146541745|NCT01995201|528491510|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
146541746|NCT01995201|528491511|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
146541747|NCT01995201|528491512|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
146541748|NCT01995201|528491513|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
146541749|NCT01995201|528491507|FG000|From Baseline Until Week 24|Physician Decision|0|||
146541750|NCT01995201|528491508|FG001|From Baseline Until Week 24|Physician Decision|2|||
146541751|NCT01995201|528491509|FG002|From Baseline Until Week 24|Physician Decision|0|||
146541752|NCT01995201|528491510|FG003|From Baseline Until Week 24|Physician Decision|0|||
146541753|NCT01995201|528491511|FG004|From Baseline Until Week 24|Physician Decision|0|||
146541754|NCT01995201|528491512|FG005|From Baseline Until Week 24|Physician Decision|0|||
146541755|NCT01995201|528491513|FG006|From Baseline Until Week 24|Physician Decision|0|||
146541756|NCT01995201|528491507|FG000|From Baseline Until Week 24|Protocol Violation|0|||
146541757|NCT01995201|528491508|FG001|From Baseline Until Week 24|Protocol Violation|9|||
146541758|NCT01995201|528491509|FG002|From Baseline Until Week 24|Protocol Violation|0|||
146541759|NCT01995201|528491510|FG003|From Baseline Until Week 24|Protocol Violation|0|||
146541760|NCT01995201|528491511|FG004|From Baseline Until Week 24|Protocol Violation|0|||
146541761|NCT01995201|528491512|FG005|From Baseline Until Week 24|Protocol Violation|0|||
146541762|NCT01995201|528491513|FG006|From Baseline Until Week 24|Protocol Violation|0|||
146541763|NCT01995201|528491507|FG000|From Week 24 Until Week 48|Adverse Event|0|||
146541764|NCT01995201|528491508|FG001|From Week 24 Until Week 48|Adverse Event|0|||
146541765|NCT01995201|528491509|FG002|From Week 24 Until Week 48|Adverse Event|2|||
146541766|NCT01995201|528491510|FG003|From Week 24 Until Week 48|Adverse Event|1|||
146541767|NCT01995201|528491511|FG004|From Week 24 Until Week 48|Adverse Event|1|||
146541768|NCT01995201|528491512|FG005|From Week 24 Until Week 48|Adverse Event|3|||
146541769|NCT01995201|528491513|FG006|From Week 24 Until Week 48|Adverse Event|1|||
146541770|NCT01995201|528491507|FG000|From Week 24 Until Week 48|Death|0|||
146541771|NCT01995201|528491508|FG001|From Week 24 Until Week 48|Death|0|||
146541772|NCT01995201|528491509|FG002|From Week 24 Until Week 48|Death|0|||
146541773|NCT01995201|528491510|FG003|From Week 24 Until Week 48|Death|0|||
146541774|NCT01995201|528491511|FG004|From Week 24 Until Week 48|Death|0|||
146541775|NCT01995201|528491512|FG005|From Week 24 Until Week 48|Death|2|||
146541776|NCT01995201|528491513|FG006|From Week 24 Until Week 48|Death|0|||
146541777|NCT01995201|528491507|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
146541778|NCT01995201|528491508|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
146541779|NCT01995201|528491509|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
146541780|NCT01995201|528491510|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
146541781|NCT01995201|528491511|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
146541782|NCT01995201|528491512|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
146541783|NCT01995201|528491513|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
146541784|NCT01995201|528491507|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
146541785|NCT01995201|528491508|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
146541786|NCT01995201|528491509|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
146541787|NCT01995201|528491510|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
146541788|NCT01995201|528491511|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
146541789|NCT01995201|528491512|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
146541790|NCT01995201|528491513|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
146764192|NCT02377362|529303009|FG002|Part A Second Treatment|Protocol Violation|0|||
146966438|NCT00650806|530038802|FG003|Overall Study|Withdrawal by Subject|6|||
146541791|NCT01995201|528491507|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
146541792|NCT01995201|528491508|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
146541793|NCT01995201|528491509|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
146541794|NCT01995201|528491510|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
146541795|NCT01995201|528491511|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
146541796|NCT01995201|528491512|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
146541797|NCT01995201|528491513|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
146541798|NCT01995201|528491507|FG000|From Week 24 Until Week 48|Physician Decision|0|||
146541799|NCT01995201|528491508|FG001|From Week 24 Until Week 48|Physician Decision|0|||
146541800|NCT01995201|528491509|FG002|From Week 24 Until Week 48|Physician Decision|0|||
146541801|NCT01995201|528491510|FG003|From Week 24 Until Week 48|Physician Decision|0|||
146541802|NCT01995201|528491511|FG004|From Week 24 Until Week 48|Physician Decision|1|||
146541803|NCT01995201|528491512|FG005|From Week 24 Until Week 48|Physician Decision|0|||
146541804|NCT01995201|528491513|FG006|From Week 24 Until Week 48|Physician Decision|0|||
146541805|NCT01995201|528491507|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
146541806|NCT01995201|528491508|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
146541807|NCT01995201|528491509|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
146541808|NCT01995201|528491510|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
146541809|NCT01995201|528491511|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
146541810|NCT01995201|528491512|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
146541811|NCT01995201|528491513|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
146541812|NCT03329001|528491514|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
146541813|NCT03329001|528491515|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
146541814|NCT03329001|528491516|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
146541815|NCT03329001|528491517|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
146541816|NCT03329001|528491518|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
146541817|NCT03329001|528491519|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
146541818|NCT03329001|528491520|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
146541819|NCT03329001|528491521|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
146541820|NCT03329001|528491514|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
146541821|NCT03329001|528491515|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
146541822|NCT03329001|528491516|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
146541823|NCT03329001|528491517|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
146541824|NCT03329001|528491518|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
146541825|NCT03329001|528491519|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
146541826|NCT03329001|528491520|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
146541827|NCT03329001|528491521|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
146541828|NCT03329001|528491514|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
146541829|NCT03329001|528491515|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
146541830|NCT03329001|528491516|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
146541831|NCT03329001|528491517|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
146541832|NCT03329001|528491518|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
146541833|NCT03329001|528491519|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
146541834|NCT03329001|528491520|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
146541835|NCT03329001|528491521|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
146541836|NCT03329001|528491514|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
146541837|NCT03329001|528491515|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
146541838|NCT03329001|528491516|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
146541839|NCT03329001|528491517|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
146541840|NCT03329001|528491518|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
146541841|NCT03329001|528491519|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
146541842|NCT03329001|528491520|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
146541843|NCT03329001|528491521|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
146541844|NCT03329001|528491514|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
146541845|NCT03329001|528491515|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
146541846|NCT03329001|528491516|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
146541847|NCT03329001|528491517|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
146541848|NCT03329001|528491518|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
146541849|NCT03329001|528491519|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
146541850|NCT03329001|528491520|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
146628017|NCT00106704|528813548|FG001|Overall Study|Lack of Efficacy|69|||
146872418|NCT00117598|529703245|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
146872419|NCT00117598|529703246|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
146872420|NCT00117598|529703247|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
146872421|NCT00117598|529703248|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
146872422|NCT00117598|529703249|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
146872423|NCT00117598|529703245|FG000|After Treament Cross Over|Other|0|||
146872424|NCT00117598|529703246|FG001|After Treament Cross Over|Other|0|||
146872425|NCT00117598|529703247|FG002|After Treament Cross Over|Other|0|||
146872426|NCT00117598|529703248|FG003|After Treament Cross Over|Other|1|||
146872427|NCT00117598|529703249|FG004|After Treament Cross Over|Other|2|||
146872428|NCT02054325|529703250|FG000|Overall Study|Lost to Follow-up|8|||
146872429|NCT02054325|529703251|FG001|Overall Study|Lost to Follow-up|5|||
146872430|NCT01708291|529703252|FG000|Overall Study|fighting|2|||
146872431|NCT01708291|529703253|FG001|Overall Study|fighting|1|||
146872432|NCT01536951|529703254|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
146872433|NCT01536951|529703255|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
146872434|NCT01536951|529703256|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
146872435|NCT01536951|529703257|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
146872436|NCT01536951|529703258|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
146872437|NCT01536951|529703259|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
146872438|NCT01536951|529703260|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
146872439|NCT01536951|529703261|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
146872440|NCT01536951|529703262|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
146872441|NCT01536951|529703254|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
146872442|NCT01536951|529703255|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
146872443|NCT01536951|529703256|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
146872444|NCT01536951|529703257|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
146872445|NCT01536951|529703258|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
146872446|NCT01536951|529703259|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
146541851|NCT03329001|528491521|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
146541852|NCT03329001|528491514|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
146541853|NCT03329001|528491515|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
146541854|NCT03329001|528491516|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
146872447|NCT01536951|529703260|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
146541855|NCT03329001|528491517|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
146568781|NCT00658541|528595452|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
146541856|NCT03329001|528491518|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
146541857|NCT03329001|528491519|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
146541858|NCT03329001|528491520|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
146541859|NCT03329001|528491521|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
146541860|NCT03329001|528491514|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
146541861|NCT03329001|528491515|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
146541862|NCT03329001|528491516|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
146541863|NCT03329001|528491517|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
146541864|NCT03329001|528491518|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
146541865|NCT03329001|528491519|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
146541866|NCT03329001|528491520|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
146541867|NCT03329001|528491521|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
146541868|NCT03329001|528491514|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
146541869|NCT03329001|528491515|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
146541870|NCT03329001|528491516|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
146541871|NCT03329001|528491517|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
146541872|NCT03329001|528491518|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
146541873|NCT03329001|528491519|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
146541874|NCT03329001|528491520|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
146541875|NCT03329001|528491521|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
146541876|NCT03329001|528491514|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
146541877|NCT03329001|528491515|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
146541878|NCT03329001|528491516|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
146541879|NCT03329001|528491517|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
146541880|NCT03329001|528491518|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
146541881|NCT03329001|528491519|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
146541882|NCT03329001|528491520|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
146541883|NCT03329001|528491521|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
146541884|NCT03329001|528491514|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
146541885|NCT03329001|528491515|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
146541886|NCT03329001|528491516|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
146541887|NCT03329001|528491517|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
146541888|NCT03329001|528491518|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
146541889|NCT03329001|528491519|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
146541890|NCT03329001|528491520|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
146541891|NCT03329001|528491521|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
146541892|NCT03329001|528491514|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
146541893|NCT03329001|528491515|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
146541894|NCT03329001|528491516|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
146541895|NCT03329001|528491517|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
146541896|NCT03329001|528491518|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
146541897|NCT03329001|528491519|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
146541898|NCT03329001|528491520|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
146541899|NCT03329001|528491521|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
146541900|NCT03329001|528491514|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
146541901|NCT03329001|528491515|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
146541902|NCT03329001|528491516|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
146541903|NCT03329001|528491517|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
146628018|NCT00106704|528813547|FG000|Overall Study|Lost to Follow-up|7|||
146541904|NCT03329001|528491518|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
146541905|NCT03329001|528491519|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
146541906|NCT03329001|528491520|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
146541907|NCT03329001|528491521|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
146541908|NCT03329001|528491514|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
146541909|NCT03329001|528491515|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
146541910|NCT03329001|528491516|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
146541911|NCT03329001|528491517|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
146541912|NCT03329001|528491518|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
146541913|NCT03329001|528491519|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
146541914|NCT03329001|528491520|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
146541915|NCT03329001|528491521|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
146541916|NCT03329001|528491514|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
146541917|NCT03329001|528491515|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
146541918|NCT03329001|528491516|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
146541919|NCT03329001|528491517|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
146541920|NCT03329001|528491518|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
146541921|NCT03329001|528491519|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
146541922|NCT03329001|528491520|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
146541923|NCT03329001|528491521|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
146628019|NCT00106704|528813548|FG001|Overall Study|Lost to Follow-up|3|||
146541924|NCT03329001|528491514|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
146541925|NCT03329001|528491515|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
146541926|NCT03329001|528491516|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
146541927|NCT03329001|528491517|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
146541928|NCT03329001|528491518|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
146872448|NCT01536951|529703261|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
146872449|NCT01536951|529703262|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
146872450|NCT01817751|529703267|FG000|Overall Study|Physician Decision|1|||
146872451|NCT00382018|529703268|FG000|Overall Study|Progression|0|||
146872452|NCT00382018|529703269|FG001|Overall Study|Progression|136|||
146872453|NCT00382018|529703270|FG002|Overall Study|Progression|51|||
146872454|NCT00382018|529703271|FG003|Overall Study|Progression|43|||
146872455|NCT00382018|529703268|FG000|Overall Study|Death|0|||
146872456|NCT00382018|529703269|FG001|Overall Study|Death|9|||
146872457|NCT00382018|529703270|FG002|Overall Study|Death|7|||
146872458|NCT00382018|529703271|FG003|Overall Study|Death|11|||
146872459|NCT00382018|529703268|FG000|Overall Study|Withdrawal by Subject|0|||
146872460|NCT00382018|529703269|FG001|Overall Study|Withdrawal by Subject|4|||
146872461|NCT00382018|529703270|FG002|Overall Study|Withdrawal by Subject|3|||
146872462|NCT00382018|529703271|FG003|Overall Study|Withdrawal by Subject|4|||
146872463|NCT00382018|529703268|FG000|Overall Study|Other, not protocol specified|0|||
146872464|NCT00382018|529703269|FG001|Overall Study|Other, not protocol specified|16|||
146872465|NCT00382018|529703270|FG002|Overall Study|Other, not protocol specified|3|||
146872466|NCT00382018|529703271|FG003|Overall Study|Other, not protocol specified|1|||
146872467|NCT00427349|529703274|FG000|Overall Study|Lack of Efficacy|23|||
146872468|NCT00427349|529703274|FG000|Overall Study|Adverse Event|14|||
146872469|NCT00427349|529703274|FG000|Overall Study|Death|1|||
146872470|NCT00427349|529703274|FG000|Overall Study|Withdrawal by Subject|3|||
146872471|NCT00427349|529703274|FG000|Overall Study|Alternative therapy|1|||
146872472|NCT00427349|529703274|FG000|Overall Study|Other|2|||
146872473|NCT00427349|529703274|FG000|Overall Study|Ineligible|1|||
146872474|NCT00427349|529703274|FG000|Overall Study|Never started therapy|1|||
146872475|NCT05082376|529703275|FG000|Overall Study|Lost to Follow-up|2|||
146872476|NCT00766038|529704827|FG000|Overall Study|Lost to Follow-up|15|||
146872477|NCT00766038|529704828|FG001|Overall Study|Lost to Follow-up|14|||
146872478|NCT00449670|529704829|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
146541929|NCT03329001|528491519|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
146541930|NCT03329001|528491520|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
146541931|NCT03329001|528491521|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
146541932|NCT03329001|528491514|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
146541933|NCT03329001|528491515|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
146541934|NCT03329001|528491516|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
146541935|NCT03329001|528491517|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
146541936|NCT03329001|528491518|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
146541937|NCT03329001|528491519|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
146541938|NCT03329001|528491520|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
146541939|NCT03329001|528491521|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
146541940|NCT03329001|528491514|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
146541941|NCT03329001|528491515|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
146541942|NCT03329001|528491516|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
146541943|NCT03329001|528491517|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
146541944|NCT03329001|528491518|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
146541945|NCT03329001|528491519|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
146541946|NCT03329001|528491520|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
146541947|NCT03329001|528491521|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
146568782|NCT00658541|528595451|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
146872479|NCT00449670|529704830|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
146872480|NCT00449670|529704829|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
146872481|NCT00449670|529704830|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
146872482|NCT00449670|529704829|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
146872483|NCT00449670|529704830|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
146872484|NCT00449670|529704829|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
146872485|NCT00449670|529704830|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
146872486|NCT00449670|529704829|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
146872487|NCT00449670|529704830|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
146872488|NCT00449670|529704829|FG000|Booster Phase (Study no.109873)|Other|0|||
146872489|NCT00449670|529704830|FG001|Booster Phase (Study no.109873)|Other|2|||
146872490|NCT04183790|529704831|FG000|Overall Study|Participants did not rollover to Part B|12|||
146872491|NCT04183790|529704832|FG001|Overall Study|Participants did not rollover to Part B|0|||
146872492|NCT04183790|529704831|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
146872493|NCT04183790|529704832|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
146872494|NCT04183790|529704831|FG000|Overall Study|Commercial drug is available for participant|6|||
146872495|NCT04183790|529704832|FG001|Overall Study|Commercial drug is available for participant|0|||
146872496|NCT04183790|529704831|FG000|Overall Study|Adverse Event|1|||
146872497|NCT04183790|529704832|FG001|Overall Study|Adverse Event|0|||
146872498|NCT04183790|529704831|FG000|Overall Study|Not enrolled in 107 study|0|||
146872499|NCT04183790|529704832|FG001|Overall Study|Not enrolled in 107 study|2|||
146872500|NCT01251653|529704833|FG000|Overall Study|Progressive Disease|1|||
146872501|NCT01251653|529704834|FG001|Overall Study|Progressive Disease|7|||
146872502|NCT01251653|529704835|FG002|Overall Study|Progressive Disease|16|||
146872503|NCT01251653|529704836|FG003|Overall Study|Progressive Disease|4|||
146872504|NCT01251653|529704837|FG004|Overall Study|Progressive Disease|0|||
146872505|NCT01251653|529704838|FG005|Overall Study|Progressive Disease|17|||
146872506|NCT01251653|529704839|FG006|Overall Study|Progressive Disease|14|||
146872507|NCT01251653|529704840|FG007|Overall Study|Progressive Disease|7|||
146872508|NCT01251653|529704841|FG008|Overall Study|Progressive Disease|5|||
146872509|NCT01251653|529704833|FG000|Overall Study|Dose-limiting toxicity|0|||
146872510|NCT01251653|529704834|FG001|Overall Study|Dose-limiting toxicity|1|||
146872511|NCT01251653|529704835|FG002|Overall Study|Dose-limiting toxicity|1|||
146872512|NCT01251653|529704836|FG003|Overall Study|Dose-limiting toxicity|1|||
146872513|NCT01251653|529704837|FG004|Overall Study|Dose-limiting toxicity|0|||
146872514|NCT01251653|529704838|FG005|Overall Study|Dose-limiting toxicity|0|||
146872515|NCT01251653|529704839|FG006|Overall Study|Dose-limiting toxicity|2|||
146872516|NCT01251653|529704840|FG007|Overall Study|Dose-limiting toxicity|0|||
146872517|NCT01251653|529704841|FG008|Overall Study|Dose-limiting toxicity|0|||
146872518|NCT01251653|529704833|FG000|Overall Study|Adverse Event|1|||
146872519|NCT01251653|529704834|FG001|Overall Study|Adverse Event|0|||
146872520|NCT01251653|529704835|FG002|Overall Study|Adverse Event|2|||
146872521|NCT01251653|529704836|FG003|Overall Study|Adverse Event|1|||
146872522|NCT01251653|529704837|FG004|Overall Study|Adverse Event|1|||
146872523|NCT01251653|529704838|FG005|Overall Study|Adverse Event|0|||
146872524|NCT01251653|529704839|FG006|Overall Study|Adverse Event|2|||
146872525|NCT01251653|529704840|FG007|Overall Study|Adverse Event|2|||
146872526|NCT01251653|529704841|FG008|Overall Study|Adverse Event|1|||
146872527|NCT01251653|529704833|FG000|Overall Study|Withdrawal by Subject|1|||
146872528|NCT01251653|529704834|FG001|Overall Study|Withdrawal by Subject|0|||
146872529|NCT01251653|529704835|FG002|Overall Study|Withdrawal by Subject|1|||
146872530|NCT01251653|529704836|FG003|Overall Study|Withdrawal by Subject|0|||
146872531|NCT01251653|529704837|FG004|Overall Study|Withdrawal by Subject|1|||
146541948|NCT03329001|528491514|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
146541949|NCT03329001|528491515|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
146541950|NCT03329001|528491516|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
146541951|NCT03329001|528491517|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
146541952|NCT03329001|528491518|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
146541953|NCT03329001|528491519|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
146541954|NCT03329001|528491520|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
146541955|NCT03329001|528491521|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
146541956|NCT03329001|528491514|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
146541957|NCT03329001|528491515|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
146541958|NCT03329001|528491516|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
146541959|NCT03329001|528491517|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
146541960|NCT03329001|528491518|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
146541961|NCT03329001|528491519|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
146541962|NCT03329001|528491520|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
146541963|NCT03329001|528491521|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
146764193|NCT02377362|529303010|FG003|Part A Second Treatment|Protocol Violation|0|||
146764194|NCT02377362|529303011|FG004|Part A Second Treatment|Protocol Violation|1|||
146764195|NCT02377362|529303012|FG005|Part A Second Treatment|Protocol Violation|0|||
146764196|NCT02377362|529303013|FG006|Part A Second Treatment|Protocol Violation|0|||
146764197|NCT02377362|529303014|FG007|Part A Second Treatment|Protocol Violation|0|||
146764198|NCT02377362|529303015|FG008|Part A Second Treatment|Protocol Violation|0|||
146764199|NCT02377362|529303016|FG009|Part A Second Treatment|Protocol Violation|0|||
146764200|NCT02377362|529303017|FG010|Part A Second Treatment|Protocol Violation|0|||
146764201|NCT02377362|529303018|FG011|Part A Second Treatment|Protocol Violation|0|||
146764202|NCT02377362|529303019|FG012|Part A Second Treatment|Protocol Violation|0|||
146764203|NCT02377362|529303007|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
146764204|NCT02377362|529303008|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
146764205|NCT02377362|529303009|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
146764206|NCT02377362|529303010|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
146764207|NCT02377362|529303011|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
146764208|NCT02377362|529303012|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
146764209|NCT02377362|529303013|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
146764210|NCT02377362|529303014|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
146764211|NCT02377362|529303015|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
146764212|NCT02377362|529303016|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
146764213|NCT02377362|529303017|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
146764214|NCT02377362|529303018|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
146764215|NCT02377362|529303019|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
146764216|NCT02377362|529303007|FG000|Part B Overall|Protocol Violation|0|||
146872532|NCT01251653|529704838|FG005|Overall Study|Withdrawal by Subject|1|||
146872533|NCT01251653|529704839|FG006|Overall Study|Withdrawal by Subject|0|||
146872534|NCT01251653|529704840|FG007|Overall Study|Withdrawal by Subject|1|||
146872535|NCT01251653|529704841|FG008|Overall Study|Withdrawal by Subject|0|||
146872536|NCT01251653|529704833|FG000|Overall Study|Other reason not mentioned above|0|||
146872537|NCT01251653|529704834|FG001|Overall Study|Other reason not mentioned above|0|||
146872538|NCT01251653|529704835|FG002|Overall Study|Other reason not mentioned above|0|||
146872539|NCT01251653|529704836|FG003|Overall Study|Other reason not mentioned above|0|||
146872540|NCT01251653|529704837|FG004|Overall Study|Other reason not mentioned above|0|||
146872541|NCT01251653|529704838|FG005|Overall Study|Other reason not mentioned above|0|||
146872542|NCT01251653|529704839|FG006|Overall Study|Other reason not mentioned above|0|||
146872543|NCT01251653|529704840|FG007|Overall Study|Other reason not mentioned above|2|||
146872544|NCT01251653|529704841|FG008|Overall Study|Other reason not mentioned above|0|||
146872545|NCT01524198|529704843|FG000|Overall Study|Protocol Violation|8|||
146872546|NCT01524198|529704844|FG001|Overall Study|Protocol Violation|6|||
146872547|NCT01524198|529704843|FG000|Overall Study|Withdrawal by Subject|15|||
146872548|NCT01524198|529704844|FG001|Overall Study|Withdrawal by Subject|10|||
146872549|NCT02232802|529704846|FG000|Period 1|Sponsor request|1|||
146872550|NCT02232802|529704847|FG001|Period 1|Sponsor request|0|||
146872551|NCT02232802|529704846|FG000|Period 1|Adverse Event|1|||
146872552|NCT02232802|529704847|FG001|Period 1|Adverse Event|1|||
146872553|NCT00885703|529704849|FG000|Overall Study|Death|9|||
146872554|NCT00885703|529704850|FG001|Overall Study|Death|7|||
146872555|NCT00885703|529704851|FG002|Overall Study|Death|8|||
146872556|NCT00885703|529704852|FG003|Overall Study|Death|7|||
146872557|NCT00885703|529704853|FG004|Overall Study|Death|7|||
146872558|NCT00885703|529704854|FG005|Overall Study|Death|8|||
146872559|NCT00885703|529704855|FG006|Overall Study|Death|4|||
146872560|NCT00885703|529704849|FG000|Overall Study|Lost to Follow-up|0|||
146872561|NCT00885703|529704850|FG001|Overall Study|Lost to Follow-up|0|||
146872562|NCT00885703|529704851|FG002|Overall Study|Lost to Follow-up|1|||
146872563|NCT00885703|529704852|FG003|Overall Study|Lost to Follow-up|0|||
146872564|NCT00885703|529704853|FG004|Overall Study|Lost to Follow-up|0|||
146872565|NCT00885703|529704854|FG005|Overall Study|Lost to Follow-up|1|||
146872566|NCT00885703|529704855|FG006|Overall Study|Lost to Follow-up|0|||
146872567|NCT00885703|529704849|FG000|Overall Study|Withdrawal by Subject|0|||
146872568|NCT00885703|529704850|FG001|Overall Study|Withdrawal by Subject|0|||
146872569|NCT00885703|529704851|FG002|Overall Study|Withdrawal by Subject|0|||
146872570|NCT00885703|529704852|FG003|Overall Study|Withdrawal by Subject|1|||
146872571|NCT00885703|529704853|FG004|Overall Study|Withdrawal by Subject|3|||
146872572|NCT00885703|529704854|FG005|Overall Study|Withdrawal by Subject|1|||
146872573|NCT00885703|529704855|FG006|Overall Study|Withdrawal by Subject|1|||
146872574|NCT00885703|529704849|FG000|Overall Study|Ineligible (no CM)|1|||
146872575|NCT00885703|529704850|FG001|Overall Study|Ineligible (no CM)|3|||
146872576|NCT00885703|529704851|FG002|Overall Study|Ineligible (no CM)|2|||
146872577|NCT00885703|529704852|FG003|Overall Study|Ineligible (no CM)|1|||
146872578|NCT00885703|529704853|FG004|Overall Study|Ineligible (no CM)|2|||
146872579|NCT00885703|529704854|FG005|Overall Study|Ineligible (no CM)|3|||
146872580|NCT00885703|529704855|FG006|Overall Study|Ineligible (no CM)|1|||
146872581|NCT01490450|529704858|FG000|Period 1|Lack of Efficacy|2|||
146872582|NCT01490450|529704859|FG001|Period 1|Lack of Efficacy|0|||
146872583|NCT01490450|529704860|FG002|Period 1|Lack of Efficacy|3|||
146541964|NCT03329001|528491514|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
146872584|NCT01490450|529704861|FG003|Period 1|Lack of Efficacy|0|||
146872585|NCT01490450|529704858|FG000|Period 1|Adverse Event|0|||
146628020|NCT00106704|528813547|FG000|Overall Study|Pregnancy|1|||
146872586|NCT01490450|529704859|FG001|Period 1|Adverse Event|0|||
146872587|NCT01490450|529704860|FG002|Period 1|Adverse Event|0|||
146872588|NCT01490450|529704861|FG003|Period 1|Adverse Event|5|||
146872589|NCT01490450|529704858|FG000|Period 1|Request to discontinue treatment|1|||
146872590|NCT01490450|529704859|FG001|Period 1|Request to discontinue treatment|0|||
146872591|NCT01490450|529704860|FG002|Period 1|Request to discontinue treatment|0|||
146872592|NCT01490450|529704861|FG003|Period 1|Request to discontinue treatment|0|||
146872593|NCT01490450|529704858|FG000|Period 1|Withdrawal by Subject|0|||
146872594|NCT01490450|529704859|FG001|Period 1|Withdrawal by Subject|0|||
146872595|NCT01490450|529704860|FG002|Period 1|Withdrawal by Subject|0|||
146872596|NCT01490450|529704861|FG003|Period 1|Withdrawal by Subject|3|||
146872597|NCT01490450|529704858|FG000|Period 1|No longer met study criteria|0|||
146872598|NCT01490450|529704859|FG001|Period 1|No longer met study criteria|1|||
146872599|NCT01490450|529704860|FG002|Period 1|No longer met study criteria|1|||
146872600|NCT01490450|529704861|FG003|Period 1|No longer met study criteria|0|||
146872601|NCT01490450|529704858|FG000|Period 2|Lack of Efficacy|0|||
146872602|NCT01490450|529704859|FG001|Period 2|Lack of Efficacy|0|||
146872603|NCT01490450|529704860|FG002|Period 2|Lack of Efficacy|0|||
146872604|NCT01490450|529704861|FG003|Period 2|Lack of Efficacy|1|||
146872605|NCT01490450|529704858|FG000|Period 2|Adverse Event|1|||
146872606|NCT01490450|529704859|FG001|Period 2|Adverse Event|1|||
146872607|NCT01490450|529704860|FG002|Period 2|Adverse Event|0|||
146872608|NCT01490450|529704861|FG003|Period 2|Adverse Event|1|||
146541965|NCT03329001|528491515|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
146541966|NCT03329001|528491516|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
146541967|NCT03329001|528491517|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
146541968|NCT03329001|528491518|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
146541969|NCT03329001|528491519|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
146541970|NCT03329001|528491520|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
146541971|NCT03329001|528491521|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
146541972|NCT03329001|528491514|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
146872609|NCT01490450|529704858|FG000|Period 2|Withdrawal by Subject|1|||
146872610|NCT01490450|529704859|FG001|Period 2|Withdrawal by Subject|0|||
146872611|NCT01490450|529704860|FG002|Period 2|Withdrawal by Subject|0|||
146872612|NCT01490450|529704861|FG003|Period 2|Withdrawal by Subject|0|||
146872613|NCT01490450|529704858|FG000|Period 2|Lost to Follow-up|0|||
146872614|NCT01490450|529704859|FG001|Period 2|Lost to Follow-up|0|||
146541973|NCT03329001|528491515|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
146541974|NCT03329001|528491516|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
146541975|NCT03329001|528491517|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
146541976|NCT03329001|528491518|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
146541977|NCT03329001|528491519|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
146541978|NCT03329001|528491520|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
146541979|NCT03329001|528491521|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
146541980|NCT03329001|528491514|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
146541981|NCT03329001|528491515|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
146541982|NCT03329001|528491516|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
146628021|NCT00106704|528813548|FG001|Overall Study|Pregnancy|0|||
146541983|NCT03329001|528491517|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
146541984|NCT03329001|528491518|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
146541985|NCT03329001|528491519|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
146541986|NCT03329001|528491520|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
146541987|NCT03329001|528491521|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
146541988|NCT03329001|528491514|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
146541989|NCT03329001|528491515|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
146764217|NCT02377362|529303008|FG001|Part B Overall|Protocol Violation|0|||
146764218|NCT02377362|529303009|FG002|Part B Overall|Protocol Violation|0|||
146764219|NCT02377362|529303010|FG003|Part B Overall|Protocol Violation|0|||
146764220|NCT02377362|529303011|FG004|Part B Overall|Protocol Violation|0|||
146764221|NCT02377362|529303012|FG005|Part B Overall|Protocol Violation|0|||
146872615|NCT01490450|529704860|FG002|Period 2|Lost to Follow-up|0|||
146872616|NCT01490450|529704861|FG003|Period 2|Lost to Follow-up|2|||
146872617|NCT03197493|529704862|FG000|Overall Study|Withdrawal by Subject|5|||
146872618|NCT00938717|529704863|FG000|Overall Study|Adverse Event|10|||
146872619|NCT00938717|529704864|FG001|Overall Study|Adverse Event|41|||
146872620|NCT00938717|529704863|FG000|Overall Study|Protocol Violation|11|||
146872621|NCT00938717|529704864|FG001|Overall Study|Protocol Violation|8|||
146872622|NCT00938717|529704863|FG000|Overall Study|Withdrawal by Subject|26|||
146872623|NCT00938717|529704864|FG001|Overall Study|Withdrawal by Subject|24|||
146872624|NCT00938717|529704863|FG000|Overall Study|Lost to Follow-up|13|||
146872625|NCT00938717|529704864|FG001|Overall Study|Lost to Follow-up|18|||
146872626|NCT00938717|529704863|FG000|Overall Study|Lack of Efficacy|33|||
146872627|NCT00938717|529704864|FG001|Overall Study|Lack of Efficacy|15|||
146872628|NCT00938717|529704863|FG000|Overall Study|Other reason|5|||
146872629|NCT00938717|529704864|FG001|Overall Study|Other reason|2|||
146872630|NCT01462435|529704866|FG000|Overall Study|Lack of Efficacy|1|||
146872631|NCT01462435|529704867|FG001|Overall Study|Lack of Efficacy|0|||
146872632|NCT01462435|529704868|FG002|Overall Study|Lack of Efficacy|0|||
146872633|NCT01462435|529704869|FG003|Overall Study|Lack of Efficacy|3|||
146872634|NCT01462435|529704866|FG000|Overall Study|Physician Decision|0|||
146872635|NCT01462435|529704867|FG001|Overall Study|Physician Decision|0|||
146872636|NCT01462435|529704868|FG002|Overall Study|Physician Decision|1|||
146872637|NCT01462435|529704869|FG003|Overall Study|Physician Decision|0|||
146872638|NCT01462435|529704866|FG000|Overall Study|Withdrawal by Subject|0|||
146872639|NCT01462435|529704867|FG001|Overall Study|Withdrawal by Subject|0|||
146872640|NCT01462435|529704868|FG002|Overall Study|Withdrawal by Subject|0|||
146872641|NCT01462435|529704869|FG003|Overall Study|Withdrawal by Subject|1|||
146872642|NCT01462435|529704866|FG000|Overall Study|Lost to Follow-up|0|||
146872643|NCT01462435|529704867|FG001|Overall Study|Lost to Follow-up|0|||
146872644|NCT01462435|529704868|FG002|Overall Study|Lost to Follow-up|0|||
146872645|NCT01462435|529704869|FG003|Overall Study|Lost to Follow-up|1|||
146872646|NCT01543152|529704876|FG000|Overall Study|Withdrawal by Subject|0|||
146872647|NCT01543152|529704877|FG001|Overall Study|Withdrawal by Subject|2|||
146872648|NCT01543152|529704878|FG002|Overall Study|Withdrawal by Subject|0|||
146872649|NCT01543152|529704879|FG003|Overall Study|Withdrawal by Subject|0|||
146872650|NCT01543152|529704880|FG004|Overall Study|Withdrawal by Subject|0|||
146872651|NCT02053168|529704881|FG000|Overall Study|Withdrawal by Subject|1|||
146872652|NCT02053168|529704881|FG000|Overall Study|Physician Decision|1|||
146872653|NCT02053168|529704881|FG000|Overall Study|Lost to Follow-up|1|||
146872654|NCT00636675|529704883|FG000|Overall Study|Lost to Follow-up|121|||
146872655|NCT00636675|529704884|FG001|Overall Study|Lost to Follow-up|31|||
146872656|NCT00636675|529704883|FG000|Overall Study|Withdrawal by Subject|19|||
146872657|NCT00636675|529704884|FG001|Overall Study|Withdrawal by Subject|10|||
146872658|NCT02687542|529704885|FG000|Overall Study|Medication error without associated AEs|0|||
146764222|NCT02377362|529303013|FG006|Part B Overall|Protocol Violation|0|||
146764223|NCT02377362|529303014|FG007|Part B Overall|Protocol Violation|0|||
146764224|NCT02377362|529303015|FG008|Part B Overall|Protocol Violation|0|||
146764225|NCT02377362|529303016|FG009|Part B Overall|Protocol Violation|1|||
146764226|NCT02377362|529303017|FG010|Part B Overall|Protocol Violation|0|||
146764227|NCT02377362|529303018|FG011|Part B Overall|Protocol Violation|0|||
146872659|NCT02687542|529704886|FG001|Overall Study|Medication error without associated AEs|0|||
146872660|NCT02687542|529704887|FG002|Overall Study|Medication error without associated AEs|0|||
146872661|NCT02687542|529704888|FG003|Overall Study|Medication error without associated AEs|0|||
146872662|NCT02687542|529704889|FG004|Overall Study|Medication error without associated AEs|1|||
146872663|NCT02687542|529704885|FG000|Overall Study|Lost to Follow-up|0|||
146872664|NCT02687542|529704886|FG001|Overall Study|Lost to Follow-up|0|||
146872665|NCT02687542|529704887|FG002|Overall Study|Lost to Follow-up|0|||
146872666|NCT02687542|529704888|FG003|Overall Study|Lost to Follow-up|0|||
146872667|NCT02687542|529704889|FG004|Overall Study|Lost to Follow-up|1|||
146872668|NCT02687542|529704885|FG000|Overall Study|Protocol Violation|0|||
146872669|NCT02687542|529704886|FG001|Overall Study|Protocol Violation|1|||
146872670|NCT02687542|529704887|FG002|Overall Study|Protocol Violation|0|||
146872671|NCT02687542|529704888|FG003|Overall Study|Protocol Violation|0|||
146872672|NCT02687542|529704889|FG004|Overall Study|Protocol Violation|0|||
146872673|NCT02687542|529704885|FG000|Overall Study|Other|5|||
146872674|NCT02687542|529704886|FG001|Overall Study|Other|9|||
146764228|NCT02377362|529303019|FG012|Part B Overall|Protocol Violation|0|||
146764229|NCT02377362|529303007|FG000|Part B Overall|Adverse Event|0|||
146872675|NCT02687542|529704887|FG002|Overall Study|Other|10|||
146872676|NCT02687542|529704888|FG003|Overall Study|Other|6|||
146872677|NCT02687542|529704889|FG004|Overall Study|Other|5|||
146872678|NCT02687542|529704885|FG000|Overall Study|Adverse Event|3|||
146872679|NCT02687542|529704886|FG001|Overall Study|Adverse Event|1|||
146872680|NCT02687542|529704887|FG002|Overall Study|Adverse Event|3|||
146872681|NCT02687542|529704888|FG003|Overall Study|Adverse Event|2|||
146872682|NCT02687542|529704889|FG004|Overall Study|Adverse Event|9|||
146872683|NCT02687542|529704885|FG000|Overall Study|Withdrawal by Subject|0|||
146872684|NCT02687542|529704886|FG001|Overall Study|Withdrawal by Subject|1|||
146872685|NCT02687542|529704887|FG002|Overall Study|Withdrawal by Subject|1|||
146872686|NCT02687542|529704888|FG003|Overall Study|Withdrawal by Subject|2|||
146872687|NCT02687542|529704889|FG004|Overall Study|Withdrawal by Subject|4|||
146872688|NCT01838616|529704890|FG000|Titration Period|Adverse Event|18|||
146872689|NCT01838616|529704891|FG001|Titration Period|Adverse Event|48|||
146872690|NCT01838616|529704890|FG000|Titration Period|Lack of Efficacy|5|||
146872691|NCT01838616|529704891|FG001|Titration Period|Lack of Efficacy|12|||
146872692|NCT01838616|529704890|FG000|Titration Period|Withdrawal by Subject|5|||
146872693|NCT01838616|529704891|FG001|Titration Period|Withdrawal by Subject|5|||
146872694|NCT01838616|529704890|FG000|Titration Period|Technical problems|1|||
146872695|NCT01838616|529704891|FG001|Titration Period|Technical problems|0|||
146541990|NCT03329001|528491516|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
146541991|NCT03329001|528491517|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
146872696|NCT01838616|529704890|FG000|Titration Period|Other|1|||
146872697|NCT01838616|529704891|FG001|Titration Period|Other|0|||
146872698|NCT01838616|529704890|FG000|Titration Period|Protocol Violation|0|||
146966439|NCT00650806|530038799|FG000|Overall Study|Noncompliance with study drug regimen|1|||
146764230|NCT02377362|529303008|FG001|Part B Overall|Adverse Event|0|||
146764231|NCT02377362|529303009|FG002|Part B Overall|Adverse Event|0|||
146764232|NCT02377362|529303010|FG003|Part B Overall|Adverse Event|0|||
146764233|NCT02377362|529303011|FG004|Part B Overall|Adverse Event|0|||
146764234|NCT02377362|529303012|FG005|Part B Overall|Adverse Event|0|||
146764235|NCT02377362|529303013|FG006|Part B Overall|Adverse Event|1|||
146764236|NCT02377362|529303014|FG007|Part B Overall|Adverse Event|1|||
146764237|NCT02377362|529303015|FG008|Part B Overall|Adverse Event|0|||
146872699|NCT01838616|529704891|FG001|Titration Period|Protocol Violation|1|||
146872700|NCT01838616|529704890|FG000|Continuation Period|Lack of Efficacy|3|||
146872701|NCT01838616|529704891|FG001|Continuation Period|Lack of Efficacy|5|||
146872702|NCT01838616|529704890|FG000|Continuation Period|Adverse Event|8|||
146872703|NCT01838616|529704891|FG001|Continuation Period|Adverse Event|4|||
146872704|NCT01838616|529704890|FG000|Continuation Period|Protocol Violation|2|||
146872705|NCT01838616|529704891|FG001|Continuation Period|Protocol Violation|0|||
146872706|NCT01838616|529704890|FG000|Continuation Period|Lost to Follow-up|1|||
146872707|NCT01838616|529704891|FG001|Continuation Period|Lost to Follow-up|0|||
146872708|NCT01838616|529704890|FG000|Continuation Period|Withdrawal by Subject|0|||
146872709|NCT01838616|529704891|FG001|Continuation Period|Withdrawal by Subject|4|||
146872710|NCT01838616|529704890|FG000|Continuation Period|Technical problems|0|||
146872711|NCT01838616|529704891|FG001|Continuation Period|Technical problems|1|||
146872712|NCT01838616|529704890|FG000|Pick-up Arm|Lack of Efficacy|4|||
146872713|NCT01838616|529704891|FG001|Pick-up Arm|Lack of Efficacy|0|||
146872714|NCT01838616|529704890|FG000|Pick-up Arm|Adverse Event|9|||
146872715|NCT01838616|529704891|FG001|Pick-up Arm|Adverse Event|0|||
146872716|NCT01838616|529704890|FG000|Pick-up Arm|Withdrawal by Subject|1|||
146872717|NCT01838616|529704891|FG001|Pick-up Arm|Withdrawal by Subject|0|||
146872718|NCT01838616|529704890|FG000|Pick-up Arm|Technical problems|1|||
146872719|NCT01838616|529704891|FG001|Pick-up Arm|Technical problems|0|||
146872720|NCT00139776|529704892|FG000|Period I|Did not enter Period II|575|||
146872721|NCT00139776|529704893|FG001|Period I|Did not enter Period II|0|||
146541992|NCT03329001|528491518|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
146541993|NCT03329001|528491519|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
146541994|NCT03329001|528491520|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
146541995|NCT03329001|528491521|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
146541996|NCT03329001|528491514|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
146541997|NCT03329001|528491515|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
146541998|NCT03329001|528491516|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
146541999|NCT03329001|528491517|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
146542000|NCT03329001|528491518|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
146542001|NCT03329001|528491519|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
146542002|NCT03329001|528491520|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
146542003|NCT03329001|528491521|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
146542004|NCT03329001|528491514|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
146542005|NCT03329001|528491515|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
146542006|NCT03329001|528491516|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
146542007|NCT03329001|528491517|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
146542008|NCT03329001|528491518|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
146764238|NCT02377362|529303016|FG009|Part B Overall|Adverse Event|0|||
146764239|NCT02377362|529303017|FG010|Part B Overall|Adverse Event|0|||
146764240|NCT02377362|529303018|FG011|Part B Overall|Adverse Event|0|||
146872722|NCT00139776|529704894|FG002|Period I|Did not enter Period II|0|||
146872723|NCT00139776|529704895|FG003|Period I|Did not enter Period II|0|||
146872724|NCT00139776|529704892|FG000|Period II|Not Randomized into Period III|0|||
146872725|NCT00139776|529704893|FG001|Period II|Not Randomized into Period III|322|||
146872726|NCT00139776|529704894|FG002|Period II|Not Randomized into Period III|0|||
146872727|NCT00139776|529704895|FG003|Period II|Not Randomized into Period III|0|||
146542009|NCT03329001|528491519|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
146542010|NCT03329001|528491520|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
146542011|NCT03329001|528491521|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
146542012|NCT03329001|528491514|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
146542013|NCT03329001|528491515|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
146542014|NCT03329001|528491516|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
146542015|NCT03329001|528491517|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
146542016|NCT03329001|528491518|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
146542017|NCT03329001|528491519|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
146542018|NCT03329001|528491520|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
146542019|NCT03329001|528491521|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
146542020|NCT03329001|528491514|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
146542021|NCT03329001|528491515|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
146542022|NCT03329001|528491516|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
146872728|NCT00139776|529704892|FG000|Period III|Adverse Event|0|||
146542023|NCT03329001|528491517|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
146542024|NCT03329001|528491518|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
146542025|NCT03329001|528491519|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
146542026|NCT03329001|528491520|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
146542027|NCT03329001|528491521|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
146542028|NCT03329001|528491514|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
146872729|NCT00139776|529704893|FG001|Period III|Adverse Event|0|||
146872730|NCT00139776|529704894|FG002|Period III|Adverse Event|22|||
146872731|NCT00139776|529704895|FG003|Period III|Adverse Event|23|||
146872732|NCT00139776|529704892|FG000|Period III|Other|0|||
146872733|NCT00139776|529704893|FG001|Period III|Other|0|||
146872734|NCT00139776|529704894|FG002|Period III|Other|23|||
146872735|NCT00139776|529704895|FG003|Period III|Other|34|||
146872736|NCT00139776|529704892|FG000|Period III|Lack of Efficacy|0|||
146872737|NCT00139776|529704893|FG001|Period III|Lack of Efficacy|0|||
146872738|NCT00139776|529704894|FG002|Period III|Lack of Efficacy|10|||
146872739|NCT00139776|529704895|FG003|Period III|Lack of Efficacy|24|||
146872740|NCT00139776|529704892|FG000|Period III|Lost to Follow-up|0|||
146872741|NCT00139776|529704893|FG001|Period III|Lost to Follow-up|0|||
146872742|NCT00139776|529704894|FG002|Period III|Lost to Follow-up|5|||
146872743|NCT00139776|529704895|FG003|Period III|Lost to Follow-up|4|||
146872744|NCT00139776|529704892|FG000|Period III|Withdrawal by Subject|0|||
146872745|NCT00139776|529704893|FG001|Period III|Withdrawal by Subject|0|||
146628022|NCT00106704|528813547|FG000|Overall Study|Protocol Violation|4|||
146872746|NCT00139776|529704894|FG002|Period III|Withdrawal by Subject|16|||
146872747|NCT00139776|529704895|FG003|Period III|Withdrawal by Subject|21|||
146872748|NCT00914927|529704904|FG000|Overall Study|Adverse Event|0|||
146872749|NCT00914927|529704905|FG001|Overall Study|Adverse Event|0|||
146966440|NCT00650806|530038800|FG001|Overall Study|Noncompliance with study drug regimen|1|||
146872750|NCT00914927|529704906|FG002|Overall Study|Adverse Event|0|||
146872751|NCT00914927|529704907|FG003|Overall Study|Adverse Event|0|||
146872752|NCT00914927|529704908|FG004|Overall Study|Adverse Event|1|||
146872753|NCT00914927|529704909|FG005|Overall Study|Adverse Event|0|||
146872754|NCT00914927|529704910|FG006|Overall Study|Adverse Event|0|||
146872755|NCT00914927|529704904|FG000|Overall Study|Withdrawal by Subject|0|||
146872756|NCT00914927|529704905|FG001|Overall Study|Withdrawal by Subject|1|||
146872757|NCT00914927|529704906|FG002|Overall Study|Withdrawal by Subject|0|||
146872758|NCT00914927|529704907|FG003|Overall Study|Withdrawal by Subject|1|||
146872759|NCT00914927|529704908|FG004|Overall Study|Withdrawal by Subject|0|||
146872760|NCT00914927|529704909|FG005|Overall Study|Withdrawal by Subject|0|||
146872761|NCT00914927|529704910|FG006|Overall Study|Withdrawal by Subject|0|||
146872762|NCT00914927|529704904|FG000|Overall Study|Lost to Follow-up|0|||
146872763|NCT00914927|529704905|FG001|Overall Study|Lost to Follow-up|0|||
146872764|NCT00914927|529704906|FG002|Overall Study|Lost to Follow-up|0|||
146872765|NCT00914927|529704907|FG003|Overall Study|Lost to Follow-up|1|||
146872766|NCT00914927|529704908|FG004|Overall Study|Lost to Follow-up|0|||
146872767|NCT00914927|529704909|FG005|Overall Study|Lost to Follow-up|0|||
146872768|NCT00914927|529704910|FG006|Overall Study|Lost to Follow-up|0|||
146872769|NCT00914927|529704904|FG000|Overall Study|Administrative/Other|2|||
146872770|NCT00914927|529704905|FG001|Overall Study|Administrative/Other|1|||
146872771|NCT00914927|529704906|FG002|Overall Study|Administrative/Other|0|||
146872772|NCT00914927|529704907|FG003|Overall Study|Administrative/Other|0|||
146872773|NCT00914927|529704908|FG004|Overall Study|Administrative/Other|1|||
146872774|NCT00914927|529704909|FG005|Overall Study|Administrative/Other|0|||
146872775|NCT00914927|529704910|FG006|Overall Study|Administrative/Other|0|||
146872776|NCT02164929|529704921|FG000|Overall Study|Converted to open procedure|1|||
146872777|NCT02164929|529704922|FG001|Overall Study|Converted to open procedure|0|||
146872778|NCT02164929|529704923|FG002|Overall Study|Converted to open procedure|0|||
146872779|NCT02164929|529704924|FG003|Overall Study|Converted to open procedure|2|||
146872780|NCT02164929|529704921|FG000|Overall Study|Failed regional block|0|||
146872781|NCT02164929|529704922|FG001|Overall Study|Failed regional block|0|||
146872782|NCT02164929|529704923|FG002|Overall Study|Failed regional block|1|||
146872783|NCT02164929|529704924|FG003|Overall Study|Failed regional block|0|||
146872784|NCT00971178|529704928|FG000|Overall Study|Lost to Follow-up|2|||
146872785|NCT00971178|529704929|FG001|Overall Study|Lost to Follow-up|2|||
146872786|NCT00971178|529704930|FG002|Overall Study|Lost to Follow-up|2|||
146872787|NCT00365456|529704933|FG000|Trial Period I (12 Months)|Adverse Event|84|||
146872788|NCT00365456|529704934|FG001|Trial Period I (12 Months)|Adverse Event|0|||
146872789|NCT00365456|529704933|FG000|Trial Period I (12 Months)|Non-compliance|3|||
146872790|NCT00365456|529704934|FG001|Trial Period I (12 Months)|Non-compliance|0|||
146872791|NCT00365456|529704933|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
146872792|NCT00365456|529704934|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
146872793|NCT00365456|529704933|FG000|Trial Period I (12 Months)|Other|11|||
146872794|NCT00365456|529704934|FG001|Trial Period I (12 Months)|Other|0|||
146872795|NCT00365456|529704933|FG000|Trial Period II (12 Months)|Adverse Event|0|||
146872796|NCT00365456|529704934|FG001|Trial Period II (12 Months)|Adverse Event|6|||
146872797|NCT00365456|529704933|FG000|Trial Period II (12 Months)|Non-compliance|0|||
146872798|NCT00365456|529704934|FG001|Trial Period II (12 Months)|Non-compliance|2|||
146872799|NCT00365456|529704933|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
146872800|NCT00365456|529704934|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
146872801|NCT00365456|529704933|FG000|Trial Period II (12 Months)|Other|0|||
146872802|NCT00365456|529704934|FG001|Trial Period II (12 Months)|Other|1|||
146872803|NCT00365456|529704933|FG000|Trial Period III (12 Months)|Adverse Event|13|||
146872804|NCT00365456|529704934|FG001|Trial Period III (12 Months)|Adverse Event|3|||
146872805|NCT00365456|529704933|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
146872806|NCT00365456|529704934|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
146872807|NCT00365456|529704933|FG000|Trial Period III (12 Months)|Other|1|||
146872808|NCT00365456|529704934|FG001|Trial Period III (12 Months)|Other|1|||
146872809|NCT00714285|529704935|FG000|Overall Study|Lost to Follow-up|0|||
146872810|NCT00714285|529704936|FG001|Overall Study|Lost to Follow-up|2|||
146872811|NCT00714285|529704937|FG002|Overall Study|Lost to Follow-up|0|||
146872812|NCT00714285|529704938|FG003|Overall Study|Lost to Follow-up|1|||
146542029|NCT03329001|528491515|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
146542030|NCT03329001|528491516|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
146542031|NCT03329001|528491517|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
146542032|NCT03329001|528491518|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
146542033|NCT03329001|528491519|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
146542034|NCT03329001|528491520|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
146542035|NCT03329001|528491521|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
146542036|NCT03329001|528491514|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
146542037|NCT03329001|528491515|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
146542038|NCT03329001|528491516|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
146542039|NCT03329001|528491517|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
146542040|NCT03329001|528491518|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
146628023|NCT00106704|528813548|FG001|Overall Study|Protocol Violation|7|||
146542041|NCT03329001|528491519|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
146872813|NCT00714285|529704935|FG000|Overall Study|Migrated/moved from study area|0|||
146872814|NCT00714285|529704936|FG001|Overall Study|Migrated/moved from study area|1|||
146872815|NCT00714285|529704937|FG002|Overall Study|Migrated/moved from study area|0|||
146872816|NCT00714285|529704938|FG003|Overall Study|Migrated/moved from study area|0|||
146872817|NCT01131676|529704939|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
146872818|NCT01131676|529704940|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
146872819|NCT01131676|529704941|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
146872820|NCT01131676|529704939|FG000|Discontinuation From Treatment|Not treated|4|||
146872821|NCT01131676|529704940|FG001|Discontinuation From Treatment|Not treated|2|||
146872822|NCT01131676|529704941|FG002|Discontinuation From Treatment|Not treated|2|||
146872823|NCT01131676|529704939|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
146872824|NCT01131676|529704940|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
146872825|NCT01131676|529704941|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
146872826|NCT01131676|529704939|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
146872827|NCT01131676|529704940|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
146872828|NCT01131676|529704941|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
146872829|NCT01131676|529704939|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
146872830|NCT01131676|529704940|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
146872831|NCT01131676|529704941|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
146872832|NCT01131676|529704939|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
146872833|NCT01131676|529704940|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
146542042|NCT03329001|528491520|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
146542043|NCT03329001|528491521|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
146542044|NCT00963235|528491524|FG000|Overall Study|Withdrawal by Subject|22|||
146542045|NCT00963235|528491524|FG000|Overall Study|Lost to Follow-up|14|||
146542046|NCT00963235|528491524|FG000|Overall Study|Failed to return|9|||
146542047|NCT00963235|528491524|FG000|Overall Study|Protocol Violation|7|||
146542048|NCT00963235|528491524|FG000|Overall Study|Adverse Event|5|||
146542049|NCT00963235|528491524|FG000|Overall Study|Physician Decision|2|||
146542050|NCT00963235|528491524|FG000|Overall Study|Other|1|||
146542051|NCT01341470|528491526|FG000|Overall Study|Sponsor decision|0|||
146542052|NCT01341470|528491527|FG001|Overall Study|Sponsor decision|0|||
146542053|NCT01341470|528491528|FG002|Overall Study|Sponsor decision|1|||
146542054|NCT01341470|528491529|FG003|Overall Study|Sponsor decision|1|||
146542055|NCT01341470|528491530|FG004|Overall Study|Sponsor decision|0|||
146542056|NCT01341470|528491531|FG005|Overall Study|Sponsor decision|1|||
146542057|NCT00311168|528491535|FG000|First Intervention|Withdrawal by Subject|2|||
146542058|NCT00311168|528491536|FG001|First Intervention|Withdrawal by Subject|2|||
146542059|NCT00311168|528491535|FG000|First Intervention|Lost to Follow-up|1|||
146542060|NCT00311168|528491536|FG001|First Intervention|Lost to Follow-up|1|||
146542061|NCT00311168|528491535|FG000|First Intervention|Protocol Violation|1|||
146542062|NCT00311168|528491536|FG001|First Intervention|Protocol Violation|1|||
146542063|NCT00311168|528491535|FG000|First Intervention|Adverse Event|1|||
146542064|NCT00311168|528491536|FG001|First Intervention|Adverse Event|0|||
146542065|NCT00311168|528491535|FG000|First Intervention|Other|2|||
146542066|NCT00311168|528491536|FG001|First Intervention|Other|2|||
146542067|NCT00311168|528491535|FG000|Second Intervention|Lost to Follow-up|9|||
146542068|NCT00311168|528491536|FG001|Second Intervention|Lost to Follow-up|2|||
146542069|NCT00311168|528491535|FG000|Second Intervention|Withdrawal by Subject|0|||
146542070|NCT00311168|528491536|FG001|Second Intervention|Withdrawal by Subject|1|||
146542071|NCT00311168|528491535|FG000|Second Intervention|Other|1|||
146542072|NCT00311168|528491536|FG001|Second Intervention|Other|1|||
146542073|NCT03965923|528491541|FG000|Overall Study|Withdrawal by Subject|1|||
146542074|NCT03965923|528491542|FG001|Overall Study|Withdrawal by Subject|2|||
146542075|NCT03965923|528491543|FG002|Overall Study|Withdrawal by Subject|3|||
146542076|NCT03965923|528491544|FG003|Overall Study|Withdrawal by Subject|1|||
146542077|NCT03965923|528491545|FG004|Overall Study|Withdrawal by Subject|2|||
146542078|NCT03965923|528491546|FG005|Overall Study|Withdrawal by Subject|0|||
146542079|NCT03965923|528491547|FG006|Overall Study|Withdrawal by Subject|4|||
146542080|NCT03965923|528491548|FG007|Overall Study|Withdrawal by Subject|3|||
146542081|NCT03965923|528491549|FG008|Overall Study|Withdrawal by Subject|4|||
146542082|NCT03965923|528491550|FG009|Overall Study|Withdrawal by Subject|0|||
146542083|NCT03965923|528491551|FG010|Overall Study|Withdrawal by Subject|2|||
146542084|NCT03965923|528491552|FG011|Overall Study|Withdrawal by Subject|0|||
146542085|NCT03965923|528491541|FG000|Overall Study|Lost to Follow-up|2|||
146542086|NCT03965923|528491542|FG001|Overall Study|Lost to Follow-up|1|||
146542087|NCT03965923|528491543|FG002|Overall Study|Lost to Follow-up|1|||
146542088|NCT03965923|528491544|FG003|Overall Study|Lost to Follow-up|0|||
146542089|NCT03965923|528491545|FG004|Overall Study|Lost to Follow-up|2|||
146542090|NCT03965923|528491546|FG005|Overall Study|Lost to Follow-up|1|||
146542091|NCT03965923|528491547|FG006|Overall Study|Lost to Follow-up|2|||
146542092|NCT03965923|528491548|FG007|Overall Study|Lost to Follow-up|1|||
146542093|NCT03965923|528491549|FG008|Overall Study|Lost to Follow-up|0|||
146542094|NCT03965923|528491550|FG009|Overall Study|Lost to Follow-up|2|||
146542095|NCT03965923|528491551|FG010|Overall Study|Lost to Follow-up|0|||
146542096|NCT03965923|528491552|FG011|Overall Study|Lost to Follow-up|0|||
146542097|NCT03965923|528491541|FG000|Overall Study|Death|0|||
146872834|NCT01131676|529704941|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
146542098|NCT03965923|528491542|FG001|Overall Study|Death|0|||
146542099|NCT03965923|528491543|FG002|Overall Study|Death|0|||
146542100|NCT03965923|528491544|FG003|Overall Study|Death|0|||
146542101|NCT03965923|528491545|FG004|Overall Study|Death|0|||
146542102|NCT03965923|528491546|FG005|Overall Study|Death|0|||
146542103|NCT03965923|528491547|FG006|Overall Study|Death|0|||
146542104|NCT03965923|528491548|FG007|Overall Study|Death|1|||
146872835|NCT01131676|529704939|FG000|Discontinuation From Treatment|Other than those specified|162|||
146542105|NCT03965923|528491549|FG008|Overall Study|Death|4|||
146872836|NCT01131676|529704940|FG001|Discontinuation From Treatment|Other than those specified|142|||
146872837|NCT01131676|529704941|FG002|Discontinuation From Treatment|Other than those specified|125|||
146872838|NCT01131676|529704939|FG000|Discontinuation From Treatment|Adverse Event|303|||
146872839|NCT01131676|529704940|FG001|Discontinuation From Treatment|Adverse Event|267|||
146872840|NCT01131676|529704941|FG002|Discontinuation From Treatment|Adverse Event|273|||
146872841|NCT01131676|529704939|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
146542106|NCT03965923|528491550|FG009|Overall Study|Death|0|||
146542107|NCT03965923|528491551|FG010|Overall Study|Death|4|||
146542108|NCT03965923|528491552|FG011|Overall Study|Death|0|||
146542109|NCT03965923|528491541|FG000|Overall Study|Other reason|0|||
146542110|NCT03965923|528491542|FG001|Overall Study|Other reason|0|||
146542111|NCT03965923|528491543|FG002|Overall Study|Other reason|0|||
146542112|NCT03965923|528491544|FG003|Overall Study|Other reason|1|||
146542113|NCT03965923|528491545|FG004|Overall Study|Other reason|0|||
146542114|NCT03965923|528491546|FG005|Overall Study|Other reason|0|||
146542115|NCT03965923|528491547|FG006|Overall Study|Other reason|0|||
146542116|NCT03965923|528491548|FG007|Overall Study|Other reason|0|||
146542117|NCT03965923|528491549|FG008|Overall Study|Other reason|0|||
146542118|NCT03965923|528491550|FG009|Overall Study|Other reason|0|||
146542119|NCT03965923|528491551|FG010|Overall Study|Other reason|2|||
146542120|NCT03965923|528491552|FG011|Overall Study|Other reason|0|||
146542121|NCT02452190|528491553|FG000|Overall Study|Withdrawal by Sponsor|1|||
146542122|NCT02452190|528491554|FG001|Overall Study|Withdrawal by Sponsor|3|||
146542123|NCT02452190|528491553|FG000|Overall Study|Pregnancy|1|||
146542124|NCT02452190|528491554|FG001|Overall Study|Pregnancy|0|||
146542125|NCT02452190|528491553|FG000|Overall Study|Investigator's Decision|2|||
146542126|NCT02452190|528491554|FG001|Overall Study|Investigator's Decision|0|||
146542127|NCT02452190|528491553|FG000|Overall Study|Lack of Efficacy|3|||
146542128|NCT02452190|528491554|FG001|Overall Study|Lack of Efficacy|1|||
146542129|NCT02452190|528491553|FG000|Overall Study|Lost to Follow-up|4|||
146542130|NCT02452190|528491554|FG001|Overall Study|Lost to Follow-up|3|||
146542131|NCT02452190|528491553|FG000|Overall Study|Adverse Event|2|||
146542132|NCT02452190|528491554|FG001|Overall Study|Adverse Event|5|||
146542133|NCT02452190|528491553|FG000|Overall Study|Withdrawal by Subject|20|||
146542134|NCT02452190|528491554|FG001|Overall Study|Withdrawal by Subject|11|||
146542135|NCT02452190|528491553|FG000|Overall Study|Noncompliance with study drug|1|||
146542136|NCT02452190|528491554|FG001|Overall Study|Noncompliance with study drug|0|||
146542137|NCT02452190|528491553|FG000|Overall Study|Participant traveled abroad|1|||
146542138|NCT02452190|528491554|FG001|Overall Study|Participant traveled abroad|0|||
146542139|NCT02452190|528491553|FG000|Overall Study|Death|0|||
146542140|NCT02452190|528491554|FG001|Overall Study|Death|1|||
146542141|NCT06001021|528491557|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
146542142|NCT06001021|528491558|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
146542143|NCT06001021|528491559|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
146542144|NCT06001021|528491560|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
146542145|NCT06001021|528491561|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
146542146|NCT06001021|528491562|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
146542147|NCT06001021|528491563|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
146542148|NCT06001021|528491557|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
146542149|NCT06001021|528491558|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
146542150|NCT06001021|528491559|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
146542151|NCT06001021|528491560|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
146542152|NCT06001021|528491561|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
146542153|NCT06001021|528491562|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
146542154|NCT06001021|528491563|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
146542155|NCT00390013|528491564|FG000|Phase 1|tired|0|||
146542156|NCT00390013|528491565|FG001|Phase 1|tired|0|||
146542157|NCT00390013|528491566|FG002|Phase 1|tired|0|||
146542158|NCT00390013|528491567|FG003|Phase 1|tired|1|||
146542159|NCT00390013|528491564|FG000|Phase 2 First Treatment|tired|1|||
146542160|NCT00390013|528491565|FG001|Phase 2 First Treatment|tired|0|||
146542161|NCT00390013|528491566|FG002|Phase 2 First Treatment|tired|0|||
146542162|NCT00390013|528491567|FG003|Phase 2 First Treatment|tired|0|||
146542163|NCT00390013|528491564|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
146542164|NCT00390013|528491565|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
146542165|NCT00390013|528491566|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
146542166|NCT00390013|528491567|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
146542167|NCT02225587|528491568|FG000|Overall Study|Adverse Event|5|||
146542168|NCT02225587|528491569|FG001|Overall Study|Adverse Event|5|||
146542169|NCT02225587|528491568|FG000|Overall Study|Lost to Follow-up|5|||
146542170|NCT02225587|528491569|FG001|Overall Study|Lost to Follow-up|5|||
146542171|NCT02225587|528491568|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146542172|NCT02225587|528491569|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146542173|NCT02225587|528491568|FG000|Overall Study|Physician Decision|2|||
146542174|NCT02225587|528491569|FG001|Overall Study|Physician Decision|0|||
146542175|NCT02225587|528491568|FG000|Overall Study|Protocol Violation|1|||
146542176|NCT02225587|528491569|FG001|Overall Study|Protocol Violation|0|||
146542177|NCT02225587|528491568|FG000|Overall Study|Participant Moved|1|||
146542178|NCT02225587|528491569|FG001|Overall Study|Participant Moved|0|||
146542179|NCT02225587|528491568|FG000|Overall Study|Withdrawal by Subject|13|||
146542180|NCT02225587|528491569|FG001|Overall Study|Withdrawal by Subject|28|||
146542181|NCT00924898|528491570|FG000|Overall Study|Withdrawal by Subject|2|||
146542182|NCT05291689|528491576|FG000|Overall Study|Adverse Event|3|||
146542183|NCT05291689|528491576|FG000|Overall Study|Lack of Efficacy|10|||
146542184|NCT05291689|528491576|FG000|Overall Study|Withdrawal by Subject|4|||
146542185|NCT01931098|528491577|FG000|Overall Study|Withdrawal by Subject|0|||
146542186|NCT01931098|528491578|FG001|Overall Study|Withdrawal by Subject|1|||
146542187|NCT01931098|528491577|FG000|Overall Study|Enrolled in different protocol|0|||
146542188|NCT01931098|528491578|FG001|Overall Study|Enrolled in different protocol|1|||
146542189|NCT01931098|528491577|FG000|Overall Study|Unable to begin trmt:active infection|0|||
146542190|NCT01931098|528491578|FG001|Overall Study|Unable to begin trmt:active infection|1|||
146542191|NCT01931098|528491577|FG000|Overall Study|Refused further treatment|0|||
146542192|NCT01931098|528491578|FG001|Overall Study|Refused further treatment|1|||
146542193|NCT02278354|528491582|FG000|Overall Study|Lost to Follow-up|2|||
146542194|NCT02278354|528491583|FG001|Overall Study|Lost to Follow-up|2|||
146542195|NCT02278354|528491582|FG000|Overall Study|Withdrawal by Subject|0|||
146542196|NCT02278354|528491583|FG001|Overall Study|Withdrawal by Subject|1|||
146542197|NCT02278354|528491582|FG000|Overall Study|<10 professional fights|2|||
146542198|NCT02278354|528491583|FG001|Overall Study|<10 professional fights|0|||
146542199|NCT02879695|528491587|FG000|Overall Study|Did not start study treatment|2|||
146542200|NCT02879695|528491588|FG001|Overall Study|Did not start study treatment|0|||
146542201|NCT02879695|528491589|FG002|Overall Study|Did not start study treatment|3|||
146542202|NCT02879695|528491590|FG003|Overall Study|Did not start study treatment|0|||
146542203|NCT04235374|528491591|FG000|Overall Study|Death|91|||
146542204|NCT04235374|528491592|FG001|Overall Study|Death|91|||
146542205|NCT04235374|528491591|FG000|Overall Study|Refused|2|||
146542206|NCT04235374|528491592|FG001|Overall Study|Refused|2|||
146542207|NCT04235374|528491591|FG000|Overall Study|Unavailable|12|||
146542208|NCT04235374|528491592|FG001|Overall Study|Unavailable|3|||
146542209|NCT04235374|528491591|FG000|Overall Study|Withdrawal by Subject|0|||
146542210|NCT04235374|528491592|FG001|Overall Study|Withdrawal by Subject|1|||
146542211|NCT04235374|528491591|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
146542212|NCT04235374|528491592|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
146542213|NCT00314145|528491593|FG000|Overall Study|Withdrawal by Subject|8|||
146542214|NCT00314145|528491594|FG001|Overall Study|Withdrawal by Subject|10|||
146542215|NCT00314145|528491593|FG000|Overall Study|Lost to Follow-up|5|||
146542216|NCT00314145|528491594|FG001|Overall Study|Lost to Follow-up|12|||
146542217|NCT00314145|528491593|FG000|Overall Study|Physician Decision|3|||
146542218|NCT00314145|528491594|FG001|Overall Study|Physician Decision|4|||
146542219|NCT00314145|528491593|FG000|Overall Study|Adverse Event|0|||
146542220|NCT00314145|528491594|FG001|Overall Study|Adverse Event|3|||
146542221|NCT00314145|528491593|FG000|Overall Study|Protocol Violation|3|||
146542222|NCT00314145|528491594|FG001|Overall Study|Protocol Violation|0|||
146542223|NCT00314145|528491593|FG000|Overall Study|Sponsor Decision|2|||
146542224|NCT00314145|528491594|FG001|Overall Study|Sponsor Decision|0|||
146542225|NCT02572167|528491595|FG000|Overall Study|Withdrawal by Subject|0|||
146542226|NCT02572167|528491596|FG001|Overall Study|Withdrawal by Subject|3|||
146542227|NCT02572167|528491597|FG002|Overall Study|Withdrawal by Subject|0|||
146542228|NCT02572167|528491595|FG000|Overall Study|Lost to Follow-up|2|||
146542229|NCT02572167|528491596|FG001|Overall Study|Lost to Follow-up|5|||
146542230|NCT02572167|528491597|FG002|Overall Study|Lost to Follow-up|3|||
146542231|NCT02572167|528491595|FG000|Overall Study|Death|0|||
146542232|NCT02572167|528491596|FG001|Overall Study|Death|8|||
146542233|NCT02572167|528491597|FG002|Overall Study|Death|3|||
146542234|NCT02572167|528491595|FG000|Overall Study|Did not meet inclusion criteria|0|||
146542235|NCT02572167|528491596|FG001|Overall Study|Did not meet inclusion criteria|0|||
146542236|NCT02572167|528491597|FG002|Overall Study|Did not meet inclusion criteria|1|||
146542237|NCT02572167|528491595|FG000|Overall Study|Study closure by Sponsor|4|||
146542238|NCT02572167|528491596|FG001|Overall Study|Study closure by Sponsor|40|||
146542239|NCT02572167|528491597|FG002|Overall Study|Study closure by Sponsor|24|||
146542240|NCT00976027|528491600|FG000|Overall Study|Serious Adverse Event|36|||
146542241|NCT00976027|528491601|FG001|Overall Study|Serious Adverse Event|17|||
146542242|NCT00976027|528491600|FG000|Overall Study|Adverse Event|0|||
146542243|NCT00976027|528491601|FG001|Overall Study|Adverse Event|2|||
146542244|NCT00976027|528491600|FG000|Overall Study|Protocol Violation|60|||
146542245|NCT00976027|528491601|FG001|Overall Study|Protocol Violation|27|||
146542246|NCT00976027|528491600|FG000|Overall Study|Lost to Follow-up|208|||
146542247|NCT00976027|528491601|FG001|Overall Study|Lost to Follow-up|103|||
146542248|NCT00976027|528491600|FG000|Overall Study|Withdrawal by Subject|107|||
146872842|NCT01131676|529704940|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
146914650|NCT03303339|529850047|FG005|Overall Study|Study Terminated by Sponsor|0|||
146542249|NCT00976027|528491601|FG001|Overall Study|Withdrawal by Subject|66|||
146542250|NCT04435626|528491604|FG000|Overall Study|Lost to Follow-up|1|||
146542251|NCT04435626|528491605|FG001|Overall Study|Lost to Follow-up|5|||
146542252|NCT04435626|528491604|FG000|Overall Study|Withdrawal by Subject|6|||
146542253|NCT04435626|528491605|FG001|Overall Study|Withdrawal by Subject|7|||
146542254|NCT04435626|528491604|FG000|Overall Study|major GCP violations|8|||
146542255|NCT04435626|528491605|FG001|Overall Study|major GCP violations|7|||
146542256|NCT01295944|528491606|FG000|Overall Study|Switched to alternative treatment|1|||
146542257|NCT01295944|528491606|FG000|Overall Study|Ineligible|9|||
146542258|NCT01295944|528491606|FG000|Overall Study|Withdrawal by Subject|1|||
146542259|NCT01295944|528491606|FG000|Overall Study|Participant chose to be treated in Peru|1|||
146542260|NCT01295944|528491606|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
146542261|NCT01295944|528491606|FG000|Overall Study|Physician Decision|1|||
146542262|NCT01295944|528491606|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
146542263|NCT01295944|528491606|FG000|Overall Study|Disease progression|4|||
146542264|NCT01295944|528491606|FG000|Overall Study|Transferred care before starting new treatment|1|||
146542265|NCT02783274|528491607|FG000|Overall Study|Withdrawal by Subject|16|||
146542266|NCT02783274|528491607|FG000|Overall Study|Physician Decision|6|||
146542267|NCT02783274|528491607|FG000|Overall Study|Death|9|||
146542268|NCT02783274|528491607|FG000|Overall Study|Lost to Follow-up|22|||
146542269|NCT02783274|528491607|FG000|Overall Study|Other|22|||
146542270|NCT04133909|528491614|FG000|Overall Study|Death|11|||
146542271|NCT04133909|528491615|FG001|Overall Study|Death|11|||
146542272|NCT04133909|528491614|FG000|Overall Study|Adverse Event|4|||
146542273|NCT04133909|528491615|FG001|Overall Study|Adverse Event|5|||
146542274|NCT04133909|528491614|FG000|Overall Study|Lost to Follow-up|3|||
146542275|NCT04133909|528491615|FG001|Overall Study|Lost to Follow-up|5|||
146542276|NCT04133909|528491614|FG000|Overall Study|Physician Decision|4|||
146542277|NCT04133909|528491615|FG001|Overall Study|Physician Decision|7|||
146542278|NCT04133909|528491614|FG000|Overall Study|Withdrawal by Subject|40|||
146542279|NCT04133909|528491615|FG001|Overall Study|Withdrawal by Subject|35|||
146542280|NCT04133909|528491614|FG000|Overall Study|Lack of Efficacy|2|||
146542281|NCT04133909|528491615|FG001|Overall Study|Lack of Efficacy|7|||
146542282|NCT04133909|528491614|FG000|Overall Study|Randomized in error|1|||
146542283|NCT04133909|528491615|FG001|Overall Study|Randomized in error|1|||
146872843|NCT01131676|529704941|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
146764241|NCT02377362|529303019|FG012|Part B Overall|Adverse Event|0|||
146764242|NCT02377362|529303007|FG000|Part B Overall|Withdrawal by Subject|0|||
146764243|NCT02377362|529303008|FG001|Part B Overall|Withdrawal by Subject|0|||
146764244|NCT02377362|529303009|FG002|Part B Overall|Withdrawal by Subject|0|||
146764245|NCT02377362|529303010|FG003|Part B Overall|Withdrawal by Subject|0|||
146764246|NCT02377362|529303011|FG004|Part B Overall|Withdrawal by Subject|0|||
146764247|NCT02377362|529303012|FG005|Part B Overall|Withdrawal by Subject|0|||
146764248|NCT02377362|529303013|FG006|Part B Overall|Withdrawal by Subject|1|||
146764249|NCT02377362|529303014|FG007|Part B Overall|Withdrawal by Subject|0|||
146764250|NCT02377362|529303015|FG008|Part B Overall|Withdrawal by Subject|0|||
146764251|NCT02377362|529303016|FG009|Part B Overall|Withdrawal by Subject|0|||
146764252|NCT02377362|529303017|FG010|Part B Overall|Withdrawal by Subject|0|||
146764253|NCT02377362|529303018|FG011|Part B Overall|Withdrawal by Subject|1|||
146764254|NCT02377362|529303019|FG012|Part B Overall|Withdrawal by Subject|0|||
146764255|NCT01549652|529303020|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
146764256|NCT01549652|529303021|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
146764257|NCT01549652|529303022|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
146764258|NCT01549652|529303023|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
146764259|NCT01549652|529303020|FG000|Overall Study|Study Drug Titration Failure|5|||
146764260|NCT01549652|529303021|FG001|Overall Study|Study Drug Titration Failure|6|||
146764261|NCT01549652|529303022|FG002|Overall Study|Study Drug Titration Failure|0|||
146764262|NCT01549652|529303023|FG003|Overall Study|Study Drug Titration Failure|0|||
146764263|NCT01549652|529303020|FG000|Overall Study|Withdrawal Effect|0|||
146764264|NCT01549652|529303021|FG001|Overall Study|Withdrawal Effect|2|||
146764265|NCT01549652|529303022|FG002|Overall Study|Withdrawal Effect|0|||
146764266|NCT01549652|529303023|FG003|Overall Study|Withdrawal Effect|0|||
146764267|NCT01549652|529303020|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
146764268|NCT01549652|529303021|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
146764269|NCT01549652|529303022|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
146764270|NCT01549652|529303023|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
146764271|NCT01549652|529303020|FG000|Overall Study|Problem with Infusion|1|||
146764272|NCT01549652|529303021|FG001|Overall Study|Problem with Infusion|0|||
146764273|NCT01549652|529303022|FG002|Overall Study|Problem with Infusion|0|||
146764274|NCT01549652|529303023|FG003|Overall Study|Problem with Infusion|0|||
146764275|NCT01549652|529303020|FG000|Overall Study|Titration Non-Compliance|1|||
146764276|NCT01549652|529303021|FG001|Overall Study|Titration Non-Compliance|3|||
146764277|NCT01549652|529303022|FG002|Overall Study|Titration Non-Compliance|4|||
146764278|NCT01549652|529303023|FG003|Overall Study|Titration Non-Compliance|5|||
146764279|NCT01549652|529303020|FG000|Overall Study|Titration Side Effects|0|||
146764280|NCT01549652|529303021|FG001|Overall Study|Titration Side Effects|0|||
146764281|NCT01549652|529303022|FG002|Overall Study|Titration Side Effects|6|||
146764282|NCT01549652|529303023|FG003|Overall Study|Titration Side Effects|3|||
146764283|NCT01549652|529303020|FG000|Overall Study|Withdrawal by Subject|0|||
146542284|NCT01811238|528491616|FG000|Overall Study|Withdrawal by Subject|42|||
146542285|NCT01811238|528491616|FG000|Overall Study|Adverse Event|25|||
146542286|NCT01811238|528491616|FG000|Overall Study|Protocol Violation|4|||
146542287|NCT01811238|528491616|FG000|Overall Study|Lack of Efficacy|4|||
146542288|NCT01811238|528491616|FG000|Overall Study|subject refused study medication|6|||
146542289|NCT02916927|528491620|FG000|Overall Study|Discharged prior to study drug receipt|0|||
146542290|NCT02916927|528491621|FG001|Overall Study|Discharged prior to study drug receipt|2|||
146542291|NCT02916927|528491620|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
146542292|NCT02916927|528491621|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
146542293|NCT02916927|528491620|FG000|Overall Study|Withdrawal before first time point|1|||
146542294|NCT02916927|528491621|FG001|Overall Study|Withdrawal before first time point|0|||
146542295|NCT01706328|528491625|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
146542296|NCT01706328|528491626|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
146542297|NCT01706328|528491627|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
146542298|NCT01706328|528491625|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
146542299|NCT01706328|528491626|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
146542300|NCT01706328|528491627|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
146542301|NCT01706328|528491625|FG000|2-week Run-in Period|Physician Decision|4|||
146542302|NCT01706328|528491626|FG001|2-week Run-in Period|Physician Decision|0|||
146542303|NCT01706328|528491627|FG002|2-week Run-in Period|Physician Decision|0|||
146542304|NCT01706328|528491625|FG000|2-week Run-in Period|Adverse Event|4|||
146542305|NCT01706328|528491626|FG001|2-week Run-in Period|Adverse Event|0|||
146542306|NCT01706328|528491627|FG002|2-week Run-in Period|Adverse Event|0|||
146542307|NCT01706328|528491625|FG000|2-week Run-in Period|Lost to Follow-up|2|||
146542308|NCT01706328|528491626|FG001|2-week Run-in Period|Lost to Follow-up|0|||
146542309|NCT01706328|528491627|FG002|2-week Run-in Period|Lost to Follow-up|0|||
146542310|NCT01706328|528491625|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
146542311|NCT01706328|528491626|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
146542312|NCT01706328|528491627|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
146542313|NCT01706328|528491625|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
146872844|NCT01131676|529704939|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
146542314|NCT01706328|528491626|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
146542315|NCT01706328|528491627|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
146872845|NCT01131676|529704940|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
146872846|NCT01131676|529704941|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
146872847|NCT01131676|529704939|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
146872848|NCT01131676|529704940|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
146872849|NCT01131676|529704941|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
146872850|NCT01131676|529704939|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
146872851|NCT01131676|529704940|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
146872852|NCT01131676|529704941|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
146872853|NCT01131676|529704939|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
146872854|NCT01131676|529704940|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
146872855|NCT01131676|529704941|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
146872856|NCT01131676|529704939|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
146872857|NCT01131676|529704940|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
146872858|NCT01131676|529704941|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
146872859|NCT04109222|529704942|FG000|Overall Study|Adverse Event|1|||
146872860|NCT04109222|529704943|FG001|Overall Study|Adverse Event|0|||
146872861|NCT04109222|529704944|FG002|Overall Study|Adverse Event|0|||
146872862|NCT02138617|529704945|FG000|Overall Study|Death|1|||
146872863|NCT02138617|529704946|FG001|Overall Study|Death|2|||
146872864|NCT02138617|529704947|FG002|Overall Study|Death|2|||
146872865|NCT02138617|529704945|FG000|Overall Study|Adverse Event|8|||
146872866|NCT02138617|529704946|FG001|Overall Study|Adverse Event|5|||
146872867|NCT02138617|529704947|FG002|Overall Study|Adverse Event|2|||
146872868|NCT02138617|529704945|FG000|Overall Study|Disease Progression|20|||
146872869|NCT02138617|529704946|FG001|Overall Study|Disease Progression|13|||
146872870|NCT02138617|529704947|FG002|Overall Study|Disease Progression|4|||
146872871|NCT02138617|529704945|FG000|Overall Study|Withdrawal by Subject|7|||
146872872|NCT02138617|529704946|FG001|Overall Study|Withdrawal by Subject|10|||
146872873|NCT02138617|529704947|FG002|Overall Study|Withdrawal by Subject|2|||
146872874|NCT02138617|529704945|FG000|Overall Study|other complicating disease|0|||
146872875|NCT02138617|529704946|FG001|Overall Study|other complicating disease|2|||
146872876|NCT02138617|529704947|FG002|Overall Study|other complicating disease|0|||
146872877|NCT02138617|529704945|FG000|Overall Study|Protocol Violation|1|||
146542316|NCT01706328|528491625|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
146542317|NCT01706328|528491626|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
146542318|NCT01706328|528491627|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
146542319|NCT01706328|528491625|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
146542320|NCT01706328|528491626|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
146872878|NCT02138617|529704946|FG001|Overall Study|Protocol Violation|0|||
146872879|NCT02138617|529704947|FG002|Overall Study|Protocol Violation|0|||
146872880|NCT02138617|529704945|FG000|Overall Study|Physician Decision|7|||
146872881|NCT02138617|529704946|FG001|Overall Study|Physician Decision|6|||
146872882|NCT02138617|529704947|FG002|Overall Study|Physician Decision|0|||
146872883|NCT02138617|529704945|FG000|Overall Study|financial reason|0|||
146872884|NCT02138617|529704946|FG001|Overall Study|financial reason|1|||
146872885|NCT02138617|529704947|FG002|Overall Study|financial reason|0|||
146872886|NCT02138617|529704945|FG000|Overall Study|other therapy|3|||
146872887|NCT02138617|529704946|FG001|Overall Study|other therapy|4|||
146872888|NCT02138617|529704947|FG002|Overall Study|other therapy|0|||
146872889|NCT01961349|529704951|FG000|Overall Study|Withdrawal by Subject|1|||
146872890|NCT01961349|529704952|FG001|Overall Study|Withdrawal by Subject|4|||
146872891|NCT01961349|529704953|FG002|Overall Study|Withdrawal by Subject|0|||
146872892|NCT01961349|529704951|FG000|Overall Study|Adverse Event|0|||
146872893|NCT01961349|529704952|FG001|Overall Study|Adverse Event|0|||
146872894|NCT01961349|529704953|FG002|Overall Study|Adverse Event|1|||
146872895|NCT01961349|529704951|FG000|Overall Study|registration error, personal reason etc|2|||
146872896|NCT01961349|529704952|FG001|Overall Study|registration error, personal reason etc|2|||
146872897|NCT01961349|529704953|FG002|Overall Study|registration error, personal reason etc|1|||
146872898|NCT05525689|529704954|FG000|Overall Study|Lost to Follow-up|1|||
146872899|NCT05525689|529704955|FG001|Overall Study|Lost to Follow-up|0|||
146872900|NCT00509067|529704958|FG000|Overall Study|Lost to Follow-up|1|||
146872901|NCT00509067|529704959|FG001|Overall Study|Lost to Follow-up|1|||
146872902|NCT00509067|529704958|FG000|Overall Study|Adverse Event|3|||
146872903|NCT00509067|529704959|FG001|Overall Study|Adverse Event|1|||
146872904|NCT00509067|529704958|FG000|Overall Study|Protocol Violation|0|||
146872905|NCT00509067|529704959|FG001|Overall Study|Protocol Violation|3|||
146542321|NCT01706328|528491627|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
146542322|NCT01706328|528491625|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
146542323|NCT01706328|528491626|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
146872906|NCT03654976|529704965|FG000|Overall Study|Withdrawal by Subject|12|||
146872907|NCT03654976|529704966|FG001|Overall Study|Withdrawal by Subject|11|||
146872908|NCT03654976|529704965|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
146872909|NCT03654976|529704966|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
146872910|NCT03654976|529704965|FG000|Overall Study|Adverse Event|5|||
146872911|NCT03654976|529704966|FG001|Overall Study|Adverse Event|0|||
146872912|NCT03654976|529704965|FG000|Overall Study|Lost to Follow-up|2|||
146872913|NCT03654976|529704966|FG001|Overall Study|Lost to Follow-up|0|||
146872914|NCT03654976|529704965|FG000|Overall Study|Lack of Efficacy|0|||
146872915|NCT03654976|529704966|FG001|Overall Study|Lack of Efficacy|1|||
146872916|NCT00545064|529704967|FG000|Overall Study|Lost to Follow-up|3|||
146872917|NCT00545064|529704967|FG000|Overall Study|Withdrawal by Subject|2|||
146872918|NCT00545064|529704967|FG000|Overall Study|did not complete course of treatment|1|||
146872919|NCT00545064|529704967|FG000|Overall Study|cancel all appointments, no rebooking|1|||
146872920|NCT00545064|529704967|FG000|Overall Study|inclement weather|1|||
146872921|NCT04688775|529704970|FG000|Placebo-controlled Period|Randomized, not treated|1|||
146872922|NCT04688775|529704971|FG001|Placebo-controlled Period|Randomized, not treated|1|||
146872923|NCT04688775|529704972|FG002|Placebo-controlled Period|Randomized, not treated|0|||
146872924|NCT04688775|529704973|FG003|Placebo-controlled Period|Randomized, not treated|0|||
146872925|NCT04688775|529704970|FG000|Placebo-controlled Period|Adverse Event|2|||
146872926|NCT04688775|529704971|FG001|Placebo-controlled Period|Adverse Event|0|||
146872927|NCT04688775|529704972|FG002|Placebo-controlled Period|Adverse Event|0|||
146872928|NCT04688775|529704973|FG003|Placebo-controlled Period|Adverse Event|0|||
146872929|NCT04688775|529704970|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
146872930|NCT04688775|529704971|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
146872931|NCT04688775|529704972|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
146872932|NCT04688775|529704973|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
146872933|NCT04688775|529704970|FG000|Placebo-controlled Period|Protocol Violation|0|||
146872934|NCT04688775|529704971|FG001|Placebo-controlled Period|Protocol Violation|1|||
146872935|NCT04688775|529704972|FG002|Placebo-controlled Period|Protocol Violation|0|||
146872936|NCT04688775|529704973|FG003|Placebo-controlled Period|Protocol Violation|0|||
146872937|NCT04688775|529704970|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
146872938|NCT04688775|529704971|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
146872939|NCT04688775|529704972|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
146872940|NCT04688775|529704973|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
146872941|NCT04688775|529704970|FG000|Placebo-controlled Period|Other reasons|0|||
146872942|NCT04688775|529704971|FG001|Placebo-controlled Period|Other reasons|1|||
146872943|NCT04688775|529704972|FG002|Placebo-controlled Period|Other reasons|0|||
146872944|NCT04688775|529704973|FG003|Placebo-controlled Period|Other reasons|0|||
146872945|NCT04688775|529704970|FG000|Delayed Start Period|Adverse Event|0|||
146872946|NCT04688775|529704971|FG001|Delayed Start Period|Adverse Event|0|||
146872947|NCT04688775|529704972|FG002|Delayed Start Period|Adverse Event|1|||
146872948|NCT04688775|529704973|FG003|Delayed Start Period|Adverse Event|0|||
146872949|NCT04688775|529704970|FG000|Delayed Start Period|Lack of Efficacy|0|||
146872950|NCT04688775|529704971|FG001|Delayed Start Period|Lack of Efficacy|0|||
146872951|NCT04688775|529704972|FG002|Delayed Start Period|Lack of Efficacy|0|||
146872952|NCT04688775|529704973|FG003|Delayed Start Period|Lack of Efficacy|3|||
146872953|NCT04688775|529704970|FG000|Delayed Start Period|Withdrawal by Subject|0|||
146872954|NCT04688775|529704971|FG001|Delayed Start Period|Withdrawal by Subject|0|||
146872955|NCT04688775|529704972|FG002|Delayed Start Period|Withdrawal by Subject|2|||
146872956|NCT04688775|529704973|FG003|Delayed Start Period|Withdrawal by Subject|4|||
146872957|NCT04688775|529704970|FG000|Delayed Start Period|Lost to Follow-up|0|||
146872958|NCT04688775|529704971|FG001|Delayed Start Period|Lost to Follow-up|0|||
146872959|NCT04688775|529704972|FG002|Delayed Start Period|Lost to Follow-up|2|||
146872960|NCT04688775|529704973|FG003|Delayed Start Period|Lost to Follow-up|1|||
146872961|NCT04688775|529704970|FG000|Delayed Start Period|other reasons|0|||
146872962|NCT04688775|529704971|FG001|Delayed Start Period|other reasons|0|||
146872963|NCT04688775|529704972|FG002|Delayed Start Period|other reasons|1|||
146872964|NCT04688775|529704973|FG003|Delayed Start Period|other reasons|0|||
146872965|NCT01843972|529704974|FG000|Overall Study|Withdrawal by Subject|0|||
146872966|NCT01843972|529704975|FG001|Overall Study|Withdrawal by Subject|0|||
146872967|NCT01843972|529704976|FG002|Overall Study|Withdrawal by Subject|0|||
146872968|NCT01843972|529704977|FG003|Overall Study|Withdrawal by Subject|0|||
146872969|NCT01843972|529704978|FG004|Overall Study|Withdrawal by Subject|1|||
146872970|NCT01843972|529704979|FG005|Overall Study|Withdrawal by Subject|0|||
146872971|NCT01843972|529704980|FG006|Overall Study|Withdrawal by Subject|0|||
146872972|NCT01843972|529704981|FG007|Overall Study|Withdrawal by Subject|0|||
146872973|NCT01843972|529704982|FG008|Overall Study|Withdrawal by Subject|0|||
146872974|NCT01843972|529704983|FG009|Overall Study|Withdrawal by Subject|0|||
146872975|NCT01854645|529704984|FG000|Overall Study|Protocol-Specified Criteria|13|||
146872976|NCT01854645|529704985|FG001|Overall Study|Protocol-Specified Criteria|10|||
146872977|NCT01854645|529704986|FG002|Overall Study|Protocol-Specified Criteria|8|||
146872978|NCT01854645|529704987|FG003|Overall Study|Protocol-Specified Criteria|5|||
146872979|NCT01854645|529704988|FG004|Overall Study|Protocol-Specified Criteria|7|||
146872980|NCT01854645|529704984|FG000|Overall Study|Administrative Reasons / Missing|0|||
146872981|NCT01854645|529704985|FG001|Overall Study|Administrative Reasons / Missing|0|||
146872982|NCT01854645|529704986|FG002|Overall Study|Administrative Reasons / Missing|0|||
146872983|NCT01854645|529704987|FG003|Overall Study|Administrative Reasons / Missing|1|||
146872984|NCT01854645|529704988|FG004|Overall Study|Administrative Reasons / Missing|1|||
146872985|NCT01854645|529704984|FG000|Overall Study|Protocol Violation|3|||
146872986|NCT01854645|529704985|FG001|Overall Study|Protocol Violation|0|||
146872987|NCT01854645|529704986|FG002|Overall Study|Protocol Violation|5|||
146872988|NCT01854645|529704987|FG003|Overall Study|Protocol Violation|4|||
146872989|NCT01854645|529704988|FG004|Overall Study|Protocol Violation|1|||
146872990|NCT01854645|529704984|FG000|Overall Study|Lost to Follow-up|10|||
146872991|NCT01854645|529704985|FG001|Overall Study|Lost to Follow-up|7|||
146872992|NCT01854645|529704986|FG002|Overall Study|Lost to Follow-up|8|||
146872993|NCT01854645|529704987|FG003|Overall Study|Lost to Follow-up|5|||
146872994|NCT01854645|529704988|FG004|Overall Study|Lost to Follow-up|0|||
146872995|NCT01854645|529704984|FG000|Overall Study|Physician Decision|1|||
146872996|NCT01854645|529704985|FG001|Overall Study|Physician Decision|5|||
146872997|NCT01854645|529704986|FG002|Overall Study|Physician Decision|3|||
146542324|NCT01706328|528491627|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
146542325|NCT01706328|528491625|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
146542326|NCT01706328|528491626|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
146542327|NCT01706328|528491627|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
146542328|NCT01706328|528491625|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
146542329|NCT01706328|528491626|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
146542330|NCT01706328|528491627|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
146542331|NCT04409002|528491628|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
146542332|NCT02924376|528491629|FG000|Overall Study|Progressive Disease|4|||
146542333|NCT02924376|528491630|FG001|Overall Study|Progressive Disease|0|||
146542334|NCT02924376|528491631|FG002|Overall Study|Progressive Disease|1|||
146542335|NCT02924376|528491632|FG003|Overall Study|Progressive Disease|0|||
146542336|NCT02924376|528491629|FG000|Overall Study|Death|73|||
146542337|NCT02924376|528491630|FG001|Overall Study|Death|18|||
146542338|NCT02924376|528491631|FG002|Overall Study|Death|15|||
146542339|NCT02924376|528491632|FG003|Overall Study|Death|2|||
146542340|NCT02924376|528491629|FG000|Overall Study|Lost to Follow-up|3|||
146542341|NCT02924376|528491630|FG001|Overall Study|Lost to Follow-up|0|||
146542342|NCT02924376|528491631|FG002|Overall Study|Lost to Follow-up|0|||
146542343|NCT02924376|528491632|FG003|Overall Study|Lost to Follow-up|0|||
146542344|NCT02924376|528491629|FG000|Overall Study|Study Terminated by Sponsor|19|||
146542345|NCT02924376|528491630|FG001|Overall Study|Study Terminated by Sponsor|0|||
146542346|NCT02924376|528491631|FG002|Overall Study|Study Terminated by Sponsor|0|||
146542347|NCT02924376|528491632|FG003|Overall Study|Study Terminated by Sponsor|0|||
146542348|NCT02924376|528491629|FG000|Overall Study|Physician Decision|1|||
146542349|NCT02924376|528491630|FG001|Overall Study|Physician Decision|0|||
146542350|NCT02924376|528491631|FG002|Overall Study|Physician Decision|0|||
146542351|NCT02924376|528491632|FG003|Overall Study|Physician Decision|0|||
146872998|NCT01854645|529704987|FG003|Overall Study|Physician Decision|3|||
146872999|NCT01854645|529704988|FG004|Overall Study|Physician Decision|7|||
146873000|NCT01854645|529704984|FG000|Overall Study|Withdrawal by Subject|31|||
146542352|NCT02924376|528491629|FG000|Overall Study|Withdrawal by Subject|7|||
146542353|NCT02924376|528491630|FG001|Overall Study|Withdrawal by Subject|2|||
146542354|NCT02924376|528491631|FG002|Overall Study|Withdrawal by Subject|1|||
146873001|NCT01854645|529704985|FG001|Overall Study|Withdrawal by Subject|41|||
146873002|NCT01854645|529704986|FG002|Overall Study|Withdrawal by Subject|30|||
146873003|NCT01854645|529704987|FG003|Overall Study|Withdrawal by Subject|21|||
146873004|NCT01854645|529704988|FG004|Overall Study|Withdrawal by Subject|24|||
146542355|NCT02924376|528491632|FG003|Overall Study|Withdrawal by Subject|0|||
146873005|NCT01854645|529704984|FG000|Overall Study|Lack of Efficacy|7|||
146542356|NCT02924376|528491629|FG000|Overall Study|Rolled Over to Another Study|1|||
146873006|NCT01854645|529704985|FG001|Overall Study|Lack of Efficacy|12|||
146542357|NCT02924376|528491630|FG001|Overall Study|Rolled Over to Another Study|0|||
146542358|NCT02924376|528491631|FG002|Overall Study|Rolled Over to Another Study|0|||
146542359|NCT02924376|528491632|FG003|Overall Study|Rolled Over to Another Study|0|||
146542360|NCT06481579|528491633|FG000|Overall Study|Death|1|||
146542361|NCT06481579|528491634|FG001|Overall Study|Death|0|||
146542362|NCT06481579|528491633|FG000|Overall Study|Withdrawal by Subject|3|||
146542363|NCT06481579|528491634|FG001|Overall Study|Withdrawal by Subject|0|||
146542364|NCT06481579|528491633|FG000|Overall Study|Other|1|||
146873007|NCT01854645|529704986|FG002|Overall Study|Lack of Efficacy|9|||
146542365|NCT06481579|528491634|FG001|Overall Study|Other|1|||
146542366|NCT05253807|528491635|FG000|Overall Study|Death|1|||
146542367|NCT05253807|528491636|FG001|Overall Study|Death|4|||
146542368|NCT05253807|528491635|FG000|Overall Study|Withdrawal by Subject|1|||
146542369|NCT05253807|528491636|FG001|Overall Study|Withdrawal by Subject|0|||
146542370|NCT05253807|528491635|FG000|Overall Study|Study Terminated by Sponsor|1|||
146873008|NCT01854645|529704987|FG003|Overall Study|Lack of Efficacy|3|||
146873009|NCT01854645|529704988|FG004|Overall Study|Lack of Efficacy|9|||
146542371|NCT05253807|528491636|FG001|Overall Study|Study Terminated by Sponsor|1|||
146542372|NCT03595748|528493214|FG000|Overall Study|Death|11|||
146542373|NCT03595748|528493215|FG001|Overall Study|Death|12|||
146542374|NCT03595748|528493214|FG000|Overall Study|Withdrawal by Subject|28|||
146873010|NCT01854645|529704984|FG000|Overall Study|Adverse Event|33|||
146873011|NCT01854645|529704985|FG001|Overall Study|Adverse Event|31|||
146542375|NCT03595748|528493215|FG001|Overall Study|Withdrawal by Subject|29|||
146542376|NCT03595748|528493214|FG000|Overall Study|Protocol Violation|0|||
146542377|NCT03595748|528493215|FG001|Overall Study|Protocol Violation|1|||
146873012|NCT01854645|529704986|FG002|Overall Study|Adverse Event|19|||
146873013|NCT01854645|529704987|FG003|Overall Study|Adverse Event|20|||
146873014|NCT01854645|529704988|FG004|Overall Study|Adverse Event|11|||
146873015|NCT00445224|529704991|FG000|Specific Exercises|Withdrawal by Subject|3|||
146873016|NCT00445224|529704992|FG001|Specific Exercises|Withdrawal by Subject|3|||
146873017|NCT00445224|529704991|FG000|Specific Exercises|Withdrawal by Subject|1|||
146873018|NCT00445224|529704992|FG001|Specific Exercises|Withdrawal by Subject|0|||
146873019|NCT04360551|529706604|FG000|Overall Study|Withdrawal by Subject|1|||
146873020|NCT04360551|529706605|FG001|Overall Study|Withdrawal by Subject|0|||
146873021|NCT03496012|529706606|FG000|Overall Study|Withdrawal by Subject|2|||
146873022|NCT03496012|529706607|FG001|Overall Study|Withdrawal by Subject|0|||
146873023|NCT03496012|529706608|FG002|Overall Study|Withdrawal by Subject|2|||
146873024|NCT03496012|529706606|FG000|Overall Study|Adverse Event|0|||
146873025|NCT03496012|529706607|FG001|Overall Study|Adverse Event|0|||
146873026|NCT03496012|529706608|FG002|Overall Study|Adverse Event|1|||
146873027|NCT03496012|529706606|FG000|Overall Study|Reason Not Specified|2|||
146873028|NCT03496012|529706607|FG001|Overall Study|Reason Not Specified|0|||
146873029|NCT03496012|529706608|FG002|Overall Study|Reason Not Specified|1|||
146873030|NCT00404820|529706627|FG000|Overall Study|Adverse Event|4|||
146873031|NCT00404820|529706628|FG001|Overall Study|Adverse Event|16|||
146873032|NCT00404820|529706627|FG000|Overall Study|Withdrawal by Subject|5|||
146873033|NCT00404820|529706628|FG001|Overall Study|Withdrawal by Subject|3|||
146542378|NCT04809974|528493216|FG000|Lead-in Phase|Withdrawal by Subject|3|||
146542379|NCT04809974|528493217|FG001|Lead-in Phase|Withdrawal by Subject|0|||
146873034|NCT00404820|529706627|FG000|Overall Study|Lost to Follow-up|7|||
146873035|NCT00404820|529706628|FG001|Overall Study|Lost to Follow-up|3|||
146873036|NCT00404820|529706627|FG000|Overall Study|Administrative problems|2|||
146873037|NCT00404820|529706628|FG001|Overall Study|Administrative problems|0|||
146542380|NCT04809974|528493218|FG002|Lead-in Phase|Withdrawal by Subject|0|||
146542381|NCT04809974|528493216|FG000|Lead-in Phase|No longer eligible|11|||
146542382|NCT04809974|528493217|FG001|Lead-in Phase|No longer eligible|0|||
146542383|NCT04809974|528493218|FG002|Lead-in Phase|No longer eligible|0|||
146542384|NCT04809974|528493216|FG000|Randomized Phase|Lost to Follow-up|0|||
146542385|NCT04809974|528493217|FG001|Randomized Phase|Lost to Follow-up|1|||
146542386|NCT04809974|528493218|FG002|Randomized Phase|Lost to Follow-up|5|||
146542387|NCT04809974|528493216|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
146542388|NCT04809974|528493217|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
146568783|NCT00658541|528595452|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
146764284|NCT01549652|529303021|FG001|Overall Study|Withdrawal by Subject|0|||
146764285|NCT01549652|529303022|FG002|Overall Study|Withdrawal by Subject|5|||
146764286|NCT01549652|529303023|FG003|Overall Study|Withdrawal by Subject|3|||
146764287|NCT05196737|529303026|FG000|Non-intervention Week|Lost to Follow-up|2|||
146764288|NCT05196737|529303026|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
146764289|NCT03722446|529303027|FG000|Overall Study|Protocol Violation|15|||
146764290|NCT03722446|529303028|FG001|Overall Study|Protocol Violation|2|||
146764291|NCT02908464|529303033|FG000|Overall Study|Withdrawal by Subject|2|||
146764292|NCT02908464|529303034|FG001|Overall Study|Withdrawal by Subject|1|||
146764293|NCT02908464|529303033|FG000|Overall Study|Found ineligible after randomization|0|||
146764294|NCT02908464|529303034|FG001|Overall Study|Found ineligible after randomization|2|||
146764295|NCT02163915|529303035|FG000|Overall Study|Withdrawal by Subject|2|||
146628024|NCT00106704|528813547|FG000|Overall Study|Withdrawal by Subject|14|||
146764296|NCT02163915|529303036|FG001|Overall Study|Withdrawal by Subject|0|||
146764297|NCT02163915|529303037|FG002|Overall Study|Withdrawal by Subject|2|||
146764298|NCT02163915|529303038|FG003|Overall Study|Withdrawal by Subject|2|||
146764299|NCT02163915|529303039|FG004|Overall Study|Withdrawal by Subject|2|||
146764300|NCT02163915|529303035|FG000|Overall Study|Study termination|1|||
146764301|NCT02163915|529303036|FG001|Overall Study|Study termination|0|||
146764302|NCT02163915|529303037|FG002|Overall Study|Study termination|0|||
146764303|NCT02163915|529303038|FG003|Overall Study|Study termination|0|||
146764304|NCT02163915|529303039|FG004|Overall Study|Study termination|2|||
146764305|NCT02163915|529303035|FG000|Overall Study|Physician Decision|0|||
146764306|NCT02163915|529303036|FG001|Overall Study|Physician Decision|0|||
146764307|NCT02163915|529303037|FG002|Overall Study|Physician Decision|0|||
146764308|NCT02163915|529303038|FG003|Overall Study|Physician Decision|1|||
146764309|NCT02163915|529303039|FG004|Overall Study|Physician Decision|0|||
146764310|NCT03646669|529304346|FG000|Overall Study|Withdrawal by Subject|5|||
146764311|NCT03646669|529304347|FG001|Overall Study|Withdrawal by Subject|0|||
146764312|NCT00377455|529304348|FG000|Overall Study|Withdrawal by Subject|1|||
146764313|NCT00309452|529304349|FG000|Overall Study|Withdrawal by Subject|3|||
146764314|NCT00309452|529304350|FG001|Overall Study|Withdrawal by Subject|0|||
146764315|NCT01883492|529304353|FG000|Overall Study|Lost to Follow-up|3|||
146764316|NCT01883492|529304354|FG001|Overall Study|Lost to Follow-up|4|||
146764317|NCT01883492|529304353|FG000|Overall Study|Surgery on contra-lateral hip|0|||
146764318|NCT01883492|529304354|FG001|Overall Study|Surgery on contra-lateral hip|1|||
146764319|NCT01883492|529304353|FG000|Overall Study|Poor X-ray quality|7|||
146764320|NCT01883492|529304354|FG001|Overall Study|Poor X-ray quality|4|||
146764321|NCT01883492|529304353|FG000|Overall Study|Withdrawal by Subject|1|||
146764322|NCT01883492|529304354|FG001|Overall Study|Withdrawal by Subject|0|||
146764323|NCT01883492|529304353|FG000|Overall Study|inappropriate implant used|1|||
146764324|NCT01883492|529304354|FG001|Overall Study|inappropriate implant used|1|||
146764325|NCT01883492|529304353|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
146764326|NCT01883492|529304354|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
146764327|NCT01281813|529304355|FG000|Overall Study|Adverse Event|0|||
146764328|NCT01281813|529304356|FG001|Overall Study|Adverse Event|0|||
146764329|NCT01281813|529304357|FG002|Overall Study|Adverse Event|10|||
146764330|NCT01281813|529304355|FG000|Overall Study|Lost to Follow-up|0|||
146764331|NCT01281813|529304356|FG001|Overall Study|Lost to Follow-up|0|||
146764332|NCT01281813|529304357|FG002|Overall Study|Lost to Follow-up|31|||
146764333|NCT01281813|529304355|FG000|Overall Study|Withdrawal by Subject|0|||
146764334|NCT01281813|529304356|FG001|Overall Study|Withdrawal by Subject|0|||
146764335|NCT01281813|529304357|FG002|Overall Study|Withdrawal by Subject|13|||
146764336|NCT01281813|529304355|FG000|Overall Study|Subject Non-Compliant|0|||
146764337|NCT01281813|529304356|FG001|Overall Study|Subject Non-Compliant|0|||
146764338|NCT01281813|529304357|FG002|Overall Study|Subject Non-Compliant|6|||
146764339|NCT01281813|529304355|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
146764340|NCT01281813|529304356|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
146764341|NCT01281813|529304357|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
146764342|NCT01281813|529304355|FG000|Overall Study|Sponsor's Decision|4|||
146764343|NCT01281813|529304356|FG001|Overall Study|Sponsor's Decision|3|||
146764344|NCT01281813|529304357|FG002|Overall Study|Sponsor's Decision|7|||
146764345|NCT01281813|529304355|FG000|Overall Study|Switched to Commercially Available Medication|0|||
146764346|NCT01281813|529304356|FG001|Overall Study|Switched to Commercially Available Medication|0|||
146764347|NCT01281813|529304357|FG002|Overall Study|Switched to Commercially Available Medication|26|||
146764348|NCT01281813|529304355|FG000|Overall Study|Other|0|||
146764349|NCT01281813|529304356|FG001|Overall Study|Other|1|||
146764350|NCT01281813|529304357|FG002|Overall Study|Other|39|||
146764351|NCT05257798|529304358|FG000|Follow-up Phase|Lost to Follow-up|1|||
146764352|NCT05257798|529304359|FG001|Follow-up Phase|Lost to Follow-up|0|||
146764353|NCT02614560|529304362|FG000|Overall Study|Death|6|||
146542389|NCT04809974|528493218|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
146542390|NCT04809974|528493216|FG000|Randomized Phase|Adverse Event|0|||
146542391|NCT04809974|528493217|FG001|Randomized Phase|Adverse Event|1|||
146542392|NCT04809974|528493218|FG002|Randomized Phase|Adverse Event|4|||
146542393|NCT04809974|528493216|FG000|Randomized Phase|Withdrawal by Subject|0|||
146542394|NCT04809974|528493217|FG001|Randomized Phase|Withdrawal by Subject|0|||
146542395|NCT04809974|528493218|FG002|Randomized Phase|Withdrawal by Subject|5|||
146542396|NCT00770809|528493219|FG000|Overall Study|Adverse Event|9|||
146542397|NCT00770809|528493220|FG001|Overall Study|Adverse Event|1|||
146542398|NCT00770809|528493221|FG002|Overall Study|Adverse Event|12|||
146542399|NCT00770809|528493219|FG000|Overall Study|Death|1|||
146542400|NCT00770809|528493220|FG001|Overall Study|Death|0|||
146542401|NCT00770809|528493221|FG002|Overall Study|Death|0|||
146542402|NCT00770809|528493219|FG000|Overall Study|Withdrawal by Subject|3|||
146873038|NCT00404820|529706627|FG000|Overall Study|Death|1|||
146873039|NCT00404820|529706628|FG001|Overall Study|Death|0|||
146873040|NCT00404820|529706627|FG000|Overall Study|Other|0|||
146873041|NCT00404820|529706628|FG001|Overall Study|Other|2|||
146873042|NCT00176605|529706630|FG000|Overall Study|Withdrawal by Subject|2|||
146873043|NCT01321710|529706631|FG000|Overall Study|Lost to Follow-up|4|||
146873044|NCT01321710|529706632|FG001|Overall Study|Lost to Follow-up|5|||
146873045|NCT01321710|529706633|FG002|Overall Study|Lost to Follow-up|0|||
146873046|NCT01566773|529706635|FG000|Overall Study|Protocol specified criteria|4|||
146873047|NCT01566773|529706635|FG000|Overall Study|Protocol Violation|4|||
146873048|NCT01566773|529706635|FG000|Overall Study|Withdrawal by Subject|9|||
146873049|NCT01566773|529706635|FG000|Overall Study|Administrative reason|1|||
146873050|NCT01566773|529706635|FG000|Overall Study|Adverse Event|10|||
146873051|NCT01566773|529706635|FG000|Overall Study|Physician Decision|2|||
146873052|NCT00833053|529706636|FG000|Overall Study|Adverse Event|4|||
146873053|NCT00833053|529706637|FG001|Overall Study|Adverse Event|0|||
146873054|NCT00833053|529706636|FG000|Overall Study|Treatment Failure|3|||
146873055|NCT00833053|529706637|FG001|Overall Study|Treatment Failure|1|||
146873056|NCT00833053|529706636|FG000|Overall Study|Withdrawal by Subject|0|||
146873057|NCT00833053|529706637|FG001|Overall Study|Withdrawal by Subject|1|||
146873058|NCT00833053|529706636|FG000|Overall Study|Protocol Violation|2|||
146873059|NCT00833053|529706637|FG001|Overall Study|Protocol Violation|1|||
146873060|NCT02187471|529706638|FG000|Overall Study|Protocol Violation|4|||
146873061|NCT02187471|529706639|FG001|Overall Study|Protocol Violation|5|||
146873062|NCT02187471|529706640|FG002|Overall Study|Protocol Violation|4|||
146873063|NCT02187471|529706641|FG003|Overall Study|Protocol Violation|4|||
146873064|NCT02187471|529706638|FG000|Overall Study|Missing|0|||
146542403|NCT00770809|528493220|FG001|Overall Study|Withdrawal by Subject|3|||
146542404|NCT00770809|528493221|FG002|Overall Study|Withdrawal by Subject|7|||
146873065|NCT02187471|529706639|FG001|Overall Study|Missing|0|||
146873066|NCT02187471|529706640|FG002|Overall Study|Missing|0|||
146873067|NCT02187471|529706641|FG003|Overall Study|Missing|1|||
146873068|NCT02187471|529706638|FG000|Overall Study|Lack of Efficacy|18|||
146873069|NCT02187471|529706639|FG001|Overall Study|Lack of Efficacy|9|||
146873070|NCT02187471|529706640|FG002|Overall Study|Lack of Efficacy|13|||
146873071|NCT02187471|529706641|FG003|Overall Study|Lack of Efficacy|11|||
146873072|NCT02187471|529706638|FG000|Overall Study|Adverse Event|24|||
146873073|NCT02187471|529706639|FG001|Overall Study|Adverse Event|34|||
146873074|NCT02187471|529706640|FG002|Overall Study|Adverse Event|44|||
146873075|NCT02187471|529706641|FG003|Overall Study|Adverse Event|36|||
146873076|NCT02187471|529706638|FG000|Overall Study|Withdrawal by Subject|23|||
146873077|NCT02187471|529706639|FG001|Overall Study|Withdrawal by Subject|29|||
146873078|NCT02187471|529706640|FG002|Overall Study|Withdrawal by Subject|22|||
146873079|NCT02187471|529706641|FG003|Overall Study|Withdrawal by Subject|24|||
146873080|NCT02187471|529706638|FG000|Overall Study|Other|7|||
146873081|NCT02187471|529706639|FG001|Overall Study|Other|5|||
146873082|NCT02187471|529706640|FG002|Overall Study|Other|3|||
146873083|NCT02187471|529706641|FG003|Overall Study|Other|4|||
146873084|NCT02236520|529706642|FG000|Overall Study|Physician Decision|0|||
146873085|NCT02236520|529706643|FG001|Overall Study|Physician Decision|5|||
146873086|NCT02236520|529706644|FG002|Overall Study|Physician Decision|0|||
146873087|NCT02236520|529706645|FG003|Overall Study|Physician Decision|0|||
146873088|NCT02236520|529706642|FG000|Overall Study|Withdrawal by Subject|1|||
146873089|NCT02236520|529706643|FG001|Overall Study|Withdrawal by Subject|0|||
146873090|NCT02236520|529706644|FG002|Overall Study|Withdrawal by Subject|0|||
146542405|NCT00770809|528493219|FG000|Overall Study|Progression|2|||
146542406|NCT00770809|528493220|FG001|Overall Study|Progression|2|||
146542407|NCT00770809|528493221|FG002|Overall Study|Progression|0|||
146542408|NCT00770809|528493219|FG000|Overall Study|Complicating illness|0|||
146542409|NCT00770809|528493220|FG001|Overall Study|Complicating illness|0|||
146873091|NCT02236520|529706645|FG003|Overall Study|Withdrawal by Subject|1|||
146873092|NCT02236520|529706642|FG000|Overall Study|Pregnancy|1|||
146873093|NCT02236520|529706643|FG001|Overall Study|Pregnancy|0|||
146542410|NCT00770809|528493221|FG002|Overall Study|Complicating illness|1|||
146873094|NCT02236520|529706644|FG002|Overall Study|Pregnancy|0|||
146873095|NCT02236520|529706645|FG003|Overall Study|Pregnancy|0|||
146873096|NCT01785160|529706646|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
146873097|NCT01785160|529706646|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
146873098|NCT02318667|529706647|FG000|Overall Study|Adverse Event|1|||
146873099|NCT02318667|529706647|FG000|Overall Study|Lack of Efficacy|6|||
146873100|NCT02318667|529706647|FG000|Overall Study|Protocol Violation|2|||
146873101|NCT01033734|529706648|FG000|Overall Study|Withdrawal by Subject|1|||
146873102|NCT02865018|529706657|FG000|Overall Study|Withdrawal by Subject|1|||
146542411|NCT00770809|528493219|FG000|Overall Study|Other Medical Reasons|2|||
146542412|NCT00770809|528493220|FG001|Overall Study|Other Medical Reasons|4|||
146873103|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
146873104|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
146873105|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
146873106|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
146873107|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
146542413|NCT00770809|528493221|FG002|Overall Study|Other Medical Reasons|3|||
146542414|NCT00620542|528493226|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
146542415|NCT00620542|528493227|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
146542416|NCT00620542|528493228|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
146542417|NCT00620542|528493229|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
146542418|NCT00620542|528493226|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
146542419|NCT00620542|528493227|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
146542420|NCT00620542|528493228|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
146542421|NCT00620542|528493229|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
146542422|NCT00620542|528493226|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
146542423|NCT00620542|528493227|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
146542424|NCT00620542|528493228|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
146542425|NCT00620542|528493229|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
146542426|NCT00620542|528493226|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
146542427|NCT00620542|528493227|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
146542428|NCT00620542|528493228|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
146542429|NCT00620542|528493229|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
146542430|NCT00620542|528493226|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
146542431|NCT00620542|528493227|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
146542432|NCT00620542|528493228|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
146542433|NCT00620542|528493229|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
146542434|NCT00620542|528493226|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
146542435|NCT00620542|528493227|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
146542436|NCT00620542|528493228|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
146542437|NCT00620542|528493229|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
146542438|NCT00620542|528493226|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
146542439|NCT00620542|528493227|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
146542440|NCT00620542|528493228|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
146542441|NCT00620542|528493229|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
146542442|NCT00620542|528493226|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
146542443|NCT00620542|528493227|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
146542444|NCT00620542|528493228|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
146542445|NCT00620542|528493229|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
146542446|NCT00620542|528493226|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
146542447|NCT00620542|528493227|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
146542448|NCT00620542|528493228|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
146542449|NCT00620542|528493229|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
146542450|NCT00620542|528493226|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
146542451|NCT00620542|528493227|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
146542452|NCT00620542|528493228|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
146542453|NCT00620542|528493229|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
146542454|NCT00620542|528493226|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
146542455|NCT00620542|528493227|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
146542456|NCT00620542|528493228|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
146542457|NCT00620542|528493229|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
146542458|NCT00620542|528493226|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
146542459|NCT00620542|528493227|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
146628025|NCT00106704|528813548|FG001|Overall Study|Withdrawal by Subject|21|||
146628026|NCT00106704|528813547|FG000|Overall Study|Patient moved|1|||
146628027|NCT00106704|528813548|FG001|Overall Study|Patient moved|0|||
146628028|NCT00106704|528813547|FG000|Overall Study|Site terminated|0|||
146628029|NCT00106704|528813548|FG001|Overall Study|Site terminated|1|||
146628030|NCT00106704|528813547|FG000|Overall Study|Planned major surgery|1|||
146628031|NCT00106704|528813548|FG001|Overall Study|Planned major surgery|0|||
146628032|NCT00106704|528813547|FG000|Overall Study|Patient Received Glycemic Medication|22|||
146628033|NCT00106704|528813548|FG001|Overall Study|Patient Received Glycemic Medication|41|||
146628034|NCT00106704|528813547|FG000|Overall Study|Unable to re-enter US|1|||
146628035|NCT00106704|528813548|FG001|Overall Study|Unable to re-enter US|0|||
146628036|NCT00106704|528813547|FG000|Overall Study|Laboratory test|1|||
146628037|NCT00106704|528813548|FG001|Overall Study|Laboratory test|1|||
146628038|NCT01780506|528813549|FG000|Double-Blind Phase|Randomized but not Treated|3|||
146628039|NCT01780506|528813550|FG001|Double-Blind Phase|Randomized but not Treated|2|||
146628040|NCT01780506|528813549|FG000|Double-Blind Phase|Adverse Event|4|||
146628041|NCT01780506|528813550|FG001|Double-Blind Phase|Adverse Event|14|||
146628042|NCT01780506|528813549|FG000|Double-Blind Phase|Death|1|||
146628043|NCT01780506|528813550|FG001|Double-Blind Phase|Death|2|||
146628044|NCT01780506|528813549|FG000|Double-Blind Phase|Pregnancy|2|||
146628045|NCT01780506|528813550|FG001|Double-Blind Phase|Pregnancy|1|||
146873108|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
146873109|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
146628046|NCT01780506|528813549|FG000|Double-Blind Phase|Lack of Efficacy|1|||
146628047|NCT01780506|528813550|FG001|Double-Blind Phase|Lack of Efficacy|1|||
146628048|NCT01780506|528813549|FG000|Double-Blind Phase|Investigator's Discretion|5|||
146628049|NCT01780506|528813550|FG001|Double-Blind Phase|Investigator's Discretion|2|||
146628050|NCT01780506|528813549|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
146628051|NCT01780506|528813550|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
146628052|NCT01780506|528813549|FG000|Double-Blind Phase|Protocol Violation|4|||
146628053|NCT01780506|528813550|FG001|Double-Blind Phase|Protocol Violation|3|||
146873110|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
146542460|NCT00620542|528493228|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
146542461|NCT00620542|528493229|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
146542462|NCT00620542|528493226|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
146542463|NCT00620542|528493227|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
146542464|NCT00620542|528493228|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
146542465|NCT00620542|528493229|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
146542466|NCT00620542|528493226|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
146542467|NCT00620542|528493227|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
146542468|NCT00620542|528493228|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
146542469|NCT00620542|528493229|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
146542470|NCT00620542|528493226|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
146542471|NCT00620542|528493227|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
146542472|NCT00620542|528493228|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
146542473|NCT00620542|528493229|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
146542474|NCT01970371|528493230|FG000|Overall Study|Death|8|||
146542475|NCT01970371|528493231|FG001|Overall Study|Death|13|||
146542476|NCT01970371|528493232|FG002|Overall Study|Death|12|||
146542477|NCT01970371|528493230|FG000|Overall Study|Lost to Follow-up|0|||
146542478|NCT01970371|528493231|FG001|Overall Study|Lost to Follow-up|0|||
146542479|NCT01970371|528493232|FG002|Overall Study|Lost to Follow-up|1|||
146542480|NCT01481779|528493233|FG000|Overall Study|Adverse Event|23|||
146542481|NCT01481779|528493234|FG001|Overall Study|Adverse Event|5|||
146542482|NCT01481779|528493233|FG000|Overall Study|Lost to Follow-up|3|||
146542483|NCT01481779|528493234|FG001|Overall Study|Lost to Follow-up|2|||
146542484|NCT01481779|528493233|FG000|Overall Study|Protocol Violation|2|||
146542485|NCT01481779|528493234|FG001|Overall Study|Protocol Violation|3|||
146542486|NCT01481779|528493233|FG000|Overall Study|Withdrawal by Subject|26|||
146542487|NCT01481779|528493234|FG001|Overall Study|Withdrawal by Subject|13|||
146873111|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
146873112|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
146873113|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
146873114|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
146873115|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
146873116|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
146873117|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
146873118|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
146873119|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
146873120|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
146873121|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
146873122|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
146873123|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
146873124|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
146873125|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
146873126|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
146873127|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
146542488|NCT01481779|528493233|FG000|Overall Study|Physician Decision|13|||
146542489|NCT01481779|528493234|FG001|Overall Study|Physician Decision|4|||
146542490|NCT01481779|528493233|FG000|Overall Study|Sponsor Decision|3|||
146542491|NCT01481779|528493234|FG001|Overall Study|Sponsor Decision|1|||
146542492|NCT03575364|528493245|FG000|Overall Study|Death|45|||
146542493|NCT03575364|528493245|FG000|Overall Study|Lost to Follow-up|114|||
146542494|NCT03575364|528493245|FG000|Overall Study|Withdrawal by Subject|21|||
146542495|NCT03575364|528493245|FG000|Overall Study|Physician Decision|11|||
146542496|NCT03575364|528493245|FG000|Overall Study|Subject Refused Follow-up|13|||
146542497|NCT03575364|528493245|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
146873128|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
146873129|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
146873130|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
146873131|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
146873132|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
146873133|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
146873134|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
146873135|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
146873136|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
146542498|NCT03575364|528493245|FG000|Overall Study|Patient moved out of the state|1|||
146542499|NCT03575364|528493245|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
146542500|NCT03575364|528493245|FG000|Overall Study|Patient is lost to follow up|1|||
146542501|NCT03575364|528493245|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
146542502|NCT05522751|528493246|FG000|Overall Study|Adverse Event|1|||
146542503|NCT06420232|528493247|FG000|Overall Study|Withdrawal by Subject|3|||
146542504|NCT01582451|528493248|FG000|Overall Study|Adverse Event|1|||
146542505|NCT01582451|528493249|FG001|Overall Study|Adverse Event|3|||
146542506|NCT01582451|528493248|FG000|Overall Study|Death|3|||
146542507|NCT01582451|528493249|FG001|Overall Study|Death|3|||
146542508|NCT01582451|528493248|FG000|Overall Study|Lost to Follow-up|0|||
146542509|NCT01582451|528493249|FG001|Overall Study|Lost to Follow-up|2|||
146542510|NCT01582451|528493248|FG000|Overall Study|Protocol Violation|11|||
146542511|NCT01582451|528493249|FG001|Overall Study|Protocol Violation|3|||
146542512|NCT01582451|528493248|FG000|Overall Study|Withdrawal by Subject|13|||
146542513|NCT01582451|528493249|FG001|Overall Study|Withdrawal by Subject|9|||
146542514|NCT01582451|528493248|FG000|Overall Study|Physician Decision|3|||
146542515|NCT01582451|528493249|FG001|Overall Study|Physician Decision|0|||
146542516|NCT01582451|528493248|FG000|Overall Study|Sponsor Decision|1|||
146542517|NCT01582451|528493249|FG001|Overall Study|Sponsor Decision|0|||
146542518|NCT01369433|528493250|FG000|Overall Study|Adverse Event|31|||
146542519|NCT01369433|528493251|FG001|Overall Study|Adverse Event|1|||
146542520|NCT01369433|528493250|FG000|Overall Study|Required significant surgical procedure|1|||
146542521|NCT01369433|528493251|FG001|Overall Study|Required significant surgical procedure|0|||
146542522|NCT01369433|528493250|FG000|Overall Study|Non-compliance|1|||
146542523|NCT01369433|528493251|FG001|Overall Study|Non-compliance|0|||
146542524|NCT01369433|528493250|FG000|Overall Study|Withdrawal by Subject|5|||
146542525|NCT01369433|528493251|FG001|Overall Study|Withdrawal by Subject|2|||
146542526|NCT01369433|528493250|FG000|Overall Study|Study terminated by Sponsor|67|||
146542527|NCT01369433|528493251|FG001|Overall Study|Study terminated by Sponsor|0|||
146542528|NCT01369433|528493250|FG000|Overall Study|Lost to Follow-up|1|||
146542529|NCT01369433|528493251|FG001|Overall Study|Lost to Follow-up|0|||
146542530|NCT01369433|528493250|FG000|Overall Study|Death|5|||
146542531|NCT01369433|528493251|FG001|Overall Study|Death|0|||
146542532|NCT01369433|528493250|FG000|Overall Study|Investigator discretion|6|||
146542533|NCT01369433|528493251|FG001|Overall Study|Investigator discretion|1|||
146542534|NCT01369433|528493250|FG000|Overall Study|Progressive Disease|92|||
146542535|NCT01369433|528493251|FG001|Overall Study|Progressive Disease|12|||
146542536|NCT00689936|528493252|FG000|Active Treatment Phase|Adverse Event|68|||
146873137|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
146873138|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
146873139|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
146873140|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
146542537|NCT00689936|528493253|FG001|Active Treatment Phase|Adverse Event|71|||
146542538|NCT00689936|528493254|FG002|Active Treatment Phase|Adverse Event|76|||
146542539|NCT00689936|528493252|FG000|Active Treatment Phase|Disease Progression|273|||
146542540|NCT00689936|528493253|FG001|Active Treatment Phase|Disease Progression|362|||
146542541|NCT00689936|528493254|FG002|Active Treatment Phase|Disease Progression|339|||
146873141|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
146568784|NCT01063348|528595453|FG000|Overall Study|Lost to Follow-up|3|||
146568785|NCT01063348|528595454|FG001|Overall Study|Lost to Follow-up|10|||
146542542|NCT00689936|528493252|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
146542543|NCT00689936|528493253|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
146542544|NCT00689936|528493254|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
146542545|NCT00689936|528493252|FG000|Active Treatment Phase|Death|60|||
146542546|NCT00689936|528493253|FG001|Active Treatment Phase|Death|28|||
146542547|NCT00689936|528493254|FG002|Active Treatment Phase|Death|37|||
146542548|NCT00689936|528493252|FG000|Active Treatment Phase|Lost to Follow-up|0|||
146542549|NCT00689936|528493253|FG001|Active Treatment Phase|Lost to Follow-up|2|||
146542550|NCT00689936|528493254|FG002|Active Treatment Phase|Lost to Follow-up|2|||
146542551|NCT00689936|528493252|FG000|Active Treatment Phase|Protocol Violation|2|||
146542552|NCT00689936|528493253|FG001|Active Treatment Phase|Protocol Violation|2|||
146542553|NCT00689936|528493254|FG002|Active Treatment Phase|Protocol Violation|4|||
146873142|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
146873143|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
146542554|NCT00689936|528493252|FG000|Active Treatment Phase|Study Close Out|64|||
146542555|NCT00689936|528493253|FG001|Active Treatment Phase|Study Close Out|26|||
146542556|NCT00689936|528493254|FG002|Active Treatment Phase|Study Close Out|21|||
146542557|NCT00689936|528493252|FG000|Active Treatment Phase|Miscellaneous|52|||
146542558|NCT00689936|528493253|FG001|Active Treatment Phase|Miscellaneous|34|||
146542559|NCT00689936|528493254|FG002|Active Treatment Phase|Miscellaneous|47|||
146542560|NCT00689936|528493252|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
146542561|NCT00689936|528493253|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
146542562|NCT00689936|528493254|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
146542563|NCT05696847|528493257|FG000|Overall Study|Withdrawal by Subject|1|||
146542564|NCT05696847|528493258|FG001|Overall Study|Withdrawal by Subject|0|||
146542565|NCT05696847|528493259|FG002|Overall Study|Withdrawal by Subject|0|||
146542566|NCT05696847|528493260|FG003|Overall Study|Withdrawal by Subject|0|||
146542567|NCT05696847|528493261|FG004|Overall Study|Withdrawal by Subject|0|||
146542568|NCT05696847|528493262|FG005|Overall Study|Withdrawal by Subject|0|||
146542569|NCT05696847|528493257|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146542570|NCT05696847|528493258|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146542571|NCT05696847|528493259|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146542572|NCT05696847|528493260|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146542573|NCT05696847|528493261|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
146542574|NCT05696847|528493262|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
146542575|NCT05696847|528493257|FG000|Overall Study|Adverse Event|0|||
146542576|NCT05696847|528493258|FG001|Overall Study|Adverse Event|0|||
146542577|NCT05696847|528493259|FG002|Overall Study|Adverse Event|0|||
146542578|NCT05696847|528493260|FG003|Overall Study|Adverse Event|0|||
146542579|NCT05696847|528493261|FG004|Overall Study|Adverse Event|0|||
146542580|NCT05696847|528493262|FG005|Overall Study|Adverse Event|1|||
146542581|NCT05696847|528493257|FG000|Overall Study|Sponsor Decision|0|||
146542582|NCT05696847|528493258|FG001|Overall Study|Sponsor Decision|0|||
146542583|NCT05696847|528493259|FG002|Overall Study|Sponsor Decision|0|||
146542584|NCT05696847|528493260|FG003|Overall Study|Sponsor Decision|1|||
146542585|NCT05696847|528493261|FG004|Overall Study|Sponsor Decision|0|||
146542586|NCT05696847|528493262|FG005|Overall Study|Sponsor Decision|0|||
146542587|NCT06001866|528493263|FG000|Overall Study|Withdrawal by Subject|0|||
146542588|NCT06001866|528493264|FG001|Overall Study|Withdrawal by Subject|2|||
146542589|NCT06001866|528493263|FG000|Overall Study|Protocol Violation|0|||
146542590|NCT06001866|528493264|FG001|Overall Study|Protocol Violation|2|||
146542591|NCT03112603|528493267|FG000|End of Randomization Period|Lost to Follow-up|3|||
146542592|NCT03112603|528493268|FG001|End of Randomization Period|Lost to Follow-up|0|||
146542593|NCT03112603|528493269|FG002|End of Randomization Period|Lost to Follow-up|0|||
146542594|NCT03112603|528493267|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
146542595|NCT03112603|528493268|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
146542596|NCT03112603|528493269|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
146542597|NCT03112603|528493267|FG000|End of Randomization Period|Physician Decision|43|||
146542598|NCT03112603|528493268|FG001|End of Randomization Period|Physician Decision|18|||
146542599|NCT03112603|528493269|FG002|End of Randomization Period|Physician Decision|0|||
146542600|NCT03112603|528493267|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
146542601|NCT03112603|528493268|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
146542602|NCT03112603|528493269|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
146542603|NCT03112603|528493267|FG000|End of Randomization Period|Death|10|||
146542604|NCT03112603|528493268|FG001|End of Randomization Period|Death|7|||
146542605|NCT03112603|528493269|FG002|End of Randomization Period|Death|0|||
146542606|NCT03112603|528493267|FG000|End of Randomization Period|Disease Relapse|12|||
146542607|NCT03112603|528493268|FG001|End of Randomization Period|Disease Relapse|7|||
146542608|NCT03112603|528493269|FG002|End of Randomization Period|Disease Relapse|0|||
146542609|NCT03112603|528493267|FG000|End of Randomization Period|Lack of Efficacy|25|||
146542610|NCT03112603|528493268|FG001|End of Randomization Period|Lack of Efficacy|77|||
146542611|NCT03112603|528493269|FG002|End of Randomization Period|Lack of Efficacy|0|||
146542612|NCT03112603|528493267|FG000|End of Randomization Period|Adverse Event|32|||
146542613|NCT03112603|528493268|FG001|End of Randomization Period|Adverse Event|12|||
146542614|NCT03112603|528493269|FG002|End of Randomization Period|Adverse Event|0|||
146542615|NCT03112603|528493267|FG000|End of Cross Over Period|Death|0|||
146542616|NCT03112603|528493268|FG001|End of Cross Over Period|Death|0|||
146542617|NCT03112603|528493269|FG002|End of Cross Over Period|Death|2|||
146542618|NCT03112603|528493267|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
146542619|NCT03112603|528493268|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
146542620|NCT03112603|528493269|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
146542621|NCT03112603|528493267|FG000|End of Cross Over Period|Physician Decision|0|||
146542622|NCT03112603|528493268|FG001|End of Cross Over Period|Physician Decision|0|||
146542623|NCT03112603|528493269|FG002|End of Cross Over Period|Physician Decision|29|||
146542624|NCT03112603|528493267|FG000|End of Cross Over Period|Lack of Efficacy|0|||
146542625|NCT03112603|528493268|FG001|End of Cross Over Period|Lack of Efficacy|0|||
146542626|NCT03112603|528493269|FG002|End of Cross Over Period|Lack of Efficacy|8|||
146542627|NCT03112603|528493267|FG000|End of Cross Over Period|Adverse Event|0|||
146542628|NCT03112603|528493268|FG001|End of Cross Over Period|Adverse Event|0|||
146542629|NCT03112603|528493269|FG002|End of Cross Over Period|Adverse Event|6|||
146542630|NCT03112603|528493267|FG000|End of Cross Over Period|Disease Relapse|0|||
146542631|NCT03112603|528493268|FG001|End of Cross Over Period|Disease Relapse|0|||
146542632|NCT03112603|528493269|FG002|End of Cross Over Period|Disease Relapse|2|||
146542633|NCT00207740|528493270|FG000|Overall Study|Adverse Event|4|||
146542634|NCT00207740|528493271|FG001|Overall Study|Adverse Event|14|||
146542635|NCT00207740|528493272|FG002|Overall Study|Adverse Event|14|||
146542636|NCT00207740|528493273|FG003|Overall Study|Adverse Event|11|||
146542637|NCT00207740|528493270|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146542638|NCT00207740|528493271|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146542639|NCT00207740|528493272|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
146542640|NCT00207740|528493273|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
146542641|NCT00207740|528493270|FG000|Overall Study|Lost to Follow-up|0|||
146542642|NCT00207740|528493271|FG001|Overall Study|Lost to Follow-up|2|||
146542643|NCT00207740|528493272|FG002|Overall Study|Lost to Follow-up|1|||
146542644|NCT00207740|528493273|FG003|Overall Study|Lost to Follow-up|1|||
146542645|NCT00207740|528493270|FG000|Overall Study|Death|0|||
146542646|NCT00207740|528493271|FG001|Overall Study|Death|0|||
146542647|NCT00207740|528493272|FG002|Overall Study|Death|0|||
146542648|NCT00207740|528493273|FG003|Overall Study|Death|1|||
146542649|NCT00207740|528493270|FG000|Overall Study|Sponsor Directive|22|||
146542650|NCT00207740|528493271|FG001|Overall Study|Sponsor Directive|15|||
146542651|NCT00207740|528493272|FG002|Overall Study|Sponsor Directive|16|||
146542652|NCT00207740|528493273|FG003|Overall Study|Sponsor Directive|21|||
146542653|NCT00207740|528493270|FG000|Overall Study|Other|2|||
146542654|NCT00207740|528493271|FG001|Overall Study|Other|10|||
146542655|NCT00207740|528493272|FG002|Overall Study|Other|7|||
146542656|NCT00207740|528493273|FG003|Overall Study|Other|5|||
146542657|NCT03916926|528493274|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
146542658|NCT03916926|528493275|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
146542659|NCT03916926|528493274|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
146542660|NCT03916926|528493275|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
146542661|NCT03916926|528493274|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
146542662|NCT03916926|528493275|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
146542663|NCT03916926|528493274|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
146542664|NCT03916926|528493275|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
146542665|NCT04725188|528493276|FG000|Overall Study|Death|72|||
146542666|NCT04725188|528493277|FG001|Overall Study|Death|69|||
146542667|NCT04725188|528493278|FG002|Overall Study|Death|76|||
146542668|NCT04725188|528493276|FG000|Overall Study|Lost to Follow-up|1|||
146542669|NCT04725188|528493277|FG001|Overall Study|Lost to Follow-up|0|||
146542670|NCT04725188|528493278|FG002|Overall Study|Lost to Follow-up|1|||
146542671|NCT04725188|528493276|FG000|Overall Study|Withdrawal by Subject|2|||
146542672|NCT04725188|528493277|FG001|Overall Study|Withdrawal by Subject|2|||
146542673|NCT04725188|528493278|FG002|Overall Study|Withdrawal by Subject|1|||
146542674|NCT04725188|528493276|FG000|Overall Study|Sponsor Decision|12|||
146542675|NCT04725188|528493277|FG001|Overall Study|Sponsor Decision|12|||
146542676|NCT04725188|528493278|FG002|Overall Study|Sponsor Decision|7|||
146542677|NCT03330197|528493279|FG000|Overall Study|Adverse Event|0|||
146542678|NCT03330197|528493280|FG001|Overall Study|Adverse Event|1|||
146542679|NCT03330197|528493279|FG000|Overall Study|Withdrawal by Subject|0|||
146542680|NCT03330197|528493280|FG001|Overall Study|Withdrawal by Subject|1|||
146542681|NCT01771107|528493294|FG000|Overall Study|Adverse Event|1|||
146542682|NCT01771107|528493295|FG001|Overall Study|Adverse Event|3|||
146542683|NCT01771107|528493294|FG000|Overall Study|Withdrawal by Subject|0|||
146542684|NCT01771107|528493295|FG001|Overall Study|Withdrawal by Subject|2|||
146542685|NCT01771107|528493294|FG000|Overall Study|Lost to Follow-up|0|||
146542686|NCT01771107|528493295|FG001|Overall Study|Lost to Follow-up|1|||
146542687|NCT01771107|528493294|FG000|Overall Study|participant moved|0|||
146542688|NCT01771107|528493295|FG001|Overall Study|participant moved|1|||
146542689|NCT01771107|528493294|FG000|Overall Study|Other|0|||
146542690|NCT01771107|528493295|FG001|Overall Study|Other|1|||
146542691|NCT02296125|528493300|FG000|Overall Study|Withdrawal by Subject|18|||
146542692|NCT02296125|528493301|FG001|Overall Study|Withdrawal by Subject|8|||
146542693|NCT02296125|528493302|FG002|Overall Study|Withdrawal by Subject|6|||
146542694|NCT02296125|528493303|FG003|Overall Study|Withdrawal by Subject|2|||
146542695|NCT02296125|528493300|FG000|Overall Study|Adverse Event|41|||
146542696|NCT02296125|528493301|FG001|Overall Study|Adverse Event|52|||
146542697|NCT02296125|528493302|FG002|Overall Study|Adverse Event|9|||
146628054|NCT01780506|528813549|FG000|Double-Blind Phase|Withdrew Consent|23|||
146542698|NCT02296125|528493303|FG003|Overall Study|Adverse Event|4|||
146542699|NCT02296125|528493300|FG000|Overall Study|Severe non-compliance to protocol|0|||
146542700|NCT02296125|528493301|FG001|Overall Study|Severe non-compliance to protocol|1|||
146542701|NCT02296125|528493302|FG002|Overall Study|Severe non-compliance to protocol|0|||
146542702|NCT02296125|528493303|FG003|Overall Study|Severe non-compliance to protocol|0|||
146542703|NCT02296125|528493300|FG000|Overall Study|Condition under investigation worsened|153|||
146542704|NCT02296125|528493301|FG001|Overall Study|Condition under investigation worsened|199|||
146542705|NCT02296125|528493302|FG002|Overall Study|Condition under investigation worsened|39|||
146542706|NCT02296125|528493303|FG003|Overall Study|Condition under investigation worsened|56|||
146542707|NCT02296125|528493300|FG000|Overall Study|Any reason not specifically recorded|6|||
146542708|NCT02296125|528493301|FG001|Overall Study|Any reason not specifically recorded|4|||
146542709|NCT02296125|528493302|FG002|Overall Study|Any reason not specifically recorded|2|||
146542710|NCT02296125|528493303|FG003|Overall Study|Any reason not specifically recorded|0|||
146542711|NCT05248386|528493304|FG000|Overall Study|Technical problems|0|||
146542712|NCT05248386|528493305|FG001|Overall Study|Technical problems|1|||
146542713|NCT05248386|528493304|FG000|Overall Study|Withdrawal by Subject|15|||
146542714|NCT05248386|528493305|FG001|Overall Study|Withdrawal by Subject|10|||
146542715|NCT05248386|528493304|FG000|Overall Study|Physician Decision|0|||
146542716|NCT05248386|528493305|FG001|Overall Study|Physician Decision|1|||
146542717|NCT05248386|528493304|FG000|Overall Study|Adverse Event|2|||
146542718|NCT05248386|528493305|FG001|Overall Study|Adverse Event|4|||
146542719|NCT05248386|528493304|FG000|Overall Study|Other|1|||
146542720|NCT05248386|528493305|FG001|Overall Study|Other|0|||
146542721|NCT05248386|528493304|FG000|Overall Study|Lack of Efficacy|14|||
146542722|NCT05248386|528493305|FG001|Overall Study|Lack of Efficacy|12|||
146542723|NCT02864992|528493306|FG000|Overall Study|still on treatment|15|||
146542724|NCT02864992|528493307|FG001|Overall Study|still on treatment|1|||
146542725|NCT02864992|528493308|FG002|Overall Study|still on treatment|33|||
146542726|NCT03621592|528493309|FG000|Overall Study|Lost to Follow-up|1|||
146542727|NCT03621592|528493310|FG001|Overall Study|Lost to Follow-up|0|||
146542728|NCT03621592|528493309|FG000|Overall Study|Lack of Improvement|1|||
146542729|NCT03621592|528493310|FG001|Overall Study|Lack of Improvement|0|||
146542730|NCT03621592|528493309|FG000|Overall Study|Preference to receive wound care closer to home|1|||
146542731|NCT03621592|528493310|FG001|Overall Study|Preference to receive wound care closer to home|0|||
146542732|NCT03621592|528493309|FG000|Overall Study|Lack of healing|0|||
146542733|NCT03621592|528493310|FG001|Overall Study|Lack of healing|2|||
146542734|NCT04967222|528493312|FG000|Randomized|Lost to Follow-up|0|||
146542735|NCT04967222|528493313|FG001|Randomized|Lost to Follow-up|1|||
146542736|NCT04967222|528493314|FG002|Randomized|Lost to Follow-up|1|||
146542737|NCT04967222|528493312|FG000|Randomized|Physician Decision|0|||
146542738|NCT04967222|528493313|FG001|Randomized|Physician Decision|0|||
146542739|NCT04967222|528493314|FG002|Randomized|Physician Decision|1|||
146542740|NCT04967222|528493312|FG000|Randomized|Withdrawal by Subject|0|||
146542741|NCT04967222|528493313|FG001|Randomized|Withdrawal by Subject|0|||
146542742|NCT04967222|528493314|FG002|Randomized|Withdrawal by Subject|2|||
146542743|NCT04967222|528493312|FG000|Randomized|abnormal finding in MRI|0|||
146542744|NCT04967222|528493313|FG001|Randomized|abnormal finding in MRI|2|||
146764354|NCT02614560|529304363|FG001|Overall Study|Death|2|||
146764355|NCT00703911|529304364|FG000|Overall Study|Death|1|||
146764356|NCT00703911|529304364|FG000|Overall Study|Physician Decision|6|||
146764357|NCT00703911|529304364|FG000|Overall Study|Lost to Follow-up|1|||
146764358|NCT00703911|529304364|FG000|Overall Study|Withdrawal by Subject|2|||
146764359|NCT02082158|529304365|FG000|Overall Study|Withdrawal by Subject|0|||
146764360|NCT02082158|529304366|FG001|Overall Study|Withdrawal by Subject|0|||
146764361|NCT02082158|529304367|FG002|Overall Study|Withdrawal by Subject|0|||
146764362|NCT02082158|529304368|FG003|Overall Study|Withdrawal by Subject|0|||
146764363|NCT02082158|529304369|FG004|Overall Study|Withdrawal by Subject|1|||
146764364|NCT02082158|529304370|FG005|Overall Study|Withdrawal by Subject|0|||
146764365|NCT02082158|529304365|FG000|Overall Study|Failed Fit-testing|8|||
146764366|NCT02082158|529304366|FG001|Overall Study|Failed Fit-testing|8|||
146873144|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
146873145|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
146873146|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
146873147|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
146873148|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
146873149|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
146873150|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
146873151|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
146873152|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
146873153|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
146873154|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
146873155|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
146873156|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
146873157|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
146873158|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
146873159|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
146873160|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
146873161|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
146873162|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
146873163|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
146873164|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
146873165|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
146873166|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
146873167|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
146873168|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
146873169|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
146873170|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
146873171|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
146873172|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
146873173|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
146873174|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
146873175|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
146873176|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
146873177|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
146873178|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
146873179|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
146873180|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
146873181|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
146873182|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
146873183|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
146873184|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
146873185|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
146873186|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
146873187|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
146873188|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
146873189|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
146873190|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
146873191|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
146764367|NCT02082158|529304367|FG002|Overall Study|Failed Fit-testing|14|||
146764368|NCT02082158|529304368|FG003|Overall Study|Failed Fit-testing|4|||
146764369|NCT02082158|529304369|FG004|Overall Study|Failed Fit-testing|3|||
146873192|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
146873193|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
146873194|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
146873195|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
146542745|NCT04967222|528493314|FG002|Randomized|abnormal finding in MRI|0|||
146542746|NCT03785366|528493322|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
146542747|NCT03785366|528493323|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
146542748|NCT03785366|528493322|FG000|Overall Study|Lost to Follow-up|1|||
146542749|NCT03785366|528493323|FG001|Overall Study|Lost to Follow-up|0|||
146542750|NCT03785366|528493322|FG000|Overall Study|Partial IUD Expulsion|0|||
146542751|NCT03785366|528493323|FG001|Overall Study|Partial IUD Expulsion|2|||
146542752|NCT03785366|528493322|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
146542753|NCT03785366|528493323|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
146542754|NCT03240874|528493324|FG000|Overall Study|Lost to Follow-up|0|||
146542755|NCT03240874|528493325|FG001|Overall Study|Lost to Follow-up|2|||
146542756|NCT03240874|528493326|FG002|Overall Study|Lost to Follow-up|4|||
146542757|NCT03240874|528493327|FG003|Overall Study|Lost to Follow-up|1|||
146542758|NCT05252702|528493328|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
146542759|NCT05252702|528493328|FG000|Overall Study|Death|16|||
146542760|NCT05252702|528493328|FG000|Overall Study|System explant|5|||
146542761|NCT05252702|528493328|FG000|Overall Study|Lost to Follow-up|1|||
146542762|NCT05252702|528493328|FG000|Overall Study|Withdrawn by investigator|1|||
146542763|NCT05252702|528493328|FG000|Overall Study|Visit not due|306|||
146542764|NCT05252702|528493328|FG000|Overall Study|Visit within window but not completed|92|||
146542765|NCT05252702|528493328|FG000|Overall Study|Unsuccessful implant|1|||
146542766|NCT04153864|528493329|FG000|Overall Study|Withdrawal by Subject|21|||
146542767|NCT04153864|528493330|FG001|Overall Study|Withdrawal by Subject|7|||
146542768|NCT04153864|528493331|FG002|Overall Study|Withdrawal by Subject|23|||
146542769|NCT04153864|528493332|FG003|Overall Study|Withdrawal by Subject|2|||
146542770|NCT04153864|528493329|FG000|Overall Study|Lost to Follow-up|4|||
146542771|NCT04153864|528493330|FG001|Overall Study|Lost to Follow-up|0|||
146542772|NCT04153864|528493331|FG002|Overall Study|Lost to Follow-up|3|||
146542773|NCT04153864|528493332|FG003|Overall Study|Lost to Follow-up|0|||
146542774|NCT04153864|528493329|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
146542775|NCT04153864|528493330|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
146542776|NCT04153864|528493331|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
146542777|NCT04153864|528493332|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
146542778|NCT03036254|528493334|FG000|Overall Study|Adverse Event|6|||
146542779|NCT03036254|528493335|FG001|Overall Study|Adverse Event|4|||
146542780|NCT03036254|528493334|FG000|Overall Study|Death|3|||
146542781|NCT03036254|528493335|FG001|Overall Study|Death|1|||
146542782|NCT03036254|528493334|FG000|Overall Study|Lack of Efficacy|5|||
146542783|NCT03036254|528493335|FG001|Overall Study|Lack of Efficacy|1|||
146542784|NCT03036254|528493334|FG000|Overall Study|Withdrawal by Subject|3|||
146542785|NCT03036254|528493335|FG001|Overall Study|Withdrawal by Subject|5|||
146542786|NCT06354257|528493337|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146542787|NCT06354257|528493337|FG000|Treatment Period 2|Adverse Event|1|||
146542788|NCT02685735|528493338|FG000|Overall Study|Surgery Cancelled|4|||
146542789|NCT02685735|528493339|FG001|Overall Study|Surgery Cancelled|9|||
146542790|NCT02685735|528493338|FG000|Overall Study|Adverse Event|10|||
146542791|NCT02685735|528493339|FG001|Overall Study|Adverse Event|3|||
146542792|NCT02685735|528493338|FG000|Overall Study|Preop testing found to be incomplete|2|||
146542793|NCT02685735|528493339|FG001|Overall Study|Preop testing found to be incomplete|2|||
146542794|NCT02685735|528493338|FG000|Overall Study|Withdrawal by Subject|1|||
146542795|NCT02685735|528493339|FG001|Overall Study|Withdrawal by Subject|2|||
146542796|NCT02685735|528493338|FG000|Overall Study|Death|1|||
146542797|NCT02685735|528493339|FG001|Overall Study|Death|0|||
146542798|NCT04132050|528493340|FG000|Period I (Double-blind Period)|Adverse Event|3|||
146542799|NCT04132050|528493341|FG001|Period I (Double-blind Period)|Adverse Event|0|||
146542800|NCT04132050|528493340|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
146542801|NCT04132050|528493341|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
146542802|NCT04132050|528493340|FG000|R788 Treatment Period|Adverse Event|5|||
146542803|NCT04132050|528493341|FG001|R788 Treatment Period|Adverse Event|0|||
146542804|NCT04132050|528493340|FG000|R788 Treatment Period|Lack of Efficacy|5|||
146542805|NCT04132050|528493341|FG001|R788 Treatment Period|Lack of Efficacy|0|||
146628055|NCT01780506|528813550|FG001|Double-Blind Phase|Withdrew Consent|24|||
146628056|NCT01780506|528813549|FG000|Double-Blind Phase|Lost to Follow-up|23|||
146628057|NCT01780506|528813550|FG001|Double-Blind Phase|Lost to Follow-up|26|||
146628058|NCT01780506|528813549|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
146568786|NCT00269087|528595455|FG000|Overall Study|Adverse Event|20|||
146568787|NCT00269087|528595455|FG000|Overall Study|Withdrawal by Subject|1|||
146568788|NCT00269087|528595455|FG000|Overall Study|Exacerbation of COPD|13|||
146568789|NCT04828707|528595458|FG000|Overall Study|Lost to Follow-up|3|||
146568790|NCT04828707|528595459|FG001|Overall Study|Lost to Follow-up|2|||
146568791|NCT04828707|528595458|FG000|Overall Study|Withdrawal by Subject|2|||
146568792|NCT04828707|528595459|FG001|Overall Study|Withdrawal by Subject|1|||
146568793|NCT01188967|528595460|FG000|Overall Study|Withdrawal by Subject|1|||
146568794|NCT01188967|528595461|FG001|Overall Study|Withdrawal by Subject|1|||
146568795|NCT01188967|528595460|FG000|Overall Study|Physician Decision|1|||
146568796|NCT01188967|528595461|FG001|Overall Study|Physician Decision|1|||
146568797|NCT01188967|528595460|FG000|Overall Study|Lost to Follow-up|3|||
146568798|NCT01188967|528595461|FG001|Overall Study|Lost to Follow-up|2|||
146568799|NCT00523978|528595464|FG000|Overall Study|Withdrawal by Subject|3|||
146568800|NCT00523978|528595465|FG001|Overall Study|Withdrawal by Subject|7|||
146568801|NCT00523978|528595464|FG000|Overall Study|Screen Failures|5|||
146568802|NCT00523978|528595465|FG001|Overall Study|Screen Failures|1|||
146568803|NCT00523978|528595464|FG000|Overall Study|Death|1|||
146568804|NCT00523978|528595465|FG001|Overall Study|Death|0|||
146568805|NCT02394561|528595468|FG000|CORE Phase|Adverse Event|7|||
146568806|NCT02394561|528595469|FG001|CORE Phase|Adverse Event|9|||
146568807|NCT02394561|528595468|FG000|CORE Phase|Death|0|||
146568808|NCT02394561|528595469|FG001|CORE Phase|Death|1|||
146568809|NCT02394561|528595468|FG000|CORE Phase|Pregnancy|1|||
146568810|NCT02394561|528595469|FG001|CORE Phase|Pregnancy|0|||
146568811|NCT02394561|528595468|FG000|CORE Phase|Lost to Follow-up|1|||
146568812|NCT02394561|528595469|FG001|CORE Phase|Lost to Follow-up|0|||
146568813|NCT02394561|528595468|FG000|CORE Phase|Physician Decision|1|||
146568814|NCT02394561|528595469|FG001|CORE Phase|Physician Decision|1|||
146568815|NCT02394561|528595468|FG000|CORE Phase|Withdrawal by Subject|2|||
146568816|NCT02394561|528595469|FG001|CORE Phase|Withdrawal by Subject|2|||
146568817|NCT02394561|528595468|FG000|CORE Phase|Lack of Efficacy|1|||
146568818|NCT02394561|528595469|FG001|CORE Phase|Lack of Efficacy|6|||
146568819|NCT02394561|528595468|FG000|Extension Phase|Adverse Event|6|||
146568820|NCT02394561|528595469|FG001|Extension Phase|Adverse Event|1|||
146568821|NCT02394561|528595468|FG000|Extension Phase|Death|0|||
146568822|NCT02394561|528595469|FG001|Extension Phase|Death|1|||
146568823|NCT02394561|528595468|FG000|Extension Phase|Protocol Violation|1|||
146568824|NCT02394561|528595469|FG001|Extension Phase|Protocol Violation|0|||
146568825|NCT02394561|528595468|FG000|Extension Phase|Lost to Follow-up|1|||
146568826|NCT02394561|528595469|FG001|Extension Phase|Lost to Follow-up|0|||
146568827|NCT02394561|528595468|FG000|Extension Phase|Physician Decision|0|||
146568828|NCT02394561|528595469|FG001|Extension Phase|Physician Decision|2|||
146568829|NCT02394561|528595468|FG000|Extension Phase|Withdrawal by Subject|0|||
146568830|NCT02394561|528595469|FG001|Extension Phase|Withdrawal by Subject|5|||
146568831|NCT02394561|528595468|FG000|Extension Phase|Lack of Efficacy|3|||
146568832|NCT02394561|528595469|FG001|Extension Phase|Lack of Efficacy|3|||
146568833|NCT00501644|528595470|FG000|Overall Study|Adverse Event|4|||
146568834|NCT00501644|528595470|FG000|Overall Study|Withdrawal by Subject|1|||
146568835|NCT02553629|528595471|FG000|Overall Study|Logistic reasons|3|||
146568836|NCT02553629|528595472|FG001|Overall Study|Logistic reasons|6|||
146568837|NCT04577781|528595473|FG000|Overall Study|Adverse Event|2|||
146568838|NCT04577781|528595474|FG001|Overall Study|Adverse Event|2|||
146568839|NCT04577781|528595473|FG000|Overall Study|Physician Decision|1|||
146568840|NCT04577781|528595474|FG001|Overall Study|Physician Decision|0|||
146568841|NCT04103450|528595478|FG000|Overall Study|Adverse Event|4|||
146568842|NCT04103450|528595479|FG001|Overall Study|Adverse Event|2|||
146568843|NCT04103450|528595478|FG000|Overall Study|Lack of Efficacy|3|||
146568844|NCT04103450|528595479|FG001|Overall Study|Lack of Efficacy|0|||
146568845|NCT04103450|528595478|FG000|Overall Study|Withdrawal by Subject|5|||
146568846|NCT04103450|528595479|FG001|Overall Study|Withdrawal by Subject|3|||
146568847|NCT04103450|528595478|FG000|Overall Study|Lost to Follow-up|1|||
146568848|NCT04103450|528595479|FG001|Overall Study|Lost to Follow-up|2|||
146568849|NCT04103450|528595478|FG000|Overall Study|Physician Decision|1|||
146568850|NCT04103450|528595479|FG001|Overall Study|Physician Decision|2|||
146568851|NCT04103450|528595478|FG000|Overall Study|Protocol Violation|1|||
146568852|NCT04103450|528595479|FG001|Overall Study|Protocol Violation|0|||
146568853|NCT04103450|528595478|FG000|Overall Study|Other|1|||
146568854|NCT04103450|528595479|FG001|Overall Study|Other|1|||
146568855|NCT02259114|528595484|FG000|Overall Study|Progressive Disease|14|||
146568856|NCT02259114|528595485|FG001|Overall Study|Progressive Disease|2|||
146568857|NCT02259114|528595486|FG002|Overall Study|Progressive Disease|10|||
146568858|NCT02259114|528595487|FG003|Overall Study|Progressive Disease|2|||
146568859|NCT02259114|528595488|FG004|Overall Study|Progressive Disease|5|||
146873196|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
146542806|NCT04132050|528493340|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
146542807|NCT04132050|528493341|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
146542808|NCT01063114|528493342|FG000|Overall Study|Lost to Follow-up|1|||
146873197|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
146873198|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
146873199|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
146873200|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
146873201|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
146873202|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
146542809|NCT04635423|528493343|FG000|Overall Study|Ongoing|493|||
146542810|NCT04635423|528493344|FG001|Overall Study|Ongoing|501|||
146542811|NCT04635423|528493343|FG000|Overall Study|Withdrawal by Subject|36|||
146542812|NCT04635423|528493344|FG001|Overall Study|Withdrawal by Subject|29|||
146542813|NCT00832975|528493361|FG000|Overall Study|Lost to Follow-up|7|||
146542814|NCT00832975|528493361|FG000|Overall Study|Protocol Violation|6|||
146542815|NCT00832975|528493361|FG000|Overall Study|Death|5|||
146542816|NCT00832975|528493361|FG000|Overall Study|Physician Decision|4|||
146542817|NCT00832975|528493361|FG000|Overall Study|Withdrawal by Subject|3|||
146542818|NCT00832975|528493361|FG000|Overall Study|Other reasons|14|||
146542819|NCT04603066|528493366|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
146542820|NCT04603066|528493367|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
146542821|NCT05759338|528493368|FG000|Overall Study|Withdrawal by Subject|3|||
146542822|NCT04835441|528493370|FG000|Overall Study|Physician Decision|4|||
146542823|NCT04835441|528493371|FG001|Overall Study|Physician Decision|4|||
146542824|NCT04835441|528493370|FG000|Overall Study|Other|1|||
146542825|NCT04835441|528493371|FG001|Overall Study|Other|1|||
146542826|NCT04835441|528493370|FG000|Overall Study|Lost to Follow-up|0|||
146542827|NCT04835441|528493371|FG001|Overall Study|Lost to Follow-up|1|||
146542828|NCT02293499|528494395|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
146542829|NCT02293499|528494396|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
146542830|NCT02293499|528494397|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
146542831|NCT02293499|528494395|FG000|Intervention - Camp|Withdrawal by Subject|3|||
146542832|NCT02293499|528494396|FG001|Intervention - Camp|Withdrawal by Subject|6|||
146542833|NCT02293499|528494397|FG002|Intervention - Camp|Withdrawal by Subject|2|||
146542834|NCT02293499|528494395|FG000|Intervention - Camp|these are those not showing up at camp|24|||
146542835|NCT02293499|528494396|FG001|Intervention - Camp|these are those not showing up at camp|28|||
146542836|NCT02293499|528494397|FG002|Intervention - Camp|these are those not showing up at camp|4|||
146542837|NCT02293499|528494395|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
146542838|NCT02293499|528494396|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
146542839|NCT02293499|528494397|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
146542840|NCT02293499|528494395|FG000|3 Month Follow Up|Lost to Follow-up|14|||
146542841|NCT02293499|528494396|FG001|3 Month Follow Up|Lost to Follow-up|15|||
146542842|NCT02293499|528494397|FG002|3 Month Follow Up|Lost to Follow-up|6|||
146542843|NCT02293499|528494395|FG000|6 Month Follow Up|Lost to Follow-up|17|||
146542844|NCT02293499|528494396|FG001|6 Month Follow Up|Lost to Follow-up|27|||
146542845|NCT02293499|528494397|FG002|6 Month Follow Up|Lost to Follow-up|6|||
146542846|NCT02293499|528494395|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
146542847|NCT02293499|528494396|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
146542848|NCT02293499|528494397|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
146542849|NCT02293499|528494395|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
146542850|NCT02293499|528494396|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
146542851|NCT02293499|528494397|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
146542852|NCT02293499|528494395|FG000|9 Month Follow Up|Lost to Follow-up|24|||
146542853|NCT02293499|528494396|FG001|9 Month Follow Up|Lost to Follow-up|28|||
146542854|NCT02293499|528494397|FG002|9 Month Follow Up|Lost to Follow-up|4|||
146542855|NCT02293499|528494395|FG000|12 Month Follow Up|Lost to Follow-up|26|||
146542856|NCT02293499|528494396|FG001|12 Month Follow Up|Lost to Follow-up|25|||
146542857|NCT02293499|528494397|FG002|12 Month Follow Up|Lost to Follow-up|6|||
146542858|NCT02293499|528494395|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
146542859|NCT02293499|528494396|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
146542860|NCT02293499|528494397|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
146542861|NCT02293499|528494395|FG000|15 Month Follow Up|Lost to Follow-up|22|||
146542862|NCT02293499|528494396|FG001|15 Month Follow Up|Lost to Follow-up|22|||
146542863|NCT02293499|528494397|FG002|15 Month Follow Up|Lost to Follow-up|7|||
146542864|NCT00690898|528494398|FG000|SCREENING|Screen failure|18|||
146542865|NCT00690898|528494398|FG000|TREATMENT|Adverse Event|3|||
146542866|NCT00690898|528494398|FG000|TREATMENT|Lack of Efficacy|18|||
146542867|NCT00690898|528494398|FG000|TREATMENT|Withdrawal by Subject|4|||
146542868|NCT00690898|528494398|FG000|TREATMENT|Other (not otherwise specified)|1|||
146542869|NCT05977868|528494399|FG000|Overall Study|Withdrawal by Subject|1|||
146542870|NCT05977868|528494400|FG001|Overall Study|Withdrawal by Subject|2|||
146542871|NCT05977868|528494399|FG000|Overall Study|Transitioned to comfort care|1|||
146542872|NCT05977868|528494400|FG001|Overall Study|Transitioned to comfort care|0|||
146542873|NCT03317496|528494407|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
146542874|NCT03317496|528494408|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
146542875|NCT03317496|528494409|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
146542876|NCT03317496|528494410|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
146542877|NCT03317496|528494411|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
146542878|NCT03317496|528494407|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
146542879|NCT03317496|528494408|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
146542880|NCT03317496|528494409|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
146542881|NCT03317496|528494410|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
146542882|NCT03317496|528494411|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
146542883|NCT03317496|528494407|FG000|Phase 1b Lead-in: Treatment|Death|0|||
146542884|NCT03317496|528494408|FG001|Phase 1b Lead-in: Treatment|Death|0|||
146542885|NCT03317496|528494409|FG002|Phase 1b Lead-in: Treatment|Death|1|||
146542886|NCT03317496|528494410|FG003|Phase 1b Lead-in: Treatment|Death|0|||
146542887|NCT03317496|528494411|FG004|Phase 1b Lead-in: Treatment|Death|0|||
146542888|NCT03317496|528494407|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
146542889|NCT03317496|528494408|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
146542890|NCT03317496|528494409|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
146542891|NCT03317496|528494410|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
146542892|NCT03317496|528494411|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
146542893|NCT03317496|528494407|FG000|Phase 1b Lead-in: Treatment|Other|2|||
146542894|NCT03317496|528494408|FG001|Phase 1b Lead-in: Treatment|Other|1|||
146542895|NCT03317496|528494409|FG002|Phase 1b Lead-in: Treatment|Other|0|||
146542896|NCT03317496|528494410|FG003|Phase 1b Lead-in: Treatment|Other|0|||
146542897|NCT03317496|528494411|FG004|Phase 1b Lead-in: Treatment|Other|0|||
146542898|NCT03317496|528494407|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
146542899|NCT03317496|528494408|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
146542900|NCT03317496|528494409|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
146542901|NCT03317496|528494410|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
146542902|NCT03317496|528494411|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
146542903|NCT03317496|528494407|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
146542904|NCT03317496|528494408|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
146542905|NCT03317496|528494409|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
146542906|NCT03317496|528494410|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
146542907|NCT03317496|528494411|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
146542908|NCT03317496|528494407|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
146542909|NCT03317496|528494408|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
146542910|NCT03317496|528494409|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
146542911|NCT03317496|528494410|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
146542912|NCT03317496|528494411|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
146542913|NCT03317496|528494407|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
146542914|NCT03317496|528494408|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
146542915|NCT03317496|528494409|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
146542916|NCT03317496|528494410|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
146542917|NCT03317496|528494411|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
146542918|NCT03317496|528494407|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
146542919|NCT03317496|528494408|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
146542920|NCT03317496|528494409|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
146542921|NCT03317496|528494410|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
146542922|NCT03317496|528494411|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
146542923|NCT03317496|528494407|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
146542924|NCT03317496|528494408|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
146542925|NCT03317496|528494409|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
146542926|NCT03317496|528494410|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
146542927|NCT03317496|528494411|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
146542928|NCT03317496|528494407|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
146542929|NCT03317496|528494408|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
146542930|NCT03317496|528494409|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
146542931|NCT03317496|528494410|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
146542932|NCT03317496|528494411|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
146542933|NCT03317496|528494407|FG000|Phase 2: Treatment|Adverse Event|0|||
146542934|NCT03317496|528494408|FG001|Phase 2: Treatment|Adverse Event|0|||
146542935|NCT03317496|528494409|FG002|Phase 2: Treatment|Adverse Event|0|||
146542936|NCT03317496|528494410|FG003|Phase 2: Treatment|Adverse Event|0|||
146542937|NCT03317496|528494411|FG004|Phase 2: Treatment|Adverse Event|6|||
146542938|NCT03317496|528494407|FG000|Phase 2: Treatment|Progressive disease|0|||
146542939|NCT03317496|528494408|FG001|Phase 2: Treatment|Progressive disease|0|||
146764370|NCT02082158|529304370|FG005|Overall Study|Failed Fit-testing|7|||
146542940|NCT03317496|528494409|FG002|Phase 2: Treatment|Progressive disease|0|||
146542941|NCT03317496|528494410|FG003|Phase 2: Treatment|Progressive disease|0|||
146542942|NCT03317496|528494411|FG004|Phase 2: Treatment|Progressive disease|22|||
146542943|NCT03317496|528494407|FG000|Phase 2: Treatment|Other|0|||
146542944|NCT03317496|528494408|FG001|Phase 2: Treatment|Other|0|||
146542945|NCT03317496|528494409|FG002|Phase 2: Treatment|Other|0|||
146542946|NCT03317496|528494410|FG003|Phase 2: Treatment|Other|0|||
146542947|NCT03317496|528494411|FG004|Phase 2: Treatment|Other|4|||
146542948|NCT03317496|528494407|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
146542949|NCT03317496|528494408|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
146542950|NCT03317496|528494409|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
146542951|NCT03317496|528494410|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
146542952|NCT03317496|528494411|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
146542953|NCT03317496|528494407|FG000|Phase 2: Treatment|Physician Decision|0|||
146542954|NCT03317496|528494408|FG001|Phase 2: Treatment|Physician Decision|0|||
146542955|NCT03317496|528494409|FG002|Phase 2: Treatment|Physician Decision|0|||
146542956|NCT03317496|528494410|FG003|Phase 2: Treatment|Physician Decision|0|||
146542957|NCT03317496|528494411|FG004|Phase 2: Treatment|Physician Decision|1|||
146873203|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
146542958|NCT03317496|528494407|FG000|Phase 2: Treatment|Death|0|||
146542959|NCT03317496|528494408|FG001|Phase 2: Treatment|Death|0|||
146542960|NCT03317496|528494409|FG002|Phase 2: Treatment|Death|0|||
146542961|NCT03317496|528494410|FG003|Phase 2: Treatment|Death|0|||
146873204|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
146542962|NCT03317496|528494411|FG004|Phase 2: Treatment|Death|1|||
146873205|NCT00111800|529706658|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
146873206|NCT00111800|529706659|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
146873207|NCT00111800|529706660|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
146873208|NCT00111800|529706661|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
146873209|NCT00111800|529706662|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
146873210|NCT00111800|529706663|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
146873211|NCT00111800|529706658|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
146873212|NCT00111800|529706659|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
146873213|NCT00111800|529706660|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
146542963|NCT03317496|528494407|FG000|Phase 2: Follow-up|Death|0|||
146542964|NCT03317496|528494408|FG001|Phase 2: Follow-up|Death|0|||
146542965|NCT03317496|528494409|FG002|Phase 2: Follow-up|Death|0|||
146542966|NCT03317496|528494410|FG003|Phase 2: Follow-up|Death|0|||
146542967|NCT03317496|528494411|FG004|Phase 2: Follow-up|Death|24|||
146542968|NCT03317496|528494407|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
146542969|NCT03317496|528494408|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
146542970|NCT03317496|528494409|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
146542971|NCT03317496|528494410|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
146542972|NCT03317496|528494411|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
146542973|NCT03317496|528494407|FG000|Phase 2: Follow-up|Other|0|||
146542974|NCT03317496|528494408|FG001|Phase 2: Follow-up|Other|0|||
146542975|NCT03317496|528494409|FG002|Phase 2: Follow-up|Other|0|||
146542976|NCT03317496|528494410|FG003|Phase 2: Follow-up|Other|0|||
146542977|NCT03317496|528494411|FG004|Phase 2: Follow-up|Other|1|||
146542978|NCT03317496|528494407|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
146542979|NCT03317496|528494408|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
146542980|NCT03317496|528494409|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
146542981|NCT03317496|528494410|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
146542982|NCT03317496|528494411|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
146542983|NCT00487188|528494421|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
146542984|NCT00487188|528494422|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
146542985|NCT00487188|528494423|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
146542986|NCT00487188|528494421|FG000|Induction Phase|Adverse Event|5|||
146542987|NCT00487188|528494422|FG001|Induction Phase|Adverse Event|0|||
146542988|NCT00487188|528494423|FG002|Induction Phase|Adverse Event|0|||
146542989|NCT00487188|528494421|FG000|Induction Phase|Lack of Efficacy|0|||
146542990|NCT00487188|528494422|FG001|Induction Phase|Lack of Efficacy|1|||
146542991|NCT00487188|528494423|FG002|Induction Phase|Lack of Efficacy|0|||
146542992|NCT00487188|528494421|FG000|Induction Phase|Protocol Violation|1|||
146542993|NCT00487188|528494422|FG001|Induction Phase|Protocol Violation|0|||
146542994|NCT00487188|528494423|FG002|Induction Phase|Protocol Violation|0|||
146542995|NCT00487188|528494421|FG000|Induction Phase|Refused Treatment|1|||
146542996|NCT00487188|528494422|FG001|Induction Phase|Refused Treatment|2|||
146542997|NCT00487188|528494423|FG002|Induction Phase|Refused Treatment|0|||
146542998|NCT00487188|528494421|FG000|Induction Phase|Lost to Follow-up|2|||
146542999|NCT00487188|528494422|FG001|Induction Phase|Lost to Follow-up|2|||
146543000|NCT00487188|528494423|FG002|Induction Phase|Lost to Follow-up|0|||
146543001|NCT00487188|528494421|FG000|Induction Phase|Administrative|0|||
146543002|NCT00487188|528494422|FG001|Induction Phase|Administrative|1|||
146543003|NCT00487188|528494423|FG002|Induction Phase|Administrative|0|||
146873214|NCT00111800|529706661|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
146873215|NCT00111800|529706662|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
146873216|NCT00111800|529706663|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
146873217|NCT00111800|529706658|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
146873218|NCT00111800|529706659|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
146543004|NCT00487188|528494421|FG000|Maintenance Phase|Adverse Event|1|||
146543005|NCT00487188|528494422|FG001|Maintenance Phase|Adverse Event|0|||
146543006|NCT00487188|528494423|FG002|Maintenance Phase|Adverse Event|0|||
146543007|NCT00487188|528494421|FG000|Maintenance Phase|Death|1|||
146543008|NCT00487188|528494422|FG001|Maintenance Phase|Death|0|||
146543009|NCT00487188|528494423|FG002|Maintenance Phase|Death|0|||
146543010|NCT00487188|528494421|FG000|Maintenance Phase|Lost to Follow-up|1|||
146543011|NCT00487188|528494422|FG001|Maintenance Phase|Lost to Follow-up|0|||
146543012|NCT00487188|528494423|FG002|Maintenance Phase|Lost to Follow-up|0|||
146543013|NCT00487188|528494421|FG000|Maintenance Phase|Administrative|0|||
146543014|NCT00487188|528494422|FG001|Maintenance Phase|Administrative|0|||
146543015|NCT00487188|528494423|FG002|Maintenance Phase|Administrative|1|||
146543016|NCT04092777|528494428|FG000|Overall Study|Lost to Follow-up|28|||
146543017|NCT04092777|528494429|FG001|Overall Study|Lost to Follow-up|46|||
146543018|NCT04092777|528494428|FG000|Overall Study|Withdrawal by Subject|8|||
146543019|NCT04092777|528494429|FG001|Overall Study|Withdrawal by Subject|5|||
146543020|NCT00088153|528494432|FG000|Overall Study|Physician Decision|3|||
146543021|NCT00088153|528494433|FG001|Overall Study|Physician Decision|3|||
146543022|NCT00088153|528494432|FG000|Overall Study|Withdrawal by Subject|10|||
146543023|NCT00088153|528494433|FG001|Overall Study|Withdrawal by Subject|10|||
146543024|NCT00088153|528494432|FG000|Overall Study|Lost to Follow-up|11|||
146543025|NCT00088153|528494433|FG001|Overall Study|Lost to Follow-up|12|||
146873219|NCT00111800|529706660|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
146873220|NCT00111800|529706661|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
146873221|NCT00111800|529706662|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
146873222|NCT00111800|529706663|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
146873223|NCT00111800|529706658|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
146873224|NCT00111800|529706659|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
146873225|NCT00111800|529706660|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
146873226|NCT00111800|529706661|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
146873227|NCT00111800|529706662|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
146873228|NCT00111800|529706663|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
146873229|NCT00111800|529706658|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
146873230|NCT00111800|529706659|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
146873231|NCT00111800|529706660|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
146873232|NCT00111800|529706661|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
146873233|NCT00111800|529706662|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
146873234|NCT00111800|529706663|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
146873235|NCT00111800|529706658|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
146873236|NCT00111800|529706659|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
146873237|NCT00111800|529706660|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
146873238|NCT00111800|529706661|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
146873239|NCT00111800|529706662|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
146873240|NCT00111800|529706663|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
146873241|NCT00111800|529706658|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
146873242|NCT00111800|529706659|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
146873243|NCT00111800|529706660|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
146873244|NCT00111800|529706661|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
146873245|NCT00111800|529706662|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
146873246|NCT00111800|529706663|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
146873247|NCT00111800|529706658|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
146873248|NCT00111800|529706659|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
146873249|NCT00111800|529706660|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
146873250|NCT00111800|529706661|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
146873251|NCT00111800|529706662|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
146873252|NCT00111800|529706663|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
146873253|NCT00111800|529706658|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
146873254|NCT00111800|529706659|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
146873255|NCT00111800|529706660|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
146873256|NCT00111800|529706661|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
146873257|NCT00111800|529706662|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
146873258|NCT00111800|529706663|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
146873259|NCT00596947|529706664|FG000|Overall Study|study halted due to low enrollment|5|||
146543026|NCT02246777|528494445|FG000|Overall Study|Adverse Event|2|||
146543027|NCT02246777|528494445|FG000|Overall Study|Change of residence|1|||
146543028|NCT00927472|528494451|FG000|Overall Study|Withdrawal by Subject|10|||
146543029|NCT00927472|528494452|FG001|Overall Study|Withdrawal by Subject|11|||
146543030|NCT00927472|528494451|FG000|Overall Study|Lost to Follow-up|1|||
146543031|NCT00927472|528494452|FG001|Overall Study|Lost to Follow-up|6|||
146543032|NCT00927472|528494451|FG000|Overall Study|Protocol Violation|0|||
146543033|NCT00927472|528494452|FG001|Overall Study|Protocol Violation|1|||
146543034|NCT00927472|528494451|FG000|Overall Study|Post treatment Assessment out of window|0|||
146543035|NCT00927472|528494452|FG001|Overall Study|Post treatment Assessment out of window|4|||
146543036|NCT00433537|528494453|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
146543037|NCT00433537|528494454|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
146543038|NCT00433537|528494455|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
146543039|NCT00433537|528494453|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
146543040|NCT00433537|528494454|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
146543041|NCT00433537|528494455|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
146543042|NCT00433537|528494453|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
146543043|NCT00433537|528494454|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
146543044|NCT00433537|528494455|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
146543045|NCT00433537|528494453|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
146543046|NCT00433537|528494454|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
146543047|NCT00433537|528494455|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
146543048|NCT00433537|528494453|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
146543049|NCT00433537|528494454|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
146543050|NCT00433537|528494455|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
146543051|NCT00433537|528494453|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
146543052|NCT00433537|528494454|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
146543053|NCT00433537|528494455|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
146543054|NCT00433537|528494453|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
146543055|NCT00433537|528494454|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
146543056|NCT00433537|528494455|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
146543057|NCT00433537|528494453|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
146543058|NCT00433537|528494454|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
146543059|NCT00433537|528494455|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
146543060|NCT00433537|528494453|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
146543061|NCT00433537|528494454|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
146543062|NCT00433537|528494455|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
146543063|NCT05556057|528494456|FG000|Overall Study|Lost to Follow-up|5|||
146543064|NCT05556057|528494457|FG001|Overall Study|Lost to Follow-up|4|||
146543065|NCT05556057|528494456|FG000|Overall Study|Withdrawal by Subject|0|||
146543066|NCT05556057|528494457|FG001|Overall Study|Withdrawal by Subject|2|||
146543067|NCT05020743|528494458|FG000|Overall Study|Enrollment in Interventional Study|2|||
146543068|NCT05020743|528494459|FG001|Overall Study|Enrollment in Interventional Study|9|||
146543069|NCT05020743|528494460|FG002|Overall Study|Enrollment in Interventional Study|0|||
146543070|NCT05020743|528494458|FG000|Overall Study|Withdrawal by Subject|0|||
146543071|NCT05020743|528494459|FG001|Overall Study|Withdrawal by Subject|3|||
146543072|NCT05020743|528494460|FG002|Overall Study|Withdrawal by Subject|1|||
146543073|NCT05020743|528494458|FG000|Overall Study|Lost to Follow-up|1|||
146543074|NCT05020743|528494459|FG001|Overall Study|Lost to Follow-up|0|||
146543075|NCT05020743|528494460|FG002|Overall Study|Lost to Follow-up|0|||
146543076|NCT05020743|528494458|FG000|Overall Study|Study Termination by Sponsor|10|||
146543077|NCT05020743|528494459|FG001|Overall Study|Study Termination by Sponsor|11|||
146764371|NCT00549848|529304371|FG000|Overall Study|Death|1|||
146568860|NCT02259114|528595484|FG000|Overall Study|Adverse Event|2|||
146543078|NCT05020743|528494460|FG002|Overall Study|Study Termination by Sponsor|10|||
146543079|NCT03488524|528494461|FG000|Overall Study|Withdrawal by Subject|51|||
146543080|NCT03488524|528494461|FG000|Overall Study|Death|19|||
146543081|NCT03488524|528494461|FG000|Overall Study|Study Sponsor|11|||
146543082|NCT03488524|528494461|FG000|Overall Study|Physician Decision|4|||
146543083|NCT03488524|528494461|FG000|Overall Study|Lost to Follow-up|3|||
146543084|NCT02390284|528494462|FG000|Overall Study|Physician Decision|0|||
146543085|NCT02390284|528494463|FG001|Overall Study|Physician Decision|0|||
146543086|NCT02390284|528494464|FG002|Overall Study|Physician Decision|9|||
146543087|NCT03980223|528494465|FG000|Overall Study|Lost to Follow-up|3|||
146543088|NCT03980223|528494466|FG001|Overall Study|Lost to Follow-up|7|||
146543089|NCT03980223|528494467|FG002|Overall Study|Lost to Follow-up|10|||
146543090|NCT03980223|528494468|FG003|Overall Study|Lost to Follow-up|8|||
146628059|NCT01780506|528813550|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
146543091|NCT03980223|528494465|FG000|Overall Study|Withdrawal by Subject|0|||
146543092|NCT03980223|528494466|FG001|Overall Study|Withdrawal by Subject|0|||
146543093|NCT03980223|528494467|FG002|Overall Study|Withdrawal by Subject|1|||
146543094|NCT03980223|528494468|FG003|Overall Study|Withdrawal by Subject|2|||
146543095|NCT03980223|528494465|FG000|Overall Study|Physician Decision|0|||
146543096|NCT03980223|528494466|FG001|Overall Study|Physician Decision|0|||
146543097|NCT03980223|528494467|FG002|Overall Study|Physician Decision|1|||
146543098|NCT03980223|528494468|FG003|Overall Study|Physician Decision|0|||
146543099|NCT03980223|528494465|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
146543100|NCT03980223|528494466|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
146543101|NCT03980223|528494467|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
146543102|NCT03980223|528494468|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
146543103|NCT01922934|528494472|FG000|Eligible Patients|Death|0|||
146543104|NCT01922934|528494473|FG001|Eligible Patients|Death|7|||
146543105|NCT01922934|528494472|FG000|Eligible Patients|Physician Decision|17|||
146543106|NCT01922934|528494473|FG001|Eligible Patients|Physician Decision|0|||
146543107|NCT01922934|528494472|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
146543108|NCT01922934|528494473|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
146543109|NCT01922934|528494472|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
146543110|NCT01922934|528494473|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
146543111|NCT01922934|528494472|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
146543112|NCT01922934|528494473|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
146543113|NCT01922934|528494472|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
146543114|NCT01922934|528494473|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
146543115|NCT01069939|528494478|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
146543116|NCT01069939|528494479|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
146543117|NCT01069939|528494478|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
146543118|NCT01069939|528494479|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
146568861|NCT02259114|528595485|FG001|Overall Study|Adverse Event|1|||
146543119|NCT01069939|528494478|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
146543120|NCT01069939|528494479|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
146543121|NCT01069939|528494478|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
146873260|NCT00596947|529706665|FG001|Overall Study|study halted due to low enrollment|3|||
146543122|NCT01069939|528494479|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
146543123|NCT01069939|528494478|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
146543124|NCT01069939|528494479|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
146873261|NCT00596947|529706664|FG000|Overall Study|Lost to Follow-up|1|||
146873262|NCT00596947|529706665|FG001|Overall Study|Lost to Follow-up|0|||
146873263|NCT00829179|529706666|FG000|Overall Study|Withdrawal by Subject|1|||
146873264|NCT03000179|529706667|FG000|Overall Study|Lost to Follow-up|2|||
146873265|NCT02343159|529706668|FG000|Overall Study|Early Study Termination|16|||
146543125|NCT01069939|528494478|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
146873266|NCT02343159|529706669|FG001|Overall Study|Early Study Termination|19|||
146873267|NCT02343159|529706670|FG002|Overall Study|Early Study Termination|23|||
146873268|NCT02343159|529706668|FG000|Overall Study|Physician Decision|2|||
146873269|NCT02343159|529706669|FG001|Overall Study|Physician Decision|0|||
146543126|NCT01069939|528494479|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
146543127|NCT01069939|528494478|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
146543128|NCT01069939|528494479|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
146543129|NCT01069939|528494478|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
146543130|NCT01069939|528494479|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
146543131|NCT01069939|528494478|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
146543132|NCT01069939|528494479|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
146543133|NCT01069939|528494478|FG000|Randomised and Included in the Analyses|Removal|1|||
146543134|NCT01069939|528494479|FG001|Randomised and Included in the Analyses|Removal|0|||
146543135|NCT00724945|528494480|FG000|Period 1|non-compliance|1|||
146543136|NCT00724945|528494481|FG001|Period 1|non-compliance|0|||
146543137|NCT00724945|528494480|FG000|Period 1|Adverse Event|1|||
146543138|NCT00724945|528494481|FG001|Period 1|Adverse Event|1|||
146543139|NCT00724945|528494480|FG000|Period 1|Lost to Follow-up|1|||
146543140|NCT00724945|528494481|FG001|Period 1|Lost to Follow-up|0|||
146543141|NCT00724945|528494480|FG000|Period 2|lens comfort issue|3|||
146543142|NCT00724945|528494481|FG001|Period 2|lens comfort issue|0|||
146543143|NCT00724945|528494480|FG000|Period 2|lens physiology issue|1|||
146543144|NCT00724945|528494481|FG001|Period 2|lens physiology issue|0|||
146543145|NCT05166876|528494482|FG000|Overall Study|Withdrawal by Subject|1|||
146543146|NCT05166876|528494483|FG001|Overall Study|Withdrawal by Subject|0|||
146628060|NCT03486912|528813554|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
146873270|NCT02343159|529706670|FG002|Overall Study|Physician Decision|1|||
146873271|NCT02343159|529706668|FG000|Overall Study|Withdrawal by Subject|3|||
146873272|NCT02343159|529706669|FG001|Overall Study|Withdrawal by Subject|0|||
146873273|NCT02343159|529706670|FG002|Overall Study|Withdrawal by Subject|2|||
146873274|NCT02343159|529706668|FG000|Overall Study|Lost to Follow-up|0|||
146873275|NCT02343159|529706669|FG001|Overall Study|Lost to Follow-up|2|||
146873276|NCT02343159|529706670|FG002|Overall Study|Lost to Follow-up|2|||
146873277|NCT02343159|529706668|FG000|Overall Study|Adverse Event|4|||
146873278|NCT02343159|529706669|FG001|Overall Study|Adverse Event|4|||
146873279|NCT02343159|529706670|FG002|Overall Study|Adverse Event|2|||
146873280|NCT02343159|529706668|FG000|Overall Study|Sponsor Decision|0|||
146873281|NCT02343159|529706669|FG001|Overall Study|Sponsor Decision|1|||
146873282|NCT02343159|529706670|FG002|Overall Study|Sponsor Decision|0|||
146873283|NCT02343159|529706668|FG000|Overall Study|Enrollment Error|1|||
146873284|NCT02343159|529706669|FG001|Overall Study|Enrollment Error|0|||
146873285|NCT02343159|529706670|FG002|Overall Study|Enrollment Error|0|||
146873286|NCT01846624|529706675|FG000|Overall Study|Died during induction, no midostaurin|1|||
146873287|NCT04702737|529706676|FG000|Overall Study|Decision by Sponsor|1|||
146873288|NCT04702737|529706676|FG000|Overall Study|Withdrawal of Consent from Study|3|||
146873289|NCT04702737|529706676|FG000|Overall Study|Lost to Follow-up|1|||
146873290|NCT04702737|529706676|FG000|Overall Study|Death|35|||
146873291|NCT01177683|529706677|FG000|Study Treatment|Disease Progressions during treatment|2|||
146873292|NCT01177683|529706678|FG001|Study Treatment|Disease Progressions during treatment|0|||
146873293|NCT01177683|529706679|FG002|Study Treatment|Disease Progressions during treatment|3|||
146873294|NCT01177683|529706677|FG000|Study Treatment|Adverse Event|0|||
146873295|NCT01177683|529706678|FG001|Study Treatment|Adverse Event|1|||
146873296|NCT01177683|529706679|FG002|Study Treatment|Adverse Event|12|||
146873297|NCT01177683|529706677|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
146873298|NCT01177683|529706678|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
146873299|NCT01177683|529706679|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
146873300|NCT01177683|529706677|FG000|Study Treatment|Alternative therapy|0|||
146543147|NCT05166876|528494484|FG002|Overall Study|Withdrawal by Subject|0|||
146543148|NCT00658528|528494485|FG000|Overall Study|Adverse Event|5|||
146543149|NCT00658528|528494486|FG001|Overall Study|Adverse Event|7|||
146543150|NCT00658528|528494485|FG000|Overall Study|Lost to Follow-up|14|||
146543151|NCT00658528|528494486|FG001|Overall Study|Lost to Follow-up|22|||
146543152|NCT00658528|528494485|FG000|Overall Study|Withdrawal by Subject|8|||
146543153|NCT00658528|528494486|FG001|Overall Study|Withdrawal by Subject|6|||
146543154|NCT00658528|528494485|FG000|Overall Study|Withdrawal of consent|5|||
146873301|NCT01177683|529706678|FG001|Study Treatment|Alternative therapy|0|||
146873302|NCT01177683|529706679|FG002|Study Treatment|Alternative therapy|4|||
146543155|NCT00658528|528494486|FG001|Overall Study|Withdrawal of consent|6|||
146543156|NCT00658528|528494485|FG000|Overall Study|Other|8|||
146543157|NCT00658528|528494486|FG001|Overall Study|Other|4|||
146543158|NCT01147458|528494488|FG000|First Intervention|Study terminated by sponsor|8|||
146543159|NCT01147458|528494489|FG001|First Intervention|Study terminated by sponsor|8|||
146543160|NCT01147458|528494490|FG002|First Intervention|Study terminated by sponsor|7|||
146543161|NCT01147458|528494491|FG003|First Intervention|Study terminated by sponsor|8|||
146543162|NCT01147458|528494488|FG000|First Intervention|Protocol Violation|2|||
146543163|NCT01147458|528494489|FG001|First Intervention|Protocol Violation|3|||
146543164|NCT01147458|528494490|FG002|First Intervention|Protocol Violation|2|||
146543165|NCT01147458|528494491|FG003|First Intervention|Protocol Violation|3|||
146543166|NCT01147458|528494488|FG000|First Intervention|Withdrawal by Subject|3|||
146543167|NCT01147458|528494489|FG001|First Intervention|Withdrawal by Subject|0|||
146543168|NCT01147458|528494490|FG002|First Intervention|Withdrawal by Subject|1|||
146543169|NCT01147458|528494491|FG003|First Intervention|Withdrawal by Subject|0|||
146543170|NCT01147458|528494488|FG000|First Intervention|Adverse Event|0|||
146543171|NCT01147458|528494489|FG001|First Intervention|Adverse Event|3|||
146543172|NCT01147458|528494490|FG002|First Intervention|Adverse Event|2|||
146543173|NCT01147458|528494491|FG003|First Intervention|Adverse Event|3|||
146543174|NCT01147458|528494488|FG000|First Intervention|Other|1|||
146543175|NCT01147458|528494489|FG001|First Intervention|Other|2|||
146543176|NCT01147458|528494490|FG002|First Intervention|Other|0|||
146543177|NCT01147458|528494491|FG003|First Intervention|Other|0|||
146543178|NCT01147458|528494488|FG000|Second Intervention|Study terminated by sponsor|7|||
146543179|NCT01147458|528494489|FG001|Second Intervention|Study terminated by sponsor|5|||
146543180|NCT01147458|528494490|FG002|Second Intervention|Study terminated by sponsor|5|||
146543181|NCT01147458|528494491|FG003|Second Intervention|Study terminated by sponsor|3|||
146543182|NCT01147458|528494488|FG000|Second Intervention|Protocol Violation|0|||
146543183|NCT01147458|528494489|FG001|Second Intervention|Protocol Violation|1|||
146543184|NCT01147458|528494490|FG002|Second Intervention|Protocol Violation|1|||
146543185|NCT01147458|528494491|FG003|Second Intervention|Protocol Violation|0|||
146543186|NCT01147458|528494488|FG000|Second Intervention|Withdrawal by Subject|0|||
146543187|NCT01147458|528494489|FG001|Second Intervention|Withdrawal by Subject|1|||
146543188|NCT01147458|528494490|FG002|Second Intervention|Withdrawal by Subject|0|||
146543189|NCT01147458|528494491|FG003|Second Intervention|Withdrawal by Subject|0|||
146543190|NCT01147458|528494488|FG000|Second Intervention|Adverse Event|2|||
146543191|NCT01147458|528494489|FG001|Second Intervention|Adverse Event|0|||
146543192|NCT01147458|528494490|FG002|Second Intervention|Adverse Event|1|||
146543193|NCT01147458|528494491|FG003|Second Intervention|Adverse Event|1|||
146543194|NCT01147458|528494488|FG000|Second Intervention|Other|0|||
146543195|NCT01147458|528494489|FG001|Second Intervention|Other|0|||
146543196|NCT01147458|528494490|FG002|Second Intervention|Other|1|||
146543197|NCT01147458|528494491|FG003|Second Intervention|Other|0|||
146543198|NCT02811159|528494496|FG000|Treatment Course 1|Lost to Follow-up|1|||
146543199|NCT01525589|528494497|FG000|Overall Study|Non-treatment-related AE|1|||
146873303|NCT01177683|529706677|FG000|Study Treatment|Physician Decision|1|||
146873304|NCT01177683|529706678|FG001|Study Treatment|Physician Decision|0|||
146543200|NCT01525589|528494498|FG001|Overall Study|Non-treatment-related AE|0|||
146543201|NCT01525589|528494499|FG002|Overall Study|Non-treatment-related AE|0|||
146543202|NCT01525589|528494497|FG000|Overall Study|Progressive disease|48|||
146543203|NCT01525589|528494498|FG001|Overall Study|Progressive disease|15|||
146543204|NCT01525589|528494499|FG002|Overall Study|Progressive disease|29|||
146543205|NCT01525589|528494497|FG000|Overall Study|Never treated|2|||
146543206|NCT01525589|528494498|FG001|Overall Study|Never treated|0|||
146628061|NCT03486912|528813555|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
146628062|NCT03486912|528813556|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
146628063|NCT03486912|528813557|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
146628064|NCT03486912|528813554|FG000|Treatment Period|Withdrawal by Subject|3|||
146628065|NCT03486912|528813555|FG001|Treatment Period|Withdrawal by Subject|3|||
146628066|NCT03486912|528813556|FG002|Treatment Period|Withdrawal by Subject|3|||
146628067|NCT03486912|528813557|FG003|Treatment Period|Withdrawal by Subject|2|||
146628068|NCT03486912|528813554|FG000|Treatment Period|Other Reasons|0|||
146873305|NCT01177683|529706679|FG002|Study Treatment|Physician Decision|1|||
146873306|NCT01177683|529706677|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
146628069|NCT03486912|528813555|FG001|Treatment Period|Other Reasons|2|||
146628070|NCT03486912|528813556|FG002|Treatment Period|Other Reasons|1|||
146628071|NCT03486912|528813557|FG003|Treatment Period|Other Reasons|1|||
146628072|NCT03486912|528813554|FG000|Treatment Period|Adverse Event|0|||
146628073|NCT03486912|528813555|FG001|Treatment Period|Adverse Event|1|||
146628074|NCT03486912|528813556|FG002|Treatment Period|Adverse Event|1|||
146628075|NCT03486912|528813557|FG003|Treatment Period|Adverse Event|0|||
146628076|NCT03486912|528813554|FG000|Treatment Period|Lost to Follow-up|1|||
146628077|NCT03486912|528813555|FG001|Treatment Period|Lost to Follow-up|0|||
146628078|NCT03486912|528813556|FG002|Treatment Period|Lost to Follow-up|0|||
146628079|NCT03486912|528813557|FG003|Treatment Period|Lost to Follow-up|2|||
146628080|NCT01499940|528813559|FG000|Overall Study|Study was withdrawn before completion.|9|||
146628081|NCT00412984|528813560|FG000|Overall Study|Death|331|||
146628082|NCT00412984|528813561|FG001|Overall Study|Death|349|||
146628083|NCT00412984|528813560|FG000|Overall Study|Adverse Event|679|||
146628084|NCT00412984|528813561|FG001|Overall Study|Adverse Event|738|||
146628085|NCT00412984|528813560|FG000|Overall Study|Withdrawal by Subject|921|||
146628086|NCT00412984|528813561|FG001|Overall Study|Withdrawal by Subject|989|||
146628087|NCT00412984|528813560|FG000|Overall Study|Lost to Follow-up|51|||
146628088|NCT00412984|528813561|FG001|Overall Study|Lost to Follow-up|39|||
146628089|NCT00412984|528813560|FG000|Overall Study|Poor/Noncompliance|57|||
146628090|NCT00412984|528813561|FG001|Overall Study|Poor/Noncompliance|77|||
146628091|NCT00412984|528813560|FG000|Overall Study|Pregnancy|1|||
146628092|NCT00412984|528813561|FG001|Overall Study|Pregnancy|0|||
146628093|NCT00412984|528813560|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
146628094|NCT00412984|528813561|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
146628095|NCT00412984|528813560|FG000|Overall Study|Administrative Reason by Sponsor|11|||
146628096|NCT00412984|528813561|FG001|Overall Study|Administrative Reason by Sponsor|8|||
146628097|NCT00412984|528813560|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
146628098|NCT00412984|528813561|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
146628099|NCT00412984|528813560|FG000|Overall Study|Other Reason|80|||
146628100|NCT00412984|528813561|FG001|Overall Study|Other Reason|92|||
146628101|NCT00412984|528813560|FG000|Overall Study|Not Reported|11|||
146628102|NCT00412984|528813561|FG001|Overall Study|Not Reported|12|||
146628103|NCT02383576|528813562|FG000|Overall Study|Death|53|||
146628104|NCT02383576|528813563|FG001|Overall Study|Death|33|||
146628105|NCT02383576|528813562|FG000|Overall Study|Lost to Follow-up|7|||
146628106|NCT02383576|528813563|FG001|Overall Study|Lost to Follow-up|1|||
146628107|NCT02383576|528813562|FG000|Overall Study|Withdrew Consent|1|||
146628108|NCT02383576|528813563|FG001|Overall Study|Withdrew Consent|6|||
146628109|NCT02383576|528813562|FG000|Overall Study|Investigator's Decision|0|||
146628110|NCT02383576|528813563|FG001|Overall Study|Investigator's Decision|1|||
146628111|NCT02383576|528813562|FG000|Overall Study|Administrative/Other|2|||
146628112|NCT02383576|528813563|FG001|Overall Study|Administrative/Other|4|||
146628113|NCT04097678|528813564|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
146628114|NCT04097678|528813565|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
146628115|NCT03694678|528813566|FG000|Overall Study|Withdrawal by Subject|2|||
146628116|NCT03694678|528813567|FG001|Overall Study|Withdrawal by Subject|0|||
146628117|NCT03694678|528813566|FG000|Overall Study|Lost to Follow-up|2|||
146628118|NCT03694678|528813567|FG001|Overall Study|Lost to Follow-up|3|||
146628119|NCT02435212|528813568|FG000|Core Phase|Adverse Event|8|||
146628120|NCT02435212|528813569|FG001|Core Phase|Adverse Event|5|||
146628121|NCT02435212|528813568|FG000|Core Phase|Withdrawal by Subject|3|||
146628122|NCT02435212|528813569|FG001|Core Phase|Withdrawal by Subject|0|||
146628123|NCT02435212|528813568|FG000|Core Phase|Withdrawal by parent/guardian|9|||
146628124|NCT02435212|528813569|FG001|Core Phase|Withdrawal by parent/guardian|4|||
146628125|NCT02435212|528813568|FG000|Core Phase|Protocol Violation|1|||
146628126|NCT02435212|528813569|FG001|Core Phase|Protocol Violation|2|||
146628127|NCT02435212|528813568|FG000|Core Phase|Physician Decision|3|||
146628128|NCT02435212|528813569|FG001|Core Phase|Physician Decision|0|||
146628129|NCT02435212|528813568|FG000|Core Phase|Lost to Follow-up|0|||
146628130|NCT02435212|528813569|FG001|Core Phase|Lost to Follow-up|1|||
146628131|NCT02435212|528813568|FG000|Core Phase|Lack of Efficacy|0|||
146628132|NCT02435212|528813569|FG001|Core Phase|Lack of Efficacy|1|||
146628133|NCT02435212|528813568|FG000|Core Phase|Recovery|1|||
146628134|NCT02435212|528813569|FG001|Core Phase|Recovery|0|||
146628135|NCT02435212|528813568|FG000|Optional Extension Phase|Adverse Event|3|||
146543207|NCT01525589|528494499|FG002|Overall Study|Never treated|0|||
146873307|NCT01177683|529706678|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
146543208|NCT01525589|528494497|FG000|Overall Study|Physician Decision|4|||
146543209|NCT01525589|528494498|FG001|Overall Study|Physician Decision|2|||
146543210|NCT01525589|528494499|FG002|Overall Study|Physician Decision|2|||
146543211|NCT01525589|528494497|FG000|Overall Study|Death|0|||
146543212|NCT01525589|528494498|FG001|Overall Study|Death|0|||
146543213|NCT01525589|528494499|FG002|Overall Study|Death|2|||
146543214|NCT01525589|528494497|FG000|Overall Study|Treatment-related AE|1|||
146543215|NCT01525589|528494498|FG001|Overall Study|Treatment-related AE|1|||
146543216|NCT01525589|528494499|FG002|Overall Study|Treatment-related AE|2|||
146543217|NCT01525589|528494497|FG000|Overall Study|Other reasons|0|||
146543218|NCT01525589|528494498|FG001|Overall Study|Other reasons|1|||
146543219|NCT01525589|528494499|FG002|Overall Study|Other reasons|0|||
146543220|NCT01525589|528494497|FG000|Overall Study|Withdrawal by Subject|0|||
146543221|NCT01525589|528494498|FG001|Overall Study|Withdrawal by Subject|1|||
146543222|NCT01525589|528494499|FG002|Overall Study|Withdrawal by Subject|0|||
146543223|NCT04611126|528494500|FG000|Overall Study|TIL expansion unsuccessful|1|||
146543224|NCT04611126|528494501|FG001|Overall Study|TIL expansion unsuccessful|0|||
146543225|NCT03459846|528494502|FG000|Overall Study|Death|52|||
146543226|NCT03459846|528494503|FG001|Overall Study|Death|46|||
146543227|NCT03459846|528494502|FG000|Overall Study|Study terminated by sponsor|24|||
146543228|NCT03459846|528494503|FG001|Overall Study|Study terminated by sponsor|28|||
146543229|NCT03459846|528494502|FG000|Overall Study|Withdrawal by Subject|2|||
146543230|NCT03459846|528494503|FG001|Overall Study|Withdrawal by Subject|2|||
146543231|NCT06717399|528494504|FG000|Overall Study|Death|1|||
146543232|NCT00177671|528495733|FG000|Overall Study|Withdrawal by Subject|5|||
146543233|NCT00177671|528495734|FG001|Overall Study|Withdrawal by Subject|6|||
146873308|NCT01177683|529706679|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
146543234|NCT00177671|528495733|FG000|Overall Study|medical complications|2|||
146543235|NCT00177671|528495734|FG001|Overall Study|medical complications|0|||
146543236|NCT00177671|528495733|FG000|Overall Study|Adverse Event|6|||
146543237|NCT00177671|528495734|FG001|Overall Study|Adverse Event|0|||
146543238|NCT00177671|528495733|FG000|Overall Study|Physician Decision|12|||
146543239|NCT00177671|528495734|FG001|Overall Study|Physician Decision|8|||
146764372|NCT00549848|529304372|FG001|Overall Study|Death|4|||
146764373|NCT00549848|529304373|FG002|Overall Study|Death|13|||
146543240|NCT01991314|528495737|FG000|Overall Study|Adverse Event|5|||
146543241|NCT01991314|528495738|FG001|Overall Study|Adverse Event|1|||
146543242|NCT01991314|528495737|FG000|Overall Study|Lost to Follow-up|6|||
146543243|NCT01991314|528495738|FG001|Overall Study|Lost to Follow-up|10|||
146543244|NCT01136954|528495739|FG000|Overall Study|Adverse Event|3|||
146543245|NCT01136954|528495740|FG001|Overall Study|Adverse Event|2|||
146543246|NCT01136954|528495739|FG000|Overall Study|Withdrawal by Subject|6|||
146543247|NCT01136954|528495740|FG001|Overall Study|Withdrawal by Subject|2|||
146543248|NCT01136954|528495739|FG000|Overall Study|Lack of Efficacy|14|||
146543249|NCT01136954|528495740|FG001|Overall Study|Lack of Efficacy|13|||
146543250|NCT01136954|528495739|FG000|Overall Study|Physician Decision|0|||
146543251|NCT01136954|528495740|FG001|Overall Study|Physician Decision|1|||
146543252|NCT01136954|528495739|FG000|Overall Study|Other|1|||
146543253|NCT01136954|528495740|FG001|Overall Study|Other|3|||
146543254|NCT02034591|528495747|FG000|Overall Study|Withdrawal by Subject|0|||
146543255|NCT02034591|528495748|FG001|Overall Study|Withdrawal by Subject|0|||
146543256|NCT02034591|528495749|FG002|Overall Study|Withdrawal by Subject|0|||
146543257|NCT02034591|528495750|FG003|Overall Study|Withdrawal by Subject|0|||
146543258|NCT02034591|528495751|FG004|Overall Study|Withdrawal by Subject|1|||
146543259|NCT02034591|528495752|FG005|Overall Study|Withdrawal by Subject|0|||
146543260|NCT00817063|528495753|FG000|Overall Study|Adverse Event|32|||
146543261|NCT00817063|528495754|FG001|Overall Study|Adverse Event|13|||
146764374|NCT00549848|529304371|FG000|Overall Study|Physician Decision|0|||
146764375|NCT00549848|529304372|FG001|Overall Study|Physician Decision|0|||
146764376|NCT00549848|529304373|FG002|Overall Study|Physician Decision|4|||
146764377|NCT00549848|529304371|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
146764378|NCT00549848|529304372|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
146628136|NCT02435212|528813569|FG001|Optional Extension Phase|Adverse Event|9|||
146628137|NCT02435212|528813568|FG000|Optional Extension Phase|Physician Decision|6|||
146628138|NCT02435212|528813569|FG001|Optional Extension Phase|Physician Decision|8|||
146628139|NCT02435212|528813568|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
146628140|NCT02435212|528813569|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
146628141|NCT02435212|528813568|FG000|Optional Extension Phase|Lack of Efficacy|2|||
146628142|NCT02435212|528813569|FG001|Optional Extension Phase|Lack of Efficacy|3|||
146628143|NCT02435212|528813568|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
146628144|NCT02435212|528813569|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
146628145|NCT02435212|528813568|FG000|Optional Extension Phase|Protocol Violation|0|||
146628146|NCT02435212|528813569|FG001|Optional Extension Phase|Protocol Violation|1|||
146628147|NCT02435212|528813568|FG000|Optional Extension Phase|Recovery|1|||
146628148|NCT02435212|528813569|FG001|Optional Extension Phase|Recovery|1|||
146628149|NCT02435212|528813568|FG000|Optional Extension Phase|Death|1|||
146628150|NCT02435212|528813569|FG001|Optional Extension Phase|Death|0|||
146628151|NCT02435212|528813568|FG000|Optional Extension Phase|Technical problems|2|||
146628152|NCT02435212|528813569|FG001|Optional Extension Phase|Technical problems|0|||
146628153|NCT02285855|528813570|FG000|Overall Study|Withdrawal by Subject|2|||
146628154|NCT02285855|528813571|FG001|Overall Study|Withdrawal by Subject|1|||
146628155|NCT00528112|528813572|FG000|Treatment up to 3 Years|Adverse Event|313|||
146628156|NCT00528112|528813573|FG001|Treatment up to 3 Years|Adverse Event|278|||
146628157|NCT00528112|528813572|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
146628158|NCT00528112|528813573|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
146628159|NCT00528112|528813572|FG000|Treatment up to 3 Years|Protocol Violation|16|||
146628160|NCT00528112|528813573|FG001|Treatment up to 3 Years|Protocol Violation|16|||
146628161|NCT00528112|528813572|FG000|Treatment up to 3 Years|Death|0|||
146628162|NCT00528112|528813573|FG001|Treatment up to 3 Years|Death|1|||
146628163|NCT00528112|528813572|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
146628164|NCT00528112|528813573|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
146628165|NCT00528112|528813572|FG000|Treatment up to 3 Years|Pregnancy|9|||
146628166|NCT00528112|528813573|FG001|Treatment up to 3 Years|Pregnancy|10|||
146628167|NCT00528112|528813572|FG000|Treatment up to 3 Years|Other reasons|186|||
146628168|NCT00528112|528813573|FG001|Treatment up to 3 Years|Other reasons|186|||
146628169|NCT00528112|528813572|FG000|Extension Phase|Withdrawal by Subject|0|||
146628170|NCT00528112|528813573|FG001|Extension Phase|Withdrawal by Subject|3|||
146628171|NCT00528112|528813572|FG000|Extension Phase|Other reasons|0|||
146628172|NCT00528112|528813573|FG001|Extension Phase|Other reasons|100|||
146628173|NCT00528112|528813572|FG000|Extension Phase|Pregnancy|0|||
146628174|NCT00528112|528813573|FG001|Extension Phase|Pregnancy|3|||
146628175|NCT00528112|528813572|FG000|Extension Phase|Lost to Follow-up|0|||
146543262|NCT00817063|528495753|FG000|Overall Study|Death|1|||
146543263|NCT00817063|528495754|FG001|Overall Study|Death|1|||
146543264|NCT00817063|528495753|FG000|Overall Study|Lack of Efficacy|33|||
146543265|NCT00817063|528495754|FG001|Overall Study|Lack of Efficacy|86|||
146543266|NCT00817063|528495753|FG000|Overall Study|Failure to Return|13|||
146543267|NCT00817063|528495754|FG001|Overall Study|Failure to Return|12|||
146543268|NCT00817063|528495753|FG000|Overall Study|Violation of Selection at Entry|7|||
146543269|NCT00817063|528495754|FG001|Overall Study|Violation of Selection at Entry|4|||
146543270|NCT00817063|528495753|FG000|Overall Study|Protocol Violation|3|||
146543271|NCT00817063|528495754|FG001|Overall Study|Protocol Violation|8|||
146543272|NCT00817063|528495753|FG000|Overall Study|Withdrawal by Subject|17|||
146543273|NCT00817063|528495754|FG001|Overall Study|Withdrawal by Subject|37|||
146628176|NCT00528112|528813573|FG001|Extension Phase|Lost to Follow-up|12|||
146628177|NCT00528112|528813572|FG000|Extension Phase|Death|0|||
146628178|NCT00528112|528813573|FG001|Extension Phase|Death|1|||
146543274|NCT00817063|528495753|FG000|Overall Study|Early Improvement|19|||
146628179|NCT00528112|528813572|FG000|Extension Phase|Adverse Event|0|||
146628180|NCT00528112|528813573|FG001|Extension Phase|Adverse Event|36|||
146628181|NCT00528112|528813572|FG000|Extension Phase|Protocol Violation|0|||
146628182|NCT00528112|528813573|FG001|Extension Phase|Protocol Violation|2|||
146628183|NCT03050801|528813576|FG000|Experiment 1|Lost to Follow-up|0|||
146628184|NCT03050801|528813577|FG001|Experiment 1|Lost to Follow-up|1|||
146628185|NCT03050801|528813578|FG002|Experiment 1|Lost to Follow-up|0|||
146628186|NCT03050801|528813579|FG003|Experiment 1|Lost to Follow-up|0|||
146628187|NCT03050801|528813580|FG004|Experiment 1|Lost to Follow-up|0|||
146628188|NCT03050801|528813581|FG005|Experiment 1|Lost to Follow-up|0|||
146628189|NCT03050801|528813576|FG000|Experiment 1|Physician Decision|0|||
146628190|NCT03050801|528813577|FG001|Experiment 1|Physician Decision|3|||
146628191|NCT03050801|528813578|FG002|Experiment 1|Physician Decision|0|||
146628192|NCT03050801|528813579|FG003|Experiment 1|Physician Decision|0|||
146628193|NCT03050801|528813580|FG004|Experiment 1|Physician Decision|0|||
146628194|NCT03050801|528813581|FG005|Experiment 1|Physician Decision|0|||
146628195|NCT03050801|528813576|FG000|Experiment 1|Change of experimental design|0|||
146628196|NCT03050801|528813577|FG001|Experiment 1|Change of experimental design|3|||
146543275|NCT00817063|528495754|FG001|Overall Study|Early Improvement|4|||
146628197|NCT03050801|528813578|FG002|Experiment 1|Change of experimental design|0|||
146628198|NCT03050801|528813579|FG003|Experiment 1|Change of experimental design|0|||
146628199|NCT03050801|528813580|FG004|Experiment 1|Change of experimental design|0|||
146628200|NCT03050801|528813581|FG005|Experiment 1|Change of experimental design|0|||
146628201|NCT03050801|528813576|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
146628202|NCT03050801|528813577|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
146628203|NCT03050801|528813578|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
146628204|NCT03050801|528813579|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
146628205|NCT03050801|528813580|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
146628206|NCT03050801|528813581|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
146628207|NCT03050801|528813576|FG000|Experiment 2|Lost to Follow-up|0|||
146628208|NCT03050801|528813577|FG001|Experiment 2|Lost to Follow-up|0|||
146628209|NCT03050801|528813578|FG002|Experiment 2|Lost to Follow-up|0|||
146628210|NCT03050801|528813579|FG003|Experiment 2|Lost to Follow-up|1|||
146628211|NCT03050801|528813580|FG004|Experiment 2|Lost to Follow-up|1|||
146628212|NCT03050801|528813581|FG005|Experiment 2|Lost to Follow-up|0|||
146628213|NCT03050801|528813576|FG000|Experiment 2|Physician Decision|0|||
146628214|NCT03050801|528813577|FG001|Experiment 2|Physician Decision|0|||
146628215|NCT03050801|528813578|FG002|Experiment 2|Physician Decision|0|||
146628216|NCT03050801|528813579|FG003|Experiment 2|Physician Decision|0|||
146628217|NCT03050801|528813580|FG004|Experiment 2|Physician Decision|1|||
146628218|NCT03050801|528813581|FG005|Experiment 2|Physician Decision|0|||
146628219|NCT03050801|528813576|FG000|Experiment 2|Pregnancy|0|||
146628220|NCT03050801|528813577|FG001|Experiment 2|Pregnancy|0|||
146628221|NCT03050801|528813578|FG002|Experiment 2|Pregnancy|0|||
146628222|NCT03050801|528813579|FG003|Experiment 2|Pregnancy|0|||
146628223|NCT03050801|528813580|FG004|Experiment 2|Pregnancy|1|||
146628224|NCT03050801|528813581|FG005|Experiment 2|Pregnancy|0|||
146628225|NCT03050801|528813576|FG000|Experiment 2|Withdrawal by Subject|0|||
146628226|NCT03050801|528813577|FG001|Experiment 2|Withdrawal by Subject|0|||
146543276|NCT00817063|528495753|FG000|Overall Study|Administrative|10|||
146543277|NCT00817063|528495754|FG001|Overall Study|Administrative|4|||
146543278|NCT00817063|528495753|FG000|Overall Study|Abnormality of Laboratory Test|2|||
146543279|NCT00817063|528495754|FG001|Overall Study|Abnormality of Laboratory Test|1|||
146543280|NCT01496456|528495755|FG000|Overall Study|Protocol Violation|1|||
146543281|NCT01496456|528495755|FG000|Overall Study|Lost to Follow-up|7|||
146543282|NCT04919161|528495756|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
146543283|NCT04919161|528495757|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
146543284|NCT04919161|528495756|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
146543285|NCT04919161|528495757|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
146628227|NCT03050801|528813578|FG002|Experiment 2|Withdrawal by Subject|0|||
146543286|NCT04919161|528495756|FG000|Overall Study|Acute ankle sprain after session 1|0|||
146543287|NCT04919161|528495757|FG001|Overall Study|Acute ankle sprain after session 1|1|||
146543288|NCT00712920|528495758|FG000|Overall Study|Adverse Event|3|||
146628228|NCT03050801|528813579|FG003|Experiment 2|Withdrawal by Subject|1|||
146628229|NCT03050801|528813580|FG004|Experiment 2|Withdrawal by Subject|0|||
146628230|NCT03050801|528813581|FG005|Experiment 2|Withdrawal by Subject|0|||
146628231|NCT03050801|528813576|FG000|Experiment 2|Poor data quality|0|||
146628232|NCT03050801|528813577|FG001|Experiment 2|Poor data quality|0|||
146628233|NCT03050801|528813578|FG002|Experiment 2|Poor data quality|0|||
146628234|NCT03050801|528813579|FG003|Experiment 2|Poor data quality|4|||
146764379|NCT00549848|529304373|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
146764380|NCT00549848|529304371|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
146543289|NCT00712920|528495759|FG001|Overall Study|Adverse Event|4|||
146543290|NCT00712920|528495760|FG002|Overall Study|Adverse Event|7|||
146543291|NCT00712920|528495758|FG000|Overall Study|Withdrawal by Subject|4|||
146543292|NCT00712920|528495759|FG001|Overall Study|Withdrawal by Subject|2|||
146543293|NCT00712920|528495760|FG002|Overall Study|Withdrawal by Subject|1|||
146543294|NCT00712920|528495758|FG000|Overall Study|Lost to Follow-up|1|||
146543295|NCT00712920|528495759|FG001|Overall Study|Lost to Follow-up|4|||
146543296|NCT00712920|528495760|FG002|Overall Study|Lost to Follow-up|0|||
146543297|NCT00712920|528495758|FG000|Overall Study|Lack of Efficacy|1|||
146543298|NCT00712920|528495759|FG001|Overall Study|Lack of Efficacy|0|||
146543299|NCT00712920|528495760|FG002|Overall Study|Lack of Efficacy|1|||
146543300|NCT00712920|528495758|FG000|Overall Study|Other|5|||
146543301|NCT00712920|528495759|FG001|Overall Study|Other|7|||
146543302|NCT00712920|528495760|FG002|Overall Study|Other|3|||
146543303|NCT00712920|528495758|FG000|Overall Study|Non-compliance|3|||
146543304|NCT00712920|528495759|FG001|Overall Study|Non-compliance|0|||
146543305|NCT00712920|528495760|FG002|Overall Study|Non-compliance|0|||
146543306|NCT02489773|528495761|FG000|Overall Study|Lost to Follow-up|4|||
146543307|NCT02489773|528495762|FG001|Overall Study|Lost to Follow-up|1|||
146543308|NCT02489773|528495761|FG000|Overall Study|Physician Decision|1|||
146543309|NCT02489773|528495762|FG001|Overall Study|Physician Decision|0|||
146543310|NCT02489773|528495761|FG000|Overall Study|Withdrawal by Subject|1|||
146543311|NCT02489773|528495762|FG001|Overall Study|Withdrawal by Subject|0|||
146543312|NCT02489773|528495761|FG000|Overall Study|Leave the country or the state|1|||
146543313|NCT02489773|528495762|FG001|Overall Study|Leave the country or the state|1|||
146543314|NCT02696616|528495764|FG000|Overall Study|Adverse Event|0|||
146543315|NCT02696616|528495765|FG001|Overall Study|Adverse Event|1|||
146543316|NCT02696616|528495766|FG002|Overall Study|Adverse Event|0|||
146543317|NCT02696616|528495767|FG003|Overall Study|Adverse Event|0|||
146543318|NCT02696616|528495768|FG004|Overall Study|Adverse Event|0|||
146543319|NCT02696616|528495769|FG005|Overall Study|Adverse Event|0|||
146543320|NCT02696616|528495770|FG006|Overall Study|Adverse Event|0|||
146543321|NCT01732783|528495773|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
146543322|NCT01732783|528495774|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
146543323|NCT01732783|528495775|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
146543324|NCT01732783|528495773|FG000|Overall Study|Death|13|||
146543325|NCT01732783|528495774|FG001|Overall Study|Death|4|||
146543326|NCT01732783|528495775|FG002|Overall Study|Death|1|||
146543327|NCT01732783|528495773|FG000|Overall Study|Lost to Follow-up|7|||
146543328|NCT01732783|528495774|FG001|Overall Study|Lost to Follow-up|1|||
146543329|NCT01732783|528495775|FG002|Overall Study|Lost to Follow-up|1|||
146543330|NCT01732783|528495773|FG000|Overall Study|Administrative Decision|8|||
146543331|NCT01732783|528495774|FG001|Overall Study|Administrative Decision|2|||
146543332|NCT01732783|528495775|FG002|Overall Study|Administrative Decision|1|||
146543333|NCT01732783|528495773|FG000|Overall Study|Withdrawal by Subject|1|||
146543334|NCT01732783|528495774|FG001|Overall Study|Withdrawal by Subject|0|||
146543335|NCT01732783|528495775|FG002|Overall Study|Withdrawal by Subject|0|||
146543336|NCT01500083|528495776|FG000|Overall Study|Adverse Event|4|||
146543337|NCT01500083|528495777|FG001|Overall Study|Adverse Event|17|||
146543338|NCT01500083|528495776|FG000|Overall Study|Death|0|||
146543339|NCT01500083|528495777|FG001|Overall Study|Death|2|||
146543340|NCT01500083|528495776|FG000|Overall Study|Lost to Follow-up|1|||
146543341|NCT01500083|528495777|FG001|Overall Study|Lost to Follow-up|0|||
146543342|NCT01500083|528495776|FG000|Overall Study|Withdrawal of Consent|0|||
146543343|NCT01500083|528495777|FG001|Overall Study|Withdrawal of Consent|1|||
146543344|NCT01500083|528495776|FG000|Overall Study|Disease Progression|2|||
146543345|NCT01500083|528495777|FG001|Overall Study|Disease Progression|10|||
146543346|NCT01500083|528495776|FG000|Overall Study|Investigator Discretion|3|||
146543347|NCT01500083|528495777|FG001|Overall Study|Investigator Discretion|8|||
146543348|NCT01500083|528495776|FG000|Overall Study|Other Reasons|2|||
146543349|NCT01500083|528495777|FG001|Overall Study|Other Reasons|5|||
146543350|NCT01555931|528495778|FG000|Overall Study|Lost to Follow-up|2|||
146543351|NCT01555931|528495779|FG001|Overall Study|Lost to Follow-up|5|||
146543352|NCT01697579|528495782|FG000|Base Study-Cycle 1|Adverse Event|1|||
146543353|NCT01697579|528495783|FG001|Base Study-Cycle 1|Adverse Event|0|||
146543354|NCT01697579|528495784|FG002|Base Study-Cycle 1|Adverse Event|0|||
146543355|NCT01697579|528495785|FG003|Base Study-Cycle 1|Adverse Event|0|||
146543356|NCT01697579|528495786|FG004|Base Study-Cycle 1|Adverse Event|0|||
146543357|NCT01697579|528495787|FG005|Base Study-Cycle 1|Adverse Event|0|||
146543358|NCT01697579|528495788|FG006|Base Study-Cycle 1|Adverse Event|0|||
146543359|NCT01697579|528495782|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
146543360|NCT01697579|528495783|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
146543361|NCT01697579|528495784|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
146873309|NCT01177683|529706677|FG000|Study Treatment|Symptomatic Deterioration|0|||
146873310|NCT01177683|529706678|FG001|Study Treatment|Symptomatic Deterioration|0|||
146873311|NCT01177683|529706679|FG002|Study Treatment|Symptomatic Deterioration|1|||
146873312|NCT01177683|529706677|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
146873313|NCT01177683|529706678|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
146873314|NCT01177683|529706679|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
146873315|NCT01177683|529706677|FG000|Follow up|Patient lost to follow up|0|||
146873316|NCT01177683|529706678|FG001|Follow up|Patient lost to follow up|0|||
146873317|NCT01177683|529706679|FG002|Follow up|Patient lost to follow up|2|||
146873318|NCT01177683|529706677|FG000|Follow up|Death|2|||
146873319|NCT01177683|529706678|FG001|Follow up|Death|1|||
146873320|NCT01177683|529706679|FG002|Follow up|Death|7|||
146873321|NCT01177683|529706677|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
146873322|NCT01177683|529706678|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
146873323|NCT01177683|529706679|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
146873324|NCT01977820|529706684|FG000|Overall Study|Sponsor terminated the study|1|||
146873325|NCT01977820|529706685|FG001|Overall Study|Sponsor terminated the study|1|||
146873326|NCT02568475|529706688|FG000|Overall Study|Lost to Follow-up|40|||
146873327|NCT02568475|529706689|FG001|Overall Study|Lost to Follow-up|39|||
146873328|NCT02568475|529706688|FG000|Overall Study|Withdrawal by Subject|2|||
146873329|NCT02568475|529706689|FG001|Overall Study|Withdrawal by Subject|0|||
146873330|NCT02568475|529706688|FG000|Overall Study|Discharged home|4|||
146873331|NCT02568475|529706689|FG001|Overall Study|Discharged home|4|||
146873332|NCT02568475|529706688|FG000|Overall Study|Short-term: Discharge location unknown|4|||
146873333|NCT02568475|529706689|FG001|Overall Study|Short-term: Discharge location unknown|0|||
146873334|NCT02568475|529706688|FG000|Overall Study|Transferred to another facility|1|||
146873335|NCT02568475|529706689|FG001|Overall Study|Transferred to another facility|0|||
146873336|NCT02625233|529706690|FG000|Overall Study|Adverse Event|2|||
146873337|NCT02625233|529706691|FG001|Overall Study|Adverse Event|0|||
146873338|NCT04425720|529706699|FG000|Overall Study|Withdrawal by Subject|0|||
146873339|NCT04425720|529706700|FG001|Overall Study|Withdrawal by Subject|20|||
146873340|NCT00290186|529706701|FG000|Overall Study|Adverse Event|1|||
146873341|NCT00290186|529706702|FG001|Overall Study|Adverse Event|1|||
146543362|NCT01697579|528495785|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
146543363|NCT01697579|528495786|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
146543364|NCT01697579|528495787|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
146543365|NCT01697579|528495788|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
146543366|NCT01697579|528495782|FG000|Base Study-Cycle 1|Protocol Violation|0|||
146543367|NCT01697579|528495783|FG001|Base Study-Cycle 1|Protocol Violation|0|||
146543368|NCT01697579|528495784|FG002|Base Study-Cycle 1|Protocol Violation|0|||
146543369|NCT01697579|528495785|FG003|Base Study-Cycle 1|Protocol Violation|0|||
146543370|NCT01697579|528495786|FG004|Base Study-Cycle 1|Protocol Violation|3|||
146543371|NCT01697579|528495787|FG005|Base Study-Cycle 1|Protocol Violation|0|||
146543372|NCT01697579|528495788|FG006|Base Study-Cycle 1|Protocol Violation|0|||
146543373|NCT01697579|528495782|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
146543374|NCT01697579|528495783|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
146543375|NCT01697579|528495784|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
146543376|NCT01697579|528495785|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
146543377|NCT01697579|528495786|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
146543378|NCT01697579|528495787|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
146543379|NCT01697579|528495788|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
146543380|NCT01697579|528495782|FG000|Base Study-Cycle 1|Technical Problems|0|||
146543381|NCT01697579|528495783|FG001|Base Study-Cycle 1|Technical Problems|0|||
146543382|NCT01697579|528495784|FG002|Base Study-Cycle 1|Technical Problems|1|||
146543383|NCT01697579|528495785|FG003|Base Study-Cycle 1|Technical Problems|1|||
146543384|NCT01697579|528495786|FG004|Base Study-Cycle 1|Technical Problems|0|||
146543385|NCT01697579|528495787|FG005|Base Study-Cycle 1|Technical Problems|0|||
146543386|NCT01697579|528495788|FG006|Base Study-Cycle 1|Technical Problems|0|||
146543387|NCT01697579|528495782|FG000|Optional Extension-Cycles 2-6|Death|0|||
146873342|NCT00290186|529706701|FG000|Overall Study|Lost to Follow-up|3|||
146873343|NCT00290186|529706702|FG001|Overall Study|Lost to Follow-up|2|||
146873344|NCT00290186|529706701|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
146543388|NCT01697579|528495783|FG001|Optional Extension-Cycles 2-6|Death|0|||
146543389|NCT01697579|528495784|FG002|Optional Extension-Cycles 2-6|Death|0|||
146543390|NCT01697579|528495785|FG003|Optional Extension-Cycles 2-6|Death|0|||
146543391|NCT01697579|528495786|FG004|Optional Extension-Cycles 2-6|Death|0|||
146543392|NCT01697579|528495787|FG005|Optional Extension-Cycles 2-6|Death|0|||
146543393|NCT01697579|528495788|FG006|Optional Extension-Cycles 2-6|Death|2|||
146873345|NCT00290186|529706702|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
146873346|NCT00290186|529706701|FG000|Overall Study|Withdrawal by Subject|0|||
146873347|NCT00290186|529706702|FG001|Overall Study|Withdrawal by Subject|1|||
146873348|NCT03184077|529706705|FG000|Overall Study|Lost to Follow-up|21|||
146873349|NCT03184077|529706706|FG001|Overall Study|Lost to Follow-up|21|||
146543394|NCT01697579|528495782|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
146543395|NCT01697579|528495783|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
146543396|NCT01697579|528495784|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
146543397|NCT01697579|528495785|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
146543398|NCT01697579|528495786|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
146543399|NCT01697579|528495787|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
146543400|NCT01697579|528495788|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
146543401|NCT01697579|528495782|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
146543402|NCT01697579|528495783|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
146543403|NCT01697579|528495784|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
146543404|NCT01697579|528495785|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
146543405|NCT01697579|528495786|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
146543406|NCT01697579|528495787|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
146543407|NCT01697579|528495788|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
146543408|NCT01697579|528495782|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
146543409|NCT01697579|528495783|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
146543410|NCT01697579|528495784|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
146543411|NCT01697579|528495785|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
146543412|NCT01697579|528495786|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
146543413|NCT01697579|528495787|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
146543414|NCT01697579|528495788|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
146543415|NCT01697579|528495782|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
146543416|NCT01697579|528495783|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
146543417|NCT01697579|528495784|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
146543418|NCT01697579|528495785|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
146543419|NCT01697579|528495786|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
146543420|NCT01697579|528495787|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
146543421|NCT01697579|528495788|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
146543422|NCT01697579|528495782|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
146543423|NCT01697579|528495783|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
146543424|NCT01697579|528495784|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
146543425|NCT01697579|528495785|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
146543426|NCT01697579|528495786|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
146543427|NCT01697579|528495787|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
146543428|NCT01697579|528495788|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
146543429|NCT01697579|528495782|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
146543430|NCT01697579|528495783|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
146543431|NCT01697579|528495784|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
146543432|NCT01697579|528495785|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
146543433|NCT01697579|528495786|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
146543434|NCT01697579|528495787|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
146543435|NCT01697579|528495788|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
146543436|NCT01697579|528495782|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
146543437|NCT01697579|528495783|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
146543438|NCT01697579|528495784|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
146543439|NCT01697579|528495785|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
146543440|NCT01697579|528495786|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
146568862|NCT02259114|528595486|FG002|Overall Study|Adverse Event|0|||
146764381|NCT00549848|529304372|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
146764382|NCT00549848|529304373|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
146764383|NCT00549848|529304371|FG000|Overall Study|Participant/Family Withdraw|2|||
146628235|NCT03050801|528813580|FG004|Experiment 2|Poor data quality|1|||
146628236|NCT03050801|528813581|FG005|Experiment 2|Poor data quality|0|||
146628237|NCT03050801|528813576|FG000|Experiment 2|Discomfort during stimulation|0|||
146628238|NCT03050801|528813577|FG001|Experiment 2|Discomfort during stimulation|0|||
146628239|NCT03050801|528813578|FG002|Experiment 2|Discomfort during stimulation|0|||
146628240|NCT03050801|528813579|FG003|Experiment 2|Discomfort during stimulation|0|||
146628241|NCT03050801|528813580|FG004|Experiment 2|Discomfort during stimulation|0|||
146628242|NCT03050801|528813581|FG005|Experiment 2|Discomfort during stimulation|2|||
146628243|NCT04825574|528813584|FG000|Overall Study|Commercial treatment became available|1|||
146628244|NCT04825574|528813584|FG000|Overall Study|Disease progression|1|||
146628245|NCT03518086|528813585|FG000|Overall Study|Adverse Event|23|||
146628246|NCT03518086|528813586|FG001|Overall Study|Adverse Event|15|||
146628247|NCT03518086|528813587|FG002|Overall Study|Adverse Event|3|||
146628248|NCT03518086|528813588|FG003|Overall Study|Adverse Event|2|||
146628249|NCT03518086|528813585|FG000|Overall Study|Withdrawal by Subject|8|||
146628250|NCT03518086|528813586|FG001|Overall Study|Withdrawal by Subject|5|||
146628251|NCT03518086|528813587|FG002|Overall Study|Withdrawal by Subject|1|||
146628252|NCT03518086|528813588|FG003|Overall Study|Withdrawal by Subject|0|||
146628253|NCT03518086|528813585|FG000|Overall Study|Lack of Efficacy|5|||
146628254|NCT03518086|528813586|FG001|Overall Study|Lack of Efficacy|5|||
146628255|NCT03518086|528813587|FG002|Overall Study|Lack of Efficacy|0|||
146628256|NCT03518086|528813588|FG003|Overall Study|Lack of Efficacy|2|||
146628257|NCT03518086|528813585|FG000|Overall Study|Protocol Violation|1|||
146628258|NCT03518086|528813586|FG001|Overall Study|Protocol Violation|5|||
146628259|NCT03518086|528813587|FG002|Overall Study|Protocol Violation|1|||
146628260|NCT03518086|528813588|FG003|Overall Study|Protocol Violation|3|||
146628261|NCT03518086|528813585|FG000|Overall Study|Lost to Follow-up|0|||
146628262|NCT03518086|528813586|FG001|Overall Study|Lost to Follow-up|3|||
146628263|NCT03518086|528813587|FG002|Overall Study|Lost to Follow-up|0|||
146628264|NCT03518086|528813588|FG003|Overall Study|Lost to Follow-up|0|||
146628265|NCT03518086|528813585|FG000|Overall Study|Insufficient Diary Data|0|||
146628266|NCT03518086|528813586|FG001|Overall Study|Insufficient Diary Data|2|||
146628267|NCT03518086|528813587|FG002|Overall Study|Insufficient Diary Data|0|||
146628268|NCT03518086|528813588|FG003|Overall Study|Insufficient Diary Data|0|||
146628269|NCT03518086|528813585|FG000|Overall Study|Non- compliance to Protocol|0|||
146628270|NCT03518086|528813586|FG001|Overall Study|Non- compliance to Protocol|1|||
146628271|NCT03518086|528813587|FG002|Overall Study|Non- compliance to Protocol|0|||
146628272|NCT03518086|528813588|FG003|Overall Study|Non- compliance to Protocol|0|||
146628273|NCT03518086|528813585|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
146628274|NCT03518086|528813586|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
146628275|NCT03518086|528813587|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
146628276|NCT03518086|528813588|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
146628277|NCT03518086|528813585|FG000|Overall Study|Site Terminated by Sponsor|0|||
146628278|NCT03518086|528813586|FG001|Overall Study|Site Terminated by Sponsor|1|||
146628279|NCT03518086|528813587|FG002|Overall Study|Site Terminated by Sponsor|0|||
146873350|NCT00262522|529706707|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
146873351|NCT00262522|529706708|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
146873352|NCT00262522|529706709|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
146873353|NCT00262522|529706710|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
146873354|NCT00262522|529706707|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
146873355|NCT00262522|529706708|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
146873356|NCT00262522|529706709|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
146873357|NCT00262522|529706710|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
146873358|NCT00262522|529706707|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
146873359|NCT00262522|529706708|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
146873360|NCT00262522|529706709|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
146873361|NCT00262522|529706710|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
146873362|NCT00262522|529706707|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
146873363|NCT00262522|529706708|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
146628280|NCT03518086|528813588|FG003|Overall Study|Site Terminated by Sponsor|0|||
146628281|NCT03518086|528813585|FG000|Overall Study|Pregnancy|0|||
146628282|NCT03518086|528813586|FG001|Overall Study|Pregnancy|0|||
146628283|NCT03518086|528813587|FG002|Overall Study|Pregnancy|0|||
146628284|NCT03518086|528813588|FG003|Overall Study|Pregnancy|2|||
146628285|NCT02151058|528815435|FG000|Overall Study|Withdrawal by Subject|1|||
146628286|NCT02151058|528815436|FG001|Overall Study|Withdrawal by Subject|1|||
146628287|NCT02151058|528815437|FG002|Overall Study|Withdrawal by Subject|3|||
146628288|NCT02151058|528815435|FG000|Overall Study|Lost to Follow-up|1|||
146628289|NCT02151058|528815436|FG001|Overall Study|Lost to Follow-up|0|||
146628290|NCT02151058|528815437|FG002|Overall Study|Lost to Follow-up|2|||
146873364|NCT00262522|529706709|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
146873365|NCT00262522|529706710|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
146873366|NCT00262522|529706707|FG000|Study Start Through 8 Weeks|Death|1|||
146543441|NCT01697579|528495787|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
146543442|NCT01697579|528495788|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
146543443|NCT01697579|528495782|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
146543444|NCT01697579|528495783|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
146543445|NCT01697579|528495784|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
146543446|NCT01697579|528495785|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
146543447|NCT01697579|528495786|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
146543448|NCT01697579|528495787|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
146543449|NCT01697579|528495788|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
146543450|NCT01697579|528495782|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
146543451|NCT01697579|528495783|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
146543452|NCT01697579|528495784|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
146543453|NCT01697579|528495785|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
146543454|NCT01697579|528495786|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
146543455|NCT01697579|528495787|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
146543456|NCT01697579|528495788|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
146543457|NCT01697579|528495782|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
146543458|NCT01697579|528495783|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
146543459|NCT01697579|528495784|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
146543460|NCT01697579|528495785|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
146543461|NCT01697579|528495786|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
146543462|NCT01697579|528495787|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
146543463|NCT01697579|528495788|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
146543464|NCT01697579|528495782|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
146543465|NCT01697579|528495783|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
146543466|NCT01697579|528495784|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
146543467|NCT01697579|528495785|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
146543468|NCT01697579|528495786|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
146543469|NCT01697579|528495787|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
146543470|NCT01697579|528495788|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
146543471|NCT01697579|528495782|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
146543472|NCT01697579|528495783|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
146543473|NCT01697579|528495784|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
146543474|NCT01697579|528495785|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
146543475|NCT01697579|528495786|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
146543476|NCT01697579|528495787|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
146543477|NCT01697579|528495788|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
146543478|NCT01044498|528495789|FG000|Overall Study|Withdrew consent|1|||
146543479|NCT01044498|528495790|FG001|Overall Study|Withdrew consent|1|||
146543480|NCT01044498|528495789|FG000|Overall Study|Adverse Event|1|||
146543481|NCT01044498|528495790|FG001|Overall Study|Adverse Event|1|||
146543482|NCT01044498|528495789|FG000|Overall Study|Other|1|||
146543483|NCT01044498|528495790|FG001|Overall Study|Other|0|||
146543484|NCT05513950|528495791|FG000|Overall Study|Not treated due to technical reasons|0|||
146543485|NCT05513950|528495792|FG001|Overall Study|Not treated due to technical reasons|0|||
146543486|NCT05513950|528495793|FG002|Overall Study|Not treated due to technical reasons|1|||
146543487|NCT05513950|528495794|FG003|Overall Study|Not treated due to technical reasons|0|||
146543488|NCT02903914|528495795|FG000|Overall Study|Adverse Event|0|||
146543489|NCT02903914|528495796|FG001|Overall Study|Adverse Event|0|||
146543490|NCT02903914|528495797|FG002|Overall Study|Adverse Event|1|||
146543491|NCT02903914|528495798|FG003|Overall Study|Adverse Event|0|||
146543492|NCT02903914|528495799|FG004|Overall Study|Adverse Event|0|||
146543493|NCT02903914|528495800|FG005|Overall Study|Adverse Event|0|||
146628291|NCT00124943|528815438|FG000|Phase II|Adverse Event|0|||
146628292|NCT00124943|528815439|FG001|Phase II|Adverse Event|2|||
146873367|NCT00262522|529706708|FG001|Study Start Through 8 Weeks|Death|0|||
146873368|NCT00262522|529706709|FG002|Study Start Through 8 Weeks|Death|0|||
146543494|NCT02903914|528495801|FG006|Overall Study|Adverse Event|2|||
146543495|NCT02903914|528495802|FG007|Overall Study|Adverse Event|0|||
146543496|NCT02903914|528495795|FG000|Overall Study|Withdrawal by Subject|3|||
146543497|NCT02903914|528495796|FG001|Overall Study|Withdrawal by Subject|1|||
146543498|NCT02903914|528495797|FG002|Overall Study|Withdrawal by Subject|28|||
146873369|NCT00262522|529706710|FG003|Study Start Through 8 Weeks|Death|0|||
146628293|NCT00124943|528815440|FG002|Phase II|Adverse Event|0|||
146543499|NCT02903914|528495798|FG003|Overall Study|Withdrawal by Subject|0|||
146543500|NCT02903914|528495799|FG004|Overall Study|Withdrawal by Subject|1|||
146543501|NCT02903914|528495800|FG005|Overall Study|Withdrawal by Subject|2|||
146543502|NCT02903914|528495801|FG006|Overall Study|Withdrawal by Subject|12|||
146543503|NCT02903914|528495802|FG007|Overall Study|Withdrawal by Subject|0|||
146543504|NCT02903914|528495795|FG000|Overall Study|Progressive Disease|1|||
146543505|NCT02903914|528495796|FG001|Overall Study|Progressive Disease|0|||
146543506|NCT02903914|528495797|FG002|Overall Study|Progressive Disease|4|||
146543507|NCT02903914|528495798|FG003|Overall Study|Progressive Disease|0|||
146543508|NCT02903914|528495799|FG004|Overall Study|Progressive Disease|0|||
146543509|NCT02903914|528495800|FG005|Overall Study|Progressive Disease|0|||
146543510|NCT02903914|528495801|FG006|Overall Study|Progressive Disease|2|||
146543511|NCT02903914|528495802|FG007|Overall Study|Progressive Disease|0|||
146543512|NCT02903914|528495795|FG000|Overall Study|Death|0|||
146543513|NCT02903914|528495796|FG001|Overall Study|Death|0|||
146543514|NCT02903914|528495797|FG002|Overall Study|Death|9|||
146543515|NCT02903914|528495798|FG003|Overall Study|Death|0|||
146543516|NCT02903914|528495799|FG004|Overall Study|Death|1|||
146543517|NCT02903914|528495800|FG005|Overall Study|Death|3|||
146543518|NCT02903914|528495801|FG006|Overall Study|Death|24|||
146543519|NCT02903914|528495802|FG007|Overall Study|Death|2|||
146543520|NCT02903914|528495795|FG000|Overall Study|Lost to Follow-up|0|||
146543521|NCT02903914|528495796|FG001|Overall Study|Lost to Follow-up|1|||
146543522|NCT02903914|528495797|FG002|Overall Study|Lost to Follow-up|0|||
146543523|NCT02903914|528495798|FG003|Overall Study|Lost to Follow-up|0|||
146543524|NCT02903914|528495799|FG004|Overall Study|Lost to Follow-up|2|||
146543525|NCT02903914|528495800|FG005|Overall Study|Lost to Follow-up|0|||
146543526|NCT02903914|528495801|FG006|Overall Study|Lost to Follow-up|1|||
146543527|NCT02903914|528495802|FG007|Overall Study|Lost to Follow-up|0|||
146543528|NCT02903914|528495795|FG000|Overall Study|Physician Decision|0|||
146543529|NCT02903914|528495796|FG001|Overall Study|Physician Decision|0|||
146543530|NCT02903914|528495797|FG002|Overall Study|Physician Decision|1|||
146543531|NCT02903914|528495798|FG003|Overall Study|Physician Decision|0|||
146543532|NCT02903914|528495799|FG004|Overall Study|Physician Decision|0|||
146543533|NCT02903914|528495800|FG005|Overall Study|Physician Decision|0|||
146543534|NCT02903914|528495801|FG006|Overall Study|Physician Decision|1|||
146543535|NCT02903914|528495802|FG007|Overall Study|Physician Decision|0|||
146543536|NCT02903914|528495795|FG000|Overall Study|Symptomatic Deterioration|0|||
146543537|NCT02903914|528495796|FG001|Overall Study|Symptomatic Deterioration|0|||
146543538|NCT02903914|528495797|FG002|Overall Study|Symptomatic Deterioration|1|||
146543539|NCT02903914|528495798|FG003|Overall Study|Symptomatic Deterioration|0|||
146543540|NCT02903914|528495799|FG004|Overall Study|Symptomatic Deterioration|0|||
146543541|NCT02903914|528495800|FG005|Overall Study|Symptomatic Deterioration|0|||
146764384|NCT00549848|529304372|FG001|Overall Study|Participant/Family Withdraw|3|||
146543542|NCT02903914|528495801|FG006|Overall Study|Symptomatic Deterioration|0|||
146543543|NCT02903914|528495802|FG007|Overall Study|Symptomatic Deterioration|0|||
146543544|NCT02903914|528495795|FG000|Overall Study|New Cancer Therapy|2|||
146873370|NCT00262522|529706707|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
146873371|NCT00262522|529706708|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
146873372|NCT00262522|529706709|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
146873373|NCT00262522|529706710|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
146873374|NCT00262522|529706707|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
146873375|NCT00262522|529706708|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
146628294|NCT00124943|528815441|FG003|Phase II|Adverse Event|1|||
146628295|NCT00124943|528815438|FG000|Phase II|Protocol Violation|0|||
146628296|NCT00124943|528815439|FG001|Phase II|Protocol Violation|0|||
146628297|NCT00124943|528815440|FG002|Phase II|Protocol Violation|0|||
146628298|NCT00124943|528815441|FG003|Phase II|Protocol Violation|1|||
146628299|NCT00124943|528815438|FG000|Phase II|Lost to Follow-up|0|||
146628300|NCT00124943|528815439|FG001|Phase II|Lost to Follow-up|0|||
146628301|NCT00124943|528815440|FG002|Phase II|Lost to Follow-up|0|||
146628302|NCT00124943|528815441|FG003|Phase II|Lost to Follow-up|1|||
146628303|NCT00124943|528815438|FG000|Phase II|Withdrawal by Subject|0|||
146628304|NCT00124943|528815439|FG001|Phase II|Withdrawal by Subject|0|||
146628305|NCT00124943|528815440|FG002|Phase II|Withdrawal by Subject|0|||
146628306|NCT00124943|528815441|FG003|Phase II|Withdrawal by Subject|2|||
146628307|NCT03829228|528815442|FG000|Overall Study|Protocol Violation|1|||
146628308|NCT03337477|528815443|FG000|Overall Study|not categorized into the listed ones|11|||
146628309|NCT03337477|528815444|FG001|Overall Study|not categorized into the listed ones|9|||
146628310|NCT03337477|528815443|FG000|Overall Study|Withdrawal by Subject|0|||
146628311|NCT03337477|528815444|FG001|Overall Study|Withdrawal by Subject|1|||
146628312|NCT03337477|528815443|FG000|Overall Study|Death|0|||
146628313|NCT03337477|528815444|FG001|Overall Study|Death|1|||
146628314|NCT03337477|528815443|FG000|Overall Study|Lost to Follow-up|0|||
146628315|NCT03337477|528815444|FG001|Overall Study|Lost to Follow-up|2|||
146628316|NCT02443688|528815447|FG000|Overall Study|Adverse Event|2|||
146628317|NCT02443688|528815448|FG001|Overall Study|Adverse Event|3|||
146628318|NCT02443688|528815449|FG002|Overall Study|Adverse Event|2|||
146628319|NCT02443688|528815447|FG000|Overall Study|Lost to Follow-up|1|||
146628320|NCT02443688|528815448|FG001|Overall Study|Lost to Follow-up|0|||
146628321|NCT02443688|528815449|FG002|Overall Study|Lost to Follow-up|0|||
146628322|NCT02443688|528815447|FG000|Overall Study|Physician Decision|3|||
146628323|NCT02443688|528815448|FG001|Overall Study|Physician Decision|0|||
146628324|NCT02443688|528815449|FG002|Overall Study|Physician Decision|1|||
146628325|NCT02443688|528815447|FG000|Overall Study|Pregnancy|0|||
146628326|NCT02443688|528815448|FG001|Overall Study|Pregnancy|0|||
146628327|NCT02443688|528815449|FG002|Overall Study|Pregnancy|1|||
146628328|NCT02443688|528815447|FG000|Overall Study|Withdrawal by Subject|3|||
146628329|NCT02443688|528815448|FG001|Overall Study|Withdrawal by Subject|3|||
146628330|NCT02443688|528815449|FG002|Overall Study|Withdrawal by Subject|4|||
146628331|NCT02443688|528815447|FG000|Overall Study|Non-compliance with study drug|1|||
146628332|NCT02443688|528815448|FG001|Overall Study|Non-compliance with study drug|2|||
146628333|NCT02443688|528815449|FG002|Overall Study|Non-compliance with study drug|4|||
146628334|NCT02443688|528815447|FG000|Overall Study|Sponsor Request|2|||
146628335|NCT02443688|528815448|FG001|Overall Study|Sponsor Request|1|||
146628336|NCT02443688|528815449|FG002|Overall Study|Sponsor Request|0|||
146628337|NCT00408317|528815451|FG000|First Intervention Period|Adverse Event|0|||
146628338|NCT00408317|528815452|FG001|First Intervention Period|Adverse Event|1|||
146628339|NCT00408317|528815451|FG000|Second Intervention Period|Adverse Event|2|||
146628340|NCT00408317|528815452|FG001|Second Intervention Period|Adverse Event|0|||
146628341|NCT00408317|528815451|FG000|Second Intervention Period|Protocol Violation|0|||
146628342|NCT00408317|528815452|FG001|Second Intervention Period|Protocol Violation|1|||
146628343|NCT00408317|528815451|FG000|Second Intervention Period|Withdrawal of consent|0|||
146628344|NCT00408317|528815452|FG001|Second Intervention Period|Withdrawal of consent|1|||
146628345|NCT02177123|528815460|FG000|Overall Study|Lost to Follow-up|6|||
146764385|NCT00549848|529304373|FG002|Overall Study|Participant/Family Withdraw|5|||
146628346|NCT02177123|528815460|FG000|Overall Study|Withdrawal by Subject|4|||
146628347|NCT02177123|528815460|FG000|Overall Study|Adverse Event|4|||
146628348|NCT02177123|528815460|FG000|Overall Study|Physician Decision|3|||
146628349|NCT02177123|528815460|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
146628350|NCT02177123|528815460|FG000|Overall Study|Excluded for medical reasons|2|||
146628351|NCT02177123|528815460|FG000|Overall Study|Death|1|||
146628352|NCT02177123|528815460|FG000|Overall Study|Other|1|||
146628353|NCT02177123|528815460|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
146628354|NCT05660577|528815461|FG000|Overall Study|Discontinued|9|||
146628355|NCT00481832|528815466|FG000|Enrollment|Physician Decision|8|||
146628356|NCT00481832|528815466|FG000|Enrollment|Unable to collect enough stem cells|2|||
146543545|NCT02903914|528495796|FG001|Overall Study|New Cancer Therapy|2|||
146543546|NCT02903914|528495797|FG002|Overall Study|New Cancer Therapy|21|||
146543547|NCT02903914|528495798|FG003|Overall Study|New Cancer Therapy|4|||
146543548|NCT02903914|528495799|FG004|Overall Study|New Cancer Therapy|3|||
146628357|NCT00481832|528815466|FG000|Inter-transplant Period|Adverse Event|4|||
146628358|NCT00481832|528815466|FG000|Inter-transplant Period|Death|3|||
146628359|NCT00481832|528815466|FG000|Inter-transplant Period|Physician Decision|4|||
146628360|NCT00481832|528815466|FG000|Inter-transplant Period|Disease relapse|11|||
146543549|NCT02903914|528495800|FG005|Overall Study|New Cancer Therapy|6|||
146543550|NCT02903914|528495801|FG006|Overall Study|New Cancer Therapy|56|||
146543551|NCT02903914|528495802|FG007|Overall Study|New Cancer Therapy|3|||
146543552|NCT02903914|528495795|FG000|Overall Study|Didn't Return to Site|1|||
146543553|NCT02903914|528495796|FG001|Overall Study|Didn't Return to Site|0|||
146543554|NCT02903914|528495797|FG002|Overall Study|Didn't Return to Site|1|||
146543555|NCT02903914|528495798|FG003|Overall Study|Didn't Return to Site|1|||
146543556|NCT02903914|528495799|FG004|Overall Study|Didn't Return to Site|0|||
146543557|NCT02903914|528495800|FG005|Overall Study|Didn't Return to Site|0|||
146543558|NCT02903914|528495801|FG006|Overall Study|Didn't Return to Site|2|||
146543559|NCT02903914|528495802|FG007|Overall Study|Didn't Return to Site|0|||
146543560|NCT02903914|528495795|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
146543561|NCT02903914|528495796|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
146543562|NCT02903914|528495797|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
146543563|NCT02903914|528495798|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
146543564|NCT02903914|528495799|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
146543565|NCT02903914|528495800|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
146543566|NCT02903914|528495801|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
146543567|NCT02903914|528495802|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
146543568|NCT02903914|528495795|FG000|Overall Study|Follow-up Did Not Occur|0|||
146543569|NCT02903914|528495796|FG001|Overall Study|Follow-up Did Not Occur|1|||
146543570|NCT02903914|528495797|FG002|Overall Study|Follow-up Did Not Occur|1|||
146543571|NCT02903914|528495798|FG003|Overall Study|Follow-up Did Not Occur|0|||
146543572|NCT02903914|528495799|FG004|Overall Study|Follow-up Did Not Occur|2|||
146543573|NCT02903914|528495800|FG005|Overall Study|Follow-up Did Not Occur|0|||
146543574|NCT02903914|528495801|FG006|Overall Study|Follow-up Did Not Occur|8|||
146543575|NCT02903914|528495802|FG007|Overall Study|Follow-up Did Not Occur|0|||
146543576|NCT02903914|528495795|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
146543577|NCT02903914|528495796|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
146543578|NCT02903914|528495797|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
146543579|NCT02903914|528495798|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
146543580|NCT02903914|528495799|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
146543581|NCT02903914|528495800|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
146543582|NCT02903914|528495801|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
146543583|NCT02903914|528495802|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
146543584|NCT02903914|528495795|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
146543585|NCT02903914|528495796|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
146543586|NCT02903914|528495797|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
146543587|NCT02903914|528495798|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
146628361|NCT00481832|528815466|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
146543588|NCT02903914|528495799|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
146543589|NCT02903914|528495800|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
146543590|NCT02903914|528495801|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
146628362|NCT00581308|528815470|FG000|Pre Discharge|Lost to Follow-up|1|||
146628363|NCT00581308|528815470|FG000|Pre Discharge|Device Removed|1|||
146628364|NCT00581308|528815470|FG000|Month 1|Lost to Follow-up|3|||
146628365|NCT00581308|528815470|FG000|Month 1|Withdrawal by Subject|2|||
146628366|NCT00581308|528815470|FG000|Month 1|Device Removed|2|||
146628367|NCT00581308|528815470|FG000|Month 1|Uknown|1|||
146628368|NCT00581308|528815470|FG000|Month 6|Lost to Follow-up|1|||
146628369|NCT00581308|528815470|FG000|Month 6|Withdrawal by Subject|2|||
146628370|NCT00581308|528815470|FG000|Month 12|Death|1|||
146628371|NCT00581308|528815470|FG000|Month 12|Lost to Follow-up|14|||
146628372|NCT00581308|528815470|FG000|Month 12|Withdrawal by Subject|3|||
146628373|NCT00581308|528815470|FG000|Month 12|Device Removed|1|||
146628374|NCT00581308|528815470|FG000|Month 12|Other|1|||
146628375|NCT02006472|528815471|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
146628376|NCT02006472|528815472|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
146628377|NCT02006472|528815473|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
146628378|NCT02006472|528815474|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
146628379|NCT02006472|528815475|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
146628380|NCT02006472|528815471|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
146628381|NCT02006472|528815472|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
146628382|NCT02006472|528815473|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
146628383|NCT02006472|528815474|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
146628384|NCT02006472|528815475|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
146628385|NCT02006472|528815471|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
146628386|NCT02006472|528815472|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
146628387|NCT02006472|528815473|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
146628388|NCT02006472|528815474|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
146628389|NCT02006472|528815475|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
146628390|NCT02006472|528815471|FG000|Period 1 (Through Week 26)|Other|1|||
146628391|NCT02006472|528815472|FG001|Period 1 (Through Week 26)|Other|5|||
146628392|NCT02006472|528815473|FG002|Period 1 (Through Week 26)|Other|0|||
146628393|NCT02006472|528815474|FG003|Period 1 (Through Week 26)|Other|2|||
146628394|NCT02006472|528815475|FG004|Period 1 (Through Week 26)|Other|3|||
146628395|NCT02006472|528815471|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
146628396|NCT02006472|528815472|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
146628397|NCT02006472|528815473|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
146628398|NCT02006472|528815474|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
146628399|NCT02006472|528815475|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
146628400|NCT02006472|528815471|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
146628401|NCT02006472|528815472|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
146628402|NCT02006472|528815473|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
146628403|NCT02006472|528815474|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
146628404|NCT02006472|528815475|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
146628405|NCT02006472|528815471|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
146628406|NCT02006472|528815472|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
146628407|NCT02006472|528815473|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
146628408|NCT02006472|528815474|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
146628409|NCT02006472|528815475|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
146628410|NCT02006472|528815471|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
146628411|NCT02006472|528815472|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
146628412|NCT02006472|528815473|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
146628413|NCT02006472|528815474|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
146628414|NCT02006472|528815475|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
146628415|NCT02006472|528815471|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
146628416|NCT02006472|528815472|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
146628417|NCT02006472|528815473|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
146628418|NCT02006472|528815474|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
146628419|NCT02006472|528815475|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
146628420|NCT02006472|528815471|FG000|Period 2 (Through Week 52)|Other|0|||
146628421|NCT02006472|528815472|FG001|Period 2 (Through Week 52)|Other|1|||
146628422|NCT02006472|528815473|FG002|Period 2 (Through Week 52)|Other|0|||
146628423|NCT02006472|528815474|FG003|Period 2 (Through Week 52)|Other|1|||
146628424|NCT02006472|528815475|FG004|Period 2 (Through Week 52)|Other|0|||
146628425|NCT02006472|528815471|FG000|Period 2 (Through Week 52)|Not treated|0|||
146628426|NCT02006472|528815472|FG001|Period 2 (Through Week 52)|Not treated|0|||
146628427|NCT02006472|528815473|FG002|Period 2 (Through Week 52)|Not treated|2|||
146628428|NCT02006472|528815474|FG003|Period 2 (Through Week 52)|Not treated|0|||
146628429|NCT02006472|528815475|FG004|Period 2 (Through Week 52)|Not treated|0|||
146628430|NCT02006472|528815471|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
146628431|NCT02006472|528815472|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
146628432|NCT02006472|528815473|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
146628433|NCT02006472|528815474|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
146628434|NCT02006472|528815475|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
146628435|NCT02006472|528815471|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
146628436|NCT02006472|528815472|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
146628437|NCT02006472|528815473|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
146764386|NCT00549848|529304371|FG000|Overall Study|Second Malignancy|1|||
146628438|NCT02006472|528815474|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
146628439|NCT02006472|528815475|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
146628440|NCT00886379|528815476|FG000|Overall Study|Transferred Schools|0|||
146628441|NCT00886379|528815477|FG001|Overall Study|Transferred Schools|0|||
146628442|NCT00886379|528815478|FG002|Overall Study|Transferred Schools|2|||
146628443|NCT00886379|528815479|FG003|Overall Study|Transferred Schools|1|||
146628444|NCT00886379|528815480|FG004|Overall Study|Transferred Schools|1|||
146628445|NCT00886379|528815476|FG000|Overall Study|Final blood draw not obtained|3|||
146628446|NCT00886379|528815477|FG001|Overall Study|Final blood draw not obtained|3|||
146628447|NCT00886379|528815478|FG002|Overall Study|Final blood draw not obtained|4|||
146628448|NCT00886379|528815479|FG003|Overall Study|Final blood draw not obtained|2|||
146628449|NCT00886379|528815480|FG004|Overall Study|Final blood draw not obtained|2|||
146628450|NCT03219723|528815481|FG000|Overall Study|Case Report Forms Uncollected|6|||
146628451|NCT03219723|528815481|FG000|Overall Study|Protocol Deviation|4|||
146628452|NCT03137381|528815482|FG000|Overall Study|Adverse Event|3|||
146628453|NCT03137381|528815483|FG001|Overall Study|Adverse Event|0|||
146628454|NCT03137381|528815484|FG002|Overall Study|Adverse Event|2|||
146628455|NCT03137381|528815485|FG003|Overall Study|Adverse Event|0|||
146628456|NCT03137381|528815482|FG000|Overall Study|Lost to Follow-up|2|||
146628457|NCT03137381|528815483|FG001|Overall Study|Lost to Follow-up|1|||
146628458|NCT03137381|528815484|FG002|Overall Study|Lost to Follow-up|1|||
146628459|NCT03137381|528815485|FG003|Overall Study|Lost to Follow-up|0|||
146628460|NCT03137381|528815482|FG000|Overall Study|Protocol deviation|1|||
146628461|NCT03137381|528815483|FG001|Overall Study|Protocol deviation|1|||
146628462|NCT03137381|528815484|FG002|Overall Study|Protocol deviation|0|||
146628463|NCT03137381|528815485|FG003|Overall Study|Protocol deviation|1|||
146628464|NCT03137381|528815482|FG000|Overall Study|Withdrawal by Investigator|0|||
146628465|NCT03137381|528815483|FG001|Overall Study|Withdrawal by Investigator|1|||
146628466|NCT03137381|528815484|FG002|Overall Study|Withdrawal by Investigator|1|||
146628467|NCT03137381|528815485|FG003|Overall Study|Withdrawal by Investigator|0|||
146628468|NCT03137381|528815482|FG000|Overall Study|Withdrawal by Subject|3|||
146628469|NCT03137381|528815483|FG001|Overall Study|Withdrawal by Subject|4|||
146628470|NCT03137381|528815484|FG002|Overall Study|Withdrawal by Subject|3|||
146628471|NCT03137381|528815485|FG003|Overall Study|Withdrawal by Subject|0|||
146873376|NCT00262522|529706709|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
146873377|NCT00262522|529706710|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
146873378|NCT00262522|529706707|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
146873379|NCT00262522|529706708|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
146873380|NCT00262522|529706709|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
146873381|NCT00262522|529706710|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
146873382|NCT00262522|529706707|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
146873383|NCT00262522|529706708|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
146873384|NCT00262522|529706709|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
146873385|NCT00262522|529706710|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
146873386|NCT00262522|529706707|FG000|Study Start Through 48 Weeks|Death|2|||
146873387|NCT00262522|529706708|FG001|Study Start Through 48 Weeks|Death|0|||
146873388|NCT00262522|529706709|FG002|Study Start Through 48 Weeks|Death|1|||
146873389|NCT00262522|529706710|FG003|Study Start Through 48 Weeks|Death|0|||
146873390|NCT00262522|529706707|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
146873391|NCT00262522|529706708|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
146873392|NCT00262522|529706709|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
146628472|NCT03137381|528815482|FG000|Overall Study|Pregnancy|0|||
146628473|NCT03137381|528815483|FG001|Overall Study|Pregnancy|0|||
146628474|NCT03137381|528815484|FG002|Overall Study|Pregnancy|1|||
146628475|NCT03137381|528815485|FG003|Overall Study|Pregnancy|0|||
146628476|NCT00459316|528815490|FG000|Steps 1 & 2|Other eligibility failure|1|||
146628477|NCT00459316|528815491|FG001|Steps 1 & 2|Other eligibility failure|1|||
146628478|NCT00459316|528815492|FG002|Steps 1 & 2|Other eligibility failure|0|||
146628479|NCT00459316|528815490|FG000|Steps 1 & 2|Death|1|||
146628480|NCT00459316|528815491|FG001|Steps 1 & 2|Death|1|||
146628481|NCT00459316|528815492|FG002|Steps 1 & 2|Death|0|||
146873393|NCT00262522|529706710|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
146873394|NCT00262522|529706707|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
146628482|NCT00459316|528815490|FG000|Steps 1 & 2|Not able to get to clinic|7|||
146628483|NCT00459316|528815491|FG001|Steps 1 & 2|Not able to get to clinic|4|||
146628484|NCT00459316|528815492|FG002|Steps 1 & 2|Not able to get to clinic|0|||
146628485|NCT00459316|528815490|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
146628486|NCT00459316|528815491|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
146628487|NCT00459316|528815492|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
146628488|NCT00459316|528815490|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
146628489|NCT00459316|528815491|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
146628490|NCT00459316|528815492|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
146628491|NCT00459316|528815490|FG000|Steps 1 & 2|Lost to Follow-up|5|||
146628492|NCT00459316|528815491|FG001|Steps 1 & 2|Lost to Follow-up|0|||
146628493|NCT00459316|528815492|FG002|Steps 1 & 2|Lost to Follow-up|2|||
146628494|NCT00459316|528815490|FG000|Step 3|Withdrawal by Subject|3|||
146628495|NCT00459316|528815491|FG001|Step 3|Withdrawal by Subject|0|||
146628496|NCT00459316|528815492|FG002|Step 3|Withdrawal by Subject|1|||
146628497|NCT01980017|528815493|FG000|Overall Study|Lost to Follow-up|30|||
146628498|NCT01980017|528815494|FG001|Overall Study|Lost to Follow-up|21|||
146628499|NCT01980017|528815493|FG000|Overall Study|Death|0|||
146628500|NCT01980017|528815494|FG001|Overall Study|Death|1|||
146628501|NCT03044106|528815495|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
146628502|NCT03044106|528815496|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
146628503|NCT01207414|528815498|FG000|Overall Study|Adverse Event|25|||
146628504|NCT01207414|528815499|FG001|Overall Study|Adverse Event|39|||
146628505|NCT01207414|528815498|FG000|Overall Study|Abnormal test procedure results|0|||
146628506|NCT01207414|528815499|FG001|Overall Study|Abnormal test procedure results|1|||
146628507|NCT01207414|528815498|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
146628508|NCT01207414|528815499|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
146628509|NCT01207414|528815498|FG000|Overall Study|Patient withdrew consent|14|||
146628510|NCT01207414|528815499|FG001|Overall Study|Patient withdrew consent|11|||
146628511|NCT01207414|528815498|FG000|Overall Study|Lost to Follow-up|15|||
146628512|NCT01207414|528815499|FG001|Overall Study|Lost to Follow-up|17|||
146628513|NCT01207414|528815498|FG000|Overall Study|Administrative problems|1|||
146628514|NCT01207414|528815499|FG001|Overall Study|Administrative problems|1|||
146628515|NCT01207414|528815498|FG000|Overall Study|Protocol deviation|12|||
146628516|NCT01207414|528815499|FG001|Overall Study|Protocol deviation|9|||
146628517|NCT01207414|528815498|FG000|Overall Study|Randomized in error|1|||
146628518|NCT01207414|528815499|FG001|Overall Study|Randomized in error|0|||
146628519|NCT01748292|528815500|FG000|Overall Study|Adverse Event|2|||
146628520|NCT01748292|528815501|FG001|Overall Study|Adverse Event|4|||
146628521|NCT01748292|528815500|FG000|Overall Study|Lost to Follow-up|0|||
146628522|NCT01748292|528815501|FG001|Overall Study|Lost to Follow-up|3|||
146628523|NCT01748292|528815500|FG000|Overall Study|Death|0|||
146628524|NCT01748292|528815501|FG001|Overall Study|Death|3|||
146628525|NCT01748292|528815500|FG000|Overall Study|Withdrawal by Subject|0|||
146628526|NCT01748292|528815501|FG001|Overall Study|Withdrawal by Subject|2|||
146628527|NCT02057250|528815502|FG000|AID Assessment Phase|Adverse Event|3|||
146628528|NCT02057250|528815503|FG001|AID Assessment Phase|Adverse Event|2|||
146628529|NCT02057250|528815504|FG002|AID Assessment Phase|Adverse Event|6|||
146628530|NCT02057250|528815505|FG003|AID Assessment Phase|Adverse Event|1|||
146628531|NCT02057250|528815506|FG004|AID Assessment Phase|Adverse Event|0|||
146628532|NCT02057250|528815502|FG000|AID Assessment Phase|Other than specified above|1|||
146628533|NCT02057250|528815503|FG001|AID Assessment Phase|Other than specified above|1|||
146628534|NCT02057250|528815504|FG002|AID Assessment Phase|Other than specified above|1|||
146628535|NCT02057250|528815505|FG003|AID Assessment Phase|Other than specified above|1|||
146628536|NCT02057250|528815506|FG004|AID Assessment Phase|Other than specified above|0|||
146628537|NCT02057250|528815502|FG000|Extension Phase|Adverse Event|0|||
146628538|NCT02057250|528815503|FG001|Extension Phase|Adverse Event|0|||
146628539|NCT02057250|528815504|FG002|Extension Phase|Adverse Event|0|||
146873395|NCT00262522|529706708|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
146873396|NCT00262522|529706709|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
146873397|NCT00262522|529706710|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
146873398|NCT00262522|529706707|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
146628540|NCT02057250|528815505|FG003|Extension Phase|Adverse Event|0|||
146628541|NCT02057250|528815506|FG004|Extension Phase|Adverse Event|15|||
146628542|NCT02057250|528815502|FG000|Extension Phase|Lack of Efficacy|0|||
146628543|NCT02057250|528815503|FG001|Extension Phase|Lack of Efficacy|0|||
146543591|NCT02903914|528495802|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
146543592|NCT02903914|528495795|FG000|Overall Study|Clinical Disease Progression|0|||
146543593|NCT02903914|528495796|FG001|Overall Study|Clinical Disease Progression|0|||
146543594|NCT02903914|528495797|FG002|Overall Study|Clinical Disease Progression|2|||
146543595|NCT02903914|528495798|FG003|Overall Study|Clinical Disease Progression|0|||
146543596|NCT02903914|528495799|FG004|Overall Study|Clinical Disease Progression|0|||
146543597|NCT02903914|528495800|FG005|Overall Study|Clinical Disease Progression|0|||
146543598|NCT02903914|528495801|FG006|Overall Study|Clinical Disease Progression|0|||
146543599|NCT02903914|528495802|FG007|Overall Study|Clinical Disease Progression|0|||
146873399|NCT00262522|529706708|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
146873400|NCT00262522|529706709|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
146873401|NCT00262522|529706710|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
146873402|NCT00262522|529706707|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
146873403|NCT00262522|529706708|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
146873404|NCT00262522|529706709|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
146873405|NCT00262522|529706710|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
146873406|NCT00262522|529706707|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
146873407|NCT00262522|529706708|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
146873408|NCT00262522|529706709|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
146873409|NCT00262522|529706710|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
146873410|NCT00262522|529706707|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
146873411|NCT00262522|529706708|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
146873412|NCT00262522|529706709|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
146873413|NCT00262522|529706710|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
146873414|NCT00262522|529706707|FG000|Study Start Through 96 Weeks|Death|2|||
146873415|NCT00262522|529706708|FG001|Study Start Through 96 Weeks|Death|0|||
146873416|NCT00262522|529706709|FG002|Study Start Through 96 Weeks|Death|2|||
146873417|NCT00262522|529706710|FG003|Study Start Through 96 Weeks|Death|0|||
146873418|NCT00262522|529706707|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
146873419|NCT00262522|529706708|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
146873420|NCT00262522|529706709|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
146873421|NCT00262522|529706710|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
146873422|NCT00262522|529706707|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
146873423|NCT00262522|529706708|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
146873424|NCT00262522|529706709|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
146873425|NCT00262522|529706710|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
146873426|NCT02710136|529706719|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
146873427|NCT02710136|529706720|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
146873428|NCT02269787|529706724|FG000|Overall Study|Lost to Follow-up|20|||
146873429|NCT02269787|529706725|FG001|Overall Study|Lost to Follow-up|6|||
146873430|NCT02269787|529706724|FG000|Overall Study|Death|2|||
146873431|NCT02269787|529706725|FG001|Overall Study|Death|3|||
146873432|NCT02269787|529706724|FG000|Overall Study|Incapacitated|0|||
146873433|NCT02269787|529706725|FG001|Overall Study|Incapacitated|1|||
146873434|NCT00798135|529706726|FG000|Overall Study|Disease progression, relapse|11|||
146543600|NCT02903914|528495795|FG000|Overall Study|Completed Follow-up Period|0|||
146543601|NCT02903914|528495796|FG001|Overall Study|Completed Follow-up Period|0|||
146543602|NCT02903914|528495797|FG002|Overall Study|Completed Follow-up Period|6|||
146543603|NCT02903914|528495798|FG003|Overall Study|Completed Follow-up Period|2|||
146543604|NCT02903914|528495799|FG004|Overall Study|Completed Follow-up Period|1|||
146543605|NCT02903914|528495800|FG005|Overall Study|Completed Follow-up Period|0|||
146543606|NCT02903914|528495801|FG006|Overall Study|Completed Follow-up Period|9|||
146543607|NCT02903914|528495802|FG007|Overall Study|Completed Follow-up Period|1|||
146543608|NCT02903914|528495795|FG000|Overall Study|Taken off Treatment per Protocol|0|||
146543609|NCT02903914|528495796|FG001|Overall Study|Taken off Treatment per Protocol|0|||
146543610|NCT02903914|528495797|FG002|Overall Study|Taken off Treatment per Protocol|0|||
146543611|NCT02903914|528495798|FG003|Overall Study|Taken off Treatment per Protocol|0|||
146543612|NCT02903914|528495799|FG004|Overall Study|Taken off Treatment per Protocol|0|||
146543613|NCT02903914|528495800|FG005|Overall Study|Taken off Treatment per Protocol|1|||
146543614|NCT02903914|528495801|FG006|Overall Study|Taken off Treatment per Protocol|0|||
146543615|NCT02903914|528495802|FG007|Overall Study|Taken off Treatment per Protocol|0|||
146543616|NCT02903914|528495795|FG000|Overall Study|Refused Further Treatment/Contact|0|||
146543617|NCT02903914|528495796|FG001|Overall Study|Refused Further Treatment/Contact|0|||
146543618|NCT02903914|528495797|FG002|Overall Study|Refused Further Treatment/Contact|0|||
146543619|NCT02903914|528495798|FG003|Overall Study|Refused Further Treatment/Contact|0|||
146543620|NCT02903914|528495799|FG004|Overall Study|Refused Further Treatment/Contact|0|||
146543621|NCT02903914|528495800|FG005|Overall Study|Refused Further Treatment/Contact|0|||
146543622|NCT02903914|528495801|FG006|Overall Study|Refused Further Treatment/Contact|1|||
146543623|NCT02903914|528495802|FG007|Overall Study|Refused Further Treatment/Contact|0|||
146543624|NCT02903914|528495795|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
146873435|NCT00798135|529706726|FG000|Overall Study|Disease progression, refractory|1|||
146873436|NCT00798135|529706726|FG000|Overall Study|Physician Decision|1|||
146873437|NCT00687440|529706727|FG000|Overall Study|Adverse Event|3|||
146873438|NCT00687440|529706727|FG000|Overall Study|Lost to Follow-up|3|||
146873439|NCT00687440|529706727|FG000|Overall Study|Lack of Efficacy|2|||
146543625|NCT02903914|528495796|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
146873440|NCT00687440|529706727|FG000|Overall Study|Death|2|||
146873441|NCT00687440|529706727|FG000|Overall Study|Other|1|||
146873442|NCT00687440|529706727|FG000|Overall Study|Missing|1|||
146873443|NCT02228720|529706728|FG000|Open Label - Day 30|Lost to Follow-up|1|||
146873444|NCT01401842|529706731|FG000|Overall Study|Withdrawal by Subject|3|||
146543626|NCT02903914|528495797|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
146543627|NCT02903914|528495798|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
146543628|NCT02903914|528495799|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
146543629|NCT02903914|528495800|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
146543630|NCT02903914|528495801|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
146543631|NCT02903914|528495802|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
146543632|NCT04225039|528495807|FG000|Overall Study|Withdrawal by Subject|1|||
146543633|NCT04225039|528495808|FG001|Overall Study|Withdrawal by Subject|0|||
146543634|NCT04225039|528495809|FG002|Overall Study|Withdrawal by Subject|0|||
146543635|NCT04225039|528495810|FG003|Overall Study|Withdrawal by Subject|1|||
146543636|NCT04225039|528495807|FG000|Overall Study|Currently active on study treatment|0|||
146543637|NCT04225039|528495808|FG001|Overall Study|Currently active on study treatment|1|||
146543638|NCT04225039|528495809|FG002|Overall Study|Currently active on study treatment|0|||
146543639|NCT04225039|528495810|FG003|Overall Study|Currently active on study treatment|0|||
146543640|NCT04225039|528495807|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
146543641|NCT04225039|528495808|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
146543642|NCT04225039|528495809|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
146543643|NCT04225039|528495810|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
146543644|NCT04225039|528495807|FG000|Overall Study|Ineligible for treatment|0|||
146543645|NCT04225039|528495808|FG001|Overall Study|Ineligible for treatment|0|||
146543646|NCT04225039|528495809|FG002|Overall Study|Ineligible for treatment|0|||
146543647|NCT04225039|528495810|FG003|Overall Study|Ineligible for treatment|4|||
146543648|NCT00876343|528495817|FG000|Overall Study|Adverse Event|7|||
146543649|NCT00876343|528495818|FG001|Overall Study|Adverse Event|8|||
146543650|NCT00876343|528495819|FG002|Overall Study|Adverse Event|2|||
146543651|NCT00876343|528495817|FG000|Overall Study|Withdrawal by Subject|4|||
146543652|NCT00876343|528495818|FG001|Overall Study|Withdrawal by Subject|4|||
146543653|NCT00876343|528495819|FG002|Overall Study|Withdrawal by Subject|3|||
146543654|NCT00876343|528495817|FG000|Overall Study|Lack of Efficacy|0|||
146543655|NCT00876343|528495818|FG001|Overall Study|Lack of Efficacy|0|||
146543656|NCT00876343|528495819|FG002|Overall Study|Lack of Efficacy|1|||
146543657|NCT00876343|528495817|FG000|Overall Study|Protocol Violation|4|||
146543658|NCT00876343|528495818|FG001|Overall Study|Protocol Violation|1|||
146543659|NCT00876343|528495819|FG002|Overall Study|Protocol Violation|1|||
146543660|NCT00876343|528495817|FG000|Overall Study|Physician Decision|0|||
146543661|NCT00876343|528495818|FG001|Overall Study|Physician Decision|1|||
146543662|NCT00876343|528495819|FG002|Overall Study|Physician Decision|1|||
146543663|NCT00876343|528495817|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
146543664|NCT00876343|528495818|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
146543665|NCT00876343|528495819|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
146543666|NCT00876343|528495817|FG000|Overall Study|Change of residence or other commitments|2|||
146543667|NCT00876343|528495818|FG001|Overall Study|Change of residence or other commitments|2|||
146628544|NCT02057250|528815504|FG002|Extension Phase|Lack of Efficacy|0|||
146873445|NCT01401842|529706732|FG001|Overall Study|Withdrawal by Subject|2|||
146873446|NCT01401842|529706731|FG000|Overall Study|academic reason|4|||
146873447|NCT01401842|529706732|FG001|Overall Study|academic reason|1|||
146873448|NCT01401842|529706731|FG000|Overall Study|changed companies|20|||
146873449|NCT01401842|529706732|FG001|Overall Study|changed companies|34|||
146873450|NCT01401842|529706731|FG000|Overall Study|discharged from US Army|3|||
146873451|NCT01401842|529706732|FG001|Overall Study|discharged from US Army|4|||
146873452|NCT01401842|529706731|FG000|Overall Study|invalid follow-up strength data|1|||
146873453|NCT01401842|529706732|FG001|Overall Study|invalid follow-up strength data|4|||
146873454|NCT01401842|529706731|FG000|Overall Study|on profile|9|||
146873455|NCT01401842|529706732|FG001|Overall Study|on profile|5|||
146873456|NCT01401842|529706731|FG000|Overall Study|other/unknown|28|||
146873457|NCT01401842|529706732|FG001|Overall Study|other/unknown|17|||
146873458|NCT03977974|529706741|FG000|Period 2|Adverse Event|0|||
146873459|NCT03977974|529706742|FG001|Period 2|Adverse Event|0|||
146873460|NCT03977974|529706743|FG002|Period 2|Adverse Event|0|||
146873461|NCT03977974|529706744|FG003|Period 2|Adverse Event|0|||
146873462|NCT03977974|529706745|FG004|Period 2|Adverse Event|1|||
146873463|NCT03977974|529706746|FG005|Period 2|Adverse Event|0|||
146873464|NCT03977974|529706747|FG006|Period 2|Adverse Event|0|||
146873465|NCT03977974|529706748|FG007|Period 2|Adverse Event|0|||
146873466|NCT03977974|529706749|FG008|Period 2|Adverse Event|0|||
146873467|NCT03977974|529706750|FG009|Period 2|Adverse Event|0|||
146873468|NCT03977974|529706751|FG010|Period 2|Adverse Event|0|||
146873469|NCT03977974|529706752|FG011|Period 2|Adverse Event|0|||
146873470|NCT03977974|529706753|FG012|Period 2|Adverse Event|0|||
146873471|NCT00003535|529708267|FG000|Overall Study|Not evaluable|5|||
146873472|NCT02289742|529708272|FG000|First Wear Period|Adverse event prior to treatment|0|||
146873473|NCT02289742|529708273|FG001|First Wear Period|Adverse event prior to treatment|1|||
146873474|NCT02289742|529708274|FG002|First Wear Period|Adverse event prior to treatment|0|||
146873475|NCT02289742|529708275|FG003|First Wear Period|Adverse event prior to treatment|0|||
146873476|NCT02289742|529708272|FG000|First Wear Period|Adverse Event|0|||
146873477|NCT02289742|529708273|FG001|First Wear Period|Adverse Event|0|||
146873478|NCT02289742|529708274|FG002|First Wear Period|Adverse Event|1|||
146873479|NCT02289742|529708275|FG003|First Wear Period|Adverse Event|0|||
146873480|NCT02289742|529708272|FG000|First Wear Period|Other prior to treatment|0|||
146873481|NCT02289742|529708273|FG001|First Wear Period|Other prior to treatment|0|||
146873482|NCT02289742|529708274|FG002|First Wear Period|Other prior to treatment|0|||
146873483|NCT02289742|529708275|FG003|First Wear Period|Other prior to treatment|1|||
146873484|NCT02289742|529708272|FG000|Third Wear Period|Adverse Event|0|||
146873485|NCT02289742|529708273|FG001|Third Wear Period|Adverse Event|1|||
146873486|NCT02289742|529708274|FG002|Third Wear Period|Adverse Event|0|||
146873487|NCT02289742|529708275|FG003|Third Wear Period|Adverse Event|0|||
146873488|NCT02289742|529708272|FG000|Third Wear Period|Reason not given|0|||
146873489|NCT02289742|529708273|FG001|Third Wear Period|Reason not given|0|||
146873490|NCT02289742|529708274|FG002|Third Wear Period|Reason not given|0|||
146873491|NCT02289742|529708275|FG003|Third Wear Period|Reason not given|1|||
146873492|NCT01365039|529708276|FG000|Overall Study|Study related symptoms and complaints|1|||
146873493|NCT01365039|529708277|FG001|Overall Study|Study related symptoms and complaints|0|||
146873494|NCT00294060|529708278|FG000|Overall Study|Death|225|||
146873495|NCT00294060|529708278|FG000|Overall Study|Other|59|||
146873496|NCT00294060|529708278|FG000|Overall Study|Lost to Follow-up|55|||
146873497|NCT00294060|529708278|FG000|Overall Study|Withdrawal by Subject|11|||
146873498|NCT00294060|529708278|FG000|Overall Study|Physician Decision|797|||
146873499|NCT00294060|529708278|FG000|Overall Study|Medical condition|3|||
146873500|NCT00294060|529708278|FG000|Overall Study|Device explanted/not replaced|23|||
146873501|NCT01360554|529708279|FG000|Overall Study|Death|359|||
146873502|NCT01360554|529708280|FG001|Overall Study|Death|371|||
146873503|NCT01360554|529708279|FG000|Overall Study|Lost to Follow-up|4|||
146873504|NCT01360554|529708280|FG001|Overall Study|Lost to Follow-up|4|||
146543668|NCT00876343|528495819|FG002|Overall Study|Change of residence or other commitments|3|||
146543669|NCT04717557|528495828|FG000|Overall Study|Withdrawal by Subject|2|||
146543670|NCT04717557|528495829|FG001|Overall Study|Withdrawal by Subject|0|||
146543671|NCT04717557|528495828|FG000|Overall Study|Death|1|||
146543672|NCT04717557|528495829|FG001|Overall Study|Death|0|||
146543673|NCT03168672|528495832|FG000|Overall Study|Withdrawal by Subject|13|||
146543674|NCT03168672|528495832|FG000|Overall Study|Death|3|||
146543675|NCT03168672|528495832|FG000|Overall Study|Investigator's Decision|137|||
146543676|NCT03168672|528495832|FG000|Overall Study|Adverse Event|1|||
146543677|NCT03168672|528495832|FG000|Overall Study|Other|2|||
146543678|NCT03168672|528495832|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
146543679|NCT05436613|528495833|FG000|Overall Study|Lost to Follow-up|9|||
146543680|NCT05436613|528495833|FG000|Overall Study|Withdrawal by Subject|3|||
146543681|NCT05317546|528495836|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
146543682|NCT05317546|528495837|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
146543683|NCT03331250|528495838|FG000|Overall Study|Withdrawal by Subject|1|||
146543684|NCT04590963|528495839|FG000|Overall Study|Death|118|||
146543685|NCT04590963|528495840|FG001|Overall Study|Death|59|||
146543686|NCT04590963|528495839|FG000|Overall Study|Lost to Follow-up|1|||
146543687|NCT04590963|528495840|FG001|Overall Study|Lost to Follow-up|1|||
146543688|NCT04590963|528495839|FG000|Overall Study|Progressive disease|0|||
146543689|NCT04590963|528495840|FG001|Overall Study|Progressive disease|1|||
146543690|NCT04590963|528495839|FG000|Overall Study|Study terminated by sponsor|103|||
146543691|NCT04590963|528495840|FG001|Overall Study|Study terminated by sponsor|50|||
146543692|NCT04590963|528495839|FG000|Overall Study|Withdrawal by Subject|15|||
146543693|NCT04590963|528495840|FG001|Overall Study|Withdrawal by Subject|8|||
146543694|NCT04590963|528495839|FG000|Overall Study|Ongoing at data cut-off|9|||
146543695|NCT04590963|528495840|FG001|Overall Study|Ongoing at data cut-off|4|||
146543696|NCT04590963|528495839|FG000|Overall Study|Screen failure|1|||
146543697|NCT04590963|528495840|FG001|Overall Study|Screen failure|0|||
146543698|NCT05350202|528495841|FG000|Visit 1 - Baseline|Not-treated|18|||
146543699|NCT05350202|528495842|FG001|Visit 1 - Baseline|Not-treated|0|||
146543700|NCT05350202|528495841|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
146543701|NCT05350202|528495842|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
146543702|NCT05350202|528495841|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
146543703|NCT05350202|528495842|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
146543704|NCT05350202|528495841|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
146543705|NCT05350202|528495842|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
146543706|NCT05350202|528495841|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
146873505|NCT01360554|529708279|FG000|Overall Study|Withdrawal by Subject|23|||
146543707|NCT05350202|528495842|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
146543708|NCT05350202|528495841|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
146543709|NCT05350202|528495842|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
146543710|NCT05350202|528495841|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
146543711|NCT05350202|528495842|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
146873506|NCT01360554|529708280|FG001|Overall Study|Withdrawal by Subject|24|||
146873507|NCT01360554|529708279|FG000|Overall Study|Study terminated by sponsor|49|||
146543712|NCT02145390|528495855|FG000|Overall Study|Withdrawal by Subject|1|||
146543713|NCT00143507|528497174|FG000|Overall Study|Death|572|||
146543714|NCT00143507|528497175|FG001|Overall Study|Death|547|||
146543715|NCT00143507|528497174|FG000|Overall Study|Withdrawal by Subject|114|||
146543716|NCT00143507|528497175|FG001|Overall Study|Withdrawal by Subject|102|||
146543717|NCT00143507|528497174|FG000|Overall Study|Lost to Follow-up|1|||
146543718|NCT00143507|528497175|FG001|Overall Study|Lost to Follow-up|0|||
146543719|NCT00143507|528497174|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
146873508|NCT01360554|529708280|FG001|Overall Study|Study terminated by sponsor|37|||
146873509|NCT01360554|529708279|FG000|Overall Study|Other, not specified|1|||
146873510|NCT01360554|529708280|FG001|Overall Study|Other, not specified|0|||
146873511|NCT01360554|529708279|FG000|Overall Study|Randomized but not treated.|3|||
146873512|NCT01360554|529708280|FG001|Overall Study|Randomized but not treated.|3|||
146873513|NCT00187096|529708281|FG000|Overall Study|unacceptable toxicity|0|||
146873514|NCT00187096|529708282|FG001|Overall Study|unacceptable toxicity|0|||
146873515|NCT00187096|529708283|FG002|Overall Study|unacceptable toxicity|1|||
146873516|NCT03668600|529708292|FG000|Overall Study|Study Terminated by the Sponsor|157|||
146873517|NCT03668600|529708292|FG000|Overall Study|Protocol Violation|1|||
146628545|NCT02057250|528815505|FG003|Extension Phase|Lack of Efficacy|0|||
146628546|NCT02057250|528815506|FG004|Extension Phase|Lack of Efficacy|10|||
146628547|NCT02057250|528815502|FG000|Extension Phase|Entered in this period but not treated|0|||
146628548|NCT02057250|528815503|FG001|Extension Phase|Entered in this period but not treated|0|||
146873518|NCT03668600|529708292|FG000|Overall Study|Pregnancy|1|||
146873519|NCT03668600|529708292|FG000|Overall Study|Lost to Follow-up|7|||
146873520|NCT03668600|529708292|FG000|Overall Study|Withdrawal by Subject|56|||
146873521|NCT03668600|529708292|FG000|Overall Study|Lack of Efficacy|7|||
146873522|NCT03668600|529708292|FG000|Overall Study|Adverse Event|1|||
146873523|NCT00424749|529708294|FG000|Overall Study|Withdrawal by Subject|1|||
146873524|NCT01263483|529708295|FG000|Overall Study|Adverse Event|4|||
146873525|NCT01263483|529708296|FG001|Overall Study|Adverse Event|0|||
146873526|NCT01263483|529708297|FG002|Overall Study|Adverse Event|3|||
146873527|NCT01263483|529708295|FG000|Overall Study|Withdrawal by Subject|1|||
146873528|NCT01263483|529708296|FG001|Overall Study|Withdrawal by Subject|0|||
146873529|NCT01263483|529708297|FG002|Overall Study|Withdrawal by Subject|0|||
146543720|NCT00143507|528497175|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
146764387|NCT00549848|529304372|FG001|Overall Study|Second Malignancy|0|||
146764388|NCT00549848|529304373|FG002|Overall Study|Second Malignancy|0|||
146764389|NCT00549848|529304371|FG000|Overall Study|Transplant|3|||
146628549|NCT02057250|528815504|FG002|Extension Phase|Entered in this period but not treated|0|||
146628550|NCT02057250|528815505|FG003|Extension Phase|Entered in this period but not treated|0|||
146628551|NCT02057250|528815506|FG004|Extension Phase|Entered in this period but not treated|4|||
146628552|NCT02057250|528815502|FG000|Extension Phase|Other than specified above|0|||
146628553|NCT02057250|528815503|FG001|Extension Phase|Other than specified above|0|||
146628554|NCT02057250|528815504|FG002|Extension Phase|Other than specified above|0|||
146628555|NCT02057250|528815505|FG003|Extension Phase|Other than specified above|0|||
146628556|NCT02057250|528815506|FG004|Extension Phase|Other than specified above|7|||
146628557|NCT03125395|528815507|FG000|Overall Study|Adverse Event|2|||
146628558|NCT03125395|528815507|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
146628559|NCT03125395|528815507|FG000|Overall Study|Physician Decision|2|||
146628560|NCT03125395|528815507|FG000|Overall Study|Commercial drug is available|5|||
146628561|NCT04852302|528815519|FG000|Overall Study|Withdrawal by Subject|2|||
146628562|NCT04852302|528815519|FG000|Overall Study|Did not complete CALM therapy.|2|||
146628563|NCT05249582|528815520|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
146628564|NCT05249582|528815521|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
146628565|NCT05249582|528815520|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
146628566|NCT05249582|528815521|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
146628567|NCT05249582|528815520|FG000|Overall Study|Declined to use virtual reality headset|1|||
146628568|NCT05249582|528815521|FG001|Overall Study|Declined to use virtual reality headset|0|||
146628569|NCT03267277|528815522|FG000|Overall Study|Withdrawal by Subject|1|||
146873530|NCT01263483|529708295|FG000|Overall Study|Lack of Efficacy|2|||
146873531|NCT01263483|529708296|FG001|Overall Study|Lack of Efficacy|0|||
146873532|NCT01263483|529708297|FG002|Overall Study|Lack of Efficacy|0|||
146873533|NCT01263483|529708295|FG000|Overall Study|Protocol Violation|0|||
146873534|NCT01263483|529708296|FG001|Overall Study|Protocol Violation|1|||
146873535|NCT01263483|529708297|FG002|Overall Study|Protocol Violation|1|||
146873536|NCT01263483|529708295|FG000|Overall Study|Participant Unavailability|0|||
146873537|NCT01263483|529708296|FG001|Overall Study|Participant Unavailability|1|||
146873538|NCT01263483|529708297|FG002|Overall Study|Participant Unavailability|1|||
146873539|NCT00326209|529708298|FG000|Overall Study|Adverse Event|28|||
146873540|NCT00326209|529708298|FG000|Overall Study|Withdrawal by Subject|22|||
146873541|NCT00326209|529708298|FG000|Overall Study|Lack of Efficacy|31|||
146873542|NCT00326209|529708298|FG000|Overall Study|Lost to Follow-up|18|||
146873543|NCT00326209|529708298|FG000|Overall Study|Participant non-compliant|6|||
146873544|NCT00326209|529708298|FG000|Overall Study|Sponsor closed study|173|||
146873545|NCT00326209|529708298|FG000|Overall Study|Prohibited medication use|1|||
146873546|NCT00326209|529708298|FG000|Overall Study|Violation of entry criteria|1|||
146873547|NCT00326209|529708298|FG000|Overall Study|Withdrawn in error|1|||
146873548|NCT00326209|529708298|FG000|Overall Study|Pregnancy|1|||
146873549|NCT02577406|529708299|FG000|Randomized Period|Death|1|||
146873550|NCT02577406|529708300|FG001|Randomized Period|Death|0|||
146873551|NCT02577406|529708299|FG000|Randomized Period|Other reasons|0|||
146873552|NCT02577406|529708300|FG001|Randomized Period|Other reasons|20|||
146873553|NCT02577406|529708299|FG000|Treatment Period|Death|38|||
146873554|NCT02577406|529708300|FG001|Treatment Period|Death|23|||
146873555|NCT02577406|529708299|FG000|Treatment Period|Adverse Event|17|||
146873556|NCT02577406|529708300|FG001|Treatment Period|Adverse Event|12|||
146873557|NCT02577406|529708299|FG000|Treatment Period|Progressive Disease|53|||
146873558|NCT02577406|529708300|FG001|Treatment Period|Progressive Disease|37|||
146873559|NCT02577406|529708299|FG000|Treatment Period|Withdrawal by Subject|10|||
146873560|NCT02577406|529708300|FG001|Treatment Period|Withdrawal by Subject|24|||
146873561|NCT02577406|529708299|FG000|Treatment Period|Lost to Follow-up|0|||
146873562|NCT02577406|529708300|FG001|Treatment Period|Lost to Follow-up|1|||
146873563|NCT02577406|529708299|FG000|Treatment Period|Transition to commercially available treatment|1|||
146873564|NCT02577406|529708300|FG001|Treatment Period|Transition to commercially available treatment|1|||
146873565|NCT02577406|529708299|FG000|Treatment Period|Physician Decision|1|||
146873566|NCT02577406|529708300|FG001|Treatment Period|Physician Decision|0|||
146873567|NCT02577406|529708299|FG000|Treatment Period|Disease Relapse|28|||
146873568|NCT02577406|529708300|FG001|Treatment Period|Disease Relapse|1|||
146873569|NCT02577406|529708299|FG000|Treatment Period|Protocol Violation|0|||
146873570|NCT02577406|529708300|FG001|Treatment Period|Protocol Violation|1|||
146873571|NCT02577406|529708299|FG000|Treatment Period|Other Reasons|3|||
146873572|NCT02577406|529708300|FG001|Treatment Period|Other Reasons|39|||
146873573|NCT02577406|529708299|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
146873574|NCT02577406|529708300|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
146873575|NCT01111851|529708303|FG000|Overall Study|All planned PET scans were not obtained.|2|||
146873576|NCT01111851|529708304|FG001|Overall Study|All planned PET scans were not obtained.|0|||
146873577|NCT05500274|529708305|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
146873578|NCT05500274|529708306|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
146873579|NCT05500274|529708305|FG000|Overall Study|Lost to Follow-up|76|||
146873580|NCT05500274|529708306|FG001|Overall Study|Lost to Follow-up|51|||
146873581|NCT05807464|529708309|FG000|Overall Study|Adverse Event|1|||
146873582|NCT04451161|529708310|FG000|Overall Study|Lost to Follow-up|28|||
146873583|NCT04451161|529708311|FG001|Overall Study|Lost to Follow-up|37|||
146873584|NCT04451161|529708312|FG002|Overall Study|Lost to Follow-up|22|||
146873585|NCT04451161|529708313|FG003|Overall Study|Lost to Follow-up|13|||
146873586|NCT04451161|529708314|FG004|Overall Study|Lost to Follow-up|11|||
146873587|NCT04451161|529708315|FG005|Overall Study|Lost to Follow-up|14|||
146873588|NCT04451161|529708310|FG000|Overall Study|Withdrawal by Subject|3|||
146873589|NCT04451161|529708311|FG001|Overall Study|Withdrawal by Subject|0|||
146873590|NCT04451161|529708312|FG002|Overall Study|Withdrawal by Subject|0|||
146873591|NCT04451161|529708313|FG003|Overall Study|Withdrawal by Subject|0|||
146873592|NCT04451161|529708314|FG004|Overall Study|Withdrawal by Subject|2|||
146873593|NCT04451161|529708315|FG005|Overall Study|Withdrawal by Subject|4|||
146873594|NCT01555151|529708317|FG000|Overall Study|Withdrawal by Subject|6|||
146873595|NCT01555151|529708318|FG001|Overall Study|Withdrawal by Subject|2|||
146873596|NCT01555151|529708319|FG002|Overall Study|Withdrawal by Subject|0|||
146873597|NCT01555151|529708320|FG003|Overall Study|Withdrawal by Subject|2|||
146873598|NCT01555151|529708317|FG000|Overall Study|Administrative|3|||
146873599|NCT01555151|529708318|FG001|Overall Study|Administrative|1|||
146873600|NCT01555151|529708319|FG002|Overall Study|Administrative|2|||
146873601|NCT01555151|529708320|FG003|Overall Study|Administrative|0|||
146873602|NCT01555151|529708317|FG000|Overall Study|Protocol Violation|3|||
146873603|NCT01555151|529708318|FG001|Overall Study|Protocol Violation|3|||
146873604|NCT01555151|529708319|FG002|Overall Study|Protocol Violation|3|||
146873605|NCT01555151|529708320|FG003|Overall Study|Protocol Violation|5|||
146873606|NCT01555151|529708317|FG000|Overall Study|Adverse Event|1|||
146543721|NCT00876395|528497176|FG000|Overall Study|Untreated|8|||
146543722|NCT00876395|528497177|FG001|Overall Study|Untreated|1|||
146543723|NCT00876395|528497176|FG000|Overall Study|Adverse Event|63|||
146543724|NCT00876395|528497177|FG001|Overall Study|Adverse Event|11|||
146543725|NCT00876395|528497176|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146543726|NCT00876395|528497177|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146543727|NCT00876395|528497176|FG000|Overall Study|Disease progression|259|||
146543728|NCT00876395|528497177|FG001|Overall Study|Disease progression|162|||
146543729|NCT00876395|528497176|FG000|Overall Study|New cancer therapy|25|||
146543730|NCT00876395|528497177|FG001|Overall Study|New cancer therapy|7|||
146543731|NCT00876395|528497176|FG000|Overall Study|Protocol Violation|5|||
146543732|NCT00876395|528497177|FG001|Overall Study|Protocol Violation|2|||
146543733|NCT00876395|528497176|FG000|Overall Study|Withdrawal by Subject|66|||
146764390|NCT00549848|529304372|FG001|Overall Study|Transplant|3|||
146764391|NCT00549848|529304373|FG002|Overall Study|Transplant|18|||
146764392|NCT00549848|529304371|FG000|Overall Study|Unacceptable Toxicity|1|||
146764393|NCT00549848|529304372|FG001|Overall Study|Unacceptable Toxicity|6|||
146764394|NCT00549848|529304373|FG002|Overall Study|Unacceptable Toxicity|6|||
146764395|NCT05193318|529304382|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
146764396|NCT05193318|529304382|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
146764397|NCT00543725|529304383|FG000|Overall Study|Adverse Event|18|||
146543734|NCT00876395|528497177|FG001|Overall Study|Withdrawal by Subject|33|||
146543735|NCT00876395|528497176|FG000|Overall Study|Lost to Follow-up|2|||
146543736|NCT00876395|528497177|FG001|Overall Study|Lost to Follow-up|0|||
146543737|NCT00876395|528497176|FG000|Overall Study|Administrative problems|39|||
146543738|NCT00876395|528497177|FG001|Overall Study|Administrative problems|23|||
146873607|NCT01555151|529708318|FG001|Overall Study|Adverse Event|2|||
146543739|NCT00876395|528497176|FG000|Overall Study|Death|12|||
146873608|NCT01555151|529708319|FG002|Overall Study|Adverse Event|1|||
146543740|NCT00876395|528497177|FG001|Overall Study|Death|0|||
146873609|NCT01555151|529708320|FG003|Overall Study|Adverse Event|2|||
146873610|NCT01555151|529708317|FG000|Overall Study|Lost to Follow-up|0|||
146873611|NCT01555151|529708318|FG001|Overall Study|Lost to Follow-up|0|||
146873612|NCT01555151|529708319|FG002|Overall Study|Lost to Follow-up|0|||
146873613|NCT01555151|529708320|FG003|Overall Study|Lost to Follow-up|1|||
146873614|NCT03596866|529708321|FG000|Overall Study|Site terminated by Sponsor|64|||
146873615|NCT03596866|529708322|FG001|Overall Study|Site terminated by Sponsor|65|||
146873616|NCT03596866|529708321|FG000|Overall Study|Death|37|||
146873617|NCT03596866|529708322|FG001|Overall Study|Death|24|||
146873618|NCT03596866|529708321|FG000|Overall Study|Withdrawal by Subject|4|||
146873619|NCT03596866|529708322|FG001|Overall Study|Withdrawal by Subject|6|||
146873620|NCT03596866|529708321|FG000|Overall Study|Missing|0|||
146873621|NCT03596866|529708322|FG001|Overall Study|Missing|6|||
146873622|NCT03596866|529708321|FG000|Overall Study|Lost to Follow-up|2|||
146873623|NCT03596866|529708322|FG001|Overall Study|Lost to Follow-up|3|||
146873624|NCT03596866|529708321|FG000|Overall Study|Protocol Violation|1|||
146873625|NCT03596866|529708322|FG001|Overall Study|Protocol Violation|0|||
146543741|NCT00970944|528497197|FG000|Overall Study|Death|1|||
146543742|NCT00970944|528497198|FG001|Overall Study|Death|0|||
146873626|NCT03596866|529708321|FG000|Overall Study|Reason Not Specified|14|||
146873627|NCT03596866|529708322|FG001|Overall Study|Reason Not Specified|13|||
146873628|NCT01816061|529708323|FG000|Overall Study|Lost to Follow-up|13|||
146873629|NCT01816061|529708324|FG001|Overall Study|Lost to Follow-up|24|||
146873630|NCT01671111|529708326|FG000|Overall Study|Adverse Event|2|||
146873631|NCT01671111|529708326|FG000|Overall Study|Lack of Efficacy|1|||
146873632|NCT01671111|529708326|FG000|Overall Study|Withdrawal by Subject|2|||
146873633|NCT01671111|529708326|FG000|Overall Study|Physician Decision|1|||
146873634|NCT01671111|529708326|FG000|Overall Study|Other|24|||
146873635|NCT02114268|529708329|FG000|Overall Study|Lost to Follow-up|4|||
146873636|NCT02114268|529708330|FG001|Overall Study|Lost to Follow-up|1|||
146873637|NCT02114268|529708331|FG002|Overall Study|Lost to Follow-up|1|||
146873638|NCT02114268|529708332|FG003|Overall Study|Lost to Follow-up|0|||
146873639|NCT02114268|529708333|FG004|Overall Study|Lost to Follow-up|0|||
146873640|NCT02114268|529708334|FG005|Overall Study|Lost to Follow-up|2|||
146873641|NCT02114268|529708329|FG000|Overall Study|Withdrawal by Subject|1|||
146873642|NCT02114268|529708330|FG001|Overall Study|Withdrawal by Subject|0|||
146873643|NCT02114268|529708331|FG002|Overall Study|Withdrawal by Subject|0|||
146873644|NCT02114268|529708332|FG003|Overall Study|Withdrawal by Subject|0|||
146873645|NCT02114268|529708333|FG004|Overall Study|Withdrawal by Subject|0|||
146873646|NCT02114268|529708334|FG005|Overall Study|Withdrawal by Subject|1|||
146873647|NCT02114268|529708329|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
146873648|NCT02114268|529708330|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
146873649|NCT02114268|529708331|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
146873650|NCT02114268|529708332|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
146873651|NCT02114268|529708333|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
146873652|NCT02114268|529708334|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
146873653|NCT01075412|529708339|FG000|Overall Study|Withdrawal by Subject|0|||
146873654|NCT01075412|529708340|FG001|Overall Study|Withdrawal by Subject|1|||
146873655|NCT00865904|529708344|FG000|Overall Study|Randomized but not Treated|2|||
146873656|NCT00865904|529708345|FG001|Overall Study|Randomized but not Treated|0|||
146873657|NCT00865904|529708346|FG002|Overall Study|Randomized but not Treated|0|||
146873658|NCT00865904|529708347|FG003|Overall Study|Randomized but not Treated|1|||
146873659|NCT00865904|529708348|FG004|Overall Study|Randomized but not Treated|1|||
146873660|NCT01431274|529708349|FG000|Overall Study|Adverse Event|51|||
146873661|NCT01431274|529708350|FG001|Overall Study|Adverse Event|37|||
146873662|NCT01431274|529708351|FG002|Overall Study|Adverse Event|43|||
146873663|NCT01431274|529708352|FG003|Overall Study|Adverse Event|30|||
146873664|NCT01431274|529708353|FG004|Overall Study|Adverse Event|37|||
146543743|NCT00970944|528497197|FG000|Overall Study|Physician Decision|0|||
146543744|NCT00970944|528497198|FG001|Overall Study|Physician Decision|2|||
146543745|NCT02008370|528497199|FG000|Overall Study|Lost to Follow-up|7|||
146543746|NCT00662259|528497200|FG000|Overall Study|Adverse Event|2|||
146543747|NCT00662259|528497201|FG001|Overall Study|Adverse Event|0|||
146543748|NCT00972738|528497202|FG000|Overall Study|Adverse Event|7|||
146543749|NCT00972738|528497203|FG001|Overall Study|Adverse Event|1|||
146543750|NCT00972738|528497204|FG002|Overall Study|Adverse Event|8|||
146543751|NCT00972738|528497202|FG000|Overall Study|Protocol Violation|2|||
146543752|NCT00972738|528497203|FG001|Overall Study|Protocol Violation|1|||
146873665|NCT01431274|529708349|FG000|Overall Study|Consent withdrawn not due to AE|29|||
146873666|NCT01431274|529708350|FG001|Overall Study|Consent withdrawn not due to AE|20|||
146873667|NCT01431274|529708351|FG002|Overall Study|Consent withdrawn not due to AE|17|||
146873668|NCT01431274|529708352|FG003|Overall Study|Consent withdrawn not due to AE|20|||
146873669|NCT01431274|529708353|FG004|Overall Study|Consent withdrawn not due to AE|11|||
146873670|NCT01431274|529708349|FG000|Overall Study|Non compliant with protocol|5|||
146543753|NCT00972738|528497204|FG002|Overall Study|Protocol Violation|3|||
146873671|NCT01431274|529708350|FG001|Overall Study|Non compliant with protocol|8|||
146873672|NCT01431274|529708351|FG002|Overall Study|Non compliant with protocol|4|||
146873673|NCT01431274|529708352|FG003|Overall Study|Non compliant with protocol|4|||
146873674|NCT01431274|529708353|FG004|Overall Study|Non compliant with protocol|4|||
146873675|NCT01431274|529708349|FG000|Overall Study|Lost to Follow-up|6|||
146873676|NCT01431274|529708350|FG001|Overall Study|Lost to Follow-up|7|||
146873677|NCT01431274|529708351|FG002|Overall Study|Lost to Follow-up|1|||
146873678|NCT01431274|529708352|FG003|Overall Study|Lost to Follow-up|4|||
146873679|NCT01431274|529708353|FG004|Overall Study|Lost to Follow-up|0|||
146873680|NCT01431274|529708349|FG000|Overall Study|Other reason not stated above|6|||
146873681|NCT01431274|529708350|FG001|Overall Study|Other reason not stated above|5|||
146873682|NCT01431274|529708351|FG002|Overall Study|Other reason not stated above|7|||
146873683|NCT01431274|529708352|FG003|Overall Study|Other reason not stated above|2|||
146873684|NCT01431274|529708353|FG004|Overall Study|Other reason not stated above|4|||
146873685|NCT01378858|529708354|FG000|Overall Study|Withdrawal by Subject|4|||
146873686|NCT01378858|529708355|FG001|Overall Study|Withdrawal by Subject|4|||
146873687|NCT02664272|529708356|FG000|Overall Study|Fluoroscopic images not made available|2|||
146873688|NCT03073980|529708357|FG000|Overall Study|Lost to Follow-up|10|||
146873689|NCT03073980|529708358|FG001|Overall Study|Lost to Follow-up|2|||
146873690|NCT03073980|529708359|FG002|Overall Study|Lost to Follow-up|9|||
146873691|NCT03073980|529708357|FG000|Overall Study|No post-procedure data|0|||
146873692|NCT03073980|529708358|FG001|Overall Study|No post-procedure data|0|||
146873693|NCT03073980|529708359|FG002|Overall Study|No post-procedure data|2|||
146873694|NCT01358760|529708360|FG000|Overall Study|Adverse Event|3|||
146873695|NCT01358760|529708361|FG001|Overall Study|Adverse Event|4|||
146873696|NCT01358760|529708362|FG002|Overall Study|Adverse Event|3|||
146873697|NCT01358760|529708360|FG000|Overall Study|Lost to Follow-up|1|||
146873698|NCT01358760|529708361|FG001|Overall Study|Lost to Follow-up|1|||
146873699|NCT01358760|529708362|FG002|Overall Study|Lost to Follow-up|3|||
146873700|NCT01358760|529708360|FG000|Overall Study|Withdrawal by Subject|5|||
146873701|NCT01358760|529708361|FG001|Overall Study|Withdrawal by Subject|3|||
146873702|NCT01358760|529708362|FG002|Overall Study|Withdrawal by Subject|2|||
146873703|NCT01358760|529708360|FG000|Overall Study|Physician Decision|1|||
146873704|NCT01358760|529708361|FG001|Overall Study|Physician Decision|0|||
146873705|NCT01358760|529708362|FG002|Overall Study|Physician Decision|1|||
146873706|NCT01358760|529708360|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
146873707|NCT01358760|529708361|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
146873708|NCT01358760|529708362|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
146873709|NCT01506960|529708363|FG000|Overall Study|Did not meet angiographic criteria|47|||
146873710|NCT02047253|529708366|FG000|Overall Study|Lost to Follow-up|8|||
146873711|NCT03574753|529708367|FG000|Overall Study|Adverse Event|3|||
146873712|NCT03574753|529708367|FG000|Overall Study|Progression/relapse|19|||
146873713|NCT03574753|529708367|FG000|Overall Study|Death|1|||
146873714|NCT00789880|529708370|FG000|Overall Study|Adverse Event|0|||
146873715|NCT00789880|529708371|FG001|Overall Study|Adverse Event|0|||
146873716|NCT00789880|529708372|FG002|Overall Study|Adverse Event|0|||
146873717|NCT00789880|529708373|FG003|Overall Study|Adverse Event|0|||
146873718|NCT00789880|529708374|FG004|Overall Study|Adverse Event|1|||
146873719|NCT00789880|529708375|FG005|Overall Study|Adverse Event|0|||
146873720|NCT00789880|529708370|FG000|Overall Study|Protocol Violation|0|||
146873721|NCT00789880|529708371|FG001|Overall Study|Protocol Violation|1|||
146873722|NCT00789880|529708372|FG002|Overall Study|Protocol Violation|0|||
146873723|NCT00789880|529708373|FG003|Overall Study|Protocol Violation|1|||
146873724|NCT00789880|529708374|FG004|Overall Study|Protocol Violation|0|||
146873725|NCT00789880|529708375|FG005|Overall Study|Protocol Violation|0|||
146873726|NCT00789880|529708370|FG000|Overall Study|Withdrawal by Subject|1|||
146873727|NCT00789880|529708371|FG001|Overall Study|Withdrawal by Subject|0|||
146873728|NCT00789880|529708372|FG002|Overall Study|Withdrawal by Subject|0|||
146873729|NCT00789880|529708373|FG003|Overall Study|Withdrawal by Subject|0|||
146873730|NCT00789880|529708374|FG004|Overall Study|Withdrawal by Subject|2|||
146873731|NCT00789880|529708375|FG005|Overall Study|Withdrawal by Subject|0|||
146873732|NCT00609986|529708379|FG000|Overall Study|Did not receive transplant or treatment|8|||
146873733|NCT00609986|529708380|FG001|Overall Study|Did not receive transplant or treatment|3|||
146873734|NCT03159091|529708381|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
146873735|NCT03159091|529708382|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
146873736|NCT03159091|529708381|FG000|Overall Study|Patient has taken no dose of study drug|0|||
146873737|NCT03159091|529708382|FG001|Overall Study|Patient has taken no dose of study drug|1|||
146873738|NCT04814823|529708383|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
146873739|NCT02044133|529708384|FG000|Overall Study|Lost to Follow-up|1|||
146873740|NCT02044133|529708385|FG001|Overall Study|Lost to Follow-up|1|||
146873741|NCT02044133|529708384|FG000|Overall Study|Death|1|||
146873742|NCT02044133|529708385|FG001|Overall Study|Death|0|||
146873743|NCT02044133|529708384|FG000|Overall Study|Release|3|||
146873744|NCT02044133|529708385|FG001|Overall Study|Release|4|||
146873745|NCT02044133|529708384|FG000|Overall Study|Transfer|1|||
146873746|NCT02044133|529708385|FG001|Overall Study|Transfer|0|||
146873747|NCT02044133|529708384|FG000|Overall Study|refusal of blood sampling|0|||
146873748|NCT02044133|529708385|FG001|Overall Study|refusal of blood sampling|1|||
146873749|NCT04085523|529708386|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
146873750|NCT04085523|529708387|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
146873751|NCT04085523|529708388|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
146873752|NCT04085523|529708389|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
146873753|NCT04085523|529708390|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
146873754|NCT04085523|529708391|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
146873755|NCT05318937|529708396|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146873756|NCT05318937|529708397|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146873757|NCT05318937|529708396|FG000|Overall Study|Lost to Follow-up|0|||
146873758|NCT05318937|529708397|FG001|Overall Study|Lost to Follow-up|1|||
146873759|NCT05318937|529708396|FG000|Overall Study|Withdrawal by Subject|0|||
146873760|NCT05318937|529708397|FG001|Overall Study|Withdrawal by Subject|2|||
146873761|NCT05318937|529708396|FG000|Overall Study|Protocol Violation|0|||
146873762|NCT05318937|529708397|FG001|Overall Study|Protocol Violation|1|||
146873763|NCT04722042|529708398|FG000|Overall Study|Withdrawal by Subject|2|||
146873764|NCT04722042|529708399|FG001|Overall Study|Withdrawal by Subject|1|||
146873765|NCT04722042|529708400|FG002|Overall Study|Withdrawal by Subject|0|||
146873766|NCT01877915|529708401|FG000|Overall Study|Lost to Follow-up|10|||
146873767|NCT01877915|529708402|FG001|Overall Study|Lost to Follow-up|9|||
146873768|NCT01877915|529708401|FG000|Overall Study|Withdrawal by Subject|42|||
146873769|NCT01877915|529708402|FG001|Overall Study|Withdrawal by Subject|55|||
146873770|NCT01877915|529708401|FG000|Overall Study|Other|2|||
146873771|NCT01877915|529708402|FG001|Overall Study|Other|4|||
146873772|NCT04490018|529708403|FG000|Overall Study|Protocol Violation|0|||
146873773|NCT04490018|529708404|FG001|Overall Study|Protocol Violation|2|||
146873774|NCT04490018|529708405|FG002|Overall Study|Protocol Violation|1|||
146873775|NCT04490018|529708403|FG000|Overall Study|Lost to Follow-up|2|||
146873776|NCT04490018|529708404|FG001|Overall Study|Lost to Follow-up|2|||
146873777|NCT04490018|529708405|FG002|Overall Study|Lost to Follow-up|0|||
146873778|NCT04490018|529708403|FG000|Overall Study|Withdrawal by Subject|2|||
146873779|NCT04490018|529708404|FG001|Overall Study|Withdrawal by Subject|1|||
146873780|NCT04490018|529708405|FG002|Overall Study|Withdrawal by Subject|0|||
146873781|NCT04490018|529708403|FG000|Overall Study|Withdrawal by parent/guardian|2|||
146873782|NCT04490018|529708404|FG001|Overall Study|Withdrawal by parent/guardian|3|||
146873783|NCT04490018|529708405|FG002|Overall Study|Withdrawal by parent/guardian|0|||
146873784|NCT00943579|529708407|FG000|Overall Study|Adverse Event|4|||
146873785|NCT00943579|529708408|FG001|Overall Study|Adverse Event|3|||
146873786|NCT00943579|529708407|FG000|Overall Study|Lack of Efficacy|2|||
146873787|NCT00943579|529708408|FG001|Overall Study|Lack of Efficacy|2|||
146873788|NCT00418665|529708409|FG000|Treatment Period|Ineligibility determined|1|||
146873789|NCT00418665|529708410|FG001|Treatment Period|Ineligibility determined|1|||
146873790|NCT00418665|529708411|FG002|Treatment Period|Ineligibility determined|0|||
146873791|NCT00418665|529708409|FG000|Treatment Period|Adverse Event|2|||
146873792|NCT00418665|529708410|FG001|Treatment Period|Adverse Event|2|||
146873793|NCT00418665|529708411|FG002|Treatment Period|Adverse Event|0|||
146873794|NCT00418665|529708409|FG000|Treatment Period|Withdrawal by Subject|0|||
146873795|NCT00418665|529708410|FG001|Treatment Period|Withdrawal by Subject|3|||
146873796|NCT00418665|529708411|FG002|Treatment Period|Withdrawal by Subject|1|||
146873797|NCT00418665|529708409|FG000|Treatment Period|Requirement for alternative therapy|1|||
146873798|NCT00418665|529708410|FG001|Treatment Period|Requirement for alternative therapy|0|||
146543754|NCT00972738|528497202|FG000|Overall Study|Lost to Follow-up|1|||
146543755|NCT00972738|528497203|FG001|Overall Study|Lost to Follow-up|0|||
146543756|NCT00972738|528497204|FG002|Overall Study|Lost to Follow-up|1|||
146543757|NCT00972738|528497202|FG000|Overall Study|Lack of Efficacy|5|||
146543758|NCT00972738|528497203|FG001|Overall Study|Lack of Efficacy|1|||
146543759|NCT00972738|528497204|FG002|Overall Study|Lack of Efficacy|11|||
146543760|NCT00972738|528497202|FG000|Overall Study|Withdrawal by Subject|5|||
146543761|NCT00972738|528497203|FG001|Overall Study|Withdrawal by Subject|1|||
146543762|NCT00972738|528497204|FG002|Overall Study|Withdrawal by Subject|4|||
146543763|NCT00972738|528497202|FG000|Overall Study|Moved|0|||
146543764|NCT00972738|528497203|FG001|Overall Study|Moved|0|||
146543765|NCT00972738|528497204|FG002|Overall Study|Moved|1|||
146543766|NCT00972738|528497202|FG000|Overall Study|Other|1|||
146543767|NCT00972738|528497203|FG001|Overall Study|Other|2|||
146873799|NCT00418665|529708411|FG002|Treatment Period|Requirement for alternative therapy|0|||
146873800|NCT00418665|529708409|FG000|Treatment Period|Physician Decision|1|||
146873801|NCT00418665|529708410|FG001|Treatment Period|Physician Decision|0|||
146873802|NCT00418665|529708411|FG002|Treatment Period|Physician Decision|3|||
146873803|NCT00418665|529708409|FG000|Treatment Extension|Adverse Event|1|||
146873804|NCT00418665|529708410|FG001|Treatment Extension|Adverse Event|0|||
146873805|NCT00418665|529708411|FG002|Treatment Extension|Adverse Event|0|||
146873806|NCT00418665|529708409|FG000|Treatment Extension|Withdrawal by Subject|1|||
146873807|NCT00418665|529708410|FG001|Treatment Extension|Withdrawal by Subject|0|||
146873808|NCT00418665|529708411|FG002|Treatment Extension|Withdrawal by Subject|0|||
146543768|NCT00972738|528497204|FG002|Overall Study|Other|1|||
146873809|NCT00418665|529708409|FG000|Treatment Extension|Requirement for alternative therapy|2|||
146543769|NCT03915067|528497206|FG000|Overall Study|Adverse Event|0|||
146764398|NCT00543725|529304384|FG001|Overall Study|Adverse Event|27|||
146764399|NCT00543725|529304383|FG000|Overall Study|Sponsor's Decision|0|||
146764400|NCT00543725|529304384|FG001|Overall Study|Sponsor's Decision|1|||
146764401|NCT00543725|529304383|FG000|Overall Study|Subject Non-Compliant|4|||
146764402|NCT00543725|529304384|FG001|Overall Study|Subject Non-Compliant|4|||
146764403|NCT00543725|529304383|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
146764404|NCT00543725|529304384|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
146764405|NCT00543725|529304383|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
146764406|NCT00543725|529304384|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
146764407|NCT00543725|529304383|FG000|Overall Study|Protocol Violation|0|||
146764408|NCT00543725|529304384|FG001|Overall Study|Protocol Violation|1|||
146764409|NCT00543725|529304383|FG000|Overall Study|Withdrawal by Subject|4|||
146764410|NCT00543725|529304384|FG001|Overall Study|Withdrawal by Subject|13|||
146764411|NCT00543725|529304383|FG000|Overall Study|Lost to Follow-up|15|||
146764412|NCT00543725|529304384|FG001|Overall Study|Lost to Follow-up|11|||
146764413|NCT00543725|529304383|FG000|Overall Study|Other|3|||
146764414|NCT00543725|529304384|FG001|Overall Study|Other|3|||
146764415|NCT01250002|529304385|FG000|Overall Study|Change to open surgical procedure|4|||
146764416|NCT01250002|529304386|FG001|Overall Study|Change to open surgical procedure|3|||
146764417|NCT02322216|529304387|FG000|Overall Study|Adverse Event|1|||
146764418|NCT02322216|529304388|FG001|Overall Study|Adverse Event|0|||
146764419|NCT02322216|529304387|FG000|Overall Study|Withdrawal by Subject|1|||
146764420|NCT02322216|529304388|FG001|Overall Study|Withdrawal by Subject|4|||
146764421|NCT01651949|529304392|FG000|Overall Study|Unknown status|4|||
146764422|NCT01651949|529304393|FG001|Overall Study|Unknown status|4|||
146764423|NCT01651949|529304394|FG002|Overall Study|Unknown status|0|||
146764424|NCT01651949|529304392|FG000|Overall Study|Lost to Follow-up|30|||
146764425|NCT01651949|529304393|FG001|Overall Study|Lost to Follow-up|56|||
146764426|NCT01651949|529304394|FG002|Overall Study|Lost to Follow-up|20|||
146764427|NCT01651949|529304392|FG000|Overall Study|Protocol Violation|0|||
146764428|NCT01651949|529304393|FG001|Overall Study|Protocol Violation|2|||
146764429|NCT01651949|529304394|FG002|Overall Study|Protocol Violation|1|||
146764430|NCT01651949|529304392|FG000|Overall Study|Physician Decision|0|||
146764431|NCT01651949|529304393|FG001|Overall Study|Physician Decision|2|||
146764432|NCT01651949|529304394|FG002|Overall Study|Physician Decision|0|||
146764433|NCT01651949|529304392|FG000|Overall Study|Adverse Event|0|||
146764434|NCT01651949|529304393|FG001|Overall Study|Adverse Event|2|||
146764435|NCT01651949|529304394|FG002|Overall Study|Adverse Event|1|||
146764436|NCT01651949|529304392|FG000|Overall Study|Screen failure|2|||
146764437|NCT01651949|529304393|FG001|Overall Study|Screen failure|2|||
146764438|NCT01651949|529304394|FG002|Overall Study|Screen failure|0|||
146764439|NCT01651949|529304392|FG000|Overall Study|Withdrawal by Subject|17|||
146764440|NCT01651949|529304393|FG001|Overall Study|Withdrawal by Subject|18|||
146764441|NCT01651949|529304394|FG002|Overall Study|Withdrawal by Subject|9|||
146764442|NCT00678795|529304395|FG000|Overall Study|Adverse Event|7|||
146764443|NCT00678795|529304396|FG001|Overall Study|Adverse Event|3|||
146764444|NCT00678795|529304395|FG000|Overall Study|Withdrawal by Subject|3|||
146764445|NCT00678795|529304396|FG001|Overall Study|Withdrawal by Subject|0|||
146764446|NCT00678795|529304395|FG000|Overall Study|Protocol Violation|0|||
146764447|NCT00678795|529304396|FG001|Overall Study|Protocol Violation|1|||
146764448|NCT00678795|529304395|FG000|Overall Study|Lost to Follow-up|0|||
146764449|NCT00678795|529304396|FG001|Overall Study|Lost to Follow-up|1|||
146764450|NCT00678795|529304395|FG000|Overall Study|Lack of Efficacy|1|||
146764451|NCT00678795|529304396|FG001|Overall Study|Lack of Efficacy|1|||
146764452|NCT01191086|529304397|FG000|Overall Study|Adverse Event|20|||
146764453|NCT01191086|529304397|FG000|Overall Study|Lack of Efficacy|10|||
146764454|NCT01191086|529304397|FG000|Overall Study|Lost to Follow-up|4|||
146764455|NCT01191086|529304397|FG000|Overall Study|Physician Decision|2|||
146764456|NCT01191086|529304397|FG000|Overall Study|Withdrawal by Subject|24|||
146764457|NCT01191086|529304397|FG000|Overall Study|Discontinuation criterion met|1|||
146764458|NCT01191086|529304397|FG000|Overall Study|Other|1|||
146764459|NCT02057718|529304400|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
146764460|NCT02057718|529304401|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
146764461|NCT02057718|529304400|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
146764462|NCT02057718|529304401|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
146764463|NCT02057718|529304400|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
146764464|NCT02057718|529304401|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
146764465|NCT02057718|529304400|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
146764466|NCT02057718|529304401|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
146764467|NCT02057718|529304400|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
146764468|NCT02057718|529304401|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
146764469|NCT02057718|529304400|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
146764470|NCT02057718|529304401|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
146764471|NCT02057718|529304400|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
146764472|NCT02057718|529304401|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
146764473|NCT02057718|529304400|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
146764474|NCT02057718|529304401|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
146764475|NCT02057718|529304400|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
146764476|NCT02057718|529304401|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
146764477|NCT02057718|529304400|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
146764478|NCT02057718|529304401|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
146764479|NCT02057718|529304400|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
146764480|NCT02057718|529304401|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
146764481|NCT00608907|529304407|FG000|Overall Study|Adverse Event|6|||
146764482|NCT00608907|529304408|FG001|Overall Study|Adverse Event|0|||
146764483|NCT00608907|529304409|FG002|Overall Study|Adverse Event|1|||
146764484|NCT00608907|529304407|FG000|Overall Study|Death|1|||
146764485|NCT00608907|529304408|FG001|Overall Study|Death|0|||
146764486|NCT00608907|529304409|FG002|Overall Study|Death|0|||
146764487|NCT00608907|529304407|FG000|Overall Study|Withdrawal by Subject|4|||
146764488|NCT00608907|529304408|FG001|Overall Study|Withdrawal by Subject|0|||
146764489|NCT00608907|529304409|FG002|Overall Study|Withdrawal by Subject|0|||
146764490|NCT00608907|529304407|FG000|Overall Study|Progressive Disease|1|||
146764491|NCT00608907|529304408|FG001|Overall Study|Progressive Disease|0|||
146764492|NCT00608907|529304409|FG002|Overall Study|Progressive Disease|0|||
146764493|NCT00906035|529304410|FG000|Overall Study|Withdrawal by Subject|2|||
146764494|NCT00906035|529304411|FG001|Overall Study|Withdrawal by Subject|3|||
146764495|NCT00906035|529304412|FG002|Overall Study|Withdrawal by Subject|0|||
146764496|NCT03058991|529304413|FG000|Overall Study|Lost to Follow-up|17|||
146764497|NCT03058991|529304414|FG001|Overall Study|Lost to Follow-up|12|||
146764498|NCT03058991|529304415|FG002|Overall Study|Lost to Follow-up|12|||
146764499|NCT03058991|529304413|FG000|Overall Study|Withdrawal by Subject|1|||
146764500|NCT03058991|529304414|FG001|Overall Study|Withdrawal by Subject|0|||
146764501|NCT03058991|529304415|FG002|Overall Study|Withdrawal by Subject|0|||
146764502|NCT01689519|529304416|FG000|Intent to Treat|Death|157|||
146764503|NCT01689519|529304417|FG001|Intent to Treat|Death|167|||
146764504|NCT01689519|529304416|FG000|Intent to Treat|Lost to Follow-up|4|||
146764505|NCT01689519|529304417|FG001|Intent to Treat|Lost to Follow-up|8|||
146764506|NCT01689519|529304416|FG000|Intent to Treat|Other|2|||
146764507|NCT01689519|529304417|FG001|Intent to Treat|Other|4|||
146764508|NCT01689519|529304416|FG000|Intent to Treat|Physician Decision|4|||
146764509|NCT01689519|529304417|FG001|Intent to Treat|Physician Decision|1|||
146764510|NCT01689519|529304416|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
146764511|NCT01689519|529304417|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
146764512|NCT01689519|529304416|FG000|Intent to Treat|Withdrawal by Subject|21|||
146764513|NCT01689519|529304417|FG001|Intent to Treat|Withdrawal by Subject|20|||
146764514|NCT01689519|529304416|FG000|Safety Population|Death|158|||
146764515|NCT01689519|529304417|FG001|Safety Population|Death|165|||
146764516|NCT01689519|529304416|FG000|Safety Population|Lost to Follow-up|4|||
146764517|NCT01689519|529304417|FG001|Safety Population|Lost to Follow-up|8|||
146764518|NCT01689519|529304416|FG000|Safety Population|Other|2|||
146764519|NCT01689519|529304417|FG001|Safety Population|Other|4|||
146764520|NCT01689519|529304416|FG000|Safety Population|Physician Decision|4|||
146764521|NCT01689519|529304417|FG001|Safety Population|Physician Decision|1|||
146764522|NCT01689519|529304416|FG000|Safety Population|Study Terminated By Sponsor|60|||
146764523|NCT01689519|529304417|FG001|Safety Population|Study Terminated By Sponsor|47|||
146873810|NCT00418665|529708410|FG001|Treatment Extension|Requirement for alternative therapy|2|||
146873811|NCT00418665|529708411|FG002|Treatment Extension|Requirement for alternative therapy|0|||
146873812|NCT00418665|529708409|FG000|Treatment Extension|Physician Decision|2|||
146543770|NCT03915067|528497207|FG001|Overall Study|Adverse Event|0|||
146764524|NCT01689519|529304416|FG000|Safety Population|Withdrawal by Subject|20|||
146764525|NCT01689519|529304417|FG001|Safety Population|Withdrawal by Subject|20|||
146764526|NCT00559949|529304422|FG000|Overall Study|Progressive Disease during cycle 1|1|||
146764527|NCT00559949|529304422|FG000|Overall Study|Adverse Event|1|||
146764528|NCT00559949|529304422|FG000|Overall Study|Withdrawal by Subject|4|||
146764529|NCT00559949|529304422|FG000|Overall Study|No disease evaluation per protocol|1|||
146764530|NCT00835380|529304427|FG000|Overall Study|Withdrawal by Subject|2|||
146764531|NCT01582945|529304430|FG000|Overall Study|Intolerable side-effects|1|||
146764532|NCT01582945|529304430|FG000|Overall Study|Scheduling conflicts|1|||
146764533|NCT01726023|529304434|FG000|Overall Study|Death|1|||
146764534|NCT01726023|529304435|FG001|Overall Study|Death|1|||
146543771|NCT03915067|528497208|FG002|Overall Study|Adverse Event|1|||
146873813|NCT00418665|529708410|FG001|Treatment Extension|Physician Decision|2|||
146873814|NCT00418665|529708411|FG002|Treatment Extension|Physician Decision|1|||
146873815|NCT00418665|529708409|FG000|Treatment Extension|Death|0|||
146873816|NCT00418665|529708410|FG001|Treatment Extension|Death|0|||
146873817|NCT00418665|529708411|FG002|Treatment Extension|Death|1|||
146873818|NCT01133379|529708412|FG000|Overall Study|Withdrawal by Subject|0|||
146873819|NCT01133379|529708413|FG001|Overall Study|Withdrawal by Subject|1|||
146873820|NCT01133379|529708414|FG002|Overall Study|Withdrawal by Subject|1|||
146873821|NCT01133379|529708412|FG000|Overall Study|Lost to Follow-up|1|||
146873822|NCT01133379|529708413|FG001|Overall Study|Lost to Follow-up|1|||
146873823|NCT01133379|529708414|FG002|Overall Study|Lost to Follow-up|1|||
146873824|NCT00591214|529708415|FG000|Overall Study|Physician Decision|7|||
146873825|NCT00591214|529708415|FG000|Overall Study|Withdrawal by Subject|1|||
146873826|NCT04857996|529708418|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
146873827|NCT04857996|529708419|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
146873828|NCT04857996|529708418|FG000|Overall Study|Lost to Follow-up|1|||
146873829|NCT04857996|529708419|FG001|Overall Study|Lost to Follow-up|3|||
146873830|NCT04857996|529708418|FG000|Overall Study|Site Closure|1|||
146873831|NCT04857996|529708419|FG001|Overall Study|Site Closure|0|||
146873832|NCT04857996|529708418|FG000|Overall Study|Withdrawal by Subject|1|||
146873833|NCT04857996|529708419|FG001|Overall Study|Withdrawal by Subject|0|||
146873834|NCT01129921|529708420|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
146873835|NCT01129921|529708421|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
146873836|NCT01129921|529708420|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
146873837|NCT01129921|529708421|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
146873838|NCT01129921|529708420|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
146873839|NCT01129921|529708421|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
146873840|NCT01129921|529708420|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
146873841|NCT01129921|529708421|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
146873842|NCT00282295|529708422|FG000|Overall Study|Adverse Event|0|||
146873843|NCT00282295|529708423|FG001|Overall Study|Adverse Event|1|||
146873844|NCT00282295|529708424|FG002|Overall Study|Adverse Event|0|||
146873845|NCT00282295|529708422|FG000|Overall Study|Serious Adverse Events|0|||
146873846|NCT00282295|529708423|FG001|Overall Study|Serious Adverse Events|0|||
146873847|NCT00282295|529708424|FG002|Overall Study|Serious Adverse Events|1|||
146873848|NCT00282295|529708422|FG000|Overall Study|Protocol Violation|0|||
146873849|NCT00282295|529708423|FG001|Overall Study|Protocol Violation|2|||
146873850|NCT00282295|529708424|FG002|Overall Study|Protocol Violation|1|||
146873851|NCT00282295|529708422|FG000|Overall Study|Withdrawal by Subject|2|||
146873852|NCT00282295|529708423|FG001|Overall Study|Withdrawal by Subject|6|||
146873853|NCT00282295|529708424|FG002|Overall Study|Withdrawal by Subject|4|||
146873854|NCT00282295|529708422|FG000|Overall Study|Lost to Follow-up|1|||
146873855|NCT00282295|529708423|FG001|Overall Study|Lost to Follow-up|7|||
146873856|NCT00282295|529708424|FG002|Overall Study|Lost to Follow-up|2|||
146873857|NCT00282295|529708422|FG000|Overall Study|Other|0|||
146873858|NCT00282295|529708423|FG001|Overall Study|Other|1|||
146873859|NCT00282295|529708424|FG002|Overall Study|Other|0|||
146873860|NCT03337542|529708425|FG000|Overall Study|Withdrew Consent|17|||
146873861|NCT03337542|529708425|FG000|Overall Study|Allergic Adverse Event|1|||
146873862|NCT03337542|529708425|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
146873863|NCT03337542|529708425|FG000|Overall Study|Lost to Follow-up|1|||
146873864|NCT03337542|529708425|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
146873865|NCT00583024|529708434|FG000|Overall Study|Lost to Follow-up|4|||
146873866|NCT00736255|529709483|FG000|Overall Study|Adverse Event|1|||
146873867|NCT00736255|529709484|FG001|Overall Study|Adverse Event|0|||
146873868|NCT00736255|529709483|FG000|Overall Study|Physician Decision|1|||
146873869|NCT00736255|529709484|FG001|Overall Study|Physician Decision|0|||
146873870|NCT00736255|529709483|FG000|Overall Study|Non-compliance|1|||
146543772|NCT03915067|528497206|FG000|Overall Study|Withdrawal by Subject|4|||
146543773|NCT03915067|528497207|FG001|Overall Study|Withdrawal by Subject|3|||
146543774|NCT03915067|528497208|FG002|Overall Study|Withdrawal by Subject|0|||
146543775|NCT03915067|528497206|FG000|Overall Study|Lost to Follow-up|3|||
146543776|NCT03915067|528497207|FG001|Overall Study|Lost to Follow-up|2|||
146543777|NCT03915067|528497208|FG002|Overall Study|Lost to Follow-up|0|||
146543778|NCT03915067|528497206|FG000|Overall Study|Protocol Deviation|0|||
146543779|NCT03915067|528497207|FG001|Overall Study|Protocol Deviation|0|||
146543780|NCT03915067|528497208|FG002|Overall Study|Protocol Deviation|1|||
146543781|NCT03915067|528497206|FG000|Overall Study|Covid-19 Related Issues|2|||
146543782|NCT03915067|528497207|FG001|Overall Study|Covid-19 Related Issues|4|||
146543783|NCT03915067|528497208|FG002|Overall Study|Covid-19 Related Issues|4|||
146873871|NCT00736255|529709484|FG001|Overall Study|Non-compliance|1|||
146543784|NCT03915067|528497206|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
146873872|NCT00847145|529709490|FG000|Overall Study|AE or Death|0|||
146873873|NCT00847145|529709491|FG001|Overall Study|AE or Death|1|||
146543785|NCT03915067|528497207|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
146873874|NCT00847145|529709492|FG002|Overall Study|AE or Death|1|||
146873875|NCT00847145|529709493|FG003|Overall Study|AE or Death|0|||
146873876|NCT00847145|529709494|FG004|Overall Study|AE or Death|0|||
146873877|NCT00847145|529709495|FG005|Overall Study|AE or Death|0|||
146873878|NCT00847145|529709496|FG006|Overall Study|AE or Death|0|||
146873879|NCT00847145|529709497|FG007|Overall Study|AE or Death|0|||
146873880|NCT00847145|529709490|FG000|Overall Study|Withdrawal by Subject|3|||
146873881|NCT00847145|529709491|FG001|Overall Study|Withdrawal by Subject|4|||
146873882|NCT00847145|529709492|FG002|Overall Study|Withdrawal by Subject|6|||
146873883|NCT00847145|529709493|FG003|Overall Study|Withdrawal by Subject|1|||
146873884|NCT00847145|529709494|FG004|Overall Study|Withdrawal by Subject|0|||
146873885|NCT00847145|529709495|FG005|Overall Study|Withdrawal by Subject|0|||
146873886|NCT00847145|529709496|FG006|Overall Study|Withdrawal by Subject|1|||
146873887|NCT00847145|529709497|FG007|Overall Study|Withdrawal by Subject|1|||
146873888|NCT00847145|529709490|FG000|Overall Study|Lost to Follow-up|3|||
146873889|NCT00847145|529709491|FG001|Overall Study|Lost to Follow-up|1|||
146873890|NCT00847145|529709492|FG002|Overall Study|Lost to Follow-up|1|||
146873891|NCT00847145|529709493|FG003|Overall Study|Lost to Follow-up|0|||
146873892|NCT00847145|529709494|FG004|Overall Study|Lost to Follow-up|4|||
146873893|NCT00847145|529709495|FG005|Overall Study|Lost to Follow-up|4|||
146873894|NCT00847145|529709496|FG006|Overall Study|Lost to Follow-up|8|||
146873895|NCT00847145|529709497|FG007|Overall Study|Lost to Follow-up|2|||
146873896|NCT00847145|529709490|FG000|Overall Study|Inappropriate enrollment|0|||
146873897|NCT00847145|529709491|FG001|Overall Study|Inappropriate enrollment|0|||
146873898|NCT00847145|529709492|FG002|Overall Study|Inappropriate enrollment|0|||
146873899|NCT00847145|529709493|FG003|Overall Study|Inappropriate enrollment|0|||
146873900|NCT00847145|529709494|FG004|Overall Study|Inappropriate enrollment|1|||
146873901|NCT00847145|529709495|FG005|Overall Study|Inappropriate enrollment|0|||
146873902|NCT00847145|529709496|FG006|Overall Study|Inappropriate enrollment|0|||
146873903|NCT00847145|529709497|FG007|Overall Study|Inappropriate enrollment|0|||
146873904|NCT00847145|529709490|FG000|Overall Study|Protocol Violation|0|||
146873905|NCT00847145|529709491|FG001|Overall Study|Protocol Violation|0|||
146873906|NCT00847145|529709492|FG002|Overall Study|Protocol Violation|3|||
146873907|NCT00847145|529709493|FG003|Overall Study|Protocol Violation|0|||
146873908|NCT00847145|529709494|FG004|Overall Study|Protocol Violation|1|||
146873909|NCT00847145|529709495|FG005|Overall Study|Protocol Violation|0|||
146873910|NCT00847145|529709496|FG006|Overall Study|Protocol Violation|0|||
146873911|NCT00847145|529709497|FG007|Overall Study|Protocol Violation|1|||
146873912|NCT02833974|529709498|FG000|Overall Study|Lost to Follow-up|1|||
146873913|NCT02833974|529709499|FG001|Overall Study|Lost to Follow-up|0|||
146873914|NCT02833974|529709498|FG000|Overall Study|Adverse Event|0|||
146873915|NCT02833974|529709499|FG001|Overall Study|Adverse Event|3|||
146873916|NCT04419610|529709500|FG000|Overall Study|Withdrawal by Subject|3|||
146873917|NCT04419610|529709501|FG001|Overall Study|Withdrawal by Subject|1|||
146873918|NCT04419610|529709500|FG000|Overall Study|Adverse Event|1|||
146873919|NCT04419610|529709501|FG001|Overall Study|Adverse Event|0|||
146873920|NCT04419610|529709500|FG000|Overall Study|discharged early|1|||
146873921|NCT04419610|529709501|FG001|Overall Study|discharged early|1|||
146873922|NCT01439282|529709502|FG000|Overall Study|Adverse Event|5|||
146873923|NCT01439282|529709503|FG001|Overall Study|Adverse Event|0|||
146873924|NCT01439282|529709502|FG000|Overall Study|Withdrawal by Subject|2|||
146873925|NCT01439282|529709503|FG001|Overall Study|Withdrawal by Subject|0|||
146873926|NCT01439282|529709502|FG000|Overall Study|Other|1|||
146873927|NCT01439282|529709503|FG001|Overall Study|Other|1|||
146873928|NCT01502709|529709507|FG000|Overall Study|Lost to Follow-up|4|||
146873929|NCT01502709|529709508|FG001|Overall Study|Lost to Follow-up|0|||
146873930|NCT00307151|529709509|FG000|Overall Study|Death|4|||
146873931|NCT00307151|529709510|FG001|Overall Study|Death|3|||
146873932|NCT00307151|529709511|FG002|Overall Study|Death|10|||
146873933|NCT00307151|529709512|FG003|Overall Study|Death|3|||
146543786|NCT03915067|528497208|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
146543787|NCT02693418|528497209|FG000|Overall Study|Lost to Follow-up|1|||
146873934|NCT00307151|529709509|FG000|Overall Study|Severe debilitation, unable to continue|1|||
146873935|NCT00307151|529709510|FG001|Overall Study|Severe debilitation, unable to continue|0|||
146873936|NCT00307151|529709511|FG002|Overall Study|Severe debilitation, unable to continue|0|||
146873937|NCT00307151|529709512|FG003|Overall Study|Severe debilitation, unable to continue|0|||
146873938|NCT00307151|529709509|FG000|Overall Study|Subject unable to get to clinic|1|||
146873939|NCT00307151|529709510|FG001|Overall Study|Subject unable to get to clinic|0|||
146873940|NCT00307151|529709511|FG002|Overall Study|Subject unable to get to clinic|6|||
146873941|NCT00307151|529709512|FG003|Overall Study|Subject unable to get to clinic|2|||
146873942|NCT00307151|529709509|FG000|Overall Study|Withdrew consent|0|||
146873943|NCT00307151|529709510|FG001|Overall Study|Withdrew consent|1|||
146873944|NCT00307151|529709511|FG002|Overall Study|Withdrew consent|1|||
146873945|NCT00307151|529709512|FG003|Overall Study|Withdrew consent|3|||
146873946|NCT00307151|529709509|FG000|Overall Study|Not willing to adhere to study reqs|2|||
146873947|NCT00307151|529709510|FG001|Overall Study|Not willing to adhere to study reqs|0|||
146873948|NCT00307151|529709511|FG002|Overall Study|Not willing to adhere to study reqs|2|||
146873949|NCT00307151|529709512|FG003|Overall Study|Not willing to adhere to study reqs|2|||
146873950|NCT00307151|529709509|FG000|Overall Study|Clinic unable to contact subject|3|||
146873951|NCT00307151|529709510|FG001|Overall Study|Clinic unable to contact subject|3|||
146873952|NCT00307151|529709511|FG002|Overall Study|Clinic unable to contact subject|1|||
146873953|NCT00307151|529709512|FG003|Overall Study|Clinic unable to contact subject|1|||
146873954|NCT00346073|529709513|FG000|Overall Study|Serious Adverse Event|2|||
146873955|NCT00346073|529709514|FG001|Overall Study|Serious Adverse Event|0|||
146873956|NCT00346073|529709513|FG000|Overall Study|Lost to Follow-up|39|||
146873957|NCT00346073|529709514|FG001|Overall Study|Lost to Follow-up|24|||
146873958|NCT04179734|529709519|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
146873959|NCT04179734|529709520|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
146873960|NCT04179734|529709519|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
146873961|NCT04179734|529709520|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
146873962|NCT00937937|529709521|FG000|Overall Study|Adverse Event|6|||
146873963|NCT00937937|529709521|FG000|Overall Study|Withdrawal by Subject|2|||
146873964|NCT00937937|529709521|FG000|Overall Study|Progression/relapse|61|||
146873965|NCT00937937|529709521|FG000|Overall Study|Death|1|||
146873966|NCT00937937|529709521|FG000|Overall Study|Other|2|||
146873967|NCT02966509|529709522|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
146873968|NCT02966509|529709523|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
146873969|NCT02966509|529709522|FG000|Baseline Satisfaction Survey|Death|0|||
146873970|NCT02966509|529709523|FG001|Baseline Satisfaction Survey|Death|1|||
146873971|NCT02966509|529709522|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
146873972|NCT02966509|529709523|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
146873973|NCT02966509|529709522|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
146873974|NCT02966509|529709523|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
146873975|NCT02966509|529709522|FG000|6 Month Satisfaction Decision Survey|Death|22|||
146873976|NCT02966509|529709523|FG001|6 Month Satisfaction Decision Survey|Death|25|||
146873977|NCT02966509|529709522|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
146873978|NCT02966509|529709523|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
146873979|NCT02966509|529709522|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
146873980|NCT02966509|529709523|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
146873981|NCT02966509|529709522|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
146873982|NCT02966509|529709523|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
146873983|NCT02966509|529709522|FG000|6 Month Satisfaction Survey|Death|36|||
146873984|NCT02966509|529709523|FG001|6 Month Satisfaction Survey|Death|33|||
146873985|NCT02966509|529709522|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
146873986|NCT02966509|529709523|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
146873987|NCT02966509|529709522|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
146873988|NCT02966509|529709523|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
146873989|NCT02966509|529709522|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
146873990|NCT02966509|529709523|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
146873991|NCT02966509|529709522|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
146873992|NCT02966509|529709523|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
146873993|NCT02966509|529709522|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
146873994|NCT02966509|529709523|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
146873995|NCT00054704|529709525|FG000|Overall Study|Lack of Efficacy|2|||
146873996|NCT00054704|529709526|FG001|Overall Study|Lack of Efficacy|3|||
146764535|NCT01726023|529304434|FG000|Overall Study|Lost to Follow-up|5|||
146764536|NCT01726023|529304435|FG001|Overall Study|Lost to Follow-up|10|||
146764537|NCT01726023|529304434|FG000|Overall Study|Other Eligibility criteria|7|||
146764538|NCT01726023|529304435|FG001|Overall Study|Other Eligibility criteria|7|||
146764539|NCT01726023|529304434|FG000|Overall Study|Withdrawal by Subject|16|||
146764540|NCT01726023|529304435|FG001|Overall Study|Withdrawal by Subject|8|||
146764541|NCT03643211|529304438|FG000|Overall Study|Contract violation/deficiency|12|||
146764542|NCT03643211|529304438|FG000|Overall Study|Invalid registration|3|||
146764543|NCT03643211|529304438|FG000|Overall Study|No treatment information|2|||
146764544|NCT03643211|529304438|FG000|Overall Study|No adverse event information - No revisit|4|||
146764545|NCT04858425|529304439|FG000|Overall Study|Adverse Event|2|||
146764546|NCT04858425|529304440|FG001|Overall Study|Adverse Event|2|||
146764547|NCT04858425|529304439|FG000|Overall Study|Withdrawal by Subject|3|||
146764548|NCT04858425|529304440|FG001|Overall Study|Withdrawal by Subject|1|||
146764549|NCT04858425|529304439|FG000|Overall Study|Lost to Follow-up|4|||
146764550|NCT04858425|529304440|FG001|Overall Study|Lost to Follow-up|2|||
146764551|NCT04858425|529304439|FG000|Overall Study|Lost to Follow-up|1|||
146764552|NCT04858425|529304440|FG001|Overall Study|Lost to Follow-up|0|||
146543788|NCT02693418|528497210|FG001|Overall Study|Lost to Follow-up|2|||
146764553|NCT04536077|529304442|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
146764554|NCT04536077|529304443|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
146764555|NCT04536077|529304442|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
146764556|NCT04536077|529304443|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
146764557|NCT04550039|529304448|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
146764558|NCT04550039|529304449|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
146764559|NCT04550039|529304448|FG000|Overall Study|patient self-withdrew from study|0|||
146764560|NCT04550039|529304449|FG001|Overall Study|patient self-withdrew from study|1|||
146764561|NCT01155869|529304455|FG000|Overall Study|Lost to Follow-up|3|||
146764562|NCT01155869|529304456|FG001|Overall Study|Lost to Follow-up|1|||
146764563|NCT02824432|529304458|FG000|Overall Study|Major Protocol Deviation|1|||
146764564|NCT02824432|529304459|FG001|Overall Study|Major Protocol Deviation|0|||
146764565|NCT05824351|529304462|FG000|Overall Study|Adverse Event|6|||
146764566|NCT00828945|529304463|FG000|Overall Study|Death|4|||
146764567|NCT00828945|529304463|FG000|Overall Study|Participant was missing|1|||
146764568|NCT00828945|529304463|FG000|Overall Study|Other|36|||
146764569|NCT02698241|529304466|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
146764570|NCT02698241|529304466|FG000|Overall Study|Screening not met|7|||
146764571|NCT02698241|529304466|FG000|Overall Study|Withdrawal by Subject|7|||
146764572|NCT02698241|529304466|FG000|Overall Study|Physician Decision|2|||
146764573|NCT02698241|529304466|FG000|Overall Study|Subject underwent system modification|2|||
146764574|NCT02698241|529304466|FG000|Overall Study|Lost to Follow-up|3|||
146764575|NCT02698241|529304466|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
146764576|NCT02698241|529304466|FG000|Overall Study|geographic and licensing issue|1|||
146764577|NCT02698241|529304466|FG000|Overall Study|Death|2|||
146764578|NCT01543685|529304467|FG000|Overall Study|Lack of Efficacy|1|||
146764579|NCT01543685|529304468|FG001|Overall Study|Lack of Efficacy|2|||
146764580|NCT01543685|529304469|FG002|Overall Study|Lack of Efficacy|2|||
146764581|NCT01543685|529304470|FG003|Overall Study|Lack of Efficacy|0|||
146764582|NCT01543685|529304471|FG004|Overall Study|Lack of Efficacy|2|||
146764583|NCT01543685|529304467|FG000|Overall Study|Adverse Event|2|||
146764584|NCT01543685|529304468|FG001|Overall Study|Adverse Event|1|||
146764585|NCT01543685|529304469|FG002|Overall Study|Adverse Event|0|||
146764586|NCT01543685|529304470|FG003|Overall Study|Adverse Event|0|||
146764587|NCT01543685|529304471|FG004|Overall Study|Adverse Event|2|||
146764588|NCT00708097|529304474|FG000|Period 1|Protocol Violation|0|||
146764589|NCT00708097|529304475|FG001|Period 1|Protocol Violation|1|||
146764590|NCT00708097|529304476|FG002|Period 1|Protocol Violation|0|||
146764591|NCT00708097|529304477|FG003|Period 1|Protocol Violation|2|||
146764592|NCT00708097|529304478|FG004|Period 1|Protocol Violation|0|||
146764593|NCT00708097|529304474|FG000|Period 1|Other Reason|0|||
146764594|NCT00708097|529304475|FG001|Period 1|Other Reason|0|||
146764595|NCT00708097|529304476|FG002|Period 1|Other Reason|0|||
146764596|NCT00708097|529304477|FG003|Period 1|Other Reason|0|||
146764597|NCT00708097|529304478|FG004|Period 1|Other Reason|1|||
146764598|NCT00708097|529304474|FG000|Period 2|Protocol Violation|0|||
146764599|NCT00708097|529304475|FG001|Period 2|Protocol Violation|1|||
146764600|NCT00708097|529304476|FG002|Period 2|Protocol Violation|1|||
146764601|NCT00708097|529304477|FG003|Period 2|Protocol Violation|1|||
146764602|NCT00708097|529304478|FG004|Period 2|Protocol Violation|0|||
146764603|NCT00603447|529304479|FG000|Overall Study|Adverse Event|0|||
146764604|NCT00603447|529304480|FG001|Overall Study|Adverse Event|1|||
146764605|NCT00603447|529304481|FG002|Overall Study|Adverse Event|1|||
146764606|NCT00603447|529304482|FG003|Overall Study|Adverse Event|2|||
146764607|NCT00603447|529304483|FG004|Overall Study|Adverse Event|1|||
146764608|NCT00603447|529304484|FG005|Overall Study|Adverse Event|2|||
146764609|NCT00603447|529304485|FG006|Overall Study|Adverse Event|10|||
146764610|NCT00603447|529304479|FG000|Overall Study|Other|0|||
146764611|NCT00603447|529304480|FG001|Overall Study|Other|0|||
146764612|NCT00603447|529304481|FG002|Overall Study|Other|1|||
146764613|NCT00603447|529304482|FG003|Overall Study|Other|0|||
146764614|NCT00603447|529304483|FG004|Overall Study|Other|3|||
146764615|NCT00603447|529304484|FG005|Overall Study|Other|0|||
146764616|NCT00603447|529304485|FG006|Overall Study|Other|13|||
146764617|NCT00603447|529304479|FG000|Overall Study|Withdrew Consent|0|||
146628570|NCT01436149|528815523|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
146628571|NCT01436149|528815524|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
146628572|NCT01436149|528815525|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
146628573|NCT01436149|528815523|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
146628574|NCT01436149|528815524|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
146628575|NCT01436149|528815525|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
146628576|NCT01436149|528815523|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
146628577|NCT01436149|528815524|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
146628578|NCT01436149|528815525|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
146628579|NCT01436149|528815523|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
146628580|NCT01436149|528815524|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
146628581|NCT01436149|528815525|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
146628582|NCT01436149|528815523|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
146628583|NCT01436149|528815524|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
146628584|NCT01436149|528815525|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
146628585|NCT01436149|528815523|FG000|Antidepressant Lead-in Phase|Other|119|||
146628586|NCT01436149|528815524|FG001|Antidepressant Lead-in Phase|Other|0|||
146628587|NCT01436149|528815525|FG002|Antidepressant Lead-in Phase|Other|0|||
146628588|NCT01436149|528815523|FG000|Randomized Phase|Adverse Event|9|||
146628589|NCT01436149|528815524|FG001|Randomized Phase|Adverse Event|10|||
146628590|NCT01436149|528815525|FG002|Randomized Phase|Adverse Event|11|||
146628591|NCT01436149|528815523|FG000|Randomized Phase|Protocol Violation|4|||
146628592|NCT01436149|528815524|FG001|Randomized Phase|Protocol Violation|5|||
146628593|NCT01436149|528815525|FG002|Randomized Phase|Protocol Violation|0|||
146628594|NCT01436149|528815523|FG000|Randomized Phase|Withdrawal by Subject|16|||
146628595|NCT01436149|528815524|FG001|Randomized Phase|Withdrawal by Subject|10|||
146628596|NCT01436149|528815525|FG002|Randomized Phase|Withdrawal by Subject|10|||
146628597|NCT01436149|528815523|FG000|Randomized Phase|Lost to Follow-up|34|||
146628598|NCT01436149|528815524|FG001|Randomized Phase|Lost to Follow-up|5|||
146628599|NCT01436149|528815525|FG002|Randomized Phase|Lost to Follow-up|6|||
146628600|NCT01436149|528815523|FG000|Randomized Phase|Lack of Efficacy|0|||
146628601|NCT01436149|528815524|FG001|Randomized Phase|Lack of Efficacy|0|||
146628602|NCT01436149|528815525|FG002|Randomized Phase|Lack of Efficacy|1|||
146628603|NCT01436149|528815523|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
146628604|NCT01436149|528815524|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
146628605|NCT01436149|528815525|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
146628606|NCT01436149|528815523|FG000|Randomized Phase|Other|12|||
146628607|NCT01436149|528815524|FG001|Randomized Phase|Other|5|||
146873997|NCT00054704|529709525|FG000|Overall Study|Adverse Event|3|||
146628608|NCT01436149|528815525|FG002|Randomized Phase|Other|11|||
146628609|NCT04849364|528815527|FG000|Overall Study|Eligibility criteria not meet|0|||
146628610|NCT04849364|528815528|FG001|Overall Study|Eligibility criteria not meet|1|||
146628611|NCT04849364|528815529|FG002|Overall Study|Eligibility criteria not meet|0|||
146628612|NCT02738801|528815538|FG000|Overall Study|Adverse Event|1|||
146873998|NCT00054704|529709526|FG001|Overall Study|Adverse Event|1|||
146873999|NCT00054704|529709525|FG000|Overall Study|Lost to Follow-up|0|||
146874000|NCT00054704|529709526|FG001|Overall Study|Lost to Follow-up|1|||
146874001|NCT02181816|529709529|FG000|Overall Study|Case Report Forms Uncollected|38|||
146874002|NCT02181816|529709529|FG000|Overall Study|Protocol Deviation|21|||
146874003|NCT03807349|529709532|FG000|Overall Study|Early Study Termination|9|||
146874004|NCT01911442|529709533|FG000|Overall Study|Adverse Event|2|||
146874005|NCT01911442|529709534|FG001|Overall Study|Adverse Event|2|||
146874006|NCT01911442|529709535|FG002|Overall Study|Adverse Event|4|||
146874007|NCT01911442|529709533|FG000|Overall Study|Lack of Efficacy|1|||
146874008|NCT01911442|529709534|FG001|Overall Study|Lack of Efficacy|1|||
146874009|NCT01911442|529709535|FG002|Overall Study|Lack of Efficacy|1|||
146874010|NCT01911442|529709533|FG000|Overall Study|Lost to Follow-up|2|||
146874011|NCT01911442|529709534|FG001|Overall Study|Lost to Follow-up|0|||
146874012|NCT01911442|529709535|FG002|Overall Study|Lost to Follow-up|1|||
146874013|NCT01911442|529709533|FG000|Overall Study|Withdrawal by Subject|1|||
146874014|NCT01911442|529709534|FG001|Overall Study|Withdrawal by Subject|0|||
146874015|NCT01911442|529709535|FG002|Overall Study|Withdrawal by Subject|6|||
146874016|NCT01911442|529709533|FG000|Overall Study|Mother's Work Schedule|0|||
146874017|NCT01911442|529709534|FG001|Overall Study|Mother's Work Schedule|1|||
146874018|NCT01911442|529709535|FG002|Overall Study|Mother's Work Schedule|0|||
146628613|NCT02738801|528815539|FG001|Overall Study|Adverse Event|1|||
146628614|NCT02738801|528815538|FG000|Overall Study|Withdrawal by Subject|0|||
146874019|NCT02113436|529709536|FG000|Period 1: 8 Weeks|Adverse Event|1|||
146874020|NCT02113436|529709537|FG001|Period 1: 8 Weeks|Adverse Event|0|||
146874021|NCT02113436|529709538|FG002|Period 1: 8 Weeks|Adverse Event|0|||
146874022|NCT02113436|529709539|FG003|Period 1: 8 Weeks|Adverse Event|0|||
146874023|NCT02113436|529709536|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
146874024|NCT02113436|529709537|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
146874025|NCT02113436|529709538|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
146874026|NCT02113436|529709539|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
146874027|NCT02113436|529709536|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
146874028|NCT02113436|529709537|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
146874029|NCT02113436|529709538|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
146874030|NCT02113436|529709539|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
146874031|NCT02113436|529709536|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
146874032|NCT02113436|529709537|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
146874033|NCT02113436|529709538|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
146874034|NCT02113436|529709539|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
146874035|NCT02113436|529709536|FG000|Period 2: 16 Weeks|Adverse Event|0|||
146874036|NCT02113436|529709537|FG001|Period 2: 16 Weeks|Adverse Event|0|||
146874037|NCT02113436|529709538|FG002|Period 2: 16 Weeks|Adverse Event|4|||
146874038|NCT02113436|529709539|FG003|Period 2: 16 Weeks|Adverse Event|5|||
146874039|NCT02113436|529709536|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
146874040|NCT02113436|529709537|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
146874041|NCT02113436|529709538|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
146874042|NCT02113436|529709539|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
146874043|NCT02113436|529709536|FG000|Period 2: 16 Weeks|Physician Decision|0|||
146874044|NCT02113436|529709537|FG001|Period 2: 16 Weeks|Physician Decision|0|||
146874045|NCT02113436|529709538|FG002|Period 2: 16 Weeks|Physician Decision|2|||
146874046|NCT02113436|529709539|FG003|Period 2: 16 Weeks|Physician Decision|0|||
146874047|NCT02113436|529709536|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
146874048|NCT02113436|529709537|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
146874049|NCT02113436|529709538|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
146874050|NCT02113436|529709539|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
146874051|NCT02159729|529709540|FG000|Overall Study|Adverse Event|0|||
146874052|NCT02159729|529709541|FG001|Overall Study|Adverse Event|1|||
146874053|NCT02159729|529709540|FG000|Overall Study|Subject's Request|13|||
146874054|NCT02159729|529709541|FG001|Overall Study|Subject's Request|10|||
146874055|NCT02159729|529709540|FG000|Overall Study|Lost to Follow-up|24|||
146874056|NCT02159729|529709541|FG001|Overall Study|Lost to Follow-up|9|||
146874057|NCT02159729|529709540|FG000|Overall Study|Non compliance|2|||
146874058|NCT02159729|529709541|FG001|Overall Study|Non compliance|0|||
146874059|NCT02159729|529709540|FG000|Overall Study|Other Unspecified|3|||
146874060|NCT02159729|529709541|FG001|Overall Study|Other Unspecified|1|||
146874061|NCT01148537|529709542|FG000|Overall Study|Withdrawal by Subject|1|||
146874062|NCT01148537|529709543|FG001|Overall Study|Withdrawal by Subject|0|||
146874063|NCT01148537|529709544|FG002|Overall Study|Withdrawal by Subject|2|||
146874064|NCT01148537|529709542|FG000|Overall Study|Adverse Event|2|||
146874065|NCT01148537|529709543|FG001|Overall Study|Adverse Event|0|||
146874066|NCT01148537|529709544|FG002|Overall Study|Adverse Event|1|||
146874067|NCT00454857|529709545|FG000|Overall Study|Withdrawal by Subject|15|||
146874068|NCT00454857|529709545|FG000|Overall Study|Lost to Follow-up|16|||
146874069|NCT00454857|529709545|FG000|Overall Study|Noncompliance|6|||
146874070|NCT00454857|529709545|FG000|Overall Study|Death|5|||
146628615|NCT02738801|528815539|FG001|Overall Study|Withdrawal by Subject|1|||
146628616|NCT01643668|528815540|FG000|Overall Study|Death|1|||
146628617|NCT03253796|528815549|FG000|Period 1: Run-In|Adverse Event|4|||
146628618|NCT03253796|528815550|FG001|Period 1: Run-In|Adverse Event|0|||
146628619|NCT03253796|528815551|FG002|Period 1: Run-In|Adverse Event|0|||
146628620|NCT03253796|528815552|FG003|Period 1: Run-In|Adverse Event|0|||
146628621|NCT03253796|528815553|FG004|Period 1: Run-In|Adverse Event|0|||
146628622|NCT03253796|528815549|FG000|Period 1: Run-In|Lack of Efficacy|1|||
146764618|NCT00603447|529304480|FG001|Overall Study|Withdrew Consent|2|||
146764619|NCT00603447|529304481|FG002|Overall Study|Withdrew Consent|0|||
146874071|NCT00454857|529709545|FG000|Overall Study|Other|11|||
146874072|NCT00454857|529709545|FG000|Overall Study|Reason unknown|1|||
146874073|NCT05678257|529709552|FG000|Overall Study|Withdrawal by Subject|2|||
146874074|NCT05678257|529709553|FG001|Overall Study|Withdrawal by Subject|0|||
146874075|NCT05678257|529709554|FG002|Overall Study|Withdrawal by Subject|5|||
146874076|NCT05678257|529709552|FG000|Overall Study|Physician Decision|1|||
146764620|NCT00603447|529304482|FG003|Overall Study|Withdrew Consent|0|||
146628623|NCT03253796|528815550|FG001|Period 1: Run-In|Lack of Efficacy|0|||
146628624|NCT03253796|528815551|FG002|Period 1: Run-In|Lack of Efficacy|0|||
146764621|NCT00603447|529304483|FG004|Overall Study|Withdrew Consent|1|||
146764622|NCT00603447|529304484|FG005|Overall Study|Withdrew Consent|0|||
146764623|NCT00603447|529304485|FG006|Overall Study|Withdrew Consent|1|||
146764624|NCT03425643|529304488|FG000|Overall Study|Withdrawal by Subject|10|||
146764625|NCT03425643|529304489|FG001|Overall Study|Withdrawal by Subject|12|||
146764626|NCT03425643|529304488|FG000|Overall Study|Lost to Follow-up|2|||
146764627|NCT03425643|529304489|FG001|Overall Study|Lost to Follow-up|0|||
146764628|NCT03425643|529304488|FG000|Overall Study|Death|109|||
146764629|NCT03425643|529304489|FG001|Overall Study|Death|141|||
146764630|NCT03425643|529304488|FG000|Overall Study|Ongoing in study|276|||
146874077|NCT05678257|529709553|FG001|Overall Study|Physician Decision|0|||
146874078|NCT05678257|529709554|FG002|Overall Study|Physician Decision|1|||
146874079|NCT05678257|529709552|FG000|Overall Study|Adverse Event|1|||
146874080|NCT05678257|529709553|FG001|Overall Study|Adverse Event|3|||
146874081|NCT05678257|529709554|FG002|Overall Study|Adverse Event|1|||
146874082|NCT05678257|529709552|FG000|Overall Study|Progressive disease|11|||
146874083|NCT05678257|529709553|FG001|Overall Study|Progressive disease|18|||
146874084|NCT05678257|529709554|FG002|Overall Study|Progressive disease|7|||
146874085|NCT05678257|529709552|FG000|Overall Study|No longer clinically benefitting|2|||
146874086|NCT05678257|529709553|FG001|Overall Study|No longer clinically benefitting|1|||
146874087|NCT05678257|529709554|FG002|Overall Study|No longer clinically benefitting|0|||
146874088|NCT05678257|529709552|FG000|Overall Study|Sponsor decision|5|||
146874089|NCT05678257|529709553|FG001|Overall Study|Sponsor decision|9|||
146874090|NCT05678257|529709554|FG002|Overall Study|Sponsor decision|8|||
146874091|NCT05678257|529709552|FG000|Overall Study|Protocol Violation|0|||
146874092|NCT05678257|529709553|FG001|Overall Study|Protocol Violation|0|||
146874093|NCT05678257|529709554|FG002|Overall Study|Protocol Violation|1|||
146874094|NCT05678257|529709552|FG000|Overall Study|Patient non-compliance|0|||
146874095|NCT05678257|529709553|FG001|Overall Study|Patient non-compliance|0|||
146874096|NCT05678257|529709554|FG002|Overall Study|Patient non-compliance|3|||
146874097|NCT02046096|529709555|FG000|Overall Study|Death|28|||
146874098|NCT02046096|529709556|FG001|Overall Study|Death|45|||
146874099|NCT02046096|529709555|FG000|Overall Study|Lost to Follow-up|9|||
146874100|NCT02046096|529709556|FG001|Overall Study|Lost to Follow-up|20|||
146874101|NCT02046096|529709555|FG000|Overall Study|Withdrawal by Subject|5|||
146543789|NCT02693418|528497211|FG002|Overall Study|Lost to Follow-up|0|||
146543790|NCT02693418|528497212|FG003|Overall Study|Lost to Follow-up|0|||
146543791|NCT02693418|528497213|FG004|Overall Study|Lost to Follow-up|0|||
146543792|NCT02693418|528497209|FG000|Overall Study|Menses during study period|0|||
146543793|NCT02693418|528497210|FG001|Overall Study|Menses during study period|0|||
146543794|NCT02693418|528497211|FG002|Overall Study|Menses during study period|2|||
146543795|NCT02693418|528497212|FG003|Overall Study|Menses during study period|0|||
146543796|NCT02693418|528497213|FG004|Overall Study|Menses during study period|0|||
146543797|NCT01750346|528497215|FG000|Overall Study|Adverse Event|1|||
146543798|NCT01750346|528497216|FG001|Overall Study|Adverse Event|0|||
146543799|NCT01750346|528497217|FG002|Overall Study|Adverse Event|0|||
146543800|NCT01001104|528497218|FG000|Overall Study|Adverse Event|2|||
146543801|NCT01001104|528497219|FG001|Overall Study|Adverse Event|1|||
146543802|NCT01001104|528497220|FG002|Overall Study|Adverse Event|0|||
146543803|NCT01001104|528497221|FG003|Overall Study|Adverse Event|0|||
146543804|NCT01001104|528497218|FG000|Overall Study|Lost to Follow-up|0|||
146543805|NCT01001104|528497219|FG001|Overall Study|Lost to Follow-up|0|||
146543806|NCT01001104|528497220|FG002|Overall Study|Lost to Follow-up|1|||
146543807|NCT01001104|528497221|FG003|Overall Study|Lost to Follow-up|0|||
146543808|NCT01001104|528497218|FG000|Overall Study|Entry Criteria Not Met|0|||
146543809|NCT01001104|528497219|FG001|Overall Study|Entry Criteria Not Met|0|||
146543810|NCT01001104|528497220|FG002|Overall Study|Entry Criteria Not Met|0|||
146543811|NCT01001104|528497221|FG003|Overall Study|Entry Criteria Not Met|1|||
146543812|NCT01001104|528497218|FG000|Overall Study|Withdrawal by Subject|0|||
146543813|NCT01001104|528497219|FG001|Overall Study|Withdrawal by Subject|0|||
146764631|NCT03425643|529304489|FG001|Overall Study|Ongoing in study|247|||
146764632|NCT03141788|529304490|FG000|Overall Study|Lost to Follow-up|1|||
146764633|NCT03141788|529304490|FG000|Overall Study|Protocol Violation|3|||
146764634|NCT03141788|529304490|FG000|Overall Study|Withdrawal by Subject|4|||
146764635|NCT04133363|529304491|FG000|Overall Study|Lost to Follow-up|2|||
146764636|NCT04133363|529304492|FG001|Overall Study|Lost to Follow-up|1|||
146874102|NCT02046096|529709556|FG001|Overall Study|Withdrawal by Subject|17|||
146874103|NCT02046096|529709555|FG000|Overall Study|Other endpoint|2|||
146543814|NCT01001104|528497220|FG002|Overall Study|Withdrawal by Subject|0|||
146543815|NCT01001104|528497221|FG003|Overall Study|Withdrawal by Subject|2|||
146543816|NCT00599313|528497224|FG000|Overall Study|Adverse Event|19|||
146543817|NCT00599313|528497224|FG000|Overall Study|Disease Progression|12|||
146543818|NCT00599313|528497224|FG000|Overall Study|Patient Request|4|||
146764637|NCT04133363|529304493|FG002|Overall Study|Lost to Follow-up|4|||
146543819|NCT00599313|528497224|FG000|Overall Study|Ineligible|1|||
146764638|NCT01838200|529304494|FG000|Overall Study|Adverse Event|0|||
146874104|NCT02046096|529709556|FG001|Overall Study|Other endpoint|19|||
146874105|NCT03520959|529709557|FG000|Overall Study|Study terminated by Sponsor|0|||
146543820|NCT01793935|528497225|FG000|Overall Study|Pregnancy|1|||
146543821|NCT01793935|528497226|FG001|Overall Study|Pregnancy|0|||
146764639|NCT01838200|529304495|FG001|Overall Study|Adverse Event|2|||
146543822|NCT01793935|528497225|FG000|Overall Study|Protocol Violation|2|||
146874106|NCT03520959|529709558|FG001|Overall Study|Study terminated by Sponsor|1|||
146874107|NCT01449461|529709559|FG000|Overall Study|Adverse Event|0|||
146874108|NCT01449461|529709560|FG001|Overall Study|Adverse Event|3|||
146874109|NCT01449461|529709561|FG002|Overall Study|Adverse Event|2|||
146874110|NCT01449461|529709562|FG003|Overall Study|Adverse Event|3|||
146874111|NCT01449461|529709563|FG004|Overall Study|Adverse Event|4|||
146874112|NCT01449461|529709564|FG005|Overall Study|Adverse Event|4|||
146874113|NCT01449461|529709559|FG000|Overall Study|Death|0|||
146874114|NCT01449461|529709560|FG001|Overall Study|Death|2|||
146874115|NCT01449461|529709561|FG002|Overall Study|Death|0|||
146874116|NCT01449461|529709562|FG003|Overall Study|Death|0|||
146874117|NCT01449461|529709563|FG004|Overall Study|Death|7|||
146874118|NCT01449461|529709564|FG005|Overall Study|Death|1|||
146874119|NCT01449461|529709559|FG000|Overall Study|Physician Decision|0|||
146874120|NCT01449461|529709560|FG001|Overall Study|Physician Decision|1|||
146874121|NCT01449461|529709561|FG002|Overall Study|Physician Decision|0|||
146874122|NCT01449461|529709562|FG003|Overall Study|Physician Decision|4|||
146874123|NCT01449461|529709563|FG004|Overall Study|Physician Decision|1|||
146874124|NCT01449461|529709564|FG005|Overall Study|Physician Decision|0|||
146874125|NCT01449461|529709559|FG000|Overall Study|Documented Progressive Disease|4|||
146874126|NCT01449461|529709560|FG001|Overall Study|Documented Progressive Disease|7|||
146874127|NCT01449461|529709561|FG002|Overall Study|Documented Progressive Disease|14|||
146874128|NCT01449461|529709562|FG003|Overall Study|Documented Progressive Disease|15|||
146874129|NCT01449461|529709563|FG004|Overall Study|Documented Progressive Disease|24|||
146874130|NCT01449461|529709564|FG005|Overall Study|Documented Progressive Disease|5|||
146874131|NCT01449461|529709559|FG000|Overall Study|Clinical Progressive Disease|2|||
146874132|NCT01449461|529709560|FG001|Overall Study|Clinical Progressive Disease|2|||
146874133|NCT01449461|529709561|FG002|Overall Study|Clinical Progressive Disease|0|||
146874134|NCT01449461|529709562|FG003|Overall Study|Clinical Progressive Disease|3|||
146874135|NCT01449461|529709563|FG004|Overall Study|Clinical Progressive Disease|4|||
146874136|NCT01449461|529709564|FG005|Overall Study|Clinical Progressive Disease|2|||
146874137|NCT01449461|529709559|FG000|Overall Study|Protocol Violation|0|||
146874138|NCT01449461|529709560|FG001|Overall Study|Protocol Violation|0|||
146874139|NCT01449461|529709561|FG002|Overall Study|Protocol Violation|0|||
146874140|NCT01449461|529709562|FG003|Overall Study|Protocol Violation|1|||
146874141|NCT01449461|529709563|FG004|Overall Study|Protocol Violation|0|||
146874142|NCT01449461|529709564|FG005|Overall Study|Protocol Violation|0|||
146874143|NCT01449461|529709559|FG000|Overall Study|Site Terminated by Sponsor|0|||
146874144|NCT01449461|529709560|FG001|Overall Study|Site Terminated by Sponsor|1|||
146874145|NCT01449461|529709561|FG002|Overall Study|Site Terminated by Sponsor|2|||
146874146|NCT01449461|529709562|FG003|Overall Study|Site Terminated by Sponsor|3|||
146628625|NCT03253796|528815552|FG003|Period 1: Run-In|Lack of Efficacy|0|||
146628626|NCT03253796|528815553|FG004|Period 1: Run-In|Lack of Efficacy|0|||
146628627|NCT03253796|528815549|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
146628628|NCT03253796|528815550|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
146874147|NCT01449461|529709563|FG004|Overall Study|Site Terminated by Sponsor|4|||
146874148|NCT01449461|529709564|FG005|Overall Study|Site Terminated by Sponsor|1|||
146874149|NCT01449461|529709559|FG000|Overall Study|Withdrawal by Subject|0|||
146874150|NCT01449461|529709560|FG001|Overall Study|Withdrawal by Subject|1|||
146628629|NCT03253796|528815551|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
146628630|NCT03253796|528815552|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
146628631|NCT03253796|528815553|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
146628632|NCT03253796|528815549|FG000|Period 1: Run-In|Protocol Violation|5|||
146628633|NCT03253796|528815550|FG001|Period 1: Run-In|Protocol Violation|0|||
146628634|NCT03253796|528815551|FG002|Period 1: Run-In|Protocol Violation|0|||
146628635|NCT03253796|528815552|FG003|Period 1: Run-In|Protocol Violation|0|||
146628636|NCT03253796|528815553|FG004|Period 1: Run-In|Protocol Violation|0|||
146628637|NCT03253796|528815549|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
146628638|NCT03253796|528815550|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
146628639|NCT03253796|528815551|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
146874151|NCT01449461|529709561|FG002|Overall Study|Withdrawal by Subject|0|||
146874152|NCT01449461|529709562|FG003|Overall Study|Withdrawal by Subject|0|||
146874153|NCT01449461|529709563|FG004|Overall Study|Withdrawal by Subject|2|||
146874154|NCT01449461|529709564|FG005|Overall Study|Withdrawal by Subject|1|||
146874155|NCT01449461|529709559|FG000|Overall Study|Reason not Specified|0|||
146874156|NCT01449461|529709560|FG001|Overall Study|Reason not Specified|1|||
146874157|NCT01449461|529709561|FG002|Overall Study|Reason not Specified|0|||
146874158|NCT01449461|529709562|FG003|Overall Study|Reason not Specified|3|||
146874159|NCT01449461|529709563|FG004|Overall Study|Reason not Specified|2|||
146628640|NCT03253796|528815552|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
146628641|NCT03253796|528815553|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
146874160|NCT01449461|529709564|FG005|Overall Study|Reason not Specified|1|||
146874161|NCT05314517|529709566|FG000|Double-blind Period|Adverse Event|4|||
146874162|NCT05314517|529709567|FG001|Double-blind Period|Adverse Event|0|||
146628642|NCT03253796|528815549|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
146628643|NCT03253796|528815550|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
146874163|NCT05314517|529709568|FG002|Double-blind Period|Adverse Event|0|||
146874164|NCT05314517|529709569|FG003|Double-blind Period|Adverse Event|0|||
146874165|NCT05314517|529709566|FG000|Double-blind Period|Noncompliance|0|||
146874166|NCT05314517|529709567|FG001|Double-blind Period|Noncompliance|1|||
146874167|NCT05314517|529709568|FG002|Double-blind Period|Noncompliance|0|||
146874168|NCT05314517|529709569|FG003|Double-blind Period|Noncompliance|0|||
146874169|NCT05314517|529709566|FG000|Double-blind Period|Randomized, not treated|1|||
146874170|NCT05314517|529709567|FG001|Double-blind Period|Randomized, not treated|0|||
146874171|NCT05314517|529709568|FG002|Double-blind Period|Randomized, not treated|0|||
146874172|NCT05314517|529709569|FG003|Double-blind Period|Randomized, not treated|0|||
146874173|NCT05314517|529709566|FG000|Open-label Extension|Adverse Event|0|||
146874174|NCT05314517|529709567|FG001|Open-label Extension|Adverse Event|0|||
146874175|NCT05314517|529709568|FG002|Open-label Extension|Adverse Event|1|||
146874176|NCT05314517|529709569|FG003|Open-label Extension|Adverse Event|2|||
146874177|NCT05314517|529709566|FG000|Open-label Extension|Investigator decision|0|||
146874178|NCT05314517|529709567|FG001|Open-label Extension|Investigator decision|0|||
146874179|NCT05314517|529709568|FG002|Open-label Extension|Investigator decision|1|||
146874180|NCT05314517|529709569|FG003|Open-label Extension|Investigator decision|0|||
146874181|NCT05314517|529709566|FG000|Open-label Extension|Lost to Follow-up|0|||
146874182|NCT05314517|529709567|FG001|Open-label Extension|Lost to Follow-up|0|||
146874183|NCT05314517|529709568|FG002|Open-label Extension|Lost to Follow-up|0|||
146874184|NCT05314517|529709569|FG003|Open-label Extension|Lost to Follow-up|1|||
146874185|NCT05314517|529709566|FG000|Open-label Extension|Withdrawal by Subject|0|||
146874186|NCT05314517|529709567|FG001|Open-label Extension|Withdrawal by Subject|0|||
146874187|NCT05314517|529709568|FG002|Open-label Extension|Withdrawal by Subject|1|||
146874188|NCT05314517|529709569|FG003|Open-label Extension|Withdrawal by Subject|2|||
146874189|NCT05314517|529709566|FG000|Open-label Extension|Use of prohibited medication|0|||
146874190|NCT05314517|529709567|FG001|Open-label Extension|Use of prohibited medication|0|||
146874191|NCT05314517|529709568|FG002|Open-label Extension|Use of prohibited medication|1|||
146874192|NCT05314517|529709569|FG003|Open-label Extension|Use of prohibited medication|0|||
146874193|NCT05314517|529709566|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
146874194|NCT05314517|529709567|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
146874195|NCT05314517|529709568|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
146874196|NCT05314517|529709569|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
146874197|NCT04969276|529709570|FG000|Overall Study|Protocol Deviation|0|||
146874198|NCT04969276|529709571|FG001|Overall Study|Protocol Deviation|1|||
146874199|NCT04969276|529709572|FG002|Overall Study|Protocol Deviation|0|||
146874200|NCT04969276|529709570|FG000|Overall Study|Withdrawal by Subject|1|||
146874201|NCT04969276|529709571|FG001|Overall Study|Withdrawal by Subject|10|||
146874202|NCT04969276|529709572|FG002|Overall Study|Withdrawal by Subject|0|||
146874203|NCT04969276|529709570|FG000|Overall Study|Lost to Follow-up|0|||
146874204|NCT04969276|529709571|FG001|Overall Study|Lost to Follow-up|1|||
146874205|NCT04969276|529709572|FG002|Overall Study|Lost to Follow-up|0|||
146874206|NCT05248295|529709576|FG000|Overall Study|found ineligible|4|||
146874207|NCT05248295|529709577|FG001|Overall Study|found ineligible|1|||
146874208|NCT05248295|529709576|FG000|Overall Study|Withdrawal by Subject|0|||
146628644|NCT03253796|528815551|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
146628645|NCT03253796|528815552|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
146628646|NCT03253796|528815553|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
146874209|NCT05248295|529709577|FG001|Overall Study|Withdrawal by Subject|1|||
146874210|NCT05248295|529709576|FG000|Overall Study|Data loss: audio recording error|1|||
146874211|NCT05248295|529709577|FG001|Overall Study|Data loss: audio recording error|1|||
146874212|NCT04655144|529709578|FG000|Overall Study|Consumed THC|1|||
146874213|NCT04655144|529709579|FG001|Overall Study|Consumed THC|0|||
146874214|NCT04655144|529709578|FG000|Overall Study|Unilateral embolization|0|||
146874215|NCT04655144|529709579|FG001|Overall Study|Unilateral embolization|1|||
146874216|NCT01484977|529709582|FG000|Overall Study|Adverse Event|8|||
146874217|NCT01484977|529709582|FG000|Overall Study|Lack of Efficacy|4|||
146874218|NCT01484977|529709582|FG000|Overall Study|Protocol Violation|6|||
146874219|NCT01484977|529709582|FG000|Overall Study|Lost to Follow-up|1|||
146874220|NCT01484977|529709582|FG000|Overall Study|Withdrawal by Subject|4|||
146543823|NCT01793935|528497226|FG001|Overall Study|Protocol Violation|1|||
146543824|NCT01793935|528497225|FG000|Overall Study|Adverse Event|2|||
146543825|NCT01793935|528497226|FG001|Overall Study|Adverse Event|0|||
146543826|NCT01793935|528497225|FG000|Overall Study|Patient did not take study medication|1|||
146543827|NCT01793935|528497226|FG001|Overall Study|Patient did not take study medication|1|||
146543828|NCT01793935|528497225|FG000|Overall Study|Lost to Follow-up|0|||
146543829|NCT01793935|528497226|FG001|Overall Study|Lost to Follow-up|1|||
146543830|NCT01121926|528497227|FG000|First Intervention Period|Adverse Event|1|||
146543831|NCT01121926|528497228|FG001|First Intervention Period|Adverse Event|0|||
146543832|NCT01121926|528497227|FG000|Washout Period|Adverse Event|0|||
146543833|NCT01121926|528497228|FG001|Washout Period|Adverse Event|1|||
146543834|NCT01121926|528497227|FG000|Washout Period|Positive pregnancy test|0|||
146628647|NCT03253796|528815549|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
146874221|NCT01484977|529709582|FG000|Overall Study|Subject Protocol Non-compliant|1|||
146874222|NCT01484977|529709582|FG000|Overall Study|Moving Overseas|1|||
146874223|NCT01484977|529709582|FG000|Overall Study|Low White Blood Cell Count|1|||
146874224|NCT01484977|529709582|FG000|Overall Study|Lack of Compliance|1|||
146874225|NCT01392677|529709583|FG000|Overall Study|Adverse Event|3|||
146874226|NCT01392677|529709584|FG001|Overall Study|Adverse Event|1|||
146874227|NCT01392677|529709583|FG000|Overall Study|Withdrawal by Subject|0|||
146874228|NCT01392677|529709584|FG001|Overall Study|Withdrawal by Subject|2|||
146874229|NCT01392677|529709583|FG000|Overall Study|Incorrect enrollment|2|||
146874230|NCT01392677|529709584|FG001|Overall Study|Incorrect enrollment|3|||
146874231|NCT01392677|529709583|FG000|Overall Study|Other reason|3|||
146874232|NCT01392677|529709584|FG001|Overall Study|Other reason|2|||
146874233|NCT00121108|529709587|FG000|Overall Study|Lost to Follow-up|10|||
146874234|NCT00121108|529709588|FG001|Overall Study|Lost to Follow-up|22|||
146874235|NCT00121108|529709587|FG000|Overall Study|Withdrawal by Subject|106|||
146874236|NCT00121108|529709588|FG001|Overall Study|Withdrawal by Subject|195|||
146874237|NCT00121108|529709587|FG000|Overall Study|Death|5|||
146874238|NCT00121108|529709588|FG001|Overall Study|Death|8|||
146874239|NCT01380379|529709591|FG000|Overall Study|Pregnancy|1|||
146874240|NCT01357577|529709594|FG000|Overall Study|Lost to Follow-up|20|||
146874241|NCT01357577|529709595|FG001|Overall Study|Lost to Follow-up|16|||
146874242|NCT01357577|529709594|FG000|Overall Study|Withdrawal by Subject|16|||
146874243|NCT01357577|529709595|FG001|Overall Study|Withdrawal by Subject|8|||
146874244|NCT01357577|529709594|FG000|Overall Study|look at data in database?|1|||
146874245|NCT01357577|529709595|FG001|Overall Study|look at data in database?|2|||
146568863|NCT02259114|528595487|FG003|Overall Study|Adverse Event|0|||
146568864|NCT02259114|528595488|FG004|Overall Study|Adverse Event|1|||
146568865|NCT02259114|528595484|FG000|Overall Study|Death|3|||
146568866|NCT02259114|528595485|FG001|Overall Study|Death|0|||
146568867|NCT02259114|528595486|FG002|Overall Study|Death|1|||
146568868|NCT02259114|528595487|FG003|Overall Study|Death|0|||
146568869|NCT02259114|528595488|FG004|Overall Study|Death|0|||
146568870|NCT02259114|528595484|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
146568871|NCT02259114|528595485|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
146568872|NCT02259114|528595486|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
146568873|NCT02259114|528595487|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
146568874|NCT02259114|528595488|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
146568875|NCT02259114|528595484|FG000|Overall Study|Withdrawal by Subject|0|||
146568876|NCT02259114|528595485|FG001|Overall Study|Withdrawal by Subject|0|||
146568877|NCT02259114|528595486|FG002|Overall Study|Withdrawal by Subject|1|||
146568878|NCT02259114|528595487|FG003|Overall Study|Withdrawal by Subject|1|||
146568879|NCT02259114|528595488|FG004|Overall Study|Withdrawal by Subject|0|||
146568880|NCT02259114|528595484|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
146568881|NCT02259114|528595485|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
146568882|NCT02259114|528595486|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
146568883|NCT02259114|528595487|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
146568884|NCT02259114|528595488|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
146568885|NCT02259114|528595484|FG000|Overall Study|Not Treated|1|||
146568886|NCT02259114|528595485|FG001|Overall Study|Not Treated|0|||
146568887|NCT02259114|528595486|FG002|Overall Study|Not Treated|0|||
146568888|NCT02259114|528595487|FG003|Overall Study|Not Treated|0|||
146568889|NCT02259114|528595488|FG004|Overall Study|Not Treated|0|||
146568890|NCT03937479|528595489|FG000|Overall Study|Adverse Event|2|||
146568891|NCT03937479|528595490|FG001|Overall Study|Adverse Event|3|||
146568892|NCT03937479|528595491|FG002|Overall Study|Adverse Event|0|||
146568893|NCT03937479|528595492|FG003|Overall Study|Adverse Event|0|||
146568894|NCT03937479|528595493|FG004|Overall Study|Adverse Event|1|||
146568895|NCT03937479|528595489|FG000|Overall Study|Withdrawal by Subject|3|||
146568896|NCT03937479|528595490|FG001|Overall Study|Withdrawal by Subject|5|||
146568897|NCT03937479|528595491|FG002|Overall Study|Withdrawal by Subject|2|||
146568898|NCT03937479|528595492|FG003|Overall Study|Withdrawal by Subject|2|||
146568899|NCT03937479|528595493|FG004|Overall Study|Withdrawal by Subject|1|||
146568900|NCT03937479|528595489|FG000|Overall Study|Protocol Violation|5|||
146568901|NCT03937479|528595490|FG001|Overall Study|Protocol Violation|6|||
146568902|NCT03937479|528595491|FG002|Overall Study|Protocol Violation|4|||
146568903|NCT03937479|528595492|FG003|Overall Study|Protocol Violation|3|||
146568904|NCT03937479|528595493|FG004|Overall Study|Protocol Violation|2|||
146568905|NCT03937479|528595489|FG000|Overall Study|Lost to Follow-up|0|||
146568906|NCT03937479|528595490|FG001|Overall Study|Lost to Follow-up|1|||
146568907|NCT03937479|528595491|FG002|Overall Study|Lost to Follow-up|0|||
146568908|NCT03937479|528595492|FG003|Overall Study|Lost to Follow-up|1|||
146568909|NCT03937479|528595493|FG004|Overall Study|Lost to Follow-up|0|||
146568910|NCT03937479|528595489|FG000|Overall Study|Physician Decision|0|||
146568911|NCT03937479|528595490|FG001|Overall Study|Physician Decision|0|||
146568912|NCT03937479|528595491|FG002|Overall Study|Physician Decision|1|||
146568913|NCT03937479|528595492|FG003|Overall Study|Physician Decision|0|||
146568914|NCT03937479|528595493|FG004|Overall Study|Physician Decision|1|||
146568915|NCT02712788|528595496|FG000|Overall Study|Physician Decision|1|||
146874246|NCT03080883|529709596|FG000|Overall Study|Withdrawal by Subject|11|||
146874247|NCT03080883|529709597|FG001|Overall Study|Withdrawal by Subject|15|||
146874248|NCT03080883|529709596|FG000|Overall Study|Adverse Event|22|||
146874249|NCT03080883|529709597|FG001|Overall Study|Adverse Event|22|||
146874250|NCT03080883|529709596|FG000|Overall Study|Alternative Therapy|0|||
146874251|NCT03080883|529709597|FG001|Overall Study|Alternative Therapy|3|||
146874252|NCT03080883|529709596|FG000|Overall Study|Other Complicating Disease|9|||
146874253|NCT03080883|529709597|FG001|Overall Study|Other Complicating Disease|5|||
146874254|NCT03080883|529709596|FG000|Overall Study|Death|21|||
146874255|NCT03080883|529709597|FG001|Overall Study|Death|16|||
146874256|NCT03080883|529709596|FG000|Overall Study|Physician Decision|2|||
146874257|NCT03080883|529709597|FG001|Overall Study|Physician Decision|2|||
146874258|NCT03080883|529709596|FG000|Overall Study|Disease Progression|2|||
146874259|NCT03080883|529709597|FG001|Overall Study|Disease Progression|8|||
146874260|NCT03080883|529709596|FG000|Overall Study|Lost to Follow-up|1|||
146874261|NCT03080883|529709597|FG001|Overall Study|Lost to Follow-up|1|||
146874262|NCT00980200|529711152|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
146874263|NCT00980200|529711153|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
146874264|NCT00980200|529711154|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
146874265|NCT00980200|529711155|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
146874266|NCT00980200|529711156|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
146874267|NCT00980200|529711152|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
146874268|NCT00980200|529711153|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
146874269|NCT00980200|529711154|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
146874270|NCT00980200|529711155|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
146874271|NCT00980200|529711156|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
146874272|NCT01617460|529711157|FG000|Overall Study|Adverse Event|10|||
146874273|NCT01617460|529711157|FG000|Overall Study|Physician Decision|16|||
146874274|NCT01617460|529711157|FG000|Overall Study|Protocol Violation|5|||
146874275|NCT01617460|529711157|FG000|Overall Study|Withdrawal by Subject|9|||
146874276|NCT03703882|529711158|FG000|Overall Study|Adverse Event|1|||
146874277|NCT03703882|529711159|FG001|Overall Study|Adverse Event|0|||
146874278|NCT03703882|529711158|FG000|Overall Study|Lost to Follow-up|0|||
146874279|NCT03703882|529711159|FG001|Overall Study|Lost to Follow-up|2|||
146874280|NCT03703882|529711158|FG000|Overall Study|Non-compliance with study drug|0|||
146874281|NCT03703882|529711159|FG001|Overall Study|Non-compliance with study drug|1|||
146874282|NCT03703882|529711158|FG000|Overall Study|Physician Decision|0|||
146874283|NCT03703882|529711159|FG001|Overall Study|Physician Decision|1|||
146874284|NCT03703882|529711158|FG000|Overall Study|Progressive disease|1|||
146874285|NCT03703882|529711159|FG001|Overall Study|Progressive disease|0|||
146874286|NCT03703882|529711158|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146874287|NCT03703882|529711159|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146874288|NCT03703882|529711158|FG000|Overall Study|Starting another treatment|0|||
146874289|NCT03703882|529711159|FG001|Overall Study|Starting another treatment|1|||
146874290|NCT03703882|529711158|FG000|Overall Study|noncompliance with study procedures|0|||
146874291|NCT03703882|529711159|FG001|Overall Study|noncompliance with study procedures|1|||
146874292|NCT00457015|529711163|FG000|Overall Study|Left study site against medical advice|0|||
146874293|NCT00457015|529711164|FG001|Overall Study|Left study site against medical advice|1|||
146874294|NCT03670953|529711165|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
146874295|NCT03670953|529711166|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
146874296|NCT03670953|529711167|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
146874297|NCT03670953|529711168|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
146874298|NCT03670953|529711165|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
146874299|NCT03670953|529711166|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
146874300|NCT03670953|529711167|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
146874301|NCT03670953|529711168|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
146874302|NCT03670953|529711165|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
146874303|NCT03670953|529711166|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
146874304|NCT03670953|529711167|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
146874305|NCT03670953|529711168|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
146874306|NCT03670953|529711165|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
146874307|NCT03670953|529711166|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
146874308|NCT03670953|529711167|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
146874309|NCT03670953|529711168|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
146874310|NCT03670953|529711165|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
146874311|NCT03670953|529711166|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
146874312|NCT03670953|529711167|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
146874313|NCT03670953|529711168|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
146874314|NCT03670953|529711165|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
146874315|NCT03670953|529711166|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
146874316|NCT03670953|529711167|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
146568916|NCT02712788|528595497|FG001|Overall Study|Physician Decision|0|||
146568917|NCT02712788|528595496|FG000|Overall Study|Protocol Violation|1|||
146874317|NCT03670953|529711168|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
146874318|NCT03670953|529711165|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
146874319|NCT03670953|529711166|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
146874320|NCT03670953|529711167|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
146874321|NCT03670953|529711168|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
146874322|NCT03670953|529711165|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
146874323|NCT03670953|529711166|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
146874324|NCT03670953|529711167|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
146874325|NCT03670953|529711168|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
146874326|NCT03670953|529711165|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
146874327|NCT03670953|529711166|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
146874328|NCT03670953|529711167|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
146874329|NCT03670953|529711168|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
146874330|NCT03670953|529711165|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
146874331|NCT03670953|529711166|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
146874332|NCT03670953|529711167|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
146874333|NCT03670953|529711168|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
146874334|NCT03670953|529711165|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
146874335|NCT03670953|529711166|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
146874336|NCT03670953|529711167|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
146874337|NCT03670953|529711168|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
146874338|NCT03670953|529711165|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
146874339|NCT03670953|529711166|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
146874340|NCT03670953|529711167|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
146874341|NCT03670953|529711168|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
146874342|NCT03670953|529711165|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
146874343|NCT03670953|529711166|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
146874344|NCT03670953|529711167|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
146874345|NCT03670953|529711168|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
146874346|NCT03670953|529711165|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
146874347|NCT03670953|529711166|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
146874348|NCT03670953|529711167|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
146874349|NCT03670953|529711168|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
146874350|NCT03670953|529711165|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
146874351|NCT03670953|529711166|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
146874352|NCT03670953|529711167|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
146874353|NCT03670953|529711168|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
146874354|NCT03670953|529711165|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
146874355|NCT03670953|529711166|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
146874356|NCT03670953|529711167|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
146874357|NCT03670953|529711168|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
146874358|NCT03670953|529711165|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
146874359|NCT03670953|529711166|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
146874360|NCT03670953|529711167|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
146874361|NCT03670953|529711168|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
146874362|NCT03670953|529711165|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
146874363|NCT03670953|529711166|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
146874364|NCT03670953|529711167|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
146874365|NCT03670953|529711168|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
146874366|NCT00362414|529711170|FG000|Overall Study|Death|2|||
146874367|NCT00362414|529711170|FG000|Overall Study|Adverse Event|1|||
146874368|NCT02603120|529711171|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
146874369|NCT02603120|529711172|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
146874370|NCT02603120|529711171|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
146874371|NCT02603120|529711172|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
146874372|NCT02603120|529711171|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
146874373|NCT02603120|529711172|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
146874374|NCT02603120|529711171|FG000|Double-Blind Treatment Phase|Death|2|||
146874375|NCT02603120|529711172|FG001|Double-Blind Treatment Phase|Death|0|||
146874376|NCT02603120|529711171|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
146874377|NCT02603120|529711172|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
146874378|NCT02603120|529711171|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
146874379|NCT02603120|529711172|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
146543835|NCT01121926|528497228|FG001|Washout Period|Positive pregnancy test|1|||
146543836|NCT02782468|528497229|FG000|Overall Study|Progressive Disease|2|||
146543837|NCT02782468|528497230|FG001|Overall Study|Progressive Disease|5|||
146543838|NCT02782468|528497231|FG002|Overall Study|Progressive Disease|0|||
146543839|NCT02782468|528497232|FG003|Overall Study|Progressive Disease|4|||
146543840|NCT02782468|528497229|FG000|Overall Study|Adverse Event|0|||
146874380|NCT02603120|529711171|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
146874381|NCT02603120|529711172|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
146874382|NCT02603120|529711171|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
146874383|NCT02603120|529711172|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
146874384|NCT02603120|529711171|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
146874385|NCT02603120|529711172|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
146543841|NCT02782468|528497230|FG001|Overall Study|Adverse Event|2|||
146543842|NCT02782468|528497231|FG002|Overall Study|Adverse Event|2|||
146543843|NCT02782468|528497232|FG003|Overall Study|Adverse Event|3|||
146543844|NCT02782468|528497229|FG000|Overall Study|Other|0|||
146543845|NCT02782468|528497230|FG001|Overall Study|Other|0|||
146543846|NCT02782468|528497231|FG002|Overall Study|Other|1|||
146543847|NCT02782468|528497232|FG003|Overall Study|Other|1|||
146543848|NCT02782468|528497229|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
146543849|NCT02782468|528497230|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
146543850|NCT02782468|528497231|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
146543851|NCT02782468|528497232|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
146543852|NCT02782468|528497229|FG000|Overall Study|Symptomatic Deterioration|0|||
146543853|NCT02782468|528497230|FG001|Overall Study|Symptomatic Deterioration|0|||
146543854|NCT02782468|528497231|FG002|Overall Study|Symptomatic Deterioration|0|||
146543855|NCT02782468|528497232|FG003|Overall Study|Symptomatic Deterioration|1|||
146543856|NCT02782468|528497229|FG000|Overall Study|Withdrawal by Subject|1|||
146543857|NCT02782468|528497230|FG001|Overall Study|Withdrawal by Subject|0|||
146543858|NCT02782468|528497231|FG002|Overall Study|Withdrawal by Subject|0|||
146543859|NCT02782468|528497232|FG003|Overall Study|Withdrawal by Subject|0|||
146543860|NCT00356590|528497239|FG000|Overall Study|Adverse Event|54|||
146543861|NCT00356590|528497239|FG000|Overall Study|Death|10|||
146543862|NCT00356590|528497239|FG000|Overall Study|Lost to Follow-up|35|||
146543863|NCT00356590|528497239|FG000|Overall Study|Physician Decision|46|||
146543864|NCT00356590|528497239|FG000|Overall Study|Withdrawal by Subject|41|||
146543865|NCT00356590|528497239|FG000|Overall Study|Completed month 12 only|2|||
146543866|NCT00356590|528497239|FG000|Overall Study|Protocol issues|6|||
146543867|NCT00356590|528497239|FG000|Overall Study|Response status|28|||
146543868|NCT00356590|528497239|FG000|Overall Study|Other|52|||
146543869|NCT03439514|528497246|FG000|Double-Blind Treatment Period|Other|4|||
146543870|NCT03439514|528497247|FG001|Double-Blind Treatment Period|Other|1|||
146543871|NCT03439514|528497246|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
146543872|NCT03439514|528497247|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
146543873|NCT03439514|528497246|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
146543874|NCT03439514|528497247|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
146543875|NCT03439514|528497246|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
146543876|NCT03439514|528497247|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
146543877|NCT03439514|528497246|FG000|Double-Blind Treatment Period|Death|1|||
146543878|NCT03439514|528497247|FG001|Double-Blind Treatment Period|Death|2|||
146543879|NCT02175758|528497248|FG000|Treatment Phase|Lost to Follow-up|0|||
146543880|NCT02175758|528497249|FG001|Treatment Phase|Lost to Follow-up|1|||
146543881|NCT02175758|528497250|FG002|Treatment Phase|Lost to Follow-up|0|||
146543882|NCT02175758|528497251|FG003|Treatment Phase|Lost to Follow-up|0|||
146543883|NCT02175758|528497252|FG004|Treatment Phase|Lost to Follow-up|0|||
146543884|NCT02175758|528497253|FG005|Treatment Phase|Lost to Follow-up|0|||
146543885|NCT02175758|528497248|FG000|Treatment Phase|Adverse Event|0|||
146543886|NCT02175758|528497249|FG001|Treatment Phase|Adverse Event|0|||
146543887|NCT02175758|528497250|FG002|Treatment Phase|Adverse Event|0|||
146543888|NCT02175758|528497251|FG003|Treatment Phase|Adverse Event|0|||
146543889|NCT02175758|528497252|FG004|Treatment Phase|Adverse Event|1|||
146543890|NCT02175758|528497253|FG005|Treatment Phase|Adverse Event|0|||
146543891|NCT02362451|528497254|FG000|Overall Study|Withdrawal by Subject|0|||
146543892|NCT02362451|528497255|FG001|Overall Study|Withdrawal by Subject|1|||
146543893|NCT02362451|528497254|FG000|Overall Study|Lack of Efficacy|2|||
146543894|NCT02362451|528497255|FG001|Overall Study|Lack of Efficacy|0|||
146543895|NCT02362451|528497254|FG000|Overall Study|Progression|1|||
146543896|NCT02362451|528497255|FG001|Overall Study|Progression|0|||
146543897|NCT02362451|528497254|FG000|Overall Study|Participant chose other therapy.|1|||
146543898|NCT02362451|528497255|FG001|Overall Study|Participant chose other therapy.|0|||
146543899|NCT02299167|528497258|FG000|Overall Study|patients were excluded from the study|11|||
146543900|NCT03600428|528497259|FG000|Overall Study|Not eligible|0|||
146543901|NCT03600428|528497260|FG001|Overall Study|Not eligible|1|||
146543902|NCT03600428|528497259|FG000|Overall Study|Lost to Follow-up|5|||
146543903|NCT03600428|528497260|FG001|Overall Study|Lost to Follow-up|4|||
146543904|NCT00975923|528497266|FG000|Overall Study|Withdrawal by Subject|0|||
146543905|NCT00975923|528497267|FG001|Overall Study|Withdrawal by Subject|1|||
146543906|NCT00005047|528497269|FG000|Overall Study|Withdrawal by Subject|12|||
146543907|NCT00005047|528497270|FG001|Overall Study|Withdrawal by Subject|0|||
146543908|NCT00005047|528497271|FG002|Overall Study|Withdrawal by Subject|0|||
146543909|NCT00005047|528497272|FG003|Overall Study|Withdrawal by Subject|0|||
146628648|NCT03253796|528815550|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
146628649|NCT03253796|528815551|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
146628650|NCT03253796|528815552|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
146628651|NCT03253796|528815553|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
146628652|NCT03253796|528815549|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
146628653|NCT03253796|528815550|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
146628654|NCT03253796|528815551|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
146628655|NCT03253796|528815552|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
146628656|NCT03253796|528815553|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
146628657|NCT03253796|528815549|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
146628658|NCT03253796|528815550|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
146628659|NCT03253796|528815551|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
146628660|NCT03253796|528815552|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
146628661|NCT03253796|528815553|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
146628662|NCT03253796|528815549|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
146628663|NCT03253796|528815550|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
146628664|NCT03253796|528815551|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
146628665|NCT03253796|528815552|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
146628666|NCT03253796|528815553|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
146628667|NCT03253796|528815549|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
146628668|NCT03253796|528815550|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
146628669|NCT03253796|528815551|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
146628670|NCT03253796|528815552|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
146628671|NCT03253796|528815553|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
146628672|NCT01075243|528815555|FG000|Overall Study|Lost to Follow-up|5|||
146628673|NCT01075243|528815556|FG001|Overall Study|Lost to Follow-up|2|||
146628674|NCT01075243|528815557|FG002|Overall Study|Lost to Follow-up|0|||
146628675|NCT01075243|528815555|FG000|Overall Study|Withdrawal by Subject|1|||
146628676|NCT01075243|528815556|FG001|Overall Study|Withdrawal by Subject|1|||
146628677|NCT01075243|528815557|FG002|Overall Study|Withdrawal by Subject|0|||
146628678|NCT03600909|528815563|FG000|Overall Study|Not treated|0|||
146628679|NCT03600909|528815564|FG001|Overall Study|Not treated|3|||
146628680|NCT03600909|528815565|FG002|Overall Study|Not treated|0|||
146628681|NCT02246530|528815566|FG000|Overall Study|Lost to Follow-up|4|||
146628682|NCT02246530|528815567|FG001|Overall Study|Lost to Follow-up|0|||
146628683|NCT01506596|528815568|FG000|Overall Study|ineligible pathology|1|||
146628684|NCT01488890|528815571|FG000|Overall Study|Serious adverse event|2|||
146628685|NCT01488890|528815572|FG001|Overall Study|Serious adverse event|0|||
146628686|NCT01488890|528815573|FG002|Overall Study|Serious adverse event|0|||
146628687|NCT01488890|528815574|FG003|Overall Study|Serious adverse event|0|||
146628688|NCT01488890|528815571|FG000|Overall Study|Protocol Violation|3|||
146628689|NCT01488890|528815572|FG001|Overall Study|Protocol Violation|0|||
146628690|NCT01488890|528815573|FG002|Overall Study|Protocol Violation|4|||
146628691|NCT01488890|528815574|FG003|Overall Study|Protocol Violation|0|||
146628692|NCT01488890|528815571|FG000|Overall Study|Lost to Follow-up|13|||
146628693|NCT01488890|528815572|FG001|Overall Study|Lost to Follow-up|10|||
146628694|NCT01488890|528815573|FG002|Overall Study|Lost to Follow-up|20|||
146628695|NCT01488890|528815574|FG003|Overall Study|Lost to Follow-up|3|||
146628696|NCT01488890|528815571|FG000|Overall Study|Withdrawal by Subject|14|||
146628697|NCT01488890|528815572|FG001|Overall Study|Withdrawal by Subject|10|||
146628698|NCT01488890|528815573|FG002|Overall Study|Withdrawal by Subject|11|||
146628699|NCT01488890|528815574|FG003|Overall Study|Withdrawal by Subject|2|||
146628700|NCT05712460|528815575|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146628701|NCT05712460|528815576|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146628702|NCT05712460|528815577|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146628703|NCT05712460|528815578|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146628704|NCT05712460|528815579|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146628705|NCT05712460|528815580|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146628706|NCT05712460|528815581|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146628707|NCT05712460|528815582|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
146628708|NCT05712460|528815583|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146628709|NCT05712460|528815584|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146628710|NCT05712460|528815585|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146628711|NCT05712460|528815586|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146628712|NCT04366349|528815589|FG000|Overall Study|Withdrawal by Subject|1|||
146628713|NCT04366349|528815590|FG001|Overall Study|Withdrawal by Subject|0|||
146628714|NCT04366349|528815591|FG002|Overall Study|Withdrawal by Subject|0|||
146628715|NCT04366349|528815592|FG003|Overall Study|Withdrawal by Subject|0|||
146628716|NCT04366349|528815593|FG004|Overall Study|Withdrawal by Subject|0|||
146628717|NCT04366349|528815594|FG005|Overall Study|Withdrawal by Subject|0|||
146628718|NCT02532517|528815601|FG000|Overall Study|Did not complete 24-Month visit|4|||
146628719|NCT02532517|528815601|FG000|Overall Study|Failed Angiographic eligibility|1|||
146628720|NCT02532517|528815601|FG000|Overall Study|Lost to Follow-up|4|||
146628721|NCT02532517|528815601|FG000|Overall Study|Withdrawal by Subject|4|||
146628722|NCT02532517|528815601|FG000|Overall Study|Death|4|||
146628723|NCT05138653|528815604|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
146628724|NCT05138653|528815605|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146628725|NCT05138653|528815606|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146628726|NCT05138653|528815607|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146628727|NCT05138653|528815608|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146628728|NCT05138653|528815609|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146628729|NCT05138653|528815610|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146628730|NCT05138653|528815611|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146628731|NCT05138653|528815612|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146628732|NCT05138653|528815613|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146628733|NCT05138653|528815614|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146628734|NCT05138653|528815615|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146628735|NCT05138653|528815616|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146628736|NCT05138653|528815617|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146628737|NCT05138653|528815618|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146764640|NCT01838200|529304494|FG000|Overall Study|Progressive disease|3|||
146764641|NCT01838200|529304495|FG001|Overall Study|Progressive disease|0|||
146764642|NCT01875250|529305833|FG000|Overall Study|Adverse Event|2|||
146764643|NCT01875250|529305834|FG001|Overall Study|Adverse Event|0|||
146764644|NCT00482729|529305840|FG000|Overall Study|Adverse Event|29|||
146764645|NCT00482729|529305841|FG001|Overall Study|Adverse Event|33|||
146764646|NCT00482729|529305840|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
146764647|NCT00482729|529305841|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
146764648|NCT00482729|529305840|FG000|Overall Study|Hyperglycemia Criteria|7|||
146764649|NCT00482729|529305841|FG001|Overall Study|Hyperglycemia Criteria|5|||
146764650|NCT00482729|529305840|FG000|Overall Study|Lack of Efficacy|4|||
146764651|NCT00482729|529305841|FG001|Overall Study|Lack of Efficacy|16|||
146764652|NCT00482729|529305840|FG000|Overall Study|Lost to Follow-up|86|||
146764653|NCT00482729|529305841|FG001|Overall Study|Lost to Follow-up|66|||
146764654|NCT00482729|529305840|FG000|Overall Study|Physician Decision|10|||
146764655|NCT00482729|529305841|FG001|Overall Study|Physician Decision|7|||
146764656|NCT00482729|529305840|FG000|Overall Study|Pregnancy|4|||
146764657|NCT00482729|529305841|FG001|Overall Study|Pregnancy|2|||
146764658|NCT00482729|529305840|FG000|Overall Study|Protocol Violation|10|||
146764659|NCT00482729|529305841|FG001|Overall Study|Protocol Violation|18|||
146764660|NCT00482729|529305840|FG000|Overall Study|Withdrawal by Subject|67|||
146764661|NCT00482729|529305841|FG001|Overall Study|Withdrawal by Subject|69|||
146764662|NCT03140176|529305842|FG000|Overall Study|Reason missing|23|||
146764663|NCT03140176|529305842|FG000|Overall Study|Death|33|||
146764664|NCT03140176|529305842|FG000|Overall Study|Disease progression|1|||
146764665|NCT03140176|529305842|FG000|Overall Study|Physician Decision|1|||
146764666|NCT03140176|529305842|FG000|Overall Study|Withdrawal by Subject|1|||
146764667|NCT03140176|529305842|FG000|Overall Study|Lost to Follow-up|15|||
146764668|NCT00470626|529305845|FG000|Overall Study|Lost to Follow-up|10|||
146764669|NCT00470626|529305845|FG000|Overall Study|Withdrawal by Subject|7|||
146764670|NCT02689349|529305846|FG000|Overall Study|Not implanted|4|||
146764671|NCT02689349|529305847|FG001|Overall Study|Not implanted|0|||
146764672|NCT02689349|529305846|FG000|Overall Study|Withdrawal by Subject|9|||
146764673|NCT02689349|529305847|FG001|Overall Study|Withdrawal by Subject|0|||
146764674|NCT01546155|529305848|FG000|Overall Study|could not tolerate long scan duration|3|||
146764675|NCT02930343|529305849|FG000|Overall Study|Lost to Follow-up|9|||
146764676|NCT02930343|529305850|FG001|Overall Study|Lost to Follow-up|7|||
146764677|NCT00486759|529305855|FG000|Treatment|Adverse event/intercurrent illness|86|||
146764678|NCT00486759|529305856|FG001|Treatment|Adverse event/intercurrent illness|39|||
146764679|NCT00486759|529305855|FG000|Treatment|Insufficient therapeutic response|37|||
146764680|NCT00486759|529305856|FG001|Treatment|Insufficient therapeutic response|39|||
146764681|NCT00486759|529305855|FG000|Treatment|Death|17|||
146764682|NCT00486759|529305856|FG001|Treatment|Death|10|||
146764683|NCT00486759|529305855|FG000|Treatment|Withdrew consent|15|||
146764684|NCT00486759|529305856|FG001|Treatment|Withdrew consent|12|||
146764685|NCT00486759|529305855|FG000|Treatment|Administrative/reason not specified|17|||
146764686|NCT00486759|529305856|FG001|Treatment|Administrative/reason not specified|21|||
146764687|NCT00486759|529305855|FG000|Treatment|Refused treatment|10|||
146764688|NCT00486759|529305856|FG001|Treatment|Refused treatment|7|||
146764689|NCT00486759|529305855|FG000|Treatment|Violation of selection criteria at entry|3|||
146874386|NCT02603120|529711171|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
146874387|NCT02603120|529711172|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
146874388|NCT02603120|529711171|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
146874389|NCT02603120|529711172|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
146874390|NCT02603120|529711171|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
146874391|NCT02603120|529711172|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
146874392|NCT02603120|529711171|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
146874393|NCT02603120|529711172|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
146874394|NCT02603120|529711171|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
146874395|NCT02603120|529711172|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
146874396|NCT01469182|529711175|FG000|Overall Study|Adverse Event|21|||
146874397|NCT01469182|529711176|FG001|Overall Study|Adverse Event|3|||
146874398|NCT01469182|529711175|FG000|Overall Study|Lost to Follow-up|3|||
146874399|NCT01469182|529711176|FG001|Overall Study|Lost to Follow-up|0|||
146874400|NCT01469182|529711175|FG000|Overall Study|Withdrawal by Subject|4|||
146874401|NCT01469182|529711176|FG001|Overall Study|Withdrawal by Subject|1|||
146874402|NCT01469182|529711175|FG000|Overall Study|Protocol Violation|4|||
146874403|NCT01469182|529711176|FG001|Overall Study|Protocol Violation|2|||
146874404|NCT01469182|529711175|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
146874405|NCT01469182|529711176|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
146874406|NCT01227187|529711178|FG000|Overall Study|Physician Decision|0|||
146874407|NCT01227187|529711179|FG001|Overall Study|Physician Decision|0|||
146874408|NCT01227187|529711180|FG002|Overall Study|Physician Decision|0|||
146874409|NCT01227187|529711181|FG003|Overall Study|Physician Decision|1|||
146874410|NCT01761292|529711182|FG000|Part 1|Adverse Event|1|||
146874411|NCT01761292|529711182|FG000|Part 1|not receiving treatment in Part 1|1|||
146874412|NCT01761292|529711182|FG000|Extension 1|Withdrawal by Subject|1|||
146874413|NCT00840086|529711183|FG000|Overall Study|Adverse Event|1|||
146874414|NCT00840086|529711183|FG000|Overall Study|Protocol Violation|2|||
146874415|NCT00840086|529711183|FG000|Overall Study|Lost to Follow-up|1|||
146874416|NCT03332498|529711184|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
146874417|NCT03332498|529711185|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
146874418|NCT03332498|529711186|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
146874419|NCT02554019|529711187|FG000|Overall Study|Withdrawal by Subject|1|||
146874420|NCT02554019|529711188|FG001|Overall Study|Withdrawal by Subject|0|||
146874421|NCT02554019|529711189|FG002|Overall Study|Withdrawal by Subject|2|||
146874422|NCT02554019|529711187|FG000|Overall Study|Adverse Event|1|||
146874423|NCT02554019|529711188|FG001|Overall Study|Adverse Event|0|||
146874424|NCT02554019|529711189|FG002|Overall Study|Adverse Event|0|||
146874425|NCT02463409|529711190|FG000|Overall Study|Withdrawal by Subject|1|||
146874426|NCT02463409|529711190|FG000|Overall Study|Screen failure|1|||
146874427|NCT00916357|529711191|FG000|Period 1|Withdrawal by Subject|1|||
146874428|NCT00916357|529711192|FG001|Period 1|Withdrawal by Subject|0|||
146874429|NCT00916357|529711193|FG002|Period 1|Withdrawal by Subject|0|||
146874430|NCT00916357|529711194|FG003|Period 1|Withdrawal by Subject|0|||
146874431|NCT00916357|529711195|FG004|Period 1|Withdrawal by Subject|0|||
146874432|NCT00916357|529711196|FG005|Period 1|Withdrawal by Subject|0|||
146874433|NCT00916357|529711191|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
146874434|NCT00916357|529711192|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
146874435|NCT00916357|529711193|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
146874436|NCT00916357|529711194|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
146874437|NCT00916357|529711195|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
146874438|NCT00916357|529711196|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
146874439|NCT03577730|529711197|FG000|Overall Study|Physician Decision|3|||
146874440|NCT03577730|529711198|FG001|Overall Study|Physician Decision|1|||
146874441|NCT03577730|529711197|FG000|Overall Study|Did not receive allocated intervention|1|||
146874442|NCT03577730|529711198|FG001|Overall Study|Did not receive allocated intervention|0|||
146874443|NCT02634151|529711200|FG000|Overall Study|Withdrawal by Subject|1|||
146874444|NCT02634151|529711201|FG001|Overall Study|Withdrawal by Subject|0|||
146874445|NCT02634151|529711200|FG000|Overall Study|Non-Compliance|0|||
146874446|NCT02634151|529711201|FG001|Overall Study|Non-Compliance|1|||
146874447|NCT02634151|529711200|FG000|Overall Study|Other|0|||
146874448|NCT02634151|529711201|FG001|Overall Study|Other|1|||
146874449|NCT02347098|529711202|FG000|Overall Study|Death|1|||
146874450|NCT02347098|529711203|FG001|Overall Study|Death|0|||
146874451|NCT02347098|529711202|FG000|Overall Study|Withdrawal by Subject|1|||
146874452|NCT02347098|529711203|FG001|Overall Study|Withdrawal by Subject|0|||
146874453|NCT02347098|529711202|FG000|Overall Study|Lost to Follow-up|2|||
146874454|NCT02347098|529711203|FG001|Overall Study|Lost to Follow-up|2|||
146874455|NCT02347098|529711202|FG000|Overall Study|Refuse Follow-up Visit|1|||
146874456|NCT02347098|529711203|FG001|Overall Study|Refuse Follow-up Visit|5|||
146874457|NCT02347098|529711202|FG000|Overall Study|no visit due to illness|2|||
146874458|NCT02347098|529711203|FG001|Overall Study|no visit due to illness|1|||
146874459|NCT01444742|529711204|FG000|Overall Study|Death|1|||
146874460|NCT02187172|529711205|FG000|Overall Study|Lost to Follow-up|1|||
146874461|NCT02187172|529711206|FG001|Overall Study|Lost to Follow-up|2|||
146874462|NCT02187172|529711205|FG000|Overall Study|Lack of Efficacy|1|||
146874463|NCT02187172|529711206|FG001|Overall Study|Lack of Efficacy|2|||
146874464|NCT02187172|529711205|FG000|Overall Study|Adverse Event|0|||
146874465|NCT02187172|529711206|FG001|Overall Study|Adverse Event|1|||
146874466|NCT02187172|529711205|FG000|Overall Study|Physician Decision|1|||
146874467|NCT02187172|529711206|FG001|Overall Study|Physician Decision|1|||
146874468|NCT02830880|529711207|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
146874469|NCT02830880|529711207|FG000|Overall Study|Death|1|||
146874470|NCT02830880|529711207|FG000|Overall Study|Physician Decision|1|||
146874471|NCT02349048|529711212|FG000|Overall Study|Withdrawal by Subject|4|||
146874472|NCT02349048|529711213|FG001|Overall Study|Withdrawal by Subject|0|||
146874473|NCT02349048|529711212|FG000|Overall Study|Lost to Follow-up|1|||
146874474|NCT02349048|529711213|FG001|Overall Study|Lost to Follow-up|0|||
146874475|NCT00253643|529711216|FG000|Overall Study|Withdrawal by Subject|0|||
146874476|NCT00253643|529711217|FG001|Overall Study|Withdrawal by Subject|0|||
146874477|NCT00253643|529711218|FG002|Overall Study|Withdrawal by Subject|1|||
146874478|NCT00253643|529711219|FG003|Overall Study|Withdrawal by Subject|1|||
146874479|NCT00253643|529711216|FG000|Overall Study|Non-Compliance|0|||
146874480|NCT00253643|529711217|FG001|Overall Study|Non-Compliance|0|||
146874481|NCT00253643|529711218|FG002|Overall Study|Non-Compliance|0|||
146874482|NCT00253643|529711219|FG003|Overall Study|Non-Compliance|2|||
146874483|NCT01368536|529711220|FG000|Overall Study|Adverse Event|5|||
146874484|NCT01368536|529711221|FG001|Overall Study|Adverse Event|6|||
146874485|NCT01368536|529711222|FG002|Overall Study|Adverse Event|8|||
146874486|NCT01368536|529711220|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146874487|NCT01368536|529711221|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146874488|NCT01368536|529711222|FG002|Overall Study|Abnormal laboratory value(s)|2|||
146874489|NCT01368536|529711220|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146874490|NCT01368536|529711221|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146874491|NCT01368536|529711222|FG002|Overall Study|Abnormal test procedure result(s)|1|||
146874492|NCT01368536|529711220|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
146874493|NCT01368536|529711221|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146874494|NCT01368536|529711222|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
146874495|NCT01368536|529711220|FG000|Overall Study|No longer required study medication|0|||
146874496|NCT01368536|529711221|FG001|Overall Study|No longer required study medication|0|||
146874497|NCT01368536|529711222|FG002|Overall Study|No longer required study medication|1|||
146874498|NCT01368536|529711220|FG000|Overall Study|Withdrawal by Subject|2|||
146874499|NCT01368536|529711221|FG001|Overall Study|Withdrawal by Subject|5|||
146874500|NCT01368536|529711222|FG002|Overall Study|Withdrawal by Subject|4|||
146874501|NCT01368536|529711220|FG000|Overall Study|Lost to Follow-up|3|||
146874502|NCT01368536|529711221|FG001|Overall Study|Lost to Follow-up|3|||
146874503|NCT01368536|529711222|FG002|Overall Study|Lost to Follow-up|5|||
146874504|NCT01368536|529711220|FG000|Overall Study|Administrative problems|34|||
146874505|NCT01368536|529711221|FG001|Overall Study|Administrative problems|39|||
146874506|NCT01368536|529711222|FG002|Overall Study|Administrative problems|35|||
146874507|NCT01368536|529711220|FG000|Overall Study|Protocol deviation|0|||
146874508|NCT01368536|529711221|FG001|Overall Study|Protocol deviation|3|||
146874509|NCT01368536|529711222|FG002|Overall Study|Protocol deviation|1|||
146874510|NCT00383084|529711223|FG000|Overall Study|Withdrawal by Subject|12|||
146874511|NCT00383084|529711224|FG001|Overall Study|Withdrawal by Subject|10|||
146874512|NCT01648790|529711225|FG000|Treatment 3|Withdrawal by Subject|0|||
146874513|NCT01648790|529711226|FG001|Treatment 3|Withdrawal by Subject|0|||
146874514|NCT01648790|529711227|FG002|Treatment 3|Withdrawal by Subject|0|||
146874515|NCT01648790|529711228|FG003|Treatment 3|Withdrawal by Subject|1|||
146874516|NCT01648790|529711229|FG004|Treatment 3|Withdrawal by Subject|0|||
146874517|NCT01486927|529711230|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
146874518|NCT01486927|529711230|FG000|Overall Study|Physician Decision|1|||
146874519|NCT01486927|529711230|FG000|Overall Study|50 Exposure days not reached|2|||
146874520|NCT01486927|529711230|FG000|Overall Study|Withdrawal by Subject|8|||
146874521|NCT01486927|529711230|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
146874522|NCT02636582|529711234|FG000|Overall Study|Surgical Pathology|1|||
146874523|NCT02636582|529711235|FG001|Overall Study|Surgical Pathology|0|||
146874524|NCT00573430|529711236|FG000|Overall Study|Incorrect enrollment of randomization|0|||
146874525|NCT00573430|529711237|FG001|Overall Study|Incorrect enrollment of randomization|4|||
146874526|NCT00573430|529711238|FG002|Overall Study|Incorrect enrollment of randomization|3|||
146874527|NCT00573430|529711236|FG000|Overall Study|Adverse Event|0|||
146874528|NCT00573430|529711237|FG001|Overall Study|Adverse Event|0|||
146874529|NCT00573430|529711238|FG002|Overall Study|Adverse Event|2|||
146874530|NCT00573430|529711236|FG000|Overall Study|Withdrawal by Subject|1|||
146874531|NCT00573430|529711237|FG001|Overall Study|Withdrawal by Subject|0|||
146874532|NCT00573430|529711238|FG002|Overall Study|Withdrawal by Subject|1|||
146874533|NCT00573430|529711236|FG000|Overall Study|Protocol Violation|0|||
146874534|NCT00573430|529711237|FG001|Overall Study|Protocol Violation|1|||
146874535|NCT00573430|529711238|FG002|Overall Study|Protocol Violation|1|||
146874536|NCT00573430|529711236|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146874537|NCT00573430|529711237|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146874538|NCT00573430|529711238|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
146874539|NCT01278745|529711239|FG000|Overall Study|Death|2|||
146874540|NCT01278745|529711240|FG001|Overall Study|Death|5|||
146874541|NCT01278745|529711241|FG002|Overall Study|Death|7|||
146874542|NCT01278745|529711242|FG003|Overall Study|Death|0|||
146874543|NCT01278745|529711239|FG000|Overall Study|Physician Decision|1|||
146874544|NCT01278745|529711240|FG001|Overall Study|Physician Decision|0|||
146874545|NCT01278745|529711241|FG002|Overall Study|Physician Decision|0|||
146874546|NCT01278745|529711242|FG003|Overall Study|Physician Decision|9|||
146874547|NCT01278745|529711239|FG000|Overall Study|Withdrawal by Subject|1|||
146874548|NCT01278745|529711240|FG001|Overall Study|Withdrawal by Subject|1|||
146874549|NCT01278745|529711241|FG002|Overall Study|Withdrawal by Subject|5|||
146874550|NCT01278745|529711242|FG003|Overall Study|Withdrawal by Subject|1|||
146874551|NCT01278745|529711239|FG000|Overall Study|Sponsor Decision|1|||
146874552|NCT01278745|529711240|FG001|Overall Study|Sponsor Decision|0|||
146874553|NCT01278745|529711241|FG002|Overall Study|Sponsor Decision|62|||
146874554|NCT01278745|529711242|FG003|Overall Study|Sponsor Decision|6|||
146874555|NCT01278745|529711239|FG000|Overall Study|Ineligible|0|||
146874556|NCT01278745|529711240|FG001|Overall Study|Ineligible|0|||
146874557|NCT01278745|529711241|FG002|Overall Study|Ineligible|42|||
146874558|NCT01278745|529711242|FG003|Overall Study|Ineligible|61|||
146874559|NCT01278745|529711239|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
146874560|NCT01278745|529711240|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
146874561|NCT01278745|529711241|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
146874562|NCT01278745|529711242|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
146874563|NCT00632099|529711243|FG000|Overall Study|Lost to Follow-up|3|||
146874564|NCT00632099|529711244|FG001|Overall Study|Lost to Follow-up|3|||
146874565|NCT04712110|529711245|FG000|Overall Study|Lost to Follow-up|0|||
146874566|NCT04712110|529711246|FG001|Overall Study|Lost to Follow-up|1|||
146874567|NCT04712110|529711245|FG000|Overall Study|Withdrawal by Subject|0|||
146874568|NCT04712110|529711246|FG001|Overall Study|Withdrawal by Subject|4|||
146874569|NCT04712110|529711245|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
146874570|NCT04712110|529711246|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
146874571|NCT03625687|529711257|FG000|Overall Study|Death|1|||
146874572|NCT04206605|529711258|FG000|Overall Study|Adverse Event|0|||
146874573|NCT04206605|529711259|FG001|Overall Study|Adverse Event|1|||
146874574|NCT04206605|529711258|FG000|Overall Study|Withdrawal by Subject|1|||
146874575|NCT04206605|529711259|FG001|Overall Study|Withdrawal by Subject|0|||
146874576|NCT00827606|529711264|FG000|Overall Study|Protocol Violation|4|||
146874577|NCT00827606|529711265|FG001|Overall Study|Protocol Violation|3|||
146874578|NCT00827606|529711264|FG000|Overall Study|Lost to Follow-up|3|||
146874579|NCT00827606|529711265|FG001|Overall Study|Lost to Follow-up|1|||
146874580|NCT00827606|529711264|FG000|Overall Study|Withdrawal by Subject|7|||
146874581|NCT00827606|529711265|FG001|Overall Study|Withdrawal by Subject|6|||
146874582|NCT00827606|529711264|FG000|Overall Study|Pregnancy|0|||
146874583|NCT00827606|529711265|FG001|Overall Study|Pregnancy|1|||
146874584|NCT00827606|529711264|FG000|Overall Study|Other|5|||
146874585|NCT00827606|529711265|FG001|Overall Study|Other|13|||
146874586|NCT00827606|529711264|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
146874587|NCT00827606|529711265|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
146874588|NCT00827606|529711264|FG000|Overall Study|Adverse Event|4|||
146874589|NCT00827606|529711265|FG001|Overall Study|Adverse Event|2|||
146874590|NCT00589420|529711268|FG000|Overall Study|screen failure|1|||
146874591|NCT00243386|529711269|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
146874592|NCT00243386|529711270|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
146874593|NCT00243386|529711271|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
146874594|NCT00243386|529711269|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
146543910|NCT00005047|528497269|FG000|Overall Study|Adverse Event|5|||
146874595|NCT00243386|529711270|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
146874596|NCT00243386|529711271|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
146874597|NCT00243386|529711269|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
146874598|NCT00243386|529711270|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
146874599|NCT00243386|529711271|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
146543911|NCT00005047|528497270|FG001|Overall Study|Adverse Event|0|||
146874600|NCT00243386|529711269|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
146874601|NCT00243386|529711270|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
146874602|NCT00243386|529711271|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
146874603|NCT00243386|529711269|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
146874604|NCT00243386|529711270|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
146874605|NCT00243386|529711271|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
146874606|NCT00243386|529711269|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
146543912|NCT00005047|528497271|FG002|Overall Study|Adverse Event|0|||
146874607|NCT00243386|529711270|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
146874608|NCT00243386|529711271|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
146874609|NCT00243386|529711269|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
146874610|NCT00243386|529711270|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
146874611|NCT00243386|529711271|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
146874612|NCT00243386|529711269|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
146628738|NCT05138653|528815619|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146628739|NCT05138653|528815604|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146628740|NCT05138653|528815605|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
146628741|NCT05138653|528815606|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146628742|NCT05138653|528815607|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146628743|NCT05138653|528815608|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146874613|NCT00243386|529711270|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
146874614|NCT00243386|529711271|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
146874615|NCT04037748|529711272|FG000|Treatment Period 1|Withdrawal by Subject|3|||
146874616|NCT04037748|529711273|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146874617|NCT04037748|529711272|FG000|Treatment Period 1|Adverse Event|1|||
146874618|NCT04037748|529711273|FG001|Treatment Period 1|Adverse Event|1|||
146874619|NCT04037748|529711272|FG000|Treatment Period 1|Protocol Violation|4|||
146874620|NCT04037748|529711273|FG001|Treatment Period 1|Protocol Violation|5|||
146874621|NCT04037748|529711272|FG000|Treatment Period 2|Adverse Event|0|||
146874622|NCT04037748|529711273|FG001|Treatment Period 2|Adverse Event|1|||
146874623|NCT04037748|529711272|FG000|Treatment Period 2|Protocol Violation|2|||
146874624|NCT04037748|529711273|FG001|Treatment Period 2|Protocol Violation|0|||
146874625|NCT00133991|529711274|FG000|Overall Study|Death|4|||
146874626|NCT04995055|529711278|FG000|Period 1|COVID-19 Related|1|||
146874627|NCT04995055|529711279|FG001|Period 1|COVID-19 Related|0|||
146874628|NCT04995055|529711278|FG000|Period 1|Withdrawal by Subject|0|||
146874629|NCT04995055|529711279|FG001|Period 1|Withdrawal by Subject|1|||
146874630|NCT04995055|529711278|FG000|Period 1|Subject discontinued due to timing|4|||
146874631|NCT04995055|529711279|FG001|Period 1|Subject discontinued due to timing|4|||
146874632|NCT04695392|529711280|FG000|Overall Study|Withdrawn by parent/guardian|0|||
146874633|NCT04695392|529711281|FG001|Overall Study|Withdrawn by parent/guardian|1|||
146628744|NCT05138653|528815609|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146628745|NCT05138653|528815610|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146628746|NCT05138653|528815611|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146628747|NCT05138653|528815612|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
146628748|NCT05138653|528815613|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146628749|NCT05138653|528815614|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146628750|NCT05138653|528815615|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146628751|NCT05138653|528815616|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146628752|NCT05138653|528815617|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146628753|NCT05138653|528815618|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146628754|NCT05138653|528815619|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146628755|NCT05138653|528815604|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146628756|NCT05138653|528815605|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
146628757|NCT05138653|528815606|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146628758|NCT05138653|528815607|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146628759|NCT05138653|528815608|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
146628760|NCT05138653|528815609|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146628761|NCT05138653|528815610|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146628762|NCT05138653|528815611|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146628763|NCT05138653|528815612|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146628764|NCT05138653|528815613|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146628765|NCT05138653|528815614|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146628766|NCT05138653|528815615|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146874634|NCT04695392|529711280|FG000|Overall Study|Withdrawn by physician|0|||
146874635|NCT04695392|529711281|FG001|Overall Study|Withdrawn by physician|1|||
146874636|NCT00450723|529711283|FG000|Overall Study|Physician Decision|5|||
146874637|NCT01987960|529711284|FG000|Period 1|Adverse Event|24|||
146628767|NCT05138653|528815616|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146628768|NCT05138653|528815617|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146628769|NCT05138653|528815618|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146874638|NCT01987960|529711285|FG001|Period 1|Adverse Event|0|||
146874639|NCT01987960|529711286|FG002|Period 1|Adverse Event|0|||
146874640|NCT01987960|529711287|FG003|Period 1|Adverse Event|0|||
146874641|NCT01987960|529711284|FG000|Period 1|Lack of Efficacy|4|||
146874642|NCT01987960|529711285|FG001|Period 1|Lack of Efficacy|0|||
146628770|NCT05138653|528815619|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146628771|NCT05138653|528815604|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146628772|NCT05138653|528815605|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146628773|NCT05138653|528815606|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146628774|NCT05138653|528815607|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146628775|NCT05138653|528815608|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146628776|NCT05138653|528815609|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146628777|NCT05138653|528815610|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
146628778|NCT05138653|528815611|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146628779|NCT05138653|528815612|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146628780|NCT05138653|528815613|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146628781|NCT05138653|528815614|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146628782|NCT05138653|528815615|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146628783|NCT05138653|528815616|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146628784|NCT05138653|528815617|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146628785|NCT05138653|528815618|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146628786|NCT05138653|528815619|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146628787|NCT05138653|528815604|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146628788|NCT05138653|528815605|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146628789|NCT05138653|528815606|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146628790|NCT05138653|528815607|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146628791|NCT05138653|528815608|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146628792|NCT05138653|528815609|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146628793|NCT05138653|528815610|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146628794|NCT05138653|528815611|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146628795|NCT05138653|528815612|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146628796|NCT05138653|528815613|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146628797|NCT05138653|528815614|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
146628798|NCT05138653|528815615|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146628799|NCT05138653|528815616|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
146628800|NCT05138653|528815617|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146628801|NCT05138653|528815618|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
146628802|NCT05138653|528815619|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146628803|NCT05138653|528815604|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146628804|NCT05138653|528815605|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146628805|NCT05138653|528815606|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146628806|NCT05138653|528815607|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146628807|NCT05138653|528815608|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146874643|NCT01987960|529711286|FG002|Period 1|Lack of Efficacy|0|||
146874644|NCT01987960|529711287|FG003|Period 1|Lack of Efficacy|0|||
146874645|NCT01987960|529711284|FG000|Period 1|Non-compliance with IMP|6|||
146874646|NCT01987960|529711285|FG001|Period 1|Non-compliance with IMP|0|||
146874647|NCT01987960|529711286|FG002|Period 1|Non-compliance with IMP|0|||
146874648|NCT01987960|529711287|FG003|Period 1|Non-compliance with IMP|0|||
146628808|NCT05138653|528815609|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146628809|NCT05138653|528815610|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146628810|NCT05138653|528815611|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146628811|NCT05138653|528815612|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146628812|NCT05138653|528815613|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146628813|NCT05138653|528815614|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146628814|NCT05138653|528815615|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146628815|NCT05138653|528815616|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146628816|NCT05138653|528815617|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146628817|NCT05138653|528815618|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146874649|NCT01987960|529711284|FG000|Period 1|Protocol Violation|12|||
146874650|NCT01987960|529711285|FG001|Period 1|Protocol Violation|0|||
146874651|NCT01987960|529711286|FG002|Period 1|Protocol Violation|0|||
146874652|NCT01987960|529711287|FG003|Period 1|Protocol Violation|0|||
146628818|NCT05138653|528815619|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
146628819|NCT05138653|528815604|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146628820|NCT05138653|528815605|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146874653|NCT01987960|529711284|FG000|Period 1|Withdrawal by Subject|21|||
146874654|NCT01987960|529711285|FG001|Period 1|Withdrawal by Subject|0|||
146874655|NCT01987960|529711286|FG002|Period 1|Withdrawal by Subject|0|||
146874656|NCT01987960|529711287|FG003|Period 1|Withdrawal by Subject|0|||
146874657|NCT01987960|529711284|FG000|Period 1|Lost to Follow-up|40|||
146874658|NCT01987960|529711285|FG001|Period 1|Lost to Follow-up|0|||
146874659|NCT01987960|529711286|FG002|Period 1|Lost to Follow-up|0|||
146874660|NCT01987960|529711287|FG003|Period 1|Lost to Follow-up|0|||
146874661|NCT01987960|529711284|FG000|Period 1|administrative or other reason|75|||
146874662|NCT01987960|529711285|FG001|Period 1|administrative or other reason|0|||
146874663|NCT01987960|529711286|FG002|Period 1|administrative or other reason|0|||
146874664|NCT01987960|529711287|FG003|Period 1|administrative or other reason|0|||
146874665|NCT01987960|529711284|FG000|Period 1|Withdrawal of consent before treatment|4|||
146874666|NCT01987960|529711285|FG001|Period 1|Withdrawal of consent before treatment|0|||
146874667|NCT01987960|529711286|FG002|Period 1|Withdrawal of consent before treatment|0|||
146874668|NCT01987960|529711287|FG003|Period 1|Withdrawal of consent before treatment|0|||
146874669|NCT01987960|529711284|FG000|Period 2|Adverse Event|0|||
146874670|NCT01987960|529711285|FG001|Period 2|Adverse Event|0|||
146874671|NCT01987960|529711286|FG002|Period 2|Adverse Event|1|||
146874672|NCT01987960|529711287|FG003|Period 2|Adverse Event|0|||
146874673|NCT01987960|529711284|FG000|Period 2|Withdrawal by Subject|0|||
146874674|NCT01987960|529711285|FG001|Period 2|Withdrawal by Subject|0|||
146874675|NCT01987960|529711286|FG002|Period 2|Withdrawal by Subject|1|||
146874676|NCT01987960|529711287|FG003|Period 2|Withdrawal by Subject|0|||
146874677|NCT01987960|529711284|FG000|Period 2|Administrative or other reason|0|||
146874678|NCT01987960|529711285|FG001|Period 2|Administrative or other reason|5|||
146874679|NCT01987960|529711286|FG002|Period 2|Administrative or other reason|7|||
146874680|NCT01987960|529711287|FG003|Period 2|Administrative or other reason|0|||
146874681|NCT01987960|529711284|FG000|Period 3|Adverse Event|0|||
146874682|NCT01987960|529711285|FG001|Period 3|Adverse Event|0|||
146874683|NCT01987960|529711286|FG002|Period 3|Adverse Event|0|||
146874684|NCT01987960|529711287|FG003|Period 3|Adverse Event|7|||
146874685|NCT01987960|529711284|FG000|Period 3|Non-compliance with IMP|0|||
146874686|NCT01987960|529711285|FG001|Period 3|Non-compliance with IMP|0|||
146874687|NCT01987960|529711286|FG002|Period 3|Non-compliance with IMP|0|||
146874688|NCT01987960|529711287|FG003|Period 3|Non-compliance with IMP|1|||
146874689|NCT01987960|529711284|FG000|Period 3|Protocol Violation|0|||
146874690|NCT01987960|529711285|FG001|Period 3|Protocol Violation|0|||
146874691|NCT01987960|529711286|FG002|Period 3|Protocol Violation|0|||
146874692|NCT01987960|529711287|FG003|Period 3|Protocol Violation|6|||
146874693|NCT01987960|529711284|FG000|Period 3|Withdrawal by Subject|0|||
146874694|NCT01987960|529711285|FG001|Period 3|Withdrawal by Subject|0|||
146874695|NCT01987960|529711286|FG002|Period 3|Withdrawal by Subject|0|||
146874696|NCT01987960|529711287|FG003|Period 3|Withdrawal by Subject|9|||
146874697|NCT01987960|529711284|FG000|Period 3|Lost to Follow-up|0|||
146874698|NCT01987960|529711285|FG001|Period 3|Lost to Follow-up|0|||
146874699|NCT01987960|529711286|FG002|Period 3|Lost to Follow-up|0|||
146874700|NCT01987960|529711287|FG003|Period 3|Lost to Follow-up|5|||
146874701|NCT01987960|529711284|FG000|Period 3|Administrative or other reason|0|||
146874702|NCT01987960|529711285|FG001|Period 3|Administrative or other reason|0|||
146874703|NCT01987960|529711286|FG002|Period 3|Administrative or other reason|0|||
146874704|NCT01987960|529711287|FG003|Period 3|Administrative or other reason|43|||
146874705|NCT01279850|529711288|FG000|Overall Study|Protocol Violation|50|||
146874706|NCT01279850|529711288|FG000|Overall Study|No Drug Administration Information|7|||
146874707|NCT01279850|529711288|FG000|Overall Study|No Visit After Treatment|34|||
146874708|NCT01131520|529711289|FG000|Overall Study|Computer problem|1|||
146874709|NCT01131520|529711290|FG001|Overall Study|Computer problem|0|||
146874710|NCT01131520|529711289|FG000|Overall Study|Counselor not available|0|||
146874711|NCT01131520|529711290|FG001|Overall Study|Counselor not available|3|||
146874712|NCT01131520|529711289|FG000|Overall Study|Subject changed history after enrollment|0|||
146874713|NCT01131520|529711290|FG001|Overall Study|Subject changed history after enrollment|1|||
146874714|NCT01436084|529711291|FG000|Overall Study|Disease Progression|2|||
146874715|NCT01436084|529711291|FG000|Overall Study|Withdrawal by Subject|1|||
146874716|NCT01436084|529711291|FG000|Overall Study|Early Closure of Study|1|||
146874717|NCT00807742|529711292|FG000|Overall Study|Death|9|||
146874718|NCT00807742|529711293|FG001|Overall Study|Death|2|||
146874719|NCT00807742|529711292|FG000|Overall Study|Withdrawal by Subject|2|||
146874720|NCT00807742|529711293|FG001|Overall Study|Withdrawal by Subject|1|||
146874721|NCT00807742|529711292|FG000|Overall Study|Lost to Follow-up|35|||
146874722|NCT00807742|529711293|FG001|Overall Study|Lost to Follow-up|51|||
146874723|NCT03834519|529711294|FG000|Overall Study|Lost to Follow-up|2|||
146874724|NCT03834519|529711295|FG001|Overall Study|Lost to Follow-up|1|||
146874725|NCT03834519|529711294|FG000|Overall Study|Withdrawal by Subject|5|||
146874726|NCT03834519|529711295|FG001|Overall Study|Withdrawal by Subject|8|||
146874727|NCT03834519|529711294|FG000|Overall Study|Death|368|||
146874728|NCT03834519|529711295|FG001|Overall Study|Death|174|||
146874729|NCT03834519|529711294|FG000|Overall Study|Physician Decision|5|||
146874730|NCT03834519|529711295|FG001|Overall Study|Physician Decision|1|||
146874731|NCT03834519|529711294|FG000|Overall Study|Sponsor decision|149|||
146874732|NCT03834519|529711295|FG001|Overall Study|Sponsor decision|80|||
146874733|NCT00853749|529711296|FG000|Overall Study|Lost to Follow-up|0|||
146874734|NCT00853749|529711297|FG001|Overall Study|Lost to Follow-up|1|||
146874735|NCT01538628|529711300|FG000|Overall Study|Withdrawal by Subject|1|||
146874736|NCT01538628|529711301|FG001|Overall Study|Withdrawal by Subject|1|||
146874737|NCT01538628|529711300|FG000|Overall Study|Lost to Follow-up|0|||
146874738|NCT01538628|529711301|FG001|Overall Study|Lost to Follow-up|1|||
146874739|NCT00075023|529712643|FG000|Pilot Study|Physician Decision|1|||
146874740|NCT00075023|529712644|FG001|Pilot Study|Physician Decision|2|||
146874741|NCT00075023|529712643|FG000|Pilot Study|Withdrawal by Subject|1|||
146874742|NCT00075023|529712644|FG001|Pilot Study|Withdrawal by Subject|0|||
146874743|NCT02982954|529712646|FG000|Overall Study|Death|55|||
146874744|NCT02982954|529712647|FG001|Overall Study|Death|29|||
146874745|NCT02982954|529712648|FG002|Overall Study|Death|15|||
146874746|NCT02982954|529712649|FG003|Overall Study|Death|20|||
146874747|NCT02982954|529712646|FG000|Overall Study|Lost to Follow-up|2|||
146874748|NCT02982954|529712647|FG001|Overall Study|Lost to Follow-up|1|||
146874749|NCT02982954|529712648|FG002|Overall Study|Lost to Follow-up|0|||
146874750|NCT02982954|529712649|FG003|Overall Study|Lost to Follow-up|0|||
146874751|NCT02982954|529712646|FG000|Overall Study|Participant withdrew consent|7|||
146874752|NCT02982954|529712647|FG001|Overall Study|Participant withdrew consent|5|||
146874753|NCT02982954|529712648|FG002|Overall Study|Participant withdrew consent|1|||
146874754|NCT02982954|529712649|FG003|Overall Study|Participant withdrew consent|1|||
146874755|NCT02982954|529712646|FG000|Overall Study|Other reasons|42|||
146874756|NCT02982954|529712647|FG001|Overall Study|Other reasons|17|||
146874757|NCT02982954|529712648|FG002|Overall Study|Other reasons|12|||
146874758|NCT02982954|529712649|FG003|Overall Study|Other reasons|3|||
146874759|NCT02982954|529712646|FG000|Overall Study|Premature site closure|0|||
146874760|NCT02982954|529712647|FG001|Overall Study|Premature site closure|0|||
146874761|NCT02982954|529712648|FG002|Overall Study|Premature site closure|0|||
146874762|NCT02982954|529712649|FG003|Overall Study|Premature site closure|1|||
146874763|NCT00516048|529712650|FG000|Overall Study|Death|0|||
146874764|NCT00516048|529712651|FG001|Overall Study|Death|0|||
146874765|NCT00516048|529712652|FG002|Overall Study|Death|1|||
146874766|NCT00516048|529712650|FG000|Overall Study|Subject Decision|0|||
146874767|NCT00516048|529712651|FG001|Overall Study|Subject Decision|2|||
146874768|NCT00516048|529712652|FG002|Overall Study|Subject Decision|0|||
146874769|NCT02263079|529712653|FG000|Overall Study|Physician Decision|1|||
146874770|NCT02263079|529712654|FG001|Overall Study|Physician Decision|0|||
146874771|NCT02263079|529712655|FG002|Overall Study|Physician Decision|0|||
146874772|NCT02263079|529712653|FG000|Overall Study|Withdrawal by Subject|2|||
146874773|NCT02263079|529712654|FG001|Overall Study|Withdrawal by Subject|8|||
146874774|NCT02263079|529712655|FG002|Overall Study|Withdrawal by Subject|0|||
146874775|NCT00094770|529712657|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
146874776|NCT00094770|529712658|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
146874777|NCT00094770|529712657|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
146874778|NCT00094770|529712658|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
146874779|NCT00094770|529712657|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
146874780|NCT00094770|529712658|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
146874781|NCT00094770|529712657|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
146874782|NCT00094770|529712658|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
146874783|NCT00094770|529712657|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
146874784|NCT00094770|529712658|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
146874785|NCT00094770|529712657|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
146874786|NCT00094770|529712658|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
146874787|NCT00094770|529712657|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
146874788|NCT00094770|529712658|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
146874789|NCT00094770|529712657|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
146874790|NCT00094770|529712658|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
146874791|NCT00094770|529712657|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
146874792|NCT00094770|529712658|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
146874793|NCT00094770|529712657|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
146874794|NCT00094770|529712658|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
146874795|NCT00094770|529712657|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
146874796|NCT00094770|529712658|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
146874797|NCT00094770|529712657|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
146874798|NCT00094770|529712658|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
146874799|NCT00094770|529712657|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
146874800|NCT00094770|529712658|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
146874801|NCT00094770|529712657|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
146874802|NCT00094770|529712658|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
146874803|NCT00094770|529712657|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
146874804|NCT00094770|529712658|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
146874805|NCT00094770|529712657|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
146874806|NCT00094770|529712658|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
146874807|NCT00094770|529712657|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
146543913|NCT00005047|528497272|FG003|Overall Study|Adverse Event|0|||
146543914|NCT00005047|528497269|FG000|Overall Study|Lost to Follow-up|1|||
146543915|NCT00005047|528497270|FG001|Overall Study|Lost to Follow-up|0|||
146543916|NCT00005047|528497271|FG002|Overall Study|Lost to Follow-up|0|||
146543917|NCT00005047|528497272|FG003|Overall Study|Lost to Follow-up|0|||
146543918|NCT00005047|528497269|FG000|Overall Study|Lack of Efficacy|1|||
146543919|NCT00005047|528497270|FG001|Overall Study|Lack of Efficacy|0|||
146543920|NCT00005047|528497271|FG002|Overall Study|Lack of Efficacy|0|||
146543921|NCT00005047|528497272|FG003|Overall Study|Lack of Efficacy|0|||
146543922|NCT06455111|528497281|FG000|Overall Study|Withdrawal by Subject|11|||
146543923|NCT06455111|528497282|FG001|Overall Study|Withdrawal by Subject|4|||
146543924|NCT03069989|528497290|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
146543925|NCT03069989|528497291|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
146543926|NCT04398134|528498485|FG000|Overall Study|Adverse Event|0|||
146543927|NCT04398134|528498486|FG001|Overall Study|Adverse Event|0|||
146543928|NCT04398134|528498487|FG002|Overall Study|Adverse Event|1|||
146543929|NCT04398134|528498488|FG003|Overall Study|Adverse Event|0|||
146543930|NCT04398134|528498485|FG000|Overall Study|Withdrawal by Subject|2|||
146543931|NCT04398134|528498486|FG001|Overall Study|Withdrawal by Subject|0|||
146543932|NCT04398134|528498487|FG002|Overall Study|Withdrawal by Subject|0|||
146543933|NCT04398134|528498488|FG003|Overall Study|Withdrawal by Subject|1|||
146543934|NCT04398134|528498485|FG000|Overall Study|Study Terminated by Sponsor|30|||
146543935|NCT04398134|528498486|FG001|Overall Study|Study Terminated by Sponsor|11|||
146543936|NCT04398134|528498487|FG002|Overall Study|Study Terminated by Sponsor|32|||
146543937|NCT04398134|528498488|FG003|Overall Study|Study Terminated by Sponsor|11|||
146543938|NCT03506477|528498494|FG000|Overall Study|Withdrawal by Subject|1|||
146543939|NCT03506477|528498495|FG001|Overall Study|Withdrawal by Subject|0|||
146543940|NCT03462680|528498496|FG000|Overall Study|Withdrawal by Subject|3|||
146543941|NCT03462680|528498497|FG001|Overall Study|Withdrawal by Subject|5|||
146543942|NCT01757847|528498498|FG000|Overall Study|Withdrawal by Subject|3|||
146764690|NCT00486759|529305856|FG001|Treatment|Violation of selection criteria at entry|3|||
146543943|NCT01757847|528498499|FG001|Overall Study|Withdrawal by Subject|4|||
146543944|NCT04556097|528498500|FG000|Overall Study|Death|0|||
146543945|NCT04556097|528498501|FG001|Overall Study|Death|5|||
146543946|NCT04556097|528498502|FG002|Overall Study|Death|0|||
146764691|NCT00486759|529305855|FG000|Treatment|Other protocol violation|1|||
146764692|NCT00486759|529305856|FG001|Treatment|Other protocol violation|5|||
146764693|NCT00486759|529305855|FG000|Treatment|Failure to return|1|||
146764694|NCT00486759|529305856|FG001|Treatment|Failure to return|1|||
146764695|NCT00486759|529305855|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
146764696|NCT00486759|529305856|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
146764697|NCT00486759|529305855|FG000|Safety Follow-up|Death|40|||
146764698|NCT00486759|529305856|FG001|Safety Follow-up|Death|29|||
146764699|NCT00486759|529305855|FG000|Safety Follow-up|Withdrew consent|32|||
146764700|NCT00486759|529305856|FG001|Safety Follow-up|Withdrew consent|23|||
146764701|NCT00486759|529305855|FG000|Safety Follow-up|Failure to return|9|||
146764702|NCT00486759|529305856|FG001|Safety Follow-up|Failure to return|6|||
146764703|NCT00486759|529305855|FG000|Safety Follow-up|Administrative/not specified|8|||
146764704|NCT00486759|529305856|FG001|Safety Follow-up|Administrative/not specified|6|||
146764705|NCT00486759|529305855|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
146764706|NCT00486759|529305856|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
146764707|NCT00486759|529305855|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
146764708|NCT00486759|529305856|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
146764709|NCT01025843|529305857|FG000|Washout 4|Withdrawal by Subject|0|||
146764710|NCT01025843|529305858|FG001|Washout 4|Withdrawal by Subject|0|||
146764711|NCT01025843|529305859|FG002|Washout 4|Withdrawal by Subject|1|||
146764712|NCT01025843|529305860|FG003|Washout 4|Withdrawal by Subject|1|||
146764713|NCT01025843|529305861|FG004|Washout 4|Withdrawal by Subject|0|||
146764714|NCT01025843|529305862|FG005|Washout 4|Withdrawal by Subject|0|||
146764715|NCT01025843|529305863|FG006|Washout 4|Withdrawal by Subject|0|||
146764716|NCT01025843|529305864|FG007|Washout 4|Withdrawal by Subject|0|||
146764717|NCT01025843|529305865|FG008|Washout 4|Withdrawal by Subject|0|||
146764718|NCT01025843|529305866|FG009|Washout 4|Withdrawal by Subject|0|||
146764719|NCT02814643|529305871|FG000|Overall Study|Lost to Follow-up|0|||
146764720|NCT02814643|529305872|FG001|Overall Study|Lost to Follow-up|1|||
146764721|NCT02814643|529305871|FG000|Overall Study|Withdrawal by Subject|1|||
146764722|NCT02814643|529305872|FG001|Overall Study|Withdrawal by Subject|2|||
146764723|NCT02846415|529305875|FG000|Overall Study|Lost to Follow-up|2|||
146764724|NCT02846415|529305876|FG001|Overall Study|Lost to Follow-up|0|||
146764725|NCT02846415|529305875|FG000|Overall Study|Withdrawal by Subject|1|||
146874808|NCT00094770|529712658|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
146874809|NCT00094770|529712657|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
146874810|NCT00094770|529712658|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
146874811|NCT01549275|529712661|FG000|Overall Study|Lost to Follow-up|1|||
146874812|NCT01549275|529712662|FG001|Overall Study|Lost to Follow-up|0|||
146874813|NCT01040351|529712663|FG000|Overall Study|poor ovarian response|1|||
146874814|NCT01040351|529712664|FG001|Overall Study|poor ovarian response|2|||
146874815|NCT04773106|529712670|FG000|Overall Study|Withdrawal by Subject|3|||
146874816|NCT04773106|529712670|FG000|Overall Study|Death|1|||
146874817|NCT00122681|529712675|FG000|Overall Study|Adverse Event|20|||
146874818|NCT00122681|529712676|FG001|Overall Study|Adverse Event|16|||
146874819|NCT00122681|529712675|FG000|Overall Study|Lost to Follow-up|1080|||
146874820|NCT00122681|529712676|FG001|Overall Study|Lost to Follow-up|1097|||
146874821|NCT00122681|529712675|FG000|Overall Study|Protocol Violation|7|||
146874822|NCT00122681|529712676|FG001|Overall Study|Protocol Violation|10|||
146874823|NCT00122681|529712675|FG000|Overall Study|Withdrawal by Subject|257|||
146874824|NCT00122681|529712676|FG001|Overall Study|Withdrawal by Subject|251|||
146874825|NCT00122681|529712675|FG000|Overall Study|Personal reasons|150|||
146874826|NCT00122681|529712676|FG001|Overall Study|Personal reasons|147|||
146874827|NCT02819635|529712681|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
146874828|NCT02819635|529712682|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
146874829|NCT02819635|529712683|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
146874830|NCT02819635|529712684|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
146874831|NCT02819635|529712685|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
146874832|NCT02819635|529712686|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
146874833|NCT02819635|529712687|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
146874834|NCT02819635|529712688|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
146874835|NCT02819635|529712689|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
146874836|NCT02819635|529712690|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
146874837|NCT02819635|529712691|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
146874838|NCT02819635|529712692|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
146874839|NCT02819635|529712681|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146874840|NCT02819635|529712682|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146874841|NCT02819635|529712683|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146874842|NCT02819635|529712684|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146874843|NCT02819635|529712685|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
146874844|NCT02819635|529712686|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
146874845|NCT02819635|529712687|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
146874846|NCT02819635|529712688|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146874847|NCT02819635|529712689|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146874848|NCT02819635|529712690|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146874849|NCT02819635|529712691|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146874850|NCT02819635|529712692|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146874851|NCT02819635|529712681|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146874852|NCT02819635|529712682|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146874853|NCT02819635|529712683|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146874854|NCT02819635|529712684|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146874855|NCT02819635|529712685|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146874856|NCT02819635|529712686|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
146874857|NCT02819635|529712687|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
146874858|NCT02819635|529712688|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146874859|NCT02819635|529712689|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146874860|NCT02819635|529712690|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146874861|NCT02819635|529712691|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146874862|NCT02819635|529712692|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146874863|NCT02819635|529712681|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146874864|NCT02819635|529712682|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146874865|NCT02819635|529712683|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146874866|NCT02819635|529712684|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146874867|NCT02819635|529712685|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146543947|NCT04556097|528498503|FG003|Overall Study|Death|0|||
146543948|NCT04556097|528498500|FG000|Overall Study|No caregiver|43|||
146543949|NCT04556097|528498501|FG001|Overall Study|No caregiver|53|||
146543950|NCT04556097|528498502|FG002|Overall Study|No caregiver|0|||
146543951|NCT04556097|528498503|FG003|Overall Study|No caregiver|0|||
146543952|NCT04556097|528498500|FG000|Overall Study|Ineligible, SNF|2|||
146543953|NCT04556097|528498501|FG001|Overall Study|Ineligible, SNF|2|||
146543954|NCT04556097|528498502|FG002|Overall Study|Ineligible, SNF|0|||
146543955|NCT04556097|528498503|FG003|Overall Study|Ineligible, SNF|0|||
146543956|NCT04556097|528498500|FG000|Overall Study|Ineligible, health|3|||
146543957|NCT04556097|528498501|FG001|Overall Study|Ineligible, health|4|||
146543958|NCT04556097|528498502|FG002|Overall Study|Ineligible, health|0|||
146543959|NCT04556097|528498503|FG003|Overall Study|Ineligible, health|0|||
146543960|NCT04556097|528498500|FG000|Overall Study|Ineligible, language|0|||
146543961|NCT04556097|528498501|FG001|Overall Study|Ineligible, language|1|||
146543962|NCT04556097|528498502|FG002|Overall Study|Ineligible, language|0|||
146543963|NCT04556097|528498503|FG003|Overall Study|Ineligible, language|0|||
146543964|NCT04556097|528498500|FG000|Overall Study|Ineligible, no longer in care management|0|||
146543965|NCT04556097|528498501|FG001|Overall Study|Ineligible, no longer in care management|2|||
146543966|NCT04556097|528498502|FG002|Overall Study|Ineligible, no longer in care management|1|||
146543967|NCT04556097|528498503|FG003|Overall Study|Ineligible, no longer in care management|0|||
146543968|NCT04556097|528498500|FG000|Overall Study|No dementia|13|||
146543969|NCT04556097|528498501|FG001|Overall Study|No dementia|3|||
146543970|NCT04556097|528498502|FG002|Overall Study|No dementia|0|||
146543971|NCT04556097|528498503|FG003|Overall Study|No dementia|0|||
146543972|NCT04556097|528498500|FG000|Overall Study|Missing identifier|2|||
146543973|NCT04556097|528498501|FG001|Overall Study|Missing identifier|4|||
146543974|NCT04556097|528498502|FG002|Overall Study|Missing identifier|0|||
146543975|NCT04556097|528498503|FG003|Overall Study|Missing identifier|0|||
146543976|NCT04556097|528498500|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
146543977|NCT04556097|528498501|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
146543978|NCT04556097|528498502|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
146543979|NCT04556097|528498503|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
146543980|NCT02516241|528498504|FG000|Overall Study|Death|255|||
146543981|NCT02516241|528498505|FG001|Overall Study|Death|262|||
146543982|NCT02516241|528498506|FG002|Overall Study|Death|270|||
146543983|NCT02516241|528498504|FG000|Overall Study|Lost to Follow-up|1|||
146543984|NCT02516241|528498505|FG001|Overall Study|Lost to Follow-up|1|||
146543985|NCT02516241|528498506|FG002|Overall Study|Lost to Follow-up|3|||
146543986|NCT02516241|528498504|FG000|Overall Study|Withdrawal by Subject|2|||
146543987|NCT02516241|528498505|FG001|Overall Study|Withdrawal by Subject|7|||
146543988|NCT02516241|528498506|FG002|Overall Study|Withdrawal by Subject|12|||
146543989|NCT02516241|528498504|FG000|Overall Study|participants ongoing at data cut-off|84|||
146543990|NCT02516241|528498505|FG001|Overall Study|participants ongoing at data cut-off|76|||
146543991|NCT02516241|528498506|FG002|Overall Study|participants ongoing at data cut-off|59|||
146543992|NCT04057365|528498507|FG000|Overall Study|Withdrawal by Subject|2|||
146543993|NCT04057365|528498508|FG001|Overall Study|Withdrawal by Subject|0|||
146543994|NCT04738487|528498509|FG000|Overall Study|Participant Ongoing in Study|298|||
146543995|NCT04738487|528498510|FG001|Overall Study|Participant Ongoing in Study|297|||
146543996|NCT04738487|528498509|FG000|Overall Study|Withdrawal by Subject|7|||
146543997|NCT04738487|528498510|FG001|Overall Study|Withdrawal by Subject|9|||
146543998|NCT04738487|528498509|FG000|Overall Study|Lost to Follow-up|2|||
146543999|NCT04738487|528498510|FG001|Overall Study|Lost to Follow-up|0|||
146544000|NCT04738487|528498509|FG000|Overall Study|Death|287|||
146544001|NCT04738487|528498510|FG001|Overall Study|Death|306|||
146544002|NCT00325416|528498525|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
146544003|NCT00325416|528498526|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
146544004|NCT00325416|528498525|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
146544005|NCT00325416|528498526|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
146544006|NCT00325416|528498525|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
146544007|NCT00325416|528498526|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
146544008|NCT00325416|528498525|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
146544009|NCT00325416|528498526|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
146544010|NCT00325416|528498525|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
146544011|NCT00325416|528498526|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
146544012|NCT00325416|528498525|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
146544013|NCT00325416|528498526|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
146544014|NCT06239610|528498527|FG000|Overall Study|no usable migration data for minimum of one day|11|||
146544015|NCT02324153|528498528|FG000|Overall Study|Withdrawal by Subject|4|||
146544016|NCT02324153|528498529|FG001|Overall Study|Withdrawal by Subject|1|||
146544017|NCT02324153|528498528|FG000|Overall Study|Surgery postponed after randomization|3|||
146544018|NCT02324153|528498529|FG001|Overall Study|Surgery postponed after randomization|0|||
146544019|NCT02324153|528498528|FG000|Overall Study|Developed delirium preoperatively|1|||
146544020|NCT02324153|528498529|FG001|Overall Study|Developed delirium preoperatively|0|||
146544021|NCT01937299|528498533|FG000|Overall Study|Adverse Event|13|||
146544022|NCT01937299|528498534|FG001|Overall Study|Adverse Event|0|||
146544023|NCT01937299|528498533|FG000|Overall Study|Lack of Efficacy|0|||
146544024|NCT01937299|528498534|FG001|Overall Study|Lack of Efficacy|4|||
146544025|NCT01937299|528498533|FG000|Overall Study|Withdrawal by Subject|1|||
146628821|NCT05138653|528815606|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146628822|NCT05138653|528815607|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146628823|NCT05138653|528815608|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146628824|NCT05138653|528815609|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146628825|NCT05138653|528815610|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146628826|NCT05138653|528815611|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146628827|NCT05138653|528815612|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146628828|NCT05138653|528815613|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146628829|NCT05138653|528815614|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146628830|NCT05138653|528815615|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146628831|NCT05138653|528815616|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146628832|NCT05138653|528815617|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
146628833|NCT05138653|528815618|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146764726|NCT02846415|529305876|FG001|Overall Study|Withdrawal by Subject|1|||
146764727|NCT03383887|529305879|FG000|Overall Study|Lost to Follow-up|0|||
146764728|NCT03383887|529305880|FG001|Overall Study|Lost to Follow-up|1|||
146764729|NCT00975806|529305891|FG000|Overall Study|Adverse Event|2|||
146764730|NCT00975806|529305892|FG001|Overall Study|Adverse Event|1|||
146764731|NCT00975806|529305893|FG002|Overall Study|Adverse Event|2|||
146764732|NCT00975806|529305891|FG000|Overall Study|Disease Progression|1|||
146764733|NCT00975806|529305892|FG001|Overall Study|Disease Progression|5|||
146764734|NCT00975806|529305893|FG002|Overall Study|Disease Progression|1|||
146764735|NCT00975806|529305891|FG000|Overall Study|Withdrawal by Subject|1|||
146764736|NCT00975806|529305892|FG001|Overall Study|Withdrawal by Subject|0|||
146764737|NCT00975806|529305893|FG002|Overall Study|Withdrawal by Subject|0|||
146764738|NCT00975806|529305891|FG000|Overall Study|Death|0|||
146764739|NCT00975806|529305892|FG001|Overall Study|Death|1|||
146764740|NCT00975806|529305893|FG002|Overall Study|Death|0|||
146764741|NCT00975806|529305891|FG000|Overall Study|Physician decision and disease related|1|||
146764742|NCT00975806|529305892|FG001|Overall Study|Physician decision and disease related|0|||
146764743|NCT00975806|529305893|FG002|Overall Study|Physician decision and disease related|1|||
146764744|NCT00246012|529305894|FG000|Overall Study|Adverse Event|0|||
146764745|NCT00246012|529305895|FG001|Overall Study|Adverse Event|0|||
146764746|NCT00246012|529305896|FG002|Overall Study|Adverse Event|0|||
146764747|NCT00246012|529305897|FG003|Overall Study|Adverse Event|0|||
146764748|NCT00246012|529305898|FG004|Overall Study|Adverse Event|0|||
146764749|NCT00246012|529305899|FG005|Overall Study|Adverse Event|1|||
146764750|NCT00246012|529305900|FG006|Overall Study|Adverse Event|0|||
146764751|NCT00246012|529305901|FG007|Overall Study|Adverse Event|0|||
146764752|NCT00246012|529305902|FG008|Overall Study|Adverse Event|2|||
146764753|NCT00246012|529305894|FG000|Overall Study|Withdrawal by Subject|0|||
146764754|NCT00246012|529305895|FG001|Overall Study|Withdrawal by Subject|0|||
146764755|NCT00246012|529305896|FG002|Overall Study|Withdrawal by Subject|0|||
146764756|NCT00246012|529305897|FG003|Overall Study|Withdrawal by Subject|0|||
146764757|NCT00246012|529305898|FG004|Overall Study|Withdrawal by Subject|0|||
146764758|NCT00246012|529305899|FG005|Overall Study|Withdrawal by Subject|1|||
146764759|NCT00246012|529305900|FG006|Overall Study|Withdrawal by Subject|0|||
146764760|NCT00246012|529305901|FG007|Overall Study|Withdrawal by Subject|0|||
146764761|NCT00246012|529305902|FG008|Overall Study|Withdrawal by Subject|0|||
146764762|NCT00246012|529305894|FG000|Overall Study|Disease progression|3|||
146764763|NCT00246012|529305895|FG001|Overall Study|Disease progression|1|||
146764764|NCT00246012|529305896|FG002|Overall Study|Disease progression|2|||
146764765|NCT00246012|529305897|FG003|Overall Study|Disease progression|3|||
146764766|NCT00246012|529305898|FG004|Overall Study|Disease progression|3|||
146764767|NCT00246012|529305899|FG005|Overall Study|Disease progression|25|||
146764768|NCT00246012|529305900|FG006|Overall Study|Disease progression|30|||
146764769|NCT00246012|529305901|FG007|Overall Study|Disease progression|27|||
146764770|NCT00246012|529305902|FG008|Overall Study|Disease progression|26|||
146764771|NCT00246012|529305894|FG000|Overall Study|Other|0|||
146764772|NCT00246012|529305895|FG001|Overall Study|Other|0|||
146764773|NCT00246012|529305896|FG002|Overall Study|Other|0|||
146764774|NCT00246012|529305897|FG003|Overall Study|Other|0|||
146764775|NCT00246012|529305898|FG004|Overall Study|Other|0|||
146764776|NCT00246012|529305899|FG005|Overall Study|Other|0|||
146764777|NCT00246012|529305900|FG006|Overall Study|Other|0|||
146764778|NCT00246012|529305901|FG007|Overall Study|Other|1|||
146764779|NCT00246012|529305902|FG008|Overall Study|Other|0|||
146764780|NCT00246012|529305894|FG000|Overall Study|Randomly assigned but not treated|0|||
146764781|NCT00246012|529305895|FG001|Overall Study|Randomly assigned but not treated|0|||
146874868|NCT02819635|529712686|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146874869|NCT02819635|529712687|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
146874870|NCT02819635|529712688|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146874871|NCT02819635|529712689|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146874872|NCT02819635|529712690|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146874873|NCT02819635|529712691|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146874874|NCT02819635|529712692|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146874875|NCT02819635|529712681|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
146874876|NCT02819635|529712682|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
146874877|NCT02819635|529712683|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
146874878|NCT02819635|529712684|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
146874879|NCT02819635|529712685|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
146874880|NCT02819635|529712686|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
146874881|NCT02819635|529712687|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
146874882|NCT02819635|529712688|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
146874883|NCT02819635|529712689|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
146874884|NCT02819635|529712690|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
146874885|NCT02819635|529712691|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
146874886|NCT02819635|529712692|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
146874887|NCT02819635|529712681|FG000|Substudy 2, Part 2|Adverse Event|0|||
146874888|NCT02819635|529712682|FG001|Substudy 2, Part 2|Adverse Event|0|||
146874889|NCT02819635|529712683|FG002|Substudy 2, Part 2|Adverse Event|0|||
146874890|NCT02819635|529712684|FG003|Substudy 2, Part 2|Adverse Event|0|||
146874891|NCT02819635|529712685|FG004|Substudy 2, Part 2|Adverse Event|0|||
146874892|NCT02819635|529712686|FG005|Substudy 2, Part 2|Adverse Event|4|||
146874893|NCT02819635|529712687|FG006|Substudy 2, Part 2|Adverse Event|0|||
146874894|NCT02819635|529712688|FG007|Substudy 2, Part 2|Adverse Event|0|||
146874895|NCT02819635|529712689|FG008|Substudy 2, Part 2|Adverse Event|0|||
146874896|NCT02819635|529712690|FG009|Substudy 2, Part 2|Adverse Event|0|||
146874897|NCT02819635|529712691|FG010|Substudy 2, Part 2|Adverse Event|0|||
146874898|NCT02819635|529712692|FG011|Substudy 2, Part 2|Adverse Event|0|||
146874899|NCT02819635|529712681|FG000|Substudy 2, Part 2|Withdrew consent|0|||
146874900|NCT02819635|529712682|FG001|Substudy 2, Part 2|Withdrew consent|0|||
146874901|NCT02819635|529712683|FG002|Substudy 2, Part 2|Withdrew consent|0|||
146874902|NCT02819635|529712684|FG003|Substudy 2, Part 2|Withdrew consent|0|||
146874903|NCT02819635|529712685|FG004|Substudy 2, Part 2|Withdrew consent|0|||
146874904|NCT02819635|529712686|FG005|Substudy 2, Part 2|Withdrew consent|3|||
146874905|NCT02819635|529712687|FG006|Substudy 2, Part 2|Withdrew consent|1|||
146874906|NCT02819635|529712688|FG007|Substudy 2, Part 2|Withdrew consent|0|||
146874907|NCT02819635|529712689|FG008|Substudy 2, Part 2|Withdrew consent|0|||
146874908|NCT02819635|529712690|FG009|Substudy 2, Part 2|Withdrew consent|0|||
146874909|NCT02819635|529712691|FG010|Substudy 2, Part 2|Withdrew consent|0|||
146874910|NCT02819635|529712692|FG011|Substudy 2, Part 2|Withdrew consent|0|||
146874911|NCT02819635|529712681|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
146874912|NCT02819635|529712682|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
146874913|NCT02819635|529712683|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
146874914|NCT02819635|529712684|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
146874915|NCT02819635|529712685|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
146874916|NCT02819635|529712686|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
146874917|NCT02819635|529712687|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
146874918|NCT02819635|529712688|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
146874919|NCT02819635|529712689|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
146874920|NCT02819635|529712690|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
146874921|NCT02819635|529712691|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
146874922|NCT02819635|529712692|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
146568918|NCT02712788|528595497|FG001|Overall Study|Protocol Violation|0|||
146874923|NCT02819635|529712681|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146874924|NCT02819635|529712682|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146628834|NCT05138653|528815619|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146628835|NCT02331134|528815620|FG000|Overall Study|Withdrawal by Subject|1|||
146628836|NCT05967260|528815621|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
146628837|NCT05967260|528815622|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
146628838|NCT03204188|528815625|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
146628839|NCT03204188|528815625|FG000|Immunotherapy Phase (1 Year)|Death|1|||
146628840|NCT03204188|528815625|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
146628841|NCT03204188|528815625|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
146628842|NCT01350999|528815626|FG000|Overall Study|Adverse Event|4|||
146628843|NCT01350999|528815627|FG001|Overall Study|Adverse Event|9|||
146628844|NCT01350999|528815628|FG002|Overall Study|Adverse Event|10|||
146628845|NCT01350999|528815626|FG000|Overall Study|Voluntary withdrawal|3|||
146628846|NCT01350999|528815627|FG001|Overall Study|Voluntary withdrawal|4|||
146628847|NCT01350999|528815628|FG002|Overall Study|Voluntary withdrawal|6|||
146628848|NCT01350999|528815626|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
146628849|NCT01350999|528815627|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
146628850|NCT01350999|528815628|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
146628851|NCT00079417|528818266|FG000|Overall Study|Physician Decision|2|||
146628852|NCT00079417|528818266|FG000|Overall Study|Ineligible|7|||
146628853|NCT01615939|528818267|FG000|Overall Study|Lost to Follow-up|5|||
146628854|NCT01615939|528818268|FG001|Overall Study|Lost to Follow-up|0|||
146628855|NCT02121535|528818272|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
146628856|NCT02121535|528818273|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
146628857|NCT02121535|528818272|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
146628858|NCT02121535|528818273|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
146628859|NCT00092417|528818274|FG000|Overall Study|Lost to Follow-up|2|||
146628860|NCT00092417|528818275|FG001|Overall Study|Lost to Follow-up|0|||
146628861|NCT00092417|528818274|FG000|Overall Study|Withdrawal by Subject|2|||
146628862|NCT00092417|528818275|FG001|Overall Study|Withdrawal by Subject|1|||
146628863|NCT00092417|528818274|FG000|Overall Study|Other|1|||
146628864|NCT00092417|528818275|FG001|Overall Study|Other|0|||
146628865|NCT01520506|528818276|FG000|Overall Study|Missed Visit|4|||
146628866|NCT01520506|528818276|FG000|Overall Study|Lost to Follow-up|1|||
146628867|NCT01520506|528818276|FG000|Overall Study|Withdrawal by Subject|1|||
146628868|NCT00425269|528818277|FG000|Overall Study|Pregnancy|5|||
146628869|NCT00425269|528818278|FG001|Overall Study|Pregnancy|7|||
146628870|NCT00425269|528818277|FG000|Overall Study|Lost to Follow-up|9|||
146628871|NCT00425269|528818278|FG001|Overall Study|Lost to Follow-up|9|||
146628872|NCT00425269|528818277|FG000|Overall Study|moved or medical reason|5|||
146628873|NCT00425269|528818278|FG001|Overall Study|moved or medical reason|4|||
146628874|NCT01084655|528818279|FG000|Overall Study|Radiographic disease progression|3|||
146628875|NCT01084655|528818280|FG001|Overall Study|Radiographic disease progression|2|||
146628876|NCT01084655|528818281|FG002|Overall Study|Radiographic disease progression|8|||
146628877|NCT01084655|528818279|FG000|Overall Study|Withdrawal by Subject|1|||
146628878|NCT01084655|528818280|FG001|Overall Study|Withdrawal by Subject|0|||
146628879|NCT01084655|528818281|FG002|Overall Study|Withdrawal by Subject|4|||
146628880|NCT01084655|528818279|FG000|Overall Study|Adverse Event|2|||
146628881|NCT01084655|528818280|FG001|Overall Study|Adverse Event|1|||
146628882|NCT01084655|528818281|FG002|Overall Study|Adverse Event|2|||
146628883|NCT01084655|528818279|FG000|Overall Study|Other|0|||
146628884|NCT01084655|528818280|FG001|Overall Study|Other|3|||
146628885|NCT01084655|528818281|FG002|Overall Study|Other|2|||
146628886|NCT01084655|528818279|FG000|Overall Study|Symptomatic deterioration|0|||
146628887|NCT01084655|528818280|FG001|Overall Study|Symptomatic deterioration|0|||
146764782|NCT00246012|529305896|FG002|Overall Study|Randomly assigned but not treated|0|||
146628888|NCT01084655|528818281|FG002|Overall Study|Symptomatic deterioration|2|||
146628889|NCT01084655|528818279|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
146628890|NCT01084655|528818280|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
146628891|NCT01084655|528818281|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
146628892|NCT00906204|528818282|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
146628893|NCT00906204|528818283|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
146628894|NCT00906204|528818282|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
146628895|NCT00906204|528818283|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
146764783|NCT00246012|529305897|FG003|Overall Study|Randomly assigned but not treated|0|||
146764784|NCT00246012|529305898|FG004|Overall Study|Randomly assigned but not treated|0|||
146764785|NCT00246012|529305899|FG005|Overall Study|Randomly assigned but not treated|1|||
146764786|NCT00246012|529305900|FG006|Overall Study|Randomly assigned but not treated|1|||
146764787|NCT00246012|529305901|FG007|Overall Study|Randomly assigned but not treated|0|||
146764788|NCT00246012|529305902|FG008|Overall Study|Randomly assigned but not treated|0|||
146764789|NCT04889664|529305903|FG000|Screen|Lost to Follow-up|1|||
146764790|NCT04889664|529305903|FG000|Screen|Failed to meet screening criteria|1|||
146764791|NCT04889664|529305903|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
146544026|NCT01937299|528498534|FG001|Overall Study|Withdrawal by Subject|0|||
146874925|NCT02819635|529712683|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146874926|NCT02819635|529712684|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146874927|NCT02819635|529712685|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146874928|NCT02819635|529712686|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146874929|NCT02819635|529712687|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
146874930|NCT02819635|529712688|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146874931|NCT02819635|529712689|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146874932|NCT02819635|529712690|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146874933|NCT02819635|529712691|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146874934|NCT02819635|529712692|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146874935|NCT02819635|529712681|FG000|Substudy 2, Part 2|Other, not specified|0|||
146874936|NCT02819635|529712682|FG001|Substudy 2, Part 2|Other, not specified|0|||
146874937|NCT02819635|529712683|FG002|Substudy 2, Part 2|Other, not specified|0|||
146874938|NCT02819635|529712684|FG003|Substudy 2, Part 2|Other, not specified|0|||
146874939|NCT02819635|529712685|FG004|Substudy 2, Part 2|Other, not specified|0|||
146874940|NCT02819635|529712686|FG005|Substudy 2, Part 2|Other, not specified|4|||
146874941|NCT02819635|529712687|FG006|Substudy 2, Part 2|Other, not specified|8|||
146874942|NCT02819635|529712688|FG007|Substudy 2, Part 2|Other, not specified|0|||
146874943|NCT02819635|529712689|FG008|Substudy 2, Part 2|Other, not specified|0|||
146874944|NCT02819635|529712690|FG009|Substudy 2, Part 2|Other, not specified|0|||
146874945|NCT02819635|529712691|FG010|Substudy 2, Part 2|Other, not specified|0|||
146874946|NCT02819635|529712692|FG011|Substudy 2, Part 2|Other, not specified|0|||
146874947|NCT02819635|529712681|FG000|Substudy 3|Adverse Event|0|||
146874948|NCT02819635|529712682|FG001|Substudy 3|Adverse Event|0|||
146874949|NCT02819635|529712683|FG002|Substudy 3|Adverse Event|0|||
146874950|NCT02819635|529712684|FG003|Substudy 3|Adverse Event|0|||
146874951|NCT02819635|529712685|FG004|Substudy 3|Adverse Event|0|||
146874952|NCT02819635|529712686|FG005|Substudy 3|Adverse Event|0|||
146874953|NCT02819635|529712687|FG006|Substudy 3|Adverse Event|0|||
146874954|NCT02819635|529712688|FG007|Substudy 3|Adverse Event|0|||
146874955|NCT02819635|529712689|FG008|Substudy 3|Adverse Event|32|||
146874956|NCT02819635|529712690|FG009|Substudy 3|Adverse Event|3|||
146874957|NCT02819635|529712691|FG010|Substudy 3|Adverse Event|12|||
146874958|NCT02819635|529712692|FG011|Substudy 3|Adverse Event|18|||
146874959|NCT02819635|529712681|FG000|Substudy 3|Withdrew consent|0|||
146874960|NCT02819635|529712682|FG001|Substudy 3|Withdrew consent|0|||
146874961|NCT02819635|529712683|FG002|Substudy 3|Withdrew consent|0|||
146874962|NCT02819635|529712684|FG003|Substudy 3|Withdrew consent|0|||
146874963|NCT02819635|529712685|FG004|Substudy 3|Withdrew consent|0|||
146544027|NCT04017962|528498535|FG000|Overall Study|Death|2|||
146544028|NCT04017962|528498536|FG001|Overall Study|Death|0|||
146544029|NCT04017962|528498535|FG000|Overall Study|Lost to Follow-up|2|||
146544030|NCT04017962|528498536|FG001|Overall Study|Lost to Follow-up|0|||
146544031|NCT04017962|528498535|FG000|Overall Study|Physician Decision|1|||
146544032|NCT04017962|528498536|FG001|Overall Study|Physician Decision|0|||
146544033|NCT04017962|528498535|FG000|Overall Study|Discontinued LTV|5|||
146544034|NCT04017962|528498536|FG001|Overall Study|Discontinued LTV|0|||
146544035|NCT01260948|528498537|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
146544036|NCT01260948|528498538|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
146544037|NCT01260948|528498537|FG000|Second Intervention|Emesis|0|||
146544038|NCT01260948|528498538|FG001|Second Intervention|Emesis|1|||
146544039|NCT02555878|528498539|FG000|Overall Study|Lost to Follow-up|2|||
146544040|NCT02555878|528498540|FG001|Overall Study|Lost to Follow-up|3|||
146544041|NCT02555878|528498539|FG000|Overall Study|Withdrawal by Subject|48|||
146544042|NCT02555878|528498540|FG001|Overall Study|Withdrawal by Subject|48|||
146544043|NCT02555878|528498539|FG000|Overall Study|Adverse Event|12|||
146544044|NCT02555878|528498540|FG001|Overall Study|Adverse Event|8|||
146544045|NCT02555878|528498539|FG000|Overall Study|Death|74|||
146544046|NCT02555878|528498540|FG001|Overall Study|Death|59|||
146544047|NCT02555878|528498539|FG000|Overall Study|Protocol Violation|1|||
146544048|NCT02555878|528498540|FG001|Overall Study|Protocol Violation|2|||
146544049|NCT02555878|528498539|FG000|Overall Study|Physician Decision|12|||
146544050|NCT02555878|528498540|FG001|Overall Study|Physician Decision|13|||
146544051|NCT02555878|528498539|FG000|Overall Study|Other|17|||
146544052|NCT02555878|528498540|FG001|Overall Study|Other|17|||
146874964|NCT02819635|529712686|FG005|Substudy 3|Withdrew consent|0|||
146874965|NCT02819635|529712687|FG006|Substudy 3|Withdrew consent|0|||
146544053|NCT00765076|528498541|FG000|Overall Study|Adverse Event|1|||
146544054|NCT00765076|528498542|FG001|Overall Study|Adverse Event|0|||
146544055|NCT00765076|528498543|FG002|Overall Study|Adverse Event|0|||
146544056|NCT00765076|528498541|FG000|Overall Study|Withdrawal by Subject|0|||
146544057|NCT00765076|528498542|FG001|Overall Study|Withdrawal by Subject|0|||
146544058|NCT00765076|528498543|FG002|Overall Study|Withdrawal by Subject|1|||
146544059|NCT01163617|528498544|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
146544060|NCT01163617|528498545|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
146874966|NCT02819635|529712688|FG007|Substudy 3|Withdrew consent|0|||
146874967|NCT02819635|529712689|FG008|Substudy 3|Withdrew consent|11|||
146874968|NCT02819635|529712690|FG009|Substudy 3|Withdrew consent|1|||
146874969|NCT02819635|529712691|FG010|Substudy 3|Withdrew consent|4|||
146874970|NCT02819635|529712692|FG011|Substudy 3|Withdrew consent|9|||
146874971|NCT02819635|529712681|FG000|Substudy 3|Lost to Follow-up|0|||
146874972|NCT02819635|529712682|FG001|Substudy 3|Lost to Follow-up|0|||
146874973|NCT02819635|529712683|FG002|Substudy 3|Lost to Follow-up|0|||
146874974|NCT02819635|529712684|FG003|Substudy 3|Lost to Follow-up|0|||
146874975|NCT02819635|529712685|FG004|Substudy 3|Lost to Follow-up|0|||
146874976|NCT02819635|529712686|FG005|Substudy 3|Lost to Follow-up|0|||
146874977|NCT02819635|529712687|FG006|Substudy 3|Lost to Follow-up|0|||
146874978|NCT02819635|529712688|FG007|Substudy 3|Lost to Follow-up|0|||
146874979|NCT02819635|529712689|FG008|Substudy 3|Lost to Follow-up|1|||
146874980|NCT02819635|529712690|FG009|Substudy 3|Lost to Follow-up|0|||
146874981|NCT02819635|529712691|FG010|Substudy 3|Lost to Follow-up|1|||
146874982|NCT02819635|529712692|FG011|Substudy 3|Lost to Follow-up|1|||
146874983|NCT02819635|529712681|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
146874984|NCT02819635|529712682|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
146544061|NCT01163617|528498546|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
146874985|NCT02819635|529712683|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
146874986|NCT02819635|529712684|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
146874987|NCT02819635|529712685|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
146874988|NCT02819635|529712686|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
146874989|NCT02819635|529712687|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
146874990|NCT02819635|529712688|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
146874991|NCT02819635|529712689|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
146874992|NCT02819635|529712690|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
146874993|NCT02819635|529712691|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
146874994|NCT02819635|529712692|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
146874995|NCT02819635|529712681|FG000|Substudy 3|Other, not specified|0|||
146874996|NCT02819635|529712682|FG001|Substudy 3|Other, not specified|0|||
146874997|NCT02819635|529712683|FG002|Substudy 3|Other, not specified|0|||
146874998|NCT02819635|529712684|FG003|Substudy 3|Other, not specified|0|||
146874999|NCT02819635|529712685|FG004|Substudy 3|Other, not specified|0|||
146875000|NCT02819635|529712686|FG005|Substudy 3|Other, not specified|0|||
146875001|NCT02819635|529712687|FG006|Substudy 3|Other, not specified|0|||
146875002|NCT02819635|529712688|FG007|Substudy 3|Other, not specified|0|||
146544062|NCT01163617|528498547|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
146544063|NCT01163617|528498548|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
146544064|NCT01163617|528498549|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
146544065|NCT01163617|528498550|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
146544066|NCT01163617|528498551|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
146544067|NCT01163617|528498544|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
146544068|NCT01163617|528498545|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
146544069|NCT01163617|528498546|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
146544070|NCT01163617|528498547|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
146544071|NCT01163617|528498548|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
146544072|NCT01163617|528498549|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
146544073|NCT01163617|528498550|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
146544074|NCT01163617|528498551|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
146544075|NCT01163617|528498544|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
146544076|NCT01163617|528498545|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
146544077|NCT01163617|528498546|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
146544078|NCT01163617|528498547|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
146544079|NCT01163617|528498548|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
146544080|NCT01163617|528498549|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
146544081|NCT01163617|528498550|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
146544082|NCT01163617|528498551|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
146544083|NCT02875080|528498552|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
146544084|NCT02875080|528498553|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
146628896|NCT00906204|528818282|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
146875003|NCT02819635|529712689|FG008|Substudy 3|Other, not specified|202|||
146544085|NCT02875080|528498554|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
146544086|NCT02394756|528498555|FG000|Period 1|Lens Discomfort|0|||
146544087|NCT02394756|528498556|FG001|Period 1|Lens Discomfort|0|||
146875004|NCT02819635|529712690|FG009|Substudy 3|Other, not specified|5|||
146875005|NCT02819635|529712691|FG010|Substudy 3|Other, not specified|89|||
146875006|NCT02819635|529712692|FG011|Substudy 3|Other, not specified|39|||
146875007|NCT03179891|529712697|FG000|First Intervention|Withdrawal by Subject|1|||
146875008|NCT03179891|529712698|FG001|First Intervention|Withdrawal by Subject|1|||
146544088|NCT02394756|528498557|FG002|Period 1|Lens Discomfort|0|||
146875009|NCT03179891|529712697|FG000|First Intervention|Unspecified reason|1|||
146875010|NCT03179891|529712698|FG001|First Intervention|Unspecified reason|0|||
146875011|NCT03179891|529712697|FG000|First Intervention|Protocol Violation|0|||
146875012|NCT03179891|529712698|FG001|First Intervention|Protocol Violation|1|||
146875013|NCT02969187|529712699|FG000|Overall Study|Physician Decision|12|||
146875014|NCT02969187|529712700|FG001|Overall Study|Physician Decision|13|||
146875015|NCT03719690|529712703|FG000|Overall Study|Withdrawal by Subject|5|||
146875016|NCT03719690|529712704|FG001|Overall Study|Withdrawal by Subject|10|||
146875017|NCT03719690|529712703|FG000|Overall Study|Death|40|||
146875018|NCT03719690|529712704|FG001|Overall Study|Death|149|||
146875019|NCT03719690|529712703|FG000|Overall Study|Miscellaneous|12|||
146875020|NCT03719690|529712704|FG001|Overall Study|Miscellaneous|56|||
146875021|NCT03719690|529712703|FG000|Overall Study|Lost to Follow-up|2|||
146875022|NCT03719690|529712704|FG001|Overall Study|Lost to Follow-up|18|||
146875023|NCT03719690|529712703|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
146875024|NCT03719690|529712704|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
146875025|NCT01471015|529712705|FG000|Overall Study|Death|0|||
146875026|NCT01471015|529712706|FG001|Overall Study|Death|1|||
146875027|NCT01471015|529712707|FG002|Overall Study|Death|1|||
146875028|NCT01843842|529712713|FG000|Overall Study|Do not meet inclusion criteria|1|||
146875029|NCT01843842|529712714|FG001|Overall Study|Do not meet inclusion criteria|1|||
146875030|NCT02953340|529712715|FG000|Overall Study|Death|0|||
146875031|NCT02953340|529712716|FG001|Overall Study|Death|1|||
146875032|NCT02953340|529712715|FG000|Overall Study|Investigator Decision|3|||
146875033|NCT02953340|529712716|FG001|Overall Study|Investigator Decision|3|||
146875034|NCT02953340|529712715|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
146875035|NCT02953340|529712716|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
146875036|NCT02953340|529712715|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
146875037|NCT02953340|529712716|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
146875038|NCT02953340|529712715|FG000|Overall Study|Withdrawal by Subject|9|||
146875039|NCT02953340|529712716|FG001|Overall Study|Withdrawal by Subject|9|||
146875040|NCT02953340|529712715|FG000|Overall Study|Sponsor decision|0|||
146875041|NCT02953340|529712716|FG001|Overall Study|Sponsor decision|2|||
146875042|NCT02953340|529712715|FG000|Overall Study|Lost to Follow-up|3|||
146875043|NCT02953340|529712716|FG001|Overall Study|Lost to Follow-up|2|||
146875044|NCT02953340|529712715|FG000|Overall Study|Reason not specified|2|||
146875045|NCT02953340|529712716|FG001|Overall Study|Reason not specified|2|||
146875046|NCT01376778|529712717|FG000|Overall Study|Lost to Follow-up|3|||
146875047|NCT01376778|529712718|FG001|Overall Study|Lost to Follow-up|2|||
146875048|NCT01197521|529712722|FG000|Overall Study|Not reported|24|||
146875049|NCT01197521|529712723|FG001|Overall Study|Not reported|25|||
146875050|NCT01197521|529712724|FG002|Overall Study|Not reported|21|||
146875051|NCT01197521|529712722|FG000|Overall Study|Enrolment in long term extension|42|||
146875052|NCT01197521|529712723|FG001|Overall Study|Enrolment in long term extension|36|||
146875053|NCT01197521|529712724|FG002|Overall Study|Enrolment in long term extension|87|||
146875054|NCT01197521|529712722|FG000|Overall Study|Severe non-compliance to protocol|1|||
146875055|NCT01197521|529712723|FG001|Overall Study|Severe non-compliance to protocol|3|||
146875056|NCT01197521|529712724|FG002|Overall Study|Severe non-compliance to protocol|3|||
146875057|NCT01197521|529712722|FG000|Overall Study|Lack of therapeutic response|2|||
146875058|NCT01197521|529712723|FG001|Overall Study|Lack of therapeutic response|3|||
146875059|NCT01197521|529712724|FG002|Overall Study|Lack of therapeutic response|4|||
146875060|NCT01197521|529712722|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
146875061|NCT01197521|529712723|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
146875062|NCT01197521|529712724|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
146875063|NCT01197521|529712722|FG000|Overall Study|Lost to Follow-up|3|||
146875064|NCT01197521|529712723|FG001|Overall Study|Lost to Follow-up|2|||
146875065|NCT01197521|529712724|FG002|Overall Study|Lost to Follow-up|2|||
146875066|NCT01197521|529712722|FG000|Overall Study|Adverse Event|25|||
146875067|NCT01197521|529712723|FG001|Overall Study|Adverse Event|28|||
146875068|NCT01197521|529712724|FG002|Overall Study|Adverse Event|24|||
146875069|NCT00271596|529712727|FG000|Overall Study|Protocol Violation|1|||
146875070|NCT00271596|529712728|FG001|Overall Study|Protocol Violation|0|||
146875071|NCT00271596|529712727|FG000|Overall Study|Withdrawal by Subject|0|||
146875072|NCT00271596|529712728|FG001|Overall Study|Withdrawal by Subject|1|||
146875073|NCT04707157|529712729|FG000|Overall Study|Adverse Event|12|||
146875074|NCT04707157|529712730|FG001|Overall Study|Adverse Event|3|||
146875075|NCT04707157|529712729|FG000|Overall Study|Lost to Follow-up|2|||
146875076|NCT04707157|529712730|FG001|Overall Study|Lost to Follow-up|0|||
146875077|NCT04707157|529712729|FG000|Overall Study|Sponsor's decision|1|||
146875078|NCT04707157|529712730|FG001|Overall Study|Sponsor's decision|0|||
146544089|NCT02394756|528498558|FG003|Period 1|Lens Discomfort|0|||
146875079|NCT04707157|529712729|FG000|Overall Study|Physician Decision|8|||
146875080|NCT04707157|529712730|FG001|Overall Study|Physician Decision|5|||
146544090|NCT02394756|528498559|FG004|Period 1|Lens Discomfort|0|||
146875081|NCT04707157|529712729|FG000|Overall Study|Protocol Deviation|1|||
146544091|NCT02394756|528498560|FG005|Period 1|Lens Discomfort|1|||
146875082|NCT04707157|529712730|FG001|Overall Study|Protocol Deviation|0|||
146875083|NCT04707157|529712729|FG000|Overall Study|Withdrawal by Subject|1|||
146875084|NCT04707157|529712730|FG001|Overall Study|Withdrawal by Subject|1|||
146875085|NCT05879107|529712733|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
146875086|NCT05879107|529712734|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
146875087|NCT05879107|529712733|FG000|Overall Study|Migrated / moved from the study area|1|||
146875088|NCT05879107|529712734|FG001|Overall Study|Migrated / moved from the study area|1|||
146875089|NCT05879107|529712733|FG000|Overall Study|Lost to Follow-up|8|||
146875090|NCT05879107|529712734|FG001|Overall Study|Lost to Follow-up|13|||
146875091|NCT05879107|529712733|FG000|Overall Study|Death|0|||
146875092|NCT05879107|529712734|FG001|Overall Study|Death|2|||
146875093|NCT05879107|529712733|FG000|Overall Study|Other|0|||
146875094|NCT05879107|529712734|FG001|Overall Study|Other|3|||
146875095|NCT03710486|529712740|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
146875096|NCT03710486|529712741|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
146875097|NCT03710486|529712740|FG000|Overall Study|Missing|0|||
146875098|NCT03710486|529712741|FG001|Overall Study|Missing|2|||
146875099|NCT01744665|529712748|FG000|Monitoring Phase|Adverse Event|4|||
146875100|NCT01744665|529712748|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
146875101|NCT01744665|529712748|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
146875102|NCT01744665|529712748|FG000|Monitoring Phase|Withdrawal by Subject|5|||
146875103|NCT01744665|529712748|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
146875104|NCT01744665|529712748|FG000|Consolidation Phase|Adverse Event|2|||
146875105|NCT01744665|529712748|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
146875106|NCT01744665|529712748|FG000|Consolidation Phase|Withdrawal by Subject|4|||
146875107|NCT01744665|529712748|FG000|Consolidation Phase|Administrative problems|9|||
146875108|NCT01744665|529712748|FG000|Re-initiation Phase|Administrative problems|10|||
146875109|NCT01744665|529712748|FG000|Re-initiation Phase|Adverse Event|1|||
146875110|NCT01744665|529712748|FG000|Re-initiation Phase|No longer required treatment|1|||
146875111|NCT01744665|529712748|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
146875112|NCT01045798|529712750|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
146875113|NCT01045798|529712751|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
146875114|NCT01045798|529712750|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
146875115|NCT01045798|529712751|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
146875116|NCT01045798|529712750|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
146875117|NCT01045798|529712751|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
146875118|NCT01045798|529712750|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
146875119|NCT01045798|529712751|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
146875120|NCT05419128|529712752|FG000|Overall Study|Withdrawal by Subject|1|||
146875121|NCT05419128|529712753|FG001|Overall Study|Withdrawal by Subject|1|||
146875122|NCT05419128|529712754|FG002|Overall Study|Withdrawal by Subject|0|||
146875123|NCT05419128|529712755|FG003|Overall Study|Withdrawal by Subject|1|||
146875124|NCT05419128|529712756|FG004|Overall Study|Withdrawal by Subject|1|||
146875125|NCT05419128|529712757|FG005|Overall Study|Withdrawal by Subject|0|||
146875126|NCT05419128|529712752|FG000|Overall Study|Lost to Follow-up|0|||
146875127|NCT05419128|529712753|FG001|Overall Study|Lost to Follow-up|0|||
146875128|NCT05419128|529712754|FG002|Overall Study|Lost to Follow-up|1|||
146875129|NCT05419128|529712755|FG003|Overall Study|Lost to Follow-up|0|||
146875130|NCT05419128|529712756|FG004|Overall Study|Lost to Follow-up|0|||
146875131|NCT05419128|529712757|FG005|Overall Study|Lost to Follow-up|1|||
146875132|NCT04506086|529712758|FG000|Overall Study|Withdrawal by Subject|2|||
146875133|NCT02321930|529712764|FG000|Overall Study|Lost to Follow-up|1|||
146875134|NCT01293968|529712765|FG000|Overall Study|non-cooperation|3|||
146875135|NCT01293968|529712766|FG001|Overall Study|non-cooperation|3|||
146544092|NCT02394756|528498555|FG000|Period 1|Withdrawal by Subject|0|||
146544093|NCT02394756|528498556|FG001|Period 1|Withdrawal by Subject|1|||
146544094|NCT02394756|528498557|FG002|Period 1|Withdrawal by Subject|1|||
146544095|NCT02394756|528498558|FG003|Period 1|Withdrawal by Subject|1|||
146544096|NCT02394756|528498559|FG004|Period 1|Withdrawal by Subject|0|||
146544097|NCT02394756|528498560|FG005|Period 1|Withdrawal by Subject|0|||
146544098|NCT02394756|528498555|FG000|Period 2|Unsatisfactory Visual Response|0|||
146544099|NCT02394756|528498556|FG001|Period 2|Unsatisfactory Visual Response|0|||
146544100|NCT02394756|528498557|FG002|Period 2|Unsatisfactory Visual Response|0|||
146544101|NCT02394756|528498558|FG003|Period 2|Unsatisfactory Visual Response|0|||
146544102|NCT02394756|528498559|FG004|Period 2|Unsatisfactory Visual Response|1|||
146544103|NCT02394756|528498560|FG005|Period 2|Unsatisfactory Visual Response|0|||
146544104|NCT00768053|528498561|FG000|Overall Study|Adverse Event|10|||
146875136|NCT03996876|529712767|FG000|Overall Study|Incomplete Data|2|||
146875137|NCT03996876|529712768|FG001|Overall Study|Incomplete Data|4|||
146875138|NCT00597753|529712773|FG000|Overall Study|Adverse Event|6|||
146544105|NCT00768053|528498561|FG000|Overall Study|Lost to Follow-up|1|||
146544106|NCT01164475|528498562|FG000|Overall Study|Lack of Efficacy|1|||
146544107|NCT01164475|528498563|FG001|Overall Study|Lack of Efficacy|0|||
146875139|NCT00597753|529712774|FG001|Overall Study|Adverse Event|2|||
146875140|NCT00597753|529712773|FG000|Overall Study|Death|55|||
146875141|NCT00597753|529712774|FG001|Overall Study|Death|29|||
146875142|NCT00597753|529712773|FG000|Overall Study|Lack of Efficacy|2|||
146875143|NCT00597753|529712774|FG001|Overall Study|Lack of Efficacy|0|||
146875144|NCT00597753|529712773|FG000|Overall Study|Lost to Follow-up|10|||
146875145|NCT00597753|529712774|FG001|Overall Study|Lost to Follow-up|3|||
146875146|NCT00597753|529712773|FG000|Overall Study|Physician Decision|5|||
146875147|NCT00597753|529712774|FG001|Overall Study|Physician Decision|1|||
146875148|NCT00597753|529712773|FG000|Overall Study|Pregnancy|1|||
146875149|NCT00597753|529712774|FG001|Overall Study|Pregnancy|0|||
146875150|NCT00597753|529712773|FG000|Overall Study|Withdrawal by Subject|35|||
146875151|NCT00597753|529712774|FG001|Overall Study|Withdrawal by Subject|12|||
146875152|NCT00597753|529712773|FG000|Overall Study|Discontinued Dialysis|0|||
146875153|NCT00597753|529712774|FG001|Overall Study|Discontinued Dialysis|1|||
146875154|NCT00597753|529712773|FG000|Overall Study|Never dosed|2|||
146875155|NCT00597753|529712774|FG001|Overall Study|Never dosed|0|||
146875156|NCT00597753|529712773|FG000|Overall Study|Noncompliance|2|||
146875157|NCT00597753|529712774|FG001|Overall Study|Noncompliance|1|||
146875158|NCT00597753|529712773|FG000|Overall Study|Relocation|17|||
146875159|NCT00597753|529712774|FG001|Overall Study|Relocation|6|||
146875160|NCT00597753|529712773|FG000|Overall Study|Renal transplant|10|||
146875161|NCT00597753|529712774|FG001|Overall Study|Renal transplant|3|||
146875162|NCT00597753|529712773|FG000|Overall Study|Site closed by sponsor|19|||
146875163|NCT00597753|529712774|FG001|Overall Study|Site closed by sponsor|7|||
146875164|NCT00597753|529712773|FG000|Overall Study|Site elected to close|2|||
146875165|NCT00597753|529712774|FG001|Overall Study|Site elected to close|4|||
146875166|NCT00388973|529714511|FG000|Overall Study|Adverse Event|16|||
146875167|NCT00388973|529714512|FG001|Overall Study|Adverse Event|6|||
146875168|NCT00388973|529714511|FG000|Overall Study|Lack of Efficacy|1|||
146875169|NCT00388973|529714512|FG001|Overall Study|Lack of Efficacy|12|||
146875170|NCT00388973|529714511|FG000|Overall Study|Protocol Violation|3|||
146875171|NCT00388973|529714512|FG001|Overall Study|Protocol Violation|0|||
146875172|NCT00388973|529714511|FG000|Overall Study|Withdrawal by Subject|14|||
146875173|NCT00388973|529714512|FG001|Overall Study|Withdrawal by Subject|17|||
146875174|NCT00388973|529714511|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
146875175|NCT00388973|529714512|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
146875176|NCT00388973|529714511|FG000|Overall Study|Did not complete 61 days of treatment|5|||
146875177|NCT00388973|529714512|FG001|Overall Study|Did not complete 61 days of treatment|4|||
146875178|NCT00388973|529714511|FG000|Overall Study|Left region|0|||
146875179|NCT00388973|529714512|FG001|Overall Study|Left region|1|||
146875180|NCT00388973|529714511|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
146875181|NCT00388973|529714512|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
146875182|NCT01652885|529714525|FG000|Overall Study|Adverse Event|1|||
146875183|NCT00075400|529714526|FG000|Overall Study|Ineligible: wrong primary|1|||
146875184|NCT00075400|529714526|FG000|Overall Study|Never treated|2|||
146875185|NCT03723707|529714528|FG000|Overall Study|Death|32|||
146875186|NCT03723707|529714529|FG001|Overall Study|Death|32|||
146875187|NCT03723707|529714528|FG000|Overall Study|Admitted to long term care|12|||
146875188|NCT03723707|529714529|FG001|Overall Study|Admitted to long term care|12|||
146875189|NCT03723707|529714528|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
146875190|NCT03723707|529714529|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
146875191|NCT03723707|529714528|FG000|Overall Study|Lost to Follow-up|40|||
146875192|NCT03723707|529714529|FG001|Overall Study|Lost to Follow-up|22|||
146875193|NCT03723707|529714528|FG000|Overall Study|Discontinued after study closure|24|||
146875194|NCT03723707|529714529|FG001|Overall Study|Discontinued after study closure|12|||
146875195|NCT04342871|529714530|FG000|Overall Study|Death|4|||
146875196|NCT04342871|529714530|FG000|Overall Study|Clinical deterioration/illness progression|2|||
146875197|NCT04342871|529714530|FG000|Overall Study|Did not complete baseline assessments|5|||
146875198|NCT04342871|529714530|FG000|Overall Study|Lost to Follow-up|13|||
146875199|NCT00666458|529714531|FG000|Overall Study|Adverse Event|8|||
146875200|NCT00666458|529714532|FG001|Overall Study|Adverse Event|7|||
146875201|NCT00666458|529714531|FG000|Overall Study|Withdrawal by Subject|5|||
146875202|NCT00666458|529714532|FG001|Overall Study|Withdrawal by Subject|4|||
146875203|NCT00666458|529714531|FG000|Overall Study|Lost to Follow-up|0|||
146875204|NCT00666458|529714532|FG001|Overall Study|Lost to Follow-up|3|||
146875205|NCT00666458|529714531|FG000|Overall Study|Administrative reason by sponsor|1|||
146875206|NCT00666458|529714532|FG001|Overall Study|Administrative reason by sponsor|1|||
146875207|NCT00666458|529714531|FG000|Overall Study|Incorrect enrollment|7|||
146875208|NCT00666458|529714532|FG001|Overall Study|Incorrect enrollment|1|||
146875209|NCT00666458|529714531|FG000|Overall Study|Study specific discontinuation criteria|14|||
146875210|NCT00666458|529714532|FG001|Overall Study|Study specific discontinuation criteria|7|||
146875211|NCT00666458|529714531|FG000|Overall Study|Severe non-compliance to the protocol|1|||
146875212|NCT00666458|529714532|FG001|Overall Study|Severe non-compliance to the protocol|1|||
146875213|NCT00666458|529714531|FG000|Overall Study|Safety reasons|1|||
146875214|NCT00666458|529714532|FG001|Overall Study|Safety reasons|0|||
146875215|NCT00666458|529714531|FG000|Overall Study|Medical history of anemia|1|||
146544108|NCT01164475|528498562|FG000|Overall Study|Other|0|||
146544109|NCT01164475|528498563|FG001|Overall Study|Other|1|||
146875216|NCT00666458|529714532|FG001|Overall Study|Medical history of anemia|0|||
146875217|NCT02222207|529714533|FG000|Overall Study|Death|1|||
146875218|NCT02222207|529714533|FG000|Overall Study|Other reasons|2|||
146875219|NCT02222207|529714533|FG000|Overall Study|Adverse Event|1|||
146875220|NCT04682405|529714535|FG000|Overall Study|Adverse Event|0|||
146875221|NCT04682405|529714536|FG001|Overall Study|Adverse Event|1|||
146875222|NCT01429584|529714540|FG000|Overall Study|Withdrawal by Subject|1|||
146875223|NCT01429584|529714541|FG001|Overall Study|Withdrawal by Subject|0|||
146875224|NCT01429584|529714540|FG000|Overall Study|Protocol Violation|0|||
146875225|NCT01429584|529714541|FG001|Overall Study|Protocol Violation|1|||
146875226|NCT00747643|529714542|FG000|Overall Study|Withdrawal by Subject|36|||
146875227|NCT00747643|529714543|FG001|Overall Study|Withdrawal by Subject|27|||
146875228|NCT00750698|529714544|FG000|Overall Study|Withdrawal by Subject|1|||
146875229|NCT00750698|529714545|FG001|Overall Study|Withdrawal by Subject|0|||
146875230|NCT00750698|529714544|FG000|Overall Study|Progressive disease|5|||
146875231|NCT00750698|529714545|FG001|Overall Study|Progressive disease|2|||
146875232|NCT03557281|529714546|FG000|Overall Study|Investigator discretion|0|||
146875233|NCT03557281|529714547|FG001|Overall Study|Investigator discretion|0|||
146875234|NCT03557281|529714548|FG002|Overall Study|Investigator discretion|1|||
146875235|NCT03557281|529714549|FG003|Overall Study|Investigator discretion|0|||
146875236|NCT03557281|529714550|FG004|Overall Study|Investigator discretion|0|||
146875237|NCT03557281|529714546|FG000|Overall Study|Withdrawal by Subject|0|||
146875238|NCT03557281|529714547|FG001|Overall Study|Withdrawal by Subject|1|||
146875239|NCT03557281|529714548|FG002|Overall Study|Withdrawal by Subject|1|||
146875240|NCT03557281|529714549|FG003|Overall Study|Withdrawal by Subject|1|||
146875241|NCT03557281|529714550|FG004|Overall Study|Withdrawal by Subject|2|||
146875242|NCT03557281|529714546|FG000|Overall Study|Randomized, but did not receive treatment|0|||
146875243|NCT03557281|529714547|FG001|Overall Study|Randomized, but did not receive treatment|0|||
146875244|NCT03557281|529714548|FG002|Overall Study|Randomized, but did not receive treatment|0|||
146875245|NCT03557281|529714549|FG003|Overall Study|Randomized, but did not receive treatment|0|||
146875246|NCT03557281|529714550|FG004|Overall Study|Randomized, but did not receive treatment|1|||
146875247|NCT01999465|529714551|FG000|Overall Study|Lost to Follow-up|0|||
146875248|NCT01999465|529714552|FG001|Overall Study|Lost to Follow-up|2|||
146875249|NCT01999465|529714551|FG000|Overall Study|Protocol Violation|0|||
146875250|NCT01999465|529714552|FG001|Overall Study|Protocol Violation|1|||
146875251|NCT00390546|529714562|FG000|Overall Study|Renal impairment|1|||
146875252|NCT00390546|529714563|FG001|Overall Study|Renal impairment|0|||
146875253|NCT00390546|529714562|FG000|Overall Study|Physician Decision|5|||
146875254|NCT00390546|529714563|FG001|Overall Study|Physician Decision|5|||
146875255|NCT01308008|529714564|FG000|4 Weeks|Illness, disinterest, time|9|||
146875256|NCT01308008|529714565|FG001|4 Weeks|Illness, disinterest, time|2|||
146875257|NCT01417195|529714566|FG000|Overall Study|Stimulation failure|1|||
146875258|NCT01417195|529714567|FG001|Overall Study|Stimulation failure|0|||
146875259|NCT01417195|529714566|FG000|Overall Study|No embryos for transfer|0|||
146875260|NCT01417195|529714567|FG001|Overall Study|No embryos for transfer|1|||
146875261|NCT01417195|529714566|FG000|Overall Study|No transfer due to risk of OHSS|1|||
146875262|NCT01417195|529714567|FG001|Overall Study|No transfer due to risk of OHSS|0|||
146875263|NCT01417195|529714566|FG000|Overall Study|No transfer due to elevated progesterone|1|||
146875264|NCT01417195|529714567|FG001|Overall Study|No transfer due to elevated progesterone|0|||
146875265|NCT03357731|529714568|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
146875266|NCT03357731|529714569|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
146875267|NCT03357731|529714570|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
146875268|NCT03357731|529714571|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
146875269|NCT03357731|529714572|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
146875270|NCT03357731|529714573|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
146875271|NCT03357731|529714568|FG000|Overall Study|Acute bradycardia and hypotension|0|||
146875272|NCT03357731|529714569|FG001|Overall Study|Acute bradycardia and hypotension|0|||
146875273|NCT03357731|529714570|FG002|Overall Study|Acute bradycardia and hypotension|0|||
146875274|NCT03357731|529714571|FG003|Overall Study|Acute bradycardia and hypotension|1|||
146875275|NCT03357731|529714572|FG004|Overall Study|Acute bradycardia and hypotension|0|||
146875276|NCT03357731|529714573|FG005|Overall Study|Acute bradycardia and hypotension|0|||
146875277|NCT03357731|529714568|FG000|Overall Study|Adverse Event|0|||
146875278|NCT03357731|529714569|FG001|Overall Study|Adverse Event|0|||
146875279|NCT03357731|529714570|FG002|Overall Study|Adverse Event|0|||
146875280|NCT03357731|529714571|FG003|Overall Study|Adverse Event|0|||
146875281|NCT03357731|529714572|FG004|Overall Study|Adverse Event|0|||
146875282|NCT03357731|529714573|FG005|Overall Study|Adverse Event|1|||
146875283|NCT03357731|529714568|FG000|Overall Study|Hypotension|0|||
146875284|NCT03357731|529714569|FG001|Overall Study|Hypotension|0|||
146875285|NCT03357731|529714570|FG002|Overall Study|Hypotension|1|||
146875286|NCT03357731|529714571|FG003|Overall Study|Hypotension|1|||
146875287|NCT03357731|529714572|FG004|Overall Study|Hypotension|0|||
146875288|NCT03357731|529714573|FG005|Overall Study|Hypotension|0|||
146875289|NCT03357731|529714568|FG000|Overall Study|Lost to Follow-up|0|||
146875290|NCT03357731|529714569|FG001|Overall Study|Lost to Follow-up|0|||
146875291|NCT03357731|529714570|FG002|Overall Study|Lost to Follow-up|0|||
146875292|NCT03357731|529714571|FG003|Overall Study|Lost to Follow-up|1|||
146875293|NCT03357731|529714572|FG004|Overall Study|Lost to Follow-up|0|||
146875294|NCT03357731|529714573|FG005|Overall Study|Lost to Follow-up|0|||
146875295|NCT02535715|529714578|FG000|Overall Study|Withdrawal by Subject|0|||
146875296|NCT02535715|529714579|FG001|Overall Study|Withdrawal by Subject|0|||
146875297|NCT02535715|529714580|FG002|Overall Study|Withdrawal by Subject|1|||
146875298|NCT00909181|529714581|FG000|Overall Study|Lost to Follow-up|39|||
146875299|NCT00909181|529714582|FG001|Overall Study|Lost to Follow-up|18|||
146875300|NCT00909181|529714583|FG002|Overall Study|Lost to Follow-up|33|||
146875301|NCT04353284|529714584|FG000|Overall Study|Adverse Event|1|||
146875302|NCT04353284|529714585|FG001|Overall Study|Adverse Event|1|||
146875303|NCT04353284|529714584|FG000|Overall Study|Lost to Follow-up|1|||
146875304|NCT04353284|529714585|FG001|Overall Study|Lost to Follow-up|0|||
146875305|NCT00530894|529714586|FG000|Overall Study|Death|84|||
146875306|NCT00530894|529714587|FG001|Overall Study|Death|89|||
146875307|NCT00530894|529714588|FG002|Overall Study|Death|55|||
146875308|NCT00530894|529714589|FG003|Overall Study|Death|89|||
146875309|NCT00530894|529714586|FG000|Overall Study|Lost to Follow-up|1|||
146875310|NCT00530894|529714587|FG001|Overall Study|Lost to Follow-up|3|||
146875311|NCT00530894|529714588|FG002|Overall Study|Lost to Follow-up|0|||
146875312|NCT00530894|529714589|FG003|Overall Study|Lost to Follow-up|0|||
146875313|NCT00530894|529714586|FG000|Overall Study|Withdrawal by Subject|1|||
146875314|NCT00530894|529714587|FG001|Overall Study|Withdrawal by Subject|23|||
146875315|NCT00530894|529714588|FG002|Overall Study|Withdrawal by Subject|0|||
146875316|NCT00530894|529714589|FG003|Overall Study|Withdrawal by Subject|5|||
146875317|NCT00530894|529714586|FG000|Overall Study|Alive and censored prior to 1 year|2|||
146875318|NCT00530894|529714587|FG001|Overall Study|Alive and censored prior to 1 year|0|||
146875319|NCT00530894|529714588|FG002|Overall Study|Alive and censored prior to 1 year|0|||
146875320|NCT00530894|529714589|FG003|Overall Study|Alive and censored prior to 1 year|0|||
146875321|NCT01349465|529714590|FG000|Overall Study|Adverse Event|1|||
146875322|NCT01349465|529714591|FG001|Overall Study|Adverse Event|0|||
146875323|NCT01349465|529714590|FG000|Overall Study|Death|3|||
146875324|NCT01349465|529714591|FG001|Overall Study|Death|0|||
146875325|NCT01349465|529714590|FG000|Overall Study|Lost to Follow-up|10|||
146875326|NCT01349465|529714591|FG001|Overall Study|Lost to Follow-up|1|||
146875327|NCT01349465|529714590|FG000|Overall Study|Withdrawal by Subject|4|||
146875328|NCT01349465|529714591|FG001|Overall Study|Withdrawal by Subject|2|||
146875329|NCT01349465|529714590|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
146875330|NCT01349465|529714591|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
146875331|NCT00928889|529714599|FG000|Overall Study|Lost to Follow-up|3|||
146875332|NCT00928889|529714600|FG001|Overall Study|Lost to Follow-up|1|||
146875333|NCT00928889|529714599|FG000|Overall Study|Protocol Violation|0|||
146875334|NCT00928889|529714600|FG001|Overall Study|Protocol Violation|1|||
146875335|NCT00928889|529714599|FG000|Overall Study|Adverse Event|1|||
146875336|NCT00928889|529714600|FG001|Overall Study|Adverse Event|0|||
146875337|NCT00928889|529714599|FG000|Overall Study|Other|1|||
146875338|NCT00928889|529714600|FG001|Overall Study|Other|0|||
146875339|NCT02375724|529714607|FG000|Overall Study|Lack of Efficacy|1|||
146875340|NCT02375724|529714608|FG001|Overall Study|Lack of Efficacy|1|||
146875341|NCT02375724|529714607|FG000|Overall Study|Withdrawal by Subject|1|||
146875342|NCT02375724|529714608|FG001|Overall Study|Withdrawal by Subject|1|||
146875343|NCT02375724|529714607|FG000|Overall Study|Lost to Follow-up|1|||
146875344|NCT02375724|529714608|FG001|Overall Study|Lost to Follow-up|0|||
146875345|NCT02375724|529714607|FG000|Overall Study|Protocol Violation|1|||
146875346|NCT02375724|529714608|FG001|Overall Study|Protocol Violation|0|||
146875347|NCT02375724|529714607|FG000|Overall Study|Adverse Event|2|||
146875348|NCT02375724|529714608|FG001|Overall Study|Adverse Event|4|||
146875349|NCT01517893|529714611|FG000|Overall Study|Withdrawal by Subject|3|||
146875350|NCT01517893|529714612|FG001|Overall Study|Withdrawal by Subject|0|||
146875351|NCT03462576|529714613|FG000|Overall Study|Protocol Violation|5|||
146544110|NCT01164475|528498562|FG000|Overall Study|Progressive disease|0|||
146544111|NCT01164475|528498563|FG001|Overall Study|Progressive disease|1|||
146875352|NCT03462576|529714614|FG001|Overall Study|Protocol Violation|11|||
146875353|NCT03462576|529714615|FG002|Overall Study|Protocol Violation|7|||
146875354|NCT03462576|529714613|FG000|Overall Study|Device Malfunction|0|||
146875355|NCT03462576|529714614|FG001|Overall Study|Device Malfunction|0|||
146875356|NCT03462576|529714615|FG002|Overall Study|Device Malfunction|1|||
146875357|NCT01543828|529714618|FG000|Treatment 2|Lost to Follow-up|1|||
146875358|NCT01543828|529714619|FG001|Treatment 2|Lost to Follow-up|0|||
146875359|NCT01069172|529714620|FG000|Overall Study|Withdrawal by Subject|1|||
146875360|NCT01069172|529714621|FG001|Overall Study|Withdrawal by Subject|0|||
146875361|NCT00711425|529714625|FG000|Overall Study|Protocol Violation|1|||
146875362|NCT00711425|529714625|FG000|Overall Study|Death|2|||
146875363|NCT00711425|529714625|FG000|Overall Study|Lost to Follow-up|1|||
146875364|NCT03901079|529714628|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
146875365|NCT00804570|529714631|FG000|Overall Study|Adverse Event|14|||
146875366|NCT00804570|529714632|FG001|Overall Study|Adverse Event|7|||
146875367|NCT00804570|529714631|FG000|Overall Study|Lack of Efficacy|0|||
146875368|NCT00804570|529714632|FG001|Overall Study|Lack of Efficacy|1|||
146764792|NCT01806714|529305910|FG000|Overall Study|No functioning phone number|200|||
146764793|NCT01806714|529305911|FG001|Overall Study|No functioning phone number|170|||
146764794|NCT02155829|529305912|FG000|Overall Study|Adverse Event|1|||
146764795|NCT02155829|529305913|FG001|Overall Study|Adverse Event|0|||
146764796|NCT02155829|529305912|FG000|Overall Study|Withdrawal by Subject|3|||
146764797|NCT02155829|529305913|FG001|Overall Study|Withdrawal by Subject|3|||
146764798|NCT02155829|529305912|FG000|Overall Study|Protocol Violation|2|||
146764799|NCT02155829|529305913|FG001|Overall Study|Protocol Violation|0|||
146764800|NCT04107805|529305916|FG000|Overall Study|Adverse Event|0|||
146764801|NCT04107805|529305917|FG001|Overall Study|Adverse Event|0|||
146875369|NCT00804570|529714631|FG000|Overall Study|Lost to Follow-up|18|||
146875370|NCT00804570|529714632|FG001|Overall Study|Lost to Follow-up|21|||
146875371|NCT00804570|529714631|FG000|Overall Study|Entry criteria not met|5|||
146875372|NCT00804570|529714632|FG001|Overall Study|Entry criteria not met|5|||
146875373|NCT00804570|529714631|FG000|Overall Study|Protocol Violation|12|||
146875374|NCT00804570|529714632|FG001|Overall Study|Protocol Violation|16|||
146875375|NCT00804570|529714631|FG000|Overall Study|Physician Decision|1|||
146875376|NCT00804570|529714632|FG001|Overall Study|Physician Decision|2|||
146875377|NCT00804570|529714631|FG000|Overall Study|Sponsor decision|1|||
146875378|NCT00804570|529714632|FG001|Overall Study|Sponsor decision|4|||
146875379|NCT00804570|529714631|FG000|Overall Study|Withdrawal by Subject|21|||
146875380|NCT00804570|529714632|FG001|Overall Study|Withdrawal by Subject|38|||
146875381|NCT00290342|529714633|FG000|Overall Study|Other|0|||
146875382|NCT00290342|529714634|FG001|Overall Study|Other|1|||
146875383|NCT00290342|529714633|FG000|Overall Study|Withdrawal by Subject|6|||
146875384|NCT00290342|529714634|FG001|Overall Study|Withdrawal by Subject|4|||
146875385|NCT00290342|529714633|FG000|Overall Study|Lost to Follow-up|1|||
146875386|NCT00290342|529714634|FG001|Overall Study|Lost to Follow-up|0|||
146875387|NCT01056510|529714637|FG000|Overall Study|Dropout Before Start of Treatment|1|||
146875388|NCT01056510|529714638|FG001|Overall Study|Dropout Before Start of Treatment|1|||
146875389|NCT01056510|529714637|FG000|Overall Study|Withdrawal by Subject|4|||
146875390|NCT01056510|529714638|FG001|Overall Study|Withdrawal by Subject|2|||
146875391|NCT01056510|529714637|FG000|Overall Study|Death|29|||
146875392|NCT01056510|529714638|FG001|Overall Study|Death|34|||
146875393|NCT01056510|529714637|FG000|Overall Study|Noncompliance|1|||
146875394|NCT01056510|529714638|FG001|Overall Study|Noncompliance|3|||
146875395|NCT01056510|529714637|FG000|Overall Study|Physician Decision|4|||
146875396|NCT01056510|529714638|FG001|Overall Study|Physician Decision|5|||
146875397|NCT01056510|529714637|FG000|Overall Study|Lost to Follow-up|5|||
146875398|NCT01056510|529714638|FG001|Overall Study|Lost to Follow-up|6|||
146875399|NCT01056510|529714637|FG000|Overall Study|Other|10|||
146875400|NCT01056510|529714638|FG001|Overall Study|Other|12|||
146544112|NCT01164475|528498562|FG000|Overall Study|Protocol Violation|1|||
146544113|NCT01164475|528498563|FG001|Overall Study|Protocol Violation|0|||
146544114|NCT02335944|528498564|FG000|Treatment Phase|Progressive Disease|2|||
146764802|NCT04107805|529305918|FG002|Overall Study|Adverse Event|0|||
146544115|NCT02335944|528498565|FG001|Treatment Phase|Progressive Disease|5|||
146544116|NCT02335944|528498566|FG002|Treatment Phase|Progressive Disease|2|||
146544117|NCT02335944|528498567|FG003|Treatment Phase|Progressive Disease|11|||
146764803|NCT04107805|529305919|FG003|Overall Study|Adverse Event|1|||
146764804|NCT04107805|529305920|FG004|Overall Study|Adverse Event|0|||
146764805|NCT04107805|529305921|FG005|Overall Study|Adverse Event|1|||
146764806|NCT04107805|529305922|FG006|Overall Study|Adverse Event|0|||
146764807|NCT04107805|529305923|FG007|Overall Study|Adverse Event|0|||
146764808|NCT04107805|529305924|FG008|Overall Study|Adverse Event|1|||
146764809|NCT00404079|529305928|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
146764810|NCT00404079|529305929|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
146764811|NCT01120275|529305930|FG000|Overall Study|Adverse Event|3|||
146764812|NCT01120275|529305930|FG000|Overall Study|Progression|27|||
146764813|NCT01120275|529305930|FG000|Overall Study|Ineligible|3|||
146764814|NCT01120275|529305930|FG000|Overall Study|Withdrawal by Subject|1|||
146764815|NCT01120275|529305930|FG000|Overall Study|Refusal|1|||
146764816|NCT01120275|529305930|FG000|Overall Study|Not specific|1|||
146764817|NCT00771849|529305931|FG000|Overall Study|Lost to Follow-up|1|||
146764818|NCT00771849|529305932|FG001|Overall Study|Lost to Follow-up|2|||
146764819|NCT00771849|529305931|FG000|Overall Study|Withdrawal by Subject|1|||
146764820|NCT00771849|529305932|FG001|Overall Study|Withdrawal by Subject|1|||
146764821|NCT00771849|529305931|FG000|Overall Study|Not vaccinated|0|||
146764822|NCT00771849|529305932|FG001|Overall Study|Not vaccinated|1|||
146764823|NCT02736799|529305936|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
146764824|NCT02736799|529305937|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
146764825|NCT02736799|529305938|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
146764826|NCT02736799|529305939|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
146764827|NCT00197015|529305940|FG000|Overall Study|Adverse Event|3|||
146764828|NCT00197015|529305941|FG001|Overall Study|Adverse Event|0|||
146764829|NCT00197015|529305942|FG002|Overall Study|Adverse Event|1|||
146875401|NCT01056510|529714637|FG000|Overall Study|Missing|0|||
146875402|NCT01056510|529714638|FG001|Overall Study|Missing|1|||
146875403|NCT00912028|529714641|FG000|Overall Study|Lost to Follow-up|2|||
146875404|NCT00912028|529714642|FG001|Overall Study|Lost to Follow-up|3|||
146875405|NCT00912028|529714643|FG002|Overall Study|Lost to Follow-up|0|||
146875406|NCT00912028|529714644|FG003|Overall Study|Lost to Follow-up|1|||
146875407|NCT00912028|529714645|FG004|Overall Study|Lost to Follow-up|3|||
146875408|NCT00912028|529714641|FG000|Overall Study|Withdrawal by Subject|3|||
146875409|NCT00912028|529714642|FG001|Overall Study|Withdrawal by Subject|0|||
146875410|NCT00912028|529714643|FG002|Overall Study|Withdrawal by Subject|0|||
146875411|NCT00912028|529714644|FG003|Overall Study|Withdrawal by Subject|0|||
146875412|NCT00912028|529714645|FG004|Overall Study|Withdrawal by Subject|0|||
146875413|NCT03418129|529714648|FG000|Overall Study|Lost to Follow-up|11|||
146875414|NCT03418129|529714649|FG001|Overall Study|Lost to Follow-up|20|||
146875415|NCT03418129|529714650|FG002|Overall Study|Lost to Follow-up|15|||
146875416|NCT03418129|529714648|FG000|Overall Study|Withdrawal by Subject|3|||
146875417|NCT03418129|529714649|FG001|Overall Study|Withdrawal by Subject|6|||
146875418|NCT03418129|529714650|FG002|Overall Study|Withdrawal by Subject|4|||
146875419|NCT01617070|529714654|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
146875420|NCT00942175|529714655|FG000|Overall Study|Adverse Event|2|||
146875421|NCT00942175|529714656|FG001|Overall Study|Adverse Event|1|||
146875422|NCT00942175|529714657|FG002|Overall Study|Adverse Event|0|||
146875423|NCT00942175|529714658|FG003|Overall Study|Adverse Event|0|||
146875424|NCT00942175|529714655|FG000|Overall Study|Protocol Violation|0|||
146875425|NCT00942175|529714656|FG001|Overall Study|Protocol Violation|1|||
146875426|NCT00942175|529714657|FG002|Overall Study|Protocol Violation|2|||
146875427|NCT00942175|529714658|FG003|Overall Study|Protocol Violation|0|||
146875428|NCT00942175|529714655|FG000|Overall Study|Pregnancy|0|||
146875429|NCT00942175|529714656|FG001|Overall Study|Pregnancy|0|||
146875430|NCT00942175|529714657|FG002|Overall Study|Pregnancy|0|||
146875431|NCT00942175|529714658|FG003|Overall Study|Pregnancy|1|||
146875432|NCT00942175|529714655|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
146875433|NCT00942175|529714656|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
146875434|NCT00942175|529714657|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
146875435|NCT00942175|529714658|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
146875436|NCT00942175|529714655|FG000|Overall Study|Low Platelet Count|0|||
146875437|NCT00942175|529714656|FG001|Overall Study|Low Platelet Count|2|||
146875438|NCT00942175|529714657|FG002|Overall Study|Low Platelet Count|0|||
146875439|NCT00942175|529714658|FG003|Overall Study|Low Platelet Count|0|||
146875440|NCT01066585|529714659|FG000|Overall Study|Protocol Violation|1|||
146875441|NCT01066585|529714660|FG001|Overall Study|Protocol Violation|0|||
146875442|NCT01066585|529714659|FG000|Overall Study|Withdrawal by Subject|0|||
146875443|NCT01066585|529714660|FG001|Overall Study|Withdrawal by Subject|3|||
146875444|NCT00884273|529714663|FG000|Overall Study|Adverse Event|0|||
146875445|NCT00884273|529714664|FG001|Overall Study|Adverse Event|2|||
146875446|NCT00884273|529714663|FG000|Overall Study|Protocol Violation|1|||
146875447|NCT00884273|529714664|FG001|Overall Study|Protocol Violation|3|||
146875448|NCT00884273|529714663|FG000|Overall Study|Practical reasons|1|||
146875449|NCT00884273|529714664|FG001|Overall Study|Practical reasons|0|||
146875450|NCT01940471|529714665|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
146875451|NCT01940471|529714666|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
146875452|NCT01940471|529714667|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
146875453|NCT01940471|529714668|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
146875454|NCT01940471|529714665|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
146875455|NCT01940471|529714666|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
146875456|NCT01940471|529714667|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
146875457|NCT01940471|529714668|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
146875458|NCT01940471|529714665|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
146875459|NCT01940471|529714666|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
146875460|NCT01940471|529714667|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
146875461|NCT01940471|529714668|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
146875462|NCT01940471|529714665|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
146875463|NCT01940471|529714666|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
146875464|NCT01940471|529714667|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
146875465|NCT01940471|529714668|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
146875466|NCT01940471|529714665|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
146875467|NCT01940471|529714666|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
146875468|NCT01940471|529714667|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
146875469|NCT01940471|529714668|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
146875470|NCT01940471|529714665|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
146875471|NCT01940471|529714666|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
146875472|NCT01940471|529714667|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
146875473|NCT01940471|529714668|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
146875474|NCT01940471|529714665|FG000|Period 1: Double-blind Phase|Death|2|||
146875475|NCT01940471|529714666|FG001|Period 1: Double-blind Phase|Death|1|||
146875476|NCT01940471|529714667|FG002|Period 1: Double-blind Phase|Death|0|||
146875477|NCT01940471|529714668|FG003|Period 1: Double-blind Phase|Death|0|||
146875478|NCT01940471|529714665|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
146875479|NCT01940471|529714666|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
146875480|NCT01940471|529714667|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
146875481|NCT01940471|529714668|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
146875482|NCT01940471|529714665|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
146875483|NCT01940471|529714666|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
146875484|NCT01940471|529714667|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
146875485|NCT01940471|529714668|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
146875486|NCT01940471|529714665|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
146875487|NCT01940471|529714666|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
146875488|NCT01940471|529714667|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
146875489|NCT01940471|529714668|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
146875490|NCT01940471|529714665|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
146875491|NCT01940471|529714666|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
146875492|NCT01940471|529714667|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
146875493|NCT01940471|529714668|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
146875494|NCT01940471|529714665|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
146875495|NCT01940471|529714666|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
146875496|NCT01940471|529714667|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
146875497|NCT01940471|529714668|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
146875498|NCT01940471|529714665|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
146875499|NCT01940471|529714666|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
146875500|NCT01940471|529714667|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
146875501|NCT01940471|529714668|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
146875502|NCT01940471|529714665|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
146875503|NCT01940471|529714666|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
146875504|NCT01940471|529714667|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
146875505|NCT01940471|529714668|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
146875506|NCT01940471|529714665|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
146875507|NCT01940471|529714666|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
146875508|NCT01940471|529714667|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
146875509|NCT01940471|529714668|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
146875510|NCT01940471|529714665|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
146875511|NCT01940471|529714666|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
146875512|NCT01940471|529714667|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
146875513|NCT01940471|529714668|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
146875514|NCT01940471|529714665|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
146875515|NCT01940471|529714666|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
146875516|NCT01940471|529714667|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
146875517|NCT01940471|529714668|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
146875518|NCT01940471|529714665|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
146875519|NCT01940471|529714666|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
146875520|NCT01940471|529714667|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
146875521|NCT01940471|529714668|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
146875522|NCT01940471|529714665|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
146875523|NCT01940471|529714666|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
146875524|NCT01940471|529714667|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
146875525|NCT01940471|529714668|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
146875526|NCT01940471|529714665|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
146875527|NCT01940471|529714666|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
146875528|NCT01940471|529714667|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
146875529|NCT01940471|529714668|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
146875530|NCT01940471|529714665|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
146875531|NCT01940471|529714666|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
146875532|NCT01940471|529714667|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
146875533|NCT01940471|529714668|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
146875534|NCT00258674|529714669|FG000|Overall Study|Death|32|||
146875535|NCT00258674|529714670|FG001|Overall Study|Death|53|||
146875536|NCT00258674|529714671|FG002|Overall Study|Death|34|||
146875537|NCT03715153|529714672|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
146875538|NCT03715153|529714673|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
146875539|NCT03715153|529714672|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
146875540|NCT03715153|529714673|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
146875541|NCT03715153|529714672|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
146875542|NCT03715153|529714673|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
146875543|NCT03715153|529714672|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
146875544|NCT03715153|529714673|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
146875545|NCT03715153|529714672|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
146875546|NCT03715153|529714673|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
146875547|NCT03715153|529714672|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
146875548|NCT03715153|529714673|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
146875549|NCT02973087|529714676|FG000|Overall Study|Withdrawal by Subject|2|||
146875550|NCT02973087|529714677|FG001|Overall Study|Withdrawal by Subject|1|||
146875551|NCT02973087|529714676|FG000|Overall Study|Adverse Event|1|||
146875552|NCT02973087|529714677|FG001|Overall Study|Adverse Event|0|||
146875553|NCT02973087|529714676|FG000|Overall Study|other|1|||
146875554|NCT02973087|529714677|FG001|Overall Study|other|1|||
146875555|NCT02090413|529714689|FG000|Overall Study|Adverse Event|11|||
146875556|NCT02090413|529714690|FG001|Overall Study|Adverse Event|15|||
146875557|NCT02090413|529714691|FG002|Overall Study|Adverse Event|20|||
146875558|NCT02090413|529714689|FG000|Overall Study|Flushing event|2|||
146875559|NCT02090413|529714690|FG001|Overall Study|Flushing event|0|||
146875560|NCT02090413|529714691|FG002|Overall Study|Flushing event|1|||
146875561|NCT02090413|529714689|FG000|Overall Study|Withdrawal by Subject|2|||
146875562|NCT02090413|529714690|FG001|Overall Study|Withdrawal by Subject|2|||
146875563|NCT02090413|529714691|FG002|Overall Study|Withdrawal by Subject|2|||
146875564|NCT02090413|529714689|FG000|Overall Study|Investigator Decision|1|||
146875565|NCT02090413|529714690|FG001|Overall Study|Investigator Decision|1|||
146875566|NCT02090413|529714691|FG002|Overall Study|Investigator Decision|0|||
146875567|NCT02090413|529714689|FG000|Overall Study|Other|2|||
146875568|NCT02090413|529714690|FG001|Overall Study|Other|1|||
146875569|NCT02090413|529714691|FG002|Overall Study|Other|0|||
146875570|NCT02090413|529714689|FG000|Overall Study|Lost to Follow-up|1|||
146875571|NCT02090413|529714690|FG001|Overall Study|Lost to Follow-up|1|||
146875572|NCT02090413|529714691|FG002|Overall Study|Lost to Follow-up|0|||
146875573|NCT00402649|529716603|FG000|Overall Study|Lost to Follow-up|1|||
146875574|NCT00402649|529716603|FG000|Overall Study|Withdrawal by Subject|1|||
146875575|NCT01199042|529716604|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
146875576|NCT01199042|529716604|FG000|At Home (3 Months)|Lost to Follow-up|1|||
146875577|NCT01773109|529716605|FG000|Overall Study|Symptomatic Progression|2|||
146875578|NCT01773109|529716605|FG000|Overall Study|Death|1|||
146875579|NCT01239342|529716606|FG000|Overall Study|Adverse Event|1|||
146875580|NCT01239342|529716607|FG001|Overall Study|Adverse Event|0|||
146875581|NCT01239342|529716606|FG000|Overall Study|Withdrawal by Subject|1|||
146875582|NCT01239342|529716607|FG001|Overall Study|Withdrawal by Subject|5|||
146875583|NCT01239342|529716606|FG000|Overall Study|Reason Unknown|1|||
146875584|NCT01239342|529716607|FG001|Overall Study|Reason Unknown|1|||
146875585|NCT02325219|529716610|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
146875586|NCT02325219|529716611|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
146875587|NCT02325219|529716612|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
146875588|NCT02325219|529716613|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
146875589|NCT02325219|529716614|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
146875590|NCT02325219|529716610|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
146875591|NCT02325219|529716611|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
146875592|NCT02325219|529716612|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146875593|NCT02325219|529716613|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146875594|NCT02325219|529716614|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146875595|NCT02325219|529716610|FG000|Controlled Period (Week 0 - 16)|Other|0|||
146875596|NCT02325219|529716611|FG001|Controlled Period (Week 0 - 16)|Other|0|||
146875597|NCT02325219|529716612|FG002|Controlled Period (Week 0 - 16)|Other|1|||
146875598|NCT02325219|529716613|FG003|Controlled Period (Week 0 - 16)|Other|0|||
146875599|NCT02325219|529716614|FG004|Controlled Period (Week 0 - 16)|Other|0|||
146875600|NCT02325219|529716610|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
146875601|NCT02325219|529716611|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
146875602|NCT02325219|529716612|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
146875603|NCT02325219|529716613|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
146875604|NCT02325219|529716614|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
146875605|NCT02325219|529716610|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
146875606|NCT02325219|529716611|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
146875607|NCT02325219|529716612|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
146544118|NCT02335944|528498568|FG004|Treatment Phase|Progressive Disease|4|||
146875608|NCT02325219|529716613|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
146875609|NCT02325219|529716614|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
146875610|NCT02325219|529716610|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
146875611|NCT02325219|529716611|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
146875612|NCT02325219|529716612|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
146875613|NCT02325219|529716613|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
146875614|NCT02325219|529716614|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
146875615|NCT04036708|529716615|FG000|Overall Study|Lost to Follow-up|14|||
146875616|NCT04036708|529716616|FG001|Overall Study|Lost to Follow-up|4|||
146875617|NCT04036708|529716617|FG002|Overall Study|Lost to Follow-up|14|||
146875618|NCT04036708|529716618|FG003|Overall Study|Lost to Follow-up|4|||
146875619|NCT02918864|529716619|FG000|Overall Study|Withdrawal by Subject|1|||
146875620|NCT02918864|529716620|FG001|Overall Study|Withdrawal by Subject|1|||
146875621|NCT02918864|529716619|FG000|Overall Study|Lost to Follow-up|3|||
146544119|NCT02335944|528498569|FG005|Treatment Phase|Progressive Disease|25|||
146544120|NCT02335944|528498570|FG006|Treatment Phase|Progressive Disease|2|||
146544121|NCT02335944|528498571|FG007|Treatment Phase|Progressive Disease|30|||
146544122|NCT02335944|528498572|FG008|Treatment Phase|Progressive Disease|27|||
146544123|NCT02335944|528498573|FG009|Treatment Phase|Progressive Disease|0|||
146544124|NCT02335944|528498564|FG000|Treatment Phase|Adverse Event|2|||
146544125|NCT02335944|528498565|FG001|Treatment Phase|Adverse Event|0|||
146544126|NCT02335944|528498566|FG002|Treatment Phase|Adverse Event|0|||
146544127|NCT02335944|528498567|FG003|Treatment Phase|Adverse Event|2|||
146544128|NCT02335944|528498568|FG004|Treatment Phase|Adverse Event|1|||
146544129|NCT02335944|528498569|FG005|Treatment Phase|Adverse Event|15|||
146544130|NCT02335944|528498570|FG006|Treatment Phase|Adverse Event|0|||
146544131|NCT02335944|528498571|FG007|Treatment Phase|Adverse Event|5|||
146544132|NCT02335944|528498572|FG008|Treatment Phase|Adverse Event|7|||
146544133|NCT02335944|528498573|FG009|Treatment Phase|Adverse Event|0|||
146544134|NCT02335944|528498564|FG000|Treatment Phase|Physician Decision|0|||
146544135|NCT02335944|528498565|FG001|Treatment Phase|Physician Decision|0|||
146544136|NCT02335944|528498566|FG002|Treatment Phase|Physician Decision|0|||
146544137|NCT02335944|528498567|FG003|Treatment Phase|Physician Decision|1|||
146544138|NCT02335944|528498568|FG004|Treatment Phase|Physician Decision|0|||
146544139|NCT02335944|528498569|FG005|Treatment Phase|Physician Decision|6|||
146544140|NCT02335944|528498570|FG006|Treatment Phase|Physician Decision|1|||
146544141|NCT02335944|528498571|FG007|Treatment Phase|Physician Decision|2|||
146544142|NCT02335944|528498572|FG008|Treatment Phase|Physician Decision|1|||
146544143|NCT02335944|528498573|FG009|Treatment Phase|Physician Decision|0|||
146544144|NCT02335944|528498564|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
146544145|NCT02335944|528498565|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
146544146|NCT02335944|528498566|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
146544147|NCT02335944|528498567|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
146544148|NCT02335944|528498568|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
146544149|NCT02335944|528498569|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
146544150|NCT02335944|528498570|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
146544151|NCT02335944|528498571|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
146544152|NCT02335944|528498572|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
146544153|NCT02335944|528498573|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
146544154|NCT02335944|528498564|FG000|Treatment Phase|Subject/Guardian Decision|0|||
146544155|NCT02335944|528498565|FG001|Treatment Phase|Subject/Guardian Decision|0|||
146544156|NCT02335944|528498566|FG002|Treatment Phase|Subject/Guardian Decision|1|||
146544157|NCT02335944|528498567|FG003|Treatment Phase|Subject/Guardian Decision|0|||
146544158|NCT02335944|528498568|FG004|Treatment Phase|Subject/Guardian Decision|0|||
146544159|NCT02335944|528498569|FG005|Treatment Phase|Subject/Guardian Decision|1|||
146544160|NCT02335944|528498570|FG006|Treatment Phase|Subject/Guardian Decision|0|||
146544161|NCT02335944|528498571|FG007|Treatment Phase|Subject/Guardian Decision|4|||
146544162|NCT02335944|528498572|FG008|Treatment Phase|Subject/Guardian Decision|0|||
146544163|NCT02335944|528498573|FG009|Treatment Phase|Subject/Guardian Decision|0|||
146544164|NCT02335944|528498564|FG000|Post-treatment Follow-up|Progressive Disease|0|||
146544165|NCT02335944|528498565|FG001|Post-treatment Follow-up|Progressive Disease|0|||
146544166|NCT02335944|528498566|FG002|Post-treatment Follow-up|Progressive Disease|0|||
146544167|NCT02335944|528498567|FG003|Post-treatment Follow-up|Progressive Disease|1|||
146544168|NCT02335944|528498568|FG004|Post-treatment Follow-up|Progressive Disease|0|||
146544169|NCT02335944|528498569|FG005|Post-treatment Follow-up|Progressive Disease|9|||
146544170|NCT02335944|528498570|FG006|Post-treatment Follow-up|Progressive Disease|0|||
146544171|NCT02335944|528498571|FG007|Post-treatment Follow-up|Progressive Disease|2|||
146544172|NCT02335944|528498572|FG008|Post-treatment Follow-up|Progressive Disease|3|||
146544173|NCT02335944|528498573|FG009|Post-treatment Follow-up|Progressive Disease|0|||
146544174|NCT02335944|528498564|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
146875622|NCT02918864|529716620|FG001|Overall Study|Lost to Follow-up|2|||
146875623|NCT04766021|529716621|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
146875624|NCT04766021|529716621|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
146875625|NCT02257372|529716628|FG000|Overall Study|Adverse Event|3|||
146875626|NCT02257372|529716629|FG001|Overall Study|Adverse Event|7|||
146875627|NCT02257372|529716628|FG000|Overall Study|Lack of Efficacy|2|||
146875628|NCT02257372|529716629|FG001|Overall Study|Lack of Efficacy|1|||
146875629|NCT02257372|529716628|FG000|Overall Study|Protocol Violation|1|||
146875630|NCT02257372|529716629|FG001|Overall Study|Protocol Violation|1|||
146875631|NCT02257372|529716628|FG000|Overall Study|Lost to Follow-up|0|||
146875632|NCT02257372|529716629|FG001|Overall Study|Lost to Follow-up|1|||
146875633|NCT02257372|529716628|FG000|Overall Study|Withdrew consent|1|||
146875634|NCT02257372|529716629|FG001|Overall Study|Withdrew consent|0|||
146875635|NCT01849874|529716631|FG000|Overall Study|Death|89|||
146875636|NCT01849874|529716632|FG001|Overall Study|Death|42|||
146875637|NCT01849874|529716631|FG000|Overall Study|Withdrawal by Subject|17|||
146875638|NCT01849874|529716632|FG001|Overall Study|Withdrawal by Subject|16|||
146875639|NCT01849874|529716631|FG000|Overall Study|Lost to Follow-up|3|||
146875640|NCT01849874|529716632|FG001|Overall Study|Lost to Follow-up|2|||
146875641|NCT01849874|529716631|FG000|Overall Study|Study Termination By Sponsor|93|||
146875642|NCT01849874|529716632|FG001|Overall Study|Study Termination By Sponsor|48|||
146875643|NCT01849874|529716631|FG000|Overall Study|Completed as per protocol amendment 6|3|||
146875644|NCT01849874|529716632|FG001|Overall Study|Completed as per protocol amendment 6|0|||
146875645|NCT01849874|529716631|FG000|Overall Study|Physician Decision|7|||
146875646|NCT01849874|529716632|FG001|Overall Study|Physician Decision|1|||
146875647|NCT01849874|529716631|FG000|Overall Study|Other|16|||
146875648|NCT01849874|529716632|FG001|Overall Study|Other|4|||
146875649|NCT02104583|529716633|FG000|Overall Study|New ICD or CRT-D implanted|2|||
146875650|NCT02104583|529716634|FG001|Overall Study|New ICD or CRT-D implanted|0|||
146875651|NCT02104583|529716635|FG002|Overall Study|New ICD or CRT-D implanted|1|||
146875652|NCT02104583|529716636|FG003|Overall Study|New ICD or CRT-D implanted|0|||
146875653|NCT02104583|529716637|FG004|Overall Study|New ICD or CRT-D implanted|0|||
146875654|NCT02104583|529716633|FG000|Overall Study|Death|2|||
146875655|NCT02104583|529716634|FG001|Overall Study|Death|1|||
146875656|NCT02104583|529716635|FG002|Overall Study|Death|3|||
146875657|NCT02104583|529716636|FG003|Overall Study|Death|3|||
146875658|NCT02104583|529716637|FG004|Overall Study|Death|5|||
146875659|NCT02104583|529716633|FG000|Overall Study|Subject required cardiac ablation|6|||
146875660|NCT02104583|529716634|FG001|Overall Study|Subject required cardiac ablation|4|||
146875661|NCT02104583|529716635|FG002|Overall Study|Subject required cardiac ablation|4|||
146875662|NCT02104583|529716636|FG003|Overall Study|Subject required cardiac ablation|5|||
146875663|NCT02104583|529716637|FG004|Overall Study|Subject required cardiac ablation|4|||
146875664|NCT02104583|529716633|FG000|Overall Study|Subject required prohibited medication|0|||
146875665|NCT02104583|529716634|FG001|Overall Study|Subject required prohibited medication|1|||
146875666|NCT02104583|529716635|FG002|Overall Study|Subject required prohibited medication|1|||
146875667|NCT02104583|529716636|FG003|Overall Study|Subject required prohibited medication|0|||
146875668|NCT02104583|529716637|FG004|Overall Study|Subject required prohibited medication|1|||
146875669|NCT02104583|529716633|FG000|Overall Study|Withdrew Consent|3|||
146875670|NCT02104583|529716634|FG001|Overall Study|Withdrew Consent|2|||
146875671|NCT02104583|529716635|FG002|Overall Study|Withdrew Consent|0|||
146875672|NCT02104583|529716636|FG003|Overall Study|Withdrew Consent|2|||
146875673|NCT02104583|529716637|FG004|Overall Study|Withdrew Consent|1|||
146875674|NCT02104583|529716633|FG000|Overall Study|Investigator's Discretion|1|||
146875675|NCT02104583|529716634|FG001|Overall Study|Investigator's Discretion|0|||
146875676|NCT02104583|529716635|FG002|Overall Study|Investigator's Discretion|0|||
146875677|NCT02104583|529716636|FG003|Overall Study|Investigator's Discretion|0|||
146875678|NCT02104583|529716637|FG004|Overall Study|Investigator's Discretion|0|||
146875679|NCT02104583|529716633|FG000|Overall Study|Protocol Violation|0|||
146875680|NCT02104583|529716634|FG001|Overall Study|Protocol Violation|0|||
146875681|NCT02104583|529716635|FG002|Overall Study|Protocol Violation|1|||
146875682|NCT02104583|529716636|FG003|Overall Study|Protocol Violation|0|||
146875683|NCT02104583|529716637|FG004|Overall Study|Protocol Violation|0|||
146544175|NCT02335944|528498565|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
146544176|NCT02335944|528498566|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
146544177|NCT02335944|528498567|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
146544178|NCT02335944|528498568|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
146875684|NCT02104583|529716633|FG000|Overall Study|Adverse Event|3|||
146875685|NCT02104583|529716634|FG001|Overall Study|Adverse Event|3|||
146875686|NCT02104583|529716635|FG002|Overall Study|Adverse Event|6|||
146875687|NCT02104583|529716636|FG003|Overall Study|Adverse Event|6|||
146875688|NCT02104583|529716637|FG004|Overall Study|Adverse Event|1|||
146875689|NCT02104583|529716633|FG000|Overall Study|Lost to Follow-up|1|||
146875690|NCT02104583|529716634|FG001|Overall Study|Lost to Follow-up|0|||
146875691|NCT02104583|529716635|FG002|Overall Study|Lost to Follow-up|0|||
146875692|NCT02104583|529716636|FG003|Overall Study|Lost to Follow-up|0|||
146875693|NCT02104583|529716637|FG004|Overall Study|Lost to Follow-up|0|||
146875694|NCT02104583|529716633|FG000|Overall Study|Randomized but Never Treated|0|||
146875695|NCT02104583|529716634|FG001|Overall Study|Randomized but Never Treated|0|||
146875696|NCT02104583|529716635|FG002|Overall Study|Randomized but Never Treated|0|||
146875697|NCT02104583|529716636|FG003|Overall Study|Randomized but Never Treated|1|||
146875698|NCT02104583|529716637|FG004|Overall Study|Randomized but Never Treated|0|||
146875699|NCT04640272|529716639|FG000|Overall Study|Subject moved out of area|1|||
146875700|NCT04329702|529716647|FG000|Overall Study|illness|3|||
146875701|NCT04329702|529716648|FG001|Overall Study|illness|4|||
146875702|NCT04329702|529716649|FG002|Overall Study|illness|0|||
146875703|NCT04329702|529716647|FG000|Overall Study|Lost to Follow-up|0|||
146875704|NCT04329702|529716648|FG001|Overall Study|Lost to Follow-up|0|||
146875705|NCT04329702|529716649|FG002|Overall Study|Lost to Follow-up|2|||
146875706|NCT04329702|529716647|FG000|Overall Study|Death|0|||
146875707|NCT04329702|529716648|FG001|Overall Study|Death|2|||
146875708|NCT04329702|529716649|FG002|Overall Study|Death|0|||
146875709|NCT00766532|529716650|FG000|Overall Study|Protocol Violation|2|||
146875710|NCT01438489|529716651|FG000|Overall Study|Lost to Follow-up|4|||
146875711|NCT01438489|529716652|FG001|Overall Study|Lost to Follow-up|2|||
146875712|NCT01438489|529716653|FG002|Overall Study|Lost to Follow-up|2|||
146875713|NCT01438489|529716651|FG000|Overall Study|Withdrawal by Subject|11|||
146875714|NCT01438489|529716652|FG001|Overall Study|Withdrawal by Subject|3|||
146875715|NCT01438489|529716653|FG002|Overall Study|Withdrawal by Subject|8|||
146875716|NCT01438489|529716651|FG000|Overall Study|Death|0|||
146875717|NCT01438489|529716652|FG001|Overall Study|Death|0|||
146875718|NCT01438489|529716653|FG002|Overall Study|Death|1|||
146875719|NCT01438489|529716651|FG000|Overall Study|Sponsor decision|4|||
146875720|NCT01438489|529716652|FG001|Overall Study|Sponsor decision|1|||
146875721|NCT01438489|529716653|FG002|Overall Study|Sponsor decision|4|||
146875722|NCT01438489|529716651|FG000|Overall Study|Subject choice/Subject moved|2|||
146875723|NCT01438489|529716652|FG001|Overall Study|Subject choice/Subject moved|1|||
146875724|NCT01438489|529716653|FG002|Overall Study|Subject choice/Subject moved|1|||
146875725|NCT01438489|529716651|FG000|Overall Study|Investigator decision|0|||
146875726|NCT01438489|529716652|FG001|Overall Study|Investigator decision|1|||
146875727|NCT01438489|529716653|FG002|Overall Study|Investigator decision|0|||
146875728|NCT01438489|529716651|FG000|Overall Study|AE/SAEs|2|||
146875729|NCT01438489|529716652|FG001|Overall Study|AE/SAEs|1|||
146875730|NCT01438489|529716653|FG002|Overall Study|AE/SAEs|1|||
146875731|NCT01438489|529716651|FG000|Overall Study|Received prohibited medication|1|||
146875732|NCT01438489|529716652|FG001|Overall Study|Received prohibited medication|0|||
146875733|NCT01438489|529716653|FG002|Overall Study|Received prohibited medication|0|||
146875734|NCT01438489|529716651|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
146875735|NCT01438489|529716652|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
146875736|NCT01438489|529716653|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
146875737|NCT01438489|529716651|FG000|Overall Study|Inadequate venous access|0|||
146875738|NCT01438489|529716652|FG001|Overall Study|Inadequate venous access|2|||
146875739|NCT01438489|529716653|FG002|Overall Study|Inadequate venous access|0|||
146875740|NCT01476475|529716655|FG000|Overall Study|Adverse Event|6|||
146875741|NCT01476475|529716656|FG001|Overall Study|Adverse Event|0|||
146875742|NCT01476475|529716655|FG000|Overall Study|Poor compliance to protocol|1|||
146875743|NCT01476475|529716656|FG001|Overall Study|Poor compliance to protocol|1|||
146875744|NCT01476475|529716655|FG000|Overall Study|Other reasons|4|||
146875745|NCT01476475|529716656|FG001|Overall Study|Other reasons|2|||
146875746|NCT00751400|529716659|FG000|Overall Study|Lost to Follow-up|10|||
146875747|NCT01372384|529716663|FG000|Overall Study|Progression of disease|3|||
146875748|NCT01923285|529716667|FG000|Overall Study|Withdrawal by Subject|7|||
146875749|NCT01923285|529716668|FG001|Overall Study|Withdrawal by Subject|6|||
146875750|NCT03374189|529716669|FG000|Overall Study|Lost to Follow-up|1|||
146875751|NCT03374189|529716670|FG001|Overall Study|Lost to Follow-up|0|||
146875752|NCT02285777|529716673|FG000|Overall Study|Withdrawal by Subject|1|||
146875753|NCT02285777|529716674|FG001|Overall Study|Withdrawal by Subject|1|||
146875754|NCT02285777|529716673|FG000|Overall Study|Lost to Follow-up|4|||
146875755|NCT02285777|529716674|FG001|Overall Study|Lost to Follow-up|2|||
146875756|NCT03962101|529716675|FG000|Overall Study|Adverse Event|1|||
146544179|NCT02335944|528498569|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
146875757|NCT03962101|529716675|FG000|Overall Study|Physician Decision|2|||
146875758|NCT03962101|529716675|FG000|Overall Study|Not related to medical events|1|||
146875759|NCT03699007|529716676|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
146875760|NCT03699007|529716677|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
146875761|NCT03699007|529716676|FG000|6-month Follow Up|Lost to Follow-up|2|||
146764830|NCT00197015|529305940|FG000|Overall Study|Protocol Violation|0|||
146764831|NCT00197015|529305941|FG001|Overall Study|Protocol Violation|3|||
146764832|NCT00197015|529305942|FG002|Overall Study|Protocol Violation|3|||
146764833|NCT00197015|529305940|FG000|Overall Study|Withdrawal by Subject|17|||
146875762|NCT03699007|529716677|FG001|6-month Follow Up|Lost to Follow-up|3|||
146875763|NCT00843518|529716678|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
146875764|NCT00843518|529716679|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
146875765|NCT00843518|529716678|FG000|Period 2 (Double-blind Treatment)|Death|0|||
146875766|NCT00843518|529716679|FG001|Period 2 (Double-blind Treatment)|Death|1|||
146875767|NCT00843518|529716678|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
146875768|NCT00843518|529716679|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
146875769|NCT00843518|529716678|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
146875770|NCT00843518|529716679|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
146875771|NCT00843518|529716678|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
146875772|NCT00843518|529716679|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
146875773|NCT00843518|529716678|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
146875774|NCT00843518|529716679|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
146875775|NCT00843518|529716678|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
146875776|NCT00843518|529716679|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
146875777|NCT04607148|529716682|FG000|Overall Study|Withdrawal by Subject|0|||
146875778|NCT04607148|529716683|FG001|Overall Study|Withdrawal by Subject|4|||
146875779|NCT04607148|529716684|FG002|Overall Study|Withdrawal by Subject|2|||
146875780|NCT04607148|529716685|FG003|Overall Study|Withdrawal by Subject|8|||
146875781|NCT04607148|529716682|FG000|Overall Study|Study Terminated by Sponsor|14|||
146875782|NCT04607148|529716683|FG001|Overall Study|Study Terminated by Sponsor|59|||
146875783|NCT04607148|529716684|FG002|Overall Study|Study Terminated by Sponsor|9|||
146875784|NCT04607148|529716685|FG003|Overall Study|Study Terminated by Sponsor|39|||
146875785|NCT04607148|529716682|FG000|Overall Study|Sponsor Decision|0|||
146875786|NCT04607148|529716683|FG001|Overall Study|Sponsor Decision|0|||
146875787|NCT04607148|529716684|FG002|Overall Study|Sponsor Decision|1|||
146875788|NCT04607148|529716685|FG003|Overall Study|Sponsor Decision|0|||
146875789|NCT04607148|529716682|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146875790|NCT04607148|529716683|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146875791|NCT04607148|529716684|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146875792|NCT04607148|529716685|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146875793|NCT04607148|529716682|FG000|Overall Study|Lost to Follow-up|0|||
146875794|NCT04607148|529716683|FG001|Overall Study|Lost to Follow-up|2|||
146875795|NCT04607148|529716684|FG002|Overall Study|Lost to Follow-up|0|||
146875796|NCT04607148|529716685|FG003|Overall Study|Lost to Follow-up|0|||
146875797|NCT04607148|529716682|FG000|Overall Study|Death|0|||
146875798|NCT04607148|529716683|FG001|Overall Study|Death|3|||
146875799|NCT04607148|529716684|FG002|Overall Study|Death|0|||
146875800|NCT04607148|529716685|FG003|Overall Study|Death|1|||
146875801|NCT04607148|529716682|FG000|Overall Study|Adverse Event|0|||
146875802|NCT04607148|529716683|FG001|Overall Study|Adverse Event|1|||
146875803|NCT04607148|529716684|FG002|Overall Study|Adverse Event|0|||
146875804|NCT04607148|529716685|FG003|Overall Study|Adverse Event|0|||
146875805|NCT04251910|529716686|FG000|Overall Study|Covid 19 lockdown|0|||
146875806|NCT04251910|529716687|FG001|Overall Study|Covid 19 lockdown|5|||
146875807|NCT04251910|529716688|FG002|Overall Study|Covid 19 lockdown|0|||
146875808|NCT04251910|529716689|FG003|Overall Study|Covid 19 lockdown|4|||
146875809|NCT04251910|529716690|FG004|Overall Study|Covid 19 lockdown|0|||
146875810|NCT04251910|529716691|FG005|Overall Study|Covid 19 lockdown|0|||
146875811|NCT04251910|529716686|FG000|Overall Study|Assisted living facility was closed|0|||
146544180|NCT02335944|528498570|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
146544181|NCT02335944|528498571|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
146544182|NCT02335944|528498572|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
146544183|NCT02335944|528498573|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
146544184|NCT02335944|528498564|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
146544185|NCT02335944|528498565|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
146544186|NCT02335944|528498566|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
146544187|NCT02335944|528498567|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
146544188|NCT02335944|528498568|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
146544189|NCT02335944|528498569|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
146544190|NCT02335944|528498570|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
146544191|NCT02335944|528498571|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
146544192|NCT02335944|528498572|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
146544193|NCT02335944|528498573|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
146544194|NCT02335944|528498564|FG000|Post-treatment Follow-up|Adverse Event|0|||
146875812|NCT04251910|529716687|FG001|Overall Study|Assisted living facility was closed|0|||
146544195|NCT02335944|528498565|FG001|Post-treatment Follow-up|Adverse Event|0|||
146544196|NCT02335944|528498566|FG002|Post-treatment Follow-up|Adverse Event|0|||
146544197|NCT02335944|528498567|FG003|Post-treatment Follow-up|Adverse Event|0|||
146875813|NCT04251910|529716688|FG002|Overall Study|Assisted living facility was closed|0|||
146875814|NCT04251910|529716689|FG003|Overall Study|Assisted living facility was closed|0|||
146875815|NCT04251910|529716690|FG004|Overall Study|Assisted living facility was closed|1|||
146875816|NCT04251910|529716691|FG005|Overall Study|Assisted living facility was closed|0|||
146875817|NCT00916149|529716692|FG000|Overall Study|Lost to Follow-up|3|||
146875818|NCT00916149|529716693|FG001|Overall Study|Lost to Follow-up|2|||
146875819|NCT00916149|529716694|FG002|Overall Study|Lost to Follow-up|0|||
146875820|NCT00916149|529716692|FG000|Overall Study|Unable to place scalp EEG leads|1|||
146875821|NCT00916149|529716693|FG001|Overall Study|Unable to place scalp EEG leads|0|||
146875822|NCT00916149|529716694|FG002|Overall Study|Unable to place scalp EEG leads|0|||
146875823|NCT03002155|529716695|FG000|Overall Study|Lost to Follow-up|1|||
146875824|NCT03002155|529716696|FG001|Overall Study|Lost to Follow-up|2|||
146875825|NCT03002155|529716695|FG000|Overall Study|Withdrawal by Subject|1|||
146875826|NCT03002155|529716696|FG001|Overall Study|Withdrawal by Subject|0|||
146875827|NCT03002155|529716695|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
146875828|NCT03002155|529716696|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
146875829|NCT03451084|529716697|FG000|Overall Study|Withdrawal by Subject|2|||
146875830|NCT03451084|529716698|FG001|Overall Study|Withdrawal by Subject|1|||
146875831|NCT03451084|529716699|FG002|Overall Study|Withdrawal by Subject|2|||
146875832|NCT03451084|529716700|FG003|Overall Study|Withdrawal by Subject|1|||
146875833|NCT03451084|529716697|FG000|Overall Study|Disease recurrence|0|||
146875834|NCT03451084|529716698|FG001|Overall Study|Disease recurrence|2|||
146875835|NCT03451084|529716699|FG002|Overall Study|Disease recurrence|0|||
146875836|NCT03451084|529716700|FG003|Overall Study|Disease recurrence|0|||
146875837|NCT03451084|529716697|FG000|Overall Study|Lack of Efficacy|0|||
146875838|NCT03451084|529716698|FG001|Overall Study|Lack of Efficacy|3|||
146875839|NCT03451084|529716699|FG002|Overall Study|Lack of Efficacy|0|||
146875840|NCT03451084|529716700|FG003|Overall Study|Lack of Efficacy|1|||
146875841|NCT03451084|529716697|FG000|Overall Study|Death|1|||
146875842|NCT03451084|529716698|FG001|Overall Study|Death|0|||
146875843|NCT03451084|529716699|FG002|Overall Study|Death|2|||
146875844|NCT03451084|529716700|FG003|Overall Study|Death|0|||
146875845|NCT03451084|529716697|FG000|Overall Study|Physician Decision|0|||
146875846|NCT03451084|529716698|FG001|Overall Study|Physician Decision|0|||
146875847|NCT03451084|529716699|FG002|Overall Study|Physician Decision|2|||
146875848|NCT03451084|529716700|FG003|Overall Study|Physician Decision|2|||
146875849|NCT03451084|529716697|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
146875850|NCT03451084|529716698|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
146875851|NCT03451084|529716699|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
146875852|NCT03451084|529716700|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
146875853|NCT05289570|529716708|FG000|Overall Study|Physician Decision|1|||
146875854|NCT04544475|529716713|FG000|Overall Study|Withdrawal by Subject|1|||
146875855|NCT04544475|529716714|FG001|Overall Study|Withdrawal by Subject|3|||
146875856|NCT00808236|529716715|FG000|Overall Study|Was not resuscitated|50|||
146875857|NCT00808236|529716716|FG001|Overall Study|Was not resuscitated|56|||
146875858|NCT00808236|529716715|FG000|Overall Study|Pre-defined exclusion|13|||
146875859|NCT00808236|529716716|FG001|Overall Study|Pre-defined exclusion|3|||
146875860|NCT00808236|529716715|FG000|Overall Study|Lost to Follow-up|1|||
146875861|NCT00808236|529716716|FG001|Overall Study|Lost to Follow-up|1|||
146875862|NCT00808236|529716715|FG000|Overall Study|Physician Decision|0|||
146875863|NCT00808236|529716716|FG001|Overall Study|Physician Decision|1|||
146875864|NCT00808236|529716715|FG000|Overall Study|Death|18|||
146875865|NCT00808236|529716716|FG001|Overall Study|Death|30|||
146875866|NCT05376215|529716717|FG000|Overall Study|Withdrawal by Subject|2|||
146875867|NCT05376215|529716718|FG001|Overall Study|Withdrawal by Subject|1|||
146875868|NCT05376215|529716717|FG000|Overall Study|Lost to Follow-up|0|||
146875869|NCT05376215|529716718|FG001|Overall Study|Lost to Follow-up|1|||
146875870|NCT01301950|529716721|FG000|Overall Study|Surgery was cancelled by patient|0|||
146875871|NCT01301950|529716722|FG001|Overall Study|Surgery was cancelled by patient|1|||
146875872|NCT04041284|529716723|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
146875873|NCT04041284|529716724|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
146875874|NCT04041284|529716723|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
146875875|NCT04041284|529716724|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
146875876|NCT04041284|529716723|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
146875877|NCT04041284|529716724|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
146875878|NCT04041284|529716723|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
146875879|NCT04041284|529716724|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
146875880|NCT04041284|529716723|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
146875881|NCT04041284|529716724|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
146875882|NCT04041284|529716723|FG000|DB Phase (12 Weeks)|Other than specified|1|||
146875883|NCT04041284|529716724|FG001|DB Phase (12 Weeks)|Other than specified|0|||
146875884|NCT04041284|529716723|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
146875885|NCT04041284|529716724|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
146875886|NCT04041284|529716723|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
146875887|NCT04041284|529716724|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
146875888|NCT04041284|529716723|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
146875889|NCT04041284|529716724|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
146875890|NCT04041284|529716723|FG000|OL Phase (12 Weeks)|Other than specified|6|||
146875891|NCT04041284|529716724|FG001|OL Phase (12 Weeks)|Other than specified|2|||
146875892|NCT00964743|529716725|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
146875893|NCT01549002|529716726|FG000|Overall Study|Excessive pain|0|||
146875894|NCT01549002|529716727|FG001|Overall Study|Excessive pain|2|||
146875895|NCT01549002|529716726|FG000|Overall Study|Moderate sedation required|0|||
146875896|NCT01549002|529716727|FG001|Overall Study|Moderate sedation required|2|||
146875897|NCT01147744|529716728|FG000|Overall Study|Protocol Violation|1|||
146875898|NCT01147744|529716729|FG001|Overall Study|Protocol Violation|0|||
146875899|NCT01147744|529716730|FG002|Overall Study|Protocol Violation|1|||
146875900|NCT01147744|529716731|FG003|Overall Study|Protocol Violation|0|||
146875901|NCT01147744|529716732|FG004|Overall Study|Protocol Violation|1|||
146875902|NCT01147744|529716733|FG005|Overall Study|Protocol Violation|3|||
146875903|NCT01147744|529716734|FG006|Overall Study|Protocol Violation|1|||
146875904|NCT01147744|529716728|FG000|Overall Study|Physician Decision|0|||
146875905|NCT01147744|529716729|FG001|Overall Study|Physician Decision|1|||
146875906|NCT01147744|529716730|FG002|Overall Study|Physician Decision|1|||
146875907|NCT01147744|529716731|FG003|Overall Study|Physician Decision|0|||
146875908|NCT01147744|529716732|FG004|Overall Study|Physician Decision|0|||
146875909|NCT01147744|529716733|FG005|Overall Study|Physician Decision|0|||
146875910|NCT01147744|529716734|FG006|Overall Study|Physician Decision|1|||
146875911|NCT01147744|529716728|FG000|Overall Study|Lack of Efficacy|11|||
146875912|NCT01147744|529716729|FG001|Overall Study|Lack of Efficacy|11|||
146875913|NCT01147744|529716730|FG002|Overall Study|Lack of Efficacy|9|||
146875914|NCT01147744|529716731|FG003|Overall Study|Lack of Efficacy|11|||
146875915|NCT01147744|529716732|FG004|Overall Study|Lack of Efficacy|13|||
146875916|NCT01147744|529716733|FG005|Overall Study|Lack of Efficacy|8|||
146875917|NCT01147744|529716734|FG006|Overall Study|Lack of Efficacy|7|||
146875918|NCT01147744|529716728|FG000|Overall Study|Adverse Event|1|||
146875919|NCT01147744|529716729|FG001|Overall Study|Adverse Event|2|||
146875920|NCT01147744|529716730|FG002|Overall Study|Adverse Event|3|||
146875921|NCT01147744|529716731|FG003|Overall Study|Adverse Event|0|||
146875922|NCT01147744|529716732|FG004|Overall Study|Adverse Event|2|||
146875923|NCT01147744|529716733|FG005|Overall Study|Adverse Event|1|||
146875924|NCT01147744|529716734|FG006|Overall Study|Adverse Event|2|||
146875925|NCT01147744|529716728|FG000|Overall Study|Withdrawal by Subject|8|||
146875926|NCT01147744|529716729|FG001|Overall Study|Withdrawal by Subject|4|||
146875927|NCT01147744|529716730|FG002|Overall Study|Withdrawal by Subject|2|||
146875928|NCT01147744|529716731|FG003|Overall Study|Withdrawal by Subject|2|||
146875929|NCT01147744|529716732|FG004|Overall Study|Withdrawal by Subject|2|||
146875930|NCT01147744|529716733|FG005|Overall Study|Withdrawal by Subject|5|||
146875931|NCT01147744|529716734|FG006|Overall Study|Withdrawal by Subject|2|||
146875932|NCT01147744|529716728|FG000|Overall Study|Lost to Follow-up|0|||
146875933|NCT01147744|529716729|FG001|Overall Study|Lost to Follow-up|1|||
146875934|NCT01147744|529716730|FG002|Overall Study|Lost to Follow-up|0|||
146875935|NCT01147744|529716731|FG003|Overall Study|Lost to Follow-up|0|||
146875936|NCT01147744|529716732|FG004|Overall Study|Lost to Follow-up|0|||
146875937|NCT01147744|529716733|FG005|Overall Study|Lost to Follow-up|0|||
146875938|NCT01147744|529716734|FG006|Overall Study|Lost to Follow-up|0|||
146875939|NCT01147744|529716728|FG000|Overall Study|Sponsor decision to amend protocol|7|||
146875940|NCT01147744|529716729|FG001|Overall Study|Sponsor decision to amend protocol|4|||
146875941|NCT01147744|529716730|FG002|Overall Study|Sponsor decision to amend protocol|2|||
146875942|NCT01147744|529716731|FG003|Overall Study|Sponsor decision to amend protocol|5|||
146875943|NCT01147744|529716732|FG004|Overall Study|Sponsor decision to amend protocol|7|||
146875944|NCT01147744|529716733|FG005|Overall Study|Sponsor decision to amend protocol|2|||
146875945|NCT01147744|529716734|FG006|Overall Study|Sponsor decision to amend protocol|6|||
146875946|NCT01147744|529716728|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
146875947|NCT01147744|529716729|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
146875948|NCT01147744|529716730|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
146875949|NCT01147744|529716731|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
146875950|NCT01147744|529716732|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
146875951|NCT01147744|529716733|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
146875952|NCT01147744|529716734|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
146875953|NCT01342484|529716735|FG000|Overall Study|Other Reasons|1|||
146875954|NCT01342484|529716736|FG001|Overall Study|Other Reasons|0|||
146875955|NCT01342484|529716737|FG002|Overall Study|Other Reasons|0|||
146875956|NCT01342484|529716735|FG000|Overall Study|Protocol Violation|0|||
146875957|NCT01342484|529716736|FG001|Overall Study|Protocol Violation|0|||
146875958|NCT01342484|529716737|FG002|Overall Study|Protocol Violation|1|||
146875959|NCT01342484|529716735|FG000|Overall Study|Withdrawal by Subject|1|||
146875960|NCT01342484|529716736|FG001|Overall Study|Withdrawal by Subject|0|||
146875961|NCT01342484|529716737|FG002|Overall Study|Withdrawal by Subject|0|||
146875962|NCT01840579|529716738|FG000|Overall Study|Status not recorded|0|||
146875963|NCT01840579|529716739|FG001|Overall Study|Status not recorded|0|||
146875964|NCT01840579|529716740|FG002|Overall Study|Status not recorded|2|||
146875965|NCT01840579|529716741|FG003|Overall Study|Status not recorded|3|||
146875966|NCT01840579|529716742|FG004|Overall Study|Status not recorded|4|||
146875967|NCT01840579|529716743|FG005|Overall Study|Status not recorded|3|||
146875968|NCT01840579|529716744|FG006|Overall Study|Status not recorded|0|||
146875969|NCT01840579|529716745|FG007|Overall Study|Status not recorded|3|||
146875970|NCT01840579|529716746|FG008|Overall Study|Status not recorded|3|||
146875971|NCT01840579|529716747|FG009|Overall Study|Status not recorded|3|||
146875972|NCT01840579|529716738|FG000|Overall Study|Progressive disease|3|||
146875973|NCT01840579|529716739|FG001|Overall Study|Progressive disease|5|||
146875974|NCT01840579|529716740|FG002|Overall Study|Progressive disease|0|||
146875975|NCT01840579|529716741|FG003|Overall Study|Progressive disease|0|||
146875976|NCT01840579|529716742|FG004|Overall Study|Progressive disease|0|||
146875977|NCT01840579|529716743|FG005|Overall Study|Progressive disease|0|||
146875978|NCT01840579|529716744|FG006|Overall Study|Progressive disease|0|||
146875979|NCT01840579|529716745|FG007|Overall Study|Progressive disease|0|||
146875980|NCT01840579|529716746|FG008|Overall Study|Progressive disease|0|||
146875981|NCT01840579|529716747|FG009|Overall Study|Progressive disease|0|||
146875982|NCT01840579|529716738|FG000|Overall Study|Ongoing in study|0|||
146875983|NCT01840579|529716739|FG001|Overall Study|Ongoing in study|1|||
146875984|NCT01840579|529716740|FG002|Overall Study|Ongoing in study|0|||
146875985|NCT01840579|529716741|FG003|Overall Study|Ongoing in study|0|||
146875986|NCT01840579|529716742|FG004|Overall Study|Ongoing in study|0|||
146875987|NCT01840579|529716743|FG005|Overall Study|Ongoing in study|0|||
146875988|NCT01840579|529716744|FG006|Overall Study|Ongoing in study|0|||
146875989|NCT01840579|529716745|FG007|Overall Study|Ongoing in study|0|||
146875990|NCT01840579|529716746|FG008|Overall Study|Ongoing in study|0|||
146875991|NCT01840579|529716747|FG009|Overall Study|Ongoing in study|0|||
146875992|NCT01840579|529716738|FG000|Overall Study|Death|0|||
146875993|NCT01840579|529716739|FG001|Overall Study|Death|0|||
146875994|NCT01840579|529716740|FG002|Overall Study|Death|0|||
146875995|NCT01840579|529716741|FG003|Overall Study|Death|0|||
146875996|NCT01840579|529716742|FG004|Overall Study|Death|0|||
146875997|NCT01840579|529716743|FG005|Overall Study|Death|1|||
146875998|NCT01840579|529716744|FG006|Overall Study|Death|0|||
146875999|NCT01840579|529716745|FG007|Overall Study|Death|0|||
146876000|NCT01840579|529716746|FG008|Overall Study|Death|0|||
146876001|NCT01840579|529716747|FG009|Overall Study|Death|0|||
146876002|NCT01840579|529716738|FG000|Overall Study|Adverse Event|0|||
146876003|NCT01840579|529716739|FG001|Overall Study|Adverse Event|1|||
146876004|NCT01840579|529716740|FG002|Overall Study|Adverse Event|0|||
146876005|NCT01840579|529716741|FG003|Overall Study|Adverse Event|0|||
146876006|NCT01840579|529716742|FG004|Overall Study|Adverse Event|0|||
146876007|NCT01840579|529716743|FG005|Overall Study|Adverse Event|0|||
146876008|NCT01840579|529716744|FG006|Overall Study|Adverse Event|0|||
146876009|NCT01840579|529716745|FG007|Overall Study|Adverse Event|0|||
146876010|NCT01840579|529716746|FG008|Overall Study|Adverse Event|0|||
146876011|NCT01840579|529716747|FG009|Overall Study|Adverse Event|0|||
146876012|NCT01840579|529716738|FG000|Overall Study|Follow-up ended by Sponsor|0|||
146876013|NCT01840579|529716739|FG001|Overall Study|Follow-up ended by Sponsor|0|||
146876014|NCT01840579|529716740|FG002|Overall Study|Follow-up ended by Sponsor|0|||
146876015|NCT01840579|529716741|FG003|Overall Study|Follow-up ended by Sponsor|0|||
146876016|NCT01840579|529716742|FG004|Overall Study|Follow-up ended by Sponsor|0|||
146876017|NCT01840579|529716743|FG005|Overall Study|Follow-up ended by Sponsor|0|||
146876018|NCT01840579|529716744|FG006|Overall Study|Follow-up ended by Sponsor|2|||
146876019|NCT01840579|529716745|FG007|Overall Study|Follow-up ended by Sponsor|0|||
146876020|NCT01840579|529716746|FG008|Overall Study|Follow-up ended by Sponsor|0|||
146876021|NCT01840579|529716747|FG009|Overall Study|Follow-up ended by Sponsor|0|||
146876022|NCT03302975|529716749|FG000|Overall Study|Lost to Follow-up|4|||
146876023|NCT00432042|529716751|FG000|Overall Study|Protocol Violation|2|||
146876024|NCT00432042|529716752|FG001|Overall Study|Protocol Violation|0|||
146876025|NCT00432042|529716753|FG002|Overall Study|Protocol Violation|0|||
146876026|NCT00432042|529716751|FG000|Overall Study|Withdrawal by Subject|0|||
146876027|NCT00432042|529716752|FG001|Overall Study|Withdrawal by Subject|0|||
146876028|NCT00432042|529716753|FG002|Overall Study|Withdrawal by Subject|2|||
146876029|NCT00432042|529716751|FG000|Overall Study|Lost to Follow-up|5|||
146876030|NCT00432042|529716752|FG001|Overall Study|Lost to Follow-up|1|||
146876031|NCT00432042|529716753|FG002|Overall Study|Lost to Follow-up|0|||
146876032|NCT00492752|529716754|FG000|Double Blind Treatment|Death|13|||
146876033|NCT00492752|529716755|FG001|Double Blind Treatment|Death|0|||
146876034|NCT00492752|529716756|FG002|Double Blind Treatment|Death|2|||
146876035|NCT00492752|529716757|FG003|Double Blind Treatment|Death|0|||
146876036|NCT00492752|529716754|FG000|Double Blind Treatment|Adverse Event|1|||
146876037|NCT00492752|529716755|FG001|Double Blind Treatment|Adverse Event|0|||
146876038|NCT00492752|529716756|FG002|Double Blind Treatment|Adverse Event|0|||
146876039|NCT00492752|529716757|FG003|Double Blind Treatment|Adverse Event|0|||
146876040|NCT00492752|529716754|FG000|Double Blind Treatment|Protocol Violation|0|||
146876041|NCT00492752|529716755|FG001|Double Blind Treatment|Protocol Violation|0|||
146876042|NCT00492752|529716756|FG002|Double Blind Treatment|Protocol Violation|1|||
146876043|NCT00492752|529716757|FG003|Double Blind Treatment|Protocol Violation|0|||
146876044|NCT00492752|529716754|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
146876045|NCT00492752|529716755|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
146876046|NCT00492752|529716756|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
146876047|NCT00492752|529716757|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
146876048|NCT00492752|529716754|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
146876049|NCT00492752|529716755|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
146876050|NCT00492752|529716756|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
146876051|NCT00492752|529716757|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
146628897|NCT00906204|528818283|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
146628898|NCT00906204|528818282|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
146628899|NCT00906204|528818283|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
146628900|NCT00906204|528818282|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
146628901|NCT00906204|528818283|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
146628902|NCT03181932|528818286|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
146628903|NCT03181932|528818287|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
146628904|NCT03181932|528818286|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
146628905|NCT03181932|528818287|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
146628906|NCT03181932|528818286|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
146628907|NCT03181932|528818287|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
146628908|NCT03181932|528818286|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
146628909|NCT03181932|528818287|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
146628910|NCT03181932|528818286|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
146628911|NCT03181932|528818287|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
146628912|NCT03181932|528818286|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
146628913|NCT03181932|528818287|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
146628914|NCT03181932|528818286|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
146628915|NCT03181932|528818287|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
146628916|NCT03181932|528818286|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
146628917|NCT03181932|528818287|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
146876052|NCT00492752|529716754|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
146876053|NCT00492752|529716755|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
146876054|NCT00492752|529716756|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
146876055|NCT00492752|529716757|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
146876056|NCT00492752|529716754|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
146876057|NCT00492752|529716755|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
146876058|NCT00492752|529716756|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
146876059|NCT00492752|529716757|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
146876060|NCT00492752|529716754|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
146876061|NCT00492752|529716755|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
146876062|NCT00492752|529716756|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
146876063|NCT00492752|529716757|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
146876064|NCT00492752|529716754|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
146876065|NCT00492752|529716755|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
146876066|NCT00492752|529716756|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
146876067|NCT00492752|529716757|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
146876068|NCT00492752|529716754|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
146876069|NCT00492752|529716755|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
146876070|NCT00492752|529716756|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
146876071|NCT00492752|529716757|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
146876072|NCT00492752|529716754|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
146876073|NCT00492752|529716755|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
146876074|NCT00492752|529716756|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
146876075|NCT00492752|529716757|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
146876076|NCT01357655|529716758|FG000|Overall Study|Administrative Reason by Sponsor|45|||
146876077|NCT01357655|529716759|FG001|Overall Study|Administrative Reason by Sponsor|0|||
146876078|NCT01357655|529716758|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
146876079|NCT01357655|529716759|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146876080|NCT01357655|529716758|FG000|Overall Study|Disease Progression|1|||
146876081|NCT01357655|529716759|FG001|Overall Study|Disease Progression|0|||
146876082|NCT01357655|529716758|FG000|Overall Study|Lost to Follow-up|2|||
146876083|NCT01357655|529716759|FG001|Overall Study|Lost to Follow-up|0|||
146876084|NCT01357655|529716758|FG000|Overall Study|Maximum Clinical Benefit|2|||
146876085|NCT01357655|529716759|FG001|Overall Study|Maximum Clinical Benefit|0|||
146876086|NCT01357655|529716758|FG000|Overall Study|Reason Unspecified|1|||
146876087|NCT01357655|529716759|FG001|Overall Study|Reason Unspecified|0|||
146876088|NCT01357655|529716758|FG000|Overall Study|Study Drug Toxicity|11|||
146876089|NCT01357655|529716759|FG001|Overall Study|Study Drug Toxicity|0|||
146876090|NCT01357655|529716758|FG000|Overall Study|Subject Withdrew Consent|1|||
146628918|NCT03181932|528818286|FG000|Period 2 (Open-label Period)|Reason missing|2|||
146764834|NCT00197015|529305941|FG001|Overall Study|Withdrawal by Subject|37|||
146876091|NCT01357655|529716759|FG001|Overall Study|Subject Withdrew Consent|0|||
146876092|NCT05003622|529716760|FG000|Overall Study|Progressive disease|2|||
146876093|NCT05003622|529716760|FG000|Overall Study|Withdrawal by Subject|1|||
146876094|NCT03803059|529716761|FG000|Overall Study|Protocol Violation|2|||
146876095|NCT03803059|529716761|FG000|Overall Study|Lost to Follow-up|1|||
146876096|NCT04066491|529716763|FG000|Overall Study|Randomized, not treated|0|||
146876097|NCT04066491|529716764|FG001|Overall Study|Randomized, not treated|0|||
146876098|NCT04066491|529716765|FG002|Overall Study|Randomized, not treated|2|||
146876099|NCT00880399|529718218|FG000|Overall Study|Adverse Event|4|||
146876100|NCT00880399|529718219|FG001|Overall Study|Adverse Event|6|||
146876101|NCT00880399|529718220|FG002|Overall Study|Adverse Event|5|||
146876102|NCT00880399|529718218|FG000|Overall Study|Lack of Efficacy|1|||
146876103|NCT00880399|529718219|FG001|Overall Study|Lack of Efficacy|4|||
146876104|NCT00880399|529718220|FG002|Overall Study|Lack of Efficacy|2|||
146876105|NCT00880399|529718218|FG000|Overall Study|Protocol Violation|4|||
146876106|NCT00880399|529718219|FG001|Overall Study|Protocol Violation|4|||
146876107|NCT00880399|529718220|FG002|Overall Study|Protocol Violation|6|||
146876108|NCT00880399|529718218|FG000|Overall Study|Study closed/terminated|3|||
146876109|NCT00880399|529718219|FG001|Overall Study|Study closed/terminated|7|||
146876110|NCT00880399|529718220|FG002|Overall Study|Study closed/terminated|4|||
146876111|NCT00880399|529718218|FG000|Overall Study|Lost to Follow-up|8|||
146876112|NCT00880399|529718219|FG001|Overall Study|Lost to Follow-up|5|||
146876113|NCT00880399|529718220|FG002|Overall Study|Lost to Follow-up|3|||
146876114|NCT00880399|529718218|FG000|Overall Study|Physician Decision|5|||
146876115|NCT00880399|529718219|FG001|Overall Study|Physician Decision|0|||
146876116|NCT00880399|529718220|FG002|Overall Study|Physician Decision|3|||
146876117|NCT00880399|529718218|FG000|Overall Study|Withdrawal by Subject|6|||
146876118|NCT00880399|529718219|FG001|Overall Study|Withdrawal by Subject|3|||
146876119|NCT00880399|529718220|FG002|Overall Study|Withdrawal by Subject|3|||
146876120|NCT03709654|529718221|FG000|Overall Study|Lost to Follow-up|1|||
146876121|NCT03709654|529718222|FG001|Overall Study|Lost to Follow-up|1|||
146876122|NCT03709654|529718221|FG000|Overall Study|Withdrawal by Subject|1|||
146876123|NCT03709654|529718222|FG001|Overall Study|Withdrawal by Subject|1|||
146876124|NCT03709654|529718221|FG000|Overall Study|Adverse Event|1|||
146876125|NCT03709654|529718222|FG001|Overall Study|Adverse Event|0|||
146876126|NCT01902966|529718223|FG000|Overall Study|Death|1|||
146876127|NCT01902966|529718223|FG000|Overall Study|Physician Decision|1|||
146876128|NCT01902966|529718223|FG000|Overall Study|Withdrawal by Subject|1|||
146876129|NCT01230307|529718224|FG000|Overall Study|LVAD Placement|0|||
146876130|NCT01230307|529718225|FG001|Overall Study|LVAD Placement|2|||
146876131|NCT01230242|529718229|FG000|Overall Study|Physician Decision|2|||
146876132|NCT01230242|529718229|FG000|Overall Study|Withdrawal by Subject|1|||
146876133|NCT02256540|529718230|FG000|Overall Study|Withdrawal by Subject|0|||
146876134|NCT02256540|529718231|FG001|Overall Study|Withdrawal by Subject|1|||
146876135|NCT02256540|529718232|FG002|Overall Study|Withdrawal by Subject|1|||
146876136|NCT02256540|529718230|FG000|Overall Study|Back pain preventing exercise|0|||
146876137|NCT02256540|529718231|FG001|Overall Study|Back pain preventing exercise|0|||
146876138|NCT02256540|529718232|FG002|Overall Study|Back pain preventing exercise|1|||
146876139|NCT03923426|529718233|FG000|Overall Study|Other|19|||
146876140|NCT03923426|529718233|FG000|Overall Study|Lost to Follow-up|16|||
146876141|NCT03923426|529718233|FG000|Overall Study|Death|107|||
146876142|NCT03923426|529718233|FG000|Overall Study|Incomplete response to question|13|||
146876143|NCT01918007|529718234|FG000|Overall Study|Baseline oximetry not acceptable|11|||
146876144|NCT01918007|529718235|FG001|Overall Study|Baseline oximetry not acceptable|7|||
146876145|NCT01918007|529718234|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
146876146|NCT01918007|529718235|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
146876147|NCT01918007|529718234|FG000|Overall Study|Lost to Follow-up|4|||
146876148|NCT01918007|529718235|FG001|Overall Study|Lost to Follow-up|7|||
146876149|NCT01140451|529718237|FG000|Overall Study|Withdrawal by Subject|26|||
146876150|NCT01140451|529718238|FG001|Overall Study|Withdrawal by Subject|33|||
146876151|NCT01140451|529718237|FG000|Overall Study|Adverse Event|2|||
146876152|NCT01140451|529718238|FG001|Overall Study|Adverse Event|6|||
146876153|NCT01140451|529718237|FG000|Overall Study|Physician Decision|5|||
146876154|NCT01140451|529718238|FG001|Overall Study|Physician Decision|3|||
146876155|NCT01140451|529718237|FG000|Overall Study|Lost to Follow-up|2|||
146876156|NCT01140451|529718238|FG001|Overall Study|Lost to Follow-up|0|||
146876157|NCT01140451|529718237|FG000|Overall Study|Participants Planning Pregnancy|3|||
146876158|NCT01140451|529718238|FG001|Overall Study|Participants Planning Pregnancy|0|||
146876159|NCT00441974|529718239|FG000|Overall Study|Adverse Event|6|||
146876160|NCT00441974|529718239|FG000|Overall Study|Consent Withdrawn|35|||
146876161|NCT00441974|529718239|FG000|Overall Study|Lost to Follow-up|80|||
146876162|NCT00441974|529718239|FG000|Overall Study|Protocol Violation|7|||
146876163|NCT00661531|529718242|FG000|Overall Study|Withdrawal by Subject|3|||
146876164|NCT03134599|529718243|FG000|Week 1|Lost to Follow-up|0|||
146876165|NCT03134599|529718244|FG001|Week 1|Lost to Follow-up|0|||
146876166|NCT03134599|529718245|FG002|Week 1|Lost to Follow-up|0|||
146876167|NCT03134599|529718246|FG003|Week 1|Lost to Follow-up|0|||
146876168|NCT03134599|529718247|FG004|Week 1|Lost to Follow-up|1|||
146876169|NCT03134599|529718248|FG005|Week 1|Lost to Follow-up|0|||
146876170|NCT03134599|529718243|FG000|Week 2|Lost to Follow-up|1|||
146876171|NCT03134599|529718244|FG001|Week 2|Lost to Follow-up|0|||
146876172|NCT03134599|529718245|FG002|Week 2|Lost to Follow-up|0|||
146628919|NCT03181932|528818287|FG001|Period 2 (Open-label Period)|Reason missing|0|||
146628920|NCT03304626|528818288|FG000|Overall Study|Adverse Event|1|||
146628921|NCT03304626|528818289|FG001|Overall Study|Adverse Event|0|||
146628922|NCT03304626|528818288|FG000|Overall Study|Lack of Efficacy|1|||
146628923|NCT03304626|528818289|FG001|Overall Study|Lack of Efficacy|1|||
146628924|NCT00744497|528818290|FG000|Overall Study|Withdrawal by Subject|21|||
146628925|NCT00744497|528818291|FG001|Overall Study|Withdrawal by Subject|18|||
146628926|NCT00744497|528818290|FG000|Overall Study|Death|11|||
146628927|NCT00744497|528818291|FG001|Overall Study|Death|9|||
146628928|NCT00744497|528818290|FG000|Overall Study|Lost to Follow-up|4|||
146628929|NCT00744497|528818291|FG001|Overall Study|Lost to Follow-up|2|||
146628930|NCT00744497|528818290|FG000|Overall Study|Poor compliance/noncompliance|9|||
146628931|NCT00744497|528818291|FG001|Overall Study|Poor compliance/noncompliance|5|||
146628932|NCT00744497|528818290|FG000|Overall Study|No longer meets study criteria|7|||
146628933|NCT00744497|528818291|FG001|Overall Study|No longer meets study criteria|3|||
146628934|NCT00744497|528818290|FG000|Overall Study|Administrative Reason By Sponsor|25|||
146628935|NCT00744497|528818291|FG001|Overall Study|Administrative Reason By Sponsor|8|||
146628936|NCT00744497|528818290|FG000|Overall Study|Disease progression|312|||
146628937|NCT00744497|528818291|FG001|Overall Study|Disease progression|219|||
146628938|NCT00744497|528818290|FG000|Overall Study|Study drug toxicity|68|||
146628939|NCT00744497|528818291|FG001|Overall Study|Study drug toxicity|141|||
146628940|NCT00744497|528818290|FG000|Overall Study|Adverse event unrelated to study drug|78|||
146628941|NCT00744497|528818291|FG001|Overall Study|Adverse event unrelated to study drug|122|||
146628942|NCT00744497|528818290|FG000|Overall Study|Patient requested to stop study drug|65|||
146628943|NCT00744497|528818291|FG001|Overall Study|Patient requested to stop study drug|80|||
146628944|NCT00744497|528818290|FG000|Overall Study|Maximum clinical benefit|141|||
146628945|NCT00744497|528818291|FG001|Overall Study|Maximum clinical benefit|142|||
146628946|NCT00744497|528818290|FG000|Overall Study|Not defined|19|||
146628947|NCT00744497|528818291|FG001|Overall Study|Not defined|13|||
146628948|NCT03182374|528818296|FG000|Overall Study|Lost to Follow-up|3|||
146628949|NCT03182374|528818297|FG001|Overall Study|Lost to Follow-up|2|||
146628950|NCT03182374|528818296|FG000|Overall Study|Lack of Efficacy|8|||
146628951|NCT03182374|528818297|FG001|Overall Study|Lack of Efficacy|14|||
146628952|NCT03182374|528818296|FG000|Overall Study|Withdrawal by Subject|1|||
146628953|NCT03182374|528818297|FG001|Overall Study|Withdrawal by Subject|1|||
146628954|NCT03182374|528818296|FG000|Overall Study|exit for non-compliance|1|||
146628955|NCT03182374|528818297|FG001|Overall Study|exit for non-compliance|1|||
146628956|NCT03182374|528818296|FG000|Overall Study|one subject was randomized but not treated|1|||
146628957|NCT03182374|528818297|FG001|Overall Study|one subject was randomized but not treated|0|||
146628958|NCT03182374|528818296|FG000|Overall Study|Other reasons|0|||
146628959|NCT03182374|528818297|FG001|Overall Study|Other reasons|3|||
146628960|NCT03198715|528818298|FG000|Overall Study|Death|0|||
146628961|NCT03198715|528818299|FG001|Overall Study|Death|0|||
146628962|NCT03198715|528818300|FG002|Overall Study|Death|1|||
146628963|NCT03198715|528818301|FG003|Overall Study|Death|0|||
146628964|NCT03198715|528818302|FG004|Overall Study|Death|2|||
146628965|NCT03198715|528818298|FG000|Overall Study|Other|0|||
146628966|NCT03198715|528818299|FG001|Overall Study|Other|1|||
146628967|NCT03198715|528818300|FG002|Overall Study|Other|1|||
146628968|NCT03198715|528818301|FG003|Overall Study|Other|0|||
146628969|NCT03198715|528818302|FG004|Overall Study|Other|0|||
146876173|NCT03134599|529718246|FG003|Week 2|Lost to Follow-up|1|||
146876174|NCT03134599|529718247|FG004|Week 2|Lost to Follow-up|1|||
146876175|NCT03134599|529718248|FG005|Week 2|Lost to Follow-up|0|||
146876176|NCT03134599|529718243|FG000|Week 3|Lost to Follow-up|0|||
146876177|NCT03134599|529718244|FG001|Week 3|Lost to Follow-up|0|||
146876178|NCT03134599|529718245|FG002|Week 3|Lost to Follow-up|0|||
146876179|NCT03134599|529718246|FG003|Week 3|Lost to Follow-up|1|||
146628970|NCT00914316|528818305|FG000|Phase 1|Physician Decision|4|||
146628971|NCT00914316|528818306|FG001|Phase 1|Physician Decision|0|||
146628972|NCT00914316|528818307|FG002|Phase 1|Physician Decision|1|||
146628973|NCT00914316|528818308|FG003|Phase 1|Physician Decision|2|||
146628974|NCT00914316|528818305|FG000|Phase 1|Withdrawal by Subject|0|||
146628975|NCT00914316|528818306|FG001|Phase 1|Withdrawal by Subject|2|||
146628976|NCT00914316|528818307|FG002|Phase 1|Withdrawal by Subject|4|||
146628977|NCT00914316|528818308|FG003|Phase 1|Withdrawal by Subject|0|||
146628978|NCT00914316|528818305|FG000|Phase 1|Adverse Event|1|||
146628979|NCT00914316|528818306|FG001|Phase 1|Adverse Event|0|||
146628980|NCT00914316|528818307|FG002|Phase 1|Adverse Event|0|||
146628981|NCT00914316|528818308|FG003|Phase 1|Adverse Event|0|||
146628982|NCT00914316|528818305|FG000|Phase 2|Withdrawal by Subject|1|||
146628983|NCT00914316|528818306|FG001|Phase 2|Withdrawal by Subject|0|||
146628984|NCT00914316|528818307|FG002|Phase 2|Withdrawal by Subject|1|||
146628985|NCT00914316|528818308|FG003|Phase 2|Withdrawal by Subject|0|||
146628986|NCT02399163|528818311|FG000|Overall Study|Adverse Event|2|||
146628987|NCT02399163|528818311|FG000|Overall Study|Protocol Deviation|2|||
146876180|NCT03134599|529718247|FG004|Week 3|Lost to Follow-up|0|||
146628988|NCT02399163|528818311|FG000|Overall Study|Withdrawal by Participant|5|||
146628989|NCT01391546|528818317|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
146876181|NCT03134599|529718248|FG005|Week 3|Lost to Follow-up|1|||
146876182|NCT01265615|529718249|FG000|Overall Study|Protocol Violation|2|||
146876183|NCT01265615|529718250|FG001|Overall Study|Protocol Violation|2|||
146876184|NCT01265615|529718251|FG002|Overall Study|Protocol Violation|4|||
146876185|NCT01265615|529718252|FG003|Overall Study|Protocol Violation|3|||
146876186|NCT02576444|529718259|FG000|Overall Study|Death|1|||
146876187|NCT02576444|529718260|FG001|Overall Study|Death|1|||
146876188|NCT02576444|529718261|FG002|Overall Study|Death|0|||
146876189|NCT02576444|529718262|FG003|Overall Study|Death|0|||
146876190|NCT02576444|529718259|FG000|Overall Study|Withdrawal by Subject|0|||
146876191|NCT02576444|529718260|FG001|Overall Study|Withdrawal by Subject|0|||
146876192|NCT02576444|529718261|FG002|Overall Study|Withdrawal by Subject|2|||
146876193|NCT02576444|529718262|FG003|Overall Study|Withdrawal by Subject|0|||
146876194|NCT02576444|529718259|FG000|Overall Study|Adverse Event|0|||
146876195|NCT02576444|529718260|FG001|Overall Study|Adverse Event|0|||
146876196|NCT02576444|529718261|FG002|Overall Study|Adverse Event|1|||
146876197|NCT02576444|529718262|FG003|Overall Study|Adverse Event|0|||
146876198|NCT02576444|529718259|FG000|Overall Study|Physician Decision|0|||
146876199|NCT02576444|529718260|FG001|Overall Study|Physician Decision|0|||
146876200|NCT02576444|529718261|FG002|Overall Study|Physician Decision|1|||
146876201|NCT02576444|529718262|FG003|Overall Study|Physician Decision|0|||
146876202|NCT03370120|529718265|FG000|Overall Study|Adverse event, non-fatal|24|||
146876203|NCT03370120|529718265|FG000|Overall Study|Withdrawal by Subject|6|||
146876204|NCT03370120|529718265|FG000|Overall Study|Lost to Follow-up|1|||
146876205|NCT03370120|529718265|FG000|Overall Study|Lack of Efficacy|37|||
146876206|NCT03370120|529718265|FG000|Overall Study|Per sponsor's instructions|1|||
146876207|NCT03370120|529718265|FG000|Overall Study|Study was terminated by parent company UCB|2|||
146876208|NCT03370120|529718265|FG000|Overall Study|The study was ended by the promoter|3|||
146876209|NCT03370120|529718265|FG000|Overall Study|Discontinuation of drug development|3|||
146876210|NCT03370120|529718265|FG000|Overall Study|End of project|2|||
146876211|NCT03370120|529718265|FG000|Overall Study|Premature study closure|2|||
146876212|NCT03370120|529718265|FG000|Overall Study|Premature program termination|1|||
146876213|NCT03370120|529718265|FG000|Overall Study|Premature study termination|7|||
146876214|NCT03370120|529718265|FG000|Overall Study|Trial terminated by sponsor|2|||
146876215|NCT03370120|529718265|FG000|Overall Study|Trial discontinued by sponsor|2|||
146876216|NCT03370120|529718265|FG000|Overall Study|Study ended|15|||
146876217|NCT03370120|529718265|FG000|Overall Study|Clinical trial has been cancelled|1|||
146876218|NCT03370120|529718265|FG000|Overall Study|End of study per sponsor decision|2|||
146876219|NCT03370120|529718265|FG000|Overall Study|Promoter's decision|2|||
146876220|NCT03370120|529718265|FG000|Overall Study|The trial has been suspended|3|||
146876221|NCT03370120|529718265|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
146876222|NCT03370120|529718265|FG000|Overall Study|Early termination by order of sponsor|2|||
146876223|NCT03370120|529718265|FG000|Overall Study|Discontinuation of the study|5|||
146876224|NCT03370120|529718265|FG000|Overall Study|End of clinical trial discontinuation|1|||
146876225|NCT03370120|529718265|FG000|Overall Study|Because the clinical trial ended halfway|4|||
146876226|NCT03370120|529718265|FG000|Overall Study|Development discontinued|5|||
146876227|NCT03370120|529718265|FG000|Overall Study|Padsenovil program closed|3|||
146876228|NCT03370120|529718265|FG000|Overall Study|End of project|2|||
146876229|NCT03370120|529718265|FG000|Overall Study|Termination of project|1|||
146876230|NCT03370120|529718265|FG000|Overall Study|The study was interrupted by sponsor|4|||
146876231|NCT03370120|529718265|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
146876232|NCT03370120|529718265|FG000|Overall Study|End of sponsor decision|1|||
146876233|NCT03370120|529718265|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
146876234|NCT03370120|529718265|FG000|Overall Study|Early termination of studies|5|||
146876235|NCT03370120|529718265|FG000|Overall Study|This study is ended early|1|||
146876236|NCT03370120|529718265|FG000|Overall Study|End of padsevonil program|2|||
146876237|NCT03370120|529718265|FG000|Overall Study|Decision of sponsor|6|||
146876238|NCT03370120|529718265|FG000|Overall Study|Asked by the sponsor|3|||
146876239|NCT03370120|529718265|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
146876240|NCT03370120|529718265|FG000|Overall Study|PI decision poor compliance from participant|1|||
146876241|NCT03370120|529718265|FG000|Overall Study|Promoter ended the study|3|||
146876242|NCT03370120|529718265|FG000|Overall Study|Premature study close by sponsor's decision|4|||
146876243|NCT03370120|529718265|FG000|Overall Study|Study terminated by sponsor|33|||
146876244|NCT03370120|529718265|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
146876245|NCT03370120|529718265|FG000|Overall Study|Sponsor decision to terminate study|63|||
146876246|NCT03370120|529718265|FG000|Overall Study|Program closure|3|||
146876247|NCT03370120|529718265|FG000|Overall Study|Study ended prematurely|1|||
146876248|NCT03370120|529718265|FG000|Overall Study|Study stopped by sponsor|2|||
146876249|NCT03370120|529718265|FG000|Overall Study|Program termination|55|||
146876250|NCT03370120|529718265|FG000|Overall Study|Sponsor decision|62|||
146876251|NCT03370120|529718265|FG000|Overall Study|Sponsor study closure|10|||
146876252|NCT04206020|529718266|FG000|Overall Study|Adverse Event|1|||
146876253|NCT04206020|529718267|FG001|Overall Study|Adverse Event|4|||
146876254|NCT04206020|529718266|FG000|Overall Study|Protocol Violation|2|||
146876255|NCT04206020|529718267|FG001|Overall Study|Protocol Violation|0|||
146876256|NCT04206020|529718266|FG000|Overall Study|Withdrawal by Subject|2|||
146876257|NCT04206020|529718267|FG001|Overall Study|Withdrawal by Subject|0|||
146876258|NCT04206020|529718266|FG000|Overall Study|Lost to Follow-up|2|||
146876259|NCT04206020|529718267|FG001|Overall Study|Lost to Follow-up|0|||
146876260|NCT04206020|529718266|FG000|Overall Study|Pregnancy|0|||
146876261|NCT04206020|529718267|FG001|Overall Study|Pregnancy|1|||
146876262|NCT04206020|529718266|FG000|Overall Study|Unable to attend visits|1|||
146876263|NCT04206020|529718267|FG001|Overall Study|Unable to attend visits|2|||
146876264|NCT02700412|529718268|FG000|Overall Study|Adverse Event|6|||
146876265|NCT02700412|529718268|FG000|Overall Study|Death|1|||
146876266|NCT02700412|529718268|FG000|Overall Study|Lack of Efficacy|19|||
146876267|NCT02700412|529718268|FG000|Overall Study|Protocol Violation|5|||
146876268|NCT02700412|529718268|FG000|Overall Study|Withdrawal by Subject|2|||
146876269|NCT04962022|529718270|FG000|Period 1|Withdrawal by Subject|1|||
146876270|NCT04962022|529718271|FG001|Period 1|Withdrawal by Subject|0|||
146876271|NCT04416555|529718274|FG000|Overall Study|Withdrawal by Subject|0|||
146876272|NCT04416555|529718275|FG001|Overall Study|Withdrawal by Subject|3|||
146876273|NCT00530270|529718276|FG000|Overall Study|Protocol Violation|1|||
146876274|NCT00530270|529718277|FG001|Overall Study|Protocol Violation|0|||
146876275|NCT01356407|529718288|FG000|Overall Study|Lost to Follow-up|2|||
146876276|NCT01356407|529718289|FG001|Overall Study|Lost to Follow-up|0|||
146876277|NCT01356407|529718288|FG000|Overall Study|Patient Withdrew Consent|2|||
146876278|NCT01356407|529718289|FG001|Overall Study|Patient Withdrew Consent|1|||
146876279|NCT01356407|529718288|FG000|Overall Study|Could not afford IMP administration|0|||
146876280|NCT01356407|529718289|FG001|Overall Study|Could not afford IMP administration|1|||
146876281|NCT01356407|529718288|FG000|Overall Study|Not complete Endoscopy|2|||
146876282|NCT01356407|529718289|FG001|Overall Study|Not complete Endoscopy|2|||
146876283|NCT01309659|529718290|FG000|Overall Study|Protocol Violation|0|||
146876284|NCT01309659|529718291|FG001|Overall Study|Protocol Violation|1|||
146876285|NCT02018822|529718292|FG000|Overall Study|filling replaced by crown|0|||
146876286|NCT02018822|529718293|FG001|Overall Study|filling replaced by crown|1|||
146876287|NCT02018822|529718294|FG002|Overall Study|filling replaced by crown|0|||
146876288|NCT02018822|529718292|FG000|Overall Study|Physician Decision|0|||
146876289|NCT02018822|529718293|FG001|Overall Study|Physician Decision|1|||
146876290|NCT02018822|529718294|FG002|Overall Study|Physician Decision|1|||
146876291|NCT02018822|529718292|FG000|Overall Study|Lost to Follow-up|6|||
146876292|NCT02018822|529718293|FG001|Overall Study|Lost to Follow-up|6|||
146876293|NCT02018822|529718294|FG002|Overall Study|Lost to Follow-up|5|||
146876294|NCT03201458|529718295|FG000|Overall Study|No longer eligible|2|||
146876295|NCT03201458|529718296|FG001|Overall Study|No longer eligible|5|||
146876296|NCT03201458|529718295|FG000|Overall Study|Health event before starting|1|||
146876297|NCT03201458|529718296|FG001|Overall Study|Health event before starting|0|||
146876298|NCT03201458|529718295|FG000|Overall Study|Physician Decision|1|||
146876299|NCT03201458|529718296|FG001|Overall Study|Physician Decision|0|||
146876300|NCT00715026|529718299|FG000|Overall Study|Withdrawal by Subject|5|||
146876301|NCT00715026|529718299|FG000|Overall Study|Lost to Follow-up|3|||
146876302|NCT00715026|529718299|FG000|Overall Study|Protocol Violation|1|||
146876303|NCT00715026|529718299|FG000|Overall Study|Surgery done on non-study consented hip|1|||
146876304|NCT00552175|529718300|FG000|Overall Study|Lack of Efficacy|2|||
146876305|NCT00552175|529718301|FG001|Overall Study|Lack of Efficacy|0|||
146876306|NCT00552175|529718302|FG002|Overall Study|Lack of Efficacy|1|||
146876307|NCT00552175|529718300|FG000|Overall Study|Adverse Event|9|||
146876308|NCT00552175|529718301|FG001|Overall Study|Adverse Event|9|||
146876309|NCT00552175|529718302|FG002|Overall Study|Adverse Event|10|||
146876310|NCT00552175|529718300|FG000|Overall Study|Withdrawal by Subject|2|||
146876311|NCT00552175|529718301|FG001|Overall Study|Withdrawal by Subject|2|||
146876312|NCT00552175|529718302|FG002|Overall Study|Withdrawal by Subject|1|||
146876313|NCT00552175|529718300|FG000|Overall Study|Lost to Follow-up|0|||
146876314|NCT00552175|529718301|FG001|Overall Study|Lost to Follow-up|0|||
146876315|NCT00552175|529718302|FG002|Overall Study|Lost to Follow-up|1|||
146876316|NCT00552175|529718300|FG000|Overall Study|Entry Criteria Not Met|1|||
146544198|NCT02335944|528498568|FG004|Post-treatment Follow-up|Adverse Event|0|||
146876317|NCT00552175|529718301|FG001|Overall Study|Entry Criteria Not Met|1|||
146876318|NCT00552175|529718302|FG002|Overall Study|Entry Criteria Not Met|0|||
146876319|NCT00552175|529718300|FG000|Overall Study|Reason Not Specified|3|||
146876320|NCT00552175|529718301|FG001|Overall Study|Reason Not Specified|1|||
146876321|NCT00552175|529718302|FG002|Overall Study|Reason Not Specified|1|||
146876322|NCT00750737|529718303|FG000|Overall Study|Withdrawal by Subject|3|||
146876323|NCT00750737|529718304|FG001|Overall Study|Withdrawal by Subject|3|||
146876324|NCT02614859|529718305|FG000|Overall Study|Physician Decision|0|||
146544199|NCT02335944|528498569|FG005|Post-treatment Follow-up|Adverse Event|1|||
146876325|NCT02614859|529718306|FG001|Overall Study|Physician Decision|1|||
146876326|NCT03972969|529718308|FG000|3-month Follow-up|Death|1|||
146876327|NCT03972969|529718309|FG001|3-month Follow-up|Death|1|||
146876328|NCT03972969|529718310|FG002|3-month Follow-up|Death|0|||
146876329|NCT03972969|529718308|FG000|6-month Follow-up|Death|1|||
146876330|NCT03972969|529718309|FG001|6-month Follow-up|Death|1|||
146876331|NCT03972969|529718310|FG002|6-month Follow-up|Death|1|||
146876332|NCT03972969|529718308|FG000|6-month Follow-up|Lost to Follow-up|2|||
146876333|NCT03972969|529718309|FG001|6-month Follow-up|Lost to Follow-up|2|||
146876334|NCT03972969|529718310|FG002|6-month Follow-up|Lost to Follow-up|2|||
146876335|NCT01399788|529718314|FG000|First Intervention Period|Adverse Event|1|||
146876336|NCT01399788|529718315|FG001|First Intervention Period|Adverse Event|0|||
146876337|NCT02919436|529718316|FG000|Overall Study|Did not undergo surgery|16|||
146876338|NCT02919436|529718317|FG001|Overall Study|Did not undergo surgery|20|||
146876339|NCT02919436|529718316|FG000|Overall Study|Enrolled before trial registration|44|||
146876340|NCT02919436|529718317|FG001|Overall Study|Enrolled before trial registration|33|||
146876341|NCT00283595|529718319|FG000|Overall Study|Withdrawal by Subject|1|||
146876342|NCT00283595|529718320|FG001|Overall Study|Withdrawal by Subject|2|||
146876343|NCT01389752|529718321|FG000|Study Period 1|Sponsor decision|0|||
146876344|NCT01389752|529718322|FG001|Study Period 1|Sponsor decision|2|||
146876345|NCT01389752|529718321|FG000|Study Period 2|Sponsor decision|1|||
146876346|NCT01389752|529718322|FG001|Study Period 2|Sponsor decision|0|||
146876347|NCT03259074|529718323|FG000|Overall Study|Adverse Event|9|||
146876348|NCT03259074|529718324|FG001|Overall Study|Adverse Event|12|||
146876349|NCT03259074|529718325|FG002|Overall Study|Adverse Event|8|||
146876350|NCT03259074|529718323|FG000|Overall Study|Death|1|||
146876351|NCT03259074|529718324|FG001|Overall Study|Death|1|||
146876352|NCT03259074|529718325|FG002|Overall Study|Death|3|||
146876353|NCT03259074|529718323|FG000|Overall Study|Lost to Follow-up|2|||
146876354|NCT03259074|529718324|FG001|Overall Study|Lost to Follow-up|4|||
146876355|NCT03259074|529718325|FG002|Overall Study|Lost to Follow-up|3|||
146876356|NCT03259074|529718323|FG000|Overall Study|New Therapy For Study Indication|1|||
146876357|NCT03259074|529718324|FG001|Overall Study|New Therapy For Study Indication|2|||
146876358|NCT03259074|529718325|FG002|Overall Study|New Therapy For Study Indication|2|||
146876359|NCT03259074|529718323|FG000|Overall Study|Physician Decision|4|||
146876360|NCT03259074|529718324|FG001|Overall Study|Physician Decision|12|||
146544200|NCT02335944|528498570|FG006|Post-treatment Follow-up|Adverse Event|0|||
146544201|NCT02335944|528498571|FG007|Post-treatment Follow-up|Adverse Event|0|||
146876361|NCT03259074|529718325|FG002|Overall Study|Physician Decision|10|||
146544202|NCT02335944|528498572|FG008|Post-treatment Follow-up|Adverse Event|0|||
146544203|NCT02335944|528498573|FG009|Post-treatment Follow-up|Adverse Event|0|||
146876362|NCT03259074|529718323|FG000|Overall Study|Pregnancy|1|||
146876363|NCT03259074|529718324|FG001|Overall Study|Pregnancy|1|||
146876364|NCT03259074|529718325|FG002|Overall Study|Pregnancy|0|||
146876365|NCT03259074|529718323|FG000|Overall Study|Progressive Disease|1|||
146876366|NCT03259074|529718324|FG001|Overall Study|Progressive Disease|0|||
146876367|NCT03259074|529718325|FG002|Overall Study|Progressive Disease|0|||
146876368|NCT03259074|529718323|FG000|Overall Study|Protocol Deviation|1|||
146876369|NCT03259074|529718324|FG001|Overall Study|Protocol Deviation|1|||
146876370|NCT03259074|529718325|FG002|Overall Study|Protocol Deviation|3|||
146876371|NCT03259074|529718323|FG000|Overall Study|Subject/Guardian Decision|13|||
146876372|NCT03259074|529718324|FG001|Overall Study|Subject/Guardian Decision|16|||
146876373|NCT03259074|529718325|FG002|Overall Study|Subject/Guardian Decision|14|||
146876374|NCT00053417|529718336|FG000|Overall Study|Adverse Event|1|||
146876375|NCT00053417|529718337|FG001|Overall Study|Adverse Event|0|||
146876376|NCT00053417|529718338|FG002|Overall Study|Adverse Event|1|||
146876377|NCT00053417|529718339|FG003|Overall Study|Adverse Event|5|||
146876378|NCT00053417|529718336|FG000|Overall Study|Non-Compliance|0|||
146876379|NCT00053417|529718337|FG001|Overall Study|Non-Compliance|0|||
146876380|NCT00053417|529718338|FG002|Overall Study|Non-Compliance|0|||
146876381|NCT00053417|529718339|FG003|Overall Study|Non-Compliance|1|||
146876382|NCT00053417|529718336|FG000|Overall Study|Withdrawal by Subject|0|||
146876383|NCT00053417|529718337|FG001|Overall Study|Withdrawal by Subject|1|||
146544204|NCT02335944|528498564|FG000|Post-treatment Follow-up|Death|0|||
146544205|NCT02335944|528498565|FG001|Post-treatment Follow-up|Death|0|||
146876384|NCT00053417|529718338|FG002|Overall Study|Withdrawal by Subject|0|||
146876385|NCT00053417|529718339|FG003|Overall Study|Withdrawal by Subject|0|||
146876386|NCT00053417|529718336|FG000|Overall Study|Lost to Follow-up|1|||
146876387|NCT00053417|529718337|FG001|Overall Study|Lost to Follow-up|1|||
146876388|NCT00053417|529718338|FG002|Overall Study|Lost to Follow-up|0|||
146876389|NCT00053417|529718339|FG003|Overall Study|Lost to Follow-up|0|||
146876390|NCT00705783|529718342|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
146876391|NCT00705783|529718343|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
146876392|NCT00705783|529718344|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
146876393|NCT00705783|529718342|FG000|Conversion Phase|Lost to Follow-up|13|||
146876394|NCT00705783|529718343|FG001|Conversion Phase|Lost to Follow-up|0|||
146876395|NCT00705783|529718344|FG002|Conversion Phase|Lost to Follow-up|0|||
146876396|NCT00705783|529718342|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
146876397|NCT00705783|529718343|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
146876398|NCT00705783|529718344|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
146876399|NCT00705783|529718342|FG000|Conversion Phase|Withdrawn by Investigator|4|||
146876400|NCT00705783|529718343|FG001|Conversion Phase|Withdrawn by Investigator|0|||
146876401|NCT00705783|529718344|FG002|Conversion Phase|Withdrawn by Investigator|0|||
146544206|NCT02335944|528498566|FG002|Post-treatment Follow-up|Death|0|||
146544207|NCT02335944|528498567|FG003|Post-treatment Follow-up|Death|1|||
146544208|NCT02335944|528498568|FG004|Post-treatment Follow-up|Death|0|||
146544209|NCT02335944|528498569|FG005|Post-treatment Follow-up|Death|1|||
146544210|NCT02335944|528498570|FG006|Post-treatment Follow-up|Death|0|||
146544211|NCT02335944|528498571|FG007|Post-treatment Follow-up|Death|0|||
146544212|NCT02335944|528498572|FG008|Post-treatment Follow-up|Death|0|||
146544213|NCT02335944|528498573|FG009|Post-treatment Follow-up|Death|0|||
146544214|NCT02335944|528498564|FG000|Post-treatment Follow-up|Physician Decision|1|||
146544215|NCT02335944|528498565|FG001|Post-treatment Follow-up|Physician Decision|0|||
146544216|NCT02335944|528498566|FG002|Post-treatment Follow-up|Physician Decision|0|||
146544217|NCT02335944|528498567|FG003|Post-treatment Follow-up|Physician Decision|0|||
146544218|NCT02335944|528498568|FG004|Post-treatment Follow-up|Physician Decision|0|||
146544219|NCT02335944|528498569|FG005|Post-treatment Follow-up|Physician Decision|0|||
146544220|NCT02335944|528498570|FG006|Post-treatment Follow-up|Physician Decision|0|||
146544221|NCT02335944|528498571|FG007|Post-treatment Follow-up|Physician Decision|1|||
146544222|NCT02335944|528498572|FG008|Post-treatment Follow-up|Physician Decision|0|||
146544223|NCT02335944|528498573|FG009|Post-treatment Follow-up|Physician Decision|0|||
146544224|NCT03018938|528498574|FG000|Overall Study|Death|0|||
146544225|NCT03018938|528498575|FG001|Overall Study|Death|1|||
146544226|NCT03018938|528498574|FG000|Overall Study|Lost to Follow-up|21|||
146544227|NCT03018938|528498575|FG001|Overall Study|Lost to Follow-up|32|||
146544228|NCT03018938|528498574|FG000|Overall Study|Withdrawal by Subject|38|||
146876402|NCT00705783|529718342|FG000|Conversion Phase|Withdrew Consent|24|||
146876403|NCT00705783|529718343|FG001|Conversion Phase|Withdrew Consent|0|||
146876404|NCT00705783|529718344|FG002|Conversion Phase|Withdrew Consent|0|||
146876405|NCT00705783|529718342|FG000|Conversion Phase|Protocol Deviation|2|||
146876406|NCT00705783|529718343|FG001|Conversion Phase|Protocol Deviation|0|||
146876407|NCT00705783|529718344|FG002|Conversion Phase|Protocol Deviation|0|||
146876408|NCT00705783|529718342|FG000|Conversion Phase|Adverse Event|11|||
146876409|NCT00705783|529718343|FG001|Conversion Phase|Adverse Event|0|||
146876410|NCT00705783|529718344|FG002|Conversion Phase|Adverse Event|0|||
146876411|NCT00705783|529718342|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
146876412|NCT00705783|529718343|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
146876413|NCT00705783|529718344|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
146876414|NCT00705783|529718342|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
146876415|NCT00705783|529718343|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
146876416|NCT00705783|529718344|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
146876417|NCT00705783|529718342|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
146876418|NCT00705783|529718343|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
146876419|NCT00705783|529718344|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
146876420|NCT00705783|529718342|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
146876421|NCT00705783|529718343|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
146876422|NCT00705783|529718344|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
146876423|NCT00705783|529718342|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
146876424|NCT00705783|529718343|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
146876425|NCT00705783|529718344|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
146876426|NCT00705783|529718342|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
146876427|NCT00705783|529718343|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
146876428|NCT00705783|529718344|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
146876429|NCT00705783|529718342|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
146876430|NCT00705783|529718343|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
146876431|NCT00705783|529718344|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
146876432|NCT00705783|529718342|FG000|Oral Stabilization Phase|Adverse Event|14|||
146876433|NCT00705783|529718343|FG001|Oral Stabilization Phase|Adverse Event|0|||
146876434|NCT00705783|529718344|FG002|Oral Stabilization Phase|Adverse Event|0|||
146876435|NCT00705783|529718342|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
146876436|NCT00705783|529718343|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
146876437|NCT00705783|529718344|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
146876438|NCT00705783|529718342|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
146876439|NCT00705783|529718343|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
146876440|NCT00705783|529718344|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
146876441|NCT00705783|529718342|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
146876442|NCT00705783|529718343|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
146876443|NCT00705783|529718344|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
146876444|NCT00705783|529718342|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
146876445|NCT00705783|529718343|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
146876446|NCT00705783|529718344|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
146876447|NCT00705783|529718342|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
146876448|NCT00705783|529718343|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
146876449|NCT00705783|529718344|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
146876450|NCT00705783|529718342|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
146876451|NCT00705783|529718343|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
146876452|NCT00705783|529718344|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
146876453|NCT00705783|529718342|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
146876454|NCT00705783|529718343|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
146876455|NCT00705783|529718344|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
146876456|NCT00705783|529718342|FG000|Depot Stabilization Phase|Adverse Event|17|||
146876457|NCT00705783|529718343|FG001|Depot Stabilization Phase|Adverse Event|0|||
146876458|NCT00705783|529718344|FG002|Depot Stabilization Phase|Adverse Event|0|||
146876459|NCT00705783|529718342|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
146876460|NCT00705783|529718343|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
146876461|NCT00705783|529718344|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
146876462|NCT00705783|529718342|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
146876463|NCT00705783|529718343|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
146876464|NCT00705783|529718344|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
146876465|NCT00705783|529718342|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
146876466|NCT00705783|529718343|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
146876467|NCT00705783|529718344|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
146876468|NCT00705783|529718342|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
146876469|NCT00705783|529718343|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
146876470|NCT00705783|529718344|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
146876471|NCT00705783|529718342|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
146876472|NCT00705783|529718343|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
146876473|NCT00705783|529718344|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
146876474|NCT00705783|529718342|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
146876475|NCT00705783|529718343|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
146876476|NCT00705783|529718344|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
146876477|NCT00705783|529718342|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
146876478|NCT00705783|529718343|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
146876479|NCT00705783|529718344|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
146876480|NCT00705783|529718342|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
146876481|NCT00705783|529718343|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
146876482|NCT00705783|529718344|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
146876483|NCT00705783|529718342|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
146876484|NCT00705783|529718343|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
146876485|NCT00705783|529718344|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
146876486|NCT00705783|529718342|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
146876487|NCT00705783|529718343|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
146876488|NCT00705783|529718344|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
146544229|NCT03018938|528498575|FG001|Overall Study|Withdrawal by Subject|45|||
146544230|NCT03018938|528498574|FG000|Overall Study|Physician Decision|3|||
146544231|NCT03018938|528498575|FG001|Overall Study|Physician Decision|2|||
146544232|NCT03018938|528498574|FG000|Overall Study|Sponsor Decision|0|||
146544233|NCT03018938|528498575|FG001|Overall Study|Sponsor Decision|1|||
146876489|NCT00705783|529718342|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
146876490|NCT00705783|529718343|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
146876491|NCT00705783|529718344|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
146876492|NCT02184195|529718348|FG000|Overall Study|Patient decision|5|||
146876493|NCT02184195|529718349|FG001|Overall Study|Patient decision|2|||
146876494|NCT02184195|529718348|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146876495|NCT02184195|529718349|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146876496|NCT02184195|529718348|FG000|Overall Study|Death|67|||
146876497|NCT02184195|529718349|FG001|Overall Study|Death|44|||
146876498|NCT02184195|529718348|FG000|Overall Study|Lost to Follow-up|1|||
146876499|NCT02184195|529718349|FG001|Overall Study|Lost to Follow-up|5|||
146876500|NCT02184195|529718348|FG000|Overall Study|Other|0|||
146876501|NCT02184195|529718349|FG001|Overall Study|Other|3|||
146876502|NCT02285998|529718350|FG000|Overall Study|Adverse Event|9|||
146876503|NCT02285998|529718351|FG001|Overall Study|Adverse Event|8|||
146876504|NCT02285998|529718350|FG000|Overall Study|Physician Decision|1|||
146876505|NCT02285998|529718351|FG001|Overall Study|Physician Decision|2|||
146876506|NCT02285998|529718350|FG000|Overall Study|Lost to Follow-up|176|||
146876507|NCT02285998|529718351|FG001|Overall Study|Lost to Follow-up|172|||
146876508|NCT02285998|529718350|FG000|Overall Study|Withdrawal by Subject|53|||
146876509|NCT02285998|529718351|FG001|Overall Study|Withdrawal by Subject|61|||
146876510|NCT02285998|529718350|FG000|Overall Study|Other Reasons|7|||
146876511|NCT02285998|529718351|FG001|Overall Study|Other Reasons|10|||
146876512|NCT00841568|529718352|FG000|Overall Study|Adverse Event|1|||
146876513|NCT00841568|529718352|FG000|Overall Study|Death|1|||
146876514|NCT00841568|529718352|FG000|Overall Study|Withdrawal by Subject|2|||
146876515|NCT00841568|529718352|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
146876516|NCT00978029|529718353|FG000|Overall Study|Adverse Event|1|||
146876517|NCT00978029|529718354|FG001|Overall Study|Adverse Event|2|||
146876518|NCT00978029|529718355|FG002|Overall Study|Adverse Event|5|||
146876519|NCT00978029|529718353|FG000|Overall Study|Withdrawal by Subject|0|||
146876520|NCT00978029|529718354|FG001|Overall Study|Withdrawal by Subject|0|||
146876521|NCT00978029|529718355|FG002|Overall Study|Withdrawal by Subject|1|||
146876522|NCT00978029|529718353|FG000|Overall Study|Protocol Violation|0|||
146876523|NCT00978029|529718354|FG001|Overall Study|Protocol Violation|1|||
146876524|NCT00978029|529718355|FG002|Overall Study|Protocol Violation|0|||
146876525|NCT00545298|529718356|FG000|Overall Study|Issues with Standard of Care|2|||
146876526|NCT00545298|529718357|FG001|Overall Study|Issues with Standard of Care|0|||
146876527|NCT00545298|529718358|FG002|Overall Study|Issues with Standard of Care|1|||
146876528|NCT02830776|529718359|FG000|Overall Study|Lost to Follow-up|1|||
146876529|NCT01820364|529718360|FG000|Part I: LGX818|Death|1|||
146876530|NCT01820364|529718361|FG001|Part I: LGX818|Death|0|||
146876531|NCT01820364|529718360|FG000|Part I: LGX818|Administrative Problems|3|||
146876532|NCT01820364|529718361|FG001|Part I: LGX818|Administrative Problems|0|||
146876533|NCT01820364|529718360|FG000|Part I: LGX818|Adverse Event|6|||
146876534|NCT01820364|529718361|FG001|Part I: LGX818|Adverse Event|0|||
146876535|NCT01820364|529718360|FG000|Part I: LGX818|Disease Progression|4|||
146876536|NCT01820364|529718361|FG001|Part I: LGX818|Disease Progression|0|||
146876537|NCT01820364|529718360|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
146876538|NCT01820364|529718361|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
146876539|NCT01793142|529718362|FG000|Overall Study|Randomized not treated|7|||
146876540|NCT01087775|529718368|FG000|Overall Study|failed inclusion criteria|2|||
146876541|NCT03029143|529718369|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
146876542|NCT03029143|529718370|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
146876543|NCT03029143|529718371|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
146876544|NCT03029143|529718369|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
146876545|NCT03029143|529718370|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
146876546|NCT03029143|529718371|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
146876547|NCT03029143|529718369|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
146876548|NCT03029143|529718370|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
146876549|NCT03029143|529718371|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
146876550|NCT03029143|529718369|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
146628990|NCT01391546|528818318|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
146628991|NCT04225897|528818324|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146628992|NCT04225897|528818325|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
146628993|NCT04225897|528818326|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146628994|NCT04225897|528818327|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146628995|NCT04225897|528818328|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146628996|NCT04225897|528818329|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146628997|NCT04225897|528818330|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146628998|NCT04225897|528818331|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146628999|NCT04225897|528818332|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146629000|NCT04225897|528818333|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146629001|NCT04225897|528818334|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146629002|NCT04225897|528818335|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146629003|NCT04225897|528818324|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146629004|NCT04225897|528818325|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146629005|NCT04225897|528818326|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
146629006|NCT04225897|528818327|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146629007|NCT04225897|528818328|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146629008|NCT04225897|528818329|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146629009|NCT04225897|528818330|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146629010|NCT04225897|528818331|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146629011|NCT04225897|528818332|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146629012|NCT04225897|528818333|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146629013|NCT04225897|528818334|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146629014|NCT04225897|528818335|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146629015|NCT04225897|528818324|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146629016|NCT04225897|528818325|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146629017|NCT04225897|528818326|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
146629018|NCT04225897|528818327|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146629019|NCT04225897|528818328|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146876551|NCT03029143|529718370|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
146876552|NCT03029143|529718371|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
146876553|NCT03029143|529718369|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
146876554|NCT03029143|529718370|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
146876555|NCT03029143|529718371|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
146876556|NCT03029143|529718369|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
146876557|NCT03029143|529718370|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
146876558|NCT03029143|529718371|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
146876559|NCT03029143|529718369|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
146876560|NCT03029143|529718370|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
146876561|NCT03029143|529718371|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
146876562|NCT03029143|529718369|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146876563|NCT03029143|529718370|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146876564|NCT03029143|529718371|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
146876565|NCT03029143|529718369|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
146876566|NCT03029143|529718370|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
146876567|NCT03029143|529718371|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
146876568|NCT03029143|529718369|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
146876569|NCT03029143|529718370|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
146876570|NCT03029143|529718371|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
146876571|NCT03029143|529718369|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
146876572|NCT03029143|529718370|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
146876573|NCT03029143|529718371|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
146876574|NCT00974675|529718374|FG000|Overall Study|Adverse Event|2|||
146876575|NCT00974675|529718375|FG001|Overall Study|Adverse Event|1|||
146876576|NCT00974675|529718376|FG002|Overall Study|Adverse Event|1|||
146876577|NCT00974675|529718377|FG003|Overall Study|Adverse Event|1|||
146876578|NCT00974675|529718374|FG000|Overall Study|Physician Decision|0|||
146876579|NCT00974675|529718375|FG001|Overall Study|Physician Decision|0|||
146544234|NCT03018938|528498574|FG000|Overall Study|Screen failure-After randomization|4|||
146544235|NCT03018938|528498575|FG001|Overall Study|Screen failure-After randomization|2|||
146764835|NCT00197015|529305942|FG002|Overall Study|Withdrawal by Subject|34|||
146876580|NCT00974675|529718376|FG002|Overall Study|Physician Decision|1|||
146876581|NCT00974675|529718377|FG003|Overall Study|Physician Decision|0|||
146876582|NCT00974675|529718374|FG000|Overall Study|Participant on holiday; unable to attend|0|||
146629020|NCT04225897|528818329|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146629021|NCT04225897|528818330|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146629022|NCT04225897|528818331|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146629023|NCT04225897|528818332|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146629024|NCT04225897|528818333|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146629025|NCT04225897|528818334|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146629026|NCT04225897|528818335|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146629027|NCT04225897|528818324|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146629028|NCT04225897|528818325|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146629029|NCT04225897|528818326|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146629030|NCT04225897|528818327|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146629031|NCT04225897|528818328|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146629032|NCT04225897|528818329|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146629033|NCT04225897|528818330|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146629034|NCT04225897|528818331|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
146876583|NCT00974675|529718375|FG001|Overall Study|Participant on holiday; unable to attend|0|||
146876584|NCT00974675|529718376|FG002|Overall Study|Participant on holiday; unable to attend|0|||
146876585|NCT00974675|529718377|FG003|Overall Study|Participant on holiday; unable to attend|1|||
146876586|NCT05885737|529718383|FG000|DB Period|Adverse Event|4|||
146876587|NCT05885737|529718384|FG001|DB Period|Adverse Event|4|||
146876588|NCT05885737|529718383|FG000|DB Period|Lost to Follow-up|0|||
146876589|NCT05885737|529718384|FG001|DB Period|Lost to Follow-up|1|||
146876590|NCT05885737|529718383|FG000|DB Period|Physician Decision|2|||
146876591|NCT05885737|529718384|FG001|DB Period|Physician Decision|0|||
146876592|NCT05885737|529718383|FG000|DB Period|Withdrawal by Subject|12|||
146876593|NCT05885737|529718384|FG001|DB Period|Withdrawal by Subject|6|||
146876594|NCT05885737|529718383|FG000|DB Period|Other: Unspecified|2|||
146876595|NCT05885737|529718384|FG001|DB Period|Other: Unspecified|2|||
146876596|NCT05885737|529718383|FG000|OLE Period|Adverse Event|3|||
146876597|NCT05885737|529718384|FG001|OLE Period|Adverse Event|2|||
146876598|NCT05885737|529718383|FG000|OLE Period|Physician Decision|1|||
146876599|NCT05885737|529718384|FG001|OLE Period|Physician Decision|0|||
146876600|NCT05885737|529718383|FG000|OLE Period|Withdrawal by Subject|5|||
146876601|NCT05885737|529718384|FG001|OLE Period|Withdrawal by Subject|5|||
146876602|NCT05885737|529718383|FG000|OLE Period|Other: Unspecified|2|||
146876603|NCT05885737|529718384|FG001|OLE Period|Other: Unspecified|1|||
146876604|NCT02037295|529719636|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
146876605|NCT02037295|529719637|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
146876606|NCT02037295|529719638|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
146876607|NCT02037295|529719639|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
146876608|NCT02004262|529719645|FG000|Overall Study|Death|67|||
146876609|NCT02004262|529719646|FG001|Overall Study|Death|64|||
146876610|NCT02004262|529719647|FG002|Overall Study|Death|66|||
146876611|NCT02004262|529719648|FG003|Overall Study|Death|28|||
146876612|NCT02004262|529719649|FG004|Overall Study|Death|29|||
146876613|NCT02004262|529719650|FG005|Overall Study|Death|22|||
146876614|NCT02004262|529719645|FG000|Overall Study|Withdrawal by Subject|1|||
146876615|NCT02004262|529719646|FG001|Overall Study|Withdrawal by Subject|0|||
146876616|NCT02004262|529719647|FG002|Overall Study|Withdrawal by Subject|4|||
146876617|NCT02004262|529719648|FG003|Overall Study|Withdrawal by Subject|0|||
146876618|NCT02004262|529719649|FG004|Overall Study|Withdrawal by Subject|1|||
146876619|NCT02004262|529719650|FG005|Overall Study|Withdrawal by Subject|3|||
146876620|NCT02004262|529719645|FG000|Overall Study|Lost to Follow-up|1|||
146876621|NCT02004262|529719646|FG001|Overall Study|Lost to Follow-up|1|||
146876622|NCT02004262|529719647|FG002|Overall Study|Lost to Follow-up|0|||
146876623|NCT02004262|529719648|FG003|Overall Study|Lost to Follow-up|0|||
146876624|NCT02004262|529719649|FG004|Overall Study|Lost to Follow-up|0|||
146876625|NCT02004262|529719650|FG005|Overall Study|Lost to Follow-up|0|||
146876626|NCT02004262|529719645|FG000|Overall Study|Study Terminated by Sponsor|4|||
146876627|NCT02004262|529719646|FG001|Overall Study|Study Terminated by Sponsor|3|||
146876628|NCT02004262|529719647|FG002|Overall Study|Study Terminated by Sponsor|2|||
146876629|NCT02004262|529719648|FG003|Overall Study|Study Terminated by Sponsor|1|||
146876630|NCT02004262|529719649|FG004|Overall Study|Study Terminated by Sponsor|1|||
146876631|NCT02004262|529719650|FG005|Overall Study|Study Terminated by Sponsor|5|||
146876632|NCT01146873|529719651|FG000|Overall Study|Transfer out|0|||
146876633|NCT01146873|529719652|FG001|Overall Study|Transfer out|6|||
146876634|NCT03200366|529719655|FG000|Patient Navigation Intervention Given|Death|0|||
146876635|NCT03200366|529719656|FG001|Patient Navigation Intervention Given|Death|2|||
146876636|NCT03200366|529719657|FG002|Patient Navigation Intervention Given|Death|0|||
146876637|NCT03200366|529719655|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
146876638|NCT03200366|529719656|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
146876639|NCT03200366|529719657|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
146876640|NCT03200366|529719655|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
146876641|NCT03200366|529719656|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
146876642|NCT03200366|529719657|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
146876643|NCT03200366|529719655|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
146876644|NCT03200366|529719656|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
146876645|NCT03200366|529719657|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
146876646|NCT03200366|529719655|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
146876647|NCT03200366|529719656|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
146876648|NCT03200366|529719657|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
146876649|NCT03200366|529719655|FG000|6 Month Post-Baseline Interview|Death|1|||
146876650|NCT03200366|529719656|FG001|6 Month Post-Baseline Interview|Death|1|||
146876651|NCT03200366|529719657|FG002|6 Month Post-Baseline Interview|Death|1|||
146876652|NCT03200366|529719655|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
146876653|NCT03200366|529719656|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
146876654|NCT03200366|529719657|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
146876655|NCT03200366|529719655|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
146876656|NCT03200366|529719656|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
146876657|NCT03200366|529719657|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
146544236|NCT03018938|528498574|FG000|Overall Study|Not recorded|0|||
146544237|NCT03018938|528498575|FG001|Overall Study|Not recorded|2|||
146544238|NCT01202591|528498576|FG000|Overall Study|Adverse Event|2|||
146544239|NCT01202591|528498577|FG001|Overall Study|Adverse Event|1|||
146544240|NCT01202591|528498578|FG002|Overall Study|Adverse Event|4|||
146544241|NCT01202591|528498579|FG003|Overall Study|Adverse Event|4|||
146544242|NCT01202591|528498580|FG004|Overall Study|Adverse Event|0|||
146544243|NCT01202591|528498581|FG005|Overall Study|Adverse Event|0|||
146544244|NCT01202591|528498576|FG000|Overall Study|Other reason as per investigator|3|||
146544245|NCT01202591|528498577|FG001|Overall Study|Other reason as per investigator|4|||
146544246|NCT01202591|528498578|FG002|Overall Study|Other reason as per investigator|7|||
146544247|NCT01202591|528498579|FG003|Overall Study|Other reason as per investigator|3|||
146544248|NCT01202591|528498580|FG004|Overall Study|Other reason as per investigator|1|||
146544249|NCT01202591|528498581|FG005|Overall Study|Other reason as per investigator|3|||
146544250|NCT01202591|528498576|FG000|Overall Study|Withdrawal by Subject|0|||
146544251|NCT01202591|528498577|FG001|Overall Study|Withdrawal by Subject|0|||
146544252|NCT01202591|528498578|FG002|Overall Study|Withdrawal by Subject|0|||
146544253|NCT01202591|528498579|FG003|Overall Study|Withdrawal by Subject|0|||
146544254|NCT01202591|528498580|FG004|Overall Study|Withdrawal by Subject|2|||
146544255|NCT01202591|528498581|FG005|Overall Study|Withdrawal by Subject|1|||
146544256|NCT01202591|528498576|FG000|Overall Study|Objective Disease Progression|0|||
146544257|NCT01202591|528498577|FG001|Overall Study|Objective Disease Progression|0|||
146544258|NCT01202591|528498578|FG002|Overall Study|Objective Disease Progression|0|||
146544259|NCT01202591|528498579|FG003|Overall Study|Objective Disease Progression|0|||
146544260|NCT01202591|528498580|FG004|Overall Study|Objective Disease Progression|2|||
146544261|NCT01202591|528498581|FG005|Overall Study|Objective Disease Progression|0|||
146544262|NCT00191100|528498582|FG000|Overall Study|Adverse Event|18|||
146544263|NCT00191100|528498583|FG001|Overall Study|Adverse Event|1|||
146629035|NCT04225897|528818332|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146629036|NCT04225897|528818333|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146629037|NCT04225897|528818334|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146629038|NCT04225897|528818335|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146764836|NCT00197015|529305940|FG000|Overall Study|Lost to Follow-up|28|||
146764837|NCT00197015|529305941|FG001|Overall Study|Lost to Follow-up|46|||
146876658|NCT03200366|529719655|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
146876659|NCT03200366|529719656|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
146876660|NCT03200366|529719657|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
146876661|NCT03200366|529719655|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
146876662|NCT03200366|529719656|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
146876663|NCT03200366|529719657|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
146876664|NCT03200366|529719655|FG000|9 Month Post-Baseline Interview|Death|1|||
146876665|NCT03200366|529719656|FG001|9 Month Post-Baseline Interview|Death|1|||
146876666|NCT03200366|529719657|FG002|9 Month Post-Baseline Interview|Death|1|||
146764838|NCT00197015|529305942|FG002|Overall Study|Lost to Follow-up|37|||
146876667|NCT03200366|529719655|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
146876668|NCT03200366|529719656|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
146876669|NCT03200366|529719657|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
146876670|NCT03200366|529719655|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
146876671|NCT03200366|529719656|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
146876672|NCT03200366|529719657|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
146876673|NCT03200366|529719655|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
146876674|NCT03200366|529719656|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
146876675|NCT03200366|529719657|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
146876676|NCT04677959|529719658|FG000|Overall Study|Adverse Event|1|||
146876677|NCT04677959|529719659|FG001|Overall Study|Adverse Event|9|||
146876678|NCT04677959|529719658|FG000|Overall Study|Withdrawal by Subject|2|||
146876679|NCT04677959|529719659|FG001|Overall Study|Withdrawal by Subject|15|||
146876680|NCT04677959|529719658|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146876681|NCT04677959|529719659|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146876682|NCT04677959|529719658|FG000|Overall Study|Non-compliance with study drug|0|||
146876683|NCT04677959|529719659|FG001|Overall Study|Non-compliance with study drug|2|||
146876684|NCT04677959|529719658|FG000|Overall Study|Protocol deviation|0|||
146876685|NCT04677959|529719659|FG001|Overall Study|Protocol deviation|11|||
146876686|NCT04677959|529719658|FG000|Overall Study|Lost to Follow-up|9|||
146876687|NCT04677959|529719659|FG001|Overall Study|Lost to Follow-up|13|||
146876688|NCT04677959|529719658|FG000|Overall Study|Other than specified|0|||
146876689|NCT04677959|529719659|FG001|Overall Study|Other than specified|8|||
146876690|NCT00732303|529719666|FG000|Overall Study|Study Terminated|2|||
146876691|NCT01074190|529719667|FG000|Overall Study|Emergency Cesarean Delivery|1|||
146876692|NCT01074190|529719668|FG001|Overall Study|Emergency Cesarean Delivery|2|||
146876693|NCT01074190|529719669|FG002|Overall Study|Emergency Cesarean Delivery|1|||
146876694|NCT01074190|529719667|FG000|Overall Study|Protocol Violation|2|||
146876695|NCT01074190|529719668|FG001|Overall Study|Protocol Violation|1|||
146876696|NCT01074190|529719669|FG002|Overall Study|Protocol Violation|0|||
146876697|NCT01074190|529719667|FG000|Overall Study|Delivered in under 90 minutes|0|||
146876698|NCT01074190|529719668|FG001|Overall Study|Delivered in under 90 minutes|2|||
146876699|NCT01074190|529719669|FG002|Overall Study|Delivered in under 90 minutes|1|||
146876700|NCT01074190|529719667|FG000|Overall Study|Subject withdrew consent|1|||
146876701|NCT01074190|529719668|FG001|Overall Study|Subject withdrew consent|1|||
146876702|NCT01074190|529719669|FG002|Overall Study|Subject withdrew consent|1|||
146876703|NCT00264875|529719670|FG000|Overall Study|Adverse Event|6|||
146876704|NCT00264875|529719670|FG000|Overall Study|Lost to Follow-up|6|||
146876705|NCT00264875|529719670|FG000|Overall Study|Protocol Violation|11|||
146876706|NCT00264875|529719670|FG000|Overall Study|Withdrawal by Subject|7|||
146876707|NCT01500278|529719671|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
146876708|NCT01500278|529719672|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
146876709|NCT01500278|529719671|FG000|Week 0 - Week 12|Protocol Violation|10|||
146876710|NCT01500278|529719672|FG001|Week 0 - Week 12|Protocol Violation|16|||
146876711|NCT01500278|529719671|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
146876712|NCT01500278|529719672|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
146876713|NCT01500278|529719671|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
146876714|NCT01500278|529719672|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
146876715|NCT01500278|529719671|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
146876716|NCT01500278|529719672|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
146876717|NCT01500278|529719671|FG000|Week 0 - Week 12|Patient decision|1|||
146876718|NCT01500278|529719672|FG001|Week 0 - Week 12|Patient decision|0|||
146876719|NCT01500278|529719671|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
146876720|NCT01500278|529719672|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
146876721|NCT01500278|529719671|FG000|Week 0 - Week 12|Investigator decision|1|||
146544264|NCT00191100|528498582|FG000|Overall Study|Lost to Follow-up|2|||
146544265|NCT00191100|528498583|FG001|Overall Study|Lost to Follow-up|0|||
146544266|NCT00191100|528498582|FG000|Overall Study|Patient Moved|0|||
146544267|NCT00191100|528498583|FG001|Overall Study|Patient Moved|1|||
146544268|NCT00191100|528498582|FG000|Overall Study|Withdrawal by Subject|9|||
146544269|NCT00191100|528498583|FG001|Overall Study|Withdrawal by Subject|3|||
146544270|NCT00191100|528498582|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
146544271|NCT00191100|528498583|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
146544272|NCT00191100|528498582|FG000|Overall Study|Clinical Relapse|2|||
146544273|NCT00191100|528498583|FG001|Overall Study|Clinical Relapse|1|||
146544274|NCT00191100|528498582|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
146544275|NCT00191100|528498583|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
146629039|NCT00074711|528818337|FG000|Overall Study|Withdrawal by Subject|1|||
146876722|NCT01500278|529719672|FG001|Week 0 - Week 12|Investigator decision|0|||
146876723|NCT01500278|529719671|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
146876724|NCT01500278|529719672|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
146876725|NCT01500278|529719671|FG000|Week 0 - Week 12|Sponsor decision|1|||
146876726|NCT01500278|529719672|FG001|Week 0 - Week 12|Sponsor decision|0|||
146876727|NCT01500278|529719671|FG000|Week 0 - Week 12|Personal reason|0|||
146764839|NCT00197015|529305940|FG000|Overall Study|Other|2|||
146876728|NCT01500278|529719672|FG001|Week 0 - Week 12|Personal reason|1|||
146876729|NCT01500278|529719671|FG000|Week 0 - Week 12|Other serious disease|0|||
146876730|NCT01500278|529719672|FG001|Week 0 - Week 12|Other serious disease|1|||
146876731|NCT01500278|529719671|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
146876732|NCT01500278|529719672|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
146876733|NCT01500278|529719671|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
146876734|NCT01500278|529719672|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
146876735|NCT01500278|529719671|FG000|Week 13 - Week 104|Protocol Violation|6|||
146876736|NCT01500278|529719672|FG001|Week 13 - Week 104|Protocol Violation|6|||
146876737|NCT01500278|529719671|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
146876738|NCT01500278|529719672|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
146876739|NCT01500278|529719671|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
146876740|NCT01500278|529719672|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
146876741|NCT01500278|529719671|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
146876742|NCT01500278|529719672|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
146876743|NCT01500278|529719671|FG000|Week 13 - Week 104|Non/bad compliance|7|||
146876744|NCT01500278|529719672|FG001|Week 13 - Week 104|Non/bad compliance|5|||
146876745|NCT01500278|529719671|FG000|Week 13 - Week 104|Recurrent infections|1|||
146876746|NCT01500278|529719672|FG001|Week 13 - Week 104|Recurrent infections|0|||
146876747|NCT01500278|529719671|FG000|Week 13 - Week 104|False positive test|1|||
146876748|NCT01500278|529719672|FG001|Week 13 - Week 104|False positive test|2|||
146876749|NCT01500278|529719671|FG000|Week 13 - Week 104|Sponsor request|4|||
146876750|NCT01500278|529719672|FG001|Week 13 - Week 104|Sponsor request|0|||
146876751|NCT01500278|529719671|FG000|Week 13 - Week 104|Withdrawn in error|1|||
146876752|NCT01500278|529719672|FG001|Week 13 - Week 104|Withdrawn in error|0|||
146876753|NCT01500278|529719671|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
146876754|NCT01500278|529719672|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
146876755|NCT01500278|529719671|FG000|Week 13 - Week 104|Protocol deviation|1|||
146876756|NCT01500278|529719672|FG001|Week 13 - Week 104|Protocol deviation|0|||
146876757|NCT01500278|529719671|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
146876758|NCT01500278|529719672|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
146876759|NCT01500278|529719671|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
146876760|NCT01500278|529719672|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
146876761|NCT01500278|529719671|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
146876762|NCT01500278|529719672|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
146876763|NCT01500278|529719671|FG000|Week 13 - Week 104|Relocation|0|||
146876764|NCT01500278|529719672|FG001|Week 13 - Week 104|Relocation|1|||
146876765|NCT01500278|529719671|FG000|Week 13 - Week 104|Sponsor decision|0|||
146876766|NCT01500278|529719672|FG001|Week 13 - Week 104|Sponsor decision|2|||
146876767|NCT01500278|529719671|FG000|Week 13 - Week 104|Medical monitor decision|0|||
146876768|NCT01500278|529719672|FG001|Week 13 - Week 104|Medical monitor decision|2|||
146876769|NCT01500278|529719671|FG000|Week 13 - Week 104|Personal reason|0|||
146876770|NCT01500278|529719672|FG001|Week 13 - Week 104|Personal reason|1|||
146876771|NCT01500278|529719671|FG000|Week 13 - Week 104|Not completed|0|||
146876772|NCT01500278|529719672|FG001|Week 13 - Week 104|Not completed|1|||
146876773|NCT01500278|529719671|FG000|Week 13 - Week 104|Death|2|||
146876774|NCT01500278|529719672|FG001|Week 13 - Week 104|Death|4|||
146876775|NCT01500278|529719671|FG000|Week 13 - Week 104|Adverse Event|54|||
146876776|NCT01500278|529719672|FG001|Week 13 - Week 104|Adverse Event|54|||
146876777|NCT04718974|529719676|FG000|Overall Study|Death|0|||
146876778|NCT04718974|529719677|FG001|Overall Study|Death|2|||
146876779|NCT04718974|529719676|FG000|Overall Study|Lost to Follow-up|10|||
146876780|NCT04718974|529719677|FG001|Overall Study|Lost to Follow-up|20|||
146876781|NCT04718974|529719676|FG000|Overall Study|Transferred out|2|||
146876782|NCT04718974|529719677|FG001|Overall Study|Transferred out|4|||
146876783|NCT01709435|529719678|FG000|Overall Study|Adverse Event|1|||
146876784|NCT01709435|529719679|FG001|Overall Study|Adverse Event|1|||
146876785|NCT01709435|529719680|FG002|Overall Study|Adverse Event|1|||
146876786|NCT01709435|529719681|FG003|Overall Study|Adverse Event|0|||
146876787|NCT01709435|529719682|FG004|Overall Study|Adverse Event|0|||
146876788|NCT01709435|529719683|FG005|Overall Study|Adverse Event|1|||
146876789|NCT01709435|529719678|FG000|Overall Study|Lack of Efficacy|5|||
146876790|NCT01709435|529719679|FG001|Overall Study|Lack of Efficacy|7|||
146876791|NCT01709435|529719680|FG002|Overall Study|Lack of Efficacy|2|||
146876792|NCT01709435|529719681|FG003|Overall Study|Lack of Efficacy|2|||
146876793|NCT01709435|529719682|FG004|Overall Study|Lack of Efficacy|6|||
146876794|NCT01709435|529719683|FG005|Overall Study|Lack of Efficacy|3|||
146876795|NCT01709435|529719678|FG000|Overall Study|Physician Decision|0|||
146876796|NCT01709435|529719679|FG001|Overall Study|Physician Decision|1|||
146876797|NCT01709435|529719680|FG002|Overall Study|Physician Decision|0|||
146876798|NCT01709435|529719681|FG003|Overall Study|Physician Decision|1|||
146876799|NCT01709435|529719682|FG004|Overall Study|Physician Decision|2|||
146876800|NCT01709435|529719683|FG005|Overall Study|Physician Decision|0|||
146876801|NCT01709435|529719678|FG000|Overall Study|Withdrawal by Subject|0|||
146876802|NCT01709435|529719679|FG001|Overall Study|Withdrawal by Subject|0|||
146876803|NCT01709435|529719680|FG002|Overall Study|Withdrawal by Subject|3|||
146876804|NCT01709435|529719681|FG003|Overall Study|Withdrawal by Subject|0|||
146876805|NCT01709435|529719682|FG004|Overall Study|Withdrawal by Subject|2|||
146629040|NCT00074711|528818338|FG001|Overall Study|Withdrawal by Subject|1|||
146629041|NCT00074711|528818337|FG000|Overall Study|Lost to Follow-up|10|||
146876806|NCT01709435|529719683|FG005|Overall Study|Withdrawal by Subject|2|||
146876807|NCT02409290|529719684|FG000|Overall Study|Protocol Violation|3|||
146876808|NCT02409290|529719685|FG001|Overall Study|Protocol Violation|6|||
146876809|NCT02409290|529719686|FG002|Overall Study|Protocol Violation|9|||
146876810|NCT02409290|529719687|FG003|Overall Study|Protocol Violation|4|||
146764840|NCT00197015|529305941|FG001|Overall Study|Other|3|||
146876811|NCT02409290|529719684|FG000|Overall Study|No positive culture/no baseline sample|3|||
146876812|NCT02409290|529719685|FG001|Overall Study|No positive culture/no baseline sample|9|||
146876813|NCT02409290|529719686|FG002|Overall Study|No positive culture/no baseline sample|6|||
146876814|NCT02409290|529719687|FG003|Overall Study|No positive culture/no baseline sample|5|||
146876815|NCT02409290|529719684|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
146876816|NCT02409290|529719685|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
146876817|NCT02409290|529719686|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
146876818|NCT02409290|529719687|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
146876819|NCT02121262|529719688|FG000|Overall Study|Adverse Event|6|||
146876820|NCT02121262|529719689|FG001|Overall Study|Adverse Event|3|||
146876821|NCT02121262|529719688|FG000|Overall Study|Lack of Efficacy|3|||
146876822|NCT02121262|529719689|FG001|Overall Study|Lack of Efficacy|0|||
146876823|NCT02121262|529719688|FG000|Overall Study|Personal Reasons|19|||
146876824|NCT02121262|529719689|FG001|Overall Study|Personal Reasons|5|||
146876825|NCT02121262|529719688|FG000|Overall Study|Protocol Violation|1|||
146876826|NCT02121262|529719689|FG001|Overall Study|Protocol Violation|1|||
146876827|NCT02121262|529719688|FG000|Overall Study|Participant Dropped-out|0|||
146876828|NCT02121262|529719689|FG001|Overall Study|Participant Dropped-out|1|||
146876829|NCT02121262|529719688|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
146876830|NCT02121262|529719689|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
146876831|NCT02121262|529719688|FG000|Overall Study|Consent Withdrawn|1|||
146876832|NCT02121262|529719689|FG001|Overall Study|Consent Withdrawn|0|||
146876833|NCT01553188|529719690|FG000|Overall Study|Patient choice|1|||
146876834|NCT01553188|529719691|FG001|Overall Study|Patient choice|0|||
146876835|NCT01553188|529719692|FG002|Overall Study|Patient choice|0|||
146876836|NCT01553188|529719693|FG003|Overall Study|Patient choice|0|||
146876837|NCT01553188|529719690|FG000|Overall Study|Intercurrent illness and adverse event|0|||
146876838|NCT01553188|529719691|FG001|Overall Study|Intercurrent illness and adverse event|1|||
146544276|NCT00191100|528498582|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
146544277|NCT00191100|528498583|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
146544278|NCT00191100|528498582|FG000|Overall Study|Physician Decision|3|||
146876839|NCT01553188|529719692|FG002|Overall Study|Intercurrent illness and adverse event|2|||
146876840|NCT01553188|529719693|FG003|Overall Study|Intercurrent illness and adverse event|0|||
146876841|NCT04744207|529719695|FG000|Treatment|Withdrawal by Subject|2|||
146876842|NCT04744207|529719696|FG001|Treatment|Withdrawal by Subject|0|||
146876843|NCT04744207|529719695|FG000|Treatment|Adverse Event|1|||
146876844|NCT04744207|529719696|FG001|Treatment|Adverse Event|2|||
146876845|NCT01394627|529719698|FG000|First Intervention (1 Day)|poor intravenous access|0|||
146544279|NCT00191100|528498583|FG001|Overall Study|Physician Decision|1|||
146629042|NCT00074711|528818338|FG001|Overall Study|Lost to Follow-up|8|||
146876846|NCT01394627|529719699|FG001|First Intervention (1 Day)|poor intravenous access|1|||
146876847|NCT01394627|529719698|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
146876848|NCT01394627|529719699|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
146876849|NCT03223428|529719702|FG000|Overall Study|No longer taking Xermelo|27|||
146876850|NCT03223428|529719702|FG000|Overall Study|Declined Consent|1|||
146876851|NCT03223428|529719702|FG000|Overall Study|Non-responders|56|||
146876852|NCT03223428|529719702|FG000|Overall Study|Withdrawal by Subject|14|||
146876853|NCT02230384|529719704|FG000|Phase 1|Lost to Follow-up|1|||
146876854|NCT02230384|529719705|FG001|Phase 1|Lost to Follow-up|0|||
146876855|NCT02230384|529719704|FG000|Phase 1|Physician Decision|0|||
146876856|NCT02230384|529719705|FG001|Phase 1|Physician Decision|1|||
146876857|NCT02230384|529719704|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
146876858|NCT02230384|529719705|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
146876859|NCT02230384|529719704|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
146876860|NCT02230384|529719705|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
146876861|NCT02230384|529719704|FG000|Phase 2 - Switch|Adverse Event|2|||
146876862|NCT02230384|529719705|FG001|Phase 2 - Switch|Adverse Event|0|||
146876863|NCT00777101|529719706|FG000|Overall Study|Death|48|||
146876864|NCT00777101|529719707|FG001|Overall Study|Death|43|||
146876865|NCT00777101|529719706|FG000|Overall Study|Withdrawal by Subject|11|||
146876866|NCT00777101|529719707|FG001|Overall Study|Withdrawal by Subject|6|||
146876867|NCT00777101|529719706|FG000|Overall Study|Lost to Follow-up|2|||
146876868|NCT00777101|529719707|FG001|Overall Study|Lost to Follow-up|1|||
146876869|NCT00777101|529719706|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
146876870|NCT00777101|529719707|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
146876871|NCT00777101|529719706|FG000|Overall Study|Failed to Return|0|||
146876872|NCT00777101|529719707|FG001|Overall Study|Failed to Return|1|||
146876873|NCT00961220|529719708|FG000|Overall Study|Adverse Event|3|||
146876874|NCT00961220|529719708|FG000|Overall Study|Lack of Efficacy|1|||
146876875|NCT00961220|529719708|FG000|Overall Study|No IV access for O6BG|1|||
146876876|NCT00961220|529719708|FG000|Overall Study|O6BG no longer supplied|1|||
146876877|NCT00961220|529719708|FG000|Overall Study|Complete Response prior to 12 courses|1|||
146876878|NCT00282334|529719710|FG000|Overall Study|Withdrawal by Subject|8|||
146876879|NCT00282334|529719711|FG001|Overall Study|Withdrawal by Subject|5|||
146876880|NCT00825162|529719719|FG000|Overall Study|Withdrawal by Subject|11|||
146876881|NCT00825162|529719720|FG001|Overall Study|Withdrawal by Subject|13|||
146876882|NCT00825162|529719721|FG002|Overall Study|Withdrawal by Subject|3|||
146876883|NCT00825162|529719719|FG000|Overall Study|Lost to Follow-up|9|||
146876884|NCT00825162|529719720|FG001|Overall Study|Lost to Follow-up|6|||
146876885|NCT00825162|529719721|FG002|Overall Study|Lost to Follow-up|3|||
146876886|NCT00825162|529719719|FG000|Overall Study|Physician Decision|2|||
146876887|NCT00825162|529719720|FG001|Overall Study|Physician Decision|0|||
146876888|NCT00825162|529719721|FG002|Overall Study|Physician Decision|0|||
146876889|NCT00825162|529719719|FG000|Overall Study|Move away from the study area|1|||
146876890|NCT00825162|529719720|FG001|Overall Study|Move away from the study area|0|||
146876891|NCT00825162|529719721|FG002|Overall Study|Move away from the study area|0|||
146876892|NCT00825162|529719719|FG000|Overall Study|Unable to attend the study visit|5|||
146876893|NCT00825162|529719720|FG001|Overall Study|Unable to attend the study visit|2|||
146876894|NCT00825162|529719721|FG002|Overall Study|Unable to attend the study visit|0|||
146876895|NCT00781911|529719726|FG000|Overall Study|Adverse Event|4|||
146876896|NCT00781911|529719727|FG001|Overall Study|Adverse Event|4|||
146876897|NCT00781911|529719726|FG000|Overall Study|Withdrawal by Subject|1|||
146876898|NCT00781911|529719727|FG001|Overall Study|Withdrawal by Subject|2|||
146876899|NCT00781911|529719726|FG000|Overall Study|Physician Decision|0|||
146876900|NCT00781911|529719727|FG001|Overall Study|Physician Decision|2|||
146876901|NCT00781911|529719726|FG000|Overall Study|Sponsor Decision|1|||
146876902|NCT00781911|529719727|FG001|Overall Study|Sponsor Decision|0|||
146876903|NCT03317795|529719732|FG000|Overall Study|IUD Expulsion|1|||
146876904|NCT03317795|529719733|FG001|Overall Study|IUD Expulsion|0|||
146876905|NCT03317795|529719732|FG000|Overall Study|Lost to Follow-up|1|||
146629043|NCT00074711|528818337|FG000|Overall Study|Participant stopped study drug|4|||
146629044|NCT00074711|528818338|FG001|Overall Study|Participant stopped study drug|6|||
146629045|NCT03466658|528818339|FG000|Overall Study|Withdrawal by Subject|3|||
146629046|NCT00837434|528818340|FG000|Overall Study|Physician Decision|3|||
146629047|NCT00837434|528818341|FG001|Overall Study|Physician Decision|0|||
146629048|NCT00837434|528818340|FG000|Overall Study|Lost to Follow-up|1|||
146629049|NCT00837434|528818341|FG001|Overall Study|Lost to Follow-up|1|||
146629050|NCT00837434|528818340|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
146629051|NCT00837434|528818341|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
146629052|NCT00837434|528818340|FG000|Overall Study|Noncompliant|2|||
146629053|NCT00837434|528818341|FG001|Overall Study|Noncompliant|0|||
146764841|NCT00197015|529305942|FG002|Overall Study|Other|2|||
146876906|NCT03317795|529719733|FG001|Overall Study|Lost to Follow-up|3|||
146876907|NCT03317795|529719732|FG000|Overall Study|Treatment change|0|||
146876908|NCT03317795|529719733|FG001|Overall Study|Treatment change|3|||
146876909|NCT03317795|529719732|FG000|Overall Study|Intolerance of medication|0|||
146629054|NCT00837434|528818340|FG000|Overall Study|Baseline assessments not done in time|1|||
146876910|NCT03317795|529719733|FG001|Overall Study|Intolerance of medication|1|||
146876911|NCT00939783|529719734|FG000|Overall Study|Death|6|||
146876912|NCT00939783|529719734|FG000|Overall Study|Adverse Event|39|||
146629055|NCT00837434|528818341|FG001|Overall Study|Baseline assessments not done in time|0|||
146876913|NCT00939783|529719734|FG000|Overall Study|Study Terminated by Sponsor|498|||
146876914|NCT00939783|529719734|FG000|Overall Study|Withdrawal by Subject|78|||
146876915|NCT00939783|529719734|FG000|Overall Study|Other|16|||
146876916|NCT00939783|529719734|FG000|Overall Study|Lost to Follow-up|8|||
146876917|NCT00939783|529719734|FG000|Overall Study|Protocol Violation|3|||
146876918|NCT00939783|529719734|FG000|Overall Study|Enrolled but not treated|1|||
146876919|NCT00501007|529719738|FG000|Overall Study|Inclusion criteria not met.|29|||
146876920|NCT00501007|529719739|FG001|Overall Study|Inclusion criteria not met.|25|||
146876921|NCT03917823|529719740|FG000|Overall Study|Lost to Follow-up|1|||
146876922|NCT03917823|529719741|FG001|Overall Study|Lost to Follow-up|1|||
146876923|NCT03917823|529719740|FG000|Overall Study|Withdrawal by Subject|0|||
146876924|NCT03917823|529719741|FG001|Overall Study|Withdrawal by Subject|1|||
146876925|NCT00135668|529719742|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
146876926|NCT00135668|529719743|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
146876927|NCT00135668|529719744|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
146876928|NCT00135668|529719745|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
146876929|NCT02424253|529719748|FG000|Overall Study|Other, unspecified|1|||
146876930|NCT02424253|529719749|FG001|Overall Study|Other, unspecified|0|||
146876931|NCT02424253|529719748|FG000|Overall Study|Compliance problems|1|||
146876932|NCT02424253|529719749|FG001|Overall Study|Compliance problems|0|||
146876933|NCT02424253|529719748|FG000|Overall Study|Physician Decision|2|||
146876934|NCT02424253|529719749|FG001|Overall Study|Physician Decision|0|||
146876935|NCT02424253|529719748|FG000|Overall Study|Lack of Efficacy|0|||
146876936|NCT02424253|529719749|FG001|Overall Study|Lack of Efficacy|7|||
146876937|NCT02424253|529719748|FG000|Overall Study|Adverse Event|2|||
146876938|NCT02424253|529719749|FG001|Overall Study|Adverse Event|0|||
146876939|NCT02424253|529719748|FG000|Overall Study|Consent withdrawn by subject|4|||
146876940|NCT02424253|529719749|FG001|Overall Study|Consent withdrawn by subject|1|||
146876941|NCT02424253|529719748|FG000|Overall Study|Lost to Follow-up|1|||
146876942|NCT02424253|529719749|FG001|Overall Study|Lost to Follow-up|1|||
146876943|NCT01892163|529719752|FG000|Overall Study|Death|1|||
146876944|NCT01892163|529719753|FG001|Overall Study|Death|1|||
146876945|NCT01892163|529719752|FG000|Overall Study|Lost to Follow-up|1|||
146876946|NCT01892163|529719753|FG001|Overall Study|Lost to Follow-up|0|||
146876947|NCT01924182|529719754|FG000|Overall Study|Withdrawal by Subject|1|||
146876948|NCT01924182|529719755|FG001|Overall Study|Withdrawal by Subject|0|||
146876949|NCT02577146|529719757|FG000|Overall Study|Lost to Follow-up|8|||
146876950|NCT02577146|529719757|FG000|Overall Study|Physician Decision|3|||
146876951|NCT02577146|529719757|FG000|Overall Study|Screen Failure|17|||
146876952|NCT00219284|529719758|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
146876953|NCT00219284|529719759|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
146876954|NCT00219284|529719758|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
146876955|NCT00219284|529719759|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
146876956|NCT00219284|529719758|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
146876957|NCT00219284|529719759|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
146876958|NCT00219284|529719758|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
146876959|NCT00219284|529719759|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
146876960|NCT00219284|529719758|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
146876961|NCT00219284|529719759|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
146876962|NCT00219284|529719758|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
146876963|NCT00219284|529719759|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
146876964|NCT00219284|529719758|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
146876965|NCT00219284|529719759|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
146876966|NCT00219284|529719758|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
146876967|NCT00219284|529719759|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
146876968|NCT00219284|529719758|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
146876969|NCT00219284|529719759|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
146876970|NCT02258451|529719762|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
146876971|NCT02258451|529719763|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
146876972|NCT02258451|529719762|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
146876973|NCT02258451|529719763|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
146876974|NCT02258451|529719762|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
146876975|NCT02258451|529719763|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
146876976|NCT02258451|529719762|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
146876977|NCT02258451|529719763|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
146876978|NCT02258451|529719762|FG000|Overall Study|Discontinuation all treatment due to death|4|||
146876979|NCT02258451|529719763|FG001|Overall Study|Discontinuation all treatment due to death|3|||
146876980|NCT02258451|529719762|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
146876981|NCT02258451|529719763|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
146629056|NCT00837434|528818340|FG000|Overall Study|Unable to obtain study drug|1|||
146629057|NCT00837434|528818341|FG001|Overall Study|Unable to obtain study drug|0|||
146876982|NCT02258451|529719762|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
146876983|NCT02258451|529719763|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
146876984|NCT02258451|529719762|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
146544280|NCT00191100|528498582|FG000|Overall Study|Death from Study Drug Toxicity|2|||
146544281|NCT00191100|528498583|FG001|Overall Study|Death from Study Drug Toxicity|0|||
146544282|NCT00191100|528498582|FG000|Overall Study|Protocol Violation|1|||
146544283|NCT00191100|528498583|FG001|Overall Study|Protocol Violation|1|||
146544284|NCT00191100|528498582|FG000|Overall Study|Death from Other Cause|1|||
146544285|NCT00191100|528498583|FG001|Overall Study|Death from Other Cause|0|||
146544286|NCT00191100|528498582|FG000|Overall Study|Reason Not Specified|0|||
146629058|NCT01921205|528818342|FG000|Overall Study|Adverse Event|12|||
146876985|NCT02258451|529719763|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
146876986|NCT02258451|529719762|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
146876987|NCT02258451|529719763|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
146876988|NCT02258451|529719762|FG000|Overall Study|Other reason|1|||
146876989|NCT02258451|529719763|FG001|Overall Study|Other reason|1|||
146876990|NCT02258451|529719762|FG000|Overall Study|Never treated|2|||
146876991|NCT02258451|529719763|FG001|Overall Study|Never treated|3|||
146876992|NCT03021499|529719773|FG000|Overall Study|Adverse Event|1|||
146629059|NCT01921205|528818343|FG001|Overall Study|Adverse Event|7|||
146629060|NCT01921205|528818342|FG000|Overall Study|Lack of Efficacy|1|||
146629061|NCT01921205|528818343|FG001|Overall Study|Lack of Efficacy|0|||
146876993|NCT03021499|529719774|FG001|Overall Study|Adverse Event|0|||
146876994|NCT03021499|529719773|FG000|Overall Study|Death|1|||
146876995|NCT03021499|529719774|FG001|Overall Study|Death|5|||
146876996|NCT03021499|529719773|FG000|Overall Study|Lack of Efficacy|0|||
146876997|NCT03021499|529719774|FG001|Overall Study|Lack of Efficacy|1|||
146876998|NCT03021499|529719773|FG000|Overall Study|Lost to Follow-up|1|||
146876999|NCT03021499|529719774|FG001|Overall Study|Lost to Follow-up|3|||
146877000|NCT03021499|529719773|FG000|Overall Study|Physician Decision|2|||
146877001|NCT03021499|529719774|FG001|Overall Study|Physician Decision|3|||
146877002|NCT03021499|529719773|FG000|Overall Study|Pregnancy|1|||
146877003|NCT03021499|529719774|FG001|Overall Study|Pregnancy|0|||
146877004|NCT03021499|529719773|FG000|Overall Study|Withdrawal by Subject|7|||
146877005|NCT03021499|529719774|FG001|Overall Study|Withdrawal by Subject|14|||
146877006|NCT03021499|529719773|FG000|Overall Study|Prohibited medication required|1|||
146877007|NCT03021499|529719774|FG001|Overall Study|Prohibited medication required|0|||
146877008|NCT03021499|529719773|FG000|Overall Study|Protocol non-compliance|1|||
146877009|NCT03021499|529719774|FG001|Overall Study|Protocol non-compliance|1|||
146877010|NCT03021499|529719773|FG000|Overall Study|None of the above|0|||
146877011|NCT03021499|529719774|FG001|Overall Study|None of the above|4|||
146877012|NCT03021499|529719773|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
146877013|NCT03021499|529719774|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
146877014|NCT01210690|529719775|FG000|Overall Study|Adverse Event|7|||
146877015|NCT01210690|529719775|FG000|Overall Study|Lack of Efficacy|12|||
146877016|NCT01210690|529719775|FG000|Overall Study|Lost to Follow-up|3|||
146877017|NCT01210690|529719775|FG000|Overall Study|Disease Remission|1|||
146877018|NCT01210690|529719775|FG000|Overall Study|Withdrawal by Subject|1|||
146877019|NCT01210690|529719775|FG000|Overall Study|Patient refused to swallow|1|||
146877020|NCT01210690|529719775|FG000|Overall Study|Patient could not take glucose|1|||
146877021|NCT00820950|529719776|FG000|Overall Study|Scheduling Conflict|0|||
146877022|NCT00820950|529719777|FG001|Overall Study|Scheduling Conflict|0|||
146877023|NCT00820950|529719778|FG002|Overall Study|Scheduling Conflict|0|||
146877024|NCT00820950|529719779|FG003|Overall Study|Scheduling Conflict|0|||
146877025|NCT00820950|529719780|FG004|Overall Study|Scheduling Conflict|0|||
146877026|NCT00820950|529719781|FG005|Overall Study|Scheduling Conflict|0|||
146877027|NCT00820950|529719782|FG006|Overall Study|Scheduling Conflict|1|||
146877028|NCT00820950|529719783|FG007|Overall Study|Scheduling Conflict|1|||
146877029|NCT00820950|529719784|FG008|Overall Study|Scheduling Conflict|0|||
146877030|NCT00820950|529719785|FG009|Overall Study|Scheduling Conflict|0|||
146877031|NCT00820950|529719776|FG000|Overall Study|Protocol Violation|1|||
146877032|NCT00820950|529719777|FG001|Overall Study|Protocol Violation|1|||
146877033|NCT00820950|529719778|FG002|Overall Study|Protocol Violation|0|||
146877034|NCT00820950|529719779|FG003|Overall Study|Protocol Violation|0|||
146877035|NCT00820950|529719780|FG004|Overall Study|Protocol Violation|0|||
146877036|NCT00820950|529719781|FG005|Overall Study|Protocol Violation|0|||
146544287|NCT00191100|528498583|FG001|Overall Study|Reason Not Specified|1|||
146544288|NCT02337686|528498586|FG000|Overall Study|Adverse Event|1|||
146544289|NCT01913353|528498971|FG000|Overall Study|Adverse Event|2|||
146544290|NCT01913353|528498972|FG001|Overall Study|Adverse Event|0|||
146544291|NCT01913353|528498971|FG000|Overall Study|Physician Decision|0|||
146544292|NCT01913353|528498972|FG001|Overall Study|Physician Decision|2|||
146544293|NCT01913353|528498971|FG000|Overall Study|Withdrawal by Subject|20|||
146629062|NCT01921205|528818342|FG000|Overall Study|Protocol Violation|1|||
146877037|NCT00820950|529719782|FG006|Overall Study|Protocol Violation|0|||
146877038|NCT00820950|529719783|FG007|Overall Study|Protocol Violation|0|||
146877039|NCT00820950|529719784|FG008|Overall Study|Protocol Violation|0|||
146877040|NCT00820950|529719785|FG009|Overall Study|Protocol Violation|0|||
146877041|NCT00528021|529719786|FG000|Overall Study|Lack of Efficacy|17|||
146877042|NCT00528021|529719787|FG001|Overall Study|Lack of Efficacy|13|||
146629063|NCT01921205|528818343|FG001|Overall Study|Protocol Violation|3|||
146629064|NCT01921205|528818342|FG000|Overall Study|Lost to Follow-up|1|||
146629065|NCT01921205|528818343|FG001|Overall Study|Lost to Follow-up|1|||
146629066|NCT01921205|528818342|FG000|Overall Study|Withdrawal by Subject|6|||
146629067|NCT01921205|528818343|FG001|Overall Study|Withdrawal by Subject|5|||
146629068|NCT01921205|528818342|FG000|Overall Study|Use Of Prohibited Medication|0|||
146629069|NCT01921205|528818343|FG001|Overall Study|Use Of Prohibited Medication|1|||
146629070|NCT01921205|528818342|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
146629071|NCT01921205|528818343|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
146629072|NCT01921205|528818342|FG000|Overall Study|Non Compliance Of The Parent|0|||
146629073|NCT01921205|528818343|FG001|Overall Study|Non Compliance Of The Parent|1|||
146764842|NCT04511650|529305945|FG000|Overall Study|Lost to Follow-up|1|||
146877043|NCT00528021|529719788|FG002|Overall Study|Lack of Efficacy|7|||
146629074|NCT01921205|528818342|FG000|Overall Study|Non Compliance Of Child|0|||
146764843|NCT04511650|529305946|FG001|Overall Study|Lost to Follow-up|0|||
146764844|NCT04511650|529305947|FG002|Overall Study|Lost to Follow-up|0|||
146877044|NCT00528021|529719789|FG003|Overall Study|Lack of Efficacy|9|||
146877045|NCT05264740|529719790|FG000|Baseline|Withdrawal by Subject|0|||
146877046|NCT05264740|529719791|FG001|Baseline|Withdrawal by Subject|1|||
146877047|NCT05264740|529719790|FG000|Follow Up 1|Lost to Follow-up|1|||
146877048|NCT05264740|529719791|FG001|Follow Up 1|Lost to Follow-up|1|||
146877049|NCT05264740|529719790|FG000|Follow Up 1|Withdrawal by Subject|0|||
146877050|NCT05264740|529719791|FG001|Follow Up 1|Withdrawal by Subject|1|||
146877051|NCT05264740|529719790|FG000|Follow Up 2|Lost to Follow-up|1|||
146877052|NCT05264740|529719791|FG001|Follow Up 2|Lost to Follow-up|4|||
146877053|NCT05264740|529719790|FG000|Follow Up 3|Lost to Follow-up|7|||
146877054|NCT05264740|529719791|FG001|Follow Up 3|Lost to Follow-up|4|||
146877055|NCT00886600|529721028|FG000|Double-blind Monotherapy|Adverse Event|1|||
146877056|NCT00886600|529721029|FG001|Double-blind Monotherapy|Adverse Event|1|||
146877057|NCT00886600|529721030|FG002|Double-blind Monotherapy|Adverse Event|1|||
146877058|NCT00886600|529721031|FG003|Double-blind Monotherapy|Adverse Event|1|||
146877059|NCT00886600|529721028|FG000|Double-blind Monotherapy|Protocol Violation|0|||
146877060|NCT00886600|529721029|FG001|Double-blind Monotherapy|Protocol Violation|0|||
146877061|NCT00886600|529721030|FG002|Double-blind Monotherapy|Protocol Violation|0|||
146877062|NCT00886600|529721031|FG003|Double-blind Monotherapy|Protocol Violation|1|||
146877063|NCT00886600|529721028|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
146877064|NCT00886600|529721029|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
146877065|NCT00886600|529721030|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
146877066|NCT00886600|529721031|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
146877067|NCT00886600|529721028|FG000|Combination Therapy Period|Adverse Event|0|||
146877068|NCT00886600|529721029|FG001|Combination Therapy Period|Adverse Event|0|||
146877069|NCT00886600|529721030|FG002|Combination Therapy Period|Adverse Event|1|||
146877070|NCT00886600|529721031|FG003|Combination Therapy Period|Adverse Event|0|||
146877071|NCT00886600|529721028|FG000|Combination Therapy Period|Protocol Violation|0|||
146877072|NCT00886600|529721029|FG001|Combination Therapy Period|Protocol Violation|0|||
146544294|NCT01913353|528498972|FG001|Overall Study|Withdrawal by Subject|6|||
146544295|NCT01913353|528498971|FG000|Overall Study|multiple reasons|10|||
146877073|NCT00886600|529721030|FG002|Combination Therapy Period|Protocol Violation|1|||
146877074|NCT00886600|529721031|FG003|Combination Therapy Period|Protocol Violation|0|||
146544296|NCT01913353|528498972|FG001|Overall Study|multiple reasons|7|||
146544297|NCT00385840|528498973|FG000|Overall Study|Adverse Event|1|||
146877075|NCT00473343|529721033|FG000|Overall Study|Adverse Event|9|||
146544298|NCT00385840|528498974|FG001|Overall Study|Adverse Event|1|||
146544299|NCT00385840|528498973|FG000|Overall Study|Lost to Follow-up|3|||
146877076|NCT00473343|529721033|FG000|Overall Study|Lost to Follow-up|8|||
146877077|NCT00473343|529721033|FG000|Overall Study|Treatment failure|27|||
146877078|NCT00473343|529721033|FG000|Overall Study|Withdrew consent|3|||
146877079|NCT00473343|529721033|FG000|Overall Study|Other un-specified reason|3|||
146877080|NCT02290873|529721036|FG000|Overall Study|Withdrawal by Subject|0|||
146877081|NCT02290873|529721037|FG001|Overall Study|Withdrawal by Subject|1|||
146877082|NCT02290873|529721038|FG002|Overall Study|Withdrawal by Subject|1|||
146877083|NCT02290873|529721036|FG000|Overall Study|Nellcor device error|1|||
146877084|NCT02290873|529721037|FG001|Overall Study|Nellcor device error|0|||
146877085|NCT02290873|529721038|FG002|Overall Study|Nellcor device error|0|||
146544300|NCT00385840|528498974|FG001|Overall Study|Lost to Follow-up|13|||
146544301|NCT00462462|528498976|FG000|Overall Study|Physician Decision|0|||
146544302|NCT00462462|528498977|FG001|Overall Study|Physician Decision|1|||
146544303|NCT02406612|528498978|FG000|Overall Study|Screening Failure|3|||
146544304|NCT02406612|528498979|FG001|Overall Study|Screening Failure|0|||
146544305|NCT02406612|528498978|FG000|Overall Study|Intra-procedural Exclusion|1|||
146544306|NCT02406612|528498979|FG001|Overall Study|Intra-procedural Exclusion|3|||
146544307|NCT02406612|528498978|FG000|Overall Study|Guidewire Failure|0|||
146629075|NCT01921205|528818343|FG001|Overall Study|Non Compliance Of Child|1|||
146544308|NCT02406612|528498979|FG001|Overall Study|Guidewire Failure|1|||
146544309|NCT02830087|528498984|FG000|Overall Study|No study staff to follow-up patients|4|||
146629076|NCT00360230|528818344|FG000|Overall Study|Withdrawal by Subject|1|||
146629077|NCT00360230|528818345|FG001|Overall Study|Withdrawal by Subject|1|||
146877086|NCT02290873|529721036|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
146877087|NCT02290873|529721037|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
146877088|NCT02290873|529721038|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
146877089|NCT02290873|529721036|FG000|Overall Study|Protocol Violation|0|||
146877090|NCT02290873|529721037|FG001|Overall Study|Protocol Violation|0|||
146877091|NCT02290873|529721038|FG002|Overall Study|Protocol Violation|1|||
146877092|NCT01378104|529721041|FG000|Overall Study|Adverse Event|8|||
146877093|NCT01378104|529721042|FG001|Overall Study|Adverse Event|8|||
146877094|NCT01378104|529721041|FG000|Overall Study|Lack of Efficacy|7|||
146877095|NCT01378104|529721042|FG001|Overall Study|Lack of Efficacy|5|||
146877096|NCT01378104|529721041|FG000|Overall Study|Withdrawal by Subject|12|||
146877097|NCT01378104|529721042|FG001|Overall Study|Withdrawal by Subject|13|||
146877098|NCT02700997|529721043|FG000|Overall Study|Did not undergo CT imaging|1|||
146877099|NCT02700997|529721043|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
146877100|NCT00455013|529721047|FG000|Short Term Period|Adverse Event|2|||
146877101|NCT00455013|529721048|FG001|Short Term Period|Adverse Event|5|||
146877102|NCT00455013|529721049|FG002|Short Term Period|Adverse Event|0|||
146877103|NCT00455013|529721047|FG000|Short Term Period|Withdrawal by Subject|0|||
146877104|NCT00455013|529721048|FG001|Short Term Period|Withdrawal by Subject|0|||
146877105|NCT00455013|529721049|FG002|Short Term Period|Withdrawal by Subject|1|||
146877106|NCT00455013|529721047|FG000|Short Term Period|Lack of Efficacy|4|||
146877107|NCT00455013|529721048|FG001|Short Term Period|Lack of Efficacy|0|||
146629078|NCT00360230|528818346|FG002|Overall Study|Withdrawal by Subject|0|||
146629079|NCT00360230|528818347|FG003|Overall Study|Withdrawal by Subject|1|||
146629080|NCT00360230|528818348|FG004|Overall Study|Withdrawal by Subject|1|||
146629081|NCT00360230|528818349|FG005|Overall Study|Withdrawal by Subject|1|||
146629082|NCT00360230|528818350|FG006|Overall Study|Withdrawal by Subject|0|||
146629083|NCT00360230|528818344|FG000|Overall Study|Migrated|4|||
146629084|NCT00360230|528818345|FG001|Overall Study|Migrated|1|||
146629085|NCT00360230|528818346|FG002|Overall Study|Migrated|3|||
146629086|NCT00360230|528818347|FG003|Overall Study|Migrated|1|||
146629087|NCT00360230|528818348|FG004|Overall Study|Migrated|4|||
146629088|NCT00360230|528818349|FG005|Overall Study|Migrated|1|||
146629089|NCT00360230|528818350|FG006|Overall Study|Migrated|1|||
146629090|NCT00360230|528818344|FG000|Overall Study|Other|1|||
146629091|NCT00360230|528818345|FG001|Overall Study|Other|0|||
146629092|NCT00360230|528818346|FG002|Overall Study|Other|0|||
146629093|NCT00360230|528818347|FG003|Overall Study|Other|0|||
146629094|NCT00360230|528818348|FG004|Overall Study|Other|0|||
146629095|NCT00360230|528818349|FG005|Overall Study|Other|0|||
146629096|NCT00360230|528818350|FG006|Overall Study|Other|0|||
146629097|NCT00360230|528818344|FG000|Overall Study|Protocol Violation|0|||
146629098|NCT00360230|528818345|FG001|Overall Study|Protocol Violation|0|||
146629099|NCT00360230|528818346|FG002|Overall Study|Protocol Violation|0|||
146629100|NCT00360230|528818347|FG003|Overall Study|Protocol Violation|0|||
146629101|NCT00360230|528818348|FG004|Overall Study|Protocol Violation|0|||
146629102|NCT00360230|528818349|FG005|Overall Study|Protocol Violation|1|||
146629103|NCT00360230|528818350|FG006|Overall Study|Protocol Violation|0|||
146629104|NCT00360230|528818344|FG000|Overall Study|Death|0|||
146629105|NCT00360230|528818345|FG001|Overall Study|Death|1|||
146629106|NCT00360230|528818346|FG002|Overall Study|Death|0|||
146629107|NCT00360230|528818347|FG003|Overall Study|Death|0|||
146629108|NCT00360230|528818348|FG004|Overall Study|Death|0|||
146629109|NCT00360230|528818349|FG005|Overall Study|Death|1|||
146629110|NCT00360230|528818350|FG006|Overall Study|Death|1|||
146629111|NCT00456846|528818351|FG000|Overall Study|Adverse Event|2|||
146629112|NCT00456846|528818352|FG001|Overall Study|Adverse Event|15|||
146629113|NCT00456846|528818351|FG000|Overall Study|Physician Decision|11|||
146629114|NCT00456846|528818352|FG001|Overall Study|Physician Decision|6|||
146629115|NCT00456846|528818351|FG000|Overall Study|Protocol Deviation|2|||
146629116|NCT00456846|528818352|FG001|Overall Study|Protocol Deviation|0|||
146629117|NCT00456846|528818351|FG000|Overall Study|Participant Discretion|1|||
146629118|NCT00456846|528818352|FG001|Overall Study|Participant Discretion|5|||
146629119|NCT00456846|528818351|FG000|Overall Study|Other|0|||
146629120|NCT00456846|528818352|FG001|Overall Study|Other|2|||
146629121|NCT00910650|528818353|FG000|Overall Study|Death|2|||
146629122|NCT03367793|528818354|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
146629123|NCT03367793|528818355|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
146877108|NCT00455013|529721049|FG002|Short Term Period|Lack of Efficacy|0|||
146877109|NCT00455013|529721047|FG000|Short Term Period|Other|0|||
146877110|NCT00455013|529721048|FG001|Short Term Period|Other|0|||
146877111|NCT00455013|529721049|FG002|Short Term Period|Other|1|||
146877112|NCT00455013|529721047|FG000|Long Term Extension (LTE)|Adverse Event|0|||
146877113|NCT00455013|529721048|FG001|Long Term Extension (LTE)|Adverse Event|1|||
146877114|NCT00455013|529721049|FG002|Long Term Extension (LTE)|Adverse Event|1|||
146877115|NCT00455013|529721047|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
146877116|NCT00455013|529721048|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
146877117|NCT00455013|529721049|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
146877118|NCT00455013|529721047|FG000|Long Term Extension (LTE)|Death|1|||
146877119|NCT00455013|529721048|FG001|Long Term Extension (LTE)|Death|1|||
146877120|NCT00455013|529721049|FG002|Long Term Extension (LTE)|Death|0|||
146877121|NCT00455013|529721047|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
146877122|NCT00455013|529721048|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
146877123|NCT00455013|529721049|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
146877124|NCT00455013|529721047|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
146877125|NCT00455013|529721048|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
146877126|NCT00455013|529721049|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
146877127|NCT00455013|529721047|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
146877128|NCT00455013|529721048|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
146877129|NCT00455013|529721049|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
146877130|NCT00455013|529721047|FG000|Long Term Extension (LTE)|non-specified|0|||
146877131|NCT00455013|529721048|FG001|Long Term Extension (LTE)|non-specified|0|||
146877132|NCT00455013|529721049|FG002|Long Term Extension (LTE)|non-specified|1|||
146877133|NCT01445951|529721050|FG000|Overall Study|Adverse Event|16|||
146877134|NCT01445951|529721051|FG001|Overall Study|Adverse Event|9|||
146877135|NCT01445951|529721052|FG002|Overall Study|Adverse Event|0|||
146877136|NCT01445951|529721050|FG000|Overall Study|Protocol Violation|2|||
146877137|NCT01445951|529721051|FG001|Overall Study|Protocol Violation|2|||
146877138|NCT01445951|529721052|FG002|Overall Study|Protocol Violation|2|||
146877139|NCT01445951|529721050|FG000|Overall Study|Withdrawal by Subject|21|||
146877140|NCT01445951|529721051|FG001|Overall Study|Withdrawal by Subject|16|||
146877141|NCT01445951|529721052|FG002|Overall Study|Withdrawal by Subject|8|||
146877142|NCT01445951|529721050|FG000|Overall Study|Physician Decision|3|||
146877143|NCT01445951|529721051|FG001|Overall Study|Physician Decision|1|||
146877144|NCT01445951|529721052|FG002|Overall Study|Physician Decision|0|||
146877145|NCT01445951|529721050|FG000|Overall Study|Lost to Follow-up|1|||
146877146|NCT01445951|529721051|FG001|Overall Study|Lost to Follow-up|2|||
146877147|NCT01445951|529721052|FG002|Overall Study|Lost to Follow-up|4|||
146877148|NCT01445951|529721050|FG000|Overall Study|Pregnancy|0|||
146877149|NCT01445951|529721051|FG001|Overall Study|Pregnancy|1|||
146877150|NCT01445951|529721052|FG002|Overall Study|Pregnancy|4|||
146764845|NCT04511650|529305945|FG000|Overall Study|Withdrawal by Subject|1|||
146877151|NCT01445951|529721050|FG000|Overall Study|Death|0|||
146877152|NCT01445951|529721051|FG001|Overall Study|Death|0|||
146877153|NCT01445951|529721052|FG002|Overall Study|Death|1|||
146877154|NCT01445951|529721050|FG000|Overall Study|Non-compliance with study drug|1|||
146877155|NCT01445951|529721051|FG001|Overall Study|Non-compliance with study drug|2|||
146877156|NCT01445951|529721052|FG002|Overall Study|Non-compliance with study drug|0|||
146877157|NCT01445951|529721050|FG000|Overall Study|Non-compliance with protocol|0|||
146877158|NCT01445951|529721051|FG001|Overall Study|Non-compliance with protocol|1|||
146877159|NCT01445951|529721052|FG002|Overall Study|Non-compliance with protocol|0|||
146877160|NCT01445951|529721050|FG000|Overall Study|Sponsor decision - subject travel|0|||
146877161|NCT01445951|529721051|FG001|Overall Study|Sponsor decision - subject travel|1|||
146877162|NCT01445951|529721052|FG002|Overall Study|Sponsor decision - subject travel|0|||
146877163|NCT01445951|529721050|FG000|Overall Study|Cough|0|||
146877164|NCT01445951|529721051|FG001|Overall Study|Cough|1|||
146877165|NCT01445951|529721052|FG002|Overall Study|Cough|0|||
146877166|NCT01519765|529721055|FG000|Overall Study|Adverse Event|0|||
146877167|NCT01519765|529721056|FG001|Overall Study|Adverse Event|1|||
146877168|NCT01519765|529721055|FG000|Overall Study|Lack of Efficacy|2|||
146877169|NCT01519765|529721056|FG001|Overall Study|Lack of Efficacy|0|||
146877170|NCT01519765|529721055|FG000|Overall Study|Protocol Violation|1|||
146877171|NCT01519765|529721056|FG001|Overall Study|Protocol Violation|0|||
146877172|NCT01519765|529721055|FG000|Overall Study|Withdrawal by Subject|0|||
146877173|NCT01519765|529721056|FG001|Overall Study|Withdrawal by Subject|1|||
146877174|NCT00078325|529721057|FG000|Overall Study|Adverse Event|15|||
146877175|NCT00078325|529721058|FG001|Overall Study|Adverse Event|10|||
146877176|NCT00078325|529721059|FG002|Overall Study|Adverse Event|5|||
146877177|NCT00078325|529721057|FG000|Overall Study|Protocol Violation|2|||
146877178|NCT00078325|529721058|FG001|Overall Study|Protocol Violation|2|||
146877179|NCT00078325|529721059|FG002|Overall Study|Protocol Violation|0|||
146877180|NCT00078325|529721057|FG000|Overall Study|Withdrawal by Subject|1|||
146877181|NCT00078325|529721058|FG001|Overall Study|Withdrawal by Subject|5|||
146877182|NCT00078325|529721059|FG002|Overall Study|Withdrawal by Subject|3|||
146877183|NCT00078325|529721057|FG000|Overall Study|Lost to Follow-up|0|||
146877184|NCT00078325|529721058|FG001|Overall Study|Lost to Follow-up|1|||
146877185|NCT00078325|529721059|FG002|Overall Study|Lost to Follow-up|1|||
146877186|NCT00078325|529721057|FG000|Overall Study|Physician Decision|2|||
146877187|NCT00078325|529721058|FG001|Overall Study|Physician Decision|0|||
146877188|NCT00078325|529721059|FG002|Overall Study|Physician Decision|1|||
146877189|NCT00078325|529721057|FG000|Overall Study|Miscellaneous|1|||
146877190|NCT00078325|529721058|FG001|Overall Study|Miscellaneous|1|||
146877191|NCT00078325|529721059|FG002|Overall Study|Miscellaneous|1|||
146877192|NCT02739620|529721060|FG000|Overall Study|Lost to Follow-up|3|||
146877193|NCT02739620|529721061|FG001|Overall Study|Lost to Follow-up|1|||
146877194|NCT02739620|529721060|FG000|Overall Study|Adverse Event|0|||
146877195|NCT02739620|529721061|FG001|Overall Study|Adverse Event|1|||
146877196|NCT02354222|529721062|FG000|Overall Study|Adverse Event|0|||
146877197|NCT02354222|529721063|FG001|Overall Study|Adverse Event|3|||
146877198|NCT02354222|529721062|FG000|Overall Study|Physician Decision|1|||
146877199|NCT02354222|529721063|FG001|Overall Study|Physician Decision|1|||
146877200|NCT02354222|529721062|FG000|Overall Study|Pregnancy|1|||
146877201|NCT02354222|529721063|FG001|Overall Study|Pregnancy|0|||
146877202|NCT02354222|529721062|FG000|Overall Study|Withdrawal by Subject|2|||
146877203|NCT02354222|529721063|FG001|Overall Study|Withdrawal by Subject|3|||
146877204|NCT02354222|529721062|FG000|Overall Study|Conflict with the stopping criteria|0|||
146877205|NCT02354222|529721063|FG001|Overall Study|Conflict with the stopping criteria|4|||
146877206|NCT04126083|529721067|FG000|Overall Study|Withdrawal by Subject|1|||
146877207|NCT00786565|529721068|FG000|Enrollment Prior to Surgery|Site Closed|3|||
146877208|NCT00786565|529721068|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
146877209|NCT00786565|529721068|FG000|Post Surgery|Abnormal macular pucker|1|||
146877210|NCT00786565|529721068|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
146877211|NCT00578136|529721069|FG000|Overall Study|Not given intervention|1|||
146877212|NCT00578136|529721070|FG001|Overall Study|Not given intervention|1|||
146877213|NCT00754793|529721074|FG000|Overall Study|voluntary withdrawn from study|0|||
146877214|NCT00754793|529721075|FG001|Overall Study|voluntary withdrawn from study|1|||
146877215|NCT00932360|529721077|FG000|Washout (One Week)|Withdrawal by Subject|0|||
146877216|NCT00932360|529721078|FG001|Washout (One Week)|Withdrawal by Subject|0|||
146877217|NCT00932360|529721079|FG002|Washout (One Week)|Withdrawal by Subject|0|||
146877218|NCT00932360|529721080|FG003|Washout (One Week)|Withdrawal by Subject|0|||
146877219|NCT00932360|529721081|FG004|Washout (One Week)|Withdrawal by Subject|2|||
146877220|NCT00932360|529721082|FG005|Washout (One Week)|Withdrawal by Subject|0|||
146877221|NCT02536313|529721083|FG000|Overall Study|Lack of Efficacy|0|||
146877222|NCT02536313|529721084|FG001|Overall Study|Lack of Efficacy|1|||
146877223|NCT02437864|529721092|FG000|Overall Study|Protocol Violation|4|||
146877224|NCT02437864|529721093|FG001|Overall Study|Protocol Violation|0|||
146877225|NCT01585272|529721095|FG000|Overall Study|Adverse Event|22|||
146877226|NCT01585272|529721095|FG000|Overall Study|Protocol Violation|7|||
146877227|NCT01585272|529721095|FG000|Overall Study|Withdrawal by Subject|10|||
146877228|NCT00645593|529721096|FG000|Overall Study|Later found to be ineligible|1|||
146877229|NCT00645593|529721097|FG001|Overall Study|Later found to be ineligible|0|||
146877230|NCT00993265|529721102|FG000|Overall Study|Adverse Event|1|||
146877231|NCT00993265|529721103|FG001|Overall Study|Adverse Event|0|||
146877232|NCT00993265|529721102|FG000|Overall Study|Changed dose of concomitant drug|2|||
146877233|NCT00993265|529721103|FG001|Overall Study|Changed dose of concomitant drug|0|||
146877234|NCT00993265|529721102|FG000|Overall Study|Non-compliant with study medication|1|||
146877235|NCT00993265|529721103|FG001|Overall Study|Non-compliant with study medication|0|||
146877236|NCT03765138|529721104|FG000|Overall Study|Lost to Follow-up|1|||
146877237|NCT00361270|529721105|FG000|Overall Study|Death|0|||
146877238|NCT00361270|529721106|FG001|Overall Study|Death|0|||
146877239|NCT00361270|529721107|FG002|Overall Study|Death|0|||
146877240|NCT00361270|529721108|FG003|Overall Study|Death|2|||
146877241|NCT00361270|529721105|FG000|Overall Study|Lost to Follow-up|4|||
146877242|NCT00361270|529721106|FG001|Overall Study|Lost to Follow-up|1|||
146877243|NCT00361270|529721107|FG002|Overall Study|Lost to Follow-up|0|||
146877244|NCT00361270|529721108|FG003|Overall Study|Lost to Follow-up|0|||
146877245|NCT00361270|529721105|FG000|Overall Study|Physician Decision|0|||
146877246|NCT00361270|529721106|FG001|Overall Study|Physician Decision|0|||
146877247|NCT00361270|529721107|FG002|Overall Study|Physician Decision|1|||
146877248|NCT00361270|529721108|FG003|Overall Study|Physician Decision|0|||
146877249|NCT00361270|529721105|FG000|Overall Study|Protocol Violation|9|||
146877250|NCT00361270|529721106|FG001|Overall Study|Protocol Violation|4|||
146877251|NCT00361270|529721107|FG002|Overall Study|Protocol Violation|5|||
146877252|NCT00361270|529721108|FG003|Overall Study|Protocol Violation|4|||
146877253|NCT00361270|529721105|FG000|Overall Study|Withdrawal by Subject|6|||
146877254|NCT00361270|529721106|FG001|Overall Study|Withdrawal by Subject|6|||
146877255|NCT00361270|529721107|FG002|Overall Study|Withdrawal by Subject|3|||
146877256|NCT00361270|529721108|FG003|Overall Study|Withdrawal by Subject|7|||
146877257|NCT00361270|529721105|FG000|Overall Study|Afraid of Hypnosis|1|||
146877258|NCT00361270|529721106|FG001|Overall Study|Afraid of Hypnosis|2|||
146877259|NCT00361270|529721107|FG002|Overall Study|Afraid of Hypnosis|0|||
146877260|NCT00361270|529721108|FG003|Overall Study|Afraid of Hypnosis|0|||
146877261|NCT00361270|529721105|FG000|Overall Study|Problems with Transportation|4|||
146877262|NCT00361270|529721106|FG001|Overall Study|Problems with Transportation|0|||
146877263|NCT00361270|529721107|FG002|Overall Study|Problems with Transportation|0|||
146877264|NCT00361270|529721108|FG003|Overall Study|Problems with Transportation|0|||
146877265|NCT00361270|529721105|FG000|Overall Study|Adverse Event|0|||
146877266|NCT00361270|529721106|FG001|Overall Study|Adverse Event|1|||
146877267|NCT00361270|529721107|FG002|Overall Study|Adverse Event|1|||
146877268|NCT00361270|529721108|FG003|Overall Study|Adverse Event|0|||
146877269|NCT00517751|529721111|FG000|Overall Study|Death|3|||
146877270|NCT00517751|529721111|FG000|Overall Study|Withdrawal by Subject|37|||
146877271|NCT00517751|529721111|FG000|Overall Study|Lost to Follow-up|4|||
146877272|NCT00517751|529721111|FG000|Overall Study|patient not over due|6|||
146877273|NCT00517751|529721111|FG000|Overall Study|Patient not due for visit|76|||
146877274|NCT00517751|529721111|FG000|Overall Study|Missing|3|||
146877275|NCT00495820|529721112|FG000|Overall Study|Adverse Event|1|||
146877276|NCT00495820|529721113|FG001|Overall Study|Adverse Event|1|||
146877277|NCT00470054|529721114|FG000|Overall Study|Ineligible|1|||
146877278|NCT02581202|529721119|FG000|Overall Study|Lack of Efficacy|2|||
146877279|NCT02581202|529721119|FG000|Overall Study|Withdrawal by Subject|4|||
146877280|NCT02581202|529721119|FG000|Overall Study|Lost to Follow-up|5|||
146877281|NCT02581202|529721119|FG000|Overall Study|Pregnancy|3|||
146877282|NCT04050982|529721120|FG000|Overall Study|Did not meet eligibility criteria|0|||
146877283|NCT04050982|529721121|FG001|Overall Study|Did not meet eligibility criteria|1|||
146877284|NCT04050982|529721122|FG002|Overall Study|Did not meet eligibility criteria|0|||
146877285|NCT04050982|529721120|FG000|Overall Study|Withdrawal by Subject|1|||
146877286|NCT04050982|529721121|FG001|Overall Study|Withdrawal by Subject|0|||
146877287|NCT04050982|529721122|FG002|Overall Study|Withdrawal by Subject|0|||
146877288|NCT04050982|529721120|FG000|Overall Study|Unable to enroll on platform|1|||
146877289|NCT04050982|529721121|FG001|Overall Study|Unable to enroll on platform|0|||
146877290|NCT04050982|529721122|FG002|Overall Study|Unable to enroll on platform|0|||
146877291|NCT01246583|529721123|FG000|Overall Study|Lost to Follow-up|0|||
146877292|NCT01246583|529721124|FG001|Overall Study|Lost to Follow-up|0|||
146877293|NCT01246583|529721125|FG002|Overall Study|Lost to Follow-up|0|||
146764846|NCT04511650|529305946|FG001|Overall Study|Withdrawal by Subject|0|||
146877294|NCT01246583|529721126|FG003|Overall Study|Lost to Follow-up|1|||
146877295|NCT01246583|529721123|FG000|Overall Study|Protocol Violation|0|||
146877296|NCT01246583|529721124|FG001|Overall Study|Protocol Violation|0|||
146877297|NCT01246583|529721125|FG002|Overall Study|Protocol Violation|1|||
146877298|NCT01246583|529721126|FG003|Overall Study|Protocol Violation|0|||
146877299|NCT01246583|529721123|FG000|Overall Study|Withdrawal by Subject|1|||
146877300|NCT01246583|529721124|FG001|Overall Study|Withdrawal by Subject|0|||
146877301|NCT01246583|529721125|FG002|Overall Study|Withdrawal by Subject|0|||
146877302|NCT01246583|529721126|FG003|Overall Study|Withdrawal by Subject|0|||
146877303|NCT02116777|529721127|FG000|Overall Study|Adverse Event|0|||
146877304|NCT02116777|529721128|FG001|Overall Study|Adverse Event|0|||
146877305|NCT02116777|529721129|FG002|Overall Study|Adverse Event|0|||
146877306|NCT02116777|529721130|FG003|Overall Study|Adverse Event|0|||
146877307|NCT02116777|529721131|FG004|Overall Study|Adverse Event|2|||
146877308|NCT02116777|529721132|FG005|Overall Study|Adverse Event|2|||
146877309|NCT02116777|529721133|FG006|Overall Study|Adverse Event|0|||
146877310|NCT02116777|529721127|FG000|Overall Study|Death|0|||
146877311|NCT02116777|529721128|FG001|Overall Study|Death|0|||
146877312|NCT02116777|529721129|FG002|Overall Study|Death|0|||
146877313|NCT02116777|529721130|FG003|Overall Study|Death|1|||
146877314|NCT02116777|529721131|FG004|Overall Study|Death|0|||
146877315|NCT02116777|529721132|FG005|Overall Study|Death|0|||
146877316|NCT02116777|529721133|FG006|Overall Study|Death|0|||
146877317|NCT02116777|529721127|FG000|Overall Study|Lack of Efficacy|3|||
146877318|NCT02116777|529721128|FG001|Overall Study|Lack of Efficacy|3|||
146877319|NCT02116777|529721129|FG002|Overall Study|Lack of Efficacy|3|||
146877320|NCT02116777|529721130|FG003|Overall Study|Lack of Efficacy|8|||
146877321|NCT02116777|529721131|FG004|Overall Study|Lack of Efficacy|4|||
146877322|NCT02116777|529721132|FG005|Overall Study|Lack of Efficacy|1|||
146877323|NCT02116777|529721133|FG006|Overall Study|Lack of Efficacy|9|||
146877324|NCT02116777|529721127|FG000|Overall Study|Physician Decision|0|||
146877325|NCT02116777|529721128|FG001|Overall Study|Physician Decision|0|||
146877326|NCT02116777|529721129|FG002|Overall Study|Physician Decision|0|||
146877327|NCT02116777|529721130|FG003|Overall Study|Physician Decision|2|||
146877328|NCT02116777|529721131|FG004|Overall Study|Physician Decision|0|||
146877329|NCT02116777|529721132|FG005|Overall Study|Physician Decision|0|||
146877330|NCT02116777|529721133|FG006|Overall Study|Physician Decision|0|||
146877331|NCT02116777|529721127|FG000|Overall Study|Protocol Violation|0|||
146877332|NCT02116777|529721128|FG001|Overall Study|Protocol Violation|0|||
146877333|NCT02116777|529721129|FG002|Overall Study|Protocol Violation|0|||
146877334|NCT02116777|529721130|FG003|Overall Study|Protocol Violation|1|||
146877335|NCT02116777|529721131|FG004|Overall Study|Protocol Violation|0|||
146877336|NCT02116777|529721132|FG005|Overall Study|Protocol Violation|0|||
146877337|NCT02116777|529721133|FG006|Overall Study|Protocol Violation|0|||
146877338|NCT02116777|529721127|FG000|Overall Study|Withdrawal by Subject|0|||
146877339|NCT02116777|529721128|FG001|Overall Study|Withdrawal by Subject|0|||
146877340|NCT02116777|529721129|FG002|Overall Study|Withdrawal by Subject|0|||
146877341|NCT02116777|529721130|FG003|Overall Study|Withdrawal by Subject|1|||
146877342|NCT02116777|529721131|FG004|Overall Study|Withdrawal by Subject|0|||
146877343|NCT02116777|529721132|FG005|Overall Study|Withdrawal by Subject|0|||
146877344|NCT02116777|529721133|FG006|Overall Study|Withdrawal by Subject|0|||
146877345|NCT01423851|529721136|FG000|Whole Study|Disease progression|2|||
146877346|NCT01423851|529721137|FG001|Whole Study|Disease progression|1|||
146877347|NCT01423851|529721138|FG002|Whole Study|Disease progression|1|||
146877348|NCT01423851|529721139|FG003|Whole Study|Disease progression|4|||
146877349|NCT01423851|529721140|FG004|Whole Study|Disease progression|1|||
146764847|NCT04511650|529305947|FG002|Overall Study|Withdrawal by Subject|0|||
146877350|NCT01423851|529721141|FG005|Whole Study|Disease progression|3|||
146877351|NCT01423851|529721142|FG006|Whole Study|Disease progression|1|||
146877352|NCT01423851|529721143|FG007|Whole Study|Disease progression|4|||
146877353|NCT01423851|529721144|FG008|Whole Study|Disease progression|0|||
146544310|NCT02830087|528498985|FG001|Overall Study|No study staff to follow-up patients|4|||
146544311|NCT02830087|528498986|FG002|Overall Study|No study staff to follow-up patients|4|||
146544312|NCT02830087|528498987|FG003|Overall Study|No study staff to follow-up patients|3|||
146544313|NCT02830087|528498988|FG004|Overall Study|No study staff to follow-up patients|3|||
146544314|NCT02830087|528498989|FG005|Overall Study|No study staff to follow-up patients|3|||
146544315|NCT02916771|528498990|FG000|Overall Study|Withdrawal by Subject|9|||
146544316|NCT02916771|528498990|FG000|Overall Study|Physician Decision|1|||
146544317|NCT02916771|528498990|FG000|Overall Study|Began treatment for another active malignancy|1|||
146544318|NCT05578872|528499004|FG000|Overall Study|Withdrawal by Subject|2|||
146544319|NCT05578872|528499005|FG001|Overall Study|Withdrawal by Subject|1|||
146544320|NCT05578872|528499004|FG000|Overall Study|Adverse Event|1|||
146544321|NCT05578872|528499005|FG001|Overall Study|Adverse Event|1|||
146544322|NCT05578872|528499004|FG000|Overall Study|Physician Decision|1|||
146877354|NCT01423851|529721145|FG009|Whole Study|Disease progression|2|||
146877355|NCT01423851|529721146|FG010|Whole Study|Disease progression|10|||
146877356|NCT01423851|529721136|FG000|Whole Study|Physician Decision|0|||
146877357|NCT01423851|529721137|FG001|Whole Study|Physician Decision|1|||
146877358|NCT01423851|529721138|FG002|Whole Study|Physician Decision|2|||
146877359|NCT01423851|529721139|FG003|Whole Study|Physician Decision|0|||
146877360|NCT01423851|529721140|FG004|Whole Study|Physician Decision|2|||
146877361|NCT01423851|529721141|FG005|Whole Study|Physician Decision|0|||
146877362|NCT01423851|529721142|FG006|Whole Study|Physician Decision|2|||
146877363|NCT01423851|529721143|FG007|Whole Study|Physician Decision|1|||
146877364|NCT01423851|529721144|FG008|Whole Study|Physician Decision|3|||
146877365|NCT01423851|529721145|FG009|Whole Study|Physician Decision|4|||
146877366|NCT01423851|529721146|FG010|Whole Study|Physician Decision|12|||
146877367|NCT01423851|529721136|FG000|Whole Study|Withdrawal by Subject|1|||
146877368|NCT01423851|529721137|FG001|Whole Study|Withdrawal by Subject|1|||
146877369|NCT01423851|529721138|FG002|Whole Study|Withdrawal by Subject|0|||
146877370|NCT01423851|529721139|FG003|Whole Study|Withdrawal by Subject|0|||
146877371|NCT01423851|529721140|FG004|Whole Study|Withdrawal by Subject|0|||
146877372|NCT01423851|529721141|FG005|Whole Study|Withdrawal by Subject|0|||
146877373|NCT01423851|529721142|FG006|Whole Study|Withdrawal by Subject|0|||
146877374|NCT01423851|529721143|FG007|Whole Study|Withdrawal by Subject|0|||
146877375|NCT01423851|529721144|FG008|Whole Study|Withdrawal by Subject|2|||
146877376|NCT01423851|529721145|FG009|Whole Study|Withdrawal by Subject|0|||
146877377|NCT01423851|529721146|FG010|Whole Study|Withdrawal by Subject|4|||
146877378|NCT01423851|529721136|FG000|Whole Study|Adverse Event|0|||
146877379|NCT01423851|529721137|FG001|Whole Study|Adverse Event|0|||
146877380|NCT01423851|529721138|FG002|Whole Study|Adverse Event|0|||
146877381|NCT01423851|529721139|FG003|Whole Study|Adverse Event|2|||
146877382|NCT01423851|529721140|FG004|Whole Study|Adverse Event|0|||
146877383|NCT01423851|529721141|FG005|Whole Study|Adverse Event|0|||
146877384|NCT01423851|529721142|FG006|Whole Study|Adverse Event|0|||
146877385|NCT01423851|529721143|FG007|Whole Study|Adverse Event|3|||
146877386|NCT01423851|529721144|FG008|Whole Study|Adverse Event|3|||
146877387|NCT01423851|529721145|FG009|Whole Study|Adverse Event|2|||
146877388|NCT01423851|529721146|FG010|Whole Study|Adverse Event|3|||
146877389|NCT00733954|529721150|FG000|Overall Study|Lost to Follow-up|5|||
146877390|NCT00733954|529721151|FG001|Overall Study|Lost to Follow-up|2|||
146877391|NCT00733954|529721150|FG000|Overall Study|Protocol Violation|1|||
146877392|NCT00733954|529721151|FG001|Overall Study|Protocol Violation|0|||
146877393|NCT00733954|529721150|FG000|Overall Study|Withdrawal by Subject|2|||
146877394|NCT00733954|529721151|FG001|Overall Study|Withdrawal by Subject|0|||
146877395|NCT02663453|529721152|FG000|Overall Study|Death|4|||
146877396|NCT02663453|529721153|FG001|Overall Study|Death|4|||
146877397|NCT02663453|529721152|FG000|Overall Study|Withdrawal by Subject|1|||
146877398|NCT02663453|529721153|FG001|Overall Study|Withdrawal by Subject|0|||
146877399|NCT03416153|529721154|FG000|Overall Study|Physician Decision|1|||
146877400|NCT03416153|529721155|FG001|Overall Study|Physician Decision|1|||
146877401|NCT03416153|529721154|FG000|Overall Study|Withdrawal by Subject|1|||
146877402|NCT03416153|529721155|FG001|Overall Study|Withdrawal by Subject|0|||
146877403|NCT00609791|529722606|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
146877404|NCT04218201|529722607|FG000|Overall Study|Death|0|||
146877405|NCT04218201|529722608|FG001|Overall Study|Death|0|||
146877406|NCT04218201|529722609|FG002|Overall Study|Death|2|||
146877407|NCT04218201|529722610|FG003|Overall Study|Death|0|||
146877408|NCT04218201|529722607|FG000|Overall Study|Unable to contact participant|4|||
146877409|NCT04218201|529722608|FG001|Overall Study|Unable to contact participant|0|||
146877410|NCT04218201|529722609|FG002|Overall Study|Unable to contact participant|3|||
146877411|NCT04218201|529722610|FG003|Overall Study|Unable to contact participant|0|||
146877412|NCT04218201|529722607|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
146877413|NCT04218201|529722608|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
146877414|NCT04218201|529722609|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
146877415|NCT04218201|529722610|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
146877416|NCT04218201|529722607|FG000|Overall Study|Withdrawal by Subject|2|||
146877417|NCT04218201|529722608|FG001|Overall Study|Withdrawal by Subject|0|||
146877418|NCT04218201|529722609|FG002|Overall Study|Withdrawal by Subject|0|||
146877419|NCT04218201|529722610|FG003|Overall Study|Withdrawal by Subject|0|||
146877420|NCT04218201|529722607|FG000|Overall Study|PCP plans to leave practice|0|||
146877421|NCT04218201|529722608|FG001|Overall Study|PCP plans to leave practice|8|||
146877422|NCT04218201|529722609|FG002|Overall Study|PCP plans to leave practice|0|||
146877423|NCT04218201|529722610|FG003|Overall Study|PCP plans to leave practice|5|||
146877424|NCT04218201|529722607|FG000|Overall Study|Reduced panel|0|||
146877425|NCT04218201|529722608|FG001|Overall Study|Reduced panel|0|||
146877426|NCT04218201|529722609|FG002|Overall Study|Reduced panel|0|||
146877427|NCT04218201|529722610|FG003|Overall Study|Reduced panel|1|||
146877428|NCT04218201|529722607|FG000|Overall Study|No longer interested in participating|0|||
146877429|NCT04218201|529722608|FG001|Overall Study|No longer interested in participating|1|||
146877430|NCT04218201|529722609|FG002|Overall Study|No longer interested in participating|0|||
146629124|NCT03367793|528818356|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
146629125|NCT03367793|528818357|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
146629126|NCT03367793|528818358|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
146629127|NCT03367793|528818359|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
146629128|NCT00260533|528818360|FG000|Overall Study|Other|3|||
146629129|NCT00260533|528818361|FG001|Overall Study|Other|3|||
146629130|NCT00003475|528818362|FG000|Overall Study|Not evaluable|13|||
146629131|NCT04682366|528818363|FG000|Overall Study|Lost to Follow-up|1|||
146877431|NCT04218201|529722610|FG003|Overall Study|No longer interested in participating|0|||
146877432|NCT04649255|529722611|FG000|Overall Study|Death|9|||
146877433|NCT04649255|529722611|FG000|Overall Study|Withdrawal by Subject|1|||
146629132|NCT04682366|528818364|FG001|Overall Study|Lost to Follow-up|1|||
146629133|NCT02224560|528818368|FG000|Overall Study|Protocol Deviation|1|||
146629134|NCT02224560|528818369|FG001|Overall Study|Protocol Deviation|0|||
146629135|NCT02224560|528818370|FG002|Overall Study|Protocol Deviation|0|||
146629136|NCT02224560|528818368|FG000|Overall Study|Withdrawal by Subject|2|||
146629137|NCT02224560|528818369|FG001|Overall Study|Withdrawal by Subject|0|||
146629138|NCT02224560|528818370|FG002|Overall Study|Withdrawal by Subject|1|||
146629139|NCT02224560|528818368|FG000|Overall Study|Met Withdrawal Criteria|1|||
146629140|NCT02224560|528818369|FG001|Overall Study|Met Withdrawal Criteria|0|||
146629141|NCT02224560|528818370|FG002|Overall Study|Met Withdrawal Criteria|0|||
146629142|NCT02224560|528818368|FG000|Overall Study|Adverse Event|4|||
146629143|NCT02224560|528818369|FG001|Overall Study|Adverse Event|1|||
146629144|NCT02224560|528818370|FG002|Overall Study|Adverse Event|1|||
146629145|NCT02224560|528818368|FG000|Overall Study|Withdrawn by Investigator|1|||
146629146|NCT02224560|528818369|FG001|Overall Study|Withdrawn by Investigator|1|||
146629147|NCT02224560|528818370|FG002|Overall Study|Withdrawn by Investigator|0|||
146629148|NCT04543279|528818371|FG000|Overall Study|Withdrawal by Subject|1|||
146629149|NCT04543279|528818372|FG001|Overall Study|Withdrawal by Subject|0|||
146629150|NCT04543279|528818371|FG000|Overall Study|Adverse Event|1|||
146629151|NCT04543279|528818372|FG001|Overall Study|Adverse Event|0|||
146629152|NCT04543279|528818371|FG000|Overall Study|Physician Decision|1|||
146629153|NCT04543279|528818372|FG001|Overall Study|Physician Decision|0|||
146629154|NCT00929695|528818374|FG000|Overall Study|Death|2|||
146629155|NCT00929695|528818375|FG001|Overall Study|Death|1|||
146629156|NCT00929695|528818374|FG000|Overall Study|Withdrawal by Subject|0|||
146629157|NCT00929695|528818375|FG001|Overall Study|Withdrawal by Subject|2|||
146629158|NCT00929695|528818374|FG000|Overall Study|discharge home|4|||
146629159|NCT00929695|528818375|FG001|Overall Study|discharge home|3|||
146629160|NCT00929695|528818374|FG000|Overall Study|incorrect stratification|2|||
146629161|NCT00929695|528818375|FG001|Overall Study|incorrect stratification|0|||
146629162|NCT04030143|528818376|FG000|Overall Study|Adverse Event|5|||
146629163|NCT04030143|528818377|FG001|Overall Study|Adverse Event|10|||
146629164|NCT04030143|528818376|FG000|Overall Study|Lost to Follow-up|3|||
146629165|NCT04030143|528818377|FG001|Overall Study|Lost to Follow-up|7|||
146629166|NCT04030143|528818376|FG000|Overall Study|Protocol Deviation|2|||
146629167|NCT04030143|528818377|FG001|Overall Study|Protocol Deviation|2|||
146629168|NCT04030143|528818376|FG000|Overall Study|Withdrawal by Subject|16|||
146629169|NCT04030143|528818377|FG001|Overall Study|Withdrawal by Subject|18|||
146629170|NCT04030143|528818376|FG000|Overall Study|Physician Decision|1|||
146629171|NCT04030143|528818377|FG001|Overall Study|Physician Decision|1|||
146544323|NCT05578872|528499005|FG001|Overall Study|Physician Decision|2|||
146544324|NCT05578872|528499004|FG000|Overall Study|Progressive disease|10|||
146544325|NCT05578872|528499005|FG001|Overall Study|Progressive disease|9|||
146544326|NCT05578872|528499004|FG000|Overall Study|Sponsor decision|0|||
146544327|NCT05578872|528499005|FG001|Overall Study|Sponsor decision|1|||
146544328|NCT05578872|528499004|FG000|Overall Study|Toxicity and Patient's decision|0|||
146544329|NCT05578872|528499005|FG001|Overall Study|Toxicity and Patient's decision|1|||
146544330|NCT02737618|528500134|FG000|Overall Study|Withdrawal by Subject|9|||
146544331|NCT02397837|528500136|FG000|Overall Study|Withdrawal by Subject|6|||
146544332|NCT02397837|528500137|FG001|Overall Study|Withdrawal by Subject|5|||
146544333|NCT02397837|528500136|FG000|Overall Study|Physician Decision|1|||
146544334|NCT02397837|528500137|FG001|Overall Study|Physician Decision|1|||
146544335|NCT00313170|528500141|FG000|Overall Study|Death|2|||
146544336|NCT00313170|528500142|FG001|Overall Study|Death|4|||
146544337|NCT00313170|528500143|FG002|Overall Study|Death|2|||
146764848|NCT04511650|529305945|FG000|Overall Study|reason not provided|0|||
146629172|NCT04030143|528818376|FG000|Overall Study|Due to Covid-19|2|||
146629173|NCT04030143|528818377|FG001|Overall Study|Due to Covid-19|3|||
146629174|NCT04030143|528818376|FG000|Overall Study|Not Due to Covid-19|1|||
146629175|NCT04030143|528818377|FG001|Overall Study|Not Due to Covid-19|1|||
146629176|NCT03216226|528818378|FG000|Overall Study|Adverse Event|3|||
146629177|NCT03216226|528818379|FG001|Overall Study|Adverse Event|0|||
146764849|NCT04511650|529305946|FG001|Overall Study|reason not provided|0|||
146544338|NCT00313170|528500141|FG000|Overall Study|Adverse Event|1|||
146544339|NCT00313170|528500142|FG001|Overall Study|Adverse Event|2|||
146544340|NCT00313170|528500143|FG002|Overall Study|Adverse Event|0|||
146544341|NCT00313170|528500141|FG000|Overall Study|Disease progression|31|||
146629178|NCT03216226|528818378|FG000|Overall Study|Protocol Violation|1|||
146544342|NCT00313170|528500142|FG001|Overall Study|Disease progression|26|||
146544343|NCT00313170|528500143|FG002|Overall Study|Disease progression|27|||
146877434|NCT02484911|529722612|FG000|Overall Study|Withdrawal by Subject|2|||
146877435|NCT02484911|529722613|FG001|Overall Study|Withdrawal by Subject|1|||
146544344|NCT00313170|528500141|FG000|Overall Study|Withdrawal by Subject|1|||
146877436|NCT02484911|529722612|FG000|Overall Study|Protocol Violation|2|||
146877437|NCT02484911|529722613|FG001|Overall Study|Protocol Violation|1|||
146877438|NCT00490568|529722619|FG000|Overall Study|Adverse Event|116|||
146877439|NCT00490568|529722619|FG000|Overall Study|Lost to Follow-up|13|||
146877440|NCT00490568|529722619|FG000|Overall Study|Protocol Violation|45|||
146877441|NCT00490568|529722619|FG000|Overall Study|Withdrawal by Subject|135|||
146877442|NCT00490568|529722619|FG000|Overall Study|Still in the study at termination|974|||
146877443|NCT00490568|529722619|FG000|Overall Study|Other|1|||
146877444|NCT00490568|529722619|FG000|Overall Study|Exclusion criteria met|1|||
146877445|NCT00490568|529722619|FG000|Overall Study|Caregiver related|20|||
146629179|NCT03216226|528818379|FG001|Overall Study|Protocol Violation|3|||
146877446|NCT00490568|529722619|FG000|Overall Study|Abnormal ECG|25|||
146877447|NCT00490568|529722619|FG000|Overall Study|Participant refused follow-up|9|||
146877448|NCT00490568|529722619|FG000|Overall Study|Legal representative withdrew consent|1|||
146877449|NCT00490568|529722619|FG000|Overall Study|Disease progression|4|||
146877450|NCT00490568|529722619|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
146877451|NCT00490568|529722619|FG000|Overall Study|Investigator decision|3|||
146877452|NCT00490568|529722619|FG000|Overall Study|Non-Compliance|7|||
146877453|NCT00490568|529722619|FG000|Overall Study|Efficacy related|3|||
146877454|NCT00490568|529722619|FG000|Overall Study|Participant died|1|||
146877455|NCT00490568|529722619|FG000|Overall Study|Participant withdrawal due to surgery|1|||
146877456|NCT00105443|529722622|FG000|Double-Blind Treatment|Adverse Event|1|||
146877457|NCT00105443|529722623|FG001|Double-Blind Treatment|Adverse Event|0|||
146877458|NCT00105443|529722624|FG002|Double-Blind Treatment|Adverse Event|0|||
146877459|NCT00105443|529722625|FG003|Double-Blind Treatment|Adverse Event|0|||
146877460|NCT00105443|529722622|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
146877461|NCT00105443|529722623|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
146877462|NCT00105443|529722624|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
146877463|NCT00105443|529722625|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
146877464|NCT00105443|529722622|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
146877465|NCT00105443|529722623|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
146877466|NCT00105443|529722624|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
146877467|NCT00105443|529722625|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
146877468|NCT00105443|529722622|FG000|Double-Blind Treatment|Physician Decision|1|||
146877469|NCT00105443|529722623|FG001|Double-Blind Treatment|Physician Decision|0|||
146877470|NCT00105443|529722624|FG002|Double-Blind Treatment|Physician Decision|2|||
146877471|NCT00105443|529722625|FG003|Double-Blind Treatment|Physician Decision|0|||
146877472|NCT00105443|529722622|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
146877473|NCT00105443|529722623|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
146877474|NCT00105443|529722624|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
146877475|NCT00105443|529722625|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
146877476|NCT00105443|529722622|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
146877477|NCT00105443|529722623|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
146877478|NCT00105443|529722624|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
146877479|NCT00105443|529722625|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
146877480|NCT00105443|529722622|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
146877481|NCT00105443|529722623|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
146877482|NCT00105443|529722624|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
146877483|NCT00105443|529722625|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
146877484|NCT00105443|529722622|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
146877485|NCT00105443|529722623|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
146877486|NCT00105443|529722624|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
146877487|NCT00105443|529722625|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
146877488|NCT00105443|529722622|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
146877489|NCT00105443|529722623|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
146877490|NCT00105443|529722624|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
146877491|NCT00105443|529722625|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
146877492|NCT00105443|529722622|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
146877493|NCT00105443|529722623|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
146877494|NCT00105443|529722624|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
146877495|NCT00105443|529722625|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
146544345|NCT00313170|528500142|FG001|Overall Study|Withdrawal by Subject|0|||
146764850|NCT04511650|529305947|FG002|Overall Study|reason not provided|1|||
146877496|NCT00105443|529722622|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
146877497|NCT00105443|529722623|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
146544346|NCT00313170|528500143|FG002|Overall Study|Withdrawal by Subject|1|||
146877498|NCT00105443|529722624|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
146877499|NCT00105443|529722625|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
146877500|NCT00105443|529722622|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
146877501|NCT00105443|529722623|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
146877502|NCT00105443|529722624|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
146877503|NCT00105443|529722625|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
146877504|NCT00105443|529722622|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
146877505|NCT00105443|529722623|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
146877506|NCT00105443|529722624|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
146877507|NCT00105443|529722625|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
146877508|NCT00105443|529722622|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
146877509|NCT00105443|529722623|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
146877510|NCT00105443|529722624|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
146877511|NCT00105443|529722625|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
146877512|NCT00105443|529722622|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
146877513|NCT00105443|529722623|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
146877514|NCT00105443|529722624|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
146544347|NCT00313170|528500141|FG000|Overall Study|Incorrect enrollment|0|||
146764851|NCT04511650|529305945|FG000|Overall Study|Death|1|||
146877515|NCT00105443|529722625|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
146877516|NCT00105443|529722622|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
146877517|NCT00105443|529722623|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
146877518|NCT00105443|529722624|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
146877519|NCT00105443|529722625|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
146877520|NCT00105443|529722622|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
146877521|NCT00105443|529722623|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
146877522|NCT00105443|529722624|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
146764852|NCT04511650|529305946|FG001|Overall Study|Death|1|||
146764853|NCT04511650|529305947|FG002|Overall Study|Death|1|||
146877523|NCT00105443|529722625|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
146877524|NCT00105443|529722622|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
146877525|NCT00105443|529722623|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
146877526|NCT00105443|529722624|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
146877527|NCT00105443|529722625|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
146877528|NCT00105443|529722622|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
146877529|NCT00105443|529722623|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
146877530|NCT00105443|529722624|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
146877531|NCT00105443|529722625|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
146877532|NCT01157078|529722626|FG000|Overall Study|Withdrawal by Subject|12|||
146877533|NCT01157078|529722627|FG001|Overall Study|Withdrawal by Subject|14|||
146877534|NCT01157078|529722626|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
146877535|NCT01157078|529722627|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146877536|NCT01157078|529722626|FG000|Overall Study|Adverse Event|6|||
146877537|NCT01157078|529722627|FG001|Overall Study|Adverse Event|6|||
146877538|NCT01157078|529722626|FG000|Overall Study|Severe non-compliance to protocol|2|||
146877539|NCT01157078|529722627|FG001|Overall Study|Severe non-compliance to protocol|4|||
146877540|NCT01157078|529722626|FG000|Overall Study|Condition under investigation worsened|0|||
146877541|NCT01157078|529722627|FG001|Overall Study|Condition under investigation worsened|1|||
146877542|NCT01157078|529722626|FG000|Overall Study|Lack of Efficacy|2|||
146877543|NCT01157078|529722627|FG001|Overall Study|Lack of Efficacy|0|||
146877544|NCT01157078|529722626|FG000|Overall Study|Study-specific withdrawal criteria|2|||
146877545|NCT01157078|529722627|FG001|Overall Study|Study-specific withdrawal criteria|2|||
146877546|NCT01157078|529722626|FG000|Overall Study|Lost to Follow-up|7|||
146877547|NCT01157078|529722627|FG001|Overall Study|Lost to Follow-up|5|||
146877548|NCT01157078|529722626|FG000|Overall Study|Other|2|||
146877549|NCT01157078|529722627|FG001|Overall Study|Other|4|||
146877550|NCT01324232|529722635|FG000|Overall Study|Protocol Violation|0|||
146877551|NCT01324232|529722636|FG001|Overall Study|Protocol Violation|0|||
146877552|NCT01324232|529722637|FG002|Overall Study|Protocol Violation|0|||
146877553|NCT01324232|529722638|FG003|Overall Study|Protocol Violation|2|||
146877554|NCT01324232|529722635|FG000|Overall Study|Missing|0|||
146877555|NCT01324232|529722636|FG001|Overall Study|Missing|0|||
146877556|NCT01324232|529722637|FG002|Overall Study|Missing|1|||
146877557|NCT01324232|529722638|FG003|Overall Study|Missing|0|||
146877558|NCT01324232|529722635|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
146877559|NCT01324232|529722636|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
146877560|NCT01324232|529722637|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
146877561|NCT01324232|529722638|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
146877562|NCT01324232|529722635|FG000|Overall Study|Lack of Efficacy|2|||
146877563|NCT01324232|529722636|FG001|Overall Study|Lack of Efficacy|1|||
146877564|NCT01324232|529722637|FG002|Overall Study|Lack of Efficacy|2|||
146877565|NCT01324232|529722638|FG003|Overall Study|Lack of Efficacy|2|||
146877566|NCT01324232|529722635|FG000|Overall Study|Participant Refused Medication|0|||
146877567|NCT01324232|529722636|FG001|Overall Study|Participant Refused Medication|1|||
146877568|NCT01324232|529722637|FG002|Overall Study|Participant Refused Medication|0|||
146877569|NCT01324232|529722638|FG003|Overall Study|Participant Refused Medication|0|||
146877570|NCT01324232|529722635|FG000|Overall Study|Intercurrent illness|0|||
146877571|NCT01324232|529722636|FG001|Overall Study|Intercurrent illness|0|||
146877572|NCT01324232|529722637|FG002|Overall Study|Intercurrent illness|0|||
146877573|NCT01324232|529722638|FG003|Overall Study|Intercurrent illness|1|||
146877574|NCT01324232|529722635|FG000|Overall Study|Adverse Event|2|||
146877575|NCT01324232|529722636|FG001|Overall Study|Adverse Event|5|||
146877576|NCT01324232|529722637|FG002|Overall Study|Adverse Event|6|||
146877577|NCT01324232|529722638|FG003|Overall Study|Adverse Event|6|||
146877578|NCT01324232|529722635|FG000|Overall Study|Withdrawal by Subject|0|||
146877579|NCT01324232|529722636|FG001|Overall Study|Withdrawal by Subject|3|||
146544348|NCT00313170|528500142|FG001|Overall Study|Incorrect enrollment|2|||
146544349|NCT00313170|528500143|FG002|Overall Study|Incorrect enrollment|1|||
146544350|NCT00313170|528500141|FG000|Overall Study|Lost to Follow-up|0|||
146544351|NCT00313170|528500142|FG001|Overall Study|Lost to Follow-up|0|||
146544352|NCT00313170|528500143|FG002|Overall Study|Lost to Follow-up|1|||
146544353|NCT00313170|528500141|FG000|Overall Study|Progression (investigators opinion)|1|||
146544354|NCT00313170|528500142|FG001|Overall Study|Progression (investigators opinion)|0|||
146544355|NCT00313170|528500143|FG002|Overall Study|Progression (investigators opinion)|0|||
146544356|NCT00407511|528500149|FG000|Overall Study|Adverse Event|9|||
146544357|NCT00407511|528500149|FG000|Overall Study|Lost to Follow-up|4|||
146877580|NCT01324232|529722637|FG002|Overall Study|Withdrawal by Subject|4|||
146877581|NCT01324232|529722638|FG003|Overall Study|Withdrawal by Subject|0|||
146877582|NCT01324232|529722635|FG000|Overall Study|Lost to Follow-up|1|||
146877583|NCT01324232|529722636|FG001|Overall Study|Lost to Follow-up|0|||
146877584|NCT01324232|529722637|FG002|Overall Study|Lost to Follow-up|0|||
146877585|NCT01324232|529722638|FG003|Overall Study|Lost to Follow-up|0|||
146877586|NCT05440539|529722639|FG000|Overall Study|Lost to Follow-up|4|||
146629180|NCT03216226|528818378|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
146629181|NCT03216226|528818379|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
146629182|NCT03216226|528818378|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
146629183|NCT03216226|528818379|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
146764854|NCT01972152|529305950|FG000|First Treatment Visit|Lost to Follow-up|0|||
146764855|NCT01972152|529305951|FG001|First Treatment Visit|Lost to Follow-up|1|||
146877587|NCT05440539|529722640|FG001|Overall Study|Lost to Follow-up|4|||
146877588|NCT05440539|529722639|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
146764856|NCT01972152|529305952|FG002|First Treatment Visit|Lost to Follow-up|0|||
146544358|NCT00407511|528500149|FG000|Overall Study|Other|5|||
146544359|NCT00407511|528500149|FG000|Overall Study|Withdrawal by Subject|4|||
146544360|NCT00529035|528500150|FG000|Overall Study|Withdrawal by Subject|1|||
146544361|NCT01879852|528500151|FG000|Overall Study|Withdrawal by Subject|2|||
146544362|NCT01879852|528500152|FG001|Overall Study|Withdrawal by Subject|0|||
146544363|NCT02115386|528500153|FG000|Overall Study|Protocol Violation|1|||
146544364|NCT02115386|528500153|FG000|Overall Study|Administrative - trial was terminated|6|||
146544365|NCT02493855|528500154|FG000|Overall Study|Non-compliance|1|||
146544366|NCT02493855|528500155|FG001|Overall Study|Non-compliance|0|||
146544367|NCT02493855|528500156|FG002|Overall Study|Non-compliance|0|||
146544368|NCT02493855|528500154|FG000|Overall Study|Adverse Event|0|||
146544369|NCT02493855|528500155|FG001|Overall Study|Adverse Event|1|||
146544370|NCT02493855|528500156|FG002|Overall Study|Adverse Event|0|||
146544371|NCT02493855|528500154|FG000|Overall Study|Withdrawal by Subject|1|||
146544372|NCT02493855|528500155|FG001|Overall Study|Withdrawal by Subject|0|||
146544373|NCT02493855|528500156|FG002|Overall Study|Withdrawal by Subject|0|||
146544374|NCT02453048|528500159|FG000|Overall Study|Only part of initial 6 mo. study|0|||
146544375|NCT02453048|528500160|FG001|Overall Study|Only part of initial 6 mo. study|0|||
146544376|NCT02453048|528500161|FG002|Overall Study|Only part of initial 6 mo. study|0|||
146544377|NCT02453048|528500162|FG003|Overall Study|Only part of initial 6 mo. study|0|||
146544378|NCT02453048|528500163|FG004|Overall Study|Only part of initial 6 mo. study|6|||
146544379|NCT02453048|528500159|FG000|Overall Study|Lost to Follow-up|0|||
146544380|NCT02453048|528500160|FG001|Overall Study|Lost to Follow-up|1|||
146544381|NCT02453048|528500161|FG002|Overall Study|Lost to Follow-up|2|||
146544382|NCT02453048|528500162|FG003|Overall Study|Lost to Follow-up|0|||
146544383|NCT02453048|528500163|FG004|Overall Study|Lost to Follow-up|0|||
146544384|NCT01482221|528500165|FG000|Overall Study|Lack of Efficacy|1|||
146544385|NCT01482221|528500166|FG001|Overall Study|Lack of Efficacy|0|||
146544386|NCT01482221|528500167|FG002|Overall Study|Lack of Efficacy|1|||
146544387|NCT01482221|528500165|FG000|Overall Study|Lost to Follow-up|3|||
146544388|NCT01482221|528500166|FG001|Overall Study|Lost to Follow-up|2|||
146544389|NCT01482221|528500167|FG002|Overall Study|Lost to Follow-up|1|||
146544390|NCT01482221|528500165|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
146544391|NCT01482221|528500166|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
146544392|NCT01482221|528500167|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
146544393|NCT01482221|528500165|FG000|Overall Study|Condition under Investigation Worsened|3|||
146544394|NCT01482221|528500166|FG001|Overall Study|Condition under Investigation Worsened|2|||
146544395|NCT01482221|528500167|FG002|Overall Study|Condition under Investigation Worsened|4|||
146544396|NCT01482221|528500165|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
146764857|NCT01972152|529305953|FG003|First Treatment Visit|Lost to Follow-up|0|||
146544397|NCT01482221|528500166|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
146544398|NCT01482221|528500167|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
146544399|NCT01482221|528500165|FG000|Overall Study|Adverse Event|1|||
146544400|NCT01482221|528500166|FG001|Overall Study|Adverse Event|7|||
146544401|NCT01482221|528500167|FG002|Overall Study|Adverse Event|3|||
146877589|NCT05440539|529722640|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
146877590|NCT00393887|529722641|FG000|Overall Study|Physician Decision|5|||
146877591|NCT00393887|529722642|FG001|Overall Study|Physician Decision|0|||
146877592|NCT00393887|529722641|FG000|Overall Study|Lost to Follow-up|11|||
146877593|NCT00393887|529722642|FG001|Overall Study|Lost to Follow-up|9|||
146877594|NCT01967628|529722645|FG000|Overall Study|Withdrawal by Subject|2|||
146877595|NCT01967628|529722646|FG001|Overall Study|Withdrawal by Subject|0|||
146877596|NCT01967628|529722645|FG000|Overall Study|Unable to complete bronchoscopy|4|||
146877597|NCT01967628|529722646|FG001|Overall Study|Unable to complete bronchoscopy|6|||
146877598|NCT01967628|529722645|FG000|Overall Study|Lost to Follow-up|1|||
146877599|NCT01967628|529722646|FG001|Overall Study|Lost to Follow-up|0|||
146877600|NCT01967628|529722645|FG000|Overall Study|Low protein concentration in sample|20|||
146877601|NCT01967628|529722646|FG001|Overall Study|Low protein concentration in sample|25|||
146877602|NCT00838331|529722647|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
146877603|NCT02055820|529722648|FG000|Phase I: Dose-Finding|Death|1|||
146877604|NCT02055820|529722649|FG001|Phase I: Dose-Finding|Death|0|||
146877605|NCT02055820|529722650|FG002|Phase I: Dose-Finding|Death|1|||
146650223|NCT04966910|528896683|FG000|Baseline|Participant did not complete measure|0|||
146877606|NCT02055820|529722651|FG003|Phase I: Dose-Finding|Death|2|||
146877607|NCT02055820|529722652|FG004|Phase I: Dose-Finding|Death|0|||
146877608|NCT02055820|529722653|FG005|Phase I: Dose-Finding|Death|1|||
146877609|NCT02055820|529722654|FG006|Phase I: Dose-Finding|Death|1|||
146877610|NCT02055820|529722655|FG007|Phase I: Dose-Finding|Death|0|||
146629184|NCT03216226|528818378|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
146629185|NCT03216226|528818379|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
146629186|NCT04218240|528818380|FG000|Overall Study|Withdrawal by Subject|6|||
146629187|NCT04218240|528818381|FG001|Overall Study|Withdrawal by Subject|0|||
146629188|NCT04218240|528818380|FG000|Overall Study|Lack of Efficacy|24|||
146629189|NCT04218240|528818381|FG001|Overall Study|Lack of Efficacy|19|||
146629190|NCT04218240|528818380|FG000|Overall Study|Physician Decision|0|||
146629191|NCT04218240|528818381|FG001|Overall Study|Physician Decision|1|||
146629192|NCT04218240|528818380|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
146629193|NCT04218240|528818381|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
146629194|NCT05966142|528818385|FG000|Overall Study|Death|3|||
146629195|NCT05966142|528818386|FG001|Overall Study|Death|3|||
146629196|NCT05966142|528818385|FG000|Overall Study|Lost to Follow-up|55|||
146629197|NCT05966142|528818386|FG001|Overall Study|Lost to Follow-up|52|||
146629198|NCT05966142|528818385|FG000|Overall Study|Physician Decision|1|||
146629199|NCT05966142|528818386|FG001|Overall Study|Physician Decision|0|||
146629200|NCT05966142|528818385|FG000|Overall Study|Withdrawal by Subject|9|||
146629201|NCT05966142|528818386|FG001|Overall Study|Withdrawal by Subject|8|||
146629202|NCT05966142|528818385|FG000|Overall Study|Duplicate Enrollment|1|||
146629203|NCT05966142|528818386|FG001|Overall Study|Duplicate Enrollment|0|||
146629204|NCT05966142|528818385|FG000|Overall Study|Study Logistical Reason|1|||
146629205|NCT05966142|528818386|FG001|Overall Study|Study Logistical Reason|0|||
146629206|NCT05966142|528818385|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
146629207|NCT05966142|528818386|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
146629208|NCT00894803|528818389|FG000|Overall Study|Death|20|||
146629209|NCT00894803|528818390|FG001|Overall Study|Death|4|||
146629210|NCT00894803|528818389|FG000|Overall Study|Lost to Follow-up|0|||
146629211|NCT00894803|528818390|FG001|Overall Study|Lost to Follow-up|1|||
146629212|NCT03094416|528818396|FG000|Run-in|Screening failure|8|||
146629213|NCT03094416|528818396|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
146877611|NCT02055820|529722656|FG008|Phase I: Dose-Finding|Death|0|||
146629214|NCT03094416|528818396|FG000|Run-in|Withdrawal by Subject|3|||
146629215|NCT03094416|528818396|FG000|Treatment Period|Withdrawal by Subject|2|||
146629216|NCT02158442|528818399|FG000|Overall Study|Withdrawal by Subject|1|||
146629217|NCT02158442|528818400|FG001|Overall Study|Withdrawal by Subject|0|||
146629218|NCT02158442|528818399|FG000|Overall Study|Perfusion staff not available|1|||
146629219|NCT02158442|528818400|FG001|Overall Study|Perfusion staff not available|0|||
146877612|NCT02055820|529722657|FG009|Phase I: Dose-Finding|Death|0|||
146877613|NCT02055820|529722648|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146629220|NCT01409707|528818401|FG000|Overall Study|Withdrawal by Subject|5|||
146877614|NCT02055820|529722649|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146629221|NCT01409707|528818402|FG001|Overall Study|Withdrawal by Subject|17|||
146629222|NCT01409707|528818403|FG002|Overall Study|Withdrawal by Subject|16|||
146629223|NCT01217229|528818404|FG000|Overall Study|Adverse Event|1|||
146877615|NCT02055820|529722650|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146544402|NCT01482221|528500165|FG000|Overall Study|Withdrawal by Subject|10|||
146544403|NCT01482221|528500166|FG001|Overall Study|Withdrawal by Subject|7|||
146544404|NCT01482221|528500167|FG002|Overall Study|Withdrawal by Subject|12|||
146544405|NCT01482221|528500165|FG000|Overall Study|Incorrect randomization|0|||
146544406|NCT01482221|528500166|FG001|Overall Study|Incorrect randomization|1|||
146544407|NCT01482221|528500167|FG002|Overall Study|Incorrect randomization|0|||
146544408|NCT01482221|528500165|FG000|Overall Study|Physician Decision|0|||
146544409|NCT01482221|528500166|FG001|Overall Study|Physician Decision|1|||
146544410|NCT01482221|528500167|FG002|Overall Study|Physician Decision|0|||
146544411|NCT03086343|528500168|FG000|Period 1|Adverse Event|7|||
146544412|NCT03086343|528500169|FG001|Period 1|Adverse Event|7|||
146544413|NCT03086343|528500170|FG002|Period 1|Adverse Event|0|||
146544414|NCT03086343|528500171|FG003|Period 1|Adverse Event|1|||
146544415|NCT03086343|528500168|FG000|Period 1|Withdrawal by Subject|6|||
146544416|NCT03086343|528500169|FG001|Period 1|Withdrawal by Subject|10|||
146544417|NCT03086343|528500170|FG002|Period 1|Withdrawal by Subject|0|||
146544418|NCT03086343|528500171|FG003|Period 1|Withdrawal by Subject|0|||
146544419|NCT03086343|528500168|FG000|Period 1|Lost to Follow-up|1|||
146544420|NCT03086343|528500169|FG001|Period 1|Lost to Follow-up|3|||
146544421|NCT03086343|528500170|FG002|Period 1|Lost to Follow-up|1|||
146544422|NCT03086343|528500171|FG003|Period 1|Lost to Follow-up|0|||
146544423|NCT03086343|528500168|FG000|Period 1|Other, Not Specified|10|||
146544424|NCT03086343|528500169|FG001|Period 1|Other, Not Specified|12|||
146544425|NCT03086343|528500170|FG002|Period 1|Other, Not Specified|2|||
146544426|NCT03086343|528500171|FG003|Period 1|Other, Not Specified|1|||
146544427|NCT03086343|528500168|FG000|Period 1|Missing|1|||
146544428|NCT03086343|528500169|FG001|Period 1|Missing|0|||
146544429|NCT03086343|528500170|FG002|Period 1|Missing|0|||
146544430|NCT03086343|528500171|FG003|Period 1|Missing|0|||
146544431|NCT03086343|528500168|FG000|Period 2|Adverse Event|20|||
146544432|NCT03086343|528500169|FG001|Period 2|Adverse Event|11|||
146544433|NCT03086343|528500170|FG002|Period 2|Adverse Event|1|||
146544434|NCT03086343|528500171|FG003|Period 2|Adverse Event|2|||
146544435|NCT03086343|528500168|FG000|Period 2|Withdrawal by Subject|15|||
146544436|NCT03086343|528500169|FG001|Period 2|Withdrawal by Subject|25|||
146544437|NCT03086343|528500170|FG002|Period 2|Withdrawal by Subject|2|||
146544438|NCT03086343|528500171|FG003|Period 2|Withdrawal by Subject|2|||
146544439|NCT03086343|528500168|FG000|Period 2|Lost to Follow-up|6|||
146544440|NCT03086343|528500169|FG001|Period 2|Lost to Follow-up|11|||
146544441|NCT03086343|528500170|FG002|Period 2|Lost to Follow-up|1|||
146544442|NCT03086343|528500171|FG003|Period 2|Lost to Follow-up|0|||
146544443|NCT03086343|528500168|FG000|Period 2|COVID-19 Infection|5|||
146544444|NCT03086343|528500169|FG001|Period 2|COVID-19 Infection|0|||
146544445|NCT03086343|528500170|FG002|Period 2|COVID-19 Infection|0|||
146544446|NCT03086343|528500171|FG003|Period 2|COVID-19 Infection|0|||
146544447|NCT03086343|528500168|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
146544448|NCT03086343|528500169|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
146544449|NCT03086343|528500170|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
146544450|NCT03086343|528500171|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
146544451|NCT03086343|528500168|FG000|Period 2|Other, Not Specified|23|||
146544452|NCT03086343|528500169|FG001|Period 2|Other, Not Specified|22|||
146544453|NCT03086343|528500170|FG002|Period 2|Other, Not Specified|2|||
146544454|NCT03086343|528500171|FG003|Period 2|Other, Not Specified|4|||
146544455|NCT00741611|528500172|FG000|Overall Study|Death|0|||
146544456|NCT00741611|528500173|FG001|Overall Study|Death|0|||
146544457|NCT00741611|528500174|FG002|Overall Study|Death|1|||
146544458|NCT00741611|528500172|FG000|Overall Study|Withdrawal by Subject|0|||
146544459|NCT00741611|528500173|FG001|Overall Study|Withdrawal by Subject|2|||
146544460|NCT00741611|528500174|FG002|Overall Study|Withdrawal by Subject|2|||
146544461|NCT02447029|528500179|FG000|Overall Study|Withdrawal by Subject|3|||
146544462|NCT02447029|528500180|FG001|Overall Study|Withdrawal by Subject|2|||
146544463|NCT04339972|528500184|FG000|Overall Study|Scheduling Issues|3|||
146544464|NCT04339972|528500185|FG001|Overall Study|Scheduling Issues|3|||
146544465|NCT04339972|528500184|FG000|Overall Study|dropout|1|||
146544466|NCT04339972|528500185|FG001|Overall Study|dropout|1|||
146544467|NCT04339972|528500184|FG000|Overall Study|Technical issues|1|||
146544468|NCT04339972|528500185|FG001|Overall Study|Technical issues|0|||
146544469|NCT04339972|528500184|FG000|Overall Study|Claustraphobia|0|||
146544470|NCT04339972|528500185|FG001|Overall Study|Claustraphobia|1|||
146544471|NCT00776997|528500186|FG000|Overall Study|Adverse Event|2|||
146544472|NCT02403271|528500187|FG000|Period 1|Other varied reasons|1|||
146544473|NCT02403271|528500188|FG001|Period 1|Other varied reasons|0|||
146544474|NCT02403271|528500187|FG000|Period 2|Withdrawal by Subject|0|||
146544475|NCT02403271|528500188|FG001|Period 2|Withdrawal by Subject|14|||
146544476|NCT02403271|528500187|FG000|Period 2|Death|0|||
146544477|NCT02403271|528500188|FG001|Period 2|Death|84|||
146544478|NCT02403271|528500187|FG000|Period 2|Lost to Follow-up|0|||
146544479|NCT02403271|528500188|FG001|Period 2|Lost to Follow-up|2|||
146544480|NCT02403271|528500187|FG000|Period 2|Study Terminated by Sponsor|0|||
146544481|NCT02403271|528500188|FG001|Period 2|Study Terminated by Sponsor|14|||
146544482|NCT02403271|528500187|FG000|Period 2|Other varied reasons|0|||
146877616|NCT02055820|529722651|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146877617|NCT02055820|529722652|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146877618|NCT02055820|529722653|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
146877619|NCT02055820|529722654|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146877620|NCT02055820|529722655|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146877621|NCT02055820|529722656|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146877622|NCT02055820|529722657|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146877623|NCT02055820|529722648|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
146877624|NCT02055820|529722649|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
146877625|NCT02055820|529722650|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
146877626|NCT02055820|529722651|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
146877627|NCT02055820|529722652|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
146877628|NCT02055820|529722653|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
146877629|NCT02055820|529722654|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
146877630|NCT02055820|529722655|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
146877631|NCT02055820|529722656|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
146877632|NCT02055820|529722657|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
146877633|NCT02055820|529722648|FG000|Phase II: Expansion|Death|0|||
146877634|NCT02055820|529722649|FG001|Phase II: Expansion|Death|0|||
146877635|NCT02055820|529722650|FG002|Phase II: Expansion|Death|0|||
146877636|NCT02055820|529722651|FG003|Phase II: Expansion|Death|0|||
146877637|NCT02055820|529722652|FG004|Phase II: Expansion|Death|33|||
146877638|NCT02055820|529722653|FG005|Phase II: Expansion|Death|0|||
146877639|NCT02055820|529722654|FG006|Phase II: Expansion|Death|0|||
146877640|NCT02055820|529722655|FG007|Phase II: Expansion|Death|0|||
146877641|NCT02055820|529722656|FG008|Phase II: Expansion|Death|0|||
146877642|NCT02055820|529722657|FG009|Phase II: Expansion|Death|0|||
146877643|NCT02055820|529722648|FG000|Phase II: Expansion|Lost to Follow-up|0|||
146877644|NCT02055820|529722649|FG001|Phase II: Expansion|Lost to Follow-up|0|||
146877645|NCT02055820|529722650|FG002|Phase II: Expansion|Lost to Follow-up|0|||
146877646|NCT02055820|529722651|FG003|Phase II: Expansion|Lost to Follow-up|0|||
146877647|NCT02055820|529722652|FG004|Phase II: Expansion|Lost to Follow-up|4|||
146877648|NCT02055820|529722653|FG005|Phase II: Expansion|Lost to Follow-up|0|||
146877649|NCT02055820|529722654|FG006|Phase II: Expansion|Lost to Follow-up|0|||
146877650|NCT02055820|529722655|FG007|Phase II: Expansion|Lost to Follow-up|0|||
146877651|NCT02055820|529722656|FG008|Phase II: Expansion|Lost to Follow-up|0|||
146877652|NCT02055820|529722657|FG009|Phase II: Expansion|Lost to Follow-up|0|||
146877653|NCT02055820|529722648|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
146877654|NCT02055820|529722649|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
146877655|NCT02055820|529722650|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
146877656|NCT02055820|529722651|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
146877657|NCT02055820|529722652|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
146877658|NCT02055820|529722653|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
146877659|NCT02055820|529722654|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
146877660|NCT02055820|529722655|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
146877661|NCT02055820|529722656|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
146877662|NCT02055820|529722657|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
146877663|NCT00930761|529722660|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
146877664|NCT00930761|529722661|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
146877665|NCT00930761|529722660|FG000|Overall Study|less than 3 music therapy sessions|0|||
146877666|NCT00930761|529722661|FG001|Overall Study|less than 3 music therapy sessions|3|||
146877667|NCT00631020|529722662|FG000|Overall Study|Lost to Follow-up|7|||
146877668|NCT00631020|529722662|FG000|Overall Study|Incarcerated|1|||
146877669|NCT03548935|529722664|FG000|Overall Study|Withdrawal by Subject|26|||
146877670|NCT03548935|529722665|FG001|Overall Study|Withdrawal by Subject|17|||
146877671|NCT03548935|529722664|FG000|Overall Study|Lost to Follow-up|39|||
146877672|NCT03548935|529722665|FG001|Overall Study|Lost to Follow-up|28|||
146877673|NCT03548935|529722664|FG000|Overall Study|Death|1|||
146877674|NCT03548935|529722665|FG001|Overall Study|Death|1|||
146877675|NCT03571646|529722666|FG000|Overall Study|Adverse Event|1|||
146877676|NCT03571646|529722667|FG001|Overall Study|Adverse Event|0|||
146877677|NCT03571646|529722666|FG000|Overall Study|Withdrawal by Subject|1|||
146877678|NCT03571646|529722667|FG001|Overall Study|Withdrawal by Subject|1|||
146877679|NCT01970995|529722668|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
146877680|NCT01970995|529722669|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
146877681|NCT01970995|529722670|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
146877682|NCT01970995|529722668|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
146877683|NCT01970995|529722669|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
146877684|NCT01970995|529722670|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
146877685|NCT01157364|529722673|FG000|Overall Study|Other Reasons|1|||
146877686|NCT01157364|529722674|FG001|Overall Study|Other Reasons|1|||
146877687|NCT01157364|529722675|FG002|Overall Study|Other Reasons|2|||
146877688|NCT01157364|529722676|FG003|Overall Study|Other Reasons|1|||
146544483|NCT02403271|528500188|FG001|Period 2|Other varied reasons|10|||
146544484|NCT05221866|528500191|FG000|Overall Study|Withdrawal by Subject|5|||
146544485|NCT05221866|528500192|FG001|Overall Study|Withdrawal by Subject|7|||
146544486|NCT05221866|528500193|FG002|Overall Study|Withdrawal by Subject|6|||
146877689|NCT01157364|529722677|FG004|Overall Study|Other Reasons|0|||
146877690|NCT01157364|529722678|FG005|Overall Study|Other Reasons|0|||
146877691|NCT01157364|529722673|FG000|Overall Study|Personal Reasons|0|||
146877692|NCT01157364|529722674|FG001|Overall Study|Personal Reasons|2|||
146877693|NCT01157364|529722675|FG002|Overall Study|Personal Reasons|0|||
146877694|NCT01157364|529722676|FG003|Overall Study|Personal Reasons|0|||
146877695|NCT01157364|529722677|FG004|Overall Study|Personal Reasons|1|||
146877696|NCT01157364|529722678|FG005|Overall Study|Personal Reasons|1|||
146544487|NCT05221866|528500194|FG003|Overall Study|Withdrawal by Subject|4|||
146629224|NCT01217229|528818404|FG000|Overall Study|Disease progression, deterioration|2|||
146629225|NCT01217229|528818404|FG000|Overall Study|Disease progression, Cheson criteria|14|||
146629226|NCT01217229|528818404|FG000|Overall Study|Protocol Violation|1|||
146877697|NCT01157364|529722673|FG000|Overall Study|Lost to Follow-up|1|||
146877698|NCT01157364|529722674|FG001|Overall Study|Lost to Follow-up|0|||
146877699|NCT01157364|529722675|FG002|Overall Study|Lost to Follow-up|1|||
146629227|NCT01217229|528818404|FG000|Overall Study|Disease progression not confirmed|2|||
146629228|NCT05386329|528818405|FG000|Overall Study|Lost to Follow-up|3|||
146629229|NCT00521079|528818408|FG000|Overall Study|Adverse Event|7|||
146877700|NCT01157364|529722676|FG003|Overall Study|Lost to Follow-up|0|||
146877701|NCT01157364|529722677|FG004|Overall Study|Lost to Follow-up|0|||
146877702|NCT01157364|529722678|FG005|Overall Study|Lost to Follow-up|0|||
146877703|NCT01157364|529722673|FG000|Overall Study|Lack of Efficacy|0|||
146877704|NCT01157364|529722674|FG001|Overall Study|Lack of Efficacy|0|||
146877705|NCT01157364|529722675|FG002|Overall Study|Lack of Efficacy|0|||
146877706|NCT01157364|529722676|FG003|Overall Study|Lack of Efficacy|1|||
146877707|NCT01157364|529722677|FG004|Overall Study|Lack of Efficacy|0|||
146877708|NCT01157364|529722678|FG005|Overall Study|Lack of Efficacy|0|||
146877709|NCT01157364|529722673|FG000|Overall Study|Adverse Event|0|||
146877710|NCT01157364|529722674|FG001|Overall Study|Adverse Event|1|||
146877711|NCT01157364|529722675|FG002|Overall Study|Adverse Event|1|||
146544488|NCT05221866|528500191|FG000|Overall Study|Physician Decision|3|||
146544489|NCT05221866|528500192|FG001|Overall Study|Physician Decision|2|||
146544490|NCT05221866|528500193|FG002|Overall Study|Physician Decision|1|||
146877712|NCT01157364|529722676|FG003|Overall Study|Adverse Event|0|||
146544491|NCT05221866|528500194|FG003|Overall Study|Physician Decision|4|||
146877713|NCT01157364|529722677|FG004|Overall Study|Adverse Event|1|||
146877714|NCT01157364|529722678|FG005|Overall Study|Adverse Event|0|||
146544492|NCT05221866|528500191|FG000|Overall Study|Lost to Follow-up|12|||
146877715|NCT01780662|529722679|FG000|Overall Study|Adverse Event|1|||
146877716|NCT01780662|529722680|FG001|Overall Study|Adverse Event|0|||
146877717|NCT01780662|529722681|FG002|Overall Study|Adverse Event|2|||
146877718|NCT01780662|529722679|FG000|Overall Study|Physician Decision|0|||
146877719|NCT01780662|529722680|FG001|Overall Study|Physician Decision|5|||
146877720|NCT01780662|529722681|FG002|Overall Study|Physician Decision|7|||
146877721|NCT01780662|529722679|FG000|Overall Study|Protocol Violation|0|||
146877722|NCT01780662|529722680|FG001|Overall Study|Protocol Violation|1|||
146544493|NCT05221866|528500192|FG001|Overall Study|Lost to Follow-up|17|||
146877723|NCT01780662|529722681|FG002|Overall Study|Protocol Violation|0|||
146877724|NCT01780662|529722679|FG000|Overall Study|Ineligible|0|||
146877725|NCT01780662|529722680|FG001|Overall Study|Ineligible|0|||
146877726|NCT01780662|529722681|FG002|Overall Study|Ineligible|1|||
146877727|NCT01263639|529722682|FG000|Overall Study|Lost to Follow-up|66|||
146877728|NCT01263639|529722683|FG001|Overall Study|Lost to Follow-up|70|||
146877729|NCT01263639|529722682|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
146877730|NCT01263639|529722683|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
146877731|NCT00586495|529722684|FG000|Treatment Period|Adverse Event|11|||
146877732|NCT00586495|529722684|FG000|Treatment Period|Death|1|||
146877733|NCT00586495|529722684|FG000|Treatment Period|Protocol Violation|1|||
146877734|NCT00586495|529722684|FG000|Treatment Period|Withdrawal by Subject|1|||
146877735|NCT00586495|529722684|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
146877736|NCT00586495|529722684|FG000|Treatment Period|Switch to commercial drug|10|||
146544494|NCT05221866|528500193|FG002|Overall Study|Lost to Follow-up|14|||
146764858|NCT01972152|529305954|FG004|First Treatment Visit|Lost to Follow-up|0|||
146877737|NCT00586495|529722684|FG000|Follow-up|Death|40|||
146877738|NCT00586495|529722684|FG000|Follow-up|Lost to Follow-up|1|||
146877739|NCT00586495|529722684|FG000|Follow-up|Withdrawal by Subject|4|||
146877740|NCT00586495|529722684|FG000|Follow-up|Protocol driven decision point|37|||
146877741|NCT00586495|529722684|FG000|Follow-up|Switch to commercial drug|10|||
146877742|NCT02716987|529722689|FG000|Overall Study|Ligand synthesis failure|0|||
146877743|NCT02716987|529722690|FG001|Overall Study|Ligand synthesis failure|0|||
146877744|NCT02716987|529722691|FG002|Overall Study|Ligand synthesis failure|1|||
146877745|NCT02716987|529722692|FG003|Overall Study|Ligand synthesis failure|0|||
146877746|NCT02716987|529722693|FG004|Overall Study|Ligand synthesis failure|0|||
146877747|NCT02716987|529722694|FG005|Overall Study|Ligand synthesis failure|0|||
146877748|NCT02716987|529722689|FG000|Overall Study|Withdrawal by Subject|0|||
146877749|NCT02716987|529722690|FG001|Overall Study|Withdrawal by Subject|0|||
146764859|NCT01972152|529305955|FG005|First Treatment Visit|Lost to Follow-up|0|||
146877750|NCT02716987|529722691|FG002|Overall Study|Withdrawal by Subject|0|||
146877751|NCT02716987|529722692|FG003|Overall Study|Withdrawal by Subject|0|||
146877752|NCT02716987|529722693|FG004|Overall Study|Withdrawal by Subject|1|||
146877753|NCT02716987|529722694|FG005|Overall Study|Withdrawal by Subject|1|||
146877754|NCT02829138|529722695|FG000|Overall Study|Withdrawal by Subject|1|||
146877755|NCT02829138|529722696|FG001|Overall Study|Withdrawal by Subject|0|||
146877756|NCT01765920|529722697|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
146544495|NCT05221866|528500194|FG003|Overall Study|Lost to Follow-up|14|||
146877757|NCT01765920|529722698|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
146877758|NCT01765920|529722697|FG000|Overall Study|Patient code disclosure|0|||
146877759|NCT01765920|529722698|FG001|Overall Study|Patient code disclosure|1|||
146877760|NCT01081249|529722699|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
146877761|NCT01081249|529722700|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
146877762|NCT02025907|529722701|FG000|Overall Study|Lack of Efficacy|1|||
146877763|NCT02025907|529722702|FG001|Overall Study|Lack of Efficacy|0|||
146877764|NCT02025907|529722701|FG000|Overall Study|Withdrawal by Subject|15|||
146877765|NCT02025907|529722702|FG001|Overall Study|Withdrawal by Subject|8|||
146877766|NCT02025907|529722701|FG000|Overall Study|Protocol Violation|2|||
146877767|NCT02025907|529722702|FG001|Overall Study|Protocol Violation|0|||
146877768|NCT02025907|529722701|FG000|Overall Study|Physician Decision|2|||
146877769|NCT02025907|529722702|FG001|Overall Study|Physician Decision|0|||
146877770|NCT02025907|529722701|FG000|Overall Study|Lost to Follow-up|2|||
146877771|NCT02025907|529722702|FG001|Overall Study|Lost to Follow-up|2|||
146877772|NCT02025907|529722701|FG000|Overall Study|Adverse Event|3|||
146877773|NCT02025907|529722702|FG001|Overall Study|Adverse Event|1|||
146877774|NCT02025907|529722701|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
146877775|NCT02025907|529722702|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
146877776|NCT02411539|529722703|FG000|Overall Study|Lost to Follow-up|2|||
146877777|NCT02411539|529722704|FG001|Overall Study|Lost to Follow-up|0|||
146877778|NCT02411539|529722703|FG000|Overall Study|Confounding medical condition|0|||
146877779|NCT02411539|529722704|FG001|Overall Study|Confounding medical condition|1|||
146877780|NCT03631732|529722712|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
146877781|NCT03631732|529722713|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
146877782|NCT03631732|529722712|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
146877783|NCT03631732|529722713|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
146877784|NCT03631732|529722712|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
146877785|NCT03631732|529722713|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
146877786|NCT03631732|529722712|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
146764860|NCT01972152|529305950|FG000|Second Treatment Visit|Protocol Violation|0|||
146544496|NCT05221866|528500191|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
146544497|NCT05221866|528500192|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
146544498|NCT05221866|528500193|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
146544499|NCT05221866|528500194|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
146544500|NCT03487445|528500195|FG000|Randomization|Not treated for administrative reasons|1|||
146544501|NCT03487445|528500196|FG001|Randomization|Not treated for administrative reasons|0|||
146544502|NCT00221104|528500197|FG000|Overall Study|Adverse Event|1|||
146544503|NCT00221104|528500198|FG001|Overall Study|Adverse Event|0|||
146544504|NCT00221104|528500197|FG000|Overall Study|Physician Decision|1|||
146544505|NCT00221104|528500198|FG001|Overall Study|Physician Decision|0|||
146544506|NCT00221104|528500197|FG000|Overall Study|Protocol Violation|2|||
146544507|NCT00221104|528500198|FG001|Overall Study|Protocol Violation|0|||
146544508|NCT00221104|528500197|FG000|Overall Study|Withdrawal by Subject|42|||
146544509|NCT00221104|528500198|FG001|Overall Study|Withdrawal by Subject|29|||
146544510|NCT00221104|528500197|FG000|Overall Study|Others|37|||
146544511|NCT00221104|528500198|FG001|Overall Study|Others|47|||
146544512|NCT02989389|528500199|FG000|Period 1|Lost to Follow-up|0|||
146544513|NCT02989389|528500200|FG001|Period 1|Lost to Follow-up|1|||
146544514|NCT02989389|528500201|FG002|Period 1|Lost to Follow-up|0|||
146544515|NCT02989389|528500202|FG003|Period 1|Lost to Follow-up|0|||
146544516|NCT02989389|528500203|FG004|Period 1|Lost to Follow-up|0|||
146544517|NCT02989389|528500204|FG005|Period 1|Lost to Follow-up|0|||
146544518|NCT02989389|528500205|FG006|Period 1|Lost to Follow-up|0|||
146544519|NCT02989389|528500206|FG007|Period 1|Lost to Follow-up|0|||
146544520|NCT02989389|528500207|FG008|Period 1|Lost to Follow-up|0|||
146544521|NCT02989389|528500208|FG009|Period 1|Lost to Follow-up|0|||
146544522|NCT02989389|528500199|FG000|Period 1|Physician Decision|0|||
146544523|NCT02989389|528500200|FG001|Period 1|Physician Decision|0|||
146544524|NCT02989389|528500201|FG002|Period 1|Physician Decision|0|||
146544525|NCT02989389|528500202|FG003|Period 1|Physician Decision|0|||
146544526|NCT02989389|528500203|FG004|Period 1|Physician Decision|0|||
146544527|NCT02989389|528500204|FG005|Period 1|Physician Decision|0|||
146544528|NCT02989389|528500205|FG006|Period 1|Physician Decision|0|||
146544529|NCT02989389|528500206|FG007|Period 1|Physician Decision|0|||
146544530|NCT02989389|528500207|FG008|Period 1|Physician Decision|1|||
146544531|NCT02989389|528500208|FG009|Period 1|Physician Decision|0|||
146544532|NCT01666652|528500209|FG000|Overall Study|Serious Adverse Event|0|||
146544533|NCT01666652|528500210|FG001|Overall Study|Serious Adverse Event|0|||
146544534|NCT01666652|528500211|FG002|Overall Study|Serious Adverse Event|0|||
146544535|NCT01666652|528500212|FG003|Overall Study|Serious Adverse Event|1|||
146764861|NCT01972152|529305951|FG001|Second Treatment Visit|Protocol Violation|1|||
146629230|NCT00521079|528818409|FG001|Overall Study|Adverse Event|1|||
146629231|NCT00521079|528818408|FG000|Overall Study|Lost to Follow-up|2|||
146629232|NCT00521079|528818409|FG001|Overall Study|Lost to Follow-up|1|||
146629233|NCT00521079|528818408|FG000|Overall Study|Withdrawal by Subject|5|||
146629234|NCT00521079|528818409|FG001|Overall Study|Withdrawal by Subject|3|||
146629235|NCT02651675|528818410|FG000|Overall Study|Death|0|||
146629236|NCT02651675|528818411|FG001|Overall Study|Death|0|||
146629237|NCT02651675|528818412|FG002|Overall Study|Death|1|||
146629238|NCT04408989|528818414|FG000|Overall Study|Lost to Follow-up|0|||
146629239|NCT04408989|528818415|FG001|Overall Study|Lost to Follow-up|0|||
146629240|NCT04408989|528818416|FG002|Overall Study|Lost to Follow-up|1|||
146629241|NCT04408989|528818414|FG000|Overall Study|Withdrawal by Subject|0|||
146629242|NCT04408989|528818415|FG001|Overall Study|Withdrawal by Subject|0|||
146629243|NCT04408989|528818416|FG002|Overall Study|Withdrawal by Subject|2|||
146629244|NCT05135767|528818417|FG000|Baseline|Lost to Follow-up|1|||
146629245|NCT05135767|528818418|FG001|Baseline|Lost to Follow-up|1|||
146629246|NCT05135767|528818417|FG000|Baseline|Withdrawal by Subject|0|||
146629247|NCT05135767|528818418|FG001|Baseline|Withdrawal by Subject|2|||
146629248|NCT05135767|528818417|FG000|Active Study Phase|Lost to Follow-up|2|||
146629249|NCT05135767|528818418|FG001|Active Study Phase|Lost to Follow-up|0|||
146629250|NCT02694185|528818419|FG000|Overall Study|Withdrawal by Subject|45|||
146629251|NCT02694185|528818420|FG001|Overall Study|Withdrawal by Subject|0|||
146629252|NCT05082857|528818421|FG000|Overall Study|participants relocated and could not continue|2|||
146629253|NCT05082857|528818422|FG001|Overall Study|participants relocated and could not continue|1|||
146629254|NCT05082857|528818421|FG000|Overall Study|Lost to Follow-up|1|||
146629255|NCT05082857|528818422|FG001|Overall Study|Lost to Follow-up|3|||
146629256|NCT04363320|528818423|FG000|Overall Study|Lost to Follow-up|43|||
146629257|NCT04363320|528818424|FG001|Overall Study|Lost to Follow-up|42|||
146629258|NCT04363320|528818425|FG002|Overall Study|Lost to Follow-up|24|||
146629259|NCT04363320|528818426|FG003|Overall Study|Lost to Follow-up|29|||
146629260|NCT04363320|528818423|FG000|Overall Study|Death|0|||
146629261|NCT04363320|528818424|FG001|Overall Study|Death|0|||
146629262|NCT04363320|528818425|FG002|Overall Study|Death|1|||
146629263|NCT04363320|528818426|FG003|Overall Study|Death|0|||
146629264|NCT02260934|528818436|FG000|Overall Study|Lost to Follow-up|2|||
146629265|NCT02260934|528818437|FG001|Overall Study|Lost to Follow-up|1|||
146629266|NCT02260934|528818436|FG000|Overall Study|Withdrawal by Subject|0|||
146629267|NCT02260934|528818437|FG001|Overall Study|Withdrawal by Subject|2|||
146629268|NCT02260934|528818436|FG000|Overall Study|Participant Relocated|1|||
146629269|NCT02260934|528818437|FG001|Overall Study|Participant Relocated|0|||
146629270|NCT02260934|528818436|FG000|Overall Study|Site error|0|||
146629271|NCT02260934|528818437|FG001|Overall Study|Site error|1|||
146877787|NCT03631732|529722713|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
146877788|NCT03631732|529722712|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
146629272|NCT03605667|528818440|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
146629273|NCT03605667|528818441|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
146877789|NCT03631732|529722713|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
146629274|NCT03605667|528818440|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
146877790|NCT03631732|529722712|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
146629275|NCT03605667|528818441|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
146629276|NCT03605667|528818440|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
146764862|NCT01972152|529305952|FG002|Second Treatment Visit|Protocol Violation|0|||
146764863|NCT01972152|529305953|FG003|Second Treatment Visit|Protocol Violation|0|||
146877791|NCT03631732|529722713|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
146877792|NCT03631732|529722712|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
146877793|NCT03631732|529722713|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
146877794|NCT03631732|529722712|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
146877795|NCT03631732|529722713|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
146877796|NCT03631732|529722712|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
146877797|NCT03631732|529722713|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
146877798|NCT03631732|529722712|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
146877799|NCT03631732|529722713|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
146877800|NCT01251367|529722714|FG000|Overall Study|Protocol Violation|1|||
146877801|NCT01251367|529722714|FG000|Overall Study|Lack of Efficacy|2|||
146877802|NCT01251367|529722714|FG000|Overall Study|Adverse Event|19|||
146877803|NCT01251367|529722714|FG000|Overall Study|Withdrawal by Subject|36|||
146877804|NCT01251367|529722714|FG000|Overall Study|Lost to Follow-up|5|||
146877805|NCT01251367|529722714|FG000|Overall Study|Subject Required Alternative Treatment|7|||
146877806|NCT01251367|529722714|FG000|Overall Study|No Study Drug Available|1|||
146877807|NCT01251367|529722714|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
146877808|NCT01251367|529722714|FG000|Overall Study|End of Study Visit Performed in Error|1|||
146877809|NCT02255409|529722715|FG000|Overall Study|Administrative Reason|3|||
146877810|NCT02255409|529722716|FG001|Overall Study|Administrative Reason|7|||
146877811|NCT02255409|529722715|FG000|Overall Study|Withdrawal by Subject|1|||
146877812|NCT02255409|529722716|FG001|Overall Study|Withdrawal by Subject|5|||
146877813|NCT02255409|529722715|FG000|Overall Study|Lost to Follow-up|10|||
146877814|NCT02255409|529722716|FG001|Overall Study|Lost to Follow-up|19|||
146877815|NCT03775421|529722719|FG000|Overall Study|Lost to Follow-up|2|||
146877816|NCT03775421|529722719|FG000|Overall Study|Withdrawal by Subject|10|||
146877817|NCT03775421|529722719|FG000|Overall Study|Physician Decision|3|||
146877818|NCT03775421|529722719|FG000|Overall Study|Death|1|||
146877819|NCT03775421|529722719|FG000|Overall Study|Study Terminated by Sponsor|94|||
146877820|NCT02016820|529722720|FG000|Overall Study|Lost to Follow-up|2|||
146877821|NCT02016820|529722721|FG001|Overall Study|Lost to Follow-up|4|||
146877822|NCT02370615|529722724|FG000|Overall Study|Adverse Event|1|||
146877823|NCT02370615|529722725|FG001|Overall Study|Adverse Event|0|||
146877824|NCT02287623|529722729|FG000|Overall Study|Protocol Violation|0|||
146877825|NCT02287623|529722730|FG001|Overall Study|Protocol Violation|1|||
146877826|NCT00506883|529722733|FG000|Overall Study|Lost to Follow-up|1|||
146877827|NCT00506883|529722734|FG001|Overall Study|Lost to Follow-up|1|||
146877828|NCT00506883|529722735|FG002|Overall Study|Lost to Follow-up|1|||
146877829|NCT00506883|529722733|FG000|Overall Study|Withdrawal by Subject|1|||
146877830|NCT00506883|529722734|FG001|Overall Study|Withdrawal by Subject|0|||
146877831|NCT00506883|529722735|FG002|Overall Study|Withdrawal by Subject|1|||
146877832|NCT00506883|529722733|FG000|Overall Study|Lack of Efficacy|0|||
146877833|NCT00506883|529722734|FG001|Overall Study|Lack of Efficacy|1|||
146877834|NCT00506883|529722735|FG002|Overall Study|Lack of Efficacy|1|||
146877835|NCT00506883|529722733|FG000|Overall Study|Other|5|||
146877836|NCT00506883|529722734|FG001|Overall Study|Other|1|||
146877837|NCT00506883|529722735|FG002|Overall Study|Other|1|||
146877838|NCT01473563|529722736|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
146877839|NCT03610724|529722737|FG000|Overall Study|Death|17|||
146877840|NCT03610724|529722737|FG000|Overall Study|Lost to Follow-up|1|||
146877841|NCT03610724|529722737|FG000|Overall Study|Physician Decision|1|||
146877842|NCT03610724|529722737|FG000|Overall Study|Died prior to infusion|1|||
146877843|NCT02943564|529722738|FG000|Overall Study|Miscellaneous Reasons|0|||
146877844|NCT02943564|529722739|FG001|Overall Study|Miscellaneous Reasons|0|||
146877845|NCT02943564|529722740|FG002|Overall Study|Miscellaneous Reasons|3|||
146877846|NCT02943564|529722738|FG000|Overall Study|Site terminated by sponsor|0|||
146877847|NCT02943564|529722739|FG001|Overall Study|Site terminated by sponsor|1|||
146877848|NCT02943564|529722740|FG002|Overall Study|Site terminated by sponsor|0|||
146877849|NCT02943564|529722738|FG000|Overall Study|Non-compliance with study drug|0|||
146877850|NCT02943564|529722739|FG001|Overall Study|Non-compliance with study drug|1|||
146877851|NCT02943564|529722740|FG002|Overall Study|Non-compliance with study drug|0|||
146877852|NCT02943564|529722738|FG000|Overall Study|Pregnancy|0|||
146877853|NCT02943564|529722739|FG001|Overall Study|Pregnancy|1|||
146877854|NCT02943564|529722740|FG002|Overall Study|Pregnancy|1|||
146877855|NCT02943564|529722738|FG000|Overall Study|Protocol Violation|2|||
146877856|NCT02943564|529722739|FG001|Overall Study|Protocol Violation|2|||
146877857|NCT02943564|529722740|FG002|Overall Study|Protocol Violation|2|||
146877858|NCT02943564|529722738|FG000|Overall Study|Lost to Follow-up|1|||
146877859|NCT02943564|529722739|FG001|Overall Study|Lost to Follow-up|0|||
146877860|NCT02943564|529722740|FG002|Overall Study|Lost to Follow-up|0|||
146764864|NCT01972152|529305954|FG004|Second Treatment Visit|Protocol Violation|0|||
146877861|NCT02943564|529722738|FG000|Overall Study|Withdrawal by Subject|6|||
146877862|NCT02943564|529722739|FG001|Overall Study|Withdrawal by Subject|5|||
146877863|NCT02943564|529722740|FG002|Overall Study|Withdrawal by Subject|2|||
146877864|NCT02943564|529722738|FG000|Overall Study|Adverse Event|1|||
146877865|NCT02943564|529722739|FG001|Overall Study|Adverse Event|2|||
146877866|NCT02943564|529722740|FG002|Overall Study|Adverse Event|1|||
146877867|NCT02943564|529722738|FG000|Overall Study|Lack of Efficacy|0|||
146877868|NCT02943564|529722739|FG001|Overall Study|Lack of Efficacy|1|||
146629277|NCT03605667|528818441|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
146877869|NCT02943564|529722740|FG002|Overall Study|Lack of Efficacy|0|||
146877870|NCT04143009|529722741|FG000|Pilot Trial|Lost to Follow-up|0|||
146877871|NCT04143009|529722742|FG001|Pilot Trial|Lost to Follow-up|1|||
146877872|NCT04143009|529722743|FG002|Pilot Trial|Lost to Follow-up|1|||
146877873|NCT04013529|529722747|FG000|Overall Study|Withdrawal by Subject|1|||
146877874|NCT04013529|529722748|FG001|Overall Study|Withdrawal by Subject|1|||
146877875|NCT03116698|529722749|FG000|Overall Study|Adverse Event|1|||
146877876|NCT03116698|529722750|FG001|Overall Study|Adverse Event|1|||
146877877|NCT03116698|529722751|FG002|Overall Study|Adverse Event|1|||
146877878|NCT03116698|529722752|FG003|Overall Study|Adverse Event|0|||
146629278|NCT03605667|528818440|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
146629279|NCT03605667|528818441|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
146629280|NCT03605667|528818440|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
146629281|NCT03605667|528818441|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
146629282|NCT03605667|528818440|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
146629283|NCT03605667|528818441|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
146629284|NCT03605667|528818440|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
146629285|NCT03605667|528818441|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
146629286|NCT03605667|528818440|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
146629287|NCT03605667|528818441|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
146629288|NCT03605667|528818440|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
146629289|NCT03605667|528818441|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
146629290|NCT03605667|528818440|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
146629291|NCT03605667|528818441|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
146629292|NCT03605667|528818440|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
146629293|NCT03605667|528818441|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
146629294|NCT03605667|528818440|FG000|OLE Phase (48 Weeks)|Other|6|||
146629295|NCT03605667|528818441|FG001|OLE Phase (48 Weeks)|Other|8|||
146629296|NCT03605667|528818440|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
146629297|NCT03605667|528818441|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
146629298|NCT03605667|528818440|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
146629299|NCT03605667|528818441|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
146629300|NCT03605667|528818440|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
146629301|NCT03605667|528818441|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
146629302|NCT03605667|528818440|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
146629303|NCT03605667|528818441|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
146629304|NCT03605667|528818440|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
146629305|NCT03605667|528818441|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
146629306|NCT03605667|528818440|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
146629307|NCT03605667|528818441|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
146629308|NCT03605667|528818440|FG000|OLE Phase (48 Weeks)|Death|0|||
146629309|NCT03605667|528818441|FG001|OLE Phase (48 Weeks)|Death|2|||
146629310|NCT03605667|528818440|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
146629311|NCT03605667|528818441|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
146629312|NCT05632211|528818442|FG000|Overall Study|Withdrawal by Subject|2|||
146629313|NCT05632211|528818443|FG001|Overall Study|Withdrawal by Subject|0|||
146629314|NCT05632211|528818444|FG002|Overall Study|Withdrawal by Subject|2|||
146629315|NCT05632211|528818442|FG000|Overall Study|Other reasons|1|||
146629316|NCT05632211|528818443|FG001|Overall Study|Other reasons|1|||
146629317|NCT05632211|528818444|FG002|Overall Study|Other reasons|1|||
146629318|NCT05194124|528818447|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
146629319|NCT05194124|528818448|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
146629320|NCT05194124|528818449|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
146629321|NCT05194124|528818450|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
146629322|NCT05194124|528818451|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
146629323|NCT05194124|528818452|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
146629324|NCT05194124|528818453|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
146629325|NCT05194124|528818454|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
146629326|NCT05194124|528818455|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
146629327|NCT05194124|528818456|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
146629328|NCT05194124|528818447|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146629329|NCT05194124|528818448|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146629330|NCT05194124|528818449|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146629331|NCT05194124|528818450|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146629332|NCT05194124|528818451|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146629333|NCT05194124|528818452|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146629334|NCT05194124|528818453|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146629335|NCT05194124|528818454|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146629336|NCT05194124|528818455|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146629337|NCT05194124|528818456|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
146629338|NCT03642873|528818457|FG000|Third Intervention (1 Day)|Screen failure|0|||
146629339|NCT03642873|528818458|FG001|Third Intervention (1 Day)|Screen failure|0|||
146629340|NCT03642873|528818459|FG002|Third Intervention (1 Day)|Screen failure|0|||
146629341|NCT03642873|528818460|FG003|Third Intervention (1 Day)|Screen failure|0|||
146629342|NCT03642873|528818461|FG004|Third Intervention (1 Day)|Screen failure|1|||
146629343|NCT03642873|528818462|FG005|Third Intervention (1 Day)|Screen failure|0|||
146629344|NCT03312231|528818463|FG000|Overall Study|Lost to Follow-up|2|||
146629345|NCT03312231|528818464|FG001|Overall Study|Lost to Follow-up|6|||
146629346|NCT03312231|528818465|FG002|Overall Study|Lost to Follow-up|1|||
146544536|NCT01666652|528500213|FG004|Overall Study|Serious Adverse Event|0|||
146544537|NCT01666652|528500209|FG000|Overall Study|Withdrawal by Subject|0|||
146544538|NCT01666652|528500210|FG001|Overall Study|Withdrawal by Subject|0|||
146544539|NCT01666652|528500211|FG002|Overall Study|Withdrawal by Subject|0|||
146544540|NCT01666652|528500212|FG003|Overall Study|Withdrawal by Subject|0|||
146877879|NCT03116698|529722749|FG000|Overall Study|Withdrawal by Subject|1|||
146877880|NCT03116698|529722750|FG001|Overall Study|Withdrawal by Subject|4|||
146877881|NCT03116698|529722751|FG002|Overall Study|Withdrawal by Subject|5|||
146877882|NCT03116698|529722752|FG003|Overall Study|Withdrawal by Subject|2|||
146877883|NCT03116698|529722749|FG000|Overall Study|Lost to Follow-up|2|||
146877884|NCT03116698|529722750|FG001|Overall Study|Lost to Follow-up|0|||
146877885|NCT03116698|529722751|FG002|Overall Study|Lost to Follow-up|0|||
146877886|NCT03116698|529722752|FG003|Overall Study|Lost to Follow-up|0|||
146877887|NCT03116698|529722749|FG000|Overall Study|Physician Decision|1|||
146877888|NCT03116698|529722750|FG001|Overall Study|Physician Decision|1|||
146877889|NCT03116698|529722751|FG002|Overall Study|Physician Decision|0|||
146877890|NCT03116698|529722752|FG003|Overall Study|Physician Decision|0|||
146877891|NCT03116698|529722749|FG000|Overall Study|Protocol Violation|1|||
146877892|NCT03116698|529722750|FG001|Overall Study|Protocol Violation|0|||
146877893|NCT03116698|529722751|FG002|Overall Study|Protocol Violation|0|||
146877894|NCT03116698|529722752|FG003|Overall Study|Protocol Violation|0|||
146877895|NCT03116698|529722749|FG000|Overall Study|Death|0|||
146877896|NCT03116698|529722750|FG001|Overall Study|Death|0|||
146877897|NCT03116698|529722751|FG002|Overall Study|Death|2|||
146877898|NCT03116698|529722752|FG003|Overall Study|Death|0|||
146877899|NCT00788372|529722753|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
146877900|NCT00788372|529722753|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
146877901|NCT00788372|529722753|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
146877902|NCT00788372|529722753|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
146877903|NCT00788372|529722753|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
146877904|NCT00788372|529722753|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
146877905|NCT00788372|529722753|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
146877906|NCT03099187|529722756|FG000|Double-blind Treatment|Adverse Event|19|||
146877907|NCT03099187|529722757|FG001|Double-blind Treatment|Adverse Event|1|||
146877908|NCT03099187|529722758|FG002|Double-blind Treatment|Adverse Event|0|||
146877909|NCT03099187|529722759|FG003|Double-blind Treatment|Adverse Event|0|||
146877910|NCT03099187|529722756|FG000|Double-blind Treatment|Death|1|||
146877911|NCT03099187|529722757|FG001|Double-blind Treatment|Death|3|||
146877912|NCT03099187|529722758|FG002|Double-blind Treatment|Death|0|||
146877913|NCT03099187|529722759|FG003|Double-blind Treatment|Death|0|||
146877914|NCT03099187|529722756|FG000|Double-blind Treatment|Lack of Efficacy|1|||
146877915|NCT03099187|529722757|FG001|Double-blind Treatment|Lack of Efficacy|0|||
146877916|NCT03099187|529722758|FG002|Double-blind Treatment|Lack of Efficacy|0|||
146877917|NCT03099187|529722759|FG003|Double-blind Treatment|Lack of Efficacy|0|||
146877918|NCT03099187|529722756|FG000|Double-blind Treatment|Physician Decision|2|||
146877919|NCT03099187|529722757|FG001|Double-blind Treatment|Physician Decision|1|||
146877920|NCT03099187|529722758|FG002|Double-blind Treatment|Physician Decision|0|||
146877921|NCT03099187|529722759|FG003|Double-blind Treatment|Physician Decision|0|||
146877922|NCT03099187|529722756|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
146877923|NCT03099187|529722757|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
146877924|NCT03099187|529722758|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
146877925|NCT03099187|529722759|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
146877926|NCT03099187|529722756|FG000|Double-blind Treatment|Lung transplantation|0|||
146877927|NCT03099187|529722757|FG001|Double-blind Treatment|Lung transplantation|1|||
146877928|NCT03099187|529722758|FG002|Double-blind Treatment|Lung transplantation|0|||
146877929|NCT03099187|529722759|FG003|Double-blind Treatment|Lung transplantation|0|||
146877930|NCT03099187|529722756|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
146877931|NCT03099187|529722757|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
146877932|NCT03099187|529722758|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
146877933|NCT03099187|529722759|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
146877934|NCT03099187|529722756|FG000|Double-blind Treatment|Disease progression|0|||
146877935|NCT03099187|529722757|FG001|Double-blind Treatment|Disease progression|1|||
146877936|NCT03099187|529722758|FG002|Double-blind Treatment|Disease progression|0|||
146877937|NCT03099187|529722759|FG003|Double-blind Treatment|Disease progression|0|||
146877938|NCT03099187|529722756|FG000|Double-blind Treatment|Randomization error|0|||
146877939|NCT03099187|529722757|FG001|Double-blind Treatment|Randomization error|2|||
146877940|NCT03099187|529722758|FG002|Double-blind Treatment|Randomization error|0|||
146877941|NCT03099187|529722759|FG003|Double-blind Treatment|Randomization error|0|||
146877942|NCT03099187|529722756|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
146877943|NCT03099187|529722757|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
146877944|NCT03099187|529722758|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
146877945|NCT03099187|529722759|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
146877946|NCT03099187|529722756|FG000|12-month Safety Follow-up|Adverse Event|0|||
146877947|NCT03099187|529722757|FG001|12-month Safety Follow-up|Adverse Event|0|||
146877948|NCT03099187|529722758|FG002|12-month Safety Follow-up|Adverse Event|5|||
146877949|NCT03099187|529722759|FG003|12-month Safety Follow-up|Adverse Event|12|||
146877950|NCT03099187|529722756|FG000|12-month Safety Follow-up|Death|0|||
146877951|NCT03099187|529722757|FG001|12-month Safety Follow-up|Death|0|||
146877952|NCT03099187|529722758|FG002|12-month Safety Follow-up|Death|7|||
146877953|NCT03099187|529722759|FG003|12-month Safety Follow-up|Death|9|||
146877954|NCT03099187|529722756|FG000|12-month Safety Follow-up|Lung transplantation|0|||
146877955|NCT03099187|529722757|FG001|12-month Safety Follow-up|Lung transplantation|0|||
146877956|NCT03099187|529722758|FG002|12-month Safety Follow-up|Lung transplantation|2|||
146877957|NCT03099187|529722759|FG003|12-month Safety Follow-up|Lung transplantation|1|||
146877958|NCT03099187|529722756|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
146877959|NCT03099187|529722757|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
146877960|NCT03099187|529722758|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
146877961|NCT03099187|529722759|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
146877962|NCT03099187|529722756|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
146877963|NCT03099187|529722757|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
146877964|NCT03099187|529722758|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
146877965|NCT03099187|529722759|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
146877966|NCT03099187|529722756|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
146877967|NCT03099187|529722757|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
146877968|NCT03099187|529722758|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
146877969|NCT03099187|529722759|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
146877970|NCT03099187|529722756|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
146877971|NCT03099187|529722757|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
146877972|NCT03099187|529722758|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
146877973|NCT03099187|529722759|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
146877974|NCT04129528|529724216|FG000|Overall Study|Adverse Event|1|||
146877975|NCT04129528|529724217|FG001|Overall Study|Adverse Event|0|||
146544541|NCT01666652|528500213|FG004|Overall Study|Withdrawal by Subject|1|||
146544542|NCT01666652|528500209|FG000|Overall Study|Moved from study area|1|||
146544543|NCT01666652|528500210|FG001|Overall Study|Moved from study area|0|||
146544544|NCT01666652|528500211|FG002|Overall Study|Moved from study area|0|||
146544545|NCT01666652|528500212|FG003|Overall Study|Moved from study area|2|||
146544546|NCT01666652|528500213|FG004|Overall Study|Moved from study area|0|||
146544547|NCT01666652|528500209|FG000|Overall Study|Lost to Follow-up|1|||
146544548|NCT01666652|528500210|FG001|Overall Study|Lost to Follow-up|1|||
146544549|NCT01666652|528500211|FG002|Overall Study|Lost to Follow-up|1|||
146544550|NCT01666652|528500212|FG003|Overall Study|Lost to Follow-up|1|||
146544551|NCT01666652|528500213|FG004|Overall Study|Lost to Follow-up|0|||
146544552|NCT04470427|528500214|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
146544553|NCT04470427|528500215|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
146544554|NCT04470427|528500216|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
146544555|NCT04470427|528500217|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
146544556|NCT04470427|528500218|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
146544557|NCT04470427|528500219|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
146544558|NCT04470427|528500214|FG000|Part B :Open-label|Other than specified|0|||
146544559|NCT04470427|528500215|FG001|Part B :Open-label|Other than specified|0|||
146544560|NCT04470427|528500216|FG002|Part B :Open-label|Other than specified|788|||
146544561|NCT04470427|528500217|FG003|Part B :Open-label|Other than specified|0|||
146544562|NCT04470427|528500218|FG004|Part B :Open-label|Other than specified|523|||
146544563|NCT04470427|528500219|FG005|Part B :Open-label|Other than specified|0|||
146544564|NCT04470427|528500214|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
146544565|NCT04470427|528500215|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
146544566|NCT04470427|528500216|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
146544567|NCT04470427|528500217|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
146544568|NCT04470427|528500218|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
146544569|NCT04470427|528500219|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
146544570|NCT04470427|528500214|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
146544571|NCT04470427|528500215|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
146544572|NCT04470427|528500216|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
146544573|NCT04470427|528500217|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
146544574|NCT04470427|528500218|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
146544575|NCT04470427|528500219|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
146544576|NCT01018979|528500220|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
146544577|NCT01018979|528500221|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
146544578|NCT01018979|528500220|FG000|Overall Study|Not received at least one dose|0|||
146544579|NCT01018979|528500221|FG001|Overall Study|Not received at least one dose|1|||
146544580|NCT01695746|528500222|FG000|Overall Study|Adverse Event|1|||
146544581|NCT01695746|528500222|FG000|Overall Study|Non-compliance by the participant|3|||
146544582|NCT01695746|528500222|FG000|Overall Study|Protocol Violation|5|||
146544583|NCT01695746|528500222|FG000|Overall Study|Participant not willing to participate|3|||
146544584|NCT03976375|528500225|FG000|Overall Study|Death|158|||
146544585|NCT03976375|528500226|FG001|Overall Study|Death|160|||
146544586|NCT03976375|528500227|FG002|Overall Study|Death|42|||
146544587|NCT03976375|528500225|FG000|Overall Study|Lost to Follow-up|2|||
146877976|NCT04129528|529724216|FG000|Overall Study|Physician Decision|1|||
146877977|NCT04129528|529724217|FG001|Overall Study|Physician Decision|1|||
146544588|NCT03976375|528500226|FG001|Overall Study|Lost to Follow-up|1|||
146544589|NCT03976375|528500227|FG002|Overall Study|Lost to Follow-up|1|||
146544590|NCT03976375|528500225|FG000|Overall Study|Withdrawal by Subject|5|||
146544591|NCT03976375|528500226|FG001|Overall Study|Withdrawal by Subject|9|||
146544592|NCT03976375|528500227|FG002|Overall Study|Withdrawal by Subject|4|||
146544593|NCT03976375|528500225|FG000|Overall Study|Sponsor decision|20|||
146544594|NCT03976375|528500226|FG001|Overall Study|Sponsor decision|19|||
146544595|NCT03976375|528500227|FG002|Overall Study|Sponsor decision|1|||
146544596|NCT02717611|528500228|FG000|Overall Study|Death|13|||
146544597|NCT02717611|528500228|FG000|Overall Study|Withdrawal by Subject|6|||
146544598|NCT02717611|528500228|FG000|Overall Study|Active, not recruiting|40|||
146877978|NCT04129528|529724216|FG000|Overall Study|Withdrawal by Subject|1|||
146877979|NCT04129528|529724217|FG001|Overall Study|Withdrawal by Subject|1|||
146877980|NCT01395394|529724221|FG000|Baseline Study Visit|Protocol Violation|1|||
146877981|NCT01395394|529724222|FG001|Baseline Study Visit|Protocol Violation|0|||
146877982|NCT01395394|529724223|FG002|Baseline Study Visit|Protocol Violation|0|||
146877983|NCT05121480|529724224|FG000|Overall Study|Lack of Efficacy|2|||
146877984|NCT05121480|529724225|FG001|Overall Study|Lack of Efficacy|2|||
146877985|NCT05121480|529724226|FG002|Overall Study|Lack of Efficacy|1|||
146877986|NCT05121480|529724227|FG003|Overall Study|Lack of Efficacy|4|||
146877987|NCT05121480|529724228|FG004|Overall Study|Lack of Efficacy|0|||
146877988|NCT05121480|529724229|FG005|Overall Study|Lack of Efficacy|1|||
146877989|NCT05121480|529724230|FG006|Overall Study|Lack of Efficacy|0|||
146877990|NCT05121480|529724231|FG007|Overall Study|Lack of Efficacy|2|||
146877991|NCT05121480|529724224|FG000|Overall Study|Treatment Failure|0|||
146877992|NCT05121480|529724225|FG001|Overall Study|Treatment Failure|2|||
146877993|NCT05121480|529724226|FG002|Overall Study|Treatment Failure|0|||
146877994|NCT05121480|529724227|FG003|Overall Study|Treatment Failure|1|||
146877995|NCT05121480|529724228|FG004|Overall Study|Treatment Failure|0|||
146877996|NCT05121480|529724229|FG005|Overall Study|Treatment Failure|0|||
146877997|NCT05121480|529724230|FG006|Overall Study|Treatment Failure|0|||
146877998|NCT05121480|529724231|FG007|Overall Study|Treatment Failure|0|||
146877999|NCT05121480|529724224|FG000|Overall Study|Adverse Event|0|||
146878000|NCT05121480|529724225|FG001|Overall Study|Adverse Event|1|||
146878001|NCT05121480|529724226|FG002|Overall Study|Adverse Event|0|||
146878002|NCT05121480|529724227|FG003|Overall Study|Adverse Event|5|||
146878003|NCT05121480|529724228|FG004|Overall Study|Adverse Event|3|||
146878004|NCT05121480|529724229|FG005|Overall Study|Adverse Event|2|||
146878005|NCT05121480|529724230|FG006|Overall Study|Adverse Event|0|||
146878006|NCT05121480|529724231|FG007|Overall Study|Adverse Event|4|||
146878007|NCT05121480|529724224|FG000|Overall Study|Withdrawal by Subject|4|||
146878008|NCT05121480|529724225|FG001|Overall Study|Withdrawal by Subject|9|||
146878009|NCT05121480|529724226|FG002|Overall Study|Withdrawal by Subject|1|||
146878010|NCT05121480|529724227|FG003|Overall Study|Withdrawal by Subject|8|||
146878011|NCT05121480|529724228|FG004|Overall Study|Withdrawal by Subject|0|||
146878012|NCT05121480|529724229|FG005|Overall Study|Withdrawal by Subject|9|||
146878013|NCT05121480|529724230|FG006|Overall Study|Withdrawal by Subject|0|||
146878014|NCT05121480|529724231|FG007|Overall Study|Withdrawal by Subject|4|||
146878015|NCT05121480|529724224|FG000|Overall Study|Non-compliance with the protocol|0|||
146878016|NCT05121480|529724225|FG001|Overall Study|Non-compliance with the protocol|0|||
146878017|NCT05121480|529724226|FG002|Overall Study|Non-compliance with the protocol|0|||
146878018|NCT05121480|529724227|FG003|Overall Study|Non-compliance with the protocol|0|||
146878019|NCT05121480|529724228|FG004|Overall Study|Non-compliance with the protocol|1|||
146878020|NCT05121480|529724229|FG005|Overall Study|Non-compliance with the protocol|6|||
146878021|NCT05121480|529724230|FG006|Overall Study|Non-compliance with the protocol|0|||
146878022|NCT05121480|529724231|FG007|Overall Study|Non-compliance with the protocol|1|||
146878023|NCT05121480|529724224|FG000|Overall Study|Lost to Follow-up|0|||
146878024|NCT05121480|529724225|FG001|Overall Study|Lost to Follow-up|4|||
146878025|NCT05121480|529724226|FG002|Overall Study|Lost to Follow-up|1|||
146878026|NCT05121480|529724227|FG003|Overall Study|Lost to Follow-up|3|||
146878027|NCT05121480|529724228|FG004|Overall Study|Lost to Follow-up|1|||
146878028|NCT05121480|529724229|FG005|Overall Study|Lost to Follow-up|1|||
146878029|NCT05121480|529724230|FG006|Overall Study|Lost to Follow-up|1|||
146878030|NCT05121480|529724231|FG007|Overall Study|Lost to Follow-up|4|||
146544599|NCT02717611|528500228|FG000|Overall Study|Complicating disease|1|||
146544600|NCT04598828|528500229|FG000|Overall Study|Physician Decision|1|||
146544601|NCT04598828|528500230|FG001|Overall Study|Physician Decision|0|||
146544602|NCT04598828|528500229|FG000|Overall Study|Withdrawal by Subject|0|||
146544603|NCT04598828|528500230|FG001|Overall Study|Withdrawal by Subject|1|||
146544604|NCT04598828|528500229|FG000|Overall Study|Withdrawal by Subject|0|||
146544605|NCT04598828|528500230|FG001|Overall Study|Withdrawal by Subject|1|||
146544606|NCT04818112|528500231|FG000|Overall Study|Withdrawal by Subject|54|||
146544607|NCT04818112|528500232|FG001|Overall Study|Withdrawal by Subject|12|||
146544608|NCT04818112|528500231|FG000|Overall Study|Lost to Follow-up|38|||
146544609|NCT04818112|528500232|FG001|Overall Study|Lost to Follow-up|10|||
146544610|NCT02676973|528500233|FG000|Overall Study|Withdrawal by Subject|9|||
146544611|NCT02676973|528500234|FG001|Overall Study|Withdrawal by Subject|8|||
146544612|NCT02676973|528500235|FG002|Overall Study|Withdrawal by Subject|11|||
146544613|NCT02676973|528500233|FG000|Overall Study|Lost to Follow-up|8|||
146544614|NCT02676973|528500234|FG001|Overall Study|Lost to Follow-up|12|||
146878031|NCT05121480|529724224|FG000|Overall Study|Physician Decision|0|||
146878032|NCT05121480|529724225|FG001|Overall Study|Physician Decision|0|||
146878033|NCT05121480|529724226|FG002|Overall Study|Physician Decision|0|||
146878034|NCT05121480|529724227|FG003|Overall Study|Physician Decision|0|||
146878035|NCT05121480|529724228|FG004|Overall Study|Physician Decision|0|||
146878036|NCT05121480|529724229|FG005|Overall Study|Physician Decision|1|||
146878037|NCT05121480|529724230|FG006|Overall Study|Physician Decision|0|||
146878038|NCT05121480|529724231|FG007|Overall Study|Physician Decision|1|||
146878039|NCT05121480|529724224|FG000|Overall Study|Other Reason|0|||
146878040|NCT05121480|529724225|FG001|Overall Study|Other Reason|0|||
146878041|NCT05121480|529724226|FG002|Overall Study|Other Reason|0|||
146544615|NCT02676973|528500235|FG002|Overall Study|Lost to Follow-up|8|||
146878042|NCT05121480|529724227|FG003|Overall Study|Other Reason|0|||
146878043|NCT05121480|529724228|FG004|Overall Study|Other Reason|0|||
146878044|NCT05121480|529724229|FG005|Overall Study|Other Reason|1|||
146878045|NCT05121480|529724230|FG006|Overall Study|Other Reason|1|||
146878046|NCT05121480|529724231|FG007|Overall Study|Other Reason|1|||
146878047|NCT00772954|529724232|FG000|Overall Study|Adverse Event|0|||
146878048|NCT00772954|529724233|FG001|Overall Study|Adverse Event|0|||
146878049|NCT00772954|529724234|FG002|Overall Study|Adverse Event|1|||
146878050|NCT00789529|529724240|FG000|Overall Study|Withdrawal by Subject|0|||
146878051|NCT00789529|529724241|FG001|Overall Study|Withdrawal by Subject|1|||
146878052|NCT00789529|529724240|FG000|Overall Study|Other Reason|1|||
146878053|NCT00789529|529724241|FG001|Overall Study|Other Reason|0|||
146878054|NCT01135498|529724242|FG000|Overall Study|Adverse Event|20|||
146878055|NCT01135498|529724242|FG000|Overall Study|Progressive disease|38|||
146878056|NCT01135498|529724242|FG000|Overall Study|Investigator judgement|25|||
146878057|NCT01135498|529724242|FG000|Overall Study|Withdrawal by Subject|4|||
146878058|NCT01135498|529724242|FG000|Overall Study|Death|1|||
146878059|NCT01135498|529724242|FG000|Overall Study|Ongoing at time of analysis|2|||
146878060|NCT00129766|529724243|FG000|Overall Study|Death|3|||
146878061|NCT00129766|529724244|FG001|Overall Study|Death|8|||
146878062|NCT00129766|529724243|FG000|Overall Study|Withdrawal of consent|31|||
146878063|NCT00129766|529724244|FG001|Overall Study|Withdrawal of consent|30|||
146878064|NCT00129766|529724243|FG000|Overall Study|Lost to Follow-up|26|||
146878065|NCT00129766|529724244|FG001|Overall Study|Lost to Follow-up|21|||
146878066|NCT01081912|529724246|FG000|Conversion/Titration|Adverse Event|47|||
146878067|NCT01081912|529724247|FG001|Conversion/Titration|Adverse Event|0|||
146878068|NCT01081912|529724248|FG002|Conversion/Titration|Adverse Event|0|||
146878069|NCT01081912|529724246|FG000|Conversion/Titration|Lack of Efficacy|17|||
146878070|NCT01081912|529724247|FG001|Conversion/Titration|Lack of Efficacy|0|||
146878071|NCT01081912|529724248|FG002|Conversion/Titration|Lack of Efficacy|0|||
146878072|NCT01081912|529724246|FG000|Conversion/Titration|Lost to Follow-up|5|||
146878073|NCT01081912|529724247|FG001|Conversion/Titration|Lost to Follow-up|0|||
146544616|NCT02676973|528500233|FG000|Overall Study|Death|2|||
146544617|NCT02676973|528500234|FG001|Overall Study|Death|1|||
146544618|NCT02676973|528500235|FG002|Overall Study|Death|5|||
146544619|NCT01078662|528500237|FG000|Overall Study|Death|41|||
146878074|NCT01081912|529724248|FG002|Conversion/Titration|Lost to Follow-up|0|||
146544620|NCT01078662|528500238|FG001|Overall Study|Death|103|||
146878075|NCT01081912|529724246|FG000|Conversion/Titration|Physician Decision|2|||
146878076|NCT01081912|529724247|FG001|Conversion/Titration|Physician Decision|0|||
146878077|NCT01081912|529724248|FG002|Conversion/Titration|Physician Decision|0|||
146878078|NCT01081912|529724246|FG000|Conversion/Titration|Protocol Violation|67|||
146629347|NCT03312231|528818466|FG003|Overall Study|Lost to Follow-up|3|||
146629348|NCT03312231|528818467|FG004|Overall Study|Lost to Follow-up|1|||
146629349|NCT03312231|528818463|FG000|Overall Study|Withdrawal by Subject|0|||
146629350|NCT03312231|528818464|FG001|Overall Study|Withdrawal by Subject|3|||
146629351|NCT03312231|528818465|FG002|Overall Study|Withdrawal by Subject|1|||
146629352|NCT03312231|528818466|FG003|Overall Study|Withdrawal by Subject|0|||
146629353|NCT03312231|528818467|FG004|Overall Study|Withdrawal by Subject|0|||
146629354|NCT03312231|528818463|FG000|Overall Study|Death|0|||
146629355|NCT03312231|528818464|FG001|Overall Study|Death|1|||
146629356|NCT03312231|528818465|FG002|Overall Study|Death|1|||
146629357|NCT03312231|528818466|FG003|Overall Study|Death|0|||
146629358|NCT03312231|528818467|FG004|Overall Study|Death|0|||
146629359|NCT03312231|528818463|FG000|Overall Study|Study Vaccination not Received|1|||
146629360|NCT03312231|528818464|FG001|Overall Study|Study Vaccination not Received|1|||
146629361|NCT03312231|528818465|FG002|Overall Study|Study Vaccination not Received|1|||
146629362|NCT03312231|528818466|FG003|Overall Study|Study Vaccination not Received|0|||
146629363|NCT03312231|528818467|FG004|Overall Study|Study Vaccination not Received|0|||
146629364|NCT03157830|528818472|FG000|Overall Study|Lost to Follow-up|1|||
146629365|NCT03157830|528818472|FG000|Overall Study|Withdrawal by Subject|1|||
146629366|NCT00400179|528818473|FG000|Overall Study|Adverse Event|2|||
146629367|NCT00400179|528818474|FG001|Overall Study|Adverse Event|2|||
146629368|NCT00400179|528818473|FG000|Overall Study|Death|1|||
146629369|NCT00400179|528818474|FG001|Overall Study|Death|2|||
146629370|NCT00400179|528818473|FG000|Overall Study|Withdrew Consent|1|||
146629371|NCT00400179|528818474|FG001|Overall Study|Withdrew Consent|5|||
146629372|NCT00400179|528818473|FG000|Overall Study|Disease progression|1|||
146629373|NCT00400179|528818474|FG001|Overall Study|Disease progression|1|||
146629374|NCT00400179|528818473|FG000|Overall Study|Intercurrent illness|0|||
146629375|NCT00400179|528818474|FG001|Overall Study|Intercurrent illness|1|||
146629376|NCT00400179|528818473|FG000|Overall Study|Investigator judgment|0|||
146629377|NCT00400179|528818474|FG001|Overall Study|Investigator judgment|1|||
146629378|NCT00400179|528818473|FG000|Overall Study|Randomization error/patient ineligible|1|||
146629379|NCT00400179|528818474|FG001|Overall Study|Randomization error/patient ineligible|6|||
146629380|NCT04780061|528818475|FG000|Overall Study|Withdrawal by Subject|5|||
146629381|NCT04780061|528818476|FG001|Overall Study|Withdrawal by Subject|8|||
146629382|NCT04780061|528818475|FG000|Overall Study|Adverse Event|2|||
146629383|NCT04780061|528818476|FG001|Overall Study|Adverse Event|2|||
146629384|NCT04780061|528818475|FG000|Overall Study|Lost to Follow-up|1|||
146629385|NCT04780061|528818476|FG001|Overall Study|Lost to Follow-up|5|||
146629386|NCT00734149|528818477|FG000|Overall Study|Withdrawal by Subject|1|||
146629387|NCT00626106|528818478|FG000|Overall Study|Withdrawal by Subject|2|||
146629388|NCT00626106|528818479|FG001|Overall Study|Withdrawal by Subject|1|||
146629389|NCT00626106|528818478|FG000|Overall Study|Lost to Follow-up|1|||
146629390|NCT00626106|528818479|FG001|Overall Study|Lost to Follow-up|4|||
146629391|NCT00626106|528818478|FG000|Overall Study|Death|64|||
146629392|NCT00626106|528818479|FG001|Overall Study|Death|19|||
146629393|NCT03253393|528818480|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
146629394|NCT03253393|528818481|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
146629395|NCT03253393|528818482|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
146629396|NCT01586364|528819708|FG000|Overall Study|Withdrawal by Subject|40|||
146629397|NCT01586364|528819708|FG000|Overall Study|Adverse Event|37|||
146629398|NCT01586364|528819708|FG000|Overall Study|Lost to Follow-up|17|||
146878079|NCT01081912|529724247|FG001|Conversion/Titration|Protocol Violation|0|||
146878080|NCT01081912|529724248|FG002|Conversion/Titration|Protocol Violation|0|||
146878081|NCT01081912|529724246|FG000|Conversion/Titration|Withdrawal by Subject|23|||
146878082|NCT01081912|529724247|FG001|Conversion/Titration|Withdrawal by Subject|0|||
146878083|NCT01081912|529724248|FG002|Conversion/Titration|Withdrawal by Subject|0|||
146878084|NCT01081912|529724246|FG000|Conversion/Titration|Non-Compliance|47|||
146629399|NCT01586364|528819708|FG000|Overall Study|Protocol Violation|16|||
146629400|NCT01586364|528819708|FG000|Overall Study|Lack of Efficacy|1|||
146629401|NCT01586364|528819708|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
146629402|NCT01586364|528819708|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
146629403|NCT01586364|528819708|FG000|Overall Study|Other-Site closure due to PI illness|1|||
146629404|NCT01586364|528819708|FG000|Overall Study|Other-PI discretion, site closing|2|||
146629405|NCT01586364|528819708|FG000|Overall Study|Other-Not specified|1|||
146629406|NCT00091949|528819709|FG000|Overall Study|Withdrawal by Subject|117|||
146878085|NCT01081912|529724247|FG001|Conversion/Titration|Non-Compliance|0|||
146629407|NCT00091949|528819710|FG001|Overall Study|Withdrawal by Subject|110|||
146629408|NCT00091949|528819709|FG000|Overall Study|Lost to Follow-up|58|||
146629409|NCT00091949|528819710|FG001|Overall Study|Lost to Follow-up|41|||
146629410|NCT01256788|528819711|FG000|Overall Study|Lost to Follow-up|5|||
146629411|NCT01256788|528819712|FG001|Overall Study|Lost to Follow-up|8|||
146629412|NCT01256788|528819713|FG002|Overall Study|Lost to Follow-up|3|||
146629413|NCT05366738|528819714|FG000|Overall Study|Adverse Event|0|||
146629414|NCT05366738|528819715|FG001|Overall Study|Adverse Event|1|||
146878086|NCT01081912|529724248|FG002|Conversion/Titration|Non-Compliance|0|||
146878087|NCT01081912|529724246|FG000|Maintenance Treatment|Adverse Event|0|||
146878088|NCT01081912|529724247|FG001|Maintenance Treatment|Adverse Event|2|||
146878089|NCT01081912|529724248|FG002|Maintenance Treatment|Adverse Event|12|||
146878090|NCT01081912|529724246|FG000|Maintenance Treatment|Lack of Efficacy|0|||
146878091|NCT01081912|529724247|FG001|Maintenance Treatment|Lack of Efficacy|14|||
146878092|NCT01081912|529724248|FG002|Maintenance Treatment|Lack of Efficacy|64|||
146878093|NCT01081912|529724246|FG000|Maintenance Treatment|Lost to Follow-up|0|||
146878094|NCT01081912|529724247|FG001|Maintenance Treatment|Lost to Follow-up|1|||
146544621|NCT01078662|528500239|FG002|Overall Study|Death|18|||
146544622|NCT01078662|528500240|FG003|Overall Study|Death|5|||
146544623|NCT01078662|528500241|FG004|Overall Study|Death|8|||
146544624|NCT01078662|528500237|FG000|Overall Study|Patients reached data cut-off|12|||
146544625|NCT01078662|528500238|FG001|Overall Study|Patients reached data cut-off|53|||
146544626|NCT01078662|528500239|FG002|Overall Study|Patients reached data cut-off|2|||
146544627|NCT01078662|528500240|FG003|Overall Study|Patients reached data cut-off|2|||
146544628|NCT01078662|528500241|FG004|Overall Study|Patients reached data cut-off|3|||
146544629|NCT01078662|528500237|FG000|Overall Study|Withdrawal by Subject|4|||
146544630|NCT01078662|528500238|FG001|Overall Study|Withdrawal by Subject|11|||
146544631|NCT01078662|528500239|FG002|Overall Study|Withdrawal by Subject|1|||
146544632|NCT01078662|528500240|FG003|Overall Study|Withdrawal by Subject|0|||
146544633|NCT01078662|528500241|FG004|Overall Study|Withdrawal by Subject|0|||
146544634|NCT01078662|528500237|FG000|Overall Study|Protocol Violation|0|||
146544635|NCT01078662|528500238|FG001|Overall Study|Protocol Violation|1|||
146544636|NCT01078662|528500239|FG002|Overall Study|Protocol Violation|0|||
146544637|NCT01078662|528500240|FG003|Overall Study|Protocol Violation|0|||
146544638|NCT01078662|528500241|FG004|Overall Study|Protocol Violation|0|||
146544639|NCT01078662|528500237|FG000|Overall Study|Lost to Follow-up|1|||
146544640|NCT01078662|528500238|FG001|Overall Study|Lost to Follow-up|0|||
146544641|NCT01078662|528500239|FG002|Overall Study|Lost to Follow-up|0|||
146544642|NCT01078662|528500240|FG003|Overall Study|Lost to Follow-up|0|||
146544643|NCT01078662|528500241|FG004|Overall Study|Lost to Follow-up|0|||
146544644|NCT03122106|528500244|FG000|Overall Study|Not enough tissue|1|||
146544645|NCT03122106|528500244|FG000|Overall Study|Disease progression during screening|2|||
146544646|NCT03122106|528500244|FG000|Overall Study|Poor RNA quality for vaccine|1|||
146544647|NCT00700635|528500245|FG000|Overall Study|Adverse Event|1|||
146544648|NCT00700635|528500246|FG001|Overall Study|Adverse Event|0|||
146544649|NCT00700635|528500247|FG002|Overall Study|Adverse Event|0|||
146544650|NCT00700635|528500245|FG000|Overall Study|Lost to Follow-up|1|||
146544651|NCT00700635|528500246|FG001|Overall Study|Lost to Follow-up|3|||
146544652|NCT00700635|528500247|FG002|Overall Study|Lost to Follow-up|0|||
146544653|NCT00700635|528500245|FG000|Overall Study|Protocol Violation|2|||
146544654|NCT00700635|528500246|FG001|Overall Study|Protocol Violation|2|||
146544655|NCT00700635|528500247|FG002|Overall Study|Protocol Violation|0|||
146544656|NCT00700635|528500245|FG000|Overall Study|Withdrawal by Subject|7|||
146544657|NCT00700635|528500246|FG001|Overall Study|Withdrawal by Subject|3|||
146544658|NCT00700635|528500247|FG002|Overall Study|Withdrawal by Subject|1|||
146544659|NCT06170827|528500248|FG000|Overall Study|Withdrawal by Subject|1|||
146544660|NCT06170827|528500249|FG001|Overall Study|Withdrawal by Subject|1|||
146544661|NCT00632359|528500254|FG000|Overall Study|Withdrawal by Subject|2|||
146544662|NCT03043573|528500255|FG000|Overall Study|Lost to Follow-up|3|||
146544663|NCT03043573|528500256|FG001|Overall Study|Lost to Follow-up|3|||
146544664|NCT03043573|528500255|FG000|Overall Study|Physician Decision|0|||
146544665|NCT03043573|528500256|FG001|Overall Study|Physician Decision|5|||
146544666|NCT03043573|528500255|FG000|Overall Study|Withdrawal by Subject|0|||
146544667|NCT03043573|528500256|FG001|Overall Study|Withdrawal by Subject|4|||
146544668|NCT05800145|528500257|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
146544669|NCT05800145|528500258|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
146544670|NCT05800145|528500259|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
146544671|NCT05800145|528500260|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
146544672|NCT05800145|528500261|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
146544673|NCT05800145|528500262|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
146878095|NCT01081912|529724248|FG002|Maintenance Treatment|Lost to Follow-up|0|||
146878096|NCT01081912|529724246|FG000|Maintenance Treatment|Physician Decision|0|||
146878097|NCT01081912|529724247|FG001|Maintenance Treatment|Physician Decision|0|||
146878098|NCT01081912|529724248|FG002|Maintenance Treatment|Physician Decision|1|||
146878099|NCT01081912|529724246|FG000|Maintenance Treatment|Protocol Violation|0|||
146878100|NCT01081912|529724247|FG001|Maintenance Treatment|Protocol Violation|1|||
146878101|NCT01081912|529724248|FG002|Maintenance Treatment|Protocol Violation|2|||
146878102|NCT01081912|529724246|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
146878103|NCT01081912|529724247|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
146878104|NCT01081912|529724248|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
146878105|NCT01081912|529724246|FG000|Maintenance Treatment|Non-Compliance|0|||
146878106|NCT01081912|529724247|FG001|Maintenance Treatment|Non-Compliance|4|||
146878107|NCT01081912|529724248|FG002|Maintenance Treatment|Non-Compliance|7|||
146878108|NCT01081912|529724246|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
146878109|NCT01081912|529724247|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
146878110|NCT01081912|529724248|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
146878111|NCT02770547|529724252|FG000|Overall Study|Patient non-compliant|1|||
146878112|NCT02770547|529724253|FG001|Overall Study|Patient non-compliant|0|||
146878113|NCT02770547|529724252|FG000|Overall Study|Adverse Event|0|||
146878114|NCT02770547|529724253|FG001|Overall Study|Adverse Event|1|||
146878115|NCT01732796|529724254|FG000|Overall Study|Adverse Event|16|||
146878116|NCT01732796|529724255|FG001|Overall Study|Adverse Event|16|||
146878117|NCT01732796|529724256|FG002|Overall Study|Adverse Event|4|||
146878118|NCT01732796|529724254|FG000|Overall Study|Lack of Efficacy|21|||
146878119|NCT01732796|529724255|FG001|Overall Study|Lack of Efficacy|18|||
146878120|NCT01732796|529724256|FG002|Overall Study|Lack of Efficacy|5|||
146544674|NCT05800145|528500257|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
146878121|NCT01732796|529724254|FG000|Overall Study|Lost to Follow-up|2|||
146878122|NCT01732796|529724255|FG001|Overall Study|Lost to Follow-up|0|||
146878123|NCT01732796|529724256|FG002|Overall Study|Lost to Follow-up|0|||
146878124|NCT01732796|529724254|FG000|Overall Study|Withdrawal by Subject|6|||
146878125|NCT01732796|529724255|FG001|Overall Study|Withdrawal by Subject|8|||
146878126|NCT01732796|529724256|FG002|Overall Study|Withdrawal by Subject|2|||
146878127|NCT01732796|529724254|FG000|Overall Study|Other reason not defined above|1|||
146878128|NCT01732796|529724255|FG001|Overall Study|Other reason not defined above|0|||
146878129|NCT01732796|529724256|FG002|Overall Study|Other reason not defined above|2|||
146878130|NCT01379274|529724259|FG000|Overall Study|funding withdrawn|1|||
146878131|NCT00845728|529724261|FG000|Overall Study|Abnormal laboratory value (s)|2|||
146878132|NCT00845728|529724262|FG001|Overall Study|Abnormal laboratory value (s)|2|||
146878133|NCT00845728|529724261|FG000|Overall Study|Patient's inability to use the device|4|||
146878134|NCT00845728|529724262|FG001|Overall Study|Patient's inability to use the device|6|||
146878135|NCT00845728|529724261|FG000|Overall Study|Abnormal test procedure result (s)|7|||
146878136|NCT00845728|529724262|FG001|Overall Study|Abnormal test procedure result (s)|2|||
146878137|NCT00845728|529724261|FG000|Overall Study|Lost to Follow-up|22|||
146878138|NCT00845728|529724262|FG001|Overall Study|Lost to Follow-up|13|||
146878139|NCT00845728|529724261|FG000|Overall Study|Death|24|||
146878140|NCT00845728|529724262|FG001|Overall Study|Death|26|||
146878141|NCT00845728|529724261|FG000|Overall Study|Administrative Problems|34|||
146878142|NCT00845728|529724262|FG001|Overall Study|Administrative Problems|26|||
146878143|NCT00845728|529724261|FG000|Overall Study|Protocol Violation|36|||
146878144|NCT00845728|529724262|FG001|Overall Study|Protocol Violation|24|||
146878145|NCT00845728|529724261|FG000|Overall Study|Lack of Efficacy|51|||
146878146|NCT00845728|529724262|FG001|Overall Study|Lack of Efficacy|39|||
146878147|NCT00845728|529724261|FG000|Overall Study|Adverse Event|101|||
146878148|NCT00845728|529724262|FG001|Overall Study|Adverse Event|96|||
146878149|NCT00845728|529724261|FG000|Overall Study|Withdrawal by Subject|105|||
146878150|NCT00845728|529724262|FG001|Overall Study|Withdrawal by Subject|108|||
146878151|NCT01576549|529724263|FG000|Overall Study|Sponsor Decision|2|||
146878152|NCT04081363|529724266|FG000|Overall Study|Withdrawal by Subject|1|||
146878153|NCT04081363|529724267|FG001|Overall Study|Withdrawal by Subject|0|||
146878154|NCT00708500|529724268|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
146544675|NCT05800145|528500258|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
146878155|NCT00708500|529724269|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
146878156|NCT00708500|529724270|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
146878157|NCT00708500|529724268|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
146544676|NCT05800145|528500259|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
146629415|NCT05366738|528819716|FG002|Overall Study|Adverse Event|0|||
146764865|NCT01972152|529305955|FG005|Second Treatment Visit|Protocol Violation|0|||
146764866|NCT02596035|529305958|FG000|Overall Study|Disease Progression|64|||
146878158|NCT00708500|529724269|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
146878159|NCT00708500|529724270|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
146878160|NCT00708500|529724268|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
146878161|NCT00708500|529724269|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
146878162|NCT00708500|529724270|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
146878163|NCT00708500|529724268|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
146878164|NCT00708500|529724269|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
146878165|NCT00708500|529724270|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
146878166|NCT00708500|529724268|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
146878167|NCT00708500|529724269|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
146878168|NCT00708500|529724270|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
146878169|NCT00708500|529724268|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
146878170|NCT00708500|529724269|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
146878171|NCT00708500|529724270|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
146878172|NCT00708500|529724268|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
146878173|NCT00708500|529724269|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
146878174|NCT00708500|529724270|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
146878175|NCT00708500|529724268|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
146878176|NCT00708500|529724269|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
146878177|NCT00708500|529724270|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
146878178|NCT00708500|529724268|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
146878179|NCT00708500|529724269|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
146878180|NCT00708500|529724270|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
146878181|NCT00708500|529724268|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
146878182|NCT00708500|529724269|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
146878183|NCT00708500|529724270|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
146878184|NCT00708500|529724268|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
146878185|NCT00708500|529724269|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
146878186|NCT00708500|529724270|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
146878187|NCT00708500|529724268|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
146544677|NCT05800145|528500260|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
146878188|NCT00708500|529724269|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
146878189|NCT00708500|529724270|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
146878190|NCT00708500|529724268|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
146878191|NCT00708500|529724269|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
146878192|NCT00708500|529724270|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
146878193|NCT00708500|529724268|FG000|FOLLOWUP|Adverse Event|0|||
146878194|NCT00708500|529724269|FG001|FOLLOWUP|Adverse Event|1|||
146878195|NCT00708500|529724270|FG002|FOLLOWUP|Adverse Event|0|||
146878196|NCT00708500|529724268|FG000|FOLLOWUP|Lost to Follow-up|1|||
146878197|NCT00708500|529724269|FG001|FOLLOWUP|Lost to Follow-up|6|||
146878198|NCT00708500|529724270|FG002|FOLLOWUP|Lost to Follow-up|4|||
146878199|NCT00708500|529724268|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
146878200|NCT00708500|529724269|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
146878201|NCT00708500|529724270|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
146544678|NCT05800145|528500261|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
146544679|NCT05800145|528500262|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
146544680|NCT05800145|528500257|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
146544681|NCT05800145|528500258|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
146544682|NCT05800145|528500259|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
146878202|NCT00708500|529724268|FG000|FOLLOWUP|Subject withdrew consent|31|||
146878203|NCT00708500|529724269|FG001|FOLLOWUP|Subject withdrew consent|4|||
146878204|NCT00708500|529724270|FG002|FOLLOWUP|Subject withdrew consent|5|||
146878205|NCT00708500|529724268|FG000|FOLLOWUP|Non-compliance with protocol|5|||
146878206|NCT00708500|529724269|FG001|FOLLOWUP|Non-compliance with protocol|0|||
146878207|NCT00708500|529724270|FG002|FOLLOWUP|Non-compliance with protocol|1|||
146878208|NCT03975920|529724273|FG000|Overall Study|Lost to Follow-up|1|||
146878209|NCT03975920|529724274|FG001|Overall Study|Lost to Follow-up|2|||
146878210|NCT03975920|529724273|FG000|Overall Study|Protocol Violation|1|||
146878211|NCT03975920|529724274|FG001|Overall Study|Protocol Violation|1|||
146878212|NCT03975920|529724273|FG000|Overall Study|Did not complete survey|2|||
146878213|NCT03975920|529724274|FG001|Overall Study|Did not complete survey|1|||
146878214|NCT02182687|529724281|FG000|Overall Study|Withdrawal by Subject|4|||
146878215|NCT02182687|529724282|FG001|Overall Study|Withdrawal by Subject|0|||
146878216|NCT02182687|529724281|FG000|Overall Study|Adverse Event|1|||
146878217|NCT02182687|529724282|FG001|Overall Study|Adverse Event|0|||
146878218|NCT02182687|529724281|FG000|Overall Study|Lost to Follow-up|0|||
146878219|NCT02182687|529724282|FG001|Overall Study|Lost to Follow-up|1|||
146878220|NCT03882970|529724285|FG000|Overall Study|Adverse Event|5|||
146878221|NCT03882970|529724286|FG001|Overall Study|Adverse Event|7|||
146544683|NCT05800145|528500260|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
146544684|NCT05800145|528500261|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
146878222|NCT03882970|529724287|FG002|Overall Study|Adverse Event|3|||
146629416|NCT05291520|528819717|FG000|Overall Study|Lost to Follow-up|0|||
146878223|NCT03882970|529724288|FG003|Overall Study|Adverse Event|1|||
146544685|NCT05800145|528500262|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
146544686|NCT02850406|528500263|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
146544687|NCT02850406|528500264|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
146544688|NCT02850406|528500265|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
146544689|NCT02850406|528500266|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
146544690|NCT02850406|528500267|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
146544691|NCT02850406|528500268|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
146544692|NCT02850406|528500269|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
146544693|NCT02850406|528500270|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
146509040|NCT02052596|528367719|FG001|Active Phase|Withdrawal by Subject|4|||
146509041|NCT02052596|528367718|FG000|Active Phase|Enrolled in error|1|||
146509042|NCT02052596|528367719|FG001|Active Phase|Enrolled in error|0|||
146544694|NCT02850406|528500263|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
146544695|NCT02850406|528500264|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
146878224|NCT03882970|529724285|FG000|Overall Study|Death|1|||
146878225|NCT03882970|529724286|FG001|Overall Study|Death|2|||
146878226|NCT03882970|529724287|FG002|Overall Study|Death|1|||
146878227|NCT03882970|529724288|FG003|Overall Study|Death|1|||
146878228|NCT03882970|529724285|FG000|Overall Study|Lost to Follow-up|8|||
146878229|NCT03882970|529724286|FG001|Overall Study|Lost to Follow-up|9|||
146544696|NCT02850406|528500265|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
146544697|NCT02850406|528500266|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
146544698|NCT02850406|528500267|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
146544699|NCT02850406|528500268|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
146544700|NCT02850406|528500269|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
146544701|NCT02850406|528500270|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
146544702|NCT02850406|528500263|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
146544703|NCT02850406|528500264|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
146544704|NCT02850406|528500265|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
146544705|NCT02850406|528500266|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
146544706|NCT02850406|528500267|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
146629417|NCT05291520|528819718|FG001|Overall Study|Lost to Follow-up|0|||
146764867|NCT02596035|529305959|FG001|Overall Study|Disease Progression|32|||
146878230|NCT03882970|529724287|FG002|Overall Study|Lost to Follow-up|5|||
146509043|NCT02052596|528367718|FG000|Active Phase|Lost due to Crohn's disease|0|||
146509044|NCT02052596|528367719|FG001|Active Phase|Lost due to Crohn's disease|1|||
146509045|NCT02052596|528367718|FG000|Safety Phase|Adverse Event|6|||
146509046|NCT02052596|528367719|FG001|Safety Phase|Adverse Event|3|||
146509047|NCT02052596|528367718|FG000|Safety Phase|Lost to Follow-up|11|||
146509048|NCT02052596|528367719|FG001|Safety Phase|Lost to Follow-up|18|||
146509049|NCT02052596|528367718|FG000|Safety Phase|Protocol Violation|1|||
146509050|NCT02052596|528367719|FG001|Safety Phase|Protocol Violation|2|||
146878231|NCT03882970|529724288|FG003|Overall Study|Lost to Follow-up|5|||
146878232|NCT03882970|529724285|FG000|Overall Study|Physician Decision|0|||
146878233|NCT03882970|529724286|FG001|Overall Study|Physician Decision|2|||
146878234|NCT03882970|529724287|FG002|Overall Study|Physician Decision|2|||
146878235|NCT03882970|529724288|FG003|Overall Study|Physician Decision|2|||
146878236|NCT03882970|529724285|FG000|Overall Study|Protocol Violation|2|||
146878237|NCT03882970|529724286|FG001|Overall Study|Protocol Violation|0|||
146878238|NCT03882970|529724287|FG002|Overall Study|Protocol Violation|0|||
146878239|NCT03882970|529724288|FG003|Overall Study|Protocol Violation|0|||
146878240|NCT03882970|529724285|FG000|Overall Study|Withdrawal by Subject|8|||
146878241|NCT03882970|529724286|FG001|Overall Study|Withdrawal by Subject|17|||
146878242|NCT03882970|529724287|FG002|Overall Study|Withdrawal by Subject|7|||
146878243|NCT03882970|529724288|FG003|Overall Study|Withdrawal by Subject|22|||
146878244|NCT03882970|529724285|FG000|Overall Study|Personal Reason|2|||
146878245|NCT03882970|529724286|FG001|Overall Study|Personal Reason|3|||
146878246|NCT03882970|529724287|FG002|Overall Study|Personal Reason|1|||
146878247|NCT03882970|529724288|FG003|Overall Study|Personal Reason|3|||
146878248|NCT01439204|529724306|FG000|Overall Study|Withdrawal by Subject|0|||
146878249|NCT01439204|529724307|FG001|Overall Study|Withdrawal by Subject|1|||
146878250|NCT01439204|529724306|FG000|Overall Study|Lost to Follow-up|0|||
146878251|NCT01439204|529724307|FG001|Overall Study|Lost to Follow-up|2|||
146878252|NCT01439204|529724306|FG000|Overall Study|No longer meets study criteria|1|||
146878253|NCT01439204|529724307|FG001|Overall Study|No longer meets study criteria|0|||
146878254|NCT01439204|529724306|FG000|Overall Study|poor/non-compliance|3|||
146878255|NCT01439204|529724307|FG001|Overall Study|poor/non-compliance|0|||
146629418|NCT05291520|528819719|FG002|Overall Study|Lost to Follow-up|1|||
146878256|NCT01227044|529724311|FG000|Overall Study|Lost to Follow-up|5|||
146878257|NCT01227044|529724312|FG001|Overall Study|Lost to Follow-up|7|||
146878258|NCT01227044|529724311|FG000|Overall Study|Discontinued Intervention|1|||
146878259|NCT01227044|529724312|FG001|Overall Study|Discontinued Intervention|2|||
146878260|NCT00205855|529724323|FG000|Overall Study|Only received temporary implants|16|||
146878261|NCT00205855|529724323|FG000|Overall Study|Withdrawal by Subject|5|||
146878262|NCT00917150|529724326|FG000|Overall Study|Adverse Event|12|||
146878263|NCT00917150|529724327|FG001|Overall Study|Adverse Event|7|||
146878264|NCT00917150|529724328|FG002|Overall Study|Adverse Event|12|||
146878265|NCT00917150|529724329|FG003|Overall Study|Adverse Event|11|||
146878266|NCT00917150|529724326|FG000|Overall Study|Death|1|||
146878267|NCT00917150|529724327|FG001|Overall Study|Death|4|||
146878268|NCT00917150|529724328|FG002|Overall Study|Death|3|||
146878269|NCT00917150|529724329|FG003|Overall Study|Death|2|||
146878270|NCT00917150|529724326|FG000|Overall Study|Lost to Follow-up|1|||
146878271|NCT00917150|529724327|FG001|Overall Study|Lost to Follow-up|0|||
146878272|NCT00917150|529724328|FG002|Overall Study|Lost to Follow-up|4|||
146878273|NCT00917150|529724329|FG003|Overall Study|Lost to Follow-up|2|||
146878274|NCT00917150|529724326|FG000|Overall Study|Physician Decision|0|||
146878275|NCT00917150|529724327|FG001|Overall Study|Physician Decision|2|||
146878276|NCT00917150|529724328|FG002|Overall Study|Physician Decision|0|||
146878277|NCT00917150|529724329|FG003|Overall Study|Physician Decision|1|||
146878278|NCT00917150|529724326|FG000|Overall Study|Protocol Violation|5|||
146878279|NCT00917150|529724327|FG001|Overall Study|Protocol Violation|5|||
146878280|NCT00917150|529724328|FG002|Overall Study|Protocol Violation|3|||
146878281|NCT00917150|529724329|FG003|Overall Study|Protocol Violation|5|||
146878282|NCT00917150|529724326|FG000|Overall Study|Withdrawal by Subject|15|||
146878283|NCT00917150|529724327|FG001|Overall Study|Withdrawal by Subject|16|||
146878284|NCT00917150|529724328|FG002|Overall Study|Withdrawal by Subject|18|||
146878285|NCT00917150|529724329|FG003|Overall Study|Withdrawal by Subject|11|||
146878286|NCT00917150|529724326|FG000|Overall Study|Other than specified|3|||
146878287|NCT00917150|529724327|FG001|Overall Study|Other than specified|3|||
146878288|NCT00917150|529724328|FG002|Overall Study|Other than specified|2|||
146878289|NCT00917150|529724329|FG003|Overall Study|Other than specified|2|||
146878290|NCT03891264|529724330|FG000|Overall Study|Adverse Event|1|||
146544707|NCT02850406|528500268|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
146544708|NCT02850406|528500269|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
146544709|NCT02850406|528500270|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
146544710|NCT02850406|528500263|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
146544711|NCT02850406|528500264|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
146544712|NCT02850406|528500265|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
146544713|NCT02850406|528500266|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
146544714|NCT02850406|528500267|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
146544715|NCT02850406|528500268|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
146544716|NCT02850406|528500269|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
146544717|NCT02850406|528500270|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
146544718|NCT02850406|528500263|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
146544719|NCT02850406|528500264|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
146544720|NCT02850406|528500265|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
146544721|NCT02850406|528500266|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
146544722|NCT02850406|528500267|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
146544723|NCT02850406|528500268|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
146544724|NCT02850406|528500269|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
146544725|NCT02850406|528500270|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
146544726|NCT02850406|528500263|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
146878291|NCT03891264|529724330|FG000|Overall Study|Withdrawal by Subject|2|||
146878292|NCT03891264|529724330|FG000|Overall Study|Physician Decision|2|||
146878293|NCT01505634|529724331|FG000|Overall Study|Withdrawal by Subject|2|||
146878294|NCT01505634|529724332|FG001|Overall Study|Withdrawal by Subject|5|||
146878295|NCT01505634|529724333|FG002|Overall Study|Withdrawal by Subject|1|||
146544727|NCT02850406|528500264|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
146544728|NCT02850406|528500265|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
146544729|NCT02850406|528500266|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
146544730|NCT02850406|528500267|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
146544731|NCT02850406|528500268|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
146544732|NCT02850406|528500269|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
146544733|NCT02850406|528500270|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
146544734|NCT02850406|528500263|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
146544735|NCT02850406|528500264|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
146544736|NCT02850406|528500265|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
146544737|NCT02850406|528500266|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
146544738|NCT02850406|528500267|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
146544739|NCT02850406|528500268|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
146544740|NCT02850406|528500269|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
146544741|NCT02850406|528500270|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
146544742|NCT02850406|528500263|FG000|Part C (Up to 52 Weeks)|Other|0|||
146544743|NCT02850406|528500264|FG001|Part C (Up to 52 Weeks)|Other|0|||
146544744|NCT02850406|528500265|FG002|Part C (Up to 52 Weeks)|Other|0|||
146544745|NCT02850406|528500266|FG003|Part C (Up to 52 Weeks)|Other|0|||
146544746|NCT02850406|528500267|FG004|Part C (Up to 52 Weeks)|Other|1|||
146544747|NCT02850406|528500268|FG005|Part C (Up to 52 Weeks)|Other|3|||
146544748|NCT02850406|528500269|FG006|Part C (Up to 52 Weeks)|Other|0|||
146544749|NCT02850406|528500270|FG007|Part C (Up to 52 Weeks)|Other|0|||
146544750|NCT02850406|528500263|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
146544751|NCT02850406|528500264|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
146544752|NCT02850406|528500265|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
146544753|NCT02850406|528500266|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
146544754|NCT02850406|528500267|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
146544755|NCT02850406|528500268|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
146544756|NCT02850406|528500269|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
146544757|NCT02850406|528500270|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
146544758|NCT02850406|528500263|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
146544759|NCT02850406|528500264|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
146544760|NCT02850406|528500265|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
146544761|NCT02850406|528500266|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
146544762|NCT02850406|528500267|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
146544763|NCT02850406|528500268|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
146544764|NCT02850406|528500269|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
146544765|NCT02850406|528500270|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
146544766|NCT02850406|528500263|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
146764868|NCT02596035|529305960|FG002|Overall Study|Disease Progression|1|||
146544767|NCT02850406|528500264|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
146544768|NCT02850406|528500265|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
146544769|NCT02850406|528500266|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
146544770|NCT02850406|528500267|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
146878296|NCT01505634|529724331|FG000|Overall Study|Physician Decision|1|||
146544771|NCT02850406|528500268|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
146544772|NCT02850406|528500269|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
146544773|NCT02850406|528500270|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
146544774|NCT02850406|528500263|FG000|Part D (Up to 52 Weeks)|Other|0|||
146544775|NCT02850406|528500264|FG001|Part D (Up to 52 Weeks)|Other|0|||
146544776|NCT02850406|528500265|FG002|Part D (Up to 52 Weeks)|Other|0|||
146878297|NCT01505634|529724332|FG001|Overall Study|Physician Decision|1|||
146544777|NCT02850406|528500266|FG003|Part D (Up to 52 Weeks)|Other|0|||
146544778|NCT02850406|528500267|FG004|Part D (Up to 52 Weeks)|Other|0|||
146544779|NCT02850406|528500268|FG005|Part D (Up to 52 Weeks)|Other|0|||
146544780|NCT02850406|528500269|FG006|Part D (Up to 52 Weeks)|Other|0|||
146544781|NCT02850406|528500270|FG007|Part D (Up to 52 Weeks)|Other|1|||
146544782|NCT03641924|528501858|FG000|Overall Study|Withdrawal by Subject|26|||
146544783|NCT03641924|528501858|FG000|Overall Study|Lost to Follow-up|16|||
146544784|NCT03641924|528501858|FG000|Overall Study|Protocol Violation|10|||
146544785|NCT04333498|528501859|FG000|Overall Study|Lost to Follow-up|1|||
146544786|NCT04333498|528501860|FG001|Overall Study|Lost to Follow-up|0|||
146544787|NCT04333498|528501859|FG000|Overall Study|Lost to Follow-up|0|||
146544788|NCT04333498|528501860|FG001|Overall Study|Lost to Follow-up|1|||
146544789|NCT00479232|528501861|FG000|Overall Study|Adverse Event|0|||
146544790|NCT00479232|528501862|FG001|Overall Study|Adverse Event|0|||
146544791|NCT00479232|528501863|FG002|Overall Study|Adverse Event|5|||
146544792|NCT00479232|528501864|FG003|Overall Study|Adverse Event|0|||
146544793|NCT00479232|528501865|FG004|Overall Study|Adverse Event|0|||
146544794|NCT00479232|528501866|FG005|Overall Study|Adverse Event|10|||
146878298|NCT01505634|529724333|FG002|Overall Study|Physician Decision|0|||
146878299|NCT01505634|529724331|FG000|Overall Study|Adverse Event|1|||
146878300|NCT01505634|529724332|FG001|Overall Study|Adverse Event|0|||
146878301|NCT01505634|529724333|FG002|Overall Study|Adverse Event|0|||
146878302|NCT01505634|529724331|FG000|Overall Study|Insufficient supply of drug at site|1|||
146544795|NCT00479232|528501861|FG000|Overall Study|Deviation from Protocol|0|||
146544796|NCT00479232|528501862|FG001|Overall Study|Deviation from Protocol|0|||
146544797|NCT00479232|528501863|FG002|Overall Study|Deviation from Protocol|1|||
146544798|NCT00479232|528501864|FG003|Overall Study|Deviation from Protocol|0|||
146878303|NCT01505634|529724332|FG001|Overall Study|Insufficient supply of drug at site|0|||
146878304|NCT01505634|529724333|FG002|Overall Study|Insufficient supply of drug at site|0|||
146878305|NCT01505634|529724331|FG000|Overall Study|Protocol Violation|2|||
146878306|NCT01505634|529724332|FG001|Overall Study|Protocol Violation|0|||
146878307|NCT01505634|529724333|FG002|Overall Study|Protocol Violation|0|||
146878308|NCT01505634|529724331|FG000|Overall Study|Lost to Follow-up|1|||
146878309|NCT01505634|529724332|FG001|Overall Study|Lost to Follow-up|4|||
146878310|NCT01505634|529724333|FG002|Overall Study|Lost to Follow-up|4|||
146878311|NCT01505634|529724331|FG000|Overall Study|Death|1|||
146878312|NCT01505634|529724332|FG001|Overall Study|Death|0|||
146878313|NCT01505634|529724333|FG002|Overall Study|Death|0|||
146878314|NCT01505634|529724331|FG000|Overall Study|In a conflict zone|0|||
146878315|NCT01505634|529724332|FG001|Overall Study|In a conflict zone|0|||
146878316|NCT01505634|529724333|FG002|Overall Study|In a conflict zone|1|||
146878317|NCT01624662|529724337|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
146878318|NCT01624662|529724338|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
146878319|NCT01624662|529724339|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
146878320|NCT01624662|529724340|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
146878321|NCT01624662|529724337|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
146878322|NCT01624662|529724338|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
146878323|NCT01624662|529724339|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
146878324|NCT01624662|529724340|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
146878325|NCT01624662|529724337|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
146878326|NCT01624662|529724338|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
146878327|NCT01624662|529724339|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
146764869|NCT02596035|529305958|FG000|Overall Study|study drug toxicity|12|||
146764870|NCT02596035|529305959|FG001|Overall Study|study drug toxicity|3|||
146764871|NCT02596035|529305960|FG002|Overall Study|study drug toxicity|0|||
146764872|NCT02596035|529305958|FG000|Overall Study|AE unrelated to study drug|5|||
146764873|NCT02596035|529305959|FG001|Overall Study|AE unrelated to study drug|2|||
146878328|NCT01624662|529724340|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
146878329|NCT01624662|529724337|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
146878330|NCT01624662|529724338|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
146878331|NCT01624662|529724339|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
146878332|NCT01624662|529724340|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
146878333|NCT01624662|529724337|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
146878334|NCT01624662|529724338|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
146878335|NCT01624662|529724339|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
146878336|NCT01624662|529724340|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
146878337|NCT01624662|529724337|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
146878338|NCT01624662|529724338|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
146878339|NCT01624662|529724339|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
146878340|NCT01624662|529724340|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
146878341|NCT01624662|529724337|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
146878342|NCT01624662|529724338|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
146878343|NCT01624662|529724339|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
146878344|NCT01624662|529724340|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
146878345|NCT01714687|529724343|FG000|Overall Study|Withdrawal by Subject|1|||
146878346|NCT01714687|529724344|FG001|Overall Study|Withdrawal by Subject|0|||
146878347|NCT01714687|529724343|FG000|Overall Study|Lost to Follow-up|2|||
146878348|NCT01714687|529724344|FG001|Overall Study|Lost to Follow-up|4|||
146878349|NCT01439555|529724349|FG000|Overall Study|Protocol Violation|1|||
146878350|NCT04869345|529724355|FG000|Overall Study|Lost to Follow-up|8|||
146878351|NCT04869345|529724356|FG001|Overall Study|Lost to Follow-up|3|||
146878352|NCT05054114|529724370|FG000|Overall Study|Protocol Violation|13|||
146878353|NCT05054114|529724371|FG001|Overall Study|Protocol Violation|1|||
146878354|NCT05054114|529724370|FG000|Overall Study|Pregnancy|0|||
146878355|NCT05054114|529724371|FG001|Overall Study|Pregnancy|1|||
146878356|NCT01806779|529724372|FG000|Overall Study|Physician Decision|2|||
146544799|NCT00479232|528501865|FG004|Overall Study|Deviation from Protocol|0|||
146544800|NCT00479232|528501866|FG005|Overall Study|Deviation from Protocol|0|||
146544801|NCT00479232|528501861|FG000|Overall Study|Lack of Efficacy|0|||
146544802|NCT00479232|528501862|FG001|Overall Study|Lack of Efficacy|0|||
146764874|NCT02596035|529305960|FG002|Overall Study|AE unrelated to study drug|0|||
146878357|NCT01806779|529724373|FG001|Overall Study|Physician Decision|0|||
146878358|NCT01806779|529724374|FG002|Overall Study|Physician Decision|1|||
146878359|NCT01806779|529724372|FG000|Overall Study|Lack of Efficacy|1|||
146878360|NCT01806779|529724373|FG001|Overall Study|Lack of Efficacy|1|||
146878361|NCT01806779|529724374|FG002|Overall Study|Lack of Efficacy|0|||
146878362|NCT01806779|529724372|FG000|Overall Study|Lost to Follow-up|19|||
146544803|NCT00479232|528501863|FG002|Overall Study|Lack of Efficacy|2|||
146544804|NCT00479232|528501864|FG003|Overall Study|Lack of Efficacy|0|||
146878363|NCT01806779|529724373|FG001|Overall Study|Lost to Follow-up|20|||
146878364|NCT01806779|529724374|FG002|Overall Study|Lost to Follow-up|0|||
146878365|NCT01806779|529724372|FG000|Overall Study|Withdrawal by Subject|20|||
146878366|NCT01806779|529724373|FG001|Overall Study|Withdrawal by Subject|23|||
146878367|NCT01806779|529724374|FG002|Overall Study|Withdrawal by Subject|22|||
146878368|NCT02595450|529724375|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
146878369|NCT02595450|529724375|FG000|Overall Study|Enrolled, but not treated|8|||
146878370|NCT01908101|529726315|FG000|Overall Study|Physician Decision|1|||
146878371|NCT01908101|529726315|FG000|Overall Study|Withdrawal by Subject|1|||
146878372|NCT01908101|529726315|FG000|Overall Study|Incorrect Diagnosis|2|||
146878373|NCT01908101|529726315|FG000|Overall Study|Incorrect Starting Dose|1|||
146878374|NCT01908101|529726315|FG000|Overall Study|Did not complete the first cycle|4|||
146878375|NCT02356562|529726319|FG000|Overall Study|Withdrawal by Subject|0|||
146878376|NCT02356562|529726320|FG001|Overall Study|Withdrawal by Subject|1|||
146878377|NCT02356562|529726319|FG000|Overall Study|Re-entered treatment in a previous study|1|||
146878378|NCT02356562|529726320|FG001|Overall Study|Re-entered treatment in a previous study|0|||
146544805|NCT00479232|528501865|FG004|Overall Study|Lack of Efficacy|0|||
146544806|NCT00479232|528501866|FG005|Overall Study|Lack of Efficacy|4|||
146544807|NCT00479232|528501861|FG000|Overall Study|Physician Decision|0|||
146544808|NCT00479232|528501862|FG001|Overall Study|Physician Decision|0|||
146544809|NCT00479232|528501863|FG002|Overall Study|Physician Decision|2|||
146764875|NCT02596035|529305958|FG000|Overall Study|participant request to discontinue study treatment|2|||
146764876|NCT02596035|529305959|FG001|Overall Study|participant request to discontinue study treatment|0|||
146764877|NCT02596035|529305960|FG002|Overall Study|participant request to discontinue study treatment|0|||
146764878|NCT02596035|529305958|FG000|Overall Study|participant withdrew consent|2|||
146764879|NCT02596035|529305959|FG001|Overall Study|participant withdrew consent|2|||
146764880|NCT02596035|529305960|FG002|Overall Study|participant withdrew consent|0|||
146764881|NCT02596035|529305958|FG000|Overall Study|Poor/Non Comlpiance|0|||
146764882|NCT02596035|529305959|FG001|Overall Study|Poor/Non Comlpiance|1|||
146764883|NCT02596035|529305960|FG002|Overall Study|Poor/Non Comlpiance|0|||
146764884|NCT02596035|529305958|FG000|Overall Study|participant no longer meets study criteria|1|||
146764885|NCT02596035|529305959|FG001|Overall Study|participant no longer meets study criteria|0|||
146764886|NCT02596035|529305960|FG002|Overall Study|participant no longer meets study criteria|0|||
146764887|NCT02596035|529305958|FG000|Overall Study|other reasons|11|||
146764888|NCT02596035|529305959|FG001|Overall Study|other reasons|4|||
146764889|NCT02596035|529305960|FG002|Overall Study|other reasons|0|||
146764890|NCT00509769|529305961|FG000|Overall Study|Progressive disease|77|||
146764891|NCT00509769|529305961|FG000|Overall Study|Adverse Event|4|||
146764892|NCT00509769|529305961|FG000|Overall Study|Patient's decision|1|||
146764893|NCT00509769|529305961|FG000|Overall Study|Physician Decision|8|||
146764894|NCT00509769|529305961|FG000|Overall Study|Use of prohibited therapies during study|1|||
146764895|NCT04173572|529305962|FG000|Overall Study|Withdrawal by Subject|1|||
146764896|NCT04173572|529305963|FG001|Overall Study|Withdrawal by Subject|5|||
146764897|NCT04173572|529305962|FG000|Overall Study|Lost to Follow-up|3|||
146764898|NCT04173572|529305963|FG001|Overall Study|Lost to Follow-up|1|||
146764899|NCT02873754|529305964|FG000|Overall Study|Lost to Follow-up|5|||
146764900|NCT02873754|529305964|FG000|Overall Study|Couldn't complete study procedures|1|||
146764901|NCT01253226|529305965|FG000|Overall Study|Adverse Event|0|||
146764902|NCT01253226|529305966|FG001|Overall Study|Adverse Event|0|||
146764903|NCT01253226|529305967|FG002|Overall Study|Adverse Event|1|||
146764904|NCT01253226|529305968|FG003|Overall Study|Adverse Event|0|||
146764905|NCT01253226|529305969|FG004|Overall Study|Adverse Event|0|||
146764906|NCT01253226|529305965|FG000|Overall Study|Death|0|||
146764907|NCT01253226|529305966|FG001|Overall Study|Death|1|||
146764908|NCT01253226|529305967|FG002|Overall Study|Death|0|||
146764909|NCT01253226|529305968|FG003|Overall Study|Death|0|||
146764910|NCT01253226|529305969|FG004|Overall Study|Death|0|||
146764911|NCT01253226|529305965|FG000|Overall Study|Physician Decision|0|||
146764912|NCT01253226|529305966|FG001|Overall Study|Physician Decision|0|||
146764913|NCT01253226|529305967|FG002|Overall Study|Physician Decision|0|||
146764914|NCT01253226|529305968|FG003|Overall Study|Physician Decision|0|||
146878379|NCT02356562|529726319|FG000|Overall Study|site closure|1|||
146878380|NCT02356562|529726320|FG001|Overall Study|site closure|0|||
146878381|NCT00150592|529726321|FG000|Overall Study|Adverse Event|4|||
146878382|NCT00150592|529726322|FG001|Overall Study|Adverse Event|1|||
146878383|NCT00150592|529726321|FG000|Overall Study|Protocol Violation|1|||
146764915|NCT01253226|529305969|FG004|Overall Study|Physician Decision|2|||
146764916|NCT01253226|529305965|FG000|Overall Study|Withdrawal by Subject|0|||
146878384|NCT00150592|529726322|FG001|Overall Study|Protocol Violation|0|||
146878385|NCT00150592|529726321|FG000|Overall Study|Withdrawal by Subject|1|||
146878386|NCT00150592|529726322|FG001|Overall Study|Withdrawal by Subject|2|||
146544810|NCT00479232|528501864|FG003|Overall Study|Physician Decision|0|||
146878387|NCT00150592|529726321|FG000|Overall Study|Non-compliance|1|||
146878388|NCT00150592|529726322|FG001|Overall Study|Non-compliance|0|||
146764917|NCT01253226|529305966|FG001|Overall Study|Withdrawal by Subject|0|||
146764918|NCT01253226|529305967|FG002|Overall Study|Withdrawal by Subject|0|||
146544811|NCT00479232|528501865|FG004|Overall Study|Physician Decision|0|||
146764919|NCT01253226|529305968|FG003|Overall Study|Withdrawal by Subject|1|||
146764920|NCT01253226|529305969|FG004|Overall Study|Withdrawal by Subject|0|||
146764921|NCT00988637|529305970|FG000|Overall Study|Lost to Follow-up|2|||
146764922|NCT00988637|529305971|FG001|Overall Study|Lost to Follow-up|1|||
146878389|NCT00412750|529726323|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146544812|NCT00479232|528501866|FG005|Overall Study|Physician Decision|1|||
146764923|NCT00988637|529305970|FG000|Overall Study|Withdrawal by Subject|1|||
146764924|NCT00988637|529305971|FG001|Overall Study|Withdrawal by Subject|1|||
146764925|NCT00988637|529305970|FG000|Overall Study|non-compliance with study drug|0|||
146764926|NCT00988637|529305971|FG001|Overall Study|non-compliance with study drug|1|||
146764927|NCT02685033|529305972|FG000|Overall Study|Withdrawal of Consent|0|||
146764928|NCT02685033|529305973|FG001|Overall Study|Withdrawal of Consent|1|||
146764929|NCT02685033|529305972|FG000|Overall Study|Lost to Follow-up|2|||
146764930|NCT02685033|529305973|FG001|Overall Study|Lost to Follow-up|1|||
146764931|NCT02685033|529305972|FG000|Overall Study|Adverse Event|1|||
146764932|NCT02685033|529305973|FG001|Overall Study|Adverse Event|0|||
146764933|NCT01649791|529307186|FG000|Overall Study|Disease Progression|2|||
146764934|NCT01649791|529307186|FG000|Overall Study|Adverse Event|1|||
146764935|NCT00771667|529307187|FG000|Induction Phase|Adverse Event|5|||
146764936|NCT00771667|529307188|FG001|Induction Phase|Adverse Event|2|||
146764937|NCT00771667|529307189|FG002|Induction Phase|Adverse Event|4|||
146764938|NCT00771667|529307190|FG003|Induction Phase|Adverse Event|1|||
146764939|NCT00771667|529307191|FG004|Induction Phase|Adverse Event|0|||
146764940|NCT00771667|529307192|FG005|Induction Phase|Adverse Event|0|||
146764941|NCT00771667|529307193|FG006|Induction Phase|Adverse Event|0|||
146764942|NCT00771667|529307194|FG007|Induction Phase|Adverse Event|0|||
146764943|NCT00771667|529307195|FG008|Induction Phase|Adverse Event|0|||
146764944|NCT00771667|529307196|FG009|Induction Phase|Adverse Event|0|||
146764945|NCT00771667|529307187|FG000|Induction Phase|Lack of Efficacy|9|||
146764946|NCT00771667|529307188|FG001|Induction Phase|Lack of Efficacy|2|||
146764947|NCT00771667|529307189|FG002|Induction Phase|Lack of Efficacy|4|||
146764948|NCT00771667|529307190|FG003|Induction Phase|Lack of Efficacy|3|||
146764949|NCT00771667|529307191|FG004|Induction Phase|Lack of Efficacy|0|||
146764950|NCT00771667|529307192|FG005|Induction Phase|Lack of Efficacy|0|||
146764951|NCT00771667|529307193|FG006|Induction Phase|Lack of Efficacy|0|||
146764952|NCT00771667|529307194|FG007|Induction Phase|Lack of Efficacy|0|||
146764953|NCT00771667|529307195|FG008|Induction Phase|Lack of Efficacy|0|||
146764954|NCT00771667|529307196|FG009|Induction Phase|Lack of Efficacy|0|||
146764955|NCT00771667|529307187|FG000|Induction Phase|Lost to Follow-up|1|||
146764956|NCT00771667|529307188|FG001|Induction Phase|Lost to Follow-up|0|||
146764957|NCT00771667|529307189|FG002|Induction Phase|Lost to Follow-up|1|||
146764958|NCT00771667|529307190|FG003|Induction Phase|Lost to Follow-up|0|||
146764959|NCT00771667|529307191|FG004|Induction Phase|Lost to Follow-up|0|||
146764960|NCT00771667|529307192|FG005|Induction Phase|Lost to Follow-up|0|||
146764961|NCT00771667|529307193|FG006|Induction Phase|Lost to Follow-up|0|||
146764962|NCT00771667|529307194|FG007|Induction Phase|Lost to Follow-up|0|||
146764963|NCT00771667|529307195|FG008|Induction Phase|Lost to Follow-up|0|||
146764964|NCT00771667|529307196|FG009|Induction Phase|Lost to Follow-up|0|||
146764965|NCT00771667|529307187|FG000|Induction Phase|Other|4|||
146764966|NCT00771667|529307188|FG001|Induction Phase|Other|6|||
146764967|NCT00771667|529307189|FG002|Induction Phase|Other|3|||
146764968|NCT00771667|529307190|FG003|Induction Phase|Other|4|||
146764969|NCT00771667|529307191|FG004|Induction Phase|Other|0|||
146764970|NCT00771667|529307192|FG005|Induction Phase|Other|0|||
146764971|NCT00771667|529307193|FG006|Induction Phase|Other|0|||
146764972|NCT00771667|529307194|FG007|Induction Phase|Other|0|||
146764973|NCT00771667|529307195|FG008|Induction Phase|Other|0|||
146764974|NCT00771667|529307196|FG009|Induction Phase|Other|0|||
146544813|NCT00479232|528501861|FG000|Overall Study|Progressive Disease|3|||
146764975|NCT00771667|529307187|FG000|Maintenance Phase|Adverse Event|0|||
146764976|NCT00771667|529307188|FG001|Maintenance Phase|Adverse Event|0|||
146764977|NCT00771667|529307189|FG002|Maintenance Phase|Adverse Event|0|||
146764978|NCT00771667|529307190|FG003|Maintenance Phase|Adverse Event|0|||
146764979|NCT00771667|529307191|FG004|Maintenance Phase|Adverse Event|1|||
146764980|NCT00771667|529307192|FG005|Maintenance Phase|Adverse Event|3|||
146764981|NCT00771667|529307193|FG006|Maintenance Phase|Adverse Event|5|||
146764982|NCT00771667|529307194|FG007|Maintenance Phase|Adverse Event|1|||
146764983|NCT00771667|529307195|FG008|Maintenance Phase|Adverse Event|8|||
146764984|NCT00771667|529307196|FG009|Maintenance Phase|Adverse Event|7|||
146764985|NCT00771667|529307187|FG000|Maintenance Phase|Lack of Efficacy|0|||
146764986|NCT00771667|529307188|FG001|Maintenance Phase|Lack of Efficacy|0|||
146764987|NCT00771667|529307189|FG002|Maintenance Phase|Lack of Efficacy|0|||
146764988|NCT00771667|529307190|FG003|Maintenance Phase|Lack of Efficacy|0|||
146764989|NCT00771667|529307191|FG004|Maintenance Phase|Lack of Efficacy|1|||
146764990|NCT00771667|529307192|FG005|Maintenance Phase|Lack of Efficacy|3|||
146544814|NCT00479232|528501862|FG001|Overall Study|Progressive Disease|1|||
146544815|NCT00479232|528501863|FG002|Overall Study|Progressive Disease|12|||
146544816|NCT00479232|528501864|FG003|Overall Study|Progressive Disease|3|||
146544817|NCT00479232|528501865|FG004|Overall Study|Progressive Disease|3|||
146544818|NCT00479232|528501866|FG005|Overall Study|Progressive Disease|12|||
146544819|NCT00479232|528501861|FG000|Overall Study|Withdrew Consent|0|||
146544820|NCT00479232|528501862|FG001|Overall Study|Withdrew Consent|2|||
146544821|NCT00479232|528501863|FG002|Overall Study|Withdrew Consent|6|||
146544822|NCT00479232|528501864|FG003|Overall Study|Withdrew Consent|0|||
146544823|NCT00479232|528501865|FG004|Overall Study|Withdrew Consent|1|||
146544824|NCT00479232|528501866|FG005|Overall Study|Withdrew Consent|3|||
146544825|NCT05399771|528501867|FG000|Overall Study|Physician Decision|3|||
146544826|NCT05399771|528501867|FG000|Overall Study|Adverse Event|1|||
146544827|NCT00484159|528501869|FG000|Overall Study|Lost to Follow-up|1|||
146544828|NCT00484159|528501870|FG001|Overall Study|Lost to Follow-up|1|||
146544829|NCT00484159|528501871|FG002|Overall Study|Lost to Follow-up|0|||
146544830|NCT04766333|528501872|FG000|Overall Study|Lost to Follow-up|40|||
146544831|NCT04766333|528501873|FG001|Overall Study|Lost to Follow-up|826|||
146544832|NCT01239680|528501876|FG000|Overall Study|Withdrawal by Subject|2|||
146544833|NCT01239680|528501877|FG001|Overall Study|Withdrawal by Subject|0|||
146544834|NCT03033901|528501878|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
146544835|NCT03033901|528501878|FG000|Overall Study|Refused PSG|23|||
146544836|NCT03033901|528501878|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
146544837|NCT03033901|528501878|FG000|Overall Study|Missing Oximetry Data|3|||
146544838|NCT01797185|528501879|FG000|Overall Study|Adverse Event|5|||
146544839|NCT01797185|528501880|FG001|Overall Study|Adverse Event|15|||
146544840|NCT01797185|528501881|FG002|Overall Study|Adverse Event|6|||
146544841|NCT01797185|528501879|FG000|Overall Study|Withdrawal by Subject|6|||
146544842|NCT01797185|528501880|FG001|Overall Study|Withdrawal by Subject|9|||
146544843|NCT01797185|528501881|FG002|Overall Study|Withdrawal by Subject|5|||
146544844|NCT01797185|528501879|FG000|Overall Study|Site terminated|8|||
146544845|NCT01797185|528501880|FG001|Overall Study|Site terminated|4|||
146544846|NCT01797185|528501881|FG002|Overall Study|Site terminated|0|||
146544847|NCT01797185|528501879|FG000|Overall Study|Lost to Follow-up|2|||
146544848|NCT01797185|528501880|FG001|Overall Study|Lost to Follow-up|6|||
146544849|NCT01797185|528501881|FG002|Overall Study|Lost to Follow-up|1|||
146544850|NCT01797185|528501879|FG000|Overall Study|Withdrawn per sponsor|5|||
146544851|NCT01797185|528501880|FG001|Overall Study|Withdrawn per sponsor|0|||
146544852|NCT01797185|528501881|FG002|Overall Study|Withdrawn per sponsor|0|||
146544853|NCT01797185|528501879|FG000|Overall Study|Physician Decision|1|||
146544854|NCT01797185|528501880|FG001|Overall Study|Physician Decision|3|||
146544855|NCT01797185|528501881|FG002|Overall Study|Physician Decision|0|||
146629419|NCT01347112|528819720|FG000|Overall Study|Withdrawal by Subject|1|||
146544856|NCT01797185|528501879|FG000|Overall Study|Protocol Violation|1|||
146544857|NCT01797185|528501880|FG001|Overall Study|Protocol Violation|1|||
146544858|NCT01797185|528501881|FG002|Overall Study|Protocol Violation|0|||
146544859|NCT00729586|528501882|FG000|Overall Study|Ineligible|0|||
146544860|NCT00729586|528501883|FG001|Overall Study|Ineligible|1|||
146544861|NCT00729586|528501882|FG000|Overall Study|never treated|1|||
146544862|NCT00729586|528501883|FG001|Overall Study|never treated|0|||
146544863|NCT05177094|528501886|FG000|Overall Study|Adverse Event|5|||
146544864|NCT05177094|528501887|FG001|Overall Study|Adverse Event|5|||
146544865|NCT05177094|528501886|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
146544866|NCT05177094|528501887|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
146544867|NCT05177094|528501886|FG000|Overall Study|Protocol Deviation|3|||
146764991|NCT00771667|529307193|FG006|Maintenance Phase|Lack of Efficacy|3|||
146764992|NCT00771667|529307194|FG007|Maintenance Phase|Lack of Efficacy|2|||
146764993|NCT00771667|529307195|FG008|Maintenance Phase|Lack of Efficacy|11|||
146764994|NCT00771667|529307196|FG009|Maintenance Phase|Lack of Efficacy|7|||
146764995|NCT00771667|529307187|FG000|Maintenance Phase|Other|0|||
146544868|NCT05177094|528501887|FG001|Overall Study|Protocol Deviation|0|||
146544869|NCT05177094|528501886|FG000|Overall Study|Withdrawal by Subject|6|||
146544870|NCT05177094|528501887|FG001|Overall Study|Withdrawal by Subject|3|||
146544871|NCT05177094|528501886|FG000|Overall Study|Participant could not tolerate long study visits|1|||
146544872|NCT05177094|528501887|FG001|Overall Study|Participant could not tolerate long study visits|0|||
146544873|NCT01033942|528501890|FG000|Overall Study|Withdrawal by Subject|1|||
146878390|NCT00412750|529726324|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146544874|NCT01033942|528501891|FG001|Overall Study|Withdrawal by Subject|1|||
146544875|NCT01033942|528501892|FG002|Overall Study|Withdrawal by Subject|1|||
146544876|NCT01033942|528501890|FG000|Overall Study|Lost to Follow-up|1|||
146544877|NCT01033942|528501891|FG001|Overall Study|Lost to Follow-up|0|||
146544878|NCT01033942|528501892|FG002|Overall Study|Lost to Follow-up|0|||
146544879|NCT01033942|528501890|FG000|Overall Study|Enrolled in Extension Study|0|||
146544880|NCT01033942|528501891|FG001|Overall Study|Enrolled in Extension Study|3|||
146544881|NCT01033942|528501892|FG002|Overall Study|Enrolled in Extension Study|0|||
146544882|NCT02513199|528501893|FG000|Treatment|Death|1|||
146544883|NCT02513199|528501893|FG000|Treatment|Lost to Follow-up|1|||
146544884|NCT02513199|528501893|FG000|Follow-Up|Death|11|||
146544885|NCT02260986|528501901|FG000|Overall Study|Adverse Event|24|||
146544886|NCT02260986|528501902|FG001|Overall Study|Adverse Event|0|||
146544887|NCT02260986|528501903|FG002|Overall Study|Adverse Event|11|||
146544888|NCT02260986|528501901|FG000|Overall Study|Lack of Efficacy|27|||
146544889|NCT02260986|528501902|FG001|Overall Study|Lack of Efficacy|3|||
146764996|NCT00771667|529307188|FG001|Maintenance Phase|Other|0|||
146764997|NCT00771667|529307189|FG002|Maintenance Phase|Other|0|||
146764998|NCT00771667|529307190|FG003|Maintenance Phase|Other|0|||
146764999|NCT00771667|529307191|FG004|Maintenance Phase|Other|0|||
146765000|NCT00771667|529307192|FG005|Maintenance Phase|Other|1|||
146765001|NCT00771667|529307193|FG006|Maintenance Phase|Other|2|||
146765002|NCT00771667|529307194|FG007|Maintenance Phase|Other|2|||
146765003|NCT00771667|529307195|FG008|Maintenance Phase|Other|3|||
146765004|NCT00771667|529307196|FG009|Maintenance Phase|Other|3|||
146765005|NCT01897233|529307197|FG000|Part B (24 Weeks)|Adverse Event|1|||
146765006|NCT01897233|529307197|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
146765007|NCT01897233|529307197|FG000|Part B (24 Weeks)|Physician Decision|1|||
146765008|NCT04033432|529307206|FG000|Overall Study|Progressive Disease|8|||
146765009|NCT04033432|529307206|FG000|Overall Study|Adverse Event|4|||
146765010|NCT04033432|529307206|FG000|Overall Study|Death|1|||
146765011|NCT00738699|529307210|FG000|Overall Study|Withdrawal by Subject|5|||
146765012|NCT00738699|529307211|FG001|Overall Study|Withdrawal by Subject|0|||
146765013|NCT00738699|529307210|FG000|Overall Study|Lost to Follow-up|1|||
146765014|NCT00738699|529307211|FG001|Overall Study|Lost to Follow-up|0|||
146765015|NCT00738699|529307210|FG000|Overall Study|Death|144|||
146765016|NCT00738699|529307211|FG001|Overall Study|Death|68|||
146878391|NCT00412750|529726325|FG002|Overall Study|Abnormal laboratory value(s)|0|||
146878392|NCT00412750|529726323|FG000|Overall Study|Administrative problems|21|||
146878393|NCT00412750|529726324|FG001|Overall Study|Administrative problems|17|||
146878394|NCT00412750|529726325|FG002|Overall Study|Administrative problems|14|||
146878395|NCT00412750|529726323|FG000|Overall Study|Adverse Event|8|||
146878396|NCT00412750|529726324|FG001|Overall Study|Adverse Event|3|||
146878397|NCT00412750|529726325|FG002|Overall Study|Adverse Event|3|||
146878398|NCT00412750|529726323|FG000|Overall Study|Lost to Follow-up|1|||
146878399|NCT00412750|529726324|FG001|Overall Study|Lost to Follow-up|0|||
146878400|NCT00412750|529726325|FG002|Overall Study|Lost to Follow-up|1|||
146878401|NCT00412750|529726323|FG000|Overall Study|Withdrawal by Subject|0|||
146878402|NCT00412750|529726324|FG001|Overall Study|Withdrawal by Subject|1|||
146878403|NCT00412750|529726325|FG002|Overall Study|Withdrawal by Subject|2|||
146878404|NCT00412750|529726323|FG000|Overall Study|Lack of Efficacy|0|||
146765017|NCT00738699|529307210|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
146765018|NCT00738699|529307211|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
146765019|NCT00738699|529307210|FG000|Overall Study|Other|2|||
146878405|NCT00412750|529726324|FG001|Overall Study|Lack of Efficacy|0|||
146765020|NCT00738699|529307211|FG001|Overall Study|Other|0|||
146765021|NCT00868192|529307213|FG000|Overall Study|Ineligible|4|||
146878406|NCT00412750|529726325|FG002|Overall Study|Lack of Efficacy|3|||
146544890|NCT02260986|528501903|FG002|Overall Study|Lack of Efficacy|0|||
146544891|NCT02260986|528501901|FG000|Overall Study|Protocol Violation|14|||
146544892|NCT02260986|528501902|FG001|Overall Study|Protocol Violation|5|||
146544893|NCT02260986|528501903|FG002|Overall Study|Protocol Violation|16|||
146544894|NCT02260986|528501901|FG000|Overall Study|Car accident|0|||
146544895|NCT02260986|528501902|FG001|Overall Study|Car accident|0|||
146544896|NCT02260986|528501903|FG002|Overall Study|Car accident|1|||
146544897|NCT02260986|528501901|FG000|Overall Study|Withdrawal by Subject|17|||
146544898|NCT02260986|528501902|FG001|Overall Study|Withdrawal by Subject|4|||
146544899|NCT02260986|528501903|FG002|Overall Study|Withdrawal by Subject|9|||
146544900|NCT02260986|528501901|FG000|Overall Study|Incorrect randomization|0|||
146544901|NCT02260986|528501902|FG001|Overall Study|Incorrect randomization|1|||
146544902|NCT02260986|528501903|FG002|Overall Study|Incorrect randomization|0|||
146544903|NCT02260986|528501901|FG000|Overall Study|Lack of investigation product supply|2|||
146544904|NCT02260986|528501902|FG001|Overall Study|Lack of investigation product supply|0|||
146544905|NCT02260986|528501903|FG002|Overall Study|Lack of investigation product supply|1|||
146544906|NCT02260986|528501901|FG000|Overall Study|Lost to Follow-up|4|||
146544907|NCT02260986|528501902|FG001|Overall Study|Lost to Follow-up|0|||
146544908|NCT02260986|528501903|FG002|Overall Study|Lost to Follow-up|3|||
146544909|NCT02260986|528501901|FG000|Overall Study|Pregnancy|2|||
146544910|NCT02260986|528501902|FG001|Overall Study|Pregnancy|0|||
146544911|NCT02260986|528501903|FG002|Overall Study|Pregnancy|0|||
146544912|NCT01047501|528501905|FG000|Overall Study|Adverse Event|7|||
146878407|NCT00874120|529726333|FG000|First Intervention|Adverse Event|0|||
146544913|NCT01047501|528501906|FG001|Overall Study|Adverse Event|8|||
146544914|NCT01047501|528501907|FG002|Overall Study|Adverse Event|5|||
146878408|NCT00874120|529726334|FG001|First Intervention|Adverse Event|1|||
146544915|NCT01047501|528501905|FG000|Overall Study|Withdrew Consent|6|||
146544916|NCT01047501|528501906|FG001|Overall Study|Withdrew Consent|2|||
146544917|NCT01047501|528501907|FG002|Overall Study|Withdrew Consent|4|||
146544918|NCT01047501|528501905|FG000|Overall Study|Lost to Follow-up|0|||
146544919|NCT01047501|528501906|FG001|Overall Study|Lost to Follow-up|1|||
146544920|NCT01047501|528501907|FG002|Overall Study|Lost to Follow-up|1|||
146544921|NCT01047501|528501905|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
146544922|NCT01047501|528501906|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
146544923|NCT01047501|528501907|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
146544924|NCT01047501|528501905|FG000|Overall Study|Death|1|||
146544925|NCT01047501|528501906|FG001|Overall Study|Death|0|||
146544926|NCT01047501|528501907|FG002|Overall Study|Death|0|||
146544927|NCT01047501|528501905|FG000|Overall Study|Other discontinuation|1|||
146544928|NCT01047501|528501906|FG001|Overall Study|Other discontinuation|0|||
146544929|NCT01047501|528501907|FG002|Overall Study|Other discontinuation|1|||
146544930|NCT01047501|528501905|FG000|Overall Study|Investigator judgement|0|||
146544931|NCT01047501|528501906|FG001|Overall Study|Investigator judgement|0|||
146544932|NCT01047501|528501907|FG002|Overall Study|Investigator judgement|1|||
146544933|NCT04602000|528501908|FG000|Overall Study|Withdrawal by Subject|3|||
146544934|NCT04602000|528501909|FG001|Overall Study|Withdrawal by Subject|6|||
146544935|NCT04602000|528501910|FG002|Overall Study|Withdrawal by Subject|3|||
146544936|NCT04602000|528501911|FG003|Overall Study|Withdrawal by Subject|27|||
146765022|NCT00798096|529307214|FG000|Overall Study|Ongoing|2|||
146544937|NCT04602000|528501912|FG004|Overall Study|Withdrawal by Subject|39|||
146544938|NCT04602000|528501908|FG000|Overall Study|Physician Decision|1|||
146544939|NCT04602000|528501909|FG001|Overall Study|Physician Decision|0|||
146544940|NCT04602000|528501910|FG002|Overall Study|Physician Decision|0|||
146544941|NCT04602000|528501911|FG003|Overall Study|Physician Decision|2|||
146544942|NCT04602000|528501912|FG004|Overall Study|Physician Decision|2|||
146544943|NCT04602000|528501908|FG000|Overall Study|Death|0|||
146544944|NCT04602000|528501909|FG001|Overall Study|Death|1|||
146544945|NCT04602000|528501910|FG002|Overall Study|Death|0|||
146544946|NCT04602000|528501911|FG003|Overall Study|Death|1|||
146544947|NCT04602000|528501912|FG004|Overall Study|Death|2|||
146544948|NCT04602000|528501908|FG000|Overall Study|Lost to Follow-up|0|||
146544949|NCT04602000|528501909|FG001|Overall Study|Lost to Follow-up|0|||
146544950|NCT04602000|528501910|FG002|Overall Study|Lost to Follow-up|0|||
146878409|NCT00874120|529726333|FG000|First Intervention|Withdrawal by Subject|2|||
146544951|NCT04602000|528501911|FG003|Overall Study|Lost to Follow-up|3|||
146544952|NCT04602000|528501912|FG004|Overall Study|Lost to Follow-up|4|||
146544953|NCT04602000|528501908|FG000|Overall Study|Other|4|||
146544954|NCT04602000|528501909|FG001|Overall Study|Other|1|||
146509051|NCT02052596|528367718|FG000|Safety Phase|Withdrawal by Subject|8|||
146509052|NCT02052596|528367719|FG001|Safety Phase|Withdrawal by Subject|11|||
146509053|NCT02052596|528367718|FG000|Safety Phase|Enrolled in error|1|||
146509054|NCT02052596|528367719|FG001|Safety Phase|Enrolled in error|0|||
146509055|NCT02052596|528367718|FG000|Safety Phase|Lost due to Crohn's disease|0|||
146509056|NCT02052596|528367719|FG001|Safety Phase|Lost due to Crohn's disease|1|||
146509057|NCT00558896|528367720|FG000|Overall Study|Adverse Event|1|||
146509058|NCT00558896|528367721|FG001|Overall Study|Adverse Event|1|||
146509059|NCT00558896|528367722|FG002|Overall Study|Adverse Event|1|||
146509060|NCT00558896|528367723|FG003|Overall Study|Adverse Event|3|||
146509061|NCT00558896|528367724|FG004|Overall Study|Adverse Event|4|||
146509062|NCT00558896|528367725|FG005|Overall Study|Adverse Event|10|||
146509063|NCT00558896|528367726|FG006|Overall Study|Adverse Event|3|||
146509064|NCT00558896|528367720|FG000|Overall Study|Death|3|||
146509065|NCT00558896|528367721|FG001|Overall Study|Death|0|||
146509066|NCT00558896|528367722|FG002|Overall Study|Death|2|||
146509067|NCT00558896|528367723|FG003|Overall Study|Death|3|||
146509068|NCT00558896|528367724|FG004|Overall Study|Death|2|||
146509069|NCT00558896|528367725|FG005|Overall Study|Death|2|||
146509070|NCT00558896|528367726|FG006|Overall Study|Death|6|||
146509071|NCT00558896|528367720|FG000|Overall Study|Withdrawal by Subject|2|||
146509072|NCT00558896|528367721|FG001|Overall Study|Withdrawal by Subject|1|||
146509073|NCT00558896|528367722|FG002|Overall Study|Withdrawal by Subject|1|||
146509074|NCT00558896|528367723|FG003|Overall Study|Withdrawal by Subject|1|||
146509075|NCT00558896|528367724|FG004|Overall Study|Withdrawal by Subject|1|||
146509076|NCT00558896|528367725|FG005|Overall Study|Withdrawal by Subject|5|||
146509077|NCT00558896|528367726|FG006|Overall Study|Withdrawal by Subject|5|||
146509078|NCT00558896|528367720|FG000|Overall Study|Alternative Treatment|2|||
146509079|NCT00558896|528367721|FG001|Overall Study|Alternative Treatment|2|||
146509080|NCT00558896|528367722|FG002|Overall Study|Alternative Treatment|0|||
146509081|NCT00558896|528367723|FG003|Overall Study|Alternative Treatment|2|||
146509082|NCT00558896|528367724|FG004|Overall Study|Alternative Treatment|6|||
146509083|NCT00558896|528367725|FG005|Overall Study|Alternative Treatment|7|||
146509084|NCT00558896|528367726|FG006|Overall Study|Alternative Treatment|1|||
146509085|NCT00558896|528367720|FG000|Overall Study|Physician discretion|3|||
146509086|NCT00558896|528367721|FG001|Overall Study|Physician discretion|2|||
146509087|NCT00558896|528367722|FG002|Overall Study|Physician discretion|1|||
146509088|NCT00558896|528367723|FG003|Overall Study|Physician discretion|2|||
146509089|NCT00558896|528367724|FG004|Overall Study|Physician discretion|1|||
146509090|NCT00558896|528367725|FG005|Overall Study|Physician discretion|3|||
146509091|NCT00558896|528367726|FG006|Overall Study|Physician discretion|3|||
146509092|NCT00558896|528367720|FG000|Overall Study|Continues on treatment|10|||
146509093|NCT00558896|528367721|FG001|Overall Study|Continues on treatment|1|||
146509094|NCT00558896|528367722|FG002|Overall Study|Continues on treatment|0|||
146509095|NCT00558896|528367723|FG003|Overall Study|Continues on treatment|1|||
146509096|NCT00558896|528367724|FG004|Overall Study|Continues on treatment|9|||
146509097|NCT00558896|528367725|FG005|Overall Study|Continues on treatment|25|||
146509098|NCT00558896|528367726|FG006|Overall Study|Continues on treatment|6|||
146509099|NCT00250458|528367730|FG000|Overall Study|Lost to Follow-up|4|||
146878410|NCT00874120|529726334|FG001|First Intervention|Withdrawal by Subject|0|||
146878411|NCT00874120|529726333|FG000|First Intervention|Lost to Follow-up|0|||
146878412|NCT00874120|529726334|FG001|First Intervention|Lost to Follow-up|1|||
146878413|NCT00874120|529726333|FG000|First Intervention|Protocol Violation|3|||
146878414|NCT00874120|529726334|FG001|First Intervention|Protocol Violation|0|||
146878415|NCT00874120|529726333|FG000|First Intervention|positive drug test|1|||
146878416|NCT00874120|529726334|FG001|First Intervention|positive drug test|0|||
146878417|NCT00874120|529726333|FG000|Second Intervention|Withdrawal by Subject|1|||
146878418|NCT00874120|529726334|FG001|Second Intervention|Withdrawal by Subject|0|||
146878419|NCT00874120|529726333|FG000|Second Intervention|Protocol Violation|1|||
146878420|NCT00874120|529726334|FG001|Second Intervention|Protocol Violation|0|||
146878421|NCT01823679|529726335|FG000|Overall Study|Death|1|||
146878422|NCT02135692|529726343|FG000|Overall Study|Adverse Event|3|||
146878423|NCT02135692|529726343|FG000|Overall Study|Lack of Efficacy|2|||
146878424|NCT02135692|529726343|FG000|Overall Study|Protocol Violation|2|||
146878425|NCT02135692|529726343|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
146878426|NCT02135692|529726343|FG000|Overall Study|Product commercially available|159|||
146878427|NCT02135692|529726343|FG000|Overall Study|Study closed/terminated|153|||
146878428|NCT02135692|529726343|FG000|Overall Study|Lost to Follow-up|4|||
146878429|NCT02135692|529726343|FG000|Overall Study|Withdrawal by Subject|15|||
146878430|NCT01611974|529726346|FG000|Overall Study|Death|10|||
146878431|NCT01611974|529726347|FG001|Overall Study|Death|12|||
146878432|NCT01611974|529726348|FG002|Overall Study|Death|10|||
146878433|NCT01611974|529726346|FG000|Overall Study|Lost to Follow-up|0|||
146878434|NCT01611974|529726347|FG001|Overall Study|Lost to Follow-up|1|||
146878435|NCT01611974|529726348|FG002|Overall Study|Lost to Follow-up|0|||
146878436|NCT01611974|529726346|FG000|Overall Study|Physician Decision|5|||
146878437|NCT01611974|529726347|FG001|Overall Study|Physician Decision|1|||
146878438|NCT01611974|529726348|FG002|Overall Study|Physician Decision|2|||
146878439|NCT01611974|529726346|FG000|Overall Study|Withdrawal by Subject|0|||
146878440|NCT01611974|529726347|FG001|Overall Study|Withdrawal by Subject|1|||
146878441|NCT01611974|529726348|FG002|Overall Study|Withdrawal by Subject|4|||
146878442|NCT01097746|529726349|FG000|Overall Study|Adverse Event|4|||
146878443|NCT01097746|529726349|FG000|Overall Study|taken off study before any treatment given|1|||
146878444|NCT00522431|529726350|FG000|Overall Study|Adverse Event|5|||
146878445|NCT00522431|529726350|FG000|Overall Study|Protocol Violation|2|||
146878446|NCT00522431|529726350|FG000|Overall Study|Withdrawal by Subject|2|||
146878447|NCT00522431|529726350|FG000|Overall Study|Subject non-compliance|1|||
146878448|NCT00522431|529726350|FG000|Overall Study|Other/unknown|1|||
146878449|NCT02495844|529726351|FG000|Overall Study|Lack of Efficacy|1|||
146878450|NCT02495844|529726352|FG001|Overall Study|Lack of Efficacy|2|||
146878451|NCT02495844|529726351|FG000|Overall Study|AE, non-fatal|0|||
146878452|NCT02495844|529726352|FG001|Overall Study|AE, non-fatal|1|||
146878453|NCT02495844|529726351|FG000|Overall Study|Hepatitis Positivity|0|||
146878454|NCT02495844|529726352|FG001|Overall Study|Hepatitis Positivity|1|||
146878455|NCT03927105|529726353|FG000|Overall Study|Death|1|||
146878456|NCT03927105|529726353|FG000|Overall Study|In observation for potential re-treatment|2|||
146878457|NCT03927105|529726353|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
146878458|NCT02145741|529726356|FG000|Overall Study|Progressive disease|3|||
146878459|NCT02145741|529726357|FG001|Overall Study|Progressive disease|6|||
146878460|NCT02145741|529726358|FG002|Overall Study|Progressive disease|6|||
146878461|NCT02145741|529726356|FG000|Overall Study|quality issue with the administered drug|3|||
146878462|NCT02145741|529726357|FG001|Overall Study|quality issue with the administered drug|0|||
146878463|NCT02145741|529726358|FG002|Overall Study|quality issue with the administered drug|0|||
146878464|NCT05634577|529726359|FG000|Overall Study|Lost to Follow-up|1|||
146878465|NCT05634577|529726359|FG000|Overall Study|Withdrawal by Subject|1|||
146878466|NCT01192022|529726360|FG000|Overall Study|Withdrawal of Consent|3|||
146878467|NCT01192022|529726361|FG001|Overall Study|Withdrawal of Consent|1|||
146878468|NCT01192022|529726362|FG002|Overall Study|Withdrawal of Consent|0|||
146878469|NCT01192022|529726363|FG003|Overall Study|Withdrawal of Consent|0|||
146878470|NCT01192022|529726364|FG004|Overall Study|Withdrawal of Consent|0|||
146878471|NCT01192022|529726360|FG000|Overall Study|Lost to Follow-up|4|||
146878472|NCT01192022|529726361|FG001|Overall Study|Lost to Follow-up|2|||
146878473|NCT01192022|529726362|FG002|Overall Study|Lost to Follow-up|1|||
146878474|NCT01192022|529726363|FG003|Overall Study|Lost to Follow-up|1|||
146878475|NCT01192022|529726364|FG004|Overall Study|Lost to Follow-up|0|||
146878476|NCT01192022|529726360|FG000|Overall Study|Adverse Event|1|||
146878477|NCT01192022|529726361|FG001|Overall Study|Adverse Event|0|||
146878478|NCT01192022|529726362|FG002|Overall Study|Adverse Event|0|||
146878479|NCT01192022|529726363|FG003|Overall Study|Adverse Event|0|||
146878480|NCT01192022|529726364|FG004|Overall Study|Adverse Event|0|||
146878481|NCT01192022|529726360|FG000|Overall Study|Fatal Adverse Event|4|||
146878482|NCT01192022|529726361|FG001|Overall Study|Fatal Adverse Event|6|||
146878483|NCT01192022|529726362|FG002|Overall Study|Fatal Adverse Event|0|||
146878484|NCT01192022|529726363|FG003|Overall Study|Fatal Adverse Event|0|||
146878485|NCT01192022|529726364|FG004|Overall Study|Fatal Adverse Event|1|||
146878486|NCT01192022|529726360|FG000|Overall Study|Physician withdrew-patient hardship|1|||
146544955|NCT04602000|528501910|FG002|Overall Study|Other|2|||
146544956|NCT04602000|528501911|FG003|Overall Study|Other|5|||
146544957|NCT04602000|528501912|FG004|Overall Study|Other|4|||
146544958|NCT04602000|528501908|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
146544959|NCT04602000|528501909|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
146878487|NCT01192022|529726361|FG001|Overall Study|Physician withdrew-patient hardship|0|||
146878488|NCT01192022|529726362|FG002|Overall Study|Physician withdrew-patient hardship|0|||
146544960|NCT04602000|528501910|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
146544961|NCT04602000|528501911|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
146544962|NCT04602000|528501912|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
146544963|NCT05607043|528501913|FG000|Overall Study|Lost to Follow-up|2|||
146878489|NCT01192022|529726363|FG003|Overall Study|Physician withdrew-patient hardship|0|||
146544964|NCT00429299|528501918|FG000|Overall Study|Disease Progression|1|||
146544965|NCT00429299|528501919|FG001|Overall Study|Disease Progression|1|||
146544966|NCT00429299|528501920|FG002|Overall Study|Disease Progression|0|||
146544967|NCT00429299|528501918|FG000|Overall Study|Adverse Event|2|||
146544968|NCT00429299|528501919|FG001|Overall Study|Adverse Event|5|||
146544969|NCT00429299|528501920|FG002|Overall Study|Adverse Event|1|||
146544970|NCT00429299|528501918|FG000|Overall Study|Protocol Violation|1|||
146544971|NCT00429299|528501919|FG001|Overall Study|Protocol Violation|0|||
146629420|NCT01347112|528819721|FG001|Overall Study|Withdrawal by Subject|7|||
146629421|NCT01347112|528819720|FG000|Overall Study|Lost to Follow-up|3|||
146629422|NCT01347112|528819721|FG001|Overall Study|Lost to Follow-up|5|||
146629423|NCT00696072|528819722|FG000|Overall Study|continuing active treatment|10|||
146629424|NCT00696072|528819723|FG001|Overall Study|continuing active treatment|13|||
146629425|NCT00696072|528819722|FG000|Overall Study|Adverse Event|10|||
146629426|NCT00696072|528819723|FG001|Overall Study|Adverse Event|6|||
146629427|NCT00696072|528819722|FG000|Overall Study|Patient Request|3|||
146629428|NCT00696072|528819723|FG001|Overall Study|Patient Request|7|||
146629429|NCT00696072|528819722|FG000|Overall Study|Investigator Request|1|||
146629430|NCT00696072|528819723|FG001|Overall Study|Investigator Request|4|||
146629431|NCT00696072|528819722|FG000|Overall Study|Sponsor Request|0|||
146629432|NCT00696072|528819723|FG001|Overall Study|Sponsor Request|1|||
146765023|NCT03201809|529307215|FG000|Overall Study|Lost to Follow-up|2|||
146878490|NCT01192022|529726364|FG004|Overall Study|Physician withdrew-patient hardship|0|||
146878491|NCT01192022|529726360|FG000|Overall Study|Patient too sick from chemotherapy|0|||
146878492|NCT01192022|529726361|FG001|Overall Study|Patient too sick from chemotherapy|1|||
146878493|NCT01192022|529726362|FG002|Overall Study|Patient too sick from chemotherapy|0|||
146878494|NCT01192022|529726363|FG003|Overall Study|Patient too sick from chemotherapy|0|||
146878495|NCT01192022|529726364|FG004|Overall Study|Patient too sick from chemotherapy|0|||
146878496|NCT01192022|529726360|FG000|Overall Study|Patient needed surgery|0|||
146878497|NCT01192022|529726361|FG001|Overall Study|Patient needed surgery|1|||
146878498|NCT01192022|529726362|FG002|Overall Study|Patient needed surgery|0|||
146878499|NCT01192022|529726363|FG003|Overall Study|Patient needed surgery|0|||
146878500|NCT01192022|529726364|FG004|Overall Study|Patient needed surgery|0|||
146878501|NCT01192022|529726360|FG000|Overall Study|Parents did not allow all follow up|0|||
146878502|NCT01192022|529726361|FG001|Overall Study|Parents did not allow all follow up|0|||
146878503|NCT01192022|529726362|FG002|Overall Study|Parents did not allow all follow up|0|||
146878504|NCT01192022|529726363|FG003|Overall Study|Parents did not allow all follow up|1|||
146878505|NCT01192022|529726364|FG004|Overall Study|Parents did not allow all follow up|0|||
146878506|NCT01351389|529726365|FG000|Overall Study|Withdrawal by Subject|7|||
146878507|NCT01351389|529726366|FG001|Overall Study|Withdrawal by Subject|0|||
146878508|NCT01351389|529726365|FG000|Overall Study|did not complete intervention|23|||
146878509|NCT01351389|529726366|FG001|Overall Study|did not complete intervention|15|||
146878510|NCT04839978|529726367|FG000|Overall Study|Lost to Follow-up|135|||
146878511|NCT04839978|529726368|FG001|Overall Study|Lost to Follow-up|147|||
146878512|NCT00623480|529726370|FG000|Overall Study|Lost to Follow-up|0|||
146878513|NCT00623480|529726371|FG001|Overall Study|Lost to Follow-up|1|||
146878514|NCT00623480|529726370|FG000|Overall Study|Withdrawal by Subject|2|||
146878515|NCT00623480|529726371|FG001|Overall Study|Withdrawal by Subject|4|||
146878516|NCT00623480|529726370|FG000|Overall Study|Lack of Efficacy|1|||
146878517|NCT00623480|529726371|FG001|Overall Study|Lack of Efficacy|0|||
146878518|NCT00623480|529726370|FG000|Overall Study|Non-compliant with study medication|4|||
146878519|NCT00623480|529726371|FG001|Overall Study|Non-compliant with study medication|0|||
146878520|NCT00623480|529726370|FG000|Overall Study|Protocol Violation|0|||
146878521|NCT00623480|529726371|FG001|Overall Study|Protocol Violation|1|||
146878522|NCT00623480|529726370|FG000|Overall Study|Site closed by sponsor|0|||
146878523|NCT00623480|529726371|FG001|Overall Study|Site closed by sponsor|1|||
146878524|NCT03551509|529726372|FG000|Overall Study|Lost to Follow-up|0|||
146878525|NCT03551509|529726373|FG001|Overall Study|Lost to Follow-up|1|||
146878526|NCT03551509|529726374|FG002|Overall Study|Lost to Follow-up|0|||
146878527|NCT02631200|529726375|FG000|First Period|Death|1|||
146878528|NCT02631200|529726376|FG001|First Period|Death|2|||
146878529|NCT02631200|529726375|FG000|First Period|Patient ill-health|2|||
146878530|NCT02631200|529726376|FG001|First Period|Patient ill-health|4|||
146878531|NCT02631200|529726375|FG000|First Period|Withdrawal by Subject|4|||
146878532|NCT02631200|529726376|FG001|First Period|Withdrawal by Subject|1|||
146878533|NCT02631200|529726375|FG000|Deferred Period|Death|0|||
146878534|NCT02631200|529726376|FG001|Deferred Period|Death|1|||
146878535|NCT02631200|529726375|FG000|Deferred Period|Received kidney transplant|0|||
146878536|NCT02631200|529726376|FG001|Deferred Period|Received kidney transplant|1|||
146878537|NCT02631200|529726375|FG000|Deferred Period|Withdrawal by Subject|0|||
146878538|NCT02631200|529726376|FG001|Deferred Period|Withdrawal by Subject|2|||
146629433|NCT00696072|528819722|FG000|Overall Study|Disease Progression|32|||
146629434|NCT00696072|528819723|FG001|Overall Study|Disease Progression|30|||
146765024|NCT03201809|529307216|FG001|Overall Study|Lost to Follow-up|0|||
146878539|NCT02631200|529726375|FG000|Deferred Period|Lost to Follow-up|0|||
146878540|NCT02631200|529726376|FG001|Deferred Period|Lost to Follow-up|1|||
146878541|NCT01877187|529726377|FG000|Overall Study|Death|2|||
146878542|NCT01877187|529726377|FG000|Overall Study|Withdrawal by Subject|4|||
146878543|NCT01877187|529726377|FG000|Overall Study|Lost to Follow-up|3|||
146878544|NCT01877187|529726377|FG000|Overall Study|Declining clinical status|11|||
146509100|NCT00250458|528367731|FG001|Overall Study|Lost to Follow-up|2|||
146878545|NCT01877187|529726377|FG000|Overall Study|Liver transplant|2|||
146878546|NCT00769002|529726379|FG000|Overall Study|Study was not completed, no data|9|||
146878547|NCT00769002|529726380|FG001|Overall Study|Study was not completed, no data|9|||
146878548|NCT02699892|529726382|FG000|Overall Study|Other|36|||
146544972|NCT00429299|528501920|FG002|Overall Study|Protocol Violation|0|||
146544973|NCT00429299|528501918|FG000|Overall Study|Withdrawal by Subject|0|||
146544974|NCT00429299|528501919|FG001|Overall Study|Withdrawal by Subject|1|||
146544975|NCT00429299|528501920|FG002|Overall Study|Withdrawal by Subject|3|||
146544976|NCT01510756|528501921|FG000|Overall Study|Death|1|||
146544977|NCT01510756|528501921|FG000|Overall Study|Lack of Efficacy|2|||
146544978|NCT01510756|528501921|FG000|Overall Study|Physician Decision|1|||
146544979|NCT02202616|528501923|FG000|Overall Study|Screen failed|24|||
146544980|NCT02202616|528501923|FG000|Overall Study|Adverse Event|32|||
146544981|NCT02202616|528501923|FG000|Overall Study|Protocol deviation|18|||
146544982|NCT02202616|528501923|FG000|Overall Study|Patient withdrew consent|12|||
146544983|NCT02202616|528501923|FG000|Overall Study|Lost to Follow-up|6|||
146544984|NCT02202616|528501923|FG000|Overall Study|Administrative problems|6|||
146544985|NCT02202616|528501923|FG000|Overall Study|Abnormal test procedure result|1|||
146544986|NCT02202616|528501923|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146544987|NCT03244189|528501926|FG000|Overall Study|Death|0|||
146544988|NCT03244189|528501927|FG001|Overall Study|Death|2|||
146544989|NCT03244189|528501926|FG000|Overall Study|Lost to Follow-up|92|||
146544990|NCT03244189|528501927|FG001|Overall Study|Lost to Follow-up|107|||
146544991|NCT03244189|528501926|FG000|Overall Study|Physician Decision|4|||
146544992|NCT03244189|528501927|FG001|Overall Study|Physician Decision|2|||
146544993|NCT03244189|528501926|FG000|Overall Study|Pregnancy|7|||
146544994|NCT03244189|528501927|FG001|Overall Study|Pregnancy|5|||
146544995|NCT03244189|528501926|FG000|Overall Study|Protocol Violation|0|||
146544996|NCT03244189|528501927|FG001|Overall Study|Protocol Violation|2|||
146544997|NCT03244189|528501926|FG000|Overall Study|Withdrawal by Subject|45|||
146544998|NCT03244189|528501927|FG001|Overall Study|Withdrawal by Subject|23|||
146544999|NCT03244189|528501926|FG000|Overall Study|Technical Problems|2|||
146629435|NCT00696072|528819722|FG000|Overall Study|Non-specified|1|||
146629436|NCT00696072|528819723|FG001|Overall Study|Non-specified|2|||
146629437|NCT01597596|528819724|FG000|Overall Study|Study terminated by sponsor|1|||
146629438|NCT01597596|528819725|FG001|Overall Study|Study terminated by sponsor|0|||
146629439|NCT01597596|528819724|FG000|Overall Study|Physician Decision|0|||
146765025|NCT00957658|529307217|FG000|Overall Study|Death|1|||
146878549|NCT04677712|529726383|FG000|Overall Study|Lost to Follow-up|0|||
146878550|NCT04677712|529726384|FG001|Overall Study|Lost to Follow-up|1|||
146878551|NCT04677712|529726385|FG002|Overall Study|Lost to Follow-up|0|||
146878552|NCT04677712|529726386|FG003|Overall Study|Lost to Follow-up|0|||
146878553|NCT04677712|529726387|FG004|Overall Study|Lost to Follow-up|0|||
146878554|NCT04677712|529726388|FG005|Overall Study|Lost to Follow-up|0|||
146878555|NCT00711100|529726389|FG000|Overall Study|Lack of Efficacy|5|||
146878556|NCT00711100|529726389|FG000|Overall Study|Withdrawal by Subject|8|||
146878557|NCT00847912|529726390|FG000|Overall Study|Protocol Violation|6|||
146878558|NCT00847912|529726391|FG001|Overall Study|Protocol Violation|7|||
146878559|NCT00847912|529726390|FG000|Overall Study|Withdrawal by Subject|3|||
146878560|NCT00847912|529726391|FG001|Overall Study|Withdrawal by Subject|6|||
146878561|NCT00783094|529726392|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
146629440|NCT01597596|528819725|FG001|Overall Study|Physician Decision|1|||
146629441|NCT00992108|528819732|FG000|Overall Study|Lost to Follow-up|0|||
146629442|NCT00992108|528819733|FG001|Overall Study|Lost to Follow-up|1|||
146629443|NCT04639245|528819734|FG000|Overall Study|Death|1|||
146629444|NCT02419001|528819737|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
146629445|NCT02419001|528819738|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
146629446|NCT00535496|528819739|FG000|Overall Study|Lost to Follow-up|0|||
146509101|NCT00250458|528367730|FG000|Overall Study|Protocol Violation|0|||
146878562|NCT00783094|529726393|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
146878563|NCT00783094|529726394|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
146878564|NCT00783094|529726392|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
146878565|NCT00783094|529726393|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
146878566|NCT00783094|529726394|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
146878567|NCT00783094|529726392|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
146878568|NCT00783094|529726393|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
146878569|NCT00783094|529726394|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
146878570|NCT00783094|529726392|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
146878571|NCT00783094|529726393|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
146878572|NCT00783094|529726394|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
146545000|NCT03244189|528501927|FG001|Overall Study|Technical Problems|0|||
146545001|NCT03611946|528501928|FG000|Overall Study|Withdrawal by Subject|0|||
146545002|NCT03611946|528501929|FG001|Overall Study|Withdrawal by Subject|0|||
146545003|NCT03611946|528501930|FG002|Overall Study|Withdrawal by Subject|1|||
146545004|NCT03611946|528501931|FG003|Overall Study|Withdrawal by Subject|0|||
146545005|NCT02872714|528501935|FG000|Overall Study|Progressive Disease|1|||
146765026|NCT00957658|529307217|FG000|Overall Study|Lost to Follow-up|4|||
146765027|NCT00957658|529307217|FG000|Overall Study|Withdrawal by Subject|12|||
146765028|NCT00957658|529307217|FG000|Overall Study|Revision|1|||
146545006|NCT02872714|528501936|FG001|Overall Study|Progressive Disease|2|||
146765029|NCT00957658|529307217|FG000|Overall Study|Incomplete 2 yr data|28|||
146878573|NCT00783094|529726392|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
146878574|NCT00783094|529726393|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
146878575|NCT00783094|529726394|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
146878576|NCT00783094|529726392|FG000|Open-Label Extension Period|Adverse Event|12|||
146878577|NCT00783094|529726393|FG001|Open-Label Extension Period|Adverse Event|7|||
146878578|NCT00783094|529726394|FG002|Open-Label Extension Period|Adverse Event|16|||
146878579|NCT00783094|529726392|FG000|Open-Label Extension Period|Death|0|||
146878580|NCT00783094|529726393|FG001|Open-Label Extension Period|Death|0|||
146878581|NCT00783094|529726394|FG002|Open-Label Extension Period|Death|1|||
146878582|NCT00783094|529726392|FG000|Open-Label Extension Period|Protocol Violation|4|||
146878583|NCT00783094|529726393|FG001|Open-Label Extension Period|Protocol Violation|5|||
146878584|NCT00783094|529726394|FG002|Open-Label Extension Period|Protocol Violation|7|||
146878585|NCT00783094|529726392|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
146878586|NCT00783094|529726393|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
146878587|NCT00783094|529726394|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
146878588|NCT00783094|529726392|FG000|Open-Label Extension Period|Physician Decision|4|||
146878589|NCT00783094|529726393|FG001|Open-Label Extension Period|Physician Decision|2|||
146878590|NCT00783094|529726394|FG002|Open-Label Extension Period|Physician Decision|3|||
146878591|NCT00783094|529726392|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
146878592|NCT00783094|529726393|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
146878593|NCT00783094|529726394|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
146878594|NCT02513329|529726395|FG000|Overall Study|Lost to Follow-up|5|||
146878595|NCT02513329|529726396|FG001|Overall Study|Lost to Follow-up|2|||
146878596|NCT01294670|529726397|FG000|Overall Study|Not treated|1|||
146878597|NCT01294670|529726398|FG001|Overall Study|Not treated|0|||
146878598|NCT01294670|529726399|FG002|Overall Study|Not treated|0|||
146878599|NCT01294670|529726400|FG003|Overall Study|Not treated|0|||
146878600|NCT01294670|529726401|FG004|Overall Study|Not treated|0|||
146878601|NCT04091087|529726403|FG000|Overall Study|Not treated|1|||
146878602|NCT04091087|529726404|FG001|Overall Study|Not treated|0|||
146878603|NCT04091087|529726403|FG000|Overall Study|Adverse Event|4|||
146878604|NCT04091087|529726404|FG001|Overall Study|Adverse Event|4|||
146878605|NCT04091087|529726403|FG000|Overall Study|Protocol Violation|0|||
146878606|NCT04091087|529726404|FG001|Overall Study|Protocol Violation|1|||
146878607|NCT04091087|529726403|FG000|Overall Study|Withdrawal by Subject|5|||
146878608|NCT04091087|529726404|FG001|Overall Study|Withdrawal by Subject|2|||
146878609|NCT03808077|529726405|FG000|Overall Study|Physician Decision|2|||
146878610|NCT03808077|529726406|FG001|Overall Study|Physician Decision|3|||
146878611|NCT03808077|529726405|FG000|Overall Study|Withdrawal by Subject|1|||
146878612|NCT03808077|529726406|FG001|Overall Study|Withdrawal by Subject|0|||
146878613|NCT03808077|529726405|FG000|Overall Study|Equipment Issues|2|||
146878614|NCT03808077|529726406|FG001|Overall Study|Equipment Issues|1|||
146878615|NCT04152161|529726407|FG000|Overall Study|Death|0|||
146878616|NCT04152161|529726408|FG001|Overall Study|Death|1|||
146878617|NCT04152161|529726407|FG000|Overall Study|Physician Decision|0|||
146878618|NCT04152161|529726408|FG001|Overall Study|Physician Decision|1|||
146878619|NCT04152161|529726407|FG000|Overall Study|Lost to Follow-up|9|||
146878620|NCT04152161|529726408|FG001|Overall Study|Lost to Follow-up|3|||
146878621|NCT04152161|529726407|FG000|Overall Study|Protocol Violation|1|||
146878622|NCT04152161|529726408|FG001|Overall Study|Protocol Violation|0|||
146878623|NCT04152161|529726407|FG000|Overall Study|Withdrawal by Subject|29|||
146878624|NCT04152161|529726408|FG001|Overall Study|Withdrawal by Subject|28|||
146878625|NCT04152161|529726407|FG000|Overall Study|Sponsor termination of study|750|||
146878626|NCT04152161|529726408|FG001|Overall Study|Sponsor termination of study|755|||
146878627|NCT04152161|529726407|FG000|Overall Study|Other|20|||
146878628|NCT04152161|529726408|FG001|Overall Study|Other|18|||
146878629|NCT00001379|529726409|FG000|Initial Treatment|Disease progression|21|||
146878630|NCT00001379|529726410|FG001|Initial Treatment|Disease progression|3|||
146878631|NCT00001379|529726411|FG002|Initial Treatment|Disease progression|0|||
146878632|NCT00001379|529726412|FG003|Initial Treatment|Disease progression|0|||
146878633|NCT00001379|529726409|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
146878634|NCT00001379|529726410|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
146878635|NCT00001379|529726411|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
146878636|NCT00001379|529726412|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
146878637|NCT00001379|529726409|FG000|Initial Treatment|Received alternative treatment|2|||
146878638|NCT00001379|529726410|FG001|Initial Treatment|Received alternative treatment|1|||
146878639|NCT00001379|529726411|FG002|Initial Treatment|Received alternative treatment|0|||
146878640|NCT00001379|529726412|FG003|Initial Treatment|Received alternative treatment|0|||
146878641|NCT00001379|529726409|FG000|Initial Treatment|Refused further treatment|2|||
146878642|NCT00001379|529726410|FG001|Initial Treatment|Refused further treatment|0|||
146878643|NCT00001379|529726411|FG002|Initial Treatment|Refused further treatment|0|||
146878644|NCT00001379|529726412|FG003|Initial Treatment|Refused further treatment|0|||
146878645|NCT00001379|529726409|FG000|Initial Treatment|Did not receive protocol treatment|0|||
146878646|NCT00001379|529726410|FG001|Initial Treatment|Did not receive protocol treatment|0|||
146878647|NCT00001379|529726411|FG002|Initial Treatment|Did not receive protocol treatment|5|||
146878648|NCT00001379|529726412|FG003|Initial Treatment|Did not receive protocol treatment|0|||
146878649|NCT00001379|529726409|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
146878650|NCT00001379|529726410|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
146878651|NCT00001379|529726411|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
146878652|NCT00001379|529726412|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
146629447|NCT00535496|528819740|FG001|Overall Study|Lost to Follow-up|1|||
146629448|NCT00535496|528819741|FG002|Overall Study|Lost to Follow-up|0|||
146629449|NCT00535496|528819742|FG003|Overall Study|Lost to Follow-up|0|||
146629450|NCT00535496|528819739|FG000|Overall Study|Not treated with sugammadex|0|||
146629451|NCT00535496|528819740|FG001|Overall Study|Not treated with sugammadex|1|||
146629452|NCT00535496|528819741|FG002|Overall Study|Not treated with sugammadex|0|||
146629453|NCT00535496|528819742|FG003|Overall Study|Not treated with sugammadex|0|||
146629454|NCT03591406|528819744|FG000|Overall Study|Adverse Event|5|||
146629455|NCT03591406|528819745|FG001|Overall Study|Adverse Event|3|||
146629456|NCT03591406|528819744|FG000|Overall Study|Protocol Violation|2|||
146629457|NCT03591406|528819745|FG001|Overall Study|Protocol Violation|1|||
146545007|NCT02872714|528501937|FG002|Overall Study|Progressive Disease|0|||
146545008|NCT02872714|528501938|FG003|Overall Study|Progressive Disease|0|||
146545009|NCT02872714|528501939|FG004|Overall Study|Progressive Disease|0|||
146545010|NCT02872714|528501935|FG000|Overall Study|Death|87|||
146545011|NCT02872714|528501936|FG001|Overall Study|Death|36|||
146545012|NCT02872714|528501937|FG002|Overall Study|Death|8|||
146545013|NCT02872714|528501938|FG003|Overall Study|Death|81|||
146545014|NCT02872714|528501939|FG004|Overall Study|Death|2|||
146545015|NCT02872714|528501935|FG000|Overall Study|Lost to Follow-up|2|||
146545016|NCT02872714|528501936|FG001|Overall Study|Lost to Follow-up|1|||
146545017|NCT02872714|528501937|FG002|Overall Study|Lost to Follow-up|0|||
146545018|NCT02872714|528501938|FG003|Overall Study|Lost to Follow-up|3|||
146545019|NCT02872714|528501939|FG004|Overall Study|Lost to Follow-up|0|||
146545020|NCT02872714|528501935|FG000|Overall Study|Physician Decision|0|||
146545021|NCT02872714|528501936|FG001|Overall Study|Physician Decision|0|||
146545022|NCT02872714|528501937|FG002|Overall Study|Physician Decision|0|||
146545023|NCT02872714|528501938|FG003|Overall Study|Physician Decision|1|||
146629458|NCT03591406|528819744|FG000|Overall Study|Withdrawal by Subject|0|||
146545024|NCT02872714|528501939|FG004|Overall Study|Physician Decision|0|||
146545025|NCT02872714|528501935|FG000|Overall Study|Withdrawal by Subject|1|||
146545026|NCT02872714|528501936|FG001|Overall Study|Withdrawal by Subject|3|||
146545027|NCT02872714|528501937|FG002|Overall Study|Withdrawal by Subject|0|||
146545028|NCT02872714|528501938|FG003|Overall Study|Withdrawal by Subject|2|||
146545029|NCT02872714|528501939|FG004|Overall Study|Withdrawal by Subject|0|||
146545030|NCT02872714|528501935|FG000|Overall Study|Captured as Other|2|||
146878653|NCT00001379|529726409|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
146878654|NCT00001379|529726410|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
146545031|NCT02872714|528501936|FG001|Overall Study|Captured as Other|0|||
146545032|NCT02872714|528501937|FG002|Overall Study|Captured as Other|0|||
146629459|NCT03591406|528819745|FG001|Overall Study|Withdrawal by Subject|5|||
146545033|NCT02872714|528501938|FG003|Overall Study|Captured as Other|1|||
146545034|NCT02872714|528501939|FG004|Overall Study|Captured as Other|0|||
146545035|NCT03599713|528501945|FG000|Overall Study|Death|38|||
146545036|NCT03599713|528501946|FG001|Overall Study|Death|3|||
146545037|NCT03599713|528501945|FG000|Overall Study|Withdrawal by Subject|17|||
146545038|NCT03599713|528501946|FG001|Overall Study|Withdrawal by Subject|0|||
146545039|NCT03599713|528501945|FG000|Overall Study|Lost to Follow-up|4|||
146545040|NCT03599713|528501946|FG001|Overall Study|Lost to Follow-up|0|||
146545041|NCT03599713|528501945|FG000|Overall Study|Discontinued Due to End of Study|42|||
146545042|NCT03599713|528501946|FG001|Overall Study|Discontinued Due to End of Study|3|||
146545043|NCT03580928|528501951|FG000|Overall Study|Death|0|||
146545044|NCT03580928|528501952|FG001|Overall Study|Death|3|||
146545045|NCT03580928|528501951|FG000|Overall Study|Withdrawal by Subject|2|||
146545046|NCT03580928|528501952|FG001|Overall Study|Withdrawal by Subject|1|||
146545047|NCT03580928|528501951|FG000|Overall Study|Lost to Follow-up|2|||
146545048|NCT03580928|528501952|FG001|Overall Study|Lost to Follow-up|0|||
146545049|NCT03580928|528501951|FG000|Overall Study|Progressive Disease|0|||
146545050|NCT03580928|528501952|FG001|Overall Study|Progressive Disease|1|||
146545051|NCT01565694|528503010|FG000|Dose-Titration Period|Adverse Event|4|||
146545052|NCT01565694|528503010|FG000|Dose-Titration Period|Protocol Violation|10|||
146545053|NCT01565694|528503010|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
146545054|NCT01373229|528503011|FG000|Overall Study|Death|3|||
146545055|NCT01373229|528503011|FG000|Overall Study|Physician Decision|3|||
146545056|NCT03234881|528503013|FG000|Overall Study|Lost to Follow-up|9|||
146545057|NCT03234881|528503014|FG001|Overall Study|Lost to Follow-up|3|||
146545058|NCT03807843|528503015|FG000|Overall Study|Lost to Follow-up|1|||
146545059|NCT03807843|528503016|FG001|Overall Study|Lost to Follow-up|0|||
146545060|NCT01312129|528503017|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
146545061|NCT01312129|528503018|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
146545062|NCT03720847|528503019|FG000|Washout|Physician Decision|1|||
146545063|NCT03720847|528503020|FG001|Washout|Physician Decision|2|||
146545064|NCT02636283|528503023|FG000|Overall Study|Adverse Event|2|||
146545065|NCT02636283|528503024|FG001|Overall Study|Adverse Event|0|||
146545066|NCT02636283|528503023|FG000|Overall Study|Trial Terminated Prematurely|0|||
146545067|NCT02636283|528503024|FG001|Overall Study|Trial Terminated Prematurely|3|||
146545068|NCT03418675|528503025|FG000|Overall Study|Lost to Follow-up|13|||
146545069|NCT03418675|528503026|FG001|Overall Study|Lost to Follow-up|10|||
146545070|NCT03418675|528503025|FG000|Overall Study|Adverse Event|2|||
146545071|NCT03418675|528503026|FG001|Overall Study|Adverse Event|0|||
146545072|NCT01178411|528503027|FG000|Overall Study|Adverse Event|5|||
146878655|NCT00001379|529726411|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
146629460|NCT01083771|528819746|FG000|Overall Study|non-compliant|2|||
146878656|NCT00001379|529726412|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
146545073|NCT01178411|528503027|FG000|Overall Study|Withdrawal by Subject|4|||
146545074|NCT01178411|528503027|FG000|Overall Study|Protocol Violation|1|||
146545075|NCT01178411|528503027|FG000|Overall Study|Progressive disease per RECIST|32|||
146545076|NCT01178411|528503027|FG000|Overall Study|Progressive disease per clinician|9|||
146878657|NCT00001379|529726409|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
146878658|NCT00001379|529726410|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
146878659|NCT00001379|529726411|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
146878660|NCT00001379|529726412|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
146878661|NCT00001379|529726409|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
146878662|NCT00001379|529726410|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
146878663|NCT00001379|529726411|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
146878664|NCT00001379|529726412|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
146878665|NCT00001379|529726409|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
146878666|NCT00001379|529726410|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
146878667|NCT00001379|529726411|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
146878668|NCT00001379|529726412|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
146878669|NCT03703102|529726417|FG000|Overall Study|Adverse Event|4|||
146878670|NCT03703102|529726418|FG001|Overall Study|Adverse Event|3|||
146878671|NCT03703102|529726419|FG002|Overall Study|Adverse Event|7|||
146878672|NCT03703102|529726420|FG003|Overall Study|Adverse Event|3|||
146878673|NCT03703102|529726421|FG004|Overall Study|Adverse Event|13|||
146878674|NCT03703102|529726417|FG000|Overall Study|Lack of Efficacy|4|||
146878675|NCT03703102|529726418|FG001|Overall Study|Lack of Efficacy|0|||
146878676|NCT03703102|529726419|FG002|Overall Study|Lack of Efficacy|1|||
146878677|NCT03703102|529726420|FG003|Overall Study|Lack of Efficacy|4|||
146878678|NCT03703102|529726421|FG004|Overall Study|Lack of Efficacy|1|||
146878679|NCT03703102|529726417|FG000|Overall Study|Lost to Follow-up|0|||
146878680|NCT03703102|529726418|FG001|Overall Study|Lost to Follow-up|0|||
146878681|NCT03703102|529726419|FG002|Overall Study|Lost to Follow-up|1|||
146878682|NCT03703102|529726420|FG003|Overall Study|Lost to Follow-up|2|||
146878683|NCT03703102|529726421|FG004|Overall Study|Lost to Follow-up|2|||
146878684|NCT03703102|529726417|FG000|Overall Study|Physician Decision|2|||
146878685|NCT03703102|529726418|FG001|Overall Study|Physician Decision|2|||
146878686|NCT03703102|529726419|FG002|Overall Study|Physician Decision|2|||
146878687|NCT03703102|529726420|FG003|Overall Study|Physician Decision|2|||
146878688|NCT03703102|529726421|FG004|Overall Study|Physician Decision|4|||
146878689|NCT03703102|529726417|FG000|Overall Study|Withdrawal by Subject|7|||
146878690|NCT03703102|529726418|FG001|Overall Study|Withdrawal by Subject|5|||
146878691|NCT03703102|529726419|FG002|Overall Study|Withdrawal by Subject|5|||
146878692|NCT03703102|529726420|FG003|Overall Study|Withdrawal by Subject|5|||
146878693|NCT03703102|529726421|FG004|Overall Study|Withdrawal by Subject|9|||
146878694|NCT03703102|529726417|FG000|Overall Study|Ineligibility|0|||
146878695|NCT03703102|529726418|FG001|Overall Study|Ineligibility|0|||
146878696|NCT03703102|529726419|FG002|Overall Study|Ineligibility|1|||
146545077|NCT01178411|528503027|FG000|Overall Study|Physician Decision|6|||
146545078|NCT01178411|528503027|FG000|Overall Study|Death|1|||
146545079|NCT01178411|528503027|FG000|Overall Study|No reason provided|1|||
146545080|NCT01178411|528503027|FG000|Overall Study|Drug manufacturing ended|1|||
146545081|NCT02383173|528503031|FG000|Overall Study|Palliative Care Team withdrew|0|||
146545082|NCT02383173|528503032|FG001|Overall Study|Palliative Care Team withdrew|2|||
146545083|NCT04900272|528503033|FG000|Overall Study|Lost to Follow-up|2|||
146545084|NCT04900272|528503033|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
146545085|NCT04900272|528503033|FG000|Overall Study|Withdrawal by Subject|1|||
146545086|NCT01625182|528503034|FG000|Overall Study|Administrative problems|1|||
146545087|NCT01625182|528503035|FG001|Overall Study|Administrative problems|0|||
146545088|NCT01625182|528503034|FG000|Overall Study|Protocol deviation|0|||
146545089|NCT01625182|528503035|FG001|Overall Study|Protocol deviation|2|||
146545090|NCT01625182|528503034|FG000|Overall Study|Adverse Event|2|||
146545091|NCT01625182|528503035|FG001|Overall Study|Adverse Event|0|||
146545092|NCT01625182|528503034|FG000|Overall Study|Withdrawal by Subject|5|||
146545093|NCT01625182|528503035|FG001|Overall Study|Withdrawal by Subject|1|||
146545094|NCT01625182|528503034|FG000|Overall Study|Lack of Efficacy|12|||
146545095|NCT01625182|528503035|FG001|Overall Study|Lack of Efficacy|8|||
146878697|NCT03703102|529726420|FG003|Overall Study|Ineligibility|0|||
146878698|NCT03703102|529726421|FG004|Overall Study|Ineligibility|0|||
146878699|NCT03703102|529726417|FG000|Overall Study|Protocol Deviation|4|||
146878700|NCT03703102|529726418|FG001|Overall Study|Protocol Deviation|4|||
146878701|NCT03703102|529726419|FG002|Overall Study|Protocol Deviation|3|||
146545096|NCT00263562|528503036|FG000|Overall Study|Protocol Violation|3|||
146545097|NCT00263562|528503037|FG001|Overall Study|Protocol Violation|0|||
146545098|NCT05059080|528503038|FG000|Overall Study|Withdrawal by Subject|3|||
146545099|NCT05059080|528503038|FG000|Overall Study|Study Terminated by Sponsor|64|||
146545100|NCT01922011|528503039|FG000|Overall Study|Protocol Violation|0|||
146545101|NCT01922011|528503040|FG001|Overall Study|Protocol Violation|1|||
146545102|NCT01922011|528503039|FG000|Overall Study|Physician Decision|0|||
146545103|NCT01922011|528503040|FG001|Overall Study|Physician Decision|1|||
146545104|NCT01922011|528503039|FG000|Overall Study|Parent/Guardian Decision|3|||
146545105|NCT01922011|528503040|FG001|Overall Study|Parent/Guardian Decision|0|||
146545106|NCT01922011|528503039|FG000|Overall Study|Lost to Follow-up|0|||
146545107|NCT01922011|528503040|FG001|Overall Study|Lost to Follow-up|1|||
146545108|NCT01922011|528503039|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
146545109|NCT01922011|528503040|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
146545110|NCT01922011|528503039|FG000|Overall Study|Not Treated|1|||
146545111|NCT01922011|528503040|FG001|Overall Study|Not Treated|0|||
146545112|NCT01922011|528503039|FG000|Overall Study|Lack of willing home health agency|1|||
146545113|NCT01922011|528503040|FG001|Overall Study|Lack of willing home health agency|0|||
146545114|NCT01922011|528503039|FG000|Overall Study|Randomized in error|1|||
146545115|NCT01922011|528503040|FG001|Overall Study|Randomized in error|0|||
146545116|NCT04871113|528503041|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
146545117|NCT04871113|528503042|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
146545118|NCT04871113|528503043|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
146545119|NCT04871113|528503044|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
146545120|NCT04871113|528503045|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
146545121|NCT04871113|528503046|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
146545122|NCT04871113|528503047|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
146545123|NCT04871113|528503048|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
146545124|NCT04871113|528503049|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
146545125|NCT04871113|528503050|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
146545126|NCT04871113|528503041|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
146545127|NCT04871113|528503042|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
146545128|NCT04871113|528503043|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
146545129|NCT04871113|528503044|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
146878702|NCT03703102|529726420|FG003|Overall Study|Protocol Deviation|0|||
146878703|NCT03703102|529726421|FG004|Overall Study|Protocol Deviation|0|||
146545130|NCT04871113|528503045|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
146545131|NCT04871113|528503046|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
146545132|NCT04871113|528503047|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
146878704|NCT03703102|529726417|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146878705|NCT03703102|529726418|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146878706|NCT03703102|529726419|FG002|Overall Study|Non-Compliance with Study Drug|2|||
146878707|NCT03703102|529726420|FG003|Overall Study|Non-Compliance with Study Drug|1|||
146878708|NCT03703102|529726421|FG004|Overall Study|Non-Compliance with Study Drug|4|||
146878709|NCT02311153|529726422|FG000|Overall Study|Lost to Follow-up|5|||
146878710|NCT02311153|529726423|FG001|Overall Study|Lost to Follow-up|7|||
146878711|NCT00876187|529726424|FG000|Overall Study|Adverse Event|14|||
146878712|NCT00876187|529726425|FG001|Overall Study|Adverse Event|12|||
146878713|NCT00876187|529726426|FG002|Overall Study|Adverse Event|19|||
146629461|NCT01083771|528819746|FG000|Overall Study|Withdrawal by Subject|3|||
146629462|NCT00321620|528819749|FG000|Overall Study|Death|269|||
146629463|NCT00321620|528819750|FG001|Overall Study|Death|294|||
146629464|NCT00321620|528819749|FG000|Overall Study|Withdrawal by Subject|164|||
146629465|NCT00321620|528819750|FG001|Overall Study|Withdrawal by Subject|147|||
146629466|NCT00321620|528819749|FG000|Overall Study|Disease progression|113|||
146629467|NCT00321620|528819750|FG001|Overall Study|Disease progression|117|||
146629468|NCT00321620|528819749|FG000|Overall Study|Adverse Event|43|||
146629469|NCT00321620|528819750|FG001|Overall Study|Adverse Event|56|||
146629470|NCT00321620|528819749|FG000|Overall Study|Lost to Follow-up|13|||
146629471|NCT00321620|528819750|FG001|Overall Study|Lost to Follow-up|9|||
146629472|NCT00321620|528819749|FG000|Overall Study|Physician Decision|4|||
146629473|NCT00321620|528819750|FG001|Overall Study|Physician Decision|1|||
146878714|NCT00876187|529726427|FG003|Overall Study|Adverse Event|29|||
146878715|NCT00876187|529726428|FG004|Overall Study|Adverse Event|10|||
146545133|NCT04871113|528503048|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
146545134|NCT04871113|528503049|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
146545135|NCT04871113|528503050|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
146545136|NCT01239745|528503051|FG000|Overall Study|Study terminated by sponsor|45|||
146545137|NCT01239745|528503051|FG000|Overall Study|Adverse Event|1|||
146545138|NCT01257542|528503056|FG000|Overall Study|Protocol Violation|3|||
146545139|NCT01257542|528503057|FG001|Overall Study|Protocol Violation|5|||
146545140|NCT01257542|528503056|FG000|Overall Study|Withdrawal by Subject|0|||
146545141|NCT01257542|528503057|FG001|Overall Study|Withdrawal by Subject|2|||
146545142|NCT00081458|528503058|FG000|Overall Study|Adverse Event|1|||
146545143|NCT00081458|528503059|FG001|Overall Study|Adverse Event|5|||
146545144|NCT00081458|528503060|FG002|Overall Study|Adverse Event|2|||
146545145|NCT00081458|528503058|FG000|Overall Study|Withdrawal by Subject|0|||
146545146|NCT00081458|528503059|FG001|Overall Study|Withdrawal by Subject|3|||
146545147|NCT00081458|528503060|FG002|Overall Study|Withdrawal by Subject|1|||
146545148|NCT00081458|528503058|FG000|Overall Study|Randomized but not dosed|0|||
146545149|NCT00081458|528503059|FG001|Overall Study|Randomized but not dosed|0|||
146545150|NCT00081458|528503060|FG002|Overall Study|Randomized but not dosed|1|||
146545151|NCT00549328|528503064|FG000|Overall Study|Adverse Event|2|||
146545152|NCT00549328|528503064|FG000|Overall Study|Disease Progression|10|||
146545153|NCT00549328|528503064|FG000|Overall Study|Death|1|||
146545154|NCT00549328|528503064|FG000|Overall Study|Use of Prohibited Medication|1|||
146545155|NCT00770484|528503065|FG000|Overall Study|Withdrawal by Subject|1|||
146545156|NCT00770484|528503066|FG001|Overall Study|Withdrawal by Subject|0|||
146545157|NCT03097315|528503071|FG000|Overall Study|Withdrawal by Subject|1|||
146545158|NCT01946802|528503072|FG000|Overall Study|Death|1|||
146545159|NCT01946802|528503072|FG000|Overall Study|Withdrawal by Subject|2|||
146545160|NCT01946802|528503072|FG000|Overall Study|Combined septic shock|1|||
146545161|NCT01946802|528503072|FG000|Overall Study|Protocol Violation|1|||
146545162|NCT00153920|528503073|FG000|Overall Study|Adverse Event|9|||
146545163|NCT00153920|528503073|FG000|Overall Study|Progressive Disease|9|||
146629474|NCT00321620|528819749|FG000|Overall Study|Noncompliance|14|||
146629475|NCT00321620|528819750|FG001|Overall Study|Noncompliance|7|||
146629476|NCT00321620|528819749|FG000|Overall Study|Protocol deviation|4|||
146629477|NCT00321620|528819750|FG001|Overall Study|Protocol deviation|3|||
146545164|NCT00153920|528503073|FG000|Overall Study|Physician Decision|3|||
146545165|NCT00153920|528503073|FG000|Overall Study|Lack of Response|3|||
146545166|NCT00153920|528503073|FG000|Overall Study|Death|2|||
146545167|NCT00153920|528503073|FG000|Overall Study|Withdrawal by Subject|1|||
146878716|NCT00876187|529726424|FG000|Overall Study|Lack of Efficacy|59|||
146878717|NCT00876187|529726425|FG001|Overall Study|Lack of Efficacy|34|||
146878718|NCT00876187|529726426|FG002|Overall Study|Lack of Efficacy|45|||
146878719|NCT00876187|529726427|FG003|Overall Study|Lack of Efficacy|34|||
146878720|NCT00876187|529726428|FG004|Overall Study|Lack of Efficacy|59|||
146878721|NCT00876187|529726424|FG000|Overall Study|Lost to Follow-up|9|||
146878722|NCT00876187|529726425|FG001|Overall Study|Lost to Follow-up|10|||
146878723|NCT00876187|529726426|FG002|Overall Study|Lost to Follow-up|8|||
146878724|NCT00876187|529726427|FG003|Overall Study|Lost to Follow-up|8|||
146878725|NCT00876187|529726428|FG004|Overall Study|Lost to Follow-up|11|||
146878726|NCT00876187|529726424|FG000|Overall Study|Protocol Violation|6|||
146878727|NCT00876187|529726425|FG001|Overall Study|Protocol Violation|7|||
146878728|NCT00876187|529726426|FG002|Overall Study|Protocol Violation|7|||
146878729|NCT00876187|529726427|FG003|Overall Study|Protocol Violation|6|||
146878730|NCT00876187|529726428|FG004|Overall Study|Protocol Violation|3|||
146878731|NCT00876187|529726424|FG000|Overall Study|Withdrawal by Subject|16|||
146878732|NCT00876187|529726425|FG001|Overall Study|Withdrawal by Subject|26|||
146878733|NCT00876187|529726426|FG002|Overall Study|Withdrawal by Subject|32|||
146878734|NCT00876187|529726427|FG003|Overall Study|Withdrawal by Subject|38|||
146878735|NCT00876187|529726428|FG004|Overall Study|Withdrawal by Subject|37|||
146878736|NCT00876187|529726424|FG000|Overall Study|Entered extension study|101|||
146878737|NCT00876187|529726425|FG001|Overall Study|Entered extension study|120|||
146878738|NCT00876187|529726426|FG002|Overall Study|Entered extension study|156|||
146878739|NCT00876187|529726427|FG003|Overall Study|Entered extension study|151|||
146878740|NCT00876187|529726428|FG004|Overall Study|Entered extension study|144|||
146878741|NCT00876187|529726424|FG000|Overall Study|Randomized but not treated|3|||
146878742|NCT00876187|529726425|FG001|Overall Study|Randomized but not treated|1|||
146878743|NCT00876187|529726426|FG002|Overall Study|Randomized but not treated|3|||
146878744|NCT00876187|529726427|FG003|Overall Study|Randomized but not treated|2|||
146878745|NCT00876187|529726428|FG004|Overall Study|Randomized but not treated|3|||
146878746|NCT00876187|529726424|FG000|Overall Study|Other|2|||
146878747|NCT00876187|529726425|FG001|Overall Study|Other|5|||
146878748|NCT00876187|529726426|FG002|Overall Study|Other|9|||
146878749|NCT00876187|529726427|FG003|Overall Study|Other|7|||
146878750|NCT00876187|529726428|FG004|Overall Study|Other|4|||
146878751|NCT00405067|529726433|FG000|Overall Study|Adverse Event|4|||
146878752|NCT00405067|529726434|FG001|Overall Study|Adverse Event|9|||
146878753|NCT00405067|529726435|FG002|Overall Study|Adverse Event|4|||
146878754|NCT00405067|529726433|FG000|Overall Study|Lost to Follow-up|0|||
146878755|NCT00405067|529726434|FG001|Overall Study|Lost to Follow-up|0|||
146878756|NCT00405067|529726435|FG002|Overall Study|Lost to Follow-up|1|||
146878757|NCT01650636|529726436|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
146878758|NCT01650636|529726437|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
146878759|NCT01650636|529726436|FG000|Washout up to 5 Months|Physician Decision|2|||
146878760|NCT01650636|529726437|FG001|Washout up to 5 Months|Physician Decision|2|||
146878761|NCT01650636|529726436|FG000|Washout up to 5 Months|Death|1|||
146878762|NCT01650636|529726437|FG001|Washout up to 5 Months|Death|0|||
146878763|NCT01650636|529726436|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
146878764|NCT01650636|529726437|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
146878765|NCT01650636|529726436|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
146878766|NCT01650636|529726437|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
146878767|NCT01650636|529726436|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
146878768|NCT01650636|529726437|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
146878769|NCT01560780|529726438|FG000|Overall Study|Death|2|||
146878770|NCT01560780|529726439|FG001|Overall Study|Death|1|||
146878771|NCT01560780|529726438|FG000|Overall Study|Patient Preference|11|||
146878772|NCT01560780|529726439|FG001|Overall Study|Patient Preference|11|||
146878773|NCT01577186|529726440|FG000|Overall Study|Adverse Event|23|||
146878774|NCT01577186|529726440|FG000|Overall Study|Death|1|||
146878775|NCT01577186|529726440|FG000|Overall Study|Lost to Follow-up|28|||
146878776|NCT01577186|529726440|FG000|Overall Study|Withdrawal by Subject|35|||
146878777|NCT01577186|529726440|FG000|Overall Study|Insufficient Response|18|||
146878778|NCT01577186|529726440|FG000|Overall Study|Ineligible to Continue|15|||
146878779|NCT01577186|529726440|FG000|Overall Study|Non-Compliant|8|||
146878780|NCT01577186|529726440|FG000|Overall Study|Other|2|||
146878781|NCT03287219|529726441|FG000|Overall Study|Protocol Violation|0|||
146878782|NCT03287219|529726442|FG001|Overall Study|Protocol Violation|2|||
146878783|NCT00957008|529726443|FG000|Overall Study|Withdrawal by Subject|13|||
146878784|NCT00957008|529726444|FG001|Overall Study|Withdrawal by Subject|10|||
146878785|NCT00957008|529726445|FG002|Overall Study|Withdrawal by Subject|12|||
146878786|NCT00957008|529726446|FG003|Overall Study|Withdrawal by Subject|16|||
146878787|NCT00957008|529726443|FG000|Overall Study|Lost to Follow-up|3|||
146878788|NCT00957008|529726444|FG001|Overall Study|Lost to Follow-up|1|||
146878789|NCT00957008|529726445|FG002|Overall Study|Lost to Follow-up|3|||
146878790|NCT00957008|529726446|FG003|Overall Study|Lost to Follow-up|4|||
146878791|NCT00957008|529726443|FG000|Overall Study|Physician Decision|1|||
146878792|NCT00957008|529726444|FG001|Overall Study|Physician Decision|0|||
146878793|NCT00957008|529726445|FG002|Overall Study|Physician Decision|1|||
146878794|NCT00957008|529726446|FG003|Overall Study|Physician Decision|1|||
146878795|NCT00957008|529726443|FG000|Overall Study|Relocated; Family conflict|4|||
146878796|NCT00957008|529726444|FG001|Overall Study|Relocated; Family conflict|1|||
146878797|NCT00957008|529726445|FG002|Overall Study|Relocated; Family conflict|1|||
146878798|NCT00957008|529726446|FG003|Overall Study|Relocated; Family conflict|3|||
146878799|NCT01118351|529726447|FG000|Overall Study|Adverse Event|3|||
146878800|NCT01118351|529726447|FG000|Overall Study|Withdrawal by Subject|1|||
146878801|NCT00811135|529726448|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
146878802|NCT00811135|529726448|FG000|Overall Study|Death|3|||
146629478|NCT00321620|528819749|FG000|Overall Study|Ineligibility determined|2|||
146629479|NCT00321620|528819750|FG001|Overall Study|Ineligibility determined|3|||
146629480|NCT00321620|528819749|FG000|Overall Study|Participant request|75|||
146629481|NCT00321620|528819750|FG001|Overall Study|Participant request|52|||
146629482|NCT00321620|528819749|FG000|Overall Study|Other|42|||
146629483|NCT00321620|528819750|FG001|Overall Study|Other|33|||
146878803|NCT00811135|529726448|FG000|Overall Study|Protocol Violation|2|||
146878804|NCT00811135|529726448|FG000|Overall Study|Violation of Selection Criteria|1|||
146878805|NCT00811135|529726448|FG000|Overall Study|Refused Treatment|1|||
146878806|NCT00811135|529726448|FG000|Overall Study|Withdrawal by Subject|3|||
146878807|NCT00811135|529726448|FG000|Overall Study|Administrative/Other Unspecified|11|||
146878808|NCT00811135|529726448|FG000|Overall Study|Ongoing|59|||
146878809|NCT02797808|529726452|FG000|Overall Study|Withdrawal by Subject|1|||
146878810|NCT02797808|529726453|FG001|Overall Study|Withdrawal by Subject|1|||
146878811|NCT02797808|529726452|FG000|Overall Study|Physician Decision|6|||
146878812|NCT02797808|529726453|FG001|Overall Study|Physician Decision|2|||
146878813|NCT02192827|529726460|FG000|Overall Study|Lost to Follow-up|25|||
146878814|NCT02192827|529726461|FG001|Overall Study|Lost to Follow-up|27|||
146878815|NCT02192827|529726460|FG000|Overall Study|Given additional steroids with admission|13|||
146878816|NCT02192827|529726461|FG001|Overall Study|Given additional steroids with admission|11|||
146878817|NCT00794677|529726466|FG000|First Intervention|Withdrawal by Subject|2|||
146878818|NCT00794677|529726467|FG001|First Intervention|Withdrawal by Subject|0|||
146878819|NCT02863809|529726468|FG000|Overall Study|Adverse Event|8|||
146878820|NCT02863809|529726469|FG001|Overall Study|Adverse Event|8|||
146629484|NCT01462370|528819754|FG000|Overall Study|Lack of Qualifying Event|1|||
146629485|NCT01462370|528819755|FG001|Overall Study|Lack of Qualifying Event|1|||
146878821|NCT02863809|529726468|FG000|Overall Study|Withdrawal by Subject|0|||
146878822|NCT02863809|529726469|FG001|Overall Study|Withdrawal by Subject|1|||
146878823|NCT02863809|529726468|FG000|Overall Study|Lost to Follow-up|1|||
146878824|NCT02863809|529726469|FG001|Overall Study|Lost to Follow-up|1|||
146878825|NCT02863809|529726468|FG000|Overall Study|Death|1|||
146878826|NCT02863809|529726469|FG001|Overall Study|Death|0|||
146878827|NCT00607386|529726470|FG000|Overall Study|Physician Decision|1|||
146878828|NCT01422915|529726473|FG000|Overall Study|Adverse Event|1|||
146878829|NCT01265797|529726474|FG000|Run-in Month|Withdrawal by Subject|0|||
146878830|NCT01265797|529726475|FG001|Run-in Month|Withdrawal by Subject|4|||
146878831|NCT01265797|529726474|FG000|Run-in Month|1st seizure during run-in month|0|||
146878832|NCT01265797|529726475|FG001|Run-in Month|1st seizure during run-in month|1|||
146878833|NCT01265797|529726474|FG000|Blinded Month|Lack of Efficacy|5|||
146878834|NCT01265797|529726475|FG001|Blinded Month|Lack of Efficacy|0|||
146878835|NCT01265797|529726474|FG000|Blinded Month|Lost to Follow-up|1|||
146878836|NCT01265797|529726475|FG001|Blinded Month|Lost to Follow-up|0|||
146878837|NCT01265797|529726474|FG000|Blinded Month|Protocol Violation|2|||
146878838|NCT01265797|529726475|FG001|Blinded Month|Protocol Violation|1|||
146878839|NCT01265797|529726474|FG000|Blinded Month|Adverse Event|2|||
146878840|NCT01265797|529726475|FG001|Blinded Month|Adverse Event|0|||
146878841|NCT01265797|529726474|FG000|Blinded Month|Diary data incomplete|0|||
146878842|NCT01265797|529726475|FG001|Blinded Month|Diary data incomplete|1|||
146878843|NCT01265797|529726474|FG000|Open Label Month|Lost to Follow-up|0|||
146878844|NCT01265797|529726475|FG001|Open Label Month|Lost to Follow-up|1|||
146878845|NCT02980224|529726476|FG000|Overall Study|Adverse Event|4|||
146878846|NCT02980224|529726477|FG001|Overall Study|Adverse Event|1|||
146878847|NCT02980224|529726476|FG000|Overall Study|Withdrawal by Subject|0|||
146878848|NCT02980224|529726477|FG001|Overall Study|Withdrawal by Subject|2|||
146878849|NCT04247061|529726478|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
146878850|NCT04247061|529726478|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
146878851|NCT04247061|529726478|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
146878852|NCT05513625|529726479|FG000|Overall Study|Withdrawal by Subject|1|||
146878853|NCT01073267|529726481|FG000|Overall Study|Disease Progression|3|||
146878854|NCT02039375|529726486|FG000|Overall Study|Lost to Follow-up|2|||
146878855|NCT01934556|529726491|FG000|Overall Study|Withdrawal by Subject|0|||
146878856|NCT01934556|529726492|FG001|Overall Study|Withdrawal by Subject|1|||
146878857|NCT01934556|529726493|FG002|Overall Study|Withdrawal by Subject|1|||
146878858|NCT01934556|529726491|FG000|Overall Study|Lost to Follow-up|4|||
146878859|NCT01934556|529726492|FG001|Overall Study|Lost to Follow-up|10|||
146878860|NCT01934556|529726493|FG002|Overall Study|Lost to Follow-up|7|||
146878861|NCT01934556|529726491|FG000|Overall Study|Death|1|||
146878862|NCT01934556|529726492|FG001|Overall Study|Death|5|||
146878863|NCT01934556|529726493|FG002|Overall Study|Death|2|||
146878864|NCT00102960|529726496|FG000|Overall Study|Death|23|||
146878865|NCT00102960|529726497|FG001|Overall Study|Death|11|||
146878866|NCT00102960|529726498|FG002|Overall Study|Death|11|||
146878867|NCT00102960|529726496|FG000|Overall Study|Lost to Follow-up|6|||
146878868|NCT00102960|529726497|FG001|Overall Study|Lost to Follow-up|12|||
146878869|NCT00102960|529726498|FG002|Overall Study|Lost to Follow-up|16|||
146878870|NCT00102960|529726496|FG000|Overall Study|Withdrawal by Subject|1|||
146878871|NCT00102960|529726497|FG001|Overall Study|Withdrawal by Subject|0|||
146878872|NCT00102960|529726498|FG002|Overall Study|Withdrawal by Subject|1|||
146914651|NCT03303339|529850048|FG006|Overall Study|Study Terminated by Sponsor|0|||
146914652|NCT03303339|529850049|FG007|Overall Study|Study Terminated by Sponsor|0|||
146914653|NCT03303339|529850050|FG008|Overall Study|Study Terminated by Sponsor|1|||
146914654|NCT03303339|529850051|FG009|Overall Study|Study Terminated by Sponsor|0|||
146914655|NCT03303339|529850052|FG010|Overall Study|Study Terminated by Sponsor|1|||
146914656|NCT03303339|529850053|FG011|Overall Study|Study Terminated by Sponsor|1|||
146914657|NCT03303339|529850042|FG000|Overall Study|Withdrawal by Subject|1|||
146914658|NCT03303339|529850043|FG001|Overall Study|Withdrawal by Subject|0|||
146914659|NCT03303339|529850044|FG002|Overall Study|Withdrawal by Subject|0|||
146914660|NCT03303339|529850045|FG003|Overall Study|Withdrawal by Subject|0|||
146914661|NCT03303339|529850046|FG004|Overall Study|Withdrawal by Subject|0|||
146914662|NCT03303339|529850047|FG005|Overall Study|Withdrawal by Subject|1|||
146914663|NCT03303339|529850048|FG006|Overall Study|Withdrawal by Subject|1|||
146914664|NCT03303339|529850049|FG007|Overall Study|Withdrawal by Subject|0|||
146914665|NCT03303339|529850050|FG008|Overall Study|Withdrawal by Subject|0|||
146914666|NCT03303339|529850051|FG009|Overall Study|Withdrawal by Subject|0|||
146914667|NCT03303339|529850052|FG010|Overall Study|Withdrawal by Subject|0|||
146914668|NCT03303339|529850053|FG011|Overall Study|Withdrawal by Subject|2|||
146914669|NCT03303339|529850042|FG000|Overall Study|Physician Decision|0|||
146914670|NCT03303339|529850043|FG001|Overall Study|Physician Decision|0|||
146914671|NCT03303339|529850044|FG002|Overall Study|Physician Decision|0|||
146914672|NCT03303339|529850045|FG003|Overall Study|Physician Decision|0|||
146914673|NCT03303339|529850046|FG004|Overall Study|Physician Decision|1|||
146914674|NCT03303339|529850047|FG005|Overall Study|Physician Decision|0|||
146914675|NCT03303339|529850048|FG006|Overall Study|Physician Decision|0|||
146914676|NCT03303339|529850049|FG007|Overall Study|Physician Decision|0|||
146878873|NCT03770260|529727849|FG000|Overall Study|Disease progression|0|||
146878874|NCT03770260|529727850|FG001|Overall Study|Disease progression|1|||
146878875|NCT03770260|529727851|FG002|Overall Study|Disease progression|0|||
146878876|NCT03770260|529727852|FG003|Overall Study|Disease progression|0|||
146878877|NCT01594853|529727853|FG000|Overall Study|Withdrawal by Subject|1|||
146878878|NCT01594853|529727854|FG001|Overall Study|Withdrawal by Subject|1|||
146878879|NCT01594853|529727853|FG000|Overall Study|Lost to Follow-up|1|||
146878880|NCT01594853|529727854|FG001|Overall Study|Lost to Follow-up|1|||
146878881|NCT01594853|529727853|FG000|Overall Study|noncompliance with exercise|0|||
146878882|NCT01594853|529727854|FG001|Overall Study|noncompliance with exercise|1|||
146878883|NCT02083380|529727859|FG000|Overall Study|Lack of Efficacy|68|||
146878884|NCT02083380|529727860|FG001|Overall Study|Lack of Efficacy|79|||
146878885|NCT02083380|529727861|FG002|Overall Study|Lack of Efficacy|64|||
146878886|NCT02083380|529727859|FG000|Overall Study|Withdrawal by Subject|9|||
146878887|NCT02083380|529727860|FG001|Overall Study|Withdrawal by Subject|3|||
146878888|NCT02083380|529727861|FG002|Overall Study|Withdrawal by Subject|7|||
146878889|NCT02083380|529727859|FG000|Overall Study|Physician Decision|1|||
146878890|NCT02083380|529727860|FG001|Overall Study|Physician Decision|6|||
146878891|NCT02083380|529727861|FG002|Overall Study|Physician Decision|3|||
146878892|NCT02083380|529727859|FG000|Overall Study|Adverse Event|0|||
146878893|NCT02083380|529727860|FG001|Overall Study|Adverse Event|0|||
146878894|NCT02083380|529727861|FG002|Overall Study|Adverse Event|1|||
146878895|NCT02083380|529727859|FG000|Overall Study|Lost to Follow-up|5|||
146878896|NCT02083380|529727860|FG001|Overall Study|Lost to Follow-up|3|||
146878897|NCT02083380|529727861|FG002|Overall Study|Lost to Follow-up|3|||
146878898|NCT02083380|529727859|FG000|Overall Study|Other|8|||
146878899|NCT02083380|529727860|FG001|Overall Study|Other|4|||
146878900|NCT02083380|529727861|FG002|Overall Study|Other|6|||
146878901|NCT02412787|529727862|FG000|Overall Study|Withdrawal by Subject|9|||
146878902|NCT02412787|529727862|FG000|Overall Study|Participation Terminated by Investigator|1|||
146878903|NCT02412787|529727862|FG000|Overall Study|Site Terminated by Sponsor|21|||
146878904|NCT02412787|529727862|FG000|Overall Study|Technical Problems|1|||
146878905|NCT02412787|529727862|FG000|Overall Study|Reason Not Specified|1|||
146878906|NCT03246958|529727863|FG000|Overall Study|Withdrawal by Subject|0|||
146878907|NCT03246958|529727864|FG001|Overall Study|Withdrawal by Subject|1|||
146878908|NCT03246958|529727865|FG002|Overall Study|Withdrawal by Subject|0|||
146878909|NCT03246958|529727866|FG003|Overall Study|Withdrawal by Subject|0|||
146878910|NCT03246958|529727867|FG004|Overall Study|Withdrawal by Subject|0|||
146878911|NCT03246958|529727868|FG005|Overall Study|Withdrawal by Subject|1|||
146878912|NCT03246958|529727869|FG006|Overall Study|Withdrawal by Subject|0|||
146878913|NCT03246958|529727863|FG000|Overall Study|Progression|13|||
146878914|NCT03246958|529727864|FG001|Overall Study|Progression|9|||
146878915|NCT03246958|529727865|FG002|Overall Study|Progression|3|||
146878916|NCT03246958|529727866|FG003|Overall Study|Progression|2|||
146878917|NCT03246958|529727867|FG004|Overall Study|Progression|1|||
146878918|NCT03246958|529727868|FG005|Overall Study|Progression|2|||
146878919|NCT03246958|529727869|FG006|Overall Study|Progression|1|||
146878920|NCT03246958|529727863|FG000|Overall Study|Adverse Event|2|||
146878921|NCT03246958|529727864|FG001|Overall Study|Adverse Event|2|||
146878922|NCT03246958|529727865|FG002|Overall Study|Adverse Event|0|||
146878923|NCT03246958|529727866|FG003|Overall Study|Adverse Event|1|||
146878924|NCT03246958|529727867|FG004|Overall Study|Adverse Event|1|||
146878925|NCT03246958|529727868|FG005|Overall Study|Adverse Event|0|||
146878926|NCT03246958|529727869|FG006|Overall Study|Adverse Event|2|||
146878927|NCT03246958|529727863|FG000|Overall Study|Death|0|||
146878928|NCT03246958|529727864|FG001|Overall Study|Death|1|||
146878929|NCT03246958|529727865|FG002|Overall Study|Death|0|||
146878930|NCT03246958|529727866|FG003|Overall Study|Death|0|||
146878931|NCT03246958|529727867|FG004|Overall Study|Death|0|||
146878932|NCT03246958|529727868|FG005|Overall Study|Death|0|||
146629486|NCT01462370|528819754|FG000|Overall Study|Physician Decision|0|||
146629487|NCT01462370|528819755|FG001|Overall Study|Physician Decision|1|||
146878933|NCT03246958|529727869|FG006|Overall Study|Death|0|||
146878934|NCT03246958|529727863|FG000|Overall Study|Physician Decision|0|||
146878935|NCT03246958|529727864|FG001|Overall Study|Physician Decision|0|||
146878936|NCT03246958|529727865|FG002|Overall Study|Physician Decision|0|||
146878937|NCT03246958|529727866|FG003|Overall Study|Physician Decision|1|||
146878938|NCT03246958|529727867|FG004|Overall Study|Physician Decision|0|||
146878939|NCT03246958|529727868|FG005|Overall Study|Physician Decision|0|||
146878940|NCT03246958|529727869|FG006|Overall Study|Physician Decision|0|||
146878941|NCT03246958|529727863|FG000|Overall Study|Never start treatment|1|||
146878942|NCT03246958|529727864|FG001|Overall Study|Never start treatment|0|||
146878943|NCT03246958|529727865|FG002|Overall Study|Never start treatment|0|||
146878944|NCT03246958|529727866|FG003|Overall Study|Never start treatment|0|||
146878945|NCT03246958|529727867|FG004|Overall Study|Never start treatment|0|||
146878946|NCT03246958|529727868|FG005|Overall Study|Never start treatment|0|||
146878947|NCT03246958|529727869|FG006|Overall Study|Never start treatment|0|||
146878948|NCT03246958|529727863|FG000|Overall Study|Over enrollment|0|||
146509102|NCT00250458|528367731|FG001|Overall Study|Protocol Violation|1|||
146878949|NCT03246958|529727864|FG001|Overall Study|Over enrollment|2|||
146878950|NCT03246958|529727865|FG002|Overall Study|Over enrollment|0|||
146878951|NCT03246958|529727866|FG003|Overall Study|Over enrollment|0|||
146878952|NCT03246958|529727867|FG004|Overall Study|Over enrollment|0|||
146878953|NCT03246958|529727868|FG005|Overall Study|Over enrollment|0|||
146878954|NCT03246958|529727869|FG006|Overall Study|Over enrollment|0|||
146878955|NCT01032915|529727872|FG000|Overall Study|Adverse Event|2|||
146878956|NCT01032915|529727873|FG001|Overall Study|Adverse Event|2|||
146878957|NCT01032915|529727874|FG002|Overall Study|Adverse Event|1|||
146878958|NCT01032915|529727875|FG003|Overall Study|Adverse Event|1|||
146878959|NCT01032915|529727872|FG000|Overall Study|Abnormal test procedure result|0|||
146878960|NCT01032915|529727873|FG001|Overall Study|Abnormal test procedure result|0|||
146878961|NCT01032915|529727874|FG002|Overall Study|Abnormal test procedure result|1|||
146878962|NCT01032915|529727875|FG003|Overall Study|Abnormal test procedure result|0|||
146878963|NCT01032915|529727872|FG000|Overall Study|Withdrawal by Subject|0|||
146878964|NCT01032915|529727873|FG001|Overall Study|Withdrawal by Subject|3|||
146878965|NCT01032915|529727874|FG002|Overall Study|Withdrawal by Subject|1|||
146878966|NCT01032915|529727875|FG003|Overall Study|Withdrawal by Subject|1|||
146878967|NCT01032915|529727872|FG000|Overall Study|Administrative reasons|5|||
146878968|NCT01032915|529727873|FG001|Overall Study|Administrative reasons|6|||
146545168|NCT00153920|528503073|FG000|Overall Study|Non-Protocol Therapy|1|||
146545169|NCT00153920|528503073|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
146545170|NCT00153920|528503073|FG000|Overall Study|Progressive Disease before Trt|1|||
146545171|NCT00195429|528503074|FG000|Overall Study|Adverse Event|2|||
146545172|NCT00195429|528503075|FG001|Overall Study|Adverse Event|4|||
146545173|NCT00195429|528503074|FG000|Overall Study|Lack of Efficacy|2|||
146545174|NCT00195429|528503075|FG001|Overall Study|Lack of Efficacy|1|||
146545175|NCT00195429|528503074|FG000|Overall Study|Lost to Follow-up|1|||
146545176|NCT00195429|528503075|FG001|Overall Study|Lost to Follow-up|0|||
146545177|NCT02143778|528503076|FG000|Overall Study|Withdrawal by Subject|2|||
146545178|NCT02143778|528503076|FG000|Overall Study|Device malfunction|1|||
146545179|NCT03384966|528503080|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
146545180|NCT03384966|528503081|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
146545181|NCT03384966|528503082|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
146545182|NCT03384966|528503080|FG000|Follow-up Period|Adverse Event|1|||
146545183|NCT03384966|528503081|FG001|Follow-up Period|Adverse Event|0|||
146545184|NCT03384966|528503082|FG002|Follow-up Period|Adverse Event|0|||
146545185|NCT00367458|528503083|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
146545186|NCT00367458|528503084|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
146545187|NCT01334515|528503087|FG000|Overall Study|Adverse Event|1|||
146545188|NCT01334515|528503088|FG001|Overall Study|Adverse Event|6|||
146545189|NCT01334515|528503087|FG000|Overall Study|Death|1|||
146545190|NCT01334515|528503088|FG001|Overall Study|Death|0|||
146545191|NCT01334515|528503087|FG000|Overall Study|Lack of Efficacy|8|||
146545192|NCT01334515|528503088|FG001|Overall Study|Lack of Efficacy|21|||
146545193|NCT01334515|528503087|FG000|Overall Study|Physician Decision|1|||
146545194|NCT01334515|528503088|FG001|Overall Study|Physician Decision|1|||
146545195|NCT01334515|528503087|FG000|Overall Study|Withdrawal by Subject|1|||
146545196|NCT01334515|528503088|FG001|Overall Study|Withdrawal by Subject|1|||
146545197|NCT04327271|528503089|FG000|Overall Study|Death|1|||
146545198|NCT04327271|528503090|FG001|Overall Study|Death|0|||
146545199|NCT04327271|528503089|FG000|Overall Study|Withdrawal by Subject|1|||
146545200|NCT04327271|528503090|FG001|Overall Study|Withdrawal by Subject|0|||
146545201|NCT04327271|528503089|FG000|Overall Study|randomization error (data capture)|4|||
146545202|NCT04327271|528503090|FG001|Overall Study|randomization error (data capture)|3|||
146545203|NCT04795323|528503094|FG000|Overall Study|Did not interact with TARA|1|||
146545204|NCT04795323|528503095|FG001|Overall Study|Did not interact with TARA|0|||
146545205|NCT01479530|528503096|FG000|Overall Study|Adverse Event|5|||
146545206|NCT01479530|528503097|FG001|Overall Study|Adverse Event|6|||
146545207|NCT01479530|528503096|FG000|Overall Study|Lack of Efficacy|0|||
146545208|NCT01479530|528503097|FG001|Overall Study|Lack of Efficacy|1|||
146545209|NCT01479530|528503096|FG000|Overall Study|Protocol Violation|2|||
146545210|NCT01479530|528503097|FG001|Overall Study|Protocol Violation|3|||
146545211|NCT01479530|528503096|FG000|Overall Study|Withdrawal of Consent|3|||
146545212|NCT01479530|528503097|FG001|Overall Study|Withdrawal of Consent|2|||
146545213|NCT00303628|528503100|FG000|Overall Study|Disease progression|0|||
146878969|NCT01032915|529727874|FG002|Overall Study|Administrative reasons|4|||
146878970|NCT01032915|529727875|FG003|Overall Study|Administrative reasons|4|||
146878971|NCT01032915|529727872|FG000|Overall Study|Protocol Violation|1|||
146878972|NCT01032915|529727873|FG001|Overall Study|Protocol Violation|0|||
146545214|NCT00303628|528503101|FG001|Overall Study|Disease progression|1|||
146545215|NCT00303628|528503100|FG000|Overall Study|Adverse Event|26|||
146545216|NCT00303628|528503101|FG001|Overall Study|Adverse Event|36|||
146545217|NCT00303628|528503100|FG000|Overall Study|Death|0|||
146545218|NCT00303628|528503101|FG001|Overall Study|Death|1|||
146545219|NCT00303628|528503100|FG000|Overall Study|Withdrawal by Subject|11|||
146545220|NCT00303628|528503101|FG001|Overall Study|Withdrawal by Subject|20|||
146545221|NCT00303628|528503100|FG000|Overall Study|Alternative therapy|2|||
146878973|NCT01032915|529727874|FG002|Overall Study|Protocol Violation|0|||
146878974|NCT01032915|529727875|FG003|Overall Study|Protocol Violation|1|||
146878975|NCT03363321|529727876|FG000|Overall Study|Withdrawal by Subject|0|||
146878976|NCT03363321|529727877|FG001|Overall Study|Withdrawal by Subject|1|||
146878977|NCT03363321|529727878|FG002|Overall Study|Withdrawal by Subject|0|||
146878978|NCT03363321|529727879|FG003|Overall Study|Withdrawal by Subject|1|||
146878979|NCT03363321|529727880|FG004|Overall Study|Withdrawal by Subject|0|||
146878980|NCT02915523|529727881|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
146878981|NCT02915523|529727882|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
146878982|NCT02915523|529727883|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
146878983|NCT02915523|529727884|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
146878984|NCT02915523|529727881|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
146878985|NCT02915523|529727882|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
146878986|NCT02915523|529727883|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
146878987|NCT02915523|529727884|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
146878988|NCT02915523|529727881|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
146878989|NCT02915523|529727882|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
146878990|NCT02915523|529727883|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
146878991|NCT02915523|529727884|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
146878992|NCT02915523|529727881|FG000|Expansion Phase (Phase 2)|Death|0|||
146878993|NCT02915523|529727882|FG001|Expansion Phase (Phase 2)|Death|0|||
146878994|NCT02915523|529727883|FG002|Expansion Phase (Phase 2)|Death|26|||
146878995|NCT02915523|529727884|FG003|Expansion Phase (Phase 2)|Death|53|||
146878996|NCT02915523|529727881|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
146878997|NCT02915523|529727882|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
146878998|NCT02915523|529727883|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
146878999|NCT02915523|529727884|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
146879000|NCT02915523|529727881|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
146879001|NCT02915523|529727882|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
146879002|NCT02915523|529727883|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
146879003|NCT02915523|529727884|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
146879004|NCT02915523|529727881|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
146879005|NCT02915523|529727882|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
146879006|NCT02915523|529727883|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
146879007|NCT02915523|529727884|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
146879008|NCT00414453|529727886|FG000|Overall Study|Abnormal lab work|16|||
146879009|NCT01780831|529727887|FG000|Overall Study|Withdrawal by Subject|0|||
146879010|NCT01780831|529727888|FG001|Overall Study|Withdrawal by Subject|0|||
146879011|NCT01780831|529727889|FG002|Overall Study|Withdrawal by Subject|4|||
146879012|NCT01780831|529727890|FG003|Overall Study|Withdrawal by Subject|0|||
146879013|NCT01780831|529727887|FG000|Overall Study|Lost to Follow-up|0|||
146879014|NCT01780831|529727888|FG001|Overall Study|Lost to Follow-up|0|||
146879015|NCT01780831|529727889|FG002|Overall Study|Lost to Follow-up|0|||
146879016|NCT01780831|529727890|FG003|Overall Study|Lost to Follow-up|1|||
146879017|NCT00183274|529727891|FG000|Phase 1: Open-Label|Adverse Event|31|||
146879018|NCT00183274|529727892|FG001|Phase 1: Open-Label|Adverse Event|0|||
146879019|NCT00183274|529727893|FG002|Phase 1: Open-Label|Adverse Event|0|||
146879020|NCT00183274|529727894|FG003|Phase 1: Open-Label|Adverse Event|0|||
146879021|NCT00183274|529727895|FG004|Phase 1: Open-Label|Adverse Event|0|||
146879022|NCT00183274|529727896|FG005|Phase 1: Open-Label|Adverse Event|0|||
146879023|NCT00183274|529727891|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
146879024|NCT00183274|529727892|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
146879025|NCT00183274|529727893|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
146879026|NCT00183274|529727894|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
146879027|NCT00183274|529727895|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
146879028|NCT00183274|529727896|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
146879029|NCT00183274|529727891|FG000|Phase 1: Open-Label|Protocol Violation|11|||
146545222|NCT00303628|528503101|FG001|Overall Study|Alternative therapy|0|||
146879030|NCT00183274|529727892|FG001|Phase 1: Open-Label|Protocol Violation|0|||
146879031|NCT00183274|529727893|FG002|Phase 1: Open-Label|Protocol Violation|0|||
146879032|NCT00183274|529727894|FG003|Phase 1: Open-Label|Protocol Violation|0|||
146879033|NCT00183274|529727895|FG004|Phase 1: Open-Label|Protocol Violation|0|||
146879034|NCT00183274|529727896|FG005|Phase 1: Open-Label|Protocol Violation|0|||
146879035|NCT00183274|529727891|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
146879036|NCT00183274|529727892|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
146879037|NCT00183274|529727893|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
146545223|NCT00303628|528503100|FG000|Overall Study|Other complicating disease|0|||
146545224|NCT00303628|528503101|FG001|Overall Study|Other complicating disease|1|||
146545225|NCT00303628|528503100|FG000|Overall Study|Not start protocol therapy|3|||
146545226|NCT00303628|528503101|FG001|Overall Study|Not start protocol therapy|5|||
146545227|NCT00303628|528503100|FG000|Overall Study|Other|8|||
146545228|NCT00303628|528503101|FG001|Overall Study|Other|9|||
146545229|NCT04925934|528503102|FG000|Overall Study|Adverse Event|1|||
146545230|NCT04925934|528503103|FG001|Overall Study|Adverse Event|0|||
146545231|NCT04925934|528503104|FG002|Overall Study|Adverse Event|0|||
146545232|NCT04925934|528503102|FG000|Overall Study|Lost to Follow-up|2|||
146879038|NCT00183274|529727894|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
146879039|NCT00183274|529727895|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
146879040|NCT00183274|529727896|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
146879041|NCT00183274|529727891|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
146879042|NCT00183274|529727892|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
146879043|NCT00183274|529727893|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
146879044|NCT00183274|529727894|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
146879045|NCT00183274|529727895|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
146879046|NCT00183274|529727896|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
146879047|NCT00183274|529727891|FG000|Phase 1: Open-Label|Other|9|||
146879048|NCT00183274|529727892|FG001|Phase 1: Open-Label|Other|0|||
146879049|NCT00183274|529727893|FG002|Phase 1: Open-Label|Other|0|||
146879050|NCT00183274|529727894|FG003|Phase 1: Open-Label|Other|0|||
146879051|NCT00183274|529727895|FG004|Phase 1: Open-Label|Other|0|||
146879052|NCT00183274|529727896|FG005|Phase 1: Open-Label|Other|0|||
146879053|NCT00183274|529727891|FG000|Phase 2: Double-Blind|Relapsed|0|||
146879054|NCT00183274|529727892|FG001|Phase 2: Double-Blind|Relapsed|8|||
146879055|NCT00183274|529727893|FG002|Phase 2: Double-Blind|Relapsed|29|||
146879056|NCT00183274|529727894|FG003|Phase 2: Double-Blind|Relapsed|0|||
146879057|NCT00183274|529727895|FG004|Phase 2: Double-Blind|Relapsed|0|||
146879058|NCT00183274|529727896|FG005|Phase 2: Double-Blind|Relapsed|0|||
146879059|NCT00183274|529727891|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
146879060|NCT00183274|529727892|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
146879061|NCT00183274|529727893|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
146879062|NCT00183274|529727894|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
146879063|NCT00183274|529727895|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
146879064|NCT00183274|529727896|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
146879065|NCT00183274|529727891|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
146879066|NCT00183274|529727892|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
146879067|NCT00183274|529727893|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
146879068|NCT00183274|529727894|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
146879069|NCT00183274|529727895|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
146879070|NCT00183274|529727896|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
146879071|NCT00183274|529727891|FG000|Phase 3: Double-Blind|Relapsed|0|||
146879072|NCT00183274|529727892|FG001|Phase 3: Double-Blind|Relapsed|0|||
146879073|NCT00183274|529727893|FG002|Phase 3: Double-Blind|Relapsed|0|||
146879074|NCT00183274|529727894|FG003|Phase 3: Double-Blind|Relapsed|1|||
146879075|NCT00183274|529727895|FG004|Phase 3: Double-Blind|Relapsed|11|||
146879076|NCT00183274|529727896|FG005|Phase 3: Double-Blind|Relapsed|2|||
146879077|NCT00879645|529727899|FG000|Overall Study|Adverse Event|1|||
146879078|NCT00879645|529727900|FG001|Overall Study|Adverse Event|0|||
146879079|NCT00879645|529727901|FG002|Overall Study|Adverse Event|0|||
146879080|NCT00879645|529727902|FG003|Overall Study|Adverse Event|0|||
146879081|NCT00542269|529727907|FG000|Overall Study|Adverse Event|10|||
146879082|NCT00542269|529727908|FG001|Overall Study|Adverse Event|4|||
146879083|NCT00542269|529727909|FG002|Overall Study|Adverse Event|5|||
146879084|NCT00542269|529727907|FG000|Overall Study|Protocol Violation|1|||
146879085|NCT00542269|529727908|FG001|Overall Study|Protocol Violation|1|||
146879086|NCT00542269|529727909|FG002|Overall Study|Protocol Violation|0|||
146879087|NCT00542269|529727907|FG000|Overall Study|Withdrawal by Subject|1|||
146879088|NCT00542269|529727908|FG001|Overall Study|Withdrawal by Subject|0|||
146879089|NCT00542269|529727909|FG002|Overall Study|Withdrawal by Subject|0|||
146879090|NCT00542269|529727907|FG000|Overall Study|Administrative problems|1|||
146879091|NCT00542269|529727908|FG001|Overall Study|Administrative problems|1|||
146879092|NCT00542269|529727909|FG002|Overall Study|Administrative problems|1|||
146879093|NCT03873714|529727910|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
146879094|NCT00708123|529727913|FG000|Period 1|Protocol Violation|0|||
146545233|NCT04925934|528503103|FG001|Overall Study|Lost to Follow-up|0|||
146545234|NCT04925934|528503104|FG002|Overall Study|Lost to Follow-up|1|||
146545235|NCT04925934|528503102|FG000|Overall Study|Death|0|||
146545236|NCT04925934|528503103|FG001|Overall Study|Death|1|||
146545237|NCT04925934|528503104|FG002|Overall Study|Death|0|||
146545238|NCT04925934|528503102|FG000|Overall Study|Withdrawal by Subject|8|||
146545239|NCT04925934|528503103|FG001|Overall Study|Withdrawal by Subject|5|||
146545240|NCT04925934|528503104|FG002|Overall Study|Withdrawal by Subject|9|||
146545241|NCT04925934|528503102|FG000|Overall Study|Other|2|||
146545242|NCT04925934|528503103|FG001|Overall Study|Other|2|||
146545243|NCT04925934|528503104|FG002|Overall Study|Other|2|||
146545244|NCT04925934|528503102|FG000|Overall Study|Eastern European Conflict|7|||
146545245|NCT04925934|528503103|FG001|Overall Study|Eastern European Conflict|3|||
146545246|NCT04925934|528503104|FG002|Overall Study|Eastern European Conflict|2|||
146545247|NCT00376506|528503105|FG000|Overall Study|Death|0|||
146545248|NCT00376506|528503106|FG001|Overall Study|Death|2|||
146545249|NCT03158688|528503107|FG000|Overall Study|Withdrawal by Subject|14|||
146545250|NCT03158688|528503108|FG001|Overall Study|Withdrawal by Subject|28|||
146879095|NCT00708123|529727914|FG001|Period 1|Protocol Violation|1|||
146879096|NCT00708123|529727915|FG002|Period 1|Protocol Violation|0|||
146879097|NCT00708123|529727916|FG003|Period 1|Protocol Violation|1|||
146879098|NCT00708123|529727917|FG004|Period 1|Protocol Violation|0|||
146879099|NCT00708123|529727913|FG000|Period 1|Adverse Event|0|||
146879100|NCT00708123|529727914|FG001|Period 1|Adverse Event|0|||
146879101|NCT00708123|529727915|FG002|Period 1|Adverse Event|1|||
146879102|NCT00708123|529727916|FG003|Period 1|Adverse Event|0|||
146879103|NCT00708123|529727917|FG004|Period 1|Adverse Event|0|||
146879104|NCT00708123|529727913|FG000|Period 2|Protocol Violation|0|||
146879105|NCT00708123|529727914|FG001|Period 2|Protocol Violation|0|||
146879106|NCT00708123|529727915|FG002|Period 2|Protocol Violation|0|||
146879107|NCT00708123|529727916|FG003|Period 2|Protocol Violation|1|||
146879108|NCT00708123|529727917|FG004|Period 2|Protocol Violation|0|||
146879109|NCT00708123|529727913|FG000|Period 2|Other Reason|1|||
146879110|NCT00708123|529727914|FG001|Period 2|Other Reason|0|||
146879111|NCT00708123|529727915|FG002|Period 2|Other Reason|0|||
146879112|NCT00708123|529727916|FG003|Period 2|Other Reason|0|||
146879113|NCT00708123|529727917|FG004|Period 2|Other Reason|0|||
146879114|NCT00708123|529727913|FG000|Period 3|Lost to Follow-up|0|||
146879115|NCT00708123|529727914|FG001|Period 3|Lost to Follow-up|0|||
146879116|NCT00708123|529727915|FG002|Period 3|Lost to Follow-up|1|||
146879117|NCT00708123|529727916|FG003|Period 3|Lost to Follow-up|1|||
146879118|NCT00708123|529727917|FG004|Period 3|Lost to Follow-up|0|||
146879119|NCT00708123|529727913|FG000|Period 4|Protocol Violation|0|||
146879120|NCT00708123|529727914|FG001|Period 4|Protocol Violation|1|||
146879121|NCT00708123|529727915|FG002|Period 4|Protocol Violation|0|||
146879122|NCT00708123|529727916|FG003|Period 4|Protocol Violation|0|||
146879123|NCT00708123|529727917|FG004|Period 4|Protocol Violation|0|||
146879124|NCT00401375|529727920|FG000|Overall Study|Protocol Violation|2|||
146879125|NCT00401375|529727921|FG001|Overall Study|Protocol Violation|2|||
146879126|NCT00401375|529727922|FG002|Overall Study|Protocol Violation|1|||
146879127|NCT00401375|529727920|FG000|Overall Study|Adverse Event|6|||
146879128|NCT00401375|529727921|FG001|Overall Study|Adverse Event|11|||
146879129|NCT00401375|529727922|FG002|Overall Study|Adverse Event|10|||
146879130|NCT00401375|529727920|FG000|Overall Study|Withdrawal by Subject|9|||
146879131|NCT00401375|529727921|FG001|Overall Study|Withdrawal by Subject|7|||
146879132|NCT00401375|529727922|FG002|Overall Study|Withdrawal by Subject|7|||
146879133|NCT00401375|529727920|FG000|Overall Study|Lost to Follow-up|0|||
146879134|NCT00401375|529727921|FG001|Overall Study|Lost to Follow-up|1|||
146879135|NCT00401375|529727922|FG002|Overall Study|Lost to Follow-up|1|||
146879136|NCT00401375|529727920|FG000|Overall Study|Other than specified|2|||
146879137|NCT00401375|529727921|FG001|Overall Study|Other than specified|1|||
146879138|NCT00401375|529727922|FG002|Overall Study|Other than specified|3|||
146879139|NCT00401375|529727920|FG000|Overall Study|Randomized but not treated|3|||
146879140|NCT00401375|529727921|FG001|Overall Study|Randomized but not treated|3|||
146879141|NCT00401375|529727922|FG002|Overall Study|Randomized but not treated|3|||
146879142|NCT02821715|529727923|FG000|Overall Study|Protocol Violation|1|||
146879143|NCT02821715|529727924|FG001|Overall Study|Protocol Violation|0|||
146879144|NCT02821715|529727925|FG002|Overall Study|Protocol Violation|0|||
146879145|NCT02821715|529727926|FG003|Overall Study|Protocol Violation|0|||
146879146|NCT02821715|529727927|FG004|Overall Study|Protocol Violation|0|||
146879147|NCT02821715|529727928|FG005|Overall Study|Protocol Violation|0|||
146879148|NCT00677014|529727929|FG000|Overall Study|Lost to Follow-up|20|||
146879149|NCT00677014|529727930|FG001|Overall Study|Lost to Follow-up|12|||
146879150|NCT00677014|529727931|FG002|Overall Study|Lost to Follow-up|24|||
146879151|NCT00677014|529727929|FG000|Overall Study|Death|6|||
146879152|NCT00677014|529727930|FG001|Overall Study|Death|15|||
146879153|NCT00677014|529727931|FG002|Overall Study|Death|7|||
146879154|NCT00677014|529727929|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
146545251|NCT03158688|528503107|FG000|Overall Study|Decision by sponsor|13|||
146545252|NCT03158688|528503108|FG001|Overall Study|Decision by sponsor|37|||
146545253|NCT03158688|528503107|FG000|Overall Study|Lost to Follow-up|4|||
146545254|NCT03158688|528503108|FG001|Overall Study|Lost to Follow-up|3|||
146545255|NCT03158688|528503107|FG000|Overall Study|Death|74|||
146879155|NCT00677014|529727930|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
146879156|NCT00677014|529727931|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
146545256|NCT03158688|528503108|FG001|Overall Study|Death|142|||
146879157|NCT00640328|529727932|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
146879158|NCT00640328|529727933|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
146879159|NCT00640328|529727934|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
146879160|NCT00640328|529727935|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
146879161|NCT00640328|529727936|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
146879162|NCT00640328|529727937|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
146879163|NCT00640328|529727932|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
146879164|NCT00640328|529727933|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
146879165|NCT00640328|529727934|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
146879166|NCT00640328|529727935|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
146545257|NCT02948400|528503113|FG000|Overall Study|Withdrawal by Subject|17|||
146879167|NCT00640328|529727936|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
146914677|NCT03303339|529850050|FG008|Overall Study|Physician Decision|0|||
146879168|NCT00640328|529727937|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
146879169|NCT00640328|529727932|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
146879170|NCT00640328|529727933|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
146879171|NCT00640328|529727934|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
146879172|NCT00640328|529727935|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
146879173|NCT00640328|529727936|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
146879174|NCT00640328|529727937|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
146879175|NCT00640328|529727932|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
146879176|NCT00640328|529727933|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
146879177|NCT00640328|529727934|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
146879178|NCT00640328|529727935|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
146879179|NCT00640328|529727936|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
146879180|NCT00640328|529727937|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
146879181|NCT04294719|529727938|FG000|Overall Study|Withdrawal by Subject|1|||
146879182|NCT00081159|529727940|FG000|Overall Study|Withdrawal by Subject|0|||
146879183|NCT00081159|529727941|FG001|Overall Study|Withdrawal by Subject|3|||
146879184|NCT00081159|529727940|FG000|Overall Study|Myelosuppression prior to treatment|0|||
146879185|NCT00081159|529727941|FG001|Overall Study|Myelosuppression prior to treatment|1|||
146879186|NCT00081159|529727940|FG000|Overall Study|Lost to Follow-up|2|||
146879187|NCT00081159|529727941|FG001|Overall Study|Lost to Follow-up|1|||
146879188|NCT01883635|529727942|FG000|Overall Study|Withdrawal by Subject|4|||
146879189|NCT01883635|529727943|FG001|Overall Study|Withdrawal by Subject|0|||
146545258|NCT02948400|528503114|FG001|Overall Study|Withdrawal by Subject|10|||
146545259|NCT02948400|528503113|FG000|Overall Study|failed to attend appointments|47|||
146545260|NCT02948400|528503114|FG001|Overall Study|failed to attend appointments|34|||
146545261|NCT02948400|528503113|FG000|Overall Study|COVID-related closure|6|||
146545262|NCT02948400|528503114|FG001|Overall Study|COVID-related closure|2|||
146545263|NCT02948400|528503113|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
146545264|NCT02948400|528503114|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
146545265|NCT02948400|528503113|FG000|Overall Study|motion sickness in virtual reality|2|||
146545266|NCT02948400|528503114|FG001|Overall Study|motion sickness in virtual reality|0|||
146545267|NCT01716156|528503115|FG000|Overall Study|Protocol Violation|1|||
146545268|NCT01716156|528503116|FG001|Overall Study|Protocol Violation|0|||
146545269|NCT01716156|528503117|FG002|Overall Study|Protocol Violation|0|||
146545270|NCT01716156|528503115|FG000|Overall Study|Withdrawal by Subject|0|||
146545271|NCT01716156|528503116|FG001|Overall Study|Withdrawal by Subject|1|||
146545272|NCT01716156|528503117|FG002|Overall Study|Withdrawal by Subject|2|||
146545273|NCT01716156|528503115|FG000|Overall Study|Lost to Follow-up|1|||
146545274|NCT01716156|528503116|FG001|Overall Study|Lost to Follow-up|0|||
146545275|NCT01716156|528503117|FG002|Overall Study|Lost to Follow-up|0|||
146545276|NCT01132755|528503124|FG000|Overall Study|Procedure not done due to medical reason|23|||
146545277|NCT01132755|528503124|FG000|Overall Study|Protocol Violation|15|||
146545278|NCT01132755|528503124|FG000|Overall Study|Withdrawal by Subject|4|||
146545279|NCT02393755|528503125|FG000|Overall Study|Withdrawal by Subject|0|||
146545280|NCT02393755|528503126|FG001|Overall Study|Withdrawal by Subject|3|||
146545281|NCT02393755|528503125|FG000|Overall Study|Adverse Event|0|||
146545282|NCT02393755|528503126|FG001|Overall Study|Adverse Event|2|||
146545283|NCT02393755|528503125|FG000|Overall Study|Physician Decision|0|||
146545284|NCT02393755|528503126|FG001|Overall Study|Physician Decision|2|||
146545285|NCT02949934|528503129|FG000|Natural Drinking Period|Adverse Event|1|||
146545286|NCT02949934|528503130|FG001|Natural Drinking Period|Adverse Event|0|||
146545287|NCT02949934|528503131|FG002|Natural Drinking Period|Adverse Event|0|||
146545288|NCT02949934|528503132|FG003|Natural Drinking Period|Adverse Event|1|||
146545289|NCT02949934|528503133|FG004|Natural Drinking Period|Adverse Event|0|||
146545290|NCT02949934|528503134|FG005|Natural Drinking Period|Adverse Event|0|||
146765030|NCT00957658|529307217|FG000|Overall Study|Site termination|10|||
146879190|NCT01187953|529727944|FG000|Overall Study|Death|11|||
146879191|NCT01187953|529727945|FG001|Overall Study|Death|13|||
146879192|NCT01187953|529727944|FG000|Overall Study|Adverse Event|1|||
146879193|NCT01187953|529727945|FG001|Overall Study|Adverse Event|2|||
146879194|NCT01187953|529727944|FG000|Overall Study|Lost to Follow-up|0|||
146879195|NCT01187953|529727945|FG001|Overall Study|Lost to Follow-up|3|||
146545291|NCT02949934|528503129|FG000|Natural Drinking Period|Lost to Follow-up|0|||
146545292|NCT02949934|528503130|FG001|Natural Drinking Period|Lost to Follow-up|0|||
146545293|NCT02949934|528503131|FG002|Natural Drinking Period|Lost to Follow-up|0|||
146545294|NCT02949934|528503132|FG003|Natural Drinking Period|Lost to Follow-up|0|||
146545295|NCT02949934|528503133|FG004|Natural Drinking Period|Lost to Follow-up|1|||
146879196|NCT01187953|529727944|FG000|Overall Study|Withdrawal by Subject|3|||
146879197|NCT01187953|529727945|FG001|Overall Study|Withdrawal by Subject|3|||
146879198|NCT01464307|529727946|FG000|Main Period|Death|0|||
146879199|NCT01464307|529727947|FG001|Main Period|Death|1|||
146879200|NCT01464307|529727946|FG000|Main Period|Adverse Event|6|||
146879201|NCT01464307|529727947|FG001|Main Period|Adverse Event|1|||
146879202|NCT01464307|529727946|FG000|Main Period|Lack of Efficacy|2|||
146879203|NCT01464307|529727947|FG001|Main Period|Lack of Efficacy|0|||
146879204|NCT01464307|529727946|FG000|Main Period|Withdrawal by Subject|5|||
146879205|NCT01464307|529727947|FG001|Main Period|Withdrawal by Subject|2|||
146879206|NCT01464307|529727946|FG000|Main Period|Predefined discontinuation criteria|2|||
146879207|NCT01464307|529727947|FG001|Main Period|Predefined discontinuation criteria|1|||
146879208|NCT01464307|529727946|FG000|Open-Label Extension Period|Adverse Event|15|||
146879209|NCT01464307|529727947|FG001|Open-Label Extension Period|Adverse Event|0|||
146879210|NCT01464307|529727946|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
146879211|NCT01464307|529727947|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
146879212|NCT01464307|529727946|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
146879213|NCT01464307|529727947|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
146879214|NCT01464307|529727946|FG000|Open-Label Extension Period|Death|1|||
146879215|NCT01464307|529727947|FG001|Open-Label Extension Period|Death|0|||
146879216|NCT01464307|529727946|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
146879217|NCT01464307|529727947|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
146879218|NCT01464307|529727946|FG000|Open-Label Extension Period|Non-compliance|9|||
146879219|NCT01464307|529727947|FG001|Open-Label Extension Period|Non-compliance|0|||
146879220|NCT01464307|529727946|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
146879221|NCT01464307|529727947|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
146879222|NCT00761514|529727950|FG000|Overall Study|Adverse Event|1|||
146879223|NCT00761514|529727950|FG000|Overall Study|Withdrawal by Subject|2|||
146879224|NCT00761514|529727950|FG000|Overall Study|Lost to Follow-up|1|||
146879225|NCT00761514|529727950|FG000|Overall Study|Health insurance didn't cover study drug|1|||
146879226|NCT00761514|529727950|FG000|Overall Study|Problem complying with study visit|1|||
146879227|NCT00761514|529727950|FG000|Overall Study|Unable to pay for medications|1|||
146879228|NCT02457637|529727953|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
146879229|NCT00159861|529727954|FG000|Core Study - 16 Weeks|Death|3|||
146879230|NCT00159861|529727955|FG001|Core Study - 16 Weeks|Death|0|||
146879231|NCT00159861|529727954|FG000|Core Study - 16 Weeks|Adverse Event|12|||
146879232|NCT00159861|529727955|FG001|Core Study - 16 Weeks|Adverse Event|6|||
146879233|NCT00159861|529727954|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
146879234|NCT00159861|529727955|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
146879235|NCT00159861|529727954|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
146879236|NCT00159861|529727955|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
146879237|NCT00159861|529727954|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
146879238|NCT00159861|529727955|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
146879239|NCT00159861|529727954|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
146879240|NCT00159861|529727955|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
146879241|NCT00159861|529727954|FG000|Extension Study - up to 3 Years|Death|24|||
146879242|NCT00159861|529727955|FG001|Extension Study - up to 3 Years|Death|28|||
146879243|NCT00159861|529727954|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
146879244|NCT00159861|529727955|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
146879245|NCT00159861|529727954|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
146879246|NCT00159861|529727955|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
146545296|NCT02949934|528503134|FG005|Natural Drinking Period|Lost to Follow-up|0|||
146879247|NCT00159861|529727954|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
146879248|NCT00159861|529727955|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
146879249|NCT00159861|529727954|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
146879250|NCT00159861|529727955|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
146879251|NCT01553136|529727957|FG000|Overall Study|Adverse Event|3|||
146879252|NCT01553136|529727958|FG001|Overall Study|Adverse Event|2|||
146879253|NCT01553136|529727957|FG000|Overall Study|Withdrawal by Subject|2|||
146879254|NCT01553136|529727958|FG001|Overall Study|Withdrawal by Subject|3|||
146879255|NCT01553136|529727957|FG000|Overall Study|Lost to Follow-up|4|||
146879256|NCT01553136|529727958|FG001|Overall Study|Lost to Follow-up|10|||
146879257|NCT01553136|529727957|FG000|Overall Study|Physician Decision|2|||
146879258|NCT01553136|529727958|FG001|Overall Study|Physician Decision|3|||
146879259|NCT01553136|529727957|FG000|Overall Study|Scheduling Difficulties|5|||
146879260|NCT01553136|529727958|FG001|Overall Study|Scheduling Difficulties|4|||
146879261|NCT03885089|529727959|FG000|Overall Study|No informed consent for publication of study results|2|||
146879262|NCT03349099|529727962|FG000|Overall Study|Physician Decision|3|||
146879263|NCT03349099|529727963|FG001|Overall Study|Physician Decision|4|||
146879264|NCT03349099|529727962|FG000|Overall Study|Stone migrated from the kidney|1|||
146879265|NCT03349099|529727963|FG001|Overall Study|Stone migrated from the kidney|0|||
146879266|NCT00278993|529727964|FG000|Overall Study|Adverse Event|24|||
146879267|NCT00278993|529727964|FG000|Overall Study|Withdrawal by Subject|5|||
146879268|NCT00278993|529727964|FG000|Overall Study|Progressive Disease|65|||
146879269|NCT00278993|529727964|FG000|Overall Study|Physician Decision|9|||
146879270|NCT00278993|529727964|FG000|Overall Study|Not Otherwise Specified|4|||
146879271|NCT01979536|529727968|FG000|Overall Study|Physician Decision|2|||
146879272|NCT01979536|529727969|FG001|Overall Study|Physician Decision|3|||
146879273|NCT01979536|529727968|FG000|Overall Study|Withdrawal by Subject|0|||
146879274|NCT01979536|529727969|FG001|Overall Study|Withdrawal by Subject|1|||
146879275|NCT01979536|529727968|FG000|Overall Study|Refusal|0|||
146879276|NCT01979536|529727969|FG001|Overall Study|Refusal|1|||
146879277|NCT01979536|529727968|FG000|Overall Study|Relapse|0|||
146879278|NCT01979536|529727969|FG001|Overall Study|Relapse|1|||
146879279|NCT01979536|529727968|FG000|Overall Study|Study terminated by Sponsor|0|||
146879280|NCT01979536|529727969|FG001|Overall Study|Study terminated by Sponsor|1|||
146879281|NCT01979536|529727968|FG000|Overall Study|Did not start treatment|0|||
146879282|NCT01979536|529727969|FG001|Overall Study|Did not start treatment|1|||
146879283|NCT03077685|529727970|FG000|Overall Study|Lost to Follow-up|0|||
146879284|NCT03077685|529727971|FG001|Overall Study|Lost to Follow-up|0|||
146879285|NCT03077685|529727972|FG002|Overall Study|Lost to Follow-up|0|||
146879286|NCT03077685|529727973|FG003|Overall Study|Lost to Follow-up|0|||
146879287|NCT03077685|529727974|FG004|Overall Study|Lost to Follow-up|1|||
146879288|NCT03077685|529727970|FG000|Overall Study|Death|0|||
146879289|NCT03077685|529727971|FG001|Overall Study|Death|0|||
146879290|NCT03077685|529727972|FG002|Overall Study|Death|1|||
146879291|NCT03077685|529727973|FG003|Overall Study|Death|1|||
146879292|NCT03077685|529727974|FG004|Overall Study|Death|3|||
146879293|NCT03077685|529727970|FG000|Overall Study|Withdrawal by Subject|0|||
146879294|NCT03077685|529727971|FG001|Overall Study|Withdrawal by Subject|0|||
146879295|NCT03077685|529727972|FG002|Overall Study|Withdrawal by Subject|0|||
146879296|NCT03077685|529727973|FG003|Overall Study|Withdrawal by Subject|2|||
146879297|NCT03077685|529727974|FG004|Overall Study|Withdrawal by Subject|1|||
146879298|NCT03077685|529727970|FG000|Overall Study|Physician Decision|0|||
146879299|NCT03077685|529727971|FG001|Overall Study|Physician Decision|0|||
146879300|NCT03077685|529727972|FG002|Overall Study|Physician Decision|1|||
146879301|NCT03077685|529727973|FG003|Overall Study|Physician Decision|0|||
146879302|NCT03077685|529727974|FG004|Overall Study|Physician Decision|3|||
146879303|NCT03077685|529727970|FG000|Overall Study|Disease Progression|1|||
146879304|NCT03077685|529727971|FG001|Overall Study|Disease Progression|0|||
146879305|NCT03077685|529727972|FG002|Overall Study|Disease Progression|0|||
146879306|NCT03077685|529727973|FG003|Overall Study|Disease Progression|2|||
146879307|NCT03077685|529727974|FG004|Overall Study|Disease Progression|1|||
146879308|NCT03077685|529727970|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
146879309|NCT03077685|529727971|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
146879310|NCT03077685|529727972|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
146879311|NCT03077685|529727973|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
146879312|NCT03077685|529727974|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
146879313|NCT03077685|529727970|FG000|Overall Study|Subject entered hospice care|0|||
146879314|NCT03077685|529727971|FG001|Overall Study|Subject entered hospice care|0|||
146879315|NCT03077685|529727972|FG002|Overall Study|Subject entered hospice care|0|||
146879316|NCT03077685|529727973|FG003|Overall Study|Subject entered hospice care|0|||
146879317|NCT03077685|529727974|FG004|Overall Study|Subject entered hospice care|1|||
146879318|NCT04194528|529727976|FG000|Overall Study|Adverse Event|1|||
146879319|NCT03921424|529727977|FG000|Overall Study|Lost to Follow-up|0|||
146879320|NCT03921424|529727978|FG001|Overall Study|Lost to Follow-up|1|||
146879321|NCT03921424|529727977|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
146879322|NCT03921424|529727978|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
146879323|NCT04294901|529727987|FG000|Overall Study|Death|86|||
146879324|NCT04294901|529727988|FG001|Overall Study|Death|110|||
146879325|NCT04294901|529727987|FG000|Overall Study|Provider did not have historical control patients|581|||
146879326|NCT04294901|529727988|FG001|Overall Study|Provider did not have historical control patients|0|||
146879327|NCT04294901|529727987|FG000|Overall Study|Provider did not have intervention patients|0|||
146879328|NCT04294901|529727988|FG001|Overall Study|Provider did not have intervention patients|98|||
146879329|NCT05038020|529727990|FG000|Overall Study|Early Termination|3|||
146879330|NCT05038020|529727991|FG001|Overall Study|Early Termination|0|||
146879331|NCT03451773|529730145|FG000|Overall Study|Death on study|1|||
146879332|NCT03451773|529730146|FG001|Overall Study|Death on study|5|||
146879333|NCT03451773|529730145|FG000|Overall Study|Death during follow-up period|0|||
146879334|NCT03451773|529730146|FG001|Overall Study|Death during follow-up period|1|||
146879335|NCT01964352|529730147|FG000|Overall Study|Adverse Event|13|||
146879336|NCT01964352|529730148|FG001|Overall Study|Adverse Event|3|||
146879337|NCT01964352|529730149|FG002|Overall Study|Adverse Event|4|||
146879338|NCT01964352|529730150|FG003|Overall Study|Adverse Event|3|||
146879339|NCT01964352|529730147|FG000|Overall Study|Lack of Efficacy|6|||
146879340|NCT01964352|529730148|FG001|Overall Study|Lack of Efficacy|0|||
146879341|NCT01964352|529730149|FG002|Overall Study|Lack of Efficacy|0|||
146879342|NCT01964352|529730150|FG003|Overall Study|Lack of Efficacy|0|||
146879343|NCT01964352|529730147|FG000|Overall Study|Protocol Violation|2|||
146879344|NCT01964352|529730148|FG001|Overall Study|Protocol Violation|4|||
146879345|NCT01964352|529730149|FG002|Overall Study|Protocol Violation|0|||
146879346|NCT01964352|529730150|FG003|Overall Study|Protocol Violation|2|||
146879347|NCT01964352|529730147|FG000|Overall Study|Lost to Follow-up|1|||
146879348|NCT01964352|529730148|FG001|Overall Study|Lost to Follow-up|0|||
146545297|NCT02949934|528503129|FG000|Neuroimaging|Protocol Violation|2|||
146545298|NCT02949934|528503130|FG001|Neuroimaging|Protocol Violation|0|||
146879349|NCT01964352|529730149|FG002|Overall Study|Lost to Follow-up|0|||
146879350|NCT01964352|529730150|FG003|Overall Study|Lost to Follow-up|1|||
146879351|NCT01964352|529730147|FG000|Overall Study|Withdrawal by Subject|4|||
146879352|NCT01964352|529730148|FG001|Overall Study|Withdrawal by Subject|2|||
146879353|NCT01964352|529730149|FG002|Overall Study|Withdrawal by Subject|1|||
146879354|NCT01964352|529730150|FG003|Overall Study|Withdrawal by Subject|0|||
146879355|NCT01964352|529730147|FG000|Overall Study|Other than stated above|0|||
146545299|NCT02949934|528503131|FG002|Neuroimaging|Protocol Violation|0|||
146545300|NCT02949934|528503132|FG003|Neuroimaging|Protocol Violation|0|||
146545301|NCT02949934|528503133|FG004|Neuroimaging|Protocol Violation|1|||
146879356|NCT01964352|529730148|FG001|Overall Study|Other than stated above|2|||
146879357|NCT01964352|529730149|FG002|Overall Study|Other than stated above|1|||
146879358|NCT01964352|529730150|FG003|Overall Study|Other than stated above|2|||
146879359|NCT03468855|529730151|FG000|Overall Study|Adverse Event|2|||
146879360|NCT03468855|529730151|FG000|Overall Study|Lost to Follow-up|5|||
146879361|NCT03468855|529730151|FG000|Overall Study|Withdrawal by Subject|3|||
146545302|NCT02949934|528503134|FG005|Neuroimaging|Protocol Violation|0|||
146879362|NCT03468855|529730151|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
146879363|NCT01394939|529730152|FG000|Overall Study|Adverse Event|1|||
146879364|NCT01394939|529730153|FG001|Overall Study|Adverse Event|3|||
146879365|NCT01394939|529730154|FG002|Overall Study|Adverse Event|0|||
146879366|NCT01394939|529730155|FG003|Overall Study|Adverse Event|2|||
146879367|NCT01394939|529730152|FG000|Overall Study|Death|0|||
146879368|NCT01394939|529730153|FG001|Overall Study|Death|2|||
146879369|NCT01394939|529730154|FG002|Overall Study|Death|0|||
146879370|NCT01394939|529730155|FG003|Overall Study|Death|0|||
146879371|NCT01394939|529730152|FG000|Overall Study|Physician Decision|0|||
146879372|NCT01394939|529730153|FG001|Overall Study|Physician Decision|1|||
146879373|NCT01394939|529730154|FG002|Overall Study|Physician Decision|0|||
146879374|NCT01394939|529730155|FG003|Overall Study|Physician Decision|0|||
146879375|NCT01394939|529730152|FG000|Overall Study|Withdrawal by Subject|0|||
146879376|NCT01394939|529730153|FG001|Overall Study|Withdrawal by Subject|2|||
146879377|NCT01394939|529730154|FG002|Overall Study|Withdrawal by Subject|0|||
146879378|NCT01394939|529730155|FG003|Overall Study|Withdrawal by Subject|2|||
146879379|NCT01394939|529730152|FG000|Overall Study|Others|0|||
146879380|NCT01394939|529730153|FG001|Overall Study|Others|2|||
146879381|NCT01394939|529730154|FG002|Overall Study|Others|0|||
146879382|NCT01394939|529730155|FG003|Overall Study|Others|3|||
146879383|NCT02831673|529730156|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
146879384|NCT02831673|529730157|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
146879385|NCT02831673|529730158|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
146879386|NCT02831673|529730159|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
146879387|NCT02831673|529730160|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
146879388|NCT02831673|529730156|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
146879389|NCT02831673|529730157|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
146879390|NCT02831673|529730158|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
146879391|NCT02831673|529730159|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
146879392|NCT02831673|529730160|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
146879393|NCT02831673|529730156|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
146879394|NCT02831673|529730157|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
146879395|NCT02831673|529730158|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
146879396|NCT02831673|529730159|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
146879397|NCT02831673|529730160|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
146879398|NCT02831673|529730156|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
146879399|NCT02831673|529730157|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
146879400|NCT02831673|529730158|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
146879401|NCT02831673|529730159|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
146879402|NCT02831673|529730160|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
146879403|NCT02831673|529730156|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
146879404|NCT02831673|529730157|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
146879405|NCT02831673|529730158|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
146879406|NCT02831673|529730159|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
146879407|NCT02831673|529730160|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
146879408|NCT02831673|529730156|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
146879409|NCT02831673|529730157|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
146879410|NCT02831673|529730158|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
146879411|NCT02831673|529730159|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
146879412|NCT02831673|529730160|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
146879413|NCT02831673|529730156|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
146879414|NCT02831673|529730157|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
146879415|NCT02831673|529730158|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
146879416|NCT02831673|529730159|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
146879417|NCT02831673|529730160|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
146879418|NCT02831673|529730156|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
146879419|NCT02831673|529730157|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
146629488|NCT01462370|528819754|FG000|Overall Study|Withdrawal by Subject|0|||
146629489|NCT01462370|528819755|FG001|Overall Study|Withdrawal by Subject|3|||
146879420|NCT02831673|529730158|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
146879421|NCT02831673|529730159|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
146879422|NCT02831673|529730160|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
146879423|NCT02831673|529730156|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
146879424|NCT02831673|529730157|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
146879425|NCT02831673|529730158|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
146879426|NCT02831673|529730159|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
146879427|NCT02831673|529730160|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
146879428|NCT02831673|529730156|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
146879429|NCT02831673|529730157|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
146879430|NCT02831673|529730158|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
146879431|NCT02831673|529730159|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
146879432|NCT02831673|529730160|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
146879433|NCT02831673|529730156|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
146879434|NCT02831673|529730157|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
146879435|NCT02831673|529730158|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
146879436|NCT02831673|529730159|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
146879437|NCT02831673|529730160|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
146879438|NCT02831673|529730156|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
146879439|NCT02831673|529730157|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
146879440|NCT02831673|529730158|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
146879441|NCT02831673|529730159|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
146879442|NCT02831673|529730160|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
146879443|NCT02831673|529730156|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
146879444|NCT02831673|529730157|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
146879445|NCT02831673|529730158|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
146879446|NCT02831673|529730159|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
146879447|NCT02831673|529730160|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
146879448|NCT02831673|529730156|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
146879449|NCT02831673|529730157|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
146879450|NCT02831673|529730158|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
146879451|NCT02831673|529730159|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
146879452|NCT02831673|529730160|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
146879453|NCT02831673|529730156|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
146879454|NCT02831673|529730157|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
146879455|NCT02831673|529730158|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
146879456|NCT02831673|529730159|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
146879457|NCT02831673|529730160|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
146879458|NCT02831673|529730156|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
146879459|NCT02831673|529730157|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
146879460|NCT02831673|529730158|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
146879461|NCT02831673|529730159|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
146879462|NCT02831673|529730160|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
146879463|NCT02831673|529730156|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
146879464|NCT02831673|529730157|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
146879465|NCT02831673|529730158|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
146879466|NCT02831673|529730159|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
146879467|NCT02831673|529730160|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
146879468|NCT02831673|529730156|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
146545303|NCT02949934|528503129|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
146545304|NCT02949934|528503130|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
146545305|NCT02949934|528503131|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
146879469|NCT02831673|529730157|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
146879470|NCT02831673|529730158|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
146879471|NCT02831673|529730159|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
146879472|NCT02831673|529730160|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
146879473|NCT02831673|529730156|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
146879474|NCT02831673|529730157|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
146879475|NCT02831673|529730158|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
146879476|NCT02831673|529730159|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
146879477|NCT02831673|529730160|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
146879478|NCT02831673|529730156|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
146879479|NCT02831673|529730157|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
146879480|NCT02831673|529730158|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
146879481|NCT02831673|529730159|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
146879482|NCT02831673|529730160|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
146879483|NCT00477165|529730161|FG000|Overall Study|Adverse Event|7|||
146879484|NCT00477165|529730162|FG001|Overall Study|Adverse Event|2|||
146879485|NCT01623271|529730169|FG000|Overall Study|Withdrawal by Subject|2|||
146879486|NCT00879229|529730176|FG000|Overall Study|Study terminated by Sponsor|13|||
146879487|NCT00879229|529730177|FG001|Overall Study|Study terminated by Sponsor|12|||
146879488|NCT00879229|529730176|FG000|Overall Study|Death|4|||
146879489|NCT00879229|529730177|FG001|Overall Study|Death|2|||
146879490|NCT00879229|529730176|FG000|Overall Study|Adverse Event|2|||
146879491|NCT00879229|529730177|FG001|Overall Study|Adverse Event|0|||
146879492|NCT00879229|529730176|FG000|Overall Study|Withdrawal by Subject|1|||
146879493|NCT00879229|529730177|FG001|Overall Study|Withdrawal by Subject|0|||
146879494|NCT00879229|529730176|FG000|Overall Study|Clinical status did not improve|1|||
146879495|NCT00879229|529730177|FG001|Overall Study|Clinical status did not improve|0|||
146879496|NCT00879229|529730176|FG000|Overall Study|Other|1|||
146879497|NCT00879229|529730177|FG001|Overall Study|Other|0|||
146879498|NCT00631371|529730178|FG000|Overall Study|Lost to Follow-up|24|||
146879499|NCT00631371|529730179|FG001|Overall Study|Lost to Follow-up|19|||
146879500|NCT00631371|529730178|FG000|Overall Study|Other reason|5|||
146879501|NCT00631371|529730179|FG001|Overall Study|Other reason|12|||
146879502|NCT00631371|529730178|FG000|Overall Study|subject request|38|||
146879503|NCT00631371|529730179|FG001|Overall Study|subject request|45|||
146765031|NCT00957658|529307217|FG000|Overall Study|unwilling/unable to return|2|||
146879504|NCT00631371|529730178|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
146765032|NCT00957658|529307217|FG000|Overall Study|surgery cancelled|2|||
146629490|NCT01747876|528819756|FG000|Overall Study|Adverse Event|1|||
146879505|NCT00631371|529730179|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
146879506|NCT00631371|529730178|FG000|Overall Study|Death|263|||
146879507|NCT00631371|529730179|FG001|Overall Study|Death|239|||
146629491|NCT01747876|528819757|FG001|Overall Study|Adverse Event|0|||
146629492|NCT01747876|528819758|FG002|Overall Study|Adverse Event|2|||
146629493|NCT01747876|528819756|FG000|Overall Study|Withdrawal by Subject|0|||
146629494|NCT01747876|528819757|FG001|Overall Study|Withdrawal by Subject|1|||
146879508|NCT00513409|529730185|FG000|Overall Study|Adverse Event|0|||
146879509|NCT00513409|529730186|FG001|Overall Study|Adverse Event|1|||
146879510|NCT00513409|529730185|FG000|Overall Study|Withdrawal by Subject|0|||
146879511|NCT00513409|529730186|FG001|Overall Study|Withdrawal by Subject|2|||
146879512|NCT00513409|529730185|FG000|Overall Study|Lost to Follow-up|0|||
146879513|NCT00513409|529730186|FG001|Overall Study|Lost to Follow-up|1|||
146879514|NCT00513409|529730185|FG000|Overall Study|Physician Decision|1|||
146879515|NCT00513409|529730186|FG001|Overall Study|Physician Decision|0|||
146879516|NCT00513409|529730185|FG000|Overall Study|Visit 3 not done|1|||
146879517|NCT00513409|529730186|FG001|Overall Study|Visit 3 not done|2|||
146879518|NCT01049035|529730187|FG000|Overall Study|Serious adverse event|0|||
146879519|NCT01049035|529730188|FG001|Overall Study|Serious adverse event|1|||
146879520|NCT01049035|529730189|FG002|Overall Study|Serious adverse event|1|||
146629495|NCT01747876|528819758|FG002|Overall Study|Withdrawal by Subject|1|||
146765033|NCT00957658|529307217|FG000|Overall Study|Protocol Violation|5|||
146879521|NCT01049035|529730190|FG003|Overall Study|Serious adverse event|2|||
146879522|NCT01049035|529730191|FG004|Overall Study|Serious adverse event|0|||
146879523|NCT01049035|529730192|FG005|Overall Study|Serious adverse event|0|||
146879524|NCT01049035|529730193|FG006|Overall Study|Serious adverse event|0|||
146879525|NCT01049035|529730187|FG000|Overall Study|Other adverse event (AE)|0|||
146879526|NCT01049035|529730188|FG001|Overall Study|Other adverse event (AE)|0|||
146879527|NCT01049035|529730189|FG002|Overall Study|Other adverse event (AE)|0|||
146879528|NCT01049035|529730190|FG003|Overall Study|Other adverse event (AE)|1|||
146879529|NCT01049035|529730191|FG004|Overall Study|Other adverse event (AE)|0|||
146879530|NCT01049035|529730192|FG005|Overall Study|Other adverse event (AE)|0|||
146879531|NCT01049035|529730193|FG006|Overall Study|Other adverse event (AE)|0|||
146879532|NCT01049035|529730187|FG000|Overall Study|Non-compliance with the protocol|12|||
146879533|NCT01049035|529730188|FG001|Overall Study|Non-compliance with the protocol|6|||
146879534|NCT01049035|529730189|FG002|Overall Study|Non-compliance with the protocol|14|||
146879535|NCT01049035|529730190|FG003|Overall Study|Non-compliance with the protocol|5|||
146545306|NCT02949934|528503132|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
146545307|NCT02949934|528503133|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
146545308|NCT02949934|528503134|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
146545309|NCT02949934|528503129|FG000|Neuroimaging|Not scanned|0|||
146545310|NCT02949934|528503130|FG001|Neuroimaging|Not scanned|0|||
146545311|NCT02949934|528503131|FG002|Neuroimaging|Not scanned|1|||
146545312|NCT02949934|528503132|FG003|Neuroimaging|Not scanned|0|||
146545313|NCT02949934|528503133|FG004|Neuroimaging|Not scanned|0|||
146545314|NCT02949934|528503134|FG005|Neuroimaging|Not scanned|2|||
146545315|NCT02949934|528503129|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
146545316|NCT02949934|528503130|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
146545317|NCT02949934|528503131|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
146545318|NCT02949934|528503132|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
146545319|NCT02949934|528503133|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
146545320|NCT02949934|528503134|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
146545321|NCT02949934|528503129|FG000|Bar Laboratory|Adverse Event|1|||
146545322|NCT02949934|528503130|FG001|Bar Laboratory|Adverse Event|0|||
146545323|NCT02949934|528503131|FG002|Bar Laboratory|Adverse Event|2|||
146629496|NCT01747876|528819756|FG000|Overall Study|Disease progression|4|||
146629497|NCT01747876|528819757|FG001|Overall Study|Disease progression|13|||
146629498|NCT01747876|528819758|FG002|Overall Study|Disease progression|8|||
146629499|NCT01747876|528819756|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
146879536|NCT01049035|529730191|FG004|Overall Study|Non-compliance with the protocol|3|||
146879537|NCT01049035|529730192|FG005|Overall Study|Non-compliance with the protocol|4|||
146545324|NCT02949934|528503132|FG003|Bar Laboratory|Adverse Event|0|||
146545325|NCT02949934|528503133|FG004|Bar Laboratory|Adverse Event|1|||
146545326|NCT02949934|528503134|FG005|Bar Laboratory|Adverse Event|0|||
146879538|NCT01049035|529730193|FG006|Overall Study|Non-compliance with the protocol|10|||
146879539|NCT01049035|529730187|FG000|Overall Study|Lost to Follow-up|5|||
146879540|NCT01049035|529730188|FG001|Overall Study|Lost to Follow-up|4|||
146879541|NCT01049035|529730189|FG002|Overall Study|Lost to Follow-up|4|||
146879542|NCT01049035|529730190|FG003|Overall Study|Lost to Follow-up|1|||
146879543|NCT01049035|529730191|FG004|Overall Study|Lost to Follow-up|0|||
146879544|NCT01049035|529730192|FG005|Overall Study|Lost to Follow-up|3|||
146879545|NCT01049035|529730193|FG006|Overall Study|Lost to Follow-up|3|||
146879546|NCT01049035|529730187|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
146879547|NCT01049035|529730188|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
146879548|NCT01049035|529730189|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
146879549|NCT01049035|529730190|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
146879550|NCT01049035|529730191|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
146879551|NCT01049035|529730192|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
146879552|NCT01049035|529730193|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
146879553|NCT00812214|529730199|FG000|Overall Study|Lost to Follow-up|3|||
146879554|NCT00812214|529730200|FG001|Overall Study|Lost to Follow-up|1|||
146879555|NCT01659320|529730201|FG000|Overall Study|Withdrawal by Subject|2|||
146879556|NCT01659320|529730201|FG000|Overall Study|Physician Decision|1|||
146879557|NCT00590590|529730202|FG000|Overall Study|Lack of Efficacy|1|||
146879558|NCT00590590|529730203|FG001|Overall Study|Lack of Efficacy|2|||
146879559|NCT00590590|529730204|FG002|Overall Study|Lack of Efficacy|0|||
146879560|NCT00590590|529730202|FG000|Overall Study|Adverse Event|1|||
146879561|NCT00590590|529730203|FG001|Overall Study|Adverse Event|0|||
146879562|NCT00590590|529730204|FG002|Overall Study|Adverse Event|0|||
146879563|NCT00590590|529730202|FG000|Overall Study|Protocol Violation|0|||
146879564|NCT00590590|529730203|FG001|Overall Study|Protocol Violation|0|||
146879565|NCT00590590|529730204|FG002|Overall Study|Protocol Violation|2|||
146879566|NCT00590590|529730202|FG000|Overall Study|Lost to Follow-up|4|||
146879567|NCT00590590|529730203|FG001|Overall Study|Lost to Follow-up|1|||
146879568|NCT00590590|529730204|FG002|Overall Study|Lost to Follow-up|2|||
146879569|NCT00590590|529730202|FG000|Overall Study|Withdrawal by Subject|0|||
146879570|NCT00590590|529730203|FG001|Overall Study|Withdrawal by Subject|1|||
146879571|NCT00590590|529730204|FG002|Overall Study|Withdrawal by Subject|1|||
146879572|NCT00590590|529730202|FG000|Overall Study|Did not complete due to study closure|1|||
146879573|NCT00590590|529730203|FG001|Overall Study|Did not complete due to study closure|1|||
146879574|NCT00590590|529730204|FG002|Overall Study|Did not complete due to study closure|1|||
146879575|NCT00590590|529730202|FG000|Overall Study|Did not complete study|0|||
146879576|NCT00590590|529730203|FG001|Overall Study|Did not complete study|1|||
146879577|NCT00590590|529730204|FG002|Overall Study|Did not complete study|0|||
146879578|NCT01514682|529730205|FG000|Overall Study|Withdrawal by Subject|2|||
146879579|NCT01514682|529730206|FG001|Overall Study|Withdrawal by Subject|3|||
146879580|NCT01514682|529730205|FG000|Overall Study|Physician Decision|4|||
146879581|NCT01514682|529730206|FG001|Overall Study|Physician Decision|3|||
146879582|NCT00132132|529730207|FG000|Overall Study|Lost to Follow-up|7|||
146879583|NCT00132132|529730208|FG001|Overall Study|Lost to Follow-up|2|||
146879584|NCT01870401|529730209|FG000|Overall Study|Death|48|||
146879585|NCT01870401|529730210|FG001|Overall Study|Death|24|||
146879586|NCT01870401|529730209|FG000|Overall Study|Withdrawal by Subject|39|||
146879587|NCT01870401|529730210|FG001|Overall Study|Withdrawal by Subject|26|||
146879588|NCT01870401|529730209|FG000|Overall Study|Lost to Follow-up|19|||
146879589|NCT01870401|529730210|FG001|Overall Study|Lost to Follow-up|14|||
146879590|NCT01870401|529730209|FG000|Overall Study|Other|9|||
146879591|NCT01870401|529730210|FG001|Overall Study|Other|7|||
146879592|NCT01870401|529730209|FG000|Overall Study|On-going in the Study|35|||
146879593|NCT01870401|529730210|FG001|Overall Study|On-going in the Study|25|||
146879594|NCT03605680|529730212|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
146879595|NCT03605680|529730213|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
146879596|NCT03605680|529730214|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
146879597|NCT03605680|529730215|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
146879598|NCT03605680|529730212|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
146879599|NCT03605680|529730213|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
146879600|NCT03605680|529730214|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
146879601|NCT03605680|529730215|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
146879602|NCT03605680|529730212|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
146879603|NCT03605680|529730213|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
146879604|NCT03605680|529730214|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
146879605|NCT03605680|529730215|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
146879606|NCT03605680|529730212|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
146879607|NCT03605680|529730213|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
146879608|NCT03605680|529730214|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
146879609|NCT03605680|529730215|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
146879610|NCT03605680|529730212|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
146879611|NCT03605680|529730213|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
146879612|NCT03605680|529730214|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
146879613|NCT03605680|529730215|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
146879614|NCT03605680|529730212|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
146879615|NCT03605680|529730213|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
146879616|NCT03605680|529730214|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
146879617|NCT03605680|529730215|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
146879618|NCT03605680|529730212|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
146879619|NCT03605680|529730213|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
146879620|NCT03605680|529730214|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
146879621|NCT03605680|529730215|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
146879622|NCT03605680|529730212|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
146879623|NCT03605680|529730213|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
146879624|NCT03605680|529730214|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
146879625|NCT03605680|529730215|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
146879626|NCT03605680|529730212|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
146879627|NCT03605680|529730213|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
146879628|NCT03605680|529730214|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
146879629|NCT03605680|529730215|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
146879630|NCT03605680|529730212|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
146879631|NCT03605680|529730213|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
146879632|NCT03605680|529730214|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
146879633|NCT03605680|529730215|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
146879634|NCT03605680|529730212|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
146879635|NCT03605680|529730213|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
146879636|NCT03605680|529730214|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
146879637|NCT03605680|529730215|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
146879638|NCT03605680|529730212|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
146879639|NCT03605680|529730213|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
146879640|NCT03605680|529730214|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
146879641|NCT03605680|529730215|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
146879642|NCT03605680|529730212|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
146879643|NCT03605680|529730213|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
146879644|NCT03605680|529730214|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
146879645|NCT03605680|529730215|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
146879646|NCT03605680|529730212|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
146879647|NCT03605680|529730213|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
146879648|NCT03605680|529730214|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
146879649|NCT03605680|529730215|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
146879650|NCT03605680|529730212|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
146879651|NCT03605680|529730213|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
146879652|NCT03605680|529730214|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
146879653|NCT03605680|529730215|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
146879654|NCT03605680|529730212|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
146879655|NCT03605680|529730213|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
146879656|NCT03605680|529730214|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
146879657|NCT03605680|529730215|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
146879658|NCT03605680|529730212|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
146879659|NCT03605680|529730213|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
146879660|NCT03605680|529730214|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
146879661|NCT03605680|529730215|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
146879662|NCT03605680|529730212|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
146879663|NCT03605680|529730213|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
146879664|NCT03605680|529730214|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
146879665|NCT03605680|529730215|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
146879666|NCT03605680|529730212|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
146879667|NCT03605680|529730213|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
146879668|NCT03605680|529730214|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
146879669|NCT03605680|529730215|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
146879670|NCT03189446|529730216|FG000|Overall Study|Adverse Event|2|||
146879671|NCT03189446|529730216|FG000|Overall Study|Withdrawal by Subject|2|||
146879672|NCT03189446|529730216|FG000|Overall Study|Physician Decision|1|||
146879673|NCT05594173|529730217|FG000|Overall Study|Adverse Event|1|||
146879674|NCT05594173|529730217|FG000|Overall Study|COVID-19 Pandemic|2|||
146545327|NCT02949934|528503129|FG000|Bar Laboratory|Protocol Violation|0|||
146545328|NCT02949934|528503130|FG001|Bar Laboratory|Protocol Violation|0|||
146879675|NCT00647556|529730218|FG000|Overall Study|Adverse Event|0|||
146879676|NCT00647556|529730219|FG001|Overall Study|Adverse Event|1|||
146879677|NCT00647556|529730218|FG000|Overall Study|Lost to Follow-up|1|||
146879678|NCT00647556|529730219|FG001|Overall Study|Lost to Follow-up|0|||
146879679|NCT00647556|529730218|FG000|Overall Study|Protocol Violation|0|||
146879680|NCT00647556|529730219|FG001|Overall Study|Protocol Violation|1|||
146879681|NCT00647556|529730218|FG000|Overall Study|Withdrawal by Subject|1|||
146879682|NCT00647556|529730219|FG001|Overall Study|Withdrawal by Subject|0|||
146879683|NCT00647556|529730218|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
146879684|NCT00647556|529730219|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
146879685|NCT03865706|529730221|FG000|Overall Study|Death|0|||
146879686|NCT03865706|529730222|FG001|Overall Study|Death|3|||
146879687|NCT03865706|529730223|FG002|Overall Study|Death|1|||
146879688|NCT02646982|529730224|FG000|Overall Study|Adverse Event|1|||
146879689|NCT02646982|529730225|FG001|Overall Study|Adverse Event|1|||
146879690|NCT02646982|529730224|FG000|Overall Study|Withdrawal by Subject|2|||
146879691|NCT02646982|529730225|FG001|Overall Study|Withdrawal by Subject|1|||
146879692|NCT02095535|529730226|FG000|Recruitment|Protocol Violation|2|||
146879693|NCT00713700|529730227|FG000|Overall Study|Lost to Follow-up|3|||
146879694|NCT00713700|529730227|FG000|Overall Study|Withdrawal by Subject|1|||
146879695|NCT00781456|529730228|FG000|Overall Study|Adverse Event|3|||
146879696|NCT00781456|529730229|FG001|Overall Study|Adverse Event|3|||
146879697|NCT00781456|529730228|FG000|Overall Study|Withdrawal by Subject|3|||
146879698|NCT00781456|529730229|FG001|Overall Study|Withdrawal by Subject|5|||
146879699|NCT00781456|529730228|FG000|Overall Study|Protocol Violation|4|||
146879700|NCT00781456|529730229|FG001|Overall Study|Protocol Violation|1|||
146879701|NCT00781456|529730228|FG000|Overall Study|Noncompliance With Protocol|1|||
146879702|NCT00781456|529730229|FG001|Overall Study|Noncompliance With Protocol|1|||
146879703|NCT00781456|529730228|FG000|Overall Study|Lost to Follow-up|10|||
146879704|NCT00781456|529730229|FG001|Overall Study|Lost to Follow-up|5|||
146879705|NCT00781456|529730228|FG000|Overall Study|Other Reason, Unknown|0|||
146879706|NCT00781456|529730229|FG001|Overall Study|Other Reason, Unknown|1|||
146879707|NCT03776175|529730231|FG000|Treatment Period (42 Days)|Adverse Event|0|||
146879708|NCT03776175|529730232|FG001|Treatment Period (42 Days)|Adverse Event|1|||
146879709|NCT03776175|529730233|FG002|Treatment Period (42 Days)|Adverse Event|1|||
146879710|NCT03776175|529730234|FG003|Treatment Period (42 Days)|Adverse Event|0|||
146879711|NCT03776175|529730231|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
146879712|NCT03776175|529730232|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
146879713|NCT03776175|529730233|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
146879714|NCT03776175|529730234|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
146879715|NCT03776175|529730231|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
146879716|NCT03776175|529730232|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
146879717|NCT03776175|529730233|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
146879718|NCT03776175|529730234|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
146879719|NCT03776175|529730231|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
146879720|NCT03776175|529730232|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
146879721|NCT03776175|529730233|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
146879722|NCT03776175|529730234|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
146879723|NCT03776175|529730231|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
146879724|NCT03776175|529730232|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
146879725|NCT03776175|529730233|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
146879726|NCT03776175|529730234|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
146879727|NCT03776175|529730231|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
146879728|NCT03776175|529730232|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
146879729|NCT03776175|529730233|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
146879730|NCT03776175|529730234|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
146545329|NCT02949934|528503131|FG002|Bar Laboratory|Protocol Violation|0|||
146545330|NCT02949934|528503132|FG003|Bar Laboratory|Protocol Violation|1|||
146545331|NCT02949934|528503133|FG004|Bar Laboratory|Protocol Violation|0|||
146879731|NCT00960661|529730236|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
146545332|NCT02949934|528503134|FG005|Bar Laboratory|Protocol Violation|0|||
146879732|NCT00960661|529730237|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
146879733|NCT00960661|529730238|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
146879734|NCT00960661|529730236|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
146879735|NCT00960661|529730237|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
146879736|NCT00960661|529730238|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
146879737|NCT00960661|529730236|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
146879738|NCT00960661|529730237|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
146914678|NCT03303339|529850051|FG009|Overall Study|Physician Decision|0|||
146545333|NCT05643794|528504307|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
146879739|NCT00960661|529730238|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
146879740|NCT00960661|529730236|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
146879741|NCT00960661|529730237|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
146879742|NCT00960661|529730238|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
146879743|NCT00960661|529730236|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
146879744|NCT00960661|529730237|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
146879745|NCT00960661|529730238|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
146879746|NCT00960661|529730236|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
146879747|NCT00960661|529730237|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
146629500|NCT01747876|528819757|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
146629501|NCT01747876|528819758|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
146765034|NCT01156116|529307218|FG000|Overall Study|Withdrawal by Subject|3|||
146879748|NCT00960661|529730238|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
146879749|NCT00960661|529730236|FG000|Interventional Phase|Adverse Event|0|||
146879750|NCT00960661|529730237|FG001|Interventional Phase|Adverse Event|17|||
146879751|NCT00960661|529730238|FG002|Interventional Phase|Adverse Event|8|||
146879752|NCT00960661|529730236|FG000|Interventional Phase|Death|0|||
146879753|NCT00960661|529730237|FG001|Interventional Phase|Death|1|||
146879754|NCT00960661|529730238|FG002|Interventional Phase|Death|0|||
146879755|NCT00960661|529730236|FG000|Interventional Phase|Lost to Follow-up|0|||
146879756|NCT00960661|529730237|FG001|Interventional Phase|Lost to Follow-up|0|||
146879757|NCT00960661|529730238|FG002|Interventional Phase|Lost to Follow-up|2|||
146879758|NCT00960661|529730236|FG000|Interventional Phase|entry criteria not met|0|||
146879759|NCT00960661|529730237|FG001|Interventional Phase|entry criteria not met|3|||
146879760|NCT00960661|529730238|FG002|Interventional Phase|entry criteria not met|0|||
146879761|NCT00960661|529730236|FG000|Interventional Phase|Protocol Violation|0|||
146879762|NCT00960661|529730237|FG001|Interventional Phase|Protocol Violation|7|||
146879763|NCT00960661|529730238|FG002|Interventional Phase|Protocol Violation|2|||
146879764|NCT00960661|529730236|FG000|Interventional Phase|Withdrawal by Subject|0|||
146879765|NCT00960661|529730237|FG001|Interventional Phase|Withdrawal by Subject|18|||
146879766|NCT00960661|529730238|FG002|Interventional Phase|Withdrawal by Subject|29|||
146879767|NCT00960661|529730236|FG000|Interventional Phase|Physician Decision|0|||
146879768|NCT00960661|529730237|FG001|Interventional Phase|Physician Decision|3|||
146879769|NCT00960661|529730238|FG002|Interventional Phase|Physician Decision|5|||
146879770|NCT00960661|529730236|FG000|Interventional Phase|sponsor decision|0|||
146879771|NCT00960661|529730237|FG001|Interventional Phase|sponsor decision|1|||
146879772|NCT00960661|529730238|FG002|Interventional Phase|sponsor decision|0|||
146879773|NCT00960661|529730236|FG000|Interventional Phase|Lack of Efficacy|0|||
146879774|NCT00960661|529730237|FG001|Interventional Phase|Lack of Efficacy|2|||
146879775|NCT00960661|529730238|FG002|Interventional Phase|Lack of Efficacy|0|||
146879776|NCT03273166|529730239|FG000|Overall Study|Withdrawn prior to Completion|31|||
146879777|NCT00915681|529730243|FG000|Overall Study|Screening failures|46|||
146879778|NCT03221751|529730244|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
146879779|NCT03221751|529730245|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
146879780|NCT00535132|529730251|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
146879781|NCT00535132|529730252|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
146879782|NCT00535132|529730251|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
146879783|NCT00535132|529730252|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
146879784|NCT04288154|529730253|FG000|Overall Study|Withdrawal by Subject|9|||
146545334|NCT05643794|528504308|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
146545335|NCT05643794|528504309|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
146545336|NCT05643794|528504307|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
146545337|NCT05643794|528504308|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146545338|NCT05643794|528504309|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146545339|NCT05643794|528504307|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
146545340|NCT05643794|528504308|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
146545341|NCT05643794|528504309|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
146545342|NCT05643794|528504307|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
146545343|NCT05643794|528504308|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
146545344|NCT05643794|528504309|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
146545345|NCT05643794|528504307|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
146629502|NCT00853307|528819759|FG000|Overall Study|Adverse Event|1|||
146629503|NCT00853307|528819760|FG001|Overall Study|Adverse Event|2|||
146879785|NCT04288154|529730254|FG001|Overall Study|Withdrawal by Subject|9|||
146879786|NCT00996944|529730255|FG000|Double-blind Treatment Period|Adverse Event|2|||
146879787|NCT00996944|529730256|FG001|Double-blind Treatment Period|Adverse Event|1|||
146879788|NCT00996944|529730255|FG000|Double-blind Treatment Period|Protocol Violation|1|||
146879789|NCT00996944|529730256|FG001|Double-blind Treatment Period|Protocol Violation|0|||
146879790|NCT00996944|529730255|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
146879791|NCT00996944|529730256|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
146879792|NCT00996944|529730255|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
146879793|NCT00996944|529730256|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
146879794|NCT00996944|529730255|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
146879795|NCT00996944|529730256|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
146879796|NCT00769184|529730257|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
146879797|NCT00769184|529730258|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
146879798|NCT00769184|529730257|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
146879799|NCT00769184|529730258|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
146879800|NCT00769184|529730257|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
146879801|NCT00769184|529730258|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
146879802|NCT00385255|529730259|FG000|Overall Study|Serious Adverse Event|1|||
146879803|NCT00385255|529730260|FG001|Overall Study|Serious Adverse Event|2|||
146879804|NCT00385255|529730259|FG000|Overall Study|Protocol Violation|0|||
146879805|NCT00385255|529730260|FG001|Overall Study|Protocol Violation|4|||
146879806|NCT00385255|529730259|FG000|Overall Study|Withdrawal by Subject|0|||
146879807|NCT00385255|529730260|FG001|Overall Study|Withdrawal by Subject|8|||
146879808|NCT00385255|529730259|FG000|Overall Study|Migrated/moved from study area|0|||
146879809|NCT00385255|529730260|FG001|Overall Study|Migrated/moved from study area|1|||
146879810|NCT00385255|529730259|FG000|Overall Study|Lost to Follow-up|20|||
146879811|NCT00385255|529730260|FG001|Overall Study|Lost to Follow-up|58|||
146879812|NCT00583362|529730261|FG000|Overall Study|Adverse Event|44|||
146879813|NCT00583362|529730261|FG000|Overall Study|Lack of Efficacy|22|||
146879814|NCT00583362|529730261|FG000|Overall Study|Lost to Follow-up|4|||
146879815|NCT00583362|529730261|FG000|Overall Study|Non-compliance with study drug|28|||
146879816|NCT00583362|529730261|FG000|Overall Study|Pregnancy|7|||
146879817|NCT00583362|529730261|FG000|Overall Study|Miscommunication of visit window|5|||
146879818|NCT00583362|529730261|FG000|Overall Study|Current site closed|7|||
146879819|NCT00583362|529730261|FG000|Overall Study|Subject not dosed in LBSL99|1|||
146879820|NCT00583362|529730261|FG000|Overall Study|Subject moved out of the country/state|2|||
146879821|NCT00583362|529730261|FG000|Overall Study|Missed visits due to staff changes|1|||
146879822|NCT00583362|529730261|FG000|Overall Study|Misunderstanding of protocol|1|||
146879823|NCT00583362|529730261|FG000|Overall Study|Behavioral problems and non-compliance|1|||
146879824|NCT00583362|529730261|FG000|Overall Study|Sponsor request due to missed doses|1|||
146879825|NCT00583362|529730261|FG000|Overall Study|Physician Decision|19|||
146879826|NCT00583362|529730261|FG000|Overall Study|Protocol Violation|2|||
146879827|NCT00583362|529730261|FG000|Overall Study|Withdrawal by Subject|57|||
146879828|NCT01136655|529730266|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
146879829|NCT01136655|529730266|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
146879830|NCT01136655|529730266|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
146879831|NCT01136655|529730266|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
146879832|NCT02873936|529730269|FG000|Overall Study|Withdrew Consent|4|||
146879833|NCT02873936|529730270|FG001|Overall Study|Withdrew Consent|11|||
146879834|NCT02873936|529730271|FG002|Overall Study|Withdrew Consent|20|||
146879835|NCT02873936|529730269|FG000|Overall Study|Investigator's Discretion|3|||
146879836|NCT02873936|529730270|FG001|Overall Study|Investigator's Discretion|5|||
146879837|NCT02873936|529730271|FG002|Overall Study|Investigator's Discretion|4|||
146879838|NCT02873936|529730269|FG000|Overall Study|Adverse Event|3|||
146879839|NCT02873936|529730270|FG001|Overall Study|Adverse Event|5|||
146879840|NCT02873936|529730271|FG002|Overall Study|Adverse Event|3|||
146879841|NCT02873936|529730269|FG000|Overall Study|Protocol Violation|0|||
146879842|NCT02873936|529730270|FG001|Overall Study|Protocol Violation|1|||
146879843|NCT02873936|529730271|FG002|Overall Study|Protocol Violation|3|||
146879844|NCT02873936|529730269|FG000|Overall Study|Lost to Follow-up|1|||
146879845|NCT02873936|529730270|FG001|Overall Study|Lost to Follow-up|1|||
146879846|NCT02873936|529730271|FG002|Overall Study|Lost to Follow-up|1|||
146879847|NCT02873936|529730269|FG000|Overall Study|Non-compliance With Study Drug|1|||
146879848|NCT02873936|529730270|FG001|Overall Study|Non-compliance With Study Drug|0|||
146879849|NCT02873936|529730271|FG002|Overall Study|Non-compliance With Study Drug|1|||
146879850|NCT02873936|529730269|FG000|Overall Study|Randomized but not Dosed|1|||
146879851|NCT02873936|529730270|FG001|Overall Study|Randomized but not Dosed|0|||
146879852|NCT02873936|529730271|FG002|Overall Study|Randomized but not Dosed|0|||
146879853|NCT01015768|529730272|FG000|Overall Study|Some subject data unuseable|4|||
146879854|NCT01015768|529730273|FG001|Overall Study|Some subject data unuseable|4|||
146879855|NCT01225731|529730274|FG000|Part 1|Did not meet eligibility criteria|1|||
146879856|NCT01225731|529730275|FG001|Part 1|Did not meet eligibility criteria|0|||
146879857|NCT01225731|529730276|FG002|Part 1|Did not meet eligibility criteria|0|||
146879858|NCT01225731|529730277|FG003|Part 1|Did not meet eligibility criteria|0|||
146879859|NCT01225731|529730278|FG004|Part 1|Did not meet eligibility criteria|1|||
146879860|NCT01225731|529730279|FG005|Part 1|Did not meet eligibility criteria|0|||
146879861|NCT01225731|529730280|FG006|Part 1|Did not meet eligibility criteria|0|||
146879862|NCT01225731|529730281|FG007|Part 1|Did not meet eligibility criteria|0|||
146879863|NCT01225731|529730282|FG008|Part 1|Did not meet eligibility criteria|0|||
146879864|NCT01225731|529730283|FG009|Part 1|Did not meet eligibility criteria|0|||
146879865|NCT01225731|529730284|FG010|Part 1|Did not meet eligibility criteria|0|||
146879866|NCT01225731|529730285|FG011|Part 1|Did not meet eligibility criteria|0|||
146879867|NCT01225731|529730286|FG012|Part 1|Did not meet eligibility criteria|0|||
146879868|NCT01225731|529730274|FG000|Part 1|Adverse Event|1|||
146879869|NCT01225731|529730275|FG001|Part 1|Adverse Event|2|||
146879870|NCT01225731|529730276|FG002|Part 1|Adverse Event|1|||
146879871|NCT01225731|529730277|FG003|Part 1|Adverse Event|1|||
146879872|NCT01225731|529730278|FG004|Part 1|Adverse Event|1|||
146879873|NCT01225731|529730279|FG005|Part 1|Adverse Event|0|||
146879874|NCT01225731|529730280|FG006|Part 1|Adverse Event|0|||
146879875|NCT01225731|529730281|FG007|Part 1|Adverse Event|0|||
146879876|NCT01225731|529730282|FG008|Part 1|Adverse Event|0|||
146879877|NCT01225731|529730283|FG009|Part 1|Adverse Event|0|||
146879878|NCT01225731|529730284|FG010|Part 1|Adverse Event|0|||
146879879|NCT01225731|529730285|FG011|Part 1|Adverse Event|0|||
146879880|NCT01225731|529730286|FG012|Part 1|Adverse Event|0|||
146879881|NCT01225731|529730274|FG000|Part 1|Withdrawal by Subject|0|||
146879882|NCT01225731|529730275|FG001|Part 1|Withdrawal by Subject|3|||
146879883|NCT01225731|529730276|FG002|Part 1|Withdrawal by Subject|0|||
146879884|NCT01225731|529730277|FG003|Part 1|Withdrawal by Subject|0|||
146879885|NCT01225731|529730278|FG004|Part 1|Withdrawal by Subject|4|||
146879886|NCT01225731|529730279|FG005|Part 1|Withdrawal by Subject|0|||
146879887|NCT01225731|529730280|FG006|Part 1|Withdrawal by Subject|0|||
146879888|NCT01225731|529730281|FG007|Part 1|Withdrawal by Subject|0|||
146879889|NCT01225731|529730282|FG008|Part 1|Withdrawal by Subject|0|||
146879890|NCT01225731|529730283|FG009|Part 1|Withdrawal by Subject|0|||
146879891|NCT01225731|529730284|FG010|Part 1|Withdrawal by Subject|0|||
146879892|NCT01225731|529730285|FG011|Part 1|Withdrawal by Subject|0|||
146879893|NCT01225731|529730286|FG012|Part 1|Withdrawal by Subject|0|||
146879894|NCT01225731|529730274|FG000|Part 1|Protocol Violation|0|||
146879895|NCT01225731|529730275|FG001|Part 1|Protocol Violation|0|||
146879896|NCT01225731|529730276|FG002|Part 1|Protocol Violation|0|||
146879897|NCT01225731|529730277|FG003|Part 1|Protocol Violation|1|||
146879898|NCT01225731|529730278|FG004|Part 1|Protocol Violation|0|||
146879899|NCT01225731|529730279|FG005|Part 1|Protocol Violation|0|||
146879900|NCT01225731|529730280|FG006|Part 1|Protocol Violation|0|||
146879901|NCT01225731|529730281|FG007|Part 1|Protocol Violation|0|||
146879902|NCT01225731|529730282|FG008|Part 1|Protocol Violation|0|||
146879903|NCT01225731|529730283|FG009|Part 1|Protocol Violation|0|||
146879904|NCT01225731|529730284|FG010|Part 1|Protocol Violation|0|||
146879905|NCT01225731|529730285|FG011|Part 1|Protocol Violation|0|||
146879906|NCT01225731|529730286|FG012|Part 1|Protocol Violation|0|||
146879907|NCT01225731|529730274|FG000|Part 2|Protocol Violation|0|||
146879908|NCT01225731|529730275|FG001|Part 2|Protocol Violation|0|||
146879909|NCT01225731|529730276|FG002|Part 2|Protocol Violation|0|||
146879910|NCT01225731|529730277|FG003|Part 2|Protocol Violation|0|||
146879911|NCT01225731|529730278|FG004|Part 2|Protocol Violation|0|||
146879912|NCT01225731|529730279|FG005|Part 2|Protocol Violation|1|||
146879913|NCT01225731|529730280|FG006|Part 2|Protocol Violation|0|||
146879914|NCT01225731|529730281|FG007|Part 2|Protocol Violation|0|||
146879915|NCT01225731|529730282|FG008|Part 2|Protocol Violation|1|||
146879916|NCT01225731|529730283|FG009|Part 2|Protocol Violation|0|||
146879917|NCT01225731|529730284|FG010|Part 2|Protocol Violation|0|||
146879918|NCT01225731|529730285|FG011|Part 2|Protocol Violation|0|||
146879919|NCT01225731|529730286|FG012|Part 2|Protocol Violation|0|||
146879920|NCT01225731|529730274|FG000|Part 2|Adverse Event|0|||
146879921|NCT01225731|529730275|FG001|Part 2|Adverse Event|0|||
146879922|NCT01225731|529730276|FG002|Part 2|Adverse Event|0|||
146879923|NCT01225731|529730277|FG003|Part 2|Adverse Event|0|||
146879924|NCT01225731|529730278|FG004|Part 2|Adverse Event|0|||
146879925|NCT01225731|529730279|FG005|Part 2|Adverse Event|0|||
146879926|NCT01225731|529730280|FG006|Part 2|Adverse Event|4|||
146879927|NCT01225731|529730281|FG007|Part 2|Adverse Event|4|||
146879928|NCT01225731|529730282|FG008|Part 2|Adverse Event|2|||
146879929|NCT01225731|529730283|FG009|Part 2|Adverse Event|0|||
146879930|NCT01225731|529730284|FG010|Part 2|Adverse Event|0|||
146879931|NCT01225731|529730285|FG011|Part 2|Adverse Event|0|||
146879932|NCT01225731|529730286|FG012|Part 2|Adverse Event|0|||
146879933|NCT01225731|529730274|FG000|Part 2|Lack of Efficacy|0|||
146879934|NCT01225731|529730275|FG001|Part 2|Lack of Efficacy|0|||
146879935|NCT01225731|529730276|FG002|Part 2|Lack of Efficacy|0|||
146879936|NCT01225731|529730277|FG003|Part 2|Lack of Efficacy|0|||
146879937|NCT01225731|529730278|FG004|Part 2|Lack of Efficacy|0|||
146879938|NCT01225731|529730279|FG005|Part 2|Lack of Efficacy|1|||
146879939|NCT01225731|529730280|FG006|Part 2|Lack of Efficacy|0|||
146879940|NCT01225731|529730281|FG007|Part 2|Lack of Efficacy|12|||
146879941|NCT01225731|529730282|FG008|Part 2|Lack of Efficacy|3|||
146879942|NCT01225731|529730283|FG009|Part 2|Lack of Efficacy|0|||
146879943|NCT01225731|529730284|FG010|Part 2|Lack of Efficacy|0|||
146879944|NCT01225731|529730285|FG011|Part 2|Lack of Efficacy|0|||
146879945|NCT01225731|529730286|FG012|Part 2|Lack of Efficacy|0|||
146879946|NCT01225731|529730274|FG000|Part 2|Pregnancy|0|||
146879947|NCT01225731|529730275|FG001|Part 2|Pregnancy|0|||
146879948|NCT01225731|529730276|FG002|Part 2|Pregnancy|0|||
146879949|NCT01225731|529730277|FG003|Part 2|Pregnancy|0|||
146879950|NCT01225731|529730278|FG004|Part 2|Pregnancy|0|||
146879951|NCT01225731|529730279|FG005|Part 2|Pregnancy|0|||
146879952|NCT01225731|529730280|FG006|Part 2|Pregnancy|1|||
146879953|NCT01225731|529730281|FG007|Part 2|Pregnancy|0|||
146879954|NCT01225731|529730282|FG008|Part 2|Pregnancy|1|||
146879955|NCT01225731|529730283|FG009|Part 2|Pregnancy|0|||
146879956|NCT01225731|529730284|FG010|Part 2|Pregnancy|0|||
146879957|NCT01225731|529730285|FG011|Part 2|Pregnancy|0|||
146879958|NCT01225731|529730286|FG012|Part 2|Pregnancy|0|||
146879959|NCT01225731|529730274|FG000|Part 2|Lost to Follow-up|0|||
146879960|NCT01225731|529730275|FG001|Part 2|Lost to Follow-up|0|||
146879961|NCT01225731|529730276|FG002|Part 2|Lost to Follow-up|0|||
146879962|NCT01225731|529730277|FG003|Part 2|Lost to Follow-up|0|||
146879963|NCT01225731|529730278|FG004|Part 2|Lost to Follow-up|0|||
146879964|NCT01225731|529730279|FG005|Part 2|Lost to Follow-up|0|||
146879965|NCT01225731|529730280|FG006|Part 2|Lost to Follow-up|0|||
146879966|NCT01225731|529730281|FG007|Part 2|Lost to Follow-up|3|||
146879967|NCT01225731|529730282|FG008|Part 2|Lost to Follow-up|1|||
146879968|NCT01225731|529730283|FG009|Part 2|Lost to Follow-up|0|||
146879969|NCT01225731|529730284|FG010|Part 2|Lost to Follow-up|0|||
146879970|NCT01225731|529730285|FG011|Part 2|Lost to Follow-up|0|||
146879971|NCT01225731|529730286|FG012|Part 2|Lost to Follow-up|0|||
146879972|NCT01225731|529730274|FG000|Part 2|Physician Decision|0|||
146879973|NCT01225731|529730275|FG001|Part 2|Physician Decision|0|||
146879974|NCT01225731|529730276|FG002|Part 2|Physician Decision|0|||
146879975|NCT01225731|529730277|FG003|Part 2|Physician Decision|0|||
146879976|NCT01225731|529730278|FG004|Part 2|Physician Decision|0|||
146879977|NCT01225731|529730279|FG005|Part 2|Physician Decision|0|||
146879978|NCT01225731|529730280|FG006|Part 2|Physician Decision|0|||
146879979|NCT01225731|529730281|FG007|Part 2|Physician Decision|2|||
146879980|NCT01225731|529730282|FG008|Part 2|Physician Decision|2|||
146879981|NCT01225731|529730283|FG009|Part 2|Physician Decision|0|||
146879982|NCT01225731|529730284|FG010|Part 2|Physician Decision|0|||
146545346|NCT05643794|528504308|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
146545347|NCT05643794|528504309|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
146545348|NCT05643794|528504307|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
146545349|NCT05643794|528504308|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
146545350|NCT05643794|528504309|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
146879983|NCT01225731|529730285|FG011|Part 2|Physician Decision|0|||
146879984|NCT01225731|529730286|FG012|Part 2|Physician Decision|0|||
146879985|NCT01225731|529730274|FG000|Part 2|Withdrawal by Subject|0|||
146879986|NCT01225731|529730275|FG001|Part 2|Withdrawal by Subject|0|||
146879987|NCT01225731|529730276|FG002|Part 2|Withdrawal by Subject|0|||
146879988|NCT01225731|529730277|FG003|Part 2|Withdrawal by Subject|0|||
146879989|NCT01225731|529730278|FG004|Part 2|Withdrawal by Subject|0|||
146879990|NCT01225731|529730279|FG005|Part 2|Withdrawal by Subject|1|||
146879991|NCT01225731|529730280|FG006|Part 2|Withdrawal by Subject|3|||
146879992|NCT01225731|529730281|FG007|Part 2|Withdrawal by Subject|4|||
146879993|NCT01225731|529730282|FG008|Part 2|Withdrawal by Subject|1|||
146879994|NCT01225731|529730283|FG009|Part 2|Withdrawal by Subject|0|||
146879995|NCT01225731|529730284|FG010|Part 2|Withdrawal by Subject|0|||
146879996|NCT01225731|529730285|FG011|Part 2|Withdrawal by Subject|0|||
146879997|NCT01225731|529730286|FG012|Part 2|Withdrawal by Subject|0|||
146879998|NCT01225731|529730274|FG000|Part 3|Adverse Event|0|||
146879999|NCT01225731|529730275|FG001|Part 3|Adverse Event|0|||
146880000|NCT01225731|529730276|FG002|Part 3|Adverse Event|0|||
146880001|NCT01225731|529730277|FG003|Part 3|Adverse Event|0|||
146880002|NCT01225731|529730278|FG004|Part 3|Adverse Event|0|||
146880003|NCT01225731|529730279|FG005|Part 3|Adverse Event|0|||
146880004|NCT01225731|529730280|FG006|Part 3|Adverse Event|0|||
146880005|NCT01225731|529730281|FG007|Part 3|Adverse Event|0|||
146880006|NCT01225731|529730282|FG008|Part 3|Adverse Event|0|||
146880007|NCT01225731|529730283|FG009|Part 3|Adverse Event|0|||
146880008|NCT01225731|529730284|FG010|Part 3|Adverse Event|1|||
146880009|NCT01225731|529730285|FG011|Part 3|Adverse Event|1|||
146880010|NCT01225731|529730286|FG012|Part 3|Adverse Event|0|||
146880011|NCT01225731|529730274|FG000|Part 3|Lost to Follow-up|0|||
146880012|NCT01225731|529730275|FG001|Part 3|Lost to Follow-up|0|||
146880013|NCT01225731|529730276|FG002|Part 3|Lost to Follow-up|0|||
146880014|NCT01225731|529730277|FG003|Part 3|Lost to Follow-up|0|||
146880015|NCT01225731|529730278|FG004|Part 3|Lost to Follow-up|0|||
146880016|NCT01225731|529730279|FG005|Part 3|Lost to Follow-up|0|||
146880017|NCT01225731|529730280|FG006|Part 3|Lost to Follow-up|0|||
146880018|NCT01225731|529730281|FG007|Part 3|Lost to Follow-up|0|||
146880019|NCT01225731|529730282|FG008|Part 3|Lost to Follow-up|0|||
146880020|NCT01225731|529730283|FG009|Part 3|Lost to Follow-up|0|||
146880021|NCT01225731|529730284|FG010|Part 3|Lost to Follow-up|1|||
146880022|NCT01225731|529730285|FG011|Part 3|Lost to Follow-up|2|||
146880023|NCT01225731|529730286|FG012|Part 3|Lost to Follow-up|1|||
146880024|NCT01225731|529730274|FG000|Part 3|Physician Decision|0|||
146880025|NCT01225731|529730275|FG001|Part 3|Physician Decision|0|||
146880026|NCT01225731|529730276|FG002|Part 3|Physician Decision|0|||
146880027|NCT01225731|529730277|FG003|Part 3|Physician Decision|0|||
146880028|NCT01225731|529730278|FG004|Part 3|Physician Decision|0|||
146880029|NCT01225731|529730279|FG005|Part 3|Physician Decision|0|||
146880030|NCT01225731|529730280|FG006|Part 3|Physician Decision|0|||
146880031|NCT01225731|529730281|FG007|Part 3|Physician Decision|0|||
146880032|NCT01225731|529730282|FG008|Part 3|Physician Decision|0|||
146880033|NCT01225731|529730283|FG009|Part 3|Physician Decision|0|||
146880034|NCT01225731|529730284|FG010|Part 3|Physician Decision|0|||
146880035|NCT01225731|529730285|FG011|Part 3|Physician Decision|1|||
146880036|NCT01225731|529730286|FG012|Part 3|Physician Decision|2|||
146880037|NCT01225731|529730274|FG000|Part 3|Withdrawal by Subject|0|||
146880038|NCT01225731|529730275|FG001|Part 3|Withdrawal by Subject|0|||
146880039|NCT01225731|529730276|FG002|Part 3|Withdrawal by Subject|0|||
146880040|NCT01225731|529730277|FG003|Part 3|Withdrawal by Subject|0|||
146880041|NCT01225731|529730278|FG004|Part 3|Withdrawal by Subject|0|||
146880042|NCT01225731|529730279|FG005|Part 3|Withdrawal by Subject|0|||
146880043|NCT01225731|529730280|FG006|Part 3|Withdrawal by Subject|0|||
146880044|NCT01225731|529730281|FG007|Part 3|Withdrawal by Subject|0|||
146880045|NCT01225731|529730282|FG008|Part 3|Withdrawal by Subject|0|||
146880046|NCT01225731|529730283|FG009|Part 3|Withdrawal by Subject|0|||
146880047|NCT01225731|529730284|FG010|Part 3|Withdrawal by Subject|4|||
146880048|NCT01225731|529730285|FG011|Part 3|Withdrawal by Subject|6|||
146880049|NCT01225731|529730286|FG012|Part 3|Withdrawal by Subject|4|||
146880050|NCT00577642|529730287|FG000|Overall Study|Clinical Disease Progression|1|||
146880051|NCT04770389|529730288|FG000|Overall Study|Adverse Event|1|||
146880052|NCT04770389|529730289|FG001|Overall Study|Adverse Event|2|||
146880053|NCT04770389|529730290|FG002|Overall Study|Adverse Event|0|||
146880054|NCT04770389|529730291|FG003|Overall Study|Adverse Event|1|||
146880055|NCT04770389|529730288|FG000|Overall Study|Withdrawal by Subject|0|||
146880056|NCT04770389|529730289|FG001|Overall Study|Withdrawal by Subject|2|||
146880057|NCT04770389|529730290|FG002|Overall Study|Withdrawal by Subject|1|||
146880058|NCT04770389|529730291|FG003|Overall Study|Withdrawal by Subject|0|||
146880059|NCT04770389|529730288|FG000|Overall Study|Failed attempt to draw blood|1|||
146880060|NCT04770389|529730289|FG001|Overall Study|Failed attempt to draw blood|0|||
146880061|NCT04770389|529730290|FG002|Overall Study|Failed attempt to draw blood|0|||
146545351|NCT04167670|528504312|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
146545352|NCT04167670|528504313|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
146629504|NCT00853307|528819759|FG000|Overall Study|Withdrawal by Subject|1|||
146629505|NCT00853307|528819760|FG001|Overall Study|Withdrawal by Subject|2|||
146629506|NCT00853307|528819759|FG000|Overall Study|Reason Not Specified|0|||
146629507|NCT00853307|528819760|FG001|Overall Study|Reason Not Specified|1|||
146629508|NCT02703597|528819785|FG000|Assignment to Baseline|Lost to Follow-up|17|||
146629509|NCT02703597|528819786|FG001|Assignment to Baseline|Lost to Follow-up|16|||
146629510|NCT02703597|528819785|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
146880062|NCT04770389|529730291|FG003|Overall Study|Failed attempt to draw blood|0|||
146880063|NCT04770389|529730288|FG000|Overall Study|Left the country|0|||
146880064|NCT04770389|529730289|FG001|Overall Study|Left the country|0|||
146545353|NCT04167670|528504314|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
146545354|NCT04167670|528504312|FG000|Overall Study|Significant protocol deviation|3|||
146545355|NCT04167670|528504313|FG001|Overall Study|Significant protocol deviation|1|||
146545356|NCT04167670|528504314|FG002|Overall Study|Significant protocol deviation|0|||
146545357|NCT04167670|528504312|FG000|Overall Study|Lost to Follow-up|0|||
146545358|NCT04167670|528504313|FG001|Overall Study|Lost to Follow-up|3|||
146629511|NCT02703597|528819786|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
146629512|NCT02703597|528819785|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
146629513|NCT02703597|528819786|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
146880065|NCT04770389|529730290|FG002|Overall Study|Left the country|1|||
146880066|NCT04770389|529730291|FG003|Overall Study|Left the country|2|||
146880067|NCT04770389|529730288|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
146545359|NCT04167670|528504314|FG002|Overall Study|Lost to Follow-up|3|||
146545360|NCT04167670|528504312|FG000|Overall Study|Voluntary Withdrawal|0|||
146880068|NCT04770389|529730289|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
146880069|NCT04770389|529730290|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
146880070|NCT04770389|529730291|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
146880071|NCT04770389|529730288|FG000|Overall Study|Lost to Follow-up|0|||
146880072|NCT04770389|529730289|FG001|Overall Study|Lost to Follow-up|0|||
146880073|NCT04770389|529730290|FG002|Overall Study|Lost to Follow-up|0|||
146880074|NCT04770389|529730291|FG003|Overall Study|Lost to Follow-up|1|||
146880075|NCT04770389|529730288|FG000|Overall Study|Moved away from study site|0|||
146880076|NCT04770389|529730289|FG001|Overall Study|Moved away from study site|1|||
146880077|NCT04770389|529730290|FG002|Overall Study|Moved away from study site|0|||
146880078|NCT04770389|529730291|FG003|Overall Study|Moved away from study site|0|||
146880079|NCT01970501|529730299|FG000|Overall Study|Discontinuation of study by sponsor|16|||
146880080|NCT01970501|529730300|FG001|Overall Study|Discontinuation of study by sponsor|14|||
146880081|NCT01970501|529730299|FG000|Overall Study|Withdrawal by Subject|6|||
146880082|NCT01970501|529730300|FG001|Overall Study|Withdrawal by Subject|7|||
146880083|NCT01970501|529730299|FG000|Overall Study|Adverse Event|2|||
146880084|NCT01970501|529730300|FG001|Overall Study|Adverse Event|4|||
146880085|NCT01970501|529730299|FG000|Overall Study|Death|1|||
146880086|NCT01970501|529730300|FG001|Overall Study|Death|3|||
146880087|NCT01970501|529730299|FG000|Overall Study|Physician Decision|2|||
146880088|NCT01970501|529730300|FG001|Overall Study|Physician Decision|0|||
146880089|NCT00794157|529730301|FG000|Overall Study|Adverse Event|4|||
146880090|NCT00794157|529730302|FG001|Overall Study|Adverse Event|1|||
146880091|NCT00794157|529730303|FG002|Overall Study|Adverse Event|8|||
146880092|NCT00794157|529730301|FG000|Overall Study|Subject withdrew consent|2|||
146880093|NCT00794157|529730302|FG001|Overall Study|Subject withdrew consent|0|||
146880094|NCT00794157|529730303|FG002|Overall Study|Subject withdrew consent|3|||
146545361|NCT04167670|528504313|FG001|Overall Study|Voluntary Withdrawal|1|||
146545362|NCT04167670|528504314|FG002|Overall Study|Voluntary Withdrawal|1|||
146545363|NCT04167670|528504312|FG000|Overall Study|Withdrawal of Consent|4|||
146545364|NCT04167670|528504313|FG001|Overall Study|Withdrawal of Consent|1|||
146545365|NCT04167670|528504314|FG002|Overall Study|Withdrawal of Consent|3|||
146545366|NCT04167670|528504312|FG000|Overall Study|Miscellaneous|7|||
146880095|NCT00794157|529730301|FG000|Overall Study|Lost to Follow-up|2|||
146880096|NCT00794157|529730302|FG001|Overall Study|Lost to Follow-up|0|||
146880097|NCT00794157|529730303|FG002|Overall Study|Lost to Follow-up|1|||
146880098|NCT00794157|529730301|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146545367|NCT04167670|528504313|FG001|Overall Study|Miscellaneous|5|||
146545368|NCT04167670|528504314|FG002|Overall Study|Miscellaneous|3|||
146545369|NCT01127061|528504315|FG000|Overall Study|Lost to Follow-up|7|||
146545370|NCT01127061|528504316|FG001|Overall Study|Lost to Follow-up|10|||
146880099|NCT00794157|529730302|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146914679|NCT03303339|529850052|FG010|Overall Study|Physician Decision|0|||
146629514|NCT02703597|528819785|FG000|First Post-test to First Follow-up|Site drop out|0|||
146629515|NCT02703597|528819786|FG001|First Post-test to First Follow-up|Site drop out|58|||
146545371|NCT01127061|528504315|FG000|Overall Study|Physician Decision|3|||
146545372|NCT01127061|528504316|FG001|Overall Study|Physician Decision|3|||
146545373|NCT04827446|528504319|FG000|Overall Study|Lost to Follow-up|1|||
146880100|NCT00794157|529730303|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
146880101|NCT00794157|529730301|FG000|Overall Study|Administrative problems|1|||
146545374|NCT04827446|528504320|FG001|Overall Study|Lost to Follow-up|1|||
146545375|NCT04827446|528504319|FG000|Overall Study|Death|2|||
146545376|NCT04827446|528504320|FG001|Overall Study|Death|0|||
146880102|NCT00794157|529730302|FG001|Overall Study|Administrative problems|7|||
146545377|NCT04827446|528504319|FG000|Overall Study|Withdrawal by Subject|2|||
146629516|NCT02703597|528819785|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
146545378|NCT04827446|528504320|FG001|Overall Study|Withdrawal by Subject|2|||
146545379|NCT01363076|528504323|FG000|Overall Study|Withdrawal by Subject|0|||
146629517|NCT02703597|528819786|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
146629518|NCT02703597|528819785|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
146629519|NCT02703597|528819786|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
146629520|NCT02703597|528819785|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
146629521|NCT02703597|528819786|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
146629522|NCT01614886|528819787|FG000|Overall Study|Adverse Event|15|||
146629523|NCT01614886|528819788|FG001|Overall Study|Adverse Event|20|||
146629524|NCT01614886|528819787|FG000|Overall Study|Withdrawal by Subject|4|||
146629525|NCT01614886|528819788|FG001|Overall Study|Withdrawal by Subject|4|||
146629526|NCT01614886|528819787|FG000|Overall Study|Death|1|||
146629527|NCT01614886|528819788|FG001|Overall Study|Death|0|||
146629528|NCT01614886|528819787|FG000|Overall Study|Protocol deviation|0|||
146629529|NCT01614886|528819788|FG001|Overall Study|Protocol deviation|2|||
146629530|NCT01523366|528819790|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146629531|NCT01523366|528819791|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146629532|NCT01523366|528819790|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
146629533|NCT01523366|528819791|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
146629534|NCT02461758|528819792|FG000|Overall Study|Lost to Follow-up|0|||
146629535|NCT02461758|528819793|FG001|Overall Study|Lost to Follow-up|1|||
146629536|NCT02461758|528819794|FG002|Overall Study|Lost to Follow-up|1|||
146629537|NCT02461758|528819795|FG003|Overall Study|Lost to Follow-up|0|||
146629538|NCT00449696|528819797|FG000|Overall Study|Other Treatment Required|6|||
146629539|NCT00449696|528819798|FG001|Overall Study|Other Treatment Required|1|||
146629540|NCT00449696|528819797|FG000|Overall Study|Withdrawal by Subject|5|||
146629541|NCT00449696|528819798|FG001|Overall Study|Withdrawal by Subject|5|||
146629542|NCT00449696|528819797|FG000|Overall Study|Lost to Follow-up|2|||
146629543|NCT00449696|528819798|FG001|Overall Study|Lost to Follow-up|3|||
146629544|NCT00449696|528819797|FG000|Overall Study|Others|7|||
146629545|NCT00449696|528819798|FG001|Overall Study|Others|0|||
146629546|NCT01033019|528819799|FG000|Overall Study|Withdrawal by Subject|1|||
146629547|NCT01033019|528819800|FG001|Overall Study|Withdrawal by Subject|0|||
146629548|NCT00551642|528819805|FG000|Treatment Period|Protocol Deviation|6|||
146629549|NCT00551642|528819806|FG001|Treatment Period|Protocol Deviation|11|||
146629550|NCT00551642|528819805|FG000|Treatment Period|Delivery device failure|1|||
146629551|NCT00551642|528819806|FG001|Treatment Period|Delivery device failure|3|||
146629552|NCT00551642|528819805|FG000|Treatment Period|Physician Decision|0|||
146629553|NCT00551642|528819806|FG001|Treatment Period|Physician Decision|1|||
146629554|NCT00551642|528819805|FG000|Treatment Period|Death|33|||
146629555|NCT00551642|528819806|FG001|Treatment Period|Death|31|||
146629556|NCT00551642|528819805|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
146629557|NCT00551642|528819806|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
146629558|NCT00551642|528819805|FG000|Treatment Period|Adverse Event|15|||
146629559|NCT00551642|528819806|FG001|Treatment Period|Adverse Event|12|||
146629560|NCT00551642|528819805|FG000|Treatment Period|Withdrawal by Subject|2|||
146629561|NCT00551642|528819806|FG001|Treatment Period|Withdrawal by Subject|1|||
146629562|NCT03011099|528819807|FG000|Overall Study|Withdrawal by Subject|0|||
146629563|NCT03011099|528819808|FG001|Overall Study|Withdrawal by Subject|2|||
146629564|NCT01903460|528819809|FG000|Overall Study|Adverse Event|0|||
146629565|NCT01903460|528819810|FG001|Overall Study|Adverse Event|0|||
146629566|NCT01903460|528819811|FG002|Overall Study|Adverse Event|0|||
146629567|NCT01903460|528819812|FG003|Overall Study|Adverse Event|1|||
146629568|NCT03104868|528819813|FG000|6 Week Follow up|Lost to Follow-up|5|||
146629569|NCT03104868|528819814|FG001|6 Week Follow up|Lost to Follow-up|8|||
146629570|NCT03104868|528819813|FG000|6 Week Follow up|Death|1|||
146629571|NCT03104868|528819814|FG001|6 Week Follow up|Death|1|||
146629572|NCT03104868|528819813|FG000|6 Week Follow up|Withdrawal by Subject|7|||
146629573|NCT03104868|528819814|FG001|6 Week Follow up|Withdrawal by Subject|6|||
146629574|NCT03104868|528819813|FG000|6 Week Follow up|Completed Later Timepoint|24|||
146880103|NCT00794157|529730303|FG002|Overall Study|Administrative problems|4|||
146629575|NCT03104868|528819814|FG001|6 Week Follow up|Completed Later Timepoint|22|||
146629576|NCT03104868|528819813|FG000|6 Month Follow up|Lost to Follow-up|2|||
146880104|NCT00794157|529730301|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146880105|NCT00794157|529730302|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146880106|NCT00794157|529730303|FG002|Overall Study|Abnormal test procedure result(s)|0|||
146629577|NCT03104868|528819814|FG001|6 Month Follow up|Lost to Follow-up|2|||
146629578|NCT03104868|528819813|FG000|6 Month Follow up|Death|0|||
146629579|NCT03104868|528819814|FG001|6 Month Follow up|Death|1|||
146629580|NCT03104868|528819813|FG000|6 Month Follow up|Completed Later Timepoint|22|||
146629581|NCT03104868|528819814|FG001|6 Month Follow up|Completed Later Timepoint|32|||
146880107|NCT00794157|529730301|FG000|Overall Study|Protocol deviation|0|||
146629582|NCT03104868|528819813|FG000|12 Month Follow up|Lost to Follow-up|1|||
146629583|NCT03104868|528819814|FG001|12 Month Follow up|Lost to Follow-up|2|||
146545380|NCT01363076|528504324|FG001|Overall Study|Withdrawal by Subject|1|||
146545381|NCT01112267|528504325|FG000|Overall Study|Adverse Event|24|||
146545382|NCT01112267|528504326|FG001|Overall Study|Adverse Event|6|||
146545383|NCT01112267|528504325|FG000|Overall Study|Withdrawal by Subject|3|||
146545384|NCT01112267|528504326|FG001|Overall Study|Withdrawal by Subject|5|||
146545385|NCT01112267|528504325|FG000|Overall Study|Protocol Violation|5|||
146545386|NCT01112267|528504326|FG001|Overall Study|Protocol Violation|3|||
146545387|NCT01112267|528504325|FG000|Overall Study|Participants not compliant|1|||
146545388|NCT01112267|528504326|FG001|Overall Study|Participants not compliant|2|||
146545389|NCT01112267|528504325|FG000|Overall Study|Participants not receive any study drug|1|||
146545390|NCT01112267|528504326|FG001|Overall Study|Participants not receive any study drug|2|||
146545391|NCT00003456|528504327|FG000|Overall Study|Not evaluable|8|||
146545392|NCT00587457|528504331|FG000|Overall Study|Adverse Event|1|||
146545393|NCT00587457|528504332|FG001|Overall Study|Adverse Event|2|||
146545394|NCT00587457|528504333|FG002|Overall Study|Adverse Event|1|||
146545395|NCT00587457|528504331|FG000|Overall Study|Disease progression|2|||
146545396|NCT00587457|528504332|FG001|Overall Study|Disease progression|0|||
146545397|NCT00587457|528504333|FG002|Overall Study|Disease progression|2|||
146545398|NCT00587457|528504331|FG000|Overall Study|Initiation of alternative therapy|0|||
146545399|NCT00587457|528504332|FG001|Overall Study|Initiation of alternative therapy|1|||
146545400|NCT00587457|528504333|FG002|Overall Study|Initiation of alternative therapy|0|||
146629584|NCT03104868|528819813|FG000|12 Month Follow up|Death|0|||
146629585|NCT03104868|528819814|FG001|12 Month Follow up|Death|1|||
146765035|NCT01156116|529307219|FG001|Overall Study|Withdrawal by Subject|1|||
146545401|NCT00587457|528504331|FG000|Overall Study|Undefined|0|||
146545402|NCT00587457|528504332|FG001|Overall Study|Undefined|0|||
146545403|NCT00587457|528504333|FG002|Overall Study|Undefined|1|||
146545404|NCT00587457|528504331|FG000|Overall Study|Development of neutralizing Abs|0|||
146545405|NCT00587457|528504332|FG001|Overall Study|Development of neutralizing Abs|0|||
146545406|NCT00587457|528504333|FG002|Overall Study|Development of neutralizing Abs|1|||
146880108|NCT00794157|529730302|FG001|Overall Study|Protocol deviation|1|||
146880109|NCT00794157|529730303|FG002|Overall Study|Protocol deviation|1|||
146880110|NCT01692275|529730304|FG000|Overall Study|Lost to Follow-up|57|||
146880111|NCT01692275|529730305|FG001|Overall Study|Lost to Follow-up|48|||
146880112|NCT01692275|529730304|FG000|Overall Study|Withdrawal by Subject|9|||
146880113|NCT01692275|529730305|FG001|Overall Study|Withdrawal by Subject|11|||
146880114|NCT00814892|529730306|FG000|Overall Study|Disease Progression|1|||
146880115|NCT00814892|529730306|FG000|Overall Study|Study Termination|1|||
146880116|NCT00845650|529730307|FG000|Overall Study|Withdrawal by Subject|0|||
146880117|NCT00845650|529730308|FG001|Overall Study|Withdrawal by Subject|0|||
146880118|NCT00845650|529730309|FG002|Overall Study|Withdrawal by Subject|0|||
146880119|NCT00845650|529730310|FG003|Overall Study|Withdrawal by Subject|0|||
146880120|NCT00845650|529730311|FG004|Overall Study|Withdrawal by Subject|2|||
146880121|NCT00845650|529730312|FG005|Overall Study|Withdrawal by Subject|0|||
146880122|NCT00845650|529730307|FG000|Overall Study|Lost to Follow-up|0|||
146880123|NCT00845650|529730308|FG001|Overall Study|Lost to Follow-up|0|||
146880124|NCT00845650|529730309|FG002|Overall Study|Lost to Follow-up|3|||
146880125|NCT00845650|529730310|FG003|Overall Study|Lost to Follow-up|1|||
146880126|NCT00845650|529730311|FG004|Overall Study|Lost to Follow-up|0|||
146880127|NCT00845650|529730312|FG005|Overall Study|Lost to Follow-up|1|||
146880128|NCT00845650|529730307|FG000|Overall Study|Sponsor hold on dosing|0|||
146880129|NCT00845650|529730308|FG001|Overall Study|Sponsor hold on dosing|0|||
146880130|NCT00845650|529730309|FG002|Overall Study|Sponsor hold on dosing|0|||
146880131|NCT00845650|529730310|FG003|Overall Study|Sponsor hold on dosing|0|||
146880132|NCT00845650|529730311|FG004|Overall Study|Sponsor hold on dosing|1|||
146880133|NCT00845650|529730312|FG005|Overall Study|Sponsor hold on dosing|1|||
146880134|NCT00845650|529730307|FG000|Overall Study|Unable to access IV line|1|||
146880135|NCT00845650|529730308|FG001|Overall Study|Unable to access IV line|0|||
146880136|NCT00845650|529730309|FG002|Overall Study|Unable to access IV line|0|||
146880137|NCT00845650|529730310|FG003|Overall Study|Unable to access IV line|0|||
146880138|NCT00845650|529730311|FG004|Overall Study|Unable to access IV line|0|||
146880139|NCT00845650|529730312|FG005|Overall Study|Unable to access IV line|0|||
146880140|NCT04486950|529730313|FG000|Overall Study|Lost to Follow-up|0|||
146880141|NCT04486950|529730314|FG001|Overall Study|Lost to Follow-up|0|||
146880142|NCT04486950|529730315|FG002|Overall Study|Lost to Follow-up|0|||
146880143|NCT04486950|529730316|FG003|Overall Study|Lost to Follow-up|0|||
146880144|NCT04486950|529730317|FG004|Overall Study|Lost to Follow-up|0|||
146880145|NCT04486950|529730318|FG005|Overall Study|Lost to Follow-up|1|||
146880146|NCT04486950|529730319|FG006|Overall Study|Lost to Follow-up|0|||
146880147|NCT00950664|529730320|FG000|First Intervention|Lost to Follow-up|1|||
146880148|NCT00950664|529730321|FG001|First Intervention|Lost to Follow-up|3|||
146880149|NCT00950664|529730320|FG000|First Intervention|Withdrawal by Subject|2|||
146880150|NCT00950664|529730321|FG001|First Intervention|Withdrawal by Subject|2|||
146880151|NCT02374099|529730324|FG000|Overall Study|Adverse Event|1|||
146880152|NCT02374099|529730325|FG001|Overall Study|Adverse Event|0|||
146880153|NCT02374099|529730324|FG000|Overall Study|Progressive Disease|35|||
146880154|NCT02374099|529730325|FG001|Overall Study|Progressive Disease|40|||
146880155|NCT02374099|529730324|FG000|Overall Study|Withdrawal by Subject|5|||
146880156|NCT02374099|529730325|FG001|Overall Study|Withdrawal by Subject|1|||
146880157|NCT02374099|529730324|FG000|Overall Study|Miscellaneous|2|||
146880158|NCT02374099|529730325|FG001|Overall Study|Miscellaneous|3|||
146880159|NCT02374099|529730324|FG000|Overall Study|Randomized, but not treated|2|||
146880160|NCT02374099|529730325|FG001|Overall Study|Randomized, but not treated|1|||
146880161|NCT02374099|529730324|FG000|Overall Study|Study Terminated by Sponsor|3|||
146880162|NCT02374099|529730325|FG001|Overall Study|Study Terminated by Sponsor|4|||
146880163|NCT01033825|529730326|FG000|Overall Study|Withdrawal by Subject|2|||
146880164|NCT01033825|529730327|FG001|Overall Study|Withdrawal by Subject|3|||
146545407|NCT00541229|528504334|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
146545408|NCT00541229|528504335|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
146545409|NCT00541229|528504336|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
146545410|NCT00541229|528504337|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
146880165|NCT01033825|529730328|FG002|Overall Study|Withdrawal by Subject|2|||
146880166|NCT01033825|529730329|FG003|Overall Study|Withdrawal by Subject|1|||
146880167|NCT01033825|529730330|FG004|Overall Study|Withdrawal by Subject|1|||
146880168|NCT01033825|529730331|FG005|Overall Study|Withdrawal by Subject|0|||
146880169|NCT01033825|529730332|FG006|Overall Study|Withdrawal by Subject|0|||
146880170|NCT01033825|529730326|FG000|Overall Study|Adverse Event|0|||
146880171|NCT01033825|529730327|FG001|Overall Study|Adverse Event|0|||
146545411|NCT00541229|528504338|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
146880172|NCT01033825|529730328|FG002|Overall Study|Adverse Event|0|||
146880173|NCT01033825|529730329|FG003|Overall Study|Adverse Event|1|||
146880174|NCT01033825|529730330|FG004|Overall Study|Adverse Event|0|||
146880175|NCT01033825|529730331|FG005|Overall Study|Adverse Event|0|||
146880176|NCT01033825|529730332|FG006|Overall Study|Adverse Event|0|||
146880177|NCT01033825|529730326|FG000|Overall Study|Protocol Violation|1|||
146880178|NCT01033825|529730327|FG001|Overall Study|Protocol Violation|0|||
146880179|NCT01033825|529730328|FG002|Overall Study|Protocol Violation|0|||
146545412|NCT00541229|528504339|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
146545413|NCT00541229|528504334|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
146545414|NCT00541229|528504335|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
146545415|NCT00541229|528504336|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
146545416|NCT00541229|528504337|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
146545417|NCT00541229|528504338|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
146545418|NCT00541229|528504339|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
146880180|NCT01033825|529730329|FG003|Overall Study|Protocol Violation|0|||
146765036|NCT01156116|529307218|FG000|Overall Study|CPAP intolerance|2|||
146880181|NCT01033825|529730330|FG004|Overall Study|Protocol Violation|0|||
146880182|NCT01033825|529730331|FG005|Overall Study|Protocol Violation|0|||
146880183|NCT01033825|529730332|FG006|Overall Study|Protocol Violation|0|||
146880184|NCT01033825|529730326|FG000|Overall Study|Other|0|||
146880185|NCT01033825|529730327|FG001|Overall Study|Other|0|||
146880186|NCT01033825|529730328|FG002|Overall Study|Other|0|||
146880187|NCT01033825|529730329|FG003|Overall Study|Other|0|||
146880188|NCT01033825|529730330|FG004|Overall Study|Other|1|||
146880189|NCT01033825|529730331|FG005|Overall Study|Other|0|||
146880190|NCT01033825|529730332|FG006|Overall Study|Other|0|||
146880191|NCT03693625|529730333|FG000|Overall Study|Adverse Event|2|||
146880192|NCT03693625|529730334|FG001|Overall Study|Adverse Event|0|||
146880193|NCT03693625|529730333|FG000|Overall Study|Study Terminated By Sponsor|20|||
146880194|NCT03693625|529730334|FG001|Overall Study|Study Terminated By Sponsor|7|||
146880195|NCT03693625|529730333|FG000|Overall Study|Withdrawal by Subject|1|||
146880196|NCT03693625|529730334|FG001|Overall Study|Withdrawal by Subject|1|||
146880197|NCT04311502|529731845|FG000|Overall Study|Death|1|||
146880198|NCT04311502|529731846|FG001|Overall Study|Death|1|||
146880199|NCT04311502|529731847|FG002|Overall Study|Death|1|||
146880200|NCT04311502|529731845|FG000|Overall Study|Lost to Follow-up|2|||
146880201|NCT04311502|529731846|FG001|Overall Study|Lost to Follow-up|3|||
146880202|NCT04311502|529731847|FG002|Overall Study|Lost to Follow-up|0|||
146880203|NCT04311502|529731845|FG000|Overall Study|Participant is in prison|1|||
146880204|NCT04311502|529731846|FG001|Overall Study|Participant is in prison|0|||
146880205|NCT04311502|529731847|FG002|Overall Study|Participant is in prison|0|||
146880206|NCT04311502|529731845|FG000|Overall Study|Participant moved out of country|1|||
146880207|NCT04311502|529731846|FG001|Overall Study|Participant moved out of country|0|||
146880208|NCT04311502|529731847|FG002|Overall Study|Participant moved out of country|0|||
146880209|NCT04311502|529731845|FG000|Overall Study|Withdrawal by Subject|2|||
146880210|NCT04311502|529731846|FG001|Overall Study|Withdrawal by Subject|0|||
146880211|NCT04311502|529731847|FG002|Overall Study|Withdrawal by Subject|0|||
146880212|NCT04311502|529731845|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
146880213|NCT04311502|529731846|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
146880214|NCT04311502|529731847|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
146880215|NCT03040999|529731848|FG000|Overall Study|Lost to Follow-up|2|||
146880216|NCT03040999|529731849|FG001|Overall Study|Lost to Follow-up|2|||
146880217|NCT03040999|529731848|FG000|Overall Study|Withdrawal by Subject|12|||
146880218|NCT03040999|529731849|FG001|Overall Study|Withdrawal by Subject|13|||
146880219|NCT03040999|529731848|FG000|Overall Study|Death|155|||
146880220|NCT03040999|529731849|FG001|Overall Study|Death|171|||
146880221|NCT03040999|529731848|FG000|Overall Study|Physician Decision|0|||
146880222|NCT03040999|529731849|FG001|Overall Study|Physician Decision|3|||
146880223|NCT01979523|529731850|FG000|Overall Study|Withdrawal by Subject|1|||
146880224|NCT01979523|529731851|FG001|Overall Study|Withdrawal by Subject|0|||
146880225|NCT01137773|529731852|FG000|Overall Study|Death|3|||
146880226|NCT01137773|529731853|FG001|Overall Study|Death|3|||
146880227|NCT01137773|529731852|FG000|Overall Study|Lost to Follow-up|6|||
146880228|NCT01137773|529731853|FG001|Overall Study|Lost to Follow-up|0|||
146880229|NCT00817531|529731854|FG000|Overall Study|Adverse Event|1|||
146880230|NCT00817531|529731854|FG000|Overall Study|Lack of Efficacy|1|||
146880231|NCT02239939|529731855|FG000|Overall Study|Adverse Event|1|||
146880232|NCT02239939|529731856|FG001|Overall Study|Adverse Event|0|||
146880233|NCT02239939|529731855|FG000|Overall Study|Withdrawal by Subject|1|||
146880234|NCT02239939|529731856|FG001|Overall Study|Withdrawal by Subject|1|||
146880235|NCT02239939|529731855|FG000|Overall Study|Lost to Follow-up|0|||
146880236|NCT02239939|529731856|FG001|Overall Study|Lost to Follow-up|1|||
146880237|NCT00763815|529731858|FG000|Overall Study|Adverse Event|14|||
146629586|NCT03104868|528819813|FG000|12 Month Follow up|Withdrawal by Subject|0|||
146629587|NCT03104868|528819814|FG001|12 Month Follow up|Withdrawal by Subject|3|||
146880238|NCT00763815|529731859|FG001|Overall Study|Adverse Event|29|||
146880239|NCT00763815|529731858|FG000|Overall Study|Lack of Efficacy|10|||
146880240|NCT00763815|529731859|FG001|Overall Study|Lack of Efficacy|11|||
146880241|NCT00763815|529731858|FG000|Overall Study|Poor Compliance to Protocol|6|||
146880242|NCT00763815|529731859|FG001|Overall Study|Poor Compliance to Protocol|6|||
146880243|NCT00763815|529731858|FG000|Overall Study|Lost to Follow-up|2|||
146765037|NCT01156116|529307219|FG001|Overall Study|CPAP intolerance|0|||
146880244|NCT00763815|529731859|FG001|Overall Study|Lost to Follow-up|4|||
146880245|NCT00763815|529731858|FG000|Overall Study|Early Termination|1|||
146880246|NCT00763815|529731859|FG001|Overall Study|Early Termination|0|||
146880247|NCT00763815|529731858|FG000|Overall Study|Familial and Personal Reasons|9|||
146880248|NCT00763815|529731859|FG001|Overall Study|Familial and Personal Reasons|16|||
146880249|NCT00763815|529731858|FG000|Overall Study|Physician Decision|1|||
146880250|NCT00763815|529731859|FG001|Overall Study|Physician Decision|0|||
146880251|NCT00763815|529731858|FG000|Overall Study|Withdrawal by Subject|7|||
146880252|NCT00763815|529731859|FG001|Overall Study|Withdrawal by Subject|12|||
146880253|NCT00763815|529731858|FG000|Overall Study|Protocol Violation|2|||
146880254|NCT00763815|529731859|FG001|Overall Study|Protocol Violation|5|||
146545419|NCT00541229|528504334|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
146545420|NCT00541229|528504335|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
146545421|NCT00541229|528504336|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
146545422|NCT00541229|528504337|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
146545423|NCT00541229|528504338|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
146545424|NCT00541229|528504339|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
146545425|NCT00541229|528504334|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
146629588|NCT03104868|528819813|FG000|12 Month Follow up|Completed Later Timepoint|32|||
146629589|NCT03104868|528819814|FG001|12 Month Follow up|Completed Later Timepoint|29|||
146880255|NCT00763815|529731858|FG000|Overall Study|Sponsor's Decision|0|||
146880256|NCT00763815|529731859|FG001|Overall Study|Sponsor's Decision|1|||
146880257|NCT02706873|529731866|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
146880258|NCT02706873|529731867|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
146880259|NCT02706873|529731868|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
146880260|NCT02706873|529731869|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
146880261|NCT02706873|529731866|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
146880262|NCT02706873|529731867|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
146880263|NCT02706873|529731868|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
146880264|NCT02706873|529731869|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
146880265|NCT02706873|529731866|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
146880266|NCT02706873|529731867|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
146629590|NCT03104868|528819813|FG000|18 Month Follow up|Lost to Follow-up|7|||
146629591|NCT03104868|528819814|FG001|18 Month Follow up|Lost to Follow-up|11|||
146880267|NCT02706873|529731868|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
146880268|NCT02706873|529731869|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
146880269|NCT02706873|529731866|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
146880270|NCT02706873|529731867|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
146880271|NCT02706873|529731868|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
146880272|NCT02706873|529731869|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
146880273|NCT02706873|529731866|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
146545426|NCT00541229|528504335|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
146880274|NCT02706873|529731867|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
146629592|NCT03104868|528819813|FG000|18 Month Follow up|Death|2|||
146545427|NCT00541229|528504336|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
146545428|NCT00541229|528504337|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
146880275|NCT02706873|529731868|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
146880276|NCT02706873|529731869|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
146545429|NCT00541229|528504338|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
146545430|NCT00541229|528504339|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
146545431|NCT00541229|528504334|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
146545432|NCT00541229|528504335|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
146545433|NCT00541229|528504336|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
146545434|NCT00541229|528504337|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
146545435|NCT00541229|528504338|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
146545436|NCT00541229|528504339|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
146545437|NCT00541229|528504334|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
146545438|NCT00541229|528504335|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
146545439|NCT00541229|528504336|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
146545440|NCT00541229|528504337|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
146545441|NCT00541229|528504338|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
146545442|NCT00541229|528504339|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
146545443|NCT00541229|528504334|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
146545444|NCT00541229|528504335|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
146545445|NCT00541229|528504336|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
146545446|NCT00541229|528504337|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
146545447|NCT00541229|528504338|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
146545448|NCT00541229|528504339|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
146545449|NCT00541229|528504334|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
146545450|NCT00541229|528504335|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
146545451|NCT00541229|528504336|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
146545452|NCT00541229|528504337|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
146545453|NCT00541229|528504338|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
146545454|NCT00541229|528504339|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
146545455|NCT00541229|528504334|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
146545456|NCT00541229|528504335|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
146545457|NCT00541229|528504336|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
146545458|NCT00541229|528504337|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
146545459|NCT00541229|528504338|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
146545460|NCT00541229|528504339|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
146765038|NCT01186848|529307221|FG000|Overall Study|Lost to Follow-up|4|||
146545461|NCT00541229|528504334|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
146545462|NCT00541229|528504335|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
146545463|NCT00541229|528504336|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
146545464|NCT00541229|528504337|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
146545465|NCT00541229|528504338|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
146545466|NCT00541229|528504339|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
146545467|NCT00541229|528504334|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
146765039|NCT01186848|529307221|FG000|Overall Study|Withdrawal by Subject|2|||
146765040|NCT01186848|529307221|FG000|Overall Study|Adverse Event|2|||
146765041|NCT00619645|529307226|FG000|Overall Study|Adverse Event|1|||
146880277|NCT02706873|529731866|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
146880278|NCT02706873|529731867|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
146880279|NCT02706873|529731868|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
146880280|NCT02706873|529731869|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
146880281|NCT02706873|529731866|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
146880282|NCT02706873|529731867|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
146880283|NCT02706873|529731868|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
146880284|NCT02706873|529731869|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
146880285|NCT02706873|529731866|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
146880286|NCT02706873|529731867|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
146880287|NCT02706873|529731868|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
146880288|NCT02706873|529731869|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
146880289|NCT02706873|529731866|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
146880290|NCT02706873|529731867|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
146880291|NCT02706873|529731868|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
146880292|NCT02706873|529731869|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
146880293|NCT02706873|529731866|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
146880294|NCT02706873|529731867|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
146880295|NCT02706873|529731868|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
146880296|NCT02706873|529731869|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
146880297|NCT02706873|529731866|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
146880298|NCT02706873|529731867|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
146880299|NCT02706873|529731868|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
146880300|NCT02706873|529731869|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
146880301|NCT02706873|529731866|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
146880302|NCT02706873|529731867|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
146880303|NCT02706873|529731868|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
146880304|NCT02706873|529731869|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
146880305|NCT02706873|529731866|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
146880306|NCT02706873|529731867|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
146880307|NCT02706873|529731868|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
146880308|NCT02706873|529731869|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
146880309|NCT00618410|529731876|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
146880310|NCT00618410|529731877|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
146880311|NCT03948178|529731880|FG000|Overall Study|Protocol Violation|1|||
146880312|NCT03948178|529731880|FG000|Overall Study|Lost to Follow-up|2|||
146880313|NCT03948178|529731880|FG000|Overall Study|Withdrawal by Subject|2|||
146880314|NCT03948178|529731880|FG000|Overall Study|Reason not known|2|||
146880315|NCT03948178|529731880|FG000|Overall Study|Personal reason|14|||
146880316|NCT03948178|529731880|FG000|Overall Study|Disease progression|30|||
146880317|NCT03948178|529731880|FG000|Overall Study|Adverse Event|12|||
146880318|NCT03948178|529731880|FG000|Overall Study|Sponsor terminated study|164|||
146880319|NCT01297270|529731881|FG000|Overall Study|Adverse Event|19|||
146880320|NCT01297270|529731882|FG001|Overall Study|Adverse Event|32|||
146880321|NCT01297270|529731883|FG002|Overall Study|Adverse Event|5|||
146880322|NCT01297270|529731881|FG000|Overall Study|Lack of Efficacy|15|||
146880323|NCT01297270|529731882|FG001|Overall Study|Lack of Efficacy|17|||
146880324|NCT01297270|529731883|FG002|Overall Study|Lack of Efficacy|15|||
146880325|NCT01297270|529731881|FG000|Overall Study|Lost to Follow-up|1|||
146880326|NCT01297270|529731882|FG001|Overall Study|Lost to Follow-up|2|||
146880327|NCT01297270|529731883|FG002|Overall Study|Lost to Follow-up|1|||
146880328|NCT01297270|529731881|FG000|Overall Study|Protocol Violation|0|||
146880329|NCT01297270|529731882|FG001|Overall Study|Protocol Violation|2|||
146880330|NCT01297270|529731883|FG002|Overall Study|Protocol Violation|0|||
146880331|NCT01297270|529731881|FG000|Overall Study|Withdrawal by Subject|7|||
146880332|NCT01297270|529731882|FG001|Overall Study|Withdrawal by Subject|15|||
146880333|NCT01297270|529731883|FG002|Overall Study|Withdrawal by Subject|7|||
146880334|NCT01297270|529731881|FG000|Overall Study|Other reason not defined above|3|||
146880335|NCT01297270|529731882|FG001|Overall Study|Other reason not defined above|3|||
146880336|NCT01297270|529731883|FG002|Overall Study|Other reason not defined above|1|||
146545468|NCT00541229|528504335|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
146545469|NCT00541229|528504336|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
146880337|NCT01297270|529731881|FG000|Overall Study|Not treated|0|||
146880338|NCT01297270|529731882|FG001|Overall Study|Not treated|1|||
146629593|NCT03104868|528819814|FG001|18 Month Follow up|Death|1|||
146880339|NCT01297270|529731883|FG002|Overall Study|Not treated|0|||
146880340|NCT00401752|529731884|FG000|Overall Study|Adverse Event|2|||
146880341|NCT00401752|529731885|FG001|Overall Study|Adverse Event|5|||
146880342|NCT00401752|529731884|FG000|Overall Study|Withdrawal by Subject|2|||
146880343|NCT00401752|529731885|FG001|Overall Study|Withdrawal by Subject|6|||
146880344|NCT00401752|529731884|FG000|Overall Study|Lost to Follow-up|1|||
146880345|NCT00401752|529731885|FG001|Overall Study|Lost to Follow-up|4|||
146880346|NCT00401752|529731884|FG000|Overall Study|Development of any exclusion criteria|4|||
146880347|NCT00401752|529731885|FG001|Overall Study|Development of any exclusion criteria|2|||
146880348|NCT00401752|529731884|FG000|Overall Study|Physician Decision|1|||
146880349|NCT00401752|529731885|FG001|Overall Study|Physician Decision|1|||
146880350|NCT00382993|529731886|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
146880351|NCT00382993|529731887|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
146880352|NCT00382993|529731886|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
146880353|NCT00382993|529731887|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
146880354|NCT00382993|529731886|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
146880355|NCT00382993|529731887|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
146880356|NCT00382993|529731886|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
146880357|NCT00382993|529731887|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
146880358|NCT00382993|529731886|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
146880359|NCT00382993|529731887|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
146880360|NCT00382993|529731886|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
146880361|NCT00382993|529731887|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
146880362|NCT00382993|529731886|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
146880363|NCT00382993|529731887|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
146880364|NCT00382993|529731886|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
146880365|NCT00382993|529731887|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
146880366|NCT00382993|529731886|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
146880367|NCT00382993|529731887|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
146880368|NCT00382993|529731886|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
146880369|NCT00382993|529731887|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
146880370|NCT01965262|529731897|FG000|Second Intervention (7 Days)|Discontinued|0|||
146880371|NCT01965262|529731898|FG001|Second Intervention (7 Days)|Discontinued|1|||
146880372|NCT01965262|529731897|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
146880373|NCT01965262|529731898|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
146880374|NCT01965262|529731897|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
146880375|NCT01965262|529731898|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
146880376|NCT01029366|529731899|FG000|Overall Study|Withdrawal by Subject|1|||
146880377|NCT01029366|529731900|FG001|Overall Study|Withdrawal by Subject|0|||
146880378|NCT01029366|529731899|FG000|Overall Study|Death|1|||
146880379|NCT01029366|529731900|FG001|Overall Study|Death|1|||
146880380|NCT01029366|529731899|FG000|Overall Study|disease progression|2|||
146880381|NCT01029366|529731900|FG001|Overall Study|disease progression|0|||
146880382|NCT01029366|529731899|FG000|Overall Study|manufacturing failure|0|||
146880383|NCT01029366|529731900|FG001|Overall Study|manufacturing failure|1|||
146880384|NCT00906087|529731906|FG000|Initial Washout|Withdrawal by Subject|1|||
146880385|NCT00906087|529731906|FG000|Initial Washout|Physician Decision|1|||
146880386|NCT01827670|529731915|FG000|Overall Study|Withdrawal of Consent|3|||
146880387|NCT01827670|529731916|FG001|Overall Study|Withdrawal of Consent|2|||
146880388|NCT01827670|529731915|FG000|Overall Study|Lost to Follow-up|0|||
146880389|NCT01827670|529731916|FG001|Overall Study|Lost to Follow-up|1|||
146880390|NCT02970292|529731925|FG000|Overall Study|Physician Decision|1|||
146880391|NCT02970292|529731926|FG001|Overall Study|Physician Decision|1|||
146880392|NCT02970292|529731925|FG000|Overall Study|Withdrawal by Subject|11|||
146880393|NCT02970292|529731926|FG001|Overall Study|Withdrawal by Subject|5|||
146880394|NCT02970292|529731925|FG000|Overall Study|Noncompliance with study drug|2|||
146880395|NCT02970292|529731926|FG001|Overall Study|Noncompliance with study drug|2|||
146880396|NCT02970292|529731925|FG000|Overall Study|Adverse Event|5|||
146880397|NCT02970292|529731926|FG001|Overall Study|Adverse Event|0|||
146880398|NCT02970292|529731925|FG000|Overall Study|Lack of Efficacy|1|||
146880399|NCT02970292|529731926|FG001|Overall Study|Lack of Efficacy|0|||
146880400|NCT02970292|529731925|FG000|Overall Study|Lost to Follow-up|1|||
146880401|NCT02970292|529731926|FG001|Overall Study|Lost to Follow-up|0|||
146880402|NCT02970292|529731925|FG000|Overall Study|Protocol Violation|2|||
146880403|NCT02970292|529731926|FG001|Overall Study|Protocol Violation|0|||
146880404|NCT02970292|529731925|FG000|Overall Study|Other|1|||
146880405|NCT02970292|529731926|FG001|Overall Study|Other|0|||
146880406|NCT02941627|529731935|FG000|Overall Study|Death|1|||
146880407|NCT02941627|529731935|FG000|Overall Study|Surgical failure|1|||
146880408|NCT02941627|529731935|FG000|Overall Study|cholesteatoma prevented implantation|1|||
146880409|NCT00606320|529731936|FG000|Overall Study|Adverse Event|3|||
146880410|NCT00606320|529731936|FG000|Overall Study|Lack of Efficacy|5|||
146880411|NCT00606320|529731936|FG000|Overall Study|Physician Decision|7|||
146880412|NCT00606320|529731936|FG000|Overall Study|Protocol Violation|8|||
146880413|NCT00606320|529731936|FG000|Overall Study|Withdrawal by Subject|10|||
146880414|NCT00606320|529731936|FG000|Overall Study|Progression to depressive phase|4|||
146880415|NCT01152021|529731937|FG000|Overall Study|Adverse Event|4|||
146880416|NCT01152021|529731938|FG001|Overall Study|Adverse Event|4|||
146880417|NCT01152021|529731937|FG000|Overall Study|Study drug had expired|1|||
146880418|NCT01152021|529731938|FG001|Overall Study|Study drug had expired|0|||
146880419|NCT01152021|529731937|FG000|Overall Study|Physician Decision|1|||
146880420|NCT01152021|529731938|FG001|Overall Study|Physician Decision|1|||
146880421|NCT01152021|529731937|FG000|Overall Study|No access to study drug in Pharmacy|0|||
146880422|NCT01152021|529731938|FG001|Overall Study|No access to study drug in Pharmacy|1|||
146880423|NCT00563186|529731939|FG000|Overall Study|LOS<48 hours|97|||
146880424|NCT00563186|529731940|FG001|Overall Study|LOS<48 hours|74|||
146880425|NCT00563186|529731939|FG000|Overall Study|Incomplete data|1|||
146880426|NCT00563186|529731940|FG001|Overall Study|Incomplete data|1|||
146880427|NCT02595723|529731941|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
146880428|NCT02595723|529731942|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
146880429|NCT02595723|529731943|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
146880430|NCT02595723|529731941|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
146880431|NCT02595723|529731942|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
146880432|NCT02595723|529731943|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
146880433|NCT04839380|529731944|FG000|Overall Study|Withdrawal by Subject|2|||
146880434|NCT04839380|529731944|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
146629594|NCT03104868|528819813|FG000|18 Month Follow up|Withdrawal by Subject|1|||
146629595|NCT03104868|528819814|FG001|18 Month Follow up|Withdrawal by Subject|2|||
146765042|NCT01490580|529307227|FG000|Overall Study|Parents withdrew consent|0|||
146765043|NCT01490580|529307228|FG001|Overall Study|Parents withdrew consent|2|||
146880435|NCT01087905|529731945|FG000|Overall Study|Lost to Follow-up|24|||
146880436|NCT01087905|529731946|FG001|Overall Study|Lost to Follow-up|28|||
146765044|NCT02026258|529307232|FG000|Randomized|Did not start treatment|2|||
146880437|NCT01087905|529731947|FG002|Overall Study|Lost to Follow-up|18|||
146880438|NCT01087905|529731948|FG003|Overall Study|Lost to Follow-up|31|||
146880439|NCT01087905|529731949|FG004|Overall Study|Lost to Follow-up|27|||
146880440|NCT01087905|529731950|FG005|Overall Study|Lost to Follow-up|25|||
146880441|NCT01087905|529731951|FG006|Overall Study|Lost to Follow-up|20|||
146880442|NCT01087905|529731952|FG007|Overall Study|Lost to Follow-up|24|||
146880443|NCT01087905|529731945|FG000|Overall Study|Withdrawal by Subject|5|||
146880444|NCT01087905|529731946|FG001|Overall Study|Withdrawal by Subject|4|||
146880445|NCT01087905|529731947|FG002|Overall Study|Withdrawal by Subject|4|||
146880446|NCT01087905|529731948|FG003|Overall Study|Withdrawal by Subject|5|||
146880447|NCT01087905|529731949|FG004|Overall Study|Withdrawal by Subject|4|||
146880448|NCT01087905|529731950|FG005|Overall Study|Withdrawal by Subject|3|||
146880449|NCT01087905|529731951|FG006|Overall Study|Withdrawal by Subject|3|||
146880450|NCT01087905|529731952|FG007|Overall Study|Withdrawal by Subject|5|||
146880451|NCT00513500|529731953|FG000|Overall Study|Lost to Follow-up|35|||
146880452|NCT00513500|529731954|FG001|Overall Study|Lost to Follow-up|39|||
146880453|NCT00513500|529731953|FG000|Overall Study|Death|2|||
146880454|NCT00513500|529731954|FG001|Overall Study|Death|1|||
146880455|NCT00513500|529731953|FG000|Overall Study|Hospitalized|4|||
146880456|NCT00513500|529731954|FG001|Overall Study|Hospitalized|14|||
146880457|NCT00749996|529731955|FG000|Overall Study|Lost to Follow-up|7|||
146880458|NCT00749996|529731956|FG001|Overall Study|Lost to Follow-up|4|||
146880459|NCT00749996|529731955|FG000|Overall Study|Withdrawal by Subject|5|||
146880460|NCT00749996|529731956|FG001|Overall Study|Withdrawal by Subject|4|||
146880461|NCT00749996|529731955|FG000|Overall Study|Protocol Violation|2|||
146880462|NCT00749996|529731956|FG001|Overall Study|Protocol Violation|3|||
146880463|NCT00749996|529731955|FG000|Overall Study|Physician Decision|2|||
146880464|NCT00749996|529731956|FG001|Overall Study|Physician Decision|0|||
146880465|NCT00749996|529731955|FG000|Overall Study|Pregnancy|0|||
146880466|NCT00749996|529731956|FG001|Overall Study|Pregnancy|2|||
146880467|NCT00749996|529731955|FG000|Overall Study|Adverse Event|1|||
146880468|NCT00749996|529731956|FG001|Overall Study|Adverse Event|0|||
146880469|NCT00749996|529731955|FG000|Overall Study|Death|1|||
146880470|NCT00749996|529731956|FG001|Overall Study|Death|0|||
146880471|NCT02443883|529731960|FG000|Overall Study|Adverse Event|0|||
146880472|NCT02443883|529731961|FG001|Overall Study|Adverse Event|1|||
146880473|NCT02443883|529731962|FG002|Overall Study|Adverse Event|0|||
146880474|NCT02443883|529731963|FG003|Overall Study|Adverse Event|0|||
146880475|NCT02443883|529731960|FG000|Overall Study|Lost to Follow-up|3|||
146880476|NCT02443883|529731961|FG001|Overall Study|Lost to Follow-up|2|||
146880477|NCT02443883|529731962|FG002|Overall Study|Lost to Follow-up|1|||
146880478|NCT02443883|529731963|FG003|Overall Study|Lost to Follow-up|0|||
146880479|NCT02443883|529731960|FG000|Overall Study|Physician Decision|1|||
146545470|NCT00541229|528504337|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
146880480|NCT02443883|529731961|FG001|Overall Study|Physician Decision|1|||
146880481|NCT02443883|529731962|FG002|Overall Study|Physician Decision|0|||
146880482|NCT02443883|529731963|FG003|Overall Study|Physician Decision|3|||
146880483|NCT02443883|529731960|FG000|Overall Study|Withdrawal by Subject|1|||
146880484|NCT02443883|529731961|FG001|Overall Study|Withdrawal by Subject|0|||
146880485|NCT02443883|529731962|FG002|Overall Study|Withdrawal by Subject|0|||
146880486|NCT02443883|529731963|FG003|Overall Study|Withdrawal by Subject|2|||
146880487|NCT02443883|529731960|FG000|Overall Study|Randomized, but never treated|1|||
146880488|NCT02443883|529731961|FG001|Overall Study|Randomized, but never treated|0|||
146880489|NCT02443883|529731962|FG002|Overall Study|Randomized, but never treated|0|||
146880490|NCT02443883|529731963|FG003|Overall Study|Randomized, but never treated|0|||
146880491|NCT02199080|529731964|FG000|Overall Study|Protocol Violation|12|||
146880492|NCT02250274|529731965|FG000|Overall Study|Insufficient blood draw amount|7|||
146880493|NCT02250274|529731966|FG001|Overall Study|Insufficient blood draw amount|6|||
146880494|NCT00446511|529731969|FG000|Overall Study|Adverse Event|7|||
146545471|NCT00541229|528504338|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
146545472|NCT00541229|528504339|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
146545473|NCT00541229|528504334|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
146545474|NCT00541229|528504335|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
146545475|NCT00541229|528504336|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
146545476|NCT00541229|528504337|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
146545477|NCT00541229|528504338|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
146545478|NCT00541229|528504339|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
146545479|NCT00541229|528504334|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
146545480|NCT00541229|528504335|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
146545481|NCT00541229|528504336|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
146545482|NCT00541229|528504337|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
146545483|NCT00541229|528504338|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
146880495|NCT00446511|529731970|FG001|Overall Study|Adverse Event|2|||
146880496|NCT00446511|529731971|FG002|Overall Study|Adverse Event|3|||
146880497|NCT00446511|529731972|FG003|Overall Study|Adverse Event|1|||
146880498|NCT00446511|529731969|FG000|Overall Study|Protocol Violation|0|||
146880499|NCT00446511|529731970|FG001|Overall Study|Protocol Violation|0|||
146880500|NCT00446511|529731971|FG002|Overall Study|Protocol Violation|0|||
146880501|NCT00446511|529731972|FG003|Overall Study|Protocol Violation|1|||
146880502|NCT00446511|529731969|FG000|Overall Study|Withdrawal by Subject|0|||
146880503|NCT00446511|529731970|FG001|Overall Study|Withdrawal by Subject|0|||
146880504|NCT00446511|529731971|FG002|Overall Study|Withdrawal by Subject|0|||
146880505|NCT00446511|529731972|FG003|Overall Study|Withdrawal by Subject|3|||
146880506|NCT00446511|529731969|FG000|Overall Study|Administrative Problems|3|||
146880507|NCT00446511|529731970|FG001|Overall Study|Administrative Problems|0|||
146880508|NCT00446511|529731971|FG002|Overall Study|Administrative Problems|4|||
146880509|NCT00446511|529731972|FG003|Overall Study|Administrative Problems|1|||
146880510|NCT00835237|529731975|FG000|Overall Study|Lost to Follow-up|4|||
146880511|NCT00835237|529731976|FG001|Overall Study|Lost to Follow-up|0|||
146880512|NCT00835237|529731975|FG000|Overall Study|Withdrawal by Subject|2|||
146880513|NCT00835237|529731976|FG001|Overall Study|Withdrawal by Subject|0|||
146880514|NCT01265550|529731979|FG000|Pre Randomization|Withdrawal by Subject|0|||
146880515|NCT01265550|529731980|FG001|Pre Randomization|Withdrawal by Subject|0|||
146880516|NCT01265550|529731981|FG002|Pre Randomization|Withdrawal by Subject|0|||
146880517|NCT01265550|529731982|FG003|Pre Randomization|Withdrawal by Subject|70|||
146880518|NCT01265550|529731979|FG000|Pre Randomization|Technical Exclusions|0|||
146880519|NCT01265550|529731980|FG001|Pre Randomization|Technical Exclusions|0|||
146545484|NCT00541229|528504339|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
146545485|NCT00541229|528504334|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
146545486|NCT00541229|528504335|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
146545487|NCT00541229|528504336|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
146545488|NCT00541229|528504337|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
146545489|NCT00541229|528504338|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
146545490|NCT00541229|528504339|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
146545491|NCT00541229|528504334|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
146880520|NCT01265550|529731981|FG002|Pre Randomization|Technical Exclusions|0|||
146880521|NCT01265550|529731982|FG003|Pre Randomization|Technical Exclusions|54|||
146880522|NCT01265550|529731979|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
146880523|NCT01265550|529731980|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
146880524|NCT01265550|529731981|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
146545492|NCT00541229|528504335|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
146545493|NCT00541229|528504336|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
146545494|NCT00541229|528504337|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
146545495|NCT00541229|528504338|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
146545496|NCT00541229|528504339|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
146545497|NCT00541229|528504334|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
146545498|NCT00541229|528504335|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
146545499|NCT00541229|528504336|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
146545500|NCT00541229|528504337|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
146545501|NCT00541229|528504338|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
146545502|NCT00541229|528504339|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
146914680|NCT03303339|529850053|FG011|Overall Study|Physician Decision|0|||
146880525|NCT01265550|529731982|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
146880526|NCT01265550|529731979|FG000|Pre Randomization|Non-GERD organic disorders|0|||
146545503|NCT00924651|528504340|FG000|Overall Study|Chemo started too soon|2|||
146545504|NCT00924651|528504341|FG001|Overall Study|Chemo started too soon|3|||
146629596|NCT03104868|528819813|FG000|18 Month Follow up|Graft Loss|1|||
146629597|NCT03104868|528819814|FG001|18 Month Follow up|Graft Loss|1|||
146880527|NCT01265550|529731980|FG001|Pre Randomization|Non-GERD organic disorders|0|||
146545505|NCT00924651|528504340|FG000|Overall Study|No Reason|3|||
146545506|NCT00924651|528504341|FG001|Overall Study|No Reason|7|||
146545507|NCT00924651|528504340|FG000|Overall Study|Overwhelmed|6|||
146545508|NCT00924651|528504341|FG001|Overall Study|Overwhelmed|6|||
146545509|NCT00924651|528504340|FG000|Overall Study|Noncompliant|1|||
146545510|NCT00924651|528504341|FG001|Overall Study|Noncompliant|4|||
146545511|NCT00924651|528504340|FG000|Overall Study|Medical|1|||
146545512|NCT00924651|528504341|FG001|Overall Study|Medical|3|||
146545513|NCT00924651|528504340|FG000|Overall Study|Changed Mind|10|||
146545514|NCT00924651|528504341|FG001|Overall Study|Changed Mind|1|||
146545515|NCT00924651|528504340|FG000|Overall Study|Incomplete Form|2|||
146545516|NCT00924651|528504341|FG001|Overall Study|Incomplete Form|1|||
146545517|NCT03298061|528504342|FG000|Overall Study|Adverse Event|3|||
146545518|NCT03298061|528504342|FG000|Overall Study|Lack of Efficacy|6|||
146545519|NCT03298061|528504342|FG000|Overall Study|Protocol Violation|1|||
146545520|NCT03298061|528504342|FG000|Overall Study|Physician Decision|7|||
146545521|NCT03298061|528504342|FG000|Overall Study|Withdrawal by Subject|10|||
146545522|NCT00992836|528504343|FG000|Overall Study|Lost to Follow-up|1|||
146545523|NCT00992836|528504343|FG000|Overall Study|Withdrawal by Subject|2|||
146545524|NCT00992836|528504343|FG000|Overall Study|Protocol Violation|2|||
146545525|NCT02506036|528504344|FG000|First Intervention (4-6 Weeks)|Death|1|||
146545526|NCT02506036|528504345|FG001|First Intervention (4-6 Weeks)|Death|0|||
146545527|NCT02506036|528504344|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
146545528|NCT02506036|528504345|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
146545529|NCT02506036|528504344|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
146545530|NCT02506036|528504345|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
146545531|NCT05276804|528504347|FG000|Overall Study|screen failure|23|||
146545532|NCT05276804|528504348|FG001|Overall Study|screen failure|0|||
146545533|NCT01410604|528504350|FG000|Overall Study|Adverse Event|2|||
146545534|NCT01410604|528504351|FG001|Overall Study|Adverse Event|1|||
146545535|NCT01410604|528504350|FG000|Overall Study|Lost to Follow-up|1|||
146545536|NCT01410604|528504351|FG001|Overall Study|Lost to Follow-up|0|||
146545537|NCT01410604|528504350|FG000|Overall Study|Physician Decision|0|||
146545538|NCT01410604|528504351|FG001|Overall Study|Physician Decision|1|||
146545539|NCT02827708|528504352|FG000|Overall Study|Lost to Follow-up|3|||
146545540|NCT02827708|528504353|FG001|Overall Study|Lost to Follow-up|1|||
146545541|NCT02827708|528504352|FG000|Overall Study|Withdrawal by Subject|1|||
146545542|NCT02827708|528504353|FG001|Overall Study|Withdrawal by Subject|2|||
146545543|NCT02827708|528504352|FG000|Overall Study|Death|1|||
146545544|NCT02827708|528504353|FG001|Overall Study|Death|2|||
146880528|NCT01265550|529731981|FG002|Pre Randomization|Non-GERD organic disorders|0|||
146880529|NCT01265550|529731982|FG003|Pre Randomization|Non-GERD organic disorders|23|||
146545545|NCT00898807|528504354|FG000|Overall Study|Withdrawal by Subject|5|||
146880530|NCT01265550|529731979|FG000|Pre Randomization|Functional heartburn|0|||
146880531|NCT01265550|529731980|FG001|Pre Randomization|Functional heartburn|0|||
146880532|NCT01265550|529731981|FG002|Pre Randomization|Functional heartburn|0|||
146880533|NCT01265550|529731982|FG003|Pre Randomization|Functional heartburn|99|||
146545546|NCT00898807|528504355|FG001|Overall Study|Withdrawal by Subject|3|||
146880534|NCT01627860|529731985|FG000|Overall Study|Adverse Event|9|||
146880535|NCT01627860|529731986|FG001|Overall Study|Adverse Event|4|||
146545547|NCT00898807|528504354|FG000|Overall Study|Family pressure to discontinue|2|||
146880536|NCT01627860|529731985|FG000|Overall Study|Withdrawal by Subject|2|||
146880537|NCT01627860|529731986|FG001|Overall Study|Withdrawal by Subject|1|||
146880538|NCT01627860|529731985|FG000|Overall Study|Seizure frequency doubled|0|||
146880539|NCT01627860|529731986|FG001|Overall Study|Seizure frequency doubled|1|||
146880540|NCT01627860|529731985|FG000|Overall Study|Protocol Violation|1|||
146880541|NCT01627860|529731986|FG001|Overall Study|Protocol Violation|0|||
146880542|NCT01326546|529731987|FG000|Overall Study|Lost to Follow-up|8|||
146880543|NCT01326546|529731988|FG001|Overall Study|Lost to Follow-up|7|||
146880544|NCT01326546|529731987|FG000|Overall Study|Protocol Violation|3|||
146880545|NCT01326546|529731988|FG001|Overall Study|Protocol Violation|4|||
146880546|NCT01326546|529731987|FG000|Overall Study|Pregnancy|0|||
146545548|NCT00898807|528504355|FG001|Overall Study|Family pressure to discontinue|2|||
146545549|NCT00898807|528504354|FG000|Overall Study|Lost to Follow-up|1|||
146545550|NCT00898807|528504355|FG001|Overall Study|Lost to Follow-up|3|||
146545551|NCT00898807|528504354|FG000|Overall Study|Death|0|||
146880547|NCT01326546|529731988|FG001|Overall Study|Pregnancy|1|||
146880548|NCT01326546|529731987|FG000|Overall Study|Adverse Event|1|||
146545552|NCT00898807|528504355|FG001|Overall Study|Death|1|||
146880549|NCT01326546|529731988|FG001|Overall Study|Adverse Event|0|||
146880550|NCT01326546|529731987|FG000|Overall Study|Withdrawal by Subject|5|||
146880551|NCT01326546|529731988|FG001|Overall Study|Withdrawal by Subject|1|||
146880552|NCT03152019|529731989|FG000|Overall Study|Adverse Event|0|||
146880553|NCT03152019|529731990|FG001|Overall Study|Adverse Event|1|||
146880554|NCT00923130|529731995|FG000|Overall Study|Stopped treatment due to progression|17|||
146880555|NCT00923130|529731995|FG000|Overall Study|Death|1|||
146880556|NCT00923130|529731995|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
146880557|NCT00923130|529731995|FG000|Overall Study|Switched to alternative treatment|2|||
146880558|NCT00923130|529731995|FG000|Overall Study|Refused further treatment|2|||
146880559|NCT00894556|529731996|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
146880560|NCT00894556|529731997|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
146880561|NCT00894556|529731998|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
146880562|NCT00894556|529731999|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
146880563|NCT00894556|529731996|FG000|Treatment Phase|Lost to Follow-up|2|||
146880564|NCT00894556|529731997|FG001|Treatment Phase|Lost to Follow-up|3|||
146880565|NCT00894556|529731998|FG002|Treatment Phase|Lost to Follow-up|1|||
146880566|NCT00894556|529731999|FG003|Treatment Phase|Lost to Follow-up|0|||
146545553|NCT01521364|528504358|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
146545554|NCT01521364|528504358|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
146545555|NCT00800540|528504359|FG000|Period One: 6 Weeks|Noncompliance|1|||
146545556|NCT00800540|528504360|FG001|Period One: 6 Weeks|Noncompliance|0|||
146545557|NCT00800540|528504359|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
146880567|NCT00894556|529731996|FG000|Treatment Phase|Lack of Qualifying Event|2|||
146880568|NCT00894556|529731997|FG001|Treatment Phase|Lack of Qualifying Event|1|||
146880569|NCT00894556|529731998|FG002|Treatment Phase|Lack of Qualifying Event|0|||
146880570|NCT00894556|529731999|FG003|Treatment Phase|Lack of Qualifying Event|0|||
146880571|NCT01014689|529732002|FG000|Overall Study|Lack of Efficacy|0|||
146880572|NCT01014689|529732003|FG001|Overall Study|Lack of Efficacy|1|||
146880573|NCT01014689|529732002|FG000|Overall Study|Adverse Event|3|||
146880574|NCT01014689|529732003|FG001|Overall Study|Adverse Event|0|||
146880575|NCT01014689|529732002|FG000|Overall Study|Withdrawal by Subject|5|||
146545558|NCT00800540|528504360|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
146545559|NCT00800540|528504359|FG000|Period 2: 6 Weeks|Adverse Event|0|||
146545560|NCT00800540|528504360|FG001|Period 2: 6 Weeks|Adverse Event|1|||
146545561|NCT03927157|528504364|FG000|Overall Study|Adverse Event|1|||
146880576|NCT01014689|529732003|FG001|Overall Study|Withdrawal by Subject|4|||
146880577|NCT01014689|529732002|FG000|Overall Study|Protocol Violation|1|||
146880578|NCT01014689|529732003|FG001|Overall Study|Protocol Violation|1|||
146880579|NCT01014689|529732002|FG000|Overall Study|Lost to Follow-up|3|||
146880580|NCT01014689|529732003|FG001|Overall Study|Lost to Follow-up|7|||
146880581|NCT01014689|529732002|FG000|Overall Study|Pregnancy|1|||
146545562|NCT03927157|528504365|FG001|Overall Study|Adverse Event|3|||
146880582|NCT01014689|529732003|FG001|Overall Study|Pregnancy|0|||
146880583|NCT00333359|529732006|FG000|Overall Study|Adverse Event|29|||
146545563|NCT03927157|528504364|FG000|Overall Study|Protocol Violation|1|||
146545564|NCT03927157|528504365|FG001|Overall Study|Protocol Violation|2|||
146545565|NCT03927157|528504364|FG000|Overall Study|Withdrawal by Subject|8|||
146545566|NCT03927157|528504365|FG001|Overall Study|Withdrawal by Subject|21|||
146545567|NCT03927157|528504364|FG000|Overall Study|Due to COVID-19 pandemic|5|||
146545568|NCT03927157|528504365|FG001|Overall Study|Due to COVID-19 pandemic|2|||
146545569|NCT03927157|528504364|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
146545570|NCT03927157|528504365|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
146545571|NCT03927157|528504364|FG000|Overall Study|Other than above|0|||
146545572|NCT03927157|528504365|FG001|Overall Study|Other than above|1|||
146545573|NCT00726557|528504366|FG000|Overall Study|Screening failure|4|||
146545574|NCT00726557|528504366|FG000|Overall Study|No end of treatment documentation|37|||
146545575|NCT00726557|528504366|FG000|Overall Study|No follow-up documentation available|55|||
146545576|NCT00726557|528504366|FG000|Overall Study|Treatment less than 3 months|17|||
146545577|NCT00726557|528504366|FG000|Overall Study|Inclusion criteria not met|15|||
146545578|NCT03637374|528504367|FG000|Overall Study|Death|2|||
146545579|NCT03637374|528504368|FG001|Overall Study|Death|0|||
146545580|NCT05561140|528504373|FG000|Randomized Treatment Period|Adverse Event|1|||
146545581|NCT05561140|528504374|FG001|Randomized Treatment Period|Adverse Event|0|||
146545582|NCT05561140|528504373|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
146545583|NCT05561140|528504374|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
146545584|NCT05561140|528504373|FG000|Open Label Treatment Period|Adverse Event|6|||
146545585|NCT05561140|528504374|FG001|Open Label Treatment Period|Adverse Event|4|||
146545586|NCT05561140|528504373|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
146545587|NCT05561140|528504374|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
146545588|NCT05561140|528504373|FG000|Open Label Treatment Period|Physician Decision|0|||
146545589|NCT05561140|528504374|FG001|Open Label Treatment Period|Physician Decision|1|||
146545590|NCT05561140|528504373|FG000|Open Label Treatment Period|Pregnancy|1|||
146545591|NCT05561140|528504374|FG001|Open Label Treatment Period|Pregnancy|0|||
146545592|NCT05561140|528504373|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
146545593|NCT05561140|528504374|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
146545594|NCT05561140|528504373|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
146545595|NCT05561140|528504374|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
146545596|NCT05561140|528504373|FG000|Open Label Treatment Period|Other|1|||
146545597|NCT05561140|528504374|FG001|Open Label Treatment Period|Other|0|||
146545598|NCT03301714|528504377|FG000|Overall Study|Lost to Follow-up|10|||
146545599|NCT03301714|528504378|FG001|Overall Study|Lost to Follow-up|4|||
146545600|NCT03301714|528504379|FG002|Overall Study|Lost to Follow-up|4|||
146545601|NCT03301714|528504377|FG000|Overall Study|Did not receive allocated intervention|0|||
146545602|NCT03301714|528504378|FG001|Overall Study|Did not receive allocated intervention|2|||
146545603|NCT03301714|528504379|FG002|Overall Study|Did not receive allocated intervention|3|||
146880584|NCT00333359|529732007|FG001|Overall Study|Adverse Event|35|||
146880585|NCT00333359|529732006|FG000|Overall Study|Withdrawal by Subject|19|||
146880586|NCT00333359|529732007|FG001|Overall Study|Withdrawal by Subject|37|||
146880587|NCT00333359|529732006|FG000|Overall Study|Physician Decision|2|||
146880588|NCT00333359|529732007|FG001|Overall Study|Physician Decision|2|||
146545604|NCT02112552|528504382|FG000|Overall Study|Withdrawal by Subject|1|||
146545605|NCT02112552|528504382|FG000|Overall Study|Adverse Event|1|||
146545606|NCT03349515|528504383|FG000|Overall Study|Lack of Efficacy|2|||
146545607|NCT03349515|528504384|FG001|Overall Study|Lack of Efficacy|0|||
146545608|NCT03349515|528504383|FG000|Overall Study|Physician Decision|3|||
146545609|NCT03349515|528504384|FG001|Overall Study|Physician Decision|1|||
146880589|NCT00333359|529732006|FG000|Overall Study|Protocol Non-compliance|2|||
146880590|NCT00333359|529732007|FG001|Overall Study|Protocol Non-compliance|8|||
146880591|NCT00333359|529732006|FG000|Overall Study|Lost to Follow-up|15|||
146880592|NCT00333359|529732007|FG001|Overall Study|Lost to Follow-up|25|||
146880593|NCT00333359|529732006|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
146880594|NCT00333359|529732007|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
146880595|NCT00333359|529732006|FG000|Overall Study|Treatment Failure|3|||
146880596|NCT00333359|529732007|FG001|Overall Study|Treatment Failure|8|||
146880597|NCT00333359|529732006|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
146880598|NCT00333359|529732007|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
146880599|NCT01339559|529733506|FG000|Overall Study|Adverse Event|92|||
146880600|NCT01339559|529733506|FG000|Overall Study|Death|5|||
146880601|NCT01339559|529733506|FG000|Overall Study|Lack of Efficacy|164|||
146880602|NCT01339559|529733506|FG000|Overall Study|Lost to Follow-up|22|||
146880603|NCT01339559|529733506|FG000|Overall Study|Subject choice|89|||
146880604|NCT01339559|529733506|FG000|Overall Study|Protocol Violation|15|||
146880605|NCT01339559|529733506|FG000|Overall Study|Study closure at site|1|||
146880606|NCT01339559|529733506|FG000|Overall Study|Incarcerated|2|||
146880607|NCT01339559|529733506|FG000|Overall Study|Epilepsy surgery|1|||
146880608|NCT01339559|529733506|FG000|Overall Study|Pregnancy planned|2|||
146880609|NCT01339559|529733506|FG000|Overall Study|Left the country|1|||
146880610|NCT01339559|529733506|FG000|Overall Study|Investigator decision|2|||
146880611|NCT01339559|529733506|FG000|Overall Study|Patient didn't wish to continue|1|||
146880612|NCT01339559|529733506|FG000|Overall Study|PI decision|1|||
146880613|NCT00971945|529733507|FG000|Overall Study|Progressive Disease|3|||
146880614|NCT00971945|529733507|FG000|Overall Study|Change in treatment policy|1|||
146880615|NCT00971945|529733507|FG000|Overall Study|Other reasons|2|||
146880616|NCT03354663|529733508|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
146880617|NCT03354663|529733508|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
146880618|NCT03354663|529733508|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
146880619|NCT03354663|529733508|FG000|Completed 30-day Visit|Missed Visit|1|||
146880620|NCT01661140|529733509|FG000|Open-Label Period|Adverse Event|44|||
146880621|NCT01661140|529733510|FG001|Open-Label Period|Adverse Event|0|||
146880622|NCT01661140|529733511|FG002|Open-Label Period|Adverse Event|0|||
146880623|NCT01661140|529733509|FG000|Open-Label Period|Protocol Violation|3|||
146880624|NCT01661140|529733510|FG001|Open-Label Period|Protocol Violation|0|||
146880625|NCT01661140|529733511|FG002|Open-Label Period|Protocol Violation|0|||
146880626|NCT01661140|529733509|FG000|Open-Label Period|Withdrawal by Subject|5|||
146880627|NCT01661140|529733510|FG001|Open-Label Period|Withdrawal by Subject|0|||
146880628|NCT01661140|529733511|FG002|Open-Label Period|Withdrawal by Subject|0|||
146880629|NCT01661140|529733509|FG000|Open-Label Period|Investigator Decision|3|||
146880630|NCT01661140|529733510|FG001|Open-Label Period|Investigator Decision|0|||
146880631|NCT01661140|529733511|FG002|Open-Label Period|Investigator Decision|0|||
146880632|NCT01661140|529733509|FG000|Open-Label Period|Death|1|||
146880633|NCT01661140|529733510|FG001|Open-Label Period|Death|0|||
146880634|NCT01661140|529733511|FG002|Open-Label Period|Death|0|||
146880635|NCT01661140|529733509|FG000|Open-Label Period|Administrative/Other|1|||
146880636|NCT01661140|529733510|FG001|Open-Label Period|Administrative/Other|0|||
146880637|NCT01661140|529733511|FG002|Open-Label Period|Administrative/Other|0|||
146545610|NCT04069520|528504386|FG000|Overall Study|Lost to Follow-up|0|||
146545611|NCT04069520|528504387|FG001|Overall Study|Lost to Follow-up|2|||
146545612|NCT04069520|528504386|FG000|Overall Study|Withdrawal by Subject|0|||
146545613|NCT04069520|528504387|FG001|Overall Study|Withdrawal by Subject|1|||
146545614|NCT04069520|528504386|FG000|Overall Study|Prior Injury|1|||
146545615|NCT04069520|528504387|FG001|Overall Study|Prior Injury|0|||
146545616|NCT04069520|528504386|FG000|Overall Study|Orthodontia|1|||
146545617|NCT04069520|528504387|FG001|Overall Study|Orthodontia|0|||
146545618|NCT04069520|528504386|FG000|Overall Study|Cut from team|0|||
146545619|NCT04069520|528504387|FG001|Overall Study|Cut from team|2|||
146545620|NCT00849472|528504388|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
146545621|NCT00849472|528504388|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
146545622|NCT00849472|528504388|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
146545623|NCT00849472|528504388|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
146545624|NCT00849472|528504388|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
146545625|NCT00849472|528504388|FG000|Weekly Paclitaxel|Disease Progression|1|||
146545626|NCT00849472|528504388|FG000|Weekly Paclitaxel|Adverse Event|11|||
146545627|NCT00849472|528504388|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
146545628|NCT00849472|528504388|FG000|Weekly Paclitaxel|Physician Decision|3|||
146545629|NCT00849472|528504388|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
146545630|NCT00849472|528504388|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
146545631|NCT00849472|528504388|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
146545632|NCT00849472|528504388|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
146545633|NCT00849472|528504388|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
146545634|NCT00849472|528504388|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
146545635|NCT00849472|528504388|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
146545636|NCT00849472|528504388|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
146545637|NCT00825175|528504389|FG000|Overall Study|Withdrawal by Subject|0|||
146545638|NCT00825175|528504390|FG001|Overall Study|Withdrawal by Subject|5|||
146545639|NCT04822194|528504391|FG000|Overall Study|Withdrawal by Subject|5|||
146545640|NCT04822194|528504392|FG001|Overall Study|Withdrawal by Subject|4|||
146545641|NCT04822194|528504391|FG000|Overall Study|Technical issues with MR scanner|1|||
146545642|NCT04822194|528504392|FG001|Overall Study|Technical issues with MR scanner|0|||
146545643|NCT04822194|528504391|FG000|Overall Study|Lost to Follow-up|5|||
146545644|NCT04822194|528504392|FG001|Overall Study|Lost to Follow-up|7|||
146765045|NCT02026258|529307233|FG001|Randomized|Did not start treatment|1|||
146765046|NCT02026258|529307232|FG000|Randomized|Change in treatment plan|1|||
146880638|NCT01661140|529733509|FG000|Open-Label Period|Sponsor termination|16|||
146880639|NCT01661140|529733510|FG001|Open-Label Period|Sponsor termination|0|||
146880640|NCT01661140|529733511|FG002|Open-Label Period|Sponsor termination|0|||
146880641|NCT01661140|529733509|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
146545645|NCT04615507|528504393|FG000|Period 1|Covid-19 exposure|2|||
146545646|NCT04615507|528504394|FG001|Period 1|Covid-19 exposure|1|||
146545647|NCT04615507|528504393|FG000|Period 2|Covid-19 exposure|0|||
146545648|NCT04615507|528504394|FG001|Period 2|Covid-19 exposure|1|||
146545649|NCT04615507|528504393|FG000|Period 2|Protocol Violation|1|||
146545650|NCT04615507|528504394|FG001|Period 2|Protocol Violation|0|||
146880642|NCT01661140|529733510|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
146880643|NCT01661140|529733511|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
146880644|NCT01661140|529733509|FG000|Open-Label Period|Lost to Follow-up|2|||
146880645|NCT01661140|529733510|FG001|Open-Label Period|Lost to Follow-up|0|||
146880646|NCT01661140|529733511|FG002|Open-Label Period|Lost to Follow-up|0|||
146880647|NCT01661140|529733509|FG000|Double-Blind Period|Refused Treatment|0|||
146880648|NCT01661140|529733510|FG001|Double-Blind Period|Refused Treatment|0|||
146880649|NCT01661140|529733511|FG002|Double-Blind Period|Refused Treatment|1|||
146880650|NCT01661140|529733509|FG000|Double-Blind Period|Adverse Event|0|||
146880651|NCT01661140|529733510|FG001|Double-Blind Period|Adverse Event|16|||
146880652|NCT01661140|529733511|FG002|Double-Blind Period|Adverse Event|18|||
146880653|NCT01661140|529733509|FG000|Double-Blind Period|Protocol Violation|0|||
146880654|NCT01661140|529733510|FG001|Double-Blind Period|Protocol Violation|2|||
146880655|NCT01661140|529733511|FG002|Double-Blind Period|Protocol Violation|3|||
146880656|NCT01661140|529733509|FG000|Double-Blind Period|Withdrawal by Subject|0|||
146880657|NCT01661140|529733510|FG001|Double-Blind Period|Withdrawal by Subject|1|||
146880658|NCT01661140|529733511|FG002|Double-Blind Period|Withdrawal by Subject|3|||
146880659|NCT01661140|529733509|FG000|Double-Blind Period|Investigator's Decision|0|||
146880660|NCT01661140|529733510|FG001|Double-Blind Period|Investigator's Decision|1|||
146880661|NCT01661140|529733511|FG002|Double-Blind Period|Investigator's Decision|2|||
146880662|NCT01661140|529733509|FG000|Double-Blind Period|Sponsor Termination|0|||
146880663|NCT01661140|529733510|FG001|Double-Blind Period|Sponsor Termination|14|||
146880664|NCT01661140|529733511|FG002|Double-Blind Period|Sponsor Termination|17|||
146880665|NCT01661140|529733509|FG000|Double-Blind Period|Administrative/Other|0|||
146880666|NCT01661140|529733510|FG001|Double-Blind Period|Administrative/Other|7|||
146880667|NCT01661140|529733511|FG002|Double-Blind Period|Administrative/Other|6|||
146880668|NCT03548051|529733512|FG000|Overall Study|Death|1|||
146880669|NCT03548051|529733513|FG001|Overall Study|Death|1|||
146880670|NCT03548051|529733512|FG000|Overall Study|Withdrawal by Subject|1|||
146880671|NCT03548051|529733513|FG001|Overall Study|Withdrawal by Subject|0|||
146880672|NCT03325673|529733515|FG000|Overall Study|Adverse Event|4|||
146880673|NCT03325673|529733516|FG001|Overall Study|Adverse Event|0|||
146880674|NCT02590588|529733519|FG000|Overall Study|Adverse Event|1|||
146880675|NCT02559687|529733527|FG000|Overall Study|Death|112|||
146880676|NCT02559687|529733527|FG000|Overall Study|Sponsor Decision|5|||
146880677|NCT02559687|529733527|FG000|Overall Study|Withdrawal by Subject|4|||
146880678|NCT05630937|529733530|FG000|Overall Study|Study terminated by sponsor|1|||
146880679|NCT05630937|529733531|FG001|Overall Study|Study terminated by sponsor|1|||
146880680|NCT05630937|529733532|FG002|Overall Study|Study terminated by sponsor|8|||
146880681|NCT05630937|529733533|FG003|Overall Study|Study terminated by sponsor|0|||
146880682|NCT05630937|529733530|FG000|Overall Study|Lost to Follow-up|0|||
146880683|NCT05630937|529733531|FG001|Overall Study|Lost to Follow-up|0|||
146880684|NCT05630937|529733532|FG002|Overall Study|Lost to Follow-up|1|||
146880685|NCT05630937|529733533|FG003|Overall Study|Lost to Follow-up|0|||
146880686|NCT05630937|529733530|FG000|Overall Study|Enrolled but not treated|0|||
146880687|NCT05630937|529733531|FG001|Overall Study|Enrolled but not treated|0|||
146880688|NCT05630937|529733532|FG002|Overall Study|Enrolled but not treated|0|||
146880689|NCT05630937|529733533|FG003|Overall Study|Enrolled but not treated|1|||
146880690|NCT03245450|529733535|FG000|Overall Study|Radiological disease progression|3|||
146880691|NCT03245450|529733536|FG001|Overall Study|Radiological disease progression|3|||
146880692|NCT03245450|529733537|FG002|Overall Study|Radiological disease progression|2|||
146880693|NCT03245450|529733538|FG003|Overall Study|Radiological disease progression|2|||
146545651|NCT04615507|528504393|FG000|Period 2|Withdrawal by Subject|1|||
146545652|NCT04615507|528504394|FG001|Period 2|Withdrawal by Subject|0|||
146545653|NCT04615507|528504393|FG000|Period 2|Adverse Event|0|||
146545654|NCT04615507|528504394|FG001|Period 2|Adverse Event|1|||
146880694|NCT03245450|529733539|FG004|Overall Study|Radiological disease progression|7|||
146880695|NCT03245450|529733540|FG005|Overall Study|Radiological disease progression|6|||
146880696|NCT03245450|529733541|FG006|Overall Study|Radiological disease progression|6|||
146880697|NCT03245450|529733535|FG000|Overall Study|Clinical disease progression|0|||
146880698|NCT03245450|529733536|FG001|Overall Study|Clinical disease progression|0|||
146880699|NCT03245450|529733537|FG002|Overall Study|Clinical disease progression|1|||
146880700|NCT03245450|529733538|FG003|Overall Study|Clinical disease progression|0|||
146880701|NCT03245450|529733539|FG004|Overall Study|Clinical disease progression|0|||
146880702|NCT03245450|529733540|FG005|Overall Study|Clinical disease progression|2|||
146545655|NCT04615507|528504393|FG000|Period 3|Covid-19 exposure|0|||
146545656|NCT04615507|528504394|FG001|Period 3|Covid-19 exposure|1|||
146545657|NCT00118287|528504397|FG000|Overall Study|Intracranial haemorrhage|1|||
146545658|NCT00118287|528504397|FG000|Overall Study|Muscle pain|1|||
146545659|NCT03091439|528504402|FG000|Overall Study|Study Terminated by the Sponsor|1|||
146545660|NCT03091439|528504403|FG001|Overall Study|Study Terminated by the Sponsor|0|||
146545661|NCT05172570|528504406|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
146545662|NCT05172570|528504407|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
146545663|NCT05172570|528504408|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
146545664|NCT05172570|528504406|FG000|Overall Study|PI Decision due to equipment shortages|0|||
146545665|NCT05172570|528504407|FG001|Overall Study|PI Decision due to equipment shortages|0|||
146545666|NCT05172570|528504408|FG002|Overall Study|PI Decision due to equipment shortages|1|||
146545667|NCT03010501|528504409|FG000|Study Week 1|Withdrawal by Subject|2|||
146545668|NCT03010501|528504410|FG001|Study Week 1|Withdrawal by Subject|1|||
146545669|NCT03010501|528504411|FG002|Study Week 1|Withdrawal by Subject|0|||
146545670|NCT03010501|528504412|FG003|Study Week 1|Withdrawal by Subject|2|||
146545671|NCT03010501|528504413|FG004|Study Week 1|Withdrawal by Subject|0|||
146545672|NCT03010501|528504414|FG005|Study Week 1|Withdrawal by Subject|0|||
146545673|NCT03010501|528504409|FG000|Study Week 3|Withdrawal by Subject|0|||
146545674|NCT03010501|528504410|FG001|Study Week 3|Withdrawal by Subject|0|||
146545675|NCT03010501|528504411|FG002|Study Week 3|Withdrawal by Subject|0|||
146545676|NCT03010501|528504412|FG003|Study Week 3|Withdrawal by Subject|1|||
146545677|NCT03010501|528504413|FG004|Study Week 3|Withdrawal by Subject|0|||
146545678|NCT03010501|528504414|FG005|Study Week 3|Withdrawal by Subject|0|||
146545679|NCT00640289|528504417|FG000|Overall Study|Death|3|||
146545680|NCT00640289|528504417|FG000|Overall Study|Withdrawal by Subject|1|||
146545681|NCT00640289|528504417|FG000|Overall Study|Lost to Follow-up|1|||
146545682|NCT00640289|528504417|FG000|Overall Study|Data collected under different amendment|2|||
146545683|NCT00640289|528504417|FG000|Overall Study|Transferred to another center|1|||
146545684|NCT00640289|528504417|FG000|Overall Study|Missing status|5|||
146545685|NCT03550209|528504419|FG000|Overall Study|Lost to Follow-up|1|||
146545686|NCT03550209|528504420|FG001|Overall Study|Lost to Follow-up|0|||
146545687|NCT03550209|528504421|FG002|Overall Study|Lost to Follow-up|1|||
146545688|NCT03550209|528504422|FG003|Overall Study|Lost to Follow-up|0|||
146545689|NCT03550209|528504419|FG000|Overall Study|Withdrawal by Subject|0|||
146545690|NCT03550209|528504420|FG001|Overall Study|Withdrawal by Subject|3|||
146545691|NCT03550209|528504421|FG002|Overall Study|Withdrawal by Subject|1|||
146545692|NCT03550209|528504422|FG003|Overall Study|Withdrawal by Subject|2|||
146545693|NCT03550209|528504419|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
146545694|NCT03550209|528504420|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
146545695|NCT03550209|528504421|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
146545696|NCT03550209|528504422|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
146545697|NCT02347787|528504425|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
146545698|NCT02347787|528504426|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
146545699|NCT02347787|528504425|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
146765047|NCT02026258|529307233|FG001|Randomized|Change in treatment plan|0|||
146765048|NCT02026258|529307232|FG000|Randomized|Presence of periodontal disease|1|||
146765049|NCT02026258|529307233|FG001|Randomized|Presence of periodontal disease|1|||
146765050|NCT02026258|529307232|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
146545700|NCT02347787|528504426|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
146545701|NCT02347787|528504425|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
146545702|NCT02347787|528504426|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
146545703|NCT02347787|528504425|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
146545704|NCT02347787|528504426|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
146545705|NCT03921541|528505409|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
146880703|NCT03245450|529733541|FG006|Overall Study|Clinical disease progression|0|||
146880704|NCT03245450|529733535|FG000|Overall Study|Other|0|||
146880705|NCT03245450|529733536|FG001|Overall Study|Other|0|||
146880706|NCT03245450|529733537|FG002|Overall Study|Other|0|||
146880707|NCT03245450|529733538|FG003|Overall Study|Other|1|||
146880708|NCT03245450|529733539|FG004|Overall Study|Other|1|||
146880709|NCT03245450|529733540|FG005|Overall Study|Other|1|||
146880710|NCT03245450|529733541|FG006|Overall Study|Other|1|||
146880711|NCT03245450|529733535|FG000|Overall Study|Withdrawal by Subject|0|||
146880712|NCT03245450|529733536|FG001|Overall Study|Withdrawal by Subject|1|||
146880713|NCT03245450|529733537|FG002|Overall Study|Withdrawal by Subject|0|||
146880714|NCT03245450|529733538|FG003|Overall Study|Withdrawal by Subject|0|||
146880715|NCT03245450|529733539|FG004|Overall Study|Withdrawal by Subject|0|||
146880716|NCT03245450|529733540|FG005|Overall Study|Withdrawal by Subject|0|||
146880717|NCT03245450|529733541|FG006|Overall Study|Withdrawal by Subject|0|||
146880718|NCT03245450|529733535|FG000|Overall Study|Adverse Event|0|||
146880719|NCT03245450|529733536|FG001|Overall Study|Adverse Event|0|||
146880720|NCT03245450|529733537|FG002|Overall Study|Adverse Event|0|||
146880721|NCT03245450|529733538|FG003|Overall Study|Adverse Event|0|||
146880722|NCT03245450|529733539|FG004|Overall Study|Adverse Event|1|||
146880723|NCT03245450|529733540|FG005|Overall Study|Adverse Event|0|||
146880724|NCT03245450|529733541|FG006|Overall Study|Adverse Event|2|||
146880725|NCT00267748|529733542|FG000|Non-randomized Period|Progressive disease|10|||
146880726|NCT00267748|529733543|FG001|Non-randomized Period|Progressive disease|0|||
146880727|NCT00267748|529733544|FG002|Non-randomized Period|Progressive disease|0|||
146880728|NCT00267748|529733542|FG000|Non-randomized Period|Adverse Event|8|||
146880729|NCT00267748|529733543|FG001|Non-randomized Period|Adverse Event|0|||
146880730|NCT00267748|529733544|FG002|Non-randomized Period|Adverse Event|0|||
146880731|NCT00267748|529733542|FG000|Non-randomized Period|Death|1|||
146880732|NCT00267748|529733543|FG001|Non-randomized Period|Death|0|||
146880733|NCT00267748|529733544|FG002|Non-randomized Period|Death|0|||
146880734|NCT00267748|529733542|FG000|Non-randomized Period|Participant not willing to participate|1|||
146880735|NCT00267748|529733543|FG001|Non-randomized Period|Participant not willing to participate|0|||
146880736|NCT00267748|529733544|FG002|Non-randomized Period|Participant not willing to participate|0|||
146880737|NCT00267748|529733542|FG000|Non-randomized Period|Other|3|||
146880738|NCT00267748|529733543|FG001|Non-randomized Period|Other|0|||
146880739|NCT00267748|529733544|FG002|Non-randomized Period|Other|0|||
146880740|NCT00267748|529733542|FG000|Randomized Period|Death|0|||
146880741|NCT00267748|529733543|FG001|Randomized Period|Death|2|||
146880742|NCT00267748|529733544|FG002|Randomized Period|Death|3|||
146880743|NCT00267748|529733542|FG000|Randomized Period|Adverse Event|0|||
146880744|NCT00267748|529733543|FG001|Randomized Period|Adverse Event|23|||
146880745|NCT00267748|529733544|FG002|Randomized Period|Adverse Event|25|||
146880746|NCT00267748|529733542|FG000|Randomized Period|Global deterioration of health status|0|||
146880747|NCT00267748|529733543|FG001|Randomized Period|Global deterioration of health status|6|||
146880748|NCT00267748|529733544|FG002|Randomized Period|Global deterioration of health status|7|||
146880749|NCT00267748|529733542|FG000|Randomized Period|Lost to Follow-up|0|||
146880750|NCT00267748|529733543|FG001|Randomized Period|Lost to Follow-up|1|||
146880751|NCT00267748|529733544|FG002|Randomized Period|Lost to Follow-up|0|||
146880752|NCT00267748|529733542|FG000|Randomized Period|Objective progression or relapse|0|||
146545706|NCT03921541|528505410|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
146880753|NCT00267748|529733543|FG001|Randomized Period|Objective progression or relapse|77|||
146880754|NCT00267748|529733544|FG002|Randomized Period|Objective progression or relapse|86|||
146880755|NCT00267748|529733542|FG000|Randomized Period|Withdrawal by Subject|0|||
146880756|NCT00267748|529733543|FG001|Randomized Period|Withdrawal by Subject|9|||
146880757|NCT00267748|529733544|FG002|Randomized Period|Withdrawal by Subject|2|||
146880758|NCT00267748|529733542|FG000|Randomized Period|Other|0|||
146880759|NCT00267748|529733543|FG001|Randomized Period|Other|9|||
146880760|NCT00267748|529733544|FG002|Randomized Period|Other|6|||
146880761|NCT00267748|529733542|FG000|Randomized Period|randomized but not treated|0|||
146880762|NCT00267748|529733543|FG001|Randomized Period|randomized but not treated|0|||
146880763|NCT00267748|529733544|FG002|Randomized Period|randomized but not treated|3|||
146880764|NCT05098041|529733548|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
146880765|NCT00464334|529733550|FG000|Overall Study|Adverse Event|0|||
146880766|NCT00464334|529733551|FG001|Overall Study|Adverse Event|0|||
146880767|NCT00464334|529733552|FG002|Overall Study|Adverse Event|0|||
146880768|NCT00464334|529733553|FG003|Overall Study|Adverse Event|1|||
146880769|NCT00464334|529733554|FG004|Overall Study|Adverse Event|1|||
146545707|NCT05399485|528505411|FG000|DBT Phase|Other|6|||
146545708|NCT05399485|528505412|FG001|DBT Phase|Other|5|||
146545709|NCT05399485|528505411|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
146880770|NCT00464334|529733555|FG005|Overall Study|Adverse Event|1|||
146880771|NCT00464334|529733556|FG006|Overall Study|Adverse Event|0|||
146880772|NCT00464334|529733557|FG007|Overall Study|Adverse Event|0|||
146880773|NCT00464334|529733558|FG008|Overall Study|Adverse Event|2|||
146880774|NCT00464334|529733559|FG009|Overall Study|Adverse Event|1|||
146880775|NCT00464334|529733560|FG010|Overall Study|Adverse Event|2|||
146880776|NCT00464334|529733550|FG000|Overall Study|Lack of Efficacy|0|||
146880777|NCT00464334|529733551|FG001|Overall Study|Lack of Efficacy|1|||
146880778|NCT00464334|529733552|FG002|Overall Study|Lack of Efficacy|0|||
146880779|NCT00464334|529733553|FG003|Overall Study|Lack of Efficacy|0|||
146880780|NCT00464334|529733554|FG004|Overall Study|Lack of Efficacy|0|||
146880781|NCT00464334|529733555|FG005|Overall Study|Lack of Efficacy|0|||
146880782|NCT00464334|529733556|FG006|Overall Study|Lack of Efficacy|0|||
146880783|NCT00464334|529733557|FG007|Overall Study|Lack of Efficacy|0|||
146880784|NCT00464334|529733558|FG008|Overall Study|Lack of Efficacy|0|||
146880785|NCT00464334|529733559|FG009|Overall Study|Lack of Efficacy|0|||
146880786|NCT00464334|529733560|FG010|Overall Study|Lack of Efficacy|0|||
146880787|NCT00464334|529733550|FG000|Overall Study|Lost to Follow-up|0|||
146880788|NCT00464334|529733551|FG001|Overall Study|Lost to Follow-up|0|||
146880789|NCT00464334|529733552|FG002|Overall Study|Lost to Follow-up|1|||
146880790|NCT00464334|529733553|FG003|Overall Study|Lost to Follow-up|0|||
146880791|NCT00464334|529733554|FG004|Overall Study|Lost to Follow-up|1|||
146880792|NCT00464334|529733555|FG005|Overall Study|Lost to Follow-up|0|||
146880793|NCT00464334|529733556|FG006|Overall Study|Lost to Follow-up|1|||
146880794|NCT00464334|529733557|FG007|Overall Study|Lost to Follow-up|0|||
146545710|NCT05399485|528505412|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
146545711|NCT05399485|528505411|FG000|DBT Phase|Withdrawal by Subject|3|||
146545712|NCT05399485|528505412|FG001|DBT Phase|Withdrawal by Subject|2|||
146545713|NCT05399485|528505411|FG000|DBT Phase|Protocol Violation|2|||
146545714|NCT05399485|528505412|FG001|DBT Phase|Protocol Violation|1|||
146545715|NCT05399485|528505411|FG000|DBT Phase|Physician Decision|0|||
146545716|NCT05399485|528505412|FG001|DBT Phase|Physician Decision|1|||
146545717|NCT05399485|528505411|FG000|DBT Phase|Adverse Event|2|||
146545718|NCT05399485|528505412|FG001|DBT Phase|Adverse Event|1|||
146545719|NCT05399485|528505411|FG000|OLE Phase|Protocol deviation|1|||
146545720|NCT05399485|528505412|FG001|OLE Phase|Protocol deviation|0|||
146545721|NCT05399485|528505411|FG000|OLE Phase|Other|5|||
146545722|NCT05399485|528505412|FG001|OLE Phase|Other|5|||
146545723|NCT05399485|528505411|FG000|OLE Phase|Withdrawal by Subject|12|||
146545724|NCT05399485|528505412|FG001|OLE Phase|Withdrawal by Subject|7|||
146545725|NCT05399485|528505411|FG000|OLE Phase|Pregnancy|0|||
146545726|NCT05399485|528505412|FG001|OLE Phase|Pregnancy|2|||
146545727|NCT05399485|528505411|FG000|OLE Phase|Physician Decision|3|||
146545728|NCT05399485|528505412|FG001|OLE Phase|Physician Decision|0|||
146545729|NCT05399485|528505411|FG000|OLE Phase|Adverse Event|2|||
146545730|NCT05399485|528505412|FG001|OLE Phase|Adverse Event|2|||
146545731|NCT04706403|528505415|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
146545732|NCT04706403|528505416|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
146545733|NCT04706403|528505417|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
146545734|NCT04706403|528505418|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
146545735|NCT04706403|528505419|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
146880795|NCT00464334|529733558|FG008|Overall Study|Lost to Follow-up|0|||
146880796|NCT00464334|529733559|FG009|Overall Study|Lost to Follow-up|0|||
146545736|NCT00182637|528505420|FG000|Overall Study|Adverse Event|2|||
146545737|NCT00182637|528505420|FG000|Overall Study|Disease Progression|1|||
146880797|NCT00464334|529733560|FG010|Overall Study|Lost to Follow-up|2|||
146880798|NCT00464334|529733550|FG000|Overall Study|Progressive Disease|0|||
146880799|NCT00464334|529733551|FG001|Overall Study|Progressive Disease|0|||
146880800|NCT00464334|529733552|FG002|Overall Study|Progressive Disease|0|||
146880801|NCT00464334|529733553|FG003|Overall Study|Progressive Disease|0|||
146880802|NCT00464334|529733554|FG004|Overall Study|Progressive Disease|0|||
146880803|NCT00464334|529733555|FG005|Overall Study|Progressive Disease|1|||
146880804|NCT00464334|529733556|FG006|Overall Study|Progressive Disease|0|||
146545738|NCT02642679|528505421|FG000|Overall Study|Withdrawal by Subject|1|||
146545739|NCT02642679|528505421|FG000|Overall Study|Physician Decision|1|||
146545740|NCT02642679|528505421|FG000|Overall Study|Physician Decision|1|||
146880805|NCT00464334|529733557|FG007|Overall Study|Progressive Disease|0|||
146880806|NCT00464334|529733558|FG008|Overall Study|Progressive Disease|1|||
146545741|NCT00134719|528505427|FG000|Primary Vaccination Phase|Adverse Event|4|||
146545742|NCT00134719|528505428|FG001|Primary Vaccination Phase|Adverse Event|0|||
146545743|NCT00134719|528505429|FG002|Primary Vaccination Phase|Adverse Event|0|||
146545744|NCT00134719|528505427|FG000|Primary Vaccination Phase|Protocol Violation|1|||
146545745|NCT00134719|528505428|FG001|Primary Vaccination Phase|Protocol Violation|0|||
146545746|NCT00134719|528505429|FG002|Primary Vaccination Phase|Protocol Violation|0|||
146545747|NCT00134719|528505427|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
146545748|NCT00134719|528505428|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
146545749|NCT00134719|528505429|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
146545750|NCT00134719|528505427|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
146545751|NCT00134719|528505428|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
146545752|NCT00134719|528505429|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
146545753|NCT00134719|528505427|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
146545754|NCT00134719|528505428|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
146545755|NCT00134719|528505429|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
146545756|NCT00134719|528505427|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
146545757|NCT00134719|528505428|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
146545758|NCT00134719|528505429|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
146545759|NCT01807520|528505430|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
146545760|NCT01807520|528505431|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
146545761|NCT01807520|528505432|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
146545762|NCT01807520|528505433|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
146545763|NCT01807520|528505434|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
146545764|NCT01807520|528505435|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
146545765|NCT01807520|528505436|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
146545766|NCT01807520|528505430|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
146545767|NCT01807520|528505431|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
146545768|NCT01807520|528505432|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
146545769|NCT01807520|528505433|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
146545770|NCT01807520|528505434|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
146545771|NCT01807520|528505435|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
146545772|NCT01807520|528505436|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
146545773|NCT01807520|528505430|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
146545774|NCT01807520|528505431|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
146545775|NCT01807520|528505432|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
146545776|NCT01807520|528505433|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
146545777|NCT01807520|528505434|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
146545778|NCT01807520|528505435|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
146545779|NCT01807520|528505436|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
146545780|NCT01807520|528505430|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
146545781|NCT01807520|528505431|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
146545782|NCT01807520|528505432|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
146545783|NCT01807520|528505433|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
146545784|NCT01807520|528505434|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
146545785|NCT01807520|528505435|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
146545786|NCT01807520|528505436|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
146545787|NCT01807520|528505430|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
146545788|NCT01807520|528505431|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
146545789|NCT01807520|528505432|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
146545790|NCT01807520|528505433|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
146545791|NCT01807520|528505434|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
146545792|NCT01807520|528505435|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
146545793|NCT01807520|528505436|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
146545794|NCT01807520|528505430|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
146545795|NCT01807520|528505431|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
146545796|NCT01807520|528505432|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
146545797|NCT01807520|528505433|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
146545798|NCT01807520|528505434|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
146545799|NCT01807520|528505435|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
146545800|NCT01807520|528505436|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
146629598|NCT03104868|528819813|FG000|18 Month Follow up|Completed Later Timepoint|19|||
146629599|NCT03104868|528819814|FG001|18 Month Follow up|Completed Later Timepoint|20|||
146629600|NCT03104868|528819813|FG000|24 Month Follow up|Lost to Follow-up|15|||
146545801|NCT01807520|528505430|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
146545802|NCT01807520|528505431|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
146545803|NCT01807520|528505432|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
146545804|NCT01807520|528505433|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
146545805|NCT01807520|528505434|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
146545806|NCT01807520|528505435|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
146629601|NCT03104868|528819814|FG001|24 Month Follow up|Lost to Follow-up|16|||
146629602|NCT03104868|528819813|FG000|24 Month Follow up|Death|3|||
146629603|NCT03104868|528819814|FG001|24 Month Follow up|Death|2|||
146629604|NCT03104868|528819813|FG000|24 Month Follow up|Withdrawal by Subject|1|||
146629605|NCT03104868|528819814|FG001|24 Month Follow up|Withdrawal by Subject|0|||
146629606|NCT03104868|528819813|FG000|24 Month Follow up|Graft Loss|2|||
146545807|NCT01807520|528505436|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
146545808|NCT01807520|528505430|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
146545809|NCT01807520|528505431|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
146545810|NCT01807520|528505432|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
146545811|NCT01807520|528505433|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
146545812|NCT01807520|528505434|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
146545813|NCT01807520|528505435|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
146545814|NCT01807520|528505436|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
146545815|NCT01807520|528505430|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
146545816|NCT01807520|528505431|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
146545817|NCT01807520|528505432|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
146545818|NCT01807520|528505433|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
146545819|NCT01807520|528505434|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
146545820|NCT01807520|528505435|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
146545821|NCT01807520|528505436|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
146545822|NCT01807520|528505430|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
146545823|NCT01807520|528505431|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
146545824|NCT01807520|528505432|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
146545825|NCT01807520|528505433|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
146545826|NCT01807520|528505434|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
146545827|NCT01807520|528505435|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
146545828|NCT01807520|528505436|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
146545829|NCT01807520|528505430|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
146545830|NCT01807520|528505431|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
146545831|NCT01807520|528505432|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
146545832|NCT01807520|528505433|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
146545833|NCT01807520|528505434|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
146545834|NCT01807520|528505435|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
146545835|NCT01807520|528505436|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
146545836|NCT01807520|528505430|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
146545837|NCT01807520|528505431|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
146545838|NCT01807520|528505432|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
146545839|NCT01807520|528505433|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
146545840|NCT01807520|528505434|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
146545841|NCT01807520|528505435|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
146545842|NCT01807520|528505436|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
146545843|NCT01807520|528505430|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
146545844|NCT01807520|528505431|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
146545845|NCT01807520|528505432|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
146545846|NCT01807520|528505433|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
146545847|NCT01807520|528505434|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
146545848|NCT01807520|528505435|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
146545849|NCT01807520|528505436|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
146545850|NCT01807520|528505430|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
146545851|NCT01807520|528505431|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
146545852|NCT01807520|528505432|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
146545853|NCT01807520|528505433|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
146629607|NCT03104868|528819814|FG001|24 Month Follow up|Graft Loss|0|||
146629608|NCT01253291|528819815|FG000|Overall Study|Withdrawal by Subject|1|||
146629609|NCT01253291|528819816|FG001|Overall Study|Withdrawal by Subject|1|||
146629610|NCT01253291|528819817|FG002|Overall Study|Withdrawal by Subject|0|||
146880807|NCT00464334|529733559|FG009|Overall Study|Progressive Disease|0|||
146545854|NCT01807520|528505434|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
146545855|NCT01807520|528505435|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
146545856|NCT01807520|528505436|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
146629611|NCT01253291|528819818|FG003|Overall Study|Withdrawal by Subject|0|||
146545857|NCT01807520|528505430|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
146880808|NCT00464334|529733560|FG010|Overall Study|Progressive Disease|0|||
146880809|NCT00464334|529733550|FG000|Overall Study|Study Terminated by Sponsor|0|||
146880810|NCT00464334|529733551|FG001|Overall Study|Study Terminated by Sponsor|0|||
146880811|NCT00464334|529733552|FG002|Overall Study|Study Terminated by Sponsor|0|||
146880812|NCT00464334|529733553|FG003|Overall Study|Study Terminated by Sponsor|1|||
146545858|NCT01807520|528505431|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
146545859|NCT01807520|528505432|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
146545860|NCT01807520|528505433|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
146545861|NCT01807520|528505434|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
146545862|NCT01807520|528505435|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
146545863|NCT01807520|528505436|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
146545864|NCT01807520|528505430|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
146545865|NCT01807520|528505431|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
146545866|NCT01807520|528505432|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
146545867|NCT01807520|528505433|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
146545868|NCT01807520|528505434|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
146545869|NCT01807520|528505435|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
146545870|NCT01807520|528505436|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
146545871|NCT01807520|528505430|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
146545872|NCT01807520|528505431|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
146545873|NCT01807520|528505432|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
146545874|NCT01807520|528505433|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
146545875|NCT01807520|528505434|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
146545876|NCT01807520|528505435|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
146545877|NCT01807520|528505436|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
146545878|NCT01500096|528505437|FG000|Overall Study|Lost to Follow-up|1|||
146545879|NCT01500096|528505438|FG001|Overall Study|Lost to Follow-up|0|||
146545880|NCT01500096|528505439|FG002|Overall Study|Lost to Follow-up|0|||
146545881|NCT01500096|528505440|FG003|Overall Study|Lost to Follow-up|2|||
146545882|NCT00639379|528505441|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
146545883|NCT00639379|528505442|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
146545884|NCT00639379|528505441|FG000|Period 1 - 2 Weeks|lens issue|3|||
146545885|NCT00639379|528505442|FG001|Period 1 - 2 Weeks|lens issue|0|||
146545886|NCT05427916|528505448|FG000|Overall Study|Adverse Event|3|||
146545887|NCT05427916|528505449|FG001|Overall Study|Adverse Event|0|||
146545888|NCT05427916|528505448|FG000|Overall Study|Lack of Efficacy|6|||
146545889|NCT05427916|528505449|FG001|Overall Study|Lack of Efficacy|0|||
146545890|NCT05427916|528505448|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
146545891|NCT05427916|528505449|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
146545892|NCT05630755|528505450|FG000|Overall Study|Lost to Follow-up|7|||
146545893|NCT05630755|528505451|FG001|Overall Study|Lost to Follow-up|0|||
146545894|NCT05630755|528505450|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
146545895|NCT05630755|528505451|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
146545896|NCT05630755|528505450|FG000|Overall Study|Withdrawal by Subject|9|||
146545897|NCT05630755|528505451|FG001|Overall Study|Withdrawal by Subject|3|||
146545898|NCT05630755|528505450|FG000|Overall Study|Participant moved away from trial site|0|||
146545899|NCT05630755|528505451|FG001|Overall Study|Participant moved away from trial site|1|||
146545900|NCT05630755|528505450|FG000|Overall Study|Status not Recorded|316|||
146545901|NCT05630755|528505451|FG001|Overall Study|Status not Recorded|161|||
146545902|NCT04868682|528505452|FG000|Post-treatment|Lost to Follow-up|1|||
146545903|NCT04868682|528505453|FG001|Post-treatment|Lost to Follow-up|1|||
146880813|NCT00464334|529733554|FG004|Overall Study|Study Terminated by Sponsor|0|||
146880814|NCT00464334|529733555|FG005|Overall Study|Study Terminated by Sponsor|0|||
146545904|NCT04868682|528505452|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
146545905|NCT04868682|528505453|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
146545906|NCT04868682|528505452|FG000|Six-month Assessment|Lost to Follow-up|1|||
146545907|NCT04868682|528505453|FG001|Six-month Assessment|Lost to Follow-up|0|||
146880815|NCT00464334|529733556|FG006|Overall Study|Study Terminated by Sponsor|0|||
146880816|NCT00464334|529733557|FG007|Overall Study|Study Terminated by Sponsor|0|||
146880817|NCT00464334|529733558|FG008|Overall Study|Study Terminated by Sponsor|0|||
146880818|NCT00464334|529733559|FG009|Overall Study|Study Terminated by Sponsor|0|||
146880819|NCT00464334|529733560|FG010|Overall Study|Study Terminated by Sponsor|0|||
146880820|NCT00464334|529733550|FG000|Overall Study|Withdrawal by Subject|1|||
146880821|NCT00464334|529733551|FG001|Overall Study|Withdrawal by Subject|7|||
146880822|NCT00464334|529733552|FG002|Overall Study|Withdrawal by Subject|4|||
146880823|NCT00464334|529733553|FG003|Overall Study|Withdrawal by Subject|2|||
146880824|NCT00464334|529733554|FG004|Overall Study|Withdrawal by Subject|2|||
146880825|NCT00464334|529733555|FG005|Overall Study|Withdrawal by Subject|2|||
146545908|NCT04868682|528505452|FG000|Six-month Assessment|Death|1|||
146545909|NCT04868682|528505453|FG001|Six-month Assessment|Death|0|||
146545910|NCT04868682|528505452|FG000|Six-month Assessment|Refused|0|||
146545911|NCT04868682|528505453|FG001|Six-month Assessment|Refused|1|||
146545912|NCT04868682|528505452|FG000|12-month Assessment|Lost to Follow-up|2|||
146545913|NCT04868682|528505453|FG001|12-month Assessment|Lost to Follow-up|1|||
146545914|NCT04868682|528505452|FG000|12-month Assessment|Death|0|||
146545915|NCT04868682|528505453|FG001|12-month Assessment|Death|1|||
146545916|NCT02541903|528505454|FG000|Overall Study|Death|1|||
146545917|NCT03880565|528505455|FG000|Overall Study|Withdrawal by Subject|1|||
146545918|NCT03880565|528505456|FG001|Overall Study|Withdrawal by Subject|0|||
146545919|NCT05073315|528505463|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
146545920|NCT05073315|528505464|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
146545921|NCT05073315|528505465|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
146545922|NCT05073315|528505463|FG000|Period 1 (Lead-in Period)|Death|1|||
146545923|NCT05073315|528505464|FG001|Period 1 (Lead-in Period)|Death|0|||
146545924|NCT05073315|528505465|FG002|Period 1 (Lead-in Period)|Death|0|||
146545925|NCT05073315|528505463|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
146545926|NCT05073315|528505464|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
146545927|NCT05073315|528505465|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
146545928|NCT05073315|528505463|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
146545929|NCT05073315|528505464|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
146545930|NCT05073315|528505465|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
146545931|NCT05073315|528505463|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
146545932|NCT05073315|528505464|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
146545933|NCT05073315|528505465|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
146545934|NCT05073315|528505463|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
146545935|NCT05073315|528505464|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
146545936|NCT05073315|528505465|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
146545937|NCT05073315|528505463|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
146545938|NCT05073315|528505464|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
146545939|NCT05073315|528505465|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
146545940|NCT05073315|528505463|FG000|Period 2|Adverse Event|0|||
146545941|NCT05073315|528505464|FG001|Period 2|Adverse Event|3|||
146545942|NCT05073315|528505465|FG002|Period 2|Adverse Event|6|||
146545943|NCT05073315|528505463|FG000|Period 2|Lost to Follow-up|0|||
146545944|NCT05073315|528505464|FG001|Period 2|Lost to Follow-up|5|||
146545945|NCT05073315|528505465|FG002|Period 2|Lost to Follow-up|5|||
146545946|NCT05073315|528505463|FG000|Period 2|Withdrawal by Subject|0|||
146629612|NCT01253291|528819819|FG004|Overall Study|Withdrawal by Subject|0|||
146629613|NCT01253291|528819815|FG000|Overall Study|Adverse Event|0|||
146629614|NCT01253291|528819816|FG001|Overall Study|Adverse Event|1|||
146629615|NCT01253291|528819817|FG002|Overall Study|Adverse Event|0|||
146880826|NCT00464334|529733556|FG006|Overall Study|Withdrawal by Subject|2|||
146880827|NCT00464334|529733557|FG007|Overall Study|Withdrawal by Subject|1|||
146880828|NCT00464334|529733558|FG008|Overall Study|Withdrawal by Subject|3|||
146629616|NCT01253291|528819818|FG003|Overall Study|Adverse Event|0|||
146880829|NCT00464334|529733559|FG009|Overall Study|Withdrawal by Subject|0|||
146880830|NCT00464334|529733560|FG010|Overall Study|Withdrawal by Subject|0|||
146880831|NCT00440947|529733563|FG000|36-Week Induction Phase|Adverse Event|16|||
146880832|NCT00440947|529733564|FG001|36-Week Induction Phase|Adverse Event|0|||
146880833|NCT00440947|529733565|FG002|36-Week Induction Phase|Adverse Event|0|||
146880834|NCT00440947|529733566|FG003|36-Week Induction Phase|Adverse Event|0|||
146545947|NCT05073315|528505464|FG001|Period 2|Withdrawal by Subject|4|||
146545948|NCT05073315|528505465|FG002|Period 2|Withdrawal by Subject|9|||
146545949|NCT05073315|528505463|FG000|Period 2|Protocol Violation|0|||
146545950|NCT05073315|528505464|FG001|Period 2|Protocol Violation|0|||
146545951|NCT05073315|528505465|FG002|Period 2|Protocol Violation|1|||
146545952|NCT00303953|528505466|FG000|Overall Study|Ineligible|1|||
146545953|NCT00303953|528505466|FG000|Overall Study|Death|1|||
146545954|NCT00303953|528505466|FG000|Overall Study|Adverse Event|4|||
146545955|NCT00303953|528505466|FG000|Overall Study|Lack of Efficacy|12|||
146545956|NCT00303953|528505466|FG000|Overall Study|Physician Decision|1|||
146880835|NCT00440947|529733567|FG004|36-Week Induction Phase|Adverse Event|0|||
146880836|NCT00440947|529733563|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
146880837|NCT00440947|529733564|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
146880838|NCT00440947|529733565|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
146880839|NCT00440947|529733566|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
146880840|NCT00440947|529733567|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
146880841|NCT00440947|529733563|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
146880842|NCT00440947|529733564|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
146545957|NCT02232698|528505467|FG000|Overall Study|Pregnancy|1|||
146545958|NCT02232698|528505468|FG001|Overall Study|Pregnancy|1|||
146545959|NCT02232698|528505467|FG000|Overall Study|Met exclusion criteria|1|||
146545960|NCT02232698|528505468|FG001|Overall Study|Met exclusion criteria|1|||
146545961|NCT02232698|528505467|FG000|Overall Study|Had device-associated symptoms|7|||
146545962|NCT02232698|528505468|FG001|Overall Study|Had device-associated symptoms|0|||
146545963|NCT02232698|528505467|FG000|Overall Study|Non-compliance with study device|1|||
146545964|NCT02232698|528505468|FG001|Overall Study|Non-compliance with study device|4|||
146545965|NCT02232698|528505467|FG000|Overall Study|Allocated to control group|0|||
146545966|NCT02232698|528505468|FG001|Overall Study|Allocated to control group|3|||
146545967|NCT02232698|528505467|FG000|Overall Study|Withdrawal by Subject|0|||
146545968|NCT02232698|528505468|FG001|Overall Study|Withdrawal by Subject|11|||
146545969|NCT01068912|528505471|FG000|Overall Study|Adverse Event|2|||
146880843|NCT00440947|529733565|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
146880844|NCT00440947|529733566|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
146880845|NCT00440947|529733567|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
146880846|NCT00440947|529733563|FG000|36-Week Induction Phase|Non-compliance|10|||
146880847|NCT00440947|529733564|FG001|36-Week Induction Phase|Non-compliance|0|||
146545970|NCT01068912|528505472|FG001|Overall Study|Adverse Event|3|||
146765051|NCT02026258|529307233|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
146545971|NCT01068912|528505473|FG002|Overall Study|Adverse Event|2|||
146880848|NCT00440947|529733565|FG002|36-Week Induction Phase|Non-compliance|0|||
146880849|NCT00440947|529733566|FG003|36-Week Induction Phase|Non-compliance|0|||
146880850|NCT00440947|529733567|FG004|36-Week Induction Phase|Non-compliance|0|||
146880851|NCT00440947|529733563|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
146880852|NCT00440947|529733564|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
146880853|NCT00440947|529733565|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
146880854|NCT00440947|529733566|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
146880855|NCT00440947|529733567|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
146880856|NCT00440947|529733563|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
146880857|NCT00440947|529733564|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
146880858|NCT00440947|529733565|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
146880859|NCT00440947|529733566|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
146880860|NCT00440947|529733567|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
146880861|NCT00440947|529733563|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
146880862|NCT00440947|529733564|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
146880863|NCT00440947|529733565|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
146880864|NCT00440947|529733566|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
146880865|NCT00440947|529733567|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
146880866|NCT00440947|529733563|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
146880867|NCT00440947|529733564|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
146880868|NCT00440947|529733565|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
146880869|NCT00440947|529733566|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
146880870|NCT00440947|529733567|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
146545972|NCT01068912|528505471|FG000|Overall Study|Withdrawal by Subject|5|||
146545973|NCT01068912|528505472|FG001|Overall Study|Withdrawal by Subject|6|||
146545974|NCT01068912|528505473|FG002|Overall Study|Withdrawal by Subject|6|||
146545975|NCT01068912|528505471|FG000|Overall Study|Lost to Follow-up|3|||
146545976|NCT01068912|528505472|FG001|Overall Study|Lost to Follow-up|7|||
146545977|NCT01068912|528505473|FG002|Overall Study|Lost to Follow-up|3|||
146545978|NCT01068912|528505471|FG000|Overall Study|Protocol Violation|0|||
146545979|NCT01068912|528505472|FG001|Overall Study|Protocol Violation|2|||
146545980|NCT01068912|528505473|FG002|Overall Study|Protocol Violation|0|||
146545981|NCT01068912|528505471|FG000|Overall Study|aggravation influenza|1|||
146545982|NCT01068912|528505472|FG001|Overall Study|aggravation influenza|1|||
146545983|NCT01068912|528505473|FG002|Overall Study|aggravation influenza|1|||
146545984|NCT01068912|528505471|FG000|Overall Study|other underlying illness|0|||
146545985|NCT01068912|528505472|FG001|Overall Study|other underlying illness|3|||
146545986|NCT01068912|528505473|FG002|Overall Study|other underlying illness|3|||
146545987|NCT02762604|528505474|FG000|Overall Study|Lost to Follow-up|2|||
146545988|NCT02762604|528505475|FG001|Overall Study|Lost to Follow-up|7|||
146545989|NCT02762604|528505474|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
146545990|NCT02762604|528505475|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
146545991|NCT00544882|528505487|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
146545992|NCT00544882|528505488|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
146545993|NCT00544882|528505489|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
146545994|NCT00544882|528505487|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
146545995|NCT00544882|528505488|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
146545996|NCT00544882|528505489|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
146545997|NCT00544882|528505487|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
146880871|NCT00440947|529733563|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
146880872|NCT00440947|529733564|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
146880873|NCT00440947|529733565|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
146880874|NCT00440947|529733566|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
146880875|NCT00440947|529733567|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
146880876|NCT00440947|529733563|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
146880877|NCT00440947|529733564|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
146880878|NCT00440947|529733565|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
146880879|NCT00440947|529733566|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
146545998|NCT00544882|528505488|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
146629617|NCT01253291|528819819|FG004|Overall Study|Adverse Event|0|||
146545999|NCT00544882|528505489|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
146629618|NCT01253291|528819815|FG000|Overall Study|Lack of Efficacy|1|||
146629619|NCT01253291|528819816|FG001|Overall Study|Lack of Efficacy|0|||
146629620|NCT01253291|528819817|FG002|Overall Study|Lack of Efficacy|0|||
146629621|NCT01253291|528819818|FG003|Overall Study|Lack of Efficacy|0|||
146629622|NCT01253291|528819819|FG004|Overall Study|Lack of Efficacy|0|||
146629623|NCT01253291|528819815|FG000|Overall Study|Physician Decision|2|||
146629624|NCT01253291|528819816|FG001|Overall Study|Physician Decision|0|||
146629625|NCT01253291|528819817|FG002|Overall Study|Physician Decision|0|||
146629626|NCT01253291|528819818|FG003|Overall Study|Physician Decision|0|||
146629627|NCT01253291|528819819|FG004|Overall Study|Physician Decision|2|||
146629628|NCT01838395|528819823|FG000|Overall Study|Withdrawal by Subject|0|||
146629629|NCT01838395|528819824|FG001|Overall Study|Withdrawal by Subject|0|||
146629630|NCT01838395|528819825|FG002|Overall Study|Withdrawal by Subject|0|||
146629631|NCT01838395|528819826|FG003|Overall Study|Withdrawal by Subject|0|||
146629632|NCT01838395|528819827|FG004|Overall Study|Withdrawal by Subject|1|||
146629633|NCT01838395|528819828|FG005|Overall Study|Withdrawal by Subject|0|||
146880880|NCT00440947|529733567|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
146880881|NCT00440947|529733563|FG000|36-Week Induction Phase|Incarceration|3|||
146880882|NCT00440947|529733564|FG001|36-Week Induction Phase|Incarceration|0|||
146546000|NCT00544882|528505487|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
146546001|NCT00544882|528505488|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
146546002|NCT00544882|528505489|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
146546003|NCT00544882|528505487|FG000|Cycle 3: Follow-up|Noncompliance|0|||
146546004|NCT00544882|528505488|FG001|Cycle 3: Follow-up|Noncompliance|1|||
146546005|NCT00544882|528505489|FG002|Cycle 3: Follow-up|Noncompliance|0|||
146546006|NCT00544882|528505487|FG000|Cycle 3: Follow-up|Pregnancy|0|||
146629634|NCT01838395|528819823|FG000|Overall Study|Death|0|||
146629635|NCT01838395|528819824|FG001|Overall Study|Death|0|||
146629636|NCT01838395|528819825|FG002|Overall Study|Death|1|||
146629637|NCT01838395|528819826|FG003|Overall Study|Death|0|||
146629638|NCT01838395|528819827|FG004|Overall Study|Death|0|||
146629639|NCT01838395|528819828|FG005|Overall Study|Death|0|||
146629640|NCT01838395|528819823|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
146629641|NCT01838395|528819824|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
146629642|NCT01838395|528819825|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
146629643|NCT01838395|528819826|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
146629644|NCT01838395|528819827|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
146629645|NCT01838395|528819828|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
146629646|NCT03694353|528819832|FG000|Overall Study|Withdrawal by Subject|1|||
146629647|NCT03694353|528819832|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
146629648|NCT05720897|528819834|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
146629649|NCT05720897|528819835|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
146629650|NCT05565742|528819841|FG000|Overall Study|Withdrawal by Subject|0|||
146629651|NCT05565742|528819842|FG001|Overall Study|Withdrawal by Subject|0|||
146629652|NCT05565742|528819843|FG002|Overall Study|Withdrawal by Subject|2|||
146629653|NCT05565742|528819844|FG003|Overall Study|Withdrawal by Subject|2|||
146629654|NCT05565742|528819845|FG004|Overall Study|Withdrawal by Subject|2|||
146629655|NCT05565742|528819841|FG000|Overall Study|Death|1|||
146880883|NCT00440947|529733565|FG002|36-Week Induction Phase|Incarceration|0|||
146880884|NCT00440947|529733566|FG003|36-Week Induction Phase|Incarceration|0|||
146880885|NCT00440947|529733567|FG004|36-Week Induction Phase|Incarceration|0|||
146546007|NCT00544882|528505488|FG001|Cycle 3: Follow-up|Pregnancy|1|||
146546008|NCT00544882|528505489|FG002|Cycle 3: Follow-up|Pregnancy|0|||
146546009|NCT00308685|528505490|FG000|Overall Study|Lost to Follow-up|1|||
146546010|NCT00308685|528505491|FG001|Overall Study|Lost to Follow-up|0|||
146546011|NCT00308685|528505490|FG000|Overall Study|Need to administer prohibited medication|1|||
146546012|NCT00308685|528505491|FG001|Overall Study|Need to administer prohibited medication|2|||
146546013|NCT00308685|528505490|FG000|Overall Study|Other than specified|1|||
146546014|NCT00308685|528505491|FG001|Overall Study|Other than specified|3|||
146546015|NCT03770455|528505492|FG000|Overall Study|Screen failures|3|||
146546016|NCT04937387|528505493|FG000|Overall Study|Adverse Event|1|||
146546017|NCT04937387|528505494|FG001|Overall Study|Adverse Event|0|||
146546018|NCT04937387|528505495|FG002|Overall Study|Adverse Event|2|||
146546019|NCT04937387|528505496|FG003|Overall Study|Adverse Event|0|||
146629656|NCT05565742|528819842|FG001|Overall Study|Death|0|||
146880886|NCT00440947|529733563|FG000|36-Week Induction Phase|Pregnancy|1|||
146546020|NCT04937387|528505493|FG000|Overall Study|Lack of Efficacy|1|||
146880887|NCT00440947|529733564|FG001|36-Week Induction Phase|Pregnancy|0|||
146880888|NCT00440947|529733565|FG002|36-Week Induction Phase|Pregnancy|0|||
146880889|NCT00440947|529733566|FG003|36-Week Induction Phase|Pregnancy|0|||
146880890|NCT00440947|529733567|FG004|36-Week Induction Phase|Pregnancy|0|||
146880891|NCT00440947|529733563|FG000|48-Week Randomization Phase|Adverse Event|0|||
146880892|NCT00440947|529733564|FG001|48-Week Randomization Phase|Adverse Event|2|||
146880893|NCT00440947|529733565|FG002|48-Week Randomization Phase|Adverse Event|5|||
146880894|NCT00440947|529733566|FG003|48-Week Randomization Phase|Adverse Event|0|||
146880895|NCT00440947|529733567|FG004|48-Week Randomization Phase|Adverse Event|0|||
146880896|NCT00440947|529733563|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
146880897|NCT00440947|529733564|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
146880898|NCT00440947|529733565|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
146880899|NCT00440947|529733566|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
146880900|NCT00440947|529733567|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
146880901|NCT00440947|529733563|FG000|48-Week Randomization Phase|Non-compliance|0|||
146880902|NCT00440947|529733564|FG001|48-Week Randomization Phase|Non-compliance|3|||
146880903|NCT00440947|529733565|FG002|48-Week Randomization Phase|Non-compliance|4|||
146880904|NCT00440947|529733566|FG003|48-Week Randomization Phase|Non-compliance|0|||
146880905|NCT00440947|529733567|FG004|48-Week Randomization Phase|Non-compliance|0|||
146880906|NCT00440947|529733563|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
146880907|NCT00440947|529733564|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
146880908|NCT00440947|529733565|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
146546021|NCT04937387|528505494|FG001|Overall Study|Lack of Efficacy|0|||
146880909|NCT00440947|529733566|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
146880910|NCT00440947|529733567|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
146880911|NCT00440947|529733563|FG000|48-Week Randomization Phase|Protocol Violation|0|||
146880912|NCT00440947|529733564|FG001|48-Week Randomization Phase|Protocol Violation|0|||
146880913|NCT00440947|529733565|FG002|48-Week Randomization Phase|Protocol Violation|1|||
146880914|NCT00440947|529733566|FG003|48-Week Randomization Phase|Protocol Violation|0|||
146880915|NCT00440947|529733567|FG004|48-Week Randomization Phase|Protocol Violation|0|||
146880916|NCT00440947|529733563|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
146880917|NCT00440947|529733564|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
146880918|NCT00440947|529733565|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
146880919|NCT00440947|529733566|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
146880920|NCT00440947|529733567|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
146880921|NCT00440947|529733563|FG000|48-Week Randomization Phase|Pregnancy|0|||
146880922|NCT00440947|529733564|FG001|48-Week Randomization Phase|Pregnancy|0|||
146880923|NCT00440947|529733565|FG002|48-Week Randomization Phase|Pregnancy|1|||
146880924|NCT00440947|529733566|FG003|48-Week Randomization Phase|Pregnancy|0|||
146880925|NCT00440947|529733567|FG004|48-Week Randomization Phase|Pregnancy|0|||
146880926|NCT00440947|529733563|FG000|48-Week Randomization Phase|Incarceration|0|||
146880927|NCT00440947|529733564|FG001|48-Week Randomization Phase|Incarceration|3|||
146546022|NCT04937387|528505495|FG002|Overall Study|Lack of Efficacy|0|||
146546023|NCT04937387|528505496|FG003|Overall Study|Lack of Efficacy|1|||
146546024|NCT04937387|528505493|FG000|Overall Study|Withdrawal by Subject|1|||
146546025|NCT04937387|528505494|FG001|Overall Study|Withdrawal by Subject|0|||
146546026|NCT04937387|528505495|FG002|Overall Study|Withdrawal by Subject|1|||
146546027|NCT04937387|528505496|FG003|Overall Study|Withdrawal by Subject|1|||
146546028|NCT04937387|528505493|FG000|Overall Study|Randomized in error|0|||
146546029|NCT04937387|528505494|FG001|Overall Study|Randomized in error|0|||
146546030|NCT04937387|528505495|FG002|Overall Study|Randomized in error|0|||
146546031|NCT04937387|528505496|FG003|Overall Study|Randomized in error|1|||
146546032|NCT02583269|528505497|FG000|Overall Study|Patient hospitalized prior to start|1|||
146546033|NCT02583269|528505498|FG001|Overall Study|Patient hospitalized prior to start|0|||
146546034|NCT02583269|528505499|FG002|Overall Study|Patient hospitalized prior to start|0|||
146546035|NCT02583269|528505500|FG003|Overall Study|Patient hospitalized prior to start|0|||
146546036|NCT02583269|528505501|FG004|Overall Study|Patient hospitalized prior to start|0|||
146546037|NCT01039675|528505504|FG000|Overall Study|Adverse Event|0|||
146546038|NCT01039675|528505505|FG001|Overall Study|Adverse Event|2|||
146629657|NCT05565742|528819843|FG002|Overall Study|Death|0|||
146880928|NCT00440947|529733565|FG002|48-Week Randomization Phase|Incarceration|0|||
146880929|NCT00440947|529733566|FG003|48-Week Randomization Phase|Incarceration|0|||
146880930|NCT00440947|529733567|FG004|48-Week Randomization Phase|Incarceration|0|||
146880931|NCT00440947|529733563|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
146880932|NCT00440947|529733564|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
146546039|NCT01039675|528505504|FG000|Overall Study|Lack of Efficacy|0|||
146546040|NCT01039675|528505505|FG001|Overall Study|Lack of Efficacy|2|||
146546041|NCT01039675|528505504|FG000|Overall Study|Withdrawal by Subject|0|||
146880933|NCT00440947|529733565|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
146880934|NCT00440947|529733566|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
146880935|NCT00440947|529733567|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
146880936|NCT00440947|529733563|FG000|48-Week Randomization Phase|Physician Decision|0|||
146629658|NCT05565742|528819844|FG003|Overall Study|Death|0|||
146629659|NCT05565742|528819845|FG004|Overall Study|Death|0|||
146629660|NCT05565742|528819841|FG000|Overall Study|Participant Travelled Abroad|0|||
146629661|NCT05565742|528819842|FG001|Overall Study|Participant Travelled Abroad|0|||
146629662|NCT05565742|528819843|FG002|Overall Study|Participant Travelled Abroad|0|||
146629663|NCT05565742|528819844|FG003|Overall Study|Participant Travelled Abroad|0|||
146629664|NCT05565742|528819845|FG004|Overall Study|Participant Travelled Abroad|1|||
146629665|NCT04163341|528819846|FG000|Overall Study|Withdrawal by Subject|2|||
146629666|NCT04163341|528819847|FG001|Overall Study|Withdrawal by Subject|0|||
146629667|NCT04163341|528819846|FG000|Overall Study|Lost to Follow-up|3|||
146629668|NCT04163341|528819847|FG001|Overall Study|Lost to Follow-up|4|||
146629669|NCT05417438|528819848|FG000|Overall Study|Withdrawal by Subject|3|||
146629670|NCT04272242|528819849|FG000|Overall Study|Withdrawal by Subject|3|||
146629671|NCT04272242|528819849|FG000|Overall Study|Lost to Follow-up|1|||
146629672|NCT04272242|528819849|FG000|Overall Study|Adverse Event|1|||
146629673|NCT02681523|528819852|FG000|Overall Study|Adverse Event|1|||
146629674|NCT02681523|528819852|FG000|Overall Study|Patient Non-compliance|1|||
146629675|NCT00129402|528821371|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
146629676|NCT00129402|528821372|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
146629677|NCT00129402|528821373|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
146629678|NCT00129402|528821374|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
146629679|NCT00129402|528821375|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
146629680|NCT00129402|528821376|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
146629681|NCT00129402|528821377|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
146629682|NCT00129402|528821371|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
146629683|NCT00129402|528821372|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
146629684|NCT00129402|528821373|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
146629685|NCT00129402|528821374|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
146629686|NCT00129402|528821375|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
146629687|NCT00129402|528821376|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
146629688|NCT00129402|528821377|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
146629689|NCT00129402|528821371|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
146629690|NCT00129402|528821372|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
146629691|NCT00129402|528821373|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
146629692|NCT00129402|528821374|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
146880937|NCT00440947|529733564|FG001|48-Week Randomization Phase|Physician Decision|2|||
146880938|NCT00440947|529733565|FG002|48-Week Randomization Phase|Physician Decision|0|||
146880939|NCT00440947|529733566|FG003|48-Week Randomization Phase|Physician Decision|0|||
146546042|NCT01039675|528505505|FG001|Overall Study|Withdrawal by Subject|1|||
146546043|NCT01039675|528505504|FG000|Overall Study|Lost to Follow-up|0|||
146546044|NCT01039675|528505505|FG001|Overall Study|Lost to Follow-up|1|||
146546045|NCT01039675|528505504|FG000|Overall Study|Physician Decision|0|||
146546046|NCT01039675|528505505|FG001|Overall Study|Physician Decision|1|||
146546047|NCT02207608|528505509|FG000|Overall Study|Adverse Event|1|||
146546048|NCT02207608|528505510|FG001|Overall Study|Adverse Event|0|||
146546049|NCT04941898|528506713|FG000|Overall Study|Protocol Violation|1|||
146546050|NCT01653262|528506714|FG000|Overall Study|Lack of Efficacy|1|||
146546051|NCT01653262|528506714|FG000|Overall Study|SAE, non-fatal|1|||
146546052|NCT01653262|528506714|FG000|Overall Study|AE, non-serious non-fatal|1|||
146546053|NCT00420407|528506716|FG000|Overall Study|Lost to Follow-up|0|||
146546054|NCT00420407|528506717|FG001|Overall Study|Lost to Follow-up|3|||
146546055|NCT00420407|528506716|FG000|Overall Study|Physician Decision|2|||
146546056|NCT00420407|528506717|FG001|Overall Study|Physician Decision|1|||
146546057|NCT00420407|528506716|FG000|Overall Study|subject identified as detainee|1|||
146546058|NCT00420407|528506717|FG001|Overall Study|subject identified as detainee|0|||
146546059|NCT00420407|528506716|FG000|Overall Study|subject identified as Jehovah's witness|1|||
146546060|NCT00420407|528506717|FG001|Overall Study|subject identified as Jehovah's witness|0|||
146546061|NCT00420407|528506716|FG000|Overall Study|Withdrawal by Subject|0|||
146629693|NCT00129402|528821375|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
146629694|NCT00129402|528821376|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
146629695|NCT00129402|528821377|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
146546062|NCT00420407|528506717|FG001|Overall Study|Withdrawal by Subject|2|||
146629696|NCT00129402|528821371|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
146629697|NCT00129402|528821372|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
146629698|NCT00129402|528821373|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
146546063|NCT04633447|528506720|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
146546064|NCT04633447|528506721|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
146546065|NCT04633447|528506720|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
146880940|NCT00440947|529733567|FG004|48-Week Randomization Phase|Physician Decision|0|||
146880941|NCT00440947|529733563|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
146880942|NCT00440947|529733564|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
146880943|NCT00440947|529733565|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
146880944|NCT00440947|529733566|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
146880945|NCT00440947|529733567|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
146880946|NCT00440947|529733563|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
146880947|NCT00440947|529733564|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
146880948|NCT00440947|529733565|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
146880949|NCT00440947|529733566|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
146880950|NCT00440947|529733567|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
146880951|NCT00440947|529733563|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
146880952|NCT00440947|529733564|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
146880953|NCT00440947|529733565|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
146880954|NCT00440947|529733566|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
146880955|NCT00440947|529733567|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
146880956|NCT00440947|529733563|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
146880957|NCT00440947|529733564|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
146880958|NCT00440947|529733565|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
146880959|NCT00440947|529733566|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
146880960|NCT00440947|529733567|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
146546066|NCT04633447|528506721|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
146546067|NCT04633447|528506720|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
146546068|NCT04633447|528506721|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
146546069|NCT04633447|528506720|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
146546070|NCT04633447|528506721|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
146546071|NCT04633447|528506720|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
146546072|NCT04633447|528506721|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
146546073|NCT04633447|528506720|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
146546074|NCT04633447|528506721|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
146546075|NCT05417113|528506722|FG000|Overall Study|Lost to Follow-up|2|||
146546076|NCT05417113|528506723|FG001|Overall Study|Lost to Follow-up|2|||
146546077|NCT01022580|528506724|FG000|Overall Study|Death|18|||
146546078|NCT01022580|528506725|FG001|Overall Study|Death|22|||
146546079|NCT03439839|528506726|FG000|Overall Study|Death|3|||
146546080|NCT03439839|528506727|FG001|Overall Study|Death|0|||
146546081|NCT00723944|528506733|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
146546082|NCT00723944|528506734|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
146546083|NCT00723944|528506733|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
146546084|NCT00723944|528506734|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
146546085|NCT00723944|528506733|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
146546086|NCT00723944|528506734|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
146546087|NCT02582632|528506735|FG000|Overall Study|Other|1|||
146546088|NCT01771913|528506738|FG000|Overall Study|Withdrawal by Subject|1|||
146546089|NCT01771913|528506739|FG001|Overall Study|Withdrawal by Subject|0|||
146546090|NCT04307394|528506740|FG000|Overall Study|Lost to Follow-up|3|||
146880961|NCT00440947|529733563|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
146546091|NCT04307394|528506740|FG000|Overall Study|Withdrawal by Subject|2|||
146546092|NCT01617967|528506745|FG000|Overall Study|Protocol Violation|0|||
146546093|NCT01617967|528506746|FG001|Overall Study|Protocol Violation|0|||
146546094|NCT01617967|528506747|FG002|Overall Study|Protocol Violation|0|||
146546095|NCT01617967|528506748|FG003|Overall Study|Protocol Violation|1|||
146546096|NCT01617967|528506749|FG004|Overall Study|Protocol Violation|0|||
146546097|NCT01617967|528506750|FG005|Overall Study|Protocol Violation|0|||
146546098|NCT01617967|528506745|FG000|Overall Study|Withdrawal by Subject|0|||
146546099|NCT01617967|528506746|FG001|Overall Study|Withdrawal by Subject|0|||
146546100|NCT01617967|528506747|FG002|Overall Study|Withdrawal by Subject|0|||
146765052|NCT02026258|529307232|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
146880962|NCT00440947|529733564|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
146880963|NCT00440947|529733565|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
146880964|NCT00440947|529733566|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
146880965|NCT00440947|529733567|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
146880966|NCT00440947|529733563|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
146880967|NCT00440947|529733564|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
146880968|NCT00440947|529733565|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
146880969|NCT00440947|529733566|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
146880970|NCT00440947|529733567|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
146880971|NCT00440947|529733563|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
146880972|NCT00440947|529733564|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
146880973|NCT00440947|529733565|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
146880974|NCT00440947|529733566|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
146880975|NCT00440947|529733567|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
146546101|NCT01617967|528506748|FG003|Overall Study|Withdrawal by Subject|0|||
146546102|NCT01617967|528506749|FG004|Overall Study|Withdrawal by Subject|0|||
146546103|NCT01617967|528506750|FG005|Overall Study|Withdrawal by Subject|1|||
146546104|NCT01617967|528506745|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
146546105|NCT01617967|528506746|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
146546106|NCT01617967|528506747|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
146546107|NCT01617967|528506748|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
146546108|NCT01617967|528506749|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
146546109|NCT01617967|528506750|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
146546110|NCT02536794|528506751|FG000|Reached 1st Response Assessment|Adverse Event|2|||
146546111|NCT02536794|528506751|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
146546112|NCT02536794|528506751|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
146546113|NCT02536794|528506751|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
146546114|NCT02536794|528506751|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
146546115|NCT02536794|528506751|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
146546116|NCT00416949|528506752|FG000|Overall Study|Patients refused to participate|5|||
146546117|NCT01471574|528506757|FG000|Treatment Period|Lack of Efficacy|12|||
146546118|NCT01471574|528506758|FG001|Treatment Period|Lack of Efficacy|4|||
146546119|NCT01471574|528506759|FG002|Treatment Period|Lack of Efficacy|14|||
146546120|NCT01471574|528506760|FG003|Treatment Period|Lack of Efficacy|1|||
146546121|NCT01471574|528506757|FG000|Treatment Period|Adverse Event|7|||
146546122|NCT01471574|528506758|FG001|Treatment Period|Adverse Event|3|||
146546123|NCT01471574|528506759|FG002|Treatment Period|Adverse Event|6|||
146546124|NCT01471574|528506760|FG003|Treatment Period|Adverse Event|1|||
146546125|NCT01471574|528506757|FG000|Treatment Period|Withdrawal by Subject|5|||
146546126|NCT01471574|528506758|FG001|Treatment Period|Withdrawal by Subject|1|||
146546127|NCT01471574|528506759|FG002|Treatment Period|Withdrawal by Subject|1|||
146546128|NCT01471574|528506760|FG003|Treatment Period|Withdrawal by Subject|0|||
146546129|NCT01471574|528506757|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
146546130|NCT01471574|528506758|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
146546131|NCT01471574|528506759|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
146546132|NCT01471574|528506760|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
146546133|NCT01471574|528506757|FG000|Treatment Period|Lost to Follow-up|1|||
146546134|NCT01471574|528506758|FG001|Treatment Period|Lost to Follow-up|2|||
146546135|NCT01471574|528506759|FG002|Treatment Period|Lost to Follow-up|2|||
146546136|NCT01471574|528506760|FG003|Treatment Period|Lost to Follow-up|0|||
146546137|NCT01471574|528506757|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
146546138|NCT01471574|528506758|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
146546139|NCT01471574|528506759|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
146546140|NCT01471574|528506760|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
146546141|NCT01471574|528506757|FG000|Treatment Period|Other|1|||
146546142|NCT01471574|528506758|FG001|Treatment Period|Other|0|||
146546143|NCT01471574|528506759|FG002|Treatment Period|Other|0|||
146546144|NCT01471574|528506760|FG003|Treatment Period|Other|0|||
146546145|NCT01471574|528506757|FG000|Follow-up Period|Withdrawal by Subject|3|||
146546146|NCT01471574|528506758|FG001|Follow-up Period|Withdrawal by Subject|0|||
146546147|NCT01471574|528506759|FG002|Follow-up Period|Withdrawal by Subject|3|||
146546148|NCT01471574|528506760|FG003|Follow-up Period|Withdrawal by Subject|1|||
146546149|NCT01471574|528506757|FG000|Follow-up Period|Lost to Follow-up|4|||
146546150|NCT01471574|528506758|FG001|Follow-up Period|Lost to Follow-up|1|||
146546151|NCT01471574|528506759|FG002|Follow-up Period|Lost to Follow-up|3|||
146880976|NCT00440947|529733563|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
146880977|NCT00440947|529733564|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
146880978|NCT00440947|529733565|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
146880979|NCT00440947|529733566|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
146880980|NCT00440947|529733567|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
146880981|NCT00440947|529733563|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
146880982|NCT00440947|529733564|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
146880983|NCT00440947|529733565|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
146880984|NCT00440947|529733566|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
146546152|NCT01471574|528506760|FG003|Follow-up Period|Lost to Follow-up|2|||
146880985|NCT00440947|529733567|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
146880986|NCT00440947|529733563|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
146880987|NCT00440947|529733564|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
146880988|NCT00440947|529733565|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
146880989|NCT00440947|529733566|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
146880990|NCT00440947|529733567|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
146880991|NCT00440947|529733563|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
146880992|NCT00440947|529733564|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
146880993|NCT00440947|529733565|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
146880994|NCT00440947|529733566|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
146880995|NCT00440947|529733567|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
146880996|NCT00440947|529733563|FG000|Optional 60-Week Extension Phase|Other|0|||
146880997|NCT00440947|529733564|FG001|Optional 60-Week Extension Phase|Other|0|||
146880998|NCT00440947|529733565|FG002|Optional 60-Week Extension Phase|Other|0|||
146880999|NCT00440947|529733566|FG003|Optional 60-Week Extension Phase|Other|1|||
146881000|NCT00440947|529733567|FG004|Optional 60-Week Extension Phase|Other|0|||
146881001|NCT00440947|529733563|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
146881002|NCT00440947|529733564|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
146881003|NCT00440947|529733565|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
146881004|NCT00440947|529733566|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
146881005|NCT00440947|529733567|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
146881006|NCT00440947|529733563|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
146881007|NCT00440947|529733564|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
146881008|NCT00440947|529733565|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
146881009|NCT00440947|529733566|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
146546153|NCT01471574|528506757|FG000|Follow-up Period|Death|0|||
146546154|NCT01471574|528506758|FG001|Follow-up Period|Death|0|||
146546155|NCT01471574|528506759|FG002|Follow-up Period|Death|1|||
146546156|NCT01471574|528506760|FG003|Follow-up Period|Death|0|||
146546157|NCT01471574|528506757|FG000|Follow-up Period|Follow-up no longer required|0|||
146546158|NCT01471574|528506758|FG001|Follow-up Period|Follow-up no longer required|1|||
146546159|NCT01471574|528506759|FG002|Follow-up Period|Follow-up no longer required|0|||
146546160|NCT01471574|528506760|FG003|Follow-up Period|Follow-up no longer required|0|||
146546161|NCT01137812|528506761|FG000|Overall Study|Adverse Event|21|||
146546162|NCT01137812|528506762|FG001|Overall Study|Adverse Event|14|||
146546163|NCT01137812|528506761|FG000|Overall Study|Lost to Follow-up|6|||
146546164|NCT01137812|528506762|FG001|Overall Study|Lost to Follow-up|8|||
146546165|NCT01137812|528506761|FG000|Overall Study|Physician Decision|25|||
146546166|NCT01137812|528506762|FG001|Overall Study|Physician Decision|17|||
146546167|NCT01137812|528506761|FG000|Overall Study|Protocol Violation|5|||
146546168|NCT01137812|528506762|FG001|Overall Study|Protocol Violation|4|||
146546169|NCT01137812|528506761|FG000|Overall Study|Withdrawal by Subject|5|||
146546170|NCT01137812|528506762|FG001|Overall Study|Withdrawal by Subject|13|||
146546171|NCT01137812|528506761|FG000|Overall Study|Death|2|||
146546172|NCT01137812|528506762|FG001|Overall Study|Death|0|||
146546173|NCT01137812|528506761|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
146546174|NCT01137812|528506762|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
146546175|NCT01137812|528506761|FG000|Overall Study|Other|19|||
146546176|NCT01137812|528506762|FG001|Overall Study|Other|27|||
146546177|NCT01177410|528506767|FG000|Overall Study|Adverse Event|0|||
146546178|NCT01177410|528506768|FG001|Overall Study|Adverse Event|2|||
146546179|NCT01177410|528506769|FG002|Overall Study|Adverse Event|2|||
146546180|NCT01177410|528506767|FG000|Overall Study|Withdrawal by Subject|1|||
146546181|NCT01177410|528506768|FG001|Overall Study|Withdrawal by Subject|4|||
146629699|NCT00129402|528821374|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
146629700|NCT00129402|528821375|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
146629701|NCT00129402|528821376|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
146881010|NCT00440947|529733567|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
146881011|NCT02898259|529733568|FG000|Overall Study|Adverse Event|0|||
146546182|NCT01177410|528506769|FG002|Overall Study|Withdrawal by Subject|3|||
146546183|NCT01177410|528506767|FG000|Overall Study|Lost to Follow-up|0|||
146546184|NCT01177410|528506768|FG001|Overall Study|Lost to Follow-up|1|||
146546185|NCT01177410|528506769|FG002|Overall Study|Lost to Follow-up|0|||
146546186|NCT00471354|528506770|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
146546187|NCT00471354|528506770|FG000|Overall Study|Adverse Event|13|||
146546188|NCT00471354|528506770|FG000|Overall Study|Protocol Violation|12|||
146546189|NCT00471354|528506770|FG000|Overall Study|Withdrawal by Subject|1|||
146546190|NCT00471354|528506770|FG000|Overall Study|Physician Decision|4|||
146546191|NCT00471354|528506770|FG000|Overall Study|Sponsor Decision|1|||
146546192|NCT00471354|528506770|FG000|Overall Study|Lost to Follow-up|3|||
146546193|NCT00471354|528506770|FG000|Overall Study|Lack of Efficacy|5|||
146546194|NCT00471354|528506770|FG000|Overall Study|Patient/Caregiver Decision|12|||
146629702|NCT00129402|528821377|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
146629703|NCT00129402|528821371|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
146629704|NCT00129402|528821372|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
146629705|NCT00129402|528821373|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
146629706|NCT00129402|528821374|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
146629707|NCT00129402|528821375|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
146629708|NCT00129402|528821376|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
146629709|NCT00129402|528821377|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
146629710|NCT00129402|528821371|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
146629711|NCT00129402|528821372|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
146629712|NCT00129402|528821373|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
146629713|NCT00129402|528821374|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
146629714|NCT00129402|528821375|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
146629715|NCT00129402|528821376|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
146629716|NCT00129402|528821377|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
146629717|NCT00129402|528821371|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
146629718|NCT00129402|528821372|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
146629719|NCT00129402|528821373|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
146629720|NCT00129402|528821374|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
146629721|NCT00129402|528821375|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
146546195|NCT05950906|528506772|FG000|Overall Study|Adverse Event|0|||
146546196|NCT05950906|528506773|FG001|Overall Study|Adverse Event|0|||
146546197|NCT05950906|528506774|FG002|Overall Study|Adverse Event|0|||
146546198|NCT05950906|528506775|FG003|Overall Study|Adverse Event|0|||
146546199|NCT05950906|528506776|FG004|Overall Study|Adverse Event|0|||
146546200|NCT05950906|528506777|FG005|Overall Study|Adverse Event|0|||
146629722|NCT00129402|528821376|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
146629723|NCT00129402|528821377|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
146629724|NCT00129402|528821371|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
146629725|NCT00129402|528821372|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
146629726|NCT00129402|528821373|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
146629727|NCT00129402|528821374|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
146629728|NCT00129402|528821375|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
146629729|NCT00129402|528821376|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
146765053|NCT02026258|529307233|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
146881012|NCT02898259|529733569|FG001|Overall Study|Adverse Event|0|||
146881013|NCT02898259|529733570|FG002|Overall Study|Adverse Event|1|||
146881014|NCT02898259|529733571|FG003|Overall Study|Adverse Event|0|||
146881015|NCT02898259|529733572|FG004|Overall Study|Adverse Event|0|||
146765054|NCT04246762|529307234|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
146881016|NCT02898259|529733568|FG000|Overall Study|Lack of Efficacy|1|||
146881017|NCT02898259|529733569|FG001|Overall Study|Lack of Efficacy|1|||
146881018|NCT02898259|529733570|FG002|Overall Study|Lack of Efficacy|3|||
146881019|NCT02898259|529733571|FG003|Overall Study|Lack of Efficacy|0|||
146881020|NCT02898259|529733572|FG004|Overall Study|Lack of Efficacy|0|||
146881021|NCT02898259|529733568|FG000|Overall Study|Lost to Follow-up|0|||
146881022|NCT02898259|529733569|FG001|Overall Study|Lost to Follow-up|0|||
146881023|NCT02898259|529733570|FG002|Overall Study|Lost to Follow-up|1|||
146881024|NCT02898259|529733571|FG003|Overall Study|Lost to Follow-up|0|||
146881025|NCT02898259|529733572|FG004|Overall Study|Lost to Follow-up|0|||
146881026|NCT02898259|529733568|FG000|Overall Study|Transformation before study began|0|||
146881027|NCT02898259|529733569|FG001|Overall Study|Transformation before study began|0|||
146881028|NCT02898259|529733570|FG002|Overall Study|Transformation before study began|0|||
146881029|NCT02898259|529733571|FG003|Overall Study|Transformation before study began|1|||
146546201|NCT05950906|528506778|FG006|Overall Study|Adverse Event|0|||
146881030|NCT02898259|529733572|FG004|Overall Study|Transformation before study began|0|||
146881031|NCT01046877|529733576|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
146546202|NCT05950906|528506779|FG007|Overall Study|Adverse Event|0|||
146546203|NCT05950906|528506780|FG008|Overall Study|Adverse Event|0|||
146546204|NCT05950906|528506781|FG009|Overall Study|Adverse Event|0|||
146546205|NCT05950906|528506782|FG010|Overall Study|Adverse Event|0|||
146629730|NCT00129402|528821377|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
146629731|NCT00129402|528821371|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
146629732|NCT00129402|528821372|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
146629733|NCT00129402|528821373|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
146629734|NCT00129402|528821374|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
146629735|NCT00129402|528821375|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
146629736|NCT00129402|528821376|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
146629737|NCT00129402|528821377|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
146629738|NCT00129402|528821371|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
146629739|NCT00129402|528821372|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
146629740|NCT00129402|528821373|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
146629741|NCT00129402|528821374|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
146629742|NCT00129402|528821375|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
146629743|NCT00129402|528821376|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
146629744|NCT00129402|528821377|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
146629745|NCT00129402|528821371|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
146629746|NCT00129402|528821372|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
146629747|NCT00129402|528821373|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
146629748|NCT00129402|528821374|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
146629749|NCT00129402|528821375|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
146629750|NCT00129402|528821376|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
146629751|NCT00129402|528821377|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
146629752|NCT00129402|528821371|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
146629753|NCT00129402|528821372|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
146629754|NCT00129402|528821373|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
146629755|NCT00129402|528821374|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
146629756|NCT00129402|528821375|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
146629757|NCT00129402|528821376|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
146629758|NCT00129402|528821377|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
146629759|NCT00129402|528821371|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
146629760|NCT00129402|528821372|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
146629761|NCT00129402|528821373|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
146629762|NCT00129402|528821374|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
146629763|NCT00129402|528821375|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
146629764|NCT00129402|528821376|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
146629765|NCT00129402|528821377|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
146629766|NCT03041038|528821378|FG000|Overall Study|Withdrawal by Subject|4|||
146629767|NCT03041038|528821379|FG001|Overall Study|Withdrawal by Subject|0|||
146629768|NCT03041038|528821378|FG000|Overall Study|Lost to Follow-up|1|||
146629769|NCT03041038|528821379|FG001|Overall Study|Lost to Follow-up|1|||
146629770|NCT03041038|528821378|FG000|Overall Study|Protocol Violation|1|||
146629771|NCT03041038|528821379|FG001|Overall Study|Protocol Violation|1|||
146629772|NCT02131259|528821380|FG000|Overall Study|Progressive disease|751|||
146629773|NCT02131259|528821380|FG000|Overall Study|Adverse Event|341|||
146629774|NCT02131259|528821380|FG000|Overall Study|Lost to Follow-up|7|||
146629775|NCT02131259|528821380|FG000|Overall Study|Relocation|32|||
146629776|NCT02131259|528821380|FG000|Overall Study|Other|63|||
146629777|NCT02131259|528821380|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
146629778|NCT02131259|528821380|FG000|Overall Study|Progressive disease/relocation|1|||
146629779|NCT02131259|528821380|FG000|Overall Study|Progressive disease/other|2|||
146629780|NCT02131259|528821380|FG000|Overall Study|AE/lost to follow-up|1|||
146629781|NCT02131259|528821380|FG000|Overall Study|AE/other|1|||
146629782|NCT02131259|528821380|FG000|Overall Study|Progressive disease/AE/other|1|||
146629783|NCT02131259|528821380|FG000|Overall Study|Missing|3|||
146629784|NCT02796170|528821381|FG000|Overall Study|Lost to Follow-up|3|||
146629785|NCT02796170|528821382|FG001|Overall Study|Lost to Follow-up|0|||
146629786|NCT01527370|528821385|FG000|Overall Study|Withdrawal by Subject|4|||
146629787|NCT01527370|528821385|FG000|Overall Study|Physician Decision|1|||
146629788|NCT01527370|528821385|FG000|Overall Study|Death|1|||
146881032|NCT01046877|529733576|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
146881033|NCT03016325|529733581|FG000|Treatment Period|Participant withdrew consent|0|||
146629789|NCT01352715|528821387|FG000|Overall Study|Death|3|||
146629790|NCT01352715|528821388|FG001|Overall Study|Death|3|||
146881034|NCT03016325|529733582|FG001|Treatment Period|Participant withdrew consent|1|||
146881035|NCT03016325|529733583|FG002|Treatment Period|Participant withdrew consent|0|||
146881036|NCT03016325|529733584|FG003|Treatment Period|Participant withdrew consent|0|||
146881037|NCT03016325|529733585|FG004|Treatment Period|Participant withdrew consent|0|||
146881038|NCT03016325|529733586|FG005|Treatment Period|Participant withdrew consent|0|||
146881039|NCT03016325|529733587|FG006|Treatment Period|Participant withdrew consent|0|||
146881040|NCT03016325|529733588|FG007|Treatment Period|Participant withdrew consent|0|||
146881041|NCT03016325|529733581|FG000|Treatment Period|Death|0|||
146546206|NCT05950906|528506783|FG011|Overall Study|Adverse Event|0|||
146546207|NCT05950906|528506784|FG012|Overall Study|Adverse Event|1|||
146881042|NCT03016325|529733582|FG001|Treatment Period|Death|0|||
146881043|NCT03016325|529733583|FG002|Treatment Period|Death|0|||
146546208|NCT05950906|528506785|FG013|Overall Study|Adverse Event|0|||
146546209|NCT05950906|528506772|FG000|Overall Study|Physician Decision|0|||
146546210|NCT05950906|528506773|FG001|Overall Study|Physician Decision|0|||
146546211|NCT05950906|528506774|FG002|Overall Study|Physician Decision|0|||
146546212|NCT05950906|528506775|FG003|Overall Study|Physician Decision|0|||
146546213|NCT05950906|528506776|FG004|Overall Study|Physician Decision|0|||
146546214|NCT05950906|528506777|FG005|Overall Study|Physician Decision|0|||
146546215|NCT05950906|528506778|FG006|Overall Study|Physician Decision|0|||
146546216|NCT05950906|528506779|FG007|Overall Study|Physician Decision|0|||
146546217|NCT05950906|528506780|FG008|Overall Study|Physician Decision|0|||
146546218|NCT05950906|528506781|FG009|Overall Study|Physician Decision|0|||
146546219|NCT05950906|528506782|FG010|Overall Study|Physician Decision|0|||
146546220|NCT05950906|528506783|FG011|Overall Study|Physician Decision|0|||
146546221|NCT05950906|528506784|FG012|Overall Study|Physician Decision|1|||
146546222|NCT05950906|528506785|FG013|Overall Study|Physician Decision|0|||
146546223|NCT02836769|528506786|FG000|Overall Study|Lost to Follow-up|10|||
146546224|NCT02836769|528506786|FG000|Overall Study|Medical withdrawal|2|||
146546225|NCT02836769|528506786|FG000|Overall Study|Withdrawal by Subject|3|||
146546226|NCT03142750|528506792|FG000|Overall Study|Lost to Follow-up|4|||
146546227|NCT03142750|528506793|FG001|Overall Study|Lost to Follow-up|1|||
146546228|NCT02942407|528506794|FG000|Overall Study|Lost to Follow-up|3|||
146546229|NCT02942407|528506795|FG001|Overall Study|Lost to Follow-up|2|||
146546230|NCT02942407|528506794|FG000|Overall Study|Withdrawal by Subject|7|||
146546231|NCT02942407|528506795|FG001|Overall Study|Withdrawal by Subject|9|||
146546232|NCT02942407|528506794|FG000|Overall Study|Death|16|||
146546233|NCT02942407|528506795|FG001|Overall Study|Death|13|||
146546234|NCT00933166|528506796|FG000|Overall Study|Lost to Follow-up|4|||
146546235|NCT00933166|528506796|FG000|Overall Study|Lack of Efficacy|9|||
146546236|NCT00933166|528506796|FG000|Overall Study|Unavailable|4|||
146546237|NCT00933166|528506796|FG000|Overall Study|Withdrawal by Subject|1|||
146546238|NCT04618471|528506797|FG000|Overall Study|Screen Failure|62|||
146546239|NCT04618471|528506797|FG000|Overall Study|Withdrawal by Subject|6|||
146546240|NCT04618471|528506797|FG000|Overall Study|Physician Decision|2|||
146546241|NCT04618471|528506797|FG000|Overall Study|Lost to Follow-up|1|||
146546242|NCT04618471|528506797|FG000|Overall Study|Various other reasons|2|||
146546243|NCT04618471|528506797|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
146546244|NCT05774977|528506800|FG000|Overall Study|Withdrawal by Subject|2|||
146546245|NCT00374868|528506801|FG000|Overall Study|Adverse Event|12|||
146546246|NCT00374868|528506801|FG000|Overall Study|Progressive Disease|7|||
146546247|NCT00374868|528506801|FG000|Overall Study|Physician Decision|13|||
146546248|NCT00374868|528506801|FG000|Overall Study|Lost to Follow-up|1|||
146546249|NCT00374868|528506801|FG000|Overall Study|Death|2|||
146546250|NCT00374868|528506801|FG000|Overall Study|Other - Not Specified|1|||
146546251|NCT03325439|528506802|FG000|Overall Study|Ineligibility|3|||
146546252|NCT03188185|528506803|FG000|Stage 1|Adverse Event|4|||
146546253|NCT03188185|528506804|FG001|Stage 1|Adverse Event|12|||
146546254|NCT03188185|528506805|FG002|Stage 1|Adverse Event|0|||
146546255|NCT03188185|528506806|FG003|Stage 1|Adverse Event|0|||
146546256|NCT03188185|528506803|FG000|Stage 1|Lack of Efficacy|0|||
146546257|NCT03188185|528506804|FG001|Stage 1|Lack of Efficacy|2|||
146546258|NCT03188185|528506805|FG002|Stage 1|Lack of Efficacy|0|||
146546259|NCT03188185|528506806|FG003|Stage 1|Lack of Efficacy|0|||
146546260|NCT03188185|528506803|FG000|Stage 1|Lost to Follow-up|6|||
146765055|NCT03593070|529307235|FG000|Overall Study|administrative withdrawal|1|||
146881044|NCT03016325|529733584|FG003|Treatment Period|Death|0|||
146881045|NCT03016325|529733585|FG004|Treatment Period|Death|2|||
146881046|NCT03016325|529733586|FG005|Treatment Period|Death|0|||
146881047|NCT03016325|529733587|FG006|Treatment Period|Death|0|||
146881048|NCT03016325|529733588|FG007|Treatment Period|Death|0|||
146881049|NCT03016325|529733581|FG000|Treatment Period|Participant refuses assessments|0|||
146881050|NCT03016325|529733582|FG001|Treatment Period|Participant refuses assessments|0|||
146881051|NCT03016325|529733583|FG002|Treatment Period|Participant refuses assessments|1|||
146881052|NCT03016325|529733584|FG003|Treatment Period|Participant refuses assessments|0|||
146546261|NCT03188185|528506804|FG001|Stage 1|Lost to Follow-up|1|||
146546262|NCT03188185|528506805|FG002|Stage 1|Lost to Follow-up|0|||
146546263|NCT03188185|528506806|FG003|Stage 1|Lost to Follow-up|0|||
146546264|NCT03188185|528506803|FG000|Stage 1|Withdrawal by Subject|9|||
146546265|NCT03188185|528506804|FG001|Stage 1|Withdrawal by Subject|0|||
146546266|NCT03188185|528506805|FG002|Stage 1|Withdrawal by Subject|0|||
146546267|NCT03188185|528506806|FG003|Stage 1|Withdrawal by Subject|0|||
146546268|NCT03188185|528506803|FG000|Stage 1|Identified as a professional patient|0|||
146546269|NCT03188185|528506804|FG001|Stage 1|Identified as a professional patient|1|||
146546270|NCT03188185|528506805|FG002|Stage 1|Identified as a professional patient|0|||
146881053|NCT03016325|529733585|FG004|Treatment Period|Participant refuses assessments|0|||
146881054|NCT03016325|529733586|FG005|Treatment Period|Participant refuses assessments|0|||
146881055|NCT03016325|529733587|FG006|Treatment Period|Participant refuses assessments|0|||
146881056|NCT03016325|529733588|FG007|Treatment Period|Participant refuses assessments|0|||
146881057|NCT03016325|529733581|FG000|32-Day Follow-Up Period|Death|2|||
146881058|NCT03016325|529733582|FG001|32-Day Follow-Up Period|Death|0|||
146881059|NCT03016325|529733583|FG002|32-Day Follow-Up Period|Death|5|||
146881060|NCT03016325|529733584|FG003|32-Day Follow-Up Period|Death|6|||
146881061|NCT03016325|529733585|FG004|32-Day Follow-Up Period|Death|3|||
146881062|NCT03016325|529733586|FG005|32-Day Follow-Up Period|Death|0|||
146881063|NCT03016325|529733587|FG006|32-Day Follow-Up Period|Death|0|||
146881064|NCT03016325|529733588|FG007|32-Day Follow-Up Period|Death|0|||
146881065|NCT03016325|529733581|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
146629791|NCT01352715|528821387|FG000|Overall Study|Lost to Follow-up|5|||
146629792|NCT01352715|528821388|FG001|Overall Study|Lost to Follow-up|7|||
146629793|NCT01352715|528821387|FG000|Overall Study|Withdrawal by Subject|4|||
146629794|NCT01352715|528821388|FG001|Overall Study|Withdrawal by Subject|8|||
146629795|NCT01352715|528821387|FG000|Overall Study|site closure|16|||
146629796|NCT01352715|528821388|FG001|Overall Study|site closure|15|||
146629797|NCT01352715|528821387|FG000|Overall Study|no final visit in closeout period|15|||
146629798|NCT01352715|528821388|FG001|Overall Study|no final visit in closeout period|12|||
146629799|NCT01352715|528821387|FG000|Overall Study|major ineligibility|2|||
146629800|NCT01352715|528821388|FG001|Overall Study|major ineligibility|1|||
146629801|NCT04596267|528821389|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
146629802|NCT04596267|528821390|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
146629803|NCT04596267|528821389|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
146629804|NCT04596267|528821390|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
146881066|NCT03016325|529733582|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
146881067|NCT03016325|529733583|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
146629805|NCT00071058|528821391|FG000|Overall Study|brain tumor-removed from study|1|||
146629806|NCT02000440|528821397|FG000|Overall Study|Adverse Event|3|||
146629807|NCT02000440|528821397|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
146629808|NCT01690143|528821398|FG000|Overall Study|Withdrawal by Subject|1|||
146629809|NCT00870740|528821402|FG000|Overall Study|Adverse Event|2|||
146629810|NCT00870740|528821403|FG001|Overall Study|Adverse Event|1|||
146629811|NCT00870740|528821404|FG002|Overall Study|Adverse Event|3|||
146629812|NCT00870740|528821405|FG003|Overall Study|Adverse Event|2|||
146629813|NCT00870740|528821406|FG004|Overall Study|Adverse Event|1|||
146629814|NCT00870740|528821407|FG005|Overall Study|Adverse Event|6|||
146629815|NCT00870740|528821402|FG000|Overall Study|Consent Withdrawn|6|||
146629816|NCT00870740|528821403|FG001|Overall Study|Consent Withdrawn|3|||
146629817|NCT00870740|528821404|FG002|Overall Study|Consent Withdrawn|4|||
146629818|NCT00870740|528821405|FG003|Overall Study|Consent Withdrawn|6|||
146629819|NCT00870740|528821406|FG004|Overall Study|Consent Withdrawn|6|||
146629820|NCT00870740|528821407|FG005|Overall Study|Consent Withdrawn|5|||
146629821|NCT00870740|528821402|FG000|Overall Study|Investigator Decision|2|||
146629822|NCT00870740|528821403|FG001|Overall Study|Investigator Decision|0|||
146629823|NCT00870740|528821404|FG002|Overall Study|Investigator Decision|1|||
146629824|NCT00870740|528821405|FG003|Overall Study|Investigator Decision|0|||
146629825|NCT00870740|528821406|FG004|Overall Study|Investigator Decision|0|||
146629826|NCT00870740|528821407|FG005|Overall Study|Investigator Decision|0|||
146629827|NCT00870740|528821402|FG000|Overall Study|Subject Non-compliance|0|||
146629828|NCT00870740|528821403|FG001|Overall Study|Subject Non-compliance|0|||
146629829|NCT00870740|528821404|FG002|Overall Study|Subject Non-compliance|0|||
146629830|NCT00870740|528821405|FG003|Overall Study|Subject Non-compliance|0|||
146629831|NCT00870740|528821406|FG004|Overall Study|Subject Non-compliance|0|||
146881068|NCT03016325|529733584|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
146881069|NCT03016325|529733585|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
146881070|NCT03016325|529733586|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
146881071|NCT03016325|529733587|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
146881072|NCT03016325|529733588|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
146881073|NCT03016325|529733581|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
146881074|NCT03016325|529733582|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
146881075|NCT03016325|529733583|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
146881076|NCT03016325|529733584|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
146881077|NCT03016325|529733585|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
146629832|NCT00870740|528821407|FG005|Overall Study|Subject Non-compliance|1|||
146629833|NCT00870740|528821402|FG000|Overall Study|Death|0|||
146629834|NCT00870740|528821403|FG001|Overall Study|Death|0|||
146629835|NCT00870740|528821404|FG002|Overall Study|Death|0|||
146629836|NCT00870740|528821405|FG003|Overall Study|Death|0|||
146629837|NCT00870740|528821406|FG004|Overall Study|Death|1|||
146629838|NCT00870740|528821407|FG005|Overall Study|Death|0|||
146629839|NCT00870740|528821402|FG000|Overall Study|Other|2|||
146629840|NCT00870740|528821403|FG001|Overall Study|Other|5|||
146629841|NCT00870740|528821404|FG002|Overall Study|Other|2|||
146881078|NCT03016325|529733586|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
146881079|NCT03016325|529733587|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
146881080|NCT03016325|529733588|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
146629842|NCT00870740|528821405|FG003|Overall Study|Other|4|||
146629843|NCT00870740|528821406|FG004|Overall Study|Other|3|||
146629844|NCT00870740|528821407|FG005|Overall Study|Other|5|||
146629845|NCT01710345|528821414|FG000|Overall Study|Adverse Event|0|||
146629846|NCT01710345|528821415|FG001|Overall Study|Adverse Event|2|||
146629847|NCT01710345|528821416|FG002|Overall Study|Adverse Event|0|||
146629848|NCT01710345|528821414|FG000|Overall Study|Lack of Efficacy|2|||
146629849|NCT01710345|528821415|FG001|Overall Study|Lack of Efficacy|3|||
146629850|NCT01710345|528821416|FG002|Overall Study|Lack of Efficacy|1|||
146629851|NCT01710345|528821414|FG000|Overall Study|Drug Dosing Error|1|||
146629852|NCT01710345|528821415|FG001|Overall Study|Drug Dosing Error|0|||
146629853|NCT01710345|528821416|FG002|Overall Study|Drug Dosing Error|0|||
146629854|NCT00283296|528821421|FG000|Overall Study|in-home trial not completed|5|||
146629855|NCT01353898|528821422|FG000|Overall Study|Study site terminated|0|||
146629856|NCT01353898|528821423|FG001|Overall Study|Study site terminated|0|||
146629857|NCT01353898|528821424|FG002|Overall Study|Study site terminated|0|||
146629858|NCT01353898|528821425|FG003|Overall Study|Study site terminated|0|||
146629859|NCT01353898|528821426|FG004|Overall Study|Study site terminated|0|||
146629860|NCT01353898|528821427|FG005|Overall Study|Study site terminated|1|||
146629861|NCT02668653|528821428|FG000|Overall Study|Refractory disease|41|||
146629862|NCT02668653|528821429|FG001|Overall Study|Refractory disease|70|||
146629863|NCT02668653|528821428|FG000|Overall Study|Relapse|44|||
146629864|NCT02668653|528821429|FG001|Overall Study|Relapse|65|||
146629865|NCT02668653|528821428|FG000|Overall Study|Adverse Event|58|||
146629866|NCT02668653|528821429|FG001|Overall Study|Adverse Event|23|||
146629867|NCT02668653|528821428|FG000|Overall Study|Subject decision to stop study drug|25|||
146629868|NCT02668653|528821429|FG001|Overall Study|Subject decision to stop study drug|23|||
146629869|NCT02668653|528821428|FG000|Overall Study|Other reasons not specified|16|||
146629870|NCT02668653|528821429|FG001|Overall Study|Other reasons not specified|11|||
146629871|NCT02668653|528821428|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
146629872|NCT02668653|528821429|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
146629873|NCT02668653|528821428|FG000|Overall Study|Investigator decision|10|||
146629874|NCT02668653|528821429|FG001|Overall Study|Investigator decision|7|||
146629875|NCT02668653|528821428|FG000|Overall Study|Failure to meet continuation criteria|5|||
146629876|NCT02668653|528821429|FG001|Overall Study|Failure to meet continuation criteria|12|||
146629877|NCT02668653|528821428|FG000|Overall Study|Lost to Follow-up|1|||
146629878|NCT02668653|528821429|FG001|Overall Study|Lost to Follow-up|0|||
146629879|NCT02668653|528821428|FG000|Overall Study|Pregnancy|0|||
146629880|NCT02668653|528821429|FG001|Overall Study|Pregnancy|1|||
146629881|NCT02668653|528821428|FG000|Overall Study|Death|0|||
146629882|NCT02668653|528821429|FG001|Overall Study|Death|1|||
146629883|NCT03558737|528821430|FG000|Overall Study|Death|1|||
146629884|NCT03558737|528821431|FG001|Overall Study|Death|1|||
146629885|NCT01294553|528821432|FG000|Overall Study|Duplicated Participants|1|||
146629886|NCT01294553|528821432|FG000|Overall Study|Protocol Violation|268|||
146629887|NCT03041181|528821435|FG000|Overall Study|Disease Progression|1|||
146629888|NCT03041181|528821436|FG001|Overall Study|Disease Progression|2|||
146629889|NCT03224819|528821438|FG000|Overall Study|Withdrawal by Subject|0|||
146629890|NCT03224819|528821439|FG001|Overall Study|Withdrawal by Subject|0|||
146629891|NCT03224819|528821440|FG002|Overall Study|Withdrawal by Subject|0|||
146629892|NCT03224819|528821441|FG003|Overall Study|Withdrawal by Subject|0|||
146629893|NCT03224819|528821442|FG004|Overall Study|Withdrawal by Subject|0|||
146881081|NCT03016325|529733581|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
146881082|NCT03016325|529733582|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
146881083|NCT03016325|529733583|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
146629894|NCT03224819|528821443|FG005|Overall Study|Withdrawal by Subject|0|||
146629895|NCT03224819|528821444|FG006|Overall Study|Withdrawal by Subject|0|||
146629896|NCT03224819|528821445|FG007|Overall Study|Withdrawal by Subject|0|||
146629897|NCT03224819|528821446|FG008|Overall Study|Withdrawal by Subject|0|||
146629898|NCT03224819|528821447|FG009|Overall Study|Withdrawal by Subject|0|||
146881084|NCT03016325|529733584|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
146629899|NCT03224819|528821448|FG010|Overall Study|Withdrawal by Subject|0|||
146629900|NCT03224819|528821449|FG011|Overall Study|Withdrawal by Subject|0|||
146629901|NCT03224819|528821450|FG012|Overall Study|Withdrawal by Subject|1|||
146629902|NCT03224819|528821451|FG013|Overall Study|Withdrawal by Subject|0|||
146629903|NCT03224819|528821438|FG000|Overall Study|Sponsor Decision|0|||
146629904|NCT03224819|528821439|FG001|Overall Study|Sponsor Decision|0|||
146629905|NCT03224819|528821440|FG002|Overall Study|Sponsor Decision|0|||
146629906|NCT03224819|528821441|FG003|Overall Study|Sponsor Decision|1|||
146629907|NCT03224819|528821442|FG004|Overall Study|Sponsor Decision|1|||
146629908|NCT03224819|528821443|FG005|Overall Study|Sponsor Decision|2|||
146629909|NCT03224819|528821444|FG006|Overall Study|Sponsor Decision|1|||
146629910|NCT03224819|528821445|FG007|Overall Study|Sponsor Decision|1|||
146629911|NCT03224819|528821446|FG008|Overall Study|Sponsor Decision|1|||
146629912|NCT03224819|528821447|FG009|Overall Study|Sponsor Decision|2|||
146629913|NCT03224819|528821448|FG010|Overall Study|Sponsor Decision|1|||
146629914|NCT03224819|528821449|FG011|Overall Study|Sponsor Decision|1|||
146629915|NCT03224819|528821450|FG012|Overall Study|Sponsor Decision|1|||
146629916|NCT03224819|528821451|FG013|Overall Study|Sponsor Decision|0|||
146629917|NCT03224819|528821438|FG000|Overall Study|Lost to Follow-up|0|||
146629918|NCT03224819|528821439|FG001|Overall Study|Lost to Follow-up|0|||
146629919|NCT03224819|528821440|FG002|Overall Study|Lost to Follow-up|0|||
146629920|NCT03224819|528821441|FG003|Overall Study|Lost to Follow-up|0|||
146629921|NCT03224819|528821442|FG004|Overall Study|Lost to Follow-up|0|||
146629922|NCT03224819|528821443|FG005|Overall Study|Lost to Follow-up|0|||
146629923|NCT03224819|528821444|FG006|Overall Study|Lost to Follow-up|0|||
146629924|NCT03224819|528821445|FG007|Overall Study|Lost to Follow-up|0|||
146629925|NCT03224819|528821446|FG008|Overall Study|Lost to Follow-up|1|||
146629926|NCT03224819|528821447|FG009|Overall Study|Lost to Follow-up|0|||
146629927|NCT03224819|528821448|FG010|Overall Study|Lost to Follow-up|0|||
146629928|NCT03224819|528821449|FG011|Overall Study|Lost to Follow-up|0|||
146629929|NCT03224819|528821450|FG012|Overall Study|Lost to Follow-up|0|||
146629930|NCT03224819|528821451|FG013|Overall Study|Lost to Follow-up|0|||
146629931|NCT03224819|528821438|FG000|Overall Study|Death|0|||
146629932|NCT03224819|528821439|FG001|Overall Study|Death|1|||
146629933|NCT03224819|528821440|FG002|Overall Study|Death|0|||
146629934|NCT03224819|528821441|FG003|Overall Study|Death|0|||
146629935|NCT03224819|528821442|FG004|Overall Study|Death|0|||
146629936|NCT03224819|528821443|FG005|Overall Study|Death|0|||
146629937|NCT03224819|528821444|FG006|Overall Study|Death|0|||
146629938|NCT03224819|528821445|FG007|Overall Study|Death|1|||
146629939|NCT03224819|528821446|FG008|Overall Study|Death|0|||
146629940|NCT03224819|528821447|FG009|Overall Study|Death|0|||
146629941|NCT03224819|528821448|FG010|Overall Study|Death|0|||
146629942|NCT03224819|528821449|FG011|Overall Study|Death|1|||
146629943|NCT03224819|528821450|FG012|Overall Study|Death|0|||
146629944|NCT03224819|528821451|FG013|Overall Study|Death|0|||
146629945|NCT00005780|528821454|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
146629946|NCT04973449|528821455|FG000|Overall Study|Withdrawal by Subject|3|||
146629947|NCT04973449|528821456|FG001|Overall Study|Withdrawal by Subject|3|||
146629948|NCT04973449|528821457|FG002|Overall Study|Withdrawal by Subject|2|||
146629949|NCT04973449|528821458|FG003|Overall Study|Withdrawal by Subject|5|||
146629950|NCT04973449|528821459|FG004|Overall Study|Withdrawal by Subject|5|||
146629951|NCT04973449|528821460|FG005|Overall Study|Withdrawal by Subject|4|||
146546271|NCT03188185|528506806|FG003|Stage 1|Identified as a professional patient|0|||
146546272|NCT03188185|528506803|FG000|Stage 2|Adverse Event|0|||
146546273|NCT03188185|528506804|FG001|Stage 2|Adverse Event|0|||
146546274|NCT03188185|528506805|FG002|Stage 2|Adverse Event|2|||
146546275|NCT03188185|528506806|FG003|Stage 2|Adverse Event|4|||
146546276|NCT03188185|528506803|FG000|Stage 2|Lack of Efficacy|0|||
146546277|NCT03188185|528506804|FG001|Stage 2|Lack of Efficacy|0|||
146546278|NCT03188185|528506805|FG002|Stage 2|Lack of Efficacy|3|||
146629952|NCT04973449|528821461|FG006|Overall Study|Withdrawal by Subject|7|||
146629953|NCT04973449|528821462|FG007|Overall Study|Withdrawal by Subject|5|||
146881085|NCT03016325|529733585|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
146881086|NCT03016325|529733586|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
146881087|NCT03016325|529733587|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
146881088|NCT03016325|529733588|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
146881089|NCT03016325|529733581|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
146881090|NCT03016325|529733582|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
146881091|NCT03016325|529733583|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
146881092|NCT03016325|529733584|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
146881093|NCT03016325|529733585|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
146881094|NCT03016325|529733586|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
146881095|NCT03016325|529733587|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
146881096|NCT03016325|529733588|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
146881097|NCT03016325|529733581|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
146629954|NCT04973449|528821455|FG000|Overall Study|Lost to Follow-up|15|||
146629955|NCT04973449|528821456|FG001|Overall Study|Lost to Follow-up|16|||
146629956|NCT04973449|528821457|FG002|Overall Study|Lost to Follow-up|16|||
146629957|NCT04973449|528821458|FG003|Overall Study|Lost to Follow-up|13|||
146629958|NCT04973449|528821459|FG004|Overall Study|Lost to Follow-up|5|||
146629959|NCT04973449|528821460|FG005|Overall Study|Lost to Follow-up|6|||
146629960|NCT04973449|528821461|FG006|Overall Study|Lost to Follow-up|10|||
146629961|NCT04973449|528821462|FG007|Overall Study|Lost to Follow-up|6|||
146629962|NCT04973449|528821455|FG000|Overall Study|Death|1|||
146629963|NCT04973449|528821456|FG001|Overall Study|Death|0|||
146629964|NCT04973449|528821457|FG002|Overall Study|Death|0|||
146629965|NCT04973449|528821458|FG003|Overall Study|Death|0|||
146546279|NCT03188185|528506806|FG003|Stage 2|Lack of Efficacy|0|||
146546280|NCT03188185|528506803|FG000|Stage 2|Lost to Follow-up|0|||
146629966|NCT04973449|528821459|FG004|Overall Study|Death|0|||
146629967|NCT04973449|528821460|FG005|Overall Study|Death|1|||
146629968|NCT04973449|528821461|FG006|Overall Study|Death|0|||
146881098|NCT03016325|529733582|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
146881099|NCT03016325|529733583|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
146881100|NCT03016325|529733584|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
146881101|NCT03016325|529733585|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
146546281|NCT03188185|528506804|FG001|Stage 2|Lost to Follow-up|0|||
146546282|NCT03188185|528506805|FG002|Stage 2|Lost to Follow-up|1|||
146546283|NCT03188185|528506806|FG003|Stage 2|Lost to Follow-up|0|||
146546284|NCT03188185|528506803|FG000|Stage 2|Physician Decision|0|||
146546285|NCT03188185|528506804|FG001|Stage 2|Physician Decision|0|||
146546286|NCT03188185|528506805|FG002|Stage 2|Physician Decision|0|||
146546287|NCT03188185|528506806|FG003|Stage 2|Physician Decision|1|||
146546288|NCT03188185|528506803|FG000|Stage 2|Withdrawal by Subject|0|||
146546289|NCT03188185|528506804|FG001|Stage 2|Withdrawal by Subject|0|||
146546290|NCT03188185|528506805|FG002|Stage 2|Withdrawal by Subject|3|||
146546291|NCT03188185|528506806|FG003|Stage 2|Withdrawal by Subject|1|||
146546292|NCT00774748|528506807|FG000|Overall Study|Lost to Follow-up|3|||
146546293|NCT03412890|528506810|FG000|Overall Study|Adverse Event|5|||
146546294|NCT03412890|528506811|FG001|Overall Study|Adverse Event|5|||
146546295|NCT03412890|528506812|FG002|Overall Study|Adverse Event|9|||
146546296|NCT03412890|528506810|FG000|Overall Study|Protocol deviation|2|||
146546297|NCT03412890|528506811|FG001|Overall Study|Protocol deviation|1|||
146546298|NCT03412890|528506812|FG002|Overall Study|Protocol deviation|2|||
146546299|NCT03412890|528506810|FG000|Overall Study|Lost to Follow-up|7|||
146546300|NCT03412890|528506811|FG001|Overall Study|Lost to Follow-up|10|||
146546301|NCT03412890|528506812|FG002|Overall Study|Lost to Follow-up|10|||
146546302|NCT03412890|528506810|FG000|Overall Study|Withdrawal by Subject|9|||
146546303|NCT03412890|528506811|FG001|Overall Study|Withdrawal by Subject|12|||
146546304|NCT03412890|528506812|FG002|Overall Study|Withdrawal by Subject|11|||
146546305|NCT03412890|528506810|FG000|Overall Study|Lack of Efficacy|2|||
146546306|NCT03412890|528506811|FG001|Overall Study|Lack of Efficacy|7|||
146546307|NCT03412890|528506812|FG002|Overall Study|Lack of Efficacy|5|||
146546308|NCT03412890|528506810|FG000|Overall Study|Other|5|||
146546309|NCT03412890|528506811|FG001|Overall Study|Other|6|||
146546310|NCT03412890|528506812|FG002|Overall Study|Other|5|||
146546311|NCT03412890|528506810|FG000|Overall Study|Participants who did not receive any study drug|0|||
146546312|NCT03412890|528506811|FG001|Overall Study|Participants who did not receive any study drug|1|||
146546313|NCT03412890|528506812|FG002|Overall Study|Participants who did not receive any study drug|0|||
146546314|NCT02503865|528506813|FG000|Overall Study|Moved out of area|1|||
146546315|NCT02503865|528506814|FG001|Overall Study|Moved out of area|8|||
146546316|NCT02503865|528506815|FG002|Overall Study|Moved out of area|0|||
146546317|NCT02503865|528506813|FG000|Overall Study|Refused treatment|4|||
146546318|NCT02503865|528506814|FG001|Overall Study|Refused treatment|39|||
146546319|NCT02503865|528506815|FG002|Overall Study|Refused treatment|2|||
146546320|NCT01529268|528506816|FG000|Overall Study|Lost to Follow-up|9|||
146546321|NCT01529268|528506817|FG001|Overall Study|Lost to Follow-up|3|||
146546322|NCT01529268|528506816|FG000|Overall Study|Moved|3|||
146546323|NCT01529268|528506817|FG001|Overall Study|Moved|0|||
146546324|NCT02315625|528506818|FG000|First Intervention|Disease Progression|1|||
146546325|NCT02315625|528506819|FG001|First Intervention|Disease Progression|0|||
146546326|NCT02315625|528506818|FG000|Second Intervention|Physician Decision|2|||
146546327|NCT02315625|528506819|FG001|Second Intervention|Physician Decision|1|||
146546328|NCT02315625|528506818|FG000|Second Intervention|Study closure|1|||
146546329|NCT02315625|528506819|FG001|Second Intervention|Study closure|0|||
146546330|NCT02315625|528506818|FG000|Second Intervention|Disease Progression|1|||
146546331|NCT02315625|528506819|FG001|Second Intervention|Disease Progression|0|||
146546332|NCT00021255|528506820|FG000|Overall Study|Death|1|||
146546333|NCT00021255|528506821|FG001|Overall Study|Death|0|||
146629969|NCT04973449|528821462|FG007|Overall Study|Death|0|||
146629970|NCT04973449|528821455|FG000|Overall Study|Other|1|||
146629971|NCT04973449|528821456|FG001|Overall Study|Other|1|||
146881102|NCT03016325|529733586|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
146881103|NCT03016325|529733587|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
146546334|NCT00021255|528506822|FG002|Overall Study|Death|2|||
146546335|NCT00021255|528506820|FG000|Overall Study|Breast cancer relapse|5|||
146629972|NCT04973449|528821457|FG002|Overall Study|Other|2|||
146629973|NCT04973449|528821458|FG003|Overall Study|Other|1|||
146546336|NCT00021255|528506821|FG001|Overall Study|Breast cancer relapse|18|||
146546337|NCT00021255|528506822|FG002|Overall Study|Breast cancer relapse|11|||
146546338|NCT00021255|528506820|FG000|Overall Study|Second primary malignancy|0|||
146546339|NCT00021255|528506821|FG001|Overall Study|Second primary malignancy|4|||
146546340|NCT00021255|528506822|FG002|Overall Study|Second primary malignancy|1|||
146546341|NCT00021255|528506820|FG000|Overall Study|Withdrawal by Subject|41|||
146546342|NCT00021255|528506821|FG001|Overall Study|Withdrawal by Subject|64|||
146546343|NCT00021255|528506822|FG002|Overall Study|Withdrawal by Subject|26|||
146546344|NCT00021255|528506820|FG000|Overall Study|Lost to Follow-up|0|||
146546345|NCT00021255|528506821|FG001|Overall Study|Lost to Follow-up|2|||
146546346|NCT00021255|528506822|FG002|Overall Study|Lost to Follow-up|3|||
146629974|NCT04973449|528821459|FG004|Overall Study|Other|4|||
146881104|NCT03016325|529733588|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
146881105|NCT03016325|529733581|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
146881106|NCT03016325|529733582|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
146881107|NCT03016325|529733583|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
146881108|NCT03016325|529733584|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
146881109|NCT03016325|529733585|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
146881110|NCT03016325|529733586|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
146881111|NCT03016325|529733587|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
146881112|NCT03016325|529733588|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
146881113|NCT03016325|529733581|FG000|182-Day Follow-Up Period|Death|3|||
146881114|NCT03016325|529733582|FG001|182-Day Follow-Up Period|Death|3|||
146881115|NCT03016325|529733583|FG002|182-Day Follow-Up Period|Death|11|||
146881116|NCT03016325|529733584|FG003|182-Day Follow-Up Period|Death|12|||
146881117|NCT03016325|529733585|FG004|182-Day Follow-Up Period|Death|9|||
146546347|NCT00021255|528506820|FG000|Overall Study|Cardiac toxicity|0|||
146546348|NCT00021255|528506821|FG001|Overall Study|Cardiac toxicity|61|||
146546349|NCT00021255|528506822|FG002|Overall Study|Cardiac toxicity|32|||
146546350|NCT00021255|528506820|FG000|Overall Study|Herceptin toxicity|0|||
146546351|NCT00021255|528506821|FG001|Overall Study|Herceptin toxicity|22|||
146546352|NCT00021255|528506822|FG002|Overall Study|Herceptin toxicity|6|||
146546353|NCT00021255|528506820|FG000|Overall Study|Adverse Event|46|||
146546354|NCT00021255|528506821|FG001|Overall Study|Adverse Event|30|||
146546355|NCT00021255|528506822|FG002|Overall Study|Adverse Event|18|||
146546356|NCT00021255|528506820|FG000|Overall Study|Protocol Violation|0|||
146546357|NCT00021255|528506821|FG001|Overall Study|Protocol Violation|2|||
146546358|NCT00021255|528506822|FG002|Overall Study|Protocol Violation|0|||
146546359|NCT00021255|528506820|FG000|Overall Study|Other than specified above|0|||
146546360|NCT00021255|528506821|FG001|Overall Study|Other than specified above|38|||
146546361|NCT00021255|528506822|FG002|Overall Study|Other than specified above|19|||
146546362|NCT00021255|528506820|FG000|Overall Study|Missing|0|||
146546363|NCT00021255|528506821|FG001|Overall Study|Missing|27|||
146546364|NCT00021255|528506822|FG002|Overall Study|Missing|13|||
146546365|NCT00021255|528506820|FG000|Overall Study|Randomized but not treated|28|||
146546366|NCT00021255|528506821|FG001|Overall Study|Randomized but not treated|2|||
146546367|NCT00021255|528506822|FG002|Overall Study|Randomized but not treated|18|||
146546368|NCT02337946|528506823|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
146546369|NCT02337946|528506824|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
146546370|NCT02337946|528506825|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
146546371|NCT02337946|528506823|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
146546372|NCT02337946|528506824|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
146546373|NCT02337946|528506825|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
146546374|NCT02337946|528506823|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
146546375|NCT02337946|528506824|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
146546376|NCT02337946|528506825|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
146546377|NCT02337946|528506823|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
146546378|NCT02337946|528506824|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
146546379|NCT02337946|528506825|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
146546380|NCT02337946|528506823|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
146546381|NCT02337946|528506824|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
146546382|NCT02337946|528506825|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
146546383|NCT02337946|528506823|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
146546384|NCT02337946|528506824|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
146546385|NCT02337946|528506825|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
146546386|NCT02337946|528506823|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
146546387|NCT02337946|528506824|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
146546388|NCT02337946|528506825|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
146546389|NCT02337946|528506823|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
146546390|NCT02337946|528506824|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
146546391|NCT02337946|528506825|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
146546392|NCT02337946|528506823|FG000|In-between Period|Without Informed Consent|1|||
146546393|NCT02337946|528506824|FG001|In-between Period|Without Informed Consent|0|||
146546394|NCT02337946|528506825|FG002|In-between Period|Without Informed Consent|0|||
146546395|NCT02337946|528506823|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
146546396|NCT02337946|528506824|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
146546397|NCT02337946|528506825|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
146546398|NCT02337946|528506823|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
146546399|NCT02337946|528506824|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
146546400|NCT02337946|528506825|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
146546401|NCT02337946|528506823|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
146546402|NCT02337946|528506824|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
146546403|NCT02337946|528506825|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
146881118|NCT03016325|529733586|FG005|182-Day Follow-Up Period|Death|0|||
146546404|NCT02337946|528506823|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
146546405|NCT02337946|528506824|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
146546406|NCT02337946|528506825|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
146546407|NCT02337946|528506823|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
146546408|NCT02337946|528506824|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
146546409|NCT02337946|528506825|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
146546410|NCT02337946|528506823|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
146546411|NCT02337946|528506824|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
146546412|NCT02337946|528506825|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
146546413|NCT05324371|528506827|FG000|Overall Study|Withdrawal by Subject|1|||
146546414|NCT05324371|528506827|FG000|Overall Study|Death|1|||
146546415|NCT01131585|528506828|FG000|Overall Study|Adverse Event|0|||
146546416|NCT01131585|528506829|FG001|Overall Study|Adverse Event|2|||
146546417|NCT01131585|528506828|FG000|Overall Study|Abnormal laboratory value|1|||
146546418|NCT01131585|528506829|FG001|Overall Study|Abnormal laboratory value|0|||
146546419|NCT01131585|528506828|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146546420|NCT01131585|528506829|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
146546421|NCT01131585|528506828|FG000|Overall Study|Protocol Violation|2|||
146546422|NCT01131585|528506829|FG001|Overall Study|Protocol Violation|1|||
146546423|NCT01131585|528506828|FG000|Overall Study|Withdrawal by Subject|3|||
146546424|NCT01131585|528506829|FG001|Overall Study|Withdrawal by Subject|3|||
146546425|NCT01131585|528506828|FG000|Overall Study|Lost to Follow-up|0|||
146546426|NCT01131585|528506829|FG001|Overall Study|Lost to Follow-up|1|||
146546427|NCT01131585|528506828|FG000|Overall Study|Administrative problems|1|||
146546428|NCT01131585|528506829|FG001|Overall Study|Administrative problems|1|||
146546429|NCT01131585|528506828|FG000|Overall Study|Study termination|78|||
146546430|NCT01131585|528506829|FG001|Overall Study|Study termination|32|||
146546431|NCT01786109|528506830|FG000|Overall Study|fail manometry barostat tube placement|1|||
146546432|NCT01786109|528506831|FG001|Overall Study|fail manometry barostat tube placement|0|||
146546433|NCT01786109|528506832|FG002|Overall Study|fail manometry barostat tube placement|0|||
146546434|NCT01786109|528506830|FG000|Overall Study|unrelated illness|0|||
146546435|NCT01786109|528506831|FG001|Overall Study|unrelated illness|0|||
146546436|NCT01786109|528506832|FG002|Overall Study|unrelated illness|1|||
146546437|NCT01786109|528506830|FG000|Overall Study|adverse effects colon preparation|0|||
146546438|NCT01786109|528506831|FG001|Overall Study|adverse effects colon preparation|0|||
146546439|NCT01786109|528506832|FG002|Overall Study|adverse effects colon preparation|1|||
146546440|NCT03442569|528506836|FG000|Overall Study|Subject was ineligible after enrollment|1|||
146546441|NCT04439175|528507653|FG000|Overall Study|Never started treatment|4|||
146546442|NCT04439175|528507653|FG000|Overall Study|Ineligible|5|||
146765056|NCT03593070|529307236|FG001|Overall Study|administrative withdrawal|1|||
146765057|NCT03098030|529307239|FG000|Overall Study|Death|10|||
146765058|NCT03098030|529307240|FG001|Overall Study|Death|156|||
146765059|NCT03098030|529307241|FG002|Overall Study|Death|156|||
146765060|NCT03098030|529307242|FG003|Overall Study|Death|82|||
146765061|NCT03098030|529307239|FG000|Overall Study|Withdrawal by Subject|0|||
146765062|NCT03098030|529307240|FG001|Overall Study|Withdrawal by Subject|7|||
146765063|NCT03098030|529307241|FG002|Overall Study|Withdrawal by Subject|8|||
146765064|NCT03098030|529307242|FG003|Overall Study|Withdrawal by Subject|2|||
146765065|NCT03098030|529307239|FG000|Overall Study|Lost to Follow-up|0|||
146765066|NCT03098030|529307240|FG001|Overall Study|Lost to Follow-up|0|||
146765067|NCT03098030|529307241|FG002|Overall Study|Lost to Follow-up|2|||
146765068|NCT03098030|529307242|FG003|Overall Study|Lost to Follow-up|1|||
146765069|NCT03310983|529307243|FG000|Overall Study|Lost to Follow-up|15|||
146765070|NCT03310983|529307244|FG001|Overall Study|Lost to Follow-up|17|||
146765071|NCT03612804|529307245|FG000|Overall Study|Death|0|||
146765072|NCT03612804|529307246|FG001|Overall Study|Death|7|||
146765073|NCT03612804|529307247|FG002|Overall Study|Death|0|||
146765074|NCT03612804|529307248|FG003|Overall Study|Death|8|||
146765075|NCT03612804|529307245|FG000|Overall Study|Medication copay coverage issues|0|||
146765076|NCT03612804|529307246|FG001|Overall Study|Medication copay coverage issues|0|||
146765077|NCT03612804|529307247|FG002|Overall Study|Medication copay coverage issues|0|||
146881119|NCT03016325|529733587|FG006|182-Day Follow-Up Period|Death|0|||
146881120|NCT03016325|529733588|FG007|182-Day Follow-Up Period|Death|1|||
146881121|NCT03016325|529733581|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
146881122|NCT03016325|529733582|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
146546443|NCT04439175|528507653|FG000|Overall Study|Adverse Event|6|||
146546444|NCT04439175|528507653|FG000|Overall Study|Death|4|||
146546445|NCT04439175|528507653|FG000|Overall Study|Disease progression|44|||
146546446|NCT04439175|528507653|FG000|Overall Study|Withdrawal by Subject|4|||
146546447|NCT04439175|528507653|FG000|Overall Study|Alternative Therapy|1|||
146765078|NCT03612804|529307248|FG003|Overall Study|Medication copay coverage issues|17|||
146765079|NCT03612804|529307245|FG000|Overall Study|Not current smoker at time of screening|0|||
146546448|NCT04439175|528507653|FG000|Overall Study|Other|2|||
146765080|NCT03612804|529307246|FG001|Overall Study|Not current smoker at time of screening|1|||
146629975|NCT04973449|528821460|FG005|Overall Study|Other|0|||
146629976|NCT04973449|528821461|FG006|Overall Study|Other|2|||
146629977|NCT04973449|528821462|FG007|Overall Study|Other|2|||
146629978|NCT00829426|528821463|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
146629979|NCT00829426|528821464|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
146629980|NCT03597347|528821468|FG000|Overall Study|Withdrawal by Subject|1|||
146629981|NCT03597347|528821469|FG001|Overall Study|Withdrawal by Subject|1|||
146629982|NCT03597347|528821470|FG002|Overall Study|Withdrawal by Subject|0|||
146629983|NCT03597347|528821468|FG000|Overall Study|Withdrawal due to Covid-19|3|||
146629984|NCT03597347|528821469|FG001|Overall Study|Withdrawal due to Covid-19|0|||
146629985|NCT03597347|528821470|FG002|Overall Study|Withdrawal due to Covid-19|0|||
146629986|NCT03597347|528821468|FG000|Overall Study|Sponsor decision to terminate study|3|||
146629987|NCT03597347|528821469|FG001|Overall Study|Sponsor decision to terminate study|2|||
146629988|NCT03597347|528821470|FG002|Overall Study|Sponsor decision to terminate study|4|||
146629989|NCT04606134|528821471|FG000|Overall Study|Adverse Event|0|||
146629990|NCT04606134|528821472|FG001|Overall Study|Adverse Event|1|||
146629991|NCT00107653|528821473|FG000|Overall Study|Adverse Event|24|||
146881123|NCT03016325|529733583|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
146881124|NCT03016325|529733584|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
146881125|NCT03016325|529733585|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
146629992|NCT00107653|528821474|FG001|Overall Study|Adverse Event|43|||
146629993|NCT00107653|528821473|FG000|Overall Study|Insufficient Therapeutic Response|25|||
146629994|NCT00107653|528821474|FG001|Overall Study|Insufficient Therapeutic Response|11|||
146881126|NCT03016325|529733586|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
146881127|NCT03016325|529733587|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
146881128|NCT03016325|529733588|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
146881129|NCT03016325|529733581|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
146881130|NCT03016325|529733582|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
146881131|NCT03016325|529733583|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
146881132|NCT03016325|529733584|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
146881133|NCT03016325|529733585|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
146881134|NCT03016325|529733586|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
146881135|NCT03016325|529733587|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
146881136|NCT03016325|529733588|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
146881137|NCT03016325|529733581|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
146881138|NCT03016325|529733582|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
146881139|NCT03016325|529733583|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
146881140|NCT03016325|529733584|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
146881141|NCT03016325|529733585|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
146881142|NCT03016325|529733586|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
146881143|NCT03016325|529733587|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
146881144|NCT03016325|529733588|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
146881145|NCT03016325|529733581|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
146881146|NCT03016325|529733582|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
146881147|NCT03016325|529733583|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
146881148|NCT03016325|529733584|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
146881149|NCT03016325|529733585|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
146881150|NCT03016325|529733586|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
146881151|NCT03016325|529733587|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
146881152|NCT03016325|529733588|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
146881153|NCT03016325|529733581|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
146881154|NCT03016325|529733582|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
146881155|NCT03016325|529733583|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
146881156|NCT03016325|529733584|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
146881157|NCT03016325|529733585|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
146881158|NCT03016325|529733586|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
146881159|NCT03016325|529733587|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
146881160|NCT03016325|529733588|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
146881161|NCT03016325|529733581|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
146881162|NCT03016325|529733582|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
146629995|NCT00107653|528821473|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
146881163|NCT03016325|529733583|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
146881164|NCT03016325|529733584|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
146881165|NCT03016325|529733585|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
146881166|NCT03016325|529733586|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
146881167|NCT03016325|529733587|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
146881168|NCT03016325|529733588|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
146629996|NCT00107653|528821474|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
146629997|NCT00107653|528821473|FG000|Overall Study|Protocol Violation|1|||
146881169|NCT03016325|529733581|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
146881170|NCT03016325|529733582|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
146881171|NCT03016325|529733583|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
146881172|NCT03016325|529733584|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
146881173|NCT03016325|529733585|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
146881174|NCT03016325|529733586|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
146881175|NCT03016325|529733587|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
146881176|NCT03016325|529733588|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
146881177|NCT03681119|529733589|FG000|Overall Study|No specific reason|4|||
146881178|NCT03681119|529733590|FG001|Overall Study|No specific reason|0|||
146881179|NCT03681119|529733589|FG000|Overall Study|Sickness|2|||
146881180|NCT03681119|529733590|FG001|Overall Study|Sickness|0|||
146881181|NCT02813694|529733593|FG000|Overall Study|Physician Decision|0|||
146881182|NCT02813694|529733594|FG001|Overall Study|Physician Decision|1|||
146881183|NCT02813694|529733593|FG000|Overall Study|Withdrawal by Subject|10|||
146881184|NCT02813694|529733594|FG001|Overall Study|Withdrawal by Subject|9|||
146881185|NCT02813694|529733593|FG000|Overall Study|Lost to Follow-up|1|||
146881186|NCT02813694|529733594|FG001|Overall Study|Lost to Follow-up|1|||
146881187|NCT02813694|529733593|FG000|Overall Study|Death|3|||
146881188|NCT02813694|529733594|FG001|Overall Study|Death|3|||
146881189|NCT02813694|529733593|FG000|Overall Study|Randomized- did not receive study drug|2|||
146881190|NCT02813694|529733594|FG001|Overall Study|Randomized- did not receive study drug|0|||
146881191|NCT02813694|529733593|FG000|Overall Study|Patient hospitalized|1|||
146881192|NCT02813694|529733594|FG001|Overall Study|Patient hospitalized|0|||
146881193|NCT01347554|529733598|FG000|Overall Study|Lack of Efficacy|7|||
146881194|NCT01347554|529733599|FG001|Overall Study|Lack of Efficacy|11|||
146881195|NCT00004259|529733603|FG000|Overall Study|Protocol Violation|1|||
146881196|NCT00004259|529733604|FG001|Overall Study|Protocol Violation|2|||
146881197|NCT00004259|529733605|FG002|Overall Study|Protocol Violation|0|||
146881198|NCT00004259|529733606|FG003|Overall Study|Protocol Violation|0|||
146881199|NCT00004259|529733603|FG000|Overall Study|Withdrawal by Subject|0|||
146881200|NCT00004259|529733604|FG001|Overall Study|Withdrawal by Subject|2|||
146881201|NCT00004259|529733605|FG002|Overall Study|Withdrawal by Subject|0|||
146881202|NCT00004259|529733606|FG003|Overall Study|Withdrawal by Subject|0|||
146881203|NCT01902290|529733611|FG000|Overall Study|Withdrawal by Subject|19|||
146881204|NCT01902290|529733612|FG001|Overall Study|Withdrawal by Subject|27|||
146881205|NCT01902290|529733611|FG000|Overall Study|Lost to Follow-up|2|||
146881206|NCT01902290|529733612|FG001|Overall Study|Lost to Follow-up|2|||
146881207|NCT01902290|529733611|FG000|Overall Study|Death|1|||
146881208|NCT01902290|529733612|FG001|Overall Study|Death|0|||
146881209|NCT01902290|529733611|FG000|Overall Study|Sponsor Decision|26|||
146881210|NCT01902290|529733612|FG001|Overall Study|Sponsor Decision|24|||
146881211|NCT00517829|529733613|FG000|Overall Study|Adverse Event|22|||
146881212|NCT00517829|529733614|FG001|Overall Study|Adverse Event|34|||
146881213|NCT00517829|529733613|FG000|Overall Study|Disease Progression|39|||
146881214|NCT00517829|529733614|FG001|Overall Study|Disease Progression|32|||
146881215|NCT00517829|529733613|FG000|Overall Study|Patient Request|6|||
146881216|NCT00517829|529733614|FG001|Overall Study|Patient Request|5|||
146881217|NCT00517829|529733613|FG000|Overall Study|Investigator Request|5|||
146881218|NCT00517829|529733614|FG001|Overall Study|Investigator Request|3|||
146881219|NCT00517829|529733613|FG000|Overall Study|Other|3|||
146881220|NCT00517829|529733614|FG001|Overall Study|Other|1|||
146881221|NCT00109707|529733620|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
146881222|NCT00109707|529733621|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
146881223|NCT00109707|529733622|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
146881224|NCT00109707|529733620|FG000|Overall Study|Abnormal laboratory values|1|||
146881225|NCT00109707|529733621|FG001|Overall Study|Abnormal laboratory values|0|||
146881226|NCT00109707|529733622|FG002|Overall Study|Abnormal laboratory values|0|||
146881227|NCT00109707|529733620|FG000|Overall Study|Administrative problems|2|||
146881228|NCT00109707|529733621|FG001|Overall Study|Administrative problems|0|||
146881229|NCT00109707|529733622|FG002|Overall Study|Administrative problems|1|||
146881230|NCT00109707|529733620|FG000|Overall Study|Adverse Event|10|||
146881231|NCT00109707|529733621|FG001|Overall Study|Adverse Event|2|||
146881232|NCT00109707|529733622|FG002|Overall Study|Adverse Event|3|||
146546449|NCT01847209|528507654|FG000|Overall Study|Withdrawal by Subject|1|||
146881233|NCT00109707|529733620|FG000|Overall Study|Death|4|||
146881234|NCT00109707|529733621|FG001|Overall Study|Death|0|||
146881235|NCT00109707|529733622|FG002|Overall Study|Death|0|||
146881236|NCT00109707|529733620|FG000|Overall Study|Disease progression|12|||
146881237|NCT00109707|529733621|FG001|Overall Study|Disease progression|4|||
146881238|NCT00109707|529733622|FG002|Overall Study|Disease progression|3|||
146629998|NCT00107653|528821474|FG001|Overall Study|Protocol Violation|0|||
146881239|NCT00109707|529733620|FG000|Overall Study|Lost to Follow-up|3|||
146881240|NCT00109707|529733621|FG001|Overall Study|Lost to Follow-up|0|||
146881241|NCT00109707|529733622|FG002|Overall Study|Lost to Follow-up|0|||
146881242|NCT00109707|529733620|FG000|Overall Study|Protocol Violation|1|||
146881243|NCT00109707|529733621|FG001|Overall Study|Protocol Violation|0|||
146881244|NCT00109707|529733622|FG002|Overall Study|Protocol Violation|0|||
146881245|NCT00109707|529733620|FG000|Overall Study|Patient withdrew consent|6|||
146881246|NCT00109707|529733621|FG001|Overall Study|Patient withdrew consent|1|||
146881247|NCT00109707|529733622|FG002|Overall Study|Patient withdrew consent|0|||
146881248|NCT03436862|529733624|FG000|Overall Study|Adverse Event|4|||
146881249|NCT03436862|529733624|FG000|Overall Study|Progressive Disease|2|||
146881250|NCT02937818|529733625|FG000|Overall Study|Participants decision|2|||
146881251|NCT02937818|529733626|FG001|Overall Study|Participants decision|1|||
146881252|NCT02937818|529733627|FG002|Overall Study|Participants decision|1|||
146881253|NCT02937818|529733628|FG003|Overall Study|Participants decision|1|||
146881254|NCT02937818|529733625|FG000|Overall Study|Adverse Event|2|||
146881255|NCT02937818|529733626|FG001|Overall Study|Adverse Event|4|||
146881256|NCT02937818|529733627|FG002|Overall Study|Adverse Event|1|||
146881257|NCT02937818|529733628|FG003|Overall Study|Adverse Event|1|||
146881258|NCT02937818|529733625|FG000|Overall Study|Disease progression|17|||
146881259|NCT02937818|529733626|FG001|Overall Study|Disease progression|15|||
146881260|NCT02937818|529733627|FG002|Overall Study|Disease progression|7|||
146881261|NCT02937818|529733628|FG003|Overall Study|Disease progression|19|||
146881262|NCT02937818|529733625|FG000|Overall Study|Condition under investigation worsened|0|||
146881263|NCT02937818|529733626|FG001|Overall Study|Condition under investigation worsened|0|||
146881264|NCT02937818|529733627|FG002|Overall Study|Condition under investigation worsened|1|||
146881265|NCT02937818|529733628|FG003|Overall Study|Condition under investigation worsened|0|||
146881266|NCT02054897|529733630|FG000|Overall Study|Withdrawal by Subject|2|||
146881267|NCT02054897|529733631|FG001|Overall Study|Withdrawal by Subject|0|||
146881268|NCT02054897|529733632|FG002|Overall Study|Withdrawal by Subject|2|||
146881269|NCT02054897|529733630|FG000|Overall Study|Missing follow-up information|3|||
146881270|NCT02054897|529733631|FG001|Overall Study|Missing follow-up information|5|||
146881271|NCT02054897|529733632|FG002|Overall Study|Missing follow-up information|3|||
146881272|NCT02054897|529733630|FG000|Overall Study|Lost to Follow-up|4|||
146881273|NCT02054897|529733631|FG001|Overall Study|Lost to Follow-up|2|||
146881274|NCT02054897|529733632|FG002|Overall Study|Lost to Follow-up|7|||
146881275|NCT02054897|529733630|FG000|Overall Study|Randomized but not exposed|1|||
146881276|NCT02054897|529733631|FG001|Overall Study|Randomized but not exposed|0|||
146881277|NCT02054897|529733632|FG002|Overall Study|Randomized but not exposed|0|||
146881278|NCT00550680|529733633|FG000|Overall Study|Administrative Reasons|1|||
146881279|NCT00550680|529733633|FG000|Overall Study|Adverse Event|5|||
146881280|NCT00550680|529733633|FG000|Overall Study|Death|3|||
146881281|NCT00550680|529733633|FG000|Overall Study|Early Improvement|1|||
146881282|NCT00550680|529733633|FG000|Overall Study|Lost to Follow-up|3|||
146881283|NCT00550680|529733633|FG000|Overall Study|Lack of Efficacy|1|||
146881284|NCT00550680|529733633|FG000|Overall Study|Other|10|||
146881285|NCT00550680|529733633|FG000|Overall Study|Protocol Violation|7|||
146881286|NCT00550680|529733633|FG000|Overall Study|Refused Treatment|19|||
146881287|NCT00550680|529733633|FG000|Overall Study|Screen Failure|6|||
146881288|NCT01119248|529733634|FG000|Overall Study|Physician Decision|5|||
146881289|NCT01967550|529733635|FG000|Overall Study|Withdrawal by Subject|1|||
146881290|NCT01967550|529733636|FG001|Overall Study|Withdrawal by Subject|0|||
146881291|NCT01967550|529733635|FG000|Overall Study|Adverse Event|2|||
146881292|NCT01967550|529733636|FG001|Overall Study|Adverse Event|0|||
146881293|NCT01967550|529733635|FG000|Overall Study|Protocol Violation|2|||
146881294|NCT01967550|529733636|FG001|Overall Study|Protocol Violation|1|||
146881295|NCT01967550|529733635|FG000|Overall Study|Non Compliance|0|||
146881296|NCT01967550|529733636|FG001|Overall Study|Non Compliance|1|||
146881297|NCT01100437|529733637|FG000|Titration/Stabilization|Adverse Event|0|||
146881298|NCT01100437|529733638|FG001|Titration/Stabilization|Adverse Event|0|||
146881299|NCT01100437|529733639|FG002|Titration/Stabilization|Adverse Event|4|||
146546450|NCT01847209|528507654|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
146546451|NCT01631188|528507655|FG000|Overall Study|Physician Decision|75|||
146546452|NCT03600350|528507658|FG000|Overall Study|Death|1|||
146546453|NCT03600350|528507658|FG000|Overall Study|On Follow Up|18|||
146546454|NCT04575324|528507659|FG000|Overall Study|Lost to Follow-up|29|||
146546455|NCT04575324|528507660|FG001|Overall Study|Lost to Follow-up|25|||
146546456|NCT04575324|528507659|FG000|Overall Study|Death|1|||
146546457|NCT04575324|528507660|FG001|Overall Study|Death|2|||
146881300|NCT01100437|529733637|FG000|Titration/Stabilization|Non-compliance|0|||
146881301|NCT01100437|529733638|FG001|Titration/Stabilization|Non-compliance|0|||
146881302|NCT01100437|529733639|FG002|Titration/Stabilization|Non-compliance|1|||
146546458|NCT04575324|528507659|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
146546459|NCT04575324|528507660|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
146881303|NCT01100437|529733637|FG000|Titration/Stabilization|Sponsor canceled study|0|||
146881304|NCT01100437|529733638|FG001|Titration/Stabilization|Sponsor canceled study|0|||
146881305|NCT01100437|529733639|FG002|Titration/Stabilization|Sponsor canceled study|1|||
146881306|NCT01100437|529733637|FG000|Maintenance|Withdrawal by Subject|0|||
146881307|NCT01100437|529733638|FG001|Maintenance|Withdrawal by Subject|0|||
146881308|NCT01100437|529733639|FG002|Maintenance|Withdrawal by Subject|1|||
146881309|NCT01100437|529733637|FG000|Maintenance|Sponsor termination of study|0|||
146881310|NCT01100437|529733638|FG001|Maintenance|Sponsor termination of study|0|||
146881311|NCT01100437|529733639|FG002|Maintenance|Sponsor termination of study|1|||
146881312|NCT00805480|529733648|FG000|Overall Study|Withdrawal by Subject|13|||
146881313|NCT00805480|529733649|FG001|Overall Study|Withdrawal by Subject|5|||
146881314|NCT00805480|529733650|FG002|Overall Study|Withdrawal by Subject|11|||
146881315|NCT00805480|529733651|FG003|Overall Study|Withdrawal by Subject|5|||
146881316|NCT00805480|529733648|FG000|Overall Study|Lost to Follow-up|1|||
146881317|NCT00805480|529733649|FG001|Overall Study|Lost to Follow-up|2|||
146881318|NCT00805480|529733650|FG002|Overall Study|Lost to Follow-up|0|||
146881319|NCT00805480|529733651|FG003|Overall Study|Lost to Follow-up|0|||
146881320|NCT00805480|529733648|FG000|Overall Study|Adverse Event|0|||
146881321|NCT00805480|529733649|FG001|Overall Study|Adverse Event|0|||
146881322|NCT00805480|529733650|FG002|Overall Study|Adverse Event|1|||
146881323|NCT00805480|529733651|FG003|Overall Study|Adverse Event|0|||
146881324|NCT01534533|529733652|FG000|Overall Study|Lost to Follow-up|3|||
146881325|NCT01534533|529733653|FG001|Overall Study|Lost to Follow-up|0|||
146881326|NCT01534533|529733654|FG002|Overall Study|Lost to Follow-up|4|||
146881327|NCT01534533|529733655|FG003|Overall Study|Lost to Follow-up|3|||
146881328|NCT01534533|529733652|FG000|Overall Study|Withdrawal by Subject|5|||
146881329|NCT01534533|529733653|FG001|Overall Study|Withdrawal by Subject|3|||
146881330|NCT01534533|529733654|FG002|Overall Study|Withdrawal by Subject|4|||
146546460|NCT00845182|528507668|FG000|Overall Study|Lost to Follow-up|3|||
146546461|NCT00845182|528507669|FG001|Overall Study|Lost to Follow-up|3|||
146546462|NCT00845182|528507670|FG002|Overall Study|Lost to Follow-up|4|||
146546463|NCT00845182|528507668|FG000|Overall Study|Adverse Event|0|||
146546464|NCT00845182|528507669|FG001|Overall Study|Adverse Event|1|||
146546465|NCT00845182|528507670|FG002|Overall Study|Adverse Event|1|||
146546466|NCT00845182|528507668|FG000|Overall Study|Physician Decision|0|||
146546467|NCT00845182|528507669|FG001|Overall Study|Physician Decision|0|||
146546468|NCT00845182|528507670|FG002|Overall Study|Physician Decision|1|||
146546469|NCT04621760|528507671|FG000|Overall Study|Lost to Follow-up|2|||
146546470|NCT04621760|528507672|FG001|Overall Study|Lost to Follow-up|4|||
146546471|NCT04621760|528507671|FG000|Overall Study|Withdrawal by Subject|1|||
146546472|NCT04621760|528507672|FG001|Overall Study|Withdrawal by Subject|0|||
146546473|NCT00447278|528507673|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
146546474|NCT00447278|528507674|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
146546475|NCT00447278|528507673|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
146546476|NCT00447278|528507674|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
146546477|NCT00447278|528507673|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
146546478|NCT00447278|528507674|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
146546479|NCT00447278|528507673|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
146546480|NCT00447278|528507674|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
146546481|NCT00447278|528507673|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
146546482|NCT00447278|528507674|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
146546483|NCT00447278|528507673|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
146546484|NCT00447278|528507674|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
146546485|NCT00447278|528507673|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
146546486|NCT00447278|528507674|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
146546487|NCT00447278|528507673|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
146546488|NCT00447278|528507674|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
146546489|NCT00447278|528507673|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
146546490|NCT00447278|528507674|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
146546491|NCT00447278|528507673|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
146546492|NCT00447278|528507674|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
146546493|NCT00447278|528507673|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
146546494|NCT00447278|528507674|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
146546495|NCT00447278|528507673|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
146546496|NCT00447278|528507674|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
146546497|NCT00447278|528507673|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
146546498|NCT00447278|528507674|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
146546499|NCT00447278|528507673|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
146546500|NCT00447278|528507674|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
146546501|NCT03677401|528507675|FG000|Overall Study|Adverse Event|4|||
146546502|NCT03677401|528507676|FG001|Overall Study|Adverse Event|14|||
146629999|NCT00107653|528821473|FG000|Overall Study|Withdrawal by Subject|12|||
146546503|NCT03677401|528507675|FG000|Overall Study|Lack of Efficacy|3|||
146546504|NCT03677401|528507676|FG001|Overall Study|Lack of Efficacy|1|||
146546505|NCT03677401|528507675|FG000|Overall Study|Withdrawal by Subject|2|||
146630000|NCT00107653|528821474|FG001|Overall Study|Withdrawal by Subject|13|||
146881331|NCT01534533|529733655|FG003|Overall Study|Withdrawal by Subject|1|||
146881332|NCT04099251|529735289|FG000|Pre-Treatment|Other reasons|1|||
146881333|NCT04099251|529735290|FG001|Pre-Treatment|Other reasons|0|||
146881334|NCT04099251|529735289|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
146630001|NCT00107653|528821473|FG000|Overall Study|Lost to Follow-up|13|||
146630002|NCT00107653|528821474|FG001|Overall Study|Lost to Follow-up|5|||
146630003|NCT00107653|528821473|FG000|Overall Study|Administrative Reasons|3|||
146630004|NCT00107653|528821474|FG001|Overall Study|Administrative Reasons|3|||
146630005|NCT02018562|528821480|FG000|Overall Study|Withdrawal by Subject|2|||
146630006|NCT02018562|528821481|FG001|Overall Study|Withdrawal by Subject|0|||
146630007|NCT02018562|528821480|FG000|Overall Study|Discharged prior to study completion|1|||
146881335|NCT04099251|529735290|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
146881336|NCT04099251|529735289|FG000|Blinded Treatment Phase|Other reasons|16|||
146881337|NCT04099251|529735290|FG001|Blinded Treatment Phase|Other reasons|7|||
146881338|NCT04099251|529735289|FG000|Blinded Treatment Phase|Disease recurrence|26|||
146881339|NCT04099251|529735290|FG001|Blinded Treatment Phase|Disease recurrence|41|||
146881340|NCT04099251|529735289|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
146546506|NCT03677401|528507676|FG001|Overall Study|Withdrawal by Subject|2|||
146546507|NCT03677401|528507675|FG000|Overall Study|Sponsor decision|0|||
146546508|NCT03677401|528507676|FG001|Overall Study|Sponsor decision|1|||
146546509|NCT03677401|528507675|FG000|Overall Study|Reason Unspecified|1|||
146546510|NCT03677401|528507676|FG001|Overall Study|Reason Unspecified|0|||
146546511|NCT06262607|528507682|FG000|Overall Study|Physician Decision|0|||
146546512|NCT06262607|528507683|FG001|Overall Study|Physician Decision|1|||
146546513|NCT06262607|528507682|FG000|Overall Study|Withdrawal by Subject|2|||
146546514|NCT06262607|528507683|FG001|Overall Study|Withdrawal by Subject|0|||
146546515|NCT00927082|528507684|FG000|Overall Study|Lost to Follow-up|9|||
146546516|NCT00927082|528507685|FG001|Overall Study|Lost to Follow-up|8|||
146546517|NCT00927082|528507686|FG002|Overall Study|Lost to Follow-up|12|||
146546518|NCT00927082|528507687|FG003|Overall Study|Lost to Follow-up|16|||
146546519|NCT00927082|528507684|FG000|Overall Study|Withdrawal by Subject|3|||
146546520|NCT00927082|528507685|FG001|Overall Study|Withdrawal by Subject|2|||
146546521|NCT00927082|528507686|FG002|Overall Study|Withdrawal by Subject|7|||
146546522|NCT00927082|528507687|FG003|Overall Study|Withdrawal by Subject|2|||
146546523|NCT00927082|528507684|FG000|Overall Study|Death|0|||
146546524|NCT00927082|528507685|FG001|Overall Study|Death|0|||
146546525|NCT00927082|528507686|FG002|Overall Study|Death|1|||
146546526|NCT00927082|528507687|FG003|Overall Study|Death|0|||
146546527|NCT00927082|528507684|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
146546528|NCT00927082|528507685|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
146546529|NCT00927082|528507686|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
146546530|NCT00927082|528507687|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
146546531|NCT03369223|528507688|FG000|Overall Study|Lost to Follow-up|0|||
146546532|NCT03369223|528507689|FG001|Overall Study|Lost to Follow-up|0|||
146546533|NCT03369223|528507690|FG002|Overall Study|Lost to Follow-up|0|||
146546534|NCT03369223|528507691|FG003|Overall Study|Lost to Follow-up|0|||
146546535|NCT03369223|528507692|FG004|Overall Study|Lost to Follow-up|0|||
146546536|NCT03369223|528507693|FG005|Overall Study|Lost to Follow-up|0|||
146546537|NCT03369223|528507694|FG006|Overall Study|Lost to Follow-up|0|||
146546538|NCT03369223|528507695|FG007|Overall Study|Lost to Follow-up|0|||
146546539|NCT03369223|528507696|FG008|Overall Study|Lost to Follow-up|0|||
146546540|NCT03369223|528507697|FG009|Overall Study|Lost to Follow-up|0|||
146546541|NCT03369223|528507698|FG010|Overall Study|Lost to Follow-up|0|||
146546542|NCT03369223|528507699|FG011|Overall Study|Lost to Follow-up|0|||
146546543|NCT03369223|528507700|FG012|Overall Study|Lost to Follow-up|0|||
146546544|NCT03369223|528507701|FG013|Overall Study|Lost to Follow-up|0|||
146546545|NCT03369223|528507702|FG014|Overall Study|Lost to Follow-up|0|||
146546546|NCT03369223|528507703|FG015|Overall Study|Lost to Follow-up|0|||
146546547|NCT03369223|528507704|FG016|Overall Study|Lost to Follow-up|0|||
146546548|NCT03369223|528507705|FG017|Overall Study|Lost to Follow-up|0|||
146546549|NCT03369223|528507706|FG018|Overall Study|Lost to Follow-up|2|||
146546550|NCT03369223|528507707|FG019|Overall Study|Lost to Follow-up|1|||
146546551|NCT03369223|528507688|FG000|Overall Study|Participant no longer meets study criteria|0|||
146546552|NCT03369223|528507689|FG001|Overall Study|Participant no longer meets study criteria|0|||
146546553|NCT03369223|528507690|FG002|Overall Study|Participant no longer meets study criteria|0|||
146630008|NCT02018562|528821481|FG001|Overall Study|Discharged prior to study completion|0|||
146630009|NCT04050553|528821491|FG000|Period 1|Physician Decision|2|||
146546554|NCT03369223|528507691|FG003|Overall Study|Participant no longer meets study criteria|0|||
146546555|NCT03369223|528507692|FG004|Overall Study|Participant no longer meets study criteria|0|||
146546556|NCT03369223|528507693|FG005|Overall Study|Participant no longer meets study criteria|0|||
146546557|NCT03369223|528507694|FG006|Overall Study|Participant no longer meets study criteria|0|||
146546558|NCT03369223|528507695|FG007|Overall Study|Participant no longer meets study criteria|0|||
146546559|NCT03369223|528507696|FG008|Overall Study|Participant no longer meets study criteria|0|||
146546560|NCT03369223|528507697|FG009|Overall Study|Participant no longer meets study criteria|0|||
146546561|NCT03369223|528507698|FG010|Overall Study|Participant no longer meets study criteria|0|||
146546562|NCT03369223|528507699|FG011|Overall Study|Participant no longer meets study criteria|0|||
146546563|NCT03369223|528507700|FG012|Overall Study|Participant no longer meets study criteria|0|||
146630010|NCT04050553|528821492|FG001|Period 1|Physician Decision|2|||
146630011|NCT04050553|528821491|FG000|Period 1|Adverse Event|1|||
146546564|NCT03369223|528507701|FG013|Overall Study|Participant no longer meets study criteria|0|||
146881341|NCT04099251|529735290|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
146881342|NCT04099251|529735289|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
146881343|NCT04099251|529735290|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
146546565|NCT03369223|528507702|FG014|Overall Study|Participant no longer meets study criteria|2|||
146546566|NCT03369223|528507703|FG015|Overall Study|Participant no longer meets study criteria|0|||
146546567|NCT03369223|528507704|FG016|Overall Study|Participant no longer meets study criteria|2|||
146546568|NCT03369223|528507705|FG017|Overall Study|Participant no longer meets study criteria|0|||
146546569|NCT03369223|528507706|FG018|Overall Study|Participant no longer meets study criteria|0|||
146546570|NCT03369223|528507707|FG019|Overall Study|Participant no longer meets study criteria|0|||
146546571|NCT03369223|528507688|FG000|Overall Study|Other reasons|0|||
146546572|NCT03369223|528507689|FG001|Overall Study|Other reasons|0|||
146546573|NCT03369223|528507690|FG002|Overall Study|Other reasons|0|||
146546574|NCT03369223|528507691|FG003|Overall Study|Other reasons|0|||
146546575|NCT03369223|528507692|FG004|Overall Study|Other reasons|0|||
146546576|NCT03369223|528507693|FG005|Overall Study|Other reasons|0|||
146546577|NCT03369223|528507694|FG006|Overall Study|Other reasons|0|||
146546578|NCT03369223|528507695|FG007|Overall Study|Other reasons|0|||
146546579|NCT03369223|528507696|FG008|Overall Study|Other reasons|0|||
146546580|NCT03369223|528507697|FG009|Overall Study|Other reasons|0|||
146546581|NCT03369223|528507698|FG010|Overall Study|Other reasons|0|||
146546582|NCT03369223|528507699|FG011|Overall Study|Other reasons|0|||
146546583|NCT03369223|528507700|FG012|Overall Study|Other reasons|0|||
146546584|NCT03369223|528507701|FG013|Overall Study|Other reasons|1|||
146546585|NCT03369223|528507702|FG014|Overall Study|Other reasons|2|||
146546586|NCT03369223|528507703|FG015|Overall Study|Other reasons|0|||
146546587|NCT03369223|528507704|FG016|Overall Study|Other reasons|1|||
146546588|NCT03369223|528507705|FG017|Overall Study|Other reasons|0|||
146546589|NCT03369223|528507706|FG018|Overall Study|Other reasons|0|||
146546590|NCT03369223|528507707|FG019|Overall Study|Other reasons|2|||
146546591|NCT03369223|528507688|FG000|Overall Study|Death|0|||
146546592|NCT03369223|528507689|FG001|Overall Study|Death|0|||
146546593|NCT03369223|528507690|FG002|Overall Study|Death|0|||
146546594|NCT03369223|528507691|FG003|Overall Study|Death|0|||
146546595|NCT03369223|528507692|FG004|Overall Study|Death|0|||
146546596|NCT03369223|528507693|FG005|Overall Study|Death|0|||
146546597|NCT03369223|528507694|FG006|Overall Study|Death|0|||
146546598|NCT03369223|528507695|FG007|Overall Study|Death|0|||
146546599|NCT03369223|528507696|FG008|Overall Study|Death|0|||
146546600|NCT03369223|528507697|FG009|Overall Study|Death|0|||
146546601|NCT03369223|528507698|FG010|Overall Study|Death|0|||
146546602|NCT03369223|528507699|FG011|Overall Study|Death|0|||
146546603|NCT03369223|528507700|FG012|Overall Study|Death|0|||
146546604|NCT03369223|528507701|FG013|Overall Study|Death|1|||
146546605|NCT03369223|528507702|FG014|Overall Study|Death|0|||
146546606|NCT03369223|528507703|FG015|Overall Study|Death|0|||
146546607|NCT03369223|528507704|FG016|Overall Study|Death|0|||
146546608|NCT03369223|528507705|FG017|Overall Study|Death|0|||
146546609|NCT03369223|528507706|FG018|Overall Study|Death|1|||
146546610|NCT03369223|528507707|FG019|Overall Study|Death|0|||
146546611|NCT03369223|528507688|FG000|Overall Study|Adverse event unrelated to study drug|0|||
146546612|NCT03369223|528507689|FG001|Overall Study|Adverse event unrelated to study drug|0|||
146546613|NCT03369223|528507690|FG002|Overall Study|Adverse event unrelated to study drug|0|||
146546614|NCT03369223|528507691|FG003|Overall Study|Adverse event unrelated to study drug|0|||
146546615|NCT03369223|528507692|FG004|Overall Study|Adverse event unrelated to study drug|0|||
146546616|NCT03369223|528507693|FG005|Overall Study|Adverse event unrelated to study drug|0|||
146546617|NCT03369223|528507694|FG006|Overall Study|Adverse event unrelated to study drug|1|||
146546618|NCT03369223|528507695|FG007|Overall Study|Adverse event unrelated to study drug|0|||
146546619|NCT03369223|528507696|FG008|Overall Study|Adverse event unrelated to study drug|0|||
146546620|NCT03369223|528507697|FG009|Overall Study|Adverse event unrelated to study drug|1|||
146546621|NCT03369223|528507698|FG010|Overall Study|Adverse event unrelated to study drug|0|||
146546622|NCT03369223|528507699|FG011|Overall Study|Adverse event unrelated to study drug|0|||
146546623|NCT03369223|528507700|FG012|Overall Study|Adverse event unrelated to study drug|0|||
146881344|NCT04099251|529735289|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
146881345|NCT04099251|529735290|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
146546624|NCT03369223|528507701|FG013|Overall Study|Adverse event unrelated to study drug|4|||
146546625|NCT03369223|528507702|FG014|Overall Study|Adverse event unrelated to study drug|2|||
146546626|NCT03369223|528507703|FG015|Overall Study|Adverse event unrelated to study drug|0|||
146546627|NCT03369223|528507704|FG016|Overall Study|Adverse event unrelated to study drug|2|||
146546628|NCT03369223|528507705|FG017|Overall Study|Adverse event unrelated to study drug|1|||
146546629|NCT03369223|528507706|FG018|Overall Study|Adverse event unrelated to study drug|3|||
146546630|NCT03369223|528507707|FG019|Overall Study|Adverse event unrelated to study drug|2|||
146546631|NCT03369223|528507688|FG000|Overall Study|Disease progression|6|||
146546632|NCT03369223|528507689|FG001|Overall Study|Disease progression|8|||
146546633|NCT03369223|528507690|FG002|Overall Study|Disease progression|5|||
146546634|NCT03369223|528507691|FG003|Overall Study|Disease progression|1|||
146546635|NCT03369223|528507692|FG004|Overall Study|Disease progression|9|||
146546636|NCT03369223|528507693|FG005|Overall Study|Disease progression|9|||
146546637|NCT03369223|528507694|FG006|Overall Study|Disease progression|4|||
146546638|NCT03369223|528507695|FG007|Overall Study|Disease progression|6|||
146546639|NCT03369223|528507696|FG008|Overall Study|Disease progression|10|||
146546640|NCT03369223|528507697|FG009|Overall Study|Disease progression|7|||
146546641|NCT03369223|528507698|FG010|Overall Study|Disease progression|4|||
146546642|NCT03369223|528507699|FG011|Overall Study|Disease progression|1|||
146546643|NCT03369223|528507700|FG012|Overall Study|Disease progression|1|||
146546644|NCT03369223|528507701|FG013|Overall Study|Disease progression|25|||
146546645|NCT03369223|528507702|FG014|Overall Study|Disease progression|22|||
146546646|NCT03369223|528507703|FG015|Overall Study|Disease progression|2|||
146546647|NCT03369223|528507704|FG016|Overall Study|Disease progression|10|||
146546648|NCT03369223|528507705|FG017|Overall Study|Disease progression|1|||
146546649|NCT03369223|528507706|FG018|Overall Study|Disease progression|18|||
146546650|NCT03369223|528507707|FG019|Overall Study|Disease progression|28|||
146546651|NCT03369223|528507688|FG000|Overall Study|Study drug toxicity|0|||
146546652|NCT03369223|528507689|FG001|Overall Study|Study drug toxicity|1|||
146546653|NCT03369223|528507690|FG002|Overall Study|Study drug toxicity|4|||
146546654|NCT03369223|528507691|FG003|Overall Study|Study drug toxicity|0|||
146546655|NCT03369223|528507692|FG004|Overall Study|Study drug toxicity|1|||
146546656|NCT03369223|528507693|FG005|Overall Study|Study drug toxicity|2|||
146546657|NCT03369223|528507694|FG006|Overall Study|Study drug toxicity|4|||
146546658|NCT03369223|528507695|FG007|Overall Study|Study drug toxicity|2|||
146546659|NCT03369223|528507696|FG008|Overall Study|Study drug toxicity|2|||
146546660|NCT03369223|528507697|FG009|Overall Study|Study drug toxicity|0|||
146546661|NCT03369223|528507698|FG010|Overall Study|Study drug toxicity|6|||
146546662|NCT03369223|528507699|FG011|Overall Study|Study drug toxicity|1|||
146546663|NCT03369223|528507700|FG012|Overall Study|Study drug toxicity|2|||
146546664|NCT03369223|528507701|FG013|Overall Study|Study drug toxicity|19|||
146546665|NCT03369223|528507702|FG014|Overall Study|Study drug toxicity|19|||
146546666|NCT03369223|528507703|FG015|Overall Study|Study drug toxicity|0|||
146546667|NCT03369223|528507704|FG016|Overall Study|Study drug toxicity|18|||
146546668|NCT03369223|528507705|FG017|Overall Study|Study drug toxicity|3|||
146546669|NCT03369223|528507706|FG018|Overall Study|Study drug toxicity|11|||
146546670|NCT03369223|528507707|FG019|Overall Study|Study drug toxicity|7|||
146546671|NCT03369223|528507688|FG000|Overall Study|Participant request to discontinue study treatment|0|||
146546672|NCT03369223|528507689|FG001|Overall Study|Participant request to discontinue study treatment|1|||
146546673|NCT03369223|528507690|FG002|Overall Study|Participant request to discontinue study treatment|0|||
146546674|NCT03369223|528507691|FG003|Overall Study|Participant request to discontinue study treatment|0|||
146881346|NCT04099251|529735289|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
146881347|NCT04099251|529735290|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
146881348|NCT04099251|529735289|FG000|Blinded Treatment Phase|Death|6|||
146881349|NCT04099251|529735290|FG001|Blinded Treatment Phase|Death|2|||
146881350|NCT04099251|529735289|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
146881351|NCT04099251|529735290|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
146881352|NCT04099251|529735289|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
146881353|NCT04099251|529735290|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
146881354|NCT04099251|529735289|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
146881355|NCT04099251|529735290|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
146881356|NCT04099251|529735289|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
146881357|NCT04099251|529735290|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
146881358|NCT04099251|529735289|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
146881359|NCT04099251|529735290|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
146881360|NCT04099251|529735289|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
146881361|NCT04099251|529735290|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
146881362|NCT04099251|529735289|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
146881363|NCT04099251|529735290|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
146881364|NCT04099251|529735289|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
146881365|NCT04099251|529735290|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
146881366|NCT04099251|529735289|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
146881367|NCT04099251|529735290|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
146881368|NCT05032157|529735291|FG000|Overall Study|Adverse Event|12|||
146881369|NCT05032157|529735292|FG001|Overall Study|Adverse Event|7|||
146881370|NCT05032157|529735291|FG000|Overall Study|Pregnancy|0|||
146881371|NCT05032157|529735292|FG001|Overall Study|Pregnancy|2|||
146546675|NCT03369223|528507692|FG004|Overall Study|Participant request to discontinue study treatment|1|||
146881372|NCT05032157|529735291|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146546676|NCT03369223|528507693|FG005|Overall Study|Participant request to discontinue study treatment|1|||
146546677|NCT03369223|528507694|FG006|Overall Study|Participant request to discontinue study treatment|1|||
146546678|NCT03369223|528507695|FG007|Overall Study|Participant request to discontinue study treatment|0|||
146630012|NCT04050553|528821492|FG001|Period 1|Adverse Event|1|||
146881373|NCT05032157|529735292|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
146881374|NCT05032157|529735291|FG000|Overall Study|Protocol Deviation|8|||
146546679|NCT03369223|528507696|FG008|Overall Study|Participant request to discontinue study treatment|0|||
146546680|NCT03369223|528507697|FG009|Overall Study|Participant request to discontinue study treatment|0|||
146546681|NCT03369223|528507698|FG010|Overall Study|Participant request to discontinue study treatment|0|||
146546682|NCT03369223|528507699|FG011|Overall Study|Participant request to discontinue study treatment|0|||
146546683|NCT03369223|528507700|FG012|Overall Study|Participant request to discontinue study treatment|0|||
146546684|NCT03369223|528507701|FG013|Overall Study|Participant request to discontinue study treatment|1|||
146546685|NCT03369223|528507702|FG014|Overall Study|Participant request to discontinue study treatment|1|||
146546686|NCT03369223|528507703|FG015|Overall Study|Participant request to discontinue study treatment|0|||
146546687|NCT03369223|528507704|FG016|Overall Study|Participant request to discontinue study treatment|0|||
146546688|NCT03369223|528507705|FG017|Overall Study|Participant request to discontinue study treatment|0|||
146546689|NCT03369223|528507706|FG018|Overall Study|Participant request to discontinue study treatment|1|||
146546690|NCT03369223|528507707|FG019|Overall Study|Participant request to discontinue study treatment|0|||
146546691|NCT03369223|528507688|FG000|Overall Study|Participant withdrew consent|0|||
146546692|NCT03369223|528507689|FG001|Overall Study|Participant withdrew consent|1|||
146546693|NCT03369223|528507690|FG002|Overall Study|Participant withdrew consent|1|||
146546694|NCT03369223|528507691|FG003|Overall Study|Participant withdrew consent|0|||
146546695|NCT03369223|528507692|FG004|Overall Study|Participant withdrew consent|0|||
146546696|NCT03369223|528507693|FG005|Overall Study|Participant withdrew consent|0|||
146546697|NCT03369223|528507694|FG006|Overall Study|Participant withdrew consent|1|||
146546698|NCT03369223|528507695|FG007|Overall Study|Participant withdrew consent|1|||
146546699|NCT03369223|528507696|FG008|Overall Study|Participant withdrew consent|1|||
146546700|NCT03369223|528507697|FG009|Overall Study|Participant withdrew consent|0|||
146546701|NCT03369223|528507698|FG010|Overall Study|Participant withdrew consent|0|||
146546702|NCT03369223|528507699|FG011|Overall Study|Participant withdrew consent|1|||
146546703|NCT03369223|528507700|FG012|Overall Study|Participant withdrew consent|0|||
146546704|NCT03369223|528507701|FG013|Overall Study|Participant withdrew consent|0|||
146546705|NCT03369223|528507702|FG014|Overall Study|Participant withdrew consent|3|||
146546706|NCT03369223|528507703|FG015|Overall Study|Participant withdrew consent|0|||
146546707|NCT03369223|528507704|FG016|Overall Study|Participant withdrew consent|1|||
146546708|NCT03369223|528507705|FG017|Overall Study|Participant withdrew consent|0|||
146546709|NCT03369223|528507706|FG018|Overall Study|Participant withdrew consent|4|||
146546710|NCT03369223|528507707|FG019|Overall Study|Participant withdrew consent|2|||
146546711|NCT03369223|528507688|FG000|Overall Study|Randomized but not treated|0|||
146546712|NCT03369223|528507689|FG001|Overall Study|Randomized but not treated|0|||
146546713|NCT03369223|528507690|FG002|Overall Study|Randomized but not treated|0|||
146546714|NCT03369223|528507691|FG003|Overall Study|Randomized but not treated|0|||
146546715|NCT03369223|528507692|FG004|Overall Study|Randomized but not treated|0|||
146546716|NCT03369223|528507693|FG005|Overall Study|Randomized but not treated|0|||
146546717|NCT03369223|528507694|FG006|Overall Study|Randomized but not treated|0|||
146546718|NCT03369223|528507695|FG007|Overall Study|Randomized but not treated|0|||
146546719|NCT03369223|528507696|FG008|Overall Study|Randomized but not treated|0|||
146546720|NCT03369223|528507697|FG009|Overall Study|Randomized but not treated|0|||
146546721|NCT03369223|528507698|FG010|Overall Study|Randomized but not treated|0|||
146546722|NCT03369223|528507699|FG011|Overall Study|Randomized but not treated|0|||
146630013|NCT04050553|528821491|FG000|Period 1|Withdrawal by Subject|0|||
146630014|NCT04050553|528821492|FG001|Period 1|Withdrawal by Subject|1|||
146881375|NCT05032157|529735292|FG001|Overall Study|Protocol Deviation|4|||
146881376|NCT05032157|529735291|FG000|Overall Study|Lost to Follow-up|1|||
146881377|NCT05032157|529735292|FG001|Overall Study|Lost to Follow-up|3|||
146881378|NCT05032157|529735291|FG000|Overall Study|Physician Decision|7|||
146881379|NCT05032157|529735292|FG001|Overall Study|Physician Decision|2|||
146881380|NCT05032157|529735291|FG000|Overall Study|Patient Decision|38|||
146881381|NCT05032157|529735292|FG001|Overall Study|Patient Decision|19|||
146881382|NCT02068547|529735293|FG000|Overall Study|Lost to Follow-up|3|||
146881383|NCT02068547|529735294|FG001|Overall Study|Lost to Follow-up|3|||
146881384|NCT02068547|529735293|FG000|Overall Study|Physician Decision|1|||
146881385|NCT02068547|529735294|FG001|Overall Study|Physician Decision|0|||
146881386|NCT03657043|529735295|FG000|Overall Study|Withdrawal by Subject|1|||
146881387|NCT03657043|529735296|FG001|Overall Study|Withdrawal by Subject|1|||
146881388|NCT03657043|529735297|FG002|Overall Study|Withdrawal by Subject|0|||
146881389|NCT03657043|529735298|FG003|Overall Study|Withdrawal by Subject|0|||
146881390|NCT03657043|529735299|FG004|Overall Study|Withdrawal by Subject|4|||
146881391|NCT03657043|529735295|FG000|Overall Study|Study closure by Sponsor|0|||
146881392|NCT03657043|529735296|FG001|Overall Study|Study closure by Sponsor|2|||
146881393|NCT03657043|529735297|FG002|Overall Study|Study closure by Sponsor|0|||
146881394|NCT03657043|529735298|FG003|Overall Study|Study closure by Sponsor|0|||
146881395|NCT03657043|529735299|FG004|Overall Study|Study closure by Sponsor|17|||
146881396|NCT03657043|529735295|FG000|Overall Study|Lost to Follow-up|0|||
146881397|NCT03657043|529735296|FG001|Overall Study|Lost to Follow-up|0|||
146881398|NCT03657043|529735297|FG002|Overall Study|Lost to Follow-up|0|||
146881399|NCT03657043|529735298|FG003|Overall Study|Lost to Follow-up|0|||
146881400|NCT03657043|529735299|FG004|Overall Study|Lost to Follow-up|4|||
146881401|NCT03657043|529735295|FG000|Overall Study|Death|6|||
146881402|NCT03657043|529735296|FG001|Overall Study|Death|5|||
146881403|NCT03657043|529735297|FG002|Overall Study|Death|0|||
146881404|NCT03657043|529735298|FG003|Overall Study|Death|0|||
146881405|NCT03657043|529735299|FG004|Overall Study|Death|53|||
146881406|NCT03657043|529735295|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
146881407|NCT03657043|529735296|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
146546723|NCT03369223|528507700|FG012|Overall Study|Randomized but not treated|0|||
146546724|NCT03369223|528507701|FG013|Overall Study|Randomized but not treated|1|||
146546725|NCT03369223|528507702|FG014|Overall Study|Randomized but not treated|1|||
146546726|NCT03369223|528507703|FG015|Overall Study|Randomized but not treated|0|||
146546727|NCT03369223|528507704|FG016|Overall Study|Randomized but not treated|0|||
146546728|NCT03369223|528507705|FG017|Overall Study|Randomized but not treated|0|||
146546729|NCT03369223|528507706|FG018|Overall Study|Randomized but not treated|0|||
146546730|NCT03369223|528507707|FG019|Overall Study|Randomized but not treated|0|||
146546731|NCT03659916|528507708|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
146546732|NCT03659916|528507709|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
146546733|NCT03659916|528507710|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
146546734|NCT03659916|528507708|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
146546735|NCT03659916|528507709|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
146546736|NCT03659916|528507710|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
146546737|NCT03659916|528507708|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
146546738|NCT03659916|528507709|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
146546739|NCT03659916|528507710|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
146546740|NCT03659916|528507708|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
146546741|NCT03659916|528507709|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
146546742|NCT03659916|528507710|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
146546743|NCT03659916|528507708|FG000|Treatment Period (72 Weeks)|Other|1|||
146546744|NCT03659916|528507709|FG001|Treatment Period (72 Weeks)|Other|3|||
146546745|NCT03659916|528507710|FG002|Treatment Period (72 Weeks)|Other|9|||
146546746|NCT03659916|528507708|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
146546747|NCT03659916|528507709|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
146546748|NCT03659916|528507710|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
146546749|NCT03659916|528507708|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
146546750|NCT03659916|528507709|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
146546751|NCT03659916|528507710|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
146546752|NCT03659916|528507708|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
146546753|NCT03659916|528507709|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
146546754|NCT03659916|528507710|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
146546755|NCT03659916|528507708|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
146546756|NCT03659916|528507709|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
146546757|NCT03659916|528507710|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
146546758|NCT03659916|528507708|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
146546759|NCT03659916|528507709|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
146546760|NCT03659916|528507710|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
146546761|NCT03659916|528507708|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
146546762|NCT03659916|528507709|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
146546763|NCT03659916|528507710|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
146546764|NCT02369458|528507714|FG000|Overall Study|Determined to be not eligible|1|||
146546765|NCT02369458|528507715|FG001|Overall Study|Determined to be not eligible|0|||
146546766|NCT03853798|528507716|FG000|Overall Study|Death|0|||
146546767|NCT03853798|528507717|FG001|Overall Study|Death|0|||
146546768|NCT03853798|528507718|FG002|Overall Study|Death|0|||
146546769|NCT03853798|528507719|FG003|Overall Study|Death|0|||
146546770|NCT03853798|528507720|FG004|Overall Study|Death|0|||
146546771|NCT03853798|528507721|FG005|Overall Study|Death|1|||
146546772|NCT03853798|528507722|FG006|Overall Study|Death|0|||
146546773|NCT03853798|528507723|FG007|Overall Study|Death|0|||
146546774|NCT03853798|528507724|FG008|Overall Study|Death|0|||
146881408|NCT03657043|529735297|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
146881409|NCT03657043|529735298|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
146881410|NCT03657043|529735299|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
146881411|NCT03657043|529735295|FG000|Overall Study|Adverse Event|0|||
146881412|NCT03657043|529735296|FG001|Overall Study|Adverse Event|0|||
146881413|NCT03657043|529735297|FG002|Overall Study|Adverse Event|0|||
146881414|NCT03657043|529735298|FG003|Overall Study|Adverse Event|0|||
146881415|NCT03657043|529735299|FG004|Overall Study|Adverse Event|2|||
146881416|NCT03657043|529735295|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
146881417|NCT03657043|529735296|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
146546775|NCT03853798|528507716|FG000|Overall Study|Adverse Event|0|||
146546776|NCT03853798|528507717|FG001|Overall Study|Adverse Event|0|||
146546777|NCT03853798|528507718|FG002|Overall Study|Adverse Event|2|||
146546778|NCT03853798|528507719|FG003|Overall Study|Adverse Event|0|||
146546779|NCT03853798|528507720|FG004|Overall Study|Adverse Event|0|||
146546780|NCT03853798|528507721|FG005|Overall Study|Adverse Event|0|||
146546781|NCT03853798|528507722|FG006|Overall Study|Adverse Event|0|||
146546782|NCT03853798|528507723|FG007|Overall Study|Adverse Event|0|||
146546783|NCT03853798|528507724|FG008|Overall Study|Adverse Event|0|||
146546784|NCT03853798|528507716|FG000|Overall Study|Withdrawal by Subject|0|||
146546785|NCT03853798|528507717|FG001|Overall Study|Withdrawal by Subject|1|||
146546786|NCT03853798|528507718|FG002|Overall Study|Withdrawal by Subject|4|||
146546787|NCT03853798|528507719|FG003|Overall Study|Withdrawal by Subject|0|||
146546788|NCT03853798|528507720|FG004|Overall Study|Withdrawal by Subject|0|||
146546789|NCT03853798|528507721|FG005|Overall Study|Withdrawal by Subject|5|||
146546790|NCT03853798|528507722|FG006|Overall Study|Withdrawal by Subject|0|||
146546791|NCT03853798|528507723|FG007|Overall Study|Withdrawal by Subject|0|||
146546792|NCT03853798|528507724|FG008|Overall Study|Withdrawal by Subject|4|||
146546793|NCT03853798|528507716|FG000|Overall Study|Physician Decision|1|||
146546794|NCT03853798|528507717|FG001|Overall Study|Physician Decision|0|||
146546795|NCT03853798|528507718|FG002|Overall Study|Physician Decision|0|||
146546796|NCT03853798|528507719|FG003|Overall Study|Physician Decision|0|||
146546797|NCT03853798|528507720|FG004|Overall Study|Physician Decision|0|||
146546798|NCT03853798|528507721|FG005|Overall Study|Physician Decision|0|||
146546799|NCT03853798|528507722|FG006|Overall Study|Physician Decision|0|||
146546800|NCT03853798|528507723|FG007|Overall Study|Physician Decision|0|||
146546801|NCT03853798|528507724|FG008|Overall Study|Physician Decision|1|||
146546802|NCT03853798|528507716|FG000|Overall Study|Lack of Efficacy|0|||
146546803|NCT03853798|528507717|FG001|Overall Study|Lack of Efficacy|0|||
146546804|NCT03853798|528507718|FG002|Overall Study|Lack of Efficacy|2|||
146546805|NCT03853798|528507719|FG003|Overall Study|Lack of Efficacy|0|||
146546806|NCT03853798|528507720|FG004|Overall Study|Lack of Efficacy|0|||
146546807|NCT03853798|528507721|FG005|Overall Study|Lack of Efficacy|0|||
146546808|NCT03853798|528507722|FG006|Overall Study|Lack of Efficacy|0|||
146546809|NCT03853798|528507723|FG007|Overall Study|Lack of Efficacy|0|||
146546810|NCT03853798|528507724|FG008|Overall Study|Lack of Efficacy|1|||
146546811|NCT03853798|528507716|FG000|Overall Study|Approved Drug Available for Indication|0|||
146546812|NCT03853798|528507717|FG001|Overall Study|Approved Drug Available for Indication|0|||
146546813|NCT03853798|528507718|FG002|Overall Study|Approved Drug Available for Indication|1|||
146546814|NCT03853798|528507719|FG003|Overall Study|Approved Drug Available for Indication|0|||
146546815|NCT03853798|528507720|FG004|Overall Study|Approved Drug Available for Indication|0|||
146546816|NCT03853798|528507721|FG005|Overall Study|Approved Drug Available for Indication|1|||
146546817|NCT03853798|528507722|FG006|Overall Study|Approved Drug Available for Indication|0|||
146546818|NCT03853798|528507723|FG007|Overall Study|Approved Drug Available for Indication|0|||
146546819|NCT03853798|528507724|FG008|Overall Study|Approved Drug Available for Indication|0|||
146546820|NCT03853798|528507716|FG000|Overall Study|Other un-specified|0|||
146546821|NCT03853798|528507717|FG001|Overall Study|Other un-specified|0|||
146546822|NCT03853798|528507718|FG002|Overall Study|Other un-specified|2|||
146546823|NCT03853798|528507719|FG003|Overall Study|Other un-specified|0|||
146546824|NCT03853798|528507720|FG004|Overall Study|Other un-specified|0|||
146546825|NCT03853798|528507721|FG005|Overall Study|Other un-specified|1|||
146546826|NCT03853798|528507722|FG006|Overall Study|Other un-specified|0|||
146546827|NCT03853798|528507723|FG007|Overall Study|Other un-specified|0|||
146546828|NCT03853798|528507724|FG008|Overall Study|Other un-specified|0|||
146546829|NCT02743494|528507725|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
146546830|NCT02743494|528507726|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
146546831|NCT02743494|528507725|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
146546832|NCT02743494|528507726|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
146546833|NCT02743494|528507725|FG000|Treatment Period|Disease recurrence|152|||
146546834|NCT02743494|528507726|FG001|Treatment Period|Disease recurrence|115|||
146546835|NCT02743494|528507725|FG000|Treatment Period|Study drug toxicity|56|||
146546836|NCT02743494|528507726|FG001|Treatment Period|Study drug toxicity|8|||
146881418|NCT03657043|529735297|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
146546837|NCT02743494|528507725|FG000|Treatment Period|Death|1|||
146546838|NCT02743494|528507726|FG001|Treatment Period|Death|1|||
146546839|NCT02743494|528507725|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
146546840|NCT02743494|528507726|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
146881419|NCT03657043|529735298|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
146546841|NCT02743494|528507725|FG000|Treatment Period|Participant request to discontinue treatment|31|||
146546842|NCT02743494|528507726|FG001|Treatment Period|Participant request to discontinue treatment|5|||
146546843|NCT02743494|528507725|FG000|Treatment Period|Participant withdrew consent|11|||
146546844|NCT02743494|528507726|FG001|Treatment Period|Participant withdrew consent|4|||
146546845|NCT02743494|528507725|FG000|Treatment Period|Lost to Follow-up|0|||
146546846|NCT02743494|528507726|FG001|Treatment Period|Lost to Follow-up|1|||
146546847|NCT02743494|528507725|FG000|Treatment Period|Poor/Non-compliance|2|||
146546848|NCT02743494|528507726|FG001|Treatment Period|Poor/Non-compliance|0|||
146546849|NCT02743494|528507725|FG000|Treatment Period|Other reasons|4|||
146546850|NCT02743494|528507726|FG001|Treatment Period|Other reasons|1|||
146546851|NCT02068794|528509262|FG000|Overall Study|Withdrawal by Subject|0|||
146546852|NCT02068794|528509263|FG001|Overall Study|Withdrawal by Subject|1|||
146546853|NCT02068794|528509264|FG002|Overall Study|Withdrawal by Subject|2|||
146546854|NCT02068794|528509262|FG000|Overall Study|Early Progression|1|||
146546855|NCT02068794|528509263|FG001|Overall Study|Early Progression|0|||
146546856|NCT02068794|528509264|FG002|Overall Study|Early Progression|1|||
146546857|NCT02068794|528509262|FG000|Overall Study|Ineligible|0|||
146546858|NCT02068794|528509263|FG001|Overall Study|Ineligible|0|||
146546859|NCT02068794|528509264|FG002|Overall Study|Ineligible|1|||
146546860|NCT01002105|528509265|FG000|Overall Study|Lost to Follow-up|10|||
146546861|NCT01002105|528509266|FG001|Overall Study|Lost to Follow-up|16|||
146546862|NCT01002105|528509265|FG000|Overall Study|non compliance|5|||
146546863|NCT01002105|528509266|FG001|Overall Study|non compliance|3|||
146546864|NCT01002105|528509265|FG000|Overall Study|condition worsened|4|||
146546865|NCT01002105|528509266|FG001|Overall Study|condition worsened|2|||
146546866|NCT03695094|528509268|FG000|Overall Study|Adverse Event|1|||
146546867|NCT03695094|528509269|FG001|Overall Study|Adverse Event|1|||
146546868|NCT03695094|528509268|FG000|Overall Study|Withdrawal by Subject|1|||
146546869|NCT03695094|528509269|FG001|Overall Study|Withdrawal by Subject|0|||
146546870|NCT00266812|528509270|FG000|Overall Study|Disease Progression|9|||
146546871|NCT00266812|528509271|FG001|Overall Study|Disease Progression|3|||
146546872|NCT00266812|528509270|FG000|Overall Study|Death|5|||
146546873|NCT00266812|528509271|FG001|Overall Study|Death|4|||
146546874|NCT00266812|528509270|FG000|Overall Study|Adverse Event|3|||
146546875|NCT00266812|528509271|FG001|Overall Study|Adverse Event|1|||
146546876|NCT00266812|528509270|FG000|Overall Study|Protocol Violation|0|||
146546877|NCT00266812|528509271|FG001|Overall Study|Protocol Violation|1|||
146546878|NCT00266812|528509270|FG000|Overall Study|Withdrawal by Subject|0|||
146546879|NCT00266812|528509271|FG001|Overall Study|Withdrawal by Subject|2|||
146546880|NCT00266812|528509270|FG000|Overall Study|Discontinued before starting study drug|4|||
146546881|NCT00266812|528509271|FG001|Overall Study|Discontinued before starting study drug|0|||
146546882|NCT00552058|528509277|FG000|Overall Study|Adverse Event|8|||
146546883|NCT00552058|528509278|FG001|Overall Study|Adverse Event|7|||
146546884|NCT00552058|528509277|FG000|Overall Study|Lack of Efficacy|1|||
146546885|NCT00552058|528509278|FG001|Overall Study|Lack of Efficacy|5|||
146546886|NCT00552058|528509277|FG000|Overall Study|Lost to Follow-up|1|||
146546887|NCT00552058|528509278|FG001|Overall Study|Lost to Follow-up|0|||
146546888|NCT00552058|528509277|FG000|Overall Study|Withdrawal by Subject|4|||
146546889|NCT00552058|528509278|FG001|Overall Study|Withdrawal by Subject|4|||
146546890|NCT00552058|528509277|FG000|Overall Study|Other: Protocol Violation|0|||
146546891|NCT00552058|528509278|FG001|Overall Study|Other: Protocol Violation|1|||
146546892|NCT00552058|528509277|FG000|Overall Study|Other: Non Compliance|1|||
146546893|NCT00552058|528509278|FG001|Overall Study|Other: Non Compliance|2|||
146546894|NCT00552058|528509277|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
146546895|NCT00552058|528509278|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
146546896|NCT00552058|528509277|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
146546897|NCT00552058|528509278|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
146546898|NCT00552058|528509277|FG000|Overall Study|Other: Positive Stool Result|0|||
146546899|NCT00552058|528509278|FG001|Overall Study|Other: Positive Stool Result|1|||
146546900|NCT00552058|528509277|FG000|Overall Study|Other: Randomized in error|0|||
146546901|NCT00552058|528509278|FG001|Overall Study|Other: Randomized in error|1|||
146546902|NCT00552058|528509277|FG000|Overall Study|Other: Sponsors Decision|0|||
146546903|NCT00552058|528509278|FG001|Overall Study|Other: Sponsors Decision|1|||
146546904|NCT00552058|528509277|FG000|Overall Study|Other: Early Roll Over|1|||
146630015|NCT04050553|528821491|FG000|Wash-out|Adverse Event|0|||
146546905|NCT00552058|528509278|FG001|Overall Study|Other: Early Roll Over|0|||
146546906|NCT03520569|528509279|FG000|Overall Study|Withdrawal by Subject|1|||
146630016|NCT04050553|528821492|FG001|Wash-out|Adverse Event|1|||
146546907|NCT02965716|528509281|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
146546908|NCT02965716|528509282|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
146546909|NCT02965716|528509281|FG000|Overall Study|Progression/Relapse|8|||
146546910|NCT02965716|528509282|FG001|Overall Study|Progression/Relapse|16|||
146546911|NCT02965716|528509281|FG000|Overall Study|Death|1|||
146546912|NCT02965716|528509282|FG001|Overall Study|Death|0|||
146546913|NCT02965716|528509281|FG000|Overall Study|Not Protocol Specified|1|||
146630017|NCT04050553|528821491|FG000|Wash-out|Withdrawal by Subject|0|||
146630018|NCT04050553|528821492|FG001|Wash-out|Withdrawal by Subject|1|||
146630019|NCT05430854|528821493|FG000|Overall Study|Trial terminated by Sponsor|39|||
146630020|NCT05430854|528821494|FG001|Overall Study|Trial terminated by Sponsor|50|||
146630021|NCT05430854|528821495|FG002|Overall Study|Trial terminated by Sponsor|46|||
146630022|NCT05430854|528821493|FG000|Overall Study|Withdrawal by Subject|0|||
146630023|NCT05430854|528821494|FG001|Overall Study|Withdrawal by Subject|3|||
146630024|NCT05430854|528821495|FG002|Overall Study|Withdrawal by Subject|0|||
146630025|NCT04314284|528821496|FG000|Overall Study|Withdrawal by Subject|4|||
146630026|NCT04314284|528821497|FG001|Overall Study|Withdrawal by Subject|7|||
146630027|NCT04314284|528821496|FG000|Overall Study|Consented but did not complete survey|0|||
146630028|NCT04314284|528821497|FG001|Overall Study|Consented but did not complete survey|6|||
146630029|NCT01652235|528821501|FG000|Overall Study|Death|9|||
146630030|NCT01652235|528821501|FG000|Overall Study|Lost to Follow-up|5|||
146630031|NCT01652235|528821501|FG000|Overall Study|Withdrawal by Subject|2|||
146630032|NCT02023086|528821502|FG000|Overall Study|Withdrawal by Subject|2|||
146630033|NCT02023086|528821503|FG001|Overall Study|Withdrawal by Subject|0|||
146630034|NCT03589859|528821506|FG000|Overall Study|Withdrawal by Subject|0|||
146630035|NCT03589859|528821507|FG001|Overall Study|Withdrawal by Subject|6|||
146630036|NCT03472885|528821509|FG000|24-Week Treatment Period|Adverse Event|1|||
146630037|NCT02201953|528821510|FG000|Overall Study|Randomized but Never Treated|1|||
146630038|NCT02201953|528821511|FG001|Overall Study|Randomized but Never Treated|5|||
146630039|NCT02201953|528821510|FG000|Overall Study|Lack of Efficacy|9|||
146630040|NCT02201953|528821511|FG001|Overall Study|Lack of Efficacy|30|||
146630041|NCT02201953|528821510|FG000|Overall Study|Lost to Follow-up|8|||
146630042|NCT02201953|528821511|FG001|Overall Study|Lost to Follow-up|8|||
146630043|NCT02201953|528821510|FG000|Overall Study|Withdrew Consent|2|||
146630044|NCT02201953|528821511|FG001|Overall Study|Withdrew Consent|5|||
146630045|NCT02201953|528821510|FG000|Overall Study|Adverse Event|0|||
146630046|NCT02201953|528821511|FG001|Overall Study|Adverse Event|5|||
146630047|NCT02201953|528821510|FG000|Overall Study|Death|0|||
146630048|NCT02201953|528821511|FG001|Overall Study|Death|3|||
146630049|NCT01198795|528823944|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
146630050|NCT01198795|528823944|FG000|Overall Study|Withdrawal by Subject|17|||
146630051|NCT01198795|528823944|FG000|Overall Study|Lost to Follow-up|15|||
146630052|NCT01198795|528823944|FG000|Overall Study|Adverse Event|9|||
146630053|NCT01198795|528823944|FG000|Overall Study|Lack of Efficacy|5|||
146630054|NCT01198795|528823944|FG000|Overall Study|Protocol Violation|2|||
146630055|NCT01198795|528823944|FG000|Overall Study|Other Reason|4|||
146630056|NCT01472289|528823945|FG000|Overall Study|Death|2|||
146630057|NCT02435992|528823946|FG000|Overall Study|non compliance with protocol|2|||
146630058|NCT02435992|528823947|FG001|Overall Study|non compliance with protocol|0|||
146630059|NCT02435992|528823948|FG002|Overall Study|non compliance with protocol|1|||
146630060|NCT02435992|528823949|FG003|Overall Study|non compliance with protocol|0|||
146630061|NCT02435992|528823950|FG004|Overall Study|non compliance with protocol|0|||
146630062|NCT02435992|528823946|FG000|Overall Study|Adverse Event|11|||
146630063|NCT02435992|528823947|FG001|Overall Study|Adverse Event|6|||
146630064|NCT02435992|528823948|FG002|Overall Study|Adverse Event|12|||
146630065|NCT02435992|528823949|FG003|Overall Study|Adverse Event|0|||
146630066|NCT02435992|528823950|FG004|Overall Study|Adverse Event|0|||
146630067|NCT02435992|528823946|FG000|Overall Study|Lack of Efficacy|4|||
146630068|NCT02435992|528823947|FG001|Overall Study|Lack of Efficacy|10|||
146630069|NCT02435992|528823948|FG002|Overall Study|Lack of Efficacy|9|||
146630070|NCT02435992|528823949|FG003|Overall Study|Lack of Efficacy|0|||
146630071|NCT02435992|528823950|FG004|Overall Study|Lack of Efficacy|0|||
146630072|NCT02435992|528823946|FG000|Overall Study|Withdrawal by Subject|10|||
146630073|NCT02435992|528823947|FG001|Overall Study|Withdrawal by Subject|8|||
146630074|NCT02435992|528823948|FG002|Overall Study|Withdrawal by Subject|20|||
146630075|NCT02435992|528823949|FG003|Overall Study|Withdrawal by Subject|0|||
146630076|NCT02435992|528823950|FG004|Overall Study|Withdrawal by Subject|0|||
146630077|NCT02435992|528823946|FG000|Overall Study|Other Reason|1|||
146630078|NCT02435992|528823947|FG001|Overall Study|Other Reason|0|||
146630079|NCT02435992|528823948|FG002|Overall Study|Other Reason|0|||
146630080|NCT02435992|528823949|FG003|Overall Study|Other Reason|0|||
146630081|NCT02435992|528823950|FG004|Overall Study|Other Reason|0|||
146630082|NCT02435992|528823946|FG000|Overall Study|Physician Decision|0|||
146630083|NCT02435992|528823947|FG001|Overall Study|Physician Decision|0|||
146630084|NCT02435992|528823948|FG002|Overall Study|Physician Decision|1|||
146630085|NCT02435992|528823949|FG003|Overall Study|Physician Decision|0|||
146630086|NCT02435992|528823950|FG004|Overall Study|Physician Decision|0|||
146765081|NCT03612804|529307247|FG002|Overall Study|Not current smoker at time of screening|0|||
146765082|NCT03612804|529307248|FG003|Overall Study|Not current smoker at time of screening|3|||
146630087|NCT04004988|528823951|FG000|Period 1|Physician Decision|2|||
146630088|NCT04004988|528823952|FG001|Period 1|Physician Decision|0|||
146630089|NCT04004988|528823951|FG000|Period 1|Withdrawal by Subject|0|||
146630090|NCT04004988|528823952|FG001|Period 1|Withdrawal by Subject|1|||
146630091|NCT04004988|528823951|FG000|Period 1|Adverse Event|1|||
146630092|NCT04004988|528823952|FG001|Period 1|Adverse Event|2|||
146630093|NCT03873116|528823953|FG000|Part 1|Study drug discontinuation due to rash|0|||
146630094|NCT03873116|528823954|FG001|Part 1|Study drug discontinuation due to rash|0|||
146630095|NCT03873116|528823955|FG002|Part 1|Study drug discontinuation due to rash|0|||
146630096|NCT03873116|528823956|FG003|Part 1|Study drug discontinuation due to rash|0|||
146630097|NCT03873116|528823957|FG004|Part 1|Study drug discontinuation due to rash|0|||
146630098|NCT03873116|528823958|FG005|Part 1|Study drug discontinuation due to rash|1|||
146630099|NCT03873116|528823953|FG000|Part 2|Withdrawal by Subject|0|||
146630100|NCT03873116|528823954|FG001|Part 2|Withdrawal by Subject|0|||
146630101|NCT03873116|528823955|FG002|Part 2|Withdrawal by Subject|1|||
146630102|NCT03873116|528823956|FG003|Part 2|Withdrawal by Subject|0|||
146630103|NCT03873116|528823957|FG004|Part 2|Withdrawal by Subject|0|||
146630104|NCT03873116|528823958|FG005|Part 2|Withdrawal by Subject|0|||
146630105|NCT03873116|528823953|FG000|Part 2|Lab abnormality or AE|0|||
146630106|NCT03873116|528823954|FG001|Part 2|Lab abnormality or AE|0|||
146630107|NCT03873116|528823955|FG002|Part 2|Lab abnormality or AE|0|||
146630108|NCT03873116|528823956|FG003|Part 2|Lab abnormality or AE|0|||
146630109|NCT03873116|528823957|FG004|Part 2|Lab abnormality or AE|1|||
146630110|NCT03873116|528823958|FG005|Part 2|Lab abnormality or AE|0|||
146630111|NCT03873116|528823953|FG000|Part 3|Withdrawal by Subject|0|||
146630112|NCT03873116|528823954|FG001|Part 3|Withdrawal by Subject|0|||
146630113|NCT03873116|528823955|FG002|Part 3|Withdrawal by Subject|0|||
146630114|NCT03873116|528823956|FG003|Part 3|Withdrawal by Subject|0|||
146630115|NCT03873116|528823957|FG004|Part 3|Withdrawal by Subject|1|||
146630116|NCT03873116|528823958|FG005|Part 3|Withdrawal by Subject|0|||
146630117|NCT02531802|528823961|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
146630118|NCT02531802|528823962|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
146630119|NCT02531802|528823963|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
146630120|NCT02531802|528823964|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
146630121|NCT02531802|528823965|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
146630122|NCT02531802|528823966|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
146630123|NCT02531802|528823967|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
146630124|NCT02531802|528823968|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
146630125|NCT02531802|528823969|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
146630126|NCT02531802|528823970|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
146630127|NCT02531802|528823971|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
146630128|NCT02531802|528823972|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
146630129|NCT02531802|528823973|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
146630130|NCT02531802|528823974|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
146630131|NCT02531802|528823975|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
146630132|NCT02531802|528823976|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
146630133|NCT02531802|528823977|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
146630134|NCT02531802|528823978|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
146630135|NCT02531802|528823979|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
146630136|NCT02531802|528823980|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
146630137|NCT02531802|528823981|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
146630138|NCT02531802|528823961|FG000|Received Vaccination 2|Physician Decision|0|||
146630139|NCT02531802|528823962|FG001|Received Vaccination 2|Physician Decision|0|||
146630140|NCT02531802|528823963|FG002|Received Vaccination 2|Physician Decision|0|||
146630141|NCT02531802|528823964|FG003|Received Vaccination 2|Physician Decision|0|||
146630142|NCT02531802|528823965|FG004|Received Vaccination 2|Physician Decision|0|||
146630143|NCT02531802|528823966|FG005|Received Vaccination 2|Physician Decision|1|||
146630144|NCT02531802|528823967|FG006|Received Vaccination 2|Physician Decision|0|||
146630145|NCT02531802|528823968|FG007|Received Vaccination 2|Physician Decision|0|||
146630146|NCT02531802|528823969|FG008|Received Vaccination 2|Physician Decision|0|||
146630147|NCT02531802|528823970|FG009|Received Vaccination 2|Physician Decision|2|||
146630148|NCT02531802|528823971|FG010|Received Vaccination 2|Physician Decision|0|||
146630149|NCT02531802|528823972|FG011|Received Vaccination 2|Physician Decision|0|||
146630150|NCT02531802|528823973|FG012|Received Vaccination 2|Physician Decision|0|||
146630151|NCT02531802|528823974|FG013|Received Vaccination 2|Physician Decision|1|||
146630152|NCT02531802|528823975|FG014|Received Vaccination 2|Physician Decision|0|||
146630153|NCT02531802|528823976|FG015|Received Vaccination 2|Physician Decision|0|||
146630154|NCT02531802|528823977|FG016|Received Vaccination 2|Physician Decision|0|||
146630155|NCT02531802|528823978|FG017|Received Vaccination 2|Physician Decision|1|||
146630156|NCT02531802|528823979|FG018|Received Vaccination 2|Physician Decision|0|||
146630157|NCT02531802|528823980|FG019|Received Vaccination 2|Physician Decision|0|||
146630158|NCT02531802|528823981|FG020|Received Vaccination 2|Physician Decision|0|||
146630159|NCT02531802|528823961|FG000|Received Vaccination 2|Adverse Event|0|||
146630160|NCT02531802|528823962|FG001|Received Vaccination 2|Adverse Event|0|||
146630161|NCT02531802|528823963|FG002|Received Vaccination 2|Adverse Event|0|||
146630162|NCT02531802|528823964|FG003|Received Vaccination 2|Adverse Event|0|||
146630163|NCT02531802|528823965|FG004|Received Vaccination 2|Adverse Event|0|||
146630164|NCT02531802|528823966|FG005|Received Vaccination 2|Adverse Event|2|||
146630165|NCT02531802|528823967|FG006|Received Vaccination 2|Adverse Event|0|||
146630166|NCT02531802|528823968|FG007|Received Vaccination 2|Adverse Event|0|||
146630167|NCT02531802|528823969|FG008|Received Vaccination 2|Adverse Event|0|||
146630168|NCT02531802|528823970|FG009|Received Vaccination 2|Adverse Event|0|||
146630169|NCT02531802|528823971|FG010|Received Vaccination 2|Adverse Event|0|||
146630170|NCT02531802|528823972|FG011|Received Vaccination 2|Adverse Event|0|||
146630171|NCT02531802|528823973|FG012|Received Vaccination 2|Adverse Event|0|||
146630172|NCT02531802|528823974|FG013|Received Vaccination 2|Adverse Event|0|||
146630173|NCT02531802|528823975|FG014|Received Vaccination 2|Adverse Event|0|||
146630174|NCT02531802|528823976|FG015|Received Vaccination 2|Adverse Event|0|||
146630175|NCT02531802|528823977|FG016|Received Vaccination 2|Adverse Event|0|||
146630176|NCT02531802|528823978|FG017|Received Vaccination 2|Adverse Event|2|||
146630177|NCT02531802|528823979|FG018|Received Vaccination 2|Adverse Event|1|||
146630178|NCT02531802|528823980|FG019|Received Vaccination 2|Adverse Event|0|||
146630179|NCT02531802|528823981|FG020|Received Vaccination 2|Adverse Event|1|||
146630180|NCT02531802|528823961|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
146630181|NCT02531802|528823962|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
146630182|NCT02531802|528823963|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
146630183|NCT02531802|528823964|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
146630184|NCT02531802|528823965|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
146630185|NCT02531802|528823966|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
146630186|NCT02531802|528823967|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
146630187|NCT02531802|528823968|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
146630188|NCT02531802|528823969|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
146630189|NCT02531802|528823970|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
146630190|NCT02531802|528823971|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
146630191|NCT02531802|528823972|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
146630192|NCT02531802|528823973|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
146630193|NCT02531802|528823974|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
146630194|NCT02531802|528823975|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
146630195|NCT02531802|528823976|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
146630196|NCT02531802|528823977|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
146630197|NCT02531802|528823978|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
146630198|NCT02531802|528823979|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
146630199|NCT02531802|528823980|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
146630200|NCT02531802|528823981|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
146630201|NCT00538902|528823991|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
146630202|NCT00538902|528823992|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
146630203|NCT00538902|528823993|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
146630204|NCT00538902|528823991|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
146630205|NCT00538902|528823992|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
146630206|NCT00538902|528823993|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
146630207|NCT00538902|528823991|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
146630208|NCT00538902|528823992|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
146630209|NCT00538902|528823993|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
146630210|NCT00538902|528823991|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
146630211|NCT00538902|528823992|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
146630212|NCT00538902|528823993|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
146630213|NCT00538902|528823991|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
146630214|NCT00538902|528823992|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
146630215|NCT00538902|528823993|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
146630216|NCT00538902|528823991|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
146630217|NCT00538902|528823992|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
146630218|NCT00538902|528823993|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
146630219|NCT00538902|528823991|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
146630220|NCT00538902|528823992|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
146630221|NCT00538902|528823993|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
146630222|NCT00538902|528823991|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
146765083|NCT03612804|529307245|FG000|Overall Study|Non-veteran status|0|||
146630223|NCT00538902|528823992|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
146630224|NCT00538902|528823993|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
146630225|NCT03131570|528823995|FG000|Overall Study|Adverse Event|1|||
146630226|NCT03131570|528823996|FG001|Overall Study|Adverse Event|0|||
146630227|NCT04109547|528823999|FG000|Overall Study|Withdrawal by Subject|3|||
146630228|NCT04109547|528824000|FG001|Overall Study|Withdrawal by Subject|2|||
146765084|NCT03612804|529307246|FG001|Overall Study|Non-veteran status|1|||
146546914|NCT02965716|528509282|FG001|Overall Study|Not Protocol Specified|3|||
146546915|NCT05558410|528509283|FG000|Overall Study|Adverse Event|1|||
146546916|NCT05558410|528509284|FG001|Overall Study|Adverse Event|2|||
146546917|NCT05558410|528509285|FG002|Overall Study|Adverse Event|0|||
146546918|NCT05558410|528509283|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
146546919|NCT05558410|528509284|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
146546920|NCT05558410|528509285|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
146546921|NCT05558410|528509283|FG000|Overall Study|Lost to Follow-up|10|||
146546922|NCT05558410|528509284|FG001|Overall Study|Lost to Follow-up|17|||
146546923|NCT05558410|528509285|FG002|Overall Study|Lost to Follow-up|19|||
146546924|NCT05558410|528509283|FG000|Overall Study|Death|1|||
146546925|NCT05558410|528509284|FG001|Overall Study|Death|0|||
146546926|NCT05558410|528509285|FG002|Overall Study|Death|0|||
146546927|NCT05558410|528509283|FG000|Overall Study|Other non-compliance|0|||
146546928|NCT05558410|528509284|FG001|Overall Study|Other non-compliance|1|||
146546929|NCT05558410|528509285|FG002|Overall Study|Other non-compliance|2|||
146546930|NCT05558410|528509283|FG000|Overall Study|Sponsor Decision|1|||
146546931|NCT05558410|528509284|FG001|Overall Study|Sponsor Decision|0|||
146546932|NCT05558410|528509285|FG002|Overall Study|Sponsor Decision|0|||
146546933|NCT05558410|528509283|FG000|Overall Study|Other|1|||
146546934|NCT05558410|528509284|FG001|Overall Study|Other|0|||
146546935|NCT05558410|528509285|FG002|Overall Study|Other|1|||
146546936|NCT02265744|528509288|FG000|Overall Study|Poor/Non-compliance|1|||
146546937|NCT02265744|528509289|FG001|Overall Study|Poor/Non-compliance|1|||
146546938|NCT02265744|528509290|FG002|Overall Study|Poor/Non-compliance|0|||
146546939|NCT02265744|528509291|FG003|Overall Study|Poor/Non-compliance|0|||
146546940|NCT02265744|528509292|FG004|Overall Study|Poor/Non-compliance|2|||
146546941|NCT02265744|528509288|FG000|Overall Study|Lost to Follow-up|0|||
146546942|NCT02265744|528509289|FG001|Overall Study|Lost to Follow-up|0|||
146546943|NCT02265744|528509290|FG002|Overall Study|Lost to Follow-up|0|||
146546944|NCT02265744|528509291|FG003|Overall Study|Lost to Follow-up|1|||
146546945|NCT02265744|528509292|FG004|Overall Study|Lost to Follow-up|0|||
146546946|NCT02265744|528509288|FG000|Overall Study|Death|0|||
146546947|NCT02265744|528509289|FG001|Overall Study|Death|0|||
146546948|NCT02265744|528509290|FG002|Overall Study|Death|0|||
146546949|NCT02265744|528509291|FG003|Overall Study|Death|2|||
146546950|NCT02265744|528509292|FG004|Overall Study|Death|0|||
146546951|NCT02265744|528509288|FG000|Overall Study|Withdrawal by Subject|2|||
146546952|NCT02265744|528509289|FG001|Overall Study|Withdrawal by Subject|0|||
146546953|NCT02265744|528509290|FG002|Overall Study|Withdrawal by Subject|0|||
146546954|NCT02265744|528509291|FG003|Overall Study|Withdrawal by Subject|2|||
146546955|NCT02265744|528509292|FG004|Overall Study|Withdrawal by Subject|0|||
146546956|NCT02265744|528509288|FG000|Overall Study|Participant request to discontinue|2|||
146546957|NCT02265744|528509289|FG001|Overall Study|Participant request to discontinue|2|||
146546958|NCT02265744|528509290|FG002|Overall Study|Participant request to discontinue|2|||
146546959|NCT02265744|528509291|FG003|Overall Study|Participant request to discontinue|0|||
146546960|NCT02265744|528509292|FG004|Overall Study|Participant request to discontinue|0|||
146546961|NCT02265744|528509288|FG000|Overall Study|Adverse Event|8|||
146546962|NCT02265744|528509289|FG001|Overall Study|Adverse Event|4|||
146546963|NCT02265744|528509290|FG002|Overall Study|Adverse Event|9|||
146546964|NCT02265744|528509291|FG003|Overall Study|Adverse Event|8|||
146546965|NCT02265744|528509292|FG004|Overall Study|Adverse Event|2|||
146546966|NCT02265744|528509288|FG000|Overall Study|Lack of Efficacy|2|||
146546967|NCT02265744|528509289|FG001|Overall Study|Lack of Efficacy|4|||
146546968|NCT02265744|528509290|FG002|Overall Study|Lack of Efficacy|3|||
146546969|NCT02265744|528509291|FG003|Overall Study|Lack of Efficacy|4|||
146546970|NCT02265744|528509292|FG004|Overall Study|Lack of Efficacy|5|||
146546971|NCT02265744|528509288|FG000|Overall Study|Reason not provided by Investigator|1|||
146546972|NCT02265744|528509289|FG001|Overall Study|Reason not provided by Investigator|0|||
146546973|NCT02265744|528509290|FG002|Overall Study|Reason not provided by Investigator|0|||
146546974|NCT02265744|528509291|FG003|Overall Study|Reason not provided by Investigator|2|||
146546975|NCT02265744|528509292|FG004|Overall Study|Reason not provided by Investigator|0|||
146546976|NCT02265744|528509288|FG000|Overall Study|Administrative reason by sponsor|3|||
146546977|NCT02265744|528509289|FG001|Overall Study|Administrative reason by sponsor|2|||
146546978|NCT02265744|528509290|FG002|Overall Study|Administrative reason by sponsor|2|||
146546979|NCT02265744|528509291|FG003|Overall Study|Administrative reason by sponsor|3|||
146546980|NCT02265744|528509292|FG004|Overall Study|Administrative reason by sponsor|3|||
146546981|NCT02265744|528509288|FG000|Overall Study|Subject no longer meets study criteria|0|||
146546982|NCT02265744|528509289|FG001|Overall Study|Subject no longer meets study criteria|0|||
146546983|NCT02265744|528509290|FG002|Overall Study|Subject no longer meets study criteria|0|||
146546984|NCT02265744|528509291|FG003|Overall Study|Subject no longer meets study criteria|0|||
146546985|NCT02265744|528509292|FG004|Overall Study|Subject no longer meets study criteria|1|||
146546986|NCT02265744|528509288|FG000|Overall Study|Pregnancy|1|||
146546987|NCT02265744|528509289|FG001|Overall Study|Pregnancy|2|||
146546988|NCT02265744|528509290|FG002|Overall Study|Pregnancy|1|||
146546989|NCT02265744|528509291|FG003|Overall Study|Pregnancy|1|||
146546990|NCT02265744|528509292|FG004|Overall Study|Pregnancy|0|||
146630229|NCT04109547|528824001|FG002|Overall Study|Withdrawal by Subject|6|||
146630230|NCT04109547|528824002|FG003|Overall Study|Withdrawal by Subject|6|||
146630231|NCT04109547|528823999|FG000|Overall Study|Lost to Follow-up|0|||
146630232|NCT04109547|528824000|FG001|Overall Study|Lost to Follow-up|0|||
146630233|NCT04109547|528824001|FG002|Overall Study|Lost to Follow-up|0|||
146630234|NCT04109547|528824002|FG003|Overall Study|Lost to Follow-up|1|||
146630235|NCT04109547|528823999|FG000|Overall Study|Physician Decision|1|||
146630236|NCT04109547|528824000|FG001|Overall Study|Physician Decision|2|||
146630237|NCT04109547|528824001|FG002|Overall Study|Physician Decision|0|||
146630238|NCT04109547|528824002|FG003|Overall Study|Physician Decision|0|||
146630239|NCT00871975|528824003|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
146630240|NCT00871975|528824003|FG000|Overall Study|Catheters could not be inserted|1|||
146630241|NCT00871975|528824003|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
146630242|NCT00871975|528824003|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
146630243|NCT01210313|528824004|FG000|Overall Study|Withdrawal by Subject|3|||
146630244|NCT01210313|528824004|FG000|Overall Study|Adverse Event|2|||
146630245|NCT01210313|528824004|FG000|Overall Study|Distant recurrence|4|||
146630246|NCT01210313|528824004|FG000|Overall Study|Non-compliance|7|||
146630247|NCT03773978|528824009|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
146630248|NCT03773978|528824010|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
146630249|NCT03773978|528824009|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
146630250|NCT03773978|528824010|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
146630251|NCT03773978|528824009|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
146630252|NCT03773978|528824010|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
146630253|NCT03773978|528824009|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
146630254|NCT03773978|528824010|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
146630255|NCT03773978|528824009|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
146630256|NCT03773978|528824010|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
146630257|NCT03773978|528824009|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
146630258|NCT03773978|528824010|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
146630259|NCT03773978|528824009|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
146630260|NCT03773978|528824010|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
146630261|NCT03773978|528824009|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
146630262|NCT03773978|528824010|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
146630263|NCT03773978|528824009|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
146630264|NCT03773978|528824010|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
146630265|NCT03773978|528824009|FG000|DBW Period|Adverse Event|2|||
146630266|NCT03773978|528824010|FG001|DBW Period|Adverse Event|2|||
146630267|NCT03773978|528824009|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
146630268|NCT03773978|528824010|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
146630269|NCT03773978|528824009|FG000|DBW Period|Withdrawal by Subject|2|||
146630270|NCT03773978|528824010|FG001|DBW Period|Withdrawal by Subject|1|||
146630271|NCT03773978|528824009|FG000|DBW Period|Due to epidemic or pandemic|5|||
146630272|NCT03773978|528824010|FG001|DBW Period|Due to epidemic or pandemic|6|||
146630273|NCT03773978|528824009|FG000|DBW Period|Study team decision|1|||
146630274|NCT03773978|528824010|FG001|DBW Period|Study team decision|0|||
146630275|NCT03755934|528824013|FG000|Overall Study|Adverse Event|4|||
146630276|NCT03755934|528824014|FG001|Overall Study|Adverse Event|1|||
146630277|NCT03755934|528824015|FG002|Overall Study|Adverse Event|1|||
146630278|NCT03755934|528824016|FG003|Overall Study|Adverse Event|3|||
146630279|NCT03755934|528824013|FG000|Overall Study|Physician Decision|2|||
146630280|NCT03755934|528824014|FG001|Overall Study|Physician Decision|0|||
146630281|NCT03755934|528824015|FG002|Overall Study|Physician Decision|0|||
146630282|NCT03755934|528824016|FG003|Overall Study|Physician Decision|1|||
146630283|NCT03755934|528824013|FG000|Overall Study|Withdrawal by Subject|5|||
146630284|NCT03755934|528824014|FG001|Overall Study|Withdrawal by Subject|0|||
146630285|NCT03755934|528824015|FG002|Overall Study|Withdrawal by Subject|0|||
146630286|NCT03755934|528824016|FG003|Overall Study|Withdrawal by Subject|1|||
146630287|NCT03755934|528824013|FG000|Overall Study|Other|3|||
146630288|NCT03755934|528824014|FG001|Overall Study|Other|1|||
146630289|NCT03755934|528824015|FG002|Overall Study|Other|3|||
146630290|NCT03755934|528824016|FG003|Overall Study|Other|1|||
146630291|NCT01498068|528824017|FG000|Overall Study|Withdrawal by Subject|1|||
146630292|NCT01498068|528824018|FG001|Overall Study|Withdrawal by Subject|1|||
146630293|NCT03944577|528824019|FG000|Overall Study|Adverse Event|3|||
146630294|NCT00198822|528824020|FG000|Overall Study|Lost to Follow-up|14|||
146630295|NCT00198822|528824021|FG001|Overall Study|Lost to Follow-up|20|||
146630296|NCT00198822|528824022|FG002|Overall Study|Lost to Follow-up|21|||
146630297|NCT01467960|528824025|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
146630298|NCT01467960|528824026|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
146630299|NCT01467960|528824027|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
146630300|NCT01467960|528824028|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
146630301|NCT01467960|528824029|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
146630302|NCT01467960|528824030|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
146630303|NCT00888173|528824031|FG000|Overall Study|Wrong Primary|1|||
146630304|NCT00888173|528824031|FG000|Overall Study|Ineligible: required test not done|1|||
146630305|NCT00737672|528824038|FG000|Overall Study|Graft Abandonment|48|||
146630306|NCT00737672|528824039|FG001|Overall Study|Graft Abandonment|56|||
146630307|NCT00737672|528824038|FG000|Overall Study|Death|23|||
146630308|NCT00737672|528824039|FG001|Overall Study|Death|22|||
146630309|NCT00737672|528824038|FG000|Overall Study|Withdrawal by Subject|1|||
146630310|NCT00737672|528824039|FG001|Overall Study|Withdrawal by Subject|2|||
146630311|NCT00737672|528824038|FG000|Overall Study|Lost to Follow-up|1|||
146630312|NCT00737672|528824039|FG001|Overall Study|Lost to Follow-up|0|||
146630313|NCT00737672|528824038|FG000|Overall Study|Miscellaneous|7|||
146630314|NCT00737672|528824039|FG001|Overall Study|Miscellaneous|1|||
146630315|NCT00737672|528824038|FG000|Overall Study|Physician Decision|0|||
146630316|NCT00737672|528824039|FG001|Overall Study|Physician Decision|2|||
146630317|NCT03955146|528824045|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
146630318|NCT03955146|528824046|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
146630319|NCT03955146|528824047|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
146630320|NCT03955146|528824048|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
146630321|NCT03955146|528824045|FG000|DB Period (48 Weeks)|Adverse Event|2|||
146630322|NCT03955146|528824046|FG001|DB Period (48 Weeks)|Adverse Event|5|||
146630323|NCT03955146|528824047|FG002|DB Period (48 Weeks)|Adverse Event|1|||
146630324|NCT03955146|528824048|FG003|DB Period (48 Weeks)|Adverse Event|2|||
146630325|NCT03955146|528824045|FG000|DB Period (48 Weeks)|Death|13|||
146630326|NCT03955146|528824046|FG001|DB Period (48 Weeks)|Death|17|||
146630327|NCT03955146|528824047|FG002|DB Period (48 Weeks)|Death|1|||
146630328|NCT03955146|528824048|FG003|DB Period (48 Weeks)|Death|0|||
146630329|NCT03955146|528824045|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
146630330|NCT03955146|528824046|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
146630331|NCT03955146|528824047|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
146630332|NCT03955146|528824048|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
146630333|NCT03955146|528824045|FG000|DB Period (48 Weeks)|Disease Progression|2|||
146630334|NCT03955146|528824046|FG001|DB Period (48 Weeks)|Disease Progression|0|||
146630335|NCT03955146|528824047|FG002|DB Period (48 Weeks)|Disease Progression|0|||
146630336|NCT03955146|528824048|FG003|DB Period (48 Weeks)|Disease Progression|0|||
146630337|NCT03955146|528824045|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
146630338|NCT03955146|528824046|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
146630339|NCT03955146|528824047|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
146630340|NCT03955146|528824048|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
146630341|NCT03955146|528824045|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
146630342|NCT03955146|528824046|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
146630343|NCT03955146|528824047|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
146630344|NCT03955146|528824048|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
146630345|NCT03955146|528824045|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
146630346|NCT03955146|528824046|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
146630347|NCT03955146|528824047|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
146630348|NCT03955146|528824048|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
146630349|NCT03955146|528824045|FG000|DB Period (48 Weeks)|Participant Decision|9|||
146630350|NCT03955146|528824046|FG001|DB Period (48 Weeks)|Participant Decision|12|||
146630351|NCT03955146|528824047|FG002|DB Period (48 Weeks)|Participant Decision|1|||
146630352|NCT03955146|528824048|FG003|DB Period (48 Weeks)|Participant Decision|1|||
146630353|NCT03955146|528824045|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
146630354|NCT03955146|528824046|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
146630355|NCT03955146|528824047|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
146765085|NCT03612804|529307247|FG002|Overall Study|Non-veteran status|0|||
146881420|NCT03657043|529735299|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
146881421|NCT03657043|529735295|FG000|Overall Study|Withdrawal - declined follow-up|0|||
146881422|NCT03657043|529735296|FG001|Overall Study|Withdrawal - declined follow-up|0|||
146881423|NCT03657043|529735297|FG002|Overall Study|Withdrawal - declined follow-up|0|||
146881424|NCT03657043|529735298|FG003|Overall Study|Withdrawal - declined follow-up|0|||
146881425|NCT03657043|529735299|FG004|Overall Study|Withdrawal - declined follow-up|1|||
146881426|NCT03047980|529735300|FG000|Overall Study|Adverse Event|1|||
146630356|NCT03955146|528824048|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
146630357|NCT03955146|528824045|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
146630358|NCT03955146|528824046|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
146630359|NCT03955146|528824047|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
146630360|NCT03955146|528824048|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
146630361|NCT03955146|528824045|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
146630362|NCT03955146|528824046|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
146630363|NCT03955146|528824047|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
146881427|NCT02627495|529735303|FG000|Overall Study|Withdrawal by Subject|4|||
146546991|NCT00574951|528509293|FG000|Overall Study|Ineligible - improper prior treatment|1|||
146546992|NCT05161936|528509294|FG000|Overall Study|Study terminated by Sponsor|1|||
146546993|NCT05161936|528509295|FG001|Overall Study|Study terminated by Sponsor|0|||
146546994|NCT05161936|528509296|FG002|Overall Study|Study terminated by Sponsor|0|||
146546995|NCT05161936|528509294|FG000|Overall Study|Withdrawal by Subject|0|||
146546996|NCT05161936|528509295|FG001|Overall Study|Withdrawal by Subject|0|||
146546997|NCT05161936|528509296|FG002|Overall Study|Withdrawal by Subject|1|||
146546998|NCT05278065|528509297|FG000|Overall Study|Withdrawal by Subject|1|||
146546999|NCT05278065|528509298|FG001|Overall Study|Withdrawal by Subject|0|||
146547000|NCT02029443|528509299|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
146547001|NCT02029443|528509300|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
146547002|NCT02029443|528509301|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
146547003|NCT02029443|528509302|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
146547004|NCT02029443|528509303|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
146547005|NCT02029443|528509299|FG000|Overall Study|Death|13|||
146547006|NCT02029443|528509300|FG001|Overall Study|Death|2|||
146547007|NCT02029443|528509301|FG002|Overall Study|Death|2|||
146547008|NCT02029443|528509302|FG003|Overall Study|Death|11|||
146547009|NCT02029443|528509303|FG004|Overall Study|Death|2|||
146547010|NCT02029443|528509299|FG000|Overall Study|Lost to Follow-up|1|||
146547011|NCT02029443|528509300|FG001|Overall Study|Lost to Follow-up|0|||
146547012|NCT02029443|528509301|FG002|Overall Study|Lost to Follow-up|1|||
146547013|NCT02029443|528509302|FG003|Overall Study|Lost to Follow-up|1|||
146547014|NCT02029443|528509303|FG004|Overall Study|Lost to Follow-up|0|||
146547015|NCT02029443|528509299|FG000|Overall Study|Started other anti-cancer therapy|17|||
146547016|NCT02029443|528509300|FG001|Overall Study|Started other anti-cancer therapy|4|||
146547017|NCT02029443|528509301|FG002|Overall Study|Started other anti-cancer therapy|7|||
146547018|NCT02029443|528509302|FG003|Overall Study|Started other anti-cancer therapy|9|||
146547019|NCT02029443|528509303|FG004|Overall Study|Started other anti-cancer therapy|3|||
146547020|NCT02029443|528509299|FG000|Overall Study|Withdrawal by Subject|3|||
146547021|NCT02029443|528509300|FG001|Overall Study|Withdrawal by Subject|1|||
146547022|NCT02029443|528509301|FG002|Overall Study|Withdrawal by Subject|1|||
146547023|NCT02029443|528509302|FG003|Overall Study|Withdrawal by Subject|1|||
146547024|NCT02029443|528509303|FG004|Overall Study|Withdrawal by Subject|0|||
146547025|NCT02029443|528509299|FG000|Overall Study|Other|6|||
146547026|NCT02029443|528509300|FG001|Overall Study|Other|6|||
146547027|NCT02029443|528509301|FG002|Overall Study|Other|4|||
146547028|NCT02029443|528509302|FG003|Overall Study|Other|2|||
146547029|NCT02029443|528509303|FG004|Overall Study|Other|0|||
146547030|NCT02639559|528509306|FG000|Overall Study|Mobilization failure|0|||
146547031|NCT02639559|528509307|FG001|Overall Study|Mobilization failure|3|||
146881428|NCT00880893|529735304|FG000|Overall Study|Protocol Violation|13|||
146881429|NCT00880893|529735305|FG001|Overall Study|Protocol Violation|1|||
146547032|NCT02639559|528509306|FG000|Overall Study|Issues with vascular acess|1|||
146547033|NCT02639559|528509307|FG001|Overall Study|Issues with vascular acess|0|||
146547034|NCT04999020|528509312|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
146547035|NCT04999020|528509313|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
146547036|NCT04999020|528509314|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
146547037|NCT04999020|528509315|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
146547038|NCT04999020|528509312|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
146547039|NCT04999020|528509313|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
146547040|NCT04999020|528509314|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
146547041|NCT04999020|528509315|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
146547042|NCT04999020|528509312|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
146547043|NCT04999020|528509313|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
146547044|NCT04999020|528509314|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
146547045|NCT04999020|528509315|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
146547046|NCT04999020|528509312|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
146547047|NCT04999020|528509313|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
146547048|NCT04999020|528509314|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
146547049|NCT04999020|528509315|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
146547050|NCT04999020|528509312|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
146547051|NCT04999020|528509313|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
146547052|NCT04999020|528509314|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
146547053|NCT04999020|528509315|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
146547054|NCT04999020|528509312|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
146547055|NCT04999020|528509313|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
146547056|NCT04999020|528509314|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
146547057|NCT04999020|528509315|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
146547058|NCT04999020|528509312|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
146547059|NCT04999020|528509313|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
146547060|NCT04999020|528509314|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
146547061|NCT04999020|528509315|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
146547062|NCT04999020|528509312|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
146547063|NCT04999020|528509313|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
146547064|NCT04999020|528509314|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
146547065|NCT04999020|528509315|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
146881430|NCT00880893|529735304|FG000|Overall Study|Withdrawal by Subject|15|||
146881431|NCT00880893|529735305|FG001|Overall Study|Withdrawal by Subject|11|||
146547066|NCT02969018|528509316|FG000|Overall Study|Adverse Event|2|||
146547067|NCT02969018|528509317|FG001|Overall Study|Adverse Event|4|||
146547068|NCT02969018|528509318|FG002|Overall Study|Adverse Event|1|||
146547069|NCT02969018|528509319|FG003|Overall Study|Adverse Event|2|||
146547070|NCT02969018|528509320|FG004|Overall Study|Adverse Event|0|||
146881432|NCT00880893|529735304|FG000|Overall Study|Lost to Follow-up|76|||
146881433|NCT00880893|529735305|FG001|Overall Study|Lost to Follow-up|33|||
146547071|NCT02969018|528509321|FG005|Overall Study|Adverse Event|1|||
146547072|NCT02969018|528509322|FG006|Overall Study|Adverse Event|2|||
146547073|NCT02969018|528509323|FG007|Overall Study|Adverse Event|0|||
146547074|NCT02969018|528509316|FG000|Overall Study|Lack of Efficacy|0|||
146547075|NCT02969018|528509317|FG001|Overall Study|Lack of Efficacy|1|||
146547076|NCT02969018|528509318|FG002|Overall Study|Lack of Efficacy|0|||
146547077|NCT02969018|528509319|FG003|Overall Study|Lack of Efficacy|0|||
146547078|NCT02969018|528509320|FG004|Overall Study|Lack of Efficacy|1|||
146547079|NCT02969018|528509321|FG005|Overall Study|Lack of Efficacy|1|||
146547080|NCT02969018|528509322|FG006|Overall Study|Lack of Efficacy|1|||
146547081|NCT02969018|528509323|FG007|Overall Study|Lack of Efficacy|1|||
146547082|NCT02969018|528509316|FG000|Overall Study|Lost to Follow-up|1|||
146547083|NCT02969018|528509317|FG001|Overall Study|Lost to Follow-up|2|||
146547084|NCT02969018|528509318|FG002|Overall Study|Lost to Follow-up|2|||
146547085|NCT02969018|528509319|FG003|Overall Study|Lost to Follow-up|0|||
146547086|NCT02969018|528509320|FG004|Overall Study|Lost to Follow-up|1|||
146547087|NCT02969018|528509321|FG005|Overall Study|Lost to Follow-up|1|||
146547088|NCT02969018|528509322|FG006|Overall Study|Lost to Follow-up|0|||
146547089|NCT02969018|528509323|FG007|Overall Study|Lost to Follow-up|1|||
146547090|NCT02969018|528509316|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
146547091|NCT02969018|528509317|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146547092|NCT02969018|528509318|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
146547093|NCT02969018|528509319|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
146547094|NCT02969018|528509320|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
146547095|NCT02969018|528509321|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
146547096|NCT02969018|528509322|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
146547097|NCT02969018|528509323|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
146547098|NCT02969018|528509316|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146547099|NCT02969018|528509317|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146547100|NCT02969018|528509318|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146547101|NCT02969018|528509319|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146547102|NCT02969018|528509320|FG004|Overall Study|Non-Compliance With Study Drug|0|||
146547103|NCT02969018|528509321|FG005|Overall Study|Non-Compliance With Study Drug|0|||
146547104|NCT02969018|528509322|FG006|Overall Study|Non-Compliance With Study Drug|0|||
146547105|NCT02969018|528509323|FG007|Overall Study|Non-Compliance With Study Drug|0|||
146547106|NCT02969018|528509316|FG000|Overall Study|Other|0|||
146765086|NCT03612804|529307248|FG003|Overall Study|Non-veteran status|0|||
146765087|NCT03612804|529307245|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
146881434|NCT00880893|529735304|FG000|Overall Study|Serious adverse event|3|||
146547107|NCT02969018|528509317|FG001|Overall Study|Other|0|||
146547108|NCT02969018|528509318|FG002|Overall Study|Other|0|||
146547109|NCT02969018|528509319|FG003|Overall Study|Other|1|||
146547110|NCT02969018|528509320|FG004|Overall Study|Other|0|||
146547111|NCT02969018|528509321|FG005|Overall Study|Other|0|||
146547112|NCT02969018|528509322|FG006|Overall Study|Other|0|||
146881435|NCT00880893|529735305|FG001|Overall Study|Serious adverse event|0|||
146881436|NCT01995071|529735306|FG000|Overall Study|Adverse Event|0|||
146881437|NCT01995071|529735307|FG001|Overall Study|Adverse Event|0|||
146881438|NCT01995071|529735308|FG002|Overall Study|Adverse Event|0|||
146881439|NCT01995071|529735309|FG003|Overall Study|Adverse Event|0|||
146881440|NCT01995071|529735310|FG004|Overall Study|Adverse Event|0|||
146881441|NCT01995071|529735311|FG005|Overall Study|Adverse Event|0|||
146881442|NCT01995071|529735312|FG006|Overall Study|Adverse Event|1|||
146881443|NCT01995071|529735313|FG007|Overall Study|Adverse Event|0|||
146881444|NCT01995071|529735314|FG008|Overall Study|Adverse Event|0|||
146881445|NCT01995071|529735315|FG009|Overall Study|Adverse Event|0|||
146881446|NCT01995071|529735316|FG010|Overall Study|Adverse Event|0|||
146881447|NCT01995071|529735317|FG011|Overall Study|Adverse Event|0|||
146881448|NCT01995071|529735306|FG000|Overall Study|Moved|0|||
146881449|NCT01995071|529735307|FG001|Overall Study|Moved|0|||
146881450|NCT01995071|529735308|FG002|Overall Study|Moved|1|||
146881451|NCT01995071|529735309|FG003|Overall Study|Moved|0|||
146881452|NCT01995071|529735310|FG004|Overall Study|Moved|1|||
146881453|NCT01995071|529735311|FG005|Overall Study|Moved|0|||
146881454|NCT01995071|529735312|FG006|Overall Study|Moved|0|||
146881455|NCT01995071|529735313|FG007|Overall Study|Moved|0|||
146881456|NCT01995071|529735314|FG008|Overall Study|Moved|0|||
146881457|NCT01995071|529735315|FG009|Overall Study|Moved|0|||
146881458|NCT01995071|529735316|FG010|Overall Study|Moved|1|||
146881459|NCT01995071|529735317|FG011|Overall Study|Moved|0|||
146881460|NCT01995071|529735306|FG000|Overall Study|Lost to Follow-up|1|||
146881461|NCT01995071|529735307|FG001|Overall Study|Lost to Follow-up|0|||
146881462|NCT01995071|529735308|FG002|Overall Study|Lost to Follow-up|0|||
146881463|NCT01995071|529735309|FG003|Overall Study|Lost to Follow-up|0|||
146881464|NCT01995071|529735310|FG004|Overall Study|Lost to Follow-up|0|||
146881465|NCT01995071|529735311|FG005|Overall Study|Lost to Follow-up|0|||
146881466|NCT01995071|529735312|FG006|Overall Study|Lost to Follow-up|0|||
146881467|NCT01995071|529735313|FG007|Overall Study|Lost to Follow-up|1|||
146881468|NCT01995071|529735314|FG008|Overall Study|Lost to Follow-up|1|||
146881469|NCT01995071|529735315|FG009|Overall Study|Lost to Follow-up|0|||
146881470|NCT01995071|529735316|FG010|Overall Study|Lost to Follow-up|0|||
146881471|NCT01995071|529735317|FG011|Overall Study|Lost to Follow-up|0|||
146881472|NCT01995071|529735306|FG000|Overall Study|Incarcerated|0|||
146881473|NCT01995071|529735307|FG001|Overall Study|Incarcerated|0|||
146881474|NCT01995071|529735308|FG002|Overall Study|Incarcerated|0|||
146881475|NCT01995071|529735309|FG003|Overall Study|Incarcerated|0|||
146881476|NCT01995071|529735310|FG004|Overall Study|Incarcerated|0|||
146881477|NCT01995071|529735311|FG005|Overall Study|Incarcerated|0|||
146881478|NCT01995071|529735312|FG006|Overall Study|Incarcerated|0|||
146881479|NCT01995071|529735313|FG007|Overall Study|Incarcerated|1|||
146881480|NCT01995071|529735314|FG008|Overall Study|Incarcerated|0|||
146881481|NCT01995071|529735315|FG009|Overall Study|Incarcerated|0|||
146881482|NCT01995071|529735316|FG010|Overall Study|Incarcerated|0|||
146881483|NCT01995071|529735317|FG011|Overall Study|Incarcerated|0|||
146881484|NCT01783678|529735318|FG000|Overall Study|Randomized but Not Treated|0|||
146881485|NCT01783678|529735319|FG001|Overall Study|Randomized but Not Treated|0|||
146881486|NCT01783678|529735320|FG002|Overall Study|Randomized but Not Treated|0|||
146881487|NCT01783678|529735321|FG003|Overall Study|Randomized but Not Treated|1|||
146881488|NCT01783678|529735322|FG004|Overall Study|Randomized but Not Treated|0|||
146881489|NCT01783678|529735323|FG005|Overall Study|Randomized but Not Treated|0|||
146881490|NCT01783678|529735318|FG000|Overall Study|Lack of Efficacy|1|||
146881491|NCT01783678|529735319|FG001|Overall Study|Lack of Efficacy|13|||
146881492|NCT01783678|529735320|FG002|Overall Study|Lack of Efficacy|1|||
146881493|NCT01783678|529735321|FG003|Overall Study|Lack of Efficacy|3|||
146881494|NCT01783678|529735322|FG004|Overall Study|Lack of Efficacy|6|||
146881495|NCT01783678|529735323|FG005|Overall Study|Lack of Efficacy|5|||
146881496|NCT01783678|529735318|FG000|Overall Study|Lost to Follow-up|0|||
146881497|NCT01783678|529735319|FG001|Overall Study|Lost to Follow-up|4|||
146881498|NCT01783678|529735320|FG002|Overall Study|Lost to Follow-up|0|||
146881499|NCT01783678|529735321|FG003|Overall Study|Lost to Follow-up|2|||
146881500|NCT01783678|529735322|FG004|Overall Study|Lost to Follow-up|1|||
146881501|NCT01783678|529735323|FG005|Overall Study|Lost to Follow-up|0|||
146881502|NCT01783678|529735318|FG000|Overall Study|Withdrew Consent|1|||
146881503|NCT01783678|529735319|FG001|Overall Study|Withdrew Consent|1|||
146881504|NCT01783678|529735320|FG002|Overall Study|Withdrew Consent|0|||
146881505|NCT01783678|529735321|FG003|Overall Study|Withdrew Consent|2|||
146881506|NCT01783678|529735322|FG004|Overall Study|Withdrew Consent|0|||
146881507|NCT01783678|529735323|FG005|Overall Study|Withdrew Consent|0|||
146881508|NCT02404103|529735324|FG000|Overall Study|Adverse Event|1|||
146881509|NCT02404103|529735325|FG001|Overall Study|Adverse Event|0|||
146881510|NCT02404103|529735324|FG000|Overall Study|Lost to Follow-up|3|||
146881511|NCT02404103|529735325|FG001|Overall Study|Lost to Follow-up|3|||
146881512|NCT00112905|529735326|FG000|Overall Study|Adverse Event|4|||
146881513|NCT00112905|529735326|FG000|Overall Study|Death|1|||
146881514|NCT00112905|529735326|FG000|Overall Study|Ineligibility|5|||
146881515|NCT00112905|529735326|FG000|Overall Study|Alternative treatment|1|||
146630364|NCT03955146|528824048|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
146630365|NCT03955146|528824045|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
146630366|NCT03955146|528824046|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
146630367|NCT03955146|528824047|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
146630368|NCT03955146|528824048|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
146630369|NCT03955146|528824045|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
146630370|NCT03955146|528824046|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
146630371|NCT03955146|528824047|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
146630372|NCT03955146|528824048|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
146630373|NCT03955146|528824045|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
146630374|NCT03955146|528824046|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
146630375|NCT03955146|528824047|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
146630376|NCT03955146|528824048|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
146630377|NCT03955146|528824045|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
146630378|NCT03955146|528824046|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
146630379|NCT03955146|528824047|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
146630380|NCT03955146|528824048|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
146630381|NCT03955146|528824045|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
146630382|NCT03955146|528824046|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
146630383|NCT03955146|528824047|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
146630384|NCT03955146|528824048|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
146630385|NCT03955146|528824045|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
146630386|NCT03955146|528824046|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
146630387|NCT03955146|528824047|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
146630388|NCT03955146|528824048|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
146630389|NCT03955146|528824045|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
146630390|NCT03955146|528824046|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
146630391|NCT03955146|528824047|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
146630392|NCT03955146|528824048|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
146630393|NCT03955146|528824045|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
146630394|NCT03955146|528824046|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
146630395|NCT03955146|528824047|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
146630396|NCT03955146|528824048|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
146630397|NCT02002598|528824053|FG000|Dose Level 1|Withdrawal by Subject|1|||
146630398|NCT02002598|528824054|FG001|Dose Level 1|Withdrawal by Subject|0|||
146630399|NCT02002598|528824055|FG002|Dose Level 1|Withdrawal by Subject|0|||
146630400|NCT02002598|528824056|FG003|Dose Level 1|Withdrawal by Subject|0|||
146881516|NCT00112905|529735326|FG000|Overall Study|performance status was deteiorating|1|||
146881517|NCT01042600|529735327|FG000|Overall Study|Ineligible|1|||
146881518|NCT01042600|529735328|FG001|Overall Study|Ineligible|0|||
146881519|NCT02600507|529735329|FG000|Overall Study|Adverse Event|3|||
146881520|NCT02600507|529735330|FG001|Overall Study|Adverse Event|15|||
146630401|NCT02002598|528824057|FG004|Dose Level 1|Withdrawal by Subject|0|||
146630402|NCT02628873|528824058|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
146881521|NCT02600507|529735331|FG002|Overall Study|Adverse Event|5|||
146881522|NCT02600507|529735329|FG000|Overall Study|Lack of Efficacy|3|||
146881523|NCT02600507|529735330|FG001|Overall Study|Lack of Efficacy|8|||
146881524|NCT02600507|529735331|FG002|Overall Study|Lack of Efficacy|5|||
146881525|NCT02600507|529735329|FG000|Overall Study|Lost to Follow-up|3|||
146881526|NCT02600507|529735330|FG001|Overall Study|Lost to Follow-up|5|||
146881527|NCT02600507|529735331|FG002|Overall Study|Lost to Follow-up|2|||
146881528|NCT02600507|529735329|FG000|Overall Study|Protocol Violation|12|||
146881529|NCT02600507|529735330|FG001|Overall Study|Protocol Violation|4|||
146881530|NCT02600507|529735331|FG002|Overall Study|Protocol Violation|4|||
146881531|NCT02600507|529735329|FG000|Overall Study|Physician Decision|1|||
146881532|NCT02600507|529735330|FG001|Overall Study|Physician Decision|0|||
146881533|NCT02600507|529735331|FG002|Overall Study|Physician Decision|1|||
146881534|NCT02600507|529735329|FG000|Overall Study|Withdrawal by Subject|7|||
146881535|NCT02600507|529735330|FG001|Overall Study|Withdrawal by Subject|11|||
146881536|NCT02600507|529735331|FG002|Overall Study|Withdrawal by Subject|7|||
146881537|NCT02600507|529735329|FG000|Overall Study|Other|0|||
146881538|NCT02600507|529735330|FG001|Overall Study|Other|1|||
146881539|NCT02600507|529735331|FG002|Overall Study|Other|1|||
146881540|NCT04541004|529735336|FG000|Overall Study|Adverse Event|2|||
146881541|NCT00605085|529735337|FG000|Overall Study|Withdrawal by Subject|8|||
146881542|NCT00605085|529735338|FG001|Overall Study|Withdrawal by Subject|5|||
146881543|NCT00605085|529735337|FG000|Overall Study|Adverse Event|9|||
146881544|NCT00605085|529735338|FG001|Overall Study|Adverse Event|5|||
146881545|NCT00605085|529735337|FG000|Overall Study|Pregnancy|2|||
146881546|NCT00605085|529735338|FG001|Overall Study|Pregnancy|0|||
146881547|NCT00605085|529735337|FG000|Overall Study|Protocol Violation|3|||
146881548|NCT00605085|529735338|FG001|Overall Study|Protocol Violation|2|||
146881549|NCT00605085|529735337|FG000|Overall Study|Lost to Follow-up|10|||
146881550|NCT00605085|529735338|FG001|Overall Study|Lost to Follow-up|5|||
146881551|NCT00605085|529735337|FG000|Overall Study|administrative reasons|18|||
146881552|NCT00605085|529735338|FG001|Overall Study|administrative reasons|8|||
146881553|NCT00621504|529735339|FG000|Overall Study|Adverse Event|1|||
146881554|NCT00621504|529735340|FG001|Overall Study|Adverse Event|3|||
146881555|NCT00621504|529735339|FG000|Overall Study|At the request of sponsor/investigator|1|||
146881556|NCT00621504|529735340|FG001|Overall Study|At the request of sponsor/investigator|0|||
146881557|NCT00621504|529735339|FG000|Overall Study|Withdrew consent|9|||
146881558|NCT00621504|529735340|FG001|Overall Study|Withdrew consent|6|||
146881559|NCT00621504|529735339|FG000|Overall Study|Lost to Follow-up|8|||
146881560|NCT00621504|529735340|FG001|Overall Study|Lost to Follow-up|10|||
146881561|NCT00621504|529735339|FG000|Overall Study|Other|1|||
146881562|NCT00621504|529735340|FG001|Overall Study|Other|0|||
146881563|NCT00621504|529735339|FG000|Overall Study|Death|6|||
146881564|NCT00621504|529735340|FG001|Overall Study|Death|6|||
146881565|NCT03311711|529735345|FG000|Overall Study|Death|1|||
146881566|NCT03311711|529735346|FG001|Overall Study|Death|0|||
146881567|NCT03311711|529735347|FG002|Overall Study|Death|0|||
146881568|NCT03311711|529735348|FG003|Overall Study|Death|0|||
146881569|NCT03311711|529735349|FG004|Overall Study|Death|0|||
146881570|NCT03311711|529735350|FG005|Overall Study|Death|0|||
146881571|NCT03311711|529735351|FG006|Overall Study|Death|1|||
146881572|NCT03311711|529735352|FG007|Overall Study|Death|0|||
146881573|NCT03311711|529735353|FG008|Overall Study|Death|1|||
146881574|NCT03311711|529735354|FG009|Overall Study|Death|0|||
146881575|NCT03311711|529735345|FG000|Overall Study|Death of dyad partner|0|||
146881576|NCT03311711|529735346|FG001|Overall Study|Death of dyad partner|1|||
146881577|NCT03311711|529735347|FG002|Overall Study|Death of dyad partner|0|||
146881578|NCT03311711|529735348|FG003|Overall Study|Death of dyad partner|0|||
146881579|NCT03311711|529735349|FG004|Overall Study|Death of dyad partner|0|||
146881580|NCT03311711|529735350|FG005|Overall Study|Death of dyad partner|0|||
146881581|NCT03311711|529735351|FG006|Overall Study|Death of dyad partner|0|||
146881582|NCT03311711|529735352|FG007|Overall Study|Death of dyad partner|1|||
146881583|NCT03311711|529735353|FG008|Overall Study|Death of dyad partner|0|||
146881584|NCT03311711|529735354|FG009|Overall Study|Death of dyad partner|1|||
146881585|NCT03311711|529735345|FG000|Overall Study|Lost to Follow-up|2|||
146881586|NCT03311711|529735346|FG001|Overall Study|Lost to Follow-up|2|||
146881587|NCT03311711|529735347|FG002|Overall Study|Lost to Follow-up|0|||
146881588|NCT03311711|529735348|FG003|Overall Study|Lost to Follow-up|0|||
146881589|NCT03311711|529735349|FG004|Overall Study|Lost to Follow-up|0|||
146881590|NCT03311711|529735350|FG005|Overall Study|Lost to Follow-up|0|||
146881591|NCT03311711|529735351|FG006|Overall Study|Lost to Follow-up|1|||
146881592|NCT03311711|529735352|FG007|Overall Study|Lost to Follow-up|1|||
146881593|NCT03311711|529735353|FG008|Overall Study|Lost to Follow-up|0|||
146881594|NCT03311711|529735354|FG009|Overall Study|Lost to Follow-up|0|||
146881595|NCT03311711|529735345|FG000|Overall Study|Withdrawal by Subject|1|||
146881596|NCT03311711|529735346|FG001|Overall Study|Withdrawal by Subject|1|||
146881597|NCT03311711|529735347|FG002|Overall Study|Withdrawal by Subject|0|||
146881598|NCT03311711|529735348|FG003|Overall Study|Withdrawal by Subject|0|||
146881599|NCT03311711|529735349|FG004|Overall Study|Withdrawal by Subject|0|||
146881600|NCT03311711|529735350|FG005|Overall Study|Withdrawal by Subject|0|||
146881601|NCT03311711|529735351|FG006|Overall Study|Withdrawal by Subject|3|||
146881602|NCT03311711|529735352|FG007|Overall Study|Withdrawal by Subject|3|||
146881603|NCT03311711|529735353|FG008|Overall Study|Withdrawal by Subject|0|||
146881604|NCT03311711|529735354|FG009|Overall Study|Withdrawal by Subject|0|||
146881605|NCT02229552|529735355|FG000|Baseline|Withdrawal by Subject|6|||
146881606|NCT02229552|529735355|FG000|1-year Follow up|Withdrawal by Subject|7|||
146881607|NCT02229552|529735355|FG000|1-year Follow up|Lost to Follow-up|18|||
146881608|NCT02229552|529735355|FG000|2-Year Follow up|Withdrawal by Subject|9|||
146881609|NCT02229552|529735355|FG000|2-Year Follow up|Lost to Follow-up|17|||
146881610|NCT01982292|529735356|FG000|Overall Study|Adverse Event|2|||
146881611|NCT01982292|529735357|FG001|Overall Study|Adverse Event|0|||
146881612|NCT01982292|529735356|FG000|Overall Study|Death|1|||
146881613|NCT01982292|529735357|FG001|Overall Study|Death|0|||
146881614|NCT01982292|529735356|FG000|Overall Study|Lost to Follow-up|2|||
146881615|NCT01982292|529735357|FG001|Overall Study|Lost to Follow-up|0|||
146881616|NCT01982292|529735356|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
146881617|NCT01982292|529735357|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
146881618|NCT01982292|529735356|FG000|Overall Study|Protocol Deviation|1|||
146881619|NCT01982292|529735357|FG001|Overall Study|Protocol Deviation|0|||
146881620|NCT01982292|529735356|FG000|Overall Study|Patient/Guardian Decision|3|||
146881621|NCT01982292|529735357|FG001|Overall Study|Patient/Guardian Decision|1|||
146881622|NCT01982292|529735356|FG000|Overall Study|Technical Problems|2|||
146881623|NCT01982292|529735357|FG001|Overall Study|Technical Problems|0|||
146881624|NCT01496885|529735359|FG000|Overall Study|Lost to Follow-up|13|||
146881625|NCT01496885|529735359|FG000|Overall Study|Withdrawal by Subject|7|||
146881626|NCT01496885|529735359|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
146881627|NCT01496885|529735359|FG000|Overall Study|Death|1|||
146881628|NCT02669017|529735361|FG000|Overall Study|Death|1|||
146881629|NCT02669017|529735362|FG001|Overall Study|Death|2|||
146547113|NCT02969018|528509323|FG007|Overall Study|Other|2|||
146881630|NCT02669017|529735363|FG002|Overall Study|Death|2|||
146881631|NCT02669017|529735364|FG003|Overall Study|Death|3|||
146881632|NCT02669017|529735365|FG004|Overall Study|Death|8|||
146881633|NCT02669017|529735366|FG005|Overall Study|Death|18|||
146881634|NCT02669017|529735367|FG006|Overall Study|Death|10|||
146881635|NCT02669017|529735368|FG007|Overall Study|Death|47|||
146881636|NCT02669017|529735369|FG008|Overall Study|Death|20|||
146881637|NCT02669017|529735361|FG000|Overall Study|Withdrawal by Subject|0|||
146881638|NCT02669017|529735362|FG001|Overall Study|Withdrawal by Subject|0|||
146881639|NCT02669017|529735363|FG002|Overall Study|Withdrawal by Subject|0|||
146881640|NCT02669017|529735364|FG003|Overall Study|Withdrawal by Subject|1|||
146881641|NCT02669017|529735365|FG004|Overall Study|Withdrawal by Subject|2|||
146881642|NCT02669017|529735366|FG005|Overall Study|Withdrawal by Subject|0|||
146881643|NCT02669017|529735367|FG006|Overall Study|Withdrawal by Subject|0|||
146881644|NCT02669017|529735368|FG007|Overall Study|Withdrawal by Subject|2|||
146881645|NCT02669017|529735369|FG008|Overall Study|Withdrawal by Subject|2|||
146881646|NCT02669017|529735361|FG000|Overall Study|Lost to Follow-up|0|||
146881647|NCT02669017|529735362|FG001|Overall Study|Lost to Follow-up|0|||
146881648|NCT02669017|529735363|FG002|Overall Study|Lost to Follow-up|0|||
146881649|NCT02669017|529735364|FG003|Overall Study|Lost to Follow-up|0|||
146881650|NCT02669017|529735365|FG004|Overall Study|Lost to Follow-up|0|||
146881651|NCT02669017|529735366|FG005|Overall Study|Lost to Follow-up|0|||
146881652|NCT02669017|529735367|FG006|Overall Study|Lost to Follow-up|0|||
146881653|NCT02669017|529735368|FG007|Overall Study|Lost to Follow-up|0|||
146881654|NCT02669017|529735369|FG008|Overall Study|Lost to Follow-up|1|||
146881655|NCT02669017|529735361|FG000|Overall Study|Miscellaneous|0|||
146881656|NCT02669017|529735362|FG001|Overall Study|Miscellaneous|0|||
146881657|NCT02669017|529735363|FG002|Overall Study|Miscellaneous|0|||
146881658|NCT02669017|529735364|FG003|Overall Study|Miscellaneous|0|||
146881659|NCT02669017|529735365|FG004|Overall Study|Miscellaneous|2|||
146881660|NCT02669017|529735366|FG005|Overall Study|Miscellaneous|1|||
146881661|NCT02669017|529735367|FG006|Overall Study|Miscellaneous|1|||
146881662|NCT02669017|529735368|FG007|Overall Study|Miscellaneous|13|||
146881663|NCT02669017|529735369|FG008|Overall Study|Miscellaneous|2|||
146881664|NCT01289015|529735370|FG000|Overall Study|Protocol Violation|12|||
146881665|NCT01289015|529735371|FG001|Overall Study|Protocol Violation|9|||
146881666|NCT01289015|529735370|FG000|Overall Study|Adverse Event|3|||
146881667|NCT01289015|529735371|FG001|Overall Study|Adverse Event|0|||
146881668|NCT01289015|529735370|FG000|Overall Study|Lost to Follow-up|33|||
146881669|NCT01289015|529735371|FG001|Overall Study|Lost to Follow-up|17|||
146881670|NCT01289015|529735370|FG000|Overall Study|Withdrawal by Subject|17|||
146881671|NCT01289015|529735371|FG001|Overall Study|Withdrawal by Subject|8|||
146881672|NCT01289015|529735370|FG000|Overall Study|Disease progression|1|||
146881673|NCT01289015|529735371|FG001|Overall Study|Disease progression|0|||
146881674|NCT01289015|529735370|FG000|Overall Study|Negative baseline culture and others|33|||
146881675|NCT01289015|529735371|FG001|Overall Study|Negative baseline culture and others|20|||
146881676|NCT01485627|529735375|FG000|Overall Study|Patient withdrew|6|||
146881677|NCT01485627|529735376|FG001|Overall Study|Patient withdrew|5|||
146881678|NCT01485627|529735375|FG000|Overall Study|Patient died|3|||
146881679|NCT01485627|529735376|FG001|Overall Study|Patient died|1|||
146881680|NCT01485627|529735375|FG000|Overall Study|Patient lost to followup|0|||
146881681|NCT01485627|529735376|FG001|Overall Study|Patient lost to followup|1|||
146881682|NCT01485627|529735375|FG000|Overall Study|Caregiver withdrew|3|||
146881683|NCT01485627|529735376|FG001|Overall Study|Caregiver withdrew|3|||
146881684|NCT01485627|529735375|FG000|Overall Study|Caregiver lost to follow up|11|||
146881685|NCT01485627|529735376|FG001|Overall Study|Caregiver lost to follow up|12|||
146881686|NCT01485627|529735375|FG000|Overall Study|Caregiver died|1|||
146881687|NCT01485627|529735376|FG001|Overall Study|Caregiver died|0|||
146881688|NCT01485627|529735375|FG000|Overall Study|caregiver was not bereaved|42|||
146881689|NCT01485627|529735376|FG001|Overall Study|caregiver was not bereaved|35|||
146881690|NCT01709149|529735378|FG000|Open-label Lead-in Phase|Adverse Event|109|||
146881691|NCT01709149|529735379|FG001|Open-label Lead-in Phase|Adverse Event|0|||
146881692|NCT01709149|529735380|FG002|Open-label Lead-in Phase|Adverse Event|0|||
146881693|NCT01709149|529735378|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
146881694|NCT01709149|529735379|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
146881695|NCT01709149|529735380|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
146881696|NCT01709149|529735378|FG000|Open-label Lead-in Phase|Death|1|||
146881697|NCT01709149|529735379|FG001|Open-label Lead-in Phase|Death|0|||
146547114|NCT02969018|528509316|FG000|Overall Study|Pregnancy|0|||
146547115|NCT02969018|528509317|FG001|Overall Study|Pregnancy|0|||
146547116|NCT02969018|528509318|FG002|Overall Study|Pregnancy|0|||
146547117|NCT02969018|528509319|FG003|Overall Study|Pregnancy|0|||
146547118|NCT02969018|528509320|FG004|Overall Study|Pregnancy|0|||
146547119|NCT02969018|528509321|FG005|Overall Study|Pregnancy|1|||
146547120|NCT02969018|528509322|FG006|Overall Study|Pregnancy|0|||
146547121|NCT02969018|528509323|FG007|Overall Study|Pregnancy|0|||
146547122|NCT02969018|528509316|FG000|Overall Study|Protocol Violation|0|||
146547123|NCT02969018|528509317|FG001|Overall Study|Protocol Violation|0|||
146547124|NCT02969018|528509318|FG002|Overall Study|Protocol Violation|1|||
146547125|NCT02969018|528509319|FG003|Overall Study|Protocol Violation|1|||
146547126|NCT02969018|528509320|FG004|Overall Study|Protocol Violation|0|||
146547127|NCT02969018|528509321|FG005|Overall Study|Protocol Violation|0|||
146547128|NCT02969018|528509322|FG006|Overall Study|Protocol Violation|0|||
146881698|NCT01709149|529735380|FG002|Open-label Lead-in Phase|Death|0|||
146881699|NCT01709149|529735378|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
146881700|NCT01709149|529735379|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
146881701|NCT01709149|529735380|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
146881702|NCT01709149|529735378|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
146881703|NCT01709149|529735379|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
146881704|NCT01709149|529735380|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
146881705|NCT01709149|529735378|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
146881706|NCT01709149|529735379|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
146881707|NCT01709149|529735380|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
146881708|NCT01709149|529735378|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
146547129|NCT02969018|528509323|FG007|Overall Study|Protocol Violation|0|||
146881709|NCT01709149|529735379|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
146881710|NCT01709149|529735380|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
146881711|NCT01709149|529735378|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
146881712|NCT01709149|529735379|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
146881713|NCT01709149|529735380|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
146881714|NCT01709149|529735378|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
146881715|NCT01709149|529735379|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
146881716|NCT01709149|529735380|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
146881717|NCT01709149|529735378|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146881718|NCT01709149|529735379|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
146881719|NCT01709149|529735380|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146881720|NCT03509350|529735381|FG000|Overall Study|Withdrawal by Subject|0|||
146881721|NCT03509350|529735382|FG001|Overall Study|Withdrawal by Subject|2|||
146881722|NCT01425203|529735383|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
146881723|NCT01425203|529735384|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
146881724|NCT01425203|529735385|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
146881725|NCT01425203|529735383|FG000|Treatment Phase|Failure at futility timepoint|8|||
146881726|NCT01425203|529735384|FG001|Treatment Phase|Failure at futility timepoint|27|||
146881727|NCT01425203|529735385|FG002|Treatment Phase|Failure at futility timepoint|0|||
146881728|NCT01425203|529735383|FG000|Treatment Phase|Other virologic failure criteria|5|||
146881729|NCT01425203|529735384|FG001|Treatment Phase|Other virologic failure criteria|3|||
146881730|NCT01425203|529735385|FG002|Treatment Phase|Other virologic failure criteria|0|||
146881731|NCT01425203|529735383|FG000|Treatment Phase|Unidentified reasons|11|||
146881732|NCT01425203|529735384|FG001|Treatment Phase|Unidentified reasons|5|||
146881733|NCT01425203|529735385|FG002|Treatment Phase|Unidentified reasons|0|||
146881734|NCT01425203|529735383|FG000|Treatment Phase|Did not receive treatment|0|||
146881735|NCT01425203|529735384|FG001|Treatment Phase|Did not receive treatment|1|||
146881736|NCT01425203|529735385|FG002|Treatment Phase|Did not receive treatment|0|||
146881737|NCT01425203|529735383|FG000|Crossover Phase|Failure at futility timepoint|0|||
146881738|NCT01425203|529735384|FG001|Crossover Phase|Failure at futility timepoint|0|||
146881739|NCT01425203|529735385|FG002|Crossover Phase|Failure at futility timepoint|3|||
146881740|NCT01425203|529735383|FG000|Crossover Phase|Other virologic failure criteria|0|||
146881741|NCT01425203|529735384|FG001|Crossover Phase|Other virologic failure criteria|0|||
146881742|NCT01425203|529735385|FG002|Crossover Phase|Other virologic failure criteria|3|||
146881743|NCT04951037|529735390|FG000|Overall Study|Lost to Follow-up|16|||
146881744|NCT04951037|529735390|FG000|Overall Study|Withdrawal by Subject|5|||
146881745|NCT04951037|529735390|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
146881746|NCT03031301|529735391|FG000|Overall Study|Protocol Violation|4|||
146881747|NCT03031301|529735392|FG001|Overall Study|Protocol Violation|8|||
146881748|NCT03031301|529735391|FG000|Overall Study|Withdrawal by Subject|7|||
146881749|NCT03031301|529735392|FG001|Overall Study|Withdrawal by Subject|4|||
146881750|NCT03031301|529735391|FG000|Overall Study|Lost to Follow-up|4|||
146881751|NCT03031301|529735392|FG001|Overall Study|Lost to Follow-up|12|||
146881752|NCT03031301|529735391|FG000|Overall Study|Noncompliance|1|||
146881753|NCT03031301|529735392|FG001|Overall Study|Noncompliance|3|||
146547130|NCT02969018|528509316|FG000|Overall Study|Withdrawal by Subject|0|||
146547131|NCT02969018|528509317|FG001|Overall Study|Withdrawal by Subject|1|||
146547132|NCT02969018|528509318|FG002|Overall Study|Withdrawal by Subject|2|||
146881754|NCT03031301|529735391|FG000|Overall Study|Technical issue|1|||
146881755|NCT03031301|529735392|FG001|Overall Study|Technical issue|1|||
146881756|NCT03031301|529735391|FG000|Overall Study|Adverse Event|1|||
146881757|NCT03031301|529735392|FG001|Overall Study|Adverse Event|0|||
146765088|NCT03612804|529307246|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
146765089|NCT03612804|529307247|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
146881758|NCT02429414|529735394|FG000|Overall Study|Physician Decision|0|||
146881759|NCT02429414|529735395|FG001|Overall Study|Physician Decision|1|||
146881760|NCT01784861|529735401|FG000|Overall Study|Adverse Event|0|||
146881761|NCT01784861|529735402|FG001|Overall Study|Adverse Event|0|||
146881762|NCT01784861|529735403|FG002|Overall Study|Adverse Event|1|||
146881763|NCT01784861|529735404|FG003|Overall Study|Adverse Event|2|||
146881764|NCT01784861|529735405|FG004|Overall Study|Adverse Event|1|||
146881765|NCT01784861|529735406|FG005|Overall Study|Adverse Event|0|||
146881766|NCT01784861|529735401|FG000|Overall Study|Withdrawal by Subject|0|||
146881767|NCT01784861|529735402|FG001|Overall Study|Withdrawal by Subject|0|||
146881768|NCT01784861|529735403|FG002|Overall Study|Withdrawal by Subject|0|||
146881769|NCT01784861|529735404|FG003|Overall Study|Withdrawal by Subject|1|||
146881770|NCT01784861|529735405|FG004|Overall Study|Withdrawal by Subject|0|||
146881771|NCT01784861|529735406|FG005|Overall Study|Withdrawal by Subject|0|||
146881772|NCT01784861|529735401|FG000|Overall Study|Physician Decision|0|||
146881773|NCT01784861|529735402|FG001|Overall Study|Physician Decision|0|||
146881774|NCT01784861|529735403|FG002|Overall Study|Physician Decision|0|||
146881775|NCT01784861|529735404|FG003|Overall Study|Physician Decision|2|||
146881776|NCT01784861|529735405|FG004|Overall Study|Physician Decision|0|||
146881777|NCT01784861|529735406|FG005|Overall Study|Physician Decision|1|||
146881778|NCT01604265|529735407|FG000|Overall Study|Adverse Event|1|||
146881779|NCT01604265|529735408|FG001|Overall Study|Adverse Event|0|||
146881780|NCT01604265|529735407|FG000|Overall Study|Withdrawal by Subject|1|||
146881781|NCT01604265|529735408|FG001|Overall Study|Withdrawal by Subject|0|||
146881782|NCT02599961|529735409|FG000|Overall Study|Withdrawal by Subject|1|||
146881783|NCT02599961|529735409|FG000|Overall Study|Subject Non-Compliance|2|||
146881784|NCT02599961|529735409|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
146881785|NCT02599961|529735409|FG000|Overall Study|Other, Not Specified|3|||
146881786|NCT02432235|529735410|FG000|Overall Study|Death|1|||
146881787|NCT02432235|529735411|FG001|Overall Study|Death|1|||
146881788|NCT02432235|529735412|FG002|Overall Study|Death|2|||
146881789|NCT02432235|529735413|FG003|Overall Study|Death|2|||
146881790|NCT02432235|529735414|FG004|Overall Study|Death|1|||
146881791|NCT02432235|529735415|FG005|Overall Study|Death|3|||
146881792|NCT02432235|529735416|FG006|Overall Study|Death|11|||
146881793|NCT02432235|529735417|FG007|Overall Study|Death|15|||
146881794|NCT02432235|529735418|FG008|Overall Study|Death|15|||
146881795|NCT02432235|529735419|FG009|Overall Study|Death|3|||
146881796|NCT02432235|529735420|FG010|Overall Study|Death|1|||
146881797|NCT02432235|529735421|FG011|Overall Study|Death|0|||
146881798|NCT02432235|529735410|FG000|Overall Study|Withdrawal by Subject|0|||
146881799|NCT02432235|529735411|FG001|Overall Study|Withdrawal by Subject|1|||
146881800|NCT02432235|529735412|FG002|Overall Study|Withdrawal by Subject|0|||
146881801|NCT02432235|529735413|FG003|Overall Study|Withdrawal by Subject|0|||
146881802|NCT02432235|529735414|FG004|Overall Study|Withdrawal by Subject|0|||
146881803|NCT02432235|529735415|FG005|Overall Study|Withdrawal by Subject|2|||
146881804|NCT02432235|529735416|FG006|Overall Study|Withdrawal by Subject|5|||
146881805|NCT02432235|529735417|FG007|Overall Study|Withdrawal by Subject|3|||
146881806|NCT02432235|529735418|FG008|Overall Study|Withdrawal by Subject|1|||
146881807|NCT02432235|529735419|FG009|Overall Study|Withdrawal by Subject|0|||
146881808|NCT02432235|529735420|FG010|Overall Study|Withdrawal by Subject|0|||
146881809|NCT02432235|529735421|FG011|Overall Study|Withdrawal by Subject|0|||
146881810|NCT02432235|529735410|FG000|Overall Study|Lost to Follow-up|0|||
146881811|NCT02432235|529735411|FG001|Overall Study|Lost to Follow-up|0|||
146630403|NCT02628873|528824059|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
146630404|NCT02628873|528824058|FG000|Second Test (1 Hour)|Physician Decision|1|||
146630405|NCT02628873|528824059|FG001|Second Test (1 Hour)|Physician Decision|0|||
146630406|NCT04672239|528824060|FG000|Week 2 Survey|Failed survey check items|1|||
146630407|NCT04672239|528824061|FG001|Week 2 Survey|Failed survey check items|2|||
146630408|NCT04672239|528824062|FG002|Week 2 Survey|Failed survey check items|3|||
146630409|NCT04672239|528824060|FG000|Week 2 Survey|Partially completed survey|7|||
146881812|NCT02432235|529735412|FG002|Overall Study|Lost to Follow-up|0|||
146881813|NCT02432235|529735413|FG003|Overall Study|Lost to Follow-up|0|||
146881814|NCT02432235|529735414|FG004|Overall Study|Lost to Follow-up|0|||
146881815|NCT02432235|529735415|FG005|Overall Study|Lost to Follow-up|1|||
146881816|NCT02432235|529735416|FG006|Overall Study|Lost to Follow-up|0|||
146881817|NCT02432235|529735417|FG007|Overall Study|Lost to Follow-up|0|||
146881818|NCT02432235|529735418|FG008|Overall Study|Lost to Follow-up|1|||
146881819|NCT02432235|529735419|FG009|Overall Study|Lost to Follow-up|0|||
146881820|NCT02432235|529735420|FG010|Overall Study|Lost to Follow-up|0|||
146630410|NCT04672239|528824061|FG001|Week 2 Survey|Partially completed survey|1|||
146630411|NCT04672239|528824062|FG002|Week 2 Survey|Partially completed survey|4|||
146881821|NCT02432235|529735421|FG011|Overall Study|Lost to Follow-up|0|||
146881822|NCT02432235|529735410|FG000|Overall Study|Miscellaneous|0|||
146881823|NCT02432235|529735411|FG001|Overall Study|Miscellaneous|0|||
146881824|NCT02432235|529735412|FG002|Overall Study|Miscellaneous|0|||
146881825|NCT02432235|529735413|FG003|Overall Study|Miscellaneous|0|||
146881826|NCT02432235|529735414|FG004|Overall Study|Miscellaneous|1|||
146881827|NCT02432235|529735415|FG005|Overall Study|Miscellaneous|6|||
146881828|NCT02432235|529735416|FG006|Overall Study|Miscellaneous|2|||
146881829|NCT02432235|529735417|FG007|Overall Study|Miscellaneous|2|||
146881830|NCT02432235|529735418|FG008|Overall Study|Miscellaneous|4|||
146881831|NCT02432235|529735419|FG009|Overall Study|Miscellaneous|0|||
146881832|NCT02432235|529735420|FG010|Overall Study|Miscellaneous|0|||
146881833|NCT02432235|529735421|FG011|Overall Study|Miscellaneous|1|||
146881834|NCT01895322|529735422|FG000|Overall Study|Adverse Event|1|||
146630412|NCT04672239|528824060|FG000|Week 2 Survey|Withdrawal by Subject|0|||
146630413|NCT04672239|528824061|FG001|Week 2 Survey|Withdrawal by Subject|1|||
146881835|NCT01895322|529735422|FG000|Overall Study|Withdrawal by Subject|2|||
146881836|NCT01895322|529735422|FG000|Overall Study|Protocol Violation|10|||
146881837|NCT00143312|529735423|FG000|Overall Study|Death|11|||
146881838|NCT00143312|529735423|FG000|Overall Study|Adverse Event|2|||
146881839|NCT00143312|529735423|FG000|Overall Study|Lost to Follow-up|1|||
146881840|NCT00143312|529735423|FG000|Overall Study|Other|1|||
146881841|NCT00143312|529735423|FG000|Overall Study|Withdrawal by Subject|1|||
146881842|NCT01834274|529735424|FG000|Overall Study|Study Termination|41|||
146881843|NCT01834274|529735425|FG001|Overall Study|Study Termination|38|||
146881844|NCT01834274|529735424|FG000|Overall Study|Withdrawal by Subject|1|||
146881845|NCT01834274|529735425|FG001|Overall Study|Withdrawal by Subject|1|||
146881846|NCT01834274|529735424|FG000|Overall Study|Lost to Follow-up|3|||
146881847|NCT01834274|529735425|FG001|Overall Study|Lost to Follow-up|1|||
146881848|NCT01834274|529735424|FG000|Overall Study|Other|2|||
146881849|NCT01834274|529735425|FG001|Overall Study|Other|1|||
146881850|NCT01618214|529735426|FG000|Overall Study|Adverse Event|3|||
146881851|NCT01618214|529735427|FG001|Overall Study|Adverse Event|1|||
146881852|NCT01618214|529735426|FG000|Overall Study|Lack of Efficacy|1|||
146881853|NCT01618214|529735427|FG001|Overall Study|Lack of Efficacy|1|||
146881854|NCT01618214|529735426|FG000|Overall Study|Protocol Violation|1|||
146881855|NCT01618214|529735427|FG001|Overall Study|Protocol Violation|4|||
146881856|NCT01618214|529735426|FG000|Overall Study|Withdrawal Criteria|1|||
146881857|NCT01618214|529735427|FG001|Overall Study|Withdrawal Criteria|2|||
146881858|NCT01618214|529735426|FG000|Overall Study|Unclassified|4|||
146881859|NCT01618214|529735427|FG001|Overall Study|Unclassified|5|||
146881860|NCT00606086|529735428|FG000|Overall Study|Adverse Event|1|||
146881861|NCT00606086|529735429|FG001|Overall Study|Adverse Event|1|||
146881862|NCT00606086|529735428|FG000|Overall Study|Lost to Follow-up|4|||
146881863|NCT00606086|529735429|FG001|Overall Study|Lost to Follow-up|8|||
146881864|NCT00606086|529735428|FG000|Overall Study|Protocol Violation|1|||
146881865|NCT00606086|529735429|FG001|Overall Study|Protocol Violation|0|||
146881866|NCT00606086|529735428|FG000|Overall Study|Withdrawal by Subject|5|||
146881867|NCT00606086|529735429|FG001|Overall Study|Withdrawal by Subject|3|||
146881868|NCT00606086|529735428|FG000|Overall Study|Non-compliance|0|||
146881869|NCT00606086|529735429|FG001|Overall Study|Non-compliance|1|||
146881870|NCT00606086|529735428|FG000|Overall Study|Randomized, not treated|1|||
146881871|NCT00606086|529735429|FG001|Overall Study|Randomized, not treated|2|||
146881872|NCT01929408|529735434|FG000|Overall Study|received HCT as initial treatment|8|||
146881873|NCT00391222|529735437|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
146881874|NCT00391222|529735438|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
146881875|NCT00391222|529735439|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
146881876|NCT00391222|529735440|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
146881877|NCT00391222|529735437|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
146881878|NCT00391222|529735438|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
146881879|NCT00391222|529735439|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
146881880|NCT00391222|529735440|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
146881881|NCT00391222|529735437|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
146881882|NCT00391222|529735438|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
146881883|NCT00391222|529735439|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
146881884|NCT00391222|529735440|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
146881885|NCT00391222|529735437|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
146881886|NCT00391222|529735438|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
146547133|NCT02969018|528509319|FG003|Overall Study|Withdrawal by Subject|1|||
146547134|NCT02969018|528509320|FG004|Overall Study|Withdrawal by Subject|0|||
146547135|NCT02969018|528509321|FG005|Overall Study|Withdrawal by Subject|4|||
146547136|NCT02969018|528509322|FG006|Overall Study|Withdrawal by Subject|4|||
146547137|NCT02969018|528509323|FG007|Overall Study|Withdrawal by Subject|3|||
146547138|NCT02691663|528509326|FG000|Overall Study|Screen failure after baseline|2|||
146547139|NCT02691663|528509327|FG001|Overall Study|Screen failure after baseline|2|||
146547140|NCT02691663|528509326|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
146547141|NCT02691663|528509327|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
146547142|NCT02691663|528509326|FG000|Overall Study|Withdrawn after Follow up 2|1|||
146547143|NCT02691663|528509327|FG001|Overall Study|Withdrawn after Follow up 2|1|||
146881887|NCT00391222|529735439|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
146881888|NCT00391222|529735440|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
146881889|NCT00391222|529735437|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
146881890|NCT00391222|529735438|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
146881891|NCT00391222|529735439|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
146881892|NCT00391222|529735440|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
146881893|NCT00391222|529735437|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
146881894|NCT00391222|529735438|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
146881895|NCT00391222|529735439|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
146881896|NCT00391222|529735440|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
146881897|NCT00391222|529735437|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
146881898|NCT00391222|529735438|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
146881899|NCT00391222|529735439|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
146881900|NCT00391222|529735440|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
146881901|NCT00391222|529735437|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
146881902|NCT00391222|529735438|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
146881903|NCT00391222|529735439|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
146881904|NCT00391222|529735440|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
146881905|NCT00391222|529735437|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
146881906|NCT00391222|529735438|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
146881907|NCT00391222|529735439|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
146881908|NCT00391222|529735440|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
146881909|NCT00391222|529735437|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
146881910|NCT00391222|529735438|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
146881911|NCT00391222|529735439|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
146881912|NCT00391222|529735440|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
146881913|NCT00391222|529735437|FG000|Period III (Double-Blind Treatment)|Other|6|||
146881914|NCT00391222|529735438|FG001|Period III (Double-Blind Treatment)|Other|1|||
146881915|NCT00391222|529735439|FG002|Period III (Double-Blind Treatment)|Other|6|||
146881916|NCT00391222|529735440|FG003|Period III (Double-Blind Treatment)|Other|0|||
146881917|NCT00689871|529735444|FG000|Overall Study|Lost to Follow-up|123|||
146881918|NCT00689871|529735445|FG001|Overall Study|Lost to Follow-up|13|||
146881919|NCT00689871|529735446|FG002|Overall Study|Lost to Follow-up|37|||
146881920|NCT00689871|529735447|FG003|Overall Study|Lost to Follow-up|1|||
146881921|NCT00689871|529735444|FG000|Overall Study|Explanted of All Study Devices|36|||
146881922|NCT00689871|529735445|FG001|Overall Study|Explanted of All Study Devices|25|||
146881923|NCT00689871|529735446|FG002|Overall Study|Explanted of All Study Devices|29|||
146881924|NCT00689871|529735447|FG003|Overall Study|Explanted of All Study Devices|3|||
146881925|NCT00689871|529735444|FG000|Overall Study|Withdrawal by Subject|13|||
146881926|NCT00689871|529735445|FG001|Overall Study|Withdrawal by Subject|3|||
146881927|NCT00689871|529735446|FG002|Overall Study|Withdrawal by Subject|4|||
146881928|NCT00689871|529735447|FG003|Overall Study|Withdrawal by Subject|1|||
146630414|NCT04672239|528824062|FG002|Week 2 Survey|Withdrawal by Subject|0|||
146630415|NCT04672239|528824060|FG000|Week 2 Survey|Lost to Follow-up|3|||
146630416|NCT04672239|528824061|FG001|Week 2 Survey|Lost to Follow-up|2|||
146630417|NCT04672239|528824062|FG002|Week 2 Survey|Lost to Follow-up|5|||
146630418|NCT04672239|528824060|FG000|Week 6 Survey|Failed survey check items|2|||
146630419|NCT04672239|528824061|FG001|Week 6 Survey|Failed survey check items|2|||
146630420|NCT04672239|528824062|FG002|Week 6 Survey|Failed survey check items|2|||
146630421|NCT04672239|528824060|FG000|Week 6 Survey|Partially completed survey|3|||
146630422|NCT04672239|528824061|FG001|Week 6 Survey|Partially completed survey|3|||
146630423|NCT04672239|528824062|FG002|Week 6 Survey|Partially completed survey|2|||
146630424|NCT04672239|528824060|FG000|Week 6 Survey|Withdrawal by Subject|1|||
146765090|NCT03612804|529307248|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
146881929|NCT00689871|529735444|FG000|Overall Study|Death|1|||
146881930|NCT00689871|529735445|FG001|Overall Study|Death|10|||
146881931|NCT00689871|529735446|FG002|Overall Study|Death|2|||
146881932|NCT00689871|529735447|FG003|Overall Study|Death|2|||
146881933|NCT00689871|529735444|FG000|Overall Study|Physician Decision|2|||
146881934|NCT00689871|529735445|FG001|Overall Study|Physician Decision|1|||
146881935|NCT00689871|529735446|FG002|Overall Study|Physician Decision|1|||
146881936|NCT00689871|529735447|FG003|Overall Study|Physician Decision|0|||
146881937|NCT00960843|529735448|FG000|Overall Study|Lost to Follow-up|2|||
146881938|NCT00960843|529735449|FG001|Overall Study|Lost to Follow-up|0|||
146881939|NCT00960843|529735448|FG000|Overall Study|Protocol Violation|0|||
146881940|NCT00960843|529735449|FG001|Overall Study|Protocol Violation|4|||
146881941|NCT00960843|529735448|FG000|Overall Study|Repeated needle dislodgment|0|||
146547144|NCT02691663|528509326|FG000|Overall Study|Lost to Follow-up|3|||
146547145|NCT02691663|528509327|FG001|Overall Study|Lost to Follow-up|2|||
146547146|NCT04425018|528509330|FG000|Overall Study|Withdrawal by Subject|1|||
146547147|NCT04425018|528509331|FG001|Overall Study|Withdrawal by Subject|2|||
146547148|NCT01944774|528509332|FG000|Overall Study|Withdrawal by Subject|2|||
146547149|NCT01944774|528509333|FG001|Overall Study|Withdrawal by Subject|3|||
146547150|NCT01944774|528509334|FG002|Overall Study|Withdrawal by Subject|3|||
146547151|NCT01944774|528509332|FG000|Overall Study|Adverse Event|3|||
146547152|NCT01944774|528509333|FG001|Overall Study|Adverse Event|2|||
146547153|NCT01944774|528509334|FG002|Overall Study|Adverse Event|3|||
146547154|NCT01944774|528509332|FG000|Overall Study|Lack of Efficacy|1|||
146547155|NCT01944774|528509333|FG001|Overall Study|Lack of Efficacy|2|||
146630425|NCT04672239|528824061|FG001|Week 6 Survey|Withdrawal by Subject|1|||
146630426|NCT04672239|528824062|FG002|Week 6 Survey|Withdrawal by Subject|1|||
146881942|NCT00960843|529735449|FG001|Overall Study|Repeated needle dislodgment|1|||
146630427|NCT04672239|528824060|FG000|Week 6 Survey|Withdrawn by PI|0|||
146630428|NCT04672239|528824061|FG001|Week 6 Survey|Withdrawn by PI|1|||
146881943|NCT00652366|529735450|FG000|Overall Study|Adverse Event|8|||
146881944|NCT00652366|529735451|FG001|Overall Study|Adverse Event|4|||
146881945|NCT00652366|529735452|FG002|Overall Study|Adverse Event|7|||
146881946|NCT00652366|529735453|FG003|Overall Study|Adverse Event|17|||
146881947|NCT00652366|529735454|FG004|Overall Study|Adverse Event|13|||
146881948|NCT00652366|529735450|FG000|Overall Study|Death|5|||
146881949|NCT00652366|529735451|FG001|Overall Study|Death|4|||
146881950|NCT00652366|529735452|FG002|Overall Study|Death|1|||
146881951|NCT00652366|529735453|FG003|Overall Study|Death|8|||
146881952|NCT00652366|529735454|FG004|Overall Study|Death|5|||
146881953|NCT00652366|529735450|FG000|Overall Study|Lack of Efficacy|84|||
146881954|NCT00652366|529735451|FG001|Overall Study|Lack of Efficacy|58|||
146881955|NCT00652366|529735452|FG002|Overall Study|Lack of Efficacy|53|||
146881956|NCT00652366|529735453|FG003|Overall Study|Lack of Efficacy|133|||
146881957|NCT00652366|529735454|FG004|Overall Study|Lack of Efficacy|13|||
146881958|NCT00652366|529735450|FG000|Overall Study|Violation of Selection Criteria|0|||
146881959|NCT00652366|529735451|FG001|Overall Study|Violation of Selection Criteria|0|||
146881960|NCT00652366|529735452|FG002|Overall Study|Violation of Selection Criteria|1|||
146881961|NCT00652366|529735453|FG003|Overall Study|Violation of Selection Criteria|0|||
146881962|NCT00652366|529735454|FG004|Overall Study|Violation of Selection Criteria|0|||
146881963|NCT00652366|529735450|FG000|Overall Study|Protocol Violation|1|||
146881964|NCT00652366|529735451|FG001|Overall Study|Protocol Violation|0|||
146881965|NCT00652366|529735452|FG002|Overall Study|Protocol Violation|0|||
146881966|NCT00652366|529735453|FG003|Overall Study|Protocol Violation|0|||
146881967|NCT00652366|529735454|FG004|Overall Study|Protocol Violation|0|||
146881968|NCT00652366|529735450|FG000|Overall Study|Refused treatment|3|||
146881969|NCT00652366|529735451|FG001|Overall Study|Refused treatment|7|||
146881970|NCT00652366|529735452|FG002|Overall Study|Refused treatment|6|||
146881971|NCT00652366|529735453|FG003|Overall Study|Refused treatment|17|||
146881972|NCT00652366|529735454|FG004|Overall Study|Refused treatment|5|||
146881973|NCT00652366|529735450|FG000|Overall Study|Other|5|||
146881974|NCT00652366|529735451|FG001|Overall Study|Other|2|||
146881975|NCT00652366|529735452|FG002|Overall Study|Other|3|||
146881976|NCT00652366|529735453|FG003|Overall Study|Other|4|||
146881977|NCT00652366|529735454|FG004|Overall Study|Other|0|||
146881978|NCT00889265|529735455|FG000|Overall Study|Adverse Event|1|||
146881979|NCT00889265|529735455|FG000|Overall Study|Lost to Follow-up|5|||
146881980|NCT00889265|529735455|FG000|Overall Study|Protocol Violation|1|||
146881981|NCT02069899|529735456|FG000|Overall Study|Adverse Event|6|||
146547156|NCT01944774|528509334|FG002|Overall Study|Lack of Efficacy|2|||
146547157|NCT01944774|528509332|FG000|Overall Study|Lost to Follow-up|0|||
146547158|NCT01944774|528509333|FG001|Overall Study|Lost to Follow-up|1|||
146547159|NCT01944774|528509334|FG002|Overall Study|Lost to Follow-up|0|||
146547160|NCT00866320|528509337|FG000|Overall Study|Withdrawal by Subject|4|||
146547161|NCT00866320|528509337|FG000|Overall Study|Death|2|||
146547162|NCT00387127|528509338|FG000|Overall Study|Lost to Follow-up|0|||
146547163|NCT00387127|528509339|FG001|Overall Study|Lost to Follow-up|4|||
146547164|NCT00387127|528509338|FG000|Overall Study|Death|16|||
146547165|NCT00387127|528509339|FG001|Overall Study|Death|16|||
146547166|NCT00387127|528509338|FG000|Overall Study|Physician Decision|0|||
146547167|NCT00387127|528509339|FG001|Overall Study|Physician Decision|1|||
146547168|NCT00387127|528509338|FG000|Overall Study|Withdrawal by Subject|3|||
146547169|NCT00387127|528509339|FG001|Overall Study|Withdrawal by Subject|2|||
146547170|NCT00387127|528509338|FG000|Overall Study|Required by Protocol Amendment #4|12|||
146547171|NCT00387127|528509339|FG001|Overall Study|Required by Protocol Amendment #4|10|||
146547172|NCT00387127|528509338|FG000|Overall Study|Serious Adverse Event|1|||
146547173|NCT00387127|528509339|FG001|Overall Study|Serious Adverse Event|1|||
146547174|NCT00387127|528509338|FG000|Overall Study|Sponsor Unblinded|1|||
146547175|NCT00387127|528509339|FG001|Overall Study|Sponsor Unblinded|0|||
146881982|NCT02069899|529735457|FG001|Overall Study|Adverse Event|0|||
146881983|NCT02069899|529735458|FG002|Overall Study|Adverse Event|1|||
146547176|NCT05101317|528509340|FG000|Week1-13|Adverse Event|0|||
146547177|NCT05101317|528509341|FG001|Week1-13|Adverse Event|1|||
146547178|NCT05101317|528509342|FG002|Week1-13|Adverse Event|0|||
146547179|NCT05101317|528509343|FG003|Week1-13|Adverse Event|0|||
146881984|NCT02069899|529735456|FG000|Overall Study|Withdrawal by Participant|2|||
146881985|NCT02069899|529735457|FG001|Overall Study|Withdrawal by Participant|0|||
146881986|NCT02069899|529735458|FG002|Overall Study|Withdrawal by Participant|0|||
146547180|NCT05101317|528509340|FG000|Week1-13|Withdrawal by Subject|0|||
146547181|NCT05101317|528509341|FG001|Week1-13|Withdrawal by Subject|2|||
146547182|NCT05101317|528509342|FG002|Week1-13|Withdrawal by Subject|0|||
146547183|NCT05101317|528509343|FG003|Week1-13|Withdrawal by Subject|0|||
146881987|NCT02069899|529735456|FG000|Overall Study|Lost to Follow-up|1|||
146881988|NCT02069899|529735457|FG001|Overall Study|Lost to Follow-up|0|||
146547184|NCT05101317|528509340|FG000|Week1-13|Early Withdrawl|0|||
146547185|NCT05101317|528509341|FG001|Week1-13|Early Withdrawl|0|||
146881989|NCT02069899|529735458|FG002|Overall Study|Lost to Follow-up|1|||
146881990|NCT02069899|529735456|FG000|Overall Study|Other|4|||
146881991|NCT02069899|529735457|FG001|Overall Study|Other|0|||
146881992|NCT02069899|529735458|FG002|Overall Study|Other|0|||
146881993|NCT02069899|529735456|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
146881994|NCT02069899|529735457|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
146881995|NCT02069899|529735458|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
146881996|NCT02069899|529735456|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
146881997|NCT02069899|529735457|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
146881998|NCT02069899|529735458|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
146881999|NCT00531752|529735461|FG000|First Double-blind Intervention Period|Adverse Event|2|||
146882000|NCT00531752|529735462|FG001|First Double-blind Intervention Period|Adverse Event|0|||
146882001|NCT00531752|529735463|FG002|First Double-blind Intervention Period|Adverse Event|1|||
146882002|NCT00531752|529735464|FG003|First Double-blind Intervention Period|Adverse Event|1|||
146882003|NCT00531752|529735461|FG000|First Double-blind Intervention Period|Other|1|||
146882004|NCT00531752|529735462|FG001|First Double-blind Intervention Period|Other|4|||
146882005|NCT00531752|529735463|FG002|First Double-blind Intervention Period|Other|4|||
146882006|NCT00531752|529735464|FG003|First Double-blind Intervention Period|Other|0|||
146882007|NCT00531752|529735461|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
146882008|NCT00531752|529735462|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
146882009|NCT00531752|529735463|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
146882010|NCT00531752|529735464|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
146882011|NCT00531752|529735461|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
146882012|NCT00531752|529735462|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
146882013|NCT00531752|529735463|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
146882014|NCT00531752|529735464|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
146882015|NCT00531752|529735461|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
146882016|NCT00531752|529735462|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
146882017|NCT00531752|529735463|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
146882018|NCT00531752|529735464|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
146882019|NCT00531752|529735461|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
146882020|NCT00531752|529735462|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
146882021|NCT00531752|529735463|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
146882022|NCT00531752|529735464|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
146882023|NCT00531752|529735461|FG000|Second Double-blind Intervention Period|Other|1|||
146882024|NCT00531752|529735462|FG001|Second Double-blind Intervention Period|Other|1|||
146882025|NCT00531752|529735463|FG002|Second Double-blind Intervention Period|Other|0|||
146882026|NCT00531752|529735464|FG003|Second Double-blind Intervention Period|Other|0|||
146882027|NCT00531752|529735461|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
146882028|NCT00531752|529735462|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
146882029|NCT00531752|529735463|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
146882030|NCT00531752|529735464|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
146882031|NCT00531752|529735461|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
146882032|NCT00531752|529735462|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
146882033|NCT00531752|529735463|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
146882034|NCT00531752|529735464|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
146882035|NCT00490451|529735465|FG000|Overall Study|Adverse Event|3|||
146882036|NCT00490451|529735466|FG001|Overall Study|Adverse Event|3|||
146882037|NCT00490451|529735465|FG000|Overall Study|Death|3|||
146882038|NCT00490451|529735466|FG001|Overall Study|Death|1|||
146547186|NCT05101317|528509342|FG002|Week1-13|Early Withdrawl|0|||
146547187|NCT05101317|528509343|FG003|Week1-13|Early Withdrawl|1|||
146547188|NCT05101317|528509340|FG000|Week 13-25|Lost to Follow-up|0|||
146882039|NCT00490451|529735465|FG000|Overall Study|Withdrawal by Subject|2|||
146882040|NCT00490451|529735466|FG001|Overall Study|Withdrawal by Subject|0|||
146882041|NCT00490451|529735465|FG000|Overall Study|Investigator Decision|1|||
146882042|NCT00490451|529735466|FG001|Overall Study|Investigator Decision|0|||
146882043|NCT00490451|529735465|FG000|Overall Study|Protocol Violation|1|||
146882044|NCT00490451|529735466|FG001|Overall Study|Protocol Violation|0|||
146882045|NCT00490451|529735465|FG000|Overall Study|Progressive Disease|53|||
146882046|NCT00490451|529735466|FG001|Overall Study|Progressive Disease|34|||
146882047|NCT01181011|529735467|FG000|Overall Study|Adverse Event|2|||
146882048|NCT01181011|529735467|FG000|Overall Study|Lost to Follow-up|1|||
146882049|NCT04703075|529735468|FG000|Overall Study|Adverse Event|11|||
146882050|NCT04703075|529735469|FG001|Overall Study|Adverse Event|7|||
146882051|NCT04703075|529735468|FG000|Overall Study|Lost to Follow-up|6|||
146882052|NCT04703075|529735469|FG001|Overall Study|Lost to Follow-up|12|||
146882053|NCT04703075|529735468|FG000|Overall Study|Physician Decision|3|||
146882054|NCT04703075|529735469|FG001|Overall Study|Physician Decision|0|||
146882055|NCT04703075|529735468|FG000|Overall Study|Moved|0|||
146882056|NCT04703075|529735469|FG001|Overall Study|Moved|2|||
146882057|NCT04703075|529735468|FG000|Overall Study|Index INH Resistant|0|||
146882058|NCT04703075|529735469|FG001|Overall Study|Index INH Resistant|1|||
146547189|NCT05101317|528509341|FG001|Week 13-25|Lost to Follow-up|0|||
146882059|NCT04703075|529735468|FG000|Overall Study|Lack of Efficacy|6|||
146882060|NCT04703075|529735469|FG001|Overall Study|Lack of Efficacy|18|||
146882061|NCT00254501|529735472|FG000|Overall Study|Lost to Follow-up|1|||
146882062|NCT00254501|529735473|FG001|Overall Study|Lost to Follow-up|1|||
146882063|NCT00250835|529735478|FG000|Overall Study|Withdrawal by Subject|1|||
146882064|NCT01035905|529735482|FG000|Overall Study|Lack of Efficacy|1|||
146882065|NCT01035905|529735483|FG001|Overall Study|Lack of Efficacy|1|||
146882066|NCT04942925|529735484|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
146882067|NCT04942925|529735485|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
146882068|NCT04942925|529735484|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
146882069|NCT04942925|529735485|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
146882070|NCT03368170|529737091|FG000|Overall Study|Adverse Event|2|||
146882071|NCT03368170|529737092|FG001|Overall Study|Adverse Event|1|||
146882072|NCT02164981|529737096|FG000|Started|Withdrawal by Subject|2|||
146882073|NCT02164981|529737097|FG001|Started|Withdrawal by Subject|1|||
146882074|NCT02164981|529737098|FG002|Started|Withdrawal by Subject|0|||
146882075|NCT02164981|529737096|FG000|Started|Protocol Violation|2|||
146882076|NCT02164981|529737097|FG001|Started|Protocol Violation|0|||
146882077|NCT02164981|529737098|FG002|Started|Protocol Violation|0|||
146882078|NCT02164981|529737096|FG000|Started|Adverse Event|1|||
146882079|NCT02164981|529737097|FG001|Started|Adverse Event|2|||
146882080|NCT02164981|529737098|FG002|Started|Adverse Event|0|||
146882081|NCT02164981|529737096|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
146882082|NCT02164981|529737097|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
146882083|NCT02164981|529737098|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
146882084|NCT02164981|529737096|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
146882085|NCT02164981|529737097|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
146882086|NCT02164981|529737098|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
146882087|NCT02164981|529737096|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
146882088|NCT02164981|529737097|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
146882089|NCT02164981|529737098|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
146882090|NCT01736579|529737099|FG000|Overall Study|Termination of Study by Sponsor|2|||
146882091|NCT01736579|529737100|FG001|Overall Study|Termination of Study by Sponsor|2|||
146882092|NCT02543528|529737107|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
146882093|NCT02543528|529737108|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
146882094|NCT02543528|529737109|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
146882095|NCT02543528|529737110|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
146882096|NCT02543528|529737111|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
146882097|NCT02543528|529737107|FG000|Adaptation Period|Lens Handling Difficultes|0|||
146882098|NCT02543528|529737108|FG001|Adaptation Period|Lens Handling Difficultes|0|||
146882099|NCT02543528|529737109|FG002|Adaptation Period|Lens Handling Difficultes|0|||
146882100|NCT02543528|529737110|FG003|Adaptation Period|Lens Handling Difficultes|0|||
146882101|NCT02543528|529737111|FG004|Adaptation Period|Lens Handling Difficultes|8|||
146882102|NCT02543528|529737107|FG000|Adaptation Period|Lost to Follow-up|0|||
146882103|NCT02543528|529737108|FG001|Adaptation Period|Lost to Follow-up|0|||
146882104|NCT02543528|529737109|FG002|Adaptation Period|Lost to Follow-up|0|||
146882105|NCT02543528|529737110|FG003|Adaptation Period|Lost to Follow-up|0|||
146882106|NCT02543528|529737111|FG004|Adaptation Period|Lost to Follow-up|14|||
146882107|NCT02543528|529737107|FG000|Adaptation Period|Adverse Event|0|||
146882108|NCT02543528|529737108|FG001|Adaptation Period|Adverse Event|0|||
146882109|NCT02543528|529737109|FG002|Adaptation Period|Adverse Event|0|||
146882110|NCT02543528|529737110|FG003|Adaptation Period|Adverse Event|0|||
146882111|NCT02543528|529737111|FG004|Adaptation Period|Adverse Event|2|||
146882112|NCT02543528|529737107|FG000|Extended Wear Period|Adverse Event|17|||
146882113|NCT02543528|529737108|FG001|Extended Wear Period|Adverse Event|11|||
146882114|NCT02543528|529737109|FG002|Extended Wear Period|Adverse Event|16|||
146882115|NCT02543528|529737110|FG003|Extended Wear Period|Adverse Event|3|||
146882116|NCT02543528|529737111|FG004|Extended Wear Period|Adverse Event|0|||
146882117|NCT02543528|529737107|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
146882118|NCT02543528|529737108|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
146882119|NCT02543528|529737109|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
146882120|NCT02543528|529737110|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
146882121|NCT02543528|529737111|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
146882122|NCT02543528|529737107|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
146882123|NCT02543528|529737108|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
146882124|NCT02543528|529737109|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
146882125|NCT02543528|529737110|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
146882126|NCT02543528|529737111|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
146882127|NCT02543528|529737107|FG000|Extended Wear Period|Lost to Follow-up|0|||
146882128|NCT02543528|529737108|FG001|Extended Wear Period|Lost to Follow-up|1|||
146882129|NCT02543528|529737109|FG002|Extended Wear Period|Lost to Follow-up|2|||
146882130|NCT02543528|529737110|FG003|Extended Wear Period|Lost to Follow-up|1|||
146882131|NCT02543528|529737111|FG004|Extended Wear Period|Lost to Follow-up|0|||
146882132|NCT02543528|529737107|FG000|Extended Wear Period|Withdrawal by Subject|10|||
146882133|NCT02543528|529737108|FG001|Extended Wear Period|Withdrawal by Subject|9|||
146882134|NCT02543528|529737109|FG002|Extended Wear Period|Withdrawal by Subject|4|||
146882135|NCT02543528|529737110|FG003|Extended Wear Period|Withdrawal by Subject|5|||
146882136|NCT02543528|529737111|FG004|Extended Wear Period|Withdrawal by Subject|0|||
146882137|NCT01408147|529737112|FG000|Overall Study|Withdrawal by Subject|0|||
146882138|NCT01408147|529737113|FG001|Overall Study|Withdrawal by Subject|1|||
146882139|NCT01761266|529737114|FG000|Overall Study|Death|415|||
146882140|NCT01761266|529737115|FG001|Overall Study|Death|402|||
146882141|NCT01761266|529737114|FG000|Overall Study|Lost to Follow-up|8|||
146882142|NCT01761266|529737115|FG001|Overall Study|Lost to Follow-up|12|||
146882143|NCT01761266|529737114|FG000|Overall Study|Withdrawal by Subject|14|||
146882144|NCT01761266|529737115|FG001|Overall Study|Withdrawal by Subject|10|||
146882145|NCT01761266|529737114|FG000|Overall Study|Sponsor Decision|41|||
146882146|NCT01761266|529737115|FG001|Overall Study|Sponsor Decision|52|||
146882147|NCT05048719|529737116|FG000|Overall Study|Withdrawal by Subject|2|||
146882148|NCT05048719|529737117|FG001|Overall Study|Withdrawal by Subject|1|||
146882149|NCT05048719|529737118|FG002|Overall Study|Withdrawal by Subject|3|||
146882150|NCT05048719|529737119|FG003|Overall Study|Withdrawal by Subject|1|||
146882151|NCT05048719|529737120|FG004|Overall Study|Withdrawal by Subject|0|||
146882152|NCT05048719|529737121|FG005|Overall Study|Withdrawal by Subject|2|||
146882153|NCT05048719|529737122|FG006|Overall Study|Withdrawal by Subject|1|||
146882154|NCT05048719|529737123|FG007|Overall Study|Withdrawal by Subject|1|||
146547190|NCT05101317|528509342|FG002|Week 13-25|Lost to Follow-up|1|||
146547191|NCT05101317|528509343|FG003|Week 13-25|Lost to Follow-up|0|||
146547192|NCT05101317|528509340|FG000|Week 13-25|Withdrawal by Subject|1|||
146547193|NCT05101317|528509341|FG001|Week 13-25|Withdrawal by Subject|1|||
146547194|NCT05101317|528509342|FG002|Week 13-25|Withdrawal by Subject|0|||
146547195|NCT05101317|528509343|FG003|Week 13-25|Withdrawal by Subject|0|||
146547196|NCT05101317|528509340|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
146547197|NCT05101317|528509341|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
146547198|NCT05101317|528509342|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
146547199|NCT05101317|528509343|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
146547200|NCT01327703|528509344|FG000|Second Treatment Period|Adverse Event|1|||
146547201|NCT01327703|528509345|FG001|Second Treatment Period|Adverse Event|1|||
146547202|NCT01327703|528509344|FG000|Second Treatment Period|Protocol Violation|0|||
146547203|NCT01327703|528509345|FG001|Second Treatment Period|Protocol Violation|1|||
146547204|NCT00812097|528509346|FG000|Overall Study|Death|3|||
146547205|NCT00812097|528509347|FG001|Overall Study|Death|10|||
146882155|NCT05048719|529737124|FG008|Overall Study|Withdrawal by Subject|0|||
146882156|NCT05048719|529737116|FG000|Overall Study|Death|1|||
146882157|NCT05048719|529737117|FG001|Overall Study|Death|0|||
146882158|NCT05048719|529737118|FG002|Overall Study|Death|0|||
146882159|NCT05048719|529737119|FG003|Overall Study|Death|0|||
146882160|NCT05048719|529737120|FG004|Overall Study|Death|0|||
146882161|NCT05048719|529737121|FG005|Overall Study|Death|0|||
146547206|NCT00812097|528509348|FG002|Overall Study|Death|3|||
146547207|NCT00812097|528509349|FG003|Overall Study|Death|3|||
146547208|NCT00812097|528509346|FG000|Overall Study|Withdrawal by Subject|14|||
146547209|NCT00812097|528509347|FG001|Overall Study|Withdrawal by Subject|12|||
146547210|NCT00812097|528509348|FG002|Overall Study|Withdrawal by Subject|8|||
146882162|NCT05048719|529737122|FG006|Overall Study|Death|0|||
146882163|NCT05048719|529737123|FG007|Overall Study|Death|0|||
146882164|NCT05048719|529737124|FG008|Overall Study|Death|0|||
146882165|NCT05048719|529737116|FG000|Overall Study|Adverse Event|0|||
146882166|NCT05048719|529737117|FG001|Overall Study|Adverse Event|1|||
146882167|NCT05048719|529737118|FG002|Overall Study|Adverse Event|2|||
146882168|NCT05048719|529737119|FG003|Overall Study|Adverse Event|0|||
146882169|NCT05048719|529737120|FG004|Overall Study|Adverse Event|1|||
146882170|NCT05048719|529737121|FG005|Overall Study|Adverse Event|0|||
146882171|NCT05048719|529737122|FG006|Overall Study|Adverse Event|0|||
146882172|NCT05048719|529737123|FG007|Overall Study|Adverse Event|0|||
146882173|NCT05048719|529737124|FG008|Overall Study|Adverse Event|0|||
146882174|NCT05048719|529737116|FG000|Overall Study|Lost to Follow-up|0|||
146882175|NCT05048719|529737117|FG001|Overall Study|Lost to Follow-up|0|||
146882176|NCT05048719|529737118|FG002|Overall Study|Lost to Follow-up|1|||
146882177|NCT05048719|529737119|FG003|Overall Study|Lost to Follow-up|3|||
146882178|NCT05048719|529737120|FG004|Overall Study|Lost to Follow-up|1|||
146882179|NCT05048719|529737121|FG005|Overall Study|Lost to Follow-up|1|||
146882180|NCT05048719|529737122|FG006|Overall Study|Lost to Follow-up|1|||
146882181|NCT05048719|529737123|FG007|Overall Study|Lost to Follow-up|1|||
146882182|NCT05048719|529737124|FG008|Overall Study|Lost to Follow-up|0|||
146882183|NCT05048719|529737116|FG000|Overall Study|Physician Decision|0|||
146882184|NCT05048719|529737117|FG001|Overall Study|Physician Decision|0|||
146882185|NCT05048719|529737118|FG002|Overall Study|Physician Decision|0|||
146882186|NCT05048719|529737119|FG003|Overall Study|Physician Decision|0|||
146882187|NCT05048719|529737120|FG004|Overall Study|Physician Decision|0|||
146882188|NCT05048719|529737121|FG005|Overall Study|Physician Decision|0|||
146882189|NCT05048719|529737122|FG006|Overall Study|Physician Decision|0|||
146882190|NCT05048719|529737123|FG007|Overall Study|Physician Decision|1|||
146882191|NCT05048719|529737124|FG008|Overall Study|Physician Decision|1|||
146882192|NCT05048719|529737116|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
146882193|NCT05048719|529737117|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
146882194|NCT05048719|529737118|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
146882195|NCT05048719|529737119|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
146882196|NCT05048719|529737120|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
146882197|NCT05048719|529737121|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
146882198|NCT05048719|529737122|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
146882199|NCT05048719|529737123|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
146882200|NCT05048719|529737124|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
146882201|NCT05048719|529737116|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
146882202|NCT05048719|529737117|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
146882203|NCT05048719|529737118|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
146882204|NCT05048719|529737119|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
146882205|NCT05048719|529737120|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
146882206|NCT05048719|529737121|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
146882207|NCT05048719|529737122|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
146882208|NCT05048719|529737123|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
146882209|NCT05048719|529737124|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
146882210|NCT05048719|529737116|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
146882211|NCT05048719|529737117|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
146882212|NCT05048719|529737118|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
146882213|NCT05048719|529737119|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
146547211|NCT00812097|528509349|FG003|Overall Study|Withdrawal by Subject|2|||
146547212|NCT00812097|528509346|FG000|Overall Study|Lost to Follow-up|90|||
146547213|NCT00812097|528509347|FG001|Overall Study|Lost to Follow-up|14|||
146547214|NCT00812097|528509348|FG002|Overall Study|Lost to Follow-up|17|||
146547215|NCT00812097|528509349|FG003|Overall Study|Lost to Follow-up|5|||
146547216|NCT00812097|528509346|FG000|Overall Study|Explantation of study device(s)|27|||
146547217|NCT00812097|528509347|FG001|Overall Study|Explantation of study device(s)|29|||
146547218|NCT00812097|528509348|FG002|Overall Study|Explantation of study device(s)|14|||
146547219|NCT00812097|528509349|FG003|Overall Study|Explantation of study device(s)|20|||
146547220|NCT00812097|528509346|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
146547221|NCT00812097|528509347|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
146547222|NCT00812097|528509348|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
146547223|NCT00812097|528509349|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
146547224|NCT02513563|528509353|FG000|Overall Study|Death|4|||
146547225|NCT02513563|528509353|FG000|Overall Study|Withdrawal by Subject|4|||
146547226|NCT02513563|528509353|FG000|Overall Study|Physician Decision|1|||
146547227|NCT03674411|528509356|FG000|Overall Study|Non-treatment|4|||
146547228|NCT06038643|528509360|FG000|Overall Study|Withdrawal by Subject|9|||
146547229|NCT06038643|528509361|FG001|Overall Study|Withdrawal by Subject|4|||
146547230|NCT06038643|528509360|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
146547231|NCT06038643|528509361|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
146547232|NCT02227199|528509362|FG000|Overall Study|Physician Decision|0|||
146547233|NCT02227199|528509363|FG001|Overall Study|Physician Decision|0|||
146547234|NCT02227199|528509364|FG002|Overall Study|Physician Decision|1|||
146547235|NCT02227199|528509362|FG000|Overall Study|Adverse Event|0|||
146547236|NCT02227199|528509363|FG001|Overall Study|Adverse Event|0|||
146547237|NCT02227199|528509364|FG002|Overall Study|Adverse Event|3|||
146547238|NCT03998462|528509366|FG000|Overall Study|Withdrawal by Subject|10|||
146547239|NCT03998462|528509367|FG001|Overall Study|Withdrawal by Subject|4|||
146547240|NCT03998462|528509366|FG000|Overall Study|Lost to Follow-up|1|||
146882214|NCT05048719|529737120|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
146882215|NCT05048719|529737121|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
146882216|NCT05048719|529737122|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
146882217|NCT05048719|529737123|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
146882218|NCT05048719|529737124|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
146882219|NCT05048719|529737116|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
146882220|NCT05048719|529737117|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
146882221|NCT05048719|529737118|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
146882222|NCT05048719|529737119|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
146882223|NCT05048719|529737120|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
146882224|NCT05048719|529737121|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
146882225|NCT05048719|529737122|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
146882226|NCT05048719|529737123|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
146882227|NCT05048719|529737124|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
146882228|NCT05048719|529737116|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
146882229|NCT05048719|529737117|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
146882230|NCT05048719|529737118|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
146882231|NCT05048719|529737119|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
146882232|NCT05048719|529737120|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
146882233|NCT05048719|529737121|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
146882234|NCT05048719|529737122|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
146882235|NCT05048719|529737123|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
146882236|NCT05048719|529737124|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
146547241|NCT03998462|528509367|FG001|Overall Study|Lost to Follow-up|0|||
146547242|NCT03998462|528509366|FG000|Overall Study|Technical Difficulties|1|||
146547243|NCT03998462|528509367|FG001|Overall Study|Technical Difficulties|2|||
146547244|NCT05710224|528509368|FG000|Overall Study|Death|1|||
146547245|NCT05710224|528509369|FG001|Overall Study|Death|0|||
146547246|NCT05710224|528509368|FG000|Overall Study|Lost to Follow-up|16|||
146547247|NCT05710224|528509369|FG001|Overall Study|Lost to Follow-up|7|||
146882237|NCT03257267|529737127|FG000|Overall Study|Adverse Event|17|||
146882238|NCT03257267|529737128|FG001|Overall Study|Adverse Event|7|||
146882239|NCT03257267|529737127|FG000|Overall Study|Death|96|||
146882240|NCT03257267|529737128|FG001|Overall Study|Death|98|||
146882241|NCT03257267|529737127|FG000|Overall Study|Lost to Follow-up|2|||
146882242|NCT03257267|529737128|FG001|Overall Study|Lost to Follow-up|2|||
146882243|NCT03257267|529737127|FG000|Overall Study|Non-compliance with Study Drug|0|||
146882244|NCT03257267|529737128|FG001|Overall Study|Non-compliance with Study Drug|2|||
146882245|NCT03257267|529737127|FG000|Overall Study|Participant Decision|35|||
146882246|NCT03257267|529737128|FG001|Overall Study|Participant Decision|43|||
146882247|NCT03257267|529737127|FG000|Overall Study|Sponsor Decision|1|||
146882248|NCT03257267|529737128|FG001|Overall Study|Sponsor Decision|0|||
146882249|NCT03257267|529737127|FG000|Overall Study|Physician Decision|1|||
146882250|NCT03257267|529737128|FG001|Overall Study|Physician Decision|3|||
146882251|NCT03257267|529737127|FG000|Overall Study|Disease Progression|109|||
146882252|NCT03257267|529737128|FG001|Overall Study|Disease Progression|121|||
146882253|NCT03257267|529737127|FG000|Overall Study|Withdrawal by Subject|8|||
146882254|NCT03257267|529737128|FG001|Overall Study|Withdrawal by Subject|26|||
146882255|NCT03257267|529737127|FG000|Overall Study|Other|0|||
146882256|NCT03257267|529737128|FG001|Overall Study|Other|2|||
146882257|NCT03445000|529737129|FG000|Overall Study|Disease progression|8|||
146882258|NCT03445000|529737129|FG000|Overall Study|Adverse Event|3|||
146882259|NCT03445000|529737129|FG000|Overall Study|Death|2|||
146882260|NCT03445000|529737129|FG000|Overall Study|Physician Decision|1|||
146882261|NCT00706134|529737130|FG000|Overall Study|Adverse Event|8|||
146882262|NCT00706134|529737131|FG001|Overall Study|Adverse Event|7|||
146882263|NCT00706134|529737132|FG002|Overall Study|Adverse Event|2|||
146882264|NCT00706134|529737133|FG003|Overall Study|Adverse Event|3|||
146882265|NCT00706134|529737130|FG000|Overall Study|Lost to Follow-up|0|||
146882266|NCT00706134|529737131|FG001|Overall Study|Lost to Follow-up|1|||
146882267|NCT00706134|529737132|FG002|Overall Study|Lost to Follow-up|0|||
146882268|NCT00706134|529737133|FG003|Overall Study|Lost to Follow-up|0|||
146882269|NCT00706134|529737130|FG000|Overall Study|Protocol Violation|0|||
146882270|NCT00706134|529737131|FG001|Overall Study|Protocol Violation|6|||
146882271|NCT00706134|529737132|FG002|Overall Study|Protocol Violation|0|||
146882272|NCT00706134|529737133|FG003|Overall Study|Protocol Violation|3|||
146882273|NCT00706134|529737130|FG000|Overall Study|Withdrawal by Subject|1|||
146882274|NCT00706134|529737131|FG001|Overall Study|Withdrawal by Subject|2|||
146882275|NCT00706134|529737132|FG002|Overall Study|Withdrawal by Subject|1|||
146882276|NCT00706134|529737133|FG003|Overall Study|Withdrawal by Subject|0|||
146882277|NCT00706134|529737130|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
146882278|NCT00706134|529737131|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
146882279|NCT00706134|529737132|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
146882280|NCT00706134|529737133|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
146882281|NCT00706134|529737130|FG000|Overall Study|Did not meet study criteria|2|||
146882282|NCT00706134|529737131|FG001|Overall Study|Did not meet study criteria|0|||
146882283|NCT00706134|529737132|FG002|Overall Study|Did not meet study criteria|0|||
146882284|NCT00706134|529737133|FG003|Overall Study|Did not meet study criteria|0|||
146882285|NCT00746252|529737136|FG000|Overall Study|weight gain >7.5 %|1|||
146882286|NCT00746252|529737137|FG001|Overall Study|weight gain >7.5 %|2|||
146882287|NCT01391000|529737138|FG000|Overall Study|Lost to Follow-up|2|||
146882288|NCT01391000|529737139|FG001|Overall Study|Lost to Follow-up|0|||
146882289|NCT00082888|529737140|FG000|Overall Study|Ineligible|1|||
146882290|NCT00082888|529737141|FG001|Overall Study|Ineligible|0|||
146882291|NCT00082888|529737142|FG002|Overall Study|Ineligible|0|||
146882292|NCT02684981|529737145|FG000|Overall Study|Permanently discontinued the treatment|157|||
146882293|NCT02684981|529737146|FG001|Overall Study|Permanently discontinued the treatment|161|||
146882294|NCT02684981|529737147|FG002|Overall Study|Permanently discontinued the treatment|110|||
146882295|NCT02684981|529737145|FG000|Overall Study|Other|83|||
146882296|NCT02684981|529737146|FG001|Overall Study|Other|49|||
146882297|NCT02684981|529737147|FG002|Overall Study|Other|17|||
146882298|NCT00820898|529737150|FG000|Overall Study|Inelgible - wrong primary site|1|||
146882299|NCT00452699|529737153|FG000|Overall Study|Adverse Event|10|||
146882300|NCT00452699|529737154|FG001|Overall Study|Adverse Event|3|||
146882301|NCT00452699|529737153|FG000|Overall Study|Lack of Efficacy|6|||
146882302|NCT00452699|529737154|FG001|Overall Study|Lack of Efficacy|4|||
146882303|NCT00452699|529737153|FG000|Overall Study|Lost to Follow-up|6|||
146882304|NCT00452699|529737154|FG001|Overall Study|Lost to Follow-up|9|||
146882305|NCT00452699|529737153|FG000|Overall Study|Protocol Violation|21|||
146547248|NCT05710224|528509368|FG000|Overall Study|Withdrawal by Subject|4|||
146882306|NCT00452699|529737154|FG001|Overall Study|Protocol Violation|25|||
146882307|NCT00452699|529737153|FG000|Overall Study|Withdrawal by Subject|26|||
146882308|NCT00452699|529737154|FG001|Overall Study|Withdrawal by Subject|25|||
146882309|NCT00452699|529737153|FG000|Overall Study|Other|12|||
146882310|NCT00452699|529737154|FG001|Overall Study|Other|7|||
146882311|NCT02921971|529737155|FG000|Overall Study|Adverse Event|1|||
146882312|NCT02921971|529737156|FG001|Overall Study|Adverse Event|2|||
146882313|NCT02921971|529737155|FG000|Overall Study|Lack of Efficacy|3|||
146882314|NCT02921971|529737156|FG001|Overall Study|Lack of Efficacy|1|||
146882315|NCT02921971|529737155|FG000|Overall Study|Other than specified above|2|||
146882316|NCT02921971|529737156|FG001|Overall Study|Other than specified above|1|||
146882317|NCT02228590|529737171|FG000|Overall Study|Withdrawal by Subject|1|||
146882318|NCT02111993|529737172|FG000|Overall Study|Physician Decision|5|||
146882319|NCT02111993|529737173|FG001|Overall Study|Physician Decision|4|||
146882320|NCT01097863|529737174|FG000|Overall Study|Discomfort|1|||
146882321|NCT01097863|529737175|FG001|Overall Study|Discomfort|0|||
146882322|NCT01097863|529737176|FG002|Overall Study|Discomfort|1|||
146882323|NCT01097863|529737174|FG000|Overall Study|Did not return for final visit|0|||
146882324|NCT01097863|529737175|FG001|Overall Study|Did not return for final visit|0|||
146882325|NCT01097863|529737176|FG002|Overall Study|Did not return for final visit|1|||
146882326|NCT00796315|529737177|FG000|Overall Study|Protocol Violation|0|||
146882327|NCT00796315|529737178|FG001|Overall Study|Protocol Violation|1|||
146882328|NCT00796315|529737179|FG002|Overall Study|Protocol Violation|0|||
146882329|NCT01400451|529737186|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
146882330|NCT01400451|529737187|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
146882331|NCT01400451|529737188|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
146882332|NCT01400451|529737186|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
146882333|NCT01400451|529737187|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
146882334|NCT01400451|529737188|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
146882335|NCT01400451|529737186|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
146547249|NCT05710224|528509369|FG001|Overall Study|Withdrawal by Subject|6|||
146547250|NCT05710224|528509368|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
146547251|NCT05710224|528509369|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
146547252|NCT05710224|528509368|FG000|Overall Study|Participants Left The City|0|||
146547253|NCT05710224|528509369|FG001|Overall Study|Participants Left The City|2|||
146547254|NCT03573882|528509370|FG000|Overall Study|Study Terminated by Sponsor|22|||
146547255|NCT03573882|528509371|FG001|Overall Study|Study Terminated by Sponsor|17|||
146547256|NCT03573882|528509372|FG002|Overall Study|Study Terminated by Sponsor|18|||
146547257|NCT03573882|528509370|FG000|Overall Study|Withdrawal by Subject|6|||
146547258|NCT03573882|528509371|FG001|Overall Study|Withdrawal by Subject|11|||
146547259|NCT03573882|528509372|FG002|Overall Study|Withdrawal by Subject|7|||
146547260|NCT03573882|528509370|FG000|Overall Study|Adverse Event|7|||
146547261|NCT03573882|528509371|FG001|Overall Study|Adverse Event|5|||
146547262|NCT03573882|528509372|FG002|Overall Study|Adverse Event|6|||
146547263|NCT03573882|528509370|FG000|Overall Study|Lost to Follow-up|2|||
146547264|NCT03573882|528509371|FG001|Overall Study|Lost to Follow-up|5|||
146547265|NCT03573882|528509372|FG002|Overall Study|Lost to Follow-up|3|||
146547266|NCT03573882|528509370|FG000|Overall Study|Physician Decision|4|||
146547267|NCT03573882|528509371|FG001|Overall Study|Physician Decision|3|||
146547268|NCT03573882|528509372|FG002|Overall Study|Physician Decision|2|||
146547269|NCT03573882|528509370|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
146547270|NCT03573882|528509371|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
146547271|NCT03573882|528509372|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
146547272|NCT03573882|528509370|FG000|Overall Study|Pregnancy|1|||
146547273|NCT03573882|528509371|FG001|Overall Study|Pregnancy|2|||
146547274|NCT03573882|528509372|FG002|Overall Study|Pregnancy|0|||
146547275|NCT03573882|528509370|FG000|Overall Study|Other|4|||
146547276|NCT03573882|528509371|FG001|Overall Study|Other|2|||
146547277|NCT03573882|528509372|FG002|Overall Study|Other|2|||
146547278|NCT02965833|528509374|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
146547279|NCT02965833|528509375|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
146547280|NCT02965833|528509374|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
146547281|NCT02965833|528509375|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
146547282|NCT02965833|528509374|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
146547283|NCT02965833|528509375|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
146547284|NCT02965833|528509374|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
146547285|NCT02965833|528509375|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
146547286|NCT02965833|528509374|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
146547287|NCT02965833|528509375|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
146547288|NCT03370302|528509379|FG000|Dose Escalation Phase|Other|0|||
146547289|NCT03370302|528509380|FG001|Dose Escalation Phase|Other|1|||
146547290|NCT03370302|528509381|FG002|Dose Escalation Phase|Other|1|||
146547291|NCT03370302|528509382|FG003|Dose Escalation Phase|Other|0|||
146547292|NCT03370302|528509383|FG004|Dose Escalation Phase|Other|0|||
146547293|NCT03370302|528509384|FG005|Dose Escalation Phase|Other|0|||
146547294|NCT03370302|528509379|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
146547295|NCT03370302|528509380|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
146547296|NCT03370302|528509381|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
146547297|NCT03370302|528509382|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
146547298|NCT03370302|528509383|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
146547299|NCT03370302|528509384|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
146547300|NCT03370302|528509379|FG000|Dose Escalation Phase|Adverse Event|1|||
146547301|NCT03370302|528509380|FG001|Dose Escalation Phase|Adverse Event|0|||
146882336|NCT01400451|529737187|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
146882337|NCT01400451|529737188|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
146882338|NCT01400451|529737186|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
146882339|NCT01400451|529737187|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
146882340|NCT01400451|529737188|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
146882341|NCT01400451|529737186|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
146882342|NCT01400451|529737187|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
146882343|NCT01400451|529737188|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
146882344|NCT03028870|529737193|FG000|Overall Study|Adverse Event|7|||
146882345|NCT03028870|529737194|FG001|Overall Study|Adverse Event|4|||
146882346|NCT03028870|529737195|FG002|Overall Study|Adverse Event|3|||
146882347|NCT03028870|529737196|FG003|Overall Study|Adverse Event|3|||
146882348|NCT03028870|529737193|FG000|Overall Study|Withdrawal by Subject|1|||
146882349|NCT03028870|529737194|FG001|Overall Study|Withdrawal by Subject|1|||
146882350|NCT03028870|529737195|FG002|Overall Study|Withdrawal by Subject|1|||
146882351|NCT03028870|529737196|FG003|Overall Study|Withdrawal by Subject|2|||
146882352|NCT03028870|529737193|FG000|Overall Study|Lost to Follow-up|1|||
146882353|NCT03028870|529737194|FG001|Overall Study|Lost to Follow-up|0|||
146882354|NCT03028870|529737195|FG002|Overall Study|Lost to Follow-up|0|||
146882355|NCT03028870|529737196|FG003|Overall Study|Lost to Follow-up|0|||
146882356|NCT03028870|529737193|FG000|Overall Study|Lack of Efficacy|3|||
146882357|NCT03028870|529737194|FG001|Overall Study|Lack of Efficacy|0|||
146882358|NCT03028870|529737195|FG002|Overall Study|Lack of Efficacy|0|||
146882359|NCT03028870|529737196|FG003|Overall Study|Lack of Efficacy|0|||
146882360|NCT03028870|529737193|FG000|Overall Study|Administrative|5|||
146882361|NCT03028870|529737194|FG001|Overall Study|Administrative|5|||
146882362|NCT03028870|529737195|FG002|Overall Study|Administrative|12|||
146882363|NCT03028870|529737196|FG003|Overall Study|Administrative|4|||
146882364|NCT01836783|529737203|FG000|Overall Study|Withdrawal by Subject|0|||
146882365|NCT01836783|529737204|FG001|Overall Study|Withdrawal by Subject|2|||
146882366|NCT01273883|529737206|FG000|First Intervention|Adverse Event|2|||
146882367|NCT01273883|529737207|FG001|First Intervention|Adverse Event|1|||
146882368|NCT01273883|529737206|FG000|Second Intervention|Lost to Follow-up|1|||
146882369|NCT01273883|529737207|FG001|Second Intervention|Lost to Follow-up|1|||
146882370|NCT01273883|529737206|FG000|Second Intervention|Lack of Efficacy|1|||
146882371|NCT01273883|529737207|FG001|Second Intervention|Lack of Efficacy|0|||
146882372|NCT04489888|529737210|FG000|Overall Study|Death|75|||
146882373|NCT04489888|529737210|FG000|Overall Study|Sponsor Decision|26|||
146882374|NCT02043548|529737213|FG000|Overall Study|Lack of Efficacy|1|||
146882375|NCT02043548|529737214|FG001|Overall Study|Lack of Efficacy|0|||
146882376|NCT02043548|529737213|FG000|Overall Study|Adverse Event|0|||
146882377|NCT02043548|529737214|FG001|Overall Study|Adverse Event|1|||
146882378|NCT01430455|529737224|FG000|Overall Study|Withdrawal by Subject|1|||
146882379|NCT01430455|529737224|FG000|Overall Study|Switched to follow-up phase|1|||
146882380|NCT03829657|529737225|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
146882381|NCT03829657|529737226|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
146882382|NCT03829657|529737227|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
146882383|NCT03829657|529737228|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
146882384|NCT03829657|529737229|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
146882385|NCT03829657|529737225|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
146882386|NCT03829657|529737226|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146882387|NCT03829657|529737227|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146882388|NCT03829657|529737228|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146882389|NCT03829657|529737229|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146882390|NCT03829657|529737225|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
146882391|NCT03829657|529737226|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
146882392|NCT03829657|529737227|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
146882393|NCT03829657|529737228|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
146882394|NCT03829657|529737229|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
146882395|NCT03829657|529737225|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
146882396|NCT03829657|529737226|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
146882397|NCT03829657|529737227|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
146882398|NCT03829657|529737228|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
146882399|NCT03829657|529737229|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
146882400|NCT03829657|529737225|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
146882401|NCT03829657|529737226|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
146882402|NCT03829657|529737227|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
146882403|NCT03829657|529737228|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
146882404|NCT03829657|529737229|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
146882405|NCT03829657|529737225|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
146882406|NCT03829657|529737226|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
146882407|NCT03829657|529737227|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
146882408|NCT03829657|529737228|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
146882409|NCT03829657|529737229|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
146882410|NCT03829657|529737225|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
146882411|NCT03829657|529737226|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
146882412|NCT03829657|529737227|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
146882413|NCT03829657|529737228|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
146882414|NCT03829657|529737229|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
146882415|NCT03829657|529737225|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
146882416|NCT03829657|529737226|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
146882417|NCT03829657|529737227|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
146882418|NCT03829657|529737228|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
146882419|NCT03829657|529737229|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
146882420|NCT03829657|529737225|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
146882421|NCT03829657|529737226|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
146882422|NCT03829657|529737227|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
146882423|NCT03829657|529737228|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
146882424|NCT03829657|529737229|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
146882425|NCT03829657|529737225|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
146882426|NCT03829657|529737226|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
146882427|NCT03829657|529737227|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
146882428|NCT03829657|529737228|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
146882429|NCT03829657|529737229|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
146882430|NCT04418076|529737231|FG000|Overall Study|Death|1|||
146882431|NCT04418076|529737232|FG001|Overall Study|Death|0|||
146882432|NCT04418076|529737233|FG002|Overall Study|Death|0|||
146882433|NCT04418076|529737234|FG003|Overall Study|Death|0|||
146882434|NCT04418076|529737231|FG000|Overall Study|Lost to Follow-up|2|||
146882435|NCT04418076|529737232|FG001|Overall Study|Lost to Follow-up|5|||
146882436|NCT04418076|529737233|FG002|Overall Study|Lost to Follow-up|1|||
146882437|NCT04418076|529737234|FG003|Overall Study|Lost to Follow-up|2|||
146882438|NCT04418076|529737231|FG000|Overall Study|Withdrawal by Subject|1|||
146882439|NCT04418076|529737232|FG001|Overall Study|Withdrawal by Subject|0|||
146882440|NCT04418076|529737233|FG002|Overall Study|Withdrawal by Subject|1|||
146882441|NCT04418076|529737234|FG003|Overall Study|Withdrawal by Subject|1|||
146882442|NCT04418076|529737231|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
146882443|NCT04418076|529737232|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
146882444|NCT04418076|529737233|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
146882445|NCT04418076|529737234|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
146882446|NCT01425008|529737235|FG000|Dose Escalation Phase|Progressive Disease|2|||
146882447|NCT01425008|529737236|FG001|Dose Escalation Phase|Progressive Disease|3|||
146882448|NCT01425008|529737237|FG002|Dose Escalation Phase|Progressive Disease|2|||
146882449|NCT01425008|529737238|FG003|Dose Escalation Phase|Progressive Disease|3|||
146882450|NCT01425008|529737239|FG004|Dose Escalation Phase|Progressive Disease|5|||
146882451|NCT01425008|529737240|FG005|Dose Escalation Phase|Progressive Disease|4|||
146882452|NCT01425008|529737241|FG006|Dose Escalation Phase|Progressive Disease|0|||
146882453|NCT01425008|529737242|FG007|Dose Escalation Phase|Progressive Disease|2|||
146882454|NCT01425008|529737243|FG008|Dose Escalation Phase|Progressive Disease|6|||
146882455|NCT01425008|529737244|FG009|Dose Escalation Phase|Progressive Disease|2|||
146882456|NCT01425008|529737245|FG010|Dose Escalation Phase|Progressive Disease|0|||
146882457|NCT01425008|529737246|FG011|Dose Escalation Phase|Progressive Disease|0|||
146882458|NCT01425008|529737247|FG012|Dose Escalation Phase|Progressive Disease|0|||
146882459|NCT01425008|529737248|FG013|Dose Escalation Phase|Progressive Disease|0|||
146882460|NCT01425008|529737249|FG014|Dose Escalation Phase|Progressive Disease|0|||
146882461|NCT01425008|529737250|FG015|Dose Escalation Phase|Progressive Disease|0|||
146882462|NCT01425008|529737251|FG016|Dose Escalation Phase|Progressive Disease|0|||
146882463|NCT01425008|529737252|FG017|Dose Escalation Phase|Progressive Disease|0|||
146882464|NCT01425008|529737253|FG018|Dose Escalation Phase|Progressive Disease|0|||
146882465|NCT01425008|529737235|FG000|Dose Escalation Phase|Adverse Event|2|||
146882466|NCT01425008|529737236|FG001|Dose Escalation Phase|Adverse Event|0|||
146882467|NCT01425008|529737237|FG002|Dose Escalation Phase|Adverse Event|0|||
146882468|NCT01425008|529737238|FG003|Dose Escalation Phase|Adverse Event|0|||
146882469|NCT01425008|529737239|FG004|Dose Escalation Phase|Adverse Event|0|||
146882470|NCT01425008|529737240|FG005|Dose Escalation Phase|Adverse Event|2|||
146882471|NCT01425008|529737241|FG006|Dose Escalation Phase|Adverse Event|0|||
146882472|NCT01425008|529737242|FG007|Dose Escalation Phase|Adverse Event|0|||
146882473|NCT01425008|529737243|FG008|Dose Escalation Phase|Adverse Event|2|||
146882474|NCT01425008|529737244|FG009|Dose Escalation Phase|Adverse Event|0|||
146882475|NCT01425008|529737245|FG010|Dose Escalation Phase|Adverse Event|0|||
146882476|NCT01425008|529737246|FG011|Dose Escalation Phase|Adverse Event|0|||
146882477|NCT01425008|529737247|FG012|Dose Escalation Phase|Adverse Event|0|||
146882478|NCT01425008|529737248|FG013|Dose Escalation Phase|Adverse Event|0|||
146882479|NCT01425008|529737249|FG014|Dose Escalation Phase|Adverse Event|0|||
146882480|NCT01425008|529737250|FG015|Dose Escalation Phase|Adverse Event|0|||
146882481|NCT01425008|529737251|FG016|Dose Escalation Phase|Adverse Event|0|||
146882482|NCT01425008|529737252|FG017|Dose Escalation Phase|Adverse Event|0|||
146882483|NCT01425008|529737253|FG018|Dose Escalation Phase|Adverse Event|0|||
146882484|NCT01425008|529737235|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146882485|NCT01425008|529737236|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146882486|NCT01425008|529737237|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146882487|NCT01425008|529737238|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146882488|NCT01425008|529737239|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
146882489|NCT01425008|529737240|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146882490|NCT01425008|529737241|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
146882491|NCT01425008|529737242|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
146882492|NCT01425008|529737243|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
146882493|NCT01425008|529737244|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146882494|NCT01425008|529737245|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146882495|NCT01425008|529737246|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146882496|NCT01425008|529737247|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146882497|NCT01425008|529737248|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146882498|NCT01425008|529737249|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146882499|NCT01425008|529737250|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146882500|NCT01425008|529737251|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146882501|NCT01425008|529737252|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146882502|NCT01425008|529737253|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146882503|NCT01425008|529737235|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
146882504|NCT01425008|529737236|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
146882505|NCT01425008|529737237|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
146882506|NCT01425008|529737238|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
146882507|NCT01425008|529737239|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
146882508|NCT01425008|529737240|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
146882509|NCT01425008|529737241|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
146882510|NCT01425008|529737242|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
146882511|NCT01425008|529737243|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
146882512|NCT01425008|529737244|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
146882513|NCT01425008|529737245|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
146547302|NCT03370302|528509381|FG002|Dose Escalation Phase|Adverse Event|2|||
146547303|NCT03370302|528509382|FG003|Dose Escalation Phase|Adverse Event|0|||
146547304|NCT03370302|528509383|FG004|Dose Escalation Phase|Adverse Event|0|||
146547305|NCT03370302|528509384|FG005|Dose Escalation Phase|Adverse Event|0|||
146547306|NCT03370302|528509379|FG000|Dose Escalation Phase|Progressive Disease|2|||
146547307|NCT03370302|528509380|FG001|Dose Escalation Phase|Progressive Disease|4|||
146882514|NCT01425008|529737246|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
146882515|NCT01425008|529737247|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
146882516|NCT01425008|529737248|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
146882517|NCT01425008|529737249|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
146882518|NCT01425008|529737250|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
146547308|NCT03370302|528509381|FG002|Dose Escalation Phase|Progressive Disease|2|||
146547309|NCT03370302|528509382|FG003|Dose Escalation Phase|Progressive Disease|0|||
146547310|NCT03370302|528509383|FG004|Dose Escalation Phase|Progressive Disease|3|||
146547311|NCT03370302|528509384|FG005|Dose Escalation Phase|Progressive Disease|1|||
146547312|NCT03370302|528509379|FG000|Dose Expansion Phase|Progressive Disease|0|||
146547313|NCT03370302|528509380|FG001|Dose Expansion Phase|Progressive Disease|0|||
146547314|NCT03370302|528509381|FG002|Dose Expansion Phase|Progressive Disease|0|||
146547315|NCT03370302|528509382|FG003|Dose Expansion Phase|Progressive Disease|6|||
146547316|NCT03370302|528509383|FG004|Dose Expansion Phase|Progressive Disease|0|||
146547317|NCT03370302|528509384|FG005|Dose Expansion Phase|Progressive Disease|0|||
146547318|NCT03407482|528509385|FG000|Overall Study|Adverse Event|12|||
146882519|NCT01425008|529737251|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
146882520|NCT01425008|529737252|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
146882521|NCT01425008|529737253|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
146547319|NCT03407482|528509385|FG000|Overall Study|Disease Relapse|1|||
146547320|NCT03407482|528509385|FG000|Overall Study|Lost to Follow-up|1|||
146547321|NCT03407482|528509385|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146882522|NCT01425008|529737235|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
146882523|NCT01425008|529737236|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
146882524|NCT01425008|529737237|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
146882525|NCT01425008|529737238|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
146882526|NCT01425008|529737239|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
146882527|NCT01425008|529737240|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
146882528|NCT01425008|529737241|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
146882529|NCT01425008|529737242|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
146882530|NCT01425008|529737243|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
146882531|NCT01425008|529737244|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
146882532|NCT01425008|529737245|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
146882533|NCT01425008|529737246|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
146882534|NCT01425008|529737247|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
146882535|NCT01425008|529737248|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
146882536|NCT01425008|529737249|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
146882537|NCT01425008|529737250|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
146882538|NCT01425008|529737251|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
146882539|NCT01425008|529737252|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
146547322|NCT03407482|528509385|FG000|Overall Study|Pregnancy|2|||
146547323|NCT03407482|528509385|FG000|Overall Study|Protocol Violation|1|||
146547324|NCT03407482|528509385|FG000|Overall Study|Study Terminated By Sponsor|106|||
146547325|NCT03407482|528509385|FG000|Overall Study|Withdrawal by Subject|6|||
146547326|NCT03407482|528509385|FG000|Overall Study|Data Entry Error|1|||
146547327|NCT05942040|528509386|FG000|Overall Study|No longer employed at study site.|0|||
146547328|NCT05942040|528509387|FG001|Overall Study|No longer employed at study site.|0|||
146547329|NCT05942040|528509388|FG002|Overall Study|No longer employed at study site.|3|||
146547330|NCT06061952|528509390|FG000|Overall Study|Withdrawal by Subject|1|||
146547331|NCT06061952|528509391|FG001|Overall Study|Withdrawal by Subject|2|||
146547332|NCT06061952|528509390|FG000|Overall Study|Lost to Follow-up|2|||
146547333|NCT06061952|528509391|FG001|Overall Study|Lost to Follow-up|2|||
146547334|NCT01685437|528509392|FG000|Overall Study|Withdrawal by Subject|22|||
146547335|NCT01685437|528509392|FG000|Overall Study|Lost to Follow-up|3|||
146547336|NCT01685437|528509392|FG000|Overall Study|Adverse Event|1|||
146547337|NCT01685437|528509392|FG000|Overall Study|Protocol Violation|4|||
146547338|NCT01685437|528509392|FG000|Overall Study|Unable to make visits due to work|1|||
146547339|NCT00504231|528510904|FG000|Overall Study|Discrepant chart documentation re route|0|||
146547340|NCT00504231|528510905|FG001|Overall Study|Discrepant chart documentation re route|0|||
146547341|NCT00504231|528510906|FG002|Overall Study|Discrepant chart documentation re route|1|||
146547342|NCT00504231|528510907|FG003|Overall Study|Discrepant chart documentation re route|0|||
146547343|NCT00835978|528510908|FG000|Overall Study|Death|33|||
146547344|NCT00835978|528510909|FG001|Overall Study|Death|40|||
146547345|NCT00835978|528510910|FG002|Overall Study|Death|49|||
146547346|NCT00835978|528510911|FG003|Overall Study|Death|4|||
146547347|NCT00835978|528510908|FG000|Overall Study|Lost to Follow-up|3|||
146547348|NCT00835978|528510909|FG001|Overall Study|Lost to Follow-up|4|||
146547349|NCT00835978|528510910|FG002|Overall Study|Lost to Follow-up|2|||
146547350|NCT00835978|528510911|FG003|Overall Study|Lost to Follow-up|1|||
146547351|NCT00835978|528510908|FG000|Overall Study|Other|5|||
146547352|NCT00835978|528510909|FG001|Overall Study|Other|1|||
146547353|NCT00835978|528510910|FG002|Overall Study|Other|8|||
146547354|NCT00835978|528510911|FG003|Overall Study|Other|0|||
146547355|NCT00835978|528510908|FG000|Overall Study|Objective progression or relapse|2|||
146547356|NCT00835978|528510909|FG001|Overall Study|Objective progression or relapse|0|||
146547357|NCT00835978|528510910|FG002|Overall Study|Objective progression or relapse|1|||
146547358|NCT00835978|528510911|FG003|Overall Study|Objective progression or relapse|0|||
146547359|NCT00835978|528510908|FG000|Overall Study|Adverse Event|1|||
146547360|NCT00835978|528510909|FG001|Overall Study|Adverse Event|0|||
146547361|NCT00835978|528510910|FG002|Overall Study|Adverse Event|1|||
146547362|NCT00835978|528510911|FG003|Overall Study|Adverse Event|0|||
146547363|NCT00835978|528510908|FG000|Overall Study|Withdrawal by Subject|0|||
146547364|NCT00835978|528510909|FG001|Overall Study|Withdrawal by Subject|3|||
146547365|NCT00835978|528510910|FG002|Overall Study|Withdrawal by Subject|0|||
146547366|NCT00835978|528510911|FG003|Overall Study|Withdrawal by Subject|5|||
146547367|NCT00835978|528510908|FG000|Overall Study|Study terminated by sponsor|12|||
146547368|NCT00835978|528510909|FG001|Overall Study|Study terminated by sponsor|8|||
146547369|NCT00835978|528510910|FG002|Overall Study|Study terminated by sponsor|30|||
146547370|NCT00835978|528510911|FG003|Overall Study|Study terminated by sponsor|0|||
146547371|NCT02400736|528510914|FG000|Overall Study|Lost to Follow-up|6|||
146547372|NCT02400736|528510915|FG001|Overall Study|Lost to Follow-up|6|||
146547373|NCT02400736|528510914|FG000|Overall Study|Withdrawal by Subject|2|||
146547374|NCT02400736|528510915|FG001|Overall Study|Withdrawal by Subject|1|||
146547375|NCT02400736|528510914|FG000|Overall Study|Moved from the area|3|||
146882540|NCT01425008|529737253|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
146882541|NCT01425008|529737235|FG000|Dose Escalation Phase|Other|0|||
146547376|NCT02400736|528510915|FG001|Overall Study|Moved from the area|1|||
146547377|NCT02927145|528510917|FG000|Initial Recruitment|Withdrawal by Subject|0|||
146547378|NCT02927145|528510918|FG001|Initial Recruitment|Withdrawal by Subject|1|||
146547379|NCT02927145|528510919|FG002|Initial Recruitment|Withdrawal by Subject|1|||
146547380|NCT02927145|528510920|FG003|Initial Recruitment|Withdrawal by Subject|4|||
146882542|NCT01425008|529737236|FG001|Dose Escalation Phase|Other|0|||
146882543|NCT01425008|529737237|FG002|Dose Escalation Phase|Other|0|||
146882544|NCT01425008|529737238|FG003|Dose Escalation Phase|Other|0|||
146882545|NCT01425008|529737239|FG004|Dose Escalation Phase|Other|0|||
146882546|NCT01425008|529737240|FG005|Dose Escalation Phase|Other|0|||
146882547|NCT01425008|529737241|FG006|Dose Escalation Phase|Other|0|||
146882548|NCT01425008|529737242|FG007|Dose Escalation Phase|Other|0|||
146882549|NCT01425008|529737243|FG008|Dose Escalation Phase|Other|1|||
146882550|NCT01425008|529737244|FG009|Dose Escalation Phase|Other|0|||
146882551|NCT01425008|529737245|FG010|Dose Escalation Phase|Other|0|||
146882552|NCT01425008|529737246|FG011|Dose Escalation Phase|Other|0|||
146882553|NCT01425008|529737247|FG012|Dose Escalation Phase|Other|0|||
146882554|NCT01425008|529737248|FG013|Dose Escalation Phase|Other|0|||
146882555|NCT01425008|529737249|FG014|Dose Escalation Phase|Other|0|||
146882556|NCT01425008|529737250|FG015|Dose Escalation Phase|Other|0|||
146882557|NCT01425008|529737251|FG016|Dose Escalation Phase|Other|0|||
146882558|NCT01425008|529737252|FG017|Dose Escalation Phase|Other|0|||
146882559|NCT01425008|529737253|FG018|Dose Escalation Phase|Other|0|||
146882560|NCT01425008|529737235|FG000|Dose Expansion Phase|Progressive Disease|0|||
146882561|NCT01425008|529737236|FG001|Dose Expansion Phase|Progressive Disease|0|||
146882562|NCT01425008|529737237|FG002|Dose Expansion Phase|Progressive Disease|0|||
146882563|NCT01425008|529737238|FG003|Dose Expansion Phase|Progressive Disease|0|||
146882564|NCT01425008|529737239|FG004|Dose Expansion Phase|Progressive Disease|0|||
146882565|NCT01425008|529737240|FG005|Dose Expansion Phase|Progressive Disease|0|||
146882566|NCT01425008|529737241|FG006|Dose Expansion Phase|Progressive Disease|0|||
146882567|NCT01425008|529737242|FG007|Dose Expansion Phase|Progressive Disease|0|||
146882568|NCT01425008|529737243|FG008|Dose Expansion Phase|Progressive Disease|0|||
146882569|NCT01425008|529737244|FG009|Dose Expansion Phase|Progressive Disease|0|||
146882570|NCT01425008|529737245|FG010|Dose Expansion Phase|Progressive Disease|10|||
146882571|NCT01425008|529737246|FG011|Dose Expansion Phase|Progressive Disease|4|||
146882572|NCT01425008|529737247|FG012|Dose Expansion Phase|Progressive Disease|12|||
146882573|NCT01425008|529737248|FG013|Dose Expansion Phase|Progressive Disease|1|||
146882574|NCT01425008|529737249|FG014|Dose Expansion Phase|Progressive Disease|5|||
146882575|NCT01425008|529737250|FG015|Dose Expansion Phase|Progressive Disease|8|||
146882576|NCT01425008|529737251|FG016|Dose Expansion Phase|Progressive Disease|9|||
146882577|NCT01425008|529737252|FG017|Dose Expansion Phase|Progressive Disease|2|||
146882578|NCT01425008|529737253|FG018|Dose Expansion Phase|Progressive Disease|10|||
146882579|NCT01425008|529737235|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
146882580|NCT01425008|529737236|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
146882581|NCT01425008|529737237|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
146882582|NCT01425008|529737238|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
146882583|NCT01425008|529737239|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
146882584|NCT01425008|529737240|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
146882585|NCT01425008|529737241|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
146882586|NCT01425008|529737242|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
146882587|NCT01425008|529737243|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
146882588|NCT01425008|529737244|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
146882589|NCT01425008|529737245|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
146882590|NCT01425008|529737246|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
146882591|NCT01425008|529737247|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
146882592|NCT01425008|529737248|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
146882593|NCT01425008|529737249|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
146882594|NCT01425008|529737250|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
146882595|NCT01425008|529737251|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
146882596|NCT01425008|529737252|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
146882597|NCT01425008|529737253|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
146882598|NCT01425008|529737235|FG000|Dose Expansion Phase|Other|0|||
146882599|NCT01425008|529737236|FG001|Dose Expansion Phase|Other|0|||
146882600|NCT01425008|529737237|FG002|Dose Expansion Phase|Other|0|||
146882601|NCT01425008|529737238|FG003|Dose Expansion Phase|Other|0|||
146882602|NCT01425008|529737239|FG004|Dose Expansion Phase|Other|0|||
146882603|NCT01425008|529737240|FG005|Dose Expansion Phase|Other|0|||
146882604|NCT01425008|529737241|FG006|Dose Expansion Phase|Other|0|||
146882605|NCT01425008|529737242|FG007|Dose Expansion Phase|Other|0|||
146882606|NCT01425008|529737243|FG008|Dose Expansion Phase|Other|0|||
146882607|NCT01425008|529737244|FG009|Dose Expansion Phase|Other|0|||
146882608|NCT01425008|529737245|FG010|Dose Expansion Phase|Other|0|||
146882609|NCT01425008|529737246|FG011|Dose Expansion Phase|Other|0|||
146882610|NCT01425008|529737247|FG012|Dose Expansion Phase|Other|1|||
146882611|NCT01425008|529737248|FG013|Dose Expansion Phase|Other|0|||
146882612|NCT01425008|529737249|FG014|Dose Expansion Phase|Other|0|||
146882613|NCT01425008|529737250|FG015|Dose Expansion Phase|Other|0|||
146882614|NCT01425008|529737251|FG016|Dose Expansion Phase|Other|2|||
146882615|NCT01425008|529737252|FG017|Dose Expansion Phase|Other|0|||
146882616|NCT01425008|529737253|FG018|Dose Expansion Phase|Other|4|||
146882617|NCT01425008|529737235|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
146882618|NCT01425008|529737236|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
146882619|NCT01425008|529737237|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
146882620|NCT01425008|529737238|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
146882621|NCT01425008|529737239|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
146882622|NCT01425008|529737240|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
146882623|NCT01425008|529737241|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
146882624|NCT01425008|529737242|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
146882625|NCT01425008|529737243|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
146882626|NCT01425008|529737244|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
146882627|NCT01425008|529737245|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
146882628|NCT01425008|529737246|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
146882629|NCT01425008|529737247|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
146882630|NCT01425008|529737248|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
146882631|NCT01425008|529737249|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
146882632|NCT01425008|529737250|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
146882633|NCT01425008|529737251|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
146882634|NCT01425008|529737252|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
146882635|NCT01425008|529737253|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
146882636|NCT01425008|529737235|FG000|Dose Expansion Phase|Adverse Event|0|||
146882637|NCT01425008|529737236|FG001|Dose Expansion Phase|Adverse Event|0|||
146882638|NCT01425008|529737237|FG002|Dose Expansion Phase|Adverse Event|0|||
146882639|NCT01425008|529737238|FG003|Dose Expansion Phase|Adverse Event|0|||
146882640|NCT01425008|529737239|FG004|Dose Expansion Phase|Adverse Event|0|||
146882641|NCT01425008|529737240|FG005|Dose Expansion Phase|Adverse Event|0|||
146882642|NCT01425008|529737241|FG006|Dose Expansion Phase|Adverse Event|0|||
146882643|NCT01425008|529737242|FG007|Dose Expansion Phase|Adverse Event|0|||
146882644|NCT01425008|529737243|FG008|Dose Expansion Phase|Adverse Event|0|||
146882645|NCT01425008|529737244|FG009|Dose Expansion Phase|Adverse Event|0|||
146882646|NCT01425008|529737245|FG010|Dose Expansion Phase|Adverse Event|2|||
146882647|NCT01425008|529737246|FG011|Dose Expansion Phase|Adverse Event|3|||
146882648|NCT01425008|529737247|FG012|Dose Expansion Phase|Adverse Event|3|||
146882649|NCT01425008|529737248|FG013|Dose Expansion Phase|Adverse Event|0|||
146882650|NCT01425008|529737249|FG014|Dose Expansion Phase|Adverse Event|1|||
146882651|NCT01425008|529737250|FG015|Dose Expansion Phase|Adverse Event|1|||
146882652|NCT01425008|529737251|FG016|Dose Expansion Phase|Adverse Event|5|||
146547381|NCT02927145|528510921|FG004|Initial Recruitment|Withdrawal by Subject|1|||
146547382|NCT02927145|528510922|FG005|Initial Recruitment|Withdrawal by Subject|1|||
146547383|NCT02927145|528510923|FG006|Initial Recruitment|Withdrawal by Subject|0|||
146547384|NCT02927145|528510924|FG007|Initial Recruitment|Withdrawal by Subject|0|||
146547385|NCT02927145|528510925|FG008|Initial Recruitment|Withdrawal by Subject|2|||
146547386|NCT02927145|528510917|FG000|Initial Recruitment|Adverse Event|0|||
146547387|NCT02927145|528510918|FG001|Initial Recruitment|Adverse Event|0|||
146547388|NCT02927145|528510919|FG002|Initial Recruitment|Adverse Event|0|||
146547389|NCT02927145|528510920|FG003|Initial Recruitment|Adverse Event|0|||
146547390|NCT02927145|528510921|FG004|Initial Recruitment|Adverse Event|2|||
146547391|NCT02927145|528510922|FG005|Initial Recruitment|Adverse Event|0|||
146547392|NCT02927145|528510923|FG006|Initial Recruitment|Adverse Event|0|||
146547393|NCT02927145|528510924|FG007|Initial Recruitment|Adverse Event|0|||
146547394|NCT02927145|528510925|FG008|Initial Recruitment|Adverse Event|0|||
146547395|NCT02927145|528510917|FG000|Invitation for Additional Challenge|Pregnancy|0|||
146547396|NCT02927145|528510918|FG001|Invitation for Additional Challenge|Pregnancy|0|||
146547397|NCT02927145|528510919|FG002|Invitation for Additional Challenge|Pregnancy|0|||
146547398|NCT02927145|528510920|FG003|Invitation for Additional Challenge|Pregnancy|0|||
146547399|NCT02927145|528510921|FG004|Invitation for Additional Challenge|Pregnancy|0|||
146547400|NCT02927145|528510922|FG005|Invitation for Additional Challenge|Pregnancy|0|||
146547401|NCT02927145|528510923|FG006|Invitation for Additional Challenge|Pregnancy|1|||
146547402|NCT02927145|528510924|FG007|Invitation for Additional Challenge|Pregnancy|0|||
146547403|NCT02927145|528510925|FG008|Invitation for Additional Challenge|Pregnancy|0|||
146547404|NCT01363440|528510926|FG000|Overall Study|Adverse Event|5|||
146547405|NCT01363440|528510927|FG001|Overall Study|Adverse Event|4|||
146882653|NCT01425008|529737252|FG017|Dose Expansion Phase|Adverse Event|0|||
146882654|NCT01425008|529737253|FG018|Dose Expansion Phase|Adverse Event|3|||
146882655|NCT01425008|529737235|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
146882656|NCT01425008|529737236|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
146882657|NCT01425008|529737237|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
146882658|NCT01425008|529737238|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
146882659|NCT01425008|529737239|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
146882660|NCT01425008|529737240|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
146882661|NCT01425008|529737241|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
146882662|NCT01425008|529737242|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
146547406|NCT01363440|528510928|FG002|Overall Study|Adverse Event|4|||
146547407|NCT01363440|528510926|FG000|Overall Study|Death|3|||
146547408|NCT01363440|528510927|FG001|Overall Study|Death|7|||
146547409|NCT01363440|528510928|FG002|Overall Study|Death|5|||
146882663|NCT01425008|529737243|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
146882664|NCT01425008|529737244|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
146882665|NCT01425008|529737245|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
146882666|NCT01425008|529737246|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
146882667|NCT01425008|529737247|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
146882668|NCT01425008|529737248|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
146882669|NCT01425008|529737249|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
146882670|NCT01425008|529737250|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
146882671|NCT01425008|529737251|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
146882672|NCT01425008|529737252|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
146882673|NCT01425008|529737253|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
146882674|NCT01425008|529737235|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882675|NCT01425008|529737236|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882676|NCT01425008|529737237|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882677|NCT01425008|529737238|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882678|NCT01425008|529737239|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882679|NCT01425008|529737240|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882680|NCT01425008|529737241|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882681|NCT01425008|529737242|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882682|NCT01425008|529737243|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882683|NCT01425008|529737244|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882684|NCT01425008|529737245|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882685|NCT01425008|529737246|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882686|NCT01425008|529737247|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882687|NCT01425008|529737248|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882688|NCT01425008|529737249|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882689|NCT01425008|529737250|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882690|NCT01425008|529737251|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882691|NCT01425008|529737252|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146882692|NCT01425008|529737253|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
146882693|NCT00264238|529737254|FG000|Overall Study|Protocol Violation|1|||
146882694|NCT00562588|529737257|FG000|Overall Study|Adverse Event|40|||
146882695|NCT00562588|529737258|FG001|Overall Study|Adverse Event|58|||
146882696|NCT00562588|529737257|FG000|Overall Study|Protocol Violation|30|||
146882697|NCT00562588|529737258|FG001|Overall Study|Protocol Violation|26|||
146882698|NCT00562588|529737257|FG000|Overall Study|Lost to Follow-up|12|||
146882699|NCT00562588|529737258|FG001|Overall Study|Lost to Follow-up|4|||
146882700|NCT00562588|529737257|FG000|Overall Study|Withdrawal by Subject|10|||
146882701|NCT00562588|529737258|FG001|Overall Study|Withdrawal by Subject|9|||
146882702|NCT00562588|529737257|FG000|Overall Study|Other|0|||
146882703|NCT00562588|529737258|FG001|Overall Study|Other|2|||
146882704|NCT01452152|529737259|FG000|Overall Study|Study termination by sponsor|5|||
146882705|NCT01452152|529737260|FG001|Overall Study|Study termination by sponsor|0|||
146547410|NCT01363440|528510926|FG000|Overall Study|Withdrawal by Subject|9|||
146547411|NCT01363440|528510927|FG001|Overall Study|Withdrawal by Subject|11|||
146547412|NCT01363440|528510928|FG002|Overall Study|Withdrawal by Subject|11|||
146547413|NCT01363440|528510926|FG000|Overall Study|Lost to Follow-up|2|||
146547414|NCT01363440|528510927|FG001|Overall Study|Lost to Follow-up|4|||
146547415|NCT01363440|528510928|FG002|Overall Study|Lost to Follow-up|5|||
146547416|NCT01363440|528510926|FG000|Overall Study|Other|4|||
146547417|NCT01363440|528510927|FG001|Overall Study|Other|5|||
146547418|NCT01363440|528510928|FG002|Overall Study|Other|2|||
146882706|NCT01452152|529737261|FG002|Overall Study|Study termination by sponsor|4|||
146882707|NCT02867995|529737264|FG000|Overall Study|Withdrawal by Subject|0|||
146882708|NCT02867995|529737265|FG001|Overall Study|Withdrawal by Subject|1|||
146882709|NCT02867995|529737264|FG000|Overall Study|Lost to Follow-up|0|||
146882710|NCT02867995|529737265|FG001|Overall Study|Lost to Follow-up|2|||
146882711|NCT03315871|529737266|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
146882712|NCT03315871|529737267|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
146882713|NCT03315871|529737268|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
146882714|NCT03315871|529737266|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
146882715|NCT03315871|529737267|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
146882716|NCT03315871|529737268|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
146882717|NCT03315871|529737266|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
146882718|NCT03315871|529737267|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
146882719|NCT03315871|529737268|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
146882720|NCT03315871|529737266|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
146547419|NCT01166945|528510930|FG000|Randomized|diagnosed with Group A strep|4|||
146547420|NCT01166945|528510931|FG001|Randomized|diagnosed with Group A strep|4|||
146547421|NCT01166945|528510930|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
146547422|NCT01166945|528510931|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
146630429|NCT04672239|528824062|FG002|Week 6 Survey|Withdrawn by PI|0|||
146882721|NCT03315871|529737267|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
146882722|NCT03315871|529737268|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
146882723|NCT03315871|529737266|FG000|PROSTVAC + CV301|Progressive disease|0|||
146882724|NCT03315871|529737267|FG001|PROSTVAC + CV301|Progressive disease|0|||
146882725|NCT03315871|529737268|FG002|PROSTVAC + CV301|Progressive disease|1|||
146882726|NCT03315871|529737266|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
146882727|NCT03315871|529737267|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
146882728|NCT03315871|529737268|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
146882729|NCT03468309|529738650|FG000|Overall Study|Lost to Follow-up|4|||
146882730|NCT03468309|529738650|FG000|Overall Study|Withdrawal by Subject|2|||
146882731|NCT00179309|529738653|FG000|Treatment|Toxicity|2|||
146882732|NCT00179309|529738654|FG001|Treatment|Toxicity|3|||
146882733|NCT00179309|529738653|FG000|Treatment|Withdrawal by Subject|1|||
146882734|NCT00179309|529738654|FG001|Treatment|Withdrawal by Subject|2|||
146882735|NCT00179309|529738653|FG000|Treatment|Allergy|1|||
146882736|NCT00179309|529738654|FG001|Treatment|Allergy|0|||
146882737|NCT00488982|529738655|FG000|Course 1|Physician Decision|0|||
146882738|NCT00488982|529738656|FG001|Course 1|Physician Decision|2|||
146882739|NCT00488982|529738657|FG002|Course 1|Physician Decision|4|||
146882740|NCT00488982|529738655|FG000|Course 1|Withdrawal by Subject|0|||
146882741|NCT00488982|529738656|FG001|Course 1|Withdrawal by Subject|8|||
146882742|NCT00488982|529738657|FG002|Course 1|Withdrawal by Subject|2|||
146882743|NCT00488982|529738655|FG000|Course 1|nonprotocol therapy|0|||
146882744|NCT00488982|529738656|FG001|Course 1|nonprotocol therapy|2|||
146882745|NCT00488982|529738657|FG002|Course 1|nonprotocol therapy|2|||
146882746|NCT00488982|529738655|FG000|Course 1|Adverse Event|0|||
146882747|NCT00488982|529738656|FG001|Course 1|Adverse Event|0|||
146882748|NCT00488982|529738657|FG002|Course 1|Adverse Event|6|||
146882749|NCT01777152|529738660|FG000|Overall Study|Withdrawal by Subject|22|||
146882750|NCT01777152|529738661|FG001|Overall Study|Withdrawal by Subject|16|||
146882751|NCT01777152|529738660|FG000|Overall Study|Lost to Follow-up|3|||
146882752|NCT01777152|529738661|FG001|Overall Study|Lost to Follow-up|5|||
146882753|NCT01777152|529738660|FG000|Overall Study|Death|68|||
146882754|NCT01777152|529738661|FG001|Overall Study|Death|89|||
146882755|NCT01777152|529738660|FG000|Overall Study|Not eligible, no study drug received|1|||
146882756|NCT01777152|529738661|FG001|Overall Study|Not eligible, no study drug received|0|||
146882757|NCT01777152|529738660|FG000|Overall Study|Change of diagnosis|1|||
146882758|NCT01777152|529738661|FG001|Overall Study|Change of diagnosis|0|||
146882759|NCT03548558|529738662|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
146882760|NCT03548558|529738663|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
146882761|NCT03548558|529738664|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
146882762|NCT03548558|529738665|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
146882763|NCT03548558|529738666|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
146882764|NCT03548558|529738667|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
146882765|NCT03548558|529738668|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
146882766|NCT03548558|529738662|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
146882767|NCT03548558|529738663|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
146882768|NCT03548558|529738664|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
146882769|NCT03548558|529738665|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
146882770|NCT03548558|529738666|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
146882771|NCT03548558|529738667|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
146882772|NCT03548558|529738668|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
146547423|NCT01166945|528510930|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
146547424|NCT01166945|528510931|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
146547425|NCT01166945|528510930|FG000|Day 30|Lost to Follow-up|4|||
146547426|NCT01166945|528510931|FG001|Day 30|Lost to Follow-up|3|||
146882773|NCT03548558|529738662|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
146882774|NCT03548558|529738663|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
146882775|NCT03548558|529738664|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
146882776|NCT03548558|529738665|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
146882777|NCT03548558|529738666|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
146882778|NCT03548558|529738667|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
146882779|NCT03548558|529738668|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
146882780|NCT03548558|529738662|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
146882781|NCT03548558|529738663|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
146882782|NCT03548558|529738664|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
146882783|NCT03548558|529738665|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
146882784|NCT03548558|529738666|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
146547427|NCT00923702|528510937|FG000|Overall Study|Ongoing enrollment|0|||
146547428|NCT00923702|528510938|FG001|Overall Study|Ongoing enrollment|0|||
146547429|NCT00923702|528510939|FG002|Overall Study|Ongoing enrollment|0|||
146547430|NCT00923702|528510940|FG003|Overall Study|Ongoing enrollment|0|||
146547431|NCT00923702|528510941|FG004|Overall Study|Ongoing enrollment|354|||
146882785|NCT03548558|529738667|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
146882786|NCT03548558|529738668|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
146882787|NCT03548558|529738662|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
146882788|NCT03548558|529738663|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
146882789|NCT03548558|529738664|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
146882790|NCT03548558|529738665|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
146882791|NCT03548558|529738666|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
146882792|NCT03548558|529738667|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
146882793|NCT03548558|529738668|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
146882794|NCT03548558|529738662|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
146882795|NCT03548558|529738663|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
146882796|NCT03548558|529738664|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
146882797|NCT03548558|529738665|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
146882798|NCT03548558|529738666|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
146882799|NCT03548558|529738667|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
146882800|NCT03548558|529738668|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
146882801|NCT01903837|529738678|FG000|Part A|Withdrawal by Subject|4|||
146882802|NCT01903837|529738679|FG001|Part A|Withdrawal by Subject|9|||
146882803|NCT01903837|529738680|FG002|Part A|Withdrawal by Subject|8|||
146882804|NCT01903837|529738681|FG003|Part A|Withdrawal by Subject|5|||
146882805|NCT01903837|529738678|FG000|Part A|Adverse Event|3|||
146882806|NCT01903837|529738679|FG001|Part A|Adverse Event|6|||
146882807|NCT01903837|529738680|FG002|Part A|Adverse Event|9|||
146882808|NCT01903837|529738681|FG003|Part A|Adverse Event|6|||
146882809|NCT01903837|529738678|FG000|Part A|Lost to Follow-up|9|||
146882810|NCT01903837|529738679|FG001|Part A|Lost to Follow-up|7|||
146882811|NCT01903837|529738680|FG002|Part A|Lost to Follow-up|7|||
146882812|NCT01903837|529738681|FG003|Part A|Lost to Follow-up|2|||
146882813|NCT01903837|529738678|FG000|Part A|Non-compliance with study drug|1|||
146882814|NCT01903837|529738679|FG001|Part A|Non-compliance with study drug|4|||
146882815|NCT01903837|529738680|FG002|Part A|Non-compliance with study drug|4|||
146882816|NCT01903837|529738681|FG003|Part A|Non-compliance with study drug|0|||
146882817|NCT01903837|529738678|FG000|Part A|Physician Decision|1|||
146882818|NCT01903837|529738679|FG001|Part A|Physician Decision|1|||
146882819|NCT01903837|529738680|FG002|Part A|Physician Decision|0|||
146882820|NCT01903837|529738681|FG003|Part A|Physician Decision|0|||
146882821|NCT01903837|529738678|FG000|Part A|Protocol Violation|1|||
146882822|NCT01903837|529738679|FG001|Part A|Protocol Violation|1|||
146882823|NCT01903837|529738680|FG002|Part A|Protocol Violation|0|||
146882824|NCT01903837|529738681|FG003|Part A|Protocol Violation|0|||
146882825|NCT01903837|529738678|FG000|Part B|Lost to Follow-up|0|||
146882826|NCT01903837|529738679|FG001|Part B|Lost to Follow-up|3|||
146882827|NCT01903837|529738680|FG002|Part B|Lost to Follow-up|3|||
146882828|NCT01903837|529738681|FG003|Part B|Lost to Follow-up|4|||
146882829|NCT01903837|529738678|FG000|Part B|Withdrawal by Subject|1|||
146882830|NCT01903837|529738679|FG001|Part B|Withdrawal by Subject|2|||
146882831|NCT01903837|529738680|FG002|Part B|Withdrawal by Subject|0|||
146882832|NCT01903837|529738681|FG003|Part B|Withdrawal by Subject|3|||
146547432|NCT01158404|528510944|FG000|Overall Study|Withdrawal by Subject|0|||
146547433|NCT01158404|528510945|FG001|Overall Study|Withdrawal by Subject|1|||
146547434|NCT01158404|528510946|FG002|Overall Study|Withdrawal by Subject|0|||
146547435|NCT01158404|528510947|FG003|Overall Study|Withdrawal by Subject|0|||
146547436|NCT01158404|528510948|FG004|Overall Study|Withdrawal by Subject|3|||
146547437|NCT01158404|528510949|FG005|Overall Study|Withdrawal by Subject|1|||
146547438|NCT01158404|528510950|FG006|Overall Study|Withdrawal by Subject|0|||
146547439|NCT01158404|528510951|FG007|Overall Study|Withdrawal by Subject|1|||
146547440|NCT01158404|528510944|FG000|Overall Study|Physician Decision|0|||
146547441|NCT01158404|528510945|FG001|Overall Study|Physician Decision|0|||
146547442|NCT01158404|528510946|FG002|Overall Study|Physician Decision|0|||
146547443|NCT01158404|528510947|FG003|Overall Study|Physician Decision|0|||
146882833|NCT01903837|529738678|FG000|Part B|Adverse Event|3|||
146882834|NCT01903837|529738679|FG001|Part B|Adverse Event|0|||
146882835|NCT01903837|529738680|FG002|Part B|Adverse Event|2|||
146882836|NCT01903837|529738681|FG003|Part B|Adverse Event|0|||
146882837|NCT01903837|529738678|FG000|Part B|Non-compliance with study drug|2|||
146882838|NCT01903837|529738679|FG001|Part B|Non-compliance with study drug|0|||
146882839|NCT01903837|529738680|FG002|Part B|Non-compliance with study drug|0|||
146882840|NCT01903837|529738681|FG003|Part B|Non-compliance with study drug|1|||
146882841|NCT01903837|529738678|FG000|Part B|Incarceration|2|||
146882842|NCT01903837|529738679|FG001|Part B|Incarceration|0|||
146882843|NCT01903837|529738680|FG002|Part B|Incarceration|0|||
146547444|NCT01158404|528510948|FG004|Overall Study|Physician Decision|0|||
146547445|NCT01158404|528510949|FG005|Overall Study|Physician Decision|0|||
146547446|NCT01158404|528510950|FG006|Overall Study|Physician Decision|0|||
146882844|NCT01903837|529738681|FG003|Part B|Incarceration|1|||
146882845|NCT01903837|529738678|FG000|Part B|Physician Decision|1|||
146547447|NCT01158404|528510951|FG007|Overall Study|Physician Decision|1|||
146882846|NCT01903837|529738679|FG001|Part B|Physician Decision|0|||
146882847|NCT01903837|529738680|FG002|Part B|Physician Decision|0|||
146882848|NCT01903837|529738681|FG003|Part B|Physician Decision|2|||
146882849|NCT01903837|529738678|FG000|Part B|Lack of Efficacy|0|||
146882850|NCT01903837|529738679|FG001|Part B|Lack of Efficacy|1|||
146882851|NCT01903837|529738680|FG002|Part B|Lack of Efficacy|0|||
146882852|NCT01903837|529738681|FG003|Part B|Lack of Efficacy|0|||
146882853|NCT01857869|529738685|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
146882854|NCT01857869|529738686|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
146882855|NCT01857869|529738687|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
146882856|NCT01857869|529738688|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
146882857|NCT01857869|529738689|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
146882858|NCT01857869|529738690|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
146882859|NCT01857869|529738691|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
146882860|NCT01857869|529738692|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
146882861|NCT01857869|529738693|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
146882862|NCT01857869|529738694|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
146882863|NCT01857869|529738685|FG000|Primary/Challenge Phase|Pregnancy|1|||
146882864|NCT01857869|529738686|FG001|Primary/Challenge Phase|Pregnancy|0|||
146882865|NCT01857869|529738687|FG002|Primary/Challenge Phase|Pregnancy|0|||
146882866|NCT01857869|529738688|FG003|Primary/Challenge Phase|Pregnancy|0|||
146882867|NCT01857869|529738689|FG004|Primary/Challenge Phase|Pregnancy|0|||
146882868|NCT01857869|529738690|FG005|Primary/Challenge Phase|Pregnancy|0|||
146882869|NCT01857869|529738691|FG006|Primary/Challenge Phase|Pregnancy|0|||
146882870|NCT01857869|529738692|FG007|Primary/Challenge Phase|Pregnancy|0|||
146882871|NCT01857869|529738693|FG008|Primary/Challenge Phase|Pregnancy|0|||
146882872|NCT01857869|529738694|FG009|Primary/Challenge Phase|Pregnancy|0|||
146882873|NCT01857869|529738685|FG000|Primary/Challenge Phase|Protocol Violation|1|||
146882874|NCT01857869|529738686|FG001|Primary/Challenge Phase|Protocol Violation|0|||
146882875|NCT01857869|529738687|FG002|Primary/Challenge Phase|Protocol Violation|0|||
146882876|NCT01857869|529738688|FG003|Primary/Challenge Phase|Protocol Violation|0|||
146882877|NCT01857869|529738689|FG004|Primary/Challenge Phase|Protocol Violation|0|||
146882878|NCT01857869|529738690|FG005|Primary/Challenge Phase|Protocol Violation|0|||
146882879|NCT01857869|529738691|FG006|Primary/Challenge Phase|Protocol Violation|0|||
146882880|NCT01857869|529738692|FG007|Primary/Challenge Phase|Protocol Violation|0|||
146882881|NCT01857869|529738693|FG008|Primary/Challenge Phase|Protocol Violation|0|||
146882882|NCT01857869|529738694|FG009|Primary/Challenge Phase|Protocol Violation|0|||
146882883|NCT01857869|529738685|FG000|Primary/Challenge Phase|Other|1|||
146882884|NCT01857869|529738686|FG001|Primary/Challenge Phase|Other|1|||
146882885|NCT01857869|529738687|FG002|Primary/Challenge Phase|Other|0|||
146882886|NCT01857869|529738688|FG003|Primary/Challenge Phase|Other|0|||
146882887|NCT01857869|529738689|FG004|Primary/Challenge Phase|Other|0|||
146882888|NCT01857869|529738690|FG005|Primary/Challenge Phase|Other|0|||
146882889|NCT01857869|529738691|FG006|Primary/Challenge Phase|Other|0|||
146882890|NCT01857869|529738692|FG007|Primary/Challenge Phase|Other|0|||
146547448|NCT01158404|528510944|FG000|Overall Study|Progressive Disease|0|||
146547449|NCT01158404|528510945|FG001|Overall Study|Progressive Disease|0|||
146547450|NCT01158404|528510946|FG002|Overall Study|Progressive Disease|0|||
146547451|NCT01158404|528510947|FG003|Overall Study|Progressive Disease|0|||
146547452|NCT01158404|528510948|FG004|Overall Study|Progressive Disease|0|||
146547453|NCT01158404|528510949|FG005|Overall Study|Progressive Disease|0|||
146547454|NCT01158404|528510950|FG006|Overall Study|Progressive Disease|1|||
146547455|NCT01158404|528510951|FG007|Overall Study|Progressive Disease|0|||
146882891|NCT01857869|529738693|FG008|Primary/Challenge Phase|Other|0|||
146882892|NCT01857869|529738694|FG009|Primary/Challenge Phase|Other|0|||
146882893|NCT01857869|529738685|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146882894|NCT01857869|529738686|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146882895|NCT01857869|529738687|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146882896|NCT01857869|529738688|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
146882897|NCT01857869|529738689|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146882898|NCT01857869|529738690|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146882899|NCT01857869|529738691|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146882900|NCT01857869|529738692|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146882901|NCT01857869|529738693|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146882902|NCT01857869|529738694|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146882903|NCT01857869|529738685|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146882904|NCT01857869|529738686|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146882905|NCT01857869|529738687|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146882906|NCT01857869|529738688|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
146882907|NCT01857869|529738689|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146882908|NCT01857869|529738690|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146882909|NCT01857869|529738691|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146882910|NCT01857869|529738692|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146547456|NCT00827242|528510953|FG000|Overall Study|Withdrawal by Subject|2|||
146547457|NCT00827242|528510954|FG001|Overall Study|Withdrawal by Subject|4|||
146547458|NCT00827242|528510953|FG000|Overall Study|Protocol Violation|1|||
146882911|NCT01857869|529738693|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146882912|NCT01857869|529738694|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146882913|NCT03603496|529738698|FG000|Overall Study|Death|19|||
146882914|NCT03603496|529738699|FG001|Overall Study|Death|24|||
146882915|NCT03603496|529738698|FG000|Overall Study|Lost to Follow-up|141|||
146882916|NCT03603496|529738699|FG001|Overall Study|Lost to Follow-up|141|||
146882917|NCT03603496|529738698|FG000|Overall Study|Withdrawal by Subject|26|||
146882918|NCT03603496|529738699|FG001|Overall Study|Withdrawal by Subject|20|||
146882919|NCT03594227|529738700|FG000|Overall Study|Adverse Event|2|||
146882920|NCT03594227|529738701|FG001|Overall Study|Adverse Event|1|||
146882921|NCT03594227|529738702|FG002|Overall Study|Adverse Event|0|||
146882922|NCT03594227|529738703|FG003|Overall Study|Adverse Event|2|||
146882923|NCT03594227|529738700|FG000|Overall Study|Lost to Follow-up|1|||
146882924|NCT03594227|529738701|FG001|Overall Study|Lost to Follow-up|1|||
146882925|NCT03594227|529738702|FG002|Overall Study|Lost to Follow-up|1|||
146882926|NCT03594227|529738703|FG003|Overall Study|Lost to Follow-up|0|||
146882927|NCT03594227|529738700|FG000|Overall Study|Withdrawal by Subject|1|||
146882928|NCT03594227|529738701|FG001|Overall Study|Withdrawal by Subject|1|||
146882929|NCT03594227|529738702|FG002|Overall Study|Withdrawal by Subject|1|||
146882930|NCT03594227|529738703|FG003|Overall Study|Withdrawal by Subject|1|||
146882931|NCT03594227|529738700|FG000|Overall Study|Pregnancy|0|||
146882932|NCT03594227|529738701|FG001|Overall Study|Pregnancy|1|||
146882933|NCT03594227|529738702|FG002|Overall Study|Pregnancy|0|||
146882934|NCT03594227|529738703|FG003|Overall Study|Pregnancy|0|||
146882935|NCT03594227|529738700|FG000|Overall Study|Sponsor Decision|0|||
146882936|NCT03594227|529738701|FG001|Overall Study|Sponsor Decision|0|||
146882937|NCT03594227|529738702|FG002|Overall Study|Sponsor Decision|0|||
146547459|NCT00827242|528510954|FG001|Overall Study|Protocol Violation|3|||
146547460|NCT00827242|528510953|FG000|Overall Study|Lost to Follow-up|0|||
146547461|NCT00827242|528510954|FG001|Overall Study|Lost to Follow-up|3|||
146547462|NCT00827242|528510953|FG000|Overall Study|Adverse Event Excluding Death|2|||
146547463|NCT00827242|528510954|FG001|Overall Study|Adverse Event Excluding Death|1|||
146547464|NCT00827242|528510953|FG000|Overall Study|Entry Criteria Not Met|4|||
146547465|NCT00827242|528510954|FG001|Overall Study|Entry Criteria Not Met|1|||
146547466|NCT00827242|528510953|FG000|Overall Study|Physician Decision|2|||
146547467|NCT00827242|528510954|FG001|Overall Study|Physician Decision|0|||
146547468|NCT00827242|528510953|FG000|Overall Study|Death|1|||
146547469|NCT00827242|528510954|FG001|Overall Study|Death|0|||
146547470|NCT00827242|528510953|FG000|Overall Study|Lack of Efficacy|1|||
146547471|NCT00827242|528510954|FG001|Overall Study|Lack of Efficacy|0|||
146547472|NCT04790201|528510955|FG000|Overall Study|Lost to Follow-up|0|||
146547473|NCT04790201|528510956|FG001|Overall Study|Lost to Follow-up|0|||
146547474|NCT04790201|528510957|FG002|Overall Study|Lost to Follow-up|2|||
146547475|NCT04790201|528510955|FG000|Overall Study|Death|0|||
146547476|NCT04790201|528510956|FG001|Overall Study|Death|1|||
146547477|NCT04790201|528510957|FG002|Overall Study|Death|0|||
146547478|NCT04790201|528510955|FG000|Overall Study|Protocol Violation|1|||
146547479|NCT04790201|528510956|FG001|Overall Study|Protocol Violation|0|||
146547480|NCT04790201|528510957|FG002|Overall Study|Protocol Violation|1|||
146547481|NCT02609633|528510958|FG000|Overall Study|Consent Withdrawn|0|||
146547482|NCT02609633|528510959|FG001|Overall Study|Consent Withdrawn|1|||
146547483|NCT02609633|528510958|FG000|Overall Study|Protocol Deviation|1|||
146547484|NCT02609633|528510959|FG001|Overall Study|Protocol Deviation|0|||
146547485|NCT02609633|528510958|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
146547486|NCT02609633|528510959|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
146547487|NCT02609633|528510958|FG000|Overall Study|Reason not Specified|2|||
146547488|NCT02609633|528510959|FG001|Overall Study|Reason not Specified|1|||
146547489|NCT05762679|528510962|FG000|Overall Study|Withdrawal by Subject|1|||
146882938|NCT03594227|529738703|FG003|Overall Study|Sponsor Decision|1|||
146547490|NCT05762679|528510962|FG000|Overall Study|No analyzable imaging data|1|||
146547491|NCT03670628|528510963|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
146547492|NCT03670628|528510964|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
146547493|NCT03670628|528510963|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
146547494|NCT03670628|528510964|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
146547495|NCT00997126|528510968|FG000|Overall Study|Physician Decision|7|||
146547496|NCT00997126|528510969|FG001|Overall Study|Physician Decision|11|||
146547497|NCT00471107|528510972|FG000|Overall Study|Technical problems/data loss|3|||
146547498|NCT00471107|528510973|FG001|Overall Study|Technical problems/data loss|1|||
146547499|NCT00471107|528510974|FG002|Overall Study|Technical problems/data loss|3|||
146547500|NCT03925220|528510975|FG000|Overall Study|Withdrawal by Subject|4|||
146547501|NCT03925220|528510976|FG001|Overall Study|Withdrawal by Subject|4|||
146547502|NCT03925220|528510977|FG002|Overall Study|Withdrawal by Subject|4|||
146547503|NCT03925220|528510978|FG003|Overall Study|Withdrawal by Subject|4|||
146882939|NCT03594227|529738700|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
146882940|NCT03594227|529738701|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
146882941|NCT03594227|529738702|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
146882942|NCT03594227|529738703|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
146882943|NCT00790907|529738704|FG000|Overall Study|Adverse Event|9|||
146882944|NCT00790907|529738705|FG001|Overall Study|Adverse Event|7|||
146882945|NCT00790907|529738706|FG002|Overall Study|Adverse Event|6|||
146882946|NCT00790907|529738704|FG000|Overall Study|Physician Decision|304|||
146882947|NCT00790907|529738705|FG001|Overall Study|Physician Decision|271|||
146882948|NCT00790907|529738706|FG002|Overall Study|Physician Decision|255|||
146882949|NCT00790907|529738704|FG000|Overall Study|Withdrawal by Subject|1|||
146882950|NCT00790907|529738705|FG001|Overall Study|Withdrawal by Subject|7|||
146882951|NCT00790907|529738706|FG002|Overall Study|Withdrawal by Subject|5|||
146882952|NCT00790907|529738704|FG000|Overall Study|Bleeding Event|11|||
146882953|NCT00790907|529738705|FG001|Overall Study|Bleeding Event|16|||
146882954|NCT00790907|529738706|FG002|Overall Study|Bleeding Event|21|||
146882955|NCT00790907|529738704|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
146882956|NCT00790907|529738705|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
146882957|NCT00790907|529738706|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
146882958|NCT00790907|529738704|FG000|Overall Study|Qualifying Condition Not Present|29|||
146882959|NCT00790907|529738705|FG001|Overall Study|Qualifying Condition Not Present|14|||
146882960|NCT00790907|529738706|FG002|Overall Study|Qualifying Condition Not Present|16|||
146882961|NCT00790907|529738704|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
146882962|NCT00790907|529738705|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
146882963|NCT00790907|529738706|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
146882964|NCT00790907|529738704|FG000|Overall Study|Did Not Receive Study Drug|10|||
146882965|NCT00790907|529738705|FG001|Overall Study|Did Not Receive Study Drug|0|||
146882966|NCT00790907|529738706|FG002|Overall Study|Did Not Receive Study Drug|0|||
146882967|NCT01888640|529738707|FG000|Overall Study|Lost to Follow-up|1|||
146882968|NCT01888640|529738708|FG001|Overall Study|Lost to Follow-up|2|||
146882969|NCT01888640|529738709|FG002|Overall Study|Lost to Follow-up|0|||
146882970|NCT01888640|529738707|FG000|Overall Study|Withdrawal by Subject|15|||
146882971|NCT01888640|529738708|FG001|Overall Study|Withdrawal by Subject|11|||
146882972|NCT01888640|529738709|FG002|Overall Study|Withdrawal by Subject|4|||
146882973|NCT01888640|529738707|FG000|Overall Study|Minimum dose not met|10|||
146882974|NCT01888640|529738708|FG001|Overall Study|Minimum dose not met|16|||
146882975|NCT01888640|529738709|FG002|Overall Study|Minimum dose not met|0|||
146882976|NCT01888640|529738707|FG000|Overall Study|Given wrong unit (placebo)|1|||
146882977|NCT01888640|529738708|FG001|Overall Study|Given wrong unit (placebo)|0|||
146882978|NCT01888640|529738709|FG002|Overall Study|Given wrong unit (placebo)|0|||
146882979|NCT01888640|529738707|FG000|Overall Study|Excluded for prior TENS|0|||
146882980|NCT01888640|529738708|FG001|Overall Study|Excluded for prior TENS|1|||
146882981|NCT01888640|529738709|FG002|Overall Study|Excluded for prior TENS|0|||
146882982|NCT01888640|529738707|FG000|Overall Study|Researcher Termination of Participant|0|||
146882983|NCT01888640|529738708|FG001|Overall Study|Researcher Termination of Participant|1|||
146882984|NCT01888640|529738709|FG002|Overall Study|Researcher Termination of Participant|1|||
146882985|NCT00774345|529738710|FG000|Pre-treatment|Other reasons|2|||
146882986|NCT00774345|529738711|FG001|Pre-treatment|Other reasons|0|||
146882987|NCT00774345|529738710|FG000|Treatment|Adverse Event|61|||
146882988|NCT00774345|529738711|FG001|Treatment|Adverse Event|15|||
146882989|NCT00774345|529738710|FG000|Treatment|Progressive Disease without histologic transformation|51|||
146882990|NCT00774345|529738711|FG001|Treatment|Progressive Disease without histologic transformation|111|||
146882991|NCT00774345|529738710|FG000|Treatment|Progressive Disease with histologic transformation|4|||
146882992|NCT00774345|529738711|FG001|Treatment|Progressive Disease with histologic transformation|2|||
146882993|NCT00774345|529738710|FG000|Treatment|Withdrawal by Subject|5|||
146882994|NCT00774345|529738711|FG001|Treatment|Withdrawal by Subject|2|||
146882995|NCT00774345|529738710|FG000|Treatment|Lost to Follow-up|1|||
146882996|NCT00774345|529738711|FG001|Treatment|Lost to Follow-up|1|||
146882997|NCT00774345|529738710|FG000|Treatment|Death|4|||
146882998|NCT00774345|529738711|FG001|Treatment|Death|0|||
146882999|NCT00774345|529738710|FG000|Treatment|Other Reasons|32|||
146883000|NCT00774345|529738711|FG001|Treatment|Other Reasons|26|||
146883001|NCT01277549|529738712|FG000|Overall Study|Failed to meet eligibility criteria|13|||
146883002|NCT01277549|529738713|FG001|Overall Study|Failed to meet eligibility criteria|9|||
146883003|NCT01277549|529738712|FG000|Overall Study|Withdrawal by Subject|1|||
146883004|NCT01277549|529738713|FG001|Overall Study|Withdrawal by Subject|3|||
146883005|NCT01277549|529738712|FG000|Overall Study|Protocol Violation|10|||
146883006|NCT01277549|529738713|FG001|Overall Study|Protocol Violation|1|||
146883007|NCT01277549|529738712|FG000|Overall Study|Physician Decision|2|||
146883008|NCT01277549|529738713|FG001|Overall Study|Physician Decision|1|||
146883009|NCT00075504|529738714|FG000|Overall Study|Withdrawal by Subject|9|||
146883010|NCT00075504|529738715|FG001|Overall Study|Withdrawal by Subject|7|||
146883011|NCT02109484|529738716|FG000|Overall Study|Lost to Follow-up|0|||
146883012|NCT02109484|529738717|FG001|Overall Study|Lost to Follow-up|0|||
146883013|NCT02109484|529738718|FG002|Overall Study|Lost to Follow-up|0|||
146883014|NCT02109484|529738719|FG003|Overall Study|Lost to Follow-up|1|||
146883015|NCT02109484|529738720|FG004|Overall Study|Lost to Follow-up|1|||
146883016|NCT02109484|529738721|FG005|Overall Study|Lost to Follow-up|0|||
146883017|NCT02109484|529738722|FG006|Overall Study|Lost to Follow-up|1|||
146883018|NCT02109484|529738723|FG007|Overall Study|Lost to Follow-up|0|||
146883019|NCT02109484|529738716|FG000|Overall Study|Withdrawal by Subject|0|||
146883020|NCT02109484|529738717|FG001|Overall Study|Withdrawal by Subject|0|||
146966441|NCT00650806|530038801|FG002|Overall Study|Noncompliance with study drug regimen|0|||
146966442|NCT00650806|530038802|FG003|Overall Study|Noncompliance with study drug regimen|0|||
146966443|NCT00650806|530038799|FG000|Overall Study|Study terminated by sponsor|2|||
146966444|NCT00650806|530038800|FG001|Overall Study|Study terminated by sponsor|3|||
146883021|NCT02109484|529738718|FG002|Overall Study|Withdrawal by Subject|0|||
146883022|NCT02109484|529738719|FG003|Overall Study|Withdrawal by Subject|0|||
146883023|NCT02109484|529738720|FG004|Overall Study|Withdrawal by Subject|1|||
146883024|NCT02109484|529738721|FG005|Overall Study|Withdrawal by Subject|1|||
146883025|NCT02109484|529738722|FG006|Overall Study|Withdrawal by Subject|1|||
146883026|NCT02109484|529738723|FG007|Overall Study|Withdrawal by Subject|0|||
146883027|NCT02109484|529738716|FG000|Overall Study|Physician Decision|0|||
146883028|NCT02109484|529738717|FG001|Overall Study|Physician Decision|0|||
146883029|NCT02109484|529738718|FG002|Overall Study|Physician Decision|0|||
146883030|NCT02109484|529738719|FG003|Overall Study|Physician Decision|0|||
146883031|NCT02109484|529738720|FG004|Overall Study|Physician Decision|2|||
146883032|NCT02109484|529738721|FG005|Overall Study|Physician Decision|0|||
146883033|NCT02109484|529738722|FG006|Overall Study|Physician Decision|0|||
146883034|NCT02109484|529738723|FG007|Overall Study|Physician Decision|0|||
146883035|NCT02109484|529738716|FG000|Overall Study|Death|0|||
146883036|NCT02109484|529738717|FG001|Overall Study|Death|0|||
146883037|NCT02109484|529738718|FG002|Overall Study|Death|0|||
146883038|NCT02109484|529738719|FG003|Overall Study|Death|0|||
146883039|NCT02109484|529738720|FG004|Overall Study|Death|0|||
146883040|NCT02109484|529738721|FG005|Overall Study|Death|0|||
146883041|NCT02109484|529738722|FG006|Overall Study|Death|0|||
146883042|NCT02109484|529738723|FG007|Overall Study|Death|2|||
146883043|NCT02109484|529738716|FG000|Overall Study|Moved away from study area|0|||
146883044|NCT02109484|529738717|FG001|Overall Study|Moved away from study area|0|||
146883045|NCT02109484|529738718|FG002|Overall Study|Moved away from study area|0|||
146883046|NCT02109484|529738719|FG003|Overall Study|Moved away from study area|0|||
146883047|NCT02109484|529738720|FG004|Overall Study|Moved away from study area|0|||
146883048|NCT02109484|529738721|FG005|Overall Study|Moved away from study area|0|||
146883049|NCT02109484|529738722|FG006|Overall Study|Moved away from study area|1|||
146883050|NCT02109484|529738723|FG007|Overall Study|Moved away from study area|1|||
146883051|NCT03215771|529738732|FG000|Overall Study|Withdrawal by Subject|2|||
146883052|NCT03215771|529738732|FG000|Overall Study|Physician Decision|1|||
146883053|NCT00574275|529738737|FG000|Overall Study|Randomized but not treated|2|||
146883054|NCT00574275|529738738|FG001|Overall Study|Randomized but not treated|3|||
146883055|NCT00574275|529738737|FG000|Overall Study|Adverse Event|32|||
146883056|NCT00574275|529738738|FG001|Overall Study|Adverse Event|76|||
146883057|NCT00574275|529738737|FG000|Overall Study|Disease progression|160|||
146883058|NCT00574275|529738738|FG001|Overall Study|Disease progression|146|||
146883059|NCT00574275|529738737|FG000|Overall Study|Lost to Follow-up|2|||
146883060|NCT00574275|529738738|FG001|Overall Study|Lost to Follow-up|1|||
146883061|NCT00574275|529738737|FG000|Overall Study|Study stopped based on DMC decision|62|||
146883062|NCT00574275|529738738|FG001|Overall Study|Study stopped based on DMC decision|23|||
146883063|NCT00574275|529738737|FG000|Overall Study|Withdrawal by Subject|15|||
146883064|NCT00574275|529738738|FG001|Overall Study|Withdrawal by Subject|17|||
146883065|NCT00574275|529738737|FG000|Overall Study|Error calculating tumor measurement|1|||
146883066|NCT00574275|529738738|FG001|Overall Study|Error calculating tumor measurement|0|||
146883067|NCT00574275|529738737|FG000|Overall Study|Physician Decision|1|||
146883068|NCT00574275|529738738|FG001|Overall Study|Physician Decision|1|||
146883069|NCT00574275|529738737|FG000|Overall Study|Protocol Violation|0|||
146883070|NCT00574275|529738738|FG001|Overall Study|Protocol Violation|1|||
146883071|NCT00574275|529738737|FG000|Overall Study|Patient and Investigator decision|0|||
146630430|NCT04672239|528824060|FG000|Week 6 Survey|Lost to Follow-up|12|||
146630431|NCT04672239|528824061|FG001|Week 6 Survey|Lost to Follow-up|2|||
146630432|NCT04672239|528824062|FG002|Week 6 Survey|Lost to Follow-up|5|||
146630433|NCT04672239|528824060|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
146883072|NCT00574275|529738738|FG001|Overall Study|Patient and Investigator decision|1|||
146630434|NCT04672239|528824061|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
146883073|NCT00574275|529738737|FG000|Overall Study|Insurance change|0|||
146883074|NCT00574275|529738738|FG001|Overall Study|Insurance change|1|||
146630435|NCT04672239|528824062|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
146630436|NCT04672239|528824060|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
146883075|NCT00574275|529738737|FG000|Overall Study|Operation for curative intent|0|||
146883076|NCT00574275|529738738|FG001|Overall Study|Operation for curative intent|1|||
146883077|NCT02703311|529738739|FG000|Overall Study|Death|5|||
146883078|NCT02703311|529738739|FG000|Overall Study|Withdrawal by Subject|3|||
146883079|NCT01967537|529738742|FG000|Overall Study|Withdrawal by Subject|52|||
146883080|NCT01967537|529738742|FG000|Overall Study|Refuse treatment|2|||
146883081|NCT01967537|529738742|FG000|Overall Study|Lost to Follow-up|6|||
146883082|NCT00137111|529738743|FG000|Total Therapy|Death|35|||
146883083|NCT00137111|529738744|FG001|Total Therapy|Death|0|||
146883084|NCT00137111|529738745|FG002|Total Therapy|Death|0|||
146883085|NCT00137111|529738746|FG003|Total Therapy|Death|0|||
146883086|NCT00137111|529738743|FG000|Total Therapy|Non Compliance|5|||
146883087|NCT00137111|529738744|FG001|Total Therapy|Non Compliance|0|||
146883088|NCT00137111|529738745|FG002|Total Therapy|Non Compliance|0|||
146883089|NCT00137111|529738746|FG003|Total Therapy|Non Compliance|0|||
146883090|NCT02788747|529738747|FG000|Overall Study|Adverse Event|1|||
146883091|NCT02788747|529738748|FG001|Overall Study|Adverse Event|0|||
146883092|NCT02788747|529738749|FG002|Overall Study|Adverse Event|0|||
146883093|NCT00562354|529738750|FG000|Overall Study|Physician Decision|0|||
146883094|NCT00562354|529738751|FG001|Overall Study|Physician Decision|1|||
146883095|NCT00562354|529738750|FG000|Overall Study|Lost to Follow-up|0|||
146883096|NCT00562354|529738751|FG001|Overall Study|Lost to Follow-up|1|||
146883097|NCT00317109|529738752|FG000|Overall Study|Withdrawal by Subject|2|||
146883098|NCT00317109|529738753|FG001|Overall Study|Withdrawal by Subject|0|||
146883099|NCT00317109|529738752|FG000|Overall Study|Migated/moved from study area|1|||
146883100|NCT00317109|529738753|FG001|Overall Study|Migated/moved from study area|0|||
146883101|NCT01079182|529738755|FG000|Overall Study|Lost to Follow-up|1634|||
146883102|NCT01079182|529738755|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
146883103|NCT01079182|529738755|FG000|Overall Study|Lack of Efficacy|514|||
146883104|NCT01079182|529738755|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
146883105|NCT01079182|529738755|FG000|Overall Study|Reasons not Evaluated|271|||
146883106|NCT01026831|529738756|FG000|Overall Study|Adverse Event|4|||
146883107|NCT01026831|529738757|FG001|Overall Study|Adverse Event|3|||
146883108|NCT01026831|529738756|FG000|Overall Study|Lost to Follow-up|2|||
146883109|NCT01026831|529738757|FG001|Overall Study|Lost to Follow-up|0|||
146883110|NCT01026831|529738756|FG000|Overall Study|Physician Decision|1|||
146883111|NCT01026831|529738757|FG001|Overall Study|Physician Decision|1|||
146883112|NCT01026831|529738756|FG000|Overall Study|Protocol Violation|0|||
146883113|NCT01026831|529738757|FG001|Overall Study|Protocol Violation|2|||
146883114|NCT01026831|529738756|FG000|Overall Study|Withdrawal by Subject|7|||
146883115|NCT01026831|529738757|FG001|Overall Study|Withdrawal by Subject|5|||
146883116|NCT04417894|529738758|FG000|Overall Study|Lost to Follow-up|3|||
146883117|NCT04417894|529738759|FG001|Overall Study|Lost to Follow-up|0|||
146883118|NCT04417894|529738758|FG000|Overall Study|Withdrawal by Subject|7|||
146883119|NCT04417894|529738759|FG001|Overall Study|Withdrawal by Subject|6|||
146883120|NCT04417894|529738758|FG000|Overall Study|Lack of Efficacy|3|||
146883121|NCT04417894|529738759|FG001|Overall Study|Lack of Efficacy|1|||
146883122|NCT01508702|529738760|FG000|Overall Study|Adverse Event|7|||
146883123|NCT01508702|529738761|FG001|Overall Study|Adverse Event|3|||
146883124|NCT01508702|529738760|FG000|Overall Study|Gout flare|2|||
146883125|NCT01508702|529738761|FG001|Overall Study|Gout flare|0|||
146883126|NCT01508702|529738760|FG000|Overall Study|Protocol Violation|2|||
146883127|NCT01508702|529738761|FG001|Overall Study|Protocol Violation|1|||
146883128|NCT01508702|529738760|FG000|Overall Study|Lost to Follow-up|1|||
146883129|NCT01508702|529738761|FG001|Overall Study|Lost to Follow-up|2|||
146883130|NCT01508702|529738760|FG000|Overall Study|Withdrawal by Subject|11|||
146883131|NCT01508702|529738761|FG001|Overall Study|Withdrawal by Subject|7|||
146883132|NCT00879697|529738770|FG000|Overall Study|Physician Decision|2|||
146883133|NCT00879697|529738771|FG001|Overall Study|Physician Decision|2|||
146883134|NCT02500121|529738772|FG000|Overall Study|Lost to Follow-up|0|||
146883135|NCT02500121|529738773|FG001|Overall Study|Lost to Follow-up|1|||
146883136|NCT02500121|529738772|FG000|Overall Study|Withdrawal by Subject|1|||
146883137|NCT02500121|529738773|FG001|Overall Study|Withdrawal by Subject|1|||
146883138|NCT02500121|529738772|FG000|Overall Study|Death|26|||
146883139|NCT02500121|529738773|FG001|Overall Study|Death|24|||
146883140|NCT01437397|529738775|FG000|Overall Study|Lost to Follow-up|9|||
146883141|NCT01437397|529738776|FG001|Overall Study|Lost to Follow-up|4|||
146883142|NCT01437397|529738777|FG002|Overall Study|Lost to Follow-up|2|||
146883143|NCT01437397|529738778|FG003|Overall Study|Lost to Follow-up|4|||
146883144|NCT01437397|529738779|FG004|Overall Study|Lost to Follow-up|5|||
146883145|NCT01437397|529738775|FG000|Overall Study|Withdrawal by Subject|11|||
146883146|NCT01437397|529738776|FG001|Overall Study|Withdrawal by Subject|12|||
146883147|NCT01437397|529738777|FG002|Overall Study|Withdrawal by Subject|24|||
146883148|NCT01437397|529738778|FG003|Overall Study|Withdrawal by Subject|11|||
146883149|NCT01437397|529738779|FG004|Overall Study|Withdrawal by Subject|22|||
146883150|NCT01437397|529738775|FG000|Overall Study|Protocol Violation|10|||
146883151|NCT01437397|529738776|FG001|Overall Study|Protocol Violation|12|||
146883152|NCT01437397|529738777|FG002|Overall Study|Protocol Violation|13|||
146547504|NCT03925220|528510975|FG000|Overall Study|Lost to Follow-up|40|||
146883153|NCT01437397|529738778|FG003|Overall Study|Protocol Violation|21|||
146883154|NCT01437397|529738779|FG004|Overall Study|Protocol Violation|19|||
146883155|NCT01437397|529738775|FG000|Overall Study|Lack of Efficacy|5|||
146883156|NCT01437397|529738776|FG001|Overall Study|Lack of Efficacy|4|||
146883157|NCT01437397|529738777|FG002|Overall Study|Lack of Efficacy|8|||
146883158|NCT01437397|529738778|FG003|Overall Study|Lack of Efficacy|10|||
146883159|NCT01437397|529738779|FG004|Overall Study|Lack of Efficacy|20|||
146883160|NCT01437397|529738775|FG000|Overall Study|Adverse Event|21|||
146883161|NCT01437397|529738776|FG001|Overall Study|Adverse Event|22|||
146883162|NCT01437397|529738777|FG002|Overall Study|Adverse Event|16|||
146883163|NCT01437397|529738778|FG003|Overall Study|Adverse Event|14|||
146883164|NCT01437397|529738779|FG004|Overall Study|Adverse Event|21|||
146883165|NCT01437397|529738775|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
146883166|NCT01437397|529738776|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
146883167|NCT01437397|529738777|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
146883168|NCT01437397|529738778|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
146883169|NCT01437397|529738779|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
146883170|NCT00903175|529738780|FG000|Period 1 - First Line|Adverse Event|36|||
146883171|NCT00903175|529738781|FG001|Period 1 - First Line|Adverse Event|50|||
146883172|NCT00903175|529738780|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
146883173|NCT00903175|529738781|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
146883174|NCT00903175|529738780|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
146883175|NCT00903175|529738781|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
146883176|NCT00903175|529738780|FG000|Period 1 - First Line|Protocol Violation|3|||
146883177|NCT00903175|529738781|FG001|Period 1 - First Line|Protocol Violation|3|||
146883178|NCT00903175|529738780|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
146883179|NCT00903175|529738781|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
146883180|NCT00903175|529738780|FG000|Period 1 - First Line|Administrative problems|12|||
146883181|NCT00903175|529738781|FG001|Period 1 - First Line|Administrative problems|13|||
146883182|NCT00903175|529738780|FG000|Period 1 - First Line|Death|17|||
146883183|NCT00903175|529738781|FG001|Period 1 - First Line|Death|10|||
146883184|NCT00903175|529738780|FG000|Period 2 - Second Line|Missing|1|||
146883185|NCT00903175|529738781|FG001|Period 2 - Second Line|Missing|0|||
146883186|NCT00903175|529738780|FG000|Period 2 - Second Line|Adverse Event|16|||
146883187|NCT00903175|529738781|FG001|Period 2 - Second Line|Adverse Event|20|||
146883188|NCT00903175|529738780|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
146883189|NCT00903175|529738781|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
146883190|NCT00903175|529738780|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
146883191|NCT00903175|529738781|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
146883192|NCT00903175|529738780|FG000|Period 2 - Second Line|Administrative problems|19|||
146883193|NCT00903175|529738781|FG001|Period 2 - Second Line|Administrative problems|9|||
146547505|NCT03925220|528510976|FG001|Overall Study|Lost to Follow-up|46|||
146883194|NCT00903175|529738780|FG000|Period 2 - Second Line|Death|5|||
146883195|NCT00903175|529738781|FG001|Period 2 - Second Line|Death|2|||
146883196|NCT03074474|529738782|FG000|Overall Study|Lost to Follow-up|10|||
146883197|NCT03074474|529738782|FG000|Overall Study|Withdrawal by Subject|10|||
146883198|NCT03074474|529738782|FG000|Overall Study|Death|4|||
146883199|NCT03074474|529738782|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
146883200|NCT02124564|529738789|FG000|Treatment Period|Adverse Event|2|||
146883201|NCT02124564|529738789|FG000|Treatment Period|Lack of Efficacy|3|||
146883202|NCT02124564|529738789|FG000|Treatment Period|Withdrawal by Subject|2|||
146883203|NCT00328627|529741869|FG000|Overall Study|Hyperglycemic Rescue|41|||
146883204|NCT00328627|529741870|FG001|Overall Study|Hyperglycemic Rescue|18|||
146883205|NCT00328627|529741871|FG002|Overall Study|Hyperglycemic Rescue|16|||
146547506|NCT03925220|528510977|FG002|Overall Study|Lost to Follow-up|37|||
146883206|NCT00328627|529741872|FG003|Overall Study|Hyperglycemic Rescue|13|||
146883207|NCT00328627|529741873|FG004|Overall Study|Hyperglycemic Rescue|6|||
146883208|NCT00328627|529741874|FG005|Overall Study|Hyperglycemic Rescue|5|||
146883209|NCT00328627|529741875|FG006|Overall Study|Hyperglycemic Rescue|19|||
146883210|NCT00328627|529741876|FG007|Overall Study|Hyperglycemic Rescue|6|||
146547507|NCT03925220|528510978|FG003|Overall Study|Lost to Follow-up|38|||
146883211|NCT00328627|529741877|FG008|Overall Study|Hyperglycemic Rescue|6|||
146883212|NCT00328627|529741878|FG009|Overall Study|Hyperglycemic Rescue|11|||
146547508|NCT04828486|528510979|FG000|Overall Study|Adverse Event|2|||
146547509|NCT04828486|528510979|FG000|Overall Study|Death|1|||
146883213|NCT00328627|529741879|FG010|Overall Study|Hyperglycemic Rescue|3|||
146883214|NCT00328627|529741880|FG011|Overall Study|Hyperglycemic Rescue|2|||
146883215|NCT00328627|529741869|FG000|Overall Study|Adverse Event|3|||
146883216|NCT00328627|529741870|FG001|Overall Study|Adverse Event|1|||
146883217|NCT00328627|529741871|FG002|Overall Study|Adverse Event|2|||
146883218|NCT00328627|529741872|FG003|Overall Study|Adverse Event|3|||
146883219|NCT00328627|529741873|FG004|Overall Study|Adverse Event|1|||
146883220|NCT00328627|529741874|FG005|Overall Study|Adverse Event|2|||
146883221|NCT00328627|529741875|FG006|Overall Study|Adverse Event|1|||
146883222|NCT00328627|529741876|FG007|Overall Study|Adverse Event|2|||
146883223|NCT00328627|529741877|FG008|Overall Study|Adverse Event|0|||
146883224|NCT00328627|529741878|FG009|Overall Study|Adverse Event|7|||
146883225|NCT00328627|529741879|FG010|Overall Study|Adverse Event|5|||
146883226|NCT00328627|529741880|FG011|Overall Study|Adverse Event|4|||
146883227|NCT00328627|529741869|FG000|Overall Study|Protocol Violation|2|||
146883228|NCT00328627|529741870|FG001|Overall Study|Protocol Violation|2|||
146883229|NCT00328627|529741871|FG002|Overall Study|Protocol Violation|2|||
146883230|NCT00328627|529741872|FG003|Overall Study|Protocol Violation|8|||
146883231|NCT00328627|529741873|FG004|Overall Study|Protocol Violation|5|||
146883232|NCT00328627|529741874|FG005|Overall Study|Protocol Violation|5|||
146883233|NCT00328627|529741875|FG006|Overall Study|Protocol Violation|6|||
146883234|NCT00328627|529741876|FG007|Overall Study|Protocol Violation|2|||
146883235|NCT00328627|529741877|FG008|Overall Study|Protocol Violation|1|||
146883236|NCT00328627|529741878|FG009|Overall Study|Protocol Violation|4|||
146883237|NCT00328627|529741879|FG010|Overall Study|Protocol Violation|6|||
146883238|NCT00328627|529741880|FG011|Overall Study|Protocol Violation|2|||
146883239|NCT00328627|529741869|FG000|Overall Study|Lost to Follow-up|4|||
146883240|NCT00328627|529741870|FG001|Overall Study|Lost to Follow-up|2|||
146883241|NCT00328627|529741871|FG002|Overall Study|Lost to Follow-up|2|||
146883242|NCT00328627|529741872|FG003|Overall Study|Lost to Follow-up|4|||
146883243|NCT00328627|529741873|FG004|Overall Study|Lost to Follow-up|0|||
146883244|NCT00328627|529741874|FG005|Overall Study|Lost to Follow-up|2|||
146883245|NCT00328627|529741875|FG006|Overall Study|Lost to Follow-up|3|||
146883246|NCT00328627|529741876|FG007|Overall Study|Lost to Follow-up|0|||
146883247|NCT00328627|529741877|FG008|Overall Study|Lost to Follow-up|3|||
146883248|NCT00328627|529741878|FG009|Overall Study|Lost to Follow-up|2|||
146883249|NCT00328627|529741879|FG010|Overall Study|Lost to Follow-up|0|||
146883250|NCT00328627|529741880|FG011|Overall Study|Lost to Follow-up|1|||
146883251|NCT00328627|529741869|FG000|Overall Study|Withdrawal by Subject|5|||
146883252|NCT00328627|529741870|FG001|Overall Study|Withdrawal by Subject|4|||
146883253|NCT00328627|529741871|FG002|Overall Study|Withdrawal by Subject|5|||
146883254|NCT00328627|529741872|FG003|Overall Study|Withdrawal by Subject|6|||
146883255|NCT00328627|529741873|FG004|Overall Study|Withdrawal by Subject|2|||
146883256|NCT00328627|529741874|FG005|Overall Study|Withdrawal by Subject|5|||
146883257|NCT00328627|529741875|FG006|Overall Study|Withdrawal by Subject|4|||
146883258|NCT00328627|529741876|FG007|Overall Study|Withdrawal by Subject|4|||
146883259|NCT00328627|529741877|FG008|Overall Study|Withdrawal by Subject|4|||
146883260|NCT00328627|529741878|FG009|Overall Study|Withdrawal by Subject|5|||
146883261|NCT00328627|529741879|FG010|Overall Study|Withdrawal by Subject|2|||
146883262|NCT00328627|529741880|FG011|Overall Study|Withdrawal by Subject|7|||
146883263|NCT00328627|529741869|FG000|Overall Study|Pregnancy|0|||
146883264|NCT00328627|529741870|FG001|Overall Study|Pregnancy|1|||
146883265|NCT00328627|529741871|FG002|Overall Study|Pregnancy|0|||
146883266|NCT00328627|529741872|FG003|Overall Study|Pregnancy|0|||
146883267|NCT00328627|529741873|FG004|Overall Study|Pregnancy|0|||
146883268|NCT00328627|529741874|FG005|Overall Study|Pregnancy|0|||
146883269|NCT00328627|529741875|FG006|Overall Study|Pregnancy|0|||
146883270|NCT00328627|529741876|FG007|Overall Study|Pregnancy|0|||
146883271|NCT00328627|529741877|FG008|Overall Study|Pregnancy|0|||
146883272|NCT00328627|529741878|FG009|Overall Study|Pregnancy|0|||
146883273|NCT00328627|529741879|FG010|Overall Study|Pregnancy|0|||
146883274|NCT00328627|529741880|FG011|Overall Study|Pregnancy|0|||
146883275|NCT00328627|529741869|FG000|Overall Study|Physician Decision|4|||
146883276|NCT00328627|529741870|FG001|Overall Study|Physician Decision|3|||
146883277|NCT00328627|529741871|FG002|Overall Study|Physician Decision|1|||
146883278|NCT00328627|529741872|FG003|Overall Study|Physician Decision|2|||
146883279|NCT00328627|529741873|FG004|Overall Study|Physician Decision|1|||
146883280|NCT00328627|529741874|FG005|Overall Study|Physician Decision|1|||
146883281|NCT00328627|529741875|FG006|Overall Study|Physician Decision|1|||
146883282|NCT00328627|529741876|FG007|Overall Study|Physician Decision|0|||
146883283|NCT00328627|529741877|FG008|Overall Study|Physician Decision|3|||
146883284|NCT00328627|529741878|FG009|Overall Study|Physician Decision|2|||
146883285|NCT00328627|529741879|FG010|Overall Study|Physician Decision|1|||
146883286|NCT00328627|529741880|FG011|Overall Study|Physician Decision|0|||
146883287|NCT00328627|529741869|FG000|Overall Study|Other|0|||
146883288|NCT00328627|529741870|FG001|Overall Study|Other|0|||
146883289|NCT00328627|529741871|FG002|Overall Study|Other|0|||
146883290|NCT00328627|529741872|FG003|Overall Study|Other|1|||
146883291|NCT00328627|529741873|FG004|Overall Study|Other|0|||
146883292|NCT00328627|529741874|FG005|Overall Study|Other|0|||
146883293|NCT00328627|529741875|FG006|Overall Study|Other|1|||
146883294|NCT00328627|529741876|FG007|Overall Study|Other|0|||
146883295|NCT00328627|529741877|FG008|Overall Study|Other|0|||
146883296|NCT00328627|529741878|FG009|Overall Study|Other|1|||
146883297|NCT00328627|529741879|FG010|Overall Study|Other|1|||
146883298|NCT00328627|529741880|FG011|Overall Study|Other|0|||
146883299|NCT02049944|529741881|FG000|Overall Study|Protocol Violation|2|||
146883300|NCT01765673|529741882|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
146883301|NCT01284114|529741883|FG000|Overall Study|viral infection|1|||
146883302|NCT01284114|529741883|FG000|Overall Study|From the results of ALLTITUDE study|1|||
146883303|NCT01284114|529741883|FG000|Overall Study|Symptomatic hypotension|1|||
146883304|NCT01284114|529741883|FG000|Overall Study|dizziness|1|||
146883305|NCT03409744|529741884|FG000|Overall Study|Death|2|||
146883306|NCT03409744|529741884|FG000|Overall Study|Physician Decision|5|||
146883307|NCT03409744|529741884|FG000|Overall Study|Pregnancy|1|||
146883308|NCT03409744|529741884|FG000|Overall Study|Lost to Follow-up|1|||
146883309|NCT03409744|529741884|FG000|Overall Study|Protocol Violation|1|||
146883310|NCT04872101|529741885|FG000|Overall Study|Withdrawal by Subject|10|||
146883311|NCT04872101|529741886|FG001|Overall Study|Withdrawal by Subject|16|||
146883312|NCT04872101|529741885|FG000|Overall Study|Lack of Efficacy|6|||
146883313|NCT04872101|529741886|FG001|Overall Study|Lack of Efficacy|14|||
146883314|NCT04872101|529741885|FG000|Overall Study|Adverse Event|1|||
146883315|NCT04872101|529741886|FG001|Overall Study|Adverse Event|6|||
146883316|NCT04872101|529741885|FG000|Overall Study|Lost to Follow-up|2|||
146883317|NCT04872101|529741886|FG001|Overall Study|Lost to Follow-up|1|||
146883318|NCT04872101|529741885|FG000|Overall Study|Pregnancy|2|||
146883319|NCT04872101|529741886|FG001|Overall Study|Pregnancy|0|||
146883320|NCT04872101|529741885|FG000|Overall Study|Prohibited Medication|1|||
146883321|NCT04872101|529741886|FG001|Overall Study|Prohibited Medication|0|||
146547510|NCT04828486|528510979|FG000|Overall Study|Disease Progression|8|||
146547511|NCT04828486|528510979|FG000|Overall Study|Other Complicating Disease|1|||
146547512|NCT04828486|528510979|FG000|Overall Study|Withdrawal by Subject|1|||
146547513|NCT02063724|528510980|FG000|Overall Study|Disease progression|1|||
146547514|NCT00896233|528510981|FG000|Overall Study|Claustrophobia during MRI|1|||
146547515|NCT02965456|528510982|FG000|Overall Study|Lost to Follow-up|40|||
146547516|NCT02965456|528510983|FG001|Overall Study|Lost to Follow-up|18|||
146547517|NCT02965456|528510982|FG000|Overall Study|Subject Request|22|||
146547518|NCT02965456|528510983|FG001|Overall Study|Subject Request|13|||
146547519|NCT02965456|528510982|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
146547520|NCT02965456|528510983|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
146547521|NCT02965456|528510982|FG000|Overall Study|Adverse Event|3|||
146547522|NCT02965456|528510983|FG001|Overall Study|Adverse Event|0|||
146547523|NCT02965456|528510982|FG000|Overall Study|Noncompliance with Study Drug|1|||
146547524|NCT02965456|528510983|FG001|Overall Study|Noncompliance with Study Drug|1|||
146547525|NCT02965456|528510982|FG000|Overall Study|Worsening Condition|0|||
146547526|NCT02965456|528510983|FG001|Overall Study|Worsening Condition|2|||
146547527|NCT02965456|528510982|FG000|Overall Study|Lack of Efficacy|1|||
146547528|NCT02965456|528510983|FG001|Overall Study|Lack of Efficacy|0|||
146547529|NCT02965456|528510982|FG000|Overall Study|Physician Decision|0|||
146547530|NCT02965456|528510983|FG001|Overall Study|Physician Decision|1|||
146547531|NCT02965456|528510982|FG000|Overall Study|Pregnancy|1|||
146547532|NCT02965456|528510983|FG001|Overall Study|Pregnancy|0|||
146547533|NCT02965456|528510982|FG000|Overall Study|Protocol Violation|0|||
146547534|NCT02965456|528510983|FG001|Overall Study|Protocol Violation|1|||
146547535|NCT02965456|528510982|FG000|Overall Study|Participant ran out of study drug|0|||
146547536|NCT02965456|528510983|FG001|Overall Study|Participant ran out of study drug|1|||
146547537|NCT04465955|528510984|FG000|Overall Study|Withdrew consent|6|||
146547538|NCT04465955|528510985|FG001|Overall Study|Withdrew consent|10|||
146547539|NCT04465955|528510986|FG002|Overall Study|Withdrew consent|7|||
146547540|NCT04465955|528510984|FG000|Overall Study|Adverse Event|6|||
146547541|NCT04465955|528510985|FG001|Overall Study|Adverse Event|5|||
146547542|NCT04465955|528510986|FG002|Overall Study|Adverse Event|1|||
146547543|NCT04465955|528510984|FG000|Overall Study|Lost to Follow-up|2|||
146883322|NCT04872101|529741885|FG000|Overall Study|Not dosed|1|||
146883323|NCT04872101|529741886|FG001|Overall Study|Not dosed|0|||
146883324|NCT00264004|529741887|FG000|Overall Study|Adverse Event|2|||
146883325|NCT00264004|529741888|FG001|Overall Study|Adverse Event|3|||
146883326|NCT00264004|529741889|FG002|Overall Study|Adverse Event|6|||
146547544|NCT04465955|528510985|FG001|Overall Study|Lost to Follow-up|0|||
146883327|NCT00264004|529741890|FG003|Overall Study|Adverse Event|4|||
146883328|NCT00264004|529741887|FG000|Overall Study|Withdrawal by Subject|0|||
146883329|NCT00264004|529741888|FG001|Overall Study|Withdrawal by Subject|1|||
146547545|NCT04465955|528510986|FG002|Overall Study|Lost to Follow-up|3|||
146547546|NCT04465955|528510984|FG000|Overall Study|Other|1|||
146547547|NCT04465955|528510985|FG001|Overall Study|Other|1|||
146547548|NCT04465955|528510986|FG002|Overall Study|Other|3|||
146547549|NCT00317369|528510992|FG000|Overall Study|Adverse Event|2|||
146547550|NCT00317369|528510993|FG001|Overall Study|Adverse Event|1|||
146547551|NCT00317369|528510994|FG002|Overall Study|Adverse Event|0|||
146547552|NCT00317369|528510992|FG000|Overall Study|Lack of Efficacy|0|||
146883330|NCT00264004|529741889|FG002|Overall Study|Withdrawal by Subject|2|||
146883331|NCT00264004|529741890|FG003|Overall Study|Withdrawal by Subject|2|||
146883332|NCT00264004|529741887|FG000|Overall Study|Other|2|||
146883333|NCT00264004|529741888|FG001|Overall Study|Other|2|||
146883334|NCT00264004|529741889|FG002|Overall Study|Other|0|||
146883335|NCT00264004|529741890|FG003|Overall Study|Other|3|||
146883336|NCT00264004|529741887|FG000|Overall Study|Development study specific disc. crit.|1|||
146883337|NCT00264004|529741888|FG001|Overall Study|Development study specific disc. crit.|0|||
146883338|NCT00264004|529741889|FG002|Overall Study|Development study specific disc. crit.|1|||
146883339|NCT00264004|529741890|FG003|Overall Study|Development study specific disc. crit.|0|||
146883340|NCT00264004|529741887|FG000|Overall Study|Cond. under inv. worsened|9|||
146883341|NCT00264004|529741888|FG001|Overall Study|Cond. under inv. worsened|5|||
146883342|NCT00264004|529741889|FG002|Overall Study|Cond. under inv. worsened|3|||
146883343|NCT00264004|529741890|FG003|Overall Study|Cond. under inv. worsened|4|||
146883344|NCT00264004|529741887|FG000|Overall Study|Not treated|3|||
146883345|NCT00264004|529741888|FG001|Overall Study|Not treated|0|||
146883346|NCT00264004|529741889|FG002|Overall Study|Not treated|2|||
146883347|NCT00264004|529741890|FG003|Overall Study|Not treated|2|||
146883348|NCT03691974|529741891|FG000|Overall Study|Physician Decision|1|||
146883349|NCT03691974|529741892|FG001|Overall Study|Physician Decision|0|||
146883350|NCT03691974|529741891|FG000|Overall Study|Adverse Event|1|||
146883351|NCT03691974|529741892|FG001|Overall Study|Adverse Event|0|||
146883352|NCT03691974|529741891|FG000|Overall Study|Withdrawal by Subject|11|||
146883353|NCT03691974|529741892|FG001|Overall Study|Withdrawal by Subject|9|||
146883354|NCT03691974|529741891|FG000|Overall Study|Protocol Violation|1|||
146883355|NCT03691974|529741892|FG001|Overall Study|Protocol Violation|0|||
146883356|NCT03691974|529741891|FG000|Overall Study|Lost to Follow-up|8|||
146883357|NCT03691974|529741892|FG001|Overall Study|Lost to Follow-up|7|||
146883358|NCT00691483|529741893|FG000|Overall Study|Adverse Event|14|||
146883359|NCT00691483|529741894|FG001|Overall Study|Adverse Event|6|||
146883360|NCT00691483|529741893|FG000|Overall Study|Lost to Follow-up|17|||
146883361|NCT00691483|529741894|FG001|Overall Study|Lost to Follow-up|10|||
146883362|NCT00691483|529741893|FG000|Overall Study|Withdrawal by Subject|24|||
146883363|NCT00691483|529741894|FG001|Overall Study|Withdrawal by Subject|7|||
146883364|NCT00691483|529741893|FG000|Overall Study|Other known cause|6|||
146883365|NCT00691483|529741894|FG001|Overall Study|Other known cause|1|||
146883366|NCT00691483|529741893|FG000|Overall Study|Randomized by not treated|7|||
146883367|NCT00691483|529741894|FG001|Overall Study|Randomized by not treated|1|||
146883368|NCT03860961|529741896|FG000|Overall Study|Withdrawal by Subject|6|||
146883369|NCT03860961|529741897|FG001|Overall Study|Withdrawal by Subject|11|||
146883370|NCT03860961|529741896|FG000|Overall Study|Death|10|||
146883371|NCT03860961|529741897|FG001|Overall Study|Death|6|||
146883372|NCT03860961|529741896|FG000|Overall Study|Incomplete two-year data|4|||
146883373|NCT03860961|529741897|FG001|Overall Study|Incomplete two-year data|0|||
146883374|NCT02475681|529741898|FG000|Overall Study|Death|16|||
146883375|NCT02475681|529741899|FG001|Overall Study|Death|6|||
146883376|NCT02475681|529741900|FG002|Overall Study|Death|9|||
146883377|NCT02475681|529741898|FG000|Overall Study|Physician Decision|0|||
146883378|NCT02475681|529741899|FG001|Overall Study|Physician Decision|3|||
146883379|NCT02475681|529741900|FG002|Overall Study|Physician Decision|1|||
146883380|NCT02475681|529741898|FG000|Overall Study|Withdrawal by Subject|12|||
146883381|NCT02475681|529741899|FG001|Overall Study|Withdrawal by Subject|6|||
146883382|NCT02475681|529741900|FG002|Overall Study|Withdrawal by Subject|9|||
146883383|NCT02475681|529741898|FG000|Overall Study|Lost to Follow-up|2|||
146883384|NCT02475681|529741899|FG001|Overall Study|Lost to Follow-up|1|||
146883385|NCT02475681|529741900|FG002|Overall Study|Lost to Follow-up|3|||
146883386|NCT02475681|529741898|FG000|Overall Study|Ongoing in Study|0|||
146883387|NCT02475681|529741899|FG001|Overall Study|Ongoing in Study|163|||
146883388|NCT02475681|529741900|FG002|Overall Study|Ongoing in Study|157|||
146883389|NCT02475681|529741898|FG000|Overall Study|Reasons other than above listed|2|||
146883390|NCT02475681|529741899|FG001|Overall Study|Reasons other than above listed|0|||
146883391|NCT02475681|529741900|FG002|Overall Study|Reasons other than above listed|0|||
146883392|NCT02105454|529741913|FG000|Overall Study|Withdrawal by Subject|1|||
146883393|NCT00272038|529741914|FG000|Overall Study|withdrew before they received 2 cycles|7|||
146883394|NCT00493870|529741915|FG000|Overall Study|Lost to Follow-up|12|||
146883395|NCT00493870|529741916|FG001|Overall Study|Lost to Follow-up|15|||
146883396|NCT02721355|529741917|FG000|Overall Study|Lost to Follow-up|6|||
146883397|NCT02721355|529741918|FG001|Overall Study|Lost to Follow-up|1|||
146883398|NCT00356278|529741919|FG000|Overall Study|Withdrawal by Subject|25|||
146883399|NCT00356278|529741920|FG001|Overall Study|Withdrawal by Subject|15|||
146883400|NCT00356278|529741921|FG002|Overall Study|Withdrawal by Subject|19|||
146883401|NCT00883337|529741924|FG000|Core Treatment Period|Adverse Event|9|||
146883402|NCT00883337|529741925|FG001|Core Treatment Period|Adverse Event|12|||
146883403|NCT00883337|529741926|FG002|Core Treatment Period|Adverse Event|22|||
146883404|NCT00883337|529741924|FG000|Core Treatment Period|Lack of Efficacy|7|||
146883405|NCT00883337|529741925|FG001|Core Treatment Period|Lack of Efficacy|4|||
146883406|NCT00883337|529741926|FG002|Core Treatment Period|Lack of Efficacy|2|||
146883407|NCT00883337|529741924|FG000|Core Treatment Period|Lost to Follow-up|1|||
146883408|NCT00883337|529741925|FG001|Core Treatment Period|Lost to Follow-up|1|||
146966445|NCT00650806|530038801|FG002|Overall Study|Study terminated by sponsor|5|||
146547553|NCT00317369|528510993|FG001|Overall Study|Lack of Efficacy|1|||
146883409|NCT00883337|529741926|FG002|Core Treatment Period|Lost to Follow-up|0|||
146883410|NCT00883337|529741924|FG000|Core Treatment Period|Withdrawal by Subject|2|||
146883411|NCT00883337|529741925|FG001|Core Treatment Period|Withdrawal by Subject|2|||
146547554|NCT00317369|528510994|FG002|Overall Study|Lack of Efficacy|1|||
146547555|NCT00317369|528510992|FG000|Overall Study|Withdrawal by Subject|0|||
146547556|NCT00317369|528510993|FG001|Overall Study|Withdrawal by Subject|0|||
146883412|NCT00883337|529741926|FG002|Core Treatment Period|Withdrawal by Subject|6|||
146883413|NCT00883337|529741924|FG000|Core Treatment Period|Wish to be pregnant|1|||
146883414|NCT00883337|529741925|FG001|Core Treatment Period|Wish to be pregnant|2|||
146883415|NCT00883337|529741926|FG002|Core Treatment Period|Wish to be pregnant|1|||
146883416|NCT00883337|529741924|FG000|Core Treatment Period|Poor compliance to protocol|0|||
146883417|NCT00883337|529741925|FG001|Core Treatment Period|Poor compliance to protocol|0|||
146883418|NCT00883337|529741926|FG002|Core Treatment Period|Poor compliance to protocol|1|||
146883419|NCT00883337|529741924|FG000|Core Treatment Period|Other than above|0|||
146883420|NCT00883337|529741925|FG001|Core Treatment Period|Other than above|1|||
146883421|NCT00883337|529741926|FG002|Core Treatment Period|Other than above|1|||
146883422|NCT00883337|529741924|FG000|Extension Treatment Period|Adverse Event|8|||
146883423|NCT00883337|529741925|FG001|Extension Treatment Period|Adverse Event|5|||
146883424|NCT00883337|529741926|FG002|Extension Treatment Period|Adverse Event|5|||
146883425|NCT00883337|529741924|FG000|Extension Treatment Period|Lack of Efficacy|8|||
146883426|NCT00883337|529741925|FG001|Extension Treatment Period|Lack of Efficacy|8|||
146883427|NCT00883337|529741926|FG002|Extension Treatment Period|Lack of Efficacy|8|||
146883428|NCT00883337|529741924|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
146883429|NCT00883337|529741925|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
146883430|NCT00883337|529741926|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
146883431|NCT00883337|529741924|FG000|Extension Treatment Period|Lost to Follow-up|1|||
146883432|NCT00883337|529741925|FG001|Extension Treatment Period|Lost to Follow-up|0|||
146883433|NCT00883337|529741926|FG002|Extension Treatment Period|Lost to Follow-up|0|||
146883434|NCT00883337|529741924|FG000|Extension Treatment Period|Other than above|10|||
146883435|NCT00883337|529741925|FG001|Extension Treatment Period|Other than above|9|||
146883436|NCT00883337|529741926|FG002|Extension Treatment Period|Other than above|5|||
146883437|NCT01652287|529741928|FG000|Overall Study|Withdrawal by Subject|2|||
146883438|NCT01652287|529741929|FG001|Overall Study|Withdrawal by Subject|0|||
146883439|NCT00527605|529741930|FG000|Overall Study|Adverse Event|3|||
146883440|NCT00527605|529741931|FG001|Overall Study|Adverse Event|0|||
146883441|NCT00527605|529741930|FG000|Overall Study|Withdrawal by Subject|3|||
146883442|NCT00527605|529741931|FG001|Overall Study|Withdrawal by Subject|7|||
146883443|NCT00527605|529741930|FG000|Overall Study|Lost to Follow-up|6|||
146883444|NCT00527605|529741931|FG001|Overall Study|Lost to Follow-up|2|||
146883445|NCT00527605|529741930|FG000|Overall Study|Protocol Violation|1|||
146883446|NCT00527605|529741931|FG001|Overall Study|Protocol Violation|2|||
146883447|NCT00763139|529741937|FG000|Overall Study|Adverse Event|4|||
146883448|NCT00763139|529741938|FG001|Overall Study|Adverse Event|2|||
146883449|NCT00763139|529741937|FG000|Overall Study|Withdrawal by Subject|0|||
146883450|NCT00763139|529741938|FG001|Overall Study|Withdrawal by Subject|1|||
146883451|NCT00763139|529741937|FG000|Overall Study|med change not allowed by protocol|1|||
146883452|NCT00763139|529741938|FG001|Overall Study|med change not allowed by protocol|0|||
146883453|NCT01592760|529741939|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
146883454|NCT01592760|529741940|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
146883455|NCT01592760|529741941|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
146883456|NCT04312009|529741942|FG000|Overall Study|Withdrawal by Subject|2|||
146883457|NCT04312009|529741943|FG001|Overall Study|Withdrawal by Subject|1|||
146883458|NCT01363986|529741946|FG000|Overall Study|Disease progression|1|||
146883459|NCT01637142|529741947|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
146883460|NCT02354703|529741948|FG000|Overall Study|Withdrawal by Subject|1|||
146883461|NCT02354703|529741949|FG001|Overall Study|Withdrawal by Subject|1|||
146883462|NCT02354703|529741950|FG002|Overall Study|Withdrawal by Subject|1|||
146883463|NCT02354703|529741951|FG003|Overall Study|Withdrawal by Subject|1|||
146883464|NCT02354703|529741948|FG000|Overall Study|Lost to Follow-up|2|||
146883465|NCT02354703|529741949|FG001|Overall Study|Lost to Follow-up|7|||
146883466|NCT02354703|529741950|FG002|Overall Study|Lost to Follow-up|9|||
146547557|NCT00317369|528510994|FG002|Overall Study|Withdrawal by Subject|1|||
146883467|NCT02354703|529741951|FG003|Overall Study|Lost to Follow-up|2|||
146883468|NCT02354703|529741948|FG000|Overall Study|Adverse Event|0|||
146883469|NCT02354703|529741949|FG001|Overall Study|Adverse Event|0|||
146883470|NCT02354703|529741950|FG002|Overall Study|Adverse Event|1|||
146547558|NCT06042855|528510996|FG000|Overall Study|No Receipt of Study Drug|48|||
146547559|NCT06042855|528510997|FG001|Overall Study|No Receipt of Study Drug|57|||
146883471|NCT02354703|529741951|FG003|Overall Study|Adverse Event|0|||
146883472|NCT04986202|529741956|FG000|Overall Study|Death|10|||
146883473|NCT04986202|529741957|FG001|Overall Study|Death|3|||
146883474|NCT04986202|529741958|FG002|Overall Study|Death|10|||
146883475|NCT04986202|529741956|FG000|Overall Study|Physician Decision|3|||
146966446|NCT00650806|530038802|FG003|Overall Study|Study terminated by sponsor|4|||
146883476|NCT04986202|529741957|FG001|Overall Study|Physician Decision|1|||
146883477|NCT04986202|529741958|FG002|Overall Study|Physician Decision|2|||
146883478|NCT04986202|529741956|FG000|Overall Study|Withdrawal by Subject|4|||
146883479|NCT04986202|529741957|FG001|Overall Study|Withdrawal by Subject|2|||
146883480|NCT04986202|529741958|FG002|Overall Study|Withdrawal by Subject|4|||
146883481|NCT02118792|529741959|FG000|Overall Study|Withdrawal by Subject|6|||
146883482|NCT02118792|529741960|FG001|Overall Study|Withdrawal by Subject|3|||
146883483|NCT02118792|529741959|FG000|Overall Study|Lost to Follow-up|4|||
146883484|NCT02118792|529741960|FG001|Overall Study|Lost to Follow-up|4|||
146883485|NCT02118792|529741959|FG000|Overall Study|Adverse Event|5|||
146883486|NCT02118792|529741960|FG001|Overall Study|Adverse Event|4|||
146883487|NCT02118792|529741959|FG000|Overall Study|Withdrawal by parent/guardian|14|||
146883488|NCT02118792|529741960|FG001|Overall Study|Withdrawal by parent/guardian|20|||
146883489|NCT02118792|529741959|FG000|Overall Study|Other|1|||
146883490|NCT02118792|529741960|FG001|Overall Study|Other|6|||
146883491|NCT02118792|529741959|FG000|Overall Study|Randomised but not treated|1|||
146883492|NCT02118792|529741960|FG001|Overall Study|Randomised but not treated|0|||
146547560|NCT06042855|528510996|FG000|Overall Study|Administratively Withdrawn|59|||
146547561|NCT06042855|528510997|FG001|Overall Study|Administratively Withdrawn|59|||
146547562|NCT01428128|528510999|FG000|Overall Study|Withdrawal by Subject|4|||
146547563|NCT01428128|528510999|FG000|Overall Study|Screen failure by p53|10|||
146547564|NCT01428128|528510999|FG000|Overall Study|Received Neulasta in one cycle|2|||
146547565|NCT01428128|528510999|FG000|Overall Study|Adverse Event|1|||
146547566|NCT00250718|528511003|FG000|Overall Study|Death|1|||
146547567|NCT00250718|528511003|FG000|Overall Study|Adverse Event|1|||
146547568|NCT00250718|528511003|FG000|Overall Study|Withdrawal by Subject|1|||
146883493|NCT05131204|529741961|FG000|Overall Study|Sponsor request|2|||
146883494|NCT05131204|529741962|FG001|Overall Study|Sponsor request|1|||
146883495|NCT05980299|529741966|FG000|Overall Study|Death|28|||
146883496|NCT05980299|529741967|FG001|Overall Study|Death|0|||
146883497|NCT05980299|529741966|FG000|Overall Study|Discharged from Nursing Home|9|||
146883498|NCT05980299|529741967|FG001|Overall Study|Discharged from Nursing Home|0|||
146883499|NCT05980299|529741966|FG000|Overall Study|Lost to Follow-up|0|||
146883500|NCT05980299|529741967|FG001|Overall Study|Lost to Follow-up|10|||
146883501|NCT00290433|529741970|FG000|Overall Study|Disease Progression|13|||
146883502|NCT00290433|529741970|FG000|Overall Study|Adverse Event|14|||
146883503|NCT00290433|529741970|FG000|Overall Study|Withdrawal by Subject|1|||
146883504|NCT00290433|529741970|FG000|Overall Study|Non-Compliance|1|||
146883505|NCT00290433|529741970|FG000|Overall Study|Congestive Heart Failure|1|||
146883506|NCT00290433|529741970|FG000|Overall Study|Transplant in CR|5|||
146883507|NCT00290433|529741970|FG000|Overall Study|Unrelated Infection/Death|1|||
146883508|NCT02264990|529741975|FG000|Overall Study|Death|255|||
146883509|NCT02264990|529741976|FG001|Overall Study|Death|250|||
146883510|NCT02264990|529741975|FG000|Overall Study|Withdrawal by Subject|4|||
146883511|NCT02264990|529741976|FG001|Overall Study|Withdrawal by Subject|5|||
146883512|NCT02264990|529741975|FG000|Overall Study|Lost to Follow-up|1|||
146883513|NCT02264990|529741976|FG001|Overall Study|Lost to Follow-up|3|||
146883514|NCT02264990|529741975|FG000|Overall Study|Other|0|||
146883515|NCT02264990|529741976|FG001|Overall Study|Other|1|||
146883516|NCT01098071|529741985|FG000|Overall Study|Surgery (adenoidectomy)|2|||
146883517|NCT01098071|529741985|FG000|Overall Study|Lost to Follow-up|13|||
146883518|NCT01662895|529741986|FG000|Overall Study|Lost to Follow-up|0|||
146883519|NCT01662895|529741987|FG001|Overall Study|Lost to Follow-up|1|||
146883520|NCT00705939|529741988|FG000|Overall Study|Protocol Violation|0|||
146883521|NCT00705939|529741989|FG001|Overall Study|Protocol Violation|0|||
146883522|NCT00705939|529741990|FG002|Overall Study|Protocol Violation|1|||
146883523|NCT00705939|529741988|FG000|Overall Study|Withdrawal by Subject|0|||
146547569|NCT05259033|528511008|FG000|Overall Study|Withdrawal by Subject|10|||
146547570|NCT05259033|528511009|FG001|Overall Study|Withdrawal by Subject|5|||
146547571|NCT05259033|528511008|FG000|Overall Study|Lost to Follow-up|1|||
146547572|NCT05259033|528511009|FG001|Overall Study|Lost to Follow-up|0|||
146883524|NCT00705939|529741989|FG001|Overall Study|Withdrawal by Subject|1|||
146883525|NCT00705939|529741990|FG002|Overall Study|Withdrawal by Subject|3|||
146883526|NCT00705939|529741988|FG000|Overall Study|Physician Decision|0|||
146883527|NCT00705939|529741989|FG001|Overall Study|Physician Decision|1|||
146883528|NCT00705939|529741990|FG002|Overall Study|Physician Decision|0|||
146883529|NCT05048342|529741991|FG000|Overall Study|Adverse Event|1|||
146883530|NCT05048342|529741991|FG000|Overall Study|Subject decision|2|||
146883531|NCT01441063|529741992|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
146883532|NCT01441063|529741992|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
146883533|NCT00797732|529741996|FG000|Overall Study|Withdrawal by Subject|3|||
146883534|NCT00797732|529741997|FG001|Overall Study|Withdrawal by Subject|3|||
146883535|NCT00797732|529741998|FG002|Overall Study|Withdrawal by Subject|0|||
146883536|NCT00797732|529741996|FG000|Overall Study|Lost to Follow-up|1|||
146883537|NCT00797732|529741997|FG001|Overall Study|Lost to Follow-up|0|||
146883538|NCT00797732|529741998|FG002|Overall Study|Lost to Follow-up|0|||
146883539|NCT00797732|529741996|FG000|Overall Study|Death|1|||
146883540|NCT00797732|529741997|FG001|Overall Study|Death|0|||
146883541|NCT00797732|529741998|FG002|Overall Study|Death|0|||
146883542|NCT00797732|529741996|FG000|Overall Study|Not meet inclusion criteria|0|||
146883543|NCT00797732|529741997|FG001|Overall Study|Not meet inclusion criteria|0|||
146883544|NCT00797732|529741998|FG002|Overall Study|Not meet inclusion criteria|7|||
146883545|NCT00797732|529741996|FG000|Overall Study|Excluded due to time constraints|0|||
146883546|NCT00797732|529741997|FG001|Overall Study|Excluded due to time constraints|0|||
146883547|NCT00797732|529741998|FG002|Overall Study|Excluded due to time constraints|24|||
146883548|NCT00797732|529741996|FG000|Overall Study|Refused to Participate|0|||
146883549|NCT00797732|529741997|FG001|Overall Study|Refused to Participate|0|||
146883550|NCT00797732|529741998|FG002|Overall Study|Refused to Participate|123|||
146883551|NCT02275338|529742005|FG000|Overall Study|Adverse Event|15|||
146883552|NCT02275338|529742005|FG000|Overall Study|Lack of Efficacy|3|||
146883553|NCT02275338|529742005|FG000|Overall Study|Withdrawal by Subject|4|||
146883554|NCT02275338|529742005|FG000|Overall Study|Disease progression (death)|1|||
146883555|NCT02275338|529742005|FG000|Overall Study|Ineligible to start Phase 2|4|||
146883556|NCT02275338|529742005|FG000|Overall Study|Reason not specified|5|||
146883557|NCT02275338|529742005|FG000|Overall Study|Does not meet entry criteria|1|||
146883558|NCT04607733|529742009|FG000|Overall Study|Lost to Follow-up|1|||
146883559|NCT04607733|529742010|FG001|Overall Study|Lost to Follow-up|0|||
146883560|NCT04607733|529742011|FG002|Overall Study|Lost to Follow-up|0|||
146883561|NCT04607733|529742012|FG003|Overall Study|Lost to Follow-up|1|||
146883562|NCT04607733|529742013|FG004|Overall Study|Lost to Follow-up|1|||
146883563|NCT04607733|529742014|FG005|Overall Study|Lost to Follow-up|0|||
146883564|NCT04607733|529742009|FG000|Overall Study|Withdrawal by Subject|0|||
146883565|NCT04607733|529742010|FG001|Overall Study|Withdrawal by Subject|0|||
146883566|NCT04607733|529742011|FG002|Overall Study|Withdrawal by Subject|0|||
146883567|NCT04607733|529742012|FG003|Overall Study|Withdrawal by Subject|0|||
146883568|NCT04607733|529742013|FG004|Overall Study|Withdrawal by Subject|1|||
146883569|NCT04607733|529742014|FG005|Overall Study|Withdrawal by Subject|0|||
146883570|NCT01665807|529742015|FG000|Overall Study|Withdrawal by Subject|2|||
146883571|NCT01665807|529742016|FG001|Overall Study|Withdrawal by Subject|0|||
146883572|NCT01665807|529742017|FG002|Overall Study|Withdrawal by Subject|1|||
146883573|NCT03504397|529742018|FG000|Overall Study|Progressive Disease|151|||
146883574|NCT03504397|529742019|FG001|Overall Study|Progressive Disease|199|||
146883575|NCT03504397|529742018|FG000|Overall Study|Withdrawal by Subject|29|||
146883576|NCT03504397|529742019|FG001|Overall Study|Withdrawal by Subject|17|||
146883577|NCT03504397|529742018|FG000|Overall Study|Lost to Follow-up|1|||
146883578|NCT03504397|529742019|FG001|Overall Study|Lost to Follow-up|0|||
146883579|NCT03504397|529742018|FG000|Overall Study|Death|14|||
146883580|NCT03504397|529742019|FG001|Overall Study|Death|16|||
146883581|NCT03504397|529742018|FG000|Overall Study|Adverse Event|40|||
146883582|NCT03504397|529742019|FG001|Overall Study|Adverse Event|14|||
146883583|NCT03504397|529742018|FG000|Overall Study|miscellaneous|17|||
146883584|NCT03504397|529742019|FG001|Overall Study|miscellaneous|15|||
146883585|NCT03504397|529742018|FG000|Overall Study|Protocol deviation|1|||
146883586|NCT03504397|529742019|FG001|Overall Study|Protocol deviation|0|||
146883587|NCT03504397|529742018|FG000|Overall Study|Participants who did not take the study drug|4|||
146883588|NCT03504397|529742019|FG001|Overall Study|Participants who did not take the study drug|4|||
146883589|NCT00784654|529742022|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
146883590|NCT00784654|529742023|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
146883591|NCT00784654|529742024|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
146883592|NCT00784654|529742022|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
146883593|NCT00784654|529742023|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
146883594|NCT00784654|529742024|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
146883595|NCT00784654|529742022|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
146883596|NCT00784654|529742023|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
146883597|NCT00784654|529742024|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
146883598|NCT00784654|529742022|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
146883599|NCT00784654|529742023|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
146883600|NCT00784654|529742024|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
146883601|NCT00784654|529742022|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
146883602|NCT00784654|529742023|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
146883603|NCT00784654|529742024|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
146883604|NCT00784654|529742022|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
146883605|NCT00784654|529742023|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
146883606|NCT00784654|529742024|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
146883607|NCT00784654|529742022|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
146883608|NCT00784654|529742023|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
146883609|NCT00784654|529742024|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
146883610|NCT00784654|529742022|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
146883611|NCT00784654|529742023|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
146883612|NCT00784654|529742024|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
146883613|NCT00784654|529742022|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
146630437|NCT04672239|528824061|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
146883614|NCT00784654|529742023|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
146883615|NCT00784654|529742024|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
146883616|NCT00784654|529742022|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
146883617|NCT00784654|529742023|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
146883618|NCT00784654|529742024|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
146883619|NCT00784654|529742022|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
146883620|NCT00784654|529742023|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
146883621|NCT00784654|529742024|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
146883622|NCT00784654|529742022|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
146883623|NCT00784654|529742023|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
146883624|NCT00784654|529742024|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
146883625|NCT00784654|529742022|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
146883626|NCT00784654|529742023|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
146883627|NCT00784654|529742024|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
146883628|NCT00784654|529742022|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146883629|NCT00784654|529742023|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
146883630|NCT00784654|529742024|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
146883631|NCT00784654|529742022|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
146883632|NCT00784654|529742023|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
146883633|NCT00784654|529742024|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
146883634|NCT00784654|529742022|FG000|Randomized Withdrawal Period|Adverse Event|0|||
146883635|NCT00784654|529742023|FG001|Randomized Withdrawal Period|Adverse Event|1|||
146883636|NCT00784654|529742024|FG002|Randomized Withdrawal Period|Adverse Event|1|||
146883637|NCT00784654|529742022|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
146883638|NCT00784654|529742023|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
146883639|NCT00784654|529742024|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
146883640|NCT00784654|529742022|FG000|Randomized Withdrawal Period|Family reasons|0|||
146883641|NCT00784654|529742023|FG001|Randomized Withdrawal Period|Family reasons|0|||
146883642|NCT00784654|529742024|FG002|Randomized Withdrawal Period|Family reasons|1|||
146883643|NCT03461757|529742025|FG000|Overall Study|Adverse Event|1|||
146883644|NCT03461757|529742026|FG001|Overall Study|Adverse Event|0|||
146883645|NCT03461757|529742025|FG000|Overall Study|Lost to Follow-up|13|||
146883646|NCT03461757|529742026|FG001|Overall Study|Lost to Follow-up|7|||
146883647|NCT03461757|529742025|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
146883648|NCT03461757|529742026|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
146883649|NCT03461757|529742025|FG000|Overall Study|Non-compliance with study treatment|0|||
146883650|NCT03461757|529742026|FG001|Overall Study|Non-compliance with study treatment|1|||
146883651|NCT03461757|529742025|FG000|Overall Study|Pregnancy|2|||
146883652|NCT03461757|529742026|FG001|Overall Study|Pregnancy|0|||
146883653|NCT03461757|529742025|FG000|Overall Study|Protocol Violation|1|||
146883654|NCT03461757|529742026|FG001|Overall Study|Protocol Violation|1|||
146883655|NCT03461757|529742025|FG000|Overall Study|Withdrawal by Subject|7|||
146883656|NCT03461757|529742026|FG001|Overall Study|Withdrawal by Subject|7|||
146883657|NCT03461757|529742025|FG000|Overall Study|Other Reasons|1|||
146883658|NCT03461757|529742026|FG001|Overall Study|Other Reasons|4|||
146883659|NCT02425826|529742027|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
146883660|NCT02425826|529742028|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
146883661|NCT02425826|529742029|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
146883662|NCT02425826|529742027|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
146883663|NCT02425826|529742028|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
146883664|NCT02425826|529742029|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
146883665|NCT02425826|529742027|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
146883666|NCT02425826|529742028|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
146883667|NCT02425826|529742029|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
146630438|NCT04672239|528824062|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
146630439|NCT04672239|528824060|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
146630440|NCT04672239|528824061|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
146630441|NCT04672239|528824062|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
146630442|NCT04672239|528824060|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
146630443|NCT04672239|528824061|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
146630444|NCT04672239|528824062|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
146630445|NCT04672239|528824060|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
146883668|NCT02425826|529742027|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
146883669|NCT02425826|529742028|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
146883670|NCT02425826|529742029|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
146883671|NCT02425826|529742027|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
146966447|NCT00650806|530038799|FG000|Overall Study|Other|1|||
146883672|NCT02425826|529742028|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
146883673|NCT02425826|529742029|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
146883674|NCT02425826|529742027|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
146883675|NCT02425826|529742028|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
146883676|NCT02425826|529742029|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
146883677|NCT02425826|529742027|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
146883678|NCT02425826|529742028|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
146883679|NCT02425826|529742029|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
146883680|NCT02425826|529742027|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
146883681|NCT02425826|529742028|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
146883682|NCT02425826|529742029|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
146883683|NCT02425826|529742027|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
146883684|NCT02425826|529742028|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
146883685|NCT02425826|529742029|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
146883686|NCT02425826|529742027|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
146883687|NCT02425826|529742028|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
146883688|NCT02425826|529742029|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
146883689|NCT03861559|529742030|FG000|Overall Study|Adverse Event|0|||
146883690|NCT03861559|529742031|FG001|Overall Study|Adverse Event|2|||
146883691|NCT03861559|529742030|FG000|Overall Study|Treatment failure|0|||
146883692|NCT03861559|529742031|FG001|Overall Study|Treatment failure|2|||
146883693|NCT03861559|529742030|FG000|Overall Study|Noncompliance|1|||
146883694|NCT03861559|529742031|FG001|Overall Study|Noncompliance|1|||
146883695|NCT03861559|529742030|FG000|Overall Study|Did not meet eligibility requirements|1|||
146883696|NCT03861559|529742031|FG001|Overall Study|Did not meet eligibility requirements|0|||
146883697|NCT01344876|529742034|FG000|Overall Study|Adverse Event|0|||
146883698|NCT01344876|529742035|FG001|Overall Study|Adverse Event|0|||
146883699|NCT01344876|529742036|FG002|Overall Study|Adverse Event|0|||
146883700|NCT01344876|529742037|FG003|Overall Study|Adverse Event|0|||
146883701|NCT01344876|529742038|FG004|Overall Study|Adverse Event|1|||
146883702|NCT01344876|529742034|FG000|Overall Study|Withdrawal by Subject|0|||
146883703|NCT01344876|529742035|FG001|Overall Study|Withdrawal by Subject|0|||
146883704|NCT01344876|529742036|FG002|Overall Study|Withdrawal by Subject|1|||
146883705|NCT01344876|529742037|FG003|Overall Study|Withdrawal by Subject|0|||
146883706|NCT01344876|529742038|FG004|Overall Study|Withdrawal by Subject|0|||
146883707|NCT01344876|529742034|FG000|Overall Study|Definite progression of primary disease|1|||
146883708|NCT01344876|529742035|FG001|Overall Study|Definite progression of primary disease|0|||
146883709|NCT01344876|529742036|FG002|Overall Study|Definite progression of primary disease|0|||
146883710|NCT01344876|529742037|FG003|Overall Study|Definite progression of primary disease|3|||
146883711|NCT01344876|529742038|FG004|Overall Study|Definite progression of primary disease|0|||
146883712|NCT05107765|529742039|FG000|Overall Study|Lost to Follow-up|4|||
146883713|NCT05107765|529742040|FG001|Overall Study|Lost to Follow-up|1|||
146883714|NCT05107765|529742039|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
146883715|NCT05107765|529742040|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
146883716|NCT05107765|529742039|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
146883717|NCT05107765|529742040|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
146883718|NCT01662440|529743538|FG000|Overall Study|Adverse Event|1|||
146883719|NCT01662440|529743539|FG001|Overall Study|Adverse Event|0|||
146883720|NCT01662440|529743540|FG002|Overall Study|Adverse Event|0|||
146883721|NCT01662440|529743541|FG003|Overall Study|Adverse Event|1|||
146883722|NCT01662440|529743538|FG000|Overall Study|Death|0|||
146883723|NCT01662440|529743539|FG001|Overall Study|Death|1|||
146765091|NCT03612804|529307245|FG000|Overall Study|Provider retired from VA|0|||
146883724|NCT01662440|529743540|FG002|Overall Study|Death|0|||
146883725|NCT01662440|529743541|FG003|Overall Study|Death|0|||
146883726|NCT01662440|529743538|FG000|Overall Study|Lost to Follow-up|2|||
146883727|NCT01662440|529743539|FG001|Overall Study|Lost to Follow-up|2|||
146883728|NCT01662440|529743540|FG002|Overall Study|Lost to Follow-up|4|||
146883729|NCT01662440|529743541|FG003|Overall Study|Lost to Follow-up|1|||
146883730|NCT01662440|529743538|FG000|Overall Study|Subject moved to another country.|0|||
146883731|NCT01662440|529743539|FG001|Overall Study|Subject moved to another country.|1|||
146547573|NCT05259033|528511008|FG000|Overall Study|Death|2|||
146547574|NCT05259033|528511009|FG001|Overall Study|Death|0|||
146547575|NCT01068249|528511010|FG000|Overall Study|Death|1|||
146547576|NCT01068249|528511010|FG000|Overall Study|Withdrawal by Subject|3|||
146765092|NCT03612804|529307246|FG001|Overall Study|Provider retired from VA|0|||
146883732|NCT01662440|529743540|FG002|Overall Study|Subject moved to another country.|0|||
146883733|NCT01662440|529743541|FG003|Overall Study|Subject moved to another country.|0|||
146883734|NCT01662440|529743538|FG000|Overall Study|Protocol Violation|1|||
146883735|NCT01662440|529743539|FG001|Overall Study|Protocol Violation|0|||
146883736|NCT01662440|529743540|FG002|Overall Study|Protocol Violation|0|||
146883737|NCT01662440|529743541|FG003|Overall Study|Protocol Violation|0|||
146883738|NCT01662440|529743538|FG000|Overall Study|Withdrawal by Subject|5|||
146883739|NCT01662440|529743539|FG001|Overall Study|Withdrawal by Subject|2|||
146883740|NCT01662440|529743540|FG002|Overall Study|Withdrawal by Subject|2|||
146883741|NCT01662440|529743541|FG003|Overall Study|Withdrawal by Subject|2|||
146883742|NCT01745146|529743542|FG000|Overall Study|Withdrawal by Subject|1|||
146883743|NCT01745146|529743543|FG001|Overall Study|Withdrawal by Subject|3|||
146883744|NCT01745146|529743542|FG000|Overall Study|Lost to Follow-up|2|||
146883745|NCT01745146|529743543|FG001|Overall Study|Lost to Follow-up|0|||
146883746|NCT04623242|529743544|FG000|Overall Study|Withdrawal by Subject|7|||
146883747|NCT04623242|529743545|FG001|Overall Study|Withdrawal by Subject|12|||
146883748|NCT04623242|529743546|FG002|Overall Study|Withdrawal by Subject|5|||
146883749|NCT04623242|529743547|FG003|Overall Study|Withdrawal by Subject|7|||
146883750|NCT04623242|529743548|FG004|Overall Study|Withdrawal by Subject|0|||
146883751|NCT04623242|529743544|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
146883752|NCT04623242|529743545|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
146883753|NCT04623242|529743546|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
146883754|NCT04623242|529743547|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
146883755|NCT04623242|529743548|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
146883756|NCT04623242|529743544|FG000|Overall Study|Subject unblinded to mutation status|0|||
146883757|NCT04623242|529743545|FG001|Overall Study|Subject unblinded to mutation status|0|||
146883758|NCT04623242|529743546|FG002|Overall Study|Subject unblinded to mutation status|0|||
146883759|NCT04623242|529743547|FG003|Overall Study|Subject unblinded to mutation status|13|||
146883760|NCT04623242|529743548|FG004|Overall Study|Subject unblinded to mutation status|0|||
146883761|NCT00326898|529743549|FG000|Overall Study|Disease progression|52|||
146883762|NCT00326898|529743550|FG001|Overall Study|Disease progression|54|||
146883763|NCT00326898|529743551|FG002|Overall Study|Disease progression|102|||
146966448|NCT00650806|530038800|FG001|Overall Study|Other|1|||
146547577|NCT04439123|528511019|FG000|Overall Study|Adverse Event|11|||
146547578|NCT04439123|528511019|FG000|Overall Study|Death|1|||
146547579|NCT04439123|528511019|FG000|Overall Study|Disease progression|19|||
146547580|NCT04439123|528511019|FG000|Overall Study|Withdrawal by Subject|2|||
146547581|NCT04439123|528511019|FG000|Overall Study|Still on treatment|2|||
146883764|NCT00326898|529743549|FG000|Overall Study|Adverse Event|124|||
146966449|NCT00650806|530038801|FG002|Overall Study|Other|2|||
146883765|NCT00326898|529743550|FG001|Overall Study|Adverse Event|128|||
146883766|NCT00326898|529743551|FG002|Overall Study|Adverse Event|33|||
146883767|NCT00326898|529743549|FG000|Overall Study|Death|2|||
146883768|NCT00326898|529743550|FG001|Overall Study|Death|0|||
146883769|NCT00326898|529743551|FG002|Overall Study|Death|0|||
146883770|NCT00326898|529743549|FG000|Overall Study|Withdrawal by Subject|134|||
146883771|NCT00326898|529743550|FG001|Overall Study|Withdrawal by Subject|128|||
146883772|NCT00326898|529743551|FG002|Overall Study|Withdrawal by Subject|32|||
146883773|NCT00326898|529743549|FG000|Overall Study|Alternative therapy|1|||
146883774|NCT00326898|529743550|FG001|Overall Study|Alternative therapy|0|||
146883775|NCT00326898|529743551|FG002|Overall Study|Alternative therapy|0|||
146883776|NCT00326898|529743549|FG000|Overall Study|Other complicating disease|5|||
146883777|NCT00326898|529743550|FG001|Overall Study|Other complicating disease|5|||
146883778|NCT00326898|529743551|FG002|Overall Study|Other complicating disease|4|||
146883779|NCT00326898|529743549|FG000|Overall Study|Other/Missing/Unknown|33|||
146883780|NCT00326898|529743550|FG001|Overall Study|Other/Missing/Unknown|28|||
146883781|NCT00326898|529743551|FG002|Overall Study|Other/Missing/Unknown|32|||
146883782|NCT03847987|529743552|FG000|Overall Study|Lost to Follow-up|1|||
146883783|NCT03847987|529743553|FG001|Overall Study|Lost to Follow-up|0|||
146883784|NCT03847987|529743552|FG000|Overall Study|Adverse Event|2|||
146883785|NCT03847987|529743553|FG001|Overall Study|Adverse Event|0|||
146883786|NCT02605642|529743557|FG000|Overall Study|Other|11|||
146883787|NCT02605642|529743558|FG001|Overall Study|Other|1|||
146883788|NCT02605642|529743557|FG000|Overall Study|Participant non-compliance|2|||
146883789|NCT02605642|529743558|FG001|Overall Study|Participant non-compliance|4|||
146883790|NCT02605642|529743557|FG000|Overall Study|Physician Decision|10|||
146883791|NCT02605642|529743558|FG001|Overall Study|Physician Decision|0|||
146883792|NCT02605642|529743557|FG000|Overall Study|Lost to Follow-up|12|||
146883793|NCT02605642|529743558|FG001|Overall Study|Lost to Follow-up|1|||
146883794|NCT02605642|529743557|FG000|Overall Study|Adverse Event|14|||
146883795|NCT02605642|529743558|FG001|Overall Study|Adverse Event|2|||
146883796|NCT02605642|529743557|FG000|Overall Study|Withdrawal by Subject|23|||
146883797|NCT02605642|529743558|FG001|Overall Study|Withdrawal by Subject|2|||
146883798|NCT02605642|529743557|FG000|Overall Study|Lack of response|24|||
146883799|NCT02605642|529743558|FG001|Overall Study|Lack of response|11|||
146883800|NCT02111564|529743567|FG000|Overall Study|Death|109|||
146630446|NCT04672239|528824061|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
146630447|NCT04672239|528824062|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
146630448|NCT04672239|528824060|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
146883801|NCT02111564|529743568|FG001|Overall Study|Death|120|||
146883802|NCT02111564|529743567|FG000|Overall Study|Lost to Follow-up|2|||
146883803|NCT02111564|529743568|FG001|Overall Study|Lost to Follow-up|3|||
146883804|NCT02111564|529743567|FG000|Overall Study|Withdrawal by Subject|20|||
146883805|NCT02111564|529743568|FG001|Overall Study|Withdrawal by Subject|20|||
146883806|NCT00687362|529743569|FG000|Overall Study|Protocol Violation|2|||
146883807|NCT00687362|529743569|FG000|Overall Study|Withdrawal by Subject|1|||
146883808|NCT01268293|529743574|FG000|Overall Study|Disease progression|7|||
146883809|NCT01268293|529743574|FG000|Overall Study|Adverse Event|1|||
146883810|NCT01268293|529743574|FG000|Overall Study|Subject choice|1|||
146883811|NCT00699348|529743575|FG000|Overall Study|Death|6|||
146883812|NCT00699348|529743575|FG000|Overall Study|Adverse Event|15|||
146883813|NCT00699348|529743575|FG000|Overall Study|Withdrawal by Subject|11|||
146883814|NCT00699348|529743575|FG000|Overall Study|Protocol Violation|10|||
146883815|NCT00699348|529743575|FG000|Overall Study|Lack of Efficacy|8|||
146883816|NCT00699348|529743575|FG000|Overall Study|Failure to return|1|||
146883817|NCT00699348|529743575|FG000|Overall Study|Blood transfusion|24|||
146883818|NCT00699348|529743575|FG000|Overall Study|Renal transplantation|10|||
146883819|NCT00699348|529743575|FG000|Overall Study|Other|5|||
146883820|NCT02597855|529743576|FG000|Overall Study|Lost to Follow-up|2|||
146883821|NCT02597855|529743577|FG001|Overall Study|Lost to Follow-up|1|||
146883822|NCT03704194|529743585|FG000|Overall Study|Withdrawal by Subject|0|||
146883823|NCT03704194|529743586|FG001|Overall Study|Withdrawal by Subject|1|||
146883824|NCT00925015|529743587|FG000|Overall Study|Adverse Event|1|||
146883825|NCT00925015|529743588|FG001|Overall Study|Adverse Event|2|||
146883826|NCT00925015|529743589|FG002|Overall Study|Adverse Event|1|||
146883827|NCT00925015|529743587|FG000|Overall Study|Physician Decision|0|||
146630449|NCT04672239|528824061|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
146630450|NCT04672239|528824062|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
146630451|NCT04672239|528824060|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
146630452|NCT04672239|528824061|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
146630453|NCT04672239|528824062|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
146630454|NCT00541658|528824063|FG000|Overall Study|Adverse Event|28|||
146883828|NCT00925015|529743588|FG001|Overall Study|Physician Decision|1|||
146883829|NCT00925015|529743589|FG002|Overall Study|Physician Decision|0|||
146883830|NCT00925015|529743587|FG000|Overall Study|Progressive Disease|7|||
146883831|NCT00925015|529743588|FG001|Overall Study|Progressive Disease|3|||
146883832|NCT00925015|529743589|FG002|Overall Study|Progressive Disease|4|||
146630455|NCT00541658|528824064|FG001|Overall Study|Adverse Event|37|||
146630456|NCT00541658|528824065|FG002|Overall Study|Adverse Event|25|||
146630457|NCT00541658|528824063|FG000|Overall Study|Physician Decision|0|||
146630458|NCT00541658|528824064|FG001|Overall Study|Physician Decision|0|||
146630459|NCT00541658|528824065|FG002|Overall Study|Physician Decision|4|||
146630460|NCT00541658|528824063|FG000|Overall Study|Lost to Follow-up|3|||
146630461|NCT00541658|528824064|FG001|Overall Study|Lost to Follow-up|3|||
146630462|NCT00541658|528824065|FG002|Overall Study|Lost to Follow-up|6|||
146630463|NCT00541658|528824063|FG000|Overall Study|Protocol Violation|0|||
146630464|NCT00541658|528824064|FG001|Overall Study|Protocol Violation|1|||
146630465|NCT00541658|528824065|FG002|Overall Study|Protocol Violation|1|||
146630466|NCT00541658|528824063|FG000|Overall Study|Withdrawal by Subject|28|||
146883833|NCT00925015|529743587|FG000|Overall Study|Withdrawal by Subject|0|||
146883834|NCT00925015|529743588|FG001|Overall Study|Withdrawal by Subject|0|||
146883835|NCT00925015|529743589|FG002|Overall Study|Withdrawal by Subject|1|||
146883836|NCT04681170|529743590|FG000|Stratified Enrolment & run-in|Death|1|||
146883837|NCT04681170|529743591|FG001|Stratified Enrolment & run-in|Death|0|||
146883838|NCT04681170|529743590|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
146883839|NCT04681170|529743591|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
146883840|NCT04681170|529743590|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
146883841|NCT04681170|529743591|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
146630467|NCT00541658|528824064|FG001|Overall Study|Withdrawal by Subject|32|||
146630468|NCT00541658|528824065|FG002|Overall Study|Withdrawal by Subject|32|||
146630469|NCT00541658|528824063|FG000|Overall Study|Took No Study Drug|1|||
146630470|NCT00541658|528824064|FG001|Overall Study|Took No Study Drug|0|||
146765093|NCT03612804|529307247|FG002|Overall Study|Provider retired from VA|2|||
146883842|NCT04681170|529743590|FG000|Open Label Efficacy Phase|Adverse Event|0|||
146883843|NCT04681170|529743591|FG001|Open Label Efficacy Phase|Adverse Event|2|||
146883844|NCT04681170|529743590|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
146883845|NCT04681170|529743591|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
146883846|NCT04681170|529743590|FG000|Open Label Safety Phase|AEs and none compliance|0|||
146883847|NCT04681170|529743591|FG001|Open Label Safety Phase|AEs and none compliance|1|||
146883848|NCT01407926|529743592|FG000|Overall Study|Lost to Follow-up|55|||
146883849|NCT02814565|529743593|FG000|Overall Study|Lack of Efficacy|0|||
146883850|NCT02814565|529743594|FG001|Overall Study|Lack of Efficacy|1|||
146883851|NCT02814565|529743593|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
146883852|NCT02814565|529743594|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
146883853|NCT02468648|529743595|FG000|Overall Study|Death|1|||
146883854|NCT04232696|529743596|FG000|Overall Study|Implant attempted but not completed|5|||
146883855|NCT04232696|529743597|FG001|Overall Study|Implant attempted but not completed|2|||
146883856|NCT04232696|529743596|FG000|Overall Study|Not satisfied with therapy outcome|0|||
146883857|NCT04232696|529743597|FG001|Overall Study|Not satisfied with therapy outcome|8|||
146883858|NCT04232696|529743596|FG000|Overall Study|Adverse Event|0|||
146883859|NCT04232696|529743597|FG001|Overall Study|Adverse Event|3|||
146883860|NCT04232696|529743596|FG000|Overall Study|Withdrawal by Subject|0|||
146883861|NCT04232696|529743597|FG001|Overall Study|Withdrawal by Subject|3|||
146883862|NCT04232696|529743596|FG000|Overall Study|Missed Visit|0|||
146883863|NCT04232696|529743597|FG001|Overall Study|Missed Visit|2|||
146883864|NCT04232696|529743596|FG000|Overall Study|Other reason|0|||
146883865|NCT04232696|529743597|FG001|Overall Study|Other reason|1|||
146883866|NCT02787863|529743598|FG000|Overall Study|Death|1|||
146883867|NCT02787863|529743599|FG001|Overall Study|Death|0|||
146883868|NCT02787863|529743600|FG002|Overall Study|Death|1|||
146883869|NCT02787863|529743601|FG003|Overall Study|Death|0|||
146883870|NCT02787863|529743602|FG004|Overall Study|Death|0|||
146883871|NCT02787863|529743603|FG005|Overall Study|Death|0|||
146883872|NCT02787863|529743604|FG006|Overall Study|Death|0|||
146883873|NCT02787863|529743605|FG007|Overall Study|Death|0|||
146883874|NCT02787863|529743598|FG000|Overall Study|Withdrawal by Subject|0|||
146883875|NCT02787863|529743599|FG001|Overall Study|Withdrawal by Subject|1|||
146883876|NCT02787863|529743600|FG002|Overall Study|Withdrawal by Subject|1|||
146883877|NCT02787863|529743601|FG003|Overall Study|Withdrawal by Subject|0|||
146883878|NCT02787863|529743602|FG004|Overall Study|Withdrawal by Subject|0|||
146883879|NCT02787863|529743603|FG005|Overall Study|Withdrawal by Subject|0|||
146883880|NCT02787863|529743604|FG006|Overall Study|Withdrawal by Subject|0|||
146883881|NCT02787863|529743605|FG007|Overall Study|Withdrawal by Subject|0|||
146883882|NCT01368835|529743606|FG000|Overall Study|Inclusion criteria/photography quality|22|||
146883883|NCT01368835|529743606|FG000|Overall Study|Lost to Follow-up|11|||
146883884|NCT01678144|529743607|FG000|Stage 1: MAR Classic|Adverse Event|1|||
146883885|NCT03118297|529743608|FG000|Overall Study|Lost to Follow-up|0|||
146883886|NCT03118297|529743609|FG001|Overall Study|Lost to Follow-up|2|||
146883887|NCT02754726|529743610|FG000|Overall Study|Progressive Disease by RECIST|13|||
146883888|NCT02754726|529743610|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
146883889|NCT02754726|529743610|FG000|Overall Study|Clinical Disease Progression|5|||
146883890|NCT02754726|529743610|FG000|Overall Study|Adverse Event|3|||
146883891|NCT02754726|529743610|FG000|Overall Study|Withdrawal by Subject|1|||
146883892|NCT02754726|529743610|FG000|Overall Study|Tolerability|1|||
146883893|NCT01885000|529743611|FG000|Overall Study|Adverse Event|1|||
146883894|NCT01885000|529743612|FG001|Overall Study|Adverse Event|0|||
146883895|NCT01885000|529743611|FG000|Overall Study|Withdrawal by Subject|1|||
146883896|NCT01885000|529743612|FG001|Overall Study|Withdrawal by Subject|1|||
146883897|NCT01885000|529743611|FG000|Overall Study|Protocol Violation|0|||
146883898|NCT01885000|529743612|FG001|Overall Study|Protocol Violation|1|||
146883899|NCT02162732|529743614|FG000|Overall Study|Biopsy not performed.|18|||
146883900|NCT02363686|529743616|FG000|Overall Study|Withdrawal by Subject|22|||
146883901|NCT02363686|529743616|FG000|Overall Study|incomplete FEES examinations|13|||
146883902|NCT02469090|529743625|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
146883903|NCT02469090|529743626|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
146883904|NCT02469090|529743627|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
146883905|NCT02469090|529743625|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
146630471|NCT00541658|528824065|FG002|Overall Study|Took No Study Drug|0|||
146883906|NCT02469090|529743626|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
146765094|NCT03612804|529307248|FG003|Overall Study|Provider retired from VA|0|||
146883907|NCT02469090|529743627|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
146883908|NCT02469090|529743625|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
146883909|NCT02469090|529743626|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
146883910|NCT02469090|529743627|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
146883911|NCT02469090|529743625|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
146883912|NCT02469090|529743626|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
146883913|NCT02469090|529743627|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
146883914|NCT02469090|529743625|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
146883915|NCT02469090|529743626|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
146883916|NCT02469090|529743627|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
146883917|NCT02469090|529743625|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
146883918|NCT02469090|529743626|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
146883919|NCT02469090|529743627|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
146883920|NCT02469090|529743625|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
146883921|NCT02469090|529743626|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
146883922|NCT02469090|529743627|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
146883923|NCT02469090|529743625|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
146883924|NCT02469090|529743626|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
146883925|NCT02469090|529743627|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
146883926|NCT03446885|529743631|FG000|Overall Study|Lost to Follow-up|1|||
146883927|NCT03446885|529743632|FG001|Overall Study|Lost to Follow-up|0|||
146883928|NCT03446885|529743631|FG000|Overall Study|Did not complete entire visit|1|||
146883929|NCT03446885|529743632|FG001|Overall Study|Did not complete entire visit|0|||
146883930|NCT03823391|529743635|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
146883931|NCT03823391|529743636|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
146883932|NCT03823391|529743635|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
146883933|NCT03823391|529743636|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
146883934|NCT05882318|529743643|FG000|Overall Study|Withdrawal by Subject|1|||
146883935|NCT05882318|529743644|FG001|Overall Study|Withdrawal by Subject|0|||
146883936|NCT05882318|529743643|FG000|Overall Study|Protocol Violation|0|||
146883937|NCT05882318|529743644|FG001|Overall Study|Protocol Violation|1|||
146883938|NCT05030311|529743647|FG000|Overall Study|Technical problems|0|||
146883939|NCT05030311|529743648|FG001|Overall Study|Technical problems|1|||
146883940|NCT05030311|529743647|FG000|Overall Study|Withdrawal by Subject|31|||
146883941|NCT05030311|529743648|FG001|Overall Study|Withdrawal by Subject|17|||
146883942|NCT05030311|529743647|FG000|Overall Study|Adverse Event|13|||
146883943|NCT05030311|529743648|FG001|Overall Study|Adverse Event|5|||
146883944|NCT05030311|529743647|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146883945|NCT05030311|529743648|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
146883946|NCT05030311|529743647|FG000|Overall Study|Physician Decision|5|||
146883947|NCT05030311|529743648|FG001|Overall Study|Physician Decision|2|||
146883948|NCT05030311|529743647|FG000|Overall Study|Lost to Follow-up|5|||
146883949|NCT05030311|529743648|FG001|Overall Study|Lost to Follow-up|1|||
146883950|NCT05030311|529743647|FG000|Overall Study|Protocol Violation|4|||
146883951|NCT05030311|529743648|FG001|Overall Study|Protocol Violation|4|||
146883952|NCT04735653|529743649|FG000|Overall Study|Lost to Follow-up|17|||
146883953|NCT04735653|529743650|FG001|Overall Study|Lost to Follow-up|7|||
146883954|NCT04735653|529743649|FG000|Overall Study|Withdrawal by Subject|8|||
146883955|NCT04735653|529743650|FG001|Overall Study|Withdrawal by Subject|2|||
146883956|NCT04735653|529743649|FG000|Overall Study|Death|0|||
146630472|NCT01099267|528824066|FG000|MDS-003 Study|Adverse Event|37|||
146630473|NCT01099267|528824066|FG000|MDS-003 Study|Lack of Efficacy|52|||
146630474|NCT01099267|528824066|FG000|MDS-003 Study|Withdrawal by Subject|8|||
146630475|NCT01099267|528824066|FG000|MDS-003 Study|Lost to Follow-up|1|||
146630476|NCT01099267|528824066|FG000|MDS-003 Study|Death|11|||
146630477|NCT01099267|528824066|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
146630478|NCT01099267|528824066|FG000|MDS-003 Study|Disease Progression|7|||
146630479|NCT01099267|528824066|FG000|MDS-003 Study|Investigator Decision|2|||
146630480|NCT01099267|528824066|FG000|MDS-003 Study|Non-Compliance|2|||
146630481|NCT01099267|528824066|FG000|MDS-003 Study|Loss of Response|1|||
146630482|NCT01099267|528824066|FG000|MDS-003 Study|Secondary Malign Disease|1|||
146883957|NCT04735653|529743650|FG001|Overall Study|Death|2|||
146966450|NCT00650806|530038802|FG003|Overall Study|Other|0|||
146883958|NCT04735653|529743649|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
146883959|NCT04735653|529743650|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
146883960|NCT03042468|529743652|FG000|Overall Study|Death|0|||
146547582|NCT04337021|528511020|FG000|Overall Study|Lost to Follow-up|54|||
146883961|NCT03042468|529743653|FG001|Overall Study|Death|1|||
146883962|NCT03042468|529743654|FG002|Overall Study|Death|1|||
146883963|NCT03042468|529743655|FG003|Overall Study|Death|0|||
146883964|NCT03042468|529743656|FG004|Overall Study|Death|0|||
146883965|NCT03042468|529743657|FG005|Overall Study|Death|0|||
146883966|NCT03042468|529743652|FG000|Overall Study|Withdrawal by Subject|0|||
146883967|NCT03042468|529743653|FG001|Overall Study|Withdrawal by Subject|0|||
146883968|NCT03042468|529743654|FG002|Overall Study|Withdrawal by Subject|0|||
146883969|NCT03042468|529743655|FG003|Overall Study|Withdrawal by Subject|0|||
146883970|NCT03042468|529743656|FG004|Overall Study|Withdrawal by Subject|0|||
146883971|NCT03042468|529743657|FG005|Overall Study|Withdrawal by Subject|1|||
146883972|NCT03042468|529743652|FG000|Overall Study|Lost to Follow-up|0|||
146883973|NCT03042468|529743653|FG001|Overall Study|Lost to Follow-up|0|||
146883974|NCT03042468|529743654|FG002|Overall Study|Lost to Follow-up|0|||
146883975|NCT03042468|529743655|FG003|Overall Study|Lost to Follow-up|0|||
146883976|NCT03042468|529743656|FG004|Overall Study|Lost to Follow-up|1|||
146883977|NCT03042468|529743657|FG005|Overall Study|Lost to Follow-up|1|||
146883978|NCT03557359|529743660|FG000|Dose 1: 240 mg|Adverse Event|1|||
146883979|NCT03557359|529743661|FG001|Dose 1: 240 mg|Adverse Event|0|||
146883980|NCT03092726|529743662|FG000|Overall Study|Adverse Event|3|||
146883981|NCT03092726|529743663|FG001|Overall Study|Adverse Event|10|||
146883982|NCT03092726|529743662|FG000|Overall Study|Lack of Efficacy|0|||
146883983|NCT03092726|529743663|FG001|Overall Study|Lack of Efficacy|1|||
146883984|NCT03092726|529743662|FG000|Overall Study|Lost to Follow-up|1|||
146883985|NCT03092726|529743663|FG001|Overall Study|Lost to Follow-up|0|||
146883986|NCT03092726|529743662|FG000|Overall Study|Withdrawal by Subject|5|||
146883987|NCT03092726|529743663|FG001|Overall Study|Withdrawal by Subject|3|||
146883988|NCT00252057|529743670|FG000|Overall Study|Withdrawal by Subject|2|||
146883989|NCT00252057|529743671|FG001|Overall Study|Withdrawal by Subject|5|||
146883990|NCT00252057|529743670|FG000|Overall Study|Death|1|||
146883991|NCT00252057|529743671|FG001|Overall Study|Death|2|||
146883992|NCT00252057|529743670|FG000|Overall Study|Participant previously enrolled|0|||
146883993|NCT00252057|529743671|FG001|Overall Study|Participant previously enrolled|1|||
146883994|NCT00623428|529743676|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
146883995|NCT00623428|529743677|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
146883996|NCT00623428|529743676|FG000|Treatment Period|Death|0|||
146883997|NCT00623428|529743677|FG001|Treatment Period|Death|1|||
146883998|NCT00623428|529743676|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
146883999|NCT00623428|529743677|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
146547583|NCT04337021|528511021|FG001|Overall Study|Lost to Follow-up|66|||
146547584|NCT01405911|528511023|FG000|Overall Study|Pre-treatment lab AE|0|||
146884000|NCT00623428|529743676|FG000|Treatment Period|Insufficient therapeutic response|0|||
146884001|NCT00623428|529743677|FG001|Treatment Period|Insufficient therapeutic response|2|||
146884002|NCT00623428|529743676|FG000|Treatment Period|Other|0|||
146884003|NCT00623428|529743677|FG001|Treatment Period|Other|1|||
146884004|NCT00623428|529743676|FG000|Treatment Period|Withdrawal by Subject|0|||
146884005|NCT00623428|529743677|FG001|Treatment Period|Withdrawal by Subject|1|||
146884006|NCT00623428|529743676|FG000|Follow-up Period|Relapse post-treatment|11|||
146884007|NCT00623428|529743677|FG001|Follow-up Period|Relapse post-treatment|3|||
146884008|NCT00623428|529743676|FG000|Follow-up Period|Failure to return|10|||
146884009|NCT00623428|529743677|FG001|Follow-up Period|Failure to return|2|||
146884010|NCT00623428|529743676|FG000|Follow-up Period|Patient withdrew consent|5|||
146884011|NCT00623428|529743677|FG001|Follow-up Period|Patient withdrew consent|4|||
146884012|NCT00623428|529743676|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
146884013|NCT00623428|529743677|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
146884014|NCT00623428|529743676|FG000|Follow-up Period|Did not cooperate|0|||
146884015|NCT00623428|529743677|FG001|Follow-up Period|Did not cooperate|3|||
146884016|NCT00623428|529743676|FG000|Follow-up Period|Reason not specified|1|||
146884017|NCT00623428|529743677|FG001|Follow-up Period|Reason not specified|1|||
146884018|NCT00623428|529743676|FG000|Follow-up Period|Death|0|||
146884019|NCT00623428|529743677|FG001|Follow-up Period|Death|1|||
146884020|NCT01692301|529743680|FG000|Overall Study|Adverse Event|15|||
146884021|NCT01692301|529743681|FG001|Overall Study|Adverse Event|12|||
146884022|NCT01692301|529743680|FG000|Overall Study|Death|1|||
146884023|NCT01692301|529743681|FG001|Overall Study|Death|2|||
146884024|NCT01692301|529743680|FG000|Overall Study|Lack of Efficacy|0|||
146884025|NCT01692301|529743681|FG001|Overall Study|Lack of Efficacy|5|||
146884026|NCT01692301|529743680|FG000|Overall Study|Non-compliance with study treatment|1|||
146884027|NCT01692301|529743681|FG001|Overall Study|Non-compliance with study treatment|2|||
146884028|NCT01692301|529743680|FG000|Overall Study|Protocol deviation|9|||
146884029|NCT01692301|529743681|FG001|Overall Study|Protocol deviation|2|||
146884030|NCT01692301|529743680|FG000|Overall Study|Patient/guardian decision|16|||
146884031|NCT01692301|529743681|FG001|Overall Study|Patient/guardian decision|15|||
146884032|NCT01692301|529743680|FG000|Overall Study|Technical problems|0|||
146884033|NCT01692301|529743681|FG001|Overall Study|Technical problems|1|||
146884034|NCT01692301|529743680|FG000|Overall Study|Physician Decision|2|||
146884035|NCT01692301|529743681|FG001|Overall Study|Physician Decision|2|||
146884036|NCT01692301|529743680|FG000|Overall Study|Lost to Follow-up|1|||
146884037|NCT01692301|529743681|FG001|Overall Study|Lost to Follow-up|1|||
146884038|NCT01142726|529743682|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
146884039|NCT01142726|529743683|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
146884040|NCT01142726|529743684|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
146884041|NCT01142726|529743682|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
146884042|NCT01142726|529743683|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
146884043|NCT01142726|529743684|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
146884044|NCT01142726|529743682|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
146884045|NCT01142726|529743683|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
146884046|NCT01142726|529743684|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
146884047|NCT01142726|529743682|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
146884048|NCT01142726|529743683|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
146547585|NCT01405911|528511024|FG001|Overall Study|Pre-treatment lab AE|1|||
146547586|NCT01405911|528511025|FG002|Overall Study|Pre-treatment lab AE|0|||
146547587|NCT01405911|528511023|FG000|Overall Study|Lost to Follow-up|0|||
146884049|NCT01142726|529743684|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
146884050|NCT01142726|529743682|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
146884051|NCT01142726|529743683|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
146884052|NCT01142726|529743684|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
146884053|NCT01142726|529743682|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
146884054|NCT01142726|529743683|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
146884055|NCT01142726|529743684|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
146884056|NCT01142726|529743682|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
146884057|NCT01142726|529743683|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
146884058|NCT01142726|529743684|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
146884059|NCT01142726|529743682|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
146884060|NCT01142726|529743683|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
146884061|NCT01142726|529743684|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
146547588|NCT01405911|528511024|FG001|Overall Study|Lost to Follow-up|1|||
146884062|NCT01142726|529743682|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
146884063|NCT01142726|529743683|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
146884064|NCT01142726|529743684|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
146884065|NCT01142726|529743682|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
146884066|NCT01142726|529743683|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
146884067|NCT01142726|529743684|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
146884068|NCT01142726|529743682|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
146884069|NCT01142726|529743683|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
146884070|NCT01142726|529743684|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
146884071|NCT01142726|529743682|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
146884072|NCT01142726|529743683|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
146884073|NCT01142726|529743684|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
146884074|NCT01142726|529743682|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
146884075|NCT01142726|529743683|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
146884076|NCT01142726|529743684|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
146884077|NCT01142726|529743682|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
146884078|NCT01142726|529743683|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
146884079|NCT01142726|529743684|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
146884080|NCT01142726|529743682|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
146884081|NCT01142726|529743683|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
146884082|NCT01142726|529743684|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
146884083|NCT01142726|529743682|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
146884084|NCT01142726|529743683|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
146884085|NCT01142726|529743684|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
146884086|NCT00293579|529743688|FG000|Overall Study|Withdrawal by Subject|1|||
146884087|NCT00419380|529743689|FG000|Overall Study|Lack of Efficacy|1|||
146884088|NCT00419380|529743690|FG001|Overall Study|Lack of Efficacy|7|||
146884089|NCT00419380|529743689|FG000|Overall Study|Physician Decision|0|||
146884090|NCT00419380|529743690|FG001|Overall Study|Physician Decision|1|||
146884091|NCT00419380|529743689|FG000|Overall Study|Lost to Follow-up|0|||
146884092|NCT00419380|529743690|FG001|Overall Study|Lost to Follow-up|1|||
146884093|NCT00419380|529743689|FG000|Overall Study|Withdrawal by Subject|0|||
146884094|NCT00419380|529743690|FG001|Overall Study|Withdrawal by Subject|1|||
146884095|NCT03099707|529743691|FG000|Overall Study|Withdrawal by Subject|0|||
146884096|NCT03099707|529743692|FG001|Overall Study|Withdrawal by Subject|3|||
146884097|NCT03099707|529743691|FG000|Overall Study|Lost to Follow-up|0|||
146884098|NCT03099707|529743692|FG001|Overall Study|Lost to Follow-up|1|||
146884099|NCT04428424|529743693|FG000|Overall Study|Does not meet entrance criteria|132|||
146884100|NCT04428424|529743693|FG000|Overall Study|Lost to Follow-up|115|||
146884101|NCT01262365|529745430|FG000|Overall Study|Lack of Efficacy|35|||
146884102|NCT01262365|529745431|FG001|Overall Study|Lack of Efficacy|30|||
146884103|NCT01262365|529745432|FG002|Overall Study|Lack of Efficacy|47|||
146884104|NCT01262365|529745430|FG000|Overall Study|Protocol Violation|3|||
146884105|NCT01262365|529745431|FG001|Overall Study|Protocol Violation|1|||
146884106|NCT01262365|529745432|FG002|Overall Study|Protocol Violation|1|||
146884107|NCT01262365|529745430|FG000|Overall Study|Lost to Follow-up|3|||
146884108|NCT01262365|529745431|FG001|Overall Study|Lost to Follow-up|7|||
146884109|NCT01262365|529745432|FG002|Overall Study|Lost to Follow-up|6|||
146884110|NCT01262365|529745430|FG000|Overall Study|Withdrawal by Subject|17|||
146884111|NCT01262365|529745431|FG001|Overall Study|Withdrawal by Subject|22|||
146884112|NCT01262365|529745432|FG002|Overall Study|Withdrawal by Subject|22|||
146884113|NCT01262365|529745430|FG000|Overall Study|Death|1|||
146884114|NCT01262365|529745431|FG001|Overall Study|Death|2|||
146884115|NCT01262365|529745432|FG002|Overall Study|Death|1|||
146884116|NCT01262365|529745430|FG000|Overall Study|Adverse Event|26|||
146884117|NCT01262365|529745431|FG001|Overall Study|Adverse Event|16|||
146884118|NCT01262365|529745432|FG002|Overall Study|Adverse Event|11|||
146884119|NCT01262365|529745430|FG000|Overall Study|sponsor decision|1|||
146884120|NCT01262365|529745431|FG001|Overall Study|sponsor decision|1|||
146884121|NCT01262365|529745432|FG002|Overall Study|sponsor decision|0|||
146884122|NCT01262365|529745430|FG000|Overall Study|Randomization error|1|||
146884123|NCT01262365|529745431|FG001|Overall Study|Randomization error|0|||
146884124|NCT01262365|529745432|FG002|Overall Study|Randomization error|2|||
146884125|NCT01262365|529745430|FG000|Overall Study|Non-compliance|1|||
146884126|NCT01262365|529745431|FG001|Overall Study|Non-compliance|0|||
146884127|NCT01262365|529745432|FG002|Overall Study|Non-compliance|2|||
146884128|NCT01262365|529745430|FG000|Overall Study|Suspected pregnancy|1|||
146884129|NCT01262365|529745431|FG001|Overall Study|Suspected pregnancy|0|||
146547589|NCT01405911|528511025|FG002|Overall Study|Lost to Follow-up|0|||
146547590|NCT01405911|528511023|FG000|Overall Study|Protocol Violation|1|||
146547591|NCT01405911|528511024|FG001|Overall Study|Protocol Violation|0|||
146547592|NCT01405911|528511025|FG002|Overall Study|Protocol Violation|0|||
146547593|NCT01405911|528511023|FG000|Overall Study|Withdrawal by Subject|3|||
146547594|NCT01405911|528511024|FG001|Overall Study|Withdrawal by Subject|1|||
146765095|NCT03612804|529307245|FG000|Overall Study|Withdrawal by Subject|0|||
146884130|NCT01262365|529745432|FG002|Overall Study|Suspected pregnancy|0|||
146884131|NCT01262365|529745430|FG000|Overall Study|Patient pregnant|1|||
146884132|NCT01262365|529745431|FG001|Overall Study|Patient pregnant|0|||
146884133|NCT01262365|529745432|FG002|Overall Study|Patient pregnant|1|||
146884134|NCT01262365|529745430|FG000|Overall Study|Toxicity related to study drug|0|||
146884135|NCT01262365|529745431|FG001|Overall Study|Toxicity related to study drug|1|||
146884136|NCT01262365|529745432|FG002|Overall Study|Toxicity related to study drug|0|||
146884137|NCT01262365|529745430|FG000|Overall Study|Cannot tolerate the protocol|0|||
146884138|NCT01262365|529745431|FG001|Overall Study|Cannot tolerate the protocol|1|||
146884139|NCT01262365|529745432|FG002|Overall Study|Cannot tolerate the protocol|0|||
146884140|NCT01262365|529745430|FG000|Overall Study|Patient unavailable|0|||
146884141|NCT01262365|529745431|FG001|Overall Study|Patient unavailable|0|||
146884142|NCT01262365|529745432|FG002|Overall Study|Patient unavailable|1|||
146884143|NCT02792842|529745439|FG000|Overall Study|Adverse Event|4|||
146884144|NCT02792842|529745440|FG001|Overall Study|Adverse Event|2|||
146884145|NCT02792842|529745441|FG002|Overall Study|Adverse Event|3|||
146884146|NCT02792842|529745439|FG000|Overall Study|Withdrawal by Subject|0|||
146884147|NCT02792842|529745440|FG001|Overall Study|Withdrawal by Subject|1|||
146884148|NCT02792842|529745441|FG002|Overall Study|Withdrawal by Subject|2|||
146884149|NCT02792842|529745439|FG000|Overall Study|Lost to Follow-up|0|||
146884150|NCT02792842|529745440|FG001|Overall Study|Lost to Follow-up|0|||
146884151|NCT02792842|529745441|FG002|Overall Study|Lost to Follow-up|1|||
146884152|NCT02792842|529745439|FG000|Overall Study|Schedule delay|0|||
146884153|NCT02792842|529745440|FG001|Overall Study|Schedule delay|1|||
146884154|NCT02792842|529745441|FG002|Overall Study|Schedule delay|1|||
146884155|NCT01294800|529745442|FG000|Overall Study|Adverse Event|7|||
146884156|NCT01294800|529745443|FG001|Overall Study|Adverse Event|6|||
146884157|NCT01294800|529745444|FG002|Overall Study|Adverse Event|12|||
146884158|NCT01294800|529745445|FG003|Overall Study|Adverse Event|5|||
146884159|NCT01294800|529745442|FG000|Overall Study|Subject Withdrew Consent|2|||
146884160|NCT01294800|529745443|FG001|Overall Study|Subject Withdrew Consent|2|||
146884161|NCT01294800|529745444|FG002|Overall Study|Subject Withdrew Consent|2|||
146884162|NCT01294800|529745445|FG003|Overall Study|Subject Withdrew Consent|11|||
146884163|NCT01294800|529745442|FG000|Overall Study|Lost to Follow-up|0|||
146884164|NCT01294800|529745443|FG001|Overall Study|Lost to Follow-up|0|||
146884165|NCT01294800|529745444|FG002|Overall Study|Lost to Follow-up|1|||
146884166|NCT01294800|529745445|FG003|Overall Study|Lost to Follow-up|0|||
146884167|NCT01294800|529745442|FG000|Overall Study|Non-compliance With Protocol|0|||
146547595|NCT01405911|528511025|FG002|Overall Study|Withdrawal by Subject|1|||
146630483|NCT04986904|528824067|FG000|Overall Study|Lost to Follow-up|11|||
146884168|NCT01294800|529745443|FG001|Overall Study|Non-compliance With Protocol|1|||
146884169|NCT01294800|529745444|FG002|Overall Study|Non-compliance With Protocol|1|||
146884170|NCT01294800|529745445|FG003|Overall Study|Non-compliance With Protocol|0|||
146884171|NCT01294800|529745442|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
146884172|NCT01294800|529745443|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
146884173|NCT01294800|529745444|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
146547596|NCT06375655|528511026|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
146547597|NCT06375655|528511027|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
146884174|NCT01294800|529745445|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
146884175|NCT00493038|529745446|FG000|Treatment|Adverse Event|8|||
146547598|NCT04124965|528511031|FG000|Overall Study|Adverse event, non-fatal|3|||
146547599|NCT04124965|528511032|FG001|Overall Study|Adverse event, non-fatal|1|||
146630484|NCT04986904|528824067|FG000|Overall Study|Withdrawal by Subject|1|||
146630485|NCT04123470|528824070|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
146630486|NCT04123470|528824071|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
146630487|NCT04123470|528824070|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
146630488|NCT04123470|528824071|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
146630489|NCT04123470|528824070|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
146630490|NCT04123470|528824071|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
146630491|NCT04123470|528824070|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
146630492|NCT04123470|528824071|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
146630493|NCT05972993|528824077|FG000|Overall Study|Lost to Follow-up|2|||
146630494|NCT05972993|528824078|FG001|Overall Study|Lost to Follow-up|0|||
146630495|NCT05972993|528824079|FG002|Overall Study|Lost to Follow-up|1|||
146630496|NCT05972993|528824080|FG003|Overall Study|Lost to Follow-up|0|||
146630497|NCT05972993|528824081|FG004|Overall Study|Lost to Follow-up|0|||
146630498|NCT05972993|528824082|FG005|Overall Study|Lost to Follow-up|0|||
146630499|NCT05972993|528824083|FG006|Overall Study|Lost to Follow-up|0|||
146630500|NCT05972993|528824084|FG007|Overall Study|Lost to Follow-up|2|||
146630501|NCT05972993|528824085|FG008|Overall Study|Lost to Follow-up|0|||
146630502|NCT03866577|528824088|FG000|Overall Study|Protocol Violation|0|||
146630503|NCT03866577|528824089|FG001|Overall Study|Protocol Violation|0|||
146630504|NCT03866577|528824090|FG002|Overall Study|Protocol Violation|0|||
146630505|NCT03866577|528824091|FG003|Overall Study|Protocol Violation|0|||
146630506|NCT03866577|528824092|FG004|Overall Study|Protocol Violation|0|||
146884176|NCT00493038|529745447|FG001|Treatment|Adverse Event|4|||
146884177|NCT00493038|529745446|FG000|Treatment|Lost to Follow-up|5|||
146884178|NCT00493038|529745447|FG001|Treatment|Lost to Follow-up|3|||
146630507|NCT03866577|528824093|FG005|Overall Study|Protocol Violation|0|||
146630508|NCT03866577|528824094|FG006|Overall Study|Protocol Violation|0|||
146630509|NCT03866577|528824095|FG007|Overall Study|Protocol Violation|0|||
146630510|NCT03866577|528824096|FG008|Overall Study|Protocol Violation|0|||
146630511|NCT03866577|528824097|FG009|Overall Study|Protocol Violation|0|||
146884179|NCT00493038|529745446|FG000|Treatment|Withdrawal by Subject|11|||
146884180|NCT00493038|529745447|FG001|Treatment|Withdrawal by Subject|12|||
146884181|NCT00493038|529745446|FG000|Treatment|Other|0|||
146884182|NCT00493038|529745447|FG001|Treatment|Other|1|||
146884183|NCT00493038|529745446|FG000|Follow-up|Lost to Follow-up|1|||
146884184|NCT00493038|529745447|FG001|Follow-up|Lost to Follow-up|0|||
146884185|NCT04418765|529745448|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
146884186|NCT04418765|529745449|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
146884187|NCT04418765|529745450|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
146884188|NCT04418765|529745448|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
146884189|NCT04418765|529745449|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
146884190|NCT04418765|529745450|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
146884191|NCT04418765|529745448|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
146884192|NCT04418765|529745449|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
146884193|NCT04418765|529745450|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
146884194|NCT04418765|529745448|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
146884195|NCT04418765|529745449|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
146884196|NCT04418765|529745450|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
146884197|NCT04418765|529745448|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
146884198|NCT04418765|529745449|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
146884199|NCT04418765|529745450|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
146884200|NCT04418765|529745448|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
146884201|NCT04418765|529745449|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
146884202|NCT04418765|529745450|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
146884203|NCT04418765|529745448|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
146884204|NCT04418765|529745449|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
146966451|NCT04456998|530038805|FG000|Overall Study|Adverse Event|0|||
146547600|NCT04124965|528511031|FG000|Overall Study|Withdrawal by Subject|1|||
146547601|NCT04124965|528511032|FG001|Overall Study|Withdrawal by Subject|1|||
146547602|NCT04124965|528511031|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
146547603|NCT04124965|528511032|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
146547604|NCT04124965|528511031|FG000|Overall Study|Pregnancy|1|||
146547605|NCT04124965|528511032|FG001|Overall Study|Pregnancy|0|||
146547606|NCT04124965|528511031|FG000|Overall Study|Sponsor and participant decision|0|||
146547607|NCT04124965|528511032|FG001|Overall Study|Sponsor and participant decision|1|||
146547608|NCT04124965|528511031|FG000|Overall Study|Personal surgery|0|||
146547609|NCT04124965|528511032|FG001|Overall Study|Personal surgery|1|||
146884205|NCT04418765|529745450|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
146884206|NCT04418765|529745448|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
146884207|NCT04418765|529745449|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
146884208|NCT04418765|529745450|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
146884209|NCT04418765|529745448|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
146884210|NCT04418765|529745449|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
146884211|NCT04418765|529745450|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
146884212|NCT04418765|529745448|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
146884213|NCT04418765|529745449|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
146884214|NCT04418765|529745450|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
146884215|NCT04418765|529745448|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
146884216|NCT04418765|529745449|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
146884217|NCT04418765|529745450|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
146884218|NCT04418765|529745448|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
146966452|NCT04456998|530038806|FG001|Overall Study|Adverse Event|4|||
146547610|NCT04124965|528511031|FG000|Overall Study|Physician Decision|0|||
146547611|NCT04124965|528511032|FG001|Overall Study|Physician Decision|1|||
146547612|NCT01121575|528511043|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
146547613|NCT01121575|528511044|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
146884219|NCT04418765|529745449|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
146884220|NCT04418765|529745450|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
146884221|NCT04418765|529745448|FG000|Extension Period (48 Weeks)|Other than specified|0|||
146547614|NCT01121575|528511045|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
146547615|NCT01121575|528511046|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
146547616|NCT01121575|528511047|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
146547617|NCT01121575|528511048|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
146547618|NCT01121575|528511043|FG000|Overall Study|Unspecified Reasons|8|||
146547619|NCT01121575|528511044|FG001|Overall Study|Unspecified Reasons|6|||
146547620|NCT01121575|528511045|FG002|Overall Study|Unspecified Reasons|7|||
146547621|NCT01121575|528511046|FG003|Overall Study|Unspecified Reasons|5|||
146547622|NCT01121575|528511047|FG004|Overall Study|Unspecified Reasons|13|||
146547623|NCT01121575|528511048|FG005|Overall Study|Unspecified Reasons|10|||
146547624|NCT01121575|528511043|FG000|Overall Study|Death|6|||
146547625|NCT01121575|528511044|FG001|Overall Study|Death|0|||
146630512|NCT03866577|528824098|FG010|Overall Study|Protocol Violation|0|||
146630513|NCT03866577|528824099|FG011|Overall Study|Protocol Violation|1|||
146630514|NCT03866577|528824100|FG012|Overall Study|Protocol Violation|0|||
146630515|NCT03866577|528824088|FG000|Overall Study|Withdrawal by Subject|0|||
146630516|NCT03866577|528824089|FG001|Overall Study|Withdrawal by Subject|0|||
146630517|NCT03866577|528824090|FG002|Overall Study|Withdrawal by Subject|0|||
146630518|NCT03866577|528824091|FG003|Overall Study|Withdrawal by Subject|0|||
146630519|NCT03866577|528824092|FG004|Overall Study|Withdrawal by Subject|0|||
146630520|NCT03866577|528824093|FG005|Overall Study|Withdrawal by Subject|0|||
146630521|NCT03866577|528824094|FG006|Overall Study|Withdrawal by Subject|0|||
146630522|NCT03866577|528824095|FG007|Overall Study|Withdrawal by Subject|0|||
146630523|NCT03866577|528824096|FG008|Overall Study|Withdrawal by Subject|1|||
146630524|NCT03866577|528824097|FG009|Overall Study|Withdrawal by Subject|1|||
146630525|NCT03866577|528824098|FG010|Overall Study|Withdrawal by Subject|0|||
146630526|NCT03866577|528824099|FG011|Overall Study|Withdrawal by Subject|0|||
146630527|NCT03866577|528824100|FG012|Overall Study|Withdrawal by Subject|0|||
146630528|NCT03866577|528824088|FG000|Overall Study|Not qualified for IVIg infusion|0|||
146630529|NCT03866577|528824089|FG001|Overall Study|Not qualified for IVIg infusion|0|||
146630530|NCT03866577|528824090|FG002|Overall Study|Not qualified for IVIg infusion|0|||
146884222|NCT04418765|529745449|FG001|Extension Period (48 Weeks)|Other than specified|5|||
146630531|NCT03866577|528824091|FG003|Overall Study|Not qualified for IVIg infusion|0|||
146630532|NCT03866577|528824092|FG004|Overall Study|Not qualified for IVIg infusion|0|||
146630533|NCT03866577|528824093|FG005|Overall Study|Not qualified for IVIg infusion|0|||
146547626|NCT01121575|528511045|FG002|Overall Study|Death|0|||
146884223|NCT04418765|529745450|FG002|Extension Period (48 Weeks)|Other than specified|2|||
146884224|NCT03345472|529745451|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
146884225|NCT03345472|529745451|FG000|Implant to 3 Months|Physician Decision|1|||
146884226|NCT03345472|529745451|FG000|Implant to 3 Months|Adverse Event|1|||
146884227|NCT03345472|529745451|FG000|3 Months to 12 Months|Physician Decision|3|||
146884228|NCT03345472|529745451|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
146884229|NCT03345472|529745451|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
146884230|NCT03345472|529745451|FG000|3 Months to 12 Months|Adverse Event|1|||
146884231|NCT03345472|529745451|FG000|3 Months to 12 Months|Death|1|||
146884232|NCT01926782|529745452|FG000|Overall Study|Participant moved|2|||
146884233|NCT01926782|529745453|FG001|Overall Study|Participant moved|0|||
146884234|NCT01926782|529745454|FG002|Overall Study|Participant moved|1|||
146884235|NCT01926782|529745455|FG003|Overall Study|Participant moved|1|||
146547627|NCT01121575|528511046|FG003|Overall Study|Death|1|||
146547628|NCT01121575|528511047|FG004|Overall Study|Death|7|||
146547629|NCT01121575|528511048|FG005|Overall Study|Death|1|||
146547630|NCT03011372|528511058|FG000|Overall Study|Death|16|||
146547631|NCT03011372|528511058|FG000|Overall Study|Lost to Follow-up|2|||
146547632|NCT03011372|528511058|FG000|Overall Study|Sponsor Decision|17|||
146547633|NCT03011372|528511058|FG000|Overall Study|Withdrawal by Subject|7|||
146547634|NCT03011372|528511058|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
146547635|NCT03011372|528511058|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
146547636|NCT03011372|528511058|FG000|Overall Study|Sponsor's Decision|2|||
146547637|NCT03860584|528511059|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
146547638|NCT03860584|528511060|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
146547639|NCT03860584|528511059|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
146547640|NCT03860584|528511060|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
146547641|NCT03860584|528511059|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
146547642|NCT03860584|528511060|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
146547643|NCT03860584|528511059|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
146547644|NCT03860584|528511060|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
146547645|NCT01105130|528512584|FG000|Overall Study|Withdrawal by Subject|4|||
146630534|NCT03866577|528824094|FG006|Overall Study|Not qualified for IVIg infusion|0|||
146630535|NCT03866577|528824095|FG007|Overall Study|Not qualified for IVIg infusion|0|||
146630536|NCT03866577|528824096|FG008|Overall Study|Not qualified for IVIg infusion|0|||
146630537|NCT03866577|528824097|FG009|Overall Study|Not qualified for IVIg infusion|1|||
146630538|NCT03866577|528824098|FG010|Overall Study|Not qualified for IVIg infusion|0|||
146630539|NCT03866577|528824099|FG011|Overall Study|Not qualified for IVIg infusion|0|||
146630540|NCT03866577|528824100|FG012|Overall Study|Not qualified for IVIg infusion|0|||
146630541|NCT05530252|528824101|FG000|Overall Study|Lost to Follow-up|1|||
146630542|NCT05530252|528824102|FG001|Overall Study|Lost to Follow-up|1|||
146630543|NCT05530252|528824103|FG002|Overall Study|Lost to Follow-up|1|||
146884236|NCT01926782|529745456|FG004|Overall Study|Participant moved|0|||
146884237|NCT01926782|529745457|FG005|Overall Study|Participant moved|3|||
146630544|NCT01535040|528824109|FG000|Overall Study|Physician Decision|0|||
146630545|NCT01535040|528824110|FG001|Overall Study|Physician Decision|1|||
146630546|NCT01535040|528824109|FG000|Overall Study|Withdrawal by Subject|13|||
146884238|NCT01926782|529745452|FG000|Overall Study|Physician Decision|0|||
146884239|NCT01926782|529745453|FG001|Overall Study|Physician Decision|2|||
146884240|NCT01926782|529745454|FG002|Overall Study|Physician Decision|1|||
146884241|NCT01926782|529745455|FG003|Overall Study|Physician Decision|1|||
146884242|NCT01926782|529745456|FG004|Overall Study|Physician Decision|0|||
146884243|NCT01926782|529745457|FG005|Overall Study|Physician Decision|0|||
146884244|NCT01926782|529745452|FG000|Overall Study|Other than specified|2|||
146884245|NCT01926782|529745453|FG001|Overall Study|Other than specified|3|||
146884246|NCT01926782|529745454|FG002|Overall Study|Other than specified|5|||
146547646|NCT01105130|528512585|FG001|Overall Study|Withdrawal by Subject|6|||
146547647|NCT01105130|528512586|FG002|Overall Study|Withdrawal by Subject|2|||
146547648|NCT01105130|528512584|FG000|Overall Study|Never Started|2|||
146547649|NCT01105130|528512585|FG001|Overall Study|Never Started|2|||
146547650|NCT01105130|528512586|FG002|Overall Study|Never Started|4|||
146547651|NCT01105130|528512584|FG000|Overall Study|Toxicity|1|||
146547652|NCT01105130|528512585|FG001|Overall Study|Toxicity|3|||
146547653|NCT01105130|528512586|FG002|Overall Study|Toxicity|2|||
146547654|NCT01105130|528512584|FG000|Overall Study|Multiple Reasons|3|||
146547655|NCT01105130|528512585|FG001|Overall Study|Multiple Reasons|0|||
146884247|NCT01926782|529745455|FG003|Overall Study|Other than specified|12|||
146884248|NCT01926782|529745456|FG004|Overall Study|Other than specified|4|||
146884249|NCT01926782|529745457|FG005|Overall Study|Other than specified|11|||
146547656|NCT01105130|528512586|FG002|Overall Study|Multiple Reasons|2|||
146547657|NCT00327171|528512587|FG000|Overall Study|Did not receive study medication|3|||
146884250|NCT01926782|529745452|FG000|Overall Study|Adverse Event|13|||
146547658|NCT00327171|528512588|FG001|Overall Study|Did not receive study medication|0|||
146884251|NCT01926782|529745453|FG001|Overall Study|Adverse Event|4|||
146547659|NCT00327171|528512587|FG000|Overall Study|Adverse Event|23|||
146547660|NCT00327171|528512588|FG001|Overall Study|Adverse Event|23|||
146547661|NCT00327171|528512587|FG000|Overall Study|Disease progression/lack of efficacy|68|||
146547662|NCT00327171|528512588|FG001|Overall Study|Disease progression/lack of efficacy|69|||
146547663|NCT00327171|528512587|FG000|Overall Study|Investigator/participant request|1|||
146547664|NCT00327171|528512588|FG001|Overall Study|Investigator/participant request|8|||
146547665|NCT00327171|528512587|FG000|Overall Study|Clinical progression|12|||
146547666|NCT00327171|528512588|FG001|Overall Study|Clinical progression|8|||
146884252|NCT01926782|529745454|FG002|Overall Study|Adverse Event|17|||
146884253|NCT01926782|529745455|FG003|Overall Study|Adverse Event|4|||
146884254|NCT01926782|529745456|FG004|Overall Study|Adverse Event|3|||
146884255|NCT01926782|529745457|FG005|Overall Study|Adverse Event|14|||
146884256|NCT01926782|529745452|FG000|Overall Study|Poor compliance to protocol|5|||
146884257|NCT01926782|529745453|FG001|Overall Study|Poor compliance to protocol|3|||
146884258|NCT01926782|529745454|FG002|Overall Study|Poor compliance to protocol|8|||
146884259|NCT01926782|529745455|FG003|Overall Study|Poor compliance to protocol|0|||
146884260|NCT01926782|529745456|FG004|Overall Study|Poor compliance to protocol|1|||
146547667|NCT00327171|528512587|FG000|Overall Study|Undisclosed history of ischemia|0|||
146884261|NCT01926782|529745457|FG005|Overall Study|Poor compliance to protocol|6|||
146547668|NCT00327171|528512588|FG001|Overall Study|Undisclosed history of ischemia|1|||
146547669|NCT00327171|528512587|FG000|Overall Study|Other|1|||
146547670|NCT00327171|528512588|FG001|Overall Study|Other|0|||
146884262|NCT01926782|529745452|FG000|Overall Study|Randomized and not treated|0|||
146884263|NCT01926782|529745453|FG001|Overall Study|Randomized and not treated|0|||
146884264|NCT01926782|529745454|FG002|Overall Study|Randomized and not treated|0|||
146630547|NCT01535040|528824110|FG001|Overall Study|Withdrawal by Subject|10|||
146630548|NCT01535040|528824109|FG000|Overall Study|Never Started|9|||
146630549|NCT01535040|528824110|FG001|Overall Study|Never Started|4|||
146630550|NCT01535040|528824109|FG000|Overall Study|Toxicity|7|||
146630551|NCT01535040|528824110|FG001|Overall Study|Toxicity|5|||
146884265|NCT01926782|529745455|FG003|Overall Study|Randomized and not treated|1|||
146884266|NCT01926782|529745456|FG004|Overall Study|Randomized and not treated|0|||
146884267|NCT01926782|529745457|FG005|Overall Study|Randomized and not treated|0|||
146884268|NCT01926782|529745452|FG000|Overall Study|Withdrawal by Subject|6|||
146884269|NCT01926782|529745453|FG001|Overall Study|Withdrawal by Subject|1|||
146884270|NCT01926782|529745454|FG002|Overall Study|Withdrawal by Subject|8|||
146884271|NCT01926782|529745455|FG003|Overall Study|Withdrawal by Subject|1|||
146884272|NCT01926782|529745456|FG004|Overall Study|Withdrawal by Subject|0|||
146884273|NCT01926782|529745457|FG005|Overall Study|Withdrawal by Subject|5|||
146630552|NCT01535040|528824109|FG000|Overall Study|Multiple Reasons|1|||
146630553|NCT01535040|528824110|FG001|Overall Study|Multiple Reasons|1|||
146966453|NCT04456998|530038805|FG000|Overall Study|Protocol Deviation|0|||
146966454|NCT04456998|530038806|FG001|Overall Study|Protocol Deviation|1|||
146884274|NCT01926782|529745452|FG000|Overall Study|Related to study drug administration|0|||
146884275|NCT01926782|529745453|FG001|Overall Study|Related to study drug administration|0|||
146884276|NCT01926782|529745454|FG002|Overall Study|Related to study drug administration|0|||
146884277|NCT01926782|529745455|FG003|Overall Study|Related to study drug administration|0|||
146547671|NCT02323334|528512589|FG000|Period 3|Lost to Follow-up|0|||
146547672|NCT02323334|528512590|FG001|Period 3|Lost to Follow-up|0|||
146547673|NCT02323334|528512591|FG002|Period 3|Lost to Follow-up|1|||
146547674|NCT02323334|528512592|FG003|Period 3|Lost to Follow-up|0|||
146547675|NCT02323334|528512593|FG004|Period 3|Lost to Follow-up|0|||
146547676|NCT02323334|528512594|FG005|Period 3|Lost to Follow-up|0|||
146547677|NCT02323334|528512595|FG006|Period 3|Lost to Follow-up|0|||
146547678|NCT02323334|528512596|FG007|Period 3|Lost to Follow-up|0|||
146547679|NCT02323334|528512597|FG008|Period 3|Lost to Follow-up|0|||
146547680|NCT02323334|528512598|FG009|Period 3|Lost to Follow-up|0|||
146547681|NCT02323334|528512599|FG010|Period 3|Lost to Follow-up|0|||
146547682|NCT02323334|528512600|FG011|Period 3|Lost to Follow-up|0|||
146547683|NCT02323334|528512601|FG012|Period 3|Lost to Follow-up|0|||
146547684|NCT02323334|528512602|FG013|Period 3|Lost to Follow-up|0|||
146547685|NCT02323334|528512603|FG014|Period 3|Lost to Follow-up|0|||
146547686|NCT02323334|528512604|FG015|Period 3|Lost to Follow-up|0|||
146547687|NCT02323334|528512605|FG016|Period 3|Lost to Follow-up|0|||
146547688|NCT02323334|528512589|FG000|Period 3|Withdrawal by Subject|1|||
146547689|NCT02323334|528512590|FG001|Period 3|Withdrawal by Subject|0|||
146547690|NCT02323334|528512591|FG002|Period 3|Withdrawal by Subject|0|||
146547691|NCT02323334|528512592|FG003|Period 3|Withdrawal by Subject|0|||
146547692|NCT02323334|528512593|FG004|Period 3|Withdrawal by Subject|0|||
146547693|NCT02323334|528512594|FG005|Period 3|Withdrawal by Subject|0|||
146547694|NCT02323334|528512595|FG006|Period 3|Withdrawal by Subject|0|||
146547695|NCT02323334|528512596|FG007|Period 3|Withdrawal by Subject|0|||
146547696|NCT02323334|528512597|FG008|Period 3|Withdrawal by Subject|0|||
146547697|NCT02323334|528512598|FG009|Period 3|Withdrawal by Subject|0|||
146547698|NCT02323334|528512599|FG010|Period 3|Withdrawal by Subject|0|||
146547699|NCT02323334|528512600|FG011|Period 3|Withdrawal by Subject|0|||
146547700|NCT02323334|528512601|FG012|Period 3|Withdrawal by Subject|0|||
146547701|NCT02323334|528512602|FG013|Period 3|Withdrawal by Subject|0|||
146547702|NCT02323334|528512603|FG014|Period 3|Withdrawal by Subject|0|||
146547703|NCT02323334|528512604|FG015|Period 3|Withdrawal by Subject|0|||
146547704|NCT02323334|528512605|FG016|Period 3|Withdrawal by Subject|0|||
146547705|NCT00530075|528512606|FG000|Overall Study|Adverse Event|1|||
146547706|NCT00530075|528512606|FG000|Overall Study|Death|1|||
146547707|NCT00530075|528512606|FG000|Overall Study|Lack of Efficacy|3|||
146547708|NCT00530075|528512606|FG000|Overall Study|Protocol Violation|1|||
146547709|NCT00530075|528512606|FG000|Overall Study|Withdrawal by Subject|1|||
146547710|NCT03422718|528512607|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
146630554|NCT01074970|528824111|FG000|Overall Study|Never Treated|0|||
146630555|NCT01074970|528824112|FG001|Overall Study|Never Treated|0|||
146630556|NCT01074970|528824113|FG002|Overall Study|Never Treated|8|||
146630557|NCT01074970|528824114|FG003|Overall Study|Never Treated|1|||
146630558|NCT01074970|528824111|FG000|Overall Study|Adverse Event|1|||
146630559|NCT01074970|528824112|FG001|Overall Study|Adverse Event|0|||
146630560|NCT01074970|528824113|FG002|Overall Study|Adverse Event|4|||
146630561|NCT01074970|528824114|FG003|Overall Study|Adverse Event|3|||
146630562|NCT01074970|528824111|FG000|Overall Study|Disease progression during treatment|3|||
146630563|NCT01074970|528824112|FG001|Overall Study|Disease progression during treatment|1|||
146630564|NCT01074970|528824113|FG002|Overall Study|Disease progression during treatment|2|||
146630565|NCT01074970|528824114|FG003|Overall Study|Disease progression during treatment|9|||
146630566|NCT01074970|528824111|FG000|Overall Study|Lost to Follow-up|0|||
146630567|NCT01074970|528824112|FG001|Overall Study|Lost to Follow-up|0|||
146630568|NCT01074970|528824113|FG002|Overall Study|Lost to Follow-up|1|||
146630569|NCT01074970|528824114|FG003|Overall Study|Lost to Follow-up|0|||
146630570|NCT01074970|528824111|FG000|Overall Study|Withdrawal by Subject|0|||
146630571|NCT01074970|528824112|FG001|Overall Study|Withdrawal by Subject|0|||
146630572|NCT01074970|528824113|FG002|Overall Study|Withdrawal by Subject|6|||
146630573|NCT01074970|528824114|FG003|Overall Study|Withdrawal by Subject|4|||
146630574|NCT05523089|528824117|FG000|Overall Study|Withdrawal by Subject|1|||
146630575|NCT05523089|528824118|FG001|Overall Study|Withdrawal by Subject|0|||
146630576|NCT05523089|528824119|FG002|Overall Study|Withdrawal by Subject|0|||
146630577|NCT05523089|528824117|FG000|Overall Study|Lost to Follow-up|1|||
146630578|NCT05523089|528824118|FG001|Overall Study|Lost to Follow-up|0|||
146630579|NCT05523089|528824119|FG002|Overall Study|Lost to Follow-up|0|||
146630580|NCT02514083|528824120|FG000|Overall Study|Adverse Event|1|||
146630581|NCT01899040|528824121|FG000|Overall Study|Randomized in error|0|||
146630582|NCT01899040|528824122|FG001|Overall Study|Randomized in error|1|||
146630583|NCT01899040|528824123|FG002|Overall Study|Randomized in error|1|||
146630584|NCT01899040|528824121|FG000|Overall Study|Adverse Event|3|||
146630585|NCT01899040|528824122|FG001|Overall Study|Adverse Event|1|||
146630586|NCT01899040|528824123|FG002|Overall Study|Adverse Event|2|||
146630587|NCT01899040|528824121|FG000|Overall Study|Unspecified reasons|4|||
146630588|NCT01899040|528824122|FG001|Overall Study|Unspecified reasons|4|||
146630589|NCT01899040|528824123|FG002|Overall Study|Unspecified reasons|0|||
146630590|NCT01899040|528824121|FG000|Overall Study|Compliance issues|1|||
146630591|NCT01899040|528824122|FG001|Overall Study|Compliance issues|2|||
146630592|NCT01899040|528824123|FG002|Overall Study|Compliance issues|0|||
146630593|NCT02638220|528824124|FG000|Overall Study|Lost to Follow-up|6|||
146630594|NCT02638220|528824124|FG000|Overall Study|Withdrawal by Subject|3|||
146630595|NCT02638220|528824124|FG000|Overall Study|Physician Decision|1|||
146630596|NCT02638220|528824124|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
146630597|NCT01710501|528826054|FG000|Overall Study|Lost to Follow-up|2|||
146630598|NCT01710501|528826055|FG001|Overall Study|Lost to Follow-up|0|||
146630599|NCT01710501|528826056|FG002|Overall Study|Lost to Follow-up|0|||
146630600|NCT02536976|528826057|FG000|Overall Study|Physician Decision|0|||
146630601|NCT02536976|528826058|FG001|Overall Study|Physician Decision|1|||
146630602|NCT02144610|528826061|FG000|Overall Study|Physician Decision|1|||
146630603|NCT02144610|528826062|FG001|Overall Study|Physician Decision|0|||
146630604|NCT02144610|528826061|FG000|Overall Study|Withdrawal by Subject|1|||
146630605|NCT02144610|528826062|FG001|Overall Study|Withdrawal by Subject|5|||
146630606|NCT02144610|528826061|FG000|Overall Study|Death|2|||
146630607|NCT02144610|528826062|FG001|Overall Study|Death|2|||
146630608|NCT02144610|528826061|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
146630609|NCT02144610|528826062|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
146630610|NCT02144610|528826061|FG000|Overall Study|Other|0|||
146630611|NCT02144610|528826062|FG001|Overall Study|Other|1|||
146630612|NCT01432730|528826064|FG000|Period 1|Adverse Event|2|||
146630613|NCT01432730|528826065|FG001|Period 1|Adverse Event|0|||
146630614|NCT01432730|528826064|FG000|Period 2|Adverse Event|0|||
146630615|NCT01432730|528826065|FG001|Period 2|Adverse Event|4|||
146630616|NCT03038100|528826079|FG000|Overall Study|Death|289|||
146547711|NCT03422718|528512608|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
146547712|NCT03422718|528512609|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
146547713|NCT03422718|528512610|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
146547714|NCT03422718|528512611|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
146547715|NCT03422718|528512612|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
146547716|NCT03422718|528512613|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
146547717|NCT03422718|528512614|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
146547718|NCT03422718|528512607|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
146547719|NCT03422718|528512608|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
146547720|NCT03422718|528512609|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
146547721|NCT03422718|528512610|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
146547722|NCT03422718|528512611|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
146547723|NCT03422718|528512612|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
146547724|NCT03422718|528512613|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
146547725|NCT03422718|528512614|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
146547726|NCT03422718|528512607|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
146547727|NCT03422718|528512608|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
146547728|NCT03422718|528512609|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
146547729|NCT03422718|528512610|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
146547730|NCT03422718|528512611|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
146547731|NCT03422718|528512612|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
146547732|NCT03422718|528512613|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
146547733|NCT03422718|528512614|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
146547734|NCT03422718|528512607|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
146547735|NCT03422718|528512608|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
146547736|NCT03422718|528512609|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
146547737|NCT03422718|528512610|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
146547738|NCT03422718|528512611|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
146547739|NCT03422718|528512612|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
146547740|NCT03422718|528512613|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
146547741|NCT03422718|528512614|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
146547742|NCT03422718|528512607|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
146547743|NCT03422718|528512608|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
146547744|NCT03422718|528512609|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
146547745|NCT03422718|528512610|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
146547746|NCT03422718|528512611|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
146547747|NCT03422718|528512612|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
146547748|NCT03422718|528512613|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
146547749|NCT03422718|528512614|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
146547750|NCT03422718|528512607|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
146547751|NCT03422718|528512608|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
146547752|NCT03422718|528512609|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
146547753|NCT03422718|528512610|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
146547754|NCT03422718|528512611|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
146547755|NCT03422718|528512612|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
146630617|NCT03038100|528826080|FG001|Overall Study|Death|272|||
146884278|NCT01926782|529745456|FG004|Overall Study|Related to study drug administration|0|||
146884279|NCT01926782|529745457|FG005|Overall Study|Related to study drug administration|2|||
146884280|NCT02728830|529745488|FG000|Overall Study|Exclusionary Surgery|9|||
146884281|NCT02728830|529745488|FG000|Overall Study|Exclusionary Pathology|6|||
146884282|NCT02728830|529745488|FG000|Overall Study|Physician Decision|3|||
146547756|NCT03422718|528512613|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
146547757|NCT03422718|528512614|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
146547758|NCT03309605|528512615|FG000|Overall Study|Adverse Event|0|||
146547759|NCT03309605|528512616|FG001|Overall Study|Adverse Event|0|||
146547760|NCT03309605|528512617|FG002|Overall Study|Adverse Event|0|||
146547761|NCT03309605|528512618|FG003|Overall Study|Adverse Event|1|||
146884283|NCT02728830|529745488|FG000|Overall Study|Withdrawal by Subject|2|||
146966455|NCT04456998|530038805|FG000|Overall Study|Withdrawal by Subject|0|||
146547762|NCT03309605|528512619|FG004|Overall Study|Adverse Event|0|||
146547763|NCT03309605|528512620|FG005|Overall Study|Adverse Event|0|||
146547764|NCT03309605|528512621|FG006|Overall Study|Adverse Event|2|||
146547765|NCT03309605|528512622|FG007|Overall Study|Adverse Event|1|||
146547766|NCT03309605|528512615|FG000|Overall Study|Withdrawal by Subject|0|||
146547767|NCT03309605|528512616|FG001|Overall Study|Withdrawal by Subject|0|||
146547768|NCT03309605|528512617|FG002|Overall Study|Withdrawal by Subject|0|||
146547769|NCT03309605|528512618|FG003|Overall Study|Withdrawal by Subject|0|||
146547770|NCT03309605|528512619|FG004|Overall Study|Withdrawal by Subject|1|||
146547771|NCT03309605|528512620|FG005|Overall Study|Withdrawal by Subject|0|||
146547772|NCT03309605|528512621|FG006|Overall Study|Withdrawal by Subject|1|||
146547773|NCT03309605|528512622|FG007|Overall Study|Withdrawal by Subject|1|||
146547774|NCT01129284|528512623|FG000|Overall Study|Adverse Event|2|||
146547775|NCT01129284|528512624|FG001|Overall Study|Adverse Event|0|||
146547776|NCT01129284|528512625|FG002|Overall Study|Adverse Event|1|||
146547777|NCT00784927|528512628|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
146547778|NCT00784927|528512628|FG000|Overall Study|Protocol Violation|1|||
146547779|NCT00784927|528512628|FG000|Overall Study|Ineligible|1|||
146547780|NCT00422461|528512636|FG000|Overall Study|Adverse Event|1|||
146547781|NCT00422461|528512637|FG001|Overall Study|Adverse Event|2|||
146547782|NCT00422461|528512638|FG002|Overall Study|Adverse Event|1|||
146547783|NCT00422461|528512639|FG003|Overall Study|Adverse Event|1|||
146547784|NCT00422461|528512636|FG000|Overall Study|Other|0|||
146547785|NCT00422461|528512637|FG001|Overall Study|Other|0|||
146547786|NCT00422461|528512638|FG002|Overall Study|Other|0|||
146547787|NCT00422461|528512639|FG003|Overall Study|Other|2|||
146547788|NCT00422461|528512636|FG000|Overall Study|Participants no longer willing to participate in study|1|||
146547789|NCT00422461|528512637|FG001|Overall Study|Participants no longer willing to participate in study|0|||
146547790|NCT00422461|528512638|FG002|Overall Study|Participants no longer willing to participate in study|0|||
146547791|NCT00422461|528512639|FG003|Overall Study|Participants no longer willing to participate in study|0|||
146547792|NCT00422461|528512636|FG000|Overall Study|Randomized but not treated|1|||
146547793|NCT00422461|528512637|FG001|Overall Study|Randomized but not treated|1|||
146547794|NCT00422461|528512638|FG002|Overall Study|Randomized but not treated|0|||
146547795|NCT00422461|528512639|FG003|Overall Study|Randomized but not treated|0|||
146547796|NCT01795937|528512640|FG000|Overall Study|Withdrawal by Subject|1|||
146547797|NCT01795937|528512641|FG001|Overall Study|Withdrawal by Subject|0|||
146547798|NCT01795937|528512642|FG002|Overall Study|Withdrawal by Subject|0|||
146547799|NCT01795937|528512640|FG000|Overall Study|Physician Decision|0|||
146547800|NCT01795937|528512641|FG001|Overall Study|Physician Decision|1|||
146547801|NCT01795937|528512642|FG002|Overall Study|Physician Decision|0|||
146547802|NCT01028053|528512643|FG000|Overall Study|Screen Failure|113|||
146547803|NCT01028053|528512643|FG000|Overall Study|Patient Request|11|||
146547804|NCT01028053|528512643|FG000|Overall Study|Protocol Violation|1|||
146547805|NCT01028053|528512643|FG000|Overall Study|Physician Decision|2|||
146547806|NCT01028053|528512643|FG000|Overall Study|Technical Problem|1|||
146884284|NCT02728830|529745488|FG000|Overall Study|Lost to Follow-up|1|||
146884285|NCT02728830|529745488|FG000|Overall Study|Exclusionary Lab Values|1|||
146884286|NCT02728830|529745488|FG000|Overall Study|Contraindicated Illness|1|||
146884287|NCT02728830|529745488|FG000|Overall Study|Language Barrier|1|||
146884288|NCT00070941|529745489|FG000|Overall Study|Adverse Event|10|||
146884289|NCT00070941|529745490|FG001|Overall Study|Adverse Event|8|||
146884290|NCT00070941|529745491|FG002|Overall Study|Adverse Event|4|||
146884291|NCT01568593|529745492|FG000|Overall Study|Lack of Efficacy|4|||
146884292|NCT01568593|529745493|FG001|Overall Study|Lack of Efficacy|1|||
146884293|NCT01568593|529745492|FG000|Overall Study|Adverse Event|3|||
146884294|NCT01568593|529745493|FG001|Overall Study|Adverse Event|2|||
146884295|NCT02780648|529745494|FG000|Overall Study|Disease Progression|1|||
146884296|NCT02780648|529745495|FG001|Overall Study|Disease Progression|0|||
146884297|NCT03167073|529745500|FG000|Overall Study|Stillbirth|1|||
146884298|NCT03167073|529745501|FG001|Overall Study|Stillbirth|0|||
146884299|NCT01276236|529745502|FG000|Overall Study|Lack of Efficacy|2|||
146884300|NCT01276236|529745502|FG000|Overall Study|Withdrawal by Subject|4|||
146884301|NCT03127384|529745504|FG000|Overall Study|Lost to Follow-up|4|||
146884302|NCT03127384|529745504|FG000|Overall Study|Subject request|2|||
146884303|NCT00343889|529745512|FG000|Overall Study|Lost to Follow-up|2|||
146884304|NCT00343889|529745513|FG001|Overall Study|Lost to Follow-up|0|||
146884305|NCT00343889|529745512|FG000|Overall Study|Withdrawal by Subject|0|||
146884306|NCT00343889|529745513|FG001|Overall Study|Withdrawal by Subject|1|||
146884307|NCT00343889|529745512|FG000|Overall Study|Protocol Violation|1|||
146884308|NCT00343889|529745513|FG001|Overall Study|Protocol Violation|0|||
146884309|NCT01294579|529745516|FG000|Overall Study|Disease progression|12|||
146884310|NCT01294579|529745516|FG000|Overall Study|Adverse Event|11|||
146884311|NCT01294579|529745516|FG000|Overall Study|Study closed/terminated|3|||
146884312|NCT01294579|529745516|FG000|Overall Study|Lost to Follow-up|1|||
146884313|NCT01294579|529745516|FG000|Overall Study|Physician Decision|3|||
146884314|NCT01294579|529745516|FG000|Overall Study|Withdrawal by Subject|5|||
146884315|NCT04472429|529745517|FG000|Randomized Period|Ongoing|90|||
146884316|NCT04472429|529745518|FG001|Randomized Period|Ongoing|40|||
146884317|NCT04472429|529745519|FG002|Randomized Period|Ongoing|0|||
146884318|NCT04472429|529745517|FG000|Randomized Period|Death|52|||
146884319|NCT04472429|529745518|FG001|Randomized Period|Death|37|||
146884320|NCT04472429|529745519|FG002|Randomized Period|Death|0|||
146884321|NCT04472429|529745517|FG000|Randomized Period|Lost to Follow-up|4|||
146884322|NCT04472429|529745518|FG001|Randomized Period|Lost to Follow-up|0|||
146884323|NCT04472429|529745519|FG002|Randomized Period|Lost to Follow-up|0|||
146884324|NCT04472429|529745517|FG000|Randomized Period|Physician Decision|1|||
146884325|NCT04472429|529745518|FG001|Randomized Period|Physician Decision|2|||
146884326|NCT04472429|529745519|FG002|Randomized Period|Physician Decision|0|||
146884327|NCT04472429|529745517|FG000|Randomized Period|Withdrawal by Subject|6|||
146884328|NCT04472429|529745518|FG001|Randomized Period|Withdrawal by Subject|5|||
146884329|NCT04472429|529745519|FG002|Randomized Period|Withdrawal by Subject|0|||
146884330|NCT04472429|529745517|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
146884331|NCT04472429|529745518|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
146547807|NCT01028053|528512643|FG000|Overall Study|Terminated by Sponsor|1|||
146547808|NCT01028053|528512643|FG000|Overall Study|Various reasons|4|||
146884332|NCT04472429|529745519|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
146884333|NCT04472429|529745517|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
146884334|NCT04472429|529745518|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
146884335|NCT04472429|529745519|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
146884336|NCT04472429|529745517|FG000|Open-label Monotherapy Period|Ongoing|0|||
146884337|NCT04472429|529745518|FG001|Open-label Monotherapy Period|Ongoing|0|||
146884338|NCT04472429|529745519|FG002|Open-label Monotherapy Period|Ongoing|32|||
146884339|NCT04472429|529745517|FG000|Open-label Monotherapy Period|Death|0|||
146547809|NCT01913470|528512650|FG000|Overall Study|Lost to Follow-up|0|||
146547810|NCT01913470|528512651|FG001|Overall Study|Lost to Follow-up|1|||
146547811|NCT01913470|528512650|FG000|Overall Study|Physician Decision|0|||
146547812|NCT01913470|528512651|FG001|Overall Study|Physician Decision|1|||
146547813|NCT01913470|528512650|FG000|Overall Study|Withdrawal by Subject|0|||
146884340|NCT04472429|529745518|FG001|Open-label Monotherapy Period|Death|0|||
146884341|NCT04472429|529745519|FG002|Open-label Monotherapy Period|Death|35|||
146884342|NCT04472429|529745517|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
146884343|NCT04472429|529745518|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
146884344|NCT04472429|529745519|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
146884345|NCT01180660|529745520|FG000|Overall Study|Changed to open surgery|1|||
146884346|NCT01180660|529745521|FG001|Overall Study|Changed to open surgery|0|||
146884347|NCT00262873|529745522|FG000|Overall Study|Adverse Event|3|||
146547814|NCT01913470|528512651|FG001|Overall Study|Withdrawal by Subject|1|||
146884348|NCT00262873|529745522|FG000|Overall Study|Withdrawal by Subject|5|||
146884349|NCT05130463|529745523|FG000|Overall Study|Unspecified reasons|2|||
146884350|NCT05130463|529745523|FG000|Overall Study|off-label indication dose|435|||
146884351|NCT00844753|529745524|FG000|Overall Study|Lack of Efficacy|1|||
146547815|NCT00245570|528512652|FG000|Washout Between Periods III and IV|Adverse Event|0|||
146630618|NCT03038100|528826079|FG000|Overall Study|Lost to Follow-up|9|||
146630619|NCT03038100|528826080|FG001|Overall Study|Lost to Follow-up|10|||
146630620|NCT03038100|528826079|FG000|Overall Study|Protocol Deviation|1|||
146630621|NCT03038100|528826080|FG001|Overall Study|Protocol Deviation|4|||
146630622|NCT03038100|528826079|FG000|Overall Study|Withdrawal by Subject|45|||
146630623|NCT03038100|528826080|FG001|Overall Study|Withdrawal by Subject|51|||
146630624|NCT03038100|528826079|FG000|Overall Study|Study Terminated By Sponsor|305|||
146630625|NCT03038100|528826080|FG001|Overall Study|Study Terminated By Sponsor|311|||
146630626|NCT03038100|528826079|FG000|Overall Study|Physician Decision|1|||
146630627|NCT03038100|528826080|FG001|Overall Study|Physician Decision|3|||
146630628|NCT03250273|528826113|FG000|Overall Study|Disease Progression|2|||
146630629|NCT03250273|528826114|FG001|Overall Study|Disease Progression|11|||
146630630|NCT03250273|528826113|FG000|Overall Study|Death|0|||
146630631|NCT03250273|528826114|FG001|Overall Study|Death|1|||
146630632|NCT04154904|528826115|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
146630633|NCT04154904|528826116|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
146630634|NCT04154904|528826117|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
146630635|NCT02392624|528826118|FG000|Overall Study|Withdrawal by Subject|15|||
146630636|NCT02392624|528826119|FG001|Overall Study|Withdrawal by Subject|12|||
146630637|NCT02392624|528826120|FG002|Overall Study|Withdrawal by Subject|9|||
146630638|NCT02392624|528826118|FG000|Overall Study|Adverse Event|4|||
146630639|NCT02392624|528826119|FG001|Overall Study|Adverse Event|1|||
146630640|NCT02392624|528826120|FG002|Overall Study|Adverse Event|2|||
146630641|NCT02392624|528826118|FG000|Overall Study|Pregnancy|1|||
146630642|NCT02392624|528826119|FG001|Overall Study|Pregnancy|0|||
146630643|NCT02392624|528826120|FG002|Overall Study|Pregnancy|0|||
146630644|NCT02392624|528826118|FG000|Overall Study|Protocol Violation|0|||
146630645|NCT02392624|528826119|FG001|Overall Study|Protocol Violation|0|||
146630646|NCT02392624|528826120|FG002|Overall Study|Protocol Violation|1|||
146630647|NCT02392624|528826118|FG000|Overall Study|Sponsor/Investigator Decision|2|||
146630648|NCT02392624|528826119|FG001|Overall Study|Sponsor/Investigator Decision|1|||
146630649|NCT02392624|528826120|FG002|Overall Study|Sponsor/Investigator Decision|0|||
146630650|NCT02392624|528826118|FG000|Overall Study|Other|49|||
146630651|NCT02392624|528826119|FG001|Overall Study|Other|1|||
146630652|NCT02392624|528826120|FG002|Overall Study|Other|1|||
146630653|NCT00936715|528826121|FG000|Overall Study|Investigators Discretion|1|||
146630654|NCT00936715|528826121|FG000|Overall Study|Protocol Violation|1|||
146630655|NCT00936715|528826121|FG000|Overall Study|Safety or Tolerability Reasons|4|||
146630656|NCT03841604|528826122|FG000|Overall Study|Withdrawal by Subject|3|||
146630657|NCT03841604|528826123|FG001|Overall Study|Withdrawal by Subject|1|||
146630658|NCT03841604|528826122|FG000|Overall Study|Adverse Event|4|||
146630659|NCT03841604|528826123|FG001|Overall Study|Adverse Event|2|||
146630660|NCT03841604|528826122|FG000|Overall Study|Physician Decision|1|||
146630661|NCT03841604|528826123|FG001|Overall Study|Physician Decision|0|||
146630662|NCT02492763|528826124|FG000|Overall Study|Withdrawal by Subject|0|||
146630663|NCT02492763|528826125|FG001|Overall Study|Withdrawal by Subject|2|||
146630664|NCT02492763|528826126|FG002|Overall Study|Withdrawal by Subject|1|||
146630665|NCT02492763|528826127|FG003|Overall Study|Withdrawal by Subject|0|||
146630666|NCT02492763|528826124|FG000|Overall Study|Adverse Event|3|||
146630667|NCT02492763|528826125|FG001|Overall Study|Adverse Event|1|||
146630668|NCT02492763|528826126|FG002|Overall Study|Adverse Event|1|||
146630669|NCT02492763|528826127|FG003|Overall Study|Adverse Event|2|||
146630670|NCT02492763|528826124|FG000|Overall Study|Death|0|||
146630671|NCT02492763|528826125|FG001|Overall Study|Death|0|||
146765096|NCT03612804|529307246|FG001|Overall Study|Withdrawal by Subject|0|||
146765097|NCT03612804|529307247|FG002|Overall Study|Withdrawal by Subject|7|||
146765098|NCT03612804|529307248|FG003|Overall Study|Withdrawal by Subject|0|||
146884352|NCT00844753|529745525|FG001|Overall Study|Lack of Efficacy|0|||
146884353|NCT00844753|529745526|FG002|Overall Study|Lack of Efficacy|2|||
146884354|NCT00844753|529745527|FG003|Overall Study|Lack of Efficacy|2|||
146884355|NCT00844753|529745524|FG000|Overall Study|Adverse Event|3|||
146630672|NCT02492763|528826126|FG002|Overall Study|Death|1|||
146630673|NCT02492763|528826127|FG003|Overall Study|Death|0|||
146630674|NCT02492763|528826124|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
146884356|NCT00844753|529745525|FG001|Overall Study|Adverse Event|2|||
146630675|NCT02492763|528826125|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
146630676|NCT02492763|528826126|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
146630677|NCT02492763|528826127|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
146630678|NCT02492763|528826124|FG000|Overall Study|Lost to Follow-up|0|||
146765099|NCT03612804|529307245|FG000|Overall Study|Provider involved with study activities|1|||
146884357|NCT00844753|529745526|FG002|Overall Study|Adverse Event|5|||
146884358|NCT00844753|529745527|FG003|Overall Study|Adverse Event|5|||
146884359|NCT00844753|529745524|FG000|Overall Study|Lost to Follow-up|1|||
146884360|NCT00844753|529745525|FG001|Overall Study|Lost to Follow-up|1|||
146884361|NCT00844753|529745526|FG002|Overall Study|Lost to Follow-up|0|||
146884362|NCT00844753|529745527|FG003|Overall Study|Lost to Follow-up|1|||
146884363|NCT00844753|529745524|FG000|Overall Study|could not swallow medication|2|||
146884364|NCT00844753|529745525|FG001|Overall Study|could not swallow medication|0|||
146884365|NCT00844753|529745526|FG002|Overall Study|could not swallow medication|0|||
146884366|NCT00844753|529745527|FG003|Overall Study|could not swallow medication|0|||
146884367|NCT00844753|529745524|FG000|Overall Study|Withdrawal by Subject|1|||
146884368|NCT00844753|529745525|FG001|Overall Study|Withdrawal by Subject|0|||
146884369|NCT00844753|529745526|FG002|Overall Study|Withdrawal by Subject|0|||
146884370|NCT00844753|529745527|FG003|Overall Study|Withdrawal by Subject|3|||
146884371|NCT03440814|529745530|FG000|Overall Study|Adverse Event|2|||
146884372|NCT03440814|529745531|FG001|Overall Study|Adverse Event|1|||
146884373|NCT03440814|529745530|FG000|Overall Study|Lost to Follow-up|2|||
146884374|NCT03440814|529745531|FG001|Overall Study|Lost to Follow-up|0|||
146884375|NCT03440814|529745530|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
146884376|NCT03440814|529745531|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
146884377|NCT00088374|529745532|FG000|Overall Study|patient did not receive any 17AAG|1|||
146884378|NCT00088374|529745532|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
146884379|NCT00852995|529745533|FG000|Overall Study|Adverse Event|1|||
146884380|NCT00852995|529745534|FG001|Overall Study|Adverse Event|0|||
146884381|NCT00852995|529745535|FG002|Overall Study|Adverse Event|4|||
146884382|NCT00852995|529745536|FG003|Overall Study|Adverse Event|0|||
146884383|NCT00852995|529745537|FG004|Overall Study|Adverse Event|0|||
146884384|NCT00852995|529745533|FG000|Overall Study|Lost to Follow-up|0|||
146884385|NCT00852995|529745534|FG001|Overall Study|Lost to Follow-up|1|||
146884386|NCT00852995|529745535|FG002|Overall Study|Lost to Follow-up|1|||
146884387|NCT00852995|529745536|FG003|Overall Study|Lost to Follow-up|0|||
146884388|NCT00852995|529745537|FG004|Overall Study|Lost to Follow-up|0|||
146884389|NCT00852995|529745533|FG000|Overall Study|Withdrawal by Subject|4|||
146884390|NCT00852995|529745534|FG001|Overall Study|Withdrawal by Subject|0|||
146884391|NCT00852995|529745535|FG002|Overall Study|Withdrawal by Subject|0|||
146884392|NCT00852995|529745536|FG003|Overall Study|Withdrawal by Subject|1|||
146884393|NCT00852995|529745537|FG004|Overall Study|Withdrawal by Subject|2|||
146884394|NCT00852995|529745533|FG000|Overall Study|Non-Compliance|0|||
146884395|NCT00852995|529745534|FG001|Overall Study|Non-Compliance|0|||
146884396|NCT00852995|529745535|FG002|Overall Study|Non-Compliance|0|||
146884397|NCT00852995|529745536|FG003|Overall Study|Non-Compliance|2|||
146884398|NCT00852995|529745537|FG004|Overall Study|Non-Compliance|0|||
146884399|NCT00852995|529745533|FG000|Overall Study|Progressive Disease|1|||
146884400|NCT00852995|529745534|FG001|Overall Study|Progressive Disease|0|||
146884401|NCT00852995|529745535|FG002|Overall Study|Progressive Disease|0|||
146884402|NCT00852995|529745536|FG003|Overall Study|Progressive Disease|2|||
146884403|NCT00852995|529745537|FG004|Overall Study|Progressive Disease|1|||
146884404|NCT00852995|529745533|FG000|Overall Study|Physician Decision|1|||
146884405|NCT00852995|529745534|FG001|Overall Study|Physician Decision|0|||
146884406|NCT00852995|529745535|FG002|Overall Study|Physician Decision|0|||
146884407|NCT00852995|529745536|FG003|Overall Study|Physician Decision|0|||
146884408|NCT00852995|529745537|FG004|Overall Study|Physician Decision|0|||
146884409|NCT00852995|529745533|FG000|Overall Study|Protocol Violation|0|||
146884410|NCT00852995|529745534|FG001|Overall Study|Protocol Violation|0|||
146884411|NCT00852995|529745535|FG002|Overall Study|Protocol Violation|0|||
146884412|NCT00852995|529745536|FG003|Overall Study|Protocol Violation|0|||
146884413|NCT00852995|529745537|FG004|Overall Study|Protocol Violation|1|||
146884414|NCT00852995|529745533|FG000|Overall Study|Moved Out of Area|1|||
146884415|NCT00852995|529745534|FG001|Overall Study|Moved Out of Area|0|||
146884416|NCT00852995|529745535|FG002|Overall Study|Moved Out of Area|0|||
146884417|NCT00852995|529745536|FG003|Overall Study|Moved Out of Area|0|||
146884418|NCT00852995|529745537|FG004|Overall Study|Moved Out of Area|0|||
146884419|NCT03595553|529745538|FG000|Overall Study|Withdrawal by Subject|20|||
146884420|NCT03595553|529745539|FG001|Overall Study|Withdrawal by Subject|8|||
146884421|NCT03595553|529745538|FG000|Overall Study|Physician Decision|3|||
146884422|NCT03595553|529745539|FG001|Overall Study|Physician Decision|2|||
146884423|NCT03595553|529745538|FG000|Overall Study|Adverse Event|2|||
146884424|NCT03595553|529745539|FG001|Overall Study|Adverse Event|5|||
146884425|NCT03595553|529745538|FG000|Overall Study|Death|24|||
146884426|NCT03595553|529745539|FG001|Overall Study|Death|22|||
146884427|NCT03595553|529745538|FG000|Overall Study|Lost to Follow-up|6|||
146884428|NCT03595553|529745539|FG001|Overall Study|Lost to Follow-up|7|||
146884429|NCT03595553|529745538|FG000|Overall Study|Other as indicated in CSR|3|||
146884430|NCT03595553|529745539|FG001|Overall Study|Other as indicated in CSR|3|||
146884431|NCT03595553|529745538|FG000|Overall Study|Sponsor Decision|0|||
146884432|NCT03595553|529745539|FG001|Overall Study|Sponsor Decision|1|||
146884433|NCT05073458|529745546|FG000|24-week Double-blind Period|Adverse Event|1|||
146884434|NCT05073458|529745547|FG001|24-week Double-blind Period|Adverse Event|0|||
146884435|NCT05073458|529745546|FG000|24-week Double-blind Period|Physician Decision|1|||
146884436|NCT05073458|529745547|FG001|24-week Double-blind Period|Physician Decision|0|||
146884437|NCT05073458|529745546|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
146884438|NCT05073458|529745547|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
146884439|NCT05073458|529745546|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
146884440|NCT05073458|529745547|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
146884441|NCT05073458|529745546|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
146884442|NCT05073458|529745547|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
146884443|NCT05073458|529745546|FG000|24-week Open-label Period|Adverse Event|1|||
146884444|NCT05073458|529745547|FG001|24-week Open-label Period|Adverse Event|2|||
146884445|NCT01632566|529745548|FG000|Overall Study|Withdrawal by Subject|0|||
146884446|NCT01632566|529745549|FG001|Overall Study|Withdrawal by Subject|1|||
146884447|NCT01632566|529745550|FG002|Overall Study|Withdrawal by Subject|0|||
146884448|NCT01632566|529745551|FG003|Overall Study|Withdrawal by Subject|0|||
146884449|NCT01632566|529745552|FG004|Overall Study|Withdrawal by Subject|0|||
146884450|NCT01632566|529745548|FG000|Overall Study|Sponsor Decision|0|||
146884451|NCT01632566|529745549|FG001|Overall Study|Sponsor Decision|2|||
146884452|NCT01632566|529745550|FG002|Overall Study|Sponsor Decision|9|||
146884453|NCT01632566|529745551|FG003|Overall Study|Sponsor Decision|2|||
146884454|NCT01632566|529745552|FG004|Overall Study|Sponsor Decision|2|||
146884455|NCT02158091|529745560|FG000|Overall Study|DLT|2|||
146884456|NCT02158091|529745561|FG001|Overall Study|DLT|1|||
146884457|NCT02158091|529745562|FG002|Overall Study|DLT|0|||
146884458|NCT05913232|529745563|FG000|Overall Study|Adverse Event|0|||
146884459|NCT05913232|529745564|FG001|Overall Study|Adverse Event|2|||
146884460|NCT05913232|529745565|FG002|Overall Study|Adverse Event|1|||
146884461|NCT05913232|529745566|FG003|Overall Study|Adverse Event|1|||
146884462|NCT01318109|529745567|FG000|Overall Study|Adverse Event|0|||
146884463|NCT01318109|529745568|FG001|Overall Study|Adverse Event|2|||
146884464|NCT01318109|529745569|FG002|Overall Study|Adverse Event|0|||
146884465|NCT01318109|529745567|FG000|Overall Study|Withdrawal by Subject|1|||
146884466|NCT01318109|529745568|FG001|Overall Study|Withdrawal by Subject|0|||
146884467|NCT01318109|529745569|FG002|Overall Study|Withdrawal by Subject|0|||
146884468|NCT01318109|529745567|FG000|Overall Study|Schedule Conflict|0|||
146884469|NCT01318109|529745568|FG001|Overall Study|Schedule Conflict|1|||
146884470|NCT01318109|529745569|FG002|Overall Study|Schedule Conflict|0|||
146884471|NCT01328951|529745570|FG000|Overall Study|Disease Progression|17|||
146884472|NCT01328951|529745571|FG001|Overall Study|Disease Progression|14|||
146884473|NCT01328951|529745570|FG000|Overall Study|Adverse Event|2|||
146884474|NCT01328951|529745571|FG001|Overall Study|Adverse Event|0|||
146884475|NCT01328951|529745570|FG000|Overall Study|Death|243|||
146884476|NCT01328951|529745571|FG001|Overall Study|Death|258|||
146884477|NCT01328951|529745570|FG000|Overall Study|Lost to Follow-up|6|||
146884478|NCT01328951|529745571|FG001|Overall Study|Lost to Follow-up|7|||
146884479|NCT01328951|529745570|FG000|Overall Study|Withdrawal by Subject|6|||
146884480|NCT01328951|529745571|FG001|Overall Study|Withdrawal by Subject|6|||
146884481|NCT01328951|529745570|FG000|Overall Study|Study Closed by the Sponsor|36|||
146884482|NCT01328951|529745571|FG001|Overall Study|Study Closed by the Sponsor|31|||
146884483|NCT01328951|529745570|FG000|Overall Study|Other|11|||
146884484|NCT01328951|529745571|FG001|Overall Study|Other|6|||
146884485|NCT01627899|529745577|FG000|Overall Study|Study terminated early by sponsor.|5|||
146884486|NCT04428476|529745578|FG000|Overall Study|Withdrawal by Subject|1|||
146884487|NCT04428476|529745578|FG000|Overall Study|Still on treatment|12|||
146884488|NCT04982250|529745580|FG000|Overall Study|Lost to Follow-up|0|||
146884489|NCT04982250|529745581|FG001|Overall Study|Lost to Follow-up|26|||
146884490|NCT04982250|529745582|FG002|Overall Study|Lost to Follow-up|0|||
146884491|NCT04982250|529745583|FG003|Overall Study|Lost to Follow-up|0|||
146884492|NCT04982250|529745584|FG004|Overall Study|Lost to Follow-up|72|||
146884493|NCT04982250|529745585|FG005|Overall Study|Lost to Follow-up|69|||
146884494|NCT04982250|529745580|FG000|Overall Study|Not Eligible to Enroll|0|||
146884495|NCT04982250|529745581|FG001|Overall Study|Not Eligible to Enroll|0|||
146884496|NCT04982250|529745582|FG002|Overall Study|Not Eligible to Enroll|0|||
146884497|NCT04982250|529745583|FG003|Overall Study|Not Eligible to Enroll|0|||
146884498|NCT04982250|529745584|FG004|Overall Study|Not Eligible to Enroll|10|||
146884499|NCT04982250|529745585|FG005|Overall Study|Not Eligible to Enroll|7|||
146884500|NCT01358864|529745588|FG000|Overall Study|Adverse Event|0|||
146884501|NCT01358864|529745589|FG001|Overall Study|Adverse Event|6|||
146884502|NCT01358864|529745590|FG002|Overall Study|Adverse Event|9|||
146884503|NCT01358864|529745591|FG003|Overall Study|Adverse Event|0|||
146547816|NCT00245570|528512653|FG001|Washout Between Periods III and IV|Adverse Event|1|||
146547817|NCT00245570|528512654|FG002|Washout Between Periods III and IV|Adverse Event|0|||
146547818|NCT00245570|528512655|FG003|Washout Between Periods III and IV|Adverse Event|0|||
146547819|NCT00245570|528512656|FG004|Washout Between Periods III and IV|Adverse Event|0|||
146547820|NCT00245570|528512657|FG005|Washout Between Periods III and IV|Adverse Event|0|||
146630679|NCT02492763|528826125|FG001|Overall Study|Lost to Follow-up|0|||
146630680|NCT02492763|528826126|FG002|Overall Study|Lost to Follow-up|1|||
146630681|NCT02492763|528826127|FG003|Overall Study|Lost to Follow-up|0|||
146630682|NCT02492763|528826124|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146630683|NCT02492763|528826125|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146630684|NCT02492763|528826126|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146630685|NCT02492763|528826127|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146630686|NCT02492763|528826124|FG000|Overall Study|Screen Failure|0|||
146630687|NCT02492763|528826125|FG001|Overall Study|Screen Failure|0|||
146630688|NCT02492763|528826126|FG002|Overall Study|Screen Failure|0|||
146630689|NCT02492763|528826127|FG003|Overall Study|Screen Failure|1|||
146630690|NCT02492763|528826124|FG000|Overall Study|Study Terminated by Sponsor|13|||
146630691|NCT02492763|528826125|FG001|Overall Study|Study Terminated by Sponsor|10|||
146630692|NCT02492763|528826126|FG002|Overall Study|Study Terminated by Sponsor|6|||
146630693|NCT02492763|528826127|FG003|Overall Study|Study Terminated by Sponsor|10|||
146630694|NCT03877510|528826128|FG000|Overall Study|Death|6|||
146630695|NCT03877510|528826128|FG000|Overall Study|Lost to Follow-up|2|||
146630696|NCT03877510|528826128|FG000|Overall Study|Non-compliance with study drug|2|||
146630697|NCT03877510|528826128|FG000|Overall Study|Lack of Efficacy|14|||
146630698|NCT03877510|528826128|FG000|Overall Study|Adverse Event|20|||
146630699|NCT03877510|528826128|FG000|Overall Study|Withdrawal by Subject|22|||
146630700|NCT03877510|528826128|FG000|Overall Study|Miscellaneous|1|||
146630701|NCT01337960|528826129|FG000|Overall Study|Lost to Follow-up|1|||
146630702|NCT01337960|528826130|FG001|Overall Study|Lost to Follow-up|0|||
146884504|NCT01358864|529745592|FG004|Overall Study|Adverse Event|4|||
146547821|NCT02384460|528512681|FG000|Overall Study|Protocol Violation|0|||
146547822|NCT02384460|528512682|FG001|Overall Study|Protocol Violation|1|||
146547823|NCT02384460|528512681|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
146547824|NCT02384460|528512682|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
146547825|NCT02384460|528512681|FG000|Overall Study|Adverse Event|5|||
146547826|NCT02384460|528512682|FG001|Overall Study|Adverse Event|2|||
146547827|NCT02384460|528512681|FG000|Overall Study|Withdrawal by Subject|0|||
146547828|NCT02384460|528512682|FG001|Overall Study|Withdrawal by Subject|3|||
146547829|NCT02384460|528512681|FG000|Overall Study|Elective medical treatment|1|||
146547830|NCT02384460|528512682|FG001|Overall Study|Elective medical treatment|0|||
146547831|NCT02384460|528512681|FG000|Overall Study|Non-compliance|1|||
146547832|NCT02384460|528512682|FG001|Overall Study|Non-compliance|0|||
146547833|NCT02400580|528512685|FG000|Overall Study|Withdrawal by Subject|1|||
146630703|NCT01337960|528826131|FG002|Overall Study|Lost to Follow-up|0|||
146630704|NCT01337960|528826129|FG000|Overall Study|Withdrawal by Subject|1|||
146630705|NCT01337960|528826130|FG001|Overall Study|Withdrawal by Subject|0|||
146765100|NCT03612804|529307246|FG001|Overall Study|Provider involved with study activities|0|||
146765101|NCT03612804|529307247|FG002|Overall Study|Provider involved with study activities|0|||
146765102|NCT03612804|529307248|FG003|Overall Study|Provider involved with study activities|0|||
146765103|NCT01656304|529307249|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
146765104|NCT04391309|529307250|FG000|Overall Study|Death|1|||
146884505|NCT01358864|529745593|FG005|Overall Study|Adverse Event|8|||
146884506|NCT01358864|529745594|FG006|Overall Study|Adverse Event|12|||
146547834|NCT02400580|528512686|FG001|Overall Study|Withdrawal by Subject|1|||
146547835|NCT02400580|528512685|FG000|Overall Study|Adverse Event|1|||
146547836|NCT02400580|528512686|FG001|Overall Study|Adverse Event|0|||
146630706|NCT01337960|528826131|FG002|Overall Study|Withdrawal by Subject|0|||
146630707|NCT02085161|528826133|FG000|Overall Study|Not Treated|1|||
146630708|NCT02085161|528826134|FG001|Overall Study|Not Treated|0|||
146765105|NCT04391309|529307251|FG001|Overall Study|Death|1|||
146765106|NCT04391309|529307250|FG000|Overall Study|Lost to Follow-up|3|||
146765107|NCT04391309|529307251|FG001|Overall Study|Lost to Follow-up|2|||
146765108|NCT04391309|529307250|FG000|Overall Study|Withdrawal by Subject|2|||
146765109|NCT04391309|529307251|FG001|Overall Study|Withdrawal by Subject|2|||
146765110|NCT00881335|529307252|FG000|Overall Study|Lost to Follow-up|3|||
146765111|NCT00881335|529307253|FG001|Overall Study|Lost to Follow-up|2|||
146765112|NCT00554801|529307255|FG000|Overall Study|left area before completion|5|||
146765113|NCT00554801|529307256|FG001|Overall Study|left area before completion|0|||
146765114|NCT00554801|529307255|FG000|Overall Study|Withdrawal by Subject|14|||
146765115|NCT00554801|529307256|FG001|Overall Study|Withdrawal by Subject|0|||
146765116|NCT05826431|529307257|FG000|Overall Study|Withdrawal by Subject|1|||
146765117|NCT02104765|529307260|FG000|Overall Study|Lost to Follow-up|0|||
146765118|NCT02104765|529307261|FG001|Overall Study|Lost to Follow-up|0|||
146765119|NCT02104765|529307262|FG002|Overall Study|Lost to Follow-up|1|||
146765120|NCT02104765|529307263|FG003|Overall Study|Lost to Follow-up|0|||
146765121|NCT02104765|529307264|FG004|Overall Study|Lost to Follow-up|0|||
146765122|NCT02104765|529307265|FG005|Overall Study|Lost to Follow-up|0|||
146765123|NCT02104765|529307266|FG006|Overall Study|Lost to Follow-up|0|||
146547837|NCT00965094|528512687|FG000|Overall Study|Adverse Event|5|||
146547838|NCT00965094|528512688|FG001|Overall Study|Adverse Event|0|||
146547839|NCT00965094|528512687|FG000|Overall Study|Lost to Follow-up|0|||
146547840|NCT00965094|528512688|FG001|Overall Study|Lost to Follow-up|1|||
146547841|NCT01060111|528512689|FG000|Overall Study|Adverse Event|9|||
146547842|NCT01060111|528512690|FG001|Overall Study|Adverse Event|5|||
146547843|NCT01060111|528512691|FG002|Overall Study|Adverse Event|18|||
146547844|NCT01060111|528512689|FG000|Overall Study|Lack of Efficacy|2|||
146547845|NCT01060111|528512690|FG001|Overall Study|Lack of Efficacy|1|||
146547846|NCT01060111|528512691|FG002|Overall Study|Lack of Efficacy|0|||
146547847|NCT01060111|528512689|FG000|Overall Study|Inappropriate participant|5|||
146547848|NCT01060111|528512690|FG001|Overall Study|Inappropriate participant|4|||
146547849|NCT01060111|528512691|FG002|Overall Study|Inappropriate participant|5|||
146547850|NCT01060111|528512689|FG000|Overall Study|Participants' evasion for hospital visit|0|||
146547851|NCT01060111|528512690|FG001|Overall Study|Participants' evasion for hospital visit|3|||
146547852|NCT01060111|528512691|FG002|Overall Study|Participants' evasion for hospital visit|2|||
146547853|NCT01060111|528512689|FG000|Overall Study|Participants' non-cooperation|8|||
146547854|NCT01060111|528512690|FG001|Overall Study|Participants' non-cooperation|6|||
146547855|NCT01060111|528512691|FG002|Overall Study|Participants' non-cooperation|6|||
146547856|NCT01060111|528512689|FG000|Overall Study|Adverse event and insufficient effect|0|||
146547857|NCT01060111|528512690|FG001|Overall Study|Adverse event and insufficient effect|1|||
146547858|NCT01060111|528512691|FG002|Overall Study|Adverse event and insufficient effect|0|||
146547859|NCT01060111|528512689|FG000|Overall Study|Participants' non-cooperation|1|||
146547860|NCT01060111|528512690|FG001|Overall Study|Participants' non-cooperation|0|||
146547861|NCT01060111|528512691|FG002|Overall Study|Participants' non-cooperation|0|||
146547862|NCT01060111|528512689|FG000|Overall Study|Other|2|||
146547863|NCT01060111|528512690|FG001|Overall Study|Other|3|||
146547864|NCT01060111|528512691|FG002|Overall Study|Other|4|||
146547865|NCT01336972|528512694|FG000|Overall Study|Adverse Event|1|||
146547866|NCT01336972|528512695|FG001|Overall Study|Adverse Event|1|||
146547867|NCT01336972|528512696|FG002|Overall Study|Adverse Event|0|||
146547868|NCT02441114|528512700|FG000|Washout2|Withdrawal by Subject|4|||
146547869|NCT03446573|528512702|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
146547870|NCT03446573|528512703|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
146765124|NCT02104765|529307260|FG000|Overall Study|Withdrawal by Subject|0|||
146765125|NCT02104765|529307261|FG001|Overall Study|Withdrawal by Subject|0|||
146765126|NCT02104765|529307262|FG002|Overall Study|Withdrawal by Subject|0|||
146765127|NCT02104765|529307263|FG003|Overall Study|Withdrawal by Subject|1|||
146765128|NCT02104765|529307264|FG004|Overall Study|Withdrawal by Subject|1|||
146884507|NCT01358864|529745595|FG007|Overall Study|Adverse Event|7|||
146884508|NCT01358864|529745588|FG000|Overall Study|Lack of Efficacy|26|||
146884509|NCT01358864|529745589|FG001|Overall Study|Lack of Efficacy|3|||
146884510|NCT01358864|529745590|FG002|Overall Study|Lack of Efficacy|4|||
146884511|NCT01358864|529745591|FG003|Overall Study|Lack of Efficacy|19|||
146884512|NCT01358864|529745592|FG004|Overall Study|Lack of Efficacy|7|||
146884513|NCT01358864|529745593|FG005|Overall Study|Lack of Efficacy|4|||
146884514|NCT01358864|529745594|FG006|Overall Study|Lack of Efficacy|49|||
146884515|NCT01358864|529745595|FG007|Overall Study|Lack of Efficacy|44|||
146884516|NCT01358864|529745588|FG000|Overall Study|Lost to Follow-up|0|||
146884517|NCT01358864|529745589|FG001|Overall Study|Lost to Follow-up|0|||
146884518|NCT01358864|529745590|FG002|Overall Study|Lost to Follow-up|1|||
146884519|NCT01358864|529745591|FG003|Overall Study|Lost to Follow-up|0|||
146884520|NCT01358864|529745592|FG004|Overall Study|Lost to Follow-up|0|||
146884521|NCT01358864|529745593|FG005|Overall Study|Lost to Follow-up|0|||
146884522|NCT01358864|529745594|FG006|Overall Study|Lost to Follow-up|0|||
146884523|NCT01358864|529745595|FG007|Overall Study|Lost to Follow-up|1|||
146884524|NCT01358864|529745588|FG000|Overall Study|Withdrawal by Subject|3|||
146884525|NCT01358864|529745589|FG001|Overall Study|Withdrawal by Subject|4|||
146884526|NCT01358864|529745590|FG002|Overall Study|Withdrawal by Subject|2|||
146884527|NCT01358864|529745591|FG003|Overall Study|Withdrawal by Subject|0|||
146884528|NCT01358864|529745592|FG004|Overall Study|Withdrawal by Subject|0|||
146884529|NCT01358864|529745593|FG005|Overall Study|Withdrawal by Subject|1|||
146884530|NCT01358864|529745594|FG006|Overall Study|Withdrawal by Subject|1|||
146884531|NCT01358864|529745595|FG007|Overall Study|Withdrawal by Subject|3|||
146884532|NCT01358864|529745588|FG000|Overall Study|Other reason not defined above|2|||
146884533|NCT01358864|529745589|FG001|Overall Study|Other reason not defined above|0|||
146884534|NCT01358864|529745590|FG002|Overall Study|Other reason not defined above|0|||
146884535|NCT01358864|529745591|FG003|Overall Study|Other reason not defined above|0|||
146884536|NCT01358864|529745592|FG004|Overall Study|Other reason not defined above|0|||
146884537|NCT01358864|529745593|FG005|Overall Study|Other reason not defined above|0|||
146884538|NCT01358864|529745594|FG006|Overall Study|Other reason not defined above|2|||
146884539|NCT01358864|529745595|FG007|Overall Study|Other reason not defined above|0|||
146884540|NCT01358864|529745588|FG000|Overall Study|Not treated|0|||
146884541|NCT01358864|529745589|FG001|Overall Study|Not treated|0|||
146884542|NCT01358864|529745590|FG002|Overall Study|Not treated|0|||
146884543|NCT01358864|529745591|FG003|Overall Study|Not treated|0|||
146884544|NCT01358864|529745592|FG004|Overall Study|Not treated|0|||
146884545|NCT01358864|529745593|FG005|Overall Study|Not treated|0|||
146884546|NCT01358864|529745594|FG006|Overall Study|Not treated|1|||
146884547|NCT01358864|529745595|FG007|Overall Study|Not treated|0|||
146884548|NCT04042103|529745600|FG000|Overall Study|Lost to Follow-up|1|||
146884549|NCT04042103|529745600|FG000|Overall Study|Withdrawal by Subject|1|||
146884550|NCT04518462|529745602|FG000|Overall Study|Withdrawal by Subject|0|||
146884551|NCT04518462|529745603|FG001|Overall Study|Withdrawal by Subject|0|||
146884552|NCT04518462|529745604|FG002|Overall Study|Withdrawal by Subject|1|||
146884553|NCT04518462|529745602|FG000|Overall Study|Physician Decision|1|||
146884554|NCT04518462|529745603|FG001|Overall Study|Physician Decision|1|||
146884555|NCT04518462|529745604|FG002|Overall Study|Physician Decision|0|||
146884556|NCT01003210|529745605|FG000|Overall Study|Lost to Follow-up|1|||
146884557|NCT01003210|529745606|FG001|Overall Study|Lost to Follow-up|3|||
146884558|NCT00271817|529745607|FG000|Part 1|Adverse Event|68|||
146884559|NCT00271817|529745608|FG001|Part 1|Adverse Event|25|||
146884560|NCT00271817|529745609|FG002|Part 1|Adverse Event|156|||
146884561|NCT00271817|529745607|FG000|Part 1|Lost to Follow-up|6|||
146884562|NCT00271817|529745608|FG001|Part 1|Lost to Follow-up|8|||
146884563|NCT00271817|529745609|FG002|Part 1|Lost to Follow-up|24|||
146884564|NCT00271817|529745607|FG000|Part 1|Protocol Violation|5|||
146884565|NCT00271817|529745608|FG001|Part 1|Protocol Violation|4|||
146884566|NCT00271817|529745609|FG002|Part 1|Protocol Violation|7|||
146630709|NCT02085161|528826135|FG002|Overall Study|Not Treated|0|||
146884567|NCT00271817|529745607|FG000|Part 1|Patient Moved|3|||
146884568|NCT00271817|529745608|FG001|Part 1|Patient Moved|1|||
146884569|NCT00271817|529745609|FG002|Part 1|Patient Moved|5|||
146630710|NCT02085161|528826136|FG003|Overall Study|Not Treated|0|||
146884570|NCT00271817|529745607|FG000|Part 1|Withdrawal by Subject|23|||
146884571|NCT00271817|529745608|FG001|Part 1|Withdrawal by Subject|17|||
146884572|NCT00271817|529745609|FG002|Part 1|Withdrawal by Subject|45|||
146884573|NCT00271817|529745607|FG000|Part 1|LDL < 50 mg/dL|1|||
146547871|NCT03446573|528512702|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
146547872|NCT03446573|528512703|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
146547873|NCT03446573|528512702|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
146547874|NCT03446573|528512703|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
146547875|NCT03446573|528512702|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
146547876|NCT03446573|528512703|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
146547877|NCT03446573|528512702|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
146547878|NCT03446573|528512703|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
146547879|NCT03446573|528512702|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
146547880|NCT03446573|528512703|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
146547881|NCT03446573|528512702|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
146547882|NCT03446573|528512703|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
146547883|NCT03446573|528512702|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
146547884|NCT03446573|528512703|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
146547885|NCT03446573|528512702|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
146547886|NCT03446573|528512703|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
146547887|NCT03446573|528512702|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
146547888|NCT03446573|528512703|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
146547889|NCT03446573|528512702|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
146547890|NCT03446573|528512703|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
146547891|NCT03446573|528512702|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
146547892|NCT03446573|528512703|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
146547893|NCT03446573|528512702|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
146547894|NCT03446573|528512703|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
146547895|NCT00625378|528512708|FG000|Overall Study|Adverse Event|22|||
146547896|NCT00625378|528512709|FG001|Overall Study|Adverse Event|0|||
146547897|NCT00625378|528512708|FG000|Overall Study|Withdrawal by Subject|16|||
146547898|NCT00625378|528512709|FG001|Overall Study|Withdrawal by Subject|0|||
146547899|NCT00625378|528512708|FG000|Overall Study|Death|38|||
146547900|NCT00625378|528512709|FG001|Overall Study|Death|0|||
146547901|NCT00625378|528512708|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
146547902|NCT00625378|528512709|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
146547903|NCT00625378|528512708|FG000|Overall Study|Lost to Follow-up|17|||
146547904|NCT00625378|528512709|FG001|Overall Study|Lost to Follow-up|0|||
146547905|NCT00625378|528512708|FG000|Overall Study|Non-compliant with study medication|3|||
146547906|NCT00625378|528512709|FG001|Overall Study|Non-compliant with study medication|0|||
146547907|NCT00625378|528512708|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
146547908|NCT00625378|528512709|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
146547909|NCT00625378|528512708|FG000|Overall Study|Medical decision|1|||
146547910|NCT00625378|528512709|FG001|Overall Study|Medical decision|0|||
146547911|NCT00625378|528512708|FG000|Overall Study|Multiple toxicities|1|||
146547912|NCT00625378|528512709|FG001|Overall Study|Multiple toxicities|0|||
146547913|NCT00625378|528512708|FG000|Overall Study|New cancer|1|||
146547914|NCT00625378|528512709|FG001|Overall Study|New cancer|0|||
146547915|NCT00625378|528512708|FG000|Overall Study|PTA program|2|||
146547916|NCT00625378|528512709|FG001|Overall Study|PTA program|0|||
146547917|NCT00625378|528512708|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
146547918|NCT00625378|528512709|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
146547919|NCT00625378|528512708|FG000|Overall Study|Sponsor decision|1|||
146547920|NCT00625378|528512709|FG001|Overall Study|Sponsor decision|0|||
146547921|NCT00625378|528512708|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
146547922|NCT00625378|528512709|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
146547923|NCT00625378|528512708|FG000|Overall Study|Switch to commercial drug|6|||
146547924|NCT00625378|528512709|FG001|Overall Study|Switch to commercial drug|1|||
146547925|NCT00625378|528512708|FG000|Overall Study|Missing|2|||
146547926|NCT00625378|528512709|FG001|Overall Study|Missing|0|||
146547927|NCT00625378|528512708|FG000|Overall Study|End of treatment not available|2|||
146547928|NCT00625378|528512709|FG001|Overall Study|End of treatment not available|0|||
146547929|NCT00625378|528512708|FG000|Overall Study|Never treated|2|||
146547930|NCT00625378|528512709|FG001|Overall Study|Never treated|0|||
146547931|NCT04270760|528512710|FG000|Overall Study|Withdrawal by Subject|0|||
146547932|NCT04270760|528512711|FG001|Overall Study|Withdrawal by Subject|1|||
146547933|NCT04270760|528512712|FG002|Overall Study|Withdrawal by Subject|3|||
146547934|NCT04270760|528512713|FG003|Overall Study|Withdrawal by Subject|0|||
146547935|NCT04270760|528512714|FG004|Overall Study|Withdrawal by Subject|0|||
146547936|NCT04270760|528512710|FG000|Overall Study|Lost to Follow-up|1|||
146630711|NCT02085161|528826133|FG000|Overall Study|Adverse Event|8|||
146630712|NCT02085161|528826134|FG001|Overall Study|Adverse Event|5|||
146630713|NCT02085161|528826135|FG002|Overall Study|Adverse Event|4|||
146630714|NCT02085161|528826136|FG003|Overall Study|Adverse Event|5|||
146630715|NCT02085161|528826133|FG000|Overall Study|Protocol Violation|0|||
146630716|NCT02085161|528826134|FG001|Overall Study|Protocol Violation|1|||
146630717|NCT02085161|528826135|FG002|Overall Study|Protocol Violation|0|||
146630718|NCT02085161|528826136|FG003|Overall Study|Protocol Violation|1|||
146630719|NCT02085161|528826133|FG000|Overall Study|Withdrawal by Subject|2|||
146630720|NCT02085161|528826134|FG001|Overall Study|Withdrawal by Subject|4|||
146630721|NCT02085161|528826135|FG002|Overall Study|Withdrawal by Subject|0|||
146630722|NCT02085161|528826136|FG003|Overall Study|Withdrawal by Subject|3|||
146630723|NCT02085161|528826133|FG000|Overall Study|Other Reason|1|||
146630724|NCT02085161|528826134|FG001|Overall Study|Other Reason|0|||
146630725|NCT02085161|528826135|FG002|Overall Study|Other Reason|1|||
146630726|NCT02085161|528826136|FG003|Overall Study|Other Reason|1|||
146630727|NCT01936870|528826141|FG000|Overall Study|No Visit After Treatment|176|||
146630728|NCT01936870|528826141|FG000|Overall Study|Protocol Violation|12|||
146630729|NCT01936870|528826141|FG000|Overall Study|No Drug Administration|1|||
146630730|NCT00628108|528826147|FG000|Overall Study|Adverse Event|0|||
146630731|NCT00628108|528826148|FG001|Overall Study|Adverse Event|3|||
146630732|NCT00628108|528826147|FG000|Overall Study|Withdrawal by Subject|1|||
146630733|NCT00628108|528826148|FG001|Overall Study|Withdrawal by Subject|0|||
146630734|NCT03848832|528826149|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
146630735|NCT03848832|528826150|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
146630736|NCT03848832|528826151|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
146630737|NCT03848832|528826149|FG000|Overall Study|Withdrawal by Subject|0|||
146630738|NCT03848832|528826150|FG001|Overall Study|Withdrawal by Subject|0|||
146630739|NCT03848832|528826151|FG002|Overall Study|Withdrawal by Subject|1|||
146630740|NCT03848832|528826149|FG000|Overall Study|Withdrawal (Covid-19)|0|||
146630741|NCT03848832|528826150|FG001|Overall Study|Withdrawal (Covid-19)|2|||
146630742|NCT03848832|528826151|FG002|Overall Study|Withdrawal (Covid-19)|0|||
146630743|NCT03848832|528826149|FG000|Overall Study|Physician Decision|2|||
146630744|NCT03848832|528826150|FG001|Overall Study|Physician Decision|1|||
146630745|NCT03848832|528826151|FG002|Overall Study|Physician Decision|3|||
146630746|NCT03848832|528826149|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
146630747|NCT03848832|528826150|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
146630748|NCT03848832|528826151|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
146630749|NCT03848832|528826149|FG000|Overall Study|Adverse Event|1|||
146630750|NCT03848832|528826150|FG001|Overall Study|Adverse Event|0|||
146630751|NCT03848832|528826151|FG002|Overall Study|Adverse Event|0|||
146630752|NCT00719472|528826153|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
146630753|NCT00719472|528826153|FG000|Enrolled in Study|Subject decision to withdraw|8|||
146630754|NCT00719472|528826153|FG000|Enrolled in Study|Various Reasons|17|||
146630755|NCT00719472|528826153|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
146630756|NCT00719472|528826153|FG000|Received Cycle 1 Treatment|Death|5|||
146630757|NCT00719472|528826153|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
146630758|NCT00719472|528826153|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
146630759|NCT00719472|528826153|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
146630760|NCT00719472|528826153|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
146630761|NCT00719472|528826153|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
146630762|NCT00719472|528826153|FG000|Received Cycle 2 Treatment|Death|6|||
146630763|NCT00719472|528826153|FG000|Received Cycle 2 Treatment|Disease progression|3|||
146630764|NCT00719472|528826153|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
146630765|NCT00719472|528826153|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
146630766|NCT00719472|528826153|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
146630767|NCT00719472|528826153|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
146630768|NCT00711191|528826156|FG000|Overall Study|Adverse Event|1|||
146630769|NCT00711191|528826157|FG001|Overall Study|Adverse Event|1|||
146630770|NCT00711191|528826158|FG002|Overall Study|Adverse Event|2|||
146630771|NCT00711191|528826156|FG000|Overall Study|Objective progression or relapse|2|||
146630772|NCT00711191|528826157|FG001|Overall Study|Objective progression or relapse|3|||
146884574|NCT00271817|529745608|FG001|Part 1|LDL < 50 mg/dL|4|||
146884575|NCT00271817|529745609|FG002|Part 1|LDL < 50 mg/dL|48|||
146630773|NCT00711191|528826158|FG002|Overall Study|Objective progression or relapse|7|||
146630774|NCT00711191|528826156|FG000|Overall Study|Withdrawal by Subject|0|||
146630775|NCT00711191|528826157|FG001|Overall Study|Withdrawal by Subject|1|||
146630776|NCT00711191|528826158|FG002|Overall Study|Withdrawal by Subject|3|||
146630777|NCT01744977|528826159|FG000|Overall Study|Withdrawal by Subject|1|||
146630778|NCT01744977|528826160|FG001|Overall Study|Withdrawal by Subject|2|||
146630779|NCT01744977|528826159|FG000|Overall Study|Death|2|||
146884576|NCT00271817|529745607|FG000|Part 2|Adverse Event|0|||
146630780|NCT01744977|528826160|FG001|Overall Study|Death|3|||
146630781|NCT01744977|528826159|FG000|Overall Study|Lost to Follow-up|2|||
146630782|NCT01744977|528826160|FG001|Overall Study|Lost to Follow-up|0|||
146884577|NCT00271817|529745608|FG001|Part 2|Adverse Event|17|||
146884578|NCT00271817|529745609|FG002|Part 2|Adverse Event|33|||
146884579|NCT00271817|529745607|FG000|Part 2|Lack of Efficacy|0|||
146884580|NCT00271817|529745608|FG001|Part 2|Lack of Efficacy|1|||
146884581|NCT00271817|529745609|FG002|Part 2|Lack of Efficacy|6|||
146884582|NCT00271817|529745607|FG000|Part 2|Lost to Follow-up|0|||
146884583|NCT00271817|529745608|FG001|Part 2|Lost to Follow-up|6|||
146884584|NCT00271817|529745609|FG002|Part 2|Lost to Follow-up|18|||
146884585|NCT00271817|529745607|FG000|Part 2|Protocol Violation|0|||
146884586|NCT00271817|529745608|FG001|Part 2|Protocol Violation|3|||
146884587|NCT00271817|529745609|FG002|Part 2|Protocol Violation|5|||
146884588|NCT00271817|529745607|FG000|Part 2|Patient Moved|0|||
146884589|NCT00271817|529745608|FG001|Part 2|Patient Moved|0|||
146884590|NCT00271817|529745609|FG002|Part 2|Patient Moved|5|||
146884591|NCT00271817|529745607|FG000|Part 2|Withdrawal by Subject|0|||
146884592|NCT00271817|529745608|FG001|Part 2|Withdrawal by Subject|2|||
146884593|NCT00271817|529745609|FG002|Part 2|Withdrawal by Subject|13|||
146884594|NCT00271817|529745607|FG000|Part 2|LDL < 50 mg/dL|0|||
146884595|NCT00271817|529745608|FG001|Part 2|LDL < 50 mg/dL|3|||
146884596|NCT00271817|529745609|FG002|Part 2|LDL < 50 mg/dL|4|||
146884597|NCT01471782|529745610|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
146884598|NCT01471782|529745611|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
146884599|NCT01471782|529745612|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
146884600|NCT01471782|529745613|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
146884601|NCT01471782|529745614|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
146884602|NCT01471782|529745615|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
146884603|NCT01471782|529745610|FG000|Overall Study|Lack of Efficacy|1|||
146884604|NCT01471782|529745611|FG001|Overall Study|Lack of Efficacy|2|||
146884605|NCT01471782|529745612|FG002|Overall Study|Lack of Efficacy|1|||
146884606|NCT01471782|529745613|FG003|Overall Study|Lack of Efficacy|1|||
146884607|NCT01471782|529745614|FG004|Overall Study|Lack of Efficacy|5|||
146884608|NCT01471782|529745615|FG005|Overall Study|Lack of Efficacy|18|||
146884609|NCT01471782|529745610|FG000|Overall Study|Adverse Event|1|||
146884610|NCT01471782|529745611|FG001|Overall Study|Adverse Event|1|||
146884611|NCT01471782|529745612|FG002|Overall Study|Adverse Event|2|||
146547937|NCT04270760|528512711|FG001|Overall Study|Lost to Follow-up|2|||
146547938|NCT04270760|528512712|FG002|Overall Study|Lost to Follow-up|1|||
146765129|NCT02104765|529307265|FG005|Overall Study|Withdrawal by Subject|0|||
146547939|NCT04270760|528512713|FG003|Overall Study|Lost to Follow-up|0|||
146547940|NCT04270760|528512714|FG004|Overall Study|Lost to Follow-up|0|||
146765130|NCT02104765|529307266|FG006|Overall Study|Withdrawal by Subject|1|||
146765131|NCT04436120|529307270|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
146765132|NCT04436120|529307271|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
146884612|NCT01471782|529745613|FG003|Overall Study|Adverse Event|2|||
146884613|NCT01471782|529745614|FG004|Overall Study|Adverse Event|3|||
146884614|NCT01471782|529745615|FG005|Overall Study|Adverse Event|1|||
146884615|NCT01471782|529745610|FG000|Overall Study|Other|0|||
146884616|NCT01471782|529745611|FG001|Overall Study|Other|0|||
146884617|NCT01471782|529745612|FG002|Overall Study|Other|1|||
146884618|NCT01471782|529745613|FG003|Overall Study|Other|1|||
146884619|NCT01471782|529745614|FG004|Overall Study|Other|6|||
146884620|NCT01471782|529745615|FG005|Overall Study|Other|5|||
146884621|NCT01471782|529745610|FG000|Overall Study|Change of Chemotherapy|1|||
146884622|NCT01471782|529745611|FG001|Overall Study|Change of Chemotherapy|1|||
146884623|NCT01471782|529745612|FG002|Overall Study|Change of Chemotherapy|0|||
146884624|NCT01471782|529745613|FG003|Overall Study|Change of Chemotherapy|0|||
146884625|NCT01471782|529745614|FG004|Overall Study|Change of Chemotherapy|1|||
146884626|NCT01471782|529745615|FG005|Overall Study|Change of Chemotherapy|4|||
146884627|NCT01471782|529745610|FG000|Overall Study|Disease Relapse|0|||
146884628|NCT01471782|529745611|FG001|Overall Study|Disease Relapse|0|||
146884629|NCT01471782|529745612|FG002|Overall Study|Disease Relapse|0|||
146884630|NCT01471782|529745613|FG003|Overall Study|Disease Relapse|1|||
146884631|NCT01471782|529745614|FG004|Overall Study|Disease Relapse|2|||
146884632|NCT01471782|529745615|FG005|Overall Study|Disease Relapse|1|||
146884633|NCT01471782|529745610|FG000|Overall Study|Physician Decision|0|||
146884634|NCT01471782|529745611|FG001|Overall Study|Physician Decision|0|||
146884635|NCT01471782|529745612|FG002|Overall Study|Physician Decision|0|||
146884636|NCT01471782|529745613|FG003|Overall Study|Physician Decision|0|||
146884637|NCT01471782|529745614|FG004|Overall Study|Physician Decision|3|||
146547941|NCT04270760|528512710|FG000|Overall Study|Death|0|||
146547942|NCT04270760|528512711|FG001|Overall Study|Death|0|||
146547943|NCT04270760|528512712|FG002|Overall Study|Death|0|||
146547944|NCT04270760|528512713|FG003|Overall Study|Death|0|||
146547945|NCT04270760|528512714|FG004|Overall Study|Death|1|||
146547946|NCT02070991|528512715|FG000|Overall Study|Death|2|||
146547947|NCT02070991|528512716|FG001|Overall Study|Death|0|||
146547948|NCT02070991|528512715|FG000|Overall Study|Withdrawal by Subject|1|||
146547949|NCT02070991|528512716|FG001|Overall Study|Withdrawal by Subject|0|||
146547950|NCT02448043|528512719|FG000|Overall Study|Withdrawal by Subject|2|||
146547951|NCT02448043|528512720|FG001|Overall Study|Withdrawal by Subject|2|||
146547952|NCT02448043|528512719|FG000|Overall Study|Protocol Violation|1|||
146547953|NCT02448043|528512720|FG001|Overall Study|Protocol Violation|2|||
146547954|NCT01769443|528512725|FG000|Overall Study|Study closure|1|||
146547955|NCT01769443|528512726|FG001|Overall Study|Study closure|0|||
146547956|NCT00002874|528512736|FG000|Overall Study|Withdrawal by Subject|1|||
146547957|NCT00002874|528512737|FG001|Overall Study|Withdrawal by Subject|1|||
146547958|NCT00002874|528512736|FG000|Overall Study|Protocol Violation|44|||
146547959|NCT00002874|528512737|FG001|Overall Study|Protocol Violation|34|||
146547960|NCT01397747|528512740|FG000|Overall Study|Multitarget DNA test excluded|689|||
146547961|NCT01397747|528512740|FG000|Overall Study|Colonoscopy excluded|304|||
146547962|NCT01397747|528512740|FG000|Overall Study|FIT excluded|34|||
146547963|NCT03828383|528512741|FG000|Overall Study|Lost to Follow-up|3|||
146547964|NCT03828383|528512742|FG001|Overall Study|Lost to Follow-up|2|||
146884638|NCT01471782|529745615|FG005|Overall Study|Physician Decision|8|||
146884639|NCT01471782|529745610|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146884640|NCT01471782|529745611|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146884641|NCT01471782|529745612|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146884642|NCT01471782|529745613|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146884643|NCT01471782|529745614|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
146884644|NCT01471782|529745615|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
146884645|NCT01471782|529745610|FG000|Overall Study|Death|0|||
146884646|NCT01471782|529745611|FG001|Overall Study|Death|0|||
146884647|NCT01471782|529745612|FG002|Overall Study|Death|0|||
146884648|NCT01471782|529745613|FG003|Overall Study|Death|0|||
146884649|NCT01471782|529745614|FG004|Overall Study|Death|0|||
146884650|NCT01471782|529745615|FG005|Overall Study|Death|1|||
146884651|NCT00936208|529745616|FG000|Overall Study|Protocol Violation|37|||
146884652|NCT00936208|529745617|FG001|Overall Study|Protocol Violation|22|||
146884653|NCT00861744|529745618|FG000|Overall Study|Adverse Event|0|||
146884654|NCT00861744|529745619|FG001|Overall Study|Adverse Event|0|||
146884655|NCT00861744|529745620|FG002|Overall Study|Adverse Event|0|||
146884656|NCT00861744|529745621|FG003|Overall Study|Adverse Event|1|||
146884657|NCT00861744|529745618|FG000|Overall Study|Lost to Follow-up|7|||
146884658|NCT00861744|529745619|FG001|Overall Study|Lost to Follow-up|19|||
146884659|NCT00861744|529745620|FG002|Overall Study|Lost to Follow-up|17|||
146884660|NCT00861744|529745621|FG003|Overall Study|Lost to Follow-up|12|||
146884661|NCT00861744|529745618|FG000|Overall Study|Withdrawal by Subject|10|||
146547965|NCT03828383|528512741|FG000|Overall Study|Withdrawal by Subject|4|||
146547966|NCT03828383|528512742|FG001|Overall Study|Withdrawal by Subject|5|||
146547967|NCT00504309|528512743|FG000|Overall Study|Death|0|||
146547968|NCT00504309|528512744|FG001|Overall Study|Death|0|||
146547969|NCT00504309|528512745|FG002|Overall Study|Death|0|||
146547970|NCT00504309|528512746|FG003|Overall Study|Death|0|||
146547971|NCT00504309|528512747|FG004|Overall Study|Death|1|||
146547972|NCT00504309|528512748|FG005|Overall Study|Death|0|||
146765133|NCT04436120|529307272|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
146547973|NCT00504309|528512743|FG000|Overall Study|Withdrawal by Subject|0|||
146547974|NCT00504309|528512744|FG001|Overall Study|Withdrawal by Subject|0|||
146884662|NCT00861744|529745619|FG001|Overall Study|Withdrawal by Subject|6|||
146884663|NCT00861744|529745620|FG002|Overall Study|Withdrawal by Subject|6|||
146884664|NCT00861744|529745621|FG003|Overall Study|Withdrawal by Subject|19|||
146884665|NCT00861744|529745618|FG000|Overall Study|Protocol Violation|0|||
146884666|NCT00861744|529745619|FG001|Overall Study|Protocol Violation|1|||
146884667|NCT00861744|529745620|FG002|Overall Study|Protocol Violation|0|||
146884668|NCT00861744|529745621|FG003|Overall Study|Protocol Violation|0|||
146884669|NCT00861744|529745618|FG000|Overall Study|Migration from study area|0|||
146884670|NCT00861744|529745619|FG001|Overall Study|Migration from study area|3|||
146884671|NCT00861744|529745620|FG002|Overall Study|Migration from study area|1|||
146884672|NCT00861744|529745621|FG003|Overall Study|Migration from study area|0|||
146884673|NCT00861744|529745618|FG000|Overall Study|Blood draws|0|||
146884674|NCT00861744|529745619|FG001|Overall Study|Blood draws|0|||
146884675|NCT00861744|529745620|FG002|Overall Study|Blood draws|0|||
146884676|NCT00861744|529745621|FG003|Overall Study|Blood draws|1|||
146884677|NCT01411085|529745622|FG000|Overall Study|Physician Decision|1|||
146884678|NCT01411085|529745622|FG000|Overall Study|Protocol Violation|1|||
146884679|NCT01411085|529745622|FG000|Overall Study|Adverse Event|1|||
146884680|NCT04818593|529745623|FG000|Overall Study|Low Oocyte Yield|8|||
146884681|NCT04818593|529745624|FG001|Overall Study|Low Oocyte Yield|8|||
146884682|NCT04818593|529745623|FG000|Overall Study|Not ICSI Insemination|7|||
146884683|NCT04818593|529745624|FG001|Overall Study|Not ICSI Insemination|7|||
146884684|NCT04818593|529745623|FG000|Overall Study|Poor Sperm Quality|2|||
146884685|NCT04818593|529745624|FG001|Overall Study|Poor Sperm Quality|2|||
146884686|NCT04818593|529745623|FG000|Overall Study|Withdrawal by Subject|2|||
146884687|NCT04818593|529745624|FG001|Overall Study|Withdrawal by Subject|2|||
146884688|NCT04818593|529745623|FG000|Overall Study|Conversion to IUI due to low response|1|||
146884689|NCT04818593|529745624|FG001|Overall Study|Conversion to IUI due to low response|1|||
146884690|NCT01564862|529745625|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
146884691|NCT01564862|529745626|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
146884692|NCT01564862|529745627|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
146884693|NCT01564862|529745625|FG000|Overall Study|Major Protocol Deviation|3|||
146884694|NCT01564862|529745626|FG001|Overall Study|Major Protocol Deviation|3|||
146884695|NCT01564862|529745627|FG002|Overall Study|Major Protocol Deviation|4|||
146884696|NCT01564862|529745625|FG000|Overall Study|Lost to Follow-up|10|||
146884697|NCT01564862|529745626|FG001|Overall Study|Lost to Follow-up|8|||
146884698|NCT01564862|529745627|FG002|Overall Study|Lost to Follow-up|6|||
146884699|NCT01564862|529745625|FG000|Overall Study|Voluntary Withdrawal|9|||
146884700|NCT01564862|529745626|FG001|Overall Study|Voluntary Withdrawal|6|||
146884701|NCT01564862|529745627|FG002|Overall Study|Voluntary Withdrawal|8|||
146884702|NCT01564862|529745625|FG000|Overall Study|Lack of Efficacy|1|||
146884703|NCT01564862|529745626|FG001|Overall Study|Lack of Efficacy|5|||
146884704|NCT01564862|529745627|FG002|Overall Study|Lack of Efficacy|6|||
146884705|NCT01564862|529745625|FG000|Overall Study|Other reason(s)|1|||
146884706|NCT01564862|529745626|FG001|Overall Study|Other reason(s)|0|||
146884707|NCT01564862|529745627|FG002|Overall Study|Other reason(s)|0|||
146884708|NCT03809611|529745628|FG000|Overall Study|Withdrawal by Subject|1|||
146884709|NCT03809611|529745629|FG001|Overall Study|Withdrawal by Subject|1|||
146884710|NCT02193074|529745630|FG000|Overall Study|Withdrawal by Subject|1|||
146547975|NCT00504309|528512745|FG002|Overall Study|Withdrawal by Subject|1|||
146547976|NCT00504309|528512746|FG003|Overall Study|Withdrawal by Subject|0|||
146547977|NCT00504309|528512747|FG004|Overall Study|Withdrawal by Subject|0|||
146547978|NCT00504309|528512748|FG005|Overall Study|Withdrawal by Subject|0|||
146547979|NCT03345095|528512750|FG000|Overall Study|Lack of Efficacy|184|||
146547980|NCT03345095|528512751|FG001|Overall Study|Lack of Efficacy|156|||
146547981|NCT03345095|528512750|FG000|Overall Study|Adverse Event|36|||
146884711|NCT02193074|529745631|FG001|Overall Study|Withdrawal by Subject|2|||
146884712|NCT02193074|529745630|FG000|Overall Study|Adverse Event|16|||
146884713|NCT02193074|529745631|FG001|Overall Study|Adverse Event|13|||
146884714|NCT04179175|529747793|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
146884715|NCT04179175|529747794|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
146547982|NCT03345095|528512751|FG001|Overall Study|Adverse Event|118|||
146884716|NCT04179175|529747795|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
146884717|NCT04179175|529747796|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
146884718|NCT04179175|529747797|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
146884719|NCT04179175|529747798|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
146884720|NCT04179175|529747793|FG000|Overall Study|Adverse Event|5|||
146884721|NCT04179175|529747794|FG001|Overall Study|Adverse Event|3|||
146547983|NCT03345095|528512750|FG000|Overall Study|Withdrawal by Subject|22|||
146547984|NCT03345095|528512751|FG001|Overall Study|Withdrawal by Subject|59|||
146547985|NCT03345095|528512750|FG000|Overall Study|Physician Decision|3|||
146547986|NCT03345095|528512751|FG001|Overall Study|Physician Decision|18|||
146547987|NCT03345095|528512750|FG000|Overall Study|Death|2|||
146547988|NCT03345095|528512751|FG001|Overall Study|Death|4|||
146547989|NCT03345095|528512750|FG000|Overall Study|Other reasons|2|||
146547990|NCT03345095|528512751|FG001|Overall Study|Other reasons|11|||
146547991|NCT03345095|528512750|FG000|Overall Study|Protocol Violation|0|||
146547992|NCT03345095|528512751|FG001|Overall Study|Protocol Violation|1|||
146547993|NCT03158311|528512752|FG000|Overall Study|Subject/Guardian Decision|10|||
146547994|NCT03158311|528512753|FG001|Overall Study|Subject/Guardian Decision|6|||
146547995|NCT03158311|528512754|FG002|Overall Study|Subject/Guardian Decision|11|||
146547996|NCT03158311|528512752|FG000|Overall Study|Adverse Event|5|||
146547997|NCT03158311|528512753|FG001|Overall Study|Adverse Event|3|||
146547998|NCT03158311|528512754|FG002|Overall Study|Adverse Event|3|||
146547999|NCT03158311|528512752|FG000|Overall Study|Techinical Problems|3|||
146548000|NCT03158311|528512753|FG001|Overall Study|Techinical Problems|1|||
146548001|NCT03158311|528512754|FG002|Overall Study|Techinical Problems|5|||
146548002|NCT03158311|528512752|FG000|Overall Study|Physician Decision|2|||
146548003|NCT03158311|528512753|FG001|Overall Study|Physician Decision|3|||
146630783|NCT01744977|528826159|FG000|Overall Study|No longer meets inclusion|6|||
146630784|NCT01744977|528826160|FG001|Overall Study|No longer meets inclusion|0|||
146548004|NCT03158311|528512754|FG002|Overall Study|Physician Decision|7|||
146548005|NCT03158311|528512752|FG000|Overall Study|Lost to Follow-up|1|||
146548006|NCT03158311|528512753|FG001|Overall Study|Lost to Follow-up|1|||
146548007|NCT03158311|528512754|FG002|Overall Study|Lost to Follow-up|1|||
146548008|NCT03158311|528512752|FG000|Overall Study|Sponsor decision|1|||
146548009|NCT03158311|528512753|FG001|Overall Study|Sponsor decision|0|||
146548010|NCT03158311|528512754|FG002|Overall Study|Sponsor decision|0|||
146548011|NCT03158311|528512752|FG000|Overall Study|Pregnancy|0|||
146548012|NCT03158311|528512753|FG001|Overall Study|Pregnancy|2|||
146548013|NCT03158311|528512754|FG002|Overall Study|Pregnancy|0|||
146548014|NCT03158311|528512752|FG000|Overall Study|Randomized in error|0|||
146548015|NCT03158311|528512753|FG001|Overall Study|Randomized in error|0|||
146548016|NCT03158311|528512754|FG002|Overall Study|Randomized in error|1|||
146548017|NCT02665455|528512755|FG000|Overall Study|Withdrawal by Subject|6|||
146548018|NCT02665455|528512755|FG000|Overall Study|Lost to Follow-up|1|||
146548019|NCT02665455|528512755|FG000|Overall Study|Adverse Event|1|||
146548020|NCT02665455|528512755|FG000|Overall Study|Protocol Violation|1|||
146548021|NCT05865886|528512759|FG000|Overall Study|Serious adverse event|0|||
146548022|NCT05865886|528512760|FG001|Overall Study|Serious adverse event|1|||
146548023|NCT03554473|528514642|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
146548024|NCT03554473|528514643|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
146548025|NCT03554473|528514644|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
146548026|NCT03554473|528514642|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
146548027|NCT03554473|528514643|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
146548028|NCT03554473|528514644|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
146548029|NCT03554473|528514642|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
146548030|NCT03554473|528514643|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
146548031|NCT03554473|528514644|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
146548032|NCT04971837|528514648|FG000|Overall Study|Long Term Illness|1|||
146548033|NCT04971837|528514648|FG000|Overall Study|BMI too low|9|||
146548034|NCT04971837|528514648|FG000|Overall Study|geographic location|1|||
146548035|NCT04971837|528514648|FG000|Overall Study|Discontinued scheduling conflict|1|||
146548036|NCT05206604|528514649|FG000|Overall Study|Non-compliance with study drug|0|||
146548037|NCT05206604|528514650|FG001|Overall Study|Non-compliance with study drug|0|||
146548038|NCT05206604|528514651|FG002|Overall Study|Non-compliance with study drug|0|||
146548039|NCT05206604|528514652|FG003|Overall Study|Non-compliance with study drug|0|||
146548040|NCT05206604|528514653|FG004|Overall Study|Non-compliance with study drug|0|||
146548041|NCT05206604|528514654|FG005|Overall Study|Non-compliance with study drug|1|||
146548042|NCT05206604|528514655|FG006|Overall Study|Non-compliance with study drug|0|||
146548043|NCT05206604|528514656|FG007|Overall Study|Non-compliance with study drug|0|||
146548044|NCT03735498|528514657|FG000|Overall Study|Withdrawal by Subject|3|||
146548045|NCT03735498|528514657|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
146548046|NCT00160615|528514658|FG000|Overall Study|Adverse Event|5|||
146548047|NCT00160615|528514659|FG001|Overall Study|Adverse Event|12|||
146548048|NCT00160615|528514658|FG000|Overall Study|Withdrawal by Subject|0|||
146884722|NCT04179175|529747795|FG002|Overall Study|Adverse Event|3|||
146884723|NCT04179175|529747796|FG003|Overall Study|Adverse Event|4|||
146884724|NCT04179175|529747797|FG004|Overall Study|Adverse Event|6|||
146884725|NCT04179175|529747798|FG005|Overall Study|Adverse Event|6|||
146884726|NCT04179175|529747793|FG000|Overall Study|Lack of Efficacy|5|||
146884727|NCT04179175|529747794|FG001|Overall Study|Lack of Efficacy|1|||
146884728|NCT04179175|529747795|FG002|Overall Study|Lack of Efficacy|3|||
146884729|NCT04179175|529747796|FG003|Overall Study|Lack of Efficacy|2|||
146548049|NCT00160615|528514659|FG001|Overall Study|Withdrawal by Subject|2|||
146884730|NCT04179175|529747797|FG004|Overall Study|Lack of Efficacy|18|||
146884731|NCT04179175|529747798|FG005|Overall Study|Lack of Efficacy|7|||
146884732|NCT04179175|529747793|FG000|Overall Study|Lost to Follow-up|5|||
146884733|NCT04179175|529747794|FG001|Overall Study|Lost to Follow-up|3|||
146884734|NCT04179175|529747795|FG002|Overall Study|Lost to Follow-up|2|||
146884735|NCT04179175|529747796|FG003|Overall Study|Lost to Follow-up|2|||
146884736|NCT04179175|529747797|FG004|Overall Study|Lost to Follow-up|4|||
146884737|NCT04179175|529747798|FG005|Overall Study|Lost to Follow-up|5|||
146884738|NCT04179175|529747793|FG000|Overall Study|Physician Decision|2|||
146884739|NCT04179175|529747794|FG001|Overall Study|Physician Decision|0|||
146884740|NCT04179175|529747795|FG002|Overall Study|Physician Decision|2|||
146884741|NCT04179175|529747796|FG003|Overall Study|Physician Decision|3|||
146884742|NCT04179175|529747797|FG004|Overall Study|Physician Decision|1|||
146884743|NCT04179175|529747798|FG005|Overall Study|Physician Decision|1|||
146884744|NCT04179175|529747793|FG000|Overall Study|Pregnancy|3|||
146884745|NCT04179175|529747794|FG001|Overall Study|Pregnancy|0|||
146884746|NCT04179175|529747795|FG002|Overall Study|Pregnancy|3|||
146884747|NCT04179175|529747796|FG003|Overall Study|Pregnancy|0|||
146884748|NCT04179175|529747797|FG004|Overall Study|Pregnancy|1|||
146884749|NCT04179175|529747798|FG005|Overall Study|Pregnancy|2|||
146884750|NCT04179175|529747793|FG000|Overall Study|Withdrawal by Subject|22|||
146884751|NCT04179175|529747794|FG001|Overall Study|Withdrawal by Subject|10|||
146884752|NCT04179175|529747795|FG002|Overall Study|Withdrawal by Subject|12|||
146884753|NCT04179175|529747796|FG003|Overall Study|Withdrawal by Subject|8|||
146884754|NCT04179175|529747797|FG004|Overall Study|Withdrawal by Subject|23|||
146884755|NCT04179175|529747798|FG005|Overall Study|Withdrawal by Subject|31|||
146884756|NCT04179175|529747793|FG000|Overall Study|Technical problems|0|||
146884757|NCT04179175|529747794|FG001|Overall Study|Technical problems|0|||
146884758|NCT04179175|529747795|FG002|Overall Study|Technical problems|1|||
146884759|NCT04179175|529747796|FG003|Overall Study|Technical problems|1|||
146884760|NCT04179175|529747797|FG004|Overall Study|Technical problems|0|||
146884761|NCT04179175|529747798|FG005|Overall Study|Technical problems|0|||
146884762|NCT05593016|529747799|FG000|Overall Study|Death|1|||
146884763|NCT05593016|529747800|FG001|Overall Study|Death|1|||
146884764|NCT05593016|529747801|FG002|Overall Study|Death|1|||
146884765|NCT05593016|529747802|FG003|Overall Study|Death|0|||
146884766|NCT05593016|529747803|FG004|Overall Study|Death|0|||
146884767|NCT05593016|529747799|FG000|Overall Study|Lost to Follow-up|1|||
146884768|NCT05593016|529747800|FG001|Overall Study|Lost to Follow-up|1|||
146884769|NCT05593016|529747801|FG002|Overall Study|Lost to Follow-up|1|||
146884770|NCT05593016|529747802|FG003|Overall Study|Lost to Follow-up|2|||
146884771|NCT05593016|529747803|FG004|Overall Study|Lost to Follow-up|0|||
146884772|NCT04705051|529747804|FG000|Overall Study|Enrolled but not treated|1|||
146884773|NCT04705051|529747804|FG000|Overall Study|Study terminated by sponsor|23|||
146884774|NCT00598975|529747805|FG000|Overall Study|Adverse Event|1|||
146884775|NCT00598975|529747806|FG001|Overall Study|Adverse Event|1|||
146884776|NCT00598975|529747805|FG000|Overall Study|Brain metastases|1|||
146884777|NCT00598975|529747806|FG001|Overall Study|Brain metastases|0|||
146884778|NCT00598975|529747805|FG000|Overall Study|Withdrawal by Subject|1|||
146884779|NCT00598975|529747806|FG001|Overall Study|Withdrawal by Subject|1|||
146884780|NCT00598975|529747805|FG000|Overall Study|Withdrawal of consent|0|||
146884781|NCT00598975|529747806|FG001|Overall Study|Withdrawal of consent|1|||
146884782|NCT00598975|529747805|FG000|Overall Study|Disease progression|8|||
146884783|NCT00598975|529747806|FG001|Overall Study|Disease progression|3|||
146884784|NCT00598975|529747805|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
146884785|NCT00598975|529747806|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
146884786|NCT01178138|529747807|FG000|Overall Study|Lost to Follow-up|8|||
146548050|NCT00160615|528514658|FG000|Overall Study|Lack of Efficacy|11|||
146548051|NCT00160615|528514659|FG001|Overall Study|Lack of Efficacy|23|||
146884787|NCT01178138|529747807|FG000|Overall Study|Withdrawal by Subject|7|||
146884788|NCT01178138|529747807|FG000|Overall Study|Physician Decision|8|||
146884789|NCT01241708|529747808|FG000|Overall Study|Withdrawal by Subject|6|||
146884790|NCT01241708|529747808|FG000|Overall Study|Screen Failure|6|||
146884791|NCT01241708|529747808|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
146884792|NCT01241708|529747808|FG000|Overall Study|Lost to Follow-up|5|||
146884793|NCT01790503|529747813|FG000|Overall Study|Adverse Event|1|||
146884794|NCT01790503|529747814|FG001|Overall Study|Adverse Event|0|||
146884795|NCT01790503|529747815|FG002|Overall Study|Adverse Event|0|||
146884796|NCT01790503|529747816|FG003|Overall Study|Adverse Event|0|||
146884797|NCT01790503|529747817|FG004|Overall Study|Adverse Event|0|||
146884798|NCT01790503|529747818|FG005|Overall Study|Adverse Event|2|||
146884799|NCT01790503|529747819|FG006|Overall Study|Adverse Event|0|||
146884800|NCT01790503|529747820|FG007|Overall Study|Adverse Event|0|||
146884801|NCT01790503|529747821|FG008|Overall Study|Adverse Event|2|||
146884802|NCT01790503|529747822|FG009|Overall Study|Adverse Event|4|||
146884803|NCT01790503|529747823|FG010|Overall Study|Adverse Event|7|||
146884804|NCT01790503|529747813|FG000|Overall Study|Withdrawal by Subject|0|||
146884805|NCT01790503|529747814|FG001|Overall Study|Withdrawal by Subject|0|||
146884806|NCT01790503|529747815|FG002|Overall Study|Withdrawal by Subject|1|||
146884807|NCT01790503|529747816|FG003|Overall Study|Withdrawal by Subject|1|||
146884808|NCT01790503|529747817|FG004|Overall Study|Withdrawal by Subject|1|||
146884809|NCT01790503|529747818|FG005|Overall Study|Withdrawal by Subject|2|||
146884810|NCT01790503|529747819|FG006|Overall Study|Withdrawal by Subject|1|||
146884811|NCT01790503|529747820|FG007|Overall Study|Withdrawal by Subject|0|||
146884812|NCT01790503|529747821|FG008|Overall Study|Withdrawal by Subject|0|||
146884813|NCT01790503|529747822|FG009|Overall Study|Withdrawal by Subject|0|||
146548052|NCT00160615|528514658|FG000|Overall Study|Patient decision|1|||
146548053|NCT00160615|528514659|FG001|Overall Study|Patient decision|2|||
146548054|NCT00160615|528514658|FG000|Overall Study|Investigator decision|1|||
146548055|NCT00160615|528514659|FG001|Overall Study|Investigator decision|1|||
146548056|NCT00160615|528514658|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
146548057|NCT00160615|528514659|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
146548058|NCT00160615|528514658|FG000|Overall Study|Switch to surgical treatment|0|||
146548059|NCT00160615|528514659|FG001|Overall Study|Switch to surgical treatment|2|||
146548060|NCT00160615|528514658|FG000|Overall Study|Non-compliance was suspected|0|||
146548061|NCT00160615|528514659|FG001|Overall Study|Non-compliance was suspected|1|||
146548062|NCT00160615|528514658|FG000|Overall Study|Poor compliance|0|||
146548063|NCT00160615|528514659|FG001|Overall Study|Poor compliance|1|||
146548064|NCT03166631|528514660|FG000|Overall Study|Progressive disease|2|||
146548065|NCT03166631|528514661|FG001|Overall Study|Progressive disease|1|||
146548066|NCT03166631|528514662|FG002|Overall Study|Progressive disease|3|||
146548067|NCT03166631|528514663|FG003|Overall Study|Progressive disease|4|||
146548068|NCT03166631|528514664|FG004|Overall Study|Progressive disease|2|||
146548069|NCT03166631|528514665|FG005|Overall Study|Progressive disease|2|||
146548070|NCT03166631|528514666|FG006|Overall Study|Progressive disease|5|||
146548071|NCT03166631|528514667|FG007|Overall Study|Progressive disease|6|||
146548072|NCT03166631|528514668|FG008|Overall Study|Progressive disease|11|||
146548073|NCT03166631|528514669|FG009|Overall Study|Progressive disease|5|||
146548074|NCT03166631|528514670|FG010|Overall Study|Progressive disease|7|||
146630785|NCT00912808|528826163|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
146884814|NCT01790503|529747823|FG010|Overall Study|Withdrawal by Subject|1|||
146884815|NCT01790503|529747813|FG000|Overall Study|Disease progression|2|||
146548075|NCT03166631|528514660|FG000|Overall Study|Physician Decision|0|||
146548076|NCT03166631|528514661|FG001|Overall Study|Physician Decision|0|||
146548077|NCT03166631|528514662|FG002|Overall Study|Physician Decision|0|||
146548078|NCT03166631|528514663|FG003|Overall Study|Physician Decision|0|||
146548079|NCT03166631|528514664|FG004|Overall Study|Physician Decision|0|||
146884816|NCT01790503|529747814|FG001|Overall Study|Disease progression|1|||
146884817|NCT01790503|529747815|FG002|Overall Study|Disease progression|0|||
146884818|NCT01790503|529747816|FG003|Overall Study|Disease progression|1|||
146884819|NCT01790503|529747817|FG004|Overall Study|Disease progression|2|||
146884820|NCT01790503|529747818|FG005|Overall Study|Disease progression|1|||
146884821|NCT01790503|529747819|FG006|Overall Study|Disease progression|0|||
146884822|NCT01790503|529747820|FG007|Overall Study|Disease progression|1|||
146884823|NCT01790503|529747821|FG008|Overall Study|Disease progression|0|||
146884824|NCT01790503|529747822|FG009|Overall Study|Disease progression|17|||
146884825|NCT01790503|529747823|FG010|Overall Study|Disease progression|7|||
146884826|NCT01790503|529747813|FG000|Overall Study|Protocol Violation|0|||
146884827|NCT01790503|529747814|FG001|Overall Study|Protocol Violation|0|||
146884828|NCT01790503|529747815|FG002|Overall Study|Protocol Violation|0|||
146884829|NCT01790503|529747816|FG003|Overall Study|Protocol Violation|0|||
146884830|NCT01790503|529747817|FG004|Overall Study|Protocol Violation|0|||
146884831|NCT01790503|529747818|FG005|Overall Study|Protocol Violation|0|||
146548080|NCT03166631|528514665|FG005|Overall Study|Physician Decision|0|||
146548081|NCT03166631|528514666|FG006|Overall Study|Physician Decision|1|||
146548082|NCT03166631|528514667|FG007|Overall Study|Physician Decision|0|||
146548083|NCT03166631|528514668|FG008|Overall Study|Physician Decision|1|||
146548084|NCT03166631|528514669|FG009|Overall Study|Physician Decision|0|||
146548085|NCT03166631|528514670|FG010|Overall Study|Physician Decision|1|||
146548086|NCT03166631|528514660|FG000|Overall Study|Death|0|||
146548087|NCT03166631|528514661|FG001|Overall Study|Death|0|||
146548088|NCT03166631|528514662|FG002|Overall Study|Death|0|||
146548089|NCT03166631|528514663|FG003|Overall Study|Death|0|||
146548090|NCT03166631|528514664|FG004|Overall Study|Death|1|||
146548091|NCT03166631|528514665|FG005|Overall Study|Death|0|||
146548092|NCT03166631|528514666|FG006|Overall Study|Death|1|||
146548093|NCT03166631|528514667|FG007|Overall Study|Death|0|||
146548094|NCT03166631|528514668|FG008|Overall Study|Death|0|||
146548095|NCT03166631|528514669|FG009|Overall Study|Death|0|||
146548096|NCT03166631|528514670|FG010|Overall Study|Death|0|||
146548097|NCT03166631|528514660|FG000|Overall Study|Adverse Event|1|||
146548098|NCT03166631|528514661|FG001|Overall Study|Adverse Event|0|||
146884832|NCT01790503|529747819|FG006|Overall Study|Protocol Violation|0|||
146884833|NCT01790503|529747820|FG007|Overall Study|Protocol Violation|0|||
146884834|NCT01790503|529747821|FG008|Overall Study|Protocol Violation|0|||
146884835|NCT01790503|529747822|FG009|Overall Study|Protocol Violation|1|||
146884836|NCT01790503|529747823|FG010|Overall Study|Protocol Violation|0|||
146884837|NCT01790503|529747813|FG000|Overall Study|Physician Decision|0|||
146884838|NCT01790503|529747814|FG001|Overall Study|Physician Decision|0|||
146884839|NCT01790503|529747815|FG002|Overall Study|Physician Decision|0|||
146884840|NCT01790503|529747816|FG003|Overall Study|Physician Decision|0|||
146884841|NCT01790503|529747817|FG004|Overall Study|Physician Decision|0|||
146884842|NCT01790503|529747818|FG005|Overall Study|Physician Decision|0|||
146884843|NCT01790503|529747819|FG006|Overall Study|Physician Decision|0|||
146884844|NCT01790503|529747820|FG007|Overall Study|Physician Decision|0|||
146884845|NCT01790503|529747821|FG008|Overall Study|Physician Decision|0|||
146884846|NCT01790503|529747822|FG009|Overall Study|Physician Decision|1|||
146884847|NCT01790503|529747823|FG010|Overall Study|Physician Decision|1|||
146884848|NCT01790503|529747813|FG000|Overall Study|Death|0|||
146884849|NCT01790503|529747814|FG001|Overall Study|Death|0|||
146884850|NCT01790503|529747815|FG002|Overall Study|Death|0|||
146884851|NCT01790503|529747816|FG003|Overall Study|Death|0|||
146884852|NCT01790503|529747817|FG004|Overall Study|Death|0|||
146884853|NCT01790503|529747818|FG005|Overall Study|Death|0|||
146884854|NCT01790503|529747819|FG006|Overall Study|Death|0|||
146884855|NCT01790503|529747820|FG007|Overall Study|Death|0|||
146884856|NCT01790503|529747821|FG008|Overall Study|Death|0|||
146884857|NCT01790503|529747822|FG009|Overall Study|Death|1|||
146884858|NCT01790503|529747823|FG010|Overall Study|Death|0|||
146884859|NCT01790503|529747813|FG000|Overall Study|Non Compliance|0|||
146884860|NCT01790503|529747814|FG001|Overall Study|Non Compliance|0|||
146884861|NCT01790503|529747815|FG002|Overall Study|Non Compliance|0|||
146884862|NCT01790503|529747816|FG003|Overall Study|Non Compliance|0|||
146884863|NCT01790503|529747817|FG004|Overall Study|Non Compliance|1|||
146884864|NCT01790503|529747818|FG005|Overall Study|Non Compliance|0|||
146884865|NCT01790503|529747819|FG006|Overall Study|Non Compliance|0|||
146884866|NCT01790503|529747820|FG007|Overall Study|Non Compliance|0|||
146884867|NCT01790503|529747821|FG008|Overall Study|Non Compliance|0|||
146884868|NCT01790503|529747822|FG009|Overall Study|Non Compliance|0|||
146884869|NCT01790503|529747823|FG010|Overall Study|Non Compliance|0|||
146884870|NCT01790503|529747813|FG000|Overall Study|Other|0|||
146884871|NCT01790503|529747814|FG001|Overall Study|Other|0|||
146884872|NCT01790503|529747815|FG002|Overall Study|Other|0|||
146884873|NCT01790503|529747816|FG003|Overall Study|Other|0|||
146884874|NCT01790503|529747817|FG004|Overall Study|Other|1|||
146548099|NCT03166631|528514662|FG002|Overall Study|Adverse Event|0|||
146548100|NCT03166631|528514663|FG003|Overall Study|Adverse Event|0|||
146548101|NCT03166631|528514664|FG004|Overall Study|Adverse Event|0|||
146548102|NCT03166631|528514665|FG005|Overall Study|Adverse Event|1|||
146548103|NCT03166631|528514666|FG006|Overall Study|Adverse Event|1|||
146548104|NCT03166631|528514667|FG007|Overall Study|Adverse Event|0|||
146548105|NCT03166631|528514668|FG008|Overall Study|Adverse Event|1|||
146884875|NCT01790503|529747818|FG005|Overall Study|Other|0|||
146884876|NCT01790503|529747819|FG006|Overall Study|Other|0|||
146884877|NCT01790503|529747820|FG007|Overall Study|Other|0|||
146884878|NCT01790503|529747821|FG008|Overall Study|Other|1|||
146630786|NCT00912808|528826164|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
146630787|NCT00912808|528826163|FG000|Washout|Withdrawal by Subject|0|||
146630788|NCT00912808|528826164|FG001|Washout|Withdrawal by Subject|1|||
146630789|NCT00912808|528826163|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
146630790|NCT00912808|528826164|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
146630791|NCT00912808|528826163|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
146630792|NCT00912808|528826164|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
146630793|NCT03345784|528826167|FG000|Overall Study|Withdrawal by Subject|2|||
146765134|NCT04436120|529307273|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
146884879|NCT01790503|529747822|FG009|Overall Study|Other|2|||
146630794|NCT03345784|528826168|FG001|Overall Study|Withdrawal by Subject|1|||
146630795|NCT00482053|528826173|FG000|Inter-treatment Period|Disease progression|1|||
146630796|NCT00728689|528826174|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
146630797|NCT00728689|528826175|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
146630798|NCT01055197|528826178|FG000|Overall Study|Protocol Violation|7|||
146630799|NCT01055197|528826179|FG001|Overall Study|Protocol Violation|2|||
146630800|NCT01055197|528826178|FG000|Overall Study|Withdrawal by Subject|2|||
146630801|NCT01055197|528826179|FG001|Overall Study|Withdrawal by Subject|0|||
146630802|NCT00389610|528826180|FG000|Overall Study|Disease Progression|0|||
146630803|NCT00389610|528826181|FG001|Overall Study|Disease Progression|19|||
146630804|NCT00389610|528826180|FG000|Overall Study|Death|0|||
146630805|NCT00389610|528826181|FG001|Overall Study|Death|1|||
146630806|NCT00389610|528826180|FG000|Overall Study|Physician Decision|0|||
146630807|NCT00389610|528826181|FG001|Overall Study|Physician Decision|1|||
146630808|NCT00389610|528826180|FG000|Overall Study|Withdrawal by Subject|0|||
146630809|NCT00389610|528826181|FG001|Overall Study|Withdrawal by Subject|1|||
146630810|NCT00887809|528826182|FG000|Overall Study|Patient Not Treated|3|||
146630811|NCT00887809|528826183|FG001|Overall Study|Patient Not Treated|0|||
146630812|NCT00887809|528826182|FG000|Overall Study|Death|1|||
146630813|NCT00887809|528826183|FG001|Overall Study|Death|0|||
146630814|NCT01550003|528826186|FG000|Overall Study|Adverse Event|0|||
146630815|NCT01550003|528826187|FG001|Overall Study|Adverse Event|9|||
146630816|NCT01550003|528826188|FG002|Overall Study|Adverse Event|15|||
146630817|NCT01550003|528826186|FG000|Overall Study|Lack of Efficacy|4|||
146630818|NCT01550003|528826187|FG001|Overall Study|Lack of Efficacy|11|||
146630819|NCT01550003|528826188|FG002|Overall Study|Lack of Efficacy|15|||
146630820|NCT01550003|528826186|FG000|Overall Study|Protocol Violation|0|||
146630821|NCT01550003|528826187|FG001|Overall Study|Protocol Violation|3|||
146630822|NCT01550003|528826188|FG002|Overall Study|Protocol Violation|2|||
146630823|NCT01550003|528826186|FG000|Overall Study|Lost to Follow-up|1|||
146630824|NCT01550003|528826187|FG001|Overall Study|Lost to Follow-up|4|||
146630825|NCT01550003|528826188|FG002|Overall Study|Lost to Follow-up|8|||
146630826|NCT01550003|528826186|FG000|Overall Study|Consent withdrawn|2|||
146630827|NCT01550003|528826187|FG001|Overall Study|Consent withdrawn|11|||
146630828|NCT01550003|528826188|FG002|Overall Study|Consent withdrawn|23|||
146630829|NCT01550003|528826186|FG000|Overall Study|Missing|1|||
146630830|NCT01550003|528826187|FG001|Overall Study|Missing|0|||
146630831|NCT01550003|528826188|FG002|Overall Study|Missing|2|||
146630832|NCT01550003|528826186|FG000|Overall Study|Study closure as announced by sponsor|7|||
146630833|NCT01550003|528826187|FG001|Overall Study|Study closure as announced by sponsor|6|||
146630834|NCT01550003|528826188|FG002|Overall Study|Study closure as announced by sponsor|24|||
146630835|NCT01550003|528826186|FG000|Overall Study|Protocol Noncompliance|1|||
146630836|NCT01550003|528826187|FG001|Overall Study|Protocol Noncompliance|0|||
146630837|NCT01550003|528826188|FG002|Overall Study|Protocol Noncompliance|0|||
146630838|NCT01550003|528826186|FG000|Overall Study|Study closure|0|||
146630839|NCT01550003|528826187|FG001|Overall Study|Study closure|1|||
146630840|NCT01550003|528826188|FG002|Overall Study|Study closure|1|||
146884880|NCT01790503|529747823|FG010|Overall Study|Other|0|||
146884881|NCT00049673|529747824|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
146884882|NCT00049673|529747825|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
146884883|NCT01535729|529747826|FG000|Overall Study|Withdrawal by Subject|2|||
146884884|NCT01535729|529747826|FG000|Overall Study|Disease progression|230|||
146630841|NCT01550003|528826186|FG000|Overall Study|Patient reached adulthood|0|||
146884885|NCT01535729|529747826|FG000|Overall Study|Discontinued treatment|25|||
146630842|NCT01550003|528826187|FG001|Overall Study|Patient reached adulthood|1|||
146630843|NCT01550003|528826188|FG002|Overall Study|Patient reached adulthood|0|||
146630844|NCT01550003|528826186|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
146884886|NCT01535729|529747826|FG000|Overall Study|Lost to Follow-up|8|||
146630845|NCT01550003|528826187|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
146630846|NCT01550003|528826188|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
146630847|NCT01550003|528826186|FG000|Overall Study|Sponsor's order|0|||
146630848|NCT01550003|528826187|FG001|Overall Study|Sponsor's order|3|||
146630849|NCT01550003|528826188|FG002|Overall Study|Sponsor's order|3|||
146630850|NCT01550003|528826186|FG000|Overall Study|Sponsor's decision|1|||
146630851|NCT01550003|528826187|FG001|Overall Study|Sponsor's decision|5|||
146630852|NCT01550003|528826188|FG002|Overall Study|Sponsor's decision|4|||
146630853|NCT01550003|528826186|FG000|Overall Study|Subject mother passed away|0|||
146630854|NCT01550003|528826187|FG001|Overall Study|Subject mother passed away|1|||
146630855|NCT01550003|528826188|FG002|Overall Study|Subject mother passed away|0|||
146630856|NCT01550003|528826186|FG000|Overall Study|Discontinuation|0|||
146630857|NCT01550003|528826187|FG001|Overall Study|Discontinuation|1|||
146630858|NCT01550003|528826188|FG002|Overall Study|Discontinuation|0|||
146630859|NCT01550003|528826186|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
146630860|NCT01550003|528826187|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
146630861|NCT01550003|528826188|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
146630862|NCT01550003|528826186|FG000|Overall Study|Site closure|0|||
146630863|NCT01550003|528826187|FG001|Overall Study|Site closure|2|||
146630864|NCT01550003|528826188|FG002|Overall Study|Site closure|0|||
146630865|NCT01550003|528826186|FG000|Overall Study|Pregnancy|0|||
146630866|NCT01550003|528826187|FG001|Overall Study|Pregnancy|1|||
146630867|NCT01550003|528826188|FG002|Overall Study|Pregnancy|0|||
146630868|NCT01550003|528826186|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
146630869|NCT01550003|528826187|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
146630870|NCT01550003|528826188|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
146630871|NCT01550003|528826186|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
146630872|NCT01550003|528826187|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
146630873|NCT01550003|528826188|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
146630874|NCT01550003|528826186|FG000|Overall Study|Switching to adult rheumatologist|0|||
146630875|NCT01550003|528826187|FG001|Overall Study|Switching to adult rheumatologist|0|||
146630876|NCT01550003|528826188|FG002|Overall Study|Switching to adult rheumatologist|1|||
146630877|NCT01550003|528826186|FG000|Overall Study|Patient transition to adult care|0|||
146630878|NCT01550003|528826187|FG001|Overall Study|Patient transition to adult care|0|||
146630879|NCT01550003|528826188|FG002|Overall Study|Patient transition to adult care|1|||
146630880|NCT01550003|528826186|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
146630881|NCT01550003|528826187|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
146630882|NCT01550003|528826188|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
146630883|NCT01550003|528826186|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
146630884|NCT01550003|528826187|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
146630885|NCT01550003|528826188|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
146630886|NCT01550003|528826186|FG000|Overall Study|Per Sponsor request|1|||
146630887|NCT01550003|528826187|FG001|Overall Study|Per Sponsor request|0|||
146630888|NCT01550003|528826188|FG002|Overall Study|Per Sponsor request|1|||
146630889|NCT01550003|528826186|FG000|Overall Study|Patient not compliance|0|||
146630890|NCT01550003|528826187|FG001|Overall Study|Patient not compliance|0|||
146630891|NCT01550003|528826188|FG002|Overall Study|Patient not compliance|1|||
146630892|NCT01550003|528826186|FG000|Overall Study|Non-compliance|0|||
146630893|NCT01550003|528826187|FG001|Overall Study|Non-compliance|0|||
146630894|NCT01550003|528826188|FG002|Overall Study|Non-compliance|1|||
146630895|NCT01550003|528826186|FG000|Overall Study|Study closed|0|||
146884887|NCT01535729|529747826|FG000|Overall Study|Death|52|||
146630896|NCT01550003|528826187|FG001|Overall Study|Study closed|1|||
146630897|NCT01550003|528826188|FG002|Overall Study|Study closed|0|||
146630898|NCT01550003|528826186|FG000|Overall Study|Transitioned to adult rheumatology|0|||
146630899|NCT01550003|528826187|FG001|Overall Study|Transitioned to adult rheumatology|0|||
146630900|NCT01550003|528826188|FG002|Overall Study|Transitioned to adult rheumatology|1|||
146630901|NCT05567783|528826189|FG000|Overall Study|Death|2|||
146630902|NCT05567783|528826190|FG001|Overall Study|Death|3|||
146630903|NCT05567783|528826191|FG002|Overall Study|Death|0|||
146630904|NCT05567783|528826189|FG000|Overall Study|Lost to Follow-up|25|||
146630905|NCT05567783|528826190|FG001|Overall Study|Lost to Follow-up|19|||
146630906|NCT05567783|528826191|FG002|Overall Study|Lost to Follow-up|17|||
146765135|NCT04436120|529307274|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
146884888|NCT01535729|529747826|FG000|Overall Study|Other|19|||
146884889|NCT01535729|529747826|FG000|Overall Study|Did not sign informed consent|1|||
146884890|NCT01535729|529747826|FG000|Overall Study|No previous chemotherapy|33|||
146884891|NCT01535729|529747826|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
146884892|NCT01535729|529747826|FG000|Overall Study|Protocol Violation|11|||
146884893|NCT01535729|529747826|FG000|Overall Study|Screening failure|1|||
146884894|NCT01535729|529747826|FG000|Overall Study|Not treated|9|||
146884895|NCT01535729|529747826|FG000|Overall Study|No participant record available|5|||
146884896|NCT00494091|529747829|FG000|Overall Study|Death|5|||
146884897|NCT00494091|529747830|FG001|Overall Study|Death|54|||
146884898|NCT00494091|529747829|FG000|Overall Study|Lost to Follow-up|0|||
146884899|NCT00494091|529747830|FG001|Overall Study|Lost to Follow-up|4|||
146884900|NCT00494091|529747829|FG000|Overall Study|Other|1|||
146884901|NCT00494091|529747830|FG001|Overall Study|Other|11|||
146884902|NCT00494091|529747829|FG000|Overall Study|Withdrawal by Subject|0|||
146884903|NCT00494091|529747830|FG001|Overall Study|Withdrawal by Subject|7|||
146884904|NCT04161131|529747831|FG000|Overall Study|Ineligible|2|||
146884905|NCT04161131|529747831|FG000|Overall Study|Lost to Follow-up|4|||
146884906|NCT00984204|529747835|FG000|Overall Study|Death|1|||
146884907|NCT00984204|529747835|FG000|Overall Study|Lost to Follow-up|4|||
146884908|NCT00984204|529747835|FG000|Overall Study|Lack of Efficacy|10|||
146884909|NCT03757988|529747844|FG000|Overall Study|Withdrawal by Subject|1|||
146884910|NCT03806127|529747845|FG000|Overall Study|Withdrawal by Subject|4|||
146884911|NCT03806127|529747846|FG001|Overall Study|Withdrawal by Subject|5|||
146884912|NCT03806127|529747845|FG000|Overall Study|Protocol Violation|3|||
146884913|NCT03806127|529747846|FG001|Overall Study|Protocol Violation|1|||
146884914|NCT03806127|529747845|FG000|Overall Study|Adverse Event|3|||
146884915|NCT03806127|529747846|FG001|Overall Study|Adverse Event|0|||
146884916|NCT03806127|529747845|FG000|Overall Study|Unable to Complete Procedures|0|||
146884917|NCT03806127|529747846|FG001|Overall Study|Unable to Complete Procedures|1|||
146884918|NCT03806127|529747845|FG000|Overall Study|Pregnancy|0|||
146884919|NCT03806127|529747846|FG001|Overall Study|Pregnancy|1|||
146884920|NCT03806127|529747845|FG000|Overall Study|Lost to Follow-up|5|||
146884921|NCT03806127|529747846|FG001|Overall Study|Lost to Follow-up|1|||
146884922|NCT03806127|529747845|FG000|Overall Study|Physician Decision|1|||
146884923|NCT03806127|529747846|FG001|Overall Study|Physician Decision|1|||
146884924|NCT03806127|529747845|FG000|Overall Study|Could Not Come Due to Covid|1|||
146884925|NCT03806127|529747846|FG001|Overall Study|Could Not Come Due to Covid|0|||
146884926|NCT03806127|529747845|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
146884927|NCT03806127|529747846|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
146884928|NCT03806127|529747845|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
146884929|NCT03806127|529747846|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
146884930|NCT03806127|529747845|FG000|Overall Study|Covid 19 Restrictions|2|||
146884931|NCT03806127|529747846|FG001|Overall Study|Covid 19 Restrictions|0|||
146884932|NCT03806127|529747845|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
146884933|NCT03806127|529747846|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
146884934|NCT03806127|529747845|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
146884935|NCT03806127|529747846|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
146884936|NCT01100944|529747847|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
146884937|NCT01100944|529747848|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
146884938|NCT01100944|529747849|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
146884939|NCT01100944|529747847|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
146884940|NCT01100944|529747848|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
146884941|NCT01100944|529747849|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
146884942|NCT01100944|529747847|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
146884943|NCT01100944|529747848|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
146884944|NCT01100944|529747849|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
146884945|NCT01100944|529747847|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
146884946|NCT01100944|529747848|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
146884947|NCT01100944|529747849|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
146884948|NCT00577993|529747852|FG000|Overall Study|Adverse Event|1|||
146884949|NCT00577993|529747853|FG001|Overall Study|Adverse Event|0|||
146884950|NCT00577993|529747854|FG002|Overall Study|Adverse Event|0|||
146884951|NCT00577993|529747852|FG000|Overall Study|Death|0|||
146884952|NCT00577993|529747853|FG001|Overall Study|Death|1|||
146884953|NCT00577993|529747854|FG002|Overall Study|Death|1|||
146884954|NCT00577993|529747852|FG000|Overall Study|Lack of Efficacy|0|||
146884955|NCT00577993|529747853|FG001|Overall Study|Lack of Efficacy|1|||
146884956|NCT00577993|529747854|FG002|Overall Study|Lack of Efficacy|0|||
146884957|NCT00577993|529747852|FG000|Overall Study|Protocol Violation|2|||
146884958|NCT00577993|529747853|FG001|Overall Study|Protocol Violation|3|||
146630907|NCT05567783|528826189|FG000|Overall Study|Physician Decision|10|||
146630908|NCT05567783|528826190|FG001|Overall Study|Physician Decision|7|||
146630909|NCT05567783|528826191|FG002|Overall Study|Physician Decision|9|||
146630910|NCT05567783|528826189|FG000|Overall Study|Study Terminated by Sponsor|924|||
146630911|NCT05567783|528826190|FG001|Overall Study|Study Terminated by Sponsor|937|||
146630912|NCT05567783|528826191|FG002|Overall Study|Study Terminated by Sponsor|941|||
146630913|NCT05567783|528826189|FG000|Overall Study|Withdrawal by Subject|23|||
146630914|NCT05567783|528826190|FG001|Overall Study|Withdrawal by Subject|27|||
146630915|NCT05567783|528826191|FG002|Overall Study|Withdrawal by Subject|24|||
146630916|NCT05567783|528826189|FG000|Overall Study|Incarcerated|1|||
146630917|NCT05567783|528826190|FG001|Overall Study|Incarcerated|0|||
146630918|NCT05567783|528826191|FG002|Overall Study|Incarcerated|0|||
146630919|NCT05567783|528826189|FG000|Overall Study|Participant randomized in error|4|||
146630920|NCT05567783|528826190|FG001|Overall Study|Participant randomized in error|2|||
146630921|NCT05567783|528826191|FG002|Overall Study|Participant randomized in error|2|||
146630922|NCT03675126|528826194|FG000|Overall Study|Study Terminated by Sponsor|9|||
146630923|NCT03675126|528826194|FG000|Overall Study|Death|2|||
146630924|NCT03675126|528826194|FG000|Overall Study|Withdrawal by Subject|4|||
146630925|NCT00001959|528826195|FG000|Overall Study|newly diagnosed colon cancer|1|||
146630926|NCT00001959|528826195|FG000|Overall Study|disabling sedation|1|||
146630927|NCT00001959|528826195|FG000|Overall Study|non-compliance|1|||
146630928|NCT03113487|528826196|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
146630929|NCT03777982|528826197|FG000|Overall Study|Physician Decision|0|||
146630930|NCT03777982|528826198|FG001|Overall Study|Physician Decision|1|||
146630931|NCT04189952|528826201|FG000|Follow-up Period|Death|1|||
146630932|NCT04189952|528826201|FG000|Follow-up Period|Withdrawal by Subject|1|||
146630933|NCT04298697|528826204|FG000|Overall Study|Lost to Follow-up|5|||
146630934|NCT04298697|528826205|FG001|Overall Study|Lost to Follow-up|5|||
146630935|NCT04298697|528826206|FG002|Overall Study|Lost to Follow-up|1|||
146630936|NCT04298697|528826207|FG003|Overall Study|Lost to Follow-up|0|||
146630937|NCT04298697|528826204|FG000|Overall Study|Withdrawal by Subject|0|||
146630938|NCT04298697|528826205|FG001|Overall Study|Withdrawal by Subject|3|||
146630939|NCT04298697|528826206|FG002|Overall Study|Withdrawal by Subject|2|||
146630940|NCT04298697|528826207|FG003|Overall Study|Withdrawal by Subject|3|||
146630941|NCT03995368|528826208|FG000|Overall Study|Lost to Follow-up|1|||
146630942|NCT03995368|528826209|FG001|Overall Study|Lost to Follow-up|4|||
146630943|NCT03995368|528826210|FG002|Overall Study|Lost to Follow-up|1|||
146630944|NCT03995368|528826208|FG000|Overall Study|Did not meet inclusion criteria|1|||
146630945|NCT03995368|528826209|FG001|Overall Study|Did not meet inclusion criteria|6|||
146630946|NCT03995368|528826210|FG002|Overall Study|Did not meet inclusion criteria|3|||
146630947|NCT03995368|528826208|FG000|Overall Study|Withdrawal by Subject|0|||
146630948|NCT03995368|528826209|FG001|Overall Study|Withdrawal by Subject|1|||
146630949|NCT03995368|528826210|FG002|Overall Study|Withdrawal by Subject|1|||
146630950|NCT03592186|528826211|FG000|Overall Study|Withdrawal by Subject|1|||
146630951|NCT03592186|528826212|FG001|Overall Study|Withdrawal by Subject|0|||
146630952|NCT03592186|528826211|FG000|Overall Study|Lost to Follow-up|16|||
146630953|NCT03592186|528826212|FG001|Overall Study|Lost to Follow-up|11|||
146630954|NCT01052493|528826213|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
146630955|NCT01052493|528826214|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
146630956|NCT01052493|528826215|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
146630957|NCT00307801|528826216|FG000|Overall Study|Adverse Event|12|||
146630958|NCT00307801|528826217|FG001|Overall Study|Adverse Event|4|||
146630959|NCT00307801|528826216|FG000|Overall Study|Withdrawal by Subject|9|||
146630960|NCT00307801|528826217|FG001|Overall Study|Withdrawal by Subject|4|||
146630961|NCT00307801|528826216|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
146630962|NCT00307801|528826217|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
146630963|NCT00307801|528826216|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
146630964|NCT00307801|528826217|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
146630965|NCT00307801|528826216|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
146630966|NCT00307801|528826217|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
146630967|NCT00307801|528826216|FG000|Overall Study|Wrong Randomization|1|||
146630968|NCT00307801|528826217|FG001|Overall Study|Wrong Randomization|0|||
146630969|NCT00307801|528826216|FG000|Overall Study|Lack of Efficacy|0|||
146630970|NCT00307801|528826217|FG001|Overall Study|Lack of Efficacy|2|||
146630971|NCT00307801|528826216|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
146630972|NCT00307801|528826217|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
146630973|NCT00307801|528826216|FG000|Overall Study|Frustration with e-diary|1|||
146630974|NCT00307801|528826217|FG001|Overall Study|Frustration with e-diary|0|||
146630975|NCT00307801|528826216|FG000|Overall Study|Protocol Violation|3|||
146630976|NCT00307801|528826217|FG001|Overall Study|Protocol Violation|2|||
146630977|NCT00307801|528826216|FG000|Overall Study|No reason specified|2|||
146630978|NCT00307801|528826217|FG001|Overall Study|No reason specified|0|||
146630979|NCT00307801|528826216|FG000|Overall Study|Pregnancy|0|||
146630980|NCT00307801|528826217|FG001|Overall Study|Pregnancy|1|||
146630981|NCT00391586|528826221|FG000|Overall Study|Progressive disease|13|||
146630982|NCT00391586|528826221|FG000|Overall Study|Adverse Event|5|||
146765136|NCT04436120|529307275|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
146884959|NCT00577993|529747854|FG002|Overall Study|Protocol Violation|0|||
146884960|NCT00577993|529747852|FG000|Overall Study|Withdrawal by Subject|1|||
146884961|NCT00577993|529747853|FG001|Overall Study|Withdrawal by Subject|0|||
146884962|NCT00577993|529747854|FG002|Overall Study|Withdrawal by Subject|2|||
146884963|NCT00577993|529747852|FG000|Overall Study|Conversion|2|||
146884964|NCT00577993|529747853|FG001|Overall Study|Conversion|5|||
146548106|NCT03166631|528514669|FG009|Overall Study|Adverse Event|2|||
146548107|NCT03166631|528514670|FG010|Overall Study|Adverse Event|1|||
146548108|NCT03166631|528514660|FG000|Overall Study|Withdrawal by Subject|0|||
146548109|NCT03166631|528514661|FG001|Overall Study|Withdrawal by Subject|0|||
146548110|NCT03166631|528514662|FG002|Overall Study|Withdrawal by Subject|0|||
146548111|NCT03166631|528514663|FG003|Overall Study|Withdrawal by Subject|0|||
146548112|NCT03166631|528514664|FG004|Overall Study|Withdrawal by Subject|0|||
146548113|NCT03166631|528514665|FG005|Overall Study|Withdrawal by Subject|0|||
146548114|NCT03166631|528514666|FG006|Overall Study|Withdrawal by Subject|0|||
146548115|NCT03166631|528514667|FG007|Overall Study|Withdrawal by Subject|0|||
146548116|NCT03166631|528514668|FG008|Overall Study|Withdrawal by Subject|1|||
146548117|NCT03166631|528514669|FG009|Overall Study|Withdrawal by Subject|1|||
146548118|NCT03166631|528514670|FG010|Overall Study|Withdrawal by Subject|0|||
146548119|NCT03787212|528514674|FG000|Period 1|Study Termination|2|||
146548120|NCT03787212|528514675|FG001|Period 1|Study Termination|2|||
146548121|NCT02014103|528514676|FG000|Overall Study|Protocol Violation|7|||
146548122|NCT02014103|528514677|FG001|Overall Study|Protocol Violation|7|||
146548123|NCT02014103|528514676|FG000|Overall Study|Adverse Event|1|||
146548124|NCT02014103|528514677|FG001|Overall Study|Adverse Event|0|||
146548125|NCT02014103|528514676|FG000|Overall Study|Lost venous access|1|||
146548126|NCT02014103|528514677|FG001|Overall Study|Lost venous access|0|||
146548127|NCT02014103|528514676|FG000|Overall Study|Withdrawal by Subject|0|||
146548128|NCT02014103|528514677|FG001|Overall Study|Withdrawal by Subject|2|||
146548129|NCT05638737|528514678|FG000|Overall Study|Withdrawal by Subject|4|||
146884965|NCT00577993|529747854|FG002|Overall Study|Conversion|0|||
146884966|NCT00577993|529747852|FG000|Overall Study|Uninsured|1|||
146884967|NCT00577993|529747853|FG001|Overall Study|Uninsured|0|||
146884968|NCT00577993|529747854|FG002|Overall Study|Uninsured|0|||
146884969|NCT02217566|529747855|FG000|Overall Study|Lost to Follow-up|2|||
146548130|NCT05638737|528514679|FG001|Overall Study|Withdrawal by Subject|7|||
146548131|NCT00567580|528514682|FG000|Overall Study|Protocol Violation|28|||
146630983|NCT00391586|528826221|FG000|Overall Study|Physician Decision|2|||
146630984|NCT00391586|528826221|FG000|Overall Study|Death|4|||
146630985|NCT00453206|528826222|FG000|Overall Study|Death|1|||
146630986|NCT03058146|528826223|FG000|Overall Study|Withdrawal by Subject|4|||
146630987|NCT03058146|528826224|FG001|Overall Study|Withdrawal by Subject|1|||
146630988|NCT03058146|528826223|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
146630989|NCT03058146|528826224|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
146630990|NCT00632229|528826225|FG000|Overall Study|Adverse Event|6|||
146630991|NCT00632229|528826226|FG001|Overall Study|Adverse Event|0|||
146630992|NCT00632229|528826225|FG000|Overall Study|Lost to Follow-up|0|||
146630993|NCT00632229|528826226|FG001|Overall Study|Lost to Follow-up|3|||
146630994|NCT00632229|528826225|FG000|Overall Study|Lack of Efficacy|0|||
146630995|NCT00632229|528826226|FG001|Overall Study|Lack of Efficacy|2|||
146630996|NCT00632229|528826225|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
146765137|NCT04436120|529307276|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
146765138|NCT02357784|529307277|FG000|Overall Study|Withdrawal by Subject|1|||
146765139|NCT00462943|529307280|FG000|Overall Study|Failure to achieve a response|5|||
146630997|NCT00632229|528826226|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
146630998|NCT00577889|528826228|FG000|Overall Study|Withdrawal by Subject|1|||
146630999|NCT00577889|528826229|FG001|Overall Study|Withdrawal by Subject|0|||
146631000|NCT00577889|528826230|FG002|Overall Study|Withdrawal by Subject|0|||
146631001|NCT00993967|528826234|FG000|Overall Study|Adverse Event|8|||
146631002|NCT00993967|528826234|FG000|Overall Study|Death|1|||
146884970|NCT02217566|529747855|FG000|Overall Study|Death|3|||
146884971|NCT02217566|529747855|FG000|Overall Study|Early study termination|6|||
146884972|NCT02296242|529747856|FG000|Overall Study|Death|1|||
146884973|NCT02296242|529747857|FG001|Overall Study|Death|1|||
146884974|NCT02296242|529747858|FG002|Overall Study|Death|1|||
146884975|NCT02296242|529747859|FG003|Overall Study|Death|1|||
146884976|NCT02296242|529747860|FG004|Overall Study|Death|1|||
146884977|NCT02296242|529747856|FG000|Overall Study|Withdrawal by Subject|0|||
146884978|NCT02296242|529747857|FG001|Overall Study|Withdrawal by Subject|0|||
146884979|NCT02296242|529747858|FG002|Overall Study|Withdrawal by Subject|1|||
146884980|NCT02296242|529747859|FG003|Overall Study|Withdrawal by Subject|1|||
146884981|NCT02296242|529747860|FG004|Overall Study|Withdrawal by Subject|3|||
146884982|NCT02296242|529747856|FG000|Overall Study|Disease Progression|1|||
146884983|NCT02296242|529747857|FG001|Overall Study|Disease Progression|3|||
146884984|NCT02296242|529747858|FG002|Overall Study|Disease Progression|2|||
146884985|NCT02296242|529747859|FG003|Overall Study|Disease Progression|8|||
146884986|NCT02296242|529747860|FG004|Overall Study|Disease Progression|11|||
146884987|NCT02296242|529747856|FG000|Overall Study|Unacceptable Toxicity|0|||
146884988|NCT02296242|529747857|FG001|Overall Study|Unacceptable Toxicity|0|||
146884989|NCT02296242|529747858|FG002|Overall Study|Unacceptable Toxicity|0|||
146884990|NCT02296242|529747859|FG003|Overall Study|Unacceptable Toxicity|0|||
146884991|NCT02296242|529747860|FG004|Overall Study|Unacceptable Toxicity|1|||
146884992|NCT02296242|529747856|FG000|Overall Study|Patient Condition Changed|0|||
146884993|NCT02296242|529747857|FG001|Overall Study|Patient Condition Changed|0|||
146884994|NCT02296242|529747858|FG002|Overall Study|Patient Condition Changed|2|||
146884995|NCT02296242|529747859|FG003|Overall Study|Patient Condition Changed|0|||
146884996|NCT02296242|529747860|FG004|Overall Study|Patient Condition Changed|1|||
146884997|NCT02296242|529747856|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
146884998|NCT02296242|529747857|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
146884999|NCT02296242|529747858|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
146885000|NCT02296242|529747859|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
146885001|NCT02296242|529747860|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
146885002|NCT02296242|529747856|FG000|Overall Study|Lost to Follow-up|1|||
146885003|NCT02296242|529747857|FG001|Overall Study|Lost to Follow-up|0|||
146885004|NCT02296242|529747858|FG002|Overall Study|Lost to Follow-up|0|||
146885005|NCT02296242|529747859|FG003|Overall Study|Lost to Follow-up|0|||
146885006|NCT02296242|529747860|FG004|Overall Study|Lost to Follow-up|0|||
146885007|NCT02296242|529747856|FG000|Overall Study|Need for Hydroxyurea|2|||
146885008|NCT02296242|529747857|FG001|Overall Study|Need for Hydroxyurea|0|||
146885009|NCT02296242|529747858|FG002|Overall Study|Need for Hydroxyurea|0|||
146885010|NCT02296242|529747859|FG003|Overall Study|Need for Hydroxyurea|0|||
146885011|NCT02296242|529747860|FG004|Overall Study|Need for Hydroxyurea|0|||
146885012|NCT02296242|529747856|FG000|Overall Study|Screened for Other Protocol|0|||
146885013|NCT02296242|529747857|FG001|Overall Study|Screened for Other Protocol|1|||
146885014|NCT02296242|529747858|FG002|Overall Study|Screened for Other Protocol|0|||
146885015|NCT02296242|529747859|FG003|Overall Study|Screened for Other Protocol|0|||
146885016|NCT02296242|529747860|FG004|Overall Study|Screened for Other Protocol|0|||
146885017|NCT02296242|529747856|FG000|Overall Study|Physician Decision|0|||
146885018|NCT02296242|529747857|FG001|Overall Study|Physician Decision|1|||
146885019|NCT02296242|529747858|FG002|Overall Study|Physician Decision|0|||
146885020|NCT02296242|529747859|FG003|Overall Study|Physician Decision|1|||
146885021|NCT02296242|529747860|FG004|Overall Study|Physician Decision|0|||
146885022|NCT02296242|529747856|FG000|Overall Study|Alternative Treatment|0|||
146885023|NCT02296242|529747857|FG001|Overall Study|Alternative Treatment|0|||
146885024|NCT02296242|529747858|FG002|Overall Study|Alternative Treatment|0|||
146885025|NCT02296242|529747859|FG003|Overall Study|Alternative Treatment|1|||
146885026|NCT02296242|529747860|FG004|Overall Study|Alternative Treatment|0|||
146885027|NCT02296242|529747856|FG000|Overall Study|Adverse Event|0|||
146885028|NCT02296242|529747857|FG001|Overall Study|Adverse Event|0|||
146885029|NCT02296242|529747858|FG002|Overall Study|Adverse Event|0|||
146885030|NCT02296242|529747859|FG003|Overall Study|Adverse Event|1|||
146885031|NCT02296242|529747860|FG004|Overall Study|Adverse Event|0|||
146885032|NCT02296242|529747856|FG000|Overall Study|Lack of Efficacy|0|||
146885033|NCT02296242|529747857|FG001|Overall Study|Lack of Efficacy|0|||
146885034|NCT02296242|529747858|FG002|Overall Study|Lack of Efficacy|0|||
146885035|NCT02296242|529747859|FG003|Overall Study|Lack of Efficacy|0|||
146885036|NCT02296242|529747860|FG004|Overall Study|Lack of Efficacy|3|||
146885037|NCT01639833|529747862|FG000|Overall Study|Death|4|||
146885038|NCT01639833|529747863|FG001|Overall Study|Death|2|||
146885039|NCT01639833|529747862|FG000|Overall Study|Withdrawal by Subject|2|||
146885040|NCT01639833|529747863|FG001|Overall Study|Withdrawal by Subject|2|||
146885041|NCT02064387|529747865|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146885042|NCT02064387|529747866|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146885043|NCT02064387|529747867|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146548132|NCT00567580|528514683|FG001|Overall Study|Protocol Violation|24|||
146548133|NCT00567580|528514684|FG002|Overall Study|Protocol Violation|24|||
146548134|NCT00884949|528514686|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
146548135|NCT00884949|528514686|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
146548136|NCT03022630|528514687|FG000|Overall Study|Death|9|||
146548137|NCT03022630|528514688|FG001|Overall Study|Death|7|||
146548138|NCT03022630|528514687|FG000|Overall Study|Withdrawal by Subject|0|||
146548139|NCT03022630|528514688|FG001|Overall Study|Withdrawal by Subject|5|||
146548140|NCT00382070|528514689|FG000|Overall Study|No follow up data mapped to Other|17|||
146548141|NCT00382070|528514690|FG001|Overall Study|No follow up data mapped to Other|19|||
146548142|NCT00382070|528514689|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
146548143|NCT00382070|528514690|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
146548144|NCT00382070|528514689|FG000|Overall Study|No clinical assessment|9|||
146548145|NCT00382070|528514690|FG001|Overall Study|No clinical assessment|11|||
146548146|NCT04149353|528514694|FG000|Overall Study|Study terminated|1|||
146548147|NCT02068599|528514695|FG000|Overall Study|Adverse Event|4|||
146548148|NCT02068599|528514696|FG001|Overall Study|Adverse Event|1|||
146548149|NCT02068599|528514697|FG002|Overall Study|Adverse Event|1|||
146548150|NCT02068599|528514695|FG000|Overall Study|Withdrawal by Subject|2|||
146548151|NCT02068599|528514696|FG001|Overall Study|Withdrawal by Subject|7|||
146548152|NCT02068599|528514697|FG002|Overall Study|Withdrawal by Subject|5|||
146548153|NCT02068599|528514695|FG000|Overall Study|Protocol Violation|4|||
146548154|NCT02068599|528514696|FG001|Overall Study|Protocol Violation|2|||
146548155|NCT02068599|528514697|FG002|Overall Study|Protocol Violation|3|||
146548156|NCT02068599|528514695|FG000|Overall Study|Lost to Follow-up|1|||
146548157|NCT02068599|528514696|FG001|Overall Study|Lost to Follow-up|0|||
146885044|NCT02064387|529747868|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146885045|NCT02064387|529747869|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146548158|NCT02068599|528514697|FG002|Overall Study|Lost to Follow-up|0|||
146548159|NCT02068599|528514695|FG000|Overall Study|Lack of Efficacy|0|||
146548160|NCT02068599|528514696|FG001|Overall Study|Lack of Efficacy|0|||
146548161|NCT02068599|528514697|FG002|Overall Study|Lack of Efficacy|3|||
146548162|NCT02068599|528514695|FG000|Overall Study|Noncompliance|0|||
146548163|NCT02068599|528514696|FG001|Overall Study|Noncompliance|0|||
146548164|NCT02068599|528514697|FG002|Overall Study|Noncompliance|1|||
146548165|NCT01871727|528514698|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
146885046|NCT02064387|529747870|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146885047|NCT02064387|529747871|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146885048|NCT02064387|529747872|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
146548166|NCT01871727|528514699|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
146548167|NCT01871727|528514700|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
146631003|NCT00993967|528826234|FG000|Overall Study|Lost to Follow-up|14|||
146885049|NCT02064387|529747873|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146885050|NCT02064387|529747874|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
146885051|NCT02064387|529747875|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146885052|NCT02064387|529747876|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146885053|NCT02064387|529747865|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146885054|NCT02064387|529747866|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146885055|NCT02064387|529747867|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146885056|NCT02064387|529747868|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146885057|NCT02064387|529747869|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146885058|NCT02064387|529747870|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146885059|NCT02064387|529747871|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146885060|NCT02064387|529747872|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
146885061|NCT02064387|529747873|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146885062|NCT02064387|529747874|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146885063|NCT02064387|529747875|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146885064|NCT02064387|529747876|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146885065|NCT02064387|529747865|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146885066|NCT02064387|529747866|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146885067|NCT02064387|529747867|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146885068|NCT02064387|529747868|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146885069|NCT02064387|529747869|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146885070|NCT02064387|529747870|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146885071|NCT02064387|529747871|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146885072|NCT02064387|529747872|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146885073|NCT02064387|529747873|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
146885074|NCT02064387|529747874|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146885075|NCT02064387|529747875|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146885076|NCT02064387|529747876|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146885077|NCT02064387|529747865|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
146885078|NCT02064387|529747866|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
146885079|NCT02064387|529747867|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
146885080|NCT02064387|529747868|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
146885081|NCT02064387|529747869|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
146885082|NCT02064387|529747870|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
146548168|NCT01871727|528514701|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
146548169|NCT01871727|528514702|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
146548170|NCT01871727|528514698|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
146548171|NCT01871727|528514699|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
146548172|NCT01871727|528514700|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
146548173|NCT01871727|528514701|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
146548174|NCT01871727|528514702|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
146548175|NCT01871727|528514698|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
146548176|NCT01871727|528514699|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
146548177|NCT01871727|528514700|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
146548178|NCT01871727|528514701|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
146548179|NCT01871727|528514702|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
146548180|NCT01871727|528514698|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
146548181|NCT01871727|528514699|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
146548182|NCT01871727|528514700|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
146548183|NCT01871727|528514701|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
146548184|NCT01871727|528514702|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
146548185|NCT01871727|528514698|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
146548186|NCT01871727|528514699|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
146548187|NCT01871727|528514700|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
146548188|NCT01871727|528514701|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
146548189|NCT01871727|528514702|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
146548190|NCT01871727|528514698|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
146548191|NCT01871727|528514699|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
146548192|NCT01871727|528514700|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
146548193|NCT01871727|528514701|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
146548194|NCT01871727|528514702|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
146548195|NCT01871727|528514698|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
146548196|NCT01871727|528514699|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
146548197|NCT01871727|528514700|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
146548198|NCT01871727|528514701|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
146885083|NCT02064387|529747871|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
146885084|NCT02064387|529747872|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
146885085|NCT02064387|529747873|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
146885086|NCT02064387|529747874|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
146885087|NCT02064387|529747875|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
146885088|NCT02064387|529747876|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
146885089|NCT02064387|529747865|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146885090|NCT02064387|529747866|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146885091|NCT02064387|529747867|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146885092|NCT02064387|529747868|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146885093|NCT02064387|529747869|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146885094|NCT02064387|529747870|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146885095|NCT02064387|529747871|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146885096|NCT02064387|529747872|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146885097|NCT02064387|529747873|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146885098|NCT02064387|529747874|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146885099|NCT02064387|529747875|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
146885100|NCT02064387|529747876|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146885101|NCT02499029|529747877|FG000|Overall Study|Lost to Follow-up|2|||
146885102|NCT02499029|529747878|FG001|Overall Study|Lost to Follow-up|2|||
146885103|NCT02499029|529747877|FG000|Overall Study|Physician Decision|2|||
146885104|NCT02499029|529747878|FG001|Overall Study|Physician Decision|1|||
146885105|NCT02499029|529747877|FG000|Overall Study|Death|1|||
146885106|NCT02499029|529747878|FG001|Overall Study|Death|0|||
146885107|NCT02462473|529747879|FG000|Overall Study|Death|1|||
146885108|NCT02462473|529747879|FG000|Overall Study|Other|3|||
146885109|NCT03728309|529747883|FG000|Overall Study|Randomized but not Treated|0|||
146885110|NCT03728309|529747884|FG001|Overall Study|Randomized but not Treated|1|||
146885111|NCT03728309|529747883|FG000|Overall Study|Adverse Event|0|||
146885112|NCT03728309|529747884|FG001|Overall Study|Adverse Event|1|||
146885113|NCT03728309|529747883|FG000|Overall Study|Withdrawal by Subject|2|||
146885114|NCT03728309|529747884|FG001|Overall Study|Withdrawal by Subject|8|||
146885115|NCT03728309|529747883|FG000|Overall Study|Lost to Follow-up|9|||
146885116|NCT03728309|529747884|FG001|Overall Study|Lost to Follow-up|10|||
146885117|NCT03728309|529747883|FG000|Overall Study|Protocol Deviation|0|||
146885118|NCT03728309|529747884|FG001|Overall Study|Protocol Deviation|1|||
146885119|NCT03728309|529747883|FG000|Overall Study|Due to COVID|1|||
146885120|NCT03728309|529747884|FG001|Overall Study|Due to COVID|3|||
146885121|NCT02436876|529747885|FG000|Overall Study|Lost to Follow-up|0|||
146885122|NCT02436876|529747886|FG001|Overall Study|Lost to Follow-up|1|||
146885123|NCT02436876|529747887|FG002|Overall Study|Lost to Follow-up|1|||
146885124|NCT02436876|529747888|FG003|Overall Study|Lost to Follow-up|1|||
146885125|NCT02436876|529747885|FG000|Overall Study|Withdrawal by Subject|1|||
146885126|NCT02436876|529747886|FG001|Overall Study|Withdrawal by Subject|0|||
146885127|NCT02436876|529747887|FG002|Overall Study|Withdrawal by Subject|0|||
146885128|NCT02436876|529747888|FG003|Overall Study|Withdrawal by Subject|1|||
146548199|NCT01871727|528514702|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
146548200|NCT01263028|528514703|FG000|Overall Study|Withdrawal by Subject|1|||
146548201|NCT01263028|528514703|FG000|Overall Study|Adverse Event|1|||
146548202|NCT01263028|528514703|FG000|Overall Study|Study terminated due to low enrollment.|4|||
146885129|NCT02436876|529747885|FG000|Overall Study|Physician Decision|0|||
146885130|NCT02436876|529747886|FG001|Overall Study|Physician Decision|2|||
146885131|NCT02436876|529747887|FG002|Overall Study|Physician Decision|1|||
146885132|NCT02436876|529747888|FG003|Overall Study|Physician Decision|0|||
146885133|NCT02436876|529747885|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
146885134|NCT02436876|529747886|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
146885135|NCT02436876|529747887|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
146548203|NCT03019588|528514704|FG000|Overall Study|Death|44|||
146548204|NCT03019588|528514705|FG001|Overall Study|Death|46|||
146885136|NCT02436876|529747888|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
146885137|NCT00999908|529747891|FG000|Treatment Period 1|Subject withdrew consent|2|||
146885138|NCT00999908|529747892|FG001|Treatment Period 1|Subject withdrew consent|0|||
146885139|NCT00999908|529747893|FG002|Treatment Period 1|Subject withdrew consent|0|||
146885140|NCT00999908|529747891|FG000|Treatment Period 2|Protocol Violation|1|||
146885141|NCT00999908|529747892|FG001|Treatment Period 2|Protocol Violation|0|||
146885142|NCT00999908|529747893|FG002|Treatment Period 2|Protocol Violation|0|||
146885143|NCT01707693|529747895|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
146885144|NCT01707693|529747896|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
146885145|NCT01707693|529747895|FG000|Overall Study Allocation|Protocol Violation|4|||
146885146|NCT01707693|529747896|FG001|Overall Study Allocation|Protocol Violation|3|||
146885147|NCT01707693|529747895|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
146885148|NCT01707693|529747896|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
146885149|NCT01707693|529747895|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
146885150|NCT01707693|529747896|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
146885151|NCT00927095|529747898|FG000|Overall Study|Adverse Event|3|||
146885152|NCT00927095|529747899|FG001|Overall Study|Adverse Event|1|||
146885153|NCT00927095|529747900|FG002|Overall Study|Adverse Event|0|||
146885154|NCT00927095|529747898|FG000|Overall Study|Withdrawal by Subject|2|||
146885155|NCT00927095|529747899|FG001|Overall Study|Withdrawal by Subject|1|||
146885156|NCT00927095|529747900|FG002|Overall Study|Withdrawal by Subject|1|||
146885157|NCT00927095|529747898|FG000|Overall Study|Physician Decision|1|||
146885158|NCT00927095|529747899|FG001|Overall Study|Physician Decision|2|||
146885159|NCT00927095|529747900|FG002|Overall Study|Physician Decision|1|||
146885160|NCT01290692|529747904|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
146548205|NCT03019588|528514704|FG000|Overall Study|Study terminated by Sponsor|3|||
146548206|NCT03019588|528514705|FG001|Overall Study|Study terminated by Sponsor|1|||
146548207|NCT00887588|528514708|FG000|Core Period|Death|1|||
146548208|NCT00887588|528514709|FG001|Core Period|Death|1|||
146548209|NCT00887588|528514708|FG000|Core Period|Lost to Follow-up|3|||
146548210|NCT00887588|528514709|FG001|Core Period|Lost to Follow-up|1|||
146548211|NCT00887588|528514708|FG000|Core Period|Withdrawal by Subject|6|||
146548212|NCT00887588|528514709|FG001|Core Period|Withdrawal by Subject|8|||
146548213|NCT00887588|528514708|FG000|Core Period|Adverse Event|9|||
146548214|NCT00887588|528514709|FG001|Core Period|Adverse Event|11|||
146548215|NCT00887588|528514708|FG000|Extension Period|Adverse Event|4|||
146548216|NCT00887588|528514709|FG001|Extension Period|Adverse Event|4|||
146548217|NCT00887588|528514708|FG000|Extension Period|Death|0|||
146548218|NCT00887588|528514709|FG001|Extension Period|Death|1|||
146548219|NCT00887588|528514708|FG000|Extension Period|Protocol deviation|1|||
146548220|NCT00887588|528514709|FG001|Extension Period|Protocol deviation|0|||
146548221|NCT00887588|528514708|FG000|Extension Period|Lost to Follow-up|1|||
146548222|NCT00887588|528514709|FG001|Extension Period|Lost to Follow-up|0|||
146548223|NCT00366535|528514710|FG000|First Phase: 12 Weeks|Adverse Event|1|||
146548224|NCT00366535|528514711|FG001|First Phase: 12 Weeks|Adverse Event|3|||
146548225|NCT00366535|528514710|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
146548226|NCT00366535|528514711|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
146548227|NCT00366535|528514710|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
146631004|NCT00993967|528826234|FG000|Overall Study|Withdrawal by Subject|36|||
146885161|NCT03115151|529747908|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
146885162|NCT03115151|529747909|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
146885163|NCT03115151|529747908|FG000|Overall Study|Epidural catheter removal|1|||
146885164|NCT03115151|529747909|FG001|Overall Study|Epidural catheter removal|0|||
146548228|NCT00366535|528514711|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
146548229|NCT00366535|528514710|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
146548230|NCT00366535|528514711|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
146548231|NCT02958527|528514716|FG000|Overall Study|Not collected CRFs|12|||
146548232|NCT02691572|528514717|FG000|Overall Study|Withdrawal by Subject|1|||
146548233|NCT02691572|528514718|FG001|Overall Study|Withdrawal by Subject|0|||
146548234|NCT02691572|528514717|FG000|Overall Study|Protocol Violation|0|||
146548235|NCT02691572|528514718|FG001|Overall Study|Protocol Violation|1|||
146548236|NCT00699751|528514719|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
146548237|NCT00699751|528514720|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
146548238|NCT00699751|528514719|FG000|Period 1: Without/Before Drug Switch|Death|28|||
146548239|NCT00699751|528514720|FG001|Period 1: Without/Before Drug Switch|Death|29|||
146548240|NCT00699751|528514719|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
146548241|NCT00699751|528514720|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
146548242|NCT00699751|528514719|FG000|Period 1: Without/Before Drug Switch|Other|30|||
146548243|NCT00699751|528514720|FG001|Period 1: Without/Before Drug Switch|Other|20|||
146548244|NCT00699751|528514719|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
146885165|NCT03115151|529747908|FG000|Overall Study|Withdrawal by Subject|0|||
146885166|NCT03115151|529747909|FG001|Overall Study|Withdrawal by Subject|1|||
146885167|NCT03115151|529747908|FG000|Overall Study|Intervention not received according to the protocol.|1|||
146885168|NCT03115151|529747909|FG001|Overall Study|Intervention not received according to the protocol.|1|||
146885169|NCT03115151|529747908|FG000|Overall Study|Physician Decision|1|||
146885170|NCT03115151|529747909|FG001|Overall Study|Physician Decision|0|||
146885171|NCT03115151|529747908|FG000|Overall Study|Randomization not applied|1|||
146885172|NCT03115151|529747909|FG001|Overall Study|Randomization not applied|1|||
146885173|NCT03403205|529747910|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
146548245|NCT00699751|528514720|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
146548246|NCT00699751|528514719|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
146548247|NCT00699751|528514720|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
146548248|NCT00699751|528514719|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
146548249|NCT00699751|528514720|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
146548250|NCT00699751|528514719|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
146548251|NCT00699751|528514720|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
146548252|NCT01947933|528514721|FG000|Overall Study|Withdrawal by Subject|0|||
146885174|NCT03403205|529747911|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
146885175|NCT03403205|529747912|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
146885176|NCT03403205|529747913|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
146885177|NCT03403205|529747914|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
146885178|NCT03403205|529747915|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
146885179|NCT03403205|529747910|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
146885180|NCT03403205|529747911|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146885181|NCT03403205|529747912|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
146885182|NCT03403205|529747913|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146885183|NCT03403205|529747914|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146885184|NCT03403205|529747915|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146885185|NCT03403205|529747910|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
146885186|NCT03403205|529747911|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
146885187|NCT03403205|529747912|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
146885188|NCT03403205|529747913|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
146885189|NCT03403205|529747914|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
146885190|NCT03403205|529747915|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
146885191|NCT03403205|529747910|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
146548253|NCT01947933|528514722|FG001|Overall Study|Withdrawal by Subject|0|||
146548254|NCT01947933|528514723|FG002|Overall Study|Withdrawal by Subject|1|||
146548255|NCT01947933|528514724|FG003|Overall Study|Withdrawal by Subject|0|||
146548256|NCT01947933|528514725|FG004|Overall Study|Withdrawal by Subject|0|||
146548257|NCT01947933|528514726|FG005|Overall Study|Withdrawal by Subject|0|||
146548258|NCT01947933|528514727|FG006|Overall Study|Withdrawal by Subject|0|||
146548259|NCT01947933|528514728|FG007|Overall Study|Withdrawal by Subject|0|||
146548260|NCT01947933|528514729|FG008|Overall Study|Withdrawal by Subject|0|||
146548261|NCT01947933|528514721|FG000|Overall Study|Lost to Follow-up|0|||
146548262|NCT01947933|528514722|FG001|Overall Study|Lost to Follow-up|0|||
146548263|NCT01947933|528514723|FG002|Overall Study|Lost to Follow-up|0|||
146548264|NCT01947933|528514724|FG003|Overall Study|Lost to Follow-up|0|||
146548265|NCT01947933|528514725|FG004|Overall Study|Lost to Follow-up|0|||
146548266|NCT01947933|528514726|FG005|Overall Study|Lost to Follow-up|0|||
146548267|NCT01947933|528514727|FG006|Overall Study|Lost to Follow-up|0|||
146548268|NCT01947933|528514728|FG007|Overall Study|Lost to Follow-up|0|||
146548269|NCT01947933|528514729|FG008|Overall Study|Lost to Follow-up|1|||
146548270|NCT00294398|528514730|FG000|Overall Study|Lost to Follow-up|21|||
146548271|NCT00294398|528514731|FG001|Overall Study|Lost to Follow-up|26|||
146548272|NCT00985790|528514732|FG000|Overall Study|Withdrawal by Subject|1|||
146548273|NCT00985790|528514733|FG001|Overall Study|Withdrawal by Subject|1|||
146548274|NCT00985790|528514732|FG000|Overall Study|Lost to Follow-up|6|||
146548275|NCT00985790|528514733|FG001|Overall Study|Lost to Follow-up|7|||
146548276|NCT03753542|528514737|FG000|Overall Study|Lost to Follow-up|9|||
146548277|NCT03753542|528514738|FG001|Overall Study|Lost to Follow-up|14|||
146548278|NCT06100250|528514739|FG000|Overall Study|Lost to Follow-up|5|||
146548279|NCT05089357|528514742|FG000|Overall Study|Withdrawal by Subject|23|||
146548280|NCT05089357|528514742|FG000|Overall Study|Lost to Follow-up|6|||
146548281|NCT05089357|528514742|FG000|Overall Study|Medical reason|1|||
146548282|NCT05089357|528514742|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
146548283|NCT05089357|528514742|FG000|Overall Study|Pregnancy|2|||
146548284|NCT05537571|528514743|FG000|Overall Study|Withdrawal by Subject|1|||
146548285|NCT05537571|528514744|FG001|Overall Study|Withdrawal by Subject|1|||
146548286|NCT05537571|528514745|FG002|Overall Study|Withdrawal by Subject|0|||
146548287|NCT05537571|528514746|FG003|Overall Study|Withdrawal by Subject|0|||
146548288|NCT05537571|528514747|FG004|Overall Study|Withdrawal by Subject|0|||
146548289|NCT05537571|528514743|FG000|Overall Study|Adverse Event|2|||
146548290|NCT05537571|528514744|FG001|Overall Study|Adverse Event|0|||
146548291|NCT05537571|528514745|FG002|Overall Study|Adverse Event|0|||
146548292|NCT05537571|528514746|FG003|Overall Study|Adverse Event|0|||
146548293|NCT05537571|528514747|FG004|Overall Study|Adverse Event|0|||
146548294|NCT05537571|528514743|FG000|Overall Study|Hepatitis A screening result|2|||
146548295|NCT05537571|528514744|FG001|Overall Study|Hepatitis A screening result|0|||
146548296|NCT05537571|528514745|FG002|Overall Study|Hepatitis A screening result|0|||
146548297|NCT05537571|528514746|FG003|Overall Study|Hepatitis A screening result|0|||
146548298|NCT05537571|528514747|FG004|Overall Study|Hepatitis A screening result|0|||
146548299|NCT05537571|528514743|FG000|Overall Study|Lost to Follow-up|0|||
146548300|NCT05537571|528514744|FG001|Overall Study|Lost to Follow-up|0|||
146548301|NCT05537571|528514745|FG002|Overall Study|Lost to Follow-up|1|||
146548302|NCT05537571|528514746|FG003|Overall Study|Lost to Follow-up|0|||
146548303|NCT05537571|528514747|FG004|Overall Study|Lost to Follow-up|1|||
146548304|NCT04180696|528514748|FG000|Overall Study|Death|5|||
146548305|NCT04180696|528514749|FG001|Overall Study|Death|6|||
146548306|NCT04180696|528514748|FG000|Overall Study|Lost to Follow-up|1|||
146631005|NCT00993967|528826234|FG000|Overall Study|Protocol Violation|2|||
146631006|NCT04825678|528826237|FG000|Overall Study|Decision by Sponsor|2|||
146631007|NCT04825678|528826238|FG001|Overall Study|Decision by Sponsor|3|||
146631008|NCT04825678|528826237|FG000|Overall Study|Withdrawal of Consent From Study|7|||
146631009|NCT04825678|528826238|FG001|Overall Study|Withdrawal of Consent From Study|9|||
146631010|NCT04825678|528826237|FG000|Overall Study|Lost to Follow-up|3|||
146631011|NCT04825678|528826238|FG001|Overall Study|Lost to Follow-up|4|||
146631012|NCT04825678|528826237|FG000|Overall Study|Never Received Investigational Product|1|||
146631013|NCT04825678|528826238|FG001|Overall Study|Never Received Investigational Product|1|||
146631014|NCT00651742|528826239|FG000|Overall Study|Objective Disease Progression|22|||
146631015|NCT00651742|528826239|FG000|Overall Study|Toxicity|3|||
146631016|NCT00651742|528826239|FG000|Overall Study|Investigator Judgment|1|||
146631017|NCT00651742|528826239|FG000|Overall Study|Withdrawal of Consent|1|||
146631018|NCT00651742|528826239|FG000|Overall Study|Enrolled but not treated|1|||
146631019|NCT00911170|528826240|FG000|Treatment Period|Randomized in error|1|||
146631020|NCT00911170|528826241|FG001|Treatment Period|Randomized in error|1|||
146631021|NCT00911170|528826240|FG000|Treatment Period|Ineligibility determined|1|||
146631022|NCT00911170|528826241|FG001|Treatment Period|Ineligibility determined|3|||
146631023|NCT00911170|528826240|FG000|Treatment Period|Protocol deviation|1|||
146631024|NCT00911170|528826241|FG001|Treatment Period|Protocol deviation|2|||
146631025|NCT00911170|528826240|FG000|Treatment Period|Adverse Event|9|||
146631026|NCT00911170|528826241|FG001|Treatment Period|Adverse Event|10|||
146631027|NCT00911170|528826240|FG000|Treatment Period|Withdrawal by Subject|4|||
146631028|NCT00911170|528826241|FG001|Treatment Period|Withdrawal by Subject|4|||
146631029|NCT00911170|528826240|FG000|Treatment Period|Disease progression|0|||
146631030|NCT00911170|528826241|FG001|Treatment Period|Disease progression|2|||
146631031|NCT00911170|528826240|FG000|Treatment Period|Physician Decision|5|||
146631032|NCT00911170|528826241|FG001|Treatment Period|Physician Decision|5|||
146631033|NCT00911170|528826240|FG000|Treatment Period|Lost to Follow-up|0|||
146631034|NCT00911170|528826241|FG001|Treatment Period|Lost to Follow-up|1|||
146631035|NCT00911170|528826240|FG000|Treatment Period|Death|6|||
146631036|NCT00911170|528826241|FG001|Treatment Period|Death|9|||
146631037|NCT00911170|528826240|FG000|Long Term Follow-Up|Continuing in study|274|||
146631038|NCT00911170|528826241|FG001|Long Term Follow-Up|Continuing in study|269|||
146631039|NCT00911170|528826240|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
146631040|NCT00911170|528826241|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
146631041|NCT00911170|528826240|FG000|Long Term Follow-Up|Physician Decision|5|||
146631042|NCT00911170|528826241|FG001|Long Term Follow-Up|Physician Decision|4|||
146631043|NCT00911170|528826240|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
146631044|NCT00911170|528826241|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
146631045|NCT00911170|528826240|FG000|Long Term Follow-Up|Death|116|||
146631046|NCT00911170|528826241|FG001|Long Term Follow-Up|Death|121|||
146885192|NCT03403205|529747911|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
146631047|NCT02594124|528826242|FG000|Overall Study|Adverse Event|0|||
146631048|NCT02594124|528826243|FG001|Overall Study|Adverse Event|5|||
146631049|NCT02594124|528826244|FG002|Overall Study|Adverse Event|8|||
146631050|NCT02594124|528826245|FG003|Overall Study|Adverse Event|1|||
146631051|NCT02594124|528826246|FG004|Overall Study|Adverse Event|0|||
146631052|NCT02594124|528826247|FG005|Overall Study|Adverse Event|0|||
146631053|NCT02594124|528826248|FG006|Overall Study|Adverse Event|2|||
146885193|NCT03403205|529747912|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
146631054|NCT02594124|528826249|FG007|Overall Study|Adverse Event|2|||
146885194|NCT03403205|529747913|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
146631055|NCT02594124|528826250|FG008|Overall Study|Adverse Event|0|||
146631056|NCT02594124|528826242|FG000|Overall Study|Withdrawal by Subject|2|||
146548307|NCT04180696|528514749|FG001|Overall Study|Lost to Follow-up|0|||
146548308|NCT04180696|528514748|FG000|Overall Study|Withdrawal by Subject|0|||
146548309|NCT04180696|528514749|FG001|Overall Study|Withdrawal by Subject|1|||
146548310|NCT04210375|528514750|FG000|Overall Study|Death|0|||
146548311|NCT04210375|528514751|FG001|Overall Study|Death|1|||
146548312|NCT04210375|528514752|FG002|Overall Study|Death|0|||
146548313|NCT04210375|528514753|FG003|Overall Study|Death|0|||
146548314|NCT05752487|528514754|FG000|Overall Study|Enrolled, not treated|9|||
146548315|NCT05752487|528514754|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
146548316|NCT05752487|528514754|FG000|Overall Study|Withdrawal by Subject|2|||
146548317|NCT00424008|528514755|FG000|Overall Study|Adverse Event|8|||
146548318|NCT00424008|528514756|FG001|Overall Study|Adverse Event|6|||
146548319|NCT00424008|528514755|FG000|Overall Study|Lack of Efficacy|40|||
146548320|NCT00424008|528514756|FG001|Overall Study|Lack of Efficacy|34|||
146548321|NCT00424008|528514755|FG000|Overall Study|Lost to Follow-up|1|||
146548322|NCT00424008|528514756|FG001|Overall Study|Lost to Follow-up|2|||
146548323|NCT00424008|528514755|FG000|Overall Study|Withdrawal by Subject|5|||
146548324|NCT00424008|528514756|FG001|Overall Study|Withdrawal by Subject|8|||
146548325|NCT00424008|528514755|FG000|Overall Study|Noncompliance with protocol|13|||
146548326|NCT00424008|528514756|FG001|Overall Study|Noncompliance with protocol|7|||
146548327|NCT00424008|528514755|FG000|Overall Study|Did not meet protocol eligibility|16|||
146885195|NCT03403205|529747914|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
146885196|NCT03403205|529747915|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
146885197|NCT03403205|529747910|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
146548328|NCT00424008|528514756|FG001|Overall Study|Did not meet protocol eligibility|21|||
146548329|NCT00424008|528514755|FG000|Overall Study|Administrative|266|||
146548330|NCT00424008|528514756|FG001|Overall Study|Administrative|257|||
146548331|NCT01860989|528514757|FG000|Overall Study|Unsatisfactory therapeutic|5|||
146548332|NCT02593864|528514758|FG000|Overall Study|Withdrawal by Subject|3|||
146548333|NCT02593864|528514758|FG000|Overall Study|Lost to Follow-up|3|||
146548334|NCT02184156|528514759|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
146548335|NCT02184156|528514760|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
146548336|NCT02184156|528514759|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
146548337|NCT02184156|528514760|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
146548338|NCT02114684|528514764|FG000|Overall Study|Death|6|||
146548339|NCT02114684|528514765|FG001|Overall Study|Death|4|||
146548340|NCT02114684|528514764|FG000|Overall Study|Lost to Follow-up|1|||
146548341|NCT02114684|528514765|FG001|Overall Study|Lost to Follow-up|2|||
146548342|NCT02114684|528514764|FG000|Overall Study|Withdrawal by Subject|1|||
146548343|NCT02114684|528514765|FG001|Overall Study|Withdrawal by Subject|2|||
146548344|NCT02114684|528514764|FG000|Overall Study|Relocation|3|||
146548345|NCT02114684|528514765|FG001|Overall Study|Relocation|1|||
146548346|NCT02114684|528514764|FG000|Overall Study|Rifampicin resistant on culture|0|||
146548347|NCT02114684|528514765|FG001|Overall Study|Rifampicin resistant on culture|1|||
146548348|NCT02114684|528514764|FG000|Overall Study|Patient Incarcerated|1|||
146548349|NCT02114684|528514765|FG001|Overall Study|Patient Incarcerated|0|||
146548350|NCT02530242|528514771|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
146548351|NCT02530242|528514772|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
146548352|NCT00283959|528514773|FG000|Extension Period|Low Compliance|1|||
146548353|NCT01214720|528514774|FG000|Overall Study|Alive and still on treatment|34|||
146548354|NCT01214720|528514775|FG001|Overall Study|Alive and still on treatment|18|||
146548355|NCT01214720|528514774|FG000|Overall Study|Alive and in follow-up|45|||
146548356|NCT01214720|528514775|FG001|Overall Study|Alive and in follow-up|48|||
146548357|NCT01214720|528514774|FG000|Overall Study|Lost to Follow-up|6|||
146548358|NCT01214720|528514775|FG001|Overall Study|Lost to Follow-up|2|||
146548359|NCT05591755|528514776|FG000|Overall Study|Screen Failure|1|||
146548360|NCT05591755|528514777|FG001|Overall Study|Screen Failure|0|||
146548361|NCT05591755|528514778|FG002|Overall Study|Screen Failure|0|||
146548362|NCT05591755|528514779|FG003|Overall Study|Screen Failure|0|||
146548363|NCT05591755|528514776|FG000|Overall Study|Protocol Violation|0|||
146548364|NCT05591755|528514777|FG001|Overall Study|Protocol Violation|0|||
146548365|NCT05591755|528514778|FG002|Overall Study|Protocol Violation|2|||
146548366|NCT05591755|528514779|FG003|Overall Study|Protocol Violation|0|||
146548367|NCT05591755|528514776|FG000|Overall Study|Withdrawal by Subject|0|||
146548368|NCT05591755|528514777|FG001|Overall Study|Withdrawal by Subject|1|||
146548369|NCT05591755|528514778|FG002|Overall Study|Withdrawal by Subject|0|||
146548370|NCT05591755|528514779|FG003|Overall Study|Withdrawal by Subject|0|||
146548371|NCT01671059|528514780|FG000|Overall Study|Adverse Event|4|||
146548372|NCT01671059|528514780|FG000|Overall Study|Lack of Efficacy|1|||
146548373|NCT01033071|528514786|FG000|Overall Study|Adverse Event|28|||
146548374|NCT01033071|528514787|FG001|Overall Study|Adverse Event|51|||
146548375|NCT01033071|528514788|FG002|Overall Study|Adverse Event|26|||
146548376|NCT01033071|528514786|FG000|Overall Study|Protocol Violation|0|||
146548377|NCT01033071|528514787|FG001|Overall Study|Protocol Violation|2|||
146548378|NCT01033071|528514788|FG002|Overall Study|Protocol Violation|1|||
146548379|NCT01033071|528514786|FG000|Overall Study|Lost to Follow-up|4|||
146765140|NCT00462943|529307281|FG001|Overall Study|Failure to achieve a response|5|||
146765141|NCT00462943|529307282|FG002|Overall Study|Failure to achieve a response|1|||
146765142|NCT00462943|529307280|FG000|Overall Study|Adverse Event|6|||
146765143|NCT00462943|529307281|FG001|Overall Study|Adverse Event|4|||
146765144|NCT00462943|529307282|FG002|Overall Study|Adverse Event|1|||
146765145|NCT00462943|529307280|FG000|Overall Study|Protocol Violation|1|||
146765146|NCT00462943|529307281|FG001|Overall Study|Protocol Violation|0|||
146765147|NCT00462943|529307282|FG002|Overall Study|Protocol Violation|0|||
146765148|NCT00462943|529307280|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
146765149|NCT00462943|529307281|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
146765150|NCT00462943|529307282|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
146765151|NCT00462943|529307280|FG000|Overall Study|Disease Progression|15|||
146765152|NCT00462943|529307281|FG001|Overall Study|Disease Progression|15|||
146885198|NCT03403205|529747911|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
146548380|NCT01033071|528514787|FG001|Overall Study|Lost to Follow-up|5|||
146548381|NCT01033071|528514788|FG002|Overall Study|Lost to Follow-up|5|||
146548382|NCT01033071|528514786|FG000|Overall Study|Withdrawal by Subject|17|||
146548383|NCT01033071|528514787|FG001|Overall Study|Withdrawal by Subject|14|||
146548384|NCT01033071|528514788|FG002|Overall Study|Withdrawal by Subject|11|||
146548385|NCT01033071|528514786|FG000|Overall Study|Lack of Efficacy|0|||
146548386|NCT01033071|528514787|FG001|Overall Study|Lack of Efficacy|1|||
146548387|NCT01033071|528514788|FG002|Overall Study|Lack of Efficacy|1|||
146548388|NCT01033071|528514786|FG000|Overall Study|Other|6|||
146548389|NCT01033071|528514787|FG001|Overall Study|Other|4|||
146548390|NCT01033071|528514788|FG002|Overall Study|Other|3|||
146548391|NCT02564978|528514789|FG000|Overall Study|Adverse Event|8|||
146548392|NCT02564978|528514789|FG000|Overall Study|Death|1|||
146548393|NCT02564978|528514789|FG000|Overall Study|Lost to Follow-up|1|||
146548394|NCT02564978|528514789|FG000|Overall Study|Withdrawal by Subject|15|||
146548395|NCT02564978|528514789|FG000|Overall Study|Early Study Closure|2|||
146548396|NCT02564978|528514789|FG000|Overall Study|Other Reason|5|||
146548397|NCT04289298|528516731|FG000|Overall Study|Lost to Follow-up|5|||
146548398|NCT04289298|528516732|FG001|Overall Study|Lost to Follow-up|0|||
146548399|NCT04289298|528516731|FG000|Overall Study|Withdrawal by Subject|2|||
146548400|NCT04289298|528516732|FG001|Overall Study|Withdrawal by Subject|0|||
146548401|NCT01734928|528516733|FG000|Randomization|Physician Decision|0|||
146548402|NCT01734928|528516734|FG001|Randomization|Physician Decision|1|||
146548403|NCT01734928|528516733|FG000|Randomization|clinical progression|0|||
146548404|NCT01734928|528516734|FG001|Randomization|clinical progression|1|||
146548405|NCT01734928|528516733|FG000|Randomization|progressive disease|0|||
146548406|NCT01734928|528516734|FG001|Randomization|progressive disease|2|||
146548407|NCT01734928|528516733|FG000|Randomization|Withdrew informed consent|0|||
146548408|NCT01734928|528516734|FG001|Randomization|Withdrew informed consent|4|||
146548409|NCT01734928|528516733|FG000|Randomization|Death|1|||
146548410|NCT01734928|528516734|FG001|Randomization|Death|0|||
146548411|NCT01734928|528516733|FG000|Randomization|Randomization error|1|||
146548412|NCT01734928|528516734|FG001|Randomization|Randomization error|0|||
146548413|NCT01734928|528516733|FG000|Randomization|Lost to Follow-up|1|||
146548414|NCT01734928|528516734|FG001|Randomization|Lost to Follow-up|0|||
146548415|NCT01734928|528516733|FG000|Treatment Period|Lost to Follow-up|0|||
146548416|NCT01734928|528516734|FG001|Treatment Period|Lost to Follow-up|2|||
146548417|NCT01734928|528516733|FG000|Treatment Period|Progressive Disease|167|||
146548418|NCT01734928|528516734|FG001|Treatment Period|Progressive Disease|165|||
146548419|NCT01734928|528516733|FG000|Treatment Period|Adverse Event|39|||
146548420|NCT01734928|528516734|FG001|Treatment Period|Adverse Event|52|||
146548421|NCT01734928|528516733|FG000|Treatment Period|Withdrawal of Consent|25|||
146548422|NCT01734928|528516734|FG001|Treatment Period|Withdrawal of Consent|22|||
146548423|NCT01734928|528516733|FG000|Treatment Period|Death|20|||
146548424|NCT01734928|528516734|FG001|Treatment Period|Death|9|||
146548425|NCT01734928|528516733|FG000|Treatment Period|Other Reasons|27|||
146765153|NCT00462943|529307282|FG002|Overall Study|Disease Progression|9|||
146765154|NCT00462943|529307280|FG000|Overall Study|Death|5|||
146548426|NCT01734928|528516734|FG001|Treatment Period|Other Reasons|19|||
146548427|NCT01734928|528516733|FG000|Treatment Period|Pregnancy|0|||
146548428|NCT01734928|528516734|FG001|Treatment Period|Pregnancy|1|||
146548429|NCT00620035|528516735|FG000|Overall Study|Adverse Event|106|||
146548430|NCT00620035|528516735|FG000|Overall Study|Withdrawal of Informed Consent|1|||
146548431|NCT00620035|528516735|FG000|Overall Study|Other Reason|38|||
146548432|NCT01778985|528516738|FG000|Overall Study|Lost to Follow-up|1|||
146548433|NCT01778985|528516739|FG001|Overall Study|Lost to Follow-up|0|||
146548434|NCT01778985|528516738|FG000|Overall Study|Physician Decision|2|||
146548435|NCT01778985|528516739|FG001|Overall Study|Physician Decision|2|||
146548436|NCT01778985|528516738|FG000|Overall Study|Protocol Violation|4|||
146548437|NCT01778985|528516739|FG001|Overall Study|Protocol Violation|1|||
146548438|NCT01629563|528516741|FG000|Overall Study|Adverse Event|16|||
146548439|NCT01629563|528516742|FG001|Overall Study|Adverse Event|16|||
146548440|NCT01629563|528516741|FG000|Overall Study|Death|2|||
146548441|NCT01629563|528516742|FG001|Overall Study|Death|0|||
146548442|NCT01629563|528516741|FG000|Overall Study|Lack of Efficacy|2|||
146548443|NCT01629563|528516742|FG001|Overall Study|Lack of Efficacy|3|||
146548444|NCT01629563|528516741|FG000|Overall Study|Lost to Follow-up|1|||
146548445|NCT01629563|528516742|FG001|Overall Study|Lost to Follow-up|0|||
146548446|NCT01629563|528516741|FG000|Overall Study|Pregnancy|1|||
146548447|NCT01629563|528516742|FG001|Overall Study|Pregnancy|2|||
146548448|NCT01629563|528516741|FG000|Overall Study|Protocol Violation|0|||
146548449|NCT01629563|528516742|FG001|Overall Study|Protocol Violation|1|||
146548450|NCT01629563|528516741|FG000|Overall Study|Withdrawal by Subject|27|||
146548451|NCT01629563|528516742|FG001|Overall Study|Withdrawal by Subject|20|||
146548452|NCT01629563|528516741|FG000|Overall Study|surgery|0|||
146548453|NCT01629563|528516742|FG001|Overall Study|surgery|3|||
146548454|NCT01629563|528516741|FG000|Overall Study|Lack of return of menses|12|||
146548455|NCT01629563|528516742|FG001|Overall Study|Lack of return of menses|7|||
146548456|NCT01629563|528516741|FG000|Overall Study|Protocol Violation|0|||
146548457|NCT01629563|528516742|FG001|Overall Study|Protocol Violation|1|||
146548458|NCT00088881|528516745|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
146548459|NCT00088881|528516745|FG000|Step 1 - R-CHOP|Adverse Event|1|||
146548460|NCT00088881|528516745|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
146548461|NCT00088881|528516745|FG000|Step 1 - R-CHOP|Physician Decision|1|||
146548462|NCT00088881|528516745|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
146548463|NCT00088881|528516745|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
146548464|NCT00088881|528516745|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
146548465|NCT02370394|528516753|FG000|Overall Study|Lost to Follow-up|2|||
146885199|NCT03403205|529747912|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
146885200|NCT03403205|529747913|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
146885201|NCT03403205|529747914|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
146885202|NCT03403205|529747915|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
146885203|NCT03403205|529747910|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
146548466|NCT02370394|528516754|FG001|Overall Study|Lost to Follow-up|1|||
146765155|NCT00462943|529307281|FG001|Overall Study|Death|2|||
146885204|NCT03403205|529747911|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
146885205|NCT03403205|529747912|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
146885206|NCT03403205|529747913|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
146885207|NCT03403205|529747914|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
146885208|NCT03403205|529747915|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
146885209|NCT03403205|529747910|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
146885210|NCT03403205|529747911|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
146885211|NCT03403205|529747912|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
146885212|NCT03403205|529747913|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
146885213|NCT03403205|529747914|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
146885214|NCT03403205|529747915|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
146885215|NCT03403205|529747910|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
146885216|NCT03403205|529747911|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
146885217|NCT03403205|529747912|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
146885218|NCT03403205|529747913|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
146885219|NCT03403205|529747914|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
146885220|NCT03403205|529747915|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
146885221|NCT03403205|529747910|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
146885222|NCT03403205|529747911|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
146885223|NCT03403205|529747912|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
146885224|NCT03403205|529747913|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
146885225|NCT03403205|529747914|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
146885226|NCT03403205|529747915|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
146885227|NCT03403205|529747910|FG000|Extension Period (Up to 60 Months)|Death|1|||
146885228|NCT03403205|529747911|FG001|Extension Period (Up to 60 Months)|Death|0|||
146885229|NCT03403205|529747912|FG002|Extension Period (Up to 60 Months)|Death|0|||
146885230|NCT03403205|529747913|FG003|Extension Period (Up to 60 Months)|Death|0|||
146631057|NCT02594124|528826243|FG001|Overall Study|Withdrawal by Subject|3|||
146631058|NCT02594124|528826244|FG002|Overall Study|Withdrawal by Subject|5|||
146631059|NCT02594124|528826245|FG003|Overall Study|Withdrawal by Subject|1|||
146631060|NCT02594124|528826246|FG004|Overall Study|Withdrawal by Subject|8|||
146631061|NCT02594124|528826247|FG005|Overall Study|Withdrawal by Subject|4|||
146631062|NCT02594124|528826248|FG006|Overall Study|Withdrawal by Subject|13|||
146631063|NCT02594124|528826249|FG007|Overall Study|Withdrawal by Subject|19|||
146631064|NCT02594124|528826250|FG008|Overall Study|Withdrawal by Subject|0|||
146631065|NCT02594124|528826242|FG000|Overall Study|Physician Decision|0|||
146631066|NCT02594124|528826243|FG001|Overall Study|Physician Decision|2|||
146631067|NCT02594124|528826244|FG002|Overall Study|Physician Decision|0|||
146631068|NCT02594124|528826245|FG003|Overall Study|Physician Decision|0|||
146631069|NCT02594124|528826246|FG004|Overall Study|Physician Decision|0|||
146631070|NCT02594124|528826247|FG005|Overall Study|Physician Decision|0|||
146631071|NCT02594124|528826248|FG006|Overall Study|Physician Decision|0|||
146631072|NCT02594124|528826249|FG007|Overall Study|Physician Decision|1|||
146631073|NCT02594124|528826250|FG008|Overall Study|Physician Decision|0|||
146631074|NCT02594124|528826242|FG000|Overall Study|Commercial drug|0|||
146548467|NCT02370394|528516753|FG000|Overall Study|Withdrawal by Subject|0|||
146631075|NCT02594124|528826243|FG001|Overall Study|Commercial drug|1|||
146631076|NCT02594124|528826244|FG002|Overall Study|Commercial drug|6|||
146631077|NCT02594124|528826245|FG003|Overall Study|Commercial drug|3|||
146631078|NCT02594124|528826246|FG004|Overall Study|Commercial drug|0|||
146631079|NCT02594124|528826247|FG005|Overall Study|Commercial drug|0|||
146631080|NCT02594124|528826248|FG006|Overall Study|Commercial drug|7|||
146631081|NCT02594124|528826249|FG007|Overall Study|Commercial drug|11|||
146631082|NCT02594124|528826250|FG008|Overall Study|Commercial drug|2|||
146885231|NCT03403205|529747914|FG004|Extension Period (Up to 60 Months)|Death|0|||
146885232|NCT03403205|529747915|FG005|Extension Period (Up to 60 Months)|Death|0|||
146885233|NCT03403205|529747910|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
146885234|NCT03403205|529747911|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
146548468|NCT02370394|528516754|FG001|Overall Study|Withdrawal by Subject|1|||
146548469|NCT03684057|528516755|FG000|Overall Study|Withdrawal by Subject|4|||
146548470|NCT03684057|528516756|FG001|Overall Study|Withdrawal by Subject|5|||
146548471|NCT00456612|528516757|FG000|Overall Study|Withdrawal by Subject|3|||
146548472|NCT02316613|528516760|FG000|Overall Study|Death|63|||
146548473|NCT02316613|528516760|FG000|Overall Study|Lost to Follow-up|9|||
146548474|NCT02316613|528516760|FG000|Overall Study|Lymphoma transformation|2|||
146548475|NCT02316613|528516760|FG000|Overall Study|Participant moved/changed medical team|11|||
146548476|NCT02316613|528516760|FG000|Overall Study|No data and duplicate cases|5|||
146548477|NCT02316613|528516760|FG000|Overall Study|Did not met selection criteria|14|||
146548478|NCT01108796|528516761|FG000|Overall Study|Adverse Event|0|||
146548479|NCT01108796|528516762|FG001|Overall Study|Adverse Event|1|||
146548480|NCT01108796|528516761|FG000|Overall Study|Lost to Follow-up|7|||
146548481|NCT01108796|528516762|FG001|Overall Study|Lost to Follow-up|6|||
146548482|NCT00758043|528516763|FG000|Overall Study|Adverse Event|1|||
146548483|NCT00758043|528516764|FG001|Overall Study|Adverse Event|20|||
146548484|NCT00758043|528516765|FG002|Overall Study|Adverse Event|12|||
146548485|NCT00758043|528516766|FG003|Overall Study|Adverse Event|62|||
146548486|NCT00758043|528516763|FG000|Overall Study|Lack of Efficacy|0|||
146548487|NCT00758043|528516764|FG001|Overall Study|Lack of Efficacy|6|||
146548488|NCT00758043|528516765|FG002|Overall Study|Lack of Efficacy|18|||
146548489|NCT00758043|528516766|FG003|Overall Study|Lack of Efficacy|12|||
146548490|NCT00758043|528516763|FG000|Overall Study|Refused Further Treatment|0|||
146548491|NCT00758043|528516764|FG001|Overall Study|Refused Further Treatment|11|||
146548492|NCT00758043|528516765|FG002|Overall Study|Refused Further Treatment|5|||
146548493|NCT00758043|528516766|FG003|Overall Study|Refused Further Treatment|8|||
146548494|NCT00758043|528516763|FG000|Overall Study|Lost to Follow-up|0|||
146548495|NCT00758043|528516764|FG001|Overall Study|Lost to Follow-up|2|||
146548496|NCT00758043|528516765|FG002|Overall Study|Lost to Follow-up|2|||
146548497|NCT00758043|528516766|FG003|Overall Study|Lost to Follow-up|5|||
146548498|NCT00758043|528516763|FG000|Overall Study|Withdrawal by Subject|0|||
146885235|NCT03403205|529747912|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
146548499|NCT00758043|528516764|FG001|Overall Study|Withdrawal by Subject|1|||
146548500|NCT00758043|528516765|FG002|Overall Study|Withdrawal by Subject|1|||
146548501|NCT00758043|528516766|FG003|Overall Study|Withdrawal by Subject|4|||
146548502|NCT00758043|528516763|FG000|Overall Study|Required Prohibited Medication|0|||
146631083|NCT02594124|528826242|FG000|Overall Study|Reason Not Specified|1|||
146548503|NCT00758043|528516764|FG001|Overall Study|Required Prohibited Medication|0|||
146631084|NCT02594124|528826243|FG001|Overall Study|Reason Not Specified|3|||
146631085|NCT02594124|528826244|FG002|Overall Study|Reason Not Specified|4|||
146631086|NCT02594124|528826245|FG003|Overall Study|Reason Not Specified|0|||
146631087|NCT02594124|528826246|FG004|Overall Study|Reason Not Specified|0|||
146548504|NCT00758043|528516765|FG002|Overall Study|Required Prohibited Medication|1|||
146548505|NCT00758043|528516766|FG003|Overall Study|Required Prohibited Medication|3|||
146548506|NCT00758043|528516763|FG000|Overall Study|Non-Compliant With study Drug|0|||
146885236|NCT03403205|529747913|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
146966456|NCT04456998|530038806|FG001|Overall Study|Withdrawal by Subject|1|||
146966457|NCT04455620|530038810|FG000|Overall Study|Withdrawal by Subject|0|||
146966458|NCT04455620|530038811|FG001|Overall Study|Withdrawal by Subject|0|||
146966459|NCT04455620|530038812|FG002|Overall Study|Withdrawal by Subject|2|||
146966460|NCT04455620|530038813|FG003|Overall Study|Withdrawal by Subject|0|||
146966461|NCT04455620|530038814|FG004|Overall Study|Withdrawal by Subject|1|||
146966462|NCT04455620|530038810|FG000|Overall Study|Lost to Follow-up|0|||
146966463|NCT04455620|530038811|FG001|Overall Study|Lost to Follow-up|0|||
146966464|NCT04455620|530038812|FG002|Overall Study|Lost to Follow-up|1|||
146966465|NCT04455620|530038813|FG003|Overall Study|Lost to Follow-up|1|||
146966466|NCT04455620|530038814|FG004|Overall Study|Lost to Follow-up|0|||
146966467|NCT04455620|530038810|FG000|Overall Study|Death|1|||
146966468|NCT04455620|530038811|FG001|Overall Study|Death|6|||
146966469|NCT04455620|530038812|FG002|Overall Study|Death|20|||
146966470|NCT04455620|530038813|FG003|Overall Study|Death|1|||
146966471|NCT04455620|530038814|FG004|Overall Study|Death|7|||
146966472|NCT04455620|530038810|FG000|Overall Study|Study Termination|0|||
146885237|NCT03403205|529747914|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
146885238|NCT03403205|529747915|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
146885239|NCT03403205|529747910|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
146885240|NCT03403205|529747911|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
146885241|NCT03403205|529747912|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
146885242|NCT03403205|529747913|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
146885243|NCT03403205|529747914|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
146885244|NCT03403205|529747915|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
146885245|NCT03403205|529747910|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
146885246|NCT03403205|529747911|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
146885247|NCT03403205|529747912|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
146885248|NCT03403205|529747913|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
146885249|NCT03403205|529747914|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
146885250|NCT03403205|529747915|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
146885251|NCT03403205|529747910|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
146885252|NCT03403205|529747911|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
146885253|NCT03403205|529747912|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
146885254|NCT03403205|529747913|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
146548507|NCT00758043|528516764|FG001|Overall Study|Non-Compliant With study Drug|0|||
146548508|NCT00758043|528516765|FG002|Overall Study|Non-Compliant With study Drug|0|||
146548509|NCT00758043|528516766|FG003|Overall Study|Non-Compliant With study Drug|1|||
146548510|NCT00758043|528516763|FG000|Overall Study|Other Reasons|0|||
146548511|NCT00758043|528516764|FG001|Overall Study|Other Reasons|1|||
146548512|NCT00758043|528516765|FG002|Overall Study|Other Reasons|0|||
146548513|NCT00758043|528516766|FG003|Overall Study|Other Reasons|5|||
146548514|NCT05788328|528516775|FG000|Treatment Period 4 (5 Days)|Other|1|||
146548515|NCT05788328|528516775|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
146548516|NCT00145327|528516776|FG000|Overall Study|Withdrawal by Subject|77|||
146548517|NCT00145327|528516777|FG001|Overall Study|Withdrawal by Subject|72|||
146548518|NCT00145327|528516778|FG002|Overall Study|Withdrawal by Subject|164|||
146548519|NCT00145327|528516776|FG000|Overall Study|Death|26|||
146548520|NCT00145327|528516777|FG001|Overall Study|Death|18|||
146548521|NCT00145327|528516778|FG002|Overall Study|Death|30|||
146548522|NCT00145327|528516776|FG000|Overall Study|Adverse Event|14|||
146548523|NCT00145327|528516777|FG001|Overall Study|Adverse Event|11|||
146548524|NCT00145327|528516778|FG002|Overall Study|Adverse Event|22|||
146548525|NCT00145327|528516776|FG000|Overall Study|Lost to Follow-up|9|||
146548526|NCT00145327|528516777|FG001|Overall Study|Lost to Follow-up|14|||
146548527|NCT00145327|528516778|FG002|Overall Study|Lost to Follow-up|14|||
146548528|NCT00145327|528516776|FG000|Overall Study|Administrative problems|12|||
146548529|NCT00145327|528516777|FG001|Overall Study|Administrative problems|9|||
146548530|NCT00145327|528516778|FG002|Overall Study|Administrative problems|13|||
146548531|NCT00145327|528516776|FG000|Overall Study|Protocol Violation|2|||
146548532|NCT00145327|528516777|FG001|Overall Study|Protocol Violation|0|||
146548533|NCT00145327|528516778|FG002|Overall Study|Protocol Violation|2|||
146548534|NCT00145327|528516776|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146548535|NCT00145327|528516777|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146548536|NCT00145327|528516778|FG002|Overall Study|Abnormal laboratory value(s)|2|||
146548537|NCT00145327|528516776|FG000|Overall Study|Missing - not stated|1|||
146548538|NCT00145327|528516777|FG001|Overall Study|Missing - not stated|0|||
146548539|NCT00145327|528516778|FG002|Overall Study|Missing - not stated|1|||
146548540|NCT04027946|528516779|FG000|Overall Study|Screen failures|3|||
146548541|NCT03315689|528516784|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
146548542|NCT03315689|528516785|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
146548543|NCT03315689|528516784|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
146548544|NCT03315689|528516785|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
146548545|NCT03315689|528516784|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
146548546|NCT03315689|528516785|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
146548547|NCT00864513|528516786|FG000|Overall Study|Withdrawal by Subject|3|||
146548548|NCT03073109|528516787|FG000|Overall Study|Adverse Event|0|||
146548549|NCT03073109|528516788|FG001|Overall Study|Adverse Event|1|||
146548550|NCT03073109|528516787|FG000|Overall Study|Other|2|||
146548551|NCT03073109|528516788|FG001|Overall Study|Other|0|||
146548552|NCT03073109|528516787|FG000|Overall Study|Lost to Follow-up|8|||
146548553|NCT03073109|528516788|FG001|Overall Study|Lost to Follow-up|1|||
146885255|NCT03403205|529747914|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
146885256|NCT03403205|529747915|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
146966473|NCT04455620|530038811|FG001|Overall Study|Study Termination|2|||
146548554|NCT01297244|528516789|FG000|Overall Study|Progressive disease|22|||
146548555|NCT01297244|528516790|FG001|Overall Study|Progressive disease|3|||
146548556|NCT01297244|528516789|FG000|Overall Study|Adverse Event|9|||
146885257|NCT03403205|529747910|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
146548557|NCT01297244|528516790|FG001|Overall Study|Adverse Event|1|||
146548558|NCT01297244|528516789|FG000|Overall Study|Death|1|||
146548559|NCT01297244|528516790|FG001|Overall Study|Death|1|||
146548560|NCT01297244|528516789|FG000|Overall Study|Clinical progression|1|||
146548561|NCT01297244|528516790|FG001|Overall Study|Clinical progression|1|||
146548562|NCT01297244|528516789|FG000|Overall Study|Withdrawal by Subject|2|||
146548563|NCT01297244|528516790|FG001|Overall Study|Withdrawal by Subject|0|||
146548564|NCT01348698|528516791|FG000|Overall Study|Does not meet lesion size criteria|1|||
146548565|NCT01348698|528516791|FG000|Overall Study|Death|3|||
146548566|NCT01348698|528516791|FG000|Overall Study|PI decision to close study|68|||
146548567|NCT01875237|528516792|FG000|Overall Study|GVDH before DLI|1|||
146548568|NCT01875237|528516793|FG001|Overall Study|GVDH before DLI|0|||
146548569|NCT01875237|528516792|FG000|Overall Study|DLI cells could not be produced|1|||
146548570|NCT01875237|528516793|FG001|Overall Study|DLI cells could not be produced|0|||
146548571|NCT03558672|528516794|FG000|Overall Study|Study Early Termination|10|||
146548572|NCT00983957|528516797|FG000|Overall Study|Adverse Event|1|||
146548573|NCT00983957|528516797|FG000|Overall Study|Personal Reasons|1|||
146548574|NCT03055195|528516798|FG000|Overall Study|Lack of Efficacy|1|||
146548575|NCT03055195|528516799|FG001|Overall Study|Lack of Efficacy|0|||
146548576|NCT03055195|528516798|FG000|Overall Study|Withdrawal by Subject|6|||
146548577|NCT03055195|528516799|FG001|Overall Study|Withdrawal by Subject|7|||
146548578|NCT03055195|528516798|FG000|Overall Study|Study Terminated by Sponsor|2|||
146548579|NCT03055195|528516799|FG001|Overall Study|Study Terminated by Sponsor|6|||
146548580|NCT03055195|528516798|FG000|Overall Study|Protocol Violation|2|||
146548581|NCT03055195|528516799|FG001|Overall Study|Protocol Violation|1|||
146548582|NCT03055195|528516798|FG000|Overall Study|Physician Decision|1|||
146548583|NCT03055195|528516799|FG001|Overall Study|Physician Decision|0|||
146548584|NCT00986232|528516800|FG000|Overall Study|Adverse Event|1|||
146548585|NCT00986232|528516801|FG001|Overall Study|Adverse Event|2|||
146548586|NCT00986232|528516802|FG002|Overall Study|Adverse Event|3|||
146548587|NCT00986232|528516803|FG003|Overall Study|Adverse Event|0|||
146548588|NCT00986232|528516800|FG000|Overall Study|Lost to Follow-up|19|||
146548589|NCT00986232|528516801|FG001|Overall Study|Lost to Follow-up|12|||
146548590|NCT00986232|528516802|FG002|Overall Study|Lost to Follow-up|12|||
146548591|NCT00986232|528516803|FG003|Overall Study|Lost to Follow-up|7|||
146548592|NCT00986232|528516800|FG000|Overall Study|Protocol Violation|2|||
146548593|NCT00986232|528516801|FG001|Overall Study|Protocol Violation|3|||
146548594|NCT00986232|528516802|FG002|Overall Study|Protocol Violation|0|||
146548595|NCT00986232|528516803|FG003|Overall Study|Protocol Violation|1|||
146548596|NCT00986232|528516800|FG000|Overall Study|Withdrawal by Subject|13|||
146548597|NCT00986232|528516801|FG001|Overall Study|Withdrawal by Subject|16|||
146548598|NCT00986232|528516802|FG002|Overall Study|Withdrawal by Subject|12|||
146548599|NCT00986232|528516803|FG003|Overall Study|Withdrawal by Subject|3|||
146548600|NCT00986232|528516800|FG000|Overall Study|Missed one or more bleeds|13|||
146548601|NCT00986232|528516801|FG001|Overall Study|Missed one or more bleeds|10|||
146548602|NCT00986232|528516802|FG002|Overall Study|Missed one or more bleeds|6|||
146548603|NCT00986232|528516803|FG003|Overall Study|Missed one or more bleeds|7|||
146548604|NCT00986232|528516800|FG000|Overall Study|Incomplete safety follow-up|3|||
146548605|NCT00986232|528516801|FG001|Overall Study|Incomplete safety follow-up|7|||
146548606|NCT00986232|528516802|FG002|Overall Study|Incomplete safety follow-up|2|||
146548607|NCT00986232|528516803|FG003|Overall Study|Incomplete safety follow-up|2|||
146548608|NCT00790933|528516804|FG000|Overall Study|Adverse Event|94|||
146548609|NCT00790933|528516805|FG001|Overall Study|Adverse Event|119|||
146548610|NCT00790933|528516806|FG002|Overall Study|Adverse Event|65|||
146548611|NCT00790933|528516807|FG003|Overall Study|Adverse Event|5|||
146548612|NCT00790933|528516808|FG004|Overall Study|Adverse Event|69|||
146548613|NCT00790933|528516804|FG000|Overall Study|Protocol Violation(s)|8|||
146548614|NCT00790933|528516805|FG001|Overall Study|Protocol Violation(s)|18|||
146548615|NCT00790933|528516806|FG002|Overall Study|Protocol Violation(s)|7|||
146548616|NCT00790933|528516807|FG003|Overall Study|Protocol Violation(s)|0|||
146885258|NCT03403205|529747911|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
146885259|NCT03403205|529747912|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
146885260|NCT03403205|529747913|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
146885261|NCT03403205|529747914|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
146548617|NCT00790933|528516808|FG004|Overall Study|Protocol Violation(s)|12|||
146548618|NCT00790933|528516804|FG000|Overall Study|Lack of Efficacy|192|||
146548619|NCT00790933|528516805|FG001|Overall Study|Lack of Efficacy|176|||
146548620|NCT00790933|528516806|FG002|Overall Study|Lack of Efficacy|130|||
146548621|NCT00790933|528516807|FG003|Overall Study|Lack of Efficacy|1|||
146548622|NCT00790933|528516808|FG004|Overall Study|Lack of Efficacy|121|||
146548623|NCT00790933|528516804|FG000|Overall Study|Study Terminated by Sponsor|0|||
146548624|NCT00790933|528516805|FG001|Overall Study|Study Terminated by Sponsor|0|||
146548625|NCT00790933|528516806|FG002|Overall Study|Study Terminated by Sponsor|1|||
146548626|NCT00790933|528516807|FG003|Overall Study|Study Terminated by Sponsor|0|||
146548627|NCT00790933|528516808|FG004|Overall Study|Study Terminated by Sponsor|0|||
146548628|NCT00790933|528516804|FG000|Overall Study|Withdrawal by Subject|123|||
146548629|NCT00790933|528516805|FG001|Overall Study|Withdrawal by Subject|120|||
146548630|NCT00790933|528516806|FG002|Overall Study|Withdrawal by Subject|52|||
146548631|NCT00790933|528516807|FG003|Overall Study|Withdrawal by Subject|6|||
146548632|NCT00790933|528516808|FG004|Overall Study|Withdrawal by Subject|50|||
146548633|NCT00790933|528516804|FG000|Overall Study|Lost to Follow-up|13|||
146548634|NCT00790933|528516805|FG001|Overall Study|Lost to Follow-up|31|||
146548635|NCT00790933|528516806|FG002|Overall Study|Lost to Follow-up|10|||
146548636|NCT00790933|528516807|FG003|Overall Study|Lost to Follow-up|1|||
146548637|NCT00790933|528516808|FG004|Overall Study|Lost to Follow-up|15|||
146548638|NCT00790933|528516804|FG000|Overall Study|Reason Not Specified|8|||
146548639|NCT00790933|528516805|FG001|Overall Study|Reason Not Specified|16|||
146548640|NCT00790933|528516806|FG002|Overall Study|Reason Not Specified|4|||
146548641|NCT00790933|528516807|FG003|Overall Study|Reason Not Specified|1|||
146548642|NCT00790933|528516808|FG004|Overall Study|Reason Not Specified|9|||
146548643|NCT00875667|528516809|FG000|Overall Study|Adverse Event|29|||
146548644|NCT00875667|528516810|FG001|Overall Study|Adverse Event|10|||
146548645|NCT00875667|528516809|FG000|Overall Study|Withdrawal by Subject|17|||
146548646|NCT00875667|528516810|FG001|Overall Study|Withdrawal by Subject|5|||
146548647|NCT00875667|528516809|FG000|Overall Study|Death|7|||
146548648|NCT00875667|528516810|FG001|Overall Study|Death|2|||
146548649|NCT00875667|528516809|FG000|Overall Study|Protocol Violation|2|||
146548650|NCT00875667|528516810|FG001|Overall Study|Protocol Violation|0|||
146548651|NCT00875667|528516809|FG000|Overall Study|Disease Progression|100|||
146548652|NCT00875667|528516810|FG001|Overall Study|Disease Progression|49|||
146548653|NCT00875667|528516809|FG000|Overall Study|Miscellaneous|12|||
146548654|NCT00875667|528516810|FG001|Overall Study|Miscellaneous|6|||
146548655|NCT00875667|528516809|FG000|Overall Study|Randomized but no Study Drug Given|3|||
146548656|NCT00875667|528516810|FG001|Overall Study|Randomized but no Study Drug Given|1|||
146548657|NCT00894647|528516813|FG000|Overall Study|Adverse Event|5|||
146548658|NCT00894647|528516814|FG001|Overall Study|Adverse Event|4|||
146548659|NCT00894647|528516813|FG000|Overall Study|Withdrawal by Subject|4|||
146548660|NCT00894647|528516814|FG001|Overall Study|Withdrawal by Subject|4|||
146548661|NCT00894647|528516813|FG000|Overall Study|Lost to Follow-up|0|||
146548662|NCT00894647|528516814|FG001|Overall Study|Lost to Follow-up|2|||
146548663|NCT00894647|528516813|FG000|Overall Study|Non-compliance with study procedures|0|||
146548664|NCT00894647|528516814|FG001|Overall Study|Non-compliance with study procedures|2|||
146548665|NCT00894647|528516813|FG000|Overall Study|Other, not due to AE|1|||
146548666|NCT00894647|528516814|FG001|Overall Study|Other, not due to AE|2|||
146548667|NCT01967277|528516815|FG000|Overall Study|Lost to Follow-up|1|||
146548668|NCT01967277|528516816|FG001|Overall Study|Lost to Follow-up|2|||
146548669|NCT01967277|528516815|FG000|Overall Study|Unrelated illness|0|||
146548670|NCT01967277|528516816|FG001|Overall Study|Unrelated illness|1|||
146548671|NCT01829165|528516817|FG000|Overall Study|Did not complete intervention|2|||
146548672|NCT01829165|528516818|FG001|Overall Study|Did not complete intervention|0|||
146885262|NCT03403205|529747915|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
146548673|NCT02573467|528516819|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
146548674|NCT02573467|528516820|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
146548675|NCT02573467|528516821|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
146548676|NCT02573467|528516822|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
146548677|NCT02573467|528516819|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
146548678|NCT02573467|528516820|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
146548679|NCT02573467|528516821|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
146548680|NCT02573467|528516822|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
146548681|NCT02573467|528516819|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
146548682|NCT02573467|528516820|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
146548683|NCT02573467|528516821|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
146548684|NCT02573467|528516822|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
146548685|NCT02573467|528516819|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
146548686|NCT02573467|528516820|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
146548687|NCT02573467|528516821|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
146548688|NCT02573467|528516822|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
146548689|NCT02573467|528516819|FG000|Post-treatment Follow up Epoch|Death|1|||
146548690|NCT02573467|528516820|FG001|Post-treatment Follow up Epoch|Death|1|||
146548691|NCT02573467|528516821|FG002|Post-treatment Follow up Epoch|Death|0|||
146548692|NCT02573467|528516822|FG003|Post-treatment Follow up Epoch|Death|1|||
146548693|NCT02573467|528516819|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
146548694|NCT02573467|528516820|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
146548695|NCT02573467|528516821|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
146548696|NCT02573467|528516822|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
146548697|NCT02573467|528516819|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
146548698|NCT02573467|528516820|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
146548699|NCT02573467|528516821|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
146548700|NCT02573467|528516822|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
146548701|NCT00710970|528516826|FG000|Overall Study|Never took drug|3|||
146548702|NCT01028560|528516827|FG000|Overall Study|Lack of Efficacy|3|||
146548703|NCT01028560|528516828|FG001|Overall Study|Lack of Efficacy|6|||
146548704|NCT01028560|528516827|FG000|Overall Study|Withdrawal by Subject|7|||
146548705|NCT01028560|528516828|FG001|Overall Study|Withdrawal by Subject|12|||
146548706|NCT02153827|528516829|FG000|Overall Study|Lost to Follow-up|3|||
146548707|NCT02153827|528516830|FG001|Overall Study|Lost to Follow-up|9|||
146548708|NCT00397930|528516833|FG000|Overall Study|Personal reasons|14|||
146548709|NCT00397930|528516834|FG001|Overall Study|Personal reasons|8|||
146548710|NCT00397930|528516833|FG000|Overall Study|Other medical|9|||
146548711|NCT00397930|528516834|FG001|Overall Study|Other medical|4|||
146548712|NCT00397930|528516833|FG000|Overall Study|Unknown reasons|9|||
146548713|NCT00397930|528516834|FG001|Overall Study|Unknown reasons|14|||
146548714|NCT00397930|528516833|FG000|Overall Study|Noncompliant|3|||
146548715|NCT00397930|528516834|FG001|Overall Study|Noncompliant|2|||
146548716|NCT00397930|528516833|FG000|Overall Study|Too time-consuming|2|||
146548717|NCT00397930|528516834|FG001|Overall Study|Too time-consuming|9|||
146548718|NCT00397930|528516833|FG000|Overall Study|Started own yoga program|1|||
146548719|NCT00397930|528516834|FG001|Overall Study|Started own yoga program|1|||
146548720|NCT00397930|528516833|FG000|Overall Study|Did not want to be in control group|0|||
146548721|NCT00397930|528516834|FG001|Overall Study|Did not want to be in control group|1|||
146548722|NCT00397930|528516833|FG000|Overall Study|Withdrawal by Subject|0|||
146548723|NCT00397930|528516834|FG001|Overall Study|Withdrawal by Subject|8|||
146548724|NCT00397930|528516833|FG000|Overall Study|Missing data|0|||
146548725|NCT00397930|528516834|FG001|Overall Study|Missing data|4|||
146548726|NCT01960842|528516835|FG000|Overall Study|Adverse Event|1|||
146548727|NCT01960842|528516835|FG000|Overall Study|Withdrawal by Subject|2|||
146548728|NCT02391584|528516836|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
146548729|NCT02391584|528516837|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
146548730|NCT02391584|528516836|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
146548731|NCT02391584|528516837|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
146548732|NCT02391584|528516836|FG000|3 Month|Lost to Follow-up|1|||
146548733|NCT02391584|528516837|FG001|3 Month|Lost to Follow-up|0|||
146548734|NCT02391584|528516836|FG000|6 Month|Withdrawal by Subject|1|||
146548735|NCT02391584|528516837|FG001|6 Month|Withdrawal by Subject|0|||
146548736|NCT02391584|528516836|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
146548737|NCT02391584|528516837|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
146548738|NCT02061592|528516851|FG000|Period 1|Withdrawal by Subject|1|||
146548739|NCT02061592|528516852|FG001|Period 1|Withdrawal by Subject|0|||
146548740|NCT02061592|528516851|FG000|Period 1|Protocol Violation|1|||
146548741|NCT02061592|528516852|FG001|Period 1|Protocol Violation|0|||
146548742|NCT02061592|528516851|FG000|Period 2|Lost to Follow-up|0|||
146548743|NCT02061592|528516852|FG001|Period 2|Lost to Follow-up|1|||
146548744|NCT04996264|528516853|FG000|Overall Study|Lost to Follow-up|0|||
146548745|NCT04996264|528516854|FG001|Overall Study|Lost to Follow-up|1|||
146548746|NCT04996264|528516853|FG000|Overall Study|Withdrawal by Subject|4|||
146548747|NCT04996264|528516854|FG001|Overall Study|Withdrawal by Subject|3|||
146885263|NCT03403205|529747910|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
146885264|NCT03403205|529747911|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
146885265|NCT03403205|529747912|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
146885266|NCT03403205|529747913|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
146885267|NCT03403205|529747914|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
146885268|NCT03403205|529747915|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
146885269|NCT00706030|529747916|FG000|Overall Study|Disease Progression|4|||
146885270|NCT00706030|529747917|FG001|Overall Study|Disease Progression|6|||
146885271|NCT00706030|529747918|FG002|Overall Study|Disease Progression|46|||
146885272|NCT00706030|529747919|FG003|Overall Study|Disease Progression|12|||
146885273|NCT00706030|529747916|FG000|Overall Study|Adverse Event|1|||
146885274|NCT00706030|529747917|FG001|Overall Study|Adverse Event|0|||
146885275|NCT00706030|529747918|FG002|Overall Study|Adverse Event|4|||
146885276|NCT00706030|529747919|FG003|Overall Study|Adverse Event|2|||
146885277|NCT00706030|529747916|FG000|Overall Study|Withdrawal by Subject|1|||
146885278|NCT00706030|529747917|FG001|Overall Study|Withdrawal by Subject|0|||
146885279|NCT00706030|529747918|FG002|Overall Study|Withdrawal by Subject|2|||
146885280|NCT00706030|529747919|FG003|Overall Study|Withdrawal by Subject|0|||
146885281|NCT00706030|529747916|FG000|Overall Study|Physician Decision|0|||
146885282|NCT00706030|529747917|FG001|Overall Study|Physician Decision|0|||
146885283|NCT00706030|529747918|FG002|Overall Study|Physician Decision|2|||
146885284|NCT00706030|529747919|FG003|Overall Study|Physician Decision|0|||
146885285|NCT00706030|529747916|FG000|Overall Study|Not recorded|0|||
146885286|NCT00706030|529747917|FG001|Overall Study|Not recorded|0|||
146885287|NCT00706030|529747918|FG002|Overall Study|Not recorded|2|||
146885288|NCT00706030|529747919|FG003|Overall Study|Not recorded|0|||
146885289|NCT00706030|529747916|FG000|Overall Study|Protocol Violation|0|||
146885290|NCT00706030|529747917|FG001|Overall Study|Protocol Violation|0|||
146885291|NCT00706030|529747918|FG002|Overall Study|Protocol Violation|1|||
146885292|NCT00706030|529747919|FG003|Overall Study|Protocol Violation|1|||
146885293|NCT00706030|529747916|FG000|Overall Study|Failed to return|0|||
146885294|NCT00706030|529747917|FG001|Overall Study|Failed to return|0|||
146885295|NCT00706030|529747918|FG002|Overall Study|Failed to return|1|||
146885296|NCT00706030|529747919|FG003|Overall Study|Failed to return|0|||
146885297|NCT00706030|529747916|FG000|Overall Study|Symptomatic Deterioration|0|||
146548748|NCT04996264|528516853|FG000|Overall Study|1 left AMA|0|||
146548749|NCT04996264|528516854|FG001|Overall Study|1 left AMA|1|||
146548750|NCT04996264|528516853|FG000|Overall Study|Subject changed hospitals|0|||
146548751|NCT04996264|528516854|FG001|Overall Study|Subject changed hospitals|1|||
146548752|NCT04996264|528516853|FG000|Overall Study|unable to complete due to work|0|||
146548753|NCT04996264|528516854|FG001|Overall Study|unable to complete due to work|1|||
146548754|NCT01018953|528516865|FG000|Overall Study|Adverse Event|2|||
146885298|NCT00706030|529747917|FG001|Overall Study|Symptomatic Deterioration|0|||
146885299|NCT00706030|529747918|FG002|Overall Study|Symptomatic Deterioration|1|||
146885300|NCT00706030|529747919|FG003|Overall Study|Symptomatic Deterioration|0|||
146548755|NCT01018953|528516865|FG000|Overall Study|Withdrawal by Subject|1|||
146885301|NCT00706030|529747916|FG000|Overall Study|No treatment received|0|||
146885302|NCT00706030|529747917|FG001|Overall Study|No treatment received|0|||
146885303|NCT00706030|529747918|FG002|Overall Study|No treatment received|0|||
146885304|NCT00706030|529747919|FG003|Overall Study|No treatment received|1|||
146885305|NCT00706030|529747916|FG000|Overall Study|Death|0|||
146885306|NCT00706030|529747917|FG001|Overall Study|Death|0|||
146885307|NCT00706030|529747918|FG002|Overall Study|Death|1|||
146885308|NCT00706030|529747919|FG003|Overall Study|Death|0|||
146885309|NCT05779072|529747920|FG000|Overall Study|Lost to Follow-up|0|||
146548756|NCT01018953|528516865|FG000|Overall Study|Study termination by sponsor|5|||
146548757|NCT01186419|528516868|FG000|Overall Study|Withdrawal by Subject|5|||
146765156|NCT00462943|529307282|FG002|Overall Study|Death|7|||
146966474|NCT04455620|530038812|FG002|Overall Study|Study Termination|1|||
146885310|NCT05779072|529747921|FG001|Overall Study|Lost to Follow-up|1|||
146885311|NCT05779072|529747920|FG000|Overall Study|Withdrawal by Subject|1|||
146885312|NCT05779072|529747921|FG001|Overall Study|Withdrawal by Subject|5|||
146885313|NCT02682901|529747922|FG000|Overall Study|Adverse Event|10|||
146885314|NCT02682901|529747923|FG001|Overall Study|Adverse Event|3|||
146885315|NCT02682901|529747922|FG000|Overall Study|Lack of Efficacy|0|||
146885316|NCT02682901|529747923|FG001|Overall Study|Lack of Efficacy|1|||
146885317|NCT03713944|529747924|FG000|Study Treatment|Patient non-compliance|1|||
146885318|NCT03713944|529747924|FG000|Study Treatment|Alternative Cancer Therapy|3|||
146885319|NCT03713944|529747924|FG000|Study Treatment|Disease Progression|18|||
146885320|NCT03713944|529747924|FG000|Study Treatment|AE/Side Effects/Complications|2|||
146885321|NCT03713944|529747924|FG000|Study Treatment|Death|2|||
146885322|NCT03713944|529747924|FG000|Study Treatment|Withdrawal by Subject|1|||
146885323|NCT03713944|529747924|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
146885324|NCT03713944|529747924|FG000|Study Treatment|Symptomatic Deterioration|2|||
146885325|NCT03713944|529747924|FG000|Follow up|Withdrawal by Subject|2|||
146885326|NCT03713944|529747924|FG000|Follow up|Death|11|||
146885327|NCT03713944|529747924|FG000|Follow up|Study Terminated|3|||
146885328|NCT03847610|529747925|FG000|Overall Study|Withdrawal by Subject|1|||
146885329|NCT03298022|529747926|FG000|Overall Study|Lack of Efficacy|4|||
146885330|NCT03298022|529747926|FG000|Overall Study|Withdrawal by Subject|7|||
146885331|NCT03298022|529747926|FG000|Overall Study|Adverse Event|1|||
146885332|NCT03298022|529747926|FG000|Overall Study|disease relapse|1|||
146885333|NCT00044512|529747927|FG000|Follow Up|Lost to Follow-up|2|||
146885334|NCT02751502|529747928|FG000|Overall Study|Lack of funding|4|||
146885335|NCT02573155|529747929|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
146885336|NCT02573155|529747930|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
146885337|NCT02573155|529747929|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
146885338|NCT02573155|529747930|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
146885339|NCT02573155|529747929|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
146885340|NCT02573155|529747930|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
146885341|NCT02573155|529747929|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
146885342|NCT02573155|529747930|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
146885343|NCT02573155|529747929|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
146885344|NCT02573155|529747930|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
146885345|NCT02573155|529747929|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
146885346|NCT02573155|529747930|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
146885347|NCT02573155|529747929|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
146885348|NCT02573155|529747930|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
146885349|NCT02573155|529747929|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
146885350|NCT02573155|529747930|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
146885351|NCT00371865|529747931|FG000|Overall Study|Lack of Efficacy|0|||
146885352|NCT00371865|529747932|FG001|Overall Study|Lack of Efficacy|2|||
146885353|NCT00371865|529747931|FG000|Overall Study|Protocol Violation|3|||
146885354|NCT00371865|529747932|FG001|Overall Study|Protocol Violation|2|||
146885355|NCT00371865|529747931|FG000|Overall Study|Withdrawal by Subject|12|||
146885356|NCT00371865|529747932|FG001|Overall Study|Withdrawal by Subject|10|||
146885357|NCT05103332|529747938|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885358|NCT05103332|529747939|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
146885359|NCT05103332|529747940|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
146885360|NCT05103332|529747941|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885361|NCT05103332|529747942|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885362|NCT05103332|529747943|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
146885363|NCT05103332|529747944|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146548758|NCT01186419|528516869|FG001|Overall Study|Withdrawal by Subject|3|||
146548759|NCT01186419|528516868|FG000|Overall Study|Adverse Event|1|||
146548760|NCT01186419|528516869|FG001|Overall Study|Adverse Event|2|||
146548761|NCT01186419|528516868|FG000|Overall Study|Physician Decision|0|||
146548762|NCT01186419|528516869|FG001|Overall Study|Physician Decision|3|||
146885364|NCT05103332|529747945|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885365|NCT05103332|529747946|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885366|NCT05103332|529747947|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885367|NCT05103332|529747948|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885368|NCT05103332|529747949|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146548763|NCT01186419|528516868|FG000|Overall Study|Other|1|||
146548764|NCT01186419|528516869|FG001|Overall Study|Other|1|||
146885369|NCT05103332|529747950|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885370|NCT05103332|529747951|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885371|NCT05103332|529747952|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146966475|NCT04455620|530038813|FG003|Overall Study|Study Termination|0|||
146631088|NCT02594124|528826247|FG005|Overall Study|Reason Not Specified|1|||
146631089|NCT02594124|528826248|FG006|Overall Study|Reason Not Specified|1|||
146631090|NCT02594124|528826249|FG007|Overall Study|Reason Not Specified|6|||
146631091|NCT02594124|528826250|FG008|Overall Study|Reason Not Specified|1|||
146631092|NCT01824836|528826251|FG000|Overall Study|Adverse Event|48|||
146631093|NCT01824836|528826251|FG000|Overall Study|Withdrawal by Subject|63|||
146631094|NCT01824836|528826251|FG000|Overall Study|Other complicating disease|116|||
146631095|NCT01824836|528826251|FG000|Overall Study|Disease progression|5|||
146631096|NCT01824836|528826251|FG000|Overall Study|Alternative therapy|2|||
146631097|NCT01824836|528826251|FG000|Overall Study|Depression|1|||
146631098|NCT01824836|528826251|FG000|Overall Study|Non-compliance|3|||
146631099|NCT01824836|528826251|FG000|Overall Study|Patient regained ovarian function|3|||
146631100|NCT01824836|528826251|FG000|Overall Study|Lost to Follow-up|8|||
146631101|NCT01824836|528826251|FG000|Overall Study|Physician Decision|2|||
146631102|NCT01824836|528826251|FG000|Overall Study|Research office was closed|3|||
146631103|NCT01824836|528826251|FG000|Overall Study|Relocation|3|||
146631104|NCT01824836|528826251|FG000|Overall Study|Insurance-related issue|1|||
146631105|NCT01824836|528826251|FG000|Overall Study|Transportation issue|1|||
146631106|NCT01824836|528826251|FG000|Overall Study|Patient transferred care|1|||
146631107|NCT01824836|528826251|FG000|Overall Study|Unknown reasons|4|||
146631108|NCT01824836|528826251|FG000|Overall Study|Never started treatment|16|||
146631109|NCT04323124|528826255|FG000|Overall Study|Adverse Event|0|||
146631110|NCT04323124|528826256|FG001|Overall Study|Adverse Event|0|||
146631111|NCT04323124|528826257|FG002|Overall Study|Adverse Event|0|||
146631112|NCT04323124|528826258|FG003|Overall Study|Adverse Event|0|||
146631113|NCT04323124|528826259|FG004|Overall Study|Adverse Event|0|||
146631114|NCT04323124|528826260|FG005|Overall Study|Adverse Event|1|||
146631115|NCT04323124|528826261|FG006|Overall Study|Adverse Event|0|||
146631116|NCT04323124|528826262|FG007|Overall Study|Adverse Event|1|||
146631117|NCT04323124|528826263|FG008|Overall Study|Adverse Event|1|||
146631118|NCT04323124|528826264|FG009|Overall Study|Adverse Event|0|||
146631119|NCT04323124|528826265|FG010|Overall Study|Adverse Event|0|||
146631120|NCT04323124|528826266|FG011|Overall Study|Adverse Event|0|||
146631121|NCT04323124|528826267|FG012|Overall Study|Adverse Event|0|||
146631122|NCT04323124|528826268|FG013|Overall Study|Adverse Event|0|||
146631123|NCT04323124|528826269|FG014|Overall Study|Adverse Event|0|||
146631124|NCT04323124|528826255|FG000|Overall Study|Other|0|||
146631125|NCT04323124|528826256|FG001|Overall Study|Other|0|||
146631126|NCT04323124|528826257|FG002|Overall Study|Other|0|||
146631127|NCT04323124|528826258|FG003|Overall Study|Other|0|||
146631128|NCT04323124|528826259|FG004|Overall Study|Other|1|||
146631129|NCT04323124|528826260|FG005|Overall Study|Other|0|||
146631130|NCT04323124|528826261|FG006|Overall Study|Other|0|||
146631131|NCT04323124|528826262|FG007|Overall Study|Other|0|||
146631132|NCT04323124|528826263|FG008|Overall Study|Other|1|||
146631133|NCT04323124|528826264|FG009|Overall Study|Other|0|||
146631134|NCT04323124|528826265|FG010|Overall Study|Other|0|||
146631135|NCT04323124|528826266|FG011|Overall Study|Other|0|||
146631136|NCT04323124|528826267|FG012|Overall Study|Other|0|||
146631137|NCT04323124|528826268|FG013|Overall Study|Other|0|||
146885372|NCT05103332|529747953|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885373|NCT05103332|529747954|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146631138|NCT04323124|528826269|FG014|Overall Study|Other|0|||
146631139|NCT04323124|528826255|FG000|Overall Study|Coming from a red zone (COVID)|0|||
146631140|NCT04323124|528826256|FG001|Overall Study|Coming from a red zone (COVID)|0|||
146631141|NCT04323124|528826257|FG002|Overall Study|Coming from a red zone (COVID)|0|||
146631142|NCT04323124|528826258|FG003|Overall Study|Coming from a red zone (COVID)|0|||
146631143|NCT04323124|528826259|FG004|Overall Study|Coming from a red zone (COVID)|1|||
146631144|NCT04323124|528826260|FG005|Overall Study|Coming from a red zone (COVID)|1|||
146631145|NCT04323124|528826261|FG006|Overall Study|Coming from a red zone (COVID)|0|||
146631146|NCT04323124|528826262|FG007|Overall Study|Coming from a red zone (COVID)|0|||
146631147|NCT04323124|528826263|FG008|Overall Study|Coming from a red zone (COVID)|0|||
146631148|NCT04323124|528826264|FG009|Overall Study|Coming from a red zone (COVID)|0|||
146631149|NCT04323124|528826265|FG010|Overall Study|Coming from a red zone (COVID)|0|||
146548765|NCT00853047|528516870|FG000|Core Phase|Participant Request|0|||
146548766|NCT00853047|528516871|FG001|Core Phase|Participant Request|0|||
146548767|NCT00853047|528516872|FG002|Core Phase|Participant Request|0|||
146548768|NCT00853047|528516873|FG003|Core Phase|Participant Request|1|||
146548769|NCT00853047|528516874|FG004|Core Phase|Participant Request|0|||
146548770|NCT00853047|528516875|FG005|Core Phase|Participant Request|0|||
146548771|NCT00853047|528516870|FG000|Open-Label Extension Phase|Participant Request|0|||
146548772|NCT00853047|528516871|FG001|Open-Label Extension Phase|Participant Request|0|||
146548773|NCT00853047|528516872|FG002|Open-Label Extension Phase|Participant Request|0|||
146548774|NCT00853047|528516873|FG003|Open-Label Extension Phase|Participant Request|0|||
146548775|NCT00853047|528516874|FG004|Open-Label Extension Phase|Participant Request|0|||
146548776|NCT00853047|528516875|FG005|Open-Label Extension Phase|Participant Request|7|||
146548777|NCT00853047|528516870|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
146548778|NCT00853047|528516871|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
146548779|NCT00853047|528516872|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
146548780|NCT00853047|528516873|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
146548781|NCT00853047|528516874|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
146548782|NCT00853047|528516875|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
146548783|NCT00853047|528516870|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
146548784|NCT00853047|528516871|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
146631150|NCT04323124|528826266|FG011|Overall Study|Coming from a red zone (COVID)|0|||
146885374|NCT05103332|529747955|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885375|NCT05103332|529747938|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
146885376|NCT05103332|529747939|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
146885377|NCT05103332|529747940|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
146885378|NCT05103332|529747941|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
146885379|NCT05103332|529747942|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
146885380|NCT05103332|529747943|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
146885381|NCT05103332|529747944|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
146885382|NCT05103332|529747945|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
146885383|NCT05103332|529747946|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
146885384|NCT05103332|529747947|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
146885385|NCT05103332|529747948|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
146885386|NCT05103332|529747949|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
146885387|NCT05103332|529747950|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
146885388|NCT05103332|529747951|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
146885389|NCT05103332|529747952|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
146885390|NCT05103332|529747953|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
146885391|NCT05103332|529747954|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
146885392|NCT05103332|529747955|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
146885393|NCT05103332|529747938|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
146885394|NCT05103332|529747939|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
146885395|NCT05103332|529747940|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
146885396|NCT05103332|529747941|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
146885397|NCT05103332|529747942|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
146885398|NCT05103332|529747943|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
146885399|NCT05103332|529747944|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885400|NCT05103332|529747945|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885401|NCT05103332|529747946|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885402|NCT05103332|529747947|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885403|NCT05103332|529747948|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885404|NCT05103332|529747949|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885405|NCT05103332|529747950|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885406|NCT05103332|529747951|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885407|NCT05103332|529747952|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885408|NCT05103332|529747953|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885409|NCT05103332|529747954|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146914681|NCT03303339|529850042|FG000|Overall Study|Safety/Non-compliance|0|||
146914682|NCT03303339|529850043|FG001|Overall Study|Safety/Non-compliance|0|||
146885410|NCT05103332|529747955|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885411|NCT05103332|529747938|FG000|DB Period (6 Months=168 Days)|Other|0|||
146885412|NCT05103332|529747939|FG001|DB Period (6 Months=168 Days)|Other|0|||
146885413|NCT05103332|529747940|FG002|DB Period (6 Months=168 Days)|Other|0|||
146885414|NCT05103332|529747941|FG003|DB Period (6 Months=168 Days)|Other|1|||
146885415|NCT05103332|529747942|FG004|DB Period (6 Months=168 Days)|Other|0|||
146885416|NCT05103332|529747943|FG005|DB Period (6 Months=168 Days)|Other|0|||
146885417|NCT05103332|529747944|FG006|DB Period (6 Months=168 Days)|Other|0|||
146885418|NCT05103332|529747945|FG007|DB Period (6 Months=168 Days)|Other|0|||
146885419|NCT05103332|529747946|FG008|DB Period (6 Months=168 Days)|Other|0|||
146885420|NCT05103332|529747947|FG009|DB Period (6 Months=168 Days)|Other|0|||
146885421|NCT05103332|529747948|FG010|DB Period (6 Months=168 Days)|Other|0|||
146885422|NCT05103332|529747949|FG011|DB Period (6 Months=168 Days)|Other|0|||
146885423|NCT05103332|529747950|FG012|DB Period (6 Months=168 Days)|Other|0|||
146885424|NCT05103332|529747951|FG013|DB Period (6 Months=168 Days)|Other|0|||
146885425|NCT05103332|529747952|FG014|DB Period (6 Months=168 Days)|Other|0|||
146885426|NCT05103332|529747953|FG015|DB Period (6 Months=168 Days)|Other|0|||
146885427|NCT05103332|529747954|FG016|DB Period (6 Months=168 Days)|Other|0|||
146885428|NCT05103332|529747955|FG017|DB Period (6 Months=168 Days)|Other|0|||
146885429|NCT05103332|529747938|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146885430|NCT05103332|529747939|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146885431|NCT05103332|529747940|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146885432|NCT05103332|529747941|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146885433|NCT05103332|529747942|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146885434|NCT05103332|529747943|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146885435|NCT05103332|529747944|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146885436|NCT05103332|529747945|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146885437|NCT05103332|529747946|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146885438|NCT05103332|529747947|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146885439|NCT05103332|529747948|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
146885440|NCT05103332|529747949|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146885441|NCT05103332|529747950|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146885442|NCT05103332|529747951|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146885443|NCT05103332|529747952|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146885444|NCT05103332|529747953|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146885445|NCT05103332|529747954|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146885446|NCT05103332|529747955|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146548785|NCT00853047|528516872|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
146548786|NCT00853047|528516873|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
146548787|NCT00853047|528516874|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
146548788|NCT00853047|528516875|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
146548789|NCT00853047|528516870|FG000|Open-Label Extension Phase|Investigator Decision|0|||
146548790|NCT00853047|528516871|FG001|Open-Label Extension Phase|Investigator Decision|0|||
146548791|NCT00853047|528516872|FG002|Open-Label Extension Phase|Investigator Decision|0|||
146548792|NCT00853047|528516873|FG003|Open-Label Extension Phase|Investigator Decision|0|||
146548793|NCT00853047|528516874|FG004|Open-Label Extension Phase|Investigator Decision|0|||
146548794|NCT00853047|528516875|FG005|Open-Label Extension Phase|Investigator Decision|1|||
146548795|NCT00853047|528516870|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
146548796|NCT00853047|528516871|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
146548797|NCT00853047|528516872|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
146765157|NCT00462943|529307280|FG000|Overall Study|Stem Cell Transplant|1|||
146765158|NCT00462943|529307281|FG001|Overall Study|Stem Cell Transplant|1|||
146885447|NCT05103332|529747938|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146885448|NCT05103332|529747939|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146885449|NCT05103332|529747940|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146885450|NCT05103332|529747941|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146885451|NCT05103332|529747942|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146885452|NCT05103332|529747943|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146885453|NCT05103332|529747944|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146885454|NCT05103332|529747945|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146885455|NCT05103332|529747946|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
146885456|NCT05103332|529747947|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146885457|NCT05103332|529747948|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146885458|NCT05103332|529747949|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146885459|NCT05103332|529747950|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146548798|NCT00853047|528516873|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
146548799|NCT00853047|528516874|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
146548800|NCT00853047|528516875|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
146765159|NCT00462943|529307282|FG002|Overall Study|Stem Cell Transplant|0|||
146885460|NCT05103332|529747951|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146885461|NCT05103332|529747952|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146885462|NCT05103332|529747953|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146885463|NCT05103332|529747954|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146885464|NCT05103332|529747955|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146885465|NCT05103332|529747938|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885466|NCT05103332|529747939|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885467|NCT05103332|529747940|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885468|NCT05103332|529747941|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885469|NCT05103332|529747942|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885470|NCT05103332|529747943|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885471|NCT05103332|529747944|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885472|NCT05103332|529747945|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885473|NCT05103332|529747946|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885474|NCT05103332|529747947|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885475|NCT05103332|529747948|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885476|NCT05103332|529747949|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
146885477|NCT05103332|529747950|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885478|NCT05103332|529747951|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885479|NCT05103332|529747952|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885480|NCT05103332|529747953|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885481|NCT05103332|529747954|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885482|NCT05103332|529747955|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146885483|NCT05103332|529747938|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146885484|NCT05103332|529747939|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146885485|NCT05103332|529747940|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146885486|NCT05103332|529747941|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146885487|NCT05103332|529747942|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146885488|NCT05103332|529747943|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146885489|NCT05103332|529747944|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
146548801|NCT01695772|528516878|FG000|Overall Study|Withdrawal by Subject|18|||
146548802|NCT01695772|528516878|FG000|Overall Study|Progressive Disease|8|||
146548803|NCT01695772|528516878|FG000|Overall Study|Investigator Decision|5|||
146548804|NCT01695772|528516878|FG000|Overall Study|Lost to Follow-up|4|||
146548805|NCT01695772|528516878|FG000|Overall Study|Protocol Violation|2|||
146885490|NCT05103332|529747945|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
146885491|NCT05103332|529747946|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146885492|NCT05103332|529747947|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
146885493|NCT05103332|529747948|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
146548806|NCT01695772|528516878|FG000|Overall Study|Unspecified Reason|1|||
146548807|NCT00004859|528516881|FG000|Overall Study|Lack of Efficacy|43|||
146548808|NCT00004859|528516882|FG001|Overall Study|Lack of Efficacy|113|||
146548809|NCT00004859|528516881|FG000|Overall Study|Adverse Event|31|||
146548810|NCT00004859|528516882|FG001|Overall Study|Adverse Event|93|||
146548811|NCT00004859|528516881|FG000|Overall Study|Death|5|||
146885494|NCT05103332|529747949|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
146885495|NCT05103332|529747950|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146885496|NCT05103332|529747951|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146885497|NCT05103332|529747952|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146885498|NCT05103332|529747953|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146885499|NCT05103332|529747954|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146885500|NCT05103332|529747955|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146885501|NCT05103332|529747938|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885502|NCT05103332|529747939|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885503|NCT05103332|529747940|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885504|NCT05103332|529747941|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885505|NCT05103332|529747942|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885506|NCT05103332|529747943|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885507|NCT05103332|529747944|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885508|NCT05103332|529747945|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885509|NCT05103332|529747946|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885510|NCT05103332|529747947|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885511|NCT05103332|529747948|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146548812|NCT00004859|528516882|FG001|Overall Study|Death|5|||
146548813|NCT00004859|528516881|FG000|Overall Study|Withdrawal by Subject|7|||
146548814|NCT00004859|528516882|FG001|Overall Study|Withdrawal by Subject|33|||
146548815|NCT00004859|528516881|FG000|Overall Study|Protocol Violation|2|||
146548816|NCT00004859|528516882|FG001|Overall Study|Protocol Violation|2|||
146548817|NCT00004859|528516881|FG000|Overall Study|other disease|0|||
146548818|NCT00004859|528516882|FG001|Overall Study|other disease|3|||
146548819|NCT00004859|528516881|FG000|Overall Study|error|3|||
146548820|NCT00004859|528516882|FG001|Overall Study|error|1|||
146548821|NCT00004859|528516881|FG000|Overall Study|missing data|14|||
146548822|NCT00004859|528516882|FG001|Overall Study|missing data|11|||
146548823|NCT00004859|528516881|FG000|Overall Study|Other|13|||
146548824|NCT00004859|528516882|FG001|Overall Study|Other|21|||
146885512|NCT05103332|529747949|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146885513|NCT05103332|529747950|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
146885514|NCT05103332|529747951|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
146885515|NCT05103332|529747952|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
146631151|NCT04323124|528826267|FG012|Overall Study|Coming from a red zone (COVID)|0|||
146631152|NCT04323124|528826268|FG013|Overall Study|Coming from a red zone (COVID)|0|||
146631153|NCT04323124|528826269|FG014|Overall Study|Coming from a red zone (COVID)|0|||
146631154|NCT04323124|528826255|FG000|Overall Study|No longer meets eligibility criteria|0|||
146631155|NCT04323124|528826256|FG001|Overall Study|No longer meets eligibility criteria|0|||
146631156|NCT04323124|528826257|FG002|Overall Study|No longer meets eligibility criteria|0|||
146631157|NCT04323124|528826258|FG003|Overall Study|No longer meets eligibility criteria|0|||
146631158|NCT04323124|528826259|FG004|Overall Study|No longer meets eligibility criteria|0|||
146631159|NCT04323124|528826260|FG005|Overall Study|No longer meets eligibility criteria|0|||
146631160|NCT04323124|528826261|FG006|Overall Study|No longer meets eligibility criteria|0|||
146631161|NCT04323124|528826262|FG007|Overall Study|No longer meets eligibility criteria|1|||
146631162|NCT04323124|528826263|FG008|Overall Study|No longer meets eligibility criteria|0|||
146631163|NCT04323124|528826264|FG009|Overall Study|No longer meets eligibility criteria|0|||
146631164|NCT04323124|528826265|FG010|Overall Study|No longer meets eligibility criteria|0|||
146631165|NCT04323124|528826266|FG011|Overall Study|No longer meets eligibility criteria|0|||
146631166|NCT04323124|528826267|FG012|Overall Study|No longer meets eligibility criteria|0|||
146631167|NCT04323124|528826268|FG013|Overall Study|No longer meets eligibility criteria|1|||
146631168|NCT04323124|528826269|FG014|Overall Study|No longer meets eligibility criteria|1|||
146885516|NCT05103332|529747953|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
146885517|NCT05103332|529747954|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
146885518|NCT05103332|529747955|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
146885519|NCT05103332|529747938|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146885520|NCT05103332|529747939|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146885521|NCT05103332|529747940|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146885522|NCT05103332|529747941|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146885523|NCT05103332|529747942|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146885524|NCT05103332|529747943|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146885525|NCT05103332|529747944|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146885526|NCT05103332|529747945|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146885527|NCT05103332|529747946|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146885528|NCT05103332|529747947|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146885529|NCT05103332|529747948|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146885530|NCT05103332|529747949|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146765160|NCT00462943|529307280|FG000|Overall Study|Bone Marrow Transplant|1|||
146885531|NCT05103332|529747950|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146885532|NCT05103332|529747951|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146631169|NCT04323124|528826255|FG000|Overall Study|Study terminated by sponsor|0|||
146765161|NCT00462943|529307281|FG001|Overall Study|Bone Marrow Transplant|0|||
146631170|NCT04323124|528826256|FG001|Overall Study|Study terminated by sponsor|0|||
146631171|NCT04323124|528826257|FG002|Overall Study|Study terminated by sponsor|0|||
146631172|NCT04323124|528826258|FG003|Overall Study|Study terminated by sponsor|0|||
146631173|NCT04323124|528826259|FG004|Overall Study|Study terminated by sponsor|0|||
146631174|NCT04323124|528826260|FG005|Overall Study|Study terminated by sponsor|0|||
146631175|NCT04323124|528826261|FG006|Overall Study|Study terminated by sponsor|0|||
146631176|NCT04323124|528826262|FG007|Overall Study|Study terminated by sponsor|0|||
146631177|NCT04323124|528826263|FG008|Overall Study|Study terminated by sponsor|0|||
146631178|NCT04323124|528826264|FG009|Overall Study|Study terminated by sponsor|0|||
146631179|NCT04323124|528826265|FG010|Overall Study|Study terminated by sponsor|0|||
146631180|NCT04323124|528826266|FG011|Overall Study|Study terminated by sponsor|2|||
146631181|NCT04323124|528826267|FG012|Overall Study|Study terminated by sponsor|1|||
146631182|NCT04323124|528826268|FG013|Overall Study|Study terminated by sponsor|0|||
146631183|NCT04323124|528826269|FG014|Overall Study|Study terminated by sponsor|0|||
146631184|NCT02083354|528828330|FG000|Overall Study|Withdrawal by Subject|9|||
146631185|NCT02083354|528828330|FG000|Overall Study|Lost to Follow-up|1|||
146631186|NCT02083354|528828330|FG000|Overall Study|Adverse Event|3|||
146631187|NCT02083354|528828330|FG000|Overall Study|Disease progression|46|||
146631188|NCT02083354|528828330|FG000|Overall Study|Study closed/terminated|5|||
146631189|NCT02066181|528828345|FG000|Overall Study|Withdrawal by Subject|1|||
146631190|NCT02066181|528828346|FG001|Overall Study|Withdrawal by Subject|1|||
146631191|NCT02141295|528828350|FG000|Overall Study|Adverse Event|1|||
146631192|NCT02141295|528828351|FG001|Overall Study|Adverse Event|18|||
146631193|NCT02141295|528828352|FG002|Overall Study|Adverse Event|11|||
146631194|NCT02141295|528828350|FG000|Overall Study|Physician Decision|2|||
146631195|NCT02141295|528828351|FG001|Overall Study|Physician Decision|19|||
146631196|NCT02141295|528828352|FG002|Overall Study|Physician Decision|14|||
146631197|NCT02141295|528828350|FG000|Overall Study|Study terminated by sponsor|0|||
146631198|NCT02141295|528828351|FG001|Overall Study|Study terminated by sponsor|6|||
146631199|NCT02141295|528828352|FG002|Overall Study|Study terminated by sponsor|6|||
146631200|NCT02141295|528828350|FG000|Overall Study|Non-compliance|0|||
146631201|NCT02141295|528828351|FG001|Overall Study|Non-compliance|1|||
146631202|NCT02141295|528828352|FG002|Overall Study|Non-compliance|0|||
146631203|NCT02141295|528828350|FG000|Overall Study|Progressive disease|3|||
146885533|NCT05103332|529747952|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146885534|NCT05103332|529747953|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146885535|NCT05103332|529747954|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146885536|NCT05103332|529747955|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
146885537|NCT05103332|529747938|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885538|NCT05103332|529747939|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885539|NCT05103332|529747940|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885540|NCT05103332|529747941|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885541|NCT05103332|529747942|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885542|NCT05103332|529747943|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146631204|NCT02141295|528828351|FG001|Overall Study|Progressive disease|32|||
146631205|NCT02141295|528828352|FG002|Overall Study|Progressive disease|50|||
146631206|NCT02141295|528828350|FG000|Overall Study|Reason not specified|0|||
146631207|NCT02141295|528828351|FG001|Overall Study|Reason not specified|9|||
146631208|NCT02141295|528828352|FG002|Overall Study|Reason not specified|10|||
146631209|NCT02141295|528828350|FG000|Overall Study|Withdrawal by Subject|0|||
146631210|NCT02141295|528828351|FG001|Overall Study|Withdrawal by Subject|9|||
146631211|NCT02141295|528828352|FG002|Overall Study|Withdrawal by Subject|4|||
146631212|NCT01671319|528828353|FG000|Overall Study|Withdrawal by Subject|1|||
146631213|NCT01389596|528828354|FG000|Overall Study|Protocol Violation|3|||
146631214|NCT01389596|528828355|FG001|Overall Study|Protocol Violation|4|||
146631215|NCT01389596|528828356|FG002|Overall Study|Protocol Violation|3|||
146631216|NCT01389596|528828354|FG000|Overall Study|Withdrawal by Subject|1|||
146631217|NCT01389596|528828355|FG001|Overall Study|Withdrawal by Subject|2|||
146631218|NCT01389596|528828356|FG002|Overall Study|Withdrawal by Subject|2|||
146631219|NCT01389596|528828354|FG000|Overall Study|Insufficient Clinical Response|3|||
146631220|NCT01389596|528828355|FG001|Overall Study|Insufficient Clinical Response|4|||
146631221|NCT01389596|528828356|FG002|Overall Study|Insufficient Clinical Response|5|||
146631222|NCT01389596|528828354|FG000|Overall Study|Adverse Event|1|||
146631223|NCT01389596|528828355|FG001|Overall Study|Adverse Event|4|||
146631224|NCT01389596|528828356|FG002|Overall Study|Adverse Event|0|||
146631225|NCT01389596|528828354|FG000|Overall Study|Death|0|||
146631226|NCT01389596|528828355|FG001|Overall Study|Death|1|||
146631227|NCT01389596|528828356|FG002|Overall Study|Death|0|||
146631228|NCT01389596|528828354|FG000|Overall Study|Other Unspecified|2|||
146765162|NCT00462943|529307282|FG002|Overall Study|Bone Marrow Transplant|0|||
146765163|NCT00462943|529307280|FG000|Overall Study|Required Lymphocyte Infusion|1|||
146765164|NCT00462943|529307281|FG001|Overall Study|Required Lymphocyte Infusion|0|||
146631229|NCT01389596|528828355|FG001|Overall Study|Other Unspecified|1|||
146631230|NCT01389596|528828356|FG002|Overall Study|Other Unspecified|0|||
146631231|NCT00214201|528828357|FG000|Overall Study|Withdrawal by Subject|2|||
146631232|NCT00214201|528828358|FG001|Overall Study|Withdrawal by Subject|0|||
146765165|NCT00462943|529307282|FG002|Overall Study|Required Lymphocyte Infusion|0|||
146765166|NCT00462943|529307280|FG000|Overall Study|Transplant - not specified|1|||
146885543|NCT05103332|529747944|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885544|NCT05103332|529747945|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885545|NCT05103332|529747946|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885546|NCT05103332|529747947|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885547|NCT05103332|529747948|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885548|NCT05103332|529747949|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146885549|NCT05103332|529747950|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
146885550|NCT05103332|529747951|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
146885551|NCT05103332|529747952|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
146885552|NCT05103332|529747953|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
146885553|NCT05103332|529747954|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
146885554|NCT05103332|529747955|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
146885555|NCT05103332|529747938|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146885556|NCT05103332|529747939|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146885557|NCT05103332|529747940|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146885558|NCT05103332|529747941|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146885559|NCT05103332|529747942|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146885560|NCT05103332|529747943|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146885561|NCT05103332|529747944|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146885562|NCT05103332|529747945|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146885563|NCT05103332|529747946|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146885564|NCT05103332|529747947|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146885565|NCT05103332|529747948|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146885566|NCT05103332|529747949|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146885567|NCT05103332|529747950|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146885568|NCT05103332|529747951|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146548825|NCT04073407|528516883|FG000|Part 1|Withdrawal by Subject|1|||
146548826|NCT04073407|528516884|FG001|Part 1|Withdrawal by Subject|0|||
146548827|NCT04073407|528516883|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
146548828|NCT04073407|528516884|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
146548829|NCT04073407|528516883|FG000|Part 2|Withdrawal by Subject|0|||
146548830|NCT04073407|528516884|FG001|Part 2|Withdrawal by Subject|1|||
146548831|NCT00960856|528518243|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
146548832|NCT00960856|528518244|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
146548833|NCT00960856|528518245|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
146548834|NCT00960856|528518246|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
146548835|NCT00960856|528518243|FG000|Washout Period of 7 Days|Adverse Event|0|||
146548836|NCT00960856|528518244|FG001|Washout Period of 7 Days|Adverse Event|0|||
146548837|NCT00960856|528518245|FG002|Washout Period of 7 Days|Adverse Event|1|||
146548838|NCT00960856|528518246|FG003|Washout Period of 7 Days|Adverse Event|0|||
146548839|NCT05938010|528518247|FG000|Overall Study|Lost to Follow-up|2|||
146548840|NCT01562444|528518252|FG000|Overall Study|Did not meet entry criteria|2|||
146548841|NCT01562444|528518253|FG001|Overall Study|Did not meet entry criteria|0|||
146548842|NCT01562444|528518254|FG002|Overall Study|Did not meet entry criteria|3|||
146631233|NCT00214201|528828357|FG000|Overall Study|Death|0|||
146885569|NCT05103332|529747952|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
146885570|NCT05103332|529747953|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
146885571|NCT05103332|529747954|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146966476|NCT04455620|530038814|FG004|Overall Study|Study Termination|6|||
146548843|NCT01562444|528518252|FG000|Overall Study|Did not comply with blood draw schedule|1|||
146548844|NCT01562444|528518253|FG001|Overall Study|Did not comply with blood draw schedule|0|||
146885572|NCT05103332|529747955|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
146885573|NCT05103332|529747938|FG000|SFU Period (6 Months=168 Days)|Death|0|||
146548845|NCT01562444|528518254|FG002|Overall Study|Did not comply with blood draw schedule|1|||
146548846|NCT01562444|528518252|FG000|Overall Study|Unavailable serological results|0|||
146548847|NCT01562444|528518253|FG001|Overall Study|Unavailable serological results|2|||
146548848|NCT01562444|528518254|FG002|Overall Study|Unavailable serological results|2|||
146548849|NCT01562444|528518252|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
146548850|NCT01562444|528518253|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
146885574|NCT05103332|529747939|FG001|SFU Period (6 Months=168 Days)|Death|0|||
146885575|NCT05103332|529747940|FG002|SFU Period (6 Months=168 Days)|Death|0|||
146885576|NCT05103332|529747941|FG003|SFU Period (6 Months=168 Days)|Death|0|||
146885577|NCT05103332|529747942|FG004|SFU Period (6 Months=168 Days)|Death|0|||
146885578|NCT05103332|529747943|FG005|SFU Period (6 Months=168 Days)|Death|0|||
146885579|NCT05103332|529747944|FG006|SFU Period (6 Months=168 Days)|Death|0|||
146885580|NCT05103332|529747945|FG007|SFU Period (6 Months=168 Days)|Death|0|||
146885581|NCT05103332|529747946|FG008|SFU Period (6 Months=168 Days)|Death|0|||
146885582|NCT05103332|529747947|FG009|SFU Period (6 Months=168 Days)|Death|0|||
146885583|NCT05103332|529747948|FG010|SFU Period (6 Months=168 Days)|Death|0|||
146885584|NCT05103332|529747949|FG011|SFU Period (6 Months=168 Days)|Death|0|||
146885585|NCT05103332|529747950|FG012|SFU Period (6 Months=168 Days)|Death|0|||
146885586|NCT05103332|529747951|FG013|SFU Period (6 Months=168 Days)|Death|0|||
146885587|NCT05103332|529747952|FG014|SFU Period (6 Months=168 Days)|Death|1|||
146885588|NCT05103332|529747953|FG015|SFU Period (6 Months=168 Days)|Death|0|||
146885589|NCT05103332|529747954|FG016|SFU Period (6 Months=168 Days)|Death|0|||
146885590|NCT05103332|529747955|FG017|SFU Period (6 Months=168 Days)|Death|1|||
146885591|NCT04209855|529747965|FG000|Overall Study|Death|161|||
146885592|NCT04209855|529747966|FG001|Overall Study|Death|177|||
146885593|NCT04209855|529747965|FG000|Overall Study|PI Discretion|1|||
146885594|NCT04209855|529747966|FG001|Overall Study|PI Discretion|1|||
146885595|NCT04209855|529747965|FG000|Overall Study|Lost to Follow-up|5|||
146885596|NCT04209855|529747966|FG001|Overall Study|Lost to Follow-up|2|||
146885597|NCT04209855|529747965|FG000|Overall Study|Withdrew consent|10|||
146885598|NCT04209855|529747966|FG001|Overall Study|Withdrew consent|24|||
146885599|NCT04209855|529747965|FG000|Overall Study|Sponsor decision|44|||
146885600|NCT04209855|529747966|FG001|Overall Study|Sponsor decision|18|||
146885601|NCT04209855|529747965|FG000|Overall Study|Other than specified|6|||
146885602|NCT04209855|529747966|FG001|Overall Study|Other than specified|4|||
146885603|NCT02289950|529747967|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
146885604|NCT02289950|529747968|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
146885605|NCT02289950|529747967|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
146885606|NCT02289950|529747968|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
146885607|NCT02289950|529747967|FG000|Overall Study|Lost to Follow-up|1|||
146885608|NCT02289950|529747968|FG001|Overall Study|Lost to Follow-up|0|||
146885609|NCT02289950|529747967|FG000|Overall Study|Physician Decision|9|||
146885610|NCT02289950|529747968|FG001|Overall Study|Physician Decision|3|||
146885611|NCT02289950|529747967|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
146885612|NCT02289950|529747968|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
146885613|NCT02289950|529747967|FG000|Overall Study|Withdrawal by Subject|1|||
146885614|NCT02289950|529747968|FG001|Overall Study|Withdrawal by Subject|3|||
146885615|NCT02289950|529747967|FG000|Overall Study|Test article held for greater than 28 days|0|||
146885616|NCT02289950|529747968|FG001|Overall Study|Test article held for greater than 28 days|1|||
146885617|NCT02289950|529747967|FG000|Overall Study|Adverse Event|11|||
146885618|NCT02289950|529747968|FG001|Overall Study|Adverse Event|3|||
146548851|NCT01562444|528518254|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
146548852|NCT01562444|528518252|FG000|Overall Study|Protocol forbidden medication|1|||
146548853|NCT01562444|528518253|FG001|Overall Study|Protocol forbidden medication|0|||
146885619|NCT02289950|529747967|FG000|Overall Study|Death|1|||
146885620|NCT02289950|529747968|FG001|Overall Study|Death|1|||
146885621|NCT02289950|529747967|FG000|Overall Study|Other|5|||
146548854|NCT01562444|528518254|FG002|Overall Study|Protocol forbidden medication|0|||
146548855|NCT03387046|528518256|FG000|Overall Study|Adverse Event|1|||
146548856|NCT03387046|528518257|FG001|Overall Study|Adverse Event|1|||
146885622|NCT02289950|529747968|FG001|Overall Study|Other|2|||
146885623|NCT02289950|529747967|FG000|Overall Study|Not Treated|2|||
146885624|NCT02289950|529747968|FG001|Overall Study|Not Treated|1|||
146885625|NCT04153188|529747973|FG000|Overall Study|Lost to Follow-up|1|||
146548857|NCT01027416|528518260|FG000|Overall Study|Withdrawal by Subject|0|||
146885626|NCT04153188|529747974|FG001|Overall Study|Lost to Follow-up|1|||
146885627|NCT04153188|529747973|FG000|Overall Study|Withdrawal by Subject|2|||
146885628|NCT04153188|529747974|FG001|Overall Study|Withdrawal by Subject|0|||
146885629|NCT04153188|529747973|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
146885630|NCT04153188|529747974|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
146885631|NCT02600494|529747985|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
146885632|NCT02600494|529747986|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
146885633|NCT02600494|529747987|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
146885634|NCT02600494|529747985|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
146885635|NCT02600494|529747986|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
146885636|NCT02600494|529747987|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
146885637|NCT02600494|529747985|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
146885638|NCT02600494|529747986|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
146885639|NCT02600494|529747987|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
146885640|NCT02600494|529747985|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
146885641|NCT02600494|529747986|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
146885642|NCT02600494|529747987|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
146885643|NCT02600494|529747985|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
146885644|NCT02600494|529747986|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
146885645|NCT02600494|529747987|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
146885646|NCT02600494|529747985|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
146885647|NCT02600494|529747986|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
146885648|NCT02600494|529747987|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
146885649|NCT02600494|529747985|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
146885650|NCT02600494|529747986|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
146885651|NCT02600494|529747987|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
146885652|NCT02600494|529747985|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
146885653|NCT02600494|529747986|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
146885654|NCT02600494|529747987|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
146885655|NCT02600494|529747985|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
146885656|NCT02600494|529747986|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
146885657|NCT02600494|529747987|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
146885658|NCT02600494|529747985|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
146885659|NCT02600494|529747986|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
146548858|NCT01027416|528518261|FG001|Overall Study|Withdrawal by Subject|1|||
146885660|NCT02600494|529747987|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
146885661|NCT02600494|529747985|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
146548859|NCT01027416|528518260|FG000|Overall Study|Physician Decision|1|||
146548860|NCT01027416|528518261|FG001|Overall Study|Physician Decision|4|||
146548861|NCT00120250|528518262|FG000|Overall Study|Lost to Follow-up|1|||
146548862|NCT00120250|528518263|FG001|Overall Study|Lost to Follow-up|1|||
146548863|NCT00120250|528518262|FG000|Overall Study|Protocol Violation|0|||
146548864|NCT00120250|528518263|FG001|Overall Study|Protocol Violation|1|||
146548865|NCT00720083|528518264|FG000|Overall Study|Ineligible|1|||
146548866|NCT00720083|528518265|FG001|Overall Study|Ineligible|2|||
146548867|NCT04233580|528518267|FG000|Overall Study|Adverse Event|3|||
146548868|NCT04233580|528518268|FG001|Overall Study|Adverse Event|3|||
146548869|NCT04233580|528518267|FG000|Overall Study|Withdrawal by Subject|2|||
146548870|NCT04233580|528518268|FG001|Overall Study|Withdrawal by Subject|1|||
146548871|NCT01371565|528518269|FG000|Overall Study|Withdrawal by Subject|1|||
146548872|NCT01371565|528518269|FG000|Overall Study|Death|1|||
146548873|NCT01371565|528518269|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
146548874|NCT04433975|528518271|FG000|1-month Follow Up|Withdrawal by Subject|1|||
146548875|NCT04433975|528518272|FG001|1-month Follow Up|Withdrawal by Subject|1|||
146548876|NCT04433975|528518271|FG000|1-month Follow Up|Lost to Follow-up|21|||
146548877|NCT04433975|528518272|FG001|1-month Follow Up|Lost to Follow-up|25|||
146548878|NCT04433975|528518271|FG000|3-month Follow Up|Lost to Follow-up|20|||
146548879|NCT04433975|528518272|FG001|3-month Follow Up|Lost to Follow-up|24|||
146548880|NCT04433975|528518271|FG000|3-month Follow Up|Death|1|||
146548881|NCT04433975|528518272|FG001|3-month Follow Up|Death|0|||
146548882|NCT04433975|528518271|FG000|3-month Follow Up|Withdrawal by Subject|2|||
146548883|NCT04433975|528518272|FG001|3-month Follow Up|Withdrawal by Subject|0|||
146548884|NCT04433975|528518271|FG000|6-month Follow Up|Lost to Follow-up|23|||
146548885|NCT04433975|528518272|FG001|6-month Follow Up|Lost to Follow-up|28|||
146548886|NCT04433975|528518271|FG000|6-month Follow Up|Withdrawal by Subject|1|||
146548887|NCT04433975|528518272|FG001|6-month Follow Up|Withdrawal by Subject|1|||
146548888|NCT04433975|528518271|FG000|9-month Follow Up|Lost to Follow-up|27|||
146548889|NCT04433975|528518272|FG001|9-month Follow Up|Lost to Follow-up|36|||
146548890|NCT04433975|528518271|FG000|9-month Follow Up|Death|0|||
146548891|NCT04433975|528518272|FG001|9-month Follow Up|Death|1|||
146548892|NCT04433975|528518271|FG000|12-month Follow Up|Lost to Follow-up|27|||
146548893|NCT04433975|528518272|FG001|12-month Follow Up|Lost to Follow-up|31|||
146548894|NCT00685698|528518273|FG000|Overall Study|Withdrawal by Subject|1|||
146548895|NCT00685698|528518273|FG000|Overall Study|Protocol Violation|6|||
146548896|NCT00685698|528518273|FG000|Overall Study|Adverse Event|3|||
146548897|NCT00685698|528518273|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
146548898|NCT00685698|528518273|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
146548899|NCT00685698|528518273|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
146548900|NCT04392635|528518274|FG000|Overall Study|Lost to Follow-up|0|||
146548901|NCT04392635|528518275|FG001|Overall Study|Lost to Follow-up|1|||
146548902|NCT02030418|528518277|FG000|Overall Study|Death|78|||
146548903|NCT02030418|528518277|FG000|Overall Study|Missed 12-Month Visit|9|||
146548904|NCT02030418|528518277|FG000|Overall Study|Withdrawn|57|||
146548905|NCT01179516|528518278|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
146548906|NCT01179516|528518279|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
146548907|NCT01179516|528518280|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
146548908|NCT01179516|528518278|FG000|Overall Study|Lack of Efficacy|4|||
146548909|NCT01179516|528518279|FG001|Overall Study|Lack of Efficacy|2|||
146548910|NCT01179516|528518280|FG002|Overall Study|Lack of Efficacy|0|||
146548911|NCT01179516|528518278|FG000|Overall Study|Noncompliance with Study Drug|2|||
146548912|NCT01179516|528518279|FG001|Overall Study|Noncompliance with Study Drug|0|||
146548913|NCT01179516|528518280|FG002|Overall Study|Noncompliance with Study Drug|1|||
146548914|NCT01179516|528518278|FG000|Overall Study|Protocol Deviations|4|||
146631234|NCT00214201|528828358|FG001|Overall Study|Death|2|||
146548915|NCT01179516|528518279|FG001|Overall Study|Protocol Deviations|3|||
146548916|NCT01179516|528518280|FG002|Overall Study|Protocol Deviations|3|||
146548917|NCT01179516|528518278|FG000|Overall Study|Withdrawal of Consent|2|||
146548918|NCT01179516|528518279|FG001|Overall Study|Withdrawal of Consent|6|||
146885662|NCT02600494|529747986|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
146885663|NCT02600494|529747987|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
146548919|NCT01179516|528518280|FG002|Overall Study|Withdrawal of Consent|10|||
146548920|NCT01179516|528518278|FG000|Overall Study|Lost to Follow-up|7|||
146548921|NCT01179516|528518279|FG001|Overall Study|Lost to Follow-up|7|||
146548922|NCT01179516|528518280|FG002|Overall Study|Lost to Follow-up|3|||
146548923|NCT01179516|528518278|FG000|Overall Study|Other|2|||
146548924|NCT01179516|528518279|FG001|Overall Study|Other|0|||
146548925|NCT01179516|528518280|FG002|Overall Study|Other|2|||
146548926|NCT02697422|528518286|FG000|Overall Study|Declined exit survey|9|||
146548927|NCT02697422|528518287|FG001|Overall Study|Declined exit survey|2|||
146548928|NCT02697422|528518286|FG000|Overall Study|Lost to Follow-up|13|||
146548929|NCT02697422|528518287|FG001|Overall Study|Lost to Follow-up|8|||
146548930|NCT02697422|528518286|FG000|Overall Study|Death|2|||
146548931|NCT02697422|528518287|FG001|Overall Study|Death|1|||
146548932|NCT02697422|528518286|FG000|Overall Study|Withdrawal by Subject|0|||
146548933|NCT02697422|528518287|FG001|Overall Study|Withdrawal by Subject|1|||
146548934|NCT02697422|528518286|FG000|Overall Study|Physician Decision|1|||
146548935|NCT02697422|528518287|FG001|Overall Study|Physician Decision|1|||
146548936|NCT02697422|528518286|FG000|Overall Study|Exit survey data lost|1|||
146548937|NCT02697422|528518287|FG001|Overall Study|Exit survey data lost|0|||
146548938|NCT03501277|528518289|FG000|Intervention Period 1 (4 Days)|Other|0|||
146548939|NCT03501277|528518290|FG001|Intervention Period 1 (4 Days)|Other|0|||
146548940|NCT03501277|528518291|FG002|Intervention Period 1 (4 Days)|Other|1|||
146548941|NCT03501277|528518292|FG003|Intervention Period 1 (4 Days)|Other|0|||
146548942|NCT03501277|528518289|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
146548943|NCT03501277|528518290|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
146548944|NCT03501277|528518291|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
146548945|NCT03501277|528518292|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
146548946|NCT03501277|528518289|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
146548947|NCT03501277|528518290|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
146548948|NCT03501277|528518291|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
146548949|NCT03501277|528518292|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
146548950|NCT03501277|528518289|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
146548951|NCT03501277|528518290|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
146548952|NCT03501277|528518291|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
146548953|NCT03501277|528518292|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
146548954|NCT01873833|528518294|FG000|Overall Study|Withdrawal by Subject|1|||
146548955|NCT03983109|528518297|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
146548956|NCT03983109|528518298|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
146548957|NCT02939781|528518299|FG000|Overall Study|Protocol Violation|8|||
146548958|NCT02939781|528518299|FG000|Overall Study|Withdrawal by Subject|1|||
146548959|NCT01740427|528518300|FG000|Overall Study|Objective Progression or Relapse|286|||
146548960|NCT01740427|528518301|FG001|Overall Study|Objective Progression or Relapse|172|||
146548961|NCT01740427|528518300|FG000|Overall Study|Adverse Event|32|||
146548962|NCT01740427|528518301|FG001|Overall Study|Adverse Event|9|||
146548963|NCT01740427|528518300|FG000|Overall Study|Global Deterioration of Health Status|28|||
146548964|NCT01740427|528518301|FG001|Overall Study|Global Deterioration of Health Status|12|||
146548965|NCT01740427|528518300|FG000|Overall Study|Participant Refused Continued Treatment|27|||
146548966|NCT01740427|528518301|FG001|Overall Study|Participant Refused Continued Treatment|15|||
146548967|NCT01740427|528518300|FG000|Overall Study|Unspecified reasons|52|||
146548968|NCT01740427|528518301|FG001|Overall Study|Unspecified reasons|8|||
146548969|NCT01740427|528518300|FG000|Overall Study|Death|10|||
146548970|NCT01740427|528518301|FG001|Overall Study|Death|3|||
146548971|NCT01740427|528518300|FG000|Overall Study|Protocol Violation|5|||
146548972|NCT01740427|528518301|FG001|Overall Study|Protocol Violation|3|||
146548973|NCT01740427|528518300|FG000|Overall Study|Lost to Follow-up|3|||
146548974|NCT01740427|528518301|FG001|Overall Study|Lost to Follow-up|0|||
146548975|NCT01740427|528518300|FG000|Overall Study|Site Terminated by Sponsor|1|||
146548976|NCT01740427|528518301|FG001|Overall Study|Site Terminated by Sponsor|0|||
146548977|NCT04739709|528518307|FG000|Overall Study|Physician Decision|1|||
146548978|NCT04739709|528518308|FG001|Overall Study|Physician Decision|0|||
146548979|NCT01980888|528518309|FG000|Overall Study|Study Terminated by Sponsor|116|||
146548980|NCT01980888|528518310|FG001|Overall Study|Study Terminated by Sponsor|122|||
146548981|NCT01980888|528518309|FG000|Overall Study|Withdrew Consent|17|||
146548982|NCT01980888|528518310|FG001|Overall Study|Withdrew Consent|6|||
146548983|NCT01980888|528518309|FG000|Overall Study|Investigator's Discretion|8|||
146548984|NCT01980888|528518310|FG001|Overall Study|Investigator's Discretion|3|||
146548985|NCT01980888|528518309|FG000|Overall Study|Non-Compliance with Study Drug|3|||
146548986|NCT01980888|528518310|FG001|Overall Study|Non-Compliance with Study Drug|2|||
146548987|NCT04625972|528518312|FG000|Overall Study|Death|3|||
146548988|NCT04625972|528518313|FG001|Overall Study|Death|2|||
146548989|NCT04625972|528518312|FG000|Overall Study|Lost to Follow-up|82|||
146548990|NCT04625972|528518313|FG001|Overall Study|Lost to Follow-up|38|||
146548991|NCT04625972|528518312|FG000|Overall Study|Physician Decision|2|||
146548992|NCT04625972|528518313|FG001|Overall Study|Physician Decision|0|||
146966477|NCT05012943|530038816|FG000|Overall Study|Adverse Event|2|||
146548993|NCT04625972|528518312|FG000|Overall Study|Protocol Violation|0|||
146548994|NCT04625972|528518313|FG001|Overall Study|Protocol Violation|1|||
146548995|NCT04625972|528518312|FG000|Overall Study|Withdrawal by Subject|37|||
146548996|NCT04625972|528518313|FG001|Overall Study|Withdrawal by Subject|24|||
146548997|NCT04625972|528518312|FG000|Overall Study|Not specified elsewhere|8|||
146548998|NCT04625972|528518313|FG001|Overall Study|Not specified elsewhere|6|||
146548999|NCT00433290|528518314|FG000|Overall Study|Adverse Event|24|||
146549000|NCT00433290|528518315|FG001|Overall Study|Adverse Event|7|||
146549001|NCT00433290|528518314|FG000|Overall Study|Lack of Efficacy|1|||
146549002|NCT00433290|528518315|FG001|Overall Study|Lack of Efficacy|5|||
146549003|NCT00433290|528518314|FG000|Overall Study|Withdrawal by Subject|4|||
146549004|NCT00433290|528518315|FG001|Overall Study|Withdrawal by Subject|2|||
146549005|NCT00433290|528518314|FG000|Overall Study|Protocol Violation|3|||
146549006|NCT00433290|528518315|FG001|Overall Study|Protocol Violation|2|||
146549007|NCT00433290|528518314|FG000|Overall Study|Physician Decision|2|||
146549008|NCT00433290|528518315|FG001|Overall Study|Physician Decision|0|||
146549009|NCT00433290|528518314|FG000|Overall Study|Entry Criteria Not Met|0|||
146549010|NCT00433290|528518315|FG001|Overall Study|Entry Criteria Not Met|1|||
146549011|NCT00433290|528518314|FG000|Overall Study|Lost to Follow-up|1|||
146549012|NCT00433290|528518315|FG001|Overall Study|Lost to Follow-up|0|||
146549013|NCT01483651|528518316|FG000|Overall Study|Withdrawal by Subject|0|||
146549014|NCT01483651|528518317|FG001|Overall Study|Withdrawal by Subject|1|||
146549015|NCT01483651|528518318|FG002|Overall Study|Withdrawal by Subject|1|||
146549016|NCT01483651|528518319|FG003|Overall Study|Withdrawal by Subject|0|||
146549017|NCT01483651|528518320|FG004|Overall Study|Withdrawal by Subject|0|||
146549018|NCT01483651|528518321|FG005|Overall Study|Withdrawal by Subject|1|||
146549019|NCT00724503|528518323|FG000|Overall Study|Lost to Follow-up|4|||
146549020|NCT00724503|528518324|FG001|Overall Study|Lost to Follow-up|8|||
146549021|NCT00724503|528518323|FG000|Overall Study|Withdrawal by Subject|11|||
146549022|NCT00724503|528518324|FG001|Overall Study|Withdrawal by Subject|23|||
146549023|NCT00724503|528518323|FG000|Overall Study|Death|190|||
146549024|NCT00724503|528518324|FG001|Overall Study|Death|182|||
146549025|NCT00724503|528518323|FG000|Overall Study|Adverse Event|1|||
146549026|NCT00724503|528518324|FG001|Overall Study|Adverse Event|0|||
146549027|NCT00724503|528518323|FG000|Overall Study|Not otherwise specified|4|||
146549028|NCT00724503|528518324|FG001|Overall Study|Not otherwise specified|7|||
146549029|NCT01928771|528518326|FG000|Overall Study|Adverse Event|6|||
146549030|NCT01928771|528518327|FG001|Overall Study|Adverse Event|5|||
146549031|NCT01928771|528518328|FG002|Overall Study|Adverse Event|1|||
146549032|NCT01928771|528518326|FG000|Overall Study|Death|2|||
146549033|NCT01928771|528518327|FG001|Overall Study|Death|2|||
146549034|NCT01928771|528518328|FG002|Overall Study|Death|2|||
146549035|NCT01928771|528518326|FG000|Overall Study|Lost to Follow-up|5|||
146549036|NCT01928771|528518327|FG001|Overall Study|Lost to Follow-up|6|||
146549037|NCT01928771|528518328|FG002|Overall Study|Lost to Follow-up|3|||
146549038|NCT01928771|528518326|FG000|Overall Study|Withdrawal by Subject|20|||
146549039|NCT01928771|528518327|FG001|Overall Study|Withdrawal by Subject|15|||
146549040|NCT01928771|528518328|FG002|Overall Study|Withdrawal by Subject|17|||
146549041|NCT01928771|528518326|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
146549042|NCT01928771|528518327|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
146549043|NCT01928771|528518328|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
146549044|NCT01928771|528518326|FG000|Overall Study|Other Reasons|9|||
146549045|NCT01928771|528518327|FG001|Overall Study|Other Reasons|9|||
146549046|NCT01928771|528518328|FG002|Overall Study|Other Reasons|14|||
146549047|NCT01928771|528518326|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
146549048|NCT01928771|528518327|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
146549049|NCT01928771|528518328|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
146549050|NCT01937117|528518329|FG000|Overall Study|Disease Progression|7|||
146549051|NCT01937117|528518329|FG000|Overall Study|Physician Decision|4|||
146549052|NCT01937117|528518329|FG000|Overall Study|Adverse Event|2|||
146549053|NCT01407367|528518332|FG000|Overall Study|Death|24|||
146549054|NCT01407367|528518333|FG001|Overall Study|Death|32|||
146549055|NCT01407367|528518332|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
146549056|NCT01407367|528518333|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
146549057|NCT01407367|528518332|FG000|Overall Study|Withdrawal by Subject|4|||
146549058|NCT01407367|528518333|FG001|Overall Study|Withdrawal by Subject|15|||
146549059|NCT01407367|528518332|FG000|Overall Study|Lost to Follow-up|0|||
146549060|NCT01407367|528518333|FG001|Overall Study|Lost to Follow-up|2|||
146549061|NCT01245062|528518337|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
146549062|NCT01245062|528518338|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
146549063|NCT01245062|528518339|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
146549064|NCT01245062|528518337|FG000|Randomization and Crossover Phase|Physician Decision|2|||
146549065|NCT01245062|528518338|FG001|Randomization and Crossover Phase|Physician Decision|4|||
146549066|NCT01245062|528518339|FG002|Randomization and Crossover Phase|Physician Decision|0|||
146549067|NCT01245062|528518337|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
146549068|NCT01245062|528518338|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
146885664|NCT02600494|529747985|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
146885665|NCT02600494|529747986|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
146885666|NCT02600494|529747987|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
146885667|NCT02600494|529747985|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
146885668|NCT02600494|529747986|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
146885669|NCT02600494|529747987|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
146885670|NCT03124563|529747988|FG000|Overall Study|Lost to Follow-up|1|||
146885671|NCT03124563|529747989|FG001|Overall Study|Lost to Follow-up|1|||
146885672|NCT03124563|529747988|FG000|Overall Study|Withdrawal by Subject|1|||
146885673|NCT03124563|529747989|FG001|Overall Study|Withdrawal by Subject|1|||
146885674|NCT02396589|529747997|FG000|Intervention|Lost to Follow-up|1|||
146885675|NCT02396589|529747998|FG001|Intervention|Lost to Follow-up|0|||
146885676|NCT02396589|529747997|FG000|6 Month Follow-up|change in health status|0|||
146885677|NCT02396589|529747998|FG001|6 Month Follow-up|change in health status|1|||
146885678|NCT02396589|529747997|FG000|9 Month Follow-up|Death|0|||
146885679|NCT02396589|529747998|FG001|9 Month Follow-up|Death|1|||
146885680|NCT02396589|529747997|FG000|12 Month Follow up|Lost to Follow-up|0|||
146885681|NCT02396589|529747998|FG001|12 Month Follow up|Lost to Follow-up|2|||
146885682|NCT02787850|529750046|FG000|Overall Study|Withdrawal by Subject|0|||
146885683|NCT02787850|529750047|FG001|Overall Study|Withdrawal by Subject|1|||
146885684|NCT02322710|529750050|FG000|Overall Study|No efficacy assessment post-baseline|0|||
146885685|NCT02322710|529750051|FG001|Overall Study|No efficacy assessment post-baseline|1|||
146885686|NCT02322710|529750050|FG000|Overall Study|Protocol Violation|20|||
146885687|NCT02322710|529750051|FG001|Overall Study|Protocol Violation|25|||
146885688|NCT03733392|529750052|FG000|Overall Study|Withdrawal by Subject|11|||
146885689|NCT03733392|529750053|FG001|Overall Study|Withdrawal by Subject|1|||
146885690|NCT03733392|529750052|FG000|Overall Study|Death|1|||
146885691|NCT03733392|529750053|FG001|Overall Study|Death|0|||
146885692|NCT03733392|529750052|FG000|Overall Study|Lost to Follow-up|5|||
146885693|NCT03733392|529750053|FG001|Overall Study|Lost to Follow-up|0|||
146885694|NCT03733392|529750052|FG000|Overall Study|Protocol Violation|0|||
146885695|NCT03733392|529750053|FG001|Overall Study|Protocol Violation|1|||
146885696|NCT03733392|529750052|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
146885697|NCT03733392|529750053|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
146885698|NCT03733392|529750052|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
146885699|NCT03733392|529750053|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
146631235|NCT01354899|528828359|FG000|Overall Study|discharge from the hospital|2|||
146631236|NCT01354899|528828359|FG000|Overall Study|Protocol Violation|1|||
146631237|NCT00463567|528828360|FG000|Overall Study|Adverse Event|29|||
146885700|NCT03733392|529750052|FG000|Overall Study|Patient Non-Compliance|2|||
146885701|NCT03733392|529750053|FG001|Overall Study|Patient Non-Compliance|1|||
146885702|NCT03733392|529750052|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
146885703|NCT03733392|529750053|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
146549069|NCT01245062|528518339|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
146549070|NCT01245062|528518337|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
146549071|NCT01245062|528518338|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
146549072|NCT01245062|528518339|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
146549073|NCT01245062|528518337|FG000|Cross-over Phase|Lost to Follow-up|0|||
146549074|NCT01245062|528518338|FG001|Cross-over Phase|Lost to Follow-up|0|||
146549075|NCT01245062|528518339|FG002|Cross-over Phase|Lost to Follow-up|1|||
146549076|NCT01245062|528518337|FG000|Cross-over Phase|Physician Decision|0|||
146549077|NCT01245062|528518338|FG001|Cross-over Phase|Physician Decision|0|||
146549078|NCT01245062|528518339|FG002|Cross-over Phase|Physician Decision|1|||
146549079|NCT01245062|528518337|FG000|Cross-over Phase|Withdrew Consent|0|||
146549080|NCT01245062|528518338|FG001|Cross-over Phase|Withdrew Consent|0|||
146549081|NCT01245062|528518339|FG002|Cross-over Phase|Withdrew Consent|4|||
146549082|NCT01245062|528518337|FG000|Cross-over Phase|Study closed/ terminated|0|||
146549083|NCT01245062|528518338|FG001|Cross-over Phase|Study closed/ terminated|0|||
146631238|NCT00463567|528828361|FG001|Overall Study|Adverse Event|26|||
146549084|NCT01245062|528518339|FG002|Cross-over Phase|Study closed/ terminated|11|||
146549085|NCT06025695|528518340|FG000|Overall Study|Adverse Event|5|||
146885704|NCT03733392|529750052|FG000|Overall Study|Withdrawal prior to procedure|5|||
146885705|NCT03733392|529750053|FG001|Overall Study|Withdrawal prior to procedure|2|||
146885706|NCT00559507|529750062|FG000|Overall Study|Not treated, patient ineligible|3|||
146885707|NCT01191697|529750063|FG000|Overall Study|Death|1|||
146885708|NCT01191697|529750063|FG000|Overall Study|Physician Decision|2|||
146885709|NCT01191697|529750063|FG000|Overall Study|Pursue chemoradiation|2|||
146885710|NCT01191697|529750063|FG000|Overall Study|Break from chemotherapy|2|||
146885711|NCT01191697|529750063|FG000|Overall Study|Withdrawal by Subject|1|||
146885712|NCT01191697|529750063|FG000|Overall Study|Surveillance|1|||
146885713|NCT01191697|529750063|FG000|Overall Study|Adverse Event|2|||
146885714|NCT01191697|529750063|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
146885715|NCT01191697|529750063|FG000|Overall Study|Not completed but analyzed|25|||
146885716|NCT04227899|529750064|FG000|Overall Study|Withdrawal by Subject|6|||
146885717|NCT04227899|529750065|FG001|Overall Study|Withdrawal by Subject|3|||
146885718|NCT04227899|529750064|FG000|Overall Study|Death|12|||
146885719|NCT04227899|529750065|FG001|Overall Study|Death|6|||
146885720|NCT04227899|529750064|FG000|Overall Study|Lost to Follow-up|2|||
146885721|NCT04227899|529750065|FG001|Overall Study|Lost to Follow-up|1|||
146885722|NCT02479802|529750066|FG000|Overall Study|Lost to Follow-up|1|||
146885723|NCT02479802|529750066|FG000|Overall Study|Adverse Event|1|||
146885724|NCT03124784|529750067|FG000|Overall Study|Adverse Event|1|||
146885725|NCT03124784|529750067|FG000|Overall Study|Computer/Equip Malfunction|1|||
146885726|NCT05702515|529750068|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
146885727|NCT01784965|529750069|FG000|Overall Study|Withdrawal by Subject|6|||
146885728|NCT01784965|529750070|FG001|Overall Study|Withdrawal by Subject|3|||
146885729|NCT01784965|529750069|FG000|Overall Study|Adverse Event|0|||
146885730|NCT01784965|529750070|FG001|Overall Study|Adverse Event|8|||
146885731|NCT01467492|529750073|FG000|Overall Study|Withdrawal by Subject|6|||
146885732|NCT01467492|529750074|FG001|Overall Study|Withdrawal by Subject|4|||
146885733|NCT01467492|529750073|FG000|Overall Study|Study Terminated by Sponsor|6|||
146885734|NCT01467492|529750074|FG001|Overall Study|Study Terminated by Sponsor|4|||
146885735|NCT01467492|529750073|FG000|Overall Study|Adverse Event|4|||
146885736|NCT01467492|529750074|FG001|Overall Study|Adverse Event|3|||
146885737|NCT01467492|529750073|FG000|Overall Study|Lost to Follow-up|3|||
146885738|NCT01467492|529750074|FG001|Overall Study|Lost to Follow-up|2|||
146885739|NCT01467492|529750073|FG000|Overall Study|Undefined|2|||
146885740|NCT01467492|529750074|FG001|Overall Study|Undefined|0|||
146885741|NCT01467492|529750073|FG000|Overall Study|Enrolled But Not Treated|1|||
146885742|NCT01467492|529750074|FG001|Overall Study|Enrolled But Not Treated|0|||
146885743|NCT01562548|529750075|FG000|Overall Study|Lost to Follow-up|0|||
146885744|NCT01562548|529750076|FG001|Overall Study|Lost to Follow-up|0|||
146885745|NCT01562548|529750077|FG002|Overall Study|Lost to Follow-up|1|||
146885746|NCT01562548|529750078|FG003|Overall Study|Lost to Follow-up|0|||
146885747|NCT01239160|529750079|FG000|Overall Study|Lost to Follow-up|3|||
146885748|NCT01239160|529750080|FG001|Overall Study|Lost to Follow-up|5|||
146885749|NCT01239160|529750081|FG002|Overall Study|Lost to Follow-up|0|||
146885750|NCT01239160|529750079|FG000|Overall Study|Withdrawal by Subject|17|||
146885751|NCT01239160|529750080|FG001|Overall Study|Withdrawal by Subject|6|||
146885752|NCT01239160|529750081|FG002|Overall Study|Withdrawal by Subject|2|||
146885753|NCT01239160|529750079|FG000|Overall Study|Physician Decision|5|||
146885754|NCT01239160|529750080|FG001|Overall Study|Physician Decision|7|||
146885755|NCT01239160|529750081|FG002|Overall Study|Physician Decision|2|||
146885756|NCT01239160|529750079|FG000|Overall Study|Early Termination Due to Study Closure|0|||
146885757|NCT01239160|529750080|FG001|Overall Study|Early Termination Due to Study Closure|1|||
146885758|NCT01239160|529750081|FG002|Overall Study|Early Termination Due to Study Closure|6|||
146885759|NCT04781816|529750086|FG000|Overall Study|Adverse Event|0|||
146885760|NCT04781816|529750087|FG001|Overall Study|Adverse Event|1|||
146885761|NCT04781816|529750086|FG000|Overall Study|Withdrawal by Subject|1|||
146885762|NCT04781816|529750087|FG001|Overall Study|Withdrawal by Subject|1|||
146885763|NCT04781816|529750086|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
146885764|NCT04781816|529750087|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
146885765|NCT01121393|529750088|FG000|Overall Study|Progressive disease|201|||
146885766|NCT01121393|529750089|FG001|Overall Study|Progressive disease|20|||
146885767|NCT01121393|529750088|FG000|Overall Study|Other Adverse events|24|||
146885768|NCT01121393|529750089|FG001|Overall Study|Other Adverse events|45|||
146885769|NCT01121393|529750088|FG000|Overall Study|Non-compliant with protocol|0|||
146885770|NCT01121393|529750089|FG001|Overall Study|Non-compliant with protocol|3|||
146885771|NCT01121393|529750088|FG000|Overall Study|Lost to Follow-up|1|||
146885772|NCT01121393|529750089|FG001|Overall Study|Lost to Follow-up|0|||
146885773|NCT01121393|529750088|FG000|Overall Study|Refused cont. medication|7|||
146885774|NCT01121393|529750089|FG001|Overall Study|Refused cont. medication|7|||
146885775|NCT01121393|529750088|FG000|Overall Study|Not treated|3|||
146885776|NCT01121393|529750089|FG001|Overall Study|Not treated|9|||
146885777|NCT01121393|529750088|FG000|Overall Study|Other than listed|6|||
146885778|NCT01121393|529750089|FG001|Overall Study|Other than listed|0|||
146885779|NCT04372927|529750092|FG000|Overall Study|Death|1|||
146885780|NCT00608985|529750098|FG000|Overall Study|Adverse Event|2|||
146885781|NCT00608985|529750099|FG001|Overall Study|Adverse Event|7|||
146885782|NCT00608985|529750100|FG002|Overall Study|Adverse Event|4|||
146885783|NCT00608985|529750101|FG003|Overall Study|Adverse Event|6|||
146885784|NCT00608985|529750098|FG000|Overall Study|Administrative/Other|7|||
146885785|NCT00608985|529750099|FG001|Overall Study|Administrative/Other|4|||
146549086|NCT06025695|528518341|FG001|Overall Study|Adverse Event|6|||
146549087|NCT06025695|528518340|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
146549088|NCT06025695|528518341|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
146549089|NCT06025695|528518340|FG000|Overall Study|Other|23|||
146549090|NCT06025695|528518341|FG001|Overall Study|Other|19|||
146549091|NCT06025695|528518340|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
146549092|NCT06025695|528518341|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
146549093|NCT01452347|528518342|FG000|Overall Study|Adverse Event|2|||
146549094|NCT01452347|528518343|FG001|Overall Study|Adverse Event|1|||
146549095|NCT01452347|528518342|FG000|Overall Study|Non compliance protocol|2|||
146549096|NCT01452347|528518343|FG001|Overall Study|Non compliance protocol|0|||
146549097|NCT01452347|528518342|FG000|Overall Study|Lost to Follow-up|2|||
146549098|NCT01452347|528518343|FG001|Overall Study|Lost to Follow-up|0|||
146549099|NCT01452347|528518342|FG000|Overall Study|Withdrawal by Subject|3|||
146549100|NCT01452347|528518343|FG001|Overall Study|Withdrawal by Subject|3|||
146549101|NCT01452347|528518342|FG000|Overall Study|Not treated|6|||
146549102|NCT01452347|528518343|FG001|Overall Study|Not treated|3|||
146549103|NCT01452347|528518342|FG000|Overall Study|Other reason not defined above|2|||
146549104|NCT01452347|528518343|FG001|Overall Study|Other reason not defined above|0|||
146549105|NCT05762744|528518344|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
146549106|NCT05762744|528518345|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
146549107|NCT05762744|528518344|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
146549108|NCT05762744|528518345|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
146966478|NCT05012943|530038817|FG001|Overall Study|Adverse Event|1|||
146549109|NCT01560416|528518349|FG000|Randomized Phase|Crossover Participants|7|||
146966479|NCT05012943|530038818|FG002|Overall Study|Adverse Event|0|||
146549110|NCT01560416|528518350|FG001|Randomized Phase|Crossover Participants|0|||
146549111|NCT02724644|528519883|FG000|Overall Study|Adverse Event|7|||
146549112|NCT02724644|528519884|FG001|Overall Study|Adverse Event|1|||
146549113|NCT02724644|528519883|FG000|Overall Study|Lost to Follow-up|6|||
146549114|NCT02724644|528519884|FG001|Overall Study|Lost to Follow-up|2|||
146885786|NCT00608985|529750100|FG002|Overall Study|Administrative/Other|1|||
146885787|NCT00608985|529750101|FG003|Overall Study|Administrative/Other|2|||
146885788|NCT00608985|529750098|FG000|Overall Study|Withdrawal of Consent|5|||
146885789|NCT00608985|529750099|FG001|Overall Study|Withdrawal of Consent|1|||
146885790|NCT00608985|529750100|FG002|Overall Study|Withdrawal of Consent|1|||
146885791|NCT00608985|529750101|FG003|Overall Study|Withdrawal of Consent|1|||
146885792|NCT00608985|529750098|FG000|Overall Study|Lost to Follow-up|2|||
146885793|NCT00608985|529750099|FG001|Overall Study|Lost to Follow-up|1|||
146885794|NCT00608985|529750100|FG002|Overall Study|Lost to Follow-up|0|||
146549115|NCT02724644|528519883|FG000|Overall Study|Withdrawal by Subject|7|||
146549116|NCT02724644|528519884|FG001|Overall Study|Withdrawal by Subject|1|||
146549117|NCT02724644|528519883|FG000|Overall Study|Administrative|1|||
146549118|NCT02724644|528519884|FG001|Overall Study|Administrative|0|||
146549119|NCT02545127|528519887|FG000|Overall Study|Lost to Follow-up|1|||
146549120|NCT02545127|528519888|FG001|Overall Study|Lost to Follow-up|0|||
146549121|NCT03197935|528519889|FG000|Overall Study|Death due to any cause|26|||
146549122|NCT03197935|528519890|FG001|Overall Study|Death due to any cause|15|||
146549123|NCT03197935|528519889|FG000|Overall Study|Lost to Follow-up|3|||
146549124|NCT03197935|528519890|FG001|Overall Study|Lost to Follow-up|5|||
146549125|NCT03197935|528519889|FG000|Overall Study|Physician Decision|2|||
146549126|NCT03197935|528519890|FG001|Overall Study|Physician Decision|1|||
146549127|NCT03197935|528519889|FG000|Overall Study|Withdrawal by Subject|16|||
146549128|NCT03197935|528519890|FG001|Overall Study|Withdrawal by Subject|8|||
146549129|NCT00985192|528519892|FG000|Overall Study|Withdrawal by Subject|1|||
146549130|NCT00985192|528519892|FG000|Overall Study|Disease Progression|1|||
146549131|NCT00985192|528519892|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
146549132|NCT02595749|528519893|FG000|Overall Study|Withdrawal by Subject|12|||
146549133|NCT02595749|528519894|FG001|Overall Study|Withdrawal by Subject|7|||
146549134|NCT00669331|528519895|FG000|Randomisation to First Dose|Adverse Event|1|||
146549135|NCT00669331|528519896|FG001|Randomisation to First Dose|Adverse Event|0|||
146549136|NCT00669331|528519895|FG000|Randomisation to First Dose|Protocol Violation|1|||
146549137|NCT00669331|528519896|FG001|Randomisation to First Dose|Protocol Violation|0|||
146549138|NCT00669331|528519895|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
146549139|NCT00669331|528519896|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
146549140|NCT00669331|528519895|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
146549141|NCT00669331|528519896|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
146549142|NCT00669331|528519895|FG000|Randomisation to First Dose|Death|1|||
146549143|NCT00669331|528519896|FG001|Randomisation to First Dose|Death|0|||
146549144|NCT00669331|528519895|FG000|Randomisation to First Dose|Sponsor decision|0|||
146549145|NCT00669331|528519896|FG001|Randomisation to First Dose|Sponsor decision|1|||
146885795|NCT00608985|529750101|FG003|Overall Study|Lost to Follow-up|0|||
146885796|NCT03033745|529750102|FG000|Overall Study|Protocol Violation|0|||
146885797|NCT03033745|529750103|FG001|Overall Study|Protocol Violation|0|||
146885798|NCT03033745|529750104|FG002|Overall Study|Protocol Violation|1|||
146549146|NCT00669331|528519895|FG000|Randomisation to First Dose|Randomised in error|3|||
146549147|NCT00669331|528519896|FG001|Randomisation to First Dose|Randomised in error|10|||
146549148|NCT00669331|528519895|FG000|Blinded Treatment Period|Adverse Event|16|||
146549149|NCT00669331|528519896|FG001|Blinded Treatment Period|Adverse Event|10|||
146549150|NCT00669331|528519895|FG000|Blinded Treatment Period|Protocol Violation|1|||
146885799|NCT03033745|529750102|FG000|Overall Study|Adverse Event|1|||
146885800|NCT03033745|529750103|FG001|Overall Study|Adverse Event|0|||
146885801|NCT03033745|529750104|FG002|Overall Study|Adverse Event|1|||
146885802|NCT03033745|529750102|FG000|Overall Study|Withdrawal by Subject|0|||
146885803|NCT03033745|529750103|FG001|Overall Study|Withdrawal by Subject|1|||
146885804|NCT03033745|529750104|FG002|Overall Study|Withdrawal by Subject|0|||
146885805|NCT02706730|529750106|FG000|Overall Study|Adverse Event|3|||
146885806|NCT02706730|529750106|FG000|Overall Study|Lack of Efficacy|5|||
146885807|NCT02706730|529750106|FG000|Overall Study|Withdrawal by Subject|11|||
146885808|NCT02706730|529750106|FG000|Overall Study|Study Terminated by Sponsor|11|||
146765167|NCT00462943|529307281|FG001|Overall Study|Transplant - not specified|0|||
146765168|NCT00462943|529307282|FG002|Overall Study|Transplant - not specified|1|||
146765169|NCT00462943|529307280|FG000|Overall Study|Physician Decision|1|||
146765170|NCT00462943|529307281|FG001|Overall Study|Physician Decision|0|||
146765171|NCT00462943|529307282|FG002|Overall Study|Physician Decision|0|||
146885809|NCT02706730|529750106|FG000|Overall Study|Subject chose not to receive injection|3|||
146885810|NCT01999582|529750107|FG000|Overall Study|Withdrawal by Subject|0|||
146885811|NCT01999582|529750108|FG001|Overall Study|Withdrawal by Subject|0|||
146885812|NCT01999582|529750109|FG002|Overall Study|Withdrawal by Subject|0|||
146885813|NCT01999582|529750110|FG003|Overall Study|Withdrawal by Subject|1|||
146885814|NCT01999582|529750111|FG004|Overall Study|Withdrawal by Subject|0|||
146885815|NCT01999582|529750112|FG005|Overall Study|Withdrawal by Subject|0|||
146885816|NCT01999582|529750107|FG000|Overall Study|Adverse Event|0|||
146885817|NCT01999582|529750108|FG001|Overall Study|Adverse Event|0|||
146885818|NCT01999582|529750109|FG002|Overall Study|Adverse Event|3|||
146885819|NCT01999582|529750110|FG003|Overall Study|Adverse Event|0|||
146885820|NCT01999582|529750111|FG004|Overall Study|Adverse Event|1|||
146885821|NCT01999582|529750112|FG005|Overall Study|Adverse Event|0|||
146885822|NCT01999582|529750107|FG000|Overall Study|Other Reasons|1|||
146885823|NCT01999582|529750108|FG001|Overall Study|Other Reasons|0|||
146885824|NCT01999582|529750109|FG002|Overall Study|Other Reasons|3|||
146885825|NCT01999582|529750110|FG003|Overall Study|Other Reasons|1|||
146885826|NCT01999582|529750111|FG004|Overall Study|Other Reasons|1|||
146885827|NCT01999582|529750112|FG005|Overall Study|Other Reasons|2|||
146885828|NCT01999582|529750107|FG000|Overall Study|Protocol Violation|1|||
146549151|NCT00669331|528519896|FG001|Blinded Treatment Period|Protocol Violation|1|||
146549152|NCT00669331|528519895|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
146549153|NCT00669331|528519896|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
146549154|NCT00669331|528519895|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
146549155|NCT00669331|528519896|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
146549156|NCT00669331|528519895|FG000|Blinded Treatment Period|Death|0|||
146549157|NCT00669331|528519896|FG001|Blinded Treatment Period|Death|2|||
146549158|NCT00669331|528519895|FG000|Blinded Treatment Period|Physician Decision|3|||
146549159|NCT00669331|528519896|FG001|Blinded Treatment Period|Physician Decision|3|||
146549160|NCT00669331|528519895|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
146549161|NCT00669331|528519896|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
146549162|NCT01454063|528519897|FG000|Randomized|Adverse Event|1|||
146549163|NCT01454063|528519898|FG001|Randomized|Adverse Event|1|||
146549164|NCT01454063|528519897|FG000|Randomized|Protocol Violation|0|||
146549165|NCT01454063|528519898|FG001|Randomized|Protocol Violation|1|||
146549166|NCT00509600|528519907|FG000|Overall Study|Adverse Event|1|||
146549167|NCT02568423|528519910|FG000|Overall Study|Lost to Follow-up|0|||
146549168|NCT02568423|528519911|FG001|Overall Study|Lost to Follow-up|2|||
146549169|NCT02568423|528519912|FG002|Overall Study|Lost to Follow-up|0|||
146549170|NCT02568423|528519913|FG003|Overall Study|Lost to Follow-up|0|||
146549171|NCT02568423|528519914|FG004|Overall Study|Lost to Follow-up|0|||
146549172|NCT02568423|528519915|FG005|Overall Study|Lost to Follow-up|0|||
146549173|NCT02568423|528519916|FG006|Overall Study|Lost to Follow-up|0|||
146549174|NCT02568423|528519917|FG007|Overall Study|Lost to Follow-up|0|||
146549175|NCT02568423|528519910|FG000|Overall Study|Physician Decision|0|||
146549176|NCT02568423|528519911|FG001|Overall Study|Physician Decision|0|||
146765172|NCT00462943|529307280|FG000|Overall Study|Withdrawal by Subject|0|||
146765173|NCT00462943|529307281|FG001|Overall Study|Withdrawal by Subject|1|||
146885829|NCT01999582|529750108|FG001|Overall Study|Protocol Violation|0|||
146885830|NCT01999582|529750109|FG002|Overall Study|Protocol Violation|0|||
146885831|NCT01999582|529750110|FG003|Overall Study|Protocol Violation|0|||
146765174|NCT00462943|529307282|FG002|Overall Study|Withdrawal by Subject|0|||
146765175|NCT01697319|529307284|FG000|Primary Phase|Withdrawal by Subject|1|||
146885832|NCT01999582|529750111|FG004|Overall Study|Protocol Violation|0|||
146549177|NCT02568423|528519912|FG002|Overall Study|Physician Decision|0|||
146549178|NCT02568423|528519913|FG003|Overall Study|Physician Decision|0|||
146549179|NCT02568423|528519914|FG004|Overall Study|Physician Decision|0|||
146549180|NCT02568423|528519915|FG005|Overall Study|Physician Decision|1|||
146549181|NCT02568423|528519916|FG006|Overall Study|Physician Decision|0|||
146885833|NCT01999582|529750112|FG005|Overall Study|Protocol Violation|1|||
146966480|NCT05012943|530038816|FG000|Overall Study|Withdrawal by Subject|1052|||
146549182|NCT02568423|528519917|FG007|Overall Study|Physician Decision|0|||
146885834|NCT01999582|529750107|FG000|Overall Study|Lack of Efficacy|1|||
146885835|NCT01999582|529750108|FG001|Overall Study|Lack of Efficacy|3|||
146885836|NCT01999582|529750109|FG002|Overall Study|Lack of Efficacy|0|||
146885837|NCT01999582|529750110|FG003|Overall Study|Lack of Efficacy|1|||
146885838|NCT01999582|529750111|FG004|Overall Study|Lack of Efficacy|0|||
146885839|NCT01999582|529750112|FG005|Overall Study|Lack of Efficacy|0|||
146885840|NCT01081795|529750113|FG000|Overall Study|Adverse Event|18|||
146885841|NCT01081795|529750114|FG001|Overall Study|Adverse Event|23|||
146885842|NCT01081795|529750115|FG002|Overall Study|Adverse Event|6|||
146885843|NCT01081795|529750113|FG000|Overall Study|Lack of Efficacy|7|||
146549183|NCT03794544|528519918|FG000|Overall Study|Withdrawal by Subject|1|||
146549184|NCT03794544|528519919|FG001|Overall Study|Withdrawal by Subject|1|||
146549185|NCT03794544|528519920|FG002|Overall Study|Withdrawal by Subject|0|||
146549186|NCT03794544|528519921|FG003|Overall Study|Withdrawal by Subject|0|||
146549187|NCT03794544|528519918|FG000|Overall Study|Death|0|||
146549188|NCT03794544|528519919|FG001|Overall Study|Death|0|||
146549189|NCT03794544|528519920|FG002|Overall Study|Death|0|||
146549190|NCT03794544|528519921|FG003|Overall Study|Death|1|||
146549191|NCT03794544|528519918|FG000|Overall Study|Lost to Follow-up|0|||
146549192|NCT03794544|528519919|FG001|Overall Study|Lost to Follow-up|1|||
146549193|NCT03794544|528519920|FG002|Overall Study|Lost to Follow-up|1|||
146549194|NCT03794544|528519921|FG003|Overall Study|Lost to Follow-up|0|||
146549195|NCT03794544|528519918|FG000|Overall Study|Other|0|||
146549196|NCT03794544|528519919|FG001|Overall Study|Other|1|||
146549197|NCT03794544|528519920|FG002|Overall Study|Other|0|||
146549198|NCT03794544|528519921|FG003|Overall Study|Other|0|||
146549199|NCT00421733|528519922|FG000|Overall Study|Adverse Event|4|||
146549200|NCT00421733|528519923|FG001|Overall Study|Adverse Event|9|||
146549201|NCT00421733|528519924|FG002|Overall Study|Adverse Event|2|||
146549202|NCT00421733|528519922|FG000|Overall Study|Lost to Follow-up|1|||
146549203|NCT00421733|528519923|FG001|Overall Study|Lost to Follow-up|2|||
146549204|NCT00421733|528519924|FG002|Overall Study|Lost to Follow-up|4|||
146549205|NCT00421733|528519922|FG000|Overall Study|Withdrawal by Subject|1|||
146549206|NCT00421733|528519923|FG001|Overall Study|Withdrawal by Subject|2|||
146549207|NCT00421733|528519924|FG002|Overall Study|Withdrawal by Subject|7|||
146549208|NCT00421733|528519922|FG000|Overall Study|Death|0|||
146549209|NCT00421733|528519923|FG001|Overall Study|Death|3|||
146549210|NCT00421733|528519924|FG002|Overall Study|Death|0|||
146549211|NCT00421733|528519922|FG000|Overall Study|Required dialysis|1|||
146549212|NCT00421733|528519923|FG001|Overall Study|Required dialysis|0|||
146549213|NCT00421733|528519924|FG002|Overall Study|Required dialysis|0|||
146549214|NCT00421733|528519922|FG000|Overall Study|Administrative|2|||
146549215|NCT00421733|528519923|FG001|Overall Study|Administrative|0|||
146549216|NCT00421733|528519924|FG002|Overall Study|Administrative|0|||
146549217|NCT00421733|528519922|FG000|Overall Study|Did not satisfy entry criteria|1|||
146549218|NCT00421733|528519923|FG001|Overall Study|Did not satisfy entry criteria|3|||
146549219|NCT00421733|528519924|FG002|Overall Study|Did not satisfy entry criteria|2|||
146549220|NCT00421733|528519922|FG000|Overall Study|Sponsor request|1|||
146549221|NCT00421733|528519923|FG001|Overall Study|Sponsor request|0|||
146549222|NCT00421733|528519924|FG002|Overall Study|Sponsor request|3|||
146549223|NCT00421733|528519922|FG000|Overall Study|Protocol deviation|4|||
146549224|NCT00421733|528519923|FG001|Overall Study|Protocol deviation|7|||
146549225|NCT00421733|528519924|FG002|Overall Study|Protocol deviation|2|||
146549226|NCT00585585|528519927|FG000|Overall Study|Adverse Event|1|||
146549227|NCT00103506|528519928|FG000|Overall Study|Study closed by sponsor|34|||
146549228|NCT00103506|528519929|FG001|Overall Study|Study closed by sponsor|37|||
146549229|NCT00103506|528519928|FG000|Overall Study|Death|257|||
146549230|NCT00103506|528519929|FG001|Overall Study|Death|253|||
146549231|NCT00103506|528519928|FG000|Overall Study|Lost to Follow-up|13|||
146549232|NCT00103506|528519929|FG001|Overall Study|Lost to Follow-up|13|||
146549233|NCT00103506|528519928|FG000|Overall Study|Withdrawal by Subject|18|||
146549234|NCT00103506|528519929|FG001|Overall Study|Withdrawal by Subject|21|||
146765176|NCT01697319|529307284|FG000|Extension Phase|Terminated by Sponsor|15|||
146765177|NCT04222959|529307287|FG000|Overall Study|Lost to Follow-up|76|||
146765178|NCT04222959|529307288|FG001|Overall Study|Lost to Follow-up|28|||
146549235|NCT02056288|528519932|FG000|In-Hospital Data|Surgery cancelled|1|||
146549236|NCT02056288|528519933|FG001|In-Hospital Data|Surgery cancelled|0|||
146549237|NCT02056288|528519932|FG000|In-Hospital Data|Protocol Violation|3|||
146549238|NCT02056288|528519933|FG001|In-Hospital Data|Protocol Violation|0|||
146549239|NCT02056288|528519932|FG000|In-Hospital Data|Physician Decision|1|||
146549240|NCT02056288|528519933|FG001|In-Hospital Data|Physician Decision|0|||
146549241|NCT02056288|528519932|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
146549242|NCT02056288|528519933|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
146549243|NCT01441414|528519934|FG000|Overall Study|Participant died|9|||
146549244|NCT01441414|528519934|FG000|Overall Study|Other reasons|3|||
146549245|NCT01441414|528519934|FG000|Overall Study|Study terminated by sponsor|2|||
146549246|NCT01441414|528519934|FG000|Overall Study|Subject refused further follow-up|1|||
146549247|NCT01433978|528519935|FG000|Core Study|Adverse Event, Non-Fatal|0|||
146549248|NCT01433978|528519936|FG001|Core Study|Adverse Event, Non-Fatal|1|||
146549249|NCT01433978|528519937|FG002|Core Study|Adverse Event, Non-Fatal|0|||
146549250|NCT01433978|528519935|FG000|Core Study|Lack of Efficacy|5|||
146885844|NCT01081795|529750114|FG001|Overall Study|Lack of Efficacy|5|||
146885845|NCT01081795|529750115|FG002|Overall Study|Lack of Efficacy|19|||
146885846|NCT01081795|529750113|FG000|Overall Study|Subject's schedule|1|||
146549251|NCT01433978|528519936|FG001|Core Study|Lack of Efficacy|1|||
146549252|NCT01433978|528519937|FG002|Core Study|Lack of Efficacy|0|||
146549253|NCT01433978|528519935|FG000|Core Study|Study Terminated by Sponsor|6|||
146549254|NCT01433978|528519936|FG001|Core Study|Study Terminated by Sponsor|9|||
146549255|NCT01433978|528519937|FG002|Core Study|Study Terminated by Sponsor|0|||
146549256|NCT01433978|528519935|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
146549257|NCT01433978|528519936|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
146549258|NCT01433978|528519937|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
146549259|NCT01433978|528519935|FG000|Extension Phase|Lack of Efficacy|0|||
146549260|NCT01433978|528519936|FG001|Extension Phase|Lack of Efficacy|0|||
146549261|NCT01433978|528519937|FG002|Extension Phase|Lack of Efficacy|1|||
146549262|NCT01433978|528519935|FG000|Extension Phase|Study Terminated by Sponsor|0|||
146549263|NCT01433978|528519936|FG001|Extension Phase|Study Terminated by Sponsor|0|||
146549264|NCT01433978|528519937|FG002|Extension Phase|Study Terminated by Sponsor|4|||
146549265|NCT01773889|528519938|FG000|Overall Study|lack of funding|2|||
146549266|NCT00500110|528519939|FG000|Overall Study|Withdrawal by Subject|3|||
146549267|NCT03954938|528519940|FG000|Overall Study|Withdrawal by Subject|2|||
146549268|NCT03954938|528519940|FG000|Overall Study|Adverse Event|1|||
146549269|NCT02565186|528519946|FG000|Overall Study|Adverse Event|113|||
146549270|NCT02565186|528519947|FG001|Overall Study|Adverse Event|148|||
146549271|NCT02565186|528519946|FG000|Overall Study|Lost to Follow-up|102|||
146549272|NCT02565186|528519947|FG001|Overall Study|Lost to Follow-up|93|||
146549273|NCT02565186|528519946|FG000|Overall Study|Non-Compliance|57|||
146549274|NCT02565186|528519947|FG001|Overall Study|Non-Compliance|55|||
146549275|NCT02565186|528519946|FG000|Overall Study|Withdrawal by Subject|229|||
146549276|NCT02565186|528519947|FG001|Overall Study|Withdrawal by Subject|214|||
146549277|NCT02565186|528519946|FG000|Overall Study|Physician Decision|18|||
146549278|NCT02565186|528519947|FG001|Overall Study|Physician Decision|16|||
146885847|NCT01081795|529750114|FG001|Overall Study|Subject's schedule|1|||
146885848|NCT01081795|529750115|FG002|Overall Study|Subject's schedule|2|||
146885849|NCT01081795|529750113|FG000|Overall Study|Revocation of informed consent|2|||
146885850|NCT01081795|529750114|FG001|Overall Study|Revocation of informed consent|0|||
146885851|NCT01081795|529750115|FG002|Overall Study|Revocation of informed consent|0|||
146885852|NCT01081795|529750113|FG000|Overall Study|Ineligible for participation|1|||
146885853|NCT01081795|529750114|FG001|Overall Study|Ineligible for participation|0|||
146885854|NCT01081795|529750115|FG002|Overall Study|Ineligible for participation|0|||
146885855|NCT01081795|529750113|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
146885856|NCT01081795|529750114|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
146885857|NCT01081795|529750115|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
146885858|NCT01081795|529750113|FG000|Overall Study|Using drug with restricted days of use|2|||
146885859|NCT01081795|529750114|FG001|Overall Study|Using drug with restricted days of use|3|||
146885860|NCT01081795|529750115|FG002|Overall Study|Using drug with restricted days of use|2|||
146885861|NCT01081795|529750113|FG000|Overall Study|Other|1|||
146885862|NCT01081795|529750114|FG001|Overall Study|Other|2|||
146885863|NCT01081795|529750115|FG002|Overall Study|Other|0|||
146885864|NCT00661271|529750116|FG000|Overall Study|Lost to Follow-up|28|||
146885865|NCT00661271|529750117|FG001|Overall Study|Lost to Follow-up|25|||
146885866|NCT00953758|529750118|FG000|Overall Study|Death|2|||
146885867|NCT00953758|529750119|FG001|Overall Study|Death|0|||
146885868|NCT00953758|529750120|FG002|Overall Study|Death|1|||
146885869|NCT00953758|529750121|FG003|Overall Study|Death|1|||
146885870|NCT00953758|529750122|FG004|Overall Study|Death|1|||
146885871|NCT00953758|529750123|FG005|Overall Study|Death|1|||
146885872|NCT00953758|529750124|FG006|Overall Study|Death|1|||
146885873|NCT00953758|529750125|FG007|Overall Study|Death|3|||
146885874|NCT00953758|529750126|FG008|Overall Study|Death|1|||
146885875|NCT00953758|529750127|FG009|Overall Study|Death|0|||
146885876|NCT00953758|529750118|FG000|Overall Study|Participant refused further follow-up|0|||
146885877|NCT00953758|529750119|FG001|Overall Study|Participant refused further follow-up|0|||
146885878|NCT00953758|529750120|FG002|Overall Study|Participant refused further follow-up|1|||
146885879|NCT00953758|529750121|FG003|Overall Study|Participant refused further follow-up|0|||
146885880|NCT00953758|529750122|FG004|Overall Study|Participant refused further follow-up|3|||
146885881|NCT00953758|529750123|FG005|Overall Study|Participant refused further follow-up|0|||
146885882|NCT00953758|529750124|FG006|Overall Study|Participant refused further follow-up|0|||
146885883|NCT00953758|529750125|FG007|Overall Study|Participant refused further follow-up|0|||
146885884|NCT00953758|529750126|FG008|Overall Study|Participant refused further follow-up|1|||
146885885|NCT00953758|529750127|FG009|Overall Study|Participant refused further follow-up|0|||
146885886|NCT00953758|529750118|FG000|Overall Study|Lost to Follow-up|0|||
146885887|NCT00953758|529750119|FG001|Overall Study|Lost to Follow-up|0|||
146885888|NCT00953758|529750120|FG002|Overall Study|Lost to Follow-up|0|||
146885889|NCT00953758|529750121|FG003|Overall Study|Lost to Follow-up|1|||
146885890|NCT00953758|529750122|FG004|Overall Study|Lost to Follow-up|0|||
146885891|NCT00953758|529750123|FG005|Overall Study|Lost to Follow-up|0|||
146885892|NCT00953758|529750124|FG006|Overall Study|Lost to Follow-up|0|||
146885893|NCT00953758|529750125|FG007|Overall Study|Lost to Follow-up|1|||
146885894|NCT00953758|529750126|FG008|Overall Study|Lost to Follow-up|0|||
146885895|NCT00953758|529750127|FG009|Overall Study|Lost to Follow-up|1|||
146885896|NCT00953758|529750118|FG000|Overall Study|Physician Decision|0|||
146885897|NCT00953758|529750119|FG001|Overall Study|Physician Decision|0|||
146885898|NCT00953758|529750120|FG002|Overall Study|Physician Decision|0|||
146885899|NCT00953758|529750121|FG003|Overall Study|Physician Decision|0|||
146885900|NCT00953758|529750122|FG004|Overall Study|Physician Decision|1|||
146885901|NCT00953758|529750123|FG005|Overall Study|Physician Decision|0|||
146885902|NCT00953758|529750124|FG006|Overall Study|Physician Decision|0|||
146885903|NCT00953758|529750125|FG007|Overall Study|Physician Decision|0|||
146885904|NCT00953758|529750126|FG008|Overall Study|Physician Decision|0|||
146885905|NCT00953758|529750127|FG009|Overall Study|Physician Decision|0|||
146885906|NCT00953758|529750118|FG000|Overall Study|Disease progression|0|||
146885907|NCT00953758|529750119|FG001|Overall Study|Disease progression|0|||
146885908|NCT00953758|529750120|FG002|Overall Study|Disease progression|0|||
146885909|NCT00953758|529750121|FG003|Overall Study|Disease progression|0|||
146885910|NCT00953758|529750122|FG004|Overall Study|Disease progression|1|||
146885911|NCT00953758|529750123|FG005|Overall Study|Disease progression|0|||
146885912|NCT00953758|529750124|FG006|Overall Study|Disease progression|0|||
146885913|NCT00953758|529750125|FG007|Overall Study|Disease progression|0|||
146885914|NCT00953758|529750126|FG008|Overall Study|Disease progression|0|||
146885915|NCT00953758|529750127|FG009|Overall Study|Disease progression|0|||
146885916|NCT00953758|529750118|FG000|Overall Study|Participant went for transplant|0|||
146885917|NCT00953758|529750119|FG001|Overall Study|Participant went for transplant|0|||
146885918|NCT00953758|529750120|FG002|Overall Study|Participant went for transplant|0|||
146885919|NCT00953758|529750121|FG003|Overall Study|Participant went for transplant|0|||
146885920|NCT00953758|529750122|FG004|Overall Study|Participant went for transplant|0|||
146885921|NCT00953758|529750123|FG005|Overall Study|Participant went for transplant|0|||
146885922|NCT00953758|529750124|FG006|Overall Study|Participant went for transplant|0|||
146885923|NCT00953758|529750125|FG007|Overall Study|Participant went for transplant|0|||
146885924|NCT00953758|529750126|FG008|Overall Study|Participant went for transplant|1|||
146885925|NCT00953758|529750127|FG009|Overall Study|Participant went for transplant|0|||
146885926|NCT01536860|529750128|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
146885927|NCT01536860|529750129|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
146885928|NCT01536860|529750130|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
146885929|NCT02902120|529750131|FG000|Overall Study|Lack of Efficacy|1|||
146885930|NCT01445769|529750132|FG000|Overall Study|Consent Withdrawn|2|||
146885931|NCT01445769|529750132|FG000|Overall Study|Disease Progression|1|||
146885932|NCT01445769|529750132|FG000|Overall Study|Lost to Follow-up|5|||
146885933|NCT03694925|529750133|FG000|Overall Study|Inadequate laboratory testing|0|||
146885934|NCT03694925|529750134|FG001|Overall Study|Inadequate laboratory testing|3|||
146885935|NCT03694925|529750135|FG002|Overall Study|Inadequate laboratory testing|0|||
146885936|NCT02799069|529750140|FG000|Overall Study|Adverse Event|0|||
146885937|NCT02799069|529750141|FG001|Overall Study|Adverse Event|2|||
146885938|NCT02799069|529750142|FG002|Overall Study|Adverse Event|2|||
146885939|NCT02799069|529750140|FG000|Overall Study|Lack of Efficacy|2|||
146885940|NCT02799069|529750141|FG001|Overall Study|Lack of Efficacy|0|||
146885941|NCT02799069|529750142|FG002|Overall Study|Lack of Efficacy|0|||
146549279|NCT02565186|528519946|FG000|Overall Study|Sponsor Request|5|||
146885942|NCT02799069|529750140|FG000|Overall Study|Lost to Follow-up|1|||
146885943|NCT02799069|529750141|FG001|Overall Study|Lost to Follow-up|1|||
146885944|NCT02799069|529750142|FG002|Overall Study|Lost to Follow-up|0|||
146885945|NCT02799069|529750140|FG000|Overall Study|Withdrawal by Subject|4|||
146885946|NCT02799069|529750141|FG001|Overall Study|Withdrawal by Subject|4|||
146885947|NCT02799069|529750142|FG002|Overall Study|Withdrawal by Subject|3|||
146885948|NCT02799069|529750140|FG000|Overall Study|Protocol Violation|1|||
146885949|NCT02799069|529750141|FG001|Overall Study|Protocol Violation|0|||
146885950|NCT02799069|529750142|FG002|Overall Study|Protocol Violation|2|||
146885951|NCT03652662|529750145|FG000|Overall Study|Withdrawal by Subject|2|||
146885952|NCT03652662|529750146|FG001|Overall Study|Withdrawal by Subject|1|||
146885953|NCT03652662|529750145|FG000|Overall Study|Lost to Follow-up|1|||
146885954|NCT03652662|529750146|FG001|Overall Study|Lost to Follow-up|0|||
146885955|NCT00487539|529750147|FG000|Overall Study|Adverse Event|3|||
146885956|NCT00487539|529750148|FG001|Overall Study|Adverse Event|2|||
146885957|NCT00487539|529750149|FG002|Overall Study|Adverse Event|1|||
146885958|NCT00487539|529750150|FG003|Overall Study|Adverse Event|1|||
146885959|NCT00487539|529750147|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146885960|NCT00487539|529750148|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146885961|NCT00487539|529750149|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146885962|NCT00487539|529750150|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
146885963|NCT00487539|529750147|FG000|Overall Study|Other|3|||
146885964|NCT00487539|529750148|FG001|Overall Study|Other|1|||
146549280|NCT02565186|528519947|FG001|Overall Study|Sponsor Request|9|||
146885965|NCT00487539|529750149|FG002|Overall Study|Other|2|||
146885966|NCT00487539|529750150|FG003|Overall Study|Other|2|||
146885967|NCT02695628|529750151|FG000|Overall Study|Withdrawal by Subject|1|||
146885968|NCT02678390|529750152|FG000|AE (1 Day)|Withdrawal by Subject|0|||
146885969|NCT02678390|529750153|FG001|AE (1 Day)|Withdrawal by Subject|1|||
146885970|NCT03499028|529750154|FG000|Overall Study|Lost to Follow-up|12|||
146885971|NCT03499028|529750155|FG001|Overall Study|Lost to Follow-up|9|||
146885972|NCT03499028|529750154|FG000|Overall Study|Withdrawal by Subject|5|||
146885973|NCT03499028|529750155|FG001|Overall Study|Withdrawal by Subject|8|||
146885974|NCT03499028|529750154|FG000|Overall Study|Unplanned SNF discharge|5|||
146885975|NCT03499028|529750155|FG001|Overall Study|Unplanned SNF discharge|8|||
146885976|NCT00720109|529750156|FG000|Induction Period|Did not meet eligibility criteria|3|||
146885977|NCT00720109|529750157|FG001|Induction Period|Did not meet eligibility criteria|0|||
146885978|NCT00720109|529750158|FG002|Induction Period|Did not meet eligibility criteria|0|||
146885979|NCT00720109|529750156|FG000|Induction Period|Bone Marrow Transplant|2|||
146885980|NCT00720109|529750157|FG001|Induction Period|Bone Marrow Transplant|0|||
146885981|NCT00720109|529750158|FG002|Induction Period|Bone Marrow Transplant|0|||
146549281|NCT02565186|528519946|FG000|Overall Study|Missing|1|||
146549282|NCT02565186|528519947|FG001|Overall Study|Missing|0|||
146549283|NCT02565186|528519946|FG000|Overall Study|Did Not Receive Study Drug|55|||
146885982|NCT00720109|529750156|FG000|Induction Period|Physician Decision|1|||
146885983|NCT00720109|529750157|FG001|Induction Period|Physician Decision|0|||
146885984|NCT00720109|529750158|FG002|Induction Period|Physician Decision|0|||
146885985|NCT00720109|529750156|FG000|Risk Stratification Period|Adverse Event|0|||
146885986|NCT00720109|529750157|FG001|Risk Stratification Period|Adverse Event|1|||
146885987|NCT00720109|529750158|FG002|Risk Stratification Period|Adverse Event|0|||
146885988|NCT00720109|529750156|FG000|Risk Stratification Period|Physician Decision|0|||
146885989|NCT00720109|529750157|FG001|Risk Stratification Period|Physician Decision|2|||
146885990|NCT00720109|529750158|FG002|Risk Stratification Period|Physician Decision|1|||
146885991|NCT00720109|529750156|FG000|Risk Stratification Period|Bone marrow transplant|0|||
146885992|NCT00720109|529750157|FG001|Risk Stratification Period|Bone marrow transplant|9|||
146885993|NCT00720109|529750158|FG002|Risk Stratification Period|Bone marrow transplant|7|||
146885994|NCT00720109|529750156|FG000|Risk Stratification Period|Disease progression or relapse|0|||
146885995|NCT00720109|529750157|FG001|Risk Stratification Period|Disease progression or relapse|2|||
146885996|NCT00720109|529750158|FG002|Risk Stratification Period|Disease progression or relapse|0|||
146885997|NCT00720109|529750156|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
146885998|NCT00720109|529750157|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
146885999|NCT00720109|529750158|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
146886000|NCT03467958|529750160|FG000|Overall Study|Adverse Event|20|||
146886001|NCT03467958|529750161|FG001|Overall Study|Adverse Event|32|||
146886002|NCT03467958|529750162|FG002|Overall Study|Adverse Event|5|||
146886003|NCT03467958|529750163|FG003|Overall Study|Adverse Event|3|||
146886004|NCT03467958|529750164|FG004|Overall Study|Adverse Event|3|||
146886005|NCT03467958|529750165|FG005|Overall Study|Adverse Event|3|||
146886006|NCT03467958|529750166|FG006|Overall Study|Adverse Event|6|||
146886007|NCT03467958|529750167|FG007|Overall Study|Adverse Event|5|||
146886008|NCT03467958|529750168|FG008|Overall Study|Adverse Event|0|||
146886009|NCT03467958|529750160|FG000|Overall Study|Lack of Efficacy|59|||
146886010|NCT03467958|529750161|FG001|Overall Study|Lack of Efficacy|120|||
146886011|NCT03467958|529750162|FG002|Overall Study|Lack of Efficacy|6|||
146886012|NCT03467958|529750163|FG003|Overall Study|Lack of Efficacy|9|||
146886013|NCT03467958|529750164|FG004|Overall Study|Lack of Efficacy|8|||
146886014|NCT03467958|529750165|FG005|Overall Study|Lack of Efficacy|9|||
146886015|NCT03467958|529750166|FG006|Overall Study|Lack of Efficacy|11|||
146886016|NCT03467958|529750167|FG007|Overall Study|Lack of Efficacy|9|||
146886017|NCT03467958|529750168|FG008|Overall Study|Lack of Efficacy|3|||
146886018|NCT03467958|529750160|FG000|Overall Study|Lost to Follow-up|1|||
146886019|NCT03467958|529750161|FG001|Overall Study|Lost to Follow-up|2|||
146886020|NCT03467958|529750162|FG002|Overall Study|Lost to Follow-up|1|||
146886021|NCT03467958|529750163|FG003|Overall Study|Lost to Follow-up|0|||
146886022|NCT03467958|529750164|FG004|Overall Study|Lost to Follow-up|4|||
146886023|NCT03467958|529750165|FG005|Overall Study|Lost to Follow-up|0|||
146886024|NCT03467958|529750166|FG006|Overall Study|Lost to Follow-up|0|||
146886025|NCT03467958|529750167|FG007|Overall Study|Lost to Follow-up|0|||
146886026|NCT03467958|529750168|FG008|Overall Study|Lost to Follow-up|0|||
146886027|NCT03467958|529750160|FG000|Overall Study|Other reasons|8|||
146886028|NCT03467958|529750161|FG001|Overall Study|Other reasons|14|||
146886029|NCT03467958|529750162|FG002|Overall Study|Other reasons|2|||
146886030|NCT03467958|529750163|FG003|Overall Study|Other reasons|1|||
146886031|NCT03467958|529750164|FG004|Overall Study|Other reasons|4|||
146886032|NCT03467958|529750165|FG005|Overall Study|Other reasons|0|||
146886033|NCT03467958|529750166|FG006|Overall Study|Other reasons|1|||
146886034|NCT03467958|529750167|FG007|Overall Study|Other reasons|0|||
146886035|NCT03467958|529750168|FG008|Overall Study|Other reasons|1|||
146886036|NCT03467958|529750160|FG000|Overall Study|Pregnancy|1|||
146886037|NCT03467958|529750161|FG001|Overall Study|Pregnancy|0|||
146886038|NCT03467958|529750162|FG002|Overall Study|Pregnancy|0|||
146886039|NCT03467958|529750163|FG003|Overall Study|Pregnancy|0|||
146886040|NCT03467958|529750164|FG004|Overall Study|Pregnancy|0|||
146886041|NCT03467958|529750165|FG005|Overall Study|Pregnancy|1|||
146886042|NCT03467958|529750166|FG006|Overall Study|Pregnancy|0|||
146886043|NCT03467958|529750167|FG007|Overall Study|Pregnancy|0|||
146886044|NCT03467958|529750168|FG008|Overall Study|Pregnancy|0|||
146886045|NCT03467958|529750160|FG000|Overall Study|Study terminated by sponsor|65|||
146886046|NCT03467958|529750161|FG001|Overall Study|Study terminated by sponsor|117|||
146886047|NCT03467958|529750162|FG002|Overall Study|Study terminated by sponsor|45|||
146886048|NCT03467958|529750163|FG003|Overall Study|Study terminated by sponsor|64|||
146886049|NCT03467958|529750164|FG004|Overall Study|Study terminated by sponsor|66|||
146886050|NCT03467958|529750165|FG005|Overall Study|Study terminated by sponsor|17|||
146886051|NCT03467958|529750166|FG006|Overall Study|Study terminated by sponsor|11|||
146886052|NCT03467958|529750167|FG007|Overall Study|Study terminated by sponsor|5|||
146886053|NCT03467958|529750168|FG008|Overall Study|Study terminated by sponsor|5|||
146886054|NCT03467958|529750160|FG000|Overall Study|Withdrawal by Subject|25|||
146886055|NCT03467958|529750161|FG001|Overall Study|Withdrawal by Subject|44|||
146886056|NCT03467958|529750162|FG002|Overall Study|Withdrawal by Subject|7|||
146886057|NCT03467958|529750163|FG003|Overall Study|Withdrawal by Subject|8|||
146886058|NCT03467958|529750164|FG004|Overall Study|Withdrawal by Subject|6|||
146886059|NCT03467958|529750165|FG005|Overall Study|Withdrawal by Subject|8|||
146886060|NCT03467958|529750166|FG006|Overall Study|Withdrawal by Subject|4|||
146886061|NCT03467958|529750167|FG007|Overall Study|Withdrawal by Subject|1|||
146886062|NCT03467958|529750168|FG008|Overall Study|Withdrawal by Subject|4|||
146886063|NCT02925156|529750169|FG000|Overall Study|Lost to Follow-up|27|||
146886064|NCT02925156|529750170|FG001|Overall Study|Lost to Follow-up|53|||
146886065|NCT02925156|529750171|FG002|Overall Study|Lost to Follow-up|51|||
146886066|NCT02925156|529750172|FG003|Overall Study|Lost to Follow-up|59|||
146886067|NCT02925156|529750173|FG004|Overall Study|Lost to Follow-up|89|||
146886068|NCT02925156|529750174|FG005|Overall Study|Lost to Follow-up|107|||
146966481|NCT05012943|530038817|FG001|Overall Study|Withdrawal by Subject|1006|||
146966482|NCT05012943|530038818|FG002|Overall Study|Withdrawal by Subject|20|||
146966483|NCT05012943|530038816|FG000|Overall Study|Death|25|||
146966484|NCT05012943|530038817|FG001|Overall Study|Death|17|||
146966485|NCT05012943|530038818|FG002|Overall Study|Death|4|||
146966486|NCT05012943|530038816|FG000|Overall Study|Lost to Follow-up|11|||
146549284|NCT02565186|528519947|FG001|Overall Study|Did Not Receive Study Drug|86|||
146549285|NCT00617903|528519948|FG000|Overall Study|Withdrawal by Subject|2|||
146549286|NCT00617903|528519949|FG001|Overall Study|Withdrawal by Subject|3|||
146549287|NCT00617903|528519948|FG000|Overall Study|Lost to Follow-up|1|||
146549288|NCT00617903|528519949|FG001|Overall Study|Lost to Follow-up|1|||
146549289|NCT00617903|528519948|FG000|Overall Study|Lack of Efficacy|0|||
146549290|NCT00617903|528519949|FG001|Overall Study|Lack of Efficacy|1|||
146549291|NCT00617903|528519948|FG000|Overall Study|Adverse Event|0|||
146886069|NCT02925156|529750175|FG006|Overall Study|Lost to Follow-up|34|||
146886070|NCT02925156|529750176|FG007|Overall Study|Lost to Follow-up|36|||
146886071|NCT02925156|529750177|FG008|Overall Study|Lost to Follow-up|73|||
146886072|NCT02925156|529750178|FG009|Overall Study|Lost to Follow-up|34|||
146886073|NCT00866307|529750179|FG000|Induction|Adverse Event|5|||
146966487|NCT05012943|530038817|FG001|Overall Study|Lost to Follow-up|24|||
146886074|NCT00866307|529750180|FG001|Induction|Adverse Event|0|||
146886075|NCT00866307|529750181|FG002|Induction|Adverse Event|0|||
146886076|NCT00866307|529750179|FG000|Induction|Death|2|||
146886077|NCT00866307|529750180|FG001|Induction|Death|0|||
146549292|NCT00617903|528519949|FG001|Overall Study|Adverse Event|1|||
146966488|NCT05012943|530038818|FG002|Overall Study|Lost to Follow-up|3|||
146966489|NCT05012943|530038816|FG000|Overall Study|Physician Decision|1|||
146886078|NCT00866307|529750181|FG002|Induction|Death|0|||
146886079|NCT00866307|529750179|FG000|Induction|Physician Decision|5|||
146631239|NCT00463567|528828362|FG002|Overall Study|Adverse Event|17|||
146631240|NCT00463567|528828363|FG003|Overall Study|Adverse Event|46|||
146631241|NCT00463567|528828364|FG004|Overall Study|Adverse Event|10|||
146631242|NCT00463567|528828365|FG005|Overall Study|Adverse Event|10|||
146631243|NCT00463567|528828366|FG006|Overall Study|Adverse Event|4|||
146631244|NCT00463567|528828360|FG000|Overall Study|Withdrawal by Subject|29|||
146631245|NCT00463567|528828361|FG001|Overall Study|Withdrawal by Subject|22|||
146631246|NCT00463567|528828362|FG002|Overall Study|Withdrawal by Subject|20|||
146631247|NCT00463567|528828363|FG003|Overall Study|Withdrawal by Subject|37|||
146631248|NCT00463567|528828364|FG004|Overall Study|Withdrawal by Subject|6|||
146631249|NCT00463567|528828365|FG005|Overall Study|Withdrawal by Subject|5|||
146631250|NCT00463567|528828366|FG006|Overall Study|Withdrawal by Subject|1|||
146631251|NCT00463567|528828360|FG000|Overall Study|Protocol Deviation|13|||
146966490|NCT05012943|530038817|FG001|Overall Study|Physician Decision|1|||
146549293|NCT00617903|528519948|FG000|Overall Study|noncompliance|0|||
146549294|NCT00617903|528519949|FG001|Overall Study|noncompliance|1|||
146549295|NCT00976391|528519950|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
146549296|NCT00976391|528519951|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
146549297|NCT00976391|528519950|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
146549298|NCT00976391|528519951|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
146549299|NCT00976391|528519950|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
146549300|NCT00976391|528519951|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
146549301|NCT00976391|528519950|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
146631252|NCT00463567|528828361|FG001|Overall Study|Protocol Deviation|9|||
146966491|NCT05012943|530038818|FG002|Overall Study|Physician Decision|0|||
146549302|NCT00976391|528519951|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
146549303|NCT00976391|528519950|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
146631253|NCT00463567|528828362|FG002|Overall Study|Protocol Deviation|14|||
146631254|NCT00463567|528828363|FG003|Overall Study|Protocol Deviation|11|||
146631255|NCT00463567|528828364|FG004|Overall Study|Protocol Deviation|1|||
146886080|NCT00866307|529750180|FG001|Induction|Physician Decision|0|||
146886081|NCT00866307|529750181|FG002|Induction|Physician Decision|0|||
146549304|NCT00976391|528519951|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
146549305|NCT00976391|528519950|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
146549306|NCT00976391|528519951|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
146549307|NCT00976391|528519950|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
146549308|NCT00976391|528519951|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
146549309|NCT00976391|528519950|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
146549310|NCT00976391|528519951|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
146549311|NCT00976391|528519950|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
146549312|NCT00976391|528519951|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
146549313|NCT00976391|528519950|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
146549314|NCT00976391|528519951|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
146549315|NCT00976391|528519950|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
146549316|NCT00976391|528519951|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
146549317|NCT00976391|528519950|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
146549318|NCT00976391|528519951|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
146549319|NCT00976391|528519950|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
146549320|NCT00976391|528519951|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
146549321|NCT00976391|528519950|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
146549322|NCT00976391|528519951|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
146549323|NCT04676646|528519952|FG000|Open-label Run-in Phase|Adverse Event|3|||
146549324|NCT04676646|528519953|FG001|Open-label Run-in Phase|Adverse Event|0|||
146549325|NCT04676646|528519954|FG002|Open-label Run-in Phase|Adverse Event|0|||
146549326|NCT04676646|528519952|FG000|Open-label Run-in Phase|Death|3|||
146549327|NCT04676646|528519953|FG001|Open-label Run-in Phase|Death|0|||
146549328|NCT04676646|528519954|FG002|Open-label Run-in Phase|Death|0|||
146549329|NCT04676646|528519952|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
146549330|NCT04676646|528519953|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
146549331|NCT04676646|528519954|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
146549332|NCT04676646|528519952|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
146549333|NCT04676646|528519953|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
146549334|NCT04676646|528519954|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
146549335|NCT04676646|528519952|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
146549336|NCT04676646|528519953|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
146549337|NCT04676646|528519954|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
146549338|NCT04676646|528519952|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
146549339|NCT04676646|528519953|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
146549340|NCT04676646|528519954|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
146549341|NCT04676646|528519952|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
146549342|NCT04676646|528519953|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
146549343|NCT04676646|528519954|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
146549344|NCT04676646|528519952|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
146549345|NCT04676646|528519953|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
146549346|NCT04676646|528519954|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
146549347|NCT04676646|528519952|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
146549348|NCT04676646|528519953|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
146549349|NCT04676646|528519954|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
146886082|NCT00866307|529750179|FG000|Induction|Progressive Disease|1|||
146886083|NCT00866307|529750180|FG001|Induction|Progressive Disease|0|||
146886084|NCT00866307|529750181|FG002|Induction|Progressive Disease|0|||
146549350|NCT04676646|528519952|FG000|Randomised-withdrawal Phase|Death|0|||
146549351|NCT04676646|528519953|FG001|Randomised-withdrawal Phase|Death|1|||
146549352|NCT04676646|528519954|FG002|Randomised-withdrawal Phase|Death|2|||
146549353|NCT04676646|528519952|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
146886085|NCT00866307|529750179|FG000|Induction|Identification of Patients with Day 29 M|3|||
146886086|NCT00866307|529750180|FG001|Induction|Identification of Patients with Day 29 M|0|||
146549354|NCT04676646|528519953|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
146549355|NCT04676646|528519954|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
146549356|NCT04676646|528519952|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
146549357|NCT04676646|528519953|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
146549358|NCT04676646|528519954|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
146549359|NCT04676646|528519952|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
146549360|NCT04676646|528519953|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
146549361|NCT04676646|528519954|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
146549362|NCT04676646|528519952|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
146549363|NCT04676646|528519953|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
146549364|NCT04676646|528519954|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
146549365|NCT04676646|528519952|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
146549366|NCT04676646|528519953|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
146549367|NCT04676646|528519954|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
146549368|NCT04676646|528519952|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
146549369|NCT04676646|528519953|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
146549370|NCT04676646|528519954|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
146549371|NCT04676646|528519952|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
146549372|NCT04676646|528519953|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
146549373|NCT04676646|528519954|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
146549374|NCT02217982|528519955|FG000|Overall Study|Trial discontinued|1|||
146549375|NCT02217982|528519956|FG001|Overall Study|Trial discontinued|0|||
146549376|NCT02217982|528519955|FG000|Overall Study|Adverse Event|0|||
146549377|NCT02217982|528519956|FG001|Overall Study|Adverse Event|1|||
146549378|NCT05156125|528519957|FG000|Overall Study|Lack of Efficacy|1|||
146549379|NCT05156125|528519958|FG001|Overall Study|Lack of Efficacy|1|||
146549380|NCT05156125|528519959|FG002|Overall Study|Lack of Efficacy|1|||
146549381|NCT05156125|528519957|FG000|Overall Study|Physician Decision|0|||
146549382|NCT05156125|528519958|FG001|Overall Study|Physician Decision|0|||
146549383|NCT05156125|528519959|FG002|Overall Study|Physician Decision|1|||
146549384|NCT05156125|528519957|FG000|Overall Study|Non-compliance|0|||
146549385|NCT05156125|528519958|FG001|Overall Study|Non-compliance|1|||
146549386|NCT05156125|528519959|FG002|Overall Study|Non-compliance|1|||
146549387|NCT05156125|528519957|FG000|Overall Study|Withdrawal by Subject|0|||
146549388|NCT05156125|528519958|FG001|Overall Study|Withdrawal by Subject|0|||
146549389|NCT05156125|528519959|FG002|Overall Study|Withdrawal by Subject|1|||
146549390|NCT05156125|528519957|FG000|Overall Study|Adverse Event|2|||
146549391|NCT05156125|528519958|FG001|Overall Study|Adverse Event|1|||
146549392|NCT05156125|528519959|FG002|Overall Study|Adverse Event|0|||
146549393|NCT02421510|528519963|FG000|Overall Study|Other|4|||
146549394|NCT02421510|528519964|FG001|Overall Study|Other|2|||
146549395|NCT02421510|528519965|FG002|Overall Study|Other|3|||
146549396|NCT02421510|528519963|FG000|Overall Study|Protocol Violation|1|||
146549397|NCT02421510|528519964|FG001|Overall Study|Protocol Violation|2|||
146549398|NCT02421510|528519965|FG002|Overall Study|Protocol Violation|0|||
146549399|NCT02421510|528519963|FG000|Overall Study|Death|1|||
146549400|NCT02421510|528519964|FG001|Overall Study|Death|0|||
146549401|NCT02421510|528519965|FG002|Overall Study|Death|0|||
146549402|NCT02421510|528519963|FG000|Overall Study|Noncompliance with study drug|1|||
146549403|NCT02421510|528519964|FG001|Overall Study|Noncompliance with study drug|0|||
146549404|NCT02421510|528519965|FG002|Overall Study|Noncompliance with study drug|0|||
146549405|NCT02421510|528519963|FG000|Overall Study|Physician Decision|1|||
146549406|NCT02421510|528519964|FG001|Overall Study|Physician Decision|1|||
146549407|NCT02421510|528519965|FG002|Overall Study|Physician Decision|3|||
146549408|NCT02421510|528519963|FG000|Overall Study|Adverse Event|9|||
146549409|NCT02421510|528519964|FG001|Overall Study|Adverse Event|10|||
146549410|NCT02421510|528519965|FG002|Overall Study|Adverse Event|18|||
146549411|NCT02421510|528519963|FG000|Overall Study|Pregnancy|1|||
146549412|NCT02421510|528519964|FG001|Overall Study|Pregnancy|1|||
146549413|NCT02421510|528519965|FG002|Overall Study|Pregnancy|0|||
146549414|NCT02421510|528519963|FG000|Overall Study|Withdrawal by Subject|14|||
146549415|NCT02421510|528519964|FG001|Overall Study|Withdrawal by Subject|18|||
146549416|NCT02421510|528519965|FG002|Overall Study|Withdrawal by Subject|12|||
146549417|NCT02421510|528519963|FG000|Overall Study|Lost to Follow-up|1|||
146549418|NCT02421510|528519964|FG001|Overall Study|Lost to Follow-up|1|||
146549419|NCT02421510|528519965|FG002|Overall Study|Lost to Follow-up|0|||
146549420|NCT02852434|528519966|FG000|Overall Study|Withdrawal by Subject|0|||
146549421|NCT02852434|528519967|FG001|Overall Study|Withdrawal by Subject|1|||
146549422|NCT02852434|528519966|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
146549423|NCT02852434|528519967|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
146549424|NCT03123588|528519972|FG000|Overall Study|Study Terminated by Sponsor|2|||
146549425|NCT03123588|528519973|FG001|Overall Study|Study Terminated by Sponsor|5|||
146549426|NCT03123588|528519972|FG000|Overall Study|Withdrawal by Subject|1|||
146549427|NCT03123588|528519973|FG001|Overall Study|Withdrawal by Subject|0|||
146549428|NCT03123588|528519972|FG000|Overall Study|Adverse Event|1|||
146549429|NCT03123588|528519973|FG001|Overall Study|Adverse Event|0|||
146549430|NCT03123588|528519972|FG000|Overall Study|Physician Decision|2|||
146549431|NCT03123588|528519973|FG001|Overall Study|Physician Decision|1|||
146549432|NCT01717859|528519975|FG000|Overall Study|Adverse Event|5|||
146549433|NCT01717859|528519975|FG000|Overall Study|Moved out of state|1|||
146549434|NCT01717859|528519975|FG000|Overall Study|Patient concerned about mental health|1|||
146549435|NCT01717859|528519975|FG000|Overall Study|Lost to Follow-up|1|||
146549436|NCT01717859|528519975|FG000|Overall Study|Withdrawal by Subject|2|||
146549437|NCT01623752|528519976|FG000|Phase 1 (78 Weeks)|No Data|249|||
146549438|NCT01623752|528519977|FG001|Phase 1 (78 Weeks)|No Data|66|||
146549439|NCT01623752|528519978|FG002|Phase 1 (78 Weeks)|No Data|2|||
146549440|NCT01623752|528519976|FG000|Phase 1 (78 Weeks)|Other|33|||
146549441|NCT01623752|528519977|FG001|Phase 1 (78 Weeks)|Other|20|||
146549442|NCT01623752|528519978|FG002|Phase 1 (78 Weeks)|Other|0|||
146549443|NCT01623752|528519976|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
146549444|NCT01623752|528519977|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
146549445|NCT01623752|528519978|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
146549446|NCT01623752|528519976|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
146549447|NCT01623752|528519977|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
146549448|NCT01623752|528519978|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
146549449|NCT01623752|528519976|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
146549450|NCT01623752|528519977|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
146549451|NCT01623752|528519978|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
146549452|NCT01623752|528519976|FG000|Phase 2 (78 Weeks)|Other|5|||
146549453|NCT01623752|528519977|FG001|Phase 2 (78 Weeks)|Other|1|||
146549454|NCT01623752|528519978|FG002|Phase 2 (78 Weeks)|Other|0|||
146549455|NCT01623752|528519976|FG000|Phase 2 (78 Weeks)|No Data|43|||
146549456|NCT01623752|528519977|FG001|Phase 2 (78 Weeks)|No Data|11|||
146549457|NCT01623752|528519978|FG002|Phase 2 (78 Weeks)|No Data|0|||
146549458|NCT01623752|528519976|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
146549459|NCT01623752|528519977|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
146549460|NCT01623752|528519978|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
146886087|NCT00866307|529750181|FG002|Induction|Identification of Patients with Day 29 M|0|||
146886088|NCT00866307|529750179|FG000|Induction|Inadequate cytognetic samples th|1|||
146549461|NCT01755637|528519979|FG000|Period 1|Adverse Event|0|||
146549462|NCT01755637|528519980|FG001|Period 1|Adverse Event|1|||
146549463|NCT01814332|528519981|FG000|Overall Study|Adverse Event|8|||
146886089|NCT00866307|529750180|FG001|Induction|Inadequate cytognetic samples th|0|||
146549464|NCT01814332|528519982|FG001|Overall Study|Adverse Event|3|||
146549465|NCT01814332|528519981|FG000|Overall Study|Withdrawal by Subject|3|||
146549466|NCT01814332|528519982|FG001|Overall Study|Withdrawal by Subject|8|||
146549467|NCT01814332|528519981|FG000|Overall Study|Protocol Violation|0|||
146549468|NCT01814332|528519982|FG001|Overall Study|Protocol Violation|4|||
146549469|NCT01814332|528519981|FG000|Overall Study|Lost to Follow-up|5|||
146549470|NCT01814332|528519982|FG001|Overall Study|Lost to Follow-up|1|||
146549471|NCT04389671|528519984|FG000|Overall Study|Death|7|||
146886090|NCT00866307|529750181|FG002|Induction|Inadequate cytognetic samples th|0|||
146549472|NCT02287025|528519985|FG000|Overall Study|Not treated|2|||
146886091|NCT00866307|529750179|FG000|Induction|Improper post-induction consent|2|||
146886092|NCT00866307|529750180|FG001|Induction|Improper post-induction consent|0|||
146886093|NCT00866307|529750181|FG002|Induction|Improper post-induction consent|0|||
146886094|NCT00866307|529750179|FG000|Induction|Study was closed at the time|1|||
146886095|NCT00866307|529750180|FG001|Induction|Study was closed at the time|0|||
146886096|NCT00866307|529750181|FG002|Induction|Study was closed at the time|0|||
146886097|NCT00866307|529750179|FG000|Consolidation/Maintenance|Adverse Event|0|||
146886098|NCT00866307|529750180|FG001|Consolidation/Maintenance|Adverse Event|0|||
146886099|NCT00866307|529750181|FG002|Consolidation/Maintenance|Adverse Event|8|||
146886100|NCT00866307|529750179|FG000|Consolidation/Maintenance|Death|0|||
146886101|NCT00866307|529750180|FG001|Consolidation/Maintenance|Death|0|||
146886102|NCT00866307|529750181|FG002|Consolidation/Maintenance|Death|1|||
146886103|NCT00866307|529750179|FG000|Consolidation/Maintenance|Physician Decision|0|||
146549473|NCT02287025|528519986|FG001|Overall Study|Not treated|0|||
146549474|NCT02287025|528519985|FG000|Overall Study|Progression of disease|3|||
146549475|NCT02287025|528519986|FG001|Overall Study|Progression of disease|2|||
146549476|NCT02287025|528519985|FG000|Overall Study|Adverse Event|2|||
146549477|NCT02287025|528519986|FG001|Overall Study|Adverse Event|4|||
146549478|NCT02287025|528519985|FG000|Overall Study|Withdrawal by Subject|2|||
146549479|NCT02287025|528519986|FG001|Overall Study|Withdrawal by Subject|2|||
146549480|NCT02287025|528519985|FG000|Overall Study|Screening failed|1|||
146549481|NCT02287025|528519986|FG001|Overall Study|Screening failed|1|||
146549482|NCT00899847|528519987|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
146549483|NCT05987540|528519988|FG000|Overall Study|Withdrawal by Subject|2|||
146549484|NCT05987540|528519988|FG000|Overall Study|Death|1|||
146549485|NCT05987540|528519988|FG000|Overall Study|Study Termination|1|||
146549486|NCT05987540|528519988|FG000|Overall Study|Adverse Event|2|||
146549487|NCT04053452|528519989|FG000|Overall Study|Withdrawal by Subject|1|||
146549488|NCT04053452|528519990|FG001|Overall Study|Withdrawal by Subject|0|||
146549489|NCT04053452|528519989|FG000|Overall Study|Time restraint due to inpatient needs|1|||
146549490|NCT04053452|528519990|FG001|Overall Study|Time restraint due to inpatient needs|2|||
146549491|NCT01421134|528519991|FG000|Overall Study|Adverse Event|3|||
146549492|NCT01421134|528519992|FG001|Overall Study|Adverse Event|5|||
146549493|NCT01421134|528519991|FG000|Overall Study|Lack of Efficacy|2|||
146549494|NCT01421134|528519992|FG001|Overall Study|Lack of Efficacy|4|||
146549495|NCT01421134|528519991|FG000|Overall Study|Protocol Violation|0|||
146549496|NCT01421134|528519992|FG001|Overall Study|Protocol Violation|3|||
146549497|NCT01421134|528519991|FG000|Overall Study|Withdrawal by Subject|1|||
146549498|NCT01421134|528519992|FG001|Overall Study|Withdrawal by Subject|1|||
146549499|NCT01421134|528519991|FG000|Overall Study|Administrative|0|||
146549500|NCT01421134|528519992|FG001|Overall Study|Administrative|1|||
146549501|NCT01421134|528519991|FG000|Overall Study|Lost to Follow-up|1|||
146549502|NCT01421134|528519992|FG001|Overall Study|Lost to Follow-up|1|||
146549503|NCT03528577|528519995|FG000|Sequence 1|Failed Spirometry|1|||
146549504|NCT03528577|528519995|FG000|Sequence 1|Restricted medication|1|||
146549505|NCT03528577|528519995|FG000|Sequence 2|Adverse Event|1|||
146549506|NCT03528577|528519995|FG000|Sequence 2|Withdrawal by Subject|1|||
146549507|NCT03528577|528519995|FG000|Sequence 2|Failed Spirometry|1|||
146549508|NCT03528577|528519995|FG000|Sequence 3|Failed Spirometry|1|||
146549509|NCT03528577|528519995|FG000|Sequence 4|Failed Spirometry|2|||
146549510|NCT03528577|528519995|FG000|Sequence 4|Adverse Event|1|||
146765179|NCT00604721|529307295|FG000|Overall Study|Physician Decision|1|||
146886104|NCT00866307|529750180|FG001|Consolidation/Maintenance|Physician Decision|3|||
146886105|NCT00866307|529750181|FG002|Consolidation/Maintenance|Physician Decision|2|||
146886106|NCT00866307|529750179|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
146886107|NCT00866307|529750180|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
146886108|NCT00866307|529750181|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
146886109|NCT00866307|529750179|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
146886110|NCT00866307|529750180|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
146886111|NCT00866307|529750181|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
146549511|NCT04882215|528519996|FG000|Overall Study|Withdrawal by Subject|5|||
146549512|NCT04882215|528519997|FG001|Overall Study|Withdrawal by Subject|0|||
146549513|NCT04098302|528520002|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
146549514|NCT04098302|528520003|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
146631256|NCT00463567|528828365|FG005|Overall Study|Protocol Deviation|1|||
146886112|NCT00866307|529750179|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
146886113|NCT00866307|529750180|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
146886114|NCT00866307|529750181|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
146886115|NCT00866307|529750179|FG000|Consolidation/Maintenance|Therapy error|0|||
146886116|NCT00866307|529750180|FG001|Consolidation/Maintenance|Therapy error|1|||
146886117|NCT00866307|529750181|FG002|Consolidation/Maintenance|Therapy error|0|||
146886118|NCT00866307|529750179|FG000|Consolidation/Maintenance|Non-compliance|0|||
146886119|NCT00866307|529750180|FG001|Consolidation/Maintenance|Non-compliance|0|||
146886120|NCT00866307|529750181|FG002|Consolidation/Maintenance|Non-compliance|1|||
146886121|NCT00866307|529750179|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
146886122|NCT00866307|529750180|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
146886123|NCT00866307|529750181|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
146886124|NCT01687712|529750182|FG000|Cycle 1|Not Biochemically Pregnant|386|||
146886125|NCT01687712|529750183|FG001|Cycle 1|Not Biochemically Pregnant|348|||
146886126|NCT01687712|529750182|FG000|Cycle 1|Early Pregnancy Loss|43|||
146886127|NCT01687712|529750183|FG001|Cycle 1|Early Pregnancy Loss|60|||
146886128|NCT01687712|529750182|FG000|Cycle 1|Ectopic Pregnancy|5|||
146886129|NCT01687712|529750183|FG001|Cycle 1|Ectopic Pregnancy|5|||
146886130|NCT01687712|529750182|FG000|Cycle 1|Heterotropic Pregnancy|1|||
146886131|NCT01687712|529750183|FG001|Cycle 1|Heterotropic Pregnancy|0|||
146886132|NCT01687712|529750182|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
146886133|NCT01687712|529750183|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
146886134|NCT01687712|529750182|FG000|Cycle 1|Abortion|3|||
146886135|NCT01687712|529750183|FG001|Cycle 1|Abortion|0|||
146886136|NCT01687712|529750182|FG000|Cycle 1|Intrauterine Fetal Death|0|||
146886137|NCT01687712|529750183|FG001|Cycle 1|Intrauterine Fetal Death|1|||
146886138|NCT01687712|529750182|FG000|Cycle 1|Lost to Follow-up|1|||
146886139|NCT01687712|529750183|FG001|Cycle 1|Lost to Follow-up|1|||
146886140|NCT01687712|529750182|FG000|Cycle 2|Not Biochemically Pregnant|74|||
146886141|NCT01687712|529750183|FG001|Cycle 2|Not Biochemically Pregnant|77|||
146886142|NCT01687712|529750182|FG000|Cycle 2|Early Pregnancy Loss|18|||
146631257|NCT00463567|528828366|FG006|Overall Study|Protocol Deviation|2|||
146631258|NCT00463567|528828360|FG000|Overall Study|Lost to Follow-up|12|||
146631259|NCT00463567|528828361|FG001|Overall Study|Lost to Follow-up|6|||
146631260|NCT00463567|528828362|FG002|Overall Study|Lost to Follow-up|13|||
146631261|NCT00463567|528828363|FG003|Overall Study|Lost to Follow-up|8|||
146631262|NCT00463567|528828364|FG004|Overall Study|Lost to Follow-up|1|||
146631263|NCT00463567|528828365|FG005|Overall Study|Lost to Follow-up|1|||
146631264|NCT00463567|528828366|FG006|Overall Study|Lost to Follow-up|1|||
146631265|NCT00463567|528828360|FG000|Overall Study|Administrative problems|5|||
146631266|NCT00463567|528828361|FG001|Overall Study|Administrative problems|3|||
146631267|NCT00463567|528828362|FG002|Overall Study|Administrative problems|6|||
146631268|NCT00463567|528828363|FG003|Overall Study|Administrative problems|9|||
146631269|NCT00463567|528828364|FG004|Overall Study|Administrative problems|3|||
146631270|NCT00463567|528828365|FG005|Overall Study|Administrative problems|2|||
146631271|NCT00463567|528828366|FG006|Overall Study|Administrative problems|2|||
146631272|NCT00463567|528828360|FG000|Overall Study|Lack of Efficacy|4|||
146631273|NCT00463567|528828361|FG001|Overall Study|Lack of Efficacy|9|||
146631274|NCT00463567|528828362|FG002|Overall Study|Lack of Efficacy|9|||
146631275|NCT00463567|528828363|FG003|Overall Study|Lack of Efficacy|17|||
146631276|NCT00463567|528828364|FG004|Overall Study|Lack of Efficacy|1|||
146631277|NCT00463567|528828365|FG005|Overall Study|Lack of Efficacy|0|||
146631278|NCT00463567|528828366|FG006|Overall Study|Lack of Efficacy|1|||
146631279|NCT00463567|528828360|FG000|Overall Study|Abnormal lab value(s)|1|||
146631280|NCT00463567|528828361|FG001|Overall Study|Abnormal lab value(s)|1|||
146631281|NCT00463567|528828362|FG002|Overall Study|Abnormal lab value(s)|2|||
146631282|NCT00463567|528828363|FG003|Overall Study|Abnormal lab value(s)|1|||
146631283|NCT00463567|528828364|FG004|Overall Study|Abnormal lab value(s)|1|||
146886143|NCT01687712|529750183|FG001|Cycle 2|Early Pregnancy Loss|16|||
146886144|NCT01687712|529750182|FG000|Cycle 2|Ectopic Pregnancy|0|||
146886145|NCT01687712|529750183|FG001|Cycle 2|Ectopic Pregnancy|1|||
146886146|NCT01687712|529750182|FG000|Cycle 2|Still Birth|1|||
146886147|NCT01687712|529750183|FG001|Cycle 2|Still Birth|0|||
146886148|NCT01687712|529750182|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
146886149|NCT01687712|529750183|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
146886150|NCT01687712|529750182|FG000|Cycle 3|Not Biochemically Pregnant|21|||
146886151|NCT01687712|529750183|FG001|Cycle 3|Not Biochemically Pregnant|22|||
146886152|NCT01687712|529750182|FG000|Cycle 3|Early Pregnancy Loss|1|||
146886153|NCT01687712|529750183|FG001|Cycle 3|Early Pregnancy Loss|2|||
146886154|NCT01687712|529750182|FG000|Cycle 3|Ectopic Pregnancy|1|||
146886155|NCT01687712|529750183|FG001|Cycle 3|Ectopic Pregnancy|0|||
146886156|NCT01687712|529750182|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
146886157|NCT01687712|529750183|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
146886158|NCT01681433|529750184|FG000|Overall Study|Lack of Efficacy|23|||
146886159|NCT01681433|529750185|FG001|Overall Study|Lack of Efficacy|23|||
146631284|NCT00463567|528828365|FG005|Overall Study|Abnormal lab value(s)|0|||
146631285|NCT00463567|528828366|FG006|Overall Study|Abnormal lab value(s)|0|||
146631286|NCT00463567|528828360|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146549515|NCT04098302|528520004|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
146886160|NCT01681433|529750184|FG000|Overall Study|Withdrawal by Subject|5|||
146886161|NCT01681433|529750185|FG001|Overall Study|Withdrawal by Subject|5|||
146886162|NCT01681433|529750184|FG000|Overall Study|Protocol Violation|2|||
146549516|NCT04098302|528520005|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
146549517|NCT04098302|528520002|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
146549518|NCT04098302|528520003|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
146549519|NCT04098302|528520004|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
146549520|NCT04098302|528520005|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
146549521|NCT04098302|528520002|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
146549522|NCT04098302|528520003|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
146549523|NCT04098302|528520004|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
146549524|NCT04098302|528520005|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
146549525|NCT04098302|528520002|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
146549526|NCT04098302|528520003|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
146549527|NCT04098302|528520004|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
146549528|NCT04098302|528520005|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
146549529|NCT04098302|528520002|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
146549530|NCT04098302|528520003|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
146549531|NCT04098302|528520004|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
146549532|NCT04098302|528520005|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
146549533|NCT04098302|528520002|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
146549534|NCT04098302|528520003|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
146549535|NCT04098302|528520004|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
146549536|NCT04098302|528520005|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
146549537|NCT04098302|528520002|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
146549538|NCT04098302|528520003|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
146549539|NCT04098302|528520004|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
146549540|NCT04098302|528520005|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
146549541|NCT04098302|528520002|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
146549542|NCT04098302|528520003|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
146549543|NCT04098302|528520004|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
146549544|NCT04098302|528520005|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
146549545|NCT05061706|528520008|FG000|Overall Study|Adverse Event|29|||
146549546|NCT05061706|528520009|FG001|Overall Study|Adverse Event|1|||
146549547|NCT05061706|528520008|FG000|Overall Study|Lack of Efficacy|0|||
146549548|NCT05061706|528520009|FG001|Overall Study|Lack of Efficacy|1|||
146549549|NCT05061706|528520008|FG000|Overall Study|Lost to Follow-up|2|||
146549550|NCT05061706|528520009|FG001|Overall Study|Lost to Follow-up|2|||
146549551|NCT05061706|528520008|FG000|Overall Study|Protocol Violation|3|||
146549552|NCT05061706|528520009|FG001|Overall Study|Protocol Violation|1|||
146549553|NCT05061706|528520008|FG000|Overall Study|Withdrawal by Subject|3|||
146549554|NCT05061706|528520009|FG001|Overall Study|Withdrawal by Subject|9|||
146549555|NCT00724893|528520010|FG000|Overall Study|Adverse Event|76|||
146549556|NCT00724893|528520011|FG001|Overall Study|Adverse Event|142|||
146549557|NCT00724893|528520010|FG000|Overall Study|Withdrawal by Subject|0|||
146549558|NCT00724893|528520011|FG001|Overall Study|Withdrawal by Subject|1|||
146549559|NCT00724893|528520010|FG000|Overall Study|Lack of virologic response|94|||
146549560|NCT00724893|528520011|FG001|Overall Study|Lack of virologic response|202|||
146549561|NCT00724893|528520010|FG000|Overall Study|Reason not specified|193|||
146549562|NCT00724893|528520011|FG001|Overall Study|Reason not specified|7|||
146549563|NCT00724893|528520010|FG000|Overall Study|Patient choice|0|||
146549564|NCT00724893|528520011|FG001|Overall Study|Patient choice|26|||
146549565|NCT00724893|528520010|FG000|Overall Study|Geographic reasons|0|||
146886163|NCT01681433|529750185|FG001|Overall Study|Protocol Violation|0|||
146886164|NCT01681433|529750184|FG000|Overall Study|Adverse Event|2|||
146549566|NCT00724893|528520011|FG001|Overall Study|Geographic reasons|11|||
146549567|NCT00724893|528520010|FG000|Overall Study|Incarceration|0|||
146549568|NCT00724893|528520011|FG001|Overall Study|Incarceration|9|||
146549569|NCT00724893|528520010|FG000|Overall Study|Substance abuse|0|||
146549570|NCT00724893|528520011|FG001|Overall Study|Substance abuse|3|||
146549571|NCT00724893|528520010|FG000|Overall Study|Financial reasons|0|||
146549572|NCT00724893|528520011|FG001|Overall Study|Financial reasons|2|||
146549573|NCT00724893|528520010|FG000|Overall Study|Assigned shorter treatment|0|||
146549574|NCT00724893|528520011|FG001|Overall Study|Assigned shorter treatment|2|||
146549575|NCT00724893|528520010|FG000|Overall Study|Lost to Follow-up|0|||
146549576|NCT00724893|528520011|FG001|Overall Study|Lost to Follow-up|52|||
146549577|NCT00724893|528520010|FG000|Overall Study|Unknown, missing data|1|||
146549578|NCT00724893|528520011|FG001|Overall Study|Unknown, missing data|1|||
146549579|NCT01290731|528520014|FG000|Overall Study|Withdrawal by Subject|1|||
146549580|NCT01279200|528520017|FG000|Overall Study|Withdrawal by Subject|1|||
146549581|NCT01279200|528520018|FG001|Overall Study|Withdrawal by Subject|3|||
146549582|NCT01279200|528520017|FG000|Overall Study|Patient withdrawal due to high cost|0|||
146549583|NCT01279200|528520018|FG001|Overall Study|Patient withdrawal due to high cost|1|||
146549584|NCT01279200|528520017|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
146549585|NCT01279200|528520018|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
146549586|NCT01279200|528520017|FG000|Overall Study|ultrasound screening failure|0|||
146549587|NCT01279200|528520018|FG001|Overall Study|ultrasound screening failure|1|||
146549588|NCT01279200|528520017|FG000|Overall Study|Lost to Follow-up|0|||
146549589|NCT01279200|528520018|FG001|Overall Study|Lost to Follow-up|1|||
146549590|NCT01279200|528520017|FG000|Overall Study|Adverse Event|1|||
146549591|NCT01279200|528520018|FG001|Overall Study|Adverse Event|0|||
146549592|NCT01399099|528520019|FG000|Overall Study|Lost to Follow-up|14|||
146549593|NCT01399099|528520019|FG000|Overall Study|Physician Decision|1|||
146549594|NCT01399099|528520019|FG000|Overall Study|Protocol Violation|1|||
146549595|NCT01399099|528520019|FG000|Overall Study|Skin Irritation|13|||
146549596|NCT01399099|528520019|FG000|Overall Study|Infection|1|||
146549597|NCT01399099|528520019|FG000|Overall Study|Miscellaneous|4|||
146549598|NCT01149538|528520023|FG000|Overall Study|Lost to Follow-up|0|||
146549599|NCT01149538|528520024|FG001|Overall Study|Lost to Follow-up|1|||
146549600|NCT01149538|528520023|FG000|Overall Study|Withdrawal by Subject|5|||
146549601|NCT01149538|528520024|FG001|Overall Study|Withdrawal by Subject|3|||
146549602|NCT00888849|528520025|FG000|Overall Study|Death|4|||
146549603|NCT00888849|528520026|FG001|Overall Study|Death|7|||
146549604|NCT00888849|528520025|FG000|Overall Study|Lost to Follow-up|1|||
146549605|NCT00888849|528520026|FG001|Overall Study|Lost to Follow-up|2|||
146549606|NCT02336503|528520028|FG000|Overall Study|Lost to Follow-up|0|||
146549607|NCT02336503|528520029|FG001|Overall Study|Lost to Follow-up|3|||
146549608|NCT02336503|528520030|FG002|Overall Study|Lost to Follow-up|0|||
146549609|NCT02336503|528520031|FG003|Overall Study|Lost to Follow-up|2|||
146549610|NCT02336503|528520028|FG000|Overall Study|Withdrawal by Subject|2|||
146549611|NCT02336503|528520029|FG001|Overall Study|Withdrawal by Subject|0|||
146549612|NCT02336503|528520030|FG002|Overall Study|Withdrawal by Subject|0|||
146549613|NCT02336503|528520031|FG003|Overall Study|Withdrawal by Subject|4|||
146549614|NCT02336503|528520028|FG000|Overall Study|Adverse Event|0|||
146549615|NCT02336503|528520029|FG001|Overall Study|Adverse Event|0|||
146549616|NCT02336503|528520030|FG002|Overall Study|Adverse Event|1|||
146549617|NCT02336503|528520031|FG003|Overall Study|Adverse Event|0|||
146549618|NCT02583477|528520032|FG000|Overall Study|Adverse Event|0|||
146549619|NCT02583477|528520033|FG001|Overall Study|Adverse Event|2|||
146549620|NCT02583477|528520032|FG000|Overall Study|Death|1|||
146549621|NCT02583477|528520033|FG001|Overall Study|Death|16|||
146549622|NCT02583477|528520032|FG000|Overall Study|Study terminated|2|||
146549623|NCT02583477|528520033|FG001|Overall Study|Study terminated|2|||
146549624|NCT01301092|528520037|FG000|Overall Study|Lost to Follow-up|0|||
146549625|NCT01301092|528520038|FG001|Overall Study|Lost to Follow-up|0|||
146549626|NCT01301092|528520039|FG002|Overall Study|Lost to Follow-up|1|||
146549627|NCT01350973|528520040|FG000|Overall Study|Adverse Event|4|||
146549628|NCT01350973|528520041|FG001|Overall Study|Adverse Event|7|||
146549629|NCT01350973|528520042|FG002|Overall Study|Adverse Event|7|||
146549630|NCT01350973|528520040|FG000|Overall Study|Voluntary Withdrawal|2|||
146549631|NCT01350973|528520041|FG001|Overall Study|Voluntary Withdrawal|1|||
146549632|NCT01350973|528520042|FG002|Overall Study|Voluntary Withdrawal|1|||
146549633|NCT03738215|528520043|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
146549634|NCT03738215|528520044|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
146549635|NCT03738215|528520045|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
146549636|NCT03738215|528520043|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
146549637|NCT03738215|528520044|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
146549638|NCT03738215|528520045|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
146549639|NCT03738215|528520043|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
146549640|NCT03738215|528520044|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
146549641|NCT03738215|528520045|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
146549642|NCT03738215|528520043|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
146549643|NCT03738215|528520044|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
146549644|NCT03738215|528520045|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
146549645|NCT03738215|528520043|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
146549646|NCT03738215|528520044|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
146549647|NCT03738215|528520045|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
146549648|NCT03738215|528520043|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
146549649|NCT03738215|528520044|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
146549650|NCT03738215|528520045|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
146549651|NCT03738215|528520043|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
146549652|NCT03738215|528520044|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
146549653|NCT03738215|528520045|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
146886165|NCT01681433|529750185|FG001|Overall Study|Adverse Event|4|||
146549654|NCT03738215|528520043|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
146886166|NCT01681433|529750184|FG000|Overall Study|Lost to Follow-up|0|||
146549655|NCT03738215|528520044|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
146549656|NCT03738215|528520045|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
146886167|NCT01681433|529750185|FG001|Overall Study|Lost to Follow-up|1|||
146886168|NCT00730639|529750186|FG000|Overall Study|Adverse Event|3|||
146886169|NCT00730639|529750187|FG001|Overall Study|Adverse Event|0|||
146549657|NCT03738215|528520043|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
146886170|NCT00730639|529750188|FG002|Overall Study|Adverse Event|9|||
146549658|NCT03738215|528520044|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
146549659|NCT03738215|528520045|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
146549660|NCT03738215|528520043|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
146549661|NCT03738215|528520044|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
146549662|NCT03738215|528520045|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
146549663|NCT02638493|528520046|FG000|Overall Study|Inability to provide semen samples|2|||
146549664|NCT02638493|528520047|FG001|Overall Study|Inability to provide semen samples|0|||
146549665|NCT02638493|528520048|FG002|Overall Study|Inability to provide semen samples|0|||
146549666|NCT03882801|528522192|FG000|Period 1|Adverse Event|0|||
146549667|NCT03882801|528522193|FG001|Period 1|Adverse Event|1|||
146549668|NCT03882801|528522192|FG000|Period 1|Non-compliance with study drug|1|||
146549669|NCT03882801|528522193|FG001|Period 1|Non-compliance with study drug|1|||
146886171|NCT00730639|529750189|FG003|Overall Study|Adverse Event|8|||
146886172|NCT00730639|529750190|FG004|Overall Study|Adverse Event|23|||
146886173|NCT00730639|529750186|FG000|Overall Study|Complete Response|0|||
146886174|NCT00730639|529750187|FG001|Overall Study|Complete Response|0|||
146549670|NCT03882801|528522192|FG000|Period 1|Never treated with study drug|1|||
146549671|NCT03882801|528522193|FG001|Period 1|Never treated with study drug|0|||
146631287|NCT00463567|528828361|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146631288|NCT00463567|528828362|FG002|Overall Study|Abnormal test procedure result(s)|6|||
146631289|NCT00463567|528828363|FG003|Overall Study|Abnormal test procedure result(s)|2|||
146631290|NCT00463567|528828364|FG004|Overall Study|Abnormal test procedure result(s)|0|||
146631291|NCT00463567|528828365|FG005|Overall Study|Abnormal test procedure result(s)|2|||
146631292|NCT00463567|528828366|FG006|Overall Study|Abnormal test procedure result(s)|0|||
146631293|NCT00463567|528828360|FG000|Overall Study|Death|1|||
146631294|NCT00463567|528828361|FG001|Overall Study|Death|0|||
146631295|NCT00463567|528828362|FG002|Overall Study|Death|2|||
146631296|NCT00463567|528828363|FG003|Overall Study|Death|0|||
146631297|NCT00463567|528828364|FG004|Overall Study|Death|0|||
146631298|NCT00463567|528828365|FG005|Overall Study|Death|0|||
146631299|NCT00463567|528828366|FG006|Overall Study|Death|0|||
146886175|NCT00730639|529750188|FG002|Overall Study|Complete Response|2|||
146886176|NCT00730639|529750189|FG003|Overall Study|Complete Response|2|||
146886177|NCT00730639|529750190|FG004|Overall Study|Complete Response|1|||
146549672|NCT03882801|528522192|FG000|Washout Period|Physician Decision|0|||
146549673|NCT03882801|528522193|FG001|Washout Period|Physician Decision|1|||
146549674|NCT03882801|528522192|FG000|Period 2|Non-compliance with study drug|0|||
146549675|NCT03882801|528522193|FG001|Period 2|Non-compliance with study drug|1|||
146549676|NCT04193176|528522197|FG000|Overall Study|Withdrawal by Subject|6|||
146549677|NCT04193176|528522198|FG001|Overall Study|Withdrawal by Subject|10|||
146549678|NCT00944645|528522199|FG000|Period 2|Adverse Event|1|||
146549679|NCT00944645|528522200|FG001|Period 2|Adverse Event|0|||
146549680|NCT00944645|528522199|FG000|Period 2|Lost to Follow-up|0|||
146549681|NCT00944645|528522200|FG001|Period 2|Lost to Follow-up|3|||
146549682|NCT00944645|528522199|FG000|Period 2|Withdrawal by Subject|7|||
146549683|NCT00944645|528522200|FG001|Period 2|Withdrawal by Subject|6|||
146549684|NCT03928704|528522204|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
146549685|NCT03928704|528522205|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
146549686|NCT03928704|528522206|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
146549687|NCT03928704|528522207|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
146549688|NCT03928704|528522208|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
146549689|NCT03928704|528522209|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
146549690|NCT03928704|528522204|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
146549691|NCT03928704|528522205|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
146549692|NCT03928704|528522206|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
146549693|NCT03928704|528522207|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
146549694|NCT03928704|528522208|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
146549695|NCT03928704|528522209|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
146549696|NCT03928704|528522204|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
146549697|NCT03928704|528522205|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
146549698|NCT03928704|528522206|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
146549699|NCT03928704|528522207|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
146549700|NCT03928704|528522208|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
146549701|NCT03928704|528522209|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
146549702|NCT03928704|528522204|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
146549703|NCT03928704|528522205|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
146549704|NCT03928704|528522206|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
146549705|NCT03928704|528522207|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
146549706|NCT03928704|528522208|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
146549707|NCT03928704|528522209|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
146549708|NCT03928704|528522204|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
146886178|NCT00730639|529750186|FG000|Overall Study|Completed Maximum Cycles|0|||
146886179|NCT00730639|529750187|FG001|Overall Study|Completed Maximum Cycles|0|||
146549709|NCT03928704|528522205|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
146549710|NCT03928704|528522206|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
146549711|NCT03928704|528522207|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
146549712|NCT03928704|528522208|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
146549713|NCT03928704|528522209|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
146549714|NCT03928704|528522204|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
146549715|NCT03928704|528522205|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
146549716|NCT03928704|528522206|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
146549717|NCT03928704|528522207|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
146549718|NCT03928704|528522208|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
146549719|NCT03928704|528522209|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
146549720|NCT03928704|528522204|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
146549721|NCT03928704|528522205|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
146549722|NCT03928704|528522206|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
146549723|NCT03928704|528522207|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
146549724|NCT03928704|528522208|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
146549725|NCT03928704|528522209|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
146549726|NCT03928704|528522204|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
146549727|NCT03928704|528522205|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
146549728|NCT03928704|528522206|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
146549729|NCT03928704|528522207|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
146549730|NCT03928704|528522208|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
146549731|NCT03928704|528522209|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
146549732|NCT03928704|528522204|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
146549733|NCT03928704|528522205|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
146549734|NCT03928704|528522206|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
146549735|NCT03928704|528522207|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
146549736|NCT03928704|528522208|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
146631300|NCT01124006|528828367|FG000|Overall Study|Withdrawal by Subject|2|||
146549737|NCT03928704|528522209|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
146549738|NCT03928704|528522204|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
146549739|NCT03928704|528522205|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
146886180|NCT00730639|529750188|FG002|Overall Study|Completed Maximum Cycles|11|||
146549740|NCT03928704|528522206|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
146549741|NCT03928704|528522207|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
146549742|NCT03928704|528522208|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
146549743|NCT03928704|528522209|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
146549744|NCT01245751|528522215|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
146549745|NCT01245751|528522216|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
146549746|NCT01245751|528522217|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
146549747|NCT01245751|528522218|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
146549748|NCT01245751|528522215|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
146549749|NCT01245751|528522216|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
146549750|NCT01245751|528522217|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
146549751|NCT01245751|528522218|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
146549752|NCT01245751|528522215|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
146549753|NCT01245751|528522216|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
146886181|NCT00730639|529750189|FG003|Overall Study|Completed Maximum Cycles|3|||
146886182|NCT00730639|529750190|FG004|Overall Study|Completed Maximum Cycles|6|||
146549754|NCT01245751|528522217|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
146886183|NCT00730639|529750186|FG000|Overall Study|Death|0|||
146886184|NCT00730639|529750187|FG001|Overall Study|Death|0|||
146886185|NCT00730639|529750188|FG002|Overall Study|Death|0|||
146631301|NCT01124006|528828368|FG001|Overall Study|Withdrawal by Subject|2|||
146631302|NCT01124006|528828369|FG002|Overall Study|Withdrawal by Subject|0|||
146631303|NCT01124006|528828367|FG000|Overall Study|Lost to Follow-up|1|||
146631304|NCT01124006|528828368|FG001|Overall Study|Lost to Follow-up|0|||
146631305|NCT01124006|528828369|FG002|Overall Study|Lost to Follow-up|1|||
146631306|NCT01124006|528828367|FG000|Overall Study|Other|0|||
146631307|NCT01124006|528828368|FG001|Overall Study|Other|0|||
146631308|NCT01124006|528828369|FG002|Overall Study|Other|1|||
146631309|NCT01803607|528828371|FG000|Overall Study|Adverse Event|5|||
146631310|NCT01803607|528828372|FG001|Overall Study|Adverse Event|3|||
146631311|NCT01803607|528828371|FG000|Overall Study|Lack of Efficacy|0|||
146631312|NCT01803607|528828372|FG001|Overall Study|Lack of Efficacy|1|||
146631313|NCT01803607|528828371|FG000|Overall Study|Protocol Violation|3|||
146631314|NCT01803607|528828372|FG001|Overall Study|Protocol Violation|2|||
146631315|NCT01803607|528828371|FG000|Overall Study|Study terminated by sponsor|54|||
146631316|NCT01803607|528828372|FG001|Overall Study|Study terminated by sponsor|56|||
146631317|NCT01803607|528828371|FG000|Overall Study|Withdrawal by Subject|6|||
146631318|NCT01803607|528828372|FG001|Overall Study|Withdrawal by Subject|5|||
146631319|NCT00706238|528828379|FG000|Overall Study|Disease progression|4|||
146631320|NCT00706238|528828379|FG000|Overall Study|Other|1|||
146631321|NCT03819114|528828380|FG000|Overall Study|Protocol Violation|0|||
146631322|NCT03819114|528828381|FG001|Overall Study|Protocol Violation|1|||
146631323|NCT03819114|528828382|FG002|Overall Study|Protocol Violation|1|||
146631324|NCT03819114|528828383|FG003|Overall Study|Protocol Violation|0|||
146631325|NCT03819114|528828380|FG000|Overall Study|Lost to Follow-up|0|||
146631326|NCT03819114|528828381|FG001|Overall Study|Lost to Follow-up|0|||
146631327|NCT03819114|528828382|FG002|Overall Study|Lost to Follow-up|1|||
146631328|NCT03819114|528828383|FG003|Overall Study|Lost to Follow-up|0|||
146631329|NCT04646044|528828385|FG000|Overall Study|Lost to Follow-up|0|||
146631330|NCT04646044|528828386|FG001|Overall Study|Lost to Follow-up|0|||
146631331|NCT04646044|528828387|FG002|Overall Study|Lost to Follow-up|1|||
146631332|NCT04646044|528828388|FG003|Overall Study|Lost to Follow-up|0|||
146631333|NCT04646044|528828385|FG000|Overall Study|Withdrawal by Subject|0|||
146631334|NCT04646044|528828386|FG001|Overall Study|Withdrawal by Subject|1|||
146631335|NCT04646044|528828387|FG002|Overall Study|Withdrawal by Subject|0|||
146631336|NCT04646044|528828388|FG003|Overall Study|Withdrawal by Subject|0|||
146631337|NCT03038880|528828394|FG000|Overall Study|Death|1|||
146631338|NCT03038880|528828395|FG001|Overall Study|Death|2|||
146631339|NCT03038880|528828396|FG002|Overall Study|Death|0|||
146631340|NCT03038880|528828394|FG000|Overall Study|Physician Decision|2|||
146631341|NCT03038880|528828395|FG001|Overall Study|Physician Decision|1|||
146631342|NCT03038880|528828396|FG002|Overall Study|Physician Decision|0|||
146631343|NCT02803580|528828397|FG000|Overall Study|Death|13|||
146631344|NCT02803580|528828397|FG000|Overall Study|Lost to Follow-up|19|||
146631345|NCT02803580|528828397|FG000|Overall Study|Withdrawal by Subject|3|||
146631346|NCT02803580|528828397|FG000|Overall Study|Inclusion in clinical trial|1|||
146631347|NCT02633306|528828398|FG000|Overall Study|Withdrawal by Subject|3|||
146631348|NCT03910244|528828399|FG000|Overall Study|Adverse Event|14|||
146631349|NCT03910244|528828400|FG001|Overall Study|Adverse Event|0|||
146631350|NCT03910244|528828399|FG000|Overall Study|Death|1|||
146631351|NCT03910244|528828400|FG001|Overall Study|Death|0|||
146631352|NCT03910244|528828399|FG000|Overall Study|Lost to Follow-up|0|||
146631353|NCT03910244|528828400|FG001|Overall Study|Lost to Follow-up|2|||
146631354|NCT03910244|528828399|FG000|Overall Study|Joint withdrawal decision|1|||
146631355|NCT03910244|528828400|FG001|Overall Study|Joint withdrawal decision|0|||
146631356|NCT03910244|528828399|FG000|Overall Study|Study Terminated by Sponsor|7|||
146631357|NCT03910244|528828400|FG001|Overall Study|Study Terminated by Sponsor|4|||
146631358|NCT03910244|528828399|FG000|Overall Study|Physician Decision|1|||
146631359|NCT03910244|528828400|FG001|Overall Study|Physician Decision|0|||
146631360|NCT03910244|528828399|FG000|Overall Study|Protocol Violation|1|||
146631361|NCT03910244|528828400|FG001|Overall Study|Protocol Violation|0|||
146631362|NCT03910244|528828399|FG000|Overall Study|Withdrawal by Subject|7|||
146631363|NCT03910244|528828400|FG001|Overall Study|Withdrawal by Subject|2|||
146631364|NCT01213472|528828401|FG000|Overall Study|Recurrence/Progressive disease|25|||
146631365|NCT01213472|528828401|FG000|Overall Study|Withdrawal by Subject|1|||
146631366|NCT01213472|528828401|FG000|Overall Study|Physician Decision|1|||
146631367|NCT03774576|528828404|FG000|Period 2|Adverse Event|1|||
146631368|NCT01746901|528828405|FG000|Naloxone Challenge Phase|Adverse Event|2|||
146631369|NCT01746901|528828406|FG001|Naloxone Challenge Phase|Adverse Event|0|||
146631370|NCT01746901|528828407|FG002|Naloxone Challenge Phase|Adverse Event|0|||
146631371|NCT01746901|528828408|FG003|Naloxone Challenge Phase|Adverse Event|0|||
146631372|NCT01746901|528828409|FG004|Naloxone Challenge Phase|Adverse Event|0|||
146631373|NCT01746901|528828410|FG005|Naloxone Challenge Phase|Adverse Event|0|||
146631374|NCT01746901|528828411|FG006|Naloxone Challenge Phase|Adverse Event|0|||
146631375|NCT01746901|528828412|FG007|Naloxone Challenge Phase|Adverse Event|0|||
146631376|NCT01746901|528828413|FG008|Naloxone Challenge Phase|Adverse Event|0|||
146631377|NCT01746901|528828405|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
146631378|NCT01746901|528828406|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
146631379|NCT01746901|528828407|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
146631380|NCT01746901|528828408|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
146631381|NCT01746901|528828409|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
146631382|NCT01746901|528828410|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
146631383|NCT01746901|528828411|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
146631384|NCT01746901|528828412|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
146631385|NCT01746901|528828413|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
146631386|NCT01746901|528828405|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
146631387|NCT01746901|528828406|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
146631388|NCT01746901|528828407|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
146631389|NCT01746901|528828408|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
146631390|NCT01746901|528828409|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
146631391|NCT01746901|528828410|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
146631392|NCT01746901|528828411|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
146631393|NCT01746901|528828412|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
146631394|NCT01746901|528828413|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
146765180|NCT00604721|529307295|FG000|Overall Study|Withdrawal by Subject|1|||
146765181|NCT01838551|529307299|FG000|Overall Study|Adverse Event|16|||
146765182|NCT01838551|529307299|FG000|Overall Study|Death|1|||
146765183|NCT01838551|529307299|FG000|Overall Study|Lack of Efficacy|10|||
146549755|NCT01245751|528522218|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
146549756|NCT02082483|528522219|FG000|Overall Study|Lost to Follow-up|1|||
146549757|NCT02082483|528522220|FG001|Overall Study|Lost to Follow-up|1|||
146549758|NCT02082483|528522219|FG000|Overall Study|Withdrawal by Subject|2|||
146549759|NCT02082483|528522220|FG001|Overall Study|Withdrawal by Subject|1|||
146549760|NCT02082483|528522219|FG000|Overall Study|Physician Decision|1|||
146549761|NCT02082483|528522220|FG001|Overall Study|Physician Decision|1|||
146549762|NCT02082483|528522219|FG000|Overall Study|Death|2|||
146549763|NCT02082483|528522220|FG001|Overall Study|Death|3|||
146549764|NCT02181621|528522221|FG000|Overall Study|Adverse Event|1|||
146549765|NCT02181621|528522222|FG001|Overall Study|Adverse Event|0|||
146549766|NCT02181621|528522221|FG000|Overall Study|Previously Enrolled|0|||
146549767|NCT02181621|528522222|FG001|Overall Study|Previously Enrolled|1|||
146549768|NCT02181621|528522221|FG000|Overall Study|Enrollment Hold|1|||
146549769|NCT02181621|528522222|FG001|Overall Study|Enrollment Hold|1|||
146549770|NCT00762788|528522223|FG000|Overall Study|Lost to Follow-up|26|||
146549771|NCT00762788|528522224|FG001|Overall Study|Lost to Follow-up|37|||
146549772|NCT00762788|528522225|FG002|Overall Study|Lost to Follow-up|21|||
146549773|NCT00762788|528522226|FG003|Overall Study|Lost to Follow-up|26|||
146549774|NCT00762788|528522227|FG004|Overall Study|Lost to Follow-up|13|||
146765184|NCT01838551|529307299|FG000|Overall Study|Physician Decision|4|||
146886186|NCT00730639|529750189|FG003|Overall Study|Death|0|||
146549775|NCT00762788|528522228|FG005|Overall Study|Lost to Follow-up|21|||
146765185|NCT01838551|529307299|FG000|Overall Study|Withdrawal by Subject|10|||
146549776|NCT01783015|528522229|FG000|Blinded Treatment|Adverse Event|0|||
146549777|NCT01783015|528522230|FG001|Blinded Treatment|Adverse Event|1|||
146549778|NCT01783015|528522231|FG002|Blinded Treatment|Adverse Event|0|||
146886187|NCT00730639|529750190|FG004|Overall Study|Death|2|||
146886188|NCT00730639|529750186|FG000|Overall Study|Disease Progression|12|||
146886189|NCT00730639|529750187|FG001|Overall Study|Disease Progression|13|||
146886190|NCT00730639|529750188|FG002|Overall Study|Disease Progression|48|||
146886191|NCT00730639|529750189|FG003|Overall Study|Disease Progression|32|||
146886192|NCT00730639|529750190|FG004|Overall Study|Disease Progression|88|||
146549779|NCT01783015|528522229|FG000|Blinded Treatment|Protocol Violation|0|||
146549780|NCT01783015|528522230|FG001|Blinded Treatment|Protocol Violation|1|||
146549781|NCT01783015|528522231|FG002|Blinded Treatment|Protocol Violation|0|||
146549782|NCT01783015|528522229|FG000|Blinded Treatment|Withdrawal by Subject|0|||
146549783|NCT01783015|528522230|FG001|Blinded Treatment|Withdrawal by Subject|1|||
146549784|NCT01783015|528522231|FG002|Blinded Treatment|Withdrawal by Subject|0|||
146549785|NCT01783015|528522229|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
146549786|NCT01783015|528522230|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
146549787|NCT01783015|528522231|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
146549788|NCT01783015|528522229|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
146549789|NCT01783015|528522230|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
146549790|NCT01783015|528522231|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
146549791|NCT00289978|528522235|FG000|Overall Study|Withdrawal by Subject|31|||
146549792|NCT00289978|528522236|FG001|Overall Study|Withdrawal by Subject|17|||
146549793|NCT00289978|528522237|FG002|Overall Study|Withdrawal by Subject|28|||
146549794|NCT00289978|528522235|FG000|Overall Study|Adverse Event|22|||
146549795|NCT00289978|528522236|FG001|Overall Study|Adverse Event|13|||
146549796|NCT00289978|528522237|FG002|Overall Study|Adverse Event|18|||
146549797|NCT00289978|528522235|FG000|Overall Study|Lack of Efficacy|13|||
146549798|NCT00289978|528522236|FG001|Overall Study|Lack of Efficacy|6|||
146549799|NCT00289978|528522237|FG002|Overall Study|Lack of Efficacy|25|||
146549800|NCT00289978|528522235|FG000|Overall Study|Abnormal laboratory value(s)|20|||
146549801|NCT00289978|528522236|FG001|Overall Study|Abnormal laboratory value(s)|9|||
146549802|NCT00289978|528522237|FG002|Overall Study|Abnormal laboratory value(s)|1|||
146549803|NCT00289978|528522235|FG000|Overall Study|Lost to Follow-up|3|||
146549804|NCT00289978|528522236|FG001|Overall Study|Lost to Follow-up|5|||
146549805|NCT00289978|528522237|FG002|Overall Study|Lost to Follow-up|7|||
146549806|NCT00289978|528522235|FG000|Overall Study|Protocol Violation|5|||
146549807|NCT00289978|528522236|FG001|Overall Study|Protocol Violation|5|||
146549808|NCT00289978|528522237|FG002|Overall Study|Protocol Violation|4|||
146631395|NCT01746901|528828405|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
146631396|NCT01746901|528828406|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
146631397|NCT01746901|528828407|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
146631398|NCT01746901|528828408|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
146631399|NCT01746901|528828409|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
146886193|NCT00730639|529750186|FG000|Overall Study|non-specified|0|||
146886194|NCT00730639|529750187|FG001|Overall Study|non-specified|0|||
146549809|NCT00289978|528522235|FG000|Overall Study|Abnormal test procedure result(s)|2|||
146886195|NCT00730639|529750188|FG002|Overall Study|non-specified|4|||
146549810|NCT00289978|528522236|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146549811|NCT00289978|528522237|FG002|Overall Study|Abnormal test procedure result(s)|1|||
146886196|NCT00730639|529750189|FG003|Overall Study|non-specified|2|||
146886197|NCT00730639|529750190|FG004|Overall Study|non-specified|3|||
146886198|NCT00730639|529750186|FG000|Overall Study|Protocol Violation|0|||
146886199|NCT00730639|529750187|FG001|Overall Study|Protocol Violation|0|||
146886200|NCT00730639|529750188|FG002|Overall Study|Protocol Violation|1|||
146886201|NCT00730639|529750189|FG003|Overall Study|Protocol Violation|0|||
146549812|NCT00289978|528522235|FG000|Overall Study|Death|1|||
146549813|NCT00289978|528522236|FG001|Overall Study|Death|0|||
146549814|NCT00289978|528522237|FG002|Overall Study|Death|2|||
146549815|NCT01524705|528522238|FG000|Overall Study|Adverse Event|2|||
146549816|NCT01524705|528522239|FG001|Overall Study|Adverse Event|0|||
146549817|NCT01524705|528522238|FG000|Overall Study|Death|1|||
146549818|NCT01524705|528522239|FG001|Overall Study|Death|0|||
146549819|NCT01524705|528522238|FG000|Overall Study|Lost to Follow-up|0|||
146549820|NCT01524705|528522239|FG001|Overall Study|Lost to Follow-up|1|||
146549821|NCT01524705|528522238|FG000|Overall Study|Withdrawal by Subject|0|||
146549822|NCT01524705|528522239|FG001|Overall Study|Withdrawal by Subject|1|||
146549823|NCT01524705|528522238|FG000|Overall Study|Pancreatic Cancer|0|||
146549824|NCT01524705|528522239|FG001|Overall Study|Pancreatic Cancer|1|||
146549825|NCT01243424|528522240|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
146549826|NCT01243424|528522241|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
146549827|NCT01243424|528522240|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
146549828|NCT01243424|528522241|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
146549829|NCT01243424|528522240|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
146549830|NCT01243424|528522241|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
146549831|NCT01243424|528522240|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
146549832|NCT01243424|528522241|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
146549833|NCT01243424|528522240|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
146549834|NCT01243424|528522241|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
146549835|NCT01243424|528522240|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
146549836|NCT01243424|528522241|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
146549837|NCT01243424|528522240|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
146549838|NCT01243424|528522241|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
146549839|NCT01243424|528522240|FG000|Discontinuation From Treatment|Not treated|5|||
146549840|NCT01243424|528522241|FG001|Discontinuation From Treatment|Not treated|4|||
146549841|NCT01243424|528522240|FG000|Discontinuation From Treatment|Adverse Event|457|||
146549842|NCT01243424|528522241|FG001|Discontinuation From Treatment|Adverse Event|523|||
146549843|NCT01243424|528522240|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
146549844|NCT01243424|528522241|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
146549845|NCT01243424|528522240|FG000|Discontinuation From Treatment|Protocol Violation|46|||
146549846|NCT01243424|528522241|FG001|Discontinuation From Treatment|Protocol Violation|47|||
146549847|NCT01243424|528522240|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
146549848|NCT01243424|528522241|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
146549849|NCT01243424|528522240|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
146549850|NCT01243424|528522241|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
146549851|NCT01243424|528522240|FG000|Discontinuation From Treatment|Other than listed above|230|||
146549852|NCT01243424|528522241|FG001|Discontinuation From Treatment|Other than listed above|211|||
146549853|NCT01160744|528522248|FG000|Overall Study|Withdrawal by Subject|11|||
146549854|NCT01160744|528522249|FG001|Overall Study|Withdrawal by Subject|5|||
146549855|NCT01160744|528522250|FG002|Overall Study|Withdrawal by Subject|6|||
146549856|NCT01160744|528522251|FG003|Overall Study|Withdrawal by Subject|4|||
146549857|NCT01160744|528522248|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
146549858|NCT01160744|528522249|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
146549859|NCT01160744|528522250|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
146549860|NCT01160744|528522251|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
146549861|NCT02959892|528522257|FG000|Overall Study|PET tracer synthesis failure|1|||
146549862|NCT02959892|528522258|FG001|Overall Study|PET tracer synthesis failure|0|||
146549863|NCT02959892|528522257|FG000|Overall Study|Study termination|0|||
146549864|NCT02959892|528522258|FG001|Overall Study|Study termination|1|||
146549865|NCT03338023|528522259|FG000|Overall Study|Withdrawal by Subject|3|||
146549866|NCT03338023|528522260|FG001|Overall Study|Withdrawal by Subject|4|||
146549867|NCT03338023|528522259|FG000|Overall Study|Protocol Violation|3|||
146549868|NCT03338023|528522260|FG001|Overall Study|Protocol Violation|3|||
146549869|NCT03338023|528522259|FG000|Overall Study|Lost to Follow-up|2|||
146549870|NCT03338023|528522260|FG001|Overall Study|Lost to Follow-up|1|||
146631400|NCT01746901|528828410|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
146886202|NCT00730639|529750190|FG004|Overall Study|Protocol Violation|0|||
146886203|NCT00730639|529750186|FG000|Overall Study|Withdrawal by Subject|0|||
146886204|NCT00730639|529750187|FG001|Overall Study|Withdrawal by Subject|0|||
146886205|NCT00730639|529750188|FG002|Overall Study|Withdrawal by Subject|6|||
146886206|NCT00730639|529750189|FG003|Overall Study|Withdrawal by Subject|3|||
146886207|NCT00730639|529750190|FG004|Overall Study|Withdrawal by Subject|4|||
146886208|NCT00730639|529750186|FG000|Overall Study|Treatment on-going|2|||
146886209|NCT00730639|529750187|FG001|Overall Study|Treatment on-going|5|||
146886210|NCT00730639|529750188|FG002|Overall Study|Treatment on-going|5|||
146549871|NCT03338023|528522259|FG000|Overall Study|Physician Decision|1|||
146549872|NCT03338023|528522260|FG001|Overall Study|Physician Decision|2|||
146549873|NCT04865978|528522261|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
146549874|NCT04865978|528522262|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
146549875|NCT02181738|528522267|FG000|Overall Study|Participant Withdrew Consent|2|||
146549876|NCT02181738|528522268|FG001|Overall Study|Participant Withdrew Consent|1|||
146549877|NCT02181738|528522269|FG002|Overall Study|Participant Withdrew Consent|1|||
146549878|NCT02181738|528522270|FG003|Overall Study|Participant Withdrew Consent|1|||
146549879|NCT02181738|528522267|FG000|Overall Study|Lost to Follow-up|1|||
146549880|NCT02181738|528522268|FG001|Overall Study|Lost to Follow-up|2|||
146549881|NCT02181738|528522269|FG002|Overall Study|Lost to Follow-up|1|||
146549882|NCT02181738|528522270|FG003|Overall Study|Lost to Follow-up|1|||
146549883|NCT02181738|528522267|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
146549884|NCT02181738|528522268|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
146549885|NCT02181738|528522269|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
146549886|NCT02181738|528522270|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
146549887|NCT02181738|528522267|FG000|Overall Study|Poor/Non-Compliance|1|||
146549888|NCT02181738|528522268|FG001|Overall Study|Poor/Non-Compliance|0|||
146549889|NCT02181738|528522269|FG002|Overall Study|Poor/Non-Compliance|2|||
146549890|NCT02181738|528522270|FG003|Overall Study|Poor/Non-Compliance|1|||
146549891|NCT02181738|528522267|FG000|Overall Study|Disease Progression|28|||
146549892|NCT02181738|528522268|FG001|Overall Study|Disease Progression|35|||
146549893|NCT02181738|528522269|FG002|Overall Study|Disease Progression|40|||
146549894|NCT02181738|528522270|FG003|Overall Study|Disease Progression|0|||
146549895|NCT02181738|528522267|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
146549896|NCT02181738|528522268|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
146549897|NCT02181738|528522269|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
146549898|NCT02181738|528522270|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
146549899|NCT02181738|528522267|FG000|Overall Study|Study Drug Toxicity|6|||
146549900|NCT02181738|528522268|FG001|Overall Study|Study Drug Toxicity|11|||
146549901|NCT02181738|528522269|FG002|Overall Study|Study Drug Toxicity|8|||
146549902|NCT02181738|528522270|FG003|Overall Study|Study Drug Toxicity|1|||
146549903|NCT02181738|528522267|FG000|Overall Study|Other Reasons|14|||
146549904|NCT02181738|528522268|FG001|Overall Study|Other Reasons|16|||
146549905|NCT02181738|528522269|FG002|Overall Study|Other Reasons|28|||
146549906|NCT02181738|528522270|FG003|Overall Study|Other Reasons|0|||
146549907|NCT02181738|528522267|FG000|Overall Study|Maximum Clinical Benefit|3|||
146549908|NCT02181738|528522268|FG001|Overall Study|Maximum Clinical Benefit|0|||
146549909|NCT02181738|528522269|FG002|Overall Study|Maximum Clinical Benefit|1|||
146549910|NCT02181738|528522270|FG003|Overall Study|Maximum Clinical Benefit|0|||
146549911|NCT02181738|528522267|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
146549912|NCT02181738|528522268|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
146549913|NCT02181738|528522269|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
146549914|NCT02181738|528522270|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146549915|NCT01668537|528522271|FG000|Overall Study|Request to Discontinue Prematurely|1|||
146549916|NCT01668537|528522272|FG001|Overall Study|Request to Discontinue Prematurely|1|||
146549917|NCT01668537|528522271|FG000|Overall Study|Subject unwilling/unable to comply|5|||
146549918|NCT01668537|528522272|FG001|Overall Study|Subject unwilling/unable to comply|0|||
146549919|NCT01668537|528522271|FG000|Overall Study|Reason Precludes Participation|1|||
146549920|NCT01668537|528522272|FG001|Overall Study|Reason Precludes Participation|0|||
146549921|NCT01668537|528522271|FG000|Overall Study|Lost to Follow-up|13|||
146549922|NCT01668537|528522272|FG001|Overall Study|Lost to Follow-up|6|||
146549923|NCT01668537|528522271|FG000|Overall Study|Other|2|||
146549924|NCT01668537|528522272|FG001|Overall Study|Other|3|||
146549925|NCT05064800|528522278|FG000|Period 3|Withdrawal by Subject|0|||
146549926|NCT05064800|528522279|FG001|Period 3|Withdrawal by Subject|0|||
146549927|NCT05064800|528522280|FG002|Period 3|Withdrawal by Subject|0|||
146549928|NCT05064800|528522281|FG003|Period 3|Withdrawal by Subject|0|||
146549929|NCT05064800|528522282|FG004|Period 3|Withdrawal by Subject|1|||
146886211|NCT00730639|529750189|FG003|Overall Study|Treatment on-going|4|||
146549930|NCT05064800|528522283|FG005|Period 3|Withdrawal by Subject|0|||
146549931|NCT01181128|528522284|FG000|Overall Study|Withdrawal by Subject|2|||
146549932|NCT01181128|528522285|FG001|Overall Study|Withdrawal by Subject|2|||
146549933|NCT01181128|528522286|FG002|Overall Study|Withdrawal by Subject|0|||
146549934|NCT01181128|528522284|FG000|Overall Study|Death|1|||
146886212|NCT00730639|529750190|FG004|Overall Study|Treatment on-going|4|||
146549935|NCT01181128|528522285|FG001|Overall Study|Death|0|||
146549936|NCT01181128|528522286|FG002|Overall Study|Death|0|||
146886213|NCT00903929|529750191|FG000|Overall Study|Withdrawal by Subject|0|||
146549937|NCT01181128|528522284|FG000|Overall Study|Physician Decision|2|||
146886214|NCT00903929|529750192|FG001|Overall Study|Withdrawal by Subject|0|||
146886215|NCT00903929|529750193|FG002|Overall Study|Withdrawal by Subject|1|||
146886216|NCT00903929|529750194|FG003|Overall Study|Withdrawal by Subject|2|||
146886217|NCT00903929|529750191|FG000|Overall Study|Adverse Event|0|||
146886218|NCT00903929|529750192|FG001|Overall Study|Adverse Event|0|||
146549938|NCT01181128|528522285|FG001|Overall Study|Physician Decision|0|||
146549939|NCT01181128|528522286|FG002|Overall Study|Physician Decision|0|||
146549940|NCT01181128|528522284|FG000|Overall Study|Adverse Event|0|||
146549941|NCT01181128|528522285|FG001|Overall Study|Adverse Event|2|||
146549942|NCT01181128|528522286|FG002|Overall Study|Adverse Event|0|||
146549943|NCT01181128|528522284|FG000|Overall Study|Other|1|||
146549944|NCT01181128|528522285|FG001|Overall Study|Other|1|||
146549945|NCT01181128|528522286|FG002|Overall Study|Other|1|||
146549946|NCT00629239|528522287|FG000|Overall Study|Adverse Event|7|||
146549947|NCT00629239|528522288|FG001|Overall Study|Adverse Event|4|||
146549948|NCT00629239|528522287|FG000|Overall Study|Physician Decision|1|||
146549949|NCT00629239|528522288|FG001|Overall Study|Physician Decision|0|||
146549950|NCT04477486|528522291|FG000|Overall Study|Death|2|||
146549951|NCT04477486|528522291|FG000|Overall Study|Ongoing at Time of Analysis|11|||
146549952|NCT01851369|528522292|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
146549953|NCT01851369|528522293|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
146549954|NCT01851369|528522294|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
146549955|NCT01851369|528522295|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
146549956|NCT01851369|528522296|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
146549957|NCT01851369|528522297|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
146549958|NCT01851369|528522298|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
146549959|NCT01851369|528522299|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
146549960|NCT01851369|528522300|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
146549961|NCT01851369|528522301|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
146549962|NCT01851369|528522302|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
146549963|NCT01851369|528522303|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
146549964|NCT01851369|528522304|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
146549965|NCT00183391|528522305|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
146549966|NCT00183391|528522306|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
146549967|NCT00183391|528522305|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
146549968|NCT00183391|528522306|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
146549969|NCT01543503|528522308|FG000|Overall Study|Lost to Follow-up|32|||
146549970|NCT01543503|528522309|FG001|Overall Study|Lost to Follow-up|36|||
146549971|NCT01543503|528522308|FG000|Overall Study|Adverse Event|9|||
146549972|NCT01543503|528522309|FG001|Overall Study|Adverse Event|13|||
146549973|NCT01543503|528522308|FG000|Overall Study|Lack of Efficacy|4|||
146549974|NCT01543503|528522309|FG001|Overall Study|Lack of Efficacy|16|||
146549975|NCT01543503|528522308|FG000|Overall Study|Participant withdrew informed consent|8|||
146549976|NCT01543503|528522309|FG001|Overall Study|Participant withdrew informed consent|10|||
146549977|NCT01543503|528522308|FG000|Overall Study|Change of jobs|0|||
146549978|NCT01543503|528522309|FG001|Overall Study|Change of jobs|1|||
146549979|NCT01543503|528522308|FG000|Overall Study|Intolerance to the biologic treatment|0|||
146549980|NCT01543503|528522309|FG001|Overall Study|Intolerance to the biologic treatment|1|||
146549981|NCT01543503|528522308|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
146549982|NCT01543503|528522309|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
146549983|NCT01543503|528522308|FG000|Overall Study|Participant did not complete last visit|0|||
146549984|NCT01543503|528522309|FG001|Overall Study|Participant did not complete last visit|2|||
146549985|NCT01543503|528522308|FG000|Overall Study|Refused to continue treatment|7|||
146549986|NCT01543503|528522309|FG001|Overall Study|Refused to continue treatment|0|||
146549987|NCT01543503|528522308|FG000|Overall Study|Incorrect medication received|1|||
146549988|NCT01543503|528522309|FG001|Overall Study|Incorrect medication received|0|||
146549989|NCT01543503|528522308|FG000|Overall Study|Participant moved to another city|2|||
146549990|NCT01543503|528522309|FG001|Overall Study|Participant moved to another city|0|||
146549991|NCT01543503|528522308|FG000|Overall Study|Participant will not return for visits|0|||
146549992|NCT01543503|528522309|FG001|Overall Study|Participant will not return for visits|2|||
146549993|NCT01543503|528522308|FG000|Overall Study|Participant transferred to another city|1|||
146549994|NCT01543503|528522309|FG001|Overall Study|Participant transferred to another city|0|||
146549995|NCT01543503|528522308|FG000|Overall Study|Participant moved to Scotland|1|||
146549996|NCT01543503|528522309|FG001|Overall Study|Participant moved to Scotland|0|||
146549997|NCT01543503|528522308|FG000|Overall Study|Participant decision to stop treatment|1|||
146886219|NCT00903929|529750193|FG002|Overall Study|Adverse Event|0|||
146886220|NCT00903929|529750194|FG003|Overall Study|Adverse Event|1|||
146886221|NCT01844895|529750197|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
146886222|NCT01844895|529750197|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
146631401|NCT01746901|528828411|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
146631402|NCT01746901|528828412|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
146631403|NCT01746901|528828413|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
146631404|NCT01746901|528828405|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
146631405|NCT01746901|528828406|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
146631406|NCT01746901|528828407|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
146631407|NCT01746901|528828408|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
146631408|NCT01746901|528828409|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
146631409|NCT01746901|528828410|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
146631410|NCT01746901|528828411|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
146631411|NCT01746901|528828412|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
146631412|NCT01746901|528828413|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
146631413|NCT01746901|528828405|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
146631414|NCT01746901|528828406|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
146631415|NCT01746901|528828407|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
146631416|NCT01746901|528828408|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
146631417|NCT01746901|528828409|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
146631418|NCT01746901|528828410|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
146631419|NCT01746901|528828411|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
146631420|NCT01746901|528828412|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
146631421|NCT01746901|528828413|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
146631422|NCT01746901|528828405|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
146631423|NCT01746901|528828406|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
146631424|NCT01746901|528828407|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
146631425|NCT01746901|528828408|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
146631426|NCT01746901|528828409|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
146631427|NCT01746901|528828410|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
146631428|NCT01746901|528828411|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
146631429|NCT01746901|528828412|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
146631430|NCT01746901|528828413|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
146631431|NCT01746901|528828405|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
146631432|NCT01746901|528828406|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
146631433|NCT01746901|528828407|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
146631434|NCT01746901|528828408|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
146631435|NCT01746901|528828409|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
146631436|NCT01746901|528828410|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
146631437|NCT01746901|528828411|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
146631438|NCT01746901|528828412|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
146631439|NCT01746901|528828413|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
146631440|NCT01746901|528828405|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
146631441|NCT01746901|528828406|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
146631442|NCT01746901|528828407|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
146631443|NCT01746901|528828408|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
146631444|NCT01746901|528828409|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
146631445|NCT01746901|528828410|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
146886223|NCT01844895|529750197|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
146886224|NCT01844895|529750197|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
146886225|NCT01844895|529750197|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
146886226|NCT01844895|529750197|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
146886227|NCT01844895|529750197|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
146886228|NCT02508194|529750199|FG000|Overall Study|Death|5|||
146886229|NCT02508194|529750200|FG001|Overall Study|Death|3|||
146886230|NCT02508194|529750199|FG000|Overall Study|Lost to Follow-up|25|||
146886231|NCT02508194|529750200|FG001|Overall Study|Lost to Follow-up|18|||
146886232|NCT02508194|529750199|FG000|Overall Study|Withdrawal by Subject|20|||
146886233|NCT02508194|529750200|FG001|Overall Study|Withdrawal by Subject|18|||
146886234|NCT02508194|529750199|FG000|Overall Study|Error in Randomization|1|||
146886235|NCT02508194|529750200|FG001|Overall Study|Error in Randomization|3|||
146886236|NCT02508194|529750199|FG000|Overall Study|Principal Investigator Decision|1|||
146886237|NCT02508194|529750200|FG001|Overall Study|Principal Investigator Decision|2|||
146886238|NCT00511355|529750201|FG000|Overall Study|Adverse Event|4|||
146886239|NCT00511355|529750202|FG001|Overall Study|Adverse Event|4|||
146886240|NCT00511355|529750201|FG000|Overall Study|Pregnancy Wish|1|||
146886241|NCT00511355|529750202|FG001|Overall Study|Pregnancy Wish|0|||
146886242|NCT00511355|529750201|FG000|Overall Study|Lost to Follow-up|2|||
146886243|NCT00511355|529750202|FG001|Overall Study|Lost to Follow-up|1|||
146886244|NCT00511355|529750201|FG000|Overall Study|Other Reason|0|||
146886245|NCT00511355|529750202|FG001|Overall Study|Other Reason|1|||
146631446|NCT01746901|528828411|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
146631447|NCT01746901|528828412|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
146631448|NCT01746901|528828413|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
146631449|NCT01746901|528828405|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
146631450|NCT01746901|528828406|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
146631451|NCT01746901|528828407|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
146631452|NCT01746901|528828408|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
146631453|NCT01746901|528828409|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
146631454|NCT01746901|528828410|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
146631455|NCT01746901|528828411|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
146631456|NCT01746901|528828412|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
146631457|NCT01746901|528828413|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
146631458|NCT01746901|528828405|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
146631459|NCT01746901|528828406|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
146631460|NCT01746901|528828407|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
146631461|NCT01746901|528828408|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
146631462|NCT01746901|528828409|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
146631463|NCT01746901|528828410|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
146631464|NCT01746901|528828411|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
146631465|NCT01746901|528828412|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
146631466|NCT01746901|528828413|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
146631467|NCT01746901|528828405|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
146631468|NCT01746901|528828406|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
146631469|NCT01746901|528828407|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
146631470|NCT01746901|528828408|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
146631471|NCT01746901|528828409|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
146631472|NCT01746901|528828410|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
146631473|NCT01746901|528828411|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
146631474|NCT01746901|528828412|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
146631475|NCT01746901|528828413|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
146631476|NCT03594110|528828417|FG000|Interventional Part|Participant concerned about study treatment|23|||
146631477|NCT03594110|528828418|FG001|Interventional Part|Participant concerned about study treatment|28|||
146631478|NCT03594110|528828417|FG000|Interventional Part|Doctor advice|38|||
146631479|NCT03594110|528828418|FG001|Interventional Part|Doctor advice|40|||
146631480|NCT03594110|528828417|FG000|Interventional Part|Participants' wish|89|||
146631481|NCT03594110|528828418|FG001|Interventional Part|Participants' wish|68|||
146631482|NCT03594110|528828417|FG000|Interventional Part|Adverse event-non-fatal events|119|||
146631483|NCT03594110|528828418|FG001|Interventional Part|Adverse event-non-fatal events|116|||
146631484|NCT03594110|528828417|FG000|Interventional Part|Study drug stopped, reason missing|336|||
146631485|NCT03594110|528828418|FG001|Interventional Part|Study drug stopped, reason missing|294|||
146631486|NCT03594110|528828417|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
146631487|NCT03594110|528828418|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
146631488|NCT03594110|528828417|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
146631489|NCT03594110|528828418|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
146631490|NCT03594110|528828417|FG000|Interventional Part|Contraindicated drug started|32|||
146631491|NCT03594110|528828418|FG001|Interventional Part|Contraindicated drug started|18|||
146631492|NCT03594110|528828417|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
146631493|NCT03594110|528828418|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
146631494|NCT03594110|528828417|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
146631495|NCT03594110|528828418|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
146631496|NCT03594110|528828417|FG000|Non-interventional Part|Withdrawal by Subject|3|||
146631497|NCT03594110|528828418|FG001|Non-interventional Part|Withdrawal by Subject|4|||
146631498|NCT03594110|528828417|FG000|Non-interventional Part|Lost to Follow-up|45|||
146886246|NCT00511355|529750201|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
146886247|NCT00511355|529750202|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
146631499|NCT03594110|528828418|FG001|Non-interventional Part|Lost to Follow-up|41|||
146631500|NCT02085460|528828420|FG000|Overall Study|Adverse Event|2|||
146631501|NCT02085460|528828421|FG001|Overall Study|Adverse Event|2|||
146631502|NCT02085460|528828422|FG002|Overall Study|Adverse Event|1|||
146631503|NCT02085460|528828420|FG000|Overall Study|Physician Decision|1|||
146631504|NCT02085460|528828421|FG001|Overall Study|Physician Decision|1|||
146631505|NCT02085460|528828422|FG002|Overall Study|Physician Decision|2|||
146631506|NCT02085460|528828420|FG000|Overall Study|Withdrawal by Subject|11|||
146631507|NCT02085460|528828421|FG001|Overall Study|Withdrawal by Subject|5|||
146631508|NCT02085460|528828422|FG002|Overall Study|Withdrawal by Subject|7|||
146631509|NCT00907335|528828425|FG000|Overall Study|Withdrawal by Subject|2|||
146631510|NCT00907335|528828426|FG001|Overall Study|Withdrawal by Subject|0|||
146631511|NCT00907335|528828425|FG000|Overall Study|Adverse Event|4|||
146631512|NCT00907335|528828426|FG001|Overall Study|Adverse Event|1|||
146631513|NCT00907335|528828425|FG000|Overall Study|Lost to Follow-up|2|||
146631514|NCT00907335|528828426|FG001|Overall Study|Lost to Follow-up|0|||
146631515|NCT03879772|528828427|FG000|Overall Study|Adverse Event|2|||
146631516|NCT03879772|528828428|FG001|Overall Study|Adverse Event|2|||
146631517|NCT03879772|528828429|FG002|Overall Study|Adverse Event|3|||
146631518|NCT03879772|528828430|FG003|Overall Study|Adverse Event|4|||
146631519|NCT03879772|528828431|FG004|Overall Study|Adverse Event|3|||
146631520|NCT03879772|528828427|FG000|Overall Study|Treatment Failure|1|||
146631521|NCT03879772|528828428|FG001|Overall Study|Treatment Failure|0|||
146631522|NCT03879772|528828429|FG002|Overall Study|Treatment Failure|0|||
146631523|NCT03879772|528828430|FG003|Overall Study|Treatment Failure|2|||
146631524|NCT03879772|528828431|FG004|Overall Study|Treatment Failure|1|||
146631525|NCT03879772|528828427|FG000|Overall Study|Lost to Follow-up|0|||
146631526|NCT03879772|528828428|FG001|Overall Study|Lost to Follow-up|0|||
146631527|NCT03879772|528828429|FG002|Overall Study|Lost to Follow-up|0|||
146631528|NCT03879772|528828430|FG003|Overall Study|Lost to Follow-up|0|||
146631529|NCT03879772|528828431|FG004|Overall Study|Lost to Follow-up|1|||
146631530|NCT03879772|528828427|FG000|Overall Study|Withdrawal by Subject|0|||
146631531|NCT03879772|528828428|FG001|Overall Study|Withdrawal by Subject|1|||
146631532|NCT03879772|528828429|FG002|Overall Study|Withdrawal by Subject|3|||
146631533|NCT03879772|528828430|FG003|Overall Study|Withdrawal by Subject|1|||
146631534|NCT03879772|528828431|FG004|Overall Study|Withdrawal by Subject|1|||
146631535|NCT03879772|528828427|FG000|Overall Study|Protocol Violation|0|||
146631536|NCT03879772|528828428|FG001|Overall Study|Protocol Violation|0|||
146631537|NCT03879772|528828429|FG002|Overall Study|Protocol Violation|3|||
146631538|NCT03879772|528828430|FG003|Overall Study|Protocol Violation|1|||
146631539|NCT03879772|528828431|FG004|Overall Study|Protocol Violation|2|||
146631540|NCT03879772|528828427|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
146631541|NCT03879772|528828428|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
146631542|NCT03879772|528828429|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
146631543|NCT03879772|528828430|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
146631544|NCT03879772|528828431|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
146631545|NCT00930046|528828432|FG000|Overall Study|Wound catheter malfunctioned|1|||
146631546|NCT00930046|528828433|FG001|Overall Study|Wound catheter malfunctioned|2|||
146631547|NCT01598532|528828434|FG000|Overall Study|Lost to Follow-up|3|||
146631548|NCT01598532|528828434|FG000|Overall Study|Did not meet inclusion criteria|8|||
146631549|NCT00702221|528828435|FG000|Overall Study|Adverse Event|4|||
146631550|NCT00702221|528828436|FG001|Overall Study|Adverse Event|3|||
146631551|NCT04798196|528828440|FG000|Overall Study|Lost to Follow-up|3|||
146631552|NCT04798196|528828441|FG001|Overall Study|Lost to Follow-up|1|||
146631553|NCT04798196|528828442|FG002|Overall Study|Lost to Follow-up|3|||
146631554|NCT01249261|528828443|FG000|Overall Study|Withdrawal by Subject|1|||
146770096|NCT01426269|529327375|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
146886248|NCT00511355|529750201|FG000|Overall Study|Withdrawal of informed consent|0|||
146631555|NCT01249261|528828444|FG001|Overall Study|Withdrawal by Subject|0|||
146631556|NCT01967940|528828446|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
146631557|NCT01967940|528828447|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
146631558|NCT01967940|528828448|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
146631559|NCT01967940|528828449|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
146631560|NCT01967940|528828446|FG000|Part 2|Adverse Event|0|||
146631561|NCT01967940|528828447|FG001|Part 2|Adverse Event|0|||
146631562|NCT01967940|528828448|FG002|Part 2|Adverse Event|0|||
146631563|NCT01967940|528828449|FG003|Part 2|Adverse Event|1|||
146631564|NCT01967940|528828446|FG000|Part 2|Unknown Reason|0|||
146631565|NCT01967940|528828447|FG001|Part 2|Unknown Reason|0|||
146631566|NCT01967940|528828448|FG002|Part 2|Unknown Reason|0|||
146631567|NCT01967940|528828449|FG003|Part 2|Unknown Reason|1|||
146631568|NCT00361296|528828450|FG000|Overall Study|Physician Decision|1|||
146631569|NCT00361296|528828450|FG000|Overall Study|Lack of Efficacy|2|||
146631570|NCT00904982|528828453|FG000|Overall Study|Withdrawal by Subject|2|||
146631571|NCT00904982|528828454|FG001|Overall Study|Withdrawal by Subject|0|||
146631572|NCT00904982|528828455|FG002|Overall Study|Withdrawal by Subject|0|||
146631573|NCT00904982|528828456|FG003|Overall Study|Withdrawal by Subject|0|||
146631574|NCT02072668|528828461|FG000|Second Intervention|Lost to Follow-up|1|||
146631575|NCT02072668|528828462|FG001|Second Intervention|Lost to Follow-up|0|||
146631576|NCT01352793|528828473|FG000|Overall Study|Lost to Follow-up|289|||
146631577|NCT01352793|528828474|FG001|Overall Study|Lost to Follow-up|125|||
146631578|NCT01352793|528828473|FG000|Overall Study|Withdrawal by Subject|120|||
146631579|NCT01352793|528828474|FG001|Overall Study|Withdrawal by Subject|55|||
146631580|NCT01352793|528828473|FG000|Overall Study|Protocol Violation|44|||
146631581|NCT01352793|528828474|FG001|Overall Study|Protocol Violation|23|||
146631582|NCT01352793|528828473|FG000|Overall Study|Adverse Event|44|||
146631583|NCT01352793|528828474|FG001|Overall Study|Adverse Event|10|||
146631584|NCT01352793|528828473|FG000|Overall Study|Physician Decision|1|||
146631585|NCT01352793|528828474|FG001|Overall Study|Physician Decision|0|||
146631586|NCT01352793|528828473|FG000|Overall Study|Pregnancy|26|||
146631587|NCT01352793|528828474|FG001|Overall Study|Pregnancy|8|||
146631588|NCT01352793|528828473|FG000|Overall Study|Other|25|||
146631589|NCT01352793|528828474|FG001|Overall Study|Other|7|||
146631590|NCT01352793|528828473|FG000|Overall Study|Medication error|2|||
146631591|NCT01352793|528828474|FG001|Overall Study|Medication error|2|||
146631592|NCT01352793|528828473|FG000|Overall Study|Death|1|||
146631593|NCT01352793|528828474|FG001|Overall Study|Death|0|||
146631594|NCT01352793|528828473|FG000|Overall Study|Randomized but not vaccinated|8|||
146631595|NCT01352793|528828474|FG001|Overall Study|Randomized but not vaccinated|0|||
146631596|NCT01352793|528828473|FG000|Overall Study|No longer meets eligibility criteria|25|||
146631597|NCT01352793|528828474|FG001|Overall Study|No longer meets eligibility criteria|15|||
146631598|NCT01929317|528828477|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
146631599|NCT01929317|528828478|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
146631600|NCT01929317|528828477|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
146631601|NCT01929317|528828478|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
146631602|NCT01929317|528828477|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
146631603|NCT01929317|528828478|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
146631604|NCT01929317|528828477|FG000|Long-term Phase|Adverse Event|5|||
146631605|NCT01929317|528828478|FG001|Long-term Phase|Adverse Event|1|||
146631606|NCT01929317|528828477|FG000|Long-term Phase|Physician Decision|3|||
146631607|NCT01929317|528828478|FG001|Long-term Phase|Physician Decision|0|||
146631608|NCT01929317|528828477|FG000|Long-term Phase|Withdrawal by Subject|4|||
146631609|NCT01929317|528828478|FG001|Long-term Phase|Withdrawal by Subject|0|||
146631610|NCT01929317|528828477|FG000|Long-term Phase|Protocol Violation|1|||
146631611|NCT01929317|528828478|FG001|Long-term Phase|Protocol Violation|0|||
146631612|NCT01929317|528828477|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
146631613|NCT01929317|528828478|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
146631614|NCT01929317|528828477|FG000|Long-term Phase|Study Closed/Terminated|5|||
146631615|NCT01929317|528828478|FG001|Long-term Phase|Study Closed/Terminated|3|||
146631616|NCT02667119|528828479|FG000|Overall Study|Lost to Follow-up|3|||
146631617|NCT02667119|528828480|FG001|Overall Study|Lost to Follow-up|0|||
146631618|NCT03783078|528828481|FG000|Overall Study|Death|31|||
146631619|NCT03783078|528828481|FG000|Overall Study|Sponsor Decision|23|||
146631620|NCT03783078|528828481|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146631621|NCT03205423|528828484|FG000|Overall Study|Personal|1|||
146631622|NCT03205423|528828485|FG001|Overall Study|Personal|1|||
146631623|NCT03205423|528828484|FG000|Overall Study|Physician Decision|0|||
146631624|NCT03205423|528828485|FG001|Overall Study|Physician Decision|2|||
146631625|NCT04467905|528828486|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
146631626|NCT04467905|528828487|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
146631627|NCT04467905|528828488|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
146631628|NCT04467905|528828486|FG000|Overall Study|Conversion to SR|0|||
146631629|NCT04467905|528828487|FG001|Overall Study|Conversion to SR|0|||
146765186|NCT01838551|529307299|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
146765187|NCT00906282|529307300|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
146765188|NCT00906282|529307300|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
146631630|NCT04467905|528828488|FG002|Overall Study|Conversion to SR|3|||
146631631|NCT04467905|528828486|FG000|Overall Study|Technical issue with Holter ECG|0|||
146631632|NCT04467905|528828487|FG001|Overall Study|Technical issue with Holter ECG|0|||
146631633|NCT04467905|528828488|FG002|Overall Study|Technical issue with Holter ECG|3|||
146631634|NCT04467905|528828486|FG000|Overall Study|Hemodynamic instability|0|||
146631635|NCT04467905|528828487|FG001|Overall Study|Hemodynamic instability|0|||
146765189|NCT00906282|529307300|FG000|Preoperative Chemotherapy|Progressive disease|6|||
146549998|NCT01543503|528522309|FG001|Overall Study|Participant decision to stop treatment|0|||
146549999|NCT01543503|528522308|FG000|Overall Study|Investigator did not wish to participate|1|||
146550000|NCT01543503|528522309|FG001|Overall Study|Investigator did not wish to participate|1|||
146550001|NCT01543503|528522308|FG000|Overall Study|Participant recruited after closing date|0|||
146550002|NCT01543503|528522309|FG001|Overall Study|Participant recruited after closing date|1|||
146550003|NCT01543503|528522308|FG000|Overall Study|Site stopped participation|5|||
146550004|NCT01543503|528522309|FG001|Overall Study|Site stopped participation|1|||
146550005|NCT01543503|528522308|FG000|Overall Study|Participant did not attend a visit|1|||
146550006|NCT01543503|528522309|FG001|Overall Study|Participant did not attend a visit|0|||
146550007|NCT01543503|528522308|FG000|Overall Study|Moved to other rheumatologic site|0|||
146550008|NCT01543503|528522309|FG001|Overall Study|Moved to other rheumatologic site|1|||
146550009|NCT01543503|528522308|FG000|Overall Study|Participant consented to another study|0|||
146550010|NCT01543503|528522309|FG001|Overall Study|Participant consented to another study|2|||
146550011|NCT01543503|528522308|FG000|Overall Study|Participant went to United States|1|||
146550012|NCT01543503|528522309|FG001|Overall Study|Participant went to United States|0|||
146550013|NCT01543503|528522308|FG000|Overall Study|Screen failure|1|||
146550014|NCT01543503|528522309|FG001|Overall Study|Screen failure|0|||
146550015|NCT02460380|528522310|FG000|Overall Study|Withdrawal by Subject|10|||
146550016|NCT02460380|528522311|FG001|Overall Study|Withdrawal by Subject|5|||
146550017|NCT00395512|528522312|FG000|Overall Study|Adverse Event|3|||
146550018|NCT00395512|528522313|FG001|Overall Study|Adverse Event|8|||
146550019|NCT00395512|528522314|FG002|Overall Study|Adverse Event|6|||
146550020|NCT00395512|528522315|FG003|Overall Study|Adverse Event|6|||
146550021|NCT00395512|528522312|FG000|Overall Study|Protocol Violation|2|||
146550022|NCT00395512|528522313|FG001|Overall Study|Protocol Violation|3|||
146550023|NCT00395512|528522314|FG002|Overall Study|Protocol Violation|6|||
146550024|NCT00395512|528522315|FG003|Overall Study|Protocol Violation|7|||
146550025|NCT00395512|528522312|FG000|Overall Study|Lost to Follow-up|2|||
146550026|NCT00395512|528522313|FG001|Overall Study|Lost to Follow-up|6|||
146550027|NCT00395512|528522314|FG002|Overall Study|Lost to Follow-up|5|||
146550028|NCT00395512|528522315|FG003|Overall Study|Lost to Follow-up|5|||
146550029|NCT00395512|528522312|FG000|Overall Study|Withdrawal by Subject|6|||
146550030|NCT00395512|528522313|FG001|Overall Study|Withdrawal by Subject|5|||
146550031|NCT00395512|528522314|FG002|Overall Study|Withdrawal by Subject|5|||
146550032|NCT00395512|528522315|FG003|Overall Study|Withdrawal by Subject|12|||
146550033|NCT00395512|528522312|FG000|Overall Study|Physician Decision|6|||
146550034|NCT00395512|528522313|FG001|Overall Study|Physician Decision|4|||
146550035|NCT00395512|528522314|FG002|Overall Study|Physician Decision|2|||
146550036|NCT00395512|528522315|FG003|Overall Study|Physician Decision|2|||
146550037|NCT00395512|528522312|FG000|Overall Study|Other|1|||
146550038|NCT00395512|528522313|FG001|Overall Study|Other|1|||
146550039|NCT00395512|528522314|FG002|Overall Study|Other|0|||
146550040|NCT00395512|528522315|FG003|Overall Study|Other|0|||
146550041|NCT00395512|528522312|FG000|Overall Study|Hyperglycemic Rescue|18|||
146550042|NCT00395512|528522313|FG001|Overall Study|Hyperglycemic Rescue|10|||
146550043|NCT00395512|528522314|FG002|Overall Study|Hyperglycemic Rescue|4|||
146550044|NCT00395512|528522315|FG003|Overall Study|Hyperglycemic Rescue|6|||
146550045|NCT01478087|528522319|FG000|Overall Study|due to sponsor closing study|1|||
146550046|NCT04576949|528522324|FG000|Overall Study|Adverse Event|1|||
146550047|NCT04576949|528522325|FG001|Overall Study|Adverse Event|3|||
146550048|NCT04576949|528522326|FG002|Overall Study|Adverse Event|2|||
146550049|NCT04576949|528522324|FG000|Overall Study|Withdrawal by Subject|41|||
146550050|NCT04576949|528522325|FG001|Overall Study|Withdrawal by Subject|26|||
146550051|NCT04576949|528522326|FG002|Overall Study|Withdrawal by Subject|18|||
146550052|NCT04576949|528522324|FG000|Overall Study|Physician Decision|3|||
146550053|NCT04576949|528522325|FG001|Overall Study|Physician Decision|0|||
146550054|NCT04576949|528522326|FG002|Overall Study|Physician Decision|0|||
146550055|NCT04576949|528522324|FG000|Overall Study|Death|0|||
146550056|NCT04576949|528522325|FG001|Overall Study|Death|1|||
146550057|NCT04576949|528522326|FG002|Overall Study|Death|0|||
146550058|NCT04576949|528522324|FG000|Overall Study|Lost to Follow-up|29|||
146550059|NCT04576949|528522325|FG001|Overall Study|Lost to Follow-up|37|||
146550060|NCT04576949|528522326|FG002|Overall Study|Lost to Follow-up|24|||
146550061|NCT04576949|528522324|FG000|Overall Study|Other, Not Specified|2|||
146550062|NCT04576949|528522325|FG001|Overall Study|Other, Not Specified|3|||
146550063|NCT04576949|528522326|FG002|Overall Study|Other, Not Specified|1|||
146765190|NCT00906282|529307300|FG000|Preoperative Chemotherapy|Toxicity|1|||
146550064|NCT04576949|528522324|FG000|Overall Study|Other|1|||
146550065|NCT04576949|528522325|FG001|Overall Study|Other|0|||
146550066|NCT04576949|528522326|FG002|Overall Study|Other|0|||
146550067|NCT00052715|528522327|FG000|Overall Study|wrong histology|1|||
146550068|NCT01936974|528522328|FG000|Overall Study|Physician Decision|2|||
146550069|NCT01936974|528522329|FG001|Overall Study|Physician Decision|5|||
146550070|NCT04584554|528522330|FG000|Overall Study|Withdrawal by Subject|2|||
146550071|NCT04584554|528522331|FG001|Overall Study|Withdrawal by Subject|2|||
146550072|NCT05507450|528522333|FG000|Overall Study|Death|0|||
146550073|NCT05507450|528522334|FG001|Overall Study|Death|0|||
146550074|NCT05507450|528522335|FG002|Overall Study|Death|1|||
146550075|NCT05507450|528522336|FG003|Overall Study|Death|0|||
146550076|NCT05507450|528522333|FG000|Overall Study|Lost to Follow-up|22|||
146550077|NCT05507450|528522334|FG001|Overall Study|Lost to Follow-up|20|||
146550078|NCT05507450|528522335|FG002|Overall Study|Lost to Follow-up|20|||
146550079|NCT05507450|528522336|FG003|Overall Study|Lost to Follow-up|7|||
146550080|NCT05507450|528522333|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146550081|NCT05507450|528522334|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
146550082|NCT05507450|528522335|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
146550083|NCT05507450|528522336|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146550084|NCT05507450|528522333|FG000|Overall Study|Withdrawal by Subject|4|||
146550085|NCT05507450|528522334|FG001|Overall Study|Withdrawal by Subject|11|||
146550086|NCT05507450|528522335|FG002|Overall Study|Withdrawal by Subject|7|||
146550087|NCT05507450|528522336|FG003|Overall Study|Withdrawal by Subject|3|||
146550088|NCT05507450|528522333|FG000|Overall Study|Participant left the country|0|||
146550089|NCT05507450|528522334|FG001|Overall Study|Participant left the country|0|||
146550090|NCT05507450|528522335|FG002|Overall Study|Participant left the country|1|||
146550091|NCT05507450|528522336|FG003|Overall Study|Participant left the country|0|||
146550092|NCT05436288|528522337|FG000|Overall Study|Lost to Follow-up|1|||
146550093|NCT05436288|528522337|FG000|Overall Study|Adverse Event|1|||
146550094|NCT03767894|528522341|FG000|Overall Study|Withdrawal by Subject|1|||
146550095|NCT01860404|528522346|FG000|Overall Study|Lost to Follow-up|3|||
146550096|NCT01860404|528522347|FG001|Overall Study|Lost to Follow-up|4|||
146550097|NCT01860404|528522348|FG002|Overall Study|Lost to Follow-up|1|||
146550098|NCT01860404|528522349|FG003|Overall Study|Lost to Follow-up|6|||
146550099|NCT01860404|528522350|FG004|Overall Study|Lost to Follow-up|4|||
146550100|NCT01860404|528522346|FG000|Overall Study|Withdrawal by Subject|0|||
146550101|NCT01860404|528522347|FG001|Overall Study|Withdrawal by Subject|0|||
146550102|NCT01860404|528522348|FG002|Overall Study|Withdrawal by Subject|4|||
146550103|NCT01860404|528522349|FG003|Overall Study|Withdrawal by Subject|0|||
146550104|NCT01860404|528522350|FG004|Overall Study|Withdrawal by Subject|0|||
146550105|NCT00356421|528522353|FG000|Overall Study|Lack of Efficacy|3|||
146550106|NCT00356421|528522354|FG001|Overall Study|Lack of Efficacy|0|||
146550107|NCT00356421|528522353|FG000|Overall Study|Withdrawal by Subject|9|||
146550108|NCT00356421|528522354|FG001|Overall Study|Withdrawal by Subject|2|||
146550109|NCT00356421|528522353|FG000|Overall Study|Related to study drug|15|||
146550110|NCT00356421|528522354|FG001|Overall Study|Related to study drug|12|||
146550111|NCT00356421|528522353|FG000|Overall Study|Not related to study drug|5|||
146550112|NCT00356421|528522354|FG001|Overall Study|Not related to study drug|3|||
146550113|NCT02187055|528522355|FG000|Overall Study|Lack of Efficacy|10|||
146550114|NCT02187055|528522356|FG001|Overall Study|Lack of Efficacy|3|||
146550115|NCT02187055|528522357|FG002|Overall Study|Lack of Efficacy|7|||
146550116|NCT02187055|528522355|FG000|Overall Study|Lost to Follow-up|2|||
146550117|NCT02187055|528522356|FG001|Overall Study|Lost to Follow-up|7|||
146550118|NCT02187055|528522357|FG002|Overall Study|Lost to Follow-up|3|||
146550119|NCT02187055|528522355|FG000|Overall Study|No longer meets eligibility criteria|0|||
146550120|NCT02187055|528522356|FG001|Overall Study|No longer meets eligibility criteria|2|||
146550121|NCT02187055|528522357|FG002|Overall Study|No longer meets eligibility criteria|0|||
146550122|NCT02187055|528522355|FG000|Overall Study|No longer willing to participate|6|||
146550123|NCT02187055|528522356|FG001|Overall Study|No longer willing to participate|8|||
146550124|NCT02187055|528522357|FG002|Overall Study|No longer willing to participate|10|||
146550125|NCT02187055|528522355|FG000|Overall Study|Other|5|||
146550126|NCT02187055|528522356|FG001|Overall Study|Other|6|||
146550127|NCT02187055|528522357|FG002|Overall Study|Other|3|||
146550128|NCT02187055|528522355|FG000|Overall Study|Protocol Violation|9|||
146550129|NCT02187055|528522356|FG001|Overall Study|Protocol Violation|9|||
146550130|NCT02187055|528522357|FG002|Overall Study|Protocol Violation|4|||
146550131|NCT02187055|528522355|FG000|Overall Study|Pregnancy|3|||
146550132|NCT02187055|528522356|FG001|Overall Study|Pregnancy|1|||
146550133|NCT02187055|528522357|FG002|Overall Study|Pregnancy|0|||
146550134|NCT02187055|528522355|FG000|Overall Study|Withdrawal by Subject|11|||
146550135|NCT02187055|528522356|FG001|Overall Study|Withdrawal by Subject|11|||
146550136|NCT02187055|528522357|FG002|Overall Study|Withdrawal by Subject|11|||
146550137|NCT02187055|528522355|FG000|Overall Study|Adverse Event|21|||
146550138|NCT02187055|528522356|FG001|Overall Study|Adverse Event|26|||
146550139|NCT02187055|528522357|FG002|Overall Study|Adverse Event|36|||
146550140|NCT02187055|528522355|FG000|Overall Study|Death|2|||
146550141|NCT02187055|528522356|FG001|Overall Study|Death|0|||
146550142|NCT02187055|528522357|FG002|Overall Study|Death|0|||
146550143|NCT03462563|528522358|FG000|Overall Study|Death|1|||
146550144|NCT03462563|528522359|FG001|Overall Study|Death|1|||
146550145|NCT03462563|528522358|FG000|Overall Study|Termination of study|2|||
146550146|NCT03462563|528522359|FG001|Overall Study|Termination of study|1|||
146550147|NCT03462563|528522358|FG000|Overall Study|Adverse Event|1|||
146550148|NCT03462563|528522359|FG001|Overall Study|Adverse Event|3|||
146550149|NCT03462563|528522358|FG000|Overall Study|Unspecified reason|10|||
146631636|NCT04467905|528828488|FG002|Overall Study|Hemodynamic instability|1|||
146631637|NCT04467905|528828486|FG000|Overall Study|Site misinterpretation of protocol|0|||
146631638|NCT04467905|528828487|FG001|Overall Study|Site misinterpretation of protocol|0|||
146631639|NCT04467905|528828488|FG002|Overall Study|Site misinterpretation of protocol|1|||
146631640|NCT04145349|528829991|FG000|Overall Study|Withdrawal by Subject|3|||
146631641|NCT04145349|528829992|FG001|Overall Study|Withdrawal by Subject|0|||
146631642|NCT04145349|528829991|FG000|Overall Study|Lost to Follow-up|0|||
146631643|NCT04145349|528829992|FG001|Overall Study|Lost to Follow-up|1|||
146631644|NCT04145349|528829991|FG000|Overall Study|On study treatment (Ongoing)|0|||
146631645|NCT04145349|528829992|FG001|Overall Study|On study treatment (Ongoing)|1|||
146631646|NCT03312634|528829993|FG000|Overall Study|Adverse Event|11|||
146631647|NCT03312634|528829994|FG001|Overall Study|Adverse Event|0|||
146631648|NCT03312634|528829993|FG000|Overall Study|Sponsor request|2|||
146631649|NCT03312634|528829994|FG001|Overall Study|Sponsor request|0|||
146631650|NCT03312634|528829993|FG000|Overall Study|Withdrawal by Subject|31|||
146631651|NCT03312634|528829994|FG001|Overall Study|Withdrawal by Subject|9|||
146631652|NCT03312634|528829993|FG000|Overall Study|Enrolled in an interventional study|0|||
146631653|NCT03312634|528829994|FG001|Overall Study|Enrolled in an interventional study|52|||
146631654|NCT03312634|528829993|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
146631655|NCT03312634|528829994|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
146631656|NCT03312634|528829993|FG000|Overall Study|Death|0|||
146631657|NCT03312634|528829994|FG001|Overall Study|Death|1|||
146631658|NCT03312634|528829993|FG000|Overall Study|Non-compliance|0|||
146631659|NCT03312634|528829994|FG001|Overall Study|Non-compliance|2|||
146631660|NCT03312634|528829993|FG000|Overall Study|Lost to Follow-up|0|||
146631661|NCT03312634|528829994|FG001|Overall Study|Lost to Follow-up|1|||
146631662|NCT03312634|528829993|FG000|Overall Study|Enrolled into non-interventional study|0|||
146631663|NCT03312634|528829994|FG001|Overall Study|Enrolled into non-interventional study|5|||
146631664|NCT03312634|528829993|FG000|Overall Study|Worsening clinical condition|0|||
146631665|NCT03312634|528829994|FG001|Overall Study|Worsening clinical condition|1|||
146631666|NCT03312634|528829993|FG000|Overall Study|Participant did not want to travel|0|||
146631667|NCT03312634|528829994|FG001|Overall Study|Participant did not want to travel|1|||
146631668|NCT03312634|528829993|FG000|Overall Study|Physician Decision|1|||
146631669|NCT03312634|528829994|FG001|Overall Study|Physician Decision|0|||
146631670|NCT03312634|528829993|FG000|Overall Study|Other|13|||
146631671|NCT03312634|528829994|FG001|Overall Study|Other|0|||
146631672|NCT01148979|528830003|FG000|Overall Study|Lost to Follow-up|0|||
146631673|NCT01148979|528830004|FG001|Overall Study|Lost to Follow-up|1|||
146631674|NCT00777153|528830005|FG000|Overall Study|Lost to Follow-up|1|||
146631675|NCT00777153|528830006|FG001|Overall Study|Lost to Follow-up|1|||
146631676|NCT00777153|528830007|FG002|Overall Study|Lost to Follow-up|0|||
146631677|NCT00777153|528830005|FG000|Overall Study|Death|85|||
146631678|NCT00777153|528830006|FG001|Overall Study|Death|73|||
146631679|NCT00777153|528830007|FG002|Overall Study|Death|33|||
146631680|NCT00777153|528830005|FG000|Overall Study|Withdrawal by Subject|3|||
146631681|NCT00777153|528830006|FG001|Overall Study|Withdrawal by Subject|4|||
146631682|NCT00777153|528830007|FG002|Overall Study|Withdrawal by Subject|3|||
146631683|NCT00777153|528830005|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
146631684|NCT00777153|528830006|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
146631685|NCT00777153|528830007|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
146631686|NCT00554216|528830008|FG000|Overall Study|Lost to Follow-up|92|||
146631687|NCT00554216|528830009|FG001|Overall Study|Lost to Follow-up|31|||
146631688|NCT00554216|528830010|FG002|Overall Study|Lost to Follow-up|63|||
146631689|NCT00554216|528830008|FG000|Overall Study|Adverse Event|16|||
146631690|NCT00554216|528830009|FG001|Overall Study|Adverse Event|16|||
146631691|NCT00554216|528830010|FG002|Overall Study|Adverse Event|36|||
146631692|NCT00554216|528830008|FG000|Overall Study|Withdrawal by Subject|92|||
146631693|NCT00554216|528830009|FG001|Overall Study|Withdrawal by Subject|31|||
146631694|NCT00554216|528830010|FG002|Overall Study|Withdrawal by Subject|43|||
146631695|NCT00554216|528830008|FG000|Overall Study|Non compliance|10|||
146631696|NCT00554216|528830009|FG001|Overall Study|Non compliance|4|||
146631697|NCT00554216|528830010|FG002|Overall Study|Non compliance|5|||
146631698|NCT00554216|528830008|FG000|Overall Study|Pregnancy|2|||
146631699|NCT00554216|528830009|FG001|Overall Study|Pregnancy|1|||
146631700|NCT00554216|528830010|FG002|Overall Study|Pregnancy|14|||
146631701|NCT00554216|528830008|FG000|Overall Study|Restricted med|3|||
146631702|NCT00554216|528830009|FG001|Overall Study|Restricted med|1|||
146631703|NCT00554216|528830010|FG002|Overall Study|Restricted med|1|||
146631704|NCT00554216|528830008|FG000|Overall Study|Other|12|||
146631705|NCT00554216|528830009|FG001|Overall Study|Other|7|||
146631706|NCT00554216|528830010|FG002|Overall Study|Other|10|||
146631707|NCT00554216|528830008|FG000|Overall Study|Lack of Efficacy|15|||
146631708|NCT00554216|528830009|FG001|Overall Study|Lack of Efficacy|3|||
146631709|NCT00554216|528830010|FG002|Overall Study|Lack of Efficacy|0|||
146631710|NCT05462756|528830013|FG000|Treatment Period|Adverse Event|3|||
146886249|NCT00511355|529750202|FG001|Overall Study|Withdrawal of informed consent|1|||
146886250|NCT00511355|529750201|FG000|Overall Study|Other reason pre-treatment|0|||
146886251|NCT00511355|529750202|FG001|Overall Study|Other reason pre-treatment|1|||
146886252|NCT00454805|529750206|FG000|Overall Study|Withdrawal by Subject|9|||
146886253|NCT00454805|529750207|FG001|Overall Study|Withdrawal by Subject|2|||
146886254|NCT00454805|529750206|FG000|Overall Study|Death|0|||
146886255|NCT00454805|529750207|FG001|Overall Study|Death|2|||
146886256|NCT00454805|529750206|FG000|Overall Study|Disease progression|16|||
146886257|NCT00454805|529750207|FG001|Overall Study|Disease progression|19|||
146886258|NCT00454805|529750206|FG000|Overall Study|In order to begin radiotherapy|1|||
146886259|NCT00454805|529750207|FG001|Overall Study|In order to begin radiotherapy|0|||
146886260|NCT00217087|529750208|FG000|Overall Study|decided to have esophagectomy|1|||
146886261|NCT00217087|529750209|FG001|Overall Study|decided to have esophagectomy|2|||
146886262|NCT00217087|529750208|FG000|Overall Study|completed less than 12 months return|10|||
146886263|NCT00217087|529750209|FG001|Overall Study|completed less than 12 months return|18|||
146886264|NCT03208231|529750212|FG000|Overall Study|Death|1|||
146886265|NCT03208231|529750213|FG001|Overall Study|Death|2|||
146886266|NCT03208231|529750212|FG000|Overall Study|Moved and unable to get to clinic|1|||
146886267|NCT03208231|529750213|FG001|Overall Study|Moved and unable to get to clinic|0|||
146886268|NCT03208231|529750212|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
146886269|NCT03208231|529750213|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
146886270|NCT04947800|529750219|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
146886271|NCT04947800|529750220|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
146886272|NCT04947800|529750221|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
146886273|NCT03977467|529750222|FG000|Overall Study|Disease Progression|1|||
146886274|NCT03977467|529750223|FG001|Overall Study|Disease Progression|1|||
146886275|NCT03977467|529750224|FG002|Overall Study|Disease Progression|30|||
146886276|NCT03977467|529750225|FG003|Overall Study|Disease Progression|0|||
146886277|NCT03977467|529750222|FG000|Overall Study|Adverse Event|0|||
146886278|NCT03977467|529750223|FG001|Overall Study|Adverse Event|1|||
146886279|NCT03977467|529750224|FG002|Overall Study|Adverse Event|0|||
146886280|NCT03977467|529750225|FG003|Overall Study|Adverse Event|0|||
146886281|NCT03977467|529750222|FG000|Overall Study|Death|0|||
146886282|NCT03977467|529750223|FG001|Overall Study|Death|0|||
146886283|NCT03977467|529750224|FG002|Overall Study|Death|3|||
146886284|NCT03977467|529750225|FG003|Overall Study|Death|0|||
146886285|NCT03977467|529750222|FG000|Overall Study|Lack of Efficacy|0|||
146886286|NCT03977467|529750223|FG001|Overall Study|Lack of Efficacy|0|||
146886287|NCT03977467|529750224|FG002|Overall Study|Lack of Efficacy|1|||
146550150|NCT03462563|528522359|FG001|Overall Study|Unspecified reason|12|||
146550151|NCT03462563|528522358|FG000|Overall Study|Physician Decision|1|||
146550152|NCT03462563|528522359|FG001|Overall Study|Physician Decision|0|||
146550153|NCT05737745|528522360|FG000|Overall Study|Withdrawal by Subject|0|||
146550154|NCT05737745|528522361|FG001|Overall Study|Withdrawal by Subject|6|||
146550155|NCT05737745|528522362|FG002|Overall Study|Withdrawal by Subject|1|||
146550156|NCT02021318|528522363|FG000|Overall Study|Adverse Event|2|||
146550157|NCT02021318|528522364|FG001|Overall Study|Adverse Event|1|||
146550158|NCT02021318|528522363|FG000|Overall Study|Death|33|||
146550159|NCT02021318|528522364|FG001|Overall Study|Death|34|||
146550160|NCT02021318|528522363|FG000|Overall Study|Lost to Follow-up|3|||
146550161|NCT02021318|528522364|FG001|Overall Study|Lost to Follow-up|3|||
146550162|NCT02021318|528522363|FG000|Overall Study|Progressive Disease|0|||
146550163|NCT02021318|528522364|FG001|Overall Study|Progressive Disease|1|||
146550164|NCT02021318|528522363|FG000|Overall Study|Withdrawal by Subject|30|||
146550165|NCT02021318|528522364|FG001|Overall Study|Withdrawal by Subject|18|||
146550166|NCT02021318|528522363|FG000|Overall Study|Physician Decision|3|||
146886288|NCT03977467|529750225|FG003|Overall Study|Lack of Efficacy|0|||
146550167|NCT02021318|528522364|FG001|Overall Study|Physician Decision|3|||
146550168|NCT02021318|528522363|FG000|Overall Study|Miscellaneous|2|||
146550169|NCT02021318|528522364|FG001|Overall Study|Miscellaneous|3|||
146550170|NCT00689052|528522365|FG000|Overall Study|Adverse Event|4|||
146550171|NCT00689052|528522366|FG001|Overall Study|Adverse Event|6|||
146550172|NCT00689052|528522365|FG000|Overall Study|Protocol Violation|1|||
146550173|NCT00689052|528522366|FG001|Overall Study|Protocol Violation|0|||
146550174|NCT00689052|528522365|FG000|Overall Study|Lost to Follow-up|2|||
146886289|NCT03977467|529750222|FG000|Overall Study|Withdrawal by Subject|2|||
146886290|NCT03977467|529750223|FG001|Overall Study|Withdrawal by Subject|1|||
146886291|NCT03977467|529750224|FG002|Overall Study|Withdrawal by Subject|4|||
146886292|NCT03977467|529750225|FG003|Overall Study|Withdrawal by Subject|0|||
146886293|NCT03977467|529750222|FG000|Overall Study|Study Terminated|1|||
146886294|NCT03977467|529750223|FG001|Overall Study|Study Terminated|0|||
146886295|NCT03977467|529750224|FG002|Overall Study|Study Terminated|0|||
146886296|NCT03977467|529750225|FG003|Overall Study|Study Terminated|1|||
146886297|NCT01314716|529750230|FG000|Double-Blind Phase|Randomized but not treated|1|||
146886298|NCT01314716|529750231|FG001|Double-Blind Phase|Randomized but not treated|1|||
146886299|NCT01314716|529750230|FG000|Double-Blind Phase|Adverse Event|10|||
146886300|NCT01314716|529750231|FG001|Double-Blind Phase|Adverse Event|4|||
146886301|NCT01314716|529750230|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
146886302|NCT01314716|529750231|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
146886303|NCT01314716|529750230|FG000|Double-Blind Phase|Lost to Follow-up|0|||
146886304|NCT01314716|529750231|FG001|Double-Blind Phase|Lost to Follow-up|1|||
146886305|NCT01314716|529750230|FG000|Double-Blind Phase|Sponsor request|1|||
146886306|NCT01314716|529750231|FG001|Double-Blind Phase|Sponsor request|2|||
146886307|NCT01314716|529750230|FG000|Double-Blind Phase|Physician Decision|0|||
146886308|NCT01314716|529750231|FG001|Double-Blind Phase|Physician Decision|1|||
146886309|NCT01314716|529750230|FG000|Open-Label Phase|Adverse Event|4|||
146886310|NCT01314716|529750231|FG001|Open-Label Phase|Adverse Event|6|||
146886311|NCT01314716|529750230|FG000|Open-Label Phase|Withdrawal by Subject|1|||
146886312|NCT01314716|529750231|FG001|Open-Label Phase|Withdrawal by Subject|2|||
146886313|NCT01314716|529750230|FG000|Open-Label Phase|Physician Decision|5|||
146886314|NCT01314716|529750231|FG001|Open-Label Phase|Physician Decision|4|||
146886315|NCT00700271|529750232|FG000|Overall Study|Adverse Event|4|||
146886316|NCT00700271|529750233|FG001|Overall Study|Adverse Event|6|||
146886317|NCT00700271|529750232|FG000|Overall Study|Protocol Violation|1|||
146886318|NCT00700271|529750233|FG001|Overall Study|Protocol Violation|0|||
146886319|NCT00700271|529750232|FG000|Overall Study|Administrative Reasons|1|||
146886320|NCT00700271|529750233|FG001|Overall Study|Administrative Reasons|0|||
146886321|NCT00700271|529750232|FG000|Overall Study|Withdrawal by Subject|6|||
146886322|NCT00700271|529750233|FG001|Overall Study|Withdrawal by Subject|4|||
146886323|NCT00700271|529750232|FG000|Overall Study|Lost to Follow-up|2|||
146886324|NCT00700271|529750233|FG001|Overall Study|Lost to Follow-up|2|||
146886325|NCT04440592|529750234|FG000|Overall Study|Adverse Event|8|||
146886326|NCT04440592|529750235|FG001|Overall Study|Adverse Event|0|||
146886327|NCT04440592|529750234|FG000|Overall Study|Lost to Follow-up|1|||
146886328|NCT04440592|529750235|FG001|Overall Study|Lost to Follow-up|0|||
146886329|NCT04440592|529750234|FG000|Overall Study|Withdrawal by Subject|1|||
146886330|NCT04440592|529750235|FG001|Overall Study|Withdrawal by Subject|1|||
146886331|NCT04440592|529750234|FG000|Overall Study|Other therapy needed|0|||
146886332|NCT04440592|529750235|FG001|Overall Study|Other therapy needed|1|||
146886333|NCT02028455|529750238|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
146886334|NCT02028455|529750239|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
146886335|NCT02028455|529750240|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
146886336|NCT02028455|529750241|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
146631711|NCT05462756|528830014|FG001|Treatment Period|Adverse Event|0|||
146631712|NCT05462756|528830013|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
146631713|NCT05462756|528830014|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
146631714|NCT05462756|528830013|FG000|Treatment Period|Death|0|||
146631715|NCT05462756|528830014|FG001|Treatment Period|Death|1|||
146631716|NCT05462756|528830013|FG000|Treatment Period|Lost to Follow-up|2|||
146631717|NCT05462756|528830014|FG001|Treatment Period|Lost to Follow-up|1|||
146631718|NCT05462756|528830013|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
146631719|NCT05462756|528830014|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
146631720|NCT05462756|528830013|FG000|Treatment Period|Physician Decision|2|||
146631721|NCT05462756|528830014|FG001|Treatment Period|Physician Decision|0|||
146886337|NCT02028455|529750242|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
146886338|NCT02028455|529750243|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
146886339|NCT02028455|529750244|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
146886340|NCT02028455|529750245|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
146886341|NCT02028455|529750238|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
146886342|NCT02028455|529750239|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
146886343|NCT02028455|529750240|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
146886344|NCT02028455|529750241|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
146886345|NCT02028455|529750242|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
146886346|NCT02028455|529750243|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
146886347|NCT02028455|529750244|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
146631722|NCT05462756|528830013|FG000|Treatment Period|Protocol Violation|0|||
146631723|NCT05462756|528830014|FG001|Treatment Period|Protocol Violation|1|||
146631724|NCT05462756|528830013|FG000|Treatment Period|Withdrawal by Subject|5|||
146631725|NCT05462756|528830014|FG001|Treatment Period|Withdrawal by Subject|12|||
146765191|NCT02289560|529307303|FG000|Overall Study|Lost to Follow-up|6|||
146765192|NCT02289560|529307303|FG000|Overall Study|Alternative Treatment|4|||
146765193|NCT02289560|529307303|FG000|Overall Study|Inadequate Treatment|2|||
146886348|NCT02028455|529750245|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
146886349|NCT02028455|529750238|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
146765194|NCT02289560|529307303|FG000|Overall Study|Withdrawal by Subject|23|||
146765195|NCT02540213|529307304|FG000|Overall Study|Death/adverse event|18|||
146765196|NCT02540213|529307304|FG000|Overall Study|Administrative reasons|3|||
146765197|NCT02540213|529307304|FG000|Overall Study|Kidney transplant|3|||
146765198|NCT02540213|529307304|FG000|Overall Study|Lack of Efficacy|6|||
146765199|NCT02540213|529307304|FG000|Overall Study|Consent withdrawn|7|||
146765200|NCT02540213|529307304|FG000|Overall Study|Enrolled but not treated|2|||
146765201|NCT00038103|529307307|FG000|Overall Study|Adverse Event|5|||
146765202|NCT00038103|529307308|FG001|Overall Study|Adverse Event|6|||
146765203|NCT00038103|529307307|FG000|Overall Study|Lack of Efficacy|48|||
146765204|NCT00038103|529307308|FG001|Overall Study|Lack of Efficacy|41|||
146765205|NCT00038103|529307307|FG000|Overall Study|Withdrawal by Subject|0|||
146765206|NCT00038103|529307308|FG001|Overall Study|Withdrawal by Subject|3|||
146765207|NCT00038103|529307307|FG000|Overall Study|Lost to Follow-up|0|||
146765208|NCT00038103|529307308|FG001|Overall Study|Lost to Follow-up|3|||
146765209|NCT00038103|529307307|FG000|Overall Study|Protocol Violation|0|||
146765210|NCT00038103|529307308|FG001|Overall Study|Protocol Violation|2|||
146765211|NCT00038103|529307307|FG000|Overall Study|Sponsor Decision|0|||
146765212|NCT00038103|529307308|FG001|Overall Study|Sponsor Decision|1|||
146765213|NCT00038103|529307307|FG000|Overall Study|Randomized/never treated|2|||
146765214|NCT00038103|529307308|FG001|Overall Study|Randomized/never treated|0|||
146765215|NCT01981356|529307314|FG000|Overall Study|Lost to Follow-up|4|||
146765216|NCT01981356|529307315|FG001|Overall Study|Lost to Follow-up|1|||
146765217|NCT01981356|529307314|FG000|Overall Study|Withdrawal by Subject|1|||
146765218|NCT01981356|529307315|FG001|Overall Study|Withdrawal by Subject|1|||
146765219|NCT01981356|529307314|FG000|Overall Study|Protocol Violation|2|||
146765220|NCT01981356|529307315|FG001|Overall Study|Protocol Violation|0|||
146765221|NCT01751724|529307319|FG000|Overall Study|extubated bef.start assigned treatment|1|||
146765222|NCT01751724|529307320|FG001|Overall Study|extubated bef.start assigned treatment|0|||
146550175|NCT00689052|528522366|FG001|Overall Study|Lost to Follow-up|0|||
146550176|NCT00689052|528522365|FG000|Overall Study|Withdrawal by Subject|2|||
146550177|NCT00689052|528522366|FG001|Overall Study|Withdrawal by Subject|0|||
146550178|NCT00689052|528522365|FG000|Overall Study|Early termination of the trial|22|||
146550179|NCT00689052|528522366|FG001|Overall Study|Early termination of the trial|24|||
146550180|NCT00421993|528522369|FG000|Overall Study|Withdrawal by Subject|22|||
146550181|NCT00421993|528522370|FG001|Overall Study|Withdrawal by Subject|23|||
146550182|NCT00421993|528522371|FG002|Overall Study|Withdrawal by Subject|23|||
146550183|NCT00421993|528522372|FG003|Overall Study|Withdrawal by Subject|24|||
146550184|NCT00421993|528522369|FG000|Overall Study|Lost to Follow-up|18|||
146550185|NCT00421993|528522370|FG001|Overall Study|Lost to Follow-up|19|||
146550186|NCT00421993|528522371|FG002|Overall Study|Lost to Follow-up|22|||
146550187|NCT00421993|528522372|FG003|Overall Study|Lost to Follow-up|20|||
146550188|NCT00421993|528522369|FG000|Overall Study|Adverse Event|11|||
146550189|NCT00421993|528522370|FG001|Overall Study|Adverse Event|1|||
146550190|NCT00421993|528522371|FG002|Overall Study|Adverse Event|6|||
146550191|NCT00421993|528522372|FG003|Overall Study|Adverse Event|4|||
146631726|NCT05462756|528830013|FG000|Follow-Up Period|Adverse Event|1|||
146631727|NCT05462756|528830014|FG001|Follow-Up Period|Adverse Event|0|||
146631728|NCT05462756|528830013|FG000|Follow-Up Period|Death|1|||
146631729|NCT05462756|528830014|FG001|Follow-Up Period|Death|0|||
146631730|NCT05462756|528830013|FG000|Follow-Up Period|Lost to Follow-up|3|||
146631731|NCT05462756|528830014|FG001|Follow-Up Period|Lost to Follow-up|1|||
146631732|NCT05462756|528830013|FG000|Follow-Up Period|Withdrawal by Subject|0|||
146631733|NCT05462756|528830014|FG001|Follow-Up Period|Withdrawal by Subject|4|||
146631734|NCT02079246|528830015|FG000|OLEX|Withdrawal before treatment|1|||
146631735|NCT02079246|528830016|FG001|OLEX|Withdrawal before treatment|0|||
146631736|NCT02079246|528830015|FG000|OLEX|Death|11|||
146631737|NCT02079246|528830016|FG001|OLEX|Death|0|||
146631738|NCT02079246|528830015|FG000|OLEX|Adverse Event|66|||
146631739|NCT02079246|528830016|FG001|OLEX|Adverse Event|0|||
146631740|NCT02079246|528830015|FG000|OLEX|Withdrawal by Subject|60|||
146631741|NCT02079246|528830016|FG001|OLEX|Withdrawal by Subject|0|||
146631742|NCT02079246|528830015|FG000|OLEX|Lost to Follow-up|6|||
146765223|NCT01751724|529307319|FG000|Overall Study|withdrawn by parent|0|||
146765224|NCT01751724|529307320|FG001|Overall Study|withdrawn by parent|2|||
146765225|NCT02465359|529307325|FG000|Overall Study|Lack of Efficacy|1|||
146765226|NCT02465359|529307325|FG000|Overall Study|Withdrawal by Subject|1|||
146765227|NCT02465359|529307325|FG000|Overall Study|Adverse Event|1|||
146765228|NCT01278862|529307326|FG000|Overall Study|Lost to Follow-up|1|||
146765229|NCT01278862|529307327|FG001|Overall Study|Lost to Follow-up|1|||
146765230|NCT02952261|529307328|FG000|Overall Study|Withdrawal by Subject|4|||
146765231|NCT02952261|529307329|FG001|Overall Study|Withdrawal by Subject|5|||
146631743|NCT02079246|528830016|FG001|OLEX|Lost to Follow-up|0|||
146631744|NCT02079246|528830015|FG000|OLEX|Protocol Violation|6|||
146631745|NCT02079246|528830016|FG001|OLEX|Protocol Violation|0|||
146631746|NCT02079246|528830015|FG000|OLEX|Lack of Efficacy|3|||
146631747|NCT02079246|528830016|FG001|OLEX|Lack of Efficacy|0|||
146631748|NCT02079246|528830015|FG000|OLEX|Results of the lead-in studies|58|||
146765232|NCT02952261|529307328|FG000|Overall Study|Protocol Violation|1|||
146631749|NCT02079246|528830016|FG001|OLEX|Results of the lead-in studies|0|||
146966492|NCT05012943|530038816|FG000|Overall Study|Other than Specified|2|||
146550192|NCT00421993|528522369|FG000|Overall Study|Protocol Violation|2|||
146550193|NCT00421993|528522370|FG001|Overall Study|Protocol Violation|2|||
146550194|NCT00421993|528522371|FG002|Overall Study|Protocol Violation|0|||
146550195|NCT00421993|528522372|FG003|Overall Study|Protocol Violation|1|||
146550196|NCT00421993|528522369|FG000|Overall Study|Lack of Efficacy|0|||
146550197|NCT00421993|528522370|FG001|Overall Study|Lack of Efficacy|3|||
146550198|NCT00421993|528522371|FG002|Overall Study|Lack of Efficacy|0|||
146550199|NCT00421993|528522372|FG003|Overall Study|Lack of Efficacy|5|||
146550200|NCT00421993|528522369|FG000|Overall Study|Pregnancy|0|||
146550201|NCT00421993|528522370|FG001|Overall Study|Pregnancy|1|||
146550202|NCT00421993|528522371|FG002|Overall Study|Pregnancy|1|||
146550203|NCT00421993|528522372|FG003|Overall Study|Pregnancy|2|||
146550204|NCT00421993|528522369|FG000|Overall Study|Subject transportation issues|0|||
146550205|NCT00421993|528522370|FG001|Overall Study|Subject transportation issues|0|||
146550206|NCT00421993|528522371|FG002|Overall Study|Subject transportation issues|0|||
146550207|NCT00421993|528522372|FG003|Overall Study|Subject transportation issues|1|||
146550208|NCT02547935|528522373|FG000|Overall Study|Other|0|||
146550209|NCT02547935|528522374|FG001|Overall Study|Other|1|||
146550210|NCT02547935|528522375|FG002|Overall Study|Other|0|||
146550211|NCT02547935|528522373|FG000|Overall Study|Withdrawal by Subject|2|||
146550212|NCT02547935|528522374|FG001|Overall Study|Withdrawal by Subject|3|||
146550213|NCT02547935|528522375|FG002|Overall Study|Withdrawal by Subject|4|||
146550214|NCT02547935|528522373|FG000|Overall Study|Screen Failure|2|||
146550215|NCT02547935|528522374|FG001|Overall Study|Screen Failure|0|||
146550216|NCT02547935|528522375|FG002|Overall Study|Screen Failure|0|||
146550217|NCT02547935|528522373|FG000|Overall Study|Physician Decision|0|||
146550218|NCT02547935|528522374|FG001|Overall Study|Physician Decision|1|||
146550219|NCT02547935|528522375|FG002|Overall Study|Physician Decision|0|||
146550220|NCT02547935|528522373|FG000|Overall Study|Lost to Follow-up|0|||
146550221|NCT02547935|528522374|FG001|Overall Study|Lost to Follow-up|2|||
146550222|NCT02547935|528522375|FG002|Overall Study|Lost to Follow-up|1|||
146966493|NCT05012943|530038817|FG001|Overall Study|Other than Specified|1|||
146550223|NCT02547935|528522373|FG000|Overall Study|Death|1|||
146550224|NCT02547935|528522374|FG001|Overall Study|Death|1|||
146550225|NCT02547935|528522375|FG002|Overall Study|Death|0|||
146550226|NCT00003474|528522379|FG000|Overall Study|Not Evaluable|14|||
146550227|NCT02015104|528522380|FG000|Overall Study|Withdrew consent after first dose drug|1|||
146550228|NCT02015104|528522381|FG001|Overall Study|Withdrew consent after first dose drug|0|||
146966494|NCT05012943|530038818|FG002|Overall Study|Other than Specified|0|||
146550229|NCT02015104|528522380|FG000|Overall Study|Withdrew consent prior to treatment|0|||
146550230|NCT02015104|528522381|FG001|Overall Study|Withdrew consent prior to treatment|1|||
146550231|NCT03334175|528522382|FG000|Overall Study|Lost to Follow-up|0|||
146550232|NCT03334175|528522383|FG001|Overall Study|Lost to Follow-up|1|||
146550233|NCT02018887|528524181|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
146550234|NCT02018887|528524182|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
146550235|NCT02018887|528524183|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
146550236|NCT02018887|528524184|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
146550237|NCT02018887|528524185|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
146550238|NCT02018887|528524186|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
146550239|NCT02018887|528524187|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
146550240|NCT02018887|528524188|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
146550241|NCT02018887|528524189|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
146550242|NCT02018887|528524190|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
146550243|NCT02018887|528524191|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
146550244|NCT02018887|528524181|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
146550245|NCT02018887|528524182|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
146550246|NCT02018887|528524183|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
146550247|NCT02018887|528524184|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
146550248|NCT02018887|528524185|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
146550249|NCT02018887|528524186|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
146550250|NCT02018887|528524187|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
146550251|NCT02018887|528524188|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
146550252|NCT02018887|528524189|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
146550253|NCT02018887|528524190|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
146550254|NCT02018887|528524191|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
146550255|NCT02018887|528524181|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
146550256|NCT02018887|528524182|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
146550257|NCT02018887|528524183|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
146550258|NCT02018887|528524184|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
146631750|NCT02079246|528830015|FG000|OLEX|Other: Disallowed medication|8|||
146550259|NCT02018887|528524185|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
146550260|NCT02018887|528524186|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
146550261|NCT02018887|528524187|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
146550262|NCT02018887|528524188|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
146550263|NCT02018887|528524189|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
146550264|NCT02018887|528524190|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
146550265|NCT02018887|528524191|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
146550266|NCT02018887|528524181|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
146550267|NCT02018887|528524182|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
146886350|NCT02028455|529750239|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
146886351|NCT02028455|529750240|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
146886352|NCT02028455|529750241|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
146886353|NCT02028455|529750242|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
146886354|NCT02028455|529750243|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
146550268|NCT02018887|528524183|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
146550269|NCT02018887|528524184|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
146550270|NCT02018887|528524185|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
146550271|NCT02018887|528524186|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
146550272|NCT02018887|528524187|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
146550273|NCT02018887|528524188|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
146550274|NCT02018887|528524189|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
146550275|NCT02018887|528524190|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
146550276|NCT02018887|528524191|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
146550277|NCT01058005|528524192|FG000|Overall Study|Adverse Event|0|||
146550278|NCT01058005|528524193|FG001|Overall Study|Adverse Event|2|||
146550279|NCT01058005|528524194|FG002|Overall Study|Adverse Event|1|||
146550280|NCT01058005|528524192|FG000|Overall Study|Physician Decision|2|||
146550281|NCT01058005|528524193|FG001|Overall Study|Physician Decision|2|||
146886355|NCT02028455|529750244|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
146886356|NCT02028455|529750245|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
146886357|NCT02028455|529750238|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
146550282|NCT01058005|528524194|FG002|Overall Study|Physician Decision|0|||
146550283|NCT01058005|528524192|FG000|Overall Study|Withdrawal by Subject|4|||
146550284|NCT01058005|528524193|FG001|Overall Study|Withdrawal by Subject|5|||
146550285|NCT01058005|528524194|FG002|Overall Study|Withdrawal by Subject|11|||
146550286|NCT01058005|528524192|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
146550287|NCT01058005|528524193|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
146886358|NCT02028455|529750239|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
146550288|NCT01058005|528524194|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
146550289|NCT01058005|528524192|FG000|Overall Study|Reason Missing|5|||
146550290|NCT01058005|528524193|FG001|Overall Study|Reason Missing|3|||
146550291|NCT01058005|528524194|FG002|Overall Study|Reason Missing|1|||
146550292|NCT01145222|528524195|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
146550293|NCT01145222|528524196|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
146550294|NCT01145222|528524197|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
146550295|NCT01145222|528524198|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
146550296|NCT01145222|528524195|FG000|Overall Study|Poor bowel preparation|0|||
146550297|NCT01145222|528524196|FG001|Overall Study|Poor bowel preparation|0|||
146550298|NCT01145222|528524197|FG002|Overall Study|Poor bowel preparation|0|||
146550299|NCT01145222|528524198|FG003|Overall Study|Poor bowel preparation|1|||
146631751|NCT02079246|528830016|FG001|OLEX|Other: Disallowed medication|0|||
146886359|NCT02028455|529750240|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
146886360|NCT02028455|529750241|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
146886361|NCT02028455|529750242|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
146886362|NCT02028455|529750243|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
146886363|NCT02028455|529750244|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
146886364|NCT02028455|529750245|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
146886365|NCT03087955|529751685|FG000|Overall Study|Death|4|||
146886366|NCT03087955|529751686|FG001|Overall Study|Death|0|||
146886367|NCT03087955|529751685|FG000|Overall Study|Lack of Efficacy|2|||
146886368|NCT03087955|529751686|FG001|Overall Study|Lack of Efficacy|0|||
146886369|NCT03087955|529751685|FG000|Overall Study|Lost to Follow-up|1|||
146886370|NCT03087955|529751686|FG001|Overall Study|Lost to Follow-up|0|||
146886371|NCT02392429|529751687|FG000|Screening|Screen failure|15|||
146886372|NCT02392429|529751687|FG000|Enrolled Participants|Ineligible due to disease|3|||
146886373|NCT02392429|529751687|FG000|Enrolled Participants|Withdrawal by Subject|4|||
146886374|NCT02392429|529751687|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
146886375|NCT02392429|529751687|FG000|Evaluable|Death|5|||
146886376|NCT02392429|529751687|FG000|Evaluable|Withdrawal by Subject|1|||
146550300|NCT01698008|528524199|FG000|Overall Study|Withdrawal by Subject|1|||
146550301|NCT01698008|528524200|FG001|Overall Study|Withdrawal by Subject|2|||
146550302|NCT00122187|528524208|FG000|Overall Study|Withdrew because of resource limitations|2|||
146550303|NCT00122187|528524209|FG001|Overall Study|Withdrew because of resource limitations|2|||
146886377|NCT02392429|529751687|FG000|Evaluable|Adverse Event|1|||
146886378|NCT02392429|529751687|FG000|Evaluable|remission bone marrow biopsy|3|||
146886379|NCT02968810|529751691|FG000|Overall Study|Lost to Follow-up|1|||
146886380|NCT02968810|529751692|FG001|Overall Study|Lost to Follow-up|0|||
146886381|NCT02968810|529751691|FG000|Overall Study|Physician Decision|1|||
146886382|NCT02968810|529751692|FG001|Overall Study|Physician Decision|0|||
146886383|NCT02968810|529751691|FG000|Overall Study|Withdrawal by Subject|1|||
146886384|NCT02968810|529751692|FG001|Overall Study|Withdrawal by Subject|3|||
146550304|NCT00799864|528524213|FG000|Overall Study|Participant reached a virologic endpoint|9|||
146550305|NCT00799864|528524214|FG001|Overall Study|Participant reached a virologic endpoint|2|||
146550306|NCT00799864|528524215|FG002|Overall Study|Participant reached a virologic endpoint|2|||
146550307|NCT00799864|528524216|FG003|Overall Study|Participant reached a virologic endpoint|0|||
146550308|NCT00799864|528524217|FG004|Overall Study|Participant reached a virologic endpoint|0|||
146550309|NCT00799864|528524213|FG000|Overall Study|Other|2|||
146550310|NCT00799864|528524214|FG001|Overall Study|Other|1|||
146550311|NCT00799864|528524215|FG002|Overall Study|Other|0|||
146550312|NCT00799864|528524216|FG003|Overall Study|Other|0|||
146550313|NCT00799864|528524217|FG004|Overall Study|Other|0|||
146550314|NCT04263532|528524218|FG000|Overall Study|Withdrawal by Subject|2|||
146550315|NCT04263532|528524219|FG001|Overall Study|Withdrawal by Subject|0|||
146550316|NCT01210443|528524228|FG000|Overall Study|Study terminated by sponsor|2|||
146550317|NCT02807181|528524231|FG000|Overall Study|Death|28|||
146550318|NCT02807181|528524232|FG001|Overall Study|Death|24|||
146550319|NCT02807181|528524231|FG000|Overall Study|Withdrawal by Subject|1|||
146550320|NCT02807181|528524232|FG001|Overall Study|Withdrawal by Subject|1|||
146550321|NCT02807181|528524231|FG000|Overall Study|Lost to Follow-up|0|||
146550322|NCT02807181|528524232|FG001|Overall Study|Lost to Follow-up|2|||
146550323|NCT02807181|528524231|FG000|Overall Study|Subject decision|1|||
146550324|NCT02807181|528524232|FG001|Overall Study|Subject decision|0|||
146550325|NCT02807181|528524231|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
146550326|NCT02807181|528524232|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
146550327|NCT02807181|528524231|FG000|Overall Study|In Study|3|||
146550328|NCT02807181|528524232|FG001|Overall Study|In Study|3|||
146550329|NCT02807181|528524231|FG000|Overall Study|Post Progression|3|||
146886385|NCT02968810|529751691|FG000|Overall Study|Disease Progression|0|||
146886386|NCT02968810|529751692|FG001|Overall Study|Disease Progression|1|||
146886387|NCT04183335|529751693|FG000|Overall Study|Adverse Event|1|||
146886388|NCT04183335|529751694|FG001|Overall Study|Adverse Event|0|||
146886389|NCT04183335|529751693|FG000|Overall Study|Withdrawal by Subject|12|||
146886390|NCT04183335|529751694|FG001|Overall Study|Withdrawal by Subject|3|||
146886391|NCT00130832|529751695|FG000|Overall Study|Adverse Event|1|||
146886392|NCT00130832|529751696|FG001|Overall Study|Adverse Event|1|||
146886393|NCT00130832|529751695|FG000|Overall Study|Lost to Follow-up|1|||
146886394|NCT00130832|529751696|FG001|Overall Study|Lost to Follow-up|2|||
146886395|NCT00130832|529751695|FG000|Overall Study|Protocol Violation|6|||
146886396|NCT00130832|529751696|FG001|Overall Study|Protocol Violation|8|||
146886397|NCT00130832|529751695|FG000|Overall Study|Withdrawal by Subject|6|||
146886398|NCT00130832|529751696|FG001|Overall Study|Withdrawal by Subject|1|||
146550330|NCT02807181|528524232|FG001|Overall Study|Post Progression|2|||
146550331|NCT00063999|528524233|FG000|Overall Study|Withdrawal by Subject|1|||
146550332|NCT00063999|528524234|FG001|Overall Study|Withdrawal by Subject|0|||
146550333|NCT00063999|528524233|FG000|Overall Study|Ineligible|44|||
146550334|NCT00063999|528524234|FG001|Overall Study|Ineligible|24|||
146550335|NCT01078545|528524235|FG000|Overall Study|Lost to Follow-up|13|||
146550336|NCT01078545|528524235|FG000|Overall Study|Physician Decision|6|||
146550337|NCT01078545|528524235|FG000|Overall Study|Withdrawal by Subject|3|||
146550338|NCT01078545|528524235|FG000|Overall Study|Death|3|||
146550339|NCT01078545|528524235|FG000|Overall Study|Participant moved to another physician|1|||
146550340|NCT02497755|528524236|FG000|Overall Study|Protocol Violation|1|||
146550341|NCT02497755|528524237|FG001|Overall Study|Protocol Violation|0|||
146550342|NCT01774370|528524238|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
146550343|NCT01774370|528524238|FG000|Overall Study|Administered prior to the contract date|4|||
146550344|NCT01774370|528524238|FG000|Overall Study|Subjects of contraindications|34|||
146550345|NCT01774370|528524238|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
146550346|NCT01774370|528524238|FG000|Overall Study|Follow-up failure|34|||
146550347|NCT00514917|528524239|FG000|Overall Study|Death|4|||
146550348|NCT00514917|528524240|FG001|Overall Study|Death|10|||
146550349|NCT00514917|528524239|FG000|Overall Study|Protocol Violation|1|||
146550350|NCT00514917|528524240|FG001|Overall Study|Protocol Violation|0|||
146550351|NCT00514917|528524239|FG000|Overall Study|Lost to Follow-up|4|||
146550352|NCT00514917|528524240|FG001|Overall Study|Lost to Follow-up|3|||
146550353|NCT00514917|528524239|FG000|Overall Study|Withdrawal by Subject|18|||
146550354|NCT00514917|528524240|FG001|Overall Study|Withdrawal by Subject|16|||
146550355|NCT00514917|528524239|FG000|Overall Study|Discontinued due to study closure|88|||
146550356|NCT00514917|528524240|FG001|Overall Study|Discontinued due to study closure|81|||
146550357|NCT00514917|528524239|FG000|Overall Study|Undefined|11|||
146550358|NCT00514917|528524240|FG001|Overall Study|Undefined|5|||
146550359|NCT02280499|528524243|FG000|Overall Study|Death|14|||
146550360|NCT02280499|528524243|FG000|Overall Study|Lost to Follow-up|42|||
146550361|NCT02280499|528524243|FG000|Overall Study|Adverse Event|5|||
146550362|NCT01436500|528524245|FG000|Overall Study|Death|1|||
146550363|NCT01436500|528524246|FG001|Overall Study|Death|0|||
146550364|NCT01436500|528524247|FG002|Overall Study|Death|0|||
146550365|NCT01436500|528524248|FG003|Overall Study|Death|0|||
146550366|NCT01436500|528524249|FG004|Overall Study|Death|0|||
146550367|NCT01436500|528524245|FG000|Overall Study|Adverse Event|0|||
146550368|NCT01436500|528524246|FG001|Overall Study|Adverse Event|2|||
146550369|NCT01436500|528524247|FG002|Overall Study|Adverse Event|2|||
146550370|NCT01436500|528524248|FG003|Overall Study|Adverse Event|0|||
146550371|NCT01436500|528524249|FG004|Overall Study|Adverse Event|1|||
146550372|NCT01436500|528524245|FG000|Overall Study|Withdrawal by Subject|0|||
146550373|NCT01436500|528524246|FG001|Overall Study|Withdrawal by Subject|0|||
146550374|NCT01436500|528524247|FG002|Overall Study|Withdrawal by Subject|2|||
146550375|NCT01436500|528524248|FG003|Overall Study|Withdrawal by Subject|0|||
146550376|NCT01436500|528524249|FG004|Overall Study|Withdrawal by Subject|2|||
146550377|NCT01436500|528524245|FG000|Overall Study|Physician Decision|0|||
146550378|NCT01436500|528524246|FG001|Overall Study|Physician Decision|0|||
146550379|NCT01436500|528524247|FG002|Overall Study|Physician Decision|1|||
146550380|NCT01436500|528524248|FG003|Overall Study|Physician Decision|0|||
146550381|NCT01436500|528524249|FG004|Overall Study|Physician Decision|0|||
146550382|NCT01436500|528524245|FG000|Overall Study|liver transplant|1|||
146550383|NCT01436500|528524246|FG001|Overall Study|liver transplant|0|||
146550384|NCT01436500|528524247|FG002|Overall Study|liver transplant|0|||
146550385|NCT01436500|528524248|FG003|Overall Study|liver transplant|0|||
146550386|NCT01436500|528524249|FG004|Overall Study|liver transplant|0|||
146550387|NCT01436500|528524245|FG000|Overall Study|initiation of dialysis|0|||
146550388|NCT01436500|528524246|FG001|Overall Study|initiation of dialysis|0|||
146550389|NCT01436500|528524247|FG002|Overall Study|initiation of dialysis|0|||
146550390|NCT01436500|528524248|FG003|Overall Study|initiation of dialysis|0|||
146550391|NCT01436500|528524249|FG004|Overall Study|initiation of dialysis|1|||
146550392|NCT01436500|528524245|FG000|Overall Study|discontinued study drug|1|||
146886399|NCT00130832|529751695|FG000|Overall Study|Moved|2|||
146886400|NCT00130832|529751696|FG001|Overall Study|Moved|2|||
146886401|NCT00130832|529751695|FG000|Overall Study|Other|0|||
146886402|NCT00130832|529751696|FG001|Overall Study|Other|3|||
146886403|NCT03905863|529751697|FG000|Overall Study|Adverse Event|2|||
146886404|NCT03905863|529751698|FG001|Overall Study|Adverse Event|4|||
146886405|NCT03905863|529751697|FG000|Overall Study|Withdrawal by Subject|2|||
146886406|NCT03905863|529751698|FG001|Overall Study|Withdrawal by Subject|2|||
146886407|NCT03905863|529751697|FG000|Overall Study|Physician Decision|0|||
146886408|NCT03905863|529751698|FG001|Overall Study|Physician Decision|3|||
146886409|NCT03905863|529751697|FG000|Overall Study|Lost to Follow-up|1|||
146886410|NCT03905863|529751698|FG001|Overall Study|Lost to Follow-up|0|||
146886411|NCT03905863|529751697|FG000|Overall Study|Protocol Violation|0|||
146886412|NCT03905863|529751698|FG001|Overall Study|Protocol Violation|2|||
146886413|NCT03905863|529751697|FG000|Overall Study|Death|0|||
146886414|NCT03905863|529751698|FG001|Overall Study|Death|1|||
146886415|NCT00618748|529751699|FG000|Overall Study|Adverse Event|4|||
146886416|NCT00618748|529751700|FG001|Overall Study|Adverse Event|3|||
146886417|NCT00618748|529751701|FG002|Overall Study|Adverse Event|8|||
146886418|NCT00618748|529751699|FG000|Overall Study|Physician Decision|3|||
146886419|NCT00618748|529751700|FG001|Overall Study|Physician Decision|1|||
146886420|NCT00618748|529751701|FG002|Overall Study|Physician Decision|1|||
146886421|NCT00618748|529751699|FG000|Overall Study|Withdrawal by Subject|4|||
146886422|NCT00618748|529751700|FG001|Overall Study|Withdrawal by Subject|1|||
146886423|NCT00618748|529751701|FG002|Overall Study|Withdrawal by Subject|5|||
146886424|NCT04401267|529751702|FG000|Overall Study|Death|0|||
146886425|NCT04401267|529751703|FG001|Overall Study|Death|1|||
146886426|NCT04401267|529751702|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
146886427|NCT04401267|529751703|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
146886428|NCT04401267|529751702|FG000|Overall Study|Found to be Ineligible|1|||
146886429|NCT04401267|529751703|FG001|Overall Study|Found to be Ineligible|0|||
146886430|NCT02770326|529751708|FG000|Overall Study|Death|3|||
146886431|NCT02770326|529751708|FG000|Overall Study|Lost to Follow-up|1|||
146886432|NCT02421887|529751710|FG000|Overall Study|Lost to Follow-up|5|||
146886433|NCT02421887|529751711|FG001|Overall Study|Lost to Follow-up|0|||
146886434|NCT02421887|529751710|FG000|Overall Study|Withdrawal by Subject|8|||
146886435|NCT02421887|529751711|FG001|Overall Study|Withdrawal by Subject|5|||
146886436|NCT02421887|529751710|FG000|Overall Study|Physician Decision|2|||
146886437|NCT02421887|529751711|FG001|Overall Study|Physician Decision|4|||
146886438|NCT02421887|529751710|FG000|Overall Study|Adverse Event|2|||
146886439|NCT02421887|529751711|FG001|Overall Study|Adverse Event|0|||
146886440|NCT01882907|529751712|FG000|Overall Study|Adverse Event|3|||
146886441|NCT01882907|529751713|FG001|Overall Study|Adverse Event|1|||
146886442|NCT01882907|529751712|FG000|Overall Study|Lack of Efficacy|0|||
146886443|NCT01882907|529751713|FG001|Overall Study|Lack of Efficacy|3|||
146886444|NCT01882907|529751712|FG000|Overall Study|Lost to Follow-up|1|||
146886445|NCT01882907|529751713|FG001|Overall Study|Lost to Follow-up|4|||
146886446|NCT01882907|529751712|FG000|Overall Study|Protocol Violation|10|||
146886447|NCT01882907|529751713|FG001|Overall Study|Protocol Violation|14|||
146886448|NCT01882907|529751712|FG000|Overall Study|Withdrawal by Subject|0|||
146886449|NCT01882907|529751713|FG001|Overall Study|Withdrawal by Subject|6|||
146886450|NCT02450487|529751714|FG000|Overall Study|Lost to Follow-up|3|||
146886451|NCT04269395|529751715|FG000|Overall Study|Lost to Follow-up|1|||
146886452|NCT04269395|529751716|FG001|Overall Study|Lost to Follow-up|0|||
146886453|NCT04269395|529751715|FG000|Overall Study|Study terminated by Sponsor|13|||
146886454|NCT04269395|529751716|FG001|Overall Study|Study terminated by Sponsor|10|||
146886455|NCT01491178|529751717|FG000|Overall Study|Adverse Event|1016|||
146886456|NCT01491178|529751717|FG000|Overall Study|Improvement of NVAF|210|||
146886457|NCT01491178|529751717|FG000|Overall Study|To conduct invasive treatment|59|||
146886458|NCT01491178|529751717|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
146886459|NCT01491178|529751717|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
146886460|NCT01491178|529751717|FG000|Overall Study|To take a contraindication|20|||
146886461|NCT01491178|529751717|FG000|Overall Study|Other than specified above|657|||
146886462|NCT03132636|529751718|FG000|Overall Study|Adverse Event|1|||
146886463|NCT03132636|529751719|FG001|Overall Study|Adverse Event|2|||
146886464|NCT03132636|529751718|FG000|Overall Study|Death|4|||
146886465|NCT03132636|529751719|FG001|Overall Study|Death|7|||
146886466|NCT03132636|529751718|FG000|Overall Study|Lost to Follow-up|3|||
146886467|NCT03132636|529751719|FG001|Overall Study|Lost to Follow-up|2|||
146886468|NCT03132636|529751718|FG000|Overall Study|Non compliance with protocol by participant|1|||
146886469|NCT03132636|529751719|FG001|Overall Study|Non compliance with protocol by participant|1|||
146886470|NCT03132636|529751718|FG000|Overall Study|Subject decision|1|||
146886471|NCT03132636|529751719|FG001|Overall Study|Subject decision|9|||
146886472|NCT03132636|529751718|FG000|Overall Study|Sponsor decision|0|||
146886473|NCT03132636|529751719|FG001|Overall Study|Sponsor decision|1|||
146886474|NCT03132636|529751718|FG000|Overall Study|Physician Decision|1|||
146886475|NCT03132636|529751719|FG001|Overall Study|Physician Decision|0|||
146886476|NCT03132636|529751718|FG000|Overall Study|Progressive disease|33|||
146886477|NCT03132636|529751719|FG001|Overall Study|Progressive disease|36|||
146966495|NCT04228107|530038819|FG000|Overall Study|Protocol Violation|1|||
146886478|NCT03132636|529751718|FG000|Overall Study|Withdrawal of consent|2|||
146886479|NCT03132636|529751719|FG001|Overall Study|Withdrawal of consent|5|||
146886480|NCT03132636|529751718|FG000|Overall Study|Did not re-consent|1|||
146886481|NCT03132636|529751719|FG001|Overall Study|Did not re-consent|0|||
146886482|NCT03132636|529751718|FG000|Overall Study|Lost insurance coverage|1|||
146886483|NCT03132636|529751719|FG001|Overall Study|Lost insurance coverage|0|||
146886484|NCT03132636|529751718|FG000|Overall Study|Related to radiological outcomes|0|||
146886485|NCT03132636|529751719|FG001|Overall Study|Related to radiological outcomes|1|||
146886486|NCT03132636|529751718|FG000|Overall Study|Unable to come to site for continued visits|0|||
146886487|NCT03132636|529751719|FG001|Overall Study|Unable to come to site for continued visits|1|||
146886488|NCT01415752|529751720|FG000|Induction (Step 1)|Ineligible|4|||
146886489|NCT01415752|529751721|FG001|Induction (Step 1)|Ineligible|3|||
146886490|NCT01415752|529751722|FG002|Induction (Step 1)|Ineligible|4|||
146886491|NCT01415752|529751723|FG003|Induction (Step 1)|Ineligible|4|||
146886492|NCT01415752|529751720|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
146631752|NCT02079246|528830015|FG000|OLEX|Other: Insufficient compliance|2|||
146631753|NCT02079246|528830016|FG001|OLEX|Other: Insufficient compliance|0|||
146631754|NCT02079246|528830015|FG000|OLEX|Other: Caregiver unavailable|3|||
146631755|NCT02079246|528830016|FG001|OLEX|Other: Caregiver unavailable|0|||
146631756|NCT02079246|528830015|FG000|OLEX|Other: Coordinator decision|1|||
146631757|NCT02079246|528830016|FG001|OLEX|Other: Coordinator decision|0|||
146631758|NCT02079246|528830015|FG000|OLEX|Other: Worsening of condition|1|||
146631759|NCT02079246|528830016|FG001|OLEX|Other: Worsening of condition|0|||
146631760|NCT02079246|528830015|FG000|OLEX|Other: Moved to nursing home|1|||
146631761|NCT02079246|528830016|FG001|OLEX|Other: Moved to nursing home|0|||
146631762|NCT02079246|528830015|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
146631763|NCT02079246|528830016|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
146631764|NCT02079246|528830015|FG000|OLEX-MEM|Adverse Event|0|||
146631765|NCT02079246|528830016|FG001|OLEX-MEM|Adverse Event|6|||
146631766|NCT02079246|528830015|FG000|OLEX-MEM|Withdrawal by Subject|0|||
146631767|NCT02079246|528830016|FG001|OLEX-MEM|Withdrawal by Subject|7|||
146631768|NCT02079246|528830015|FG000|OLEX-MEM|Protocol Violation|0|||
146631769|NCT02079246|528830016|FG001|OLEX-MEM|Protocol Violation|2|||
146631770|NCT02079246|528830015|FG000|OLEX-MEM|Lost to Follow-up|0|||
146631771|NCT02079246|528830016|FG001|OLEX-MEM|Lost to Follow-up|1|||
146886493|NCT01415752|529751721|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
146886494|NCT01415752|529751722|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
146886495|NCT01415752|529751723|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
146886496|NCT01415752|529751720|FG000|Maintenance (Step 2)|Adverse Event|3|||
146886497|NCT01415752|529751721|FG001|Maintenance (Step 2)|Adverse Event|4|||
146886498|NCT01415752|529751722|FG002|Maintenance (Step 2)|Adverse Event|9|||
146886499|NCT01415752|529751723|FG003|Maintenance (Step 2)|Adverse Event|6|||
146886500|NCT01415752|529751720|FG000|Maintenance (Step 2)|Death|1|||
146886501|NCT01415752|529751721|FG001|Maintenance (Step 2)|Death|1|||
146886502|NCT01415752|529751722|FG002|Maintenance (Step 2)|Death|2|||
146886503|NCT01415752|529751723|FG003|Maintenance (Step 2)|Death|0|||
146886504|NCT01415752|529751720|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
146886505|NCT01415752|529751721|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
146886506|NCT01415752|529751722|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
146886507|NCT01415752|529751723|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
146886508|NCT01415752|529751720|FG000|Maintenance (Step 2)|Alternative therapy|0|||
146886509|NCT01415752|529751721|FG001|Maintenance (Step 2)|Alternative therapy|1|||
146886510|NCT01415752|529751722|FG002|Maintenance (Step 2)|Alternative therapy|0|||
146886511|NCT01415752|529751723|FG003|Maintenance (Step 2)|Alternative therapy|0|||
146886512|NCT01415752|529751720|FG000|Maintenance (Step 2)|Other reasons|3|||
146886513|NCT01415752|529751721|FG001|Maintenance (Step 2)|Other reasons|6|||
146886514|NCT01415752|529751722|FG002|Maintenance (Step 2)|Other reasons|4|||
146886515|NCT01415752|529751723|FG003|Maintenance (Step 2)|Other reasons|6|||
146886516|NCT01415752|529751720|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
146886517|NCT01415752|529751721|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
146886518|NCT01415752|529751722|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
146886519|NCT01415752|529751723|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
146886520|NCT01415752|529751720|FG000|Maintenance (Step 2)|ineligible|1|||
146886521|NCT01415752|529751721|FG001|Maintenance (Step 2)|ineligible|1|||
146886522|NCT01415752|529751722|FG002|Maintenance (Step 2)|ineligible|1|||
146886523|NCT01415752|529751723|FG003|Maintenance (Step 2)|ineligible|0|||
146886524|NCT01415752|529751720|FG000|Maintenance (Step 2)|Missing|4|||
146886525|NCT01415752|529751721|FG001|Maintenance (Step 2)|Missing|1|||
146886526|NCT01415752|529751722|FG002|Maintenance (Step 2)|Missing|4|||
146966496|NCT04228107|530038820|FG001|Overall Study|Protocol Violation|0|||
146966497|NCT04228107|530038819|FG000|Overall Study|Withdrawal by Subject|6|||
146631772|NCT02079246|528830015|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
146631773|NCT02079246|528830016|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
146631774|NCT04040933|528830021|FG000|Overall Study|Protocol Violation|1|||
146631775|NCT04040933|528830021|FG000|Overall Study|Withdrawal by Subject|2|||
146631776|NCT00775190|528830022|FG000|Overall Study|Lost to Follow-up|2|||
146631777|NCT00775190|528830023|FG001|Overall Study|Lost to Follow-up|3|||
146631778|NCT00775190|528830022|FG000|Overall Study|Withdrawal by Subject|1|||
146631779|NCT00775190|528830023|FG001|Overall Study|Withdrawal by Subject|2|||
146631780|NCT00775190|528830022|FG000|Overall Study|Protocol Violation|1|||
146631781|NCT00775190|528830023|FG001|Overall Study|Protocol Violation|0|||
146631782|NCT01709084|528830024|FG000|Overall Study|Lost to Follow-up|4|||
146631783|NCT01709084|528830025|FG001|Overall Study|Lost to Follow-up|7|||
146631784|NCT01709084|528830024|FG000|Overall Study|Withdrawal by Subject|2|||
146765233|NCT02952261|529307329|FG001|Overall Study|Protocol Violation|0|||
146765234|NCT00798265|529307330|FG000|Overall Study|Lost to Follow-up|1|||
146765235|NCT00798265|529307331|FG001|Overall Study|Lost to Follow-up|10|||
146765236|NCT00798265|529307330|FG000|Overall Study|Study closing|7|||
146765237|NCT00798265|529307331|FG001|Overall Study|Study closing|6|||
146765238|NCT00798265|529307330|FG000|Overall Study|Withdrawal by Subject|0|||
146765239|NCT00798265|529307331|FG001|Overall Study|Withdrawal by Subject|1|||
146765240|NCT00798265|529307330|FG000|Overall Study|Screen failure|0|||
146765241|NCT00798265|529307331|FG001|Overall Study|Screen failure|1|||
146765242|NCT03354390|529307332|FG000|Level 1|Death|2|||
146765243|NCT03354390|529307333|FG001|Level 1|Death|0|||
146765244|NCT03354390|529307334|FG002|Level 1|Death|0|||
146765245|NCT03354390|529307335|FG003|Level 1|Death|0|||
146765246|NCT03354390|529307332|FG000|Level 1|Physician Decision|1|||
146631785|NCT01709084|528830025|FG001|Overall Study|Withdrawal by Subject|2|||
146631786|NCT01709084|528830024|FG000|Overall Study|Adverse Event|5|||
146765247|NCT03354390|529307333|FG001|Level 1|Physician Decision|0|||
146765248|NCT03354390|529307334|FG002|Level 1|Physician Decision|0|||
146765249|NCT03354390|529307335|FG003|Level 1|Physician Decision|0|||
146550393|NCT01436500|528524246|FG001|Overall Study|discontinued study drug|0|||
146550394|NCT01436500|528524247|FG002|Overall Study|discontinued study drug|0|||
146550395|NCT01436500|528524248|FG003|Overall Study|discontinued study drug|0|||
146550396|NCT01436500|528524249|FG004|Overall Study|discontinued study drug|0|||
146550397|NCT01436500|528524245|FG000|Overall Study|Other|0|||
146550398|NCT01436500|528524246|FG001|Overall Study|Other|1|||
146550399|NCT01436500|528524247|FG002|Overall Study|Other|0|||
146550400|NCT01436500|528524248|FG003|Overall Study|Other|1|||
146550401|NCT01436500|528524249|FG004|Overall Study|Other|0|||
146550402|NCT00977561|528524256|FG000|Overall Study|Death|3|||
146550403|NCT00977561|528524257|FG001|Overall Study|Death|2|||
146550404|NCT00977561|528524256|FG000|Overall Study|Study terminated|0|||
146550405|NCT00977561|528524257|FG001|Overall Study|Study terminated|2|||
146550406|NCT00977561|528524256|FG000|Overall Study|Other|2|||
146550407|NCT00977561|528524257|FG001|Overall Study|Other|0|||
146550408|NCT03511066|528524263|FG000|Overall Study|Withdrawal by Subject|1|||
146550409|NCT03511066|528524264|FG001|Overall Study|Withdrawal by Subject|2|||
146550410|NCT03511066|528524265|FG002|Overall Study|Withdrawal by Subject|3|||
146550411|NCT03511066|528524263|FG000|Overall Study|Lost to Follow-up|2|||
146550412|NCT03511066|528524264|FG001|Overall Study|Lost to Follow-up|3|||
146550413|NCT03511066|528524265|FG002|Overall Study|Lost to Follow-up|0|||
146550414|NCT04560309|528524267|FG000|Overall Study|Meet drop out criteria|1|||
146550415|NCT04560309|528524268|FG001|Overall Study|Meet drop out criteria|1|||
146550416|NCT04146909|528524269|FG000|Overall Study|Withdrawal by Subject|3|||
146550417|NCT04146909|528524269|FG000|Overall Study|Did not qualify after consented|1|||
146550418|NCT05085405|528524270|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
146550419|NCT05085405|528524271|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
146550420|NCT05085405|528524272|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
146550421|NCT05085405|528524273|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
146550422|NCT05085405|528524274|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
146550423|NCT05085405|528524275|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
146550424|NCT05085405|528524270|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
146631787|NCT01709084|528830025|FG001|Overall Study|Adverse Event|0|||
146631788|NCT01709084|528830024|FG000|Overall Study|Other|5|||
146631789|NCT01709084|528830025|FG001|Overall Study|Other|3|||
146550425|NCT05085405|528524271|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
146550426|NCT05085405|528524272|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
146550427|NCT05085405|528524273|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
146765250|NCT03354390|529307332|FG000|Level 2|Physician Decision|0|||
146550428|NCT05085405|528524274|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
146550429|NCT05085405|528524275|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
146550430|NCT01663987|528524276|FG000|Overall Study|Adverse Event|7|||
146550431|NCT01663987|528524277|FG001|Overall Study|Adverse Event|2|||
146550432|NCT01663987|528524276|FG000|Overall Study|Lost to Follow-up|1|||
146550433|NCT01663987|528524277|FG001|Overall Study|Lost to Follow-up|1|||
146550434|NCT01663987|528524276|FG000|Overall Study|Withdrawal by Subject|2|||
146550435|NCT01663987|528524277|FG001|Overall Study|Withdrawal by Subject|3|||
146550436|NCT01663987|528524276|FG000|Overall Study|Other reason not defined above|3|||
146550437|NCT01663987|528524277|FG001|Overall Study|Other reason not defined above|0|||
146550438|NCT04193527|528524282|FG000|Overall Study|Other|1|||
146550439|NCT04193527|528524283|FG001|Overall Study|Other|1|||
146550440|NCT04193527|528524284|FG002|Overall Study|Other|0|||
146550441|NCT03808909|528524285|FG000|Overall Study|Lost to Follow-up|3|||
146550442|NCT03808909|528524286|FG001|Overall Study|Lost to Follow-up|0|||
146550443|NCT00676689|528524287|FG000|Overall Study|Screen Failure|2|||
146550444|NCT00676689|528524287|FG000|Overall Study|Death|2|||
146550445|NCT00676689|528524287|FG000|Overall Study|Lost to Follow-up|4|||
146550446|NCT00676689|528524287|FG000|Overall Study|Physician Decision|1|||
146550447|NCT00676689|528524287|FG000|Overall Study|Withdrawal by Subject|3|||
146550448|NCT00676689|528524287|FG000|Overall Study|Continuing FU|49|||
146550449|NCT01827943|528524288|FG000|Overall Study|Protocol Violation|8|||
146550450|NCT01827943|528524288|FG000|Overall Study|Never treated because of an rapid progression|1|||
146550451|NCT00309244|528524289|FG000|Overall Study|Adverse Event|29|||
146550452|NCT00309244|528524290|FG001|Overall Study|Adverse Event|12|||
146550453|NCT00309244|528524289|FG000|Overall Study|Lost to Follow-up|6|||
146550454|NCT00309244|528524290|FG001|Overall Study|Lost to Follow-up|22|||
146550455|NCT00309244|528524289|FG000|Overall Study|Physician Decision|5|||
146550456|NCT00309244|528524290|FG001|Overall Study|Physician Decision|8|||
146550457|NCT00309244|528524289|FG000|Overall Study|Protocol Violation|6|||
146550458|NCT00309244|528524290|FG001|Overall Study|Protocol Violation|3|||
146550459|NCT00309244|528524289|FG000|Overall Study|Withdrawal by Subject|50|||
146550460|NCT00309244|528524290|FG001|Overall Study|Withdrawal by Subject|32|||
146550461|NCT00309244|528524289|FG000|Overall Study|Various|7|||
146550462|NCT00309244|528524290|FG001|Overall Study|Various|7|||
146550463|NCT00309244|528524289|FG000|Overall Study|Randomized but not dosed|11|||
146550464|NCT00309244|528524290|FG001|Overall Study|Randomized but not dosed|12|||
146550465|NCT00309244|528524289|FG000|Overall Study|Death|4|||
146550466|NCT00309244|528524290|FG001|Overall Study|Death|1|||
146550467|NCT00501085|528524292|FG000|Overall Study|Lost to Follow-up|195|||
146550468|NCT00501085|528524292|FG000|Overall Study|Withdrawal by Subject|34|||
146550469|NCT00501085|528524292|FG000|Overall Study|Subject Decision|1|||
146550470|NCT00501085|528524292|FG000|Overall Study|Revision Surgery|7|||
146550471|NCT00501085|528524292|FG000|Overall Study|Explantation Surgery|26|||
146631790|NCT01709084|528830024|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
146631791|NCT01709084|528830025|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
146631792|NCT01709084|528830024|FG000|Overall Study|Not Treated|0|||
146631793|NCT01709084|528830025|FG001|Overall Study|Not Treated|2|||
146631794|NCT00641667|528830031|FG000|Overall Study|Withdrawal by Subject|1|||
146631795|NCT00641667|528830031|FG000|Overall Study|Adverse Event|1|||
146631796|NCT00641667|528830031|FG000|Overall Study|Physician Decision|1|||
146631797|NCT00641667|528830031|FG000|Overall Study|Worsening of underlying disease|3|||
146631798|NCT01235741|528830032|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
146631799|NCT01235741|528830033|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
146631800|NCT01235741|528830034|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
146631801|NCT01235741|528830032|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
146631802|NCT01235741|528830033|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
146631803|NCT01235741|528830034|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
146631804|NCT01235741|528830032|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
146631805|NCT01235741|528830033|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
146550472|NCT00501085|528524292|FG000|Overall Study|Adverse Event|4|||
146550473|NCT00501085|528524292|FG000|Overall Study|Non-Compliance|24|||
146550474|NCT00501085|528524292|FG000|Overall Study|Study closed by sponsor|109|||
146550475|NCT00501085|528524292|FG000|Overall Study|Other loss to follow-up|32|||
146550476|NCT01487161|528524293|FG000|Overall Study|Adverse Event|1|||
146550477|NCT01487161|528524294|FG001|Overall Study|Adverse Event|0|||
146550478|NCT01487161|528524295|FG002|Overall Study|Adverse Event|0|||
146550479|NCT01487161|528524296|FG003|Overall Study|Adverse Event|0|||
146550480|NCT01487161|528524293|FG000|Overall Study|Withdrawal by Subject|1|||
146550481|NCT01487161|528524294|FG001|Overall Study|Withdrawal by Subject|1|||
146550482|NCT01487161|528524295|FG002|Overall Study|Withdrawal by Subject|1|||
146550483|NCT01487161|528524296|FG003|Overall Study|Withdrawal by Subject|2|||
146631806|NCT01235741|528830034|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
146550484|NCT01487161|528524293|FG000|Overall Study|missing data|0|||
146550485|NCT01487161|528524294|FG001|Overall Study|missing data|1|||
146550486|NCT01487161|528524295|FG002|Overall Study|missing data|0|||
146550487|NCT01487161|528524296|FG003|Overall Study|missing data|0|||
146550488|NCT00663351|528524297|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
146550489|NCT00663351|528524298|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
146550490|NCT00663351|528524297|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
146550491|NCT00663351|528524298|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
146550492|NCT00663351|528524297|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
146550493|NCT00663351|528524298|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
146550494|NCT00663351|528524297|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
146550495|NCT00663351|528524298|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
146550496|NCT00663351|528524297|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
146550497|NCT00663351|528524298|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
146550498|NCT00663351|528524297|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
146550499|NCT00663351|528524298|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
146550500|NCT00567112|528524299|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
146550501|NCT00567112|528524300|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
146550502|NCT00567112|528524301|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
146550503|NCT00567112|528524299|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
146550504|NCT00567112|528524300|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
146550505|NCT00567112|528524301|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
146550506|NCT00567112|528524299|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
146550507|NCT00567112|528524300|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
146550508|NCT00567112|528524301|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
146550509|NCT02945046|528524302|FG000|Overall Study|Adverse Event|1|||
146550510|NCT02945046|528524303|FG001|Overall Study|Adverse Event|0|||
146550511|NCT02945046|528524304|FG002|Overall Study|Adverse Event|2|||
146550512|NCT02945046|528524302|FG000|Overall Study|Withdrawal by Subject|3|||
146550513|NCT02945046|528524303|FG001|Overall Study|Withdrawal by Subject|3|||
146550514|NCT02945046|528524304|FG002|Overall Study|Withdrawal by Subject|3|||
146550515|NCT02945046|528524302|FG000|Overall Study|Protocol Violation|2|||
146550516|NCT02945046|528524303|FG001|Overall Study|Protocol Violation|3|||
146550517|NCT02945046|528524304|FG002|Overall Study|Protocol Violation|2|||
146550518|NCT02945046|528524302|FG000|Overall Study|Lost to Follow-up|1|||
146550519|NCT02945046|528524303|FG001|Overall Study|Lost to Follow-up|1|||
146550520|NCT02945046|528524304|FG002|Overall Study|Lost to Follow-up|0|||
146550521|NCT02945046|528524302|FG000|Overall Study|Lack of Efficacy|1|||
146550522|NCT02945046|528524303|FG001|Overall Study|Lack of Efficacy|2|||
146550523|NCT02945046|528524304|FG002|Overall Study|Lack of Efficacy|1|||
146550524|NCT02945046|528524302|FG000|Overall Study|Other than specified|5|||
146550525|NCT02945046|528524303|FG001|Overall Study|Other than specified|4|||
146550526|NCT02945046|528524304|FG002|Overall Study|Other than specified|7|||
146550527|NCT03113136|528524305|FG000|Overall Study|Lost to Follow-up|22|||
146550528|NCT03113136|528524306|FG001|Overall Study|Lost to Follow-up|47|||
146550529|NCT03113136|528524307|FG002|Overall Study|Lost to Follow-up|54|||
146550530|NCT03113136|528524305|FG000|Overall Study|Withdrawal by Subject|4|||
146550531|NCT03113136|528524306|FG001|Overall Study|Withdrawal by Subject|13|||
146550532|NCT03113136|528524307|FG002|Overall Study|Withdrawal by Subject|14|||
146550533|NCT03113136|528524305|FG000|Overall Study|Ineligible|0|||
146550534|NCT03113136|528524306|FG001|Overall Study|Ineligible|2|||
146550535|NCT03113136|528524307|FG002|Overall Study|Ineligible|1|||
146550536|NCT03113136|528524305|FG000|Overall Study|Study Team Decision|1|||
146550537|NCT03113136|528524306|FG001|Overall Study|Study Team Decision|4|||
146550538|NCT03113136|528524307|FG002|Overall Study|Study Team Decision|0|||
146550539|NCT04689009|528524312|FG000|Overall Study|Adverse Event|1|||
146550540|NCT04689009|528524313|FG001|Overall Study|Adverse Event|0|||
146550541|NCT04689009|528524312|FG000|Overall Study|Lost to Follow-up|1|||
146550542|NCT04689009|528524313|FG001|Overall Study|Lost to Follow-up|2|||
146550543|NCT04689009|528524312|FG000|Overall Study|Withdrawal by Subject|4|||
146550544|NCT04689009|528524313|FG001|Overall Study|Withdrawal by Subject|3|||
146550545|NCT04689009|528524312|FG000|Overall Study|Protocol Violation|1|||
146550546|NCT04689009|528524313|FG001|Overall Study|Protocol Violation|0|||
146550547|NCT02362412|528524314|FG000|Treatment Period III|Lost to Follow-up|0|||
146550548|NCT02362412|528524315|FG001|Treatment Period III|Lost to Follow-up|1|||
146550549|NCT03336866|528524316|FG000|Overall Study|Lost to Follow-up|2|||
146550550|NCT03336866|528524317|FG001|Overall Study|Lost to Follow-up|0|||
146550551|NCT03336866|528524318|FG002|Overall Study|Lost to Follow-up|3|||
146550552|NCT03336866|528524316|FG000|Overall Study|Withdrawal by Subject|1|||
146550553|NCT03336866|528524317|FG001|Overall Study|Withdrawal by Subject|1|||
146550554|NCT03336866|528524318|FG002|Overall Study|Withdrawal by Subject|0|||
146550555|NCT03336866|528524316|FG000|Overall Study|Noncompliance with clinic house rules|0|||
146550556|NCT03336866|528524317|FG001|Overall Study|Noncompliance with clinic house rules|0|||
146550557|NCT03336866|528524318|FG002|Overall Study|Noncompliance with clinic house rules|1|||
146550558|NCT02569242|528524321|FG000|Overall Study|Death|1|||
146550559|NCT02569242|528524322|FG001|Overall Study|Death|0|||
146550560|NCT02569242|528524321|FG000|Overall Study|Withdrawal by Subject|0|||
146550561|NCT02569242|528524322|FG001|Overall Study|Withdrawal by Subject|1|||
146550562|NCT04796207|528524325|FG000|Overall Study|Lost to Follow-up|7|||
146550563|NCT04796207|528524326|FG001|Overall Study|Lost to Follow-up|2|||
146550564|NCT03003468|528524327|FG000|Overall Study|Withdrawal by Subject|0|||
146550565|NCT03003468|528524328|FG001|Overall Study|Withdrawal by Subject|0|||
146550566|NCT03003468|528524329|FG002|Overall Study|Withdrawal by Subject|1|||
146550567|NCT03003468|528524327|FG000|Overall Study|No measurable lesions|0|||
146550568|NCT03003468|528524328|FG001|Overall Study|No measurable lesions|0|||
146550569|NCT03003468|528524329|FG002|Overall Study|No measurable lesions|1|||
146550570|NCT02405962|528524330|FG000|Overall Study|Lost to Follow-up|1|||
146550571|NCT02405962|528524331|FG001|Overall Study|Lost to Follow-up|4|||
146550572|NCT02405962|528524330|FG000|Overall Study|A participant has moved to another place|0|||
146550573|NCT02405962|528524331|FG001|Overall Study|A participant has moved to another place|1|||
146550574|NCT00165698|528524332|FG000|Overall Study|Adverse Event|2|||
146550575|NCT00165698|528524333|FG001|Overall Study|Adverse Event|10|||
146550576|NCT00165698|528524332|FG000|Overall Study|Lost to Follow-up|2|||
146550577|NCT00165698|528524333|FG001|Overall Study|Lost to Follow-up|2|||
146550578|NCT00165698|528524332|FG000|Overall Study|Withdrawal by Subject|2|||
146550579|NCT00165698|528524333|FG001|Overall Study|Withdrawal by Subject|1|||
146550580|NCT00165698|528524332|FG000|Overall Study|Protocol Violation|1|||
146631807|NCT01235741|528830032|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
146550581|NCT00165698|528524333|FG001|Overall Study|Protocol Violation|0|||
146550582|NCT00165698|528524332|FG000|Overall Study|Not Taken/Lost the medicine|1|||
146550583|NCT00165698|528524333|FG001|Overall Study|Not Taken/Lost the medicine|2|||
146550584|NCT01107457|528524334|FG000|Part A|Adverse Event|1|||
146550585|NCT01107457|528524335|FG001|Part A|Adverse Event|2|||
146550586|NCT01107457|528524336|FG002|Part A|Adverse Event|1|||
146550587|NCT01107457|528524337|FG003|Part A|Adverse Event|0|||
146550588|NCT01107457|528524338|FG004|Part A|Adverse Event|0|||
146631808|NCT01235741|528830033|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
146550589|NCT01107457|528524339|FG005|Part A|Adverse Event|0|||
146550590|NCT01107457|528524334|FG000|Part A|Withdrawal by Subject|3|||
146550591|NCT01107457|528524335|FG001|Part A|Withdrawal by Subject|3|||
146550592|NCT01107457|528524336|FG002|Part A|Withdrawal by Subject|0|||
146550593|NCT01107457|528524337|FG003|Part A|Withdrawal by Subject|3|||
146550594|NCT01107457|528524338|FG004|Part A|Withdrawal by Subject|1|||
146550595|NCT01107457|528524339|FG005|Part A|Withdrawal by Subject|0|||
146550596|NCT01107457|528524334|FG000|Part A|Lost to Follow-up|0|||
146550597|NCT01107457|528524335|FG001|Part A|Lost to Follow-up|1|||
146550598|NCT01107457|528524336|FG002|Part A|Lost to Follow-up|0|||
146886527|NCT01415752|529751723|FG003|Maintenance (Step 2)|Missing|3|||
146886528|NCT03286842|529751724|FG000|Overall Study|Patients rolled over to another study|80|||
146550599|NCT01107457|528524337|FG003|Part A|Lost to Follow-up|0|||
146550600|NCT01107457|528524338|FG004|Part A|Lost to Follow-up|0|||
146886529|NCT01391507|529751728|FG000|Overall Study|Death|0|||
146886530|NCT01391507|529751729|FG001|Overall Study|Death|0|||
146886531|NCT01391507|529751730|FG002|Overall Study|Death|0|||
146886532|NCT01391507|529751731|FG003|Overall Study|Death|1|||
146886533|NCT01391507|529751728|FG000|Overall Study|Adverse Event|1|||
146550601|NCT01107457|528524339|FG005|Part A|Lost to Follow-up|0|||
146550602|NCT01107457|528524334|FG000|Part A|Lack of Efficacy|1|||
146886534|NCT01391507|529751729|FG001|Overall Study|Adverse Event|1|||
146631809|NCT01235741|528830034|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
146631810|NCT01235741|528830032|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
146631811|NCT01235741|528830033|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
146631812|NCT01235741|528830034|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
146631813|NCT01235741|528830032|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
146631814|NCT01235741|528830033|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
146631815|NCT01235741|528830034|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
146631816|NCT01235741|528830032|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
146631817|NCT01235741|528830033|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
146631818|NCT01235741|528830034|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
146631819|NCT01235741|528830032|FG000|Randomized to Treatment|Adverse Event|0|||
146631820|NCT01235741|528830033|FG001|Randomized to Treatment|Adverse Event|1|||
146631821|NCT01235741|528830034|FG002|Randomized to Treatment|Adverse Event|1|||
146631822|NCT01235741|528830032|FG000|Randomized to Treatment|Sponsor terminated study|0|||
146631823|NCT01235741|528830033|FG001|Randomized to Treatment|Sponsor terminated study|35|||
146631824|NCT01235741|528830034|FG002|Randomized to Treatment|Sponsor terminated study|34|||
146631825|NCT01235741|528830032|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
146631826|NCT01235741|528830033|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
146631827|NCT01235741|528830034|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
146631828|NCT01235741|528830032|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
146631829|NCT01235741|528830033|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
146631830|NCT01235741|528830034|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
146631831|NCT01235741|528830032|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
146631832|NCT01235741|528830033|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
146631833|NCT01235741|528830034|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
146631834|NCT01421719|528830035|FG000|Overall Study|Withdrawal by Subject|4|||
146631835|NCT01712399|528830039|FG000|Overall Study|Lost to Follow-up|1|||
146631836|NCT01712399|528830039|FG000|Overall Study|Withdrawal by Subject|39|||
146631837|NCT01712399|528830039|FG000|Overall Study|Death|1|||
146631838|NCT01712399|528830039|FG000|Overall Study|Adverse Event|11|||
146631839|NCT01712399|528830039|FG000|Overall Study|Study closure|345|||
146631840|NCT01357850|528830044|FG000|Overall Study|Lost to Follow-up|1|||
146631841|NCT01357850|528830045|FG001|Overall Study|Lost to Follow-up|0|||
146631842|NCT01357850|528830046|FG002|Overall Study|Lost to Follow-up|0|||
146631843|NCT01357850|528830047|FG003|Overall Study|Lost to Follow-up|0|||
146631844|NCT04610281|528830048|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
146631845|NCT04610281|528830049|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
146631846|NCT01772316|528830050|FG000|Overall Study|Serious adverse event|1|||
146631847|NCT01772316|528830050|FG000|Overall Study|Inform consent withdrawn|1|||
146631848|NCT01772316|528830050|FG000|Overall Study|Withdrawn by sponsor decision|5|||
146631849|NCT01774721|528830052|FG000|Overall Study|Death|133|||
146631850|NCT01774721|528830053|FG001|Overall Study|Death|152|||
146631851|NCT01774721|528830052|FG000|Overall Study|Withdrawal by Subject|20|||
146631852|NCT01774721|528830053|FG001|Overall Study|Withdrawal by Subject|14|||
146631853|NCT01774721|528830052|FG000|Overall Study|Lost to Follow-up|6|||
146631854|NCT01774721|528830053|FG001|Overall Study|Lost to Follow-up|7|||
146631855|NCT01774721|528830052|FG000|Overall Study|Did not meet eligibility criteria|0|||
146631856|NCT01774721|528830053|FG001|Overall Study|Did not meet eligibility criteria|3|||
146631857|NCT01774721|528830052|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
146631858|NCT01774721|528830053|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
146631859|NCT01774721|528830052|FG000|Overall Study|Study terminated by sponsor|5|||
146631860|NCT01774721|528830053|FG001|Overall Study|Study terminated by sponsor|0|||
146631861|NCT01774721|528830052|FG000|Overall Study|Disease progression|5|||
146631862|NCT01774721|528830053|FG001|Overall Study|Disease progression|0|||
146631863|NCT02453321|528830057|FG000|Overall Study|Weakness|1|||
146631864|NCT02453321|528830058|FG001|Overall Study|Weakness|1|||
146631865|NCT02453321|528830059|FG002|Overall Study|Weakness|2|||
146765251|NCT03354390|529307333|FG001|Level 2|Physician Decision|2|||
146765252|NCT03354390|529307334|FG002|Level 2|Physician Decision|0|||
146886535|NCT01391507|529751730|FG002|Overall Study|Adverse Event|2|||
146886536|NCT01391507|529751731|FG003|Overall Study|Adverse Event|2|||
146886537|NCT01391507|529751728|FG000|Overall Study|Withdrawal by Subject|1|||
146765253|NCT03354390|529307335|FG003|Level 2|Physician Decision|0|||
146886538|NCT01391507|529751729|FG001|Overall Study|Withdrawal by Subject|2|||
146631866|NCT02453321|528830057|FG000|Overall Study|Deep Venous Thrombosis|0|||
146631867|NCT02453321|528830058|FG001|Overall Study|Deep Venous Thrombosis|1|||
146631868|NCT02453321|528830059|FG002|Overall Study|Deep Venous Thrombosis|0|||
146765254|NCT03354390|529307332|FG000|Level 2|Lack of Efficacy|0|||
146765255|NCT03354390|529307333|FG001|Level 2|Lack of Efficacy|1|||
146886539|NCT01391507|529751730|FG002|Overall Study|Withdrawal by Subject|1|||
146550603|NCT01107457|528524335|FG001|Part A|Lack of Efficacy|0|||
146550604|NCT01107457|528524336|FG002|Part A|Lack of Efficacy|0|||
146886540|NCT01391507|529751731|FG003|Overall Study|Withdrawal by Subject|1|||
146886541|NCT01391507|529751728|FG000|Overall Study|Lack of Efficacy|0|||
146886542|NCT01391507|529751729|FG001|Overall Study|Lack of Efficacy|0|||
146886543|NCT01391507|529751730|FG002|Overall Study|Lack of Efficacy|0|||
146550605|NCT01107457|528524337|FG003|Part A|Lack of Efficacy|0|||
146550606|NCT01107457|528524338|FG004|Part A|Lack of Efficacy|0|||
146550607|NCT01107457|528524339|FG005|Part A|Lack of Efficacy|0|||
146550608|NCT01107457|528524334|FG000|Part A|Protocol Violation|0|||
146550609|NCT01107457|528524335|FG001|Part A|Protocol Violation|1|||
146550610|NCT01107457|528524336|FG002|Part A|Protocol Violation|0|||
146550611|NCT01107457|528524337|FG003|Part A|Protocol Violation|0|||
146550612|NCT01107457|528524338|FG004|Part A|Protocol Violation|0|||
146886544|NCT01391507|529751731|FG003|Overall Study|Lack of Efficacy|1|||
146550613|NCT01107457|528524339|FG005|Part A|Protocol Violation|0|||
146550614|NCT01107457|528524334|FG000|Part B and C|Adverse Event|0|||
146550615|NCT01107457|528524335|FG001|Part B and C|Adverse Event|0|||
146550616|NCT01107457|528524336|FG002|Part B and C|Adverse Event|0|||
146886545|NCT01391507|529751728|FG000|Overall Study|Protocol Violation|2|||
146631869|NCT02054104|528830061|FG000|Overall Study|Did not want to continue due to college classes|1|||
146631870|NCT02054104|528830062|FG001|Overall Study|Did not want to continue due to college classes|0|||
146631871|NCT02054104|528830061|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
146631872|NCT02054104|528830062|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
146631873|NCT02054104|528830061|FG000|Overall Study|No evidence of immunologic response|2|||
146631874|NCT02054104|528830062|FG001|Overall Study|No evidence of immunologic response|2|||
146631875|NCT02054104|528830061|FG000|Overall Study|Disease Progression On Study|4|||
146631876|NCT02054104|528830062|FG001|Overall Study|Disease Progression On Study|5|||
146631877|NCT02054104|528830061|FG000|Overall Study|Diagnosis of lymphoma|0|||
146631878|NCT02054104|528830062|FG001|Overall Study|Diagnosis of lymphoma|1|||
146631879|NCT02054104|528830061|FG000|Overall Study|Inconclusive response|0|||
146631880|NCT02054104|528830062|FG001|Overall Study|Inconclusive response|1|||
146631881|NCT00763035|528830066|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
146631882|NCT00763035|528830067|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
146631883|NCT00763035|528830066|FG000|First Intervention|Adverse Event|0|||
146631884|NCT00763035|528830067|FG001|First Intervention|Adverse Event|1|||
146631885|NCT00763035|528830066|FG000|Second Intervention|Adverse Event|1|||
146631886|NCT00763035|528830067|FG001|Second Intervention|Adverse Event|0|||
146631887|NCT00763035|528830066|FG000|Second Intervention|Physician Decision|2|||
146631888|NCT00763035|528830067|FG001|Second Intervention|Physician Decision|0|||
146631889|NCT01658436|528830078|FG000|Overall Study|Adverse Event|6|||
146631890|NCT01658436|528830079|FG001|Overall Study|Adverse Event|5|||
146631891|NCT01658436|528830078|FG000|Overall Study|Physician Decision|1|||
146631892|NCT01658436|528830079|FG001|Overall Study|Physician Decision|0|||
146631893|NCT01658436|528830078|FG000|Overall Study|Progressive disease|12|||
146631894|NCT01658436|528830079|FG001|Overall Study|Progressive disease|4|||
146631895|NCT01658436|528830078|FG000|Overall Study|Study terminated by sponsor|0|||
146631896|NCT01658436|528830079|FG001|Overall Study|Study terminated by sponsor|1|||
146631897|NCT01658436|528830078|FG000|Overall Study|Subject/guardian decision|0|||
146631898|NCT01658436|528830079|FG001|Overall Study|Subject/guardian decision|1|||
146631899|NCT01658436|528830078|FG000|Overall Study|Death|1|||
146631900|NCT01658436|528830079|FG001|Overall Study|Death|0|||
146631901|NCT00686712|528830080|FG000|Overall Study|Protocol Violation|8|||
146631902|NCT00686712|528830081|FG001|Overall Study|Protocol Violation|8|||
146631903|NCT00686712|528830082|FG002|Overall Study|Protocol Violation|10|||
146631904|NCT00686712|528830080|FG000|Overall Study|Lost to Follow-up|1|||
146631905|NCT00686712|528830081|FG001|Overall Study|Lost to Follow-up|2|||
146631906|NCT00686712|528830082|FG002|Overall Study|Lost to Follow-up|3|||
146631907|NCT00686712|528830080|FG000|Overall Study|Adverse Event|1|||
146631908|NCT00686712|528830081|FG001|Overall Study|Adverse Event|1|||
146765256|NCT03354390|529307334|FG002|Level 2|Lack of Efficacy|0|||
146631909|NCT00686712|528830082|FG002|Overall Study|Adverse Event|0|||
146765257|NCT03354390|529307335|FG003|Level 2|Lack of Efficacy|0|||
146886546|NCT01391507|529751729|FG001|Overall Study|Protocol Violation|1|||
146550617|NCT01107457|528524337|FG003|Part B and C|Adverse Event|0|||
146550618|NCT01107457|528524338|FG004|Part B and C|Adverse Event|0|||
146550619|NCT01107457|528524339|FG005|Part B and C|Adverse Event|12|||
146550620|NCT01107457|528524334|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
146550621|NCT01107457|528524335|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
146550622|NCT01107457|528524336|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
146550623|NCT01107457|528524337|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
146550624|NCT01107457|528524338|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
146550625|NCT01107457|528524339|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
146550626|NCT01107457|528524334|FG000|Part B and C|Physician Decision|0|||
146550627|NCT01107457|528524335|FG001|Part B and C|Physician Decision|0|||
146550628|NCT01107457|528524336|FG002|Part B and C|Physician Decision|0|||
146550629|NCT01107457|528524337|FG003|Part B and C|Physician Decision|0|||
146550630|NCT01107457|528524338|FG004|Part B and C|Physician Decision|0|||
146550631|NCT01107457|528524339|FG005|Part B and C|Physician Decision|3|||
146550632|NCT01107457|528524334|FG000|Part B and C|Lack of Efficacy|0|||
146886547|NCT01391507|529751730|FG002|Overall Study|Protocol Violation|1|||
146886548|NCT01391507|529751731|FG003|Overall Study|Protocol Violation|2|||
146886549|NCT01453855|529751732|FG000|Overall Study|Adverse Event|3|||
146886550|NCT01453855|529751733|FG001|Overall Study|Adverse Event|4|||
146550633|NCT01107457|528524335|FG001|Part B and C|Lack of Efficacy|0|||
146550634|NCT01107457|528524336|FG002|Part B and C|Lack of Efficacy|0|||
146550635|NCT01107457|528524337|FG003|Part B and C|Lack of Efficacy|0|||
146631910|NCT01318915|528830085|FG000|Overall Study|Lost to Follow-up|1|||
146631911|NCT00926237|528830086|FG000|Overall Study|Withdrawal by Subject|2|||
146631912|NCT00926237|528830087|FG001|Overall Study|Withdrawal by Subject|1|||
146631913|NCT04119414|528830088|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
146631914|NCT04322526|528830090|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
146631915|NCT04322526|528830091|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
146631916|NCT04322526|528830090|FG000|Washout (1 Week)|Lost to Follow-up|1|||
146631917|NCT04322526|528830091|FG001|Washout (1 Week)|Lost to Follow-up|2|||
146631918|NCT01716234|528830092|FG000|Overall Study|Protocol Violation|0|||
146631919|NCT01716234|528830093|FG001|Overall Study|Protocol Violation|0|||
146886551|NCT01453855|529751732|FG000|Overall Study|Lost to Follow-up|2|||
146886552|NCT01453855|529751733|FG001|Overall Study|Lost to Follow-up|1|||
146886553|NCT01453855|529751732|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
146886554|NCT01453855|529751733|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
146886555|NCT01453855|529751732|FG000|Overall Study|Noncompliance|1|||
146886556|NCT01453855|529751733|FG001|Overall Study|Noncompliance|0|||
146886557|NCT01453855|529751732|FG000|Overall Study|Inadequate Control of IOP|1|||
146886558|NCT01453855|529751733|FG001|Overall Study|Inadequate Control of IOP|5|||
146886559|NCT01453855|529751732|FG000|Overall Study|Other|0|||
146886560|NCT01453855|529751733|FG001|Overall Study|Other|1|||
146886561|NCT01285908|529751740|FG000|Baseline Measurement|unable to insert catheter|1|||
146886562|NCT01285908|529751741|FG001|Baseline Measurement|unable to insert catheter|0|||
146886563|NCT01285908|529751742|FG002|Baseline Measurement|unable to insert catheter|0|||
146886564|NCT01285908|529751740|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
146886565|NCT01285908|529751741|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
146886566|NCT01285908|529751742|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
146886567|NCT01285908|529751740|FG000|Baseline Measurement|unable to tolerate procedure|1|||
146886568|NCT01285908|529751741|FG001|Baseline Measurement|unable to tolerate procedure|0|||
146886569|NCT01285908|529751742|FG002|Baseline Measurement|unable to tolerate procedure|0|||
146886570|NCT02926209|529751743|FG000|Study Cohort|Poor Bowel Preparation|1|||
146886571|NCT02926209|529751744|FG001|Study Cohort|Poor Bowel Preparation|0|||
146886572|NCT01764633|529751745|FG000|Overall Study|Withdrawal by Subject|105|||
146886573|NCT01764633|529751746|FG001|Overall Study|Withdrawal by Subject|88|||
146886574|NCT01764633|529751745|FG000|Overall Study|Lost to Follow-up|13|||
146886575|NCT01764633|529751746|FG001|Overall Study|Lost to Follow-up|5|||
146886576|NCT04142983|529751748|FG000|Overall Study|Lost to Follow-up|73|||
146886577|NCT04142983|529751748|FG000|Overall Study|Withdrawal by Subject|10|||
146886578|NCT04142983|529751748|FG000|Overall Study|Physician Decision|1|||
146886579|NCT04142983|529751748|FG000|Overall Study|Adverse Event|1|||
146886580|NCT04142983|529751748|FG000|Overall Study|No longer eligible|4|||
146886581|NCT04142983|529751748|FG000|Overall Study|Screen Failure|10|||
146886582|NCT02062658|529751750|FG000|Overall Study|Withdrawal by Subject|1|||
146886583|NCT02062658|529751750|FG000|Overall Study|Lack of Efficacy|1|||
146886584|NCT01789970|529751751|FG000|Open-label Titration Period|Adverse Event|68|||
146886585|NCT01789970|529751752|FG001|Open-label Titration Period|Adverse Event|0|||
146886586|NCT01789970|529751753|FG002|Open-label Titration Period|Adverse Event|0|||
146886587|NCT01789970|529751751|FG000|Open-label Titration Period|Lack of Efficacy|31|||
146886588|NCT01789970|529751752|FG001|Open-label Titration Period|Lack of Efficacy|0|||
146886589|NCT01789970|529751753|FG002|Open-label Titration Period|Lack of Efficacy|0|||
146886590|NCT01789970|529751751|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
146886591|NCT01789970|529751752|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
146886592|NCT01789970|529751753|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
146886593|NCT01789970|529751751|FG000|Open-label Titration Period|Protocol Violation|18|||
146886594|NCT01789970|529751752|FG001|Open-label Titration Period|Protocol Violation|0|||
146886595|NCT01789970|529751753|FG002|Open-label Titration Period|Protocol Violation|0|||
146886596|NCT01789970|529751751|FG000|Open-label Titration Period|Lost to Follow-up|5|||
146886597|NCT01789970|529751752|FG001|Open-label Titration Period|Lost to Follow-up|0|||
146886598|NCT01789970|529751753|FG002|Open-label Titration Period|Lost to Follow-up|0|||
146886599|NCT01789970|529751751|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
146886600|NCT01789970|529751752|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
146966498|NCT04228107|530038820|FG001|Overall Study|Withdrawal by Subject|0|||
146966499|NCT04228107|530038819|FG000|Overall Study|Lost to Follow-up|18|||
146765258|NCT03354390|529307332|FG000|Level 2|Lost to Follow-up|0|||
146886601|NCT01789970|529751753|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
146886602|NCT01789970|529751751|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
146886603|NCT01789970|529751752|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
146886604|NCT01789970|529751753|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
146886605|NCT01789970|529751751|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
146886606|NCT01789970|529751752|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
146631920|NCT01716234|528830094|FG002|Overall Study|Protocol Violation|0|||
146765259|NCT03354390|529307333|FG001|Level 2|Lost to Follow-up|1|||
146550636|NCT01107457|528524338|FG004|Part B and C|Lack of Efficacy|0|||
146550637|NCT01107457|528524339|FG005|Part B and C|Lack of Efficacy|7|||
146550638|NCT01107457|528524334|FG000|Part B and C|Lost to Follow-up|0|||
146550639|NCT01107457|528524335|FG001|Part B and C|Lost to Follow-up|0|||
146550640|NCT01107457|528524336|FG002|Part B and C|Lost to Follow-up|0|||
146550641|NCT01107457|528524337|FG003|Part B and C|Lost to Follow-up|0|||
146550642|NCT01107457|528524338|FG004|Part B and C|Lost to Follow-up|0|||
146550643|NCT01107457|528524339|FG005|Part B and C|Lost to Follow-up|10|||
146550644|NCT01107457|528524334|FG000|Part B and C|Protocol Violation|0|||
146550645|NCT01107457|528524335|FG001|Part B and C|Protocol Violation|0|||
146550646|NCT01107457|528524336|FG002|Part B and C|Protocol Violation|0|||
146550647|NCT01107457|528524337|FG003|Part B and C|Protocol Violation|0|||
146550648|NCT01107457|528524338|FG004|Part B and C|Protocol Violation|0|||
146550649|NCT01107457|528524339|FG005|Part B and C|Protocol Violation|1|||
146550650|NCT01107457|528524334|FG000|Part B and C|Sponsor Decision|0|||
146550651|NCT01107457|528524335|FG001|Part B and C|Sponsor Decision|0|||
146550652|NCT01107457|528524336|FG002|Part B and C|Sponsor Decision|0|||
146550653|NCT01107457|528524337|FG003|Part B and C|Sponsor Decision|0|||
146550654|NCT01107457|528524338|FG004|Part B and C|Sponsor Decision|0|||
146550655|NCT01107457|528524339|FG005|Part B and C|Sponsor Decision|66|||
146550656|NCT01107457|528524334|FG000|Part B and C|Withdrawal by Subject|0|||
146550657|NCT01107457|528524335|FG001|Part B and C|Withdrawal by Subject|0|||
146550658|NCT01107457|528524336|FG002|Part B and C|Withdrawal by Subject|0|||
146550659|NCT01107457|528524337|FG003|Part B and C|Withdrawal by Subject|0|||
146550660|NCT01107457|528524338|FG004|Part B and C|Withdrawal by Subject|0|||
146550661|NCT01107457|528524339|FG005|Part B and C|Withdrawal by Subject|16|||
146550662|NCT01107457|528524334|FG000|Part B and C|Clinical Relapse|0|||
146550663|NCT01107457|528524335|FG001|Part B and C|Clinical Relapse|0|||
146550664|NCT01107457|528524336|FG002|Part B and C|Clinical Relapse|0|||
146550665|NCT01107457|528524337|FG003|Part B and C|Clinical Relapse|0|||
146550666|NCT01107457|528524338|FG004|Part B and C|Clinical Relapse|0|||
146550667|NCT01107457|528524339|FG005|Part B and C|Clinical Relapse|4|||
146550668|NCT03020888|528524340|FG000|Overall Study|Physician Decision|4|||
146550669|NCT03020888|528524340|FG000|Overall Study|Withdrawal by Subject|6|||
146550670|NCT03020888|528524340|FG000|Overall Study|Insurance coverage|2|||
146550671|NCT03020888|528524340|FG000|Overall Study|Lost to Follow-up|1|||
146550672|NCT00300495|528524341|FG000|Overall Study|Protocol Violation|4|||
146550673|NCT00300495|528524342|FG001|Overall Study|Protocol Violation|1|||
146550674|NCT01348490|528524343|FG000|Overall Study|Death|1|||
146550675|NCT01348490|528524343|FG000|Overall Study|Adverse Event|3|||
146550676|NCT01348490|528524343|FG000|Overall Study|Consent withdrawn|7|||
146550677|NCT01348490|528524343|FG000|Overall Study|Disease progression|3|||
146550678|NCT01348490|528524343|FG000|Overall Study|Lost to Follow-up|1|||
146550679|NCT01348490|528524343|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
146550680|NCT01348490|528524343|FG000|Overall Study|Other Unspecified|8|||
146550681|NCT01198548|528524357|FG000|Overall Study|Disease Progression|9|||
146550682|NCT01198548|528524357|FG000|Overall Study|Administrative Decision|1|||
146550683|NCT02186171|528524358|FG000|Overall Study|Withdrawal by Subject|1|||
146550684|NCT02186171|528524359|FG001|Overall Study|Withdrawal by Subject|9|||
146550685|NCT02186171|528524358|FG000|Overall Study|Lost to Follow-up|2|||
146550686|NCT02186171|528524359|FG001|Overall Study|Lost to Follow-up|2|||
146550687|NCT02186171|528524358|FG000|Overall Study|Death|1|||
146550688|NCT02186171|528524359|FG001|Overall Study|Death|2|||
146550689|NCT02186171|528524358|FG000|Overall Study|Protocol-specified Criteria|0|||
146550690|NCT02186171|528524359|FG001|Overall Study|Protocol-specified Criteria|2|||
146550691|NCT01030900|528524361|FG000|Overall Study|Not treated due to congestive heart failure|1|||
146550692|NCT01030900|528524361|FG000|Overall Study|Not treated due to rapid disease|1|||
146550693|NCT01179399|528524362|FG000|Overall Study|Adverse Event|1|||
146550694|NCT01179399|528524362|FG000|Overall Study|Lack of Efficacy|30|||
146550695|NCT01179399|528524362|FG000|Overall Study|Withdrawal by Subject|1|||
146550696|NCT00441896|528524363|FG000|Overall Study|Withdrawal by Subject|0|||
146550697|NCT00441896|528524364|FG001|Overall Study|Withdrawal by Subject|0|||
146550698|NCT00441896|528524365|FG002|Overall Study|Withdrawal by Subject|0|||
146550699|NCT00441896|528524366|FG003|Overall Study|Withdrawal by Subject|1|||
146550700|NCT00441896|528524367|FG004|Overall Study|Withdrawal by Subject|0|||
146550701|NCT00441896|528524368|FG005|Overall Study|Withdrawal by Subject|0|||
146550702|NCT00441896|528524369|FG006|Overall Study|Withdrawal by Subject|0|||
146550703|NCT00441896|528524370|FG007|Overall Study|Withdrawal by Subject|0|||
146550704|NCT00441896|528524371|FG008|Overall Study|Withdrawal by Subject|0|||
146550705|NCT00441896|528524372|FG009|Overall Study|Withdrawal by Subject|0|||
146550706|NCT00441896|528524363|FG000|Overall Study|Other|0|||
146550707|NCT00441896|528524364|FG001|Overall Study|Other|0|||
146550708|NCT00441896|528524365|FG002|Overall Study|Other|0|||
146550709|NCT00441896|528524366|FG003|Overall Study|Other|0|||
146550710|NCT00441896|528524367|FG004|Overall Study|Other|1|||
146550711|NCT00441896|528524368|FG005|Overall Study|Other|0|||
146550712|NCT00441896|528524369|FG006|Overall Study|Other|0|||
146550713|NCT00441896|528524370|FG007|Overall Study|Other|0|||
146550714|NCT00441896|528524371|FG008|Overall Study|Other|0|||
146550715|NCT00441896|528524372|FG009|Overall Study|Other|0|||
146550716|NCT03055221|528526867|FG000|Overall Study|Adverse Event|2|||
146550717|NCT03055221|528526867|FG000|Overall Study|Withdrawal by Subject|4|||
146550718|NCT03055221|528526867|FG000|Overall Study|Death|6|||
146550719|NCT03055221|528526867|FG000|Overall Study|Physician Decision|1|||
146550720|NCT03055221|528526867|FG000|Overall Study|Study terminated by Sponsor|3|||
146550721|NCT03055221|528526867|FG000|Overall Study|Lost to Follow-up|4|||
146550722|NCT01964560|528526872|FG000|Overall Study|Adverse Event|23|||
146550723|NCT01964560|528526872|FG000|Overall Study|Lack of Efficacy|46|||
146550724|NCT01964560|528526872|FG000|Overall Study|Protocol deviation|2|||
146550725|NCT01964560|528526872|FG000|Overall Study|Lost to Follow-up|4|||
146550726|NCT01964560|528526872|FG000|Overall Study|Withdrawal by Subject|64|||
146550727|NCT01964560|528526872|FG000|Overall Study|Surgery-hemispherotomy|1|||
146550728|NCT01964560|528526872|FG000|Overall Study|Surgery|1|||
146550729|NCT01964560|528526872|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
146550730|NCT01964560|528526872|FG000|Overall Study|Patient and Investigator choice|1|||
146550731|NCT01964560|528526872|FG000|Overall Study|Patient was prescribed CBD|1|||
146550732|NCT01964560|528526872|FG000|Overall Study|Participant moved to another country|1|||
146550733|NCT00710554|528526878|FG000|Overall Study|Adverse Event|24|||
146550734|NCT00710554|528526879|FG001|Overall Study|Adverse Event|7|||
146550735|NCT00710554|528526878|FG000|Overall Study|Withdrawal by Subject|7|||
146550736|NCT00710554|528526879|FG001|Overall Study|Withdrawal by Subject|3|||
146550737|NCT00710554|528526878|FG000|Overall Study|Lost to Follow-up|7|||
146550738|NCT00710554|528526879|FG001|Overall Study|Lost to Follow-up|1|||
146550739|NCT00710554|528526878|FG000|Overall Study|Lack of Efficacy|11|||
146550740|NCT00710554|528526879|FG001|Overall Study|Lack of Efficacy|12|||
146550741|NCT00710554|528526878|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
146550742|NCT00710554|528526879|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
146550743|NCT01093885|528526880|FG000|Overall Study|Adverse Event|4|||
146550744|NCT01093885|528526880|FG000|Overall Study|Lost to Follow-up|1|||
146550745|NCT01301001|528526881|FG000|First Intervention|Lost to Follow-up|4|||
146550746|NCT01301001|528526882|FG001|First Intervention|Lost to Follow-up|4|||
146550747|NCT01301001|528526881|FG000|First Intervention|Withdrawal by Subject|1|||
146550748|NCT01301001|528526882|FG001|First Intervention|Withdrawal by Subject|4|||
146550749|NCT01301001|528526881|FG000|First Intervention|Adverse Event|5|||
146550750|NCT01301001|528526882|FG001|First Intervention|Adverse Event|0|||
146550751|NCT01301001|528526881|FG000|First Intervention|Protocol Violation|0|||
146550752|NCT01301001|528526882|FG001|First Intervention|Protocol Violation|1|||
146550753|NCT01301001|528526881|FG000|Second Intervention|Adverse Event|2|||
146550754|NCT01301001|528526882|FG001|Second Intervention|Adverse Event|0|||
146550755|NCT01301001|528526881|FG000|Second Intervention|Withdrawal by Subject|2|||
146550756|NCT01301001|528526882|FG001|Second Intervention|Withdrawal by Subject|0|||
146550757|NCT01560988|528526883|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
146550758|NCT01560988|528526884|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
146550759|NCT01560988|528526883|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
146550760|NCT01560988|528526884|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
146550761|NCT01560988|528526883|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
146550762|NCT01560988|528526884|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
146550763|NCT02301429|528526891|FG000|Overall Study|not acceptable vascular anatomy|3|||
146550764|NCT01502072|528526892|FG000|Overall Study|Withdrawal by Subject|1|||
146550765|NCT01502072|528526893|FG001|Overall Study|Withdrawal by Subject|0|||
146550766|NCT01502072|528526894|FG002|Overall Study|Withdrawal by Subject|0|||
146550767|NCT01502072|528526892|FG000|Overall Study|Death|0|||
146550768|NCT01502072|528526893|FG001|Overall Study|Death|1|||
146550769|NCT01502072|528526894|FG002|Overall Study|Death|0|||
146631921|NCT01716234|528830095|FG003|Overall Study|Protocol Violation|1|||
146886607|NCT01789970|529751753|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
146886608|NCT01789970|529751751|FG000|Open-label Titration Period|Pregnancy|2|||
146886609|NCT01789970|529751752|FG001|Open-label Titration Period|Pregnancy|0|||
146631922|NCT01716234|528830096|FG004|Overall Study|Protocol Violation|1|||
146886610|NCT01789970|529751753|FG002|Open-label Titration Period|Pregnancy|0|||
146886611|NCT01789970|529751751|FG000|Open-label Titration Period|Other|76|||
146886612|NCT01789970|529751752|FG001|Open-label Titration Period|Other|0|||
146886613|NCT01789970|529751753|FG002|Open-label Titration Period|Other|0|||
146550770|NCT01975285|528526905|FG000|Overall Study|Failed Block and follow up|2|||
146550771|NCT01975285|528526906|FG001|Overall Study|Failed Block and follow up|2|||
146550772|NCT04535362|528526907|FG000|Overall Study|Lost to Follow-up|3|||
146550773|NCT04535362|528526908|FG001|Overall Study|Lost to Follow-up|1|||
146550774|NCT03791060|528526909|FG000|Overall Study|Withdrawal by Subject|1|||
146550775|NCT03774810|528526910|FG000|Phase 1|Lack of Efficacy|21|||
146550776|NCT03774810|528526911|FG001|Phase 1|Lack of Efficacy|0|||
146550777|NCT03774810|528526912|FG002|Phase 1|Lack of Efficacy|0|||
146550778|NCT03774810|528526913|FG003|Phase 1|Lack of Efficacy|0|||
146550779|NCT03774810|528526914|FG004|Phase 1|Lack of Efficacy|0|||
146550780|NCT03774810|528526910|FG000|Phase 1|Withdrawal by Subject|9|||
146550781|NCT03774810|528526911|FG001|Phase 1|Withdrawal by Subject|0|||
146550782|NCT03774810|528526912|FG002|Phase 1|Withdrawal by Subject|0|||
146550783|NCT03774810|528526913|FG003|Phase 1|Withdrawal by Subject|0|||
146550784|NCT03774810|528526914|FG004|Phase 1|Withdrawal by Subject|0|||
146550785|NCT03774810|528526910|FG000|Phase 1|Lost to Follow-up|2|||
146550786|NCT03774810|528526911|FG001|Phase 1|Lost to Follow-up|0|||
146550787|NCT03774810|528526912|FG002|Phase 1|Lost to Follow-up|0|||
146550788|NCT03774810|528526913|FG003|Phase 1|Lost to Follow-up|0|||
146550789|NCT03774810|528526914|FG004|Phase 1|Lost to Follow-up|0|||
146550790|NCT03774810|528526910|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
146550791|NCT03774810|528526911|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
146550792|NCT03774810|528526912|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
146550793|NCT03774810|528526913|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
146550794|NCT03774810|528526914|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
146550795|NCT03774810|528526910|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
146550796|NCT03774810|528526911|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
146550797|NCT03774810|528526912|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
146550798|NCT03774810|528526913|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
146550799|NCT03774810|528526914|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
146550800|NCT03774810|528526910|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
146550801|NCT03774810|528526911|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
146550802|NCT03774810|528526912|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
146550803|NCT03774810|528526913|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
146886614|NCT01789970|529751751|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
146886615|NCT01789970|529751752|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
146886616|NCT01789970|529751753|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
146550804|NCT03774810|528526914|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
146550805|NCT03774810|528526910|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
146550806|NCT03774810|528526911|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
146550807|NCT03774810|528526912|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
146550808|NCT03774810|528526913|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
146886617|NCT01789970|529751751|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
146550809|NCT03774810|528526914|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
146550810|NCT03774810|528526910|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
146550811|NCT03774810|528526911|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
146550812|NCT03774810|528526912|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
146886618|NCT01789970|529751752|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
146886619|NCT01789970|529751753|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
146886620|NCT01789970|529751751|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
146631923|NCT01716234|528830097|FG005|Overall Study|Protocol Violation|1|||
146550813|NCT03774810|528526913|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
146550814|NCT03774810|528526914|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
146550815|NCT03774810|528526910|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
146550816|NCT03774810|528526911|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
146550817|NCT03774810|528526912|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
146550818|NCT03774810|528526913|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
146550819|NCT03774810|528526914|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
146550820|NCT00927186|528526915|FG000|12 Months Primary Study|Adverse Event|5|||
146550821|NCT00927186|528526916|FG001|12 Months Primary Study|Adverse Event|2|||
146550822|NCT00927186|528526915|FG000|12 Months Primary Study|Lost to Follow-up|1|||
146550823|NCT00927186|528526916|FG001|12 Months Primary Study|Lost to Follow-up|0|||
146550824|NCT00927186|528526915|FG000|12 Months Primary Study|Protocol Violation|0|||
146550825|NCT00927186|528526916|FG001|12 Months Primary Study|Protocol Violation|1|||
146550826|NCT00927186|528526915|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
146550827|NCT00927186|528526916|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
146550828|NCT00604383|528526917|FG000|Overall Study|Withdrawal by Subject|33|||
146550829|NCT00604383|528526918|FG001|Overall Study|Withdrawal by Subject|31|||
146550830|NCT00604383|528526917|FG000|Overall Study|Lost to Follow-up|24|||
146550831|NCT00604383|528526918|FG001|Overall Study|Lost to Follow-up|19|||
146550832|NCT00604383|528526917|FG000|Overall Study|Death|14|||
146550833|NCT00604383|528526918|FG001|Overall Study|Death|22|||
146550834|NCT00604383|528526917|FG000|Overall Study|Adverse Event|16|||
146886621|NCT01789970|529751752|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
146886622|NCT01789970|529751753|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
146550835|NCT00604383|528526918|FG001|Overall Study|Adverse Event|9|||
146550836|NCT00604383|528526917|FG000|Overall Study|Physician Decision|0|||
146550837|NCT00604383|528526918|FG001|Overall Study|Physician Decision|3|||
146550838|NCT01011283|528526919|FG000|Overall Study|Adverse Event|4|||
146550839|NCT01011283|528526920|FG001|Overall Study|Adverse Event|2|||
146966500|NCT04228107|530038820|FG001|Overall Study|Lost to Follow-up|0|||
146550840|NCT01011283|528526919|FG000|Overall Study|Progressive Disease|0|||
146550841|NCT01011283|528526920|FG001|Overall Study|Progressive Disease|2|||
146631924|NCT01716234|528830098|FG006|Overall Study|Protocol Violation|0|||
146631925|NCT01716234|528830092|FG000|Overall Study|Lack of Efficacy|0|||
146631926|NCT01716234|528830093|FG001|Overall Study|Lack of Efficacy|0|||
146631927|NCT01716234|528830094|FG002|Overall Study|Lack of Efficacy|0|||
146631928|NCT01716234|528830095|FG003|Overall Study|Lack of Efficacy|1|||
146631929|NCT01716234|528830096|FG004|Overall Study|Lack of Efficacy|0|||
146631930|NCT01716234|528830097|FG005|Overall Study|Lack of Efficacy|0|||
146631931|NCT01716234|528830098|FG006|Overall Study|Lack of Efficacy|0|||
146631932|NCT01716234|528830092|FG000|Overall Study|Did not meet protocol eligibility|0|||
146631933|NCT01716234|528830093|FG001|Overall Study|Did not meet protocol eligibility|0|||
146631934|NCT01716234|528830094|FG002|Overall Study|Did not meet protocol eligibility|1|||
146631935|NCT01716234|528830095|FG003|Overall Study|Did not meet protocol eligibility|0|||
146631936|NCT01716234|528830096|FG004|Overall Study|Did not meet protocol eligibility|0|||
146631937|NCT01716234|528830097|FG005|Overall Study|Did not meet protocol eligibility|4|||
146631938|NCT01716234|528830098|FG006|Overall Study|Did not meet protocol eligibility|0|||
146631939|NCT01716234|528830092|FG000|Overall Study|Adverse Event|7|||
146631940|NCT01716234|528830093|FG001|Overall Study|Adverse Event|10|||
146631941|NCT01716234|528830094|FG002|Overall Study|Adverse Event|2|||
146631942|NCT01716234|528830095|FG003|Overall Study|Adverse Event|8|||
146631943|NCT01716234|528830096|FG004|Overall Study|Adverse Event|3|||
146631944|NCT01716234|528830097|FG005|Overall Study|Adverse Event|6|||
146631945|NCT01716234|528830098|FG006|Overall Study|Adverse Event|0|||
146631946|NCT01716234|528830092|FG000|Overall Study|Withdrawal by Subject|3|||
146631947|NCT01716234|528830093|FG001|Overall Study|Withdrawal by Subject|0|||
146631948|NCT01716234|528830094|FG002|Overall Study|Withdrawal by Subject|2|||
146631949|NCT01716234|528830095|FG003|Overall Study|Withdrawal by Subject|2|||
146631950|NCT01716234|528830096|FG004|Overall Study|Withdrawal by Subject|1|||
146631951|NCT01716234|528830097|FG005|Overall Study|Withdrawal by Subject|3|||
146631952|NCT01716234|528830098|FG006|Overall Study|Withdrawal by Subject|0|||
146631953|NCT01523756|528830099|FG000|Baseline Period|Adverse Event|0|||
146631954|NCT01523756|528830100|FG001|Baseline Period|Adverse Event|1|||
146631955|NCT01523756|528830099|FG000|Test Period 1|Adverse Event|1|||
146631956|NCT01523756|528830100|FG001|Test Period 1|Adverse Event|0|||
146631957|NCT01523756|528830099|FG000|Test Period 2|Withdrawal by Subject|0|||
146631958|NCT01523756|528830100|FG001|Test Period 2|Withdrawal by Subject|1|||
146631959|NCT00474812|528830106|FG000|Overall Study|Withdrawal by Subject|5|||
146631960|NCT00474812|528830106|FG000|Overall Study|No Initiation of treatment|2|||
146631961|NCT02059278|528830107|FG000|Overall Study|Adverse Event|1|||
146631962|NCT02059278|528830108|FG001|Overall Study|Adverse Event|1|||
146631963|NCT02059278|528830107|FG000|Overall Study|Lost to Follow-up|1|||
146631964|NCT02059278|528830108|FG001|Overall Study|Lost to Follow-up|0|||
146631965|NCT02059278|528830107|FG000|Overall Study|Withdrawal by Subject|0|||
146631966|NCT02059278|528830108|FG001|Overall Study|Withdrawal by Subject|3|||
146631967|NCT02059278|528830107|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
146631968|NCT02059278|528830108|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
146631969|NCT05408429|528830111|FG000|Overall Study|Lost to Follow-up|1|||
146631970|NCT05408429|528830112|FG001|Overall Study|Lost to Follow-up|1|||
146631971|NCT05408429|528830113|FG002|Overall Study|Lost to Follow-up|0|||
146631972|NCT05408429|528830111|FG000|Overall Study|Withdrawal by Subject|5|||
146631973|NCT05408429|528830112|FG001|Overall Study|Withdrawal by Subject|0|||
146631974|NCT05408429|528830113|FG002|Overall Study|Withdrawal by Subject|1|||
146631975|NCT03435211|528830114|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
146631976|NCT02195518|528830115|FG000|Overall Study|Adverse Event|1|||
146631977|NCT02195518|528830115|FG000|Overall Study|Protocol Violation|4|||
146631978|NCT02195518|528830115|FG000|Overall Study|Pregnancy|2|||
146631979|NCT02195518|528830115|FG000|Overall Study|Withdrawal by Subject|1|||
146631980|NCT02195518|528830115|FG000|Overall Study|Lost to Follow-up|1|||
146631981|NCT03818256|528830116|FG000|Overall Study|Withdrawal by Subject|2|||
146631982|NCT03818256|528830117|FG001|Overall Study|Withdrawal by Subject|2|||
146631983|NCT03818256|528830116|FG000|Overall Study|Adverse Event|3|||
146631984|NCT03818256|528830117|FG001|Overall Study|Adverse Event|1|||
146631985|NCT03818256|528830116|FG000|Overall Study|Lost to Follow-up|0|||
146631986|NCT03818256|528830117|FG001|Overall Study|Lost to Follow-up|5|||
146631987|NCT03818256|528830116|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
146631988|NCT03818256|528830117|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
146631989|NCT03818256|528830116|FG000|Overall Study|Not reporting for scheduled visits|1|||
146631990|NCT03818256|528830117|FG001|Overall Study|Not reporting for scheduled visits|0|||
146631991|NCT03818256|528830116|FG000|Overall Study|Non-compliant with investigational product|1|||
146631992|NCT03818256|528830117|FG001|Overall Study|Non-compliant with investigational product|0|||
146631993|NCT01342211|528830118|FG000|Overall Study|Lost to Follow-up|0|||
146631994|NCT01342211|528830119|FG001|Overall Study|Lost to Follow-up|0|||
146631995|NCT01342211|528830120|FG002|Overall Study|Lost to Follow-up|0|||
146631996|NCT01342211|528830121|FG003|Overall Study|Lost to Follow-up|1|||
146966501|NCT04228107|530038819|FG000|Overall Study|No controller use data|1|||
146631997|NCT01342211|528830122|FG004|Overall Study|Lost to Follow-up|0|||
146886623|NCT01789970|529751751|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146886624|NCT01789970|529751752|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
146886625|NCT01789970|529751753|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
146886626|NCT01789970|529751751|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
146886627|NCT01789970|529751752|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
146550842|NCT01011283|528526919|FG000|Overall Study|Terminated by Sponsor|5|||
146550843|NCT01011283|528526920|FG001|Overall Study|Terminated by Sponsor|5|||
146550844|NCT01011283|528526919|FG000|Overall Study|Other|2|||
146550845|NCT01011283|528526920|FG001|Overall Study|Other|2|||
146550846|NCT02619812|528526921|FG000|Overall Study|Withdrawal by Subject|0|||
146550847|NCT02619812|528526922|FG001|Overall Study|Withdrawal by Subject|0|||
146550848|NCT02619812|528526923|FG002|Overall Study|Withdrawal by Subject|1|||
146550849|NCT02619812|528526924|FG003|Overall Study|Withdrawal by Subject|2|||
146550850|NCT01096186|528526925|FG000|Overall Study|Adverse Event|16|||
146550851|NCT01096186|528526925|FG000|Overall Study|Death|4|||
146550852|NCT01096186|528526925|FG000|Overall Study|Lack of Efficacy|4|||
146550853|NCT01096186|528526925|FG000|Overall Study|Lost to Follow-up|2|||
146550854|NCT01096186|528526925|FG000|Overall Study|Withdrawal by Subject|22|||
146550855|NCT01096186|528526925|FG000|Overall Study|Physician Decision|1|||
146550856|NCT01096186|528526925|FG000|Overall Study|Noncompliance with study drug|1|||
146550857|NCT02829957|528526929|FG000|Overall Study|Lost to Follow-up|2|||
146550858|NCT02829957|528526930|FG001|Overall Study|Lost to Follow-up|1|||
146550859|NCT02675452|528526934|FG000|Overall Study|Sponsor decision|0|||
146550860|NCT02675452|528526935|FG001|Overall Study|Sponsor decision|0|||
146550861|NCT02675452|528526936|FG002|Overall Study|Sponsor decision|0|||
146550862|NCT02675452|528526937|FG003|Overall Study|Sponsor decision|0|||
146550863|NCT02675452|528526938|FG004|Overall Study|Sponsor decision|0|||
146550864|NCT02675452|528526939|FG005|Overall Study|Sponsor decision|0|||
146550865|NCT02675452|528526940|FG006|Overall Study|Sponsor decision|0|||
146550866|NCT02675452|528526941|FG007|Overall Study|Sponsor decision|0|||
146550867|NCT02675452|528526942|FG008|Overall Study|Sponsor decision|0|||
146550868|NCT02675452|528526943|FG009|Overall Study|Sponsor decision|1|||
146550869|NCT02675452|528526944|FG010|Overall Study|Sponsor decision|0|||
146550870|NCT02675452|528526945|FG011|Overall Study|Sponsor decision|0|||
146550871|NCT02675452|528526946|FG012|Overall Study|Sponsor decision|0|||
146550872|NCT02675452|528526947|FG013|Overall Study|Sponsor decision|2|||
146550873|NCT02675452|528526948|FG014|Overall Study|Sponsor decision|1|||
146550874|NCT02675452|528526949|FG015|Overall Study|Sponsor decision|0|||
146550875|NCT02675452|528526950|FG016|Overall Study|Sponsor decision|1|||
146550876|NCT02675452|528526951|FG017|Overall Study|Sponsor decision|0|||
146550877|NCT02675452|528526952|FG018|Overall Study|Sponsor decision|0|||
146550878|NCT02675452|528526953|FG019|Overall Study|Sponsor decision|0|||
146550879|NCT02675452|528526954|FG020|Overall Study|Sponsor decision|0|||
146550880|NCT02675452|528526955|FG021|Overall Study|Sponsor decision|0|||
146550881|NCT02675452|528526956|FG022|Overall Study|Sponsor decision|0|||
146550882|NCT02675452|528526957|FG023|Overall Study|Sponsor decision|0|||
146631998|NCT01342211|528830118|FG000|Overall Study|Adverse Event|0|||
146631999|NCT01342211|528830119|FG001|Overall Study|Adverse Event|0|||
146632000|NCT01342211|528830120|FG002|Overall Study|Adverse Event|0|||
146632001|NCT01342211|528830121|FG003|Overall Study|Adverse Event|0|||
146632002|NCT01342211|528830122|FG004|Overall Study|Adverse Event|1|||
146632003|NCT01342211|528830118|FG000|Overall Study|Withdrawal by Subject|0|||
146632004|NCT01342211|528830119|FG001|Overall Study|Withdrawal by Subject|0|||
146632005|NCT01342211|528830120|FG002|Overall Study|Withdrawal by Subject|0|||
146632006|NCT01342211|528830121|FG003|Overall Study|Withdrawal by Subject|1|||
146632007|NCT01342211|528830122|FG004|Overall Study|Withdrawal by Subject|0|||
146886628|NCT01789970|529751753|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
146886629|NCT01789970|529751751|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
146886630|NCT01789970|529751752|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
146886631|NCT01789970|529751753|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
146632008|NCT01342211|528830118|FG000|Overall Study|Randomized, but not Treated|0|||
146632009|NCT01342211|528830119|FG001|Overall Study|Randomized, but not Treated|2|||
146632010|NCT01342211|528830120|FG002|Overall Study|Randomized, but not Treated|0|||
146632011|NCT01342211|528830121|FG003|Overall Study|Randomized, but not Treated|0|||
146632012|NCT01342211|528830122|FG004|Overall Study|Randomized, but not Treated|1|||
146550883|NCT02675452|528526958|FG024|Overall Study|Sponsor decision|0|||
146550884|NCT02675452|528526959|FG025|Overall Study|Sponsor decision|0|||
146550885|NCT02675452|528526960|FG026|Overall Study|Sponsor decision|2|||
146550886|NCT02675452|528526961|FG027|Overall Study|Sponsor decision|0|||
146550887|NCT02675452|528526962|FG028|Overall Study|Sponsor decision|0|||
146550888|NCT02675452|528526934|FG000|Overall Study|Withdrawal by Subject|0|||
146550889|NCT02675452|528526935|FG001|Overall Study|Withdrawal by Subject|0|||
146550890|NCT02675452|528526936|FG002|Overall Study|Withdrawal by Subject|0|||
146550891|NCT02675452|528526937|FG003|Overall Study|Withdrawal by Subject|0|||
146550892|NCT02675452|528526938|FG004|Overall Study|Withdrawal by Subject|0|||
146550893|NCT02675452|528526939|FG005|Overall Study|Withdrawal by Subject|0|||
146886632|NCT01789970|529751751|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
146886633|NCT01789970|529751752|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
146886634|NCT01789970|529751753|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
146886635|NCT01789970|529751751|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146886636|NCT01789970|529751752|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
146886637|NCT01789970|529751753|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
146886638|NCT01789970|529751751|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
146886639|NCT01789970|529751752|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
146886640|NCT01789970|529751753|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
146886641|NCT01789970|529751751|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
146886642|NCT01789970|529751752|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
146886643|NCT01789970|529751753|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
146886644|NCT01789970|529751751|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
146886645|NCT01789970|529751752|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
146886646|NCT01789970|529751753|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
146886647|NCT00643994|529751754|FG000|Overall Study|Death|24|||
146886648|NCT00643994|529751754|FG000|Overall Study|Lost to Follow-up|72|||
146886649|NCT01847885|529751762|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
146886650|NCT01847885|529751763|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
146886651|NCT01847885|529751764|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
146886652|NCT01847885|529751762|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
146886653|NCT01847885|529751763|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
146886654|NCT01847885|529751764|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
146886655|NCT01847885|529751762|FG000|Initial Enrollment (Consented)|Screen failure|39|||
146886656|NCT01847885|529751763|FG001|Initial Enrollment (Consented)|Screen failure|0|||
146886657|NCT01847885|529751764|FG002|Initial Enrollment (Consented)|Screen failure|0|||
146886658|NCT01847885|529751762|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
146886659|NCT01847885|529751763|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
146886660|NCT01847885|529751764|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
146886661|NCT01847885|529751762|FG000|Randomization|Protocol Violation|0|||
146886662|NCT01847885|529751763|FG001|Randomization|Protocol Violation|1|||
146886663|NCT01847885|529751764|FG002|Randomization|Protocol Violation|0|||
146886664|NCT01847885|529751762|FG000|Randomization|Withdrawal by Subject|0|||
146886665|NCT01847885|529751763|FG001|Randomization|Withdrawal by Subject|0|||
146886666|NCT01847885|529751764|FG002|Randomization|Withdrawal by Subject|2|||
146886667|NCT01847885|529751762|FG000|Randomization|Screen Failure|0|||
146886668|NCT01847885|529751763|FG001|Randomization|Screen Failure|3|||
146886669|NCT01847885|529751764|FG002|Randomization|Screen Failure|0|||
146886670|NCT02574637|529751767|FG000|Double-blind Period|Adverse Event|1|||
146886671|NCT02574637|529751768|FG001|Double-blind Period|Adverse Event|0|||
146886672|NCT02574637|529751769|FG002|Double-blind Period|Adverse Event|0|||
146886673|NCT02574637|529751770|FG003|Double-blind Period|Adverse Event|0|||
146886674|NCT02574637|529751771|FG004|Double-blind Period|Adverse Event|0|||
146886675|NCT02574637|529751772|FG005|Double-blind Period|Adverse Event|0|||
146886676|NCT02574637|529751773|FG006|Double-blind Period|Adverse Event|0|||
146886677|NCT02574637|529751774|FG007|Double-blind Period|Adverse Event|0|||
146886678|NCT02574637|529751775|FG008|Double-blind Period|Adverse Event|0|||
146550894|NCT02675452|528526940|FG006|Overall Study|Withdrawal by Subject|0|||
146550895|NCT02675452|528526941|FG007|Overall Study|Withdrawal by Subject|0|||
146550896|NCT02675452|528526942|FG008|Overall Study|Withdrawal by Subject|0|||
146550897|NCT02675452|528526943|FG009|Overall Study|Withdrawal by Subject|1|||
146550898|NCT02675452|528526944|FG010|Overall Study|Withdrawal by Subject|0|||
146886679|NCT02574637|529751776|FG009|Double-blind Period|Adverse Event|0|||
146886680|NCT02574637|529751767|FG000|Double-blind Period|Lack of Efficacy|0|||
146886681|NCT02574637|529751768|FG001|Double-blind Period|Lack of Efficacy|0|||
146886682|NCT02574637|529751769|FG002|Double-blind Period|Lack of Efficacy|2|||
146886683|NCT02574637|529751770|FG003|Double-blind Period|Lack of Efficacy|0|||
146886684|NCT02574637|529751771|FG004|Double-blind Period|Lack of Efficacy|0|||
146886685|NCT02574637|529751772|FG005|Double-blind Period|Lack of Efficacy|0|||
146886686|NCT02574637|529751773|FG006|Double-blind Period|Lack of Efficacy|0|||
146550899|NCT02675452|528526945|FG011|Overall Study|Withdrawal by Subject|1|||
146550900|NCT02675452|528526946|FG012|Overall Study|Withdrawal by Subject|0|||
146550901|NCT02675452|528526947|FG013|Overall Study|Withdrawal by Subject|1|||
146886687|NCT02574637|529751774|FG007|Double-blind Period|Lack of Efficacy|0|||
146886688|NCT02574637|529751775|FG008|Double-blind Period|Lack of Efficacy|0|||
146886689|NCT02574637|529751776|FG009|Double-blind Period|Lack of Efficacy|0|||
146550902|NCT02675452|528526948|FG014|Overall Study|Withdrawal by Subject|1|||
146550903|NCT02675452|528526949|FG015|Overall Study|Withdrawal by Subject|0|||
146550904|NCT02675452|528526950|FG016|Overall Study|Withdrawal by Subject|2|||
146550905|NCT02675452|528526951|FG017|Overall Study|Withdrawal by Subject|0|||
146550906|NCT02675452|528526952|FG018|Overall Study|Withdrawal by Subject|0|||
146886690|NCT02574637|529751767|FG000|Double-blind Period|Protocol Deviation|1|||
146886691|NCT02574637|529751768|FG001|Double-blind Period|Protocol Deviation|0|||
146886692|NCT02574637|529751769|FG002|Double-blind Period|Protocol Deviation|0|||
146550907|NCT02675452|528526953|FG019|Overall Study|Withdrawal by Subject|0|||
146550908|NCT02675452|528526954|FG020|Overall Study|Withdrawal by Subject|0|||
146550909|NCT02675452|528526955|FG021|Overall Study|Withdrawal by Subject|0|||
146550910|NCT02675452|528526956|FG022|Overall Study|Withdrawal by Subject|3|||
146550911|NCT02675452|528526957|FG023|Overall Study|Withdrawal by Subject|0|||
146550912|NCT02675452|528526958|FG024|Overall Study|Withdrawal by Subject|1|||
146550913|NCT02675452|528526959|FG025|Overall Study|Withdrawal by Subject|0|||
146550914|NCT02675452|528526960|FG026|Overall Study|Withdrawal by Subject|1|||
146550915|NCT02675452|528526961|FG027|Overall Study|Withdrawal by Subject|3|||
146550916|NCT02675452|528526962|FG028|Overall Study|Withdrawal by Subject|4|||
146550917|NCT02675452|528526934|FG000|Overall Study|Death|0|||
146550918|NCT02675452|528526935|FG001|Overall Study|Death|0|||
146550919|NCT02675452|528526936|FG002|Overall Study|Death|1|||
146550920|NCT02675452|528526937|FG003|Overall Study|Death|0|||
146550921|NCT02675452|528526938|FG004|Overall Study|Death|0|||
146550922|NCT02675452|528526939|FG005|Overall Study|Death|1|||
146550923|NCT02675452|528526940|FG006|Overall Study|Death|0|||
146550924|NCT02675452|528526941|FG007|Overall Study|Death|0|||
146550925|NCT02675452|528526942|FG008|Overall Study|Death|1|||
146550926|NCT02675452|528526943|FG009|Overall Study|Death|0|||
146550927|NCT02675452|528526944|FG010|Overall Study|Death|0|||
146550928|NCT02675452|528526945|FG011|Overall Study|Death|0|||
146550929|NCT02675452|528526946|FG012|Overall Study|Death|1|||
146550930|NCT02675452|528526947|FG013|Overall Study|Death|0|||
146550931|NCT02675452|528526948|FG014|Overall Study|Death|0|||
146550932|NCT02675452|528526949|FG015|Overall Study|Death|2|||
146550933|NCT02675452|528526950|FG016|Overall Study|Death|0|||
146550934|NCT02675452|528526951|FG017|Overall Study|Death|0|||
146550935|NCT02675452|528526952|FG018|Overall Study|Death|4|||
146550936|NCT02675452|528526953|FG019|Overall Study|Death|3|||
146550937|NCT02675452|528526954|FG020|Overall Study|Death|3|||
146550938|NCT02675452|528526955|FG021|Overall Study|Death|3|||
146550939|NCT02675452|528526956|FG022|Overall Study|Death|7|||
146550940|NCT02675452|528526957|FG023|Overall Study|Death|5|||
146550941|NCT02675452|528526958|FG024|Overall Study|Death|3|||
146550942|NCT02675452|528526959|FG025|Overall Study|Death|4|||
146886693|NCT02574637|529751770|FG003|Double-blind Period|Protocol Deviation|0|||
146886694|NCT02574637|529751771|FG004|Double-blind Period|Protocol Deviation|0|||
146886695|NCT02574637|529751772|FG005|Double-blind Period|Protocol Deviation|0|||
146886696|NCT02574637|529751773|FG006|Double-blind Period|Protocol Deviation|0|||
146886697|NCT02574637|529751774|FG007|Double-blind Period|Protocol Deviation|0|||
146886698|NCT02574637|529751775|FG008|Double-blind Period|Protocol Deviation|0|||
146886699|NCT02574637|529751776|FG009|Double-blind Period|Protocol Deviation|0|||
146886700|NCT02574637|529751767|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
146886701|NCT02574637|529751768|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
146886702|NCT02574637|529751769|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
146886703|NCT02574637|529751770|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
146886704|NCT02574637|529751771|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
146886705|NCT02574637|529751772|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
146886706|NCT02574637|529751773|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
146886707|NCT02574637|529751774|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
146886708|NCT02574637|529751775|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
146886709|NCT02574637|529751776|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
146886710|NCT02574637|529751767|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
146886711|NCT02574637|529751768|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
146886712|NCT02574637|529751769|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
146886713|NCT02574637|529751770|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
146966502|NCT04228107|530038820|FG001|Overall Study|No controller use data|0|||
146966503|NCT04228107|530038819|FG000|Overall Study|No medication data collected|1|||
146966504|NCT04228107|530038820|FG001|Overall Study|No medication data collected|0|||
146550943|NCT02675452|528526960|FG026|Overall Study|Death|7|||
146550944|NCT02675452|528526961|FG027|Overall Study|Death|6|||
146550945|NCT02675452|528526962|FG028|Overall Study|Death|9|||
146550946|NCT02675452|528526934|FG000|Overall Study|Lost to Follow-up|0|||
146550947|NCT02675452|528526935|FG001|Overall Study|Lost to Follow-up|1|||
146550948|NCT02675452|528526936|FG002|Overall Study|Lost to Follow-up|0|||
146550949|NCT02675452|528526937|FG003|Overall Study|Lost to Follow-up|0|||
146550950|NCT02675452|528526938|FG004|Overall Study|Lost to Follow-up|0|||
146550951|NCT02675452|528526939|FG005|Overall Study|Lost to Follow-up|0|||
146550952|NCT02675452|528526940|FG006|Overall Study|Lost to Follow-up|0|||
146550953|NCT02675452|528526941|FG007|Overall Study|Lost to Follow-up|0|||
146550954|NCT02675452|528526942|FG008|Overall Study|Lost to Follow-up|0|||
146550955|NCT02675452|528526943|FG009|Overall Study|Lost to Follow-up|0|||
146550956|NCT02675452|528526944|FG010|Overall Study|Lost to Follow-up|0|||
146550957|NCT02675452|528526945|FG011|Overall Study|Lost to Follow-up|0|||
146550958|NCT02675452|528526946|FG012|Overall Study|Lost to Follow-up|1|||
146550959|NCT02675452|528526947|FG013|Overall Study|Lost to Follow-up|0|||
146550960|NCT02675452|528526948|FG014|Overall Study|Lost to Follow-up|0|||
146550961|NCT02675452|528526949|FG015|Overall Study|Lost to Follow-up|0|||
146550962|NCT02675452|528526950|FG016|Overall Study|Lost to Follow-up|0|||
146550963|NCT02675452|528526951|FG017|Overall Study|Lost to Follow-up|0|||
146886714|NCT02574637|529751771|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
146886715|NCT02574637|529751772|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
146886716|NCT02574637|529751773|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
146886717|NCT02574637|529751774|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
146886718|NCT02574637|529751775|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
146886719|NCT02574637|529751776|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
146886720|NCT02574637|529751767|FG000|Double-blind Period|Reason Not Specified|0|||
146966505|NCT00400985|530038821|FG000|Overall Study|Withdrawal by Subject|5|||
146966506|NCT00400985|530038821|FG000|Overall Study|system modification|8|||
146966507|NCT00400985|530038821|FG000|Overall Study|Death|30|||
146966508|NCT00400985|530038821|FG000|Overall Study|Lost to Follow-up|9|||
146966509|NCT00965562|530038822|FG000|Overall Study|Lost to Follow-up|1|||
146966510|NCT00965562|530038823|FG001|Overall Study|Lost to Follow-up|2|||
146966511|NCT00965562|530038824|FG002|Overall Study|Lost to Follow-up|3|||
146966512|NCT00965562|530038822|FG000|Overall Study|Withdrawal by Subject|2|||
146966513|NCT00965562|530038823|FG001|Overall Study|Withdrawal by Subject|2|||
146966514|NCT00965562|530038824|FG002|Overall Study|Withdrawal by Subject|0|||
146966515|NCT03792633|530038825|FG000|Overall Study|Alternative Treatment|17|||
146550964|NCT02675452|528526952|FG018|Overall Study|Lost to Follow-up|0|||
146550965|NCT02675452|528526953|FG019|Overall Study|Lost to Follow-up|0|||
146550966|NCT02675452|528526954|FG020|Overall Study|Lost to Follow-up|0|||
146550967|NCT02675452|528526955|FG021|Overall Study|Lost to Follow-up|0|||
146550968|NCT02675452|528526956|FG022|Overall Study|Lost to Follow-up|0|||
146550969|NCT02675452|528526957|FG023|Overall Study|Lost to Follow-up|0|||
146550970|NCT02675452|528526958|FG024|Overall Study|Lost to Follow-up|0|||
146550971|NCT02675452|528526959|FG025|Overall Study|Lost to Follow-up|0|||
146550972|NCT02675452|528526960|FG026|Overall Study|Lost to Follow-up|1|||
146550973|NCT02675452|528526961|FG027|Overall Study|Lost to Follow-up|0|||
146966516|NCT03792633|530038826|FG001|Overall Study|Alternative Treatment|19|||
146550974|NCT02675452|528526962|FG028|Overall Study|Lost to Follow-up|0|||
146550975|NCT02675452|528526934|FG000|Overall Study|Other|0|||
146550976|NCT02675452|528526935|FG001|Overall Study|Other|0|||
146550977|NCT02675452|528526936|FG002|Overall Study|Other|0|||
146550978|NCT02675452|528526937|FG003|Overall Study|Other|0|||
146550979|NCT02675452|528526938|FG004|Overall Study|Other|0|||
146550980|NCT02675452|528526939|FG005|Overall Study|Other|0|||
146550981|NCT02675452|528526940|FG006|Overall Study|Other|0|||
146550982|NCT02675452|528526941|FG007|Overall Study|Other|0|||
146550983|NCT02675452|528526942|FG008|Overall Study|Other|0|||
146550984|NCT02675452|528526943|FG009|Overall Study|Other|0|||
146550985|NCT02675452|528526944|FG010|Overall Study|Other|0|||
146550986|NCT02675452|528526945|FG011|Overall Study|Other|0|||
146550987|NCT02675452|528526946|FG012|Overall Study|Other|0|||
146550988|NCT02675452|528526947|FG013|Overall Study|Other|0|||
146550989|NCT02675452|528526948|FG014|Overall Study|Other|0|||
146550990|NCT02675452|528526949|FG015|Overall Study|Other|0|||
146550991|NCT02675452|528526950|FG016|Overall Study|Other|0|||
146550992|NCT02675452|528526951|FG017|Overall Study|Other|0|||
146550993|NCT02675452|528526952|FG018|Overall Study|Other|0|||
146550994|NCT02675452|528526953|FG019|Overall Study|Other|0|||
146550995|NCT02675452|528526954|FG020|Overall Study|Other|0|||
146550996|NCT02675452|528526955|FG021|Overall Study|Other|0|||
146550997|NCT02675452|528526956|FG022|Overall Study|Other|0|||
146550998|NCT02675452|528526957|FG023|Overall Study|Other|0|||
146550999|NCT02675452|528526958|FG024|Overall Study|Other|0|||
146551000|NCT02675452|528526959|FG025|Overall Study|Other|0|||
146551001|NCT02675452|528526960|FG026|Overall Study|Other|1|||
146551002|NCT02675452|528526961|FG027|Overall Study|Other|0|||
146551003|NCT02675452|528526962|FG028|Overall Study|Other|0|||
146551004|NCT00545948|528526963|FG000|Overall Study|Not Treated|1|||
146551005|NCT00545948|528526964|FG001|Overall Study|Not Treated|1|||
146551006|NCT00545948|528526965|FG002|Overall Study|Not Treated|7|||
146551007|NCT03467945|528526966|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146886721|NCT02574637|529751768|FG001|Double-blind Period|Reason Not Specified|0|||
146886722|NCT02574637|529751769|FG002|Double-blind Period|Reason Not Specified|0|||
146551008|NCT03467945|528526967|FG001|Treatment Period 2|Withdrawal by Subject|1|||
146551009|NCT03467945|528526968|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146551010|NCT03467945|528526969|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146551011|NCT03467945|528526966|FG000|Treatment Period 3|Withdrawal by Subject|1|||
146551012|NCT03467945|528526967|FG001|Treatment Period 3|Withdrawal by Subject|0|||
146551013|NCT03467945|528526968|FG002|Treatment Period 3|Withdrawal by Subject|2|||
146551014|NCT03467945|528526969|FG003|Treatment Period 3|Withdrawal by Subject|1|||
146551015|NCT00541775|528526986|FG000|Overall Study|Adverse Event|3|||
146551016|NCT00541775|528526987|FG001|Overall Study|Adverse Event|2|||
146551017|NCT00541775|528526988|FG002|Overall Study|Adverse Event|1|||
146886723|NCT02574637|529751770|FG003|Double-blind Period|Reason Not Specified|1|||
146886724|NCT02574637|529751771|FG004|Double-blind Period|Reason Not Specified|0|||
146886725|NCT02574637|529751772|FG005|Double-blind Period|Reason Not Specified|0|||
146966517|NCT03792633|530038825|FG000|Overall Study|Death|2|||
146966518|NCT03792633|530038826|FG001|Overall Study|Death|0|||
146551018|NCT00541775|528526986|FG000|Overall Study|Lack of Efficacy|0|||
146551019|NCT00541775|528526987|FG001|Overall Study|Lack of Efficacy|0|||
146551020|NCT00541775|528526988|FG002|Overall Study|Lack of Efficacy|3|||
146886726|NCT02574637|529751773|FG006|Double-blind Period|Reason Not Specified|0|||
146886727|NCT02574637|529751774|FG007|Double-blind Period|Reason Not Specified|0|||
146886728|NCT02574637|529751775|FG008|Double-blind Period|Reason Not Specified|0|||
146886729|NCT02574637|529751776|FG009|Double-blind Period|Reason Not Specified|0|||
146886730|NCT02574637|529751767|FG000|Open-label (OL) Period|Adverse Event|0|||
146632013|NCT01588522|528830127|FG000|Overall Study|Withdrawal by Subject|1|||
146632014|NCT01588522|528830128|FG001|Overall Study|Withdrawal by Subject|5|||
146632015|NCT01588522|528830129|FG002|Overall Study|Withdrawal by Subject|3|||
146632016|NCT01588522|528830130|FG003|Overall Study|Withdrawal by Subject|1|||
146632017|NCT01588522|528830131|FG004|Overall Study|Withdrawal by Subject|2|||
146632018|NCT01588522|528830132|FG005|Overall Study|Withdrawal by Subject|0|||
146632019|NCT01588522|528830127|FG000|Overall Study|Lack of Efficacy|0|||
146632020|NCT01588522|528830128|FG001|Overall Study|Lack of Efficacy|0|||
146632021|NCT01588522|528830129|FG002|Overall Study|Lack of Efficacy|0|||
146632022|NCT01588522|528830130|FG003|Overall Study|Lack of Efficacy|0|||
146632023|NCT01588522|528830131|FG004|Overall Study|Lack of Efficacy|1|||
146632024|NCT01588522|528830132|FG005|Overall Study|Lack of Efficacy|0|||
146632025|NCT01588522|528830127|FG000|Overall Study|Adverse Event|0|||
146632026|NCT01588522|528830128|FG001|Overall Study|Adverse Event|0|||
146632027|NCT01588522|528830129|FG002|Overall Study|Adverse Event|0|||
146632028|NCT01588522|528830130|FG003|Overall Study|Adverse Event|1|||
146632029|NCT01588522|528830131|FG004|Overall Study|Adverse Event|0|||
146632030|NCT01588522|528830132|FG005|Overall Study|Adverse Event|0|||
146632031|NCT01588522|528830127|FG000|Overall Study|Grade 2 alopecia|1|||
146632032|NCT01588522|528830128|FG001|Overall Study|Grade 2 alopecia|0|||
146886731|NCT02574637|529751768|FG001|Open-label (OL) Period|Adverse Event|0|||
146886732|NCT02574637|529751769|FG002|Open-label (OL) Period|Adverse Event|0|||
146886733|NCT02574637|529751770|FG003|Open-label (OL) Period|Adverse Event|0|||
146632033|NCT01588522|528830129|FG002|Overall Study|Grade 2 alopecia|0|||
146632034|NCT01588522|528830130|FG003|Overall Study|Grade 2 alopecia|0|||
146632035|NCT01588522|528830131|FG004|Overall Study|Grade 2 alopecia|0|||
146632036|NCT01588522|528830132|FG005|Overall Study|Grade 2 alopecia|0|||
146632037|NCT01588522|528830127|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
146632038|NCT01588522|528830128|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
146632039|NCT01588522|528830129|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
146632040|NCT01588522|528830130|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
146632041|NCT01588522|528830131|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
146632042|NCT01588522|528830132|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
146632043|NCT01588522|528830127|FG000|Overall Study|Taken off taxane-based regimen|0|||
146632044|NCT01588522|528830128|FG001|Overall Study|Taken off taxane-based regimen|0|||
146632045|NCT01588522|528830129|FG002|Overall Study|Taken off taxane-based regimen|0|||
146632046|NCT01588522|528830130|FG003|Overall Study|Taken off taxane-based regimen|1|||
146632047|NCT01588522|528830131|FG004|Overall Study|Taken off taxane-based regimen|0|||
146632048|NCT01588522|528830132|FG005|Overall Study|Taken off taxane-based regimen|0|||
146632049|NCT01588522|528830127|FG000|Overall Study|Did not initiate chemotherapy|0|||
146632050|NCT01588522|528830128|FG001|Overall Study|Did not initiate chemotherapy|0|||
146632051|NCT01588522|528830129|FG002|Overall Study|Did not initiate chemotherapy|0|||
146632052|NCT01588522|528830130|FG003|Overall Study|Did not initiate chemotherapy|0|||
146632053|NCT01588522|528830131|FG004|Overall Study|Did not initiate chemotherapy|1|||
146632054|NCT01588522|528830132|FG005|Overall Study|Did not initiate chemotherapy|0|||
146632055|NCT03043794|528830133|FG000|Overall Study|Lost to Follow-up|1|||
146632056|NCT02749422|528830136|FG000|Overall Study|Lost to Follow-up|0|||
146632057|NCT02749422|528830137|FG001|Overall Study|Lost to Follow-up|2|||
146632058|NCT02749422|528830136|FG000|Overall Study|Ineligible|0|||
146632059|NCT02749422|528830137|FG001|Overall Study|Ineligible|1|||
146632060|NCT02855125|528830138|FG000|Overall Study|Withdrawal by Subject|2|||
146632061|NCT02855125|528830139|FG001|Overall Study|Withdrawal by Subject|2|||
146886734|NCT02574637|529751771|FG004|Open-label (OL) Period|Adverse Event|0|||
146886735|NCT02574637|529751772|FG005|Open-label (OL) Period|Adverse Event|0|||
146886736|NCT02574637|529751773|FG006|Open-label (OL) Period|Adverse Event|0|||
146886737|NCT02574637|529751774|FG007|Open-label (OL) Period|Adverse Event|0|||
146886738|NCT02574637|529751775|FG008|Open-label (OL) Period|Adverse Event|1|||
146886739|NCT02574637|529751776|FG009|Open-label (OL) Period|Adverse Event|0|||
146886740|NCT02574637|529751767|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
146632062|NCT02855125|528830138|FG000|Overall Study|Clinical Disease Progression|5|||
146632063|NCT02855125|528830139|FG001|Overall Study|Clinical Disease Progression|4|||
146632064|NCT02855125|528830138|FG000|Overall Study|Radiologic Disease Progression|36|||
146632065|NCT02855125|528830139|FG001|Overall Study|Radiologic Disease Progression|39|||
146632066|NCT02855125|528830138|FG000|Overall Study|Adverse Event|11|||
146632067|NCT02855125|528830139|FG001|Overall Study|Adverse Event|7|||
146632068|NCT02855125|528830138|FG000|Overall Study|Physician Decision|1|||
146632069|NCT02855125|528830139|FG001|Overall Study|Physician Decision|0|||
146632070|NCT02855125|528830138|FG000|Overall Study|On Treatment|9|||
146632071|NCT02855125|528830139|FG001|Overall Study|On Treatment|11|||
146886741|NCT02574637|529751768|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
146886742|NCT02574637|529751769|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
146632072|NCT02855125|528830138|FG000|Overall Study|Randomized but not treated|0|||
146632073|NCT02855125|528830139|FG001|Overall Study|Randomized but not treated|1|||
146632074|NCT04586205|528830149|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
146632075|NCT04586205|528830150|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
146632076|NCT01646125|528831701|FG000|Overall Study|Untreated|2|||
146632077|NCT01646125|528831702|FG001|Overall Study|Untreated|5|||
146632078|NCT01646125|528831701|FG000|Overall Study|Adverse Event|2|||
146632079|NCT01646125|528831702|FG001|Overall Study|Adverse Event|1|||
146632080|NCT01646125|528831701|FG000|Overall Study|Death|1|||
146632081|NCT01646125|528831702|FG001|Overall Study|Death|1|||
146632082|NCT01646125|528831701|FG000|Overall Study|Physician Decision|1|||
146632083|NCT01646125|528831702|FG001|Overall Study|Physician Decision|3|||
146632084|NCT01646125|528831701|FG000|Overall Study|Progressive disease|22|||
146632085|NCT01646125|528831702|FG001|Overall Study|Progressive disease|16|||
146632086|NCT01646125|528831701|FG000|Overall Study|Study terminated by sponsor|2|||
146632087|NCT01646125|528831702|FG001|Overall Study|Study terminated by sponsor|1|||
146632088|NCT01646125|528831701|FG000|Overall Study|Subject/Guardian decision|1|||
146632089|NCT01646125|528831702|FG001|Overall Study|Subject/Guardian decision|1|||
146632090|NCT01942837|528831711|FG000|Overall Study|Death|1|||
146632091|NCT01942837|528831711|FG000|Overall Study|Symptomatic or radiographic progression|49|||
146632092|NCT01942837|528831711|FG000|Overall Study|Adverse Event|6|||
146632093|NCT01942837|528831711|FG000|Overall Study|Physician Decision|3|||
146632094|NCT01942837|528831711|FG000|Overall Study|Withdrawal by Subject|2|||
146632095|NCT01942837|528831711|FG000|Overall Study|Intercurrent Illness|1|||
146632096|NCT01942837|528831711|FG000|Overall Study|On treatment|3|||
146632097|NCT01942837|528831711|FG000|Overall Study|Never initiate the treatment|2|||
146632098|NCT01298648|528831712|FG000|Overall Study|Withdrawal by Subject|2|||
146632099|NCT01298648|528831712|FG000|Overall Study|Lost to Follow-up|21|||
146632100|NCT03077412|528831716|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
146632101|NCT03077412|528831717|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
146632102|NCT03077412|528831718|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
146632103|NCT03077412|528831716|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
146632104|NCT03077412|528831717|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
146632105|NCT03077412|528831718|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
146632106|NCT03077412|528831716|FG000|Overall Study|Adverse Event|1|||
146632107|NCT03077412|528831717|FG001|Overall Study|Adverse Event|2|||
146632108|NCT03077412|528831718|FG002|Overall Study|Adverse Event|2|||
146632109|NCT03077412|528831716|FG000|Overall Study|Investigator's Discretion|0|||
146632110|NCT03077412|528831717|FG001|Overall Study|Investigator's Discretion|1|||
146632111|NCT03077412|528831718|FG002|Overall Study|Investigator's Discretion|1|||
146632112|NCT03077412|528831716|FG000|Overall Study|Withdrew Consent|0|||
146632113|NCT03077412|528831717|FG001|Overall Study|Withdrew Consent|2|||
146632114|NCT03077412|528831718|FG002|Overall Study|Withdrew Consent|0|||
146632115|NCT02266888|528831720|FG000|Overall Study|Death|2|||
146632116|NCT02266888|528831721|FG001|Overall Study|Death|2|||
146632117|NCT02266888|528831722|FG002|Overall Study|Death|4|||
146632118|NCT02266888|528831723|FG003|Overall Study|Death|2|||
146632119|NCT02266888|528831720|FG000|Overall Study|Physician Decision|0|||
146632120|NCT02266888|528831721|FG001|Overall Study|Physician Decision|1|||
146632121|NCT02266888|528831722|FG002|Overall Study|Physician Decision|2|||
146632122|NCT02266888|528831723|FG003|Overall Study|Physician Decision|2|||
146632123|NCT02266888|528831720|FG000|Overall Study|Study Terminated|5|||
146632124|NCT02266888|528831721|FG001|Overall Study|Study Terminated|1|||
146632125|NCT02266888|528831722|FG002|Overall Study|Study Terminated|0|||
146632126|NCT02266888|528831723|FG003|Overall Study|Study Terminated|0|||
146632127|NCT02266888|528831720|FG000|Overall Study|No Longer Eligible|0|||
146632128|NCT02266888|528831721|FG001|Overall Study|No Longer Eligible|0|||
146632129|NCT02266888|528831722|FG002|Overall Study|No Longer Eligible|0|||
146632130|NCT02266888|528831723|FG003|Overall Study|No Longer Eligible|2|||
146632131|NCT02266888|528831720|FG000|Overall Study|Randomization Closed|0|||
146632132|NCT02266888|528831721|FG001|Overall Study|Randomization Closed|0|||
146632133|NCT02266888|528831722|FG002|Overall Study|Randomization Closed|4|||
146886743|NCT02574637|529751770|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
146886744|NCT02574637|529751771|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
146886745|NCT02574637|529751772|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
146886746|NCT02574637|529751773|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
146632134|NCT02266888|528831723|FG003|Overall Study|Randomization Closed|0|||
146632135|NCT02266888|528831720|FG000|Overall Study|Personnel unavailable at transplant|0|||
146632136|NCT02266888|528831721|FG001|Overall Study|Personnel unavailable at transplant|0|||
146632137|NCT02266888|528831722|FG002|Overall Study|Personnel unavailable at transplant|0|||
146632138|NCT02266888|528831723|FG003|Overall Study|Personnel unavailable at transplant|1|||
146632139|NCT02266888|528831720|FG000|Overall Study|Transfer of care|0|||
146632140|NCT02266888|528831721|FG001|Overall Study|Transfer of care|0|||
146886747|NCT02574637|529751774|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
146886748|NCT02574637|529751775|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
146551021|NCT00541775|528526986|FG000|Overall Study|Lost to Follow-up|0|||
146551022|NCT00541775|528526987|FG001|Overall Study|Lost to Follow-up|0|||
146551023|NCT00541775|528526988|FG002|Overall Study|Lost to Follow-up|2|||
146551024|NCT00541775|528526986|FG000|Overall Study|Protocol Violation|1|||
146551025|NCT00541775|528526987|FG001|Overall Study|Protocol Violation|0|||
146551026|NCT00541775|528526988|FG002|Overall Study|Protocol Violation|0|||
146551027|NCT00541775|528526986|FG000|Overall Study|Withdrawal by Subject and Other|5|||
146551028|NCT00541775|528526987|FG001|Overall Study|Withdrawal by Subject and Other|0|||
146551029|NCT00541775|528526988|FG002|Overall Study|Withdrawal by Subject and Other|2|||
146551030|NCT01666314|528526989|FG000|Overall Study|Adverse Event|3|||
146551031|NCT01666314|528526990|FG001|Overall Study|Adverse Event|13|||
146551032|NCT01666314|528526991|FG002|Overall Study|Adverse Event|7|||
146551033|NCT01666314|528526992|FG003|Overall Study|Adverse Event|7|||
146551034|NCT01666314|528526989|FG000|Overall Study|Progressive Disease|11|||
146551035|NCT01666314|528526990|FG001|Overall Study|Progressive Disease|9|||
146551036|NCT01666314|528526991|FG002|Overall Study|Progressive Disease|19|||
146551037|NCT01666314|528526992|FG003|Overall Study|Progressive Disease|20|||
146551038|NCT01666314|528526989|FG000|Overall Study|Symptomatic Deterioration|1|||
146551039|NCT01666314|528526990|FG001|Overall Study|Symptomatic Deterioration|0|||
146551040|NCT01666314|528526991|FG002|Overall Study|Symptomatic Deterioration|2|||
146551041|NCT01666314|528526992|FG003|Overall Study|Symptomatic Deterioration|0|||
146551042|NCT01666314|528526989|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
146551043|NCT01666314|528526990|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
146551044|NCT01666314|528526991|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
146551045|NCT01666314|528526992|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
146551046|NCT01666314|528526989|FG000|Overall Study|Withdrawal by Subject|1|||
146551047|NCT01666314|528526990|FG001|Overall Study|Withdrawal by Subject|1|||
146632141|NCT02266888|528831722|FG002|Overall Study|Transfer of care|1|||
146632142|NCT02266888|528831723|FG003|Overall Study|Transfer of care|0|||
146551048|NCT01666314|528526991|FG002|Overall Study|Withdrawal by Subject|2|||
146551049|NCT01666314|528526992|FG003|Overall Study|Withdrawal by Subject|3|||
146551050|NCT01666314|528526989|FG000|Overall Study|Reason not Specified|10|||
146632143|NCT02351856|528831724|FG000|Overall Study|Adverse Event|2|||
146551051|NCT01666314|528526990|FG001|Overall Study|Reason not Specified|7|||
146551052|NCT01666314|528526991|FG002|Overall Study|Reason not Specified|5|||
146551053|NCT01666314|528526992|FG003|Overall Study|Reason not Specified|5|||
146551054|NCT00032487|528526993|FG000|Overall Study|Withdrawal by Subject|67|||
146551055|NCT00032487|528526994|FG001|Overall Study|Withdrawal by Subject|43|||
146551056|NCT00032487|528526993|FG000|Overall Study|Adverse Event|3|||
146551057|NCT00032487|528526994|FG001|Overall Study|Adverse Event|7|||
146551058|NCT00032487|528526993|FG000|Overall Study|Lost to Follow-up|57|||
146551059|NCT00032487|528526994|FG001|Overall Study|Lost to Follow-up|58|||
146551060|NCT00032487|528526993|FG000|Overall Study|Had other reason|12|||
146551061|NCT00032487|528526994|FG001|Overall Study|Had other reason|12|||
146551062|NCT04913675|528526996|FG000|Main Study (Up to Week 36)|Death|0|||
146551063|NCT04913675|528526997|FG001|Main Study (Up to Week 36)|Death|2|||
146551064|NCT04913675|528526998|FG002|Main Study (Up to Week 36)|Death|2|||
146551065|NCT04913675|528526999|FG003|Main Study (Up to Week 36)|Death|0|||
146551066|NCT04913675|528526996|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
146551067|NCT04913675|528526997|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
146551068|NCT04913675|528526998|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
146551069|NCT04913675|528526999|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
146551070|NCT04913675|528526996|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
146551071|NCT04913675|528526997|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
146551072|NCT04913675|528526998|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
146551073|NCT04913675|528526999|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
146551074|NCT04913675|528526996|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
146551075|NCT04913675|528526997|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
146551076|NCT04913675|528526998|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
146551077|NCT04913675|528526999|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
146551078|NCT04913675|528526996|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
146551079|NCT04913675|528526997|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
146551080|NCT04913675|528526998|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
146551081|NCT04913675|528526999|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
146551082|NCT02975700|528527000|FG000|Overall Study|Adverse Event|1|||
146551083|NCT02975700|528527000|FG000|Overall Study|Progressive disease|3|||
146551084|NCT02975700|528527000|FG000|Overall Study|Failed screening criteria|2|||
146551085|NCT01541254|528527002|FG000|Overall Study|Withdrawal by Subject|1|||
146551086|NCT01541254|528527002|FG000|Overall Study|excluded - metal allergy|1|||
146551087|NCT01541254|528527002|FG000|Overall Study|enrolled after study closed|1|||
146551088|NCT01541254|528527002|FG000|Overall Study|GI bleed prior to procedure|1|||
146551089|NCT01541254|528527002|FG000|Overall Study|stent not required|1|||
146551090|NCT01541254|528527002|FG000|Overall Study|alternate stent used|1|||
146551091|NCT05660538|528527003|FG000|Overall Study|Adverse Event|0|||
146551092|NCT05660538|528527004|FG001|Overall Study|Adverse Event|0|||
146551093|NCT05660538|528527005|FG002|Overall Study|Adverse Event|1|||
146551094|NCT05660538|528527006|FG003|Overall Study|Adverse Event|0|||
146551095|NCT05660538|528527003|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
146551096|NCT05660538|528527004|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
146551097|NCT05660538|528527005|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
146551098|NCT05660538|528527006|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
146551099|NCT05660538|528527003|FG000|Overall Study|Lost to Follow-up|0|||
146551100|NCT05660538|528527004|FG001|Overall Study|Lost to Follow-up|0|||
146551101|NCT05660538|528527005|FG002|Overall Study|Lost to Follow-up|1|||
146551102|NCT05660538|528527006|FG003|Overall Study|Lost to Follow-up|1|||
146551103|NCT05660538|528527003|FG000|Overall Study|Death|0|||
146551104|NCT05660538|528527004|FG001|Overall Study|Death|0|||
146551105|NCT05660538|528527005|FG002|Overall Study|Death|1|||
146886749|NCT02574637|529751776|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
146886750|NCT02574637|529751767|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
146886751|NCT02574637|529751768|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
146886752|NCT02574637|529751769|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
146886753|NCT02574637|529751770|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
146551106|NCT05660538|528527006|FG003|Overall Study|Death|0|||
146551107|NCT05660538|528527003|FG000|Overall Study|Physician Decision|0|||
146551108|NCT05660538|528527004|FG001|Overall Study|Physician Decision|0|||
146551109|NCT05660538|528527005|FG002|Overall Study|Physician Decision|0|||
146551110|NCT05660538|528527006|FG003|Overall Study|Physician Decision|1|||
146886754|NCT02574637|529751771|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
146551111|NCT05660538|528527003|FG000|Overall Study|Sponsor Decision|1|||
146551112|NCT05660538|528527004|FG001|Overall Study|Sponsor Decision|0|||
146551113|NCT05660538|528527005|FG002|Overall Study|Sponsor Decision|0|||
146551114|NCT05660538|528527006|FG003|Overall Study|Sponsor Decision|0|||
146551115|NCT05660538|528527003|FG000|Overall Study|Other|1|||
146551116|NCT05660538|528527004|FG001|Overall Study|Other|0|||
146632144|NCT02351856|528831724|FG000|Overall Study|Physician Decision|5|||
146632145|NCT02351856|528831724|FG000|Overall Study|Study terminated by sponsor|1|||
146632146|NCT01458392|528831727|FG000|Overall Study|Death|2|||
146632147|NCT01458392|528831728|FG001|Overall Study|Death|11|||
146632148|NCT01458392|528831729|FG002|Overall Study|Death|22|||
146632149|NCT01458392|528831727|FG000|Overall Study|At the discretion of the sponsor|0|||
146632150|NCT01458392|528831728|FG001|Overall Study|At the discretion of the sponsor|2|||
146632151|NCT01458392|528831729|FG002|Overall Study|At the discretion of the sponsor|7|||
146632152|NCT01458392|528831727|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
146632153|NCT01458392|528831728|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
146632154|NCT01458392|528831729|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
146632155|NCT01281124|528831732|FG000|Overall Study|Death|1|||
146632156|NCT00918255|528831733|FG000|Overall Study|Adverse Event|1|||
146632157|NCT00918255|528831734|FG001|Overall Study|Adverse Event|0|||
146632158|NCT00918255|528831735|FG002|Overall Study|Adverse Event|0|||
146632159|NCT00918255|528831733|FG000|Overall Study|Withdrawal by Subject|1|||
146632160|NCT00918255|528831734|FG001|Overall Study|Withdrawal by Subject|0|||
146632161|NCT00918255|528831735|FG002|Overall Study|Withdrawal by Subject|2|||
146632162|NCT00918255|528831733|FG000|Overall Study|Lack of Efficacy|1|||
146632163|NCT00918255|528831734|FG001|Overall Study|Lack of Efficacy|0|||
146632164|NCT00918255|528831735|FG002|Overall Study|Lack of Efficacy|0|||
146632165|NCT00918255|528831733|FG000|Overall Study|Lost to Follow-up|1|||
146632166|NCT00918255|528831734|FG001|Overall Study|Lost to Follow-up|0|||
146632167|NCT00918255|528831735|FG002|Overall Study|Lost to Follow-up|2|||
146632168|NCT00918255|528831733|FG000|Overall Study|Exceeded allowed number of interventions|0|||
146632169|NCT00918255|528831734|FG001|Overall Study|Exceeded allowed number of interventions|0|||
146632170|NCT00918255|528831735|FG002|Overall Study|Exceeded allowed number of interventions|1|||
146632171|NCT00918255|528831733|FG000|Overall Study|Non-compliance|1|||
146632172|NCT00918255|528831734|FG001|Overall Study|Non-compliance|0|||
146632173|NCT00918255|528831735|FG002|Overall Study|Non-compliance|0|||
146632174|NCT00918255|528831733|FG000|Overall Study|Investigator discretion|1|||
146632175|NCT00918255|528831734|FG001|Overall Study|Investigator discretion|0|||
146632176|NCT00918255|528831735|FG002|Overall Study|Investigator discretion|0|||
146632177|NCT02038933|528831736|FG000|Overall Study|Disease progression|104|||
146632178|NCT02038933|528831736|FG000|Overall Study|Study drug toxicity|6|||
146632179|NCT02038933|528831736|FG000|Overall Study|Adverse event unrelated to study drug|6|||
146632180|NCT02038933|528831736|FG000|Overall Study|Participant request to discontinue treatment|2|||
146632181|NCT02038933|528831736|FG000|Overall Study|Lost to Follow-up|1|||
146632182|NCT02038933|528831736|FG000|Overall Study|Other reasons|2|||
146632183|NCT00753506|528831737|FG000|Overall Study|Withdrawal by Subject|4|||
146632184|NCT00753506|528831738|FG001|Overall Study|Withdrawal by Subject|1|||
146632185|NCT00753506|528831737|FG000|Overall Study|Lost to Follow-up|2|||
146632186|NCT00753506|528831738|FG001|Overall Study|Lost to Follow-up|0|||
146632187|NCT00753506|528831737|FG000|Overall Study|Other reason|1|||
146632188|NCT00753506|528831738|FG001|Overall Study|Other reason|1|||
146632189|NCT04226742|528831741|FG000|Overall Study|Lost to Follow-up|16|||
146632190|NCT04226742|528831742|FG001|Overall Study|Lost to Follow-up|13|||
146632191|NCT04226742|528831741|FG000|Overall Study|Withdrawal by Subject|5|||
146632192|NCT04226742|528831742|FG001|Overall Study|Withdrawal by Subject|3|||
146632193|NCT01193244|528831745|FG000|Overall Study|Withdrawal by Subject|79|||
146632194|NCT01193244|528831746|FG001|Overall Study|Withdrawal by Subject|97|||
146632195|NCT01193244|528831745|FG000|Overall Study|Other|303|||
146632196|NCT01193244|528831746|FG001|Overall Study|Other|278|||
146632197|NCT01193244|528831745|FG000|Overall Study|Lost to Follow-up|6|||
146632198|NCT01193244|528831746|FG001|Overall Study|Lost to Follow-up|15|||
146632199|NCT01417377|528831747|FG000|Overall Study|Lost to Follow-up|12|||
146632200|NCT01417377|528831747|FG000|Overall Study|Enrolled, but not treated|1|||
146632201|NCT02113982|528831748|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
146632202|NCT02113982|528831749|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
146632203|NCT02113982|528831750|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
146632204|NCT02113982|528831751|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
146632205|NCT02113982|528831752|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
146632206|NCT02113982|528831753|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
146632207|NCT02113982|528831754|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
146632208|NCT02113982|528831755|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
146632209|NCT02113982|528831756|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
146632210|NCT02113982|528831757|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
146632211|NCT02113982|528831758|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
146632212|NCT02113982|528831759|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
146632213|NCT02113982|528831760|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
146632214|NCT02113982|528831761|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
146632215|NCT02113982|528831748|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
146632216|NCT02113982|528831749|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
146632217|NCT02113982|528831750|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
146632218|NCT02113982|528831751|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
146632219|NCT02113982|528831752|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
146551117|NCT05660538|528527005|FG002|Overall Study|Other|0|||
146551118|NCT05660538|528527006|FG003|Overall Study|Other|1|||
146551119|NCT05660538|528527003|FG000|Overall Study|Randomized but did not receive study drug|1|||
146551120|NCT05660538|528527004|FG001|Overall Study|Randomized but did not receive study drug|0|||
146551121|NCT05660538|528527005|FG002|Overall Study|Randomized but did not receive study drug|0|||
146551122|NCT05660538|528527006|FG003|Overall Study|Randomized but did not receive study drug|1|||
146551123|NCT05660538|528527003|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
146551124|NCT05660538|528527004|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
146551125|NCT05660538|528527005|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
146551126|NCT05660538|528527006|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
146551127|NCT04518410|528527008|FG000|Overall Study|Lost to Follow-up|1|||
146551128|NCT04518410|528527009|FG001|Overall Study|Lost to Follow-up|1|||
146551129|NCT04518410|528527010|FG002|Overall Study|Lost to Follow-up|8|||
146551130|NCT04518410|528527011|FG003|Overall Study|Lost to Follow-up|5|||
146551131|NCT04518410|528527012|FG004|Overall Study|Lost to Follow-up|92|||
146551132|NCT04518410|528527013|FG005|Overall Study|Lost to Follow-up|25|||
146551133|NCT04518410|528527014|FG006|Overall Study|Lost to Follow-up|25|||
146551134|NCT04518410|528527015|FG007|Overall Study|Lost to Follow-up|3|||
146551135|NCT04518410|528527016|FG008|Overall Study|Lost to Follow-up|2|||
146551136|NCT04518410|528527017|FG009|Overall Study|Lost to Follow-up|13|||
146551137|NCT04518410|528527018|FG010|Overall Study|Lost to Follow-up|9|||
146551138|NCT04518410|528527019|FG011|Overall Study|Lost to Follow-up|13|||
146551139|NCT04518410|528527020|FG012|Overall Study|Lost to Follow-up|9|||
146551140|NCT04518410|528527021|FG013|Overall Study|Lost to Follow-up|13|||
146551141|NCT04518410|528527022|FG014|Overall Study|Lost to Follow-up|8|||
146551142|NCT04518410|528527023|FG015|Overall Study|Lost to Follow-up|10|||
146551143|NCT04518410|528527024|FG016|Overall Study|Lost to Follow-up|6|||
146551144|NCT04518410|528527025|FG017|Overall Study|Lost to Follow-up|13|||
146551145|NCT04518410|528527026|FG018|Overall Study|Lost to Follow-up|21|||
146551146|NCT04518410|528527027|FG019|Overall Study|Lost to Follow-up|6|||
146551147|NCT04518410|528527028|FG020|Overall Study|Lost to Follow-up|7|||
146551148|NCT04518410|528527029|FG021|Overall Study|Lost to Follow-up|21|||
146551149|NCT04518410|528527030|FG022|Overall Study|Lost to Follow-up|1|||
146551150|NCT04518410|528527031|FG023|Overall Study|Lost to Follow-up|7|||
146551151|NCT04518410|528527032|FG024|Overall Study|Lost to Follow-up|6|||
146551152|NCT04518410|528527008|FG000|Overall Study|Withdrawal by Subject|1|||
146551153|NCT04518410|528527009|FG001|Overall Study|Withdrawal by Subject|2|||
146551154|NCT04518410|528527010|FG002|Overall Study|Withdrawal by Subject|2|||
146551155|NCT04518410|528527011|FG003|Overall Study|Withdrawal by Subject|3|||
146551156|NCT04518410|528527012|FG004|Overall Study|Withdrawal by Subject|20|||
146551157|NCT04518410|528527013|FG005|Overall Study|Withdrawal by Subject|20|||
146551158|NCT04518410|528527014|FG006|Overall Study|Withdrawal by Subject|25|||
146551159|NCT04518410|528527015|FG007|Overall Study|Withdrawal by Subject|6|||
146551160|NCT04518410|528527016|FG008|Overall Study|Withdrawal by Subject|1|||
146551161|NCT04518410|528527017|FG009|Overall Study|Withdrawal by Subject|12|||
146551162|NCT04518410|528527018|FG010|Overall Study|Withdrawal by Subject|5|||
146551163|NCT04518410|528527019|FG011|Overall Study|Withdrawal by Subject|7|||
146551164|NCT04518410|528527020|FG012|Overall Study|Withdrawal by Subject|2|||
146551165|NCT04518410|528527021|FG013|Overall Study|Withdrawal by Subject|13|||
146551166|NCT04518410|528527022|FG014|Overall Study|Withdrawal by Subject|4|||
146551167|NCT04518410|528527023|FG015|Overall Study|Withdrawal by Subject|9|||
146551168|NCT04518410|528527024|FG016|Overall Study|Withdrawal by Subject|0|||
146551169|NCT04518410|528527025|FG017|Overall Study|Withdrawal by Subject|15|||
146551170|NCT04518410|528527026|FG018|Overall Study|Withdrawal by Subject|12|||
146551171|NCT04518410|528527027|FG019|Overall Study|Withdrawal by Subject|9|||
146551172|NCT04518410|528527028|FG020|Overall Study|Withdrawal by Subject|14|||
146551173|NCT04518410|528527029|FG021|Overall Study|Withdrawal by Subject|3|||
146551174|NCT04518410|528527030|FG022|Overall Study|Withdrawal by Subject|2|||
146551175|NCT04518410|528527031|FG023|Overall Study|Withdrawal by Subject|9|||
146632220|NCT02113982|528831753|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
146551176|NCT04518410|528527032|FG024|Overall Study|Withdrawal by Subject|8|||
146966519|NCT03792633|530038825|FG000|Overall Study|Disease progression|8|||
146966520|NCT03792633|530038826|FG001|Overall Study|Disease progression|9|||
146551177|NCT04518410|528527008|FG000|Overall Study|Other|1|||
146551178|NCT04518410|528527009|FG001|Overall Study|Other|0|||
146551179|NCT04518410|528527010|FG002|Overall Study|Other|0|||
146551180|NCT04518410|528527011|FG003|Overall Study|Other|1|||
146551181|NCT04518410|528527012|FG004|Overall Study|Other|6|||
146551182|NCT04518410|528527013|FG005|Overall Study|Other|6|||
146886755|NCT02574637|529751772|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
146886756|NCT02574637|529751773|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
146886757|NCT02574637|529751774|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
146886758|NCT02574637|529751775|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
146886759|NCT02574637|529751776|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
146886760|NCT04016311|529751777|FG000|Overall Study|Withdrawal by Subject|1|||
146886761|NCT04016311|529751778|FG001|Overall Study|Withdrawal by Subject|0|||
146886762|NCT04029519|529751781|FG000|Overall Study|Protocol Violation|1|||
146886763|NCT04029519|529751781|FG000|Overall Study|Withdrawal by Subject|3|||
146886764|NCT04029519|529751781|FG000|Overall Study|Lost to Follow-up|1|||
146886765|NCT00094055|529751788|FG000|Overall Study|Adverse Event|11|||
146886766|NCT00094055|529751788|FG000|Overall Study|Death|4|||
146886767|NCT00094055|529751788|FG000|Overall Study|Lack of Efficacy|17|||
146886768|NCT00094055|529751788|FG000|Overall Study|Lost to Follow-up|2|||
146886769|NCT00094055|529751788|FG000|Overall Study|progressive disease|2|||
146886770|NCT00094055|529751788|FG000|Overall Study|clinical progression|1|||
146886771|NCT00094055|529751788|FG000|Overall Study|roll-over to another study|14|||
146886772|NCT00094055|529751788|FG000|Overall Study|Withdrawal by Subject|9|||
146886773|NCT01164722|529751794|FG000|Overall Study|Adverse Event|0|||
146886774|NCT01164722|529751795|FG001|Overall Study|Adverse Event|1|||
146886775|NCT01164722|529751794|FG000|Overall Study|Withdrawal by Subject|3|||
146886776|NCT01164722|529751795|FG001|Overall Study|Withdrawal by Subject|4|||
146886777|NCT01164722|529751794|FG000|Overall Study|Lost to Follow-up|3|||
146886778|NCT01164722|529751795|FG001|Overall Study|Lost to Follow-up|6|||
146886779|NCT01164722|529751794|FG000|Overall Study|met protocol criteria for non-treatment|11|||
146886780|NCT01164722|529751795|FG001|Overall Study|met protocol criteria for non-treatment|1|||
146886781|NCT01164722|529751794|FG000|Overall Study|enrolled on other study, concomitant med|1|||
146886782|NCT01164722|529751795|FG001|Overall Study|enrolled on other study, concomitant med|3|||
146886783|NCT04673786|529751796|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
146886784|NCT04673786|529751797|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
146886785|NCT04673786|529751798|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
146886786|NCT04673786|529751796|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
146886787|NCT04673786|529751797|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
146886788|NCT04673786|529751798|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
146886789|NCT04673786|529751796|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
146886790|NCT04673786|529751797|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
146886791|NCT04673786|529751798|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
146886792|NCT04673786|529751796|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
146886793|NCT04673786|529751797|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
146886794|NCT04673786|529751798|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
146886795|NCT04673786|529751796|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
146551183|NCT04518410|528527014|FG006|Overall Study|Other|5|||
146886796|NCT04673786|529751797|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
146886797|NCT04673786|529751798|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
146886798|NCT04673786|529751796|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
146886799|NCT04673786|529751797|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
146886800|NCT04673786|529751798|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
146886801|NCT01422239|529751799|FG000|Overall Study|Lost to Follow-up|4|||
146886802|NCT01422239|529751800|FG001|Overall Study|Lost to Follow-up|3|||
146886803|NCT01110200|529751801|FG000|Overall Study|Adverse Event|28|||
146886804|NCT01110200|529751802|FG001|Overall Study|Adverse Event|28|||
146551184|NCT04518410|528527015|FG007|Overall Study|Other|2|||
146551185|NCT04518410|528527016|FG008|Overall Study|Other|0|||
146551186|NCT04518410|528527017|FG009|Overall Study|Other|1|||
146551187|NCT04518410|528527018|FG010|Overall Study|Other|0|||
146551188|NCT04518410|528527019|FG011|Overall Study|Other|2|||
146551189|NCT04518410|528527020|FG012|Overall Study|Other|0|||
146551190|NCT04518410|528527021|FG013|Overall Study|Other|0|||
146551191|NCT04518410|528527022|FG014|Overall Study|Other|0|||
146551192|NCT04518410|528527023|FG015|Overall Study|Other|3|||
146551193|NCT04518410|528527024|FG016|Overall Study|Other|1|||
146551194|NCT04518410|528527025|FG017|Overall Study|Other|1|||
146551195|NCT04518410|528527026|FG018|Overall Study|Other|1|||
146966521|NCT03792633|530038825|FG000|Overall Study|Lost to Follow-up|1|||
146551196|NCT04518410|528527027|FG019|Overall Study|Other|0|||
146765260|NCT03354390|529307334|FG002|Level 2|Lost to Follow-up|0|||
146765261|NCT03354390|529307335|FG003|Level 2|Lost to Follow-up|0|||
146765262|NCT03354390|529307332|FG000|Level 3|Death|0|||
146551197|NCT04518410|528527028|FG020|Overall Study|Other|1|||
146551198|NCT04518410|528527029|FG021|Overall Study|Other|0|||
146551199|NCT04518410|528527030|FG022|Overall Study|Other|1|||
146551200|NCT04518410|528527031|FG023|Overall Study|Other|2|||
146551201|NCT04518410|528527032|FG024|Overall Study|Other|2|||
146966522|NCT03792633|530038826|FG001|Overall Study|Lost to Follow-up|1|||
146632221|NCT02113982|528831754|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
146632222|NCT02113982|528831755|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
146632223|NCT02113982|528831756|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
146632224|NCT02113982|528831757|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
146966523|NCT03792633|530038825|FG000|Overall Study|Screen fail|1|||
146966524|NCT03792633|530038826|FG001|Overall Study|Screen fail|0|||
146765263|NCT03354390|529307333|FG001|Level 3|Death|0|||
146886805|NCT01110200|529751801|FG000|Overall Study|Withdrawal by Subject|25|||
146886806|NCT01110200|529751802|FG001|Overall Study|Withdrawal by Subject|32|||
146886807|NCT01110200|529751801|FG000|Overall Study|Lack of Efficacy|16|||
146886808|NCT01110200|529751802|FG001|Overall Study|Lack of Efficacy|25|||
146551202|NCT04518410|528527008|FG000|Overall Study|Protocol Violation|0|||
146551203|NCT04518410|528527009|FG001|Overall Study|Protocol Violation|0|||
146551204|NCT04518410|528527010|FG002|Overall Study|Protocol Violation|0|||
146551205|NCT04518410|528527011|FG003|Overall Study|Protocol Violation|2|||
146551206|NCT04518410|528527012|FG004|Overall Study|Protocol Violation|17|||
146551207|NCT04518410|528527013|FG005|Overall Study|Protocol Violation|1|||
146551208|NCT04518410|528527014|FG006|Overall Study|Protocol Violation|2|||
146551209|NCT04518410|528527015|FG007|Overall Study|Protocol Violation|1|||
146551210|NCT04518410|528527016|FG008|Overall Study|Protocol Violation|0|||
146551211|NCT04518410|528527017|FG009|Overall Study|Protocol Violation|0|||
146551212|NCT04518410|528527018|FG010|Overall Study|Protocol Violation|0|||
146551213|NCT04518410|528527019|FG011|Overall Study|Protocol Violation|0|||
146551214|NCT04518410|528527020|FG012|Overall Study|Protocol Violation|0|||
146551215|NCT04518410|528527021|FG013|Overall Study|Protocol Violation|0|||
146551216|NCT04518410|528527022|FG014|Overall Study|Protocol Violation|0|||
146551217|NCT04518410|528527023|FG015|Overall Study|Protocol Violation|0|||
146551218|NCT04518410|528527024|FG016|Overall Study|Protocol Violation|1|||
146551219|NCT04518410|528527025|FG017|Overall Study|Protocol Violation|1|||
146551220|NCT04518410|528527026|FG018|Overall Study|Protocol Violation|0|||
146551221|NCT04518410|528527027|FG019|Overall Study|Protocol Violation|0|||
146551222|NCT04518410|528527028|FG020|Overall Study|Protocol Violation|1|||
146632225|NCT02113982|528831758|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
146632226|NCT02113982|528831759|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
146551223|NCT04518410|528527029|FG021|Overall Study|Protocol Violation|2|||
146551224|NCT04518410|528527030|FG022|Overall Study|Protocol Violation|0|||
146551225|NCT04518410|528527031|FG023|Overall Study|Protocol Violation|3|||
146551226|NCT04518410|528527032|FG024|Overall Study|Protocol Violation|0|||
146551227|NCT04518410|528527008|FG000|Overall Study|Death|0|||
146966525|NCT03792633|530038825|FG000|Overall Study|Second malignancy|0|||
146551228|NCT04518410|528527009|FG001|Overall Study|Death|0|||
146551229|NCT04518410|528527010|FG002|Overall Study|Death|0|||
146551230|NCT04518410|528527011|FG003|Overall Study|Death|0|||
146551231|NCT04518410|528527012|FG004|Overall Study|Death|12|||
146551232|NCT04518410|528527013|FG005|Overall Study|Death|2|||
146551233|NCT04518410|528527014|FG006|Overall Study|Death|11|||
146551234|NCT04518410|528527015|FG007|Overall Study|Death|0|||
146551235|NCT04518410|528527016|FG008|Overall Study|Death|1|||
146551236|NCT04518410|528527017|FG009|Overall Study|Death|0|||
146551237|NCT04518410|528527018|FG010|Overall Study|Death|0|||
146551238|NCT04518410|528527019|FG011|Overall Study|Death|0|||
146551239|NCT04518410|528527020|FG012|Overall Study|Death|0|||
146551240|NCT04518410|528527021|FG013|Overall Study|Death|1|||
146551241|NCT04518410|528527022|FG014|Overall Study|Death|1|||
146551242|NCT04518410|528527023|FG015|Overall Study|Death|0|||
146551243|NCT04518410|528527024|FG016|Overall Study|Death|0|||
146551244|NCT04518410|528527025|FG017|Overall Study|Death|1|||
146551245|NCT04518410|528527026|FG018|Overall Study|Death|4|||
146551246|NCT04518410|528527027|FG019|Overall Study|Death|4|||
146551247|NCT04518410|528527028|FG020|Overall Study|Death|1|||
146551248|NCT04518410|528527029|FG021|Overall Study|Death|0|||
146551249|NCT04518410|528527030|FG022|Overall Study|Death|0|||
146551250|NCT04518410|528527031|FG023|Overall Study|Death|0|||
146551251|NCT04518410|528527032|FG024|Overall Study|Death|0|||
146551252|NCT04518410|528527008|FG000|Overall Study|Requirement to start alternative therapy|0|||
146551253|NCT04518410|528527009|FG001|Overall Study|Requirement to start alternative therapy|0|||
146886809|NCT01110200|529751801|FG000|Overall Study|Protocol Violation|14|||
146886810|NCT01110200|529751802|FG001|Overall Study|Protocol Violation|12|||
146886811|NCT01110200|529751801|FG000|Overall Study|Physician Decision|13|||
146886812|NCT01110200|529751802|FG001|Overall Study|Physician Decision|17|||
146886813|NCT01110200|529751801|FG000|Overall Study|Lost to Follow-up|10|||
146886814|NCT01110200|529751802|FG001|Overall Study|Lost to Follow-up|7|||
146886815|NCT01250379|529751813|FG000|Overall Study|Death|141|||
146886816|NCT01250379|529751814|FG001|Overall Study|Death|148|||
146886817|NCT01250379|529751813|FG000|Overall Study|Withdrawal by Subject|32|||
146886818|NCT01250379|529751814|FG001|Overall Study|Withdrawal by Subject|20|||
146551254|NCT04518410|528527010|FG002|Overall Study|Requirement to start alternative therapy|1|||
146551255|NCT04518410|528527011|FG003|Overall Study|Requirement to start alternative therapy|0|||
146551256|NCT04518410|528527012|FG004|Overall Study|Requirement to start alternative therapy|0|||
146551257|NCT04518410|528527013|FG005|Overall Study|Requirement to start alternative therapy|0|||
146551258|NCT04518410|528527014|FG006|Overall Study|Requirement to start alternative therapy|0|||
146551259|NCT04518410|528527015|FG007|Overall Study|Requirement to start alternative therapy|0|||
146551260|NCT04518410|528527016|FG008|Overall Study|Requirement to start alternative therapy|0|||
146551261|NCT04518410|528527017|FG009|Overall Study|Requirement to start alternative therapy|0|||
146551262|NCT04518410|528527018|FG010|Overall Study|Requirement to start alternative therapy|0|||
146551263|NCT04518410|528527019|FG011|Overall Study|Requirement to start alternative therapy|0|||
146551264|NCT04518410|528527020|FG012|Overall Study|Requirement to start alternative therapy|0|||
146551265|NCT04518410|528527021|FG013|Overall Study|Requirement to start alternative therapy|0|||
146551266|NCT04518410|528527022|FG014|Overall Study|Requirement to start alternative therapy|0|||
146551267|NCT04518410|528527023|FG015|Overall Study|Requirement to start alternative therapy|0|||
146886819|NCT01250379|529751813|FG000|Overall Study|Physician Decision|11|||
146886820|NCT01250379|529751814|FG001|Overall Study|Physician Decision|3|||
146886821|NCT01250379|529751813|FG000|Overall Study|Protocol Violation|2|||
146551268|NCT04518410|528527024|FG016|Overall Study|Requirement to start alternative therapy|0|||
146551269|NCT04518410|528527025|FG017|Overall Study|Requirement to start alternative therapy|0|||
146886822|NCT01250379|529751814|FG001|Overall Study|Protocol Violation|8|||
146551270|NCT04518410|528527026|FG018|Overall Study|Requirement to start alternative therapy|0|||
146551271|NCT04518410|528527027|FG019|Overall Study|Requirement to start alternative therapy|0|||
146551272|NCT04518410|528527028|FG020|Overall Study|Requirement to start alternative therapy|0|||
146551273|NCT04518410|528527029|FG021|Overall Study|Requirement to start alternative therapy|0|||
146551274|NCT04518410|528527030|FG022|Overall Study|Requirement to start alternative therapy|0|||
146551275|NCT04518410|528527031|FG023|Overall Study|Requirement to start alternative therapy|0|||
146886823|NCT01250379|529751813|FG000|Overall Study|Lost to Follow-up|9|||
146886824|NCT01250379|529751814|FG001|Overall Study|Lost to Follow-up|6|||
146886825|NCT01250379|529751813|FG000|Overall Study|Adverse Event|5|||
146886826|NCT01250379|529751814|FG001|Overall Study|Adverse Event|4|||
146886827|NCT01250379|529751813|FG000|Overall Study|Other|0|||
146886828|NCT01250379|529751814|FG001|Overall Study|Other|4|||
146886829|NCT01250379|529751813|FG000|Overall Study|Participant noncompliance|2|||
146886830|NCT01250379|529751814|FG001|Overall Study|Participant noncompliance|0|||
146886831|NCT01489527|529751815|FG000|Overall Study|Pregnancy|9|||
146886832|NCT01489527|529751816|FG001|Overall Study|Pregnancy|14|||
146886833|NCT01489527|529751815|FG000|Overall Study|Participant moved|6|||
146886834|NCT01489527|529751816|FG001|Overall Study|Participant moved|7|||
146886835|NCT01489527|529751815|FG000|Overall Study|Withdrawal by Subject|0|||
146886836|NCT01489527|529751816|FG001|Overall Study|Withdrawal by Subject|4|||
146886837|NCT01489527|529751815|FG000|Overall Study|Lost to Follow-up|5|||
146886838|NCT01489527|529751816|FG001|Overall Study|Lost to Follow-up|1|||
146886839|NCT01489527|529751815|FG000|Overall Study|Procedures|1|||
146886840|NCT01489527|529751816|FG001|Overall Study|Procedures|0|||
146886841|NCT01489527|529751815|FG000|Overall Study|Not compliant|1|||
146886842|NCT01489527|529751816|FG001|Overall Study|Not compliant|0|||
146886843|NCT01984268|529751817|FG000|Overall Study|Study Terminated|15|||
146886844|NCT04899232|529751818|FG000|Screening Period|Physician Decision|1|||
146886845|NCT04899232|529751819|FG001|Screening Period|Physician Decision|0|||
146886846|NCT04899232|529751820|FG002|Screening Period|Physician Decision|0|||
146886847|NCT04899232|529751818|FG000|Screening Period|Withdrawal by Subject|1|||
146886848|NCT04899232|529751819|FG001|Screening Period|Withdrawal by Subject|0|||
146886849|NCT04899232|529751820|FG002|Screening Period|Withdrawal by Subject|0|||
146886850|NCT04899232|529751818|FG000|Screening Period|Participant discharged before receiving intervention|3|||
146886851|NCT04899232|529751819|FG001|Screening Period|Participant discharged before receiving intervention|0|||
146886852|NCT04899232|529751820|FG002|Screening Period|Participant discharged before receiving intervention|0|||
146886853|NCT02926950|529751824|FG000|Overall Study|Adverse Event|4|||
146886854|NCT02926950|529751825|FG001|Overall Study|Adverse Event|6|||
146886855|NCT02926950|529751824|FG000|Overall Study|At the participant's own request|21|||
146886856|NCT02926950|529751825|FG001|Overall Study|At the participant's own request|25|||
146886857|NCT02926950|529751824|FG000|Overall Study|Reason not Specified|17|||
146886858|NCT02926950|529751825|FG001|Overall Study|Reason not Specified|9|||
146886859|NCT02926950|529751824|FG000|Overall Study|Lost to Follow-up|7|||
146886860|NCT02926950|529751825|FG001|Overall Study|Lost to Follow-up|8|||
146886861|NCT05036083|529751826|FG000|Overall Study|Physician Decision|1|||
146886862|NCT05036083|529751826|FG000|Overall Study|Withdrawal by Subject|1|||
146886863|NCT05036083|529751826|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
146886864|NCT05036083|529751826|FG000|Overall Study|IV not sustainable|1|||
146886865|NCT05061719|529751827|FG000|Overall Study|Adverse Event|60|||
146886866|NCT05061719|529751827|FG000|Overall Study|Death|1|||
146886867|NCT05061719|529751827|FG000|Overall Study|Lack of Efficacy|7|||
146886868|NCT05061719|529751827|FG000|Overall Study|Lost to Follow-up|5|||
146886869|NCT05061719|529751827|FG000|Overall Study|Pregnancy|1|||
146886870|NCT05061719|529751827|FG000|Overall Study|Protocol Violation|8|||
146886871|NCT05061719|529751827|FG000|Overall Study|Withdrawal by Subject|41|||
146886872|NCT05061719|529751827|FG000|Overall Study|Site Closure|2|||
146886873|NCT04341948|529751828|FG000|Overall Study|Adverse Event|0|||
146886874|NCT04341948|529751829|FG001|Overall Study|Adverse Event|1|||
146886875|NCT04341948|529751828|FG000|Overall Study|Lost to Follow-up|6|||
146886876|NCT04341948|529751829|FG001|Overall Study|Lost to Follow-up|1|||
146886877|NCT04341948|529751828|FG000|Overall Study|Physician Decision|1|||
146886878|NCT04341948|529751829|FG001|Overall Study|Physician Decision|2|||
146886879|NCT04341948|529751828|FG000|Overall Study|Withdrawal by Participant|6|||
146886880|NCT04341948|529751829|FG001|Overall Study|Withdrawal by Participant|3|||
146886881|NCT04341948|529751828|FG000|Overall Study|Lack of compliance by Participant|1|||
146886882|NCT04341948|529751829|FG001|Overall Study|Lack of compliance by Participant|0|||
146632227|NCT02113982|528831760|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
146886883|NCT00482014|529753880|FG000|Overall Study|Withdrawal by Subject|1|||
146886884|NCT00482014|529753881|FG001|Overall Study|Withdrawal by Subject|2|||
146886885|NCT00482014|529753882|FG002|Overall Study|Withdrawal by Subject|3|||
146886886|NCT00482014|529753883|FG003|Overall Study|Withdrawal by Subject|4|||
146632228|NCT02113982|528831761|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
146551276|NCT04518410|528527032|FG024|Overall Study|Requirement to start alternative therapy|0|||
146551277|NCT04518410|528527008|FG000|Overall Study|Randomized but not treated|0|||
146551278|NCT04518410|528527009|FG001|Overall Study|Randomized but not treated|0|||
146551279|NCT04518410|528527010|FG002|Overall Study|Randomized but not treated|0|||
146551280|NCT04518410|528527011|FG003|Overall Study|Randomized but not treated|2|||
146551281|NCT04518410|528527012|FG004|Overall Study|Randomized but not treated|6|||
146551282|NCT04518410|528527013|FG005|Overall Study|Randomized but not treated|4|||
146551283|NCT04518410|528527014|FG006|Overall Study|Randomized but not treated|3|||
146551284|NCT04518410|528527015|FG007|Overall Study|Randomized but not treated|3|||
146632229|NCT02113982|528831748|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146632230|NCT02113982|528831749|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146551285|NCT04518410|528527016|FG008|Overall Study|Randomized but not treated|0|||
146551286|NCT04518410|528527017|FG009|Overall Study|Randomized but not treated|4|||
146551287|NCT04518410|528527018|FG010|Overall Study|Randomized but not treated|0|||
146551288|NCT04518410|528527019|FG011|Overall Study|Randomized but not treated|0|||
146551289|NCT04518410|528527020|FG012|Overall Study|Randomized but not treated|1|||
146551290|NCT04518410|528527021|FG013|Overall Study|Randomized but not treated|3|||
146551291|NCT04518410|528527022|FG014|Overall Study|Randomized but not treated|3|||
146551292|NCT04518410|528527023|FG015|Overall Study|Randomized but not treated|3|||
146551293|NCT04518410|528527024|FG016|Overall Study|Randomized but not treated|4|||
146551294|NCT04518410|528527025|FG017|Overall Study|Randomized but not treated|5|||
146551295|NCT04518410|528527026|FG018|Overall Study|Randomized but not treated|4|||
146551296|NCT04518410|528527027|FG019|Overall Study|Randomized but not treated|0|||
146551297|NCT04518410|528527028|FG020|Overall Study|Randomized but not treated|0|||
146551298|NCT04518410|528527029|FG021|Overall Study|Randomized but not treated|5|||
146551299|NCT04518410|528527030|FG022|Overall Study|Randomized but not treated|0|||
146551300|NCT04518410|528527031|FG023|Overall Study|Randomized but not treated|3|||
146551301|NCT04518410|528527032|FG024|Overall Study|Randomized but not treated|1|||
146551302|NCT04518410|528527008|FG000|Overall Study|Screen Fail but Randomized|0|||
146551303|NCT04518410|528527009|FG001|Overall Study|Screen Fail but Randomized|0|||
146551304|NCT04518410|528527010|FG002|Overall Study|Screen Fail but Randomized|0|||
146551305|NCT04518410|528527011|FG003|Overall Study|Screen Fail but Randomized|0|||
146551306|NCT04518410|528527012|FG004|Overall Study|Screen Fail but Randomized|2|||
146551307|NCT04518410|528527013|FG005|Overall Study|Screen Fail but Randomized|0|||
146551308|NCT04518410|528527014|FG006|Overall Study|Screen Fail but Randomized|0|||
146551309|NCT04518410|528527015|FG007|Overall Study|Screen Fail but Randomized|0|||
146551310|NCT04518410|528527016|FG008|Overall Study|Screen Fail but Randomized|0|||
146551311|NCT04518410|528527017|FG009|Overall Study|Screen Fail but Randomized|0|||
146551312|NCT04518410|528527018|FG010|Overall Study|Screen Fail but Randomized|0|||
146551313|NCT04518410|528527019|FG011|Overall Study|Screen Fail but Randomized|0|||
146551314|NCT04518410|528527020|FG012|Overall Study|Screen Fail but Randomized|0|||
146551315|NCT04518410|528527021|FG013|Overall Study|Screen Fail but Randomized|0|||
146551316|NCT04518410|528527022|FG014|Overall Study|Screen Fail but Randomized|0|||
146551317|NCT04518410|528527023|FG015|Overall Study|Screen Fail but Randomized|0|||
146551318|NCT04518410|528527024|FG016|Overall Study|Screen Fail but Randomized|0|||
146551319|NCT04518410|528527025|FG017|Overall Study|Screen Fail but Randomized|0|||
146551320|NCT04518410|528527026|FG018|Overall Study|Screen Fail but Randomized|0|||
146551321|NCT04518410|528527027|FG019|Overall Study|Screen Fail but Randomized|0|||
146551322|NCT04518410|528527028|FG020|Overall Study|Screen Fail but Randomized|0|||
146551323|NCT04518410|528527029|FG021|Overall Study|Screen Fail but Randomized|0|||
146551324|NCT04518410|528527030|FG022|Overall Study|Screen Fail but Randomized|0|||
146551325|NCT04518410|528527031|FG023|Overall Study|Screen Fail but Randomized|0|||
146551326|NCT04518410|528527032|FG024|Overall Study|Screen Fail but Randomized|0|||
146551327|NCT04518410|528527008|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
146551328|NCT04518410|528527009|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
146551329|NCT04518410|528527010|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
146551330|NCT04518410|528527011|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
146551331|NCT04518410|528527012|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
146551332|NCT04518410|528527013|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
146632231|NCT02113982|528831750|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146632232|NCT02113982|528831751|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146632233|NCT02113982|528831752|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146632234|NCT02113982|528831753|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146632235|NCT02113982|528831754|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
146632236|NCT02113982|528831755|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146632237|NCT02113982|528831756|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146632238|NCT02113982|528831757|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146632239|NCT02113982|528831758|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146632240|NCT02113982|528831759|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146632241|NCT02113982|528831760|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146632242|NCT02113982|528831761|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146632243|NCT02113982|528831748|FG000|Stage 1: Dose Escalation|Transplant|0|||
146632244|NCT02113982|528831749|FG001|Stage 1: Dose Escalation|Transplant|1|||
146765264|NCT03354390|529307334|FG002|Level 3|Death|1|||
146632245|NCT02113982|528831750|FG002|Stage 1: Dose Escalation|Transplant|0|||
146632246|NCT02113982|528831751|FG003|Stage 1: Dose Escalation|Transplant|0|||
146765265|NCT03354390|529307335|FG003|Level 3|Death|0|||
146886887|NCT00482014|529753880|FG000|Overall Study|Adverse Event|3|||
146886888|NCT00482014|529753881|FG001|Overall Study|Adverse Event|0|||
146886889|NCT00482014|529753882|FG002|Overall Study|Adverse Event|2|||
146886890|NCT00482014|529753883|FG003|Overall Study|Adverse Event|8|||
146765266|NCT03354390|529307332|FG000|Level 3|Physician Decision|0|||
146551333|NCT04518410|528527014|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
146551334|NCT04518410|528527015|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
146551335|NCT04518410|528527016|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
146551336|NCT04518410|528527017|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
146551337|NCT04518410|528527018|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
146551338|NCT04518410|528527019|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
146966526|NCT03792633|530038826|FG001|Overall Study|Second malignancy|1|||
146966527|NCT05048875|530038828|FG000|Overall Study|Withdrawal by Subject|1|||
146886891|NCT00482014|529753880|FG000|Overall Study|Death|1|||
146886892|NCT00482014|529753881|FG001|Overall Study|Death|2|||
146886893|NCT00482014|529753882|FG002|Overall Study|Death|1|||
146886894|NCT00482014|529753883|FG003|Overall Study|Death|4|||
146886895|NCT00482014|529753880|FG000|Overall Study|Lack of Efficacy|1|||
146886896|NCT00482014|529753881|FG001|Overall Study|Lack of Efficacy|0|||
146886897|NCT00482014|529753882|FG002|Overall Study|Lack of Efficacy|4|||
146886898|NCT00482014|529753883|FG003|Overall Study|Lack of Efficacy|6|||
146886899|NCT00482014|529753880|FG000|Overall Study|Sponsor Decision|1|||
146886900|NCT00482014|529753881|FG001|Overall Study|Sponsor Decision|2|||
146886901|NCT00482014|529753882|FG002|Overall Study|Sponsor Decision|1|||
146886902|NCT00482014|529753883|FG003|Overall Study|Sponsor Decision|1|||
146886903|NCT03686397|529753884|FG000|Overall Study|Lack of Efficacy|3|||
146886904|NCT03686397|529753885|FG001|Overall Study|Lack of Efficacy|5|||
146632247|NCT02113982|528831752|FG004|Stage 1: Dose Escalation|Transplant|0|||
146632248|NCT02113982|528831753|FG005|Stage 1: Dose Escalation|Transplant|1|||
146632249|NCT02113982|528831754|FG006|Stage 1: Dose Escalation|Transplant|0|||
146632250|NCT02113982|528831755|FG007|Stage 1: Dose Escalation|Transplant|0|||
146632251|NCT02113982|528831756|FG008|Stage 1: Dose Escalation|Transplant|0|||
146632252|NCT02113982|528831757|FG009|Stage 1: Dose Escalation|Transplant|0|||
146632253|NCT02113982|528831758|FG010|Stage 1: Dose Escalation|Transplant|0|||
146632254|NCT02113982|528831759|FG011|Stage 1: Dose Escalation|Transplant|0|||
146632255|NCT02113982|528831760|FG012|Stage 1: Dose Escalation|Transplant|0|||
146632256|NCT02113982|528831761|FG013|Stage 1: Dose Escalation|Transplant|0|||
146632257|NCT02113982|528831748|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
146632258|NCT02113982|528831749|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
146886905|NCT03686397|529753884|FG000|Overall Study|Adverse Event|0|||
146886906|NCT03686397|529753885|FG001|Overall Study|Adverse Event|1|||
146765267|NCT03354390|529307333|FG001|Level 3|Physician Decision|0|||
146551339|NCT04518410|528527020|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
146551340|NCT04518410|528527021|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
146886907|NCT03686397|529753884|FG000|Overall Study|Protocol Violation|0|||
146551341|NCT04518410|528527022|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
146551342|NCT04518410|528527023|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
146551343|NCT04518410|528527024|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
146551344|NCT04518410|528527025|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
146886908|NCT03686397|529753885|FG001|Overall Study|Protocol Violation|1|||
146886909|NCT03686397|529753884|FG000|Overall Study|Withdrawal by Subject|0|||
146886910|NCT03686397|529753885|FG001|Overall Study|Withdrawal by Subject|1|||
146886911|NCT03686397|529753884|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
146886912|NCT03686397|529753885|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
146886913|NCT02740478|529753891|FG000|Overall Study|Withdrawal by Subject|1|||
146551345|NCT04518410|528527026|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
146551346|NCT04518410|528527027|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
146551347|NCT04518410|528527028|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
146551348|NCT04518410|528527029|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
146568919|NCT00940602|528595501|FG000|Overall Study|Administrative problems|1|||
146886914|NCT01072344|529753893|FG000|Overall Study|Relasped-reached end point|7|||
146886915|NCT01072344|529753894|FG001|Overall Study|Relasped-reached end point|12|||
146886916|NCT01072344|529753893|FG000|Overall Study|Protocol Violation|1|||
146886917|NCT01072344|529753894|FG001|Overall Study|Protocol Violation|2|||
146886918|NCT01072344|529753893|FG000|Overall Study|Lost to Follow-up|3|||
146632259|NCT02113982|528831750|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
146632260|NCT02113982|528831751|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
146632261|NCT02113982|528831752|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
146632262|NCT02113982|528831753|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
146632263|NCT02113982|528831754|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
146632264|NCT02113982|528831755|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
146632265|NCT02113982|528831756|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
146632266|NCT02113982|528831757|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
146632267|NCT02113982|528831758|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
146886919|NCT01072344|529753894|FG001|Overall Study|Lost to Follow-up|4|||
146632268|NCT02113982|528831759|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
146632269|NCT02113982|528831760|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
146886920|NCT01934140|529753895|FG000|Persistence Phase (Year 6-10)|Other|24|||
146886921|NCT01934140|529753896|FG001|Persistence Phase (Year 6-10)|Other|6|||
146886922|NCT01934140|529753895|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
146886923|NCT01934140|529753896|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
146632270|NCT02113982|528831761|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
146632271|NCT02113982|528831748|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
146886924|NCT01934140|529753895|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
146886925|NCT01934140|529753896|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
146765268|NCT03354390|529307334|FG002|Level 3|Physician Decision|2|||
146551349|NCT04518410|528527030|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
146551350|NCT04518410|528527031|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
146551351|NCT04518410|528527032|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
146551352|NCT04518410|528527008|FG000|Overall Study|Dual Enrolled Subject|0|||
146551353|NCT04518410|528527009|FG001|Overall Study|Dual Enrolled Subject|0|||
146551354|NCT04518410|528527010|FG002|Overall Study|Dual Enrolled Subject|0|||
146886926|NCT01934140|529753895|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
146886927|NCT01934140|529753896|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
146886928|NCT01934140|529753895|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
146886929|NCT01934140|529753896|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
146886930|NCT01934140|529753895|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
146886931|NCT01934140|529753896|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
146886932|NCT01934140|529753895|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
146886933|NCT01934140|529753896|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
146886934|NCT01934140|529753895|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
146886935|NCT01934140|529753896|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
146886936|NCT02944448|529753897|FG000|Overall Study|Adverse Event|37|||
146551355|NCT04518410|528527011|FG003|Overall Study|Dual Enrolled Subject|0|||
146551356|NCT04518410|528527012|FG004|Overall Study|Dual Enrolled Subject|0|||
146551357|NCT04518410|528527013|FG005|Overall Study|Dual Enrolled Subject|0|||
146551358|NCT04518410|528527014|FG006|Overall Study|Dual Enrolled Subject|0|||
146551359|NCT04518410|528527015|FG007|Overall Study|Dual Enrolled Subject|0|||
146551360|NCT04518410|528527016|FG008|Overall Study|Dual Enrolled Subject|0|||
146551361|NCT04518410|528527017|FG009|Overall Study|Dual Enrolled Subject|0|||
146551362|NCT04518410|528527018|FG010|Overall Study|Dual Enrolled Subject|0|||
146551363|NCT04518410|528527019|FG011|Overall Study|Dual Enrolled Subject|0|||
146551364|NCT04518410|528527020|FG012|Overall Study|Dual Enrolled Subject|0|||
146551365|NCT04518410|528527021|FG013|Overall Study|Dual Enrolled Subject|0|||
146551366|NCT04518410|528527022|FG014|Overall Study|Dual Enrolled Subject|0|||
146551367|NCT04518410|528527023|FG015|Overall Study|Dual Enrolled Subject|0|||
146551368|NCT04518410|528527024|FG016|Overall Study|Dual Enrolled Subject|0|||
146551369|NCT04518410|528527025|FG017|Overall Study|Dual Enrolled Subject|1|||
146551370|NCT04518410|528527026|FG018|Overall Study|Dual Enrolled Subject|0|||
146551371|NCT04518410|528527027|FG019|Overall Study|Dual Enrolled Subject|0|||
146551372|NCT04518410|528527028|FG020|Overall Study|Dual Enrolled Subject|0|||
146551373|NCT04518410|528527029|FG021|Overall Study|Dual Enrolled Subject|0|||
146551374|NCT04518410|528527030|FG022|Overall Study|Dual Enrolled Subject|0|||
146551375|NCT04518410|528527031|FG023|Overall Study|Dual Enrolled Subject|0|||
146551376|NCT04518410|528527032|FG024|Overall Study|Dual Enrolled Subject|0|||
146551377|NCT01125748|528527034|FG000|Overall Study|Adverse Event|0|||
146551378|NCT01125748|528527035|FG001|Overall Study|Adverse Event|2|||
146551379|NCT01125748|528527034|FG000|Overall Study|Lost to Follow-up|0|||
146551380|NCT01125748|528527035|FG001|Overall Study|Lost to Follow-up|1|||
146551381|NCT01125748|528527034|FG000|Overall Study|Physician Decision|8|||
146551382|NCT01125748|528527035|FG001|Overall Study|Physician Decision|7|||
146551383|NCT01125748|528527034|FG000|Overall Study|Patient Decision to Withdraw|2|||
146551384|NCT01125748|528527035|FG001|Overall Study|Patient Decision to Withdraw|4|||
146551385|NCT01751685|528527036|FG000|6-mo Followup|Missed study visit|1|||
146551386|NCT01751685|528527037|FG001|6-mo Followup|Missed study visit|0|||
146551387|NCT01751685|528527036|FG000|6-mo Followup|Withdrawal by Subject|2|||
146886937|NCT02944448|529753898|FG001|Overall Study|Adverse Event|6|||
146765269|NCT03354390|529307335|FG003|Level 3|Physician Decision|0|||
146886938|NCT02944448|529753897|FG000|Overall Study|Lack of Efficacy|8|||
146551388|NCT01751685|528527037|FG001|6-mo Followup|Withdrawal by Subject|2|||
146765270|NCT03354390|529307332|FG000|Level 4|Death|0|||
146886939|NCT02944448|529753898|FG001|Overall Study|Lack of Efficacy|5|||
146551389|NCT01751685|528527036|FG000|6-mo Followup|Lost to Follow-up|0|||
146551390|NCT01751685|528527037|FG001|6-mo Followup|Lost to Follow-up|1|||
146551391|NCT01751685|528527036|FG000|12-mo Followup|Lost to Follow-up|5|||
146551392|NCT01751685|528527037|FG001|12-mo Followup|Lost to Follow-up|0|||
146551393|NCT01028391|528527038|FG000|Overall Study|Adverse Event|4|||
146551394|NCT01028391|528527039|FG001|Overall Study|Adverse Event|0|||
146551395|NCT01028391|528527038|FG000|Overall Study|Lack of Efficacy|0|||
146551396|NCT01028391|528527039|FG001|Overall Study|Lack of Efficacy|2|||
146551397|NCT01028391|528527038|FG000|Overall Study|Lost to Follow-up|3|||
146551398|NCT01028391|528527039|FG001|Overall Study|Lost to Follow-up|4|||
146551399|NCT01028391|528527038|FG000|Overall Study|Physician Decision|0|||
146551400|NCT01028391|528527039|FG001|Overall Study|Physician Decision|1|||
146966528|NCT05048875|530038829|FG001|Overall Study|Withdrawal by Subject|0|||
146966529|NCT05048875|530038830|FG002|Overall Study|Withdrawal by Subject|0|||
146551401|NCT01028391|528527038|FG000|Overall Study|Withdrawal by Subject|6|||
146551402|NCT01028391|528527039|FG001|Overall Study|Withdrawal by Subject|3|||
146551403|NCT01028391|528527038|FG000|Overall Study|Needed excluded medication|1|||
146765271|NCT03354390|529307333|FG001|Level 4|Death|0|||
146632272|NCT02113982|528831749|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
146632273|NCT02113982|528831750|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
146632274|NCT02113982|528831751|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
146632275|NCT02113982|528831752|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
146632276|NCT02113982|528831753|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
146632277|NCT02113982|528831754|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
146632278|NCT02113982|528831755|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
146632279|NCT02113982|528831756|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
146632280|NCT02113982|528831757|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
146632281|NCT02113982|528831758|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
146632282|NCT02113982|528831759|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
146632283|NCT02113982|528831760|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
146632284|NCT02113982|528831761|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
146632285|NCT02113982|528831748|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
146632286|NCT02113982|528831749|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
146632287|NCT02113982|528831750|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
146632288|NCT02113982|528831751|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
146632289|NCT02113982|528831752|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
146632290|NCT02113982|528831753|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
146632291|NCT02113982|528831754|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
146632292|NCT02113982|528831755|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
146632293|NCT02113982|528831756|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
146632294|NCT02113982|528831757|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
146632295|NCT02113982|528831758|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
146632296|NCT02113982|528831759|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
146632297|NCT02113982|528831760|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
146632298|NCT02113982|528831761|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
146632299|NCT02113982|528831748|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
146632300|NCT02113982|528831749|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
146632301|NCT02113982|528831750|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
146632302|NCT02113982|528831751|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
146632303|NCT02113982|528831752|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
146632304|NCT02113982|528831753|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
146632305|NCT02113982|528831754|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
146632306|NCT02113982|528831755|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
146632307|NCT02113982|528831756|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
146632308|NCT02113982|528831757|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
146632309|NCT02113982|528831758|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
146632310|NCT02113982|528831759|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
146551404|NCT01028391|528527039|FG001|Overall Study|Needed excluded medication|1|||
146551405|NCT00694161|528527040|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
146551406|NCT00694161|528527040|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
146551407|NCT00694161|528527040|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
146551408|NCT03601052|528527041|FG000|Overall Study|Lost to Follow-up|2|||
146551409|NCT00837330|528527042|FG000|Overall Study|Lost to Follow-up|1|||
146551410|NCT00837330|528527043|FG001|Overall Study|Lost to Follow-up|3|||
146551411|NCT01227395|528527044|FG000|Overall Study|Protocol Violation|0|||
146551412|NCT01227395|528527045|FG001|Overall Study|Protocol Violation|1|||
146551413|NCT03259308|528527056|FG000|Overall Study|Adverse Event|5|||
146551414|NCT03259308|528527057|FG001|Overall Study|Adverse Event|4|||
146551415|NCT03259308|528527058|FG002|Overall Study|Adverse Event|1|||
146551416|NCT03259308|528527056|FG000|Overall Study|Withdrawal by Subject|2|||
146551417|NCT03259308|528527057|FG001|Overall Study|Withdrawal by Subject|1|||
146551418|NCT03259308|528527058|FG002|Overall Study|Withdrawal by Subject|3|||
146551419|NCT03259308|528527056|FG000|Overall Study|Lost to Follow-up|0|||
146551420|NCT03259308|528527057|FG001|Overall Study|Lost to Follow-up|0|||
146551421|NCT03259308|528527058|FG002|Overall Study|Lost to Follow-up|1|||
146551422|NCT03259308|528527056|FG000|Overall Study|Pregnancy|0|||
146551423|NCT03259308|528527057|FG001|Overall Study|Pregnancy|0|||
146551424|NCT03259308|528527058|FG002|Overall Study|Pregnancy|1|||
146632311|NCT02113982|528831760|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
146632312|NCT02113982|528831761|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
146551425|NCT03259308|528527056|FG000|Overall Study|Protocol Deviation|0|||
146551426|NCT03259308|528527057|FG001|Overall Study|Protocol Deviation|3|||
146551427|NCT03259308|528527058|FG002|Overall Study|Protocol Deviation|0|||
146551428|NCT03259308|528527056|FG000|Overall Study|Lack of Efficacy|0|||
146551429|NCT03259308|528527057|FG001|Overall Study|Lack of Efficacy|0|||
146632313|NCT02113982|528831748|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
146632314|NCT02113982|528831749|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
146886940|NCT02944448|529753897|FG000|Overall Study|Lost to Follow-up|3|||
146551430|NCT03259308|528527058|FG002|Overall Study|Lack of Efficacy|1|||
146551431|NCT00694122|528527063|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
146632315|NCT02113982|528831750|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
146966530|NCT05048875|530038831|FG003|Overall Study|Withdrawal by Subject|0|||
146966531|NCT05048875|530038832|FG004|Overall Study|Withdrawal by Subject|0|||
146551432|NCT00694122|528527064|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
146551433|NCT00694122|528527063|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
146551434|NCT00694122|528527064|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
146551435|NCT00694122|528527063|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
146551436|NCT00694122|528527064|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
146551437|NCT00105508|528527065|FG000|Overall Study|Prephase Dropout|1|||
146551438|NCT00105508|528527066|FG001|Overall Study|Prephase Dropout|0|||
146551439|NCT00105508|528527065|FG000|Overall Study|Adverse Event|16|||
146551440|NCT00105508|528527066|FG001|Overall Study|Adverse Event|19|||
146551441|NCT00105508|528527065|FG000|Overall Study|Insufficient Efficacy|1|||
146551442|NCT00105508|528527066|FG001|Overall Study|Insufficient Efficacy|0|||
146551443|NCT00105508|528527065|FG000|Overall Study|Withdrawal by Subject|10|||
146551444|NCT00105508|528527066|FG001|Overall Study|Withdrawal by Subject|6|||
146551445|NCT00105508|528527065|FG000|Overall Study|Lost to Follow-up|3|||
146551446|NCT00105508|528527066|FG001|Overall Study|Lost to Follow-up|0|||
146551447|NCT00105508|528527065|FG000|Overall Study|Protocol Violation|1|||
146551448|NCT00105508|528527066|FG001|Overall Study|Protocol Violation|2|||
146551449|NCT00105508|528527065|FG000|Overall Study|Other|8|||
146551450|NCT00105508|528527066|FG001|Overall Study|Other|9|||
146551451|NCT00086307|528527067|FG000|Overall Study|Lack of Efficacy|1|||
146551452|NCT00086307|528527068|FG001|Overall Study|Lack of Efficacy|1|||
146551453|NCT00086307|528527069|FG002|Overall Study|Lack of Efficacy|2|||
146551454|NCT00086307|528527067|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
146551455|NCT00086307|528527068|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
146551456|NCT00086307|528527069|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
146551457|NCT00086307|528527067|FG000|Overall Study|Nausea and headaches|0|||
146551458|NCT00086307|528527068|FG001|Overall Study|Nausea and headaches|0|||
146551459|NCT00086307|528527069|FG002|Overall Study|Nausea and headaches|1|||
146551460|NCT00086307|528527067|FG000|Overall Study|Constipation and sleepiness|0|||
146551461|NCT00086307|528527068|FG001|Overall Study|Constipation and sleepiness|0|||
146765272|NCT03354390|529307334|FG002|Level 4|Death|0|||
146551462|NCT00086307|528527069|FG002|Overall Study|Constipation and sleepiness|1|||
146551463|NCT00086307|528527067|FG000|Overall Study|Suicidal ideation|0|||
146551464|NCT00086307|528527068|FG001|Overall Study|Suicidal ideation|0|||
146551465|NCT00086307|528527069|FG002|Overall Study|Suicidal ideation|1|||
146765273|NCT03354390|529307335|FG003|Level 4|Death|3|||
146886941|NCT02944448|529753898|FG001|Overall Study|Lost to Follow-up|1|||
146886942|NCT02944448|529753897|FG000|Overall Study|Protocol Violation|25|||
146886943|NCT02944448|529753898|FG001|Overall Study|Protocol Violation|7|||
146886944|NCT02944448|529753897|FG000|Overall Study|Withdrawal by Subject|14|||
146886945|NCT02944448|529753898|FG001|Overall Study|Withdrawal by Subject|4|||
146886946|NCT02944448|529753897|FG000|Overall Study|Sponsor did not supply drug in time|0|||
146886947|NCT02944448|529753898|FG001|Overall Study|Sponsor did not supply drug in time|1|||
146886948|NCT02944448|529753897|FG000|Overall Study|Noncompliant with dosing|1|||
146886949|NCT02944448|529753898|FG001|Overall Study|Noncompliant with dosing|0|||
146886950|NCT02944448|529753897|FG000|Overall Study|Abnormal laboratory values|1|||
146886951|NCT02944448|529753898|FG001|Overall Study|Abnormal laboratory values|0|||
146886952|NCT00808444|529753901|FG000|Overall Study|Withdrawal by Subject|1|||
146886953|NCT00808444|529753902|FG001|Overall Study|Withdrawal by Subject|0|||
146886954|NCT00808444|529753901|FG000|Overall Study|Lost to Follow-up|0|||
146886955|NCT00808444|529753902|FG001|Overall Study|Lost to Follow-up|1|||
146886956|NCT00122135|529753903|FG000|Overall Study|Withdrawal by Subject|3|||
146886957|NCT00122135|529753904|FG001|Overall Study|Withdrawal by Subject|0|||
146886958|NCT03269344|529753905|FG000|Overall Study|Protocol Violation|4|||
146886959|NCT03269344|529753906|FG001|Overall Study|Protocol Violation|3|||
146886960|NCT00200850|529753907|FG000|Overall Study|relocation|1|||
146886961|NCT00200850|529753908|FG001|Overall Study|relocation|0|||
146886962|NCT00200850|529753909|FG002|Overall Study|relocation|1|||
146886963|NCT00200850|529753907|FG000|Overall Study|too busy|1|||
146886964|NCT00200850|529753908|FG001|Overall Study|too busy|0|||
146886965|NCT00200850|529753909|FG002|Overall Study|too busy|0|||
146886966|NCT00200850|529753907|FG000|Overall Study|Pregnancy|0|||
146765274|NCT00726596|529308582|FG000|Overall Study|Adverse Event|2|||
146886967|NCT00200850|529753908|FG001|Overall Study|Pregnancy|0|||
146886968|NCT00200850|529753909|FG002|Overall Study|Pregnancy|1|||
146886969|NCT00200850|529753907|FG000|Overall Study|Poor adherence|0|||
146886970|NCT00200850|529753908|FG001|Overall Study|Poor adherence|0|||
146886971|NCT00200850|529753909|FG002|Overall Study|Poor adherence|1|||
146886972|NCT00200850|529753907|FG000|Overall Study|optic neuritis|0|||
146886973|NCT00200850|529753908|FG001|Overall Study|optic neuritis|0|||
146886974|NCT00200850|529753909|FG002|Overall Study|optic neuritis|1|||
146886975|NCT00200850|529753907|FG000|Overall Study|Adverse Event|1|||
146886976|NCT00200850|529753908|FG001|Overall Study|Adverse Event|1|||
146551466|NCT00086307|528527067|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
146551467|NCT00086307|528527068|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
146551468|NCT00086307|528527069|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
146551469|NCT00086307|528527067|FG000|Overall Study|Withdrawal by Subject|0|||
146551470|NCT00086307|528527068|FG001|Overall Study|Withdrawal by Subject|0|||
146551471|NCT00086307|528527069|FG002|Overall Study|Withdrawal by Subject|2|||
146551472|NCT00683384|528527070|FG000|Overall Study|Death|1|||
146551473|NCT00683384|528527070|FG000|Overall Study|Adverse Event|1|||
146551474|NCT00120874|528527071|FG000|Overall Study|Death|0|||
146551475|NCT00120874|528527072|FG001|Overall Study|Death|1|||
146551476|NCT01727154|528527073|FG000|Overall Study|Death|17|||
146551477|NCT01727154|528527073|FG000|Overall Study|Withdrawal by Subject|14|||
146551478|NCT01727154|528527073|FG000|Overall Study|Subject Withdrew Consent|18|||
146551479|NCT01727154|528527073|FG000|Overall Study|Study Terminated|6|||
146551480|NCT01727154|528527073|FG000|Overall Study|No Discontinuation Documentation|4|||
146551481|NCT01184118|528527080|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
146551482|NCT01184118|528527080|FG000|Overall Study|No physiologic confirmation of asthma|8|||
146551483|NCT01184118|528527080|FG000|Overall Study|FEV1 <60% predicted|2|||
146551484|NCT01184118|528527080|FG000|Overall Study|Exclusionary medical condition|2|||
146551485|NCT01184118|528527080|FG000|Overall Study|Withdrawal by Subject|5|||
146551486|NCT03834883|528527081|FG000|Second Treatment|Withdrawal by Subject|1|||
146551487|NCT03834883|528527082|FG001|Second Treatment|Withdrawal by Subject|0|||
146551488|NCT03834883|528527083|FG002|Second Treatment|Withdrawal by Subject|0|||
146551489|NCT03834883|528527084|FG003|Second Treatment|Withdrawal by Subject|0|||
146551490|NCT03834883|528527081|FG000|Second Treatment|COVID-19 pandemic|1|||
146551491|NCT03834883|528527082|FG001|Second Treatment|COVID-19 pandemic|0|||
146551492|NCT03834883|528527083|FG002|Second Treatment|COVID-19 pandemic|1|||
146551493|NCT03834883|528527084|FG003|Second Treatment|COVID-19 pandemic|1|||
146551494|NCT03572218|528527085|FG000|Overall Study|Lost to Follow-up|3|||
146551495|NCT03572218|528527086|FG001|Overall Study|Lost to Follow-up|2|||
146551496|NCT03572218|528527085|FG000|Overall Study|No longer available for study visits|2|||
146551497|NCT03572218|528527086|FG001|Overall Study|No longer available for study visits|1|||
146551498|NCT03572218|528527085|FG000|Overall Study|No longer interested|1|||
146551499|NCT03572218|528527086|FG001|Overall Study|No longer interested|2|||
146551500|NCT01793129|528528827|FG000|Overall Study|Lost to Follow-up|3|||
146551501|NCT01793129|528528828|FG001|Overall Study|Lost to Follow-up|7|||
146551502|NCT01793129|528528827|FG000|Overall Study|Withdrawal by Subject|0|||
146551503|NCT01793129|528528828|FG001|Overall Study|Withdrawal by Subject|2|||
146551504|NCT01567085|528528831|FG000|Overall Study|Death|6|||
146551505|NCT01567085|528528831|FG000|Overall Study|Adverse Event|6|||
146551506|NCT01567085|528528831|FG000|Overall Study|Lost to Follow-up|3|||
146551507|NCT01567085|528528831|FG000|Overall Study|Graft loss|2|||
146551508|NCT01567085|528528831|FG000|Overall Study|Renal transplantectomy|1|||
146551509|NCT01567085|528528831|FG000|Overall Study|Returned to chronic dialysis|1|||
146551510|NCT01567085|528528831|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
146551511|NCT03312114|528528837|FG000|Overall Study|All the five enrolled dropped out of the|5|||
146551512|NCT03537729|528528838|FG000|Overall Study|Death|2|||
146551513|NCT03537729|528528839|FG001|Overall Study|Death|2|||
146551514|NCT03537729|528528840|FG002|Overall Study|Death|7|||
146551515|NCT03537729|528528838|FG000|Overall Study|Withdrawal by Subject|3|||
146632316|NCT02113982|528831751|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
146632317|NCT02113982|528831752|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
146632318|NCT02113982|528831753|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
146632319|NCT02113982|528831754|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
146632320|NCT02113982|528831755|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
146632321|NCT02113982|528831756|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
146632322|NCT02113982|528831757|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
146632323|NCT02113982|528831758|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
146632324|NCT02113982|528831759|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
146632325|NCT02113982|528831760|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
146632326|NCT02113982|528831761|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
146632327|NCT02113982|528831748|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146632328|NCT02113982|528831749|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146632329|NCT02113982|528831750|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146632330|NCT02113982|528831751|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146632331|NCT02113982|528831752|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146632332|NCT02113982|528831753|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146632333|NCT02113982|528831754|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146632334|NCT02113982|528831755|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
146632335|NCT02113982|528831756|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146632336|NCT02113982|528831757|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
146632337|NCT02113982|528831758|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146632338|NCT02113982|528831759|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146632339|NCT02113982|528831760|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146632340|NCT02113982|528831761|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146632341|NCT02113982|528831748|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146632342|NCT02113982|528831749|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146632343|NCT02113982|528831750|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146966532|NCT05048875|530038833|FG005|Overall Study|Withdrawal by Subject|0|||
146966533|NCT05048875|530038834|FG006|Overall Study|Withdrawal by Subject|0|||
146966534|NCT05048875|530038835|FG007|Overall Study|Withdrawal by Subject|0|||
146966535|NCT05048875|530038828|FG000|Overall Study|Adverse Event|0|||
146966536|NCT05048875|530038829|FG001|Overall Study|Adverse Event|0|||
146966537|NCT05048875|530038830|FG002|Overall Study|Adverse Event|0|||
146966538|NCT05048875|530038831|FG003|Overall Study|Adverse Event|1|||
146632344|NCT02113982|528831751|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146632345|NCT02113982|528831752|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146632346|NCT02113982|528831753|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146632347|NCT02113982|528831754|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146632348|NCT02113982|528831755|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
146632349|NCT02113982|528831756|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146632350|NCT02113982|528831757|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146632351|NCT02113982|528831758|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146632352|NCT02113982|528831759|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146632353|NCT02113982|528831760|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146632354|NCT02113982|528831761|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146632355|NCT02113982|528831748|FG000|Stage 2: Cohort Expansion|Transplant|0|||
146632356|NCT02113982|528831749|FG001|Stage 2: Cohort Expansion|Transplant|0|||
146632357|NCT02113982|528831750|FG002|Stage 2: Cohort Expansion|Transplant|0|||
146632358|NCT02113982|528831751|FG003|Stage 2: Cohort Expansion|Transplant|0|||
146632359|NCT02113982|528831752|FG004|Stage 2: Cohort Expansion|Transplant|0|||
146765275|NCT00726596|529308583|FG001|Overall Study|Adverse Event|1|||
146966539|NCT05048875|530038832|FG004|Overall Study|Adverse Event|0|||
146966540|NCT05048875|530038833|FG005|Overall Study|Adverse Event|0|||
146966541|NCT05048875|530038834|FG006|Overall Study|Adverse Event|0|||
146632360|NCT02113982|528831753|FG005|Stage 2: Cohort Expansion|Transplant|0|||
146632361|NCT02113982|528831754|FG006|Stage 2: Cohort Expansion|Transplant|0|||
146966542|NCT05048875|530038835|FG007|Overall Study|Adverse Event|0|||
146551516|NCT03537729|528528839|FG001|Overall Study|Withdrawal by Subject|3|||
146551517|NCT03537729|528528840|FG002|Overall Study|Withdrawal by Subject|0|||
146551518|NCT03537729|528528838|FG000|Overall Study|Subject Moved|8|||
146551519|NCT03537729|528528839|FG001|Overall Study|Subject Moved|5|||
146551520|NCT03537729|528528840|FG002|Overall Study|Subject Moved|4|||
146551521|NCT03537729|528528838|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
146551522|NCT03537729|528528839|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
146551523|NCT03537729|528528840|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
146551524|NCT03537729|528528838|FG000|Overall Study|COVID-19 Site Restrictions|11|||
146551525|NCT03537729|528528839|FG001|Overall Study|COVID-19 Site Restrictions|15|||
146551526|NCT03537729|528528840|FG002|Overall Study|COVID-19 Site Restrictions|18|||
146551527|NCT03537729|528528838|FG000|Overall Study|Decline in Health|5|||
146551528|NCT03537729|528528839|FG001|Overall Study|Decline in Health|9|||
146551529|NCT03537729|528528840|FG002|Overall Study|Decline in Health|4|||
146551530|NCT03537729|528528838|FG000|Overall Study|Determined Ineligible|0|||
146551531|NCT03537729|528528839|FG001|Overall Study|Determined Ineligible|0|||
146551532|NCT03537729|528528840|FG002|Overall Study|Determined Ineligible|1|||
146551533|NCT00284934|528528841|FG000|Overall Study|Adverse Event|1|||
146551534|NCT00284934|528528842|FG001|Overall Study|Adverse Event|2|||
146551535|NCT00284934|528528841|FG000|Overall Study|Other reasons|3|||
146551536|NCT00284934|528528842|FG001|Overall Study|Other reasons|1|||
146551537|NCT00454142|528528843|FG000|Overall Study|Withdrawal by Subject|1|||
146551538|NCT00520572|528528851|FG000|Overall Study|Adverse Event|9|||
146551539|NCT00520572|528528852|FG001|Overall Study|Adverse Event|3|||
146551540|NCT00520572|528528853|FG002|Overall Study|Adverse Event|6|||
146551541|NCT00520572|528528854|FG003|Overall Study|Adverse Event|9|||
146551542|NCT00520572|528528855|FG004|Overall Study|Adverse Event|7|||
146551543|NCT00520572|528528856|FG005|Overall Study|Adverse Event|2|||
146551544|NCT00520572|528528851|FG000|Overall Study|Withdrawal by Subject|0|||
146551545|NCT00520572|528528852|FG001|Overall Study|Withdrawal by Subject|9|||
146551546|NCT00520572|528528853|FG002|Overall Study|Withdrawal by Subject|5|||
146551547|NCT00520572|528528854|FG003|Overall Study|Withdrawal by Subject|2|||
146551548|NCT00520572|528528855|FG004|Overall Study|Withdrawal by Subject|2|||
146551549|NCT00520572|528528856|FG005|Overall Study|Withdrawal by Subject|0|||
146551550|NCT00520572|528528851|FG000|Overall Study|Protocol Violation|0|||
146551551|NCT00520572|528528852|FG001|Overall Study|Protocol Violation|0|||
146551552|NCT00520572|528528853|FG002|Overall Study|Protocol Violation|1|||
146551553|NCT00520572|528528854|FG003|Overall Study|Protocol Violation|0|||
146551554|NCT00520572|528528855|FG004|Overall Study|Protocol Violation|0|||
146551555|NCT00520572|528528856|FG005|Overall Study|Protocol Violation|0|||
146551556|NCT00520572|528528851|FG000|Overall Study|Lack of Efficacy|1|||
146551557|NCT00520572|528528852|FG001|Overall Study|Lack of Efficacy|1|||
146551558|NCT00520572|528528853|FG002|Overall Study|Lack of Efficacy|1|||
146551559|NCT00520572|528528854|FG003|Overall Study|Lack of Efficacy|2|||
146551560|NCT00520572|528528855|FG004|Overall Study|Lack of Efficacy|1|||
146551561|NCT00520572|528528856|FG005|Overall Study|Lack of Efficacy|0|||
146551562|NCT00520572|528528851|FG000|Overall Study|Lost to Follow-up|0|||
146551563|NCT00520572|528528852|FG001|Overall Study|Lost to Follow-up|0|||
146551564|NCT00520572|528528853|FG002|Overall Study|Lost to Follow-up|0|||
146551565|NCT00520572|528528854|FG003|Overall Study|Lost to Follow-up|0|||
146886977|NCT00200850|529753909|FG002|Overall Study|Adverse Event|2|||
146886978|NCT01449708|529753919|FG000|Overall Study|Protocol Violation|0|||
146886979|NCT01449708|529753920|FG001|Overall Study|Protocol Violation|1|||
146886980|NCT01449708|529753919|FG000|Overall Study|surgical complication|1|||
146886981|NCT01449708|529753920|FG001|Overall Study|surgical complication|2|||
146886982|NCT01449708|529753919|FG000|Overall Study|respiratory failure|1|||
146886983|NCT01449708|529753920|FG001|Overall Study|respiratory failure|0|||
146886984|NCT05499559|529753928|FG000|Overall Study|Lost to Follow-up|467|||
146886985|NCT00223496|529753929|FG000|Overall Study|screen failure|9|||
146886986|NCT00223496|529753929|FG000|Overall Study|Lost to Follow-up|4|||
146886987|NCT00223496|529753929|FG000|Overall Study|Lack of Efficacy|6|||
146886988|NCT00223496|529753929|FG000|Overall Study|Withdrawal by Subject|1|||
146886989|NCT00223496|529753929|FG000|Overall Study|Physician Decision|2|||
146886990|NCT02889796|529753930|FG000|Overall Study|Withdrew Consent|18|||
146886991|NCT02889796|529753931|FG001|Overall Study|Withdrew Consent|29|||
146886992|NCT02889796|529753932|FG002|Overall Study|Withdrew Consent|20|||
146886993|NCT02889796|529753933|FG003|Overall Study|Withdrew Consent|1|||
146886994|NCT02889796|529753934|FG004|Overall Study|Withdrew Consent|2|||
146551566|NCT00520572|528528855|FG004|Overall Study|Lost to Follow-up|1|||
146551567|NCT00520572|528528856|FG005|Overall Study|Lost to Follow-up|0|||
146551568|NCT00520572|528528851|FG000|Overall Study|Incorrect enrollment|1|||
146551569|NCT00520572|528528852|FG001|Overall Study|Incorrect enrollment|0|||
146551570|NCT00520572|528528853|FG002|Overall Study|Incorrect enrollment|1|||
146551571|NCT00520572|528528854|FG003|Overall Study|Incorrect enrollment|0|||
146551572|NCT00520572|528528855|FG004|Overall Study|Incorrect enrollment|1|||
146551573|NCT00520572|528528856|FG005|Overall Study|Incorrect enrollment|0|||
146886995|NCT02889796|529753935|FG005|Overall Study|Withdrew Consent|35|||
146886996|NCT02889796|529753930|FG000|Overall Study|Investigator's Discretion|10|||
146551574|NCT00520572|528528851|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
146551575|NCT00520572|528528852|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
146551576|NCT00520572|528528853|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
146551577|NCT00520572|528528854|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
146551578|NCT00520572|528528855|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
146551579|NCT00520572|528528856|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
146551580|NCT00520572|528528851|FG000|Overall Study|Long break in taking Medication|0|||
146551581|NCT00520572|528528852|FG001|Overall Study|Long break in taking Medication|0|||
146551582|NCT00520572|528528853|FG002|Overall Study|Long break in taking Medication|0|||
146551583|NCT00520572|528528854|FG003|Overall Study|Long break in taking Medication|1|||
146551584|NCT00520572|528528855|FG004|Overall Study|Long break in taking Medication|0|||
146551585|NCT00520572|528528856|FG005|Overall Study|Long break in taking Medication|0|||
146551586|NCT00520572|528528851|FG000|Overall Study|Did not receive Treatment|1|||
146551587|NCT00520572|528528852|FG001|Overall Study|Did not receive Treatment|0|||
146551588|NCT00520572|528528853|FG002|Overall Study|Did not receive Treatment|1|||
146551589|NCT00520572|528528854|FG003|Overall Study|Did not receive Treatment|0|||
146551590|NCT00520572|528528855|FG004|Overall Study|Did not receive Treatment|0|||
146551591|NCT00520572|528528856|FG005|Overall Study|Did not receive Treatment|0|||
146551592|NCT02802865|528528859|FG000|Overall Study|Pregnancy|1|||
146551593|NCT02802865|528528860|FG001|Overall Study|Pregnancy|1|||
146551594|NCT02802865|528528859|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
146551595|NCT02802865|528528860|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
146551596|NCT01803737|528528864|FG000|Overall Study|Lack of Time|1|||
146551597|NCT01803737|528528865|FG001|Overall Study|Lack of Time|0|||
146551598|NCT01803737|528528864|FG000|Overall Study|Medical Reason|0|||
146551599|NCT01803737|528528865|FG001|Overall Study|Medical Reason|1|||
146551600|NCT01803737|528528864|FG000|Overall Study|Lost to Follow-up|0|||
146551601|NCT01803737|528528865|FG001|Overall Study|Lost to Follow-up|2|||
146551602|NCT01748552|528528866|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
146551603|NCT01748552|528528867|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
146551604|NCT01748552|528528868|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
146551605|NCT01748552|528528869|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
146551606|NCT01748552|528528870|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
146551607|NCT01748552|528528871|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
146551608|NCT01748552|528528872|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
146551609|NCT01748552|528528873|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
146551610|NCT01748552|528528874|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
146551611|NCT01748552|528528875|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
146551612|NCT01748552|528528876|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
146551613|NCT01748552|528528877|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
146551614|NCT01748552|528528866|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
146551615|NCT01748552|528528867|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
146551616|NCT01748552|528528868|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
146551617|NCT01748552|528528869|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
146551618|NCT01748552|528528870|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
146551619|NCT01748552|528528871|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
146551620|NCT01748552|528528872|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
146551621|NCT01748552|528528873|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
146551622|NCT01748552|528528874|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
146551623|NCT01748552|528528875|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
146551624|NCT01748552|528528876|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
146551625|NCT01748552|528528877|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
146551626|NCT00504556|528528878|FG000|Overall Study|Adverse Event|11|||
146551627|NCT00504556|528528879|FG001|Overall Study|Adverse Event|11|||
146551628|NCT00504556|528528880|FG002|Overall Study|Adverse Event|14|||
146551629|NCT00504556|528528881|FG003|Overall Study|Adverse Event|13|||
146551630|NCT00504556|528528882|FG004|Overall Study|Adverse Event|5|||
146551631|NCT00504556|528528878|FG000|Overall Study|Death|3|||
146551632|NCT00504556|528528879|FG001|Overall Study|Death|3|||
146551633|NCT00504556|528528880|FG002|Overall Study|Death|1|||
146551634|NCT00504556|528528881|FG003|Overall Study|Death|0|||
146551635|NCT00504556|528528882|FG004|Overall Study|Death|2|||
146551636|NCT00504556|528528878|FG000|Overall Study|Protocol Violation|1|||
146551637|NCT00504556|528528879|FG001|Overall Study|Protocol Violation|3|||
146551638|NCT00504556|528528880|FG002|Overall Study|Protocol Violation|2|||
146551639|NCT00504556|528528881|FG003|Overall Study|Protocol Violation|1|||
146551640|NCT00504556|528528882|FG004|Overall Study|Protocol Violation|2|||
146551641|NCT00504556|528528878|FG000|Overall Study|Lost to Follow-up|0|||
146551642|NCT00504556|528528879|FG001|Overall Study|Lost to Follow-up|0|||
146966543|NCT05455684|530038839|FG000|Overall Study|Withdrawal by Subject|7|||
146551643|NCT00504556|528528880|FG002|Overall Study|Lost to Follow-up|1|||
146551644|NCT00504556|528528881|FG003|Overall Study|Lost to Follow-up|1|||
146551645|NCT00504556|528528882|FG004|Overall Study|Lost to Follow-up|1|||
146551646|NCT00504556|528528878|FG000|Overall Study|Withdrawal by Subject|16|||
146551647|NCT00504556|528528879|FG001|Overall Study|Withdrawal by Subject|16|||
146551648|NCT00504556|528528880|FG002|Overall Study|Withdrawal by Subject|7|||
146551649|NCT00504556|528528881|FG003|Overall Study|Withdrawal by Subject|8|||
146551650|NCT00504556|528528882|FG004|Overall Study|Withdrawal by Subject|12|||
146551651|NCT00504556|528528878|FG000|Overall Study|administrative reasons|0|||
146551652|NCT00504556|528528879|FG001|Overall Study|administrative reasons|2|||
146551653|NCT00504556|528528880|FG002|Overall Study|administrative reasons|2|||
146551654|NCT00504556|528528881|FG003|Overall Study|administrative reasons|1|||
146551655|NCT00504556|528528882|FG004|Overall Study|administrative reasons|2|||
146551656|NCT00504556|528528878|FG000|Overall Study|did not meet entry criteria|2|||
146551657|NCT00504556|528528879|FG001|Overall Study|did not meet entry criteria|0|||
146551658|NCT00504556|528528880|FG002|Overall Study|did not meet entry criteria|1|||
146551659|NCT00504556|528528881|FG003|Overall Study|did not meet entry criteria|1|||
146551660|NCT00504556|528528882|FG004|Overall Study|did not meet entry criteria|0|||
146551661|NCT00504556|528528878|FG000|Overall Study|data monitor committee decision|0|||
146551662|NCT00504556|528528879|FG001|Overall Study|data monitor committee decision|0|||
146551663|NCT00504556|528528880|FG002|Overall Study|data monitor committee decision|0|||
146551664|NCT00504556|528528881|FG003|Overall Study|data monitor committee decision|100|||
146551665|NCT00504556|528528882|FG004|Overall Study|data monitor committee decision|0|||
146551666|NCT00504556|528528878|FG000|Overall Study|Other|2|||
146551667|NCT00504556|528528879|FG001|Overall Study|Other|2|||
146551668|NCT00504556|528528880|FG002|Overall Study|Other|2|||
146551669|NCT00504556|528528881|FG003|Overall Study|Other|3|||
146551670|NCT00504556|528528882|FG004|Overall Study|Other|0|||
146966544|NCT05455684|530038840|FG001|Overall Study|Withdrawal by Subject|4|||
146966545|NCT05455684|530038839|FG000|Overall Study|Lost to Follow-up|3|||
146966546|NCT05455684|530038840|FG001|Overall Study|Lost to Follow-up|3|||
146966547|NCT05455684|530038839|FG000|Overall Study|Adverse Event|2|||
146966548|NCT05455684|530038840|FG001|Overall Study|Adverse Event|3|||
146966549|NCT05455684|530038839|FG000|Overall Study|Protocol Violation|1|||
146966550|NCT05455684|530038840|FG001|Overall Study|Protocol Violation|1|||
146966551|NCT05455684|530038839|FG000|Overall Study|Non-Compliant with study drug|0|||
146966552|NCT05455684|530038840|FG001|Overall Study|Non-Compliant with study drug|1|||
146966553|NCT05455684|530038839|FG000|Overall Study|Other|1|||
146966554|NCT05455684|530038840|FG001|Overall Study|Other|2|||
146966555|NCT05455684|530038839|FG000|Overall Study|Randomized but not treated|1|||
146966556|NCT05455684|530038840|FG001|Overall Study|Randomized but not treated|0|||
146966557|NCT05116241|530038841|FG000|Study|Withdrawal by Subject|5|||
146966558|NCT05116241|530038842|FG001|Study|Withdrawal by Subject|2|||
146966559|NCT05116241|530038843|FG002|Study|Withdrawal by Subject|1|||
146966560|NCT05116241|530038841|FG000|Study|Lost to Follow-up|0|||
146966561|NCT05116241|530038842|FG001|Study|Lost to Follow-up|2|||
146966562|NCT05116241|530038843|FG002|Study|Lost to Follow-up|2|||
146966563|NCT05204563|530038844|FG000|Overall Study|Other than Specified|2|||
146966564|NCT05204563|530038845|FG001|Overall Study|Other than Specified|1|||
146966565|NCT05204563|530038844|FG000|Overall Study|Death|18|||
146966566|NCT05204563|530038845|FG001|Overall Study|Death|4|||
146966567|NCT05204563|530038844|FG000|Overall Study|Lost to Follow-up|6|||
146966568|NCT05204563|530038845|FG001|Overall Study|Lost to Follow-up|3|||
146966569|NCT05204563|530038844|FG000|Overall Study|Withdrawal by Subject|12|||
146966570|NCT05204563|530038845|FG001|Overall Study|Withdrawal by Subject|3|||
146966571|NCT05204563|530038844|FG000|Overall Study|Enrolled, Not Treated|1|||
146966572|NCT05204563|530038845|FG001|Overall Study|Enrolled, Not Treated|0|||
146966573|NCT04755283|530038848|FG000|Overall Study|Withdrawal by Subject|14|||
146966574|NCT04755283|530038849|FG001|Overall Study|Withdrawal by Subject|3|||
146966575|NCT04755283|530038850|FG002|Overall Study|Withdrawal by Subject|6|||
146551671|NCT00504556|528528878|FG000|Overall Study|not in safety analysis set|0|||
146551672|NCT00504556|528528879|FG001|Overall Study|not in safety analysis set|1|||
146551673|NCT00504556|528528880|FG002|Overall Study|not in safety analysis set|1|||
146966576|NCT04755283|530038848|FG000|Overall Study|Lost to Follow-up|0|||
146966577|NCT04755283|530038849|FG001|Overall Study|Lost to Follow-up|0|||
146966578|NCT04755283|530038850|FG002|Overall Study|Lost to Follow-up|1|||
146966579|NCT04755283|530038848|FG000|Overall Study|Death|31|||
146966580|NCT04755283|530038849|FG001|Overall Study|Death|36|||
146966581|NCT04755283|530038850|FG002|Overall Study|Death|34|||
146551674|NCT00504556|528528881|FG003|Overall Study|not in safety analysis set|0|||
146551675|NCT00504556|528528882|FG004|Overall Study|not in safety analysis set|1|||
146551676|NCT01529112|528528885|FG000|Overall Study|Adverse Event|2|||
146966582|NCT04342390|530038852|FG000|Overall Study|Lost to Follow-up|3|||
146966583|NCT04342390|530038853|FG001|Overall Study|Lost to Follow-up|0|||
146551677|NCT01529112|528528886|FG001|Overall Study|Adverse Event|0|||
146551678|NCT01529112|528528885|FG000|Overall Study|Death|59|||
146966584|NCT04584294|530038859|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
146551679|NCT01529112|528528886|FG001|Overall Study|Death|38|||
146551680|NCT01529112|528528885|FG000|Overall Study|Protocol Violation|1|||
146551681|NCT01529112|528528886|FG001|Overall Study|Protocol Violation|0|||
146551682|NCT01529112|528528885|FG000|Overall Study|Withdrawal by Subject|7|||
146551683|NCT01529112|528528886|FG001|Overall Study|Withdrawal by Subject|3|||
146551684|NCT03607695|528528888|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
146551685|NCT03607695|528528888|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
146551686|NCT02741193|528528889|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
146551687|NCT02741193|528528889|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
146551688|NCT02502383|528528890|FG000|Overall Study|Lost to Follow-up|130|||
146551689|NCT02502383|528528891|FG001|Overall Study|Lost to Follow-up|131|||
146551690|NCT02502383|528528890|FG000|Overall Study|Withdrawal by Subject|31|||
146551691|NCT02502383|528528891|FG001|Overall Study|Withdrawal by Subject|24|||
146551692|NCT00676052|528528892|FG000|Overall Study|Adverse Event|0|||
146551693|NCT00676052|528528893|FG001|Overall Study|Adverse Event|1|||
146551694|NCT00676052|528528894|FG002|Overall Study|Adverse Event|1|||
146551695|NCT00676052|528528895|FG003|Overall Study|Adverse Event|2|||
146551696|NCT00676052|528528896|FG004|Overall Study|Adverse Event|2|||
146551697|NCT00676052|528528897|FG005|Overall Study|Adverse Event|2|||
146551698|NCT00676052|528528892|FG000|Overall Study|Lack of Efficacy|2|||
146551699|NCT00676052|528528893|FG001|Overall Study|Lack of Efficacy|2|||
146551700|NCT00676052|528528894|FG002|Overall Study|Lack of Efficacy|1|||
146551701|NCT00676052|528528895|FG003|Overall Study|Lack of Efficacy|1|||
146551702|NCT00676052|528528896|FG004|Overall Study|Lack of Efficacy|2|||
146551703|NCT00676052|528528897|FG005|Overall Study|Lack of Efficacy|1|||
146551704|NCT00676052|528528892|FG000|Overall Study|Protocol Violation|5|||
146551705|NCT00676052|528528893|FG001|Overall Study|Protocol Violation|3|||
146551706|NCT00676052|528528894|FG002|Overall Study|Protocol Violation|2|||
146551707|NCT00676052|528528895|FG003|Overall Study|Protocol Violation|2|||
146551708|NCT00676052|528528896|FG004|Overall Study|Protocol Violation|1|||
146551709|NCT00676052|528528897|FG005|Overall Study|Protocol Violation|2|||
146551710|NCT00676052|528528892|FG000|Overall Study|Lost to Follow-up|0|||
146551711|NCT00676052|528528893|FG001|Overall Study|Lost to Follow-up|0|||
146551712|NCT00676052|528528894|FG002|Overall Study|Lost to Follow-up|0|||
146551713|NCT00676052|528528895|FG003|Overall Study|Lost to Follow-up|0|||
146551714|NCT00676052|528528896|FG004|Overall Study|Lost to Follow-up|1|||
146551715|NCT00676052|528528897|FG005|Overall Study|Lost to Follow-up|0|||
146551716|NCT00676052|528528892|FG000|Overall Study|Physician Decision|1|||
146551717|NCT00676052|528528893|FG001|Overall Study|Physician Decision|1|||
146551718|NCT00676052|528528894|FG002|Overall Study|Physician Decision|1|||
146551719|NCT00676052|528528895|FG003|Overall Study|Physician Decision|0|||
146551720|NCT00676052|528528896|FG004|Overall Study|Physician Decision|0|||
146551721|NCT00676052|528528897|FG005|Overall Study|Physician Decision|1|||
146551722|NCT00676052|528528892|FG000|Overall Study|Withdrawal by Subject|1|||
146551723|NCT00676052|528528893|FG001|Overall Study|Withdrawal by Subject|0|||
146551724|NCT00676052|528528894|FG002|Overall Study|Withdrawal by Subject|1|||
146551725|NCT00676052|528528895|FG003|Overall Study|Withdrawal by Subject|0|||
146551726|NCT00676052|528528896|FG004|Overall Study|Withdrawal by Subject|0|||
146551727|NCT00676052|528528897|FG005|Overall Study|Withdrawal by Subject|0|||
146551728|NCT01428713|528528898|FG000|Overall Study|Non-compliance|2|||
146551729|NCT01428713|528528899|FG001|Overall Study|Non-compliance|2|||
146551730|NCT01428713|528528898|FG000|Overall Study|Withdrawal by Subject|1|||
146551731|NCT01428713|528528899|FG001|Overall Study|Withdrawal by Subject|1|||
146551732|NCT01428713|528528898|FG000|Overall Study|Adverse Event|0|||
146551733|NCT01428713|528528899|FG001|Overall Study|Adverse Event|2|||
146551734|NCT02930941|528528900|FG000|Overall Study|Lost to Follow-up|1|||
146551735|NCT02930941|528528901|FG001|Overall Study|Lost to Follow-up|2|||
146551736|NCT00903344|528528904|FG000|Overall Study|Pregnancy|2|||
146551737|NCT00903344|528528905|FG001|Overall Study|Pregnancy|3|||
146551738|NCT00903344|528528904|FG000|Overall Study|Lost to Follow-up|3|||
146551739|NCT00903344|528528905|FG001|Overall Study|Lost to Follow-up|0|||
146551740|NCT00585169|528528919|FG000|Overall Study|Withdrawal by Subject|1|||
146551741|NCT01530256|528528920|FG000|Overall Study|Death|2|||
146551742|NCT00527748|528528922|FG000|Overall Study|Other|3|||
146551743|NCT01174459|528528933|FG000|Overall Study|case report form (CRF) not collected|5|||
146551744|NCT00290758|528528940|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
146551745|NCT00290758|528528941|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
146551746|NCT00290758|528528940|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
146551747|NCT00290758|528528941|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
146551748|NCT00290758|528528940|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
146551749|NCT00290758|528528941|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
146551750|NCT00290758|528528940|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
146551751|NCT00290758|528528941|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
146551752|NCT00290758|528528940|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
146551753|NCT00290758|528528941|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
146886997|NCT02889796|529753931|FG001|Overall Study|Investigator's Discretion|9|||
146886998|NCT02889796|529753932|FG002|Overall Study|Investigator's Discretion|10|||
146886999|NCT02889796|529753933|FG003|Overall Study|Investigator's Discretion|3|||
146887000|NCT02889796|529753934|FG004|Overall Study|Investigator's Discretion|0|||
146887001|NCT02889796|529753935|FG005|Overall Study|Investigator's Discretion|15|||
146887002|NCT02889796|529753930|FG000|Overall Study|Adverse Event|17|||
146887003|NCT02889796|529753931|FG001|Overall Study|Adverse Event|8|||
146887004|NCT02889796|529753932|FG002|Overall Study|Adverse Event|8|||
146887005|NCT02889796|529753933|FG003|Overall Study|Adverse Event|4|||
146887006|NCT02889796|529753934|FG004|Overall Study|Adverse Event|1|||
146887007|NCT02889796|529753935|FG005|Overall Study|Adverse Event|7|||
146887008|NCT02889796|529753930|FG000|Overall Study|Lost to Follow-up|5|||
146887009|NCT02889796|529753931|FG001|Overall Study|Lost to Follow-up|7|||
146887010|NCT02889796|529753932|FG002|Overall Study|Lost to Follow-up|2|||
146887011|NCT02889796|529753933|FG003|Overall Study|Lost to Follow-up|0|||
146887012|NCT02889796|529753934|FG004|Overall Study|Lost to Follow-up|2|||
146887013|NCT02889796|529753935|FG005|Overall Study|Lost to Follow-up|6|||
146887014|NCT02889796|529753930|FG000|Overall Study|Protocol Violation|0|||
146887015|NCT02889796|529753931|FG001|Overall Study|Protocol Violation|1|||
146887016|NCT02889796|529753932|FG002|Overall Study|Protocol Violation|3|||
146887017|NCT02889796|529753933|FG003|Overall Study|Protocol Violation|0|||
146887018|NCT02889796|529753934|FG004|Overall Study|Protocol Violation|0|||
146887019|NCT02889796|529753935|FG005|Overall Study|Protocol Violation|4|||
146887020|NCT02889796|529753930|FG000|Overall Study|Non-compliance With Study Drug|0|||
146887021|NCT02889796|529753931|FG001|Overall Study|Non-compliance With Study Drug|2|||
146887022|NCT02889796|529753932|FG002|Overall Study|Non-compliance With Study Drug|0|||
146887023|NCT02889796|529753933|FG003|Overall Study|Non-compliance With Study Drug|0|||
146887024|NCT02889796|529753934|FG004|Overall Study|Non-compliance With Study Drug|1|||
146887025|NCT02889796|529753935|FG005|Overall Study|Non-compliance With Study Drug|2|||
146887026|NCT02889796|529753930|FG000|Overall Study|Death|1|||
146887027|NCT02889796|529753931|FG001|Overall Study|Death|1|||
146887028|NCT02889796|529753932|FG002|Overall Study|Death|0|||
146887029|NCT02889796|529753933|FG003|Overall Study|Death|1|||
146887030|NCT02889796|529753934|FG004|Overall Study|Death|0|||
146887031|NCT02889796|529753935|FG005|Overall Study|Death|1|||
146887032|NCT02889796|529753930|FG000|Overall Study|Pregnancy|0|||
146887033|NCT02889796|529753931|FG001|Overall Study|Pregnancy|1|||
146887034|NCT02889796|529753932|FG002|Overall Study|Pregnancy|1|||
146887035|NCT02889796|529753933|FG003|Overall Study|Pregnancy|0|||
146887036|NCT02889796|529753934|FG004|Overall Study|Pregnancy|0|||
146887037|NCT02889796|529753935|FG005|Overall Study|Pregnancy|0|||
146551754|NCT00290758|528528940|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
146551755|NCT00290758|528528941|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
146551756|NCT00290758|528528940|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
146551757|NCT00290758|528528941|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
146551758|NCT00290758|528528940|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
146551759|NCT00290758|528528941|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
146551760|NCT03994120|528528943|FG000|Overall Study|Lost to Follow-up|3|||
146551761|NCT03994120|528528944|FG001|Overall Study|Lost to Follow-up|1|||
146551762|NCT01111292|528528945|FG000|Treatment|Physician Decision|1|||
146551763|NCT01111292|528528946|FG001|Treatment|Physician Decision|1|||
146551764|NCT05587998|528528949|FG000|Overall Study|Withdrawal by Subject|1|||
146551765|NCT05587998|528528950|FG001|Overall Study|Withdrawal by Subject|1|||
146551766|NCT05587998|528528949|FG000|Overall Study|Not treated|3|||
146551767|NCT05587998|528528950|FG001|Overall Study|Not treated|1|||
146551768|NCT05587998|528528949|FG000|Overall Study|Non-compliance with study procedures|0|||
146551769|NCT05587998|528528950|FG001|Overall Study|Non-compliance with study procedures|1|||
146887038|NCT02889796|529753930|FG000|Overall Study|Randomized but not Dosed|2|||
146887039|NCT02889796|529753931|FG001|Overall Study|Randomized but not Dosed|0|||
146887040|NCT02889796|529753932|FG002|Overall Study|Randomized but not Dosed|0|||
146887041|NCT02889796|529753933|FG003|Overall Study|Randomized but not Dosed|0|||
146887042|NCT02889796|529753934|FG004|Overall Study|Randomized but not Dosed|0|||
146887043|NCT02889796|529753935|FG005|Overall Study|Randomized but not Dosed|2|||
146887044|NCT04294459|529753938|FG000|Overall Study|Adverse Event|0|||
146887045|NCT04294459|529753939|FG001|Overall Study|Adverse Event|1|||
146551770|NCT03892915|528528951|FG000|Overall Study|Lost to Follow-up|6|||
146551771|NCT03892915|528528952|FG001|Overall Study|Lost to Follow-up|12|||
146551772|NCT03892915|528528951|FG000|Overall Study|Death|0|||
146551773|NCT03892915|528528952|FG001|Overall Study|Death|2|||
146887046|NCT04033367|529753940|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
146887047|NCT04033367|529753941|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
146887048|NCT04033367|529753940|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
146887049|NCT04033367|529753941|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
146551774|NCT03892915|528528951|FG000|Overall Study|Withdrawal by Subject|1|||
146551775|NCT03892915|528528952|FG001|Overall Study|Withdrawal by Subject|1|||
146551776|NCT03892915|528528951|FG000|Overall Study|unsuccessful delivery|13|||
146551777|NCT03892915|528528952|FG001|Overall Study|unsuccessful delivery|18|||
146765276|NCT00726596|529308582|FG000|Overall Study|Withdrawal by Subject|3|||
146887050|NCT04033367|529753940|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
146887051|NCT04033367|529753941|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
146887052|NCT04033367|529753940|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
146551778|NCT00191152|528528953|FG000|Initial Treatment|Adverse Event|43|||
146551779|NCT00191152|528528954|FG001|Initial Treatment|Adverse Event|67|||
146551780|NCT00191152|528528953|FG000|Initial Treatment|Physician Decision|40|||
146551781|NCT00191152|528528954|FG001|Initial Treatment|Physician Decision|31|||
146551782|NCT00191152|528528953|FG000|Initial Treatment|Withdrawal by Subject|40|||
146551783|NCT00191152|528528954|FG001|Initial Treatment|Withdrawal by Subject|28|||
146551784|NCT00191152|528528953|FG000|Initial Treatment|Lost to Follow-up|0|||
146551785|NCT00191152|528528954|FG001|Initial Treatment|Lost to Follow-up|6|||
146551786|NCT00191152|528528953|FG000|Initial Treatment|Other|18|||
146551787|NCT00191152|528528954|FG001|Initial Treatment|Other|21|||
146551788|NCT00191152|528528953|FG000|Crossover Treatment|Adverse Event|8|||
146551789|NCT00191152|528528954|FG001|Crossover Treatment|Adverse Event|8|||
146551790|NCT00191152|528528953|FG000|Crossover Treatment|Physician Decision|7|||
146551791|NCT00191152|528528954|FG001|Crossover Treatment|Physician Decision|7|||
146551792|NCT00191152|528528953|FG000|Crossover Treatment|Withdrawal by Subject|6|||
146551793|NCT00191152|528528954|FG001|Crossover Treatment|Withdrawal by Subject|9|||
146551794|NCT00191152|528528953|FG000|Crossover Treatment|Lost to Follow-up|2|||
146551795|NCT00191152|528528954|FG001|Crossover Treatment|Lost to Follow-up|1|||
146551796|NCT00191152|528528953|FG000|Crossover Treatment|Other|4|||
146551797|NCT00191152|528528954|FG001|Crossover Treatment|Other|3|||
146551798|NCT00114777|528528955|FG000|Randomization to Month 36|Death|10|||
146551799|NCT00114777|528528956|FG001|Randomization to Month 36|Death|4|||
146551800|NCT00114777|528528957|FG002|Randomization to Month 36|Death|3|||
146551801|NCT00114777|528528955|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
146551802|NCT00114777|528528956|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
146551803|NCT00114777|528528957|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
146551804|NCT00114777|528528955|FG000|Randomization to Month 36|Lack of Efficacy|19|||
146551805|NCT00114777|528528956|FG001|Randomization to Month 36|Lack of Efficacy|15|||
146551806|NCT00114777|528528957|FG002|Randomization to Month 36|Lack of Efficacy|17|||
146551807|NCT00114777|528528955|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
146551808|NCT00114777|528528956|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
146551809|NCT00114777|528528957|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
146551810|NCT00114777|528528955|FG000|Randomization to Month 36|Adverse Event|34|||
146551811|NCT00114777|528528956|FG001|Randomization to Month 36|Adverse Event|35|||
146551812|NCT00114777|528528957|FG002|Randomization to Month 36|Adverse Event|44|||
146551813|NCT00114777|528528955|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
146551814|NCT00114777|528528956|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
146551815|NCT00114777|528528957|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
146551816|NCT00114777|528528955|FG000|Randomization to Month 36|Other|9|||
146551817|NCT00114777|528528956|FG001|Randomization to Month 36|Other|3|||
146551818|NCT00114777|528528957|FG002|Randomization to Month 36|Other|12|||
146551819|NCT00114777|528528955|FG000|Long-Term Extension to Month 84|Death|8|||
146551820|NCT00114777|528528956|FG001|Long-Term Extension to Month 84|Death|13|||
146551821|NCT00114777|528528957|FG002|Long-Term Extension to Month 84|Death|7|||
146551822|NCT00114777|528528955|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
146551823|NCT00114777|528528956|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
146551824|NCT00114777|528528957|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
146551825|NCT00114777|528528955|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
146551826|NCT00114777|528528956|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
146551827|NCT00114777|528528957|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
146551828|NCT00114777|528528955|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
146551829|NCT00114777|528528956|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
146551830|NCT00114777|528528957|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
146551831|NCT00114777|528528955|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
146551832|NCT00114777|528528956|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
146551833|NCT00114777|528528957|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
146551834|NCT00114777|528528955|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
146551835|NCT00114777|528528956|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
146765277|NCT00726596|529308583|FG001|Overall Study|Withdrawal by Subject|3|||
146765278|NCT01185522|529308585|FG000|Overall Study|Lack of Efficacy|28|||
146765279|NCT01185522|529308585|FG000|Overall Study|Lost to Follow-up|19|||
146765280|NCT01185522|529308585|FG000|Overall Study|Withdrawal by Subject|10|||
146887053|NCT04033367|529753941|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
146551836|NCT00114777|528528957|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
146551837|NCT00114777|528528955|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
146551838|NCT00114777|528528956|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
146551839|NCT00114777|528528957|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
146551840|NCT00114777|528528955|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
146765281|NCT01185522|529308585|FG000|Overall Study|Poor tolerance|39|||
146551841|NCT00114777|528528956|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
146551842|NCT00114777|528528957|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
146551843|NCT00114777|528528955|FG000|Long-Term Extension to Month 84|Other|2|||
146551844|NCT00114777|528528956|FG001|Long-Term Extension to Month 84|Other|0|||
146551845|NCT00114777|528528957|FG002|Long-Term Extension to Month 84|Other|2|||
146551846|NCT04243837|528528961|FG000|Overall Study|Adverse Event|2|||
146551847|NCT04243837|528528962|FG001|Overall Study|Adverse Event|1|||
146551848|NCT04243837|528528961|FG000|Overall Study|Withdrawal by Subject|4|||
146551849|NCT04243837|528528962|FG001|Overall Study|Withdrawal by Subject|2|||
146551850|NCT04243837|528528961|FG000|Overall Study|Covid-19 lock down|1|||
146551851|NCT04243837|528528962|FG001|Overall Study|Covid-19 lock down|0|||
146551852|NCT04243837|528528961|FG000|Overall Study|Study Terminated by Sponsor|11|||
146551853|NCT04243837|528528962|FG001|Overall Study|Study Terminated by Sponsor|12|||
146551854|NCT00455455|528528968|FG000|Washout|Withdrawal by Subject|0|||
146551855|NCT00455455|528528969|FG001|Washout|Withdrawal by Subject|1|||
146551856|NCT00455455|528528968|FG000|Washout|Withdrawal by Subject|1|||
146551857|NCT00455455|528528969|FG001|Washout|Withdrawal by Subject|0|||
146551858|NCT01370538|528528970|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
146551859|NCT01370538|528528971|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
146551860|NCT01370538|528528970|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146551861|NCT01370538|528528971|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146551862|NCT01370538|528528970|FG000|Overall Study|Adverse Event|1|||
146551863|NCT01370538|528528971|FG001|Overall Study|Adverse Event|0|||
146551864|NCT01370538|528528970|FG000|Overall Study|Protocol Violation|8|||
146551865|NCT01370538|528528971|FG001|Overall Study|Protocol Violation|5|||
146551866|NCT01370538|528528970|FG000|Overall Study|Development of study specific withdrawal|1|||
146551867|NCT01370538|528528971|FG001|Overall Study|Development of study specific withdrawal|1|||
146551868|NCT01370538|528528970|FG000|Overall Study|Lost to follow up|6|||
146551869|NCT01370538|528528971|FG001|Overall Study|Lost to follow up|10|||
146551870|NCT03632720|528528977|FG000|Overall Study|Adverse Event|2|||
146551871|NCT03632720|528528978|FG001|Overall Study|Adverse Event|0|||
146551872|NCT03632720|528528979|FG002|Overall Study|Adverse Event|0|||
146551873|NCT03632720|528528977|FG000|Overall Study|Lost to Follow-up|0|||
146551874|NCT03632720|528528978|FG001|Overall Study|Lost to Follow-up|1|||
146551875|NCT03632720|528528979|FG002|Overall Study|Lost to Follow-up|0|||
146551876|NCT03632720|528528977|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
146551877|NCT03632720|528528978|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
146551878|NCT03632720|528528979|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
146551879|NCT03632720|528528977|FG000|Overall Study|Screen failure|0|||
146551880|NCT03632720|528528978|FG001|Overall Study|Screen failure|1|||
146551881|NCT03632720|528528979|FG002|Overall Study|Screen failure|0|||
146551882|NCT01117350|528528980|FG000|Comparative Period|Not Treated|5|||
146551883|NCT01117350|528528981|FG001|Comparative Period|Not Treated|8|||
146551884|NCT01117350|528528980|FG000|Comparative Period|Adverse Event|6|||
146551885|NCT01117350|528528981|FG001|Comparative Period|Adverse Event|33|||
146551886|NCT01117350|528528980|FG000|Comparative Period|Lost to Follow-up|11|||
146551887|NCT01117350|528528981|FG001|Comparative Period|Lost to Follow-up|7|||
146551888|NCT01117350|528528980|FG000|Comparative Period|Withdrawal by Subject|9|||
146551889|NCT01117350|528528981|FG001|Comparative Period|Withdrawal by Subject|13|||
146551890|NCT01117350|528528980|FG000|Comparative Period|Protocol Violation|8|||
146551891|NCT01117350|528528981|FG001|Comparative Period|Protocol Violation|12|||
146551892|NCT01117350|528528980|FG000|Comparative Period|Lack of Efficacy|1|||
146551893|NCT01117350|528528981|FG001|Comparative Period|Lack of Efficacy|0|||
146551894|NCT01117350|528528980|FG000|Comparative Period|Physician Decision|0|||
146551895|NCT01117350|528528981|FG001|Comparative Period|Physician Decision|1|||
146551896|NCT01117350|528528980|FG000|Comparative Period|Move to another city/country|2|||
146551897|NCT01117350|528528981|FG001|Comparative Period|Move to another city/country|1|||
146551898|NCT01117350|528528980|FG000|Extension Period|Not included in extension, not treated|0|||
146551899|NCT01117350|528528981|FG001|Extension Period|Not included in extension, not treated|50|||
146551900|NCT01117350|528528980|FG000|Extension Period|Adverse Event|0|||
146551901|NCT01117350|528528981|FG001|Extension Period|Adverse Event|2|||
146551902|NCT01117350|528528980|FG000|Extension Period|Protocol Violation|0|||
146551903|NCT01117350|528528981|FG001|Extension Period|Protocol Violation|2|||
146765282|NCT01185522|529308585|FG000|Overall Study|Other reasons|12|||
146765283|NCT00954707|529308586|FG000|Overall Study|Death|34|||
146966585|NCT04584294|530038860|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
146551904|NCT01117350|528528980|FG000|Extension Period|Lost to Follow-up|0|||
146551905|NCT01117350|528528981|FG001|Extension Period|Lost to Follow-up|2|||
146551906|NCT01117350|528528980|FG000|Extension Period|Withdrawal by Subject|0|||
146551907|NCT01117350|528528981|FG001|Extension Period|Withdrawal by Subject|3|||
146551908|NCT01117350|528528980|FG000|Extension Period|Lack of Efficacy|0|||
146551909|NCT01117350|528528981|FG001|Extension Period|Lack of Efficacy|2|||
146551910|NCT01117350|528528980|FG000|Extension Period|Inclusion criteria not respected|0|||
146551911|NCT01117350|528528981|FG001|Extension Period|Inclusion criteria not respected|1|||
146551912|NCT01117350|528528980|FG000|Extension Period|Prohibited medication|0|||
146887054|NCT02723201|529753942|FG000|Second Intervention Period|Protocol Violation|1|||
146551913|NCT01117350|528528981|FG001|Extension Period|Prohibited medication|1|||
146551914|NCT01049828|528528984|FG000|Overall Study|Claustrophibia and Frustration|2|||
146551915|NCT00290238|528528985|FG000|Overall Study|Study terminated|27|||
146551916|NCT00290238|528528986|FG001|Overall Study|Study terminated|27|||
146551917|NCT00290238|528528985|FG000|Overall Study|Lost to Follow-up|0|||
146551918|NCT00290238|528528986|FG001|Overall Study|Lost to Follow-up|1|||
146551919|NCT00290238|528528985|FG000|Overall Study|Withdrawal by Subject|15|||
146551920|NCT00290238|528528986|FG001|Overall Study|Withdrawal by Subject|13|||
146551921|NCT02487199|528528993|FG000|Overall Study|Withdrew Consent|0|||
146551922|NCT02487199|528528994|FG001|Overall Study|Withdrew Consent|1|||
146551923|NCT01213251|528530845|FG000|Overall Study|Death|2|||
146551924|NCT01213251|528530846|FG001|Overall Study|Death|1|||
146551925|NCT01213251|528530847|FG002|Overall Study|Death|2|||
146551926|NCT01213251|528530845|FG000|Overall Study|Exit|3|||
146551927|NCT01213251|528530846|FG001|Overall Study|Exit|2|||
146551928|NCT01213251|528530847|FG002|Overall Study|Exit|8|||
146551929|NCT01213251|528530845|FG000|Overall Study|Protocol Violation|1|||
146551930|NCT01213251|528530846|FG001|Overall Study|Protocol Violation|1|||
146551931|NCT01213251|528530847|FG002|Overall Study|Protocol Violation|0|||
146551932|NCT01213251|528530845|FG000|Overall Study|Missed 18-Month Follow-up|0|||
146551933|NCT01213251|528530846|FG001|Overall Study|Missed 18-Month Follow-up|0|||
146551934|NCT01213251|528530847|FG002|Overall Study|Missed 18-Month Follow-up|1|||
146551935|NCT01557244|528530852|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
146551936|NCT01557244|528530853|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
146551937|NCT01557244|528530854|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
146551938|NCT01557244|528530855|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
146551939|NCT01557244|528530856|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
146551940|NCT01557244|528530857|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
146551941|NCT01557244|528530858|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
146551942|NCT01557244|528530852|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
146551943|NCT01557244|528530853|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
146551944|NCT01557244|528530854|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
146551945|NCT01557244|528530855|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
146551946|NCT01557244|528530856|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
146551947|NCT01557244|528530857|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
146551948|NCT01557244|528530858|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
146551949|NCT01557244|528530852|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
146551950|NCT01557244|528530853|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
146551951|NCT01557244|528530854|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
146551952|NCT01557244|528530855|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
146551953|NCT01557244|528530856|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
146551954|NCT01557244|528530857|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
146551955|NCT01557244|528530858|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
146551956|NCT01557244|528530852|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
146551957|NCT01557244|528530853|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
146551958|NCT01557244|528530854|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
146551959|NCT01557244|528530855|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
146551960|NCT01557244|528530856|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
146551961|NCT01557244|528530857|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
146551962|NCT01557244|528530858|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
146551963|NCT01557244|528530852|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
146551964|NCT01557244|528530853|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
146551965|NCT01557244|528530854|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
146551966|NCT01557244|528530855|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
146551967|NCT01557244|528530856|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
146551968|NCT01557244|528530857|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
146551969|NCT01557244|528530858|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
146551970|NCT01557244|528530852|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
146551971|NCT01557244|528530853|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
146551972|NCT01557244|528530854|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
146551973|NCT01557244|528530855|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
146551974|NCT01557244|528530856|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
146551975|NCT01557244|528530857|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
146887055|NCT02723201|529753943|FG001|Second Intervention Period|Protocol Violation|0|||
146551976|NCT01557244|528530858|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
146551977|NCT01557244|528530852|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
146551978|NCT01557244|528530853|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
146551979|NCT01557244|528530854|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
146551980|NCT01557244|528530855|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
146551981|NCT01557244|528530856|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
146551982|NCT01557244|528530857|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
146551983|NCT01557244|528530858|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
146551984|NCT01557244|528530852|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
146551985|NCT01557244|528530853|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
146551986|NCT01557244|528530854|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
146551987|NCT01557244|528530855|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
146551988|NCT01557244|528530856|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
146551989|NCT01557244|528530857|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
146551990|NCT01557244|528530858|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
146551991|NCT01557244|528530852|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
146551992|NCT01557244|528530853|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
146551993|NCT01557244|528530854|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
146551994|NCT01557244|528530855|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
146551995|NCT01557244|528530856|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
146551996|NCT01557244|528530857|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
146551997|NCT01557244|528530858|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
146551998|NCT01557244|528530852|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
146551999|NCT01557244|528530853|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
146552000|NCT01557244|528530854|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
146552001|NCT01557244|528530855|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
146552002|NCT01557244|528530856|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
146552003|NCT01557244|528530857|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
146552004|NCT01557244|528530858|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
146552005|NCT01557244|528530852|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
146552006|NCT01557244|528530853|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
146552007|NCT01557244|528530854|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
146552008|NCT01557244|528530855|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
146552009|NCT01557244|528530856|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
146552010|NCT01557244|528530857|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
146552011|NCT01557244|528530858|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
146552012|NCT01557244|528530852|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
146552013|NCT01557244|528530853|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
146552014|NCT01557244|528530854|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
146552015|NCT01557244|528530855|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
146552016|NCT01557244|528530856|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
146552017|NCT01557244|528530857|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
146552018|NCT01557244|528530858|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
146552019|NCT01313676|528530859|FG000|Overall Study|Adverse Event|395|||
146552020|NCT01313676|528530860|FG001|Overall Study|Adverse Event|365|||
146552021|NCT01313676|528530861|FG002|Overall Study|Adverse Event|372|||
146552022|NCT01313676|528530862|FG003|Overall Study|Adverse Event|333|||
146552023|NCT01313676|528530859|FG000|Overall Study|Lack of Efficacy|98|||
146552024|NCT01313676|528530860|FG001|Overall Study|Lack of Efficacy|90|||
146552025|NCT01313676|528530861|FG002|Overall Study|Lack of Efficacy|65|||
146552026|NCT01313676|528530862|FG003|Overall Study|Lack of Efficacy|46|||
146552027|NCT01313676|528530859|FG000|Overall Study|Protocol Violation|37|||
146552028|NCT01313676|528530860|FG001|Overall Study|Protocol Violation|44|||
146552029|NCT01313676|528530861|FG002|Overall Study|Protocol Violation|46|||
146552030|NCT01313676|528530862|FG003|Overall Study|Protocol Violation|44|||
146552031|NCT01313676|528530859|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
146552032|NCT01313676|528530860|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
146552033|NCT01313676|528530861|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
146552034|NCT01313676|528530862|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
146552035|NCT01313676|528530859|FG000|Overall Study|Study Closed/terminated|7|||
146552036|NCT01313676|528530860|FG001|Overall Study|Study Closed/terminated|6|||
146552037|NCT01313676|528530861|FG002|Overall Study|Study Closed/terminated|9|||
146552038|NCT01313676|528530862|FG003|Overall Study|Study Closed/terminated|9|||
146552039|NCT01313676|528530859|FG000|Overall Study|Lost to Follow-up|0|||
146552040|NCT01313676|528530860|FG001|Overall Study|Lost to Follow-up|0|||
146552041|NCT01313676|528530861|FG002|Overall Study|Lost to Follow-up|1|||
146887056|NCT02723201|529753944|FG002|Second Intervention Period|Protocol Violation|0|||
146887057|NCT02723201|529753942|FG000|Second Intervention Period|Adverse Event|1|||
146632362|NCT02113982|528831755|FG007|Stage 2: Cohort Expansion|Transplant|0|||
146632363|NCT02113982|528831756|FG008|Stage 2: Cohort Expansion|Transplant|0|||
146632364|NCT02113982|528831757|FG009|Stage 2: Cohort Expansion|Transplant|4|||
146632365|NCT02113982|528831758|FG010|Stage 2: Cohort Expansion|Transplant|2|||
146632366|NCT02113982|528831759|FG011|Stage 2: Cohort Expansion|Transplant|0|||
146632367|NCT02113982|528831760|FG012|Stage 2: Cohort Expansion|Transplant|0|||
146632368|NCT02113982|528831761|FG013|Stage 2: Cohort Expansion|Transplant|0|||
146632369|NCT02113982|528831748|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
146632370|NCT02113982|528831749|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
146632371|NCT02113982|528831750|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
146632372|NCT02113982|528831751|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
146632373|NCT02113982|528831752|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
146632374|NCT02113982|528831753|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
146632375|NCT02113982|528831754|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
146632376|NCT02113982|528831755|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
146632377|NCT02113982|528831756|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
146632378|NCT02113982|528831757|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
146632379|NCT02113982|528831758|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
146632380|NCT02113982|528831759|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
146632381|NCT02113982|528831760|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
146632382|NCT02113982|528831761|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
146632383|NCT02113982|528831748|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
146632384|NCT02113982|528831749|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
146632385|NCT02113982|528831750|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
146632386|NCT02113982|528831751|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
146632387|NCT02113982|528831752|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
146632388|NCT02113982|528831753|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
146632389|NCT02113982|528831754|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
146632390|NCT02113982|528831755|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
146632391|NCT02113982|528831756|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
146632392|NCT02113982|528831757|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
146632393|NCT02113982|528831758|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
146632394|NCT02113982|528831759|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
146632395|NCT02113982|528831760|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
146632396|NCT02113982|528831761|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
146632397|NCT02113982|528831748|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
146632398|NCT02113982|528831749|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
146632399|NCT02113982|528831750|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
146632400|NCT02113982|528831751|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
146632401|NCT02113982|528831752|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
146632402|NCT02113982|528831753|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
146632403|NCT02113982|528831754|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
146632404|NCT02113982|528831755|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
146632405|NCT02113982|528831756|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
146632406|NCT02113982|528831757|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
146632407|NCT02113982|528831758|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
146632408|NCT02113982|528831759|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
146632409|NCT02113982|528831760|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
146632410|NCT02113982|528831761|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
146632411|NCT02113982|528831748|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
146632412|NCT02113982|528831749|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
146632413|NCT02113982|528831750|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
146632414|NCT02113982|528831751|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
146632415|NCT02113982|528831752|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
146632416|NCT02113982|528831753|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
146632417|NCT02113982|528831754|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
146632418|NCT02113982|528831755|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
146632419|NCT02113982|528831756|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
146632420|NCT02113982|528831757|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
146632421|NCT02113982|528831758|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
146887058|NCT02723201|529753943|FG001|Second Intervention Period|Adverse Event|0|||
146887059|NCT02723201|529753944|FG002|Second Intervention Period|Adverse Event|0|||
146887060|NCT02908880|529753945|FG000|Overall Study|Lost to Follow-up|4|||
146887061|NCT02908880|529753945|FG000|Overall Study|Explantation of the device|1|||
146887062|NCT02908880|529753945|FG000|Overall Study|Withdrawal by Subject|17|||
146632422|NCT02113982|528831759|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
146632423|NCT02113982|528831760|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
146887063|NCT02908880|529753945|FG000|Overall Study|Death|5|||
146887064|NCT01978093|529753948|FG000|Overall Study|Death|1|||
146632424|NCT02113982|528831761|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
146632425|NCT02113982|528831748|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146632426|NCT02113982|528831749|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146632427|NCT02113982|528831750|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146552042|NCT01313676|528530862|FG003|Overall Study|Lost to Follow-up|0|||
146552043|NCT01313676|528530859|FG000|Overall Study|Physician Decision|53|||
146552044|NCT01313676|528530860|FG001|Overall Study|Physician Decision|64|||
146552045|NCT01313676|528530861|FG002|Overall Study|Physician Decision|62|||
146552046|NCT01313676|528530862|FG003|Overall Study|Physician Decision|48|||
146552047|NCT01313676|528530859|FG000|Overall Study|Decision by Participant or Proxy|643|||
146552048|NCT01313676|528530860|FG001|Overall Study|Decision by Participant or Proxy|527|||
146552049|NCT01313676|528530861|FG002|Overall Study|Decision by Participant or Proxy|515|||
146552050|NCT01313676|528530862|FG003|Overall Study|Decision by Participant or Proxy|492|||
146552051|NCT01313676|528530859|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
146552052|NCT01313676|528530860|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
146552053|NCT01313676|528530861|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
146552054|NCT01313676|528530862|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
146552055|NCT01313676|528530859|FG000|Overall Study|Investigator Site Closed|12|||
146552056|NCT01313676|528530860|FG001|Overall Study|Investigator Site Closed|11|||
146552057|NCT01313676|528530861|FG002|Overall Study|Investigator Site Closed|15|||
146552058|NCT01313676|528530862|FG003|Overall Study|Investigator Site Closed|10|||
146552059|NCT01313676|528530859|FG000|Overall Study|Missing|1|||
146552060|NCT01313676|528530860|FG001|Overall Study|Missing|1|||
146552061|NCT01313676|528530861|FG002|Overall Study|Missing|1|||
146552062|NCT01313676|528530862|FG003|Overall Study|Missing|0|||
146552063|NCT01862029|528530863|FG000|Overall Study|Physician Decision|1|||
146552064|NCT03931785|528530864|FG000|Overall Study|Lost to Follow-up|4|||
146552065|NCT03931785|528530865|FG001|Overall Study|Lost to Follow-up|1|||
146552066|NCT03931785|528530866|FG002|Overall Study|Lost to Follow-up|4|||
146552067|NCT03931785|528530867|FG003|Overall Study|Lost to Follow-up|3|||
146552068|NCT03931785|528530864|FG000|Overall Study|Adverse Event|1|||
146552069|NCT03931785|528530865|FG001|Overall Study|Adverse Event|0|||
146552070|NCT03931785|528530866|FG002|Overall Study|Adverse Event|3|||
146552071|NCT03931785|528530867|FG003|Overall Study|Adverse Event|4|||
146552072|NCT03931785|528530864|FG000|Overall Study|Protocol Violation|0|||
146552073|NCT03931785|528530865|FG001|Overall Study|Protocol Violation|1|||
146552074|NCT03931785|528530866|FG002|Overall Study|Protocol Violation|0|||
146552075|NCT03931785|528530867|FG003|Overall Study|Protocol Violation|0|||
146552076|NCT03931785|528530864|FG000|Overall Study|Noncompliance With Study drug|0|||
146552077|NCT03931785|528530865|FG001|Overall Study|Noncompliance With Study drug|1|||
146552078|NCT03931785|528530866|FG002|Overall Study|Noncompliance With Study drug|0|||
146552079|NCT03931785|528530867|FG003|Overall Study|Noncompliance With Study drug|0|||
146552080|NCT03931785|528530864|FG000|Overall Study|Other Not specified|0|||
146552081|NCT03931785|528530865|FG001|Overall Study|Other Not specified|2|||
146552082|NCT03931785|528530866|FG002|Overall Study|Other Not specified|2|||
146552083|NCT03931785|528530867|FG003|Overall Study|Other Not specified|2|||
146552084|NCT03931785|528530864|FG000|Overall Study|Withdrawal by Subject|0|||
146552085|NCT03931785|528530865|FG001|Overall Study|Withdrawal by Subject|2|||
146552086|NCT03931785|528530866|FG002|Overall Study|Withdrawal by Subject|4|||
146552087|NCT03931785|528530867|FG003|Overall Study|Withdrawal by Subject|1|||
146552088|NCT03931785|528530864|FG000|Overall Study|Pregnancy|0|||
146552089|NCT03931785|528530865|FG001|Overall Study|Pregnancy|0|||
146552090|NCT03931785|528530866|FG002|Overall Study|Pregnancy|0|||
146552091|NCT03931785|528530867|FG003|Overall Study|Pregnancy|1|||
146552092|NCT03548415|528530869|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
146552093|NCT03548415|528530870|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
146552094|NCT03548415|528530871|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
146552095|NCT03548415|528530872|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
146552096|NCT03548415|528530873|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
146552097|NCT04605588|528530874|FG000|Overall Study|Withdrawal by Subject|1|||
146552098|NCT04605588|528530875|FG001|Overall Study|Withdrawal by Subject|0|||
146552099|NCT01230814|528530876|FG000|Overall Study|Lost to Follow-up|11|||
146552100|NCT01230814|528530877|FG001|Overall Study|Lost to Follow-up|3|||
146552101|NCT01230814|528530876|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
146552102|NCT01230814|528530877|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
146552103|NCT02004275|528530888|FG000|Phase 1|Ineligible|0|||
146552104|NCT02004275|528530889|FG001|Phase 1|Ineligible|0|||
146552105|NCT02004275|528530890|FG002|Phase 1|Ineligible|0|||
146552106|NCT02004275|528530891|FG003|Phase 1|Ineligible|1|||
146552107|NCT02004275|528530892|FG004|Phase 1|Ineligible|1|||
146552108|NCT02004275|528530893|FG005|Phase 1|Ineligible|0|||
146552109|NCT02004275|528530888|FG000|Phase 1|Protocol Violation|0|||
146552110|NCT02004275|528530889|FG001|Phase 1|Protocol Violation|0|||
146966586|NCT04584294|530038859|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
146966587|NCT04584294|530038860|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
146966588|NCT04584294|530038859|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
146765284|NCT00954707|529308586|FG000|Overall Study|Withdrawal by Subject|100|||
146966589|NCT04584294|530038860|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
146966590|NCT04584294|530038859|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
146966591|NCT04584294|530038860|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
146552111|NCT02004275|528530890|FG002|Phase 1|Protocol Violation|0|||
146552112|NCT02004275|528530891|FG003|Phase 1|Protocol Violation|1|||
146552113|NCT02004275|528530892|FG004|Phase 1|Protocol Violation|0|||
146552114|NCT02004275|528530893|FG005|Phase 1|Protocol Violation|5|||
146552115|NCT02004275|528530888|FG000|Phase 2 Part 1|Ineligible|6|||
146552116|NCT02004275|528530889|FG001|Phase 2 Part 1|Ineligible|9|||
146552117|NCT02004275|528530890|FG002|Phase 2 Part 1|Ineligible|0|||
146552118|NCT02004275|528530891|FG003|Phase 2 Part 1|Ineligible|0|||
146552119|NCT02004275|528530892|FG004|Phase 2 Part 1|Ineligible|0|||
146552120|NCT02004275|528530893|FG005|Phase 2 Part 1|Ineligible|0|||
146552121|NCT02004275|528530888|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
146552122|NCT02004275|528530889|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
146552123|NCT02004275|528530890|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
146552124|NCT02004275|528530891|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
146552125|NCT02004275|528530892|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
146552126|NCT02004275|528530893|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
146552127|NCT04621786|528530894|FG000|Overall Study|Lost to Follow-up|9|||
146552128|NCT04621786|528530894|FG000|Overall Study|Protocol Violation|3|||
146552129|NCT00292370|528530895|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
146552130|NCT00292370|528530896|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
146552131|NCT00292370|528530897|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
146552132|NCT00292370|528530895|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
146552133|NCT00292370|528530896|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
146552134|NCT00292370|528530897|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
146552135|NCT00292370|528530895|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
146552136|NCT00292370|528530896|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
146552137|NCT00292370|528530897|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
146552138|NCT00292370|528530895|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
146552139|NCT00292370|528530896|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
146552140|NCT00292370|528530897|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
146552141|NCT00292370|528530895|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
146552142|NCT00292370|528530896|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
146552143|NCT00292370|528530897|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
146552144|NCT00292370|528530895|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
146552145|NCT00292370|528530896|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
146552146|NCT00292370|528530897|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
146552147|NCT02533674|528530898|FG000|Dose Level I|Progressive disease|1|||
146552148|NCT02533674|528530899|FG001|Dose Level I|Progressive disease|0|||
146552149|NCT02533674|528530900|FG002|Dose Level I|Progressive disease|0|||
146552150|NCT02533674|528530901|FG003|Dose Level I|Progressive disease|0|||
146552151|NCT02533674|528530902|FG004|Dose Level I|Progressive disease|0|||
146552152|NCT02533674|528530903|FG005|Dose Level I|Progressive disease|0|||
146552153|NCT02533674|528530904|FG006|Dose Level I|Progressive disease|0|||
146552154|NCT02533674|528530905|FG007|Dose Level I|Progressive disease|0|||
146552155|NCT02533674|528530898|FG000|Dose Level I|Withdrawal by Subject|1|||
146552156|NCT02533674|528530899|FG001|Dose Level I|Withdrawal by Subject|0|||
146552157|NCT02533674|528530900|FG002|Dose Level I|Withdrawal by Subject|0|||
146552158|NCT02533674|528530901|FG003|Dose Level I|Withdrawal by Subject|0|||
146552159|NCT02533674|528530902|FG004|Dose Level I|Withdrawal by Subject|0|||
146552160|NCT02533674|528530903|FG005|Dose Level I|Withdrawal by Subject|0|||
146552161|NCT02533674|528530904|FG006|Dose Level I|Withdrawal by Subject|0|||
146552162|NCT02533674|528530905|FG007|Dose Level I|Withdrawal by Subject|0|||
146552163|NCT02533674|528530898|FG000|Dose Level I|Physician Decision|1|||
146552164|NCT02533674|528530899|FG001|Dose Level I|Physician Decision|0|||
146552165|NCT02533674|528530900|FG002|Dose Level I|Physician Decision|0|||
146552166|NCT02533674|528530901|FG003|Dose Level I|Physician Decision|0|||
146552167|NCT02533674|528530902|FG004|Dose Level I|Physician Decision|0|||
146552168|NCT02533674|528530903|FG005|Dose Level I|Physician Decision|0|||
146552169|NCT02533674|528530904|FG006|Dose Level I|Physician Decision|0|||
146552170|NCT02533674|528530905|FG007|Dose Level I|Physician Decision|0|||
146552171|NCT02533674|528530898|FG000|Dose Level I|Death|1|||
146765285|NCT00954707|529308586|FG000|Overall Study|Lost to Follow-up|33|||
146765286|NCT02962674|529308587|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
146765287|NCT00364286|529308589|FG000|Overall Study|Withdrawal by Subject|1|||
146552172|NCT02533674|528530899|FG001|Dose Level I|Death|0|||
146552173|NCT02533674|528530900|FG002|Dose Level I|Death|0|||
146552174|NCT02533674|528530901|FG003|Dose Level I|Death|0|||
146552175|NCT02533674|528530902|FG004|Dose Level I|Death|0|||
146552176|NCT02533674|528530903|FG005|Dose Level I|Death|0|||
146552177|NCT02533674|528530904|FG006|Dose Level I|Death|0|||
146552178|NCT02533674|528530905|FG007|Dose Level I|Death|0|||
146552179|NCT02533674|528530898|FG000|Dose Level I|Never Treated|1|||
146552180|NCT02533674|528530899|FG001|Dose Level I|Never Treated|0|||
146552181|NCT02533674|528530900|FG002|Dose Level I|Never Treated|0|||
146552182|NCT02533674|528530901|FG003|Dose Level I|Never Treated|0|||
146632428|NCT02113982|528831751|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146632429|NCT02113982|528831752|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146632430|NCT02113982|528831753|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146632431|NCT02113982|528831754|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146632432|NCT02113982|528831755|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146632433|NCT02113982|528831756|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146632434|NCT02113982|528831757|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146632435|NCT02113982|528831758|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146632436|NCT02113982|528831759|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
146887065|NCT01978093|529753949|FG001|Overall Study|Death|0|||
146887066|NCT01978093|529753948|FG000|Overall Study|Adverse Event|0|||
146887067|NCT01978093|529753949|FG001|Overall Study|Adverse Event|5|||
146887068|NCT01978093|529753948|FG000|Overall Study|Protocol Violation|8|||
146632437|NCT02113982|528831760|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146632438|NCT02113982|528831761|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146632439|NCT02113982|528831748|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
146632440|NCT02113982|528831749|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
146632441|NCT02113982|528831750|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
146632442|NCT02113982|528831751|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
146632443|NCT02113982|528831752|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
146632444|NCT02113982|528831753|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
146632445|NCT02113982|528831754|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
146632446|NCT02113982|528831755|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
146632447|NCT02113982|528831756|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
146632448|NCT02113982|528831757|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
146632449|NCT02113982|528831758|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
146632450|NCT02113982|528831759|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
146632451|NCT02113982|528831760|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
146632452|NCT02113982|528831761|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
146632453|NCT02113982|528831748|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146632454|NCT02113982|528831749|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146632455|NCT02113982|528831750|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146632456|NCT02113982|528831751|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146632457|NCT02113982|528831752|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146632458|NCT02113982|528831753|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146632459|NCT02113982|528831754|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146632460|NCT02113982|528831755|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146632461|NCT02113982|528831756|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146632462|NCT02113982|528831757|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146632463|NCT02113982|528831758|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146632464|NCT02113982|528831759|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146632465|NCT02113982|528831760|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
146632466|NCT02113982|528831761|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146632467|NCT02113982|528831748|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146632468|NCT02113982|528831749|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146632469|NCT02113982|528831750|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146632470|NCT02113982|528831751|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146632471|NCT02113982|528831752|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146632472|NCT02113982|528831753|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146632473|NCT02113982|528831754|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146632474|NCT02113982|528831755|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146632475|NCT02113982|528831756|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146632476|NCT02113982|528831757|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146632477|NCT02113982|528831758|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146632478|NCT02113982|528831759|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146632479|NCT02113982|528831760|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
146632480|NCT02113982|528831761|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
146887069|NCT01978093|529753949|FG001|Overall Study|Protocol Violation|2|||
146887070|NCT01978093|529753948|FG000|Overall Study|Withdrawal by Subject|29|||
146887071|NCT01978093|529753949|FG001|Overall Study|Withdrawal by Subject|25|||
146887072|NCT01978093|529753948|FG000|Overall Study|Lost to Follow-up|11|||
146887073|NCT01978093|529753949|FG001|Overall Study|Lost to Follow-up|15|||
146887074|NCT01978093|529753948|FG000|Overall Study|Migrated/moved from study area|11|||
146632481|NCT02113982|528831748|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146632482|NCT02113982|528831749|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146632483|NCT02113982|528831750|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146632484|NCT02113982|528831751|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146887075|NCT01978093|529753949|FG001|Overall Study|Migrated/moved from study area|13|||
146632485|NCT02113982|528831752|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146765288|NCT00364286|529308589|FG000|Overall Study|Adverse Event|2|||
146887076|NCT01978093|529753948|FG000|Overall Study|Loss of kaiser coverage|4|||
146887077|NCT01978093|529753949|FG001|Overall Study|Loss of kaiser coverage|10|||
146887078|NCT01978093|529753948|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
146887079|NCT01978093|529753949|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
146887080|NCT01978093|529753948|FG000|Overall Study|Mother lost custody of child|0|||
146887081|NCT01978093|529753949|FG001|Overall Study|Mother lost custody of child|1|||
146887082|NCT01978093|529753948|FG000|Overall Study|Child was in care of grandmother|0|||
146887083|NCT01978093|529753949|FG001|Overall Study|Child was in care of grandmother|1|||
146887084|NCT01978093|529753948|FG000|Overall Study|N/A for vaccine administration|0|||
146552183|NCT02533674|528530902|FG004|Dose Level I|Never Treated|0|||
146552184|NCT02533674|528530903|FG005|Dose Level I|Never Treated|0|||
146552185|NCT02533674|528530904|FG006|Dose Level I|Never Treated|0|||
146552186|NCT02533674|528530905|FG007|Dose Level I|Never Treated|0|||
146552187|NCT02533674|528530898|FG000|Dose Level II|Progressive disease|0|||
146552188|NCT02533674|528530899|FG001|Dose Level II|Progressive disease|3|||
146552189|NCT02533674|528530900|FG002|Dose Level II|Progressive disease|0|||
146552190|NCT02533674|528530901|FG003|Dose Level II|Progressive disease|0|||
146552191|NCT02533674|528530902|FG004|Dose Level II|Progressive disease|0|||
146552192|NCT02533674|528530903|FG005|Dose Level II|Progressive disease|0|||
146552193|NCT02533674|528530904|FG006|Dose Level II|Progressive disease|0|||
146552194|NCT02533674|528530905|FG007|Dose Level II|Progressive disease|0|||
146552195|NCT02533674|528530898|FG000|Dose Level II|Withdrawal by Subject|0|||
146552196|NCT02533674|528530899|FG001|Dose Level II|Withdrawal by Subject|1|||
146552197|NCT02533674|528530900|FG002|Dose Level II|Withdrawal by Subject|0|||
146552198|NCT02533674|528530901|FG003|Dose Level II|Withdrawal by Subject|0|||
146552199|NCT02533674|528530902|FG004|Dose Level II|Withdrawal by Subject|0|||
146552200|NCT02533674|528530903|FG005|Dose Level II|Withdrawal by Subject|0|||
146552201|NCT02533674|528530904|FG006|Dose Level II|Withdrawal by Subject|0|||
146552202|NCT02533674|528530905|FG007|Dose Level II|Withdrawal by Subject|0|||
146552203|NCT02533674|528530898|FG000|Dose Level II|Treatment-related AE|0|||
146552204|NCT02533674|528530899|FG001|Dose Level II|Treatment-related AE|1|||
146552205|NCT02533674|528530900|FG002|Dose Level II|Treatment-related AE|0|||
146552206|NCT02533674|528530901|FG003|Dose Level II|Treatment-related AE|0|||
146552207|NCT02533674|528530902|FG004|Dose Level II|Treatment-related AE|0|||
146552208|NCT02533674|528530903|FG005|Dose Level II|Treatment-related AE|0|||
146552209|NCT02533674|528530904|FG006|Dose Level II|Treatment-related AE|0|||
146552210|NCT02533674|528530905|FG007|Dose Level II|Treatment-related AE|0|||
146552211|NCT02533674|528530898|FG000|Dose Level II|Physician Decision|0|||
146552212|NCT02533674|528530899|FG001|Dose Level II|Physician Decision|1|||
146552213|NCT02533674|528530900|FG002|Dose Level II|Physician Decision|0|||
146552214|NCT02533674|528530901|FG003|Dose Level II|Physician Decision|0|||
146552215|NCT02533674|528530902|FG004|Dose Level II|Physician Decision|0|||
146552216|NCT02533674|528530903|FG005|Dose Level II|Physician Decision|0|||
146552217|NCT02533674|528530904|FG006|Dose Level II|Physician Decision|0|||
146552218|NCT02533674|528530905|FG007|Dose Level II|Physician Decision|0|||
146552219|NCT02533674|528530898|FG000|Dose Level II|Non-treatment-related AE|0|||
146552220|NCT02533674|528530899|FG001|Dose Level II|Non-treatment-related AE|1|||
146552221|NCT02533674|528530900|FG002|Dose Level II|Non-treatment-related AE|0|||
146552222|NCT02533674|528530901|FG003|Dose Level II|Non-treatment-related AE|0|||
146552223|NCT02533674|528530902|FG004|Dose Level II|Non-treatment-related AE|0|||
146552224|NCT02533674|528530903|FG005|Dose Level II|Non-treatment-related AE|0|||
146552225|NCT02533674|528530904|FG006|Dose Level II|Non-treatment-related AE|0|||
146552226|NCT02533674|528530905|FG007|Dose Level II|Non-treatment-related AE|0|||
146552227|NCT02533674|528530898|FG000|Dose Level III|Progressive disease|0|||
146552228|NCT02533674|528530899|FG001|Dose Level III|Progressive disease|0|||
146552229|NCT02533674|528530900|FG002|Dose Level III|Progressive disease|2|||
146552230|NCT02533674|528530901|FG003|Dose Level III|Progressive disease|0|||
146552231|NCT02533674|528530902|FG004|Dose Level III|Progressive disease|0|||
146552232|NCT02533674|528530903|FG005|Dose Level III|Progressive disease|0|||
146552233|NCT02533674|528530904|FG006|Dose Level III|Progressive disease|0|||
146552234|NCT02533674|528530905|FG007|Dose Level III|Progressive disease|0|||
146552235|NCT02533674|528530898|FG000|Dose Level III|Withdrawal by Subject|0|||
146552236|NCT02533674|528530899|FG001|Dose Level III|Withdrawal by Subject|0|||
146552237|NCT02533674|528530900|FG002|Dose Level III|Withdrawal by Subject|1|||
146552238|NCT02533674|528530901|FG003|Dose Level III|Withdrawal by Subject|0|||
146552239|NCT02533674|528530902|FG004|Dose Level III|Withdrawal by Subject|0|||
146552240|NCT02533674|528530903|FG005|Dose Level III|Withdrawal by Subject|0|||
146552241|NCT02533674|528530904|FG006|Dose Level III|Withdrawal by Subject|0|||
146552242|NCT02533674|528530905|FG007|Dose Level III|Withdrawal by Subject|0|||
146552243|NCT02533674|528530898|FG000|Dose Level III|Treatment-related AE|0|||
146552244|NCT02533674|528530899|FG001|Dose Level III|Treatment-related AE|0|||
146552245|NCT02533674|528530900|FG002|Dose Level III|Treatment-related AE|1|||
146552246|NCT02533674|528530901|FG003|Dose Level III|Treatment-related AE|0|||
146552247|NCT02533674|528530902|FG004|Dose Level III|Treatment-related AE|0|||
146552248|NCT02533674|528530903|FG005|Dose Level III|Treatment-related AE|0|||
146765289|NCT00628862|529308590|FG000|Overall Study|Adverse Event|6|||
146552249|NCT02533674|528530904|FG006|Dose Level III|Treatment-related AE|0|||
146552250|NCT02533674|528530905|FG007|Dose Level III|Treatment-related AE|0|||
146552251|NCT02533674|528530898|FG000|Dose Level IV|Progressive disease|0|||
146552252|NCT02533674|528530899|FG001|Dose Level IV|Progressive disease|0|||
146552253|NCT02533674|528530900|FG002|Dose Level IV|Progressive disease|0|||
146552254|NCT02533674|528530901|FG003|Dose Level IV|Progressive disease|3|||
146552255|NCT02533674|528530902|FG004|Dose Level IV|Progressive disease|0|||
146552256|NCT02533674|528530903|FG005|Dose Level IV|Progressive disease|0|||
146552257|NCT02533674|528530904|FG006|Dose Level IV|Progressive disease|0|||
146552258|NCT02533674|528530905|FG007|Dose Level IV|Progressive disease|0|||
146552259|NCT02533674|528530898|FG000|Dose Level IV|Withdrawal by Subject|0|||
146552260|NCT02533674|528530899|FG001|Dose Level IV|Withdrawal by Subject|0|||
146552261|NCT02533674|528530900|FG002|Dose Level IV|Withdrawal by Subject|0|||
146552262|NCT02533674|528530901|FG003|Dose Level IV|Withdrawal by Subject|1|||
146552263|NCT02533674|528530902|FG004|Dose Level IV|Withdrawal by Subject|0|||
146552264|NCT02533674|528530903|FG005|Dose Level IV|Withdrawal by Subject|0|||
146552265|NCT02533674|528530904|FG006|Dose Level IV|Withdrawal by Subject|0|||
146552266|NCT02533674|528530905|FG007|Dose Level IV|Withdrawal by Subject|0|||
146552267|NCT02533674|528530898|FG000|Dose Level IV|Physician Decision|0|||
146552268|NCT02533674|528530899|FG001|Dose Level IV|Physician Decision|0|||
146552269|NCT02533674|528530900|FG002|Dose Level IV|Physician Decision|0|||
146552270|NCT02533674|528530901|FG003|Dose Level IV|Physician Decision|1|||
146552271|NCT02533674|528530902|FG004|Dose Level IV|Physician Decision|0|||
146552272|NCT02533674|528530903|FG005|Dose Level IV|Physician Decision|0|||
146552273|NCT02533674|528530904|FG006|Dose Level IV|Physician Decision|0|||
146552274|NCT02533674|528530905|FG007|Dose Level IV|Physician Decision|0|||
146552275|NCT02533674|528530898|FG000|Dose Level V|Progressive disease|0|||
146552276|NCT02533674|528530899|FG001|Dose Level V|Progressive disease|0|||
146552277|NCT02533674|528530900|FG002|Dose Level V|Progressive disease|0|||
146552278|NCT02533674|528530901|FG003|Dose Level V|Progressive disease|0|||
146552279|NCT02533674|528530902|FG004|Dose Level V|Progressive disease|3|||
146552280|NCT02533674|528530903|FG005|Dose Level V|Progressive disease|0|||
146552281|NCT02533674|528530904|FG006|Dose Level V|Progressive disease|0|||
146552282|NCT02533674|528530905|FG007|Dose Level V|Progressive disease|0|||
146552283|NCT02533674|528530898|FG000|Dose Level V|Withdrawal by Subject|0|||
146552284|NCT02533674|528530899|FG001|Dose Level V|Withdrawal by Subject|0|||
146552285|NCT02533674|528530900|FG002|Dose Level V|Withdrawal by Subject|0|||
146552286|NCT02533674|528530901|FG003|Dose Level V|Withdrawal by Subject|0|||
146552287|NCT02533674|528530902|FG004|Dose Level V|Withdrawal by Subject|1|||
146552288|NCT02533674|528530903|FG005|Dose Level V|Withdrawal by Subject|0|||
146552289|NCT02533674|528530904|FG006|Dose Level V|Withdrawal by Subject|0|||
146552290|NCT02533674|528530905|FG007|Dose Level V|Withdrawal by Subject|0|||
146552291|NCT02533674|528530898|FG000|Dose Level V|Physician Decision|0|||
146552292|NCT02533674|528530899|FG001|Dose Level V|Physician Decision|0|||
146552293|NCT02533674|528530900|FG002|Dose Level V|Physician Decision|0|||
146552294|NCT02533674|528530901|FG003|Dose Level V|Physician Decision|0|||
146552295|NCT02533674|528530902|FG004|Dose Level V|Physician Decision|1|||
146552296|NCT02533674|528530903|FG005|Dose Level V|Physician Decision|0|||
146552297|NCT02533674|528530904|FG006|Dose Level V|Physician Decision|0|||
146552298|NCT02533674|528530905|FG007|Dose Level V|Physician Decision|0|||
146552299|NCT02533674|528530898|FG000|Dose Level VI|Progressive disease|0|||
146552300|NCT02533674|528530899|FG001|Dose Level VI|Progressive disease|0|||
146552301|NCT02533674|528530900|FG002|Dose Level VI|Progressive disease|0|||
146552302|NCT02533674|528530901|FG003|Dose Level VI|Progressive disease|0|||
146552303|NCT02533674|528530902|FG004|Dose Level VI|Progressive disease|0|||
146552304|NCT02533674|528530903|FG005|Dose Level VI|Progressive disease|7|||
146552305|NCT02533674|528530904|FG006|Dose Level VI|Progressive disease|0|||
146552306|NCT02533674|528530905|FG007|Dose Level VI|Progressive disease|0|||
146552307|NCT02533674|528530898|FG000|Dose Level VI|Withdrawal by Subject|0|||
146966592|NCT04584294|530038859|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
146552308|NCT02533674|528530899|FG001|Dose Level VI|Withdrawal by Subject|0|||
146552309|NCT02533674|528530900|FG002|Dose Level VI|Withdrawal by Subject|0|||
146552310|NCT02533674|528530901|FG003|Dose Level VI|Withdrawal by Subject|0|||
146552311|NCT02533674|528530902|FG004|Dose Level VI|Withdrawal by Subject|0|||
146552312|NCT02533674|528530903|FG005|Dose Level VI|Withdrawal by Subject|1|||
146552313|NCT02533674|528530904|FG006|Dose Level VI|Withdrawal by Subject|0|||
146632486|NCT02113982|528831753|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146632487|NCT02113982|528831754|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146552314|NCT02533674|528530905|FG007|Dose Level VI|Withdrawal by Subject|0|||
146552315|NCT02533674|528530898|FG000|Dose Level VI|Treatment-related AE|0|||
146552316|NCT02533674|528530899|FG001|Dose Level VI|Treatment-related AE|0|||
146552317|NCT02533674|528530900|FG002|Dose Level VI|Treatment-related AE|0|||
146552318|NCT02533674|528530901|FG003|Dose Level VI|Treatment-related AE|0|||
146552319|NCT02533674|528530902|FG004|Dose Level VI|Treatment-related AE|0|||
146552320|NCT02533674|528530903|FG005|Dose Level VI|Treatment-related AE|1|||
146552321|NCT02533674|528530904|FG006|Dose Level VI|Treatment-related AE|0|||
146552322|NCT02533674|528530905|FG007|Dose Level VI|Treatment-related AE|0|||
146552323|NCT02533674|528530898|FG000|Dose Level VII|Progressive disease|0|||
146632488|NCT02113982|528831755|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146632489|NCT02113982|528831756|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146632490|NCT02113982|528831757|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146552324|NCT02533674|528530899|FG001|Dose Level VII|Progressive disease|0|||
146552325|NCT02533674|528530900|FG002|Dose Level VII|Progressive disease|0|||
146552326|NCT02533674|528530901|FG003|Dose Level VII|Progressive disease|0|||
146552327|NCT02533674|528530902|FG004|Dose Level VII|Progressive disease|0|||
146552328|NCT02533674|528530903|FG005|Dose Level VII|Progressive disease|0|||
146552329|NCT02533674|528530904|FG006|Dose Level VII|Progressive disease|10|||
146552330|NCT02533674|528530905|FG007|Dose Level VII|Progressive disease|0|||
146632491|NCT02113982|528831758|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146632492|NCT02113982|528831759|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146632493|NCT02113982|528831760|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
146966593|NCT04584294|530038860|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
146966594|NCT04584294|530038859|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
146552331|NCT02533674|528530898|FG000|Dose Level VII|Withdrawal by Subject|0|||
146966595|NCT04584294|530038860|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
146632494|NCT02113982|528831761|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
146552332|NCT02533674|528530899|FG001|Dose Level VII|Withdrawal by Subject|0|||
146887085|NCT01978093|529753949|FG001|Overall Study|N/A for vaccine administration|1|||
146887086|NCT01396005|529753950|FG000|Overall Study|Withdrawal by Subject|0|||
146887087|NCT01396005|529753951|FG001|Overall Study|Withdrawal by Subject|1|||
146887088|NCT01396005|529753950|FG000|Overall Study|Non-compliance with protocol|0|||
146632495|NCT02113982|528831748|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146632496|NCT02113982|528831749|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146632497|NCT02113982|528831750|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146632498|NCT02113982|528831751|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146632499|NCT02113982|528831752|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146632500|NCT02113982|528831753|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146632501|NCT02113982|528831754|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146632502|NCT02113982|528831755|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146632503|NCT02113982|528831756|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146632504|NCT02113982|528831757|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146632505|NCT02113982|528831758|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146632506|NCT02113982|528831759|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146632507|NCT02113982|528831760|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
146632508|NCT02113982|528831761|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
146632509|NCT02113982|528831748|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146632510|NCT02113982|528831749|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146632511|NCT02113982|528831750|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146632512|NCT02113982|528831751|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146632513|NCT02113982|528831752|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146632514|NCT02113982|528831753|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146632515|NCT02113982|528831754|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146632516|NCT02113982|528831755|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146632517|NCT02113982|528831756|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146632518|NCT02113982|528831757|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146632519|NCT02113982|528831758|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146632520|NCT02113982|528831759|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146632521|NCT02113982|528831760|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
146632522|NCT02113982|528831761|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146632523|NCT02113982|528831748|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146632524|NCT02113982|528831749|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146632525|NCT02113982|528831750|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146632526|NCT02113982|528831751|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146632527|NCT02113982|528831752|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146632528|NCT02113982|528831753|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146632529|NCT02113982|528831754|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146632530|NCT02113982|528831755|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146632531|NCT02113982|528831756|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146632532|NCT02113982|528831757|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146632533|NCT02113982|528831758|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146552333|NCT02533674|528530900|FG002|Dose Level VII|Withdrawal by Subject|0|||
146552334|NCT02533674|528530901|FG003|Dose Level VII|Withdrawal by Subject|0|||
146552335|NCT02533674|528530902|FG004|Dose Level VII|Withdrawal by Subject|0|||
146632534|NCT02113982|528831759|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146632535|NCT02113982|528831760|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
146632536|NCT02113982|528831761|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146632537|NCT02113982|528831748|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146552336|NCT02533674|528530903|FG005|Dose Level VII|Withdrawal by Subject|0|||
146552337|NCT02533674|528530904|FG006|Dose Level VII|Withdrawal by Subject|3|||
146552338|NCT02533674|528530905|FG007|Dose Level VII|Withdrawal by Subject|0|||
146552339|NCT02533674|528530898|FG000|Dose Level VII|Treatment-related AE|0|||
146552340|NCT02533674|528530899|FG001|Dose Level VII|Treatment-related AE|0|||
146552341|NCT02533674|528530900|FG002|Dose Level VII|Treatment-related AE|0|||
146552342|NCT02533674|528530901|FG003|Dose Level VII|Treatment-related AE|0|||
146632538|NCT02113982|528831749|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146632539|NCT02113982|528831750|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146632540|NCT02113982|528831751|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146552343|NCT02533674|528530902|FG004|Dose Level VII|Treatment-related AE|0|||
146552344|NCT02533674|528530903|FG005|Dose Level VII|Treatment-related AE|0|||
146552345|NCT02533674|528530904|FG006|Dose Level VII|Treatment-related AE|1|||
146887089|NCT01396005|529753951|FG001|Overall Study|Non-compliance with protocol|1|||
146887090|NCT01604512|529753952|FG000|Overall Study|Withdrawal by Subject|3|||
146887091|NCT01604512|529753952|FG000|Overall Study|Not treated|4|||
146887092|NCT03529773|529753955|FG000|Overall Study|Adverse Event|0|||
146887093|NCT03529773|529753956|FG001|Overall Study|Adverse Event|0|||
146552346|NCT02533674|528530905|FG007|Dose Level VII|Treatment-related AE|0|||
146552347|NCT02533674|528530898|FG000|Dose Level VII|Death|0|||
146552348|NCT02533674|528530899|FG001|Dose Level VII|Death|0|||
146552349|NCT02533674|528530900|FG002|Dose Level VII|Death|0|||
146552350|NCT02533674|528530901|FG003|Dose Level VII|Death|0|||
146552351|NCT02533674|528530902|FG004|Dose Level VII|Death|0|||
146552352|NCT02533674|528530903|FG005|Dose Level VII|Death|0|||
146552353|NCT02533674|528530904|FG006|Dose Level VII|Death|2|||
146552354|NCT02533674|528530905|FG007|Dose Level VII|Death|0|||
146552355|NCT02533674|528530898|FG000|Dose Level VIII|Progressive disease|0|||
146552356|NCT02533674|528530899|FG001|Dose Level VIII|Progressive disease|0|||
146552357|NCT02533674|528530900|FG002|Dose Level VIII|Progressive disease|0|||
146552358|NCT02533674|528530901|FG003|Dose Level VIII|Progressive disease|0|||
146552359|NCT02533674|528530902|FG004|Dose Level VIII|Progressive disease|0|||
146552360|NCT02533674|528530903|FG005|Dose Level VIII|Progressive disease|0|||
146552361|NCT02533674|528530904|FG006|Dose Level VIII|Progressive disease|0|||
146552362|NCT02533674|528530905|FG007|Dose Level VIII|Progressive disease|3|||
146552363|NCT02533674|528530898|FG000|Dose Level VIII|Withdrawal by Subject|0|||
146552364|NCT02533674|528530899|FG001|Dose Level VIII|Withdrawal by Subject|0|||
146552365|NCT02533674|528530900|FG002|Dose Level VIII|Withdrawal by Subject|0|||
146552366|NCT02533674|528530901|FG003|Dose Level VIII|Withdrawal by Subject|0|||
146552367|NCT02533674|528530902|FG004|Dose Level VIII|Withdrawal by Subject|0|||
146552368|NCT02533674|528530903|FG005|Dose Level VIII|Withdrawal by Subject|0|||
146552369|NCT02533674|528530904|FG006|Dose Level VIII|Withdrawal by Subject|0|||
146552370|NCT02533674|528530905|FG007|Dose Level VIII|Withdrawal by Subject|1|||
146552371|NCT02533674|528530898|FG000|Dose Level VIII|Treatment-related AE|0|||
146552372|NCT02533674|528530899|FG001|Dose Level VIII|Treatment-related AE|0|||
146552373|NCT02533674|528530900|FG002|Dose Level VIII|Treatment-related AE|0|||
146552374|NCT02533674|528530901|FG003|Dose Level VIII|Treatment-related AE|0|||
146552375|NCT02533674|528530902|FG004|Dose Level VIII|Treatment-related AE|0|||
146552376|NCT02533674|528530903|FG005|Dose Level VIII|Treatment-related AE|0|||
146552377|NCT02533674|528530904|FG006|Dose Level VIII|Treatment-related AE|0|||
146552378|NCT02533674|528530905|FG007|Dose Level VIII|Treatment-related AE|1|||
146552379|NCT02533674|528530898|FG000|Dose Level VIII|Never treated|0|||
146552380|NCT02533674|528530899|FG001|Dose Level VIII|Never treated|0|||
146552381|NCT02533674|528530900|FG002|Dose Level VIII|Never treated|0|||
146552382|NCT02533674|528530901|FG003|Dose Level VIII|Never treated|0|||
146552383|NCT02533674|528530902|FG004|Dose Level VIII|Never treated|0|||
146552384|NCT02533674|528530903|FG005|Dose Level VIII|Never treated|0|||
146552385|NCT02533674|528530904|FG006|Dose Level VIII|Never treated|0|||
146552386|NCT02533674|528530905|FG007|Dose Level VIII|Never treated|1|||
146552387|NCT01346709|528530906|FG000|Overall Study|Protocol Violation|35|||
146552388|NCT01346709|528530906|FG000|Overall Study|Lost to Follow-up|31|||
146552389|NCT01346709|528530906|FG000|Overall Study|Missing data in candidate risk factor|285|||
146552390|NCT02365064|528530915|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
146552391|NCT02365064|528530916|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
146552392|NCT02365064|528530915|FG000|Overall Study|Withdrawal by Subject|6|||
146552393|NCT02365064|528530916|FG001|Overall Study|Withdrawal by Subject|9|||
146552394|NCT02365064|528530915|FG000|Overall Study|Treatment intolerance|2|||
146552395|NCT02365064|528530916|FG001|Overall Study|Treatment intolerance|4|||
146552396|NCT00605657|528530921|FG000|Overall Study|Adverse Event|1|||
146552397|NCT00605657|528530921|FG000|Overall Study|Protocol Violation|1|||
146552398|NCT02123511|528530922|FG000|Overall Study|Cancelled treatment|1|||
146552399|NCT02123511|528530923|FG001|Overall Study|Cancelled treatment|0|||
146552400|NCT02123511|528530922|FG000|Overall Study|Incomplete data|1|||
146887094|NCT03529773|529753957|FG002|Overall Study|Adverse Event|0|||
146887095|NCT03529773|529753958|FG003|Overall Study|Adverse Event|0|||
146887096|NCT03529773|529753959|FG004|Overall Study|Adverse Event|0|||
146887097|NCT03529773|529753960|FG005|Overall Study|Adverse Event|0|||
146887098|NCT03529773|529753961|FG006|Overall Study|Adverse Event|0|||
146887099|NCT03529773|529753962|FG007|Overall Study|Adverse Event|0|||
146887100|NCT03529773|529753963|FG008|Overall Study|Adverse Event|0|||
146887101|NCT03529773|529753964|FG009|Overall Study|Adverse Event|0|||
146887102|NCT03529773|529753965|FG010|Overall Study|Adverse Event|0|||
146552401|NCT02123511|528530923|FG001|Overall Study|Incomplete data|3|||
146552402|NCT02123511|528530922|FG000|Overall Study|Ineligible|0|||
146552403|NCT02123511|528530923|FG001|Overall Study|Ineligible|1|||
146552404|NCT04821245|528530924|FG000|Overall Study|Withdrawal by Subject|3|||
146552405|NCT04821245|528530924|FG000|Overall Study|Physician Decision|1|||
146887103|NCT03529773|529753966|FG011|Overall Study|Adverse Event|0|||
146887104|NCT03529773|529753967|FG012|Overall Study|Adverse Event|0|||
146552406|NCT04821245|528530924|FG000|Overall Study|Protocol Violation|5|||
146552407|NCT00458705|528530925|FG000|Overall Study|Adverse Event|4|||
146552408|NCT00458705|528530925|FG000|Overall Study|Not Treated|1|||
146552409|NCT00378560|528530930|FG000|Overall Study|Adverse Event|1|||
146552410|NCT00378560|528530931|FG001|Overall Study|Adverse Event|0|||
146552411|NCT00378560|528530930|FG000|Overall Study|Lost to Follow-up|24|||
146552412|NCT00378560|528530931|FG001|Overall Study|Lost to Follow-up|29|||
146552413|NCT00378560|528530930|FG000|Overall Study|Protocol Violation|2|||
146552414|NCT00378560|528530931|FG001|Overall Study|Protocol Violation|0|||
146552415|NCT00378560|528530930|FG000|Overall Study|Withdrawal by Subject|17|||
146552416|NCT00378560|528530931|FG001|Overall Study|Withdrawal by Subject|21|||
146552417|NCT00378560|528530930|FG000|Overall Study|Moved|4|||
146552418|NCT00378560|528530931|FG001|Overall Study|Moved|3|||
146552419|NCT00378560|528530930|FG000|Overall Study|Pregnancy|7|||
146552420|NCT00378560|528530931|FG001|Overall Study|Pregnancy|5|||
146552421|NCT00378560|528530930|FG000|Overall Study|Laboratory test values abnormal|1|||
146552422|NCT00378560|528530931|FG001|Overall Study|Laboratory test values abnormal|0|||
146887105|NCT03529773|529753968|FG013|Overall Study|Adverse Event|0|||
146887106|NCT03529773|529753969|FG014|Overall Study|Adverse Event|0|||
146887107|NCT03529773|529753970|FG015|Overall Study|Adverse Event|0|||
146887108|NCT03529773|529753971|FG016|Overall Study|Adverse Event|0|||
146887109|NCT03529773|529753972|FG017|Overall Study|Adverse Event|0|||
146765290|NCT00628862|529308591|FG001|Overall Study|Adverse Event|8|||
146632541|NCT02113982|528831752|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146632542|NCT02113982|528831753|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146632543|NCT02113982|528831754|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146632544|NCT02113982|528831755|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146632545|NCT02113982|528831756|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146632546|NCT02113982|528831757|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146632547|NCT02113982|528831758|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146632548|NCT02113982|528831759|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146887110|NCT03529773|529753973|FG018|Overall Study|Adverse Event|0|||
146887111|NCT03529773|529753974|FG019|Overall Study|Adverse Event|0|||
146887112|NCT03529773|529753975|FG020|Overall Study|Adverse Event|0|||
146887113|NCT03529773|529753976|FG021|Overall Study|Adverse Event|0|||
146887114|NCT03529773|529753977|FG022|Overall Study|Adverse Event|0|||
146887115|NCT03529773|529753978|FG023|Overall Study|Adverse Event|0|||
146887116|NCT03529773|529753979|FG024|Overall Study|Adverse Event|0|||
146887117|NCT03529773|529753980|FG025|Overall Study|Adverse Event|0|||
146887118|NCT03529773|529753981|FG026|Overall Study|Adverse Event|0|||
146632549|NCT02113982|528831760|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
146632550|NCT02113982|528831761|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146632551|NCT03763877|528831771|FG000|Overall Study|Withdrawal by Subject|3|||
146632552|NCT03763877|528831772|FG001|Overall Study|Withdrawal by Subject|1|||
146632553|NCT03763877|528831773|FG002|Overall Study|Withdrawal by Subject|3|||
146632554|NCT03763877|528831774|FG003|Overall Study|Withdrawal by Subject|4|||
146632555|NCT03763877|528831771|FG000|Overall Study|Adverse Event|1|||
146632556|NCT03763877|528831772|FG001|Overall Study|Adverse Event|1|||
146632557|NCT03763877|528831773|FG002|Overall Study|Adverse Event|3|||
146632558|NCT03763877|528831774|FG003|Overall Study|Adverse Event|1|||
146632559|NCT03763877|528831771|FG000|Overall Study|Protocol Violation|1|||
146632560|NCT03763877|528831772|FG001|Overall Study|Protocol Violation|1|||
146632561|NCT03763877|528831773|FG002|Overall Study|Protocol Violation|0|||
146887119|NCT03529773|529753982|FG027|Overall Study|Adverse Event|0|||
146887120|NCT03529773|529753983|FG028|Overall Study|Adverse Event|0|||
146887121|NCT03529773|529753984|FG029|Overall Study|Adverse Event|0|||
146887122|NCT03529773|529753985|FG030|Overall Study|Adverse Event|1|||
146887123|NCT03529773|529753986|FG031|Overall Study|Adverse Event|0|||
146887124|NCT03529773|529753987|FG032|Overall Study|Adverse Event|0|||
146887125|NCT03529773|529753988|FG033|Overall Study|Adverse Event|0|||
146632562|NCT03763877|528831774|FG003|Overall Study|Protocol Violation|0|||
146765291|NCT00628862|529308592|FG002|Overall Study|Adverse Event|10|||
146887126|NCT03529773|529753989|FG034|Overall Study|Adverse Event|0|||
146887127|NCT03529773|529753990|FG035|Overall Study|Adverse Event|1|||
146887128|NCT03529773|529753991|FG036|Overall Study|Adverse Event|0|||
146966596|NCT04242498|530038863|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
146632563|NCT03763877|528831771|FG000|Overall Study|Lost to Follow-up|0|||
146632564|NCT03763877|528831772|FG001|Overall Study|Lost to Follow-up|1|||
146632565|NCT03763877|528831773|FG002|Overall Study|Lost to Follow-up|1|||
146632566|NCT03763877|528831774|FG003|Overall Study|Lost to Follow-up|0|||
146632567|NCT03040336|528831775|FG000|Overall Study|Death|1|||
146632568|NCT03040336|528831776|FG001|Overall Study|Death|0|||
146632569|NCT03040336|528831775|FG000|Overall Study|Withdrawal by Subject|2|||
146632570|NCT03040336|528831776|FG001|Overall Study|Withdrawal by Subject|3|||
146632571|NCT00068692|528831781|FG000|Step 1: Registration|Disese progression/relapse|5|||
146632572|NCT00068692|528831782|FG001|Step 1: Registration|Disese progression/relapse|0|||
146632573|NCT00068692|528831783|FG002|Step 1: Registration|Disese progression/relapse|0|||
146632574|NCT00068692|528831784|FG003|Step 1: Registration|Disese progression/relapse|0|||
146632575|NCT00068692|528831785|FG004|Step 1: Registration|Disese progression/relapse|0|||
146632576|NCT00068692|528831786|FG005|Step 1: Registration|Disese progression/relapse|0|||
146887129|NCT03529773|529753992|FG037|Overall Study|Adverse Event|0|||
146887130|NCT03529773|529753993|FG038|Overall Study|Adverse Event|1|||
146887131|NCT03529773|529753994|FG039|Overall Study|Adverse Event|1|||
146887132|NCT03529773|529753955|FG000|Overall Study|Death|0|||
146887133|NCT03529773|529753956|FG001|Overall Study|Death|0|||
146887134|NCT03529773|529753957|FG002|Overall Study|Death|0|||
146887135|NCT03529773|529753958|FG003|Overall Study|Death|0|||
146887136|NCT03529773|529753959|FG004|Overall Study|Death|0|||
146887137|NCT03529773|529753960|FG005|Overall Study|Death|0|||
146887138|NCT03529773|529753961|FG006|Overall Study|Death|0|||
146887139|NCT03529773|529753962|FG007|Overall Study|Death|0|||
146887140|NCT03529773|529753963|FG008|Overall Study|Death|0|||
146887141|NCT03529773|529753964|FG009|Overall Study|Death|0|||
146887142|NCT03529773|529753965|FG010|Overall Study|Death|0|||
146887143|NCT03529773|529753966|FG011|Overall Study|Death|0|||
146887144|NCT03529773|529753967|FG012|Overall Study|Death|1|||
146887145|NCT03529773|529753968|FG013|Overall Study|Death|0|||
146887146|NCT03529773|529753969|FG014|Overall Study|Death|0|||
146887147|NCT03529773|529753970|FG015|Overall Study|Death|0|||
146887148|NCT03529773|529753971|FG016|Overall Study|Death|0|||
146887149|NCT03529773|529753972|FG017|Overall Study|Death|0|||
146887150|NCT03529773|529753973|FG018|Overall Study|Death|0|||
146552423|NCT02773537|528530932|FG000|Overall Study|Lost to Follow-up|0|||
146552424|NCT02773537|528530933|FG001|Overall Study|Lost to Follow-up|1|||
146552425|NCT02773537|528530934|FG002|Overall Study|Lost to Follow-up|4|||
146552426|NCT00662038|528530935|FG000|Overall Study|Reason not specified|3|||
146552427|NCT00662038|528530935|FG000|Overall Study|Withdrawn consent|22|||
146552428|NCT00662038|528530935|FG000|Overall Study|Withdrawal by Subject|83|||
146552429|NCT00662038|528530935|FG000|Overall Study|Sponsor decision|1|||
146552430|NCT00662038|528530935|FG000|Overall Study|Physician Decision|19|||
146552431|NCT00662038|528530935|FG000|Overall Study|Lung transplantation|44|||
146552432|NCT00662038|528530935|FG000|Overall Study|Lost to Follow-up|1|||
146552433|NCT00662038|528530935|FG000|Overall Study|Death|95|||
146552434|NCT00662038|528530935|FG000|Overall Study|Adverse Event|358|||
146552435|NCT00662038|528530935|FG000|Overall Study|Continued treatment|5|||
146552436|NCT01840163|528530936|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
146552437|NCT01840163|528530937|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
146552438|NCT01840163|528530936|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
146552439|NCT01840163|528530937|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
146552440|NCT01840163|528530936|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
146552441|NCT01840163|528530937|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
146552442|NCT00397046|528530938|FG000|Overall Study|Disease Progression|3|||
146632577|NCT00068692|528831787|FG006|Step 1: Registration|Disese progression/relapse|0|||
146887151|NCT03529773|529753974|FG019|Overall Study|Death|1|||
146887152|NCT03529773|529753975|FG020|Overall Study|Death|0|||
146887153|NCT03529773|529753976|FG021|Overall Study|Death|0|||
146887154|NCT03529773|529753977|FG022|Overall Study|Death|1|||
146887155|NCT03529773|529753978|FG023|Overall Study|Death|0|||
146887156|NCT03529773|529753979|FG024|Overall Study|Death|0|||
146887157|NCT03529773|529753980|FG025|Overall Study|Death|0|||
146887158|NCT03529773|529753981|FG026|Overall Study|Death|0|||
146632578|NCT00068692|528831788|FG007|Step 1: Registration|Disese progression/relapse|0|||
146632579|NCT00068692|528831781|FG000|Step 1: Registration|Adverse Event|7|||
146632580|NCT00068692|528831782|FG001|Step 1: Registration|Adverse Event|0|||
146887159|NCT03529773|529753982|FG027|Overall Study|Death|0|||
146887160|NCT03529773|529753983|FG028|Overall Study|Death|0|||
146887161|NCT03529773|529753984|FG029|Overall Study|Death|0|||
146552443|NCT00397046|528530939|FG001|Overall Study|Disease Progression|3|||
146552444|NCT00397046|528530940|FG002|Overall Study|Disease Progression|10|||
146552445|NCT00397046|528530941|FG003|Overall Study|Disease Progression|5|||
146552446|NCT03636269|528530943|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
146887162|NCT03529773|529753985|FG030|Overall Study|Death|0|||
146887163|NCT03529773|529753986|FG031|Overall Study|Death|0|||
146887164|NCT03529773|529753987|FG032|Overall Study|Death|0|||
146887165|NCT03529773|529753988|FG033|Overall Study|Death|1|||
146887166|NCT03529773|529753989|FG034|Overall Study|Death|1|||
146887167|NCT03529773|529753990|FG035|Overall Study|Death|0|||
146887168|NCT03529773|529753991|FG036|Overall Study|Death|1|||
146887169|NCT03529773|529753992|FG037|Overall Study|Death|0|||
146887170|NCT03529773|529753993|FG038|Overall Study|Death|0|||
146887171|NCT03529773|529753994|FG039|Overall Study|Death|0|||
146887172|NCT03529773|529753955|FG000|Overall Study|Lost to Follow-up|0|||
146887173|NCT03529773|529753956|FG001|Overall Study|Lost to Follow-up|0|||
146887174|NCT03529773|529753957|FG002|Overall Study|Lost to Follow-up|1|||
146887175|NCT03529773|529753958|FG003|Overall Study|Lost to Follow-up|0|||
146887176|NCT03529773|529753959|FG004|Overall Study|Lost to Follow-up|1|||
146887177|NCT03529773|529753960|FG005|Overall Study|Lost to Follow-up|1|||
146887178|NCT03529773|529753961|FG006|Overall Study|Lost to Follow-up|0|||
146887179|NCT03529773|529753962|FG007|Overall Study|Lost to Follow-up|0|||
146887180|NCT03529773|529753963|FG008|Overall Study|Lost to Follow-up|0|||
146887181|NCT03529773|529753964|FG009|Overall Study|Lost to Follow-up|0|||
146887182|NCT03529773|529753965|FG010|Overall Study|Lost to Follow-up|0|||
146887183|NCT03529773|529753966|FG011|Overall Study|Lost to Follow-up|0|||
146887184|NCT03529773|529753967|FG012|Overall Study|Lost to Follow-up|0|||
146887185|NCT03529773|529753968|FG013|Overall Study|Lost to Follow-up|1|||
146887186|NCT03529773|529753969|FG014|Overall Study|Lost to Follow-up|4|||
146887187|NCT03529773|529753970|FG015|Overall Study|Lost to Follow-up|1|||
146887188|NCT03529773|529753971|FG016|Overall Study|Lost to Follow-up|1|||
146887189|NCT03529773|529753972|FG017|Overall Study|Lost to Follow-up|0|||
146887190|NCT03529773|529753973|FG018|Overall Study|Lost to Follow-up|1|||
146887191|NCT03529773|529753974|FG019|Overall Study|Lost to Follow-up|1|||
146887192|NCT03529773|529753975|FG020|Overall Study|Lost to Follow-up|2|||
146887193|NCT03529773|529753976|FG021|Overall Study|Lost to Follow-up|4|||
146887194|NCT03529773|529753977|FG022|Overall Study|Lost to Follow-up|3|||
146887195|NCT03529773|529753978|FG023|Overall Study|Lost to Follow-up|4|||
146887196|NCT03529773|529753979|FG024|Overall Study|Lost to Follow-up|3|||
146887197|NCT03529773|529753980|FG025|Overall Study|Lost to Follow-up|5|||
146887198|NCT03529773|529753981|FG026|Overall Study|Lost to Follow-up|5|||
146887199|NCT03529773|529753982|FG027|Overall Study|Lost to Follow-up|0|||
146887200|NCT03529773|529753983|FG028|Overall Study|Lost to Follow-up|0|||
146887201|NCT03529773|529753984|FG029|Overall Study|Lost to Follow-up|0|||
146887202|NCT03529773|529753985|FG030|Overall Study|Lost to Follow-up|1|||
146632581|NCT00068692|528831783|FG002|Step 1: Registration|Adverse Event|0|||
146887203|NCT03529773|529753986|FG031|Overall Study|Lost to Follow-up|0|||
146887204|NCT03529773|529753987|FG032|Overall Study|Lost to Follow-up|0|||
146887205|NCT03529773|529753988|FG033|Overall Study|Lost to Follow-up|1|||
146887206|NCT03529773|529753989|FG034|Overall Study|Lost to Follow-up|1|||
146887207|NCT03529773|529753990|FG035|Overall Study|Lost to Follow-up|0|||
146887208|NCT03529773|529753991|FG036|Overall Study|Lost to Follow-up|0|||
146632582|NCT00068692|528831784|FG003|Step 1: Registration|Adverse Event|0|||
146632583|NCT00068692|528831785|FG004|Step 1: Registration|Adverse Event|0|||
146887209|NCT03529773|529753992|FG037|Overall Study|Lost to Follow-up|3|||
146887210|NCT03529773|529753993|FG038|Overall Study|Lost to Follow-up|1|||
146887211|NCT03529773|529753994|FG039|Overall Study|Lost to Follow-up|1|||
146887212|NCT03529773|529753955|FG000|Overall Study|No longer meets eligibility criteria|0|||
146887213|NCT03529773|529753956|FG001|Overall Study|No longer meets eligibility criteria|0|||
146887214|NCT03529773|529753957|FG002|Overall Study|No longer meets eligibility criteria|0|||
146887215|NCT03529773|529753958|FG003|Overall Study|No longer meets eligibility criteria|0|||
146887216|NCT03529773|529753959|FG004|Overall Study|No longer meets eligibility criteria|0|||
146887217|NCT03529773|529753960|FG005|Overall Study|No longer meets eligibility criteria|0|||
146632584|NCT00068692|528831786|FG005|Step 1: Registration|Adverse Event|0|||
146632585|NCT00068692|528831787|FG006|Step 1: Registration|Adverse Event|0|||
146632586|NCT00068692|528831788|FG007|Step 1: Registration|Adverse Event|0|||
146632587|NCT00068692|528831781|FG000|Step 1: Registration|Death|1|||
146632588|NCT00068692|528831782|FG001|Step 1: Registration|Death|0|||
146887218|NCT03529773|529753961|FG006|Overall Study|No longer meets eligibility criteria|0|||
146887219|NCT03529773|529753962|FG007|Overall Study|No longer meets eligibility criteria|0|||
146887220|NCT03529773|529753963|FG008|Overall Study|No longer meets eligibility criteria|0|||
146887221|NCT03529773|529753964|FG009|Overall Study|No longer meets eligibility criteria|0|||
146887222|NCT03529773|529753965|FG010|Overall Study|No longer meets eligibility criteria|0|||
146887223|NCT03529773|529753966|FG011|Overall Study|No longer meets eligibility criteria|0|||
146887224|NCT03529773|529753967|FG012|Overall Study|No longer meets eligibility criteria|0|||
146887225|NCT03529773|529753968|FG013|Overall Study|No longer meets eligibility criteria|0|||
146887226|NCT03529773|529753969|FG014|Overall Study|No longer meets eligibility criteria|0|||
146632589|NCT00068692|528831783|FG002|Step 1: Registration|Death|0|||
146632590|NCT00068692|528831784|FG003|Step 1: Registration|Death|0|||
146887227|NCT03529773|529753970|FG015|Overall Study|No longer meets eligibility criteria|0|||
146887228|NCT03529773|529753971|FG016|Overall Study|No longer meets eligibility criteria|0|||
146887229|NCT03529773|529753972|FG017|Overall Study|No longer meets eligibility criteria|0|||
146887230|NCT03529773|529753973|FG018|Overall Study|No longer meets eligibility criteria|0|||
146632591|NCT00068692|528831785|FG004|Step 1: Registration|Death|0|||
146632592|NCT00068692|528831786|FG005|Step 1: Registration|Death|0|||
146632593|NCT00068692|528831787|FG006|Step 1: Registration|Death|0|||
146632594|NCT00068692|528831788|FG007|Step 1: Registration|Death|0|||
146632595|NCT00068692|528831781|FG000|Step 1: Registration|Withdrawal by Subject|11|||
146887231|NCT03529773|529753974|FG019|Overall Study|No longer meets eligibility criteria|0|||
146887232|NCT03529773|529753975|FG020|Overall Study|No longer meets eligibility criteria|0|||
146887233|NCT03529773|529753976|FG021|Overall Study|No longer meets eligibility criteria|0|||
146887234|NCT03529773|529753977|FG022|Overall Study|No longer meets eligibility criteria|1|||
146887235|NCT03529773|529753978|FG023|Overall Study|No longer meets eligibility criteria|0|||
146632596|NCT00068692|528831782|FG001|Step 1: Registration|Withdrawal by Subject|0|||
146887236|NCT03529773|529753979|FG024|Overall Study|No longer meets eligibility criteria|0|||
146887237|NCT03529773|529753980|FG025|Overall Study|No longer meets eligibility criteria|0|||
146887238|NCT03529773|529753981|FG026|Overall Study|No longer meets eligibility criteria|0|||
146887239|NCT03529773|529753982|FG027|Overall Study|No longer meets eligibility criteria|0|||
146887240|NCT03529773|529753983|FG028|Overall Study|No longer meets eligibility criteria|0|||
146765292|NCT00628862|529308590|FG000|Overall Study|Withdrawal by Subject|4|||
146887241|NCT03529773|529753984|FG029|Overall Study|No longer meets eligibility criteria|0|||
146887242|NCT03529773|529753985|FG030|Overall Study|No longer meets eligibility criteria|0|||
146887243|NCT03529773|529753986|FG031|Overall Study|No longer meets eligibility criteria|0|||
146887244|NCT03529773|529753987|FG032|Overall Study|No longer meets eligibility criteria|0|||
146765293|NCT00628862|529308591|FG001|Overall Study|Withdrawal by Subject|6|||
146887245|NCT03529773|529753988|FG033|Overall Study|No longer meets eligibility criteria|0|||
146887246|NCT03529773|529753989|FG034|Overall Study|No longer meets eligibility criteria|0|||
146887247|NCT03529773|529753990|FG035|Overall Study|No longer meets eligibility criteria|0|||
146887248|NCT03529773|529753991|FG036|Overall Study|No longer meets eligibility criteria|0|||
146887249|NCT03529773|529753992|FG037|Overall Study|No longer meets eligibility criteria|0|||
146887250|NCT03529773|529753993|FG038|Overall Study|No longer meets eligibility criteria|1|||
146887251|NCT03529773|529753994|FG039|Overall Study|No longer meets eligibility criteria|0|||
146887252|NCT03529773|529753955|FG000|Overall Study|Other|0|||
146887253|NCT03529773|529753956|FG001|Overall Study|Other|0|||
146887254|NCT03529773|529753957|FG002|Overall Study|Other|0|||
146887255|NCT03529773|529753958|FG003|Overall Study|Other|0|||
146887256|NCT03529773|529753959|FG004|Overall Study|Other|0|||
146887257|NCT03529773|529753960|FG005|Overall Study|Other|0|||
146887258|NCT03529773|529753961|FG006|Overall Study|Other|0|||
146887259|NCT03529773|529753962|FG007|Overall Study|Other|0|||
146887260|NCT03529773|529753963|FG008|Overall Study|Other|0|||
146887261|NCT03529773|529753964|FG009|Overall Study|Other|0|||
146887262|NCT03529773|529753965|FG010|Overall Study|Other|0|||
146887263|NCT03529773|529753966|FG011|Overall Study|Other|0|||
146887264|NCT03529773|529753967|FG012|Overall Study|Other|1|||
146887265|NCT03529773|529753968|FG013|Overall Study|Other|0|||
146887266|NCT03529773|529753969|FG014|Overall Study|Other|2|||
146887267|NCT03529773|529753970|FG015|Overall Study|Other|0|||
146887268|NCT03529773|529753971|FG016|Overall Study|Other|0|||
146887269|NCT03529773|529753972|FG017|Overall Study|Other|3|||
146887270|NCT03529773|529753973|FG018|Overall Study|Other|0|||
146887271|NCT03529773|529753974|FG019|Overall Study|Other|0|||
146887272|NCT03529773|529753975|FG020|Overall Study|Other|1|||
146887273|NCT03529773|529753976|FG021|Overall Study|Other|0|||
146887274|NCT03529773|529753977|FG022|Overall Study|Other|1|||
146887275|NCT03529773|529753978|FG023|Overall Study|Other|0|||
146887276|NCT03529773|529753979|FG024|Overall Study|Other|3|||
146887277|NCT03529773|529753980|FG025|Overall Study|Other|2|||
146887278|NCT03529773|529753981|FG026|Overall Study|Other|2|||
146887279|NCT03529773|529753982|FG027|Overall Study|Other|0|||
146887280|NCT03529773|529753983|FG028|Overall Study|Other|0|||
146887281|NCT03529773|529753984|FG029|Overall Study|Other|0|||
146887282|NCT03529773|529753985|FG030|Overall Study|Other|0|||
146887283|NCT03529773|529753986|FG031|Overall Study|Other|0|||
146887284|NCT03529773|529753987|FG032|Overall Study|Other|0|||
146887285|NCT03529773|529753988|FG033|Overall Study|Other|0|||
146887286|NCT03529773|529753989|FG034|Overall Study|Other|1|||
146887287|NCT03529773|529753990|FG035|Overall Study|Other|1|||
146887288|NCT03529773|529753991|FG036|Overall Study|Other|0|||
146887289|NCT03529773|529753992|FG037|Overall Study|Other|0|||
146887290|NCT03529773|529753993|FG038|Overall Study|Other|0|||
146887291|NCT03529773|529753994|FG039|Overall Study|Other|0|||
146887292|NCT03529773|529753955|FG000|Overall Study|Physician Decision|0|||
146887293|NCT03529773|529753956|FG001|Overall Study|Physician Decision|0|||
146552447|NCT03636269|528530944|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
146552448|NCT03636269|528530945|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
146552449|NCT03636269|528530943|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
146552450|NCT03636269|528530944|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
146552451|NCT03636269|528530945|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
146552452|NCT03636269|528530943|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
146552453|NCT03636269|528530944|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
146552454|NCT03636269|528530945|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
146552455|NCT03636269|528530943|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
146552456|NCT03636269|528530944|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
146552457|NCT03636269|528530945|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
146887294|NCT03529773|529753957|FG002|Overall Study|Physician Decision|0|||
146887295|NCT03529773|529753958|FG003|Overall Study|Physician Decision|0|||
146887296|NCT03529773|529753959|FG004|Overall Study|Physician Decision|0|||
146887297|NCT03529773|529753960|FG005|Overall Study|Physician Decision|0|||
146552458|NCT03636269|528530943|FG000|Period 1: Double-blind Phase|Other|6|||
146765294|NCT00628862|529308592|FG002|Overall Study|Withdrawal by Subject|11|||
146887298|NCT03529773|529753961|FG006|Overall Study|Physician Decision|0|||
146887299|NCT03529773|529753962|FG007|Overall Study|Physician Decision|0|||
146887300|NCT03529773|529753963|FG008|Overall Study|Physician Decision|0|||
146887301|NCT03529773|529753964|FG009|Overall Study|Physician Decision|0|||
146887302|NCT03529773|529753965|FG010|Overall Study|Physician Decision|0|||
146887303|NCT03529773|529753966|FG011|Overall Study|Physician Decision|0|||
146887304|NCT03529773|529753967|FG012|Overall Study|Physician Decision|0|||
146887305|NCT03529773|529753968|FG013|Overall Study|Physician Decision|0|||
146887306|NCT03529773|529753969|FG014|Overall Study|Physician Decision|0|||
146887307|NCT03529773|529753970|FG015|Overall Study|Physician Decision|0|||
146887308|NCT03529773|529753971|FG016|Overall Study|Physician Decision|0|||
146887309|NCT03529773|529753972|FG017|Overall Study|Physician Decision|0|||
146887310|NCT03529773|529753973|FG018|Overall Study|Physician Decision|0|||
146887311|NCT03529773|529753974|FG019|Overall Study|Physician Decision|1|||
146887312|NCT03529773|529753975|FG020|Overall Study|Physician Decision|1|||
146887313|NCT03529773|529753976|FG021|Overall Study|Physician Decision|0|||
146887314|NCT03529773|529753977|FG022|Overall Study|Physician Decision|0|||
146887315|NCT03529773|529753978|FG023|Overall Study|Physician Decision|0|||
146887316|NCT03529773|529753979|FG024|Overall Study|Physician Decision|0|||
146552459|NCT03636269|528530944|FG001|Period 1: Double-blind Phase|Other|3|||
146552460|NCT03636269|528530945|FG002|Period 1: Double-blind Phase|Other|0|||
146552461|NCT03636269|528530943|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
146552462|NCT03636269|528530944|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
146552463|NCT03636269|528530945|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
146552464|NCT03636269|528530943|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
146552465|NCT03636269|528530944|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
146552466|NCT03636269|528530945|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
146552467|NCT03636269|528530943|FG000|Period 2: Open-label Phase|Adverse Event|0|||
146552468|NCT03636269|528530944|FG001|Period 2: Open-label Phase|Adverse Event|0|||
146552469|NCT03636269|528530945|FG002|Period 2: Open-label Phase|Adverse Event|21|||
146552470|NCT03636269|528530943|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
146552471|NCT03636269|528530944|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
146552472|NCT03636269|528530945|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
146552473|NCT03636269|528530943|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
146552474|NCT03636269|528530944|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
146552475|NCT03636269|528530945|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
146552476|NCT03636269|528530943|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
146552477|NCT03636269|528530944|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
146552478|NCT03636269|528530945|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
146552479|NCT03636269|528530943|FG000|Period 2: Open-label Phase|Administrative|0|||
146552480|NCT03636269|528530944|FG001|Period 2: Open-label Phase|Administrative|0|||
146552481|NCT03636269|528530945|FG002|Period 2: Open-label Phase|Administrative|36|||
146552482|NCT03636269|528530943|FG000|Period 2: Open-label Phase|Other|0|||
146552483|NCT03636269|528530944|FG001|Period 2: Open-label Phase|Other|0|||
146552484|NCT03636269|528530945|FG002|Period 2: Open-label Phase|Other|9|||
146552485|NCT03636269|528530943|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
146552486|NCT03636269|528530944|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
146552487|NCT03636269|528530945|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
146552488|NCT00493285|528530951|FG000|Overall Study|Lost to Follow-up|0|||
146552489|NCT00493285|528530952|FG001|Overall Study|Lost to Follow-up|0|||
146552490|NCT00493285|528530953|FG002|Overall Study|Lost to Follow-up|0|||
146552491|NCT00493285|528530954|FG003|Overall Study|Lost to Follow-up|0|||
146552492|NCT00493285|528530955|FG004|Overall Study|Lost to Follow-up|1|||
146552493|NCT00493285|528530956|FG005|Overall Study|Lost to Follow-up|0|||
146552494|NCT03021005|528530957|FG000|Overall Study|Lost to Follow-up|39|||
146552495|NCT03021005|528530958|FG001|Overall Study|Lost to Follow-up|26|||
146552496|NCT00337194|528530959|FG000|Overall Study|Adverse Event|5|||
146552497|NCT00337194|528530960|FG001|Overall Study|Adverse Event|1|||
146552498|NCT00337194|528530959|FG000|Overall Study|Death|2|||
146552499|NCT00337194|528530960|FG001|Overall Study|Death|0|||
146552500|NCT00337194|528530959|FG000|Overall Study|Withdrawal by Subject|1|||
146552501|NCT00337194|528530960|FG001|Overall Study|Withdrawal by Subject|0|||
146552502|NCT00337194|528530959|FG000|Overall Study|Disease progression|1|||
146552503|NCT00337194|528530960|FG001|Overall Study|Disease progression|2|||
146552504|NCT00337194|528530959|FG000|Overall Study|Subsequent non-protocol therapy|3|||
146887317|NCT03529773|529753980|FG025|Overall Study|Physician Decision|0|||
146552505|NCT00337194|528530960|FG001|Overall Study|Subsequent non-protocol therapy|1|||
146552506|NCT03188705|528530961|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
146552507|NCT03188705|528530961|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
146552508|NCT04914000|528530968|FG000|Overall Study|Lost to Follow-up|8|||
146552509|NCT04914000|528530968|FG000|Overall Study|Withdrawal by Subject|1|||
146552510|NCT00981175|528530969|FG000|Primary Dose Vaccination|Adverse Event|1|||
146887318|NCT03529773|529753981|FG026|Overall Study|Physician Decision|0|||
146887319|NCT03529773|529753982|FG027|Overall Study|Physician Decision|0|||
146887320|NCT03529773|529753983|FG028|Overall Study|Physician Decision|0|||
146552511|NCT00981175|528530970|FG001|Primary Dose Vaccination|Adverse Event|0|||
146552512|NCT00981175|528530969|FG000|Primary Dose Vaccination|Protocol Violation|0|||
146552513|NCT00981175|528530970|FG001|Primary Dose Vaccination|Protocol Violation|1|||
146765295|NCT00628862|529308590|FG000|Overall Study|Lost to Follow-up|0|||
146887321|NCT03529773|529753984|FG029|Overall Study|Physician Decision|0|||
146887322|NCT03529773|529753985|FG030|Overall Study|Physician Decision|0|||
146887323|NCT03529773|529753986|FG031|Overall Study|Physician Decision|0|||
146887324|NCT03529773|529753987|FG032|Overall Study|Physician Decision|0|||
146887325|NCT03529773|529753988|FG033|Overall Study|Physician Decision|0|||
146887326|NCT03529773|529753989|FG034|Overall Study|Physician Decision|0|||
146887327|NCT03529773|529753990|FG035|Overall Study|Physician Decision|0|||
146887328|NCT03529773|529753991|FG036|Overall Study|Physician Decision|0|||
146887329|NCT03529773|529753992|FG037|Overall Study|Physician Decision|0|||
146887330|NCT03529773|529753993|FG038|Overall Study|Physician Decision|0|||
146887331|NCT03529773|529753994|FG039|Overall Study|Physician Decision|0|||
146887332|NCT03529773|529753955|FG000|Overall Study|Protocol Violation|0|||
146887333|NCT03529773|529753956|FG001|Overall Study|Protocol Violation|0|||
146887334|NCT03529773|529753957|FG002|Overall Study|Protocol Violation|0|||
146887335|NCT03529773|529753958|FG003|Overall Study|Protocol Violation|0|||
146887336|NCT03529773|529753959|FG004|Overall Study|Protocol Violation|0|||
146887337|NCT03529773|529753960|FG005|Overall Study|Protocol Violation|0|||
146887338|NCT03529773|529753961|FG006|Overall Study|Protocol Violation|0|||
146887339|NCT03529773|529753962|FG007|Overall Study|Protocol Violation|0|||
146887340|NCT03529773|529753963|FG008|Overall Study|Protocol Violation|0|||
146887341|NCT03529773|529753964|FG009|Overall Study|Protocol Violation|0|||
146887342|NCT03529773|529753965|FG010|Overall Study|Protocol Violation|0|||
146887343|NCT03529773|529753966|FG011|Overall Study|Protocol Violation|0|||
146887344|NCT03529773|529753967|FG012|Overall Study|Protocol Violation|0|||
146887345|NCT03529773|529753968|FG013|Overall Study|Protocol Violation|0|||
146887346|NCT03529773|529753969|FG014|Overall Study|Protocol Violation|0|||
146887347|NCT03529773|529753970|FG015|Overall Study|Protocol Violation|0|||
146887348|NCT03529773|529753971|FG016|Overall Study|Protocol Violation|0|||
146887349|NCT03529773|529753972|FG017|Overall Study|Protocol Violation|0|||
146887350|NCT03529773|529753973|FG018|Overall Study|Protocol Violation|0|||
146887351|NCT03529773|529753974|FG019|Overall Study|Protocol Violation|0|||
146887352|NCT03529773|529753975|FG020|Overall Study|Protocol Violation|0|||
146887353|NCT03529773|529753976|FG021|Overall Study|Protocol Violation|0|||
146887354|NCT03529773|529753977|FG022|Overall Study|Protocol Violation|0|||
146887355|NCT03529773|529753978|FG023|Overall Study|Protocol Violation|0|||
146887356|NCT03529773|529753979|FG024|Overall Study|Protocol Violation|0|||
146887357|NCT03529773|529753980|FG025|Overall Study|Protocol Violation|0|||
146887358|NCT03529773|529753981|FG026|Overall Study|Protocol Violation|0|||
146887359|NCT03529773|529753982|FG027|Overall Study|Protocol Violation|0|||
146887360|NCT03529773|529753983|FG028|Overall Study|Protocol Violation|0|||
146887361|NCT03529773|529753984|FG029|Overall Study|Protocol Violation|0|||
146887362|NCT03529773|529753985|FG030|Overall Study|Protocol Violation|1|||
146887363|NCT03529773|529753986|FG031|Overall Study|Protocol Violation|0|||
146552514|NCT00981175|528530969|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
146552515|NCT00981175|528530970|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
146552516|NCT00981175|528530969|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
146552517|NCT00981175|528530970|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
146552518|NCT01750281|528530972|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
146552519|NCT01750281|528530973|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
146552520|NCT01750281|528530974|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
146552521|NCT01750281|528530972|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
146552522|NCT01750281|528530973|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
146552523|NCT01750281|528530974|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
146552524|NCT01750281|528530972|FG000|Overall Study|Did not receive treatment|0|||
146552525|NCT01750281|528530973|FG001|Overall Study|Did not receive treatment|1|||
146552526|NCT01750281|528530974|FG002|Overall Study|Did not receive treatment|0|||
146552527|NCT04189588|528530975|FG000|Overall Study|Death|0|||
146552528|NCT04189588|528530976|FG001|Overall Study|Death|1|||
146552529|NCT04189588|528530975|FG000|Overall Study|Lost to Follow-up|0|||
146552530|NCT04189588|528530976|FG001|Overall Study|Lost to Follow-up|1|||
146552531|NCT03757715|528530978|FG000|Overall Study|Lost to Follow-up|4|||
146552532|NCT03757715|528530979|FG001|Overall Study|Lost to Follow-up|9|||
146552533|NCT03757715|528530978|FG000|Overall Study|Withdrawal by Subject|1|||
146552534|NCT03757715|528530979|FG001|Overall Study|Withdrawal by Subject|1|||
146552535|NCT03156621|528530980|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
146552536|NCT03156621|528530981|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
146552537|NCT03156621|528530980|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146552538|NCT03156621|528530981|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
146552539|NCT03302936|528530982|FG000|Overall Study|Protocol Violation|3|||
146887364|NCT03529773|529753987|FG032|Overall Study|Protocol Violation|0|||
146887365|NCT03529773|529753988|FG033|Overall Study|Protocol Violation|0|||
146887366|NCT03529773|529753989|FG034|Overall Study|Protocol Violation|0|||
146887367|NCT03529773|529753990|FG035|Overall Study|Protocol Violation|0|||
146887368|NCT03529773|529753991|FG036|Overall Study|Protocol Violation|0|||
146887369|NCT03529773|529753992|FG037|Overall Study|Protocol Violation|0|||
146887370|NCT03529773|529753993|FG038|Overall Study|Protocol Violation|0|||
146887371|NCT03529773|529753994|FG039|Overall Study|Protocol Violation|0|||
146887372|NCT03529773|529753955|FG000|Overall Study|Withdrawal by Subject|0|||
146887373|NCT03529773|529753956|FG001|Overall Study|Withdrawal by Subject|0|||
146887374|NCT03529773|529753957|FG002|Overall Study|Withdrawal by Subject|0|||
146887375|NCT03529773|529753958|FG003|Overall Study|Withdrawal by Subject|0|||
146887376|NCT03529773|529753959|FG004|Overall Study|Withdrawal by Subject|0|||
146632597|NCT00068692|528831783|FG002|Step 1: Registration|Withdrawal by Subject|0|||
146632598|NCT00068692|528831784|FG003|Step 1: Registration|Withdrawal by Subject|0|||
146632599|NCT00068692|528831785|FG004|Step 1: Registration|Withdrawal by Subject|0|||
146632600|NCT00068692|528831786|FG005|Step 1: Registration|Withdrawal by Subject|0|||
146632601|NCT00068692|528831787|FG006|Step 1: Registration|Withdrawal by Subject|0|||
146632602|NCT00068692|528831788|FG007|Step 1: Registration|Withdrawal by Subject|0|||
146632603|NCT00068692|528831781|FG000|Step 1: Registration|Alternative therapy|2|||
146632604|NCT00068692|528831782|FG001|Step 1: Registration|Alternative therapy|0|||
146632605|NCT00068692|528831783|FG002|Step 1: Registration|Alternative therapy|0|||
146632606|NCT00068692|528831784|FG003|Step 1: Registration|Alternative therapy|0|||
146632607|NCT00068692|528831785|FG004|Step 1: Registration|Alternative therapy|0|||
146632608|NCT00068692|528831786|FG005|Step 1: Registration|Alternative therapy|0|||
146632609|NCT00068692|528831787|FG006|Step 1: Registration|Alternative therapy|0|||
146632610|NCT00068692|528831788|FG007|Step 1: Registration|Alternative therapy|0|||
146632611|NCT00068692|528831781|FG000|Step 1: Registration|Complicating disease|2|||
146632612|NCT00068692|528831782|FG001|Step 1: Registration|Complicating disease|0|||
146632613|NCT00068692|528831783|FG002|Step 1: Registration|Complicating disease|0|||
146632614|NCT00068692|528831784|FG003|Step 1: Registration|Complicating disease|0|||
146632615|NCT00068692|528831785|FG004|Step 1: Registration|Complicating disease|0|||
146632616|NCT00068692|528831786|FG005|Step 1: Registration|Complicating disease|0|||
146632617|NCT00068692|528831787|FG006|Step 1: Registration|Complicating disease|0|||
146632618|NCT00068692|528831788|FG007|Step 1: Registration|Complicating disease|0|||
146632619|NCT00068692|528831781|FG000|Step 1: Registration|Protocol Violation|1|||
146632620|NCT00068692|528831782|FG001|Step 1: Registration|Protocol Violation|0|||
146632621|NCT00068692|528831783|FG002|Step 1: Registration|Protocol Violation|0|||
146632622|NCT00068692|528831784|FG003|Step 1: Registration|Protocol Violation|0|||
146632623|NCT00068692|528831785|FG004|Step 1: Registration|Protocol Violation|0|||
146632624|NCT00068692|528831786|FG005|Step 1: Registration|Protocol Violation|0|||
146632625|NCT00068692|528831787|FG006|Step 1: Registration|Protocol Violation|0|||
146632626|NCT00068692|528831788|FG007|Step 1: Registration|Protocol Violation|0|||
146632627|NCT00068692|528831781|FG000|Step 1: Registration|Not eligible|6|||
146632628|NCT00068692|528831782|FG001|Step 1: Registration|Not eligible|0|||
146632629|NCT00068692|528831783|FG002|Step 1: Registration|Not eligible|0|||
146632630|NCT00068692|528831784|FG003|Step 1: Registration|Not eligible|0|||
146632631|NCT00068692|528831785|FG004|Step 1: Registration|Not eligible|0|||
146632632|NCT00068692|528831786|FG005|Step 1: Registration|Not eligible|0|||
146632633|NCT00068692|528831787|FG006|Step 1: Registration|Not eligible|0|||
146632634|NCT00068692|528831788|FG007|Step 1: Registration|Not eligible|0|||
146632635|NCT00068692|528831781|FG000|Step 1: Registration|Other|2|||
146632636|NCT00068692|528831782|FG001|Step 1: Registration|Other|0|||
146632637|NCT00068692|528831783|FG002|Step 1: Registration|Other|0|||
146632638|NCT00068692|528831784|FG003|Step 1: Registration|Other|0|||
146632639|NCT00068692|528831785|FG004|Step 1: Registration|Other|0|||
146632640|NCT00068692|528831786|FG005|Step 1: Registration|Other|0|||
146632641|NCT00068692|528831787|FG006|Step 1: Registration|Other|0|||
146632642|NCT00068692|528831788|FG007|Step 1: Registration|Other|0|||
146632643|NCT00068692|528831781|FG000|Step 1: Registration|Not start protocol therapy|3|||
146632644|NCT00068692|528831782|FG001|Step 1: Registration|Not start protocol therapy|0|||
146632645|NCT00068692|528831783|FG002|Step 1: Registration|Not start protocol therapy|0|||
146632646|NCT00068692|528831784|FG003|Step 1: Registration|Not start protocol therapy|0|||
146632647|NCT00068692|528831785|FG004|Step 1: Registration|Not start protocol therapy|0|||
146632648|NCT00068692|528831786|FG005|Step 1: Registration|Not start protocol therapy|0|||
146632649|NCT00068692|528831787|FG006|Step 1: Registration|Not start protocol therapy|0|||
146632650|NCT00068692|528831788|FG007|Step 1: Registration|Not start protocol therapy|0|||
146632651|NCT00068692|528831781|FG000|Step 1: Registration|Registered but not randomized|0|||
146632652|NCT00068692|528831782|FG001|Step 1: Registration|Registered but not randomized|1|||
146632653|NCT00068692|528831783|FG002|Step 1: Registration|Registered but not randomized|0|||
146632654|NCT00068692|528831784|FG003|Step 1: Registration|Registered but not randomized|0|||
146632655|NCT00068692|528831785|FG004|Step 1: Registration|Registered but not randomized|0|||
146632656|NCT00068692|528831786|FG005|Step 1: Registration|Registered but not randomized|0|||
146632657|NCT00068692|528831787|FG006|Step 1: Registration|Registered but not randomized|0|||
146632658|NCT00068692|528831788|FG007|Step 1: Registration|Registered but not randomized|0|||
146632659|NCT00068692|528831781|FG000|Step 2: Randomization|Disesae progression/replase|0|||
146887377|NCT03529773|529753960|FG005|Overall Study|Withdrawal by Subject|0|||
146887378|NCT03529773|529753961|FG006|Overall Study|Withdrawal by Subject|0|||
146887379|NCT03529773|529753962|FG007|Overall Study|Withdrawal by Subject|1|||
146632660|NCT00068692|528831782|FG001|Step 2: Randomization|Disesae progression/replase|0|||
146887380|NCT03529773|529753963|FG008|Overall Study|Withdrawal by Subject|0|||
146887381|NCT03529773|529753964|FG009|Overall Study|Withdrawal by Subject|1|||
146887382|NCT03529773|529753965|FG010|Overall Study|Withdrawal by Subject|1|||
146887383|NCT03529773|529753966|FG011|Overall Study|Withdrawal by Subject|0|||
146887384|NCT03529773|529753967|FG012|Overall Study|Withdrawal by Subject|0|||
146887385|NCT03529773|529753968|FG013|Overall Study|Withdrawal by Subject|0|||
146887386|NCT03529773|529753969|FG014|Overall Study|Withdrawal by Subject|0|||
146887387|NCT03529773|529753970|FG015|Overall Study|Withdrawal by Subject|3|||
146887388|NCT03529773|529753971|FG016|Overall Study|Withdrawal by Subject|0|||
146887389|NCT03529773|529753972|FG017|Overall Study|Withdrawal by Subject|2|||
146887390|NCT03529773|529753973|FG018|Overall Study|Withdrawal by Subject|3|||
146887391|NCT03529773|529753974|FG019|Overall Study|Withdrawal by Subject|1|||
146887392|NCT03529773|529753975|FG020|Overall Study|Withdrawal by Subject|3|||
146887393|NCT03529773|529753976|FG021|Overall Study|Withdrawal by Subject|1|||
146887394|NCT03529773|529753977|FG022|Overall Study|Withdrawal by Subject|1|||
146887395|NCT03529773|529753978|FG023|Overall Study|Withdrawal by Subject|2|||
146887396|NCT03529773|529753979|FG024|Overall Study|Withdrawal by Subject|2|||
146632661|NCT00068692|528831783|FG002|Step 2: Randomization|Disesae progression/replase|1|||
146632662|NCT00068692|528831784|FG003|Step 2: Randomization|Disesae progression/replase|1|||
146887397|NCT03529773|529753980|FG025|Overall Study|Withdrawal by Subject|4|||
146887398|NCT03529773|529753981|FG026|Overall Study|Withdrawal by Subject|2|||
146887399|NCT03529773|529753982|FG027|Overall Study|Withdrawal by Subject|1|||
146887400|NCT03529773|529753983|FG028|Overall Study|Withdrawal by Subject|1|||
146887401|NCT03529773|529753984|FG029|Overall Study|Withdrawal by Subject|0|||
146887402|NCT03529773|529753985|FG030|Overall Study|Withdrawal by Subject|0|||
146887403|NCT03529773|529753986|FG031|Overall Study|Withdrawal by Subject|0|||
146887404|NCT03529773|529753987|FG032|Overall Study|Withdrawal by Subject|0|||
146887405|NCT03529773|529753988|FG033|Overall Study|Withdrawal by Subject|0|||
146887406|NCT03529773|529753989|FG034|Overall Study|Withdrawal by Subject|1|||
146887407|NCT03529773|529753990|FG035|Overall Study|Withdrawal by Subject|2|||
146887408|NCT03529773|529753991|FG036|Overall Study|Withdrawal by Subject|0|||
146887409|NCT03529773|529753992|FG037|Overall Study|Withdrawal by Subject|2|||
146887410|NCT03529773|529753993|FG038|Overall Study|Withdrawal by Subject|1|||
146887411|NCT03529773|529753994|FG039|Overall Study|Withdrawal by Subject|1|||
146887412|NCT03529773|529753955|FG000|Overall Study|Screen Failure|0|||
146887413|NCT03529773|529753956|FG001|Overall Study|Screen Failure|0|||
146887414|NCT03529773|529753957|FG002|Overall Study|Screen Failure|0|||
146887415|NCT03529773|529753958|FG003|Overall Study|Screen Failure|0|||
146887416|NCT03529773|529753959|FG004|Overall Study|Screen Failure|0|||
146887417|NCT03529773|529753960|FG005|Overall Study|Screen Failure|0|||
146887418|NCT03529773|529753961|FG006|Overall Study|Screen Failure|0|||
146887419|NCT03529773|529753962|FG007|Overall Study|Screen Failure|0|||
146887420|NCT03529773|529753963|FG008|Overall Study|Screen Failure|0|||
146632663|NCT00068692|528831785|FG004|Step 2: Randomization|Disesae progression/replase|0|||
146632664|NCT00068692|528831786|FG005|Step 2: Randomization|Disesae progression/replase|0|||
146632665|NCT00068692|528831787|FG006|Step 2: Randomization|Disesae progression/replase|0|||
146632666|NCT00068692|528831788|FG007|Step 2: Randomization|Disesae progression/replase|0|||
146632667|NCT00068692|528831781|FG000|Step 2: Randomization|Adverse Event|0|||
146632668|NCT00068692|528831782|FG001|Step 2: Randomization|Adverse Event|0|||
146632669|NCT00068692|528831783|FG002|Step 2: Randomization|Adverse Event|4|||
146632670|NCT00068692|528831784|FG003|Step 2: Randomization|Adverse Event|2|||
146632671|NCT00068692|528831785|FG004|Step 2: Randomization|Adverse Event|2|||
146632672|NCT00068692|528831786|FG005|Step 2: Randomization|Adverse Event|3|||
146632673|NCT00068692|528831787|FG006|Step 2: Randomization|Adverse Event|4|||
146632674|NCT00068692|528831788|FG007|Step 2: Randomization|Adverse Event|4|||
146632675|NCT00068692|528831781|FG000|Step 2: Randomization|Death|0|||
146632676|NCT00068692|528831782|FG001|Step 2: Randomization|Death|0|||
146632677|NCT00068692|528831783|FG002|Step 2: Randomization|Death|0|||
146632678|NCT00068692|528831784|FG003|Step 2: Randomization|Death|0|||
146632679|NCT00068692|528831785|FG004|Step 2: Randomization|Death|1|||
146632680|NCT00068692|528831786|FG005|Step 2: Randomization|Death|0|||
146632681|NCT00068692|528831787|FG006|Step 2: Randomization|Death|0|||
146632682|NCT00068692|528831788|FG007|Step 2: Randomization|Death|1|||
146632683|NCT00068692|528831781|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
146632684|NCT00068692|528831782|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
146632685|NCT00068692|528831783|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
146632686|NCT00068692|528831784|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
146632687|NCT00068692|528831785|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
146632688|NCT00068692|528831786|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
146632689|NCT00068692|528831787|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
146632690|NCT00068692|528831788|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
146632691|NCT00068692|528831781|FG000|Step 2: Randomization|alternative therapy|0|||
146632692|NCT00068692|528831782|FG001|Step 2: Randomization|alternative therapy|0|||
146632693|NCT00068692|528831783|FG002|Step 2: Randomization|alternative therapy|0|||
146632694|NCT00068692|528831784|FG003|Step 2: Randomization|alternative therapy|1|||
146632695|NCT00068692|528831785|FG004|Step 2: Randomization|alternative therapy|1|||
146632696|NCT00068692|528831786|FG005|Step 2: Randomization|alternative therapy|0|||
146632697|NCT00068692|528831787|FG006|Step 2: Randomization|alternative therapy|0|||
146632698|NCT00068692|528831788|FG007|Step 2: Randomization|alternative therapy|0|||
146632699|NCT00068692|528831781|FG000|Step 2: Randomization|Physician Decision|0|||
146632700|NCT00068692|528831782|FG001|Step 2: Randomization|Physician Decision|0|||
146887421|NCT03529773|529753964|FG009|Overall Study|Screen Failure|0|||
146887422|NCT03529773|529753965|FG010|Overall Study|Screen Failure|0|||
146887423|NCT03529773|529753966|FG011|Overall Study|Screen Failure|0|||
146632701|NCT00068692|528831783|FG002|Step 2: Randomization|Physician Decision|0|||
146632702|NCT00068692|528831784|FG003|Step 2: Randomization|Physician Decision|1|||
146632703|NCT00068692|528831785|FG004|Step 2: Randomization|Physician Decision|1|||
146632704|NCT00068692|528831786|FG005|Step 2: Randomization|Physician Decision|0|||
146632705|NCT00068692|528831787|FG006|Step 2: Randomization|Physician Decision|0|||
146632706|NCT00068692|528831788|FG007|Step 2: Randomization|Physician Decision|0|||
146632707|NCT00068692|528831781|FG000|Step 2: Randomization|Other|0|||
146632708|NCT00068692|528831782|FG001|Step 2: Randomization|Other|0|||
146887424|NCT03529773|529753967|FG012|Overall Study|Screen Failure|0|||
146887425|NCT03529773|529753968|FG013|Overall Study|Screen Failure|0|||
146887426|NCT03529773|529753969|FG014|Overall Study|Screen Failure|0|||
146887427|NCT03529773|529753970|FG015|Overall Study|Screen Failure|0|||
146887428|NCT03529773|529753971|FG016|Overall Study|Screen Failure|0|||
146887429|NCT03529773|529753972|FG017|Overall Study|Screen Failure|0|||
146887430|NCT03529773|529753973|FG018|Overall Study|Screen Failure|0|||
146887431|NCT03529773|529753974|FG019|Overall Study|Screen Failure|0|||
146887432|NCT03529773|529753975|FG020|Overall Study|Screen Failure|0|||
146887433|NCT03529773|529753976|FG021|Overall Study|Screen Failure|0|||
146887434|NCT03529773|529753977|FG022|Overall Study|Screen Failure|0|||
146887435|NCT03529773|529753978|FG023|Overall Study|Screen Failure|0|||
146887436|NCT03529773|529753979|FG024|Overall Study|Screen Failure|0|||
146887437|NCT03529773|529753980|FG025|Overall Study|Screen Failure|0|||
146887438|NCT03529773|529753981|FG026|Overall Study|Screen Failure|0|||
146887439|NCT03529773|529753982|FG027|Overall Study|Screen Failure|0|||
146887440|NCT03529773|529753983|FG028|Overall Study|Screen Failure|0|||
146887441|NCT03529773|529753984|FG029|Overall Study|Screen Failure|0|||
146887442|NCT03529773|529753985|FG030|Overall Study|Screen Failure|0|||
146887443|NCT03529773|529753986|FG031|Overall Study|Screen Failure|0|||
146887444|NCT03529773|529753987|FG032|Overall Study|Screen Failure|0|||
146887445|NCT03529773|529753988|FG033|Overall Study|Screen Failure|0|||
146887446|NCT03529773|529753989|FG034|Overall Study|Screen Failure|0|||
146887447|NCT03529773|529753990|FG035|Overall Study|Screen Failure|0|||
146887448|NCT03529773|529753991|FG036|Overall Study|Screen Failure|1|||
146887449|NCT03529773|529753992|FG037|Overall Study|Screen Failure|1|||
146887450|NCT03529773|529753993|FG038|Overall Study|Screen Failure|0|||
146552540|NCT03302936|528530983|FG001|Overall Study|Protocol Violation|4|||
146552541|NCT01122680|528530984|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
146552542|NCT01122680|528530985|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
146887451|NCT03529773|529753994|FG039|Overall Study|Screen Failure|1|||
146887452|NCT03529773|529753955|FG000|Overall Study|Randomized but not vaccinated|0|||
146552543|NCT01122680|528530986|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
146552544|NCT01122680|528530987|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
146552545|NCT01122680|528530984|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
146552546|NCT01122680|528530985|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
146552547|NCT01122680|528530986|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
146887453|NCT03529773|529753956|FG001|Overall Study|Randomized but not vaccinated|0|||
146887454|NCT03529773|529753957|FG002|Overall Study|Randomized but not vaccinated|0|||
146552548|NCT01122680|528530987|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
146552549|NCT01122680|528530984|FG000|Period 1 (4 Weeks)|Other|1|||
146552550|NCT01122680|528530985|FG001|Period 1 (4 Weeks)|Other|1|||
146552551|NCT01122680|528530986|FG002|Period 1 (4 Weeks)|Other|0|||
146887455|NCT03529773|529753958|FG003|Overall Study|Randomized but not vaccinated|0|||
146887456|NCT03529773|529753959|FG004|Overall Study|Randomized but not vaccinated|0|||
146552552|NCT01122680|528530987|FG003|Period 1 (4 Weeks)|Other|0|||
146552553|NCT01122680|528530984|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
146887457|NCT03529773|529753960|FG005|Overall Study|Randomized but not vaccinated|0|||
146887458|NCT03529773|529753961|FG006|Overall Study|Randomized but not vaccinated|0|||
146887459|NCT03529773|529753962|FG007|Overall Study|Randomized but not vaccinated|0|||
146887460|NCT03529773|529753963|FG008|Overall Study|Randomized but not vaccinated|0|||
146887461|NCT03529773|529753964|FG009|Overall Study|Randomized but not vaccinated|0|||
146887462|NCT03529773|529753965|FG010|Overall Study|Randomized but not vaccinated|0|||
146887463|NCT03529773|529753966|FG011|Overall Study|Randomized but not vaccinated|0|||
146887464|NCT03529773|529753967|FG012|Overall Study|Randomized but not vaccinated|0|||
146887465|NCT03529773|529753968|FG013|Overall Study|Randomized but not vaccinated|0|||
146887466|NCT03529773|529753969|FG014|Overall Study|Randomized but not vaccinated|0|||
146887467|NCT03529773|529753970|FG015|Overall Study|Randomized but not vaccinated|0|||
146887468|NCT03529773|529753971|FG016|Overall Study|Randomized but not vaccinated|0|||
146765296|NCT00628862|529308591|FG001|Overall Study|Lost to Follow-up|2|||
146887469|NCT03529773|529753972|FG017|Overall Study|Randomized but not vaccinated|1|||
146887470|NCT03529773|529753973|FG018|Overall Study|Randomized but not vaccinated|0|||
146887471|NCT03529773|529753974|FG019|Overall Study|Randomized but not vaccinated|0|||
146887472|NCT03529773|529753975|FG020|Overall Study|Randomized but not vaccinated|0|||
146887473|NCT03529773|529753976|FG021|Overall Study|Randomized but not vaccinated|0|||
146887474|NCT03529773|529753977|FG022|Overall Study|Randomized but not vaccinated|0|||
146887475|NCT03529773|529753978|FG023|Overall Study|Randomized but not vaccinated|0|||
146966597|NCT04242498|530038864|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
146966598|NCT04242498|530038865|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
146966599|NCT04242498|530038866|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
146966600|NCT04242498|530038867|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
146966601|NCT04242498|530038868|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
146966602|NCT04242498|530038869|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
146966603|NCT04242498|530038863|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
146966604|NCT04242498|530038864|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
146966605|NCT04242498|530038865|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
146966606|NCT04242498|530038866|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
146966607|NCT04242498|530038867|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
146966608|NCT04242498|530038868|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
146966609|NCT04242498|530038869|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
146966610|NCT04242498|530038863|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
146966611|NCT04242498|530038864|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146552554|NCT01122680|528530985|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
146552555|NCT01122680|528530986|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
146552556|NCT01122680|528530987|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
146552557|NCT01122680|528530984|FG000|Period 2 (4 Weeks)|Other|1|||
146552558|NCT01122680|528530985|FG001|Period 2 (4 Weeks)|Other|0|||
146552559|NCT01122680|528530986|FG002|Period 2 (4 Weeks)|Other|0|||
146552560|NCT01122680|528530987|FG003|Period 2 (4 Weeks)|Other|0|||
146552561|NCT01122680|528530984|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
146552562|NCT01122680|528530985|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
146552563|NCT01122680|528530986|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
146552564|NCT01122680|528530987|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
146887476|NCT03529773|529753979|FG024|Overall Study|Randomized but not vaccinated|0|||
146887477|NCT03529773|529753980|FG025|Overall Study|Randomized but not vaccinated|0|||
146887478|NCT03529773|529753981|FG026|Overall Study|Randomized but not vaccinated|0|||
146966612|NCT04242498|530038865|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
146552565|NCT01122680|528530984|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
146552566|NCT01122680|528530985|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
146552567|NCT01122680|528530986|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
146887479|NCT03529773|529753982|FG027|Overall Study|Randomized but not vaccinated|1|||
146887480|NCT03529773|529753983|FG028|Overall Study|Randomized but not vaccinated|0|||
146552568|NCT01122680|528530987|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
146552569|NCT01986751|528530998|FG000|Overall Study|improperly consented|10|||
146966613|NCT04242498|530038866|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146966614|NCT04242498|530038867|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146552570|NCT01986751|528530999|FG001|Overall Study|improperly consented|2|||
146966615|NCT04242498|530038868|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146552571|NCT03566550|528531001|FG000|Overall Study|Withdrawal by Subject|0|||
146552572|NCT03566550|528531002|FG001|Overall Study|Withdrawal by Subject|1|||
146887481|NCT03529773|529753984|FG029|Overall Study|Randomized but not vaccinated|0|||
146887482|NCT03529773|529753985|FG030|Overall Study|Randomized but not vaccinated|0|||
146887483|NCT03529773|529753986|FG031|Overall Study|Randomized but not vaccinated|0|||
146887484|NCT03529773|529753987|FG032|Overall Study|Randomized but not vaccinated|0|||
146887485|NCT03529773|529753988|FG033|Overall Study|Randomized but not vaccinated|0|||
146887486|NCT03529773|529753989|FG034|Overall Study|Randomized but not vaccinated|0|||
146887487|NCT03529773|529753990|FG035|Overall Study|Randomized but not vaccinated|0|||
146887488|NCT03529773|529753991|FG036|Overall Study|Randomized but not vaccinated|0|||
146887489|NCT03529773|529753992|FG037|Overall Study|Randomized but not vaccinated|0|||
146887490|NCT03529773|529753993|FG038|Overall Study|Randomized but not vaccinated|0|||
146887491|NCT03529773|529753994|FG039|Overall Study|Randomized but not vaccinated|0|||
146887492|NCT01496066|529753996|FG000|Overall Study|Lost to Follow-up|8|||
146887493|NCT01496066|529753997|FG001|Overall Study|Lost to Follow-up|5|||
146552573|NCT01968785|528531003|FG000|Overall Study|Withdrawal by Subject|1|||
146552574|NCT01968785|528531004|FG001|Overall Study|Withdrawal by Subject|0|||
146552575|NCT00098293|528531005|FG000|Double-blind (DB) Phase|Adverse Event|14|||
146552576|NCT00098293|528531006|FG001|Double-blind (DB) Phase|Adverse Event|27|||
146552577|NCT00098293|528531007|FG002|Double-blind (DB) Phase|Adverse Event|60|||
146552578|NCT00098293|528531008|FG003|Double-blind (DB) Phase|Adverse Event|0|||
146552579|NCT00098293|528531009|FG004|Double-blind (DB) Phase|Adverse Event|0|||
146552580|NCT00098293|528531005|FG000|Double-blind (DB) Phase|Pregnancy|0|||
146552581|NCT00098293|528531006|FG001|Double-blind (DB) Phase|Pregnancy|7|||
146552582|NCT00098293|528531007|FG002|Double-blind (DB) Phase|Pregnancy|9|||
146552583|NCT00098293|528531008|FG003|Double-blind (DB) Phase|Pregnancy|0|||
146552584|NCT00098293|528531009|FG004|Double-blind (DB) Phase|Pregnancy|0|||
146552585|NCT00098293|528531005|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
146552586|NCT00098293|528531006|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
146552587|NCT00098293|528531007|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
146552588|NCT00098293|528531008|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
146552589|NCT00098293|528531009|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
146552590|NCT00098293|528531005|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
146552591|NCT00098293|528531006|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
146552592|NCT00098293|528531007|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
146552593|NCT00098293|528531008|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
146552594|NCT00098293|528531009|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
146552595|NCT00098293|528531005|FG000|Double-blind (DB) Phase|Death|1|||
146887494|NCT01496066|529753996|FG000|Overall Study|Explant|3|||
146887495|NCT01496066|529753997|FG001|Overall Study|Explant|0|||
146887496|NCT01496066|529753996|FG000|Overall Study|Death|1|||
146887497|NCT01496066|529753997|FG001|Overall Study|Death|4|||
146552596|NCT00098293|528531006|FG001|Double-blind (DB) Phase|Death|2|||
146552597|NCT00098293|528531007|FG002|Double-blind (DB) Phase|Death|2|||
146552598|NCT00098293|528531008|FG003|Double-blind (DB) Phase|Death|0|||
146552599|NCT00098293|528531009|FG004|Double-blind (DB) Phase|Death|0|||
146887498|NCT01587079|529753998|FG000|Overall Study|Protocol-specified criteria|9|||
146887499|NCT01587079|529753998|FG000|Overall Study|Protocol Violation|5|||
146887500|NCT01587079|529753998|FG000|Overall Study|Lost to Follow-up|2|||
146887501|NCT01587079|529753998|FG000|Overall Study|Physician Decision|2|||
146966616|NCT04242498|530038869|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146552600|NCT00098293|528531005|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
146552601|NCT00098293|528531006|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
146552602|NCT00098293|528531007|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
146887502|NCT01587079|529753998|FG000|Overall Study|Withdrawal by Subject|7|||
146887503|NCT01587079|529753998|FG000|Overall Study|Adverse Event|14|||
146887504|NCT04823949|529754000|FG000|Overall Study|Withdrawal by Subject|0|||
146887505|NCT04823949|529754001|FG001|Overall Study|Withdrawal by Subject|4|||
146887506|NCT04823949|529754000|FG000|Overall Study|Physician Decision|0|||
146887507|NCT04823949|529754001|FG001|Overall Study|Physician Decision|1|||
146887508|NCT00756938|529754002|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
146887509|NCT00756938|529754003|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
146887510|NCT00756938|529754004|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
146887511|NCT00756938|529754005|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
146887512|NCT00756938|529754002|FG000|12-week Base Study|Protocol Violation|0|||
146887513|NCT00756938|529754003|FG001|12-week Base Study|Protocol Violation|0|||
146632709|NCT00068692|528831783|FG002|Step 2: Randomization|Other|0|||
146632710|NCT00068692|528831784|FG003|Step 2: Randomization|Other|1|||
146632711|NCT00068692|528831785|FG004|Step 2: Randomization|Other|0|||
146632712|NCT00068692|528831786|FG005|Step 2: Randomization|Other|1|||
146632713|NCT00068692|528831787|FG006|Step 2: Randomization|Other|0|||
146632714|NCT00068692|528831788|FG007|Step 2: Randomization|Other|0|||
146632715|NCT00068692|528831781|FG000|Step 2: Randomization|never start protocol therapy|0|||
146632716|NCT00068692|528831782|FG001|Step 2: Randomization|never start protocol therapy|0|||
146632717|NCT00068692|528831783|FG002|Step 2: Randomization|never start protocol therapy|1|||
146632718|NCT00068692|528831784|FG003|Step 2: Randomization|never start protocol therapy|0|||
146632719|NCT00068692|528831785|FG004|Step 2: Randomization|never start protocol therapy|1|||
146632720|NCT00068692|528831786|FG005|Step 2: Randomization|never start protocol therapy|0|||
146632721|NCT00068692|528831787|FG006|Step 2: Randomization|never start protocol therapy|0|||
146632722|NCT00068692|528831788|FG007|Step 2: Randomization|never start protocol therapy|0|||
146632723|NCT01600716|528831790|FG000|Overall Study|Other Reasons|3|||
146632724|NCT01600716|528831791|FG001|Overall Study|Other Reasons|1|||
146632725|NCT01600716|528831790|FG000|Overall Study|Personal Reasons|0|||
146632726|NCT01600716|528831791|FG001|Overall Study|Personal Reasons|2|||
146632727|NCT01600716|528831790|FG000|Overall Study|Lost to Follow-up|0|||
146632728|NCT01600716|528831791|FG001|Overall Study|Lost to Follow-up|2|||
146632729|NCT01600716|528831790|FG000|Overall Study|Pregnancy|1|||
146632730|NCT01600716|528831791|FG001|Overall Study|Pregnancy|0|||
146632731|NCT01600716|528831790|FG000|Overall Study|Lack of Efficacy|2|||
146632732|NCT01600716|528831791|FG001|Overall Study|Lack of Efficacy|1|||
146632733|NCT01600716|528831790|FG000|Overall Study|Adverse Event|1|||
146632734|NCT01600716|528831791|FG001|Overall Study|Adverse Event|1|||
146632735|NCT00248040|528831792|FG000|Overall Study|transplantectomy|2|||
146632736|NCT00248040|528831793|FG001|Overall Study|transplantectomy|1|||
146632737|NCT00248040|528831794|FG002|Overall Study|transplantectomy|3|||
146632738|NCT00248040|528831792|FG000|Overall Study|transplant cancelled post treat start|1|||
146632739|NCT00248040|528831793|FG001|Overall Study|transplant cancelled post treat start|0|||
146632740|NCT00248040|528831794|FG002|Overall Study|transplant cancelled post treat start|0|||
146632741|NCT00248040|528831792|FG000|Overall Study|Death|0|||
146632742|NCT00248040|528831793|FG001|Overall Study|Death|0|||
146632743|NCT00248040|528831794|FG002|Overall Study|Death|1|||
146632744|NCT03557034|528831799|FG000|Overall Study|Withdrawal by Subject|1|||
146632745|NCT03557034|528831800|FG001|Overall Study|Withdrawal by Subject|0|||
146632746|NCT01759446|528831803|FG000|Overall Study|Protocol Violation|1|||
146632747|NCT01759446|528831804|FG001|Overall Study|Protocol Violation|0|||
146632748|NCT01759446|528831805|FG002|Overall Study|Protocol Violation|1|||
146632749|NCT01759446|528831806|FG003|Overall Study|Protocol Violation|0|||
146632750|NCT01759446|528831807|FG004|Overall Study|Protocol Violation|0|||
146632751|NCT01759446|528831803|FG000|Overall Study|Withdrawal by Subject|0|||
146632752|NCT01759446|528831804|FG001|Overall Study|Withdrawal by Subject|1|||
146887514|NCT00756938|529754004|FG002|12-week Base Study|Protocol Violation|1|||
146887515|NCT00756938|529754005|FG003|12-week Base Study|Protocol Violation|0|||
146632753|NCT01759446|528831805|FG002|Overall Study|Withdrawal by Subject|0|||
146632754|NCT01759446|528831806|FG003|Overall Study|Withdrawal by Subject|1|||
146632755|NCT01759446|528831807|FG004|Overall Study|Withdrawal by Subject|0|||
146632756|NCT01760733|528831808|FG000|Waiting List|Death|18|||
146632757|NCT01760733|528831808|FG000|Waiting List|Removed from waiting list|41|||
146632758|NCT01760733|528831808|FG000|Waiting List|Not received a transplant yet|13|||
146887516|NCT00756938|529754002|FG000|12-week Base Study|Lost to Follow-up|1|||
146887517|NCT00756938|529754003|FG001|12-week Base Study|Lost to Follow-up|0|||
146887518|NCT00756938|529754004|FG002|12-week Base Study|Lost to Follow-up|0|||
146887519|NCT00756938|529754005|FG003|12-week Base Study|Lost to Follow-up|0|||
146632759|NCT01760733|528831808|FG000|Transplanted|Not reached 10 years post transplant|184|||
146887520|NCT00756938|529754002|FG000|Optional Extension|Lack of Efficacy|0|||
146887521|NCT00756938|529754003|FG001|Optional Extension|Lack of Efficacy|0|||
146887522|NCT00756938|529754004|FG002|Optional Extension|Lack of Efficacy|0|||
146632760|NCT01760733|528831808|FG000|Transplanted|Death|26|||
146632761|NCT01760733|528831808|FG000|Transplanted|Graft loss|7|||
146632762|NCT00815659|528831809|FG000|Overall Study|Adverse Event|9|||
146632763|NCT00815659|528831809|FG000|Overall Study|Withdrawal by Subject|9|||
146887523|NCT00756938|529754005|FG003|Optional Extension|Lack of Efficacy|1|||
146887524|NCT00756938|529754002|FG000|Optional Extension|End of Study|0|||
146887525|NCT00756938|529754003|FG001|Optional Extension|End of Study|0|||
146887526|NCT00756938|529754004|FG002|Optional Extension|End of Study|0|||
146887527|NCT00756938|529754005|FG003|Optional Extension|End of Study|11|||
146887528|NCT00756938|529754002|FG000|Optional Extension|Protocol-specific criteria met|0|||
146887529|NCT00756938|529754003|FG001|Optional Extension|Protocol-specific criteria met|0|||
146552603|NCT00098293|528531008|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
146552604|NCT00098293|528531009|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
146552605|NCT00098293|528531005|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
146552606|NCT00098293|528531006|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
146552607|NCT00098293|528531007|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
146552608|NCT00098293|528531008|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
146552609|NCT00098293|528531009|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
146552610|NCT00098293|528531005|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
146552611|NCT00098293|528531006|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
146552612|NCT00098293|528531007|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
146552613|NCT00098293|528531008|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
146552614|NCT00098293|528531009|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
146552615|NCT00098293|528531005|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
146552616|NCT00098293|528531006|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
146552617|NCT00098293|528531007|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
146552618|NCT00098293|528531008|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
146552619|NCT00098293|528531009|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
146552620|NCT00098293|528531005|FG000|Open-label (OL) Phase|Adverse Event|0|||
146552621|NCT00098293|528531006|FG001|Open-label (OL) Phase|Adverse Event|3|||
146552622|NCT00098293|528531007|FG002|Open-label (OL) Phase|Adverse Event|7|||
146552623|NCT00098293|528531008|FG003|Open-label (OL) Phase|Adverse Event|6|||
146552624|NCT00098293|528531009|FG004|Open-label (OL) Phase|Adverse Event|0|||
146552625|NCT00098293|528531005|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
146552626|NCT00098293|528531006|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
146552627|NCT00098293|528531007|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
146552628|NCT00098293|528531008|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
146552629|NCT00098293|528531009|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
146552630|NCT00098293|528531005|FG000|Open-label (OL) Phase|Pregnancy|0|||
146552631|NCT00098293|528531006|FG001|Open-label (OL) Phase|Pregnancy|1|||
146552632|NCT00098293|528531007|FG002|Open-label (OL) Phase|Pregnancy|0|||
146552633|NCT00098293|528531008|FG003|Open-label (OL) Phase|Pregnancy|3|||
146552634|NCT00098293|528531009|FG004|Open-label (OL) Phase|Pregnancy|0|||
146552635|NCT00098293|528531005|FG000|Open-label (OL) Phase|Protocol Violation|0|||
146552636|NCT00098293|528531006|FG001|Open-label (OL) Phase|Protocol Violation|6|||
146552637|NCT00098293|528531007|FG002|Open-label (OL) Phase|Protocol Violation|13|||
146552638|NCT00098293|528531008|FG003|Open-label (OL) Phase|Protocol Violation|16|||
146552639|NCT00098293|528531009|FG004|Open-label (OL) Phase|Protocol Violation|0|||
146552640|NCT00098293|528531005|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
146552641|NCT00098293|528531006|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
146552642|NCT00098293|528531007|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
146552643|NCT00098293|528531008|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
146552644|NCT00098293|528531009|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
146552645|NCT00098293|528531005|FG000|Open-label (OL) Phase|Death|0|||
146552646|NCT00098293|528531006|FG001|Open-label (OL) Phase|Death|2|||
146552647|NCT00098293|528531007|FG002|Open-label (OL) Phase|Death|3|||
146552648|NCT00098293|528531008|FG003|Open-label (OL) Phase|Death|0|||
146552649|NCT00098293|528531009|FG004|Open-label (OL) Phase|Death|0|||
146552650|NCT00098293|528531005|FG000|Supplemental Phase (SP)|Death|0|||
146552651|NCT00098293|528531006|FG001|Supplemental Phase (SP)|Death|0|||
146887530|NCT00756938|529754004|FG002|Optional Extension|Protocol-specific criteria met|0|||
146552652|NCT00098293|528531007|FG002|Supplemental Phase (SP)|Death|0|||
146552653|NCT00098293|528531008|FG003|Supplemental Phase (SP)|Death|0|||
146887531|NCT00756938|529754005|FG003|Optional Extension|Protocol-specific criteria met|9|||
146887532|NCT00756938|529754002|FG000|Optional Extension|Physician Decision|0|||
146887533|NCT00756938|529754003|FG001|Optional Extension|Physician Decision|0|||
146887534|NCT00756938|529754004|FG002|Optional Extension|Physician Decision|0|||
146552654|NCT00098293|528531009|FG004|Supplemental Phase (SP)|Death|1|||
146552655|NCT00098293|528531005|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
146887535|NCT00756938|529754005|FG003|Optional Extension|Physician Decision|3|||
146552656|NCT00098293|528531006|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
146552657|NCT00098293|528531007|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
146552658|NCT00098293|528531008|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
146552659|NCT00098293|528531009|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
146966617|NCT04242498|530038863|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
146966618|NCT04242498|530038864|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146966619|NCT04242498|530038865|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
146966620|NCT04242498|530038866|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146966621|NCT04242498|530038867|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146966622|NCT04242498|530038868|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146966623|NCT04242498|530038869|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146966624|NCT04242498|530038863|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
146966625|NCT04242498|530038864|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
146966626|NCT04242498|530038865|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
146552660|NCT00098293|528531005|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
146552661|NCT00098293|528531006|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
146552662|NCT00098293|528531007|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
146552663|NCT00098293|528531008|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
146552664|NCT00098293|528531009|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
146552665|NCT00098293|528531005|FG000|Supplemental Phase (SP)|Other|0|||
146552666|NCT00098293|528531006|FG001|Supplemental Phase (SP)|Other|0|||
146552667|NCT00098293|528531007|FG002|Supplemental Phase (SP)|Other|0|||
146552668|NCT00098293|528531008|FG003|Supplemental Phase (SP)|Other|0|||
146552669|NCT00098293|528531009|FG004|Supplemental Phase (SP)|Other|22|||
146552670|NCT00754559|528531012|FG000|Overall Study|Adverse Event|15|||
146552671|NCT00754559|528531012|FG000|Overall Study|Protocol Violation|11|||
146552672|NCT00754559|528531012|FG000|Overall Study|Lack of Efficacy|10|||
146552673|NCT00754559|528531012|FG000|Overall Study|Lost to Follow-up|2|||
146552674|NCT00754559|528531012|FG000|Overall Study|Administrative reason|1|||
146552675|NCT00754559|528531012|FG000|Overall Study|Other|5|||
146552676|NCT00754559|528531012|FG000|Overall Study|Withdrawal by Subject|3|||
146552677|NCT04000724|528531013|FG000|Overall Study|Withdrawal by Subject|5|||
146552678|NCT04000724|528531014|FG001|Overall Study|Withdrawal by Subject|3|||
146552679|NCT04000724|528531015|FG002|Overall Study|Withdrawal by Subject|4|||
146552680|NCT04000724|528531013|FG000|Overall Study|Lost to Follow-up|11|||
146552681|NCT04000724|528531014|FG001|Overall Study|Lost to Follow-up|7|||
146552682|NCT04000724|528531015|FG002|Overall Study|Lost to Follow-up|13|||
146552683|NCT01084135|528531016|FG000|20 Week|Physician Decision|0|||
146552684|NCT01084135|528531017|FG001|20 Week|Physician Decision|1|||
146552685|NCT03335566|528531018|FG000|Overall Study|Adverse Event|0|||
146552686|NCT03335566|528531019|FG001|Overall Study|Adverse Event|1|||
146552687|NCT03335566|528531018|FG000|Overall Study|Lost to Follow-up|1|||
146552688|NCT03335566|528531019|FG001|Overall Study|Lost to Follow-up|0|||
146552689|NCT03335566|528531018|FG000|Overall Study|Technical Problems|1|||
146552690|NCT03335566|528531019|FG001|Overall Study|Technical Problems|0|||
146552691|NCT03335566|528531018|FG000|Overall Study|Protocol Violation|1|||
146552692|NCT03335566|528531019|FG001|Overall Study|Protocol Violation|0|||
146552693|NCT03335566|528531018|FG000|Overall Study|Other than specified above|1|||
146552694|NCT03335566|528531019|FG001|Overall Study|Other than specified above|2|||
146552695|NCT04595370|528531020|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
146552696|NCT04595370|528531021|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
146552697|NCT04595370|528531022|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
146552698|NCT04595370|528531023|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
146552699|NCT04595370|528531024|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
146552700|NCT04595370|528531025|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
146552701|NCT04595370|528531020|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
146552702|NCT04595370|528531021|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
146552703|NCT04595370|528531022|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
146552704|NCT04595370|528531023|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
146552705|NCT04595370|528531024|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
146552706|NCT04595370|528531025|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
146552707|NCT04595370|528531020|FG000|Overall Study|Adverse Event|0|||
146552708|NCT04595370|528531021|FG001|Overall Study|Adverse Event|4|||
146552709|NCT04595370|528531022|FG002|Overall Study|Adverse Event|3|||
146552710|NCT04595370|528531023|FG003|Overall Study|Adverse Event|1|||
146552711|NCT04595370|528531024|FG004|Overall Study|Adverse Event|1|||
146552712|NCT04595370|528531025|FG005|Overall Study|Adverse Event|1|||
146552713|NCT04595370|528531020|FG000|Overall Study|Withdrawal of Consent|1|||
146552714|NCT04595370|528531021|FG001|Overall Study|Withdrawal of Consent|1|||
146552715|NCT04595370|528531022|FG002|Overall Study|Withdrawal of Consent|1|||
146552716|NCT04595370|528531023|FG003|Overall Study|Withdrawal of Consent|0|||
146552717|NCT04595370|528531024|FG004|Overall Study|Withdrawal of Consent|0|||
146552718|NCT04595370|528531025|FG005|Overall Study|Withdrawal of Consent|0|||
146552719|NCT04595370|528531020|FG000|Overall Study|Death|0|||
146552720|NCT04595370|528531021|FG001|Overall Study|Death|1|||
146887536|NCT00756938|529754002|FG000|Optional Extension|Lost to Follow-up|0|||
146887537|NCT00756938|529754003|FG001|Optional Extension|Lost to Follow-up|0|||
146887538|NCT00756938|529754004|FG002|Optional Extension|Lost to Follow-up|0|||
146887539|NCT00756938|529754005|FG003|Optional Extension|Lost to Follow-up|1|||
146887540|NCT00756938|529754002|FG000|Optional Extension|Protocol Violation|0|||
146887541|NCT00756938|529754003|FG001|Optional Extension|Protocol Violation|0|||
146887542|NCT00756938|529754004|FG002|Optional Extension|Protocol Violation|0|||
146887543|NCT00756938|529754005|FG003|Optional Extension|Protocol Violation|1|||
146887544|NCT00756938|529754002|FG000|Optional Extension|Withdrawal by Subject|0|||
146887545|NCT00756938|529754003|FG001|Optional Extension|Withdrawal by Subject|0|||
146887546|NCT00756938|529754004|FG002|Optional Extension|Withdrawal by Subject|0|||
146887547|NCT00756938|529754005|FG003|Optional Extension|Withdrawal by Subject|10|||
146887548|NCT00756938|529754002|FG000|Optional Extension|Adverse Event|0|||
146887549|NCT00756938|529754003|FG001|Optional Extension|Adverse Event|0|||
146887550|NCT00756938|529754004|FG002|Optional Extension|Adverse Event|0|||
146887551|NCT00756938|529754005|FG003|Optional Extension|Adverse Event|1|||
146887552|NCT02347176|529754007|FG000|Overall Study|Lost to Follow-up|2|||
146887553|NCT02347176|529754008|FG001|Overall Study|Lost to Follow-up|3|||
146887554|NCT02347176|529754009|FG002|Overall Study|Lost to Follow-up|1|||
146887555|NCT02347176|529754010|FG003|Overall Study|Lost to Follow-up|1|||
146887556|NCT02347176|529754007|FG000|Overall Study|Withdrawal by Subject|9|||
146887557|NCT02347176|529754008|FG001|Overall Study|Withdrawal by Subject|5|||
146887558|NCT02347176|529754009|FG002|Overall Study|Withdrawal by Subject|5|||
146887559|NCT02347176|529754010|FG003|Overall Study|Withdrawal by Subject|3|||
146887560|NCT02347176|529754007|FG000|Overall Study|Other|1|||
146887561|NCT02347176|529754008|FG001|Overall Study|Other|2|||
146887562|NCT02347176|529754009|FG002|Overall Study|Other|2|||
146887563|NCT02347176|529754010|FG003|Overall Study|Other|0|||
146887564|NCT00430508|529754011|FG000|Overall Study|Adverse Event|2|||
146887565|NCT00430508|529754012|FG001|Overall Study|Adverse Event|3|||
146887566|NCT00430508|529754013|FG002|Overall Study|Adverse Event|5|||
146887567|NCT00430508|529754014|FG003|Overall Study|Adverse Event|3|||
146887568|NCT00430508|529754011|FG000|Overall Study|Withdrawal by Subject|0|||
146887569|NCT00430508|529754012|FG001|Overall Study|Withdrawal by Subject|1|||
146887570|NCT00430508|529754013|FG002|Overall Study|Withdrawal by Subject|1|||
146887571|NCT00430508|529754014|FG003|Overall Study|Withdrawal by Subject|1|||
146887572|NCT00430508|529754011|FG000|Overall Study|responder at visit 4|0|||
146887573|NCT00430508|529754012|FG001|Overall Study|responder at visit 4|0|||
146887574|NCT00430508|529754013|FG002|Overall Study|responder at visit 4|2|||
146887575|NCT00430508|529754014|FG003|Overall Study|responder at visit 4|0|||
146887576|NCT00430508|529754011|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
146887577|NCT00430508|529754012|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
146887578|NCT00430508|529754013|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
146887579|NCT00430508|529754014|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
146887580|NCT00430508|529754011|FG000|Overall Study|Other|1|||
146887581|NCT00430508|529754012|FG001|Overall Study|Other|1|||
146887582|NCT00430508|529754013|FG002|Overall Study|Other|3|||
146552721|NCT04595370|528531022|FG002|Overall Study|Death|0|||
146552722|NCT04595370|528531023|FG003|Overall Study|Death|0|||
146552723|NCT04595370|528531024|FG004|Overall Study|Death|1|||
146887583|NCT00430508|529754014|FG003|Overall Study|Other|0|||
146887584|NCT01703858|529754017|FG000|Overall Study|Withdrawal by Subject|0|||
146887585|NCT01703858|529754018|FG001|Overall Study|Withdrawal by Subject|1|||
146887586|NCT01703858|529754019|FG002|Overall Study|Withdrawal by Subject|0|||
146887587|NCT02556255|529754020|FG000|Overall Study|Lost to Follow-up|4|||
146887588|NCT01543087|529754023|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
146887589|NCT01543087|529754024|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
146887590|NCT01543087|529754025|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
146887591|NCT01543087|529754026|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
146887592|NCT01543087|529754027|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
146887593|NCT01543087|529754028|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
146887594|NCT01543087|529754023|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
146887595|NCT01543087|529754024|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
146887596|NCT01543087|529754025|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
146887597|NCT01543087|529754026|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
146887598|NCT01543087|529754027|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
146887599|NCT01543087|529754028|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
146887600|NCT01543087|529754023|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
146887601|NCT01543087|529754024|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
146552724|NCT04595370|528531025|FG005|Overall Study|Death|0|||
146552725|NCT04595370|528531020|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146887602|NCT01543087|529754025|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
146887603|NCT01543087|529754026|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
146887604|NCT01543087|529754027|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
146887605|NCT01543087|529754028|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
146887606|NCT01543087|529754023|FG000|Stage 1 (48 Months)|Other than specified|5|||
146887607|NCT01543087|529754024|FG001|Stage 1 (48 Months)|Other than specified|0|||
146887608|NCT01543087|529754025|FG002|Stage 1 (48 Months)|Other than specified|9|||
146887609|NCT01543087|529754026|FG003|Stage 1 (48 Months)|Other than specified|0|||
146887610|NCT01543087|529754027|FG004|Stage 1 (48 Months)|Other than specified|0|||
146887611|NCT01543087|529754028|FG005|Stage 1 (48 Months)|Other than specified|0|||
146887612|NCT01543087|529754023|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
146887613|NCT01543087|529754024|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
146887614|NCT01543087|529754025|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
146887615|NCT01543087|529754026|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
146887616|NCT01543087|529754027|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
146887617|NCT01543087|529754028|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
146887618|NCT01543087|529754023|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
146887619|NCT01543087|529754024|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
146887620|NCT01543087|529754025|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
146887621|NCT01543087|529754026|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
146887622|NCT01543087|529754027|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
146887623|NCT01543087|529754028|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
146887624|NCT01543087|529754023|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
146887625|NCT01543087|529754024|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
146552726|NCT04595370|528531021|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146552727|NCT04595370|528531022|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
146552728|NCT04595370|528531023|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146552729|NCT04595370|528531024|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146552730|NCT04595370|528531025|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146552731|NCT04595370|528531020|FG000|Overall Study|Withdrawal by Subject|0|||
146552732|NCT04595370|528531021|FG001|Overall Study|Withdrawal by Subject|0|||
146765297|NCT00628862|529308592|FG002|Overall Study|Lost to Follow-up|1|||
146887626|NCT01543087|529754025|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
146887627|NCT01543087|529754026|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
146887628|NCT01543087|529754027|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
146887629|NCT01543087|529754028|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
146552733|NCT04595370|528531022|FG002|Overall Study|Withdrawal by Subject|1|||
146552734|NCT04595370|528531023|FG003|Overall Study|Withdrawal by Subject|0|||
146552735|NCT04595370|528531024|FG004|Overall Study|Withdrawal by Subject|2|||
146552736|NCT04595370|528531025|FG005|Overall Study|Withdrawal by Subject|0|||
146552737|NCT04595370|528531020|FG000|Overall Study|Lost to Follow-up|0|||
146552738|NCT04595370|528531021|FG001|Overall Study|Lost to Follow-up|0|||
146552739|NCT04595370|528531022|FG002|Overall Study|Lost to Follow-up|0|||
146552740|NCT04595370|528531023|FG003|Overall Study|Lost to Follow-up|0|||
146552741|NCT04595370|528531024|FG004|Overall Study|Lost to Follow-up|1|||
146552742|NCT04595370|528531025|FG005|Overall Study|Lost to Follow-up|0|||
146552743|NCT04595370|528531020|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
146552744|NCT04595370|528531021|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
146552745|NCT04595370|528531022|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
146552746|NCT04595370|528531023|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
146552747|NCT04595370|528531024|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
146552748|NCT04595370|528531025|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
146552749|NCT02218268|528531026|FG000|24 Hour Washout|Physician Decision|11|||
146552750|NCT02218268|528531027|FG001|24 Hour Washout|Physician Decision|9|||
146552751|NCT03651336|528531028|FG000|Overall Study|Withdrawal by Subject|4|||
146552752|NCT01341990|528531029|FG000|Overall Study|Adverse Event|0|||
146552753|NCT01341990|528531030|FG001|Overall Study|Adverse Event|1|||
146552754|NCT01341990|528531029|FG000|Overall Study|Torn Study Lens|1|||
146552755|NCT01341990|528531030|FG001|Overall Study|Torn Study Lens|0|||
146552756|NCT01341990|528531029|FG000|Overall Study|Withdrawal by Subject|2|||
146552757|NCT01341990|528531030|FG001|Overall Study|Withdrawal by Subject|0|||
146552758|NCT01658735|528532576|FG000|Overall Study|Lack of Efficacy|1|||
146552759|NCT01658735|528532577|FG001|Overall Study|Lack of Efficacy|0|||
146552760|NCT01658735|528532578|FG002|Overall Study|Lack of Efficacy|1|||
146552761|NCT01658735|528532576|FG000|Overall Study|Lost to Follow-up|1|||
146552762|NCT01658735|528532577|FG001|Overall Study|Lost to Follow-up|1|||
146552763|NCT01658735|528532578|FG002|Overall Study|Lost to Follow-up|0|||
146552764|NCT01658735|528532576|FG000|Overall Study|Protocol Violation|0|||
146552765|NCT01658735|528532577|FG001|Overall Study|Protocol Violation|1|||
146552766|NCT01658735|528532578|FG002|Overall Study|Protocol Violation|0|||
146552767|NCT01658735|528532576|FG000|Overall Study|Withdrawal by Subject|3|||
146552768|NCT01658735|528532577|FG001|Overall Study|Withdrawal by Subject|5|||
146552769|NCT01658735|528532578|FG002|Overall Study|Withdrawal by Subject|3|||
146552770|NCT01379937|528532579|FG000|Overall Study|Protocol Violation|0|||
146552771|NCT01379937|528532580|FG001|Overall Study|Protocol Violation|0|||
146552772|NCT01379937|528532581|FG002|Overall Study|Protocol Violation|0|||
146552773|NCT01379937|528532582|FG003|Overall Study|Protocol Violation|1|||
146552774|NCT01379937|528532579|FG000|Overall Study|Consent withdrawal|0|||
146552775|NCT01379937|528532580|FG001|Overall Study|Consent withdrawal|1|||
146552776|NCT01379937|528532581|FG002|Overall Study|Consent withdrawal|0|||
146552777|NCT01379937|528532582|FG003|Overall Study|Consent withdrawal|0|||
146552778|NCT01379937|528532579|FG000|Overall Study|Lost to Follow-up|1|||
146552779|NCT01379937|528532580|FG001|Overall Study|Lost to Follow-up|2|||
146552780|NCT01379937|528532581|FG002|Overall Study|Lost to Follow-up|2|||
146552781|NCT01379937|528532582|FG003|Overall Study|Lost to Follow-up|0|||
146552782|NCT04985682|528532583|FG000|Overall Study|Withdrawal by Subject|1|||
146552783|NCT03016403|528532588|FG000|Baseline|Death|5|||
146887630|NCT01325428|529754029|FG000|Part A|Progressive disease according to RECIST|9|||
146887631|NCT01325428|529754029|FG000|Part A|Clinical signs, symptoms of progression|2|||
146552784|NCT03016403|528532589|FG001|Baseline|Death|8|||
146552785|NCT03016403|528532590|FG002|Baseline|Death|1|||
146552786|NCT03016403|528532591|FG003|Baseline|Death|0|||
146552787|NCT03016403|528532588|FG000|Baseline|Withdrawal by Subject|2|||
146552788|NCT03016403|528532589|FG001|Baseline|Withdrawal by Subject|8|||
146887632|NCT01325428|529754029|FG000|Part A|Other adverse event|1|||
146887633|NCT01325428|529754029|FG000|Part A|Refused continue taking trial medication|2|||
146887634|NCT01325428|529754029|FG000|Part A|Other reason not defined above|2|||
146887635|NCT01325428|529754029|FG000|Part B|Refused continue taking trial medication|2|||
146887636|NCT01325428|529754029|FG000|Part B|Other reason not defined above|1|||
146887637|NCT02004873|529754031|FG000|Overall Study|Implant unsuccessful|6|||
146887638|NCT02004873|529754031|FG000|Overall Study|Awaiting 6-month visit|390|||
146887639|NCT02004873|529754031|FG000|Overall Study|Missed 6-month visit|4|||
146887640|NCT02004873|529754031|FG000|Overall Study|Death|23|||
146887641|NCT02004873|529754031|FG000|Overall Study|Withdrawal by Subject|1|||
146887642|NCT01353703|529754032|FG000|Overall Study|Migrated/moved from study area|1|||
146887643|NCT01353703|529754033|FG001|Overall Study|Migrated/moved from study area|0|||
146887644|NCT02665286|529754052|FG000|Overall Study|Lost to Follow-up|3|||
146887645|NCT02665286|529754053|FG001|Overall Study|Lost to Follow-up|2|||
146887646|NCT02665286|529754054|FG002|Overall Study|Lost to Follow-up|1|||
146887647|NCT04622046|529754055|FG000|Intervention Period|Adverse Event|1|||
146632764|NCT00815659|528831809|FG000|Overall Study|Lost to Follow-up|4|||
146632765|NCT00815659|528831809|FG000|Overall Study|Protocol Violation|1|||
146632766|NCT02395471|528831810|FG000|Overall Study|Lost to Follow-up|2|||
146887648|NCT04622046|529754055|FG000|Intervention Period|Withdrawal by Subject|2|||
146887649|NCT04622046|529754055|FG000|Extension Period|Ongoing in the Extension Period|21|||
146887650|NCT03505021|529754056|FG000|Overall Study|Protocol Violation|1|||
146887651|NCT03505021|529754057|FG001|Overall Study|Protocol Violation|0|||
146887652|NCT03505021|529754056|FG000|Overall Study|Death|9|||
146887653|NCT03505021|529754057|FG001|Overall Study|Death|8|||
146887654|NCT03505021|529754056|FG000|Overall Study|Consent withdrawn by subject|6|||
146887655|NCT03505021|529754057|FG001|Overall Study|Consent withdrawn by subject|1|||
146887656|NCT03505021|529754056|FG000|Overall Study|Lost to Follow-up|5|||
146887657|NCT03505021|529754057|FG001|Overall Study|Lost to Follow-up|3|||
146887658|NCT03505021|529754056|FG000|Overall Study|Adverse Event|26|||
146887659|NCT03505021|529754057|FG001|Overall Study|Adverse Event|9|||
146887660|NCT03505021|529754056|FG000|Overall Study|Disease progression|33|||
146887661|NCT03505021|529754057|FG001|Overall Study|Disease progression|17|||
146887662|NCT03505021|529754056|FG000|Overall Study|Other|11|||
146887663|NCT03505021|529754057|FG001|Overall Study|Other|5|||
146887664|NCT03505021|529754056|FG000|Overall Study|Personal reason|21|||
146887665|NCT03505021|529754057|FG001|Overall Study|Personal reason|12|||
146887666|NCT00403260|529755734|FG000|Overall Study|Adverse Event|5|||
146887667|NCT00403260|529755735|FG001|Overall Study|Adverse Event|4|||
146887668|NCT00403260|529755734|FG000|Overall Study|Withdrawal by Subject|5|||
146887669|NCT00403260|529755735|FG001|Overall Study|Withdrawal by Subject|6|||
146632767|NCT02395471|528831811|FG001|Overall Study|Lost to Follow-up|0|||
146632768|NCT02395471|528831810|FG000|Overall Study|Withdrawal by Subject|2|||
146632769|NCT02395471|528831811|FG001|Overall Study|Withdrawal by Subject|1|||
146887670|NCT00403260|529755734|FG000|Overall Study|Lost to Follow-up|49|||
146887671|NCT00403260|529755735|FG001|Overall Study|Lost to Follow-up|25|||
146632770|NCT02395471|528831810|FG000|Overall Study|Physician Decision|1|||
146632771|NCT02395471|528831811|FG001|Overall Study|Physician Decision|0|||
146632772|NCT02395471|528831810|FG000|Overall Study|Protocol Violation|0|||
146887672|NCT00403260|529755734|FG000|Overall Study|Re-appearance of P. falciparum|34|||
146887673|NCT00403260|529755735|FG001|Overall Study|Re-appearance of P. falciparum|25|||
146887674|NCT00403260|529755734|FG000|Overall Study|P. vivax infection|26|||
146887675|NCT00403260|529755735|FG001|Overall Study|P. vivax infection|4|||
146887676|NCT00403260|529755734|FG000|Overall Study|Mixed infection with P. vivax|2|||
146887677|NCT00403260|529755735|FG001|Overall Study|Mixed infection with P. vivax|0|||
146887678|NCT00403260|529755734|FG000|Overall Study|Mixed infection with P. falciparum|1|||
146887679|NCT00403260|529755735|FG001|Overall Study|Mixed infection with P. falciparum|0|||
146887680|NCT00403260|529755734|FG000|Overall Study|P. vivax infection at screening|1|||
146887681|NCT00403260|529755735|FG001|Overall Study|P. vivax infection at screening|0|||
146887682|NCT00403260|529755734|FG000|Overall Study|P. ovale infection|1|||
146887683|NCT00403260|529755735|FG001|Overall Study|P. ovale infection|0|||
146887684|NCT00403260|529755734|FG000|Overall Study|Gametocyte re-appearance|1|||
146887685|NCT00403260|529755735|FG001|Overall Study|Gametocyte re-appearance|1|||
146887686|NCT00403260|529755734|FG000|Overall Study|Withdrawn from study accidentally|0|||
146887687|NCT00403260|529755735|FG001|Overall Study|Withdrawn from study accidentally|1|||
146887688|NCT04137887|529755737|FG000|Overall Study|Death|102|||
146887689|NCT04137887|529755738|FG001|Overall Study|Death|92|||
146887690|NCT04137887|529755737|FG000|Overall Study|Withdrawal by Subject|2|||
146887691|NCT04137887|529755738|FG001|Overall Study|Withdrawal by Subject|3|||
146887692|NCT04137887|529755737|FG000|Overall Study|Randomized but not treated|0|||
146552789|NCT03016403|528532590|FG002|Baseline|Withdrawal by Subject|4|||
146552790|NCT03016403|528532591|FG003|Baseline|Withdrawal by Subject|10|||
146887693|NCT04137887|529755738|FG001|Overall Study|Randomized but not treated|1|||
146887694|NCT03718143|529755740|FG000|Overall Study|Death|1|||
146887695|NCT03718143|529755741|FG001|Overall Study|Death|0|||
146887696|NCT03718143|529755742|FG002|Overall Study|Death|0|||
146887697|NCT03718143|529755740|FG000|Overall Study|Progression of Disease|1|||
146887698|NCT03718143|529755741|FG001|Overall Study|Progression of Disease|0|||
146887699|NCT03718143|529755742|FG002|Overall Study|Progression of Disease|0|||
146887700|NCT03718143|529755740|FG000|Overall Study|Withdrawal of Informed Consent|1|||
146887701|NCT03718143|529755741|FG001|Overall Study|Withdrawal of Informed Consent|2|||
146887702|NCT03718143|529755742|FG002|Overall Study|Withdrawal of Informed Consent|1|||
146887703|NCT05064059|529755743|FG000|Overall Study|Death|199|||
146887704|NCT05064059|529755744|FG001|Overall Study|Death|196|||
146887705|NCT05064059|529755743|FG000|Overall Study|Physician Decision|4|||
146887706|NCT05064059|529755744|FG001|Overall Study|Physician Decision|2|||
146887707|NCT05064059|529755743|FG000|Overall Study|Sponsor Decision|14|||
146887708|NCT05064059|529755744|FG001|Overall Study|Sponsor Decision|11|||
146887709|NCT05064059|529755743|FG000|Overall Study|Withdrawal by Subject|4|||
146887710|NCT05064059|529755744|FG001|Overall Study|Withdrawal by Subject|11|||
146887711|NCT02615990|529755745|FG000|Overall Study|study terminated|1|||
146887712|NCT02615990|529755746|FG001|Overall Study|study terminated|1|||
146887713|NCT04316585|529755747|FG000|Overall Study|Adverse Event|2|||
146887714|NCT04316585|529755748|FG001|Overall Study|Adverse Event|1|||
146887715|NCT04316585|529755747|FG000|Overall Study|Lost to Follow-up|1|||
146887716|NCT04316585|529755748|FG001|Overall Study|Lost to Follow-up|0|||
146887717|NCT04316585|529755747|FG000|Overall Study|Withdrawal by Subject|2|||
146552791|NCT03016403|528532588|FG000|Baseline|Lost to Follow-up|9|||
146552792|NCT03016403|528532589|FG001|Baseline|Lost to Follow-up|11|||
146552793|NCT03016403|528532590|FG002|Baseline|Lost to Follow-up|6|||
146552794|NCT03016403|528532591|FG003|Baseline|Lost to Follow-up|24|||
146552795|NCT03016403|528532588|FG000|6-week Follow-up|Death|1|||
146552796|NCT03016403|528532589|FG001|6-week Follow-up|Death|4|||
146552797|NCT03016403|528532590|FG002|6-week Follow-up|Death|0|||
146552798|NCT03016403|528532591|FG003|6-week Follow-up|Death|0|||
146552799|NCT03016403|528532588|FG000|6-week Follow-up|Lost to Follow-up|2|||
146552800|NCT03016403|528532589|FG001|6-week Follow-up|Lost to Follow-up|7|||
146552801|NCT03016403|528532590|FG002|6-week Follow-up|Lost to Follow-up|4|||
146552802|NCT03016403|528532591|FG003|6-week Follow-up|Lost to Follow-up|8|||
146552803|NCT03016403|528532588|FG000|6-week Follow-up|Withdrawal by Subject|0|||
146552804|NCT03016403|528532589|FG001|6-week Follow-up|Withdrawal by Subject|2|||
146552805|NCT03016403|528532590|FG002|6-week Follow-up|Withdrawal by Subject|0|||
146552806|NCT03016403|528532591|FG003|6-week Follow-up|Withdrawal by Subject|1|||
146552807|NCT03016403|528532588|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
146632773|NCT02395471|528831811|FG001|Overall Study|Protocol Violation|1|||
146765298|NCT00628862|529308590|FG000|Overall Study|Protocol Violation|1|||
146552808|NCT03016403|528532589|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
146552809|NCT03016403|528532590|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
146552810|NCT03016403|528532591|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
146887718|NCT04316585|529755748|FG001|Overall Study|Withdrawal by Subject|3|||
146887719|NCT04316585|529755747|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
146887720|NCT04316585|529755748|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
146887721|NCT04316585|529755747|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
146887722|NCT04316585|529755748|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
146887723|NCT01461044|529755759|FG000|Overall Study|Death|58|||
146887724|NCT01461044|529755760|FG001|Overall Study|Death|35|||
146887725|NCT01461044|529755759|FG000|Overall Study|Lost to Follow-up|12|||
146887726|NCT01461044|529755760|FG001|Overall Study|Lost to Follow-up|5|||
146887727|NCT00716976|529755761|FG000|Overall Study|Adverse Event|2|||
146887728|NCT00716976|529755762|FG001|Overall Study|Adverse Event|0|||
146887729|NCT00716976|529755761|FG000|Overall Study|Death|1|||
146887730|NCT00716976|529755762|FG001|Overall Study|Death|0|||
146887731|NCT00716976|529755761|FG000|Overall Study|Physician Decision|2|||
146887732|NCT00716976|529755762|FG001|Overall Study|Physician Decision|2|||
146552811|NCT03016403|528532588|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
146552812|NCT03016403|528532589|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
146552813|NCT03016403|528532590|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
146552814|NCT03016403|528532591|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
146887733|NCT00716976|529755761|FG000|Overall Study|Withdrawal by Subject|5|||
146887734|NCT00716976|529755762|FG001|Overall Study|Withdrawal by Subject|1|||
146887735|NCT00716976|529755761|FG000|Overall Study|Premature discontinuation cisplatin|5|||
146887736|NCT00716976|529755762|FG001|Overall Study|Premature discontinuation cisplatin|4|||
146887737|NCT00716976|529755761|FG000|Overall Study|Radiation during protocol|1|||
146887738|NCT00716976|529755762|FG001|Overall Study|Radiation during protocol|0|||
146887739|NCT00716976|529755761|FG000|Overall Study|Ineligibles|4|||
146887740|NCT00716976|529755762|FG001|Overall Study|Ineligibles|2|||
146887741|NCT00805740|529755763|FG000|Overall Study|Death|7|||
146887742|NCT00805740|529755764|FG001|Overall Study|Death|4|||
146887743|NCT00805740|529755763|FG000|Overall Study|Withdrawal by Subject|1|||
146887744|NCT00805740|529755764|FG001|Overall Study|Withdrawal by Subject|0|||
146887745|NCT00805740|529755763|FG000|Overall Study|Lost to Follow-up|1|||
146887746|NCT00805740|529755764|FG001|Overall Study|Lost to Follow-up|0|||
146887747|NCT00805740|529755763|FG000|Overall Study|Randomized, but not treated|2|||
146887748|NCT00805740|529755764|FG001|Overall Study|Randomized, but not treated|0|||
146887749|NCT05227690|529755765|FG000|Overall Study|Adverse Event|5|||
146887750|NCT05227690|529755766|FG001|Overall Study|Adverse Event|6|||
146887751|NCT05227690|529755767|FG002|Overall Study|Adverse Event|10|||
146887752|NCT05227690|529755765|FG000|Overall Study|Lack of Efficacy|2|||
146887753|NCT05227690|529755766|FG001|Overall Study|Lack of Efficacy|4|||
146887754|NCT05227690|529755767|FG002|Overall Study|Lack of Efficacy|1|||
146887755|NCT05227690|529755765|FG000|Overall Study|Physician Decision|6|||
146887756|NCT05227690|529755766|FG001|Overall Study|Physician Decision|0|||
146887757|NCT05227690|529755767|FG002|Overall Study|Physician Decision|4|||
146887758|NCT05227690|529755765|FG000|Overall Study|Withdrawal of consent|28|||
146887759|NCT05227690|529755766|FG001|Overall Study|Withdrawal of consent|27|||
146887760|NCT05227690|529755767|FG002|Overall Study|Withdrawal of consent|21|||
146887761|NCT05227690|529755765|FG000|Overall Study|Other, not specified|2|||
146887762|NCT05227690|529755766|FG001|Overall Study|Other, not specified|2|||
146887763|NCT05227690|529755767|FG002|Overall Study|Other, not specified|1|||
146887764|NCT01414257|529755773|FG000|Overall Study|No Visit After First Day of Treatment|12|||
146887765|NCT01414257|529755773|FG000|Overall Study|Protocol Violation|10|||
146552815|NCT03016403|528532588|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
146552816|NCT03016403|528532589|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
146552817|NCT03016403|528532590|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
146552818|NCT03016403|528532591|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
146552819|NCT05463705|528532592|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
146552820|NCT05463705|528532593|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
146552821|NCT05463705|528532594|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
146552822|NCT05463705|528532595|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
146552823|NCT05463705|528532596|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
146552824|NCT05463705|528532597|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
146552825|NCT00621322|528532598|FG000|Overall Study|Lost to Follow-up|0|||
146552826|NCT00621322|528532599|FG001|Overall Study|Lost to Follow-up|0|||
146552827|NCT00621322|528532600|FG002|Overall Study|Lost to Follow-up|0|||
146552828|NCT00621322|528532601|FG003|Overall Study|Lost to Follow-up|0|||
146552829|NCT00621322|528532602|FG004|Overall Study|Lost to Follow-up|1|||
146552830|NCT00621322|528532603|FG005|Overall Study|Lost to Follow-up|0|||
146887766|NCT01534676|529755774|FG000|Overall Study|Study closed due to poor enrollment|2|||
146887767|NCT01534676|529755775|FG001|Overall Study|Study closed due to poor enrollment|1|||
146887768|NCT02634580|529755776|FG000|Double-blind Treatment Period|Subject Request|1|||
146887769|NCT02634580|529755777|FG001|Double-blind Treatment Period|Subject Request|0|||
146887770|NCT02634580|529755778|FG002|Double-blind Treatment Period|Subject Request|1|||
146887771|NCT02634580|529755779|FG003|Double-blind Treatment Period|Subject Request|1|||
146887772|NCT02634580|529755776|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
146887773|NCT02634580|529755777|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
146887774|NCT02634580|529755778|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
146887775|NCT02634580|529755779|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
146887776|NCT00424827|529755785|FG000|Overall Study|Adverse Event|1|||
146887777|NCT00491179|529755788|FG000|Overall Study|Adverse Event|5|||
146887778|NCT00491179|529755789|FG001|Overall Study|Adverse Event|1|||
146887779|NCT00491179|529755788|FG000|Overall Study|Withdrawal by Subject|2|||
146887780|NCT00491179|529755789|FG001|Overall Study|Withdrawal by Subject|1|||
146887781|NCT01790048|529755791|FG000|Overall Study|Incorrect Age|9|||
146887782|NCT01790048|529755792|FG001|Overall Study|Incorrect Age|14|||
146887783|NCT01790048|529755791|FG000|Overall Study|data entry error|0|||
146887784|NCT01790048|529755792|FG001|Overall Study|data entry error|1|||
146887785|NCT01790048|529755791|FG000|Overall Study|Other|0|||
146887786|NCT01790048|529755792|FG001|Overall Study|Other|2|||
146887787|NCT01790048|529755791|FG000|Overall Study|SAM at Enrollment|2|||
146887788|NCT01790048|529755792|FG001|Overall Study|SAM at Enrollment|0|||
146887789|NCT01790048|529755791|FG000|Overall Study|Measurement error|1|||
146887790|NCT01790048|529755792|FG001|Overall Study|Measurement error|0|||
146887791|NCT00159432|529755793|FG000|Overall Study|Adverse Event|1|||
146887792|NCT00159432|529755793|FG000|Overall Study|Death|1|||
146887793|NCT00159432|529755793|FG000|Overall Study|Lack of Efficacy|8|||
146887794|NCT05689047|529755796|FG000|Overall Study|Lost to Follow-up|0|||
146887795|NCT05689047|529755797|FG001|Overall Study|Lost to Follow-up|1|||
146887796|NCT05689047|529755796|FG000|Overall Study|Protocol Deviation|1|||
146887797|NCT05689047|529755797|FG001|Overall Study|Protocol Deviation|0|||
146887798|NCT03083886|529755798|FG000|Overall Study|Withdrawal by Subject|51|||
146887799|NCT03083886|529755799|FG001|Overall Study|Withdrawal by Subject|73|||
146887800|NCT03083886|529755800|FG002|Overall Study|Withdrawal by Subject|104|||
146887801|NCT03083886|529755798|FG000|Overall Study|Missing Baseline data|43|||
146552831|NCT00621322|528532598|FG000|Overall Study|Physician Decision|0|||
146552832|NCT00621322|528532599|FG001|Overall Study|Physician Decision|0|||
146552833|NCT00621322|528532600|FG002|Overall Study|Physician Decision|1|||
146552834|NCT00621322|528532601|FG003|Overall Study|Physician Decision|1|||
146552835|NCT00621322|528532602|FG004|Overall Study|Physician Decision|0|||
146552836|NCT00621322|528532603|FG005|Overall Study|Physician Decision|0|||
146552837|NCT00621322|528532598|FG000|Overall Study|Withdrawal by Subject|0|||
146552838|NCT00621322|528532599|FG001|Overall Study|Withdrawal by Subject|0|||
146552839|NCT00621322|528532600|FG002|Overall Study|Withdrawal by Subject|0|||
146552840|NCT00621322|528532601|FG003|Overall Study|Withdrawal by Subject|1|||
146552841|NCT00621322|528532602|FG004|Overall Study|Withdrawal by Subject|0|||
146552842|NCT00621322|528532603|FG005|Overall Study|Withdrawal by Subject|2|||
146552843|NCT00621322|528532598|FG000|Overall Study|Migrated/moved from study area|1|||
146552844|NCT00621322|528532599|FG001|Overall Study|Migrated/moved from study area|0|||
146552845|NCT00621322|528532600|FG002|Overall Study|Migrated/moved from study area|1|||
146552846|NCT00621322|528532601|FG003|Overall Study|Migrated/moved from study area|1|||
146552847|NCT00621322|528532602|FG004|Overall Study|Migrated/moved from study area|0|||
146552848|NCT00621322|528532603|FG005|Overall Study|Migrated/moved from study area|2|||
146552849|NCT00225758|528532604|FG000|Overall Study|Adverse Event|4|||
146552850|NCT00576407|528532605|FG000|Overall Study|Death|7|||
146552851|NCT00576407|528532605|FG000|Overall Study|Physician Decision|1|||
146552852|NCT00079781|528532606|FG000|Pre-implant Period|Withdrawal by Subject|2|||
146552853|NCT00079781|528532607|FG001|Pre-implant Period|Withdrawal by Subject|0|||
146552854|NCT00079781|528532608|FG002|Pre-implant Period|Withdrawal by Subject|0|||
146765299|NCT00628862|529308591|FG001|Overall Study|Protocol Violation|0|||
146887802|NCT03083886|529755799|FG001|Overall Study|Missing Baseline data|42|||
146887803|NCT03083886|529755800|FG002|Overall Study|Missing Baseline data|31|||
146887804|NCT03083886|529755798|FG000|Overall Study|Investigator terminated|1|||
146887805|NCT03083886|529755799|FG001|Overall Study|Investigator terminated|6|||
146887806|NCT03083886|529755800|FG002|Overall Study|Investigator terminated|3|||
146887807|NCT03178487|529755801|FG000|Period 1|Adverse Event|1|||
146887808|NCT03178487|529755802|FG001|Period 1|Adverse Event|2|||
146887809|NCT03178487|529755801|FG000|Period 1|Withdrawal by Subject|2|||
146887810|NCT03178487|529755802|FG001|Period 1|Withdrawal by Subject|1|||
146966627|NCT04242498|530038866|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
146552855|NCT00079781|528532606|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
146552856|NCT00079781|528532607|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
146552857|NCT00079781|528532608|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
146552858|NCT00079781|528532606|FG000|Follow-up Period|Withdrawal by Subject|3|||
146552859|NCT00079781|528532607|FG001|Follow-up Period|Withdrawal by Subject|0|||
146552860|NCT00079781|528532608|FG002|Follow-up Period|Withdrawal by Subject|1|||
146552861|NCT00079781|528532606|FG000|Follow-up Period|Lost to Follow-up|1|||
146552862|NCT00079781|528532607|FG001|Follow-up Period|Lost to Follow-up|0|||
146887811|NCT03178487|529755801|FG000|Period 1|Lost to Follow-up|1|||
146552863|NCT00079781|528532608|FG002|Follow-up Period|Lost to Follow-up|0|||
146552864|NCT00079781|528532606|FG000|Follow-up Period|Death|0|||
146887812|NCT03178487|529755802|FG001|Period 1|Lost to Follow-up|0|||
146887813|NCT03178487|529755801|FG000|Period 1|Other|0|||
146887814|NCT03178487|529755802|FG001|Period 1|Other|1|||
146887815|NCT03178487|529755801|FG000|Period 2|Adverse Event|4|||
146887816|NCT03178487|529755802|FG001|Period 2|Adverse Event|4|||
146887817|NCT03178487|529755801|FG000|Period 2|Withdrawal by Subject|6|||
146887818|NCT03178487|529755802|FG001|Period 2|Withdrawal by Subject|6|||
146887819|NCT03178487|529755801|FG000|Period 2|Lost to Follow-up|2|||
146887820|NCT03178487|529755802|FG001|Period 2|Lost to Follow-up|2|||
146887821|NCT03178487|529755801|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
146887822|NCT03178487|529755802|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
146887823|NCT03178487|529755801|FG000|Period 2|Other|8|||
146887824|NCT03178487|529755802|FG001|Period 2|Other|7|||
146887825|NCT00253630|529755803|FG000|Overall Study|ineligible|2|||
146887826|NCT00209339|529755804|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
146887827|NCT00209339|529755804|FG000|At 12 Months Follow-up|Death|1|||
146887828|NCT00209339|529755804|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
146887829|NCT00209339|529755804|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
146887830|NCT00209339|529755804|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
146887831|NCT00209339|529755804|FG000|At 24 Months Follow-up|Death|1|||
146887832|NCT00209339|529755804|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
146887833|NCT00209339|529755804|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
146632774|NCT02395471|528831810|FG000|Overall Study|Failure to swollow sponge twice|1|||
146632775|NCT02395471|528831811|FG001|Overall Study|Failure to swollow sponge twice|0|||
146632776|NCT02395471|528831810|FG000|Overall Study|Patient did not return for procedure|0|||
146632777|NCT02395471|528831811|FG001|Overall Study|Patient did not return for procedure|1|||
146632778|NCT02395471|528831810|FG000|Overall Study|Subject not eligible|1|||
146632779|NCT02395471|528831811|FG001|Overall Study|Subject not eligible|0|||
146632780|NCT03847896|528831812|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
146632781|NCT03847896|528831813|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
146632782|NCT03847896|528831814|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
146632783|NCT03847896|528831815|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
146632784|NCT03847896|528831816|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
146632785|NCT03847896|528831812|FG000|Overall Study|Withdrawal by Subject|2|||
146632786|NCT03847896|528831813|FG001|Overall Study|Withdrawal by Subject|10|||
146632787|NCT03847896|528831814|FG002|Overall Study|Withdrawal by Subject|5|||
146632788|NCT03847896|528831815|FG003|Overall Study|Withdrawal by Subject|9|||
146632789|NCT03847896|528831816|FG004|Overall Study|Withdrawal by Subject|8|||
146632790|NCT03847896|528831812|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146632791|NCT03847896|528831813|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146632792|NCT03847896|528831814|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146632793|NCT03847896|528831815|FG003|Overall Study|Withdrawal by parent/guardian|0|||
146552865|NCT00079781|528532607|FG001|Follow-up Period|Death|0|||
146552866|NCT00079781|528532608|FG002|Follow-up Period|Death|1|||
146552867|NCT04641975|528532609|FG000|Overall Study|Protocol Violation|1|||
146552868|NCT04641975|528532610|FG001|Overall Study|Protocol Violation|2|||
146552869|NCT04641975|528532611|FG002|Overall Study|Protocol Violation|0|||
146552870|NCT04641975|528532612|FG003|Overall Study|Protocol Violation|0|||
146552871|NCT04641975|528532609|FG000|Overall Study|Adverse Event|0|||
146552872|NCT04641975|528532610|FG001|Overall Study|Adverse Event|0|||
146552873|NCT04641975|528532611|FG002|Overall Study|Adverse Event|1|||
146552874|NCT04641975|528532612|FG003|Overall Study|Adverse Event|1|||
146552875|NCT04641975|528532609|FG000|Overall Study|Withdrawal by Subject|1|||
146552876|NCT04641975|528532610|FG001|Overall Study|Withdrawal by Subject|0|||
146552877|NCT04641975|528532611|FG002|Overall Study|Withdrawal by Subject|0|||
146552878|NCT04641975|528532612|FG003|Overall Study|Withdrawal by Subject|0|||
146552879|NCT01259024|528532616|FG000|Overall Study|Physician Decision|1|||
146552880|NCT01657500|528532617|FG000|Overall Study|set impropperly matched|3|||
146552881|NCT01657500|528532618|FG001|Overall Study|set impropperly matched|3|||
146552882|NCT01657500|528532617|FG000|Overall Study|Lost to Follow-up|2|||
146552883|NCT01657500|528532618|FG001|Overall Study|Lost to Follow-up|2|||
146552884|NCT00756444|528532621|FG000|Overall Study|Adverse Event|1|||
146552885|NCT00756444|528532622|FG001|Overall Study|Adverse Event|1|||
146552886|NCT00756444|528532621|FG000|Overall Study|Withdrawal by Subject|6|||
146552887|NCT00756444|528532622|FG001|Overall Study|Withdrawal by Subject|8|||
146552888|NCT00756444|528532621|FG000|Overall Study|Lost to Follow-up|0|||
146552889|NCT00756444|528532622|FG001|Overall Study|Lost to Follow-up|1|||
146552890|NCT00756444|528532621|FG000|Overall Study|Death|5|||
146552891|NCT00756444|528532622|FG001|Overall Study|Death|4|||
146552892|NCT00756444|528532621|FG000|Overall Study|Disease Progression|2|||
146552893|NCT00756444|528532622|FG001|Overall Study|Disease Progression|7|||
146552894|NCT00756444|528532621|FG000|Overall Study|Ineligibility Determined|1|||
146552895|NCT00756444|528532622|FG001|Overall Study|Ineligibility Determined|0|||
146552896|NCT00564070|528532623|FG000|Overall Study|Lost to Follow-up|9|||
146552897|NCT00564070|528532624|FG001|Overall Study|Lost to Follow-up|7|||
146552898|NCT00564070|528532623|FG000|Overall Study|Worsening depression, referred to care|3|||
146552899|NCT00564070|528532624|FG001|Overall Study|Worsening depression, referred to care|0|||
146552900|NCT02264821|528532626|FG000|Overall Study|Protocol Violation|1|||
146552901|NCT02264821|528532627|FG001|Overall Study|Protocol Violation|3|||
146552902|NCT02264821|528532628|FG002|Overall Study|Protocol Violation|6|||
146552903|NCT00552279|528532629|FG000|Overall Study|Adverse Event|0|||
146552904|NCT00552279|528532630|FG001|Overall Study|Adverse Event|1|||
146552905|NCT00552279|528532629|FG000|Overall Study|Withdrawal by Subject|12|||
146552906|NCT00552279|528532630|FG001|Overall Study|Withdrawal by Subject|1|||
146552907|NCT00552279|528532629|FG000|Overall Study|Lost to Follow-up|1|||
146552908|NCT00552279|528532630|FG001|Overall Study|Lost to Follow-up|0|||
146552909|NCT00552279|528532629|FG000|Overall Study|Other|1|||
146552910|NCT00552279|528532630|FG001|Overall Study|Other|1|||
146552911|NCT03142334|528532632|FG000|Overall Study|Death|18|||
146552912|NCT03142334|528532633|FG001|Overall Study|Death|33|||
146552913|NCT03142334|528532632|FG000|Overall Study|Withdrawal by Subject|15|||
146552914|NCT03142334|528532633|FG001|Overall Study|Withdrawal by Subject|11|||
146552915|NCT03142334|528532632|FG000|Overall Study|Ongoing on trial follow up|463|||
146552916|NCT03142334|528532633|FG001|Overall Study|Ongoing on trial follow up|454|||
146552917|NCT01655069|528532634|FG000|Overall Study|Physician Decision|0|||
146552918|NCT01655069|528532635|FG001|Overall Study|Physician Decision|0|||
146552919|NCT01655069|528532636|FG002|Overall Study|Physician Decision|0|||
146552920|NCT01655069|528532637|FG003|Overall Study|Physician Decision|1|||
146552921|NCT01655069|528532634|FG000|Overall Study|Adverse Event|6|||
146552922|NCT01655069|528532635|FG001|Overall Study|Adverse Event|7|||
146552923|NCT01655069|528532636|FG002|Overall Study|Adverse Event|2|||
146552924|NCT01655069|528532637|FG003|Overall Study|Adverse Event|3|||
146552925|NCT01655069|528532634|FG000|Overall Study|Lack of Efficacy|0|||
146552926|NCT01655069|528532635|FG001|Overall Study|Lack of Efficacy|1|||
146552927|NCT01655069|528532636|FG002|Overall Study|Lack of Efficacy|0|||
146552928|NCT01655069|528532637|FG003|Overall Study|Lack of Efficacy|0|||
146552929|NCT01655069|528532634|FG000|Overall Study|No Treatment Needed|0|||
146552930|NCT01655069|528532635|FG001|Overall Study|No Treatment Needed|1|||
146552931|NCT01655069|528532636|FG002|Overall Study|No Treatment Needed|0|||
146552932|NCT01655069|528532637|FG003|Overall Study|No Treatment Needed|0|||
146552933|NCT01655069|528532634|FG000|Overall Study|Withdrawal by Subject|2|||
146552934|NCT01655069|528532635|FG001|Overall Study|Withdrawal by Subject|3|||
146552935|NCT01655069|528532636|FG002|Overall Study|Withdrawal by Subject|0|||
146552936|NCT01655069|528532637|FG003|Overall Study|Withdrawal by Subject|0|||
146552937|NCT02346370|528532638|FG000|Overall Study|Not treated|1|||
146552938|NCT02346370|528532639|FG001|Overall Study|Not treated|0|||
146552939|NCT02346370|528532640|FG002|Overall Study|Not treated|0|||
146552940|NCT02346370|528532638|FG000|Overall Study|Withdrawal of consent|1|||
146552941|NCT02346370|528532639|FG001|Overall Study|Withdrawal of consent|0|||
146552942|NCT02346370|528532640|FG002|Overall Study|Withdrawal of consent|0|||
146552943|NCT02346370|528532638|FG000|Overall Study|Death|1|||
146552944|NCT02346370|528532639|FG001|Overall Study|Death|3|||
146552945|NCT02346370|528532640|FG002|Overall Study|Death|1|||
146552946|NCT02346370|528532638|FG000|Overall Study|Sponsor discontinued study|5|||
146552947|NCT02346370|528532639|FG001|Overall Study|Sponsor discontinued study|0|||
146552948|NCT02346370|528532640|FG002|Overall Study|Sponsor discontinued study|2|||
146552949|NCT02346370|528532638|FG000|Overall Study|Radiologic progression|0|||
146552950|NCT02346370|528532639|FG001|Overall Study|Radiologic progression|0|||
146552951|NCT02346370|528532640|FG002|Overall Study|Radiologic progression|1|||
146552952|NCT02346370|528532638|FG000|Overall Study|Physician Decision|0|||
146632794|NCT03847896|528831816|FG004|Overall Study|Withdrawal by parent/guardian|0|||
146632795|NCT03847896|528831812|FG000|Overall Study|Adverse Event|2|||
146632796|NCT03847896|528831813|FG001|Overall Study|Adverse Event|1|||
146632797|NCT03847896|528831814|FG002|Overall Study|Adverse Event|3|||
146632798|NCT03847896|528831815|FG003|Overall Study|Adverse Event|2|||
146632799|NCT03847896|528831816|FG004|Overall Study|Adverse Event|4|||
146632800|NCT03847896|528831812|FG000|Overall Study|A severe exacerbation event|0|||
146632801|NCT03847896|528831813|FG001|Overall Study|A severe exacerbation event|0|||
146632802|NCT03847896|528831814|FG002|Overall Study|A severe exacerbation event|0|||
146632803|NCT03847896|528831815|FG003|Overall Study|A severe exacerbation event|0|||
146632804|NCT03847896|528831816|FG004|Overall Study|A severe exacerbation event|3|||
146632805|NCT03847896|528831812|FG000|Overall Study|Protocol Violation|0|||
146632806|NCT03847896|528831813|FG001|Overall Study|Protocol Violation|2|||
146632807|NCT03847896|528831814|FG002|Overall Study|Protocol Violation|1|||
146632808|NCT03847896|528831815|FG003|Overall Study|Protocol Violation|0|||
146632809|NCT03847896|528831816|FG004|Overall Study|Protocol Violation|2|||
146632810|NCT03847896|528831812|FG000|Overall Study|Lost to Follow-up|0|||
146632811|NCT03847896|528831813|FG001|Overall Study|Lost to Follow-up|0|||
146632812|NCT03847896|528831814|FG002|Overall Study|Lost to Follow-up|0|||
146632813|NCT03847896|528831815|FG003|Overall Study|Lost to Follow-up|1|||
146632814|NCT03847896|528831816|FG004|Overall Study|Lost to Follow-up|0|||
146632815|NCT03847896|528831812|FG000|Overall Study|Condition under investigation worsened|0|||
146632816|NCT03847896|528831813|FG001|Overall Study|Condition under investigation worsened|0|||
146632817|NCT03847896|528831814|FG002|Overall Study|Condition under investigation worsened|0|||
146765300|NCT00628862|529308592|FG002|Overall Study|Protocol Violation|0|||
146632818|NCT03847896|528831815|FG003|Overall Study|Condition under investigation worsened|1|||
146632819|NCT03847896|528831816|FG004|Overall Study|Condition under investigation worsened|1|||
146632820|NCT03847896|528831812|FG000|Overall Study|Lack of Efficacy|0|||
146632821|NCT03847896|528831813|FG001|Overall Study|Lack of Efficacy|0|||
146632822|NCT03847896|528831814|FG002|Overall Study|Lack of Efficacy|0|||
146632823|NCT03847896|528831815|FG003|Overall Study|Lack of Efficacy|2|||
146632824|NCT03847896|528831816|FG004|Overall Study|Lack of Efficacy|2|||
146632825|NCT03847896|528831812|FG000|Overall Study|Other reasons|3|||
146765301|NCT00628862|529308590|FG000|Overall Study|COPD Exacerbation|0|||
146552953|NCT02346370|528532639|FG001|Overall Study|Physician Decision|1|||
146552954|NCT02346370|528532640|FG002|Overall Study|Physician Decision|0|||
146552955|NCT01217047|528532641|FG000|Overall Study|Lost to Follow-up|0|||
146552956|NCT01217047|528532642|FG001|Overall Study|Lost to Follow-up|1|||
146552957|NCT01217047|528532643|FG002|Overall Study|Lost to Follow-up|0|||
146552958|NCT06399471|528532644|FG000|Overall Study|Withdrawal by Subject|1|||
146552959|NCT05529173|528532645|FG000|Overall Study|Physician Decision|3|||
146552960|NCT05529173|528532646|FG001|Overall Study|Physician Decision|6|||
146552961|NCT05529173|528532645|FG000|Overall Study|Sample shipment delay more than one day|4|||
146632826|NCT03847896|528831813|FG001|Overall Study|Other reasons|3|||
146632827|NCT03847896|528831814|FG002|Overall Study|Other reasons|1|||
146632828|NCT03847896|528831815|FG003|Overall Study|Other reasons|2|||
146632829|NCT03847896|528831816|FG004|Overall Study|Other reasons|1|||
146632830|NCT00118417|528831817|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
146632831|NCT00118417|528831818|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
146632832|NCT00118417|528831817|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
146632833|NCT00118417|528831818|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
146632834|NCT00118417|528831817|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
146632835|NCT00118417|528831818|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
146632836|NCT00118417|528831817|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
146632837|NCT00118417|528831818|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
146632838|NCT00118417|528831817|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
146632839|NCT00118417|528831818|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
146632840|NCT02978781|528831819|FG000|Part A|Adverse Event|1|||
146632841|NCT02978781|528831820|FG001|Part A|Adverse Event|1|||
146632842|NCT02978781|528831821|FG002|Part A|Adverse Event|0|||
146632843|NCT02978781|528831822|FG003|Part A|Adverse Event|0|||
146632844|NCT02978781|528831823|FG004|Part A|Adverse Event|0|||
146632845|NCT02978781|528831819|FG000|Part A|Withdrawal by Subject|0|||
146632846|NCT02978781|528831820|FG001|Part A|Withdrawal by Subject|1|||
146632847|NCT02978781|528831821|FG002|Part A|Withdrawal by Subject|0|||
146632848|NCT02978781|528831822|FG003|Part A|Withdrawal by Subject|0|||
146632849|NCT02978781|528831823|FG004|Part A|Withdrawal by Subject|0|||
146632850|NCT02978781|528831819|FG000|Part B|Withdrawal by Subject|0|||
146632851|NCT02978781|528831820|FG001|Part B|Withdrawal by Subject|0|||
146632852|NCT02978781|528831821|FG002|Part B|Withdrawal by Subject|0|||
146632853|NCT02978781|528831822|FG003|Part B|Withdrawal by Subject|1|||
146632854|NCT02978781|528831823|FG004|Part B|Withdrawal by Subject|0|||
146632855|NCT02978781|528831819|FG000|Part C|Adverse Event|0|||
146632856|NCT02978781|528831820|FG001|Part C|Adverse Event|0|||
146632857|NCT02978781|528831821|FG002|Part C|Adverse Event|0|||
146632858|NCT02978781|528831822|FG003|Part C|Adverse Event|0|||
146632859|NCT02978781|528831823|FG004|Part C|Adverse Event|2|||
146632860|NCT02978781|528831819|FG000|Part C|Withdrawal by Subject|0|||
146632861|NCT02978781|528831820|FG001|Part C|Withdrawal by Subject|0|||
146632862|NCT02978781|528831821|FG002|Part C|Withdrawal by Subject|0|||
146632863|NCT02978781|528831822|FG003|Part C|Withdrawal by Subject|0|||
146632864|NCT02978781|528831823|FG004|Part C|Withdrawal by Subject|1|||
146632865|NCT02978781|528831819|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
146632866|NCT02978781|528831820|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
146632867|NCT02978781|528831821|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
146632868|NCT02978781|528831822|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
146632869|NCT02978781|528831823|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
146632870|NCT00785785|528831824|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
146632871|NCT00785785|528831825|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
146632872|NCT00785785|528831824|FG000|Core Phase up to 36 Months|Adverse Event|31|||
146632873|NCT00785785|528831825|FG001|Core Phase up to 36 Months|Adverse Event|21|||
146632874|NCT00785785|528831824|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
146632875|NCT00785785|528831825|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
146632876|NCT00785785|528831824|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
146632877|NCT00785785|528831825|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
146552962|NCT05529173|528532646|FG001|Overall Study|Sample shipment delay more than one day|0|||
146632878|NCT00785785|528831824|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
146632879|NCT00785785|528831825|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
146632880|NCT00785785|528831824|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
146552963|NCT03835117|528532647|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
146552964|NCT03835117|528532648|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
146632881|NCT00785785|528831825|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
146632882|NCT00785785|528831824|FG000|Core Phase up to 36 Months|Administrative problems|3|||
146632883|NCT00785785|528831825|FG001|Core Phase up to 36 Months|Administrative problems|3|||
146632884|NCT00785785|528831824|FG000|Core Phase up to 36 Months|Death|5|||
146632885|NCT00785785|528831825|FG001|Core Phase up to 36 Months|Death|8|||
146632886|NCT00785785|528831824|FG000|Core Phase up to 36 Months|Disease progression|139|||
146632887|NCT00785785|528831825|FG001|Core Phase up to 36 Months|Disease progression|119|||
146632888|NCT00785785|528831824|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
146632889|NCT00785785|528831825|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
146632890|NCT00785785|528831824|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
146632891|NCT00785785|528831825|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
146632892|NCT00785785|528831824|FG000|Optional Extension Phase|Adverse Event|4|||
146632893|NCT00785785|528831825|FG001|Optional Extension Phase|Adverse Event|5|||
146632894|NCT00785785|528831824|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
146632895|NCT00785785|528831825|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
146632896|NCT00785785|528831824|FG000|Optional Extension Phase|Lost to Follow-up|1|||
146632897|NCT00785785|528831825|FG001|Optional Extension Phase|Lost to Follow-up|0|||
146632898|NCT00785785|528831824|FG000|Optional Extension Phase|Administrative problems|2|||
146632899|NCT00785785|528831825|FG001|Optional Extension Phase|Administrative problems|0|||
146632900|NCT00785785|528831824|FG000|Optional Extension Phase|Death|1|||
146632901|NCT00785785|528831825|FG001|Optional Extension Phase|Death|5|||
146632902|NCT00785785|528831824|FG000|Optional Extension Phase|Disease progression|22|||
146632903|NCT00785785|528831825|FG001|Optional Extension Phase|Disease progression|70|||
146632904|NCT00785785|528831824|FG000|Optional Extension Phase|Protocol deviation|0|||
146632905|NCT00785785|528831825|FG001|Optional Extension Phase|Protocol deviation|2|||
146632906|NCT00785785|528831824|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
146632907|NCT00785785|528831825|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
146632908|NCT01244893|528831826|FG000|Baseline|Protocol Violation|0|||
146632909|NCT01244893|528831827|FG001|Baseline|Protocol Violation|1|||
146632910|NCT01244893|528831826|FG000|1-Week Follow Up|Lost to Follow-up|1|||
146632911|NCT01244893|528831827|FG001|1-Week Follow Up|Lost to Follow-up|0|||
146632912|NCT00357552|528831828|FG000|Screening|Did not meet eligibility criteria|84|||
146632913|NCT00357552|528831828|FG000|Weeks 0 to 24|Death|1|||
146632914|NCT00357552|528831828|FG000|Weeks 24 to 104|Death|3|||
146632915|NCT00357552|528831828|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
146632916|NCT00882557|528831835|FG000|Overall Study|Withdrawal by Subject|1|||
146632917|NCT00882557|528831836|FG001|Overall Study|Withdrawal by Subject|0|||
146632918|NCT00882557|528831835|FG000|Overall Study|Trouble with Vein Access|1|||
146632919|NCT00882557|528831836|FG001|Overall Study|Trouble with Vein Access|0|||
146632920|NCT00882557|528831835|FG000|Overall Study|Randomized Not Treated|0|||
146632921|NCT00882557|528831836|FG001|Overall Study|Randomized Not Treated|1|||
146632922|NCT02282605|528831838|FG000|Overall Study|negative SA result on Day -1|3|||
146632923|NCT02282605|528831839|FG001|Overall Study|negative SA result on Day -1|0|||
146632924|NCT02282605|528831840|FG002|Overall Study|negative SA result on Day -1|0|||
146632925|NCT01528969|528831841|FG000|Overall Study|absent from the school at baseline|2|||
146632926|NCT01528969|528831842|FG001|Overall Study|absent from the school at baseline|0|||
146632927|NCT03584789|528831847|FG000|Overall Study|refused EHR permission|19|||
146632928|NCT03584789|528831848|FG001|Overall Study|refused EHR permission|28|||
146632929|NCT03584789|528831849|FG002|Overall Study|refused EHR permission|23|||
146632930|NCT03584789|528831847|FG000|Overall Study|patients tied to a provider who retired|0|||
146632931|NCT03584789|528831848|FG001|Overall Study|patients tied to a provider who retired|0|||
146632932|NCT03584789|528831849|FG002|Overall Study|patients tied to a provider who retired|3|||
146632933|NCT02035267|528831851|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
146632934|NCT02035267|528831852|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
146632935|NCT02035267|528831853|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
146632936|NCT02035267|528831854|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
146632937|NCT02035267|528831851|FG000|Overall Study|Adverse Event|0|||
146632938|NCT02035267|528831852|FG001|Overall Study|Adverse Event|0|||
146632939|NCT02035267|528831853|FG002|Overall Study|Adverse Event|1|||
146552965|NCT06083493|528532649|FG000|Overall Study|Technical issues with the interventional device|2|||
146552966|NCT06083493|528532650|FG001|Overall Study|Technical issues with the interventional device|2|||
146552967|NCT06083493|528532649|FG000|Overall Study|Performed incorrect visual task|1|||
146552968|NCT06083493|528532650|FG001|Overall Study|Performed incorrect visual task|0|||
146552969|NCT06083493|528532649|FG000|Overall Study|Insufficient baseline performance|0|||
146552970|NCT06083493|528532650|FG001|Overall Study|Insufficient baseline performance|1|||
146552971|NCT04034056|528532651|FG000|Overall Study|Withdrawal by Subject|2|||
146552972|NCT04034056|528532651|FG000|Overall Study|Reason Not Specified|13|||
146552973|NCT04034056|528532651|FG000|Overall Study|Adverse Event|56|||
146552974|NCT03225989|528532652|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
146632940|NCT02035267|528831854|FG003|Overall Study|Adverse Event|0|||
146632941|NCT02035267|528831851|FG000|Overall Study|Lost to Follow-up|0|||
146632942|NCT02035267|528831852|FG001|Overall Study|Lost to Follow-up|0|||
146632943|NCT02035267|528831853|FG002|Overall Study|Lost to Follow-up|0|||
146632944|NCT02035267|528831854|FG003|Overall Study|Lost to Follow-up|1|||
146632945|NCT02035267|528831851|FG000|Overall Study|Other unspecified|0|||
146632946|NCT02035267|528831852|FG001|Overall Study|Other unspecified|1|||
146632947|NCT02035267|528831853|FG002|Overall Study|Other unspecified|0|||
146632948|NCT02035267|528831854|FG003|Overall Study|Other unspecified|0|||
146632949|NCT02404025|528831855|FG000|Overall Study|Adverse Event|1|||
146632950|NCT02404025|528831855|FG000|Overall Study|Lack of Efficacy|3|||
146632951|NCT00823615|528831856|FG000|Period 2|Lost to Follow-up|2|||
146632952|NCT00823615|528831857|FG001|Period 2|Lost to Follow-up|0|||
146632953|NCT00823615|528831856|FG000|Period 2|Time/Job Conflict|1|||
146632954|NCT00823615|528831857|FG001|Period 2|Time/Job Conflict|2|||
146632955|NCT00084136|528831861|FG000|PI Comparison|Death|10|||
146632956|NCT00084136|528831862|FG001|PI Comparison|Death|9|||
146632957|NCT00084136|528831863|FG002|PI Comparison|Death|0|||
146632958|NCT00084136|528831861|FG000|PI Comparison|Lost to Follow-up|11|||
146632959|NCT00084136|528831862|FG001|PI Comparison|Lost to Follow-up|8|||
146632960|NCT00084136|528831863|FG002|PI Comparison|Lost to Follow-up|0|||
146632961|NCT00084136|528831861|FG000|PI Comparison|Withdrawal by Subject|33|||
146632962|NCT00084136|528831862|FG001|PI Comparison|Withdrawal by Subject|30|||
146632963|NCT00084136|528831863|FG002|PI Comparison|Withdrawal by Subject|0|||
146632964|NCT00084136|528831861|FG000|PI Comparison|Clinic site closed|1|||
146632965|NCT00084136|528831862|FG001|PI Comparison|Clinic site closed|0|||
146632966|NCT00084136|528831863|FG002|PI Comparison|Clinic site closed|0|||
146632967|NCT00084136|528831861|FG000|NRTI Comparison|Death|20|||
146632968|NCT00084136|528831862|FG001|NRTI Comparison|Death|0|||
146632969|NCT00084136|528831863|FG002|NRTI Comparison|Death|18|||
146632970|NCT00084136|528831861|FG000|NRTI Comparison|Lost to Follow-up|14|||
146632971|NCT00084136|528831862|FG001|NRTI Comparison|Lost to Follow-up|0|||
146632972|NCT00084136|528831863|FG002|NRTI Comparison|Lost to Follow-up|12|||
146632973|NCT00084136|528831861|FG000|NRTI Comparison|Withdrawal by Subject|54|||
146632974|NCT00084136|528831862|FG001|NRTI Comparison|Withdrawal by Subject|0|||
146632975|NCT00084136|528831863|FG002|NRTI Comparison|Withdrawal by Subject|38|||
146632976|NCT00084136|528831861|FG000|NRTI Comparison|Clinic site closed|12|||
146632977|NCT00084136|528831862|FG001|NRTI Comparison|Clinic site closed|0|||
146632978|NCT00084136|528831863|FG002|NRTI Comparison|Clinic site closed|14|||
146632979|NCT00084136|528831861|FG000|NRTI Comparison|Not reason above|1|||
146632980|NCT00084136|528831862|FG001|NRTI Comparison|Not reason above|0|||
146632981|NCT00084136|528831863|FG002|NRTI Comparison|Not reason above|0|||
146632982|NCT02420821|528831866|FG000|Overall Study|Lost to Follow-up|6|||
146632983|NCT02420821|528831867|FG001|Overall Study|Lost to Follow-up|6|||
146632984|NCT02420821|528831866|FG000|Overall Study|Non-compliance|0|||
146632985|NCT02420821|528831867|FG001|Overall Study|Non-compliance|2|||
146632986|NCT02420821|528831866|FG000|Overall Study|Physician Decision|6|||
146632987|NCT02420821|528831867|FG001|Overall Study|Physician Decision|2|||
146632988|NCT02420821|528831866|FG000|Overall Study|Withdrawal by Subject|32|||
146632989|NCT02420821|528831867|FG001|Overall Study|Withdrawal by Subject|25|||
146632990|NCT02420821|528831866|FG000|Overall Study|Death|270|||
146632991|NCT02420821|528831867|FG001|Overall Study|Death|263|||
146632992|NCT02420821|528831866|FG000|Overall Study|Study Terminated By Sponsor|145|||
146632993|NCT02420821|528831867|FG001|Overall Study|Study Terminated By Sponsor|149|||
146632994|NCT02420821|528831866|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
146632995|NCT02420821|528831867|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
146632996|NCT02420821|528831866|FG000|Overall Study|Adverse Event|0|||
146632997|NCT02420821|528831867|FG001|Overall Study|Adverse Event|1|||
146632998|NCT02420821|528831866|FG000|Overall Study|Protinuria|0|||
146632999|NCT02420821|528831867|FG001|Overall Study|Protinuria|1|||
146633000|NCT02420821|528831866|FG000|Overall Study|Progressive Disease|1|||
146633001|NCT02420821|528831867|FG001|Overall Study|Progressive Disease|1|||
146633002|NCT02420821|528831866|FG000|Overall Study|Disease Progression|0|||
146633003|NCT02420821|528831867|FG001|Overall Study|Disease Progression|1|||
146633004|NCT02420821|528831866|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
146633005|NCT02420821|528831867|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
146633006|NCT05786651|528831870|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
146633007|NCT00904033|528834026|FG000|Overall Study|Withdrawal by Subject|1|||
146633008|NCT00904033|528834027|FG001|Overall Study|Withdrawal by Subject|1|||
146633009|NCT00904033|528834028|FG002|Overall Study|Withdrawal by Subject|0|||
146633010|NCT00904033|528834029|FG003|Overall Study|Withdrawal by Subject|0|||
146633011|NCT00904033|528834026|FG000|Overall Study|Physician Decision|0|||
146633012|NCT00904033|528834027|FG001|Overall Study|Physician Decision|0|||
146633013|NCT00904033|528834028|FG002|Overall Study|Physician Decision|1|||
146633014|NCT00904033|528834029|FG003|Overall Study|Physician Decision|0|||
146633015|NCT00904033|528834026|FG000|Overall Study|Unable to obtain final blood draw|0|||
146633016|NCT00904033|528834027|FG001|Overall Study|Unable to obtain final blood draw|0|||
146633017|NCT00904033|528834028|FG002|Overall Study|Unable to obtain final blood draw|0|||
146633018|NCT00904033|528834029|FG003|Overall Study|Unable to obtain final blood draw|2|||
146633019|NCT00865566|528834030|FG000|Overall Study|Death|1|||
146633020|NCT00865566|528834031|FG001|Overall Study|Death|11|||
146633021|NCT00865566|528834030|FG000|Overall Study|Lost to Follow-up|314|||
146633022|NCT00865566|528834031|FG001|Overall Study|Lost to Follow-up|315|||
146633023|NCT00865566|528834030|FG000|Overall Study|Withdrawal by Subject|45|||
146633024|NCT00865566|528834031|FG001|Overall Study|Withdrawal by Subject|65|||
146633025|NCT00865566|528834030|FG000|Overall Study|Physician Decision|0|||
146633026|NCT00865566|528834031|FG001|Overall Study|Physician Decision|1|||
146633027|NCT00865566|528834030|FG000|Overall Study|Participant relocated|78|||
146633028|NCT00865566|528834031|FG001|Overall Study|Participant relocated|107|||
146633029|NCT00865566|528834030|FG000|Overall Study|Participant unable to adhere|27|||
146633030|NCT00865566|528834031|FG001|Overall Study|Participant unable to adhere|42|||
146633031|NCT00865566|528834030|FG000|Overall Study|Other; N=245 due to early study closure|154|||
146633032|NCT00865566|528834031|FG001|Overall Study|Other; N=245 due to early study closure|139|||
146633033|NCT00865566|528834030|FG000|Overall Study|HIV infection|5|||
146633034|NCT00865566|528834031|FG001|Overall Study|HIV infection|7|||
146633035|NCT03252925|528834034|FG000|Overall Study|Withdrawal by Subject|1|||
146633036|NCT03252925|528834035|FG001|Overall Study|Withdrawal by Subject|0|||
146633037|NCT03252925|528834034|FG000|Overall Study|Protocol Violation|6|||
146633038|NCT03252925|528834035|FG001|Overall Study|Protocol Violation|0|||
146633039|NCT03252925|528834034|FG000|Overall Study|Adverse Event|1|||
146633040|NCT03252925|528834035|FG001|Overall Study|Adverse Event|0|||
146633041|NCT03252925|528834034|FG000|Overall Study|Lost to Follow-up|6|||
146633042|NCT03252925|528834035|FG001|Overall Study|Lost to Follow-up|6|||
146633043|NCT00521404|528834036|FG000|Overall Study|Adverse Event|13|||
146633044|NCT00521404|528834036|FG000|Overall Study|Disease Progression|33|||
146633045|NCT00521404|528834036|FG000|Overall Study|Investigator decision|5|||
146633046|NCT00521404|528834036|FG000|Overall Study|Withdrawal of consent|3|||
146633047|NCT00521404|528834036|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
146633048|NCT00521404|528834036|FG000|Overall Study|Other|7|||
146633049|NCT01383356|528834037|FG000|Period 1|Adverse Event|5|||
146633050|NCT01383356|528834038|FG001|Period 1|Adverse Event|3|||
146633051|NCT01383356|528834037|FG000|Period 1|Non-compliance|3|||
146633052|NCT01383356|528834038|FG001|Period 1|Non-compliance|0|||
146633053|NCT01383356|528834037|FG000|Period 1|Out of Range Mid-study-Test|0|||
146633054|NCT01383356|528834038|FG001|Period 1|Out of Range Mid-study-Test|1|||
146633055|NCT01383356|528834037|FG000|Period 1|Personal|0|||
146633056|NCT01383356|528834038|FG001|Period 1|Personal|2|||
146633057|NCT00602472|528834039|FG000|Overall Study|Adverse Event|5|||
146633058|NCT00602472|528834040|FG001|Overall Study|Adverse Event|23|||
146633059|NCT00602472|528834039|FG000|Overall Study|Protocol Violation|4|||
146633060|NCT00602472|528834040|FG001|Overall Study|Protocol Violation|19|||
146633061|NCT00602472|528834039|FG000|Overall Study|Withdrawal by Subject|8|||
146633062|NCT00602472|528834040|FG001|Overall Study|Withdrawal by Subject|14|||
146633063|NCT00602472|528834039|FG000|Overall Study|Other incl. lack of efficacy|4|||
146633064|NCT00602472|528834040|FG001|Overall Study|Other incl. lack of efficacy|2|||
146633065|NCT01908803|528834047|FG000|Overall Study|Adverse Event|1|||
146633066|NCT01908803|528834048|FG001|Overall Study|Adverse Event|0|||
146633067|NCT01908803|528834047|FG000|Overall Study|Physician Decision|0|||
146633068|NCT01908803|528834048|FG001|Overall Study|Physician Decision|1|||
146633069|NCT01908803|528834047|FG000|Overall Study|Withdrawal by Subject|1|||
146633070|NCT01908803|528834048|FG001|Overall Study|Withdrawal by Subject|0|||
146633071|NCT01908803|528834047|FG000|Overall Study|Randomization Error|1|||
146633072|NCT01908803|528834048|FG001|Overall Study|Randomization Error|0|||
146633073|NCT01908803|528834047|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
146633074|NCT01908803|528834048|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
146633075|NCT00098813|528834049|FG000|Overall Study|Death|8|||
146633076|NCT00098813|528834049|FG000|Overall Study|Protocol Violation|1|||
146633077|NCT00098813|528834049|FG000|Overall Study|Withdrawal by Subject|7|||
146633078|NCT00098813|528834049|FG000|Overall Study|Progression of Disease|1|||
146633079|NCT00098813|528834049|FG000|Overall Study|Other complicating disease|1|||
146765302|NCT00628862|529308591|FG001|Overall Study|COPD Exacerbation|1|||
146633080|NCT00098813|528834049|FG000|Overall Study|Reversal of RAI resistance|1|||
146633081|NCT03926611|528834050|FG000|Overall Study|Adverse Event|0|||
146633082|NCT03926611|528834051|FG001|Overall Study|Adverse Event|0|||
146633083|NCT03926611|528834052|FG002|Overall Study|Adverse Event|0|||
146765303|NCT00628862|529308592|FG002|Overall Study|COPD Exacerbation|0|||
146765304|NCT01227278|529308595|FG000|Overall Study|Withdrawal by Subject|4|||
146633084|NCT03926611|528834053|FG003|Overall Study|Adverse Event|3|||
146633085|NCT03926611|528834054|FG004|Overall Study|Adverse Event|1|||
146633086|NCT03926611|528834055|FG005|Overall Study|Adverse Event|3|||
146633087|NCT03926611|528834056|FG006|Overall Study|Adverse Event|0|||
146633088|NCT03926611|528834050|FG000|Overall Study|Lack of Efficacy|1|||
146633089|NCT03926611|528834051|FG001|Overall Study|Lack of Efficacy|2|||
146633090|NCT03926611|528834052|FG002|Overall Study|Lack of Efficacy|0|||
146633091|NCT03926611|528834053|FG003|Overall Study|Lack of Efficacy|0|||
146633092|NCT03926611|528834054|FG004|Overall Study|Lack of Efficacy|1|||
146633093|NCT03926611|528834055|FG005|Overall Study|Lack of Efficacy|0|||
146633094|NCT03926611|528834056|FG006|Overall Study|Lack of Efficacy|1|||
146633095|NCT03926611|528834050|FG000|Overall Study|Physician Decision|0|||
146633096|NCT03926611|528834051|FG001|Overall Study|Physician Decision|0|||
146633097|NCT03926611|528834052|FG002|Overall Study|Physician Decision|0|||
146633098|NCT03926611|528834053|FG003|Overall Study|Physician Decision|0|||
146633099|NCT03926611|528834054|FG004|Overall Study|Physician Decision|0|||
146633100|NCT03926611|528834055|FG005|Overall Study|Physician Decision|1|||
146633101|NCT03926611|528834056|FG006|Overall Study|Physician Decision|0|||
146552975|NCT03225989|528532653|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
146552976|NCT03225989|528532654|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
146552977|NCT03225989|528532652|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
146552978|NCT03225989|528532653|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
146552979|NCT03225989|528532654|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
146552980|NCT03225989|528532652|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
146552981|NCT03225989|528532653|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
146552982|NCT03225989|528532654|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
146552983|NCT03225989|528532652|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
146552984|NCT03225989|528532653|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
146552985|NCT03225989|528532654|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
146552986|NCT03225989|528532652|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
146552987|NCT03225989|528532653|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
146552988|NCT03225989|528532654|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
146552989|NCT03225989|528532652|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
146552990|NCT03225989|528532653|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
146552991|NCT03225989|528532654|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
146552992|NCT03225989|528532652|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
146552993|NCT03225989|528532653|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
146552994|NCT03225989|528532654|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
146552995|NCT03225989|528532652|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
146552996|NCT03225989|528532653|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
146552997|NCT03225989|528532654|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
146552998|NCT03225989|528532652|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
146552999|NCT03225989|528532653|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
146553000|NCT03225989|528532654|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
146553001|NCT03225989|528532652|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
146553002|NCT03225989|528532653|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
146553003|NCT03225989|528532654|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
146553004|NCT03225989|528532652|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
146553005|NCT03225989|528532653|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
146553006|NCT03225989|528532654|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
146553007|NCT03225989|528532652|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
146553008|NCT03225989|528532653|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
146553009|NCT03225989|528532654|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
146553010|NCT03093870|528532655|FG000|Overall Study|Withdrawal by Subject|2|||
146553011|NCT03093870|528532656|FG001|Overall Study|Withdrawal by Subject|6|||
146553012|NCT03093870|528532657|FG002|Overall Study|Withdrawal by Subject|5|||
146553013|NCT03093870|528532655|FG000|Overall Study|Death|1|||
146553014|NCT03093870|528532656|FG001|Overall Study|Death|35|||
146553015|NCT03093870|528532657|FG002|Overall Study|Death|35|||
146553016|NCT03093870|528532655|FG000|Overall Study|Radiographic disease progression|10|||
146553017|NCT03093870|528532656|FG001|Overall Study|Radiographic disease progression|0|||
146553018|NCT03093870|528532657|FG002|Overall Study|Radiographic disease progression|0|||
146553019|NCT03093870|528532655|FG000|Overall Study|Clinical disease progression|1|||
146553020|NCT03093870|528532656|FG001|Overall Study|Clinical disease progression|0|||
146553021|NCT03093870|528532657|FG002|Overall Study|Clinical disease progression|0|||
146553022|NCT03093870|528532655|FG000|Overall Study|Physician Decision|2|||
146633102|NCT03926611|528834050|FG000|Overall Study|Protocol Violation|1|||
146633103|NCT03926611|528834051|FG001|Overall Study|Protocol Violation|0|||
146633104|NCT03926611|528834052|FG002|Overall Study|Protocol Violation|0|||
146633105|NCT03926611|528834053|FG003|Overall Study|Protocol Violation|1|||
146633106|NCT03926611|528834054|FG004|Overall Study|Protocol Violation|1|||
146633107|NCT03926611|528834055|FG005|Overall Study|Protocol Violation|1|||
146633108|NCT03926611|528834056|FG006|Overall Study|Protocol Violation|1|||
146633109|NCT03926611|528834050|FG000|Overall Study|Technical problems|0|||
146633110|NCT03926611|528834051|FG001|Overall Study|Technical problems|0|||
146633111|NCT03926611|528834052|FG002|Overall Study|Technical problems|0|||
146633112|NCT03926611|528834053|FG003|Overall Study|Technical problems|0|||
146633113|NCT03926611|528834054|FG004|Overall Study|Technical problems|0|||
146633114|NCT03926611|528834055|FG005|Overall Study|Technical problems|1|||
146633115|NCT03926611|528834056|FG006|Overall Study|Technical problems|0|||
146633116|NCT03926611|528834050|FG000|Overall Study|Withdrawal by Subject|1|||
146633117|NCT03926611|528834051|FG001|Overall Study|Withdrawal by Subject|1|||
146633118|NCT03926611|528834052|FG002|Overall Study|Withdrawal by Subject|1|||
146633119|NCT03926611|528834053|FG003|Overall Study|Withdrawal by Subject|0|||
146633120|NCT03926611|528834054|FG004|Overall Study|Withdrawal by Subject|0|||
146633121|NCT03926611|528834055|FG005|Overall Study|Withdrawal by Subject|1|||
146633122|NCT03926611|528834056|FG006|Overall Study|Withdrawal by Subject|3|||
146633123|NCT03926611|528834050|FG000|Overall Study|Covid-19 pandemic|0|||
146633124|NCT03926611|528834051|FG001|Overall Study|Covid-19 pandemic|0|||
146633125|NCT03926611|528834052|FG002|Overall Study|Covid-19 pandemic|1|||
146633126|NCT03926611|528834053|FG003|Overall Study|Covid-19 pandemic|0|||
146633127|NCT03926611|528834054|FG004|Overall Study|Covid-19 pandemic|1|||
146633128|NCT03926611|528834055|FG005|Overall Study|Covid-19 pandemic|2|||
146633129|NCT03926611|528834056|FG006|Overall Study|Covid-19 pandemic|0|||
146633130|NCT02230670|528834057|FG000|Overall Study|Adverse Event|1|||
146633131|NCT02230670|528834058|FG001|Overall Study|Adverse Event|2|||
146633132|NCT02230670|528834057|FG000|Overall Study|Withdrawal by Subject|2|||
146633133|NCT02230670|528834058|FG001|Overall Study|Withdrawal by Subject|2|||
146633134|NCT02230670|528834057|FG000|Overall Study|Physician Decision|0|||
146633135|NCT02230670|528834058|FG001|Overall Study|Physician Decision|1|||
146633136|NCT02230670|528834057|FG000|Overall Study|Protocol Violation|0|||
146633137|NCT02230670|528834058|FG001|Overall Study|Protocol Violation|1|||
146633138|NCT02230670|528834057|FG000|Overall Study|Progression to Child-Pugh C|1|||
146633139|NCT02230670|528834058|FG001|Overall Study|Progression to Child-Pugh C|2|||
146633140|NCT01524796|528834059|FG000|Overall Study|Adverse Event|13|||
146633141|NCT01524796|528834059|FG000|Overall Study|Lack of Efficacy|3|||
146633142|NCT01524796|528834059|FG000|Overall Study|Lost to Follow-up|1|||
146633143|NCT01524796|528834059|FG000|Overall Study|The price|1|||
146633144|NCT01524796|528834059|FG000|Overall Study|Withdrawal by Subject|4|||
146633145|NCT01524796|528834059|FG000|Overall Study|Move|1|||
146633146|NCT01524796|528834059|FG000|Overall Study|Deterioration of pains|1|||
146633147|NCT01524796|528834059|FG000|Overall Study|Gall stone surgery|1|||
146633148|NCT01524796|528834059|FG000|Overall Study|Nervous about confidentiality|1|||
146633149|NCT01524796|528834059|FG000|Overall Study|Switch to carbamazapine|1|||
146633150|NCT01524796|528834059|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
146633151|NCT00836693|528834064|FG000|Overall Study|Adverse Event|4|||
146633152|NCT00836693|528834065|FG001|Overall Study|Adverse Event|1|||
146633153|NCT00836693|528834064|FG000|Overall Study|Sponsor Decision|0|||
146633154|NCT00836693|528834065|FG001|Overall Study|Sponsor Decision|1|||
146633155|NCT00836693|528834064|FG000|Overall Study|Physician Decision|2|||
146633156|NCT00836693|528834065|FG001|Overall Study|Physician Decision|0|||
146633157|NCT00836693|528834064|FG000|Overall Study|Withdrawal by Subject|9|||
146633158|NCT00836693|528834065|FG001|Overall Study|Withdrawal by Subject|4|||
146633159|NCT00836693|528834064|FG000|Overall Study|Protocol Violation|1|||
146633160|NCT00836693|528834065|FG001|Overall Study|Protocol Violation|0|||
146633161|NCT00836693|528834064|FG000|Overall Study|Lost to Follow-up|1|||
146633162|NCT00836693|528834065|FG001|Overall Study|Lost to Follow-up|0|||
146633163|NCT03938259|528834066|FG000|Overall Study|unable to establish baseline for ventilation|1|||
146633164|NCT03938259|528834067|FG001|Overall Study|unable to establish baseline for ventilation|1|||
146633165|NCT02612779|528834068|FG000|Overall Study|Administrative reason by sponsor|4|||
146633166|NCT02612779|528834069|FG001|Overall Study|Administrative reason by sponsor|1|||
146633167|NCT02612779|528834068|FG000|Overall Study|No longer meet study criteria|0|||
146633168|NCT02612779|528834069|FG001|Overall Study|No longer meet study criteria|1|||
146633169|NCT02612779|528834068|FG000|Overall Study|Disease progression|29|||
146633170|NCT02612779|528834069|FG001|Overall Study|Disease progression|2|||
146633171|NCT02612779|528834068|FG000|Overall Study|Study drug toxicity|10|||
146633172|NCT02612779|528834069|FG001|Overall Study|Study drug toxicity|1|||
146633173|NCT02612779|528834068|FG000|Overall Study|Death|1|||
146765305|NCT01227278|529308596|FG001|Overall Study|Withdrawal by Subject|4|||
146765306|NCT01227278|529308595|FG000|Overall Study|Death|0|||
146765307|NCT01227278|529308596|FG001|Overall Study|Death|2|||
146633174|NCT02612779|528834069|FG001|Overall Study|Death|0|||
146633175|NCT02612779|528834068|FG000|Overall Study|Adverse event unrelated to study drug|5|||
146633176|NCT02612779|528834069|FG001|Overall Study|Adverse event unrelated to study drug|0|||
146633177|NCT02612779|528834068|FG000|Overall Study|Participant withdrew consent|4|||
146633178|NCT02612779|528834069|FG001|Overall Study|Participant withdrew consent|0|||
146633179|NCT02612779|528834068|FG000|Overall Study|Lost to Follow-up|1|||
146633180|NCT02612779|528834069|FG001|Overall Study|Lost to Follow-up|0|||
146633181|NCT02612779|528834068|FG000|Overall Study|Maximum clinical benefit|10|||
146633182|NCT02612779|528834069|FG001|Overall Study|Maximum clinical benefit|1|||
146633183|NCT02612779|528834068|FG000|Overall Study|Other reasons|4|||
146633184|NCT02612779|528834069|FG001|Overall Study|Other reasons|0|||
146633185|NCT01002339|528834070|FG000|Overall Study|Withdrawal by Subject|0|||
146633186|NCT01002339|528834071|FG001|Overall Study|Withdrawal by Subject|1|||
146633187|NCT01002339|528834072|FG002|Overall Study|Withdrawal by Subject|0|||
146633188|NCT01002339|528834070|FG000|Overall Study|Incorrect treatment assignment|0|||
146633189|NCT01002339|528834071|FG001|Overall Study|Incorrect treatment assignment|0|||
146633190|NCT01002339|528834072|FG002|Overall Study|Incorrect treatment assignment|1|||
146633191|NCT01002339|528834070|FG000|Overall Study|Protocol Violation|0|||
146633192|NCT01002339|528834071|FG001|Overall Study|Protocol Violation|0|||
146633193|NCT01002339|528834072|FG002|Overall Study|Protocol Violation|2|||
146633194|NCT01002339|528834070|FG000|Overall Study|Lung cancer detected before transplant|0|||
146633195|NCT01002339|528834071|FG001|Overall Study|Lung cancer detected before transplant|0|||
146633196|NCT01002339|528834072|FG002|Overall Study|Lung cancer detected before transplant|1|||
146633197|NCT01002339|528834070|FG000|Overall Study|Randomized. Not transplanted|0|||
146633198|NCT01002339|528834071|FG001|Overall Study|Randomized. Not transplanted|0|||
146633199|NCT01002339|528834072|FG002|Overall Study|Randomized. Not transplanted|1|||
146633200|NCT01907854|528834073|FG000|Overall Study|Protocol Violation|1|||
146633201|NCT01907854|528834074|FG001|Overall Study|Protocol Violation|1|||
146633202|NCT01907854|528834073|FG000|Overall Study|Withdrawal by Subject|9|||
146633203|NCT01907854|528834074|FG001|Overall Study|Withdrawal by Subject|7|||
146633204|NCT01907854|528834073|FG000|Overall Study|Lost to Follow-up|2|||
146633205|NCT01907854|528834074|FG001|Overall Study|Lost to Follow-up|2|||
146633206|NCT01907854|528834073|FG000|Overall Study|Unclassified|4|||
146633207|NCT01907854|528834074|FG001|Overall Study|Unclassified|3|||
146633208|NCT02215252|528834075|FG000|Overall Study|Adverse Event|1|||
146633209|NCT02215252|528834076|FG001|Overall Study|Adverse Event|5|||
146633210|NCT02215252|528834077|FG002|Overall Study|Adverse Event|2|||
146633211|NCT02215252|528834075|FG000|Overall Study|Lost to Follow-up|0|||
146633212|NCT02215252|528834076|FG001|Overall Study|Lost to Follow-up|0|||
146633213|NCT02215252|528834077|FG002|Overall Study|Lost to Follow-up|1|||
146633214|NCT02215252|528834075|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
146633215|NCT02215252|528834076|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
146633216|NCT02215252|528834077|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
146633217|NCT02215252|528834075|FG000|Overall Study|Protocol Violation|0|||
146633218|NCT02215252|528834076|FG001|Overall Study|Protocol Violation|1|||
146633219|NCT02215252|528834077|FG002|Overall Study|Protocol Violation|0|||
146633220|NCT02215252|528834075|FG000|Overall Study|Withdrawal by Subject|1|||
146633221|NCT02215252|528834076|FG001|Overall Study|Withdrawal by Subject|0|||
146633222|NCT02215252|528834077|FG002|Overall Study|Withdrawal by Subject|0|||
146633223|NCT02215252|528834075|FG000|Overall Study|Other|0|||
146633224|NCT02215252|528834076|FG001|Overall Study|Other|1|||
146633225|NCT02215252|528834077|FG002|Overall Study|Other|1|||
146633226|NCT00892099|528834078|FG000|Overall Study|Death|1|||
146633227|NCT00892099|528834079|FG001|Overall Study|Death|0|||
146633228|NCT00892099|528834080|FG002|Overall Study|Death|1|||
146633229|NCT00892099|528834078|FG000|Overall Study|Adverse Event|1|||
146633230|NCT00892099|528834079|FG001|Overall Study|Adverse Event|0|||
146633231|NCT00892099|528834080|FG002|Overall Study|Adverse Event|0|||
146633232|NCT00892099|528834078|FG000|Overall Study|replocated|1|||
146553023|NCT03093870|528532656|FG001|Overall Study|Physician Decision|0|||
146553024|NCT03093870|528532657|FG002|Overall Study|Physician Decision|0|||
146553025|NCT03093870|528532655|FG000|Overall Study|Adverse Event|7|||
146553026|NCT03093870|528532656|FG001|Overall Study|Adverse Event|0|||
146553027|NCT03093870|528532657|FG002|Overall Study|Adverse Event|0|||
146553028|NCT03093870|528532655|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
146553029|NCT03093870|528532656|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
146553030|NCT03093870|528532657|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
146553031|NCT03093870|528532655|FG000|Overall Study|Lost to Follow-up|0|||
146553032|NCT03093870|528532656|FG001|Overall Study|Lost to Follow-up|0|||
146553033|NCT03093870|528532657|FG002|Overall Study|Lost to Follow-up|1|||
146553034|NCT00601107|528532658|FG000|Overall Study|Adverse Event|0|||
146553035|NCT00601107|528532659|FG001|Overall Study|Adverse Event|1|||
146553036|NCT00601107|528532660|FG002|Overall Study|Adverse Event|3|||
146553037|NCT00601107|528532661|FG003|Overall Study|Adverse Event|0|||
146633233|NCT00892099|528834079|FG001|Overall Study|replocated|0|||
146633234|NCT00892099|528834080|FG002|Overall Study|replocated|2|||
146633235|NCT00892099|528834078|FG000|Overall Study|Prolonged hospitalization|1|||
146633236|NCT00892099|528834079|FG001|Overall Study|Prolonged hospitalization|0|||
146633237|NCT00892099|528834080|FG002|Overall Study|Prolonged hospitalization|1|||
146633238|NCT00892099|528834078|FG000|Overall Study|no further details|1|||
146633239|NCT00892099|528834079|FG001|Overall Study|no further details|0|||
146633240|NCT00892099|528834080|FG002|Overall Study|no further details|1|||
146633241|NCT00892099|528834078|FG000|Overall Study|kidney function recovered|0|||
146633242|NCT00892099|528834079|FG001|Overall Study|kidney function recovered|1|||
146633243|NCT00892099|528834080|FG002|Overall Study|kidney function recovered|0|||
146633244|NCT00892099|528834078|FG000|Overall Study|investigator decision|0|||
146633245|NCT00892099|528834079|FG001|Overall Study|investigator decision|0|||
146633246|NCT00892099|528834080|FG002|Overall Study|investigator decision|1|||
146633247|NCT00892099|528834078|FG000|Overall Study|Lost to Follow-up|0|||
146633248|NCT00892099|528834079|FG001|Overall Study|Lost to Follow-up|0|||
146633249|NCT00892099|528834080|FG002|Overall Study|Lost to Follow-up|1|||
146633250|NCT01657019|528834081|FG000|Overall Study|Withdrawal by Subject|65|||
146633251|NCT01657019|528834081|FG000|Overall Study|Adverse Event|55|||
146633252|NCT01657019|528834081|FG000|Overall Study|Lost to Follow-up|48|||
146633253|NCT01657019|528834081|FG000|Overall Study|Protocol Violation|6|||
146633254|NCT01657019|528834081|FG000|Overall Study|Lack of Efficacy|3|||
146633255|NCT01657019|528834081|FG000|Overall Study|Other|58|||
146633256|NCT00956007|528834082|FG000|Overall Study|Protocol Violation|27|||
146633257|NCT00956007|528834083|FG001|Overall Study|Protocol Violation|23|||
146633258|NCT01750229|528834084|FG000|Randomized Crossover Phase|Adverse Event|1|||
146633259|NCT01750229|528834084|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
146633260|NCT01750229|528834084|FG000|Long-term Follow-up Phase|Adverse Event|2|||
146633261|NCT01750229|528834084|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
146633262|NCT02346721|528834085|FG000|Overall Study|Withdrew Consent|3|||
146633263|NCT02346721|528834085|FG000|Overall Study|Lack of Efficacy|1|||
146633264|NCT01285323|528834086|FG000|Overall Study|Adverse Event|9|||
146633265|NCT01285323|528834087|FG001|Overall Study|Adverse Event|8|||
146633266|NCT01285323|528834086|FG000|Overall Study|Lack of Efficacy|4|||
146633267|NCT01285323|528834087|FG001|Overall Study|Lack of Efficacy|2|||
146633268|NCT01285323|528834086|FG000|Overall Study|Withdrawal by Subject|15|||
146633269|NCT01285323|528834087|FG001|Overall Study|Withdrawal by Subject|11|||
146633270|NCT01285323|528834086|FG000|Overall Study|Protocol Violation|1|||
146633271|NCT01285323|528834087|FG001|Overall Study|Protocol Violation|2|||
146633272|NCT01285323|528834086|FG000|Overall Study|Non-compliance with study procedures|2|||
146633273|NCT01285323|528834087|FG001|Overall Study|Non-compliance with study procedures|3|||
146633274|NCT01285323|528834086|FG000|Overall Study|Lost to Follow-up|1|||
146633275|NCT01285323|528834087|FG001|Overall Study|Lost to Follow-up|1|||
146633276|NCT01285323|528834086|FG000|Overall Study|Other|1|||
146633277|NCT01285323|528834087|FG001|Overall Study|Other|3|||
146633278|NCT00803569|528834090|FG000|Overall Study|Progressive Disease|3|||
146633279|NCT00803569|528834090|FG000|Overall Study|Noncompliance|1|||
146633280|NCT02900378|528834098|FG000|Randomization (Visit 2)|Adverse Event|14|||
146633281|NCT02900378|528834099|FG001|Randomization (Visit 2)|Adverse Event|11|||
146633282|NCT02900378|528834098|FG000|Randomization (Visit 2)|Death|1|||
146633283|NCT02900378|528834099|FG001|Randomization (Visit 2)|Death|4|||
146633284|NCT02900378|528834098|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
146633285|NCT02900378|528834099|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
146633286|NCT02900378|528834098|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
146633287|NCT02900378|528834099|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
146633288|NCT02900378|528834098|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
146633289|NCT02900378|528834099|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
146633290|NCT02900378|528834098|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
146633291|NCT02900378|528834099|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
146633292|NCT02900378|528834098|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
146633293|NCT02900378|528834099|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
146633294|NCT03818321|528834100|FG000|Overall Study|Withdrawal by Subject|1|||
146633295|NCT03818321|528834101|FG001|Overall Study|Withdrawal by Subject|2|||
146633296|NCT01134055|528834102|FG000|Overall Study|Adverse Event|5|||
146633297|NCT01134055|528834103|FG001|Overall Study|Adverse Event|2|||
146633298|NCT01134055|528834104|FG002|Overall Study|Adverse Event|2|||
146633299|NCT01134055|528834105|FG003|Overall Study|Adverse Event|2|||
146633300|NCT01134055|528834106|FG004|Overall Study|Adverse Event|5|||
146633301|NCT01134055|528834107|FG005|Overall Study|Adverse Event|7|||
146633302|NCT01134055|528834108|FG006|Overall Study|Adverse Event|2|||
146633303|NCT01134055|528834102|FG000|Overall Study|Lost to Follow-up|0|||
146633304|NCT01134055|528834103|FG001|Overall Study|Lost to Follow-up|1|||
146633305|NCT01134055|528834104|FG002|Overall Study|Lost to Follow-up|0|||
146633306|NCT01134055|528834105|FG003|Overall Study|Lost to Follow-up|1|||
146633307|NCT01134055|528834106|FG004|Overall Study|Lost to Follow-up|0|||
146633308|NCT01134055|528834107|FG005|Overall Study|Lost to Follow-up|0|||
146633309|NCT01134055|528834108|FG006|Overall Study|Lost to Follow-up|0|||
146633310|NCT01134055|528834102|FG000|Overall Study|Withdrawal by Subject|3|||
146633311|NCT01134055|528834103|FG001|Overall Study|Withdrawal by Subject|3|||
146633312|NCT01134055|528834104|FG002|Overall Study|Withdrawal by Subject|1|||
146633313|NCT01134055|528834105|FG003|Overall Study|Withdrawal by Subject|2|||
146633314|NCT01134055|528834106|FG004|Overall Study|Withdrawal by Subject|0|||
146633315|NCT01134055|528834107|FG005|Overall Study|Withdrawal by Subject|0|||
146633316|NCT01134055|528834108|FG006|Overall Study|Withdrawal by Subject|8|||
146633317|NCT01134055|528834102|FG000|Overall Study|Protocol Violation|0|||
146633318|NCT01134055|528834103|FG001|Overall Study|Protocol Violation|0|||
146633319|NCT01134055|528834104|FG002|Overall Study|Protocol Violation|0|||
146633320|NCT01134055|528834105|FG003|Overall Study|Protocol Violation|1|||
146633321|NCT01134055|528834106|FG004|Overall Study|Protocol Violation|1|||
146633322|NCT01134055|528834107|FG005|Overall Study|Protocol Violation|0|||
146633323|NCT01134055|528834108|FG006|Overall Study|Protocol Violation|0|||
146633324|NCT01134055|528834102|FG000|Overall Study|Physician Decision|0|||
146633325|NCT01134055|528834103|FG001|Overall Study|Physician Decision|0|||
146633326|NCT01134055|528834104|FG002|Overall Study|Physician Decision|0|||
146633327|NCT01134055|528834105|FG003|Overall Study|Physician Decision|0|||
146633328|NCT01134055|528834106|FG004|Overall Study|Physician Decision|0|||
146633329|NCT01134055|528834107|FG005|Overall Study|Physician Decision|0|||
146633330|NCT01134055|528834108|FG006|Overall Study|Physician Decision|1|||
146633331|NCT05038982|528834109|FG000|Overall Study|Withdrawal by Subject|0|||
146633332|NCT05038982|528834110|FG001|Overall Study|Withdrawal by Subject|2|||
146633333|NCT01454102|528834112|FG000|Overall Study|Continuing in the treatment period|0|||
146633334|NCT01454102|528834113|FG001|Overall Study|Continuing in the treatment period|0|||
146633335|NCT01454102|528834114|FG002|Overall Study|Continuing in the treatment period|0|||
146633336|NCT01454102|528834115|FG003|Overall Study|Continuing in the treatment period|0|||
146633337|NCT01454102|528834116|FG004|Overall Study|Continuing in the treatment period|3|||
146633338|NCT01454102|528834117|FG005|Overall Study|Continuing in the treatment period|3|||
146633339|NCT01454102|528834118|FG006|Overall Study|Continuing in the treatment period|2|||
146633340|NCT01454102|528834119|FG007|Overall Study|Continuing in the treatment period|0|||
146633341|NCT01454102|528834120|FG008|Overall Study|Continuing in the treatment period|1|||
146633342|NCT01454102|528834121|FG009|Overall Study|Continuing in the treatment period|0|||
146633343|NCT01454102|528834122|FG010|Overall Study|Continuing in the treatment period|0|||
146633344|NCT01454102|528834123|FG011|Overall Study|Continuing in the treatment period|4|||
146633345|NCT01454102|528834124|FG012|Overall Study|Continuing in the treatment period|7|||
146633346|NCT01454102|528834125|FG013|Overall Study|Continuing in the treatment period|4|||
146633347|NCT01454102|528834126|FG014|Overall Study|Continuing in the treatment period|3|||
146633348|NCT01454102|528834127|FG015|Overall Study|Continuing in the treatment period|1|||
146633349|NCT03739203|528834128|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
146633350|NCT03739203|528834129|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
146633351|NCT03739203|528834130|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
146633352|NCT03739203|528834128|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
146633353|NCT03739203|528834129|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
146633354|NCT03739203|528834130|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
146633355|NCT03739203|528834128|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
146633356|NCT03739203|528834129|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
146633357|NCT03739203|528834130|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
146633358|NCT03739203|528834128|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
146633359|NCT03739203|528834129|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
146633360|NCT03739203|528834130|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
146633361|NCT03739203|528834128|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
146633362|NCT03739203|528834129|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
146633363|NCT03739203|528834130|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
146633364|NCT03739203|528834128|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
146633365|NCT03739203|528834129|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
146633366|NCT03739203|528834130|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
146633367|NCT03739203|528834128|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
146633368|NCT03739203|528834129|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
146633369|NCT03739203|528834130|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
146633370|NCT03739203|528834128|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
146633371|NCT03739203|528834129|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
146633372|NCT03739203|528834130|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
146633373|NCT03739203|528834128|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
146633374|NCT03739203|528834129|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
146633375|NCT03739203|528834130|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
146633376|NCT03739203|528834128|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
146633377|NCT03739203|528834129|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
146633378|NCT03739203|528834130|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
146633379|NCT03739203|528834128|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
146633380|NCT03739203|528834129|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
146633381|NCT03739203|528834130|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
146633382|NCT01782378|528834131|FG000|First Series|Lost to Follow-up|7|||
146633383|NCT01782378|528834132|FG001|First Series|Lost to Follow-up|8|||
146633384|NCT01782378|528834131|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
146633385|NCT01782378|528834132|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
146633386|NCT01782378|528834131|FG000|Second Series|Lost to Follow-up|8|||
146633387|NCT01782378|528834132|FG001|Second Series|Lost to Follow-up|7|||
146633388|NCT01782378|528834131|FG000|Second Series|Did not choose to complete S2 Optional|18|||
146633389|NCT01782378|528834132|FG001|Second Series|Did not choose to complete S2 Optional|0|||
146633390|NCT01663103|528834135|FG000|Overall Study|Withdrawal by Subject|1|||
146633391|NCT01663103|528834136|FG001|Overall Study|Withdrawal by Subject|2|||
146633392|NCT01663103|528834135|FG000|Overall Study|Adverse Event|1|||
146633393|NCT01663103|528834136|FG001|Overall Study|Adverse Event|0|||
146633394|NCT01663103|528834135|FG000|Overall Study|dog bite|1|||
146633395|NCT01663103|528834136|FG001|Overall Study|dog bite|0|||
146633396|NCT01656408|528834137|FG000|Overall Study|Adverse Event|0|||
146633397|NCT01656408|528834138|FG001|Overall Study|Adverse Event|0|||
146633398|NCT01656408|528834139|FG002|Overall Study|Adverse Event|1|||
146633399|NCT01656408|528834140|FG003|Overall Study|Adverse Event|0|||
146633400|NCT01656408|528834141|FG004|Overall Study|Adverse Event|0|||
146633401|NCT01656408|528834142|FG005|Overall Study|Adverse Event|1|||
146633402|NCT01656408|528834143|FG006|Overall Study|Adverse Event|1|||
146633403|NCT01656408|528834144|FG007|Overall Study|Adverse Event|0|||
146633404|NCT01656408|528834145|FG008|Overall Study|Adverse Event|1|||
146633405|NCT01656408|528834146|FG009|Overall Study|Adverse Event|0|||
146633406|NCT01656408|528834137|FG000|Overall Study|Physician Decision|1|||
146633407|NCT01656408|528834138|FG001|Overall Study|Physician Decision|0|||
146633408|NCT01656408|528834139|FG002|Overall Study|Physician Decision|1|||
146633409|NCT01656408|528834140|FG003|Overall Study|Physician Decision|0|||
146633410|NCT01656408|528834141|FG004|Overall Study|Physician Decision|1|||
146633411|NCT01656408|528834142|FG005|Overall Study|Physician Decision|1|||
146633412|NCT01656408|528834143|FG006|Overall Study|Physician Decision|0|||
146633413|NCT01656408|528834144|FG007|Overall Study|Physician Decision|1|||
146633414|NCT01656408|528834145|FG008|Overall Study|Physician Decision|1|||
146633415|NCT01656408|528834146|FG009|Overall Study|Physician Decision|3|||
146633416|NCT00888940|528834157|FG000|Overall Study|Adverse Event|12|||
146633417|NCT00888940|528834158|FG001|Overall Study|Adverse Event|3|||
146633418|NCT00888940|528834157|FG000|Overall Study|Lost to Follow-up|5|||
146633419|NCT00888940|528834158|FG001|Overall Study|Lost to Follow-up|5|||
146633420|NCT00888940|528834157|FG000|Overall Study|Randomized Not Treated|11|||
146633421|NCT00888940|528834158|FG001|Overall Study|Randomized Not Treated|13|||
146633422|NCT03815929|528834163|FG000|Overall Study|Lost to Follow-up|2|||
146633423|NCT03815929|528834164|FG001|Overall Study|Lost to Follow-up|1|||
146633424|NCT03815929|528834165|FG002|Overall Study|Lost to Follow-up|0|||
146633425|NCT03815929|528834163|FG000|Overall Study|Physician Decision|2|||
146633426|NCT03815929|528834164|FG001|Overall Study|Physician Decision|2|||
146966628|NCT04242498|530038867|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
146966629|NCT04242498|530038868|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
146966630|NCT04242498|530038869|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
146966631|NCT04242498|530038863|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
146966632|NCT04242498|530038864|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
146966633|NCT04242498|530038865|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
146966634|NCT04242498|530038866|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
146966635|NCT04242498|530038867|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
146966636|NCT04242498|530038868|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
146966637|NCT04242498|530038869|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
146966638|NCT04242498|530038863|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
146966639|NCT04242498|530038864|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
146966640|NCT04242498|530038865|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
146966641|NCT04242498|530038866|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
146966642|NCT04242498|530038867|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
146966643|NCT04242498|530038868|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
146966644|NCT04242498|530038869|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
146966645|NCT04242498|530038863|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146966646|NCT04242498|530038864|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
146633427|NCT03815929|528834165|FG002|Overall Study|Physician Decision|0|||
146633428|NCT03815929|528834163|FG000|Overall Study|Withdrawal by Subject|0|||
146633429|NCT03815929|528834164|FG001|Overall Study|Withdrawal by Subject|0|||
146633430|NCT03815929|528834165|FG002|Overall Study|Withdrawal by Subject|1|||
146633431|NCT03313037|528834166|FG000|Overall Study|Protocol Violation|4|||
146633432|NCT03313037|528834167|FG001|Overall Study|Protocol Violation|1|||
146633433|NCT03313037|528834166|FG000|Overall Study|Other|1|||
146633434|NCT03313037|528834167|FG001|Overall Study|Other|1|||
146633435|NCT03313037|528834166|FG000|Overall Study|Withdrawal by Subject|4|||
146633436|NCT03313037|528834167|FG001|Overall Study|Withdrawal by Subject|3|||
146633437|NCT03313037|528834166|FG000|Overall Study|No longer meets eligibility criteria|1|||
146633438|NCT03313037|528834167|FG001|Overall Study|No longer meets eligibility criteria|7|||
146765308|NCT01227278|529308595|FG000|Overall Study|Other|1|||
146553038|NCT00601107|528532658|FG000|Overall Study|Withdrawal by Subject|5|||
146553039|NCT00601107|528532659|FG001|Overall Study|Withdrawal by Subject|4|||
146553040|NCT00601107|528532660|FG002|Overall Study|Withdrawal by Subject|7|||
146553041|NCT00601107|528532661|FG003|Overall Study|Withdrawal by Subject|4|||
146553042|NCT00601107|528532658|FG000|Overall Study|Lost to Follow-up|3|||
146553043|NCT00601107|528532659|FG001|Overall Study|Lost to Follow-up|3|||
146553044|NCT00601107|528532660|FG002|Overall Study|Lost to Follow-up|0|||
146553045|NCT00601107|528532661|FG003|Overall Study|Lost to Follow-up|3|||
146553046|NCT00601107|528532658|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
146553047|NCT00601107|528532659|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
146553048|NCT00601107|528532660|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
146553049|NCT00601107|528532661|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
146553050|NCT00601107|528532658|FG000|Overall Study|Worsening of Psoriasis|4|||
146553051|NCT00601107|528532659|FG001|Overall Study|Worsening of Psoriasis|1|||
146553052|NCT00601107|528532660|FG002|Overall Study|Worsening of Psoriasis|1|||
146553053|NCT00601107|528532661|FG003|Overall Study|Worsening of Psoriasis|4|||
146553054|NCT00601107|528532658|FG000|Overall Study|Undefined|1|||
146553055|NCT00601107|528532659|FG001|Overall Study|Undefined|0|||
146553056|NCT00601107|528532660|FG002|Overall Study|Undefined|1|||
146553057|NCT00601107|528532661|FG003|Overall Study|Undefined|0|||
146553058|NCT01530997|528532662|FG000|Overall Study|Physician Decision|1|||
146553059|NCT01530997|528532662|FG000|Overall Study|Withdrawal by Subject|1|||
146553060|NCT00609973|528532664|FG000|Overall Study|Adverse Event|2|||
146553061|NCT00609973|528532665|FG001|Overall Study|Adverse Event|1|||
146553062|NCT00609973|528532664|FG000|Overall Study|Protocol Violation|4|||
146553063|NCT00609973|528532665|FG001|Overall Study|Protocol Violation|3|||
146553064|NCT00609973|528532664|FG000|Overall Study|Lost to Follow-up|2|||
146553065|NCT00609973|528532665|FG001|Overall Study|Lost to Follow-up|1|||
146553066|NCT00609973|528532664|FG000|Overall Study|Withdrawal by Subject|0|||
146553067|NCT00609973|528532665|FG001|Overall Study|Withdrawal by Subject|1|||
146553068|NCT01362270|528532667|FG000|Overall Study|Withdrawal by Subject|1|||
146553069|NCT01362270|528532668|FG001|Overall Study|Withdrawal by Subject|0|||
146553070|NCT01362270|528532667|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
146553071|NCT01362270|528532668|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
146553072|NCT01362270|528532667|FG000|Overall Study|Met excl. criteria before 1st session|1|||
146553073|NCT01362270|528532668|FG001|Overall Study|Met excl. criteria before 1st session|1|||
146553074|NCT02318277|528532669|FG000|Overall Study|Physician Decision|0|||
146553075|NCT02318277|528532670|FG001|Overall Study|Physician Decision|0|||
146553076|NCT02318277|528532671|FG002|Overall Study|Physician Decision|0|||
146553077|NCT02318277|528532672|FG003|Overall Study|Physician Decision|0|||
146553078|NCT02318277|528532673|FG004|Overall Study|Physician Decision|0|||
146553079|NCT02318277|528532674|FG005|Overall Study|Physician Decision|0|||
146553080|NCT02318277|528532675|FG006|Overall Study|Physician Decision|0|||
146553081|NCT02318277|528532676|FG007|Overall Study|Physician Decision|1|||
146553082|NCT02318277|528532669|FG000|Overall Study|Other|0|||
146553083|NCT02318277|528532670|FG001|Overall Study|Other|0|||
146553084|NCT02318277|528532671|FG002|Overall Study|Other|0|||
146553085|NCT02318277|528532672|FG003|Overall Study|Other|0|||
146553086|NCT02318277|528532673|FG004|Overall Study|Other|0|||
146553087|NCT02318277|528532674|FG005|Overall Study|Other|0|||
146553088|NCT02318277|528532675|FG006|Overall Study|Other|1|||
146553089|NCT02318277|528532676|FG007|Overall Study|Other|0|||
146553090|NCT02318277|528532669|FG000|Overall Study|Withdrawal by Subject|0|||
146553091|NCT02318277|528532670|FG001|Overall Study|Withdrawal by Subject|0|||
146553092|NCT02318277|528532671|FG002|Overall Study|Withdrawal by Subject|1|||
146553093|NCT02318277|528532672|FG003|Overall Study|Withdrawal by Subject|0|||
146553094|NCT02318277|528532673|FG004|Overall Study|Withdrawal by Subject|1|||
146553095|NCT02318277|528532674|FG005|Overall Study|Withdrawal by Subject|1|||
146553096|NCT02318277|528532675|FG006|Overall Study|Withdrawal by Subject|6|||
146553097|NCT02318277|528532676|FG007|Overall Study|Withdrawal by Subject|14|||
146553098|NCT02318277|528532669|FG000|Overall Study|Participant trial terminated by sponsor|0|||
146553099|NCT02318277|528532670|FG001|Overall Study|Participant trial terminated by sponsor|0|||
146553100|NCT02318277|528532671|FG002|Overall Study|Participant trial terminated by sponsor|1|||
146553101|NCT02318277|528532672|FG003|Overall Study|Participant trial terminated by sponsor|0|||
146553102|NCT02318277|528532673|FG004|Overall Study|Participant trial terminated by sponsor|1|||
146553103|NCT02318277|528532674|FG005|Overall Study|Participant trial terminated by sponsor|2|||
146553104|NCT02318277|528532675|FG006|Overall Study|Participant trial terminated by sponsor|5|||
146553105|NCT02318277|528532676|FG007|Overall Study|Participant trial terminated by sponsor|16|||
146553106|NCT02318277|528532669|FG000|Overall Study|Lost to Follow-up|1|||
146553107|NCT02318277|528532670|FG001|Overall Study|Lost to Follow-up|0|||
146553108|NCT02318277|528532671|FG002|Overall Study|Lost to Follow-up|1|||
146553109|NCT02318277|528532672|FG003|Overall Study|Lost to Follow-up|0|||
146553110|NCT02318277|528532673|FG004|Overall Study|Lost to Follow-up|0|||
146553111|NCT02318277|528532674|FG005|Overall Study|Lost to Follow-up|0|||
146765309|NCT01227278|529308596|FG001|Overall Study|Other|2|||
146553112|NCT02318277|528532675|FG006|Overall Study|Lost to Follow-up|3|||
146553113|NCT02318277|528532676|FG007|Overall Study|Lost to Follow-up|4|||
146553114|NCT02318277|528532669|FG000|Overall Study|Death|5|||
146553115|NCT02318277|528532670|FG001|Overall Study|Death|3|||
146553116|NCT02318277|528532671|FG002|Overall Study|Death|1|||
146553117|NCT02318277|528532672|FG003|Overall Study|Death|4|||
146553118|NCT02318277|528532673|FG004|Overall Study|Death|6|||
146553119|NCT02318277|528532674|FG005|Overall Study|Death|5|||
146553120|NCT02318277|528532675|FG006|Overall Study|Death|34|||
146553121|NCT02318277|528532676|FG007|Overall Study|Death|58|||
146553122|NCT02318277|528532669|FG000|Overall Study|Transitioned to Hospice|0|||
146553123|NCT02318277|528532670|FG001|Overall Study|Transitioned to Hospice|0|||
146553124|NCT02318277|528532671|FG002|Overall Study|Transitioned to Hospice|0|||
146553125|NCT02318277|528532672|FG003|Overall Study|Transitioned to Hospice|0|||
146553126|NCT02318277|528532673|FG004|Overall Study|Transitioned to Hospice|0|||
146553127|NCT02318277|528532674|FG005|Overall Study|Transitioned to Hospice|1|||
146553128|NCT02318277|528532675|FG006|Overall Study|Transitioned to Hospice|0|||
146553129|NCT02318277|528532676|FG007|Overall Study|Transitioned to Hospice|0|||
146553130|NCT02453191|528532677|FG000|Overall Study|Withdrawal by Subject|1|||
146553131|NCT03364686|528532678|FG000|Overall Study|Physician Decision|2|||
146553132|NCT01520714|528532679|FG000|Overall Study|Protocol Violation|0|||
146553133|NCT01520714|528532680|FG001|Overall Study|Protocol Violation|3|||
146553134|NCT01520714|528532679|FG000|Overall Study|Adverse Event|0|||
146553135|NCT01520714|528532680|FG001|Overall Study|Adverse Event|2|||
146553136|NCT01520714|528532679|FG000|Overall Study|Lack of Efficacy|0|||
146553137|NCT01520714|528532680|FG001|Overall Study|Lack of Efficacy|1|||
146553138|NCT00407030|528532685|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
146633439|NCT03313037|528834166|FG000|Overall Study|Lost to Follow-up|9|||
146633440|NCT03313037|528834167|FG001|Overall Study|Lost to Follow-up|8|||
146633441|NCT03313037|528834166|FG000|Overall Study|Randomized but not treated|1|||
146633442|NCT03313037|528834167|FG001|Overall Study|Randomized but not treated|0|||
146633443|NCT02760498|528834168|FG000|Overall Study|Adverse Event|3|||
146633444|NCT02760498|528834169|FG001|Overall Study|Adverse Event|3|||
146553139|NCT00407030|528532686|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
146553140|NCT00407030|528532687|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
146553141|NCT00407030|528532685|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
146553142|NCT00407030|528532686|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
146553143|NCT00407030|528532687|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
146553144|NCT00407030|528532685|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
146633445|NCT02760498|528834170|FG002|Overall Study|Adverse Event|1|||
146633446|NCT02760498|528834171|FG003|Overall Study|Adverse Event|1|||
146633447|NCT02760498|528834172|FG004|Overall Study|Adverse Event|0|||
146633448|NCT02760498|528834173|FG005|Overall Study|Adverse Event|6|||
146633449|NCT02760498|528834168|FG000|Overall Study|Death|7|||
146633450|NCT02760498|528834169|FG001|Overall Study|Death|5|||
146633451|NCT02760498|528834170|FG002|Overall Study|Death|5|||
146633452|NCT02760498|528834171|FG003|Overall Study|Death|7|||
146633453|NCT02760498|528834172|FG004|Overall Study|Death|0|||
146633454|NCT02760498|528834173|FG005|Overall Study|Death|23|||
146633455|NCT02760498|528834168|FG000|Overall Study|Lost to Follow-up|0|||
146633456|NCT02760498|528834169|FG001|Overall Study|Lost to Follow-up|0|||
146633457|NCT02760498|528834170|FG002|Overall Study|Lost to Follow-up|0|||
146633458|NCT02760498|528834171|FG003|Overall Study|Lost to Follow-up|0|||
146633459|NCT02760498|528834172|FG004|Overall Study|Lost to Follow-up|0|||
146633460|NCT02760498|528834173|FG005|Overall Study|Lost to Follow-up|3|||
146633461|NCT02760498|528834168|FG000|Overall Study|Non-compliance with study drug|0|||
146633462|NCT02760498|528834169|FG001|Overall Study|Non-compliance with study drug|2|||
146633463|NCT02760498|528834170|FG002|Overall Study|Non-compliance with study drug|0|||
146633464|NCT02760498|528834171|FG003|Overall Study|Non-compliance with study drug|0|||
146553145|NCT00407030|528532686|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
146553146|NCT00407030|528532687|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
146553147|NCT00407030|528532685|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
146553148|NCT00407030|528532686|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
146553149|NCT00407030|528532687|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
146633465|NCT02760498|528834172|FG004|Overall Study|Non-compliance with study drug|0|||
146633466|NCT02760498|528834173|FG005|Overall Study|Non-compliance with study drug|0|||
146633467|NCT02760498|528834168|FG000|Overall Study|Participant decision|1|||
146633468|NCT02760498|528834169|FG001|Overall Study|Participant decision|4|||
146633469|NCT02760498|528834170|FG002|Overall Study|Participant decision|2|||
146633470|NCT02760498|528834171|FG003|Overall Study|Participant decision|2|||
146553150|NCT00407030|528532685|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
146553151|NCT00407030|528532686|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
146633471|NCT02760498|528834172|FG004|Overall Study|Participant decision|1|||
146633472|NCT02760498|528834173|FG005|Overall Study|Participant decision|6|||
146633473|NCT02760498|528834168|FG000|Overall Study|Sponsor decision|0|||
146633474|NCT02760498|528834169|FG001|Overall Study|Sponsor decision|0|||
146633475|NCT02760498|528834170|FG002|Overall Study|Sponsor decision|0|||
146633476|NCT02760498|528834171|FG003|Overall Study|Sponsor decision|3|||
146633477|NCT02760498|528834172|FG004|Overall Study|Sponsor decision|0|||
146633478|NCT02760498|528834173|FG005|Overall Study|Sponsor decision|0|||
146633479|NCT02760498|528834168|FG000|Overall Study|Physician Decision|3|||
146633480|NCT02760498|528834169|FG001|Overall Study|Physician Decision|4|||
146633481|NCT02760498|528834170|FG002|Overall Study|Physician Decision|1|||
146633482|NCT02760498|528834171|FG003|Overall Study|Physician Decision|4|||
146633483|NCT02760498|528834172|FG004|Overall Study|Physician Decision|0|||
146633484|NCT02760498|528834173|FG005|Overall Study|Physician Decision|2|||
146633485|NCT02760498|528834168|FG000|Overall Study|Disease progression|21|||
146633486|NCT02760498|528834169|FG001|Overall Study|Disease progression|19|||
146633487|NCT02760498|528834170|FG002|Overall Study|Disease progression|20|||
146633488|NCT02760498|528834171|FG003|Overall Study|Disease progression|18|||
146633489|NCT02760498|528834172|FG004|Overall Study|Disease progression|4|||
146633490|NCT02760498|528834173|FG005|Overall Study|Disease progression|55|||
146633491|NCT02760498|528834168|FG000|Overall Study|Withdrawal by Subject|4|||
146633492|NCT02760498|528834169|FG001|Overall Study|Withdrawal by Subject|7|||
146633493|NCT02760498|528834170|FG002|Overall Study|Withdrawal by Subject|5|||
146633494|NCT02760498|528834171|FG003|Overall Study|Withdrawal by Subject|1|||
146633495|NCT02760498|528834172|FG004|Overall Study|Withdrawal by Subject|0|||
146633496|NCT02760498|528834173|FG005|Overall Study|Withdrawal by Subject|6|||
146633497|NCT02760498|528834168|FG000|Overall Study|Other than specified|1|||
146633498|NCT02760498|528834169|FG001|Overall Study|Other than specified|6|||
146633499|NCT02760498|528834170|FG002|Overall Study|Other than specified|0|||
146633500|NCT02760498|528834171|FG003|Overall Study|Other than specified|3|||
146633501|NCT02760498|528834172|FG004|Overall Study|Other than specified|1|||
146633502|NCT02760498|528834173|FG005|Overall Study|Other than specified|0|||
146633503|NCT02760498|528834168|FG000|Overall Study|Not treated|0|||
146633504|NCT02760498|528834169|FG001|Overall Study|Not treated|0|||
146633505|NCT02760498|528834170|FG002|Overall Study|Not treated|0|||
146633506|NCT02760498|528834171|FG003|Overall Study|Not treated|0|||
146633507|NCT02760498|528834172|FG004|Overall Study|Not treated|0|||
146633508|NCT02760498|528834173|FG005|Overall Study|Not treated|2|||
146633509|NCT02205736|528834174|FG000|Overall Study|Lost to Follow-up|106|||
146633510|NCT03326713|528834175|FG000|Overall Study|Death|2|||
146633511|NCT03326713|528834176|FG001|Overall Study|Death|1|||
146633512|NCT03326713|528834177|FG002|Overall Study|Death|0|||
146633513|NCT03326713|528834175|FG000|Overall Study|Lost to Follow-up|20|||
146633514|NCT03326713|528834176|FG001|Overall Study|Lost to Follow-up|21|||
146633515|NCT03326713|528834177|FG002|Overall Study|Lost to Follow-up|33|||
146633516|NCT03326713|528834175|FG000|Overall Study|Withdrawal by Subject|1|||
146633517|NCT03326713|528834176|FG001|Overall Study|Withdrawal by Subject|2|||
146633518|NCT03326713|528834177|FG002|Overall Study|Withdrawal by Subject|11|||
146633519|NCT03326713|528834175|FG000|Overall Study|Found Ineligible|11|||
146633520|NCT03326713|528834176|FG001|Overall Study|Found Ineligible|11|||
146633521|NCT03326713|528834177|FG002|Overall Study|Found Ineligible|8|||
146633522|NCT00771758|528834178|FG000|Overall Study|Adverse Event|2|||
146633523|NCT00771758|528834179|FG001|Overall Study|Adverse Event|8|||
146633524|NCT00771758|528834180|FG002|Overall Study|Adverse Event|1|||
146633525|NCT00771758|528834178|FG000|Overall Study|Lack of Efficacy|0|||
146633526|NCT00771758|528834179|FG001|Overall Study|Lack of Efficacy|2|||
146633527|NCT00771758|528834180|FG002|Overall Study|Lack of Efficacy|1|||
146633528|NCT00771758|528834178|FG000|Overall Study|Lost to Follow-up|1|||
146633529|NCT00771758|528834179|FG001|Overall Study|Lost to Follow-up|0|||
146633530|NCT00771758|528834180|FG002|Overall Study|Lost to Follow-up|0|||
146633531|NCT00771758|528834178|FG000|Overall Study|Protocol Violation|1|||
146633532|NCT00771758|528834179|FG001|Overall Study|Protocol Violation|0|||
146633533|NCT00771758|528834180|FG002|Overall Study|Protocol Violation|0|||
146633534|NCT00771758|528834178|FG000|Overall Study|Withdrawal by Subject|1|||
146633535|NCT00771758|528834179|FG001|Overall Study|Withdrawal by Subject|0|||
146633536|NCT00771758|528834180|FG002|Overall Study|Withdrawal by Subject|0|||
146633537|NCT00771758|528834178|FG000|Overall Study|Other|3|||
146633538|NCT00771758|528834179|FG001|Overall Study|Other|2|||
146633539|NCT00771758|528834180|FG002|Overall Study|Other|0|||
146633540|NCT03067077|528834181|FG000|Overall Study|Did not receive surgery|4|||
146633541|NCT03067077|528834182|FG001|Overall Study|Did not receive surgery|5|||
146633542|NCT03067077|528834181|FG000|Overall Study|Lost to Follow-up|3|||
146633543|NCT03067077|528834182|FG001|Overall Study|Lost to Follow-up|2|||
146633544|NCT00935584|528834185|FG000|Overall Study|Withdrawal by Subject|9|||
146553152|NCT00407030|528532687|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
146553153|NCT00407030|528532685|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
146553154|NCT00407030|528532686|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
146553155|NCT00407030|528532687|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
146553156|NCT00407030|528532685|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
146553157|NCT00407030|528532686|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
146553158|NCT00407030|528532687|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
146553159|NCT00407030|528532685|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
146553160|NCT00407030|528532686|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
146553161|NCT00407030|528532687|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
146553162|NCT00407030|528532685|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
146553163|NCT00407030|528532686|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
146553164|NCT00407030|528532687|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
146553165|NCT00407030|528532685|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
146553166|NCT00407030|528532686|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
146553167|NCT00407030|528532687|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
146553168|NCT00407030|528532685|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
146553169|NCT00407030|528532686|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
146553170|NCT00407030|528532687|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
146553171|NCT00407030|528532685|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
146553172|NCT00407030|528532686|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
146553173|NCT00407030|528532687|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
146553174|NCT00407030|528532685|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
146553175|NCT00407030|528532686|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
146553176|NCT00407030|528532687|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
146553177|NCT03722030|528532688|FG000|Overall Study|Withdrawal by Subject|1|||
146553178|NCT03722030|528532689|FG001|Overall Study|Withdrawal by Subject|0|||
146553179|NCT01489358|528532690|FG000|Overall Study|Lost to Follow-up|0|||
146553180|NCT01489358|528532691|FG001|Overall Study|Lost to Follow-up|0|||
146553181|NCT01489358|528532692|FG002|Overall Study|Lost to Follow-up|2|||
146553182|NCT00736476|528532693|FG000|Overall Study|Adverse Event|1|||
146553183|NCT00736476|528532694|FG001|Overall Study|Adverse Event|0|||
146553184|NCT03518203|528532695|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
146553185|NCT03518203|528532695|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
146553186|NCT00345592|528532696|FG000|Overall Study|Death|14|||
146553187|NCT00345592|528532697|FG001|Overall Study|Death|16|||
146553188|NCT00345592|528532696|FG000|Overall Study|Withdrawal by Subject|11|||
146553189|NCT00345592|528532697|FG001|Overall Study|Withdrawal by Subject|8|||
146765310|NCT03546907|529308605|FG000|Overall Study|Lack of Efficacy|1|||
146633545|NCT00935584|528834186|FG001|Overall Study|Withdrawal by Subject|0|||
146633546|NCT00935584|528834185|FG000|Overall Study|Death|3|||
146633547|NCT00935584|528834186|FG001|Overall Study|Death|0|||
146633548|NCT00935584|528834185|FG000|Overall Study|Lost to Follow-up|8|||
146633549|NCT00935584|528834186|FG001|Overall Study|Lost to Follow-up|0|||
146633550|NCT00935584|528834185|FG000|Overall Study|No show|9|||
146633551|NCT00935584|528834186|FG001|Overall Study|No show|0|||
146633552|NCT00935584|528834185|FG000|Overall Study|Relocated|3|||
146633553|NCT00935584|528834186|FG001|Overall Study|Relocated|0|||
146633554|NCT00935584|528834185|FG000|Overall Study|Patient changed provider|3|||
146633555|NCT00935584|528834186|FG001|Overall Study|Patient changed provider|0|||
146633556|NCT00935584|528834185|FG000|Overall Study|Provider dropped out of study|14|||
146633557|NCT00935584|528834186|FG001|Overall Study|Provider dropped out of study|4|||
146633558|NCT00174187|528834193|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
146633559|NCT00174187|528834194|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
146633560|NCT00174187|528834195|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
146633561|NCT00174187|528834193|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
146633562|NCT00174187|528834194|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
146633563|NCT00174187|528834195|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
146765311|NCT03546907|529308606|FG001|Overall Study|Lack of Efficacy|1|||
146887834|NCT00209339|529755804|FG000|At 4 Years Follow-up|Death|1|||
146553190|NCT02366130|528532699|FG000|Overall Study|Withdrawal by Subject|3|||
146553191|NCT02366130|528532699|FG000|Overall Study|Ineligible|6|||
146553192|NCT01065766|528532700|FG000|Overall Study|Assessed before the contracted date|1|||
146633564|NCT00174187|528834193|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
146633565|NCT00174187|528834194|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
146633566|NCT00174187|528834195|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
146633567|NCT00174187|528834193|FG000|Period 1 (up to 3 Years)|Other|0|||
146633568|NCT00174187|528834194|FG001|Period 1 (up to 3 Years)|Other|1|||
146633569|NCT00174187|528834195|FG002|Period 1 (up to 3 Years)|Other|0|||
146553193|NCT01065766|528532700|FG000|Overall Study|Contraindication to administration|6|||
146966647|NCT04242498|530038865|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
146966648|NCT04242498|530038866|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146553194|NCT01065766|528532700|FG000|Overall Study|Violated dosage/administration|25|||
146553195|NCT04223687|528532701|FG000|Overall Study|Missing primary outcome|1|||
146553196|NCT04223687|528532702|FG001|Overall Study|Missing primary outcome|0|||
146553197|NCT01608308|528532703|FG000|Overall Study|pretreatment medical and billing reasons|0|||
146553198|NCT01608308|528532704|FG001|Overall Study|pretreatment medical and billing reasons|2|||
146553199|NCT01016015|528532705|FG000|Overall Study|Not Treated|3|||
146553200|NCT01016015|528532705|FG000|Overall Study|Withdrawal by Subject|1|||
146553201|NCT01016015|528532705|FG000|Overall Study|Adverse Event|15|||
146553202|NCT00682435|528532707|FG000|Overall Study|Insufficient data|5|||
146553203|NCT00682435|528532707|FG000|Overall Study|Erroneously enrolled twice|2|||
146553204|NCT00286455|528532709|FG000|Overall Study|Hyperglycemia rescue|19|||
146553205|NCT00286455|528532710|FG001|Overall Study|Hyperglycemia rescue|13|||
146553206|NCT00286455|528532711|FG002|Overall Study|Hyperglycemia rescue|10|||
146553207|NCT00286455|528532709|FG000|Overall Study|Adverse Event|1|||
146553208|NCT00286455|528532710|FG001|Overall Study|Adverse Event|3|||
146553209|NCT00286455|528532711|FG002|Overall Study|Adverse Event|2|||
146553210|NCT00286455|528532709|FG000|Overall Study|Lost to Follow-up|0|||
146553211|NCT00286455|528532710|FG001|Overall Study|Lost to Follow-up|3|||
146553212|NCT00286455|528532711|FG002|Overall Study|Lost to Follow-up|3|||
146553213|NCT00286455|528532709|FG000|Overall Study|Physician Decision|3|||
146553214|NCT00286455|528532710|FG001|Overall Study|Physician Decision|0|||
146553215|NCT00286455|528532711|FG002|Overall Study|Physician Decision|2|||
146553216|NCT00286455|528532709|FG000|Overall Study|Protocol Violation|1|||
146553217|NCT00286455|528532710|FG001|Overall Study|Protocol Violation|1|||
146553218|NCT00286455|528532711|FG002|Overall Study|Protocol Violation|0|||
146553219|NCT00286455|528532709|FG000|Overall Study|Participant Non-compliance|1|||
146553220|NCT00286455|528532710|FG001|Overall Study|Participant Non-compliance|0|||
146553221|NCT00286455|528532711|FG002|Overall Study|Participant Non-compliance|0|||
146553222|NCT00286455|528532709|FG000|Overall Study|Withdrawal by Subject|0|||
146553223|NCT00286455|528532710|FG001|Overall Study|Withdrawal by Subject|8|||
146553224|NCT00286455|528532711|FG002|Overall Study|Withdrawal by Subject|7|||
146553225|NCT04495478|528532712|FG000|Overall Study|Withdrawal by Subject|0|||
146553226|NCT04495478|528532713|FG001|Overall Study|Withdrawal by Subject|0|||
146553227|NCT04495478|528532714|FG002|Overall Study|Withdrawal by Subject|0|||
146553228|NCT04495478|528532715|FG003|Overall Study|Withdrawal by Subject|1|||
146553229|NCT04495478|528532716|FG004|Overall Study|Withdrawal by Subject|0|||
146553230|NCT04495478|528532717|FG005|Overall Study|Withdrawal by Subject|0|||
146553231|NCT04495478|528532718|FG006|Overall Study|Withdrawal by Subject|0|||
146553232|NCT04495478|528532712|FG000|Overall Study|Physician Decision|0|||
146553233|NCT04495478|528532713|FG001|Overall Study|Physician Decision|1|||
146553234|NCT04495478|528532714|FG002|Overall Study|Physician Decision|0|||
146553235|NCT04495478|528532715|FG003|Overall Study|Physician Decision|0|||
146553236|NCT04495478|528532716|FG004|Overall Study|Physician Decision|1|||
146553237|NCT04495478|528532717|FG005|Overall Study|Physician Decision|0|||
146553238|NCT04495478|528532718|FG006|Overall Study|Physician Decision|0|||
146553239|NCT01755156|528534426|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
146553240|NCT01755156|528534427|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
146553241|NCT01755156|528534426|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
146553242|NCT01755156|528534427|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
146553243|NCT01755156|528534426|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
146553244|NCT01755156|528534427|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
146553245|NCT01755156|528534426|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
146553246|NCT01755156|528534427|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
146553247|NCT01755156|528534426|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
146553248|NCT01755156|528534427|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
146553249|NCT01755156|528534426|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
146553250|NCT01755156|528534427|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
146553251|NCT01755156|528534426|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
146553252|NCT01755156|528534427|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
146633570|NCT00174187|528834193|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
146633571|NCT00174187|528834194|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
146633572|NCT00174187|528834195|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
146633573|NCT00174187|528834193|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
146633574|NCT00174187|528834194|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
146633575|NCT00174187|528834195|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
146633576|NCT00174187|528834193|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
146633577|NCT00174187|528834194|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
146633578|NCT00174187|528834195|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
146633579|NCT00174187|528834193|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
146633580|NCT00174187|528834194|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
146633581|NCT00174187|528834195|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
146633582|NCT00174187|528834193|FG000|Period 2 (After 3 Years)|Other|0|||
146633583|NCT00174187|528834194|FG001|Period 2 (After 3 Years)|Other|0|||
146633584|NCT00174187|528834195|FG002|Period 2 (After 3 Years)|Other|5|||
146633585|NCT01198977|528834197|FG000|Overall Study|Lost to Follow-up|1|||
146633586|NCT01198977|528834198|FG001|Overall Study|Lost to Follow-up|0|||
146633587|NCT01285557|528834199|FG000|Overall Study|Death|173|||
146633588|NCT01285557|528834200|FG001|Overall Study|Death|90|||
146633589|NCT01285557|528834199|FG000|Overall Study|Lost to Follow-up|6|||
146633590|NCT01285557|528834200|FG001|Overall Study|Lost to Follow-up|2|||
146633591|NCT01285557|528834199|FG000|Overall Study|Withdrew Consent|6|||
146633592|NCT01285557|528834200|FG001|Overall Study|Withdrew Consent|1|||
146633593|NCT01285557|528834199|FG000|Overall Study|Sponsor Study Termination|23|||
146633594|NCT01285557|528834200|FG001|Overall Study|Sponsor Study Termination|13|||
146633595|NCT01285557|528834199|FG000|Overall Study|Randomized but not treated|1|||
146633596|NCT01285557|528834200|FG001|Overall Study|Randomized but not treated|1|||
146633597|NCT01285557|528834199|FG000|Overall Study|Study follow-up ongoing|28|||
146633598|NCT01285557|528834200|FG001|Overall Study|Study follow-up ongoing|14|||
146633599|NCT01285557|528834199|FG000|Overall Study|Sponsor Decision|2|||
146633600|NCT01285557|528834200|FG001|Overall Study|Sponsor Decision|1|||
146633601|NCT01648751|528834207|FG000|Overall Study|Withdrawal by Subject|2|||
146633602|NCT01648751|528834208|FG001|Overall Study|Withdrawal by Subject|3|||
146633603|NCT02484391|528834213|FG000|Overall Study|Lack of Efficacy|15|||
146633604|NCT02484391|528834214|FG001|Overall Study|Lack of Efficacy|14|||
146633605|NCT02484391|528834215|FG002|Overall Study|Lack of Efficacy|3|||
146633606|NCT02484391|528834213|FG000|Overall Study|Lost to Follow-up|0|||
146633607|NCT02484391|528834214|FG001|Overall Study|Lost to Follow-up|0|||
146633608|NCT02484391|528834215|FG002|Overall Study|Lost to Follow-up|2|||
146633609|NCT02484391|528834213|FG000|Overall Study|Physician Decision|1|||
146633610|NCT02484391|528834214|FG001|Overall Study|Physician Decision|3|||
146633611|NCT02484391|528834215|FG002|Overall Study|Physician Decision|0|||
146633612|NCT02484391|528834213|FG000|Overall Study|Went to Transplant|5|||
146633613|NCT02484391|528834214|FG001|Overall Study|Went to Transplant|3|||
146633614|NCT02484391|528834215|FG002|Overall Study|Went to Transplant|2|||
146633615|NCT00905164|528834216|FG000|Period 1|Protocol Violation|0|||
146633616|NCT00905164|528834217|FG001|Period 1|Protocol Violation|1|||
146633617|NCT00790842|528835831|FG000|Dose Level 1|Adverse Event|1|||
146633618|NCT00790842|528835832|FG001|Dose Level 1|Adverse Event|0|||
146633619|NCT00790842|528835833|FG002|Dose Level 1|Adverse Event|0|||
146633620|NCT00790842|528835834|FG003|Dose Level 1|Adverse Event|2|||
146633621|NCT00790842|528835835|FG004|Dose Level 1|Adverse Event|0|||
146633622|NCT00790842|528835836|FG005|Dose Level 1|Adverse Event|0|||
146633623|NCT00790842|528835837|FG006|Dose Level 1|Adverse Event|0|||
146633624|NCT00790842|528835838|FG007|Dose Level 1|Adverse Event|1|||
146633625|NCT00790842|528835839|FG008|Dose Level 1|Adverse Event|0|||
146633626|NCT00790842|528835840|FG009|Dose Level 1|Adverse Event|0|||
146633627|NCT00790842|528835841|FG010|Dose Level 1|Adverse Event|0|||
146633628|NCT00790842|528835831|FG000|Dose Level 1|Physician Decision|1|||
146765312|NCT03546907|529308605|FG000|Overall Study|Withdrawal by Subject|8|||
146765313|NCT03546907|529308606|FG001|Overall Study|Withdrawal by Subject|9|||
146765314|NCT03546907|529308605|FG000|Overall Study|Adverse events (AEs)|7|||
146633629|NCT00790842|528835832|FG001|Dose Level 1|Physician Decision|0|||
146633630|NCT00790842|528835833|FG002|Dose Level 1|Physician Decision|0|||
146633631|NCT00790842|528835834|FG003|Dose Level 1|Physician Decision|0|||
146633632|NCT00790842|528835835|FG004|Dose Level 1|Physician Decision|0|||
146633633|NCT00790842|528835836|FG005|Dose Level 1|Physician Decision|0|||
146633634|NCT00790842|528835837|FG006|Dose Level 1|Physician Decision|0|||
146633635|NCT00790842|528835838|FG007|Dose Level 1|Physician Decision|1|||
146633636|NCT00790842|528835839|FG008|Dose Level 1|Physician Decision|0|||
146633637|NCT00790842|528835840|FG009|Dose Level 1|Physician Decision|0|||
146633638|NCT00790842|528835841|FG010|Dose Level 1|Physician Decision|0|||
146633639|NCT00790842|528835831|FG000|Dose Level 1|Withdrawal by Subject|1|||
146633640|NCT00790842|528835832|FG001|Dose Level 1|Withdrawal by Subject|0|||
146633641|NCT00790842|528835833|FG002|Dose Level 1|Withdrawal by Subject|0|||
146633642|NCT00790842|528835834|FG003|Dose Level 1|Withdrawal by Subject|0|||
146633643|NCT00790842|528835835|FG004|Dose Level 1|Withdrawal by Subject|0|||
146633644|NCT00790842|528835836|FG005|Dose Level 1|Withdrawal by Subject|0|||
146633645|NCT00790842|528835837|FG006|Dose Level 1|Withdrawal by Subject|0|||
146633646|NCT00790842|528835838|FG007|Dose Level 1|Withdrawal by Subject|0|||
146633647|NCT00790842|528835839|FG008|Dose Level 1|Withdrawal by Subject|0|||
146633648|NCT00790842|528835840|FG009|Dose Level 1|Withdrawal by Subject|0|||
146633649|NCT00790842|528835841|FG010|Dose Level 1|Withdrawal by Subject|0|||
146633650|NCT00790842|528835831|FG000|Dose Level 2|Death|0|||
146633651|NCT00790842|528835832|FG001|Dose Level 2|Death|1|||
146633652|NCT00790842|528835833|FG002|Dose Level 2|Death|0|||
146633653|NCT00790842|528835834|FG003|Dose Level 2|Death|0|||
146633654|NCT00790842|528835835|FG004|Dose Level 2|Death|1|||
146633655|NCT00790842|528835836|FG005|Dose Level 2|Death|0|||
146633656|NCT00790842|528835837|FG006|Dose Level 2|Death|0|||
146633657|NCT00790842|528835838|FG007|Dose Level 2|Death|0|||
146633658|NCT00790842|528835839|FG008|Dose Level 2|Death|0|||
146633659|NCT00790842|528835840|FG009|Dose Level 2|Death|0|||
146633660|NCT00790842|528835841|FG010|Dose Level 2|Death|0|||
146633661|NCT00790842|528835831|FG000|Dose Level 2|Physician Decision|0|||
146633662|NCT00790842|528835832|FG001|Dose Level 2|Physician Decision|1|||
146633663|NCT00790842|528835833|FG002|Dose Level 2|Physician Decision|0|||
146633664|NCT00790842|528835834|FG003|Dose Level 2|Physician Decision|0|||
146633665|NCT00790842|528835835|FG004|Dose Level 2|Physician Decision|0|||
146633666|NCT00790842|528835836|FG005|Dose Level 2|Physician Decision|0|||
146633667|NCT00790842|528835837|FG006|Dose Level 2|Physician Decision|0|||
146633668|NCT00790842|528835838|FG007|Dose Level 2|Physician Decision|0|||
146633669|NCT00790842|528835839|FG008|Dose Level 2|Physician Decision|0|||
146633670|NCT00790842|528835840|FG009|Dose Level 2|Physician Decision|0|||
146633671|NCT00790842|528835841|FG010|Dose Level 2|Physician Decision|0|||
146633672|NCT00790842|528835831|FG000|Dose Level 2|Withdrawal by Subject|0|||
146633673|NCT00790842|528835832|FG001|Dose Level 2|Withdrawal by Subject|1|||
146633674|NCT00790842|528835833|FG002|Dose Level 2|Withdrawal by Subject|0|||
146633675|NCT00790842|528835834|FG003|Dose Level 2|Withdrawal by Subject|0|||
146633676|NCT00790842|528835835|FG004|Dose Level 2|Withdrawal by Subject|0|||
146633677|NCT00790842|528835836|FG005|Dose Level 2|Withdrawal by Subject|0|||
146633678|NCT00790842|528835837|FG006|Dose Level 2|Withdrawal by Subject|0|||
146633679|NCT00790842|528835838|FG007|Dose Level 2|Withdrawal by Subject|0|||
146633680|NCT00790842|528835839|FG008|Dose Level 2|Withdrawal by Subject|0|||
146633681|NCT00790842|528835840|FG009|Dose Level 2|Withdrawal by Subject|0|||
146633682|NCT00790842|528835841|FG010|Dose Level 2|Withdrawal by Subject|0|||
146633683|NCT00790842|528835831|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146633684|NCT00790842|528835832|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146633685|NCT00790842|528835833|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146633686|NCT00790842|528835834|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146633687|NCT00790842|528835835|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146633688|NCT00790842|528835836|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146633689|NCT00790842|528835837|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146553253|NCT01755156|528534426|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
146553254|NCT01755156|528534427|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
146553255|NCT01755156|528534426|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
146553256|NCT01755156|528534427|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
146553257|NCT01755156|528534426|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
146553258|NCT01755156|528534427|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
146553259|NCT01755156|528534426|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
146553260|NCT01755156|528534427|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
146553261|NCT03071965|528534435|FG000|Overall Study|Adverse Event|0|||
146553262|NCT03071965|528534436|FG001|Overall Study|Adverse Event|0|||
146553263|NCT03071965|528534437|FG002|Overall Study|Adverse Event|1|||
146553264|NCT03071965|528534438|FG003|Overall Study|Adverse Event|0|||
146553265|NCT03071965|528534435|FG000|Overall Study|Death|0|||
146553266|NCT03071965|528534436|FG001|Overall Study|Death|0|||
146553267|NCT03071965|528534437|FG002|Overall Study|Death|1|||
146553268|NCT03071965|528534438|FG003|Overall Study|Death|1|||
146633690|NCT00790842|528835838|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146633691|NCT00790842|528835839|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
146633692|NCT00790842|528835840|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146633693|NCT00790842|528835841|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146633694|NCT00790842|528835831|FG000|Dose Level 3|Adverse Event|0|||
146633695|NCT00790842|528835832|FG001|Dose Level 3|Adverse Event|0|||
146633696|NCT00790842|528835833|FG002|Dose Level 3|Adverse Event|1|||
146633697|NCT00790842|528835834|FG003|Dose Level 3|Adverse Event|0|||
146553269|NCT03071965|528534435|FG000|Overall Study|COVID-19|0|||
146633698|NCT00790842|528835835|FG004|Dose Level 3|Adverse Event|0|||
146633699|NCT00790842|528835836|FG005|Dose Level 3|Adverse Event|0|||
146633700|NCT00790842|528835837|FG006|Dose Level 3|Adverse Event|0|||
146633701|NCT00790842|528835838|FG007|Dose Level 3|Adverse Event|0|||
146633702|NCT00790842|528835839|FG008|Dose Level 3|Adverse Event|0|||
146633703|NCT00790842|528835840|FG009|Dose Level 3|Adverse Event|0|||
146633704|NCT00790842|528835841|FG010|Dose Level 3|Adverse Event|0|||
146633705|NCT00790842|528835831|FG000|Dose Level 3|Withdrawal by Subject|0|||
146633706|NCT00790842|528835832|FG001|Dose Level 3|Withdrawal by Subject|0|||
146633707|NCT00790842|528835833|FG002|Dose Level 3|Withdrawal by Subject|3|||
146633708|NCT00790842|528835834|FG003|Dose Level 3|Withdrawal by Subject|0|||
146633709|NCT00790842|528835835|FG004|Dose Level 3|Withdrawal by Subject|0|||
146633710|NCT00790842|528835836|FG005|Dose Level 3|Withdrawal by Subject|0|||
146633711|NCT00790842|528835837|FG006|Dose Level 3|Withdrawal by Subject|0|||
146633712|NCT00790842|528835838|FG007|Dose Level 3|Withdrawal by Subject|0|||
146633713|NCT00790842|528835839|FG008|Dose Level 3|Withdrawal by Subject|0|||
146633714|NCT00790842|528835840|FG009|Dose Level 3|Withdrawal by Subject|2|||
146633715|NCT00790842|528835841|FG010|Dose Level 3|Withdrawal by Subject|0|||
146633716|NCT00790842|528835831|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146633717|NCT00790842|528835832|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146633718|NCT00790842|528835833|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146633719|NCT00790842|528835834|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146633720|NCT00790842|528835835|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146633721|NCT00790842|528835836|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
146633722|NCT00790842|528835837|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146633723|NCT00790842|528835838|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146633724|NCT00790842|528835839|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146633725|NCT00790842|528835840|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146633726|NCT00790842|528835841|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146633727|NCT00790842|528835831|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146633728|NCT00790842|528835832|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146633729|NCT00790842|528835833|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
146633730|NCT00790842|528835834|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146633731|NCT00790842|528835835|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146633732|NCT00790842|528835836|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146633733|NCT00790842|528835837|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146633734|NCT00790842|528835838|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146633735|NCT00790842|528835839|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146633736|NCT00790842|528835840|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146633737|NCT00790842|528835841|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146633738|NCT00790842|528835831|FG000|Dose Level 4|Adverse Event|0|||
146633739|NCT00790842|528835832|FG001|Dose Level 4|Adverse Event|0|||
146633740|NCT00790842|528835833|FG002|Dose Level 4|Adverse Event|0|||
146633741|NCT00790842|528835834|FG003|Dose Level 4|Adverse Event|0|||
146633742|NCT00790842|528835835|FG004|Dose Level 4|Adverse Event|0|||
146633743|NCT00790842|528835836|FG005|Dose Level 4|Adverse Event|0|||
146633744|NCT00790842|528835837|FG006|Dose Level 4|Adverse Event|1|||
146633745|NCT00790842|528835838|FG007|Dose Level 4|Adverse Event|0|||
146633746|NCT00790842|528835839|FG008|Dose Level 4|Adverse Event|0|||
146633747|NCT00790842|528835840|FG009|Dose Level 4|Adverse Event|0|||
146633748|NCT00790842|528835841|FG010|Dose Level 4|Adverse Event|0|||
146633749|NCT00790842|528835831|FG000|Dose Level 4|Physician Decision|0|||
146633750|NCT00790842|528835832|FG001|Dose Level 4|Physician Decision|0|||
146633751|NCT00790842|528835833|FG002|Dose Level 4|Physician Decision|0|||
146633752|NCT00790842|528835834|FG003|Dose Level 4|Physician Decision|0|||
146633753|NCT00790842|528835835|FG004|Dose Level 4|Physician Decision|0|||
146633754|NCT00790842|528835836|FG005|Dose Level 4|Physician Decision|0|||
146633755|NCT00790842|528835837|FG006|Dose Level 4|Physician Decision|1|||
146633756|NCT00790842|528835838|FG007|Dose Level 4|Physician Decision|0|||
146633757|NCT00790842|528835839|FG008|Dose Level 4|Physician Decision|0|||
146633758|NCT00790842|528835840|FG009|Dose Level 4|Physician Decision|0|||
146633759|NCT00790842|528835841|FG010|Dose Level 4|Physician Decision|1|||
146633760|NCT00790842|528835831|FG000|Dose Level 4|Withdrawal by Subject|0|||
146633761|NCT00790842|528835832|FG001|Dose Level 4|Withdrawal by Subject|0|||
146633762|NCT00790842|528835833|FG002|Dose Level 4|Withdrawal by Subject|0|||
146633763|NCT00790842|528835834|FG003|Dose Level 4|Withdrawal by Subject|0|||
146633764|NCT00790842|528835835|FG004|Dose Level 4|Withdrawal by Subject|0|||
146633765|NCT00790842|528835836|FG005|Dose Level 4|Withdrawal by Subject|0|||
146633766|NCT00790842|528835837|FG006|Dose Level 4|Withdrawal by Subject|0|||
146633767|NCT00790842|528835838|FG007|Dose Level 4|Withdrawal by Subject|0|||
146633768|NCT00790842|528835839|FG008|Dose Level 4|Withdrawal by Subject|0|||
146633769|NCT00790842|528835840|FG009|Dose Level 4|Withdrawal by Subject|0|||
146966649|NCT04242498|530038867|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146633770|NCT00790842|528835841|FG010|Dose Level 4|Withdrawal by Subject|1|||
146633771|NCT00790842|528835831|FG000|Expansion Cohort|Adverse Event|0|||
146633772|NCT00790842|528835832|FG001|Expansion Cohort|Adverse Event|0|||
146633773|NCT00790842|528835833|FG002|Expansion Cohort|Adverse Event|0|||
146633774|NCT00790842|528835834|FG003|Expansion Cohort|Adverse Event|0|||
146633775|NCT00790842|528835835|FG004|Expansion Cohort|Adverse Event|0|||
146633776|NCT00790842|528835836|FG005|Expansion Cohort|Adverse Event|0|||
146633777|NCT00790842|528835837|FG006|Expansion Cohort|Adverse Event|1|||
146633778|NCT00790842|528835838|FG007|Expansion Cohort|Adverse Event|0|||
146633779|NCT00790842|528835839|FG008|Expansion Cohort|Adverse Event|0|||
146633780|NCT00790842|528835840|FG009|Expansion Cohort|Adverse Event|0|||
146633781|NCT00790842|528835841|FG010|Expansion Cohort|Adverse Event|0|||
146633782|NCT00790842|528835831|FG000|Expansion Cohort|Death|0|||
146633783|NCT00790842|528835832|FG001|Expansion Cohort|Death|0|||
146633784|NCT00790842|528835833|FG002|Expansion Cohort|Death|2|||
146633785|NCT00790842|528835834|FG003|Expansion Cohort|Death|0|||
146633786|NCT00790842|528835835|FG004|Expansion Cohort|Death|0|||
146633787|NCT00790842|528835836|FG005|Expansion Cohort|Death|0|||
146633788|NCT00790842|528835837|FG006|Expansion Cohort|Death|0|||
146633789|NCT00790842|528835838|FG007|Expansion Cohort|Death|0|||
146633790|NCT00790842|528835839|FG008|Expansion Cohort|Death|0|||
146633791|NCT00790842|528835840|FG009|Expansion Cohort|Death|0|||
146633792|NCT00790842|528835841|FG010|Expansion Cohort|Death|0|||
146633793|NCT00790842|528835831|FG000|Expansion Cohort|Physician Decision|0|||
146633794|NCT00790842|528835832|FG001|Expansion Cohort|Physician Decision|0|||
146633795|NCT00790842|528835833|FG002|Expansion Cohort|Physician Decision|1|||
146633796|NCT00790842|528835834|FG003|Expansion Cohort|Physician Decision|0|||
146633797|NCT00790842|528835835|FG004|Expansion Cohort|Physician Decision|0|||
146633798|NCT00790842|528835836|FG005|Expansion Cohort|Physician Decision|0|||
146633799|NCT00790842|528835837|FG006|Expansion Cohort|Physician Decision|0|||
146633800|NCT00790842|528835838|FG007|Expansion Cohort|Physician Decision|0|||
146633801|NCT00790842|528835839|FG008|Expansion Cohort|Physician Decision|0|||
146633802|NCT00790842|528835840|FG009|Expansion Cohort|Physician Decision|0|||
146633803|NCT00790842|528835841|FG010|Expansion Cohort|Physician Decision|0|||
146633804|NCT00790842|528835831|FG000|Expansion Cohort|Withdrawal by Subject|0|||
146633805|NCT00790842|528835832|FG001|Expansion Cohort|Withdrawal by Subject|0|||
146633806|NCT00790842|528835833|FG002|Expansion Cohort|Withdrawal by Subject|3|||
146633807|NCT00790842|528835834|FG003|Expansion Cohort|Withdrawal by Subject|0|||
146633808|NCT00790842|528835835|FG004|Expansion Cohort|Withdrawal by Subject|0|||
146633809|NCT00790842|528835836|FG005|Expansion Cohort|Withdrawal by Subject|0|||
146633810|NCT00790842|528835837|FG006|Expansion Cohort|Withdrawal by Subject|0|||
146633811|NCT00790842|528835838|FG007|Expansion Cohort|Withdrawal by Subject|0|||
146633812|NCT00790842|528835839|FG008|Expansion Cohort|Withdrawal by Subject|0|||
146633813|NCT00790842|528835840|FG009|Expansion Cohort|Withdrawal by Subject|0|||
146633814|NCT00790842|528835841|FG010|Expansion Cohort|Withdrawal by Subject|0|||
146633815|NCT00790842|528835831|FG000|Expansion Cohort|Study Closure|0|||
146633816|NCT00790842|528835832|FG001|Expansion Cohort|Study Closure|0|||
146633817|NCT00790842|528835833|FG002|Expansion Cohort|Study Closure|1|||
146633818|NCT00790842|528835834|FG003|Expansion Cohort|Study Closure|0|||
146633819|NCT00790842|528835835|FG004|Expansion Cohort|Study Closure|0|||
146633820|NCT00790842|528835836|FG005|Expansion Cohort|Study Closure|0|||
146633821|NCT00790842|528835837|FG006|Expansion Cohort|Study Closure|0|||
146633822|NCT00790842|528835838|FG007|Expansion Cohort|Study Closure|0|||
146633823|NCT00790842|528835839|FG008|Expansion Cohort|Study Closure|0|||
146633824|NCT00790842|528835840|FG009|Expansion Cohort|Study Closure|0|||
146633825|NCT00790842|528835841|FG010|Expansion Cohort|Study Closure|0|||
146633826|NCT02968004|528835842|FG000|Main Study Phase|Adverse Event|1|||
146633827|NCT02968004|528835843|FG001|Main Study Phase|Adverse Event|0|||
146633828|NCT02968004|528835842|FG000|Main Study Phase|Withdrawal by Subject|0|||
146633829|NCT02968004|528835843|FG001|Main Study Phase|Withdrawal by Subject|1|||
146633830|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
146633831|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
146633832|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
146633833|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
146633834|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
146633835|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
146633836|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
146633837|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
146633838|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
146633839|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
146633840|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
146633841|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
146633842|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
146633843|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
146633844|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
146633845|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
146633846|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
146633847|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
146633848|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
146633849|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
146633850|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
146633851|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
146633852|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
146553270|NCT03071965|528534436|FG001|Overall Study|COVID-19|1|||
146553271|NCT03071965|528534437|FG002|Overall Study|COVID-19|0|||
146553272|NCT03071965|528534438|FG003|Overall Study|COVID-19|1|||
146553273|NCT03071965|528534435|FG000|Overall Study|Other Health Reason|0|||
146553274|NCT03071965|528534436|FG001|Overall Study|Other Health Reason|0|||
146553275|NCT03071965|528534437|FG002|Overall Study|Other Health Reason|0|||
146553276|NCT03071965|528534438|FG003|Overall Study|Other Health Reason|1|||
146553277|NCT00986102|528534439|FG000|Overall Study|Lost to Follow-up|0|||
146553278|NCT00986102|528534440|FG001|Overall Study|Lost to Follow-up|1|||
146553279|NCT00986102|528534441|FG002|Overall Study|Lost to Follow-up|0|||
146553280|NCT00986102|528534442|FG003|Overall Study|Lost to Follow-up|1|||
146553281|NCT00986102|528534439|FG000|Overall Study|Withdrawal by Subject|1|||
146553282|NCT00986102|528534440|FG001|Overall Study|Withdrawal by Subject|1|||
146553283|NCT00986102|528534441|FG002|Overall Study|Withdrawal by Subject|0|||
146553284|NCT00986102|528534442|FG003|Overall Study|Withdrawal by Subject|0|||
146553285|NCT01691482|528534445|FG000|Treatment Period 2|Adverse Event|0|||
146553286|NCT01691482|528534446|FG001|Treatment Period 2|Adverse Event|1|||
146553287|NCT01691482|528534445|FG000|Treatment Period 2|Protocol Violation|1|||
146553288|NCT01691482|528534446|FG001|Treatment Period 2|Protocol Violation|1|||
146553289|NCT01392495|528534447|FG000|Overall Study|Death|3|||
146553290|NCT01392495|528534447|FG000|Overall Study|Administrative problems|8|||
146553291|NCT01392495|528534447|FG000|Overall Study|Withdrawal by Subject|2|||
146553292|NCT01392495|528534447|FG000|Overall Study|Adverse Event|3|||
146553293|NCT01063881|528534458|FG000|Overall Study|Adverse Event|12|||
146553294|NCT01063881|528534459|FG001|Overall Study|Adverse Event|2|||
146553295|NCT01063881|528534460|FG002|Overall Study|Adverse Event|0|||
146553296|NCT01063881|528534458|FG000|Overall Study|Lost to Follow-up|13|||
146553297|NCT01063881|528534459|FG001|Overall Study|Lost to Follow-up|7|||
146553298|NCT01063881|528534460|FG002|Overall Study|Lost to Follow-up|1|||
146553299|NCT01063881|528534458|FG000|Overall Study|Withdrawal by Subject|25|||
146553300|NCT01063881|528534459|FG001|Overall Study|Withdrawal by Subject|1|||
146553301|NCT01063881|528534460|FG002|Overall Study|Withdrawal by Subject|0|||
146553302|NCT01063881|528534458|FG000|Overall Study|Reason for not completed not specified|5|||
146553303|NCT01063881|528534459|FG001|Overall Study|Reason for not completed not specified|1|||
146553304|NCT01063881|528534460|FG002|Overall Study|Reason for not completed not specified|0|||
146553305|NCT01309100|528534461|FG000|Overall Study|Protocol Violation|1|||
146553306|NCT01309100|528534461|FG000|Overall Study|Positive Slit lamp finding|1|||
146553307|NCT01452789|528534464|FG000|Overall Study|Withdrawal by Subject|3|||
146553308|NCT01452789|528534465|FG001|Overall Study|Withdrawal by Subject|2|||
146553309|NCT01340170|528534466|FG000|Overall Study|Lost to Follow-up|2|||
146553310|NCT01340170|528534467|FG001|Overall Study|Lost to Follow-up|4|||
146553311|NCT01340170|528534468|FG002|Overall Study|Lost to Follow-up|0|||
146553312|NCT01340170|528534466|FG000|Overall Study|Implant failure|1|||
146553313|NCT01340170|528534467|FG001|Overall Study|Implant failure|3|||
146553314|NCT01340170|528534468|FG002|Overall Study|Implant failure|0|||
146553315|NCT01796470|528534471|FG000|Overall Study|Adverse Event|4|||
146553316|NCT01796470|528534472|FG001|Overall Study|Adverse Event|2|||
146553317|NCT01796470|528534473|FG002|Overall Study|Adverse Event|2|||
146553318|NCT01796470|528534474|FG003|Overall Study|Adverse Event|1|||
146553319|NCT01796470|528534475|FG004|Overall Study|Adverse Event|3|||
146553320|NCT01796470|528534471|FG000|Overall Study|Death|2|||
146553321|NCT01796470|528534472|FG001|Overall Study|Death|0|||
146553322|NCT01796470|528534473|FG002|Overall Study|Death|0|||
146553323|NCT01796470|528534474|FG003|Overall Study|Death|0|||
146553324|NCT01796470|528534475|FG004|Overall Study|Death|1|||
146553325|NCT01796470|528534471|FG000|Overall Study|Initiated New Therapy|9|||
146553326|NCT01796470|528534472|FG001|Overall Study|Initiated New Therapy|0|||
146553327|NCT01796470|528534473|FG002|Overall Study|Initiated New Therapy|0|||
146553328|NCT01796470|528534474|FG003|Overall Study|Initiated New Therapy|0|||
146553329|NCT01796470|528534475|FG004|Overall Study|Initiated New Therapy|2|||
146553330|NCT01796470|528534471|FG000|Overall Study|Lost to Follow-up|0|||
146553331|NCT01796470|528534472|FG001|Overall Study|Lost to Follow-up|1|||
146553332|NCT01796470|528534473|FG002|Overall Study|Lost to Follow-up|0|||
146553333|NCT01796470|528534474|FG003|Overall Study|Lost to Follow-up|0|||
146553334|NCT01796470|528534475|FG004|Overall Study|Lost to Follow-up|0|||
146553335|NCT01796470|528534471|FG000|Overall Study|Physician Decision|5|||
146553336|NCT01796470|528534472|FG001|Overall Study|Physician Decision|4|||
146553337|NCT01796470|528534473|FG002|Overall Study|Physician Decision|1|||
146553338|NCT01796470|528534474|FG003|Overall Study|Physician Decision|0|||
146553339|NCT01796470|528534475|FG004|Overall Study|Physician Decision|1|||
146553340|NCT01796470|528534471|FG000|Overall Study|Progressive Disease|7|||
146553341|NCT01796470|528534472|FG001|Overall Study|Progressive Disease|7|||
146553342|NCT01796470|528534473|FG002|Overall Study|Progressive Disease|3|||
146553343|NCT01796470|528534474|FG003|Overall Study|Progressive Disease|2|||
146553344|NCT01796470|528534475|FG004|Overall Study|Progressive Disease|0|||
146553345|NCT01796470|528534471|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
146553346|NCT01796470|528534472|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
146553347|NCT01796470|528534473|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
146553348|NCT01796470|528534474|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
146633853|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
146633854|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
146633855|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
146633856|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
146633857|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
146633858|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
146553349|NCT01796470|528534475|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
146553350|NCT01796470|528534471|FG000|Overall Study|Withdrawal by Subject|7|||
146633859|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
146633860|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
146633861|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
146633862|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
146633863|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
146633864|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
146633865|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
146633866|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
146633867|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
146633868|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
146633869|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
146633870|NCT02968004|528835842|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
146633871|NCT02968004|528835843|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
146633872|NCT05029362|528835844|FG000|Overall Study|Lost to Follow-up|9|||
146633873|NCT00419952|528835847|FG000|Overall Study|Adverse Event|8|||
146633874|NCT00419952|528835848|FG001|Overall Study|Adverse Event|10|||
146633875|NCT00419952|528835847|FG000|Overall Study|Withdrawal by Subject|44|||
146633876|NCT00419952|528835848|FG001|Overall Study|Withdrawal by Subject|43|||
146633877|NCT00419952|528835847|FG000|Overall Study|Lost to Follow-up|43|||
146633878|NCT00419952|528835848|FG001|Overall Study|Lost to Follow-up|34|||
146633879|NCT00419952|528835847|FG000|Overall Study|Protocol Violation|32|||
146633880|NCT00419952|528835848|FG001|Overall Study|Protocol Violation|24|||
146553351|NCT01796470|528534472|FG001|Overall Study|Withdrawal by Subject|0|||
146553352|NCT01796470|528534473|FG002|Overall Study|Withdrawal by Subject|0|||
146553353|NCT01796470|528534474|FG003|Overall Study|Withdrawal by Subject|0|||
146553354|NCT01796470|528534475|FG004|Overall Study|Withdrawal by Subject|1|||
146553355|NCT00147537|528534476|FG000|Phase 1b|Death|0|||
146553356|NCT00147537|528534477|FG001|Phase 1b|Death|1|||
146553357|NCT00147537|528534478|FG002|Phase 1b|Death|2|||
146553358|NCT00147537|528534479|FG003|Phase 1b|Death|1|||
146553359|NCT00147537|528534480|FG004|Phase 1b|Death|2|||
146553360|NCT00147537|528534481|FG005|Phase 1b|Death|2|||
146553361|NCT00147537|528534482|FG006|Phase 1b|Death|1|||
146553362|NCT00147537|528534483|FG007|Phase 1b|Death|3|||
146553363|NCT00147537|528534484|FG008|Phase 1b|Death|9|||
146553364|NCT00147537|528534485|FG009|Phase 1b|Death|0|||
146553365|NCT00147537|528534486|FG010|Phase 1b|Death|0|||
146553366|NCT00147537|528534476|FG000|Phase 1b|Lost to Follow-up|2|||
146553367|NCT00147537|528534477|FG001|Phase 1b|Lost to Follow-up|1|||
146553368|NCT00147537|528534478|FG002|Phase 1b|Lost to Follow-up|0|||
146553369|NCT00147537|528534479|FG003|Phase 1b|Lost to Follow-up|0|||
146553370|NCT00147537|528534480|FG004|Phase 1b|Lost to Follow-up|0|||
146553371|NCT00147537|528534481|FG005|Phase 1b|Lost to Follow-up|0|||
146553372|NCT00147537|528534482|FG006|Phase 1b|Lost to Follow-up|2|||
146553373|NCT00147537|528534483|FG007|Phase 1b|Lost to Follow-up|0|||
146553374|NCT00147537|528534484|FG008|Phase 1b|Lost to Follow-up|1|||
146553375|NCT00147537|528534485|FG009|Phase 1b|Lost to Follow-up|0|||
146553376|NCT00147537|528534486|FG010|Phase 1b|Lost to Follow-up|0|||
146633881|NCT00419952|528835847|FG000|Overall Study|Pregnancy|4|||
146633882|NCT00419952|528835848|FG001|Overall Study|Pregnancy|2|||
146633883|NCT00419952|528835847|FG000|Overall Study|Physician Decision|1|||
146633884|NCT00419952|528835848|FG001|Overall Study|Physician Decision|3|||
146633885|NCT00419952|528835847|FG000|Overall Study|Incorrectly enrolled|10|||
146633886|NCT00419952|528835848|FG001|Overall Study|Incorrectly enrolled|3|||
146633887|NCT00419952|528835847|FG000|Overall Study|Intake of prohibited medication|2|||
146633888|NCT00419952|528835848|FG001|Overall Study|Intake of prohibited medication|2|||
146633889|NCT00419952|528835847|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
146553377|NCT00147537|528534476|FG000|Phase 1b|Other|0|||
146633890|NCT00419952|528835848|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
146553378|NCT00147537|528534477|FG001|Phase 1b|Other|0|||
146633891|NCT00419952|528835847|FG000|Overall Study|Diary or medication non-compliance|2|||
146633892|NCT00419952|528835848|FG001|Overall Study|Diary or medication non-compliance|4|||
146553379|NCT00147537|528534478|FG002|Phase 1b|Other|2|||
146553380|NCT00147537|528534479|FG003|Phase 1b|Other|1|||
146553381|NCT00147537|528534480|FG004|Phase 1b|Other|1|||
146553382|NCT00147537|528534481|FG005|Phase 1b|Other|1|||
146553383|NCT00147537|528534482|FG006|Phase 1b|Other|14|||
146553384|NCT00147537|528534483|FG007|Phase 1b|Other|4|||
146553385|NCT00147537|528534484|FG008|Phase 1b|Other|4|||
146633893|NCT00419952|528835847|FG000|Overall Study|Abnormal ECG|1|||
146633894|NCT00419952|528835848|FG001|Overall Study|Abnormal ECG|0|||
146633895|NCT03126591|528835849|FG000|Overall Study|Death|6|||
146633896|NCT03126591|528835850|FG001|Overall Study|Death|3|||
146633897|NCT03126591|528835851|FG002|Overall Study|Death|17|||
146633898|NCT03126591|528835849|FG000|Overall Study|Progressive Disease|0|||
146633899|NCT03126591|528835850|FG001|Overall Study|Progressive Disease|1|||
146633900|NCT03126591|528835851|FG002|Overall Study|Progressive Disease|2|||
146633901|NCT03126591|528835849|FG000|Overall Study|Terminated by Sponsor|0|||
146633902|NCT03126591|528835850|FG001|Overall Study|Terminated by Sponsor|1|||
146633903|NCT03126591|528835851|FG002|Overall Study|Terminated by Sponsor|4|||
146633904|NCT03126591|528835849|FG000|Overall Study|Withdrawal by Subject|1|||
146633905|NCT03126591|528835850|FG001|Overall Study|Withdrawal by Subject|1|||
146633906|NCT03126591|528835851|FG002|Overall Study|Withdrawal by Subject|4|||
146633907|NCT02606643|528835852|FG000|Overall Study|did not meet inclusion criteria|1|||
146633908|NCT02606643|528835853|FG001|Overall Study|did not meet inclusion criteria|3|||
146633909|NCT02158546|528835860|FG000|Overall Study|Physician Decision|0|||
146633910|NCT02158546|528835861|FG001|Overall Study|Physician Decision|1|||
146633911|NCT02158546|528835862|FG002|Overall Study|Physician Decision|0|||
146633912|NCT02158546|528835863|FG003|Overall Study|Physician Decision|0|||
146633913|NCT02158546|528835860|FG000|Overall Study|Non-compliance|0|||
146633914|NCT02158546|528835861|FG001|Overall Study|Non-compliance|1|||
146633915|NCT02158546|528835862|FG002|Overall Study|Non-compliance|0|||
146633916|NCT02158546|528835863|FG003|Overall Study|Non-compliance|1|||
146633917|NCT02158546|528835860|FG000|Overall Study|Failure to meet eligibility criteria|0|||
146633918|NCT02158546|528835861|FG001|Overall Study|Failure to meet eligibility criteria|1|||
146633919|NCT02158546|528835862|FG002|Overall Study|Failure to meet eligibility criteria|0|||
146633920|NCT02158546|528835863|FG003|Overall Study|Failure to meet eligibility criteria|0|||
146633921|NCT02158546|528835860|FG000|Overall Study|Lack of Efficacy|1|||
146633922|NCT02158546|528835861|FG001|Overall Study|Lack of Efficacy|1|||
146633923|NCT02158546|528835862|FG002|Overall Study|Lack of Efficacy|0|||
146633924|NCT02158546|528835863|FG003|Overall Study|Lack of Efficacy|0|||
146633925|NCT02158546|528835860|FG000|Overall Study|Adverse Event|2|||
146633926|NCT02158546|528835861|FG001|Overall Study|Adverse Event|2|||
146633927|NCT02158546|528835862|FG002|Overall Study|Adverse Event|0|||
146633928|NCT02158546|528835863|FG003|Overall Study|Adverse Event|0|||
146633929|NCT02158546|528835860|FG000|Overall Study|Withdrawal by Subject|6|||
146633930|NCT02158546|528835861|FG001|Overall Study|Withdrawal by Subject|2|||
146633931|NCT02158546|528835862|FG002|Overall Study|Withdrawal by Subject|1|||
146633932|NCT02158546|528835863|FG003|Overall Study|Withdrawal by Subject|0|||
146966650|NCT04242498|530038868|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146966651|NCT04242498|530038869|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146966652|NCT04242498|530038863|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
146966653|NCT04242498|530038864|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
146966654|NCT04242498|530038865|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
146966655|NCT04242498|530038866|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
146966656|NCT04242498|530038867|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
146966657|NCT04242498|530038868|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
146966658|NCT04242498|530038869|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
146966659|NCT04242498|530038863|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
146966660|NCT04242498|530038864|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
146633933|NCT02158546|528835860|FG000|Overall Study|Lost to Follow-up|5|||
146553386|NCT00147537|528534485|FG009|Phase 1b|Other|0|||
146553387|NCT00147537|528534486|FG010|Phase 1b|Other|0|||
146553388|NCT00147537|528534476|FG000|Phase 1b|Withdrawal by Subject|0|||
146553389|NCT00147537|528534477|FG001|Phase 1b|Withdrawal by Subject|0|||
146553390|NCT00147537|528534478|FG002|Phase 1b|Withdrawal by Subject|0|||
146553391|NCT00147537|528534479|FG003|Phase 1b|Withdrawal by Subject|0|||
146553392|NCT00147537|528534480|FG004|Phase 1b|Withdrawal by Subject|0|||
146553393|NCT00147537|528534481|FG005|Phase 1b|Withdrawal by Subject|0|||
146553394|NCT00147537|528534482|FG006|Phase 1b|Withdrawal by Subject|0|||
146553395|NCT00147537|528534483|FG007|Phase 1b|Withdrawal by Subject|0|||
146553396|NCT00147537|528534484|FG008|Phase 1b|Withdrawal by Subject|2|||
146553397|NCT00147537|528534485|FG009|Phase 1b|Withdrawal by Subject|0|||
146553398|NCT00147537|528534486|FG010|Phase 1b|Withdrawal by Subject|0|||
146633934|NCT02158546|528835861|FG001|Overall Study|Lost to Follow-up|4|||
146633935|NCT02158546|528835862|FG002|Overall Study|Lost to Follow-up|0|||
146633936|NCT02158546|528835863|FG003|Overall Study|Lost to Follow-up|1|||
146633937|NCT02158546|528835860|FG000|Overall Study|Site Excluded|5|||
146633938|NCT02158546|528835861|FG001|Overall Study|Site Excluded|5|||
146633939|NCT02158546|528835862|FG002|Overall Study|Site Excluded|3|||
146966661|NCT04242498|530038865|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
146553399|NCT00147537|528534476|FG000|Phase 1b|Randomized but not treated|0|||
146633940|NCT02158546|528835863|FG003|Overall Study|Site Excluded|4|||
146633941|NCT02351817|528835864|FG000|Period 1|Adverse Event|1|||
146633942|NCT02351817|528835865|FG001|Period 1|Adverse Event|2|||
146633943|NCT02351817|528835864|FG000|Period 1|Lack of Efficacy|0|||
146633944|NCT02351817|528835865|FG001|Period 1|Lack of Efficacy|1|||
146633945|NCT02351817|528835864|FG000|Period 2|Adverse Event|0|||
146633946|NCT02351817|528835865|FG001|Period 2|Adverse Event|2|||
146633947|NCT02351817|528835864|FG000|Period 2|Protocol Violation|1|||
146633948|NCT02351817|528835865|FG001|Period 2|Protocol Violation|0|||
146633949|NCT02488915|528835868|FG000|Overall Study|Death|21|||
146633950|NCT02488915|528835868|FG000|Overall Study|Lost to Follow-up|4|||
146633951|NCT02488915|528835868|FG000|Overall Study|Withdrawal by Subject|1|||
146633952|NCT00885170|528835871|FG000|Overall Study|Adverse Event|12|||
146633953|NCT00885170|528835872|FG001|Overall Study|Adverse Event|4|||
146633954|NCT00885170|528835871|FG000|Overall Study|Excessive bone loss|6|||
146633955|NCT00885170|528835872|FG001|Overall Study|Excessive bone loss|3|||
146633956|NCT00885170|528835871|FG000|Overall Study|Lost to Follow-up|2|||
146633957|NCT00885170|528835872|FG001|Overall Study|Lost to Follow-up|1|||
146633958|NCT00885170|528835871|FG000|Overall Study|Physician Decision|2|||
146633959|NCT00885170|528835872|FG001|Overall Study|Physician Decision|1|||
146633960|NCT00885170|528835871|FG000|Overall Study|Protocol Violation|3|||
146633961|NCT00885170|528835872|FG001|Overall Study|Protocol Violation|1|||
146633962|NCT00885170|528835871|FG000|Overall Study|Withdrawal by Subject|13|||
146633963|NCT00885170|528835872|FG001|Overall Study|Withdrawal by Subject|13|||
146633964|NCT03771664|528835873|FG000|Overall Study|Adverse Event|1|||
146633965|NCT03771664|528835874|FG001|Overall Study|Adverse Event|0|||
146633966|NCT03771664|528835873|FG000|Overall Study|Lost to Follow-up|1|||
146633967|NCT03771664|528835874|FG001|Overall Study|Lost to Follow-up|0|||
146633968|NCT03771664|528835873|FG000|Overall Study|Withdrawal by Participant|1|||
146633969|NCT03771664|528835874|FG001|Overall Study|Withdrawal by Participant|4|||
146633970|NCT03771664|528835873|FG000|Overall Study|Randomized but not Treated|0|||
146633971|NCT03771664|528835874|FG001|Overall Study|Randomized but not Treated|1|||
146633972|NCT01208207|528835877|FG000|Part I|Adverse Event|19|||
146633973|NCT01208207|528835878|FG001|Part I|Adverse Event|2|||
146633974|NCT01208207|528835879|FG002|Part I|Adverse Event|6|||
146633975|NCT01208207|528835880|FG003|Part I|Adverse Event|0|||
146633976|NCT01208207|528835881|FG004|Part I|Adverse Event|0|||
146633977|NCT01208207|528835882|FG005|Part I|Adverse Event|0|||
146633978|NCT01208207|528835883|FG006|Part I|Adverse Event|0|||
146633979|NCT01208207|528835877|FG000|Part I|Lack of Efficacy|21|||
146633980|NCT01208207|528835878|FG001|Part I|Lack of Efficacy|3|||
146633981|NCT01208207|528835879|FG002|Part I|Lack of Efficacy|2|||
146633982|NCT01208207|528835880|FG003|Part I|Lack of Efficacy|0|||
146633983|NCT01208207|528835881|FG004|Part I|Lack of Efficacy|0|||
146633984|NCT01208207|528835882|FG005|Part I|Lack of Efficacy|0|||
146633985|NCT01208207|528835883|FG006|Part I|Lack of Efficacy|0|||
146633986|NCT01208207|528835877|FG000|Part I|Lost to Follow-up|6|||
146633987|NCT01208207|528835878|FG001|Part I|Lost to Follow-up|1|||
146633988|NCT01208207|528835879|FG002|Part I|Lost to Follow-up|0|||
146633989|NCT01208207|528835880|FG003|Part I|Lost to Follow-up|0|||
146633990|NCT01208207|528835881|FG004|Part I|Lost to Follow-up|0|||
146633991|NCT01208207|528835882|FG005|Part I|Lost to Follow-up|0|||
146633992|NCT01208207|528835883|FG006|Part I|Lost to Follow-up|0|||
146553400|NCT00147537|528534477|FG001|Phase 1b|Randomized but not treated|0|||
146553401|NCT00147537|528534478|FG002|Phase 1b|Randomized but not treated|0|||
146553402|NCT00147537|528534479|FG003|Phase 1b|Randomized but not treated|0|||
146553403|NCT00147537|528534480|FG004|Phase 1b|Randomized but not treated|0|||
146553404|NCT00147537|528534481|FG005|Phase 1b|Randomized but not treated|0|||
146553405|NCT00147537|528534482|FG006|Phase 1b|Randomized but not treated|1|||
146553406|NCT00147537|528534483|FG007|Phase 1b|Randomized but not treated|0|||
146633993|NCT01208207|528835877|FG000|Part I|Non-Compliance With Study Drug|1|||
146633994|NCT01208207|528835878|FG001|Part I|Non-Compliance With Study Drug|0|||
146633995|NCT01208207|528835879|FG002|Part I|Non-Compliance With Study Drug|1|||
146633996|NCT01208207|528835880|FG003|Part I|Non-Compliance With Study Drug|0|||
146633997|NCT01208207|528835881|FG004|Part I|Non-Compliance With Study Drug|0|||
146633998|NCT01208207|528835882|FG005|Part I|Non-Compliance With Study Drug|0|||
146633999|NCT01208207|528835883|FG006|Part I|Non-Compliance With Study Drug|0|||
146634000|NCT01208207|528835877|FG000|Part I|Physician Decision|0|||
146634001|NCT01208207|528835878|FG001|Part I|Physician Decision|1|||
146634002|NCT01208207|528835879|FG002|Part I|Physician Decision|0|||
146634003|NCT01208207|528835880|FG003|Part I|Physician Decision|0|||
146634004|NCT01208207|528835881|FG004|Part I|Physician Decision|0|||
146634005|NCT01208207|528835882|FG005|Part I|Physician Decision|0|||
146634006|NCT01208207|528835883|FG006|Part I|Physician Decision|0|||
146634007|NCT01208207|528835877|FG000|Part I|Progressive Disease|1|||
146634008|NCT01208207|528835878|FG001|Part I|Progressive Disease|0|||
146634009|NCT01208207|528835879|FG002|Part I|Progressive Disease|0|||
146634010|NCT01208207|528835880|FG003|Part I|Progressive Disease|0|||
146634011|NCT01208207|528835881|FG004|Part I|Progressive Disease|0|||
146634012|NCT01208207|528835882|FG005|Part I|Progressive Disease|0|||
146634013|NCT01208207|528835883|FG006|Part I|Progressive Disease|0|||
146634014|NCT01208207|528835877|FG000|Part I|Protocol Violation|8|||
146634015|NCT01208207|528835878|FG001|Part I|Protocol Violation|0|||
146634016|NCT01208207|528835879|FG002|Part I|Protocol Violation|2|||
146634017|NCT01208207|528835880|FG003|Part I|Protocol Violation|0|||
146634018|NCT01208207|528835881|FG004|Part I|Protocol Violation|0|||
146634019|NCT01208207|528835882|FG005|Part I|Protocol Violation|0|||
146634020|NCT01208207|528835883|FG006|Part I|Protocol Violation|0|||
146634021|NCT01208207|528835877|FG000|Part I|Withdrawal by Subject|14|||
146634022|NCT01208207|528835878|FG001|Part I|Withdrawal by Subject|4|||
146634023|NCT01208207|528835879|FG002|Part I|Withdrawal by Subject|4|||
146634024|NCT01208207|528835880|FG003|Part I|Withdrawal by Subject|0|||
146634025|NCT01208207|528835881|FG004|Part I|Withdrawal by Subject|0|||
146634026|NCT01208207|528835882|FG005|Part I|Withdrawal by Subject|0|||
146634027|NCT01208207|528835883|FG006|Part I|Withdrawal by Subject|0|||
146634028|NCT01208207|528835877|FG000|Part II|Withdrawal by Subject|0|||
146634029|NCT01208207|528835878|FG001|Part II|Withdrawal by Subject|0|||
146634030|NCT01208207|528835879|FG002|Part II|Withdrawal by Subject|0|||
146634031|NCT01208207|528835880|FG003|Part II|Withdrawal by Subject|10|||
146634032|NCT01208207|528835881|FG004|Part II|Withdrawal by Subject|9|||
146634033|NCT01208207|528835882|FG005|Part II|Withdrawal by Subject|3|||
146634034|NCT01208207|528835883|FG006|Part II|Withdrawal by Subject|5|||
146634035|NCT01208207|528835877|FG000|Part II|Adverse Event|0|||
146634036|NCT01208207|528835878|FG001|Part II|Adverse Event|0|||
146634037|NCT01208207|528835879|FG002|Part II|Adverse Event|0|||
146634038|NCT01208207|528835880|FG003|Part II|Adverse Event|5|||
146634039|NCT01208207|528835881|FG004|Part II|Adverse Event|9|||
146634040|NCT01208207|528835882|FG005|Part II|Adverse Event|4|||
146634041|NCT01208207|528835883|FG006|Part II|Adverse Event|2|||
146634042|NCT01208207|528835877|FG000|Part II|Lack of Efficacy|0|||
146634043|NCT01208207|528835878|FG001|Part II|Lack of Efficacy|0|||
146634044|NCT01208207|528835879|FG002|Part II|Lack of Efficacy|0|||
146634045|NCT01208207|528835880|FG003|Part II|Lack of Efficacy|6|||
146553407|NCT00147537|528534484|FG008|Phase 1b|Randomized but not treated|1|||
146634046|NCT01208207|528835881|FG004|Part II|Lack of Efficacy|4|||
146634047|NCT01208207|528835882|FG005|Part II|Lack of Efficacy|3|||
146634048|NCT01208207|528835883|FG006|Part II|Lack of Efficacy|3|||
146634049|NCT01208207|528835877|FG000|Part II|Lost to Follow-up|0|||
146634050|NCT01208207|528835878|FG001|Part II|Lost to Follow-up|0|||
146634051|NCT01208207|528835879|FG002|Part II|Lost to Follow-up|0|||
146634052|NCT01208207|528835880|FG003|Part II|Lost to Follow-up|4|||
146634053|NCT01208207|528835881|FG004|Part II|Lost to Follow-up|0|||
146634054|NCT01208207|528835882|FG005|Part II|Lost to Follow-up|2|||
146634055|NCT01208207|528835883|FG006|Part II|Lost to Follow-up|1|||
146634056|NCT01208207|528835877|FG000|Part II|Non-Compliance With Study Drug|0|||
146634057|NCT01208207|528835878|FG001|Part II|Non-Compliance With Study Drug|0|||
146553408|NCT00147537|528534485|FG009|Phase 1b|Randomized but not treated|0|||
146553409|NCT00147537|528534486|FG010|Phase 1b|Randomized but not treated|0|||
146553410|NCT00147537|528534476|FG000|Phase 2|Death|0|||
146634058|NCT01208207|528835879|FG002|Part II|Non-Compliance With Study Drug|0|||
146634059|NCT01208207|528835880|FG003|Part II|Non-Compliance With Study Drug|4|||
146634060|NCT01208207|528835881|FG004|Part II|Non-Compliance With Study Drug|1|||
146634061|NCT01208207|528835882|FG005|Part II|Non-Compliance With Study Drug|1|||
146634062|NCT01208207|528835883|FG006|Part II|Non-Compliance With Study Drug|0|||
146634063|NCT01208207|528835877|FG000|Part II|Physician Decision|0|||
146634064|NCT01208207|528835878|FG001|Part II|Physician Decision|0|||
146634065|NCT01208207|528835879|FG002|Part II|Physician Decision|0|||
146553411|NCT00147537|528534477|FG001|Phase 2|Death|0|||
146634066|NCT01208207|528835880|FG003|Part II|Physician Decision|1|||
146634067|NCT01208207|528835881|FG004|Part II|Physician Decision|0|||
146634068|NCT01208207|528835882|FG005|Part II|Physician Decision|2|||
146634069|NCT01208207|528835883|FG006|Part II|Physician Decision|0|||
146634070|NCT01208207|528835877|FG000|Part II|Protocol Violation|0|||
146634071|NCT01208207|528835878|FG001|Part II|Protocol Violation|0|||
146634072|NCT01208207|528835879|FG002|Part II|Protocol Violation|0|||
146634073|NCT01208207|528835880|FG003|Part II|Protocol Violation|1|||
146634074|NCT01208207|528835881|FG004|Part II|Protocol Violation|0|||
146634075|NCT01208207|528835882|FG005|Part II|Protocol Violation|0|||
146634076|NCT01208207|528835883|FG006|Part II|Protocol Violation|0|||
146634077|NCT01208207|528835877|FG000|Part II|Technical Problems|0|||
146634078|NCT01208207|528835878|FG001|Part II|Technical Problems|0|||
146634079|NCT01208207|528835879|FG002|Part II|Technical Problems|0|||
146634080|NCT01208207|528835880|FG003|Part II|Technical Problems|1|||
146634081|NCT01208207|528835881|FG004|Part II|Technical Problems|0|||
146634082|NCT01208207|528835882|FG005|Part II|Technical Problems|1|||
146634083|NCT01208207|528835883|FG006|Part II|Technical Problems|0|||
146634084|NCT04041414|528835886|FG000|Overall Study|Lost to Follow-up|1|||
146634085|NCT04041414|528835887|FG001|Overall Study|Lost to Follow-up|2|||
146634086|NCT00665652|528835888|FG000|Overall Study|Adverse Event|4|||
146634087|NCT00665652|528835888|FG000|Overall Study|Death|1|||
146634088|NCT00665652|528835888|FG000|Overall Study|No longer met inclusion criteria.|1|||
146634089|NCT02161016|528835889|FG000|Overall Study|withdrawn by IRB|1|||
146634090|NCT00380367|528835905|FG000|Overall Study|Lost to Follow-up|1|||
146634091|NCT00380367|528835905|FG000|Overall Study|Withdrawal by Subject|1|||
146634092|NCT01605799|528835906|FG000|Overall Study|Withdrawal by Subject|2|||
146634093|NCT01605799|528835907|FG001|Overall Study|Withdrawal by Subject|1|||
146634094|NCT00830440|528835918|FG000|Overall Study|Protocol Violation|1|||
146634095|NCT00830440|528835919|FG001|Overall Study|Protocol Violation|0|||
146634096|NCT00830440|528835918|FG000|Overall Study|Withdrawal by Subject|1|||
146634097|NCT00830440|528835919|FG001|Overall Study|Withdrawal by Subject|0|||
146553412|NCT00147537|528534478|FG002|Phase 2|Death|0|||
146553413|NCT00147537|528534479|FG003|Phase 2|Death|0|||
146553414|NCT00147537|528534480|FG004|Phase 2|Death|0|||
146553415|NCT00147537|528534481|FG005|Phase 2|Death|0|||
146553416|NCT00147537|528534482|FG006|Phase 2|Death|0|||
146553417|NCT00147537|528534483|FG007|Phase 2|Death|0|||
146553418|NCT00147537|528534484|FG008|Phase 2|Death|0|||
146553419|NCT00147537|528534485|FG009|Phase 2|Death|85|||
146553420|NCT00147537|528534486|FG010|Phase 2|Death|31|||
146553421|NCT00147537|528534476|FG000|Phase 2|Lost to Follow-up|0|||
146553422|NCT00147537|528534477|FG001|Phase 2|Lost to Follow-up|0|||
146553423|NCT00147537|528534478|FG002|Phase 2|Lost to Follow-up|0|||
146553424|NCT00147537|528534479|FG003|Phase 2|Lost to Follow-up|0|||
146553425|NCT00147537|528534480|FG004|Phase 2|Lost to Follow-up|0|||
146553426|NCT00147537|528534481|FG005|Phase 2|Lost to Follow-up|0|||
146553427|NCT00147537|528534482|FG006|Phase 2|Lost to Follow-up|0|||
146553428|NCT00147537|528534483|FG007|Phase 2|Lost to Follow-up|0|||
146553429|NCT00147537|528534484|FG008|Phase 2|Lost to Follow-up|0|||
146553430|NCT00147537|528534485|FG009|Phase 2|Lost to Follow-up|12|||
146553431|NCT00147537|528534486|FG010|Phase 2|Lost to Follow-up|4|||
146553432|NCT00147537|528534476|FG000|Phase 2|Other|0|||
146553433|NCT00147537|528534477|FG001|Phase 2|Other|0|||
146553434|NCT00147537|528534478|FG002|Phase 2|Other|0|||
146553435|NCT00147537|528534479|FG003|Phase 2|Other|0|||
146553436|NCT00147537|528534480|FG004|Phase 2|Other|0|||
146553437|NCT00147537|528534481|FG005|Phase 2|Other|0|||
146553438|NCT00147537|528534482|FG006|Phase 2|Other|0|||
146553439|NCT00147537|528534483|FG007|Phase 2|Other|0|||
146553440|NCT00147537|528534484|FG008|Phase 2|Other|0|||
146553441|NCT00147537|528534485|FG009|Phase 2|Other|47|||
146553442|NCT00147537|528534486|FG010|Phase 2|Other|12|||
146553443|NCT00147537|528534476|FG000|Phase 2|Withdrawal by Subject|0|||
146553444|NCT00147537|528534477|FG001|Phase 2|Withdrawal by Subject|0|||
146634098|NCT00830440|528835918|FG000|Overall Study|unsuccessful procedure|4|||
146634099|NCT00830440|528835919|FG001|Overall Study|unsuccessful procedure|0|||
146634100|NCT00830440|528835918|FG000|Overall Study|Adverse Event|2|||
146634101|NCT00830440|528835919|FG001|Overall Study|Adverse Event|0|||
146634102|NCT02592798|528835920|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
146634103|NCT02592798|528835921|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
146553445|NCT00147537|528534478|FG002|Phase 2|Withdrawal by Subject|0|||
146553446|NCT00147537|528534479|FG003|Phase 2|Withdrawal by Subject|0|||
146553447|NCT00147537|528534480|FG004|Phase 2|Withdrawal by Subject|0|||
146553448|NCT00147537|528534481|FG005|Phase 2|Withdrawal by Subject|0|||
146553449|NCT00147537|528534482|FG006|Phase 2|Withdrawal by Subject|0|||
146553450|NCT00147537|528534483|FG007|Phase 2|Withdrawal by Subject|0|||
146553451|NCT00147537|528534484|FG008|Phase 2|Withdrawal by Subject|0|||
146634104|NCT02592798|528835920|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
146634105|NCT02592798|528835921|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
146634106|NCT02592798|528835920|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
146634107|NCT02592798|528835921|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
146634108|NCT02592798|528835920|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
146634109|NCT02592798|528835921|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
146634110|NCT02592798|528835920|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
146634111|NCT02592798|528835921|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
146634112|NCT02592798|528835920|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
146634113|NCT02592798|528835921|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
146634114|NCT02592798|528835920|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
146634115|NCT02592798|528835921|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
146634116|NCT02592798|528835920|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
146634117|NCT02592798|528835921|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
146634118|NCT02592798|528835920|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
146634119|NCT02592798|528835921|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
146634120|NCT02592798|528835920|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
146634121|NCT02592798|528835921|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
146634122|NCT02592798|528835920|FG000|Transition From DB2 to OLE|Other reasons|1|||
146634123|NCT02592798|528835921|FG001|Transition From DB2 to OLE|Other reasons|0|||
146634124|NCT02592798|528835920|FG000|Open Label Period (OLE)|Other reasons|0|||
146634125|NCT02592798|528835921|FG001|Open Label Period (OLE)|Other reasons|2|||
146634126|NCT02592798|528835920|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
146634127|NCT02592798|528835921|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
146634128|NCT02592798|528835920|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
146634129|NCT02592798|528835921|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
146634130|NCT02592798|528835920|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
146634131|NCT02592798|528835921|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
146634132|NCT02592798|528835920|FG000|Open Label Period (OLE)|Adverse Event|0|||
146634133|NCT02592798|528835921|FG001|Open Label Period (OLE)|Adverse Event|1|||
146634134|NCT00942604|528835922|FG000|Overall Study|Protocol Violation|1|||
146634135|NCT00942604|528835923|FG001|Overall Study|Protocol Violation|1|||
146634136|NCT00942604|528835922|FG000|Overall Study|Adverse Event|0|||
146634137|NCT00942604|528835923|FG001|Overall Study|Adverse Event|1|||
146634138|NCT00942604|528835922|FG000|Overall Study|Withdrawal by Subject|0|||
146634139|NCT00942604|528835923|FG001|Overall Study|Withdrawal by Subject|1|||
146634140|NCT00942604|528835922|FG000|Overall Study|Patient relocation|1|||
146634141|NCT00942604|528835923|FG001|Overall Study|Patient relocation|1|||
146634142|NCT01143246|528835924|FG000|Overall Study|Adverse Event|24|||
146634143|NCT01143246|528835925|FG001|Overall Study|Adverse Event|28|||
146634144|NCT01143246|528835924|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
146634145|NCT01143246|528835925|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
146634146|NCT01143246|528835924|FG000|Overall Study|Lost to Follow-up|0|||
146634147|NCT01143246|528835925|FG001|Overall Study|Lost to Follow-up|1|||
146634148|NCT01143246|528835924|FG000|Overall Study|Death|16|||
146634149|NCT01143246|528835925|FG001|Overall Study|Death|15|||
146634150|NCT01143246|528835924|FG000|Overall Study|Reason not Specified|3|||
146634151|NCT01143246|528835925|FG001|Overall Study|Reason not Specified|5|||
146634152|NCT03987503|528835927|FG000|Overall Study|Lost to Follow-up|20|||
146634153|NCT03987503|528835927|FG000|Overall Study|Withdrawal by Subject|2|||
146634154|NCT03486834|528835929|FG000|Overall Study|Withdrawal by Subject|46|||
146634155|NCT03486834|528835930|FG001|Overall Study|Withdrawal by Subject|46|||
146634156|NCT03486834|528835931|FG002|Overall Study|Withdrawal by Subject|52|||
146634157|NCT03486834|528835929|FG000|Overall Study|Adverse Event|8|||
146634158|NCT03486834|528835930|FG001|Overall Study|Adverse Event|7|||
146634159|NCT03486834|528835931|FG002|Overall Study|Adverse Event|0|||
146634160|NCT03486834|528835929|FG000|Overall Study|Lost to Follow-up|41|||
146634161|NCT03486834|528835930|FG001|Overall Study|Lost to Follow-up|24|||
146634162|NCT03486834|528835931|FG002|Overall Study|Lost to Follow-up|39|||
146634163|NCT03486834|528835929|FG000|Overall Study|Non-compliance with Study Drug|2|||
146634164|NCT03486834|528835930|FG001|Overall Study|Non-compliance with Study Drug|2|||
146634165|NCT03486834|528835931|FG002|Overall Study|Non-compliance with Study Drug|0|||
146634166|NCT03486834|528835929|FG000|Overall Study|Physician Decision|5|||
146634167|NCT03486834|528835930|FG001|Overall Study|Physician Decision|2|||
146634168|NCT03486834|528835931|FG002|Overall Study|Physician Decision|3|||
146634169|NCT03486834|528835929|FG000|Overall Study|Pregnancy|10|||
146634170|NCT03486834|528835930|FG001|Overall Study|Pregnancy|12|||
146634171|NCT03486834|528835931|FG002|Overall Study|Pregnancy|12|||
146634172|NCT03486834|528835929|FG000|Overall Study|Protocol Deviation|2|||
146634173|NCT03486834|528835930|FG001|Overall Study|Protocol Deviation|3|||
146634174|NCT03486834|528835931|FG002|Overall Study|Protocol Deviation|3|||
146634175|NCT03486834|528835929|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146634176|NCT03486834|528835930|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
146634177|NCT03486834|528835931|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
146765315|NCT03546907|529308606|FG001|Overall Study|Adverse events (AEs)|10|||
146765316|NCT03546907|529308605|FG000|Overall Study|Other-unspecified|1|||
146634178|NCT03486834|528835929|FG000|Overall Study|Randomized but not treated|4|||
146634179|NCT03486834|528835930|FG001|Overall Study|Randomized but not treated|4|||
146553452|NCT00147537|528534485|FG009|Phase 2|Withdrawal by Subject|16|||
146553453|NCT00147537|528534486|FG010|Phase 2|Withdrawal by Subject|4|||
146553454|NCT00147537|528534476|FG000|Phase 2|Randomized but not treated|0|||
146553455|NCT00147537|528534477|FG001|Phase 2|Randomized but not treated|0|||
146553456|NCT00147537|528534478|FG002|Phase 2|Randomized but not treated|0|||
146553457|NCT00147537|528534479|FG003|Phase 2|Randomized but not treated|0|||
146553458|NCT00147537|528534480|FG004|Phase 2|Randomized but not treated|0|||
146553459|NCT00147537|528534481|FG005|Phase 2|Randomized but not treated|0|||
146553460|NCT00147537|528534482|FG006|Phase 2|Randomized but not treated|0|||
146553461|NCT00147537|528534483|FG007|Phase 2|Randomized but not treated|0|||
146553462|NCT00147537|528534484|FG008|Phase 2|Randomized but not treated|0|||
146553463|NCT00147537|528534485|FG009|Phase 2|Randomized but not treated|1|||
146553464|NCT00147537|528534486|FG010|Phase 2|Randomized but not treated|1|||
146553465|NCT01927861|528534487|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
146553466|NCT01927861|528534488|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
146553467|NCT01927861|528534487|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
146553468|NCT01927861|528534488|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
146553469|NCT01248468|528534490|FG000|Overall Study|Administrative problem|1|||
146553470|NCT01248468|528534491|FG001|Overall Study|Administrative problem|0|||
146553471|NCT01248468|528534492|FG002|Overall Study|Administrative problem|0|||
146553472|NCT01248468|528534490|FG000|Overall Study|Lost to Follow-up|9|||
146553473|NCT01248468|528534491|FG001|Overall Study|Lost to Follow-up|12|||
146553474|NCT01248468|528534492|FG002|Overall Study|Lost to Follow-up|4|||
146553475|NCT01248468|528534490|FG000|Overall Study|Pregnancy|1|||
146553476|NCT01248468|528534491|FG001|Overall Study|Pregnancy|0|||
146553477|NCT01248468|528534492|FG002|Overall Study|Pregnancy|0|||
146553478|NCT01248468|528534490|FG000|Overall Study|Withdrawal by Subject|4|||
146553479|NCT01248468|528534491|FG001|Overall Study|Withdrawal by Subject|2|||
146553480|NCT01248468|528534492|FG002|Overall Study|Withdrawal by Subject|0|||
146553481|NCT00468546|528534494|FG000|Week 24 Analysis|Lack of Efficacy|83|||
146553482|NCT00468546|528534495|FG001|Week 24 Analysis|Lack of Efficacy|37|||
146553483|NCT00468546|528534494|FG000|Week 24 Analysis|Refused treatment|5|||
146553484|NCT00468546|528534495|FG001|Week 24 Analysis|Refused treatment|5|||
146553485|NCT00468546|528534494|FG000|Week 24 Analysis|Adverse Event|1|||
146553486|NCT00468546|528534495|FG001|Week 24 Analysis|Adverse Event|8|||
146553487|NCT00468546|528534494|FG000|Week 24 Analysis|Failure to return|3|||
146553488|NCT00468546|528534495|FG001|Week 24 Analysis|Failure to return|4|||
146553489|NCT00468546|528534494|FG000|Week 24 Analysis|Rescue therapy|2|||
146553490|NCT00468546|528534495|FG001|Week 24 Analysis|Rescue therapy|0|||
146553491|NCT00468546|528534494|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
146553492|NCT00468546|528534495|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
146553493|NCT00468546|528534494|FG000|Week 24 Analysis|Due to clinical hold|1|||
146553494|NCT00468546|528534495|FG001|Week 24 Analysis|Due to clinical hold|0|||
146553495|NCT00468546|528534494|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
146553496|NCT00468546|528534495|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
146553497|NCT00468546|528534494|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
146553498|NCT00468546|528534495|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
146553499|NCT00468546|528534494|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
146553500|NCT00468546|528534495|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
146553501|NCT00468546|528534494|FG000|Week 24 to Week 104 Analysis|Death|1|||
146553502|NCT00468546|528534495|FG001|Week 24 to Week 104 Analysis|Death|0|||
146553503|NCT00468546|528534494|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
146553504|NCT00468546|528534495|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
146553505|NCT00468546|528534494|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
146553506|NCT00468546|528534495|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
146553507|NCT00468546|528534494|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
146553508|NCT00468546|528534495|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
146553509|NCT00468546|528534494|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
146553510|NCT00468546|528534495|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
146553511|NCT00468546|528534494|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
146553512|NCT00468546|528534495|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
146553513|NCT00468546|528534494|FG000|Week 24 to Week 104 Analysis|Other|17|||
146553514|NCT00468546|528534495|FG001|Week 24 to Week 104 Analysis|Other|14|||
146553515|NCT00472641|528534496|FG000|Overall Study|Lack of Efficacy|3|||
146553516|NCT00472641|528534496|FG000|Overall Study|Adverse Event|3|||
146553517|NCT00472641|528534496|FG000|Overall Study|Lost to Follow-up|1|||
146553518|NCT02006654|528534497|FG000|Overall Study|Withdrawal before treatment|4|||
146553519|NCT02006654|528534498|FG001|Overall Study|Withdrawal before treatment|2|||
146553520|NCT02006654|528534497|FG000|Overall Study|Adverse Event|16|||
146553521|NCT02006654|528534498|FG001|Overall Study|Adverse Event|17|||
146553522|NCT02006654|528534497|FG000|Overall Study|Death|1|||
146553523|NCT02006654|528534498|FG001|Overall Study|Death|0|||
146553524|NCT02006654|528534497|FG000|Overall Study|Withdrawal by Subject|14|||
146553525|NCT02006654|528534498|FG001|Overall Study|Withdrawal by Subject|12|||
146553526|NCT02006654|528534497|FG000|Overall Study|Protocol Violation|5|||
146553527|NCT02006654|528534498|FG001|Overall Study|Protocol Violation|8|||
146553528|NCT02006654|528534497|FG000|Overall Study|Lost to Follow-up|1|||
146553529|NCT02006654|528534498|FG001|Overall Study|Lost to Follow-up|0|||
146553530|NCT02006654|528534497|FG000|Overall Study|patient's will|2|||
146553531|NCT02006654|528534498|FG001|Overall Study|patient's will|1|||
146553532|NCT02006654|528534497|FG000|Overall Study|insufficient compliance|1|||
146553533|NCT02006654|528534498|FG001|Overall Study|insufficient compliance|0|||
146553534|NCT02006654|528534497|FG000|Overall Study|worsening cognitive condition|0|||
146553535|NCT02006654|528534498|FG001|Overall Study|worsening cognitive condition|1|||
146553536|NCT02006654|528534497|FG000|Overall Study|faecal incontinence|0|||
146553537|NCT02006654|528534498|FG001|Overall Study|faecal incontinence|1|||
146553538|NCT02006654|528534497|FG000|Overall Study|mood disorder|0|||
146553539|NCT02006654|528534498|FG001|Overall Study|mood disorder|1|||
146553540|NCT02006654|528534497|FG000|Overall Study|disallowed medication|1|||
146553541|NCT02006654|528534498|FG001|Overall Study|disallowed medication|0|||
146553542|NCT02006654|528534497|FG000|Overall Study|moving out of state|0|||
146553543|NCT02006654|528534498|FG001|Overall Study|moving out of state|1|||
146553544|NCT02991859|528534501|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
146553545|NCT02991859|528534502|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
146553546|NCT02991859|528534503|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
146553547|NCT02991859|528534504|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
146553548|NCT02991859|528534505|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
146553549|NCT02991859|528534506|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
146553550|NCT02991859|528534507|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
146553551|NCT02991859|528534508|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
146553552|NCT02991859|528534509|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
146553553|NCT02991859|528534510|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
146553554|NCT02991859|528534511|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
146553555|NCT02991859|528534512|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
146634180|NCT03486834|528835931|FG002|Overall Study|Randomized but not treated|1|||
146553556|NCT02991859|528534513|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
146553557|NCT02991859|528534514|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
146553558|NCT02991859|528534515|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
146553559|NCT02991859|528534516|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
146553560|NCT02991859|528534517|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
146553561|NCT02991859|528534501|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
146553562|NCT02991859|528534502|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
146553563|NCT02991859|528534503|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
146553564|NCT02991859|528534504|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
146553565|NCT02991859|528534505|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
146553566|NCT02991859|528534506|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
146553567|NCT02991859|528534507|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
146553568|NCT02991859|528534508|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
146553569|NCT02991859|528534509|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
146553570|NCT02991859|528534510|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
146553571|NCT02991859|528534511|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
146553572|NCT02991859|528534512|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
146553573|NCT02991859|528534513|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
146553574|NCT02991859|528534514|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
146553575|NCT02991859|528534515|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
146553576|NCT02991859|528534516|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
146553577|NCT02991859|528534517|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
146553578|NCT02991859|528534501|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
146553579|NCT02991859|528534502|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
146553580|NCT02991859|528534503|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
146553581|NCT02991859|528534504|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
146553582|NCT02991859|528534505|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
146553583|NCT02991859|528534506|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
146553584|NCT02991859|528534507|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
146553585|NCT02991859|528534508|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
146553586|NCT02991859|528534509|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
146553587|NCT02991859|528534510|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
146553588|NCT02991859|528534511|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
146553589|NCT02991859|528534512|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
146553590|NCT02991859|528534513|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
146553591|NCT02991859|528534514|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
146553592|NCT02991859|528534515|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
146553593|NCT02991859|528534516|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
146553594|NCT02991859|528534517|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
146553595|NCT02991859|528534501|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
146553596|NCT02991859|528534502|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
146553597|NCT02991859|528534503|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
146553598|NCT02991859|528534504|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
146553599|NCT02991859|528534505|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
146553600|NCT02991859|528534506|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
146553601|NCT02991859|528534507|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
146553602|NCT02991859|528534508|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
146553603|NCT02991859|528534509|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
146553604|NCT02991859|528534510|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
146553605|NCT02991859|528534511|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
146553606|NCT02991859|528534512|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
146553607|NCT02991859|528534513|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
146553608|NCT02991859|528534514|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
146553609|NCT02991859|528534515|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
146553610|NCT02991859|528534516|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
146553611|NCT02991859|528534517|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
146553612|NCT02991859|528534501|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
146553613|NCT02991859|528534502|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
146553614|NCT02991859|528534503|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
146553615|NCT02991859|528534504|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
146553616|NCT02991859|528534505|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
146553617|NCT02991859|528534506|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
146553618|NCT02991859|528534507|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
146553619|NCT02991859|528534508|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
146553620|NCT02991859|528534509|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
146553621|NCT02991859|528534510|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
146553622|NCT02991859|528534511|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
146553623|NCT02991859|528534512|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
146553624|NCT02991859|528534513|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
146553625|NCT02991859|528534514|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
146553626|NCT02991859|528534515|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
146553627|NCT02991859|528534516|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
146553628|NCT02991859|528534517|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
146553629|NCT04128228|528534525|FG000|Overall Study|Withdrawal by Subject|3|||
146553630|NCT04128228|528534526|FG001|Overall Study|Withdrawal by Subject|3|||
146553631|NCT04128228|528534527|FG002|Overall Study|Withdrawal by Subject|0|||
146553632|NCT04128228|528534528|FG003|Overall Study|Withdrawal by Subject|0|||
146553633|NCT04128228|528534525|FG000|Overall Study|noncompliance|2|||
146553634|NCT04128228|528534526|FG001|Overall Study|noncompliance|2|||
146553635|NCT04128228|528534527|FG002|Overall Study|noncompliance|0|||
146553636|NCT04128228|528534528|FG003|Overall Study|noncompliance|0|||
146553637|NCT03520387|528534529|FG000|Pre-Randomization|Withdrawal by Subject|1|||
146553638|NCT03520387|528534530|FG001|Pre-Randomization|Withdrawal by Subject|0|||
146553639|NCT03520387|528534531|FG002|Pre-Randomization|Withdrawal by Subject|0|||
146553640|NCT03520387|528534532|FG003|Pre-Randomization|Withdrawal by Subject|0|||
146553641|NCT03520387|528534533|FG004|Pre-Randomization|Withdrawal by Subject|0|||
146553642|NCT03520387|528534529|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
146553643|NCT03520387|528534530|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
146553644|NCT03520387|528534531|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
146553645|NCT03520387|528534532|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
146553646|NCT03520387|528534533|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
146553647|NCT01945242|528534534|FG000|Overall Study|Physician Decision|3|||
146553648|NCT01945242|528534535|FG001|Overall Study|Physician Decision|3|||
146553649|NCT03163264|528534538|FG000|Overall Study|Withdrawal by Subject|13|||
146553650|NCT03163264|528534539|FG001|Overall Study|Withdrawal by Subject|3|||
146966662|NCT04242498|530038866|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
146966663|NCT04242498|530038867|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
146634181|NCT02745119|528835933|FG000|Overall Study|Adverse Event|1|||
146966664|NCT04242498|530038868|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
146966665|NCT04242498|530038869|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
146966666|NCT04242498|530038863|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
146966667|NCT04242498|530038864|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
146966668|NCT04242498|530038865|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
146966669|NCT04242498|530038866|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
146966670|NCT04242498|530038867|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
146966671|NCT04242498|530038868|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
146966672|NCT04242498|530038869|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
146966673|NCT04242498|530038863|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
146966674|NCT04242498|530038864|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
146966675|NCT04242498|530038865|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
146966676|NCT04242498|530038866|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
146966677|NCT04242498|530038867|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
146966678|NCT04242498|530038868|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
146966679|NCT04242498|530038869|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
146966680|NCT04242498|530038863|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
146966681|NCT04242498|530038864|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
146966682|NCT04242498|530038865|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
146966683|NCT04242498|530038866|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
146966684|NCT04242498|530038867|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
146966685|NCT04242498|530038868|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
146966686|NCT04242498|530038869|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
146966687|NCT04242498|530038863|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
146966688|NCT04242498|530038864|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
146966689|NCT04242498|530038865|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
146966690|NCT04242498|530038866|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
146966691|NCT04242498|530038867|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
146966692|NCT04242498|530038868|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
146966693|NCT04242498|530038869|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
146966694|NCT04242498|530038863|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
146966695|NCT04242498|530038864|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
146966696|NCT04242498|530038865|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
146966697|NCT04242498|530038866|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
146966698|NCT04242498|530038867|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
146966699|NCT04242498|530038868|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
146966700|NCT04242498|530038869|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
146966701|NCT04242498|530038863|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
146966702|NCT04242498|530038864|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
146966703|NCT04242498|530038865|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
146966704|NCT04242498|530038866|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
146966705|NCT04242498|530038867|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
146966706|NCT04242498|530038868|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
146634182|NCT02745119|528835934|FG001|Overall Study|Adverse Event|0|||
146634183|NCT02745119|528835935|FG002|Overall Study|Adverse Event|1|||
146634184|NCT02745119|528835936|FG003|Overall Study|Adverse Event|3|||
146634185|NCT02745119|528835933|FG000|Overall Study|Death|3|||
146634186|NCT02745119|528835934|FG001|Overall Study|Death|3|||
146634187|NCT02745119|528835935|FG002|Overall Study|Death|0|||
146634188|NCT02745119|528835936|FG003|Overall Study|Death|4|||
146634189|NCT02745119|528835933|FG000|Overall Study|Lost to Follow-up|0|||
146634190|NCT02745119|528835934|FG001|Overall Study|Lost to Follow-up|0|||
146634191|NCT02745119|528835935|FG002|Overall Study|Lost to Follow-up|0|||
146634192|NCT02745119|528835936|FG003|Overall Study|Lost to Follow-up|1|||
146634193|NCT02745119|528835933|FG000|Overall Study|Protocol Deviation|0|||
146634194|NCT02745119|528835934|FG001|Overall Study|Protocol Deviation|0|||
146634195|NCT02745119|528835935|FG002|Overall Study|Protocol Deviation|0|||
146634196|NCT02745119|528835936|FG003|Overall Study|Protocol Deviation|1|||
146553651|NCT03163264|528534540|FG002|Overall Study|Withdrawal by Subject|4|||
146553652|NCT03163264|528534541|FG003|Overall Study|Withdrawal by Subject|2|||
146553653|NCT03163264|528534538|FG000|Overall Study|Lost to Follow-up|17|||
146553654|NCT03163264|528534539|FG001|Overall Study|Lost to Follow-up|20|||
146553655|NCT03163264|528534540|FG002|Overall Study|Lost to Follow-up|0|||
146553656|NCT03163264|528534541|FG003|Overall Study|Lost to Follow-up|0|||
146553657|NCT03163264|528534538|FG000|Overall Study|Death|0|||
146553658|NCT03163264|528534539|FG001|Overall Study|Death|2|||
146553659|NCT03163264|528534540|FG002|Overall Study|Death|0|||
146553660|NCT03163264|528534541|FG003|Overall Study|Death|0|||
146553661|NCT02057666|528534542|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
146553662|NCT02057666|528534543|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
146553663|NCT02057666|528534542|FG000|Double Blind Treatment Period|Poor tolerability|7|||
146553664|NCT02057666|528534543|FG001|Double Blind Treatment Period|Poor tolerability|2|||
146553665|NCT02057666|528534542|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
146553666|NCT02057666|528534543|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
146553667|NCT02057666|528534542|FG000|Double Blind Treatment Period|Physician Decision|1|||
146553668|NCT02057666|528534543|FG001|Double Blind Treatment Period|Physician Decision|0|||
146553669|NCT02057666|528534542|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
146553670|NCT02057666|528534543|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
146553671|NCT02057666|528534542|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
146553672|NCT02057666|528534543|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
146553673|NCT02057666|528534542|FG000|Double Blind Treatment Period|Sponsor's request|70|||
146553674|NCT02057666|528534543|FG001|Double Blind Treatment Period|Sponsor's request|34|||
146553675|NCT02057666|528534542|FG000|Open-Label Treatment Period|Poor tolerability|0|||
146553676|NCT02057666|528534543|FG001|Open-Label Treatment Period|Poor tolerability|1|||
146553677|NCT02057666|528534542|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
146553678|NCT02057666|528534543|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
146553679|NCT02057666|528534542|FG000|Open-Label Treatment Period|Sponsor's request|0|||
146553680|NCT02057666|528534543|FG001|Open-Label Treatment Period|Sponsor's request|4|||
146553681|NCT05661734|528534544|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
146634197|NCT02745119|528835933|FG000|Overall Study|Withdrawal by Subject|7|||
146634198|NCT02745119|528835934|FG001|Overall Study|Withdrawal by Subject|15|||
146634199|NCT02745119|528835935|FG002|Overall Study|Withdrawal by Subject|8|||
146634200|NCT02745119|528835936|FG003|Overall Study|Withdrawal by Subject|14|||
146634201|NCT02745119|528835933|FG000|Overall Study|Study Terminated by Sponsor|134|||
146634202|NCT02745119|528835934|FG001|Overall Study|Study Terminated by Sponsor|252|||
146634203|NCT02745119|528835935|FG002|Overall Study|Study Terminated by Sponsor|135|||
146634204|NCT02745119|528835936|FG003|Overall Study|Study Terminated by Sponsor|251|||
146634205|NCT02745119|528835933|FG000|Overall Study|Physician Decision|0|||
146634206|NCT02745119|528835934|FG001|Overall Study|Physician Decision|2|||
146634207|NCT02745119|528835935|FG002|Overall Study|Physician Decision|2|||
146634208|NCT02745119|528835936|FG003|Overall Study|Physician Decision|2|||
146634209|NCT02745119|528835933|FG000|Overall Study|Reason Not Specified|0|||
146634210|NCT02745119|528835934|FG001|Overall Study|Reason Not Specified|2|||
146634211|NCT02745119|528835935|FG002|Overall Study|Reason Not Specified|0|||
146634212|NCT02745119|528835936|FG003|Overall Study|Reason Not Specified|1|||
146634213|NCT00687193|528835940|FG000|Overall Study|Adverse Event|0|||
146634214|NCT00687193|528835941|FG001|Overall Study|Adverse Event|1|||
146634215|NCT00687193|528835942|FG002|Overall Study|Adverse Event|2|||
146634216|NCT00687193|528835943|FG003|Overall Study|Adverse Event|3|||
146634217|NCT00687193|528835944|FG004|Overall Study|Adverse Event|0|||
146634218|NCT00687193|528835945|FG005|Overall Study|Adverse Event|2|||
146634219|NCT00687193|528835940|FG000|Overall Study|Lack of Efficacy|1|||
146634220|NCT00687193|528835941|FG001|Overall Study|Lack of Efficacy|1|||
146634221|NCT00687193|528835942|FG002|Overall Study|Lack of Efficacy|0|||
146634222|NCT00687193|528835943|FG003|Overall Study|Lack of Efficacy|0|||
146634223|NCT00687193|528835944|FG004|Overall Study|Lack of Efficacy|0|||
146634224|NCT00687193|528835945|FG005|Overall Study|Lack of Efficacy|2|||
146634225|NCT00687193|528835940|FG000|Overall Study|Protocol Violation|1|||
146634226|NCT00687193|528835941|FG001|Overall Study|Protocol Violation|2|||
146634227|NCT00687193|528835942|FG002|Overall Study|Protocol Violation|0|||
146634228|NCT00687193|528835943|FG003|Overall Study|Protocol Violation|1|||
146634229|NCT00687193|528835944|FG004|Overall Study|Protocol Violation|2|||
146634230|NCT00687193|528835945|FG005|Overall Study|Protocol Violation|0|||
146634231|NCT02447003|528835946|FG000|Overall Study|Other|0|||
146634232|NCT02447003|528835947|FG001|Overall Study|Other|4|||
146634233|NCT02447003|528835946|FG000|Overall Study|Site discontinued|0|||
146634234|NCT02447003|528835947|FG001|Overall Study|Site discontinued|2|||
146634235|NCT02447003|528835946|FG000|Overall Study|Physician Decision|0|||
146634236|NCT02447003|528835947|FG001|Overall Study|Physician Decision|1|||
146634237|NCT02447003|528835946|FG000|Overall Study|Withdrawal by Subject|4|||
146634238|NCT02447003|528835947|FG001|Overall Study|Withdrawal by Subject|3|||
146634239|NCT02447003|528835946|FG000|Overall Study|Sponsor Decision|6|||
146634240|NCT02447003|528835947|FG001|Overall Study|Sponsor Decision|11|||
146634241|NCT02447003|528835946|FG000|Overall Study|Progressive Disease|1|||
146634242|NCT02447003|528835947|FG001|Overall Study|Progressive Disease|0|||
146634243|NCT02447003|528835946|FG000|Overall Study|Lost to Follow-up|5|||
146634244|NCT02447003|528835947|FG001|Overall Study|Lost to Follow-up|0|||
146634245|NCT02447003|528835946|FG000|Overall Study|Death|154|||
146634246|NCT02447003|528835947|FG001|Overall Study|Death|63|||
146634247|NCT01394016|528835948|FG000|Overall Study|Progressive Disease|2|||
146634248|NCT01394016|528835949|FG001|Overall Study|Progressive Disease|0|||
146634249|NCT01394016|528835950|FG002|Overall Study|Progressive Disease|0|||
146634250|NCT01394016|528835951|FG003|Overall Study|Progressive Disease|0|||
146634251|NCT01394016|528835952|FG004|Overall Study|Progressive Disease|0|||
146634252|NCT01394016|528835953|FG005|Overall Study|Progressive Disease|0|||
146634253|NCT01394016|528835954|FG006|Overall Study|Progressive Disease|0|||
146634254|NCT01394016|528835955|FG007|Overall Study|Progressive Disease|0|||
146634255|NCT01394016|528835956|FG008|Overall Study|Progressive Disease|0|||
146634256|NCT01394016|528835957|FG009|Overall Study|Progressive Disease|0|||
146634257|NCT01394016|528835958|FG010|Overall Study|Progressive Disease|0|||
146634258|NCT01394016|528835959|FG011|Overall Study|Progressive Disease|0|||
146634259|NCT01394016|528835960|FG012|Overall Study|Progressive Disease|0|||
146634260|NCT01394016|528835961|FG013|Overall Study|Progressive Disease|0|||
146634261|NCT01394016|528835962|FG014|Overall Study|Progressive Disease|0|||
146634262|NCT01394016|528835963|FG015|Overall Study|Progressive Disease|0|||
146634263|NCT01394016|528835964|FG016|Overall Study|Progressive Disease|0|||
146634264|NCT01394016|528835965|FG017|Overall Study|Progressive Disease|0|||
146634265|NCT01394016|528835966|FG018|Overall Study|Progressive Disease|0|||
146634266|NCT01394016|528835948|FG000|Overall Study|Withdrawal by Subject|0|||
146634267|NCT01394016|528835949|FG001|Overall Study|Withdrawal by Subject|0|||
146634268|NCT01394016|528835950|FG002|Overall Study|Withdrawal by Subject|0|||
146634269|NCT01394016|528835951|FG003|Overall Study|Withdrawal by Subject|0|||
146634270|NCT01394016|528835952|FG004|Overall Study|Withdrawal by Subject|0|||
146634271|NCT01394016|528835953|FG005|Overall Study|Withdrawal by Subject|0|||
146634272|NCT01394016|528835954|FG006|Overall Study|Withdrawal by Subject|0|||
146634273|NCT01394016|528835955|FG007|Overall Study|Withdrawal by Subject|1|||
146634274|NCT01394016|528835956|FG008|Overall Study|Withdrawal by Subject|1|||
146634275|NCT01394016|528835957|FG009|Overall Study|Withdrawal by Subject|1|||
146634276|NCT01394016|528835958|FG010|Overall Study|Withdrawal by Subject|4|||
146634277|NCT01394016|528835959|FG011|Overall Study|Withdrawal by Subject|0|||
146887835|NCT00209339|529755804|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
146553682|NCT05661734|528534544|FG000|Overall Study|Lost to Follow-up|13|||
146553683|NCT05661734|528534544|FG000|Overall Study|Enrolled but not dosed|2|||
146553684|NCT02489045|528534547|FG000|Overall Study|unable to collect usable data|53|||
146553685|NCT02489045|528534547|FG000|Follow-up|Lost to Follow-up|10|||
146553686|NCT04401293|528534549|FG000|Overall Study|Withdrawal by Subject|1|||
146553687|NCT04401293|528534550|FG001|Overall Study|Withdrawal by Subject|3|||
146553688|NCT03679884|528534551|FG000|Overall Study|Other|12|||
146553689|NCT03679884|528534552|FG001|Overall Study|Other|12|||
146553690|NCT03679884|528534553|FG002|Overall Study|Other|12|||
146553691|NCT03679884|528534554|FG003|Overall Study|Other|7|||
146553692|NCT03679884|528534555|FG004|Overall Study|Other|8|||
146553693|NCT03679884|528534551|FG000|Overall Study|Lack of Efficacy|15|||
146553694|NCT03679884|528534552|FG001|Overall Study|Lack of Efficacy|29|||
146553695|NCT03679884|528534553|FG002|Overall Study|Lack of Efficacy|13|||
146553696|NCT03679884|528534554|FG003|Overall Study|Lack of Efficacy|29|||
146634278|NCT01394016|528835960|FG012|Overall Study|Withdrawal by Subject|0|||
146966707|NCT04242498|530038869|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
146966708|NCT02684162|530038872|FG000|Overall Study|Physician Decision|0|||
146966709|NCT02684162|530038873|FG001|Overall Study|Physician Decision|1|||
146553697|NCT03679884|528534555|FG004|Overall Study|Lack of Efficacy|10|||
146553698|NCT03679884|528534551|FG000|Overall Study|Death|1|||
146553699|NCT03679884|528534552|FG001|Overall Study|Death|0|||
146966710|NCT02684162|530038874|FG002|Overall Study|Physician Decision|0|||
146553700|NCT03679884|528534553|FG002|Overall Study|Death|0|||
146553701|NCT03679884|528534554|FG003|Overall Study|Death|0|||
146553702|NCT03679884|528534555|FG004|Overall Study|Death|0|||
146553703|NCT03679884|528534551|FG000|Overall Study|Adverse Event|2|||
146553704|NCT03679884|528534552|FG001|Overall Study|Adverse Event|10|||
146553705|NCT03679884|528534553|FG002|Overall Study|Adverse Event|9|||
146553706|NCT03679884|528534554|FG003|Overall Study|Adverse Event|6|||
146553707|NCT03679884|528534555|FG004|Overall Study|Adverse Event|6|||
146553708|NCT03679884|528534551|FG000|Overall Study|Withdrawal by Subject|12|||
146634279|NCT01394016|528835961|FG013|Overall Study|Withdrawal by Subject|3|||
146634280|NCT01394016|528835962|FG014|Overall Study|Withdrawal by Subject|1|||
146553709|NCT03679884|528534552|FG001|Overall Study|Withdrawal by Subject|23|||
146553710|NCT03679884|528534553|FG002|Overall Study|Withdrawal by Subject|8|||
146553711|NCT03679884|528534554|FG003|Overall Study|Withdrawal by Subject|8|||
146553712|NCT03679884|528534555|FG004|Overall Study|Withdrawal by Subject|9|||
146553713|NCT03679884|528534551|FG000|Overall Study|Lost to Follow-up|1|||
146553714|NCT03679884|528534552|FG001|Overall Study|Lost to Follow-up|4|||
146553715|NCT03679884|528534553|FG002|Overall Study|Lost to Follow-up|2|||
146553716|NCT03679884|528534554|FG003|Overall Study|Lost to Follow-up|0|||
146553717|NCT03679884|528534555|FG004|Overall Study|Lost to Follow-up|3|||
146553718|NCT01026038|528534556|FG000|Overall Study|Lost to Follow-up|1|||
146553719|NCT01026038|528534557|FG001|Overall Study|Lost to Follow-up|1|||
146553720|NCT01026038|528534558|FG002|Overall Study|Lost to Follow-up|0|||
146553721|NCT00930176|528534561|FG000|Overall Study|Death|1|||
146553722|NCT01108055|528534562|FG000|Overall Study|Ineligible|11|||
146634281|NCT01394016|528835963|FG015|Overall Study|Withdrawal by Subject|3|||
146634282|NCT01394016|528835964|FG016|Overall Study|Withdrawal by Subject|1|||
146634283|NCT01394016|528835965|FG017|Overall Study|Withdrawal by Subject|1|||
146553723|NCT01108055|528534562|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
146553724|NCT00362609|528534563|FG000|Overall Study|Withdrawal by Subject|0|||
146553725|NCT00362609|528534564|FG001|Overall Study|Withdrawal by Subject|1|||
146634284|NCT01394016|528835966|FG018|Overall Study|Withdrawal by Subject|2|||
146553726|NCT00362609|528534563|FG000|Overall Study|Protocol Violation|0|||
146553727|NCT00362609|528534564|FG001|Overall Study|Protocol Violation|1|||
146553728|NCT00236197|528534568|FG000|Overall Study|Withdrawal by Subject|3|||
146553729|NCT00236197|528534569|FG001|Overall Study|Withdrawal by Subject|2|||
146553730|NCT00236197|528534568|FG000|Overall Study|Lost to Follow-up|1|||
146966711|NCT05153629|530038876|FG000|Overall Study|Withdrawal by Subject|0|||
146966712|NCT05153629|530038877|FG001|Overall Study|Withdrawal by Subject|2|||
146966713|NCT04089566|530038880|FG000|Overall Study|Death|0|||
146966714|NCT04089566|530038881|FG001|Overall Study|Death|6|||
146634285|NCT01394016|528835948|FG000|Overall Study|Adverse Event|0|||
146634286|NCT01394016|528835949|FG001|Overall Study|Adverse Event|0|||
146634287|NCT01394016|528835950|FG002|Overall Study|Adverse Event|0|||
146634288|NCT01394016|528835951|FG003|Overall Study|Adverse Event|0|||
146634289|NCT01394016|528835952|FG004|Overall Study|Adverse Event|0|||
146634290|NCT01394016|528835953|FG005|Overall Study|Adverse Event|0|||
146634291|NCT01394016|528835954|FG006|Overall Study|Adverse Event|0|||
146634292|NCT01394016|528835955|FG007|Overall Study|Adverse Event|0|||
146634293|NCT01394016|528835956|FG008|Overall Study|Adverse Event|0|||
146634294|NCT01394016|528835957|FG009|Overall Study|Adverse Event|1|||
146634295|NCT01394016|528835958|FG010|Overall Study|Adverse Event|0|||
146634296|NCT01394016|528835959|FG011|Overall Study|Adverse Event|0|||
146634297|NCT01394016|528835960|FG012|Overall Study|Adverse Event|0|||
146634298|NCT01394016|528835961|FG013|Overall Study|Adverse Event|0|||
146634299|NCT01394016|528835962|FG014|Overall Study|Adverse Event|0|||
146634300|NCT01394016|528835963|FG015|Overall Study|Adverse Event|0|||
146634301|NCT01394016|528835964|FG016|Overall Study|Adverse Event|1|||
146634302|NCT01394016|528835965|FG017|Overall Study|Adverse Event|1|||
146634303|NCT01394016|528835966|FG018|Overall Study|Adverse Event|0|||
146634304|NCT01394016|528835948|FG000|Overall Study|Sponsor Decision|0|||
146634305|NCT01394016|528835949|FG001|Overall Study|Sponsor Decision|0|||
146634306|NCT01394016|528835950|FG002|Overall Study|Sponsor Decision|0|||
146634307|NCT01394016|528835951|FG003|Overall Study|Sponsor Decision|0|||
146634308|NCT01394016|528835952|FG004|Overall Study|Sponsor Decision|0|||
146634309|NCT01394016|528835953|FG005|Overall Study|Sponsor Decision|0|||
146634310|NCT01394016|528835954|FG006|Overall Study|Sponsor Decision|0|||
146634311|NCT01394016|528835955|FG007|Overall Study|Sponsor Decision|0|||
146634312|NCT01394016|528835956|FG008|Overall Study|Sponsor Decision|0|||
146634313|NCT01394016|528835957|FG009|Overall Study|Sponsor Decision|0|||
146634314|NCT01394016|528835958|FG010|Overall Study|Sponsor Decision|0|||
146634315|NCT01394016|528835959|FG011|Overall Study|Sponsor Decision|0|||
146634316|NCT01394016|528835960|FG012|Overall Study|Sponsor Decision|1|||
146634317|NCT01394016|528835961|FG013|Overall Study|Sponsor Decision|0|||
146634318|NCT01394016|528835962|FG014|Overall Study|Sponsor Decision|0|||
146634319|NCT01394016|528835963|FG015|Overall Study|Sponsor Decision|0|||
146634320|NCT01394016|528835964|FG016|Overall Study|Sponsor Decision|0|||
146634321|NCT01394016|528835965|FG017|Overall Study|Sponsor Decision|0|||
146634322|NCT01394016|528835966|FG018|Overall Study|Sponsor Decision|0|||
146634323|NCT01394016|528835948|FG000|Overall Study|Lost to Follow-up|0|||
146634324|NCT01394016|528835949|FG001|Overall Study|Lost to Follow-up|0|||
146634325|NCT01394016|528835950|FG002|Overall Study|Lost to Follow-up|0|||
146634326|NCT01394016|528835951|FG003|Overall Study|Lost to Follow-up|0|||
146634327|NCT01394016|528835952|FG004|Overall Study|Lost to Follow-up|0|||
146634328|NCT01394016|528835953|FG005|Overall Study|Lost to Follow-up|0|||
146634329|NCT01394016|528835954|FG006|Overall Study|Lost to Follow-up|0|||
146634330|NCT01394016|528835955|FG007|Overall Study|Lost to Follow-up|0|||
146634331|NCT01394016|528835956|FG008|Overall Study|Lost to Follow-up|0|||
146634332|NCT01394016|528835957|FG009|Overall Study|Lost to Follow-up|0|||
146634333|NCT01394016|528835958|FG010|Overall Study|Lost to Follow-up|0|||
146634334|NCT01394016|528835959|FG011|Overall Study|Lost to Follow-up|0|||
146634335|NCT01394016|528835960|FG012|Overall Study|Lost to Follow-up|0|||
146634336|NCT01394016|528835961|FG013|Overall Study|Lost to Follow-up|0|||
146634337|NCT01394016|528835962|FG014|Overall Study|Lost to Follow-up|0|||
146634338|NCT01394016|528835963|FG015|Overall Study|Lost to Follow-up|0|||
146634339|NCT01394016|528835964|FG016|Overall Study|Lost to Follow-up|0|||
146634340|NCT01394016|528835965|FG017|Overall Study|Lost to Follow-up|0|||
146634341|NCT01394016|528835966|FG018|Overall Study|Lost to Follow-up|1|||
146634342|NCT03534804|528835967|FG000|Overall Study|Withdrawal by Subject|1|||
146634343|NCT04161157|528835968|FG000|Overall Study|Lost to Follow-up|4|||
146634344|NCT04161157|528835968|FG000|Overall Study|Death|3|||
146634345|NCT04161157|528835968|FG000|Overall Study|Ineligible|2|||
146634346|NCT04161157|528835968|FG000|Overall Study|Withdrawal by Subject|4|||
146634347|NCT04922216|528835976|FG000|Overall Study|Withdrawal by Subject|0|||
146634348|NCT04922216|528835977|FG001|Overall Study|Withdrawal by Subject|1|||
146634349|NCT04922216|528835978|FG002|Overall Study|Withdrawal by Subject|0|||
146634350|NCT04922216|528835979|FG003|Overall Study|Withdrawal by Subject|0|||
146634351|NCT04922216|528835980|FG004|Overall Study|Withdrawal by Subject|0|||
146634352|NCT04922216|528835981|FG005|Overall Study|Withdrawal by Subject|0|||
146634353|NCT04922216|528835982|FG006|Overall Study|Withdrawal by Subject|0|||
146765317|NCT03546907|529308606|FG001|Overall Study|Other-unspecified|1|||
146634354|NCT04922216|528835983|FG007|Overall Study|Withdrawal by Subject|2|||
146634355|NCT04922216|528835984|FG008|Overall Study|Withdrawal by Subject|0|||
146634356|NCT04922216|528835985|FG009|Overall Study|Withdrawal by Subject|0|||
146634357|NCT04922216|528835986|FG010|Overall Study|Withdrawal by Subject|0|||
146634358|NCT04922216|528835987|FG011|Overall Study|Withdrawal by Subject|0|||
146634359|NCT04922216|528835988|FG012|Overall Study|Withdrawal by Subject|1|||
146634360|NCT04922216|528835989|FG013|Overall Study|Withdrawal by Subject|1|||
146634361|NCT04922216|528835990|FG014|Overall Study|Withdrawal by Subject|1|||
146634362|NCT04922216|528835991|FG015|Overall Study|Withdrawal by Subject|0|||
146634363|NCT04922216|528835992|FG016|Overall Study|Withdrawal by Subject|0|||
146553731|NCT00236197|528534569|FG001|Overall Study|Lost to Follow-up|5|||
146553732|NCT00236197|528534568|FG000|Overall Study|Protocol Violation|0|||
146553733|NCT00236197|528534569|FG001|Overall Study|Protocol Violation|3|||
146553734|NCT00236197|528534568|FG000|Overall Study|Medication non-compliance|1|||
146553735|NCT00236197|528534569|FG001|Overall Study|Medication non-compliance|2|||
146553736|NCT00236197|528534568|FG000|Overall Study|Other|0|||
146553737|NCT00236197|528534569|FG001|Overall Study|Other|2|||
146553738|NCT01800058|528534570|FG000|Overall Study|Lost to Follow-up|1|||
146553739|NCT00800384|528534571|FG000|Overall Study|Withdrawal by Subject|24|||
146553740|NCT00800384|528534572|FG001|Overall Study|Withdrawal by Subject|17|||
146553741|NCT00800384|528534571|FG000|Overall Study|Lost to Follow-up|17|||
146553742|NCT00800384|528534572|FG001|Overall Study|Lost to Follow-up|26|||
146553743|NCT05486065|528534573|FG000|Overall Study|Withdrawal by Subject|1|||
146553744|NCT05486065|528534574|FG001|Overall Study|Withdrawal by Subject|5|||
146553745|NCT05486065|528534575|FG002|Overall Study|Withdrawal by Subject|4|||
146553746|NCT05486065|528534576|FG003|Overall Study|Withdrawal by Subject|3|||
146553747|NCT05486065|528534573|FG000|Overall Study|Lost to Follow-up|4|||
146553748|NCT05486065|528534574|FG001|Overall Study|Lost to Follow-up|2|||
146553749|NCT05486065|528534575|FG002|Overall Study|Lost to Follow-up|2|||
146553750|NCT05486065|528534576|FG003|Overall Study|Lost to Follow-up|2|||
146553751|NCT05486065|528534573|FG000|Overall Study|Physician Decision|0|||
146553752|NCT05486065|528534574|FG001|Overall Study|Physician Decision|1|||
146553753|NCT05486065|528534575|FG002|Overall Study|Physician Decision|1|||
146553754|NCT05486065|528534576|FG003|Overall Study|Physician Decision|0|||
146553755|NCT05486065|528534573|FG000|Overall Study|Failure to meet randomization criteria|0|||
146553756|NCT05486065|528534574|FG001|Overall Study|Failure to meet randomization criteria|0|||
146553757|NCT05486065|528534575|FG002|Overall Study|Failure to meet randomization criteria|0|||
146553758|NCT05486065|528534576|FG003|Overall Study|Failure to meet randomization criteria|1|||
146553759|NCT01064622|528534577|FG000|Randomized Phase II|Withdrawal by Subject|2|||
146553760|NCT01064622|528534578|FG001|Randomized Phase II|Withdrawal by Subject|2|||
146553761|NCT01064622|528534577|FG000|Randomized Phase II|Protocol Violation|0|||
146553762|NCT01064622|528534578|FG001|Randomized Phase II|Protocol Violation|1|||
146553763|NCT00450749|528534579|FG000|Overall Study|Withdrawal by Subject|0|||
146553764|NCT00450749|528534580|FG001|Overall Study|Withdrawal by Subject|0|||
146553765|NCT00450749|528534581|FG002|Overall Study|Withdrawal by Subject|2|||
146553766|NCT00450749|528534579|FG000|Overall Study|Noncompliant|0|||
146553767|NCT00450749|528534580|FG001|Overall Study|Noncompliant|1|||
146553768|NCT00450749|528534581|FG002|Overall Study|Noncompliant|0|||
146553769|NCT01245049|528534582|FG000|Overall Study|Migrated/moved from study area|0|||
146634364|NCT04922216|528835993|FG017|Overall Study|Withdrawal by Subject|1|||
146634365|NCT04922216|528835994|FG018|Overall Study|Withdrawal by Subject|1|||
146634366|NCT04922216|528835995|FG019|Overall Study|Withdrawal by Subject|1|||
146634367|NCT04922216|528835996|FG020|Overall Study|Withdrawal by Subject|1|||
146634368|NCT04922216|528835997|FG021|Overall Study|Withdrawal by Subject|0|||
146634369|NCT04922216|528835998|FG022|Overall Study|Withdrawal by Subject|0|||
146634370|NCT04922216|528835999|FG023|Overall Study|Withdrawal by Subject|2|||
146634371|NCT04922216|528836000|FG024|Overall Study|Withdrawal by Subject|0|||
146634372|NCT04922216|528836001|FG025|Overall Study|Withdrawal by Subject|0|||
146634373|NCT04922216|528836002|FG026|Overall Study|Withdrawal by Subject|1|||
146634374|NCT04922216|528836003|FG027|Overall Study|Withdrawal by Subject|0|||
146634375|NCT04922216|528836004|FG028|Overall Study|Withdrawal by Subject|0|||
146634376|NCT04922216|528836005|FG029|Overall Study|Withdrawal by Subject|0|||
146634377|NCT04922216|528836006|FG030|Overall Study|Withdrawal by Subject|1|||
146634378|NCT04922216|528836007|FG031|Overall Study|Withdrawal by Subject|0|||
146634379|NCT04922216|528835976|FG000|Overall Study|Lost to Follow-up|1|||
146634380|NCT04922216|528835977|FG001|Overall Study|Lost to Follow-up|0|||
146966715|NCT04089566|530038882|FG002|Overall Study|Death|10|||
146634381|NCT04922216|528835978|FG002|Overall Study|Lost to Follow-up|2|||
146634382|NCT04922216|528835979|FG003|Overall Study|Lost to Follow-up|0|||
146553770|NCT01245049|528534583|FG001|Overall Study|Migrated/moved from study area|1|||
146553771|NCT01245049|528534582|FG000|Overall Study|Withdrawal by Subject|0|||
146634383|NCT04922216|528835980|FG004|Overall Study|Lost to Follow-up|0|||
146634384|NCT04922216|528835981|FG005|Overall Study|Lost to Follow-up|2|||
146634385|NCT04922216|528835982|FG006|Overall Study|Lost to Follow-up|0|||
146634386|NCT04922216|528835983|FG007|Overall Study|Lost to Follow-up|1|||
146634387|NCT04922216|528835984|FG008|Overall Study|Lost to Follow-up|1|||
146634388|NCT04922216|528835985|FG009|Overall Study|Lost to Follow-up|2|||
146634389|NCT04922216|528835986|FG010|Overall Study|Lost to Follow-up|2|||
146634390|NCT04922216|528835987|FG011|Overall Study|Lost to Follow-up|1|||
146634391|NCT04922216|528835988|FG012|Overall Study|Lost to Follow-up|1|||
146634392|NCT04922216|528835989|FG013|Overall Study|Lost to Follow-up|0|||
146634393|NCT04922216|528835990|FG014|Overall Study|Lost to Follow-up|1|||
146634394|NCT04922216|528835991|FG015|Overall Study|Lost to Follow-up|0|||
146634395|NCT04922216|528835992|FG016|Overall Study|Lost to Follow-up|0|||
146634396|NCT04922216|528835993|FG017|Overall Study|Lost to Follow-up|2|||
146634397|NCT04922216|528835994|FG018|Overall Study|Lost to Follow-up|1|||
146634398|NCT04922216|528835995|FG019|Overall Study|Lost to Follow-up|0|||
146634399|NCT04922216|528835996|FG020|Overall Study|Lost to Follow-up|1|||
146634400|NCT04922216|528835997|FG021|Overall Study|Lost to Follow-up|0|||
146634401|NCT04922216|528835998|FG022|Overall Study|Lost to Follow-up|2|||
146634402|NCT04922216|528835999|FG023|Overall Study|Lost to Follow-up|1|||
146634403|NCT04922216|528836000|FG024|Overall Study|Lost to Follow-up|0|||
146634404|NCT04922216|528836001|FG025|Overall Study|Lost to Follow-up|2|||
146634405|NCT04922216|528836002|FG026|Overall Study|Lost to Follow-up|0|||
146634406|NCT04922216|528836003|FG027|Overall Study|Lost to Follow-up|0|||
146634407|NCT04922216|528836004|FG028|Overall Study|Lost to Follow-up|1|||
146634408|NCT04922216|528836005|FG029|Overall Study|Lost to Follow-up|0|||
146634409|NCT04922216|528836006|FG030|Overall Study|Lost to Follow-up|2|||
146634410|NCT04922216|528836007|FG031|Overall Study|Lost to Follow-up|1|||
146634411|NCT04721977|528836008|FG000|Overall Study|Death|15|||
146634412|NCT04721977|528836008|FG000|Overall Study|Ongoing|51|||
146634413|NCT03278249|528836009|FG000|Overall Study|Withdrawal by Subject|2|||
146634414|NCT03278249|528836009|FG000|Overall Study|Lost to Follow-up|1|||
146634415|NCT02017405|528836010|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
146634416|NCT02017405|528836011|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
146634417|NCT02017405|528836012|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
146634418|NCT02017405|528836013|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
146634419|NCT02017405|528836014|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
146634420|NCT02017405|528836015|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
146634421|NCT02017405|528836010|FG000|Open-label Phase|Adverse Event|1|||
146634422|NCT02017405|528836011|FG001|Open-label Phase|Adverse Event|1|||
146634423|NCT02017405|528836012|FG002|Open-label Phase|Adverse Event|0|||
146634424|NCT02017405|528836013|FG003|Open-label Phase|Adverse Event|0|||
146634425|NCT02017405|528836014|FG004|Open-label Phase|Adverse Event|0|||
146634426|NCT02017405|528836015|FG005|Open-label Phase|Adverse Event|0|||
146634427|NCT02864394|528836017|FG000|Overall Study|Death|184|||
146634428|NCT02864394|528836018|FG001|Overall Study|Death|189|||
146634429|NCT02864394|528836017|FG000|Overall Study|Lost to Follow-up|0|||
146634430|NCT02864394|528836018|FG001|Overall Study|Lost to Follow-up|2|||
146634431|NCT02864394|528836017|FG000|Overall Study|Sponsor Decision|26|||
146634432|NCT02864394|528836018|FG001|Overall Study|Sponsor Decision|11|||
146634433|NCT02864394|528836017|FG000|Overall Study|Withdrawal by Subject|3|||
146634434|NCT02864394|528836018|FG001|Overall Study|Withdrawal by Subject|10|||
146634435|NCT02374450|528836019|FG000|Overall Study|Protocol Violation|0|||
146634436|NCT02374450|528836020|FG001|Overall Study|Protocol Violation|1|||
146634437|NCT02374450|528836021|FG002|Overall Study|Protocol Violation|0|||
146634438|NCT02374450|528836019|FG000|Overall Study|Withdrawal by Subject|91|||
146634439|NCT02374450|528836020|FG001|Overall Study|Withdrawal by Subject|110|||
146634440|NCT02374450|528836021|FG002|Overall Study|Withdrawal by Subject|4|||
146634441|NCT02374450|528836019|FG000|Overall Study|Lost to Follow-up|168|||
146634442|NCT02374450|528836020|FG001|Overall Study|Lost to Follow-up|194|||
146634443|NCT02374450|528836021|FG002|Overall Study|Lost to Follow-up|138|||
146634444|NCT02374450|528836019|FG000|Overall Study|Death|173|||
146634445|NCT02374450|528836020|FG001|Overall Study|Death|185|||
146634446|NCT02374450|528836021|FG002|Overall Study|Death|81|||
146634447|NCT02374450|528836019|FG000|Overall Study|Migrated from the study area|538|||
146634448|NCT02374450|528836020|FG001|Overall Study|Migrated from the study area|648|||
146634449|NCT02374450|528836021|FG002|Overall Study|Migrated from the study area|181|||
146634450|NCT02374450|528836019|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
146634451|NCT02374450|528836020|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
146634452|NCT02374450|528836021|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
146634453|NCT02374450|528836019|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
146634454|NCT02374450|528836020|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
146634455|NCT02374450|528836021|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
146634456|NCT02374450|528836019|FG000|Overall Study|Other|0|||
146634457|NCT02374450|528836020|FG001|Overall Study|Other|21|||
146634458|NCT02374450|528836021|FG002|Overall Study|Other|79|||
146634459|NCT04730804|528836022|FG000|Overall Study|Physician Decision|0|||
146634460|NCT04730804|528836023|FG001|Overall Study|Physician Decision|0|||
146634461|NCT04730804|528836024|FG002|Overall Study|Physician Decision|0|||
146634462|NCT04730804|528836025|FG003|Overall Study|Physician Decision|0|||
146634463|NCT04730804|528836026|FG004|Overall Study|Physician Decision|0|||
146634464|NCT04730804|528836027|FG005|Overall Study|Physician Decision|1|||
146634465|NCT04730804|528836022|FG000|Overall Study|Withdrawal by Subject|0|||
146634466|NCT04730804|528836023|FG001|Overall Study|Withdrawal by Subject|0|||
146634467|NCT04730804|528836024|FG002|Overall Study|Withdrawal by Subject|0|||
146634468|NCT04730804|528836025|FG003|Overall Study|Withdrawal by Subject|0|||
146634469|NCT04730804|528836026|FG004|Overall Study|Withdrawal by Subject|1|||
146634470|NCT04730804|528836027|FG005|Overall Study|Withdrawal by Subject|2|||
146634471|NCT02202759|528837235|FG000|Overall Study|Study Terminated by Sponsor|3|||
146634472|NCT02202759|528837236|FG001|Overall Study|Study Terminated by Sponsor|3|||
146634473|NCT02202759|528837237|FG002|Overall Study|Study Terminated by Sponsor|3|||
146634474|NCT02202759|528837235|FG000|Overall Study|Withdrawal by Subject|2|||
146634475|NCT02202759|528837236|FG001|Overall Study|Withdrawal by Subject|1|||
146634476|NCT02202759|528837237|FG002|Overall Study|Withdrawal by Subject|1|||
146634477|NCT02202759|528837235|FG000|Overall Study|Reason not Specified|4|||
146634478|NCT02202759|528837236|FG001|Overall Study|Reason not Specified|11|||
146634479|NCT02202759|528837237|FG002|Overall Study|Reason not Specified|10|||
146634480|NCT03722238|528837243|FG000|Overall Study|Protocol Violation|1|||
146634481|NCT03722238|528837244|FG001|Overall Study|Protocol Violation|0|||
146634482|NCT03722238|528837243|FG000|Overall Study|Physician Decision|1|||
146634483|NCT03722238|528837244|FG001|Overall Study|Physician Decision|0|||
146634484|NCT03722238|528837243|FG000|Overall Study|Death|1|||
146634485|NCT03722238|528837244|FG001|Overall Study|Death|0|||
146634486|NCT03722238|528837243|FG000|Overall Study|Lost to Follow-up|6|||
146634487|NCT03722238|528837244|FG001|Overall Study|Lost to Follow-up|0|||
146634488|NCT03722238|528837243|FG000|Overall Study|Partial missing data|44|||
146634489|NCT03722238|528837244|FG001|Overall Study|Partial missing data|1|||
146634490|NCT03722238|528837243|FG000|Overall Study|Withdrawal by Subject|2|||
146634491|NCT03722238|528837244|FG001|Overall Study|Withdrawal by Subject|0|||
146634492|NCT03722238|528837243|FG000|Overall Study|Other|4|||
146634493|NCT03722238|528837244|FG001|Overall Study|Other|0|||
146650224|NCT04966910|528896684|FG001|Baseline|Participant did not complete measure|0|||
146634494|NCT03722238|528837243|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
146634495|NCT03722238|528837244|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
146634496|NCT03722238|528837243|FG000|Overall Study|Did not meet risk classification group criteria|90|||
146634497|NCT03722238|528837244|FG001|Overall Study|Did not meet risk classification group criteria|0|||
146634498|NCT03722238|528837243|FG000|Overall Study|Did not sign consent|17|||
146634499|NCT03722238|528837244|FG001|Overall Study|Did not sign consent|0|||
146634500|NCT03722238|528837243|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
146634501|NCT03722238|528837244|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
146634502|NCT03722238|528837243|FG000|Overall Study|Not willing to purchase study medication|142|||
146634503|NCT03722238|528837244|FG001|Overall Study|Not willing to purchase study medication|0|||
146634504|NCT03722238|528837243|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
146634505|NCT03722238|528837244|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
146634506|NCT00561925|528837245|FG000|14 Day Lead-In Period|Adverse Event|38|||
146634507|NCT00561925|528837246|FG001|14 Day Lead-In Period|Adverse Event|0|||
146634508|NCT00561925|528837247|FG002|14 Day Lead-In Period|Adverse Event|0|||
146634509|NCT00561925|528837248|FG003|14 Day Lead-In Period|Adverse Event|0|||
146634510|NCT00561925|528837249|FG004|14 Day Lead-In Period|Adverse Event|0|||
146634511|NCT00561925|528837245|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
146634512|NCT00561925|528837246|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
146634513|NCT00561925|528837247|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
146634514|NCT00561925|528837248|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
146634515|NCT00561925|528837249|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
146634516|NCT00561925|528837245|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
146634517|NCT00561925|528837246|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
146634518|NCT00561925|528837247|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
146634519|NCT00561925|528837248|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
146634520|NCT00561925|528837249|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
146634521|NCT00561925|528837245|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
146634522|NCT00561925|528837246|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
146634523|NCT00561925|528837247|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
146634524|NCT00561925|528837248|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
146634525|NCT00561925|528837249|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
146634526|NCT00561925|528837245|FG000|14 Day Lead-In Period|Other|5|||
146634527|NCT00561925|528837246|FG001|14 Day Lead-In Period|Other|0|||
146634528|NCT00561925|528837247|FG002|14 Day Lead-In Period|Other|0|||
146634529|NCT00561925|528837248|FG003|14 Day Lead-In Period|Other|0|||
146634530|NCT00561925|528837249|FG004|14 Day Lead-In Period|Other|0|||
146634531|NCT00561925|528837245|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
146634532|NCT00561925|528837246|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
146634533|NCT00561925|528837247|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
146634534|NCT00561925|528837248|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
146634535|NCT00561925|528837249|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
146634536|NCT00561925|528837245|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
146634537|NCT00561925|528837246|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
146634538|NCT00561925|528837247|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
146634539|NCT00561925|528837248|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
146634540|NCT00561925|528837249|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
146634541|NCT00561925|528837245|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
146765318|NCT03720210|529308609|FG000|Overall Study|Lost to Follow-up|1|||
146765319|NCT02174562|529308612|FG000|Overall Study|Withdrawal by Subject|7|||
146765320|NCT02174562|529308613|FG001|Overall Study|Withdrawal by Subject|2|||
146634542|NCT00561925|528837246|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
146634543|NCT00561925|528837247|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
146634544|NCT00561925|528837248|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
146634545|NCT00561925|528837249|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
146634546|NCT00561925|528837245|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
146634547|NCT00561925|528837246|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
146634548|NCT00561925|528837247|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
146634549|NCT00561925|528837248|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
146634550|NCT00561925|528837249|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
146634551|NCT00561925|528837245|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
146634552|NCT00561925|528837246|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
146634553|NCT00561925|528837247|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
146634554|NCT00561925|528837248|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
146634555|NCT00561925|528837249|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
146634556|NCT00561925|528837245|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
146634557|NCT00561925|528837246|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
146634558|NCT00561925|528837247|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
146634559|NCT00561925|528837248|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
146634560|NCT00561925|528837249|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
146634561|NCT00561925|528837245|FG000|144-week Double-blind, Double-dummy|Death|0|||
146634562|NCT00561925|528837246|FG001|144-week Double-blind, Double-dummy|Death|6|||
146634563|NCT00561925|528837247|FG002|144-week Double-blind, Double-dummy|Death|3|||
146634564|NCT00561925|528837248|FG003|144-week Double-blind, Double-dummy|Death|0|||
146634565|NCT00561925|528837249|FG004|144-week Double-blind, Double-dummy|Death|0|||
146634566|NCT00561925|528837245|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
146634567|NCT00561925|528837246|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
146634568|NCT00561925|528837247|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
146634569|NCT00561925|528837248|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
146634570|NCT00561925|528837249|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
146634571|NCT00561925|528837245|FG000|144-week Double-blind, Double-dummy|Other|0|||
146634572|NCT00561925|528837246|FG001|144-week Double-blind, Double-dummy|Other|8|||
146634573|NCT00561925|528837247|FG002|144-week Double-blind, Double-dummy|Other|11|||
146634574|NCT00561925|528837248|FG003|144-week Double-blind, Double-dummy|Other|0|||
146634575|NCT00561925|528837249|FG004|144-week Double-blind, Double-dummy|Other|0|||
146634576|NCT00561925|528837245|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
146634577|NCT00561925|528837246|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
146634578|NCT00561925|528837247|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
146634579|NCT00561925|528837248|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
146634580|NCT00561925|528837249|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
146634581|NCT00684021|528837252|FG000|Overall Study|MRI Contraindicated|1|||
146634582|NCT00684021|528837253|FG001|Overall Study|MRI Contraindicated|1|||
146634583|NCT00684021|528837254|FG002|Overall Study|MRI Contraindicated|1|||
146634584|NCT00684021|528837255|FG003|Overall Study|MRI Contraindicated|0|||
146634585|NCT00684021|528837252|FG000|Overall Study|MRI not performed|0|||
146634586|NCT00684021|528837253|FG001|Overall Study|MRI not performed|1|||
146634587|NCT00684021|528837254|FG002|Overall Study|MRI not performed|1|||
146634588|NCT00684021|528837255|FG003|Overall Study|MRI not performed|2|||
146634589|NCT00684021|528837252|FG000|Overall Study|Death|1|||
146634590|NCT00684021|528837253|FG001|Overall Study|Death|0|||
146634591|NCT00684021|528837254|FG002|Overall Study|Death|0|||
146634592|NCT00684021|528837255|FG003|Overall Study|Death|0|||
146634593|NCT00891904|528837256|FG000|Overall Study|Death|1|||
146634594|NCT00891904|528837256|FG000|Overall Study|Adverse Event|1|||
146634595|NCT02976038|528837257|FG000|Overall Study|Physician Decision|22|||
146634596|NCT02976038|528837257|FG000|Overall Study|Withdrawal by Subject|3|||
146634597|NCT02976038|528837257|FG000|Overall Study|Lost to Follow-up|2|||
146634598|NCT02976038|528837257|FG000|Overall Study|Adverse Event|1|||
146634599|NCT01046396|528837258|FG000|Overall Study|Withdrawal by Subject|5|||
146634600|NCT00724698|528837259|FG000|Overall Study|Adverse Event|9|||
146634601|NCT00724698|528837259|FG000|Overall Study|Failure of Therapy|4|||
146634602|NCT00724698|528837259|FG000|Overall Study|Poor Compliance|16|||
146634603|NCT00724698|528837259|FG000|Overall Study|Lost to Follow-up|36|||
146634604|NCT00724698|528837259|FG000|Overall Study|No Info|25|||
146634605|NCT02177032|528837260|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
146634606|NCT02177032|528837261|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
146634607|NCT02177032|528837262|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
146634608|NCT02177032|528837263|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
146553772|NCT01245049|528534583|FG001|Overall Study|Withdrawal by Subject|1|||
146553773|NCT01245049|528534582|FG000|Overall Study|Lost to Follow-up|1|||
146553774|NCT01245049|528534583|FG001|Overall Study|Lost to Follow-up|2|||
146553775|NCT02151604|528534584|FG000|Overall Study|Lost to Follow-up|3|||
146553776|NCT02151604|528534584|FG000|Overall Study|Withdrawal by Subject|2|||
146553777|NCT02151604|528534584|FG000|Overall Study|Physician Decision|3|||
146553778|NCT02151604|528534584|FG000|Overall Study|Death|1|||
146553779|NCT03178942|528534586|FG000|Overall Study|Withdrawal by Subject|2|||
146553780|NCT03178942|528534587|FG001|Overall Study|Withdrawal by Subject|0|||
146553781|NCT03178942|528534586|FG000|Overall Study|Lost to Follow-up|1|||
146553782|NCT03178942|528534587|FG001|Overall Study|Lost to Follow-up|2|||
146553783|NCT06097273|528534588|FG000|Overall Study|Death|2|||
146553784|NCT06097273|528534589|FG001|Overall Study|Death|1|||
146553785|NCT06097273|528534590|FG002|Overall Study|Death|2|||
146553786|NCT06097273|528534591|FG003|Overall Study|Death|2|||
146553787|NCT06097273|528534588|FG000|Overall Study|Lost to Follow-up|27|||
146553788|NCT06097273|528534589|FG001|Overall Study|Lost to Follow-up|18|||
146553789|NCT06097273|528534590|FG002|Overall Study|Lost to Follow-up|36|||
146553790|NCT06097273|528534591|FG003|Overall Study|Lost to Follow-up|31|||
146553791|NCT06097273|528534588|FG000|Overall Study|Physician Decision|0|||
146553792|NCT06097273|528534589|FG001|Overall Study|Physician Decision|1|||
146553793|NCT06097273|528534590|FG002|Overall Study|Physician Decision|0|||
146553794|NCT06097273|528534591|FG003|Overall Study|Physician Decision|3|||
146553795|NCT06097273|528534588|FG000|Overall Study|Protocol Violation|1|||
146553796|NCT06097273|528534589|FG001|Overall Study|Protocol Violation|1|||
146553797|NCT06097273|528534590|FG002|Overall Study|Protocol Violation|2|||
146553798|NCT06097273|528534591|FG003|Overall Study|Protocol Violation|1|||
146553799|NCT06097273|528534588|FG000|Overall Study|Withdrawal by Subject|14|||
146553800|NCT06097273|528534589|FG001|Overall Study|Withdrawal by Subject|11|||
146553801|NCT06097273|528534590|FG002|Overall Study|Withdrawal by Subject|14|||
146553802|NCT06097273|528534591|FG003|Overall Study|Withdrawal by Subject|15|||
146553803|NCT06097273|528534588|FG000|Overall Study|Other Than Specified|7|||
146553804|NCT06097273|528534589|FG001|Overall Study|Other Than Specified|3|||
146553805|NCT06097273|528534590|FG002|Overall Study|Other Than Specified|11|||
146553806|NCT06097273|528534591|FG003|Overall Study|Other Than Specified|6|||
146553807|NCT02698787|528536133|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
146553808|NCT02698787|528536134|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
146553809|NCT02469961|528536144|FG000|Overall Study|Physician Decision|4|||
146553810|NCT02469961|528536145|FG001|Overall Study|Physician Decision|1|||
146553811|NCT03635996|528536151|FG000|Overall Study|Study terminated by Sponsor|94|||
146553812|NCT03635996|528536151|FG000|Overall Study|Withdrawal by Subject|20|||
146553813|NCT03635996|528536151|FG000|Overall Study|Ablation|26|||
146553814|NCT03635996|528536151|FG000|Overall Study|Adverse Event|7|||
146553815|NCT03635996|528536151|FG000|Overall Study|Physician Decision|3|||
146553816|NCT03635996|528536151|FG000|Overall Study|Prohibited medication|5|||
146553817|NCT03635996|528536151|FG000|Overall Study|Did not meet eligibility criteria|5|||
146553818|NCT03635996|528536151|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
146553819|NCT03635996|528536151|FG000|Overall Study|Protocol Violation|1|||
146553820|NCT03635996|528536151|FG000|Overall Study|Lost to Follow-up|1|||
146553821|NCT00326495|528536152|FG000|Overall Study|Switched to alternative treatment|1|||
146553822|NCT00326495|528536152|FG000|Overall Study|Disease progression before treatment|1|||
146553823|NCT00326495|528536152|FG000|Overall Study|Refused further treatment|2|||
146553824|NCT00326495|528536152|FG000|Overall Study|Subject off study before assessment|1|||
146553825|NCT02933151|528536153|FG000|Overall Study|Lost to Follow-up|19|||
146553826|NCT02933151|528536154|FG001|Overall Study|Lost to Follow-up|18|||
146553827|NCT02933151|528536153|FG000|Overall Study|Death|1732|||
146553828|NCT02933151|528536154|FG001|Overall Study|Death|1827|||
146553829|NCT02933151|528536153|FG000|Overall Study|Transplant|210|||
146553830|NCT02933151|528536154|FG001|Overall Study|Transplant|278|||
146553831|NCT02933151|528536153|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
146966716|NCT04089566|530038883|FG003|Overall Study|Death|0|||
146553832|NCT02933151|528536154|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
146553833|NCT02933151|528536153|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
146553834|NCT02933151|528536154|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
146634609|NCT02177032|528837260|FG000|Overall Study|Lost to Follow-up|0|||
146553835|NCT02933151|528536153|FG000|Overall Study|Recovered Kidney Function|47|||
146553836|NCT02933151|528536154|FG001|Overall Study|Recovered Kidney Function|29|||
146553837|NCT00394472|528536155|FG000|Overall Study|Protocol Violation|1|||
146553838|NCT00394472|528536156|FG001|Overall Study|Protocol Violation|3|||
146553839|NCT00394472|528536155|FG000|Overall Study|incorrect enrolment|4|||
146553840|NCT00394472|528536156|FG001|Overall Study|incorrect enrolment|2|||
146553841|NCT00394472|528536155|FG000|Overall Study|Adverse Event|4|||
146553842|NCT00394472|528536156|FG001|Overall Study|Adverse Event|2|||
146553843|NCT00394472|528536155|FG000|Overall Study|Withdrawal by Subject|0|||
146553844|NCT00394472|528536156|FG001|Overall Study|Withdrawal by Subject|2|||
146553845|NCT00394472|528536155|FG000|Overall Study|Physician Decision|0|||
146553846|NCT00394472|528536156|FG001|Overall Study|Physician Decision|1|||
146553847|NCT00394472|528536155|FG000|Overall Study|Lost to Follow-up|0|||
146553848|NCT00394472|528536156|FG001|Overall Study|Lost to Follow-up|1|||
146553849|NCT04359680|528536157|FG000|Overall Study|Withdrawal by Subject|29|||
146553850|NCT04359680|528536158|FG001|Overall Study|Withdrawal by Subject|24|||
146553851|NCT04359680|528536157|FG000|Overall Study|Adverse Event|6|||
146553852|NCT04359680|528536158|FG001|Overall Study|Adverse Event|2|||
146553853|NCT04359680|528536157|FG000|Overall Study|Lost to Follow-up|56|||
146553854|NCT04359680|528536158|FG001|Overall Study|Lost to Follow-up|59|||
146553855|NCT04359680|528536157|FG000|Overall Study|Protocol Violation|3|||
146553856|NCT04359680|528536158|FG001|Overall Study|Protocol Violation|5|||
146553857|NCT04359680|528536157|FG000|Overall Study|Physician Decision|1|||
146553858|NCT04359680|528536158|FG001|Overall Study|Physician Decision|1|||
146553859|NCT04359680|528536157|FG000|Overall Study|Sponsor Decision|0|||
146553860|NCT04359680|528536158|FG001|Overall Study|Sponsor Decision|1|||
146553861|NCT03280615|528536159|FG000|Overall Study|Lost to Follow-up|1|||
146553862|NCT03280615|528536160|FG001|Overall Study|Lost to Follow-up|2|||
146553863|NCT03280615|528536159|FG000|Overall Study|Adverse Event|1|||
146553864|NCT03280615|528536160|FG001|Overall Study|Adverse Event|1|||
146553865|NCT03280615|528536159|FG000|Overall Study|Withdrawal by Subject|2|||
146765321|NCT02174562|529308612|FG000|Overall Study|Death|2|||
146553866|NCT03280615|528536160|FG001|Overall Study|Withdrawal by Subject|2|||
146553867|NCT00004228|528536165|FG000|Overall Study|Adverse Event|0|||
146553868|NCT00004228|528536166|FG001|Overall Study|Adverse Event|1|||
146553869|NCT00004228|528536167|FG002|Overall Study|Adverse Event|0|||
146553870|NCT00004228|528536168|FG003|Overall Study|Adverse Event|0|||
146553871|NCT00004228|528536169|FG004|Overall Study|Adverse Event|1|||
146634610|NCT02177032|528837261|FG001|Overall Study|Lost to Follow-up|2|||
146634611|NCT02177032|528837262|FG002|Overall Study|Lost to Follow-up|0|||
146966717|NCT04089566|530038884|FG004|Overall Study|Death|0|||
146553872|NCT00004228|528536170|FG005|Overall Study|Adverse Event|0|||
146553873|NCT00004228|528536171|FG006|Overall Study|Adverse Event|0|||
146553874|NCT00004228|528536165|FG000|Overall Study|Death|0|||
146553875|NCT00004228|528536166|FG001|Overall Study|Death|1|||
146553876|NCT00004228|528536167|FG002|Overall Study|Death|2|||
146553877|NCT00004228|528536168|FG003|Overall Study|Death|0|||
146553878|NCT00004228|528536169|FG004|Overall Study|Death|1|||
146553879|NCT00004228|528536170|FG005|Overall Study|Death|0|||
146553880|NCT00004228|528536171|FG006|Overall Study|Death|0|||
146553881|NCT00004228|528536165|FG000|Overall Study|Lack of Efficacy|1|||
146553882|NCT00004228|528536166|FG001|Overall Study|Lack of Efficacy|6|||
146553883|NCT00004228|528536167|FG002|Overall Study|Lack of Efficacy|5|||
146553884|NCT00004228|528536168|FG003|Overall Study|Lack of Efficacy|3|||
146553885|NCT00004228|528536169|FG004|Overall Study|Lack of Efficacy|9|||
146553886|NCT00004228|528536170|FG005|Overall Study|Lack of Efficacy|8|||
146553887|NCT00004228|528536171|FG006|Overall Study|Lack of Efficacy|4|||
146553888|NCT00004228|528536165|FG000|Overall Study|Lost to Follow-up|0|||
146553889|NCT00004228|528536166|FG001|Overall Study|Lost to Follow-up|0|||
146553890|NCT00004228|528536167|FG002|Overall Study|Lost to Follow-up|1|||
146634612|NCT02177032|528837263|FG003|Overall Study|Lost to Follow-up|0|||
146634613|NCT02177032|528837260|FG000|Overall Study|OTHER|2|||
146553891|NCT00004228|528536168|FG003|Overall Study|Lost to Follow-up|0|||
146553892|NCT00004228|528536169|FG004|Overall Study|Lost to Follow-up|0|||
146553893|NCT00004228|528536170|FG005|Overall Study|Lost to Follow-up|0|||
146553894|NCT00004228|528536171|FG006|Overall Study|Lost to Follow-up|0|||
146765322|NCT02174562|529308613|FG001|Overall Study|Death|0|||
146553895|NCT00004228|528536165|FG000|Overall Study|Physician Decision|1|||
146553896|NCT00004228|528536166|FG001|Overall Study|Physician Decision|0|||
146553897|NCT00004228|528536167|FG002|Overall Study|Physician Decision|3|||
146634614|NCT02177032|528837261|FG001|Overall Study|OTHER|0|||
146634615|NCT02177032|528837262|FG002|Overall Study|OTHER|1|||
146634616|NCT02177032|528837263|FG003|Overall Study|OTHER|0|||
146634617|NCT02177032|528837260|FG000|Overall Study|Withdrawal by Subject|1|||
146634618|NCT02177032|528837261|FG001|Overall Study|Withdrawal by Subject|0|||
146634619|NCT02177032|528837262|FG002|Overall Study|Withdrawal by Subject|1|||
146634620|NCT02177032|528837263|FG003|Overall Study|Withdrawal by Subject|0|||
146634621|NCT02556177|528837265|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
146553898|NCT00004228|528536168|FG003|Overall Study|Physician Decision|2|||
146553899|NCT00004228|528536169|FG004|Overall Study|Physician Decision|1|||
146553900|NCT00004228|528536170|FG005|Overall Study|Physician Decision|1|||
146553901|NCT00004228|528536171|FG006|Overall Study|Physician Decision|1|||
146553902|NCT00004228|528536165|FG000|Overall Study|Protocol Violation|0|||
146553903|NCT00004228|528536166|FG001|Overall Study|Protocol Violation|5|||
146553904|NCT00004228|528536167|FG002|Overall Study|Protocol Violation|2|||
146553905|NCT00004228|528536168|FG003|Overall Study|Protocol Violation|1|||
146553906|NCT00004228|528536169|FG004|Overall Study|Protocol Violation|1|||
146553907|NCT00004228|528536170|FG005|Overall Study|Protocol Violation|2|||
146553908|NCT00004228|528536171|FG006|Overall Study|Protocol Violation|0|||
146553909|NCT00004228|528536165|FG000|Overall Study|Withdrawal by Subject|3|||
146553910|NCT00004228|528536166|FG001|Overall Study|Withdrawal by Subject|0|||
146553911|NCT00004228|528536167|FG002|Overall Study|Withdrawal by Subject|1|||
146553912|NCT00004228|528536168|FG003|Overall Study|Withdrawal by Subject|0|||
146553913|NCT00004228|528536169|FG004|Overall Study|Withdrawal by Subject|2|||
146553914|NCT00004228|528536170|FG005|Overall Study|Withdrawal by Subject|1|||
146553915|NCT00004228|528536171|FG006|Overall Study|Withdrawal by Subject|2|||
146553916|NCT00004228|528536165|FG000|Overall Study|Other|0|||
146553917|NCT00004228|528536166|FG001|Overall Study|Other|0|||
146553918|NCT00004228|528536167|FG002|Overall Study|Other|1|||
146553919|NCT00004228|528536168|FG003|Overall Study|Other|0|||
146553920|NCT00004228|528536169|FG004|Overall Study|Other|0|||
146553921|NCT00004228|528536170|FG005|Overall Study|Other|0|||
146553922|NCT00004228|528536171|FG006|Overall Study|Other|0|||
146553923|NCT00004228|528536165|FG000|Overall Study|ineligible|4|||
146553924|NCT00004228|528536166|FG001|Overall Study|ineligible|2|||
146553925|NCT00004228|528536167|FG002|Overall Study|ineligible|4|||
146553926|NCT00004228|528536168|FG003|Overall Study|ineligible|1|||
146553927|NCT00004228|528536169|FG004|Overall Study|ineligible|1|||
146553928|NCT00004228|528536170|FG005|Overall Study|ineligible|2|||
146553929|NCT00004228|528536171|FG006|Overall Study|ineligible|5|||
146553930|NCT02255279|528536172|FG000|Overall Study|Lost to Follow-up|2|||
146553931|NCT02255279|528536173|FG001|Overall Study|Lost to Follow-up|2|||
146553932|NCT02255279|528536172|FG000|Overall Study|Protocol Violation|0|||
146634622|NCT02556177|528837266|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
146634623|NCT00658359|528837267|FG000|Overall Study|Death|3|||
146553933|NCT02255279|528536173|FG001|Overall Study|Protocol Violation|1|||
146553934|NCT02255279|528536172|FG000|Overall Study|Withdrawal by Subject|3|||
146553935|NCT02255279|528536173|FG001|Overall Study|Withdrawal by Subject|6|||
146553936|NCT01013870|528536174|FG000|Overall Study|Lost to Follow-up|1|||
146553937|NCT01013870|528536175|FG001|Overall Study|Lost to Follow-up|3|||
146553938|NCT01386645|528536176|FG000|Overall Study|Physician Decision|0|||
146553939|NCT01386645|528536177|FG001|Overall Study|Physician Decision|0|||
146765323|NCT02174562|529308612|FG000|Overall Study|Lost to Follow-up|0|||
146553940|NCT01386645|528536178|FG002|Overall Study|Physician Decision|1|||
146553941|NCT01386645|528536176|FG000|Overall Study|Withdrawal by Subject|0|||
146634624|NCT00658359|528837268|FG001|Overall Study|Death|1|||
146553942|NCT01386645|528536177|FG001|Overall Study|Withdrawal by Subject|1|||
146634625|NCT00658359|528837269|FG002|Overall Study|Death|2|||
146553943|NCT01386645|528536178|FG002|Overall Study|Withdrawal by Subject|1|||
146765324|NCT02174562|529308613|FG001|Overall Study|Lost to Follow-up|3|||
146553944|NCT00432991|528536179|FG000|Overall Study|Protocol Violation|7|||
146553945|NCT00432991|528536180|FG001|Overall Study|Protocol Violation|12|||
146553946|NCT00862277|528536190|FG000|Overall Study|Protocol Violation|1|||
146553947|NCT00862277|528536191|FG001|Overall Study|Protocol Violation|2|||
146553948|NCT00862277|528536192|FG002|Overall Study|Protocol Violation|5|||
146553949|NCT01292473|528536193|FG000|Overall Study|Adverse Event|1|||
146553950|NCT01292473|528536194|FG001|Overall Study|Adverse Event|0|||
146553951|NCT01292473|528536195|FG002|Overall Study|Adverse Event|1|||
146553952|NCT01292473|528536196|FG003|Overall Study|Adverse Event|1|||
146553953|NCT01292473|528536193|FG000|Overall Study|Lost to Follow-up|1|||
146553954|NCT01292473|528536194|FG001|Overall Study|Lost to Follow-up|1|||
146553955|NCT01292473|528536195|FG002|Overall Study|Lost to Follow-up|2|||
146553956|NCT01292473|528536196|FG003|Overall Study|Lost to Follow-up|2|||
146553957|NCT01292473|528536193|FG000|Overall Study|Withdrawal by Subject|3|||
146553958|NCT01292473|528536194|FG001|Overall Study|Withdrawal by Subject|4|||
146553959|NCT01292473|528536195|FG002|Overall Study|Withdrawal by Subject|3|||
146553960|NCT01292473|528536196|FG003|Overall Study|Withdrawal by Subject|3|||
146553961|NCT01292473|528536193|FG000|Overall Study|Physician Decision|0|||
146553962|NCT01292473|528536194|FG001|Overall Study|Physician Decision|1|||
146553963|NCT01292473|528536195|FG002|Overall Study|Physician Decision|0|||
146553964|NCT01292473|528536196|FG003|Overall Study|Physician Decision|0|||
146553965|NCT01292473|528536193|FG000|Overall Study|Disease Progression|0|||
146553966|NCT01292473|528536194|FG001|Overall Study|Disease Progression|1|||
146553967|NCT01292473|528536195|FG002|Overall Study|Disease Progression|3|||
146553968|NCT01292473|528536196|FG003|Overall Study|Disease Progression|6|||
146553969|NCT04432298|528536197|FG000|Overall Study|Other than specified|1|||
146553970|NCT04432298|528536198|FG001|Overall Study|Other than specified|0|||
146553971|NCT04432298|528536197|FG000|Overall Study|Lost to Follow-up|0|||
146553972|NCT04432298|528536198|FG001|Overall Study|Lost to Follow-up|1|||
146553973|NCT04432298|528536197|FG000|Overall Study|Death|3|||
146553974|NCT04432298|528536198|FG001|Overall Study|Death|2|||
146553975|NCT04432298|528536197|FG000|Overall Study|Withdrawal by Subject|2|||
146553976|NCT04432298|528536198|FG001|Overall Study|Withdrawal by Subject|0|||
146553977|NCT02451007|528536201|FG000|Overall Study|Withdrawal by Subject|4|||
146553978|NCT02451007|528536201|FG000|Overall Study|Adverse Event|1|||
146553979|NCT02451007|528536201|FG000|Overall Study|Disease Progression|2|||
146553980|NCT00348374|528536202|FG000|Overall Study|Adverse Event|1|||
146553981|NCT00348374|528536203|FG001|Overall Study|Adverse Event|4|||
146553982|NCT00348374|528536202|FG000|Overall Study|Lost to Follow-up|1|||
146553983|NCT00348374|528536203|FG001|Overall Study|Lost to Follow-up|3|||
146553984|NCT00348374|528536202|FG000|Overall Study|Withdrawal by Subject|5|||
146553985|NCT00348374|528536203|FG001|Overall Study|Withdrawal by Subject|5|||
146553986|NCT00348374|528536202|FG000|Overall Study|Other|11|||
146553987|NCT00348374|528536203|FG001|Overall Study|Other|12|||
146553988|NCT00348374|528536202|FG000|Overall Study|ongoing at date of cutoff|1|||
146553989|NCT00348374|528536203|FG001|Overall Study|ongoing at date of cutoff|1|||
146553990|NCT00348374|528536202|FG000|Overall Study|randomized but did not receive treatment|0|||
146553991|NCT00348374|528536203|FG001|Overall Study|randomized but did not receive treatment|7|||
146553992|NCT02105012|528536214|FG000|Overall Study|Withdrawal by Subject|11|||
146553993|NCT02105012|528536214|FG000|Overall Study|Protocol Specified Criteria|9|||
146553994|NCT02105012|528536214|FG000|Overall Study|Lost to Follow-up|4|||
146553995|NCT02105012|528536214|FG000|Overall Study|Protocol Violation|4|||
146553996|NCT02105012|528536214|FG000|Overall Study|Physician Decision|3|||
146553997|NCT02105012|528536214|FG000|Overall Study|Adverse Event|1|||
146553998|NCT02105012|528536214|FG000|Overall Study|Lack of Efficacy|1|||
146553999|NCT00474968|528536221|FG000|Overall Study|Withdrawal by Subject|8|||
146554000|NCT00474968|528536222|FG001|Overall Study|Withdrawal by Subject|7|||
146554001|NCT00474968|528536221|FG000|Overall Study|Protocol Violation|9|||
146554002|NCT00474968|528536222|FG001|Overall Study|Protocol Violation|8|||
146554003|NCT00474968|528536221|FG000|Overall Study|Sample not collected|1|||
146554004|NCT00474968|528536222|FG001|Overall Study|Sample not collected|1|||
146554005|NCT00215553|528536223|FG000|Overall Study|Adverse Event|0|||
146554006|NCT00215553|528536224|FG001|Overall Study|Adverse Event|1|||
146554007|NCT00215553|528536225|FG002|Overall Study|Adverse Event|2|||
146554008|NCT00215553|528536226|FG003|Overall Study|Adverse Event|1|||
146554009|NCT00215553|528536227|FG004|Overall Study|Adverse Event|2|||
146554010|NCT00215553|528536228|FG005|Overall Study|Adverse Event|6|||
146554011|NCT00215553|528536229|FG006|Overall Study|Adverse Event|0|||
146554012|NCT01429623|528536230|FG000|Overall Study|Death|1|||
146554013|NCT01429623|528536231|FG001|Overall Study|Death|0|||
146554014|NCT01429623|528536230|FG000|Overall Study|Adverse Event|7|||
146554015|NCT01429623|528536231|FG001|Overall Study|Adverse Event|14|||
146554016|NCT01429623|528536230|FG000|Overall Study|Withdrawal by Subject|19|||
146554017|NCT01429623|528536231|FG001|Overall Study|Withdrawal by Subject|13|||
146554018|NCT01429623|528536230|FG000|Overall Study|Physician Decision|2|||
146554019|NCT01429623|528536231|FG001|Overall Study|Physician Decision|3|||
146554020|NCT01429623|528536230|FG000|Overall Study|Protocol Violation|3|||
146554021|NCT01429623|528536231|FG001|Overall Study|Protocol Violation|2|||
146554022|NCT01429623|528536230|FG000|Overall Study|Assorted|1|||
146554023|NCT01429623|528536231|FG001|Overall Study|Assorted|2|||
146554024|NCT01429623|528536230|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
146554025|NCT01429623|528536231|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
146554026|NCT01429623|528536230|FG000|Overall Study|No post baseline data|4|||
146554027|NCT01429623|528536231|FG001|Overall Study|No post baseline data|4|||
146554028|NCT05345405|528536232|FG000|Overall Study|Withdrawal by Subject|2|||
146554029|NCT05345405|528536233|FG001|Overall Study|Withdrawal by Subject|0|||
146554030|NCT05345405|528536234|FG002|Overall Study|Withdrawal by Subject|0|||
146554031|NCT05345405|528536232|FG000|Overall Study|Did not meet eligibility criteria|0|||
146554032|NCT05345405|528536233|FG001|Overall Study|Did not meet eligibility criteria|2|||
146554033|NCT05345405|528536234|FG002|Overall Study|Did not meet eligibility criteria|0|||
146554034|NCT05345405|528536232|FG000|Overall Study|Lost to Follow-up|0|||
146554035|NCT05345405|528536233|FG001|Overall Study|Lost to Follow-up|0|||
146554036|NCT05345405|528536234|FG002|Overall Study|Lost to Follow-up|1|||
146554037|NCT01550965|528536236|FG000|Overall Study|Adverse Event|26|||
146554038|NCT01550965|528536236|FG000|Overall Study|Withdrawal by Subject|10|||
146554039|NCT01550965|528536236|FG000|Overall Study|Lost to Follow-up|2|||
146554040|NCT01550965|528536236|FG000|Overall Study|Lack of Efficacy|59|||
146554041|NCT01550965|528536236|FG000|Overall Study|Other|13|||
146554042|NCT04135352|528536238|FG000|Overall Study|Not treated-randomization error|0|||
146554043|NCT04135352|528536239|FG001|Overall Study|Not treated-randomization error|0|||
146554044|NCT04135352|528536240|FG002|Overall Study|Not treated-randomization error|1|||
146554045|NCT04135352|528536241|FG003|Overall Study|Not treated-randomization error|0|||
146554046|NCT04135352|528536242|FG004|Overall Study|Not treated-randomization error|0|||
146554047|NCT04135352|528536243|FG005|Overall Study|Not treated-randomization error|0|||
146554048|NCT04135352|528536244|FG006|Overall Study|Not treated-randomization error|0|||
146554049|NCT04135352|528536245|FG007|Overall Study|Not treated-randomization error|0|||
146554050|NCT04135352|528536238|FG000|Overall Study|Withdrawal by Subject|0|||
146554051|NCT04135352|528536239|FG001|Overall Study|Withdrawal by Subject|0|||
146554052|NCT04135352|528536240|FG002|Overall Study|Withdrawal by Subject|2|||
146554053|NCT04135352|528536241|FG003|Overall Study|Withdrawal by Subject|0|||
146554054|NCT04135352|528536242|FG004|Overall Study|Withdrawal by Subject|0|||
146554055|NCT04135352|528536243|FG005|Overall Study|Withdrawal by Subject|0|||
146554056|NCT04135352|528536244|FG006|Overall Study|Withdrawal by Subject|0|||
146554057|NCT04135352|528536245|FG007|Overall Study|Withdrawal by Subject|0|||
146554058|NCT04135352|528536238|FG000|Overall Study|Sponsor Decision|0|||
146554059|NCT04135352|528536239|FG001|Overall Study|Sponsor Decision|0|||
146554060|NCT04135352|528536240|FG002|Overall Study|Sponsor Decision|2|||
146554061|NCT04135352|528536241|FG003|Overall Study|Sponsor Decision|5|||
146554062|NCT04135352|528536242|FG004|Overall Study|Sponsor Decision|1|||
146554063|NCT04135352|528536243|FG005|Overall Study|Sponsor Decision|4|||
146554064|NCT04135352|528536244|FG006|Overall Study|Sponsor Decision|0|||
146554065|NCT04135352|528536245|FG007|Overall Study|Sponsor Decision|0|||
146554066|NCT04135352|528536238|FG000|Overall Study|Physician Decision|0|||
146554067|NCT04135352|528536239|FG001|Overall Study|Physician Decision|0|||
146554068|NCT04135352|528536240|FG002|Overall Study|Physician Decision|1|||
146554069|NCT04135352|528536241|FG003|Overall Study|Physician Decision|0|||
146554070|NCT04135352|528536242|FG004|Overall Study|Physician Decision|1|||
146554071|NCT04135352|528536243|FG005|Overall Study|Physician Decision|0|||
146554072|NCT04135352|528536244|FG006|Overall Study|Physician Decision|0|||
146554073|NCT04135352|528536245|FG007|Overall Study|Physician Decision|0|||
146554074|NCT04135352|528536238|FG000|Overall Study|Death|3|||
146554075|NCT04135352|528536239|FG001|Overall Study|Death|4|||
146554076|NCT04135352|528536240|FG002|Overall Study|Death|7|||
146554077|NCT04135352|528536241|FG003|Overall Study|Death|0|||
146554078|NCT04135352|528536242|FG004|Overall Study|Death|3|||
146554079|NCT04135352|528536243|FG005|Overall Study|Death|1|||
146554080|NCT04135352|528536244|FG006|Overall Study|Death|0|||
146554081|NCT04135352|528536245|FG007|Overall Study|Death|0|||
146554082|NCT00819832|528536246|FG000|Overall Study|Sponsor Termination of Study|3|||
146554083|NCT00819832|528536247|FG001|Overall Study|Sponsor Termination of Study|0|||
146554084|NCT00819832|528536248|FG002|Overall Study|Sponsor Termination of Study|0|||
146554085|NCT00819832|528536249|FG003|Overall Study|Sponsor Termination of Study|0|||
146554086|NCT00819832|528536250|FG004|Overall Study|Sponsor Termination of Study|0|||
146554087|NCT00819832|528536251|FG005|Overall Study|Sponsor Termination of Study|0|||
146554088|NCT01089543|528536252|FG000|Overall Study|Withdrawal by Subject|2|||
146554089|NCT01089543|528536253|FG001|Overall Study|Withdrawal by Subject|3|||
146765325|NCT03670602|529308615|FG000|Overall Study|Lost to Follow-up|1|||
146554090|NCT01089543|528536254|FG002|Overall Study|Withdrawal by Subject|3|||
146554091|NCT01089543|528536255|FG003|Overall Study|Withdrawal by Subject|1|||
146554092|NCT01089543|528536252|FG000|Overall Study|Physician Decision|1|||
146554093|NCT01089543|528536253|FG001|Overall Study|Physician Decision|0|||
146554094|NCT01089543|528536254|FG002|Overall Study|Physician Decision|0|||
146554095|NCT01089543|528536255|FG003|Overall Study|Physician Decision|1|||
146554096|NCT01089543|528536252|FG000|Overall Study|Adverse Event|0|||
146554097|NCT01089543|528536253|FG001|Overall Study|Adverse Event|1|||
146554098|NCT01089543|528536254|FG002|Overall Study|Adverse Event|0|||
146554099|NCT01089543|528536255|FG003|Overall Study|Adverse Event|0|||
146554100|NCT01905267|528536259|FG000|Overall Study|Physician Decision|2|||
146554101|NCT01905267|528536260|FG001|Overall Study|Physician Decision|2|||
146554102|NCT03438656|528536261|FG000|Overall Study|Lost to Follow-up|2|||
146554103|NCT01189227|528536262|FG000|Overall Study|Study terminated due to low accrual|6|||
146554104|NCT01189227|528536263|FG001|Overall Study|Study terminated due to low accrual|3|||
146554105|NCT05652140|528536266|FG000|Overall Study|Lost to Follow-up|7|||
146554106|NCT05652140|528536267|FG001|Overall Study|Lost to Follow-up|16|||
146554107|NCT05652140|528536268|FG002|Overall Study|Lost to Follow-up|22|||
146554108|NCT05652140|528536269|FG003|Overall Study|Lost to Follow-up|31|||
146554109|NCT04648241|528536271|FG000|Overall Study|Lost to Follow-up|1|||
146554110|NCT04648241|528536272|FG001|Overall Study|Lost to Follow-up|0|||
146554111|NCT02774278|528536273|FG000|Overall Study|Lack of Efficacy|199|||
146554112|NCT02774278|528536273|FG000|Overall Study|Death|29|||
146554113|NCT02774278|528536273|FG000|Overall Study|Adverse event/intercurrent illness|16|||
146554114|NCT02774278|528536273|FG000|Overall Study|Refused treatment/did not cooperate|9|||
146554115|NCT02774278|528536273|FG000|Overall Study|Administrative reasons|6|||
146554116|NCT02774278|528536273|FG000|Overall Study|Withdrawal by Subject|3|||
146554117|NCT02774278|528536273|FG000|Overall Study|Protocol Violation|2|||
146554118|NCT03339453|528536282|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
146554119|NCT03339453|528536283|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
146554120|NCT03760666|528536288|FG000|Overall Study|Adverse Event|2|||
146554121|NCT03760666|528536289|FG001|Overall Study|Adverse Event|4|||
146554122|NCT03760666|528536290|FG002|Overall Study|Adverse Event|1|||
146554123|NCT03760666|528536288|FG000|Overall Study|AML Disease Progression|3|||
146554124|NCT03760666|528536289|FG001|Overall Study|AML Disease Progression|3|||
146554125|NCT03760666|528536290|FG002|Overall Study|AML Disease Progression|0|||
146554126|NCT03760666|528536288|FG000|Overall Study|Physician Decision|0|||
146554127|NCT03760666|528536289|FG001|Overall Study|Physician Decision|3|||
146554128|NCT03760666|528536290|FG002|Overall Study|Physician Decision|0|||
146554129|NCT03760666|528536288|FG000|Overall Study|Withdrawal by Subject|0|||
146554130|NCT03760666|528536289|FG001|Overall Study|Withdrawal by Subject|1|||
146554131|NCT03760666|528536290|FG002|Overall Study|Withdrawal by Subject|0|||
146554132|NCT02946996|528536298|FG000|Overall Study|non-evaluable|3|||
146554133|NCT02946996|528536299|FG001|Overall Study|non-evaluable|6|||
146554134|NCT02946996|528536300|FG002|Overall Study|non-evaluable|5|||
146554135|NCT06868667|528536301|FG000|Overall Study|Death|0|||
146554136|NCT06868667|528536302|FG001|Overall Study|Death|4|||
146554137|NCT06868667|528536301|FG000|Overall Study|Lost to Follow-up|0|||
146554138|NCT06868667|528536302|FG001|Overall Study|Lost to Follow-up|1|||
146554139|NCT06868667|528536301|FG000|Overall Study|Withdrawal by Subject|1|||
146554140|NCT06868667|528536302|FG001|Overall Study|Withdrawal by Subject|0|||
146554141|NCT06868667|528536301|FG000|Overall Study|Ongoing|9|||
146554142|NCT06868667|528536302|FG001|Overall Study|Ongoing|9|||
146554143|NCT05330429|528536305|FG000|Overall Study|Study Terminated by Sponsor|4|||
146554144|NCT05330429|528536306|FG001|Overall Study|Study Terminated by Sponsor|33|||
146554145|NCT05330429|528536307|FG002|Overall Study|Study Terminated by Sponsor|12|||
146554146|NCT05330429|528536305|FG000|Overall Study|Death|5|||
146554147|NCT05330429|528536306|FG001|Overall Study|Death|2|||
146554148|NCT05330429|528536307|FG002|Overall Study|Death|4|||
146554149|NCT05330429|528536305|FG000|Overall Study|Withdrew Consent|0|||
146554150|NCT05330429|528536306|FG001|Overall Study|Withdrew Consent|5|||
146554151|NCT05330429|528536307|FG002|Overall Study|Withdrew Consent|4|||
146554152|NCT05330429|528536305|FG000|Overall Study|Investigator's Discretion|0|||
146554153|NCT05330429|528536306|FG001|Overall Study|Investigator's Discretion|1|||
146554154|NCT05330429|528536307|FG002|Overall Study|Investigator's Discretion|3|||
146554155|NCT05330429|528536305|FG000|Overall Study|Subject Decision|1|||
146554156|NCT05330429|528536306|FG001|Overall Study|Subject Decision|2|||
146554157|NCT05330429|528536307|FG002|Overall Study|Subject Decision|0|||
146554158|NCT05330429|528536305|FG000|Overall Study|Lost to Follow-up|0|||
146554159|NCT05330429|528536306|FG001|Overall Study|Lost to Follow-up|1|||
146554160|NCT05330429|528536307|FG002|Overall Study|Lost to Follow-up|0|||
146554161|NCT00655746|528536308|FG000|Overall Study|Withdrawal by Subject|1|||
146554162|NCT02931539|528536309|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
146554163|NCT02931539|528536310|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
146554164|NCT02931539|528536311|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
146554165|NCT02931539|528536309|FG000|Period 1: Treatment Phase|Adverse Event|5|||
146554166|NCT02931539|528536310|FG001|Period 1: Treatment Phase|Adverse Event|1|||
146554167|NCT02931539|528536311|FG002|Period 1: Treatment Phase|Adverse Event|0|||
146554168|NCT02931539|528536309|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
146554169|NCT02931539|528536310|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
146634626|NCT00658359|528837267|FG000|Overall Study|Adverse Event|13|||
146634627|NCT00658359|528837268|FG001|Overall Study|Adverse Event|6|||
146634628|NCT00658359|528837269|FG002|Overall Study|Adverse Event|9|||
146634629|NCT00658359|528837267|FG000|Overall Study|Protocol Violation|1|||
146634630|NCT00658359|528837268|FG001|Overall Study|Protocol Violation|0|||
146634631|NCT00658359|528837269|FG002|Overall Study|Protocol Violation|0|||
146634632|NCT00658359|528837267|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
146634633|NCT00658359|528837268|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
146634634|NCT00658359|528837269|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
146634635|NCT00658359|528837267|FG000|Overall Study|Withdrawal by Subject|7|||
146634636|NCT00658359|528837268|FG001|Overall Study|Withdrawal by Subject|4|||
146634637|NCT00658359|528837269|FG002|Overall Study|Withdrawal by Subject|2|||
146634638|NCT00658359|528837267|FG000|Overall Study|Lost to Follow-up|2|||
146634639|NCT00658359|528837268|FG001|Overall Study|Lost to Follow-up|2|||
146634640|NCT00658359|528837269|FG002|Overall Study|Lost to Follow-up|4|||
146634641|NCT00658359|528837267|FG000|Overall Study|Lack of Efficacy|0|||
146634642|NCT00658359|528837268|FG001|Overall Study|Lack of Efficacy|1|||
146634643|NCT00658359|528837269|FG002|Overall Study|Lack of Efficacy|0|||
146634644|NCT00734539|528837270|FG000|Main Study|Death|33|||
146634645|NCT00734539|528837271|FG001|Main Study|Death|32|||
146634646|NCT00734539|528837270|FG000|Main Study|Physician Decision|2|||
146634647|NCT00734539|528837271|FG001|Main Study|Physician Decision|0|||
146634648|NCT00734539|528837270|FG000|Main Study|Withdrawal by Subject|1|||
146634649|NCT00734539|528837271|FG001|Main Study|Withdrawal by Subject|3|||
146634650|NCT00734539|528837270|FG000|Main Study|Enrolled in error; ineligible|1|||
146634651|NCT00734539|528837271|FG001|Main Study|Enrolled in error; ineligible|0|||
146634652|NCT02504151|528837274|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
146634653|NCT02504151|528837275|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
146634654|NCT02504151|528837274|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
146634655|NCT02504151|528837275|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
146634656|NCT02504151|528837274|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
146634657|NCT02504151|528837275|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
146634658|NCT02504151|528837274|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
146634659|NCT02504151|528837275|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
146634660|NCT00705016|528837276|FG000|Overall Study|Adverse Event|6|||
146634661|NCT00705016|528837277|FG001|Overall Study|Adverse Event|11|||
146634662|NCT00705016|528837278|FG002|Overall Study|Adverse Event|10|||
146634663|NCT00705016|528837276|FG000|Overall Study|Death|5|||
146634664|NCT00705016|528837277|FG001|Overall Study|Death|7|||
146634665|NCT00705016|528837278|FG002|Overall Study|Death|5|||
146634666|NCT00705016|528837276|FG000|Overall Study|Protocol Violation|0|||
146634667|NCT00705016|528837277|FG001|Overall Study|Protocol Violation|1|||
146634668|NCT00705016|528837278|FG002|Overall Study|Protocol Violation|1|||
146634669|NCT00705016|528837276|FG000|Overall Study|Withdrawal by Subject|4|||
146634670|NCT00705016|528837277|FG001|Overall Study|Withdrawal by Subject|3|||
146634671|NCT00705016|528837278|FG002|Overall Study|Withdrawal by Subject|2|||
146634672|NCT00705016|528837276|FG000|Overall Study|Progressive Disease|33|||
146634673|NCT00705016|528837277|FG001|Overall Study|Progressive Disease|29|||
146634674|NCT00705016|528837278|FG002|Overall Study|Progressive Disease|33|||
146634675|NCT00705016|528837276|FG000|Overall Study|Symptomatic Deterioration|3|||
146634676|NCT00705016|528837277|FG001|Overall Study|Symptomatic Deterioration|1|||
146634677|NCT00705016|528837278|FG002|Overall Study|Symptomatic Deterioration|1|||
146634678|NCT00705016|528837276|FG000|Overall Study|Other|9|||
146634679|NCT00705016|528837277|FG001|Overall Study|Other|6|||
146634680|NCT00705016|528837278|FG002|Overall Study|Other|6|||
146634681|NCT01188343|528837279|FG000|Overall Study|Not vaccinated|0|||
146634682|NCT01188343|528837280|FG001|Overall Study|Not vaccinated|2|||
146634683|NCT01188343|528837281|FG002|Overall Study|Not vaccinated|1|||
146634684|NCT01188343|528837279|FG000|Overall Study|Withdrawal by Subject|1|||
146634685|NCT01188343|528837280|FG001|Overall Study|Withdrawal by Subject|24|||
146634686|NCT01188343|528837281|FG002|Overall Study|Withdrawal by Subject|0|||
146634687|NCT01457703|528837284|FG000|Overall Study|Screen Failure|5|||
146634688|NCT01457703|528837285|FG001|Overall Study|Screen Failure|7|||
146634689|NCT01457703|528837284|FG000|Overall Study|Withdrawal by Subject|1|||
146634690|NCT01457703|528837285|FG001|Overall Study|Withdrawal by Subject|4|||
146634691|NCT03133793|528837290|FG000|Overall Study|Withdrawal by Subject|0|||
146634692|NCT03133793|528837291|FG001|Overall Study|Withdrawal by Subject|4|||
146634693|NCT03133793|528837292|FG002|Overall Study|Withdrawal by Subject|2|||
146634694|NCT03133793|528837293|FG003|Overall Study|Withdrawal by Subject|4|||
146634695|NCT03133793|528837290|FG000|Overall Study|Lost to Follow-up|1|||
146634696|NCT03133793|528837291|FG001|Overall Study|Lost to Follow-up|0|||
146634697|NCT03133793|528837292|FG002|Overall Study|Lost to Follow-up|2|||
146634698|NCT03133793|528837293|FG003|Overall Study|Lost to Follow-up|0|||
146634699|NCT03133793|528837290|FG000|Overall Study|Death|0|||
146634700|NCT03133793|528837291|FG001|Overall Study|Death|0|||
146634701|NCT03133793|528837292|FG002|Overall Study|Death|0|||
146634702|NCT03133793|528837293|FG003|Overall Study|Death|1|||
146634703|NCT00515619|528837299|FG000|Overall Study|Adverse Event|34|||
146634704|NCT00515619|528837299|FG000|Overall Study|Lack of Efficacy|92|||
146634705|NCT00515619|528837299|FG000|Overall Study|Withdrawal by Subject|66|||
146634706|NCT00515619|528837299|FG000|Overall Study|Protocol Violation|3|||
146634707|NCT00515619|528837299|FG000|Overall Study|Lost to Follow-up|4|||
146634708|NCT00515619|528837299|FG000|Overall Study|Unsatisfactory compliance|6|||
146634709|NCT00515619|528837299|FG000|Overall Study|Other: Site discontinuing trials|2|||
146634710|NCT00515619|528837299|FG000|Overall Study|Other: Subject cannot attend visits|2|||
146634711|NCT00515619|528837299|FG000|Overall Study|Other: Subject required surgery|1|||
146634712|NCT00515619|528837299|FG000|Overall Study|Other: Subject moved to another country|1|||
146634713|NCT00515619|528837299|FG000|Overall Study|Other: Investigator decision|1|||
146634714|NCT00515619|528837299|FG000|Overall Study|Other: Subject became pregnant|1|||
146634715|NCT00515619|528837299|FG000|Overall Study|Other: Request from sponsor|1|||
146634716|NCT00515619|528837299|FG000|Overall Study|Other: Drug available on license|1|||
146634717|NCT00515619|528837299|FG000|Overall Study|Other: Subject interested in other AED|1|||
146634718|NCT02379091|528837300|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
146634719|NCT02379091|528837301|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
146634720|NCT02379091|528837302|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
146634721|NCT02379091|528837303|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
146634722|NCT02379091|528837300|FG000|Overall Study|Principal Investigator Discretion|0|||
146634723|NCT02379091|528837301|FG001|Overall Study|Principal Investigator Discretion|1|||
146634724|NCT02379091|528837302|FG002|Overall Study|Principal Investigator Discretion|0|||
146634725|NCT02379091|528837303|FG003|Overall Study|Principal Investigator Discretion|0|||
146634726|NCT02379091|528837300|FG000|Overall Study|Lost to Follow-up|0|||
146634727|NCT02379091|528837301|FG001|Overall Study|Lost to Follow-up|0|||
146634728|NCT02379091|528837302|FG002|Overall Study|Lost to Follow-up|0|||
146634729|NCT02379091|528837303|FG003|Overall Study|Lost to Follow-up|1|||
146634730|NCT02379091|528837300|FG000|Overall Study|Voluntary Withdrawal|2|||
146634731|NCT02379091|528837301|FG001|Overall Study|Voluntary Withdrawal|5|||
146634732|NCT02379091|528837302|FG002|Overall Study|Voluntary Withdrawal|2|||
146634733|NCT02379091|528837303|FG003|Overall Study|Voluntary Withdrawal|4|||
146634734|NCT02379091|528837300|FG000|Overall Study|Study Termination|7|||
146634735|NCT02379091|528837301|FG001|Overall Study|Study Termination|2|||
146634736|NCT02379091|528837302|FG002|Overall Study|Study Termination|5|||
146634737|NCT02379091|528837303|FG003|Overall Study|Study Termination|8|||
146634738|NCT02379091|528837300|FG000|Overall Study|Lack of Efficacy|3|||
146634739|NCT02379091|528837301|FG001|Overall Study|Lack of Efficacy|0|||
146634740|NCT02379091|528837302|FG002|Overall Study|Lack of Efficacy|0|||
146634741|NCT02379091|528837303|FG003|Overall Study|Lack of Efficacy|0|||
146634742|NCT02129699|528837305|FG000|Overall Study|Did not start treatment|3|||
146634743|NCT02129699|528837306|FG001|Overall Study|Did not start treatment|2|||
146634744|NCT00670748|528837311|FG000|Overall Study|Death during treatment|1|||
146634745|NCT00670748|528837312|FG001|Overall Study|Death during treatment|1|||
146634746|NCT00670748|528837313|FG002|Overall Study|Death during treatment|1|||
146634747|NCT00670748|528837314|FG003|Overall Study|Death during treatment|0|||
146634748|NCT00670748|528837311|FG000|Overall Study|Not off study|2|||
146634749|NCT00670748|528837312|FG001|Overall Study|Not off study|1|||
146634750|NCT00670748|528837313|FG002|Overall Study|Not off study|1|||
146634751|NCT00670748|528837314|FG003|Overall Study|Not off study|1|||
146634752|NCT03863080|528837319|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
146634753|NCT03863080|528837320|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
146634754|NCT03863080|528837321|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
146634755|NCT03863080|528837322|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
146634756|NCT03863080|528837319|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
146634757|NCT03863080|528837320|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
146634758|NCT03863080|528837321|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
146634759|NCT03863080|528837322|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
146634760|NCT03863080|528837319|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
146634761|NCT03863080|528837320|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
146634762|NCT03863080|528837321|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
146634763|NCT03863080|528837322|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
146634764|NCT02991768|528837332|FG000|Overall Study|Physician Decision|4|||
146634765|NCT03467750|528837333|FG000|Overall Study|Surgery canceled|1|||
146634766|NCT03467750|528837334|FG001|Overall Study|Surgery canceled|0|||
146634767|NCT03467750|528837333|FG000|Overall Study|Protocol Violation|1|||
146634768|NCT03467750|528837334|FG001|Overall Study|Protocol Violation|1|||
146634769|NCT03467750|528837333|FG000|Overall Study|Withdrawal by Subject|0|||
146634770|NCT03467750|528837334|FG001|Overall Study|Withdrawal by Subject|1|||
146634771|NCT05673876|528837335|FG000|Overall Study|Death|3|||
146634772|NCT05673876|528837336|FG001|Overall Study|Death|1|||
146634773|NCT05673876|528837335|FG000|Overall Study|Study Terminated by Sponsor|0|||
146634774|NCT05673876|528837336|FG001|Overall Study|Study Terminated by Sponsor|1|||
146634775|NCT05673876|528837335|FG000|Overall Study|Physician Decision|0|||
146634776|NCT05673876|528837336|FG001|Overall Study|Physician Decision|1|||
146634777|NCT03529422|528837337|FG000|Overall Study|Withdrawal by Subject|1|||
146634778|NCT03529422|528837337|FG000|Overall Study|Protocol Violation|1|||
146634779|NCT03529422|528837337|FG000|Overall Study|Disease progression|2|||
146634780|NCT02000115|528837340|FG000|Overall Study|Death|56|||
146634781|NCT02000115|528837341|FG001|Overall Study|Death|45|||
146634782|NCT02000115|528837342|FG002|Overall Study|Death|0|||
146634783|NCT02000115|528837343|FG003|Overall Study|Death|0|||
146634784|NCT02000115|528837340|FG000|Overall Study|Missed Visit|6|||
146634785|NCT02000115|528837341|FG001|Overall Study|Missed Visit|8|||
146634786|NCT02000115|528837342|FG002|Overall Study|Missed Visit|1|||
146634787|NCT02000115|528837343|FG003|Overall Study|Missed Visit|0|||
146634788|NCT02000115|528837340|FG000|Overall Study|Protocol Violation|2|||
146634789|NCT02000115|528837341|FG001|Overall Study|Protocol Violation|1|||
146634790|NCT02000115|528837342|FG002|Overall Study|Protocol Violation|0|||
146634791|NCT02000115|528837343|FG003|Overall Study|Protocol Violation|0|||
146634792|NCT02000115|528837340|FG000|Overall Study|Physician Decision|2|||
146634793|NCT02000115|528837341|FG001|Overall Study|Physician Decision|0|||
146634794|NCT02000115|528837342|FG002|Overall Study|Physician Decision|0|||
146634795|NCT02000115|528837343|FG003|Overall Study|Physician Decision|0|||
146634796|NCT02000115|528837340|FG000|Overall Study|Withdrawal by Subject|11|||
146634797|NCT02000115|528837341|FG001|Overall Study|Withdrawal by Subject|11|||
146634798|NCT02000115|528837342|FG002|Overall Study|Withdrawal by Subject|0|||
146634799|NCT02000115|528837343|FG003|Overall Study|Withdrawal by Subject|0|||
146634800|NCT02000115|528837340|FG000|Overall Study|Lost to Follow-up|0|||
146634801|NCT02000115|528837341|FG001|Overall Study|Lost to Follow-up|1|||
146634802|NCT02000115|528837342|FG002|Overall Study|Lost to Follow-up|0|||
146634803|NCT02000115|528837343|FG003|Overall Study|Lost to Follow-up|0|||
146634804|NCT02000115|528837340|FG000|Overall Study|Non-compliance|2|||
146634805|NCT02000115|528837341|FG001|Overall Study|Non-compliance|1|||
146634806|NCT02000115|528837342|FG002|Overall Study|Non-compliance|0|||
146634807|NCT02000115|528837343|FG003|Overall Study|Non-compliance|0|||
146634808|NCT02000115|528837340|FG000|Overall Study|Withdrawn on day of randomization|0|||
146634809|NCT02000115|528837341|FG001|Overall Study|Withdrawn on day of randomization|1|||
146634810|NCT02000115|528837342|FG002|Overall Study|Withdrawn on day of randomization|0|||
146634811|NCT02000115|528837343|FG003|Overall Study|Withdrawn on day of randomization|0|||
146634812|NCT02000115|528837340|FG000|Overall Study|Still on Study|0|||
146634813|NCT02000115|528837341|FG001|Overall Study|Still on Study|0|||
146634814|NCT02000115|528837342|FG002|Overall Study|Still on Study|0|||
146634815|NCT02000115|528837343|FG003|Overall Study|Still on Study|53|||
146634816|NCT05006573|528837346|FG000|Double-blind Treatment Period|Physician Decision|2|||
146634817|NCT05006573|528837347|FG001|Double-blind Treatment Period|Physician Decision|0|||
146634818|NCT05006573|528837346|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
146634819|NCT05006573|528837347|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
146634820|NCT05006573|528837346|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
146634821|NCT05006573|528837347|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
146634822|NCT05006573|528837346|FG000|Double-blind Treatment Period|Protocol Violation|2|||
146634823|NCT05006573|528837347|FG001|Double-blind Treatment Period|Protocol Violation|0|||
146634824|NCT05006573|528837346|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
146634825|NCT05006573|528837347|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
146634826|NCT05006573|528837346|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
146634827|NCT05006573|528837347|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
146765326|NCT03670602|529308616|FG001|Overall Study|Lost to Follow-up|0|||
146634828|NCT04949490|528837348|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
146634829|NCT04949490|528837349|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
146634830|NCT04949490|528837350|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
146634831|NCT04949490|528837351|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
146634832|NCT04949490|528837352|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
146634833|NCT04949490|528837353|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
146634834|NCT04949490|528837348|FG000|Group A and Group B|Withdrawal by Subject|0|||
146634835|NCT04949490|528837349|FG001|Group A and Group B|Withdrawal by Subject|0|||
146634836|NCT04949490|528837350|FG002|Group A and Group B|Withdrawal by Subject|1|||
146634837|NCT04949490|528837351|FG003|Group A and Group B|Withdrawal by Subject|0|||
146634838|NCT04949490|528837352|FG004|Group A and Group B|Withdrawal by Subject|0|||
146634839|NCT04949490|528837353|FG005|Group A and Group B|Withdrawal by Subject|0|||
146634840|NCT04949490|528837348|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
146634841|NCT04949490|528837349|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
146634842|NCT04949490|528837350|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
146634843|NCT04949490|528837351|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
146634844|NCT04949490|528837352|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
146634845|NCT04949490|528837353|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
146634846|NCT04949490|528837348|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
146634847|NCT04949490|528837349|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
146634848|NCT04949490|528837350|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
146634849|NCT04949490|528837351|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
146634850|NCT04949490|528837352|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
146634851|NCT04949490|528837353|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
146634852|NCT04988477|528837356|FG000|Overall Study|Death|1|||
146554170|NCT02931539|528536311|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
146554171|NCT02931539|528536309|FG000|Period 1: Treatment Phase|Death|8|||
146554172|NCT02931539|528536310|FG001|Period 1: Treatment Phase|Death|24|||
146554173|NCT02931539|528536311|FG002|Period 1: Treatment Phase|Death|0|||
146554174|NCT02931539|528536309|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
146554175|NCT02931539|528536310|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
146554176|NCT02931539|528536311|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
146554177|NCT02931539|528536309|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
146554178|NCT02931539|528536310|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
146554179|NCT02931539|528536311|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
146554180|NCT02931539|528536309|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
146554181|NCT02931539|528536310|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
146554182|NCT02931539|528536311|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
146554183|NCT02931539|528536309|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
146554184|NCT02931539|528536310|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
146554185|NCT02931539|528536311|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
146554186|NCT01569763|528538355|FG000|Overall Study|Lack of Efficacy|2|||
146966718|NCT04089566|530038885|FG005|Overall Study|Death|0|||
146966719|NCT04089566|530038880|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
146554187|NCT01569763|528538356|FG001|Overall Study|Lack of Efficacy|7|||
146554188|NCT01569763|528538355|FG000|Overall Study|Adverse Event|1|||
146554189|NCT01569763|528538356|FG001|Overall Study|Adverse Event|0|||
146554190|NCT01926509|528538357|FG000|Overall Study|vital sign met discontinuation criteria|1|||
146554191|NCT01926509|528538358|FG001|Overall Study|vital sign met discontinuation criteria|0|||
146554192|NCT01926509|528538359|FG002|Overall Study|vital sign met discontinuation criteria|0|||
146554193|NCT01926509|528538360|FG003|Overall Study|vital sign met discontinuation criteria|0|||
146554194|NCT02730169|528538361|FG000|Overall Study|Protocol Violation|1|||
146554195|NCT02730169|528538362|FG001|Overall Study|Protocol Violation|0|||
146554196|NCT02730169|528538363|FG002|Overall Study|Protocol Violation|0|||
146554197|NCT02730169|528538364|FG003|Overall Study|Protocol Violation|1|||
146554198|NCT02730169|528538361|FG000|Overall Study|Adverse Event|2|||
146554199|NCT02730169|528538362|FG001|Overall Study|Adverse Event|3|||
146554200|NCT02730169|528538363|FG002|Overall Study|Adverse Event|3|||
146554201|NCT02730169|528538364|FG003|Overall Study|Adverse Event|0|||
146554202|NCT02730169|528538361|FG000|Overall Study|Adverse Event of Special Interest|0|||
146554203|NCT02730169|528538362|FG001|Overall Study|Adverse Event of Special Interest|1|||
146554204|NCT02730169|528538363|FG002|Overall Study|Adverse Event of Special Interest|2|||
146554205|NCT02730169|528538364|FG003|Overall Study|Adverse Event of Special Interest|0|||
146554206|NCT02730169|528538361|FG000|Overall Study|Withdrawal by Subject|6|||
146554207|NCT02730169|528538362|FG001|Overall Study|Withdrawal by Subject|11|||
146554208|NCT02730169|528538363|FG002|Overall Study|Withdrawal by Subject|6|||
146554209|NCT02730169|528538364|FG003|Overall Study|Withdrawal by Subject|8|||
146554210|NCT02730169|528538361|FG000|Overall Study|Lost to Follow-up|5|||
146554211|NCT02730169|528538362|FG001|Overall Study|Lost to Follow-up|6|||
146554212|NCT02730169|528538363|FG002|Overall Study|Lost to Follow-up|5|||
146554213|NCT02730169|528538364|FG003|Overall Study|Lost to Follow-up|6|||
146554214|NCT02730169|528538361|FG000|Overall Study|Other|0|||
146554215|NCT02730169|528538362|FG001|Overall Study|Other|0|||
146554216|NCT02730169|528538363|FG002|Overall Study|Other|1|||
146554217|NCT02730169|528538364|FG003|Overall Study|Other|1|||
146554218|NCT03004183|528538365|FG000|Overall Study|Adverse Event|7|||
146554219|NCT03004183|528538365|FG000|Overall Study|Lost to Follow-up|1|||
146554220|NCT03004183|528538365|FG000|Overall Study|Physician Decision|40|||
146554221|NCT03004183|528538365|FG000|Overall Study|Withdrawal by Subject|1|||
146554222|NCT03004183|528538365|FG000|Overall Study|COVID-19|1|||
146554223|NCT03681093|528538366|FG000|Overall Study|Subject decision|0|||
146554224|NCT03681093|528538367|FG001|Overall Study|Subject decision|2|||
146554225|NCT03681093|528538368|FG002|Overall Study|Subject decision|1|||
146554226|NCT01027754|528538369|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
146554227|NCT01027754|528538370|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
146554228|NCT01027754|528538369|FG000|Overall Study|Withdrawal by Subject|0|||
146554229|NCT01027754|528538370|FG001|Overall Study|Withdrawal by Subject|5|||
146554230|NCT02529488|528538371|FG000|Overall Study|Adverse Event|1|||
146554231|NCT02529488|528538371|FG000|Overall Study|Death|3|||
146554232|NCT01882829|528538372|FG000|Overall Study|Adverse Event|4|||
146554233|NCT01882829|528538372|FG000|Overall Study|Protocol Violation|1|||
146554234|NCT01882829|528538372|FG000|Overall Study|Withdrawal by Subject|1|||
146554235|NCT02562040|528538373|FG000|Overall Study|Lost to Follow-up|20|||
146554236|NCT02562040|528538374|FG001|Overall Study|Lost to Follow-up|28|||
146554237|NCT02562040|528538373|FG000|Overall Study|Withdrawal by Subject|8|||
146554238|NCT02562040|528538374|FG001|Overall Study|Withdrawal by Subject|7|||
146554239|NCT02562040|528538373|FG000|Overall Study|Adverse Event|1|||
146554240|NCT02562040|528538374|FG001|Overall Study|Adverse Event|0|||
146554241|NCT01699685|528538376|FG000|Period 1|Adverse Event|1|||
146554242|NCT01699685|528538377|FG001|Period 1|Adverse Event|1|||
146554243|NCT01699685|528538376|FG000|Period 1|Medical or ethical, noncompliance|2|||
146554244|NCT01699685|528538377|FG001|Period 1|Medical or ethical, noncompliance|0|||
146554245|NCT01699685|528538376|FG000|Period 1|Other|0|||
146554246|NCT01699685|528538377|FG001|Period 1|Other|1|||
146554247|NCT01699685|528538376|FG000|Period 1|Patient request|0|||
146554248|NCT01699685|528538377|FG001|Period 1|Patient request|1|||
146554249|NCT01699685|528538376|FG000|Period 2|Lost to Follow-up|1|||
146554250|NCT01699685|528538377|FG001|Period 2|Lost to Follow-up|0|||
146554251|NCT02821000|528538378|FG000|Overall Study|Death|89|||
146554252|NCT02821000|528538378|FG000|Overall Study|Sponsor Decision|12|||
146554253|NCT02821000|528538378|FG000|Overall Study|Withdrawal by Subject|2|||
146554254|NCT01654250|528538379|FG000|Overall Study|Lost to Follow-up|1|||
146554255|NCT01654250|528538380|FG001|Overall Study|Lost to Follow-up|0|||
146554256|NCT02596893|528538381|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
146554257|NCT02596893|528538382|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
146554258|NCT02596893|528538383|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
146554259|NCT02596893|528538384|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
146554260|NCT02596893|528538381|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
146554261|NCT02596893|528538382|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
146554262|NCT02596893|528538383|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
146554263|NCT02596893|528538384|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
146554264|NCT02596893|528538381|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
146554265|NCT02596893|528538382|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
146554266|NCT02596893|528538383|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
146554267|NCT02596893|528538384|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
146554268|NCT02596893|528538381|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
146554269|NCT02596893|528538382|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
146554270|NCT02596893|528538383|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
146554271|NCT02596893|528538384|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
146554272|NCT02596893|528538381|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
146554273|NCT02596893|528538382|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
146554274|NCT02596893|528538383|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
146554275|NCT02596893|528538384|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
146554276|NCT02596893|528538381|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
146554277|NCT02596893|528538382|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
146554278|NCT02596893|528538383|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
146554279|NCT02596893|528538384|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
146554280|NCT02596893|528538381|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
146554281|NCT02596893|528538382|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
146554282|NCT02596893|528538383|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
146554283|NCT02596893|528538384|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
146765327|NCT03670602|529308615|FG000|Overall Study|Withdrawal by Subject|0|||
146765328|NCT03670602|529308616|FG001|Overall Study|Withdrawal by Subject|3|||
146554284|NCT02596893|528538381|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
146554285|NCT02596893|528538382|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
146554286|NCT02596893|528538383|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
146554287|NCT02596893|528538384|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
146554288|NCT02596893|528538381|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
146554289|NCT02596893|528538382|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
146554290|NCT02596893|528538383|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
146554291|NCT02596893|528538384|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
146554292|NCT02596893|528538381|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
146554293|NCT02596893|528538382|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
146554294|NCT02596893|528538383|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
146554295|NCT02596893|528538384|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
146634853|NCT04988477|528837357|FG001|Overall Study|Death|0|||
146634854|NCT04988477|528837358|FG002|Overall Study|Death|0|||
146634855|NCT04988477|528837356|FG000|Overall Study|Lost to Follow-up|5|||
146634856|NCT04988477|528837357|FG001|Overall Study|Lost to Follow-up|2|||
146634857|NCT04988477|528837358|FG002|Overall Study|Lost to Follow-up|0|||
146634858|NCT04988477|528837356|FG000|Overall Study|Withdrawal by Subject|2|||
146634859|NCT04988477|528837357|FG001|Overall Study|Withdrawal by Subject|0|||
146634860|NCT04988477|528837358|FG002|Overall Study|Withdrawal by Subject|0|||
146634861|NCT01987453|528838795|FG000|Overall Study|Death|0|||
146634862|NCT01987453|528838796|FG001|Overall Study|Death|0|||
146634863|NCT01987453|528838797|FG002|Overall Study|Death|1|||
146634864|NCT01987453|528838795|FG000|Overall Study|Lack of Efficacy|1|||
146634865|NCT01987453|528838796|FG001|Overall Study|Lack of Efficacy|12|||
146634866|NCT01987453|528838797|FG002|Overall Study|Lack of Efficacy|0|||
146634867|NCT01590888|528838798|FG000|Overall Study|Adverse Event|3|||
146634868|NCT01590888|528838799|FG001|Overall Study|Adverse Event|0|||
146634869|NCT01590888|528838800|FG002|Overall Study|Adverse Event|1|||
146634870|NCT01590888|528838798|FG000|Overall Study|Lost to Follow-up|1|||
146634871|NCT01590888|528838799|FG001|Overall Study|Lost to Follow-up|0|||
146634872|NCT01590888|528838800|FG002|Overall Study|Lost to Follow-up|0|||
146634873|NCT04953728|528838801|FG000|Overall Study|Withdrawal by Subject|3|||
146634874|NCT04953728|528838801|FG000|Overall Study|Physician Decision|1|||
146634875|NCT02105662|528838802|FG000|Overall Study|Lost to Follow-up|5|||
146634876|NCT02105662|528838802|FG000|Overall Study|Withdrawal by Subject|1|||
146634877|NCT02331277|528838803|FG000|Overall Study|Withdrawal by Subject|1|||
146634878|NCT02331277|528838804|FG001|Overall Study|Withdrawal by Subject|0|||
146634879|NCT00990704|528838807|FG000|Overall Study|Adverse Event|1|||
146634880|NCT00990704|528838808|FG001|Overall Study|Adverse Event|1|||
146634881|NCT00990704|528838807|FG000|Overall Study|Physician Decision|0|||
146634882|NCT00990704|528838808|FG001|Overall Study|Physician Decision|1|||
146634883|NCT01399372|528838809|FG000|Overall Study|Protocol Violation|3|||
146634884|NCT01399372|528838810|FG001|Overall Study|Protocol Violation|1|||
146634885|NCT01376804|528838811|FG000|Treatment Period|Withdrawal by Subject|1|||
146634886|NCT01376804|528838811|FG000|Treatment Period|Adverse Event|6|||
146634887|NCT01376804|528838811|FG000|Treatment Period|Patient did not receive study drug|1|||
146634888|NCT01071798|528838812|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
146634889|NCT01071798|528838812|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
146634890|NCT01071798|528838812|FG000|Participants Who Received One Cycle|Patient requirement|20|||
146634891|NCT01071798|528838812|FG000|Participants Who Received One Cycle|Death|5|||
146634892|NCT01071798|528838812|FG000|Participants Who Received One Cycle|Change of therapy|6|||
146634893|NCT01071798|528838812|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
146634894|NCT01071798|528838812|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
146634895|NCT01071798|528838812|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
146634896|NCT01071798|528838812|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
146634897|NCT01071798|528838812|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
146634898|NCT01705509|528838819|FG000|Inclusion CPET|Screen Failure|5|||
146634899|NCT01705509|528838819|FG000|Inclusion CPET|Withdrawal by Subject|2|||
146634900|NCT01705509|528838819|FG000|CPET w/ Ranexa|Screen Failure|2|||
146634901|NCT02736890|528838820|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
146634902|NCT02736890|528838821|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
146634903|NCT02736890|528838820|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
146634904|NCT02736890|528838821|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
146634905|NCT02904954|528838822|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
146634906|NCT02904954|528838823|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
146634907|NCT02904954|528838822|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
146634908|NCT02904954|528838823|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
146634909|NCT02904954|528838822|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
146634910|NCT02904954|528838823|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
146634911|NCT02904954|528838822|FG000|Adjuvant Durvalumab|Recurrence|2|||
146634912|NCT02904954|528838823|FG001|Adjuvant Durvalumab|Recurrence|0|||
146634913|NCT02904954|528838822|FG000|Adjuvant Durvalumab|Adverse Event|2|||
146634914|NCT02904954|528838823|FG001|Adjuvant Durvalumab|Adverse Event|6|||
146634915|NCT02904954|528838822|FG000|Adjuvant Durvalumab|Participant wishes|12|||
146634916|NCT02904954|528838823|FG001|Adjuvant Durvalumab|Participant wishes|7|||
146634917|NCT02904954|528838822|FG000|Adjuvant Durvalumab|Physician Decision|2|||
146634918|NCT02904954|528838823|FG001|Adjuvant Durvalumab|Physician Decision|1|||
146634919|NCT02904954|528838822|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
146634920|NCT02904954|528838823|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
146634921|NCT02904954|528838822|FG000|Adjuvant Durvalumab|Death|0|||
146634922|NCT02904954|528838823|FG001|Adjuvant Durvalumab|Death|1|||
146634923|NCT02904954|528838822|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
146634924|NCT02904954|528838823|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
146634925|NCT05097963|528838824|FG000|Overall Study|Protocol Violation|13|||
146634926|NCT05097963|528838824|FG000|Overall Study|Withdrawal by Subject|21|||
146634927|NCT03349034|528838827|FG000|Overall Study|catheters dislodged during transport|2|||
146634928|NCT03349034|528838828|FG001|Overall Study|catheters dislodged during transport|0|||
146634929|NCT03349034|528838827|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
146634930|NCT03349034|528838828|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
146634931|NCT03349034|528838827|FG000|Overall Study|soft tissue flap used|1|||
146966720|NCT04089566|530038881|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
146634932|NCT03349034|528838828|FG001|Overall Study|soft tissue flap used|0|||
146634933|NCT03349034|528838827|FG000|Overall Study|Other|0|||
146554296|NCT02596893|528538381|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
146554297|NCT02596893|528538382|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
146554298|NCT02596893|528538383|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
146554299|NCT02596893|528538384|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
146554300|NCT00363467|528538385|FG000|Overall Study|Physician Decision|1|||
146554301|NCT03048019|528538386|FG000|Overall Study|Adverse Event|1|||
146966721|NCT04089566|530038882|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
146966722|NCT04089566|530038883|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
146966723|NCT04089566|530038884|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
146554302|NCT03048019|528538387|FG001|Overall Study|Adverse Event|0|||
146554303|NCT01052428|528538388|FG000|Overall Study|Death|1|||
146554304|NCT01052428|528538389|FG001|Overall Study|Death|0|||
146554305|NCT01052428|528538388|FG000|Overall Study|Withdrawal by Subject|0|||
146554306|NCT01052428|528538389|FG001|Overall Study|Withdrawal by Subject|1|||
146554307|NCT00382863|528538390|FG000|Overall Study|Death|9|||
146554308|NCT00382863|528538391|FG001|Overall Study|Death|9|||
146554309|NCT00382863|528538390|FG000|Overall Study|Lost to Follow-up|1|||
146554310|NCT00382863|528538391|FG001|Overall Study|Lost to Follow-up|2|||
146554311|NCT00382863|528538390|FG000|Overall Study|Withdrawal by Subject|5|||
146554312|NCT00382863|528538391|FG001|Overall Study|Withdrawal by Subject|25|||
146554313|NCT02168439|528538392|FG000|Overall Study|Protocol Violation|0|||
146554314|NCT02168439|528538393|FG001|Overall Study|Protocol Violation|2|||
146554315|NCT03400787|528538394|FG000|Overall Study|Lost to Follow-up|1|||
146554316|NCT03400787|528538395|FG001|Overall Study|Lost to Follow-up|0|||
146554317|NCT03400787|528538394|FG000|Overall Study|Death|1|||
146554318|NCT03400787|528538395|FG001|Overall Study|Death|0|||
146554319|NCT03400787|528538394|FG000|Overall Study|Protocol Violation|0|||
146554320|NCT03400787|528538395|FG001|Overall Study|Protocol Violation|2|||
146634934|NCT03349034|528838828|FG001|Overall Study|Other|1|||
146634935|NCT01039376|528838829|FG000|Overall Study|Lost to Follow-up|5|||
146634936|NCT01039376|528838830|FG001|Overall Study|Lost to Follow-up|12|||
146634937|NCT01039376|528838829|FG000|Overall Study|Physician Decision|15|||
146634938|NCT01039376|528838830|FG001|Overall Study|Physician Decision|10|||
146554321|NCT03400787|528538394|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
146554322|NCT03400787|528538395|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
146554323|NCT02595437|528538400|FG000|Triferic Via IV|Withdrawal by Subject|1|||
146554324|NCT01423084|528538404|FG000|Overall Study|Adverse Event|0|||
146554325|NCT01423084|528538405|FG001|Overall Study|Adverse Event|1|||
146554326|NCT01423084|528538404|FG000|Overall Study|Withdrawal by Subject|2|||
146554327|NCT01423084|528538405|FG001|Overall Study|Withdrawal by Subject|3|||
146554328|NCT02180672|528538407|FG000|Overall Study|Lost to Follow-up|5|||
146554329|NCT02180672|528538408|FG001|Overall Study|Lost to Follow-up|7|||
146554330|NCT00661687|528538409|FG000|Overall Study|Study related symptoms and complaints|5|||
146554331|NCT00661687|528538409|FG000|Overall Study|Positive slit lamp findings|4|||
146554332|NCT00661687|528538409|FG000|Overall Study|Inability to maintain wearing schedule|3|||
146554333|NCT00661687|528538409|FG000|Overall Study|Physician Decision|1|||
146554334|NCT00661687|528538409|FG000|Overall Study|Adverse Event|2|||
146554335|NCT03574389|528538410|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
146554336|NCT03574389|528538411|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
146554337|NCT03574389|528538412|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
146554338|NCT03574389|528538413|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
146554339|NCT03574389|528538414|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
146554340|NCT03574389|528538415|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
146554341|NCT03574389|528538416|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
146554342|NCT03574389|528538410|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
146554343|NCT03574389|528538411|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
146554344|NCT03574389|528538412|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
146554345|NCT03574389|528538413|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
146554346|NCT03574389|528538414|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
146634939|NCT01039376|528838829|FG000|Overall Study|Withdrawal by Subject|20|||
146634940|NCT01039376|528838830|FG001|Overall Study|Withdrawal by Subject|32|||
146634941|NCT01039376|528838829|FG000|Overall Study|Study terminated by Sponsor|90|||
146634942|NCT01039376|528838830|FG001|Overall Study|Study terminated by Sponsor|72|||
146634943|NCT00123422|528838831|FG000|Overall Study|Physician Decision|2|||
146634944|NCT00123422|528838832|FG001|Overall Study|Physician Decision|2|||
146634945|NCT00123422|528838833|FG002|Overall Study|Physician Decision|6|||
146554347|NCT03574389|528538415|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
146554348|NCT03574389|528538416|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
146554349|NCT03574389|528538410|FG000|Vaccination Period|Other|6|||
146554350|NCT03574389|528538411|FG001|Vaccination Period|Other|0|||
146554351|NCT03574389|528538412|FG002|Vaccination Period|Other|0|||
146634946|NCT00123422|528838831|FG000|Overall Study|Withdrawal by Subject|1|||
146634947|NCT00123422|528838832|FG001|Overall Study|Withdrawal by Subject|2|||
146634948|NCT00123422|528838833|FG002|Overall Study|Withdrawal by Subject|2|||
146634949|NCT00123422|528838831|FG000|Overall Study|Lost to Follow-up|1|||
146634950|NCT00123422|528838832|FG001|Overall Study|Lost to Follow-up|2|||
146634951|NCT00123422|528838833|FG002|Overall Study|Lost to Follow-up|2|||
146634952|NCT01554241|528838834|FG000|Overall Study|Death|3|||
146634953|NCT01554241|528838835|FG001|Overall Study|Death|1|||
146634954|NCT01554241|528838836|FG002|Overall Study|Death|1|||
146634955|NCT01554241|528838837|FG003|Overall Study|Death|0|||
146634956|NCT01554241|528838834|FG000|Overall Study|protocol specified renal stone|0|||
146634957|NCT01554241|528838835|FG001|Overall Study|protocol specified renal stone|0|||
146634958|NCT01554241|528838836|FG002|Overall Study|protocol specified renal stone|0|||
146634959|NCT01554241|528838837|FG003|Overall Study|protocol specified renal stone|1|||
146554352|NCT03574389|528538413|FG003|Vaccination Period|Other|0|||
146554353|NCT03574389|528538414|FG004|Vaccination Period|Other|0|||
146554354|NCT03574389|528538415|FG005|Vaccination Period|Other|0|||
146554355|NCT03574389|528538416|FG006|Vaccination Period|Other|0|||
146554356|NCT03574389|528538410|FG000|Vaccination Period|Adverse Event|0|||
146554357|NCT03574389|528538411|FG001|Vaccination Period|Adverse Event|1|||
146554358|NCT03574389|528538412|FG002|Vaccination Period|Adverse Event|0|||
146554359|NCT03574389|528538413|FG003|Vaccination Period|Adverse Event|0|||
146554360|NCT03574389|528538414|FG004|Vaccination Period|Adverse Event|0|||
146554361|NCT03574389|528538415|FG005|Vaccination Period|Adverse Event|0|||
146554362|NCT03574389|528538416|FG006|Vaccination Period|Adverse Event|0|||
146554363|NCT03574389|528538410|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
146554364|NCT03574389|528538411|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
146554365|NCT03574389|528538412|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
146554366|NCT03574389|528538413|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
146554367|NCT03574389|528538414|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
146554368|NCT03574389|528538415|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
146554369|NCT03574389|528538416|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
146554370|NCT02837952|528538423|FG000|Overall Study|Adverse Event|0|||
146554371|NCT02837952|528538424|FG001|Overall Study|Adverse Event|1|||
146554372|NCT02837952|528538423|FG000|Overall Study|Withdrawal by Subject|4|||
146554373|NCT02837952|528538424|FG001|Overall Study|Withdrawal by Subject|5|||
146554374|NCT02837952|528538423|FG000|Overall Study|Medication Error|1|||
146554375|NCT02837952|528538424|FG001|Overall Study|Medication Error|0|||
146634960|NCT01554241|528838834|FG000|Overall Study|protocol specified change in eGFR|0|||
146554376|NCT02070380|528538425|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
146554377|NCT02070380|528538426|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
146554378|NCT02070380|528538427|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
146554379|NCT02070380|528538428|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
146554380|NCT02070380|528538425|FG000|Second Injection|Image sets missing or technically inadeq|0|||
146554381|NCT02070380|528538426|FG001|Second Injection|Image sets missing or technically inadeq|1|||
146634961|NCT01554241|528838835|FG001|Overall Study|protocol specified change in eGFR|0|||
146634962|NCT01554241|528838836|FG002|Overall Study|protocol specified change in eGFR|1|||
146634963|NCT01554241|528838837|FG003|Overall Study|protocol specified change in eGFR|0|||
146554382|NCT02070380|528538427|FG002|Second Injection|Image sets missing or technically inadeq|0|||
146554383|NCT02070380|528538428|FG003|Second Injection|Image sets missing or technically inadeq|0|||
146554384|NCT02070380|528538425|FG000|Second Injection|Protocol Violation|0|||
146554385|NCT02070380|528538426|FG001|Second Injection|Protocol Violation|1|||
146554386|NCT02070380|528538427|FG002|Second Injection|Protocol Violation|1|||
146554387|NCT02070380|528538428|FG003|Second Injection|Protocol Violation|5|||
146554388|NCT01362530|528538441|FG000|Base Study (Cycle 1)|Adverse Event|2|||
146554389|NCT01362530|528538442|FG001|Base Study (Cycle 1)|Adverse Event|0|||
146554390|NCT01362530|528538441|FG000|Base Study (Cycle 1)|Physician Decision|0|||
146554391|NCT01362530|528538442|FG001|Base Study (Cycle 1)|Physician Decision|1|||
146554392|NCT01362530|528538441|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
146554393|NCT01362530|528538442|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
146554394|NCT01362530|528538441|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
146554395|NCT01362530|528538442|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
146554396|NCT01362530|528538441|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
146554397|NCT01362530|528538442|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
146554398|NCT01362530|528538441|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
146554399|NCT01362530|528538442|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
146554400|NCT01362530|528538441|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
146554401|NCT01362530|528538442|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
146554402|NCT01362530|528538441|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
146554403|NCT01362530|528538442|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
146554404|NCT01362530|528538441|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
146554405|NCT01362530|528538442|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
146554406|NCT01362530|528538441|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
146554407|NCT01362530|528538442|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
146554408|NCT01362530|528538441|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
146554409|NCT01362530|528538442|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
146554410|NCT01362530|528538441|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
146554411|NCT01362530|528538442|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
146554412|NCT01362530|528538441|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
146554413|NCT01362530|528538442|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
146554414|NCT01133977|528538443|FG000|Overall Study|Adverse Event|0|||
146554415|NCT01133977|528538444|FG001|Overall Study|Adverse Event|0|||
146554416|NCT01133977|528538445|FG002|Overall Study|Adverse Event|1|||
146554417|NCT01133977|528538446|FG003|Overall Study|Adverse Event|0|||
146554418|NCT01133977|528538447|FG004|Overall Study|Adverse Event|0|||
146554419|NCT01133977|528538443|FG000|Overall Study|Death|1|||
146554420|NCT01133977|528538444|FG001|Overall Study|Death|1|||
146554421|NCT01133977|528538445|FG002|Overall Study|Death|1|||
146554422|NCT01133977|528538446|FG003|Overall Study|Death|7|||
146554423|NCT01133977|528538447|FG004|Overall Study|Death|3|||
146554424|NCT01133977|528538443|FG000|Overall Study|Started a New Line of Therapy|2|||
146554425|NCT01133977|528538444|FG001|Overall Study|Started a New Line of Therapy|6|||
146554426|NCT01133977|528538445|FG002|Overall Study|Started a New Line of Therapy|4|||
146554427|NCT01133977|528538446|FG003|Overall Study|Started a New Line of Therapy|25|||
146554428|NCT01133977|528538447|FG004|Overall Study|Started a New Line of Therapy|33|||
146554429|NCT01133977|528538443|FG000|Overall Study|Lost to Follow-up|0|||
146554430|NCT01133977|528538444|FG001|Overall Study|Lost to Follow-up|0|||
146554431|NCT01133977|528538445|FG002|Overall Study|Lost to Follow-up|0|||
146554432|NCT01133977|528538446|FG003|Overall Study|Lost to Follow-up|2|||
146554433|NCT01133977|528538447|FG004|Overall Study|Lost to Follow-up|1|||
146554434|NCT01133977|528538443|FG000|Overall Study|Withdrawal by Subject|0|||
146554435|NCT01133977|528538444|FG001|Overall Study|Withdrawal by Subject|0|||
146554436|NCT01133977|528538445|FG002|Overall Study|Withdrawal by Subject|0|||
146554437|NCT01133977|528538446|FG003|Overall Study|Withdrawal by Subject|5|||
146554438|NCT01133977|528538447|FG004|Overall Study|Withdrawal by Subject|1|||
146554439|NCT01682603|528538448|FG000|Overall Study|Lost to Follow-up|3|||
146554440|NCT02462057|528538449|FG000|Overall Study|Left Vitality|32|||
146554441|NCT02462057|528538450|FG001|Overall Study|Left Vitality|27|||
146554442|NCT02462057|528538451|FG002|Overall Study|Left Vitality|23|||
146554443|NCT02462057|528538452|FG003|Overall Study|Left Vitality|35|||
146554444|NCT02462057|528538453|FG004|Overall Study|Left Vitality|33|||
146554445|NCT02462057|528538449|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
146554446|NCT02462057|528538450|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
146554447|NCT02462057|528538451|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
146554448|NCT02462057|528538452|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
146554449|NCT02462057|528538453|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
146554450|NCT01791205|528538455|FG000|Phase II|Lack of Efficacy|6|||
146554451|NCT01791205|528538456|FG001|Phase II|Lack of Efficacy|0|||
146554452|NCT01791205|528538455|FG000|Phase II|Adverse Event|2|||
146554453|NCT01791205|528538456|FG001|Phase II|Adverse Event|0|||
146634964|NCT01554241|528838834|FG000|Overall Study|Withdrawal by Subject|0|||
146634965|NCT01554241|528838835|FG001|Overall Study|Withdrawal by Subject|0|||
146634966|NCT01554241|528838836|FG002|Overall Study|Withdrawal by Subject|2|||
146634967|NCT01554241|528838837|FG003|Overall Study|Withdrawal by Subject|0|||
146634968|NCT02118961|528838838|FG000|Overall Study|Withdrawal by Subject|1|||
146634969|NCT02118961|528838839|FG001|Overall Study|Withdrawal by Subject|0|||
146634970|NCT03809104|528838842|FG000|Overall Study|Withdrawal by Subject|3|||
146634971|NCT01532986|528838843|FG000|Overall Study|Death|9|||
146634972|NCT01532986|528838844|FG001|Overall Study|Death|9|||
146634973|NCT01532986|528838843|FG000|Overall Study|Withdrawal by Subject|7|||
146634974|NCT01532986|528838844|FG001|Overall Study|Withdrawal by Subject|10|||
146634975|NCT01532986|528838843|FG000|Overall Study|Physician Decision|7|||
146634976|NCT01532986|528838844|FG001|Overall Study|Physician Decision|5|||
146634977|NCT02120898|528838845|FG000|Overall Study|Withdrawal by Subject|4|||
146634978|NCT02120898|528838846|FG001|Overall Study|Withdrawal by Subject|2|||
146554454|NCT01791205|528538455|FG000|Phase II|Safety|1|||
146554455|NCT01791205|528538456|FG001|Phase II|Safety|0|||
146554456|NCT01791205|528538455|FG000|Phase II|Lost to Follow-up|1|||
146554457|NCT01791205|528538456|FG001|Phase II|Lost to Follow-up|0|||
146554458|NCT01791205|528538455|FG000|Phase II|Remission of disease|1|||
146554459|NCT01791205|528538456|FG001|Phase II|Remission of disease|0|||
146554460|NCT01791205|528538455|FG000|Phase II|Physician's decision|1|||
146554461|NCT01791205|528538456|FG001|Phase II|Physician's decision|0|||
146554462|NCT01908699|528538457|FG000|Overall Study|Adverse Event|8|||
146554463|NCT01908699|528538458|FG001|Overall Study|Adverse Event|12|||
146554464|NCT01908699|528538457|FG000|Overall Study|Lack of Efficacy|2|||
146554465|NCT01908699|528538458|FG001|Overall Study|Lack of Efficacy|2|||
146554466|NCT01908699|528538457|FG000|Overall Study|Lost to Follow-up|2|||
146554467|NCT01908699|528538458|FG001|Overall Study|Lost to Follow-up|4|||
146554468|NCT01908699|528538457|FG000|Overall Study|Physician Decision|8|||
146554469|NCT01908699|528538458|FG001|Overall Study|Physician Decision|8|||
146554470|NCT01908699|528538457|FG000|Overall Study|Withdrawal by Subject|15|||
146554471|NCT01908699|528538458|FG001|Overall Study|Withdrawal by Subject|10|||
146554472|NCT01908699|528538457|FG000|Overall Study|Pregnancy|0|||
146554473|NCT01908699|528538458|FG001|Overall Study|Pregnancy|1|||
146554474|NCT01908699|528538457|FG000|Overall Study|Randomized in Error|1|||
146554475|NCT01908699|528538458|FG001|Overall Study|Randomized in Error|0|||
146554476|NCT01908699|528538457|FG000|Overall Study|Death|9|||
146554477|NCT01908699|528538458|FG001|Overall Study|Death|12|||
146554478|NCT01908699|528538457|FG000|Overall Study|Progressive Disease|30|||
146554479|NCT01908699|528538458|FG001|Overall Study|Progressive Disease|29|||
146554480|NCT01697501|528538459|FG000|Overall Study|Protocol Violation|2|||
146554481|NCT02242903|528538460|FG000|Overall Study|Withdrawal by Subject|1|||
146554482|NCT02242903|528538461|FG001|Overall Study|Withdrawal by Subject|0|||
146554483|NCT02242903|528538462|FG002|Overall Study|Withdrawal by Subject|0|||
146554484|NCT02242903|528538463|FG003|Overall Study|Withdrawal by Subject|0|||
146554485|NCT02242903|528538464|FG004|Overall Study|Withdrawal by Subject|0|||
146554486|NCT02242903|528538465|FG005|Overall Study|Withdrawal by Subject|0|||
146554487|NCT02242903|528538466|FG006|Overall Study|Withdrawal by Subject|0|||
146554488|NCT01896986|528538469|FG000|Overall Study|samples lost|14|||
146554489|NCT01896986|528538470|FG001|Overall Study|samples lost|23|||
146554490|NCT00281580|528538472|FG000|Overall Study|Adverse Event|2|||
146554491|NCT00281580|528538473|FG001|Overall Study|Adverse Event|0|||
146554492|NCT00281580|528538474|FG002|Overall Study|Adverse Event|2|||
146554493|NCT00281580|528538475|FG003|Overall Study|Adverse Event|4|||
146554494|NCT00281580|528538476|FG004|Overall Study|Adverse Event|1|||
146554495|NCT00281580|528538477|FG005|Overall Study|Adverse Event|0|||
146554496|NCT00281580|528538478|FG006|Overall Study|Adverse Event|1|||
146554497|NCT00281580|528538479|FG007|Overall Study|Adverse Event|0|||
146554498|NCT00281580|528538480|FG008|Overall Study|Adverse Event|1|||
146554499|NCT00281580|528538481|FG009|Overall Study|Adverse Event|6|||
146554500|NCT00281580|528538482|FG010|Overall Study|Adverse Event|0|||
146554501|NCT00281580|528538483|FG011|Overall Study|Adverse Event|5|||
146554502|NCT00281580|528538484|FG012|Overall Study|Adverse Event|8|||
146554503|NCT00281580|528538485|FG013|Overall Study|Adverse Event|2|||
146554504|NCT00281580|528538486|FG014|Overall Study|Adverse Event|3|||
146554505|NCT00281580|528538487|FG015|Overall Study|Adverse Event|3|||
146554506|NCT00281580|528538472|FG000|Overall Study|Protocol Violation|0|||
146554507|NCT00281580|528538473|FG001|Overall Study|Protocol Violation|0|||
146554508|NCT00281580|528538474|FG002|Overall Study|Protocol Violation|1|||
146554509|NCT00281580|528538475|FG003|Overall Study|Protocol Violation|1|||
146554510|NCT00281580|528538476|FG004|Overall Study|Protocol Violation|0|||
146554511|NCT00281580|528538477|FG005|Overall Study|Protocol Violation|0|||
146554512|NCT00281580|528538478|FG006|Overall Study|Protocol Violation|1|||
146634979|NCT02120898|528838847|FG002|Overall Study|Withdrawal by Subject|2|||
146634980|NCT02120898|528838845|FG000|Overall Study|Non-compliance with study drug|3|||
146634981|NCT02120898|528838846|FG001|Overall Study|Non-compliance with study drug|0|||
146634982|NCT02120898|528838847|FG002|Overall Study|Non-compliance with study drug|0|||
146634983|NCT02120898|528838845|FG000|Overall Study|Adverse Event|1|||
146634984|NCT02120898|528838846|FG001|Overall Study|Adverse Event|2|||
146634985|NCT02120898|528838847|FG002|Overall Study|Adverse Event|1|||
146634986|NCT02120898|528838845|FG000|Overall Study|Protocol Violation|1|||
146634987|NCT02120898|528838846|FG001|Overall Study|Protocol Violation|2|||
146634988|NCT02120898|528838847|FG002|Overall Study|Protocol Violation|0|||
146634989|NCT02120898|528838845|FG000|Overall Study|Lost to Follow-up|0|||
146634990|NCT02120898|528838846|FG001|Overall Study|Lost to Follow-up|0|||
146634991|NCT02120898|528838847|FG002|Overall Study|Lost to Follow-up|1|||
146634992|NCT04313244|528838848|FG000|Overall Study|Withdrawal of Consent|3|||
146634993|NCT04313244|528838849|FG001|Overall Study|Withdrawal of Consent|3|||
146634994|NCT04313244|528838848|FG000|Overall Study|Met Exclusion Criteria|1|||
146634995|NCT04313244|528838849|FG001|Overall Study|Met Exclusion Criteria|0|||
146634996|NCT04313244|528838848|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
146634997|NCT04313244|528838849|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
146634998|NCT05021978|528838850|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
146634999|NCT05021978|528838851|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
146635000|NCT05021978|528838852|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
146554513|NCT00281580|528538479|FG007|Overall Study|Protocol Violation|0|||
146554514|NCT00281580|528538480|FG008|Overall Study|Protocol Violation|2|||
146554515|NCT00281580|528538481|FG009|Overall Study|Protocol Violation|0|||
146554516|NCT00281580|528538482|FG010|Overall Study|Protocol Violation|1|||
146554517|NCT00281580|528538483|FG011|Overall Study|Protocol Violation|2|||
146554518|NCT00281580|528538484|FG012|Overall Study|Protocol Violation|0|||
146554519|NCT00281580|528538485|FG013|Overall Study|Protocol Violation|1|||
146554520|NCT00281580|528538486|FG014|Overall Study|Protocol Violation|1|||
146554521|NCT00281580|528538487|FG015|Overall Study|Protocol Violation|3|||
146554522|NCT00281580|528538472|FG000|Overall Study|Withdrawal by Subject|3|||
146635001|NCT05021978|528838853|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
146635002|NCT05021978|528838850|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
146635003|NCT05021978|528838851|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
146635004|NCT05021978|528838852|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
146635005|NCT05021978|528838853|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
146635006|NCT01411891|528838858|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
146635007|NCT01411891|528838859|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
146635008|NCT02004093|528838860|FG000|Overall Study|Death|2|||
146635009|NCT02004093|528838861|FG001|Overall Study|Death|1|||
146635010|NCT02004093|528838860|FG000|Overall Study|Lack of Efficacy|66|||
146635011|NCT02004093|528838861|FG001|Overall Study|Lack of Efficacy|62|||
146635012|NCT02004093|528838860|FG000|Overall Study|Protocol Violation|0|||
146635013|NCT02004093|528838861|FG001|Overall Study|Protocol Violation|1|||
146635014|NCT02004093|528838860|FG000|Overall Study|Lost to Follow-up|0|||
146635015|NCT02004093|528838861|FG001|Overall Study|Lost to Follow-up|1|||
146635016|NCT02004093|528838860|FG000|Overall Study|Withdrawal by Subject|3|||
146635017|NCT02004093|528838861|FG001|Overall Study|Withdrawal by Subject|7|||
146635018|NCT02004093|528838860|FG000|Overall Study|Other|3|||
146635019|NCT02004093|528838861|FG001|Overall Study|Other|1|||
146635020|NCT04085289|528838862|FG000|Overall Study|Withdrawal by Subject|0|||
146635021|NCT04085289|528838863|FG001|Overall Study|Withdrawal by Subject|0|||
146635022|NCT04085289|528838864|FG002|Overall Study|Withdrawal by Subject|1|||
146635023|NCT00414596|528838865|FG000|Overall Study|Protocol Violation|2|||
146635024|NCT04639258|528838866|FG000|Overall Study|Screen failure|5|||
146635025|NCT04639258|528838866|FG000|Overall Study|Physician Decision|2|||
146635026|NCT04639258|528838866|FG000|Overall Study|Early study termination|3|||
146635027|NCT04639258|528838866|FG000|Overall Study|Withdrawal by Subject|1|||
146635028|NCT04614974|528838868|FG000|Overall Study|Lost to Follow-up|14|||
146635029|NCT04614974|528838869|FG001|Overall Study|Lost to Follow-up|11|||
146635030|NCT02754440|528838871|FG000|Overall Study|Protocol Violation|3|||
146635031|NCT02754440|528838872|FG001|Overall Study|Protocol Violation|2|||
146635032|NCT02754440|528838873|FG002|Overall Study|Protocol Violation|2|||
146635033|NCT02754440|528838874|FG003|Overall Study|Protocol Violation|6|||
146635034|NCT02754440|528838871|FG000|Overall Study|Adverse Event|3|||
146554523|NCT00281580|528538473|FG001|Overall Study|Withdrawal by Subject|0|||
146554524|NCT00281580|528538474|FG002|Overall Study|Withdrawal by Subject|1|||
146554525|NCT00281580|528538475|FG003|Overall Study|Withdrawal by Subject|1|||
146554526|NCT00281580|528538476|FG004|Overall Study|Withdrawal by Subject|1|||
146554527|NCT00281580|528538477|FG005|Overall Study|Withdrawal by Subject|2|||
146554528|NCT00281580|528538478|FG006|Overall Study|Withdrawal by Subject|2|||
146554529|NCT00281580|528538479|FG007|Overall Study|Withdrawal by Subject|0|||
146554530|NCT00281580|528538480|FG008|Overall Study|Withdrawal by Subject|1|||
146554531|NCT00281580|528538481|FG009|Overall Study|Withdrawal by Subject|4|||
146554532|NCT00281580|528538482|FG010|Overall Study|Withdrawal by Subject|1|||
146554533|NCT00281580|528538483|FG011|Overall Study|Withdrawal by Subject|1|||
146554534|NCT00281580|528538484|FG012|Overall Study|Withdrawal by Subject|2|||
146554535|NCT00281580|528538485|FG013|Overall Study|Withdrawal by Subject|2|||
146554536|NCT00281580|528538486|FG014|Overall Study|Withdrawal by Subject|1|||
146554537|NCT00281580|528538487|FG015|Overall Study|Withdrawal by Subject|5|||
146554538|NCT00281580|528538472|FG000|Overall Study|Lack of Efficacy|2|||
146554539|NCT00281580|528538473|FG001|Overall Study|Lack of Efficacy|1|||
146554540|NCT00281580|528538474|FG002|Overall Study|Lack of Efficacy|1|||
146554541|NCT00281580|528538475|FG003|Overall Study|Lack of Efficacy|6|||
146554542|NCT00281580|528538476|FG004|Overall Study|Lack of Efficacy|2|||
146554543|NCT00281580|528538477|FG005|Overall Study|Lack of Efficacy|0|||
146635035|NCT02754440|528838872|FG001|Overall Study|Adverse Event|1|||
146635036|NCT02754440|528838873|FG002|Overall Study|Adverse Event|0|||
146554544|NCT00281580|528538478|FG006|Overall Study|Lack of Efficacy|0|||
146554545|NCT00281580|528538479|FG007|Overall Study|Lack of Efficacy|0|||
146554546|NCT00281580|528538480|FG008|Overall Study|Lack of Efficacy|0|||
146635037|NCT02754440|528838874|FG003|Overall Study|Adverse Event|9|||
146554547|NCT00281580|528538481|FG009|Overall Study|Lack of Efficacy|0|||
146635038|NCT02754440|528838871|FG000|Overall Study|Withdrawal by Subject|0|||
146554548|NCT00281580|528538482|FG010|Overall Study|Lack of Efficacy|0|||
146554549|NCT00281580|528538483|FG011|Overall Study|Lack of Efficacy|1|||
146554550|NCT00281580|528538484|FG012|Overall Study|Lack of Efficacy|0|||
146554551|NCT00281580|528538485|FG013|Overall Study|Lack of Efficacy|2|||
146554552|NCT00281580|528538486|FG014|Overall Study|Lack of Efficacy|1|||
146554553|NCT00281580|528538487|FG015|Overall Study|Lack of Efficacy|0|||
146554554|NCT00281580|528538472|FG000|Overall Study|Lost to Follow-up|0|||
146554555|NCT00281580|528538473|FG001|Overall Study|Lost to Follow-up|0|||
146554556|NCT00281580|528538474|FG002|Overall Study|Lost to Follow-up|0|||
146554557|NCT00281580|528538475|FG003|Overall Study|Lost to Follow-up|3|||
146635039|NCT02754440|528838872|FG001|Overall Study|Withdrawal by Subject|0|||
146635040|NCT02754440|528838873|FG002|Overall Study|Withdrawal by Subject|0|||
146635041|NCT02754440|528838874|FG003|Overall Study|Withdrawal by Subject|1|||
146635042|NCT02754440|528838871|FG000|Overall Study|Equipment failure|0|||
146635043|NCT02754440|528838872|FG001|Overall Study|Equipment failure|5|||
146554558|NCT00281580|528538476|FG004|Overall Study|Lost to Follow-up|0|||
146554559|NCT00281580|528538477|FG005|Overall Study|Lost to Follow-up|1|||
146554560|NCT00281580|528538478|FG006|Overall Study|Lost to Follow-up|0|||
146554561|NCT00281580|528538479|FG007|Overall Study|Lost to Follow-up|1|||
146554562|NCT00281580|528538480|FG008|Overall Study|Lost to Follow-up|2|||
146554563|NCT00281580|528538481|FG009|Overall Study|Lost to Follow-up|1|||
146554564|NCT00281580|528538482|FG010|Overall Study|Lost to Follow-up|1|||
146554565|NCT00281580|528538483|FG011|Overall Study|Lost to Follow-up|0|||
146554566|NCT00281580|528538484|FG012|Overall Study|Lost to Follow-up|1|||
146554567|NCT00281580|528538485|FG013|Overall Study|Lost to Follow-up|0|||
146554568|NCT00281580|528538486|FG014|Overall Study|Lost to Follow-up|0|||
146554569|NCT00281580|528538487|FG015|Overall Study|Lost to Follow-up|0|||
146554570|NCT00281580|528538472|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
146554571|NCT00281580|528538473|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
146554572|NCT00281580|528538474|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
146554573|NCT00281580|528538475|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
146554574|NCT00281580|528538476|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
146635044|NCT02754440|528838873|FG002|Overall Study|Equipment failure|5|||
146635045|NCT02754440|528838874|FG003|Overall Study|Equipment failure|7|||
146554575|NCT00281580|528538477|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
146554576|NCT00281580|528538478|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
146554577|NCT00281580|528538479|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
146554578|NCT00281580|528538480|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
146554579|NCT00281580|528538481|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
146554580|NCT00281580|528538482|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
146554581|NCT00281580|528538483|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
146554582|NCT00281580|528538484|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
146554583|NCT00281580|528538485|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
146554584|NCT00281580|528538486|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
146554585|NCT00281580|528538487|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
146554586|NCT01696214|528538490|FG000|Overall Study|Lost to Follow-up|1|||
146554587|NCT01696214|528538491|FG001|Overall Study|Lost to Follow-up|0|||
146554588|NCT01696214|528538492|FG002|Overall Study|Lost to Follow-up|0|||
146554589|NCT01696214|528538493|FG003|Overall Study|Lost to Follow-up|0|||
146554590|NCT00066170|528538495|FG000|Overall Study|Adverse Event|2|||
146554591|NCT00066170|528538496|FG001|Overall Study|Adverse Event|4|||
146554592|NCT00066170|528538497|FG002|Overall Study|Adverse Event|1|||
146554593|NCT00066170|528538498|FG003|Overall Study|Adverse Event|7|||
146554594|NCT00066170|528538495|FG000|Overall Study|Serious Adverse Event|0|||
146554595|NCT00066170|528538496|FG001|Overall Study|Serious Adverse Event|0|||
146554596|NCT00066170|528538497|FG002|Overall Study|Serious Adverse Event|1|||
146554597|NCT00066170|528538498|FG003|Overall Study|Serious Adverse Event|1|||
146554598|NCT00066170|528538495|FG000|Overall Study|Lost to Follow-up|0|||
146554599|NCT00066170|528538496|FG001|Overall Study|Lost to Follow-up|1|||
146554600|NCT00066170|528538497|FG002|Overall Study|Lost to Follow-up|0|||
146554601|NCT00066170|528538498|FG003|Overall Study|Lost to Follow-up|0|||
146554602|NCT00066170|528538495|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
146554603|NCT00066170|528538496|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
146554604|NCT00066170|528538497|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
146765329|NCT00864682|529308618|FG000|Overall Study|Protocol Violation|2|||
146635046|NCT02754440|528838871|FG000|Overall Study|Subject issues not resulting in AE|0|||
146635047|NCT02754440|528838872|FG001|Overall Study|Subject issues not resulting in AE|0|||
146635048|NCT02754440|528838873|FG002|Overall Study|Subject issues not resulting in AE|0|||
146635049|NCT02754440|528838874|FG003|Overall Study|Subject issues not resulting in AE|12|||
146635050|NCT02558296|528838875|FG000|Completed the Study Through Week 24|Adverse Event|9|||
146635051|NCT02558296|528838876|FG001|Completed the Study Through Week 24|Adverse Event|3|||
146635052|NCT02558296|528838875|FG000|Completed the Study Through Week 24|Death|7|||
146635053|NCT02558296|528838876|FG001|Completed the Study Through Week 24|Death|7|||
146635054|NCT02558296|528838875|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
146635055|NCT02558296|528838876|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
146635056|NCT02558296|528838875|FG000|Completed the Study Through Week 24|Physician Decision|1|||
146635057|NCT02558296|528838876|FG001|Completed the Study Through Week 24|Physician Decision|0|||
146635058|NCT02558296|528838875|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
146635059|NCT02558296|528838876|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
146635060|NCT02558296|528838875|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
146635061|NCT02558296|528838876|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
146635062|NCT02558296|528838875|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
146635063|NCT02558296|528838876|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
146635064|NCT02558296|528838875|FG000|Completed the Study|Adverse Event|14|||
146635065|NCT02558296|528838876|FG001|Completed the Study|Adverse Event|5|||
146635066|NCT02558296|528838875|FG000|Completed the Study|Death|39|||
146635067|NCT02558296|528838876|FG001|Completed the Study|Death|25|||
146635068|NCT02558296|528838875|FG000|Completed the Study|Lost to Follow-up|31|||
146635069|NCT02558296|528838876|FG001|Completed the Study|Lost to Follow-up|23|||
146635070|NCT02558296|528838875|FG000|Completed the Study|Physician Decision|6|||
146635071|NCT02558296|528838876|FG001|Completed the Study|Physician Decision|0|||
146635072|NCT02558296|528838875|FG000|Completed the Study|Protocol Violation|2|||
146635073|NCT02558296|528838876|FG001|Completed the Study|Protocol Violation|1|||
146635074|NCT02558296|528838875|FG000|Completed the Study|Withdrawal by Subject|53|||
146635075|NCT02558296|528838876|FG001|Completed the Study|Withdrawal by Subject|31|||
146635076|NCT02558296|528838875|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
146635077|NCT02558296|528838876|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
146635078|NCT02919995|528838879|FG000|Overall Study|Adverse Event|0|||
146635079|NCT02919995|528838880|FG001|Overall Study|Adverse Event|0|||
146635080|NCT02919995|528838881|FG002|Overall Study|Adverse Event|0|||
146635081|NCT02919995|528838882|FG003|Overall Study|Adverse Event|0|||
146635082|NCT02919995|528838883|FG004|Overall Study|Adverse Event|0|||
146635083|NCT02919995|528838884|FG005|Overall Study|Adverse Event|1|||
146635084|NCT02560558|528838885|FG000|Overall Study|Adverse Event|1|||
146635085|NCT02560558|528838886|FG001|Overall Study|Adverse Event|0|||
146635086|NCT02560558|528838885|FG000|Overall Study|Death|0|||
146635087|NCT02560558|528838886|FG001|Overall Study|Death|2|||
146635088|NCT02560558|528838885|FG000|Overall Study|Lost to Follow-up|0|||
146635089|NCT02560558|528838886|FG001|Overall Study|Lost to Follow-up|4|||
146635090|NCT02560558|528838885|FG000|Overall Study|Protocol Violation|3|||
146635091|NCT02560558|528838886|FG001|Overall Study|Protocol Violation|0|||
146635092|NCT02560558|528838885|FG000|Overall Study|Withdrawal by Subject|3|||
146635093|NCT02560558|528838886|FG001|Overall Study|Withdrawal by Subject|0|||
146635094|NCT01263197|528838888|FG000|First Intervention (Period 1)|Adverse Event|0|||
146635095|NCT01263197|528838889|FG001|First Intervention (Period 1)|Adverse Event|0|||
146635096|NCT01263197|528838890|FG002|First Intervention (Period 1)|Adverse Event|0|||
146635097|NCT01263197|528838891|FG003|First Intervention (Period 1)|Adverse Event|0|||
146635098|NCT01263197|528838892|FG004|First Intervention (Period 1)|Adverse Event|0|||
146635099|NCT01263197|528838893|FG005|First Intervention (Period 1)|Adverse Event|1|||
146635100|NCT01263197|528838888|FG000|Washout Period 1|Protocol Violation|0|||
146635101|NCT01263197|528838889|FG001|Washout Period 1|Protocol Violation|0|||
146635102|NCT01263197|528838890|FG002|Washout Period 1|Protocol Violation|0|||
146635103|NCT01263197|528838891|FG003|Washout Period 1|Protocol Violation|0|||
146635104|NCT01263197|528838892|FG004|Washout Period 1|Protocol Violation|1|||
146635105|NCT01263197|528838893|FG005|Washout Period 1|Protocol Violation|0|||
146635106|NCT01263197|528838888|FG000|Washout Period 2|Physician Decision|0|||
146635107|NCT01263197|528838889|FG001|Washout Period 2|Physician Decision|0|||
146635108|NCT01263197|528838890|FG002|Washout Period 2|Physician Decision|0|||
146635109|NCT01263197|528838891|FG003|Washout Period 2|Physician Decision|0|||
146635110|NCT01263197|528838892|FG004|Washout Period 2|Physician Decision|0|||
146635111|NCT01263197|528838893|FG005|Washout Period 2|Physician Decision|1|||
146635112|NCT01263197|528838888|FG000|Washout Period 2|Protocol Violation|0|||
146635113|NCT01263197|528838889|FG001|Washout Period 2|Protocol Violation|0|||
146635114|NCT01263197|528838890|FG002|Washout Period 2|Protocol Violation|0|||
146635115|NCT01263197|528838891|FG003|Washout Period 2|Protocol Violation|1|||
146635116|NCT01263197|528838892|FG004|Washout Period 2|Protocol Violation|0|||
146635117|NCT01263197|528838893|FG005|Washout Period 2|Protocol Violation|0|||
146554605|NCT00066170|528538498|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
146554606|NCT00066170|528538495|FG000|Overall Study|Protocol Violation|3|||
146554607|NCT00066170|528538496|FG001|Overall Study|Protocol Violation|0|||
146554608|NCT00066170|528538497|FG002|Overall Study|Protocol Violation|0|||
146554609|NCT00066170|528538498|FG003|Overall Study|Protocol Violation|0|||
146554610|NCT00066170|528538495|FG000|Overall Study|Other|1|||
146554611|NCT00066170|528538496|FG001|Overall Study|Other|5|||
146554612|NCT00066170|528538497|FG002|Overall Study|Other|2|||
146554613|NCT00066170|528538498|FG003|Overall Study|Other|0|||
146635118|NCT01263197|528838888|FG000|Third Intervention (Period 3)|Adverse Event|0|||
146554614|NCT00987935|528538499|FG000|Overall Study|Progressive disease|3|||
146635119|NCT01263197|528838889|FG001|Third Intervention (Period 3)|Adverse Event|1|||
146554615|NCT00987935|528538500|FG001|Overall Study|Progressive disease|2|||
146554616|NCT00987935|528538501|FG002|Overall Study|Progressive disease|3|||
146554617|NCT00987935|528538502|FG003|Overall Study|Progressive disease|2|||
146554618|NCT00987935|528538503|FG004|Overall Study|Progressive disease|5|||
146554619|NCT00987935|528538504|FG005|Overall Study|Progressive disease|3|||
146554620|NCT00987935|528538505|FG006|Overall Study|Progressive disease|9|||
146554621|NCT00987935|528538506|FG007|Overall Study|Progressive disease|48|||
146554622|NCT00987935|528538507|FG008|Overall Study|Progressive disease|23|||
146554623|NCT00987935|528538499|FG000|Overall Study|Adverse Event|0|||
146554624|NCT00987935|528538500|FG001|Overall Study|Adverse Event|1|||
146554625|NCT00987935|528538501|FG002|Overall Study|Adverse Event|0|||
146554626|NCT00987935|528538502|FG003|Overall Study|Adverse Event|1|||
146554627|NCT00987935|528538503|FG004|Overall Study|Adverse Event|1|||
146635120|NCT01263197|528838890|FG002|Third Intervention (Period 3)|Adverse Event|0|||
146635121|NCT01263197|528838891|FG003|Third Intervention (Period 3)|Adverse Event|0|||
146635122|NCT01263197|528838892|FG004|Third Intervention (Period 3)|Adverse Event|0|||
146635123|NCT01263197|528838893|FG005|Third Intervention (Period 3)|Adverse Event|0|||
146635124|NCT01967576|528838894|FG000|Overall Study|Withdrawal by Subject|3|||
146635125|NCT01967576|528838894|FG000|Overall Study|Progressed/Removed from treatment|1|||
146635126|NCT01967576|528838894|FG000|Overall Study|Study closing at site|1|||
146635127|NCT01967576|528838894|FG000|Overall Study|Adverse Event|1|||
146635128|NCT01967576|528838894|FG000|Overall Study|Refused further treatment|1|||
146635129|NCT01821118|528838902|FG000|Overall Study|Death|0|||
146635130|NCT01821118|528838903|FG001|Overall Study|Death|1|||
146635131|NCT00345358|528838904|FG000|Primary Vaccination Phase|Other|0|||
146635132|NCT00345358|528838905|FG001|Primary Vaccination Phase|Other|1|||
146635133|NCT00345358|528838906|FG002|Primary Vaccination Phase|Other|1|||
146635134|NCT00345358|528838907|FG003|Primary Vaccination Phase|Other|0|||
146635135|NCT00345358|528838904|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
146635136|NCT00345358|528838905|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
146635137|NCT00345358|528838906|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
146635138|NCT00345358|528838907|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
146635139|NCT00345358|528838904|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
146635140|NCT00345358|528838905|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
146635141|NCT00345358|528838906|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
146635142|NCT00345358|528838907|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
146635143|NCT00345358|528838904|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
146635144|NCT00345358|528838905|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
146635145|NCT00345358|528838906|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
146635146|NCT00345358|528838907|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
146635147|NCT00345358|528838904|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
146635148|NCT00345358|528838905|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
146635149|NCT00345358|528838906|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
146635150|NCT00345358|528838907|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
146635151|NCT00345358|528838904|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
146635152|NCT00345358|528838905|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
146635153|NCT00345358|528838906|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
146635154|NCT00345358|528838907|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
146635155|NCT00346697|528838909|FG000|Overall Study|Lost to Follow-up|0|||
146635156|NCT00346697|528838910|FG001|Overall Study|Lost to Follow-up|1|||
146635157|NCT00499083|528838911|FG000|Overall Study|Not evaluable|3|||
146635158|NCT00318643|528838915|FG000|Overall Study|Adverse Event|0|||
146635159|NCT00318643|528838916|FG001|Overall Study|Adverse Event|0|||
146635160|NCT00318643|528838917|FG002|Overall Study|Adverse Event|0|||
146635161|NCT00318643|528838918|FG003|Overall Study|Adverse Event|0|||
146635162|NCT00318643|528838919|FG004|Overall Study|Adverse Event|1|||
146635163|NCT00318643|528838915|FG000|Overall Study|Participant's Decision|0|||
146635164|NCT00318643|528838916|FG001|Overall Study|Participant's Decision|0|||
146635165|NCT00318643|528838917|FG002|Overall Study|Participant's Decision|0|||
146887836|NCT00209339|529755804|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
146635166|NCT00318643|528838918|FG003|Overall Study|Participant's Decision|0|||
146765330|NCT00864682|529308619|FG001|Overall Study|Protocol Violation|1|||
146635167|NCT00318643|528838919|FG004|Overall Study|Participant's Decision|1|||
146635168|NCT00318643|528838915|FG000|Overall Study|Investigator's Decision|0|||
146635169|NCT00318643|528838916|FG001|Overall Study|Investigator's Decision|0|||
146635170|NCT00318643|528838917|FG002|Overall Study|Investigator's Decision|0|||
146635171|NCT00318643|528838918|FG003|Overall Study|Investigator's Decision|0|||
146635172|NCT00318643|528838919|FG004|Overall Study|Investigator's Decision|1|||
146635173|NCT01812252|528838920|FG000|Overall Study|Persistent Disease|1|||
146635174|NCT01812252|528838921|FG001|Overall Study|Persistent Disease|0|||
146635175|NCT01812252|528838920|FG000|Overall Study|Not transplanted|11|||
146635176|NCT01812252|528838921|FG001|Overall Study|Not transplanted|11|||
146635177|NCT01812252|528838920|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
146635178|NCT01812252|528838921|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
146635179|NCT01812252|528838920|FG000|Overall Study|Withdrawal by Subject|1|||
146635180|NCT01812252|528838921|FG001|Overall Study|Withdrawal by Subject|1|||
146887837|NCT00209339|529755804|FG000|At 5 Years Follow-up|Death|1|||
146887838|NCT00429858|529755805|FG000|Overall Study|Withdrawal by Subject|1|||
146554628|NCT00987935|528538504|FG005|Overall Study|Adverse Event|0|||
146966724|NCT04089566|530038885|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
146966725|NCT04089566|530038880|FG000|Overall Study|Reason not Specified|0|||
146966726|NCT04089566|530038881|FG001|Overall Study|Reason not Specified|4|||
146966727|NCT04089566|530038882|FG002|Overall Study|Reason not Specified|4|||
146966728|NCT04089566|530038883|FG003|Overall Study|Reason not Specified|1|||
146966729|NCT04089566|530038884|FG004|Overall Study|Reason not Specified|0|||
146966730|NCT04089566|530038885|FG005|Overall Study|Reason not Specified|0|||
146966731|NCT01083121|530038886|FG000|Overall Study|Use of Humira outside the approved label|81|||
146966732|NCT04115488|530038889|FG000|Overall Study|Adverse Event|8|||
146966733|NCT04115488|530038890|FG001|Overall Study|Adverse Event|4|||
146966734|NCT04115488|530038889|FG000|Overall Study|Withdrawal by Subject|3|||
146966735|NCT04115488|530038890|FG001|Overall Study|Withdrawal by Subject|6|||
146966736|NCT04115488|530038889|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
146966737|NCT04115488|530038890|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
146966738|NCT04115488|530038889|FG000|Overall Study|Patient 's location change|1|||
146966739|NCT04115488|530038890|FG001|Overall Study|Patient 's location change|0|||
146966740|NCT04115488|530038889|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
146966741|NCT04115488|530038890|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
146966742|NCT00885677|530038891|FG000|Overall Study|Death|40|||
146966743|NCT00885677|530038892|FG001|Overall Study|Death|34|||
146966744|NCT00885677|530038891|FG000|Overall Study|Lost to Follow-up|15|||
146966745|NCT00885677|530038892|FG001|Overall Study|Lost to Follow-up|13|||
146966746|NCT00885677|530038891|FG000|Overall Study|Protocol Violation|54|||
146966747|NCT00885677|530038892|FG001|Overall Study|Protocol Violation|54|||
146966748|NCT00885677|530038891|FG000|Overall Study|premature study closure|41|||
146966749|NCT00885677|530038892|FG001|Overall Study|premature study closure|44|||
146966750|NCT00885677|530038891|FG000|Overall Study|device/lead revision or replacement|7|||
146966751|NCT00885677|530038892|FG001|Overall Study|device/lead revision or replacement|6|||
146966752|NCT00885677|530038891|FG000|Overall Study|Heart transplantation|1|||
146554629|NCT00987935|528538505|FG006|Overall Study|Adverse Event|2|||
146554630|NCT00987935|528538506|FG007|Overall Study|Adverse Event|10|||
146554631|NCT00987935|528538507|FG008|Overall Study|Adverse Event|6|||
146554632|NCT00987935|528538499|FG000|Overall Study|Refused to continue taking trial med.|1|||
146554633|NCT00987935|528538500|FG001|Overall Study|Refused to continue taking trial med.|0|||
146554634|NCT00987935|528538501|FG002|Overall Study|Refused to continue taking trial med.|0|||
146554635|NCT00987935|528538502|FG003|Overall Study|Refused to continue taking trial med.|0|||
146554636|NCT00987935|528538503|FG004|Overall Study|Refused to continue taking trial med.|1|||
146554637|NCT00987935|528538504|FG005|Overall Study|Refused to continue taking trial med.|0|||
146966753|NCT00885677|530038892|FG001|Overall Study|Heart transplantation|0|||
146966754|NCT00885677|530038891|FG000|Overall Study|Inclusion/exclusion not met|25|||
146966755|NCT00885677|530038892|FG001|Overall Study|Inclusion/exclusion not met|27|||
146966756|NCT01233284|530038907|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
146887839|NCT00429858|529755805|FG000|Overall Study|Study Termination|1|||
146554638|NCT00987935|528538505|FG006|Overall Study|Refused to continue taking trial med.|4|||
146554639|NCT00987935|528538506|FG007|Overall Study|Refused to continue taking trial med.|4|||
146554640|NCT00987935|528538507|FG008|Overall Study|Refused to continue taking trial med.|2|||
146554641|NCT00987935|528538499|FG000|Overall Study|Reason other than those specified above|0|||
146554642|NCT00987935|528538500|FG001|Overall Study|Reason other than those specified above|0|||
146554643|NCT00987935|528538501|FG002|Overall Study|Reason other than those specified above|0|||
146635181|NCT01812252|528838920|FG000|Overall Study|Screen Failure|1|||
146635182|NCT01812252|528838921|FG001|Overall Study|Screen Failure|0|||
146635183|NCT02557139|528838922|FG000|Overall Study|Significant liver elevation|1|||
146635184|NCT02557139|528838923|FG001|Overall Study|Significant liver elevation|0|||
146635185|NCT02557139|528838924|FG002|Overall Study|Significant liver elevation|1|||
146635186|NCT02557139|528838922|FG000|Overall Study|Withdrawal by Subject|1|||
146635187|NCT02557139|528838923|FG001|Overall Study|Withdrawal by Subject|0|||
146635188|NCT02557139|528838924|FG002|Overall Study|Withdrawal by Subject|0|||
146635189|NCT02557139|528838922|FG000|Overall Study|Illness of prohibited medication|0|||
146635190|NCT02557139|528838923|FG001|Overall Study|Illness of prohibited medication|0|||
146635191|NCT02557139|528838924|FG002|Overall Study|Illness of prohibited medication|1|||
146635192|NCT01146795|528838926|FG000|Overall Study|Withdrawal by Subject|4|||
146635193|NCT01146795|528838926|FG000|Overall Study|Adverse Event|6|||
146635194|NCT01146795|528838926|FG000|Overall Study|Still in treatment at study closure|10|||
146635195|NCT05375760|528838927|FG000|Overall Study|Adverse Event|1|||
146635196|NCT05375760|528838928|FG001|Overall Study|Adverse Event|0|||
146966757|NCT01233284|530038908|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
146966758|NCT01233284|530038909|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
146966759|NCT01233284|530038910|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
146966760|NCT01233284|530038911|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
146966761|NCT01233284|530038907|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
146966762|NCT01233284|530038908|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
146966763|NCT01233284|530038909|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
146966764|NCT01233284|530038910|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
146966765|NCT01233284|530038911|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
146966766|NCT01233284|530038907|FG000|Period 1 (4 Weeks)|Other|0|||
146966767|NCT01233284|530038908|FG001|Period 1 (4 Weeks)|Other|0|||
146966768|NCT01233284|530038909|FG002|Period 1 (4 Weeks)|Other|1|||
146966769|NCT01233284|530038910|FG003|Period 1 (4 Weeks)|Other|0|||
146966770|NCT01233284|530038911|FG004|Period 1 (4 Weeks)|Other|0|||
146966771|NCT01233284|530038907|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146966772|NCT01233284|530038908|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146966773|NCT01233284|530038909|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
146966774|NCT01233284|530038910|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146966775|NCT01233284|530038911|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146966776|NCT01233284|530038907|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
146966777|NCT01233284|530038908|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
146635197|NCT05375760|528838927|FG000|Overall Study|Death|0|||
146635198|NCT05375760|528838928|FG001|Overall Study|Death|1|||
146635199|NCT05375760|528838927|FG000|Overall Study|Lost to Follow-up|6|||
146635200|NCT05375760|528838928|FG001|Overall Study|Lost to Follow-up|6|||
146635201|NCT05375760|528838927|FG000|Overall Study|Withdrawal by Subject|17|||
146635202|NCT05375760|528838928|FG001|Overall Study|Withdrawal by Subject|19|||
146635203|NCT05375760|528838927|FG000|Overall Study|Dosing halted by FDA|96|||
146635204|NCT05375760|528838928|FG001|Overall Study|Dosing halted by FDA|100|||
146635205|NCT05375760|528838927|FG000|Overall Study|Not compliant with study visit|2|||
146635206|NCT05375760|528838928|FG001|Overall Study|Not compliant with study visit|0|||
146635207|NCT05375760|528838927|FG000|Overall Study|Physician Decision|1|||
146635208|NCT05375760|528838928|FG001|Overall Study|Physician Decision|0|||
146635209|NCT05375760|528838927|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
146635210|NCT05375760|528838928|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
146966778|NCT01233284|530038909|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
146966779|NCT01233284|530038910|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
146966780|NCT01233284|530038911|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
146966781|NCT01233284|530038907|FG000|Period 3 (4 Weeks)|Other|0|||
146966782|NCT01233284|530038908|FG001|Period 3 (4 Weeks)|Other|0|||
146635211|NCT05375760|528838927|FG000|Overall Study|Participant moved|1|||
146635212|NCT05375760|528838928|FG001|Overall Study|Participant moved|0|||
146635213|NCT00363480|528838929|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
146635214|NCT00363480|528838929|FG000|Overall Study|Adverse Event|4|||
146635215|NCT00363480|528838929|FG000|Overall Study|Lost to Follow-up|5|||
146554644|NCT00987935|528538502|FG003|Overall Study|Reason other than those specified above|0|||
146554645|NCT00987935|528538503|FG004|Overall Study|Reason other than those specified above|0|||
146554646|NCT00987935|528538504|FG005|Overall Study|Reason other than those specified above|0|||
146554647|NCT00987935|528538505|FG006|Overall Study|Reason other than those specified above|0|||
146554648|NCT00987935|528538506|FG007|Overall Study|Reason other than those specified above|0|||
146554649|NCT00987935|528538507|FG008|Overall Study|Reason other than those specified above|1|||
146554650|NCT00452530|528538508|FG000|Overall Study|Death|1|||
146554651|NCT00452530|528538509|FG001|Overall Study|Death|0|||
146554652|NCT00452530|528538508|FG000|Overall Study|Adverse Event|40|||
146554653|NCT00452530|528538509|FG001|Overall Study|Adverse Event|44|||
146554654|NCT00452530|528538508|FG000|Overall Study|Withdrawal by Subject|68|||
146554655|NCT00452530|528538509|FG001|Overall Study|Withdrawal by Subject|57|||
146554656|NCT00452530|528538508|FG000|Overall Study|Lost to Follow-up|1|||
146554657|NCT00452530|528538509|FG001|Overall Study|Lost to Follow-up|0|||
146554658|NCT00452530|528538508|FG000|Overall Study|Poor compliance/noncompliance|1|||
146554659|NCT00452530|528538509|FG001|Overall Study|Poor compliance/noncompliance|2|||
146554660|NCT00452530|528538508|FG000|Overall Study|No longer met study criteria|18|||
146554661|NCT00452530|528538509|FG001|Overall Study|No longer met study criteria|22|||
146554662|NCT00452530|528538508|FG000|Overall Study|Other|7|||
146554663|NCT00452530|528538509|FG001|Overall Study|Other|11|||
146554664|NCT03888482|528538510|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
146554665|NCT03888482|528538511|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
146554666|NCT03888482|528538510|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
146554667|NCT03888482|528538511|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
146635216|NCT00363480|528838929|FG000|Overall Study|Withdrawal by Subject|5|||
146635217|NCT00363480|528838929|FG000|Overall Study|Non-compliance of subject|1|||
146635218|NCT00363480|528838929|FG000|Overall Study|Participant discontinued on its own|1|||
146635219|NCT03853109|528838930|FG000|Overall Study|Withdrawal by Subject|0|||
146635220|NCT03853109|528838931|FG001|Overall Study|Withdrawal by Subject|0|||
146635221|NCT03853109|528838932|FG002|Overall Study|Withdrawal by Subject|1|||
146887840|NCT02268058|529755806|FG000|Overall Study|Protocol Violation|1|||
146554668|NCT00563316|528538512|FG000|Overall Study|Adverse Event|2|||
146554669|NCT00563316|528538512|FG000|Overall Study|Physician Decision|1|||
146554670|NCT00563316|528538512|FG000|Overall Study|Lost to Follow-up|2|||
146554671|NCT00563316|528538512|FG000|Overall Study|Death|1|||
146554672|NCT00563316|528538512|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
146635222|NCT03853109|528838933|FG003|Overall Study|Withdrawal by Subject|2|||
146887841|NCT02268058|529755807|FG001|Overall Study|Protocol Violation|0|||
146966783|NCT01233284|530038909|FG002|Period 3 (4 Weeks)|Other|0|||
146966784|NCT01233284|530038910|FG003|Period 3 (4 Weeks)|Other|1|||
146966785|NCT01233284|530038911|FG004|Period 3 (4 Weeks)|Other|0|||
146966786|NCT01233284|530038907|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
146966787|NCT01233284|530038908|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
146966788|NCT01233284|530038909|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
146966789|NCT01233284|530038910|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
146966790|NCT01233284|530038911|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
146966791|NCT01233284|530038907|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
146966792|NCT01233284|530038908|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
146966793|NCT01233284|530038909|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
146966794|NCT01233284|530038910|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
146966795|NCT01233284|530038911|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
146966796|NCT01058707|530038913|FG000|Overall Study|Disease Progression|15|||
146966797|NCT01058707|530038914|FG001|Overall Study|Disease Progression|20|||
146966798|NCT01058707|530038915|FG002|Overall Study|Disease Progression|20|||
146966799|NCT01058707|530038916|FG003|Overall Study|Disease Progression|15|||
146966800|NCT01058707|530038917|FG004|Overall Study|Disease Progression|23|||
146966801|NCT01058707|530038918|FG005|Overall Study|Disease Progression|10|||
146554673|NCT00563316|528538512|FG000|Overall Study|Other|1|||
146554674|NCT00425854|528538514|FG000|Overall Study|Progressive Disease|19|||
146554675|NCT00425854|528538515|FG001|Overall Study|Progressive Disease|12|||
146554676|NCT00425854|528538514|FG000|Overall Study|Dose reduction toxicity AE|8|||
146554677|NCT00425854|528538515|FG001|Overall Study|Dose reduction toxicity AE|7|||
146554678|NCT00425854|528538514|FG000|Overall Study|Other Adverse Event|2|||
146554679|NCT00425854|528538515|FG001|Overall Study|Other Adverse Event|2|||
146554680|NCT01630811|528538521|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
146554681|NCT01630811|528538522|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
146554682|NCT04818086|528538525|FG000|Overall Study|Physician Decision|1|||
146554683|NCT04818086|528538526|FG001|Overall Study|Physician Decision|0|||
146966802|NCT01058707|530038919|FG006|Overall Study|Disease Progression|12|||
146966803|NCT01058707|530038913|FG000|Overall Study|Adverse Event|11|||
146966804|NCT01058707|530038914|FG001|Overall Study|Adverse Event|4|||
146966805|NCT01058707|530038915|FG002|Overall Study|Adverse Event|7|||
146966806|NCT01058707|530038916|FG003|Overall Study|Adverse Event|6|||
146966807|NCT01058707|530038917|FG004|Overall Study|Adverse Event|7|||
146966808|NCT01058707|530038918|FG005|Overall Study|Adverse Event|3|||
146554684|NCT04818086|528538525|FG000|Overall Study|Withdrawal by Subject|0|||
146554685|NCT04818086|528538526|FG001|Overall Study|Withdrawal by Subject|1|||
146554686|NCT00537082|528538539|FG000|Overall Study|Adverse Event|6|||
146554687|NCT00537082|528538540|FG001|Overall Study|Adverse Event|6|||
146554688|NCT00537082|528538541|FG002|Overall Study|Adverse Event|3|||
146554689|NCT00537082|528538539|FG000|Overall Study|Protocol Violation|0|||
146554690|NCT00537082|528538540|FG001|Overall Study|Protocol Violation|2|||
146554691|NCT00537082|528538541|FG002|Overall Study|Protocol Violation|1|||
146554692|NCT00537082|528538539|FG000|Overall Study|Lack of Efficacy|0|||
146554693|NCT00537082|528538540|FG001|Overall Study|Lack of Efficacy|0|||
146554694|NCT00537082|528538541|FG002|Overall Study|Lack of Efficacy|2|||
146554695|NCT00537082|528538539|FG000|Overall Study|Withdrawal by Subject|0|||
146887842|NCT02268058|529755808|FG002|Overall Study|Protocol Violation|0|||
146554696|NCT00537082|528538540|FG001|Overall Study|Withdrawal by Subject|1|||
146554697|NCT00537082|528538541|FG002|Overall Study|Withdrawal by Subject|0|||
146554698|NCT00537082|528538539|FG000|Overall Study|Discontinued before initiating treatment|3|||
146554699|NCT00537082|528538540|FG001|Overall Study|Discontinued before initiating treatment|0|||
146635223|NCT03853109|528838934|FG004|Overall Study|Withdrawal by Subject|1|||
146635224|NCT03853109|528838935|FG005|Overall Study|Withdrawal by Subject|4|||
146635225|NCT03853109|528838936|FG006|Overall Study|Withdrawal by Subject|5|||
146635226|NCT03853109|528838937|FG007|Overall Study|Withdrawal by Subject|3|||
146635227|NCT03853109|528838930|FG000|Overall Study|Decision by Sponsor|0|||
146635228|NCT03853109|528838931|FG001|Overall Study|Decision by Sponsor|0|||
146635229|NCT03853109|528838932|FG002|Overall Study|Decision by Sponsor|1|||
146635230|NCT03853109|528838933|FG003|Overall Study|Decision by Sponsor|0|||
146635231|NCT03853109|528838934|FG004|Overall Study|Decision by Sponsor|1|||
146635232|NCT03853109|528838935|FG005|Overall Study|Decision by Sponsor|1|||
146554700|NCT00537082|528538541|FG002|Overall Study|Discontinued before initiating treatment|0|||
146554701|NCT02568254|528538542|FG000|Period 2|Adverse Event|0|||
146554702|NCT02568254|528538543|FG001|Period 2|Adverse Event|0|||
146635233|NCT03853109|528838936|FG006|Overall Study|Decision by Sponsor|10|||
146635234|NCT03853109|528838937|FG007|Overall Study|Decision by Sponsor|2|||
146635235|NCT03853109|528838930|FG000|Overall Study|Lost to Follow-up|0|||
146635236|NCT03853109|528838931|FG001|Overall Study|Lost to Follow-up|0|||
146635237|NCT03853109|528838932|FG002|Overall Study|Lost to Follow-up|0|||
146635238|NCT03853109|528838933|FG003|Overall Study|Lost to Follow-up|0|||
146635239|NCT03853109|528838934|FG004|Overall Study|Lost to Follow-up|1|||
146635240|NCT03853109|528838935|FG005|Overall Study|Lost to Follow-up|3|||
146635241|NCT03853109|528838936|FG006|Overall Study|Lost to Follow-up|0|||
146635242|NCT03853109|528838937|FG007|Overall Study|Lost to Follow-up|0|||
146635243|NCT03853109|528838930|FG000|Overall Study|Death|2|||
146635244|NCT03853109|528838931|FG001|Overall Study|Death|5|||
146635245|NCT03853109|528838932|FG002|Overall Study|Death|8|||
146635246|NCT03853109|528838933|FG003|Overall Study|Death|10|||
146635247|NCT03853109|528838934|FG004|Overall Study|Death|3|||
146635248|NCT03853109|528838935|FG005|Overall Study|Death|20|||
146635249|NCT03853109|528838936|FG006|Overall Study|Death|10|||
146635250|NCT03853109|528838937|FG007|Overall Study|Death|5|||
146635251|NCT04634253|528838938|FG000|Overall Study|Adverse Event|1|||
146635252|NCT04634253|528838939|FG001|Overall Study|Adverse Event|1|||
146635253|NCT04634253|528838940|FG002|Overall Study|Adverse Event|0|||
146635254|NCT04634253|528838938|FG000|Overall Study|Physician Decision|0|||
146635255|NCT04634253|528838939|FG001|Overall Study|Physician Decision|1|||
146635256|NCT04634253|528838940|FG002|Overall Study|Physician Decision|0|||
146635257|NCT04634253|528838938|FG000|Overall Study|Withdrawal by Subject|1|||
146635258|NCT04634253|528838939|FG001|Overall Study|Withdrawal by Subject|0|||
146635259|NCT04634253|528838940|FG002|Overall Study|Withdrawal by Subject|3|||
146635260|NCT01499355|528838941|FG000|Run-In Period|Study Termination|15|||
146635261|NCT01499355|528838942|FG001|Run-In Period|Study Termination|0|||
146635262|NCT01499355|528838943|FG002|Run-In Period|Study Termination|0|||
146635263|NCT01499355|528838944|FG003|Run-In Period|Study Termination|0|||
146635264|NCT01499355|528838941|FG000|Run-In Period|Other|3|||
146635265|NCT01499355|528838942|FG001|Run-In Period|Other|0|||
146635266|NCT01499355|528838943|FG002|Run-In Period|Other|0|||
146635267|NCT01499355|528838944|FG003|Run-In Period|Other|0|||
146635268|NCT01499355|528838941|FG000|Run-In Period|Death|2|||
146635269|NCT01499355|528838942|FG001|Run-In Period|Death|0|||
146635270|NCT01499355|528838943|FG002|Run-In Period|Death|0|||
146635271|NCT01499355|528838944|FG003|Run-In Period|Death|0|||
146635272|NCT01499355|528838941|FG000|Run-In Period|Investigator Decision|2|||
146765331|NCT00864682|529308620|FG002|Overall Study|Protocol Violation|2|||
146554703|NCT02568254|528538544|FG002|Period 2|Adverse Event|1|||
146554704|NCT02568254|528538545|FG003|Period 2|Adverse Event|0|||
146554705|NCT02568254|528538546|FG004|Period 2|Adverse Event|0|||
146554706|NCT02568254|528538547|FG005|Period 2|Adverse Event|0|||
146554707|NCT02568254|528538542|FG000|Period 3|Unstatisfactory Lens fitting|0|||
146554708|NCT02568254|528538543|FG001|Period 3|Unstatisfactory Lens fitting|0|||
146554709|NCT02568254|528538544|FG002|Period 3|Unstatisfactory Lens fitting|0|||
146554710|NCT02568254|528538545|FG003|Period 3|Unstatisfactory Lens fitting|0|||
146554711|NCT02568254|528538546|FG004|Period 3|Unstatisfactory Lens fitting|1|||
146554712|NCT02568254|528538547|FG005|Period 3|Unstatisfactory Lens fitting|0|||
146635273|NCT01499355|528838942|FG001|Run-In Period|Investigator Decision|0|||
146635274|NCT01499355|528838943|FG002|Run-In Period|Investigator Decision|0|||
146635275|NCT01499355|528838944|FG003|Run-In Period|Investigator Decision|0|||
146635276|NCT01499355|528838941|FG000|Run-In Period|Consent Withdrawn|1|||
146635277|NCT01499355|528838942|FG001|Run-In Period|Consent Withdrawn|0|||
146635278|NCT01499355|528838943|FG002|Run-In Period|Consent Withdrawn|0|||
146635279|NCT01499355|528838944|FG003|Run-In Period|Consent Withdrawn|0|||
146635280|NCT01499355|528838941|FG000|Run-In Period|Adverse Event|8|||
146635281|NCT01499355|528838942|FG001|Run-In Period|Adverse Event|0|||
146635282|NCT01499355|528838943|FG002|Run-In Period|Adverse Event|0|||
146635283|NCT01499355|528838944|FG003|Run-In Period|Adverse Event|0|||
146635284|NCT01499355|528838941|FG000|Double-Blind Period|Adverse Event|0|||
146554713|NCT03061214|528538552|FG000|Overall Study|Withdrawal by Subject|21|||
146554714|NCT03061214|528538553|FG001|Overall Study|Withdrawal by Subject|26|||
146554715|NCT03061214|528538554|FG002|Overall Study|Withdrawal by Subject|9|||
146554716|NCT03061214|528538552|FG000|Overall Study|Lost to Follow-up|3|||
146554717|NCT03061214|528538553|FG001|Overall Study|Lost to Follow-up|1|||
146554718|NCT03061214|528538554|FG002|Overall Study|Lost to Follow-up|1|||
146554719|NCT03061214|528538552|FG000|Overall Study|Death|1|||
146554720|NCT03061214|528538553|FG001|Overall Study|Death|1|||
146554721|NCT03061214|528538554|FG002|Overall Study|Death|0|||
146554722|NCT00368849|528540408|FG000|Overall Study|Withdrawal by Subject|0|||
146554723|NCT00368849|528540409|FG001|Overall Study|Withdrawal by Subject|1|||
146554724|NCT00368849|528540408|FG000|Overall Study|Physician Decision|0|||
146554725|NCT00368849|528540409|FG001|Overall Study|Physician Decision|1|||
146554726|NCT01902303|528540413|FG000|Overall Study|Adverse Event|0|||
146554727|NCT01902303|528540414|FG001|Overall Study|Adverse Event|1|||
146635285|NCT01499355|528838942|FG001|Double-Blind Period|Adverse Event|2|||
146635286|NCT01499355|528838943|FG002|Double-Blind Period|Adverse Event|3|||
146554728|NCT01902303|528540413|FG000|Overall Study|Lost to Follow-up|0|||
146554729|NCT01902303|528540414|FG001|Overall Study|Lost to Follow-up|1|||
146554730|NCT01902303|528540413|FG000|Overall Study|Protocol Violation|2|||
146554731|NCT01902303|528540414|FG001|Overall Study|Protocol Violation|2|||
146554732|NCT01902303|528540413|FG000|Overall Study|subject lost investigational product|0|||
146554733|NCT01902303|528540414|FG001|Overall Study|subject lost investigational product|1|||
146554734|NCT01902303|528540413|FG000|Overall Study|Did not develop a cold sore|21|||
146554735|NCT01902303|528540414|FG001|Overall Study|Did not develop a cold sore|19|||
146554736|NCT05058456|528540415|FG000|Overall Study|Death|1|||
146635287|NCT01499355|528838944|FG003|Double-Blind Period|Adverse Event|2|||
146554737|NCT05058456|528540415|FG000|Overall Study|End of Study data not yet due for release|34|||
146635288|NCT01499355|528838941|FG000|Double-Blind Period|Study Termination|0|||
146635289|NCT01499355|528838942|FG001|Double-Blind Period|Study Termination|18|||
146635290|NCT01499355|528838943|FG002|Double-Blind Period|Study Termination|16|||
146635291|NCT01499355|528838944|FG003|Double-Blind Period|Study Termination|14|||
146635292|NCT01499355|528838941|FG000|Double-Blind Period|Other|0|||
146635293|NCT01499355|528838942|FG001|Double-Blind Period|Other|1|||
146635294|NCT01499355|528838943|FG002|Double-Blind Period|Other|2|||
146635295|NCT01499355|528838944|FG003|Double-Blind Period|Other|2|||
146635296|NCT01499355|528838941|FG000|Double-Blind Period|Death|0|||
146635297|NCT01499355|528838942|FG001|Double-Blind Period|Death|1|||
146635298|NCT01499355|528838943|FG002|Double-Blind Period|Death|0|||
146635299|NCT01499355|528838944|FG003|Double-Blind Period|Death|0|||
146635300|NCT01499355|528838941|FG000|Double-Blind Period|Investigator Decision|0|||
146635301|NCT01499355|528838942|FG001|Double-Blind Period|Investigator Decision|0|||
146635302|NCT01499355|528838943|FG002|Double-Blind Period|Investigator Decision|3|||
146635303|NCT01499355|528838944|FG003|Double-Blind Period|Investigator Decision|3|||
146635304|NCT01499355|528838941|FG000|Double-Blind Period|Consent Withdrawn|0|||
146635305|NCT01499355|528838942|FG001|Double-Blind Period|Consent Withdrawn|0|||
146635306|NCT01499355|528838943|FG002|Double-Blind Period|Consent Withdrawn|1|||
146635307|NCT01499355|528838944|FG003|Double-Blind Period|Consent Withdrawn|2|||
146635308|NCT01499355|528838941|FG000|Double-Blind Period|Lost to Follow-up|0|||
146635309|NCT01499355|528838942|FG001|Double-Blind Period|Lost to Follow-up|1|||
146635310|NCT01499355|528838943|FG002|Double-Blind Period|Lost to Follow-up|0|||
146635311|NCT01499355|528838944|FG003|Double-Blind Period|Lost to Follow-up|0|||
146635312|NCT00432172|528838947|FG000|Overall Study|Physician Decision|0|||
146635313|NCT00432172|528838948|FG001|Overall Study|Physician Decision|0|||
146635314|NCT00432172|528838949|FG002|Overall Study|Physician Decision|2|||
146635315|NCT00432172|528838950|FG003|Overall Study|Physician Decision|0|||
146635316|NCT00432172|528838947|FG000|Overall Study|Adverse Event|4|||
146635317|NCT00432172|528838948|FG001|Overall Study|Adverse Event|2|||
146635318|NCT00432172|528838949|FG002|Overall Study|Adverse Event|4|||
146635319|NCT00432172|528838950|FG003|Overall Study|Adverse Event|3|||
146635320|NCT00432172|528838947|FG000|Overall Study|Disease progression|0|||
146635321|NCT00432172|528838948|FG001|Overall Study|Disease progression|2|||
146635322|NCT00432172|528838949|FG002|Overall Study|Disease progression|5|||
146635323|NCT00432172|528838950|FG003|Overall Study|Disease progression|1|||
146635324|NCT00432172|528838947|FG000|Overall Study|Withdrawal by Subject|0|||
146635325|NCT00432172|528838948|FG001|Overall Study|Withdrawal by Subject|1|||
146635326|NCT00432172|528838949|FG002|Overall Study|Withdrawal by Subject|0|||
146635327|NCT00432172|528838950|FG003|Overall Study|Withdrawal by Subject|2|||
146635328|NCT00432172|528838947|FG000|Overall Study|No treatment received|2|||
146635329|NCT00432172|528838948|FG001|Overall Study|No treatment received|2|||
146635330|NCT00432172|528838949|FG002|Overall Study|No treatment received|0|||
146635331|NCT00432172|528838950|FG003|Overall Study|No treatment received|1|||
146635332|NCT02536963|528838951|FG000|Overall Study|Withdrawal by Subject|18|||
146635333|NCT02141204|528838952|FG000|Overall Study|Lost to Follow-up|2|||
146635334|NCT02141204|528838953|FG001|Overall Study|Lost to Follow-up|1|||
146635335|NCT02141204|528838952|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
146635336|NCT02141204|528838953|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
146635337|NCT02141204|528838952|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
146635338|NCT02141204|528838953|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
146635339|NCT02141204|528838952|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
146635340|NCT02141204|528838953|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
146635341|NCT01177397|528840891|FG000|Overall Study|Protocol Violation|0|||
146635342|NCT01177397|528840892|FG001|Overall Study|Protocol Violation|0|||
146635343|NCT01177397|528840893|FG002|Overall Study|Protocol Violation|0|||
146635344|NCT01177397|528840894|FG003|Overall Study|Protocol Violation|0|||
146635345|NCT01177397|528840895|FG004|Overall Study|Protocol Violation|0|||
146635346|NCT01177397|528840896|FG005|Overall Study|Protocol Violation|1|||
146635347|NCT01177397|528840897|FG006|Overall Study|Protocol Violation|0|||
146635348|NCT01177397|528840898|FG007|Overall Study|Protocol Violation|0|||
146635349|NCT01177397|528840899|FG008|Overall Study|Protocol Violation|0|||
146635350|NCT01177397|528840900|FG009|Overall Study|Protocol Violation|0|||
146635351|NCT01177397|528840901|FG010|Overall Study|Protocol Violation|0|||
146635352|NCT01177397|528840902|FG011|Overall Study|Protocol Violation|0|||
146635353|NCT01177397|528840891|FG000|Overall Study|Lost to Follow-up|0|||
146635354|NCT01177397|528840892|FG001|Overall Study|Lost to Follow-up|0|||
146635355|NCT01177397|528840893|FG002|Overall Study|Lost to Follow-up|0|||
146635356|NCT01177397|528840894|FG003|Overall Study|Lost to Follow-up|0|||
146635357|NCT01177397|528840895|FG004|Overall Study|Lost to Follow-up|1|||
146635358|NCT01177397|528840896|FG005|Overall Study|Lost to Follow-up|0|||
146635359|NCT01177397|528840897|FG006|Overall Study|Lost to Follow-up|0|||
146635360|NCT01177397|528840898|FG007|Overall Study|Lost to Follow-up|2|||
146635361|NCT01177397|528840899|FG008|Overall Study|Lost to Follow-up|0|||
146635362|NCT01177397|528840900|FG009|Overall Study|Lost to Follow-up|0|||
146635363|NCT01177397|528840901|FG010|Overall Study|Lost to Follow-up|0|||
146635364|NCT01177397|528840902|FG011|Overall Study|Lost to Follow-up|0|||
146635365|NCT01177397|528840891|FG000|Overall Study|Death|0|||
146635366|NCT01177397|528840892|FG001|Overall Study|Death|0|||
146554738|NCT01832038|528540416|FG000|Overall Study|Death|5|||
146554739|NCT01832038|528540416|FG000|Overall Study|Adverse Event|50|||
146554740|NCT01832038|528540416|FG000|Overall Study|Lack of Efficacy|81|||
146554741|NCT01832038|528540416|FG000|Overall Study|Protocol Violation|7|||
146554742|NCT01832038|528540416|FG000|Overall Study|Lost to Follow-up|10|||
146554743|NCT01832038|528540416|FG000|Overall Study|Withdrawal by Subject|49|||
146554744|NCT01832038|528540416|FG000|Overall Study|Visit non-compliance|2|||
146554745|NCT01832038|528540416|FG000|Overall Study|Subject refused to return visit|2|||
146554746|NCT01832038|528540416|FG000|Overall Study|Not convenient to come back to site|2|||
146635367|NCT01177397|528840893|FG002|Overall Study|Death|1|||
146635368|NCT01177397|528840894|FG003|Overall Study|Death|1|||
146635369|NCT01177397|528840895|FG004|Overall Study|Death|0|||
146635370|NCT01177397|528840896|FG005|Overall Study|Death|0|||
146635371|NCT01177397|528840897|FG006|Overall Study|Death|0|||
146635372|NCT01177397|528840898|FG007|Overall Study|Death|5|||
146635373|NCT01177397|528840899|FG008|Overall Study|Death|2|||
146635374|NCT01177397|528840900|FG009|Overall Study|Death|1|||
146635375|NCT01177397|528840901|FG010|Overall Study|Death|0|||
146635376|NCT01177397|528840902|FG011|Overall Study|Death|0|||
146635377|NCT01177397|528840891|FG000|Overall Study|Withdrawal by Subject|0|||
146635378|NCT01177397|528840892|FG001|Overall Study|Withdrawal by Subject|0|||
146635379|NCT01177397|528840893|FG002|Overall Study|Withdrawal by Subject|1|||
146635380|NCT01177397|528840894|FG003|Overall Study|Withdrawal by Subject|1|||
146635381|NCT01177397|528840895|FG004|Overall Study|Withdrawal by Subject|1|||
146635382|NCT01177397|528840896|FG005|Overall Study|Withdrawal by Subject|2|||
146635383|NCT01177397|528840897|FG006|Overall Study|Withdrawal by Subject|0|||
146635384|NCT01177397|528840898|FG007|Overall Study|Withdrawal by Subject|5|||
146635385|NCT01177397|528840899|FG008|Overall Study|Withdrawal by Subject|9|||
146635386|NCT01177397|528840900|FG009|Overall Study|Withdrawal by Subject|1|||
146635387|NCT01177397|528840901|FG010|Overall Study|Withdrawal by Subject|1|||
146635388|NCT01177397|528840902|FG011|Overall Study|Withdrawal by Subject|0|||
146635389|NCT01177397|528840891|FG000|Overall Study|Adverse Event|0|||
146635390|NCT01177397|528840892|FG001|Overall Study|Adverse Event|0|||
146635391|NCT01177397|528840893|FG002|Overall Study|Adverse Event|1|||
146635392|NCT01177397|528840894|FG003|Overall Study|Adverse Event|2|||
146635393|NCT01177397|528840895|FG004|Overall Study|Adverse Event|0|||
146635394|NCT01177397|528840896|FG005|Overall Study|Adverse Event|12|||
146635395|NCT01177397|528840897|FG006|Overall Study|Adverse Event|1|||
146635396|NCT01177397|528840898|FG007|Overall Study|Adverse Event|14|||
146635397|NCT01177397|528840899|FG008|Overall Study|Adverse Event|8|||
146765332|NCT02469064|529308621|FG000|Overall Study|Request not to receive intervention.|1|||
146554747|NCT01832038|528540416|FG000|Overall Study|Participant was asked to quit|5|||
146554748|NCT01832038|528540416|FG000|Overall Study|Back home|1|||
146554749|NCT01832038|528540416|FG000|Overall Study|Pregnancy|1|||
146635398|NCT01177397|528840900|FG009|Overall Study|Adverse Event|6|||
146635399|NCT01177397|528840901|FG010|Overall Study|Adverse Event|3|||
146635400|NCT01177397|528840902|FG011|Overall Study|Adverse Event|7|||
146635401|NCT01177397|528840891|FG000|Overall Study|Disease progression|1|||
146635402|NCT01177397|528840892|FG001|Overall Study|Disease progression|2|||
146635403|NCT01177397|528840893|FG002|Overall Study|Disease progression|5|||
146635404|NCT01177397|528840894|FG003|Overall Study|Disease progression|5|||
146635405|NCT01177397|528840895|FG004|Overall Study|Disease progression|4|||
146635406|NCT01177397|528840896|FG005|Overall Study|Disease progression|10|||
146635407|NCT01177397|528840897|FG006|Overall Study|Disease progression|10|||
146554750|NCT01832038|528540416|FG000|Overall Study|Low compliance|3|||
146554751|NCT01832038|528540416|FG000|Overall Study|Prohibit procedure|2|||
146887843|NCT02268058|529755809|FG003|Overall Study|Protocol Violation|0|||
146635408|NCT01177397|528840898|FG007|Overall Study|Disease progression|21|||
146635409|NCT01177397|528840899|FG008|Overall Study|Disease progression|18|||
146635410|NCT01177397|528840900|FG009|Overall Study|Disease progression|12|||
146635411|NCT01177397|528840901|FG010|Overall Study|Disease progression|10|||
146635412|NCT01177397|528840902|FG011|Overall Study|Disease progression|8|||
146635413|NCT01177397|528840891|FG000|Overall Study|Other reasons|0|||
146635414|NCT01177397|528840892|FG001|Overall Study|Other reasons|0|||
146635415|NCT01177397|528840893|FG002|Overall Study|Other reasons|1|||
146635416|NCT01177397|528840894|FG003|Overall Study|Other reasons|0|||
146635417|NCT01177397|528840895|FG004|Overall Study|Other reasons|1|||
146635418|NCT01177397|528840896|FG005|Overall Study|Other reasons|1|||
146635419|NCT01177397|528840897|FG006|Overall Study|Other reasons|2|||
146635420|NCT01177397|528840898|FG007|Overall Study|Other reasons|6|||
146635421|NCT01177397|528840899|FG008|Overall Study|Other reasons|10|||
146635422|NCT01177397|528840900|FG009|Overall Study|Other reasons|8|||
146635423|NCT01177397|528840901|FG010|Overall Study|Other reasons|0|||
146635424|NCT01177397|528840902|FG011|Overall Study|Other reasons|2|||
146635425|NCT04555616|528840903|FG000|Overall Study|Death|1|||
146635426|NCT04555616|528840904|FG001|Overall Study|Death|0|||
146635427|NCT04555616|528840905|FG002|Overall Study|Death|1|||
146635428|NCT04555616|528840903|FG000|Overall Study|Withdrawal by Subject|2|||
146635429|NCT04555616|528840904|FG001|Overall Study|Withdrawal by Subject|1|||
146635430|NCT04555616|528840905|FG002|Overall Study|Withdrawal by Subject|0|||
146635431|NCT01106690|528840911|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
146635432|NCT01106690|528840912|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
146635433|NCT01106690|528840913|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
146635434|NCT01106690|528840911|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
146635435|NCT01106690|528840912|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
146635436|NCT01106690|528840913|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
146635437|NCT01106690|528840911|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
146635438|NCT01106690|528840912|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
146635439|NCT01106690|528840913|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
146635440|NCT01106690|528840911|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
146635441|NCT01106690|528840912|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
146635442|NCT01106690|528840913|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
146635443|NCT01106690|528840911|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
146635444|NCT01106690|528840912|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
146635445|NCT01106690|528840913|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
146635446|NCT01106690|528840911|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
146635447|NCT01106690|528840912|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
146635448|NCT01106690|528840913|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
146635449|NCT01106690|528840911|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
146635450|NCT01106690|528840912|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
146635451|NCT01106690|528840913|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
146635452|NCT01106690|528840911|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
146635453|NCT01106690|528840912|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
146635454|NCT01106690|528840913|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
146635455|NCT01106690|528840911|FG000|Core Period: Baseline to Week 26|Other|10|||
146635456|NCT01106690|528840912|FG001|Core Period: Baseline to Week 26|Other|2|||
146635457|NCT01106690|528840913|FG002|Core Period: Baseline to Week 26|Other|6|||
146635458|NCT01106690|528840911|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
146635459|NCT01106690|528840912|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
146635460|NCT01106690|528840913|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
146635461|NCT01106690|528840911|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
146635462|NCT01106690|528840912|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
146635463|NCT01106690|528840913|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
146635464|NCT01106690|528840911|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
146635465|NCT01106690|528840912|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
146635466|NCT01106690|528840913|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
146635467|NCT01106690|528840911|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
146635468|NCT01106690|528840912|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
146635469|NCT01106690|528840913|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
146635470|NCT01106690|528840911|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
146635471|NCT01106690|528840912|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
146635472|NCT01106690|528840913|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
146635473|NCT01106690|528840911|FG000|Extension Period: Week 26 to Week 52|Other|8|||
146635474|NCT01106690|528840912|FG001|Extension Period: Week 26 to Week 52|Other|3|||
146635475|NCT01106690|528840913|FG002|Extension Period: Week 26 to Week 52|Other|4|||
146887844|NCT02475655|529755810|FG000|Overall Study|Lost to Follow-up|0|||
146635476|NCT01106690|528840911|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
146635477|NCT01106690|528840912|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
146635478|NCT01106690|528840913|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
146554752|NCT01832038|528540416|FG000|Overall Study|Not possible to visit the hospital|1|||
146554753|NCT01832038|528540416|FG000|Overall Study|Changes of implementation system|3|||
146554754|NCT01832038|528540416|FG000|Overall Study|Plan to pregnancy|7|||
146554755|NCT01832038|528540416|FG000|Overall Study|Bad mood and has suicidal thought|1|||
146554756|NCT01832038|528540416|FG000|Overall Study|Prohibited concomitant medication|1|||
146554757|NCT01832038|528540416|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
146554758|NCT01832038|528540416|FG000|Overall Study|Subject considered the efficacy was poor|1|||
146554759|NCT03211858|528540417|FG000|Overall Study|Adverse Event|8|||
146554760|NCT03211858|528540418|FG001|Overall Study|Adverse Event|6|||
146554761|NCT03211858|528540417|FG000|Overall Study|Lack of Efficacy|0|||
146554762|NCT03211858|528540418|FG001|Overall Study|Lack of Efficacy|4|||
146554763|NCT03211858|528540417|FG000|Overall Study|Poor compliance to protocol|6|||
146554764|NCT03211858|528540418|FG001|Overall Study|Poor compliance to protocol|2|||
146554765|NCT03211858|528540417|FG000|Overall Study|Non-serious Hypoglycemia|1|||
146554766|NCT03211858|528540418|FG001|Overall Study|Non-serious Hypoglycemia|0|||
146554767|NCT03211858|528540417|FG000|Overall Study|Other than specified above|22|||
146554768|NCT03211858|528540418|FG001|Overall Study|Other than specified above|21|||
146554769|NCT02457546|528540428|FG000|Overall Study|Other reasons|4|||
146554770|NCT02457546|528540429|FG001|Overall Study|Other reasons|1|||
146554771|NCT02457546|528540428|FG000|Overall Study|Refused to complete study/procedures|1|||
146554772|NCT02457546|528540429|FG001|Overall Study|Refused to complete study/procedures|1|||
146554773|NCT02457546|528540428|FG000|Overall Study|Lost to Follow-up|4|||
146554774|NCT02457546|528540429|FG001|Overall Study|Lost to Follow-up|1|||
146554775|NCT02457546|528540428|FG000|Overall Study|Adverse Event|0|||
146554776|NCT02457546|528540429|FG001|Overall Study|Adverse Event|1|||
146554777|NCT01897896|528540430|FG000|Overall Study|Death|1|||
146554778|NCT01897896|528540431|FG001|Overall Study|Death|0|||
146554779|NCT01897896|528540430|FG000|Overall Study|Adverse Event|11|||
146554780|NCT01897896|528540431|FG001|Overall Study|Adverse Event|1|||
146554781|NCT01897896|528540430|FG000|Overall Study|Lost to Follow-up|1|||
146554782|NCT01897896|528540431|FG001|Overall Study|Lost to Follow-up|0|||
146554783|NCT01897896|528540430|FG000|Overall Study|Non-compliance with study drug dosing|1|||
146554784|NCT01897896|528540431|FG001|Overall Study|Non-compliance with study drug dosing|1|||
146554785|NCT01897896|528540430|FG000|Overall Study|Withdrawal by Subject|7|||
146554786|NCT01897896|528540431|FG001|Overall Study|Withdrawal by Subject|1|||
146554787|NCT01897896|528540430|FG000|Overall Study|Require drug that interfere with study|1|||
146554788|NCT01897896|528540431|FG001|Overall Study|Require drug that interfere with study|4|||
146554789|NCT01897896|528540430|FG000|Overall Study|Protocol Violation|1|||
146554790|NCT01897896|528540431|FG001|Overall Study|Protocol Violation|1|||
146554791|NCT01897896|528540430|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
146554792|NCT01897896|528540431|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
146554793|NCT01897896|528540430|FG000|Overall Study|Caregiver can no longer participate|0|||
146554794|NCT01897896|528540431|FG001|Overall Study|Caregiver can no longer participate|2|||
146554795|NCT01897896|528540430|FG000|Overall Study|Other than specified|2|||
146554796|NCT01897896|528540431|FG001|Overall Study|Other than specified|1|||
146554797|NCT05069415|528540434|FG000|Overall Study|Withdrawal by Subject|2|||
146554798|NCT05069415|528540435|FG001|Overall Study|Withdrawal by Subject|0|||
146554799|NCT05069415|528540434|FG000|Overall Study|Adverse Event|2|||
146554800|NCT05069415|528540435|FG001|Overall Study|Adverse Event|0|||
146635479|NCT00998296|528840914|FG000|Overall Study|Progressive disease|0|||
146554801|NCT03142451|528540436|FG000|Overall Study|Adverse Event|5|||
146554802|NCT03142451|528540437|FG001|Overall Study|Adverse Event|2|||
146554803|NCT03142451|528540436|FG000|Overall Study|Lost to Follow-up|25|||
146554804|NCT03142451|528540437|FG001|Overall Study|Lost to Follow-up|8|||
146554805|NCT03142451|528540436|FG000|Overall Study|Participant request|24|||
146554806|NCT03142451|528540437|FG001|Overall Study|Participant request|12|||
146554807|NCT03142451|528540436|FG000|Overall Study|Protocol Violation|3|||
146635480|NCT00998296|528840915|FG001|Overall Study|Progressive disease|1|||
146554808|NCT03142451|528540437|FG001|Overall Study|Protocol Violation|1|||
146554809|NCT03142451|528540436|FG000|Overall Study|Other|1|||
146554810|NCT03142451|528540437|FG001|Overall Study|Other|1|||
146635481|NCT00998296|528840916|FG002|Overall Study|Progressive disease|0|||
146635482|NCT00998296|528840917|FG003|Overall Study|Progressive disease|0|||
146635483|NCT00998296|528840918|FG004|Overall Study|Progressive disease|0|||
146635484|NCT00998296|528840919|FG005|Overall Study|Progressive disease|0|||
146635485|NCT00998296|528840920|FG006|Overall Study|Progressive disease|1|||
146635486|NCT00998296|528840921|FG007|Overall Study|Progressive disease|0|||
146635487|NCT00998296|528840922|FG008|Overall Study|Progressive disease|0|||
146635488|NCT00998296|528840923|FG009|Overall Study|Progressive disease|14|||
146635489|NCT00998296|528840924|FG010|Overall Study|Progressive disease|5|||
146635490|NCT00998296|528840914|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
146635491|NCT00998296|528840915|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
146635492|NCT00998296|528840916|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
146635493|NCT00998296|528840917|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
146635494|NCT00998296|528840918|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
146635495|NCT00998296|528840919|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
146635496|NCT00998296|528840920|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
146635497|NCT00998296|528840921|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
146635498|NCT00998296|528840922|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
146635499|NCT00998296|528840923|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
146635500|NCT00998296|528840924|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
146635501|NCT00998296|528840914|FG000|Overall Study|Other adverse event|0|||
146635502|NCT00998296|528840915|FG001|Overall Study|Other adverse event|0|||
146635503|NCT00998296|528840916|FG002|Overall Study|Other adverse event|0|||
146635504|NCT00998296|528840917|FG003|Overall Study|Other adverse event|0|||
146635505|NCT00998296|528840918|FG004|Overall Study|Other adverse event|1|||
146635506|NCT00998296|528840919|FG005|Overall Study|Other adverse event|0|||
146635507|NCT00998296|528840920|FG006|Overall Study|Other adverse event|0|||
146635508|NCT00998296|528840921|FG007|Overall Study|Other adverse event|0|||
146635509|NCT00998296|528840922|FG008|Overall Study|Other adverse event|0|||
146635510|NCT00998296|528840923|FG009|Overall Study|Other adverse event|1|||
146635511|NCT00998296|528840924|FG010|Overall Study|Other adverse event|2|||
146635512|NCT00998296|528840914|FG000|Overall Study|Refused to continue taking trial med.|0|||
146635513|NCT00998296|528840915|FG001|Overall Study|Refused to continue taking trial med.|0|||
146635514|NCT00998296|528840916|FG002|Overall Study|Refused to continue taking trial med.|0|||
146635515|NCT00998296|528840917|FG003|Overall Study|Refused to continue taking trial med.|0|||
146635516|NCT00998296|528840918|FG004|Overall Study|Refused to continue taking trial med.|0|||
146635517|NCT00998296|528840919|FG005|Overall Study|Refused to continue taking trial med.|0|||
146635518|NCT00998296|528840920|FG006|Overall Study|Refused to continue taking trial med.|0|||
146635519|NCT00998296|528840921|FG007|Overall Study|Refused to continue taking trial med.|0|||
146635520|NCT00998296|528840922|FG008|Overall Study|Refused to continue taking trial med.|0|||
146635521|NCT00998296|528840923|FG009|Overall Study|Refused to continue taking trial med.|2|||
146635522|NCT00998296|528840924|FG010|Overall Study|Refused to continue taking trial med.|0|||
146635523|NCT00998296|528840914|FG000|Overall Study|Reason other than those specified above|0|||
146635524|NCT00998296|528840915|FG001|Overall Study|Reason other than those specified above|0|||
146635525|NCT00998296|528840916|FG002|Overall Study|Reason other than those specified above|0|||
146635526|NCT00998296|528840917|FG003|Overall Study|Reason other than those specified above|0|||
146887845|NCT02475655|529755811|FG001|Overall Study|Lost to Follow-up|1|||
146635527|NCT00998296|528840918|FG004|Overall Study|Reason other than those specified above|0|||
146554811|NCT00090402|528540438|FG000|Overall Study|Death|1|||
146554812|NCT00090402|528540439|FG001|Overall Study|Death|1|||
146554813|NCT00090402|528540440|FG002|Overall Study|Death|0|||
146554814|NCT00090402|528540438|FG000|Overall Study|subject moved|0|||
146554815|NCT00090402|528540439|FG001|Overall Study|subject moved|1|||
146554816|NCT00090402|528540440|FG002|Overall Study|subject moved|0|||
146554817|NCT00090402|528540438|FG000|Overall Study|stopped taking study medication|1|||
146554818|NCT00090402|528540439|FG001|Overall Study|stopped taking study medication|0|||
146554819|NCT00090402|528540440|FG002|Overall Study|stopped taking study medication|1|||
146554820|NCT01730729|528540443|FG000|Overall Study|Adverse Event|1|||
146554821|NCT01730729|528540443|FG000|Overall Study|Death|1|||
146554822|NCT01730729|528540443|FG000|Overall Study|Progressive Disease|12|||
146635528|NCT00998296|528840919|FG005|Overall Study|Reason other than those specified above|0|||
146554823|NCT00871000|528540444|FG000|Overall Study|Withdrawal by Subject|1|||
146554824|NCT00871000|528540445|FG001|Overall Study|Withdrawal by Subject|0|||
146635529|NCT00998296|528840920|FG006|Overall Study|Reason other than those specified above|0|||
146635530|NCT00998296|528840921|FG007|Overall Study|Reason other than those specified above|0|||
146635531|NCT00998296|528840922|FG008|Overall Study|Reason other than those specified above|0|||
146554825|NCT02402907|528540448|FG000|Overall Study|Delivered vaginally|9|||
146554826|NCT02402907|528540449|FG001|Overall Study|Delivered vaginally|3|||
146554827|NCT02402907|528540448|FG000|Overall Study|Delivered outside of Sinai|1|||
146554828|NCT02402907|528540449|FG001|Overall Study|Delivered outside of Sinai|1|||
146554829|NCT02402907|528540448|FG000|Overall Study|Lost to follow up after C-Section|10|||
146554830|NCT02402907|528540449|FG001|Overall Study|Lost to follow up after C-Section|23|||
146554831|NCT01716559|528540450|FG000|Overall Study|Adverse Event|11|||
146554832|NCT01716559|528540450|FG000|Overall Study|Death|21|||
146554833|NCT01716559|528540450|FG000|Overall Study|Withdrawal by Subject|4|||
146554834|NCT01716559|528540450|FG000|Overall Study|Other withdrawal reason|75|||
146554835|NCT02771145|528540458|FG000|Overall Study|Adverse Event|3|||
146554836|NCT02771145|528540458|FG000|Overall Study|Lost to Follow-up|1|||
146554837|NCT00276380|528540459|FG000|Overall Study|Adverse Event|5|||
146554838|NCT00276380|528540460|FG001|Overall Study|Adverse Event|3|||
146554839|NCT00276380|528540459|FG000|Overall Study|Lost to Follow-up|1|||
146554840|NCT00276380|528540460|FG001|Overall Study|Lost to Follow-up|1|||
146554841|NCT00276380|528540459|FG000|Overall Study|Withdrawal by Subject|3|||
146554842|NCT00276380|528540460|FG001|Overall Study|Withdrawal by Subject|6|||
146554843|NCT00276380|528540459|FG000|Overall Study|Death|5|||
146554844|NCT00276380|528540460|FG001|Overall Study|Death|3|||
146554845|NCT00276380|528540459|FG000|Overall Study|Abnormal aPPT Levels|0|||
146554846|NCT00276380|528540460|FG001|Overall Study|Abnormal aPPT Levels|1|||
146554847|NCT01651208|528540465|FG000|Overall Study|Lost to Follow-up|14|||
146554848|NCT01651208|528540466|FG001|Overall Study|Lost to Follow-up|16|||
146554849|NCT02067156|528540470|FG000|Overall Study|Lost to Follow-up|4|||
146554850|NCT03596983|528540471|FG000|Overall Study|Withdrawal by Subject|3|||
146554851|NCT03473301|528540472|FG000|Overall Study|Protocol Violation|4|||
146554852|NCT03473301|528540473|FG001|Overall Study|Protocol Violation|0|||
146554853|NCT03473301|528540474|FG002|Overall Study|Protocol Violation|0|||
146554854|NCT03473301|528540472|FG000|Overall Study|Withdrawal by Subject|0|||
146554855|NCT03473301|528540473|FG001|Overall Study|Withdrawal by Subject|1|||
146554856|NCT03473301|528540474|FG002|Overall Study|Withdrawal by Subject|0|||
146554857|NCT03473301|528540472|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
146554858|NCT03473301|528540473|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
146554859|NCT03473301|528540474|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
146554860|NCT04829214|528540475|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
146554861|NCT04829214|528540476|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
146554862|NCT04829214|528540475|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
146554863|NCT04829214|528540476|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
146554864|NCT05287685|528540477|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
146554865|NCT05287685|528540478|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
146554866|NCT05287685|528540477|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
146554867|NCT05287685|528540478|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
146554868|NCT02965976|528540479|FG000|Overall Study|Withdrawal by Subject|2|||
146554869|NCT02965976|528540480|FG001|Overall Study|Withdrawal by Subject|0|||
146554870|NCT02134028|528540481|FG000|Overall Study|Lack of Efficacy|1|||
146554871|NCT02134028|528540482|FG001|Overall Study|Lack of Efficacy|0|||
146554872|NCT02134028|528540483|FG002|Overall Study|Lack of Efficacy|3|||
146554873|NCT02134028|528540484|FG003|Overall Study|Lack of Efficacy|2|||
146554874|NCT02134028|528540485|FG004|Overall Study|Lack of Efficacy|1|||
146554875|NCT02134028|528540486|FG005|Overall Study|Lack of Efficacy|2|||
146554876|NCT02134028|528540487|FG006|Overall Study|Lack of Efficacy|1|||
146554877|NCT02134028|528540488|FG007|Overall Study|Lack of Efficacy|0|||
146554878|NCT02134028|528540481|FG000|Overall Study|Poor compliance to protocol|1|||
146554879|NCT02134028|528540482|FG001|Overall Study|Poor compliance to protocol|1|||
146554880|NCT02134028|528540483|FG002|Overall Study|Poor compliance to protocol|3|||
146554881|NCT02134028|528540484|FG003|Overall Study|Poor compliance to protocol|7|||
146554882|NCT02134028|528540485|FG004|Overall Study|Poor compliance to protocol|1|||
146554883|NCT02134028|528540486|FG005|Overall Study|Poor compliance to protocol|1|||
146554884|NCT02134028|528540487|FG006|Overall Study|Poor compliance to protocol|0|||
146554885|NCT02134028|528540488|FG007|Overall Study|Poor compliance to protocol|0|||
146966809|NCT01058707|530038919|FG006|Overall Study|Adverse Event|1|||
146635532|NCT00998296|528840923|FG009|Overall Study|Reason other than those specified above|1|||
146635533|NCT00998296|528840924|FG010|Overall Study|Reason other than those specified above|0|||
146635534|NCT04396639|528840925|FG000|Overall Study|Withdrawal by Subject|1|||
146554886|NCT02134028|528540481|FG000|Overall Study|Other unspecified|4|||
146554887|NCT02134028|528540482|FG001|Overall Study|Other unspecified|22|||
146554888|NCT02134028|528540483|FG002|Overall Study|Other unspecified|33|||
146635535|NCT04396639|528840925|FG000|Overall Study|Other|1|||
146635536|NCT01544335|528840926|FG000|Overall Study|Lost to Follow-up|27|||
146635537|NCT01544335|528840926|FG000|Overall Study|Death|4|||
146635538|NCT01544335|528840926|FG000|Overall Study|Disease progression|3|||
146635539|NCT01544335|528840926|FG000|Overall Study|Baseline Measurements not Available|19|||
146635540|NCT03219528|528840933|FG000|Overall Study|Lost to Follow-up|5|||
146635541|NCT03219528|528840934|FG001|Overall Study|Lost to Follow-up|4|||
146635542|NCT03219528|528840933|FG000|Overall Study|Withdrawal by Subject|4|||
146635543|NCT03219528|528840934|FG001|Overall Study|Withdrawal by Subject|4|||
146635544|NCT00241839|528840935|FG000|Overall Study|Withdrawal by Subject|18|||
146635545|NCT00241839|528840936|FG001|Overall Study|Withdrawal by Subject|17|||
146635546|NCT00241839|528840935|FG000|Overall Study|Adverse Event|1|||
146635547|NCT00241839|528840936|FG001|Overall Study|Adverse Event|1|||
146635548|NCT00927953|528840939|FG000|Overall Study|Death|2|||
146635549|NCT00927953|528840940|FG001|Overall Study|Death|1|||
146635550|NCT00196313|528840943|FG000|Overall Study|Protocol Violation|2|||
146635551|NCT00196313|528840944|FG001|Overall Study|Protocol Violation|3|||
146635552|NCT00196313|528840943|FG000|Overall Study|Withdrawal by Subject|3|||
146635553|NCT00196313|528840944|FG001|Overall Study|Withdrawal by Subject|1|||
146635554|NCT00196313|528840943|FG000|Overall Study|Adverse Event|3|||
146635555|NCT00196313|528840944|FG001|Overall Study|Adverse Event|1|||
146635556|NCT00196313|528840943|FG000|Overall Study|Subject Pregnant|1|||
146635557|NCT00196313|528840944|FG001|Overall Study|Subject Pregnant|1|||
146635558|NCT00196313|528840943|FG000|Overall Study|Lost to Follow-up|2|||
146635559|NCT00196313|528840944|FG001|Overall Study|Lost to Follow-up|2|||
146554889|NCT02134028|528540484|FG003|Overall Study|Other unspecified|64|||
146554890|NCT02134028|528540485|FG004|Overall Study|Other unspecified|8|||
146554891|NCT02134028|528540486|FG005|Overall Study|Other unspecified|6|||
146554892|NCT02134028|528540487|FG006|Overall Study|Other unspecified|2|||
146554893|NCT02134028|528540488|FG007|Overall Study|Other unspecified|1|||
146554894|NCT02134028|528540481|FG000|Overall Study|Adverse Event|3|||
146554895|NCT02134028|528540482|FG001|Overall Study|Adverse Event|19|||
146554896|NCT02134028|528540483|FG002|Overall Study|Adverse Event|13|||
146635560|NCT00043979|528840945|FG000|Period 1|recipient with progressive disease|7|||
146635561|NCT00043979|528840946|FG001|Period 1|recipient with progressive disease|4|||
146966810|NCT01058707|530038913|FG000|Overall Study|Subject Decision|5|||
146554897|NCT02134028|528540484|FG003|Overall Study|Adverse Event|32|||
146554898|NCT02134028|528540485|FG004|Overall Study|Adverse Event|4|||
146554899|NCT02134028|528540486|FG005|Overall Study|Adverse Event|5|||
146635562|NCT00043979|528840947|FG002|Period 1|recipient with progressive disease|3|||
146635563|NCT03096288|528840948|FG000|Overall Study|Withdrawal by Subject|0|||
146554900|NCT02134028|528540487|FG006|Overall Study|Adverse Event|1|||
146554901|NCT02134028|528540488|FG007|Overall Study|Adverse Event|2|||
146887846|NCT00257010|529755812|FG000|Overall Study|Lack of Efficacy|11|||
146554902|NCT00806026|528540489|FG000|Overall Study|Death|0|||
146554903|NCT00806026|528540490|FG001|Overall Study|Death|0|||
146554904|NCT00806026|528540491|FG002|Overall Study|Death|0|||
146554905|NCT00806026|528540492|FG003|Overall Study|Death|1|||
146554906|NCT00806026|528540493|FG004|Overall Study|Death|0|||
146554907|NCT00806026|528540494|FG005|Overall Study|Death|0|||
146554908|NCT00806026|528540489|FG000|Overall Study|Did not meet entrance criteria|4|||
146554909|NCT00806026|528540490|FG001|Overall Study|Did not meet entrance criteria|1|||
146554910|NCT00806026|528540491|FG002|Overall Study|Did not meet entrance criteria|2|||
146554911|NCT00806026|528540492|FG003|Overall Study|Did not meet entrance criteria|1|||
146554912|NCT00806026|528540493|FG004|Overall Study|Did not meet entrance criteria|0|||
146554913|NCT00806026|528540494|FG005|Overall Study|Did not meet entrance criteria|0|||
146554914|NCT00806026|528540489|FG000|Overall Study|Lack of Efficacy|5|||
146554915|NCT00806026|528540490|FG001|Overall Study|Lack of Efficacy|18|||
146554916|NCT00806026|528540491|FG002|Overall Study|Lack of Efficacy|13|||
146554917|NCT00806026|528540492|FG003|Overall Study|Lack of Efficacy|4|||
146554918|NCT00806026|528540493|FG004|Overall Study|Lack of Efficacy|8|||
146554919|NCT00806026|528540494|FG005|Overall Study|Lack of Efficacy|7|||
146554920|NCT00806026|528540489|FG000|Overall Study|Lost to Follow-up|8|||
146554921|NCT00806026|528540490|FG001|Overall Study|Lost to Follow-up|15|||
146554922|NCT00806026|528540491|FG002|Overall Study|Lost to Follow-up|8|||
146554923|NCT00806026|528540492|FG003|Overall Study|Lost to Follow-up|2|||
146554924|NCT00806026|528540493|FG004|Overall Study|Lost to Follow-up|6|||
146554925|NCT00806026|528540494|FG005|Overall Study|Lost to Follow-up|6|||
146554926|NCT00806026|528540489|FG000|Overall Study|Withdrawal by Subject|14|||
146554927|NCT00806026|528540490|FG001|Overall Study|Withdrawal by Subject|17|||
146554928|NCT00806026|528540491|FG002|Overall Study|Withdrawal by Subject|9|||
146554929|NCT00806026|528540492|FG003|Overall Study|Withdrawal by Subject|2|||
146554930|NCT00806026|528540493|FG004|Overall Study|Withdrawal by Subject|5|||
146554931|NCT00806026|528540494|FG005|Overall Study|Withdrawal by Subject|3|||
146554932|NCT00806026|528540489|FG000|Overall Study|Other|3|||
146554933|NCT00806026|528540490|FG001|Overall Study|Other|6|||
146554934|NCT00806026|528540491|FG002|Overall Study|Other|8|||
146554935|NCT00806026|528540492|FG003|Overall Study|Other|2|||
146554936|NCT00806026|528540493|FG004|Overall Study|Other|0|||
146554937|NCT00806026|528540494|FG005|Overall Study|Other|4|||
146554938|NCT00806026|528540489|FG000|Overall Study|Protocol Violation|6|||
146554939|NCT00806026|528540490|FG001|Overall Study|Protocol Violation|9|||
146554940|NCT00806026|528540491|FG002|Overall Study|Protocol Violation|9|||
146554941|NCT00806026|528540492|FG003|Overall Study|Protocol Violation|0|||
146554942|NCT00806026|528540493|FG004|Overall Study|Protocol Violation|2|||
146554943|NCT00806026|528540494|FG005|Overall Study|Protocol Violation|3|||
146554944|NCT00806026|528540489|FG000|Overall Study|Adverse Event|52|||
146554945|NCT00806026|528540490|FG001|Overall Study|Adverse Event|35|||
146554946|NCT00806026|528540491|FG002|Overall Study|Adverse Event|44|||
146554947|NCT00806026|528540492|FG003|Overall Study|Adverse Event|17|||
146554948|NCT00806026|528540493|FG004|Overall Study|Adverse Event|9|||
146554949|NCT00806026|528540494|FG005|Overall Study|Adverse Event|9|||
146554950|NCT01370642|528540495|FG000|Overall Study|Adverse Event|2|||
146554951|NCT01370642|528540496|FG001|Overall Study|Adverse Event|1|||
146554952|NCT01370642|528540497|FG002|Overall Study|Adverse Event|1|||
146554953|NCT01370642|528540495|FG000|Overall Study|Detectable HCV RNA|0|||
146554954|NCT01370642|528540496|FG001|Overall Study|Detectable HCV RNA|0|||
146554955|NCT01370642|528540497|FG002|Overall Study|Detectable HCV RNA|22|||
146554956|NCT01370642|528540495|FG000|Overall Study|Lost to Follow-up|0|||
146554957|NCT01370642|528540496|FG001|Overall Study|Lost to Follow-up|0|||
146554958|NCT01370642|528540497|FG002|Overall Study|Lost to Follow-up|1|||
146554959|NCT01370642|528540495|FG000|Overall Study|Physician Decision|4|||
146554960|NCT01370642|528540496|FG001|Overall Study|Physician Decision|1|||
146554961|NCT01370642|528540497|FG002|Overall Study|Physician Decision|2|||
146554962|NCT01370642|528540495|FG000|Overall Study|Withdrawal by Subject|2|||
146554963|NCT01370642|528540496|FG001|Overall Study|Withdrawal by Subject|4|||
146554964|NCT01370642|528540497|FG002|Overall Study|Withdrawal by Subject|3|||
146554965|NCT03721107|528540504|FG000|Overall Study|Adverse Event|1|||
146887847|NCT00257010|529755812|FG000|Overall Study|Lost to Follow-up|53|||
146887848|NCT00257010|529755812|FG000|Overall Study|Withdrawal by Subject|34|||
146554966|NCT03721107|528540505|FG001|Overall Study|Adverse Event|1|||
146554967|NCT03721107|528540506|FG002|Overall Study|Adverse Event|6|||
146554968|NCT03721107|528540507|FG003|Overall Study|Adverse Event|5|||
146554969|NCT03721107|528540504|FG000|Overall Study|Lost to Follow-up|2|||
146554970|NCT03721107|528540505|FG001|Overall Study|Lost to Follow-up|0|||
146554971|NCT03721107|528540506|FG002|Overall Study|Lost to Follow-up|3|||
146554972|NCT03721107|528540507|FG003|Overall Study|Lost to Follow-up|0|||
146554973|NCT03721107|528540504|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
146554974|NCT03721107|528540505|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
146887849|NCT00257010|529755812|FG000|Overall Study|Adverse Event|10|||
146554975|NCT03721107|528540506|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
146765333|NCT02469064|529308622|FG001|Overall Study|Request not to receive intervention.|3|||
146765334|NCT01585038|529308623|FG000|Overall Study|Adverse Event|2|||
146554976|NCT03721107|528540507|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
146554977|NCT03721107|528540504|FG000|Overall Study|Physician Decision|0|||
146554978|NCT03721107|528540505|FG001|Overall Study|Physician Decision|1|||
146554979|NCT03721107|528540506|FG002|Overall Study|Physician Decision|0|||
146554980|NCT03721107|528540507|FG003|Overall Study|Physician Decision|0|||
146554981|NCT03721107|528540504|FG000|Overall Study|Pregnancy|0|||
146554982|NCT03721107|528540505|FG001|Overall Study|Pregnancy|0|||
146554983|NCT03721107|528540506|FG002|Overall Study|Pregnancy|1|||
146554984|NCT03721107|528540507|FG003|Overall Study|Pregnancy|0|||
146554985|NCT03721107|528540504|FG000|Overall Study|Withdrawal by Subject|1|||
146554986|NCT03721107|528540505|FG001|Overall Study|Withdrawal by Subject|1|||
146554987|NCT03721107|528540506|FG002|Overall Study|Withdrawal by Subject|5|||
146966811|NCT01058707|530038914|FG001|Overall Study|Subject Decision|3|||
146966812|NCT01058707|530038915|FG002|Overall Study|Subject Decision|3|||
146554988|NCT03721107|528540507|FG003|Overall Study|Withdrawal by Subject|5|||
146554989|NCT03721107|528540504|FG000|Overall Study|Other|1|||
146554990|NCT03721107|528540505|FG001|Overall Study|Other|0|||
146554991|NCT03721107|528540506|FG002|Overall Study|Other|0|||
146554992|NCT03721107|528540507|FG003|Overall Study|Other|1|||
146554993|NCT02294019|528540508|FG000|Overall Study|Adverse Event|2|||
146554994|NCT02294019|528540508|FG000|Overall Study|Protocol Violation|68|||
146554995|NCT02294019|528540508|FG000|Overall Study|Lost to Follow-up|31|||
146635564|NCT03096288|528840949|FG001|Overall Study|Withdrawal by Subject|1|||
146635565|NCT03096288|528840950|FG002|Overall Study|Withdrawal by Subject|0|||
146635566|NCT03096288|528840951|FG003|Overall Study|Withdrawal by Subject|1|||
146635567|NCT01635153|528840954|FG000|Overall Study|Lost to Follow-up|40|||
146554996|NCT02294019|528540508|FG000|Overall Study|Other|1|||
146635568|NCT01635153|528840955|FG001|Overall Study|Lost to Follow-up|43|||
146635569|NCT00297258|528840966|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
146966813|NCT01058707|530038916|FG003|Overall Study|Subject Decision|1|||
146554997|NCT02294019|528540508|FG000|Overall Study|Withdrawal by Subject|1|||
146554998|NCT06048705|528540510|FG000|Overall Study|Physician Decision|1|||
146554999|NCT06048705|528540511|FG001|Overall Study|Physician Decision|0|||
146635570|NCT00297258|528840966|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
146635571|NCT00297258|528840966|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
146635572|NCT00297258|528840966|FG000|Overall Study|Intercurrent Illness|3|||
146635573|NCT00297258|528840966|FG000|Overall Study|Intercurrent Death|2|||
146635574|NCT00297258|528840966|FG000|Overall Study|Deteriorization of General Condition|1|||
146635575|NCT00297258|528840966|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
146635576|NCT00297258|528840966|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
146635577|NCT00297258|528840966|FG000|Overall Study|Switch to Commercial Treatment|1|||
146635578|NCT00297258|528840966|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
146635579|NCT01470326|528840967|FG000|Overall Study|Protocol Violation|32|||
146635580|NCT01470326|528840967|FG000|Overall Study|No Drug Administration Information|2|||
146555000|NCT06048705|528540512|FG002|Overall Study|Physician Decision|0|||
146555001|NCT06048705|528540510|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
146555002|NCT06048705|528540511|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
146555003|NCT06048705|528540512|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
146555004|NCT06048705|528540510|FG000|Overall Study|Death prior to lymphodepletion|0|||
146555005|NCT06048705|528540511|FG001|Overall Study|Death prior to lymphodepletion|0|||
146555006|NCT06048705|528540512|FG002|Overall Study|Death prior to lymphodepletion|1|||
146635581|NCT01470326|528840967|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
146635582|NCT03967444|528840968|FG000|Overall Study|Lost to Follow-up|1|||
146635583|NCT03967444|528840969|FG001|Overall Study|Lost to Follow-up|2|||
146635584|NCT02892448|528840970|FG000|Overall Study|Screening failure|2|||
146635585|NCT02892448|528840971|FG001|Overall Study|Screening failure|2|||
146635586|NCT02892448|528840972|FG002|Overall Study|Screening failure|1|||
146635587|NCT01519921|528840978|FG000|Overall Study|Adverse Event|10|||
146635588|NCT01519921|528840979|FG001|Overall Study|Adverse Event|9|||
146635589|NCT01519921|528840978|FG000|Overall Study|Lack of Efficacy|4|||
146635590|NCT01519921|528840979|FG001|Overall Study|Lack of Efficacy|3|||
146887850|NCT00257010|529755812|FG000|Overall Study|various|11|||
146887851|NCT00257010|529755812|FG000|Overall Study|no headache reported|9|||
146887852|NCT00441545|529755813|FG000|First Intervention|Adverse Event|6|||
146635591|NCT01519921|528840978|FG000|Overall Study|Withdrawal by Subject|3|||
146635592|NCT01519921|528840979|FG001|Overall Study|Withdrawal by Subject|0|||
146635593|NCT01519921|528840978|FG000|Overall Study|Lost to Follow-up|2|||
146635594|NCT01519921|528840979|FG001|Overall Study|Lost to Follow-up|1|||
146635595|NCT01519921|528840978|FG000|Overall Study|Treatment refusal|2|||
146635596|NCT01519921|528840979|FG001|Overall Study|Treatment refusal|1|||
146635597|NCT01519921|528840978|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
146635598|NCT01519921|528840979|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
146635599|NCT01216189|528840981|FG000|Overall Study|Lost to Follow-up|21|||
146635600|NCT01216189|528840982|FG001|Overall Study|Lost to Follow-up|3|||
146635601|NCT01216189|528840981|FG000|Overall Study|Death|4|||
146635602|NCT01216189|528840982|FG001|Overall Study|Death|2|||
146635603|NCT00541385|528840983|FG000|Overall Study|Adverse Event|6|||
146635604|NCT00541385|528840984|FG001|Overall Study|Adverse Event|3|||
146635605|NCT00541385|528840983|FG000|Overall Study|Withdrawal by Subject|2|||
146635606|NCT00541385|528840984|FG001|Overall Study|Withdrawal by Subject|2|||
146635607|NCT00541385|528840983|FG000|Overall Study|Lost to Follow-up|6|||
146635608|NCT00541385|528840984|FG001|Overall Study|Lost to Follow-up|1|||
146635609|NCT00541385|528840983|FG000|Overall Study|Parasite reappearance/malaria|67|||
146635610|NCT00541385|528840984|FG001|Overall Study|Parasite reappearance/malaria|32|||
146635611|NCT01733680|528840985|FG000|Overall Study|Withdrawal by Subject|0|||
146635612|NCT01733680|528840986|FG001|Overall Study|Withdrawal by Subject|1|||
146635613|NCT04269889|528840988|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
146635614|NCT01721044|528840989|FG000|Treatment Period|Adverse Event|7|||
146635615|NCT01721044|528840990|FG001|Treatment Period|Adverse Event|7|||
146635616|NCT01721044|528840991|FG002|Treatment Period|Adverse Event|10|||
146887853|NCT00441545|529755814|FG001|First Intervention|Adverse Event|5|||
146635617|NCT01721044|528840989|FG000|Treatment Period|Death|0|||
146887854|NCT00441545|529755813|FG000|First Intervention|Protocol Violation|2|||
146887855|NCT00441545|529755814|FG001|First Intervention|Protocol Violation|2|||
146887856|NCT00441545|529755813|FG000|First Intervention|Withdrawal by Subject|3|||
146887857|NCT00441545|529755814|FG001|First Intervention|Withdrawal by Subject|3|||
146887858|NCT00441545|529755813|FG000|First Intervention|Kidney transplant|1|||
146887859|NCT00441545|529755814|FG001|First Intervention|Kidney transplant|1|||
146887860|NCT00441545|529755813|FG000|First Intervention|Lack of Efficacy|2|||
146887861|NCT00441545|529755814|FG001|First Intervention|Lack of Efficacy|0|||
146887862|NCT00441545|529755813|FG000|First Intervention|Subject exceeded safety criteria|0|||
146887863|NCT00441545|529755814|FG001|First Intervention|Subject exceeded safety criteria|1|||
146887864|NCT00441545|529755813|FG000|First Intervention|Subject met an exclusionary criteria|1|||
146635618|NCT01721044|528840990|FG001|Treatment Period|Death|0|||
146635619|NCT01721044|528840991|FG002|Treatment Period|Death|1|||
146635620|NCT01721044|528840989|FG000|Treatment Period|Lack of Efficacy|16|||
146635621|NCT01721044|528840990|FG001|Treatment Period|Lack of Efficacy|4|||
146635622|NCT01721044|528840991|FG002|Treatment Period|Lack of Efficacy|4|||
146635623|NCT01721044|528840989|FG000|Treatment Period|Lost to Follow-up|0|||
146635624|NCT01721044|528840990|FG001|Treatment Period|Lost to Follow-up|0|||
146635625|NCT01721044|528840991|FG002|Treatment Period|Lost to Follow-up|1|||
146635626|NCT01721044|528840989|FG000|Treatment Period|Physician Decision|1|||
146635627|NCT01721044|528840990|FG001|Treatment Period|Physician Decision|0|||
146635628|NCT01721044|528840991|FG002|Treatment Period|Physician Decision|2|||
146635629|NCT01721044|528840989|FG000|Treatment Period|Protocol Violation|1|||
146635630|NCT01721044|528840990|FG001|Treatment Period|Protocol Violation|0|||
146635631|NCT01721044|528840991|FG002|Treatment Period|Protocol Violation|0|||
146635632|NCT01721044|528840989|FG000|Treatment Period|Withdrawal by Subject|7|||
146635633|NCT01721044|528840990|FG001|Treatment Period|Withdrawal by Subject|6|||
146635634|NCT01721044|528840991|FG002|Treatment Period|Withdrawal by Subject|1|||
146887865|NCT00441545|529755814|FG001|First Intervention|Subject met an exclusionary criteria|0|||
146887866|NCT00441545|529755813|FG000|First Intervention|Extended hospitalization|1|||
146887867|NCT00441545|529755814|FG001|First Intervention|Extended hospitalization|0|||
146635635|NCT03155841|528840994|FG000|Overall Study|Protocol Violation|3|||
146635636|NCT03155841|528840995|FG001|Overall Study|Protocol Violation|4|||
146635637|NCT01526733|528840996|FG000|Phase 1|Protocol Violation|1|||
146635638|NCT01526733|528840997|FG001|Phase 1|Protocol Violation|0|||
146635639|NCT01526733|528840996|FG000|Phase 1|Withdrawal by Subject|1|||
146635640|NCT01526733|528840997|FG001|Phase 1|Withdrawal by Subject|1|||
146635641|NCT04032093|528840998|FG000|Overall Study|Lost to Follow-up|7|||
146635642|NCT04032093|528840999|FG001|Overall Study|Lost to Follow-up|7|||
146635643|NCT04032093|528841000|FG002|Overall Study|Lost to Follow-up|6|||
146635644|NCT04032093|528841001|FG003|Overall Study|Lost to Follow-up|10|||
146635645|NCT04032093|528841002|FG004|Overall Study|Lost to Follow-up|13|||
146635646|NCT04032093|528841003|FG005|Overall Study|Lost to Follow-up|7|||
146635647|NCT04032093|528841004|FG006|Overall Study|Lost to Follow-up|7|||
146635648|NCT04032093|528841005|FG007|Overall Study|Lost to Follow-up|5|||
146635649|NCT04032093|528841006|FG008|Overall Study|Lost to Follow-up|9|||
146635650|NCT04032093|528841007|FG009|Overall Study|Lost to Follow-up|12|||
146635651|NCT04032093|528840998|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
146635652|NCT04032093|528840999|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146635653|NCT04032093|528841000|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
146765335|NCT01585038|529308624|FG001|Overall Study|Adverse Event|2|||
146635654|NCT04032093|528841001|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
146635655|NCT04032093|528841002|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
146635656|NCT04032093|528841003|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
146635657|NCT04032093|528841004|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
146635658|NCT04032093|528841005|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
146635659|NCT04032093|528841006|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
146635660|NCT04032093|528841007|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
146635661|NCT04032093|528840998|FG000|Overall Study|Other|1|||
146635662|NCT04032093|528840999|FG001|Overall Study|Other|0|||
146635663|NCT04032093|528841000|FG002|Overall Study|Other|0|||
146635664|NCT04032093|528841001|FG003|Overall Study|Other|1|||
146635665|NCT04032093|528841002|FG004|Overall Study|Other|1|||
146635666|NCT04032093|528841003|FG005|Overall Study|Other|0|||
146635667|NCT04032093|528841004|FG006|Overall Study|Other|0|||
146635668|NCT04032093|528841005|FG007|Overall Study|Other|0|||
146635669|NCT04032093|528841006|FG008|Overall Study|Other|0|||
146635670|NCT04032093|528841007|FG009|Overall Study|Other|1|||
146635671|NCT04032093|528840998|FG000|Overall Study|Withdrawal by Subject|1|||
146635672|NCT04032093|528840999|FG001|Overall Study|Withdrawal by Subject|3|||
146635673|NCT04032093|528841000|FG002|Overall Study|Withdrawal by Subject|2|||
146635674|NCT04032093|528841001|FG003|Overall Study|Withdrawal by Subject|2|||
146635675|NCT04032093|528841002|FG004|Overall Study|Withdrawal by Subject|3|||
146635676|NCT04032093|528841003|FG005|Overall Study|Withdrawal by Subject|0|||
146635677|NCT04032093|528841004|FG006|Overall Study|Withdrawal by Subject|0|||
146635678|NCT04032093|528841005|FG007|Overall Study|Withdrawal by Subject|0|||
146635679|NCT04032093|528841006|FG008|Overall Study|Withdrawal by Subject|0|||
146635680|NCT04032093|528841007|FG009|Overall Study|Withdrawal by Subject|0|||
146635681|NCT04032093|528840998|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146635682|NCT04032093|528840999|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146635683|NCT04032093|528841000|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146635684|NCT04032093|528841001|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146635685|NCT04032093|528841002|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
146635686|NCT04032093|528841003|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
146635687|NCT04032093|528841004|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
146635688|NCT04032093|528841005|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
146635689|NCT04032093|528841006|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
146635690|NCT04032093|528841007|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
146635691|NCT04032093|528840998|FG000|Overall Study|Adverse Event|0|||
146635692|NCT04032093|528840999|FG001|Overall Study|Adverse Event|0|||
146635693|NCT04032093|528841000|FG002|Overall Study|Adverse Event|0|||
146635694|NCT04032093|528841001|FG003|Overall Study|Adverse Event|0|||
146635695|NCT04032093|528841002|FG004|Overall Study|Adverse Event|0|||
146765336|NCT02046616|529308627|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
146765337|NCT02046616|529308627|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
146765338|NCT02046616|529308627|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
146765339|NCT02046616|529308627|FG000|24-Week Treatment Period|Physician Decision|3|||
146765340|NCT02046616|529308627|FG000|24-Week Treatment Period|Other|1|||
146765341|NCT02046616|529308627|FG000|8-Week FU Period|Lost to Follow-up|1|||
146765342|NCT01833832|529308631|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
146765343|NCT04842604|529308632|FG000|Overall Study|Death|1|||
146765344|NCT04842604|529308633|FG001|Overall Study|Death|0|||
146765345|NCT04842604|529308632|FG000|Overall Study|Other|4|||
146765346|NCT04842604|529308633|FG001|Overall Study|Other|4|||
146765347|NCT04842604|529308632|FG000|Overall Study|Randomized but not treated|1|||
146765348|NCT04842604|529308633|FG001|Overall Study|Randomized but not treated|0|||
146765349|NCT00344019|529308635|FG000|Overall Study|did not meet final inclusion criteria|0|||
146765350|NCT00344019|529308636|FG001|Overall Study|did not meet final inclusion criteria|0|||
146765351|NCT00344019|529308637|FG002|Overall Study|did not meet final inclusion criteria|74|||
146765352|NCT02503202|529308638|FG000|Base Study: Up to Month 6|Death|1|||
146765353|NCT02503202|529308639|FG001|Base Study: Up to Month 6|Death|1|||
146765354|NCT02503202|529308640|FG002|Base Study: Up to Month 6|Death|0|||
146765355|NCT02503202|529308641|FG003|Base Study: Up to Month 6|Death|0|||
146765356|NCT02503202|529308642|FG004|Base Study: Up to Month 6|Death|0|||
146765357|NCT02503202|529308638|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
146887868|NCT00441545|529755813|FG000|First Intervention|Site error|1|||
146887869|NCT00441545|529755814|FG001|First Intervention|Site error|0|||
146887870|NCT00441545|529755813|FG000|First Intervention|Sponsor's request|1|||
146887871|NCT00441545|529755814|FG001|First Intervention|Sponsor's request|0|||
146887872|NCT00441545|529755813|FG000|Second Intervention|Adverse Event|5|||
146887873|NCT00441545|529755814|FG001|Second Intervention|Adverse Event|2|||
146887874|NCT00441545|529755813|FG000|Second Intervention|Protocol Violation|4|||
146887875|NCT00441545|529755814|FG001|Second Intervention|Protocol Violation|1|||
146887876|NCT00441545|529755813|FG000|Second Intervention|Withdrawal by Subject|1|||
146887877|NCT00441545|529755814|FG001|Second Intervention|Withdrawal by Subject|1|||
146887878|NCT00441545|529755813|FG000|Second Intervention|Kidney Transplant|1|||
146887879|NCT00441545|529755814|FG001|Second Intervention|Kidney Transplant|1|||
146887880|NCT00441545|529755813|FG000|Second Intervention|Lack of Efficacy|0|||
146887881|NCT00441545|529755814|FG001|Second Intervention|Lack of Efficacy|1|||
146887882|NCT00441545|529755813|FG000|Second Intervention|Subject exceeded safety criteria|1|||
146887883|NCT00441545|529755814|FG001|Second Intervention|Subject exceeded safety criteria|0|||
146887884|NCT00441545|529755813|FG000|Second Intervention|Subject moved|0|||
146887885|NCT00441545|529755814|FG001|Second Intervention|Subject moved|1|||
146887886|NCT00411554|529755815|FG000|Overall Study|Adverse Event|2|||
146887887|NCT00411554|529755816|FG001|Overall Study|Adverse Event|4|||
146966814|NCT01058707|530038917|FG004|Overall Study|Subject Decision|2|||
146887888|NCT00411554|529755815|FG000|Overall Study|Lack of Efficacy|2|||
146887889|NCT00411554|529755816|FG001|Overall Study|Lack of Efficacy|5|||
146887890|NCT00411554|529755815|FG000|Overall Study|Withdrawal by Subject|3|||
146887891|NCT00411554|529755816|FG001|Overall Study|Withdrawal by Subject|0|||
146887892|NCT00411554|529755815|FG000|Overall Study|Patient Moved|1|||
146887893|NCT00411554|529755816|FG001|Overall Study|Patient Moved|0|||
146887894|NCT00699907|529755821|FG000|Overall Study|Withdrawal by Subject|2|||
146555007|NCT00968968|528540513|FG000|Overall Study|Study closed/terminated|10|||
146555008|NCT00968968|528540514|FG001|Overall Study|Study closed/terminated|10|||
146555009|NCT00968968|528540513|FG000|Overall Study|Protocol defined stopping criteria|3|||
146555010|NCT00968968|528540514|FG001|Overall Study|Protocol defined stopping criteria|1|||
146555011|NCT00968968|528540513|FG000|Overall Study|Withdrawal by Subject|2|||
146555012|NCT00968968|528540514|FG001|Overall Study|Withdrawal by Subject|0|||
146555013|NCT00968968|528540513|FG000|Overall Study|Physician Decision|1|||
146555014|NCT00968968|528540514|FG001|Overall Study|Physician Decision|2|||
146555015|NCT00968968|528540513|FG000|Overall Study|Lost to Follow-up|0|||
146555016|NCT00968968|528540514|FG001|Overall Study|Lost to Follow-up|1|||
146555017|NCT01185366|528540515|FG000|First Line Therapy|Insurance Coverage Denied|1|||
146555018|NCT01185366|528540516|FG001|First Line Therapy|Insurance Coverage Denied|1|||
146555019|NCT01185366|528540515|FG000|First Line Therapy|Withdrawal by Subject|1|||
146555020|NCT01185366|528540516|FG001|First Line Therapy|Withdrawal by Subject|0|||
146555021|NCT01185366|528540515|FG000|First Line Therapy|Lack of Metastatic Site|1|||
146555022|NCT01185366|528540516|FG001|First Line Therapy|Lack of Metastatic Site|0|||
146555023|NCT01185366|528540515|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
146555024|NCT01185366|528540516|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
146555025|NCT01185366|528540515|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
146555026|NCT01185366|528540516|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
146555027|NCT01185366|528540515|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
146555028|NCT01185366|528540516|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
146555029|NCT01185366|528540515|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
146555030|NCT01185366|528540516|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
146555031|NCT00127933|528540519|FG000|Overall Study|Randomized but not dosed|1|||
146555032|NCT00127933|528540520|FG001|Overall Study|Randomized but not dosed|0|||
146555033|NCT01783938|528540526|FG000|Overall Study|Disease Progression|18|||
146555034|NCT01783938|528540527|FG001|Overall Study|Disease Progression|41|||
146555035|NCT01783938|528540526|FG000|Overall Study|Study Drug Toxicity|27|||
146555036|NCT01783938|528540527|FG001|Overall Study|Study Drug Toxicity|14|||
146555037|NCT01783938|528540526|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
146555038|NCT01783938|528540527|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
146555039|NCT01783938|528540526|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
146555040|NCT01783938|528540527|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
146555041|NCT01783938|528540526|FG000|Overall Study|Participant Withdrew Consent|2|||
146555042|NCT01783938|528540527|FG001|Overall Study|Participant Withdrew Consent|0|||
146635696|NCT04032093|528841003|FG005|Overall Study|Adverse Event|0|||
146635697|NCT04032093|528841004|FG006|Overall Study|Adverse Event|0|||
146635698|NCT04032093|528841005|FG007|Overall Study|Adverse Event|0|||
146635699|NCT04032093|528841006|FG008|Overall Study|Adverse Event|0|||
146635700|NCT04032093|528841007|FG009|Overall Study|Adverse Event|1|||
146635701|NCT04032093|528840998|FG000|Overall Study|Physician Decision|0|||
146966815|NCT01058707|530038918|FG005|Overall Study|Subject Decision|3|||
146635702|NCT04032093|528840999|FG001|Overall Study|Physician Decision|0|||
146635703|NCT04032093|528841000|FG002|Overall Study|Physician Decision|0|||
146635704|NCT04032093|528841001|FG003|Overall Study|Physician Decision|0|||
146635705|NCT04032093|528841002|FG004|Overall Study|Physician Decision|0|||
146966816|NCT01058707|530038919|FG006|Overall Study|Subject Decision|6|||
146966817|NCT01058707|530038913|FG000|Overall Study|Lost to Follow-up|0|||
146635706|NCT04032093|528841003|FG005|Overall Study|Physician Decision|1|||
146635707|NCT04032093|528841004|FG006|Overall Study|Physician Decision|0|||
146635708|NCT04032093|528841005|FG007|Overall Study|Physician Decision|0|||
146635709|NCT04032093|528841006|FG008|Overall Study|Physician Decision|0|||
146635710|NCT04032093|528841007|FG009|Overall Study|Physician Decision|0|||
146635711|NCT00949702|528841013|FG000|Overall Study|Death|40|||
146635712|NCT00949702|528841013|FG000|Overall Study|Disease progression|7|||
146635713|NCT00949702|528841013|FG000|Overall Study|Withdrawal of consent|1|||
146635714|NCT01654302|528841014|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
146635715|NCT01654302|528841015|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
146635716|NCT02699749|528841022|FG000|Overall Study|Other|0|||
146635717|NCT02699749|528841023|FG001|Overall Study|Other|0|||
146635718|NCT02699749|528841024|FG002|Overall Study|Other|2|||
146635719|NCT02699749|528841025|FG003|Overall Study|Other|0|||
146635720|NCT02699749|528841026|FG004|Overall Study|Other|0|||
146635721|NCT02699749|528841027|FG005|Overall Study|Other|1|||
146635722|NCT02699749|528841028|FG006|Overall Study|Other|1|||
146635723|NCT02699749|528841029|FG007|Overall Study|Other|0|||
146635724|NCT02699749|528841030|FG008|Overall Study|Other|0|||
146635725|NCT02699749|528841031|FG009|Overall Study|Other|0|||
146635726|NCT02699749|528841032|FG010|Overall Study|Other|1|||
146635727|NCT02699749|528841033|FG011|Overall Study|Other|0|||
146966818|NCT01058707|530038914|FG001|Overall Study|Lost to Follow-up|0|||
146966819|NCT01058707|530038915|FG002|Overall Study|Lost to Follow-up|1|||
146966820|NCT01058707|530038916|FG003|Overall Study|Lost to Follow-up|0|||
146635728|NCT02699749|528841034|FG012|Overall Study|Other|0|||
146635729|NCT02699749|528841035|FG013|Overall Study|Other|0|||
146635730|NCT02699749|528841022|FG000|Overall Study|Progressive Disease|3|||
146966821|NCT01058707|530038917|FG004|Overall Study|Lost to Follow-up|0|||
146966822|NCT01058707|530038918|FG005|Overall Study|Lost to Follow-up|0|||
146635731|NCT02699749|528841023|FG001|Overall Study|Progressive Disease|3|||
146555043|NCT01783938|528540526|FG000|Overall Study|Maximum Clinical Benefit|1|||
146555044|NCT01783938|528540527|FG001|Overall Study|Maximum Clinical Benefit|0|||
146555045|NCT01783938|528540526|FG000|Overall Study|Other Reasons|3|||
146555046|NCT01783938|528540527|FG001|Overall Study|Other Reasons|1|||
146635732|NCT02699749|528841024|FG002|Overall Study|Progressive Disease|14|||
146635733|NCT02699749|528841025|FG003|Overall Study|Progressive Disease|3|||
146635734|NCT02699749|528841026|FG004|Overall Study|Progressive Disease|3|||
146635735|NCT02699749|528841027|FG005|Overall Study|Progressive Disease|7|||
146635736|NCT02699749|528841028|FG006|Overall Study|Progressive Disease|5|||
146635737|NCT02699749|528841029|FG007|Overall Study|Progressive Disease|5|||
146635738|NCT02699749|528841030|FG008|Overall Study|Progressive Disease|6|||
146635739|NCT02699749|528841031|FG009|Overall Study|Progressive Disease|6|||
146635740|NCT02699749|528841032|FG010|Overall Study|Progressive Disease|5|||
146635741|NCT02699749|528841033|FG011|Overall Study|Progressive Disease|4|||
146635742|NCT02699749|528841034|FG012|Overall Study|Progressive Disease|3|||
146635743|NCT02699749|528841035|FG013|Overall Study|Progressive Disease|5|||
146635744|NCT02699749|528841022|FG000|Overall Study|Death|0|||
146635745|NCT02699749|528841023|FG001|Overall Study|Death|0|||
146635746|NCT02699749|528841024|FG002|Overall Study|Death|0|||
146635747|NCT02699749|528841025|FG003|Overall Study|Death|0|||
146635748|NCT02699749|528841026|FG004|Overall Study|Death|0|||
146635749|NCT02699749|528841027|FG005|Overall Study|Death|0|||
146635750|NCT02699749|528841028|FG006|Overall Study|Death|0|||
146635751|NCT02699749|528841029|FG007|Overall Study|Death|0|||
146635752|NCT02699749|528841030|FG008|Overall Study|Death|0|||
146635753|NCT02699749|528841031|FG009|Overall Study|Death|0|||
146635754|NCT02699749|528841032|FG010|Overall Study|Death|0|||
146555047|NCT03111732|528540531|FG000|Overall Study|Enrolled in different study|1|||
146555048|NCT03111732|528540531|FG000|Overall Study|Progressive disease|3|||
146555049|NCT03111732|528540531|FG000|Overall Study|Withdrawal by Subject|1|||
146555050|NCT03072875|528540532|FG000|Overall Study|Lost to Follow-up|1|||
146555051|NCT00401830|528540533|FG000|Overall Study|Adverse Event|10|||
146555052|NCT00401830|528540534|FG001|Overall Study|Adverse Event|18|||
146555053|NCT00401830|528540533|FG000|Overall Study|Lack of Efficacy|11|||
146555054|NCT00401830|528540534|FG001|Overall Study|Lack of Efficacy|5|||
146555055|NCT00401830|528540533|FG000|Overall Study|Withdrawal by Subject|4|||
146555056|NCT00401830|528540534|FG001|Overall Study|Withdrawal by Subject|3|||
146555057|NCT00401830|528540533|FG000|Overall Study|Protocol Violation|3|||
146555058|NCT00401830|528540534|FG001|Overall Study|Protocol Violation|3|||
146555059|NCT00401830|528540533|FG000|Overall Study|Non-compliance with drug study|1|||
146555060|NCT00401830|528540534|FG001|Overall Study|Non-compliance with drug study|0|||
146555061|NCT00401830|528540533|FG000|Overall Study|Lost to Follow-up|1|||
146555062|NCT00401830|528540534|FG001|Overall Study|Lost to Follow-up|3|||
146555063|NCT00401830|528540533|FG000|Overall Study|Other: Personal / Family problems|1|||
146555064|NCT00401830|528540534|FG001|Overall Study|Other: Personal / Family problems|0|||
146555065|NCT01943825|528540535|FG000|Overall Study|Lost to Follow-up|9|||
146555066|NCT01943825|528540536|FG001|Overall Study|Lost to Follow-up|3|||
146555067|NCT01943825|528540537|FG002|Overall Study|Lost to Follow-up|12|||
146555068|NCT01943825|528540538|FG003|Overall Study|Lost to Follow-up|8|||
146555069|NCT01943825|528540535|FG000|Overall Study|Withdrawal by Subject|1|||
146555070|NCT01943825|528540536|FG001|Overall Study|Withdrawal by Subject|0|||
146555071|NCT01943825|528540537|FG002|Overall Study|Withdrawal by Subject|3|||
146887895|NCT00699907|529755822|FG001|Overall Study|Withdrawal by Subject|1|||
146635755|NCT02699749|528841033|FG011|Overall Study|Death|0|||
146555072|NCT01943825|528540538|FG003|Overall Study|Withdrawal by Subject|2|||
146635756|NCT02699749|528841034|FG012|Overall Study|Death|0|||
146635757|NCT02699749|528841035|FG013|Overall Study|Death|1|||
146635758|NCT02699749|528841022|FG000|Overall Study|Lost to Follow-up|0|||
146635759|NCT02699749|528841023|FG001|Overall Study|Lost to Follow-up|0|||
146635760|NCT02699749|528841024|FG002|Overall Study|Lost to Follow-up|0|||
146555073|NCT01943825|528540535|FG000|Overall Study|Other than specified above|0|||
146555074|NCT01943825|528540536|FG001|Overall Study|Other than specified above|1|||
146555075|NCT01943825|528540537|FG002|Overall Study|Other than specified above|0|||
146635761|NCT02699749|528841025|FG003|Overall Study|Lost to Follow-up|0|||
146635762|NCT02699749|528841026|FG004|Overall Study|Lost to Follow-up|0|||
146887896|NCT00699907|529755823|FG002|Overall Study|Withdrawal by Subject|0|||
146635763|NCT02699749|528841027|FG005|Overall Study|Lost to Follow-up|1|||
146635764|NCT02699749|528841028|FG006|Overall Study|Lost to Follow-up|0|||
146635765|NCT02699749|528841029|FG007|Overall Study|Lost to Follow-up|1|||
146887897|NCT00699907|529755821|FG000|Overall Study|No usable sample|0|||
146555076|NCT01943825|528540538|FG003|Overall Study|Other than specified above|1|||
146555077|NCT00452400|528540539|FG000|Overall Study|Adverse Event|1|||
146555078|NCT00452400|528540540|FG001|Overall Study|Adverse Event|1|||
146555079|NCT00452400|528540541|FG002|Overall Study|Adverse Event|5|||
146555080|NCT00452400|528540542|FG003|Overall Study|Adverse Event|0|||
146555081|NCT00452400|528540543|FG004|Overall Study|Adverse Event|2|||
146555082|NCT00452400|528540539|FG000|Overall Study|Protocol Violation|0|||
146555083|NCT00452400|528540540|FG001|Overall Study|Protocol Violation|0|||
146555084|NCT00452400|528540541|FG002|Overall Study|Protocol Violation|1|||
146555085|NCT00452400|528540542|FG003|Overall Study|Protocol Violation|0|||
146765358|NCT02503202|529308639|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
146765359|NCT02503202|529308640|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
146765360|NCT02503202|529308641|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
146765361|NCT02503202|529308642|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
146765362|NCT02503202|529308638|FG000|Base Study: Up to Month 6|Physician Decision|0|||
146765363|NCT02503202|529308639|FG001|Base Study: Up to Month 6|Physician Decision|0|||
146765364|NCT02503202|529308640|FG002|Base Study: Up to Month 6|Physician Decision|0|||
146765365|NCT02503202|529308641|FG003|Base Study: Up to Month 6|Physician Decision|0|||
146765366|NCT02503202|529308642|FG004|Base Study: Up to Month 6|Physician Decision|1|||
146765367|NCT02503202|529308638|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
146765368|NCT02503202|529308639|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
146765369|NCT02503202|529308640|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
146765370|NCT02503202|529308641|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
146765371|NCT02503202|529308642|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
146765372|NCT02503202|529308638|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
146765373|NCT02503202|529308639|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
146765374|NCT02503202|529308640|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
146765375|NCT02503202|529308641|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
146765376|NCT02503202|529308642|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
146765377|NCT02503202|529308638|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
146765378|NCT02503202|529308639|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
146765379|NCT02503202|529308640|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
146765380|NCT02503202|529308641|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
146765381|NCT02503202|529308642|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
146765382|NCT02503202|529308638|FG000|Extension: Month 6 to 24|Death|1|||
146765383|NCT02503202|529308639|FG001|Extension: Month 6 to 24|Death|0|||
146765384|NCT02503202|529308640|FG002|Extension: Month 6 to 24|Death|0|||
146765385|NCT02503202|529308641|FG003|Extension: Month 6 to 24|Death|0|||
146765386|NCT02503202|529308642|FG004|Extension: Month 6 to 24|Death|0|||
146765387|NCT02503202|529308638|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
146765388|NCT02503202|529308639|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
146765389|NCT02503202|529308640|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
146765390|NCT02503202|529308641|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
146765391|NCT02503202|529308642|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
146765392|NCT02503202|529308638|FG000|Extension: Month 6 to 24|Physician Decision|1|||
146765393|NCT02503202|529308639|FG001|Extension: Month 6 to 24|Physician Decision|0|||
146765394|NCT02503202|529308640|FG002|Extension: Month 6 to 24|Physician Decision|1|||
146765395|NCT02503202|529308641|FG003|Extension: Month 6 to 24|Physician Decision|3|||
146765396|NCT02503202|529308642|FG004|Extension: Month 6 to 24|Physician Decision|0|||
146765397|NCT02503202|529308638|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
146765398|NCT02503202|529308639|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
146765399|NCT02503202|529308640|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
146765400|NCT02503202|529308641|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
146765401|NCT02503202|529308642|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
146765402|NCT00130637|529308645|FG000|Overall Study|Adverse Event|2|||
146765403|NCT00130637|529308645|FG000|Overall Study|Withdrawal by Subject|1|||
146765404|NCT01191788|529308646|FG000|Overall Study|Lost to Follow-up|21|||
146765405|NCT01191788|529308647|FG001|Overall Study|Lost to Follow-up|22|||
146765406|NCT00217672|529308649|FG000|Allocation|Ineligible|2|||
146765407|NCT00217672|529308650|FG001|Allocation|Ineligible|0|||
146765408|NCT00217672|529308649|FG000|Treatment|disease progression|33|||
146765409|NCT00217672|529308650|FG001|Treatment|disease progression|4|||
146765410|NCT00217672|529308649|FG000|Treatment|Adverse Event|18|||
146765411|NCT00217672|529308650|FG001|Treatment|Adverse Event|2|||
146765412|NCT00217672|529308649|FG000|Treatment|reqd treatment not permitted by protocol|6|||
146765413|NCT00217672|529308650|FG001|Treatment|reqd treatment not permitted by protocol|0|||
146765414|NCT00217672|529308649|FG000|Treatment|Physician Decision|6|||
146765415|NCT00217672|529308650|FG001|Treatment|Physician Decision|0|||
146765416|NCT00217672|529308649|FG000|Treatment|insurance issues|1|||
146765417|NCT00217672|529308650|FG001|Treatment|insurance issues|1|||
146765418|NCT00217672|529308649|FG000|Treatment|Death|2|||
146765419|NCT00217672|529308650|FG001|Treatment|Death|0|||
146765420|NCT00217672|529308649|FG000|Treatment|secondary malignancy|1|||
146765421|NCT00217672|529308650|FG001|Treatment|secondary malignancy|0|||
146765422|NCT00217672|529308649|FG000|Follow-up|Withdrawal by Subject|4|||
146765423|NCT00217672|529308650|FG001|Follow-up|Withdrawal by Subject|0|||
146765424|NCT00217672|529308649|FG000|Follow-up|Lost to Follow-up|1|||
146765425|NCT00217672|529308650|FG001|Follow-up|Lost to Follow-up|0|||
146765426|NCT01591616|529308651|FG000|Overall Study|Withdrawal by Subject|1|||
146765427|NCT01959412|529308652|FG000|Overall Study|Protocol deviation|1|||
146765428|NCT01959412|529308653|FG001|Overall Study|Protocol deviation|1|||
146765429|NCT01959412|529308654|FG002|Overall Study|Protocol deviation|0|||
146765430|NCT01959412|529308655|FG003|Overall Study|Protocol deviation|1|||
146765431|NCT01959412|529308656|FG004|Overall Study|Protocol deviation|3|||
146765432|NCT01959412|529308657|FG005|Overall Study|Protocol deviation|0|||
146765433|NCT01959412|529308652|FG000|Overall Study|Adverse Event|0|||
146765434|NCT01959412|529308653|FG001|Overall Study|Adverse Event|0|||
146765435|NCT01959412|529308654|FG002|Overall Study|Adverse Event|0|||
146765436|NCT01959412|529308655|FG003|Overall Study|Adverse Event|1|||
146765437|NCT01959412|529308656|FG004|Overall Study|Adverse Event|0|||
146765438|NCT01959412|529308657|FG005|Overall Study|Adverse Event|0|||
146765439|NCT00158054|529308660|FG000|Overall Study|Refused to continue|3|||
146765440|NCT00158054|529308661|FG001|Overall Study|Refused to continue|0|||
146765441|NCT00158054|529308660|FG000|Overall Study|Unavailable for follow up|7|||
146765442|NCT00158054|529308661|FG001|Overall Study|Unavailable for follow up|3|||
146765443|NCT04567888|529308662|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
146765444|NCT04567888|529308663|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
146765445|NCT04567888|529308662|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
146765446|NCT04567888|529308663|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
146765447|NCT04567888|529308662|FG000|Overall Study|Reported Unusual Birth Year|2|||
146765448|NCT04567888|529308663|FG001|Overall Study|Reported Unusual Birth Year|3|||
146765449|NCT04567888|529308662|FG000|Overall Study|Duplicate Responses|0|||
146765450|NCT04567888|529308663|FG001|Overall Study|Duplicate Responses|1|||
146765451|NCT00414648|529308664|FG000|Overall Study|Adverse Event|5|||
146765452|NCT00414648|529308665|FG001|Overall Study|Adverse Event|5|||
146765453|NCT00414648|529308664|FG000|Overall Study|Death|0|||
146765454|NCT00414648|529308665|FG001|Overall Study|Death|1|||
146765455|NCT00414648|529308664|FG000|Overall Study|Lack of Efficacy|0|||
146765456|NCT00414648|529308665|FG001|Overall Study|Lack of Efficacy|2|||
146765457|NCT00414648|529308664|FG000|Overall Study|Withdrawal by Subject|0|||
146765458|NCT00414648|529308665|FG001|Overall Study|Withdrawal by Subject|1|||
146765459|NCT01194258|529308666|FG000|Titration Period|Withdrawal by Subject|6|||
146635766|NCT02699749|528841030|FG008|Overall Study|Lost to Follow-up|0|||
146635767|NCT02699749|528841031|FG009|Overall Study|Lost to Follow-up|0|||
146635768|NCT02699749|528841032|FG010|Overall Study|Lost to Follow-up|0|||
146635769|NCT02699749|528841033|FG011|Overall Study|Lost to Follow-up|0|||
146635770|NCT02699749|528841034|FG012|Overall Study|Lost to Follow-up|0|||
146635771|NCT02699749|528841035|FG013|Overall Study|Lost to Follow-up|0|||
146635772|NCT02377817|528841037|FG000|Overall Study|Transportation/childcare barriers.|2|||
146635773|NCT02377817|528841038|FG001|Overall Study|Transportation/childcare barriers.|0|||
146765460|NCT01194258|529308667|FG001|Titration Period|Withdrawal by Subject|0|||
146765461|NCT01194258|529308668|FG002|Titration Period|Withdrawal by Subject|0|||
146765462|NCT01194258|529308669|FG003|Titration Period|Withdrawal by Subject|0|||
146765463|NCT01194258|529308670|FG004|Titration Period|Withdrawal by Subject|0|||
146765464|NCT01194258|529308666|FG000|Titration Period|Lost to Follow-up|2|||
146765465|NCT01194258|529308667|FG001|Titration Period|Lost to Follow-up|0|||
146765466|NCT01194258|529308668|FG002|Titration Period|Lost to Follow-up|0|||
146765467|NCT01194258|529308669|FG003|Titration Period|Lost to Follow-up|0|||
146765468|NCT01194258|529308670|FG004|Titration Period|Lost to Follow-up|0|||
146765469|NCT01194258|529308666|FG000|Titration Period|Titration failure|3|||
146765470|NCT01194258|529308667|FG001|Titration Period|Titration failure|0|||
146765471|NCT01194258|529308668|FG002|Titration Period|Titration failure|0|||
146635774|NCT02377817|528841037|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
146635775|NCT02377817|528841038|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
146635776|NCT02839200|528841039|FG000|Overall Study|Withdrawal by Subject|2|||
146635777|NCT02839200|528841040|FG001|Overall Study|Withdrawal by Subject|0|||
146635778|NCT02839200|528841041|FG002|Overall Study|Withdrawal by Subject|1|||
146635779|NCT02839200|528841042|FG003|Overall Study|Withdrawal by Subject|0|||
146635780|NCT02839200|528841043|FG004|Overall Study|Withdrawal by Subject|0|||
146635781|NCT02839200|528841044|FG005|Overall Study|Withdrawal by Subject|1|||
146635782|NCT02839200|528841039|FG000|Overall Study|Lost to Follow-up|2|||
146635783|NCT02839200|528841040|FG001|Overall Study|Lost to Follow-up|0|||
146635784|NCT02839200|528841041|FG002|Overall Study|Lost to Follow-up|0|||
146635785|NCT02839200|528841042|FG003|Overall Study|Lost to Follow-up|0|||
146635786|NCT02839200|528841043|FG004|Overall Study|Lost to Follow-up|1|||
146635787|NCT02839200|528841044|FG005|Overall Study|Lost to Follow-up|0|||
146635788|NCT02839200|528841039|FG000|Overall Study|Adverse Event|0|||
146635789|NCT02839200|528841040|FG001|Overall Study|Adverse Event|0|||
146635790|NCT02839200|528841041|FG002|Overall Study|Adverse Event|0|||
146635791|NCT02839200|528841042|FG003|Overall Study|Adverse Event|0|||
146635792|NCT02839200|528841043|FG004|Overall Study|Adverse Event|1|||
146635793|NCT02839200|528841044|FG005|Overall Study|Adverse Event|0|||
146635794|NCT02839200|528841039|FG000|Overall Study|Randomized in error|0|||
146635795|NCT02839200|528841040|FG001|Overall Study|Randomized in error|1|||
146635796|NCT02839200|528841041|FG002|Overall Study|Randomized in error|0|||
146635797|NCT02839200|528841042|FG003|Overall Study|Randomized in error|0|||
146635798|NCT02839200|528841043|FG004|Overall Study|Randomized in error|0|||
146635799|NCT02839200|528841044|FG005|Overall Study|Randomized in error|0|||
146635800|NCT02952820|528841045|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
146635801|NCT02952820|528841046|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
146635802|NCT02952820|528841047|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
146635803|NCT02952820|528841045|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
146635804|NCT02952820|528841046|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
146635805|NCT02952820|528841047|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
146635806|NCT02952820|528841045|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
146635807|NCT02952820|528841046|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
146635808|NCT02952820|528841047|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
146635809|NCT02952820|528841045|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
146635810|NCT02952820|528841046|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
146765472|NCT01194258|529308669|FG003|Titration Period|Titration failure|0|||
146765473|NCT01194258|529308670|FG004|Titration Period|Titration failure|0|||
146765474|NCT01194258|529308666|FG000|Period 1 (12 Weeks)|Death|0|||
146966823|NCT01058707|530038919|FG006|Overall Study|Lost to Follow-up|0|||
146555086|NCT00452400|528540543|FG004|Overall Study|Protocol Violation|0|||
146555087|NCT00452400|528540539|FG000|Overall Study|Lost to Follow-up|1|||
146555088|NCT00452400|528540540|FG001|Overall Study|Lost to Follow-up|0|||
146555089|NCT00452400|528540541|FG002|Overall Study|Lost to Follow-up|0|||
146555090|NCT00452400|528540542|FG003|Overall Study|Lost to Follow-up|0|||
146555091|NCT00452400|528540543|FG004|Overall Study|Lost to Follow-up|0|||
146555092|NCT00452400|528540539|FG000|Overall Study|Withdrawal by Subject|1|||
146555093|NCT00452400|528540540|FG001|Overall Study|Withdrawal by Subject|0|||
146555094|NCT00452400|528540541|FG002|Overall Study|Withdrawal by Subject|1|||
146555095|NCT00452400|528540542|FG003|Overall Study|Withdrawal by Subject|0|||
146555096|NCT00452400|528540543|FG004|Overall Study|Withdrawal by Subject|0|||
146555097|NCT00452400|528540539|FG000|Overall Study|Lack of Efficacy|2|||
146555098|NCT00452400|528540540|FG001|Overall Study|Lack of Efficacy|0|||
146555099|NCT00452400|528540541|FG002|Overall Study|Lack of Efficacy|0|||
146555100|NCT00452400|528540542|FG003|Overall Study|Lack of Efficacy|0|||
146555101|NCT00452400|528540543|FG004|Overall Study|Lack of Efficacy|0|||
146555102|NCT00452400|528540539|FG000|Overall Study|Other reasons not listed above|0|||
146555103|NCT00452400|528540540|FG001|Overall Study|Other reasons not listed above|0|||
146555104|NCT00452400|528540541|FG002|Overall Study|Other reasons not listed above|0|||
146635811|NCT02952820|528841047|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
146555105|NCT00452400|528540542|FG003|Overall Study|Other reasons not listed above|1|||
146555106|NCT00452400|528540543|FG004|Overall Study|Other reasons not listed above|1|||
146555107|NCT02792257|528540544|FG000|Overall Study|Lost to Follow-up|3|||
146555108|NCT02792257|528540545|FG001|Overall Study|Lost to Follow-up|4|||
146555109|NCT02792257|528540544|FG000|Overall Study|Allergy|0|||
146555110|NCT02792257|528540545|FG001|Overall Study|Allergy|1|||
146555111|NCT02792257|528540544|FG000|Overall Study|Protocol Violation|2|||
146555112|NCT02792257|528540545|FG001|Overall Study|Protocol Violation|0|||
146555113|NCT02792257|528540544|FG000|Overall Study|Excessive Agitation|0|||
146555114|NCT02792257|528540545|FG001|Overall Study|Excessive Agitation|1|||
146555115|NCT02792257|528540544|FG000|Overall Study|Not Feeling Well|0|||
146555116|NCT02792257|528540545|FG001|Overall Study|Not Feeling Well|1|||
146555117|NCT00553475|528540546|FG000|Overall Study|Adverse Event|7|||
146635812|NCT02952820|528841045|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
146635813|NCT02952820|528841046|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
146966824|NCT01058707|530038913|FG000|Overall Study|Reason Not Specified|0|||
146555118|NCT00553475|528540547|FG001|Overall Study|Adverse Event|17|||
146555119|NCT00553475|528540548|FG002|Overall Study|Adverse Event|13|||
146555120|NCT00553475|528540546|FG000|Overall Study|Lack of Efficacy|7|||
146887898|NCT00699907|529755822|FG001|Overall Study|No usable sample|9|||
146555121|NCT00553475|528540547|FG001|Overall Study|Lack of Efficacy|1|||
146555122|NCT00553475|528540548|FG002|Overall Study|Lack of Efficacy|0|||
146555123|NCT00553475|528540546|FG000|Overall Study|Withdrawal by Subject|1|||
146555124|NCT00553475|528540547|FG001|Overall Study|Withdrawal by Subject|1|||
146555125|NCT00553475|528540548|FG002|Overall Study|Withdrawal by Subject|0|||
146555126|NCT00553475|528540546|FG000|Overall Study|Physician Decision|1|||
146555127|NCT00553475|528540547|FG001|Overall Study|Physician Decision|0|||
146555128|NCT00553475|528540548|FG002|Overall Study|Physician Decision|0|||
146555129|NCT00553475|528540546|FG000|Overall Study|Due to moving|0|||
146555130|NCT00553475|528540547|FG001|Overall Study|Due to moving|1|||
146555131|NCT00553475|528540548|FG002|Overall Study|Due to moving|0|||
146555132|NCT01623154|528540549|FG000|Overall Study|Did not drink Pranactin Citric|4|||
146555133|NCT00954538|528540553|FG000|Part III|Withdrawal by Subject|0|||
146555134|NCT00954538|528540554|FG001|Part III|Withdrawal by Subject|0|||
146555135|NCT00954538|528540555|FG002|Part III|Withdrawal by Subject|0|||
146555136|NCT00954538|528540556|FG003|Part III|Withdrawal by Subject|0|||
146555137|NCT00954538|528540557|FG004|Part III|Withdrawal by Subject|1|||
146555138|NCT00954538|528540558|FG005|Part III|Withdrawal by Subject|0|||
146555139|NCT01905683|528540561|FG000|Overall Study|Protocol Violation|1|||
146555140|NCT01905683|528540561|FG000|Overall Study|Re-injection criteria not met; others|13|||
146555141|NCT01905683|528540561|FG000|Overall Study|Physician Decision|1|||
146555142|NCT01905683|528540561|FG000|Overall Study|Lack of Efficacy|8|||
146555143|NCT01905683|528540561|FG000|Overall Study|Withdrawal by Subject|20|||
146887899|NCT00699907|529755823|FG002|Overall Study|No usable sample|8|||
146887900|NCT02161211|529755824|FG000|Overall Study|Lost to Follow-up|21|||
146887901|NCT02161211|529755825|FG001|Overall Study|Lost to Follow-up|27|||
146555144|NCT01905683|528540561|FG000|Overall Study|Adverse Event|4|||
146555145|NCT01905683|528540561|FG000|Overall Study|Lost to Follow-up|4|||
146555146|NCT00107614|528542384|FG000|Overall Study|Physician Decision|10|||
146555147|NCT00107614|528542384|FG000|Overall Study|Death|2|||
146555148|NCT00101400|528542385|FG000|Survival Follow-Up|Alive|7|||
146555149|NCT03160573|528542386|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
146555150|NCT03160573|528542387|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
146555151|NCT03160573|528542388|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
146555152|NCT03160573|528542389|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
146555153|NCT00449787|528542395|FG000|Overall Study|Lost to Follow-up|10|||
146555154|NCT00449787|528542396|FG001|Overall Study|Lost to Follow-up|8|||
146555155|NCT00449787|528542395|FG000|Overall Study|Did not require medication|95|||
146555156|NCT00449787|528542396|FG001|Overall Study|Did not require medication|92|||
146555157|NCT02003898|528542397|FG000|Overall Study|Death|3|||
146555158|NCT02003898|528542397|FG000|Overall Study|Lost to Follow-up|12|||
146555159|NCT02003898|528542397|FG000|Overall Study|Withdrawal by Subject|52|||
146555160|NCT01537432|528542398|FG000|Overall Study|Lost to Follow-up|3|||
146555161|NCT01537432|528542399|FG001|Overall Study|Lost to Follow-up|1|||
146555162|NCT01537432|528542398|FG000|Overall Study|Withdrawal by Subject|0|||
146555163|NCT01537432|528542399|FG001|Overall Study|Withdrawal by Subject|1|||
146555164|NCT01537432|528542398|FG000|Overall Study|Administrative problems|1|||
146555165|NCT01537432|528542399|FG001|Overall Study|Administrative problems|0|||
146555166|NCT01537432|528542398|FG000|Overall Study|Adverse Event|1|||
146555167|NCT01537432|528542399|FG001|Overall Study|Adverse Event|0|||
146555168|NCT01537432|528542398|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146555169|NCT01537432|528542399|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146555170|NCT05166902|528542400|FG000|First Intervention|Lost to Follow-up|0|||
146555171|NCT05166902|528542401|FG001|First Intervention|Lost to Follow-up|1|||
146555172|NCT01998477|528542402|FG000|Overall Study|Lost to Follow-up|4|||
146555173|NCT01998477|528542403|FG001|Overall Study|Lost to Follow-up|5|||
146555174|NCT01998477|528542402|FG000|Overall Study|Withdrawal by Subject|6|||
146555175|NCT01998477|528542403|FG001|Overall Study|Withdrawal by Subject|0|||
146555176|NCT03436420|528542404|FG000|Overall Study|Lack of Efficacy|3|||
146555177|NCT01061710|528542405|FG000|Overall Study|Protocol Violation|14|||
146555178|NCT00159874|528542406|FG000|Overall Study|Adverse Event|2|||
146555179|NCT00159874|528542407|FG001|Overall Study|Adverse Event|2|||
146555180|NCT00159874|528542408|FG002|Overall Study|Adverse Event|5|||
146555181|NCT00159874|528542409|FG003|Overall Study|Adverse Event|1|||
146555182|NCT00159874|528542410|FG004|Overall Study|Adverse Event|1|||
146555183|NCT00159874|528542411|FG005|Overall Study|Adverse Event|2|||
146555184|NCT00159874|528542412|FG006|Overall Study|Adverse Event|0|||
146555185|NCT00159874|528542406|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
146555186|NCT00159874|528542407|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
146555187|NCT00159874|528542408|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
146555188|NCT00159874|528542409|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
146555189|NCT00159874|528542410|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
146555190|NCT00159874|528542411|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
146555191|NCT00159874|528542412|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
146555192|NCT00159874|528542406|FG000|Overall Study|Lack of Efficacy|2|||
146555193|NCT00159874|528542407|FG001|Overall Study|Lack of Efficacy|0|||
146555194|NCT00159874|528542408|FG002|Overall Study|Lack of Efficacy|1|||
146887902|NCT02161211|529755826|FG002|Overall Study|Lost to Follow-up|21|||
146887903|NCT02161211|529755824|FG000|Overall Study|Dropped|12|||
146555195|NCT00159874|528542409|FG003|Overall Study|Lack of Efficacy|1|||
146555196|NCT00159874|528542410|FG004|Overall Study|Lack of Efficacy|0|||
146887904|NCT02161211|529755825|FG001|Overall Study|Dropped|5|||
146555197|NCT00159874|528542411|FG005|Overall Study|Lack of Efficacy|3|||
146555198|NCT00159874|528542412|FG006|Overall Study|Lack of Efficacy|0|||
146555199|NCT00159874|528542406|FG000|Overall Study|Lost to Follow-up|1|||
146555200|NCT00159874|528542407|FG001|Overall Study|Lost to Follow-up|0|||
146555201|NCT00159874|528542408|FG002|Overall Study|Lost to Follow-up|3|||
146555202|NCT00159874|528542409|FG003|Overall Study|Lost to Follow-up|0|||
146555203|NCT00159874|528542410|FG004|Overall Study|Lost to Follow-up|1|||
146555204|NCT00159874|528542411|FG005|Overall Study|Lost to Follow-up|2|||
146555205|NCT00159874|528542412|FG006|Overall Study|Lost to Follow-up|1|||
146555206|NCT00159874|528542406|FG000|Overall Study|Other|8|||
146555207|NCT00159874|528542407|FG001|Overall Study|Other|8|||
146555208|NCT00159874|528542408|FG002|Overall Study|Other|8|||
146555209|NCT00159874|528542409|FG003|Overall Study|Other|0|||
146555210|NCT00159874|528542410|FG004|Overall Study|Other|2|||
146555211|NCT00159874|528542411|FG005|Overall Study|Other|1|||
146555212|NCT00159874|528542412|FG006|Overall Study|Other|3|||
146555213|NCT00159874|528542406|FG000|Overall Study|Protocol Violation|0|||
146555214|NCT00159874|528542407|FG001|Overall Study|Protocol Violation|5|||
146555215|NCT00159874|528542408|FG002|Overall Study|Protocol Violation|2|||
146555216|NCT00159874|528542409|FG003|Overall Study|Protocol Violation|0|||
146555217|NCT00159874|528542410|FG004|Overall Study|Protocol Violation|0|||
146555218|NCT00159874|528542411|FG005|Overall Study|Protocol Violation|0|||
146555219|NCT00159874|528542412|FG006|Overall Study|Protocol Violation|0|||
146555220|NCT00159874|528542406|FG000|Overall Study|Death|3|||
146555221|NCT00159874|528542407|FG001|Overall Study|Death|8|||
146966825|NCT01058707|530038914|FG001|Overall Study|Reason Not Specified|3|||
146966826|NCT01058707|530038915|FG002|Overall Study|Reason Not Specified|2|||
146966827|NCT01058707|530038916|FG003|Overall Study|Reason Not Specified|0|||
146966828|NCT01058707|530038917|FG004|Overall Study|Reason Not Specified|7|||
146966829|NCT01058707|530038918|FG005|Overall Study|Reason Not Specified|1|||
146966830|NCT01058707|530038919|FG006|Overall Study|Reason Not Specified|7|||
146966831|NCT00167414|530038921|FG000|Overall Study|Death|10|||
146635814|NCT02952820|528841047|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
146635815|NCT02952820|528841045|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
146635816|NCT02952820|528841046|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
146635817|NCT02952820|528841047|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
146635818|NCT02952820|528841045|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
146635819|NCT02952820|528841046|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
146635820|NCT02952820|528841047|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
146635821|NCT02952820|528841045|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
146635822|NCT02952820|528841046|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
146635823|NCT02952820|528841047|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
146635824|NCT02952820|528841045|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
146635825|NCT02952820|528841046|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
146635826|NCT02952820|528841047|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
146635827|NCT02952820|528841045|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
146635828|NCT02952820|528841046|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
146635829|NCT02952820|528841047|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
146635830|NCT02952820|528841045|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
146635831|NCT02952820|528841046|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
146635832|NCT02952820|528841047|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
146635833|NCT02952820|528841045|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
146635834|NCT02952820|528841046|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
146635835|NCT02952820|528841047|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
146635836|NCT02952820|528841045|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
146635837|NCT02952820|528841046|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
146635838|NCT02952820|528841047|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
146635839|NCT02952820|528841045|FG000|Active Treatment Period (6 Months)|Not treated|0|||
146635840|NCT02952820|528841046|FG001|Active Treatment Period (6 Months)|Not treated|0|||
146765475|NCT01194258|529308667|FG001|Period 1 (12 Weeks)|Death|0|||
146765476|NCT01194258|529308668|FG002|Period 1 (12 Weeks)|Death|0|||
146765477|NCT01194258|529308669|FG003|Period 1 (12 Weeks)|Death|0|||
146765478|NCT01194258|529308670|FG004|Period 1 (12 Weeks)|Death|1|||
146765479|NCT01194258|529308666|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
146765480|NCT01194258|529308667|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
146765481|NCT01194258|529308668|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
146765482|NCT01194258|529308669|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
146765483|NCT01194258|529308670|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
146765484|NCT01194258|529308666|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
146765485|NCT01194258|529308667|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
146765486|NCT01194258|529308668|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
146765487|NCT01194258|529308669|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
146765488|NCT01194258|529308670|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
146765489|NCT01194258|529308666|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146765490|NCT01194258|529308667|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146765491|NCT01194258|529308668|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146765492|NCT01194258|529308669|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146765493|NCT01194258|529308670|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146765494|NCT00383188|529308671|FG000|Overall Study|Adverse Event|4|||
146765495|NCT00383188|529308672|FG001|Overall Study|Adverse Event|7|||
146765496|NCT00383188|529308673|FG002|Overall Study|Adverse Event|9|||
146555222|NCT00159874|528542408|FG002|Overall Study|Death|15|||
146555223|NCT00159874|528542409|FG003|Overall Study|Death|0|||
146765497|NCT00383188|529308674|FG003|Overall Study|Adverse Event|8|||
146555224|NCT00159874|528542410|FG004|Overall Study|Death|1|||
146555225|NCT00159874|528542411|FG005|Overall Study|Death|2|||
146555226|NCT00159874|528542412|FG006|Overall Study|Death|0|||
146555227|NCT00159874|528542406|FG000|Overall Study|Withdrawal by Subject|2|||
146555228|NCT00159874|528542407|FG001|Overall Study|Withdrawal by Subject|6|||
146555229|NCT00159874|528542408|FG002|Overall Study|Withdrawal by Subject|8|||
146555230|NCT00159874|528542409|FG003|Overall Study|Withdrawal by Subject|4|||
146555231|NCT00159874|528542410|FG004|Overall Study|Withdrawal by Subject|3|||
146555232|NCT00159874|528542411|FG005|Overall Study|Withdrawal by Subject|2|||
146555233|NCT00159874|528542412|FG006|Overall Study|Withdrawal by Subject|1|||
146555234|NCT00159874|528542406|FG000|Overall Study|Pregnancy|1|||
146555235|NCT00159874|528542407|FG001|Overall Study|Pregnancy|1|||
146555236|NCT00159874|528542408|FG002|Overall Study|Pregnancy|0|||
146555237|NCT00159874|528542409|FG003|Overall Study|Pregnancy|0|||
146555238|NCT00159874|528542410|FG004|Overall Study|Pregnancy|0|||
146555239|NCT00159874|528542411|FG005|Overall Study|Pregnancy|0|||
146555240|NCT00159874|528542412|FG006|Overall Study|Pregnancy|0|||
146555241|NCT01104870|528542414|FG000|Overall Study|Adverse Event|1|||
146555242|NCT01104870|528542415|FG001|Overall Study|Adverse Event|1|||
146555243|NCT01104870|528542416|FG002|Overall Study|Adverse Event|0|||
146555244|NCT01104870|528542414|FG000|Overall Study|Death|0|||
146555245|NCT01104870|528542415|FG001|Overall Study|Death|0|||
146555246|NCT01104870|528542416|FG002|Overall Study|Death|1|||
146555247|NCT01104870|528542414|FG000|Overall Study|Withdrawal by Subject|0|||
146555248|NCT01104870|528542415|FG001|Overall Study|Withdrawal by Subject|0|||
146555249|NCT01104870|528542416|FG002|Overall Study|Withdrawal by Subject|1|||
146555250|NCT02150863|528542424|FG000|Overall Study|Lost to Follow-up|0|||
146555251|NCT02150863|528542425|FG001|Overall Study|Lost to Follow-up|1|||
146555252|NCT02150863|528542426|FG002|Overall Study|Lost to Follow-up|0|||
146555253|NCT00835549|528542429|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
146555254|NCT00835549|528542430|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
146555255|NCT00835042|528542431|FG000|First Intervention|Withdrawal by Subject|3|||
146555256|NCT00835042|528542432|FG001|First Intervention|Withdrawal by Subject|0|||
146555257|NCT00835042|528542431|FG000|First Intervention|Adverse Event|1|||
146555258|NCT00835042|528542432|FG001|First Intervention|Adverse Event|2|||
146555259|NCT00835042|528542431|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
146555260|NCT00835042|528542432|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
146555261|NCT04008069|528542433|FG000|Open-Label Period|Adverse Event|1|||
146555262|NCT04008069|528542434|FG001|Open-Label Period|Adverse Event|0|||
146555263|NCT04008069|528542435|FG002|Open-Label Period|Adverse Event|0|||
146555264|NCT04008069|528542433|FG000|Open-Label Period|Lack of Efficacy|4|||
146555265|NCT04008069|528542434|FG001|Open-Label Period|Lack of Efficacy|0|||
146555266|NCT04008069|528542435|FG002|Open-Label Period|Lack of Efficacy|0|||
146555267|NCT04008069|528542433|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
146555268|NCT04008069|528542434|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
146555269|NCT04008069|528542435|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
146555270|NCT04008069|528542433|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
146555271|NCT04008069|528542434|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
146555272|NCT04008069|528542435|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
146555273|NCT00511199|528542437|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
146555274|NCT00511199|528542438|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
146555275|NCT00511199|528542437|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
146555276|NCT00511199|528542438|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
146555277|NCT00511199|528542437|FG000|Overall Study|Withdrawal of Informed Consent|19|||
146555278|NCT00511199|528542438|FG001|Overall Study|Withdrawal of Informed Consent|4|||
146555279|NCT00511199|528542437|FG000|Overall Study|Pregnancy|6|||
146555280|NCT00511199|528542438|FG001|Overall Study|Pregnancy|3|||
146555281|NCT00511199|528542437|FG000|Overall Study|Pregnancy Wish|16|||
146555282|NCT00511199|528542438|FG001|Overall Study|Pregnancy Wish|8|||
146555283|NCT00511199|528542437|FG000|Overall Study|Lost to Follow-up|40|||
146555284|NCT00511199|528542438|FG001|Overall Study|Lost to Follow-up|17|||
146555285|NCT00511199|528542437|FG000|Overall Study|Other Reason|78|||
146555286|NCT00511199|528542438|FG001|Overall Study|Other Reason|37|||
146555287|NCT02314247|528542443|FG000|Overall Study|Adverse Event|2|||
146555288|NCT02314247|528542444|FG001|Overall Study|Adverse Event|1|||
146555289|NCT02314247|528542445|FG002|Overall Study|Adverse Event|0|||
146555290|NCT02314247|528542443|FG000|Overall Study|Withdrawal by Subject|1|||
146635841|NCT02952820|528841047|FG002|Active Treatment Period (6 Months)|Not treated|1|||
146635842|NCT04139018|528841048|FG000|Overall Study|Screen fail|1|||
146635843|NCT04139018|528841049|FG001|Overall Study|Screen fail|0|||
146635844|NCT04139018|528841048|FG000|Overall Study|Withdrawal by Subject|2|||
146555291|NCT02314247|528542444|FG001|Overall Study|Withdrawal by Subject|3|||
146555292|NCT02314247|528542445|FG002|Overall Study|Withdrawal by Subject|1|||
146555293|NCT02314247|528542443|FG000|Overall Study|Progression of Disease|6|||
146555294|NCT02314247|528542444|FG001|Overall Study|Progression of Disease|2|||
146555295|NCT02314247|528542445|FG002|Overall Study|Progression of Disease|0|||
146555296|NCT01953354|528542446|FG000|Overall Study|Withdrawal by Subject|0|||
146555297|NCT01953354|528542447|FG001|Overall Study|Withdrawal by Subject|1|||
146555298|NCT01953354|528542446|FG000|Overall Study|Decision of Sponsor|0|||
146555299|NCT01953354|528542447|FG001|Overall Study|Decision of Sponsor|1|||
146555300|NCT01953354|528542446|FG000|Overall Study|Disease Exacerbation|1|||
146555301|NCT01953354|528542447|FG001|Overall Study|Disease Exacerbation|0|||
146555302|NCT02571244|528542448|FG000|Overall Study|Lost to Follow-up|0|||
146555303|NCT02571244|528542449|FG001|Overall Study|Lost to Follow-up|1|||
146555304|NCT02571244|528542448|FG000|Overall Study|Unable to reach out post discharge|3|||
146555305|NCT02571244|528542449|FG001|Overall Study|Unable to reach out post discharge|0|||
146555306|NCT01570192|528542450|FG000|Overall Study|no qualifying organism|6|||
146555307|NCT01570192|528542451|FG001|Overall Study|no qualifying organism|12|||
146555308|NCT01570192|528542450|FG000|Overall Study|changed to palliative care|1|||
146555309|NCT01570192|528542451|FG001|Overall Study|changed to palliative care|0|||
146555310|NCT01570192|528542450|FG000|Overall Study|Physician Decision|0|||
146555311|NCT01570192|528542451|FG001|Overall Study|Physician Decision|1|||
146555312|NCT00489359|528542454|FG000|Overall Study|Death|0|||
146555313|NCT00489359|528542455|FG001|Overall Study|Death|2|||
146555314|NCT00489359|528542454|FG000|Overall Study|Progressive Disease|5|||
146555315|NCT00489359|528542455|FG001|Overall Study|Progressive Disease|6|||
146555316|NCT00489359|528542454|FG000|Overall Study|Lost to Follow-up|1|||
146555317|NCT00489359|528542455|FG001|Overall Study|Lost to Follow-up|0|||
146555318|NCT00489359|528542454|FG000|Overall Study|Withdrawal by Subject|1|||
146555319|NCT00489359|528542455|FG001|Overall Study|Withdrawal by Subject|5|||
146555320|NCT00489359|528542454|FG000|Overall Study|Adverse Event|0|||
146555321|NCT00489359|528542455|FG001|Overall Study|Adverse Event|16|||
146555322|NCT04191733|528542456|FG000|Overall Study|Withdrawn due to study closure|13|||
146555323|NCT04191733|528542457|FG001|Overall Study|Withdrawn due to study closure|14|||
146555324|NCT04191733|528542456|FG000|Overall Study|Withdrawal by Subject|2|||
146555325|NCT04191733|528542457|FG001|Overall Study|Withdrawal by Subject|4|||
146555326|NCT04191733|528542456|FG000|Overall Study|Physician Decision|1|||
146555327|NCT04191733|528542457|FG001|Overall Study|Physician Decision|1|||
146555328|NCT04191733|528542456|FG000|Overall Study|Lost to Follow-up|5|||
146555329|NCT04191733|528542457|FG001|Overall Study|Lost to Follow-up|6|||
146555330|NCT04191733|528542456|FG000|Overall Study|Death|0|||
146555331|NCT04191733|528542457|FG001|Overall Study|Death|1|||
146555332|NCT01260311|528542459|FG000|Overall Study|Adverse Event|11|||
146555333|NCT01260311|528542459|FG000|Overall Study|Lack of Efficacy|4|||
146555334|NCT01260311|528542459|FG000|Overall Study|Lost to Follow-up|25|||
146555335|NCT01260311|528542459|FG000|Overall Study|Withdrawal by Subject|6|||
146555336|NCT01260311|528542459|FG000|Overall Study|Financial Constraints|77|||
146555337|NCT01260311|528542459|FG000|Overall Study|Gone to Province|2|||
146555338|NCT01260311|528542459|FG000|Overall Study|Medication Stopped|1|||
146555339|NCT01260311|528542459|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
146555340|NCT01903733|528542462|FG000|Overall Study|Death|23|||
146555341|NCT01903733|528542463|FG001|Overall Study|Death|54|||
146555342|NCT01903733|528542464|FG002|Overall Study|Death|30|||
146555343|NCT01903733|528542465|FG003|Overall Study|Death|98|||
146555344|NCT01903733|528542462|FG000|Overall Study|Participant refused further follow-up|35|||
146555345|NCT01903733|528542463|FG001|Overall Study|Participant refused further follow-up|38|||
146555346|NCT01903733|528542464|FG002|Overall Study|Participant refused further follow-up|13|||
146555347|NCT01903733|528542465|FG003|Overall Study|Participant refused further follow-up|9|||
146555348|NCT01903733|528542462|FG000|Overall Study|Lost to Follow-up|18|||
146555349|NCT01903733|528542463|FG001|Overall Study|Lost to Follow-up|19|||
146555350|NCT01903733|528542464|FG002|Overall Study|Lost to Follow-up|6|||
146555351|NCT01903733|528542465|FG003|Overall Study|Lost to Follow-up|9|||
146555352|NCT01903733|528542462|FG000|Overall Study|Other|10|||
146555353|NCT01903733|528542463|FG001|Overall Study|Other|15|||
146555354|NCT01903733|528542464|FG002|Overall Study|Other|12|||
146555355|NCT01903733|528542465|FG003|Overall Study|Other|3|||
146555356|NCT01903733|528542462|FG000|Overall Study|Missing|2|||
146555357|NCT01903733|528542463|FG001|Overall Study|Missing|0|||
146555358|NCT01903733|528542464|FG002|Overall Study|Missing|0|||
146555359|NCT01903733|528542465|FG003|Overall Study|Missing|0|||
146555360|NCT01903733|528542462|FG000|Overall Study|Investigator request|18|||
146555361|NCT01903733|528542463|FG001|Overall Study|Investigator request|0|||
146555362|NCT01903733|528542464|FG002|Overall Study|Investigator request|0|||
146555363|NCT01903733|528542465|FG003|Overall Study|Investigator request|0|||
146555364|NCT01714063|528542466|FG000|Overall Study|Equipment malfunction|2|||
146555365|NCT03878602|528542467|FG000|Overall Study|cord blood donation|7|||
146555366|NCT03878602|528542468|FG001|Overall Study|cord blood donation|1|||
146555367|NCT03878602|528542467|FG000|Overall Study|incomplete data collection|2|||
146555368|NCT03878602|528542468|FG001|Overall Study|incomplete data collection|0|||
146555369|NCT02191397|528542470|FG000|Overall Study|Adverse Event|28|||
146555370|NCT02191397|528542471|FG001|Overall Study|Adverse Event|17|||
146555371|NCT02191397|528542470|FG000|Overall Study|Lack of Efficacy|10|||
146555372|NCT02191397|528542471|FG001|Overall Study|Lack of Efficacy|5|||
146555373|NCT02191397|528542470|FG000|Overall Study|Protocol Violation|0|||
146555374|NCT02191397|528542471|FG001|Overall Study|Protocol Violation|3|||
146555375|NCT02191397|528542470|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
146555376|NCT02191397|528542471|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
146555377|NCT02191397|528542470|FG000|Overall Study|Lost to Follow-up|10|||
146555378|NCT02191397|528542471|FG001|Overall Study|Lost to Follow-up|11|||
146555379|NCT02191397|528542470|FG000|Overall Study|Physician Decision|8|||
146555380|NCT02191397|528542471|FG001|Overall Study|Physician Decision|3|||
146555381|NCT02191397|528542470|FG000|Overall Study|Withdrawal by Subject|22|||
146555382|NCT02191397|528542471|FG001|Overall Study|Withdrawal by Subject|27|||
146765498|NCT00383188|529308675|FG004|Overall Study|Adverse Event|8|||
146555383|NCT02176525|528542473|FG000|Overall Study|Adverse Event|0|||
146555384|NCT02176525|528542474|FG001|Overall Study|Adverse Event|0|||
146555385|NCT02176525|528542475|FG002|Overall Study|Adverse Event|0|||
146555386|NCT02176525|528542476|FG003|Overall Study|Adverse Event|1|||
146555387|NCT02176525|528542477|FG004|Overall Study|Adverse Event|1|||
146555388|NCT02176525|528542478|FG005|Overall Study|Adverse Event|0|||
146555389|NCT02176525|528542479|FG006|Overall Study|Adverse Event|1|||
146765499|NCT00383188|529308671|FG000|Overall Study|Lack of Efficacy|9|||
146555390|NCT02176525|528542480|FG007|Overall Study|Adverse Event|0|||
146555391|NCT02176525|528542473|FG000|Overall Study|not treated|1|||
146555392|NCT02176525|528542474|FG001|Overall Study|not treated|0|||
146555393|NCT02176525|528542475|FG002|Overall Study|not treated|0|||
146555394|NCT02176525|528542476|FG003|Overall Study|not treated|0|||
146555395|NCT02176525|528542477|FG004|Overall Study|not treated|0|||
146555396|NCT02176525|528542478|FG005|Overall Study|not treated|1|||
146555397|NCT02176525|528542479|FG006|Overall Study|not treated|0|||
146555398|NCT02176525|528542480|FG007|Overall Study|not treated|0|||
146555399|NCT00478140|528542483|FG000|Overall Study|Clinical Disease Progression|1|||
146555400|NCT00728182|528542484|FG000|Overall Study|Adverse Event|1|||
146555401|NCT00728182|528542485|FG001|Overall Study|Adverse Event|0|||
146555402|NCT00728182|528542484|FG000|Overall Study|Lost to Follow-up|2|||
146555403|NCT00728182|528542485|FG001|Overall Study|Lost to Follow-up|0|||
146555404|NCT00728182|528542484|FG000|Overall Study|Death|0|||
146555405|NCT00728182|528542485|FG001|Overall Study|Death|2|||
146555406|NCT00728182|528542484|FG000|Overall Study|Protocol Noncompliance|0|||
146555407|NCT00728182|528542485|FG001|Overall Study|Protocol Noncompliance|1|||
146555408|NCT01725308|528542492|FG000|Treatment Period I|Did Not Receive Drug|1|||
146555409|NCT01725308|528542493|FG001|Treatment Period I|Did Not Receive Drug|0|||
146555410|NCT01725308|528542494|FG002|Treatment Period I|Did Not Receive Drug|0|||
146555411|NCT01725308|528542492|FG000|Treatment Period I|Adverse Event|5|||
146555412|NCT01725308|528542493|FG001|Treatment Period I|Adverse Event|4|||
146555413|NCT01725308|528542494|FG002|Treatment Period I|Adverse Event|21|||
146555414|NCT01725308|528542492|FG000|Treatment Period I|Insufficient Response|7|||
146555415|NCT01725308|528542493|FG001|Treatment Period I|Insufficient Response|0|||
146555416|NCT01725308|528542494|FG002|Treatment Period I|Insufficient Response|5|||
146555417|NCT01725308|528542492|FG000|Treatment Period I|Worsening of the Target Disease|8|||
146555418|NCT01725308|528542493|FG001|Treatment Period I|Worsening of the Target Disease|0|||
146555419|NCT01725308|528542494|FG002|Treatment Period I|Worsening of the Target Disease|2|||
146555420|NCT01725308|528542492|FG000|Treatment Period I|Changes in the Episodes|3|||
146555421|NCT01725308|528542493|FG001|Treatment Period I|Changes in the Episodes|0|||
146555422|NCT01725308|528542494|FG002|Treatment Period I|Changes in the Episodes|2|||
146555423|NCT01725308|528542492|FG000|Treatment Period I|Withdrawal of Consent|12|||
146555424|NCT01725308|528542493|FG001|Treatment Period I|Withdrawal of Consent|7|||
146555425|NCT01725308|528542494|FG002|Treatment Period I|Withdrawal of Consent|5|||
146555426|NCT01725308|528542492|FG000|Treatment Period I|Lost to Follow-up|3|||
146555427|NCT01725308|528542493|FG001|Treatment Period I|Lost to Follow-up|2|||
146555428|NCT01725308|528542494|FG002|Treatment Period I|Lost to Follow-up|2|||
146555429|NCT01725308|528542492|FG000|Treatment Period I|Protocol Deviations|3|||
146555430|NCT01725308|528542493|FG001|Treatment Period I|Protocol Deviations|1|||
146555431|NCT01725308|528542494|FG002|Treatment Period I|Protocol Deviations|1|||
146555432|NCT01725308|528542492|FG000|Treatment Period I|Miscellaneous|2|||
146765500|NCT00383188|529308672|FG001|Overall Study|Lack of Efficacy|3|||
146765501|NCT00383188|529308673|FG002|Overall Study|Lack of Efficacy|3|||
146765502|NCT00383188|529308674|FG003|Overall Study|Lack of Efficacy|2|||
146765503|NCT00383188|529308675|FG004|Overall Study|Lack of Efficacy|6|||
146765504|NCT00383188|529308671|FG000|Overall Study|Other|3|||
146765505|NCT00383188|529308672|FG001|Overall Study|Other|1|||
146765506|NCT00383188|529308673|FG002|Overall Study|Other|0|||
146765507|NCT00383188|529308674|FG003|Overall Study|Other|2|||
146765508|NCT00383188|529308675|FG004|Overall Study|Other|6|||
146765509|NCT00383188|529308671|FG000|Overall Study|No longer willing to participate|1|||
146765510|NCT00383188|529308672|FG001|Overall Study|No longer willing to participate|0|||
146765511|NCT00383188|529308673|FG002|Overall Study|No longer willing to participate|1|||
146765512|NCT00383188|529308674|FG003|Overall Study|No longer willing to participate|0|||
146765513|NCT00383188|529308675|FG004|Overall Study|No longer willing to participate|2|||
146765514|NCT00383188|529308671|FG000|Overall Study|Lost to Follow-up|0|||
146765515|NCT00383188|529308672|FG001|Overall Study|Lost to Follow-up|0|||
146765516|NCT00383188|529308673|FG002|Overall Study|Lost to Follow-up|0|||
146765517|NCT00383188|529308674|FG003|Overall Study|Lost to Follow-up|0|||
146765518|NCT00383188|529308675|FG004|Overall Study|Lost to Follow-up|1|||
146765519|NCT00597519|529308676|FG000|Overall Study|Death|1|||
146765520|NCT00410124|529308677|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
146765521|NCT00410124|529308678|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
146765522|NCT00410124|529308677|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
146765523|NCT00410124|529308678|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
146765524|NCT00410124|529308677|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
146765525|NCT00410124|529308678|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
146765526|NCT00410124|529308677|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
146765527|NCT00410124|529308678|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
146765528|NCT00410124|529308677|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
146765529|NCT00410124|529308678|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
146765530|NCT00410124|529308677|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
146765531|NCT00410124|529308678|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
146765532|NCT00410124|529308677|FG000|Core Phase Double Blind (15 Months)|Death|7|||
146765533|NCT00410124|529308678|FG001|Core Phase Double Blind (15 Months)|Death|4|||
146765534|NCT00410124|529308677|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
146765535|NCT00410124|529308678|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
146765536|NCT00410124|529308677|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
146765537|NCT00410124|529308678|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
146765538|NCT00410124|529308677|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
146765539|NCT00410124|529308678|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
146765540|NCT00410124|529308677|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
146765541|NCT00410124|529308678|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
146765542|NCT00410124|529308677|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
146765543|NCT00410124|529308678|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
146555433|NCT01725308|528542493|FG001|Treatment Period I|Miscellaneous|0|||
146765544|NCT00410124|529308677|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
146765545|NCT00410124|529308678|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
146765546|NCT00410124|529308677|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
146887905|NCT02161211|529755826|FG002|Overall Study|Dropped|9|||
146887906|NCT03889639|529755828|FG000|Overall Study|Withdrawal by Subject|0|||
146887907|NCT03889639|529755829|FG001|Overall Study|Withdrawal by Subject|0|||
146887908|NCT03889639|529755830|FG002|Overall Study|Withdrawal by Subject|0|||
146887909|NCT03889639|529755831|FG003|Overall Study|Withdrawal by Subject|0|||
146887910|NCT03889639|529755832|FG004|Overall Study|Withdrawal by Subject|0|||
146555434|NCT01725308|528542494|FG002|Treatment Period I|Miscellaneous|3|||
146635845|NCT04139018|528841049|FG001|Overall Study|Withdrawal by Subject|0|||
146635846|NCT04139018|528841048|FG000|Overall Study|Lost to Follow-up|0|||
146765547|NCT00410124|529308678|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
146765548|NCT00410124|529308677|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
146555435|NCT01725308|528542492|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
146555436|NCT01725308|528542493|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
146555437|NCT01725308|528542494|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
146555438|NCT01725308|528542492|FG000|Treatment Period II|Did Not Receive Drug|4|||
146555439|NCT01725308|528542493|FG001|Treatment Period II|Did Not Receive Drug|0|||
146555440|NCT01725308|528542494|FG002|Treatment Period II|Did Not Receive Drug|0|||
146555441|NCT01725308|528542492|FG000|Treatment Period II|Adverse Event|13|||
146555442|NCT01725308|528542493|FG001|Treatment Period II|Adverse Event|8|||
146555443|NCT01725308|528542494|FG002|Treatment Period II|Adverse Event|20|||
146555444|NCT01725308|528542492|FG000|Treatment Period II|Insufficient Response|2|||
146555445|NCT01725308|528542493|FG001|Treatment Period II|Insufficient Response|4|||
146555446|NCT01725308|528542494|FG002|Treatment Period II|Insufficient Response|6|||
146555447|NCT01725308|528542492|FG000|Treatment Period II|Worsening of the Target Disease|1|||
146555448|NCT01725308|528542493|FG001|Treatment Period II|Worsening of the Target Disease|4|||
146555449|NCT01725308|528542494|FG002|Treatment Period II|Worsening of the Target Disease|2|||
146555450|NCT01725308|528542492|FG000|Treatment Period II|Changes in the Episodes|1|||
146555451|NCT01725308|528542493|FG001|Treatment Period II|Changes in the Episodes|0|||
146555452|NCT01725308|528542494|FG002|Treatment Period II|Changes in the Episodes|5|||
146555453|NCT01725308|528542492|FG000|Treatment Period II|Withdrawal of Consent|28|||
146555454|NCT01725308|528542493|FG001|Treatment Period II|Withdrawal of Consent|2|||
146555455|NCT01725308|528542494|FG002|Treatment Period II|Withdrawal of Consent|16|||
146555456|NCT01725308|528542492|FG000|Treatment Period II|Lost to Follow-up|1|||
146555457|NCT01725308|528542493|FG001|Treatment Period II|Lost to Follow-up|5|||
146555458|NCT01725308|528542494|FG002|Treatment Period II|Lost to Follow-up|3|||
146555459|NCT01725308|528542492|FG000|Treatment Period II|Protocol Deviations|0|||
146555460|NCT01725308|528542493|FG001|Treatment Period II|Protocol Deviations|0|||
146555461|NCT01725308|528542494|FG002|Treatment Period II|Protocol Deviations|1|||
146555462|NCT01725308|528542492|FG000|Treatment Period II|Miscellaneous|5|||
146555463|NCT01725308|528542493|FG001|Treatment Period II|Miscellaneous|3|||
146555464|NCT01725308|528542494|FG002|Treatment Period II|Miscellaneous|7|||
146555465|NCT02971137|528542500|FG000|Overall Study|Lost to Follow-up|44|||
146555466|NCT02971137|528542501|FG001|Overall Study|Lost to Follow-up|56|||
146555467|NCT00911157|528542502|FG000|Overall Study|Adverse Event|4|||
146555468|NCT00911157|528542503|FG001|Overall Study|Adverse Event|1|||
146555469|NCT00911157|528542502|FG000|Overall Study|Withdrawal by Subject|1|||
146555470|NCT00911157|528542503|FG001|Overall Study|Withdrawal by Subject|1|||
146555471|NCT00911157|528542502|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
146555472|NCT00911157|528542503|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
146555473|NCT00911157|528542502|FG000|Overall Study|Need to treat for lung cancer|1|||
146555474|NCT00911157|528542503|FG001|Overall Study|Need to treat for lung cancer|0|||
146635847|NCT04139018|528841049|FG001|Overall Study|Lost to Follow-up|1|||
146635848|NCT02565108|528841050|FG000|Overall Study|Adverse Event|1|||
146635849|NCT02565108|528841051|FG001|Overall Study|Adverse Event|0|||
146635850|NCT02565108|528841050|FG000|Overall Study|Withdrew Consent|1|||
146635851|NCT02565108|528841051|FG001|Overall Study|Withdrew Consent|0|||
146635852|NCT01310075|528841068|FG000|Overall Study|Lost to Follow-up|1|||
146635853|NCT01310075|528841069|FG001|Overall Study|Lost to Follow-up|0|||
146635854|NCT01310075|528841068|FG000|Overall Study|Physician Decision|10|||
146555475|NCT00215657|528542507|FG000|Overall Study|Adverse Event|5|||
146555476|NCT00215657|528542508|FG001|Overall Study|Adverse Event|1|||
146765549|NCT00410124|529308678|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
146765550|NCT00410124|529308677|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
146765551|NCT00410124|529308678|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
146765552|NCT05484726|529308679|FG000|Overall Study|Protocol Violation|3|||
146765553|NCT05484726|529308680|FG001|Overall Study|Protocol Violation|3|||
146765554|NCT05484726|529308679|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
146765555|NCT05484726|529308680|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
146765556|NCT05484726|529308679|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
146765557|NCT05484726|529308680|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
146765558|NCT05484726|529308679|FG000|Overall Study|continued need of mechanical ventilation|2|||
146555477|NCT00215657|528542509|FG002|Overall Study|Adverse Event|3|||
146555478|NCT00215657|528542510|FG003|Overall Study|Adverse Event|0|||
146555479|NCT00215657|528542511|FG004|Overall Study|Adverse Event|3|||
146555480|NCT00215657|528542512|FG005|Overall Study|Adverse Event|1|||
146555481|NCT00215657|528542513|FG006|Overall Study|Adverse Event|0|||
146555482|NCT00215657|528542514|FG007|Overall Study|Adverse Event|3|||
146555483|NCT00215657|528542507|FG000|Overall Study|Withdrawal by Subject|6|||
146555484|NCT00215657|528542508|FG001|Overall Study|Withdrawal by Subject|3|||
146555485|NCT00215657|528542509|FG002|Overall Study|Withdrawal by Subject|3|||
146765559|NCT05484726|529308680|FG001|Overall Study|continued need of mechanical ventilation|3|||
146765560|NCT05484726|529308679|FG000|Overall Study|Withdrawal by Subject|2|||
146555486|NCT00215657|528542510|FG003|Overall Study|Withdrawal by Subject|1|||
146635855|NCT01310075|528841069|FG001|Overall Study|Physician Decision|7|||
146635856|NCT01310075|528841068|FG000|Overall Study|Protocol Violation|2|||
146765561|NCT05484726|529308680|FG001|Overall Study|Withdrawal by Subject|3|||
146635857|NCT01310075|528841069|FG001|Overall Study|Protocol Violation|2|||
146635858|NCT01310075|528841068|FG000|Overall Study|Withdrawal by Subject|1|||
146635859|NCT01310075|528841069|FG001|Overall Study|Withdrawal by Subject|1|||
146765562|NCT05484726|529308679|FG000|Overall Study|IVH (G III & IV)|2|||
146765563|NCT05484726|529308680|FG001|Overall Study|IVH (G III & IV)|1|||
146765564|NCT05484726|529308679|FG000|Overall Study|NEC (stage II & III)|2|||
146765565|NCT05484726|529308680|FG001|Overall Study|NEC (stage II & III)|3|||
146765566|NCT02781584|529308681|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
146765567|NCT02781584|529308682|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
146765568|NCT02781584|529308683|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
146765569|NCT02781584|529308684|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
146765570|NCT02781584|529308685|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
146555487|NCT00215657|528542511|FG004|Overall Study|Withdrawal by Subject|6|||
146635860|NCT03614156|528841070|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
146635861|NCT03614156|528841071|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
146635862|NCT03614156|528841072|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
146635863|NCT03614156|528841073|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
146635864|NCT03614156|528841070|FG000|Open-Label Treatment Period|Adverse Event|7|||
146635865|NCT03614156|528841071|FG001|Open-Label Treatment Period|Adverse Event|0|||
146635866|NCT03614156|528841072|FG002|Open-Label Treatment Period|Adverse Event|0|||
146635867|NCT03614156|528841073|FG003|Open-Label Treatment Period|Adverse Event|0|||
146635868|NCT03614156|528841070|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
146635869|NCT03614156|528841071|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
146635870|NCT03614156|528841072|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
146635871|NCT03614156|528841073|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
146635872|NCT03614156|528841070|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
146635873|NCT03614156|528841071|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
146635874|NCT03614156|528841072|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
146635875|NCT03614156|528841073|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
146635876|NCT03614156|528841070|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
146635877|NCT03614156|528841071|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
146635878|NCT03614156|528841072|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
146765571|NCT02781584|529308686|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
146765572|NCT02781584|529308687|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
146887911|NCT03889639|529755833|FG005|Overall Study|Withdrawal by Subject|0|||
146887912|NCT03889639|529755834|FG006|Overall Study|Withdrawal by Subject|0|||
146555488|NCT00215657|528542512|FG005|Overall Study|Withdrawal by Subject|1|||
146555489|NCT00215657|528542513|FG006|Overall Study|Withdrawal by Subject|10|||
146635879|NCT03614156|528841073|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
146765573|NCT02781584|529308688|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
146765574|NCT02781584|529308689|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
146635880|NCT03614156|528841070|FG000|Open-Label Treatment Period|Protocol Violation|2|||
146555490|NCT00215657|528542514|FG007|Overall Study|Withdrawal by Subject|3|||
146555491|NCT00215657|528542507|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
146555492|NCT00215657|528542508|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
146555493|NCT00215657|528542509|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
146555494|NCT00215657|528542510|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
146555495|NCT00215657|528542511|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
146555496|NCT00215657|528542512|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
146555497|NCT00215657|528542513|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
146555498|NCT00215657|528542514|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
146555499|NCT00215657|528542507|FG000|Overall Study|Insufficient testosterone response|5|||
146555500|NCT00215657|528542508|FG001|Overall Study|Insufficient testosterone response|4|||
146555501|NCT00215657|528542509|FG002|Overall Study|Insufficient testosterone response|1|||
146555502|NCT00215657|528542510|FG003|Overall Study|Insufficient testosterone response|12|||
146555503|NCT00215657|528542511|FG004|Overall Study|Insufficient testosterone response|8|||
146555504|NCT00215657|528542512|FG005|Overall Study|Insufficient testosterone response|12|||
146555505|NCT00215657|528542513|FG006|Overall Study|Insufficient testosterone response|4|||
146555506|NCT00215657|528542514|FG007|Overall Study|Insufficient testosterone response|7|||
146555507|NCT00215657|528542507|FG000|Overall Study|Other|3|||
146555508|NCT00215657|528542508|FG001|Overall Study|Other|1|||
146555509|NCT00215657|528542509|FG002|Overall Study|Other|2|||
146555510|NCT00215657|528542510|FG003|Overall Study|Other|3|||
146555511|NCT00215657|528542511|FG004|Overall Study|Other|5|||
146555512|NCT00215657|528542512|FG005|Overall Study|Other|4|||
146555513|NCT00215657|528542513|FG006|Overall Study|Other|6|||
146555514|NCT00215657|528542514|FG007|Overall Study|Other|1|||
146555515|NCT02614066|528542515|FG000|Overall Study|Death|6|||
146555516|NCT02614066|528542516|FG001|Overall Study|Death|14|||
146555517|NCT02614066|528542517|FG002|Overall Study|Death|11|||
146555518|NCT02614066|528542518|FG003|Overall Study|Death|29|||
146555519|NCT02614066|528542515|FG000|Overall Study|Full consent withdrawn|0|||
146555520|NCT02614066|528542516|FG001|Overall Study|Full consent withdrawn|1|||
146555521|NCT02614066|528542517|FG002|Overall Study|Full consent withdrawn|0|||
146555522|NCT02614066|528542518|FG003|Overall Study|Full consent withdrawn|8|||
146555523|NCT02614066|528542515|FG000|Overall Study|Lost to Follow-up|0|||
146555524|NCT02614066|528542516|FG001|Overall Study|Lost to Follow-up|2|||
146555525|NCT02614066|528542517|FG002|Overall Study|Lost to Follow-up|2|||
146555526|NCT02614066|528542518|FG003|Overall Study|Lost to Follow-up|2|||
146555527|NCT02614066|528542515|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
146555528|NCT02614066|528542516|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
146555529|NCT02614066|528542517|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
146555530|NCT02614066|528542518|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
146635881|NCT03614156|528841071|FG001|Open-Label Treatment Period|Protocol Violation|0|||
146635882|NCT03614156|528841072|FG002|Open-Label Treatment Period|Protocol Violation|0|||
146635883|NCT03614156|528841073|FG003|Open-Label Treatment Period|Protocol Violation|0|||
146635884|NCT03614156|528841070|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
146635885|NCT03614156|528841071|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
146555531|NCT02614066|528542515|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
146555532|NCT02614066|528542516|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
146555533|NCT02614066|528542517|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
146555534|NCT02614066|528542518|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
146555535|NCT02614066|528542515|FG000|Overall Study|Reason not specified|0|||
146555536|NCT02614066|528542516|FG001|Overall Study|Reason not specified|2|||
146555537|NCT02614066|528542517|FG002|Overall Study|Reason not specified|1|||
146555538|NCT02614066|528542518|FG003|Overall Study|Reason not specified|1|||
146555539|NCT01539525|528542531|FG000|Overall Study|Lost to Follow-up|19|||
146555540|NCT01539525|528542532|FG001|Overall Study|Lost to Follow-up|12|||
146555541|NCT01539525|528542533|FG002|Overall Study|Lost to Follow-up|11|||
146555542|NCT01539525|528542531|FG000|Overall Study|Withdrawal by Subject|0|||
146555543|NCT01539525|528542532|FG001|Overall Study|Withdrawal by Subject|3|||
146555544|NCT01539525|528542533|FG002|Overall Study|Withdrawal by Subject|2|||
146555545|NCT01539525|528542531|FG000|Overall Study|Protocol Violation|1|||
146555546|NCT01539525|528542532|FG001|Overall Study|Protocol Violation|1|||
146555547|NCT01539525|528542533|FG002|Overall Study|Protocol Violation|4|||
146555548|NCT02205359|528542535|FG000|Overall Study|Death|293|||
146635886|NCT03614156|528841072|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
146887913|NCT03889639|529755835|FG007|Overall Study|Withdrawal by Subject|1|||
146555549|NCT02205359|528542536|FG001|Overall Study|Death|327|||
146555550|NCT02205359|528542535|FG000|Overall Study|Lost to Follow-up|182|||
146555551|NCT02205359|528542536|FG001|Overall Study|Lost to Follow-up|162|||
146555552|NCT02205359|528542535|FG000|Overall Study|Physician Decision|51|||
146555553|NCT02205359|528542536|FG001|Overall Study|Physician Decision|53|||
146887914|NCT00993031|529755838|FG000|Overall Study|Death|0|||
146887915|NCT00993031|529755839|FG001|Overall Study|Death|1|||
146887916|NCT00993031|529755838|FG000|Overall Study|Physician Decision|0|||
146555554|NCT02205359|528542535|FG000|Overall Study|Withdrawal by Subject|167|||
146555555|NCT02205359|528542536|FG001|Overall Study|Withdrawal by Subject|169|||
146635887|NCT03614156|528841073|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
146635888|NCT03614156|528841070|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
146635889|NCT03614156|528841071|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
146635890|NCT03614156|528841072|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
146635891|NCT03614156|528841073|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
146635892|NCT03614156|528841070|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
146635893|NCT03614156|528841071|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
146635894|NCT03614156|528841072|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
146887917|NCT00993031|529755839|FG001|Overall Study|Physician Decision|2|||
146887918|NCT00993031|529755838|FG000|Overall Study|Withdrawal by Subject|3|||
146555556|NCT02496156|528542539|FG000|Overall Study|Lost to Follow-up|5|||
146555557|NCT02496156|528542540|FG001|Overall Study|Lost to Follow-up|0|||
146555558|NCT02496156|528542539|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
146555559|NCT02496156|528542540|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
146555560|NCT01412983|528542541|FG000|1st Period|Ineligible|0|||
146555561|NCT01412983|528542542|FG001|1st Period|Ineligible|1|||
146555562|NCT01412983|528542541|FG000|1st Period|Positive slit lamp finding|0|||
146555563|NCT01412983|528542542|FG001|1st Period|Positive slit lamp finding|1|||
146555564|NCT01412983|528542541|FG000|1st Period|Unacceptable lens movement|0|||
146555565|NCT01412983|528542542|FG001|1st Period|Unacceptable lens movement|1|||
146555566|NCT01412983|528542541|FG000|1st Period|Inability to maintain wear|0|||
146555567|NCT01412983|528542542|FG001|1st Period|Inability to maintain wear|1|||
146555568|NCT00890097|528542543|FG000|Overall Study|Adverse Event|21|||
146555569|NCT00890097|528542544|FG001|Overall Study|Adverse Event|32|||
146555570|NCT00890097|528542545|FG002|Overall Study|Adverse Event|28|||
146555571|NCT00890097|528542543|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
146555572|NCT00890097|528542544|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
146555573|NCT00890097|528542545|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
146555574|NCT00890097|528542543|FG000|Overall Study|Withdrew Consent|9|||
146555575|NCT00890097|528542544|FG001|Overall Study|Withdrew Consent|6|||
146555576|NCT00890097|528542545|FG002|Overall Study|Withdrew Consent|9|||
146555577|NCT00890097|528542543|FG000|Overall Study|Lost to Follow-up|5|||
146555578|NCT00890097|528542544|FG001|Overall Study|Lost to Follow-up|5|||
146555579|NCT00890097|528542545|FG002|Overall Study|Lost to Follow-up|5|||
146555580|NCT00890097|528542543|FG000|Overall Study|Noncompliance|0|||
146555581|NCT00890097|528542544|FG001|Overall Study|Noncompliance|4|||
146555582|NCT00890097|528542545|FG002|Overall Study|Noncompliance|4|||
146555583|NCT00890097|528542543|FG000|Overall Study|Sponsor Decision|7|||
146555584|NCT00890097|528542544|FG001|Overall Study|Sponsor Decision|11|||
146555585|NCT00890097|528542545|FG002|Overall Study|Sponsor Decision|7|||
146555586|NCT00890097|528542543|FG000|Overall Study|Did not attend final visit|2|||
146555587|NCT00890097|528542544|FG001|Overall Study|Did not attend final visit|3|||
146555588|NCT00890097|528542545|FG002|Overall Study|Did not attend final visit|0|||
146555589|NCT00890097|528542543|FG000|Overall Study|Subject Decision|3|||
146555590|NCT00890097|528542544|FG001|Overall Study|Subject Decision|2|||
146555591|NCT00890097|528542545|FG002|Overall Study|Subject Decision|6|||
146555592|NCT00890097|528542543|FG000|Overall Study|Randomization Error|2|||
146555593|NCT00890097|528542544|FG001|Overall Study|Randomization Error|0|||
146555594|NCT00890097|528542545|FG002|Overall Study|Randomization Error|0|||
146555595|NCT00890097|528542543|FG000|Overall Study|Failed inclusion criteria|3|||
146555596|NCT00890097|528542544|FG001|Overall Study|Failed inclusion criteria|4|||
146635895|NCT03614156|528841073|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
146635896|NCT03614156|528841070|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
146635897|NCT03614156|528841071|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
146635898|NCT03614156|528841072|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
146635899|NCT03614156|528841073|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
146635900|NCT03614156|528841070|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146635901|NCT03614156|528841071|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146635902|NCT03614156|528841072|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
146635903|NCT03614156|528841073|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
146635904|NCT03614156|528841070|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
146635905|NCT03614156|528841071|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
146635906|NCT03614156|528841072|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
146635907|NCT03614156|528841073|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
146635908|NCT03614156|528841070|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
146635909|NCT03614156|528841071|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
146635910|NCT03614156|528841072|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
146555597|NCT00890097|528542545|FG002|Overall Study|Failed inclusion criteria|0|||
146635911|NCT03614156|528841073|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
146635912|NCT03614156|528841070|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
146555598|NCT00890097|528542543|FG000|Overall Study|Transportation|0|||
146555599|NCT00890097|528542544|FG001|Overall Study|Transportation|2|||
146635913|NCT03614156|528841071|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
146635914|NCT03614156|528841072|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
146555600|NCT00890097|528542545|FG002|Overall Study|Transportation|0|||
146555601|NCT00890097|528542543|FG000|Overall Study|Subject Moved|0|||
146555602|NCT00890097|528542544|FG001|Overall Study|Subject Moved|4|||
146555603|NCT00890097|528542545|FG002|Overall Study|Subject Moved|0|||
146555604|NCT00890097|528542543|FG000|Overall Study|Protocol Deviation|1|||
146555605|NCT00890097|528542544|FG001|Overall Study|Protocol Deviation|1|||
146555606|NCT00890097|528542545|FG002|Overall Study|Protocol Deviation|1|||
146555607|NCT01703221|528542546|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
146887919|NCT00993031|529755839|FG001|Overall Study|Withdrawal by Subject|3|||
146887920|NCT00993031|529755838|FG000|Overall Study|Lost to Follow-up|19|||
146887921|NCT00993031|529755839|FG001|Overall Study|Lost to Follow-up|13|||
146887922|NCT01834729|529755843|FG000|Overall Study|Did not return bowel diaries|0|||
146887923|NCT01834729|529755844|FG001|Overall Study|Did not return bowel diaries|0|||
146887924|NCT01834729|529755845|FG002|Overall Study|Did not return bowel diaries|3|||
146887925|NCT01834729|529755846|FG003|Overall Study|Did not return bowel diaries|0|||
146887926|NCT01834729|529755843|FG000|Overall Study|Withdrawal by Subject|1|||
146887927|NCT01834729|529755844|FG001|Overall Study|Withdrawal by Subject|1|||
146887928|NCT01834729|529755845|FG002|Overall Study|Withdrawal by Subject|0|||
146887929|NCT01834729|529755846|FG003|Overall Study|Withdrawal by Subject|0|||
146887930|NCT01834729|529755843|FG000|Overall Study|Adverse Event|0|||
146887931|NCT01834729|529755844|FG001|Overall Study|Adverse Event|0|||
146887932|NCT01834729|529755845|FG002|Overall Study|Adverse Event|0|||
146887933|NCT01834729|529755846|FG003|Overall Study|Adverse Event|2|||
146887934|NCT00143455|529755850|FG000|Cohort 1|Adverse Event|8|||
146887935|NCT00143455|529755851|FG001|Cohort 1|Adverse Event|4|||
146887936|NCT00143455|529755852|FG002|Cohort 1|Adverse Event|0|||
146887937|NCT00143455|529755853|FG003|Cohort 1|Adverse Event|0|||
146887938|NCT00143455|529755850|FG000|Cohort 1|Death|5|||
146887939|NCT00143455|529755851|FG001|Cohort 1|Death|2|||
146887940|NCT00143455|529755852|FG002|Cohort 1|Death|0|||
146887941|NCT00143455|529755853|FG003|Cohort 1|Death|0|||
146887942|NCT00143455|529755850|FG000|Cohort 1|Progressive Disease|0|||
146887943|NCT00143455|529755851|FG001|Cohort 1|Progressive Disease|6|||
146887944|NCT00143455|529755852|FG002|Cohort 1|Progressive Disease|0|||
146887945|NCT00143455|529755853|FG003|Cohort 1|Progressive Disease|0|||
146887946|NCT00143455|529755850|FG000|Cohort 1|Withdrawal by Subject|1|||
146887947|NCT00143455|529755851|FG001|Cohort 1|Withdrawal by Subject|4|||
146887948|NCT00143455|529755852|FG002|Cohort 1|Withdrawal by Subject|0|||
146887949|NCT00143455|529755853|FG003|Cohort 1|Withdrawal by Subject|0|||
146887950|NCT00143455|529755850|FG000|Cohort 1|Randomized But Not Treated|0|||
146887951|NCT00143455|529755851|FG001|Cohort 1|Randomized But Not Treated|1|||
146887952|NCT00143455|529755852|FG002|Cohort 1|Randomized But Not Treated|0|||
146887953|NCT00143455|529755853|FG003|Cohort 1|Randomized But Not Treated|0|||
146887954|NCT00143455|529755850|FG000|Cohort 2|Adverse Event|0|||
146887955|NCT00143455|529755851|FG001|Cohort 2|Adverse Event|0|||
146887956|NCT00143455|529755852|FG002|Cohort 2|Adverse Event|42|||
146887957|NCT00143455|529755853|FG003|Cohort 2|Adverse Event|30|||
146887958|NCT00143455|529755850|FG000|Cohort 2|No Longer Required Study Treatment|0|||
146887959|NCT00143455|529755851|FG001|Cohort 2|No Longer Required Study Treatment|0|||
146887960|NCT00143455|529755852|FG002|Cohort 2|No Longer Required Study Treatment|1|||
146887961|NCT00143455|529755853|FG003|Cohort 2|No Longer Required Study Treatment|0|||
146887962|NCT00143455|529755850|FG000|Cohort 2|Protocol Violation|0|||
146887963|NCT00143455|529755851|FG001|Cohort 2|Protocol Violation|0|||
146887964|NCT00143455|529755852|FG002|Cohort 2|Protocol Violation|1|||
146887965|NCT00143455|529755853|FG003|Cohort 2|Protocol Violation|1|||
146887966|NCT00143455|529755850|FG000|Cohort 2|Lost to Follow-up|0|||
146887967|NCT00143455|529755851|FG001|Cohort 2|Lost to Follow-up|0|||
146887968|NCT00143455|529755852|FG002|Cohort 2|Lost to Follow-up|1|||
146887969|NCT00143455|529755853|FG003|Cohort 2|Lost to Follow-up|4|||
146887970|NCT00143455|529755850|FG000|Cohort 2|Death|0|||
146887971|NCT00143455|529755851|FG001|Cohort 2|Death|0|||
146887972|NCT00143455|529755852|FG002|Cohort 2|Death|20|||
146887973|NCT00143455|529755853|FG003|Cohort 2|Death|12|||
146887974|NCT00143455|529755850|FG000|Cohort 2|Progressive Disease|0|||
146887975|NCT00143455|529755851|FG001|Cohort 2|Progressive Disease|0|||
146887976|NCT00143455|529755852|FG002|Cohort 2|Progressive Disease|20|||
146887977|NCT00143455|529755853|FG003|Cohort 2|Progressive Disease|27|||
146887978|NCT00143455|529755850|FG000|Cohort 2|Withdrawal by Subject|0|||
146887979|NCT00143455|529755851|FG001|Cohort 2|Withdrawal by Subject|0|||
146555608|NCT01703221|528542547|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
146887980|NCT00143455|529755852|FG002|Cohort 2|Withdrawal by Subject|13|||
146887981|NCT00143455|529755853|FG003|Cohort 2|Withdrawal by Subject|12|||
146887982|NCT00143455|529755850|FG000|Cohort 2|Other|0|||
146887983|NCT00143455|529755851|FG001|Cohort 2|Other|0|||
146887984|NCT00143455|529755852|FG002|Cohort 2|Other|7|||
146887985|NCT00143455|529755853|FG003|Cohort 2|Other|6|||
146887986|NCT00143455|529755850|FG000|Cohort 2|Randomized But Not Treated|0|||
146887987|NCT00143455|529755851|FG001|Cohort 2|Randomized But Not Treated|0|||
146887988|NCT00143455|529755852|FG002|Cohort 2|Randomized But Not Treated|1|||
146887989|NCT00143455|529755853|FG003|Cohort 2|Randomized But Not Treated|1|||
146887990|NCT02387580|529755854|FG000|Overall Study|Withdrawal by Subject|0|||
146887991|NCT02387580|529755855|FG001|Overall Study|Withdrawal by Subject|0|||
146887992|NCT02387580|529755856|FG002|Overall Study|Withdrawal by Subject|0|||
146887993|NCT02387580|529755857|FG003|Overall Study|Withdrawal by Subject|1|||
146887994|NCT02387580|529755858|FG004|Overall Study|Withdrawal by Subject|0|||
146887995|NCT02387580|529755859|FG005|Overall Study|Withdrawal by Subject|0|||
146555609|NCT01703221|528542548|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
146765575|NCT02781584|529308690|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
146765576|NCT02781584|529308691|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
146555610|NCT01703221|528542546|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
146555611|NCT01703221|528542547|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
146555612|NCT01703221|528542548|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
146555613|NCT01703221|528542546|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
146555614|NCT01703221|528542547|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146555615|NCT01703221|528542548|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146555616|NCT01703221|528542546|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
146555617|NCT01703221|528542547|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
146555618|NCT01703221|528542548|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
146555619|NCT01703221|528542546|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146555620|NCT01703221|528542547|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146555621|NCT01703221|528542548|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
146555622|NCT01703221|528542546|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
146555623|NCT01703221|528542547|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
146555624|NCT01703221|528542548|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
146555625|NCT01703221|528542546|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
146555626|NCT01703221|528542547|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
146765577|NCT02781584|529308692|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
146765578|NCT02781584|529308693|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
146765579|NCT02781584|529308681|FG000|Pre-treatment Phase|Adverse Event|0|||
146765580|NCT02781584|529308682|FG001|Pre-treatment Phase|Adverse Event|0|||
146765581|NCT02781584|529308683|FG002|Pre-treatment Phase|Adverse Event|0|||
146765582|NCT02781584|529308684|FG003|Pre-treatment Phase|Adverse Event|0|||
146765583|NCT02781584|529308685|FG004|Pre-treatment Phase|Adverse Event|0|||
146765584|NCT02781584|529308686|FG005|Pre-treatment Phase|Adverse Event|0|||
146765585|NCT02781584|529308687|FG006|Pre-treatment Phase|Adverse Event|0|||
146765586|NCT02781584|529308688|FG007|Pre-treatment Phase|Adverse Event|0|||
146765587|NCT02781584|529308689|FG008|Pre-treatment Phase|Adverse Event|0|||
146765588|NCT02781584|529308690|FG009|Pre-treatment Phase|Adverse Event|0|||
146765589|NCT02781584|529308691|FG010|Pre-treatment Phase|Adverse Event|0|||
146765590|NCT02781584|529308692|FG011|Pre-treatment Phase|Adverse Event|1|||
146765591|NCT02781584|529308693|FG012|Pre-treatment Phase|Adverse Event|0|||
146765592|NCT02781584|529308681|FG000|Treatment Phase|Withdrew Consent|0|||
146765593|NCT02781584|529308682|FG001|Treatment Phase|Withdrew Consent|0|||
146765594|NCT02781584|529308683|FG002|Treatment Phase|Withdrew Consent|0|||
146765595|NCT02781584|529308684|FG003|Treatment Phase|Withdrew Consent|0|||
146765596|NCT02781584|529308685|FG004|Treatment Phase|Withdrew Consent|0|||
146765597|NCT02781584|529308686|FG005|Treatment Phase|Withdrew Consent|1|||
146765598|NCT02781584|529308687|FG006|Treatment Phase|Withdrew Consent|0|||
146765599|NCT02781584|529308688|FG007|Treatment Phase|Withdrew Consent|0|||
146765600|NCT02781584|529308689|FG008|Treatment Phase|Withdrew Consent|0|||
146765601|NCT02781584|529308690|FG009|Treatment Phase|Withdrew Consent|0|||
146765602|NCT02781584|529308691|FG010|Treatment Phase|Withdrew Consent|1|||
146765603|NCT02781584|529308692|FG011|Treatment Phase|Withdrew Consent|2|||
146765604|NCT02781584|529308693|FG012|Treatment Phase|Withdrew Consent|0|||
146765605|NCT02781584|529308681|FG000|Treatment Phase|Adverse Event|0|||
146765606|NCT02781584|529308682|FG001|Treatment Phase|Adverse Event|0|||
146765607|NCT02781584|529308683|FG002|Treatment Phase|Adverse Event|0|||
146765608|NCT02781584|529308684|FG003|Treatment Phase|Adverse Event|0|||
146765609|NCT02781584|529308685|FG004|Treatment Phase|Adverse Event|0|||
146765610|NCT02781584|529308686|FG005|Treatment Phase|Adverse Event|0|||
146765611|NCT02781584|529308687|FG006|Treatment Phase|Adverse Event|0|||
146765612|NCT02781584|529308688|FG007|Treatment Phase|Adverse Event|1|||
146765613|NCT02781584|529308689|FG008|Treatment Phase|Adverse Event|0|||
146765614|NCT02781584|529308690|FG009|Treatment Phase|Adverse Event|0|||
146765615|NCT02781584|529308691|FG010|Treatment Phase|Adverse Event|0|||
146765616|NCT02781584|529308692|FG011|Treatment Phase|Adverse Event|0|||
146765617|NCT02781584|529308693|FG012|Treatment Phase|Adverse Event|0|||
146765618|NCT03396913|529308694|FG000|Overall Study|Lost to Follow-up|0|||
146765619|NCT03396913|529308695|FG001|Overall Study|Lost to Follow-up|6|||
146765620|NCT04771273|529308698|FG000|Dose Escalation Period|Not treated with trial medication|0|||
146765621|NCT04771273|529308699|FG001|Dose Escalation Period|Not treated with trial medication|1|||
146765622|NCT04771273|529308700|FG002|Dose Escalation Period|Not treated with trial medication|1|||
146765623|NCT04771273|529308701|FG003|Dose Escalation Period|Not treated with trial medication|0|||
146765624|NCT04771273|529308698|FG000|Dose Escalation Period|Other reasons than listed|2|||
146765625|NCT04771273|529308699|FG001|Dose Escalation Period|Other reasons than listed|0|||
146765626|NCT04771273|529308700|FG002|Dose Escalation Period|Other reasons than listed|2|||
146765627|NCT04771273|529308701|FG003|Dose Escalation Period|Other reasons than listed|1|||
146765628|NCT04771273|529308698|FG000|Dose Escalation Period|Protocol Violation|0|||
146635915|NCT03614156|528841073|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
146555627|NCT01703221|528542548|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
146555628|NCT01703221|528542546|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
146555629|NCT01703221|528542547|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
146555630|NCT01703221|528542548|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
146555631|NCT03810495|528542549|FG000|Overall Study|Lost to Follow-up|2|||
146555632|NCT03810495|528542549|FG000|Overall Study|Withdrawal by Subject|1|||
146555633|NCT03810365|528544321|FG000|Overall Study|Lost to Follow-up|2|||
146555634|NCT03810365|528544322|FG001|Overall Study|Lost to Follow-up|2|||
146555635|NCT03810365|528544321|FG000|Overall Study|Withdrawal by Subject|4|||
146555636|NCT03810365|528544322|FG001|Overall Study|Withdrawal by Subject|5|||
146555637|NCT05333965|528544326|FG000|First Intervention|Adverse Event|0|||
146555638|NCT05333965|528544327|FG001|First Intervention|Adverse Event|1|||
146555639|NCT05333965|528544326|FG000|First Intervention|Withdrawal by Subject|0|||
146555640|NCT05333965|528544327|FG001|First Intervention|Withdrawal by Subject|1|||
146555641|NCT02144337|528544328|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
146555642|NCT02144337|528544329|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
146555643|NCT02144337|528544328|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
146555644|NCT02144337|528544329|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
146555645|NCT02144337|528544328|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
146555646|NCT02144337|528544329|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
146765629|NCT04771273|529308699|FG001|Dose Escalation Period|Protocol Violation|0|||
146555647|NCT02144337|528544328|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
146555648|NCT02144337|528544329|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
146635916|NCT03614156|528841070|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
146765630|NCT04771273|529308700|FG002|Dose Escalation Period|Protocol Violation|3|||
146635917|NCT03614156|528841071|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
146765631|NCT04771273|529308701|FG003|Dose Escalation Period|Protocol Violation|1|||
146765632|NCT04771273|529308698|FG000|Dose Escalation Period|Burden of study procedures|1|||
146765633|NCT04771273|529308699|FG001|Dose Escalation Period|Burden of study procedures|0|||
146765634|NCT04771273|529308700|FG002|Dose Escalation Period|Burden of study procedures|0|||
146765635|NCT04771273|529308701|FG003|Dose Escalation Period|Burden of study procedures|0|||
146765636|NCT04771273|529308698|FG000|Dose Escalation Period|Change of residence|0|||
146765637|NCT04771273|529308699|FG001|Dose Escalation Period|Change of residence|0|||
146765638|NCT04771273|529308700|FG002|Dose Escalation Period|Change of residence|0|||
146765639|NCT04771273|529308701|FG003|Dose Escalation Period|Change of residence|1|||
146765640|NCT04771273|529308698|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
146765641|NCT04771273|529308699|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
146765642|NCT04771273|529308700|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
146765643|NCT04771273|529308701|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
146765644|NCT04771273|529308698|FG000|Dose Escalation Period|Adverse Event|8|||
146765645|NCT04771273|529308699|FG001|Dose Escalation Period|Adverse Event|9|||
146765646|NCT04771273|529308700|FG002|Dose Escalation Period|Adverse Event|12|||
146765647|NCT04771273|529308701|FG003|Dose Escalation Period|Adverse Event|2|||
146765648|NCT04771273|529308698|FG000|Maintenance Period|Other than listed|4|||
146765649|NCT04771273|529308699|FG001|Maintenance Period|Other than listed|2|||
146765650|NCT04771273|529308700|FG002|Maintenance Period|Other than listed|0|||
146765651|NCT04771273|529308701|FG003|Maintenance Period|Other than listed|3|||
146765652|NCT04771273|529308698|FG000|Maintenance Period|Burden of study procedures|1|||
146765653|NCT04771273|529308699|FG001|Maintenance Period|Burden of study procedures|0|||
146765654|NCT04771273|529308700|FG002|Maintenance Period|Burden of study procedures|0|||
146765655|NCT04771273|529308701|FG003|Maintenance Period|Burden of study procedures|0|||
146765656|NCT04771273|529308698|FG000|Maintenance Period|Change of residence|0|||
146765657|NCT04771273|529308699|FG001|Maintenance Period|Change of residence|1|||
146765658|NCT04771273|529308700|FG002|Maintenance Period|Change of residence|3|||
146765659|NCT04771273|529308701|FG003|Maintenance Period|Change of residence|0|||
146765660|NCT04771273|529308698|FG000|Maintenance Period|Perceived lack of efficacy|0|||
146765661|NCT04771273|529308699|FG001|Maintenance Period|Perceived lack of efficacy|0|||
146765662|NCT04771273|529308700|FG002|Maintenance Period|Perceived lack of efficacy|0|||
146765663|NCT04771273|529308701|FG003|Maintenance Period|Perceived lack of efficacy|1|||
146765664|NCT04771273|529308698|FG000|Maintenance Period|Adverse Event|4|||
146765665|NCT04771273|529308699|FG001|Maintenance Period|Adverse Event|5|||
146765666|NCT04771273|529308700|FG002|Maintenance Period|Adverse Event|5|||
146765667|NCT04771273|529308701|FG003|Maintenance Period|Adverse Event|0|||
146765668|NCT04776213|529308704|FG000|Overall Study|Other|1|||
146765669|NCT04776213|529308704|FG000|Overall Study|Withdrawal by Subject|7|||
146765670|NCT04776213|529308704|FG000|Overall Study|Protocol Violation|1|||
146765671|NCT04776213|529308704|FG000|Overall Study|Lost to Follow-up|2|||
146765672|NCT03395353|529308705|FG000|Overall Study|Adverse Event|20|||
146765673|NCT03395353|529308705|FG000|Overall Study|Protocol Violation|1|||
146765674|NCT03395353|529308705|FG000|Overall Study|Lack of Efficacy|3|||
146887996|NCT01298492|529755860|FG000|Overall Study|Death|2|||
146887997|NCT01298492|529755860|FG000|Overall Study|Insufficient Clinical Response|22|||
146887998|NCT01298492|529755860|FG000|Overall Study|Lost to Follow-up|12|||
146887999|NCT01298492|529755860|FG000|Overall Study|Withdrawal by Subject|47|||
146888000|NCT01298492|529755860|FG000|Overall Study|Other (Unspecified)|7|||
146888001|NCT01298492|529755860|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
146888002|NCT01298492|529755860|FG000|Overall Study|Protocol Violation|2|||
146888003|NCT01298492|529755860|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
146888004|NCT01298492|529755860|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
146888005|NCT03870555|529755861|FG000|Period 3 (2 Days)|Adverse Event|1|||
146888006|NCT03870555|529755862|FG001|Period 3 (2 Days)|Adverse Event|0|||
146888007|NCT03870555|529755863|FG002|Period 3 (2 Days)|Adverse Event|0|||
146888008|NCT02340663|529755864|FG000|Overall Study|Lost to Follow-up|1|||
146888009|NCT02340663|529755865|FG001|Overall Study|Lost to Follow-up|0|||
146888010|NCT02340663|529755864|FG000|Overall Study|Protocol Violation|1|||
146888011|NCT02340663|529755865|FG001|Overall Study|Protocol Violation|0|||
146888012|NCT02340663|529755864|FG000|Overall Study|Withdrawal by Subject|3|||
146555649|NCT02144337|528544328|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
146555650|NCT02144337|528544329|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
146555651|NCT03701074|528544330|FG000|Overall Study|Physician Decision|1|||
146555652|NCT03701074|528544331|FG001|Overall Study|Physician Decision|0|||
146555653|NCT01517178|528544332|FG000|Period 1|Adverse Event|1|||
146555654|NCT01517178|528544333|FG001|Period 1|Adverse Event|2|||
146555655|NCT01517178|528544332|FG000|Period 1|Lack of Efficacy|0|||
146555656|NCT01517178|528544333|FG001|Period 1|Lack of Efficacy|1|||
146555657|NCT01517178|528544332|FG000|Period 1|E.g. study termination|3|||
146555658|NCT01517178|528544333|FG001|Period 1|E.g. study termination|1|||
146555659|NCT01517178|528544332|FG000|Period 1|Withdrawal by Subject|0|||
146555660|NCT01517178|528544333|FG001|Period 1|Withdrawal by Subject|1|||
146555661|NCT01517178|528544332|FG000|Period 2|Adverse Event|1|||
146555662|NCT01517178|528544333|FG001|Period 2|Adverse Event|0|||
146635918|NCT03614156|528841072|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
146635919|NCT03614156|528841073|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
146635920|NCT03614156|528841070|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
146635921|NCT03614156|528841071|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
146635922|NCT03614156|528841072|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
146635923|NCT03614156|528841073|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
146635924|NCT03614156|528841070|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
146635925|NCT03614156|528841071|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
146635926|NCT03614156|528841072|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
146635927|NCT03614156|528841073|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
146635928|NCT01094119|528841075|FG000|Overall Study|Lack of Efficacy|2|||
146635929|NCT01094119|528841076|FG001|Overall Study|Lack of Efficacy|4|||
146635930|NCT00960999|528841077|FG000|Overall Study|Withdrawal by Subject|1|||
146635931|NCT00960999|528841078|FG001|Overall Study|Withdrawal by Subject|0|||
146635932|NCT00960999|528841077|FG000|Overall Study|Protocol Violation|5|||
146635933|NCT00960999|528841078|FG001|Overall Study|Protocol Violation|2|||
146635934|NCT00960999|528841077|FG000|Overall Study|RT dose constraints not met|2|||
146635935|NCT00960999|528841078|FG001|Overall Study|RT dose constraints not met|0|||
146635936|NCT04774094|528841084|FG000|Overall Study|Other|2|||
146635937|NCT04774094|528841084|FG000|Overall Study|Withdrawal by Subject|9|||
146635938|NCT04774094|528841084|FG000|Overall Study|Lost to Follow-up|7|||
146635939|NCT04774094|528841084|FG000|Overall Study|Lack of Efficacy|5|||
146635940|NCT04774094|528841084|FG000|Overall Study|Death|17|||
146635941|NCT04774094|528841084|FG000|Overall Study|Adverse Event|4|||
146888013|NCT02340663|529755865|FG001|Overall Study|Withdrawal by Subject|1|||
146888014|NCT00087646|529755866|FG000|Overall Study|Adverse Event|37|||
146888015|NCT00087646|529755867|FG001|Overall Study|Adverse Event|6|||
146888016|NCT00087646|529755868|FG002|Overall Study|Adverse Event|18|||
146888017|NCT00087646|529755869|FG003|Overall Study|Adverse Event|20|||
146888018|NCT00087646|529755866|FG000|Overall Study|Death|0|||
146888019|NCT00087646|529755867|FG001|Overall Study|Death|1|||
146888020|NCT00087646|529755868|FG002|Overall Study|Death|0|||
146555663|NCT01517178|528544332|FG000|Period 2|Withdrawal by Subject|3|||
146555664|NCT01517178|528544333|FG001|Period 2|Withdrawal by Subject|0|||
146635942|NCT05232682|528841087|FG000|Overall Study|Lost to Follow-up|2|||
146888021|NCT00087646|529755869|FG003|Overall Study|Death|0|||
146888022|NCT00087646|529755866|FG000|Overall Study|Withdrawal by Subject|6|||
146888023|NCT00087646|529755867|FG001|Overall Study|Withdrawal by Subject|1|||
146888024|NCT00087646|529755868|FG002|Overall Study|Withdrawal by Subject|2|||
146555665|NCT01517178|528544332|FG000|Period 2|E.g. study termination|2|||
146555666|NCT01517178|528544333|FG001|Period 2|E.g. study termination|2|||
146635943|NCT03207763|528842597|FG000|Overall Study|Lost to Follow-up|1|||
146635944|NCT03207763|528842598|FG001|Overall Study|Lost to Follow-up|0|||
146635945|NCT03751657|528842599|FG000|Overall Study|Physician Decision|0|||
146888025|NCT00087646|529755869|FG003|Overall Study|Withdrawal by Subject|2|||
146888026|NCT00087646|529755866|FG000|Overall Study|Insufficient therapeutic response|64|||
146888027|NCT00087646|529755867|FG001|Overall Study|Insufficient therapeutic response|24|||
146888028|NCT00087646|529755868|FG002|Overall Study|Insufficient therapeutic response|38|||
146888029|NCT00087646|529755869|FG003|Overall Study|Insufficient therapeutic response|51|||
146888030|NCT00087646|529755866|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
146888031|NCT00087646|529755867|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
146888032|NCT00087646|529755868|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
146888033|NCT00087646|529755869|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
146888034|NCT00087646|529755866|FG000|Overall Study|Failure to Return|5|||
146888035|NCT00087646|529755867|FG001|Overall Study|Failure to Return|2|||
146888036|NCT00087646|529755868|FG002|Overall Study|Failure to Return|2|||
146888037|NCT00087646|529755869|FG003|Overall Study|Failure to Return|3|||
146888038|NCT00087646|529755866|FG000|Overall Study|Administrative/Other|6|||
146888039|NCT00087646|529755867|FG001|Overall Study|Administrative/Other|1|||
146888040|NCT00087646|529755868|FG002|Overall Study|Administrative/Other|1|||
146888041|NCT00087646|529755869|FG003|Overall Study|Administrative/Other|2|||
146888042|NCT00087646|529755866|FG000|Overall Study|Other Protocol Violation|3|||
146888043|NCT00087646|529755867|FG001|Overall Study|Other Protocol Violation|1|||
146888044|NCT00087646|529755868|FG002|Overall Study|Other Protocol Violation|0|||
146888045|NCT00087646|529755869|FG003|Overall Study|Other Protocol Violation|0|||
146888046|NCT00087646|529755866|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
146888047|NCT00087646|529755867|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
146888048|NCT00087646|529755868|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
146888049|NCT00087646|529755869|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
146888050|NCT04925752|529755872|FG000|Overall Study|Still on Study|1826|||
146888051|NCT04925752|529755873|FG001|Overall Study|Still on Study|926|||
146888052|NCT04925752|529755872|FG000|Overall Study|Withdrew Consent|128|||
146888053|NCT04925752|529755873|FG001|Overall Study|Withdrew Consent|59|||
146888054|NCT04925752|529755872|FG000|Overall Study|Lost to Follow-up|73|||
146888055|NCT04925752|529755873|FG001|Overall Study|Lost to Follow-up|47|||
146888056|NCT04925752|529755872|FG000|Overall Study|Randomized but Never Treated|12|||
146888057|NCT04925752|529755873|FG001|Overall Study|Randomized but Never Treated|9|||
146888058|NCT04925752|529755872|FG000|Overall Study|Hiv-1 Infection|6|||
146888059|NCT04925752|529755873|FG001|Overall Study|Hiv-1 Infection|7|||
146888060|NCT04925752|529755872|FG000|Overall Study|Investigator's discretion|8|||
146888061|NCT04925752|529755873|FG001|Overall Study|Investigator's discretion|5|||
146888062|NCT04925752|529755872|FG000|Overall Study|Non-compliance with Study Drug|8|||
146888063|NCT04925752|529755873|FG001|Overall Study|Non-compliance with Study Drug|5|||
146888064|NCT04925752|529755872|FG000|Overall Study|Adverse Event|5|||
146888065|NCT04925752|529755873|FG001|Overall Study|Adverse Event|2|||
146888066|NCT04925752|529755872|FG000|Overall Study|Death|4|||
146888067|NCT04925752|529755873|FG001|Overall Study|Death|2|||
146888068|NCT04925752|529755872|FG000|Overall Study|Protocol Violation|1|||
146888069|NCT04925752|529755873|FG001|Overall Study|Protocol Violation|3|||
146888070|NCT04925752|529755872|FG000|Overall Study|Withdrew Assent|1|||
146888071|NCT04925752|529755873|FG001|Overall Study|Withdrew Assent|0|||
146888072|NCT00516737|529755874|FG000|Overall Study|Lost to Follow-up|2|||
146888073|NCT00516737|529755875|FG001|Overall Study|Lost to Follow-up|0|||
146888074|NCT00516737|529755874|FG000|Overall Study|Physician Decision|0|||
146888075|NCT00516737|529755875|FG001|Overall Study|Physician Decision|1|||
146888076|NCT00516737|529755874|FG000|Overall Study|Withdrawal by Subject|0|||
146888077|NCT00516737|529755875|FG001|Overall Study|Withdrawal by Subject|1|||
146888078|NCT00516737|529755874|FG000|Overall Study|Lack of Qualifying Event|9|||
146888079|NCT00516737|529755875|FG001|Overall Study|Lack of Qualifying Event|6|||
146888080|NCT00512798|529755876|FG000|Overall Study|Death|0|||
146888081|NCT00512798|529755877|FG001|Overall Study|Death|3|||
146635946|NCT03751657|528842600|FG001|Overall Study|Physician Decision|1|||
146635947|NCT03751657|528842599|FG000|Overall Study|Withdrawal by Subject|1|||
146635948|NCT03751657|528842600|FG001|Overall Study|Withdrawal by Subject|1|||
146635949|NCT03751657|528842599|FG000|Overall Study|Lost to Follow-up|2|||
146635950|NCT03751657|528842600|FG001|Overall Study|Lost to Follow-up|1|||
146635951|NCT01938716|528842605|FG000|Overall Study|Physician Decision|2|||
146635952|NCT01938716|528842605|FG000|Overall Study|Withdrawal by Subject|2|||
146635953|NCT01358721|528842606|FG000|Overall Study|Withdrawal by Subject|0|||
146635954|NCT01358721|528842607|FG001|Overall Study|Withdrawal by Subject|0|||
146635955|NCT01358721|528842608|FG002|Overall Study|Withdrawal by Subject|0|||
146635956|NCT01358721|528842609|FG003|Overall Study|Withdrawal by Subject|1|||
146635957|NCT01358721|528842606|FG000|Overall Study|Death|0|||
146635958|NCT01358721|528842607|FG001|Overall Study|Death|2|||
146888082|NCT00512798|529755876|FG000|Overall Study|Adverse Event|2|||
146888083|NCT00512798|529755877|FG001|Overall Study|Adverse Event|4|||
146888084|NCT00512798|529755876|FG000|Overall Study|Progression of disease|14|||
146888085|NCT00512798|529755877|FG001|Overall Study|Progression of disease|20|||
146888086|NCT00512798|529755876|FG000|Overall Study|Withdrawal by Subject|3|||
146888087|NCT00512798|529755877|FG001|Overall Study|Withdrawal by Subject|0|||
146635959|NCT01358721|528842608|FG002|Overall Study|Death|0|||
146888088|NCT03266016|529757827|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
146888089|NCT03266016|529757828|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
146888090|NCT03266016|529757829|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
146888091|NCT03266016|529757830|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
146888092|NCT03266016|529757827|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
146888093|NCT03266016|529757828|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
146888094|NCT03266016|529757829|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
146888095|NCT03266016|529757830|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
146888096|NCT00975156|529757840|FG000|Overall Study|Protocol Violation|0|||
146888097|NCT00975156|529757841|FG001|Overall Study|Protocol Violation|1|||
146888098|NCT02971202|529757842|FG000|Overall Study|Pregnancy|1|||
146888099|NCT02971202|529757843|FG001|Overall Study|Pregnancy|0|||
146888100|NCT02971202|529757844|FG002|Overall Study|Pregnancy|0|||
146888101|NCT02971202|529757842|FG000|Overall Study|screen fail after consent|1|||
146888102|NCT02971202|529757843|FG001|Overall Study|screen fail after consent|0|||
146888103|NCT02971202|529757844|FG002|Overall Study|screen fail after consent|1|||
146888104|NCT05425563|529757845|FG000|Overall Study|Withdrawal by Subject|17|||
146888105|NCT02009878|529757846|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
146888106|NCT02009878|529757847|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
146888107|NCT02009878|529757848|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
146888108|NCT00584233|529757849|FG000|Overall Study|Withdrawal by Subject|5|||
146888109|NCT00584233|529757849|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
146888110|NCT04537208|529757850|FG000|Overall Study|Adverse Event|0|||
146888111|NCT04537208|529757851|FG001|Overall Study|Adverse Event|0|||
146888112|NCT04537208|529757852|FG002|Overall Study|Adverse Event|0|||
146888113|NCT04537208|529757853|FG003|Overall Study|Adverse Event|0|||
146888114|NCT04537208|529757854|FG004|Overall Study|Adverse Event|0|||
146888115|NCT04537208|529757855|FG005|Overall Study|Adverse Event|0|||
146888116|NCT04537208|529757856|FG006|Overall Study|Adverse Event|0|||
146888117|NCT04537208|529757857|FG007|Overall Study|Adverse Event|0|||
146888118|NCT04537208|529757858|FG008|Overall Study|Adverse Event|1|||
146888119|NCT04537208|529757859|FG009|Overall Study|Adverse Event|0|||
146888120|NCT04537208|529757860|FG010|Overall Study|Adverse Event|0|||
146888121|NCT04537208|529757850|FG000|Overall Study|Protocol deviation|0|||
146888122|NCT04537208|529757851|FG001|Overall Study|Protocol deviation|0|||
146888123|NCT04537208|529757852|FG002|Overall Study|Protocol deviation|2|||
146888124|NCT04537208|529757853|FG003|Overall Study|Protocol deviation|0|||
146888125|NCT04537208|529757854|FG004|Overall Study|Protocol deviation|0|||
146888126|NCT04537208|529757855|FG005|Overall Study|Protocol deviation|2|||
146888127|NCT04537208|529757856|FG006|Overall Study|Protocol deviation|4|||
146888128|NCT04537208|529757857|FG007|Overall Study|Protocol deviation|0|||
146888129|NCT04537208|529757858|FG008|Overall Study|Protocol deviation|1|||
146888130|NCT04537208|529757859|FG009|Overall Study|Protocol deviation|0|||
146888131|NCT04537208|529757860|FG010|Overall Study|Protocol deviation|2|||
146888132|NCT04537208|529757850|FG000|Overall Study|Withdrawal by Subject|4|||
146888133|NCT04537208|529757851|FG001|Overall Study|Withdrawal by Subject|2|||
146888134|NCT04537208|529757852|FG002|Overall Study|Withdrawal by Subject|1|||
146888135|NCT04537208|529757853|FG003|Overall Study|Withdrawal by Subject|3|||
146888136|NCT04537208|529757854|FG004|Overall Study|Withdrawal by Subject|5|||
146888137|NCT04537208|529757855|FG005|Overall Study|Withdrawal by Subject|1|||
146888138|NCT04537208|529757856|FG006|Overall Study|Withdrawal by Subject|6|||
146888139|NCT04537208|529757857|FG007|Overall Study|Withdrawal by Subject|1|||
146888140|NCT04537208|529757858|FG008|Overall Study|Withdrawal by Subject|7|||
146888141|NCT04537208|529757859|FG009|Overall Study|Withdrawal by Subject|2|||
146888142|NCT04537208|529757860|FG010|Overall Study|Withdrawal by Subject|4|||
146888143|NCT04537208|529757850|FG000|Overall Study|Lost to Follow-up|4|||
146888144|NCT04537208|529757851|FG001|Overall Study|Lost to Follow-up|1|||
146888145|NCT04537208|529757852|FG002|Overall Study|Lost to Follow-up|3|||
146888146|NCT04537208|529757853|FG003|Overall Study|Lost to Follow-up|4|||
146888147|NCT04537208|529757854|FG004|Overall Study|Lost to Follow-up|3|||
146888148|NCT04537208|529757855|FG005|Overall Study|Lost to Follow-up|2|||
146888149|NCT04537208|529757856|FG006|Overall Study|Lost to Follow-up|3|||
146555667|NCT01633112|528544334|FG000|Overall Study|Lack of Efficacy|1|||
146555668|NCT01633112|528544335|FG001|Overall Study|Lack of Efficacy|6|||
146966840|NCT01875731|530038928|FG000|Overall Study|Fail to obtain lab sample|1|||
146888150|NCT04537208|529757857|FG007|Overall Study|Lost to Follow-up|2|||
146888151|NCT04537208|529757858|FG008|Overall Study|Lost to Follow-up|7|||
146555669|NCT01633112|528544336|FG002|Overall Study|Lack of Efficacy|13|||
146555670|NCT01633112|528544334|FG000|Overall Study|Abnormal laboratory value(s)|3|||
146888152|NCT04537208|529757859|FG009|Overall Study|Lost to Follow-up|2|||
146888153|NCT04537208|529757860|FG010|Overall Study|Lost to Follow-up|2|||
146966841|NCT01875731|530038929|FG001|Overall Study|Fail to obtain lab sample|0|||
146888154|NCT04161495|529757861|FG000|Overall Study|Withdrawal by Subject|3|||
146888155|NCT04161495|529757862|FG001|Overall Study|Withdrawal by Subject|0|||
146888156|NCT04161495|529757861|FG000|Overall Study|Protocol Violation|1|||
146888157|NCT04161495|529757862|FG001|Overall Study|Protocol Violation|0|||
146888158|NCT04161495|529757861|FG000|Overall Study|Prohibited concomitant medication|3|||
146888159|NCT04161495|529757862|FG001|Overall Study|Prohibited concomitant medication|0|||
146888160|NCT04161495|529757861|FG000|Overall Study|Adverse Event|1|||
146888161|NCT04161495|529757862|FG001|Overall Study|Adverse Event|0|||
146888162|NCT04161495|529757861|FG000|Overall Study|Other - Unspecified|1|||
146888163|NCT04161495|529757862|FG001|Overall Study|Other - Unspecified|0|||
146888164|NCT04161495|529757861|FG000|Overall Study|Death|0|||
146888165|NCT04161495|529757862|FG001|Overall Study|Death|1|||
146888166|NCT03655756|529757863|FG000|Overall Study|Death|1|||
146888167|NCT01340209|529757864|FG000|Overall Study|Adverse Event|1|||
146888168|NCT01340209|529757865|FG001|Overall Study|Adverse Event|1|||
146888169|NCT01340209|529757866|FG002|Overall Study|Adverse Event|2|||
146888170|NCT01340209|529757864|FG000|Overall Study|Protocol Violation|1|||
146888171|NCT01340209|529757865|FG001|Overall Study|Protocol Violation|2|||
146888172|NCT01340209|529757866|FG002|Overall Study|Protocol Violation|1|||
146888173|NCT01340209|529757864|FG000|Overall Study|Withdrawal by Subject|0|||
146888174|NCT01340209|529757865|FG001|Overall Study|Withdrawal by Subject|0|||
146888175|NCT01340209|529757866|FG002|Overall Study|Withdrawal by Subject|1|||
146888176|NCT01340209|529757864|FG000|Overall Study|Other reason not defined above|3|||
146888177|NCT01340209|529757865|FG001|Overall Study|Other reason not defined above|5|||
146888178|NCT01340209|529757866|FG002|Overall Study|Other reason not defined above|4|||
146888179|NCT03237065|529757869|FG000|Overall Study|Adverse Event|0|||
146888180|NCT03237065|529757870|FG001|Overall Study|Adverse Event|2|||
146888181|NCT03237065|529757869|FG000|Overall Study|Protocol Violation|0|||
146888182|NCT03237065|529757870|FG001|Overall Study|Protocol Violation|1|||
146888183|NCT03237065|529757869|FG000|Overall Study|Withdrawal by Subject|3|||
146888184|NCT03237065|529757870|FG001|Overall Study|Withdrawal by Subject|0|||
146888185|NCT03237065|529757869|FG000|Overall Study|Lost to Follow-up|1|||
146888186|NCT03237065|529757870|FG001|Overall Study|Lost to Follow-up|0|||
146888187|NCT03237065|529757869|FG000|Overall Study|Unable to obtain venous access|0|||
146888188|NCT03237065|529757870|FG001|Overall Study|Unable to obtain venous access|1|||
146888189|NCT00704964|529757872|FG000|Overall Study|Not completed on time|328|||
146888190|NCT02161562|529757873|FG000|Overall Study|Withdrawal by Subject|5|||
146888191|NCT02161562|529757874|FG001|Overall Study|Withdrawal by Subject|8|||
146888192|NCT02161562|529757873|FG000|Overall Study|Protocol Violation|9|||
146888193|NCT02161562|529757874|FG001|Overall Study|Protocol Violation|4|||
146888194|NCT02161562|529757873|FG000|Overall Study|Pregnancy|1|||
146888195|NCT02161562|529757874|FG001|Overall Study|Pregnancy|2|||
146888196|NCT02161562|529757873|FG000|Overall Study|Lost to Follow-up|3|||
146888197|NCT02161562|529757874|FG001|Overall Study|Lost to Follow-up|1|||
146888198|NCT02161562|529757873|FG000|Overall Study|Lack of Efficacy|4|||
146888199|NCT02161562|529757874|FG001|Overall Study|Lack of Efficacy|1|||
146888200|NCT02161562|529757873|FG000|Overall Study|Adverse Event|1|||
146888201|NCT02161562|529757874|FG001|Overall Study|Adverse Event|1|||
146888202|NCT02161562|529757873|FG000|Overall Study|Participant moved back to home country|1|||
146888203|NCT02161562|529757874|FG001|Overall Study|Participant moved back to home country|0|||
146888204|NCT02161562|529757873|FG000|Overall Study|Withdrew due to being out of the country|1|||
146888205|NCT02161562|529757874|FG001|Overall Study|Withdrew due to being out of the country|0|||
146888206|NCT02161562|529757873|FG000|Overall Study|Participant moved out of province|1|||
146888207|NCT02161562|529757874|FG001|Overall Study|Participant moved out of province|0|||
146888208|NCT01699087|529757888|FG000|Overall Study|Lost to Follow-up|7|||
146888209|NCT01699087|529757888|FG000|Overall Study|Screen failure (prior to treatment)|15|||
146888210|NCT01699087|529757888|FG000|Overall Study|Unable to make future visits|2|||
146888211|NCT00094757|529757889|FG000|Overall Study|Adverse Event|11|||
146888212|NCT00094757|529757890|FG001|Overall Study|Adverse Event|9|||
146888213|NCT00094757|529757891|FG002|Overall Study|Adverse Event|6|||
146888214|NCT00094757|529757889|FG000|Overall Study|Lack of Efficacy|11|||
146888215|NCT00094757|529757890|FG001|Overall Study|Lack of Efficacy|15|||
146888216|NCT00094757|529757891|FG002|Overall Study|Lack of Efficacy|8|||
146888217|NCT00094757|529757889|FG000|Overall Study|Lost to Follow-up|3|||
146888218|NCT00094757|529757890|FG001|Overall Study|Lost to Follow-up|5|||
146888219|NCT00094757|529757891|FG002|Overall Study|Lost to Follow-up|6|||
146888220|NCT00094757|529757889|FG000|Overall Study|Patient Moved|2|||
146555671|NCT01633112|528544335|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146555672|NCT01633112|528544336|FG002|Overall Study|Abnormal laboratory value(s)|0|||
146888221|NCT00094757|529757890|FG001|Overall Study|Patient Moved|1|||
146888222|NCT00094757|529757891|FG002|Overall Study|Patient Moved|1|||
146966842|NCT03417102|530038930|FG000|Overall Study|Adverse Event|0|||
146966843|NCT03417102|530038931|FG001|Overall Study|Adverse Event|1|||
146888223|NCT00094757|529757889|FG000|Overall Study|Protocol Violation|8|||
146888224|NCT00094757|529757890|FG001|Overall Study|Protocol Violation|5|||
146888225|NCT00094757|529757891|FG002|Overall Study|Protocol Violation|3|||
146888226|NCT00094757|529757889|FG000|Overall Study|Withdrawal by Subject|14|||
146888227|NCT00094757|529757890|FG001|Overall Study|Withdrawal by Subject|21|||
146888228|NCT00094757|529757891|FG002|Overall Study|Withdrawal by Subject|5|||
146888229|NCT00094757|529757889|FG000|Overall Study|Other|3|||
146888230|NCT00094757|529757890|FG001|Overall Study|Other|3|||
146888231|NCT00094757|529757891|FG002|Overall Study|Other|1|||
146888232|NCT00094757|529757889|FG000|Overall Study|Protocol specified discontinuation|1|||
146888233|NCT00094757|529757890|FG001|Overall Study|Protocol specified discontinuation|3|||
146888234|NCT00094757|529757891|FG002|Overall Study|Protocol specified discontinuation|0|||
146555673|NCT01633112|528544334|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146966844|NCT03417102|530038930|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
146966845|NCT03417102|530038931|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
146966846|NCT03417102|530038930|FG000|Overall Study|Other|0|||
146966847|NCT03417102|530038931|FG001|Overall Study|Other|1|||
146966848|NCT03188991|530038932|FG000|Overall Study|Withdrawal by Subject|0|||
146966849|NCT03188991|530038933|FG001|Overall Study|Withdrawal by Subject|0|||
146966850|NCT03188991|530038934|FG002|Overall Study|Withdrawal by Subject|0|||
146966851|NCT03188991|530038935|FG003|Overall Study|Withdrawal by Subject|1|||
146888235|NCT00939692|529757898|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
146888236|NCT00939692|529757899|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
146888237|NCT00939692|529757898|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
146888238|NCT00939692|529757899|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
146888239|NCT04317274|529757900|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
146888240|NCT04317274|529757901|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
146888241|NCT04317274|529757902|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
146888242|NCT04317274|529757903|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
146888243|NCT00797823|529757911|FG000|First Period (Initial Randomization)|Physician Decision|1|||
146888244|NCT00797823|529757912|FG001|First Period (Initial Randomization)|Physician Decision|0|||
146888245|NCT00797823|529757913|FG002|First Period (Initial Randomization)|Physician Decision|0|||
146888246|NCT00288080|529757918|FG000|Overall Study|Withdrawal by Subject|1|||
146888247|NCT00288080|529757919|FG001|Overall Study|Withdrawal by Subject|3|||
146966852|NCT01656850|530040059|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
146966853|NCT01656850|530040060|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
146888248|NCT00288080|529757918|FG000|Overall Study|Protocol Violation|25|||
146888249|NCT00288080|529757919|FG001|Overall Study|Protocol Violation|20|||
146888250|NCT03403192|529757920|FG000|Overall Study|Lost to Follow-up|1|||
146888251|NCT03403192|529757921|FG001|Overall Study|Lost to Follow-up|2|||
146888252|NCT03403192|529757922|FG002|Overall Study|Lost to Follow-up|0|||
146888253|NCT03403192|529757923|FG003|Overall Study|Lost to Follow-up|0|||
146966854|NCT00396318|530040061|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
146966855|NCT03255226|530040067|FG000|Overall Study|Adverse Event|2|||
146966856|NCT03255226|530040067|FG000|Overall Study|Physician Decision|3|||
146888254|NCT03403192|529757920|FG000|Overall Study|Unable to respond|0|||
146966857|NCT03255226|530040067|FG000|Overall Study|Withdrawal by Subject|1|||
146966858|NCT03255226|530040067|FG000|Overall Study|Serum or blood sodium increased|4|||
146966859|NCT03255226|530040067|FG000|Overall Study|Serum or blood potassium increased|4|||
146966860|NCT00602927|530040068|FG000|Period 1: 13 Days|Protocol Violation|2|||
146888255|NCT03403192|529757921|FG001|Overall Study|Unable to respond|1|||
146888256|NCT03403192|529757922|FG002|Overall Study|Unable to respond|0|||
146888257|NCT03403192|529757923|FG003|Overall Study|Unable to respond|0|||
146888258|NCT03403192|529757920|FG000|Overall Study|Incomplete|3|||
146888259|NCT03403192|529757921|FG001|Overall Study|Incomplete|1|||
146888260|NCT03403192|529757922|FG002|Overall Study|Incomplete|3|||
146555674|NCT01633112|528544335|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146555675|NCT01633112|528544336|FG002|Overall Study|Abnormal test procedure result(s)|0|||
146555676|NCT01633112|528544334|FG000|Overall Study|Administrative problems|1|||
146966861|NCT00602927|530040069|FG001|Period 1: 13 Days|Protocol Violation|4|||
146966862|NCT00602927|530040068|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
146966863|NCT00602927|530040069|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
146966864|NCT00602927|530040068|FG000|Period 1: 13 Days|Time|1|||
146966865|NCT00602927|530040069|FG001|Period 1: 13 Days|Time|0|||
146966866|NCT00602927|530040068|FG000|Period 1: 13 Days|Claustrophobia|0|||
146966867|NCT00602927|530040069|FG001|Period 1: 13 Days|Claustrophobia|1|||
146966868|NCT00602927|530040068|FG000|Period 2: 14 Days|Protocol Violation|0|||
146966869|NCT00602927|530040069|FG001|Period 2: 14 Days|Protocol Violation|2|||
146966870|NCT00602927|530040068|FG000|Period 3: 13 Days|Protocol Violation|0|||
146966871|NCT00602927|530040069|FG001|Period 3: 13 Days|Protocol Violation|1|||
146966872|NCT00602927|530040068|FG000|Period 3: 13 Days|MRI data quality|2|||
146966873|NCT00602927|530040069|FG001|Period 3: 13 Days|MRI data quality|2|||
146966874|NCT00685763|530040076|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
146966875|NCT00685763|530040076|FG000|Overall Study|Protocol Violation|1|||
146966876|NCT02525627|530040077|FG000|Overall Study|Revision|1|||
146966877|NCT02525627|530040078|FG001|Overall Study|Revision|1|||
146966878|NCT02525627|530040077|FG000|Overall Study|Withdrawal by Subject|1|||
146966879|NCT02525627|530040078|FG001|Overall Study|Withdrawal by Subject|2|||
146966880|NCT02525627|530040077|FG000|Overall Study|Death|1|||
146966881|NCT02525627|530040078|FG001|Overall Study|Death|0|||
146888261|NCT03403192|529757923|FG003|Overall Study|Incomplete|6|||
146888262|NCT03033875|529757939|FG000|Overall Study|Withdrawal by Subject|5|||
146555677|NCT01633112|528544335|FG001|Overall Study|Administrative problems|2|||
146555678|NCT01633112|528544336|FG002|Overall Study|Administrative problems|5|||
146966882|NCT02525627|530040077|FG000|Overall Study|Site terminated|11|||
146888263|NCT03033875|529757940|FG001|Overall Study|Withdrawal by Subject|9|||
146888264|NCT03033875|529757941|FG002|Overall Study|Withdrawal by Subject|4|||
146888265|NCT03033875|529757939|FG000|Overall Study|Other|14|||
146888266|NCT03033875|529757940|FG001|Overall Study|Other|15|||
146888267|NCT03033875|529757941|FG002|Overall Study|Other|8|||
146888268|NCT02286947|529757942|FG000|Overall Study|Withdrawal by Subject|2|||
146888269|NCT01614093|529757947|FG000|Overall Study|Withdrawal by Subject|1|||
146888270|NCT00848354|529757948|FG000|Phase 1|Adverse Event|5|||
146888271|NCT00848354|529757949|FG001|Phase 1|Adverse Event|4|||
146888272|NCT00848354|529757948|FG000|Phase 1|Discontinuation of study by sponsor|2|||
146888273|NCT00848354|529757949|FG001|Phase 1|Discontinuation of study by sponsor|1|||
146888274|NCT00848354|529757948|FG000|Phase 1|Failed to return|0|||
146888275|NCT00848354|529757949|FG001|Phase 1|Failed to return|1|||
146888276|NCT00848354|529757948|FG000|Phase 1|Lost to Follow-up|1|||
146888277|NCT00848354|529757949|FG001|Phase 1|Lost to Follow-up|1|||
146888278|NCT00848354|529757948|FG000|Phase 1|Unspecified Reason|1|||
146888279|NCT00848354|529757949|FG001|Phase 1|Unspecified Reason|1|||
146888280|NCT00848354|529757948|FG000|Phase 1|Protocol Violation|1|||
146888281|NCT00848354|529757949|FG001|Phase 1|Protocol Violation|1|||
146555679|NCT01633112|528544334|FG000|Overall Study|Adverse Event|16|||
146555680|NCT01633112|528544335|FG001|Overall Study|Adverse Event|18|||
146555681|NCT01633112|528544336|FG002|Overall Study|Adverse Event|20|||
146555682|NCT01633112|528544334|FG000|Overall Study|Lost to Follow-up|7|||
146555683|NCT01633112|528544335|FG001|Overall Study|Lost to Follow-up|19|||
146555684|NCT01633112|528544336|FG002|Overall Study|Lost to Follow-up|6|||
146555685|NCT01633112|528544334|FG000|Overall Study|Protocol Violation|4|||
146555686|NCT01633112|528544335|FG001|Overall Study|Protocol Violation|0|||
146555687|NCT01633112|528544336|FG002|Overall Study|Protocol Violation|2|||
146555688|NCT01633112|528544334|FG000|Overall Study|Subject no longer requires study drug|0|||
146555689|NCT01633112|528544335|FG001|Overall Study|Subject no longer requires study drug|0|||
146555690|NCT01633112|528544336|FG002|Overall Study|Subject no longer requires study drug|1|||
146555691|NCT01633112|528544334|FG000|Overall Study|Withdrawal by Subject|20|||
146555692|NCT01633112|528544335|FG001|Overall Study|Withdrawal by Subject|12|||
146555693|NCT01633112|528544336|FG002|Overall Study|Withdrawal by Subject|41|||
146555694|NCT01633112|528544334|FG000|Overall Study|missing Study Completion CRF|1|||
146555695|NCT01633112|528544335|FG001|Overall Study|missing Study Completion CRF|1|||
146555696|NCT01633112|528544336|FG002|Overall Study|missing Study Completion CRF|4|||
146555697|NCT01959919|528544337|FG000|Overall Study|Did not meet the eligibility criteria|2|||
146555698|NCT03439072|528544338|FG000|Overall Study|Withdrawal by Subject|2|||
146555699|NCT03439072|528544339|FG001|Overall Study|Withdrawal by Subject|3|||
146555700|NCT03439072|528544338|FG000|Overall Study|Physician Decision|0|||
146555701|NCT03439072|528544339|FG001|Overall Study|Physician Decision|1|||
146555702|NCT02094885|528544341|FG000|Overall Study|Death|1|||
146555703|NCT02094885|528544342|FG001|Overall Study|Death|5|||
146555704|NCT02094885|528544341|FG000|Overall Study|Withdrawn due to age|1|||
146555705|NCT02094885|528544342|FG001|Overall Study|Withdrawn due to age|0|||
146555706|NCT00779909|528544343|FG000|Overall Study|Lost to Follow-up|1|||
146888282|NCT00848354|529757948|FG000|Phase 1|Withdrawal by Subject|2|||
146888283|NCT00848354|529757949|FG001|Phase 1|Withdrawal by Subject|4|||
146888284|NCT00848354|529757948|FG000|Phase 1|Lack of Efficacy|0|||
146888285|NCT00848354|529757949|FG001|Phase 1|Lack of Efficacy|1|||
146888286|NCT00848354|529757948|FG000|Phase 2 Year 1|Adverse Event|7|||
146888287|NCT00848354|529757949|FG001|Phase 2 Year 1|Adverse Event|2|||
146555707|NCT00779909|528544344|FG001|Overall Study|Lost to Follow-up|0|||
146555708|NCT00779909|528544345|FG002|Overall Study|Lost to Follow-up|0|||
146555709|NCT00779909|528544346|FG003|Overall Study|Lost to Follow-up|1|||
146555710|NCT00779909|528544343|FG000|Overall Study|Withdrawal by Subject|0|||
146555711|NCT00779909|528544344|FG001|Overall Study|Withdrawal by Subject|1|||
146888288|NCT00848354|529757948|FG000|Phase 2 Year 1|Death|1|||
146888289|NCT00848354|529757949|FG001|Phase 2 Year 1|Death|0|||
146888290|NCT00848354|529757948|FG000|Phase 2 Year 1|Failed to Return|1|||
146555712|NCT00779909|528544345|FG002|Overall Study|Withdrawal by Subject|0|||
146888291|NCT00848354|529757949|FG001|Phase 2 Year 1|Failed to Return|1|||
146888292|NCT00848354|529757948|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
146888293|NCT00848354|529757949|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
146888294|NCT00848354|529757948|FG000|Phase 2 Year 1|Unspecified Reason|3|||
146888295|NCT00848354|529757949|FG001|Phase 2 Year 1|Unspecified Reason|0|||
146888296|NCT00848354|529757948|FG000|Phase 2 Year 1|Protocol Violation|4|||
146888297|NCT00848354|529757949|FG001|Phase 2 Year 1|Protocol Violation|1|||
146888298|NCT00848354|529757948|FG000|Phase 2 Year 1|Subject Request|1|||
146888299|NCT00848354|529757949|FG001|Phase 2 Year 1|Subject Request|2|||
146888300|NCT00848354|529757948|FG000|Phase 2 Year 2|Adverse Event|12|||
146888301|NCT00848354|529757949|FG001|Phase 2 Year 2|Adverse Event|2|||
146888302|NCT00848354|529757948|FG000|Phase 2 Year 2|Death|2|||
146888303|NCT00848354|529757949|FG001|Phase 2 Year 2|Death|0|||
146888304|NCT00848354|529757948|FG000|Phase 2 Year 2|Failed to return|3|||
146888305|NCT00848354|529757949|FG001|Phase 2 Year 2|Failed to return|0|||
146888306|NCT00848354|529757948|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
146888307|NCT00848354|529757949|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
146888308|NCT00848354|529757948|FG000|Phase 2 Year 2|Unspecified Reason|1|||
146888309|NCT00848354|529757949|FG001|Phase 2 Year 2|Unspecified Reason|0|||
146888310|NCT00848354|529757948|FG000|Phase 2 Year 2|Protocol Violation|1|||
146888311|NCT00848354|529757949|FG001|Phase 2 Year 2|Protocol Violation|1|||
146888312|NCT00848354|529757948|FG000|Phase 2 Year 2|Subject Request|1|||
146888313|NCT00848354|529757949|FG001|Phase 2 Year 2|Subject Request|1|||
146888314|NCT00848354|529757948|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
146888315|NCT00848354|529757949|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
146888316|NCT00915343|529757952|FG000|Part B - Open Label Period|Treatment switch|0|||
146888317|NCT00915343|529757953|FG001|Part B - Open Label Period|Treatment switch|0|||
146888318|NCT00915343|529757954|FG002|Part B - Open Label Period|Treatment switch|1|||
146888319|NCT00915343|529757952|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
146888320|NCT00915343|529757953|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
146888321|NCT00915343|529757954|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
146888322|NCT03920670|529757955|FG000|Overall Study|Protocol Violation|2|||
146888323|NCT03920670|529757956|FG001|Overall Study|Protocol Violation|2|||
146888324|NCT03920670|529757955|FG000|Overall Study|Adverse Event|1|||
146888325|NCT03920670|529757956|FG001|Overall Study|Adverse Event|0|||
146888326|NCT04820309|529757962|FG000|Overall Study|Adverse Event|96|||
146888327|NCT04820309|529757962|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
146888328|NCT04820309|529757962|FG000|Overall Study|Consent Withdrawn|93|||
146888329|NCT04820309|529757962|FG000|Overall Study|failure to adhere to protocol|32|||
146888330|NCT04820309|529757962|FG000|Overall Study|alcohol or drug use|6|||
146888331|NCT04820309|529757962|FG000|Overall Study|Lost to Follow-up|46|||
146888332|NCT04820309|529757962|FG000|Overall Study|Death|2|||
146888333|NCT04820309|529757962|FG000|Overall Study|Pregnancy|1|||
146888334|NCT04820309|529757962|FG000|Overall Study|Other reasons|12|||
146888335|NCT04811716|529757965|FG000|Overall Study|Withdrawal by Subject|2|||
146888336|NCT04811716|529757966|FG001|Overall Study|Withdrawal by Subject|0|||
146888337|NCT04202679|529757967|FG000|Overall Study|Adverse Event|2|||
146888338|NCT04202679|529757968|FG001|Overall Study|Adverse Event|0|||
146888339|NCT04202679|529757967|FG000|Overall Study|Poor compliance to protocol|1|||
146888340|NCT04202679|529757968|FG001|Overall Study|Poor compliance to protocol|0|||
146888341|NCT04202679|529757967|FG000|Overall Study|Withdrawal by Subject|23|||
146888342|NCT04202679|529757968|FG001|Overall Study|Withdrawal by Subject|6|||
146888343|NCT05902364|529757969|FG000|Overall Study|Adverse Event|1|||
146888344|NCT05902364|529757970|FG001|Overall Study|Adverse Event|0|||
146888345|NCT02270242|529757971|FG000|Overall Study|Withdrawal by Subject|18|||
146888346|NCT02270242|529757972|FG001|Overall Study|Withdrawal by Subject|25|||
146888347|NCT02270242|529757971|FG000|Overall Study|Lost to Follow-up|41|||
146888348|NCT02270242|529757972|FG001|Overall Study|Lost to Follow-up|27|||
146888349|NCT02270242|529757971|FG000|Overall Study|Physician Decision|0|||
146888350|NCT02270242|529757972|FG001|Overall Study|Physician Decision|1|||
146888351|NCT03864653|529757973|FG000|Overall Study|Withdrawal by Subject|1|||
146888352|NCT03048422|529757974|FG000|Overall Study|Death|1|||
146888353|NCT03048422|529757975|FG001|Overall Study|Death|0|||
146888354|NCT03048422|529757976|FG002|Overall Study|Death|0|||
146888355|NCT03048422|529757974|FG000|Overall Study|Lost to Follow-up|5|||
146888356|NCT03048422|529757975|FG001|Overall Study|Lost to Follow-up|0|||
146888357|NCT03048422|529757976|FG002|Overall Study|Lost to Follow-up|1|||
146888358|NCT03048422|529757974|FG000|Overall Study|Withdrawal by Subject|5|||
146888359|NCT03048422|529757975|FG001|Overall Study|Withdrawal by Subject|7|||
146888360|NCT03048422|529757976|FG002|Overall Study|Withdrawal by Subject|4|||
146888361|NCT03048422|529757974|FG000|Overall Study|Moved|3|||
146888362|NCT03048422|529757975|FG001|Overall Study|Moved|2|||
146888363|NCT03048422|529757976|FG002|Overall Study|Moved|2|||
146888364|NCT03048422|529757974|FG000|Overall Study|Noncompliant with Study Requirements|2|||
146888365|NCT03048422|529757975|FG001|Overall Study|Noncompliant with Study Requirements|1|||
146888366|NCT03048422|529757976|FG002|Overall Study|Noncompliant with Study Requirements|2|||
146888367|NCT03048422|529757974|FG000|Overall Study|Not Able to Get to Clinic|1|||
146888368|NCT03048422|529757975|FG001|Overall Study|Not Able to Get to Clinic|0|||
146888369|NCT03048422|529757976|FG002|Overall Study|Not Able to Get to Clinic|0|||
146888370|NCT02482129|529757977|FG000|Overall Study|Adverse Event-prior to treatment|0|||
146888371|NCT02482129|529757978|FG001|Overall Study|Adverse Event-prior to treatment|1|||
146888372|NCT02482129|529757977|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
146888373|NCT02482129|529757978|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
146888374|NCT02482129|529757977|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
146888375|NCT02482129|529757978|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
146635960|NCT01358721|528842609|FG003|Overall Study|Death|0|||
146888376|NCT02482129|529757977|FG000|Overall Study|Criteria not met-prior to treatment|1|||
146888377|NCT02482129|529757978|FG001|Overall Study|Criteria not met-prior to treatment|0|||
146555713|NCT00779909|528544346|FG003|Overall Study|Withdrawal by Subject|0|||
146555714|NCT00128492|528544347|FG000|Overall Study|AE unrelated to study|2|||
146555715|NCT00128492|528544348|FG001|Overall Study|AE unrelated to study|9|||
146555716|NCT00128492|528544347|FG000|Overall Study|Study drug intolerance (AE)|2|||
146555717|NCT00128492|528544348|FG001|Overall Study|Study drug intolerance (AE)|8|||
146555718|NCT00128492|528544347|FG000|Overall Study|AE related to study|1|||
146555719|NCT00128492|528544348|FG001|Overall Study|AE related to study|4|||
146555720|NCT00128492|528544347|FG000|Overall Study|Death|1|||
146765675|NCT03395353|529308705|FG000|Overall Study|Withdrawal by Subject|24|||
146555721|NCT00128492|528544348|FG001|Overall Study|Death|0|||
146765676|NCT03395353|529308705|FG000|Overall Study|Discontinued visit|1|||
146765677|NCT03395353|529308705|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
146765678|NCT03395353|529308705|FG000|Overall Study|Physician Decision|4|||
146765679|NCT03395353|529308705|FG000|Overall Study|Early termination of overall study|33|||
146765680|NCT02013037|529308707|FG000|Overall Study|Death|6|||
146765681|NCT02013037|529308707|FG000|Overall Study|Withdrawal by Subject|1|||
146765682|NCT02013037|529308707|FG000|Overall Study|Awaiting Transplantation|7|||
146765683|NCT02013037|529308707|FG000|Overall Study|Transplanted without DSA|2|||
146770097|NCT01426269|529327376|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
146770098|NCT01426269|529327374|FG000|Period 1: 12 Weeks|Pregnancy|1|||
146770099|NCT01426269|529327375|FG001|Period 1: 12 Weeks|Pregnancy|0|||
146770100|NCT01426269|529327376|FG002|Period 1: 12 Weeks|Pregnancy|0|||
146770101|NCT01426269|529327374|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
146770102|NCT01426269|529327375|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
146770103|NCT01426269|529327376|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
146770104|NCT01426269|529327374|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
146770105|NCT01426269|529327375|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
146770106|NCT01426269|529327376|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
146770107|NCT01426269|529327374|FG000|Period 2: 40 Weeks|Adverse Event|0|||
146770108|NCT01426269|529327375|FG001|Period 2: 40 Weeks|Adverse Event|1|||
146770109|NCT01426269|529327376|FG002|Period 2: 40 Weeks|Adverse Event|2|||
146770110|NCT01426269|529327374|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
146770111|NCT01426269|529327375|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
146770112|NCT01426269|529327376|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
146770113|NCT01426269|529327374|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
146770114|NCT01426269|529327375|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
146770115|NCT01426269|529327376|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
146770116|NCT01426269|529327374|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
146770117|NCT01426269|529327375|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
146770118|NCT01426269|529327376|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
146770119|NCT01426269|529327374|FG000|Period 2: 40 Weeks|Site closed|0|||
146770120|NCT01426269|529327375|FG001|Period 2: 40 Weeks|Site closed|6|||
146770121|NCT01426269|529327376|FG002|Period 2: 40 Weeks|Site closed|5|||
146770122|NCT01426269|529327374|FG000|Period 2: 40 Weeks|Relapsed|0|||
146770123|NCT01426269|529327375|FG001|Period 2: 40 Weeks|Relapsed|9|||
146770124|NCT01426269|529327376|FG002|Period 2: 40 Weeks|Relapsed|18|||
146770125|NCT00818454|529327377|FG000|Treatment Period 1|Adverse Event|0|||
146770126|NCT00818454|529327378|FG001|Treatment Period 1|Adverse Event|1|||
146770127|NCT00818454|529327379|FG002|Treatment Period 1|Adverse Event|0|||
146770128|NCT00818454|529327380|FG003|Treatment Period 1|Adverse Event|0|||
146770129|NCT00818454|529327377|FG000|Treatment Period 1|Other|3|||
146770130|NCT00818454|529327378|FG001|Treatment Period 1|Other|0|||
146770131|NCT00818454|529327379|FG002|Treatment Period 1|Other|0|||
146770132|NCT00818454|529327380|FG003|Treatment Period 1|Other|0|||
146770133|NCT00818454|529327377|FG000|Washout Period of 1 Week|Adverse Event|1|||
146770134|NCT00818454|529327378|FG001|Washout Period of 1 Week|Adverse Event|1|||
146770135|NCT00818454|529327379|FG002|Washout Period of 1 Week|Adverse Event|0|||
146770136|NCT00818454|529327380|FG003|Washout Period of 1 Week|Adverse Event|0|||
146966883|NCT02525627|530040078|FG001|Overall Study|Site terminated|10|||
146966884|NCT02875340|530040080|FG000|Overall Study|Death|2|||
146765684|NCT00357396|529310350|FG000|Overall Study|Adverse Event|1|||
146765685|NCT00357396|529310351|FG001|Overall Study|Adverse Event|0|||
146765686|NCT02488980|529310353|FG000|Overall Study|Protocol Violation|2|||
146765687|NCT02488980|529310354|FG001|Overall Study|Protocol Violation|2|||
146765688|NCT02488980|529310355|FG002|Overall Study|Protocol Violation|2|||
146765689|NCT05174013|529310356|FG000|Overall Study|Lost to Follow-up|0|||
146765690|NCT05174013|529310357|FG001|Overall Study|Lost to Follow-up|0|||
146765691|NCT05174013|529310358|FG002|Overall Study|Lost to Follow-up|0|||
146765692|NCT05174013|529310359|FG003|Overall Study|Lost to Follow-up|1|||
146765693|NCT05174013|529310360|FG004|Overall Study|Lost to Follow-up|0|||
146765694|NCT05174013|529310361|FG005|Overall Study|Lost to Follow-up|0|||
146765695|NCT05174013|529310356|FG000|Overall Study|Withdrawal by Subject|0|||
146765696|NCT05174013|529310357|FG001|Overall Study|Withdrawal by Subject|0|||
146765697|NCT05174013|529310358|FG002|Overall Study|Withdrawal by Subject|1|||
146765698|NCT05174013|529310359|FG003|Overall Study|Withdrawal by Subject|0|||
146765699|NCT05174013|529310360|FG004|Overall Study|Withdrawal by Subject|0|||
146765700|NCT05174013|529310361|FG005|Overall Study|Withdrawal by Subject|0|||
146765701|NCT02034916|529310362|FG000|Overall Study|Death|39|||
146765702|NCT02034916|529310363|FG001|Overall Study|Death|28|||
146765703|NCT02034916|529310362|FG000|Overall Study|Withdrawal by Subject|2|||
146765704|NCT02034916|529310363|FG001|Overall Study|Withdrawal by Subject|1|||
146765705|NCT02034916|529310362|FG000|Overall Study|Lost to Follow-up|4|||
146765706|NCT02034916|529310363|FG001|Overall Study|Lost to Follow-up|1|||
146765707|NCT02034916|529310362|FG000|Overall Study|Study terminated by sponsor|4|||
146765708|NCT02034916|529310363|FG001|Overall Study|Study terminated by sponsor|5|||
146765709|NCT00436644|529310377|FG000|Overall Study|Adverse Event|2|||
146765710|NCT00436644|529310377|FG000|Overall Study|Death|1|||
146765711|NCT04364269|529310378|FG000|Overall Study|Adverse Event|1|||
146765712|NCT04364269|529310379|FG001|Overall Study|Adverse Event|0|||
146765713|NCT04364269|529310380|FG002|Overall Study|Adverse Event|0|||
146765714|NCT04364269|529310378|FG000|Overall Study|Withdrawal by Subject|0|||
146765715|NCT04364269|529310379|FG001|Overall Study|Withdrawal by Subject|1|||
146765716|NCT04364269|529310380|FG002|Overall Study|Withdrawal by Subject|0|||
146765717|NCT00878722|529310381|FG000|Overall Study|Progressive disease|3|||
146765718|NCT00878722|529310382|FG001|Overall Study|Progressive disease|3|||
146765719|NCT00878722|529310383|FG002|Overall Study|Progressive disease|3|||
146765720|NCT00878722|529310384|FG003|Overall Study|Progressive disease|7|||
146765721|NCT00878722|529310385|FG004|Overall Study|Progressive disease|7|||
146765722|NCT00878722|529310386|FG005|Overall Study|Progressive disease|1|||
146765723|NCT00878722|529310387|FG006|Overall Study|Progressive disease|4|||
146765724|NCT00878722|529310388|FG007|Overall Study|Progressive disease|3|||
146765725|NCT00878722|529310381|FG000|Overall Study|Death|0|||
146765726|NCT00878722|529310382|FG001|Overall Study|Death|0|||
146765727|NCT00878722|529310383|FG002|Overall Study|Death|0|||
146765728|NCT00878722|529310384|FG003|Overall Study|Death|1|||
146765729|NCT00878722|529310385|FG004|Overall Study|Death|0|||
146765730|NCT00878722|529310386|FG005|Overall Study|Death|1|||
146765731|NCT00878722|529310387|FG006|Overall Study|Death|0|||
146765732|NCT00878722|529310388|FG007|Overall Study|Death|2|||
146765733|NCT00878722|529310381|FG000|Overall Study|Adverse Event|0|||
146765734|NCT00878722|529310382|FG001|Overall Study|Adverse Event|0|||
146765735|NCT00878722|529310383|FG002|Overall Study|Adverse Event|0|||
146765736|NCT00878722|529310384|FG003|Overall Study|Adverse Event|0|||
146765737|NCT00878722|529310385|FG004|Overall Study|Adverse Event|0|||
146765738|NCT00878722|529310386|FG005|Overall Study|Adverse Event|0|||
146765739|NCT00878722|529310387|FG006|Overall Study|Adverse Event|2|||
146765740|NCT00878722|529310388|FG007|Overall Study|Adverse Event|0|||
146765741|NCT00878722|529310381|FG000|Overall Study|Withdrawal by Subject|0|||
146765742|NCT00878722|529310382|FG001|Overall Study|Withdrawal by Subject|0|||
146635961|NCT01358721|528842606|FG000|Overall Study|Study Drug Toxicity|1|||
146635962|NCT01358721|528842607|FG001|Overall Study|Study Drug Toxicity|3|||
146635963|NCT01358721|528842608|FG002|Overall Study|Study Drug Toxicity|4|||
146635964|NCT01358721|528842609|FG003|Overall Study|Study Drug Toxicity|5|||
146635965|NCT01358721|528842606|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
146888378|NCT02482129|529757977|FG000|Overall Study|Adverse Event|1|||
146888379|NCT02482129|529757978|FG001|Overall Study|Adverse Event|0|||
146888380|NCT02482129|529757977|FG000|Overall Study|Withdrawal by Subject|2|||
146888381|NCT02482129|529757978|FG001|Overall Study|Withdrawal by Subject|0|||
146888382|NCT02482129|529757977|FG000|Overall Study|Criteria not met|1|||
146888383|NCT02482129|529757978|FG001|Overall Study|Criteria not met|0|||
146888384|NCT00429585|529757981|FG000|Overall Study|Death|1|||
146888385|NCT00429585|529757982|FG001|Overall Study|Death|0|||
146888386|NCT00429585|529757981|FG000|Overall Study|Lost to Follow-up|27|||
146888387|NCT00429585|529757982|FG001|Overall Study|Lost to Follow-up|20|||
146888388|NCT00429585|529757981|FG000|Overall Study|Physician Decision|2|||
146888389|NCT00429585|529757982|FG001|Overall Study|Physician Decision|0|||
146888390|NCT00772668|529757986|FG000|Overall Study|Physician Decision|3|||
146888391|NCT03406897|529757988|FG000|Overall Study|Lost to Follow-up|1|||
146888392|NCT03406897|529757989|FG001|Overall Study|Lost to Follow-up|2|||
146888393|NCT03406897|529757988|FG000|Overall Study|Withdrawal by Subject|4|||
146888394|NCT03406897|529757989|FG001|Overall Study|Withdrawal by Subject|4|||
146888395|NCT03406897|529757988|FG000|Overall Study|Physician Decision|0|||
146888396|NCT03406897|529757989|FG001|Overall Study|Physician Decision|1|||
146888397|NCT01299766|529759519|FG000|Overall Study|Death|5|||
146888398|NCT01299766|529759520|FG001|Overall Study|Death|4|||
146888399|NCT01299766|529759519|FG000|Overall Study|Withdrawal by Subject|29|||
146888400|NCT01299766|529759520|FG001|Overall Study|Withdrawal by Subject|19|||
146888401|NCT03160560|529759523|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
146635966|NCT01358721|528842607|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
146635967|NCT01358721|528842608|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
146635968|NCT01358721|528842609|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
146888402|NCT03160560|529759524|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
146888403|NCT03160560|529759525|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
146888404|NCT03160560|529759526|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
146888405|NCT03160560|529759523|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
146888406|NCT03160560|529759524|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
146888407|NCT03160560|529759525|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
146555722|NCT00128492|528544347|FG000|Overall Study|Lost to Follow-up|1|||
146555723|NCT00128492|528544348|FG001|Overall Study|Lost to Follow-up|5|||
146555724|NCT00128492|528544347|FG000|Overall Study|Noncompliance|0|||
146555725|NCT00128492|528544348|FG001|Overall Study|Noncompliance|5|||
146555726|NCT00128492|528544347|FG000|Overall Study|Personal or administrative|10|||
146555727|NCT00128492|528544348|FG001|Overall Study|Personal or administrative|22|||
146555728|NCT00128492|528544347|FG000|Overall Study|Withdrawal by Subject|3|||
146555729|NCT00128492|528544348|FG001|Overall Study|Withdrawal by Subject|5|||
146555730|NCT00128492|528544347|FG000|Overall Study|Pregnancy|0|||
146555731|NCT00128492|528544348|FG001|Overall Study|Pregnancy|1|||
146555732|NCT01687595|528544349|FG000|Overall Study|Withdrawal by Subject|8|||
146555733|NCT01687595|528544350|FG001|Overall Study|Withdrawal by Subject|0|||
146555734|NCT01687595|528544349|FG000|Overall Study|Lost to Follow-up|3|||
146555735|NCT01687595|528544350|FG001|Overall Study|Lost to Follow-up|1|||
146555736|NCT01687595|528544349|FG000|Overall Study|Investigator's decision|1|||
146555737|NCT01687595|528544350|FG001|Overall Study|Investigator's decision|0|||
146555738|NCT01687595|528544349|FG000|Overall Study|Sponsor's decision|1|||
146555739|NCT01687595|528544350|FG001|Overall Study|Sponsor's decision|0|||
146555740|NCT01687595|528544349|FG000|Overall Study|Noncompliance|1|||
146555741|NCT01687595|528544350|FG001|Overall Study|Noncompliance|2|||
146555742|NCT01687595|528544349|FG000|Overall Study|Other than specified|56|||
146555743|NCT01687595|528544350|FG001|Overall Study|Other than specified|7|||
146555744|NCT03180138|528544351|FG000|Overall Study|Mobile-phone could not be verified|2|||
146555745|NCT03180138|528544352|FG001|Overall Study|Mobile-phone could not be verified|13|||
146555746|NCT03180138|528544353|FG002|Overall Study|Mobile-phone could not be verified|15|||
146555747|NCT03180138|528544351|FG000|Overall Study|No prior immunization records|17|||
146555748|NCT03180138|528544352|FG001|Overall Study|No prior immunization records|0|||
146555749|NCT03180138|528544353|FG002|Overall Study|No prior immunization records|6|||
146555750|NCT03180138|528544351|FG000|Overall Study|Found to be >24 mon after randomization|3|||
146555751|NCT03180138|528544352|FG001|Overall Study|Found to be >24 mon after randomization|0|||
146555752|NCT03180138|528544353|FG002|Overall Study|Found to be >24 mon after randomization|3|||
146555753|NCT02633527|528544355|FG000|Overall Study|Failed to meet eligibility|0|||
146555754|NCT02633527|528544356|FG001|Overall Study|Failed to meet eligibility|1|||
146635969|NCT01358721|528842606|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
146888408|NCT03160560|529759526|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
146888409|NCT01354028|529759537|FG000|Overall Study|Physician Decision|0|||
146888410|NCT01354028|529759538|FG001|Overall Study|Physician Decision|2|||
146888411|NCT01354028|529759537|FG000|Overall Study|Discharged before study start|2|||
146888412|NCT01354028|529759538|FG001|Overall Study|Discharged before study start|2|||
146888413|NCT01354028|529759537|FG000|Overall Study|No quiet alert state|0|||
146888414|NCT01354028|529759538|FG001|Overall Study|No quiet alert state|1|||
146888415|NCT01777763|529759539|FG000|Overall Study|Adverse Event|2|||
146888416|NCT01777763|529759540|FG001|Overall Study|Adverse Event|32|||
146888417|NCT01777763|529759539|FG000|Overall Study|Protocol Violation|1|||
146888418|NCT01777763|529759540|FG001|Overall Study|Protocol Violation|7|||
146888419|NCT01777763|529759539|FG000|Overall Study|Withdrawal by Subject|0|||
146888420|NCT01777763|529759540|FG001|Overall Study|Withdrawal by Subject|2|||
146888421|NCT01777763|529759539|FG000|Overall Study|Treatment Failure|1|||
146555755|NCT02633527|528544357|FG002|Overall Study|Failed to meet eligibility|1|||
146555756|NCT02633527|528544358|FG003|Overall Study|Failed to meet eligibility|0|||
146555757|NCT02633527|528544359|FG004|Overall Study|Failed to meet eligibility|1|||
146888422|NCT01777763|529759540|FG001|Overall Study|Treatment Failure|6|||
146888423|NCT02222714|529759542|FG000|Overall Study|Death|0|||
146888424|NCT02222714|529759543|FG001|Overall Study|Death|2|||
146888425|NCT02222714|529759544|FG002|Overall Study|Death|3|||
146888426|NCT02222714|529759545|FG003|Overall Study|Death|4|||
146888427|NCT02222714|529759546|FG004|Overall Study|Death|6|||
146888428|NCT02222714|529759542|FG000|Overall Study|Withdrawal by Subject|0|||
146888429|NCT02222714|529759543|FG001|Overall Study|Withdrawal by Subject|0|||
146888430|NCT02222714|529759544|FG002|Overall Study|Withdrawal by Subject|1|||
146888431|NCT02222714|529759545|FG003|Overall Study|Withdrawal by Subject|0|||
146888432|NCT02222714|529759546|FG004|Overall Study|Withdrawal by Subject|1|||
146888433|NCT02450578|529759552|FG000|Overall Study|ECG abnormality so not treated|1|||
146888434|NCT02450578|529759553|FG001|Overall Study|ECG abnormality so not treated|0|||
146888435|NCT02450578|529759554|FG002|Overall Study|ECG abnormality so not treated|0|||
146888436|NCT02450578|529759555|FG003|Overall Study|ECG abnormality so not treated|0|||
146888437|NCT02918019|529759556|FG000|Overall Study|Death|0|||
146888438|NCT02918019|529759557|FG001|Overall Study|Death|0|||
146888439|NCT02918019|529759558|FG002|Overall Study|Death|1|||
146888440|NCT02918019|529759559|FG003|Overall Study|Death|0|||
146888441|NCT02918019|529759556|FG000|Overall Study|Lost to Follow-up|1|||
146888442|NCT02918019|529759557|FG001|Overall Study|Lost to Follow-up|1|||
146888443|NCT02918019|529759558|FG002|Overall Study|Lost to Follow-up|0|||
146888444|NCT02918019|529759559|FG003|Overall Study|Lost to Follow-up|1|||
146888445|NCT02918019|529759556|FG000|Overall Study|Principal investigator request|0|||
146888446|NCT02918019|529759557|FG001|Overall Study|Principal investigator request|0|||
146888447|NCT02918019|529759558|FG002|Overall Study|Principal investigator request|0|||
146888448|NCT02918019|529759559|FG003|Overall Study|Principal investigator request|1|||
146888449|NCT02918019|529759556|FG000|Overall Study|Physician Decision|1|||
146888450|NCT02918019|529759557|FG001|Overall Study|Physician Decision|3|||
146888451|NCT02918019|529759558|FG002|Overall Study|Physician Decision|2|||
146888452|NCT02918019|529759559|FG003|Overall Study|Physician Decision|0|||
146888453|NCT02918019|529759556|FG000|Overall Study|Protocol deviation|1|||
146888454|NCT02918019|529759557|FG001|Overall Study|Protocol deviation|1|||
146888455|NCT02918019|529759558|FG002|Overall Study|Protocol deviation|0|||
146888456|NCT02918019|529759559|FG003|Overall Study|Protocol deviation|2|||
146888457|NCT02918019|529759556|FG000|Overall Study|Withdrawal by Subject|3|||
146888458|NCT02918019|529759557|FG001|Overall Study|Withdrawal by Subject|4|||
146888459|NCT02918019|529759558|FG002|Overall Study|Withdrawal by Subject|6|||
146888460|NCT02918019|529759559|FG003|Overall Study|Withdrawal by Subject|4|||
146888461|NCT02918019|529759556|FG000|Overall Study|Adverse Event|0|||
146888462|NCT02918019|529759557|FG001|Overall Study|Adverse Event|1|||
146888463|NCT02918019|529759558|FG002|Overall Study|Adverse Event|0|||
146888464|NCT02918019|529759559|FG003|Overall Study|Adverse Event|1|||
146888465|NCT00662792|529759560|FG000|Period 1|Personal Reasons|0|||
146888466|NCT00662792|529759561|FG001|Period 1|Personal Reasons|0|||
146888467|NCT00662792|529759562|FG002|Period 1|Personal Reasons|1|||
146888468|NCT00662792|529759563|FG003|Period 1|Personal Reasons|0|||
146888469|NCT00662792|529759560|FG000|Period 1|Refused continuing medication|0|||
146888470|NCT00662792|529759561|FG001|Period 1|Refused continuing medication|1|||
146888471|NCT00662792|529759562|FG002|Period 1|Refused continuing medication|1|||
146888472|NCT00662792|529759563|FG003|Period 1|Refused continuing medication|0|||
146888473|NCT00662792|529759560|FG000|Period 1|Lost to Follow-up|1|||
146888474|NCT00662792|529759561|FG001|Period 1|Lost to Follow-up|0|||
146888475|NCT00662792|529759562|FG002|Period 1|Lost to Follow-up|0|||
146888476|NCT00662792|529759563|FG003|Period 1|Lost to Follow-up|0|||
146888477|NCT00662792|529759560|FG000|Period 1|Other adverse event (AE)|0|||
146888478|NCT00662792|529759561|FG001|Period 1|Other adverse event (AE)|2|||
146888479|NCT00662792|529759562|FG002|Period 1|Other adverse event (AE)|0|||
146555758|NCT02633527|528544355|FG000|Overall Study|Adverse Event|0|||
146888480|NCT00662792|529759563|FG003|Period 1|Other adverse event (AE)|0|||
146888481|NCT00662792|529759560|FG000|Period 1|Worsening of disease under study (AE)|1|||
146888482|NCT00662792|529759561|FG001|Period 1|Worsening of disease under study (AE)|3|||
146888483|NCT00662792|529759562|FG002|Period 1|Worsening of disease under study (AE)|2|||
146888484|NCT00662792|529759563|FG003|Period 1|Worsening of disease under study (AE)|0|||
146888485|NCT00662792|529759560|FG000|Period 1|Not treated|0|||
146888486|NCT00662792|529759561|FG001|Period 1|Not treated|1|||
146888487|NCT00662792|529759562|FG002|Period 1|Not treated|0|||
146888488|NCT00662792|529759563|FG003|Period 1|Not treated|0|||
146888489|NCT00662792|529759560|FG000|Period 2|Worsening of disease under study|1|||
146888490|NCT00662792|529759561|FG001|Period 2|Worsening of disease under study|0|||
146888491|NCT00662792|529759562|FG002|Period 2|Worsening of disease under study|0|||
146888492|NCT00662792|529759563|FG003|Period 2|Worsening of disease under study|3|||
146888493|NCT00662792|529759560|FG000|Period 3|Refused continuing medication|1|||
146888494|NCT00662792|529759561|FG001|Period 3|Refused continuing medication|0|||
146888495|NCT00662792|529759562|FG002|Period 3|Refused continuing medication|1|||
146888496|NCT00662792|529759563|FG003|Period 3|Refused continuing medication|0|||
146888497|NCT00662792|529759560|FG000|Period 3|Other adverse event (AE)|0|||
146888498|NCT00662792|529759561|FG001|Period 3|Other adverse event (AE)|0|||
146888499|NCT00662792|529759562|FG002|Period 3|Other adverse event (AE)|1|||
146888500|NCT00662792|529759563|FG003|Period 3|Other adverse event (AE)|1|||
146888501|NCT00662792|529759560|FG000|Period 4|Refused continuing medication|0|||
146888502|NCT00662792|529759561|FG001|Period 4|Refused continuing medication|1|||
146888503|NCT00662792|529759562|FG002|Period 4|Refused continuing medication|0|||
146888504|NCT00662792|529759563|FG003|Period 4|Refused continuing medication|0|||
146888505|NCT00662792|529759560|FG000|Period 4|Other adverse event (AE)|1|||
146888506|NCT00662792|529759561|FG001|Period 4|Other adverse event (AE)|0|||
146888507|NCT00662792|529759562|FG002|Period 4|Other adverse event (AE)|0|||
146888508|NCT00662792|529759563|FG003|Period 4|Other adverse event (AE)|0|||
146888509|NCT00662792|529759560|FG000|Period 4|Worsening of disease under study (AE)|0|||
146888510|NCT00662792|529759561|FG001|Period 4|Worsening of disease under study (AE)|0|||
146888511|NCT00662792|529759562|FG002|Period 4|Worsening of disease under study (AE)|0|||
146888512|NCT00662792|529759563|FG003|Period 4|Worsening of disease under study (AE)|1|||
146888513|NCT02474082|529759564|FG000|Overall Study|Adverse Event|2|||
146888514|NCT02474082|529759565|FG001|Overall Study|Adverse Event|32|||
146888515|NCT02474082|529759564|FG000|Overall Study|Withdrawal of informed consent|1|||
146888516|NCT02474082|529759565|FG001|Overall Study|Withdrawal of informed consent|11|||
146888517|NCT02474082|529759564|FG000|Overall Study|Lost to Follow-up|2|||
146888518|NCT02474082|529759565|FG001|Overall Study|Lost to Follow-up|2|||
146888519|NCT02474082|529759564|FG000|Overall Study|Dose tapering not achieved|0|||
146888520|NCT02474082|529759565|FG001|Overall Study|Dose tapering not achieved|4|||
146888521|NCT02474082|529759564|FG000|Overall Study|Participant/guardian decision|1|||
146888522|NCT02474082|529759565|FG001|Overall Study|Participant/guardian decision|2|||
146888523|NCT02474082|529759564|FG000|Overall Study|Non-compliance with study treatment|0|||
146888524|NCT02474082|529759565|FG001|Overall Study|Non-compliance with study treatment|2|||
146888525|NCT02474082|529759564|FG000|Overall Study|Protocol deviation|0|||
146888526|NCT02474082|529759565|FG001|Overall Study|Protocol deviation|1|||
146888527|NCT01528787|529759566|FG000|Overall Study|Withdrawal by Subject|0|||
146888528|NCT01528787|529759567|FG001|Overall Study|Withdrawal by Subject|0|||
146888529|NCT01528787|529759568|FG002|Overall Study|Withdrawal by Subject|0|||
146888530|NCT01528787|529759569|FG003|Overall Study|Withdrawal by Subject|1|||
146888531|NCT01528787|529759566|FG000|Overall Study|Family Emergency|0|||
146888532|NCT01528787|529759567|FG001|Overall Study|Family Emergency|0|||
146888533|NCT01528787|529759568|FG002|Overall Study|Family Emergency|1|||
146888534|NCT01528787|529759569|FG003|Overall Study|Family Emergency|0|||
146888535|NCT03433781|529759570|FG000|Overall Study|Progression of Disease|1|||
146888536|NCT03433781|529759571|FG001|Overall Study|Progression of Disease|0|||
146888537|NCT03433781|529759572|FG002|Overall Study|Progression of Disease|0|||
146888538|NCT03433781|529759570|FG000|Overall Study|Physician Decision|0|||
146888539|NCT03433781|529759571|FG001|Overall Study|Physician Decision|1|||
146888540|NCT03433781|529759572|FG002|Overall Study|Physician Decision|0|||
146635970|NCT01358721|528842607|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
146635971|NCT01358721|528842608|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
146635972|NCT01358721|528842609|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
146635973|NCT01358721|528842606|FG000|Overall Study|Adverse Event related to study drug|1|||
146635974|NCT01358721|528842607|FG001|Overall Study|Adverse Event related to study drug|0|||
146635975|NCT01358721|528842608|FG002|Overall Study|Adverse Event related to study drug|0|||
146635976|NCT01358721|528842609|FG003|Overall Study|Adverse Event related to study drug|1|||
146888541|NCT02971670|529759575|FG000|Overall Study|Withdrawal by Subject|4|||
146888542|NCT02971670|529759576|FG001|Overall Study|Withdrawal by Subject|1|||
146888543|NCT02971670|529759577|FG002|Overall Study|Withdrawal by Subject|1|||
146888544|NCT02971670|529759578|FG003|Overall Study|Withdrawal by Subject|2|||
146888545|NCT02793232|529759579|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
146635977|NCT01358721|528842606|FG000|Overall Study|Disease Progression|19|||
146888546|NCT02793232|529759580|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
146888547|NCT02793232|529759581|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
146888548|NCT02793232|529759582|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
146888549|NCT02793232|529759583|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
146888550|NCT02793232|529759584|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
146888551|NCT02793232|529759585|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
146888552|NCT02793232|529759586|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
146888553|NCT02793232|529759587|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
146888554|NCT04849780|529759588|FG000|Period 1|Covid-19 Related|1|||
146888555|NCT04849780|529759589|FG001|Period 1|Covid-19 Related|0|||
146888556|NCT04849780|529759588|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
146888557|NCT04849780|529759589|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
146888558|NCT04849780|529759588|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
146888559|NCT04849780|529759589|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
146888560|NCT01580397|529759590|FG000|Overall Study|Lack of Efficacy|14|||
146888561|NCT00357500|529759593|FG000|Overall Study|Adverse Event|3|||
146888562|NCT00357500|529759593|FG000|Overall Study|Withdrawal by Subject|5|||
146888563|NCT00357500|529759593|FG000|Overall Study|Progressive Disease|65|||
146888564|NCT00357500|529759593|FG000|Overall Study|Not Started Protocol Therapy|4|||
146888565|NCT03979274|529759596|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146888566|NCT03979274|529759597|FG001|Treatment Period 2|Withdrawal by Subject|1|||
146888567|NCT02301403|529759598|FG000|Overall Study|Withdrawal by Subject|28|||
146888568|NCT02301403|529759599|FG001|Overall Study|Withdrawal by Subject|41|||
146888569|NCT01816243|529759602|FG000|Overall Study|Adverse Event|6|||
146888570|NCT01816243|529759602|FG000|Overall Study|Lost to Follow-up|1|||
146888571|NCT01816243|529759602|FG000|Overall Study|Lack of Efficacy|1|||
146888572|NCT01816243|529759602|FG000|Overall Study|Not eligible for the study|1|||
146888573|NCT01816243|529759602|FG000|Overall Study|Amputation|3|||
146888574|NCT02319044|529759609|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
146888575|NCT02319044|529759610|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
146888576|NCT02319044|529759611|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
146888577|NCT02319044|529759609|FG000|Overall Study|Withdrawal by Subject|3|||
146888578|NCT02319044|529759610|FG001|Overall Study|Withdrawal by Subject|3|||
146888579|NCT02319044|529759611|FG002|Overall Study|Withdrawal by Subject|6|||
146888580|NCT02319044|529759609|FG000|Overall Study|Condition under investigation worsened|100|||
146555759|NCT02633527|528544356|FG001|Overall Study|Adverse Event|4|||
146555760|NCT02633527|528544357|FG002|Overall Study|Adverse Event|3|||
146555761|NCT02633527|528544358|FG003|Overall Study|Adverse Event|1|||
146555762|NCT02633527|528544359|FG004|Overall Study|Adverse Event|5|||
146555763|NCT02633527|528544355|FG000|Overall Study|Lost to Follow-up|1|||
146555764|NCT02633527|528544356|FG001|Overall Study|Lost to Follow-up|2|||
146555765|NCT02633527|528544357|FG002|Overall Study|Lost to Follow-up|5|||
146555766|NCT02633527|528544358|FG003|Overall Study|Lost to Follow-up|5|||
146635978|NCT01358721|528842607|FG001|Overall Study|Disease Progression|15|||
146555767|NCT02633527|528544359|FG004|Overall Study|Lost to Follow-up|4|||
146555768|NCT02633527|528544355|FG000|Overall Study|Withdrawal by Subject|0|||
146635979|NCT01358721|528842608|FG002|Overall Study|Disease Progression|17|||
146635980|NCT01358721|528842609|FG003|Overall Study|Disease Progression|15|||
146635981|NCT01358721|528842606|FG000|Overall Study|Out of State/Unmet Criteria|0|||
146635982|NCT01358721|528842607|FG001|Overall Study|Out of State/Unmet Criteria|0|||
146635983|NCT01358721|528842608|FG002|Overall Study|Out of State/Unmet Criteria|1|||
146635984|NCT01358721|528842609|FG003|Overall Study|Out of State/Unmet Criteria|0|||
146555769|NCT02633527|528544356|FG001|Overall Study|Withdrawal by Subject|3|||
146555770|NCT02633527|528544357|FG002|Overall Study|Withdrawal by Subject|5|||
146555771|NCT02633527|528544358|FG003|Overall Study|Withdrawal by Subject|4|||
146555772|NCT02633527|528544359|FG004|Overall Study|Withdrawal by Subject|4|||
146555773|NCT02633527|528544355|FG000|Overall Study|Protocol Violation|0|||
146555774|NCT02633527|528544356|FG001|Overall Study|Protocol Violation|1|||
146555775|NCT02633527|528544357|FG002|Overall Study|Protocol Violation|1|||
146635985|NCT02446899|528842614|FG000|Overall Study|Adverse Event|4|||
146635986|NCT02446899|528842615|FG001|Overall Study|Adverse Event|7|||
146635987|NCT02446899|528842614|FG000|Overall Study|Condition Under Investigation Worsened|1|||
146635988|NCT02446899|528842615|FG001|Overall Study|Condition Under Investigation Worsened|4|||
146635989|NCT02446899|528842614|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
146635990|NCT02446899|528842615|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
146635991|NCT02446899|528842614|FG000|Overall Study|Lack of Efficacy|2|||
146635992|NCT02446899|528842615|FG001|Overall Study|Lack of Efficacy|8|||
146635993|NCT02446899|528842614|FG000|Overall Study|Lost to Follow-up|1|||
146635994|NCT02446899|528842615|FG001|Overall Study|Lost to Follow-up|3|||
146635995|NCT02446899|528842614|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
146635996|NCT02446899|528842615|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
146635997|NCT02446899|528842614|FG000|Overall Study|Withdrawal by Subject|11|||
146635998|NCT02446899|528842615|FG001|Overall Study|Withdrawal by Subject|19|||
146635999|NCT02446899|528842614|FG000|Overall Study|Miscellaneous|5|||
146555776|NCT02633527|528544358|FG003|Overall Study|Protocol Violation|1|||
146555777|NCT02633527|528544359|FG004|Overall Study|Protocol Violation|1|||
146555778|NCT02633527|528544355|FG000|Overall Study|Physician Decision|0|||
146636000|NCT02446899|528842615|FG001|Overall Study|Miscellaneous|4|||
146636001|NCT02446899|528842614|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
146636002|NCT02446899|528842615|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
146765743|NCT00878722|529310383|FG002|Overall Study|Withdrawal by Subject|0|||
146765744|NCT00878722|529310384|FG003|Overall Study|Withdrawal by Subject|0|||
146555779|NCT02633527|528544356|FG001|Overall Study|Physician Decision|0|||
146555780|NCT02633527|528544357|FG002|Overall Study|Physician Decision|0|||
146555781|NCT02633527|528544358|FG003|Overall Study|Physician Decision|0|||
146765745|NCT00878722|529310385|FG004|Overall Study|Withdrawal by Subject|0|||
146765746|NCT00878722|529310386|FG005|Overall Study|Withdrawal by Subject|0|||
146765747|NCT00878722|529310387|FG006|Overall Study|Withdrawal by Subject|0|||
146765748|NCT00878722|529310388|FG007|Overall Study|Withdrawal by Subject|2|||
146765749|NCT00878722|529310381|FG000|Overall Study|Relapse|0|||
146765750|NCT00878722|529310382|FG001|Overall Study|Relapse|0|||
146765751|NCT00878722|529310383|FG002|Overall Study|Relapse|0|||
146765752|NCT00878722|529310384|FG003|Overall Study|Relapse|1|||
146765753|NCT00878722|529310385|FG004|Overall Study|Relapse|0|||
146765754|NCT00878722|529310386|FG005|Overall Study|Relapse|0|||
146765755|NCT00878722|529310387|FG006|Overall Study|Relapse|0|||
146765756|NCT00878722|529310388|FG007|Overall Study|Relapse|0|||
146765757|NCT00972504|529310389|FG000|Overall Study|Adverse Event|2|||
146765758|NCT00972504|529310389|FG000|Overall Study|Investigator discretion|1|||
146765759|NCT02878330|529310390|FG000|Overall Study|Death|3|||
146765760|NCT02878330|529310391|FG001|Overall Study|Death|2|||
146765761|NCT02878330|529310390|FG000|Overall Study|Lost to Follow-up|11|||
146765762|NCT02878330|529310391|FG001|Overall Study|Lost to Follow-up|26|||
146636003|NCT04730271|528842617|FG000|Overall Study|Adverse Event|0|||
146636004|NCT04730271|528842618|FG001|Overall Study|Adverse Event|2|||
146636005|NCT04730271|528842617|FG000|Overall Study|Withdrawal by Subject|1|||
146636006|NCT04730271|528842618|FG001|Overall Study|Withdrawal by Subject|1|||
146636007|NCT04730271|528842617|FG000|Overall Study|Protocol Violation|7|||
146636008|NCT04730271|528842618|FG001|Overall Study|Protocol Violation|13|||
146888581|NCT02319044|529759610|FG001|Overall Study|Condition under investigation worsened|50|||
146888582|NCT02319044|529759611|FG002|Overall Study|Condition under investigation worsened|46|||
146888583|NCT02319044|529759609|FG000|Overall Study|Adverse Event|17|||
146888584|NCT02319044|529759610|FG001|Overall Study|Adverse Event|2|||
146888585|NCT02319044|529759611|FG002|Overall Study|Adverse Event|8|||
146888586|NCT02319044|529759609|FG000|Overall Study|Study specific discontinuation criteria|2|||
146888587|NCT02319044|529759610|FG001|Overall Study|Study specific discontinuation criteria|2|||
146888588|NCT02319044|529759611|FG002|Overall Study|Study specific discontinuation criteria|1|||
146888589|NCT02319044|529759609|FG000|Overall Study|Not treated|0|||
146888590|NCT02319044|529759610|FG001|Overall Study|Not treated|2|||
146888591|NCT02319044|529759611|FG002|Overall Study|Not treated|2|||
146888592|NCT00626093|529759612|FG000|Overall Study|Lost to Follow-up|5|||
146888593|NCT00626093|529759612|FG000|Overall Study|Death|1|||
146888594|NCT00626093|529759612|FG000|Overall Study|Physician Decision|4|||
146888595|NCT00626093|529759612|FG000|Overall Study|Withdrawal by Subject|6|||
146888596|NCT00626093|529759612|FG000|Overall Study|Protocol Violation|1|||
146888597|NCT00626093|529759612|FG000|Overall Study|One of the required devices not implante|6|||
146888598|NCT00603915|529759613|FG000|Overall Study|Physician Decision|1|||
146888599|NCT00911989|529759614|FG000|Overall Study|Adverse Event|1|||
146888600|NCT03434977|529759615|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
146888601|NCT03434977|529759616|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
146888602|NCT03064841|529759617|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
146888603|NCT03064841|529759617|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
146888604|NCT03064841|529759617|FG000|Overall Study|Screen failure|2|||
146888605|NCT01145066|529759620|FG000|Overall Study|To resume NSAIDs|2|||
146888606|NCT01145066|529759621|FG001|Overall Study|To resume NSAIDs|2|||
146888607|NCT01145066|529759622|FG002|Overall Study|To resume NSAIDs|1|||
146888608|NCT01145066|529759620|FG000|Overall Study|Non-related surgery|0|||
146888609|NCT01145066|529759621|FG001|Overall Study|Non-related surgery|0|||
146888610|NCT01145066|529759622|FG002|Overall Study|Non-related surgery|1|||
146888611|NCT01145066|529759620|FG000|Overall Study|Withdrawal by Subject|0|||
146888612|NCT01145066|529759621|FG001|Overall Study|Withdrawal by Subject|0|||
146888613|NCT01145066|529759622|FG002|Overall Study|Withdrawal by Subject|2|||
146888614|NCT01145066|529759620|FG000|Overall Study|To start new med|1|||
146888615|NCT01145066|529759621|FG001|Overall Study|To start new med|0|||
146888616|NCT01145066|529759622|FG002|Overall Study|To start new med|0|||
146888617|NCT01145066|529759620|FG000|Overall Study|problems swallowing capsule|1|||
146888618|NCT01145066|529759621|FG001|Overall Study|problems swallowing capsule|0|||
146888619|NCT01145066|529759622|FG002|Overall Study|problems swallowing capsule|0|||
146888620|NCT01145066|529759620|FG000|Overall Study|Abdominal discomfort|0|||
146888621|NCT01145066|529759621|FG001|Overall Study|Abdominal discomfort|1|||
146888622|NCT01145066|529759622|FG002|Overall Study|Abdominal discomfort|0|||
146888623|NCT01145066|529759620|FG000|Overall Study|Low platelet count|0|||
146888624|NCT01145066|529759621|FG001|Overall Study|Low platelet count|1|||
146888625|NCT01145066|529759622|FG002|Overall Study|Low platelet count|0|||
146888626|NCT00573794|529759625|FG000|Overall Study|Adverse Event|81|||
146888627|NCT00573794|529759625|FG000|Overall Study|Withdrew Consent|90|||
146888628|NCT00573794|529759625|FG000|Overall Study|Lost to Follow-up|13|||
146636009|NCT04730271|528842617|FG000|Overall Study|Lost to Follow-up|3|||
146636010|NCT04730271|528842618|FG001|Overall Study|Lost to Follow-up|3|||
146888629|NCT00573794|529759625|FG000|Overall Study|Protocol Violation|6|||
146888630|NCT00573794|529759625|FG000|Overall Study|Lack of Efficacy|94|||
146888631|NCT00573794|529759625|FG000|Overall Study|Other|46|||
146888632|NCT03687502|529759626|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
146888633|NCT03687502|529759626|FG000|Overall Study|Lumason not available|1|||
146888634|NCT01724528|529759630|FG000|Overall Study|Death|3|||
146888635|NCT01724528|529759631|FG001|Overall Study|Death|0|||
146888636|NCT01724528|529759630|FG000|Overall Study|Withdrawal by Subject|0|||
146888637|NCT01724528|529759631|FG001|Overall Study|Withdrawal by Subject|2|||
146888638|NCT01724528|529759630|FG000|Overall Study|Protocol Violation|0|||
146888639|NCT01724528|529759631|FG001|Overall Study|Protocol Violation|1|||
146888640|NCT01724528|529759630|FG000|Overall Study|Patient refused to attend last visit|1|||
146888641|NCT01724528|529759631|FG001|Overall Study|Patient refused to attend last visit|0|||
146888642|NCT05574062|529759635|FG000|Pre Run-In|Screening failure|3|||
146888643|NCT05574062|529759636|FG001|Pre Run-In|Screening failure|0|||
146636011|NCT04730271|528842617|FG000|Overall Study|Death|1|||
146636012|NCT04730271|528842618|FG001|Overall Study|Death|0|||
146636013|NCT02223858|528842621|FG000|Overall Study|Death|1|||
146888644|NCT05574062|529759637|FG002|Pre Run-In|Screening failure|0|||
146888645|NCT05574062|529759638|FG003|Pre Run-In|Screening failure|0|||
146888646|NCT05574062|529759639|FG004|Pre Run-In|Screening failure|0|||
146888647|NCT05574062|529759635|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
146636014|NCT02223858|528842622|FG001|Overall Study|Death|1|||
146555782|NCT02633527|528544359|FG004|Overall Study|Physician Decision|1|||
146555783|NCT02633527|528544355|FG000|Overall Study|Administrative reason|1|||
146555784|NCT02633527|528544356|FG001|Overall Study|Administrative reason|0|||
146555785|NCT02633527|528544357|FG002|Overall Study|Administrative reason|0|||
146555786|NCT02633527|528544358|FG003|Overall Study|Administrative reason|1|||
146555787|NCT02633527|528544359|FG004|Overall Study|Administrative reason|0|||
146555788|NCT02633527|528544355|FG000|Overall Study|Multiple reasons|1|||
146555789|NCT02633527|528544356|FG001|Overall Study|Multiple reasons|0|||
146555790|NCT02633527|528544357|FG002|Overall Study|Multiple reasons|2|||
146555791|NCT02633527|528544358|FG003|Overall Study|Multiple reasons|2|||
146555792|NCT02633527|528544359|FG004|Overall Study|Multiple reasons|1|||
146555793|NCT02100644|528544362|FG000|LTG Escalation Phase|Adverse Event|9|||
146555794|NCT02100644|528544363|FG001|LTG Escalation Phase|Adverse Event|0|||
146555795|NCT02100644|528544364|FG002|LTG Escalation Phase|Adverse Event|0|||
146555796|NCT02100644|528544362|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
146888648|NCT05574062|529759636|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
146888649|NCT05574062|529759637|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
146888650|NCT05574062|529759638|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
146888651|NCT05574062|529759639|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
146888652|NCT05574062|529759635|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
146555797|NCT02100644|528544363|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
146555798|NCT02100644|528544364|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
146555799|NCT02100644|528544362|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
146888653|NCT05574062|529759636|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
146888654|NCT05574062|529759637|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
146888655|NCT05574062|529759638|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
146888656|NCT05574062|529759639|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
146888657|NCT05574062|529759635|FG000|Continuation Phase Period 1|Physician Decision|1|||
146888658|NCT05574062|529759636|FG001|Continuation Phase Period 1|Physician Decision|0|||
146888659|NCT05574062|529759637|FG002|Continuation Phase Period 1|Physician Decision|0|||
146888660|NCT05574062|529759638|FG003|Continuation Phase Period 1|Physician Decision|0|||
146888661|NCT05574062|529759639|FG004|Continuation Phase Period 1|Physician Decision|0|||
146888662|NCT05574062|529759635|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
146888663|NCT05574062|529759636|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
146888664|NCT05574062|529759637|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
146888665|NCT05574062|529759638|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
146888666|NCT05574062|529759639|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
146888667|NCT05574062|529759635|FG000|Continuation Phase Period 1|Adverse Event|1|||
146888668|NCT05574062|529759636|FG001|Continuation Phase Period 1|Adverse Event|0|||
146888669|NCT05574062|529759637|FG002|Continuation Phase Period 1|Adverse Event|0|||
146888670|NCT05574062|529759638|FG003|Continuation Phase Period 1|Adverse Event|0|||
146888671|NCT05574062|529759639|FG004|Continuation Phase Period 1|Adverse Event|0|||
146888672|NCT05574062|529759635|FG000|Continuation Phase Period 1|Death|1|||
146888673|NCT05574062|529759636|FG001|Continuation Phase Period 1|Death|0|||
146555800|NCT02100644|528544363|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
146555801|NCT02100644|528544364|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
146555802|NCT02852005|528544365|FG000|Overall Study|Lost to Follow-up|0|||
146555803|NCT02852005|528544366|FG001|Overall Study|Lost to Follow-up|0|||
146555804|NCT02852005|528544367|FG002|Overall Study|Lost to Follow-up|0|||
146555805|NCT02852005|528544368|FG003|Overall Study|Lost to Follow-up|0|||
146555806|NCT02852005|528544369|FG004|Overall Study|Lost to Follow-up|1|||
146555807|NCT02852005|528544365|FG000|Overall Study|Withdrawal by Subject|1|||
146555808|NCT02852005|528544366|FG001|Overall Study|Withdrawal by Subject|0|||
146555809|NCT02852005|528544367|FG002|Overall Study|Withdrawal by Subject|0|||
146555810|NCT02852005|528544368|FG003|Overall Study|Withdrawal by Subject|0|||
146555811|NCT02852005|528544369|FG004|Overall Study|Withdrawal by Subject|0|||
146555812|NCT04629521|528544370|FG000|Overall Study|Death|1|||
146555813|NCT04629521|528544370|FG000|Overall Study|Lost to Follow-up|3|||
146555814|NCT04629521|528544370|FG000|Overall Study|Subject withdrew consent|3|||
146555815|NCT04629521|528544370|FG000|Overall Study|Enrolled in error|1|||
146888674|NCT05574062|529759637|FG002|Continuation Phase Period 1|Death|0|||
146888675|NCT05574062|529759638|FG003|Continuation Phase Period 1|Death|0|||
146888676|NCT05574062|529759639|FG004|Continuation Phase Period 1|Death|0|||
146888677|NCT05574062|529759635|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
146888678|NCT05574062|529759636|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
146888679|NCT05574062|529759637|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
146888680|NCT05574062|529759638|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
146888681|NCT05574062|529759639|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
146888682|NCT01777581|529759642|FG000|Overall Study|Lost to Follow-up|1|||
146888683|NCT01777581|529759643|FG001|Overall Study|Lost to Follow-up|1|||
146888684|NCT01777581|529759642|FG000|Overall Study|Adverse Event|2|||
146888685|NCT01777581|529759643|FG001|Overall Study|Adverse Event|0|||
146888686|NCT01777581|529759642|FG000|Overall Study|Lack of Efficacy|0|||
146888687|NCT01777581|529759643|FG001|Overall Study|Lack of Efficacy|1|||
146888688|NCT02321436|529759648|FG000|Overall Study|Withdrawal by Subject|1|||
146888689|NCT02321436|529759649|FG001|Overall Study|Withdrawal by Subject|0|||
146888690|NCT02321436|529759648|FG000|Overall Study|Lost to Follow-up|0|||
146888691|NCT02321436|529759649|FG001|Overall Study|Lost to Follow-up|1|||
146888692|NCT00644787|529759650|FG000|Period 1: Titration Phase|Adverse Event|11|||
146888693|NCT00644787|529759651|FG001|Period 1: Titration Phase|Adverse Event|0|||
146888694|NCT00644787|529759652|FG002|Period 1: Titration Phase|Adverse Event|0|||
146888695|NCT00644787|529759650|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
146888696|NCT00644787|529759651|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
146888697|NCT00644787|529759652|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
146888698|NCT00644787|529759650|FG000|Period 1: Titration Phase|Physician Decision|1|||
146888699|NCT00644787|529759651|FG001|Period 1: Titration Phase|Physician Decision|0|||
146888700|NCT00644787|529759652|FG002|Period 1: Titration Phase|Physician Decision|0|||
146888701|NCT00644787|529759650|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
146888702|NCT00644787|529759651|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
146888703|NCT00644787|529759652|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
146888704|NCT00644787|529759650|FG000|Period 1: Titration Phase|Worsening of complications|1|||
146888705|NCT00644787|529759651|FG001|Period 1: Titration Phase|Worsening of complications|0|||
146888706|NCT00644787|529759652|FG002|Period 1: Titration Phase|Worsening of complications|0|||
146888707|NCT00644787|529759650|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
146888708|NCT00644787|529759651|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
146888709|NCT00644787|529759652|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
146888710|NCT00644787|529759650|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
146888711|NCT00644787|529759651|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
146888712|NCT00644787|529759652|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
146888713|NCT00644787|529759650|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
146888714|NCT00644787|529759651|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
146888715|NCT00644787|529759652|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
146888716|NCT00644787|529759650|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
146888717|NCT00644787|529759651|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
146888718|NCT00644787|529759652|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
146888719|NCT00644787|529759650|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
146888720|NCT00644787|529759651|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
146888721|NCT00644787|529759652|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
146888722|NCT00644787|529759650|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
146888723|NCT00644787|529759651|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
146888724|NCT00644787|529759652|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
146888725|NCT00644787|529759650|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
146888726|NCT00644787|529759651|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
146888727|NCT00644787|529759652|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
146888728|NCT01928381|529759658|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
146888729|NCT01928381|529759659|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
146888730|NCT01928381|529759660|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
146888731|NCT01928381|529759661|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
146888732|NCT01928381|529759662|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
146888733|NCT01928381|529759663|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
146888734|NCT01928381|529759664|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
146888735|NCT01928381|529759658|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
146888736|NCT01928381|529759659|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
146888737|NCT01928381|529759660|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
146888738|NCT01928381|529759661|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
146888739|NCT01928381|529759662|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
146888740|NCT01928381|529759663|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
146888741|NCT01928381|529759664|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
146888742|NCT01928381|529759658|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
146888743|NCT01928381|529759659|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
146888744|NCT01928381|529759660|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
146888745|NCT01928381|529759661|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
146888746|NCT01928381|529759662|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
146888747|NCT01928381|529759663|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
146888748|NCT01928381|529759664|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
146888749|NCT01928381|529759658|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
146888750|NCT01928381|529759659|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
146888751|NCT01928381|529759660|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
146888752|NCT01928381|529759661|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
146888753|NCT01928381|529759662|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
146888754|NCT01928381|529759663|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
146888755|NCT01928381|529759664|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
146888756|NCT01928381|529759658|FG000|Part 1 - Pain Training|Protocol Violation|1|||
146888757|NCT01928381|529759659|FG001|Part 1 - Pain Training|Protocol Violation|0|||
146888758|NCT01928381|529759660|FG002|Part 1 - Pain Training|Protocol Violation|0|||
146888759|NCT01928381|529759661|FG003|Part 1 - Pain Training|Protocol Violation|0|||
146888760|NCT01928381|529759662|FG004|Part 1 - Pain Training|Protocol Violation|0|||
146888761|NCT01928381|529759663|FG005|Part 1 - Pain Training|Protocol Violation|0|||
146888762|NCT01928381|529759664|FG006|Part 1 - Pain Training|Protocol Violation|0|||
146888763|NCT01928381|529759658|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
146888764|NCT01928381|529759659|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
146888765|NCT01928381|529759660|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
146888766|NCT01928381|529759661|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
146888767|NCT01928381|529759662|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
146888768|NCT01928381|529759663|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
146888769|NCT01928381|529759664|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
146888770|NCT01928381|529759658|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
146888771|NCT01928381|529759659|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
146636015|NCT02223858|528842621|FG000|Overall Study|Lost to Follow-up|6|||
146966885|NCT02875340|530040080|FG000|Overall Study|Withdrawal by Subject|2|||
146966886|NCT02875340|530040080|FG000|Overall Study|Physician Decision|3|||
146966887|NCT02875340|530040080|FG000|Overall Study|Adverse Event|1|||
146636016|NCT02223858|528842622|FG001|Overall Study|Lost to Follow-up|11|||
146966888|NCT01160770|530040081|FG000|Overall Study|Adverse Event|10|||
146888772|NCT01928381|529759660|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
146888773|NCT01928381|529759661|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
146888774|NCT01928381|529759662|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
146555816|NCT01898091|528544373|FG000|Overall Study|Lost to Follow-up|1|||
146555817|NCT01898091|528544374|FG001|Overall Study|Lost to Follow-up|1|||
146555818|NCT01898091|528544373|FG000|Overall Study|Withdrawal by Subject|1|||
146555819|NCT01898091|528544374|FG001|Overall Study|Withdrawal by Subject|5|||
146555820|NCT02369159|528544377|FG000|Overall Study|Adverse Event|0|||
146555821|NCT02369159|528544378|FG001|Overall Study|Adverse Event|1|||
146555822|NCT02369159|528544377|FG000|Overall Study|Lost to Follow-up|1|||
146555823|NCT02369159|528544378|FG001|Overall Study|Lost to Follow-up|1|||
146555824|NCT02369159|528544377|FG000|Overall Study|Withdrawal by Subject|7|||
146555825|NCT02369159|528544378|FG001|Overall Study|Withdrawal by Subject|0|||
146555826|NCT02554474|528544379|FG000|Overall Study|Protocol Violation|1|||
146555827|NCT02554474|528544380|FG001|Overall Study|Protocol Violation|1|||
146555828|NCT02554474|528544379|FG000|Overall Study|Health issue not related to the study|1|||
146555829|NCT02554474|528544380|FG001|Overall Study|Health issue not related to the study|0|||
146555830|NCT02554474|528544379|FG000|Overall Study|Withdrawal by Subject|1|||
146966889|NCT01160770|530040081|FG000|Overall Study|Protocol Violation|2|||
146888775|NCT01928381|529759663|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
146888776|NCT01928381|529759664|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
146888777|NCT01928381|529759658|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
146888778|NCT01928381|529759659|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
146888779|NCT01928381|529759660|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
146888780|NCT01928381|529759661|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
146888781|NCT01928381|529759662|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
146888782|NCT01928381|529759663|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
146888783|NCT01928381|529759664|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
146888784|NCT01928381|529759658|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
146888785|NCT01928381|529759659|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
146888786|NCT01928381|529759660|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
146888787|NCT01928381|529759661|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
146888788|NCT01928381|529759662|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
146888789|NCT01928381|529759663|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
146888790|NCT01928381|529759664|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
146888791|NCT01928381|529759658|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
146888792|NCT01928381|529759659|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
146888793|NCT01928381|529759660|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
146888794|NCT01928381|529759661|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
146888795|NCT01928381|529759662|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
146888796|NCT01928381|529759663|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
146888797|NCT01928381|529759664|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
146888798|NCT01928381|529759658|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
146888799|NCT01928381|529759659|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
146888800|NCT01928381|529759660|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
146888801|NCT01928381|529759661|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
146888802|NCT01928381|529759662|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
146888803|NCT01928381|529759663|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
146888804|NCT01928381|529759664|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
146888805|NCT01928381|529759658|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
146888806|NCT01928381|529759659|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
146636017|NCT02223858|528842621|FG000|Overall Study|Withdrawal by Subject|8|||
146636018|NCT02223858|528842622|FG001|Overall Study|Withdrawal by Subject|5|||
146636019|NCT02223858|528842621|FG000|Overall Study|Refused|9|||
146636020|NCT02223858|528842622|FG001|Overall Study|Refused|9|||
146636021|NCT04455815|528842625|FG000|Randomisation Phase|Adverse Event|1|||
146636022|NCT04455815|528842626|FG001|Randomisation Phase|Adverse Event|0|||
146636023|NCT04455815|528842625|FG000|Treatment Phase|Adverse Event|0|||
146636024|NCT04455815|528842626|FG001|Treatment Phase|Adverse Event|1|||
146636025|NCT04455815|528842625|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
146636026|NCT04455815|528842626|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
146636027|NCT04455815|528842625|FG000|Treatment Phase|Withdrawal by Subject|1|||
146636028|NCT04455815|528842626|FG001|Treatment Phase|Withdrawal by Subject|1|||
146636029|NCT02106390|528842627|FG000|Overall Study|Withdrawal by Subject|15|||
146636030|NCT02106390|528842628|FG001|Overall Study|Withdrawal by Subject|16|||
146636031|NCT02106390|528842629|FG002|Overall Study|Withdrawal by Subject|15|||
146636032|NCT02106390|528842627|FG000|Overall Study|Lost to Follow-up|25|||
146636033|NCT02106390|528842628|FG001|Overall Study|Lost to Follow-up|20|||
146636034|NCT02106390|528842629|FG002|Overall Study|Lost to Follow-up|13|||
146636035|NCT02106390|528842627|FG000|Overall Study|Other: Administrative Reason|8|||
146966890|NCT01160770|530040081|FG000|Overall Study|Subject/parent/caregiver request|33|||
146966891|NCT01160770|530040081|FG000|Overall Study|Physician Decision|1|||
146636036|NCT02106390|528842628|FG001|Overall Study|Other: Administrative Reason|5|||
146636037|NCT02106390|528842629|FG002|Overall Study|Other: Administrative Reason|12|||
146636038|NCT02106390|528842627|FG000|Overall Study|Other: Unspecified|1|||
146636039|NCT02106390|528842628|FG001|Overall Study|Other: Unspecified|4|||
146636040|NCT02106390|528842629|FG002|Overall Study|Other: Unspecified|2|||
146636041|NCT02106390|528842627|FG000|Overall Study|Adverse Event|0|||
146888807|NCT01928381|529759660|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
146888808|NCT01928381|529759661|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
146888809|NCT01928381|529759662|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
146888810|NCT01928381|529759663|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
146888811|NCT01928381|529759664|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
146888812|NCT01928381|529759658|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
146888813|NCT01928381|529759659|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
146888814|NCT01928381|529759660|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
146888815|NCT01928381|529759661|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
146888816|NCT01928381|529759662|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
146888817|NCT01928381|529759663|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
146888818|NCT01928381|529759664|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
146888819|NCT01928381|529759658|FG000|Washout First Intervention|Protocol Violation|0|||
146888820|NCT01928381|529759659|FG001|Washout First Intervention|Protocol Violation|0|||
146888821|NCT01928381|529759660|FG002|Washout First Intervention|Protocol Violation|0|||
146888822|NCT01928381|529759661|FG003|Washout First Intervention|Protocol Violation|0|||
146888823|NCT01928381|529759662|FG004|Washout First Intervention|Protocol Violation|1|||
146888824|NCT01928381|529759663|FG005|Washout First Intervention|Protocol Violation|0|||
146888825|NCT01928381|529759664|FG006|Washout First Intervention|Protocol Violation|0|||
146888826|NCT01928381|529759658|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
146636042|NCT02106390|528842628|FG001|Overall Study|Adverse Event|2|||
146636043|NCT02106390|528842629|FG002|Overall Study|Adverse Event|1|||
146636044|NCT02106390|528842627|FG000|Overall Study|Protocol Violation|0|||
146636045|NCT02106390|528842628|FG001|Overall Study|Protocol Violation|1|||
146636046|NCT02106390|528842629|FG002|Overall Study|Protocol Violation|0|||
146636047|NCT01189032|528842630|FG000|Overall Study|Adverse Event|1|||
146636048|NCT01189032|528842631|FG001|Overall Study|Adverse Event|3|||
146636049|NCT01189032|528842632|FG002|Overall Study|Adverse Event|4|||
146636050|NCT01189032|528842630|FG000|Overall Study|Lack of Efficacy|2|||
146636051|NCT01189032|528842631|FG001|Overall Study|Lack of Efficacy|3|||
146636052|NCT01189032|528842632|FG002|Overall Study|Lack of Efficacy|0|||
146636053|NCT01189032|528842630|FG000|Overall Study|Withdrawal by Subject|1|||
146636054|NCT01189032|528842631|FG001|Overall Study|Withdrawal by Subject|0|||
146636055|NCT01189032|528842632|FG002|Overall Study|Withdrawal by Subject|1|||
146888827|NCT01928381|529759659|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
146888828|NCT01928381|529759660|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
146888829|NCT01928381|529759661|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
146888830|NCT01928381|529759662|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
146888831|NCT01928381|529759663|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
146888832|NCT01928381|529759664|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
146888833|NCT01928381|529759658|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
146888834|NCT01928381|529759659|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
146888835|NCT01928381|529759660|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
146888836|NCT01928381|529759661|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
146888837|NCT01928381|529759662|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
146888838|NCT01928381|529759663|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
146888839|NCT01928381|529759664|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
146888840|NCT01877083|529759665|FG000|Treatment Phase|Disease Progression|10|||
146888841|NCT01877083|529759665|FG000|Treatment Phase|Clinical Progression|1|||
146888842|NCT01877083|529759665|FG000|Treatment Phase|Adverse Event|6|||
146888843|NCT01877083|529759665|FG000|Treatment Phase|Withdrawal by Subject|2|||
146888844|NCT01877083|529759665|FG000|Treatment Phase|Lost to Follow-up|1|||
146888845|NCT01877083|529759665|FG000|Extension Phase|Disease Progression|3|||
146888846|NCT01877083|529759665|FG000|Extension Phase|Adverse Event|2|||
146888847|NCT01582308|529759666|FG000|Period 1|Withdrawal by Subject|0|||
146888848|NCT01582308|529759667|FG001|Period 1|Withdrawal by Subject|0|||
146888849|NCT01582308|529759668|FG002|Period 1|Withdrawal by Subject|0|||
146888850|NCT01582308|529759669|FG003|Period 1|Withdrawal by Subject|0|||
146888851|NCT01582308|529759670|FG004|Period 1|Withdrawal by Subject|0|||
146888852|NCT01582308|529759671|FG005|Period 1|Withdrawal by Subject|0|||
146636056|NCT01189032|528842630|FG000|Overall Study|Protocol Violation|1|||
146888853|NCT01582308|529759672|FG006|Period 1|Withdrawal by Subject|1|||
146888854|NCT01582308|529759673|FG007|Period 1|Withdrawal by Subject|0|||
146888855|NCT01582308|529759674|FG008|Period 1|Withdrawal by Subject|0|||
146888856|NCT01582308|529759675|FG009|Period 1|Withdrawal by Subject|0|||
146888857|NCT01582308|529759666|FG000|10-day Washout Following Period 1|Physician Decision|0|||
146888858|NCT01582308|529759667|FG001|10-day Washout Following Period 1|Physician Decision|0|||
146888859|NCT01582308|529759668|FG002|10-day Washout Following Period 1|Physician Decision|0|||
146636057|NCT01189032|528842631|FG001|Overall Study|Protocol Violation|1|||
146636058|NCT01189032|528842632|FG002|Overall Study|Protocol Violation|1|||
146636059|NCT00473382|528842633|FG000|Core Study|Adverse Event|3|||
146636060|NCT00473382|528842634|FG001|Core Study|Adverse Event|1|||
146636061|NCT00473382|528842635|FG002|Core Study|Adverse Event|1|||
146636062|NCT00473382|528842633|FG000|Core Study|Death|3|||
146636063|NCT00473382|528842634|FG001|Core Study|Death|5|||
146888860|NCT01582308|529759669|FG003|10-day Washout Following Period 1|Physician Decision|0|||
146888861|NCT01582308|529759670|FG004|10-day Washout Following Period 1|Physician Decision|1|||
146888862|NCT01582308|529759671|FG005|10-day Washout Following Period 1|Physician Decision|0|||
146888863|NCT01582308|529759672|FG006|10-day Washout Following Period 1|Physician Decision|0|||
146888864|NCT01582308|529759673|FG007|10-day Washout Following Period 1|Physician Decision|0|||
146888865|NCT01582308|529759674|FG008|10-day Washout Following Period 1|Physician Decision|0|||
146888866|NCT01582308|529759675|FG009|10-day Washout Following Period 1|Physician Decision|0|||
146888867|NCT01582308|529759666|FG000|Period 4|Physician Decision|1|||
146888868|NCT01582308|529759667|FG001|Period 4|Physician Decision|0|||
146888869|NCT01582308|529759668|FG002|Period 4|Physician Decision|0|||
146888870|NCT01582308|529759669|FG003|Period 4|Physician Decision|0|||
146888871|NCT01582308|529759670|FG004|Period 4|Physician Decision|0|||
146888872|NCT01582308|529759671|FG005|Period 4|Physician Decision|1|||
146888873|NCT01582308|529759672|FG006|Period 4|Physician Decision|0|||
146888874|NCT01582308|529759673|FG007|Period 4|Physician Decision|0|||
146888875|NCT01582308|529759674|FG008|Period 4|Physician Decision|0|||
146888876|NCT01582308|529759675|FG009|Period 4|Physician Decision|1|||
146888877|NCT03631706|529759680|FG000|Overall Study|Randomized, not treated|1|||
146888878|NCT03631706|529759681|FG001|Overall Study|Randomized, not treated|0|||
146888879|NCT01844986|529759682|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
146888880|NCT01844986|529759683|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
146888881|NCT01844986|529759682|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
146888882|NCT01844986|529759683|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
146888883|NCT01844986|529759682|FG000|Overall Study (Global Cohort)|Death|55|||
146888884|NCT01844986|529759683|FG001|Overall Study (Global Cohort)|Death|26|||
146888885|NCT01844986|529759682|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
146888886|NCT01844986|529759683|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
146888887|NCT01844986|529759682|FG000|Overall Study (China Cohort)|Death|10|||
146888888|NCT01844986|529759683|FG001|Overall Study (China Cohort)|Death|6|||
146888889|NCT00865020|529759685|FG000|Overall Study|Withdrawal by Subject|22|||
146888890|NCT00865020|529759686|FG001|Overall Study|Withdrawal by Subject|16|||
146888891|NCT00865020|529759685|FG000|Overall Study|Adverse Event|9|||
146888892|NCT00865020|529759686|FG001|Overall Study|Adverse Event|14|||
146888893|NCT00865020|529759685|FG000|Overall Study|Abnormal test procedure result(s)|6|||
146888894|NCT00865020|529759686|FG001|Overall Study|Abnormal test procedure result(s)|8|||
146888895|NCT00865020|529759685|FG000|Overall Study|Lost to Follow-up|6|||
146888896|NCT00865020|529759686|FG001|Overall Study|Lost to Follow-up|4|||
146888897|NCT00865020|529759685|FG000|Overall Study|Protocol deviation|4|||
146888898|NCT00865020|529759686|FG001|Overall Study|Protocol deviation|1|||
146888899|NCT00865020|529759685|FG000|Overall Study|Administrative problems|0|||
146888900|NCT00865020|529759686|FG001|Overall Study|Administrative problems|2|||
146888901|NCT00865020|529759685|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146888902|NCT00865020|529759686|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146888903|NCT00865020|529759685|FG000|Overall Study|Death|0|||
146888904|NCT00865020|529759686|FG001|Overall Study|Death|1|||
146888905|NCT00865020|529759685|FG000|Overall Study|Randomized but discontinued|2|||
146888906|NCT00865020|529759686|FG001|Overall Study|Randomized but discontinued|4|||
146888907|NCT00935883|529761686|FG000|Treatment Period|Physician Decision|1|||
146888908|NCT00935883|529761687|FG001|Treatment Period|Physician Decision|0|||
146888909|NCT00935883|529761686|FG000|Treatment Period|Withdrawal by Subject|0|||
146888910|NCT00935883|529761687|FG001|Treatment Period|Withdrawal by Subject|2|||
146636064|NCT00473382|528842635|FG002|Core Study|Death|10|||
146636065|NCT00473382|528842633|FG000|Core Study|Lost to Follow-up|3|||
146636066|NCT00473382|528842634|FG001|Core Study|Lost to Follow-up|3|||
146888911|NCT01641939|529761690|FG000|Overall Study|Death|90|||
146888912|NCT01641939|529761691|FG001|Overall Study|Death|187|||
146888913|NCT01641939|529761692|FG002|Overall Study|Death|61|||
146888914|NCT01641939|529761690|FG000|Overall Study|Lost to Follow-up|3|||
146888915|NCT01641939|529761691|FG001|Overall Study|Lost to Follow-up|2|||
146888916|NCT01641939|529761692|FG002|Overall Study|Lost to Follow-up|1|||
146888917|NCT01641939|529761690|FG000|Overall Study|Withdrawal by Subject|14|||
146888918|NCT01641939|529761691|FG001|Overall Study|Withdrawal by Subject|11|||
146888919|NCT01641939|529761692|FG002|Overall Study|Withdrawal by Subject|5|||
146888920|NCT01641939|529761690|FG000|Overall Study|Study Terminated by Sponsor|10|||
146888921|NCT01641939|529761691|FG001|Overall Study|Study Terminated by Sponsor|28|||
146888922|NCT01641939|529761692|FG002|Overall Study|Study Terminated by Sponsor|3|||
146888923|NCT02894840|529761693|FG000|Overall Study|Lost to Follow-up|1|||
146888924|NCT02894840|529761694|FG001|Overall Study|Lost to Follow-up|0|||
146888925|NCT02894840|529761695|FG002|Overall Study|Lost to Follow-up|3|||
146888926|NCT02894840|529761696|FG003|Overall Study|Lost to Follow-up|0|||
146636067|NCT00473382|528842635|FG002|Core Study|Lost to Follow-up|3|||
146636068|NCT00473382|528842633|FG000|Core Study|Physician Decision|1|||
146888927|NCT03472560|529761702|FG000|Overall Study|Subject transfer to continuation protocol|0|||
146888928|NCT03472560|529761703|FG001|Overall Study|Subject transfer to continuation protocol|1|||
146888929|NCT03472560|529761702|FG000|Overall Study|Withdrawal by Subject|4|||
146888930|NCT03472560|529761703|FG001|Overall Study|Withdrawal by Subject|0|||
146888931|NCT03472560|529761702|FG000|Overall Study|Progressive disease|24|||
146888932|NCT03472560|529761703|FG001|Overall Study|Progressive disease|8|||
146888933|NCT03472560|529761702|FG000|Overall Study|Physician Decision|1|||
146888934|NCT03472560|529761703|FG001|Overall Study|Physician Decision|0|||
146888935|NCT03472560|529761702|FG000|Overall Study|Death|7|||
146888936|NCT03472560|529761703|FG001|Overall Study|Death|4|||
146888937|NCT03472560|529761702|FG000|Overall Study|Adverse Event|5|||
146888938|NCT03472560|529761703|FG001|Overall Study|Adverse Event|3|||
146888939|NCT03472560|529761702|FG000|Overall Study|Global deterioration of health status|0|||
146888940|NCT03472560|529761703|FG001|Overall Study|Global deterioration of health status|4|||
146888941|NCT01946178|529761704|FG000|Overall Study|Pregnancy|1|||
146888942|NCT01946178|529761704|FG000|Overall Study|Lost to Follow-up|1|||
146888943|NCT02494596|529761707|FG000|Overall Study|Insufficient Therapeutic Response|3|||
146888944|NCT02494596|529761708|FG001|Overall Study|Insufficient Therapeutic Response|3|||
146888945|NCT02494596|529761709|FG002|Overall Study|Insufficient Therapeutic Response|1|||
146888946|NCT02494596|529761707|FG000|Overall Study|Adverse Event|0|||
146888947|NCT02494596|529761708|FG001|Overall Study|Adverse Event|1|||
146888948|NCT02494596|529761709|FG002|Overall Study|Adverse Event|0|||
146888949|NCT02494596|529761707|FG000|Overall Study|Refused Treatment|0|||
146888950|NCT02494596|529761708|FG001|Overall Study|Refused Treatment|1|||
146888951|NCT02494596|529761709|FG002|Overall Study|Refused Treatment|0|||
146888952|NCT01537211|529761710|FG000|Overall Study|Lost to Follow-up|0|||
146888953|NCT01537211|529761711|FG001|Overall Study|Lost to Follow-up|1|||
146888954|NCT00343512|529761718|FG000|Overall Study|Withdrawal by Subject|2|||
146888955|NCT00323557|529761719|FG000|Overall Study|Physician Decision|1|||
146888956|NCT00323557|529761720|FG001|Overall Study|Physician Decision|0|||
146888957|NCT00197054|529761721|FG000|Overall Study|Withdrawal by Subject|9|||
146888958|NCT00197054|529761722|FG001|Overall Study|Withdrawal by Subject|3|||
146888959|NCT00197054|529761723|FG002|Overall Study|Withdrawal by Subject|3|||
146888960|NCT00197054|529761721|FG000|Overall Study|Moved from area|7|||
146888961|NCT00197054|529761722|FG001|Overall Study|Moved from area|14|||
146888962|NCT00197054|529761723|FG002|Overall Study|Moved from area|9|||
146888963|NCT00197054|529761721|FG000|Overall Study|Lost to Follow-up|1|||
146888964|NCT00197054|529761722|FG001|Overall Study|Lost to Follow-up|4|||
146888965|NCT00197054|529761723|FG002|Overall Study|Lost to Follow-up|0|||
146888966|NCT00684515|529761724|FG000|Overall Study|Adverse Event|3|||
146888967|NCT00684515|529761725|FG001|Overall Study|Adverse Event|3|||
146888968|NCT00684515|529761726|FG002|Overall Study|Adverse Event|1|||
146888969|NCT00684515|529761724|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
146555831|NCT02554474|528544380|FG001|Overall Study|Withdrawal by Subject|1|||
146555832|NCT03211832|528544381|FG000|Overall Study|No longer with agency|32|||
146555833|NCT03211832|528544382|FG001|Overall Study|No longer with agency|49|||
146555834|NCT03211832|528544383|FG002|Overall Study|No longer with agency|30|||
146555835|NCT03211832|528544381|FG000|Overall Study|Declined survey|3|||
146555836|NCT03211832|528544382|FG001|Overall Study|Declined survey|3|||
146555837|NCT03211832|528544383|FG002|Overall Study|Declined survey|2|||
146555838|NCT03211832|528544381|FG000|Overall Study|Not available during data collection|1|||
146555839|NCT03211832|528544382|FG001|Overall Study|Not available during data collection|0|||
146555840|NCT03211832|528544383|FG002|Overall Study|Not available during data collection|2|||
146555841|NCT02913326|528544390|FG000|Overall Study|Reason not listed|0|||
146555842|NCT02913326|528544391|FG001|Overall Study|Reason not listed|1|||
146555843|NCT02913326|528544390|FG000|Overall Study|Lost to Follow-up|0|||
146888970|NCT00684515|529761725|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
146888971|NCT00684515|529761726|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
146888972|NCT04428411|529761729|FG000|Overall Study|Lost to Follow-up|114|||
146888973|NCT01163786|529761730|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
146888974|NCT01163786|529761730|FG000|Treatment With Bortezomib|Adverse Event|2|||
146888975|NCT01163786|529761730|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
146888976|NCT00634569|529761731|FG000|Overall Study|Withdrawal by Subject|0|||
146888977|NCT00634569|529761732|FG001|Overall Study|Withdrawal by Subject|4|||
146888978|NCT00634569|529761731|FG000|Overall Study|Physician Decision|0|||
146888979|NCT00634569|529761732|FG001|Overall Study|Physician Decision|1|||
146888980|NCT01212185|529761733|FG000|Overall Study|Protocol Violation|2|||
146888981|NCT01212185|529761734|FG001|Overall Study|Protocol Violation|1|||
146888982|NCT03021642|529761737|FG000|Washout Period (21 Days)|Adverse Event|1|||
146888983|NCT03021642|529761738|FG001|Washout Period (21 Days)|Adverse Event|1|||
146888984|NCT00090545|529761742|FG000|Overall Study|Disease progression on study|21|||
146888985|NCT00090545|529761743|FG001|Overall Study|Disease progression on study|17|||
146888986|NCT00090545|529761742|FG000|Overall Study|Refused further treatment|1|||
146888987|NCT00090545|529761743|FG001|Overall Study|Refused further treatment|4|||
146888988|NCT00090545|529761742|FG000|Overall Study|Death|0|||
146888989|NCT00090545|529761743|FG001|Overall Study|Death|1|||
146888990|NCT00090545|529761742|FG000|Overall Study|Adverse Event|0|||
146888991|NCT00090545|529761743|FG001|Overall Study|Adverse Event|2|||
146888992|NCT01463098|529761744|FG000|Part A (11 Days)|Participant Choice|2|||
146888993|NCT01463098|529761745|FG001|Part A (11 Days)|Participant Choice|0|||
146888994|NCT01463098|529761746|FG002|Part A (11 Days)|Participant Choice|0|||
146888995|NCT01463098|529761747|FG003|Part A (11 Days)|Participant Choice|0|||
146888996|NCT01463098|529761748|FG004|Part A (11 Days)|Participant Choice|0|||
146888997|NCT01463098|529761749|FG005|Part A (11 Days)|Participant Choice|0|||
146888998|NCT01463098|529761750|FG006|Part A (11 Days)|Participant Choice|0|||
146888999|NCT01463098|529761751|FG007|Part A (11 Days)|Participant Choice|0|||
146889000|NCT01463098|529761752|FG008|Part A (11 Days)|Participant Choice|1|||
146889001|NCT01463098|529761753|FG009|Part A (11 Days)|Participant Choice|0|||
146889002|NCT01463098|529761754|FG010|Part A (11 Days)|Participant Choice|0|||
146889003|NCT01463098|529761755|FG011|Part A (11 Days)|Participant Choice|0|||
146889004|NCT01463098|529761756|FG012|Part A (11 Days)|Participant Choice|0|||
146889005|NCT01463098|529761757|FG013|Part A (11 Days)|Participant Choice|0|||
146889006|NCT01463098|529761744|FG000|Part A (11 Days)|Lost to Follow-up|0|||
146889007|NCT01463098|529761745|FG001|Part A (11 Days)|Lost to Follow-up|0|||
146889008|NCT01463098|529761746|FG002|Part A (11 Days)|Lost to Follow-up|0|||
146889009|NCT01463098|529761747|FG003|Part A (11 Days)|Lost to Follow-up|0|||
146889010|NCT01463098|529761748|FG004|Part A (11 Days)|Lost to Follow-up|1|||
146889011|NCT01463098|529761749|FG005|Part A (11 Days)|Lost to Follow-up|0|||
146889012|NCT01463098|529761750|FG006|Part A (11 Days)|Lost to Follow-up|0|||
146889013|NCT01463098|529761751|FG007|Part A (11 Days)|Lost to Follow-up|0|||
146889014|NCT01463098|529761752|FG008|Part A (11 Days)|Lost to Follow-up|0|||
146889015|NCT01463098|529761753|FG009|Part A (11 Days)|Lost to Follow-up|0|||
146889016|NCT01463098|529761754|FG010|Part A (11 Days)|Lost to Follow-up|0|||
146889017|NCT01463098|529761755|FG011|Part A (11 Days)|Lost to Follow-up|0|||
146889018|NCT01463098|529761756|FG012|Part A (11 Days)|Lost to Follow-up|0|||
146889019|NCT01463098|529761757|FG013|Part A (11 Days)|Lost to Follow-up|0|||
146889020|NCT01463098|529761744|FG000|Part B (11 Days)|Participant Choice|0|||
146889021|NCT01463098|529761745|FG001|Part B (11 Days)|Participant Choice|0|||
146889022|NCT01463098|529761746|FG002|Part B (11 Days)|Participant Choice|0|||
146889023|NCT01463098|529761747|FG003|Part B (11 Days)|Participant Choice|0|||
146889024|NCT01463098|529761748|FG004|Part B (11 Days)|Participant Choice|0|||
146889025|NCT01463098|529761749|FG005|Part B (11 Days)|Participant Choice|0|||
146889026|NCT01463098|529761750|FG006|Part B (11 Days)|Participant Choice|0|||
146889027|NCT01463098|529761751|FG007|Part B (11 Days)|Participant Choice|0|||
146889028|NCT01463098|529761752|FG008|Part B (11 Days)|Participant Choice|0|||
146889029|NCT01463098|529761753|FG009|Part B (11 Days)|Participant Choice|0|||
146889030|NCT01463098|529761754|FG010|Part B (11 Days)|Participant Choice|0|||
146889031|NCT01463098|529761755|FG011|Part B (11 Days)|Participant Choice|1|||
146889032|NCT01463098|529761756|FG012|Part B (11 Days)|Participant Choice|0|||
146889033|NCT01463098|529761757|FG013|Part B (11 Days)|Participant Choice|0|||
146889034|NCT02568046|529761760|FG000|Overall Study|Adverse Event|0|||
146889035|NCT02568046|529761761|FG001|Overall Study|Adverse Event|1|||
146889036|NCT02568046|529761760|FG000|Overall Study|Death|2|||
146889037|NCT02568046|529761761|FG001|Overall Study|Death|0|||
146889038|NCT02568046|529761760|FG000|Overall Study|Progressive Disease|1|||
146889039|NCT02568046|529761761|FG001|Overall Study|Progressive Disease|0|||
146889040|NCT02568046|529761760|FG000|Overall Study|Withdrawal by Subject|2|||
146889041|NCT02568046|529761761|FG001|Overall Study|Withdrawal by Subject|1|||
146889042|NCT02568046|529761760|FG000|Overall Study|Other Events|0|||
146889043|NCT02568046|529761761|FG001|Overall Study|Other Events|1|||
146889044|NCT02809833|529761762|FG000|Overall Study|Death|3|||
146889045|NCT02809833|529761762|FG000|Overall Study|Intolerance|54|||
146889046|NCT02809833|529761762|FG000|Overall Study|Lack of Efficacy|89|||
146889047|NCT02809833|529761762|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
146889048|NCT02809833|529761762|FG000|Overall Study|Noncompliance|1|||
146889049|NCT02809833|529761762|FG000|Overall Study|Withdrawal by Subject|34|||
146555844|NCT02913326|528544391|FG001|Overall Study|Lost to Follow-up|1|||
146889050|NCT02809833|529761762|FG000|Overall Study|Lost to Follow-up|35|||
146889051|NCT02809833|529761762|FG000|Overall Study|Adverse Event (AE)|24|||
146889052|NCT02809833|529761762|FG000|Overall Study|Other|5|||
146889053|NCT02809833|529761762|FG000|Overall Study|Missing Information|52|||
146889054|NCT00523991|529761763|FG000|Overall Study|Adverse Event|6|||
146889055|NCT00523991|529761764|FG001|Overall Study|Adverse Event|5|||
146889056|NCT00523991|529761763|FG000|Overall Study|Protocol Violation|1|||
146889057|NCT00523991|529761764|FG001|Overall Study|Protocol Violation|4|||
146889058|NCT00523991|529761763|FG000|Overall Study|Lost to Follow-up|4|||
146889059|NCT00523991|529761764|FG001|Overall Study|Lost to Follow-up|1|||
146889060|NCT00523991|529761763|FG000|Overall Study|Withdrawal by Subject|7|||
146966892|NCT01160770|530040081|FG000|Overall Study|Lost to Follow-up|7|||
146889061|NCT00523991|529761764|FG001|Overall Study|Withdrawal by Subject|17|||
146889062|NCT00523991|529761763|FG000|Overall Study|Other reason (not specified)|3|||
146889063|NCT00523991|529761764|FG001|Overall Study|Other reason (not specified)|0|||
146889064|NCT00744874|529761765|FG000|Overall Study|Lost to Follow-up|1|||
146889065|NCT00744874|529761765|FG000|Overall Study|Withdrawal by Subject|1|||
146889066|NCT00744874|529761765|FG000|Overall Study|Study Device not available at procedure|1|||
146889067|NCT00744874|529761765|FG000|Overall Study|Unable to accomodate schedule|1|||
146889068|NCT02486757|529761766|FG000|Overall Study|Lost to Follow-up|1|||
146889069|NCT00352105|529761767|FG000|Overall Study|Death|5|||
146889070|NCT00352105|529761767|FG000|Overall Study|Withdrawal by Subject|5|||
146889071|NCT00352105|529761767|FG000|Overall Study|Lack of Efficacy|9|||
146889072|NCT00352105|529761767|FG000|Overall Study|Adverse Event|19|||
146889073|NCT00352105|529761767|FG000|Overall Study|Protocol Violation|2|||
146889074|NCT02979431|529761768|FG000|Overall Study|Parent/guardian withdrew consent|2|||
146889075|NCT02979431|529761769|FG001|Overall Study|Parent/guardian withdrew consent|1|||
146889076|NCT02979431|529761770|FG002|Overall Study|Parent/guardian withdrew consent|1|||
146889077|NCT02979431|529761771|FG003|Overall Study|Parent/guardian withdrew consent|1|||
146889078|NCT02979431|529761768|FG000|Overall Study|Randomized but received no study drug|1|||
146889079|NCT02979431|529761769|FG001|Overall Study|Randomized but received no study drug|1|||
146889080|NCT02979431|529761770|FG002|Overall Study|Randomized but received no study drug|0|||
146889081|NCT02979431|529761771|FG003|Overall Study|Randomized but received no study drug|0|||
146889082|NCT02979431|529761768|FG000|Overall Study|Adverse Event|0|||
146889083|NCT02979431|529761769|FG001|Overall Study|Adverse Event|0|||
146889084|NCT02979431|529761770|FG002|Overall Study|Adverse Event|1|||
146889085|NCT02979431|529761771|FG003|Overall Study|Adverse Event|0|||
146889086|NCT02979431|529761768|FG000|Overall Study|Subject left country after Day14|1|||
146889087|NCT02979431|529761769|FG001|Overall Study|Subject left country after Day14|0|||
146889088|NCT02979431|529761770|FG002|Overall Study|Subject left country after Day14|0|||
146889089|NCT02979431|529761771|FG003|Overall Study|Subject left country after Day14|0|||
146889090|NCT01405053|529761775|FG000|Overall Study|Adverse Event|3|||
146889091|NCT01405053|529761776|FG001|Overall Study|Adverse Event|0|||
146889092|NCT01405053|529761775|FG000|Overall Study|Lost to Follow-up|0|||
146889093|NCT01405053|529761776|FG001|Overall Study|Lost to Follow-up|1|||
146889094|NCT01405053|529761775|FG000|Overall Study|Participant choice|2|||
146889095|NCT01405053|529761776|FG001|Overall Study|Participant choice|1|||
146889096|NCT01405053|529761775|FG000|Overall Study|Inadequate therapeutic effect|2|||
146889097|NCT01405053|529761776|FG001|Overall Study|Inadequate therapeutic effect|1|||
146889098|NCT01405053|529761775|FG000|Overall Study|Withdrawal by Subject|3|||
146889099|NCT01405053|529761776|FG001|Overall Study|Withdrawal by Subject|4|||
146889100|NCT01405053|529761775|FG000|Overall Study|Other|0|||
146889101|NCT01405053|529761776|FG001|Overall Study|Other|1|||
146889102|NCT06098729|529761793|FG000|Overall Study|Withdrawal by Subject|1|||
146889103|NCT01060059|529761802|FG000|Overall Study|Adverse Event|1|||
146889104|NCT01060059|529761803|FG001|Overall Study|Adverse Event|1|||
146889105|NCT01060059|529761802|FG000|Overall Study|Death|2|||
146889106|NCT01060059|529761803|FG001|Overall Study|Death|3|||
146889107|NCT01060059|529761802|FG000|Overall Study|Lost to Follow-up|18|||
146889108|NCT01060059|529761803|FG001|Overall Study|Lost to Follow-up|34|||
146889109|NCT01060059|529761802|FG000|Overall Study|entry criteria not met|4|||
146889110|NCT01060059|529761803|FG001|Overall Study|entry criteria not met|3|||
146889111|NCT01060059|529761802|FG000|Overall Study|Withdrawal by Subject|35|||
146555845|NCT02913326|528544390|FG000|Overall Study|Adverse Event|1|||
146555846|NCT02913326|528544391|FG001|Overall Study|Adverse Event|0|||
146555847|NCT01514422|528544392|FG000|Overall Study|Lost to Follow-up|1|||
146555848|NCT03511209|528544393|FG000|Overall Study|Withdrawal by Subject|2|||
146555849|NCT03511209|528544394|FG001|Overall Study|Withdrawal by Subject|4|||
146555850|NCT03511209|528544393|FG000|Overall Study|Death|1|||
146555851|NCT03511209|528544394|FG001|Overall Study|Death|0|||
146555852|NCT03511209|528544393|FG000|Overall Study|Lost to Follow-up|0|||
146555853|NCT03511209|528544394|FG001|Overall Study|Lost to Follow-up|2|||
146555854|NCT03769467|528544399|FG000|Overall Study|Adverse Event|1|||
146555855|NCT03769467|528544400|FG001|Overall Study|Adverse Event|1|||
146555856|NCT03769467|528544401|FG002|Overall Study|Adverse Event|0|||
146636069|NCT00473382|528842634|FG001|Core Study|Physician Decision|2|||
146636070|NCT00473382|528842635|FG002|Core Study|Physician Decision|2|||
146636071|NCT00473382|528842633|FG000|Core Study|Subject non-compliance|5|||
146889112|NCT01060059|529761803|FG001|Overall Study|Withdrawal by Subject|23|||
146889113|NCT01060059|529761802|FG000|Overall Study|lack of glycemic control|2|||
146889114|NCT01060059|529761803|FG001|Overall Study|lack of glycemic control|1|||
146889115|NCT01060059|529761802|FG000|Overall Study|lack of compliance|5|||
146889116|NCT01060059|529761803|FG001|Overall Study|lack of compliance|2|||
146889117|NCT02302963|529761804|FG000|Overall Study|Withdrawal by Subject|2|||
146889118|NCT02302963|529761805|FG001|Overall Study|Withdrawal by Subject|1|||
146889119|NCT02302963|529761804|FG000|Overall Study|Steroid injection|0|||
146889120|NCT02302963|529761805|FG001|Overall Study|Steroid injection|1|||
146889121|NCT02302963|529761804|FG000|Overall Study|Physician Decision|1|||
146889122|NCT02302963|529761805|FG001|Overall Study|Physician Decision|0|||
146636072|NCT00473382|528842634|FG001|Core Study|Subject non-compliance|2|||
146636073|NCT00473382|528842635|FG002|Core Study|Subject non-compliance|1|||
146636074|NCT00473382|528842633|FG000|Core Study|Subject needed other treatment|1|||
146636075|NCT00473382|528842634|FG001|Core Study|Subject needed other treatment|3|||
146636076|NCT00473382|528842635|FG002|Core Study|Subject needed other treatment|2|||
146636077|NCT00473382|528842633|FG000|Core Study|Subject's decision|12|||
146636078|NCT00473382|528842634|FG001|Core Study|Subject's decision|11|||
146636079|NCT00473382|528842635|FG002|Core Study|Subject's decision|10|||
146636080|NCT00473382|528842633|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
146636081|NCT00473382|528842634|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
146636082|NCT00473382|528842635|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
146636083|NCT00473382|528842633|FG000|Open-label Extension Through Month 48|Death|1|||
146636084|NCT00473382|528842634|FG001|Open-label Extension Through Month 48|Death|3|||
146636085|NCT00473382|528842635|FG002|Open-label Extension Through Month 48|Death|3|||
146636086|NCT00473382|528842633|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
146636087|NCT00473382|528842634|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
146636088|NCT00473382|528842635|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
146636089|NCT00473382|528842633|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
146636090|NCT00473382|528842634|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
146636091|NCT00473382|528842635|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
146636092|NCT00473382|528842633|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
146636093|NCT00473382|528842634|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
146636094|NCT00473382|528842635|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
146636095|NCT00473382|528842633|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
146636096|NCT00473382|528842634|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
146636097|NCT00473382|528842635|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
146636098|NCT00473382|528842633|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
146636099|NCT00473382|528842634|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
146636100|NCT00473382|528842635|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
146636101|NCT00473382|528842633|FG000|Open-label Extension Through Month 60|Death|1|||
146636102|NCT00473382|528842634|FG001|Open-label Extension Through Month 60|Death|7|||
146636103|NCT00473382|528842635|FG002|Open-label Extension Through Month 60|Death|4|||
146636104|NCT00473382|528842633|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
146636105|NCT00473382|528842634|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
146636106|NCT00473382|528842635|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
146636107|NCT00473382|528842633|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
146636108|NCT00473382|528842634|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
146636109|NCT00473382|528842635|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
146636110|NCT00473382|528842633|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
146636111|NCT00473382|528842634|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
146636112|NCT00473382|528842635|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
146636113|NCT00473382|528842633|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
146636114|NCT00473382|528842634|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
146636115|NCT00473382|528842635|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
146636116|NCT01166282|528842636|FG000|Open-label Period|Adverse Event|0|||
146636117|NCT01166282|528842637|FG001|Open-label Period|Adverse Event|0|||
146636118|NCT01166282|528842638|FG002|Open-label Period|Adverse Event|6|||
146636119|NCT01166282|528842636|FG000|Open-label Period|Withdrawal by Subject|0|||
146636120|NCT01166282|528842637|FG001|Open-label Period|Withdrawal by Subject|0|||
146636121|NCT01166282|528842638|FG002|Open-label Period|Withdrawal by Subject|4|||
146889123|NCT01920711|529761810|FG000|Overall Study|Death|347|||
146889124|NCT01920711|529761811|FG001|Overall Study|Death|356|||
146889125|NCT01920711|529761810|FG000|Overall Study|Lost to Follow-up|13|||
146889126|NCT01920711|529761811|FG001|Overall Study|Lost to Follow-up|14|||
146889127|NCT01920711|529761810|FG000|Overall Study|Withdrawal by Subject|4|||
146889128|NCT01920711|529761811|FG001|Overall Study|Withdrawal by Subject|3|||
146889129|NCT01972074|529761812|FG000|Overall Study|Adverse Event|4|||
146889130|NCT01972074|529761813|FG001|Overall Study|Adverse Event|1|||
146889131|NCT01972074|529761814|FG002|Overall Study|Adverse Event|0|||
146889132|NCT01972074|529761812|FG000|Overall Study|Lack of Efficacy|1|||
146889133|NCT01972074|529761813|FG001|Overall Study|Lack of Efficacy|1|||
146889134|NCT01972074|529761814|FG002|Overall Study|Lack of Efficacy|0|||
146889135|NCT01972074|529761812|FG000|Overall Study|Lost to Follow-up|0|||
146889136|NCT01972074|529761813|FG001|Overall Study|Lost to Follow-up|1|||
146889137|NCT01972074|529761814|FG002|Overall Study|Lost to Follow-up|1|||
146636122|NCT01166282|528842636|FG000|Open-label Period|Lack of Efficacy|0|||
146636123|NCT01166282|528842637|FG001|Open-label Period|Lack of Efficacy|0|||
146636124|NCT01166282|528842638|FG002|Open-label Period|Lack of Efficacy|2|||
146636125|NCT01166282|528842636|FG000|Open-label Period|Remission|0|||
146636126|NCT01166282|528842637|FG001|Open-label Period|Remission|0|||
146889138|NCT01972074|529761812|FG000|Overall Study|Withdrawal by Subject|1|||
146889139|NCT01972074|529761813|FG001|Overall Study|Withdrawal by Subject|1|||
146889140|NCT01972074|529761814|FG002|Overall Study|Withdrawal by Subject|1|||
146889141|NCT01972074|529761812|FG000|Overall Study|Scanner Unavailable|0|||
146889142|NCT01972074|529761813|FG001|Overall Study|Scanner Unavailable|0|||
146636127|NCT01166282|528842638|FG002|Open-label Period|Remission|4|||
146889143|NCT01972074|529761814|FG002|Overall Study|Scanner Unavailable|1|||
146889144|NCT03551743|529761815|FG000|Overall Study|Adverse Event|1|||
146889145|NCT03551743|529761816|FG001|Overall Study|Adverse Event|0|||
146889146|NCT03551743|529761817|FG002|Overall Study|Adverse Event|0|||
146889147|NCT03551743|529761818|FG003|Overall Study|Adverse Event|0|||
146889148|NCT03551743|529761815|FG000|Overall Study|Withdrawal by Subject|1|||
146889149|NCT03551743|529761816|FG001|Overall Study|Withdrawal by Subject|0|||
146889150|NCT03551743|529761817|FG002|Overall Study|Withdrawal by Subject|0|||
146889151|NCT03551743|529761818|FG003|Overall Study|Withdrawal by Subject|0|||
146889152|NCT02317562|529761819|FG000|Overall Study|Physician Decision|1|||
146889153|NCT02317562|529761819|FG000|Overall Study|early termination of the study|8|||
146889154|NCT02317562|529761819|FG000|Overall Study|Lack of Efficacy|4|||
146889155|NCT02317562|529761819|FG000|Overall Study|Withdrawal by Subject|1|||
146889156|NCT03891901|529761820|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
146889157|NCT03891901|529761821|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
146889158|NCT03891901|529761822|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
146889159|NCT03891901|529761823|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
146889160|NCT03891901|529761824|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
146889161|NCT03891901|529761825|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
146889162|NCT03891901|529761826|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
146889163|NCT03891901|529761827|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
146889164|NCT03891901|529761828|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
146889165|NCT03891901|529761820|FG000|Overall Study|Adverse Event|2|||
146889166|NCT03891901|529761821|FG001|Overall Study|Adverse Event|2|||
146889167|NCT03891901|529761822|FG002|Overall Study|Adverse Event|0|||
146889168|NCT03891901|529761823|FG003|Overall Study|Adverse Event|0|||
146889169|NCT03891901|529761824|FG004|Overall Study|Adverse Event|0|||
146889170|NCT03891901|529761825|FG005|Overall Study|Adverse Event|0|||
146889171|NCT03891901|529761826|FG006|Overall Study|Adverse Event|0|||
146889172|NCT03891901|529761827|FG007|Overall Study|Adverse Event|0|||
146889173|NCT03891901|529761828|FG008|Overall Study|Adverse Event|0|||
146889174|NCT03891901|529761820|FG000|Overall Study|Poor venous access|1|||
146889175|NCT03891901|529761821|FG001|Overall Study|Poor venous access|0|||
146889176|NCT03891901|529761822|FG002|Overall Study|Poor venous access|0|||
146889177|NCT03891901|529761823|FG003|Overall Study|Poor venous access|0|||
146889178|NCT03891901|529761824|FG004|Overall Study|Poor venous access|0|||
146889179|NCT03891901|529761825|FG005|Overall Study|Poor venous access|0|||
146636128|NCT01166282|528842636|FG000|Open-label Period|Irregular Compliance|0|||
146889180|NCT03891901|529761826|FG006|Overall Study|Poor venous access|0|||
146889181|NCT03891901|529761827|FG007|Overall Study|Poor venous access|0|||
146889182|NCT03891901|529761828|FG008|Overall Study|Poor venous access|0|||
146889183|NCT03891901|529761820|FG000|Overall Study|Withdrawal by Subject|0|||
146889184|NCT03891901|529761821|FG001|Overall Study|Withdrawal by Subject|2|||
146889185|NCT03891901|529761822|FG002|Overall Study|Withdrawal by Subject|0|||
146889186|NCT03891901|529761823|FG003|Overall Study|Withdrawal by Subject|0|||
146889187|NCT03891901|529761824|FG004|Overall Study|Withdrawal by Subject|0|||
146889188|NCT03891901|529761825|FG005|Overall Study|Withdrawal by Subject|0|||
146889189|NCT03891901|529761826|FG006|Overall Study|Withdrawal by Subject|0|||
146889190|NCT03891901|529761827|FG007|Overall Study|Withdrawal by Subject|0|||
146889191|NCT03891901|529761828|FG008|Overall Study|Withdrawal by Subject|0|||
146889192|NCT05702736|529761835|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
146889193|NCT05702736|529761836|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
146889194|NCT05702736|529761835|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
146889195|NCT05702736|529761836|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
146889196|NCT03110900|529761839|FG000|Overall Study|Sponsor withdrew|1|||
146889197|NCT03110900|529761840|FG001|Overall Study|Sponsor withdrew|1|||
146889198|NCT03355300|529761841|FG000|Overall Study|Physician Decision|0|||
146889199|NCT03355300|529761842|FG001|Overall Study|Physician Decision|1|||
146889200|NCT03355300|529761841|FG000|Overall Study|Lack of Efficacy|2|||
146889201|NCT03355300|529761842|FG001|Overall Study|Lack of Efficacy|1|||
146889202|NCT03355300|529761841|FG000|Overall Study|Other reason|1|||
146889203|NCT03355300|529761842|FG001|Overall Study|Other reason|0|||
146889204|NCT04484285|529763395|FG000|Overall Study|Unable to operate stimulator|3|||
146889205|NCT04484285|529763396|FG001|Overall Study|Unable to operate stimulator|0|||
146555857|NCT03769467|528544399|FG000|Overall Study|Death|3|||
146555858|NCT03769467|528544400|FG001|Overall Study|Death|3|||
146555859|NCT03769467|528544401|FG002|Overall Study|Death|0|||
146555860|NCT03769467|528544399|FG000|Overall Study|Study Terminated By Sponsor|2|||
146555861|NCT03769467|528544400|FG001|Overall Study|Study Terminated By Sponsor|1|||
146555862|NCT03769467|528544401|FG002|Overall Study|Study Terminated By Sponsor|0|||
146555863|NCT03769467|528544399|FG000|Overall Study|Withdrawal by Subject|0|||
146555864|NCT03769467|528544400|FG001|Overall Study|Withdrawal by Subject|1|||
146555865|NCT03769467|528544401|FG002|Overall Study|Withdrawal by Subject|0|||
146555866|NCT04565756|528544402|FG000|Overall Study|Withdrawal by Subject|0|||
146555867|NCT04565756|528544403|FG001|Overall Study|Withdrawal by Subject|0|||
146555868|NCT04565756|528544404|FG002|Overall Study|Withdrawal by Subject|0|||
146555869|NCT04565756|528544405|FG003|Overall Study|Withdrawal by Subject|0|||
146636129|NCT01166282|528842637|FG001|Open-label Period|Irregular Compliance|0|||
146636130|NCT01166282|528842638|FG002|Open-label Period|Irregular Compliance|1|||
146636131|NCT02577718|528842639|FG000|Overall Study|Death|6|||
146636132|NCT02577718|528842639|FG000|Overall Study|Withdrawal by Subject|2|||
146636133|NCT01995838|528842644|FG000|Overall Study|Lost to Follow-up|0|||
146636134|NCT01995838|528842645|FG001|Overall Study|Lost to Follow-up|1|||
146636135|NCT01995838|528842646|FG002|Overall Study|Lost to Follow-up|0|||
146636136|NCT01995838|528842647|FG003|Overall Study|Lost to Follow-up|0|||
146636137|NCT01995838|528842648|FG004|Overall Study|Lost to Follow-up|0|||
146636138|NCT01995838|528842649|FG005|Overall Study|Lost to Follow-up|0|||
146636139|NCT01995838|528842650|FG006|Overall Study|Lost to Follow-up|1|||
146636140|NCT01995838|528842644|FG000|Overall Study|Participant choice|2|||
146636141|NCT01995838|528842645|FG001|Overall Study|Participant choice|0|||
146636142|NCT01995838|528842646|FG002|Overall Study|Participant choice|0|||
146555870|NCT04565756|528544406|FG004|Overall Study|Withdrawal by Subject|1|||
146555871|NCT04565756|528544407|FG005|Overall Study|Withdrawal by Subject|0|||
146636143|NCT01995838|528842647|FG003|Overall Study|Participant choice|0|||
146889206|NCT01227902|529763398|FG000|Overall Study|Adverse Event|12|||
146889207|NCT01227902|529763399|FG001|Overall Study|Adverse Event|8|||
146889208|NCT01227902|529763400|FG002|Overall Study|Adverse Event|11|||
146889209|NCT01227902|529763401|FG003|Overall Study|Adverse Event|4|||
146555872|NCT04565756|528544402|FG000|Overall Study|Protocol Violation|0|||
146555873|NCT04565756|528544403|FG001|Overall Study|Protocol Violation|0|||
146636144|NCT01995838|528842648|FG004|Overall Study|Participant choice|0|||
146636145|NCT01995838|528842649|FG005|Overall Study|Participant choice|1|||
146889210|NCT01227902|529763398|FG000|Overall Study|Lack of Efficacy|1|||
146889211|NCT01227902|529763399|FG001|Overall Study|Lack of Efficacy|2|||
146889212|NCT01227902|529763400|FG002|Overall Study|Lack of Efficacy|2|||
146889213|NCT01227902|529763401|FG003|Overall Study|Lack of Efficacy|1|||
146889214|NCT01227902|529763398|FG000|Overall Study|Protocol Violation|1|||
146889215|NCT01227902|529763399|FG001|Overall Study|Protocol Violation|0|||
146889216|NCT01227902|529763400|FG002|Overall Study|Protocol Violation|0|||
146889217|NCT01227902|529763401|FG003|Overall Study|Protocol Violation|0|||
146889218|NCT01227902|529763398|FG000|Overall Study|Lost to Follow-up|0|||
146889219|NCT01227902|529763399|FG001|Overall Study|Lost to Follow-up|0|||
146889220|NCT01227902|529763400|FG002|Overall Study|Lost to Follow-up|1|||
146889221|NCT01227902|529763401|FG003|Overall Study|Lost to Follow-up|2|||
146889222|NCT01227902|529763398|FG000|Overall Study|Physician Decision|0|||
146889223|NCT01227902|529763399|FG001|Overall Study|Physician Decision|1|||
146889224|NCT01227902|529763400|FG002|Overall Study|Physician Decision|1|||
146889225|NCT01227902|529763401|FG003|Overall Study|Physician Decision|0|||
146889226|NCT01227902|529763398|FG000|Overall Study|Withdrawal by Subject|4|||
146889227|NCT01227902|529763399|FG001|Overall Study|Withdrawal by Subject|2|||
146889228|NCT01227902|529763400|FG002|Overall Study|Withdrawal by Subject|4|||
146889229|NCT01227902|529763401|FG003|Overall Study|Withdrawal by Subject|3|||
146889230|NCT05280756|529763402|FG000|Overall Study|Lost to Follow-up|1|||
146889231|NCT05280756|529763403|FG001|Overall Study|Lost to Follow-up|1|||
146889232|NCT02363478|529763404|FG000|Overall Study|Lost to Follow-up|4|||
146889233|NCT02363478|529763404|FG000|Overall Study|Adverse Event|4|||
146889234|NCT00768898|529763405|FG000|Overall Study|Unrelated injury|1|||
146889235|NCT00768898|529763405|FG000|Overall Study|Headache|1|||
146889236|NCT02527707|529763406|FG000|Overall Study|Adverse Event|1|||
146889237|NCT02527707|529763406|FG000|Overall Study|Adverse Event|1|||
146889238|NCT00930059|529763407|FG000|Overall Study|Death|1|||
146889239|NCT00930059|529763408|FG001|Overall Study|Death|0|||
146889240|NCT00930059|529763407|FG000|Overall Study|Did not meet entrance criteria|1|||
146889241|NCT00930059|529763408|FG001|Overall Study|Did not meet entrance criteria|1|||
146889242|NCT00930059|529763407|FG000|Overall Study|Withdrawal by Subject|3|||
146889243|NCT00930059|529763408|FG001|Overall Study|Withdrawal by Subject|4|||
146889244|NCT00930059|529763407|FG000|Overall Study|Other|1|||
146889245|NCT00930059|529763408|FG001|Overall Study|Other|0|||
146889246|NCT00930059|529763407|FG000|Overall Study|1 site terminated by sponsor|1|||
146889247|NCT00930059|529763408|FG001|Overall Study|1 site terminated by sponsor|1|||
146889248|NCT00930059|529763407|FG000|Overall Study|Adverse Event|1|||
146889249|NCT00930059|529763408|FG001|Overall Study|Adverse Event|6|||
146889250|NCT04002310|529763409|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
146555874|NCT04565756|528544404|FG002|Overall Study|Protocol Violation|0|||
146555875|NCT04565756|528544405|FG003|Overall Study|Protocol Violation|0|||
146555876|NCT04565756|528544406|FG004|Overall Study|Protocol Violation|0|||
146555877|NCT04565756|528544407|FG005|Overall Study|Protocol Violation|1|||
146555878|NCT05259722|528544408|FG000|Overall Study|Adverse Event|2|||
146889251|NCT04002310|529763410|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
146889252|NCT04002310|529763411|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
146889253|NCT04002310|529763412|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
146889254|NCT04002310|529763413|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
146889255|NCT00542997|529763414|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
146555879|NCT05259722|528544409|FG001|Overall Study|Adverse Event|24|||
146555880|NCT05259722|528544408|FG000|Overall Study|Lost to Follow-up|5|||
146555881|NCT05259722|528544409|FG001|Overall Study|Lost to Follow-up|1|||
146555882|NCT05259722|528544408|FG000|Overall Study|Lack of Efficacy|8|||
146555883|NCT05259722|528544409|FG001|Overall Study|Lack of Efficacy|26|||
146555884|NCT05259722|528544408|FG000|Overall Study|Withdrawal by Subject|15|||
146555885|NCT05259722|528544409|FG001|Overall Study|Withdrawal by Subject|33|||
146555886|NCT05259722|528544408|FG000|Overall Study|Various reasons|3|||
146555887|NCT05259722|528544409|FG001|Overall Study|Various reasons|9|||
146555888|NCT05259722|528544408|FG000|Overall Study|Not exposed to IMP|1|||
146555889|NCT05259722|528544409|FG001|Overall Study|Not exposed to IMP|12|||
146555890|NCT05259722|528544408|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
146889256|NCT00542997|529763414|FG000|Wash in / Wash Out Period|Adverse Event|3|||
146889257|NCT00542997|529763414|FG000|Efficacy Period|Adverse Event|3|||
146555891|NCT05259722|528544409|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
146555892|NCT03688139|528544410|FG000|Overall Study|Lost to Follow-up|2|||
146555893|NCT03688139|528544411|FG001|Overall Study|Lost to Follow-up|0|||
146889258|NCT00352534|529763415|FG000|Initial Staging|Ineligible|8|||
146889259|NCT00352534|529763416|FG001|Initial Staging|Ineligible|9|||
146889260|NCT00352534|529763417|FG002|Initial Staging|Ineligible|0|||
146889261|NCT00352534|529763418|FG003|Initial Staging|Ineligible|0|||
146889262|NCT00352534|529763419|FG004|Initial Staging|Ineligible|0|||
146555894|NCT03688139|528544410|FG000|Overall Study|Physician Decision|0|||
146555895|NCT03688139|528544411|FG001|Overall Study|Physician Decision|1|||
146889263|NCT00352534|529763420|FG005|Initial Staging|Ineligible|0|||
146889264|NCT00352534|529763421|FG006|Initial Staging|Ineligible|0|||
146889265|NCT00352534|529763415|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
146889266|NCT00352534|529763416|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
146889267|NCT00352534|529763417|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
146889268|NCT00352534|529763418|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
146889269|NCT00352534|529763419|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
146889270|NCT00352534|529763420|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
146889271|NCT00352534|529763421|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
146889272|NCT00352534|529763415|FG000|Final Risk Group Assignment|Physician Decision|0|||
146889273|NCT00352534|529763416|FG001|Final Risk Group Assignment|Physician Decision|0|||
146889274|NCT00352534|529763417|FG002|Final Risk Group Assignment|Physician Decision|0|||
146889275|NCT00352534|529763418|FG003|Final Risk Group Assignment|Physician Decision|0|||
146889276|NCT00352534|529763419|FG004|Final Risk Group Assignment|Physician Decision|0|||
146889277|NCT00352534|529763420|FG005|Final Risk Group Assignment|Physician Decision|8|||
146889278|NCT00352534|529763421|FG006|Final Risk Group Assignment|Physician Decision|0|||
146889279|NCT00352534|529763415|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
146889280|NCT00352534|529763416|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
146889281|NCT00352534|529763417|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
146889282|NCT00352534|529763418|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
146889283|NCT00352534|529763419|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
146889284|NCT00352534|529763420|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
146889285|NCT00352534|529763421|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
146889286|NCT00352534|529763415|FG000|Final Risk Group Assignment|Ineligible|0|||
146889287|NCT00352534|529763416|FG001|Final Risk Group Assignment|Ineligible|0|||
146889288|NCT00352534|529763417|FG002|Final Risk Group Assignment|Ineligible|3|||
146889289|NCT00352534|529763418|FG003|Final Risk Group Assignment|Ineligible|1|||
146889290|NCT00352534|529763419|FG004|Final Risk Group Assignment|Ineligible|0|||
146889291|NCT00352534|529763420|FG005|Final Risk Group Assignment|Ineligible|13|||
146889292|NCT00352534|529763421|FG006|Final Risk Group Assignment|Ineligible|0|||
146889293|NCT00352534|529763415|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
146889294|NCT00352534|529763416|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
146889295|NCT00352534|529763417|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
146889296|NCT00352534|529763418|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
146889297|NCT00352534|529763419|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
146889298|NCT00352534|529763420|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
146889299|NCT00352534|529763421|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
146889300|NCT00352534|529763415|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
146889301|NCT00352534|529763416|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
146889302|NCT00352534|529763417|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
146889303|NCT00352534|529763418|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
146889304|NCT00352534|529763419|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
146889305|NCT00352534|529763420|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
146889306|NCT00352534|529763421|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
146889307|NCT00352534|529763415|FG000|Final Risk Group Assignment|Death|0|||
146889308|NCT00352534|529763416|FG001|Final Risk Group Assignment|Death|0|||
146889309|NCT00352534|529763417|FG002|Final Risk Group Assignment|Death|0|||
146889310|NCT00352534|529763418|FG003|Final Risk Group Assignment|Death|0|||
146889311|NCT00352534|529763419|FG004|Final Risk Group Assignment|Death|0|||
146889312|NCT00352534|529763420|FG005|Final Risk Group Assignment|Death|2|||
146889313|NCT00352534|529763421|FG006|Final Risk Group Assignment|Death|0|||
146889314|NCT03064763|529763424|FG000|Overall Study|Lost to Follow-up|1|||
146509103|NCT00250458|528367730|FG000|Overall Study|Withdrawal by Subject|4|||
146889315|NCT03064763|529763424|FG000|Overall Study|Death|8|||
146889316|NCT00680836|529763425|FG000|Overall Study|Withdrawal by Subject|3|||
146889317|NCT00680836|529763426|FG001|Overall Study|Withdrawal by Subject|0|||
146889318|NCT00680836|529763425|FG000|Overall Study|Lost to Follow-up|3|||
146889319|NCT00680836|529763426|FG001|Overall Study|Lost to Follow-up|1|||
146889320|NCT00680836|529763425|FG000|Overall Study|Physician Decision|2|||
146509104|NCT00250458|528367731|FG001|Overall Study|Withdrawal by Subject|2|||
146509105|NCT00250458|528367730|FG000|Overall Study|Lack of Migraine Attack|20|||
146509106|NCT00250458|528367731|FG001|Overall Study|Lack of Migraine Attack|9|||
146509107|NCT00250458|528367730|FG000|Overall Study|Qualifying migraine but did not treat|3|||
146509108|NCT00250458|528367731|FG001|Overall Study|Qualifying migraine but did not treat|3|||
146509109|NCT00250458|528367730|FG000|Overall Study|Other|1|||
146509110|NCT00250458|528367731|FG001|Overall Study|Other|0|||
146509111|NCT00723190|528367735|FG000|Overall Study|Withdrawal by Subject|45|||
146509112|NCT00723190|528367735|FG000|Overall Study|Lost to Follow-up|37|||
146509113|NCT00723190|528367735|FG000|Overall Study|Adverse Event|18|||
146509114|NCT00723190|528367735|FG000|Overall Study|Lack of Efficacy|16|||
146509115|NCT00723190|528367735|FG000|Overall Study|Protocol Violation|15|||
146509116|NCT00723190|528367735|FG000|Overall Study|Other-Premature Discontinuation|9|||
146509117|NCT00723190|528367735|FG000|Overall Study|Other-Not included in safety population|2|||
146509118|NCT00454818|528367736|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
146509119|NCT00454818|528367737|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
146889321|NCT00680836|529763426|FG001|Overall Study|Physician Decision|1|||
146889322|NCT03786432|529763427|FG000|Overall Study|Screen Failure after consent|1|||
146889323|NCT03786432|529763427|FG000|Overall Study|Lost to Follow-up|4|||
146889324|NCT03786432|529763427|FG000|Overall Study|did not complete 12 month CT scan|1|||
146889325|NCT03038308|529763428|FG000|Overall Study|Surgical resection|1|||
146889326|NCT03038308|529763428|FG000|Overall Study|Withdrawal by Subject|2|||
146889327|NCT03038308|529763428|FG000|Overall Study|Lost to Follow-up|1|||
146889328|NCT00544869|529763429|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
146889329|NCT00544869|529763430|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
146889330|NCT00544869|529763431|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
146889331|NCT00544869|529763429|FG000|Overall Study|Adverse Event|6|||
146889332|NCT00544869|529763430|FG001|Overall Study|Adverse Event|1|||
146889333|NCT00544869|529763431|FG002|Overall Study|Adverse Event|0|||
146889334|NCT00544869|529763429|FG000|Overall Study|Lack of Efficacy|1|||
146889335|NCT00544869|529763430|FG001|Overall Study|Lack of Efficacy|1|||
146889336|NCT00544869|529763431|FG002|Overall Study|Lack of Efficacy|0|||
146889337|NCT00544869|529763429|FG000|Overall Study|Physician Decision|2|||
146889338|NCT00544869|529763430|FG001|Overall Study|Physician Decision|0|||
146889339|NCT00544869|529763431|FG002|Overall Study|Physician Decision|0|||
146889340|NCT00619502|529763432|FG000|Overall Study|Lost to Follow-up|8|||
146889341|NCT00619502|529763433|FG001|Overall Study|Lost to Follow-up|10|||
146889342|NCT03968419|529763434|FG000|Treatment Period|Adverse Event|0|||
146889343|NCT03968419|529763435|FG001|Treatment Period|Adverse Event|0|||
146889344|NCT03968419|529763436|FG002|Treatment Period|Adverse Event|1|||
146889345|NCT03968419|529763434|FG000|Safety Follow-up Period|Death|3|||
146889346|NCT03968419|529763435|FG001|Safety Follow-up Period|Death|2|||
146889347|NCT03968419|529763436|FG002|Safety Follow-up Period|Death|1|||
146889348|NCT03968419|529763434|FG000|Safety Follow-up Period|Subject Decision|2|||
146889349|NCT03968419|529763435|FG001|Safety Follow-up Period|Subject Decision|1|||
146889350|NCT03968419|529763436|FG002|Safety Follow-up Period|Subject Decision|0|||
146889351|NCT00804687|529763437|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
146889352|NCT00804687|529763438|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
146966893|NCT01160770|530040081|FG000|Overall Study|Study termination or sponsor request|1|||
146966894|NCT01160770|530040081|FG000|Overall Study|Death|9|||
146889353|NCT00804687|529763439|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
146889354|NCT00804687|529763440|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
146889355|NCT00804687|529763441|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
146889356|NCT00804687|529763442|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
146889357|NCT00804687|529763437|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
146889358|NCT00804687|529763438|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
146889359|NCT00804687|529763439|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
146889360|NCT00804687|529763440|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
146889361|NCT00804687|529763441|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
146889362|NCT00804687|529763442|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
146889363|NCT00804687|529763437|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
146889364|NCT00804687|529763438|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
146889365|NCT00804687|529763439|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
146889366|NCT00804687|529763440|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
146889367|NCT00804687|529763441|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
146889368|NCT00804687|529763442|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
146889369|NCT00804687|529763437|FG000|Period 5: Treatment Period|Positive drug test|1|||
146889370|NCT00804687|529763438|FG001|Period 5: Treatment Period|Positive drug test|0|||
146889371|NCT00804687|529763439|FG002|Period 5: Treatment Period|Positive drug test|0|||
146889372|NCT00804687|529763440|FG003|Period 5: Treatment Period|Positive drug test|0|||
146889373|NCT00804687|529763441|FG004|Period 5: Treatment Period|Positive drug test|0|||
146889374|NCT00804687|529763442|FG005|Period 5: Treatment Period|Positive drug test|0|||
146889375|NCT01220414|529763445|FG000|Overall Study|Withdrawal by Subject|1|||
146889376|NCT01220414|529763446|FG001|Overall Study|Withdrawal by Subject|0|||
146889377|NCT01220414|529763447|FG002|Overall Study|Withdrawal by Subject|0|||
146889378|NCT01220414|529763448|FG003|Overall Study|Withdrawal by Subject|1|||
146889379|NCT02397473|529763452|FG000|Treatment Phase|Adverse Event|1|||
146889380|NCT02397473|529763453|FG001|Treatment Phase|Adverse Event|2|||
146889381|NCT02397473|529763452|FG000|Treatment Phase|Lack of Efficacy|8|||
146889382|NCT02397473|529763453|FG001|Treatment Phase|Lack of Efficacy|1|||
146889383|NCT02397473|529763452|FG000|Treatment Phase|Lost to Follow-up|1|||
146889384|NCT02397473|529763453|FG001|Treatment Phase|Lost to Follow-up|0|||
146889385|NCT02397473|529763452|FG000|Treatment Phase|Withdrawal by Subject|2|||
146889386|NCT02397473|529763453|FG001|Treatment Phase|Withdrawal by Subject|1|||
146889387|NCT02397473|529763452|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
146889388|NCT02397473|529763453|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
146889389|NCT02397473|529763452|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
146889390|NCT02397473|529763453|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
146889391|NCT02397473|529763452|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
146889392|NCT02397473|529763453|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
146889393|NCT02397473|529763452|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
146889394|NCT02397473|529763453|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
146889395|NCT02397473|529763452|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
146889396|NCT02397473|529763453|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
146889397|NCT01337973|529763454|FG000|Overall Study|Lost to Follow-up|2|||
146889398|NCT01337973|529763455|FG001|Overall Study|Lost to Follow-up|4|||
146889399|NCT01337973|529763456|FG002|Overall Study|Lost to Follow-up|3|||
146889400|NCT01337973|529763454|FG000|Overall Study|Death|1|||
146889401|NCT01337973|529763455|FG001|Overall Study|Death|2|||
146889402|NCT01337973|529763456|FG002|Overall Study|Death|1|||
146889403|NCT01337973|529763454|FG000|Overall Study|Withdrawal by Subject|10|||
146889404|NCT01337973|529763455|FG001|Overall Study|Withdrawal by Subject|8|||
146889405|NCT01337973|529763456|FG002|Overall Study|Withdrawal by Subject|4|||
146889406|NCT01337973|529763454|FG000|Overall Study|missing data on primary outcome|3|||
146889407|NCT01337973|529763455|FG001|Overall Study|missing data on primary outcome|1|||
146889408|NCT01337973|529763456|FG002|Overall Study|missing data on primary outcome|3|||
146889409|NCT01001702|529763460|FG000|Overall Study|Lost to Follow-up|7|||
146889410|NCT01001702|529763460|FG000|Overall Study|Adverse Event|7|||
146889411|NCT01001702|529763460|FG000|Overall Study|Sponsor Discontinued Study|4|||
146889412|NCT01001702|529763460|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
146966895|NCT01160770|530040081|FG000|Overall Study|Lack of Efficacy|15|||
146966896|NCT01160770|530040081|FG000|Overall Study|Other Reasons|1|||
146555896|NCT03688139|528544410|FG000|Overall Study|Withdrawal by Subject|2|||
146555897|NCT03688139|528544411|FG001|Overall Study|Withdrawal by Subject|3|||
146555898|NCT00420056|528544412|FG000|Overall Study|Objective progression or relapse|17|||
146555899|NCT03624036|528544413|FG000|Overall Study|Death|2|||
146555900|NCT03624036|528544414|FG001|Overall Study|Death|3|||
146555901|NCT03624036|528544415|FG002|Overall Study|Death|0|||
146555902|NCT03624036|528544416|FG003|Overall Study|Death|1|||
146555903|NCT03624036|528544413|FG000|Overall Study|Withdrawal by Subject|1|||
146555904|NCT03624036|528544414|FG001|Overall Study|Withdrawal by Subject|0|||
146555905|NCT03624036|528544415|FG002|Overall Study|Withdrawal by Subject|1|||
146555906|NCT03624036|528544416|FG003|Overall Study|Withdrawal by Subject|0|||
146555907|NCT03624036|528544413|FG000|Overall Study|Enrolled but Never Treated|1|||
146555908|NCT03624036|528544414|FG001|Overall Study|Enrolled but Never Treated|0|||
146555909|NCT03624036|528544415|FG002|Overall Study|Enrolled but Never Treated|0|||
146555910|NCT03624036|528544416|FG003|Overall Study|Enrolled but Never Treated|0|||
146555911|NCT03624036|528544413|FG000|Overall Study|Reason not Specified|3|||
146555912|NCT03624036|528544414|FG001|Overall Study|Reason not Specified|0|||
146555913|NCT03624036|528544415|FG002|Overall Study|Reason not Specified|2|||
146555914|NCT03624036|528544416|FG003|Overall Study|Reason not Specified|2|||
146555915|NCT01390584|528544424|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
146555916|NCT01390584|528544425|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
146555917|NCT01390584|528544426|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
146555918|NCT00498485|528544427|FG000|Overall Study|Adverse Event|1|||
146555919|NCT00498485|528544428|FG001|Overall Study|Adverse Event|5|||
146555920|NCT03478787|528544429|FG000|Overall Study|Adverse Event|5|||
146555921|NCT03478787|528544430|FG001|Overall Study|Adverse Event|1|||
146555922|NCT03478787|528544429|FG000|Overall Study|Protocol Violation|3|||
146555923|NCT03478787|528544430|FG001|Overall Study|Protocol Violation|0|||
146555924|NCT03478787|528544429|FG000|Overall Study|Lack of Efficacy|7|||
146636146|NCT01995838|528842650|FG006|Overall Study|Participant choice|1|||
146555925|NCT03478787|528544430|FG001|Overall Study|Lack of Efficacy|1|||
146889413|NCT01001702|529763460|FG000|Overall Study|Investigator withdrew Subject|10|||
146889414|NCT01001702|529763460|FG000|Overall Study|Withdrawal by Subject|19|||
146889415|NCT01001702|529763460|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
146889416|NCT02624492|529763464|FG000|Overall Study|Adverse Event|2|||
146889417|NCT02624492|529763465|FG001|Overall Study|Adverse Event|2|||
146889418|NCT02624492|529763466|FG002|Overall Study|Adverse Event|2|||
146889419|NCT02624492|529763464|FG000|Overall Study|Progressive disease|0|||
146889420|NCT02624492|529763465|FG001|Overall Study|Progressive disease|2|||
146889421|NCT02624492|529763466|FG002|Overall Study|Progressive disease|3|||
146889422|NCT00191451|529763474|FG000|Overall Study|Withdrawal by Subject|2|||
146889423|NCT00191451|529763475|FG001|Overall Study|Withdrawal by Subject|3|||
146889424|NCT00191451|529763476|FG002|Overall Study|Withdrawal by Subject|5|||
146889425|NCT00191451|529763474|FG000|Overall Study|Physician Decision|2|||
146889426|NCT00191451|529763475|FG001|Overall Study|Physician Decision|9|||
146889427|NCT00191451|529763476|FG002|Overall Study|Physician Decision|6|||
146889428|NCT00191451|529763474|FG000|Overall Study|Sponsor Decision|1|||
146889429|NCT00191451|529763475|FG001|Overall Study|Sponsor Decision|0|||
146889430|NCT00191451|529763476|FG002|Overall Study|Sponsor Decision|0|||
146889431|NCT00191451|529763474|FG000|Overall Study|Ineligible|0|||
146889432|NCT00191451|529763475|FG001|Overall Study|Ineligible|1|||
146889433|NCT00191451|529763476|FG002|Overall Study|Ineligible|0|||
146889434|NCT00191451|529763474|FG000|Overall Study|Reason Not Specified|2|||
146889435|NCT00191451|529763475|FG001|Overall Study|Reason Not Specified|1|||
146889436|NCT00191451|529763476|FG002|Overall Study|Reason Not Specified|3|||
146889437|NCT01262976|529763477|FG000|Up to Month 2|Serious Adverse Event|0|||
146889438|NCT01262976|529763478|FG001|Up to Month 2|Serious Adverse Event|0|||
146889439|NCT01262976|529763479|FG002|Up to Month 2|Serious Adverse Event|1|||
146889440|NCT01262976|529763480|FG003|Up to Month 2|Serious Adverse Event|0|||
146889441|NCT01262976|529763481|FG004|Up to Month 2|Serious Adverse Event|0|||
146889442|NCT01262976|529763482|FG005|Up to Month 2|Serious Adverse Event|0|||
146889443|NCT01262976|529763477|FG000|Up to Month 2|Withdrawal by Subject|1|||
146889444|NCT01262976|529763478|FG001|Up to Month 2|Withdrawal by Subject|0|||
146889445|NCT01262976|529763479|FG002|Up to Month 2|Withdrawal by Subject|0|||
146889446|NCT01262976|529763480|FG003|Up to Month 2|Withdrawal by Subject|0|||
146889447|NCT01262976|529763481|FG004|Up to Month 2|Withdrawal by Subject|0|||
146889448|NCT01262976|529763482|FG005|Up to Month 2|Withdrawal by Subject|0|||
146889449|NCT01262976|529763477|FG000|Up to Month 2|Migrated/moved from study area|0|||
146889450|NCT01262976|529763478|FG001|Up to Month 2|Migrated/moved from study area|1|||
146889451|NCT01262976|529763479|FG002|Up to Month 2|Migrated/moved from study area|0|||
146889452|NCT01262976|529763480|FG003|Up to Month 2|Migrated/moved from study area|0|||
146889453|NCT01262976|529763481|FG004|Up to Month 2|Migrated/moved from study area|1|||
146889454|NCT01262976|529763482|FG005|Up to Month 2|Migrated/moved from study area|1|||
146889455|NCT01262976|529763477|FG000|Up to Month 2|Lost to Follow-up|1|||
146889456|NCT01262976|529763478|FG001|Up to Month 2|Lost to Follow-up|0|||
146889457|NCT01262976|529763479|FG002|Up to Month 2|Lost to Follow-up|0|||
146889458|NCT01262976|529763480|FG003|Up to Month 2|Lost to Follow-up|1|||
146889459|NCT01262976|529763481|FG004|Up to Month 2|Lost to Follow-up|1|||
146889460|NCT01262976|529763482|FG005|Up to Month 2|Lost to Follow-up|1|||
146889461|NCT01262976|529763477|FG000|Up to Month 2|Other|1|||
146889462|NCT01262976|529763478|FG001|Up to Month 2|Other|0|||
146889463|NCT01262976|529763479|FG002|Up to Month 2|Other|0|||
146889464|NCT01262976|529763480|FG003|Up to Month 2|Other|1|||
146889465|NCT01262976|529763481|FG004|Up to Month 2|Other|0|||
146889466|NCT01262976|529763482|FG005|Up to Month 2|Other|2|||
146966897|NCT04930536|530040084|FG000|Overall Study|Adverse Event|1|||
146889467|NCT01262976|529763477|FG000|Up to Month 7|Serious Adverse Event|0|||
146555926|NCT03478787|528544429|FG000|Overall Study|Lost to Follow-up|9|||
146555927|NCT03478787|528544430|FG001|Overall Study|Lost to Follow-up|5|||
146555928|NCT03478787|528544429|FG000|Overall Study|Withdrawal by Subject|2|||
146636147|NCT01995838|528842644|FG000|Overall Study|Adverse Event|0|||
146636148|NCT01995838|528842645|FG001|Overall Study|Adverse Event|0|||
146636149|NCT01995838|528842646|FG002|Overall Study|Adverse Event|0|||
146636150|NCT01995838|528842647|FG003|Overall Study|Adverse Event|0|||
146636151|NCT01995838|528842648|FG004|Overall Study|Adverse Event|0|||
146636152|NCT01995838|528842649|FG005|Overall Study|Adverse Event|0|||
146636153|NCT01995838|528842650|FG006|Overall Study|Adverse Event|1|||
146636154|NCT01995838|528842644|FG000|Overall Study|Withdrawal by Subject|0|||
146636155|NCT01995838|528842645|FG001|Overall Study|Withdrawal by Subject|0|||
146636156|NCT01995838|528842646|FG002|Overall Study|Withdrawal by Subject|0|||
146636157|NCT01995838|528842647|FG003|Overall Study|Withdrawal by Subject|0|||
146889468|NCT01262976|529763478|FG001|Up to Month 7|Serious Adverse Event|0|||
146889469|NCT01262976|529763479|FG002|Up to Month 7|Serious Adverse Event|2|||
146889470|NCT01262976|529763480|FG003|Up to Month 7|Serious Adverse Event|0|||
146636158|NCT01995838|528842648|FG004|Overall Study|Withdrawal by Subject|1|||
146636159|NCT01995838|528842649|FG005|Overall Study|Withdrawal by Subject|0|||
146889471|NCT01262976|529763481|FG004|Up to Month 7|Serious Adverse Event|0|||
146636160|NCT01995838|528842650|FG006|Overall Study|Withdrawal by Subject|0|||
146636161|NCT01995838|528842644|FG000|Overall Study|Other|3|||
146636162|NCT01995838|528842645|FG001|Overall Study|Other|1|||
146636163|NCT01995838|528842646|FG002|Overall Study|Other|0|||
146636164|NCT01995838|528842647|FG003|Overall Study|Other|2|||
146636165|NCT01995838|528842648|FG004|Overall Study|Other|1|||
146636166|NCT01995838|528842649|FG005|Overall Study|Other|1|||
146636167|NCT01995838|528842650|FG006|Overall Study|Other|2|||
146636168|NCT00275509|528842651|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
146636169|NCT00275509|528842652|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
146636170|NCT02819804|528842653|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
146636171|NCT03196349|528842654|FG000|Overall Study|Did not receive study drug|0|||
146765763|NCT02878330|529310390|FG000|Overall Study|Withdrawal by Subject|11|||
146889472|NCT01262976|529763482|FG005|Up to Month 7|Serious Adverse Event|0|||
146889473|NCT01262976|529763477|FG000|Up to Month 7|Withdrawal by Subject|1|||
146889474|NCT01262976|529763478|FG001|Up to Month 7|Withdrawal by Subject|0|||
146889475|NCT01262976|529763479|FG002|Up to Month 7|Withdrawal by Subject|0|||
146889476|NCT01262976|529763480|FG003|Up to Month 7|Withdrawal by Subject|0|||
146636172|NCT03196349|528842655|FG001|Overall Study|Did not receive study drug|1|||
146636173|NCT03196349|528842656|FG002|Overall Study|Did not receive study drug|2|||
146889477|NCT01262976|529763481|FG004|Up to Month 7|Withdrawal by Subject|0|||
146636174|NCT03196349|528842654|FG000|Overall Study|No data entered|2|||
146636175|NCT03196349|528842655|FG001|Overall Study|No data entered|4|||
146889478|NCT01262976|529763482|FG005|Up to Month 7|Withdrawal by Subject|0|||
146889479|NCT01262976|529763477|FG000|Up to Month 7|Migrated/moved from study area|0|||
146889480|NCT01262976|529763478|FG001|Up to Month 7|Migrated/moved from study area|0|||
146889481|NCT01262976|529763479|FG002|Up to Month 7|Migrated/moved from study area|1|||
146889482|NCT01262976|529763480|FG003|Up to Month 7|Migrated/moved from study area|3|||
146636176|NCT03196349|528842656|FG002|Overall Study|No data entered|0|||
146555929|NCT03478787|528544430|FG001|Overall Study|Withdrawal by Subject|6|||
146555930|NCT03478787|528544429|FG000|Overall Study|Other, Not Specified|3|||
146555931|NCT03478787|528544430|FG001|Overall Study|Other, Not Specified|0|||
146555932|NCT01712074|528544433|FG000|Placebo Run-in Period|Adverse Event|2|||
146555933|NCT01712074|528544434|FG001|Placebo Run-in Period|Adverse Event|0|||
146555934|NCT01712074|528544435|FG002|Placebo Run-in Period|Adverse Event|0|||
146555935|NCT01712074|528544433|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
146555936|NCT01712074|528544434|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
146555937|NCT01712074|528544435|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
146555938|NCT01712074|528544433|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
146555939|NCT01712074|528544434|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
146636177|NCT03196349|528842654|FG000|Overall Study|Study Terminated early|15|||
146636178|NCT03196349|528842655|FG001|Overall Study|Study Terminated early|9|||
146636179|NCT03196349|528842656|FG002|Overall Study|Study Terminated early|11|||
146636180|NCT03388164|528842661|FG000|Overall Study|Withdrawal by Subject|3|||
146636181|NCT03388164|528842662|FG001|Overall Study|Withdrawal by Subject|1|||
146889483|NCT01262976|529763481|FG004|Up to Month 7|Migrated/moved from study area|1|||
146889484|NCT01262976|529763482|FG005|Up to Month 7|Migrated/moved from study area|1|||
146636182|NCT00686686|528842664|FG000|Overall Study|Non-compliance|1|||
146636183|NCT00686686|528842664|FG000|Overall Study|Adverse Event|2|||
146636184|NCT00686686|528842664|FG000|Overall Study|Lost to Follow-up|3|||
146636185|NCT01012440|528842665|FG000|Overall Study|Withdrawal by Subject|2|||
146636186|NCT00131248|528842667|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
146636187|NCT00131248|528842668|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
146636188|NCT00477386|528842676|FG000|Overall Study|Adverse Event|4|||
146636189|NCT00477386|528842677|FG001|Overall Study|Adverse Event|8|||
146636190|NCT00477386|528842676|FG000|Overall Study|Disease progression, relapse|3|||
146636191|NCT00477386|528842677|FG001|Overall Study|Disease progression, relapse|4|||
146636192|NCT00477386|528842676|FG000|Overall Study|Disease progression, refractory|1|||
146636193|NCT00477386|528842677|FG001|Overall Study|Disease progression, refractory|3|||
146636194|NCT00477386|528842676|FG000|Overall Study|Other|1|||
146636195|NCT00477386|528842677|FG001|Overall Study|Other|2|||
146636196|NCT00477386|528842676|FG000|Overall Study|Physician Decision|1|||
146636197|NCT00477386|528842677|FG001|Overall Study|Physician Decision|0|||
146636198|NCT00477386|528842676|FG000|Overall Study|Withdrawal by Subject|1|||
146636199|NCT00477386|528842677|FG001|Overall Study|Withdrawal by Subject|0|||
146889485|NCT01262976|529763477|FG000|Up to Month 7|Lost to Follow-up|1|||
146636200|NCT01254422|528842678|FG000|Overall Study|Protocol Violation|1|||
146636201|NCT01254422|528842679|FG001|Overall Study|Protocol Violation|0|||
146636202|NCT01254422|528842678|FG000|Overall Study|Adverse Event|1|||
146636203|NCT01254422|528842679|FG001|Overall Study|Adverse Event|0|||
146636204|NCT01254422|528842678|FG000|Overall Study|Serious adverse event|0|||
146966898|NCT04930536|530040085|FG001|Overall Study|Adverse Event|0|||
146765764|NCT02878330|529310391|FG001|Overall Study|Withdrawal by Subject|21|||
146765765|NCT02878330|529310390|FG000|Overall Study|Other|4|||
146636205|NCT01254422|528842679|FG001|Overall Study|Serious adverse event|1|||
146636206|NCT01254422|528842678|FG000|Overall Study|Lost to Follow-up|1|||
146636207|NCT01254422|528842679|FG001|Overall Study|Lost to Follow-up|0|||
146636208|NCT02207088|528842680|FG000|Overall Study|Adverse Event|2|||
146636209|NCT00643162|528842681|FG000|Overall Study|Withdrawal by Subject|1|||
146636210|NCT00643162|528842682|FG001|Overall Study|Withdrawal by Subject|1|||
146636211|NCT02691507|528842683|FG000|Overall Study|Missed Visit 3|0|||
146636212|NCT02691507|528842684|FG001|Overall Study|Missed Visit 3|1|||
146636213|NCT03023397|528842685|FG000|Run-In|Failed screening allergen challenge|1|||
146636214|NCT03023397|528842686|FG001|Run-In|Failed screening allergen challenge|0|||
146636215|NCT03023397|528842687|FG002|Run-In|Failed screening allergen challenge|0|||
146636216|NCT03023397|528842685|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
146636217|NCT03023397|528842686|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
146889486|NCT01262976|529763478|FG001|Up to Month 7|Lost to Follow-up|0|||
146889487|NCT01262976|529763479|FG002|Up to Month 7|Lost to Follow-up|1|||
146889488|NCT01262976|529763480|FG003|Up to Month 7|Lost to Follow-up|3|||
146889489|NCT01262976|529763481|FG004|Up to Month 7|Lost to Follow-up|1|||
146889490|NCT01262976|529763482|FG005|Up to Month 7|Lost to Follow-up|3|||
146889491|NCT01262976|529763477|FG000|Up to Month 7|Other|3|||
146889492|NCT01262976|529763478|FG001|Up to Month 7|Other|0|||
146889493|NCT01262976|529763479|FG002|Up to Month 7|Other|2|||
146889494|NCT01262976|529763480|FG003|Up to Month 7|Other|0|||
146889495|NCT01262976|529763481|FG004|Up to Month 7|Other|0|||
146889496|NCT01262976|529763482|FG005|Up to Month 7|Other|0|||
146889497|NCT01262976|529763477|FG000|Up to Year 1|Serious Adverse Event|0|||
146889498|NCT01262976|529763478|FG001|Up to Year 1|Serious Adverse Event|0|||
146889499|NCT01262976|529763479|FG002|Up to Year 1|Serious Adverse Event|2|||
146555940|NCT01712074|528544435|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
146555941|NCT01712074|528544433|FG000|Placebo Run-in Period|Other|1|||
146555942|NCT01712074|528544434|FG001|Placebo Run-in Period|Other|0|||
146555943|NCT01712074|528544435|FG002|Placebo Run-in Period|Other|0|||
146555944|NCT01712074|528544433|FG000|Placebo Run-in Period|No longer willing to participate|1|||
146555945|NCT01712074|528544434|FG001|Placebo Run-in Period|No longer willing to participate|0|||
146889500|NCT01262976|529763480|FG003|Up to Year 1|Serious Adverse Event|0|||
146889501|NCT01262976|529763481|FG004|Up to Year 1|Serious Adverse Event|0|||
146889502|NCT01262976|529763482|FG005|Up to Year 1|Serious Adverse Event|0|||
146889503|NCT01262976|529763477|FG000|Up to Year 1|Withdrawal by Subject|1|||
146889504|NCT01262976|529763478|FG001|Up to Year 1|Withdrawal by Subject|0|||
146889505|NCT01262976|529763479|FG002|Up to Year 1|Withdrawal by Subject|0|||
146889506|NCT01262976|529763480|FG003|Up to Year 1|Withdrawal by Subject|0|||
146889507|NCT01262976|529763481|FG004|Up to Year 1|Withdrawal by Subject|0|||
146889508|NCT01262976|529763482|FG005|Up to Year 1|Withdrawal by Subject|0|||
146889509|NCT01262976|529763477|FG000|Up to Year 1|Migrated/moved from study area|1|||
146889510|NCT01262976|529763478|FG001|Up to Year 1|Migrated/moved from study area|0|||
146889511|NCT01262976|529763479|FG002|Up to Year 1|Migrated/moved from study area|0|||
146889512|NCT01262976|529763480|FG003|Up to Year 1|Migrated/moved from study area|3|||
146889513|NCT01262976|529763481|FG004|Up to Year 1|Migrated/moved from study area|3|||
146889514|NCT01262976|529763482|FG005|Up to Year 1|Migrated/moved from study area|2|||
146555946|NCT01712074|528544435|FG002|Placebo Run-in Period|No longer willing to participate|0|||
146555947|NCT01712074|528544433|FG000|Double Blind Period|Adverse Event|0|||
146555948|NCT01712074|528544434|FG001|Double Blind Period|Adverse Event|2|||
146555949|NCT01712074|528544435|FG002|Double Blind Period|Adverse Event|1|||
146555950|NCT01712074|528544433|FG000|Double Blind Period|No longer willing to participate|0|||
146555951|NCT01712074|528544434|FG001|Double Blind Period|No longer willing to participate|2|||
146555952|NCT01712074|528544435|FG002|Double Blind Period|No longer willing to participate|4|||
146555953|NCT01712074|528544433|FG000|Double Blind Period|Death|0|||
146555954|NCT01712074|528544434|FG001|Double Blind Period|Death|1|||
146555955|NCT01712074|528544435|FG002|Double Blind Period|Death|0|||
146555956|NCT01712074|528544433|FG000|Double Blind Period|Lost to Follow-up|0|||
146555957|NCT01712074|528544434|FG001|Double Blind Period|Lost to Follow-up|2|||
146555958|NCT01712074|528544435|FG002|Double Blind Period|Lost to Follow-up|1|||
146555959|NCT01712074|528544433|FG000|Double Blind Period|Other|0|||
146555960|NCT01712074|528544434|FG001|Double Blind Period|Other|4|||
146555961|NCT01712074|528544435|FG002|Double Blind Period|Other|1|||
146555962|NCT01712074|528544433|FG000|Double Blind Period|Protocol Violation|0|||
146555963|NCT01712074|528544434|FG001|Double Blind Period|Protocol Violation|0|||
146555964|NCT01712074|528544435|FG002|Double Blind Period|Protocol Violation|1|||
146555965|NCT01712074|528544433|FG000|Double Blind Period|No longer met eligibility criteria|0|||
146555966|NCT01712074|528544434|FG001|Double Blind Period|No longer met eligibility criteria|3|||
146555967|NCT01712074|528544435|FG002|Double Blind Period|No longer met eligibility criteria|0|||
146555968|NCT02268851|528544436|FG000|Overall Study|Death|0|||
146555969|NCT02268851|528544437|FG001|Overall Study|Death|0|||
146555970|NCT02268851|528544438|FG002|Overall Study|Death|0|||
146555971|NCT02268851|528544439|FG003|Overall Study|Death|1|||
146555972|NCT02268851|528544440|FG004|Overall Study|Death|2|||
146555973|NCT02268851|528544441|FG005|Overall Study|Death|1|||
146555974|NCT02268851|528544436|FG000|Overall Study|Adverse Event|0|||
146555975|NCT02268851|528544437|FG001|Overall Study|Adverse Event|0|||
146555976|NCT02268851|528544438|FG002|Overall Study|Adverse Event|0|||
146555977|NCT02268851|528544439|FG003|Overall Study|Adverse Event|0|||
146555978|NCT02268851|528544440|FG004|Overall Study|Adverse Event|2|||
146555979|NCT02268851|528544441|FG005|Overall Study|Adverse Event|2|||
146555980|NCT02268851|528544436|FG000|Overall Study|Withdrawal by Subject|0|||
146555981|NCT02268851|528544437|FG001|Overall Study|Withdrawal by Subject|0|||
146555982|NCT02268851|528544438|FG002|Overall Study|Withdrawal by Subject|0|||
146555983|NCT02268851|528544439|FG003|Overall Study|Withdrawal by Subject|2|||
146555984|NCT02268851|528544440|FG004|Overall Study|Withdrawal by Subject|0|||
146889515|NCT01262976|529763477|FG000|Up to Year 1|Lost to Follow-up|4|||
146889516|NCT01262976|529763478|FG001|Up to Year 1|Lost to Follow-up|0|||
146889517|NCT01262976|529763479|FG002|Up to Year 1|Lost to Follow-up|0|||
146889518|NCT01262976|529763480|FG003|Up to Year 1|Lost to Follow-up|1|||
146966899|NCT04930536|530040084|FG000|Overall Study|Disease Progression|2|||
146555985|NCT02268851|528544441|FG005|Overall Study|Withdrawal by Subject|1|||
146555986|NCT02268851|528544436|FG000|Overall Study|Progressive Disease|1|||
146555987|NCT02268851|528544437|FG001|Overall Study|Progressive Disease|3|||
146555988|NCT02268851|528544438|FG002|Overall Study|Progressive Disease|0|||
146555989|NCT02268851|528544439|FG003|Overall Study|Progressive Disease|0|||
146555990|NCT02268851|528544440|FG004|Overall Study|Progressive Disease|1|||
146889519|NCT01262976|529763481|FG004|Up to Year 1|Lost to Follow-up|6|||
146765766|NCT02878330|529310391|FG001|Overall Study|Other|7|||
146765767|NCT00082810|529310396|FG000|Overall Study|Adverse Event|3|||
146765768|NCT00082810|529310396|FG000|Overall Study|Progressive disease|24|||
146765769|NCT00082810|529310396|FG000|Overall Study|Withdrawal by Subject|4|||
146765770|NCT01321606|529310402|FG000|Overall Study|Lost to Follow-up|0|||
146765771|NCT01321606|529310403|FG001|Overall Study|Lost to Follow-up|0|||
146765772|NCT01321606|529310404|FG002|Overall Study|Lost to Follow-up|0|||
146765773|NCT01321606|529310405|FG003|Overall Study|Lost to Follow-up|1|||
146765774|NCT02341625|529310413|FG000|Overall Study|Disease Progression|2|||
146765775|NCT02341625|529310414|FG001|Overall Study|Disease Progression|2|||
146765776|NCT02341625|529310415|FG002|Overall Study|Disease Progression|3|||
146765777|NCT02341625|529310416|FG003|Overall Study|Disease Progression|6|||
146765778|NCT02341625|529310417|FG004|Overall Study|Disease Progression|7|||
146765779|NCT02341625|529310418|FG005|Overall Study|Disease Progression|7|||
146765780|NCT02341625|529310419|FG006|Overall Study|Disease Progression|28|||
146765781|NCT02341625|529310420|FG007|Overall Study|Disease Progression|5|||
146765782|NCT02341625|529310421|FG008|Overall Study|Disease Progression|4|||
146765783|NCT02341625|529310422|FG009|Overall Study|Disease Progression|19|||
146765784|NCT02341625|529310413|FG000|Overall Study|Study Drug Toxicity|0|||
146765785|NCT02341625|529310414|FG001|Overall Study|Study Drug Toxicity|0|||
146765786|NCT02341625|529310415|FG002|Overall Study|Study Drug Toxicity|0|||
146765787|NCT02341625|529310416|FG003|Overall Study|Study Drug Toxicity|1|||
146765788|NCT02341625|529310417|FG004|Overall Study|Study Drug Toxicity|0|||
146765789|NCT02341625|529310418|FG005|Overall Study|Study Drug Toxicity|3|||
146765790|NCT02341625|529310419|FG006|Overall Study|Study Drug Toxicity|10|||
146765791|NCT02341625|529310420|FG007|Overall Study|Study Drug Toxicity|0|||
146765792|NCT02341625|529310421|FG008|Overall Study|Study Drug Toxicity|0|||
146765793|NCT02341625|529310422|FG009|Overall Study|Study Drug Toxicity|3|||
146765794|NCT02341625|529310413|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146765795|NCT02341625|529310414|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146765796|NCT02341625|529310415|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146765797|NCT02341625|529310416|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146765798|NCT02341625|529310417|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146765799|NCT02341625|529310418|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146765800|NCT02341625|529310419|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
146765801|NCT02341625|529310420|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
146765802|NCT02341625|529310421|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146765803|NCT02341625|529310422|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
146765804|NCT02341625|529310413|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
146765805|NCT02341625|529310414|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
146765806|NCT02341625|529310415|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
146765807|NCT02341625|529310416|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
146765808|NCT02341625|529310417|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
146765809|NCT02341625|529310418|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
146765810|NCT02341625|529310419|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
146765811|NCT02341625|529310420|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
146765812|NCT02341625|529310421|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
146765813|NCT02341625|529310422|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
146765814|NCT02341625|529310413|FG000|Overall Study|Participant Withdrew Consent|0|||
146765815|NCT02341625|529310414|FG001|Overall Study|Participant Withdrew Consent|0|||
146765816|NCT02341625|529310415|FG002|Overall Study|Participant Withdrew Consent|0|||
146765817|NCT02341625|529310416|FG003|Overall Study|Participant Withdrew Consent|1|||
146636218|NCT03023397|528842687|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
146636219|NCT01587924|528842688|FG000|Overall Study|Adverse Event|0|||
146636220|NCT01587924|528842689|FG001|Overall Study|Adverse Event|2|||
146636221|NCT01587924|528842690|FG002|Overall Study|Adverse Event|0|||
146636222|NCT01587924|528842691|FG003|Overall Study|Adverse Event|0|||
146636223|NCT01587924|528842688|FG000|Overall Study|Protocol Violation|2|||
146636224|NCT01587924|528842689|FG001|Overall Study|Protocol Violation|1|||
146636225|NCT01587924|528842690|FG002|Overall Study|Protocol Violation|2|||
146636226|NCT01587924|528842691|FG003|Overall Study|Protocol Violation|1|||
146636227|NCT01587924|528842688|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
146636228|NCT01587924|528842689|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
146636229|NCT01587924|528842690|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
146636230|NCT01587924|528842691|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
146636231|NCT01587924|528842688|FG000|Overall Study|Withdrawal by Subject|0|||
146765818|NCT02341625|529310417|FG004|Overall Study|Participant Withdrew Consent|0|||
146765819|NCT02341625|529310418|FG005|Overall Study|Participant Withdrew Consent|0|||
146636232|NCT01587924|528842689|FG001|Overall Study|Withdrawal by Subject|1|||
146889520|NCT01262976|529763482|FG005|Up to Year 1|Lost to Follow-up|5|||
146889521|NCT01262976|529763477|FG000|Up to Year 1|Other|3|||
146765820|NCT02341625|529310419|FG006|Overall Study|Participant Withdrew Consent|0|||
146765821|NCT02341625|529310420|FG007|Overall Study|Participant Withdrew Consent|0|||
146765822|NCT02341625|529310421|FG008|Overall Study|Participant Withdrew Consent|0|||
146765823|NCT02341625|529310422|FG009|Overall Study|Participant Withdrew Consent|0|||
146765824|NCT02341625|529310413|FG000|Overall Study|Completed Treatment as per Protocol|0|||
146765825|NCT02341625|529310414|FG001|Overall Study|Completed Treatment as per Protocol|0|||
146765826|NCT02341625|529310415|FG002|Overall Study|Completed Treatment as per Protocol|0|||
146765827|NCT02341625|529310416|FG003|Overall Study|Completed Treatment as per Protocol|0|||
146765828|NCT02341625|529310417|FG004|Overall Study|Completed Treatment as per Protocol|0|||
146765829|NCT02341625|529310418|FG005|Overall Study|Completed Treatment as per Protocol|0|||
146765830|NCT02341625|529310419|FG006|Overall Study|Completed Treatment as per Protocol|0|||
146765831|NCT02341625|529310420|FG007|Overall Study|Completed Treatment as per Protocol|0|||
146765832|NCT02341625|529310421|FG008|Overall Study|Completed Treatment as per Protocol|0|||
146765833|NCT02341625|529310422|FG009|Overall Study|Completed Treatment as per Protocol|1|||
146765834|NCT02341625|529310413|FG000|Overall Study|Other Reasons|0|||
146765835|NCT02341625|529310414|FG001|Overall Study|Other Reasons|0|||
146765836|NCT02341625|529310415|FG002|Overall Study|Other Reasons|0|||
146765837|NCT02341625|529310416|FG003|Overall Study|Other Reasons|0|||
146765838|NCT02341625|529310417|FG004|Overall Study|Other Reasons|1|||
146765839|NCT02341625|529310418|FG005|Overall Study|Other Reasons|0|||
146765840|NCT02341625|529310419|FG006|Overall Study|Other Reasons|5|||
146765841|NCT02341625|529310420|FG007|Overall Study|Other Reasons|0|||
146765842|NCT02341625|529310421|FG008|Overall Study|Other Reasons|0|||
146765843|NCT02341625|529310422|FG009|Overall Study|Other Reasons|2|||
146765844|NCT02341625|529310413|FG000|Overall Study|Not Reported|0|||
146765845|NCT02341625|529310414|FG001|Overall Study|Not Reported|0|||
146765846|NCT02341625|529310415|FG002|Overall Study|Not Reported|0|||
146765847|NCT02341625|529310416|FG003|Overall Study|Not Reported|0|||
146765848|NCT02341625|529310417|FG004|Overall Study|Not Reported|0|||
146765849|NCT02341625|529310418|FG005|Overall Study|Not Reported|0|||
146765850|NCT02341625|529310419|FG006|Overall Study|Not Reported|0|||
146765851|NCT02341625|529310420|FG007|Overall Study|Not Reported|0|||
146765852|NCT02341625|529310421|FG008|Overall Study|Not Reported|0|||
146765853|NCT02341625|529310422|FG009|Overall Study|Not Reported|3|||
146765854|NCT01839877|529310425|FG000|Overall Study|Protocol Violation|1|||
146765855|NCT03368001|529310428|FG000|Allocation|Lost to Pretest|16|||
146765856|NCT03368001|529310429|FG001|Allocation|Lost to Pretest|25|||
146765857|NCT03368001|529310428|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
146765858|NCT03368001|529310429|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
146765859|NCT03368001|529310428|FG000|Posttest|Lost to Posttest|7|||
146765860|NCT03368001|529310429|FG001|Posttest|Lost to Posttest|11|||
146765861|NCT03368001|529310428|FG000|Posttest|Discontinued Intervention|6|||
146765862|NCT03368001|529310429|FG001|Posttest|Discontinued Intervention|19|||
146889522|NCT01262976|529763478|FG001|Up to Year 1|Other|1|||
146889523|NCT01262976|529763479|FG002|Up to Year 1|Other|0|||
146889524|NCT01262976|529763480|FG003|Up to Year 1|Other|0|||
146889525|NCT01262976|529763481|FG004|Up to Year 1|Other|2|||
146889526|NCT01262976|529763482|FG005|Up to Year 1|Other|1|||
146889527|NCT01262976|529763477|FG000|Up to Year 1|Subjects with unknown completion status|0|||
146889528|NCT01262976|529763478|FG001|Up to Year 1|Subjects with unknown completion status|0|||
146765863|NCT03368001|529310428|FG000|Follow-up|Lost to Follow-up|6|||
146765864|NCT03368001|529310429|FG001|Follow-up|Lost to Follow-up|3|||
146765865|NCT01093534|529310430|FG000|Overall Study|Adverse Event|2|||
146765866|NCT01093534|529310431|FG001|Overall Study|Adverse Event|5|||
146765867|NCT01093534|529310432|FG002|Overall Study|Adverse Event|2|||
146889529|NCT01262976|529763479|FG002|Up to Year 1|Subjects with unknown completion status|1|||
146889530|NCT01262976|529763480|FG003|Up to Year 1|Subjects with unknown completion status|0|||
146889531|NCT01262976|529763481|FG004|Up to Year 1|Subjects with unknown completion status|0|||
146765868|NCT01093534|529310430|FG000|Overall Study|Lack of Efficacy|2|||
146765869|NCT01093534|529310431|FG001|Overall Study|Lack of Efficacy|1|||
146765870|NCT01093534|529310432|FG002|Overall Study|Lack of Efficacy|1|||
146765871|NCT01093534|529310430|FG000|Overall Study|Withdrawal by Subject|5|||
146889532|NCT01262976|529763482|FG005|Up to Year 1|Subjects with unknown completion status|1|||
146889533|NCT01262976|529763477|FG000|Up to Year 2|Serious Adverse Event|0|||
146889534|NCT01262976|529763478|FG001|Up to Year 2|Serious Adverse Event|0|||
146889535|NCT01262976|529763479|FG002|Up to Year 2|Serious Adverse Event|2|||
146889536|NCT01262976|529763480|FG003|Up to Year 2|Serious Adverse Event|0|||
146889537|NCT01262976|529763481|FG004|Up to Year 2|Serious Adverse Event|0|||
146889538|NCT01262976|529763482|FG005|Up to Year 2|Serious Adverse Event|0|||
146889539|NCT01262976|529763477|FG000|Up to Year 2|Withdrawal by Subject|1|||
146889540|NCT01262976|529763478|FG001|Up to Year 2|Withdrawal by Subject|0|||
146889541|NCT01262976|529763479|FG002|Up to Year 2|Withdrawal by Subject|0|||
146636233|NCT01587924|528842690|FG002|Overall Study|Withdrawal by Subject|1|||
146889542|NCT01262976|529763480|FG003|Up to Year 2|Withdrawal by Subject|0|||
146889543|NCT01262976|529763481|FG004|Up to Year 2|Withdrawal by Subject|0|||
146889544|NCT01262976|529763482|FG005|Up to Year 2|Withdrawal by Subject|0|||
146765872|NCT01093534|529310431|FG001|Overall Study|Withdrawal by Subject|7|||
146765873|NCT01093534|529310432|FG002|Overall Study|Withdrawal by Subject|2|||
146765874|NCT01093534|529310430|FG000|Overall Study|Other|1|||
146765875|NCT01093534|529310431|FG001|Overall Study|Other|3|||
146765876|NCT01093534|529310432|FG002|Overall Study|Other|4|||
146765877|NCT00811057|529310433|FG000|Overall Study|Protocol Violation|5|||
146765878|NCT00811057|529310434|FG001|Overall Study|Protocol Violation|10|||
146765879|NCT00811057|529310435|FG002|Overall Study|Protocol Violation|10|||
146765880|NCT00768651|529310436|FG000|Overall Study|Withdrawal by Subject|1|||
146765881|NCT00995709|529310441|FG000|Overall Study|Adverse Event|4|||
146765882|NCT00995709|529310442|FG001|Overall Study|Adverse Event|2|||
146765883|NCT00995709|529310443|FG002|Overall Study|Adverse Event|0|||
146765884|NCT00995709|529310441|FG000|Overall Study|Lack of Efficacy|0|||
146765885|NCT00995709|529310442|FG001|Overall Study|Lack of Efficacy|1|||
146765886|NCT00995709|529310443|FG002|Overall Study|Lack of Efficacy|4|||
146765887|NCT00995709|529310441|FG000|Overall Study|Withdrawal by Subject|0|||
146765888|NCT00995709|529310442|FG001|Overall Study|Withdrawal by Subject|4|||
146765889|NCT00995709|529310443|FG002|Overall Study|Withdrawal by Subject|1|||
146765890|NCT00995709|529310441|FG000|Overall Study|Lost to Follow-up|1|||
146765891|NCT00995709|529310442|FG001|Overall Study|Lost to Follow-up|0|||
146765892|NCT00995709|529310443|FG002|Overall Study|Lost to Follow-up|0|||
146765893|NCT00995709|529310441|FG000|Overall Study|Death|0|||
146765894|NCT00995709|529310442|FG001|Overall Study|Death|1|||
146765895|NCT00995709|529310443|FG002|Overall Study|Death|0|||
146765896|NCT00995709|529310441|FG000|Overall Study|Protocol Violation|2|||
146765897|NCT00995709|529310442|FG001|Overall Study|Protocol Violation|1|||
146765898|NCT00995709|529310443|FG002|Overall Study|Protocol Violation|0|||
146889545|NCT01262976|529763477|FG000|Up to Year 2|Migrated/moved from study area|0|||
146889546|NCT01262976|529763478|FG001|Up to Year 2|Migrated/moved from study area|0|||
146889547|NCT01262976|529763479|FG002|Up to Year 2|Migrated/moved from study area|0|||
146889548|NCT01262976|529763480|FG003|Up to Year 2|Migrated/moved from study area|2|||
146889549|NCT01262976|529763481|FG004|Up to Year 2|Migrated/moved from study area|1|||
146889550|NCT01262976|529763482|FG005|Up to Year 2|Migrated/moved from study area|2|||
146889551|NCT01262976|529763477|FG000|Up to Year 2|Lost to Follow-up|1|||
146889552|NCT01262976|529763478|FG001|Up to Year 2|Lost to Follow-up|1|||
146889553|NCT01262976|529763479|FG002|Up to Year 2|Lost to Follow-up|2|||
146889554|NCT01262976|529763480|FG003|Up to Year 2|Lost to Follow-up|2|||
146889555|NCT01262976|529763481|FG004|Up to Year 2|Lost to Follow-up|3|||
146889556|NCT01262976|529763482|FG005|Up to Year 2|Lost to Follow-up|3|||
146889557|NCT01262976|529763477|FG000|Up to Year 2|Subjects with unknown completion status|0|||
146889558|NCT01262976|529763478|FG001|Up to Year 2|Subjects with unknown completion status|0|||
146889559|NCT01262976|529763479|FG002|Up to Year 2|Subjects with unknown completion status|1|||
146889560|NCT01262976|529763480|FG003|Up to Year 2|Subjects with unknown completion status|0|||
146889561|NCT01262976|529763481|FG004|Up to Year 2|Subjects with unknown completion status|0|||
146889562|NCT01262976|529763482|FG005|Up to Year 2|Subjects with unknown completion status|0|||
146889563|NCT01262976|529763477|FG000|Up to Year 2|Other|3|||
146889564|NCT01262976|529763478|FG001|Up to Year 2|Other|0|||
146889565|NCT01262976|529763479|FG002|Up to Year 2|Other|0|||
146889566|NCT01262976|529763480|FG003|Up to Year 2|Other|0|||
146889567|NCT01262976|529763481|FG004|Up to Year 2|Other|0|||
146889568|NCT01262976|529763482|FG005|Up to Year 2|Other|0|||
146889569|NCT01262976|529763477|FG000|Up to Year 3|Serious Adverse Event|0|||
146889570|NCT01262976|529763478|FG001|Up to Year 3|Serious Adverse Event|0|||
146889571|NCT01262976|529763479|FG002|Up to Year 3|Serious Adverse Event|2|||
146889572|NCT01262976|529763480|FG003|Up to Year 3|Serious Adverse Event|0|||
146889573|NCT01262976|529763481|FG004|Up to Year 3|Serious Adverse Event|0|||
146889574|NCT01262976|529763482|FG005|Up to Year 3|Serious Adverse Event|0|||
146889575|NCT01262976|529763477|FG000|Up to Year 3|Withdrawal by Subject|1|||
146889576|NCT01262976|529763478|FG001|Up to Year 3|Withdrawal by Subject|0|||
146889577|NCT01262976|529763479|FG002|Up to Year 3|Withdrawal by Subject|0|||
146889578|NCT01262976|529763480|FG003|Up to Year 3|Withdrawal by Subject|0|||
146889579|NCT01262976|529763481|FG004|Up to Year 3|Withdrawal by Subject|0|||
146889580|NCT01262976|529763482|FG005|Up to Year 3|Withdrawal by Subject|0|||
146889581|NCT01262976|529763477|FG000|Up to Year 3|Migrated/moved from study area|0|||
146889582|NCT01262976|529763478|FG001|Up to Year 3|Migrated/moved from study area|0|||
146889583|NCT01262976|529763479|FG002|Up to Year 3|Migrated/moved from study area|0|||
146889584|NCT01262976|529763480|FG003|Up to Year 3|Migrated/moved from study area|2|||
146889585|NCT01262976|529763481|FG004|Up to Year 3|Migrated/moved from study area|1|||
146889586|NCT01262976|529763482|FG005|Up to Year 3|Migrated/moved from study area|1|||
146889587|NCT01262976|529763477|FG000|Up to Year 3|Lost to Follow-up|2|||
146889588|NCT01262976|529763478|FG001|Up to Year 3|Lost to Follow-up|2|||
146555991|NCT02268851|528544441|FG005|Overall Study|Progressive Disease|4|||
146555992|NCT02268851|528544436|FG000|Overall Study|Physician Decision|0|||
146555993|NCT02268851|528544437|FG001|Overall Study|Physician Decision|0|||
146555994|NCT02268851|528544438|FG002|Overall Study|Physician Decision|1|||
146889589|NCT01262976|529763479|FG002|Up to Year 3|Lost to Follow-up|4|||
146889590|NCT01262976|529763480|FG003|Up to Year 3|Lost to Follow-up|3|||
146889591|NCT01262976|529763481|FG004|Up to Year 3|Lost to Follow-up|1|||
146889592|NCT01262976|529763482|FG005|Up to Year 3|Lost to Follow-up|3|||
146889593|NCT01262976|529763477|FG000|Up to Year 3|Subjects with unknown completion status|0|||
146889594|NCT01262976|529763478|FG001|Up to Year 3|Subjects with unknown completion status|0|||
146889595|NCT01262976|529763479|FG002|Up to Year 3|Subjects with unknown completion status|1|||
146889596|NCT01262976|529763480|FG003|Up to Year 3|Subjects with unknown completion status|0|||
146889597|NCT01262976|529763481|FG004|Up to Year 3|Subjects with unknown completion status|0|||
146889598|NCT01262976|529763482|FG005|Up to Year 3|Subjects with unknown completion status|0|||
146889599|NCT01262976|529763477|FG000|Up to Year 3|Other|3|||
146889600|NCT01262976|529763478|FG001|Up to Year 3|Other|0|||
146889601|NCT01262976|529763479|FG002|Up to Year 3|Other|0|||
146889602|NCT01262976|529763480|FG003|Up to Year 3|Other|0|||
146889603|NCT01262976|529763481|FG004|Up to Year 3|Other|0|||
146889604|NCT01262976|529763482|FG005|Up to Year 3|Other|0|||
146889605|NCT00193063|529763483|FG000|Overall Study|Lack of Efficacy|3|||
146889606|NCT00193063|529763483|FG000|Overall Study|Adverse Event|1|||
146889607|NCT03261531|529763484|FG000|Overall Study|Withdrawal by Subject|4|||
146889608|NCT01700192|529763485|FG000|Overall Study|Adverse Event|73|||
146889609|NCT01700192|529763486|FG001|Overall Study|Adverse Event|18|||
146889610|NCT01700192|529763485|FG000|Overall Study|Lack of Efficacy|1|||
146889611|NCT01700192|529763486|FG001|Overall Study|Lack of Efficacy|0|||
146889612|NCT01700192|529763485|FG000|Overall Study|Lost to Follow-up|42|||
146889613|NCT01700192|529763486|FG001|Overall Study|Lost to Follow-up|29|||
146889614|NCT01700192|529763485|FG000|Overall Study|Noncompliance with study drug|0|||
146966900|NCT04930536|530040085|FG001|Overall Study|Disease Progression|0|||
146966901|NCT04930536|530040084|FG000|Overall Study|Patient Decision|4|||
146555995|NCT02268851|528544439|FG003|Overall Study|Physician Decision|0|||
146555996|NCT02268851|528544440|FG004|Overall Study|Physician Decision|0|||
146555997|NCT02268851|528544441|FG005|Overall Study|Physician Decision|1|||
146555998|NCT02268851|528544436|FG000|Overall Study|Patient Compliance|0|||
146555999|NCT02268851|528544437|FG001|Overall Study|Patient Compliance|0|||
146556000|NCT02268851|528544438|FG002|Overall Study|Patient Compliance|0|||
146556001|NCT02268851|528544439|FG003|Overall Study|Patient Compliance|0|||
146556002|NCT02268851|528544440|FG004|Overall Study|Patient Compliance|1|||
146556003|NCT02268851|528544441|FG005|Overall Study|Patient Compliance|1|||
146556004|NCT02268851|528544436|FG000|Overall Study|Co-Morbid Condition|0|||
146556005|NCT02268851|528544437|FG001|Overall Study|Co-Morbid Condition|0|||
146556006|NCT02268851|528544438|FG002|Overall Study|Co-Morbid Condition|0|||
146556007|NCT02268851|528544439|FG003|Overall Study|Co-Morbid Condition|0|||
146556008|NCT02268851|528544440|FG004|Overall Study|Co-Morbid Condition|1|||
146556009|NCT02268851|528544441|FG005|Overall Study|Co-Morbid Condition|1|||
146556010|NCT03378635|528544444|FG000|Overall Study|Adverse Event|1|||
146556011|NCT03378635|528544445|FG001|Overall Study|Adverse Event|0|||
146556012|NCT03378635|528544446|FG002|Overall Study|Adverse Event|0|||
146556013|NCT03378635|528544444|FG000|Overall Study|Withdrawal by Subject|1|||
146889615|NCT01700192|529763486|FG001|Overall Study|Noncompliance with study drug|5|||
146889616|NCT01700192|529763485|FG000|Overall Study|Physician Decision|2|||
146889617|NCT01700192|529763486|FG001|Overall Study|Physician Decision|3|||
146889618|NCT01700192|529763485|FG000|Overall Study|Pregnancy|1|||
146889619|NCT01700192|529763486|FG001|Overall Study|Pregnancy|4|||
146889620|NCT01700192|529763485|FG000|Overall Study|Progressive disease|1|||
146889621|NCT01700192|529763486|FG001|Overall Study|Progressive disease|0|||
146556014|NCT03378635|528544445|FG001|Overall Study|Withdrawal by Subject|0|||
146556015|NCT03378635|528544446|FG002|Overall Study|Withdrawal by Subject|0|||
146889622|NCT01700192|529763485|FG000|Overall Study|Protocol Violation|3|||
146556016|NCT02539394|528544449|FG000|Overall Study|Protocol Violation|1|||
146636234|NCT01587924|528842691|FG003|Overall Study|Withdrawal by Subject|0|||
146556017|NCT02539394|528544450|FG001|Overall Study|Protocol Violation|3|||
146556018|NCT02539394|528544449|FG000|Overall Study|Lost to Follow-up|1|||
146556019|NCT02539394|528544450|FG001|Overall Study|Lost to Follow-up|2|||
146556020|NCT02539394|528544449|FG000|Overall Study|Incomplete dataset|6|||
146556021|NCT02539394|528544450|FG001|Overall Study|Incomplete dataset|6|||
146556022|NCT01472835|528544451|FG000|Overall Study|Lost to Follow-up|2|||
146556023|NCT01472835|528544452|FG001|Overall Study|Lost to Follow-up|0|||
146556024|NCT02413346|528544453|FG000|Overall Study|Adverse Event|6|||
146556025|NCT02413346|528544454|FG001|Overall Study|Adverse Event|6|||
146556026|NCT02413346|528544453|FG000|Overall Study|Withdrawal by Subject|30|||
146556027|NCT02413346|528544454|FG001|Overall Study|Withdrawal by Subject|40|||
146556028|NCT02413346|528544453|FG000|Overall Study|Lost to Follow-up|17|||
146556029|NCT02413346|528544454|FG001|Overall Study|Lost to Follow-up|21|||
146556030|NCT02413346|528544453|FG000|Overall Study|Protocol Violation|2|||
146556031|NCT02413346|528544454|FG001|Overall Study|Protocol Violation|0|||
146556032|NCT02413346|528544453|FG000|Overall Study|Other Miscellaneous Reasons|4|||
146556033|NCT02413346|528544454|FG001|Overall Study|Other Miscellaneous Reasons|3|||
146556034|NCT03425188|528544473|FG000|Overall Study|Withdrawal by Subject|1|||
146556035|NCT01835431|528544474|FG000|Overall Study|Adverse Event|1|||
146556036|NCT01835431|528544475|FG001|Overall Study|Adverse Event|0|||
146556037|NCT01835431|528544474|FG000|Overall Study|other|0|||
146556038|NCT01835431|528544475|FG001|Overall Study|other|2|||
146556039|NCT01835431|528544474|FG000|Overall Study|Withdrawal by Subject|6|||
146556040|NCT01835431|528544475|FG001|Overall Study|Withdrawal by Subject|10|||
146556041|NCT01835431|528544474|FG000|Overall Study|Protocol Violation|1|||
146556042|NCT01835431|528544475|FG001|Overall Study|Protocol Violation|0|||
146556043|NCT01316900|528544480|FG000|Overall Study|Adverse Event|10|||
146556044|NCT01316900|528544481|FG001|Overall Study|Adverse Event|10|||
146556045|NCT01316900|528544482|FG002|Overall Study|Adverse Event|15|||
146556046|NCT01316900|528544483|FG003|Overall Study|Adverse Event|9|||
146556047|NCT01316900|528544480|FG000|Overall Study|Lack of Efficacy|17|||
146556048|NCT01316900|528544481|FG001|Overall Study|Lack of Efficacy|9|||
146556049|NCT01316900|528544482|FG002|Overall Study|Lack of Efficacy|5|||
146556050|NCT01316900|528544483|FG003|Overall Study|Lack of Efficacy|7|||
146556051|NCT01316900|528544480|FG000|Overall Study|Protocol Violation|7|||
146556052|NCT01316900|528544481|FG001|Overall Study|Protocol Violation|1|||
146556053|NCT01316900|528544482|FG002|Overall Study|Protocol Violation|4|||
146556054|NCT01316900|528544483|FG003|Overall Study|Protocol Violation|0|||
146556055|NCT01316900|528544480|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
146556056|NCT01316900|528544481|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
146556057|NCT01316900|528544482|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
146556058|NCT01316900|528544483|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
146966902|NCT04930536|530040085|FG001|Overall Study|Patient Decision|2|||
146556059|NCT01316900|528544480|FG000|Overall Study|Lost to Follow-up|1|||
146556060|NCT01316900|528544481|FG001|Overall Study|Lost to Follow-up|0|||
146556061|NCT01316900|528544482|FG002|Overall Study|Lost to Follow-up|1|||
146556062|NCT01316900|528544483|FG003|Overall Study|Lost to Follow-up|1|||
146556063|NCT01316900|528544480|FG000|Overall Study|Withdrawal by Subject|7|||
146556064|NCT01316900|528544481|FG001|Overall Study|Withdrawal by Subject|8|||
146556065|NCT01316900|528544482|FG002|Overall Study|Withdrawal by Subject|6|||
146556066|NCT01316900|528544483|FG003|Overall Study|Withdrawal by Subject|9|||
146556067|NCT00562861|528544484|FG000|Overall Study|Adverse Event|1|||
146556068|NCT00562861|528544485|FG001|Overall Study|Adverse Event|1|||
146556069|NCT00562861|528544484|FG000|Overall Study|Lack of Efficacy|5|||
146556070|NCT00562861|528544485|FG001|Overall Study|Lack of Efficacy|5|||
146556071|NCT00562861|528544484|FG000|Overall Study|noncompliance, moved|7|||
146556072|NCT00562861|528544485|FG001|Overall Study|noncompliance, moved|2|||
146556073|NCT00562861|528544484|FG000|Overall Study|Lost to Follow-up|7|||
146556074|NCT00562861|528544485|FG001|Overall Study|Lost to Follow-up|3|||
146556075|NCT01684033|528544486|FG000|Period 1, First 30 Days|Adverse Event|1|||
146556076|NCT01684033|528544487|FG001|Period 1, First 30 Days|Adverse Event|1|||
146556077|NCT01684033|528544486|FG000|Period 1, First 30 Days|Noncompliance|1|||
146556078|NCT01684033|528544487|FG001|Period 1, First 30 Days|Noncompliance|0|||
146556079|NCT01684033|528544486|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
146556080|NCT01684033|528544487|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
146556081|NCT01684033|528544486|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
146556082|NCT01684033|528544487|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
146556083|NCT01684033|528544486|FG000|Period 2, Second 30 Days|Adverse Event|1|||
146556084|NCT01684033|528544487|FG001|Period 2, Second 30 Days|Adverse Event|0|||
146556085|NCT00480025|528544488|FG000|Overall Study|Protocol Violation|12|||
146556086|NCT00480025|528544489|FG001|Overall Study|Protocol Violation|7|||
146556087|NCT00480025|528544488|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
146556088|NCT00480025|528544489|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
146556089|NCT00480025|528544488|FG000|Overall Study|Disease Progression / Recurrence|449|||
146556090|NCT00480025|528544489|FG001|Overall Study|Disease Progression / Recurrence|224|||
146556091|NCT00480025|528544488|FG000|Overall Study|Adverse Event|44|||
146556092|NCT00480025|528544489|FG001|Overall Study|Adverse Event|12|||
146556093|NCT00480025|528544488|FG000|Overall Study|Other|70|||
146556094|NCT00480025|528544489|FG001|Overall Study|Other|29|||
146556095|NCT00480025|528544488|FG000|Overall Study|SAE including intercurrent illness|76|||
146556096|NCT00480025|528544489|FG001|Overall Study|SAE including intercurrent illness|42|||
146556097|NCT03726879|528544491|FG000|Overall Study|Death|11|||
146556098|NCT03726879|528544492|FG001|Overall Study|Death|13|||
146556099|NCT03726879|528544491|FG000|Overall Study|Physician Decision|0|||
146556100|NCT03726879|528544492|FG001|Overall Study|Physician Decision|2|||
146556101|NCT03726879|528544491|FG000|Overall Study|Protocol Violation|0|||
146556102|NCT03726879|528544492|FG001|Overall Study|Protocol Violation|1|||
146556103|NCT03726879|528544491|FG000|Overall Study|Withdrawal by Subject|5|||
146556104|NCT03726879|528544492|FG001|Overall Study|Withdrawal by Subject|6|||
146556105|NCT03726879|528544491|FG000|Overall Study|TSH result is unstable|0|||
146556106|NCT03726879|528544492|FG001|Overall Study|TSH result is unstable|1|||
146556107|NCT03726879|528544491|FG000|Overall Study|Disease relapse|1|||
146556108|NCT03726879|528544492|FG001|Overall Study|Disease relapse|0|||
146556109|NCT03726879|528544491|FG000|Overall Study|Lost to Follow-up|3|||
146556110|NCT03726879|528544492|FG001|Overall Study|Lost to Follow-up|0|||
146556111|NCT02766478|528544494|FG000|Overall Study|Withdrawal by Subject|1|||
146556112|NCT02766478|528544495|FG001|Overall Study|Withdrawal by Subject|1|||
146556113|NCT01093573|528544496|FG000|Overall Study|Physician Decision|0|||
146556114|NCT01093573|528544497|FG001|Overall Study|Physician Decision|0|||
146556115|NCT01093573|528544498|FG002|Overall Study|Physician Decision|1|||
146556116|NCT01093573|528544496|FG000|Overall Study|Insurance Denied|0|||
146556117|NCT01093573|528544497|FG001|Overall Study|Insurance Denied|0|||
146556118|NCT01093573|528544498|FG002|Overall Study|Insurance Denied|1|||
146556119|NCT00089583|528544499|FG000|Overall Study|Adverse Event|0|||
146556120|NCT00089583|528544500|FG001|Overall Study|Adverse Event|3|||
146556121|NCT00089583|528544499|FG000|Overall Study|Insufficient Viral Load Response|5|||
146556122|NCT00089583|528544500|FG001|Overall Study|Insufficient Viral Load Response|5|||
146556123|NCT00089583|528544499|FG000|Overall Study|Withdrawal by Subject|0|||
146556124|NCT00089583|528544500|FG001|Overall Study|Withdrawal by Subject|4|||
146556125|NCT00089583|528544499|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
146556126|NCT00089583|528544500|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
146556127|NCT00089583|528544499|FG000|Overall Study|Participant Refused Study Medication|0|||
146556128|NCT00089583|528544500|FG001|Overall Study|Participant Refused Study Medication|2|||
146556129|NCT00089583|528544499|FG000|Overall Study|Non-Compliance|0|||
146556130|NCT00089583|528544500|FG001|Overall Study|Non-Compliance|4|||
146556131|NCT00089583|528544499|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
146556132|NCT00089583|528544500|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
146556133|NCT00089583|528544499|FG000|Overall Study|Participant Management Criteria Met|0|||
146556134|NCT00089583|528544500|FG001|Overall Study|Participant Management Criteria Met|1|||
146556135|NCT00089583|528544499|FG000|Overall Study|Reason Not Provided|0|||
146556136|NCT00089583|528544500|FG001|Overall Study|Reason Not Provided|1|||
146556137|NCT00089583|528544499|FG000|Overall Study|Protocol Violation|0|||
146556138|NCT00089583|528544500|FG001|Overall Study|Protocol Violation|3|||
146889623|NCT01700192|529763486|FG001|Overall Study|Protocol Violation|4|||
146556139|NCT00089583|528544499|FG000|Overall Study|Principal Investigator Decision|0|||
146889624|NCT01700192|529763485|FG000|Overall Study|Technical problems|0|||
146889625|NCT01700192|529763486|FG001|Overall Study|Technical problems|1|||
146556140|NCT00089583|528544500|FG001|Overall Study|Principal Investigator Decision|10|||
146556141|NCT00089583|528544499|FG000|Overall Study|Start of Disallowed Medication|0|||
146556142|NCT00089583|528544500|FG001|Overall Study|Start of Disallowed Medication|1|||
146889626|NCT01700192|529763485|FG000|Overall Study|Withdrawal by Subject|56|||
146556143|NCT00089583|528544499|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
146556144|NCT00089583|528544500|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
146556145|NCT00089583|528544499|FG000|Overall Study|Participant Incarcerated|0|||
146556146|NCT00089583|528544500|FG001|Overall Study|Participant Incarcerated|1|||
146556147|NCT04349098|528544501|FG000|Overall Study|Death|16|||
146556148|NCT04349098|528544502|FG001|Overall Study|Death|8|||
146636235|NCT01696188|528842692|FG000|Overall Study|Protocol Violation|1|||
146636236|NCT01696188|528842693|FG001|Overall Study|Protocol Violation|1|||
146636237|NCT02668393|528842694|FG000|Overall Study|Progressive disease|6|||
146636238|NCT02668393|528842695|FG001|Overall Study|Progressive disease|3|||
146636239|NCT02668393|528842694|FG000|Overall Study|Adverse Event|0|||
146636240|NCT02668393|528842695|FG001|Overall Study|Adverse Event|2|||
146636241|NCT02668393|528842694|FG000|Overall Study|Withdrawal from the trial|0|||
146636242|NCT02668393|528842695|FG001|Overall Study|Withdrawal from the trial|1|||
146636243|NCT02668393|528842694|FG000|Overall Study|Lack of benefit and side effects|1|||
146636244|NCT02668393|528842695|FG001|Overall Study|Lack of benefit and side effects|0|||
146636245|NCT00606593|528842696|FG000|Overall Study|Adverse Event|0|||
146636246|NCT00606593|528842697|FG001|Overall Study|Adverse Event|0|||
146636247|NCT00606593|528842698|FG002|Overall Study|Adverse Event|0|||
146636248|NCT00606593|528842699|FG003|Overall Study|Adverse Event|1|||
146636249|NCT00606593|528842700|FG004|Overall Study|Adverse Event|1|||
146636250|NCT00606593|528842701|FG005|Overall Study|Adverse Event|0|||
146636251|NCT00606593|528842702|FG006|Overall Study|Adverse Event|1|||
146636252|NCT00606593|528842703|FG007|Overall Study|Adverse Event|2|||
146636253|NCT00606593|528842704|FG008|Overall Study|Adverse Event|1|||
146636254|NCT00606593|528842705|FG009|Overall Study|Adverse Event|0|||
146636255|NCT00606593|528842696|FG000|Overall Study|Withdrawal of consent|1|||
146636256|NCT00606593|528842697|FG001|Overall Study|Withdrawal of consent|0|||
146636257|NCT00606593|528842698|FG002|Overall Study|Withdrawal of consent|1|||
146636258|NCT00606593|528842699|FG003|Overall Study|Withdrawal of consent|0|||
146636259|NCT00606593|528842700|FG004|Overall Study|Withdrawal of consent|0|||
146636260|NCT00606593|528842701|FG005|Overall Study|Withdrawal of consent|0|||
146636261|NCT00606593|528842702|FG006|Overall Study|Withdrawal of consent|0|||
146636262|NCT00606593|528842703|FG007|Overall Study|Withdrawal of consent|0|||
146636263|NCT00606593|528842704|FG008|Overall Study|Withdrawal of consent|0|||
146636264|NCT00606593|528842705|FG009|Overall Study|Withdrawal of consent|0|||
146636265|NCT00606593|528842696|FG000|Overall Study|Administrative/Other|0|||
146636266|NCT00606593|528842697|FG001|Overall Study|Administrative/Other|0|||
146636267|NCT00606593|528842698|FG002|Overall Study|Administrative/Other|1|||
146636268|NCT00606593|528842699|FG003|Overall Study|Administrative/Other|0|||
146636269|NCT00606593|528842700|FG004|Overall Study|Administrative/Other|0|||
146636270|NCT00606593|528842701|FG005|Overall Study|Administrative/Other|0|||
146636271|NCT00606593|528842702|FG006|Overall Study|Administrative/Other|0|||
146636272|NCT00606593|528842703|FG007|Overall Study|Administrative/Other|0|||
146636273|NCT00606593|528842704|FG008|Overall Study|Administrative/Other|0|||
146636274|NCT00606593|528842705|FG009|Overall Study|Administrative/Other|0|||
146636275|NCT03181529|528842706|FG000|Overall Study|Withdrawal by Subject|1|||
146636276|NCT03181529|528842707|FG001|Overall Study|Withdrawal by Subject|1|||
146636277|NCT03181529|528842706|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
146636278|NCT03181529|528842707|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
146636279|NCT00787644|528842708|FG000|Overall Study|Lost to Follow-up|1|||
146636280|NCT00787644|528842709|FG001|Overall Study|Lost to Follow-up|1|||
146636281|NCT00787644|528842708|FG000|Overall Study|Withdrawal by Subject|1|||
146636282|NCT00787644|528842709|FG001|Overall Study|Withdrawal by Subject|1|||
146636283|NCT00536744|528842710|FG000|Overall Study|Adverse Event|13|||
146636284|NCT00536744|528842711|FG001|Overall Study|Adverse Event|10|||
146636285|NCT00536744|528842710|FG000|Overall Study|Death|2|||
146636286|NCT00536744|528842711|FG001|Overall Study|Death|1|||
146636287|NCT00536744|528842710|FG000|Overall Study|Physician Decision|3|||
146636288|NCT00536744|528842711|FG001|Overall Study|Physician Decision|1|||
146636289|NCT00536744|528842710|FG000|Overall Study|Lost to Follow-up|3|||
146636290|NCT00536744|528842711|FG001|Overall Study|Lost to Follow-up|5|||
146636291|NCT00536744|528842710|FG000|Overall Study|Withdrawal by Subject|7|||
146636292|NCT00536744|528842711|FG001|Overall Study|Withdrawal by Subject|8|||
146636293|NCT00536744|528842710|FG000|Overall Study|PI tried alternative treatment|1|||
146636294|NCT00536744|528842711|FG001|Overall Study|PI tried alternative treatment|3|||
146636295|NCT01642589|528842715|FG000|Overall Study|Withdrawal by Subject|1|||
146636296|NCT01642589|528842716|FG001|Overall Study|Withdrawal by Subject|1|||
146636297|NCT01108185|528842717|FG000|Overall Study|Non-compliance|15|||
146636298|NCT01108185|528842717|FG000|Overall Study|Lost to Follow-up|12|||
146636299|NCT02581410|528842722|FG000|Vaccination Phase|Adverse Event|2|||
146636300|NCT02581410|528842723|FG001|Vaccination Phase|Adverse Event|1|||
146636301|NCT02581410|528842722|FG000|Vaccination Phase|Withdrawal by Subject|0|||
146636302|NCT02581410|528842723|FG001|Vaccination Phase|Withdrawal by Subject|1|||
146636303|NCT02581410|528842722|FG000|Vaccination Phase|Migrated/moved from study area|0|||
146636304|NCT02581410|528842723|FG001|Vaccination Phase|Migrated/moved from study area|1|||
146636305|NCT02581410|528842722|FG000|End of Study Phase|Adverse Event|4|||
146636306|NCT02581410|528842723|FG001|End of Study Phase|Adverse Event|3|||
146636307|NCT02581410|528842722|FG000|End of Study Phase|Withdrawal by Subject|1|||
146636308|NCT02581410|528842723|FG001|End of Study Phase|Withdrawal by Subject|2|||
146636309|NCT02581410|528842722|FG000|End of Study Phase|Migrated/moved from study area|0|||
146636310|NCT02581410|528842723|FG001|End of Study Phase|Migrated/moved from study area|3|||
146556149|NCT04349098|528544501|FG000|Overall Study|Lost to Follow-up|11|||
146556150|NCT04349098|528544502|FG001|Overall Study|Lost to Follow-up|8|||
146556151|NCT04349098|528544501|FG000|Overall Study|Withdrawal by Subject|8|||
146556152|NCT04349098|528544502|FG001|Overall Study|Withdrawal by Subject|5|||
146556153|NCT04349098|528544501|FG000|Overall Study|Other|3|||
146556154|NCT04349098|528544502|FG001|Overall Study|Other|5|||
146556155|NCT02113878|528546224|FG000|Overall Study|Adverse Event|1|||
146556156|NCT02113878|528546225|FG001|Overall Study|Adverse Event|0|||
146556157|NCT02113878|528546224|FG000|Overall Study|Withdrawal by Subject|1|||
146556158|NCT02113878|528546225|FG001|Overall Study|Withdrawal by Subject|0|||
146556159|NCT02113878|528546224|FG000|Overall Study|patient non-compliance|1|||
146556160|NCT02113878|528546225|FG001|Overall Study|patient non-compliance|0|||
146556161|NCT01251965|528546226|FG000|Overall Study|Participant/physician decision|1|||
146556162|NCT01251965|528546227|FG001|Overall Study|Participant/physician decision|2|||
146556163|NCT01251965|528546228|FG002|Overall Study|Participant/physician decision|0|||
146556164|NCT01251965|528546226|FG000|Overall Study|Death|0|||
146556165|NCT01251965|528546227|FG001|Overall Study|Death|0|||
146556166|NCT01251965|528546228|FG002|Overall Study|Death|11|||
146556167|NCT00530257|528546229|FG000|Overall Study|Lost to Follow-up|1|||
146556168|NCT05130281|528546232|FG000|Overall Study|Withdrawal by Subject|0|||
146556169|NCT05130281|528546233|FG001|Overall Study|Withdrawal by Subject|0|||
146556170|NCT05130281|528546234|FG002|Overall Study|Withdrawal by Subject|1|||
146556171|NCT00203242|528546236|FG000|Overall Study|Lost to Follow-up|1|||
146556172|NCT00866775|528546237|FG000|Overall Study|Adverse Event|5|||
146556173|NCT00866775|528546238|FG001|Overall Study|Adverse Event|19|||
146556174|NCT00866775|528546237|FG000|Overall Study|Death|1|||
146556175|NCT00866775|528546238|FG001|Overall Study|Death|0|||
146556176|NCT00866775|528546237|FG000|Overall Study|Lost to Follow-up|0|||
146556177|NCT00866775|528546238|FG001|Overall Study|Lost to Follow-up|4|||
146556178|NCT00866775|528546237|FG000|Overall Study|Physician Decision|0|||
146556179|NCT00866775|528546238|FG001|Overall Study|Physician Decision|3|||
146556180|NCT00866775|528546237|FG000|Overall Study|Protocol Violation|3|||
146556181|NCT00866775|528546238|FG001|Overall Study|Protocol Violation|4|||
146556182|NCT00866775|528546237|FG000|Overall Study|Withdrawal by Subject|4|||
146556183|NCT00866775|528546238|FG001|Overall Study|Withdrawal by Subject|4|||
146556184|NCT00866775|528546237|FG000|Overall Study|met exit criteria|23|||
146556185|NCT00866775|528546238|FG001|Overall Study|met exit criteria|17|||
146556186|NCT00866775|528546237|FG000|Overall Study|discontinued due to communication error|0|||
146556187|NCT00866775|528546238|FG001|Overall Study|discontinued due to communication error|1|||
146556188|NCT01661595|528546239|FG000|Phase 1: Week 0-4|Adverse Event|1|||
146556189|NCT01661595|528546240|FG001|Phase 1: Week 0-4|Adverse Event|0|||
146556190|NCT01661595|528546241|FG002|Phase 1: Week 0-4|Adverse Event|0|||
146556191|NCT01661595|528546242|FG003|Phase 1: Week 0-4|Adverse Event|0|||
146556192|NCT01661595|528546239|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
146556193|NCT01661595|528546240|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
146556194|NCT01661595|528546241|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
146556195|NCT01661595|528546242|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
146556196|NCT01500135|528546243|FG000|Overall Study|Withdrawal of Consent|4|||
146556197|NCT01500135|528546244|FG001|Overall Study|Withdrawal of Consent|0|||
146556198|NCT01500135|528546243|FG000|Overall Study|Lost to Follow-up|6|||
146556199|NCT01500135|528546244|FG001|Overall Study|Lost to Follow-up|4|||
146556200|NCT01500135|528546243|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
146556201|NCT01500135|528546244|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
146556202|NCT01500135|528546243|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
146556203|NCT01500135|528546244|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
146556204|NCT01500135|528546243|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
146556205|NCT01500135|528546244|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
146556206|NCT01500135|528546243|FG000|Overall Study|Participant was a Safety Concern|1|||
146556207|NCT01500135|528546244|FG001|Overall Study|Participant was a Safety Concern|0|||
146556208|NCT01500135|528546243|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
146556209|NCT01500135|528546244|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
146556210|NCT00912509|528546245|FG000|Overall Study|Lost to Follow-up|1|||
146556211|NCT00912509|528546246|FG001|Overall Study|Lost to Follow-up|0|||
146556212|NCT00912509|528546245|FG000|Overall Study|Lack of Efficacy|4|||
146556213|NCT00912509|528546246|FG001|Overall Study|Lack of Efficacy|3|||
146556214|NCT05538728|528546247|FG000|Overall Study|Withdrawal by Subject|1|||
146556215|NCT05538728|528546248|FG001|Overall Study|Withdrawal by Subject|1|||
146556216|NCT01034657|528546249|FG000|Core Phase|Withdrawal by Subject|1|||
146556217|NCT01034657|528546250|FG001|Core Phase|Withdrawal by Subject|0|||
146556218|NCT01034657|528546251|FG002|Core Phase|Withdrawal by Subject|0|||
146556219|NCT01034657|528546249|FG000|Core Phase|Lack of Efficacy|2|||
146556220|NCT01034657|528546250|FG001|Core Phase|Lack of Efficacy|0|||
146556221|NCT01034657|528546251|FG002|Core Phase|Lack of Efficacy|0|||
146556222|NCT01034657|528546249|FG000|Core Phase|Abnormal laboratory value|1|||
146556223|NCT01034657|528546250|FG001|Core Phase|Abnormal laboratory value|0|||
146556224|NCT01034657|528546251|FG002|Core Phase|Abnormal laboratory value|0|||
146556225|NCT01034657|528546249|FG000|Core Phase|Adverse Event|8|||
146889627|NCT01700192|529763486|FG001|Overall Study|Withdrawal by Subject|64|||
146889628|NCT01700192|529763485|FG000|Overall Study|Never received study drug|1|||
146889629|NCT01700192|529763486|FG001|Overall Study|Never received study drug|0|||
146889630|NCT00379795|529763493|FG000|Overall Study|Death|31|||
146889631|NCT00379795|529763494|FG001|Overall Study|Death|8|||
146889632|NCT00379795|529763495|FG002|Overall Study|Death|6|||
146556226|NCT01034657|528546250|FG001|Core Phase|Adverse Event|0|||
146556227|NCT01034657|528546251|FG002|Core Phase|Adverse Event|0|||
146556228|NCT01034657|528546249|FG000|Core Phase|Protocol Violation|2|||
146556229|NCT01034657|528546250|FG001|Core Phase|Protocol Violation|0|||
146889633|NCT00379795|529763496|FG003|Overall Study|Death|4|||
146556230|NCT01034657|528546251|FG002|Core Phase|Protocol Violation|0|||
146556231|NCT01034657|528546249|FG000|Randomized Phase|Withdrawal by Subject|0|||
146556232|NCT01034657|528546250|FG001|Randomized Phase|Withdrawal by Subject|2|||
146556233|NCT01034657|528546251|FG002|Randomized Phase|Withdrawal by Subject|0|||
146556234|NCT01034657|528546249|FG000|Randomized Phase|Lack of Efficacy|5|||
146556235|NCT01034657|528546250|FG001|Randomized Phase|Lack of Efficacy|1|||
146556236|NCT01034657|528546251|FG002|Randomized Phase|Lack of Efficacy|0|||
146556237|NCT01034657|528546249|FG000|Randomized Phase|Abnormal laboratory value|0|||
146556238|NCT01034657|528546250|FG001|Randomized Phase|Abnormal laboratory value|1|||
146556239|NCT01034657|528546251|FG002|Randomized Phase|Abnormal laboratory value|0|||
146889634|NCT00379795|529763497|FG004|Overall Study|Death|7|||
146556240|NCT01034657|528546249|FG000|Randomized Phase|Adverse Event|0|||
146556241|NCT01034657|528546250|FG001|Randomized Phase|Adverse Event|2|||
146556242|NCT01034657|528546251|FG002|Randomized Phase|Adverse Event|1|||
146556243|NCT02715856|528546252|FG000|Overall Study|Software Issues|12|||
146556244|NCT02715856|528546253|FG001|Overall Study|Software Issues|7|||
146556245|NCT02715856|528546252|FG000|Overall Study|Death|6|||
146556246|NCT02715856|528546253|FG001|Overall Study|Death|5|||
146556247|NCT02715856|528546252|FG000|Overall Study|Non- Compliant|0|||
146556248|NCT02715856|528546253|FG001|Overall Study|Non- Compliant|40|||
146556249|NCT01050218|528546254|FG000|Overall Study|Adverse Event|37|||
146556250|NCT01050218|528546254|FG000|Overall Study|Lack of Efficacy|8|||
146556251|NCT01050218|528546254|FG000|Overall Study|Protocol Violation|3|||
146556252|NCT01050218|528546254|FG000|Overall Study|Withdrawal by Subject|18|||
146556253|NCT01050218|528546254|FG000|Overall Study|Discontinued by sponsor|18|||
146556254|NCT01050218|528546254|FG000|Overall Study|Compliance|2|||
146556255|NCT01050218|528546254|FG000|Overall Study|Failed to return|7|||
146556256|NCT01050218|528546254|FG000|Overall Study|Serious Adverse Event|1|||
146556257|NCT01050218|528546254|FG000|Overall Study|Family emergency|1|||
146556258|NCT01772693|528546255|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
146556259|NCT01772693|528546256|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
146556260|NCT01772693|528546255|FG000|Overall Study|Withdrawal by Subject|2|||
146556261|NCT01772693|528546256|FG001|Overall Study|Withdrawal by Subject|0|||
146556262|NCT01772693|528546255|FG000|Overall Study|Alternative Treatment|2|||
146556263|NCT01772693|528546256|FG001|Overall Study|Alternative Treatment|0|||
146556264|NCT00889005|528546267|FG000|Overall Study|Lost to Follow-up|4|||
146556265|NCT00889005|528546268|FG001|Overall Study|Lost to Follow-up|2|||
146556266|NCT00889005|528546267|FG000|Overall Study|Withdrawal by Subject|4|||
146556267|NCT00889005|528546268|FG001|Overall Study|Withdrawal by Subject|0|||
146556268|NCT00756314|528546274|FG000|Overall Study|Lost to Follow-up|2|||
146556269|NCT00756314|528546275|FG001|Overall Study|Lost to Follow-up|59|||
146556270|NCT02872142|528546277|FG000|Overall Study|Adverse Event|2|||
146556271|NCT02872142|528546277|FG000|Overall Study|Death|1|||
146556272|NCT02872142|528546277|FG000|Overall Study|Participant Decision|3|||
146556273|NCT02605967|528546278|FG000|Overall Study|subject / guardian decision|1|||
146556274|NCT02605967|528546279|FG001|Overall Study|subject / guardian decision|2|||
146556275|NCT02605967|528546278|FG000|Overall Study|Physician Decision|10|||
146556276|NCT02605967|528546279|FG001|Overall Study|Physician Decision|1|||
146556277|NCT02605967|528546278|FG000|Overall Study|Death|4|||
146556278|NCT02605967|528546279|FG001|Overall Study|Death|2|||
146556279|NCT02605967|528546278|FG000|Overall Study|Adverse Event|1|||
146556280|NCT02605967|528546279|FG001|Overall Study|Adverse Event|0|||
146556281|NCT02605967|528546278|FG000|Overall Study|progressive disease|66|||
146556282|NCT02605967|528546279|FG001|Overall Study|progressive disease|35|||
146889635|NCT00379795|529763493|FG000|Overall Study|Adverse Event|17|||
146889636|NCT00379795|529763494|FG001|Overall Study|Adverse Event|3|||
146889637|NCT00379795|529763495|FG002|Overall Study|Adverse Event|3|||
146556283|NCT01903720|528546284|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
146556284|NCT01903720|528546284|FG000|Overall Study|Adverse Event|1|||
146556285|NCT01903720|528546284|FG000|Overall Study|Rescinding of informed consent|2|||
146556286|NCT01903720|528546284|FG000|Overall Study|Lost to Follow-up|2|||
146556287|NCT01903720|528546284|FG000|Overall Study|Treatment with alternative drug|1|||
146556288|NCT03627468|528546285|FG000|Overall Study|Adverse Event|5|||
146556289|NCT03627468|528546286|FG001|Overall Study|Adverse Event|33|||
146556290|NCT03627468|528546285|FG000|Overall Study|Withdrawal by Subject|13|||
146556291|NCT03627468|528546286|FG001|Overall Study|Withdrawal by Subject|23|||
146556292|NCT03627468|528546285|FG000|Overall Study|Physician Decision|1|||
146556293|NCT03627468|528546286|FG001|Overall Study|Physician Decision|0|||
146556294|NCT03627468|528546285|FG000|Overall Study|Protocol Violation|0|||
146556295|NCT03627468|528546286|FG001|Overall Study|Protocol Violation|2|||
146556296|NCT03627468|528546285|FG000|Overall Study|Lost to Follow-up|10|||
146556297|NCT03627468|528546286|FG001|Overall Study|Lost to Follow-up|16|||
146556298|NCT03627468|528546285|FG000|Overall Study|Death|1|||
146556299|NCT03627468|528546286|FG001|Overall Study|Death|0|||
146556300|NCT03627468|528546285|FG000|Overall Study|Pregnancy|1|||
146556301|NCT03627468|528546286|FG001|Overall Study|Pregnancy|1|||
146556302|NCT03627468|528546285|FG000|Overall Study|Lack of Efficacy|0|||
146556303|NCT03627468|528546286|FG001|Overall Study|Lack of Efficacy|2|||
146556304|NCT03627468|528546285|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
146556305|NCT03627468|528546286|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
146556306|NCT05122143|528546287|FG000|Overall Study|Adverse Event|1|||
146556307|NCT05122143|528546288|FG001|Overall Study|Adverse Event|0|||
146556308|NCT05122143|528546289|FG002|Overall Study|Adverse Event|0|||
146556309|NCT05122143|528546290|FG003|Overall Study|Adverse Event|0|||
146556310|NCT05122143|528546291|FG004|Overall Study|Adverse Event|1|||
146556311|NCT05122143|528546292|FG005|Overall Study|Adverse Event|0|||
146556312|NCT05122143|528546287|FG000|Overall Study|Protocol non-compliance|0|||
146556313|NCT05122143|528546288|FG001|Overall Study|Protocol non-compliance|0|||
146556314|NCT05122143|528546289|FG002|Overall Study|Protocol non-compliance|1|||
146556315|NCT05122143|528546290|FG003|Overall Study|Protocol non-compliance|0|||
146556316|NCT05122143|528546291|FG004|Overall Study|Protocol non-compliance|0|||
146556317|NCT05122143|528546292|FG005|Overall Study|Protocol non-compliance|0|||
146556318|NCT05122143|528546287|FG000|Overall Study|Covid contact|0|||
146556319|NCT05122143|528546288|FG001|Overall Study|Covid contact|0|||
146556320|NCT05122143|528546289|FG002|Overall Study|Covid contact|0|||
146556321|NCT05122143|528546290|FG003|Overall Study|Covid contact|0|||
146556322|NCT05122143|528546291|FG004|Overall Study|Covid contact|1|||
146556323|NCT05122143|528546292|FG005|Overall Study|Covid contact|0|||
146556324|NCT00692237|528546293|FG000|Overall Study|Withdrawal by Subject|1|||
146556325|NCT00692237|528546294|FG001|Overall Study|Withdrawal by Subject|3|||
146556326|NCT00692237|528546293|FG000|Overall Study|Adverse Event|0|||
146556327|NCT00692237|528546294|FG001|Overall Study|Adverse Event|1|||
146556328|NCT00309946|528546295|FG000|Overall Study|Withdrawal by Subject|1|||
146556329|NCT01347086|528546296|FG000|Overall Study|failed screening visit|0|||
146556330|NCT01347086|528546297|FG001|Overall Study|failed screening visit|0|||
146556331|NCT01347086|528546298|FG002|Overall Study|failed screening visit|1|||
146556332|NCT01347086|528546299|FG003|Overall Study|failed screening visit|0|||
146556333|NCT01347086|528546300|FG004|Overall Study|failed screening visit|0|||
146966903|NCT04930536|530040084|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
146966904|NCT04930536|530040085|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
146966905|NCT01432600|530040086|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
146966906|NCT01432600|530040087|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
146966907|NCT01432600|530040088|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
146966908|NCT00848965|530040089|FG000|Overall Study|Adverse Event|1|||
146966909|NCT00848965|530040089|FG000|Overall Study|Withdrawal by Subject|1|||
146966910|NCT01605370|530040094|FG000|Overall Study|Adverse Event|1|||
146556334|NCT01347086|528546301|FG005|Overall Study|failed screening visit|0|||
146556335|NCT01347086|528546302|FG006|Overall Study|failed screening visit|1|||
146556336|NCT01347086|528546303|FG007|Overall Study|failed screening visit|1|||
146556337|NCT01347086|528546304|FG008|Overall Study|failed screening visit|0|||
146556338|NCT01347086|528546305|FG009|Overall Study|failed screening visit|1|||
146556339|NCT00395447|528546306|FG000|Overall Study|Death|37|||
146556340|NCT00395447|528546307|FG001|Overall Study|Death|32|||
146556341|NCT00395447|528546306|FG000|Overall Study|Lost to Follow-up|52|||
146556342|NCT00395447|528546307|FG001|Overall Study|Lost to Follow-up|43|||
146556343|NCT00395447|528546306|FG000|Overall Study|Withdrawal by Subject|24|||
146556344|NCT00395447|528546307|FG001|Overall Study|Withdrawal by Subject|19|||
146556345|NCT00395447|528546306|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
146556346|NCT00395447|528546307|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
146556347|NCT02624687|528546308|FG000|Overall Study|Withdrawal by Subject|1|||
146636311|NCT02581410|528842722|FG000|End of Study Phase|Lost to Follow-up|0|||
146636312|NCT02581410|528842723|FG001|End of Study Phase|Lost to Follow-up|2|||
146556348|NCT02624687|528546309|FG001|Overall Study|Withdrawal by Subject|1|||
146556349|NCT02624687|528546308|FG000|Overall Study|medical leave from work|0|||
146636313|NCT02581410|528842722|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
146966911|NCT01605370|530040095|FG001|Overall Study|Adverse Event|0|||
146556350|NCT02624687|528546309|FG001|Overall Study|medical leave from work|1|||
146556351|NCT00347269|528546310|FG000|Overall Study|Lost to Follow-up|74|||
146556352|NCT00347269|528546311|FG001|Overall Study|Lost to Follow-up|65|||
146556353|NCT00347269|528546310|FG000|Overall Study|Withdrawal by Subject|18|||
146556354|NCT00347269|528546311|FG001|Overall Study|Withdrawal by Subject|38|||
146556355|NCT00347269|528546310|FG000|Overall Study|Death|2|||
146556356|NCT00347269|528546311|FG001|Overall Study|Death|3|||
146556357|NCT03654326|528546312|FG000|Overall Study|Withdrawal by Subject|5|||
146556358|NCT03654326|528546313|FG001|Overall Study|Withdrawal by Subject|3|||
146556359|NCT03654326|528546312|FG000|Overall Study|Physician Decision|0|||
146556360|NCT03654326|528546313|FG001|Overall Study|Physician Decision|1|||
146556361|NCT03654326|528546312|FG000|Overall Study|Unable to adhere to study schedule|0|||
146556362|NCT03654326|528546313|FG001|Overall Study|Unable to adhere to study schedule|1|||
146556363|NCT03654326|528546312|FG000|Overall Study|Lost to Follow-up|1|||
146556364|NCT03654326|528546313|FG001|Overall Study|Lost to Follow-up|1|||
146556365|NCT04893811|528546314|FG000|Vaccination Phase|Death|1|||
146556366|NCT04893811|528546315|FG001|Vaccination Phase|Death|0|||
146556367|NCT04893811|528546314|FG000|Vaccination Phase|Lost to Follow-up|1|||
146556368|NCT04893811|528546315|FG001|Vaccination Phase|Lost to Follow-up|1|||
146556369|NCT04893811|528546314|FG000|Vaccination Phase|Protocol Violation|2|||
146556370|NCT04893811|528546315|FG001|Vaccination Phase|Protocol Violation|0|||
146556371|NCT04893811|528546314|FG000|Vaccination Phase|Withdrawal by Subject|2|||
146556372|NCT04893811|528546315|FG001|Vaccination Phase|Withdrawal by Subject|1|||
146556373|NCT04893811|528546314|FG000|Vaccination Phase|Other|0|||
146556374|NCT04893811|528546315|FG001|Vaccination Phase|Other|1|||
146556375|NCT04893811|528546314|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
146556376|NCT04893811|528546315|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
146556377|NCT04893811|528546314|FG000|Follow-up Phase|Lost to Follow-up|0|||
146556378|NCT04893811|528546315|FG001|Follow-up Phase|Lost to Follow-up|1|||
146556379|NCT02662582|528546316|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
146556380|NCT02662582|528546317|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
146556381|NCT02662582|528546316|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
146556382|NCT02662582|528546317|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
146556383|NCT02662582|528546316|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
146556384|NCT02662582|528546317|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
146556385|NCT02662582|528546316|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
146556386|NCT02662582|528546317|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
146556387|NCT01725282|528546318|FG000|Overall Study|Adverse Event|1|||
146556388|NCT01725282|528546319|FG001|Overall Study|Adverse Event|3|||
146556389|NCT01725282|528546320|FG002|Overall Study|Adverse Event|6|||
146556390|NCT01725282|528546321|FG003|Overall Study|Adverse Event|4|||
146556391|NCT01725282|528546318|FG000|Overall Study|Exacerbation of Target Disease|1|||
146556392|NCT01725282|528546319|FG001|Overall Study|Exacerbation of Target Disease|0|||
146556393|NCT01725282|528546320|FG002|Overall Study|Exacerbation of Target Disease|0|||
146556394|NCT01725282|528546321|FG003|Overall Study|Exacerbation of Target Disease|1|||
146556395|NCT01725282|528546318|FG000|Overall Study|Met Exclusion Criteria|0|||
146556396|NCT01725282|528546319|FG001|Overall Study|Met Exclusion Criteria|0|||
146556397|NCT01725282|528546320|FG002|Overall Study|Met Exclusion Criteria|1|||
146556398|NCT01725282|528546321|FG003|Overall Study|Met Exclusion Criteria|0|||
146556399|NCT01725282|528546318|FG000|Overall Study|Study Site Withdrawal|0|||
146556400|NCT01725282|528546319|FG001|Overall Study|Study Site Withdrawal|1|||
146556401|NCT01725282|528546320|FG002|Overall Study|Study Site Withdrawal|0|||
146556402|NCT01725282|528546321|FG003|Overall Study|Study Site Withdrawal|0|||
146556403|NCT01725282|528546318|FG000|Overall Study|Withdrawal by Subject|0|||
146556404|NCT01725282|528546319|FG001|Overall Study|Withdrawal by Subject|0|||
146556405|NCT01725282|528546320|FG002|Overall Study|Withdrawal by Subject|1|||
146556406|NCT01725282|528546321|FG003|Overall Study|Withdrawal by Subject|1|||
146556407|NCT01725282|528546318|FG000|Overall Study|Lack of Efficacy|0|||
146556408|NCT01725282|528546319|FG001|Overall Study|Lack of Efficacy|1|||
146556409|NCT01725282|528546320|FG002|Overall Study|Lack of Efficacy|0|||
146556410|NCT01725282|528546321|FG003|Overall Study|Lack of Efficacy|1|||
146556411|NCT05451329|528546327|FG000|Overall Study|Adverse Event|1|||
146556412|NCT05451329|528546328|FG001|Overall Study|Adverse Event|1|||
146556413|NCT05451329|528546329|FG002|Overall Study|Adverse Event|0|||
146556414|NCT05451329|528546327|FG000|Overall Study|Withdrawal by Subject|1|||
146556415|NCT05451329|528546328|FG001|Overall Study|Withdrawal by Subject|0|||
146556416|NCT05451329|528546329|FG002|Overall Study|Withdrawal by Subject|0|||
146556417|NCT05451329|528546327|FG000|Overall Study|Investigational Product Lot exchange|1|||
146556418|NCT05451329|528546328|FG001|Overall Study|Investigational Product Lot exchange|1|||
146556419|NCT05451329|528546329|FG002|Overall Study|Investigational Product Lot exchange|0|||
146556420|NCT01618708|528546332|FG000|Overall Study|Adverse Event|10|||
146889638|NCT00379795|529763496|FG003|Overall Study|Adverse Event|1|||
146889639|NCT00379795|529763497|FG004|Overall Study|Adverse Event|4|||
146556421|NCT01618708|528546333|FG001|Overall Study|Adverse Event|10|||
146556422|NCT01618708|528546332|FG000|Overall Study|Lost to Follow-up|3|||
146556423|NCT01618708|528546333|FG001|Overall Study|Lost to Follow-up|3|||
146556424|NCT01618708|528546332|FG000|Overall Study|Withdrawal by Subject|17|||
146556425|NCT01618708|528546333|FG001|Overall Study|Withdrawal by Subject|22|||
146556426|NCT01618708|528546332|FG000|Overall Study|Lack of Efficacy|8|||
146556427|NCT01618708|528546333|FG001|Overall Study|Lack of Efficacy|8|||
146556428|NCT01618708|528546332|FG000|Overall Study|Technical problems|2|||
146556429|NCT01618708|528546333|FG001|Overall Study|Technical problems|0|||
146556430|NCT01618708|528546332|FG000|Overall Study|Other than specified above|1|||
146556431|NCT01618708|528546333|FG001|Overall Study|Other than specified above|1|||
146556432|NCT01618708|528546332|FG000|Overall Study|Randomized but not treated|3|||
146556433|NCT01618708|528546333|FG001|Overall Study|Randomized but not treated|2|||
146556434|NCT00489476|528546337|FG000|Overall Study|Lost to Follow-up|0|||
146556435|NCT00489476|528546338|FG001|Overall Study|Lost to Follow-up|1|||
146556436|NCT00489476|528546339|FG002|Overall Study|Lost to Follow-up|0|||
146556437|NCT00489476|528546340|FG003|Overall Study|Lost to Follow-up|0|||
146556438|NCT02757963|528546349|FG000|Overall Study|Adverse Event|3|||
146556439|NCT02757963|528546349|FG000|Overall Study|Reached Stopping Criteria|1054|||
146556440|NCT02757963|528546349|FG000|Overall Study|Lost to Follow-up|5|||
146556441|NCT02757963|528546349|FG000|Overall Study|Physician Decision|1|||
146556442|NCT02757963|528546349|FG000|Overall Study|Withdrawal by Subject|34|||
146556443|NCT01887600|528546350|FG000|Overall Study|Death|39|||
146556444|NCT01887600|528546351|FG001|Overall Study|Death|16|||
146556445|NCT01887600|528546350|FG000|Overall Study|Lack of Efficacy|3|||
146556446|NCT01887600|528546351|FG001|Overall Study|Lack of Efficacy|26|||
146556447|NCT01887600|528546350|FG000|Overall Study|Lost to Follow-up|5|||
146556448|NCT01887600|528546351|FG001|Overall Study|Lost to Follow-up|1|||
146556449|NCT01887600|528546350|FG000|Overall Study|Physician Decision|7|||
146556450|NCT01887600|528546351|FG001|Overall Study|Physician Decision|8|||
146556451|NCT01887600|528546350|FG000|Overall Study|Protocol Deviation|3|||
146556452|NCT01887600|528546351|FG001|Overall Study|Protocol Deviation|0|||
146556453|NCT01887600|528546350|FG000|Overall Study|Withdrawal by Subject|58|||
146556454|NCT01887600|528546351|FG001|Overall Study|Withdrawal by Subject|52|||
146556455|NCT01887600|528546350|FG000|Overall Study|Adverse Event|21|||
146556456|NCT01887600|528546351|FG001|Overall Study|Adverse Event|9|||
146556457|NCT01887600|528546350|FG000|Overall Study|Non-compliance with study drug|3|||
146556458|NCT01887600|528546351|FG001|Overall Study|Non-compliance with study drug|0|||
146556459|NCT01887600|528546350|FG000|Overall Study|Miscellaneous|6|||
146556460|NCT01887600|528546351|FG001|Overall Study|Miscellaneous|2|||
146556461|NCT01887600|528546350|FG000|Overall Study|Progressive Disease|1|||
146556462|NCT01887600|528546351|FG001|Overall Study|Progressive Disease|0|||
146556463|NCT00962650|528546352|FG000|Overall Study|Transgastric DP was not completed|2|||
146556464|NCT00231465|528546353|FG000|Overall Study|Completed only one cycle|1|||
146556465|NCT00231465|528546353|FG000|Overall Study|Did not have follow up CT scans|1|||
146556466|NCT00655356|528546356|FG000|Overall Study|Withdrawal by Subject|3|||
146556467|NCT00655356|528546357|FG001|Overall Study|Withdrawal by Subject|4|||
146556468|NCT00655356|528546356|FG000|Overall Study|Sponsor Request|10|||
146556469|NCT00655356|528546357|FG001|Overall Study|Sponsor Request|4|||
146556470|NCT00655356|528546356|FG000|Overall Study|Adverse Event|1|||
146556471|NCT00655356|528546357|FG001|Overall Study|Adverse Event|1|||
146556472|NCT00655356|528546356|FG000|Overall Study|Protocol Violation|2|||
146556473|NCT00655356|528546357|FG001|Overall Study|Protocol Violation|1|||
146556474|NCT00655356|528546356|FG000|Overall Study|Other Reason|1|||
146556475|NCT00655356|528546357|FG001|Overall Study|Other Reason|0|||
146556476|NCT01044459|528546358|FG000|Overall Study|Withdrawal by Subject|21|||
146556477|NCT01044459|528546359|FG001|Overall Study|Withdrawal by Subject|28|||
146556478|NCT01044459|528546358|FG000|Overall Study|Terminated by Sponsor|22|||
146556479|NCT01044459|528546359|FG001|Overall Study|Terminated by Sponsor|21|||
146556480|NCT01044459|528546358|FG000|Overall Study|Adverse Event|22|||
146556481|NCT01044459|528546359|FG001|Overall Study|Adverse Event|20|||
146556482|NCT01044459|528546358|FG000|Overall Study|Lack of Efficacy|23|||
146556483|NCT01044459|528546359|FG001|Overall Study|Lack of Efficacy|12|||
146556484|NCT01044459|528546358|FG000|Overall Study|Protocol Violation|11|||
146556485|NCT01044459|528546359|FG001|Overall Study|Protocol Violation|16|||
146556486|NCT01044459|528546358|FG000|Overall Study|Other Reason|7|||
146556487|NCT01044459|528546359|FG001|Overall Study|Other Reason|14|||
146556488|NCT01044459|528546358|FG000|Overall Study|COPD exacerbation|9|||
146636314|NCT02581410|528842723|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
146636315|NCT02908672|528842726|FG000|Run-in Period|Death|12|||
146556489|NCT01044459|528546359|FG001|Overall Study|COPD exacerbation|8|||
146556490|NCT01044459|528546358|FG000|Overall Study|Lost to Follow-up|18|||
146636316|NCT02908672|528842727|FG001|Run-in Period|Death|10|||
146636317|NCT02908672|528842728|FG002|Run-in Period|Death|0|||
146636318|NCT02908672|528842729|FG003|Run-in Period|Death|0|||
146556491|NCT01044459|528546359|FG001|Overall Study|Lost to Follow-up|12|||
146636319|NCT02908672|528842726|FG000|Run-in Period|Lost to Follow-up|1|||
146636320|NCT02908672|528842727|FG001|Run-in Period|Lost to Follow-up|1|||
146556492|NCT04105725|528546360|FG000|Primary Intervention|Lost to Follow-up|0|||
146556493|NCT04105725|528546361|FG001|Primary Intervention|Lost to Follow-up|2|||
146556494|NCT04105725|528546360|FG000|Primary Intervention|Withdrawal by Subject|0|||
146556495|NCT04105725|528546361|FG001|Primary Intervention|Withdrawal by Subject|1|||
146556496|NCT05346640|528546362|FG000|Overall Study|Lack of Efficacy|2|||
146556497|NCT05346640|528546362|FG000|Overall Study|Lost to Follow-up|14|||
146556498|NCT05346640|528546362|FG000|Overall Study|Protocol Violation|4|||
146556499|NCT05346640|528546362|FG000|Overall Study|Withdrawal by Subject|2|||
146556500|NCT05346640|528546362|FG000|Overall Study|Physiological Complications|3|||
146556501|NCT05346640|528546362|FG000|Overall Study|Other Reason|3|||
146556502|NCT04634331|528546363|FG000|Overall Study|Withdrawal by Subject|2|||
146556503|NCT04634331|528546364|FG001|Overall Study|Withdrawal by Subject|2|||
146636321|NCT02908672|528842728|FG002|Run-in Period|Lost to Follow-up|0|||
146556504|NCT05626686|528546365|FG000|Overall Study|Protocol Violation|3|||
146556505|NCT05626686|528546365|FG000|Overall Study|Withdrawal by Subject|3|||
146556506|NCT00507507|528546366|FG000|Treatment Period|Lost to Follow-up|0|||
146556507|NCT00507507|528546367|FG001|Treatment Period|Lost to Follow-up|2|||
146556508|NCT00507507|528546366|FG000|Treatment Period|Physician Decision|4|||
146556509|NCT00507507|528546367|FG001|Treatment Period|Physician Decision|1|||
146556510|NCT00507507|528546366|FG000|Treatment Period|Protocol Violation|1|||
146556511|NCT00507507|528546367|FG001|Treatment Period|Protocol Violation|2|||
146556512|NCT00507507|528546366|FG000|Treatment Period|Adverse Event|1|||
146556513|NCT00507507|528546367|FG001|Treatment Period|Adverse Event|1|||
146556514|NCT00507507|528546366|FG000|Treatment Period|Withdrawal by Subject|46|||
146556515|NCT00507507|528546367|FG001|Treatment Period|Withdrawal by Subject|47|||
146556516|NCT00507507|528546366|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
146556517|NCT00507507|528546367|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
146556518|NCT00507507|528546366|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
146556519|NCT00507507|528546367|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
146556520|NCT00507507|528546366|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
146556521|NCT00507507|528546367|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
146556522|NCT02916433|528546368|FG000|Overall Study|Withdrawal by Subject|1|||
146556523|NCT02916433|528546369|FG001|Overall Study|Withdrawal by Subject|0|||
146556524|NCT02916433|528546368|FG000|Overall Study|Physician Decision|1|||
146556525|NCT02916433|528546369|FG001|Overall Study|Physician Decision|0|||
146556526|NCT01694771|528546371|FG000|Overall Study|Adverse Event|18|||
146556527|NCT01694771|528546372|FG001|Overall Study|Adverse Event|16|||
146556528|NCT01694771|528546371|FG000|Overall Study|Lack of Efficacy|1|||
146556529|NCT01694771|528546372|FG001|Overall Study|Lack of Efficacy|0|||
146556530|NCT01694771|528546371|FG000|Overall Study|Non compliance protocol|7|||
146556531|NCT01694771|528546372|FG001|Overall Study|Non compliance protocol|6|||
146556532|NCT01694771|528546371|FG000|Overall Study|Lost to Follow-up|2|||
146556533|NCT01694771|528546372|FG001|Overall Study|Lost to Follow-up|3|||
146556534|NCT01694771|528546371|FG000|Overall Study|Consent withdrawn|7|||
146556535|NCT01694771|528546372|FG001|Overall Study|Consent withdrawn|9|||
146556536|NCT01694771|528546371|FG000|Overall Study|Other reasons|5|||
146556537|NCT01694771|528546372|FG001|Overall Study|Other reasons|6|||
146556538|NCT00289900|528546373|FG000|Overall Study|Adverse Event|28|||
146556539|NCT00289900|528546374|FG001|Overall Study|Adverse Event|40|||
146556540|NCT00289900|528546375|FG002|Overall Study|Adverse Event|13|||
146556541|NCT00289900|528546376|FG003|Overall Study|Adverse Event|19|||
146556542|NCT00289900|528546377|FG004|Overall Study|Adverse Event|20|||
146556543|NCT00289900|528546378|FG005|Overall Study|Adverse Event|33|||
146556544|NCT00289900|528546373|FG000|Overall Study|Lost to Follow-up|7|||
146556545|NCT00289900|528546374|FG001|Overall Study|Lost to Follow-up|7|||
146556546|NCT00289900|528546375|FG002|Overall Study|Lost to Follow-up|8|||
146556547|NCT00289900|528546376|FG003|Overall Study|Lost to Follow-up|8|||
146556548|NCT00289900|528546377|FG004|Overall Study|Lost to Follow-up|4|||
146556549|NCT00289900|528546378|FG005|Overall Study|Lost to Follow-up|8|||
146556550|NCT00289900|528546373|FG000|Overall Study|Participant had flushing|18|||
146556551|NCT00289900|528546374|FG001|Overall Study|Participant had flushing|42|||
146556552|NCT00289900|528546375|FG002|Overall Study|Participant had flushing|1|||
146556553|NCT00289900|528546376|FG003|Overall Study|Participant had flushing|2|||
146556554|NCT00289900|528546377|FG004|Overall Study|Participant had flushing|0|||
146556555|NCT00289900|528546378|FG005|Overall Study|Participant had flushing|4|||
146556556|NCT00289900|528546373|FG000|Overall Study|Other|0|||
146556557|NCT00289900|528546374|FG001|Overall Study|Other|0|||
146556558|NCT00289900|528546375|FG002|Overall Study|Other|0|||
146556559|NCT00289900|528546376|FG003|Overall Study|Other|5|||
146556560|NCT00289900|528546377|FG004|Overall Study|Other|1|||
146556561|NCT00289900|528546378|FG005|Overall Study|Other|0|||
146556562|NCT00289900|528546373|FG000|Overall Study|Participant moved|1|||
146556563|NCT00289900|528546374|FG001|Overall Study|Participant moved|0|||
146556564|NCT00289900|528546375|FG002|Overall Study|Participant moved|0|||
146556565|NCT00289900|528546376|FG003|Overall Study|Participant moved|1|||
146556566|NCT00289900|528546377|FG004|Overall Study|Participant moved|1|||
146556567|NCT00289900|528546378|FG005|Overall Study|Participant moved|1|||
146556568|NCT00289900|528546373|FG000|Overall Study|Withdrawal by Subject|10|||
146556569|NCT00289900|528546374|FG001|Overall Study|Withdrawal by Subject|21|||
146556570|NCT00289900|528546375|FG002|Overall Study|Withdrawal by Subject|8|||
146556571|NCT00289900|528546376|FG003|Overall Study|Withdrawal by Subject|18|||
146556572|NCT00289900|528546377|FG004|Overall Study|Withdrawal by Subject|12|||
146556573|NCT00289900|528546378|FG005|Overall Study|Withdrawal by Subject|11|||
146556574|NCT00289900|528546373|FG000|Overall Study|Protocol Violation|3|||
146556575|NCT00289900|528546374|FG001|Overall Study|Protocol Violation|9|||
146556576|NCT00289900|528546375|FG002|Overall Study|Protocol Violation|2|||
146556577|NCT00289900|528546376|FG003|Overall Study|Protocol Violation|6|||
146556578|NCT00289900|528546377|FG004|Overall Study|Protocol Violation|7|||
146556579|NCT00289900|528546378|FG005|Overall Study|Protocol Violation|4|||
146556580|NCT00289900|528546373|FG000|Overall Study|site terminated|1|||
146556581|NCT00289900|528546374|FG001|Overall Study|site terminated|0|||
146636322|NCT02908672|528842729|FG003|Run-in Period|Lost to Follow-up|0|||
146636323|NCT02908672|528842726|FG000|Run-in Period|Reason Not Specified|2|||
146636324|NCT02908672|528842727|FG001|Run-in Period|Reason Not Specified|0|||
146636325|NCT02908672|528842728|FG002|Run-in Period|Reason Not Specified|0|||
146636326|NCT02908672|528842729|FG003|Run-in Period|Reason Not Specified|0|||
146636327|NCT02908672|528842726|FG000|Run-in Period|Protocol Violation|1|||
146556582|NCT00289900|528546375|FG002|Overall Study|site terminated|1|||
146556583|NCT00289900|528546376|FG003|Overall Study|site terminated|0|||
146636328|NCT02908672|528842727|FG001|Run-in Period|Protocol Violation|1|||
146636329|NCT02908672|528842728|FG002|Run-in Period|Protocol Violation|0|||
146636330|NCT02908672|528842729|FG003|Run-in Period|Protocol Violation|0|||
146636331|NCT02908672|528842726|FG000|Run-in Period|Study Ended by Sponsor|5|||
146765899|NCT03008915|529310446|FG000|Treatment 1|Withdrawal by Subject|0|||
146556584|NCT00289900|528546377|FG004|Overall Study|site terminated|0|||
146556585|NCT00289900|528546378|FG005|Overall Study|site terminated|0|||
146556586|NCT00289900|528546373|FG000|Overall Study|Not treated|0|||
146556587|NCT00289900|528546374|FG001|Overall Study|Not treated|1|||
146556588|NCT00289900|528546375|FG002|Overall Study|Not treated|0|||
146556589|NCT00289900|528546376|FG003|Overall Study|Not treated|0|||
146556590|NCT00289900|528546377|FG004|Overall Study|Not treated|0|||
146556591|NCT00289900|528546378|FG005|Overall Study|Not treated|0|||
146556592|NCT01152385|528546379|FG000|Overall Study|Withdrawal by Subject|3|||
146556593|NCT01152385|528546380|FG001|Overall Study|Withdrawal by Subject|1|||
146556594|NCT01152385|528546381|FG002|Overall Study|Withdrawal by Subject|1|||
146556595|NCT01152385|528546382|FG003|Overall Study|Withdrawal by Subject|1|||
146556596|NCT01152385|528546379|FG000|Overall Study|Protocol Violation|0|||
146556597|NCT01152385|528546380|FG001|Overall Study|Protocol Violation|0|||
146556598|NCT01152385|528546381|FG002|Overall Study|Protocol Violation|0|||
146556599|NCT01152385|528546382|FG003|Overall Study|Protocol Violation|1|||
146556600|NCT01152385|528546379|FG000|Overall Study|Adverse Event|1|||
146556601|NCT01152385|528546380|FG001|Overall Study|Adverse Event|1|||
146556602|NCT01152385|528546381|FG002|Overall Study|Adverse Event|0|||
146556603|NCT01152385|528546382|FG003|Overall Study|Adverse Event|0|||
146556604|NCT01152385|528546379|FG000|Overall Study|Study-specific withdrawal criteria|1|||
146556605|NCT01152385|528546380|FG001|Overall Study|Study-specific withdrawal criteria|1|||
146556606|NCT01152385|528546381|FG002|Overall Study|Study-specific withdrawal criteria|2|||
146556607|NCT01152385|528546382|FG003|Overall Study|Study-specific withdrawal criteria|0|||
146556608|NCT01152385|528546379|FG000|Overall Study|Other|4|||
146556609|NCT01152385|528546380|FG001|Overall Study|Other|3|||
146556610|NCT01152385|528546381|FG002|Overall Study|Other|2|||
146556611|NCT01152385|528546382|FG003|Overall Study|Other|3|||
146556612|NCT02656173|528546383|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
146556613|NCT02656173|528546384|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
146556614|NCT02656173|528546383|FG000|Overall Study|Adverse Event|7|||
146556615|NCT02656173|528546384|FG001|Overall Study|Adverse Event|5|||
146556616|NCT02656173|528546383|FG000|Overall Study|Withdrawal by Subject|1|||
146556617|NCT02656173|528546384|FG001|Overall Study|Withdrawal by Subject|3|||
146556618|NCT02656173|528546383|FG000|Overall Study|Protocol Violation|0|||
146556619|NCT02656173|528546384|FG001|Overall Study|Protocol Violation|1|||
146556620|NCT02656173|528546383|FG000|Overall Study|Miscellaneous|2|||
146556621|NCT02656173|528546384|FG001|Overall Study|Miscellaneous|0|||
146556622|NCT03449147|528546385|FG000|52-week Treatment Period|Death|0|||
146556623|NCT03449147|528546386|FG001|52-week Treatment Period|Death|1|||
146556624|NCT03449147|528546387|FG002|52-week Treatment Period|Death|0|||
146556625|NCT03449147|528546385|FG000|52-week Treatment Period|Lost to Follow-up|6|||
146556626|NCT03449147|528546386|FG001|52-week Treatment Period|Lost to Follow-up|2|||
146765900|NCT03008915|529310447|FG001|Treatment 1|Withdrawal by Subject|1|||
146765901|NCT00712166|529310448|FG000|Overall Study|Noncompliance|0|||
146765902|NCT00712166|529310449|FG001|Overall Study|Noncompliance|1|||
146765903|NCT01773122|529310450|FG000|Overall Study|Due to amended age eligibility criteria|3|||
146889640|NCT00379795|529763493|FG000|Overall Study|Lost to Follow-up|8|||
146889641|NCT00379795|529763494|FG001|Overall Study|Lost to Follow-up|1|||
146889642|NCT00379795|529763495|FG002|Overall Study|Lost to Follow-up|2|||
146889643|NCT00379795|529763496|FG003|Overall Study|Lost to Follow-up|1|||
146556627|NCT03449147|528546387|FG002|52-week Treatment Period|Lost to Follow-up|5|||
146556628|NCT03449147|528546385|FG000|52-week Treatment Period|Other|0|||
146556629|NCT03449147|528546386|FG001|52-week Treatment Period|Other|1|||
146556630|NCT03449147|528546387|FG002|52-week Treatment Period|Other|2|||
146556631|NCT03449147|528546385|FG000|52-week Treatment Period|Physician Decision|1|||
146556632|NCT03449147|528546386|FG001|52-week Treatment Period|Physician Decision|0|||
146636332|NCT02908672|528842727|FG001|Run-in Period|Study Ended by Sponsor|1|||
146556633|NCT03449147|528546387|FG002|52-week Treatment Period|Physician Decision|3|||
146556634|NCT03449147|528546385|FG000|52-week Treatment Period|Screen Failure|1|||
146556635|NCT03449147|528546386|FG001|52-week Treatment Period|Screen Failure|2|||
146556636|NCT03449147|528546387|FG002|52-week Treatment Period|Screen Failure|0|||
146556637|NCT03449147|528546385|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
146556638|NCT03449147|528546386|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
146889644|NCT00379795|529763497|FG004|Overall Study|Lost to Follow-up|4|||
146556639|NCT03449147|528546387|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
146556640|NCT03449147|528546385|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
146556641|NCT03449147|528546386|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
146556642|NCT03449147|528546387|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
146556643|NCT03449147|528546385|FG000|12-Week Off-Treatment Durability Period|Other|0|||
146556644|NCT03449147|528546386|FG001|12-Week Off-Treatment Durability Period|Other|1|||
146556645|NCT03449147|528546387|FG002|12-Week Off-Treatment Durability Period|Other|0|||
146556646|NCT00992394|528546388|FG000|Overall Study|Lack of Efficacy|6|||
146556647|NCT00992394|528546389|FG001|Overall Study|Lack of Efficacy|3|||
146556648|NCT00992394|528546388|FG000|Overall Study|Adverse Event|4|||
146556649|NCT00992394|528546389|FG001|Overall Study|Adverse Event|5|||
146556650|NCT00992394|528546388|FG000|Overall Study|Withdrawal by Subject|8|||
146556651|NCT00992394|528546389|FG001|Overall Study|Withdrawal by Subject|2|||
146556652|NCT00992394|528546388|FG000|Overall Study|Physician Decision|1|||
146556653|NCT00992394|528546389|FG001|Overall Study|Physician Decision|0|||
146556654|NCT00992394|528546388|FG000|Overall Study|Protocol Violation|2|||
146556655|NCT00992394|528546389|FG001|Overall Study|Protocol Violation|4|||
146556656|NCT00992394|528546388|FG000|Overall Study|Lost to Follow-up|2|||
146556657|NCT00992394|528546389|FG001|Overall Study|Lost to Follow-up|0|||
146556658|NCT00992394|528546388|FG000|Overall Study|Other event|1|||
146556659|NCT00992394|528546389|FG001|Overall Study|Other event|0|||
146556660|NCT00974233|528546393|FG000|Induction Chemoimmunotherapy|Death|2|||
146556661|NCT00974233|528546393|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
146556662|NCT00974233|528546393|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
146556663|NCT00974233|528546393|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
146556664|NCT00974233|528546393|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
146556665|NCT00974233|528546393|FG000|Maintenance Lenalidomide|Adverse Event|8|||
146556666|NCT01197300|528547570|FG000|Overall Study|Lost to Follow-up|0|||
146556667|NCT01197300|528547571|FG001|Overall Study|Lost to Follow-up|1|||
146556668|NCT01197300|528547570|FG000|Overall Study|Protocol Violation|0|||
146556669|NCT01197300|528547571|FG001|Overall Study|Protocol Violation|1|||
146556670|NCT04744831|528547572|FG000|Overall Study|Progressive Disease|31|||
146556671|NCT04744831|528547573|FG001|Overall Study|Progressive Disease|27|||
146556672|NCT04744831|528547574|FG002|Overall Study|Progressive Disease|25|||
146556673|NCT04744831|528547572|FG000|Overall Study|Adverse Event|3|||
146556674|NCT04744831|528547573|FG001|Overall Study|Adverse Event|3|||
146556675|NCT04744831|528547574|FG002|Overall Study|Adverse Event|3|||
146556676|NCT04744831|528547572|FG000|Overall Study|Clinical Progression|3|||
146556677|NCT04744831|528547573|FG001|Overall Study|Clinical Progression|2|||
146556678|NCT04744831|528547574|FG002|Overall Study|Clinical Progression|5|||
146556679|NCT04744831|528547572|FG000|Overall Study|Other|0|||
146556680|NCT04744831|528547573|FG001|Overall Study|Other|2|||
146556681|NCT04744831|528547574|FG002|Overall Study|Other|1|||
146556682|NCT04744831|528547572|FG000|Overall Study|Death|0|||
146556683|NCT04744831|528547573|FG001|Overall Study|Death|2|||
146556684|NCT04744831|528547574|FG002|Overall Study|Death|1|||
146556685|NCT00590317|528547579|FG000|Overall Study|Lack of Efficacy|1|||
146556686|NCT00590317|528547580|FG001|Overall Study|Lack of Efficacy|5|||
146556687|NCT03443401|528547587|FG000|Overall Study|Lost to Follow-up|13|||
146556688|NCT03443401|528547587|FG000|Overall Study|Influential outlier|1|||
146556689|NCT02363283|528547588|FG000|Overall Study|Withdrawal by Subject|1|||
146556690|NCT02363283|528547588|FG000|Overall Study|Not eligible due to transaminitis|1|||
146556691|NCT04616196|528547595|FG000|Overall Study|Progressive Disease|3|||
146556692|NCT04616196|528547596|FG001|Overall Study|Progressive Disease|0|||
146556693|NCT04616196|528547597|FG002|Overall Study|Progressive Disease|4|||
146556694|NCT04616196|528547598|FG003|Overall Study|Progressive Disease|1|||
146556695|NCT04616196|528547595|FG000|Overall Study|Death|2|||
146556696|NCT04616196|528547596|FG001|Overall Study|Death|4|||
146556697|NCT04616196|528547597|FG002|Overall Study|Death|1|||
146556698|NCT04616196|528547598|FG003|Overall Study|Death|0|||
146636333|NCT02908672|528842728|FG002|Run-in Period|Study Ended by Sponsor|0|||
146636334|NCT02908672|528842729|FG003|Run-in Period|Study Ended by Sponsor|0|||
146636335|NCT02908672|528842726|FG000|Run-in Period|Withdrawal by Subject|3|||
146636336|NCT02908672|528842727|FG001|Run-in Period|Withdrawal by Subject|9|||
146889645|NCT00379795|529763493|FG000|Overall Study|Physician Decision|25|||
146889646|NCT00379795|529763494|FG001|Overall Study|Physician Decision|0|||
146889647|NCT00379795|529763495|FG002|Overall Study|Physician Decision|2|||
146889648|NCT00379795|529763496|FG003|Overall Study|Physician Decision|2|||
146889649|NCT00379795|529763497|FG004|Overall Study|Physician Decision|2|||
146889650|NCT00379795|529763493|FG000|Overall Study|Withdrawal by Subject|94|||
146889651|NCT00379795|529763494|FG001|Overall Study|Withdrawal by Subject|11|||
146889652|NCT00379795|529763495|FG002|Overall Study|Withdrawal by Subject|19|||
146889653|NCT00379795|529763496|FG003|Overall Study|Withdrawal by Subject|7|||
146889654|NCT00379795|529763497|FG004|Overall Study|Withdrawal by Subject|14|||
146889655|NCT00379795|529763493|FG000|Overall Study|Subject non-compliance|7|||
146636337|NCT02908672|528842728|FG002|Run-in Period|Withdrawal by Subject|0|||
146889656|NCT00379795|529763494|FG001|Overall Study|Subject non-compliance|2|||
146556699|NCT04616196|528547595|FG000|Overall Study|Withdrawal by Subject|0|||
146556700|NCT04616196|528547596|FG001|Overall Study|Withdrawal by Subject|2|||
146966912|NCT01976104|530040096|FG000|Overall Study|Adverse Event|0|||
146966913|NCT01976104|530040097|FG001|Overall Study|Adverse Event|0|||
146636338|NCT02908672|528842729|FG003|Run-in Period|Withdrawal by Subject|0|||
146636339|NCT02908672|528842726|FG000|Triple Combination Period|Death|0|||
146966914|NCT01976104|530040098|FG002|Overall Study|Adverse Event|1|||
146966915|NCT01976104|530040099|FG003|Overall Study|Adverse Event|0|||
146966916|NCT01976104|530040096|FG000|Overall Study|Lost to Follow-up|3|||
146966917|NCT01976104|530040097|FG001|Overall Study|Lost to Follow-up|0|||
146556701|NCT04616196|528547597|FG002|Overall Study|Withdrawal by Subject|0|||
146556702|NCT04616196|528547598|FG003|Overall Study|Withdrawal by Subject|0|||
146556703|NCT04616196|528547595|FG000|Overall Study|Lost to Follow-up|1|||
146556704|NCT04616196|528547596|FG001|Overall Study|Lost to Follow-up|0|||
146556705|NCT04616196|528547597|FG002|Overall Study|Lost to Follow-up|0|||
146556706|NCT04616196|528547598|FG003|Overall Study|Lost to Follow-up|0|||
146556707|NCT04616196|528547595|FG000|Overall Study|Sponsor request|2|||
146556708|NCT04616196|528547596|FG001|Overall Study|Sponsor request|1|||
146556709|NCT04616196|528547597|FG002|Overall Study|Sponsor request|1|||
146556710|NCT04616196|528547598|FG003|Overall Study|Sponsor request|2|||
146556711|NCT01394185|528547599|FG000|Overall Study|Withdrawal by Subject|2|||
146556712|NCT01394185|528547600|FG001|Overall Study|Withdrawal by Subject|0|||
146556713|NCT01394185|528547601|FG002|Overall Study|Withdrawal by Subject|0|||
146556714|NCT01394185|528547602|FG003|Overall Study|Withdrawal by Subject|0|||
146556715|NCT01394185|528547603|FG004|Overall Study|Withdrawal by Subject|1|||
146556716|NCT01394185|528547604|FG005|Overall Study|Withdrawal by Subject|0|||
146556717|NCT01394185|528547599|FG000|Overall Study|Change in protocol|3|||
146556718|NCT01394185|528547600|FG001|Overall Study|Change in protocol|0|||
146556719|NCT01394185|528547601|FG002|Overall Study|Change in protocol|0|||
146556720|NCT01394185|528547602|FG003|Overall Study|Change in protocol|0|||
146556721|NCT01394185|528547603|FG004|Overall Study|Change in protocol|3|||
146556722|NCT01394185|528547604|FG005|Overall Study|Change in protocol|0|||
146556723|NCT01394185|528547599|FG000|Overall Study|Protocol Violation|1|||
146556724|NCT01394185|528547600|FG001|Overall Study|Protocol Violation|0|||
146556725|NCT01394185|528547601|FG002|Overall Study|Protocol Violation|0|||
146556726|NCT01394185|528547602|FG003|Overall Study|Protocol Violation|1|||
146556727|NCT01394185|528547603|FG004|Overall Study|Protocol Violation|0|||
146556728|NCT01394185|528547604|FG005|Overall Study|Protocol Violation|1|||
146556729|NCT05401409|528547605|FG000|Overall Study|Lost to Follow-up|1|||
146556730|NCT05401409|528547606|FG001|Overall Study|Lost to Follow-up|0|||
146556731|NCT02371889|528547607|FG000|Overall Study|Adverse medication effect|11|||
146966918|NCT01976104|530040098|FG002|Overall Study|Lost to Follow-up|1|||
146556732|NCT02371889|528547608|FG001|Overall Study|Adverse medication effect|2|||
146556733|NCT02371889|528547607|FG000|Overall Study|Lost to Follow-up|6|||
146556734|NCT02371889|528547608|FG001|Overall Study|Lost to Follow-up|5|||
146556735|NCT02371889|528547607|FG000|Overall Study|Personal time constraints|2|||
146556736|NCT02371889|528547608|FG001|Overall Study|Personal time constraints|4|||
146556737|NCT02371889|528547607|FG000|Overall Study|Lack of Efficacy|0|||
146556738|NCT02371889|528547608|FG001|Overall Study|Lack of Efficacy|2|||
146556739|NCT02371889|528547607|FG000|Overall Study|Relapse|0|||
146556740|NCT02371889|528547608|FG001|Overall Study|Relapse|1|||
146556741|NCT06844812|528547609|FG000|Overall Study|Lost to Follow-up|5|||
146556742|NCT06844812|528547609|FG000|Overall Study|stigmatization concerns|2|||
146556743|NCT06844812|528547609|FG000|Overall Study|medication refusal|2|||
146556744|NCT06844812|528547609|FG000|Overall Study|concerns about possible side effects|2|||
146556745|NCT06844812|528547609|FG000|Overall Study|wanting to seek another specialist opinion|2|||
146556746|NCT06844812|528547609|FG000|Overall Study|side effects (dizziness)|1|||
146556747|NCT05520333|528547610|FG000|Overall Study|Lost to Follow-up|3|||
146556748|NCT05520333|528547611|FG001|Overall Study|Lost to Follow-up|6|||
146556749|NCT02410200|528547612|FG000|Overall Study|Adverse Event|2|||
146556750|NCT02244957|528547635|FG000|Overall Study|Lack of Efficacy|1|||
146556751|NCT02244957|528547636|FG001|Overall Study|Lack of Efficacy|0|||
146556752|NCT03111108|528547640|FG000|Overall Study|Death|0|||
146556753|NCT03111108|528547641|FG001|Overall Study|Death|1|||
146556754|NCT03111108|528547640|FG000|Overall Study|Withdrawal by Subject|1|||
146556755|NCT03111108|528547641|FG001|Overall Study|Withdrawal by Subject|0|||
146556756|NCT01853280|528547642|FG000|Overall Study|Lack of Efficacy|2|||
146556757|NCT01853280|528547643|FG001|Overall Study|Lack of Efficacy|2|||
146556758|NCT01853280|528547642|FG000|Overall Study|Lost to Follow-up|0|||
146556759|NCT01853280|528547643|FG001|Overall Study|Lost to Follow-up|1|||
146889657|NCT00379795|529763495|FG002|Overall Study|Subject non-compliance|0|||
146889658|NCT00379795|529763496|FG003|Overall Study|Subject non-compliance|0|||
146556760|NCT01853280|528547642|FG000|Overall Study|Physician Decision|0|||
146556761|NCT01853280|528547643|FG001|Overall Study|Physician Decision|1|||
146556762|NCT01853280|528547642|FG000|Overall Study|Withdrawal by Subject|0|||
146556763|NCT01853280|528547643|FG001|Overall Study|Withdrawal by Subject|1|||
146889659|NCT00379795|529763497|FG004|Overall Study|Subject non-compliance|1|||
146889660|NCT00379795|529763493|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
146889661|NCT00379795|529763494|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
146889662|NCT00379795|529763495|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
146889663|NCT00379795|529763496|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
146889664|NCT00379795|529763497|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
146889665|NCT00379795|529763493|FG000|Overall Study|Subjects condition mandated intervention|34|||
146765904|NCT01773122|529310451|FG001|Overall Study|Due to amended age eligibility criteria|1|||
146765905|NCT01773122|529310452|FG002|Overall Study|Due to amended age eligibility criteria|0|||
146765906|NCT01773122|529310453|FG003|Overall Study|Due to amended age eligibility criteria|1|||
146765907|NCT01769391|529310454|FG000|Overall Study|Death|10|||
146889666|NCT00379795|529763494|FG001|Overall Study|Subjects condition mandated intervention|9|||
146765908|NCT01769391|529310455|FG001|Overall Study|Death|1|||
146765909|NCT01769391|529310454|FG000|Overall Study|Adverse Event|0|||
146765910|NCT01769391|529310455|FG001|Overall Study|Adverse Event|3|||
146765911|NCT01769391|529310454|FG000|Overall Study|Progressive Disease|1|||
146765912|NCT01769391|529310455|FG001|Overall Study|Progressive Disease|2|||
146765913|NCT01769391|529310454|FG000|Overall Study|Withdrawal by Subject|4|||
146765914|NCT01769391|529310455|FG001|Overall Study|Withdrawal by Subject|3|||
146765915|NCT01769391|529310454|FG000|Overall Study|Investigator Decision|2|||
146889667|NCT00379795|529763495|FG002|Overall Study|Subjects condition mandated intervention|7|||
146889668|NCT00379795|529763496|FG003|Overall Study|Subjects condition mandated intervention|5|||
146889669|NCT00379795|529763497|FG004|Overall Study|Subjects condition mandated intervention|7|||
146765916|NCT01769391|529310455|FG001|Overall Study|Investigator Decision|0|||
146556764|NCT01853280|528547642|FG000|Overall Study|Ineligible|0|||
146889670|NCT00379795|529763493|FG000|Overall Study|Sponsor's decision|257|||
146765917|NCT03386929|529310456|FG000|Overall Study|Death|0|||
146889671|NCT00379795|529763494|FG001|Overall Study|Sponsor's decision|17|||
146889672|NCT00379795|529763495|FG002|Overall Study|Sponsor's decision|54|||
146889673|NCT00379795|529763496|FG003|Overall Study|Sponsor's decision|47|||
146889674|NCT00379795|529763497|FG004|Overall Study|Sponsor's decision|10|||
146889675|NCT01127165|529763498|FG000|Overall Study|Adverse Event|2|||
146556765|NCT01853280|528547643|FG001|Overall Study|Ineligible|1|||
146889676|NCT01127165|529763499|FG001|Overall Study|Adverse Event|2|||
146889677|NCT01127165|529763498|FG000|Overall Study|Lack of Efficacy|10|||
146765918|NCT03386929|529310457|FG001|Overall Study|Death|0|||
146556766|NCT00104884|528547644|FG000|Overall Study|Disease progression|4|||
146556767|NCT03032484|528547645|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
146889678|NCT01127165|529763499|FG001|Overall Study|Lack of Efficacy|8|||
146889679|NCT01127165|529763498|FG000|Overall Study|Lost to Follow-up|3|||
146889680|NCT01127165|529763499|FG001|Overall Study|Lost to Follow-up|5|||
146889681|NCT01127165|529763498|FG000|Overall Study|Withdrawal by Subject|1|||
146889682|NCT01127165|529763499|FG001|Overall Study|Withdrawal by Subject|3|||
146889683|NCT01127165|529763498|FG000|Overall Study|Protocol Violation|0|||
146889684|NCT01127165|529763499|FG001|Overall Study|Protocol Violation|1|||
146889685|NCT00763321|529763500|FG000|Open-label Period|Adverse Event|24|||
146889686|NCT00763321|529763501|FG001|Open-label Period|Adverse Event|0|||
146889687|NCT00763321|529763502|FG002|Open-label Period|Adverse Event|0|||
146889688|NCT00763321|529763500|FG000|Open-label Period|Lost to Follow-up|14|||
146889689|NCT00763321|529763501|FG001|Open-label Period|Lost to Follow-up|0|||
146889690|NCT00763321|529763502|FG002|Open-label Period|Lost to Follow-up|0|||
146889691|NCT00763321|529763500|FG000|Open-label Period|Withdrawal by Subject|7|||
146889692|NCT00763321|529763501|FG001|Open-label Period|Withdrawal by Subject|0|||
146889693|NCT00763321|529763502|FG002|Open-label Period|Withdrawal by Subject|0|||
146889694|NCT00763321|529763500|FG000|Open-label Period|Subject noncompliant|7|||
146889695|NCT00763321|529763501|FG001|Open-label Period|Subject noncompliant|0|||
146889696|NCT00763321|529763502|FG002|Open-label Period|Subject noncompliant|0|||
146889697|NCT00763321|529763500|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
146889698|NCT00763321|529763501|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
146889699|NCT00763321|529763502|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
146889700|NCT00763321|529763500|FG000|Open-label Period|Lack of Efficacy|2|||
146889701|NCT00763321|529763501|FG001|Open-label Period|Lack of Efficacy|0|||
146889702|NCT00763321|529763502|FG002|Open-label Period|Lack of Efficacy|0|||
146889703|NCT00763321|529763500|FG000|Open-label Period|Other|4|||
146889704|NCT00763321|529763501|FG001|Open-label Period|Other|0|||
146889705|NCT00763321|529763502|FG002|Open-label Period|Other|0|||
146889706|NCT00763321|529763500|FG000|Double-blind Period|Lack of Efficacy|0|||
146889707|NCT00763321|529763501|FG001|Double-blind Period|Lack of Efficacy|9|||
146889708|NCT00763321|529763502|FG002|Double-blind Period|Lack of Efficacy|17|||
146889709|NCT00763321|529763500|FG000|Double-blind Period|Adverse Event|0|||
146889710|NCT00763321|529763501|FG001|Double-blind Period|Adverse Event|4|||
146889711|NCT00763321|529763502|FG002|Double-blind Period|Adverse Event|4|||
146889712|NCT00763321|529763500|FG000|Double-blind Period|Lost to Follow-up|0|||
146889713|NCT00763321|529763501|FG001|Double-blind Period|Lost to Follow-up|4|||
146889714|NCT00763321|529763502|FG002|Double-blind Period|Lost to Follow-up|2|||
146889715|NCT00763321|529763500|FG000|Double-blind Period|Withdrawal by Subject|0|||
146889716|NCT00763321|529763501|FG001|Double-blind Period|Withdrawal by Subject|2|||
146889717|NCT00763321|529763502|FG002|Double-blind Period|Withdrawal by Subject|3|||
146889718|NCT00763321|529763500|FG000|Double-blind Period|Other|0|||
146889719|NCT00763321|529763501|FG001|Double-blind Period|Other|2|||
146889720|NCT00763321|529763502|FG002|Double-blind Period|Other|3|||
146889721|NCT02435849|529763503|FG000|Overall Study|Death|23|||
146889722|NCT02435849|529763504|FG001|Overall Study|Death|0|||
146889723|NCT02435849|529763503|FG000|Overall Study|Lack of Efficacy|10|||
146889724|NCT02435849|529763504|FG001|Overall Study|Lack of Efficacy|0|||
146889725|NCT02435849|529763503|FG000|Overall Study|New therapy for study indication|8|||
146889726|NCT02435849|529763504|FG001|Overall Study|New therapy for study indication|0|||
146889727|NCT02435849|529763503|FG000|Overall Study|Subject/guardian decision|5|||
146889728|NCT02435849|529763504|FG001|Overall Study|Subject/guardian decision|1|||
146889729|NCT02435849|529763503|FG000|Overall Study|Lost to Follow-up|1|||
146889730|NCT02435849|529763504|FG001|Overall Study|Lost to Follow-up|0|||
146889731|NCT02435849|529763503|FG000|Overall Study|Physician Decision|1|||
146889732|NCT02435849|529763504|FG001|Overall Study|Physician Decision|0|||
146556768|NCT03032484|528547646|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
146889733|NCT03175549|529763505|FG000|Overall Study|Lost to Follow-up|2|||
146889734|NCT03175549|529763506|FG001|Overall Study|Lost to Follow-up|2|||
146889735|NCT03175549|529763505|FG000|Overall Study|Medication non-compliance|2|||
146889736|NCT03175549|529763506|FG001|Overall Study|Medication non-compliance|2|||
146889737|NCT01017952|529763507|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
146889738|NCT01017952|529763508|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
146556769|NCT03032484|528547645|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
146556770|NCT03032484|528547646|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
146889739|NCT01017952|529763509|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
146889740|NCT01017952|529763510|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
146889741|NCT01017952|529763511|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
146889742|NCT01017952|529763507|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
146889743|NCT01017952|529763508|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
146556771|NCT01689649|528547647|FG000|Overall Study|Lack of Efficacy|3|||
146556772|NCT01689649|528547647|FG000|Overall Study|Non-compliance|11|||
146556773|NCT01689649|528547647|FG000|Overall Study|Protocol Violation|3|||
146556774|NCT01689649|528547647|FG000|Overall Study|Lost to Follow-up|5|||
146556775|NCT03760081|528547661|FG000|Overall Study|Miscellaneous|0|||
146556776|NCT03760081|528547662|FG001|Overall Study|Miscellaneous|1|||
146765919|NCT03386929|529310458|FG002|Overall Study|Death|1|||
146556777|NCT03760081|528547661|FG000|Overall Study|Progressive Disease|5|||
146966919|NCT01976104|530040099|FG003|Overall Study|Lost to Follow-up|1|||
146966920|NCT01976104|530040096|FG000|Overall Study|Subject Choice|0|||
146966921|NCT01976104|530040097|FG001|Overall Study|Subject Choice|1|||
146966922|NCT01976104|530040098|FG002|Overall Study|Subject Choice|0|||
146966923|NCT01976104|530040099|FG003|Overall Study|Subject Choice|1|||
146966924|NCT01976104|530040096|FG000|Overall Study|Withdrawal by Subject|3|||
146966925|NCT01976104|530040097|FG001|Overall Study|Withdrawal by Subject|0|||
146966926|NCT01976104|530040098|FG002|Overall Study|Withdrawal by Subject|0|||
146966927|NCT01976104|530040099|FG003|Overall Study|Withdrawal by Subject|1|||
146966928|NCT01976104|530040096|FG000|Overall Study|Other|0|||
146966929|NCT01976104|530040097|FG001|Overall Study|Other|1|||
146966930|NCT01976104|530040098|FG002|Overall Study|Other|0|||
146966931|NCT01976104|530040099|FG003|Overall Study|Other|0|||
146966932|NCT02181673|530040103|FG000|Up to Week 24|Adverse Event|2|||
146966933|NCT02181673|530040104|FG001|Up to Week 24|Adverse Event|0|||
146966934|NCT02181673|530040105|FG002|Up to Week 24|Adverse Event|3|||
146966935|NCT02181673|530040103|FG000|Up to Week 24|Death|1|||
146966936|NCT02181673|530040104|FG001|Up to Week 24|Death|0|||
146966937|NCT02181673|530040105|FG002|Up to Week 24|Death|0|||
146966938|NCT02181673|530040103|FG000|Up to Week 24|Lack of Efficacy|1|||
146966939|NCT02181673|530040104|FG001|Up to Week 24|Lack of Efficacy|0|||
146966940|NCT02181673|530040105|FG002|Up to Week 24|Lack of Efficacy|0|||
146966941|NCT02181673|530040103|FG000|Up to Week 24|Lost to Follow-up|1|||
146966942|NCT02181673|530040104|FG001|Up to Week 24|Lost to Follow-up|0|||
146966943|NCT02181673|530040105|FG002|Up to Week 24|Lost to Follow-up|0|||
146966944|NCT02181673|530040103|FG000|Up to Week 24|Physician Decision|0|||
146966945|NCT02181673|530040104|FG001|Up to Week 24|Physician Decision|0|||
146966946|NCT02181673|530040105|FG002|Up to Week 24|Physician Decision|3|||
146966947|NCT02181673|530040103|FG000|Up to Week 24|Withdrawal by Subject|10|||
146966948|NCT02181673|530040104|FG001|Up to Week 24|Withdrawal by Subject|0|||
146966949|NCT02181673|530040105|FG002|Up to Week 24|Withdrawal by Subject|1|||
146966950|NCT02181673|530040103|FG000|Up to Week 24|Other|2|||
146966951|NCT02181673|530040104|FG001|Up to Week 24|Other|0|||
146966952|NCT02181673|530040105|FG002|Up to Week 24|Other|3|||
146966953|NCT02181673|530040103|FG000|Up to Week 24|Randomized not Treated|0|||
146966954|NCT02181673|530040104|FG001|Up to Week 24|Randomized not Treated|0|||
146556778|NCT03760081|528547662|FG001|Overall Study|Progressive Disease|10|||
146966955|NCT02181673|530040105|FG002|Up to Week 24|Randomized not Treated|1|||
146966956|NCT02181673|530040103|FG000|Week 24-Week 60|Adverse Event|0|||
146966957|NCT02181673|530040104|FG001|Week 24-Week 60|Adverse Event|4|||
146966958|NCT02181673|530040105|FG002|Week 24-Week 60|Adverse Event|10|||
146966959|NCT02181673|530040103|FG000|Week 24-Week 60|Other|0|||
146636340|NCT02908672|528842727|FG001|Triple Combination Period|Death|0|||
146636341|NCT02908672|528842728|FG002|Triple Combination Period|Death|150|||
146636342|NCT02908672|528842729|FG003|Triple Combination Period|Death|127|||
146636343|NCT02908672|528842726|FG000|Triple Combination Period|Lost to Follow-up|0|||
146636344|NCT02908672|528842727|FG001|Triple Combination Period|Lost to Follow-up|0|||
146636345|NCT02908672|528842728|FG002|Triple Combination Period|Lost to Follow-up|6|||
146636346|NCT02908672|528842729|FG003|Triple Combination Period|Lost to Follow-up|8|||
146636347|NCT02908672|528842726|FG000|Triple Combination Period|Reason Not Specified|0|||
146636348|NCT02908672|528842727|FG001|Triple Combination Period|Reason Not Specified|0|||
146636349|NCT02908672|528842728|FG002|Triple Combination Period|Reason Not Specified|0|||
146636350|NCT02908672|528842729|FG003|Triple Combination Period|Reason Not Specified|1|||
146636351|NCT02908672|528842726|FG000|Triple Combination Period|Physician Decision|0|||
146636352|NCT02908672|528842727|FG001|Triple Combination Period|Physician Decision|0|||
146636353|NCT02908672|528842728|FG002|Triple Combination Period|Physician Decision|1|||
146636354|NCT02908672|528842729|FG003|Triple Combination Period|Physician Decision|1|||
146636355|NCT02908672|528842726|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
146636356|NCT02908672|528842727|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
146636357|NCT02908672|528842728|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
146636358|NCT02908672|528842729|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
146636359|NCT02908672|528842726|FG000|Triple Combination Period|Withdrawal by Subject|0|||
146636360|NCT02908672|528842727|FG001|Triple Combination Period|Withdrawal by Subject|0|||
146636361|NCT02908672|528842728|FG002|Triple Combination Period|Withdrawal by Subject|13|||
146636362|NCT02908672|528842729|FG003|Triple Combination Period|Withdrawal by Subject|16|||
146636363|NCT01185080|528842730|FG000|Overall Study|Adverse Event|1|||
146636364|NCT01185080|528842731|FG001|Overall Study|Adverse Event|1|||
146636365|NCT01185080|528842732|FG002|Overall Study|Adverse Event|0|||
146636366|NCT01185080|528842730|FG000|Overall Study|Personal reasons|0|||
146636367|NCT01185080|528842731|FG001|Overall Study|Personal reasons|0|||
146636368|NCT01185080|528842732|FG002|Overall Study|Personal reasons|1|||
146636369|NCT02876601|528842733|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
146636370|NCT02876601|528842734|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
146636371|NCT02876601|528842735|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
146636372|NCT02876601|528842736|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
146636373|NCT00759941|528842737|FG000|Overall Study|Use of medication|1|||
146636374|NCT00759941|528842738|FG001|Overall Study|Use of medication|0|||
146636375|NCT00759941|528842737|FG000|Overall Study|Adverse Event|1|||
146636376|NCT00759941|528842738|FG001|Overall Study|Adverse Event|0|||
146636377|NCT00759941|528842737|FG000|Overall Study|Exited in error by site|1|||
146636378|NCT00759941|528842738|FG001|Overall Study|Exited in error by site|1|||
146636379|NCT05615922|528842742|FG000|Overall Study|Lost to Follow-up|1|||
146636380|NCT06083506|528842743|FG000|Overall Study|Physician Decision|2|||
146636381|NCT06083506|528842743|FG000|Overall Study|Lack of Efficacy|1|||
146636382|NCT05307692|528842745|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
146636383|NCT05307692|528842746|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
146636384|NCT05307692|528842747|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
146636385|NCT05307692|528842748|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
146636386|NCT05307692|528842745|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
146636387|NCT05307692|528842746|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
146636388|NCT05307692|528842747|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
146636389|NCT05307692|528842748|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
146636390|NCT05307692|528842745|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
146636391|NCT05307692|528842746|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
146636392|NCT05307692|528842747|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
146636393|NCT05307692|528842748|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
146636394|NCT05307692|528842745|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
146636395|NCT05307692|528842746|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
146636396|NCT05307692|528842747|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
146636397|NCT05307692|528842748|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
146636398|NCT05307692|528842745|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
146636399|NCT05307692|528842746|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
146636400|NCT05307692|528842747|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
146636401|NCT05307692|528842748|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
146765920|NCT03386929|529310456|FG000|Overall Study|Withdrawal by Subject|0|||
146765921|NCT03386929|529310457|FG001|Overall Study|Withdrawal by Subject|1|||
146966960|NCT02181673|530040104|FG001|Week 24-Week 60|Other|2|||
146966961|NCT02181673|530040105|FG002|Week 24-Week 60|Other|1|||
146966962|NCT02181673|530040103|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
146636402|NCT05307692|528842745|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
146636403|NCT05307692|528842746|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
146636404|NCT05307692|528842747|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
146636405|NCT05307692|528842748|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
146636406|NCT05307692|528842745|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
146636407|NCT05307692|528842746|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
146636408|NCT05307692|528842747|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
146636409|NCT05307692|528842748|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
146636410|NCT05307692|528842745|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
146636411|NCT05307692|528842746|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
146636412|NCT05307692|528842747|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
146636413|NCT05307692|528842748|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
146636414|NCT04500158|528842749|FG000|Overall Study|Physician Decision|17|||
146636415|NCT04500158|528842750|FG001|Overall Study|Physician Decision|11|||
146636416|NCT01967238|528842751|FG000|Overall Study|Adverse Event|1|||
146636417|NCT01967238|528842752|FG001|Overall Study|Adverse Event|1|||
146636418|NCT01967238|528842753|FG002|Overall Study|Adverse Event|0|||
146636419|NCT01967238|528842751|FG000|Overall Study|Lost to Follow-up|1|||
146636420|NCT01967238|528842752|FG001|Overall Study|Lost to Follow-up|0|||
146636421|NCT01967238|528842753|FG002|Overall Study|Lost to Follow-up|1|||
146636422|NCT01967238|528842751|FG000|Overall Study|Withdrawal by Subject|0|||
146636423|NCT01967238|528842752|FG001|Overall Study|Withdrawal by Subject|0|||
146636424|NCT01967238|528842753|FG002|Overall Study|Withdrawal by Subject|1|||
146636425|NCT03493464|528842760|FG000|Overall Study|Surgery not performed|1|||
146636426|NCT01442103|528843795|FG000|Overall Study|Lost to Follow-up|2|||
146636427|NCT02605122|528843800|FG000|Overall Study|Withdrawal by Subject|4|||
146966963|NCT02181673|530040104|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
146966964|NCT02181673|530040105|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
146636428|NCT02605122|528843801|FG001|Overall Study|Withdrawal by Subject|1|||
146636429|NCT02605122|528843800|FG000|Overall Study|Lost to Follow-up|1|||
146636430|NCT02605122|528843801|FG001|Overall Study|Lost to Follow-up|1|||
146636431|NCT03894813|528843808|FG000|Overall Study|Adverse Event|1|||
146636432|NCT03894813|528843809|FG001|Overall Study|Adverse Event|1|||
146636433|NCT03894813|528843808|FG000|Overall Study|Lack of Efficacy|3|||
146636434|NCT03894813|528843809|FG001|Overall Study|Lack of Efficacy|3|||
146636435|NCT03894813|528843808|FG000|Overall Study|Lost to Follow-up|1|||
146636436|NCT03894813|528843809|FG001|Overall Study|Lost to Follow-up|0|||
146966965|NCT02181673|530040103|FG000|Week 24-Week 60|Pregnancy|0|||
146966966|NCT02181673|530040104|FG001|Week 24-Week 60|Pregnancy|0|||
146636437|NCT03894813|528843808|FG000|Overall Study|Pregnancy|2|||
146966967|NCT02181673|530040105|FG002|Week 24-Week 60|Pregnancy|1|||
146966968|NCT02181673|530040103|FG000|Week 24-Week 60|Lack of Efficacy|0|||
146966969|NCT02181673|530040104|FG001|Week 24-Week 60|Lack of Efficacy|0|||
146966970|NCT02181673|530040105|FG002|Week 24-Week 60|Lack of Efficacy|1|||
146966971|NCT02181673|530040103|FG000|Week 24-Week 60|Lost to Follow-up|0|||
146966972|NCT02181673|530040104|FG001|Week 24-Week 60|Lost to Follow-up|0|||
146966973|NCT02181673|530040105|FG002|Week 24-Week 60|Lost to Follow-up|1|||
146966974|NCT02181673|530040103|FG000|Week 24-Week 60|Physician Decision|0|||
146966975|NCT02181673|530040104|FG001|Week 24-Week 60|Physician Decision|0|||
146966976|NCT02181673|530040105|FG002|Week 24-Week 60|Physician Decision|1|||
146966977|NCT00337727|530040106|FG000|Overall Study|Adverse Event|5|||
146966978|NCT00337727|530040107|FG001|Overall Study|Adverse Event|3|||
146966979|NCT00337727|530040106|FG000|Overall Study|Lost to Follow-up|5|||
146966980|NCT00337727|530040107|FG001|Overall Study|Lost to Follow-up|4|||
146966981|NCT00337727|530040106|FG000|Overall Study|Physician Decision|1|||
146966982|NCT00337727|530040107|FG001|Overall Study|Physician Decision|0|||
146966983|NCT00337727|530040106|FG000|Overall Study|Protocol Violation|4|||
146966984|NCT00337727|530040107|FG001|Overall Study|Protocol Violation|0|||
146966985|NCT00337727|530040106|FG000|Overall Study|Withdrawal by Subject|3|||
146966986|NCT00337727|530040107|FG001|Overall Study|Withdrawal by Subject|5|||
146966987|NCT00326625|530040108|FG000|Overall Study|Adverse Event|20|||
146966988|NCT00326625|530040109|FG001|Overall Study|Adverse Event|9|||
146966989|NCT00326625|530040108|FG000|Overall Study|Withdrawal by Subject|15|||
146966990|NCT00326625|530040109|FG001|Overall Study|Withdrawal by Subject|12|||
146966991|NCT00326625|530040108|FG000|Overall Study|Death|18|||
146966992|NCT00326625|530040109|FG001|Overall Study|Death|16|||
146966993|NCT00326625|530040108|FG000|Overall Study|Lost to Follow-up|1|||
146636438|NCT03894813|528843809|FG001|Overall Study|Pregnancy|1|||
146636439|NCT03894813|528843808|FG000|Overall Study|Protocol Violation|3|||
146636440|NCT03894813|528843809|FG001|Overall Study|Protocol Violation|7|||
146966994|NCT00326625|530040109|FG001|Overall Study|Lost to Follow-up|0|||
146966995|NCT00326625|530040108|FG000|Overall Study|prescheduled medical intervention|0|||
146966996|NCT00326625|530040109|FG001|Overall Study|prescheduled medical intervention|1|||
146889744|NCT01017952|529763509|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
146889745|NCT01017952|529763510|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
146889746|NCT01017952|529763511|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
146889747|NCT01017952|529763507|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
146889748|NCT01017952|529763508|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
146889749|NCT01017952|529763509|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
146889750|NCT01017952|529763510|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
146889751|NCT01017952|529763511|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
146889752|NCT01017952|529763507|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
146889753|NCT01017952|529763508|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
146889754|NCT01017952|529763509|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
146889755|NCT01017952|529763510|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
146889756|NCT01017952|529763511|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
146889757|NCT01017952|529763507|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
146889758|NCT01017952|529763508|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
146889759|NCT01017952|529763509|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
146889760|NCT01017952|529763510|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
146636441|NCT03894813|528843808|FG000|Overall Study|Withdrawal by Subject|1|||
146636442|NCT03894813|528843809|FG001|Overall Study|Withdrawal by Subject|3|||
146636443|NCT03894813|528843808|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
146636444|NCT03894813|528843809|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
146636445|NCT00831181|528843815|FG000|Overall Study|Adverse Event|12|||
146636446|NCT02863419|528843816|FG000|Overall Study|Lost to Follow-up|0|||
146636447|NCT02863419|528843817|FG001|Overall Study|Lost to Follow-up|1|||
146636448|NCT02863419|528843818|FG002|Overall Study|Lost to Follow-up|4|||
146765922|NCT03386929|529310458|FG002|Overall Study|Withdrawal by Subject|0|||
146636449|NCT02863419|528843816|FG000|Overall Study|Withdrawal by Subject|5|||
146636450|NCT02863419|528843817|FG001|Overall Study|Withdrawal by Subject|5|||
146636451|NCT02863419|528843818|FG002|Overall Study|Withdrawal by Subject|3|||
146636452|NCT02863419|528843816|FG000|Overall Study|Died|3|||
146636453|NCT02863419|528843817|FG001|Overall Study|Died|4|||
146636454|NCT02863419|528843818|FG002|Overall Study|Died|1|||
146636455|NCT02362282|528843819|FG000|Overall Study|Withdrawal by Subject|1|||
146636456|NCT02362282|528843820|FG001|Overall Study|Withdrawal by Subject|0|||
146636457|NCT02284243|528843827|FG000|Overall Study|Lack of Efficacy|3|||
146636458|NCT02284243|528843828|FG001|Overall Study|Lack of Efficacy|3|||
146636459|NCT02284243|528843827|FG000|Overall Study|Adverse Event|1|||
146889761|NCT01017952|529763511|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
146889762|NCT01017952|529763507|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
146889763|NCT01017952|529763508|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
146889764|NCT01017952|529763509|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
146636460|NCT02284243|528843828|FG001|Overall Study|Adverse Event|0|||
146636461|NCT01932437|528843829|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
146636462|NCT01932437|528843830|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
146636463|NCT01932437|528843831|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
146636464|NCT01932437|528843832|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
146636465|NCT01932437|528843833|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
146636466|NCT01932437|528843834|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
146636467|NCT00074490|528843835|FG000|Overall Study|Progressive malignancy|0|||
146636468|NCT00074490|528843836|FG001|Overall Study|Progressive malignancy|7|||
146636469|NCT00074490|528843837|FG002|Overall Study|Progressive malignancy|0|||
146636470|NCT00074490|528843838|FG003|Overall Study|Progressive malignancy|0|||
146636471|NCT00074490|528843839|FG004|Overall Study|Progressive malignancy|3|||
146636472|NCT00074490|528843840|FG005|Overall Study|Progressive malignancy|0|||
146636473|NCT04411667|528843843|FG000|Overall Study|Physician Decision|1|||
146636474|NCT04411667|528843844|FG001|Overall Study|Physician Decision|0|||
146636475|NCT04287517|528843850|FG000|Overall Study|Withdrawal by Subject|1|||
146889765|NCT01017952|529763510|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
146889766|NCT01017952|529763511|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
146966997|NCT06067191|530040110|FG000|Overall Study|Withdrawal by Subject|0|||
146636476|NCT04287517|528843851|FG001|Overall Study|Withdrawal by Subject|1|||
146889767|NCT01017952|529763507|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
146889768|NCT01017952|529763508|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
146636477|NCT03857867|528843852|FG000|Overall Study|Physician Decision|1|||
146636478|NCT01869764|528843853|FG000|Overall Study|Withdrawal by Subject|0|||
146889769|NCT01017952|529763509|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
146889770|NCT01017952|529763510|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
146889771|NCT01017952|529763511|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
146889772|NCT01017952|529763507|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
146636479|NCT01869764|528843854|FG001|Overall Study|Withdrawal by Subject|2|||
146636480|NCT01626872|528843855|FG000|Overall Study|Physician Decision|13|||
146889773|NCT01017952|529763508|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
146889774|NCT01017952|529763509|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
146889775|NCT01017952|529763510|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
146889776|NCT01017952|529763511|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
146889777|NCT01017952|529763507|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
146889778|NCT01017952|529763508|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
146889779|NCT01017952|529763509|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
146889780|NCT01017952|529763510|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
146889781|NCT01017952|529763511|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
146889782|NCT01017952|529763507|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
146889783|NCT01017952|529763508|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
146889784|NCT01017952|529763509|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
146889785|NCT01017952|529763510|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
146889786|NCT01017952|529763511|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
146889787|NCT01017952|529763507|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
146889788|NCT01017952|529763508|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
146889789|NCT01017952|529763509|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
146636481|NCT01626872|528843856|FG001|Overall Study|Physician Decision|9|||
146636482|NCT01626872|528843857|FG002|Overall Study|Physician Decision|6|||
146636483|NCT01626872|528843855|FG000|Overall Study|Withdrawal by Subject|19|||
146636484|NCT01626872|528843856|FG001|Overall Study|Withdrawal by Subject|27|||
146636485|NCT01626872|528843857|FG002|Overall Study|Withdrawal by Subject|8|||
146765923|NCT03386929|529310456|FG000|Overall Study|Physician Decision|0|||
146966998|NCT06067191|530040111|FG001|Overall Study|Withdrawal by Subject|1|||
146966999|NCT04764669|530040113|FG000|Overall Study|Adverse Event|1|||
146765924|NCT03386929|529310457|FG001|Overall Study|Physician Decision|0|||
146636486|NCT01626872|528843855|FG000|Overall Study|Adverse Event (including Death)|20|||
146636487|NCT01626872|528843856|FG001|Overall Study|Adverse Event (including Death)|28|||
146636488|NCT01626872|528843857|FG002|Overall Study|Adverse Event (including Death)|8|||
146636489|NCT01626872|528843855|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
146636490|NCT01626872|528843856|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
146636491|NCT01626872|528843857|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
146636492|NCT01578486|528843858|FG000|Overall Study|Physician Decision|3|||
146636493|NCT01578486|528843858|FG000|Overall Study|Withdrawal by Subject|2|||
146636494|NCT02425943|528843859|FG000|Overall Study|Adverse Event|3|||
146636495|NCT02425943|528843860|FG001|Overall Study|Adverse Event|1|||
146636496|NCT02425943|528843859|FG000|Overall Study|Lost to Follow-up|59|||
146636497|NCT02425943|528843860|FG001|Overall Study|Lost to Follow-up|37|||
146636498|NCT02425943|528843859|FG000|Overall Study|Protocol Violation|4|||
146636499|NCT02425943|528843860|FG001|Overall Study|Protocol Violation|1|||
146636500|NCT02425943|528843859|FG000|Overall Study|Withdrawal by Subject|64|||
146636501|NCT02425943|528843860|FG001|Overall Study|Withdrawal by Subject|31|||
146636502|NCT02425943|528843859|FG000|Overall Study|Other|6|||
146636503|NCT02425943|528843860|FG001|Overall Study|Other|0|||
146636504|NCT01106248|528843863|FG000|Overall Study|Adverse Event|1|||
146636505|NCT01106248|528843863|FG000|Overall Study|Administrative|2|||
146636506|NCT00357903|528843864|FG000|Overall Study|Adverse Event|87|||
146636507|NCT00357903|528843865|FG001|Overall Study|Adverse Event|4|||
146636508|NCT00357903|528843864|FG000|Overall Study|Death|33|||
146636509|NCT00357903|528843865|FG001|Overall Study|Death|0|||
146636510|NCT00357903|528843864|FG000|Overall Study|Lost to Follow-up|23|||
146636511|NCT00357903|528843865|FG001|Overall Study|Lost to Follow-up|4|||
146636512|NCT00357903|528843864|FG000|Overall Study|Physician Decision|39|||
146765925|NCT03386929|529310458|FG002|Overall Study|Physician Decision|1|||
146765926|NCT03386929|529310456|FG000|Overall Study|Progression|4|||
146765927|NCT03386929|529310457|FG001|Overall Study|Progression|4|||
146765928|NCT03386929|529310458|FG002|Overall Study|Progression|0|||
146765929|NCT03386929|529310456|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
146765930|NCT03386929|529310457|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
146765931|NCT03386929|529310458|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
146765932|NCT03386929|529310456|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
146765933|NCT03386929|529310457|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
146765934|NCT03386929|529310458|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
146765935|NCT01144182|529310462|FG000|Overall Study|Death|5|||
146765936|NCT01144182|529310463|FG001|Overall Study|Death|6|||
146765937|NCT01144182|529310462|FG000|Overall Study|Withdrawal by Subject|3|||
146765938|NCT01144182|529310463|FG001|Overall Study|Withdrawal by Subject|6|||
146765939|NCT01144182|529310462|FG000|Overall Study|Lost to Follow-up|9|||
146765940|NCT01144182|529310463|FG001|Overall Study|Lost to Follow-up|9|||
146765941|NCT02317016|529310470|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
146765942|NCT02317016|529310470|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
146765943|NCT02317016|529310470|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
146765944|NCT02317016|529310470|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
146765945|NCT02317016|529310470|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
146765946|NCT02317016|529310470|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
146765947|NCT02317016|529310470|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
146889790|NCT01017952|529763510|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
146889791|NCT01017952|529763511|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
146889792|NCT01017952|529763507|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
146889793|NCT01017952|529763508|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
146889794|NCT01017952|529763509|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
146765948|NCT03121950|529310473|FG000|Overall Study|Withdrawal by Subject|11|||
146765949|NCT03121950|529310474|FG001|Overall Study|Withdrawal by Subject|2|||
146765950|NCT03183518|529310478|FG000|Overall Study|Other (Not specified)|2|||
146765951|NCT03183518|529310478|FG000|Overall Study|Other (Withdrawal of consent)|1|||
146765952|NCT04248829|529310479|FG000|Overall Study|Disease progression|44|||
146765953|NCT04248829|529310480|FG001|Overall Study|Disease progression|109|||
146765954|NCT04248829|529310479|FG000|Overall Study|Adverse Event|19|||
146765955|NCT04248829|529310480|FG001|Overall Study|Adverse Event|18|||
146765956|NCT04248829|529310479|FG000|Overall Study|Withdrawal by Subject|11|||
146765957|NCT04248829|529310480|FG001|Overall Study|Withdrawal by Subject|2|||
146765958|NCT04248829|529310479|FG000|Overall Study|Lost to Follow-up|0|||
146765959|NCT04248829|529310480|FG001|Overall Study|Lost to Follow-up|1|||
146765960|NCT04248829|529310479|FG000|Overall Study|Death|12|||
146556779|NCT03760081|528547661|FG000|Overall Study|Death|1|||
146765961|NCT04248829|529310480|FG001|Overall Study|Death|14|||
146765962|NCT04248829|529310479|FG000|Overall Study|Physician Decision|2|||
146556780|NCT03760081|528547662|FG001|Overall Study|Death|1|||
146556781|NCT04064567|528547663|FG000|Overall Study|Lost to Follow-up|23|||
146556782|NCT04064567|528547664|FG001|Overall Study|Lost to Follow-up|22|||
146556783|NCT04064567|528547663|FG000|Overall Study|Withdrawal by Subject|0|||
146556784|NCT04064567|528547664|FG001|Overall Study|Withdrawal by Subject|1|||
146889795|NCT01017952|529763510|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
146889796|NCT01017952|529763511|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
146889797|NCT01017952|529763507|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146889798|NCT01017952|529763508|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
146889799|NCT01017952|529763509|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
146889800|NCT01017952|529763510|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
146889801|NCT01017952|529763511|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
146889802|NCT01017952|529763507|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
146889803|NCT01017952|529763508|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
146889804|NCT01017952|529763509|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
146889805|NCT01017952|529763510|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
146889806|NCT01017952|529763511|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
146889807|NCT01064167|529763512|FG000|Overall Study|Protocol Violation|14|||
146889808|NCT01064167|529763513|FG001|Overall Study|Protocol Violation|15|||
146889809|NCT00725075|529763514|FG000|Overall Study|Use of Excluded Medication|0|||
146889810|NCT00725075|529763515|FG001|Overall Study|Use of Excluded Medication|1|||
146556785|NCT04064567|528547663|FG000|Overall Study|Reincarcerated|7|||
146556786|NCT04064567|528547664|FG001|Overall Study|Reincarcerated|10|||
146967000|NCT04764669|530040114|FG001|Overall Study|Adverse Event|0|||
146967001|NCT04764669|530040115|FG002|Overall Study|Adverse Event|1|||
146967002|NCT04764669|530040116|FG003|Overall Study|Adverse Event|0|||
146967003|NCT04764669|530040113|FG000|Overall Study|Subject Choice|0|||
146967004|NCT04764669|530040114|FG001|Overall Study|Subject Choice|0|||
146967005|NCT04764669|530040115|FG002|Overall Study|Subject Choice|1|||
146967006|NCT04764669|530040116|FG003|Overall Study|Subject Choice|0|||
146967007|NCT04764669|530040113|FG000|Overall Study|Withdrawal by Subject|2|||
146967008|NCT04764669|530040114|FG001|Overall Study|Withdrawal by Subject|0|||
146967009|NCT04764669|530040115|FG002|Overall Study|Withdrawal by Subject|0|||
146967010|NCT04764669|530040116|FG003|Overall Study|Withdrawal by Subject|0|||
146967011|NCT00625846|530040117|FG000|Overall Study|Withdrawal by Subject|2|||
146967012|NCT00625846|530040118|FG001|Overall Study|Withdrawal by Subject|0|||
146967013|NCT00625846|530040119|FG002|Overall Study|Withdrawal by Subject|1|||
146967014|NCT00625846|530040120|FG003|Overall Study|Withdrawal by Subject|2|||
146967015|NCT04411641|530040123|FG000|DB Period|Other|7|||
146967016|NCT04411641|530040124|FG001|DB Period|Other|27|||
146967017|NCT04411641|530040125|FG002|DB Period|Other|0|||
146967018|NCT04411641|530040126|FG003|DB Period|Other|0|||
146967019|NCT04411641|530040123|FG000|DB Period|Withdrawal by Subject|67|||
146967020|NCT04411641|530040124|FG001|DB Period|Withdrawal by Subject|122|||
146967021|NCT04411641|530040125|FG002|DB Period|Withdrawal by Subject|0|||
146967022|NCT04411641|530040126|FG003|DB Period|Withdrawal by Subject|0|||
146967023|NCT04411641|530040123|FG000|DB Period|Progressive disease|76|||
146967024|NCT04411641|530040124|FG001|DB Period|Progressive disease|116|||
146967025|NCT04411641|530040125|FG002|DB Period|Progressive disease|0|||
146967026|NCT04411641|530040126|FG003|DB Period|Progressive disease|0|||
146967027|NCT04411641|530040123|FG000|DB Period|Poor compliance to protocol|1|||
146967028|NCT04411641|530040124|FG001|DB Period|Poor compliance to protocol|5|||
146967029|NCT04411641|530040125|FG002|DB Period|Poor compliance to protocol|0|||
146556787|NCT04064567|528547663|FG000|Overall Study|Moved out of U.S.|0|||
146967030|NCT04411641|530040126|FG003|DB Period|Poor compliance to protocol|0|||
146967031|NCT04411641|530040123|FG000|DB Period|Lack of Efficacy|19|||
146967032|NCT04411641|530040124|FG001|DB Period|Lack of Efficacy|19|||
146967033|NCT04411641|530040125|FG002|DB Period|Lack of Efficacy|0|||
146967034|NCT04411641|530040126|FG003|DB Period|Lack of Efficacy|0|||
146967035|NCT04411641|530040123|FG000|DB Period|Adverse Event|13|||
146967036|NCT04411641|530040124|FG001|DB Period|Adverse Event|29|||
146967037|NCT04411641|530040125|FG002|DB Period|Adverse Event|0|||
146967038|NCT04411641|530040126|FG003|DB Period|Adverse Event|0|||
146967039|NCT04411641|530040123|FG000|DB Period|Randomized and not treated|2|||
146967040|NCT04411641|530040124|FG001|DB Period|Randomized and not treated|2|||
146967041|NCT04411641|530040125|FG002|DB Period|Randomized and not treated|0|||
146967042|NCT04411641|530040126|FG003|DB Period|Randomized and not treated|0|||
146967043|NCT04411641|530040123|FG000|OL|Withdrawal by Subject|0|||
146967044|NCT04411641|530040124|FG001|OL|Withdrawal by Subject|0|||
146967045|NCT04411641|530040125|FG002|OL|Withdrawal by Subject|6|||
146967046|NCT04411641|530040126|FG003|OL|Withdrawal by Subject|17|||
146967047|NCT04411641|530040123|FG000|OL|Progressive disease|0|||
146967048|NCT04411641|530040124|FG001|OL|Progressive disease|0|||
146967049|NCT04411641|530040125|FG002|OL|Progressive disease|1|||
146967050|NCT04411641|530040126|FG003|OL|Progressive disease|2|||
146967051|NCT04411641|530040123|FG000|OL|Poor compliance to protocol|0|||
146967052|NCT04411641|530040124|FG001|OL|Poor compliance to protocol|0|||
146967053|NCT04411641|530040125|FG002|OL|Poor compliance to protocol|1|||
146967054|NCT04411641|530040126|FG003|OL|Poor compliance to protocol|0|||
146967055|NCT04411641|530040123|FG000|OL|Adverse Event|0|||
146556788|NCT04064567|528547664|FG001|Overall Study|Moved out of U.S.|1|||
146967056|NCT04411641|530040124|FG001|OL|Adverse Event|0|||
146967057|NCT04411641|530040125|FG002|OL|Adverse Event|1|||
146967058|NCT04411641|530040126|FG003|OL|Adverse Event|0|||
146556789|NCT05524948|528547667|FG000|Overall Study|Withdrawal by Subject|1|||
146556790|NCT05524948|528547668|FG001|Overall Study|Withdrawal by Subject|0|||
146556791|NCT05524948|528547667|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
146556792|NCT05524948|528547668|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
146556793|NCT02758626|528547671|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
146556794|NCT02758626|528547672|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
146556795|NCT02758626|528547671|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
146556796|NCT02758626|528547672|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
146556797|NCT02758626|528547671|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
146556798|NCT02758626|528547672|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
146556799|NCT02758626|528547671|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
146556800|NCT02758626|528547672|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
146636513|NCT00357903|528843865|FG001|Overall Study|Physician Decision|5|||
146636514|NCT00357903|528843864|FG000|Overall Study|Withdrawal by Subject|57|||
146636515|NCT00357903|528843865|FG001|Overall Study|Withdrawal by Subject|7|||
146636516|NCT00357903|528843864|FG000|Overall Study|Completed month 12 only|0|||
146636517|NCT00357903|528843865|FG001|Overall Study|Completed month 12 only|1|||
146636518|NCT00357903|528843864|FG000|Overall Study|Protocol issues|14|||
146636519|NCT00357903|528843865|FG001|Overall Study|Protocol issues|3|||
146636520|NCT00357903|528843864|FG000|Overall Study|Response status|61|||
146636521|NCT00357903|528843865|FG001|Overall Study|Response status|9|||
146636522|NCT00357903|528843864|FG000|Overall Study|Other|49|||
146765963|NCT04248829|529310480|FG001|Overall Study|Physician Decision|4|||
146765964|NCT04248829|529310479|FG000|Overall Study|Any reason not specifically recorded|0|||
146765965|NCT04248829|529310480|FG001|Overall Study|Any reason not specifically recorded|2|||
146765966|NCT02132702|529310481|FG000|Overall Study|Protocol Violation|2|||
146765967|NCT02132702|529310481|FG000|Overall Study|Adverse Event|3|||
146765968|NCT02132702|529310481|FG000|Overall Study|Withdrawal by Subject|3|||
146765969|NCT01867580|529310483|FG000|Overall Study|Withdrawal by Subject|2|||
146765970|NCT01867580|529310484|FG001|Overall Study|Withdrawal by Subject|3|||
146765971|NCT01867580|529310483|FG000|Overall Study|Physician Decision|17|||
146765972|NCT01867580|529310484|FG001|Overall Study|Physician Decision|12|||
146765973|NCT01867580|529310483|FG000|Overall Study|Lost to Follow-up|3|||
146765974|NCT01867580|529310484|FG001|Overall Study|Lost to Follow-up|5|||
146765975|NCT01867580|529310483|FG000|Overall Study|Sponsor terminated study|1|||
146765976|NCT01867580|529310484|FG001|Overall Study|Sponsor terminated study|0|||
146765977|NCT01867580|529310483|FG000|Overall Study|Missed follow-up assessment|2|||
146765978|NCT01867580|529310484|FG001|Overall Study|Missed follow-up assessment|1|||
146765979|NCT01867580|529310483|FG000|Overall Study|Interruption to therapy|3|||
146765980|NCT01867580|529310484|FG001|Overall Study|Interruption to therapy|0|||
146765981|NCT01867580|529310483|FG000|Overall Study|Osteomyelitis|0|||
146765982|NCT01867580|529310484|FG001|Overall Study|Osteomyelitis|1|||
146765983|NCT01867580|529310483|FG000|Overall Study|Continuation of therapy|0|||
146765984|NCT01867580|529310484|FG001|Overall Study|Continuation of therapy|1|||
146765985|NCT01867580|529310483|FG000|Overall Study|Wound recurrence|0|||
146765986|NCT01867580|529310484|FG001|Overall Study|Wound recurrence|1|||
146765987|NCT01304147|529310485|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
146765988|NCT01304147|529310486|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
146765989|NCT01244828|529310487|FG000|Overall Study|Adverse Event|37|||
146765990|NCT01244828|529310487|FG000|Overall Study|Withdrawal by Subject|31|||
146765991|NCT01244828|529310487|FG000|Overall Study|Lack of Efficacy|7|||
146765992|NCT01244828|529310487|FG000|Overall Study|Lost to Follow-up|2|||
146765993|NCT01244828|529310487|FG000|Overall Study|Other reason (not specified)|1|||
146765994|NCT05233085|529310489|FG000|Overall Study|Adverse Event|1|||
146765995|NCT05233085|529310490|FG001|Overall Study|Adverse Event|0|||
146765996|NCT05233085|529310491|FG002|Overall Study|Adverse Event|0|||
146765997|NCT05233085|529310492|FG003|Overall Study|Adverse Event|0|||
146765998|NCT05052983|529310493|FG000|Overall Study|Lack of Efficacy|3|||
146765999|NCT05052983|529310494|FG001|Overall Study|Lack of Efficacy|12|||
146766000|NCT05052983|529310493|FG000|Overall Study|Adverse Event|1|||
146766001|NCT05052983|529310494|FG001|Overall Study|Adverse Event|0|||
146766002|NCT01066923|529310495|FG000|Overall Study|Withdrawal by Subject|3|||
146766003|NCT01066923|529310496|FG001|Overall Study|Withdrawal by Subject|3|||
146766004|NCT01066923|529310497|FG002|Overall Study|Withdrawal by Subject|8|||
146766005|NCT01066923|529310498|FG003|Overall Study|Withdrawal by Subject|8|||
146766006|NCT05147233|529312076|FG000|Overall Study|Adverse Event|0|||
146967059|NCT04411641|530040123|FG000|OL|Other|0|||
146766007|NCT05147233|529312077|FG001|Overall Study|Adverse Event|1|||
146766008|NCT05147233|529312076|FG000|Overall Study|Lost to Follow-up|1|||
146766009|NCT05147233|529312077|FG001|Overall Study|Lost to Follow-up|1|||
146766010|NCT05147233|529312076|FG000|Overall Study|Protocol Violation|0|||
146766011|NCT05147233|529312077|FG001|Overall Study|Protocol Violation|1|||
146766012|NCT05147233|529312076|FG000|Overall Study|Withdrawal by Subject|2|||
146967060|NCT04411641|530040124|FG001|OL|Other|0|||
146636523|NCT00357903|528843865|FG001|Overall Study|Other|10|||
146636524|NCT02506244|528843868|FG000|Overall Study|Did not undergo active monitoring|458|||
146636525|NCT02506244|528843869|FG001|Overall Study|Did not undergo active monitoring|459|||
146636526|NCT02506244|528843870|FG002|Overall Study|Did not undergo active monitoring|0|||
146636527|NCT00314795|528843872|FG000|Overall Study|Adverse Event|8|||
146636528|NCT00314795|528843872|FG000|Overall Study|Death|4|||
146636529|NCT00314795|528843872|FG000|Overall Study|Reason not Specified|3|||
146636530|NCT00314795|528843872|FG000|Overall Study|Renal Transplant|3|||
146636531|NCT00314795|528843872|FG000|Overall Study|Participants Withdrew Consent|2|||
146636532|NCT04717336|528843873|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
146636533|NCT04717336|528843874|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
146636534|NCT04717336|528843873|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
146636535|NCT04717336|528843874|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
146636536|NCT02039843|528843875|FG000|Randomization and Observation Period|Adverse Event|2|||
146636537|NCT02039843|528843876|FG001|Randomization and Observation Period|Adverse Event|0|||
146636538|NCT02039843|528843875|FG000|Randomization and Observation Period|Death|1|||
146636539|NCT02039843|528843876|FG001|Randomization and Observation Period|Death|0|||
146636540|NCT02039843|528843875|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
146636541|NCT02039843|528843876|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
146636542|NCT02039843|528843875|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
146636543|NCT02039843|528843876|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
146636544|NCT02039843|528843875|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
146636545|NCT02039843|528843876|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
146636546|NCT02039843|528843875|FG000|Pairing With a Study Dog|Death|1|||
146636547|NCT02039843|528843876|FG001|Pairing With a Study Dog|Death|0|||
146636548|NCT02039843|528843875|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
146889811|NCT00725075|529763516|FG002|Overall Study|Use of Excluded Medication|0|||
146889812|NCT00725075|529763514|FG000|Overall Study|Protocol Violation|0|||
146636549|NCT02039843|528843876|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
146636550|NCT02039843|528843875|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
146636551|NCT02039843|528843876|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
146636552|NCT02039843|528843875|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
146636553|NCT02039843|528843876|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
146636554|NCT01958164|528843881|FG000|Overall Study|Adverse Event|0|||
146636555|NCT01958164|528843882|FG001|Overall Study|Adverse Event|2|||
146636556|NCT01958164|528843881|FG000|Overall Study|Lost to Follow-up|2|||
146636557|NCT01958164|528843882|FG001|Overall Study|Lost to Follow-up|3|||
146889813|NCT00725075|529763515|FG001|Overall Study|Protocol Violation|0|||
146889814|NCT00725075|529763516|FG002|Overall Study|Protocol Violation|1|||
146889815|NCT00725075|529763514|FG000|Overall Study|Lost to Follow-up|1|||
146636558|NCT00525161|528843885|FG000|Overall Study|Adverse Event|1|||
146636559|NCT01076361|528843886|FG000|Overall Study|22 leads were excluded from analysis|21|||
146636560|NCT03848728|528843887|FG000|Overall Study|Death|16|||
146766013|NCT05147233|529312077|FG001|Overall Study|Withdrawal by Subject|1|||
146766014|NCT00589667|529312086|FG000|Overall Study|Adverse Event|2|||
146766015|NCT00589667|529312086|FG000|Overall Study|Withdrawal by Subject|1|||
146766016|NCT03538041|529312089|FG000|12-Week Treatment Period|Adverse Event|1|||
146766017|NCT03538041|529312090|FG001|12-Week Treatment Period|Adverse Event|1|||
146766018|NCT03538041|529312089|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
146766019|NCT03538041|529312090|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
146766020|NCT03538041|529312089|FG000|Treatment Extension Period|Adverse Event|4|||
146766021|NCT03538041|529312090|FG001|Treatment Extension Period|Adverse Event|1|||
146766022|NCT03538041|529312089|FG000|Treatment Extension Period|Physician Decision|1|||
146889816|NCT00725075|529763515|FG001|Overall Study|Lost to Follow-up|0|||
146889817|NCT00725075|529763516|FG002|Overall Study|Lost to Follow-up|0|||
146889818|NCT00725075|529763514|FG000|Overall Study|Withdrawal by Subject|4|||
146889819|NCT00725075|529763515|FG001|Overall Study|Withdrawal by Subject|5|||
146766023|NCT03538041|529312090|FG001|Treatment Extension Period|Physician Decision|1|||
146766024|NCT03538041|529312089|FG000|Treatment Extension Period|Lack of Efficacy|1|||
146889820|NCT00725075|529763516|FG002|Overall Study|Withdrawal by Subject|4|||
146889821|NCT00725075|529763514|FG000|Overall Study|Adverse Event|2|||
146889822|NCT00725075|529763515|FG001|Overall Study|Adverse Event|1|||
146889823|NCT00725075|529763516|FG002|Overall Study|Adverse Event|1|||
146889824|NCT00725075|529763514|FG000|Overall Study|Worsening of Disease|2|||
146889825|NCT00725075|529763515|FG001|Overall Study|Worsening of Disease|1|||
146889826|NCT00725075|529763516|FG002|Overall Study|Worsening of Disease|2|||
146889827|NCT00725075|529763514|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
146889828|NCT00725075|529763515|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
146889829|NCT00725075|529763516|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
146889830|NCT00725075|529763514|FG000|Overall Study|Other|1|||
146889831|NCT00725075|529763515|FG001|Overall Study|Other|0|||
146889832|NCT00725075|529763516|FG002|Overall Study|Other|0|||
146636561|NCT03848728|528843888|FG001|Overall Study|Death|13|||
146889833|NCT03984305|529763518|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
146889834|NCT03984305|529763519|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
146889835|NCT03984305|529763518|FG000|Overall Study|Withdrawal by Subject|3|||
146889836|NCT03984305|529763519|FG001|Overall Study|Withdrawal by Subject|3|||
146889837|NCT03984305|529763518|FG000|Overall Study|Lost to Follow-up|1|||
146889838|NCT03984305|529763519|FG001|Overall Study|Lost to Follow-up|0|||
146889839|NCT01656434|529763522|FG000|Overall Study|Adverse Event|199|||
146889840|NCT01656434|529763523|FG001|Overall Study|Adverse Event|63|||
146889841|NCT01656434|529763522|FG000|Overall Study|Enrollment terminated at trial site|2|||
146889842|NCT01656434|529763523|FG001|Overall Study|Enrollment terminated at trial site|0|||
146889843|NCT01656434|529763522|FG000|Overall Study|Lost to Follow-up|309|||
146889844|NCT01656434|529763523|FG001|Overall Study|Lost to Follow-up|76|||
146889845|NCT01656434|529763522|FG000|Overall Study|Site discontinued study participation|24|||
146636562|NCT03848728|528843887|FG000|Overall Study|Outmigrated to non-study community|98|||
146636563|NCT03848728|528843888|FG001|Overall Study|Outmigrated to non-study community|106|||
146636564|NCT03848728|528843887|FG000|Overall Study|Transfered to non-study clinic|32|||
146636565|NCT03848728|528843888|FG001|Overall Study|Transfered to non-study clinic|48|||
146636566|NCT03848728|528843887|FG000|Overall Study|Withdrawal by Subject|1|||
146636567|NCT03848728|528843888|FG001|Overall Study|Withdrawal by Subject|0|||
146636568|NCT02807402|528843896|FG000|Overall Study|Failure to Return|1|||
146636569|NCT02807402|528843896|FG000|Overall Study|Death|3|||
146636570|NCT02807402|528843896|FG000|Overall Study|Other|2|||
146636571|NCT02139592|528845452|FG000|Overall Study|Case Report Forms Uncollected|8|||
146636572|NCT02873702|528845455|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
146636573|NCT02873702|528845456|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
146636574|NCT02873702|528845457|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
146636575|NCT02873702|528845458|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
146636576|NCT02873702|528845455|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
146636577|NCT02873702|528845456|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
146636578|NCT02873702|528845457|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
146636579|NCT02873702|528845458|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
146636580|NCT02873702|528845455|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
146636581|NCT02873702|528845456|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
146636582|NCT02873702|528845457|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
146636583|NCT02873702|528845458|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
146636584|NCT02873702|528845455|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
146636585|NCT02873702|528845456|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
146636586|NCT02873702|528845457|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
146636587|NCT02873702|528845458|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
146636588|NCT02873702|528845455|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
146636589|NCT02873702|528845456|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
146636590|NCT02873702|528845457|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
146889846|NCT01656434|529763523|FG001|Overall Study|Site discontinued study participation|9|||
146889847|NCT01656434|529763522|FG000|Overall Study|Screen failure|2|||
146889848|NCT01656434|529763523|FG001|Overall Study|Screen failure|0|||
146889849|NCT01656434|529763522|FG000|Overall Study|Protocol Violation|7|||
146556801|NCT02739828|528547673|FG000|Overall Study|Adverse Event|1|||
146556802|NCT02739828|528547673|FG000|Overall Study|Lost to Follow-up|4|||
146556803|NCT01682720|528547681|FG000|Overall Study|Randomized but Not Treated|0|||
146556804|NCT01682720|528547682|FG001|Overall Study|Randomized but Not Treated|1|||
146556805|NCT01682720|528547683|FG002|Overall Study|Randomized but Not Treated|1|||
146556806|NCT01682720|528547684|FG003|Overall Study|Randomized but Not Treated|0|||
146556807|NCT01682720|528547681|FG000|Overall Study|Terminated by Sponsor|83|||
146556808|NCT01682720|528547682|FG001|Overall Study|Terminated by Sponsor|0|||
146556809|NCT01682720|528547683|FG002|Overall Study|Terminated by Sponsor|0|||
146556810|NCT01682720|528547684|FG003|Overall Study|Terminated by Sponsor|0|||
146556811|NCT01682720|528547681|FG000|Overall Study|Efficacy Failure|0|||
146556812|NCT01682720|528547682|FG001|Overall Study|Efficacy Failure|3|||
146556813|NCT01682720|528547683|FG002|Overall Study|Efficacy Failure|3|||
146556814|NCT01682720|528547684|FG003|Overall Study|Efficacy Failure|30|||
146556815|NCT01682720|528547681|FG000|Overall Study|Lost to Follow-up|1|||
146556816|NCT01682720|528547682|FG001|Overall Study|Lost to Follow-up|1|||
146889850|NCT01656434|529763523|FG001|Overall Study|Protocol Violation|0|||
146889851|NCT01656434|529763522|FG000|Overall Study|Pregnancy wish|18|||
146889852|NCT01656434|529763523|FG001|Overall Study|Pregnancy wish|6|||
146889853|NCT01656434|529763522|FG000|Overall Study|Pregnancy|45|||
146889854|NCT01656434|529763523|FG001|Overall Study|Pregnancy|10|||
146889855|NCT01656434|529763522|FG000|Overall Study|Physician Decision|7|||
146889856|NCT01656434|529763523|FG001|Overall Study|Physician Decision|2|||
146889857|NCT01656434|529763522|FG000|Overall Study|Non-compliance with study drug|48|||
146889858|NCT01656434|529763523|FG001|Overall Study|Non-compliance with study drug|9|||
146889859|NCT01656434|529763522|FG000|Overall Study|Study terminated by sponsor|1501|||
146889860|NCT01656434|529763523|FG001|Overall Study|Study terminated by sponsor|348|||
146889861|NCT01656434|529763522|FG000|Overall Study|Participant discontinued; drug related|13|||
146889862|NCT01656434|529763523|FG001|Overall Study|Participant discontinued; drug related|4|||
146889863|NCT01656434|529763522|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
146889864|NCT01656434|529763523|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
146889865|NCT01656434|529763522|FG000|Overall Study|Non-compliance with protocol|39|||
146889866|NCT01656434|529763523|FG001|Overall Study|Non-compliance with protocol|15|||
146889867|NCT01656434|529763522|FG000|Overall Study|Participant moved|40|||
146889868|NCT01656434|529763523|FG001|Overall Study|Participant moved|12|||
146889869|NCT01656434|529763522|FG000|Overall Study|Participant withdrew consent|28|||
146889870|NCT01656434|529763523|FG001|Overall Study|Participant withdrew consent|9|||
146889871|NCT01656434|529763522|FG000|Overall Study|Withdrawal by Subject|64|||
146889872|NCT01656434|529763523|FG001|Overall Study|Withdrawal by Subject|7|||
146889873|NCT01235962|529763524|FG000|Overall Study|Withdrawal by Subject|20|||
146889874|NCT01235962|529763525|FG001|Overall Study|Withdrawal by Subject|19|||
146889875|NCT01235962|529763526|FG002|Overall Study|Withdrawal by Subject|62|||
146889876|NCT01235962|529763527|FG003|Overall Study|Withdrawal by Subject|49|||
146889877|NCT01235962|529763524|FG000|Overall Study|Lost to Follow-up|21|||
146889878|NCT01235962|529763525|FG001|Overall Study|Lost to Follow-up|16|||
146889879|NCT01235962|529763526|FG002|Overall Study|Lost to Follow-up|47|||
146889880|NCT01235962|529763527|FG003|Overall Study|Lost to Follow-up|32|||
146889881|NCT01235962|529763524|FG000|Overall Study|Physician Decision|5|||
146889882|NCT01235962|529763525|FG001|Overall Study|Physician Decision|0|||
146889883|NCT01235962|529763526|FG002|Overall Study|Physician Decision|9|||
146889884|NCT01235962|529763527|FG003|Overall Study|Physician Decision|5|||
146967061|NCT04411641|530040125|FG002|OL|Other|0|||
146967062|NCT04411641|530040126|FG003|OL|Other|6|||
146556817|NCT01682720|528547683|FG002|Overall Study|Lost to Follow-up|0|||
146556818|NCT01682720|528547684|FG003|Overall Study|Lost to Follow-up|6|||
146556819|NCT01682720|528547681|FG000|Overall Study|Subject Withdrew Consent|0|||
146556820|NCT01682720|528547682|FG001|Overall Study|Subject Withdrew Consent|0|||
146556821|NCT01682720|528547683|FG002|Overall Study|Subject Withdrew Consent|2|||
146556822|NCT01682720|528547684|FG003|Overall Study|Subject Withdrew Consent|2|||
146556823|NCT01682720|528547681|FG000|Overall Study|Adverse Event|1|||
146556824|NCT01682720|528547682|FG001|Overall Study|Adverse Event|0|||
146556825|NCT01682720|528547683|FG002|Overall Study|Adverse Event|1|||
146889885|NCT00993928|529763534|FG000|Overall Study|Withdrawal by Subject|4|||
146889886|NCT00993928|529763535|FG001|Overall Study|Withdrawal by Subject|7|||
146889887|NCT00993928|529763534|FG000|Overall Study|ineligible|1|||
146889888|NCT00993928|529763535|FG001|Overall Study|ineligible|0|||
146889889|NCT01665144|529763536|FG000|Core Part|Withdrawal by Subject|96|||
146889890|NCT01665144|529763537|FG001|Core Part|Withdrawal by Subject|77|||
146889891|NCT01665144|529763538|FG002|Core Part|Withdrawal by Subject|0|||
146889892|NCT01665144|529763536|FG000|Core Part|Adverse Event|45|||
146889893|NCT01665144|529763537|FG001|Core Part|Adverse Event|18|||
146556826|NCT01682720|528547684|FG003|Overall Study|Adverse Event|1|||
146556827|NCT04204902|528547685|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
146556828|NCT04204902|528547686|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
146556829|NCT02202577|528547689|FG000|Overall Study|Lost to Follow-up|6|||
146889894|NCT01665144|529763538|FG002|Core Part|Adverse Event|0|||
146889895|NCT01665144|529763536|FG000|Core Part|Lack of Efficacy|16|||
146889896|NCT01665144|529763537|FG001|Core Part|Lack of Efficacy|11|||
146889897|NCT01665144|529763538|FG002|Core Part|Lack of Efficacy|0|||
146889898|NCT01665144|529763536|FG000|Core Part|Lost to Follow-up|9|||
146889899|NCT01665144|529763537|FG001|Core Part|Lost to Follow-up|8|||
146889900|NCT01665144|529763538|FG002|Core Part|Lost to Follow-up|0|||
146889901|NCT01665144|529763536|FG000|Core Part|Physician Decision|13|||
146889902|NCT01665144|529763537|FG001|Core Part|Physician Decision|1|||
146636591|NCT02873702|528845458|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
146636592|NCT01255436|528845468|FG000|Overall Study|Lost to Follow-up|178|||
146636593|NCT01255436|528845469|FG001|Overall Study|Lost to Follow-up|191|||
146636594|NCT01255436|528845468|FG000|Overall Study|Death, stroke, or MI|4|||
146636595|NCT01255436|528845469|FG001|Overall Study|Death, stroke, or MI|3|||
146636596|NCT04816669|528845470|FG000|Part 1|Adverse Event|1|||
146636597|NCT04816669|528845471|FG001|Part 1|Adverse Event|1|||
146636598|NCT04816669|528845472|FG002|Part 1|Adverse Event|0|||
146636599|NCT04816669|528845473|FG003|Part 1|Adverse Event|0|||
146636600|NCT04816669|528845470|FG000|Part 1|Lost to Follow-up|2|||
146636601|NCT04816669|528845471|FG001|Part 1|Lost to Follow-up|2|||
146766025|NCT03538041|529312090|FG001|Treatment Extension Period|Lack of Efficacy|4|||
146766026|NCT03538041|529312089|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
146766027|NCT03538041|529312090|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
146636602|NCT04816669|528845472|FG002|Part 1|Lost to Follow-up|0|||
146636603|NCT04816669|528845473|FG003|Part 1|Lost to Follow-up|0|||
146636604|NCT04816669|528845470|FG000|Part 1|Protocol Violation|0|||
146889903|NCT01665144|529763538|FG002|Core Part|Physician Decision|0|||
146889904|NCT01665144|529763536|FG000|Core Part|Progressive disease|8|||
146889905|NCT01665144|529763537|FG001|Core Part|Progressive disease|4|||
146889906|NCT01665144|529763538|FG002|Core Part|Progressive disease|0|||
146889907|NCT01665144|529763536|FG000|Core Part|Non-compliance with study treatment|5|||
146889908|NCT01665144|529763537|FG001|Core Part|Non-compliance with study treatment|0|||
146889909|NCT01665144|529763538|FG002|Core Part|Non-compliance with study treatment|0|||
146889910|NCT01665144|529763536|FG000|Core Part|Death|3|||
146889911|NCT01665144|529763537|FG001|Core Part|Death|1|||
146889912|NCT01665144|529763538|FG002|Core Part|Death|0|||
146889913|NCT01665144|529763536|FG000|Core Part|Protocol deviation|3|||
146889914|NCT01665144|529763537|FG001|Core Part|Protocol deviation|1|||
146889915|NCT01665144|529763538|FG002|Core Part|Protocol deviation|0|||
146889916|NCT01665144|529763536|FG000|Core Part|New therapy for study indication|2|||
146889917|NCT01665144|529763537|FG001|Core Part|New therapy for study indication|1|||
146889918|NCT01665144|529763538|FG002|Core Part|New therapy for study indication|0|||
146889919|NCT01665144|529763536|FG000|Core Part|Technical problems|2|||
146889920|NCT01665144|529763537|FG001|Core Part|Technical problems|0|||
146889921|NCT01665144|529763538|FG002|Core Part|Technical problems|0|||
146889922|NCT01665144|529763536|FG000|Extension Part|Patient/guardian decision|180|||
146889923|NCT01665144|529763537|FG001|Extension Part|Patient/guardian decision|0|||
146967063|NCT04410978|530040136|FG000|Overall Study|Poor compliance to protocol|2|||
146636605|NCT04816669|528845471|FG001|Part 1|Protocol Violation|1|||
146766028|NCT03538041|529312089|FG000|Treatment Extension Period|Death|0|||
146889924|NCT01665144|529763538|FG002|Extension Part|Patient/guardian decision|98|||
146889925|NCT01665144|529763536|FG000|Extension Part|Adverse Event|104|||
146889926|NCT01665144|529763537|FG001|Extension Part|Adverse Event|0|||
146967064|NCT04410978|530040137|FG001|Overall Study|Poor compliance to protocol|4|||
146636606|NCT04816669|528845472|FG002|Part 1|Protocol Violation|0|||
146636607|NCT04816669|528845473|FG003|Part 1|Protocol Violation|0|||
146636608|NCT04816669|528845470|FG000|Part 1|Withdrawal by Subject|1|||
146766029|NCT03538041|529312090|FG001|Treatment Extension Period|Death|1|||
146889927|NCT01665144|529763538|FG002|Extension Part|Adverse Event|59|||
146889928|NCT01665144|529763536|FG000|Extension Part|Study closed early|42|||
146889929|NCT01665144|529763537|FG001|Extension Part|Study closed early|0|||
146889930|NCT01665144|529763538|FG002|Extension Part|Study closed early|19|||
146889931|NCT01665144|529763536|FG000|Extension Part|Progressive disease|36|||
146889932|NCT01665144|529763537|FG001|Extension Part|Progressive disease|0|||
146889933|NCT01665144|529763538|FG002|Extension Part|Progressive disease|14|||
146967065|NCT04410978|530040136|FG000|Overall Study|Withdrawal by Subject|64|||
146889934|NCT01665144|529763536|FG000|Extension Part|Lack of Efficacy|37|||
146889935|NCT01665144|529763537|FG001|Extension Part|Lack of Efficacy|0|||
146889936|NCT01665144|529763538|FG002|Extension Part|Lack of Efficacy|12|||
146889937|NCT01665144|529763536|FG000|Extension Part|Physician Decision|29|||
146889938|NCT01665144|529763537|FG001|Extension Part|Physician Decision|0|||
146889939|NCT01665144|529763538|FG002|Extension Part|Physician Decision|13|||
146889940|NCT01665144|529763536|FG000|Extension Part|Technical problems|20|||
146889941|NCT01665144|529763537|FG001|Extension Part|Technical problems|0|||
146889942|NCT01665144|529763538|FG002|Extension Part|Technical problems|8|||
146889943|NCT01665144|529763536|FG000|Extension Part|Death|20|||
146889944|NCT01665144|529763537|FG001|Extension Part|Death|0|||
146889945|NCT01665144|529763538|FG002|Extension Part|Death|4|||
146889946|NCT01665144|529763536|FG000|Extension Part|Missing|12|||
146889947|NCT01665144|529763537|FG001|Extension Part|Missing|0|||
146889948|NCT01665144|529763538|FG002|Extension Part|Missing|6|||
146889949|NCT01665144|529763536|FG000|Extension Part|Lost to Follow-up|9|||
146889950|NCT01665144|529763537|FG001|Extension Part|Lost to Follow-up|0|||
146889951|NCT01665144|529763538|FG002|Extension Part|Lost to Follow-up|5|||
146889952|NCT01665144|529763536|FG000|Extension Part|New therapy for study indication|3|||
146889953|NCT01665144|529763537|FG001|Extension Part|New therapy for study indication|0|||
146889954|NCT01665144|529763538|FG002|Extension Part|New therapy for study indication|2|||
146889955|NCT01665144|529763536|FG000|Extension Part|Protocol deviation|3|||
146889956|NCT01665144|529763537|FG001|Extension Part|Protocol deviation|0|||
146889957|NCT01665144|529763538|FG002|Extension Part|Protocol deviation|0|||
146889958|NCT01913483|529763539|FG000|Overall Study|Withdrawal by Subject|1|||
146889959|NCT01913483|529763540|FG001|Overall Study|Withdrawal by Subject|2|||
146889960|NCT01913483|529763539|FG000|Overall Study|Lost to Follow-up|6|||
146889961|NCT01913483|529763540|FG001|Overall Study|Lost to Follow-up|3|||
146889962|NCT01913483|529763539|FG000|Overall Study|Death|14|||
146889963|NCT01913483|529763540|FG001|Overall Study|Death|17|||
146889964|NCT00546052|529763541|FG000|Overall Study|Adverse Event|47|||
146889965|NCT00546052|529763541|FG000|Overall Study|Lost to Follow-up|144|||
146889966|NCT00546052|529763541|FG000|Overall Study|Protocol Violation|9|||
146889967|NCT00546052|529763541|FG000|Overall Study|Withdrawal by Subject|20|||
146889968|NCT00546052|529763541|FG000|Overall Study|Non Compliance|7|||
146889969|NCT01031446|529763543|FG000|Overall Study|Disease Progression|38|||
146889970|NCT01031446|529763543|FG000|Overall Study|Adverse Event|9|||
146889971|NCT01031446|529763543|FG000|Overall Study|Physician Decision|4|||
146889972|NCT01031446|529763543|FG000|Overall Study|Withdrawal by Subject|3|||
146889973|NCT01031446|529763543|FG000|Overall Study|Still on treatment|1|||
146889974|NCT00500682|529763544|FG000|Overall Study|Adverse Event|37|||
146889975|NCT00500682|529763545|FG001|Overall Study|Adverse Event|29|||
146889976|NCT00500682|529763544|FG000|Overall Study|Death|25|||
146889977|NCT00500682|529763545|FG001|Overall Study|Death|16|||
146889978|NCT00500682|529763544|FG000|Overall Study|Lost to Follow-up|11|||
146889979|NCT00500682|529763545|FG001|Overall Study|Lost to Follow-up|11|||
146889980|NCT00500682|529763544|FG000|Overall Study|Physician Decision|6|||
146889981|NCT00500682|529763545|FG001|Overall Study|Physician Decision|10|||
146889982|NCT00500682|529763544|FG000|Overall Study|Pregnancy|2|||
146889983|NCT00500682|529763545|FG001|Overall Study|Pregnancy|0|||
146889984|NCT00500682|529763544|FG000|Overall Study|Protocol Violation|1|||
146889985|NCT00500682|529763545|FG001|Overall Study|Protocol Violation|3|||
146889986|NCT00500682|529763544|FG000|Overall Study|Withdrawal by Subject|80|||
146889987|NCT00500682|529763545|FG001|Overall Study|Withdrawal by Subject|74|||
146889988|NCT00500682|529763544|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
146889989|NCT00500682|529763545|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
146889990|NCT02531646|529763546|FG000|Overall Study|equip. image processing issue|5|||
146889991|NCT02531646|529763547|FG001|Overall Study|equip. image processing issue|1|||
146889992|NCT02531646|529763548|FG002|Overall Study|equip. image processing issue|0|||
146889993|NCT03344003|529763549|FG000|Overall Study|Switched to alternative treatment|1|||
146889994|NCT03344003|529763550|FG001|Overall Study|Switched to alternative treatment|0|||
146889995|NCT03344003|529763549|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
146889996|NCT03344003|529763550|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
146889997|NCT00684957|529763551|FG000|Overall Study|Withdrawal by Subject|1|||
146889998|NCT00684957|529763552|FG001|Overall Study|Withdrawal by Subject|1|||
146889999|NCT00684957|529763551|FG000|Overall Study|Lost to Follow-up|1|||
146890000|NCT00684957|529763552|FG001|Overall Study|Lost to Follow-up|0|||
146890001|NCT00167245|529764758|FG000|Overall Study|Lost to Follow-up|20|||
146890002|NCT00167245|529764759|FG001|Overall Study|Lost to Follow-up|31|||
146890003|NCT00167245|529764758|FG000|Overall Study|Withdrawal by Subject|5|||
146890004|NCT00167245|529764759|FG001|Overall Study|Withdrawal by Subject|8|||
146890005|NCT00167245|529764758|FG000|Overall Study|Incarcerated|3|||
146890006|NCT00167245|529764759|FG001|Overall Study|Incarcerated|2|||
146890007|NCT00167245|529764758|FG000|Overall Study|Drowsy|1|||
146890008|NCT00167245|529764759|FG001|Overall Study|Drowsy|0|||
146890009|NCT01773421|529764762|FG000|Treatment Phase|Other|0|||
146890010|NCT01773421|529764763|FG001|Treatment Phase|Other|0|||
146890011|NCT01773421|529764764|FG002|Treatment Phase|Other|2|||
146890012|NCT01773421|529764765|FG003|Treatment Phase|Other|0|||
146556830|NCT02202577|528547690|FG001|Overall Study|Lost to Follow-up|16|||
146556831|NCT02202577|528547689|FG000|Overall Study|Protocol Violation|7|||
146556832|NCT02202577|528547690|FG001|Overall Study|Protocol Violation|3|||
146556833|NCT04754399|528547693|FG000|Overall Study|Adverse Event|5|||
146556834|NCT04754399|528547693|FG000|Overall Study|Withdrawal by Subject|6|||
146556835|NCT00025233|528547696|FG000|Overall Study|Ineligible: wrong cell type|1|||
146556836|NCT00025233|528547696|FG000|Overall Study|Ineligible: wrong primary|1|||
146556837|NCT00025233|528547696|FG000|Overall Study|Ineligible: improper prior treatment|1|||
146556838|NCT00025233|528547696|FG000|Overall Study|Never treated|1|||
146556839|NCT01720602|528547697|FG000|Overall Study|Adverse Event|3|||
146556840|NCT01720602|528547697|FG000|Overall Study|Progressive disease on therapy|2|||
146556841|NCT03927846|528547705|FG000|Overall Study|Lost to Follow-up|10|||
146556842|NCT03927846|528547706|FG001|Overall Study|Lost to Follow-up|11|||
146556843|NCT03878069|528547707|FG000|Overall Study|Death|0|||
146556844|NCT03878069|528547708|FG001|Overall Study|Death|1|||
146556845|NCT03878069|528547709|FG002|Overall Study|Death|0|||
146556846|NCT00834587|528547710|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
146556847|NCT00834587|528547711|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
146556848|NCT00176254|528547712|FG000|Overall Study|Lost to Follow-up|1|||
146556849|NCT01657942|528547717|FG000|Overall Study|Alternative Treatment|7|||
146556850|NCT01657942|528547717|FG000|Overall Study|Lost to Follow-up|1|||
146556851|NCT02904265|528548991|FG000|Overall Study|Physician Decision|1|||
146556852|NCT02904265|528548992|FG001|Overall Study|Physician Decision|2|||
146556853|NCT00003907|528549001|FG000|Overall Study|Adverse Event|2|||
146556854|NCT00003907|528549002|FG001|Overall Study|Adverse Event|11|||
146556855|NCT00003907|528549001|FG000|Overall Study|Death|2|||
146556856|NCT00003907|528549002|FG001|Overall Study|Death|0|||
146556857|NCT00003907|528549001|FG000|Overall Study|Withdrawal by Subject|1|||
146556858|NCT00003907|528549002|FG001|Overall Study|Withdrawal by Subject|3|||
146556859|NCT00003907|528549001|FG000|Overall Study|Progressive disease|4|||
146556860|NCT00003907|528549002|FG001|Overall Study|Progressive disease|4|||
146556861|NCT00003907|528549001|FG000|Overall Study|Complicating disease|1|||
146556862|NCT00003907|528549002|FG001|Overall Study|Complicating disease|0|||
146556863|NCT00003907|528549001|FG000|Overall Study|Other|1|||
146556864|NCT00003907|528549002|FG001|Overall Study|Other|3|||
146556865|NCT00003907|528549001|FG000|Overall Study|ineligible or not treated|2|||
146556866|NCT00003907|528549002|FG001|Overall Study|ineligible or not treated|2|||
146556867|NCT02336555|528549003|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146556868|NCT02336555|528549004|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
146556869|NCT02336555|528549003|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
146556870|NCT02336555|528549004|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
146556871|NCT02336555|528549003|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
146556872|NCT02336555|528549004|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
146556873|NCT00993473|528549005|FG000|Overall Study|Adverse Event|0|||
146556874|NCT00993473|528549006|FG001|Overall Study|Adverse Event|2|||
146556875|NCT00993473|528549005|FG000|Overall Study|Protocol Violation|1|||
146556876|NCT00993473|528549006|FG001|Overall Study|Protocol Violation|2|||
146556877|NCT00993473|528549005|FG000|Overall Study|Lost to Follow-up|1|||
146556878|NCT00993473|528549006|FG001|Overall Study|Lost to Follow-up|0|||
146556879|NCT00993473|528549005|FG000|Overall Study|Withdrawal by Subject|1|||
146556880|NCT00993473|528549006|FG001|Overall Study|Withdrawal by Subject|5|||
146556881|NCT00993473|528549005|FG000|Overall Study|Technical problem with CGM device|0|||
146556882|NCT00993473|528549006|FG001|Overall Study|Technical problem with CGM device|1|||
146556883|NCT00993473|528549005|FG000|Overall Study|Family event|1|||
146556884|NCT00993473|528549006|FG001|Overall Study|Family event|0|||
146556885|NCT03682367|528549015|FG000|Overall Study|Protocol Violation|2|||
146556886|NCT03682367|528549016|FG001|Overall Study|Protocol Violation|1|||
146556887|NCT03682367|528549015|FG000|Overall Study|Closed Study Early|0|||
146556888|NCT03682367|528549016|FG001|Overall Study|Closed Study Early|3|||
146556889|NCT00160563|528549017|FG000|Overall Study|Adverse Event|1|||
146556890|NCT00160563|528549018|FG001|Overall Study|Adverse Event|1|||
146556891|NCT00160563|528549019|FG002|Overall Study|Adverse Event|1|||
146556892|NCT00160563|528549017|FG000|Overall Study|Lost to Follow-up|1|||
146556893|NCT00160563|528549018|FG001|Overall Study|Lost to Follow-up|1|||
146556894|NCT00160563|528549019|FG002|Overall Study|Lost to Follow-up|2|||
146556895|NCT00160563|528549017|FG000|Overall Study|Protocol Violation|0|||
146556896|NCT00160563|528549018|FG001|Overall Study|Protocol Violation|0|||
146556897|NCT00160563|528549019|FG002|Overall Study|Protocol Violation|3|||
146967066|NCT04410978|530040137|FG001|Overall Study|Withdrawal by Subject|66|||
146967067|NCT04410978|530040136|FG000|Overall Study|Other|6|||
146967068|NCT04410978|530040137|FG001|Overall Study|Other|7|||
146967069|NCT04410978|530040136|FG000|Overall Study|Missing study status|1|||
146967070|NCT04410978|530040137|FG001|Overall Study|Missing study status|0|||
146967071|NCT01489865|530040145|FG000|Overall Study|Progression of Disease|4|||
146967072|NCT01489865|530040146|FG001|Overall Study|Progression of Disease|2|||
146967073|NCT01489865|530040147|FG002|Overall Study|Progression of Disease|2|||
146967074|NCT01489865|530040148|FG003|Overall Study|Progression of Disease|3|||
146967075|NCT01489865|530040149|FG004|Overall Study|Progression of Disease|1|||
146967076|NCT01489865|530040150|FG005|Overall Study|Progression of Disease|6|||
146967077|NCT01489865|530040151|FG006|Overall Study|Progression of Disease|3|||
146967078|NCT01489865|530040152|FG007|Overall Study|Progression of Disease|0|||
146967079|NCT01489865|530040153|FG008|Overall Study|Progression of Disease|23|||
146967080|NCT01489865|530040145|FG000|Overall Study|Adverse Event|2|||
146967081|NCT01489865|530040146|FG001|Overall Study|Adverse Event|0|||
146967082|NCT01489865|530040147|FG002|Overall Study|Adverse Event|0|||
146967083|NCT01489865|530040148|FG003|Overall Study|Adverse Event|0|||
146967084|NCT01489865|530040149|FG004|Overall Study|Adverse Event|1|||
146967085|NCT01489865|530040150|FG005|Overall Study|Adverse Event|0|||
146967086|NCT01489865|530040151|FG006|Overall Study|Adverse Event|2|||
146967087|NCT01489865|530040152|FG007|Overall Study|Adverse Event|0|||
146967088|NCT01489865|530040153|FG008|Overall Study|Adverse Event|5|||
146967089|NCT01489865|530040145|FG000|Overall Study|Death|0|||
146967090|NCT01489865|530040146|FG001|Overall Study|Death|1|||
146967091|NCT01489865|530040147|FG002|Overall Study|Death|0|||
146967092|NCT01489865|530040148|FG003|Overall Study|Death|0|||
146967093|NCT01489865|530040149|FG004|Overall Study|Death|1|||
146967094|NCT01489865|530040150|FG005|Overall Study|Death|0|||
146967095|NCT01489865|530040151|FG006|Overall Study|Death|0|||
146967096|NCT01489865|530040152|FG007|Overall Study|Death|0|||
146967097|NCT01489865|530040153|FG008|Overall Study|Death|2|||
146967098|NCT01489865|530040145|FG000|Overall Study|Withdrawal by Subject|0|||
146967099|NCT01489865|530040146|FG001|Overall Study|Withdrawal by Subject|0|||
146967100|NCT01489865|530040147|FG002|Overall Study|Withdrawal by Subject|0|||
146967101|NCT01489865|530040148|FG003|Overall Study|Withdrawal by Subject|0|||
146967102|NCT01489865|530040149|FG004|Overall Study|Withdrawal by Subject|0|||
146967103|NCT01489865|530040150|FG005|Overall Study|Withdrawal by Subject|1|||
146967104|NCT01489865|530040151|FG006|Overall Study|Withdrawal by Subject|1|||
146967105|NCT01489865|530040152|FG007|Overall Study|Withdrawal by Subject|0|||
146967106|NCT01489865|530040153|FG008|Overall Study|Withdrawal by Subject|2|||
146967107|NCT01489865|530040145|FG000|Overall Study|Shifted|0|||
146967108|NCT01489865|530040146|FG001|Overall Study|Shifted|0|||
146967109|NCT01489865|530040147|FG002|Overall Study|Shifted|1|||
146967110|NCT01489865|530040148|FG003|Overall Study|Shifted|0|||
146967111|NCT01489865|530040149|FG004|Overall Study|Shifted|0|||
146967112|NCT01489865|530040150|FG005|Overall Study|Shifted|0|||
146967113|NCT01489865|530040151|FG006|Overall Study|Shifted|0|||
146967114|NCT01489865|530040152|FG007|Overall Study|Shifted|0|||
146967115|NCT01489865|530040153|FG008|Overall Study|Shifted|0|||
146967116|NCT00972309|530040154|FG000|Overall Study|Switched to alternative treatment|0|||
146967117|NCT00972309|530040155|FG001|Overall Study|Switched to alternative treatment|2|||
146967118|NCT00972309|530040154|FG000|Overall Study|Refused further treatment|0|||
146967119|NCT00972309|530040155|FG001|Overall Study|Refused further treatment|1|||
146967120|NCT00972309|530040154|FG000|Overall Study|Late determination of ineligibility|0|||
146967121|NCT00972309|530040155|FG001|Overall Study|Late determination of ineligibility|1|||
146967122|NCT00972309|530040154|FG000|Overall Study|Second malignancy|1|||
146967123|NCT00972309|530040155|FG001|Overall Study|Second malignancy|1|||
146967124|NCT00972309|530040154|FG000|Overall Study|Visa issues|0|||
146967125|NCT00972309|530040155|FG001|Overall Study|Visa issues|1|||
146556898|NCT00160563|528549017|FG000|Overall Study|Withdrawal by Subject|1|||
146967126|NCT00972309|530040154|FG000|Overall Study|Secondary cancer (SCC)|0|||
146556899|NCT00160563|528549018|FG001|Overall Study|Withdrawal by Subject|2|||
146967127|NCT00972309|530040155|FG001|Overall Study|Secondary cancer (SCC)|1|||
146967128|NCT00972309|530040154|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
146967129|NCT00972309|530040155|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
146967130|NCT00972309|530040154|FG000|Overall Study|Lost to Follow-up|1|||
146967131|NCT00972309|530040155|FG001|Overall Study|Lost to Follow-up|1|||
146890013|NCT01773421|529764766|FG004|Treatment Phase|Other|0|||
146890014|NCT01773421|529764767|FG005|Treatment Phase|Other|0|||
146890015|NCT01773421|529764768|FG006|Treatment Phase|Other|0|||
146890016|NCT01773421|529764762|FG000|Treatment Phase|Adverse Event|0|||
146890017|NCT01773421|529764763|FG001|Treatment Phase|Adverse Event|0|||
146890018|NCT01773421|529764764|FG002|Treatment Phase|Adverse Event|3|||
146890019|NCT01773421|529764765|FG003|Treatment Phase|Adverse Event|1|||
146890020|NCT01773421|529764766|FG004|Treatment Phase|Adverse Event|0|||
146890021|NCT01773421|529764767|FG005|Treatment Phase|Adverse Event|0|||
146890022|NCT01773421|529764768|FG006|Treatment Phase|Adverse Event|0|||
146890023|NCT01773421|529764762|FG000|Treatment Phase|Withdrawal by Subject|0|||
146890024|NCT01773421|529764763|FG001|Treatment Phase|Withdrawal by Subject|0|||
146890025|NCT01773421|529764764|FG002|Treatment Phase|Withdrawal by Subject|1|||
146890026|NCT01773421|529764765|FG003|Treatment Phase|Withdrawal by Subject|1|||
146890027|NCT01773421|529764766|FG004|Treatment Phase|Withdrawal by Subject|0|||
146890028|NCT01773421|529764767|FG005|Treatment Phase|Withdrawal by Subject|0|||
146890029|NCT01773421|529764768|FG006|Treatment Phase|Withdrawal by Subject|0|||
146890030|NCT01773421|529764762|FG000|Extension Phase|Other|0|||
146890031|NCT01773421|529764763|FG001|Extension Phase|Other|0|||
146890032|NCT01773421|529764764|FG002|Extension Phase|Other|0|||
146890033|NCT01773421|529764765|FG003|Extension Phase|Other|0|||
146890034|NCT01773421|529764766|FG004|Extension Phase|Other|1|||
146890035|NCT01773421|529764767|FG005|Extension Phase|Other|2|||
146890036|NCT01773421|529764768|FG006|Extension Phase|Other|0|||
146890037|NCT01773421|529764762|FG000|Extension Phase|Adverse Event|0|||
146890038|NCT01773421|529764763|FG001|Extension Phase|Adverse Event|0|||
146890039|NCT01773421|529764764|FG002|Extension Phase|Adverse Event|0|||
146890040|NCT01773421|529764765|FG003|Extension Phase|Adverse Event|0|||
146890041|NCT01773421|529764766|FG004|Extension Phase|Adverse Event|2|||
146890042|NCT01773421|529764767|FG005|Extension Phase|Adverse Event|0|||
146890043|NCT01773421|529764768|FG006|Extension Phase|Adverse Event|0|||
146890044|NCT00688909|529764769|FG000|Overall Study|Adverse Event|28|||
146890045|NCT00688909|529764769|FG000|Overall Study|Patient withdrew consent|2|||
146890046|NCT00688909|529764769|FG000|Overall Study|Administrative problems|1|||
146890047|NCT00688909|529764769|FG000|Overall Study|Protocol Violation|2|||
146890048|NCT02472847|529764776|FG000|Overall Study|Withdrawal by Subject|1|||
146890049|NCT02472847|529764777|FG001|Overall Study|Withdrawal by Subject|5|||
146890050|NCT00669617|529764778|FG000|Period 1|Withdrawal by Subject|0|||
146890051|NCT00669617|529764779|FG001|Period 1|Withdrawal by Subject|0|||
146890052|NCT00669617|529764780|FG002|Period 1|Withdrawal by Subject|1|||
146890053|NCT00669617|529764781|FG003|Period 1|Withdrawal by Subject|0|||
146890054|NCT00669617|529764782|FG004|Period 1|Withdrawal by Subject|0|||
146890055|NCT00669617|529764778|FG000|Period 1|Protocol Deviation|0|||
146890056|NCT00669617|529764779|FG001|Period 1|Protocol Deviation|0|||
146890057|NCT00669617|529764780|FG002|Period 1|Protocol Deviation|0|||
146890058|NCT00669617|529764781|FG003|Period 1|Protocol Deviation|0|||
146890059|NCT00669617|529764782|FG004|Period 1|Protocol Deviation|1|||
146890060|NCT00669617|529764778|FG000|Period 3|Lost to Follow-up|1|||
146890061|NCT00669617|529764779|FG001|Period 3|Lost to Follow-up|0|||
146890062|NCT00669617|529764780|FG002|Period 3|Lost to Follow-up|0|||
146890063|NCT00669617|529764781|FG003|Period 3|Lost to Follow-up|0|||
146890064|NCT00669617|529764782|FG004|Period 3|Lost to Follow-up|0|||
146890065|NCT00623831|529764783|FG000|Overall Study|Withdrawal by Subject|1|||
146890066|NCT00623831|529764784|FG001|Overall Study|Withdrawal by Subject|0|||
146890067|NCT00623831|529764783|FG000|Overall Study|Progressive Disease|0|||
146967132|NCT00972309|530040154|FG000|Overall Study|Disease progression on study|10|||
146967133|NCT00972309|530040155|FG001|Overall Study|Disease progression on study|4|||
146967134|NCT01593761|530040157|FG000|Overall Study|Lost to Follow-up|1|||
146967135|NCT01593761|530040157|FG000|Overall Study|culture negative for MRSA at baseline|5|||
146967136|NCT01593761|530040157|FG000|Overall Study|positive for hepatitis C virus|1|||
146890068|NCT00623831|529764784|FG001|Overall Study|Progressive Disease|1|||
146890069|NCT01276821|529764785|FG000|Overall Study|Protocol Violation|0|||
146890070|NCT01276821|529764786|FG001|Overall Study|Protocol Violation|1|||
146890071|NCT01748071|529764789|FG000|Overall Study|Adverse Event|2|||
146890072|NCT01748071|529764790|FG001|Overall Study|Adverse Event|2|||
146890073|NCT01748071|529764791|FG002|Overall Study|Adverse Event|0|||
146890074|NCT02167945|529764794|FG000|Overall Study|Adverse Event|16|||
146890075|NCT02167945|529764794|FG000|Overall Study|Withdrew Consent|42|||
146890076|NCT02167945|529764794|FG000|Overall Study|Lost to Follow-up|122|||
146967137|NCT01593761|530040157|FG000|Overall Study|secondary cellulitis|1|||
146890077|NCT02167945|529764794|FG000|Overall Study|COVID-19 logistical restrictions|6|||
146890078|NCT02167945|529764794|FG000|Overall Study|Other, not specified|63|||
146890079|NCT00132730|529764795|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
146890080|NCT00132730|529764796|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
146636609|NCT04816669|528845471|FG001|Part 1|Withdrawal by Subject|2|||
146636610|NCT04816669|528845472|FG002|Part 1|Withdrawal by Subject|0|||
146636611|NCT04816669|528845473|FG003|Part 1|Withdrawal by Subject|0|||
146636612|NCT04816669|528845470|FG000|Part 2|Other|0|||
146636613|NCT04816669|528845471|FG001|Part 2|Other|0|||
146636614|NCT04816669|528845472|FG002|Part 2|Other|1|||
146636615|NCT04816669|528845473|FG003|Part 2|Other|0|||
146636616|NCT04816669|528845470|FG000|Part 2|Withdrawal by Subject|0|||
146636617|NCT04816669|528845471|FG001|Part 2|Withdrawal by Subject|0|||
146636618|NCT04816669|528845472|FG002|Part 2|Withdrawal by Subject|0|||
146636619|NCT04816669|528845473|FG003|Part 2|Withdrawal by Subject|1|||
146636620|NCT04816669|528845470|FG000|Part 2|Lost to Follow-up|0|||
146636621|NCT04816669|528845471|FG001|Part 2|Lost to Follow-up|0|||
146636622|NCT04816669|528845472|FG002|Part 2|Lost to Follow-up|1|||
146636623|NCT04816669|528845473|FG003|Part 2|Lost to Follow-up|0|||
146636624|NCT01229267|528845474|FG000|Overall Study|Adverse Event|4|||
146636625|NCT01229267|528845475|FG001|Overall Study|Adverse Event|6|||
146636626|NCT01229267|528845476|FG002|Overall Study|Adverse Event|3|||
146636627|NCT01229267|528845477|FG003|Overall Study|Adverse Event|2|||
146636628|NCT01229267|528845478|FG004|Overall Study|Adverse Event|10|||
146636629|NCT01229267|528845474|FG000|Overall Study|Death|40|||
146636630|NCT01229267|528845475|FG001|Overall Study|Death|37|||
146636631|NCT01229267|528845476|FG002|Overall Study|Death|35|||
146636632|NCT01229267|528845477|FG003|Overall Study|Death|13|||
146636633|NCT01229267|528845478|FG004|Overall Study|Death|103|||
146636634|NCT01229267|528845474|FG000|Overall Study|Withdrawal by Subject|23|||
146636635|NCT01229267|528845475|FG001|Overall Study|Withdrawal by Subject|22|||
146636636|NCT01229267|528845476|FG002|Overall Study|Withdrawal by Subject|32|||
146636637|NCT01229267|528845477|FG003|Overall Study|Withdrawal by Subject|14|||
146636638|NCT01229267|528845478|FG004|Overall Study|Withdrawal by Subject|59|||
146636639|NCT01229267|528845474|FG000|Overall Study|Protocol Violation|0|||
146636640|NCT01229267|528845475|FG001|Overall Study|Protocol Violation|1|||
146636641|NCT01229267|528845476|FG002|Overall Study|Protocol Violation|0|||
146636642|NCT01229267|528845477|FG003|Overall Study|Protocol Violation|0|||
146636643|NCT01229267|528845478|FG004|Overall Study|Protocol Violation|0|||
146636644|NCT01229267|528845474|FG000|Overall Study|Progressive disease|0|||
146636645|NCT01229267|528845475|FG001|Overall Study|Progressive disease|0|||
146636646|NCT01229267|528845476|FG002|Overall Study|Progressive disease|0|||
146636647|NCT01229267|528845477|FG003|Overall Study|Progressive disease|0|||
146636648|NCT01229267|528845478|FG004|Overall Study|Progressive disease|1|||
146636649|NCT01229267|528845474|FG000|Overall Study|Physician Decision|8|||
146636650|NCT01229267|528845475|FG001|Overall Study|Physician Decision|11|||
146636651|NCT01229267|528845476|FG002|Overall Study|Physician Decision|8|||
146636652|NCT01229267|528845477|FG003|Overall Study|Physician Decision|3|||
146636653|NCT01229267|528845478|FG004|Overall Study|Physician Decision|25|||
146636654|NCT01229267|528845474|FG000|Overall Study|Lost to Follow-up|6|||
146636655|NCT01229267|528845475|FG001|Overall Study|Lost to Follow-up|5|||
146636656|NCT01229267|528845476|FG002|Overall Study|Lost to Follow-up|8|||
146636657|NCT01229267|528845477|FG003|Overall Study|Lost to Follow-up|3|||
146636658|NCT01229267|528845478|FG004|Overall Study|Lost to Follow-up|22|||
146636659|NCT00867815|528845484|FG000|Overall Study|Lost to Follow-up|1|||
146636660|NCT04050202|528845485|FG000|Overall Study|Lost to Follow-up|2|||
146636661|NCT00001213|528845486|FG000|Overall Study|Death|18|||
146890081|NCT00132730|529764797|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
146890082|NCT00132730|529764798|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
146967138|NCT00795886|530040158|FG000|Overall Study|Death|10|||
146556900|NCT00160563|528549019|FG002|Overall Study|Withdrawal by Subject|3|||
146556901|NCT00160563|528549017|FG000|Overall Study|Other (listed in the study report)|48|||
146556902|NCT00160563|528549018|FG001|Overall Study|Other (listed in the study report)|40|||
146556903|NCT00160563|528549019|FG002|Overall Study|Other (listed in the study report)|81|||
146556904|NCT00160563|528549017|FG000|Overall Study|Missing reason|0|||
146556905|NCT00160563|528549018|FG001|Overall Study|Missing reason|1|||
146556906|NCT00160563|528549019|FG002|Overall Study|Missing reason|0|||
146556907|NCT04157738|528549020|FG000|Overall Study|Moved out of state|0|||
146556908|NCT04157738|528549021|FG001|Overall Study|Moved out of state|2|||
146556909|NCT04157738|528549020|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
146556910|NCT04157738|528549021|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
146636662|NCT01499277|528845489|FG000|Overall Study|Adverse Event|3|||
146636663|NCT01499277|528845490|FG001|Overall Study|Adverse Event|6|||
146636664|NCT01499277|528845489|FG000|Overall Study|Death|3|||
146636665|NCT01499277|528845490|FG001|Overall Study|Death|2|||
146636666|NCT01499277|528845489|FG000|Overall Study|Lost to Follow-up|15|||
146636667|NCT01499277|528845490|FG001|Overall Study|Lost to Follow-up|8|||
146636668|NCT01499277|528845489|FG000|Overall Study|Protocol Violation|2|||
146636669|NCT01499277|528845490|FG001|Overall Study|Protocol Violation|3|||
146556911|NCT03766906|528549026|FG000|Overall Study|Withdrawal by Subject|6|||
146636670|NCT01499277|528845489|FG000|Overall Study|Withdrawal by Subject|16|||
146636671|NCT01499277|528845490|FG001|Overall Study|Withdrawal by Subject|6|||
146636672|NCT01499277|528845489|FG000|Overall Study|Lack of therapeutic response and other|8|||
146967139|NCT05554471|530040159|FG000|Overall Study|Physician Decision|2|||
146967140|NCT05554471|530040160|FG001|Overall Study|Physician Decision|1|||
146890083|NCT00132730|529764799|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
146890084|NCT00132730|529764800|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
146890085|NCT00132730|529764795|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
146890086|NCT00132730|529764796|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
146890087|NCT00132730|529764797|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
146890088|NCT00132730|529764798|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
146890089|NCT00132730|529764799|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
146890090|NCT00132730|529764800|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
146890091|NCT00132730|529764795|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
146890092|NCT00132730|529764796|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
146890093|NCT00132730|529764797|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
146890094|NCT00132730|529764798|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
146890095|NCT00132730|529764799|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
146556912|NCT01514357|528549027|FG000|Overall Study|Screen failure|2|||
146556913|NCT01514357|528549028|FG001|Overall Study|Screen failure|0|||
146556914|NCT01514357|528549027|FG000|Overall Study|Withdrawal by Subject|2|||
146556915|NCT01514357|528549028|FG001|Overall Study|Withdrawal by Subject|0|||
146556916|NCT00752219|528549029|FG000|Overall Study|Clinical failure|0|||
146556917|NCT00752219|528549030|FG001|Overall Study|Clinical failure|1|||
146556918|NCT00752219|528549029|FG000|Overall Study|Adverse Event|5|||
146556919|NCT00752219|528549030|FG001|Overall Study|Adverse Event|3|||
146556920|NCT00752219|528549029|FG000|Overall Study|Protocol deviation|1|||
146556921|NCT00752219|528549030|FG001|Overall Study|Protocol deviation|0|||
146556922|NCT00752219|528549029|FG000|Overall Study|Lost to Follow-up|1|||
146556923|NCT00752219|528549030|FG001|Overall Study|Lost to Follow-up|2|||
146556924|NCT00752219|528549029|FG000|Overall Study|Randomized but not treated|1|||
146556925|NCT00752219|528549030|FG001|Overall Study|Randomized but not treated|0|||
146556926|NCT00752219|528549029|FG000|Overall Study|Other|3|||
146636673|NCT01499277|528845490|FG001|Overall Study|Lack of therapeutic response and other|7|||
146636674|NCT00372593|528845493|FG000|Overall Study|Adverse Event|43|||
146636675|NCT00372593|528845494|FG001|Overall Study|Adverse Event|45|||
146636676|NCT00372593|528845495|FG002|Overall Study|Adverse Event|0|||
146636677|NCT00372593|528845493|FG000|Overall Study|Death|16|||
146766030|NCT01070888|529312099|FG000|First Intervention (14 Days)|Adverse Event|0|||
146766031|NCT01070888|529312100|FG001|First Intervention (14 Days)|Adverse Event|1|||
146766032|NCT01070888|529312099|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
146766033|NCT01070888|529312100|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
146766034|NCT01070888|529312099|FG000|Washout (14 Days)|Physician Decision|1|||
146766035|NCT01070888|529312100|FG001|Washout (14 Days)|Physician Decision|0|||
146766036|NCT02631148|529312101|FG000|Overall Study|8 were ineligible|8|||
146766037|NCT02631148|529312102|FG001|Overall Study|8 were ineligible|0|||
146766038|NCT02631148|529312101|FG000|Overall Study|Withdrawal by Subject|1|||
146766039|NCT02631148|529312102|FG001|Overall Study|Withdrawal by Subject|0|||
146766040|NCT02631148|529312101|FG000|Overall Study|PAH not available to study participant|1|||
146766041|NCT02631148|529312102|FG001|Overall Study|PAH not available to study participant|0|||
146766042|NCT00487578|529312103|FG000|Overall Study|Adverse Event|1|||
146766043|NCT00487578|529312104|FG001|Overall Study|Adverse Event|2|||
146636678|NCT00372593|528845494|FG001|Overall Study|Death|20|||
146636679|NCT00372593|528845495|FG002|Overall Study|Death|1|||
146636680|NCT00372593|528845493|FG000|Overall Study|Lack of Efficacy|82|||
146636681|NCT00372593|528845494|FG001|Overall Study|Lack of Efficacy|71|||
146636682|NCT00372593|528845495|FG002|Overall Study|Lack of Efficacy|2|||
146636683|NCT00372593|528845493|FG000|Overall Study|Lost to Follow-up|1|||
146636684|NCT00372593|528845494|FG001|Overall Study|Lost to Follow-up|0|||
146636685|NCT00372593|528845495|FG002|Overall Study|Lost to Follow-up|0|||
146636686|NCT00372593|528845493|FG000|Overall Study|Physician Decision|42|||
146636687|NCT00372593|528845494|FG001|Overall Study|Physician Decision|41|||
146636688|NCT00372593|528845495|FG002|Overall Study|Physician Decision|0|||
146636689|NCT00372593|528845493|FG000|Overall Study|Ineligible|20|||
146636690|NCT00372593|528845494|FG001|Overall Study|Ineligible|21|||
146636691|NCT00372593|528845495|FG002|Overall Study|Ineligible|1|||
146636692|NCT02974543|528845496|FG000|Overall Study|Withdrawal by Subject|1|||
146636693|NCT02974543|528845497|FG001|Overall Study|Withdrawal by Subject|0|||
146636694|NCT00742235|528845498|FG000|Overall Study|Lost to Follow-up|0|||
146636695|NCT00742235|528845499|FG001|Overall Study|Lost to Follow-up|31|||
146636696|NCT00433004|528845500|FG000|Overall Study|Lost to Follow-up|5|||
146636697|NCT00433004|528845501|FG001|Overall Study|Lost to Follow-up|7|||
146636698|NCT03534180|528845502|FG000|Overall Study|Withdrawal by Subject|1|||
146636699|NCT00220636|528845503|FG000|Overall Study|Withdrawal by Subject|4|||
146636700|NCT01237899|528845506|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
146636701|NCT01237899|528845507|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
146636702|NCT01237899|528845508|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
146636703|NCT01237899|528845509|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
146636704|NCT01237899|528845510|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
146636705|NCT01237899|528845511|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
146636706|NCT01237899|528845512|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
146636707|NCT01237899|528845513|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
146967141|NCT05554471|530040159|FG000|Overall Study|Lost to Follow-up|2|||
146967142|NCT05554471|530040160|FG001|Overall Study|Lost to Follow-up|1|||
146636708|NCT01237899|528845514|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
146636709|NCT01237899|528845515|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
146636710|NCT01237899|528845516|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
146636711|NCT00790088|528845517|FG000|Overall Study|Protocol Violation|11|||
146636712|NCT00790088|528845517|FG000|Overall Study|Withdrawal by Subject|17|||
146636713|NCT00790088|528845517|FG000|Overall Study|Lost to Follow-up|7|||
146636714|NCT00790088|528845517|FG000|Overall Study|Physician Decision|4|||
146636715|NCT05661409|528845518|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
146766044|NCT00487578|529312103|FG000|Overall Study|Lack of Efficacy|0|||
146766045|NCT00487578|529312104|FG001|Overall Study|Lack of Efficacy|1|||
146766046|NCT00487578|529312103|FG000|Overall Study|Lost to Follow-up|0|||
146766047|NCT00487578|529312104|FG001|Overall Study|Lost to Follow-up|1|||
146636716|NCT05661409|528845519|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
146636717|NCT05661409|528845520|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
146636718|NCT05661409|528845521|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
146636719|NCT05661409|528845522|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
146636720|NCT05661409|528845523|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
146636721|NCT05661409|528845518|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
146636722|NCT05661409|528845519|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
146636723|NCT05661409|528845520|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
146636724|NCT05661409|528845521|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
146636725|NCT05661409|528845522|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
146636726|NCT05661409|528845523|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
146636727|NCT05661409|528845518|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
146636728|NCT05661409|528845519|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
146636729|NCT05661409|528845520|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
146636730|NCT05661409|528845521|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
146636731|NCT05661409|528845522|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
146636732|NCT05661409|528845523|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
146636733|NCT05661409|528845518|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
146636734|NCT05661409|528845519|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
146636735|NCT05661409|528845520|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
146636736|NCT05661409|528845521|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
146636737|NCT05661409|528845522|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
146636738|NCT05661409|528845523|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
146636739|NCT05661409|528845518|FG000|Overall Study|Miscommu-nication about administration|0|||
146636740|NCT05661409|528845519|FG001|Overall Study|Miscommu-nication about administration|0|||
146636741|NCT05661409|528845520|FG002|Overall Study|Miscommu-nication about administration|0|||
146636742|NCT05661409|528845521|FG003|Overall Study|Miscommu-nication about administration|0|||
146636743|NCT05661409|528845522|FG004|Overall Study|Miscommu-nication about administration|0|||
146636744|NCT05661409|528845523|FG005|Overall Study|Miscommu-nication about administration|1|||
146636745|NCT02636595|528845524|FG000|Overall Study|Lost to Follow-up|1|||
146636746|NCT02636595|528845524|FG000|Overall Study|Other|1|||
146636747|NCT02015637|528845529|FG000|Overall Study|Lost to Follow-up|3|||
146636748|NCT02015637|528845530|FG001|Overall Study|Lost to Follow-up|5|||
146636749|NCT02015637|528845529|FG000|Overall Study|Adverse Event|3|||
146636750|NCT02015637|528845530|FG001|Overall Study|Adverse Event|0|||
146636751|NCT02015637|528845529|FG000|Overall Study|Did not take study drug|2|||
146636752|NCT02015637|528845530|FG001|Overall Study|Did not take study drug|0|||
146636753|NCT03198507|528845533|FG000|Overall Study|Withdrawal by Subject|1|||
146636754|NCT03198507|528845534|FG001|Overall Study|Withdrawal by Subject|0|||
146636755|NCT02454517|528845535|FG000|Overall Study|Withdrawal by Subject|3|||
146636756|NCT02454517|528845536|FG001|Overall Study|Withdrawal by Subject|0|||
146636757|NCT02454517|528845535|FG000|Overall Study|Lost to Follow-up|4|||
146636758|NCT02454517|528845536|FG001|Overall Study|Lost to Follow-up|7|||
146636759|NCT02454517|528845535|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
146636760|NCT02454517|528845536|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
146636761|NCT02194985|528845537|FG000|Overall Study|Adverse Event|1|||
146967143|NCT05554471|530040159|FG000|Overall Study|Death|0|||
146636762|NCT02194985|528845537|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
146636763|NCT02194985|528845537|FG000|Overall Study|Physician Decision|4|||
146636764|NCT02194985|528845537|FG000|Overall Study|Lost to Follow-up|1|||
146636765|NCT02194985|528845537|FG000|Overall Study|Withdrawal by Subject|2|||
146636766|NCT02304367|528845544|FG000|Overall Study|Lack of Response to Bruosumab|1|||
146636767|NCT02304367|528845544|FG000|Overall Study|Sponsor Decision|3|||
146636768|NCT02304367|528845544|FG000|Overall Study|Death|2|||
146636769|NCT02304367|528845544|FG000|Overall Study|Physician Decision|1|||
146636770|NCT02304367|528845544|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
146636771|NCT04139798|528845549|FG000|Overall Study|Withdrawal by Subject|6|||
146636772|NCT04139798|528845550|FG001|Overall Study|Withdrawal by Subject|5|||
146636773|NCT04139798|528845549|FG000|Overall Study|Lost to Follow-up|2|||
146636774|NCT04139798|528845550|FG001|Overall Study|Lost to Follow-up|5|||
146636775|NCT04139798|528845549|FG000|Overall Study|Discontinued|4|||
146636776|NCT04139798|528845550|FG001|Overall Study|Discontinued|2|||
146636777|NCT04139798|528845549|FG000|Overall Study|Adverse Event|1|||
146636778|NCT04139798|528845550|FG001|Overall Study|Adverse Event|3|||
146636779|NCT04139798|528845549|FG000|Overall Study|Protocol Violation|1|||
146636780|NCT04139798|528845550|FG001|Overall Study|Protocol Violation|0|||
146636781|NCT03895840|528845553|FG000|Overall Study|Withdrawal by Subject|21|||
146636782|NCT01931566|528845554|FG000|Overall Study|Randomized But Not Treated|6|||
146636783|NCT01931566|528845555|FG001|Overall Study|Randomized But Not Treated|9|||
146636784|NCT01931566|528845556|FG002|Overall Study|Randomized But Not Treated|14|||
146636785|NCT01931566|528845554|FG000|Overall Study|Adverse Event|37|||
146636786|NCT01931566|528845555|FG001|Overall Study|Adverse Event|167|||
146636787|NCT01931566|528845556|FG002|Overall Study|Adverse Event|132|||
146636788|NCT01931566|528845554|FG000|Overall Study|Major Protocol Deviation|5|||
146636789|NCT01931566|528845555|FG001|Overall Study|Major Protocol Deviation|14|||
146636790|NCT01931566|528845556|FG002|Overall Study|Major Protocol Deviation|21|||
146636791|NCT01931566|528845554|FG000|Overall Study|Lost to Follow-up|3|||
146636792|NCT01931566|528845555|FG001|Overall Study|Lost to Follow-up|26|||
146636793|NCT01931566|528845556|FG002|Overall Study|Lost to Follow-up|23|||
146636794|NCT01931566|528845554|FG000|Overall Study|Voluntary Withdrawal|78|||
146636795|NCT01931566|528845555|FG001|Overall Study|Voluntary Withdrawal|245|||
146636796|NCT01931566|528845556|FG002|Overall Study|Voluntary Withdrawal|225|||
146636797|NCT01931566|528845554|FG000|Overall Study|Study Termination|289|||
146636798|NCT01931566|528845555|FG001|Overall Study|Study Termination|968|||
146636799|NCT01931566|528845556|FG002|Overall Study|Study Termination|1037|||
146636800|NCT01931566|528845554|FG000|Overall Study|Reason Not Specified|11|||
146636801|NCT01931566|528845555|FG001|Overall Study|Reason Not Specified|47|||
146636802|NCT01931566|528845556|FG002|Overall Study|Reason Not Specified|53|||
146636803|NCT01931566|528845554|FG000|Overall Study|Missing|0|||
146636804|NCT01931566|528845555|FG001|Overall Study|Missing|0|||
146636805|NCT01931566|528845556|FG002|Overall Study|Missing|1|||
146636806|NCT01599637|528845557|FG000|Overall Study|administrative problems|0|||
146636807|NCT01599637|528845558|FG001|Overall Study|administrative problems|2|||
146890096|NCT00132730|529764800|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
146890097|NCT00132730|529764795|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
146890098|NCT00132730|529764796|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
146890099|NCT00132730|529764797|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
146890100|NCT00132730|529764798|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
146890101|NCT00132730|529764799|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
146636808|NCT01599637|528845559|FG002|Overall Study|administrative problems|0|||
146636809|NCT01599637|528845557|FG000|Overall Study|Adverse Event|1|||
146636810|NCT01599637|528845558|FG001|Overall Study|Adverse Event|0|||
146636811|NCT01599637|528845559|FG002|Overall Study|Adverse Event|0|||
146636812|NCT00760617|528845561|FG000|Overall Study|Adverse Event|5|||
146636813|NCT00760617|528845562|FG001|Overall Study|Adverse Event|2|||
146636814|NCT00760617|528845563|FG002|Overall Study|Adverse Event|0|||
146636815|NCT00760617|528845561|FG000|Overall Study|Lost to Follow-up|0|||
146636816|NCT00760617|528845562|FG001|Overall Study|Lost to Follow-up|0|||
146890102|NCT00132730|529764800|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
146636817|NCT00760617|528845563|FG002|Overall Study|Lost to Follow-up|5|||
146890103|NCT00132730|529764795|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
146890104|NCT00132730|529764796|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
146890105|NCT00132730|529764797|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
146890106|NCT00132730|529764798|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
146967144|NCT05554471|530040160|FG001|Overall Study|Death|1|||
146967145|NCT02576951|530040162|FG000|Overall Study|Lost to Follow-up|0|||
146967146|NCT02576951|530040163|FG001|Overall Study|Lost to Follow-up|0|||
146890107|NCT00132730|529764799|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
146890108|NCT00132730|529764800|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
146890109|NCT00132730|529764795|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
146890110|NCT00132730|529764796|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
146890111|NCT00132730|529764797|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
146890112|NCT00132730|529764798|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
146890113|NCT00132730|529764799|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
146890114|NCT00132730|529764800|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
146967147|NCT02576951|530040164|FG002|Overall Study|Lost to Follow-up|2|||
146556927|NCT00752219|528549030|FG001|Overall Study|Other|0|||
146556928|NCT04691115|528549033|FG000|Overall Study|Withdrawal by Subject|0|||
146556929|NCT04691115|528549034|FG001|Overall Study|Withdrawal by Subject|0|||
146556930|NCT04691115|528549035|FG002|Overall Study|Withdrawal by Subject|0|||
146556931|NCT04691115|528549036|FG003|Overall Study|Withdrawal by Subject|0|||
146556932|NCT04691115|528549037|FG004|Overall Study|Withdrawal by Subject|0|||
146556933|NCT04691115|528549038|FG005|Overall Study|Withdrawal by Subject|1|||
146556934|NCT04691115|528549039|FG006|Overall Study|Withdrawal by Subject|0|||
146556935|NCT04691115|528549040|FG007|Overall Study|Withdrawal by Subject|0|||
146556936|NCT04691115|528549041|FG008|Overall Study|Withdrawal by Subject|0|||
146556937|NCT04691115|528549042|FG009|Overall Study|Withdrawal by Subject|0|||
146556938|NCT04691115|528549043|FG010|Overall Study|Withdrawal by Subject|0|||
146556939|NCT04691115|528549044|FG011|Overall Study|Withdrawal by Subject|0|||
146556940|NCT04691115|528549045|FG012|Overall Study|Withdrawal by Subject|0|||
146556941|NCT04691115|528549046|FG013|Overall Study|Withdrawal by Subject|0|||
146967148|NCT02576951|530040165|FG003|Overall Study|Lost to Follow-up|2|||
146636818|NCT04476797|528845564|FG000|Overall Study|Withdrawal by Subject|1|||
146636819|NCT04476797|528845565|FG001|Overall Study|Withdrawal by Subject|0|||
146636820|NCT04476797|528845566|FG002|Overall Study|Withdrawal by Subject|0|||
146766048|NCT02525796|529312109|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
146766049|NCT02525796|529312110|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
146766050|NCT02525796|529312111|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
146766051|NCT02525796|529312109|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
146766052|NCT02525796|529312110|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
146766053|NCT02525796|529312111|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
146766054|NCT02525796|529312109|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
146766055|NCT02525796|529312110|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
146766056|NCT02525796|529312111|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
146766057|NCT02525796|529312109|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
146766058|NCT02525796|529312110|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
146766059|NCT02525796|529312111|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
146766060|NCT02525796|529312109|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
146766061|NCT02525796|529312110|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
146766062|NCT02525796|529312111|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
146766063|NCT00726999|529312112|FG000|Overall Study|Physician Decision|0|||
146766064|NCT00726999|529312113|FG001|Overall Study|Physician Decision|1|||
146766065|NCT00726999|529312112|FG000|Overall Study|Withdrawal by Subject|2|||
146766066|NCT00726999|529312113|FG001|Overall Study|Withdrawal by Subject|0|||
146766067|NCT00726999|529312112|FG000|Overall Study|Protocol Violation|1|||
146766068|NCT00726999|529312113|FG001|Overall Study|Protocol Violation|0|||
146766069|NCT00955825|529312114|FG000|Overall Study|Adverse Event|15|||
146766070|NCT00955825|529312115|FG001|Overall Study|Adverse Event|2|||
146766071|NCT00955825|529312114|FG000|Overall Study|Withdrawal by Subject|4|||
146890115|NCT00132730|529764795|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
146636821|NCT04476797|528845564|FG000|Overall Study|Death|0|||
146636822|NCT04476797|528845565|FG001|Overall Study|Death|1|||
146636823|NCT04476797|528845566|FG002|Overall Study|Death|2|||
146636824|NCT04476797|528845564|FG000|Overall Study|Sponsor Terminated Study|0|||
146636825|NCT04476797|528845565|FG001|Overall Study|Sponsor Terminated Study|18|||
146636826|NCT04476797|528845566|FG002|Overall Study|Sponsor Terminated Study|17|||
146636827|NCT02395081|528845567|FG000|Overall Study|Withdrawal by Subject|1|||
146636828|NCT02395081|528845568|FG001|Overall Study|Withdrawal by Subject|1|||
146636829|NCT02395081|528845569|FG002|Overall Study|Withdrawal by Subject|0|||
146636830|NCT02395081|528845567|FG000|Overall Study|Moved where blood couldn't be collected|4|||
146636831|NCT02395081|528845568|FG001|Overall Study|Moved where blood couldn't be collected|1|||
146636832|NCT02395081|528845569|FG002|Overall Study|Moved where blood couldn't be collected|3|||
146636833|NCT02395081|528845567|FG000|Overall Study|Fetal Loss|2|||
146636834|NCT02395081|528845568|FG001|Overall Study|Fetal Loss|3|||
146636835|NCT02395081|528845569|FG002|Overall Study|Fetal Loss|1|||
146636836|NCT04625101|528845570|FG000|Overall Study|Withdrawal by Subject|0|||
146636837|NCT04625101|528845571|FG001|Overall Study|Withdrawal by Subject|1|||
146636838|NCT04625101|528845570|FG000|Overall Study|Protocol Deviation|1|||
146636839|NCT04625101|528845571|FG001|Overall Study|Protocol Deviation|0|||
146636840|NCT02991040|528845572|FG000|Overall Study|Withdrawal by Subject|2|||
146636841|NCT02991040|528845572|FG000|Overall Study|Lost to Follow-up|2|||
146636842|NCT02721966|528845573|FG000|Overall Study|Protocol Violation|1|||
146636843|NCT02721966|528845574|FG001|Overall Study|Protocol Violation|0|||
146636844|NCT02721966|528845575|FG002|Overall Study|Protocol Violation|0|||
146636845|NCT02721966|528845576|FG003|Overall Study|Protocol Violation|0|||
146636846|NCT02721966|528845577|FG004|Overall Study|Protocol Violation|0|||
146636847|NCT02721966|528845573|FG000|Overall Study|Withdrawal by Subject|9|||
146636848|NCT02721966|528845574|FG001|Overall Study|Withdrawal by Subject|2|||
146636849|NCT02721966|528845575|FG002|Overall Study|Withdrawal by Subject|3|||
146636850|NCT02721966|528845576|FG003|Overall Study|Withdrawal by Subject|7|||
146636851|NCT02721966|528845577|FG004|Overall Study|Withdrawal by Subject|0|||
146636852|NCT02721966|528845573|FG000|Overall Study|Adverse Event|4|||
146636853|NCT02721966|528845574|FG001|Overall Study|Adverse Event|4|||
146636854|NCT02721966|528845575|FG002|Overall Study|Adverse Event|3|||
146890116|NCT00132730|529764796|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
146890117|NCT00132730|529764797|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
146890118|NCT00132730|529764798|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
146636855|NCT02721966|528845576|FG003|Overall Study|Adverse Event|0|||
146636856|NCT02721966|528845577|FG004|Overall Study|Adverse Event|0|||
146636857|NCT02721966|528845573|FG000|Overall Study|Death|1|||
146766072|NCT00955825|529312115|FG001|Overall Study|Withdrawal by Subject|6|||
146766073|NCT00955825|529312114|FG000|Overall Study|Any other reason not above-mentioned|7|||
146636858|NCT02721966|528845574|FG001|Overall Study|Death|0|||
146636859|NCT02721966|528845575|FG002|Overall Study|Death|0|||
146636860|NCT02721966|528845576|FG003|Overall Study|Death|0|||
146636861|NCT02721966|528845577|FG004|Overall Study|Death|0|||
146890119|NCT00132730|529764799|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
146890120|NCT00132730|529764800|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
146556942|NCT01681849|528549056|FG000|Overall Study|Protocol Violation|2|||
146556943|NCT01681849|528549057|FG001|Overall Study|Protocol Violation|0|||
146556944|NCT01681849|528549058|FG002|Overall Study|Protocol Violation|0|||
146556945|NCT01681849|528549056|FG000|Overall Study|Withdrawal by Subject|3|||
146556946|NCT01681849|528549057|FG001|Overall Study|Withdrawal by Subject|5|||
146556947|NCT01681849|528549058|FG002|Overall Study|Withdrawal by Subject|33|||
146556948|NCT01681849|528549056|FG000|Overall Study|Lost to Follow-up|3|||
146556949|NCT01681849|528549057|FG001|Overall Study|Lost to Follow-up|2|||
146556950|NCT01681849|528549058|FG002|Overall Study|Lost to Follow-up|6|||
146556951|NCT04525183|528549061|FG000|Overall Study|Withdrawal by Subject|0|||
146556952|NCT04525183|528549062|FG001|Overall Study|Withdrawal by Subject|0|||
146556953|NCT04525183|528549063|FG002|Overall Study|Withdrawal by Subject|3|||
146556954|NCT04525183|528549061|FG000|Overall Study|Study non-compliance|0|||
146556955|NCT04525183|528549062|FG001|Overall Study|Study non-compliance|0|||
146556956|NCT04525183|528549063|FG002|Overall Study|Study non-compliance|1|||
146556957|NCT04525183|528549061|FG000|Overall Study|Recurrent disease before starting on study|0|||
146556958|NCT04525183|528549062|FG001|Overall Study|Recurrent disease before starting on study|0|||
146556959|NCT04525183|528549063|FG002|Overall Study|Recurrent disease before starting on study|1|||
146556960|NCT01166646|528549064|FG000|Overall Study|Protocol Violation|0|||
146556961|NCT01166646|528549065|FG001|Overall Study|Protocol Violation|1|||
146556962|NCT01166646|528549064|FG000|Overall Study|Adverse Event|1|||
146556963|NCT01166646|528549065|FG001|Overall Study|Adverse Event|0|||
146556964|NCT03777020|528549070|FG000|Overall Study|Withdrawal by Subject|4|||
146556965|NCT03777020|528549071|FG001|Overall Study|Withdrawal by Subject|4|||
146556966|NCT03777020|528549070|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
146556967|NCT03777020|528549071|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
146556968|NCT03460704|528549072|FG000|Overall Study|Withdrawal by Subject|11|||
146556969|NCT03460704|528549073|FG001|Overall Study|Withdrawal by Subject|14|||
146890121|NCT00132730|529764795|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
146890122|NCT00132730|529764796|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
146890123|NCT00132730|529764797|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
146890124|NCT00132730|529764798|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
146890125|NCT00132730|529764799|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
146890126|NCT00132730|529764800|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
146890127|NCT00132730|529764795|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
146890128|NCT00132730|529764796|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
146890129|NCT00132730|529764797|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
146890130|NCT00132730|529764798|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
146890131|NCT00132730|529764799|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
146890132|NCT00132730|529764800|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
146890133|NCT00132730|529764795|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
146890134|NCT00132730|529764796|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
146890135|NCT00132730|529764797|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
146890136|NCT00132730|529764798|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
146890137|NCT00132730|529764799|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
146890138|NCT00132730|529764800|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
146890139|NCT00132730|529764795|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
146890140|NCT00132730|529764796|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
146890141|NCT00132730|529764797|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
146890142|NCT00132730|529764798|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
146890143|NCT00132730|529764799|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
146890144|NCT00132730|529764800|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
146890145|NCT00132730|529764795|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
146890146|NCT00132730|529764796|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
146890147|NCT00132730|529764797|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
146890148|NCT00132730|529764798|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
146890149|NCT00132730|529764799|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
146890150|NCT00132730|529764800|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
146890151|NCT01192347|529764801|FG000|Overall Study|Death|3|||
146890152|NCT01192347|529764801|FG000|Overall Study|Lost to Follow-up|3|||
146890153|NCT01192347|529764801|FG000|Overall Study|Withdrawal by Subject|1|||
146890154|NCT01192347|529764801|FG000|Overall Study|Adverse Event|1|||
146890155|NCT01192347|529764801|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
146890156|NCT01192347|529764801|FG000|Overall Study|Patient seen in different hospital|1|||
146890157|NCT01192347|529764801|FG000|Overall Study|Patient not visiting hospital regularly|1|||
146890158|NCT01192347|529764801|FG000|Overall Study|Patient did not show up for visits|1|||
146890159|NCT02623335|529764802|FG000|Overall Study|Death|8|||
146890160|NCT02623335|529764803|FG001|Overall Study|Death|7|||
146890161|NCT02623335|529764802|FG000|Overall Study|Lost to Follow-up|15|||
146890162|NCT02623335|529764803|FG001|Overall Study|Lost to Follow-up|23|||
146890163|NCT02623335|529764802|FG000|Overall Study|Withdrawal by Subject|2|||
146890164|NCT02623335|529764803|FG001|Overall Study|Withdrawal by Subject|5|||
146890165|NCT02623335|529764802|FG000|Overall Study|Protocol Violation|2|||
146890166|NCT02623335|529764803|FG001|Overall Study|Protocol Violation|1|||
146890167|NCT03739528|529764804|FG000|Overall Study|Not treated|8|||
146890168|NCT03739528|529764805|FG001|Overall Study|Not treated|12|||
146890169|NCT03739528|529764804|FG000|Overall Study|Treatment and study discontinued|6|||
146890170|NCT03739528|529764805|FG001|Overall Study|Treatment and study discontinued|2|||
146890171|NCT03739528|529764804|FG000|Overall Study|Treatment discontinued + study completed|1|||
146890172|NCT03739528|529764805|FG001|Overall Study|Treatment discontinued + study completed|3|||
146890173|NCT00395967|529764806|FG000|Treatment Period|Failed Mobilization|1|||
146890174|NCT00395967|529764806|FG000|Follow-up Period|Death|1|||
146890175|NCT00395967|529764806|FG000|Follow-up Period|Lost to Follow-up|1|||
146890176|NCT01109940|529764807|FG000|Overall Study|Administrative problems|2|||
146636862|NCT02721966|528845573|FG000|Overall Study|Lack of Efficacy|7|||
146636863|NCT02721966|528845574|FG001|Overall Study|Lack of Efficacy|4|||
146636864|NCT02721966|528845575|FG002|Overall Study|Lack of Efficacy|0|||
146636865|NCT02721966|528845576|FG003|Overall Study|Lack of Efficacy|0|||
146636866|NCT02721966|528845577|FG004|Overall Study|Lack of Efficacy|0|||
146636867|NCT02721966|528845573|FG000|Overall Study|Lost to Follow-up|0|||
146636868|NCT02721966|528845574|FG001|Overall Study|Lost to Follow-up|0|||
146636869|NCT02721966|528845575|FG002|Overall Study|Lost to Follow-up|3|||
146636870|NCT02721966|528845576|FG003|Overall Study|Lost to Follow-up|0|||
146636871|NCT02721966|528845577|FG004|Overall Study|Lost to Follow-up|0|||
146636872|NCT02721966|528845573|FG000|Overall Study|Physician Decision|1|||
146636873|NCT02721966|528845574|FG001|Overall Study|Physician Decision|1|||
146636874|NCT02721966|528845575|FG002|Overall Study|Physician Decision|0|||
146636875|NCT02721966|528845576|FG003|Overall Study|Physician Decision|0|||
146636876|NCT02721966|528845577|FG004|Overall Study|Physician Decision|0|||
146636877|NCT02721966|528845573|FG000|Overall Study|Pregnancy|1|||
146636878|NCT02721966|528845574|FG001|Overall Study|Pregnancy|0|||
146636879|NCT02721966|528845575|FG002|Overall Study|Pregnancy|0|||
146636880|NCT02721966|528845576|FG003|Overall Study|Pregnancy|0|||
146636881|NCT02721966|528845577|FG004|Overall Study|Pregnancy|0|||
146636882|NCT02721966|528845573|FG000|Overall Study|Did not continue to period 2|5|||
146636883|NCT02721966|528845574|FG001|Overall Study|Did not continue to period 2|12|||
146636884|NCT02721966|528845575|FG002|Overall Study|Did not continue to period 2|0|||
146890177|NCT01109940|529764808|FG001|Overall Study|Administrative problems|0|||
146890178|NCT01109940|529764809|FG002|Overall Study|Administrative problems|0|||
146890179|NCT01109940|529764810|FG003|Overall Study|Administrative problems|0|||
146890180|NCT01109940|529764807|FG000|Overall Study|Serious Adverse Event|2|||
146890181|NCT01109940|529764808|FG001|Overall Study|Serious Adverse Event|1|||
146890182|NCT01109940|529764809|FG002|Overall Study|Serious Adverse Event|0|||
146890183|NCT01109940|529764810|FG003|Overall Study|Serious Adverse Event|0|||
146890184|NCT01109940|529764807|FG000|Overall Study|Lost to Follow-up|1|||
146890185|NCT01109940|529764808|FG001|Overall Study|Lost to Follow-up|0|||
146636885|NCT02721966|528845576|FG003|Overall Study|Did not continue to period 2|0|||
146636886|NCT02721966|528845577|FG004|Overall Study|Did not continue to period 2|5|||
146636887|NCT03070964|528845578|FG000|Overall Study|Progressive disease|8|||
146636888|NCT03070964|528845578|FG000|Overall Study|Treatment-unrelated adverse event|2|||
146636889|NCT03070964|528845578|FG000|Overall Study|Never treated|1|||
146636890|NCT03070964|528845578|FG000|Overall Study|Physician Decision|1|||
146636891|NCT03070964|528845578|FG000|Overall Study|Withdrawal by Subject|1|||
146636892|NCT03070964|528845578|FG000|Overall Study|Adverse Event|1|||
146636893|NCT01286480|528845579|FG000|Overall Study|Withdrawal by Subject|5|||
146636894|NCT01286480|528845580|FG001|Overall Study|Withdrawal by Subject|3|||
146636895|NCT00834093|528845581|FG000|Overall Study|Progressive Disease|3|||
146636896|NCT00834093|528845581|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
146636897|NCT01209325|528845582|FG000|Overall Study|Lost to Follow-up|24|||
146636898|NCT01209325|528845582|FG000|Overall Study|Adverse Event|1|||
146636899|NCT01209325|528845582|FG000|Overall Study|Relocated|3|||
146890186|NCT01109940|529764809|FG002|Overall Study|Lost to Follow-up|0|||
146636900|NCT01209325|528845582|FG000|Overall Study|Refusal after starting therapy|8|||
146636901|NCT01209325|528845582|FG000|Overall Study|Protocol Violation|4|||
146636902|NCT01209325|528845582|FG000|Overall Study|Refusal prior to therapy|1|||
146636903|NCT01209325|528845582|FG000|Overall Study|Incarceration|2|||
146556970|NCT03460704|528549072|FG000|Overall Study|Study terminated by the Sponsor|29|||
146556971|NCT03460704|528549073|FG001|Overall Study|Study terminated by the Sponsor|19|||
146556972|NCT03460704|528549072|FG000|Overall Study|Adverse Event|10|||
146556973|NCT03460704|528549073|FG001|Overall Study|Adverse Event|5|||
146556974|NCT03460704|528549072|FG000|Overall Study|Death|3|||
146556975|NCT03460704|528549073|FG001|Overall Study|Death|2|||
146556976|NCT03460704|528549072|FG000|Overall Study|Non-Compliance with Study Drug|3|||
146636904|NCT00607373|528845583|FG000|Treatment Period|Adverse Event|0|||
146636905|NCT00607373|528845584|FG001|Treatment Period|Adverse Event|4|||
146636906|NCT00607373|528845583|FG000|Treatment Period|Physician Decision|0|||
146636907|NCT00607373|528845584|FG001|Treatment Period|Physician Decision|1|||
146636908|NCT00607373|528845583|FG000|Treatment Period|Withdrawal by Subject|0|||
146636909|NCT00607373|528845584|FG001|Treatment Period|Withdrawal by Subject|1|||
146636910|NCT00607373|528845583|FG000|Follow-up Period|Other|0|||
146636911|NCT00607373|528845584|FG001|Follow-up Period|Other|1|||
146636912|NCT00607373|528845583|FG000|Follow-up Period|Protocol Violation|0|||
146636913|NCT00607373|528845584|FG001|Follow-up Period|Protocol Violation|1|||
146636914|NCT00607373|528845583|FG000|Follow-up Period|Withdrawal by Subject|1|||
146636915|NCT00607373|528845584|FG001|Follow-up Period|Withdrawal by Subject|3|||
146636916|NCT01918306|528845585|FG000|Overall Study|progresive disease|4|||
146636917|NCT01918306|528845586|FG001|Overall Study|progresive disease|0|||
146636918|NCT01918306|528845587|FG002|Overall Study|progresive disease|1|||
146636919|NCT01918306|528845588|FG003|Overall Study|progresive disease|1|||
146636920|NCT01918306|528845585|FG000|Overall Study|Withdrawal by Subject|0|||
146636921|NCT01918306|528845586|FG001|Overall Study|Withdrawal by Subject|0|||
146636922|NCT01918306|528845587|FG002|Overall Study|Withdrawal by Subject|0|||
146636923|NCT01918306|528845588|FG003|Overall Study|Withdrawal by Subject|2|||
146636924|NCT01918306|528845585|FG000|Overall Study|neutropenia|1|||
146636925|NCT01918306|528845586|FG001|Overall Study|neutropenia|0|||
146636926|NCT01918306|528845587|FG002|Overall Study|neutropenia|0|||
146636927|NCT01918306|528845588|FG003|Overall Study|neutropenia|0|||
146636928|NCT01918306|528845585|FG000|Overall Study|Lack of Efficacy|1|||
146636929|NCT01918306|528845586|FG001|Overall Study|Lack of Efficacy|0|||
146636930|NCT01918306|528845587|FG002|Overall Study|Lack of Efficacy|0|||
146636931|NCT01918306|528845588|FG003|Overall Study|Lack of Efficacy|0|||
146636932|NCT01918306|528845585|FG000|Overall Study|progress disease, crossover|0|||
146556977|NCT03460704|528549073|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146556978|NCT03460704|528549072|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146556979|NCT03460704|528549073|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
146636933|NCT01918306|528845586|FG001|Overall Study|progress disease, crossover|0|||
146556980|NCT03460704|528549072|FG000|Overall Study|Other|2|||
146556981|NCT03460704|528549073|FG001|Overall Study|Other|1|||
146556982|NCT01767857|528549074|FG000|Overall Study|Adverse Event|27|||
146636934|NCT01918306|528845587|FG002|Overall Study|progress disease, crossover|1|||
146636935|NCT01918306|528845588|FG003|Overall Study|progress disease, crossover|0|||
146636936|NCT01160822|528845593|FG000|Overall Study|Adverse Event|0|||
146636937|NCT01160822|528845594|FG001|Overall Study|Adverse Event|0|||
146636938|NCT01160822|528845595|FG002|Overall Study|Adverse Event|0|||
146636939|NCT01160822|528845596|FG003|Overall Study|Adverse Event|0|||
146636940|NCT01160822|528845597|FG004|Overall Study|Adverse Event|1|||
146556983|NCT01767857|528549075|FG001|Overall Study|Adverse Event|7|||
146556984|NCT01767857|528549074|FG000|Overall Study|Death|28|||
146556985|NCT01767857|528549075|FG001|Overall Study|Death|13|||
146556986|NCT01767857|528549074|FG000|Overall Study|Lack of Efficacy|299|||
146556987|NCT01767857|528549075|FG001|Overall Study|Lack of Efficacy|151|||
146556988|NCT01767857|528549074|FG000|Overall Study|Lost to Follow-up|1|||
146967149|NCT02576951|530040162|FG000|Overall Study|Withdrawal by Subject|1|||
146967150|NCT02576951|530040163|FG001|Overall Study|Withdrawal by Subject|0|||
146967151|NCT02576951|530040164|FG002|Overall Study|Withdrawal by Subject|0|||
146967152|NCT02576951|530040165|FG003|Overall Study|Withdrawal by Subject|2|||
146967153|NCT02576951|530040162|FG000|Overall Study|Protocol Violation|0|||
146967154|NCT02576951|530040163|FG001|Overall Study|Protocol Violation|0|||
146967155|NCT02576951|530040164|FG002|Overall Study|Protocol Violation|0|||
146967156|NCT02576951|530040165|FG003|Overall Study|Protocol Violation|1|||
146967157|NCT02062385|530040169|FG000|Overall Study|Adverse Event|19|||
146967158|NCT02062385|530040170|FG001|Overall Study|Adverse Event|13|||
146967159|NCT02062385|530040171|FG002|Overall Study|Adverse Event|1|||
146967160|NCT02062385|530040172|FG003|Overall Study|Adverse Event|0|||
146967161|NCT02062385|530040169|FG000|Overall Study|Protocol Violation|1|||
146967162|NCT02062385|530040170|FG001|Overall Study|Protocol Violation|0|||
146967163|NCT02062385|530040171|FG002|Overall Study|Protocol Violation|0|||
146556989|NCT01767857|528549075|FG001|Overall Study|Lost to Follow-up|1|||
146556990|NCT01767857|528549074|FG000|Overall Study|Withdrawal by Subject|38|||
146556991|NCT01767857|528549075|FG001|Overall Study|Withdrawal by Subject|18|||
146556992|NCT01767857|528549074|FG000|Overall Study|Physician Decision|17|||
146556993|NCT01767857|528549075|FG001|Overall Study|Physician Decision|10|||
146556994|NCT01767857|528549074|FG000|Overall Study|Protocol Terminated|1|||
146556995|NCT01767857|528549075|FG001|Overall Study|Protocol Terminated|0|||
146556996|NCT01767857|528549074|FG000|Overall Study|Randomized But Never Treated|19|||
146556997|NCT01767857|528549075|FG001|Overall Study|Randomized But Never Treated|13|||
146556998|NCT04126174|528549076|FG000|Overall Study|Lost to Follow-up|3|||
146556999|NCT04126174|528549077|FG001|Overall Study|Lost to Follow-up|3|||
146557000|NCT04439903|528549088|FG000|Overall Study|Withdrawal by Subject|2|||
146557001|NCT04439903|528549088|FG000|Overall Study|Screen Failure|1|||
146557002|NCT02899754|528549089|FG000|Overall Study|Lost to Follow-up|7|||
146557003|NCT02899754|528549090|FG001|Overall Study|Lost to Follow-up|9|||
146557004|NCT04818229|528549091|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
146557005|NCT04818229|528549092|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
146557006|NCT04818229|528549093|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
146557007|NCT04818229|528549091|FG000|Overall Study|Adverse Event|3|||
146557008|NCT04818229|528549092|FG001|Overall Study|Adverse Event|1|||
146557009|NCT04818229|528549093|FG002|Overall Study|Adverse Event|1|||
146557010|NCT04818229|528549091|FG000|Overall Study|Withdrawal by Subject|0|||
146557011|NCT04818229|528549092|FG001|Overall Study|Withdrawal by Subject|0|||
146557012|NCT04818229|528549093|FG002|Overall Study|Withdrawal by Subject|2|||
146557013|NCT04818229|528549091|FG000|Overall Study|Lost to Follow-up|0|||
146557014|NCT04818229|528549092|FG001|Overall Study|Lost to Follow-up|0|||
146557015|NCT04818229|528549093|FG002|Overall Study|Lost to Follow-up|1|||
146557016|NCT03769116|528549100|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
146557017|NCT03769116|528549101|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
146557018|NCT03769116|528549100|FG000|Part 3 - Open Label|Physician Decision|1|||
146557019|NCT03769116|528549101|FG001|Part 3 - Open Label|Physician Decision|0|||
146557020|NCT03769116|528549100|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
146557021|NCT03769116|528549101|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
146557022|NCT02181413|528549104|FG000|Overall Study|Withdrawal by Subject|45|||
146557023|NCT02181413|528549105|FG001|Overall Study|Withdrawal by Subject|61|||
146557024|NCT02181413|528549104|FG000|Overall Study|Reason Not Specified|2|||
146557025|NCT02181413|528549105|FG001|Overall Study|Reason Not Specified|5|||
146557026|NCT02181413|528549104|FG000|Overall Study|Lost to Follow-up|8|||
146557027|NCT02181413|528549105|FG001|Overall Study|Lost to Follow-up|7|||
146557028|NCT04003142|528549107|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
146557029|NCT04003142|528549108|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
146557030|NCT04003142|528549109|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
146557031|NCT04003142|528549110|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
146557032|NCT04003142|528549111|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
146557033|NCT04003142|528549107|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
146967164|NCT02062385|530040172|FG003|Overall Study|Protocol Violation|0|||
146967165|NCT02062385|530040169|FG000|Overall Study|Incomplete EPI by database lock|2|||
146967166|NCT02062385|530040170|FG001|Overall Study|Incomplete EPI by database lock|0|||
146967167|NCT02062385|530040171|FG002|Overall Study|Incomplete EPI by database lock|0|||
146967168|NCT02062385|530040172|FG003|Overall Study|Incomplete EPI by database lock|0|||
146967169|NCT02062385|530040169|FG000|Overall Study|Moved|10|||
146967170|NCT02062385|530040170|FG001|Overall Study|Moved|11|||
146967171|NCT02062385|530040171|FG002|Overall Study|Moved|1|||
146967172|NCT02062385|530040172|FG003|Overall Study|Moved|0|||
146967173|NCT02062385|530040169|FG000|Overall Study|Withdrawn by parent/guardian|46|||
146967174|NCT02062385|530040170|FG001|Overall Study|Withdrawn by parent/guardian|41|||
146967175|NCT02062385|530040171|FG002|Overall Study|Withdrawn by parent/guardian|9|||
146967176|NCT02062385|530040172|FG003|Overall Study|Withdrawn by parent/guardian|8|||
146967177|NCT02062385|530040169|FG000|Overall Study|Death|0|||
146967178|NCT02062385|530040170|FG001|Overall Study|Death|0|||
146967179|NCT02062385|530040171|FG002|Overall Study|Death|0|||
146967180|NCT02062385|530040172|FG003|Overall Study|Death|1|||
146967181|NCT02062385|530040169|FG000|Overall Study|Lost to Follow-up|0|||
146766074|NCT00955825|529312115|FG001|Overall Study|Any other reason not above-mentioned|9|||
146766075|NCT00393848|529312120|FG000|Overall Study|Surgical schedule|0|||
146967182|NCT02062385|530040170|FG001|Overall Study|Lost to Follow-up|0|||
146967183|NCT02062385|530040171|FG002|Overall Study|Lost to Follow-up|1|||
146967184|NCT02062385|530040172|FG003|Overall Study|Lost to Follow-up|0|||
146636941|NCT01160822|528845598|FG005|Overall Study|Adverse Event|2|||
146967185|NCT00157820|530040175|FG000|Randomized|Physician Decision|4|||
146636942|NCT01160822|528845599|FG006|Overall Study|Adverse Event|5|||
146890187|NCT01109940|529764810|FG003|Overall Study|Lost to Follow-up|0|||
146890188|NCT01109940|529764807|FG000|Overall Study|Patient withdrew consent|1|||
146890189|NCT01109940|529764808|FG001|Overall Study|Patient withdrew consent|1|||
146890190|NCT01109940|529764809|FG002|Overall Study|Patient withdrew consent|0|||
146890191|NCT01109940|529764810|FG003|Overall Study|Patient withdrew consent|0|||
146890192|NCT01109940|529764807|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146890193|NCT01109940|529764808|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146890194|NCT01109940|529764809|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
146890195|NCT01109940|529764810|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
146890196|NCT00179959|529764811|FG000|Overall Study|Lost to Follow-up|3|||
146890197|NCT00179959|529764812|FG001|Overall Study|Lost to Follow-up|1|||
146890198|NCT00179959|529764811|FG000|Overall Study|Withdrawal by Subject|3|||
146890199|NCT00179959|529764812|FG001|Overall Study|Withdrawal by Subject|2|||
146890200|NCT02400255|529764813|FG000|Overall Study|Relapse|4|||
146890201|NCT02400255|529764814|FG001|Overall Study|Relapse|1|||
146890202|NCT02400255|529764815|FG002|Overall Study|Relapse|1|||
146890203|NCT02400255|529764816|FG003|Overall Study|Relapse|2|||
146890204|NCT02400255|529764813|FG000|Overall Study|Adverse Event|6|||
146890205|NCT02400255|529764814|FG001|Overall Study|Adverse Event|3|||
146890206|NCT02400255|529764815|FG002|Overall Study|Adverse Event|0|||
146890207|NCT02400255|529764816|FG003|Overall Study|Adverse Event|0|||
146890208|NCT02400255|529764813|FG000|Overall Study|Physician Decision|6|||
146890209|NCT02400255|529764814|FG001|Overall Study|Physician Decision|0|||
146890210|NCT02400255|529764815|FG002|Overall Study|Physician Decision|0|||
146890211|NCT02400255|529764816|FG003|Overall Study|Physician Decision|0|||
146890212|NCT02400255|529764813|FG000|Overall Study|Loss of insurance|1|||
146890213|NCT02400255|529764814|FG001|Overall Study|Loss of insurance|0|||
146557034|NCT04003142|528549108|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
146557035|NCT04003142|528549109|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
146557036|NCT04003142|528549110|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
146557037|NCT04003142|528549111|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
146557038|NCT04003142|528549107|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
146557039|NCT04003142|528549108|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
146557040|NCT04003142|528549109|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
146557041|NCT04003142|528549110|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
146557042|NCT04003142|528549111|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
146557043|NCT04003142|528549107|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
146557044|NCT04003142|528549108|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
146557045|NCT04003142|528549109|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
146557046|NCT04003142|528549110|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
146557047|NCT04003142|528549111|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
146557048|NCT04003142|528549107|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
146557049|NCT04003142|528549108|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
146557050|NCT04003142|528549109|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
146557051|NCT04003142|528549110|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
146557052|NCT04003142|528549111|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
146557053|NCT04003142|528549107|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
146557054|NCT04003142|528549108|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
146557055|NCT04003142|528549109|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
146557056|NCT04003142|528549110|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
146557057|NCT04003142|528549111|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
146557058|NCT04003142|528549107|FG000|Extension Period (40 Weeks)|Death|0|||
146557059|NCT04003142|528549108|FG001|Extension Period (40 Weeks)|Death|0|||
146557060|NCT04003142|528549109|FG002|Extension Period (40 Weeks)|Death|0|||
146557061|NCT04003142|528549110|FG003|Extension Period (40 Weeks)|Death|0|||
146557062|NCT04003142|528549111|FG004|Extension Period (40 Weeks)|Death|1|||
146557063|NCT04003142|528549107|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
146557064|NCT04003142|528549108|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
146557065|NCT04003142|528549109|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
146557066|NCT04003142|528549110|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
146557067|NCT04003142|528549111|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
146766076|NCT00393848|529312121|FG001|Overall Study|Surgical schedule|0|||
146557068|NCT04003142|528549107|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
146557069|NCT04003142|528549108|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
146557070|NCT04003142|528549109|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
146967186|NCT00157820|530040176|FG001|Randomized|Physician Decision|2|||
146557071|NCT04003142|528549110|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
146557072|NCT04003142|528549111|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
146557073|NCT04003142|528549107|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
146557074|NCT04003142|528549108|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
146557075|NCT04003142|528549109|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
146557076|NCT04003142|528549110|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
146557077|NCT04003142|528549111|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
146557078|NCT04003142|528549107|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
146557079|NCT04003142|528549108|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
146557080|NCT04003142|528549109|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
146557081|NCT04003142|528549110|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
146557082|NCT04003142|528549111|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
146557083|NCT03382873|528549112|FG000|Overall Study|Lost to Follow-up|9|||
146557084|NCT03382873|528549113|FG001|Overall Study|Lost to Follow-up|10|||
146557085|NCT03382873|528549112|FG000|Overall Study|Withdrawal by Subject|6|||
146557086|NCT03382873|528549113|FG001|Overall Study|Withdrawal by Subject|11|||
146557087|NCT03382873|528549112|FG000|Overall Study|Visit not completed due to pandemic|16|||
146557088|NCT03382873|528549113|FG001|Overall Study|Visit not completed due to pandemic|41|||
146557089|NCT04755231|528549119|FG000|Overall Study|Lost to Follow-up|5|||
146557090|NCT04755231|528549119|FG000|Overall Study|Withdrawal by Subject|5|||
146557091|NCT03289741|528549120|FG000|Overall Study|Adverse Event|1|||
146557092|NCT03289741|528549121|FG001|Overall Study|Adverse Event|1|||
146557093|NCT03289741|528549120|FG000|Overall Study|Physician Decision|2|||
146557094|NCT03289741|528549121|FG001|Overall Study|Physician Decision|2|||
146557095|NCT03289741|528549120|FG000|Overall Study|Withdrawal by Subject|1|||
146557096|NCT03289741|528549121|FG001|Overall Study|Withdrawal by Subject|0|||
146557097|NCT02536339|528549122|FG000|Overall Study|Death|20|||
146557098|NCT02536339|528549122|FG000|Overall Study|Withdrawal by Subject|3|||
146557099|NCT02536339|528549122|FG000|Overall Study|Lost to Follow-up|2|||
146557100|NCT02536339|528549122|FG000|Overall Study|Treatment discontinued|2|||
146557101|NCT02536339|528549122|FG000|Overall Study|Physician Decision|1|||
146557102|NCT02037984|528549123|FG000|Overall Study|Lack of Efficacy|0|||
146557103|NCT02037984|528549124|FG001|Overall Study|Lack of Efficacy|0|||
146557104|NCT02037984|528549125|FG002|Overall Study|Lack of Efficacy|3|||
146557105|NCT02037984|528549126|FG003|Overall Study|Lack of Efficacy|10|||
146557106|NCT02037984|528549127|FG004|Overall Study|Lack of Efficacy|2|||
146557107|NCT02037984|528549128|FG005|Overall Study|Lack of Efficacy|2|||
146557108|NCT02037984|528549129|FG006|Overall Study|Lack of Efficacy|4|||
146557109|NCT02037984|528549130|FG007|Overall Study|Lack of Efficacy|3|||
146557110|NCT02037984|528549123|FG000|Overall Study|Lost to Follow-up|1|||
146557111|NCT02037984|528549124|FG001|Overall Study|Lost to Follow-up|0|||
146557112|NCT02037984|528549125|FG002|Overall Study|Lost to Follow-up|3|||
146557113|NCT02037984|528549126|FG003|Overall Study|Lost to Follow-up|5|||
146557114|NCT02037984|528549127|FG004|Overall Study|Lost to Follow-up|2|||
146557115|NCT02037984|528549128|FG005|Overall Study|Lost to Follow-up|2|||
146557116|NCT02037984|528549129|FG006|Overall Study|Lost to Follow-up|2|||
146557117|NCT02037984|528549130|FG007|Overall Study|Lost to Follow-up|4|||
146557118|NCT02037984|528549123|FG000|Overall Study|Physician Decision|0|||
146557119|NCT02037984|528549124|FG001|Overall Study|Physician Decision|0|||
146557120|NCT02037984|528549125|FG002|Overall Study|Physician Decision|0|||
146557121|NCT02037984|528549126|FG003|Overall Study|Physician Decision|0|||
146557122|NCT02037984|528549127|FG004|Overall Study|Physician Decision|0|||
146557123|NCT02037984|528549128|FG005|Overall Study|Physician Decision|0|||
146557124|NCT02037984|528549129|FG006|Overall Study|Physician Decision|1|||
146557125|NCT02037984|528549130|FG007|Overall Study|Physician Decision|0|||
146557126|NCT02037984|528549123|FG000|Overall Study|Protocol Violation|0|||
146557127|NCT02037984|528549124|FG001|Overall Study|Protocol Violation|0|||
146557128|NCT02037984|528549125|FG002|Overall Study|Protocol Violation|0|||
146557129|NCT02037984|528549126|FG003|Overall Study|Protocol Violation|0|||
146557130|NCT02037984|528549127|FG004|Overall Study|Protocol Violation|0|||
146557131|NCT02037984|528549128|FG005|Overall Study|Protocol Violation|1|||
146557132|NCT02037984|528549129|FG006|Overall Study|Protocol Violation|2|||
146557133|NCT02037984|528549130|FG007|Overall Study|Protocol Violation|0|||
146557134|NCT02037984|528549123|FG000|Overall Study|Technical Problems|0|||
146967187|NCT00157820|530040177|FG002|Randomized|Physician Decision|3|||
146967188|NCT00157820|530040175|FG000|Randomized|Withdrawal by Subject|1|||
146967189|NCT00157820|530040176|FG001|Randomized|Withdrawal by Subject|2|||
146967190|NCT00157820|530040177|FG002|Randomized|Withdrawal by Subject|3|||
146967191|NCT00157820|530040175|FG000|Randomized|Protocol Violation|2|||
146967192|NCT00157820|530040176|FG001|Randomized|Protocol Violation|1|||
146967193|NCT00157820|530040177|FG002|Randomized|Protocol Violation|2|||
146967194|NCT00157820|530040175|FG000|1st 8 Month|Death|7|||
146967195|NCT00157820|530040176|FG001|1st 8 Month|Death|8|||
146766077|NCT00393848|529312122|FG002|Overall Study|Surgical schedule|0|||
146766078|NCT00393848|529312123|FG003|Overall Study|Surgical schedule|1|||
146766079|NCT00393848|529312120|FG000|Overall Study|Personal reasons|0|||
146766080|NCT00393848|529312121|FG001|Overall Study|Personal reasons|0|||
146766081|NCT00393848|529312122|FG002|Overall Study|Personal reasons|2|||
146766082|NCT00393848|529312123|FG003|Overall Study|Personal reasons|0|||
146766083|NCT02192606|529312124|FG000|Overall Study|surgery type was changed|1|||
146766084|NCT02192606|529312125|FG001|Overall Study|surgery type was changed|1|||
146766085|NCT02192606|529312124|FG000|Overall Study|Physician Decision|1|||
146766086|NCT02192606|529312125|FG001|Overall Study|Physician Decision|2|||
146766087|NCT02192606|529312124|FG000|Overall Study|3D equipment rep unable to join|0|||
146766088|NCT02192606|529312125|FG001|Overall Study|3D equipment rep unable to join|1|||
146766089|NCT02224924|529312132|FG000|Overall Study|Withdrawal by Subject|7|||
146766090|NCT02224924|529312133|FG001|Overall Study|Withdrawal by Subject|6|||
146766091|NCT02224924|529312132|FG000|Overall Study|Biopsy cancelled|20|||
146766092|NCT02224924|529312133|FG001|Overall Study|Biopsy cancelled|14|||
146766093|NCT02224924|529312132|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
146967196|NCT00157820|530040177|FG002|1st 8 Month|Death|3|||
146967197|NCT00157820|530040175|FG000|1st 8 Month|Lost to Follow-up|1|||
146967198|NCT00157820|530040176|FG001|1st 8 Month|Lost to Follow-up|2|||
146967199|NCT00157820|530040177|FG002|1st 8 Month|Lost to Follow-up|1|||
146967200|NCT00157820|530040175|FG000|1st 8 Month|Premature cross-over|0|||
146967201|NCT00157820|530040176|FG001|1st 8 Month|Premature cross-over|2|||
146967202|NCT00157820|530040177|FG002|1st 8 Month|Premature cross-over|2|||
146967203|NCT00157820|530040175|FG000|2nd 8 Months|Death|3|||
146967204|NCT00157820|530040176|FG001|2nd 8 Months|Death|1|||
146967205|NCT00157820|530040177|FG002|2nd 8 Months|Death|3|||
146766094|NCT02224924|529312133|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
146967206|NCT00157820|530040175|FG000|2nd 8 Months|Lost to Follow-up|1|||
146766095|NCT02224924|529312132|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
146766096|NCT02224924|529312133|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
146967207|NCT00157820|530040176|FG001|2nd 8 Months|Lost to Follow-up|5|||
146967208|NCT00157820|530040177|FG002|2nd 8 Months|Lost to Follow-up|2|||
146766097|NCT01458210|529312134|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
146766098|NCT01458210|529312134|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
146766099|NCT01458210|529312134|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
146967209|NCT00157820|530040175|FG000|2nd 8 Months|Premature cross-over|1|||
146967210|NCT00157820|530040176|FG001|2nd 8 Months|Premature cross-over|7|||
146967211|NCT00157820|530040177|FG002|2nd 8 Months|Premature cross-over|9|||
146967212|NCT00223990|530040178|FG000|Overall Study|Moved from area|2|||
146636943|NCT01160822|528845593|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146636944|NCT01160822|528845594|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146636945|NCT01160822|528845595|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146636946|NCT01160822|528845596|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
146636947|NCT01160822|528845597|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
146636948|NCT01160822|528845598|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
146636949|NCT01160822|528845599|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
146636950|NCT01160822|528845593|FG000|Overall Study|Withdrawal by Subject|0|||
146636951|NCT01160822|528845594|FG001|Overall Study|Withdrawal by Subject|0|||
146890214|NCT02400255|529764815|FG002|Overall Study|Loss of insurance|0|||
146967213|NCT00223990|530040179|FG001|Overall Study|Moved from area|1|||
146890215|NCT02400255|529764816|FG003|Overall Study|Loss of insurance|0|||
146890216|NCT01961544|529764817|FG000|Overall Study|Protocol Violation|1|||
146890217|NCT01961544|529764817|FG000|Overall Study|Withdrawal by Subject|7|||
146890218|NCT01961544|529764817|FG000|Overall Study|Adverse Event|1|||
146890219|NCT01961544|529764817|FG000|Overall Study|Physician Decision|2|||
146890220|NCT01961544|529764817|FG000|Overall Study|Poor Tolerance|1|||
146890221|NCT01961544|529764817|FG000|Overall Study|Aggravation of Steral Pain|1|||
146967214|NCT00223990|530040178|FG000|Overall Study|Withdrawal by Subject|4|||
146967215|NCT00223990|530040179|FG001|Overall Study|Withdrawal by Subject|8|||
146967216|NCT00223990|530040178|FG000|Overall Study|Lost to Follow-up|1|||
146557135|NCT02037984|528549124|FG001|Overall Study|Technical Problems|0|||
146557136|NCT02037984|528549125|FG002|Overall Study|Technical Problems|3|||
146557137|NCT02037984|528549126|FG003|Overall Study|Technical Problems|3|||
146557138|NCT02037984|528549127|FG004|Overall Study|Technical Problems|2|||
146557139|NCT02037984|528549128|FG005|Overall Study|Technical Problems|3|||
146557140|NCT02037984|528549129|FG006|Overall Study|Technical Problems|4|||
146557141|NCT02037984|528549130|FG007|Overall Study|Technical Problems|2|||
146557142|NCT02037984|528549123|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146557143|NCT02037984|528549124|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146557144|NCT02037984|528549125|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
146557145|NCT02037984|528549126|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
146766100|NCT01458210|529312134|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
146766101|NCT01616654|529312135|FG000|Overall Study|Lack of Efficacy|1|||
146766102|NCT01616654|529312136|FG001|Overall Study|Lack of Efficacy|0|||
146766103|NCT01616654|529312137|FG002|Overall Study|Lack of Efficacy|0|||
146766104|NCT01616654|529312138|FG003|Overall Study|Lack of Efficacy|0|||
146890222|NCT01818726|529764821|FG000|Overall Study|Administrative reasons|5|||
146890223|NCT01818726|529764822|FG001|Overall Study|Administrative reasons|1|||
146890224|NCT01818726|529764821|FG000|Overall Study|Withdrawal by Subject|0|||
146967217|NCT00223990|530040179|FG001|Overall Study|Lost to Follow-up|0|||
146890225|NCT01818726|529764822|FG001|Overall Study|Withdrawal by Subject|1|||
146766105|NCT01616654|529312139|FG004|Overall Study|Lack of Efficacy|1|||
146766106|NCT01616654|529312135|FG000|Overall Study|Adverse Event|0|||
146766107|NCT01616654|529312136|FG001|Overall Study|Adverse Event|1|||
146766108|NCT01616654|529312137|FG002|Overall Study|Adverse Event|2|||
146766109|NCT01616654|529312138|FG003|Overall Study|Adverse Event|1|||
146766110|NCT01616654|529312139|FG004|Overall Study|Adverse Event|0|||
146766111|NCT01616654|529312135|FG000|Overall Study|Withdrawal by Subject|2|||
146766112|NCT01616654|529312136|FG001|Overall Study|Withdrawal by Subject|2|||
146766113|NCT01616654|529312137|FG002|Overall Study|Withdrawal by Subject|3|||
146766114|NCT01616654|529312138|FG003|Overall Study|Withdrawal by Subject|1|||
146890226|NCT01818726|529764821|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
146890227|NCT01818726|529764822|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
146890228|NCT04871711|529764823|FG000|Overall Study|Withdrawal by Subject|11|||
146890229|NCT04871711|529764824|FG001|Overall Study|Withdrawal by Subject|5|||
146890230|NCT04871711|529764823|FG000|Overall Study|Lack of Efficacy|5|||
146890231|NCT04871711|529764824|FG001|Overall Study|Lack of Efficacy|7|||
146890232|NCT04871711|529764823|FG000|Overall Study|Adverse Event|2|||
146890233|NCT04871711|529764824|FG001|Overall Study|Adverse Event|6|||
146890234|NCT04871711|529764823|FG000|Overall Study|Various reasons|2|||
146890235|NCT04871711|529764824|FG001|Overall Study|Various reasons|1|||
146636952|NCT01160822|528845595|FG002|Overall Study|Withdrawal by Subject|0|||
146890236|NCT04871711|529764823|FG000|Overall Study|Lost to Follow-up|0|||
146890237|NCT04871711|529764824|FG001|Overall Study|Lost to Follow-up|2|||
146967218|NCT03457727|530041474|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
146766115|NCT01616654|529312139|FG004|Overall Study|Withdrawal by Subject|5|||
146766116|NCT01616654|529312135|FG000|Overall Study|Protocol Violation|0|||
146766117|NCT01616654|529312136|FG001|Overall Study|Protocol Violation|5|||
146766118|NCT01616654|529312137|FG002|Overall Study|Protocol Violation|2|||
146766119|NCT01616654|529312138|FG003|Overall Study|Protocol Violation|4|||
146766120|NCT01616654|529312139|FG004|Overall Study|Protocol Violation|4|||
146766121|NCT01616654|529312135|FG000|Overall Study|Lost to Follow-up|1|||
146766122|NCT01616654|529312136|FG001|Overall Study|Lost to Follow-up|0|||
146766123|NCT01616654|529312137|FG002|Overall Study|Lost to Follow-up|3|||
146766124|NCT01616654|529312138|FG003|Overall Study|Lost to Follow-up|2|||
146766125|NCT01616654|529312139|FG004|Overall Study|Lost to Follow-up|1|||
146766126|NCT01616654|529312135|FG000|Overall Study|Pregnancy|1|||
146766127|NCT01616654|529312136|FG001|Overall Study|Pregnancy|0|||
146766128|NCT01616654|529312137|FG002|Overall Study|Pregnancy|0|||
146766129|NCT01616654|529312138|FG003|Overall Study|Pregnancy|0|||
146766130|NCT01616654|529312139|FG004|Overall Study|Pregnancy|1|||
146766131|NCT00753012|529312147|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
146766132|NCT00753012|529312148|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
146766133|NCT00753012|529312147|FG000|Overall Study|Adverse Event|2|||
146766134|NCT00753012|529312148|FG001|Overall Study|Adverse Event|0|||
146766135|NCT00753012|529312147|FG000|Overall Study|Withdrawal by Subject|0|||
146890238|NCT01469000|529764828|FG000|Overall Study|Withdrawal by Subject|16|||
146890239|NCT01469000|529764829|FG001|Overall Study|Withdrawal by Subject|3|||
146890240|NCT01469000|529764828|FG000|Overall Study|Sponsor Decision|4|||
146890241|NCT01469000|529764829|FG001|Overall Study|Sponsor Decision|1|||
146890242|NCT02026063|529764832|FG000|Overall Study|Physician Decision|0|||
146890243|NCT02026063|529764833|FG001|Overall Study|Physician Decision|10|||
146890244|NCT02026063|529764832|FG000|Overall Study|Noncompliance with Study Drug|1|||
146890245|NCT02026063|529764833|FG001|Overall Study|Noncompliance with Study Drug|1|||
146890246|NCT02026063|529764832|FG000|Overall Study|Withdrawal of Consent|1|||
146890247|NCT02026063|529764833|FG001|Overall Study|Withdrawal of Consent|6|||
146890248|NCT02026063|529764832|FG000|Overall Study|Adverse Event|5|||
146890249|NCT02026063|529764833|FG001|Overall Study|Adverse Event|20|||
146890250|NCT02026063|529764832|FG000|Overall Study|Lack of Efficacy|0|||
146890251|NCT02026063|529764833|FG001|Overall Study|Lack of Efficacy|4|||
146890252|NCT02026063|529764832|FG000|Overall Study|Lost to Follow-up|0|||
146890253|NCT02026063|529764833|FG001|Overall Study|Lost to Follow-up|1|||
146890254|NCT02026063|529764832|FG000|Overall Study|Reason not Specified|2|||
146890255|NCT02026063|529764833|FG001|Overall Study|Reason not Specified|7|||
146890256|NCT02154087|529764835|FG000|Overall Study|Study Termination|1|||
146890257|NCT00486278|529764843|FG000|Overall Study|Adverse Event|5|||
146890258|NCT00486278|529764843|FG000|Overall Study|Withdrawal by Subject|2|||
146890259|NCT00486278|529764843|FG000|Overall Study|Physician Decision|2|||
146890260|NCT02183519|529764849|FG000|Overall Study|computer error|3|||
146890261|NCT02183519|529764850|FG001|Overall Study|computer error|0|||
146890262|NCT02183519|529764849|FG000|Overall Study|Did not respond to cough inducter|0|||
146890263|NCT02183519|529764850|FG001|Overall Study|Did not respond to cough inducter|3|||
146890264|NCT04556617|529764851|FG000|Overall Study|progressive disease|0|||
146890265|NCT04556617|529764852|FG001|Overall Study|progressive disease|2|||
146890266|NCT04556617|529764853|FG002|Overall Study|progressive disease|2|||
146890267|NCT04556617|529764854|FG003|Overall Study|progressive disease|1|||
146890268|NCT04556617|529764855|FG004|Overall Study|progressive disease|1|||
146890269|NCT04556617|529764851|FG000|Overall Study|Physician Decision|0|||
146890270|NCT04556617|529764852|FG001|Overall Study|Physician Decision|0|||
146890271|NCT04556617|529764853|FG002|Overall Study|Physician Decision|2|||
146890272|NCT04556617|529764854|FG003|Overall Study|Physician Decision|0|||
146890273|NCT04556617|529764855|FG004|Overall Study|Physician Decision|0|||
146890274|NCT04556617|529764851|FG000|Overall Study|Adverse Event|0|||
146890275|NCT04556617|529764852|FG001|Overall Study|Adverse Event|0|||
146890276|NCT04556617|529764853|FG002|Overall Study|Adverse Event|2|||
146766136|NCT00753012|529312148|FG001|Overall Study|Withdrawal by Subject|1|||
146890277|NCT04556617|529764854|FG003|Overall Study|Adverse Event|3|||
146890278|NCT04556617|529764855|FG004|Overall Study|Adverse Event|0|||
146890279|NCT04556617|529764851|FG000|Overall Study|Withdrawal by Subject|0|||
146890280|NCT04556617|529764852|FG001|Overall Study|Withdrawal by Subject|2|||
146766137|NCT00753012|529312147|FG000|Overall Study|Lost to Follow-up|4|||
146766138|NCT00753012|529312148|FG001|Overall Study|Lost to Follow-up|0|||
146890281|NCT04556617|529764853|FG002|Overall Study|Withdrawal by Subject|1|||
146890282|NCT04556617|529764854|FG003|Overall Study|Withdrawal by Subject|1|||
146890283|NCT04556617|529764855|FG004|Overall Study|Withdrawal by Subject|0|||
146890284|NCT04556617|529764851|FG000|Overall Study|PSA increase|0|||
146890285|NCT04556617|529764852|FG001|Overall Study|PSA increase|1|||
146890286|NCT04556617|529764853|FG002|Overall Study|PSA increase|0|||
146890287|NCT04556617|529764854|FG003|Overall Study|PSA increase|0|||
146890288|NCT04556617|529764855|FG004|Overall Study|PSA increase|0|||
146890289|NCT04556617|529764851|FG000|Overall Study|Sponsor study termination|1|||
146890290|NCT04556617|529764852|FG001|Overall Study|Sponsor study termination|0|||
146890291|NCT04556617|529764853|FG002|Overall Study|Sponsor study termination|0|||
146890292|NCT04556617|529764854|FG003|Overall Study|Sponsor study termination|0|||
146890293|NCT04556617|529764855|FG004|Overall Study|Sponsor study termination|0|||
146890294|NCT04949841|529764856|FG000|Overall Study|Adverse Event|7|||
146890295|NCT04949841|529764856|FG000|Overall Study|Death|1|||
146890296|NCT04949841|529764856|FG000|Overall Study|Withdrawal by Subject|52|||
146890297|NCT04949841|529764856|FG000|Overall Study|Pregnancy|4|||
146890298|NCT04949841|529764856|FG000|Overall Study|Lost to Follow-up|9|||
146890299|NCT04949841|529764856|FG000|Overall Study|Lack of Efficacy|55|||
146890300|NCT04949841|529764856|FG000|Overall Study|Various reasons|9|||
146890301|NCT05168267|529764857|FG000|Overall Study|Withdrawal by Subject|2|||
146890302|NCT05168267|529764858|FG001|Overall Study|Withdrawal by Subject|1|||
146890303|NCT05168267|529764857|FG000|Overall Study|Withdrawn by Therapist|1|||
146890304|NCT05168267|529764858|FG001|Overall Study|Withdrawn by Therapist|1|||
146890305|NCT05168267|529764857|FG000|Overall Study|Left Facility|1|||
146890306|NCT05168267|529764858|FG001|Overall Study|Left Facility|0|||
146890307|NCT02937350|529764859|FG000|Overall Study|Withdrawal by Subject|0|||
146890308|NCT02937350|529764860|FG001|Overall Study|Withdrawal by Subject|1|||
146890309|NCT02937350|529764861|FG002|Overall Study|Withdrawal by Subject|0|||
146890310|NCT00695565|529764862|FG000|Overall Study|Lost to Follow-up|4|||
146890311|NCT00695565|529764863|FG001|Overall Study|Lost to Follow-up|4|||
146890312|NCT00695565|529764862|FG000|Overall Study|Adverse Event|3|||
146890313|NCT00695565|529764863|FG001|Overall Study|Adverse Event|1|||
146890314|NCT00695565|529764862|FG000|Overall Study|Protocol Violation|3|||
146890315|NCT00695565|529764863|FG001|Overall Study|Protocol Violation|1|||
146890316|NCT00695565|529764862|FG000|Overall Study|Withdrawal by Subject|1|||
146890317|NCT00695565|529764863|FG001|Overall Study|Withdrawal by Subject|1|||
146890318|NCT00695565|529764862|FG000|Overall Study|Lack of Efficacy|1|||
146890319|NCT00695565|529764863|FG001|Overall Study|Lack of Efficacy|1|||
146890320|NCT00695565|529764862|FG000|Overall Study|Subject did not follow instructions|1|||
146890321|NCT00695565|529764863|FG001|Overall Study|Subject did not follow instructions|1|||
146890322|NCT01462266|529764864|FG000|Overall Study|Adverse Event|7|||
146890323|NCT01462266|529764865|FG001|Overall Study|Adverse Event|6|||
146890324|NCT01462266|529764864|FG000|Overall Study|Death|2|||
146890325|NCT01462266|529764865|FG001|Overall Study|Death|1|||
146890326|NCT01462266|529764864|FG000|Overall Study|Lack of Efficacy|0|||
146890327|NCT01462266|529764865|FG001|Overall Study|Lack of Efficacy|2|||
146890328|NCT01462266|529764864|FG000|Overall Study|Lost to Follow-up|4|||
146890329|NCT01462266|529764865|FG001|Overall Study|Lost to Follow-up|3|||
146890330|NCT01462266|529764864|FG000|Overall Study|Non-compliance with study drug|3|||
146890331|NCT01462266|529764865|FG001|Overall Study|Non-compliance with study drug|0|||
146890332|NCT01462266|529764864|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
146890333|NCT01462266|529764865|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
146890334|NCT01462266|529764864|FG000|Overall Study|Physician Decision|2|||
146890335|NCT01462266|529764865|FG001|Overall Study|Physician Decision|5|||
146890336|NCT01462266|529764864|FG000|Overall Study|Protocol Violation|1|||
146890337|NCT01462266|529764865|FG001|Overall Study|Protocol Violation|3|||
146890338|NCT01462266|529764864|FG000|Overall Study|Withdrawal by Subject|7|||
146890339|NCT01462266|529764865|FG001|Overall Study|Withdrawal by Subject|2|||
146967219|NCT03457727|530041475|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
146967220|NCT03457727|530041476|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
146636953|NCT01160822|528845596|FG003|Overall Study|Withdrawal by Subject|0|||
146636954|NCT01160822|528845597|FG004|Overall Study|Withdrawal by Subject|0|||
146890340|NCT01462266|529764864|FG000|Overall Study|Screen failure|1|||
146890341|NCT01462266|529764865|FG001|Overall Study|Screen failure|1|||
146967221|NCT03457727|530041477|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
146890342|NCT01106846|529764866|FG000|Overall Study|Change in surgical procedure|0|||
146890343|NCT01106846|529764867|FG001|Overall Study|Change in surgical procedure|1|||
146890344|NCT02419508|529764873|FG000|Overall Study|Adverse Event|9|||
146890345|NCT02419508|529764874|FG001|Overall Study|Adverse Event|3|||
146890346|NCT02419508|529764873|FG000|Overall Study|Withdrawal by Subject|1|||
146890347|NCT02419508|529764874|FG001|Overall Study|Withdrawal by Subject|0|||
146967222|NCT00242567|530041478|FG000|Overall Study|Adverse Event|70|||
146890348|NCT02419508|529764873|FG000|Overall Study|Other - Reason not specified|0|||
146766139|NCT00753012|529312147|FG000|Overall Study|Confounded endpoint data|1|||
146766140|NCT00753012|529312148|FG001|Overall Study|Confounded endpoint data|0|||
146766141|NCT01027286|529312149|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
146766142|NCT01027286|529312150|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
146766143|NCT01027286|529312149|FG000|Overall Study|Lost to Follow-up|0|||
146766144|NCT01027286|529312150|FG001|Overall Study|Lost to Follow-up|1|||
146766145|NCT00545844|529312151|FG000|Overall Study|Lost to Follow-up|9|||
146766146|NCT00545844|529312151|FG000|Overall Study|Protocol Violation|1|||
146890349|NCT02419508|529764874|FG001|Overall Study|Other - Reason not specified|1|||
146890350|NCT04698629|529764887|FG000|Overall Study|Adverse Event|1|||
146890351|NCT02320487|529764888|FG000|Overall Study|Reason not Specified|1|||
146890352|NCT02320487|529764888|FG000|Overall Study|Physician Decision|5|||
146890353|NCT02320487|529764888|FG000|Overall Study|Withdrawal by Subject|1|||
146890354|NCT02320487|529764888|FG000|Overall Study|Death|3|||
146890355|NCT02320487|529764888|FG000|Overall Study|Adverse Event|11|||
146890356|NCT06228586|529764889|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
146890357|NCT06228586|529764890|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
146890358|NCT01182428|529764891|FG000|Overall Study|Physician Decision|1|||
146890359|NCT01182428|529764892|FG001|Overall Study|Physician Decision|0|||
146766147|NCT00545844|529312151|FG000|Overall Study|Withdrawal by Subject|2|||
146967223|NCT00242567|530041479|FG001|Overall Study|Adverse Event|43|||
146766148|NCT00094809|529312152|FG000|Overall Study|Protocol deviation|2|||
146766149|NCT00094809|529312153|FG001|Overall Study|Protocol deviation|2|||
146766150|NCT00094809|529312152|FG000|Overall Study|Noncompliance|1|||
146890360|NCT01182428|529764891|FG000|Overall Study|Lost to Follow-up|9|||
146967224|NCT00242567|530041478|FG000|Overall Study|Disease Progression|17|||
146967225|NCT00242567|530041479|FG001|Overall Study|Disease Progression|22|||
146890361|NCT01182428|529764892|FG001|Overall Study|Lost to Follow-up|1|||
146890362|NCT01182428|529764891|FG000|Overall Study|Withdrawal by Subject|1|||
146890363|NCT01182428|529764892|FG001|Overall Study|Withdrawal by Subject|0|||
146890364|NCT06272370|529767156|FG000|Overall Study|Lost to Follow-up|0|||
146890365|NCT06272370|529767157|FG001|Overall Study|Lost to Follow-up|3|||
146890366|NCT06272370|529767158|FG002|Overall Study|Lost to Follow-up|1|||
146890367|NCT06272370|529767159|FG003|Overall Study|Lost to Follow-up|1|||
146890368|NCT02949128|529767162|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
146890369|NCT02949128|529767162|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
146890370|NCT02949128|529767162|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
146890371|NCT02949128|529767162|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
146890372|NCT02949128|529767162|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
146890373|NCT02949128|529767162|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
146890374|NCT02949128|529767162|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
146890375|NCT02949128|529767162|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
146890376|NCT02949128|529767162|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
146890377|NCT02949128|529767162|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
146890378|NCT02324270|529767163|FG000|Overall Study|Withdrawal by Subject|0|||
146890379|NCT02324270|529767164|FG001|Overall Study|Withdrawal by Subject|1|||
146890380|NCT02324270|529767165|FG002|Overall Study|Withdrawal by Subject|0|||
146890381|NCT02324270|529767163|FG000|Overall Study|Lost to Follow-up|4|||
146890382|NCT02324270|529767164|FG001|Overall Study|Lost to Follow-up|3|||
146890383|NCT02324270|529767165|FG002|Overall Study|Lost to Follow-up|4|||
146890384|NCT02324270|529767163|FG000|Overall Study|Protocol Violation|0|||
146890385|NCT02324270|529767164|FG001|Overall Study|Protocol Violation|1|||
146890386|NCT02324270|529767165|FG002|Overall Study|Protocol Violation|1|||
146890387|NCT02324270|529767163|FG000|Overall Study|Non Compliance with Study Drug|1|||
146890388|NCT02324270|529767164|FG001|Overall Study|Non Compliance with Study Drug|2|||
146890389|NCT02324270|529767165|FG002|Overall Study|Non Compliance with Study Drug|0|||
146890390|NCT03521791|529767166|FG000|Overall Study|Protocol Violation|7|||
146890391|NCT03521791|529767167|FG001|Overall Study|Protocol Violation|17|||
146890392|NCT01475734|529767168|FG000|Overall Study|Withdrawal by Subject|1|||
146890393|NCT01475734|529767169|FG001|Overall Study|Withdrawal by Subject|0|||
146890394|NCT01475734|529767168|FG000|Overall Study|Protocol Violation|1|||
146890395|NCT01475734|529767169|FG001|Overall Study|Protocol Violation|0|||
146890396|NCT01475734|529767168|FG000|Overall Study|Physician Decision|0|||
146890397|NCT01475734|529767169|FG001|Overall Study|Physician Decision|1|||
146890398|NCT00771472|529767170|FG000|Overall Study|Physician Decision|2|||
146890399|NCT00771472|529767171|FG001|Overall Study|Physician Decision|3|||
146890400|NCT00771472|529767170|FG000|Overall Study|Progressive Disease|3|||
146890401|NCT00771472|529767171|FG001|Overall Study|Progressive Disease|1|||
146890402|NCT00771472|529767170|FG000|Overall Study|Protocol Violation|1|||
146890403|NCT00771472|529767171|FG001|Overall Study|Protocol Violation|0|||
146890404|NCT01390389|529767174|FG000|Overall Study|Withdrawal by Subject|2|||
146890405|NCT01390389|529767175|FG001|Overall Study|Withdrawal by Subject|0|||
146890406|NCT01390389|529767174|FG000|Overall Study|Screen Fail|2|||
146890407|NCT01390389|529767175|FG001|Overall Study|Screen Fail|1|||
146890408|NCT03593915|529767176|FG000|Overall Study|Adverse Event|0|||
146890409|NCT03593915|529767177|FG001|Overall Study|Adverse Event|0|||
146890410|NCT03593915|529767178|FG002|Overall Study|Adverse Event|0|||
146890411|NCT03593915|529767179|FG003|Overall Study|Adverse Event|1|||
146890412|NCT03593915|529767180|FG004|Overall Study|Adverse Event|0|||
146890413|NCT03593915|529767181|FG005|Overall Study|Adverse Event|0|||
146890414|NCT03593915|529767176|FG000|Overall Study|Physician Decision|0|||
146890415|NCT03593915|529767177|FG001|Overall Study|Physician Decision|0|||
146890416|NCT03593915|529767178|FG002|Overall Study|Physician Decision|0|||
146890417|NCT03593915|529767179|FG003|Overall Study|Physician Decision|0|||
146890418|NCT03593915|529767180|FG004|Overall Study|Physician Decision|0|||
146890419|NCT03593915|529767181|FG005|Overall Study|Physician Decision|1|||
146890420|NCT01583179|529767182|FG000|Overall Study|Screen failure|1|||
146890421|NCT01583179|529767183|FG001|Overall Study|Screen failure|2|||
146890422|NCT01246206|529767184|FG000|Overall Study|Patient did not receive study regiments.|1|||
146890423|NCT02002975|529767185|FG000|Overall Study|Case Report Forms Uncollected|135|||
146890424|NCT02002975|529767185|FG000|Overall Study|Protocol Deviation|437|||
146890425|NCT04660643|529767186|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
146890426|NCT04660643|529767187|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
146890427|NCT04660643|529767188|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
146890428|NCT04660643|529767186|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
146557146|NCT02037984|528549127|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
146557147|NCT02037984|528549128|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
146557148|NCT02037984|528549129|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
146557149|NCT02037984|528549130|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
146557150|NCT02037984|528549123|FG000|Overall Study|Withdrawal by Subject|0|||
146557151|NCT02037984|528549124|FG001|Overall Study|Withdrawal by Subject|0|||
146557152|NCT02037984|528549125|FG002|Overall Study|Withdrawal by Subject|0|||
146557153|NCT02037984|528549126|FG003|Overall Study|Withdrawal by Subject|1|||
146557154|NCT02037984|528549127|FG004|Overall Study|Withdrawal by Subject|1|||
146557155|NCT02037984|528549128|FG005|Overall Study|Withdrawal by Subject|3|||
146557156|NCT02037984|528549129|FG006|Overall Study|Withdrawal by Subject|0|||
146557157|NCT02037984|528549130|FG007|Overall Study|Withdrawal by Subject|1|||
146557158|NCT01691092|528549131|FG000|Overall Study|Lost to Follow-up|10|||
146557159|NCT01691092|528549131|FG000|Overall Study|Physician Decision|4|||
146557160|NCT01691092|528549131|FG000|Overall Study|Withdrawal by Subject|3|||
146557161|NCT01691092|528549131|FG000|Overall Study|non-compliance|3|||
146557162|NCT01691092|528549131|FG000|Overall Study|used for different study|2|||
146557163|NCT01691092|528549131|FG000|Overall Study|screen fail|19|||
146890429|NCT04660643|529767187|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
146890430|NCT04660643|529767188|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
146557164|NCT00561821|528549132|FG000|Overall Study|Not treated|0|||
146557165|NCT00561821|528549133|FG001|Overall Study|Not treated|0|||
146557166|NCT00561821|528549134|FG002|Overall Study|Not treated|1|||
146557167|NCT00561821|528549135|FG003|Overall Study|Not treated|0|||
146557168|NCT00561821|528549132|FG000|Overall Study|Withdrawal by Subject|0|||
146557169|NCT00561821|528549133|FG001|Overall Study|Withdrawal by Subject|1|||
146890431|NCT04660643|529767186|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
146890432|NCT04660643|529767187|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
146890433|NCT04660643|529767188|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
146890434|NCT04660643|529767186|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
146890435|NCT04660643|529767187|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
146890436|NCT04660643|529767188|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
146890437|NCT04660643|529767186|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
146890438|NCT04660643|529767187|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
146890439|NCT04660643|529767188|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
146890440|NCT04660643|529767186|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
146890441|NCT04660643|529767187|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
146890442|NCT04660643|529767188|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
146890443|NCT04660643|529767186|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
146890444|NCT04660643|529767187|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
146890445|NCT04660643|529767188|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
146890446|NCT04660643|529767186|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
146890447|NCT04660643|529767187|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
146890448|NCT04660643|529767188|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
146890449|NCT04660643|529767186|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
146890450|NCT04660643|529767187|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
146890451|NCT04660643|529767188|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
146890452|NCT04660643|529767186|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
146890453|NCT04660643|529767187|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
146967226|NCT00242567|530041478|FG000|Overall Study|Symptomatic deterioration|9|||
146557170|NCT00561821|528549134|FG002|Overall Study|Withdrawal by Subject|0|||
146557171|NCT00561821|528549135|FG003|Overall Study|Withdrawal by Subject|2|||
146557172|NCT00561821|528549132|FG000|Overall Study|Reasons not related to trial|2|||
146557173|NCT00561821|528549133|FG001|Overall Study|Reasons not related to trial|1|||
146557174|NCT00561821|528549134|FG002|Overall Study|Reasons not related to trial|0|||
146557175|NCT00561821|528549135|FG003|Overall Study|Reasons not related to trial|0|||
146890454|NCT04660643|529767188|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
146890455|NCT04660643|529767186|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
146890456|NCT04660643|529767187|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
146890457|NCT04660643|529767188|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
146890458|NCT04660643|529767186|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
146890459|NCT04660643|529767187|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
146890460|NCT04660643|529767188|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
146890461|NCT04660643|529767186|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
146890462|NCT04660643|529767187|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
146890463|NCT04660643|529767188|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
146890464|NCT04660643|529767186|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
146890465|NCT04660643|529767187|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
146890466|NCT04660643|529767188|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
146890467|NCT04660643|529767186|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
146890468|NCT04660643|529767187|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
146890469|NCT04660643|529767188|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
146890470|NCT04660643|529767186|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
146890471|NCT04660643|529767187|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
146890472|NCT04660643|529767188|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
146890473|NCT03988907|529767189|FG000|Overall Study|Unable to complete visit|0|||
146890474|NCT03988907|529767190|FG001|Overall Study|Unable to complete visit|1|||
146890475|NCT03609619|529767196|FG000|Overall Study|Adverse Event|1|||
146890476|NCT03609619|529767197|FG001|Overall Study|Adverse Event|0|||
146890477|NCT03609619|529767196|FG000|Overall Study|Lack of Efficacy|1|||
146557176|NCT00561821|528549132|FG000|Overall Study|Other (reason not specified)|1|||
146890478|NCT03609619|529767197|FG001|Overall Study|Lack of Efficacy|2|||
146890479|NCT03609619|529767196|FG000|Overall Study|Protocol Violation|5|||
146890480|NCT03609619|529767197|FG001|Overall Study|Protocol Violation|0|||
146890481|NCT03609619|529767196|FG000|Overall Study|Withdrawal by Subject|2|||
146890482|NCT03609619|529767197|FG001|Overall Study|Withdrawal by Subject|3|||
146890483|NCT03609619|529767196|FG000|Overall Study|Lost to Follow-up|1|||
146557177|NCT00561821|528549133|FG001|Overall Study|Other (reason not specified)|1|||
146557178|NCT00561821|528549134|FG002|Overall Study|Other (reason not specified)|0|||
146557179|NCT00561821|528549135|FG003|Overall Study|Other (reason not specified)|0|||
146557180|NCT00561821|528549132|FG000|Overall Study|Adverse Event|2|||
146557181|NCT00561821|528549133|FG001|Overall Study|Adverse Event|3|||
146557182|NCT00561821|528549134|FG002|Overall Study|Adverse Event|1|||
146557183|NCT00561821|528549135|FG003|Overall Study|Adverse Event|1|||
146557184|NCT00581100|528550996|FG000|Overall Study|Death|1|||
146557185|NCT00581100|528550997|FG001|Overall Study|Death|0|||
146557186|NCT00581100|528550996|FG000|Overall Study|Adverse Event|2|||
146557187|NCT00581100|528550997|FG001|Overall Study|Adverse Event|1|||
146557188|NCT00581100|528550996|FG000|Overall Study|Withdrawal by Subject|1|||
146557189|NCT00581100|528550997|FG001|Overall Study|Withdrawal by Subject|4|||
146557190|NCT00581100|528550996|FG000|Overall Study|Other|3|||
146557191|NCT00581100|528550997|FG001|Overall Study|Other|0|||
146557192|NCT04129398|528550998|FG000|Overall Study|Physician Decision|2|||
146557193|NCT04280783|528550999|FG000|Overall Study|Family issues unrelated to the study.|1|||
146557194|NCT04280783|528551000|FG001|Overall Study|Family issues unrelated to the study.|0|||
146890484|NCT03609619|529767197|FG001|Overall Study|Lost to Follow-up|1|||
146890485|NCT00568555|529767200|FG000|Overall Study|Withdrawal by Subject|1|||
146890486|NCT00568555|529767201|FG001|Overall Study|Withdrawal by Subject|1|||
146890487|NCT01871090|529767202|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
146890488|NCT01871090|529767203|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
146890489|NCT01871090|529767202|FG000|Overall Study|Interrogation not completed correctly|1|||
146890490|NCT01871090|529767203|FG001|Overall Study|Interrogation not completed correctly|0|||
146890491|NCT01871090|529767202|FG000|Overall Study|Subject Non-Compliance|0|||
146890492|NCT01871090|529767203|FG001|Overall Study|Subject Non-Compliance|1|||
146890493|NCT01231555|529767204|FG000|Overall Study|Study terminated|8|||
146890494|NCT01231555|529767205|FG001|Overall Study|Study terminated|5|||
146890495|NCT01231555|529767206|FG002|Overall Study|Study terminated|8|||
146890496|NCT01231555|529767204|FG000|Overall Study|Withdrawal by Subject|0|||
146890497|NCT01231555|529767205|FG001|Overall Study|Withdrawal by Subject|2|||
146890498|NCT01231555|529767206|FG002|Overall Study|Withdrawal by Subject|0|||
146890499|NCT03502330|529767207|FG000|Overall Study|Adverse Event|2|||
146890500|NCT03502330|529767208|FG001|Overall Study|Adverse Event|1|||
146890501|NCT03502330|529767209|FG002|Overall Study|Adverse Event|0|||
146890502|NCT03502330|529767210|FG003|Overall Study|Adverse Event|0|||
146890503|NCT03502330|529767211|FG004|Overall Study|Adverse Event|1|||
146890504|NCT03502330|529767212|FG005|Overall Study|Adverse Event|0|||
146890505|NCT03502330|529767213|FG006|Overall Study|Adverse Event|1|||
146890506|NCT03502330|529767214|FG007|Overall Study|Adverse Event|1|||
146890507|NCT03502330|529767215|FG008|Overall Study|Adverse Event|0|||
146890508|NCT03502330|529767207|FG000|Overall Study|Lack of Efficacy|1|||
146890509|NCT03502330|529767208|FG001|Overall Study|Lack of Efficacy|5|||
146890510|NCT03502330|529767209|FG002|Overall Study|Lack of Efficacy|3|||
146890511|NCT03502330|529767210|FG003|Overall Study|Lack of Efficacy|5|||
146890512|NCT03502330|529767211|FG004|Overall Study|Lack of Efficacy|1|||
146890513|NCT03502330|529767212|FG005|Overall Study|Lack of Efficacy|5|||
146890514|NCT03502330|529767213|FG006|Overall Study|Lack of Efficacy|5|||
146890515|NCT03502330|529767214|FG007|Overall Study|Lack of Efficacy|6|||
146890516|NCT03502330|529767215|FG008|Overall Study|Lack of Efficacy|0|||
146890517|NCT03502330|529767207|FG000|Overall Study|Physician Decision|0|||
146890518|NCT03502330|529767208|FG001|Overall Study|Physician Decision|0|||
146890519|NCT03502330|529767209|FG002|Overall Study|Physician Decision|0|||
146890520|NCT03502330|529767210|FG003|Overall Study|Physician Decision|0|||
146890521|NCT03502330|529767211|FG004|Overall Study|Physician Decision|1|||
146890522|NCT03502330|529767212|FG005|Overall Study|Physician Decision|0|||
146890523|NCT03502330|529767213|FG006|Overall Study|Physician Decision|0|||
146890524|NCT03502330|529767214|FG007|Overall Study|Physician Decision|0|||
146890525|NCT03502330|529767215|FG008|Overall Study|Physician Decision|0|||
146890526|NCT03502330|529767207|FG000|Overall Study|Withdrawal by Subject|0|||
146890527|NCT03502330|529767208|FG001|Overall Study|Withdrawal by Subject|0|||
146890528|NCT03502330|529767209|FG002|Overall Study|Withdrawal by Subject|0|||
146890529|NCT03502330|529767210|FG003|Overall Study|Withdrawal by Subject|0|||
146890530|NCT03502330|529767211|FG004|Overall Study|Withdrawal by Subject|0|||
146890531|NCT03502330|529767212|FG005|Overall Study|Withdrawal by Subject|1|||
146890532|NCT03502330|529767213|FG006|Overall Study|Withdrawal by Subject|0|||
146890533|NCT03502330|529767214|FG007|Overall Study|Withdrawal by Subject|1|||
146890534|NCT03502330|529767215|FG008|Overall Study|Withdrawal by Subject|0|||
146890535|NCT03502330|529767207|FG000|Overall Study|Death|0|||
146890536|NCT03502330|529767208|FG001|Overall Study|Death|0|||
146890537|NCT03502330|529767209|FG002|Overall Study|Death|0|||
146890538|NCT03502330|529767210|FG003|Overall Study|Death|0|||
146890539|NCT03502330|529767211|FG004|Overall Study|Death|0|||
146967227|NCT00242567|530041479|FG001|Overall Study|Symptomatic deterioration|3|||
146967228|NCT00242567|530041478|FG000|Overall Study|Lack of Efficacy|2|||
146557195|NCT04280783|528550999|FG000|Overall Study|Withdrawal by Subject|0|||
146557196|NCT04280783|528551000|FG001|Overall Study|Withdrawal by Subject|1|||
146557197|NCT04110145|528551001|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
146890540|NCT03502330|529767212|FG005|Overall Study|Death|0|||
146890541|NCT03502330|529767213|FG006|Overall Study|Death|2|||
146967229|NCT00242567|530041479|FG001|Overall Study|Lack of Efficacy|2|||
146557198|NCT04110145|528551002|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
146766151|NCT00094809|529312153|FG001|Overall Study|Noncompliance|0|||
146890542|NCT03502330|529767214|FG007|Overall Study|Death|0|||
146890543|NCT03502330|529767215|FG008|Overall Study|Death|0|||
146890544|NCT03068325|529767221|FG000|Overall Study|Lost to Follow-up|5|||
146890545|NCT00066690|529767222|FG000|Overall Study|Adverse Event|145|||
146890546|NCT00066690|529767223|FG001|Overall Study|Adverse Event|58|||
146890547|NCT00066690|529767224|FG002|Overall Study|Adverse Event|126|||
146890548|NCT00066690|529767222|FG000|Overall Study|Death|3|||
146890549|NCT00066690|529767223|FG001|Overall Study|Death|0|||
146890550|NCT00066690|529767224|FG002|Overall Study|Death|2|||
146890551|NCT00066690|529767222|FG000|Overall Study|Lack of Efficacy|114|||
146890552|NCT00066690|529767223|FG001|Overall Study|Lack of Efficacy|110|||
146890553|NCT00066690|529767224|FG002|Overall Study|Lack of Efficacy|76|||
146890554|NCT00066690|529767222|FG000|Overall Study|Lost to Follow-up|40|||
146890555|NCT00066690|529767223|FG001|Overall Study|Lost to Follow-up|21|||
146890556|NCT00066690|529767224|FG002|Overall Study|Lost to Follow-up|29|||
146890557|NCT00066690|529767222|FG000|Overall Study|Withdrawal by Subject|50|||
146890558|NCT00066690|529767223|FG001|Overall Study|Withdrawal by Subject|55|||
146890559|NCT00066690|529767224|FG002|Overall Study|Withdrawal by Subject|49|||
146890560|NCT00066690|529767222|FG000|Overall Study|Treatment Ongoing|246|||
146890561|NCT00066690|529767223|FG001|Overall Study|Treatment Ongoing|278|||
146890562|NCT00066690|529767224|FG002|Overall Study|Treatment Ongoing|282|||
146890563|NCT00700180|529767225|FG000|Overall Study|Death|99|||
146890564|NCT00700180|529767226|FG001|Overall Study|Death|114|||
146890565|NCT00700180|529767225|FG000|Overall Study|Alive on treatment|5|||
146890566|NCT00700180|529767226|FG001|Overall Study|Alive on treatment|3|||
146890567|NCT00700180|529767225|FG000|Overall Study|Alive in follow-up|46|||
146890568|NCT00700180|529767226|FG001|Overall Study|Alive in follow-up|27|||
146890569|NCT00700180|529767225|FG000|Overall Study|Lost to Follow-up|4|||
146890570|NCT00700180|529767226|FG001|Overall Study|Lost to Follow-up|5|||
146890571|NCT01613326|529767227|FG000|Overall Study|Adverse Event|7|||
146890572|NCT01613326|529767228|FG001|Overall Study|Adverse Event|5|||
146890573|NCT01613326|529767227|FG000|Overall Study|Withdrawal by Subject|3|||
146890574|NCT01613326|529767228|FG001|Overall Study|Withdrawal by Subject|4|||
146890575|NCT01613326|529767227|FG000|Overall Study|Abnormal test procedure result(s)|2|||
146890576|NCT01613326|529767228|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146890577|NCT01613326|529767227|FG000|Overall Study|inability to use device|1|||
146890578|NCT01613326|529767228|FG001|Overall Study|inability to use device|0|||
146890579|NCT01613326|529767227|FG000|Overall Study|Lack of Efficacy|0|||
146890580|NCT01613326|529767228|FG001|Overall Study|Lack of Efficacy|1|||
146890581|NCT01613326|529767227|FG000|Overall Study|Lost to Follow-up|0|||
146890582|NCT01613326|529767228|FG001|Overall Study|Lost to Follow-up|1|||
146890583|NCT01613326|529767227|FG000|Overall Study|Administrative|0|||
146890584|NCT01613326|529767228|FG001|Overall Study|Administrative|2|||
146890585|NCT01613326|529767227|FG000|Overall Study|Protocol Violation|0|||
146890586|NCT01613326|529767228|FG001|Overall Study|Protocol Violation|1|||
146890587|NCT03980938|529767231|FG000|Treatment Period 1|Study Terminated|1|||
146890588|NCT03980938|529767232|FG001|Treatment Period 1|Study Terminated|1|||
146890589|NCT03980938|529767231|FG000|Treatment Period 2|Study Terminated|2|||
146890590|NCT03980938|529767232|FG001|Treatment Period 2|Study Terminated|2|||
146890591|NCT02939131|529767233|FG000|Overall Study|Unable to get to clinic|6|||
146890592|NCT02939131|529767234|FG001|Overall Study|Unable to get to clinic|4|||
146890593|NCT02939131|529767233|FG000|Overall Study|Lost to Follow-up|2|||
146557199|NCT04110145|528551003|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
146890594|NCT02939131|529767234|FG001|Overall Study|Lost to Follow-up|4|||
146890595|NCT02939131|529767233|FG000|Overall Study|severe debilitation|1|||
146890596|NCT02939131|529767234|FG001|Overall Study|severe debilitation|0|||
146890597|NCT02939131|529767233|FG000|Overall Study|Other|0|||
146890598|NCT02939131|529767234|FG001|Overall Study|Other|1|||
146890599|NCT02939131|529767233|FG000|Overall Study|not willing to adhere to protocol|2|||
146890600|NCT02939131|529767234|FG001|Overall Study|not willing to adhere to protocol|0|||
146890601|NCT00605267|529767235|FG000|Overall Study|Adverse Event|0|||
146890602|NCT00605267|529767236|FG001|Overall Study|Adverse Event|1|||
146890603|NCT00605267|529767235|FG000|Overall Study|Lack of Efficacy|1|||
146890604|NCT00605267|529767236|FG001|Overall Study|Lack of Efficacy|5|||
146890605|NCT00605267|529767235|FG000|Overall Study|Withdrawal by Subject|2|||
146890606|NCT00605267|529767236|FG001|Overall Study|Withdrawal by Subject|3|||
146890607|NCT03569202|529767240|FG000|Part 3|Physician Decision|1|||
146890608|NCT03569202|529767241|FG001|Part 3|Physician Decision|0|||
146890609|NCT03569202|529767240|FG000|Part 3|Other|1|||
146890610|NCT03569202|529767241|FG001|Part 3|Other|1|||
146890611|NCT00420511|529767242|FG000|Overall Study|Adverse Event|1|||
146890612|NCT00420511|529767243|FG001|Overall Study|Adverse Event|1|||
146890613|NCT00420511|529767242|FG000|Overall Study|Lost to Follow-up|1|||
146890614|NCT00420511|529767243|FG001|Overall Study|Lost to Follow-up|0|||
146890615|NCT00454779|529767245|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
146890616|NCT00454779|529767246|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
146890617|NCT00454779|529767245|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
146890618|NCT00454779|529767246|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
146890619|NCT00454779|529767245|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
146890620|NCT00454779|529767246|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
146890621|NCT00454779|529767245|FG000|First-line Treatment Phase|Protocol Violation|0|||
146890622|NCT00454779|529767246|FG001|First-line Treatment Phase|Protocol Violation|1|||
146890623|NCT00454779|529767245|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
146890624|NCT00454779|529767246|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
146890625|NCT00454779|529767245|FG000|First-line Treatment Phase|Ongoing|1|||
146890626|NCT00454779|529767246|FG001|First-line Treatment Phase|Ongoing|0|||
146890627|NCT00454779|529767245|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
146890628|NCT00454779|529767246|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
146890629|NCT00454779|529767245|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
146890630|NCT00454779|529767246|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
146890631|NCT00454779|529767245|FG000|Second-line Treatment Phase|Ongoing|0|||
146890632|NCT00454779|529767246|FG001|Second-line Treatment Phase|Ongoing|1|||
146890633|NCT00168831|529767247|FG000|Overall Study|Adverse Event|36|||
146890634|NCT00168831|529767248|FG001|Overall Study|Adverse Event|47|||
146890635|NCT00168831|529767249|FG002|Overall Study|Adverse Event|74|||
146967230|NCT00242567|530041478|FG000|Overall Study|Lost to Follow-up|9|||
146636955|NCT01160822|528845598|FG005|Overall Study|Withdrawal by Subject|0|||
146890636|NCT00168831|529767247|FG000|Overall Study|Lost to Follow-up|5|||
146890637|NCT00168831|529767248|FG001|Overall Study|Lost to Follow-up|6|||
146890638|NCT00168831|529767249|FG002|Overall Study|Lost to Follow-up|4|||
146890639|NCT00168831|529767247|FG000|Overall Study|Withdrawal by Subject|7|||
146890640|NCT00168831|529767248|FG001|Overall Study|Withdrawal by Subject|14|||
146890641|NCT00168831|529767249|FG002|Overall Study|Withdrawal by Subject|19|||
146890642|NCT00168831|529767247|FG000|Overall Study|Protocol Violation|6|||
146890643|NCT00168831|529767248|FG001|Overall Study|Protocol Violation|11|||
146890644|NCT00168831|529767249|FG002|Overall Study|Protocol Violation|11|||
146890645|NCT00168831|529767247|FG000|Overall Study|Other|6|||
146890646|NCT00168831|529767248|FG001|Overall Study|Other|3|||
146890647|NCT00168831|529767249|FG002|Overall Study|Other|6|||
146890648|NCT01505894|529767250|FG000|Overall Study|Adverse Event|1|||
146890649|NCT01505894|529767251|FG001|Overall Study|Adverse Event|0|||
146890650|NCT01505894|529767252|FG002|Overall Study|Adverse Event|0|||
146890651|NCT01505894|529767253|FG003|Overall Study|Adverse Event|0|||
146890652|NCT01505894|529767254|FG004|Overall Study|Adverse Event|0|||
146890653|NCT01505894|529767255|FG005|Overall Study|Adverse Event|0|||
146890654|NCT01505894|529767256|FG006|Overall Study|Adverse Event|0|||
146890655|NCT01505894|529767257|FG007|Overall Study|Adverse Event|0|||
146890656|NCT01505894|529767258|FG008|Overall Study|Adverse Event|0|||
146890657|NCT01505894|529767250|FG000|Overall Study|Other than specified|0|||
146890658|NCT01505894|529767251|FG001|Overall Study|Other than specified|0|||
146967231|NCT00242567|530041479|FG001|Overall Study|Lost to Follow-up|19|||
146967232|NCT00242567|530041478|FG000|Overall Study|Withdrawal by Subject|33|||
146967233|NCT00242567|530041479|FG001|Overall Study|Withdrawal by Subject|28|||
146967234|NCT00242567|530041478|FG000|Overall Study|Protocol Violation|12|||
146967235|NCT00242567|530041479|FG001|Overall Study|Protocol Violation|12|||
146636956|NCT01160822|528845599|FG006|Overall Study|Withdrawal by Subject|1|||
146636957|NCT01160822|528845593|FG000|Overall Study|Lost to Follow-up|0|||
146636958|NCT01160822|528845594|FG001|Overall Study|Lost to Follow-up|0|||
146636959|NCT01160822|528845595|FG002|Overall Study|Lost to Follow-up|0|||
146636960|NCT01160822|528845596|FG003|Overall Study|Lost to Follow-up|0|||
146636961|NCT01160822|528845597|FG004|Overall Study|Lost to Follow-up|1|||
146636962|NCT01160822|528845598|FG005|Overall Study|Lost to Follow-up|0|||
146636963|NCT01160822|528845599|FG006|Overall Study|Lost to Follow-up|0|||
146636964|NCT01160822|528845593|FG000|Overall Study|Administrative problems|0|||
146636965|NCT01160822|528845594|FG001|Overall Study|Administrative problems|0|||
146636966|NCT01160822|528845595|FG002|Overall Study|Administrative problems|0|||
146890659|NCT01505894|529767252|FG002|Overall Study|Other than specified|0|||
146890660|NCT01505894|529767253|FG003|Overall Study|Other than specified|0|||
146636967|NCT01160822|528845596|FG003|Overall Study|Administrative problems|0|||
146636968|NCT01160822|528845597|FG004|Overall Study|Administrative problems|1|||
146890661|NCT01505894|529767254|FG004|Overall Study|Other than specified|1|||
146890662|NCT01505894|529767255|FG005|Overall Study|Other than specified|0|||
146890663|NCT01505894|529767256|FG006|Overall Study|Other than specified|0|||
146967236|NCT00242567|530041478|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
146890664|NCT01505894|529767257|FG007|Overall Study|Other than specified|0|||
146890665|NCT01505894|529767258|FG008|Overall Study|Other than specified|0|||
146890666|NCT02522767|529767260|FG000|Double-blind|Withdrawal by Subject|8|||
146890667|NCT02522767|529767261|FG001|Double-blind|Withdrawal by Subject|11|||
146890668|NCT02522767|529767260|FG000|Double-blind|Lost to Follow-up|1|||
146890669|NCT02522767|529767261|FG001|Double-blind|Lost to Follow-up|0|||
146890670|NCT02522767|529767260|FG000|Double-blind|Adverse Event|1|||
146890671|NCT02522767|529767261|FG001|Double-blind|Adverse Event|10|||
146890672|NCT02522767|529767260|FG000|Double-blind|Protocol Violation|0|||
146890673|NCT02522767|529767261|FG001|Double-blind|Protocol Violation|1|||
146890674|NCT02522767|529767260|FG000|Double-blind|Lack of Efficacy|0|||
146890675|NCT02522767|529767261|FG001|Double-blind|Lack of Efficacy|2|||
146890676|NCT02522767|529767260|FG000|Double-blind|Protocol Deviation|1|||
146890677|NCT02522767|529767261|FG001|Double-blind|Protocol Deviation|0|||
146890678|NCT02522767|529767260|FG000|Open-label|Withdrawal by Subject|2|||
146890679|NCT02522767|529767261|FG001|Open-label|Withdrawal by Subject|3|||
146890680|NCT02522767|529767260|FG000|Open-label|Lost to Follow-up|0|||
146890681|NCT02522767|529767261|FG001|Open-label|Lost to Follow-up|1|||
146890682|NCT02522767|529767260|FG000|Open-label|Adverse Event|2|||
146890683|NCT02522767|529767261|FG001|Open-label|Adverse Event|1|||
146890684|NCT02522767|529767260|FG000|Open-label|Lack of Efficacy|1|||
146890685|NCT02522767|529767261|FG001|Open-label|Lack of Efficacy|1|||
146890686|NCT02522767|529767260|FG000|Open-label|Protocol Violation|0|||
146890687|NCT02522767|529767261|FG001|Open-label|Protocol Violation|1|||
146890688|NCT02288247|529767262|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
146890689|NCT02288247|529767263|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
146890690|NCT02288247|529767262|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
146890691|NCT02288247|529767263|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
146890692|NCT02288247|529767262|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
146890693|NCT02288247|529767263|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
146890694|NCT02288247|529767262|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
146890695|NCT02288247|529767263|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
146890696|NCT02288247|529767262|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
146890697|NCT02288247|529767263|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
146890698|NCT02288247|529767262|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
146890699|NCT02288247|529767263|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
146890700|NCT02288247|529767262|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
146890701|NCT02288247|529767263|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
146890702|NCT02288247|529767262|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
146890703|NCT02288247|529767263|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
146967237|NCT00242567|530041479|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
146967238|NCT00242567|530041478|FG000|Overall Study|Other|14|||
146967239|NCT00242567|530041479|FG001|Overall Study|Other|9|||
146890704|NCT02288247|529767262|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
146890705|NCT02288247|529767263|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
146967240|NCT00464308|530041480|FG000|Overall Study|Adverse Event|22|||
146766152|NCT00094809|529312152|FG000|Overall Study|Adverse Event|3|||
146890706|NCT02288247|529767262|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
146890707|NCT02288247|529767263|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
146890708|NCT02288247|529767262|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
146890709|NCT02288247|529767263|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
146890710|NCT02288247|529767262|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
146890711|NCT02288247|529767263|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
146890712|NCT02288247|529767262|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
146890713|NCT02288247|529767263|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
146766153|NCT00094809|529312153|FG001|Overall Study|Adverse Event|1|||
146890714|NCT02288247|529767262|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
146890715|NCT02288247|529767263|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
146890716|NCT02288247|529767262|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
146890717|NCT02288247|529767263|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
146890718|NCT02288247|529767262|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
146890719|NCT02288247|529767263|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
146890720|NCT04652804|529767264|FG000|Overall Study|Ineligible post randomization|1|||
146890721|NCT04652804|529767265|FG001|Overall Study|Ineligible post randomization|0|||
146890722|NCT04652804|529767266|FG002|Overall Study|Ineligible post randomization|1|||
146890723|NCT04652804|529767267|FG003|Overall Study|Ineligible post randomization|0|||
146890724|NCT04652804|529767268|FG004|Overall Study|Ineligible post randomization|1|||
146890725|NCT04652804|529767269|FG005|Overall Study|Ineligible post randomization|1|||
146890726|NCT04652804|529767264|FG000|Overall Study|Missing SVR lab results|2|||
146890727|NCT04652804|529767265|FG001|Overall Study|Missing SVR lab results|0|||
146890728|NCT04652804|529767266|FG002|Overall Study|Missing SVR lab results|0|||
146890729|NCT04652804|529767267|FG003|Overall Study|Missing SVR lab results|0|||
146890730|NCT04652804|529767268|FG004|Overall Study|Missing SVR lab results|0|||
146890731|NCT04652804|529767269|FG005|Overall Study|Missing SVR lab results|0|||
146890732|NCT00584194|529767270|FG000|Overall Study|Other|135|||
146890733|NCT04093531|529767271|FG000|Overall Study|failed screening|4|||
146890734|NCT00841763|529767272|FG000|Overall Study|Withdrawal by Subject|60|||
146890735|NCT00841763|529767273|FG001|Overall Study|Withdrawal by Subject|17|||
146890736|NCT00841763|529767274|FG002|Overall Study|Withdrawal by Subject|4|||
146890737|NCT00841763|529767275|FG003|Overall Study|Withdrawal by Subject|1|||
146890738|NCT00841763|529767272|FG000|Overall Study|Adverse Event|9|||
146890739|NCT00841763|529767273|FG001|Overall Study|Adverse Event|10|||
146890740|NCT00841763|529767274|FG002|Overall Study|Adverse Event|3|||
146890741|NCT00841763|529767275|FG003|Overall Study|Adverse Event|2|||
146890742|NCT00841763|529767272|FG000|Overall Study|Lost to Follow-up|63|||
146766154|NCT00094809|529312152|FG000|Overall Study|Withdrawal by Subject|8|||
146766155|NCT00094809|529312153|FG001|Overall Study|Withdrawal by Subject|9|||
146890743|NCT00841763|529767273|FG001|Overall Study|Lost to Follow-up|25|||
146890744|NCT00841763|529767274|FG002|Overall Study|Lost to Follow-up|0|||
146890745|NCT00841763|529767275|FG003|Overall Study|Lost to Follow-up|0|||
146557200|NCT04110145|528551004|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
146557201|NCT04110145|528551005|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
146557202|NCT00980044|528551006|FG000|Overall Study|Withdrawal by Subject|5|||
146557203|NCT00980044|528551007|FG001|Overall Study|Withdrawal by Subject|7|||
146557204|NCT00980044|528551008|FG002|Overall Study|Withdrawal by Subject|3|||
146557205|NCT00980044|528551006|FG000|Overall Study|Protocol Violation|0|||
146557206|NCT00980044|528551007|FG001|Overall Study|Protocol Violation|0|||
146557207|NCT00980044|528551008|FG002|Overall Study|Protocol Violation|2|||
146557208|NCT00185614|528551009|FG000|Inter-treatment Period|Physician Decision|1|||
146557209|NCT00185614|528551009|FG000|Inter-treatment Period|Relapse|2|||
146557210|NCT00185614|528551009|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
146557211|NCT02579759|528551010|FG000|Overall Study|Protocol Violation|2|||
146557212|NCT02579759|528551011|FG001|Overall Study|Protocol Violation|0|||
146557213|NCT02579759|528551012|FG002|Overall Study|Protocol Violation|0|||
146557214|NCT02579759|528551010|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
146557215|NCT02579759|528551011|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
146557216|NCT02579759|528551012|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
146557217|NCT02579759|528551010|FG000|Overall Study|BfArM hold|13|||
146557218|NCT02579759|528551011|FG001|Overall Study|BfArM hold|12|||
146557219|NCT02579759|528551012|FG002|Overall Study|BfArM hold|12|||
146557220|NCT02579759|528551010|FG000|Overall Study|Sponsor stopped Dose 2|0|||
146557221|NCT02579759|528551011|FG001|Overall Study|Sponsor stopped Dose 2|41|||
146557222|NCT02579759|528551012|FG002|Overall Study|Sponsor stopped Dose 2|0|||
146557223|NCT02579759|528551010|FG000|Overall Study|Non compliance|0|||
146557224|NCT02579759|528551011|FG001|Overall Study|Non compliance|1|||
146557225|NCT02579759|528551012|FG002|Overall Study|Non compliance|0|||
146557226|NCT02579759|528551010|FG000|Overall Study|Pregnancy|0|||
146557227|NCT02579759|528551011|FG001|Overall Study|Pregnancy|1|||
146557228|NCT02579759|528551012|FG002|Overall Study|Pregnancy|0|||
146890746|NCT00841763|529767272|FG000|Overall Study|Protocol Violation|20|||
146557229|NCT02579759|528551010|FG000|Overall Study|Inclusion/exclusion criteria|0|||
146557230|NCT02579759|528551011|FG001|Overall Study|Inclusion/exclusion criteria|0|||
146557231|NCT02579759|528551012|FG002|Overall Study|Inclusion/exclusion criteria|1|||
146557232|NCT02579759|528551010|FG000|Overall Study|Adverse Event|4|||
146557233|NCT02579759|528551011|FG001|Overall Study|Adverse Event|3|||
146557234|NCT02579759|528551012|FG002|Overall Study|Adverse Event|1|||
146557235|NCT02579759|528551010|FG000|Overall Study|Withdrawal by Subject|3|||
146557236|NCT02579759|528551011|FG001|Overall Study|Withdrawal by Subject|3|||
146766156|NCT00094809|529312152|FG000|Overall Study|Disease progression|3|||
146766157|NCT00094809|529312153|FG001|Overall Study|Disease progression|3|||
146890747|NCT00841763|529767273|FG001|Overall Study|Protocol Violation|3|||
146890748|NCT00841763|529767274|FG002|Overall Study|Protocol Violation|1|||
146890749|NCT00841763|529767275|FG003|Overall Study|Protocol Violation|0|||
146890750|NCT00841763|529767272|FG000|Overall Study|Administrative Reasons|3|||
146890751|NCT00841763|529767273|FG001|Overall Study|Administrative Reasons|1|||
146890752|NCT00841763|529767274|FG002|Overall Study|Administrative Reasons|0|||
146890753|NCT00841763|529767275|FG003|Overall Study|Administrative Reasons|0|||
146890754|NCT00841763|529767272|FG000|Overall Study|Unable to Classify|7|||
146890755|NCT00841763|529767273|FG001|Overall Study|Unable to Classify|1|||
146890756|NCT00841763|529767274|FG002|Overall Study|Unable to Classify|0|||
146890757|NCT00841763|529767275|FG003|Overall Study|Unable to Classify|0|||
146890758|NCT03634800|529767276|FG000|Overall Study|Adverse Event|1|||
146890759|NCT03634800|529767276|FG000|Overall Study|Disease Progression|4|||
146890760|NCT03634800|529767276|FG000|Overall Study|Withdrawal by Subject|1|||
146890761|NCT01114529|529767279|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
146890762|NCT01114529|529767280|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
146890763|NCT01114529|529767281|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
146890764|NCT01114529|529767279|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
146890765|NCT01114529|529767280|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
146890766|NCT01114529|529767281|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
146890767|NCT01114529|529767279|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
146890768|NCT01114529|529767280|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
146890769|NCT01114529|529767281|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
146890770|NCT01114529|529767279|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
146890771|NCT01114529|529767280|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
146890772|NCT01114529|529767281|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
146890773|NCT01114529|529767279|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
146890774|NCT01114529|529767280|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
146890775|NCT01114529|529767281|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
146890776|NCT01114529|529767279|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
146890777|NCT01114529|529767280|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
146890778|NCT01114529|529767281|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
146890779|NCT01114529|529767279|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
146890780|NCT01114529|529767280|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
146890781|NCT01114529|529767281|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
146890782|NCT01114529|529767279|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
146890783|NCT01114529|529767280|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
146890784|NCT01114529|529767281|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
146890785|NCT01114529|529767279|FG000|Completed Study Medication at Month 24|Death|2|||
146890786|NCT01114529|529767280|FG001|Completed Study Medication at Month 24|Death|1|||
146890787|NCT01114529|529767281|FG002|Completed Study Medication at Month 24|Death|2|||
146890788|NCT01114529|529767279|FG000|Completed Study Medication at Month 24|Graft loss|0|||
146967241|NCT00464308|530041481|FG001|Overall Study|Adverse Event|27|||
146967242|NCT00464308|530041482|FG002|Overall Study|Adverse Event|16|||
146766158|NCT00094809|529312152|FG000|Overall Study|Physician Decision|3|||
146766159|NCT00094809|529312153|FG001|Overall Study|Physician Decision|5|||
146766160|NCT00094809|529312152|FG000|Overall Study|Lost to Follow-up|6|||
146766161|NCT00094809|529312153|FG001|Overall Study|Lost to Follow-up|6|||
146766162|NCT00094809|529312152|FG000|Overall Study|Death|19|||
146766163|NCT00094809|529312153|FG001|Overall Study|Death|25|||
146766164|NCT00094809|529312152|FG000|Overall Study|Protocol-specified criteria|1|||
146766165|NCT00094809|529312153|FG001|Overall Study|Protocol-specified criteria|1|||
146766166|NCT00094809|529312152|FG000|Overall Study|Other|2|||
146766167|NCT00094809|529312153|FG001|Overall Study|Other|4|||
146766168|NCT00094809|529312152|FG000|Overall Study|Informed consent signed after treatment|1|||
146766169|NCT00094809|529312153|FG001|Overall Study|Informed consent signed after treatment|0|||
146766170|NCT00094809|529312152|FG000|Overall Study|Study drug not received|2|||
146766171|NCT00094809|529312153|FG001|Overall Study|Study drug not received|8|||
146766172|NCT00094809|529312152|FG000|Overall Study|Other|1|||
146766173|NCT00094809|529312153|FG001|Overall Study|Other|1|||
146766174|NCT01329328|529312154|FG000|Overall Study|Withdrawal by Subject|2|||
146766175|NCT01329328|529312155|FG001|Overall Study|Withdrawal by Subject|4|||
146766176|NCT01329328|529312156|FG002|Overall Study|Withdrawal by Subject|3|||
146766177|NCT01370694|529312168|FG000|Overall Study|Switched to rituximab|4|||
146766178|NCT01370694|529312168|FG000|Overall Study|Progressive disease|2|||
146766179|NCT02957539|529312169|FG000|Baseline to Week 16|Lost to Follow-up|8|||
146766180|NCT02957539|529312170|FG001|Baseline to Week 16|Lost to Follow-up|10|||
146766181|NCT02957539|529312171|FG002|Baseline to Week 16|Lost to Follow-up|16|||
146766182|NCT02957539|529312169|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
146766183|NCT02957539|529312170|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
146766184|NCT02957539|529312171|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
146766185|NCT02957539|529312169|FG000|Week 16 to 32|Withdrawal by Subject|3|||
146766186|NCT02957539|529312170|FG001|Week 16 to 32|Withdrawal by Subject|3|||
146766187|NCT02957539|529312171|FG002|Week 16 to 32|Withdrawal by Subject|1|||
146766188|NCT02957539|529312169|FG000|Week 16 to 32|Lost to Follow-up|8|||
146766189|NCT02957539|529312170|FG001|Week 16 to 32|Lost to Follow-up|7|||
146766190|NCT02957539|529312171|FG002|Week 16 to 32|Lost to Follow-up|5|||
146766191|NCT02957539|529312169|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
146766192|NCT02957539|529312170|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
146766193|NCT02957539|529312171|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
146766194|NCT02957539|529312169|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
146766195|NCT02957539|529312170|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
146766196|NCT02957539|529312171|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
146766197|NCT01565928|529312172|FG000|Overall Study|Adverse Event|3|||
146766198|NCT01565928|529312172|FG000|Overall Study|Other|3|||
146766199|NCT01565928|529312172|FG000|Overall Study|Progressive Disease|13|||
146766200|NCT01565928|529312172|FG000|Overall Study|Withdrawal by Subject|1|||
146766201|NCT01565928|529312172|FG000|Overall Study|Death|2|||
146766202|NCT01713530|529312180|FG000|Overall Study|Adverse Event|0|||
146766203|NCT01713530|529312181|FG001|Overall Study|Adverse Event|5|||
146766204|NCT01713530|529312180|FG000|Overall Study|Withdrawal criteria|21|||
146766205|NCT01713530|529312181|FG001|Overall Study|Withdrawal criteria|12|||
146766206|NCT01713530|529312180|FG000|Overall Study|Unclassified|4|||
146766207|NCT01713530|529312181|FG001|Overall Study|Unclassified|2|||
146766208|NCT03525119|529312182|FG000|Overall Study|Adverse Event|0|||
146766209|NCT03525119|529312183|FG001|Overall Study|Adverse Event|1|||
146766210|NCT03525119|529312184|FG002|Overall Study|Adverse Event|0|||
146766211|NCT03525119|529312182|FG000|Overall Study|Lost to Follow-up|32|||
146890789|NCT01114529|529767280|FG001|Completed Study Medication at Month 24|Graft loss|2|||
146890790|NCT01114529|529767281|FG002|Completed Study Medication at Month 24|Graft loss|0|||
146557237|NCT02579759|528551012|FG002|Overall Study|Withdrawal by Subject|5|||
146557238|NCT02579759|528551010|FG000|Overall Study|Lost to Follow-up|2|||
146557239|NCT02579759|528551011|FG001|Overall Study|Lost to Follow-up|2|||
146557240|NCT02579759|528551012|FG002|Overall Study|Lost to Follow-up|2|||
146557241|NCT03257657|528551017|FG000|Overall Study|Lost to Follow-up|0|||
146557242|NCT03257657|528551018|FG001|Overall Study|Lost to Follow-up|3|||
146557243|NCT03257657|528551017|FG000|Overall Study|Withdrawn|0|||
146557244|NCT03257657|528551018|FG001|Overall Study|Withdrawn|1|||
146890791|NCT01114529|529767279|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
146967243|NCT00464308|530041480|FG000|Overall Study|Lost to Follow-up|29|||
146557245|NCT03257657|528551017|FG000|Overall Study|Noted not eligible right after enrolled|0|||
146557246|NCT03257657|528551018|FG001|Overall Study|Noted not eligible right after enrolled|1|||
146766212|NCT03525119|529312183|FG001|Overall Study|Lost to Follow-up|33|||
146766213|NCT03525119|529312184|FG002|Overall Study|Lost to Follow-up|37|||
146766214|NCT03525119|529312182|FG000|Overall Study|Withdrawal by Subject|5|||
146766215|NCT03525119|529312183|FG001|Overall Study|Withdrawal by Subject|4|||
146766216|NCT03525119|529312184|FG002|Overall Study|Withdrawal by Subject|2|||
146766217|NCT03525119|529312182|FG000|Overall Study|Reason not Specified|2|||
146766218|NCT03525119|529312183|FG001|Overall Study|Reason not Specified|1|||
146766219|NCT03525119|529312184|FG002|Overall Study|Reason not Specified|2|||
146766220|NCT03525119|529312182|FG000|Overall Study|Randomized but not Vaccinated|1|||
146766221|NCT03525119|529312183|FG001|Overall Study|Randomized but not Vaccinated|0|||
146890792|NCT01114529|529767280|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
146890793|NCT01114529|529767281|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
146890794|NCT01114529|529767279|FG000|Completed Study Medication at Month 24|Missing|2|||
146890795|NCT01114529|529767280|FG001|Completed Study Medication at Month 24|Missing|0|||
146890796|NCT01114529|529767281|FG002|Completed Study Medication at Month 24|Missing|0|||
146890797|NCT01114529|529767279|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
146890798|NCT01114529|529767280|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
146890799|NCT01114529|529767281|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
146890800|NCT01114529|529767279|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
146890801|NCT01114529|529767280|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
146890802|NCT01114529|529767281|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
146890803|NCT01114529|529767279|FG000|Completed Study Phase at Month 24|Death|8|||
146890804|NCT01114529|529767280|FG001|Completed Study Phase at Month 24|Death|5|||
146890805|NCT01114529|529767281|FG002|Completed Study Phase at Month 24|Death|4|||
146890806|NCT01114529|529767279|FG000|Completed Study Phase at Month 24|Other|2|||
146890807|NCT01114529|529767280|FG001|Completed Study Phase at Month 24|Other|0|||
146890808|NCT01114529|529767281|FG002|Completed Study Phase at Month 24|Other|0|||
146890809|NCT01114529|529767279|FG000|Completed Study Phase at Month 24|Missing|2|||
146890810|NCT01114529|529767280|FG001|Completed Study Phase at Month 24|Missing|0|||
146890811|NCT01114529|529767281|FG002|Completed Study Phase at Month 24|Missing|0|||
146766222|NCT03525119|529312184|FG002|Overall Study|Randomized but not Vaccinated|2|||
146766223|NCT03939819|529312185|FG000|Overall Study|Death|2|||
146766224|NCT03939819|529312186|FG001|Overall Study|Death|0|||
146766225|NCT04379713|529312194|FG000|Overall Study|Adverse Event|2|||
146766226|NCT04379713|529312195|FG001|Overall Study|Adverse Event|0|||
146766227|NCT04379713|529312194|FG000|Overall Study|Physician Decision|2|||
146766228|NCT04379713|529312195|FG001|Overall Study|Physician Decision|1|||
146766229|NCT04379713|529312194|FG000|Overall Study|Protocol Violation|11|||
146766230|NCT04379713|529312195|FG001|Overall Study|Protocol Violation|6|||
146766231|NCT04379713|529312194|FG000|Overall Study|No longer met eligibility criteria|14|||
146766232|NCT04379713|529312195|FG001|Overall Study|No longer met eligibility criteria|11|||
146766233|NCT04379713|529312194|FG000|Overall Study|Withdrawal by parent/guardian|36|||
146766234|NCT04379713|529312195|FG001|Overall Study|Withdrawal by parent/guardian|15|||
146766235|NCT04379713|529312194|FG000|Overall Study|Lost to Follow-up|31|||
146766236|NCT04379713|529312195|FG001|Overall Study|Lost to Follow-up|21|||
146766237|NCT03808883|529312196|FG000|Overall Study|Withdrawal by Subject|2|||
146766238|NCT03808883|529312197|FG001|Overall Study|Withdrawal by Subject|0|||
146766239|NCT03808883|529312196|FG000|Overall Study|Did not complete pre test or post test survey|4|||
146766240|NCT03808883|529312197|FG001|Overall Study|Did not complete pre test or post test survey|3|||
146766241|NCT02371746|529312209|FG000|Overall Study|Consent withdrawn|0|||
146766242|NCT02371746|529312210|FG001|Overall Study|Consent withdrawn|0|||
146766243|NCT02371746|529312211|FG002|Overall Study|Consent withdrawn|0|||
146766244|NCT02371746|529312212|FG003|Overall Study|Consent withdrawn|0|||
146766245|NCT02371746|529312213|FG004|Overall Study|Consent withdrawn|0|||
146766246|NCT02371746|529312214|FG005|Overall Study|Consent withdrawn|0|||
146766247|NCT02371746|529312215|FG006|Overall Study|Consent withdrawn|1|||
146766248|NCT02613364|529312216|FG000|Overall Study|Other|19|||
146766249|NCT02613364|529312217|FG001|Overall Study|Other|29|||
146766250|NCT02613364|529312218|FG002|Overall Study|Other|17|||
146890812|NCT00331409|529767285|FG000|Overall Study|Lack of Efficacy|4|||
146890813|NCT00272987|529767286|FG000|Overall Study|Adverse Event|1|||
146766251|NCT02613364|529312216|FG000|Overall Study|Too time consuming|21|||
146766252|NCT02613364|529312217|FG001|Overall Study|Too time consuming|26|||
146890814|NCT00272987|529767287|FG001|Overall Study|Adverse Event|0|||
146766253|NCT02613364|529312218|FG002|Overall Study|Too time consuming|26|||
146766254|NCT02613364|529312216|FG000|Overall Study|Withdrawal by Subject|13|||
146766255|NCT02613364|529312217|FG001|Overall Study|Withdrawal by Subject|18|||
146766256|NCT02613364|529312218|FG002|Overall Study|Withdrawal by Subject|17|||
146766257|NCT02613364|529312216|FG000|Overall Study|Medical|12|||
146766258|NCT02613364|529312217|FG001|Overall Study|Medical|13|||
146766259|NCT02613364|529312218|FG002|Overall Study|Medical|9|||
146766260|NCT02613364|529312216|FG000|Overall Study|Disliked Study Procedure|1|||
146890815|NCT00272987|529767288|FG002|Overall Study|Adverse Event|0|||
146890816|NCT00272987|529767286|FG000|Overall Study|Lost to Follow-up|3|||
146890817|NCT00272987|529767287|FG001|Overall Study|Lost to Follow-up|1|||
146636969|NCT01160822|528845598|FG005|Overall Study|Administrative problems|0|||
146890818|NCT00272987|529767288|FG002|Overall Study|Lost to Follow-up|1|||
146890819|NCT00272987|529767286|FG000|Overall Study|Withdrawal by Subject|1|||
146766261|NCT02613364|529312217|FG001|Overall Study|Disliked Study Procedure|1|||
146766262|NCT02613364|529312218|FG002|Overall Study|Disliked Study Procedure|4|||
146890820|NCT00272987|529767287|FG001|Overall Study|Withdrawal by Subject|0|||
146890821|NCT00272987|529767288|FG002|Overall Study|Withdrawal by Subject|3|||
146890822|NCT00272987|529767286|FG000|Overall Study|Sponsor Terminated study|0|||
146890823|NCT00272987|529767287|FG001|Overall Study|Sponsor Terminated study|1|||
146890824|NCT00272987|529767288|FG002|Overall Study|Sponsor Terminated study|1|||
146890825|NCT00272987|529767286|FG000|Overall Study|Disease progression|1|||
146890826|NCT00272987|529767287|FG001|Overall Study|Disease progression|1|||
146890827|NCT00272987|529767288|FG002|Overall Study|Disease progression|2|||
146890828|NCT00272987|529767286|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
146890829|NCT00272987|529767287|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
146890830|NCT00272987|529767288|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
146890831|NCT00272987|529767286|FG000|Overall Study|Death|1|||
146890832|NCT00272987|529767287|FG001|Overall Study|Death|0|||
146890833|NCT00272987|529767288|FG002|Overall Study|Death|0|||
146890834|NCT03555266|529767293|FG000|Overall Study|Protocol Violation|6|||
146890835|NCT03555266|529767294|FG001|Overall Study|Protocol Violation|4|||
146890836|NCT03370770|529767295|FG000|Overall Study|Patient was followed in another hospital center|1|||
146890837|NCT03370770|529767295|FG000|Overall Study|Progressive Disease|98|||
146890838|NCT03370770|529767295|FG000|Overall Study|Adverse Event|2|||
146890839|NCT03370770|529767295|FG000|Overall Study|Death|5|||
146890840|NCT03072160|529767301|FG000|Overall Study|Adverse Event|3|||
146890841|NCT03072160|529767302|FG001|Overall Study|Adverse Event|1|||
146890842|NCT03072160|529767301|FG000|Overall Study|Refused further treatment|6|||
146890843|NCT03072160|529767302|FG001|Overall Study|Refused further treatment|1|||
146890844|NCT03072160|529767301|FG000|Overall Study|Physician Decision|1|||
146890845|NCT03072160|529767302|FG001|Overall Study|Physician Decision|0|||
146890846|NCT03072160|529767301|FG000|Overall Study|Disease progression on study|1|||
146890847|NCT03072160|529767302|FG001|Overall Study|Disease progression on study|1|||
146890848|NCT03072160|529767301|FG000|Overall Study|No contact|0|||
146890849|NCT03072160|529767302|FG001|Overall Study|No contact|1|||
146890850|NCT00236080|529767303|FG000|Overall Study|Adverse Event|0|||
146890851|NCT00236080|529767304|FG001|Overall Study|Adverse Event|0|||
146890852|NCT00236080|529767305|FG002|Overall Study|Adverse Event|3|||
146890853|NCT00236080|529767306|FG003|Overall Study|Adverse Event|1|||
146890854|NCT00236080|529767307|FG004|Overall Study|Adverse Event|0|||
146890855|NCT00236080|529767303|FG000|Overall Study|Lost to Follow-up|0|||
146890856|NCT00236080|529767304|FG001|Overall Study|Lost to Follow-up|1|||
146890857|NCT00236080|529767305|FG002|Overall Study|Lost to Follow-up|0|||
146890858|NCT00236080|529767306|FG003|Overall Study|Lost to Follow-up|0|||
146890859|NCT00236080|529767307|FG004|Overall Study|Lost to Follow-up|0|||
146890860|NCT00236080|529767303|FG000|Overall Study|Physician Decision|1|||
146890861|NCT00236080|529767304|FG001|Overall Study|Physician Decision|0|||
146890862|NCT00236080|529767305|FG002|Overall Study|Physician Decision|1|||
146890863|NCT00236080|529767306|FG003|Overall Study|Physician Decision|1|||
146890864|NCT00236080|529767307|FG004|Overall Study|Physician Decision|1|||
146890865|NCT00236080|529767303|FG000|Overall Study|Withdrawal by Subject|1|||
146890866|NCT00236080|529767304|FG001|Overall Study|Withdrawal by Subject|0|||
146890867|NCT00236080|529767305|FG002|Overall Study|Withdrawal by Subject|0|||
146890868|NCT00236080|529767306|FG003|Overall Study|Withdrawal by Subject|0|||
146890869|NCT00236080|529767307|FG004|Overall Study|Withdrawal by Subject|0|||
146890870|NCT00236080|529767303|FG000|Overall Study|Miscellaneous|0|||
146890871|NCT00236080|529767304|FG001|Overall Study|Miscellaneous|0|||
146890872|NCT00236080|529767305|FG002|Overall Study|Miscellaneous|1|||
146890873|NCT00236080|529767306|FG003|Overall Study|Miscellaneous|0|||
146890874|NCT00236080|529767307|FG004|Overall Study|Miscellaneous|0|||
146890875|NCT01214044|529767308|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
146890876|NCT01214044|529767308|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
146890877|NCT01214044|529767308|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
146890878|NCT01214044|529767308|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
146890879|NCT01214044|529767308|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
146890880|NCT01214044|529767308|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
146890881|NCT00408694|529767309|FG000|Overall Study|Ineligible|1|||
146890882|NCT00408694|529767309|FG000|Overall Study|No protocol treatment|1|||
146890883|NCT03543410|529767310|FG000|Overall Study|Adverse Event|10|||
146890884|NCT03543410|529767311|FG001|Overall Study|Adverse Event|8|||
146967244|NCT00464308|530041481|FG001|Overall Study|Lost to Follow-up|19|||
146890885|NCT03543410|529767312|FG002|Overall Study|Adverse Event|2|||
146890886|NCT03543410|529767310|FG000|Overall Study|Lack of Efficacy|0|||
146890887|NCT03543410|529767311|FG001|Overall Study|Lack of Efficacy|1|||
146890888|NCT03543410|529767312|FG002|Overall Study|Lack of Efficacy|0|||
146890889|NCT03543410|529767310|FG000|Overall Study|Lost to Follow-up|0|||
146890890|NCT03543410|529767311|FG001|Overall Study|Lost to Follow-up|1|||
146890891|NCT03543410|529767312|FG002|Overall Study|Lost to Follow-up|0|||
146890892|NCT03543410|529767310|FG000|Overall Study|Withdrawal by Subject|5|||
146890893|NCT03543410|529767311|FG001|Overall Study|Withdrawal by Subject|2|||
146890894|NCT03543410|529767312|FG002|Overall Study|Withdrawal by Subject|8|||
146890895|NCT03543410|529767310|FG000|Overall Study|Protocol Violation|0|||
146890896|NCT03543410|529767311|FG001|Overall Study|Protocol Violation|1|||
146766263|NCT02613364|529312216|FG000|Overall Study|Disliked Intervention|0|||
146766264|NCT02613364|529312217|FG001|Overall Study|Disliked Intervention|3|||
146766265|NCT02613364|529312218|FG002|Overall Study|Disliked Intervention|3|||
146557247|NCT00137449|528551019|FG000|Overall Study|Disease Progression|8|||
146890897|NCT03543410|529767312|FG002|Overall Study|Protocol Violation|0|||
146890898|NCT03543410|529767310|FG000|Overall Study|Due to COVID-19|4|||
146890899|NCT03543410|529767311|FG001|Overall Study|Due to COVID-19|0|||
146890900|NCT03543410|529767312|FG002|Overall Study|Due to COVID-19|2|||
146766266|NCT01909336|529312219|FG000|Overall Study|Lost to Follow-up|4|||
146766267|NCT01909336|529312220|FG001|Overall Study|Lost to Follow-up|2|||
146890901|NCT03543410|529767310|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
146890902|NCT03543410|529767311|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
146890903|NCT03543410|529767312|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
146890904|NCT03543410|529767310|FG000|Overall Study|Not Due to COVID-19|2|||
146890905|NCT03543410|529767311|FG001|Overall Study|Not Due to COVID-19|0|||
146890906|NCT03543410|529767312|FG002|Overall Study|Not Due to COVID-19|1|||
146890907|NCT02435914|529767313|FG000|Overall Study|Ocular Adverse Event|1|||
146890908|NCT02435914|529767314|FG001|Overall Study|Ocular Adverse Event|0|||
146890909|NCT02435914|529767315|FG002|Overall Study|Ocular Adverse Event|0|||
146890910|NCT02435914|529767316|FG003|Overall Study|Ocular Adverse Event|0|||
146890911|NCT02435914|529767313|FG000|Overall Study|Withdrawal by Subject|0|||
146890912|NCT02435914|529767314|FG001|Overall Study|Withdrawal by Subject|1|||
146890913|NCT02435914|529767315|FG002|Overall Study|Withdrawal by Subject|0|||
146890914|NCT02435914|529767316|FG003|Overall Study|Withdrawal by Subject|0|||
146890915|NCT02435914|529767313|FG000|Overall Study|Other Miscellaneous Reason|0|||
146890916|NCT02435914|529767314|FG001|Overall Study|Other Miscellaneous Reason|0|||
146890917|NCT02435914|529767315|FG002|Overall Study|Other Miscellaneous Reason|1|||
146890918|NCT02435914|529767316|FG003|Overall Study|Other Miscellaneous Reason|0|||
146890919|NCT02883244|529767317|FG000|Overall Study|Lost to Follow-up|0|||
146890920|NCT02883244|529767318|FG001|Overall Study|Lost to Follow-up|1|||
146890921|NCT01727258|529767319|FG000|Overall Study|Adverse Event|0|||
146557248|NCT00137449|528551020|FG001|Overall Study|Disease Progression|13|||
146557249|NCT00137449|528551019|FG000|Overall Study|Death|4|||
146890922|NCT01727258|529767320|FG001|Overall Study|Adverse Event|2|||
146890923|NCT01727258|529767321|FG002|Overall Study|Adverse Event|0|||
146967245|NCT00464308|530041482|FG002|Overall Study|Lost to Follow-up|20|||
146557250|NCT00137449|528551020|FG001|Overall Study|Death|3|||
146890924|NCT01727258|529767319|FG000|Overall Study|Noncompliance with Study Drug|0|||
146890925|NCT01727258|529767320|FG001|Overall Study|Noncompliance with Study Drug|0|||
146890926|NCT01727258|529767321|FG002|Overall Study|Noncompliance with Study Drug|1|||
146557251|NCT00137449|528551019|FG000|Overall Study|Adverse Event|3|||
146766268|NCT01909336|529312221|FG002|Overall Study|Lost to Follow-up|2|||
146766269|NCT01909336|529312219|FG000|Overall Study|Physician Decision|0|||
146890927|NCT01727258|529767319|FG000|Overall Study|Withdrawal by Subject|1|||
146890928|NCT01727258|529767320|FG001|Overall Study|Withdrawal by Subject|1|||
146890929|NCT01727258|529767321|FG002|Overall Study|Withdrawal by Subject|0|||
146890930|NCT01727258|529767319|FG000|Overall Study|Lost to Follow-up|1|||
146890931|NCT01727258|529767320|FG001|Overall Study|Lost to Follow-up|0|||
146890932|NCT01727258|529767321|FG002|Overall Study|Lost to Follow-up|0|||
146890933|NCT03604445|529767324|FG000|Overall Study|Death|0|||
146890934|NCT03604445|529767325|FG001|Overall Study|Death|0|||
146890935|NCT03604445|529767326|FG002|Overall Study|Death|0|||
146890936|NCT03604445|529767327|FG003|Overall Study|Death|0|||
146890937|NCT03604445|529767328|FG004|Overall Study|Death|0|||
146890938|NCT03604445|529767329|FG005|Overall Study|Death|0|||
146890939|NCT03604445|529767330|FG006|Overall Study|Death|0|||
146890940|NCT03604445|529767331|FG007|Overall Study|Death|0|||
146890941|NCT03604445|529767332|FG008|Overall Study|Death|1|||
146890942|NCT03604445|529767324|FG000|Overall Study|Withdrawal by Subject|0|||
146890943|NCT03604445|529767325|FG001|Overall Study|Withdrawal by Subject|0|||
146890944|NCT03604445|529767326|FG002|Overall Study|Withdrawal by Subject|0|||
146890945|NCT03604445|529767327|FG003|Overall Study|Withdrawal by Subject|0|||
146890946|NCT03604445|529767328|FG004|Overall Study|Withdrawal by Subject|0|||
146890947|NCT03604445|529767329|FG005|Overall Study|Withdrawal by Subject|0|||
146890948|NCT03604445|529767330|FG006|Overall Study|Withdrawal by Subject|1|||
146890949|NCT03604445|529767331|FG007|Overall Study|Withdrawal by Subject|0|||
146890950|NCT03604445|529767332|FG008|Overall Study|Withdrawal by Subject|0|||
146890951|NCT03604445|529767324|FG000|Overall Study|Missing visit|0|||
146890952|NCT03604445|529767325|FG001|Overall Study|Missing visit|0|||
146890953|NCT03604445|529767326|FG002|Overall Study|Missing visit|0|||
146890954|NCT03604445|529767327|FG003|Overall Study|Missing visit|0|||
146890955|NCT03604445|529767328|FG004|Overall Study|Missing visit|0|||
146890956|NCT03604445|529767329|FG005|Overall Study|Missing visit|1|||
146890957|NCT03604445|529767330|FG006|Overall Study|Missing visit|0|||
146890958|NCT03604445|529767331|FG007|Overall Study|Missing visit|1|||
146890959|NCT03604445|529767332|FG008|Overall Study|Missing visit|0|||
146890960|NCT03604445|529767324|FG000|Overall Study|Adverse Event|0|||
146890961|NCT03604445|529767325|FG001|Overall Study|Adverse Event|0|||
146890962|NCT03604445|529767326|FG002|Overall Study|Adverse Event|0|||
146890963|NCT03604445|529767327|FG003|Overall Study|Adverse Event|1|||
146890964|NCT03604445|529767328|FG004|Overall Study|Adverse Event|0|||
146890965|NCT03604445|529767329|FG005|Overall Study|Adverse Event|0|||
146890966|NCT03604445|529767330|FG006|Overall Study|Adverse Event|0|||
146890967|NCT03604445|529767331|FG007|Overall Study|Adverse Event|0|||
146890968|NCT03604445|529767332|FG008|Overall Study|Adverse Event|1|||
146890969|NCT00773279|529767333|FG000|Period 1|Adverse Event|2|||
146890970|NCT00773279|529767334|FG001|Period 1|Adverse Event|1|||
146890971|NCT00773279|529767333|FG000|Period 1|Lack of Efficacy|0|||
146890972|NCT00773279|529767334|FG001|Period 1|Lack of Efficacy|2|||
146890973|NCT00773279|529767333|FG000|Period 1|Unclassified|5|||
146890974|NCT00773279|529767334|FG001|Period 1|Unclassified|1|||
146890975|NCT00773279|529767333|FG000|Period 2|Adverse Event|0|||
146890976|NCT00773279|529767334|FG001|Period 2|Adverse Event|1|||
146890977|NCT00773279|529767333|FG000|Period 2|Lack of Efficacy|1|||
146890978|NCT00773279|529767334|FG001|Period 2|Lack of Efficacy|0|||
146890979|NCT00773279|529767333|FG000|Period 2|Protocol Violation|0|||
146890980|NCT00773279|529767334|FG001|Period 2|Protocol Violation|3|||
146890981|NCT00773279|529767333|FG000|Period 2|Unclassified|2|||
146890982|NCT00773279|529767334|FG001|Period 2|Unclassified|2|||
146890983|NCT02251912|529767336|FG000|Overall Study|Withdrawal by Subject|2|||
146890984|NCT02251912|529767337|FG001|Overall Study|Withdrawal by Subject|3|||
146890985|NCT02251912|529767336|FG000|Overall Study|Adverse Event|0|||
146890986|NCT02251912|529767337|FG001|Overall Study|Adverse Event|2|||
146890987|NCT02551159|529767338|FG000|Overall Study|Death|352|||
146890988|NCT02551159|529767339|FG001|Overall Study|Death|174|||
146890989|NCT02551159|529767340|FG002|Overall Study|Death|161|||
146890990|NCT02551159|529767338|FG000|Overall Study|Withdrawal by Subject|8|||
146890991|NCT02551159|529767339|FG001|Overall Study|Withdrawal by Subject|5|||
146890992|NCT02551159|529767340|FG002|Overall Study|Withdrawal by Subject|16|||
146890993|NCT02551159|529767338|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
146890994|NCT02551159|529767339|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
146890995|NCT02551159|529767340|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
146890996|NCT02175680|529767341|FG000|Overall Study|non-compliance|1|||
146890997|NCT02175680|529767341|FG000|Overall Study|other non-medical reason|1|||
146967246|NCT00464308|530041480|FG000|Overall Study|Patient discontinued and other reasons|17|||
146557252|NCT00137449|528551020|FG001|Overall Study|Adverse Event|1|||
146557253|NCT00137449|528551019|FG000|Overall Study|Withdrawal by Subject|1|||
146557254|NCT00137449|528551020|FG001|Overall Study|Withdrawal by Subject|1|||
146557255|NCT03707821|528551021|FG000|Overall Study|Protocol Violation|0|||
146890998|NCT03434379|529767345|FG000|Global Period|Lost to Follow-up|3|||
146890999|NCT03434379|529767346|FG001|Global Period|Lost to Follow-up|6|||
146891000|NCT03434379|529767347|FG002|Global Period|Lost to Follow-up|0|||
146891001|NCT03434379|529767348|FG003|Global Period|Lost to Follow-up|0|||
146891002|NCT03434379|529767345|FG000|Global Period|Death|115|||
146891003|NCT03434379|529767346|FG001|Global Period|Death|228|||
146891004|NCT03434379|529767347|FG002|Global Period|Death|0|||
146967247|NCT00464308|530041481|FG001|Overall Study|Patient discontinued and other reasons|17|||
146557256|NCT03707821|528551022|FG001|Overall Study|Protocol Violation|1|||
146891005|NCT03434379|529767348|FG003|Global Period|Death|0|||
146557257|NCT03707821|528551021|FG000|Overall Study|Unsatisfactory Visual Response|1|||
146557258|NCT03707821|528551022|FG001|Overall Study|Unsatisfactory Visual Response|0|||
146557259|NCT03707821|528551021|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
146891006|NCT03434379|529767345|FG000|Global Period|Withdrawal by Subject|20|||
146891007|NCT03434379|529767346|FG001|Global Period|Withdrawal by Subject|21|||
146891008|NCT03434379|529767347|FG002|Global Period|Withdrawal by Subject|0|||
146891009|NCT03434379|529767348|FG003|Global Period|Withdrawal by Subject|0|||
146891010|NCT03434379|529767345|FG000|Global Period|Reason Unspecified|0|||
146891011|NCT03434379|529767346|FG001|Global Period|Reason Unspecified|1|||
146891012|NCT03434379|529767347|FG002|Global Period|Reason Unspecified|0|||
146891013|NCT03434379|529767348|FG003|Global Period|Reason Unspecified|0|||
146891014|NCT03434379|529767345|FG000|Global Period|Study Ended by Sponsor|26|||
146891015|NCT03434379|529767346|FG001|Global Period|Study Ended by Sponsor|80|||
146891016|NCT03434379|529767347|FG002|Global Period|Study Ended by Sponsor|0|||
146891017|NCT03434379|529767348|FG003|Global Period|Study Ended by Sponsor|0|||
146891018|NCT03434379|529767345|FG000|Global Period|Physician Decision|1|||
146891019|NCT03434379|529767346|FG001|Global Period|Physician Decision|0|||
146891020|NCT03434379|529767347|FG002|Global Period|Physician Decision|0|||
146636970|NCT01160822|528845599|FG006|Overall Study|Administrative problems|0|||
146766270|NCT01909336|529312220|FG001|Overall Study|Physician Decision|1|||
146891021|NCT03434379|529767348|FG003|Global Period|Physician Decision|0|||
146891022|NCT03434379|529767345|FG000|China Extension Period|Lost to Follow-up|0|||
146891023|NCT03434379|529767346|FG001|China Extension Period|Lost to Follow-up|0|||
146891024|NCT03434379|529767347|FG002|China Extension Period|Lost to Follow-up|2|||
146891025|NCT03434379|529767348|FG003|China Extension Period|Lost to Follow-up|3|||
146891026|NCT03434379|529767345|FG000|China Extension Period|Death|0|||
146891027|NCT03434379|529767346|FG001|China Extension Period|Death|0|||
146891028|NCT03434379|529767347|FG002|China Extension Period|Death|46|||
146891029|NCT03434379|529767348|FG003|China Extension Period|Death|88|||
146891030|NCT03434379|529767345|FG000|China Extension Period|Withdrawal by Subject|0|||
146891031|NCT03434379|529767346|FG001|China Extension Period|Withdrawal by Subject|0|||
146891032|NCT03434379|529767347|FG002|China Extension Period|Withdrawal by Subject|8|||
146891033|NCT03434379|529767348|FG003|China Extension Period|Withdrawal by Subject|6|||
146891034|NCT03434379|529767345|FG000|China Extension Period|Study Ended by Sponsor|0|||
146891035|NCT03434379|529767346|FG001|China Extension Period|Study Ended by Sponsor|0|||
146891036|NCT03434379|529767347|FG002|China Extension Period|Study Ended by Sponsor|5|||
146891037|NCT03434379|529767348|FG003|China Extension Period|Study Ended by Sponsor|36|||
146891038|NCT03179436|529767349|FG000|Overall Study|Withdrawal by Subject|1|||
146891039|NCT03179436|529767350|FG001|Overall Study|Withdrawal by Subject|0|||
146891040|NCT03179436|529767351|FG002|Overall Study|Withdrawal by Subject|0|||
146766271|NCT01909336|529312221|FG002|Overall Study|Physician Decision|1|||
146766272|NCT01235949|529312222|FG000|Primary Phase|Migrated/moved from study area|1|||
146766273|NCT01235949|529312223|FG001|Primary Phase|Migrated/moved from study area|1|||
146891041|NCT03179436|529767352|FG003|Overall Study|Withdrawal by Subject|4|||
146766274|NCT01235949|529312224|FG002|Primary Phase|Migrated/moved from study area|0|||
146766275|NCT01235949|529312225|FG003|Primary Phase|Migrated/moved from study area|0|||
146891042|NCT03179436|529767353|FG004|Overall Study|Withdrawal by Subject|2|||
146891043|NCT03179436|529767354|FG005|Overall Study|Withdrawal by Subject|2|||
146891044|NCT03179436|529767355|FG006|Overall Study|Withdrawal by Subject|5|||
146557260|NCT03707821|528551022|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
146891045|NCT03179436|529767356|FG007|Overall Study|Withdrawal by Subject|0|||
146891046|NCT03179436|529767357|FG008|Overall Study|Withdrawal by Subject|3|||
146967248|NCT00464308|530041482|FG002|Overall Study|Patient discontinued and other reasons|23|||
146967249|NCT00464308|530041480|FG000|Overall Study|Physician Decision|1|||
146967250|NCT00464308|530041481|FG001|Overall Study|Physician Decision|0|||
146967251|NCT00464308|530041482|FG002|Overall Study|Physician Decision|0|||
146967252|NCT01721200|530041483|FG000|Overall Study|Lost to Follow-up|3|||
146967253|NCT01721200|530041484|FG001|Overall Study|Lost to Follow-up|5|||
146967254|NCT00630994|530041485|FG000|Overall Study|Adverse Event|1|||
146967255|NCT00630994|530041485|FG000|Overall Study|Disease Progression|1|||
146967256|NCT00630994|530041485|FG000|Overall Study|Lack of Efficacy|1|||
146967257|NCT00630994|530041485|FG000|Overall Study|Other|1|||
146967258|NCT03722849|530041488|FG000|Overall Study|Withdrawal by Subject|1|||
146967259|NCT03722849|530041489|FG001|Overall Study|Withdrawal by Subject|1|||
146967260|NCT03533608|530041490|FG000|Overall Study|Withdrawal by Subject|3|||
146967261|NCT03533608|530041490|FG000|Overall Study|Physician Decision|2|||
146557261|NCT00770679|528551025|FG000|Overall Study|Lost to Follow-up|3|||
146891047|NCT03179436|529767358|FG009|Overall Study|Withdrawal by Subject|0|||
146891048|NCT03179436|529767359|FG010|Overall Study|Withdrawal by Subject|0|||
146891049|NCT03179436|529767360|FG011|Overall Study|Withdrawal by Subject|0|||
146891050|NCT03179436|529767349|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146891051|NCT03179436|529767350|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146891052|NCT03179436|529767351|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146891053|NCT03179436|529767352|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146891054|NCT03179436|529767353|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
146891055|NCT03179436|529767354|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
146891056|NCT03179436|529767355|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
146891057|NCT03179436|529767356|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
146891058|NCT03179436|529767357|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
146891059|NCT03179436|529767358|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
146891060|NCT03179436|529767359|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
146891061|NCT03179436|529767360|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
146891062|NCT03179436|529767349|FG000|Overall Study|Sponsor Decision|0|||
146891063|NCT03179436|529767350|FG001|Overall Study|Sponsor Decision|0|||
146891064|NCT03179436|529767351|FG002|Overall Study|Sponsor Decision|1|||
146891065|NCT03179436|529767352|FG003|Overall Study|Sponsor Decision|3|||
146891066|NCT03179436|529767353|FG004|Overall Study|Sponsor Decision|9|||
146891067|NCT03179436|529767354|FG005|Overall Study|Sponsor Decision|7|||
146967262|NCT03286426|530041491|FG000|Overall Study|Physician Decision|3|||
146967263|NCT03514121|530041492|FG000|Overall Study|Withdrawal by Subject|0|||
146967264|NCT03514121|530041493|FG001|Overall Study|Withdrawal by Subject|0|||
146967265|NCT03514121|530041494|FG002|Overall Study|Withdrawal by Subject|0|||
146891068|NCT03179436|529767355|FG006|Overall Study|Sponsor Decision|2|||
146891069|NCT03179436|529767356|FG007|Overall Study|Sponsor Decision|4|||
146891070|NCT03179436|529767357|FG008|Overall Study|Sponsor Decision|23|||
146891071|NCT03179436|529767358|FG009|Overall Study|Sponsor Decision|6|||
146967266|NCT03514121|530041495|FG003|Overall Study|Withdrawal by Subject|0|||
146557262|NCT00770679|528551025|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
146891072|NCT03179436|529767359|FG010|Overall Study|Sponsor Decision|7|||
146891073|NCT03179436|529767360|FG011|Overall Study|Sponsor Decision|5|||
146967267|NCT03514121|530041496|FG004|Overall Study|Withdrawal by Subject|1|||
146967268|NCT03514121|530041497|FG005|Overall Study|Withdrawal by Subject|2|||
146967269|NCT03514121|530041498|FG006|Overall Study|Withdrawal by Subject|1|||
146967270|NCT03514121|530041499|FG007|Overall Study|Withdrawal by Subject|1|||
146967271|NCT03514121|530041500|FG008|Overall Study|Withdrawal by Subject|7|||
146967272|NCT03514121|530041501|FG009|Overall Study|Withdrawal by Subject|2|||
146967273|NCT03514121|530041492|FG000|Overall Study|Death|0|||
146967274|NCT03514121|530041493|FG001|Overall Study|Death|0|||
146967275|NCT03514121|530041494|FG002|Overall Study|Death|0|||
146967276|NCT03514121|530041495|FG003|Overall Study|Death|0|||
146967277|NCT03514121|530041496|FG004|Overall Study|Death|0|||
146967278|NCT03514121|530041497|FG005|Overall Study|Death|3|||
146967279|NCT03514121|530041498|FG006|Overall Study|Death|2|||
146967280|NCT03514121|530041499|FG007|Overall Study|Death|1|||
146967281|NCT03514121|530041500|FG008|Overall Study|Death|26|||
146967282|NCT03514121|530041501|FG009|Overall Study|Death|3|||
146967283|NCT03514121|530041492|FG000|Overall Study|Lost to Follow-up|0|||
146967284|NCT03514121|530041493|FG001|Overall Study|Lost to Follow-up|0|||
146967285|NCT03514121|530041494|FG002|Overall Study|Lost to Follow-up|1|||
146967286|NCT03514121|530041495|FG003|Overall Study|Lost to Follow-up|0|||
146967287|NCT03514121|530041496|FG004|Overall Study|Lost to Follow-up|0|||
146967288|NCT03514121|530041497|FG005|Overall Study|Lost to Follow-up|0|||
146967289|NCT03514121|530041498|FG006|Overall Study|Lost to Follow-up|0|||
146967290|NCT03514121|530041499|FG007|Overall Study|Lost to Follow-up|0|||
146967291|NCT03514121|530041500|FG008|Overall Study|Lost to Follow-up|1|||
146967292|NCT03514121|530041501|FG009|Overall Study|Lost to Follow-up|0|||
146967293|NCT03514121|530041492|FG000|Overall Study|Adverse Event|0|||
146967294|NCT03514121|530041493|FG001|Overall Study|Adverse Event|0|||
146967295|NCT03514121|530041494|FG002|Overall Study|Adverse Event|0|||
146967296|NCT03514121|530041495|FG003|Overall Study|Adverse Event|0|||
146967297|NCT03514121|530041496|FG004|Overall Study|Adverse Event|0|||
146967298|NCT03514121|530041497|FG005|Overall Study|Adverse Event|0|||
146967299|NCT03514121|530041498|FG006|Overall Study|Adverse Event|1|||
146967300|NCT03514121|530041499|FG007|Overall Study|Adverse Event|0|||
146967301|NCT03514121|530041500|FG008|Overall Study|Adverse Event|0|||
146967302|NCT03514121|530041501|FG009|Overall Study|Adverse Event|0|||
146967303|NCT03514121|530041492|FG000|Overall Study|Other|0|||
146967304|NCT03514121|530041493|FG001|Overall Study|Other|1|||
146967305|NCT03514121|530041494|FG002|Overall Study|Other|1|||
146967306|NCT03514121|530041495|FG003|Overall Study|Other|0|||
146967307|NCT03514121|530041496|FG004|Overall Study|Other|1|||
146967308|NCT03514121|530041497|FG005|Overall Study|Other|2|||
146967309|NCT03514121|530041498|FG006|Overall Study|Other|3|||
146967310|NCT03514121|530041499|FG007|Overall Study|Other|2|||
146967311|NCT03514121|530041500|FG008|Overall Study|Other|7|||
146967312|NCT03514121|530041501|FG009|Overall Study|Other|3|||
146967313|NCT03514121|530041492|FG000|Overall Study|Study termination by Sponsor|0|||
146967314|NCT03514121|530041493|FG001|Overall Study|Study termination by Sponsor|0|||
146967315|NCT03514121|530041494|FG002|Overall Study|Study termination by Sponsor|0|||
146967316|NCT03514121|530041495|FG003|Overall Study|Study termination by Sponsor|0|||
146967317|NCT03514121|530041496|FG004|Overall Study|Study termination by Sponsor|0|||
146967318|NCT03514121|530041497|FG005|Overall Study|Study termination by Sponsor|0|||
146967319|NCT03514121|530041498|FG006|Overall Study|Study termination by Sponsor|0|||
146967320|NCT03514121|530041499|FG007|Overall Study|Study termination by Sponsor|0|||
146967321|NCT03514121|530041500|FG008|Overall Study|Study termination by Sponsor|11|||
146967322|NCT03514121|530041501|FG009|Overall Study|Study termination by Sponsor|3|||
146967323|NCT03514121|530041492|FG000|Overall Study|Investigator decision|0|||
146967324|NCT03514121|530041493|FG001|Overall Study|Investigator decision|0|||
146967325|NCT03514121|530041494|FG002|Overall Study|Investigator decision|0|||
146967326|NCT03514121|530041495|FG003|Overall Study|Investigator decision|0|||
146967327|NCT03514121|530041496|FG004|Overall Study|Investigator decision|0|||
146967328|NCT03514121|530041497|FG005|Overall Study|Investigator decision|0|||
146967329|NCT03514121|530041498|FG006|Overall Study|Investigator decision|0|||
146967330|NCT03514121|530041499|FG007|Overall Study|Investigator decision|0|||
146967331|NCT03514121|530041500|FG008|Overall Study|Investigator decision|1|||
146967332|NCT03514121|530041501|FG009|Overall Study|Investigator decision|0|||
146967333|NCT05553600|530041502|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
146967334|NCT05553600|530041503|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
146766276|NCT01235949|529312226|FG004|Primary Phase|Migrated/moved from study area|1|||
146967335|NCT05553600|530041504|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
146967336|NCT05553600|530041505|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
146967337|NCT05553600|530041502|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
146967338|NCT05553600|530041503|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
146967339|NCT05553600|530041504|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
146967340|NCT05553600|530041505|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
146967341|NCT05553600|530041502|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
146967342|NCT05553600|530041503|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
146967343|NCT05553600|530041504|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
146967344|NCT05553600|530041505|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
146967345|NCT05553600|530041502|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
146967346|NCT05553600|530041503|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
146967347|NCT05553600|530041504|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
146967348|NCT05553600|530041505|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
146967349|NCT05553600|530041502|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
146967350|NCT05553600|530041503|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
146967351|NCT05553600|530041504|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
146967352|NCT05553600|530041505|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
146967353|NCT05553600|530041502|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
146967354|NCT05553600|530041503|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
146967355|NCT05553600|530041504|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
146967356|NCT05553600|530041505|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
146967357|NCT05553600|530041502|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
146967358|NCT05553600|530041503|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
146967359|NCT05553600|530041504|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
146967360|NCT05553600|530041505|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
146967361|NCT05553600|530041502|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
146967362|NCT05553600|530041503|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
146967363|NCT05553600|530041504|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
146967364|NCT05553600|530041505|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
146967365|NCT05553600|530041502|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
146967366|NCT05553600|530041503|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
146967367|NCT05553600|530041504|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
146967368|NCT05553600|530041505|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
146967369|NCT05553600|530041502|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
146967370|NCT05553600|530041503|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
146967371|NCT05553600|530041504|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
146967372|NCT05553600|530041505|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
146967373|NCT05553600|530041502|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
146967374|NCT05553600|530041503|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
146967375|NCT05553600|530041504|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
146967376|NCT05553600|530041505|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
146967377|NCT05553600|530041502|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
146967378|NCT05553600|530041503|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
146967379|NCT05553600|530041504|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
146967380|NCT05553600|530041505|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
146967381|NCT04292171|530041506|FG000|Overall Study|Pharmacy error|2|||
146967382|NCT04292171|530041507|FG001|Overall Study|Pharmacy error|0|||
146967383|NCT04292171|530041506|FG000|Overall Study|Delivered prior to procedure|0|||
146967384|NCT04292171|530041507|FG001|Overall Study|Delivered prior to procedure|1|||
146967385|NCT03079869|530041511|FG000|Overall Study|Adverse Event|6|||
146967386|NCT03079869|530041512|FG001|Overall Study|Adverse Event|8|||
146967387|NCT03079869|530041511|FG000|Overall Study|Withdrawal by Subject|4|||
146967388|NCT03079869|530041512|FG001|Overall Study|Withdrawal by Subject|1|||
146967389|NCT03079869|530041511|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
146967390|NCT03079869|530041512|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
146967391|NCT04633434|530041513|FG000|Overall Study|Lost to Follow-up|32|||
146967392|NCT04633434|530041514|FG001|Overall Study|Lost to Follow-up|32|||
146967393|NCT00297882|530041519|FG000|Day 14|Lack of Efficacy|12|||
146967394|NCT00297882|530041520|FG001|Day 14|Lack of Efficacy|49|||
146967395|NCT00297882|530041519|FG000|Day 28|Lost to Follow-up|13|||
146967396|NCT00297882|530041520|FG001|Day 28|Lost to Follow-up|23|||
146967397|NCT00297882|530041519|FG000|Day 28|Lack of Efficacy|3|||
146967398|NCT00297882|530041520|FG001|Day 28|Lack of Efficacy|0|||
146967399|NCT00348348|530041522|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
146967400|NCT00348348|530041523|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
146967401|NCT00348348|530041522|FG000|Overall Study|Lack of Efficacy|1|||
146967402|NCT00348348|530041523|FG001|Overall Study|Lack of Efficacy|1|||
146967403|NCT00348348|530041522|FG000|Overall Study|Lost to Follow-up|8|||
146557263|NCT00129974|528551026|FG000|Overall Study|Other|1|||
146557264|NCT00414609|528551027|FG000|Core Study|Adverse Event|9|||
146766277|NCT01235949|529312227|FG005|Primary Phase|Migrated/moved from study area|2|||
146967404|NCT00348348|530041523|FG001|Overall Study|Lost to Follow-up|10|||
146967405|NCT00348348|530041522|FG000|Overall Study|Withdrawal by Subject|4|||
146967406|NCT00348348|530041523|FG001|Overall Study|Withdrawal by Subject|1|||
146967407|NCT00348348|530041522|FG000|Overall Study|Other|7|||
146967408|NCT00348348|530041523|FG001|Overall Study|Other|4|||
146891074|NCT03179436|529767349|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
146891075|NCT03179436|529767350|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
146891076|NCT03179436|529767351|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
146891077|NCT03179436|529767352|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
146891078|NCT03179436|529767353|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
146891079|NCT03179436|529767354|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
146891080|NCT03179436|529767355|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
146891081|NCT03179436|529767356|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
146891082|NCT03179436|529767357|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
146891083|NCT03179436|529767358|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
146891084|NCT03179436|529767359|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
146891085|NCT03179436|529767360|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
146891086|NCT03179436|529767349|FG000|Overall Study|Lost to Follow-up|1|||
146891087|NCT03179436|529767350|FG001|Overall Study|Lost to Follow-up|0|||
146891088|NCT03179436|529767351|FG002|Overall Study|Lost to Follow-up|0|||
146891089|NCT03179436|529767352|FG003|Overall Study|Lost to Follow-up|1|||
146891090|NCT03179436|529767353|FG004|Overall Study|Lost to Follow-up|0|||
146891091|NCT03179436|529767354|FG005|Overall Study|Lost to Follow-up|1|||
146891092|NCT03179436|529767355|FG006|Overall Study|Lost to Follow-up|0|||
146891093|NCT03179436|529767356|FG007|Overall Study|Lost to Follow-up|0|||
146891094|NCT03179436|529767357|FG008|Overall Study|Lost to Follow-up|1|||
146891095|NCT03179436|529767358|FG009|Overall Study|Lost to Follow-up|1|||
146891096|NCT03179436|529767359|FG010|Overall Study|Lost to Follow-up|0|||
146891097|NCT03179436|529767360|FG011|Overall Study|Lost to Follow-up|0|||
146891098|NCT03179436|529767349|FG000|Overall Study|Death|12|||
146891099|NCT03179436|529767350|FG001|Overall Study|Death|17|||
146891100|NCT03179436|529767351|FG002|Overall Study|Death|7|||
146891101|NCT03179436|529767352|FG003|Overall Study|Death|32|||
146891102|NCT03179436|529767353|FG004|Overall Study|Death|29|||
146891103|NCT03179436|529767354|FG005|Overall Study|Death|30|||
146891104|NCT03179436|529767355|FG006|Overall Study|Death|33|||
146891105|NCT03179436|529767356|FG007|Overall Study|Death|9|||
146891106|NCT03179436|529767357|FG008|Overall Study|Death|84|||
146891107|NCT03179436|529767358|FG009|Overall Study|Death|33|||
146891108|NCT03179436|529767359|FG010|Overall Study|Death|22|||
146891109|NCT03179436|529767360|FG011|Overall Study|Death|15|||
146891110|NCT01634555|529767369|FG000|Overall Study|Adverse Event|3|||
146891111|NCT01634555|529767369|FG000|Overall Study|Physician Decision|1|||
146891112|NCT01738971|529767374|FG000|Overall Study|Lost to Follow-up|19|||
146891113|NCT01738971|529767375|FG001|Overall Study|Lost to Follow-up|30|||
146891114|NCT01738971|529767376|FG002|Overall Study|Lost to Follow-up|17|||
146891115|NCT01602341|529769096|FG000|Overall Study|Adverse Event|0|||
146891116|NCT01602341|529769097|FG001|Overall Study|Adverse Event|1|||
146891117|NCT02152345|529769098|FG000|Overall Study|Case Cancellations|2|||
146891118|NCT02152345|529769099|FG001|Overall Study|Case Cancellations|4|||
146891119|NCT02152345|529769098|FG000|Overall Study|Withdrawal by Subject|2|||
146891120|NCT02152345|529769099|FG001|Overall Study|Withdrawal by Subject|1|||
146891121|NCT02554929|529769101|FG000|Overall Study|Lost to Follow-up|4|||
146891122|NCT02554929|529769102|FG001|Overall Study|Lost to Follow-up|4|||
146891123|NCT02554929|529769101|FG000|Overall Study|Withdrawal by Subject|2|||
146891124|NCT02554929|529769102|FG001|Overall Study|Withdrawal by Subject|8|||
146891125|NCT01916980|529769103|FG000|Overall Study|Adverse Event|4|||
146891126|NCT01916980|529769104|FG001|Overall Study|Adverse Event|2|||
146891127|NCT01916980|529769103|FG000|Overall Study|Lack of Efficacy|2|||
146891128|NCT01916980|529769104|FG001|Overall Study|Lack of Efficacy|2|||
146891129|NCT01916980|529769103|FG000|Overall Study|Withdrawal by Subject|1|||
146891130|NCT01916980|529769104|FG001|Overall Study|Withdrawal by Subject|0|||
146891131|NCT00546364|529769105|FG000|Overall Study|Disease progression|5|||
146891132|NCT00546364|529769106|FG001|Overall Study|Disease progression|11|||
146891133|NCT00546364|529769107|FG002|Overall Study|Disease progression|8|||
146891134|NCT00546364|529769105|FG000|Overall Study|Completed and off treatment|1|||
146891135|NCT00546364|529769106|FG001|Overall Study|Completed and off treatment|0|||
146891136|NCT00546364|529769107|FG002|Overall Study|Completed and off treatment|2|||
146891137|NCT00546364|529769105|FG000|Overall Study|Administrative reason by sponsor|1|||
146891138|NCT00546364|529769106|FG001|Overall Study|Administrative reason by sponsor|0|||
146891139|NCT00546364|529769107|FG002|Overall Study|Administrative reason by sponsor|0|||
146891140|NCT00546364|529769105|FG000|Overall Study|Poor compliance/noncompliance|0|||
146891141|NCT00546364|529769106|FG001|Overall Study|Poor compliance/noncompliance|0|||
146891142|NCT00546364|529769107|FG002|Overall Study|Poor compliance/noncompliance|1|||
146891143|NCT00546364|529769105|FG000|Overall Study|No longer meets study criteria|1|||
146891144|NCT00546364|529769106|FG001|Overall Study|No longer meets study criteria|1|||
146891145|NCT00546364|529769107|FG002|Overall Study|No longer meets study criteria|0|||
146891146|NCT00546364|529769105|FG000|Overall Study|Withdrawal by Subject|5|||
146891147|NCT00546364|529769106|FG001|Overall Study|Withdrawal by Subject|6|||
146891148|NCT00546364|529769107|FG002|Overall Study|Withdrawal by Subject|3|||
146891149|NCT00546364|529769105|FG000|Overall Study|Prior taxotere|1|||
146891150|NCT00546364|529769106|FG001|Overall Study|Prior taxotere|0|||
146891151|NCT00546364|529769107|FG002|Overall Study|Prior taxotere|0|||
146891152|NCT00546364|529769105|FG000|Overall Study|Mixed response|1|||
146891153|NCT00546364|529769106|FG001|Overall Study|Mixed response|0|||
146891154|NCT00546364|529769107|FG002|Overall Study|Mixed response|0|||
146891155|NCT00546364|529769105|FG000|Overall Study|Palliative treatment|1|||
146891156|NCT00546364|529769106|FG001|Overall Study|Palliative treatment|0|||
146891157|NCT00546364|529769107|FG002|Overall Study|Palliative treatment|1|||
146891158|NCT00546364|529769105|FG000|Overall Study|Target lesions resected|1|||
146891159|NCT00546364|529769106|FG001|Overall Study|Target lesions resected|0|||
146891160|NCT00546364|529769107|FG002|Overall Study|Target lesions resected|0|||
146891161|NCT00546364|529769105|FG000|Overall Study|Physician Decision|0|||
146891162|NCT00546364|529769106|FG001|Overall Study|Physician Decision|0|||
146891163|NCT00546364|529769107|FG002|Overall Study|Physician Decision|1|||
146891164|NCT00546364|529769105|FG000|Overall Study|Sponsor decision|0|||
146557265|NCT00414609|528551028|FG001|Core Study|Adverse Event|11|||
146557266|NCT00414609|528551029|FG002|Core Study|Adverse Event|0|||
146557267|NCT00414609|528551027|FG000|Core Study|Abnormal laboratory values|0|||
146557268|NCT00414609|528551028|FG001|Core Study|Abnormal laboratory values|1|||
146891165|NCT00546364|529769106|FG001|Overall Study|Sponsor decision|0|||
146891166|NCT00546364|529769107|FG002|Overall Study|Sponsor decision|1|||
146891167|NCT02090855|529769108|FG000|Overall Study|no evaluable Standard of Truth results|2|||
146891168|NCT00388947|529769110|FG000|Overall Study|Protocol Violation|47|||
146891169|NCT04187092|529769111|FG000|Overall Study|Lost to Follow-up|1|||
146557269|NCT00414609|528551029|FG002|Core Study|Abnormal laboratory values|0|||
146636971|NCT01160822|528845593|FG000|Overall Study|Protocol deviation|0|||
146891170|NCT04187092|529769112|FG001|Overall Study|Lost to Follow-up|1|||
146891171|NCT04187092|529769111|FG000|Overall Study|Withdrawal by Subject|1|||
146891172|NCT04187092|529769112|FG001|Overall Study|Withdrawal by Subject|1|||
146891173|NCT04187092|529769111|FG000|Overall Study|Adverse Event|0|||
146891174|NCT04187092|529769112|FG001|Overall Study|Adverse Event|1|||
146891175|NCT00880750|529769119|FG000|First Intervention|Adverse Event|1|||
146891176|NCT00880750|529769120|FG001|First Intervention|Adverse Event|0|||
146891177|NCT00880750|529769119|FG000|First Intervention|Unable to collect urine|4|||
146891178|NCT00880750|529769120|FG001|First Intervention|Unable to collect urine|0|||
146891179|NCT00880750|529769119|FG000|First Intervention|Non-compliance with meals|0|||
146891180|NCT00880750|529769120|FG001|First Intervention|Non-compliance with meals|1|||
146891181|NCT00880750|529769119|FG000|First Intervention|Withdrawal by Subject|2|||
146891182|NCT00880750|529769120|FG001|First Intervention|Withdrawal by Subject|0|||
146891183|NCT00880750|529769119|FG000|First Intervention|Lost to Follow-up|2|||
146891184|NCT00880750|529769120|FG001|First Intervention|Lost to Follow-up|0|||
146891185|NCT00880750|529769119|FG000|Second Intervention|Withdrawal by Subject|2|||
146891186|NCT00880750|529769120|FG001|Second Intervention|Withdrawal by Subject|2|||
146891187|NCT00880750|529769119|FG000|Second Intervention|Protocol Violation|1|||
146891188|NCT00880750|529769120|FG001|Second Intervention|Protocol Violation|0|||
146891189|NCT00880750|529769119|FG000|Second Intervention|Unable to collect urine|1|||
146891190|NCT00880750|529769120|FG001|Second Intervention|Unable to collect urine|0|||
146891191|NCT00667576|529769127|FG000|Overall Study|Withdrawal by Subject|1|||
146891192|NCT00667576|529769128|FG001|Overall Study|Withdrawal by Subject|0|||
146891193|NCT00667576|529769129|FG002|Overall Study|Withdrawal by Subject|1|||
146891194|NCT00667576|529769130|FG003|Overall Study|Withdrawal by Subject|1|||
146891195|NCT00667576|529769131|FG004|Overall Study|Withdrawal by Subject|1|||
146891196|NCT00667576|529769127|FG000|Overall Study|Adverse Event|1|||
146891197|NCT00667576|529769128|FG001|Overall Study|Adverse Event|1|||
146891198|NCT00667576|529769129|FG002|Overall Study|Adverse Event|0|||
146891199|NCT00667576|529769130|FG003|Overall Study|Adverse Event|0|||
146891200|NCT00667576|529769131|FG004|Overall Study|Adverse Event|0|||
146891201|NCT00667576|529769127|FG000|Overall Study|Lost to Follow-up|0|||
146891202|NCT00667576|529769128|FG001|Overall Study|Lost to Follow-up|0|||
146967409|NCT00348348|530041522|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
146967410|NCT00348348|530041523|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
146967411|NCT00348348|530041522|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
146967412|NCT00348348|530041523|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
146891203|NCT00667576|529769129|FG002|Overall Study|Lost to Follow-up|1|||
146891204|NCT00667576|529769130|FG003|Overall Study|Lost to Follow-up|0|||
146891205|NCT00667576|529769131|FG004|Overall Study|Lost to Follow-up|0|||
146891206|NCT00667576|529769127|FG000|Overall Study|Protocol Violation|0|||
146891207|NCT00667576|529769128|FG001|Overall Study|Protocol Violation|0|||
146891208|NCT00667576|529769129|FG002|Overall Study|Protocol Violation|0|||
146891209|NCT00667576|529769130|FG003|Overall Study|Protocol Violation|1|||
146891210|NCT00667576|529769131|FG004|Overall Study|Protocol Violation|0|||
146891211|NCT00667576|529769127|FG000|Overall Study|Physician Decision|0|||
146891212|NCT00667576|529769128|FG001|Overall Study|Physician Decision|0|||
146891213|NCT00667576|529769129|FG002|Overall Study|Physician Decision|0|||
146891214|NCT00667576|529769130|FG003|Overall Study|Physician Decision|1|||
146891215|NCT00667576|529769131|FG004|Overall Study|Physician Decision|0|||
146891216|NCT00667576|529769127|FG000|Overall Study|Missed Visit|0|||
146891217|NCT00667576|529769128|FG001|Overall Study|Missed Visit|0|||
146891218|NCT00667576|529769129|FG002|Overall Study|Missed Visit|0|||
146891219|NCT00667576|529769130|FG003|Overall Study|Missed Visit|1|||
146891220|NCT00667576|529769131|FG004|Overall Study|Missed Visit|0|||
146891221|NCT00483327|529769135|FG000|Overall Study|Adverse Event|1|||
146891222|NCT00483327|529769135|FG000|Overall Study|Withdrawal by Subject|3|||
146891223|NCT00483327|529769135|FG000|Overall Study|Lost to Follow-up|4|||
146891224|NCT00483327|529769135|FG000|Overall Study|Patient Non Compliance|2|||
146636972|NCT01160822|528845594|FG001|Overall Study|Protocol deviation|0|||
146636973|NCT01160822|528845595|FG002|Overall Study|Protocol deviation|0|||
146636974|NCT01160822|528845596|FG003|Overall Study|Protocol deviation|0|||
146766278|NCT01235949|529312228|FG006|Primary Phase|Migrated/moved from study area|0|||
146766279|NCT01235949|529312229|FG007|Primary Phase|Migrated/moved from study area|0|||
146766280|NCT01235949|529312230|FG008|Primary Phase|Migrated/moved from study area|0|||
146766281|NCT01235949|529312231|FG009|Primary Phase|Migrated/moved from study area|0|||
146557270|NCT00414609|528551027|FG000|Core Study|Abnormal test procedure results|1|||
146557271|NCT00414609|528551028|FG001|Core Study|Abnormal test procedure results|1|||
146557272|NCT00414609|528551029|FG002|Core Study|Abnormal test procedure results|0|||
146557273|NCT00414609|528551027|FG000|Core Study|Protocol deviation|0|||
146557274|NCT00414609|528551028|FG001|Core Study|Protocol deviation|1|||
146557275|NCT00414609|528551029|FG002|Core Study|Protocol deviation|0|||
146557276|NCT00414609|528551027|FG000|Core Study|Patient withdrew consent|10|||
146557277|NCT00414609|528551028|FG001|Core Study|Patient withdrew consent|11|||
146557278|NCT00414609|528551029|FG002|Core Study|Patient withdrew consent|0|||
146557279|NCT00414609|528551027|FG000|Core Study|Lost to Follow-up|7|||
146557280|NCT00414609|528551028|FG001|Core Study|Lost to Follow-up|4|||
146557281|NCT00414609|528551029|FG002|Core Study|Lost to Follow-up|0|||
146557282|NCT00414609|528551027|FG000|Core Study|Administrative problems|0|||
146557283|NCT00414609|528551028|FG001|Core Study|Administrative problems|2|||
146557284|NCT00414609|528551029|FG002|Core Study|Administrative problems|0|||
146557285|NCT00414609|528551027|FG000|Core Study|Death|7|||
146557286|NCT00414609|528551028|FG001|Core Study|Death|14|||
146557287|NCT00414609|528551029|FG002|Core Study|Death|0|||
146557288|NCT00414609|528551027|FG000|Extension Study|Adverse Event|0|||
146557289|NCT00414609|528551028|FG001|Extension Study|Adverse Event|0|||
146557290|NCT00414609|528551029|FG002|Extension Study|Adverse Event|14|||
146557291|NCT00414609|528551027|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
146557292|NCT00414609|528551028|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
146557293|NCT00414609|528551029|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
146557294|NCT00414609|528551027|FG000|Extension Study|Withdrawal by Subject|0|||
146557295|NCT00414609|528551028|FG001|Extension Study|Withdrawal by Subject|0|||
146891225|NCT00618722|529769136|FG000|Overall Study|Refusal of Treatment|0|||
146557296|NCT00414609|528551029|FG002|Extension Study|Withdrawal by Subject|13|||
146891226|NCT00618722|529769137|FG001|Overall Study|Refusal of Treatment|0|||
146557297|NCT00414609|528551027|FG000|Extension Study|Lost to Follow-up|0|||
146891227|NCT00618722|529769138|FG002|Overall Study|Refusal of Treatment|1|||
146891228|NCT00618722|529769139|FG003|Overall Study|Refusal of Treatment|0|||
146891229|NCT00618722|529769136|FG000|Overall Study|Patient Request|1|||
146891230|NCT00618722|529769137|FG001|Overall Study|Patient Request|1|||
146891231|NCT00618722|529769138|FG002|Overall Study|Patient Request|1|||
146891232|NCT00618722|529769139|FG003|Overall Study|Patient Request|1|||
146891233|NCT00618722|529769136|FG000|Overall Study|Inability to Complete Study Procedure|0|||
146891234|NCT00618722|529769137|FG001|Overall Study|Inability to Complete Study Procedure|1|||
146891235|NCT00618722|529769138|FG002|Overall Study|Inability to Complete Study Procedure|0|||
146891236|NCT00618722|529769139|FG003|Overall Study|Inability to Complete Study Procedure|0|||
146891237|NCT00618722|529769136|FG000|Overall Study|Lost to Follow-up|2|||
146891238|NCT00618722|529769137|FG001|Overall Study|Lost to Follow-up|0|||
146891239|NCT00618722|529769138|FG002|Overall Study|Lost to Follow-up|0|||
146891240|NCT00618722|529769139|FG003|Overall Study|Lost to Follow-up|2|||
146891241|NCT00618722|529769136|FG000|Overall Study|Miscellaneous Reasons|0|||
146891242|NCT00618722|529769137|FG001|Overall Study|Miscellaneous Reasons|0|||
146891243|NCT00618722|529769138|FG002|Overall Study|Miscellaneous Reasons|1|||
146891244|NCT00618722|529769139|FG003|Overall Study|Miscellaneous Reasons|1|||
146891245|NCT00200057|529769140|FG000|Overall Study|Lack of Efficacy|3|||
146891246|NCT00200057|529769140|FG000|Overall Study|Exited due to terminal illness of PI|2|||
146891247|NCT00200057|529769140|FG000|Overall Study|Withdrawal by Subject|1|||
146891248|NCT00200057|529769140|FG000|Overall Study|Change in medical condition|1|||
146891249|NCT00200057|529769140|FG000|Overall Study|Infection|1|||
146891250|NCT00200057|529769140|FG000|Overall Study|Death|1|||
146891251|NCT05512949|529769141|FG000|Overall Study|Lost to Follow-up|4|||
146891252|NCT05512949|529769142|FG001|Overall Study|Lost to Follow-up|6|||
146891253|NCT05512949|529769143|FG002|Overall Study|Lost to Follow-up|2|||
146891254|NCT05512949|529769141|FG000|Overall Study|Protocol Violation|0|||
146891255|NCT05512949|529769142|FG001|Overall Study|Protocol Violation|0|||
146891256|NCT05512949|529769143|FG002|Overall Study|Protocol Violation|1|||
146891257|NCT05512949|529769141|FG000|Overall Study|Withdrawal by Subject|1|||
146891258|NCT05512949|529769142|FG001|Overall Study|Withdrawal by Subject|1|||
146891259|NCT05512949|529769143|FG002|Overall Study|Withdrawal by Subject|2|||
146891260|NCT05512949|529769141|FG000|Overall Study|Completion status unknown|1|||
146891261|NCT05512949|529769142|FG001|Overall Study|Completion status unknown|3|||
146891262|NCT05512949|529769143|FG002|Overall Study|Completion status unknown|0|||
146891263|NCT02810964|529769144|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
146891264|NCT02810964|529769145|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
146891265|NCT02810964|529769144|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
146891266|NCT02810964|529769145|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
146891267|NCT02810964|529769144|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
146891268|NCT02810964|529769145|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
146891269|NCT02810964|529769144|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
146891270|NCT02810964|529769145|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
146766282|NCT01235949|529312232|FG010|Primary Phase|Migrated/moved from study area|0|||
146766283|NCT01235949|529312233|FG011|Primary Phase|Migrated/moved from study area|0|||
146891271|NCT03523351|529769146|FG000|Overall Study|Death|13|||
146891272|NCT03523351|529769147|FG001|Overall Study|Death|11|||
146891273|NCT03523351|529769146|FG000|Overall Study|Lost to Follow-up|2|||
146891274|NCT03523351|529769147|FG001|Overall Study|Lost to Follow-up|3|||
146891275|NCT03523351|529769146|FG000|Overall Study|Withdrawal by Subject|4|||
146891276|NCT03523351|529769147|FG001|Overall Study|Withdrawal by Subject|0|||
146891277|NCT03523351|529769146|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
146891278|NCT03523351|529769147|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
146891279|NCT01430442|529769148|FG000|Overall Study|Subject Withdrew Consent|3|||
146891280|NCT01430442|529769149|FG001|Overall Study|Subject Withdrew Consent|0|||
146891281|NCT01430442|529769150|FG002|Overall Study|Subject Withdrew Consent|1|||
146891282|NCT01430442|529769151|FG003|Overall Study|Subject Withdrew Consent|0|||
146891283|NCT01430442|529769152|FG004|Overall Study|Subject Withdrew Consent|2|||
146891284|NCT01430442|529769153|FG005|Overall Study|Subject Withdrew Consent|1|||
146891285|NCT01430442|529769154|FG006|Overall Study|Subject Withdrew Consent|5|||
146891286|NCT01430442|529769155|FG007|Overall Study|Subject Withdrew Consent|2|||
146891287|NCT01430442|529769148|FG000|Overall Study|Lost to Follow-up|2|||
146766284|NCT01235949|529312234|FG012|Primary Phase|Migrated/moved from study area|0|||
146891288|NCT01430442|529769149|FG001|Overall Study|Lost to Follow-up|0|||
146891289|NCT01430442|529769150|FG002|Overall Study|Lost to Follow-up|1|||
146636975|NCT01160822|528845597|FG004|Overall Study|Protocol deviation|2|||
146636976|NCT01160822|528845598|FG005|Overall Study|Protocol deviation|0|||
146891290|NCT01430442|529769151|FG003|Overall Study|Lost to Follow-up|2|||
146891291|NCT01430442|529769152|FG004|Overall Study|Lost to Follow-up|2|||
146891292|NCT01430442|529769153|FG005|Overall Study|Lost to Follow-up|1|||
146891293|NCT01430442|529769154|FG006|Overall Study|Lost to Follow-up|5|||
146891294|NCT01430442|529769155|FG007|Overall Study|Lost to Follow-up|1|||
146891295|NCT01430442|529769148|FG000|Overall Study|Pregnancy|1|||
146891296|NCT01430442|529769149|FG001|Overall Study|Pregnancy|0|||
146891297|NCT01430442|529769150|FG002|Overall Study|Pregnancy|0|||
146891298|NCT01430442|529769151|FG003|Overall Study|Pregnancy|0|||
146891299|NCT01430442|529769152|FG004|Overall Study|Pregnancy|0|||
146891300|NCT01430442|529769153|FG005|Overall Study|Pregnancy|1|||
146891301|NCT01430442|529769154|FG006|Overall Study|Pregnancy|0|||
146891302|NCT01430442|529769155|FG007|Overall Study|Pregnancy|0|||
146891303|NCT01430442|529769148|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
146891304|NCT01430442|529769149|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
146891305|NCT01430442|529769150|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
146891306|NCT01430442|529769151|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
146891307|NCT01430442|529769152|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
146967413|NCT00348348|530041522|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
146967414|NCT00348348|530041523|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
146967415|NCT00348348|530041522|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
146967416|NCT00348348|530041523|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
146967417|NCT00348348|530041522|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
146766285|NCT01235949|529312235|FG013|Primary Phase|Migrated/moved from study area|0|||
146967418|NCT00348348|530041523|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
146967419|NCT00348348|530041522|FG000|Overall Study|Adverse event probably related to study|1|||
146557298|NCT00414609|528551028|FG001|Extension Study|Lost to Follow-up|0|||
146891308|NCT01430442|529769153|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
146891309|NCT01430442|529769154|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
146891310|NCT01430442|529769155|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
146891311|NCT00772629|529769160|FG000|Overall Study|Subject was not vaccinated|1|||
146891312|NCT00772629|529769161|FG001|Overall Study|Subject was not vaccinated|0|||
146891313|NCT01097629|529769165|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
146891314|NCT01097629|529769166|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
146891315|NCT01097629|529769167|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
146891316|NCT01097629|529769168|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146891317|NCT01097629|529769169|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146891318|NCT01097629|529769170|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146891319|NCT01097629|529769171|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146557299|NCT00414609|528551029|FG002|Extension Study|Lost to Follow-up|10|||
146557300|NCT00414609|528551027|FG000|Extension Study|Administrative problems|0|||
146557301|NCT00414609|528551028|FG001|Extension Study|Administrative problems|0|||
146557302|NCT00414609|528551029|FG002|Extension Study|Administrative problems|1|||
146557303|NCT00414609|528551027|FG000|Extension Study|Death|0|||
146557304|NCT00414609|528551028|FG001|Extension Study|Death|0|||
146557305|NCT00414609|528551029|FG002|Extension Study|Death|17|||
146557306|NCT00266032|528551035|FG000|Treatment|Adverse Event|42|||
146557307|NCT00266032|528551036|FG001|Treatment|Adverse Event|26|||
146557308|NCT00266032|528551037|FG002|Treatment|Adverse Event|10|||
146557309|NCT00266032|528551035|FG000|Treatment|Lost to Follow-up|19|||
146557310|NCT00266032|528551036|FG001|Treatment|Lost to Follow-up|4|||
146636977|NCT01160822|528845599|FG006|Overall Study|Protocol deviation|0|||
146636978|NCT02170077|528845602|FG000|Overall Study|Withdrawal by Subject|3|||
146636979|NCT02170077|528845603|FG001|Overall Study|Withdrawal by Subject|4|||
146636980|NCT02170077|528845604|FG002|Overall Study|Withdrawal by Subject|2|||
146636981|NCT02170077|528845602|FG000|Overall Study|Adverse Event|4|||
146636982|NCT02170077|528845603|FG001|Overall Study|Adverse Event|4|||
146636983|NCT02170077|528845604|FG002|Overall Study|Adverse Event|4|||
146636984|NCT02170077|528845602|FG000|Overall Study|Lost to Follow-up|0|||
146636985|NCT02170077|528845603|FG001|Overall Study|Lost to Follow-up|1|||
146636986|NCT02170077|528845604|FG002|Overall Study|Lost to Follow-up|0|||
146636987|NCT02170077|528845602|FG000|Overall Study|Exclusion criteria|2|||
146636988|NCT02170077|528845603|FG001|Overall Study|Exclusion criteria|2|||
146636989|NCT02170077|528845604|FG002|Overall Study|Exclusion criteria|5|||
146636990|NCT02170077|528845602|FG000|Overall Study|Exacerbation of seizures|0|||
146636991|NCT02170077|528845603|FG001|Overall Study|Exacerbation of seizures|2|||
146636992|NCT02170077|528845604|FG002|Overall Study|Exacerbation of seizures|1|||
146636993|NCT01780974|528845607|FG000|Overall Study|Death|1|||
146636994|NCT01780974|528845608|FG001|Overall Study|Death|0|||
146636995|NCT01780974|528845607|FG000|Overall Study|Adverse Event|1|||
146636996|NCT01780974|528845608|FG001|Overall Study|Adverse Event|3|||
146636997|NCT01724346|528845609|FG000|Overall Study|Death|42|||
146636998|NCT01724346|528845610|FG001|Overall Study|Death|42|||
146636999|NCT01724346|528845609|FG000|Overall Study|Lost to Follow-up|5|||
146637000|NCT01724346|528845610|FG001|Overall Study|Lost to Follow-up|1|||
146637001|NCT01724346|528845609|FG000|Overall Study|Withdrawal by Subject|27|||
146637002|NCT01724346|528845610|FG001|Overall Study|Withdrawal by Subject|19|||
146637003|NCT01724346|528845609|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
146967420|NCT00348348|530041523|FG001|Overall Study|Adverse event probably related to study|0|||
146967421|NCT01353209|530041526|FG000|Overall Study|Adverse Event|1|||
146967422|NCT01353209|530041527|FG001|Overall Study|Adverse Event|1|||
146967423|NCT01301625|530041531|FG000|Overall Study|Death|5|||
146967424|NCT01301625|530041531|FG000|Overall Study|Not Due|21|||
146967425|NCT01301625|530041531|FG000|Overall Study|Expected|8|||
146557311|NCT00266032|528551037|FG002|Treatment|Lost to Follow-up|2|||
146557312|NCT00266032|528551035|FG000|Treatment|Pregnancy|3|||
146557313|NCT00266032|528551036|FG001|Treatment|Pregnancy|2|||
146557314|NCT00266032|528551037|FG002|Treatment|Pregnancy|2|||
146557315|NCT00266032|528551035|FG000|Treatment|Protocol Violation|6|||
146557316|NCT00266032|528551036|FG001|Treatment|Protocol Violation|14|||
146557317|NCT00266032|528551037|FG002|Treatment|Protocol Violation|13|||
146557318|NCT00266032|528551035|FG000|Treatment|Withdrawal by Subject|28|||
146557319|NCT00266032|528551036|FG001|Treatment|Withdrawal by Subject|13|||
146557320|NCT00266032|528551037|FG002|Treatment|Withdrawal by Subject|12|||
146557321|NCT00266032|528551035|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
146557322|NCT00266032|528551036|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
146557323|NCT00266032|528551037|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
146557324|NCT00266032|528551035|FG000|Open-label Safety Extension|Adverse Event|5|||
146557325|NCT00266032|528551036|FG001|Open-label Safety Extension|Adverse Event|0|||
146557326|NCT00266032|528551037|FG002|Open-label Safety Extension|Adverse Event|4|||
146557327|NCT00266032|528551035|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
146557328|NCT00266032|528551036|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
146557329|NCT00266032|528551037|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
146557330|NCT00266032|528551035|FG000|Open-label Safety Extension|Pregnancy|4|||
146557331|NCT00266032|528551036|FG001|Open-label Safety Extension|Pregnancy|1|||
146557332|NCT00266032|528551037|FG002|Open-label Safety Extension|Pregnancy|2|||
146557333|NCT00266032|528551035|FG000|Open-label Safety Extension|Protocol Violation|1|||
146557334|NCT00266032|528551036|FG001|Open-label Safety Extension|Protocol Violation|3|||
146557335|NCT00266032|528551037|FG002|Open-label Safety Extension|Protocol Violation|2|||
146557336|NCT00266032|528551035|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
146891320|NCT01097629|529769172|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146891321|NCT01097629|529769165|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
146891322|NCT01097629|529769166|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
146891323|NCT01097629|529769167|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
146637004|NCT01724346|528845610|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
146637005|NCT00750438|528845617|FG000|Overall Study|Protocol Violation|4|||
146637006|NCT00750438|528845618|FG001|Overall Study|Protocol Violation|1|||
146637007|NCT00750438|528845617|FG000|Overall Study|Physician Decision|2|||
146637008|NCT00750438|528845618|FG001|Overall Study|Physician Decision|2|||
146637009|NCT00750438|528845617|FG000|Overall Study|Withdrawal by Subject|1|||
146637010|NCT00750438|528845618|FG001|Overall Study|Withdrawal by Subject|1|||
146637011|NCT00256997|528845621|FG000|Overall Study|Protocol Violation|1|||
146637012|NCT00256997|528845622|FG001|Overall Study|Protocol Violation|4|||
146891324|NCT01097629|529769168|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146891325|NCT01097629|529769169|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146637013|NCT00256997|528845621|FG000|Overall Study|Lack of Efficacy|1|||
146637014|NCT00256997|528845622|FG001|Overall Study|Lack of Efficacy|4|||
146637015|NCT00256997|528845621|FG000|Overall Study|Death|2|||
146637016|NCT00256997|528845622|FG001|Overall Study|Death|0|||
146637017|NCT00256997|528845621|FG000|Overall Study|Adverse Event|4|||
146637018|NCT00256997|528845622|FG001|Overall Study|Adverse Event|0|||
146637019|NCT00256997|528845621|FG000|Overall Study|Lost to Follow-up|3|||
146637020|NCT00256997|528845622|FG001|Overall Study|Lost to Follow-up|5|||
146637021|NCT00256997|528845621|FG000|Overall Study|Withdrawal by Subject|13|||
146637022|NCT00256997|528845622|FG001|Overall Study|Withdrawal by Subject|3|||
146637023|NCT00256997|528845621|FG000|Overall Study|Started but not treated|2|||
146637024|NCT00256997|528845622|FG001|Overall Study|Started but not treated|0|||
146637025|NCT00256997|528845621|FG000|Overall Study|Other|5|||
146637026|NCT00256997|528845622|FG001|Overall Study|Other|8|||
146637027|NCT00256997|528845621|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
146637028|NCT00256997|528845622|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
146637029|NCT00256997|528845621|FG000|Overall Study|Participant Non-compliant|3|||
146637030|NCT00256997|528845622|FG001|Overall Study|Participant Non-compliant|6|||
146637031|NCT00256997|528845621|FG000|Overall Study|Investigator Withdrew Participant|2|||
146637032|NCT00256997|528845622|FG001|Overall Study|Investigator Withdrew Participant|1|||
146637033|NCT02736578|528845623|FG000|Overall Study|Adverse Event|1|||
146637034|NCT02736578|528845624|FG001|Overall Study|Adverse Event|0|||
146637035|NCT00354432|528845625|FG000|Overall Study|Adverse Event|3|||
146637036|NCT00354432|528845626|FG001|Overall Study|Adverse Event|1|||
146637037|NCT00354432|528845627|FG002|Overall Study|Adverse Event|5|||
146637038|NCT00354432|528845628|FG003|Overall Study|Adverse Event|5|||
146637039|NCT00354432|528845625|FG000|Overall Study|Off/Toxicity|3|||
146637040|NCT00354432|528845626|FG001|Overall Study|Off/Toxicity|7|||
146637041|NCT00354432|528845627|FG002|Overall Study|Off/Toxicity|5|||
146637042|NCT00354432|528845628|FG003|Overall Study|Off/Toxicity|5|||
146637043|NCT00802945|528845629|FG000|Overall Study|Death|27|||
146637044|NCT00802945|528845630|FG001|Overall Study|Death|23|||
146637045|NCT00802945|528845629|FG000|Overall Study|Terminated by sponsor|8|||
146637046|NCT00802945|528845630|FG001|Overall Study|Terminated by sponsor|12|||
146637047|NCT01104311|528845631|FG000|Overall Study|Withdrawal by Subject|6|||
146637048|NCT01104311|528845632|FG001|Overall Study|Withdrawal by Subject|6|||
146637049|NCT01104311|528845631|FG000|Overall Study|Protocol Violation|0|||
146637050|NCT01104311|528845632|FG001|Overall Study|Protocol Violation|1|||
146637051|NCT01104311|528845631|FG000|Overall Study|Physician Decision|2|||
146637052|NCT01104311|528845632|FG001|Overall Study|Physician Decision|2|||
146637053|NCT01104311|528845631|FG000|Overall Study|low compliance|1|||
146891326|NCT01097629|529769170|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146891327|NCT01097629|529769171|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146891328|NCT01097629|529769172|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146891329|NCT01097629|529769165|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
146891330|NCT01097629|529769166|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
146637054|NCT01104311|528845632|FG001|Overall Study|low compliance|1|||
146637055|NCT01104311|528845631|FG000|Overall Study|Adverse Event|1|||
146637056|NCT01104311|528845632|FG001|Overall Study|Adverse Event|2|||
146637057|NCT02102204|528847182|FG000|Overall Study|Withdrawal by Subject|137|||
146967426|NCT01301625|530041531|FG000|Overall Study|Lost to Follow-up|1|||
146637058|NCT02102204|528847182|FG000|Overall Study|Death|92|||
146637059|NCT02102204|528847182|FG000|Overall Study|Lost to Follow-up|65|||
146637060|NCT02102204|528847182|FG000|Overall Study|Sponsor Decision|5|||
146637061|NCT02102204|528847182|FG000|Overall Study|Ongoing|5|||
146637062|NCT00807001|528847184|FG000|Overall Study|Non-compliance|0|||
146637063|NCT00807001|528847185|FG001|Overall Study|Non-compliance|1|||
146637064|NCT00807001|528847186|FG002|Overall Study|Non-compliance|0|||
146637065|NCT00807001|528847187|FG003|Overall Study|Non-compliance|0|||
146637066|NCT00807001|528847188|FG004|Overall Study|Non-compliance|0|||
146637067|NCT02656693|528847189|FG000|Overall Study|Pregnancy|1|||
146637068|NCT02656693|528847190|FG001|Overall Study|Pregnancy|1|||
146891331|NCT01097629|529769167|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
146891332|NCT01097629|529769168|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146891333|NCT01097629|529769169|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146637069|NCT02656693|528847191|FG002|Overall Study|Pregnancy|1|||
146637070|NCT02656693|528847189|FG000|Overall Study|Bariatric surgery|0|||
146637071|NCT02656693|528847190|FG001|Overall Study|Bariatric surgery|1|||
146637072|NCT02656693|528847191|FG002|Overall Study|Bariatric surgery|2|||
146637073|NCT02269267|528847193|FG000|Overall Study|Death|5|||
146637074|NCT03773796|528847194|FG000|Overall Study|Adverse Event|1|||
146637075|NCT03773796|528847194|FG000|Overall Study|Withdrawal by Subject|1|||
146637076|NCT03773796|528847194|FG000|Overall Study|Lack of Efficacy|1|||
146637077|NCT03805659|528847196|FG000|Overall Study|Withdrawal by Subject|0|||
146637078|NCT03805659|528847197|FG001|Overall Study|Withdrawal by Subject|1|||
146637079|NCT02273596|528847199|FG000|24-Week Treatment Period|Adverse Event|3|||
146637080|NCT02273596|528847199|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
146637081|NCT02273596|528847199|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
146637082|NCT02273596|528847199|FG000|24-Week Treatment Period|Physician Decision|1|||
146637083|NCT02273596|528847199|FG000|24-Week Treatment Period|Protocol Deviation|1|||
146637084|NCT02273596|528847199|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
146637085|NCT02273596|528847199|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
146637086|NCT02273596|528847199|FG000|Extension Period|Lost to Follow-up|1|||
146637087|NCT02273596|528847199|FG000|Extension Period|Protocol Deviation|1|||
146637088|NCT02604160|528847200|FG000|Overall Study|Protocol Violation|0|||
146637089|NCT02604160|528847201|FG001|Overall Study|Protocol Violation|1|||
146637090|NCT02604160|528847200|FG000|Overall Study|Physician Decision|0|||
146637091|NCT02604160|528847201|FG001|Overall Study|Physician Decision|1|||
146637092|NCT03085797|528847204|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
146637093|NCT03085797|528847205|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
146637094|NCT03085797|528847204|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
146637095|NCT03085797|528847205|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
146637096|NCT03085797|528847204|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
146637097|NCT03085797|528847205|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
146637098|NCT00859456|528847206|FG000|Overall Study|Adverse Event|3|||
146637099|NCT00859456|528847206|FG000|Overall Study|Progressive disease|2|||
146637100|NCT00859456|528847206|FG000|Overall Study|Non-compliance|3|||
146637101|NCT05782179|528847208|FG000|Overall Study|Adverse Event|0|||
146637102|NCT05782179|528847209|FG001|Overall Study|Adverse Event|0|||
146637103|NCT05782179|528847210|FG002|Overall Study|Adverse Event|2|||
146637104|NCT05782179|528847211|FG003|Overall Study|Adverse Event|0|||
146637105|NCT05782179|528847212|FG004|Overall Study|Adverse Event|0|||
146891334|NCT01097629|529769170|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146637106|NCT05782179|528847213|FG005|Overall Study|Adverse Event|0|||
146637107|NCT06170242|528847214|FG000|Overall Study|Lost to Follow-up|0|||
146637108|NCT06170242|528847215|FG001|Overall Study|Lost to Follow-up|0|||
146637109|NCT06170242|528847216|FG002|Overall Study|Lost to Follow-up|1|||
146891335|NCT01097629|529769171|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146891336|NCT01097629|529769172|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146637110|NCT06170242|528847217|FG003|Overall Study|Lost to Follow-up|1|||
146637111|NCT03682770|528847227|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
146637112|NCT03682770|528847228|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
146637113|NCT03682770|528847229|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
146637114|NCT03682770|528847230|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
146637115|NCT03682770|528847231|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
146637116|NCT03682770|528847232|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
146637117|NCT03682770|528847233|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
146637118|NCT03682770|528847227|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
146637119|NCT03682770|528847228|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
146637120|NCT03682770|528847229|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
146637121|NCT03682770|528847230|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
146637122|NCT03682770|528847231|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
146891337|NCT01097629|529769165|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
146891338|NCT01097629|529769166|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
146637123|NCT03682770|528847232|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
146637124|NCT03682770|528847233|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
146637125|NCT03682770|528847227|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
146637126|NCT03682770|528847228|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
146637127|NCT03682770|528847229|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
146637128|NCT03682770|528847230|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
146637129|NCT03682770|528847231|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
146637130|NCT03682770|528847232|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
146557337|NCT00266032|528551036|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
146557338|NCT00266032|528551037|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
146557339|NCT00266032|528551035|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
146557340|NCT00266032|528551036|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
146557341|NCT00266032|528551037|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
146557342|NCT00124657|528551038|FG000|Overall Study|Toxicity|0|||
146557343|NCT00124657|528551039|FG001|Overall Study|Toxicity|0|||
146557344|NCT00124657|528551040|FG002|Overall Study|Toxicity|1|||
146557345|NCT00124657|528551038|FG000|Overall Study|Non-compliance|1|||
146557346|NCT00124657|528551039|FG001|Overall Study|Non-compliance|0|||
146557347|NCT00124657|528551040|FG002|Overall Study|Non-compliance|4|||
146557348|NCT00124657|528551038|FG000|Overall Study|Progressive disease|14|||
146557349|NCT00124657|528551039|FG001|Overall Study|Progressive disease|5|||
146557350|NCT00124657|528551040|FG002|Overall Study|Progressive disease|27|||
146557351|NCT00124657|528551038|FG000|Overall Study|Intercurrent illness|1|||
146557352|NCT00124657|528551039|FG001|Overall Study|Intercurrent illness|0|||
146557353|NCT00124657|528551040|FG002|Overall Study|Intercurrent illness|0|||
146557354|NCT00814983|528551045|FG000|Overall Study|Screen failure|1|||
146557355|NCT00814983|528551046|FG001|Overall Study|Screen failure|0|||
146557356|NCT00814983|528551045|FG000|Overall Study|Withdrawal by Subject|1|||
146557357|NCT00814983|528551046|FG001|Overall Study|Withdrawal by Subject|0|||
146557358|NCT00814983|528551045|FG000|Overall Study|Graft failure|1|||
146557359|NCT00814983|528551046|FG001|Overall Study|Graft failure|0|||
146557360|NCT01475825|528551047|FG000|Overall Study|Adverse Event|41|||
146557361|NCT01475825|528551048|FG001|Overall Study|Adverse Event|15|||
146557362|NCT01475825|528551049|FG002|Overall Study|Adverse Event|27|||
146557363|NCT01475825|528551050|FG003|Overall Study|Adverse Event|11|||
146557364|NCT01475825|528551047|FG000|Overall Study|Death|1|||
146637131|NCT03682770|528847233|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
146557365|NCT01475825|528551048|FG001|Overall Study|Death|0|||
146557366|NCT01475825|528551049|FG002|Overall Study|Death|1|||
146891339|NCT01097629|529769167|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
146891340|NCT01097629|529769168|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146891341|NCT01097629|529769169|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146891342|NCT01097629|529769170|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146891343|NCT01097629|529769171|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146891344|NCT01097629|529769172|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146557367|NCT01475825|528551050|FG003|Overall Study|Death|0|||
146891345|NCT01097629|529769165|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
146967427|NCT02684370|530041533|FG000|Part A|Adverse Event|2|||
146891346|NCT01097629|529769166|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
146891347|NCT01097629|529769167|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
146891348|NCT01097629|529769168|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146891349|NCT01097629|529769169|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146891350|NCT01097629|529769170|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146557368|NCT01475825|528551047|FG000|Overall Study|Lack of Efficacy|0|||
146557369|NCT01475825|528551048|FG001|Overall Study|Lack of Efficacy|0|||
146557370|NCT01475825|528551049|FG002|Overall Study|Lack of Efficacy|1|||
146557371|NCT01475825|528551050|FG003|Overall Study|Lack of Efficacy|0|||
146509120|NCT00454818|528367738|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
146509121|NCT00454818|528367739|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
146557372|NCT01475825|528551047|FG000|Overall Study|Lost to Follow-up|0|||
146967428|NCT02684370|530041534|FG001|Part A|Adverse Event|0|||
146509122|NCT00454818|528367740|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
146509123|NCT00454818|528367736|FG000|Phase I: Open-label Dose-escalation|Death|0|||
146509124|NCT00454818|528367737|FG001|Phase I: Open-label Dose-escalation|Death|1|||
146509125|NCT00454818|528367738|FG002|Phase I: Open-label Dose-escalation|Death|0|||
146509126|NCT00454818|528367739|FG003|Phase I: Open-label Dose-escalation|Death|0|||
146509127|NCT00454818|528367740|FG004|Phase I: Open-label Dose-escalation|Death|0|||
146557373|NCT01475825|528551048|FG001|Overall Study|Lost to Follow-up|0|||
146557374|NCT01475825|528551049|FG002|Overall Study|Lost to Follow-up|3|||
146891351|NCT01097629|529769171|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146891352|NCT01097629|529769172|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146557375|NCT01475825|528551050|FG003|Overall Study|Lost to Follow-up|1|||
146557376|NCT01475825|528551047|FG000|Overall Study|Non-compliance with Study Drug|1|||
146891353|NCT01097629|529769165|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
146967429|NCT02684370|530041535|FG002|Part A|Adverse Event|1|||
146637132|NCT03682770|528847227|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
146891354|NCT01097629|529769166|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
146891355|NCT01097629|529769167|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146891356|NCT01097629|529769168|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146637133|NCT03682770|528847228|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
146637134|NCT03682770|528847229|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
146637135|NCT03682770|528847230|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
146637136|NCT03682770|528847231|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
146637137|NCT03682770|528847232|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
146891357|NCT01097629|529769169|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146891358|NCT01097629|529769170|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146891359|NCT01097629|529769171|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146637138|NCT03682770|528847233|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
146891360|NCT01097629|529769172|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146891361|NCT01097629|529769165|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
146891362|NCT01097629|529769166|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
146891363|NCT01097629|529769167|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
146891364|NCT01097629|529769168|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146891365|NCT01097629|529769169|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146891366|NCT01097629|529769170|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146891367|NCT01097629|529769171|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146891368|NCT01097629|529769172|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146891369|NCT01097629|529769165|FG000|DB RO Phase|Withdrawal by Subject|0|||
146891370|NCT01097629|529769166|FG001|DB RO Phase|Withdrawal by Subject|0|||
146891371|NCT01097629|529769167|FG002|DB RO Phase|Withdrawal by Subject|0|||
146891372|NCT01097629|529769168|FG003|DB RO Phase|Withdrawal by Subject|0|||
146891373|NCT01097629|529769169|FG004|DB RO Phase|Withdrawal by Subject|0|||
146891374|NCT01097629|529769170|FG005|DB RO Phase|Withdrawal by Subject|0|||
146891375|NCT01097629|529769171|FG006|DB RO Phase|Withdrawal by Subject|0|||
146891376|NCT01097629|529769172|FG007|DB RO Phase|Withdrawal by Subject|1|||
146891377|NCT01097629|529769165|FG000|DB RO Phase|Protocol Violation|0|||
146891378|NCT01097629|529769166|FG001|DB RO Phase|Protocol Violation|0|||
146891379|NCT01097629|529769167|FG002|DB RO Phase|Protocol Violation|0|||
146891380|NCT01097629|529769168|FG003|DB RO Phase|Protocol Violation|1|||
146891381|NCT01097629|529769169|FG004|DB RO Phase|Protocol Violation|0|||
146891382|NCT01097629|529769170|FG005|DB RO Phase|Protocol Violation|1|||
146891383|NCT01097629|529769171|FG006|DB RO Phase|Protocol Violation|1|||
146891384|NCT01097629|529769172|FG007|DB RO Phase|Protocol Violation|0|||
146891385|NCT01097629|529769165|FG000|DB RO Phase|Lost to Follow-up|0|||
146891386|NCT01097629|529769166|FG001|DB RO Phase|Lost to Follow-up|0|||
146891387|NCT01097629|529769167|FG002|DB RO Phase|Lost to Follow-up|0|||
146891388|NCT01097629|529769168|FG003|DB RO Phase|Lost to Follow-up|0|||
146891389|NCT01097629|529769169|FG004|DB RO Phase|Lost to Follow-up|0|||
146891390|NCT01097629|529769170|FG005|DB RO Phase|Lost to Follow-up|0|||
146891391|NCT01097629|529769171|FG006|DB RO Phase|Lost to Follow-up|2|||
146891392|NCT01097629|529769172|FG007|DB RO Phase|Lost to Follow-up|0|||
146891393|NCT00132041|529769174|FG000|Baseline|Ineligible|6|||
146891394|NCT00132041|529769174|FG000|3 Months Post Ablation|Transplant|1|||
146891395|NCT00132041|529769174|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
146891396|NCT00132041|529769174|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
146891397|NCT00132041|529769174|FG000|6 Months Post Ablation|Death|2|||
146891398|NCT00132041|529769174|FG000|6 Months Post Ablation|Transplant|6|||
146891399|NCT00132041|529769174|FG000|9 Months Post Ablation|Death|1|||
146891400|NCT00132041|529769174|FG000|9 Months Post Ablation|Transplant|1|||
146891401|NCT00132041|529769174|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
146891402|NCT00132041|529769174|FG000|12 Months Post Ablation|Death|1|||
146891403|NCT00132041|529769174|FG000|12 Months Post Ablation|Transplant|1|||
146891404|NCT00132041|529769174|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
146891405|NCT00132041|529769174|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
146891406|NCT00132041|529769174|FG000|15 Months Post Ablation|Death|1|||
146891407|NCT00132041|529769174|FG000|15 Months Post Ablation|Transplant|5|||
146891408|NCT00132041|529769174|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
146891409|NCT00132041|529769174|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
146967430|NCT02684370|530041536|FG003|Part A|Adverse Event|0|||
146637139|NCT03682770|528847227|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
146891410|NCT00132041|529769174|FG000|18 Months Post Ablation|Transplant|1|||
146891411|NCT00132041|529769174|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
146891412|NCT00132041|529769174|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
146891413|NCT01171820|529769176|FG000|Overall Study|Death|3|||
146891414|NCT01171820|529769177|FG001|Overall Study|Death|3|||
146891415|NCT01171820|529769176|FG000|Overall Study|Lost to Follow-up|0|||
146891416|NCT01171820|529769177|FG001|Overall Study|Lost to Follow-up|1|||
146891417|NCT01171820|529769176|FG000|Overall Study|Withdrawal by Subject|2|||
146891418|NCT01171820|529769177|FG001|Overall Study|Withdrawal by Subject|0|||
146891419|NCT01171820|529769176|FG000|Overall Study|Physician Decision|0|||
146891420|NCT01171820|529769177|FG001|Overall Study|Physician Decision|1|||
146891421|NCT01171820|529769176|FG000|Overall Study|1-Year Missed Visit|1|||
146891422|NCT01171820|529769177|FG001|Overall Study|1-Year Missed Visit|1|||
146891423|NCT00840827|529769178|FG000|Overall Study|Adverse Event|1|||
146891424|NCT00840827|529769178|FG000|Overall Study|Lack of Efficacy|4|||
146891425|NCT00840827|529769178|FG000|Overall Study|Physician Decision|1|||
146891426|NCT01445535|529769179|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
146891427|NCT01445535|529769180|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
146891428|NCT01445535|529769181|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
146891429|NCT01445535|529769182|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
146891430|NCT01445535|529769179|FG000|Overall Study|Disease progression|1|||
146891431|NCT01445535|529769180|FG001|Overall Study|Disease progression|0|||
146891432|NCT01445535|529769181|FG002|Overall Study|Disease progression|1|||
146891433|NCT01445535|529769182|FG003|Overall Study|Disease progression|0|||
146967431|NCT02684370|530041537|FG004|Part A|Adverse Event|0|||
146891434|NCT01445535|529769179|FG000|Overall Study|PI discretion|0|||
146967432|NCT02684370|530041538|FG005|Part A|Adverse Event|0|||
146967433|NCT02684370|530041533|FG000|Part A|Lost to Follow-up|1|||
146891435|NCT01445535|529769180|FG001|Overall Study|PI discretion|0|||
146891436|NCT01445535|529769181|FG002|Overall Study|PI discretion|0|||
146891437|NCT01445535|529769182|FG003|Overall Study|PI discretion|1|||
146891438|NCT02415712|529769185|FG000|Overall Study|Protocol Violation|16|||
146891439|NCT01668654|529769186|FG000|Overall Study|Study Closed/Terminated|3|||
146967434|NCT02684370|530041534|FG001|Part A|Lost to Follow-up|1|||
146891440|NCT01668654|529769186|FG000|Overall Study|Withdrawal by Subject|1|||
146891441|NCT04557384|529769187|FG000|Overall Study|Study Terminated by Sponsor|1|||
146891442|NCT04557384|529769187|FG000|Overall Study|Death|1|||
146891443|NCT01622569|529769189|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
146891444|NCT01622569|529769190|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
146891445|NCT01622569|529769191|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
146891446|NCT01622569|529769192|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
146891447|NCT01622569|529769189|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
146891448|NCT01622569|529769190|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
146891449|NCT01622569|529769191|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
146891450|NCT01622569|529769192|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
146891451|NCT01622569|529769189|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
146891452|NCT01622569|529769190|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
146891453|NCT01622569|529769191|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
146891454|NCT01622569|529769192|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
146891455|NCT01622569|529769189|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
146891456|NCT01622569|529769190|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
146891457|NCT01622569|529769191|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
146891458|NCT01622569|529769192|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
146891459|NCT01622569|529769189|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
146891460|NCT01622569|529769190|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
146891461|NCT01622569|529769191|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
146891462|NCT01622569|529769192|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
146891463|NCT01622569|529769189|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
146891464|NCT01622569|529769190|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
146891465|NCT01622569|529769191|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
146891466|NCT01622569|529769192|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
146891467|NCT01622569|529769189|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
146891468|NCT01622569|529769190|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
146891469|NCT01622569|529769191|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
146891470|NCT01622569|529769192|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
146891471|NCT01622569|529769189|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
146891472|NCT01622569|529769190|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
146891473|NCT01622569|529769191|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
146891474|NCT01622569|529769192|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
146891475|NCT04173741|529769193|FG000|Overall Study|IVC measurement cannot be done|1|||
146891476|NCT04173741|529769194|FG001|Overall Study|IVC measurement cannot be done|1|||
146891477|NCT00254566|529769195|FG000|Overall Study|Death|1|||
146891478|NCT00254566|529769196|FG001|Overall Study|Death|0|||
146891479|NCT00254566|529769195|FG000|Overall Study|Adverse Event|5|||
146891480|NCT00254566|529769196|FG001|Overall Study|Adverse Event|4|||
146891481|NCT00254566|529769195|FG000|Overall Study|Lack of Efficacy|12|||
146891482|NCT00254566|529769196|FG001|Overall Study|Lack of Efficacy|9|||
146891483|NCT00254566|529769195|FG000|Overall Study|Other|1|||
146891484|NCT00254566|529769196|FG001|Overall Study|Other|5|||
146891485|NCT00254566|529769195|FG000|Overall Study|Withdrawal by Subject|5|||
146891486|NCT00254566|529769196|FG001|Overall Study|Withdrawal by Subject|6|||
146891487|NCT00254566|529769195|FG000|Overall Study|Lost to Follow-up|7|||
146891488|NCT00254566|529769196|FG001|Overall Study|Lost to Follow-up|2|||
146891489|NCT00059202|529769198|FG000|Overall Study|Withdrawal by Subject|5|||
146891490|NCT00059202|529769199|FG001|Overall Study|Withdrawal by Subject|9|||
146891491|NCT00059202|529769198|FG000|Overall Study|Protocol Violation|1|||
146891492|NCT00059202|529769199|FG001|Overall Study|Protocol Violation|3|||
146891493|NCT00059202|529769198|FG000|Overall Study|drug toxicity|0|||
146891494|NCT00059202|529769199|FG001|Overall Study|drug toxicity|3|||
146891495|NCT00548548|529769202|FG000|Overall Study|Death|345|||
146891496|NCT00548548|529769203|FG001|Overall Study|Death|348|||
146891497|NCT00548548|529769202|FG000|Overall Study|Lost to Follow-up|17|||
146891498|NCT00548548|529769203|FG001|Overall Study|Lost to Follow-up|18|||
146891499|NCT01705691|529769205|FG000|Overall Study|Death|1|||
146891500|NCT01705691|529769206|FG001|Overall Study|Death|2|||
146891501|NCT01705691|529769205|FG000|Overall Study|Withdrawal by Subject|1|||
146891502|NCT01705691|529769206|FG001|Overall Study|Withdrawal by Subject|2|||
146891503|NCT01705691|529769205|FG000|Overall Study|Lost to Follow-up|1|||
146967435|NCT02684370|530041535|FG002|Part A|Lost to Follow-up|0|||
146967436|NCT02684370|530041536|FG003|Part A|Lost to Follow-up|0|||
146557377|NCT01475825|528551048|FG001|Overall Study|Non-compliance with Study Drug|2|||
146557378|NCT01475825|528551049|FG002|Overall Study|Non-compliance with Study Drug|4|||
146557379|NCT01475825|528551050|FG003|Overall Study|Non-compliance with Study Drug|0|||
146557380|NCT01475825|528551047|FG000|Overall Study|Other: Not available|0|||
146557381|NCT01475825|528551048|FG001|Overall Study|Other: Not available|0|||
146557382|NCT01475825|528551049|FG002|Overall Study|Other: Not available|2|||
146557383|NCT01475825|528551050|FG003|Overall Study|Other: Not available|0|||
146557384|NCT01475825|528551047|FG000|Overall Study|Protocol Violation|1|||
146557385|NCT01475825|528551048|FG001|Overall Study|Protocol Violation|0|||
146557386|NCT01475825|528551049|FG002|Overall Study|Protocol Violation|0|||
146557387|NCT01475825|528551050|FG003|Overall Study|Protocol Violation|0|||
146557388|NCT01475825|528551047|FG000|Overall Study|Physician Decision|0|||
146557389|NCT01475825|528551048|FG001|Overall Study|Physician Decision|1|||
146557390|NCT01475825|528551049|FG002|Overall Study|Physician Decision|0|||
146557391|NCT01475825|528551050|FG003|Overall Study|Physician Decision|0|||
146557392|NCT01475825|528551047|FG000|Overall Study|Withdrawal by Subject|8|||
146557393|NCT01475825|528551048|FG001|Overall Study|Withdrawal by Subject|3|||
146891504|NCT01705691|529769206|FG001|Overall Study|Lost to Follow-up|1|||
146557394|NCT01475825|528551049|FG002|Overall Study|Withdrawal by Subject|11|||
146557395|NCT01475825|528551050|FG003|Overall Study|Withdrawal by Subject|7|||
146557396|NCT01475825|528551047|FG000|Overall Study|Did not enter OLC|15|||
146891505|NCT01705691|529769205|FG000|Overall Study|Other|0|||
146891506|NCT01705691|529769206|FG001|Overall Study|Other|1|||
146891507|NCT02658448|529769207|FG000|Overall Study|Lost to Follow-up|1|||
146557397|NCT01475825|528551048|FG001|Overall Study|Did not enter OLC|11|||
146557398|NCT01475825|528551049|FG002|Overall Study|Did not enter OLC|15|||
146557399|NCT01475825|528551050|FG003|Overall Study|Did not enter OLC|11|||
146891508|NCT03106779|529769208|FG000|Overall Study|Lack of Efficacy|33|||
146891509|NCT03106779|529769209|FG001|Overall Study|Lack of Efficacy|24|||
146891510|NCT03106779|529769208|FG000|Overall Study|Adverse Event|8|||
146891511|NCT03106779|529769209|FG001|Overall Study|Adverse Event|16|||
146967437|NCT02684370|530041537|FG004|Part A|Lost to Follow-up|0|||
146891512|NCT03106779|529769208|FG000|Overall Study|Physician Decision|10|||
146891513|NCT03106779|529769209|FG001|Overall Study|Physician Decision|6|||
146891514|NCT03106779|529769208|FG000|Overall Study|Patient/guardian decision|4|||
146891515|NCT03106779|529769209|FG001|Overall Study|Patient/guardian decision|3|||
146891516|NCT03106779|529769208|FG000|Overall Study|Progressive disease|1|||
146891517|NCT03106779|529769209|FG001|Overall Study|Progressive disease|3|||
146557400|NCT00836901|528551051|FG000|First Intervention|Withdrawal by Subject|1|||
146557401|NCT00836901|528551052|FG001|First Intervention|Withdrawal by Subject|0|||
146557402|NCT00830336|528551053|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
146557403|NCT00830336|528551054|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
146557404|NCT00867334|528551055|FG000|Overall Study|Withdrawal by Subject|0|||
146557405|NCT00867334|528551056|FG001|Overall Study|Withdrawal by Subject|1|||
146557406|NCT00867334|528551055|FG000|Overall Study|Withdrawal by Subject|1|||
146557407|NCT00867334|528551056|FG001|Overall Study|Withdrawal by Subject|0|||
146557408|NCT00867334|528551055|FG000|Overall Study|Withdrawal by Subject|1|||
146557409|NCT00867334|528551056|FG001|Overall Study|Withdrawal by Subject|0|||
146557410|NCT01047540|528551063|FG000|Overall Study|Protocol Violation|1|||
146557411|NCT01047540|528551064|FG001|Overall Study|Protocol Violation|0|||
146557412|NCT01047540|528551065|FG002|Overall Study|Protocol Violation|0|||
146557413|NCT01047540|528551066|FG003|Overall Study|Protocol Violation|0|||
146557414|NCT01047540|528551067|FG004|Overall Study|Protocol Violation|0|||
146557415|NCT01047540|528551063|FG000|Overall Study|Lost to Follow-up|1|||
146557416|NCT01047540|528551064|FG001|Overall Study|Lost to Follow-up|0|||
146557417|NCT01047540|528551065|FG002|Overall Study|Lost to Follow-up|0|||
146557418|NCT01047540|528551066|FG003|Overall Study|Lost to Follow-up|0|||
146557419|NCT01047540|528551067|FG004|Overall Study|Lost to Follow-up|0|||
146557420|NCT01047540|528551063|FG000|Overall Study|Withdrawal by Subject|1|||
146557421|NCT01047540|528551064|FG001|Overall Study|Withdrawal by Subject|0|||
146557422|NCT01047540|528551065|FG002|Overall Study|Withdrawal by Subject|3|||
146557423|NCT01047540|528551066|FG003|Overall Study|Withdrawal by Subject|0|||
146557424|NCT01047540|528551067|FG004|Overall Study|Withdrawal by Subject|1|||
146557425|NCT01047540|528551063|FG000|Overall Study|Pregnancy|1|||
146557426|NCT01047540|528551064|FG001|Overall Study|Pregnancy|0|||
146557427|NCT01047540|528551065|FG002|Overall Study|Pregnancy|0|||
146557428|NCT01047540|528551066|FG003|Overall Study|Pregnancy|0|||
146557429|NCT01047540|528551067|FG004|Overall Study|Pregnancy|0|||
146557430|NCT01047540|528551063|FG000|Overall Study|Adverse Event|1|||
146557431|NCT01047540|528551064|FG001|Overall Study|Adverse Event|0|||
146557432|NCT01047540|528551065|FG002|Overall Study|Adverse Event|0|||
146557433|NCT01047540|528551066|FG003|Overall Study|Adverse Event|0|||
146766286|NCT01235949|529312236|FG014|Primary Phase|Migrated/moved from study area|0|||
146766287|NCT01235949|529312237|FG015|Primary Phase|Migrated/moved from study area|0|||
146891518|NCT03106779|529769208|FG000|Overall Study|Lost to Follow-up|1|||
146891519|NCT03106779|529769209|FG001|Overall Study|Lost to Follow-up|2|||
146557434|NCT01047540|528551067|FG004|Overall Study|Adverse Event|0|||
146557435|NCT01437189|528551073|FG000|Overall Study|Adverse Event|3|||
146557436|NCT01437189|528551073|FG000|Overall Study|Lack of Efficacy|4|||
146557437|NCT01437189|528551073|FG000|Overall Study|Withdrawal by Subject|8|||
146557438|NCT04576481|528551079|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
146557439|NCT04576481|528551080|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
146557440|NCT04576481|528551081|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
146557441|NCT04576481|528551082|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
146557442|NCT03464461|528551084|FG000|Overall Study|exclusionary medication given ,|1|||
146557443|NCT03464461|528551085|FG001|Overall Study|exclusionary medication given ,|2|||
146557444|NCT03464461|528551086|FG002|Overall Study|exclusionary medication given ,|0|||
146557445|NCT03464461|528551084|FG000|Overall Study|Physician Decision|0|||
146557446|NCT03464461|528551085|FG001|Overall Study|Physician Decision|1|||
146557447|NCT03464461|528551086|FG002|Overall Study|Physician Decision|0|||
146557448|NCT05261490|528551088|FG000|Overall Study|Other|1|||
146766288|NCT01235949|529312238|FG016|Primary Phase|Migrated/moved from study area|0|||
146891520|NCT03106779|529769208|FG000|Overall Study|Death|1|||
146891521|NCT03106779|529769209|FG001|Overall Study|Death|0|||
146557449|NCT05261490|528551089|FG001|Overall Study|Other|0|||
146766289|NCT01235949|529312239|FG017|Primary Phase|Migrated/moved from study area|0|||
146891522|NCT03106779|529769208|FG000|Overall Study|Protocol Violation|1|||
146891523|NCT03106779|529769209|FG001|Overall Study|Protocol Violation|0|||
146557450|NCT05261490|528551090|FG002|Overall Study|Other|0|||
146891524|NCT03106779|529769208|FG000|Overall Study|Not treated|1|||
146891525|NCT03106779|529769209|FG001|Overall Study|Not treated|0|||
146891526|NCT04088409|529769210|FG000|Part A|Withdrawal by Subject|2|||
146891527|NCT04088409|529769211|FG001|Part A|Withdrawal by Subject|1|||
146891528|NCT04088409|529769210|FG000|Part A|Did Not Meet Randomization Criteria|2|||
146891529|NCT04088409|529769211|FG001|Part A|Did Not Meet Randomization Criteria|0|||
146891530|NCT04088409|529769210|FG000|Part A|Lack of Efficacy|9|||
146891531|NCT04088409|529769211|FG001|Part A|Lack of Efficacy|0|||
146891532|NCT04088409|529769210|FG000|Part A|Lost to Follow-up|1|||
146891533|NCT04088409|529769211|FG001|Part A|Lost to Follow-up|0|||
146891534|NCT04088409|529769210|FG000|Part A|Adverse Event|1|||
146891535|NCT04088409|529769211|FG001|Part A|Adverse Event|0|||
146891536|NCT04088409|529769210|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
146891537|NCT04088409|529769211|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
146891538|NCT04088409|529769210|FG000|Part B|Ongoing Treatment|10|||
146891539|NCT04088409|529769211|FG001|Part B|Ongoing Treatment|0|||
146891540|NCT04233229|529769212|FG000|Overall Study|Withdrawal by Subject|0|||
146891541|NCT04233229|529769213|FG001|Overall Study|Withdrawal by Subject|1|||
146891542|NCT04233229|529769212|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
146891543|NCT04233229|529769213|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
146891544|NCT04233229|529769212|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
146891545|NCT04233229|529769213|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
146891546|NCT00927368|529769214|FG000|Overall Study|enrollment in another study|1|||
146891547|NCT00927368|529769215|FG001|Overall Study|enrollment in another study|1|||
146891548|NCT00927368|529769216|FG002|Overall Study|enrollment in another study|2|||
146891549|NCT00927368|529769214|FG000|Overall Study|Lost to Follow-up|4|||
146891550|NCT00927368|529769215|FG001|Overall Study|Lost to Follow-up|0|||
146891551|NCT00927368|529769216|FG002|Overall Study|Lost to Follow-up|0|||
146891552|NCT00927368|529769214|FG000|Overall Study|equipment failure|1|||
146891553|NCT00927368|529769215|FG001|Overall Study|equipment failure|0|||
146891554|NCT00927368|529769216|FG002|Overall Study|equipment failure|0|||
146891555|NCT00927368|529769214|FG000|Overall Study|ineligible post randomization|0|||
146891556|NCT00927368|529769215|FG001|Overall Study|ineligible post randomization|3|||
146891557|NCT00927368|529769216|FG002|Overall Study|ineligible post randomization|1|||
146891558|NCT00927368|529769214|FG000|Overall Study|cancellation of surgery|0|||
146891559|NCT00927368|529769215|FG001|Overall Study|cancellation of surgery|1|||
146891560|NCT00927368|529769216|FG002|Overall Study|cancellation of surgery|2|||
146891561|NCT00364689|529769217|FG000|Overall Study|Lost to Follow-up|1|||
146891562|NCT01482910|529769225|FG000|Overall Study|Adverse Event|6|||
146891563|NCT01482910|529769226|FG001|Overall Study|Adverse Event|5|||
146891564|NCT01482910|529769225|FG000|Overall Study|Lost to Follow-up|0|||
146891565|NCT01482910|529769226|FG001|Overall Study|Lost to Follow-up|1|||
146891566|NCT01482910|529769225|FG000|Overall Study|Protocol Violation|1|||
146891567|NCT01482910|529769226|FG001|Overall Study|Protocol Violation|1|||
146891568|NCT01482910|529769225|FG000|Overall Study|Withdrawal by Subject|7|||
146891569|NCT01482910|529769226|FG001|Overall Study|Withdrawal by Subject|2|||
146891570|NCT01482910|529769225|FG000|Overall Study|Death|1|||
146891571|NCT01482910|529769226|FG001|Overall Study|Death|0|||
146891572|NCT03222349|529769228|FG000|Overall Study|Treatment B not done|5|||
146891573|NCT03222349|529769229|FG001|Overall Study|Treatment B not done|0|||
146891574|NCT03222349|529769228|FG000|Overall Study|Lost to Follow-up|1|||
146891575|NCT03222349|529769229|FG001|Overall Study|Lost to Follow-up|2|||
146891576|NCT03222349|529769228|FG000|Overall Study|Withdrawal by Subject|1|||
146891577|NCT03222349|529769229|FG001|Overall Study|Withdrawal by Subject|0|||
146891578|NCT03222349|529769228|FG000|Overall Study|Treatment A not done|0|||
146891579|NCT03222349|529769229|FG001|Overall Study|Treatment A not done|5|||
146891580|NCT03222349|529769228|FG000|Overall Study|Study terminated by sponsor|1|||
146891581|NCT03222349|529769229|FG001|Overall Study|Study terminated by sponsor|0|||
146891582|NCT02614079|529769230|FG000|Overall Study|Withdrawal by Subject|1|||
146891583|NCT00820755|529769231|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
146891584|NCT00820755|529769232|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
146891585|NCT00820755|529769233|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
146891586|NCT00820755|529769231|FG000|Period 1: Combination Therapy Phase|Death|28|||
146891587|NCT00820755|529769232|FG001|Period 1: Combination Therapy Phase|Death|0|||
146766290|NCT01235949|529312222|FG000|Primary Phase|Adverse Event|0|||
146891588|NCT00820755|529769233|FG002|Period 1: Combination Therapy Phase|Death|0|||
146891589|NCT00820755|529769231|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
146891590|NCT00820755|529769232|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
146891591|NCT00820755|529769233|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
146891592|NCT00820755|529769231|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
146891593|NCT00820755|529769232|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
146891594|NCT00820755|529769233|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
146891595|NCT00820755|529769231|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
146891596|NCT00820755|529769232|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
146891597|NCT00820755|529769233|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
146891598|NCT00820755|529769231|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
146891599|NCT00820755|529769232|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
146891600|NCT00820755|529769233|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
146891601|NCT00820755|529769231|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
146891602|NCT00820755|529769232|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
146891603|NCT00820755|529769233|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
146891604|NCT00820755|529769231|FG000|Period 1: Combination Therapy Phase|Other|11|||
146891605|NCT00820755|529769232|FG001|Period 1: Combination Therapy Phase|Other|0|||
146891606|NCT00820755|529769233|FG002|Period 1: Combination Therapy Phase|Other|0|||
146891607|NCT00820755|529769231|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
146891608|NCT00820755|529769232|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
146891609|NCT00820755|529769233|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
146891610|NCT00480857|529769234|FG000|Overall Study|Lack of Efficacy|2|||
146891611|NCT00243659|529769235|FG000|Overall Study|Withdrawal by Subject|1|||
146891612|NCT00243659|529769236|FG001|Overall Study|Withdrawal by Subject|1|||
146891613|NCT00243659|529769235|FG000|Overall Study|Protocol Violation|1|||
146891614|NCT00243659|529769236|FG001|Overall Study|Protocol Violation|2|||
146891615|NCT00268242|529769237|FG000|Overall Study|Death|1|||
146891616|NCT03969888|529769238|FG000|Overall Study|Never Received Study Drug|0|||
146891617|NCT03969888|529769239|FG001|Overall Study|Never Received Study Drug|0|||
146891618|NCT03969888|529769240|FG002|Overall Study|Never Received Study Drug|1|||
146891619|NCT03969888|529769241|FG003|Overall Study|Never Received Study Drug|0|||
146891620|NCT03969888|529769242|FG004|Overall Study|Never Received Study Drug|0|||
146891621|NCT03969888|529769243|FG005|Overall Study|Never Received Study Drug|0|||
146766291|NCT01235949|529312223|FG001|Primary Phase|Adverse Event|0|||
146766292|NCT01235949|529312224|FG002|Primary Phase|Adverse Event|0|||
146766293|NCT01235949|529312225|FG003|Primary Phase|Adverse Event|1|||
146766294|NCT01235949|529312226|FG004|Primary Phase|Adverse Event|0|||
146766295|NCT01235949|529312227|FG005|Primary Phase|Adverse Event|0|||
146766296|NCT01235949|529312228|FG006|Primary Phase|Adverse Event|0|||
146766297|NCT01235949|529312229|FG007|Primary Phase|Adverse Event|0|||
146891622|NCT03969888|529769244|FG006|Overall Study|Never Received Study Drug|1|||
146891623|NCT03969888|529769245|FG007|Overall Study|Never Received Study Drug|0|||
146891624|NCT03969888|529769238|FG000|Overall Study|Reason Not Specified|0|||
146891625|NCT03969888|529769239|FG001|Overall Study|Reason Not Specified|0|||
146891626|NCT03969888|529769240|FG002|Overall Study|Reason Not Specified|0|||
146891627|NCT03969888|529769241|FG003|Overall Study|Reason Not Specified|0|||
146891628|NCT03969888|529769242|FG004|Overall Study|Reason Not Specified|0|||
146891629|NCT03969888|529769243|FG005|Overall Study|Reason Not Specified|0|||
146891630|NCT03969888|529769244|FG006|Overall Study|Reason Not Specified|0|||
146891631|NCT03969888|529769245|FG007|Overall Study|Reason Not Specified|1|||
146891632|NCT00464178|529769248|FG000|Overall Study|Protocol Violation|1|||
146891633|NCT00464178|529769248|FG000|Overall Study|Withdrawal by Subject|1|||
146891634|NCT01557166|529769251|FG000|Overall Study|Adverse Event|20|||
146891635|NCT01557166|529769252|FG001|Overall Study|Adverse Event|6|||
146891636|NCT01557166|529769251|FG000|Overall Study|Lack of Efficacy|2|||
146891637|NCT01557166|529769252|FG001|Overall Study|Lack of Efficacy|1|||
146637140|NCT03682770|528847228|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
146766298|NCT01235949|529312230|FG008|Primary Phase|Adverse Event|0|||
146891638|NCT01557166|529769251|FG000|Overall Study|Protocol Violation|8|||
146766299|NCT01235949|529312231|FG009|Primary Phase|Adverse Event|0|||
146891639|NCT01557166|529769252|FG001|Overall Study|Protocol Violation|5|||
146637141|NCT03682770|528847229|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
146637142|NCT03682770|528847230|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
146891640|NCT01557166|529769251|FG000|Overall Study|Withdrawn consent|12|||
146891641|NCT01557166|529769252|FG001|Overall Study|Withdrawn consent|20|||
146891642|NCT01557166|529769251|FG000|Overall Study|Target dose not tolerated|1|||
146891643|NCT01557166|529769252|FG001|Overall Study|Target dose not tolerated|0|||
146891644|NCT01557166|529769251|FG000|Overall Study|Psychiatric disorder|1|||
146891645|NCT01557166|529769252|FG001|Overall Study|Psychiatric disorder|0|||
146891646|NCT01557166|529769251|FG000|Overall Study|Unclassified|2|||
146891647|NCT01557166|529769252|FG001|Overall Study|Unclassified|5|||
146891648|NCT04506294|529769253|FG000|Overall Study|Lost to Follow-up|70|||
146891649|NCT04506294|529769254|FG001|Overall Study|Lost to Follow-up|20|||
146891650|NCT04506294|529769253|FG000|Overall Study|Withdrawal by Subject|16|||
146967438|NCT02684370|530041538|FG005|Part A|Lost to Follow-up|0|||
146967439|NCT02684370|530041533|FG000|Part A|Subject Withdrawal|1|||
146967440|NCT02684370|530041534|FG001|Part A|Subject Withdrawal|0|||
146967441|NCT02684370|530041535|FG002|Part A|Subject Withdrawal|3|||
146967442|NCT02684370|530041536|FG003|Part A|Subject Withdrawal|0|||
146967443|NCT02684370|530041537|FG004|Part A|Subject Withdrawal|0|||
146967444|NCT02684370|530041538|FG005|Part A|Subject Withdrawal|0|||
146967445|NCT02684370|530041533|FG000|Part A|Other|0|||
146967446|NCT02684370|530041534|FG001|Part A|Other|0|||
146967447|NCT02684370|530041535|FG002|Part A|Other|1|||
146967448|NCT02684370|530041536|FG003|Part A|Other|0|||
146967449|NCT02684370|530041537|FG004|Part A|Other|0|||
146967450|NCT02684370|530041538|FG005|Part A|Other|0|||
146967451|NCT02684370|530041533|FG000|Part B|Adverse Event|0|||
146967452|NCT02684370|530041534|FG001|Part B|Adverse Event|0|||
146967453|NCT02684370|530041535|FG002|Part B|Adverse Event|0|||
146967454|NCT02684370|530041536|FG003|Part B|Adverse Event|0|||
146967455|NCT02684370|530041537|FG004|Part B|Adverse Event|2|||
146967456|NCT02684370|530041538|FG005|Part B|Adverse Event|1|||
146967457|NCT02684370|530041533|FG000|Part B|Lost to Follow-up|0|||
146967458|NCT02684370|530041534|FG001|Part B|Lost to Follow-up|0|||
146967459|NCT02684370|530041535|FG002|Part B|Lost to Follow-up|0|||
146967460|NCT02684370|530041536|FG003|Part B|Lost to Follow-up|1|||
146967461|NCT02684370|530041537|FG004|Part B|Lost to Follow-up|2|||
146557451|NCT05261490|528551088|FG000|Overall Study|Study Terminated by Sponsor|1|||
146557452|NCT05261490|528551089|FG001|Overall Study|Study Terminated by Sponsor|1|||
146557453|NCT05261490|528551090|FG002|Overall Study|Study Terminated by Sponsor|4|||
146891651|NCT04506294|529769254|FG001|Overall Study|Withdrawal by Subject|2|||
146891652|NCT00946309|529769255|FG000|Overall Study|Protocol Violation|1|||
146891653|NCT00946309|529769256|FG001|Overall Study|Protocol Violation|0|||
146891654|NCT00946309|529769255|FG000|Overall Study|Lost to Follow-up|0|||
146891655|NCT00946309|529769256|FG001|Overall Study|Lost to Follow-up|1|||
146891656|NCT00946309|529769255|FG000|Overall Study|Procedure cancelled/discontinued|0|||
146891657|NCT00946309|529769256|FG001|Overall Study|Procedure cancelled/discontinued|3|||
146891658|NCT01465659|529769257|FG000|Completed 1 Cycle of Treatment|Death|0|||
146891659|NCT01465659|529769258|FG001|Completed 1 Cycle of Treatment|Death|1|||
146967462|NCT02684370|530041538|FG005|Part B|Lost to Follow-up|5|||
146967463|NCT02684370|530041533|FG000|Part B|Subject Withdrawal|0|||
146967464|NCT02684370|530041534|FG001|Part B|Subject Withdrawal|0|||
146967465|NCT02684370|530041535|FG002|Part B|Subject Withdrawal|0|||
146967466|NCT02684370|530041536|FG003|Part B|Subject Withdrawal|1|||
146967467|NCT02684370|530041537|FG004|Part B|Subject Withdrawal|1|||
146967468|NCT02684370|530041538|FG005|Part B|Subject Withdrawal|2|||
146967469|NCT01165424|530041542|FG000|Overall Study|Clinical adverse experiences|1|||
146967470|NCT01165424|530041542|FG000|Overall Study|Laboratory adverse experiences|1|||
146891660|NCT01465659|529769259|FG002|Completed 1 Cycle of Treatment|Death|0|||
146891661|NCT01465659|529769260|FG003|Completed 1 Cycle of Treatment|Death|0|||
146891662|NCT01465659|529769257|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
146891663|NCT01465659|529769258|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
146891664|NCT01465659|529769259|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
146891665|NCT01465659|529769260|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
146891666|NCT01465659|529769257|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
146891667|NCT01465659|529769258|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
146891668|NCT01465659|529769259|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
146891669|NCT01465659|529769260|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
146891670|NCT01465659|529769257|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
146891671|NCT01465659|529769258|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
146891672|NCT01465659|529769259|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
146891673|NCT01465659|529769260|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
146891674|NCT01465659|529769257|FG000|Completed Follow for 1 Year|Death|6|||
146891675|NCT01465659|529769258|FG001|Completed Follow for 1 Year|Death|3|||
146557454|NCT05261490|528551088|FG000|Overall Study|Death|1|||
146766300|NCT01235949|529312232|FG010|Primary Phase|Adverse Event|0|||
146891676|NCT01465659|529769259|FG002|Completed Follow for 1 Year|Death|2|||
146891677|NCT01465659|529769260|FG003|Completed Follow for 1 Year|Death|4|||
146891678|NCT00428597|529769261|FG000|Overall Study|Randomized but not treated|3|||
146891679|NCT00428597|529769262|FG001|Overall Study|Randomized but not treated|3|||
146891680|NCT00428597|529769261|FG000|Overall Study|Objective Progression or Relapse|19|||
146891681|NCT00428597|529769262|FG001|Overall Study|Objective Progression or Relapse|47|||
146891682|NCT00428597|529769261|FG000|Overall Study|Study Terminated by Sponsor|41|||
146891683|NCT00428597|529769262|FG001|Overall Study|Study Terminated by Sponsor|16|||
146891684|NCT00428597|529769261|FG000|Overall Study|Adverse Event|15|||
146891685|NCT00428597|529769262|FG001|Overall Study|Adverse Event|7|||
146891686|NCT00428597|529769261|FG000|Overall Study|Global Deterioration of Health Status|1|||
146891687|NCT00428597|529769262|FG001|Overall Study|Global Deterioration of Health Status|5|||
146891688|NCT00428597|529769261|FG000|Overall Study|Protocol Violation|2|||
146891689|NCT00428597|529769262|FG001|Overall Study|Protocol Violation|1|||
146891690|NCT00428597|529769261|FG000|Overall Study|Withdrawal by Subject|2|||
146891691|NCT00428597|529769262|FG001|Overall Study|Withdrawal by Subject|1|||
146891692|NCT00428597|529769261|FG000|Overall Study|Other|1|||
146891693|NCT00428597|529769262|FG001|Overall Study|Other|1|||
146891694|NCT00428597|529769261|FG000|Overall Study|Lost to Follow-up|0|||
146891695|NCT00428597|529769262|FG001|Overall Study|Lost to Follow-up|1|||
146891696|NCT00428597|529769261|FG000|Overall Study|Pregnancy|1|||
146891697|NCT00428597|529769262|FG001|Overall Study|Pregnancy|0|||
146891698|NCT00428597|529769261|FG000|Overall Study|Death|1|||
146891699|NCT00428597|529769262|FG001|Overall Study|Death|3|||
146891700|NCT00769119|529769268|FG000|Overall Study|Voluntary discontinuation|0|||
146557455|NCT05261490|528551089|FG001|Overall Study|Death|2|||
146891701|NCT00769119|529769269|FG001|Overall Study|Voluntary discontinuation|2|||
146891702|NCT00769119|529769268|FG000|Overall Study|Adverse Event|1|||
146891703|NCT00769119|529769269|FG001|Overall Study|Adverse Event|1|||
146891704|NCT00769119|529769268|FG000|Overall Study|Disallowed medication|1|||
146891705|NCT00769119|529769269|FG001|Overall Study|Disallowed medication|0|||
146891706|NCT00686647|529769270|FG000|Overall Study|Lost to Follow-up|1|||
146891707|NCT00686647|529769270|FG000|Overall Study|Death|1|||
146891708|NCT01116544|529769271|FG000|Overall Study|Protocol Violation|1|||
146891709|NCT01116544|529769272|FG001|Overall Study|Protocol Violation|0|||
146891710|NCT01116544|529769271|FG000|Overall Study|Withdrawal by Subject|1|||
146891711|NCT01116544|529769272|FG001|Overall Study|Withdrawal by Subject|1|||
146891712|NCT00578643|529769273|FG000|Overall Study|Death|1|||
146891713|NCT00578643|529769273|FG000|Overall Study|Lost to Follow-up|1|||
146891714|NCT01725750|529769274|FG000|Overall Study|Adverse Event|1|||
146891715|NCT01725750|529769275|FG001|Overall Study|Adverse Event|0|||
146891716|NCT01725750|529769274|FG000|Overall Study|Lost to Follow-up|1|||
146891717|NCT01725750|529769275|FG001|Overall Study|Lost to Follow-up|1|||
146891718|NCT01725750|529769274|FG000|Overall Study|Withdrawal by Subject|0|||
146891719|NCT01725750|529769275|FG001|Overall Study|Withdrawal by Subject|9|||
146891720|NCT03828487|529769278|FG000|Overall Study|Physician Decision|1|||
146891721|NCT02887521|529769281|FG000|Overall Study|Withdrawal by Subject|0|||
146891722|NCT02887521|529769282|FG001|Overall Study|Withdrawal by Subject|3|||
146891723|NCT05888103|529770949|FG000|Overall Study|Participant decision|3|||
146891724|NCT05888103|529770950|FG001|Overall Study|Participant decision|3|||
146891725|NCT05900115|529770951|FG000|Overall Study|Lost to Follow-up|129|||
146891726|NCT05900115|529770952|FG001|Overall Study|Lost to Follow-up|98|||
146891727|NCT05162066|529770953|FG000|Overall Study|Adverse Event|1|||
146891728|NCT05162066|529770954|FG001|Overall Study|Adverse Event|0|||
146891729|NCT05162066|529770955|FG002|Overall Study|Adverse Event|0|||
146891730|NCT05162066|529770953|FG000|Overall Study|Perceived lack of efficacy|1|||
146891731|NCT05162066|529770954|FG001|Overall Study|Perceived lack of efficacy|0|||
146891732|NCT05162066|529770955|FG002|Overall Study|Perceived lack of efficacy|0|||
146891733|NCT03969875|529770956|FG000|Overall Study|did not receive allocated intervention|3|||
146891734|NCT03969875|529770957|FG001|Overall Study|did not receive allocated intervention|3|||
146891735|NCT03969875|529770958|FG002|Overall Study|did not receive allocated intervention|4|||
146891736|NCT03969875|529770956|FG000|Overall Study|Protocol Violation|4|||
146891737|NCT03969875|529770957|FG001|Overall Study|Protocol Violation|2|||
146891738|NCT03969875|529770958|FG002|Overall Study|Protocol Violation|2|||
146891739|NCT01307033|529770959|FG000|8-week Double-blind Period|Adverse Event|2|||
146891740|NCT01307033|529770960|FG001|8-week Double-blind Period|Adverse Event|0|||
146891741|NCT01307033|529770961|FG002|8-week Double-blind Period|Adverse Event|0|||
146891742|NCT01307033|529770962|FG003|8-week Double-blind Period|Adverse Event|0|||
146766301|NCT01235949|529312233|FG011|Primary Phase|Adverse Event|0|||
146766302|NCT01235949|529312234|FG012|Primary Phase|Adverse Event|0|||
146766303|NCT01235949|529312235|FG013|Primary Phase|Adverse Event|0|||
146891743|NCT01307033|529770959|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
146891744|NCT01307033|529770960|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
146891745|NCT01307033|529770961|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
146891746|NCT01307033|529770962|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
146891747|NCT01307033|529770959|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
146891748|NCT01307033|529770960|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
146891749|NCT01307033|529770961|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
146967471|NCT01165424|530041542|FG000|Overall Study|Did not meet entry criteria|1|||
146967472|NCT01165424|530041542|FG000|Overall Study|Participant moved (relocated)|1|||
146967473|NCT00433771|530041543|FG000|Overall Study|screen fail|14|||
146967474|NCT00433771|530041543|FG000|Overall Study|Treated and later found to be ineligible|2|||
146967475|NCT00433771|530041543|FG000|Overall Study|Death|2|||
146967476|NCT00433771|530041543|FG000|Overall Study|Failure to deploy stent|1|||
146967477|NCT00943826|530041544|FG000|Concurrent Phase|Adverse Event|50|||
146967478|NCT00943826|530041545|FG001|Concurrent Phase|Adverse Event|27|||
146967479|NCT00943826|530041544|FG000|Concurrent Phase|Withdrew consent|3|||
146967480|NCT00943826|530041545|FG001|Concurrent Phase|Withdrew consent|7|||
146967481|NCT00943826|530041544|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
146967482|NCT00943826|530041545|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
146967483|NCT00943826|530041544|FG000|Concurrent Phase|Administrative reasons|2|||
146967484|NCT00943826|530041545|FG001|Concurrent Phase|Administrative reasons|1|||
146967485|NCT00943826|530041544|FG000|Concurrent Phase|Protocol Violation|1|||
146967486|NCT00943826|530041545|FG001|Concurrent Phase|Protocol Violation|0|||
146967487|NCT00943826|530041544|FG000|Maintenance Phase|Adverse Event|31|||
146967488|NCT00943826|530041545|FG001|Maintenance Phase|Adverse Event|30|||
146967489|NCT00943826|530041544|FG000|Maintenance Phase|Withdrew consent|2|||
146967490|NCT00943826|530041545|FG001|Maintenance Phase|Withdrew consent|4|||
146967491|NCT00943826|530041544|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
146967492|NCT00943826|530041545|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
146967493|NCT00943826|530041544|FG000|Maintenance Phase|Administrative reasons|4|||
146967494|NCT00943826|530041545|FG001|Maintenance Phase|Administrative reasons|1|||
146967495|NCT00943826|530041544|FG000|Maintenance Phase|Failure to return|0|||
146967496|NCT00943826|530041545|FG001|Maintenance Phase|Failure to return|1|||
146967497|NCT00943826|530041544|FG000|Monotherapy Phase|Adverse Event|42|||
146967498|NCT00943826|530041545|FG001|Monotherapy Phase|Adverse Event|5|||
146967499|NCT00943826|530041544|FG000|Monotherapy Phase|Administrative reasons|11|||
146967500|NCT00943826|530041545|FG001|Monotherapy Phase|Administrative reasons|5|||
146967501|NCT00943826|530041544|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
146967502|NCT00943826|530041545|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
146967503|NCT00943826|530041544|FG000|Monotherapy Phase|Withdrew Consent|2|||
146967504|NCT00943826|530041545|FG001|Monotherapy Phase|Withdrew Consent|3|||
146967505|NCT00943826|530041544|FG000|Monotherapy Phase|Failure to return|2|||
146967506|NCT00943826|530041545|FG001|Monotherapy Phase|Failure to return|1|||
146967507|NCT00943826|530041544|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
146967508|NCT00943826|530041545|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
146967509|NCT00943826|530041544|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
146967510|NCT00943826|530041545|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
146967511|NCT00943826|530041544|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
146967512|NCT00943826|530041545|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
146967513|NCT00943826|530041544|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
146967514|NCT00943826|530041545|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
146557456|NCT05261490|528551090|FG002|Overall Study|Death|0|||
146967515|NCT01833897|530041555|FG000|Overall Study|Lack of Efficacy|1|||
146967516|NCT02860039|530041556|FG000|Overall Study|Death|4|||
146967517|NCT02860039|530041557|FG001|Overall Study|Death|0|||
146967518|NCT02860039|530041556|FG000|Overall Study|Lost to Follow-up|2|||
146967519|NCT02860039|530041557|FG001|Overall Study|Lost to Follow-up|2|||
146967520|NCT02860039|530041556|FG000|Overall Study|Protocol Violation|3|||
146967521|NCT02860039|530041557|FG001|Overall Study|Protocol Violation|1|||
146967522|NCT02860039|530041556|FG000|Overall Study|Withdrawal by Subject|1|||
146967523|NCT02860039|530041557|FG001|Overall Study|Withdrawal by Subject|0|||
146967524|NCT02860039|530041556|FG000|Overall Study|Not otherwise eligible|1|||
146967525|NCT02860039|530041557|FG001|Overall Study|Not otherwise eligible|1|||
146967526|NCT00669110|530041558|FG000|Overall Study|Adverse Event|4|||
146967527|NCT00669110|530041559|FG001|Overall Study|Adverse Event|3|||
146967528|NCT00669110|530041558|FG000|Overall Study|Caregiver request|3|||
146967529|NCT00669110|530041559|FG001|Overall Study|Caregiver request|2|||
146967530|NCT00669110|530041558|FG000|Overall Study|Physician Decision|0|||
146967531|NCT00669110|530041559|FG001|Overall Study|Physician Decision|1|||
146967532|NCT00669110|530041558|FG000|Overall Study|Lost to Follow-up|1|||
146967533|NCT00669110|530041559|FG001|Overall Study|Lost to Follow-up|0|||
146967534|NCT00669110|530041558|FG000|Overall Study|Protocol Violation|0|||
146967535|NCT00669110|530041559|FG001|Overall Study|Protocol Violation|5|||
146967536|NCT00669110|530041558|FG000|Overall Study|Withdrawal by Subject|0|||
146967537|NCT00669110|530041559|FG001|Overall Study|Withdrawal by Subject|2|||
146967538|NCT01244516|530041560|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
146967539|NCT01244516|530041561|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
146967540|NCT01244516|530041562|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
146967541|NCT01244516|530041560|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
146967542|NCT01244516|530041561|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
146967543|NCT01244516|530041562|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
146967544|NCT01244516|530041560|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
146967545|NCT01244516|530041561|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
146967546|NCT01244516|530041562|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
146967547|NCT01244516|530041560|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
146967548|NCT01244516|530041561|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
146967549|NCT01244516|530041562|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
146967550|NCT01244516|530041560|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
146967551|NCT01244516|530041561|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
146967552|NCT01244516|530041562|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
146967553|NCT01244516|530041560|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
146967554|NCT01244516|530041561|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
146967555|NCT01244516|530041562|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
146967556|NCT01244516|530041560|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
146967557|NCT01244516|530041561|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
146967558|NCT01244516|530041562|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
146967559|NCT00077766|530041568|FG000|Overall Study|Adverse Event|1|||
146967560|NCT00077766|530041569|FG001|Overall Study|Adverse Event|1|||
146967561|NCT00077766|530041568|FG000|Overall Study|Withdrawal by Subject|4|||
146967562|NCT00077766|530041569|FG001|Overall Study|Withdrawal by Subject|3|||
146967563|NCT00077766|530041568|FG000|Overall Study|Death|12|||
146967564|NCT00077766|530041569|FG001|Overall Study|Death|10|||
146967565|NCT00077766|530041568|FG000|Overall Study|Lost to Follow-up|2|||
146967566|NCT00077766|530041569|FG001|Overall Study|Lost to Follow-up|0|||
146967567|NCT00077766|530041568|FG000|Overall Study|Protocol Violation|1|||
146967568|NCT00077766|530041569|FG001|Overall Study|Protocol Violation|0|||
146967569|NCT00077766|530041568|FG000|Overall Study|Kidney Transplantation|9|||
146967570|NCT00077766|530041569|FG001|Overall Study|Kidney Transplantation|5|||
146891750|NCT01307033|529770962|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
146891751|NCT01307033|529770959|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
146891752|NCT01307033|529770960|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
146891753|NCT01307033|529770961|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
146891754|NCT01307033|529770962|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
146891755|NCT01307033|529770959|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
146891756|NCT01307033|529770960|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
146891757|NCT01307033|529770961|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
146891758|NCT01307033|529770962|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
146891759|NCT01307033|529770959|FG000|44-week Open-label Extension|Adverse Event|0|||
146891760|NCT01307033|529770960|FG001|44-week Open-label Extension|Adverse Event|0|||
146891761|NCT01307033|529770961|FG002|44-week Open-label Extension|Adverse Event|2|||
146891762|NCT01307033|529770962|FG003|44-week Open-label Extension|Adverse Event|1|||
146891763|NCT01307033|529770959|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
146891764|NCT01307033|529770960|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
146891765|NCT01307033|529770961|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
146891766|NCT01307033|529770962|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
146891767|NCT01307033|529770959|FG000|44-week Open-label Extension|Physician Decision|0|||
146891768|NCT01307033|529770960|FG001|44-week Open-label Extension|Physician Decision|0|||
146891769|NCT01307033|529770961|FG002|44-week Open-label Extension|Physician Decision|1|||
146891770|NCT01307033|529770962|FG003|44-week Open-label Extension|Physician Decision|0|||
146891771|NCT01307033|529770959|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
146891772|NCT01307033|529770960|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
146891773|NCT01307033|529770961|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
146891774|NCT01307033|529770962|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
146891775|NCT01307033|529770959|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
146891776|NCT01307033|529770960|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
146891777|NCT01307033|529770961|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
146891778|NCT01307033|529770962|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
146891779|NCT01307033|529770959|FG000|44-week Open-label Extension|Death|0|||
146891780|NCT01307033|529770960|FG001|44-week Open-label Extension|Death|0|||
146891781|NCT01307033|529770961|FG002|44-week Open-label Extension|Death|0|||
146891782|NCT01307033|529770962|FG003|44-week Open-label Extension|Death|1|||
146766304|NCT01235949|529312236|FG014|Primary Phase|Adverse Event|0|||
146766305|NCT01235949|529312237|FG015|Primary Phase|Adverse Event|0|||
146891783|NCT02327260|529770964|FG000|Overall Study|Lost to Follow-up|2|||
146891784|NCT02327260|529770965|FG001|Overall Study|Lost to Follow-up|3|||
146891785|NCT02327260|529770966|FG002|Overall Study|Lost to Follow-up|2|||
146891786|NCT02327260|529770964|FG000|Overall Study|invalid phone number|1|||
146891787|NCT02327260|529770965|FG001|Overall Study|invalid phone number|1|||
146891788|NCT02327260|529770966|FG002|Overall Study|invalid phone number|0|||
146891789|NCT02327260|529770964|FG000|Overall Study|non-adherence to protocol|2|||
146891790|NCT02327260|529770965|FG001|Overall Study|non-adherence to protocol|0|||
146891791|NCT02327260|529770966|FG002|Overall Study|non-adherence to protocol|0|||
146891792|NCT02327260|529770964|FG000|Overall Study|cognitive concerns|1|||
146891793|NCT02327260|529770965|FG001|Overall Study|cognitive concerns|0|||
146891794|NCT02327260|529770966|FG002|Overall Study|cognitive concerns|0|||
146891795|NCT02804763|529770969|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
146891796|NCT02804763|529770970|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
146891797|NCT02804763|529770971|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
146891798|NCT02804763|529770972|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
146891799|NCT02804763|529770969|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
146891800|NCT02804763|529770970|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
146891801|NCT02804763|529770971|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
146891802|NCT02804763|529770972|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
146891803|NCT02804763|529770969|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
146891804|NCT02804763|529770970|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
146891805|NCT02804763|529770971|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
146891806|NCT02804763|529770972|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
146891807|NCT02804763|529770969|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
146891808|NCT02804763|529770970|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
146891809|NCT02804763|529770971|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
146891810|NCT02804763|529770972|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
146891811|NCT02804763|529770969|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
146891812|NCT02804763|529770970|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
146891813|NCT02804763|529770971|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
146557457|NCT00456365|528551098|FG000|Overall Study|Lost to Follow-up|1|||
146557458|NCT00456365|528551099|FG001|Overall Study|Lost to Follow-up|3|||
146891814|NCT02804763|529770972|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
146891815|NCT02804763|529770969|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
146891816|NCT02804763|529770970|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
146891817|NCT02804763|529770971|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
146967571|NCT00077766|530041568|FG000|Overall Study|Transplantation|5|||
146766306|NCT01235949|529312238|FG016|Primary Phase|Adverse Event|0|||
146766307|NCT01235949|529312239|FG017|Primary Phase|Adverse Event|0|||
146766308|NCT01235949|529312222|FG000|Primary Phase|Withdrawal by Subject|3|||
146766309|NCT01235949|529312223|FG001|Primary Phase|Withdrawal by Subject|2|||
146766310|NCT01235949|529312224|FG002|Primary Phase|Withdrawal by Subject|2|||
146766311|NCT01235949|529312225|FG003|Primary Phase|Withdrawal by Subject|0|||
146766312|NCT01235949|529312226|FG004|Primary Phase|Withdrawal by Subject|0|||
146891818|NCT02804763|529770972|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
146891819|NCT00860158|529770973|FG000|Overall Study|Study Terminated|1|||
146891820|NCT05499520|529770974|FG000|Overall Study|Lost to Follow-up|0|||
146891821|NCT05499520|529770975|FG001|Overall Study|Lost to Follow-up|0|||
146891822|NCT05499520|529770976|FG002|Overall Study|Lost to Follow-up|38|||
146891823|NCT05499520|529770977|FG003|Overall Study|Lost to Follow-up|41|||
146891824|NCT05499520|529770978|FG004|Overall Study|Lost to Follow-up|46|||
146891825|NCT05499520|529770979|FG005|Overall Study|Lost to Follow-up|0|||
146891826|NCT05499520|529770980|FG006|Overall Study|Lost to Follow-up|31|||
146891827|NCT05499520|529770981|FG007|Overall Study|Lost to Follow-up|45|||
146891828|NCT05499520|529770982|FG008|Overall Study|Lost to Follow-up|42|||
146891829|NCT05499520|529770983|FG009|Overall Study|Lost to Follow-up|0|||
146891830|NCT05499520|529770984|FG010|Overall Study|Lost to Follow-up|0|||
146891831|NCT05499520|529770985|FG011|Overall Study|Lost to Follow-up|37|||
146891832|NCT05499520|529770986|FG012|Overall Study|Lost to Follow-up|53|||
146891833|NCT05499520|529770987|FG013|Overall Study|Lost to Follow-up|49|||
146891834|NCT05499520|529770988|FG014|Overall Study|Lost to Follow-up|0|||
146766313|NCT01235949|529312227|FG005|Primary Phase|Withdrawal by Subject|3|||
146766314|NCT01235949|529312228|FG006|Primary Phase|Withdrawal by Subject|0|||
146891835|NCT05499520|529770989|FG015|Overall Study|Lost to Follow-up|36|||
146891836|NCT05499520|529770990|FG016|Overall Study|Lost to Follow-up|58|||
146891837|NCT05499520|529770991|FG017|Overall Study|Lost to Follow-up|53|||
146891838|NCT03588741|529770992|FG000|Overall Study|Withdrawal by Subject|1|||
146891839|NCT01940484|529770997|FG000|Overall Study|Withdrawal by Subject|3|||
146891840|NCT01940484|529770997|FG000|Overall Study|Underwent transplantation|4|||
146891841|NCT01940484|529770997|FG000|Overall Study|Death|2|||
146891842|NCT01940484|529770997|FG000|Overall Study|Adverse Event|1|||
146557459|NCT00456365|528551098|FG000|Overall Study|Withdrawal by Subject|4|||
146557460|NCT00456365|528551099|FG001|Overall Study|Withdrawal by Subject|7|||
146557461|NCT00456365|528551098|FG000|Overall Study|Pregnancy|1|||
146557462|NCT00456365|528551099|FG001|Overall Study|Pregnancy|1|||
146557463|NCT00456365|528551098|FG000|Overall Study|oncologic diagnosis|1|||
146557464|NCT00456365|528551099|FG001|Overall Study|oncologic diagnosis|1|||
146557465|NCT06091956|528551100|FG000|Overall Study|Withdrawal by Subject|1|||
146557466|NCT06091956|528551100|FG000|Overall Study|Complicating Disease|1|||
146557467|NCT00979407|528551106|FG000|Overall Study|Withdrawal by Subject|3|||
146557468|NCT00979407|528551107|FG001|Overall Study|Withdrawal by Subject|4|||
146637143|NCT03682770|528847231|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
146967572|NCT00077766|530041569|FG001|Overall Study|Transplantation|1|||
146967573|NCT00077766|530041568|FG000|Overall Study|Investigators Discretion|1|||
146967574|NCT00077766|530041569|FG001|Overall Study|Investigators Discretion|0|||
146967575|NCT00077766|530041568|FG000|Overall Study|Participant's decision|1|||
146967576|NCT00077766|530041569|FG001|Overall Study|Participant's decision|0|||
146967577|NCT00077766|530041568|FG000|Overall Study|Dialysis Discontinued|1|||
146967578|NCT00077766|530041569|FG001|Overall Study|Dialysis Discontinued|0|||
146967579|NCT00077766|530041568|FG000|Overall Study|Dialysis|0|||
146967580|NCT00077766|530041569|FG001|Overall Study|Dialysis|1|||
146967581|NCT00077766|530041568|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
146967582|NCT00077766|530041569|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
146967583|NCT00077766|530041568|FG000|Overall Study|Started Nocturnal Dialysis|0|||
146967584|NCT00077766|530041569|FG001|Overall Study|Started Nocturnal Dialysis|1|||
146967585|NCT00077766|530041568|FG000|Overall Study|Stop Dialysis|0|||
146967586|NCT00077766|530041569|FG001|Overall Study|Stop Dialysis|1|||
146967587|NCT00077766|530041568|FG000|Overall Study|Participants Vacation|2|||
146967588|NCT00077766|530041569|FG001|Overall Study|Participants Vacation|1|||
146967589|NCT00352664|530041571|FG000|Overall Study|Withdrawal by Subject|7|||
146967590|NCT00352664|530041572|FG001|Overall Study|Withdrawal by Subject|0|||
146967591|NCT01319994|530043778|FG000|Overall Study|Protocol Violation|7|||
146967592|NCT01319994|530043779|FG001|Overall Study|Protocol Violation|6|||
146967593|NCT01340794|530043780|FG000|Overall Study|Withdrawal by Subject|0|||
146967594|NCT01340794|530043781|FG001|Overall Study|Withdrawal by Subject|1|||
146967595|NCT02674568|530043783|FG000|Overall Study|Withdrawal by Subject|5|||
146967596|NCT02674568|530043783|FG000|Overall Study|Death|303|||
146967597|NCT02674568|530043783|FG000|Overall Study|Physician Decision|2|||
146967598|NCT02674568|530043783|FG000|Overall Study|Lost to Follow-up|9|||
146967599|NCT02674568|530043783|FG000|Overall Study|Other, Not Specified|20|||
146967600|NCT01808508|530043786|FG000|Overall Study|Lost to Follow-up|1|||
146967601|NCT01808508|530043787|FG001|Overall Study|Lost to Follow-up|0|||
146967602|NCT01808508|530043788|FG002|Overall Study|Lost to Follow-up|0|||
146967603|NCT01118949|530043789|FG000|Overall Study|Adverse Event|5|||
146967604|NCT01118949|530043789|FG000|Overall Study|Withdrawal by Subject|4|||
146967605|NCT01035229|530043790|FG000|Overall Study|Adverse Event|61|||
146967606|NCT01035229|530043791|FG001|Overall Study|Adverse Event|14|||
146967607|NCT01035229|530043790|FG000|Overall Study|Withdrawal by Subject|20|||
146967608|NCT01035229|530043791|FG001|Overall Study|Withdrawal by Subject|7|||
146967609|NCT01035229|530043790|FG000|Overall Study|Lost to Follow-up|1|||
146967610|NCT01035229|530043791|FG001|Overall Study|Lost to Follow-up|0|||
146967611|NCT01035229|530043790|FG000|Overall Study|Administrative problems|1|||
146967612|NCT01035229|530043791|FG001|Overall Study|Administrative problems|1|||
146967613|NCT01035229|530043790|FG000|Overall Study|Death|13|||
146967614|NCT01035229|530043791|FG001|Overall Study|Death|5|||
146967615|NCT01035229|530043790|FG000|Overall Study|New cancer therapy|2|||
146967616|NCT01035229|530043791|FG001|Overall Study|New cancer therapy|0|||
146967617|NCT01035229|530043790|FG000|Overall Study|Protocol Violation|0|||
146967618|NCT01035229|530043791|FG001|Overall Study|Protocol Violation|2|||
146967619|NCT01035229|530043790|FG000|Overall Study|Sponsor's decision to end study|3|||
146967620|NCT01035229|530043791|FG001|Overall Study|Sponsor's decision to end study|3|||
146967621|NCT01035229|530043790|FG000|Overall Study|Disease Progression|261|||
146967622|NCT01035229|530043791|FG001|Overall Study|Disease Progression|152|||
146967623|NCT00698009|530043797|FG000|Overall Study|Withdrawal by Subject|1|||
146967624|NCT03387423|530043798|FG000|Overall Study|Lost to Follow-up|16|||
146967625|NCT03387423|530043799|FG001|Overall Study|Lost to Follow-up|12|||
146967626|NCT03387423|530043800|FG002|Overall Study|Lost to Follow-up|1|||
146637144|NCT03682770|528847232|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
146967627|NCT03387423|530043801|FG003|Overall Study|Lost to Follow-up|0|||
146967628|NCT03387423|530043798|FG000|Overall Study|Other|0|||
146967629|NCT03387423|530043799|FG001|Overall Study|Other|3|||
146967630|NCT03387423|530043800|FG002|Overall Study|Other|0|||
146967631|NCT03387423|530043801|FG003|Overall Study|Other|0|||
146967632|NCT03387423|530043798|FG000|Overall Study|Administrative Reason|166|||
146967633|NCT03387423|530043799|FG001|Overall Study|Administrative Reason|89|||
146967634|NCT03387423|530043800|FG002|Overall Study|Administrative Reason|17|||
146967635|NCT03387423|530043801|FG003|Overall Study|Administrative Reason|19|||
146967636|NCT03387423|530043798|FG000|Overall Study|Revocation Consent|76|||
146967637|NCT03387423|530043799|FG001|Overall Study|Revocation Consent|32|||
146891843|NCT02769624|529771002|FG000|Overall Study|Lost to Follow-up|0|||
146891844|NCT02769624|529771003|FG001|Overall Study|Lost to Follow-up|1|||
146891845|NCT01552681|529771005|FG000|Overall Study|Withdrawal by Subject|4|||
146891846|NCT01552681|529771006|FG001|Overall Study|Withdrawal by Subject|0|||
146891847|NCT01552681|529771005|FG000|Overall Study|Physician Decision|1|||
146891848|NCT01552681|529771006|FG001|Overall Study|Physician Decision|0|||
146891849|NCT01552681|529771005|FG000|Overall Study|Subject moved away|0|||
146891850|NCT01552681|529771006|FG001|Overall Study|Subject moved away|1|||
146891851|NCT00448708|529771007|FG000|Overall Study|Death|21|||
146891852|NCT00448708|529771008|FG001|Overall Study|Death|17|||
146891853|NCT00448708|529771007|FG000|Overall Study|Withdrawal by Subject|8|||
146891854|NCT00448708|529771008|FG001|Overall Study|Withdrawal by Subject|4|||
146891855|NCT00448708|529771007|FG000|Overall Study|Lost to Follow-up|6|||
146891856|NCT00448708|529771008|FG001|Overall Study|Lost to Follow-up|8|||
146891857|NCT00448708|529771007|FG000|Overall Study|not listed|0|||
146891858|NCT00448708|529771008|FG001|Overall Study|not listed|2|||
146891859|NCT04698525|529771009|FG000|Overall Study|Lost to Follow-up|1|||
146891860|NCT04698525|529771010|FG001|Overall Study|Lost to Follow-up|2|||
146891861|NCT04698525|529771009|FG000|Overall Study|Three suffered of Covid-19|2|||
146891862|NCT04698525|529771010|FG001|Overall Study|Three suffered of Covid-19|1|||
146891863|NCT00354601|529771011|FG000|Overall Study|Protocol Violation|1|||
146891864|NCT00354601|529771011|FG000|Overall Study|progression|1|||
146891865|NCT02471716|529771012|FG000|Overall Study|Withdrawal by Subject|0|||
146891866|NCT02471716|529771013|FG001|Overall Study|Withdrawal by Subject|1|||
146891867|NCT02471716|529771014|FG002|Overall Study|Withdrawal by Subject|0|||
146891868|NCT02471716|529771015|FG003|Overall Study|Withdrawal by Subject|2|||
146891869|NCT02471716|529771016|FG004|Overall Study|Withdrawal by Subject|5|||
146891870|NCT02471716|529771012|FG000|Overall Study|Study Terminiated by sponsor|0|||
146891871|NCT02471716|529771013|FG001|Overall Study|Study Terminiated by sponsor|0|||
146891872|NCT02471716|529771014|FG002|Overall Study|Study Terminiated by sponsor|0|||
146891873|NCT02471716|529771015|FG003|Overall Study|Study Terminiated by sponsor|1|||
146891874|NCT02471716|529771016|FG004|Overall Study|Study Terminiated by sponsor|0|||
146891875|NCT02471716|529771012|FG000|Overall Study|Lost to Follow-up|0|||
146891876|NCT02471716|529771013|FG001|Overall Study|Lost to Follow-up|0|||
146891877|NCT02471716|529771014|FG002|Overall Study|Lost to Follow-up|0|||
146891878|NCT02471716|529771015|FG003|Overall Study|Lost to Follow-up|3|||
146891879|NCT02471716|529771016|FG004|Overall Study|Lost to Follow-up|2|||
146891880|NCT02471716|529771012|FG000|Overall Study|Death|0|||
146891881|NCT02471716|529771013|FG001|Overall Study|Death|0|||
146891882|NCT02471716|529771014|FG002|Overall Study|Death|0|||
146891883|NCT02471716|529771015|FG003|Overall Study|Death|1|||
146891884|NCT02471716|529771016|FG004|Overall Study|Death|0|||
146891885|NCT02471716|529771012|FG000|Overall Study|Other|0|||
146891886|NCT02471716|529771013|FG001|Overall Study|Other|0|||
146891887|NCT02471716|529771014|FG002|Overall Study|Other|0|||
146891888|NCT02471716|529771015|FG003|Overall Study|Other|8|||
146891889|NCT02471716|529771016|FG004|Overall Study|Other|9|||
146891890|NCT00130286|529771021|FG000|Overall Study|Withdrawal by Subject|0|||
146891891|NCT00130286|529771022|FG001|Overall Study|Withdrawal by Subject|1|||
146891892|NCT00130286|529771023|FG002|Overall Study|Withdrawal by Subject|2|||
146891893|NCT00130286|529771024|FG003|Overall Study|Withdrawal by Subject|2|||
146891894|NCT00130286|529771021|FG000|Overall Study|Adverse Event|0|||
146891895|NCT00130286|529771022|FG001|Overall Study|Adverse Event|0|||
146891896|NCT00130286|529771023|FG002|Overall Study|Adverse Event|2|||
146891897|NCT00130286|529771024|FG003|Overall Study|Adverse Event|0|||
146891898|NCT00130286|529771021|FG000|Overall Study|Missing lab specimens|0|||
146891899|NCT00130286|529771022|FG001|Overall Study|Missing lab specimens|2|||
146891900|NCT00130286|529771023|FG002|Overall Study|Missing lab specimens|0|||
146891901|NCT00130286|529771024|FG003|Overall Study|Missing lab specimens|0|||
146891902|NCT01360645|529771025|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
146891903|NCT01360645|529771026|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
146891904|NCT01360645|529771027|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
146891905|NCT01360645|529771028|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
146891906|NCT01360645|529771025|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
146891907|NCT01360645|529771026|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
146891908|NCT01360645|529771027|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
146891909|NCT01360645|529771028|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
146891910|NCT01360645|529771025|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
146557469|NCT00979407|528551106|FG000|Overall Study|Lost to Follow-up|3|||
146891911|NCT01360645|529771026|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
146891912|NCT01360645|529771027|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
146891913|NCT01360645|529771028|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
146891914|NCT01360645|529771025|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
146891915|NCT01360645|529771026|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
146891916|NCT01360645|529771027|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
146891917|NCT01360645|529771028|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
146891918|NCT01360645|529771025|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
146891919|NCT01360645|529771026|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
146891920|NCT01360645|529771027|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
146891921|NCT01360645|529771028|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
146891922|NCT01360645|529771025|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
146891923|NCT01360645|529771026|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
146891924|NCT01360645|529771027|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
146891925|NCT01360645|529771028|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
146891926|NCT01360645|529771025|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
146891927|NCT01360645|529771026|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
146891928|NCT01360645|529771027|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
146891929|NCT01360645|529771028|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
146891930|NCT01360645|529771025|FG000|Phase B (6 Weeks)|Adverse Event|0|||
146891931|NCT01360645|529771026|FG001|Phase B (6 Weeks)|Adverse Event|6|||
146891932|NCT01360645|529771027|FG002|Phase B (6 Weeks)|Adverse Event|0|||
146891933|NCT01360645|529771028|FG003|Phase B (6 Weeks)|Adverse Event|0|||
146891934|NCT01360645|529771025|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
146891935|NCT01360645|529771026|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
146891936|NCT01360645|529771027|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
146891937|NCT01360645|529771028|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
146891938|NCT01360645|529771025|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
146891939|NCT01360645|529771026|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
146891940|NCT01360645|529771027|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
146891941|NCT01360645|529771028|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
146891942|NCT01360645|529771025|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
146891943|NCT01360645|529771026|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
146891944|NCT01360645|529771027|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
146891945|NCT01360645|529771028|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
146557470|NCT00979407|528551107|FG001|Overall Study|Lost to Follow-up|3|||
146557471|NCT03760068|528551108|FG000|Overall Study|Withdrawal by Subject|7|||
146557472|NCT03760068|528551109|FG001|Overall Study|Withdrawal by Subject|8|||
146557473|NCT03760068|528551108|FG000|Overall Study|Adverse Event|1|||
146557474|NCT03760068|528551109|FG001|Overall Study|Adverse Event|2|||
146557475|NCT03760068|528551108|FG000|Overall Study|Administrative Decision by Sponsor|0|||
146557476|NCT03760068|528551109|FG001|Overall Study|Administrative Decision by Sponsor|2|||
146557477|NCT03760068|528551108|FG000|Overall Study|Physician Decision|1|||
146557478|NCT03760068|528551109|FG001|Overall Study|Physician Decision|2|||
146637145|NCT03682770|528847233|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
146891946|NCT01360645|529771025|FG000|Phase A+|Lost to Follow-up|0|||
146891947|NCT01360645|529771026|FG001|Phase A+|Lost to Follow-up|0|||
146891948|NCT01360645|529771027|FG002|Phase A+|Lost to Follow-up|0|||
146891949|NCT01360645|529771028|FG003|Phase A+|Lost to Follow-up|7|||
146891950|NCT01360645|529771025|FG000|Phase A+|Adverse Event|0|||
146891951|NCT01360645|529771026|FG001|Phase A+|Adverse Event|0|||
146891952|NCT01360645|529771027|FG002|Phase A+|Adverse Event|0|||
146891953|NCT01360645|529771028|FG003|Phase A+|Adverse Event|2|||
146891954|NCT01360645|529771025|FG000|Phase A+|Met Withdrawal Criteria|0|||
146891955|NCT01360645|529771026|FG001|Phase A+|Met Withdrawal Criteria|0|||
146891956|NCT01360645|529771027|FG002|Phase A+|Met Withdrawal Criteria|0|||
146891957|NCT01360645|529771028|FG003|Phase A+|Met Withdrawal Criteria|4|||
146891958|NCT01360645|529771025|FG000|Phase A+|Physician Decision|0|||
146891959|NCT01360645|529771026|FG001|Phase A+|Physician Decision|0|||
146891960|NCT01360645|529771027|FG002|Phase A+|Physician Decision|0|||
146891961|NCT01360645|529771028|FG003|Phase A+|Physician Decision|2|||
146891962|NCT01360645|529771025|FG000|Phase A+|Withdrawal by Subject|0|||
146891963|NCT01360645|529771026|FG001|Phase A+|Withdrawal by Subject|0|||
146891964|NCT01360645|529771027|FG002|Phase A+|Withdrawal by Subject|0|||
146891965|NCT01360645|529771028|FG003|Phase A+|Withdrawal by Subject|5|||
146891966|NCT01360645|529771025|FG000|Phase A+|Protocol Deviation|0|||
146891967|NCT01360645|529771026|FG001|Phase A+|Protocol Deviation|0|||
146891968|NCT01360645|529771027|FG002|Phase A+|Protocol Deviation|0|||
146891969|NCT01360645|529771028|FG003|Phase A+|Protocol Deviation|4|||
146891970|NCT01014585|529771029|FG000|Overall Study|Adverse Event|0|||
146557479|NCT03760068|528551108|FG000|Overall Study|Lost to Follow-up|4|||
146891971|NCT01014585|529771030|FG001|Overall Study|Adverse Event|2|||
146891972|NCT01014585|529771031|FG002|Overall Study|Adverse Event|0|||
146891973|NCT01014585|529771032|FG003|Overall Study|Adverse Event|3|||
146891974|NCT01014585|529771029|FG000|Overall Study|Withdrawal by Subject|2|||
146891975|NCT01014585|529771030|FG001|Overall Study|Withdrawal by Subject|0|||
146891976|NCT01014585|529771031|FG002|Overall Study|Withdrawal by Subject|1|||
146891977|NCT01014585|529771032|FG003|Overall Study|Withdrawal by Subject|3|||
146891978|NCT01014585|529771029|FG000|Overall Study|Lost to Follow-up|0|||
146891979|NCT01014585|529771030|FG001|Overall Study|Lost to Follow-up|0|||
146891980|NCT01014585|529771031|FG002|Overall Study|Lost to Follow-up|0|||
146891981|NCT01014585|529771032|FG003|Overall Study|Lost to Follow-up|2|||
146891982|NCT01014585|529771029|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
146891983|NCT01014585|529771030|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
146891984|NCT01014585|529771031|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
146891985|NCT01014585|529771032|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
146891986|NCT02154425|529771033|FG000|Screening Period|Adverse Event|1|||
146891987|NCT03336502|529771034|FG000|Overall Study|Physician Decision|0|||
146891988|NCT03336502|529771035|FG001|Overall Study|Physician Decision|1|||
146891989|NCT03336502|529771034|FG000|Overall Study|Prohibited Drugs|1|||
146891990|NCT03336502|529771035|FG001|Overall Study|Prohibited Drugs|1|||
146891991|NCT03336502|529771034|FG000|Overall Study|Death|1|||
146891992|NCT03336502|529771035|FG001|Overall Study|Death|2|||
146891993|NCT03336502|529771034|FG000|Overall Study|Adverse Event|2|||
146891994|NCT03336502|529771035|FG001|Overall Study|Adverse Event|5|||
146891995|NCT00611247|529771037|FG000|Overall Study|Death|1|||
146891996|NCT00611247|529771038|FG001|Overall Study|Death|5|||
146891997|NCT00611247|529771037|FG000|Overall Study|Lack of Efficacy|1|||
146891998|NCT00611247|529771038|FG001|Overall Study|Lack of Efficacy|16|||
146891999|NCT01107444|529771039|FG000|Overall Study|Withdrawal by Subject|8|||
146892000|NCT01107444|529771040|FG001|Overall Study|Withdrawal by Subject|12|||
146892001|NCT01107444|529771039|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
146892002|NCT01107444|529771040|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
146892003|NCT01890421|529771041|FG000|Overall Study|Adverse Event|1|||
146766315|NCT01235949|529312229|FG007|Primary Phase|Withdrawal by Subject|0|||
146892004|NCT01890421|529771041|FG000|Overall Study|Other reason|10|||
146892005|NCT02526550|529771043|FG000|Overall Study|Lost to Follow-up|1|||
146892006|NCT00091832|529771047|FG000|Overall Study|Physician Decision|1|||
146892007|NCT00091832|529771048|FG001|Overall Study|Physician Decision|0|||
146892008|NCT00091832|529771049|FG002|Overall Study|Physician Decision|0|||
146892009|NCT00091832|529771050|FG003|Overall Study|Physician Decision|0|||
146892010|NCT00091832|529771051|FG004|Overall Study|Physician Decision|0|||
146892011|NCT00091832|529771052|FG005|Overall Study|Physician Decision|0|||
146637146|NCT03682770|528847227|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
146637147|NCT03682770|528847228|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
146637148|NCT03682770|528847229|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
146637149|NCT03682770|528847230|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
146892012|NCT00091832|529771047|FG000|Overall Study|Adverse Event|0|||
146892013|NCT00091832|529771048|FG001|Overall Study|Adverse Event|0|||
146892014|NCT00091832|529771049|FG002|Overall Study|Adverse Event|0|||
146892015|NCT00091832|529771050|FG003|Overall Study|Adverse Event|1|||
146892016|NCT00091832|529771051|FG004|Overall Study|Adverse Event|3|||
146892017|NCT00091832|529771052|FG005|Overall Study|Adverse Event|0|||
146892018|NCT00091832|529771047|FG000|Overall Study|Withdrawal by Subject|4|||
146892019|NCT00091832|529771048|FG001|Overall Study|Withdrawal by Subject|5|||
146892020|NCT00091832|529771049|FG002|Overall Study|Withdrawal by Subject|0|||
146892021|NCT00091832|529771050|FG003|Overall Study|Withdrawal by Subject|1|||
146892022|NCT00091832|529771051|FG004|Overall Study|Withdrawal by Subject|3|||
146892023|NCT00091832|529771052|FG005|Overall Study|Withdrawal by Subject|1|||
146892024|NCT00091832|529771047|FG000|Overall Study|Death|6|||
146892025|NCT00091832|529771048|FG001|Overall Study|Death|4|||
146892026|NCT00091832|529771049|FG002|Overall Study|Death|5|||
146892027|NCT00091832|529771050|FG003|Overall Study|Death|8|||
146892028|NCT00091832|529771051|FG004|Overall Study|Death|5|||
146892029|NCT00091832|529771052|FG005|Overall Study|Death|6|||
146892030|NCT00091832|529771047|FG000|Overall Study|Disease Progression|2|||
146892031|NCT00091832|529771048|FG001|Overall Study|Disease Progression|0|||
146892032|NCT00091832|529771049|FG002|Overall Study|Disease Progression|0|||
146892033|NCT00091832|529771050|FG003|Overall Study|Disease Progression|1|||
146892034|NCT00091832|529771051|FG004|Overall Study|Disease Progression|1|||
146892035|NCT00091832|529771052|FG005|Overall Study|Disease Progression|2|||
146892036|NCT00091832|529771047|FG000|Overall Study|Ineligibility Determined|0|||
146892037|NCT00091832|529771048|FG001|Overall Study|Ineligibility Determined|0|||
146637150|NCT03682770|528847231|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
146637151|NCT03682770|528847232|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
146637152|NCT03682770|528847233|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
146637153|NCT03682770|528847227|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
146637154|NCT03682770|528847228|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
146637155|NCT03682770|528847229|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
146637156|NCT03682770|528847230|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
146637157|NCT03682770|528847231|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
146637158|NCT03682770|528847232|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
146637159|NCT03682770|528847233|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
146892038|NCT00091832|529771049|FG002|Overall Study|Ineligibility Determined|1|||
146892039|NCT00091832|529771050|FG003|Overall Study|Ineligibility Determined|0|||
146892040|NCT00091832|529771051|FG004|Overall Study|Ineligibility Determined|1|||
146892041|NCT00091832|529771052|FG005|Overall Study|Ineligibility Determined|0|||
146892042|NCT00091832|529771047|FG000|Overall Study|Lost to Follow-up|1|||
146892043|NCT00091832|529771048|FG001|Overall Study|Lost to Follow-up|0|||
146892044|NCT00091832|529771049|FG002|Overall Study|Lost to Follow-up|3|||
146892045|NCT00091832|529771050|FG003|Overall Study|Lost to Follow-up|3|||
146892046|NCT00091832|529771051|FG004|Overall Study|Lost to Follow-up|2|||
146892047|NCT00091832|529771052|FG005|Overall Study|Lost to Follow-up|1|||
146892048|NCT00091832|529771047|FG000|Overall Study|Noncompliance|0|||
146892049|NCT00091832|529771048|FG001|Overall Study|Noncompliance|1|||
146892050|NCT00091832|529771049|FG002|Overall Study|Noncompliance|0|||
146557480|NCT03760068|528551109|FG001|Overall Study|Lost to Follow-up|9|||
146557481|NCT03760068|528551108|FG000|Overall Study|Subject Moved Out of State|1|||
146557482|NCT03760068|528551109|FG001|Overall Study|Subject Moved Out of State|0|||
146557483|NCT01335685|528551110|FG000|Overall Study|Study Terminated by Sponsor|2|||
146557484|NCT01335685|528551111|FG001|Overall Study|Study Terminated by Sponsor|1|||
146557485|NCT01335685|528551112|FG002|Overall Study|Study Terminated by Sponsor|1|||
146557486|NCT01335685|528551113|FG003|Overall Study|Study Terminated by Sponsor|10|||
146557487|NCT01335685|528551114|FG004|Overall Study|Study Terminated by Sponsor|0|||
146557488|NCT01335685|528551115|FG005|Overall Study|Study Terminated by Sponsor|4|||
146557489|NCT01335685|528551116|FG006|Overall Study|Study Terminated by Sponsor|2|||
146557490|NCT01335685|528551117|FG007|Overall Study|Study Terminated by Sponsor|3|||
146557491|NCT01335685|528551110|FG000|Overall Study|Withdrawal by Subject|1|||
146557492|NCT01335685|528551111|FG001|Overall Study|Withdrawal by Subject|0|||
146557493|NCT01335685|528551112|FG002|Overall Study|Withdrawal by Subject|0|||
146892051|NCT00091832|529771050|FG003|Overall Study|Noncompliance|0|||
146892052|NCT00091832|529771051|FG004|Overall Study|Noncompliance|0|||
146766316|NCT01235949|529312230|FG008|Primary Phase|Withdrawal by Subject|0|||
146766317|NCT01235949|529312231|FG009|Primary Phase|Withdrawal by Subject|0|||
146766318|NCT01235949|529312232|FG010|Primary Phase|Withdrawal by Subject|0|||
146766319|NCT01235949|529312233|FG011|Primary Phase|Withdrawal by Subject|0|||
146766320|NCT01235949|529312234|FG012|Primary Phase|Withdrawal by Subject|0|||
146766321|NCT01235949|529312235|FG013|Primary Phase|Withdrawal by Subject|0|||
146766322|NCT01235949|529312236|FG014|Primary Phase|Withdrawal by Subject|0|||
146766323|NCT01235949|529312237|FG015|Primary Phase|Withdrawal by Subject|0|||
146766324|NCT01235949|529312238|FG016|Primary Phase|Withdrawal by Subject|0|||
146766325|NCT01235949|529312239|FG017|Primary Phase|Withdrawal by Subject|0|||
146766326|NCT01235949|529312222|FG000|Primary Phase|Lost to Follow-up|0|||
146766327|NCT01235949|529312223|FG001|Primary Phase|Lost to Follow-up|0|||
146766328|NCT01235949|529312224|FG002|Primary Phase|Lost to Follow-up|1|||
146766329|NCT01235949|529312225|FG003|Primary Phase|Lost to Follow-up|1|||
146766330|NCT01235949|529312226|FG004|Primary Phase|Lost to Follow-up|0|||
146766331|NCT01235949|529312227|FG005|Primary Phase|Lost to Follow-up|2|||
146766332|NCT01235949|529312228|FG006|Primary Phase|Lost to Follow-up|0|||
146766333|NCT01235949|529312229|FG007|Primary Phase|Lost to Follow-up|0|||
146766334|NCT01235949|529312230|FG008|Primary Phase|Lost to Follow-up|0|||
146766335|NCT01235949|529312231|FG009|Primary Phase|Lost to Follow-up|0|||
146892053|NCT00091832|529771052|FG005|Overall Study|Noncompliance|0|||
146892054|NCT00091832|529771047|FG000|Overall Study|Other|0|||
146892055|NCT00091832|529771048|FG001|Overall Study|Other|1|||
146892056|NCT00091832|529771049|FG002|Overall Study|Other|2|||
146892057|NCT00091832|529771050|FG003|Overall Study|Other|0|||
146892058|NCT00091832|529771051|FG004|Overall Study|Other|0|||
146637160|NCT03682770|528847227|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
146766336|NCT01235949|529312232|FG010|Primary Phase|Lost to Follow-up|0|||
146766337|NCT01235949|529312233|FG011|Primary Phase|Lost to Follow-up|0|||
146766338|NCT01235949|529312234|FG012|Primary Phase|Lost to Follow-up|0|||
146766339|NCT01235949|529312235|FG013|Primary Phase|Lost to Follow-up|0|||
146766340|NCT01235949|529312236|FG014|Primary Phase|Lost to Follow-up|0|||
146766341|NCT01235949|529312237|FG015|Primary Phase|Lost to Follow-up|0|||
146892059|NCT00091832|529771052|FG005|Overall Study|Other|0|||
146557494|NCT01335685|528551113|FG003|Overall Study|Withdrawal by Subject|1|||
146892060|NCT00091832|529771047|FG000|Overall Study|Protocol Violation|0|||
146892061|NCT00091832|529771048|FG001|Overall Study|Protocol Violation|0|||
146892062|NCT00091832|529771049|FG002|Overall Study|Protocol Violation|1|||
146892063|NCT00091832|529771050|FG003|Overall Study|Protocol Violation|0|||
146892064|NCT00091832|529771051|FG004|Overall Study|Protocol Violation|0|||
146892065|NCT00091832|529771052|FG005|Overall Study|Protocol Violation|1|||
146557495|NCT01335685|528551114|FG004|Overall Study|Withdrawal by Subject|0|||
146557496|NCT01335685|528551115|FG005|Overall Study|Withdrawal by Subject|0|||
146557497|NCT01335685|528551116|FG006|Overall Study|Withdrawal by Subject|0|||
146892066|NCT01446419|529771056|FG000|Overall Study|Death|1|||
146892067|NCT01446419|529771057|FG001|Overall Study|Death|0|||
146892068|NCT01446419|529771056|FG000|Overall Study|Withdrawal by Subject|1|||
146892069|NCT01446419|529771057|FG001|Overall Study|Withdrawal by Subject|1|||
146892070|NCT01446419|529771056|FG000|Overall Study|Terminated per protocol|3|||
146892071|NCT01446419|529771057|FG001|Overall Study|Terminated per protocol|0|||
146892072|NCT02445586|529771062|FG000|Overall Study|Death|14|||
146892073|NCT02445586|529771062|FG000|Overall Study|Withdrawal by Subject|13|||
146892074|NCT02445586|529771062|FG000|Overall Study|Disease Progression|10|||
146892075|NCT02445586|529771062|FG000|Overall Study|Protocol Violation|1|||
146892076|NCT02445586|529771062|FG000|Overall Study|Medical Condition|1|||
146892077|NCT01990261|529771067|FG000|Overall Study|Death Before Treatment Start|2|||
146892078|NCT01990261|529771067|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
146892079|NCT01990261|529771067|FG000|Overall Study|Death From other Causes|1|||
146892080|NCT01990261|529771067|FG000|Overall Study|Disease Progression (PD)|8|||
146892081|NCT01990261|529771067|FG000|Overall Study|PD Before Treatment Start|1|||
146892082|NCT01990261|529771067|FG000|Overall Study|Dossier not Approved|1|||
146892083|NCT01990261|529771067|FG000|Overall Study|Lost to Follow-up|2|||
146892084|NCT01609842|529771068|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
146892085|NCT01609842|529771069|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
146892086|NCT02474329|529771071|FG000|Overall Study|Withdraw or did not contribute data.|13|||
146892087|NCT01583374|529771072|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
146892088|NCT01583374|529771073|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
146892089|NCT01583374|529771074|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
146892090|NCT01583374|529771075|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146892091|NCT01583374|529771076|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146892092|NCT01583374|529771077|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146892093|NCT01583374|529771078|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146892094|NCT01583374|529771079|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146892095|NCT01583374|529771080|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146892096|NCT01583374|529771072|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
146892097|NCT01583374|529771073|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
146892098|NCT01583374|529771074|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
146892099|NCT01583374|529771075|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146892100|NCT01583374|529771076|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146892101|NCT01583374|529771077|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146637161|NCT03682770|528847228|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
146637162|NCT03682770|528847229|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
146637163|NCT03682770|528847230|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
146892102|NCT01583374|529771078|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146557498|NCT01335685|528551117|FG007|Overall Study|Withdrawal by Subject|0|||
146557499|NCT01335685|528551110|FG000|Overall Study|Reason not Specified|0|||
146557500|NCT01335685|528551111|FG001|Overall Study|Reason not Specified|0|||
146557501|NCT01335685|528551112|FG002|Overall Study|Reason not Specified|1|||
146557502|NCT01335685|528551113|FG003|Overall Study|Reason not Specified|0|||
146557503|NCT01335685|528551114|FG004|Overall Study|Reason not Specified|0|||
146557504|NCT01335685|528551115|FG005|Overall Study|Reason not Specified|1|||
146557505|NCT01335685|528551116|FG006|Overall Study|Reason not Specified|0|||
146557506|NCT01335685|528551117|FG007|Overall Study|Reason not Specified|0|||
146557507|NCT00855166|528551118|FG000|Overall Study|Adverse Event|0|||
146557508|NCT00855166|528551119|FG001|Overall Study|Adverse Event|2|||
146557509|NCT00855166|528551118|FG000|Overall Study|Death|0|||
146557510|NCT00855166|528551119|FG001|Overall Study|Death|1|||
146557511|NCT00855166|528551118|FG000|Overall Study|Withdrawal by Subject|1|||
146557512|NCT00855166|528551119|FG001|Overall Study|Withdrawal by Subject|4|||
146557513|NCT00855166|528551118|FG000|Overall Study|Poor/non-compliance|2|||
146557514|NCT00855166|528551119|FG001|Overall Study|Poor/non-compliance|0|||
146557515|NCT00855166|528551118|FG000|Overall Study|Administrative reasons by sponsor|1|||
146557516|NCT00855166|528551119|FG001|Overall Study|Administrative reasons by sponsor|0|||
146637164|NCT03682770|528847231|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
146637165|NCT03682770|528847232|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
146637166|NCT03682770|528847233|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
146637167|NCT03682770|528847227|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
146637168|NCT03682770|528847228|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
146637169|NCT03682770|528847229|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
146637170|NCT03682770|528847230|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
146637171|NCT03682770|528847231|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
146637172|NCT03682770|528847232|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
146637173|NCT03682770|528847233|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
146637174|NCT03682770|528847227|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
146637175|NCT03682770|528847228|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
146637176|NCT03682770|528847229|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
146637177|NCT03682770|528847230|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
146637178|NCT03682770|528847231|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
146637179|NCT03682770|528847232|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
146637180|NCT03682770|528847233|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
146637181|NCT03682770|528847227|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
146637182|NCT03682770|528847228|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
146766342|NCT01235949|529312238|FG016|Primary Phase|Lost to Follow-up|0|||
146766343|NCT01235949|529312239|FG017|Primary Phase|Lost to Follow-up|0|||
146892103|NCT01583374|529771079|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146892104|NCT01583374|529771080|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146967638|NCT03387423|530043800|FG002|Overall Study|Revocation Consent|3|||
146557517|NCT00855166|528551118|FG000|Overall Study|Subject no longer meets study criteria|1|||
146557518|NCT00855166|528551119|FG001|Overall Study|Subject no longer meets study criteria|1|||
146557519|NCT00803049|528551120|FG000|Overall Study|Adverse Event|21|||
146557520|NCT00803049|528551121|FG001|Overall Study|Adverse Event|33|||
146557521|NCT00803049|528551122|FG002|Overall Study|Adverse Event|13|||
146557522|NCT00803049|528551123|FG003|Overall Study|Adverse Event|27|||
146557523|NCT00803049|528551120|FG000|Overall Study|Lack of Efficacy|10|||
146557524|NCT00803049|528551121|FG001|Overall Study|Lack of Efficacy|19|||
146557525|NCT00803049|528551122|FG002|Overall Study|Lack of Efficacy|6|||
146557526|NCT00803049|528551123|FG003|Overall Study|Lack of Efficacy|13|||
146557527|NCT00803049|528551120|FG000|Overall Study|Lost to Follow-up|0|||
146557528|NCT00803049|528551121|FG001|Overall Study|Lost to Follow-up|2|||
146557529|NCT00803049|528551122|FG002|Overall Study|Lost to Follow-up|0|||
146557530|NCT00803049|528551123|FG003|Overall Study|Lost to Follow-up|3|||
146557531|NCT00803049|528551120|FG000|Overall Study|Death|2|||
146557532|NCT00803049|528551121|FG001|Overall Study|Death|1|||
146557533|NCT00803049|528551122|FG002|Overall Study|Death|0|||
146557534|NCT00803049|528551123|FG003|Overall Study|Death|2|||
146557535|NCT00803049|528551120|FG000|Overall Study|Progressive Disease|6|||
146557536|NCT00803049|528551121|FG001|Overall Study|Progressive Disease|10|||
146557537|NCT00803049|528551122|FG002|Overall Study|Progressive Disease|6|||
146557538|NCT00803049|528551123|FG003|Overall Study|Progressive Disease|6|||
146557539|NCT00803049|528551120|FG000|Overall Study|Withdrawal by Subject|19|||
146557540|NCT00803049|528551121|FG001|Overall Study|Withdrawal by Subject|43|||
146557541|NCT00803049|528551122|FG002|Overall Study|Withdrawal by Subject|16|||
146892105|NCT01583374|529771072|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
146892106|NCT01583374|529771073|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
146892107|NCT01583374|529771074|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146892108|NCT01583374|529771075|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146892109|NCT01583374|529771076|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146892110|NCT01583374|529771077|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146892111|NCT01583374|529771078|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146892112|NCT01583374|529771079|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146892113|NCT01583374|529771080|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146892114|NCT01583374|529771072|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
146892115|NCT01583374|529771073|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
146892116|NCT01583374|529771074|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
146892117|NCT01583374|529771075|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146892118|NCT01583374|529771076|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146892119|NCT01583374|529771077|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146892120|NCT01583374|529771078|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146892121|NCT01583374|529771079|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146892122|NCT01583374|529771080|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146892123|NCT01583374|529771072|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
146892124|NCT01583374|529771073|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
146892125|NCT01583374|529771074|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
146892126|NCT01583374|529771075|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
146892127|NCT01583374|529771076|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
146892128|NCT01583374|529771077|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
146892129|NCT01583374|529771078|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
146892130|NCT01583374|529771079|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
146892131|NCT01583374|529771080|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
146892132|NCT01583374|529771072|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146892133|NCT01583374|529771073|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146892134|NCT01583374|529771074|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
146892135|NCT01583374|529771075|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146637183|NCT03682770|528847229|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
146892136|NCT01583374|529771076|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146892137|NCT01583374|529771077|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146892138|NCT01583374|529771078|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146892139|NCT01583374|529771079|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146892140|NCT01583374|529771080|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146892141|NCT01583374|529771072|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
146892142|NCT01583374|529771073|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
146892143|NCT01583374|529771074|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
146892144|NCT01583374|529771075|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
146892145|NCT01583374|529771076|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
146892146|NCT01583374|529771077|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
146892147|NCT01583374|529771078|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
146892148|NCT01583374|529771079|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
146892149|NCT01583374|529771080|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
146892150|NCT01583374|529771072|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146892151|NCT01583374|529771073|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146892152|NCT01583374|529771074|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146892153|NCT01583374|529771075|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146892154|NCT01583374|529771076|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146892155|NCT01583374|529771077|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146892156|NCT01583374|529771078|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146892157|NCT01583374|529771079|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
146557542|NCT00803049|528551123|FG003|Overall Study|Withdrawal by Subject|44|||
146557543|NCT00803049|528551120|FG000|Overall Study|Protocol Violation|0|||
146967639|NCT03387423|530043801|FG003|Overall Study|Revocation Consent|5|||
146967640|NCT03862807|530043802|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
146967641|NCT00798707|530043803|FG000|Overall Study|Adverse Event|6|||
146967642|NCT00798707|530043804|FG001|Overall Study|Adverse Event|8|||
146967643|NCT00798707|530043805|FG002|Overall Study|Adverse Event|8|||
146967644|NCT00798707|530043803|FG000|Overall Study|Failed to return|2|||
146967645|NCT00798707|530043804|FG001|Overall Study|Failed to return|2|||
146967646|NCT00798707|530043805|FG002|Overall Study|Failed to return|0|||
146967647|NCT00798707|530043803|FG000|Overall Study|Investigator|0|||
146967648|NCT00798707|530043804|FG001|Overall Study|Investigator|1|||
146967649|NCT00798707|530043805|FG002|Overall Study|Investigator|2|||
146967650|NCT00798707|530043803|FG000|Overall Study|Lack of Efficacy|2|||
146967651|NCT00798707|530043804|FG001|Overall Study|Lack of Efficacy|2|||
146967652|NCT00798707|530043805|FG002|Overall Study|Lack of Efficacy|1|||
146967653|NCT00798707|530043803|FG000|Overall Study|Lost to Follow-up|5|||
146967654|NCT00798707|530043804|FG001|Overall Study|Lost to Follow-up|6|||
146967655|NCT00798707|530043805|FG002|Overall Study|Lost to Follow-up|6|||
146967656|NCT00798707|530043803|FG000|Overall Study|Other|0|||
146967657|NCT00798707|530043804|FG001|Overall Study|Other|1|||
146967658|NCT00798707|530043805|FG002|Overall Study|Other|0|||
146967659|NCT00798707|530043803|FG000|Overall Study|Protocol Violation|4|||
146967660|NCT00798707|530043804|FG001|Overall Study|Protocol Violation|0|||
146967661|NCT00798707|530043805|FG002|Overall Study|Protocol Violation|2|||
146967662|NCT00798707|530043803|FG000|Overall Study|Withdrawal by Subject|3|||
146967663|NCT00798707|530043804|FG001|Overall Study|Withdrawal by Subject|8|||
146967664|NCT00798707|530043805|FG002|Overall Study|Withdrawal by Subject|2|||
146967665|NCT00798707|530043803|FG000|Overall Study|Randomized not treated|4|||
146967666|NCT00798707|530043804|FG001|Overall Study|Randomized not treated|5|||
146967667|NCT00798707|530043805|FG002|Overall Study|Randomized not treated|1|||
146967668|NCT01473589|530043808|FG000|Overall Study|Adverse Event|1|||
146967669|NCT01473589|530043809|FG001|Overall Study|Adverse Event|1|||
146967670|NCT01473589|530043808|FG000|Overall Study|Death|2|||
146967671|NCT01473589|530043809|FG001|Overall Study|Death|0|||
146967672|NCT01473589|530043808|FG000|Overall Study|Lost to Follow-up|2|||
146892158|NCT01583374|529771080|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146892159|NCT01583374|529771072|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
146892160|NCT01583374|529771073|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
146892161|NCT01583374|529771074|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
146892162|NCT01583374|529771075|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
146892163|NCT01583374|529771076|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
146892164|NCT01583374|529771077|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
146892165|NCT01583374|529771078|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
146892166|NCT01583374|529771079|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
146892167|NCT01583374|529771080|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
146892168|NCT01583374|529771072|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
146892169|NCT01583374|529771073|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
146892170|NCT01583374|529771074|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
146892171|NCT01583374|529771075|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
146967673|NCT01473589|530043809|FG001|Overall Study|Lost to Follow-up|2|||
146967674|NCT01473589|530043808|FG000|Overall Study|Protocol Violation|1|||
146967675|NCT01473589|530043809|FG001|Overall Study|Protocol Violation|0|||
146967676|NCT01473589|530043808|FG000|Overall Study|Withdrawal by Subject|5|||
146967677|NCT01473589|530043809|FG001|Overall Study|Withdrawal by Subject|11|||
146967678|NCT01473589|530043808|FG000|Overall Study|Physician Decision|0|||
146967679|NCT01473589|530043809|FG001|Overall Study|Physician Decision|1|||
146967680|NCT01473589|530043808|FG000|Overall Study|Entry criteria not met|0|||
146967681|NCT01473589|530043809|FG001|Overall Study|Entry criteria not met|1|||
146967682|NCT00929201|530043810|FG000|Period 1|Withdrawal by Subject|0|||
146967683|NCT00929201|530043811|FG001|Period 1|Withdrawal by Subject|1|||
146967684|NCT01299272|530043815|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
146967685|NCT01299272|530043816|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
146892172|NCT01583374|529771076|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
146967686|NCT01299272|530043817|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
146967687|NCT01299272|530043818|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
146967688|NCT01299272|530043815|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
146967689|NCT01299272|530043816|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
146892173|NCT01583374|529771077|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
146892174|NCT01583374|529771078|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
146892175|NCT01583374|529771079|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
146892176|NCT01583374|529771080|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
146892177|NCT01583374|529771072|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
146892178|NCT01583374|529771073|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
146892179|NCT01583374|529771074|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
146892180|NCT01583374|529771075|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
146892181|NCT01583374|529771076|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
146892182|NCT01583374|529771077|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
146892183|NCT01583374|529771078|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
146892184|NCT01583374|529771079|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
146892185|NCT01583374|529771080|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
146892186|NCT01583374|529771072|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
146892187|NCT01583374|529771073|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
146892188|NCT01583374|529771074|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
146892189|NCT01583374|529771075|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
146892190|NCT01583374|529771076|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
146892191|NCT01583374|529771077|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
146892192|NCT01583374|529771078|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
146892193|NCT01583374|529771079|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
146892194|NCT01583374|529771080|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
146892195|NCT01583374|529771072|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
146892196|NCT01583374|529771073|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
146892197|NCT01583374|529771074|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
146892198|NCT01583374|529771075|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
146892199|NCT01583374|529771076|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
146892200|NCT01583374|529771077|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
146892201|NCT01583374|529771078|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
146892202|NCT01583374|529771079|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
146892203|NCT01583374|529771080|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
146892204|NCT01583374|529771072|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
146892205|NCT01583374|529771073|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
146892206|NCT01583374|529771074|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
146892207|NCT01583374|529771075|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
146892208|NCT01583374|529771076|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
146892209|NCT01583374|529771077|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
146892210|NCT01583374|529771078|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
146892211|NCT01583374|529771079|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
146892212|NCT01583374|529771080|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
146892213|NCT01583374|529771072|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
146892214|NCT01583374|529771073|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
146892215|NCT01583374|529771074|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
146892216|NCT01583374|529771075|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
146892217|NCT01583374|529771076|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
146892218|NCT01583374|529771077|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
146892219|NCT01583374|529771078|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
146892220|NCT01583374|529771079|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
146892221|NCT01583374|529771080|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
146892222|NCT01583374|529771072|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
146892223|NCT01583374|529771073|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
146892224|NCT01583374|529771074|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
146892225|NCT01583374|529771075|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
146892226|NCT01583374|529771076|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
146766344|NCT01235949|529312222|FG000|Booster Phase|Migrated/moved from study area|0|||
146766345|NCT01235949|529312223|FG001|Booster Phase|Migrated/moved from study area|0|||
146892227|NCT01583374|529771077|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
146766346|NCT01235949|529312224|FG002|Booster Phase|Migrated/moved from study area|0|||
146892228|NCT01583374|529771078|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
146892229|NCT01583374|529771079|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
146892230|NCT01583374|529771080|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
146892231|NCT01583374|529771072|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
146892232|NCT01583374|529771073|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
146892233|NCT01583374|529771074|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
146892234|NCT01583374|529771075|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
146557544|NCT00803049|528551121|FG001|Overall Study|Protocol Violation|1|||
146557545|NCT00803049|528551122|FG002|Overall Study|Protocol Violation|1|||
146557546|NCT00803049|528551123|FG003|Overall Study|Protocol Violation|0|||
146967690|NCT01299272|530043817|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
146967691|NCT01299272|530043818|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
146967692|NCT01299272|530043815|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
146967693|NCT01299272|530043816|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
146967694|NCT01299272|530043817|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
146967695|NCT01299272|530043818|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
146967696|NCT01299272|530043815|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
146967697|NCT01299272|530043816|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
146967698|NCT01299272|530043817|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
146967699|NCT01299272|530043818|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
146967700|NCT01299272|530043815|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
146967701|NCT01299272|530043816|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
146967702|NCT01299272|530043817|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
146967703|NCT01299272|530043818|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
146967704|NCT01299272|530043815|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
146967705|NCT01299272|530043816|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
146967706|NCT01299272|530043817|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
146967707|NCT01299272|530043818|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
146967708|NCT01299272|530043815|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
146967709|NCT01299272|530043816|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
146967710|NCT01299272|530043817|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
146967711|NCT01299272|530043818|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
146637184|NCT03682770|528847230|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
146892235|NCT01583374|529771076|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
146892236|NCT01583374|529771077|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
146892237|NCT01583374|529771078|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
146892238|NCT01583374|529771079|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
146892239|NCT01583374|529771080|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
146892240|NCT01583374|529771072|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
146892241|NCT01583374|529771073|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
146892242|NCT01583374|529771074|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
146892243|NCT01583374|529771075|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
146892244|NCT01583374|529771076|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
146892245|NCT01583374|529771077|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
146892246|NCT01583374|529771078|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
146892247|NCT01583374|529771079|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
146892248|NCT01583374|529771080|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
146892249|NCT01583374|529771072|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
146892250|NCT01583374|529771073|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
146892251|NCT01583374|529771074|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
146892252|NCT01583374|529771075|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
146892253|NCT01583374|529771076|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
146892254|NCT01583374|529771077|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
146892255|NCT01583374|529771078|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
146892256|NCT01583374|529771079|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
146892257|NCT01583374|529771080|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
146892258|NCT02447848|529771081|FG000|Overall Study|Patient discharged|3|||
146892259|NCT02447848|529771081|FG000|Overall Study|Lack of Efficacy|4|||
146557547|NCT00803049|528551120|FG000|Overall Study|Randomized and Not Treated|0|||
146892260|NCT02447848|529771081|FG000|Overall Study|Withdrawal by Subject|4|||
146892261|NCT02307370|529771082|FG000|Overall Study|Death|5|||
146892262|NCT02307370|529771082|FG000|Overall Study|Lost to Follow-up|1|||
146892263|NCT02307370|529771082|FG000|Overall Study|Withdrawal by Subject|1|||
146892264|NCT02307370|529771082|FG000|Overall Study|Declined Addendum ICF|6|||
146892265|NCT02307370|529771082|FG000|Overall Study|No response during telephone contact|5|||
146892266|NCT02307370|529771082|FG000|Overall Study|Protocol Violation|1|||
146892267|NCT01506882|529771083|FG000|Overall Study|Lack of Efficacy|4|||
146892268|NCT01506882|529771084|FG001|Overall Study|Lack of Efficacy|3|||
146892269|NCT01506882|529771083|FG000|Overall Study|Lost to Follow-up|1|||
146892270|NCT01506882|529771084|FG001|Overall Study|Lost to Follow-up|0|||
146892271|NCT01506882|529771083|FG000|Overall Study|Withdrawal by Subject|9|||
146892272|NCT01506882|529771084|FG001|Overall Study|Withdrawal by Subject|3|||
146892273|NCT01506882|529771083|FG000|Overall Study|SAE, non-fatal|2|||
146892274|NCT01506882|529771084|FG001|Overall Study|SAE, non-fatal|0|||
146892275|NCT01506882|529771083|FG000|Overall Study|AE, non-serious non-fatal|3|||
146892276|NCT01506882|529771084|FG001|Overall Study|AE, non-serious non-fatal|1|||
146892277|NCT01506882|529771083|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
146892278|NCT01506882|529771084|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
146892279|NCT01506882|529771083|FG000|Overall Study|Other Reason|2|||
146892280|NCT01506882|529771084|FG001|Overall Study|Other Reason|0|||
146892281|NCT00793793|529773354|FG000|Overall Study|Adverse Event|0|||
146892282|NCT00793793|529773355|FG001|Overall Study|Adverse Event|0|||
146892283|NCT00793793|529773356|FG002|Overall Study|Adverse Event|1|||
146892284|NCT00793793|529773357|FG003|Overall Study|Adverse Event|1|||
146892285|NCT00793793|529773358|FG004|Overall Study|Adverse Event|0|||
146892286|NCT00793793|529773359|FG005|Overall Study|Adverse Event|1|||
146557548|NCT00803049|528551121|FG001|Overall Study|Randomized and Not Treated|0|||
146557549|NCT00803049|528551122|FG002|Overall Study|Randomized and Not Treated|0|||
146557550|NCT00803049|528551123|FG003|Overall Study|Randomized and Not Treated|2|||
146557551|NCT00803049|528551120|FG000|Overall Study|Other than Specified Above|3|||
146557552|NCT00803049|528551121|FG001|Overall Study|Other than Specified Above|9|||
146557553|NCT00803049|528551122|FG002|Overall Study|Other than Specified Above|2|||
146557554|NCT00803049|528551123|FG003|Overall Study|Other than Specified Above|5|||
146557555|NCT01421459|528551124|FG000|Overall Study|Adverse Event|6|||
146557556|NCT01421459|528551125|FG001|Overall Study|Adverse Event|10|||
146557557|NCT01421459|528551124|FG000|Overall Study|Death|1|||
146637185|NCT03682770|528847231|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
146637186|NCT03682770|528847232|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
146892287|NCT00793793|529773360|FG006|Overall Study|Adverse Event|2|||
146892288|NCT00793793|529773361|FG007|Overall Study|Adverse Event|0|||
146892289|NCT00793793|529773362|FG008|Overall Study|Adverse Event|0|||
146892290|NCT00793793|529773363|FG009|Overall Study|Adverse Event|0|||
146892291|NCT00793793|529773364|FG010|Overall Study|Adverse Event|0|||
146892292|NCT00793793|529773365|FG011|Overall Study|Adverse Event|2|||
146892293|NCT00793793|529773354|FG000|Overall Study|Protocol Violation|0|||
146892294|NCT00793793|529773355|FG001|Overall Study|Protocol Violation|0|||
146967712|NCT01299272|530043815|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
146557558|NCT01421459|528551125|FG001|Overall Study|Death|1|||
146557559|NCT01421459|528551124|FG000|Overall Study|Lack of Efficacy|1|||
146557560|NCT01421459|528551125|FG001|Overall Study|Lack of Efficacy|2|||
146892295|NCT00793793|529773356|FG002|Overall Study|Protocol Violation|0|||
146892296|NCT00793793|529773357|FG003|Overall Study|Protocol Violation|1|||
146892297|NCT00793793|529773358|FG004|Overall Study|Protocol Violation|0|||
146892298|NCT00793793|529773359|FG005|Overall Study|Protocol Violation|0|||
146967713|NCT01299272|530043816|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
146892299|NCT00793793|529773360|FG006|Overall Study|Protocol Violation|0|||
146967714|NCT01299272|530043817|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
146557561|NCT01421459|528551124|FG000|Overall Study|Lost to Follow-up|8|||
146892300|NCT00793793|529773361|FG007|Overall Study|Protocol Violation|0|||
146892301|NCT00793793|529773362|FG008|Overall Study|Protocol Violation|0|||
146892302|NCT00793793|529773363|FG009|Overall Study|Protocol Violation|0|||
146892303|NCT00793793|529773364|FG010|Overall Study|Protocol Violation|0|||
146892304|NCT00793793|529773365|FG011|Overall Study|Protocol Violation|0|||
146892305|NCT00793793|529773354|FG000|Overall Study|Lost to Follow-up|0|||
146892306|NCT00793793|529773355|FG001|Overall Study|Lost to Follow-up|0|||
146892307|NCT00793793|529773356|FG002|Overall Study|Lost to Follow-up|1|||
146892308|NCT00793793|529773357|FG003|Overall Study|Lost to Follow-up|0|||
146892309|NCT00793793|529773358|FG004|Overall Study|Lost to Follow-up|0|||
146892310|NCT00793793|529773359|FG005|Overall Study|Lost to Follow-up|0|||
146892311|NCT00793793|529773360|FG006|Overall Study|Lost to Follow-up|0|||
146892312|NCT00793793|529773361|FG007|Overall Study|Lost to Follow-up|0|||
146892313|NCT00793793|529773362|FG008|Overall Study|Lost to Follow-up|1|||
146892314|NCT00793793|529773363|FG009|Overall Study|Lost to Follow-up|3|||
146892315|NCT00793793|529773364|FG010|Overall Study|Lost to Follow-up|1|||
146892316|NCT00793793|529773365|FG011|Overall Study|Lost to Follow-up|0|||
146892317|NCT00793793|529773354|FG000|Overall Study|Withdrawal by Subject|0|||
146892318|NCT00793793|529773355|FG001|Overall Study|Withdrawal by Subject|0|||
146892319|NCT00793793|529773356|FG002|Overall Study|Withdrawal by Subject|0|||
146892320|NCT00793793|529773357|FG003|Overall Study|Withdrawal by Subject|0|||
146892321|NCT00793793|529773358|FG004|Overall Study|Withdrawal by Subject|1|||
146892322|NCT00793793|529773359|FG005|Overall Study|Withdrawal by Subject|0|||
146892323|NCT00793793|529773360|FG006|Overall Study|Withdrawal by Subject|0|||
146892324|NCT00793793|529773361|FG007|Overall Study|Withdrawal by Subject|0|||
146892325|NCT00793793|529773362|FG008|Overall Study|Withdrawal by Subject|1|||
146892326|NCT00793793|529773363|FG009|Overall Study|Withdrawal by Subject|0|||
146892327|NCT00793793|529773364|FG010|Overall Study|Withdrawal by Subject|0|||
146892328|NCT00793793|529773365|FG011|Overall Study|Withdrawal by Subject|0|||
146892329|NCT00793793|529773354|FG000|Overall Study|reason not specified|0|||
146892330|NCT00793793|529773355|FG001|Overall Study|reason not specified|1|||
146892331|NCT00793793|529773356|FG002|Overall Study|reason not specified|0|||
146892332|NCT00793793|529773357|FG003|Overall Study|reason not specified|1|||
146892333|NCT00793793|529773358|FG004|Overall Study|reason not specified|1|||
146892334|NCT00793793|529773359|FG005|Overall Study|reason not specified|1|||
146892335|NCT00793793|529773360|FG006|Overall Study|reason not specified|2|||
146892336|NCT00793793|529773361|FG007|Overall Study|reason not specified|0|||
146892337|NCT00793793|529773362|FG008|Overall Study|reason not specified|7|||
146892338|NCT00793793|529773363|FG009|Overall Study|reason not specified|6|||
146892339|NCT00793793|529773364|FG010|Overall Study|reason not specified|2|||
146892340|NCT00793793|529773365|FG011|Overall Study|reason not specified|4|||
146892341|NCT05195528|529773366|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
146892342|NCT05195528|529773367|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
146892343|NCT05195528|529773368|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
146892344|NCT05195528|529773369|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
146892345|NCT05195528|529773370|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
146892346|NCT05195528|529773366|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
146892347|NCT05195528|529773367|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
146892348|NCT05195528|529773368|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
146892349|NCT05195528|529773369|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
146967715|NCT01299272|530043818|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
146967716|NCT01299272|530043815|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
146967717|NCT01299272|530043816|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
146967718|NCT01299272|530043817|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
146892350|NCT05195528|529773370|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
146892351|NCT05195528|529773366|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
146892352|NCT05195528|529773367|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
146892353|NCT05195528|529773368|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
146892354|NCT05195528|529773369|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
146892355|NCT05195528|529773370|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
146892356|NCT05195528|529773366|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
146892357|NCT05195528|529773367|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
146892358|NCT05195528|529773368|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
146892359|NCT05195528|529773369|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
146892360|NCT05195528|529773370|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
146892361|NCT05195528|529773366|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
146892362|NCT05195528|529773367|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
146892363|NCT05195528|529773368|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
146892364|NCT05195528|529773369|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
146892365|NCT05195528|529773370|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
146892366|NCT05195528|529773366|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
146892367|NCT05195528|529773367|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
146892368|NCT05195528|529773368|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
146892369|NCT05195528|529773369|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
146892370|NCT05195528|529773370|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
146892371|NCT05195528|529773366|FG000|Placebo-controlled Treatment Period|Other|0|||
146557562|NCT01421459|528551125|FG001|Overall Study|Lost to Follow-up|9|||
146892372|NCT05195528|529773367|FG001|Placebo-controlled Treatment Period|Other|0|||
146892373|NCT05195528|529773368|FG002|Placebo-controlled Treatment Period|Other|1|||
146557563|NCT01421459|528551124|FG000|Overall Study|Physician Decision|9|||
146557564|NCT01421459|528551125|FG001|Overall Study|Physician Decision|9|||
146557565|NCT01421459|528551124|FG000|Overall Study|Protocol Violation|8|||
146557566|NCT01421459|528551125|FG001|Overall Study|Protocol Violation|5|||
146967719|NCT01299272|530043818|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
146967720|NCT01299272|530043815|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
146967721|NCT01299272|530043816|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
146967722|NCT01299272|530043817|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
146967723|NCT01299272|530043818|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
146967724|NCT01299272|530043815|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
146967725|NCT01299272|530043816|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
146967726|NCT01299272|530043817|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
146967727|NCT01299272|530043818|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
146967728|NCT01299272|530043815|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
146967729|NCT01299272|530043816|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
146557567|NCT01421459|528551124|FG000|Overall Study|Withdrawal by Subject|12|||
146892374|NCT05195528|529773369|FG003|Placebo-controlled Treatment Period|Other|0|||
146557568|NCT01421459|528551125|FG001|Overall Study|Withdrawal by Subject|16|||
146557569|NCT01422382|528551128|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
146557570|NCT04082364|528551133|FG000|Overall Study|Death|23|||
146892375|NCT05195528|529773370|FG004|Placebo-controlled Treatment Period|Other|0|||
146557571|NCT04082364|528551134|FG001|Overall Study|Death|1|||
146557572|NCT04082364|528551135|FG002|Overall Study|Death|1|||
146557573|NCT04082364|528551136|FG003|Overall Study|Death|2|||
146557574|NCT04082364|528551137|FG004|Overall Study|Death|1|||
146557575|NCT04082364|528551133|FG000|Overall Study|Lost to Follow-up|1|||
146557576|NCT04082364|528551134|FG001|Overall Study|Lost to Follow-up|0|||
146557577|NCT04082364|528551135|FG002|Overall Study|Lost to Follow-up|0|||
146557578|NCT04082364|528551136|FG003|Overall Study|Lost to Follow-up|0|||
146557579|NCT04082364|528551137|FG004|Overall Study|Lost to Follow-up|1|||
146557580|NCT04082364|528551133|FG000|Overall Study|Physician Decision|1|||
146557581|NCT04082364|528551134|FG001|Overall Study|Physician Decision|1|||
146557582|NCT04082364|528551135|FG002|Overall Study|Physician Decision|0|||
146557583|NCT04082364|528551136|FG003|Overall Study|Physician Decision|2|||
146557584|NCT04082364|528551137|FG004|Overall Study|Physician Decision|1|||
146557585|NCT04082364|528551133|FG000|Overall Study|Withdrawal by Subject|1|||
146557586|NCT04082364|528551134|FG001|Overall Study|Withdrawal by Subject|1|||
146557587|NCT04082364|528551135|FG002|Overall Study|Withdrawal by Subject|0|||
146557588|NCT04082364|528551136|FG003|Overall Study|Withdrawal by Subject|0|||
146557589|NCT04082364|528551137|FG004|Overall Study|Withdrawal by Subject|1|||
146557590|NCT04082364|528551133|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
146557591|NCT04082364|528551134|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
146557592|NCT04082364|528551135|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
146557593|NCT04082364|528551136|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
146637187|NCT03682770|528847233|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
146637188|NCT03682770|528847227|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
146637189|NCT03682770|528847228|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
146637190|NCT03682770|528847229|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
146557594|NCT04082364|528551137|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
146557595|NCT04082364|528551133|FG000|Overall Study|Disease progression|0|||
146557596|NCT04082364|528551134|FG001|Overall Study|Disease progression|0|||
146557597|NCT04082364|528551135|FG002|Overall Study|Disease progression|0|||
146892376|NCT05195528|529773366|FG000|Extension Period|PTE or AE or SAE|0|||
146557598|NCT04082364|528551136|FG003|Overall Study|Disease progression|1|||
146557599|NCT04082364|528551137|FG004|Overall Study|Disease progression|0|||
146892377|NCT05195528|529773367|FG001|Extension Period|PTE or AE or SAE|4|||
146892378|NCT05195528|529773368|FG002|Extension Period|PTE or AE or SAE|5|||
146892379|NCT05195528|529773369|FG003|Extension Period|PTE or AE or SAE|4|||
146892380|NCT05195528|529773370|FG004|Extension Period|PTE or AE or SAE|4|||
146892381|NCT05195528|529773366|FG000|Extension Period|Protocol Violation|0|||
146892382|NCT05195528|529773367|FG001|Extension Period|Protocol Violation|2|||
146892383|NCT05195528|529773368|FG002|Extension Period|Protocol Violation|1|||
146892384|NCT05195528|529773369|FG003|Extension Period|Protocol Violation|0|||
146892385|NCT05195528|529773370|FG004|Extension Period|Protocol Violation|1|||
146892386|NCT05195528|529773366|FG000|Extension Period|Lost to Follow-up|0|||
146892387|NCT05195528|529773367|FG001|Extension Period|Lost to Follow-up|6|||
146892388|NCT05195528|529773368|FG002|Extension Period|Lost to Follow-up|13|||
146892389|NCT05195528|529773369|FG003|Extension Period|Lost to Follow-up|3|||
146892390|NCT05195528|529773370|FG004|Extension Period|Lost to Follow-up|7|||
146892391|NCT05195528|529773366|FG000|Extension Period|Withdrawal by Subject|0|||
146892392|NCT05195528|529773367|FG001|Extension Period|Withdrawal by Subject|12|||
146892393|NCT05195528|529773368|FG002|Extension Period|Withdrawal by Subject|9|||
146892394|NCT05195528|529773369|FG003|Extension Period|Withdrawal by Subject|6|||
146892395|NCT05195528|529773370|FG004|Extension Period|Withdrawal by Subject|5|||
146892396|NCT05195528|529773366|FG000|Extension Period|Lack of Efficacy|0|||
146892397|NCT05195528|529773367|FG001|Extension Period|Lack of Efficacy|3|||
146892398|NCT05195528|529773368|FG002|Extension Period|Lack of Efficacy|0|||
146892399|NCT05195528|529773369|FG003|Extension Period|Lack of Efficacy|0|||
146892400|NCT05195528|529773370|FG004|Extension Period|Lack of Efficacy|2|||
146892401|NCT05195528|529773366|FG000|Extension Period|Not Treated|0|||
146892402|NCT05195528|529773367|FG001|Extension Period|Not Treated|0|||
146892403|NCT05195528|529773368|FG002|Extension Period|Not Treated|2|||
146892404|NCT05195528|529773369|FG003|Extension Period|Not Treated|3|||
146892405|NCT05195528|529773370|FG004|Extension Period|Not Treated|0|||
146892406|NCT05195528|529773366|FG000|Extension Period|Other|0|||
146892407|NCT05195528|529773367|FG001|Extension Period|Other|1|||
146892408|NCT05195528|529773368|FG002|Extension Period|Other|1|||
146892409|NCT05195528|529773369|FG003|Extension Period|Other|0|||
146892410|NCT05195528|529773370|FG004|Extension Period|Other|0|||
146892411|NCT01552902|529773371|FG000|Overall Study|Adverse Event|1|||
146892412|NCT01552902|529773372|FG001|Overall Study|Adverse Event|15|||
146892413|NCT01552902|529773373|FG002|Overall Study|Adverse Event|14|||
146892414|NCT01552902|529773371|FG000|Overall Study|Protocol Violation|3|||
146892415|NCT01552902|529773372|FG001|Overall Study|Protocol Violation|3|||
146892416|NCT01552902|529773373|FG002|Overall Study|Protocol Violation|3|||
146892417|NCT01552902|529773371|FG000|Overall Study|Lack of Efficacy|4|||
146892418|NCT01552902|529773372|FG001|Overall Study|Lack of Efficacy|3|||
146892419|NCT01552902|529773373|FG002|Overall Study|Lack of Efficacy|1|||
146892420|NCT01552902|529773371|FG000|Overall Study|Withdrawal by Subject|1|||
146892421|NCT01552902|529773372|FG001|Overall Study|Withdrawal by Subject|9|||
146892422|NCT01552902|529773373|FG002|Overall Study|Withdrawal by Subject|6|||
146892423|NCT01552902|529773371|FG000|Overall Study|Lost to Follow-up|1|||
146892424|NCT01552902|529773372|FG001|Overall Study|Lost to Follow-up|3|||
146967730|NCT01299272|530043817|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
146967731|NCT01299272|530043818|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
146967732|NCT01299272|530043815|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
146967733|NCT01299272|530043816|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
146967734|NCT01299272|530043817|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
146967735|NCT01299272|530043818|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
146967736|NCT01299272|530043815|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
146967737|NCT01299272|530043816|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
146967738|NCT01299272|530043817|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
146967739|NCT01299272|530043818|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
146967740|NCT01299272|530043815|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
146967741|NCT01299272|530043816|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
146967742|NCT01299272|530043817|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
146967743|NCT01299272|530043818|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
146967744|NCT01299272|530043815|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
146967745|NCT01299272|530043816|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
146967746|NCT01299272|530043817|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
146967747|NCT01299272|530043818|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
146967748|NCT01299272|530043815|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
146967749|NCT01299272|530043816|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
146967750|NCT01299272|530043817|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
146892425|NCT01552902|529773373|FG002|Overall Study|Lost to Follow-up|6|||
146892426|NCT01552902|529773371|FG000|Overall Study|Other|3|||
146892427|NCT01552902|529773372|FG001|Overall Study|Other|4|||
146892428|NCT01552902|529773373|FG002|Overall Study|Other|3|||
146892429|NCT02487108|529773374|FG000|Overall Study|Adverse Event|1|||
146892430|NCT02487108|529773375|FG001|Overall Study|Adverse Event|6|||
146892431|NCT02487108|529773376|FG002|Overall Study|Adverse Event|12|||
146892432|NCT02487108|529773377|FG003|Overall Study|Adverse Event|6|||
146892433|NCT02487108|529773374|FG000|Overall Study|Withdrawal by Subject|8|||
146892434|NCT02487108|529773375|FG001|Overall Study|Withdrawal by Subject|5|||
146892435|NCT02487108|529773376|FG002|Overall Study|Withdrawal by Subject|5|||
146892436|NCT02487108|529773377|FG003|Overall Study|Withdrawal by Subject|0|||
146892437|NCT02487108|529773374|FG000|Overall Study|Non-compliance to study medication|3|||
146892438|NCT02487108|529773375|FG001|Overall Study|Non-compliance to study medication|2|||
146892439|NCT02487108|529773376|FG002|Overall Study|Non-compliance to study medication|5|||
146892440|NCT02487108|529773377|FG003|Overall Study|Non-compliance to study medication|4|||
146892441|NCT02487108|529773374|FG000|Overall Study|Protocol Violation|1|||
146892442|NCT02487108|529773375|FG001|Overall Study|Protocol Violation|1|||
146892443|NCT02487108|529773376|FG002|Overall Study|Protocol Violation|2|||
146892444|NCT02487108|529773377|FG003|Overall Study|Protocol Violation|0|||
146892445|NCT02487108|529773374|FG000|Overall Study|Non-compliance to study procedures|0|||
146892446|NCT02487108|529773375|FG001|Overall Study|Non-compliance to study procedures|0|||
146892447|NCT02487108|529773376|FG002|Overall Study|Non-compliance to study procedures|0|||
146892448|NCT02487108|529773377|FG003|Overall Study|Non-compliance to study procedures|1|||
146967751|NCT01299272|530043818|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
146967752|NCT01299272|530043815|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
146967753|NCT01299272|530043816|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
146967754|NCT01299272|530043817|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
146892449|NCT02487108|529773374|FG000|Overall Study|Other than specified|3|||
146892450|NCT02487108|529773375|FG001|Overall Study|Other than specified|2|||
146892451|NCT02487108|529773376|FG002|Overall Study|Other than specified|2|||
146892452|NCT02487108|529773377|FG003|Overall Study|Other than specified|0|||
146892453|NCT02720757|529773378|FG000|Overall Study|Other reason|5|||
146892454|NCT02720757|529773378|FG000|Overall Study|Loss of contact|4|||
146892455|NCT02720757|529773378|FG000|Overall Study|Informed consent withdrawal|1|||
146892456|NCT02720757|529773378|FG000|Overall Study|Patients wish to withdraw|2|||
146892457|NCT02720757|529773378|FG000|Overall Study|Missing|3|||
146892458|NCT02720757|529773378|FG000|Overall Study|General exclusion|3|||
146892459|NCT00883493|529773379|FG000|Overall Study|Adverse Event|11|||
146892460|NCT00883493|529773380|FG001|Overall Study|Adverse Event|12|||
146892461|NCT00883493|529773379|FG000|Overall Study|Lack of Efficacy|4|||
146967755|NCT01299272|530043818|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
146967756|NCT01299272|530043815|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
146967757|NCT01299272|530043816|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
146967758|NCT01299272|530043817|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
146967759|NCT01299272|530043818|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
146967760|NCT01299272|530043815|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
146967761|NCT01299272|530043816|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
146967762|NCT01299272|530043817|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
146967763|NCT01299272|530043818|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
146967764|NCT01299272|530043815|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
146967765|NCT01299272|530043816|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
146967766|NCT01299272|530043817|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
146967767|NCT01299272|530043818|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
146967768|NCT01299272|530043815|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
146967769|NCT01299272|530043816|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
146967770|NCT01299272|530043817|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
146967771|NCT01299272|530043818|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
146967772|NCT01299272|530043815|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
146967773|NCT01299272|530043816|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
146967774|NCT01299272|530043817|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
146967775|NCT01299272|530043818|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
146967776|NCT01299272|530043815|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
146967777|NCT01299272|530043816|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
146967778|NCT01299272|530043817|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
146967779|NCT01299272|530043818|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
146967780|NCT01299272|530043815|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
146967781|NCT01299272|530043816|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
146967782|NCT01299272|530043817|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
146967783|NCT01299272|530043818|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
146967784|NCT01513759|530043819|FG000|Overall Study|Protocol Violation|4|||
146967785|NCT01513759|530043819|FG000|Overall Study|Death during catheter placement|1|||
146967786|NCT00366678|530043824|FG000|Infant Series|Withdrawal by Subject|8|||
146967787|NCT00366678|530043825|FG001|Infant Series|Withdrawal by Subject|6|||
146967788|NCT00366678|530043826|FG002|Infant Series|Withdrawal by Subject|0|||
146967789|NCT00366678|530043824|FG000|Infant Series|Protocol Violation|4|||
146967790|NCT00366678|530043825|FG001|Infant Series|Protocol Violation|3|||
146967791|NCT00366678|530043826|FG002|Infant Series|Protocol Violation|0|||
146967792|NCT00366678|530043824|FG000|Infant Series|Failed to return|1|||
146967793|NCT00366678|530043825|FG001|Infant Series|Failed to return|1|||
146967794|NCT00366678|530043826|FG002|Infant Series|Failed to return|0|||
146967795|NCT00366678|530043824|FG000|Infant Series|Adverse Event|1|||
146967796|NCT00366678|530043825|FG001|Infant Series|Adverse Event|0|||
146967797|NCT00366678|530043826|FG002|Infant Series|Adverse Event|0|||
146967798|NCT00366678|530043824|FG000|After Infant|Withdrawal by Subject|8|||
146967799|NCT00366678|530043825|FG001|After Infant|Withdrawal by Subject|4|||
146967800|NCT00366678|530043826|FG002|After Infant|Withdrawal by Subject|0|||
146967801|NCT00366678|530043824|FG000|After Infant|Lost to Follow-up|2|||
146967802|NCT00366678|530043825|FG001|After Infant|Lost to Follow-up|1|||
146967803|NCT00366678|530043826|FG002|After Infant|Lost to Follow-up|0|||
146967804|NCT00366678|530043824|FG000|After Infant|Failed to return|5|||
146967805|NCT00366678|530043825|FG001|After Infant|Failed to return|5|||
146967806|NCT00366678|530043826|FG002|After Infant|Failed to return|0|||
146967807|NCT00366678|530043824|FG000|After Infant|Adverse Event|1|||
146967808|NCT00366678|530043825|FG001|After Infant|Adverse Event|0|||
146967809|NCT00366678|530043826|FG002|After Infant|Adverse Event|0|||
146967810|NCT00366678|530043824|FG000|After Infant|Protocol Violation|1|||
146967811|NCT00366678|530043825|FG001|After Infant|Protocol Violation|0|||
146967812|NCT00366678|530043826|FG002|After Infant|Protocol Violation|0|||
146967813|NCT00366678|530043824|FG000|Toddler Dose|Protocol Violation|2|||
146967814|NCT00366678|530043825|FG001|Toddler Dose|Protocol Violation|1|||
146967815|NCT00366678|530043826|FG002|Toddler Dose|Protocol Violation|0|||
146967816|NCT00366678|530043824|FG000|Toddler Dose|Failed to return|1|||
146892462|NCT00883493|529773380|FG001|Overall Study|Lack of Efficacy|3|||
146892463|NCT00883493|529773379|FG000|Overall Study|Lost to Follow-up|7|||
146892464|NCT00883493|529773380|FG001|Overall Study|Lost to Follow-up|6|||
146892465|NCT00883493|529773379|FG000|Overall Study|Withdrawal by Subject|11|||
146892466|NCT00883493|529773380|FG001|Overall Study|Withdrawal by Subject|20|||
146892467|NCT00883493|529773379|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
146892468|NCT00883493|529773380|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
146892469|NCT00883493|529773379|FG000|Overall Study|Study specific disc. criteria|2|||
146892470|NCT00883493|529773380|FG001|Overall Study|Study specific disc. criteria|0|||
146892471|NCT00883493|529773379|FG000|Overall Study|Other|5|||
146892472|NCT00883493|529773380|FG001|Overall Study|Other|3|||
146892473|NCT01256177|529773381|FG000|Overall Study|Withdrawal by Subject|23|||
146892474|NCT01256177|529773382|FG001|Overall Study|Withdrawal by Subject|22|||
146967817|NCT00366678|530043825|FG001|Toddler Dose|Failed to return|0|||
146967818|NCT00366678|530043826|FG002|Toddler Dose|Failed to return|0|||
146892475|NCT01256177|529773381|FG000|Overall Study|Lost to Follow-up|2|||
146967819|NCT00366678|530043824|FG000|Toddler Dose|Withdrawal by Subject|1|||
146967820|NCT00366678|530043825|FG001|Toddler Dose|Withdrawal by Subject|0|||
146967821|NCT00366678|530043826|FG002|Toddler Dose|Withdrawal by Subject|0|||
146557600|NCT03186378|528551138|FG000|Overall Study|Lost to Follow-up|1|||
146892476|NCT01256177|529773382|FG001|Overall Study|Lost to Follow-up|2|||
146892477|NCT01256177|529773381|FG000|Overall Study|Adverse Event|8|||
146892478|NCT01256177|529773382|FG001|Overall Study|Adverse Event|9|||
146892479|NCT01256177|529773381|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
146892480|NCT01256177|529773382|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
146892481|NCT01256177|529773381|FG000|Overall Study|Condition under Investigation Worsened|1|||
146892482|NCT01256177|529773382|FG001|Overall Study|Condition under Investigation Worsened|0|||
146892483|NCT01256177|529773381|FG000|Overall Study|Lack of Efficacy|11|||
146557601|NCT03186378|528551139|FG001|Overall Study|Lost to Follow-up|0|||
146557602|NCT02514746|528551140|FG000|Overall Study|Chronically Ill|1|||
146892484|NCT01256177|529773382|FG001|Overall Study|Lack of Efficacy|2|||
146892485|NCT01256177|529773381|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
146892486|NCT01256177|529773382|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
146967822|NCT00366678|530043824|FG000|Toddler Dose|protocol deviation|1|||
146892487|NCT03118947|529773388|FG000|Overall Study|Adverse Event|7|||
146892488|NCT03118947|529773388|FG000|Overall Study|Death|3|||
146892489|NCT03118947|529773388|FG000|Overall Study|Lack of Efficacy|4|||
146892490|NCT03118947|529773388|FG000|Overall Study|Non-compliance with study drug|1|||
146892491|NCT03118947|529773388|FG000|Overall Study|Protocol Violation|2|||
146892492|NCT03118947|529773388|FG000|Overall Study|Withdrawal by Subject|3|||
146892493|NCT03118947|529773388|FG000|Overall Study|Withdrawal by caregiver|3|||
146892494|NCT03118947|529773388|FG000|Overall Study|Change in patient's living situation|4|||
146892495|NCT03118947|529773388|FG000|Overall Study|Lost to Follow-up|2|||
146557603|NCT02514746|528551141|FG001|Overall Study|Chronically Ill|2|||
146557604|NCT02514746|528551140|FG000|Overall Study|Physician Decision|4|||
146557605|NCT02514746|528551141|FG001|Overall Study|Physician Decision|2|||
146557606|NCT02514746|528551140|FG000|Overall Study|Withdrawal by Subject|12|||
146892496|NCT03653390|529773389|FG000|Overall Study|Lost to Follow-up|12|||
146892497|NCT03653390|529773390|FG001|Overall Study|Lost to Follow-up|8|||
146892498|NCT03653390|529773391|FG002|Overall Study|Lost to Follow-up|7|||
146892499|NCT03653390|529773389|FG000|Overall Study|Withdrawal by Subject|6|||
146892500|NCT03653390|529773390|FG001|Overall Study|Withdrawal by Subject|1|||
146892501|NCT03653390|529773391|FG002|Overall Study|Withdrawal by Subject|1|||
146892502|NCT03653390|529773389|FG000|Overall Study|Death|1|||
146892503|NCT03653390|529773390|FG001|Overall Study|Death|0|||
146892504|NCT03653390|529773391|FG002|Overall Study|Death|0|||
146892505|NCT03653390|529773389|FG000|Overall Study|Paper Survey Lost|1|||
146892506|NCT03653390|529773390|FG001|Overall Study|Paper Survey Lost|0|||
146892507|NCT03653390|529773391|FG002|Overall Study|Paper Survey Lost|0|||
146892508|NCT05099640|529773394|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
146892509|NCT05099640|529773395|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
146892510|NCT05099640|529773396|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
146892511|NCT05099640|529773394|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
146892512|NCT05099640|529773395|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
146892513|NCT05099640|529773396|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
146892514|NCT05099640|529773394|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
146892515|NCT05099640|529773395|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
146892516|NCT05099640|529773396|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
146892517|NCT05099640|529773394|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
146892518|NCT05099640|529773395|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
146892519|NCT05099640|529773396|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
146892520|NCT05099640|529773394|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
146892521|NCT05099640|529773395|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
146892522|NCT05099640|529773396|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
146967823|NCT00366678|530043825|FG001|Toddler Dose|protocol deviation|0|||
146967824|NCT00366678|530043826|FG002|Toddler Dose|protocol deviation|0|||
146892523|NCT05099640|529773394|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
146892524|NCT05099640|529773395|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
146892525|NCT05099640|529773396|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
146892526|NCT01987908|529773405|FG000|Placebo Lead-in Period|Adverse Event|2|||
146892527|NCT01987908|529773406|FG001|Placebo Lead-in Period|Adverse Event|0|||
146892528|NCT01987908|529773407|FG002|Placebo Lead-in Period|Adverse Event|0|||
146967825|NCT04242264|530043836|FG000|Overall Study|Lost to Follow-up|2|||
146557607|NCT02514746|528551141|FG001|Overall Study|Withdrawal by Subject|10|||
146557608|NCT02514746|528551140|FG000|Overall Study|Other|5|||
146557609|NCT02514746|528551141|FG001|Overall Study|Other|1|||
146557610|NCT04042311|528551142|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
146557611|NCT04042311|528551142|FG000|Overall Study|Unable to tolerate|4|||
146557612|NCT04042311|528551142|FG000|Overall Study|Concurrent illness|2|||
146557613|NCT04042311|528551142|FG000|Overall Study|Adverse Event|2|||
146557614|NCT04042311|528551142|FG000|Overall Study|No longer meeting inclusion criteria|2|||
146557615|NCT04042311|528551142|FG000|Overall Study|No reason given|1|||
146557616|NCT04042311|528551142|FG000|Overall Study|Withdrawal by Subject|4|||
146557617|NCT05021224|528551143|FG000|Overall Study|Did not complete all survey items|4|||
146557618|NCT05021224|528551144|FG001|Overall Study|Did not complete all survey items|1|||
146557619|NCT05021224|528551145|FG002|Overall Study|Did not complete all survey items|0|||
146557620|NCT05021224|528551146|FG003|Overall Study|Did not complete all survey items|2|||
146557621|NCT03996395|528551147|FG000|Overall Study|Lost to Follow-up|4|||
146892529|NCT01987908|529773405|FG000|Placebo Lead-in Period|Physician Decision|2|||
146892530|NCT01987908|529773406|FG001|Placebo Lead-in Period|Physician Decision|0|||
146892531|NCT01987908|529773407|FG002|Placebo Lead-in Period|Physician Decision|0|||
146892532|NCT01987908|529773405|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
146892533|NCT01987908|529773406|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
146892534|NCT01987908|529773407|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
146967826|NCT04242264|530043837|FG001|Overall Study|Lost to Follow-up|2|||
146557622|NCT03996395|528551147|FG000|Overall Study|Withdrawal by Subject|1|||
146557623|NCT03996395|528551147|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
146557624|NCT05375929|528551148|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
146557625|NCT05375929|528551149|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
146557626|NCT05375929|528551150|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
146557627|NCT05375929|528551151|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
146766347|NCT01235949|529312225|FG003|Booster Phase|Migrated/moved from study area|0|||
146766348|NCT01235949|529312226|FG004|Booster Phase|Migrated/moved from study area|0|||
146766349|NCT01235949|529312227|FG005|Booster Phase|Migrated/moved from study area|0|||
146766350|NCT01235949|529312228|FG006|Booster Phase|Migrated/moved from study area|0|||
146967827|NCT04242264|530043838|FG002|Overall Study|Lost to Follow-up|1|||
146892535|NCT01987908|529773405|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
146892536|NCT01987908|529773406|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
146892537|NCT01987908|529773407|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
146892538|NCT01987908|529773405|FG000|Treatment Period|Adverse Event|0|||
146892539|NCT01987908|529773406|FG001|Treatment Period|Adverse Event|1|||
146892540|NCT01987908|529773407|FG002|Treatment Period|Adverse Event|1|||
146892541|NCT01987908|529773405|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
146892542|NCT01987908|529773406|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
146892543|NCT01987908|529773407|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
146557628|NCT05375929|528551148|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
146557629|NCT05375929|528551149|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
146557630|NCT05375929|528551150|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
146892544|NCT01987908|529773405|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
146892545|NCT01987908|529773406|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
146892546|NCT01987908|529773407|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
146892547|NCT02789657|529773409|FG000|Overall Study|Withdrawal by Subject|2|||
146557631|NCT05375929|528551151|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
146892548|NCT02789657|529773410|FG001|Overall Study|Withdrawal by Subject|0|||
146892549|NCT02789657|529773411|FG002|Overall Study|Withdrawal by Subject|0|||
146892550|NCT02789657|529773412|FG003|Overall Study|Withdrawal by Subject|0|||
146892551|NCT03882424|529773415|FG000|Overall Study|Lost to Follow-up|3|||
146892552|NCT03882424|529773416|FG001|Overall Study|Lost to Follow-up|0|||
146892553|NCT03882424|529773417|FG002|Overall Study|Lost to Follow-up|0|||
146892554|NCT03882424|529773415|FG000|Overall Study|schedule conflict|1|||
146892555|NCT03882424|529773416|FG001|Overall Study|schedule conflict|0|||
146892556|NCT03882424|529773417|FG002|Overall Study|schedule conflict|0|||
146557632|NCT05375929|528551148|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
146637191|NCT03682770|528847230|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
146967828|NCT04242264|530043839|FG003|Overall Study|Lost to Follow-up|1|||
146637192|NCT03682770|528847231|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
146892557|NCT02772757|529773423|FG000|Overall Study|Withdrawal by Subject|1|||
146892558|NCT02772757|529773424|FG001|Overall Study|Withdrawal by Subject|0|||
146892559|NCT02772757|529773425|FG002|Overall Study|Withdrawal by Subject|1|||
146892560|NCT02772757|529773423|FG000|Overall Study|Protocol Violation|0|||
146892561|NCT02772757|529773424|FG001|Overall Study|Protocol Violation|0|||
146892562|NCT02772757|529773425|FG002|Overall Study|Protocol Violation|1|||
146892563|NCT02772757|529773423|FG000|Overall Study|Physician Decision|0|||
146892564|NCT02772757|529773424|FG001|Overall Study|Physician Decision|3|||
146892565|NCT02772757|529773425|FG002|Overall Study|Physician Decision|3|||
146892566|NCT03486392|529773427|FG000|Overall Study|Lost to Follow-up|0|||
146892567|NCT03486392|529773428|FG001|Overall Study|Lost to Follow-up|0|||
146892568|NCT03486392|529773429|FG002|Overall Study|Lost to Follow-up|8|||
146892569|NCT03486392|529773430|FG003|Overall Study|Lost to Follow-up|5|||
146892570|NCT03486392|529773431|FG004|Overall Study|Lost to Follow-up|2|||
146892571|NCT03486392|529773427|FG000|Overall Study|Withdrawal by Subject|3|||
146892572|NCT03486392|529773428|FG001|Overall Study|Withdrawal by Subject|0|||
146892573|NCT03486392|529773429|FG002|Overall Study|Withdrawal by Subject|6|||
146892574|NCT03486392|529773430|FG003|Overall Study|Withdrawal by Subject|4|||
146892575|NCT03486392|529773431|FG004|Overall Study|Withdrawal by Subject|1|||
146892576|NCT03486392|529773427|FG000|Overall Study|Death|0|||
146892577|NCT03486392|529773428|FG001|Overall Study|Death|0|||
146892578|NCT03486392|529773429|FG002|Overall Study|Death|0|||
146892579|NCT03486392|529773430|FG003|Overall Study|Death|0|||
146557633|NCT05375929|528551149|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
146892580|NCT03486392|529773431|FG004|Overall Study|Death|1|||
146892581|NCT01500057|529773434|FG000|Overall Study|Lost to Follow-up|6|||
146892582|NCT01500057|529773435|FG001|Overall Study|Lost to Follow-up|4|||
146892583|NCT00441792|529773436|FG000|Overall Study|Lost to Follow-up|0|||
146892584|NCT00441792|529773437|FG001|Overall Study|Lost to Follow-up|2|||
146892585|NCT01731678|529773438|FG000|Overall Study|Withdrawal by Subject|3|||
146967829|NCT04242264|530043836|FG000|Overall Study|Withdrawal by Subject|1|||
146892586|NCT01731678|529773438|FG000|Overall Study|Did not meet inclusion criteria|1|||
146892587|NCT01731678|529773438|FG000|Overall Study|RMT too high, making TMS difficult|3|||
146892588|NCT03603652|529773442|FG000|Overall Study|Death|2|||
146892589|NCT00666926|529773443|FG000|Overall Study|Adverse Event|0|||
146967830|NCT04242264|530043837|FG001|Overall Study|Withdrawal by Subject|0|||
146967831|NCT04242264|530043838|FG002|Overall Study|Withdrawal by Subject|0|||
146967832|NCT04242264|530043839|FG003|Overall Study|Withdrawal by Subject|0|||
146967833|NCT02116309|530043840|FG000|Overall Study|Lost to Follow-up|0|||
146967834|NCT02116309|530043841|FG001|Overall Study|Lost to Follow-up|1|||
146967835|NCT03292731|530043842|FG000|Overall Study|Protocol Violation|4|||
146967836|NCT03292731|530043843|FG001|Overall Study|Protocol Violation|11|||
146967837|NCT03292731|530043844|FG002|Overall Study|Protocol Violation|1|||
146967838|NCT00471237|530043845|FG000|Overall Study|Adverse Event|6|||
146967839|NCT00471237|530043846|FG001|Overall Study|Adverse Event|5|||
146967840|NCT00471237|530043847|FG002|Overall Study|Adverse Event|4|||
146967841|NCT00471237|530043848|FG003|Overall Study|Adverse Event|8|||
146967842|NCT00471237|530043849|FG004|Overall Study|Adverse Event|7|||
146967843|NCT00471237|530043850|FG005|Overall Study|Adverse Event|5|||
146967844|NCT00471237|530043851|FG006|Overall Study|Adverse Event|0|||
146967845|NCT00471237|530043845|FG000|Overall Study|Lost to Follow-up|1|||
146967846|NCT00471237|530043846|FG001|Overall Study|Lost to Follow-up|1|||
146967847|NCT00471237|530043847|FG002|Overall Study|Lost to Follow-up|0|||
146967848|NCT00471237|530043848|FG003|Overall Study|Lost to Follow-up|2|||
146967849|NCT00471237|530043849|FG004|Overall Study|Lost to Follow-up|3|||
146967850|NCT00471237|530043850|FG005|Overall Study|Lost to Follow-up|0|||
146892590|NCT00666926|529773444|FG001|Overall Study|Adverse Event|0|||
146892591|NCT00666926|529773445|FG002|Overall Study|Adverse Event|0|||
146892592|NCT00666926|529773446|FG003|Overall Study|Adverse Event|0|||
146892593|NCT00666926|529773447|FG004|Overall Study|Adverse Event|0|||
146892594|NCT00666926|529773448|FG005|Overall Study|Adverse Event|0|||
146892595|NCT00666926|529773449|FG006|Overall Study|Adverse Event|0|||
146892596|NCT00666926|529773450|FG007|Overall Study|Adverse Event|0|||
146892597|NCT00666926|529773451|FG008|Overall Study|Adverse Event|0|||
146892598|NCT00666926|529773452|FG009|Overall Study|Adverse Event|2|||
146892599|NCT00666926|529773453|FG010|Overall Study|Adverse Event|2|||
146892600|NCT00666926|529773454|FG011|Overall Study|Adverse Event|2|||
146892601|NCT00666926|529773455|FG012|Overall Study|Adverse Event|0|||
146892602|NCT00666926|529773456|FG013|Overall Study|Adverse Event|1|||
146892603|NCT00666926|529773457|FG014|Overall Study|Adverse Event|0|||
146892604|NCT00666926|529773458|FG015|Overall Study|Adverse Event|0|||
146892605|NCT00666926|529773443|FG000|Overall Study|Laboratory abnormality|0|||
146892606|NCT00666926|529773444|FG001|Overall Study|Laboratory abnormality|0|||
146892607|NCT00666926|529773445|FG002|Overall Study|Laboratory abnormality|0|||
146892608|NCT00666926|529773446|FG003|Overall Study|Laboratory abnormality|0|||
146892609|NCT00666926|529773447|FG004|Overall Study|Laboratory abnormality|0|||
146892610|NCT00666926|529773448|FG005|Overall Study|Laboratory abnormality|0|||
146892611|NCT00666926|529773449|FG006|Overall Study|Laboratory abnormality|0|||
146892612|NCT00666926|529773450|FG007|Overall Study|Laboratory abnormality|0|||
146892613|NCT00666926|529773451|FG008|Overall Study|Laboratory abnormality|0|||
146892614|NCT00666926|529773452|FG009|Overall Study|Laboratory abnormality|0|||
146892615|NCT00666926|529773453|FG010|Overall Study|Laboratory abnormality|1|||
146892616|NCT00666926|529773454|FG011|Overall Study|Laboratory abnormality|0|||
146892617|NCT00666926|529773455|FG012|Overall Study|Laboratory abnormality|0|||
146892618|NCT00666926|529773456|FG013|Overall Study|Laboratory abnormality|0|||
146892619|NCT00666926|529773457|FG014|Overall Study|Laboratory abnormality|0|||
146892620|NCT00666926|529773458|FG015|Overall Study|Laboratory abnormality|1|||
146892621|NCT00666926|529773443|FG000|Overall Study|Lack of Efficacy|0|||
146892622|NCT00666926|529773444|FG001|Overall Study|Lack of Efficacy|0|||
146892623|NCT00666926|529773445|FG002|Overall Study|Lack of Efficacy|0|||
146892624|NCT00666926|529773446|FG003|Overall Study|Lack of Efficacy|0|||
146892625|NCT00666926|529773447|FG004|Overall Study|Lack of Efficacy|0|||
146967851|NCT00471237|530043851|FG006|Overall Study|Lost to Follow-up|0|||
146967852|NCT00471237|530043845|FG000|Overall Study|Protocol Violation|3|||
146892626|NCT00666926|529773448|FG005|Overall Study|Lack of Efficacy|1|||
146892627|NCT00666926|529773449|FG006|Overall Study|Lack of Efficacy|0|||
146892628|NCT00666926|529773450|FG007|Overall Study|Lack of Efficacy|0|||
146892629|NCT00666926|529773451|FG008|Overall Study|Lack of Efficacy|0|||
146892630|NCT00666926|529773452|FG009|Overall Study|Lack of Efficacy|0|||
146967853|NCT00471237|530043846|FG001|Overall Study|Protocol Violation|6|||
146892631|NCT00666926|529773453|FG010|Overall Study|Lack of Efficacy|0|||
146892632|NCT00666926|529773454|FG011|Overall Study|Lack of Efficacy|1|||
146967854|NCT00471237|530043847|FG002|Overall Study|Protocol Violation|3|||
146892633|NCT00666926|529773455|FG012|Overall Study|Lack of Efficacy|0|||
146892634|NCT00666926|529773456|FG013|Overall Study|Lack of Efficacy|0|||
146892635|NCT00666926|529773457|FG014|Overall Study|Lack of Efficacy|0|||
146967855|NCT00471237|530043848|FG003|Overall Study|Protocol Violation|2|||
146967856|NCT00471237|530043849|FG004|Overall Study|Protocol Violation|2|||
146892636|NCT00666926|529773458|FG015|Overall Study|Lack of Efficacy|0|||
146892637|NCT00666926|529773443|FG000|Overall Study|Lost to Follow-up|0|||
146892638|NCT00666926|529773444|FG001|Overall Study|Lost to Follow-up|0|||
146892639|NCT00666926|529773445|FG002|Overall Study|Lost to Follow-up|0|||
146892640|NCT00666926|529773446|FG003|Overall Study|Lost to Follow-up|1|||
146892641|NCT00666926|529773447|FG004|Overall Study|Lost to Follow-up|0|||
146892642|NCT00666926|529773448|FG005|Overall Study|Lost to Follow-up|0|||
146892643|NCT00666926|529773449|FG006|Overall Study|Lost to Follow-up|0|||
146892644|NCT00666926|529773450|FG007|Overall Study|Lost to Follow-up|0|||
146892645|NCT00666926|529773451|FG008|Overall Study|Lost to Follow-up|0|||
146892646|NCT00666926|529773452|FG009|Overall Study|Lost to Follow-up|0|||
146892647|NCT00666926|529773453|FG010|Overall Study|Lost to Follow-up|0|||
146892648|NCT00666926|529773454|FG011|Overall Study|Lost to Follow-up|0|||
146892649|NCT00666926|529773455|FG012|Overall Study|Lost to Follow-up|0|||
146892650|NCT00666926|529773456|FG013|Overall Study|Lost to Follow-up|0|||
146892651|NCT00666926|529773457|FG014|Overall Study|Lost to Follow-up|0|||
146892652|NCT00666926|529773458|FG015|Overall Study|Lost to Follow-up|0|||
146892653|NCT00666926|529773443|FG000|Overall Study|Other|2|||
146892654|NCT00666926|529773444|FG001|Overall Study|Other|4|||
146892655|NCT00666926|529773445|FG002|Overall Study|Other|3|||
146892656|NCT00666926|529773446|FG003|Overall Study|Other|3|||
146892657|NCT00666926|529773447|FG004|Overall Study|Other|3|||
146892658|NCT00666926|529773448|FG005|Overall Study|Other|3|||
146892659|NCT00666926|529773449|FG006|Overall Study|Other|4|||
146892660|NCT00666926|529773450|FG007|Overall Study|Other|0|||
146892661|NCT00666926|529773451|FG008|Overall Study|Other|3|||
146892662|NCT00666926|529773452|FG009|Overall Study|Other|5|||
146892663|NCT00666926|529773453|FG010|Overall Study|Other|3|||
146892664|NCT00666926|529773454|FG011|Overall Study|Other|26|||
146892665|NCT00666926|529773455|FG012|Overall Study|Other|3|||
146892666|NCT00666926|529773456|FG013|Overall Study|Other|2|||
146892667|NCT00666926|529773457|FG014|Overall Study|Other|4|||
146892668|NCT00666926|529773458|FG015|Overall Study|Other|4|||
146892669|NCT00666926|529773443|FG000|Overall Study|Withdrawal by Subject|0|||
146892670|NCT00666926|529773444|FG001|Overall Study|Withdrawal by Subject|0|||
146892671|NCT00666926|529773445|FG002|Overall Study|Withdrawal by Subject|0|||
146892672|NCT00666926|529773446|FG003|Overall Study|Withdrawal by Subject|0|||
146892673|NCT00666926|529773447|FG004|Overall Study|Withdrawal by Subject|0|||
146892674|NCT00666926|529773448|FG005|Overall Study|Withdrawal by Subject|0|||
146892675|NCT00666926|529773449|FG006|Overall Study|Withdrawal by Subject|0|||
146892676|NCT00666926|529773450|FG007|Overall Study|Withdrawal by Subject|1|||
146892677|NCT00666926|529773451|FG008|Overall Study|Withdrawal by Subject|0|||
146892678|NCT00666926|529773452|FG009|Overall Study|Withdrawal by Subject|3|||
146892679|NCT00666926|529773453|FG010|Overall Study|Withdrawal by Subject|0|||
146892680|NCT00666926|529773454|FG011|Overall Study|Withdrawal by Subject|3|||
146892681|NCT00666926|529773455|FG012|Overall Study|Withdrawal by Subject|0|||
146892682|NCT00666926|529773456|FG013|Overall Study|Withdrawal by Subject|1|||
146967857|NCT00471237|530043850|FG005|Overall Study|Protocol Violation|4|||
146892683|NCT00666926|529773457|FG014|Overall Study|Withdrawal by Subject|3|||
146892684|NCT00666926|529773458|FG015|Overall Study|Withdrawal by Subject|3|||
146892685|NCT00666926|529773443|FG000|Overall Study|Death|0|||
146892686|NCT00666926|529773444|FG001|Overall Study|Death|0|||
146892687|NCT00666926|529773445|FG002|Overall Study|Death|0|||
146892688|NCT00666926|529773446|FG003|Overall Study|Death|0|||
146892689|NCT00666926|529773447|FG004|Overall Study|Death|0|||
146892690|NCT00666926|529773448|FG005|Overall Study|Death|0|||
146892691|NCT00666926|529773449|FG006|Overall Study|Death|0|||
146892692|NCT00666926|529773450|FG007|Overall Study|Death|0|||
146892693|NCT00666926|529773451|FG008|Overall Study|Death|0|||
146892694|NCT00666926|529773452|FG009|Overall Study|Death|0|||
146892695|NCT00666926|529773453|FG010|Overall Study|Death|0|||
146892696|NCT00666926|529773454|FG011|Overall Study|Death|1|||
146892697|NCT00666926|529773455|FG012|Overall Study|Death|0|||
146892698|NCT00666926|529773456|FG013|Overall Study|Death|0|||
146892699|NCT00666926|529773457|FG014|Overall Study|Death|0|||
146892700|NCT00666926|529773458|FG015|Overall Study|Death|0|||
146892701|NCT01960855|529773459|FG000|Overall Study|Subject noncompliant|1|||
146892702|NCT01960855|529773460|FG001|Overall Study|Subject noncompliant|0|||
146892703|NCT01960855|529773461|FG002|Overall Study|Subject noncompliant|0|||
146892704|NCT01960855|529773462|FG003|Overall Study|Subject noncompliant|0|||
146892705|NCT01960855|529773463|FG004|Overall Study|Subject noncompliant|0|||
146892706|NCT01960855|529773459|FG000|Overall Study|Adverse Event|2|||
146892707|NCT01960855|529773460|FG001|Overall Study|Adverse Event|0|||
146892708|NCT01960855|529773461|FG002|Overall Study|Adverse Event|6|||
146892709|NCT01960855|529773462|FG003|Overall Study|Adverse Event|2|||
146892710|NCT01960855|529773463|FG004|Overall Study|Adverse Event|2|||
146892711|NCT01960855|529773459|FG000|Overall Study|Lack of Efficacy|1|||
146892712|NCT01960855|529773460|FG001|Overall Study|Lack of Efficacy|1|||
146892713|NCT01960855|529773461|FG002|Overall Study|Lack of Efficacy|0|||
146892714|NCT01960855|529773462|FG003|Overall Study|Lack of Efficacy|0|||
146892715|NCT01960855|529773463|FG004|Overall Study|Lack of Efficacy|0|||
146766351|NCT01235949|529312229|FG007|Booster Phase|Migrated/moved from study area|0|||
146766352|NCT01235949|529312230|FG008|Booster Phase|Migrated/moved from study area|0|||
146892716|NCT01960855|529773459|FG000|Overall Study|Other|2|||
146892717|NCT01960855|529773460|FG001|Overall Study|Other|1|||
146892718|NCT01960855|529773461|FG002|Overall Study|Other|1|||
146892719|NCT01960855|529773462|FG003|Overall Study|Other|1|||
146892720|NCT01960855|529773463|FG004|Overall Study|Other|0|||
146892721|NCT01960855|529773459|FG000|Overall Study|Consent withdrawn by subject|3|||
146892722|NCT01960855|529773460|FG001|Overall Study|Consent withdrawn by subject|1|||
146892723|NCT01960855|529773461|FG002|Overall Study|Consent withdrawn by subject|2|||
146892724|NCT01960855|529773462|FG003|Overall Study|Consent withdrawn by subject|1|||
146892725|NCT01960855|529773463|FG004|Overall Study|Consent withdrawn by subject|1|||
146892726|NCT01960855|529773459|FG000|Overall Study|Lost to Follow-up|2|||
146892727|NCT01960855|529773460|FG001|Overall Study|Lost to Follow-up|1|||
146892728|NCT01960855|529773461|FG002|Overall Study|Lost to Follow-up|0|||
146892729|NCT01960855|529773462|FG003|Overall Study|Lost to Follow-up|0|||
146892730|NCT01960855|529773463|FG004|Overall Study|Lost to Follow-up|2|||
146892731|NCT02058147|529773464|FG000|Overall Study|Randomized but not treated|0|||
146892732|NCT02058147|529773465|FG001|Overall Study|Randomized but not treated|0|||
146892733|NCT02058147|529773466|FG002|Overall Study|Randomized but not treated|1|||
146557634|NCT05375929|528551150|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
146557635|NCT05375929|528551151|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
146557636|NCT05375929|528551148|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
146557637|NCT05375929|528551149|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
146557638|NCT05375929|528551150|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
146557639|NCT05375929|528551151|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
146557640|NCT05375929|528551148|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
146557641|NCT05375929|528551149|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
146557642|NCT05375929|528551150|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
146557643|NCT05375929|528551151|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
146557644|NCT05375929|528551148|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
146557645|NCT05375929|528551149|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
146557646|NCT05375929|528551150|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
146557647|NCT05375929|528551151|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
146557648|NCT05375929|528551148|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
146557649|NCT05375929|528551149|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
146557650|NCT05375929|528551150|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
146892734|NCT02058147|529773464|FG000|Overall Study|Adverse Event|12|||
146892735|NCT02058147|529773465|FG001|Overall Study|Adverse Event|9|||
146637193|NCT03682770|528847232|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
146637194|NCT03682770|528847233|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
146637195|NCT01491607|528847234|FG000|Overall Study|Lost to Follow-up|7|||
146637196|NCT01491607|528847234|FG000|Overall Study|Withdrawal by Subject|3|||
146637197|NCT01317277|528847235|FG000|Overall Study|Lost to Follow-up|3|||
146637198|NCT01317277|528847236|FG001|Overall Study|Lost to Follow-up|1|||
146637199|NCT01317277|528847235|FG000|Overall Study|Lost MEMS|1|||
146637200|NCT01317277|528847236|FG001|Overall Study|Lost MEMS|1|||
146637201|NCT01317277|528847235|FG000|Overall Study|Unable to comply with intervention|1|||
146637202|NCT01317277|528847236|FG001|Overall Study|Unable to comply with intervention|0|||
146637203|NCT01317277|528847235|FG000|Overall Study|Withdrawal by Subject|1|||
146637204|NCT01317277|528847236|FG001|Overall Study|Withdrawal by Subject|0|||
146637205|NCT01317277|528847235|FG000|Overall Study|Adverse Event|1|||
146637206|NCT01317277|528847236|FG001|Overall Study|Adverse Event|0|||
146637207|NCT00774566|528847237|FG000|Overall Study|Protocol Violation|18|||
146892736|NCT02058147|529773466|FG002|Overall Study|Adverse Event|21|||
146637208|NCT00774566|528847238|FG001|Overall Study|Protocol Violation|15|||
146637209|NCT04896073|528847245|FG000|Overall Study|Screen failure|0|||
146892737|NCT02058147|529773464|FG000|Overall Study|Lack of Efficacy|1|||
146637210|NCT04896073|528847246|FG001|Overall Study|Screen failure|2|||
146637211|NCT04896073|528847245|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
146892738|NCT02058147|529773465|FG001|Overall Study|Lack of Efficacy|0|||
146637212|NCT04896073|528847246|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
146892739|NCT02058147|529773466|FG002|Overall Study|Lack of Efficacy|3|||
146892740|NCT02058147|529773464|FG000|Overall Study|Poor compliance to protocol|8|||
146892741|NCT02058147|529773465|FG001|Overall Study|Poor compliance to protocol|9|||
146892742|NCT02058147|529773466|FG002|Overall Study|Poor compliance to protocol|4|||
146892743|NCT02058147|529773464|FG000|Overall Study|Other than specified|8|||
146892744|NCT02058147|529773465|FG001|Overall Study|Other than specified|9|||
146892745|NCT02058147|529773466|FG002|Overall Study|Other than specified|0|||
146892746|NCT01318122|529773469|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146892747|NCT01318122|529773470|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146892748|NCT01318122|529773471|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
146892749|NCT01318122|529773472|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
146892750|NCT01318122|529773469|FG000|Enrolled - Long-Term Extension Study|Other|1|||
146892751|NCT01318122|529773470|FG001|Enrolled - Long-Term Extension Study|Other|0|||
146892752|NCT01318122|529773471|FG002|Enrolled - Long-Term Extension Study|Other|0|||
146892753|NCT01318122|529773472|FG003|Enrolled - Long-Term Extension Study|Other|0|||
146892754|NCT01318122|529773469|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
146892755|NCT01318122|529773470|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
146892756|NCT01318122|529773471|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
146892757|NCT01318122|529773472|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
146892758|NCT01318122|529773469|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
146892759|NCT01318122|529773470|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146892760|NCT01318122|529773471|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146892761|NCT01318122|529773472|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146892762|NCT01318122|529773469|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
146892763|NCT01318122|529773470|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
146892764|NCT01318122|529773471|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
146892765|NCT01318122|529773472|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
146892766|NCT01318122|529773469|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
146892767|NCT01318122|529773470|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
146892768|NCT01318122|529773471|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
146892769|NCT01318122|529773472|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
146892770|NCT01486199|529773473|FG000|Two Year Period Between Study Days|Physician Decision|1|||
146892771|NCT01486199|529773474|FG001|Two Year Period Between Study Days|Physician Decision|0|||
146892772|NCT04178772|529773481|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
146892773|NCT04178772|529773481|FG000|Overall Study|study terminated early due to COVID-19|7|||
146892774|NCT02211261|529773491|FG000|Overall Study|Withdrawal by Subject|0|||
146892775|NCT02211261|529773492|FG001|Overall Study|Withdrawal by Subject|0|||
146892776|NCT02211261|529773493|FG002|Overall Study|Withdrawal by Subject|1|||
146892777|NCT02211261|529773494|FG003|Overall Study|Withdrawal by Subject|0|||
146892778|NCT02211261|529773495|FG004|Overall Study|Withdrawal by Subject|2|||
146557651|NCT05375929|528551151|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
146557652|NCT05375929|528551148|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
146892779|NCT02211261|529773496|FG005|Overall Study|Withdrawal by Subject|0|||
146892780|NCT02211261|529773497|FG006|Overall Study|Withdrawal by Subject|0|||
146892781|NCT02211261|529773498|FG007|Overall Study|Withdrawal by Subject|0|||
146892782|NCT02211261|529773499|FG008|Overall Study|Withdrawal by Subject|0|||
146557653|NCT05375929|528551149|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
146557654|NCT05375929|528551150|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
146557655|NCT05375929|528551151|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
146557656|NCT05375929|528551148|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
146892783|NCT02211261|529773500|FG009|Overall Study|Withdrawal by Subject|0|||
146892784|NCT02211261|529773501|FG010|Overall Study|Withdrawal by Subject|0|||
146892785|NCT02211261|529773491|FG000|Overall Study|Other|0|||
146892786|NCT02211261|529773492|FG001|Overall Study|Other|0|||
146892787|NCT02211261|529773493|FG002|Overall Study|Other|0|||
146892788|NCT02211261|529773494|FG003|Overall Study|Other|0|||
146892789|NCT02211261|529773495|FG004|Overall Study|Other|0|||
146892790|NCT02211261|529773496|FG005|Overall Study|Other|1|||
146892791|NCT02211261|529773497|FG006|Overall Study|Other|0|||
146892792|NCT02211261|529773498|FG007|Overall Study|Other|0|||
146557657|NCT05375929|528551149|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
146557658|NCT05375929|528551150|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
146557659|NCT05375929|528551151|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
146557660|NCT05375929|528551148|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
146557661|NCT05375929|528551149|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
146557662|NCT05375929|528551150|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
146557663|NCT05375929|528551151|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
146557664|NCT03973489|528551152|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
146557665|NCT03973489|528551153|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
146557666|NCT03973489|528551154|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
146557667|NCT03973489|528551155|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
146557668|NCT03973489|528551156|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
146557669|NCT03973489|528551157|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
146557670|NCT03973489|528551158|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
146557671|NCT03973489|528551159|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
146557672|NCT03973489|528551152|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
146557673|NCT03973489|528551153|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
146766353|NCT01235949|529312231|FG009|Booster Phase|Migrated/moved from study area|0|||
146892793|NCT02211261|529773499|FG008|Overall Study|Other|0|||
146892794|NCT02211261|529773500|FG009|Overall Study|Other|2|||
146892795|NCT02211261|529773501|FG010|Overall Study|Other|0|||
146892796|NCT02211261|529773491|FG000|Overall Study|Lost to Follow-up|0|||
146892797|NCT02211261|529773492|FG001|Overall Study|Lost to Follow-up|0|||
146892798|NCT02211261|529773493|FG002|Overall Study|Lost to Follow-up|0|||
146892799|NCT02211261|529773494|FG003|Overall Study|Lost to Follow-up|0|||
146892800|NCT02211261|529773495|FG004|Overall Study|Lost to Follow-up|0|||
146892801|NCT02211261|529773496|FG005|Overall Study|Lost to Follow-up|0|||
146557674|NCT03973489|528551154|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
146892802|NCT02211261|529773497|FG006|Overall Study|Lost to Follow-up|0|||
146892803|NCT02211261|529773498|FG007|Overall Study|Lost to Follow-up|1|||
146892804|NCT02211261|529773499|FG008|Overall Study|Lost to Follow-up|0|||
146892805|NCT02211261|529773500|FG009|Overall Study|Lost to Follow-up|0|||
146892806|NCT02211261|529773501|FG010|Overall Study|Lost to Follow-up|0|||
146892807|NCT02817087|529773502|FG000|Overall Study|Withdrawal by Subject|2|||
146557675|NCT03973489|528551155|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
146892808|NCT02817087|529773503|FG001|Overall Study|Withdrawal by Subject|0|||
146892809|NCT00508391|529773504|FG000|First Treatment|Withdrawal by Subject|6|||
146892810|NCT00508391|529773505|FG001|First Treatment|Withdrawal by Subject|3|||
146892811|NCT00508391|529773504|FG000|Second Treatment|Withdrawal by Subject|2|||
146892812|NCT00508391|529773505|FG001|Second Treatment|Withdrawal by Subject|0|||
146892813|NCT00880256|529773506|FG000|Overall Study|Lost to Follow-up|28|||
146892814|NCT00802360|529773507|FG000|Overall Study|Stimulation failure|4|||
146892815|NCT00802360|529773508|FG001|Overall Study|Stimulation failure|0|||
146892816|NCT00802360|529773509|FG002|Overall Study|Stimulation failure|3|||
146892817|NCT00802360|529773510|FG003|Overall Study|Stimulation failure|3|||
146892818|NCT00802360|529773507|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
146892819|NCT00802360|529773508|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
146892820|NCT00802360|529773509|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
146892821|NCT00802360|529773510|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
146892822|NCT00802360|529773507|FG000|Overall Study|Cycle cancelled|0|||
146892823|NCT00802360|529773508|FG001|Overall Study|Cycle cancelled|1|||
146892824|NCT00802360|529773509|FG002|Overall Study|Cycle cancelled|1|||
146892825|NCT00802360|529773510|FG003|Overall Study|Cycle cancelled|1|||
146892826|NCT00802360|529773507|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
146892827|NCT00802360|529773508|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
146892828|NCT00802360|529773509|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
146892829|NCT00802360|529773510|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
146892830|NCT00802360|529773507|FG000|Overall Study|No positive serum pregnancy|17|||
146892831|NCT00802360|529773508|FG001|Overall Study|No positive serum pregnancy|20|||
146892832|NCT00802360|529773509|FG002|Overall Study|No positive serum pregnancy|14|||
146557676|NCT03973489|528551156|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
146892833|NCT00802360|529773510|FG003|Overall Study|No positive serum pregnancy|10|||
146892834|NCT00802360|529773507|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
146892835|NCT00802360|529773508|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
146967858|NCT00471237|530043851|FG006|Overall Study|Protocol Violation|1|||
146892836|NCT00802360|529773509|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
146892837|NCT00802360|529773510|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
146892838|NCT00802360|529773507|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
146892839|NCT00802360|529773508|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
146892840|NCT00802360|529773509|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
146892841|NCT00802360|529773510|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
146892842|NCT00802360|529773507|FG000|Overall Study|Other|2|||
146637213|NCT02999672|528847248|FG000|Overall Study|Death|0|||
146637214|NCT02999672|528847249|FG001|Overall Study|Death|1|||
146637215|NCT02999672|528847248|FG000|Overall Study|Study Terminated by Sponsor|0|||
146637216|NCT02999672|528847249|FG001|Overall Study|Study Terminated by Sponsor|1|||
146637217|NCT02999672|528847248|FG000|Overall Study|Progressive Disease|9|||
146637218|NCT02999672|528847249|FG001|Overall Study|Progressive Disease|5|||
146637219|NCT02999672|528847248|FG000|Overall Study|Adverse Event|4|||
146637220|NCT02999672|528847249|FG001|Overall Study|Adverse Event|0|||
146637221|NCT03565497|528847250|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
146637222|NCT03565497|528847251|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
146967859|NCT00471237|530043845|FG000|Overall Study|Withdrawal by Subject|8|||
146637223|NCT03565497|528847252|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
146892843|NCT00802360|529773508|FG001|Overall Study|Other|3|||
146892844|NCT00802360|529773509|FG002|Overall Study|Other|6|||
146892845|NCT00802360|529773510|FG003|Overall Study|Other|3|||
146892846|NCT02041962|529773511|FG000|Overall Study|Lost Aetna Coverage|43|||
146557677|NCT03973489|528551157|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
146557678|NCT03973489|528551158|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
146892847|NCT02041962|529773512|FG001|Overall Study|Lost Aetna Coverage|40|||
146892848|NCT02041962|529773511|FG000|Overall Study|Death|1|||
146892849|NCT02041962|529773512|FG001|Overall Study|Death|1|||
146892850|NCT02041962|529773511|FG000|Overall Study|Lost to Follow-up|37|||
146892851|NCT02041962|529773512|FG001|Overall Study|Lost to Follow-up|32|||
146892852|NCT02041962|529773511|FG000|Overall Study|Withdrawal by Subject|0|||
146892853|NCT02041962|529773512|FG001|Overall Study|Withdrawal by Subject|11|||
146892854|NCT00330187|529773515|FG000|Overall Study|Lost to Follow-up|12|||
146892855|NCT00330187|529773516|FG001|Overall Study|Lost to Follow-up|13|||
146892856|NCT00330187|529773517|FG002|Overall Study|Lost to Follow-up|14|||
146892857|NCT00330187|529773518|FG003|Overall Study|Lost to Follow-up|10|||
146892858|NCT00330187|529773515|FG000|Overall Study|Withdrawal by Subject|8|||
146892859|NCT00330187|529773516|FG001|Overall Study|Withdrawal by Subject|5|||
146892860|NCT00330187|529773517|FG002|Overall Study|Withdrawal by Subject|4|||
146892861|NCT00330187|529773518|FG003|Overall Study|Withdrawal by Subject|4|||
146892862|NCT02908516|529773519|FG000|Overall Study|Study Terminated|3|||
146892863|NCT02908516|529773520|FG001|Overall Study|Study Terminated|3|||
146892864|NCT01225562|529773521|FG000|Overall Study|Withdrawal by Subject|52|||
146892865|NCT01225562|529773522|FG001|Overall Study|Withdrawal by Subject|50|||
146892866|NCT01225562|529773523|FG002|Overall Study|Withdrawal by Subject|52|||
146557679|NCT03973489|528551159|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
146557680|NCT03973489|528551152|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
146557681|NCT03973489|528551153|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
146557682|NCT03973489|528551154|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
146557683|NCT03973489|528551155|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
146557684|NCT03973489|528551156|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
146557685|NCT03973489|528551157|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
146637224|NCT03565497|528847250|FG000|Overall Study|Lost to Follow-up|1|||
146892867|NCT01225562|529773521|FG000|Overall Study|Lost to Follow-up|3|||
146892868|NCT01225562|529773522|FG001|Overall Study|Lost to Follow-up|6|||
146892869|NCT01225562|529773523|FG002|Overall Study|Lost to Follow-up|1|||
146892870|NCT01481896|529773526|FG000|Overall Study|Lost to Follow-up|12|||
146892871|NCT01162421|529773532|FG000|Overall Study|Did not receive study drug|2|||
146892872|NCT01162421|529773533|FG001|Overall Study|Did not receive study drug|1|||
146892873|NCT01162421|529773532|FG000|Overall Study|Adverse Event|2|||
146892874|NCT01162421|529773533|FG001|Overall Study|Adverse Event|5|||
146892875|NCT01162421|529773532|FG000|Overall Study|Lost to Follow-up|0|||
146892876|NCT01162421|529773533|FG001|Overall Study|Lost to Follow-up|2|||
146892877|NCT01162421|529773532|FG000|Overall Study|Lack of Efficacy|2|||
146892878|NCT01162421|529773533|FG001|Overall Study|Lack of Efficacy|2|||
146892879|NCT01162421|529773532|FG000|Overall Study|Other|2|||
146892880|NCT01162421|529773533|FG001|Overall Study|Other|3|||
146892881|NCT01948830|529773537|FG000|Overall Study|Physician Decision|1|||
146892882|NCT01948830|529773538|FG001|Overall Study|Physician Decision|3|||
146892883|NCT01948830|529773537|FG000|Overall Study|Protocol deviation|1|||
146892884|NCT01948830|529773538|FG001|Overall Study|Protocol deviation|2|||
146892885|NCT01948830|529773537|FG000|Overall Study|Lost to Follow-up|5|||
146892886|NCT01948830|529773538|FG001|Overall Study|Lost to Follow-up|4|||
146967860|NCT00471237|530043846|FG001|Overall Study|Withdrawal by Subject|6|||
146967861|NCT00471237|530043847|FG002|Overall Study|Withdrawal by Subject|5|||
146967862|NCT00471237|530043848|FG003|Overall Study|Withdrawal by Subject|8|||
146967863|NCT00471237|530043849|FG004|Overall Study|Withdrawal by Subject|7|||
146967864|NCT00471237|530043850|FG005|Overall Study|Withdrawal by Subject|4|||
146637225|NCT03565497|528847251|FG001|Overall Study|Lost to Follow-up|1|||
146892887|NCT01948830|529773537|FG000|Overall Study|Withdrawal by Subject|14|||
146892888|NCT01948830|529773538|FG001|Overall Study|Withdrawal by Subject|17|||
146892889|NCT01948830|529773537|FG000|Overall Study|Adverse Event|9|||
146892890|NCT01948830|529773538|FG001|Overall Study|Adverse Event|2|||
146892891|NCT01948830|529773537|FG000|Overall Study|Death|3|||
146967865|NCT00471237|530043851|FG006|Overall Study|Withdrawal by Subject|2|||
146967866|NCT00471237|530043845|FG000|Overall Study|Sponsor terminated study|20|||
146892892|NCT01948830|529773538|FG001|Overall Study|Death|4|||
146892893|NCT03310970|529773539|FG000|Overall Study|Withdrawal by Subject|0|||
146892894|NCT03310970|529773540|FG001|Overall Study|Withdrawal by Subject|1|||
146892895|NCT01133171|529773541|FG000|Overall Study|Withdrawal by Subject|1|||
146892896|NCT01133171|529773542|FG001|Overall Study|Withdrawal by Subject|2|||
146892897|NCT01133171|529773543|FG002|Overall Study|Withdrawal by Subject|0|||
146892898|NCT02542072|529773547|FG000|First Intervention (1 Month)|Adverse Event|1|||
146892899|NCT02542072|529773548|FG001|First Intervention (1 Month)|Adverse Event|1|||
146557686|NCT03973489|528551158|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
146557687|NCT03973489|528551159|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
146892900|NCT02542072|529773547|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
146892901|NCT02542072|529773548|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
146892902|NCT02542072|529773547|FG000|First Intervention (1 Month)|Lens discomfort|1|||
146892903|NCT02542072|529773548|FG001|First Intervention (1 Month)|Lens discomfort|2|||
146892904|NCT02542072|529773547|FG000|First Intervention (1 Month)|Protocol Violation|1|||
146637226|NCT03565497|528847252|FG002|Overall Study|Lost to Follow-up|2|||
146766354|NCT01235949|529312232|FG010|Booster Phase|Migrated/moved from study area|0|||
146766355|NCT01235949|529312233|FG011|Booster Phase|Migrated/moved from study area|1|||
146892905|NCT02542072|529773548|FG001|First Intervention (1 Month)|Protocol Violation|0|||
146892906|NCT02542072|529773547|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
146892907|NCT02542072|529773548|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
146892908|NCT02542072|529773547|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
146892909|NCT02542072|529773548|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
146892910|NCT00654498|529773549|FG000|Overall Study|Not Treated|1|||
146892911|NCT00654498|529773550|FG001|Overall Study|Not Treated|0|||
146892912|NCT00654498|529773549|FG000|Overall Study|Adverse Event|6|||
146892913|NCT00654498|529773550|FG001|Overall Study|Adverse Event|1|||
146892914|NCT00654498|529773549|FG000|Overall Study|Protocol Violation|1|||
146892915|NCT00654498|529773550|FG001|Overall Study|Protocol Violation|1|||
146892916|NCT00654498|529773549|FG000|Overall Study|Lost to Follow-up|1|||
146892917|NCT00654498|529773550|FG001|Overall Study|Lost to Follow-up|5|||
146892918|NCT00654498|529773549|FG000|Overall Study|Withdrawal by Subject|1|||
146892919|NCT00654498|529773550|FG001|Overall Study|Withdrawal by Subject|0|||
146892920|NCT00654498|529773549|FG000|Overall Study|Other reason not defined above|4|||
146892921|NCT00654498|529773550|FG001|Overall Study|Other reason not defined above|5|||
146892922|NCT00670007|529775864|FG000|Overall Study|Drug abuse|1|||
146892923|NCT00670007|529775864|FG000|Overall Study|Lung transplant|1|||
146892924|NCT00670007|529775864|FG000|Overall Study|Travel/Vacation|1|||
146892925|NCT00670007|529775864|FG000|Overall Study|Adverse event, serious fatal|1|||
146892926|NCT00670007|529775864|FG000|Overall Study|Adverse Event|1|||
146766356|NCT01235949|529312234|FG012|Booster Phase|Migrated/moved from study area|1|||
146892927|NCT00670007|529775864|FG000|Overall Study|Withdrawal by Subject|4|||
146892928|NCT00127127|529775865|FG000|Overall Study|Adverse Event|0|||
146892929|NCT00127127|529775866|FG001|Overall Study|Adverse Event|2|||
146892930|NCT00127127|529775867|FG002|Overall Study|Adverse Event|0|||
146892931|NCT00127127|529775868|FG003|Overall Study|Adverse Event|1|||
146892932|NCT00127127|529775865|FG000|Overall Study|Lack of Efficacy|1|||
146892933|NCT00127127|529775866|FG001|Overall Study|Lack of Efficacy|3|||
146637227|NCT03565497|528847250|FG000|Overall Study|Withdrawal by Subject|1|||
146892934|NCT00127127|529775867|FG002|Overall Study|Lack of Efficacy|0|||
146892935|NCT00127127|529775868|FG003|Overall Study|Lack of Efficacy|2|||
146892936|NCT01059448|529775870|FG000|Overall Study|Adverse Event|1|||
146892937|NCT01059448|529775871|FG001|Overall Study|Adverse Event|3|||
146892938|NCT01059448|529775872|FG002|Overall Study|Adverse Event|0|||
146892939|NCT01059448|529775873|FG003|Overall Study|Adverse Event|1|||
146892940|NCT01059448|529775870|FG000|Overall Study|Withdrawal by Subject|2|||
146892941|NCT01059448|529775871|FG001|Overall Study|Withdrawal by Subject|0|||
146892942|NCT01059448|529775872|FG002|Overall Study|Withdrawal by Subject|2|||
146892943|NCT01059448|529775873|FG003|Overall Study|Withdrawal by Subject|4|||
146892944|NCT01059448|529775870|FG000|Overall Study|Disease Progression|2|||
146892945|NCT01059448|529775871|FG001|Overall Study|Disease Progression|1|||
146892946|NCT01059448|529775872|FG002|Overall Study|Disease Progression|4|||
146892947|NCT01059448|529775873|FG003|Overall Study|Disease Progression|2|||
146892948|NCT01059448|529775870|FG000|Overall Study|Administrative Decision|43|||
146892949|NCT01059448|529775871|FG001|Overall Study|Administrative Decision|49|||
146892950|NCT01059448|529775872|FG002|Overall Study|Administrative Decision|45|||
146892951|NCT01059448|529775873|FG003|Overall Study|Administrative Decision|46|||
146892952|NCT01059448|529775870|FG000|Overall Study|Lost to Follow-up|0|||
146892953|NCT01059448|529775871|FG001|Overall Study|Lost to Follow-up|0|||
146892954|NCT01059448|529775872|FG002|Overall Study|Lost to Follow-up|2|||
146892955|NCT01059448|529775873|FG003|Overall Study|Lost to Follow-up|0|||
146766357|NCT01235949|529312235|FG013|Booster Phase|Migrated/moved from study area|0|||
146766358|NCT01235949|529312236|FG014|Booster Phase|Migrated/moved from study area|0|||
146892956|NCT01059448|529775870|FG000|Overall Study|Death|0|||
146892957|NCT01059448|529775871|FG001|Overall Study|Death|1|||
146892958|NCT01059448|529775872|FG002|Overall Study|Death|0|||
146892959|NCT01059448|529775873|FG003|Overall Study|Death|0|||
146892960|NCT01059448|529775870|FG000|Overall Study|Other|1|||
146892961|NCT01059448|529775871|FG001|Overall Study|Other|1|||
146892962|NCT01059448|529775872|FG002|Overall Study|Other|0|||
146892963|NCT01059448|529775873|FG003|Overall Study|Other|1|||
146892964|NCT00778830|529775874|FG000|Overall Study|Ongoing at data cut-off|0|||
146892965|NCT00778830|529775875|FG001|Overall Study|Ongoing at data cut-off|1|||
146892966|NCT01891643|529775876|FG000|Overall Study|Adverse event unrelated to study drug|2|||
146892967|NCT01891643|529775877|FG001|Overall Study|Adverse event unrelated to study drug|5|||
146637228|NCT03565497|528847251|FG001|Overall Study|Withdrawal by Subject|1|||
146637229|NCT03565497|528847252|FG002|Overall Study|Withdrawal by Subject|1|||
146892968|NCT01891643|529775876|FG000|Overall Study|Disease Progression|4|||
146892969|NCT01891643|529775877|FG001|Overall Study|Disease Progression|3|||
146892970|NCT01891643|529775876|FG000|Overall Study|Study Drug Toxicity|3|||
146892971|NCT01891643|529775877|FG001|Overall Study|Study Drug Toxicity|0|||
146892972|NCT01891643|529775876|FG000|Overall Study|Maximum Clinical Benefit|0|||
146557688|NCT03973489|528551152|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
146892973|NCT01891643|529775877|FG001|Overall Study|Maximum Clinical Benefit|1|||
146892974|NCT01891643|529775876|FG000|Overall Study|Poor/Non-compliance|0|||
146892975|NCT01891643|529775877|FG001|Overall Study|Poor/Non-compliance|1|||
146892976|NCT01891643|529775876|FG000|Overall Study|Participant request to discontinue|1|||
146892977|NCT01891643|529775877|FG001|Overall Study|Participant request to discontinue|0|||
146892978|NCT02591615|529775880|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
146892979|NCT02591615|529775881|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
146892980|NCT02591615|529775882|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
146892981|NCT02591615|529775883|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
146892982|NCT02591615|529775880|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
146892983|NCT02591615|529775881|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
146892984|NCT02591615|529775882|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
146892985|NCT02591615|529775883|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
146892986|NCT02591615|529775880|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
146892987|NCT02591615|529775881|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
146892988|NCT02591615|529775882|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
146892989|NCT02591615|529775883|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
146892990|NCT02591615|529775880|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
146892991|NCT02591615|529775881|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
146892992|NCT02591615|529775882|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
146892993|NCT02591615|529775883|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
146892994|NCT02591615|529775880|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
146766359|NCT01235949|529312237|FG015|Booster Phase|Migrated/moved from study area|0|||
146766360|NCT01235949|529312238|FG016|Booster Phase|Migrated/moved from study area|0|||
146557689|NCT03973489|528551153|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
146766361|NCT01235949|529312239|FG017|Booster Phase|Migrated/moved from study area|1|||
146557690|NCT03973489|528551154|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
146557691|NCT03973489|528551155|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
146557692|NCT03973489|528551156|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
146557693|NCT03973489|528551157|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
146766362|NCT01235949|529312222|FG000|Booster Phase|Adverse Event|0|||
146967867|NCT00471237|530043846|FG001|Overall Study|Sponsor terminated study|23|||
146557694|NCT03973489|528551158|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
146766363|NCT01235949|529312223|FG001|Booster Phase|Adverse Event|0|||
146766364|NCT01235949|529312224|FG002|Booster Phase|Adverse Event|0|||
146557695|NCT03973489|528551159|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
146557696|NCT03973489|528551152|FG000|Second Intervention (1 Day)|Adverse Event|0|||
146766365|NCT01235949|529312225|FG003|Booster Phase|Adverse Event|0|||
146557697|NCT03973489|528551153|FG001|Second Intervention (1 Day)|Adverse Event|0|||
146892995|NCT02591615|529775881|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
146892996|NCT02591615|529775882|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
146557698|NCT03973489|528551154|FG002|Second Intervention (1 Day)|Adverse Event|0|||
146557699|NCT03973489|528551155|FG003|Second Intervention (1 Day)|Adverse Event|1|||
146766366|NCT01235949|529312226|FG004|Booster Phase|Adverse Event|0|||
146967868|NCT00471237|530043847|FG002|Overall Study|Sponsor terminated study|19|||
146967869|NCT00471237|530043848|FG003|Overall Study|Sponsor terminated study|22|||
146637240|NCT01075685|528847255|FG000|Overall Study|Protocol Violation|9|||
146637241|NCT01075685|528847256|FG001|Overall Study|Protocol Violation|1|||
146967870|NCT00471237|530043849|FG004|Overall Study|Sponsor terminated study|18|||
146967871|NCT00471237|530043850|FG005|Overall Study|Sponsor terminated study|24|||
146967872|NCT00471237|530043851|FG006|Overall Study|Sponsor terminated study|0|||
146967873|NCT00471237|530043845|FG000|Overall Study|Non-compliance|0|||
146967874|NCT00471237|530043846|FG001|Overall Study|Non-compliance|1|||
146967875|NCT00471237|530043847|FG002|Overall Study|Non-compliance|0|||
146967876|NCT00471237|530043848|FG003|Overall Study|Non-compliance|1|||
146967877|NCT00471237|530043849|FG004|Overall Study|Non-compliance|0|||
146967878|NCT00471237|530043850|FG005|Overall Study|Non-compliance|0|||
146967879|NCT00471237|530043851|FG006|Overall Study|Non-compliance|0|||
146967880|NCT00471237|530043845|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
146967881|NCT00471237|530043846|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
146967882|NCT00471237|530043847|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
146967883|NCT00471237|530043848|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
146967884|NCT00471237|530043849|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
146967885|NCT00471237|530043850|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
146967886|NCT00471237|530043851|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
146967887|NCT00471237|530043845|FG000|Overall Study|Early stopping due to non-efficacy|1|||
146967888|NCT00471237|530043846|FG001|Overall Study|Early stopping due to non-efficacy|0|||
146967889|NCT00471237|530043847|FG002|Overall Study|Early stopping due to non-efficacy|0|||
146967890|NCT00471237|530043848|FG003|Overall Study|Early stopping due to non-efficacy|0|||
146967891|NCT00471237|530043849|FG004|Overall Study|Early stopping due to non-efficacy|1|||
146967892|NCT00471237|530043850|FG005|Overall Study|Early stopping due to non-efficacy|0|||
146967893|NCT00471237|530043851|FG006|Overall Study|Early stopping due to non-efficacy|0|||
146967894|NCT00471237|530043845|FG000|Overall Study|Participant planned to travel to abraod|1|||
146967895|NCT00471237|530043846|FG001|Overall Study|Participant planned to travel to abraod|0|||
146967896|NCT00471237|530043847|FG002|Overall Study|Participant planned to travel to abraod|0|||
146967897|NCT00471237|530043848|FG003|Overall Study|Participant planned to travel to abraod|0|||
146967898|NCT00471237|530043849|FG004|Overall Study|Participant planned to travel to abraod|0|||
146967899|NCT00471237|530043850|FG005|Overall Study|Participant planned to travel to abraod|1|||
146967900|NCT00471237|530043851|FG006|Overall Study|Participant planned to travel to abraod|0|||
146967901|NCT00471237|530043845|FG000|Overall Study|High parathyroid hormone|0|||
146967902|NCT00471237|530043846|FG001|Overall Study|High parathyroid hormone|0|||
146967903|NCT00471237|530043847|FG002|Overall Study|High parathyroid hormone|1|||
146967904|NCT00471237|530043848|FG003|Overall Study|High parathyroid hormone|0|||
146967905|NCT00471237|530043849|FG004|Overall Study|High parathyroid hormone|0|||
146967906|NCT00471237|530043850|FG005|Overall Study|High parathyroid hormone|0|||
146967907|NCT00471237|530043851|FG006|Overall Study|High parathyroid hormone|0|||
146967908|NCT00471237|530043845|FG000|Overall Study|Participant lost medication|0|||
146967909|NCT00471237|530043846|FG001|Overall Study|Participant lost medication|0|||
146967910|NCT00471237|530043847|FG002|Overall Study|Participant lost medication|0|||
146967911|NCT00471237|530043848|FG003|Overall Study|Participant lost medication|0|||
146967912|NCT00471237|530043849|FG004|Overall Study|Participant lost medication|1|||
146967913|NCT00471237|530043850|FG005|Overall Study|Participant lost medication|0|||
146967914|NCT00471237|530043851|FG006|Overall Study|Participant lost medication|0|||
146967915|NCT00471237|530043845|FG000|Overall Study|Administration of prohibited medicine|0|||
146967916|NCT00471237|530043846|FG001|Overall Study|Administration of prohibited medicine|0|||
146557700|NCT03973489|528551156|FG004|Second Intervention (1 Day)|Adverse Event|0|||
146557701|NCT03973489|528551157|FG005|Second Intervention (1 Day)|Adverse Event|0|||
146557702|NCT03973489|528551158|FG006|Second Intervention (1 Day)|Adverse Event|0|||
146967917|NCT00471237|530043847|FG002|Overall Study|Administration of prohibited medicine|0|||
146967918|NCT00471237|530043848|FG003|Overall Study|Administration of prohibited medicine|0|||
146967919|NCT00471237|530043849|FG004|Overall Study|Administration of prohibited medicine|1|||
146967920|NCT00471237|530043850|FG005|Overall Study|Administration of prohibited medicine|0|||
146557703|NCT03973489|528551159|FG007|Second Intervention (1 Day)|Adverse Event|0|||
146557704|NCT03301415|528551160|FG000|Overall Study|Lost to Follow-up|2|||
146557705|NCT03301415|528551160|FG000|Overall Study|Unable to comply with visit schedule|2|||
146557706|NCT03247673|528551161|FG000|Overall Study|Withdrawal by Subject|1|||
146557707|NCT03247673|528551162|FG001|Overall Study|Withdrawal by Subject|0|||
146557708|NCT03247673|528551163|FG002|Overall Study|Withdrawal by Subject|3|||
146557709|NCT03247673|528551161|FG000|Overall Study|Lost to Follow-up|0|||
146557710|NCT03247673|528551162|FG001|Overall Study|Lost to Follow-up|0|||
146557711|NCT03247673|528551163|FG002|Overall Study|Lost to Follow-up|1|||
146557712|NCT02184442|528551167|FG000|Overall Study|Death|61|||
146557713|NCT02184442|528551168|FG001|Overall Study|Death|65|||
146557714|NCT02184442|528551167|FG000|Overall Study|Withdrawal by Subject|3|||
146557715|NCT02184442|528551168|FG001|Overall Study|Withdrawal by Subject|11|||
146557716|NCT02254291|528552243|FG000|Overall Study|Withdrawal by Subject|0|||
146557717|NCT02254291|528552244|FG001|Overall Study|Withdrawal by Subject|3|||
146557718|NCT02254291|528552245|FG002|Overall Study|Withdrawal by Subject|1|||
146637242|NCT01075685|528847255|FG000|Overall Study|Withdrawal by Subject|20|||
146637243|NCT01075685|528847256|FG001|Overall Study|Withdrawal by Subject|5|||
146637244|NCT01075685|528847255|FG000|Overall Study|Lost to Follow-up|563|||
146637245|NCT01075685|528847256|FG001|Overall Study|Lost to Follow-up|220|||
146637246|NCT02858362|528847259|FG000|Overall Study|Protocol Violation|0|||
146637247|NCT02858362|528847260|FG001|Overall Study|Protocol Violation|1|||
146637248|NCT02858362|528847261|FG002|Overall Study|Protocol Violation|0|||
146637249|NCT02858362|528847259|FG000|Overall Study|Withdrawal by Subject|1|||
146637250|NCT02858362|528847260|FG001|Overall Study|Withdrawal by Subject|0|||
146637251|NCT02858362|528847261|FG002|Overall Study|Withdrawal by Subject|0|||
146637252|NCT02858362|528847259|FG000|Overall Study|Early Study Termination|0|||
146637253|NCT02858362|528847260|FG001|Overall Study|Early Study Termination|0|||
146892997|NCT02591615|529775883|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
146557719|NCT02254291|528552243|FG000|Overall Study|Missing follow-up information|0|||
146557720|NCT02254291|528552244|FG001|Overall Study|Missing follow-up information|0|||
146557721|NCT02254291|528552245|FG002|Overall Study|Missing follow-up information|1|||
146557722|NCT00833703|528552256|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
146557723|NCT00833703|528552257|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
146892998|NCT02591615|529775880|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
146557724|NCT01557569|528552260|FG000|Overall Study|Adverse Event|2|||
146557725|NCT01557569|528552261|FG001|Overall Study|Adverse Event|0|||
146557726|NCT01557569|528552260|FG000|Overall Study|high blood pressure|0|||
146557727|NCT01557569|528552261|FG001|Overall Study|high blood pressure|1|||
146557728|NCT01557569|528552260|FG000|Overall Study|Withdrawal by Subject|3|||
146557729|NCT01557569|528552261|FG001|Overall Study|Withdrawal by Subject|5|||
146557730|NCT01557569|528552260|FG000|Overall Study|noncompliance with rules of residential|0|||
146557731|NCT01557569|528552261|FG001|Overall Study|noncompliance with rules of residential|1|||
146557732|NCT02254460|528552266|FG000|Overall Study|Adverse Event|1|||
146557733|NCT02254460|528552267|FG001|Overall Study|Adverse Event|0|||
146557734|NCT02263547|528552274|FG000|Overall Study|Adverse Event|1|||
146557735|NCT02263547|528552274|FG000|Overall Study|Lost to Follow-up|2|||
146557736|NCT01935947|528552277|FG000|Overall Study|Adverse Event|0|||
146967921|NCT00471237|530043851|FG006|Overall Study|Administration of prohibited medicine|0|||
146967922|NCT00471237|530043845|FG000|Overall Study|Participant shifted residence|0|||
146967923|NCT00471237|530043846|FG001|Overall Study|Participant shifted residence|0|||
146967924|NCT00471237|530043847|FG002|Overall Study|Participant shifted residence|0|||
146967925|NCT00471237|530043848|FG003|Overall Study|Participant shifted residence|0|||
146967926|NCT00471237|530043849|FG004|Overall Study|Participant shifted residence|1|||
146967927|NCT00471237|530043850|FG005|Overall Study|Participant shifted residence|0|||
146967928|NCT00471237|530043851|FG006|Overall Study|Participant shifted residence|0|||
146967929|NCT00471237|530043845|FG000|Overall Study|Participant's decision|0|||
146967930|NCT00471237|530043846|FG001|Overall Study|Participant's decision|0|||
146967931|NCT00471237|530043847|FG002|Overall Study|Participant's decision|0|||
146967932|NCT00471237|530043848|FG003|Overall Study|Participant's decision|0|||
146967933|NCT00471237|530043849|FG004|Overall Study|Participant's decision|0|||
146967934|NCT00471237|530043850|FG005|Overall Study|Participant's decision|1|||
146967935|NCT00471237|530043851|FG006|Overall Study|Participant's decision|0|||
146967936|NCT03710824|530043852|FG000|Overall Study|Withdrawal by Subject|1|||
146557737|NCT01935947|528552278|FG001|Overall Study|Adverse Event|2|||
146557738|NCT01935947|528552279|FG002|Overall Study|Adverse Event|0|||
146557739|NCT01935947|528552277|FG000|Overall Study|Diease Progression|2|||
146766367|NCT01235949|529312227|FG005|Booster Phase|Adverse Event|0|||
146766368|NCT01235949|529312228|FG006|Booster Phase|Adverse Event|0|||
146766369|NCT01235949|529312229|FG007|Booster Phase|Adverse Event|0|||
146557740|NCT01935947|528552278|FG001|Overall Study|Diease Progression|2|||
146557741|NCT01935947|528552279|FG002|Overall Study|Diease Progression|2|||
146766370|NCT01235949|529312230|FG008|Booster Phase|Adverse Event|0|||
146967937|NCT03710824|530043852|FG000|Overall Study|Lost to Follow-up|3|||
146967938|NCT03710824|530043852|FG000|Overall Study|Adverse Event|25|||
146967939|NCT03710824|530043852|FG000|Overall Study|Treatment discontinuation|2|||
146967940|NCT03237325|530043856|FG000|Overall Study|Lost to Follow-up|3|||
146967941|NCT03237325|530043857|FG001|Overall Study|Lost to Follow-up|5|||
146967942|NCT03237325|530043856|FG000|Overall Study|Physician Decision|2|||
146967943|NCT03237325|530043857|FG001|Overall Study|Physician Decision|4|||
146766371|NCT01235949|529312231|FG009|Booster Phase|Adverse Event|0|||
146766372|NCT01235949|529312232|FG010|Booster Phase|Adverse Event|0|||
146967944|NCT03237325|530043856|FG000|Overall Study|Withdrawal by Subject|9|||
146557742|NCT01935947|528552277|FG000|Overall Study|Death|1|||
146557743|NCT01935947|528552278|FG001|Overall Study|Death|0|||
146557744|NCT01935947|528552279|FG002|Overall Study|Death|0|||
146557745|NCT01148771|528552280|FG000|Washout Period|Withdrawal by Subject|0|||
146766373|NCT01235949|529312233|FG011|Booster Phase|Adverse Event|0|||
146766374|NCT01235949|529312234|FG012|Booster Phase|Adverse Event|0|||
146766375|NCT01235949|529312235|FG013|Booster Phase|Adverse Event|0|||
146557746|NCT01148771|528552281|FG001|Washout Period|Withdrawal by Subject|1|||
146557747|NCT01229111|528552282|FG000|Overall Study|Death|1|||
146557748|NCT04102514|528552283|FG000|Overall Study|Death|3|||
146557749|NCT04102514|528552284|FG001|Overall Study|Death|0|||
146892999|NCT02591615|529775881|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
146557750|NCT04102514|528552285|FG002|Overall Study|Death|0|||
146557751|NCT04102514|528552286|FG003|Overall Study|Death|0|||
146557752|NCT04102514|528552283|FG000|Overall Study|Lost to Follow-up|0|||
146557753|NCT04102514|528552284|FG001|Overall Study|Lost to Follow-up|0|||
146557754|NCT04102514|528552285|FG002|Overall Study|Lost to Follow-up|3|||
146557755|NCT04102514|528552286|FG003|Overall Study|Lost to Follow-up|0|||
146557756|NCT04102514|528552283|FG000|Overall Study|Physician Decision|0|||
146557757|NCT04102514|528552284|FG001|Overall Study|Physician Decision|0|||
146557758|NCT04102514|528552285|FG002|Overall Study|Physician Decision|1|||
146557759|NCT04102514|528552286|FG003|Overall Study|Physician Decision|0|||
146557760|NCT04102514|528552283|FG000|Overall Study|Withdrawal by Subject|7|||
146893000|NCT02591615|529775882|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
146893001|NCT02591615|529775883|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
146893002|NCT02591615|529775880|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
146893003|NCT02591615|529775881|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
146893004|NCT02591615|529775882|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
146893005|NCT02591615|529775883|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
146893006|NCT02591615|529775880|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
146893007|NCT02591615|529775881|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
146893008|NCT02591615|529775882|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
146893009|NCT02591615|529775883|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
146893010|NCT02591615|529775880|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
146893011|NCT02591615|529775881|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
146893012|NCT02591615|529775882|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
146893013|NCT02591615|529775883|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
146893014|NCT02591615|529775880|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
146893015|NCT02591615|529775881|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
146893016|NCT02591615|529775882|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
146893017|NCT02591615|529775883|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
146893018|NCT02591615|529775880|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
146893019|NCT02591615|529775881|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
146893020|NCT02591615|529775882|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
146557761|NCT04102514|528552284|FG001|Overall Study|Withdrawal by Subject|13|||
146557762|NCT04102514|528552285|FG002|Overall Study|Withdrawal by Subject|7|||
146557763|NCT04102514|528552286|FG003|Overall Study|Withdrawal by Subject|14|||
146557764|NCT04102514|528552283|FG000|Overall Study|Moved to longterm care facility|6|||
146557765|NCT04102514|528552284|FG001|Overall Study|Moved to longterm care facility|0|||
146557766|NCT04102514|528552285|FG002|Overall Study|Moved to longterm care facility|4|||
146893021|NCT02591615|529775883|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
146893022|NCT02591615|529775880|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
146557767|NCT04102514|528552286|FG003|Overall Study|Moved to longterm care facility|0|||
146557768|NCT03268499|528552287|FG000|Overall Study|Withdrawal by Subject|2|||
146557769|NCT03268499|528552288|FG001|Overall Study|Withdrawal by Subject|1|||
146557770|NCT05071027|528552298|FG000|Overall Study|Lost to Follow-up|1|||
146557771|NCT05071027|528552299|FG001|Overall Study|Lost to Follow-up|4|||
146557772|NCT05463952|528552303|FG000|Treatment|Progressive disease|4|||
146557773|NCT05463952|528552303|FG000|Treatment|Ongoing|2|||
146967945|NCT03237325|530043857|FG001|Overall Study|Withdrawal by Subject|12|||
146967946|NCT03237325|530043856|FG000|Overall Study|Noncompliance with Study Procedures|1|||
146766376|NCT01235949|529312236|FG014|Booster Phase|Adverse Event|0|||
146967947|NCT03237325|530043857|FG001|Overall Study|Noncompliance with Study Procedures|1|||
146967948|NCT03237325|530043856|FG000|Overall Study|Termination by Sponsor|0|||
146967949|NCT03237325|530043857|FG001|Overall Study|Termination by Sponsor|1|||
146967950|NCT03237325|530043856|FG000|Overall Study|Reason other than described|0|||
146967951|NCT03237325|530043857|FG001|Overall Study|Reason other than described|2|||
146967952|NCT04139642|530043861|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
146967953|NCT04139642|530043862|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
146557774|NCT00595075|528552304|FG000|Overall Study|Withdrawal by Subject|1|||
146557775|NCT00595075|528552305|FG001|Overall Study|Withdrawal by Subject|0|||
146557776|NCT02096354|528552310|FG000|Overall Study|Physician Decision|4|||
146967954|NCT00138658|530043867|FG000|Overall Study|Adverse Event|23|||
146967955|NCT00138658|530043867|FG000|Overall Study|Death|1|||
146967956|NCT00138658|530043867|FG000|Overall Study|Disease Progression|21|||
146967957|NCT00138658|530043867|FG000|Overall Study|Physician Decision|11|||
146967958|NCT00138658|530043867|FG000|Overall Study|Withdrawal by Subject|5|||
146967959|NCT03733301|530043868|FG000|Overall Study|Screen Fail|1|||
146967960|NCT03733301|530043869|FG001|Overall Study|Screen Fail|0|||
146967961|NCT03733301|530043870|FG002|Overall Study|Screen Fail|0|||
146967962|NCT03733301|530043868|FG000|Overall Study|Non-compliance|1|||
146967963|NCT03733301|530043869|FG001|Overall Study|Non-compliance|0|||
146557777|NCT02096354|528552311|FG001|Overall Study|Physician Decision|5|||
146557778|NCT02096354|528552312|FG002|Overall Study|Physician Decision|0|||
146557779|NCT02096354|528552310|FG000|Overall Study|Withdrawal by Subject|3|||
146967964|NCT03733301|530043870|FG002|Overall Study|Non-compliance|0|||
146967965|NCT03733301|530043868|FG000|Overall Study|Lack of Efficacy|2|||
146967966|NCT03733301|530043869|FG001|Overall Study|Lack of Efficacy|3|||
146766377|NCT01235949|529312237|FG015|Booster Phase|Adverse Event|1|||
146967967|NCT03733301|530043870|FG002|Overall Study|Lack of Efficacy|0|||
146967968|NCT03733301|530043868|FG000|Overall Study|Adverse Event|0|||
146967969|NCT03733301|530043869|FG001|Overall Study|Adverse Event|1|||
146967970|NCT03733301|530043870|FG002|Overall Study|Adverse Event|3|||
146557780|NCT02096354|528552311|FG001|Overall Study|Withdrawal by Subject|1|||
146557781|NCT02096354|528552312|FG002|Overall Study|Withdrawal by Subject|0|||
146557782|NCT02096354|528552310|FG000|Overall Study|Adverse Event|7|||
146557783|NCT02096354|528552311|FG001|Overall Study|Adverse Event|4|||
146557784|NCT02096354|528552312|FG002|Overall Study|Adverse Event|0|||
146557785|NCT02096354|528552310|FG000|Overall Study|Ineligible|0|||
146893023|NCT02591615|529775881|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
146893024|NCT02591615|529775882|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
146893025|NCT02591615|529775883|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
146893026|NCT02591615|529775880|FG000|Maintenance MK-3475|Adverse Event|0|||
146893027|NCT02591615|529775881|FG001|Maintenance MK-3475|Adverse Event|3|||
146893028|NCT02591615|529775882|FG002|Maintenance MK-3475|Adverse Event|1|||
146893029|NCT02591615|529775883|FG003|Maintenance MK-3475|Adverse Event|2|||
146893030|NCT02591615|529775880|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
146893031|NCT02591615|529775881|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
146893032|NCT02591615|529775882|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
146893033|NCT02591615|529775883|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
146893034|NCT02591615|529775880|FG000|Maintenance MK-3475|Death|0|||
146893035|NCT02591615|529775881|FG001|Maintenance MK-3475|Death|1|||
146893036|NCT02591615|529775882|FG002|Maintenance MK-3475|Death|1|||
146893037|NCT02591615|529775883|FG003|Maintenance MK-3475|Death|0|||
146893038|NCT02591615|529775880|FG000|Maintenance MK-3475|Physician discretion|0|||
146893039|NCT02591615|529775881|FG001|Maintenance MK-3475|Physician discretion|0|||
146893040|NCT02591615|529775882|FG002|Maintenance MK-3475|Physician discretion|1|||
146893041|NCT02591615|529775883|FG003|Maintenance MK-3475|Physician discretion|0|||
146893042|NCT02591615|529775880|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
146893043|NCT02591615|529775881|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
146893044|NCT02591615|529775882|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
146893045|NCT02591615|529775883|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
146893046|NCT02591615|529775880|FG000|Maintenance MK-3475|In active treatment|2|||
146893047|NCT02591615|529775881|FG001|Maintenance MK-3475|In active treatment|0|||
146893048|NCT02591615|529775882|FG002|Maintenance MK-3475|In active treatment|0|||
146893049|NCT02591615|529775883|FG003|Maintenance MK-3475|In active treatment|1|||
146893050|NCT04188197|529775884|FG000|Overall Study|Lost to Follow-up|4|||
146893051|NCT04188197|529775885|FG001|Overall Study|Lost to Follow-up|1|||
146893052|NCT04188197|529775884|FG000|Overall Study|Withdrawal by Subject|1|||
146893053|NCT04188197|529775885|FG001|Overall Study|Withdrawal by Subject|1|||
146893054|NCT04188197|529775884|FG000|Overall Study|Pregnancy|0|||
146893055|NCT04188197|529775885|FG001|Overall Study|Pregnancy|1|||
146893056|NCT00956943|529775895|FG000|Overall Study|Lost to Follow-up|9|||
146893057|NCT00956943|529775896|FG001|Overall Study|Lost to Follow-up|10|||
146893058|NCT02613208|529775897|FG000|Overall Study|Withdrawal by Subject|1|||
146893059|NCT02613208|529775897|FG000|Overall Study|Change of address|2|||
146893060|NCT02613208|529775897|FG000|Overall Study|Physician Decision|2|||
146893061|NCT02613208|529775897|FG000|Overall Study|Lost to Follow-up|5|||
146893062|NCT02613208|529775897|FG000|Overall Study|Death|37|||
146893063|NCT02663895|529775898|FG000|Overall Study|Adverse Event|3|||
146893064|NCT02663895|529775898|FG000|Overall Study|Physician Decision|2|||
146893065|NCT02663895|529775898|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
146893066|NCT02663895|529775898|FG000|Overall Study|Withdrawal by Subject|1|||
146893067|NCT00809328|529775902|FG000|Overall Study|Lack of Efficacy|18|||
146893068|NCT00809328|529775902|FG000|Overall Study|Adverse Event|6|||
146893069|NCT00809328|529775902|FG000|Overall Study|Protocol Violation|3|||
146893070|NCT00809328|529775902|FG000|Overall Study|Withdrawal by Subject|2|||
146893071|NCT02911688|529775903|FG000|Washout|Lost to Follow-up|1|||
146893072|NCT02911688|529775904|FG001|Washout|Lost to Follow-up|1|||
146893073|NCT02911688|529775903|FG000|Washout|Withdrawal by Subject|0|||
146893074|NCT02911688|529775904|FG001|Washout|Withdrawal by Subject|1|||
146893075|NCT01400932|529775907|FG000|Overall Study|Adverse Event|10|||
146893076|NCT01400932|529775908|FG001|Overall Study|Adverse Event|5|||
146893077|NCT01400932|529775907|FG000|Overall Study|Lack of Efficacy|0|||
146893078|NCT01400932|529775908|FG001|Overall Study|Lack of Efficacy|3|||
146893079|NCT01400932|529775907|FG000|Overall Study|Withdrawal by Subject|2|||
146893080|NCT01400932|529775908|FG001|Overall Study|Withdrawal by Subject|6|||
146893081|NCT01400932|529775907|FG000|Overall Study|Lost to Follow-up|1|||
146893082|NCT01400932|529775908|FG001|Overall Study|Lost to Follow-up|0|||
146893083|NCT01400932|529775907|FG000|Overall Study|Protocol Deviation|0|||
146893084|NCT01400932|529775908|FG001|Overall Study|Protocol Deviation|1|||
146893085|NCT01400932|529775907|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
146893086|NCT01400932|529775908|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
146893087|NCT04656990|529775909|FG000|Baseline|pandemic|20|||
146893088|NCT04656990|529775910|FG001|Baseline|pandemic|24|||
146893089|NCT04656990|529775909|FG000|Follow Up Period|Lost to Follow-up|61|||
146893090|NCT04656990|529775910|FG001|Follow Up Period|Lost to Follow-up|73|||
146893091|NCT03244059|529775911|FG000|Specific Aim 1|Physician Decision|1|||
146893092|NCT03244059|529775912|FG001|Specific Aim 1|Physician Decision|0|||
146893093|NCT03244059|529775911|FG000|Specific Aim 2|Physician Decision|1|||
146893094|NCT03244059|529775912|FG001|Specific Aim 2|Physician Decision|0|||
146893095|NCT00282243|529775914|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
146893096|NCT00282243|529775914|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
146893097|NCT00282243|529775914|FG000|Extension Treatment Period|Adverse Event|15|||
146893098|NCT00282243|529775914|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
146893099|NCT00282243|529775914|FG000|Extension Treatment Period|Non-compliance|2|||
146893100|NCT00282243|529775914|FG000|Extension Treatment Period|Physician Decision|1|||
146893101|NCT00851903|529775915|FG000|Overall Study|Withdrawal by Subject|2|||
146893102|NCT00270894|529775916|FG000|Overall Study|Adverse Event|1|||
146893103|NCT00270894|529775916|FG000|Overall Study|Withdrawal by Subject|1|||
146893104|NCT01070329|529775917|FG000|Overall Study|Adverse Event|13|||
146893105|NCT01070329|529775918|FG001|Overall Study|Adverse Event|10|||
146893106|NCT01070329|529775917|FG000|Overall Study|Lost to Follow-up|22|||
146893107|NCT01070329|529775918|FG001|Overall Study|Lost to Follow-up|12|||
146893108|NCT01070329|529775917|FG000|Overall Study|Withdrawal by Subject|9|||
146893109|NCT01070329|529775918|FG001|Overall Study|Withdrawal by Subject|11|||
146893110|NCT01070329|529775917|FG000|Overall Study|Protocol Violation|3|||
146893111|NCT01070329|529775918|FG001|Overall Study|Protocol Violation|8|||
146893112|NCT01070329|529775917|FG000|Overall Study|Lack of Efficacy|2|||
146893113|NCT01070329|529775918|FG001|Overall Study|Lack of Efficacy|6|||
146893114|NCT01070329|529775917|FG000|Overall Study|Physician Decision|2|||
146893115|NCT01070329|529775918|FG001|Overall Study|Physician Decision|1|||
146893116|NCT01070329|529775917|FG000|Overall Study|Entry Criteria Not Met|1|||
146893117|NCT01070329|529775918|FG001|Overall Study|Entry Criteria Not Met|0|||
146893118|NCT01070329|529775917|FG000|Overall Study|Sponsor Decision|0|||
146893119|NCT01070329|529775918|FG001|Overall Study|Sponsor Decision|1|||
146893120|NCT02863848|529775919|FG000|Overall Study|Lost to Follow-up|1|||
146893121|NCT02863848|529775920|FG001|Overall Study|Lost to Follow-up|1|||
146893122|NCT02863848|529775919|FG000|Overall Study|Protocol Violation|1|||
146893123|NCT02863848|529775920|FG001|Overall Study|Protocol Violation|2|||
146893124|NCT00686127|529775923|FG000|Overall Study|Withdrawal by Subject|14|||
146893125|NCT00686127|529775924|FG001|Overall Study|Withdrawal by Subject|6|||
146893126|NCT06441877|529775925|FG000|Overall Study|Withdrawal by Subject|0|||
146893127|NCT06441877|529775926|FG001|Overall Study|Withdrawal by Subject|2|||
146893128|NCT06441877|529775927|FG002|Overall Study|Withdrawal by Subject|0|||
146893129|NCT06441877|529775928|FG003|Overall Study|Withdrawal by Subject|0|||
146893130|NCT03706365|529775935|FG000|Overall Study|Lost to Follow-up|7|||
146893131|NCT03706365|529775936|FG001|Overall Study|Lost to Follow-up|0|||
146893132|NCT03706365|529775935|FG000|Overall Study|Withdrawal by Subject|17|||
146893133|NCT03706365|529775936|FG001|Overall Study|Withdrawal by Subject|15|||
146893134|NCT03706365|529775935|FG000|Overall Study|On Study Treatment|51|||
146893135|NCT03706365|529775936|FG001|Overall Study|On Study Treatment|51|||
146967971|NCT03733301|530043868|FG000|Overall Study|Withdrawal by Subject|3|||
146557786|NCT02096354|528552311|FG001|Overall Study|Ineligible|0|||
146557787|NCT02096354|528552312|FG002|Overall Study|Ineligible|11|||
146557788|NCT03579719|528552315|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
146557789|NCT00069953|528552316|FG000|Overall Study|Protocol Violation|2|||
146557790|NCT01646216|528552317|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
146557791|NCT01646216|528552318|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
146557792|NCT01646216|528552317|FG000|Overall Study|Did not complete training|0|||
146557793|NCT01646216|528552318|FG001|Overall Study|Did not complete training|2|||
146557794|NCT01646216|528552317|FG000|Overall Study|Investigator decision|1|||
146557795|NCT01646216|528552318|FG001|Overall Study|Investigator decision|1|||
146557796|NCT00113373|528552321|FG000|Overall Study|Ineligible: wrong primary|1|||
146893136|NCT03116113|529775937|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
146893137|NCT03116113|529775938|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
146893138|NCT03116113|529775939|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
146893139|NCT03116113|529775940|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
146893140|NCT03116113|529775941|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
146893141|NCT03116113|529775942|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
146893142|NCT03116113|529775943|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
146557797|NCT00113373|528552321|FG000|Overall Study|Ineligible: second primary|1|||
146557798|NCT00113373|528552321|FG000|Overall Study|Never Treated|1|||
146893143|NCT03116113|529775944|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
146893144|NCT03116113|529775945|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
146557799|NCT02395627|528552322|FG000|Overall Study|Withdrawal by Subject|0|||
146557800|NCT02395627|528552323|FG001|Overall Study|Withdrawal by Subject|2|||
146557801|NCT02395627|528552324|FG002|Overall Study|Withdrawal by Subject|0|||
146893145|NCT02159807|529775946|FG000|Overall Study|Adverse Event|0|||
146893146|NCT02159807|529775947|FG001|Overall Study|Adverse Event|0|||
146893147|NCT02159807|529775948|FG002|Overall Study|Adverse Event|1|||
146893148|NCT02159807|529775946|FG000|Overall Study|No CSF|1|||
146557802|NCT02395627|528552322|FG000|Overall Study|Did not receive pembrolizumab|3|||
146557803|NCT02395627|528552323|FG001|Overall Study|Did not receive pembrolizumab|1|||
146893149|NCT02159807|529775947|FG001|Overall Study|No CSF|1|||
146893150|NCT02159807|529775948|FG002|Overall Study|No CSF|1|||
146893151|NCT02159807|529775946|FG000|Overall Study|elevated blood pressure|0|||
146893152|NCT02159807|529775947|FG001|Overall Study|elevated blood pressure|0|||
146893153|NCT02159807|529775948|FG002|Overall Study|elevated blood pressure|1|||
146893154|NCT00950170|529775949|FG000|Overall Study|Parent/Legal Guardian Request|1|||
146893155|NCT00950170|529775949|FG000|Overall Study|Adverse Event|2|||
146893156|NCT00950170|529775949|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
146893157|NCT01254669|529775950|FG000|Overall Study|Withdrawal by Subject|0|||
146893158|NCT01254669|529775951|FG001|Overall Study|Withdrawal by Subject|1|||
146893159|NCT01254669|529775950|FG000|Overall Study|time constraint|2|||
146893160|NCT01254669|529775951|FG001|Overall Study|time constraint|2|||
146893161|NCT01254669|529775950|FG000|Overall Study|called to clinic during intervention|1|||
146893162|NCT01254669|529775951|FG001|Overall Study|called to clinic during intervention|1|||
146893163|NCT02357420|529775952|FG000|Overall Study|Adverse Event|3|||
146893164|NCT02357420|529775953|FG001|Overall Study|Adverse Event|3|||
146893165|NCT02357420|529775954|FG002|Overall Study|Adverse Event|8|||
146893166|NCT02357420|529775955|FG003|Overall Study|Adverse Event|9|||
146893167|NCT02357420|529775952|FG000|Overall Study|Investigator Decision|1|||
146893168|NCT02357420|529775953|FG001|Overall Study|Investigator Decision|0|||
146893169|NCT02357420|529775954|FG002|Overall Study|Investigator Decision|0|||
146893170|NCT02357420|529775955|FG003|Overall Study|Investigator Decision|0|||
146893171|NCT02357420|529775952|FG000|Overall Study|Prohibited Medication|1|||
146893172|NCT02357420|529775953|FG001|Overall Study|Prohibited Medication|1|||
146893173|NCT02357420|529775954|FG002|Overall Study|Prohibited Medication|0|||
146893174|NCT02357420|529775955|FG003|Overall Study|Prohibited Medication|0|||
146893175|NCT02357420|529775952|FG000|Overall Study|Protocol Non-compliance|0|||
146893176|NCT02357420|529775953|FG001|Overall Study|Protocol Non-compliance|0|||
146893177|NCT02357420|529775954|FG002|Overall Study|Protocol Non-compliance|0|||
146893178|NCT02357420|529775955|FG003|Overall Study|Protocol Non-compliance|1|||
146893179|NCT02357420|529775952|FG000|Overall Study|Withdrawn Consent|4|||
146893180|NCT02357420|529775953|FG001|Overall Study|Withdrawn Consent|8|||
146893181|NCT02357420|529775954|FG002|Overall Study|Withdrawn Consent|6|||
146893182|NCT02357420|529775955|FG003|Overall Study|Withdrawn Consent|6|||
146893183|NCT02357420|529775952|FG000|Overall Study|Lost to Follow-up|3|||
146893184|NCT02357420|529775953|FG001|Overall Study|Lost to Follow-up|0|||
146893185|NCT02357420|529775954|FG002|Overall Study|Lost to Follow-up|2|||
146893186|NCT02357420|529775955|FG003|Overall Study|Lost to Follow-up|3|||
146893187|NCT01061008|529775956|FG000|Overall Study|Badiocephalic fistula failed|3|||
146893188|NCT01061008|529775957|FG001|Overall Study|Badiocephalic fistula failed|2|||
146893189|NCT01061008|529775956|FG000|Overall Study|Death|1|||
146557804|NCT02395627|528552324|FG002|Overall Study|Did not receive pembrolizumab|0|||
146557805|NCT03253627|528552325|FG000|Overall Study|Lost to Follow-up|1|||
146893190|NCT01061008|529775957|FG001|Overall Study|Death|0|||
146893191|NCT01061008|529775956|FG000|Overall Study|Withdrawal by Subject|1|||
146893192|NCT01061008|529775957|FG001|Overall Study|Withdrawal by Subject|3|||
146893193|NCT01061008|529775956|FG000|Overall Study|Unable to exercise following surgery|1|||
146893194|NCT01061008|529775957|FG001|Overall Study|Unable to exercise following surgery|0|||
146893195|NCT01061008|529775956|FG000|Overall Study|Adverse Event|0|||
146893196|NCT01061008|529775957|FG001|Overall Study|Adverse Event|1|||
146893197|NCT02024971|529775959|FG000|Overall Study|Data Not Available|30|||
146557806|NCT03253627|528552326|FG001|Overall Study|Lost to Follow-up|2|||
146893198|NCT02024971|529775959|FG000|Overall Study|Lost to Follow-up|6|||
146893199|NCT02908100|529775960|FG000|Overall Study|Adverse Event|7|||
146893200|NCT02908100|529775961|FG001|Overall Study|Adverse Event|6|||
146893201|NCT02908100|529775962|FG002|Overall Study|Adverse Event|9|||
146893202|NCT02908100|529775960|FG000|Overall Study|Death|2|||
146893203|NCT02908100|529775961|FG001|Overall Study|Death|0|||
146893204|NCT02908100|529775962|FG002|Overall Study|Death|0|||
146893205|NCT02908100|529775960|FG000|Overall Study|Lack of Efficacy|2|||
146893206|NCT02908100|529775961|FG001|Overall Study|Lack of Efficacy|3|||
146766378|NCT01235949|529312238|FG016|Booster Phase|Adverse Event|0|||
146893207|NCT02908100|529775962|FG002|Overall Study|Lack of Efficacy|3|||
146893208|NCT02908100|529775960|FG000|Overall Study|Lost to Follow-up|0|||
146893209|NCT02908100|529775961|FG001|Overall Study|Lost to Follow-up|1|||
146893210|NCT02908100|529775962|FG002|Overall Study|Lost to Follow-up|2|||
146557807|NCT03253627|528552325|FG000|Overall Study|Withdrawal by Subject|0|||
146557808|NCT03253627|528552326|FG001|Overall Study|Withdrawal by Subject|2|||
146557809|NCT03253627|528552325|FG000|Overall Study|Inability to complete MRI|1|||
146967972|NCT03733301|530043869|FG001|Overall Study|Withdrawal by Subject|5|||
146967973|NCT03733301|530043870|FG002|Overall Study|Withdrawal by Subject|1|||
146967974|NCT02050373|530043871|FG000|Overall Study|Adverse Event|4|||
146967975|NCT02050373|530043872|FG001|Overall Study|Adverse Event|7|||
146967976|NCT02050373|530043871|FG000|Overall Study|Death|3|||
146967977|NCT02050373|530043872|FG001|Overall Study|Death|3|||
146967978|NCT00557830|530043879|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
146967979|NCT00557830|530043880|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
146967980|NCT00557830|530043881|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
146967981|NCT00557830|530043879|FG000|Screening Treatment Phase|Adverse Event|2|||
146766379|NCT01235949|529312239|FG017|Booster Phase|Adverse Event|0|||
146967982|NCT00557830|530043880|FG001|Screening Treatment Phase|Adverse Event|0|||
146967983|NCT00557830|530043881|FG002|Screening Treatment Phase|Adverse Event|0|||
146557810|NCT03253627|528552326|FG001|Overall Study|Inability to complete MRI|0|||
146766380|NCT01235949|529312222|FG000|Booster Phase|Withdrawal by Subject|0|||
146766381|NCT01235949|529312223|FG001|Booster Phase|Withdrawal by Subject|0|||
146893211|NCT02908100|529775960|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146893212|NCT02908100|529775961|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146893213|NCT02908100|529775962|FG002|Overall Study|Non-Compliance With Study Drug|2|||
146557811|NCT03829683|528552327|FG000|Overall Study|Lost to Follow-up|1|||
146893214|NCT02908100|529775960|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
146893215|NCT02908100|529775961|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
146893216|NCT02908100|529775962|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
146893217|NCT02908100|529775960|FG000|Overall Study|Physician Decision|0|||
146893218|NCT02908100|529775961|FG001|Overall Study|Physician Decision|1|||
146893219|NCT02908100|529775962|FG002|Overall Study|Physician Decision|0|||
146557812|NCT03829683|528552328|FG001|Overall Study|Lost to Follow-up|0|||
146557813|NCT03829683|528552327|FG000|Overall Study|Physician Decision|3|||
146557814|NCT03829683|528552328|FG001|Overall Study|Physician Decision|1|||
146557815|NCT03829683|528552327|FG000|Overall Study|Withdrawal by Subject|0|||
146557816|NCT03829683|528552328|FG001|Overall Study|Withdrawal by Subject|1|||
146557817|NCT03829683|528552327|FG000|Overall Study|Discharge from hospital|1|||
146557818|NCT03829683|528552328|FG001|Overall Study|Discharge from hospital|0|||
146557819|NCT03163667|528552329|FG000|Overall Study|Death|15|||
146557820|NCT03163667|528552330|FG001|Overall Study|Death|27|||
146557821|NCT03163667|528552329|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
146557822|NCT03163667|528552330|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
146893220|NCT02908100|529775960|FG000|Overall Study|Pregnancy|1|||
146893221|NCT02908100|529775961|FG001|Overall Study|Pregnancy|2|||
146893222|NCT02908100|529775962|FG002|Overall Study|Pregnancy|0|||
146893223|NCT02908100|529775960|FG000|Overall Study|Withdrawal by Subject|8|||
146557823|NCT02420314|528552331|FG000|Overall Study|Withdrawal by Subject|1|||
146557824|NCT02420314|528552331|FG000|Overall Study|Protocol Violation|1|||
146557825|NCT05430919|528552332|FG000|Overall Study|Protocol Violation|0|||
146557826|NCT05430919|528552333|FG001|Overall Study|Protocol Violation|0|||
146557827|NCT05430919|528552334|FG002|Overall Study|Protocol Violation|1|||
146557828|NCT05430919|528552335|FG003|Overall Study|Protocol Violation|0|||
146893224|NCT02908100|529775961|FG001|Overall Study|Withdrawal by Subject|7|||
146893225|NCT02908100|529775962|FG002|Overall Study|Withdrawal by Subject|5|||
146893226|NCT02908100|529775960|FG000|Overall Study|Randomised in Error|1|||
146893227|NCT02908100|529775961|FG001|Overall Study|Randomised in Error|0|||
146766382|NCT01235949|529312224|FG002|Booster Phase|Withdrawal by Subject|0|||
146766383|NCT01235949|529312225|FG003|Booster Phase|Withdrawal by Subject|0|||
146967984|NCT00557830|530043879|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
146893228|NCT02908100|529775962|FG002|Overall Study|Randomised in Error|0|||
146893229|NCT05254418|529775964|FG000|Overall Study|Adverse Event|2|||
146893230|NCT02631538|529775965|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
146893231|NCT02631538|529775966|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
146893232|NCT02631538|529775967|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
146557829|NCT05430919|528552332|FG000|Overall Study|Lost to Follow-up|0|||
146557830|NCT05430919|528552333|FG001|Overall Study|Lost to Follow-up|1|||
146557831|NCT05430919|528552334|FG002|Overall Study|Lost to Follow-up|0|||
146557832|NCT05430919|528552335|FG003|Overall Study|Lost to Follow-up|0|||
146557833|NCT05430919|528552332|FG000|Overall Study|Withdrawal by Subject|3|||
146557834|NCT05430919|528552333|FG001|Overall Study|Withdrawal by Subject|0|||
146557835|NCT05430919|528552334|FG002|Overall Study|Withdrawal by Subject|0|||
146557836|NCT05430919|528552335|FG003|Overall Study|Withdrawal by Subject|1|||
146557837|NCT04091438|528552339|FG000|Treatment Period 1 (1 Day)|Other|1|||
146557838|NCT04091438|528552340|FG001|Treatment Period 1 (1 Day)|Other|0|||
146893233|NCT02631538|529775968|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
146893234|NCT02631538|529775965|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
146557839|NCT04091438|528552339|FG000|Washout Period (1 Day)|Protocol deviation|0|||
146557840|NCT04091438|528552340|FG001|Washout Period (1 Day)|Protocol deviation|1|||
146557841|NCT04091438|528552339|FG000|Washout Period (1 Day)|Other|0|||
146557842|NCT04091438|528552340|FG001|Washout Period (1 Day)|Other|1|||
146557843|NCT02691494|528552345|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
146557844|NCT02691494|528552346|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
146557845|NCT02691494|528552347|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
146557846|NCT02691494|528552345|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
146557847|NCT02691494|528552346|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
146557848|NCT02691494|528552347|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
146557849|NCT02691494|528552345|FG000|Post-Treatment Follow-Up Period|Other|2|||
146557850|NCT02691494|528552346|FG001|Post-Treatment Follow-Up Period|Other|1|||
146557851|NCT02691494|528552347|FG002|Post-Treatment Follow-Up Period|Other|1|||
146557852|NCT02691494|528552345|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
146893235|NCT02631538|529775966|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
146557853|NCT02691494|528552346|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
146893236|NCT02631538|529775967|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
146893237|NCT02631538|529775968|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
146893238|NCT02631538|529775965|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
146893239|NCT02631538|529775966|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
146893240|NCT02631538|529775967|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
146893241|NCT02631538|529775968|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
146893242|NCT02631538|529775965|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
146766384|NCT01235949|529312226|FG004|Booster Phase|Withdrawal by Subject|0|||
146557854|NCT02691494|528552347|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
146557855|NCT02691494|528552345|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
146557856|NCT02691494|528552346|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
146557857|NCT02691494|528552347|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
146557858|NCT03249558|528552348|FG000|Overall Study|Lost to Follow-up|2|||
146557859|NCT03249558|528552349|FG001|Overall Study|Lost to Follow-up|1|||
146557860|NCT03249558|528552350|FG002|Overall Study|Lost to Follow-up|4|||
146557861|NCT03249558|528552348|FG000|Overall Study|Physician Decision|1|||
146557862|NCT03249558|528552349|FG001|Overall Study|Physician Decision|0|||
146557863|NCT03249558|528552350|FG002|Overall Study|Physician Decision|0|||
146557864|NCT03249558|528552348|FG000|Overall Study|Withdrawal by Subject|6|||
146557865|NCT03249558|528552349|FG001|Overall Study|Withdrawal by Subject|5|||
146893243|NCT02631538|529775966|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
146893244|NCT02631538|529775967|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
146893245|NCT02631538|529775968|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
146893246|NCT02631538|529775965|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
146893247|NCT02631538|529775966|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
146893248|NCT02631538|529775967|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
146893249|NCT02631538|529775968|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
146766385|NCT01235949|529312227|FG005|Booster Phase|Withdrawal by Subject|0|||
146893250|NCT02631538|529775965|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
146893251|NCT02631538|529775966|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
146893252|NCT02631538|529775967|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
146893253|NCT02631538|529775968|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
146893254|NCT00400400|529775969|FG000|Overall Study|Adverse Event|9|||
146893255|NCT00400400|529775970|FG001|Overall Study|Adverse Event|8|||
146557866|NCT03249558|528552350|FG002|Overall Study|Withdrawal by Subject|7|||
146893256|NCT00400400|529775969|FG000|Overall Study|Protocol Violation|2|||
146893257|NCT00400400|529775970|FG001|Overall Study|Protocol Violation|0|||
146557867|NCT03249558|528552348|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
146557868|NCT03249558|528552349|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
146557869|NCT03249558|528552350|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
146557870|NCT03249558|528552348|FG000|Overall Study|Protocol Violation|1|||
146557871|NCT03249558|528552349|FG001|Overall Study|Protocol Violation|1|||
146557872|NCT03249558|528552350|FG002|Overall Study|Protocol Violation|2|||
146557873|NCT00908141|528552353|FG000|Overall Study|Withdrawal by Subject|0|||
146557874|NCT00908141|528552354|FG001|Overall Study|Withdrawal by Subject|1|||
146557875|NCT02657356|528554099|FG000|Overall Study|Death|1|||
146557876|NCT02657356|528554100|FG001|Overall Study|Death|0|||
146557877|NCT02657356|528554099|FG000|Overall Study|Withdrawal by Subject|5|||
146557878|NCT02657356|528554100|FG001|Overall Study|Withdrawal by Subject|6|||
146557879|NCT02657356|528554099|FG000|Overall Study|Terminated by Sponsor|8|||
146557880|NCT02657356|528554100|FG001|Overall Study|Terminated by Sponsor|5|||
146557881|NCT02657356|528554099|FG000|Overall Study|Rolled over to EAP study|6|||
146557882|NCT02657356|528554100|FG001|Overall Study|Rolled over to EAP study|4|||
146557883|NCT03379870|528554101|FG000|Overall Study|Lost to Follow-up|1|||
146557884|NCT03379870|528554102|FG001|Overall Study|Lost to Follow-up|0|||
146557885|NCT03379870|528554101|FG000|Overall Study|Protocol Violation|1|||
146557886|NCT03379870|528554102|FG001|Overall Study|Protocol Violation|1|||
146557887|NCT02471144|528554103|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
146557888|NCT02471144|528554104|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
146557889|NCT02471144|528554105|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
146557890|NCT02471144|528554106|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
146557891|NCT02471144|528554107|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
146557892|NCT02471144|528554108|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
146557893|NCT02471144|528554109|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
146557894|NCT02471144|528554110|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
146557895|NCT02471144|528554111|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
146557896|NCT02471144|528554112|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
146557897|NCT02471144|528554113|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
146557898|NCT02471144|528554103|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
146557899|NCT02471144|528554104|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
146557900|NCT02471144|528554105|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
146557901|NCT02471144|528554106|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
146557902|NCT02471144|528554107|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
146557903|NCT02471144|528554108|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
146557904|NCT02471144|528554109|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
146557905|NCT02471144|528554110|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
146557906|NCT02471144|528554111|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
146557907|NCT02471144|528554112|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
146557908|NCT02471144|528554113|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
146557909|NCT02471144|528554103|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
146557910|NCT02471144|528554104|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
146557911|NCT02471144|528554105|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
146557912|NCT02471144|528554106|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
146557913|NCT02471144|528554107|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
146557914|NCT02471144|528554108|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
146557915|NCT02471144|528554109|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
146557916|NCT02471144|528554110|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
146557917|NCT02471144|528554111|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
146557918|NCT02471144|528554112|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
146557919|NCT02471144|528554113|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
146557920|NCT02471144|528554103|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
146893258|NCT00400400|529775969|FG000|Overall Study|Withdrawal by Subject|1|||
146557921|NCT02471144|528554104|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
146557922|NCT02471144|528554105|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
146557923|NCT02471144|528554106|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
146557924|NCT02471144|528554107|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
146557925|NCT02471144|528554108|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
146557926|NCT02471144|528554109|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
146557927|NCT02471144|528554110|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
146557928|NCT02471144|528554111|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
146557929|NCT02471144|528554112|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
146557930|NCT02471144|528554113|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
146557931|NCT02471144|528554103|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
146557932|NCT02471144|528554104|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
146557933|NCT02471144|528554105|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
146557934|NCT02471144|528554106|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
146557935|NCT02471144|528554107|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
146557936|NCT02471144|528554108|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
146557937|NCT02471144|528554109|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
146766386|NCT01235949|529312228|FG006|Booster Phase|Withdrawal by Subject|0|||
146766387|NCT01235949|529312229|FG007|Booster Phase|Withdrawal by Subject|1|||
146766388|NCT01235949|529312230|FG008|Booster Phase|Withdrawal by Subject|1|||
146557938|NCT02471144|528554110|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
146557939|NCT02471144|528554111|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
146557940|NCT02471144|528554112|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
146557941|NCT02471144|528554113|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
146557942|NCT02471144|528554103|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
146557943|NCT02471144|528554104|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
146557944|NCT02471144|528554105|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
146557945|NCT02471144|528554106|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
146557946|NCT02471144|528554107|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
146557947|NCT02471144|528554108|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
146557948|NCT02471144|528554109|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
146557949|NCT02471144|528554110|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
146557950|NCT02471144|528554111|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
146557951|NCT02471144|528554112|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
146893259|NCT00400400|529775970|FG001|Overall Study|Withdrawal by Subject|3|||
146893260|NCT00400400|529775969|FG000|Overall Study|Administrative Problem|1|||
146893261|NCT00400400|529775970|FG001|Overall Study|Administrative Problem|0|||
146893262|NCT00400400|529775969|FG000|Overall Study|Lost to Follow-up|0|||
146893263|NCT00400400|529775970|FG001|Overall Study|Lost to Follow-up|1|||
146893264|NCT00400400|529775969|FG000|Overall Study|Did not receive study drug|1|||
146893265|NCT00400400|529775970|FG001|Overall Study|Did not receive study drug|3|||
146557952|NCT02471144|528554113|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
146557953|NCT02471144|528554103|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
146557954|NCT02471144|528554104|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
146557955|NCT02471144|528554105|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
146557956|NCT02471144|528554106|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
146557957|NCT02471144|528554107|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
146557958|NCT02471144|528554108|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
146557959|NCT02471144|528554109|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
146557960|NCT02471144|528554110|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
146557961|NCT02471144|528554111|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
146557962|NCT02471144|528554112|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
146557963|NCT02471144|528554113|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
146557964|NCT02471144|528554103|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
146557965|NCT02471144|528554104|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
146557966|NCT02471144|528554105|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
146557967|NCT02471144|528554106|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
146557968|NCT02471144|528554107|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
146557969|NCT02471144|528554108|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
146557970|NCT02471144|528554109|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
146557971|NCT02471144|528554110|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
146557972|NCT02471144|528554111|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
146557973|NCT02471144|528554112|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
146557974|NCT02471144|528554113|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
146557975|NCT02471144|528554103|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
146557976|NCT02471144|528554104|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
146557977|NCT02471144|528554105|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
146557978|NCT02471144|528554106|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
146557979|NCT02471144|528554107|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
146557980|NCT02471144|528554108|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
146557981|NCT02471144|528554109|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
146557982|NCT02471144|528554110|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
146557983|NCT02471144|528554111|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
146557984|NCT02471144|528554112|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
146557985|NCT02471144|528554113|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
146557986|NCT02471144|528554103|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
146557987|NCT02471144|528554104|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
146557988|NCT02471144|528554105|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
146557989|NCT02471144|528554106|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
146557990|NCT02471144|528554107|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
146557991|NCT02471144|528554108|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
146557992|NCT02471144|528554109|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
146557993|NCT02471144|528554110|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
146557994|NCT02471144|528554111|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
146557995|NCT02471144|528554112|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
146557996|NCT02471144|528554113|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
146557997|NCT02471144|528554103|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
146557998|NCT02471144|528554104|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
146557999|NCT02471144|528554105|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
146558000|NCT02471144|528554106|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
146893266|NCT00648167|529775971|FG000|Overall Study|Adverse Event|6|||
146893267|NCT00648167|529775971|FG000|Overall Study|unable to swallow tablets|1|||
146893268|NCT01688050|529775972|FG000|Overall Study|Death|7|||
146558001|NCT02471144|528554107|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
146558002|NCT02471144|528554108|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
146558003|NCT02471144|528554109|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
146558004|NCT02471144|528554110|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
146558005|NCT02471144|528554111|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
146893269|NCT01688050|529775972|FG000|Overall Study|Conversion to open repair|1|||
146893270|NCT01688050|529775972|FG000|Overall Study|Lost to Follow-up|13|||
146893271|NCT01688050|529775972|FG000|Overall Study|Withdrawal by Subject|10|||
146893272|NCT01554579|529775973|FG000|Overall Study|Adverse Event|6|||
146893273|NCT01554579|529775974|FG001|Overall Study|Adverse Event|25|||
146893274|NCT01554579|529775973|FG000|Overall Study|Lack of Efficacy|2|||
146893275|NCT01554579|529775974|FG001|Overall Study|Lack of Efficacy|1|||
146893276|NCT01554579|529775973|FG000|Overall Study|Withdrawal by Subject|2|||
146893277|NCT01554579|529775974|FG001|Overall Study|Withdrawal by Subject|1|||
146893278|NCT00234039|529775975|FG000|Overall Study|Adverse Event|2|||
146893279|NCT00234039|529775975|FG000|Overall Study|Progression/relapse|34|||
146893280|NCT00234039|529775975|FG000|Overall Study|Other - Not Protocol Specified|3|||
146893281|NCT00234039|529775975|FG000|Overall Study|Ineligible|9|||
146893282|NCT00234039|529775975|FG000|Overall Study|No Protocol Treatment Received|2|||
146893283|NCT00110019|529775976|FG000|Overall Study|Lack of Efficacy|253|||
146893284|NCT00110019|529775977|FG001|Overall Study|Lack of Efficacy|285|||
146893285|NCT00110019|529775976|FG000|Overall Study|Adverse Event|61|||
146893286|NCT00110019|529775977|FG001|Overall Study|Adverse Event|40|||
146893287|NCT00110019|529775976|FG000|Overall Study|Death|13|||
146893288|NCT00110019|529775977|FG001|Overall Study|Death|15|||
146893289|NCT00110019|529775976|FG000|Overall Study|Withdrawal by Subject|21|||
146893290|NCT00110019|529775977|FG001|Overall Study|Withdrawal by Subject|9|||
146893291|NCT00110019|529775976|FG000|Overall Study|alternative therapy|5|||
146893292|NCT00110019|529775977|FG001|Overall Study|alternative therapy|1|||
146893293|NCT00110019|529775976|FG000|Overall Study|complicating disease|1|||
146893294|NCT00110019|529775977|FG001|Overall Study|complicating disease|1|||
146558006|NCT02471144|528554112|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
146558007|NCT02471144|528554113|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
146558008|NCT02471144|528554103|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
146893295|NCT00110019|529775976|FG000|Overall Study|symptom deterioration|13|||
146558009|NCT02471144|528554104|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
146893296|NCT00110019|529775977|FG001|Overall Study|symptom deterioration|16|||
146893297|NCT00110019|529775976|FG000|Overall Study|Not start protocol therapy|17|||
146893298|NCT00110019|529775977|FG001|Overall Study|Not start protocol therapy|16|||
146893299|NCT00110019|529775976|FG000|Overall Study|other reasons|22|||
146893300|NCT00110019|529775977|FG001|Overall Study|other reasons|30|||
146893301|NCT01046695|529775980|FG000|Overall Study|Subject had a pacemaker|0|||
146893302|NCT01046695|529775981|FG001|Overall Study|Subject had a pacemaker|1|||
146893303|NCT01046695|529775980|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
146893304|NCT01046695|529775981|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
146893305|NCT02239263|529775982|FG000|Overall Study|Protocol Violation|6|||
146893306|NCT04426695|529775983|FG000|Overall Study|Death|2|||
146893307|NCT04426695|529775984|FG001|Overall Study|Death|0|||
146893308|NCT04426695|529775985|FG002|Overall Study|Death|1|||
146893309|NCT04426695|529775986|FG003|Overall Study|Death|27|||
146893310|NCT04426695|529775987|FG004|Overall Study|Death|25|||
146893311|NCT04426695|529775988|FG005|Overall Study|Death|21|||
146893312|NCT04426695|529775989|FG006|Overall Study|Death|42|||
146893313|NCT04426695|529775990|FG007|Overall Study|Death|23|||
146893314|NCT04426695|529775991|FG008|Overall Study|Death|37|||
146893315|NCT04426695|529775992|FG009|Overall Study|Death|14|||
146893316|NCT04426695|529775993|FG010|Overall Study|Death|8|||
146893317|NCT04426695|529775994|FG011|Overall Study|Death|7|||
146893318|NCT04426695|529775995|FG012|Overall Study|Death|13|||
146893319|NCT04426695|529775996|FG013|Overall Study|Death|25|||
146893320|NCT04426695|529775997|FG014|Overall Study|Death|19|||
146893321|NCT04426695|529775998|FG015|Overall Study|Death|7|||
146893322|NCT04426695|529775999|FG016|Overall Study|Death|8|||
146893323|NCT04426695|529776000|FG017|Overall Study|Death|4|||
146893324|NCT04426695|529775983|FG000|Overall Study|Lost to Follow-up|2|||
146893325|NCT04426695|529775984|FG001|Overall Study|Lost to Follow-up|4|||
146893326|NCT04426695|529775985|FG002|Overall Study|Lost to Follow-up|1|||
146893327|NCT04426695|529775986|FG003|Overall Study|Lost to Follow-up|19|||
146893328|NCT04426695|529775987|FG004|Overall Study|Lost to Follow-up|10|||
146893329|NCT04426695|529775988|FG005|Overall Study|Lost to Follow-up|14|||
146893330|NCT04426695|529775989|FG006|Overall Study|Lost to Follow-up|5|||
146893331|NCT04426695|529775990|FG007|Overall Study|Lost to Follow-up|14|||
146893332|NCT04426695|529775991|FG008|Overall Study|Lost to Follow-up|10|||
146893333|NCT04426695|529775992|FG009|Overall Study|Lost to Follow-up|11|||
146893334|NCT04426695|529775993|FG010|Overall Study|Lost to Follow-up|12|||
146893335|NCT04426695|529775994|FG011|Overall Study|Lost to Follow-up|6|||
146893336|NCT04426695|529775995|FG012|Overall Study|Lost to Follow-up|2|||
146893337|NCT04426695|529775996|FG013|Overall Study|Lost to Follow-up|2|||
146893338|NCT04426695|529775997|FG014|Overall Study|Lost to Follow-up|2|||
146558010|NCT02471144|528554105|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
146558011|NCT02471144|528554106|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
146558012|NCT02471144|528554107|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
146558013|NCT02471144|528554108|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
146558014|NCT02471144|528554109|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
146558015|NCT02471144|528554110|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
146558016|NCT02471144|528554111|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
146558017|NCT02471144|528554112|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
146558018|NCT02471144|528554113|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
146558019|NCT02471144|528554103|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
146558020|NCT02471144|528554104|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
146558021|NCT02471144|528554105|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
146558022|NCT02471144|528554106|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
146558023|NCT02471144|528554107|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
146558024|NCT02471144|528554108|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
146558025|NCT02471144|528554109|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
146558026|NCT02471144|528554110|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
146558027|NCT02471144|528554111|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
146558028|NCT02471144|528554112|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
146558029|NCT02471144|528554113|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
146558030|NCT02471144|528554103|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
146558031|NCT02471144|528554104|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
146558032|NCT02471144|528554105|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
146558033|NCT02471144|528554106|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
146558034|NCT02471144|528554107|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
146558035|NCT02471144|528554108|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
146558036|NCT02471144|528554109|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
146558037|NCT02471144|528554110|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
146558038|NCT02471144|528554111|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
146893339|NCT04426695|529775998|FG015|Overall Study|Lost to Follow-up|0|||
146893340|NCT04426695|529775999|FG016|Overall Study|Lost to Follow-up|0|||
146893341|NCT04426695|529776000|FG017|Overall Study|Lost to Follow-up|0|||
146893342|NCT04426695|529775983|FG000|Overall Study|Participant Decision|1|||
146893343|NCT04426695|529775984|FG001|Overall Study|Participant Decision|2|||
146558039|NCT02471144|528554112|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
146558040|NCT02471144|528554113|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
146558041|NCT03058952|528554116|FG000|Overall Study|Adverse Event|1|||
146558042|NCT03058952|528554117|FG001|Overall Study|Adverse Event|0|||
146558043|NCT03058952|528554116|FG000|Overall Study|Lost to Follow-up|15|||
146558044|NCT03058952|528554117|FG001|Overall Study|Lost to Follow-up|15|||
146558045|NCT03058952|528554116|FG000|Overall Study|Withdrawal by Subject|7|||
146558046|NCT03058952|528554117|FG001|Overall Study|Withdrawal by Subject|11|||
146558047|NCT05654181|528554118|FG000|Overall Study|Adverse Event|1|||
146558048|NCT05654181|528554119|FG001|Overall Study|Adverse Event|0|||
146558049|NCT05654181|528554120|FG002|Overall Study|Adverse Event|0|||
146558050|NCT05654181|528554121|FG003|Overall Study|Adverse Event|0|||
146558051|NCT05654181|528554122|FG004|Overall Study|Adverse Event|0|||
146558052|NCT05654181|528554123|FG005|Overall Study|Adverse Event|0|||
146558053|NCT05654181|528554124|FG006|Overall Study|Adverse Event|0|||
146558054|NCT05654181|528554125|FG007|Overall Study|Adverse Event|1|||
146558055|NCT05654181|528554126|FG008|Overall Study|Adverse Event|0|||
146637254|NCT02858362|528847261|FG002|Overall Study|Early Study Termination|3|||
146637255|NCT02858362|528847259|FG000|Overall Study|Lost to Follow-up|1|||
146637256|NCT02858362|528847260|FG001|Overall Study|Lost to Follow-up|0|||
146637257|NCT02858362|528847261|FG002|Overall Study|Lost to Follow-up|0|||
146637258|NCT00392769|528847265|FG000|Overall Study|Clinical Deterioration|9|||
146637259|NCT00392769|528847265|FG000|Overall Study|Adverse Event|1|||
146637260|NCT02561832|528847266|FG000|Overall Study|Withdrawal by Subject|1|||
146637261|NCT02561832|528847267|FG001|Overall Study|Withdrawal by Subject|1|||
146637262|NCT02561832|528847266|FG000|Overall Study|Adverse Event|3|||
146637263|NCT02561832|528847267|FG001|Overall Study|Adverse Event|0|||
146637264|NCT02561832|528847266|FG000|Overall Study|Disease progression|3|||
146637265|NCT02561832|528847267|FG001|Overall Study|Disease progression|3|||
146637266|NCT00439517|528847269|FG000|Overall Study|Subject on treatment|1|||
146637267|NCT00439517|528847270|FG001|Overall Study|Subject on treatment|0|||
146637268|NCT00439517|528847269|FG000|Overall Study|Subject in survival follow-up|1|||
146637269|NCT00439517|528847270|FG001|Overall Study|Subject in survival follow-up|0|||
146637270|NCT00594815|528847273|FG000|Overall Study|Never Treated|3|||
146637271|NCT00594815|528847273|FG000|Overall Study|Withdrawal by Subject|2|||
146637272|NCT00594815|528847273|FG000|Overall Study|Toxicity|4|||
146637273|NCT03599089|528847274|FG000|Overall Study|Lost to Follow-up|1|||
146637274|NCT03599089|528847275|FG001|Overall Study|Lost to Follow-up|0|||
146637275|NCT03599089|528847276|FG002|Overall Study|Lost to Follow-up|0|||
146637276|NCT03599089|528847277|FG003|Overall Study|Lost to Follow-up|0|||
146637277|NCT03599089|528847274|FG000|Overall Study|Withdrawal by Subject|2|||
146637278|NCT03599089|528847275|FG001|Overall Study|Withdrawal by Subject|1|||
146637279|NCT03599089|528847276|FG002|Overall Study|Withdrawal by Subject|0|||
146637280|NCT03599089|528847277|FG003|Overall Study|Withdrawal by Subject|0|||
146637281|NCT03599089|528847274|FG000|Overall Study|Lack of Efficacy|0|||
146637282|NCT03599089|528847275|FG001|Overall Study|Lack of Efficacy|0|||
146637283|NCT03599089|528847276|FG002|Overall Study|Lack of Efficacy|1|||
146637284|NCT03599089|528847277|FG003|Overall Study|Lack of Efficacy|2|||
146637285|NCT03214666|528847278|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
146558056|NCT05654181|528554127|FG009|Overall Study|Adverse Event|0|||
146558057|NCT05654181|528554118|FG000|Overall Study|Withdrawal by Subject|0|||
146558058|NCT05654181|528554119|FG001|Overall Study|Withdrawal by Subject|0|||
146558059|NCT05654181|528554120|FG002|Overall Study|Withdrawal by Subject|0|||
146558060|NCT05654181|528554121|FG003|Overall Study|Withdrawal by Subject|0|||
146637286|NCT03214666|528847279|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
146558061|NCT05654181|528554122|FG004|Overall Study|Withdrawal by Subject|0|||
146558062|NCT05654181|528554123|FG005|Overall Study|Withdrawal by Subject|0|||
146558063|NCT05654181|528554124|FG006|Overall Study|Withdrawal by Subject|0|||
146558064|NCT05654181|528554125|FG007|Overall Study|Withdrawal by Subject|1|||
146558065|NCT05654181|528554126|FG008|Overall Study|Withdrawal by Subject|0|||
146558066|NCT05654181|528554127|FG009|Overall Study|Withdrawal by Subject|0|||
146558067|NCT05654181|528554118|FG000|Overall Study|Other|0|||
146558068|NCT05654181|528554119|FG001|Overall Study|Other|0|||
146558069|NCT05654181|528554120|FG002|Overall Study|Other|0|||
146558070|NCT05654181|528554121|FG003|Overall Study|Other|0|||
146558071|NCT05654181|528554122|FG004|Overall Study|Other|1|||
146558072|NCT05654181|528554123|FG005|Overall Study|Other|1|||
146558073|NCT05654181|528554124|FG006|Overall Study|Other|0|||
146558074|NCT05654181|528554125|FG007|Overall Study|Other|0|||
146558075|NCT05654181|528554126|FG008|Overall Study|Other|0|||
146558076|NCT05654181|528554127|FG009|Overall Study|Other|0|||
146558077|NCT04101331|528554128|FG000|Overall Study|Adverse Event|9|||
146558078|NCT04101331|528554128|FG000|Overall Study|Disease progression|82|||
146558079|NCT04101331|528554128|FG000|Overall Study|Withdrawal by Subject|1|||
146893344|NCT04426695|529775985|FG002|Overall Study|Participant Decision|2|||
146893345|NCT04426695|529775986|FG003|Overall Study|Participant Decision|12|||
146893346|NCT04426695|529775987|FG004|Overall Study|Participant Decision|18|||
146558080|NCT04101331|528554128|FG000|Overall Study|Investigator decision|6|||
146558081|NCT04101331|528554128|FG000|Overall Study|Death|6|||
146558082|NCT04101331|528554128|FG000|Overall Study|Allogenic transplant|1|||
146558083|NCT01444781|528554129|FG000|Overall Study|Lost to Follow-up|0|||
146766389|NCT01235949|529312231|FG009|Booster Phase|Withdrawal by Subject|0|||
146558084|NCT01444781|528554130|FG001|Overall Study|Lost to Follow-up|3|||
146637287|NCT03214666|528847280|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
146893347|NCT04426695|529775988|FG005|Overall Study|Participant Decision|22|||
146893348|NCT04426695|529775989|FG006|Overall Study|Participant Decision|13|||
146893349|NCT04426695|529775990|FG007|Overall Study|Participant Decision|13|||
146893350|NCT04426695|529775991|FG008|Overall Study|Participant Decision|10|||
146893351|NCT04426695|529775992|FG009|Overall Study|Participant Decision|15|||
146893352|NCT04426695|529775993|FG010|Overall Study|Participant Decision|16|||
146893353|NCT04426695|529775994|FG011|Overall Study|Participant Decision|17|||
146893354|NCT04426695|529775995|FG012|Overall Study|Participant Decision|2|||
146893355|NCT04426695|529775996|FG013|Overall Study|Participant Decision|1|||
146893356|NCT04426695|529775997|FG014|Overall Study|Participant Decision|2|||
146893357|NCT04426695|529775998|FG015|Overall Study|Participant Decision|0|||
146893358|NCT04426695|529775999|FG016|Overall Study|Participant Decision|0|||
146893359|NCT04426695|529776000|FG017|Overall Study|Participant Decision|0|||
146893360|NCT04426695|529775983|FG000|Overall Study|Adverse Event|0|||
146893361|NCT04426695|529775984|FG001|Overall Study|Adverse Event|0|||
146893362|NCT04426695|529775985|FG002|Overall Study|Adverse Event|0|||
146893363|NCT04426695|529775986|FG003|Overall Study|Adverse Event|0|||
146893364|NCT04426695|529775987|FG004|Overall Study|Adverse Event|0|||
146893365|NCT04426695|529775988|FG005|Overall Study|Adverse Event|0|||
146893366|NCT04426695|529775989|FG006|Overall Study|Adverse Event|0|||
146893367|NCT04426695|529775990|FG007|Overall Study|Adverse Event|1|||
146893368|NCT04426695|529775991|FG008|Overall Study|Adverse Event|0|||
146893369|NCT04426695|529775992|FG009|Overall Study|Adverse Event|0|||
146893370|NCT04426695|529775993|FG010|Overall Study|Adverse Event|1|||
146893371|NCT04426695|529775994|FG011|Overall Study|Adverse Event|1|||
146893372|NCT04426695|529775995|FG012|Overall Study|Adverse Event|0|||
146893373|NCT04426695|529775996|FG013|Overall Study|Adverse Event|0|||
146893374|NCT04426695|529775997|FG014|Overall Study|Adverse Event|0|||
146893375|NCT04426695|529775998|FG015|Overall Study|Adverse Event|0|||
146893376|NCT04426695|529775999|FG016|Overall Study|Adverse Event|0|||
146893377|NCT04426695|529776000|FG017|Overall Study|Adverse Event|0|||
146893378|NCT04426695|529775983|FG000|Overall Study|Sponsor Request|0|||
146893379|NCT04426695|529775984|FG001|Overall Study|Sponsor Request|0|||
146893380|NCT04426695|529775985|FG002|Overall Study|Sponsor Request|0|||
146893381|NCT04426695|529775986|FG003|Overall Study|Sponsor Request|0|||
146893382|NCT04426695|529775987|FG004|Overall Study|Sponsor Request|0|||
146893383|NCT04426695|529775988|FG005|Overall Study|Sponsor Request|0|||
146893384|NCT04426695|529775989|FG006|Overall Study|Sponsor Request|1|||
146893385|NCT04426695|529775990|FG007|Overall Study|Sponsor Request|0|||
146893386|NCT04426695|529775991|FG008|Overall Study|Sponsor Request|0|||
146893387|NCT04426695|529775992|FG009|Overall Study|Sponsor Request|0|||
146893388|NCT04426695|529775993|FG010|Overall Study|Sponsor Request|0|||
146893389|NCT04426695|529775994|FG011|Overall Study|Sponsor Request|0|||
146893390|NCT04426695|529775995|FG012|Overall Study|Sponsor Request|0|||
146893391|NCT04426695|529775996|FG013|Overall Study|Sponsor Request|0|||
146893392|NCT04426695|529775997|FG014|Overall Study|Sponsor Request|0|||
146893393|NCT04426695|529775998|FG015|Overall Study|Sponsor Request|0|||
146637288|NCT03214666|528847281|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
146893394|NCT04426695|529775999|FG016|Overall Study|Sponsor Request|0|||
146893395|NCT04426695|529776000|FG017|Overall Study|Sponsor Request|0|||
146893396|NCT04426695|529775983|FG000|Overall Study|Physician Decision|0|||
146893397|NCT04426695|529775984|FG001|Overall Study|Physician Decision|0|||
146893398|NCT04426695|529775985|FG002|Overall Study|Physician Decision|0|||
146893399|NCT04426695|529775986|FG003|Overall Study|Physician Decision|0|||
146637289|NCT03214666|528847282|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
146637290|NCT03214666|528847283|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
146893400|NCT04426695|529775987|FG004|Overall Study|Physician Decision|0|||
146893401|NCT04426695|529775988|FG005|Overall Study|Physician Decision|0|||
146893402|NCT04426695|529775989|FG006|Overall Study|Physician Decision|0|||
146893403|NCT04426695|529775990|FG007|Overall Study|Physician Decision|0|||
146893404|NCT04426695|529775991|FG008|Overall Study|Physician Decision|0|||
146893405|NCT04426695|529775992|FG009|Overall Study|Physician Decision|1|||
146893406|NCT04426695|529775993|FG010|Overall Study|Physician Decision|0|||
146893407|NCT04426695|529775994|FG011|Overall Study|Physician Decision|0|||
146893408|NCT04426695|529775995|FG012|Overall Study|Physician Decision|1|||
146893409|NCT04426695|529775996|FG013|Overall Study|Physician Decision|0|||
146893410|NCT04426695|529775997|FG014|Overall Study|Physician Decision|0|||
146893411|NCT04426695|529775998|FG015|Overall Study|Physician Decision|0|||
146893412|NCT04426695|529775999|FG016|Overall Study|Physician Decision|0|||
146893413|NCT04426695|529776000|FG017|Overall Study|Physician Decision|0|||
146893414|NCT04426695|529775983|FG000|Overall Study|Randomized but Never Treated|3|||
146893415|NCT04426695|529775984|FG001|Overall Study|Randomized but Never Treated|1|||
146893416|NCT04426695|529775985|FG002|Overall Study|Randomized but Never Treated|0|||
146893417|NCT04426695|529775986|FG003|Overall Study|Randomized but Never Treated|4|||
146893418|NCT04426695|529775987|FG004|Overall Study|Randomized but Never Treated|5|||
146893419|NCT04426695|529775988|FG005|Overall Study|Randomized but Never Treated|5|||
146893420|NCT04426695|529775989|FG006|Overall Study|Randomized but Never Treated|4|||
146893421|NCT04426695|529775990|FG007|Overall Study|Randomized but Never Treated|6|||
146893422|NCT04426695|529775991|FG008|Overall Study|Randomized but Never Treated|6|||
146893423|NCT04426695|529775992|FG009|Overall Study|Randomized but Never Treated|3|||
146893424|NCT04426695|529775993|FG010|Overall Study|Randomized but Never Treated|3|||
146558085|NCT01444781|528554131|FG002|Overall Study|Lost to Follow-up|1|||
146558086|NCT01444781|528554129|FG000|Overall Study|Withdrawal by Subject|3|||
146558087|NCT01444781|528554130|FG001|Overall Study|Withdrawal by Subject|1|||
146558088|NCT01444781|528554131|FG002|Overall Study|Withdrawal by Subject|2|||
146558089|NCT00267488|528554132|FG000|Overall Study|Sponsor Terminated Study|9|||
146558090|NCT00267488|528554132|FG000|Overall Study|Protocol Violation|1|||
146558091|NCT00267488|528554132|FG000|Overall Study|Other (Disease Progression)|1|||
146558092|NCT01149460|528554133|FG000|Overall Study|Withdrawal by Subject|0|||
146558093|NCT01149460|528554134|FG001|Overall Study|Withdrawal by Subject|2|||
146558094|NCT01904279|528554140|FG000|Overall Study|Lack of Efficacy|2|||
146558095|NCT01904279|528554141|FG001|Overall Study|Lack of Efficacy|3|||
146558096|NCT01904279|528554140|FG000|Overall Study|Withdrawal by Subject|1|||
146558097|NCT01904279|528554141|FG001|Overall Study|Withdrawal by Subject|0|||
146558098|NCT02801578|528554149|FG000|Overall Study|Adverse Event|2|||
146558099|NCT01356940|528554150|FG000|First Intervention (28 Days)|Adverse Event|1|||
146558100|NCT01356940|528554151|FG001|First Intervention (28 Days)|Adverse Event|0|||
146558101|NCT01356940|528554150|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
146558102|NCT01356940|528554151|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
146558103|NCT00668642|528554157|FG000|First Off-cycle|Cancer progression|1|||
146558104|NCT00668642|528554158|FG001|First Off-cycle|Cancer progression|0|||
146558105|NCT00668642|528554157|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
146558106|NCT00668642|528554158|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
146558107|NCT03412591|528554159|FG000|Overall Study|Withdrawal by Subject|1|||
146558108|NCT03412591|528554160|FG001|Overall Study|Withdrawal by Subject|8|||
146558109|NCT03412591|528554159|FG000|Overall Study|Adverse Event|0|||
146558110|NCT03412591|528554160|FG001|Overall Study|Adverse Event|1|||
146558111|NCT02272985|528554161|FG000|Overall Study|Withdrawal by Subject|1|||
146558112|NCT02272985|528554161|FG000|Overall Study|hip fracture|1|||
146558113|NCT02272985|528554161|FG000|Overall Study|kidney transplantation|1|||
146558114|NCT02489279|528554162|FG000|Overall Study|Lost to Follow-up|12|||
146558115|NCT02489279|528554163|FG001|Overall Study|Lost to Follow-up|10|||
146558116|NCT00505687|528554164|FG000|Overall Study|Important protocol violation|2|||
146558117|NCT00505687|528554164|FG000|Overall Study|Lack of Efficacy|15|||
146558118|NCT00505687|528554164|FG000|Overall Study|Adverse Event|48|||
146558119|NCT00505687|528554164|FG000|Overall Study|Subject withdrew consent|15|||
146558120|NCT00505687|528554164|FG000|Overall Study|Lost to Follow-up|1|||
146558121|NCT00505687|528554164|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
146558122|NCT00505687|528554164|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
146558123|NCT00505687|528554164|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
146558124|NCT00505687|528554164|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
146558125|NCT00505687|528554164|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
146558126|NCT00505687|528554164|FG000|Overall Study|Other: Disease Progression|1|||
146558127|NCT00505687|528554164|FG000|Overall Study|Other: As Per Sponsor|8|||
146558128|NCT03283241|528554165|FG000|Overall Study|Adverse Event|4|||
146558129|NCT03283241|528554166|FG001|Overall Study|Adverse Event|1|||
146558130|NCT03283241|528554165|FG000|Overall Study|Withdrawal by Subject|0|||
146558131|NCT03283241|528554166|FG001|Overall Study|Withdrawal by Subject|1|||
146558132|NCT03283241|528554165|FG000|Overall Study|Subject relocated to Finland|0|||
146558133|NCT03283241|528554166|FG001|Overall Study|Subject relocated to Finland|1|||
146893425|NCT04426695|529775994|FG011|Overall Study|Randomized but Never Treated|6|||
146893426|NCT04426695|529775995|FG012|Overall Study|Randomized but Never Treated|1|||
146893427|NCT04426695|529775996|FG013|Overall Study|Randomized but Never Treated|2|||
146893428|NCT04426695|529775997|FG014|Overall Study|Randomized but Never Treated|0|||
146893429|NCT04426695|529775998|FG015|Overall Study|Randomized but Never Treated|0|||
146893430|NCT04426695|529775999|FG016|Overall Study|Randomized but Never Treated|0|||
146967985|NCT00557830|530043880|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
146967986|NCT00557830|530043881|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
146967987|NCT01803464|530043885|FG000|Overall Study|Incomplete data|0|||
146967988|NCT01803464|530043886|FG001|Overall Study|Incomplete data|0|||
146967989|NCT01803464|530043887|FG002|Overall Study|Incomplete data|4|||
146967990|NCT01803464|530043888|FG003|Overall Study|Incomplete data|0|||
146967991|NCT01803464|530043885|FG000|Overall Study|Withdrawal by Subject|1|||
146967992|NCT01803464|530043886|FG001|Overall Study|Withdrawal by Subject|0|||
146967993|NCT01803464|530043887|FG002|Overall Study|Withdrawal by Subject|0|||
146967994|NCT01803464|530043888|FG003|Overall Study|Withdrawal by Subject|0|||
146967995|NCT01856257|530043891|FG000|Overall Study|Death|2|||
146967996|NCT01856257|530043892|FG001|Overall Study|Death|0|||
146967997|NCT01856257|530043893|FG002|Overall Study|Death|0|||
146967998|NCT01856257|530043894|FG003|Overall Study|Death|0|||
146967999|NCT01856257|530043891|FG000|Overall Study|Physician Decision|0|||
146968000|NCT01856257|530043892|FG001|Overall Study|Physician Decision|0|||
146968001|NCT01856257|530043893|FG002|Overall Study|Physician Decision|0|||
146968002|NCT01856257|530043894|FG003|Overall Study|Physician Decision|1|||
146968003|NCT01856257|530043891|FG000|Overall Study|Withdrawal by Subject|1|||
146968004|NCT01856257|530043892|FG001|Overall Study|Withdrawal by Subject|1|||
146968005|NCT01856257|530043893|FG002|Overall Study|Withdrawal by Subject|0|||
146968006|NCT01856257|530043894|FG003|Overall Study|Withdrawal by Subject|0|||
146968007|NCT01856257|530043891|FG000|Overall Study|Donor complication|0|||
146968008|NCT01856257|530043892|FG001|Overall Study|Donor complication|0|||
146968009|NCT01856257|530043893|FG002|Overall Study|Donor complication|0|||
146637291|NCT02500797|528847286|FG000|Overall Study|Cancel (rapid disease progression)|0|||
146637292|NCT02500797|528847287|FG001|Overall Study|Cancel (rapid disease progression)|0|||
146637293|NCT02500797|528847288|FG002|Overall Study|Cancel (rapid disease progression)|0|||
146637294|NCT02500797|528847289|FG003|Overall Study|Cancel (rapid disease progression)|0|||
146637295|NCT02500797|528847290|FG004|Overall Study|Cancel (rapid disease progression)|1|||
146637296|NCT02500797|528847291|FG005|Overall Study|Cancel (rapid disease progression)|1|||
146637297|NCT02500797|528847292|FG006|Overall Study|Cancel (rapid disease progression)|0|||
146637298|NCT02500797|528847293|FG007|Overall Study|Cancel (rapid disease progression)|0|||
146637299|NCT02500797|528847286|FG000|Overall Study|Withdrawal by Subject|1|||
146637300|NCT02500797|528847287|FG001|Overall Study|Withdrawal by Subject|0|||
146637301|NCT02500797|528847288|FG002|Overall Study|Withdrawal by Subject|0|||
146637302|NCT02500797|528847289|FG003|Overall Study|Withdrawal by Subject|0|||
146766390|NCT01235949|529312232|FG010|Booster Phase|Withdrawal by Subject|1|||
146766391|NCT01235949|529312233|FG011|Booster Phase|Withdrawal by Subject|1|||
146893431|NCT04426695|529776000|FG017|Overall Study|Randomized but Never Treated|0|||
146893432|NCT04303000|529776001|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
146893433|NCT04303000|529776002|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
146893434|NCT04303000|529776003|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
146893435|NCT04276207|529776005|FG000|Period 1|Withdrawal by Subject|0|||
146893436|NCT04276207|529776006|FG001|Period 1|Withdrawal by Subject|1|||
146893437|NCT05655377|529776007|FG000|Overall Study|Withdrawal by Subject|2|||
146637303|NCT02500797|528847290|FG004|Overall Study|Withdrawal by Subject|0|||
146637304|NCT02500797|528847291|FG005|Overall Study|Withdrawal by Subject|0|||
146637305|NCT02500797|528847292|FG006|Overall Study|Withdrawal by Subject|0|||
146893438|NCT04451330|529776008|FG000|Overall Study|Adverse Event|1|||
146893439|NCT04451330|529776009|FG001|Overall Study|Adverse Event|2|||
146893440|NCT04451330|529776008|FG000|Overall Study|Lost to Follow-up|5|||
146893441|NCT04451330|529776009|FG001|Overall Study|Lost to Follow-up|0|||
146637306|NCT02500797|528847293|FG007|Overall Study|Withdrawal by Subject|0|||
146637307|NCT00060840|528847294|FG000|Overall Study|Change in surgical plan|2|||
146637308|NCT00060840|528847295|FG001|Overall Study|Change in surgical plan|6|||
146637309|NCT00060840|528847294|FG000|Overall Study|Death|0|||
146766392|NCT01235949|529312234|FG012|Booster Phase|Withdrawal by Subject|2|||
146893442|NCT04451330|529776008|FG000|Overall Study|Withdrawal by Subject|3|||
146893443|NCT04451330|529776009|FG001|Overall Study|Withdrawal by Subject|1|||
146968010|NCT01856257|530043894|FG003|Overall Study|Donor complication|1|||
146968011|NCT03664024|530043898|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
146968012|NCT03664024|530043898|FG000|Overall Study|Lost to Follow-up|2|||
146968013|NCT03664024|530043898|FG000|Overall Study|Withdrawal by Subject|2|||
146968014|NCT03664024|530043898|FG000|Overall Study|Death|80|||
146558134|NCT02439957|528554169|FG000|Overall Study|Study Terminated|3|||
146558135|NCT02439957|528554170|FG001|Overall Study|Study Terminated|3|||
146558136|NCT00666263|528554171|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
146558137|NCT00666263|528554172|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
146558138|NCT00666263|528554171|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
146558139|NCT00666263|528554172|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
146558140|NCT00666263|528554171|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
146558141|NCT00666263|528554172|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
146558142|NCT00586157|528554173|FG000|First Intervention|Worsening behavior|1|||
146558143|NCT00586157|528554174|FG001|First Intervention|Worsening behavior|0|||
146558144|NCT00586157|528554173|FG000|Second Intervention|Withdrawal by Subject|1|||
146558145|NCT00586157|528554174|FG001|Second Intervention|Withdrawal by Subject|0|||
146558146|NCT00586157|528554173|FG000|Second Intervention|Worsening behavior|1|||
146558147|NCT00586157|528554174|FG001|Second Intervention|Worsening behavior|0|||
146558148|NCT00586157|528554173|FG000|Second Intervention|Adverse Event|0|||
146558149|NCT00586157|528554174|FG001|Second Intervention|Adverse Event|1|||
146558150|NCT02014467|528554176|FG000|Overall Study|Adverse Event|4|||
146558151|NCT02014467|528554177|FG001|Overall Study|Adverse Event|0|||
146558152|NCT02014467|528554176|FG000|Overall Study|Protocol Violation|3|||
146558153|NCT02014467|528554177|FG001|Overall Study|Protocol Violation|0|||
146558154|NCT02014467|528554176|FG000|Overall Study|Physician Decision|2|||
146558155|NCT02014467|528554177|FG001|Overall Study|Physician Decision|3|||
146558156|NCT02014467|528554176|FG000|Overall Study|Withdrawal by Subject|16|||
146558157|NCT02014467|528554177|FG001|Overall Study|Withdrawal by Subject|4|||
146558158|NCT01230060|528554178|FG000|Overall Study|Withdrawal by Subject|1|||
146558159|NCT03802916|528554179|FG000|Overall Study|Adverse Event|0|||
146558160|NCT03802916|528554180|FG001|Overall Study|Adverse Event|1|||
146558161|NCT03802916|528554179|FG000|Overall Study|Withdrawal by Subject|0|||
146558162|NCT03802916|528554180|FG001|Overall Study|Withdrawal by Subject|1|||
146558163|NCT00480532|528554183|FG000|Overall Study|Withdrawal by Subject|2|||
146558164|NCT00480532|528554184|FG001|Overall Study|Withdrawal by Subject|4|||
146558165|NCT00480532|528554185|FG002|Overall Study|Withdrawal by Subject|3|||
146558166|NCT00480532|528554186|FG003|Overall Study|Withdrawal by Subject|1|||
146558167|NCT00480532|528554183|FG000|Overall Study|Protocol Violation|0|||
146558168|NCT00480532|528554184|FG001|Overall Study|Protocol Violation|0|||
146558169|NCT00480532|528554185|FG002|Overall Study|Protocol Violation|1|||
146558170|NCT00480532|528554186|FG003|Overall Study|Protocol Violation|0|||
146558171|NCT00831389|528554187|FG000|Overall Study|Withdrawal by Subject|0|||
146558172|NCT00831389|528554188|FG001|Overall Study|Withdrawal by Subject|1|||
146558173|NCT00278161|528554190|FG000|Overall Study|Death|11|||
146558174|NCT01817777|528554191|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
146558175|NCT01817777|528554192|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
146558176|NCT01817777|528554193|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
146637310|NCT00060840|528847295|FG001|Overall Study|Death|1|||
146637311|NCT00060840|528847294|FG000|Overall Study|Withdrawal by Subject|0|||
146637312|NCT00060840|528847295|FG001|Overall Study|Withdrawal by Subject|1|||
146637313|NCT00060840|528847294|FG000|Overall Study|Subinvestigator unavailable|0|||
146637314|NCT00060840|528847295|FG001|Overall Study|Subinvestigator unavailable|1|||
146637315|NCT00060840|528847294|FG000|Overall Study|Physician Decision|1|||
146637316|NCT00060840|528847295|FG001|Overall Study|Physician Decision|0|||
146637317|NCT00060840|528847294|FG000|Overall Study|Other|1|||
146637318|NCT00060840|528847295|FG001|Overall Study|Other|0|||
146637319|NCT00357006|528847296|FG000|Overall Study|Lost to Follow-up|1|||
146637320|NCT00357006|528847297|FG001|Overall Study|Lost to Follow-up|2|||
146637321|NCT00357006|528847298|FG002|Overall Study|Lost to Follow-up|1|||
146637322|NCT00357006|528847296|FG000|Overall Study|Withdrawal by Subject|1|||
146637323|NCT00357006|528847297|FG001|Overall Study|Withdrawal by Subject|3|||
146637324|NCT00357006|528847298|FG002|Overall Study|Withdrawal by Subject|2|||
146893444|NCT04451330|529776008|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146893445|NCT04451330|529776009|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146893446|NCT04451330|529776008|FG000|Overall Study|Other than specified|0|||
146637325|NCT00976560|528847299|FG000|Overall Study|Adverse Event|5|||
146637326|NCT00976560|528847300|FG001|Overall Study|Adverse Event|5|||
146637327|NCT00976560|528847299|FG000|Overall Study|Lack of Efficacy|3|||
146637328|NCT00976560|528847300|FG001|Overall Study|Lack of Efficacy|5|||
146637329|NCT00976560|528847299|FG000|Overall Study|Protocol Violation|1|||
146637330|NCT00976560|528847300|FG001|Overall Study|Protocol Violation|0|||
146637331|NCT00976560|528847299|FG000|Overall Study|Lost to Follow-up|1|||
146558177|NCT01817777|528554191|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
146558178|NCT01817777|528554192|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
146558179|NCT01817777|528554193|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
146558180|NCT01817777|528554191|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
146558181|NCT01817777|528554192|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
146558182|NCT01817777|528554193|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
146637332|NCT00976560|528847300|FG001|Overall Study|Lost to Follow-up|0|||
146893447|NCT04451330|529776009|FG001|Overall Study|Other than specified|1|||
146968015|NCT01157065|530043899|FG000|Overall Study|Death|0|||
146968016|NCT01157065|530043900|FG001|Overall Study|Death|1|||
146968017|NCT05275673|530043903|FG000|Overall Study|Study Termination by Sponsor|2|||
146968018|NCT05275673|530043904|FG001|Overall Study|Study Termination by Sponsor|3|||
146968019|NCT05275673|530043903|FG000|Overall Study|Death|1|||
146968020|NCT05275673|530043904|FG001|Overall Study|Death|0|||
146968021|NCT05275673|530043903|FG000|Overall Study|Withdrawal by Subject|1|||
146968022|NCT05275673|530043904|FG001|Overall Study|Withdrawal by Subject|0|||
146968023|NCT02325739|530043905|FG000|Phase I Part|Adverse Event|1|||
146637333|NCT00976560|528847299|FG000|Overall Study|Physician Decision|2|||
146637334|NCT00976560|528847300|FG001|Overall Study|Physician Decision|0|||
146637335|NCT00976560|528847299|FG000|Overall Study|Withdrawal by Subject|2|||
146637336|NCT00976560|528847300|FG001|Overall Study|Withdrawal by Subject|3|||
146637337|NCT03710161|528847301|FG000|Overall Study|Study halted due to COVID pandemic|3|||
146637338|NCT03710161|528847302|FG001|Overall Study|Study halted due to COVID pandemic|2|||
146637339|NCT05340478|528847305|FG000|Overall Study|Scheduling Issues|10|||
146637340|NCT05340478|528847306|FG001|Overall Study|Scheduling Issues|4|||
146637341|NCT05340478|528847305|FG000|Overall Study|Neither member of dyad started treatment|2|||
146637342|NCT05340478|528847306|FG001|Overall Study|Neither member of dyad started treatment|2|||
146637343|NCT05340478|528847305|FG000|Overall Study|Withdrawn from study|2|||
146637344|NCT05340478|528847306|FG001|Overall Study|Withdrawn from study|2|||
146637345|NCT05340478|528847305|FG000|Overall Study|Lost to Follow-up|1|||
146637346|NCT05340478|528847306|FG001|Overall Study|Lost to Follow-up|4|||
146637347|NCT00092443|528847309|FG000|Overall Study|Adverse Event|9|||
146637348|NCT00092443|528847310|FG001|Overall Study|Adverse Event|13|||
146637349|NCT00092443|528847309|FG000|Overall Study|Lost to Follow-up|7|||
146637350|NCT00092443|528847310|FG001|Overall Study|Lost to Follow-up|3|||
146637351|NCT00092443|528847309|FG000|Overall Study|Protocol Violation|11|||
146637352|NCT00092443|528847310|FG001|Overall Study|Protocol Violation|9|||
146637353|NCT00092443|528847309|FG000|Overall Study|Withdrawal by Subject|9|||
146637354|NCT00092443|528847310|FG001|Overall Study|Withdrawal by Subject|11|||
146637355|NCT00092443|528847309|FG000|Overall Study|Moved|5|||
146637356|NCT00092443|528847310|FG001|Overall Study|Moved|5|||
146637357|NCT00092443|528847309|FG000|Overall Study|Other|17|||
146637358|NCT00092443|528847310|FG001|Overall Study|Other|13|||
146637359|NCT02963506|528847312|FG000|Double-Blind Period|Adverse Event|0|||
146637360|NCT02963506|528847313|FG001|Double-Blind Period|Adverse Event|0|||
146637361|NCT02963506|528847314|FG002|Double-Blind Period|Adverse Event|1|||
146637362|NCT02963506|528847315|FG003|Double-Blind Period|Adverse Event|0|||
146637363|NCT02963506|528847316|FG004|Double-Blind Period|Adverse Event|0|||
146637364|NCT02963506|528847317|FG005|Double-Blind Period|Adverse Event|0|||
146637365|NCT02963506|528847318|FG006|Double-Blind Period|Adverse Event|0|||
146637366|NCT02963506|528847319|FG007|Double-Blind Period|Adverse Event|0|||
146637367|NCT02963506|528847320|FG008|Double-Blind Period|Adverse Event|0|||
146637368|NCT02963506|528847321|FG009|Double-Blind Period|Adverse Event|0|||
146637369|NCT02963506|528847322|FG010|Double-Blind Period|Adverse Event|0|||
146637370|NCT02963506|528847323|FG011|Double-Blind Period|Adverse Event|0|||
146637371|NCT02963506|528847324|FG012|Double-Blind Period|Adverse Event|0|||
146637372|NCT02963506|528847312|FG000|Double-Blind Period|Death|0|||
146637373|NCT02963506|528847313|FG001|Double-Blind Period|Death|0|||
146637374|NCT02963506|528847314|FG002|Double-Blind Period|Death|0|||
146637375|NCT02963506|528847315|FG003|Double-Blind Period|Death|1|||
146637376|NCT02963506|528847316|FG004|Double-Blind Period|Death|0|||
146637377|NCT02963506|528847317|FG005|Double-Blind Period|Death|0|||
146637378|NCT02963506|528847318|FG006|Double-Blind Period|Death|0|||
146968024|NCT02325739|530043906|FG001|Phase I Part|Adverse Event|0|||
146968025|NCT02325739|530043907|FG002|Phase I Part|Adverse Event|1|||
146968026|NCT02325739|530043908|FG003|Phase I Part|Adverse Event|2|||
146968027|NCT02325739|530043909|FG004|Phase I Part|Adverse Event|3|||
146558183|NCT01817777|528554191|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
146558184|NCT01817777|528554192|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
146558185|NCT01817777|528554193|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
146558186|NCT01817777|528554191|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
146558187|NCT01817777|528554192|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
146558188|NCT01817777|528554193|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
146558189|NCT00443456|528554194|FG000|Overall Study|Adverse Event|16|||
146558190|NCT00443456|528554194|FG000|Overall Study|Move|1|||
146637379|NCT02963506|528847319|FG007|Double-Blind Period|Death|0|||
146637380|NCT02963506|528847320|FG008|Double-Blind Period|Death|0|||
146637381|NCT02963506|528847321|FG009|Double-Blind Period|Death|0|||
146637382|NCT02963506|528847322|FG010|Double-Blind Period|Death|0|||
146637383|NCT02963506|528847323|FG011|Double-Blind Period|Death|0|||
146637384|NCT02963506|528847324|FG012|Double-Blind Period|Death|0|||
146637385|NCT02963506|528847312|FG000|Double-Blind Period|Lost to Follow-up|0|||
146637386|NCT02963506|528847313|FG001|Double-Blind Period|Lost to Follow-up|1|||
146637387|NCT02963506|528847314|FG002|Double-Blind Period|Lost to Follow-up|0|||
146637388|NCT02963506|528847315|FG003|Double-Blind Period|Lost to Follow-up|0|||
146637389|NCT02963506|528847316|FG004|Double-Blind Period|Lost to Follow-up|0|||
146637390|NCT02963506|528847317|FG005|Double-Blind Period|Lost to Follow-up|0|||
146968028|NCT02325739|530043910|FG005|Phase I Part|Adverse Event|1|||
146766393|NCT01235949|529312235|FG013|Booster Phase|Withdrawal by Subject|0|||
146766394|NCT01235949|529312236|FG014|Booster Phase|Withdrawal by Subject|2|||
146766395|NCT01235949|529312237|FG015|Booster Phase|Withdrawal by Subject|0|||
146766396|NCT01235949|529312238|FG016|Booster Phase|Withdrawal by Subject|0|||
146766397|NCT01235949|529312239|FG017|Booster Phase|Withdrawal by Subject|0|||
146766398|NCT01235949|529312222|FG000|Booster Phase|Lost to Follow-up|0|||
146766399|NCT01235949|529312223|FG001|Booster Phase|Lost to Follow-up|0|||
146766400|NCT01235949|529312224|FG002|Booster Phase|Lost to Follow-up|0|||
146766401|NCT01235949|529312225|FG003|Booster Phase|Lost to Follow-up|0|||
146766402|NCT01235949|529312226|FG004|Booster Phase|Lost to Follow-up|0|||
146766403|NCT01235949|529312227|FG005|Booster Phase|Lost to Follow-up|0|||
146766404|NCT01235949|529312228|FG006|Booster Phase|Lost to Follow-up|0|||
146766405|NCT01235949|529312229|FG007|Booster Phase|Lost to Follow-up|0|||
146766406|NCT01235949|529312230|FG008|Booster Phase|Lost to Follow-up|1|||
146766407|NCT01235949|529312231|FG009|Booster Phase|Lost to Follow-up|1|||
146766408|NCT01235949|529312232|FG010|Booster Phase|Lost to Follow-up|1|||
146766409|NCT01235949|529312233|FG011|Booster Phase|Lost to Follow-up|1|||
146766410|NCT01235949|529312234|FG012|Booster Phase|Lost to Follow-up|0|||
146766411|NCT01235949|529312235|FG013|Booster Phase|Lost to Follow-up|0|||
146766412|NCT01235949|529312236|FG014|Booster Phase|Lost to Follow-up|0|||
146766413|NCT01235949|529312237|FG015|Booster Phase|Lost to Follow-up|0|||
146766414|NCT01235949|529312238|FG016|Booster Phase|Lost to Follow-up|0|||
146766415|NCT01235949|529312239|FG017|Booster Phase|Lost to Follow-up|1|||
146766416|NCT00754936|529312240|FG000|Overall Study|Lost to Follow-up|3|||
146766417|NCT00754936|529312240|FG000|Overall Study|Physician Decision|1|||
146766418|NCT00754936|529312240|FG000|Overall Study|Withdrawal by Subject|2|||
146766419|NCT00754936|529312240|FG000|Overall Study|Side Effects|3|||
146766420|NCT00754936|529312240|FG000|Overall Study|Inter-current medical events|3|||
146766421|NCT00371566|529312245|FG000|Treatment Phase|Withdrawal by Subject|0|||
146766422|NCT00371566|529312246|FG001|Treatment Phase|Withdrawal by Subject|1|||
146766423|NCT00371566|529312245|FG000|Treatment Phase|Adverse Event|0|||
146766424|NCT00371566|529312246|FG001|Treatment Phase|Adverse Event|1|||
146766425|NCT00371566|529312245|FG000|Treatment Phase|Protocol Violation|0|||
146766426|NCT00371566|529312246|FG001|Treatment Phase|Protocol Violation|1|||
146766427|NCT00371566|529312245|FG000|Chemoradiation Phase|Physician Decision|2|||
146766428|NCT00371566|529312246|FG001|Chemoradiation Phase|Physician Decision|0|||
146766429|NCT00371566|529312245|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
146766430|NCT00371566|529312246|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
146766431|NCT00371566|529312245|FG000|Chemoradiation Phase|Non compliant|0|||
146766432|NCT00371566|529312246|FG001|Chemoradiation Phase|Non compliant|1|||
146766433|NCT00371566|529312245|FG000|Chemoradiation Phase|Progressive Disease|1|||
146766434|NCT00371566|529312246|FG001|Chemoradiation Phase|Progressive Disease|1|||
146766435|NCT00371566|529312245|FG000|Chemoradiation Phase|Death|2|||
146766436|NCT00371566|529312246|FG001|Chemoradiation Phase|Death|0|||
146766437|NCT00371566|529312245|FG000|Follow Up Phase|Death|0|||
146766438|NCT00371566|529312246|FG001|Follow Up Phase|Death|5|||
146766439|NCT00371566|529312245|FG000|Follow Up Phase|Disease progression|1|||
146766440|NCT00371566|529312246|FG001|Follow Up Phase|Disease progression|0|||
146766441|NCT00371566|529312245|FG000|Follow Up Phase|Withdrawal by Subject|0|||
146766442|NCT00371566|529312246|FG001|Follow Up Phase|Withdrawal by Subject|1|||
146766443|NCT00371566|529312245|FG000|Follow Up Phase|Physician Decision|1|||
146766444|NCT00371566|529312246|FG001|Follow Up Phase|Physician Decision|1|||
146893448|NCT02690194|529776010|FG000|Overall Study|Withdrawal by Subject|1|||
146893449|NCT02690194|529776011|FG001|Overall Study|Withdrawal by Subject|4|||
146893450|NCT02690194|529776012|FG002|Overall Study|Withdrawal by Subject|0|||
146893451|NCT00189462|529776013|FG000|Overall Study|Lack of Efficacy|5|||
146893452|NCT00189462|529776014|FG001|Overall Study|Lack of Efficacy|1|||
146893453|NCT00189462|529776013|FG000|Overall Study|Lost to Follow-up|18|||
146893454|NCT00189462|529776014|FG001|Overall Study|Lost to Follow-up|20|||
146893455|NCT00849667|529776018|FG000|Overall Study|Withdrawal by Subject|16|||
146893456|NCT00849667|529776019|FG001|Overall Study|Withdrawal by Subject|33|||
146766445|NCT00371566|529312245|FG000|Follow Up Phase|Lost to Follow-up|1|||
146766446|NCT00371566|529312246|FG001|Follow Up Phase|Lost to Follow-up|0|||
146893457|NCT00849667|529776020|FG002|Overall Study|Withdrawal by Subject|35|||
146893458|NCT00849667|529776018|FG000|Overall Study|Lost to Follow-up|8|||
146893459|NCT00849667|529776019|FG001|Overall Study|Lost to Follow-up|8|||
146893460|NCT00849667|529776020|FG002|Overall Study|Lost to Follow-up|8|||
146893461|NCT00849667|529776018|FG000|Overall Study|Adverse Event|1|||
146893462|NCT00849667|529776019|FG001|Overall Study|Adverse Event|2|||
146893463|NCT00849667|529776020|FG002|Overall Study|Adverse Event|0|||
146558191|NCT00443456|528554194|FG000|Overall Study|Withdrawal by Subject|1|||
146558192|NCT03242434|528554195|FG000|Overall Study|Death|0|||
146558193|NCT03242434|528554196|FG001|Overall Study|Death|2|||
146558194|NCT01592747|528554197|FG000|Overall Study|Loss of Therapeutic Response|107|||
146558195|NCT01592747|528554198|FG001|Overall Study|Loss of Therapeutic Response|108|||
146558196|NCT01592747|528554199|FG002|Overall Study|Loss of Therapeutic Response|100|||
146558197|NCT01592747|528554197|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
146558198|NCT01592747|528554198|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
146558199|NCT01592747|528554199|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
146558200|NCT01592747|528554197|FG000|Overall Study|Adverse Event|1|||
146558201|NCT01592747|528554198|FG001|Overall Study|Adverse Event|0|||
146558202|NCT01592747|528554199|FG002|Overall Study|Adverse Event|0|||
146558203|NCT01592747|528554197|FG000|Overall Study|Protocol Violation|4|||
146558204|NCT01592747|528554198|FG001|Overall Study|Protocol Violation|0|||
146558205|NCT01592747|528554199|FG002|Overall Study|Protocol Violation|4|||
146558206|NCT01592747|528554197|FG000|Overall Study|Lack of Efficacy|0|||
146558207|NCT01592747|528554198|FG001|Overall Study|Lack of Efficacy|1|||
146558208|NCT01592747|528554199|FG002|Overall Study|Lack of Efficacy|0|||
146558209|NCT01592747|528554197|FG000|Overall Study|Withdrawal by Subject|2|||
146558210|NCT01592747|528554198|FG001|Overall Study|Withdrawal by Subject|0|||
146558211|NCT01592747|528554199|FG002|Overall Study|Withdrawal by Subject|2|||
146558212|NCT01592747|528554197|FG000|Overall Study|Lost to Follow-up|1|||
146558213|NCT01592747|528554198|FG001|Overall Study|Lost to Follow-up|0|||
146558214|NCT01592747|528554199|FG002|Overall Study|Lost to Follow-up|1|||
146558215|NCT01592747|528554197|FG000|Overall Study|Other Reasons|1|||
146558216|NCT01592747|528554198|FG001|Overall Study|Other Reasons|1|||
146558217|NCT01592747|528554199|FG002|Overall Study|Other Reasons|0|||
146558218|NCT00425555|528554202|FG000|Overall Study|Withdrawal by Subject|11|||
146558219|NCT00425555|528554203|FG001|Overall Study|Withdrawal by Subject|8|||
146558220|NCT00425555|528554202|FG000|Overall Study|Lost to Follow-up|0|||
146558221|NCT00425555|528554203|FG001|Overall Study|Lost to Follow-up|1|||
146558222|NCT00425555|528554202|FG000|Overall Study|Administrative problems|3|||
146558223|NCT00425555|528554203|FG001|Overall Study|Administrative problems|0|||
146558224|NCT00425555|528554202|FG000|Overall Study|Death|1|||
146558225|NCT00425555|528554203|FG001|Overall Study|Death|2|||
146558226|NCT00425555|528554202|FG000|Overall Study|New cancer therapy|2|||
146558227|NCT00425555|528554203|FG001|Overall Study|New cancer therapy|1|||
146558228|NCT00425555|528554202|FG000|Overall Study|Disease progression|36|||
146558229|NCT00425555|528554203|FG001|Overall Study|Disease progression|33|||
146558230|NCT00425555|528554202|FG000|Overall Study|Adverse Event|25|||
146558231|NCT00425555|528554203|FG001|Overall Study|Adverse Event|15|||
146558232|NCT00425555|528554202|FG000|Overall Study|Protocol Violation|1|||
146558233|NCT00425555|528554203|FG001|Overall Study|Protocol Violation|0|||
146558234|NCT00619918|528554204|FG000|Overall Study|Withdrawal by Subject|4|||
146558235|NCT00619918|528554205|FG001|Overall Study|Withdrawal by Subject|3|||
146637391|NCT02963506|528847318|FG006|Double-Blind Period|Lost to Follow-up|0|||
146637392|NCT02963506|528847319|FG007|Double-Blind Period|Lost to Follow-up|0|||
146637393|NCT02963506|528847320|FG008|Double-Blind Period|Lost to Follow-up|0|||
146637394|NCT02963506|528847321|FG009|Double-Blind Period|Lost to Follow-up|0|||
146637395|NCT02963506|528847322|FG010|Double-Blind Period|Lost to Follow-up|0|||
146637396|NCT02963506|528847323|FG011|Double-Blind Period|Lost to Follow-up|0|||
146637397|NCT02963506|528847324|FG012|Double-Blind Period|Lost to Follow-up|0|||
146637398|NCT02963506|528847312|FG000|Double-Blind Period|Withdrawal by Subject|0|||
146637399|NCT02963506|528847313|FG001|Double-Blind Period|Withdrawal by Subject|0|||
146637400|NCT02963506|528847314|FG002|Double-Blind Period|Withdrawal by Subject|1|||
146637401|NCT02963506|528847315|FG003|Double-Blind Period|Withdrawal by Subject|1|||
146637402|NCT02963506|528847316|FG004|Double-Blind Period|Withdrawal by Subject|0|||
146637403|NCT02963506|528847317|FG005|Double-Blind Period|Withdrawal by Subject|0|||
146637404|NCT02963506|528847318|FG006|Double-Blind Period|Withdrawal by Subject|0|||
146637405|NCT02963506|528847319|FG007|Double-Blind Period|Withdrawal by Subject|0|||
146637406|NCT02963506|528847320|FG008|Double-Blind Period|Withdrawal by Subject|0|||
146637407|NCT02963506|528847321|FG009|Double-Blind Period|Withdrawal by Subject|0|||
146637408|NCT02963506|528847322|FG010|Double-Blind Period|Withdrawal by Subject|0|||
146637409|NCT02963506|528847323|FG011|Double-Blind Period|Withdrawal by Subject|0|||
146637410|NCT02963506|528847324|FG012|Double-Blind Period|Withdrawal by Subject|0|||
146637411|NCT02963506|528847312|FG000|Double-Blind Period|No compliance|0|||
146637412|NCT02963506|528847313|FG001|Double-Blind Period|No compliance|1|||
146637413|NCT02963506|528847314|FG002|Double-Blind Period|No compliance|0|||
146637414|NCT02963506|528847315|FG003|Double-Blind Period|No compliance|0|||
146637415|NCT02963506|528847316|FG004|Double-Blind Period|No compliance|0|||
146637416|NCT02963506|528847317|FG005|Double-Blind Period|No compliance|0|||
146637417|NCT02963506|528847318|FG006|Double-Blind Period|No compliance|0|||
146637418|NCT02963506|528847319|FG007|Double-Blind Period|No compliance|0|||
146637419|NCT02963506|528847320|FG008|Double-Blind Period|No compliance|0|||
146558236|NCT00619918|528554204|FG000|Overall Study|Physician Decision|2|||
146558237|NCT00619918|528554205|FG001|Overall Study|Physician Decision|4|||
146558238|NCT00619918|528554204|FG000|Overall Study|Transfer to outside facility|3|||
146558239|NCT00619918|528554205|FG001|Overall Study|Transfer to outside facility|3|||
146558240|NCT00619918|528554204|FG000|Overall Study|Left before receiving first dose|7|||
146558241|NCT00619918|528554205|FG001|Overall Study|Left before receiving first dose|6|||
146558242|NCT00619918|528554204|FG000|Overall Study|ICU admission|4|||
146558243|NCT00619918|528554205|FG001|Overall Study|ICU admission|6|||
146558244|NCT03533491|528554206|FG000|Overall Study|Lost to Follow-up|2|||
146558245|NCT04661839|528554211|FG000|Overall Study|Not Treated|0|||
146558246|NCT04661839|528554212|FG001|Overall Study|Not Treated|0|||
146558247|NCT04661839|528554213|FG002|Overall Study|Not Treated|1|||
146558248|NCT04661839|528554214|FG003|Overall Study|Not Treated|0|||
146558249|NCT04661839|528554211|FG000|Overall Study|Lost to Follow-up|1|||
146558250|NCT04661839|528554212|FG001|Overall Study|Lost to Follow-up|0|||
146558251|NCT04661839|528554213|FG002|Overall Study|Lost to Follow-up|0|||
146558252|NCT04661839|528554214|FG003|Overall Study|Lost to Follow-up|1|||
146558253|NCT02951819|528554218|FG000|Overall Study|Death|9|||
146558254|NCT02951819|528554219|FG001|Overall Study|Death|7|||
146558255|NCT02951819|528554218|FG000|Overall Study|Withdrawal by Subject|3|||
146558256|NCT02951819|528554219|FG001|Overall Study|Withdrawal by Subject|0|||
146558257|NCT02951819|528554218|FG000|Overall Study|Adverse Event|1|||
146558258|NCT02951819|528554219|FG001|Overall Study|Adverse Event|0|||
146558259|NCT02951819|528554218|FG000|Overall Study|Lack of Efficacy|4|||
146637420|NCT02963506|528847321|FG009|Double-Blind Period|No compliance|0|||
146637421|NCT02963506|528847322|FG010|Double-Blind Period|No compliance|0|||
146637422|NCT02963506|528847323|FG011|Double-Blind Period|No compliance|0|||
146637423|NCT02963506|528847324|FG012|Double-Blind Period|No compliance|0|||
146637424|NCT02963506|528847312|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146637425|NCT02963506|528847313|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
146637426|NCT02963506|528847314|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146637427|NCT02963506|528847315|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146637428|NCT02963506|528847316|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146637429|NCT02963506|528847317|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146637430|NCT02963506|528847318|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146637431|NCT02963506|528847319|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146637432|NCT02963506|528847320|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146637433|NCT02963506|528847321|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146637434|NCT02963506|528847322|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146637435|NCT02963506|528847323|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146637436|NCT02963506|528847324|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146637437|NCT02963506|528847312|FG000|Dose-Blind Period|Adverse Event|0|||
146637438|NCT02963506|528847313|FG001|Dose-Blind Period|Adverse Event|0|||
146637439|NCT02963506|528847314|FG002|Dose-Blind Period|Adverse Event|0|||
146637440|NCT02963506|528847315|FG003|Dose-Blind Period|Adverse Event|0|||
146637441|NCT02963506|528847316|FG004|Dose-Blind Period|Adverse Event|0|||
146637442|NCT02963506|528847317|FG005|Dose-Blind Period|Adverse Event|1|||
146637443|NCT02963506|528847318|FG006|Dose-Blind Period|Adverse Event|3|||
146637444|NCT02963506|528847319|FG007|Dose-Blind Period|Adverse Event|2|||
146637445|NCT02963506|528847320|FG008|Dose-Blind Period|Adverse Event|2|||
146637446|NCT02963506|528847321|FG009|Dose-Blind Period|Adverse Event|2|||
146637447|NCT02963506|528847322|FG010|Dose-Blind Period|Adverse Event|1|||
146637448|NCT02963506|528847323|FG011|Dose-Blind Period|Adverse Event|1|||
146637449|NCT02963506|528847324|FG012|Dose-Blind Period|Adverse Event|6|||
146637450|NCT02963506|528847312|FG000|Dose-Blind Period|Lack of Efficacy|0|||
146637451|NCT02963506|528847313|FG001|Dose-Blind Period|Lack of Efficacy|0|||
146637452|NCT02963506|528847314|FG002|Dose-Blind Period|Lack of Efficacy|0|||
146637453|NCT02963506|528847315|FG003|Dose-Blind Period|Lack of Efficacy|0|||
146637454|NCT02963506|528847316|FG004|Dose-Blind Period|Lack of Efficacy|0|||
146637455|NCT02963506|528847317|FG005|Dose-Blind Period|Lack of Efficacy|0|||
146637456|NCT02963506|528847318|FG006|Dose-Blind Period|Lack of Efficacy|0|||
146893464|NCT00849667|529776018|FG000|Overall Study|Other|18|||
146893465|NCT00849667|529776019|FG001|Overall Study|Other|19|||
146558260|NCT02951819|528554219|FG001|Overall Study|Lack of Efficacy|0|||
146558261|NCT02951819|528554218|FG000|Overall Study|Lost to Follow-up|1|||
146558262|NCT02951819|528554219|FG001|Overall Study|Lost to Follow-up|0|||
146558263|NCT02951819|528554218|FG000|Overall Study|Progressive Disease|1|||
146558264|NCT02951819|528554219|FG001|Overall Study|Progressive Disease|0|||
146558265|NCT02951819|528554218|FG000|Overall Study|Other|9|||
146558266|NCT02951819|528554219|FG001|Overall Study|Other|0|||
146637457|NCT02963506|528847319|FG007|Dose-Blind Period|Lack of Efficacy|1|||
146637458|NCT02963506|528847320|FG008|Dose-Blind Period|Lack of Efficacy|0|||
146637459|NCT02963506|528847321|FG009|Dose-Blind Period|Lack of Efficacy|1|||
146637460|NCT02963506|528847322|FG010|Dose-Blind Period|Lack of Efficacy|0|||
146637461|NCT02963506|528847323|FG011|Dose-Blind Period|Lack of Efficacy|0|||
146637462|NCT02963506|528847324|FG012|Dose-Blind Period|Lack of Efficacy|0|||
146893466|NCT00849667|529776020|FG002|Overall Study|Other|18|||
146637463|NCT02963506|528847312|FG000|Dose-Blind Period|Lost to Follow-up|0|||
146637464|NCT02963506|528847313|FG001|Dose-Blind Period|Lost to Follow-up|0|||
146637465|NCT02963506|528847314|FG002|Dose-Blind Period|Lost to Follow-up|0|||
146637466|NCT02963506|528847315|FG003|Dose-Blind Period|Lost to Follow-up|0|||
146637467|NCT02963506|528847316|FG004|Dose-Blind Period|Lost to Follow-up|0|||
146766447|NCT02914522|529312247|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
146766448|NCT02914522|529312248|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
146766449|NCT02914522|529312249|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
146766450|NCT02914522|529312250|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
146766451|NCT02914522|529312251|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
146766452|NCT02914522|529312252|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
146766453|NCT02914522|529312253|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
146766454|NCT02914522|529312254|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
146766455|NCT02914522|529312255|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
146766456|NCT02914522|529312256|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
146766457|NCT02914522|529312257|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
146766458|NCT02914522|529312247|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
146766459|NCT02914522|529312248|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
146766460|NCT02914522|529312249|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
146766461|NCT02914522|529312250|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
146766462|NCT02914522|529312251|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
146766463|NCT02914522|529312252|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
146766464|NCT02914522|529312253|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
146766465|NCT02914522|529312254|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
146766466|NCT02914522|529312255|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
146766467|NCT02914522|529312256|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
146766468|NCT02914522|529312257|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
146766469|NCT02914522|529312247|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
146766470|NCT02914522|529312248|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
146766471|NCT02914522|529312249|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
146766472|NCT02914522|529312250|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
146766473|NCT02914522|529312251|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
146766474|NCT02914522|529312252|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
146766475|NCT02914522|529312253|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
146766476|NCT02914522|529312254|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
146766477|NCT02914522|529312255|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
146766478|NCT02914522|529312256|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
146766479|NCT02914522|529312257|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
146766480|NCT02914522|529312247|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
146637468|NCT02963506|528847317|FG005|Dose-Blind Period|Lost to Follow-up|1|||
146637469|NCT02963506|528847318|FG006|Dose-Blind Period|Lost to Follow-up|0|||
146637470|NCT02963506|528847319|FG007|Dose-Blind Period|Lost to Follow-up|0|||
146637471|NCT02963506|528847320|FG008|Dose-Blind Period|Lost to Follow-up|1|||
146637472|NCT02963506|528847321|FG009|Dose-Blind Period|Lost to Follow-up|0|||
146637473|NCT02963506|528847322|FG010|Dose-Blind Period|Lost to Follow-up|0|||
146637474|NCT02963506|528847323|FG011|Dose-Blind Period|Lost to Follow-up|1|||
146637475|NCT02963506|528847324|FG012|Dose-Blind Period|Lost to Follow-up|0|||
146637476|NCT02963506|528847312|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
146637477|NCT02963506|528847313|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
146637478|NCT02963506|528847314|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
146637479|NCT02963506|528847315|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
146637480|NCT02963506|528847316|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
146637481|NCT02963506|528847317|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
146637482|NCT02963506|528847318|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
146766481|NCT02914522|529312248|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
146766482|NCT02914522|529312249|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
146766483|NCT02914522|529312250|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
146766484|NCT02914522|529312251|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
146766485|NCT02914522|529312252|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
146766486|NCT02914522|529312253|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
146637483|NCT02963506|528847319|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
146637484|NCT02963506|528847320|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
146637485|NCT02963506|528847321|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
146637486|NCT02963506|528847322|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
146893467|NCT00849667|529776018|FG000|Overall Study|Progressive disease|119|||
146893468|NCT00849667|529776019|FG001|Overall Study|Progressive disease|100|||
146893469|NCT00849667|529776020|FG002|Overall Study|Progressive disease|112|||
146893470|NCT00849667|529776018|FG000|Overall Study|Sponsor decision|208|||
146893471|NCT00849667|529776019|FG001|Overall Study|Sponsor decision|204|||
146893472|NCT00849667|529776020|FG002|Overall Study|Sponsor decision|190|||
146893473|NCT00849667|529776018|FG000|Overall Study|Investigator discretion|0|||
146893474|NCT00849667|529776019|FG001|Overall Study|Investigator discretion|0|||
146893475|NCT00849667|529776020|FG002|Overall Study|Investigator discretion|1|||
146637487|NCT02963506|528847323|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
146637488|NCT02963506|528847324|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
146637489|NCT02963506|528847312|FG000|Dose-Blind Period|Sponsor decision|0|||
146637490|NCT02963506|528847313|FG001|Dose-Blind Period|Sponsor decision|0|||
146637491|NCT02963506|528847314|FG002|Dose-Blind Period|Sponsor decision|0|||
146637492|NCT02963506|528847315|FG003|Dose-Blind Period|Sponsor decision|0|||
146637493|NCT02963506|528847316|FG004|Dose-Blind Period|Sponsor decision|0|||
146637494|NCT02963506|528847317|FG005|Dose-Blind Period|Sponsor decision|1|||
146637495|NCT02963506|528847318|FG006|Dose-Blind Period|Sponsor decision|0|||
146637496|NCT02963506|528847319|FG007|Dose-Blind Period|Sponsor decision|0|||
146637497|NCT02963506|528847320|FG008|Dose-Blind Period|Sponsor decision|0|||
146637498|NCT02963506|528847321|FG009|Dose-Blind Period|Sponsor decision|0|||
146637499|NCT02963506|528847322|FG010|Dose-Blind Period|Sponsor decision|0|||
146637500|NCT02963506|528847323|FG011|Dose-Blind Period|Sponsor decision|0|||
146637501|NCT02963506|528847324|FG012|Dose-Blind Period|Sponsor decision|0|||
146637502|NCT02963506|528847312|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146637503|NCT02963506|528847313|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146637504|NCT02963506|528847314|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146637505|NCT02963506|528847315|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146637506|NCT02963506|528847316|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146637507|NCT02963506|528847317|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146637508|NCT02963506|528847318|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146637509|NCT02963506|528847319|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146637510|NCT02963506|528847320|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146637511|NCT02963506|528847321|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146637512|NCT02963506|528847322|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146637513|NCT02963506|528847323|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146637514|NCT02963506|528847324|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
146637515|NCT00630838|528847327|FG000|Overall Study|Death|0|||
146637516|NCT00630838|528847328|FG001|Overall Study|Death|1|||
146637517|NCT00630838|528847327|FG000|Overall Study|Lost to Follow-up|0|||
146637518|NCT00630838|528847328|FG001|Overall Study|Lost to Follow-up|1|||
146637519|NCT00928408|528847329|FG000|Overall Study|Other|2|||
146637520|NCT00928408|528847329|FG000|Overall Study|Withdrawal by Subject|4|||
146637521|NCT00928408|528847329|FG000|Overall Study|Death|5|||
146637522|NCT00928408|528847329|FG000|Overall Study|Lost to Follow-up|12|||
146637523|NCT03843541|528847330|FG000|Overall Study|Adverse Event|4|||
146893476|NCT00553462|529776023|FG000|Overall Study|Adverse Event|4|||
146893477|NCT00553462|529776023|FG000|Overall Study|Progression|4|||
146893478|NCT00553462|529776023|FG000|Overall Study|Withdrawal by Subject|5|||
146893479|NCT00553462|529776023|FG000|Overall Study|Physician Decision|1|||
146893480|NCT01262625|529776024|FG000|Overall Study|Administrative Error|1|||
146893481|NCT01262625|529776025|FG001|Overall Study|Administrative Error|1|||
146893482|NCT01262625|529776024|FG000|Overall Study|Site Closed|1|||
146893483|NCT01262625|529776025|FG001|Overall Study|Site Closed|0|||
146893484|NCT01869348|529776026|FG000|Overall Study|Withdrawal by Subject|1|||
146893485|NCT01869348|529776027|FG001|Overall Study|Withdrawal by Subject|1|||
146893486|NCT03075163|529776028|FG000|Overall Study|not eligible for treatment limb|138|||
146893487|NCT03075163|529776029|FG001|Overall Study|not eligible for treatment limb|138|||
146893488|NCT04398732|529776031|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
146893489|NCT00510276|529776034|FG000|Acute Double-Blind Phase|Adverse Event|21|||
146893490|NCT00510276|529776035|FG001|Acute Double-Blind Phase|Adverse Event|6|||
146893491|NCT00510276|529776034|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
146893492|NCT00510276|529776035|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
146893493|NCT00510276|529776034|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
146893494|NCT00510276|529776035|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
146893495|NCT00510276|529776034|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
146637524|NCT03843541|528847331|FG001|Overall Study|Adverse Event|2|||
146637525|NCT03843541|528847332|FG002|Overall Study|Adverse Event|3|||
146637526|NCT03843541|528847330|FG000|Overall Study|Death|1|||
146637527|NCT03843541|528847331|FG001|Overall Study|Death|0|||
146637528|NCT03843541|528847332|FG002|Overall Study|Death|0|||
146558267|NCT03715829|528554220|FG000|Dose Ranging Period|Adverse Event|2|||
146558268|NCT03715829|528554221|FG001|Dose Ranging Period|Adverse Event|4|||
146558269|NCT03715829|528554222|FG002|Dose Ranging Period|Adverse Event|5|||
146558270|NCT03715829|528554223|FG003|Dose Ranging Period|Adverse Event|2|||
146558271|NCT03715829|528554224|FG004|Dose Ranging Period|Adverse Event|3|||
146558272|NCT03715829|528554225|FG005|Dose Ranging Period|Adverse Event|3|||
146558273|NCT03715829|528554226|FG006|Dose Ranging Period|Adverse Event|0|||
146558274|NCT03715829|528554227|FG007|Dose Ranging Period|Adverse Event|0|||
146558275|NCT03715829|528554228|FG008|Dose Ranging Period|Adverse Event|0|||
146558276|NCT03715829|528554229|FG009|Dose Ranging Period|Adverse Event|0|||
146558277|NCT03715829|528554230|FG010|Dose Ranging Period|Adverse Event|0|||
146558278|NCT03715829|528554220|FG000|Dose Ranging Period|Lack of Efficacy|0|||
146558279|NCT03715829|528554221|FG001|Dose Ranging Period|Lack of Efficacy|1|||
146558280|NCT03715829|528554222|FG002|Dose Ranging Period|Lack of Efficacy|0|||
146558281|NCT03715829|528554223|FG003|Dose Ranging Period|Lack of Efficacy|1|||
146558282|NCT03715829|528554224|FG004|Dose Ranging Period|Lack of Efficacy|0|||
146558283|NCT03715829|528554225|FG005|Dose Ranging Period|Lack of Efficacy|0|||
146558284|NCT03715829|528554226|FG006|Dose Ranging Period|Lack of Efficacy|0|||
146558285|NCT03715829|528554227|FG007|Dose Ranging Period|Lack of Efficacy|0|||
146558286|NCT03715829|528554228|FG008|Dose Ranging Period|Lack of Efficacy|0|||
146558287|NCT03715829|528554229|FG009|Dose Ranging Period|Lack of Efficacy|0|||
146558288|NCT03715829|528554230|FG010|Dose Ranging Period|Lack of Efficacy|0|||
146558289|NCT03715829|528554220|FG000|Dose Ranging Period|Lost to Follow-up|2|||
146558290|NCT03715829|528554221|FG001|Dose Ranging Period|Lost to Follow-up|0|||
146558291|NCT03715829|528554222|FG002|Dose Ranging Period|Lost to Follow-up|1|||
146558292|NCT03715829|528554223|FG003|Dose Ranging Period|Lost to Follow-up|1|||
146558293|NCT03715829|528554224|FG004|Dose Ranging Period|Lost to Follow-up|1|||
146558294|NCT03715829|528554225|FG005|Dose Ranging Period|Lost to Follow-up|2|||
146558295|NCT03715829|528554226|FG006|Dose Ranging Period|Lost to Follow-up|0|||
146558296|NCT03715829|528554227|FG007|Dose Ranging Period|Lost to Follow-up|0|||
146558297|NCT03715829|528554228|FG008|Dose Ranging Period|Lost to Follow-up|0|||
146558298|NCT03715829|528554229|FG009|Dose Ranging Period|Lost to Follow-up|0|||
146558299|NCT03715829|528554230|FG010|Dose Ranging Period|Lost to Follow-up|0|||
146558300|NCT03715829|528554220|FG000|Dose Ranging Period|Protocol Violation|0|||
146558301|NCT03715829|528554221|FG001|Dose Ranging Period|Protocol Violation|0|||
146558302|NCT03715829|528554222|FG002|Dose Ranging Period|Protocol Violation|0|||
146558303|NCT03715829|528554223|FG003|Dose Ranging Period|Protocol Violation|1|||
146558304|NCT03715829|528554224|FG004|Dose Ranging Period|Protocol Violation|0|||
146558305|NCT03715829|528554225|FG005|Dose Ranging Period|Protocol Violation|0|||
146558306|NCT03715829|528554226|FG006|Dose Ranging Period|Protocol Violation|0|||
146558307|NCT03715829|528554227|FG007|Dose Ranging Period|Protocol Violation|0|||
146558308|NCT03715829|528554228|FG008|Dose Ranging Period|Protocol Violation|0|||
146558309|NCT03715829|528554229|FG009|Dose Ranging Period|Protocol Violation|0|||
146558310|NCT03715829|528554230|FG010|Dose Ranging Period|Protocol Violation|0|||
146558311|NCT03715829|528554220|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
146893496|NCT00510276|529776035|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
146893497|NCT00510276|529776034|FG000|Acute Double-Blind Phase|Physician Decision|0|||
146893498|NCT00510276|529776035|FG001|Acute Double-Blind Phase|Physician Decision|3|||
146893499|NCT00510276|529776034|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
146893500|NCT00510276|529776035|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
146893501|NCT00510276|529776034|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
146893502|NCT00510276|529776035|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
146893503|NCT00510276|529776034|FG000|Acute Double-Blind Phase|Subject Decision|26|||
146893504|NCT00510276|529776035|FG001|Acute Double-Blind Phase|Subject Decision|28|||
146893505|NCT00510276|529776034|FG000|Extension Open-Label Phase|Adverse Event|9|||
146893506|NCT00510276|529776035|FG001|Extension Open-Label Phase|Adverse Event|18|||
146893507|NCT00510276|529776034|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
146893508|NCT00510276|529776035|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
146893509|NCT00510276|529776034|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
146893510|NCT00510276|529776035|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
146893511|NCT00510276|529776034|FG000|Extension Open-Label Phase|Physician Decision|2|||
146893512|NCT00510276|529776035|FG001|Extension Open-Label Phase|Physician Decision|3|||
146893513|NCT00510276|529776034|FG000|Extension Open-Label Phase|Protocol Violation|0|||
146893514|NCT00510276|529776035|FG001|Extension Open-Label Phase|Protocol Violation|1|||
146968029|NCT02325739|530043911|FG006|Phase I Part|Adverse Event|0|||
146558312|NCT03715829|528554221|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
146558313|NCT03715829|528554222|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
146893515|NCT00510276|529776034|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
146558314|NCT03715829|528554223|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
146558315|NCT03715829|528554224|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
146558316|NCT03715829|528554225|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
146558317|NCT03715829|528554226|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
146558318|NCT03715829|528554227|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
146558319|NCT03715829|528554228|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
146558320|NCT03715829|528554229|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
146893516|NCT00510276|529776035|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
146893517|NCT00510276|529776034|FG000|Extension Open-Label Phase|Subject Decision|7|||
146893518|NCT00510276|529776035|FG001|Extension Open-Label Phase|Subject Decision|9|||
146893519|NCT03665285|529776038|FG000|Overall Study|Started New Anticancer Treatment|1|||
146637529|NCT03843541|528847330|FG000|Overall Study|Lack of adherence to study medication|0|||
146637530|NCT03843541|528847331|FG001|Overall Study|Lack of adherence to study medication|0|||
146637531|NCT03843541|528847332|FG002|Overall Study|Lack of adherence to study medication|1|||
146637532|NCT03843541|528847330|FG000|Overall Study|Physician Decision|1|||
146637533|NCT03843541|528847331|FG001|Overall Study|Physician Decision|2|||
146637534|NCT03843541|528847332|FG002|Overall Study|Physician Decision|2|||
146637535|NCT03843541|528847330|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
146637536|NCT03843541|528847331|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
146637537|NCT03843541|528847332|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
146637538|NCT03843541|528847330|FG000|Overall Study|Withdrawal by Subject|6|||
146637539|NCT03843541|528847331|FG001|Overall Study|Withdrawal by Subject|9|||
146637540|NCT03843541|528847332|FG002|Overall Study|Withdrawal by Subject|7|||
146637541|NCT03843541|528847330|FG000|Overall Study|Administration of rescue mucolytic|0|||
146637542|NCT03843541|528847331|FG001|Overall Study|Administration of rescue mucolytic|0|||
146637543|NCT03843541|528847332|FG002|Overall Study|Administration of rescue mucolytic|1|||
146637544|NCT03843541|528847330|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
146637545|NCT03843541|528847331|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
146637546|NCT03843541|528847332|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
146637547|NCT04163016|528847334|FG000|Enrollment|Adverse Event|1|||
146637548|NCT04163016|528847335|FG001|Enrollment|Adverse Event|0|||
146637549|NCT04163016|528847336|FG002|Enrollment|Adverse Event|0|||
146637550|NCT04163016|528847337|FG003|Enrollment|Adverse Event|0|||
146637551|NCT04163016|528847334|FG000|Treatment|Adverse Event|0|||
146637552|NCT04163016|528847335|FG001|Treatment|Adverse Event|1|||
146637553|NCT04163016|528847336|FG002|Treatment|Adverse Event|0|||
146637554|NCT04163016|528847337|FG003|Treatment|Adverse Event|0|||
146637555|NCT04163016|528847334|FG000|Treatment|Withdrawal by Subject|0|||
146637556|NCT04163016|528847335|FG001|Treatment|Withdrawal by Subject|2|||
146637557|NCT04163016|528847336|FG002|Treatment|Withdrawal by Subject|0|||
146637558|NCT04163016|528847337|FG003|Treatment|Withdrawal by Subject|0|||
146637559|NCT04163016|528847334|FG000|Treatment|Indeterminate TB-test|0|||
146637560|NCT04163016|528847335|FG001|Treatment|Indeterminate TB-test|0|||
146637561|NCT04163016|528847336|FG002|Treatment|Indeterminate TB-test|0|||
146637562|NCT04163016|528847337|FG003|Treatment|Indeterminate TB-test|1|||
146637563|NCT04163016|528847334|FG000|Treatment|Participant did not want to continue in study|0|||
146637564|NCT04163016|528847335|FG001|Treatment|Participant did not want to continue in study|0|||
146637565|NCT04163016|528847336|FG002|Treatment|Participant did not want to continue in study|0|||
146637566|NCT04163016|528847337|FG003|Treatment|Participant did not want to continue in study|1|||
146637567|NCT02930018|528847341|FG000|Overall Study|Lost to Follow-up|1|||
146637568|NCT02930018|528847342|FG001|Overall Study|Lost to Follow-up|1|||
146637569|NCT02930018|528847341|FG000|Overall Study|Withdrawal by Subject|5|||
146637570|NCT02930018|528847342|FG001|Overall Study|Withdrawal by Subject|2|||
146637571|NCT01596062|528848687|FG000|Overall Study|Adverse Event|1|||
146637572|NCT01596062|528848688|FG001|Overall Study|Adverse Event|0|||
146637573|NCT01596062|528848689|FG002|Overall Study|Adverse Event|2|||
146637574|NCT01596062|528848687|FG000|Overall Study|Lack of Efficacy|0|||
146637575|NCT01596062|528848688|FG001|Overall Study|Lack of Efficacy|0|||
146637576|NCT01596062|528848689|FG002|Overall Study|Lack of Efficacy|1|||
146637577|NCT02255435|528848690|FG000|Overall Study|Patient's Limited Time Availability|0|||
146637578|NCT02255435|528848691|FG001|Overall Study|Patient's Limited Time Availability|0|||
146637579|NCT02255435|528848692|FG002|Overall Study|Patient's Limited Time Availability|0|||
146637580|NCT02255435|528848693|FG003|Overall Study|Patient's Limited Time Availability|0|||
146637581|NCT02255435|528848694|FG004|Overall Study|Patient's Limited Time Availability|0|||
146637582|NCT02255435|528848695|FG005|Overall Study|Patient's Limited Time Availability|0|||
146637583|NCT02255435|528848696|FG006|Overall Study|Patient's Limited Time Availability|0|||
146637584|NCT02255435|528848697|FG007|Overall Study|Patient's Limited Time Availability|1|||
146637585|NCT02255435|528848698|FG008|Overall Study|Patient's Limited Time Availability|0|||
146893520|NCT03665285|529776039|FG001|Overall Study|Started New Anticancer Treatment|1|||
146893521|NCT03665285|529776040|FG002|Overall Study|Started New Anticancer Treatment|2|||
146893522|NCT03665285|529776041|FG003|Overall Study|Started New Anticancer Treatment|4|||
146893523|NCT03665285|529776042|FG004|Overall Study|Started New Anticancer Treatment|1|||
146893524|NCT03665285|529776043|FG005|Overall Study|Started New Anticancer Treatment|1|||
146637586|NCT02255435|528848699|FG009|Overall Study|Patient's Limited Time Availability|0|||
146637587|NCT02255435|528848690|FG000|Overall Study|Withdrawal by Subject|0|||
146637588|NCT02255435|528848691|FG001|Overall Study|Withdrawal by Subject|0|||
146637589|NCT02255435|528848692|FG002|Overall Study|Withdrawal by Subject|0|||
146637590|NCT02255435|528848693|FG003|Overall Study|Withdrawal by Subject|0|||
146637591|NCT02255435|528848694|FG004|Overall Study|Withdrawal by Subject|0|||
146637592|NCT02255435|528848695|FG005|Overall Study|Withdrawal by Subject|0|||
146637593|NCT02255435|528848696|FG006|Overall Study|Withdrawal by Subject|0|||
146893525|NCT03665285|529776044|FG006|Overall Study|Started New Anticancer Treatment|2|||
146893526|NCT03665285|529776045|FG007|Overall Study|Started New Anticancer Treatment|15|||
146893527|NCT03665285|529776046|FG008|Overall Study|Started New Anticancer Treatment|1|||
146893528|NCT03665285|529776038|FG000|Overall Study|Disease Progression|0|||
146893529|NCT03665285|529776039|FG001|Overall Study|Disease Progression|0|||
146893530|NCT03665285|529776040|FG002|Overall Study|Disease Progression|3|||
146893531|NCT03665285|529776041|FG003|Overall Study|Disease Progression|1|||
146893532|NCT03665285|529776042|FG004|Overall Study|Disease Progression|0|||
146893533|NCT03665285|529776043|FG005|Overall Study|Disease Progression|0|||
146893534|NCT03665285|529776044|FG006|Overall Study|Disease Progression|0|||
146893535|NCT03665285|529776045|FG007|Overall Study|Disease Progression|7|||
146893536|NCT03665285|529776046|FG008|Overall Study|Disease Progression|1|||
146893537|NCT03665285|529776038|FG000|Overall Study|Hospice|0|||
146893538|NCT03665285|529776039|FG001|Overall Study|Hospice|0|||
146893539|NCT03665285|529776040|FG002|Overall Study|Hospice|0|||
146893540|NCT03665285|529776041|FG003|Overall Study|Hospice|0|||
146893541|NCT03665285|529776042|FG004|Overall Study|Hospice|0|||
146893542|NCT03665285|529776043|FG005|Overall Study|Hospice|0|||
146893543|NCT03665285|529776044|FG006|Overall Study|Hospice|0|||
146893544|NCT03665285|529776045|FG007|Overall Study|Hospice|2|||
146893545|NCT03665285|529776046|FG008|Overall Study|Hospice|0|||
146893546|NCT03665285|529776038|FG000|Overall Study|Withdrawal by Subject|0|||
146893547|NCT03665285|529776039|FG001|Overall Study|Withdrawal by Subject|0|||
146893548|NCT03665285|529776040|FG002|Overall Study|Withdrawal by Subject|0|||
146893549|NCT03665285|529776041|FG003|Overall Study|Withdrawal by Subject|0|||
146893550|NCT03665285|529776042|FG004|Overall Study|Withdrawal by Subject|1|||
146893551|NCT03665285|529776043|FG005|Overall Study|Withdrawal by Subject|0|||
146893552|NCT03665285|529776044|FG006|Overall Study|Withdrawal by Subject|0|||
146893553|NCT03665285|529776045|FG007|Overall Study|Withdrawal by Subject|2|||
146893554|NCT03665285|529776046|FG008|Overall Study|Withdrawal by Subject|0|||
146893555|NCT03665285|529776038|FG000|Overall Study|Physician Decision|0|||
146893556|NCT03665285|529776039|FG001|Overall Study|Physician Decision|0|||
146893557|NCT03665285|529776040|FG002|Overall Study|Physician Decision|0|||
146893558|NCT03665285|529776041|FG003|Overall Study|Physician Decision|0|||
146893559|NCT03665285|529776042|FG004|Overall Study|Physician Decision|0|||
146893560|NCT03665285|529776043|FG005|Overall Study|Physician Decision|0|||
146893561|NCT03665285|529776044|FG006|Overall Study|Physician Decision|0|||
146893562|NCT03665285|529776045|FG007|Overall Study|Physician Decision|2|||
146893563|NCT03665285|529776046|FG008|Overall Study|Physician Decision|0|||
146893564|NCT00888355|529776047|FG000|Overall Study|Adverse Event|10|||
146893565|NCT00888355|529776048|FG001|Overall Study|Adverse Event|0|||
146893566|NCT00888355|529776049|FG002|Overall Study|Adverse Event|3|||
146893567|NCT00888355|529776050|FG003|Overall Study|Adverse Event|3|||
146893568|NCT00888355|529776047|FG000|Overall Study|Lack of Efficacy|9|||
146893569|NCT00888355|529776048|FG001|Overall Study|Lack of Efficacy|2|||
146893570|NCT00888355|529776049|FG002|Overall Study|Lack of Efficacy|5|||
146893571|NCT00888355|529776050|FG003|Overall Study|Lack of Efficacy|2|||
146893572|NCT00888355|529776047|FG000|Overall Study|Lost to Follow-up|0|||
146893573|NCT00888355|529776048|FG001|Overall Study|Lost to Follow-up|2|||
146893574|NCT00888355|529776049|FG002|Overall Study|Lost to Follow-up|2|||
146893575|NCT00888355|529776050|FG003|Overall Study|Lost to Follow-up|0|||
146893576|NCT00888355|529776047|FG000|Overall Study|Protocol Violation|3|||
146893577|NCT00888355|529776048|FG001|Overall Study|Protocol Violation|2|||
146893578|NCT00888355|529776049|FG002|Overall Study|Protocol Violation|1|||
146893579|NCT00888355|529776050|FG003|Overall Study|Protocol Violation|2|||
146893580|NCT00888355|529776047|FG000|Overall Study|Withdrawal by Subject|0|||
146893581|NCT00888355|529776048|FG001|Overall Study|Withdrawal by Subject|3|||
146893582|NCT00888355|529776049|FG002|Overall Study|Withdrawal by Subject|1|||
146893583|NCT00888355|529776050|FG003|Overall Study|Withdrawal by Subject|3|||
146893584|NCT00331006|529776053|FG000|Screening Phase|Withdrawal by Subject|1|||
146893585|NCT00331006|529776053|FG000|Screening Phase|enrollment halted|1|||
146893586|NCT00331006|529776053|FG000|Screening Phase|Lost to Follow-up|1|||
146893587|NCT00331006|529776053|FG000|Screening Phase|Ineligible for treatment phase|4|||
146893588|NCT00331006|529776053|FG000|Treatment Phase|Withdrawal by Subject|1|||
146893589|NCT00331006|529776053|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
146893590|NCT00331006|529776053|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
146893591|NCT03213366|529776058|FG000|Overall Study|Lost to Follow-up|9|||
146893592|NCT03213366|529776059|FG001|Overall Study|Lost to Follow-up|4|||
146893593|NCT02532855|529776063|FG000|Overall Study|Lost to Follow-up|4|||
146893594|NCT02532855|529776064|FG001|Overall Study|Lost to Follow-up|3|||
146893595|NCT02532855|529776063|FG000|Overall Study|Withdrawal by Subject|4|||
146893596|NCT02532855|529776064|FG001|Overall Study|Withdrawal by Subject|8|||
146893597|NCT01737931|529776067|FG000|Overall Study|Withdrawal by Subject|0|||
146893598|NCT01737931|529776068|FG001|Overall Study|Withdrawal by Subject|1|||
146893599|NCT01737931|529776069|FG002|Overall Study|Withdrawal by Subject|1|||
146893600|NCT01737931|529776067|FG000|Overall Study|Physician Decision|0|||
146893601|NCT01737931|529776068|FG001|Overall Study|Physician Decision|1|||
146893602|NCT01737931|529776069|FG002|Overall Study|Physician Decision|0|||
146893603|NCT04897867|529776070|FG000|Overall Study|Withdrawal of Consent|1|||
146893604|NCT04897867|529776070|FG000|Overall Study|Pregnancy|1|||
146893605|NCT04897867|529776070|FG000|Overall Study|Lost to Follow-up|7|||
146893606|NCT04897867|529776070|FG000|Overall Study|Reason not Specified|2|||
146893607|NCT02601573|529776071|FG000|Overall Study|Lost to Follow-up|0|||
146893608|NCT02601573|529776072|FG001|Overall Study|Lost to Follow-up|3|||
146893609|NCT02601573|529776073|FG002|Overall Study|Lost to Follow-up|1|||
146893610|NCT02601573|529776074|FG003|Overall Study|Lost to Follow-up|0|||
146893611|NCT02601573|529776075|FG004|Overall Study|Lost to Follow-up|2|||
146893612|NCT02601573|529776071|FG000|Overall Study|Withdrawal by Subject|0|||
146893613|NCT02601573|529776072|FG001|Overall Study|Withdrawal by Subject|1|||
146893614|NCT02601573|529776073|FG002|Overall Study|Withdrawal by Subject|0|||
146893615|NCT02601573|529776074|FG003|Overall Study|Withdrawal by Subject|1|||
146893616|NCT02601573|529776075|FG004|Overall Study|Withdrawal by Subject|0|||
146893617|NCT04025632|529777664|FG000|Overall Study|Adverse Event|1|||
146893618|NCT04025632|529777665|FG001|Overall Study|Adverse Event|1|||
146893619|NCT04025632|529777664|FG000|Overall Study|Withdrawal by Subject|1|||
146893620|NCT04025632|529777665|FG001|Overall Study|Withdrawal by Subject|1|||
146893621|NCT04025632|529777664|FG000|Overall Study|Study Terminated by Sponsor|10|||
146893622|NCT04025632|529777665|FG001|Overall Study|Study Terminated by Sponsor|9|||
146893623|NCT04025632|529777664|FG000|Overall Study|Physician Decision|3|||
146893624|NCT04025632|529777665|FG001|Overall Study|Physician Decision|1|||
146893625|NCT00376961|529777666|FG000|Initial Registration|Adverse Event|1|||
146893626|NCT00376961|529777667|FG001|Initial Registration|Adverse Event|0|||
146893627|NCT00376961|529777666|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
146893628|NCT00376961|529777667|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
146893629|NCT00376961|529777666|FG000|Initial Registration|Progression/relapse|1|||
146893630|NCT00376961|529777667|FG001|Initial Registration|Progression/relapse|0|||
146893631|NCT00376961|529777666|FG000|Initial Registration|Ineligible|3|||
146893632|NCT00376961|529777667|FG001|Initial Registration|Ineligible|0|||
146893633|NCT00376961|529777666|FG000|Maintenance|Adverse Event|0|||
146893634|NCT00376961|529777667|FG001|Maintenance|Adverse Event|1|||
146893635|NCT00376961|529777666|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
146893636|NCT00376961|529777667|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
146893637|NCT00376961|529777666|FG000|Maintenance|Progression/relapse|0|||
146893638|NCT00376961|529777667|FG001|Maintenance|Progression/relapse|18|||
146893639|NCT00376961|529777666|FG000|Maintenance|Ineligible|0|||
146893640|NCT00376961|529777667|FG001|Maintenance|Ineligible|3|||
146893641|NCT00925600|529777668|FG000|Overall Study|Withdrawal by Subject|16|||
146893642|NCT00925600|529777669|FG001|Overall Study|Withdrawal by Subject|14|||
146893643|NCT00925600|529777668|FG000|Overall Study|Death|4|||
146893644|NCT00925600|529777669|FG001|Overall Study|Death|3|||
146893645|NCT00925600|529777668|FG000|Overall Study|Lost to Follow-up|2|||
146893646|NCT00925600|529777669|FG001|Overall Study|Lost to Follow-up|2|||
146968030|NCT02325739|530043912|FG007|Phase I Part|Adverse Event|2|||
146893647|NCT00925600|529777668|FG000|Overall Study|Disease Progression|1|||
146893648|NCT00925600|529777669|FG001|Overall Study|Disease Progression|3|||
146893649|NCT00925600|529777668|FG000|Overall Study|Administrative Decision|1|||
146893650|NCT00925600|529777669|FG001|Overall Study|Administrative Decision|1|||
146893651|NCT00925600|529777668|FG000|Overall Study|Noncompliance|2|||
146893652|NCT00925600|529777669|FG001|Overall Study|Noncompliance|0|||
146893653|NCT00925600|529777668|FG000|Overall Study|Ineligibility Determined|2|||
146968031|NCT02325739|530043913|FG008|Phase I Part|Adverse Event|0|||
146893654|NCT00925600|529777669|FG001|Overall Study|Ineligibility Determined|0|||
146893655|NCT00925600|529777668|FG000|Overall Study|Protocol Deviation|0|||
146893656|NCT00925600|529777669|FG001|Overall Study|Protocol Deviation|1|||
146893657|NCT00925600|529777668|FG000|Overall Study|Requirement for Alternative Therapy|0|||
146893658|NCT00925600|529777669|FG001|Overall Study|Requirement for Alternative Therapy|1|||
146893659|NCT00925600|529777668|FG000|Overall Study|Other|3|||
146893660|NCT00925600|529777669|FG001|Overall Study|Other|1|||
146637594|NCT02255435|528848697|FG007|Overall Study|Withdrawal by Subject|0|||
146637595|NCT02255435|528848698|FG008|Overall Study|Withdrawal by Subject|1|||
146637596|NCT02255435|528848699|FG009|Overall Study|Withdrawal by Subject|4|||
146637597|NCT02255435|528848690|FG000|Overall Study|Administrative reasons|0|||
146637598|NCT02255435|528848691|FG001|Overall Study|Administrative reasons|0|||
146637599|NCT02255435|528848692|FG002|Overall Study|Administrative reasons|0|||
146637600|NCT02255435|528848693|FG003|Overall Study|Administrative reasons|0|||
146637601|NCT02255435|528848694|FG004|Overall Study|Administrative reasons|0|||
146637602|NCT02255435|528848695|FG005|Overall Study|Administrative reasons|0|||
146637603|NCT02255435|528848696|FG006|Overall Study|Administrative reasons|0|||
146637604|NCT02255435|528848697|FG007|Overall Study|Administrative reasons|0|||
146637605|NCT02255435|528848698|FG008|Overall Study|Administrative reasons|0|||
146637606|NCT02255435|528848699|FG009|Overall Study|Administrative reasons|2|||
146637607|NCT01069900|528848702|FG000|Overall Study|Technical problems|0|||
146637608|NCT01069900|528848703|FG001|Overall Study|Technical problems|1|||
146637609|NCT01069900|528848702|FG000|Overall Study|Lost to Follow-up|7|||
146637610|NCT01069900|528848703|FG001|Overall Study|Lost to Follow-up|1|||
146637611|NCT01069900|528848702|FG000|Overall Study|Withdrawal by Subject|6|||
146637612|NCT01069900|528848703|FG001|Overall Study|Withdrawal by Subject|1|||
146637613|NCT01069900|528848702|FG000|Overall Study|Protocol Violation|4|||
146637614|NCT01069900|528848703|FG001|Overall Study|Protocol Violation|1|||
146637615|NCT01069900|528848702|FG000|Overall Study|Insufficient Therapeutic effect|1|||
146637616|NCT01069900|528848703|FG001|Overall Study|Insufficient Therapeutic effect|0|||
146637617|NCT00145158|528848704|FG000|Overall Study|premature withdrawal|2|||
146637618|NCT00145158|528848705|FG001|Overall Study|premature withdrawal|3|||
146637619|NCT00476008|528848706|FG000|Overall Study|Adverse Event|4|||
146637620|NCT00476008|528848707|FG001|Overall Study|Adverse Event|4|||
146637621|NCT00476008|528848706|FG000|Overall Study|Placebo concerns|2|||
146637622|NCT00476008|528848707|FG001|Overall Study|Placebo concerns|2|||
146637623|NCT00476008|528848706|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
146637624|NCT00476008|528848707|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
146637625|NCT00476008|528848706|FG000|Overall Study|Withdrawal by Subject|0|||
146637626|NCT00476008|528848707|FG001|Overall Study|Withdrawal by Subject|1|||
146637627|NCT00476008|528848706|FG000|Overall Study|Death|1|||
146637628|NCT00476008|528848707|FG001|Overall Study|Death|0|||
146637629|NCT01227018|528848708|FG000|Overall Study|Disease progression|9|||
146637630|NCT01227018|528848708|FG000|Overall Study|Toxicity|2|||
146637631|NCT01227018|528848708|FG000|Overall Study|Withdrew after beginning treatment|4|||
146637632|NCT02948634|528848709|FG000|Overall Study|Lack of efficacy and study suspended|10|||
146637633|NCT02948634|528848710|FG001|Overall Study|Lack of efficacy and study suspended|2|||
146637634|NCT01413204|528848713|FG000|Overall Study|Adverse Event|1|||
146637635|NCT01413204|528848714|FG001|Overall Study|Adverse Event|2|||
146637636|NCT01413204|528848715|FG002|Overall Study|Adverse Event|2|||
146637637|NCT01413204|528848713|FG000|Overall Study|Physician Decision|3|||
146637638|NCT01413204|528848714|FG001|Overall Study|Physician Decision|0|||
146637639|NCT01413204|528848715|FG002|Overall Study|Physician Decision|2|||
146637640|NCT01413204|528848713|FG000|Overall Study|Withdrawal by Subject|1|||
146637641|NCT01413204|528848714|FG001|Overall Study|Withdrawal by Subject|4|||
146637642|NCT01413204|528848715|FG002|Overall Study|Withdrawal by Subject|4|||
146637643|NCT01413204|528848713|FG000|Overall Study|Clearly not eligible for the study|0|||
146637644|NCT01413204|528848714|FG001|Overall Study|Clearly not eligible for the study|0|||
146637645|NCT01413204|528848715|FG002|Overall Study|Clearly not eligible for the study|1|||
146637646|NCT01413204|528848713|FG000|Overall Study|Fasting plasma glucose level increased|1|||
146637647|NCT01413204|528848714|FG001|Overall Study|Fasting plasma glucose level increased|0|||
146637648|NCT01413204|528848715|FG002|Overall Study|Fasting plasma glucose level increased|10|||
146637649|NCT00753649|528848716|FG000|Overall Study|Migrated/moved from study area|1|||
146637650|NCT00753649|528848717|FG001|Overall Study|Migrated/moved from study area|0|||
146637651|NCT00753649|528848716|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
146637652|NCT00753649|528848717|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
146637653|NCT00753649|528848716|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
146637654|NCT00753649|528848717|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
146637655|NCT00753649|528848716|FG000|Overall Study|Protocol Violation|2|||
146637656|NCT00753649|528848717|FG001|Overall Study|Protocol Violation|0|||
146637657|NCT00499616|528848718|FG000|Overall Study|Death|1|||
146637658|NCT00499616|528848719|FG001|Overall Study|Death|5|||
146766487|NCT02914522|529312254|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
146637659|NCT00499616|528848720|FG002|Overall Study|Death|3|||
146637660|NCT00499616|528848721|FG003|Overall Study|Death|1|||
146637661|NCT00499616|528848718|FG000|Overall Study|Lack of Efficacy|5|||
146637662|NCT00499616|528848719|FG001|Overall Study|Lack of Efficacy|0|||
146637663|NCT00499616|528848720|FG002|Overall Study|Lack of Efficacy|19|||
146637664|NCT00499616|528848721|FG003|Overall Study|Lack of Efficacy|0|||
146637665|NCT00499616|528848718|FG000|Overall Study|Lost to Follow-up|0|||
146637666|NCT00499616|528848719|FG001|Overall Study|Lost to Follow-up|0|||
146637667|NCT00499616|528848720|FG002|Overall Study|Lost to Follow-up|1|||
146637668|NCT00499616|528848721|FG003|Overall Study|Lost to Follow-up|0|||
146893661|NCT00925600|529777668|FG000|Overall Study|Adverse Event|1|||
146893662|NCT00925600|529777669|FG001|Overall Study|Adverse Event|2|||
146558321|NCT03715829|528554230|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
146558322|NCT03715829|528554220|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
146558323|NCT03715829|528554221|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
146558324|NCT03715829|528554222|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
146558325|NCT03715829|528554223|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
146558326|NCT03715829|528554224|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
146558327|NCT03715829|528554225|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
146558328|NCT03715829|528554226|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
146558329|NCT03715829|528554227|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
146558330|NCT03715829|528554228|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
146558331|NCT03715829|528554229|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
146558332|NCT03715829|528554230|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
146558333|NCT03715829|528554220|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
146558334|NCT03715829|528554221|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
146558335|NCT03715829|528554222|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
146558336|NCT03715829|528554223|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
146558337|NCT03715829|528554224|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
146558338|NCT03715829|528554225|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
146558339|NCT03715829|528554226|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
146558340|NCT03715829|528554227|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
146558341|NCT03715829|528554228|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
146558342|NCT03715829|528554229|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
146558343|NCT03715829|528554230|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
146558344|NCT03715829|528554220|FG000|Dose Ranging Period|Other|0|||
146558345|NCT03715829|528554221|FG001|Dose Ranging Period|Other|0|||
146558346|NCT03715829|528554222|FG002|Dose Ranging Period|Other|2|||
146558347|NCT03715829|528554223|FG003|Dose Ranging Period|Other|0|||
146558348|NCT03715829|528554224|FG004|Dose Ranging Period|Other|0|||
146558349|NCT03715829|528554225|FG005|Dose Ranging Period|Other|3|||
146558350|NCT03715829|528554226|FG006|Dose Ranging Period|Other|0|||
146558351|NCT03715829|528554227|FG007|Dose Ranging Period|Other|0|||
146558352|NCT03715829|528554228|FG008|Dose Ranging Period|Other|0|||
146558353|NCT03715829|528554229|FG009|Dose Ranging Period|Other|0|||
146558354|NCT03715829|528554230|FG010|Dose Ranging Period|Other|0|||
146558355|NCT03715829|528554220|FG000|Extension Period|Adverse Event|0|||
146558356|NCT03715829|528554221|FG001|Extension Period|Adverse Event|0|||
146558357|NCT03715829|528554222|FG002|Extension Period|Adverse Event|0|||
146637669|NCT00499616|528848718|FG000|Overall Study|Physician Decision|6|||
146558358|NCT03715829|528554223|FG003|Extension Period|Adverse Event|0|||
146558359|NCT03715829|528554224|FG004|Extension Period|Adverse Event|0|||
146558360|NCT03715829|528554225|FG005|Extension Period|Adverse Event|0|||
146558361|NCT03715829|528554226|FG006|Extension Period|Adverse Event|3|||
146558362|NCT03715829|528554227|FG007|Extension Period|Adverse Event|1|||
146766488|NCT02914522|529312255|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
146893663|NCT00947531|529777676|FG000|Overall Study|Withdrawal by Subject|10|||
146893664|NCT00947531|529777677|FG001|Overall Study|Withdrawal by Subject|7|||
146893665|NCT00947531|529777676|FG000|Overall Study|Administrative Reason|0|||
146893666|NCT00947531|529777677|FG001|Overall Study|Administrative Reason|1|||
146893667|NCT00947531|529777676|FG000|Overall Study|Adverse Event|2|||
146893668|NCT00947531|529777677|FG001|Overall Study|Adverse Event|2|||
146893669|NCT00947531|529777676|FG000|Overall Study|Lack of Efficacy|1|||
146893670|NCT00947531|529777677|FG001|Overall Study|Lack of Efficacy|0|||
146893671|NCT00947531|529777676|FG000|Overall Study|Other|1|||
146893672|NCT00947531|529777677|FG001|Overall Study|Other|1|||
146893673|NCT02367521|529777678|FG000|Overall Study|severe headache after intervention|2|||
146893674|NCT02367521|529777679|FG001|Overall Study|severe headache after intervention|0|||
146893675|NCT02367521|529777678|FG000|Overall Study|unable to find transportation|2|||
146893676|NCT02367521|529777679|FG001|Overall Study|unable to find transportation|0|||
146893677|NCT00600171|529777680|FG000|Overall Study|Adverse Event|0|||
146893678|NCT00600171|529777681|FG001|Overall Study|Adverse Event|1|||
146893679|NCT00600171|529777682|FG002|Overall Study|Adverse Event|0|||
146893680|NCT00600171|529777683|FG003|Overall Study|Adverse Event|0|||
146893681|NCT00600171|529777684|FG004|Overall Study|Adverse Event|1|||
146893682|NCT00600171|529777685|FG005|Overall Study|Adverse Event|0|||
146893683|NCT00600171|529777680|FG000|Overall Study|Lack of Efficacy|9|||
146893684|NCT00600171|529777681|FG001|Overall Study|Lack of Efficacy|12|||
146893685|NCT00600171|529777682|FG002|Overall Study|Lack of Efficacy|3|||
146893686|NCT00600171|529777683|FG003|Overall Study|Lack of Efficacy|5|||
146893687|NCT00600171|529777684|FG004|Overall Study|Lack of Efficacy|4|||
146893688|NCT00600171|529777685|FG005|Overall Study|Lack of Efficacy|0|||
146893689|NCT00600171|529777680|FG000|Overall Study|Protocol Violation|1|||
146893690|NCT00600171|529777681|FG001|Overall Study|Protocol Violation|2|||
146893691|NCT00600171|529777682|FG002|Overall Study|Protocol Violation|0|||
146893692|NCT00600171|529777683|FG003|Overall Study|Protocol Violation|1|||
146893693|NCT00600171|529777684|FG004|Overall Study|Protocol Violation|0|||
146893694|NCT00600171|529777685|FG005|Overall Study|Protocol Violation|0|||
146893695|NCT00600171|529777680|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
146893696|NCT00600171|529777681|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
146893697|NCT00600171|529777682|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
146893698|NCT00600171|529777683|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
146893699|NCT00600171|529777684|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
146893700|NCT00600171|529777685|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
146893701|NCT00600171|529777680|FG000|Overall Study|Withdrawal by Subject|3|||
146893702|NCT00600171|529777681|FG001|Overall Study|Withdrawal by Subject|0|||
146893703|NCT00600171|529777682|FG002|Overall Study|Withdrawal by Subject|0|||
146893704|NCT00600171|529777683|FG003|Overall Study|Withdrawal by Subject|1|||
146893705|NCT00600171|529777684|FG004|Overall Study|Withdrawal by Subject|1|||
146893706|NCT00600171|529777685|FG005|Overall Study|Withdrawal by Subject|1|||
146893707|NCT00600171|529777680|FG000|Overall Study|Physician Decision|0|||
146893708|NCT00600171|529777681|FG001|Overall Study|Physician Decision|1|||
146893709|NCT00600171|529777682|FG002|Overall Study|Physician Decision|0|||
146893710|NCT00600171|529777683|FG003|Overall Study|Physician Decision|1|||
146893711|NCT00600171|529777684|FG004|Overall Study|Physician Decision|0|||
146893712|NCT00600171|529777685|FG005|Overall Study|Physician Decision|2|||
146893713|NCT00600171|529777680|FG000|Overall Study|Lost to Follow-up|0|||
146893714|NCT00600171|529777681|FG001|Overall Study|Lost to Follow-up|0|||
146893715|NCT00600171|529777682|FG002|Overall Study|Lost to Follow-up|0|||
146893716|NCT00600171|529777683|FG003|Overall Study|Lost to Follow-up|1|||
146893717|NCT00600171|529777684|FG004|Overall Study|Lost to Follow-up|0|||
146893718|NCT00600171|529777685|FG005|Overall Study|Lost to Follow-up|0|||
146968032|NCT02325739|530043914|FG009|Phase I Part|Adverse Event|0|||
146968033|NCT02325739|530043915|FG010|Phase I Part|Adverse Event|0|||
146558363|NCT03715829|528554228|FG008|Extension Period|Adverse Event|6|||
146558364|NCT03715829|528554229|FG009|Extension Period|Adverse Event|0|||
146558365|NCT03715829|528554230|FG010|Extension Period|Adverse Event|0|||
146558366|NCT03715829|528554220|FG000|Extension Period|Lack of Efficacy|0|||
146558367|NCT03715829|528554221|FG001|Extension Period|Lack of Efficacy|0|||
146558368|NCT03715829|528554222|FG002|Extension Period|Lack of Efficacy|0|||
146558369|NCT03715829|528554223|FG003|Extension Period|Lack of Efficacy|0|||
146558370|NCT03715829|528554224|FG004|Extension Period|Lack of Efficacy|0|||
146558371|NCT03715829|528554225|FG005|Extension Period|Lack of Efficacy|0|||
146558372|NCT03715829|528554226|FG006|Extension Period|Lack of Efficacy|1|||
146558373|NCT03715829|528554227|FG007|Extension Period|Lack of Efficacy|9|||
146558374|NCT03715829|528554228|FG008|Extension Period|Lack of Efficacy|2|||
146558375|NCT03715829|528554229|FG009|Extension Period|Lack of Efficacy|0|||
146558376|NCT03715829|528554230|FG010|Extension Period|Lack of Efficacy|0|||
146558377|NCT03715829|528554220|FG000|Extension Period|Lost to Follow-up|0|||
146558378|NCT03715829|528554221|FG001|Extension Period|Lost to Follow-up|0|||
146893719|NCT00542191|529777689|FG000|Overall Study|Death|3|||
146893720|NCT00469612|529777690|FG000|Overall Study|Study terminated before data collected|2|||
146893721|NCT00469612|529777691|FG001|Overall Study|Study terminated before data collected|0|||
146893722|NCT00289913|529777694|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146893723|NCT00289913|529777695|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
146893724|NCT00289913|529777696|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146893725|NCT00289913|529777697|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146893726|NCT00289913|529777698|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146893727|NCT00289913|529777694|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
146893728|NCT00289913|529777695|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
146893729|NCT00289913|529777696|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
146893730|NCT00289913|529777697|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
146893731|NCT00289913|529777698|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
146893732|NCT00289913|529777694|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
146968034|NCT02325739|530043905|FG000|Phase I Part|Progressive disease|9|||
146968035|NCT02325739|530043906|FG001|Phase I Part|Progressive disease|6|||
146637670|NCT00499616|528848719|FG001|Overall Study|Physician Decision|16|||
146637671|NCT00499616|528848720|FG002|Overall Study|Physician Decision|9|||
146637672|NCT00499616|528848721|FG003|Overall Study|Physician Decision|0|||
146637673|NCT00499616|528848718|FG000|Overall Study|Withdrawal by Subject|1|||
146637674|NCT00499616|528848719|FG001|Overall Study|Withdrawal by Subject|0|||
146637675|NCT00499616|528848720|FG002|Overall Study|Withdrawal by Subject|1|||
146637676|NCT00499616|528848721|FG003|Overall Study|Withdrawal by Subject|0|||
146637677|NCT00499616|528848718|FG000|Overall Study|Ineligible|1|||
146637678|NCT00499616|528848719|FG001|Overall Study|Ineligible|2|||
146637679|NCT00499616|528848720|FG002|Overall Study|Ineligible|0|||
146637680|NCT00499616|528848721|FG003|Overall Study|Ineligible|15|||
146637681|NCT00499616|528848718|FG000|Overall Study|Not evaluable|0|||
146637682|NCT00499616|528848719|FG001|Overall Study|Not evaluable|0|||
146637683|NCT00499616|528848720|FG002|Overall Study|Not evaluable|0|||
146637684|NCT00499616|528848721|FG003|Overall Study|Not evaluable|41|||
146637685|NCT00499616|528848718|FG000|Overall Study|Patient/Parent Refusal|1|||
146637686|NCT00499616|528848719|FG001|Overall Study|Patient/Parent Refusal|5|||
146637687|NCT00499616|528848720|FG002|Overall Study|Patient/Parent Refusal|3|||
146637688|NCT00499616|528848721|FG003|Overall Study|Patient/Parent Refusal|0|||
146637689|NCT01864603|528848723|FG000|Stage 2|DSMB design modification|86056|||
146637690|NCT01864603|528848724|FG001|Stage 2|DSMB design modification|92558|||
146637691|NCT03830892|528848727|FG000|Overall Study|Physician Decision|2|||
146637692|NCT03830892|528848728|FG001|Overall Study|Physician Decision|3|||
146637693|NCT03830892|528848727|FG000|Overall Study|Study terminated due to COVID|4|||
146637694|NCT03830892|528848728|FG001|Overall Study|Study terminated due to COVID|0|||
146558379|NCT03715829|528554222|FG002|Extension Period|Lost to Follow-up|0|||
146558380|NCT03715829|528554223|FG003|Extension Period|Lost to Follow-up|0|||
146558381|NCT03715829|528554224|FG004|Extension Period|Lost to Follow-up|0|||
146558382|NCT03715829|528554225|FG005|Extension Period|Lost to Follow-up|0|||
146558383|NCT03715829|528554226|FG006|Extension Period|Lost to Follow-up|0|||
146558384|NCT03715829|528554227|FG007|Extension Period|Lost to Follow-up|0|||
146558385|NCT03715829|528554228|FG008|Extension Period|Lost to Follow-up|2|||
146558386|NCT03715829|528554229|FG009|Extension Period|Lost to Follow-up|0|||
146558387|NCT03715829|528554230|FG010|Extension Period|Lost to Follow-up|0|||
146558388|NCT03715829|528554220|FG000|Extension Period|Protocol Violation|0|||
146558389|NCT03715829|528554221|FG001|Extension Period|Protocol Violation|0|||
146558390|NCT03715829|528554222|FG002|Extension Period|Protocol Violation|0|||
146558391|NCT03715829|528554223|FG003|Extension Period|Protocol Violation|0|||
146558392|NCT03715829|528554224|FG004|Extension Period|Protocol Violation|0|||
146558393|NCT03715829|528554225|FG005|Extension Period|Protocol Violation|0|||
146558394|NCT03715829|528554226|FG006|Extension Period|Protocol Violation|0|||
146558395|NCT03715829|528554227|FG007|Extension Period|Protocol Violation|0|||
146558396|NCT03715829|528554228|FG008|Extension Period|Protocol Violation|1|||
146558397|NCT03715829|528554229|FG009|Extension Period|Protocol Violation|0|||
146558398|NCT03715829|528554230|FG010|Extension Period|Protocol Violation|0|||
146558399|NCT03715829|528554220|FG000|Extension Period|Withdrawal by Subject|0|||
146558400|NCT03715829|528554221|FG001|Extension Period|Withdrawal by Subject|0|||
146558401|NCT03715829|528554222|FG002|Extension Period|Withdrawal by Subject|0|||
146558402|NCT03715829|528554223|FG003|Extension Period|Withdrawal by Subject|0|||
146558403|NCT03715829|528554224|FG004|Extension Period|Withdrawal by Subject|0|||
146558404|NCT03715829|528554225|FG005|Extension Period|Withdrawal by Subject|0|||
146558405|NCT03715829|528554226|FG006|Extension Period|Withdrawal by Subject|3|||
146558406|NCT03715829|528554227|FG007|Extension Period|Withdrawal by Subject|3|||
146558407|NCT03715829|528554228|FG008|Extension Period|Withdrawal by Subject|12|||
146766489|NCT02914522|529312256|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
146766490|NCT02914522|529312257|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
146766491|NCT02914522|529312247|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146766492|NCT02914522|529312248|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146766493|NCT02914522|529312249|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146766494|NCT02914522|529312250|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146766495|NCT02914522|529312251|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
146766496|NCT02914522|529312252|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146766497|NCT02914522|529312253|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146766498|NCT02914522|529312254|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146766499|NCT02914522|529312255|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146766500|NCT02914522|529312256|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146766501|NCT02914522|529312257|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146766502|NCT02914522|529312247|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
146766503|NCT02914522|529312248|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146766504|NCT02914522|529312249|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146766505|NCT02914522|529312250|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146766506|NCT02914522|529312251|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146766507|NCT02914522|529312252|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146766508|NCT02914522|529312253|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146766509|NCT02914522|529312254|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146766510|NCT02914522|529312255|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146766511|NCT02914522|529312256|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146766512|NCT02914522|529312257|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146766513|NCT02914522|529312247|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
146893733|NCT00289913|529777695|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
146893734|NCT00289913|529777696|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
146893735|NCT00289913|529777697|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
146968036|NCT02325739|530043907|FG002|Phase I Part|Progressive disease|3|||
146558408|NCT03715829|528554229|FG009|Extension Period|Withdrawal by Subject|3|||
146558409|NCT03715829|528554230|FG010|Extension Period|Withdrawal by Subject|0|||
146558410|NCT03715829|528554220|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
146558411|NCT03715829|528554221|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
146558412|NCT03715829|528554222|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
146558413|NCT03715829|528554223|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
146558414|NCT03715829|528554224|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
146558415|NCT03715829|528554225|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
146558416|NCT03715829|528554226|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
146558417|NCT03715829|528554227|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
146558418|NCT03715829|528554228|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
146558419|NCT03715829|528554229|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
146558420|NCT03715829|528554230|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
146558421|NCT03715829|528554220|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
146558422|NCT03715829|528554221|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
146558423|NCT03715829|528554222|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
146558424|NCT03715829|528554223|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
146558425|NCT03715829|528554224|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
146558426|NCT03715829|528554225|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
146558427|NCT03715829|528554226|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
146558428|NCT03715829|528554227|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
146558429|NCT03715829|528554228|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
146558430|NCT03715829|528554229|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
146558431|NCT03715829|528554230|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
146558432|NCT03715829|528554220|FG000|Extension Period|Other|0|||
146558433|NCT03715829|528554221|FG001|Extension Period|Other|0|||
146558434|NCT03715829|528554222|FG002|Extension Period|Other|0|||
146558435|NCT03715829|528554223|FG003|Extension Period|Other|0|||
146558436|NCT03715829|528554224|FG004|Extension Period|Other|0|||
146558437|NCT03715829|528554225|FG005|Extension Period|Other|0|||
146558438|NCT03715829|528554226|FG006|Extension Period|Other|1|||
146558439|NCT03715829|528554227|FG007|Extension Period|Other|2|||
146558440|NCT03715829|528554228|FG008|Extension Period|Other|4|||
146558441|NCT03715829|528554229|FG009|Extension Period|Other|0|||
146558442|NCT03715829|528554230|FG010|Extension Period|Other|0|||
146558443|NCT03773562|528554231|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
146558444|NCT03773562|528554231|FG000|Overall Study|Lost to Follow-up|10|||
146558445|NCT03773562|528554231|FG000|Overall Study|Withdrawal by Subject|1|||
146558446|NCT01272219|528554232|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
146558447|NCT01272219|528554233|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
146558448|NCT01272219|528554234|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
146558449|NCT01272219|528554235|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
146558450|NCT01272219|528554236|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
146558451|NCT01272219|528554237|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
146558452|NCT01272219|528554232|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
146558453|NCT01272219|528554233|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
146558454|NCT01272219|528554234|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
146558455|NCT01272219|528554235|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
146558456|NCT01272219|528554236|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
146558457|NCT01272219|528554237|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
146558458|NCT01272219|528554232|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
146558459|NCT01272219|528554233|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
146558460|NCT01272219|528554234|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
146558461|NCT01272219|528554235|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
146558462|NCT01272219|528554236|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
146558463|NCT01272219|528554237|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
146558464|NCT01272219|528554232|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
146558465|NCT01272219|528554233|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
146558466|NCT01272219|528554234|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
146558467|NCT01272219|528554235|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
146558468|NCT01272219|528554236|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
146558469|NCT01272219|528554237|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
146558470|NCT01272219|528554232|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
146558471|NCT01272219|528554233|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
146558472|NCT01272219|528554234|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
146558473|NCT01272219|528554235|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
146558474|NCT01272219|528554236|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
146558475|NCT01272219|528554237|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
146558476|NCT01272219|528554232|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
146637695|NCT03830892|528848727|FG000|Overall Study|Protocol Violation|0|||
146637696|NCT03830892|528848728|FG001|Overall Study|Protocol Violation|1|||
146893736|NCT00289913|529777698|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
146637697|NCT03830892|528848727|FG000|Overall Study|Withdrawal by Subject|0|||
146893737|NCT00289913|529777694|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
146893738|NCT00289913|529777695|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
146893739|NCT00289913|529777696|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
146893740|NCT00289913|529777697|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
146893741|NCT00289913|529777698|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
146893742|NCT00289913|529777694|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146893743|NCT00289913|529777695|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146893744|NCT00289913|529777696|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146893745|NCT00289913|529777697|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
146893746|NCT00289913|529777698|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146893747|NCT00289913|529777694|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
146893748|NCT00289913|529777695|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
146893749|NCT00289913|529777696|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
146893750|NCT00289913|529777697|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
146893751|NCT00289913|529777698|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
146893752|NCT00289913|529777694|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
146893753|NCT00289913|529777695|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
146893754|NCT00289913|529777696|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
146893755|NCT00289913|529777697|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
146893756|NCT00289913|529777698|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
146893757|NCT00289913|529777694|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
146893758|NCT00289913|529777695|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
146893759|NCT00289913|529777696|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
146893760|NCT00289913|529777697|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
146893761|NCT00289913|529777698|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
146893762|NCT00289913|529777694|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
146893763|NCT00289913|529777695|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
146893764|NCT00289913|529777696|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
146893765|NCT00289913|529777697|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
146893766|NCT00289913|529777698|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
146893767|NCT00289913|529777694|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146893768|NCT00289913|529777695|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146893769|NCT00289913|529777696|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
146893770|NCT00289913|529777697|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146893771|NCT00289913|529777698|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146637698|NCT03830892|528848728|FG001|Overall Study|Withdrawal by Subject|2|||
146637699|NCT00330967|528848729|FG000|Overall Study|Withdrawal by Subject|0|||
146637700|NCT00330967|528848730|FG001|Overall Study|Withdrawal by Subject|5|||
146637701|NCT00330967|528848729|FG000|Overall Study|Physician Decision|0|||
146637702|NCT00330967|528848730|FG001|Overall Study|Physician Decision|9|||
146637703|NCT04269265|528848731|FG000|Overall Study|Physician Decision|1|||
146637704|NCT04269265|528848731|FG000|Overall Study|Withdrawal by Subject|1|||
146637705|NCT04269265|528848731|FG000|Overall Study|Overenrolled (sample size reached)|4|||
146893772|NCT00289913|529777694|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
146893773|NCT00289913|529777695|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
146637706|NCT04439136|528848732|FG000|Overall Study|Ineligible|1|||
146637707|NCT04439136|528848732|FG000|Overall Study|Never Started Treatment|2|||
146637708|NCT04439136|528848732|FG000|Overall Study|Adverse Event|4|||
146637709|NCT04439136|528848732|FG000|Overall Study|Death|3|||
146637710|NCT04439136|528848732|FG000|Overall Study|Disease Progression|27|||
146637711|NCT04439136|528848732|FG000|Overall Study|Alternative Therapy|1|||
146637712|NCT04439136|528848732|FG000|Overall Study|Increased Tumor Burden|1|||
146637713|NCT04439136|528848732|FG000|Overall Study|Symptomatic Detrioration|1|||
146637714|NCT02578706|528848735|FG000|Overall Study|Withdrawal by Subject|1|||
146637715|NCT02578706|528848736|FG001|Overall Study|Withdrawal by Subject|0|||
146637716|NCT02578706|528848737|FG002|Overall Study|Withdrawal by Subject|0|||
146637717|NCT02578706|528848735|FG000|Overall Study|Lost to Follow-up|0|||
146637718|NCT02578706|528848736|FG001|Overall Study|Lost to Follow-up|4|||
146637719|NCT02578706|528848737|FG002|Overall Study|Lost to Follow-up|0|||
146637720|NCT02578706|528848735|FG000|Overall Study|Physician Decision|0|||
146637721|NCT02578706|528848736|FG001|Overall Study|Physician Decision|1|||
146637722|NCT02578706|528848737|FG002|Overall Study|Physician Decision|0|||
146637723|NCT04849559|528848740|FG000|Overall Study|Withdrawal by Subject|2|||
146637724|NCT04849559|528848741|FG001|Overall Study|Withdrawal by Subject|1|||
146637725|NCT02910986|528848744|FG000|Overall Study|non-Latina|14|||
146637726|NCT02910986|528848745|FG001|Overall Study|non-Latina|13|||
146637727|NCT02910986|528848746|FG002|Overall Study|non-Latina|12|||
146637728|NCT02910986|528848744|FG000|Overall Study|Failure to return T! survey|72|||
146637729|NCT02910986|528848745|FG001|Overall Study|Failure to return T! survey|84|||
146637730|NCT02910986|528848746|FG002|Overall Study|Failure to return T! survey|72|||
146637731|NCT02910986|528848744|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
146637732|NCT02910986|528848745|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
146637733|NCT02910986|528848746|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
146637734|NCT02910986|528848744|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
146637735|NCT02910986|528848745|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
146637736|NCT02910986|528848746|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
146637737|NCT01662102|528848753|FG000|Overall Study|Sponsor's decision|1|||
146637738|NCT01662102|528848754|FG001|Overall Study|Sponsor's decision|0|||
146637739|NCT02586207|528848755|FG000|Overall Study|Physician Decision|1|||
146637740|NCT02586207|528848755|FG000|Overall Study|Withdrawal by Subject|1|||
146637741|NCT03527732|528848756|FG000|Overall Study|Lost to Follow-up|21|||
146637742|NCT03527732|528848757|FG001|Overall Study|Lost to Follow-up|23|||
146637743|NCT03527732|528848758|FG002|Overall Study|Lost to Follow-up|80|||
146637744|NCT03527732|528848759|FG003|Overall Study|Lost to Follow-up|62|||
146637745|NCT03527732|528848760|FG004|Overall Study|Lost to Follow-up|12|||
146637746|NCT03527732|528848761|FG005|Overall Study|Lost to Follow-up|20|||
146637747|NCT01262989|528848762|FG000|Period 1|Lost to Follow-up|1|||
146637748|NCT01262989|528848763|FG001|Period 1|Lost to Follow-up|1|||
146637749|NCT01262989|528848762|FG000|Period 1|Intercurrent disease|0|||
146637750|NCT01262989|528848763|FG001|Period 1|Intercurrent disease|1|||
146637751|NCT01262989|528848762|FG000|Period 1|Positive answer for exclusion criteria|0|||
146637752|NCT01262989|528848763|FG001|Period 1|Positive answer for exclusion criteria|1|||
146637753|NCT01262989|528848762|FG000|Period 2|Intercurrent disease|0|||
146637754|NCT01262989|528848763|FG001|Period 2|Intercurrent disease|1|||
146637755|NCT00470275|528848764|FG000|Overall Study|Death|1|||
146637756|NCT00470275|528848764|FG000|Overall Study|Lack of Efficacy|7|||
146637757|NCT00470275|528848764|FG000|Overall Study|Withdrawal by Subject|2|||
146637758|NCT03048578|528848765|FG000|Overall Study|Withdrawal by Subject|5|||
146637759|NCT03048578|528848766|FG001|Overall Study|Withdrawal by Subject|6|||
146637760|NCT03048578|528848765|FG000|Overall Study|Lost to Follow-up|22|||
146637761|NCT03048578|528848766|FG001|Overall Study|Lost to Follow-up|10|||
146637762|NCT03048578|528848765|FG000|Overall Study|Adverse Event|1|||
146637763|NCT03048578|528848766|FG001|Overall Study|Adverse Event|2|||
146637764|NCT03048578|528848765|FG000|Overall Study|Terminated|3|||
146637765|NCT03048578|528848766|FG001|Overall Study|Terminated|2|||
146637766|NCT00526071|528848767|FG000|Overall Study|Adverse Event|1|||
146637767|NCT00526071|528848767|FG000|Overall Study|Withdrawal by Subject|1|||
146637768|NCT00526071|528848767|FG000|Overall Study|Lack of Response to Study Drug|4|||
146637769|NCT03306173|528848768|FG000|Overall Study|Lost to Follow-up|16|||
146637770|NCT03306173|528848769|FG001|Overall Study|Lost to Follow-up|23|||
146637771|NCT03306173|528848768|FG000|Overall Study|Withdrawal by Subject|4|||
146637772|NCT03306173|528848769|FG001|Overall Study|Withdrawal by Subject|3|||
146637773|NCT03306173|528848768|FG000|Overall Study|Discontinued|4|||
146637774|NCT03306173|528848769|FG001|Overall Study|Discontinued|4|||
146637775|NCT01339052|528848772|FG000|Overall Study|Disease progression|13|||
146637776|NCT01339052|528848773|FG001|Overall Study|Disease progression|46|||
146637777|NCT01339052|528848772|FG000|Overall Study|Adverse Event|1|||
146637778|NCT01339052|528848773|FG001|Overall Study|Adverse Event|1|||
146637779|NCT01339052|528848772|FG000|Overall Study|Withdrawal by Subject|0|||
146637780|NCT01339052|528848773|FG001|Overall Study|Withdrawal by Subject|3|||
146637781|NCT01339052|528848772|FG000|Overall Study|Physician Decision|1|||
146637782|NCT01339052|528848773|FG001|Overall Study|Physician Decision|0|||
146637783|NCT02637037|528848774|FG000|Overall Study|Positive drug screen at admission|1|||
146893774|NCT00289913|529777696|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
146893775|NCT00289913|529777697|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
146893776|NCT00289913|529777698|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
146893777|NCT00289913|529777694|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
146893778|NCT00289913|529777695|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
146893779|NCT00289913|529777696|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
146893780|NCT00289913|529777697|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
146637784|NCT02637037|528848775|FG001|Overall Study|Positive drug screen at admission|0|||
146893781|NCT00289913|529777698|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
146893782|NCT00289913|529777694|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
146893783|NCT00289913|529777695|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
146968037|NCT02325739|530043908|FG003|Phase I Part|Progressive disease|23|||
146637785|NCT02637037|528848774|FG000|Overall Study|Withdrawal by Subject|2|||
146637786|NCT02637037|528848775|FG001|Overall Study|Withdrawal by Subject|1|||
146637787|NCT02637037|528848774|FG000|Overall Study|Adverse Event|1|||
146637788|NCT02637037|528848775|FG001|Overall Study|Adverse Event|0|||
146637789|NCT02023697|528848777|FG000|Treatment Period|Radiological progression|13|||
146637790|NCT02023697|528848778|FG001|Treatment Period|Radiological progression|17|||
146637791|NCT02023697|528848779|FG002|Treatment Period|Radiological progression|26|||
146637792|NCT02023697|528848777|FG000|Treatment Period|Never Treated|5|||
146637793|NCT02023697|528848778|FG001|Treatment Period|Never Treated|6|||
146637794|NCT02023697|528848779|FG002|Treatment Period|Never Treated|10|||
146637795|NCT02023697|528848777|FG000|Treatment Period|Adverse Event|13|||
146637796|NCT02023697|528848778|FG001|Treatment Period|Adverse Event|25|||
146637797|NCT02023697|528848779|FG002|Treatment Period|Adverse Event|23|||
146637798|NCT02023697|528848777|FG000|Treatment Period|Logistical difficulties|1|||
146637799|NCT02023697|528848778|FG001|Treatment Period|Logistical difficulties|1|||
146637800|NCT02023697|528848779|FG002|Treatment Period|Logistical difficulties|1|||
146637801|NCT02023697|528848777|FG000|Treatment Period|Clinical progression|10|||
146637802|NCT02023697|528848778|FG001|Treatment Period|Clinical progression|8|||
146637803|NCT02023697|528848779|FG002|Treatment Period|Clinical progression|28|||
146637804|NCT02023697|528848777|FG000|Treatment Period|Withdrawal by Subject|4|||
146637805|NCT02023697|528848778|FG001|Treatment Period|Withdrawal by Subject|5|||
146637806|NCT02023697|528848779|FG002|Treatment Period|Withdrawal by Subject|13|||
146637807|NCT02023697|528848777|FG000|Treatment Period|Safety outcome reached|0|||
146637808|NCT02023697|528848778|FG001|Treatment Period|Safety outcome reached|1|||
146637809|NCT02023697|528848779|FG002|Treatment Period|Safety outcome reached|0|||
146637810|NCT02023697|528848777|FG000|Treatment Period|Physician Decision|0|||
146637811|NCT02023697|528848778|FG001|Treatment Period|Physician Decision|0|||
146637812|NCT02023697|528848779|FG002|Treatment Period|Physician Decision|1|||
146637813|NCT02023697|528848777|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
146637814|NCT02023697|528848778|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
146637815|NCT02023697|528848779|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
146637816|NCT02023697|528848777|FG000|Active Follow-up Period|Lost to Follow-up|1|||
146637817|NCT02023697|528848778|FG001|Active Follow-up Period|Lost to Follow-up|1|||
146637818|NCT02023697|528848779|FG002|Active Follow-up Period|Lost to Follow-up|1|||
146637819|NCT02023697|528848777|FG000|Active Follow-up Period|Deterioration of general condition|1|||
146637820|NCT02023697|528848778|FG001|Active Follow-up Period|Deterioration of general condition|1|||
146637821|NCT02023697|528848779|FG002|Active Follow-up Period|Deterioration of general condition|1|||
146637822|NCT02023697|528848777|FG000|Active Follow-up Period|Other unspecified|2|||
146637823|NCT02023697|528848778|FG001|Active Follow-up Period|Other unspecified|0|||
146637824|NCT02023697|528848779|FG002|Active Follow-up Period|Other unspecified|1|||
146637825|NCT02023697|528848777|FG000|Active Follow-up Period|Clinical progression|0|||
146637826|NCT02023697|528848778|FG001|Active Follow-up Period|Clinical progression|2|||
146637827|NCT02023697|528848779|FG002|Active Follow-up Period|Clinical progression|1|||
146637828|NCT02023697|528848777|FG000|Active Follow-up Period|Radiological progression|0|||
146637829|NCT02023697|528848778|FG001|Active Follow-up Period|Radiological progression|0|||
146637830|NCT02023697|528848779|FG002|Active Follow-up Period|Radiological progression|1|||
146637831|NCT02023697|528848777|FG000|Active Follow-up Period|Death|83|||
146637832|NCT02023697|528848778|FG001|Active Follow-up Period|Death|82|||
146637833|NCT02023697|528848779|FG002|Active Follow-up Period|Death|87|||
146637834|NCT02023697|528848777|FG000|Long-term Follow-up Period|Death|9|||
146637835|NCT02023697|528848778|FG001|Long-term Follow-up Period|Death|6|||
146637836|NCT02023697|528848779|FG002|Long-term Follow-up Period|Death|4|||
146637837|NCT02023697|528848777|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
146637838|NCT02023697|528848778|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
146637839|NCT02023697|528848779|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
146637840|NCT02023697|528848777|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
146637841|NCT02023697|528848778|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
146893784|NCT00289913|529777696|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
146893785|NCT00289913|529777697|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
146893786|NCT00289913|529777698|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
146893787|NCT00289913|529777694|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
146893788|NCT00289913|529777695|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146893789|NCT00289913|529777696|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
146893790|NCT00289913|529777697|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146637842|NCT02023697|528848779|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
146637843|NCT02023697|528848777|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
146637844|NCT02023697|528848778|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
146766514|NCT02914522|529312248|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
146637845|NCT02023697|528848779|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
146637846|NCT02023697|528848777|FG000|Long-term Follow-up Period|Technical problems|0|||
146637847|NCT02023697|528848778|FG001|Long-term Follow-up Period|Technical problems|0|||
146637848|NCT02023697|528848779|FG002|Long-term Follow-up Period|Technical problems|1|||
146637849|NCT02023697|528848777|FG000|Long-term Follow-up Period|Other unspecified|6|||
146637850|NCT02023697|528848778|FG001|Long-term Follow-up Period|Other unspecified|3|||
146637851|NCT02023697|528848779|FG002|Long-term Follow-up Period|Other unspecified|5|||
146637852|NCT01469377|528848785|FG000|Overall Study|Protocol Deviation|7|||
146637853|NCT01469377|528848786|FG001|Overall Study|Protocol Deviation|10|||
146637854|NCT01469377|528848787|FG002|Overall Study|Protocol Deviation|10|||
146637855|NCT01469377|528848785|FG000|Overall Study|Lost to Follow-up|3|||
146637856|NCT01469377|528848786|FG001|Overall Study|Lost to Follow-up|2|||
146637857|NCT01469377|528848787|FG002|Overall Study|Lost to Follow-up|5|||
146637858|NCT01469377|528848785|FG000|Overall Study|Withdrawal of Consent|12|||
146637859|NCT01469377|528848786|FG001|Overall Study|Withdrawal of Consent|14|||
146637860|NCT01469377|528848787|FG002|Overall Study|Withdrawal of Consent|15|||
146637861|NCT01469377|528848785|FG000|Overall Study|Adverse Event|8|||
146637862|NCT01469377|528848786|FG001|Overall Study|Adverse Event|18|||
146637863|NCT01469377|528848787|FG002|Overall Study|Adverse Event|36|||
146637864|NCT01469377|528848785|FG000|Overall Study|Insufficient Therapeutic Response|3|||
146637865|NCT01469377|528848786|FG001|Overall Study|Insufficient Therapeutic Response|4|||
146637866|NCT01469377|528848787|FG002|Overall Study|Insufficient Therapeutic Response|0|||
146637867|NCT01469377|528848785|FG000|Overall Study|Other Miscellaneous Reasons|2|||
146637868|NCT01469377|528848786|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146637869|NCT01469377|528848787|FG002|Overall Study|Other Miscellaneous Reasons|0|||
146637870|NCT00714870|528848789|FG000|Overall Study|Lost to Follow-up|22|||
146637871|NCT00714870|528848790|FG001|Overall Study|Lost to Follow-up|5|||
146637872|NCT00714870|528848789|FG000|Overall Study|patient unable to come b/c back pain|1|||
146637873|NCT00714870|528848790|FG001|Overall Study|patient unable to come b/c back pain|0|||
146637874|NCT00714870|528848789|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
146637875|NCT00714870|528848790|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
146637876|NCT03399552|528848791|FG000|Overall Study|No evidence of disease|1|||
146637877|NCT03399552|528848791|FG000|Overall Study|Unevaluable|1|||
146637878|NCT02357368|528848792|FG000|Overall Study|Lost to Follow-up|0|||
146637879|NCT02357368|528848793|FG001|Overall Study|Lost to Follow-up|0|||
146637880|NCT02357368|528848794|FG002|Overall Study|Lost to Follow-up|0|||
146893791|NCT00289913|529777698|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146893792|NCT00289913|529777694|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
146893793|NCT00289913|529777695|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
146893794|NCT00289913|529777696|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
146893795|NCT00289913|529777697|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
146893796|NCT00289913|529777698|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
146893797|NCT00289913|529777694|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
146893798|NCT00289913|529777695|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
146893799|NCT00289913|529777696|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
146893800|NCT00289913|529777697|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
146893801|NCT00289913|529777698|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
146893802|NCT00289913|529777694|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
146893803|NCT00289913|529777695|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
146893804|NCT00289913|529777696|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
146893805|NCT00289913|529777697|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
146893806|NCT00289913|529777698|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
146893807|NCT00289913|529777694|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
146893808|NCT00289913|529777695|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
146893809|NCT00289913|529777696|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
146893810|NCT00289913|529777697|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
146893811|NCT00289913|529777698|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
146893812|NCT00289913|529777694|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
146893813|NCT00289913|529777695|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
146893814|NCT00289913|529777696|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
146893815|NCT00289913|529777697|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
146893816|NCT00289913|529777698|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
146893817|NCT00289913|529777694|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
146893818|NCT00289913|529777695|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
146637881|NCT02357368|528848795|FG003|Overall Study|Lost to Follow-up|1|||
146637882|NCT02357368|528848792|FG000|Overall Study|Pregnancy|3|||
146637883|NCT02357368|528848793|FG001|Overall Study|Pregnancy|2|||
146637884|NCT02357368|528848794|FG002|Overall Study|Pregnancy|0|||
146637885|NCT02357368|528848795|FG003|Overall Study|Pregnancy|0|||
146968038|NCT02325739|530043909|FG004|Phase I Part|Progressive disease|14|||
146968039|NCT02325739|530043910|FG005|Phase I Part|Progressive disease|6|||
146968040|NCT02325739|530043911|FG006|Phase I Part|Progressive disease|6|||
146968041|NCT02325739|530043912|FG007|Phase I Part|Progressive disease|3|||
146968042|NCT02325739|530043913|FG008|Phase I Part|Progressive disease|0|||
146968043|NCT02325739|530043914|FG009|Phase I Part|Progressive disease|0|||
146968044|NCT02325739|530043915|FG010|Phase I Part|Progressive disease|0|||
146968045|NCT02325739|530043905|FG000|Phase I Part|Subject/guardian decision|1|||
146968046|NCT02325739|530043906|FG001|Phase I Part|Subject/guardian decision|0|||
146968047|NCT02325739|530043907|FG002|Phase I Part|Subject/guardian decision|1|||
146968048|NCT02325739|530043908|FG003|Phase I Part|Subject/guardian decision|1|||
146968049|NCT02325739|530043909|FG004|Phase I Part|Subject/guardian decision|0|||
146968050|NCT02325739|530043910|FG005|Phase I Part|Subject/guardian decision|0|||
146968051|NCT02325739|530043911|FG006|Phase I Part|Subject/guardian decision|0|||
146968052|NCT02325739|530043912|FG007|Phase I Part|Subject/guardian decision|1|||
146968053|NCT02325739|530043913|FG008|Phase I Part|Subject/guardian decision|0|||
146968054|NCT02325739|530043914|FG009|Phase I Part|Subject/guardian decision|0|||
146968055|NCT02325739|530043915|FG010|Phase I Part|Subject/guardian decision|0|||
146968056|NCT02325739|530043905|FG000|Phase I Part|Death|0|||
146968057|NCT02325739|530043906|FG001|Phase I Part|Death|0|||
146968058|NCT02325739|530043907|FG002|Phase I Part|Death|0|||
146968059|NCT02325739|530043908|FG003|Phase I Part|Death|0|||
146968060|NCT02325739|530043909|FG004|Phase I Part|Death|2|||
146968061|NCT02325739|530043910|FG005|Phase I Part|Death|0|||
146968062|NCT02325739|530043911|FG006|Phase I Part|Death|0|||
146968063|NCT02325739|530043912|FG007|Phase I Part|Death|0|||
146968064|NCT02325739|530043913|FG008|Phase I Part|Death|0|||
146968065|NCT02325739|530043914|FG009|Phase I Part|Death|0|||
146968066|NCT02325739|530043915|FG010|Phase I Part|Death|0|||
146968067|NCT02325739|530043905|FG000|Phase II Part|Adverse Event|0|||
146968068|NCT02325739|530043906|FG001|Phase II Part|Adverse Event|0|||
146968069|NCT02325739|530043907|FG002|Phase II Part|Adverse Event|0|||
146968070|NCT02325739|530043908|FG003|Phase II Part|Adverse Event|0|||
146968071|NCT02325739|530043909|FG004|Phase II Part|Adverse Event|0|||
146968072|NCT02325739|530043910|FG005|Phase II Part|Adverse Event|0|||
146968073|NCT02325739|530043911|FG006|Phase II Part|Adverse Event|0|||
146968074|NCT02325739|530043912|FG007|Phase II Part|Adverse Event|0|||
146968075|NCT02325739|530043913|FG008|Phase II Part|Adverse Event|4|||
146968076|NCT02325739|530043914|FG009|Phase II Part|Adverse Event|5|||
146968077|NCT02325739|530043915|FG010|Phase II Part|Adverse Event|1|||
146968078|NCT02325739|530043905|FG000|Phase II Part|Physician Decision|0|||
146968079|NCT02325739|530043906|FG001|Phase II Part|Physician Decision|0|||
146968080|NCT02325739|530043907|FG002|Phase II Part|Physician Decision|0|||
146968081|NCT02325739|530043908|FG003|Phase II Part|Physician Decision|0|||
146968082|NCT02325739|530043909|FG004|Phase II Part|Physician Decision|0|||
146968083|NCT02325739|530043910|FG005|Phase II Part|Physician Decision|0|||
146968084|NCT02325739|530043911|FG006|Phase II Part|Physician Decision|0|||
146968085|NCT02325739|530043912|FG007|Phase II Part|Physician Decision|0|||
146968086|NCT02325739|530043913|FG008|Phase II Part|Physician Decision|0|||
146968087|NCT02325739|530043914|FG009|Phase II Part|Physician Decision|1|||
146968088|NCT02325739|530043915|FG010|Phase II Part|Physician Decision|0|||
146968089|NCT02325739|530043905|FG000|Phase II Part|Progressive disease|0|||
146968090|NCT02325739|530043906|FG001|Phase II Part|Progressive disease|0|||
146968091|NCT02325739|530043907|FG002|Phase II Part|Progressive disease|0|||
146968092|NCT02325739|530043908|FG003|Phase II Part|Progressive disease|0|||
146968093|NCT02325739|530043909|FG004|Phase II Part|Progressive disease|0|||
146968094|NCT02325739|530043910|FG005|Phase II Part|Progressive disease|0|||
146968095|NCT02325739|530043911|FG006|Phase II Part|Progressive disease|0|||
146968096|NCT02325739|530043912|FG007|Phase II Part|Progressive disease|0|||
146968097|NCT02325739|530043913|FG008|Phase II Part|Progressive disease|22|||
146968098|NCT02325739|530043914|FG009|Phase II Part|Progressive disease|29|||
146968099|NCT02325739|530043915|FG010|Phase II Part|Progressive disease|18|||
146968100|NCT02325739|530043905|FG000|Phase II Part|Subject/guardian decision|0|||
146968101|NCT02325739|530043906|FG001|Phase II Part|Subject/guardian decision|0|||
146968102|NCT02325739|530043907|FG002|Phase II Part|Subject/guardian decision|0|||
146968103|NCT02325739|530043908|FG003|Phase II Part|Subject/guardian decision|0|||
146968104|NCT02325739|530043909|FG004|Phase II Part|Subject/guardian decision|0|||
146968105|NCT02325739|530043910|FG005|Phase II Part|Subject/guardian decision|0|||
146968106|NCT02325739|530043911|FG006|Phase II Part|Subject/guardian decision|0|||
146968107|NCT02325739|530043912|FG007|Phase II Part|Subject/guardian decision|0|||
146558477|NCT01272219|528554233|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
146558478|NCT01272219|528554234|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
146558479|NCT01272219|528554235|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
146558480|NCT01272219|528554236|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
146558481|NCT01272219|528554237|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
146558482|NCT01272219|528554232|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
146558483|NCT01272219|528554233|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
146558484|NCT01272219|528554234|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
146558485|NCT01272219|528554235|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
146558486|NCT01272219|528554236|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
146637886|NCT02357368|528848792|FG000|Overall Study|Withdrawal by Subject|3|||
146637887|NCT02357368|528848793|FG001|Overall Study|Withdrawal by Subject|1|||
146893819|NCT00289913|529777696|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
146893820|NCT00289913|529777697|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
146893821|NCT00289913|529777698|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
146893822|NCT00289913|529777694|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
146893823|NCT00289913|529777695|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
146893824|NCT00289913|529777696|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
146893825|NCT00289913|529777697|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
146893826|NCT00289913|529777698|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
146893827|NCT00289913|529777694|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
146893828|NCT00289913|529777695|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
146893829|NCT00289913|529777696|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
146893830|NCT00289913|529777697|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
146893831|NCT00289913|529777698|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
146893832|NCT00289913|529777694|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
146893833|NCT00289913|529777695|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
146893834|NCT00289913|529777696|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
146893835|NCT00289913|529777697|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
146893836|NCT00289913|529777698|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
146893837|NCT00289913|529777694|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146893838|NCT00289913|529777695|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
146893839|NCT00289913|529777696|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146893840|NCT00289913|529777697|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146893841|NCT00289913|529777698|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146893842|NCT00289913|529777694|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
146893843|NCT00289913|529777695|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
146893844|NCT00289913|529777696|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
146893845|NCT00289913|529777697|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
146893846|NCT00289913|529777698|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
146893847|NCT00289913|529777694|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
146893848|NCT00289913|529777695|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
146893849|NCT00289913|529777696|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
146893850|NCT00289913|529777697|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
146893851|NCT00289913|529777698|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
146893852|NCT00289913|529777694|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146893853|NCT00289913|529777695|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146893854|NCT00289913|529777696|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146893855|NCT00289913|529777697|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146893856|NCT00289913|529777698|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
146893857|NCT00289913|529777694|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
146893858|NCT00289913|529777695|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
146893859|NCT00289913|529777696|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
146893860|NCT00289913|529777697|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
146893861|NCT00289913|529777698|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
146893862|NCT00289913|529777694|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
146893863|NCT00289913|529777695|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
146893864|NCT00289913|529777696|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
146893865|NCT00289913|529777697|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
146893866|NCT00289913|529777698|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
146893867|NCT00289913|529777694|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
146893868|NCT00289913|529777695|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
146893869|NCT00289913|529777696|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
146968108|NCT02325739|530043913|FG008|Phase II Part|Subject/guardian decision|4|||
146968109|NCT02325739|530043914|FG009|Phase II Part|Subject/guardian decision|1|||
146968110|NCT02325739|530043915|FG010|Phase II Part|Subject/guardian decision|1|||
146968111|NCT00227591|530043916|FG000|Overall Study|Withdrawal by Subject|1|||
146968112|NCT01886105|530043917|FG000|Overall Study|Lack of Efficacy|3|||
146968113|NCT02057549|530043919|FG000|Overall Study|Lost to Follow-up|1|||
146968114|NCT02057549|530043920|FG001|Overall Study|Lost to Follow-up|0|||
146968115|NCT02057549|530043919|FG000|Overall Study|Physician Decision|1|||
146968116|NCT02057549|530043920|FG001|Overall Study|Physician Decision|0|||
146968117|NCT02057549|530043919|FG000|Overall Study|Withdrawal by Subject|1|||
146968118|NCT02057549|530043920|FG001|Overall Study|Withdrawal by Subject|0|||
146637888|NCT02357368|528848794|FG002|Overall Study|Withdrawal by Subject|1|||
146637889|NCT02357368|528848795|FG003|Overall Study|Withdrawal by Subject|2|||
146637890|NCT00611026|528848798|FG000|Randomized to Double-blind Treatment|Not treated|2|||
146637891|NCT00611026|528848799|FG001|Randomized to Double-blind Treatment|Not treated|1|||
146637892|NCT00611026|528848800|FG002|Randomized to Double-blind Treatment|Not treated|3|||
146637893|NCT00611026|528848798|FG000|Double-blind Treatment Period|Death|1|||
146637894|NCT00611026|528848799|FG001|Double-blind Treatment Period|Death|0|||
146637895|NCT00611026|528848800|FG002|Double-blind Treatment Period|Death|0|||
146637896|NCT00611026|528848798|FG000|Double-blind Treatment Period|Adverse Event|9|||
146637897|NCT00611026|528848799|FG001|Double-blind Treatment Period|Adverse Event|28|||
146637898|NCT00611026|528848800|FG002|Double-blind Treatment Period|Adverse Event|46|||
146637899|NCT00611026|528848798|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
146968119|NCT03843775|530043923|FG000|Overall Study|Adverse Event|1|||
146968120|NCT03843775|530043924|FG001|Overall Study|Adverse Event|1|||
146968121|NCT03843775|530043923|FG000|Overall Study|Lack of Efficacy|2|||
146968122|NCT03843775|530043924|FG001|Overall Study|Lack of Efficacy|6|||
146968123|NCT03843775|530043923|FG000|Overall Study|Withdrawal by Subject|0|||
146968124|NCT03843775|530043924|FG001|Overall Study|Withdrawal by Subject|1|||
146968125|NCT00530621|530043928|FG000|Overall Study|Adverse Event|11|||
146968126|NCT00530621|530043929|FG001|Overall Study|Adverse Event|8|||
146968127|NCT00530621|530043928|FG000|Overall Study|Physician Decision|2|||
146968128|NCT00530621|530043929|FG001|Overall Study|Physician Decision|4|||
146968129|NCT00530621|530043928|FG000|Overall Study|Progressive Disease (PD)|47|||
146968130|NCT00530621|530043929|FG001|Overall Study|Progressive Disease (PD)|40|||
146968131|NCT00530621|530043928|FG000|Overall Study|Sponsor Decision|12|||
146968132|NCT00530621|530043929|FG001|Overall Study|Sponsor Decision|15|||
146968133|NCT00530621|530043928|FG000|Overall Study|Subject Decision|4|||
146968134|NCT00530621|530043929|FG001|Overall Study|Subject Decision|7|||
146968135|NCT00530621|530043928|FG000|Overall Study|Death|3|||
146968136|NCT00530621|530043929|FG001|Overall Study|Death|6|||
146968137|NCT00530621|530043928|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
146968138|NCT00530621|530043929|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
146968139|NCT04611152|530043930|FG000|Overall Study|Adverse Event|9|||
146968140|NCT04611152|530043931|FG001|Overall Study|Adverse Event|8|||
146968141|NCT04611152|530043930|FG000|Overall Study|Non-compliance with study schedule|1|||
146968142|NCT04611152|530043931|FG001|Overall Study|Non-compliance with study schedule|3|||
146968143|NCT04611152|530043930|FG000|Overall Study|Withdrawal by Subject|5|||
146968144|NCT04611152|530043931|FG001|Overall Study|Withdrawal by Subject|6|||
146968145|NCT04611152|530043930|FG000|Overall Study|Lost to Follow-up|11|||
146968146|NCT04611152|530043931|FG001|Overall Study|Lost to Follow-up|2|||
146968147|NCT00605839|530043939|FG000|Overall Study|Protocol Violation|1|||
146968148|NCT00605839|530043940|FG001|Overall Study|Protocol Violation|0|||
146968149|NCT00605839|530043941|FG002|Overall Study|Protocol Violation|0|||
146968150|NCT03917654|530043942|FG000|Year 1|Withdrawal by Subject|1|||
146968151|NCT03917654|530043943|FG001|Year 1|Withdrawal by Subject|0|||
146968152|NCT03917654|530043944|FG002|Year 1|Withdrawal by Subject|0|||
146968153|NCT03917654|530043945|FG003|Year 1|Withdrawal by Subject|0|||
146968154|NCT03917654|530043946|FG004|Year 1|Withdrawal by Subject|0|||
146968155|NCT03917654|530043947|FG005|Year 1|Withdrawal by Subject|1|||
146968156|NCT03917654|530043948|FG006|Year 1|Withdrawal by Subject|6|||
146637900|NCT00611026|528848799|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
146637901|NCT00611026|528848800|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
146893870|NCT00289913|529777697|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
146893871|NCT00289913|529777698|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
146968157|NCT03917654|530043949|FG007|Year 1|Withdrawal by Subject|2|||
146968158|NCT03917654|530043950|FG008|Year 1|Withdrawal by Subject|5|||
146968159|NCT03917654|530043951|FG009|Year 1|Withdrawal by Subject|3|||
146968160|NCT03917654|530043952|FG010|Year 1|Withdrawal by Subject|1|||
146968161|NCT03917654|530043953|FG011|Year 1|Withdrawal by Subject|0|||
146968162|NCT03917654|530043942|FG000|Year 1|Travel|0|||
146968163|NCT03917654|530043943|FG001|Year 1|Travel|1|||
146968164|NCT03917654|530043944|FG002|Year 1|Travel|1|||
146968165|NCT03917654|530043945|FG003|Year 1|Travel|0|||
146968166|NCT03917654|530043946|FG004|Year 1|Travel|4|||
146893872|NCT00289913|529777694|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
146893873|NCT00289913|529777695|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
146893874|NCT00289913|529777696|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
146893875|NCT00289913|529777697|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
146893876|NCT00289913|529777698|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
146893877|NCT00440726|529777701|FG000|Phase 1|Dose-Limiting Toxicity|0|||
146893878|NCT00440726|529777702|FG001|Phase 1|Dose-Limiting Toxicity|1|||
146893879|NCT00440726|529777703|FG002|Phase 1|Dose-Limiting Toxicity|0|||
146893880|NCT00440726|529777701|FG000|Phase 1|Physician Decision|1|||
146893881|NCT00440726|529777702|FG001|Phase 1|Physician Decision|0|||
146893882|NCT00440726|529777703|FG002|Phase 1|Physician Decision|0|||
146893883|NCT00440726|529777701|FG000|Phase 2|Death|0|||
146893884|NCT00440726|529777702|FG001|Phase 2|Death|0|||
146893885|NCT00440726|529777703|FG002|Phase 2|Death|1|||
146893886|NCT00440726|529777701|FG000|Phase 2|Adverse Event|0|||
146893887|NCT00440726|529777702|FG001|Phase 2|Adverse Event|0|||
146893888|NCT00440726|529777703|FG002|Phase 2|Adverse Event|1|||
146893889|NCT01808612|529777704|FG000|Treatment Period|Adverse Event|8|||
146893890|NCT01808612|529777705|FG001|Treatment Period|Adverse Event|4|||
146893891|NCT01808612|529777706|FG002|Treatment Period|Adverse Event|3|||
146893892|NCT01808612|529777704|FG000|Treatment Period|Lost to Follow-up|2|||
146893893|NCT01808612|529777705|FG001|Treatment Period|Lost to Follow-up|2|||
146968167|NCT03917654|530043947|FG005|Year 1|Travel|4|||
146968168|NCT03917654|530043948|FG006|Year 1|Travel|10|||
146968169|NCT03917654|530043949|FG007|Year 1|Travel|8|||
146893894|NCT01808612|529777706|FG002|Treatment Period|Lost to Follow-up|1|||
146893895|NCT01808612|529777704|FG000|Treatment Period|Protocol Violation|1|||
146893896|NCT01808612|529777705|FG001|Treatment Period|Protocol Violation|0|||
146893897|NCT01808612|529777706|FG002|Treatment Period|Protocol Violation|0|||
146893898|NCT01808612|529777704|FG000|Treatment Period|Withdrawal by Subject|1|||
146893899|NCT01808612|529777705|FG001|Treatment Period|Withdrawal by Subject|0|||
146893900|NCT01808612|529777706|FG002|Treatment Period|Withdrawal by Subject|4|||
146893901|NCT01808612|529777704|FG000|Treatment Period|Physician Decision|1|||
146893902|NCT01808612|529777705|FG001|Treatment Period|Physician Decision|0|||
146893903|NCT01808612|529777706|FG002|Treatment Period|Physician Decision|4|||
146893904|NCT01808612|529777704|FG000|Treatment Period|Sponsor Decision|1|||
146968170|NCT03917654|530043950|FG008|Year 1|Travel|2|||
146968171|NCT03917654|530043951|FG009|Year 1|Travel|5|||
146893905|NCT01808612|529777705|FG001|Treatment Period|Sponsor Decision|0|||
146893906|NCT01808612|529777706|FG002|Treatment Period|Sponsor Decision|0|||
146893907|NCT01808612|529777704|FG000|Treatment Period|Lack of Efficacy|1|||
146893908|NCT01808612|529777705|FG001|Treatment Period|Lack of Efficacy|1|||
146893909|NCT01808612|529777706|FG002|Treatment Period|Lack of Efficacy|2|||
146893910|NCT01808612|529777704|FG000|Discontinuation Period|Adverse Event|1|||
146893911|NCT01808612|529777705|FG001|Discontinuation Period|Adverse Event|0|||
146893912|NCT01808612|529777706|FG002|Discontinuation Period|Adverse Event|0|||
146893913|NCT01808612|529777704|FG000|Discontinuation Period|Physician Decision|1|||
146893914|NCT01808612|529777705|FG001|Discontinuation Period|Physician Decision|0|||
146893915|NCT01808612|529777706|FG002|Discontinuation Period|Physician Decision|0|||
146893916|NCT01808612|529777704|FG000|Discontinuation Period|Lost to Follow-up|0|||
146893917|NCT01808612|529777705|FG001|Discontinuation Period|Lost to Follow-up|1|||
146968172|NCT03917654|530043952|FG010|Year 1|Travel|3|||
146968173|NCT03917654|530043953|FG011|Year 1|Travel|3|||
146968174|NCT03917654|530043942|FG000|Year 1|Subject moved away from site|0|||
146968175|NCT03917654|530043943|FG001|Year 1|Subject moved away from site|1|||
146968176|NCT03917654|530043944|FG002|Year 1|Subject moved away from site|0|||
146968177|NCT03917654|530043945|FG003|Year 1|Subject moved away from site|0|||
146968178|NCT03917654|530043946|FG004|Year 1|Subject moved away from site|0|||
146968179|NCT03917654|530043947|FG005|Year 1|Subject moved away from site|0|||
146968180|NCT03917654|530043948|FG006|Year 1|Subject moved away from site|1|||
146893918|NCT01808612|529777706|FG002|Discontinuation Period|Lost to Follow-up|0|||
146893919|NCT03683394|529777707|FG000|Overall Study|Withdrawal by Subject|4|||
146893920|NCT03683394|529777708|FG001|Overall Study|Withdrawal by Subject|8|||
146893921|NCT03683394|529777707|FG000|Overall Study|Lost to Follow-up|7|||
146893922|NCT03683394|529777708|FG001|Overall Study|Lost to Follow-up|0|||
146893923|NCT03683394|529777707|FG000|Overall Study|Death|3|||
146893924|NCT03683394|529777708|FG001|Overall Study|Death|1|||
146968181|NCT03917654|530043949|FG007|Year 1|Subject moved away from site|2|||
146968182|NCT03917654|530043950|FG008|Year 1|Subject moved away from site|1|||
146968183|NCT03917654|530043951|FG009|Year 1|Subject moved away from site|0|||
146968184|NCT03917654|530043952|FG010|Year 1|Subject moved away from site|0|||
146968185|NCT03917654|530043953|FG011|Year 1|Subject moved away from site|3|||
146968186|NCT03917654|530043942|FG000|Year 1|Spouse/Family member request|0|||
146968187|NCT03917654|530043943|FG001|Year 1|Spouse/Family member request|0|||
146968188|NCT03917654|530043944|FG002|Year 1|Spouse/Family member request|1|||
146558487|NCT01272219|528554237|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
146558488|NCT01272219|528554232|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
146558489|NCT01272219|528554233|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
146558490|NCT01272219|528554234|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
146558491|NCT01272219|528554235|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
146558492|NCT01272219|528554236|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
146558493|NCT01272219|528554237|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
146558494|NCT01272219|528554232|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
146558495|NCT01272219|528554233|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
146558496|NCT01272219|528554234|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
146558497|NCT01272219|528554235|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
146558498|NCT01272219|528554236|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
146558499|NCT01272219|528554237|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
146558500|NCT01272219|528554232|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
146558501|NCT01272219|528554233|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
146558502|NCT01272219|528554234|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
146558503|NCT01272219|528554235|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
146558504|NCT01272219|528554236|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
146558505|NCT01272219|528554237|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
146558506|NCT01272219|528554232|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
146558507|NCT01272219|528554233|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
146558508|NCT01272219|528554234|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
146893925|NCT01058096|529777709|FG000|Double-blind Treatment Phase|Adverse Event|11|||
146893926|NCT01058096|529777710|FG001|Double-blind Treatment Phase|Adverse Event|15|||
146893927|NCT01058096|529777709|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
146893928|NCT01058096|529777710|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
146893929|NCT01058096|529777709|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
146893930|NCT01058096|529777710|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
146893931|NCT01058096|529777709|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
146893932|NCT01058096|529777710|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
146893933|NCT01058096|529777709|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
146893934|NCT01058096|529777710|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
146893935|NCT01058096|529777709|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
146968189|NCT03917654|530043945|FG003|Year 1|Spouse/Family member request|0|||
146968190|NCT03917654|530043946|FG004|Year 1|Spouse/Family member request|1|||
146968191|NCT03917654|530043947|FG005|Year 1|Spouse/Family member request|0|||
146968192|NCT03917654|530043948|FG006|Year 1|Spouse/Family member request|0|||
146968193|NCT03917654|530043949|FG007|Year 1|Spouse/Family member request|2|||
146968194|NCT03917654|530043950|FG008|Year 1|Spouse/Family member request|0|||
146968195|NCT03917654|530043951|FG009|Year 1|Spouse/Family member request|0|||
146893936|NCT01058096|529777710|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
146893937|NCT00559273|529777711|FG000|Correction Period (20 Weeks)|Death|3|||
146893938|NCT00559273|529777712|FG001|Correction Period (20 Weeks)|Death|4|||
146893939|NCT00559273|529777711|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
146893940|NCT00559273|529777712|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
146893941|NCT00559273|529777711|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
146893942|NCT00559273|529777712|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
146893943|NCT00559273|529777711|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
146893944|NCT00559273|529777712|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
146893945|NCT00559273|529777711|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
146893946|NCT00559273|529777712|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
146893947|NCT00559273|529777711|FG000|Evaluation Period (8 Weeks)|Death|1|||
146893948|NCT00559273|529777712|FG001|Evaluation Period (8 Weeks)|Death|3|||
146893949|NCT00559273|529777711|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
146893950|NCT00559273|529777712|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
146893951|NCT00559273|529777711|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
146893952|NCT00559273|529777712|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
146893953|NCT00559273|529777711|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
146893954|NCT00559273|529777712|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
146893955|NCT01299727|529777717|FG000|Overall Study|Withdrawal by Subject|1|||
146893956|NCT01299727|529777718|FG001|Overall Study|Withdrawal by Subject|0|||
146893957|NCT01299727|529777719|FG002|Overall Study|Withdrawal by Subject|0|||
146893958|NCT01299727|529777717|FG000|Overall Study|Adverse Event|0|||
146893959|NCT01299727|529777718|FG001|Overall Study|Adverse Event|0|||
146893960|NCT01299727|529777719|FG002|Overall Study|Adverse Event|1|||
146893961|NCT01299727|529777717|FG000|Overall Study|Completed the Treatment Period|3|||
146893962|NCT01299727|529777718|FG001|Overall Study|Completed the Treatment Period|4|||
146893963|NCT01299727|529777719|FG002|Overall Study|Completed the Treatment Period|3|||
146893964|NCT00944034|529777724|FG000|Overall Study|Inappropriate enrollment|0|||
146893965|NCT00944034|529777725|FG001|Overall Study|Inappropriate enrollment|1|||
146893966|NCT00944034|529777726|FG002|Overall Study|Inappropriate enrollment|0|||
146893967|NCT00944034|529777727|FG003|Overall Study|Inappropriate enrollment|1|||
146893968|NCT00944034|529777728|FG004|Overall Study|Inappropriate enrollment|2|||
146893969|NCT00944034|529777729|FG005|Overall Study|Inappropriate enrollment|1|||
146893970|NCT00944034|529777730|FG006|Overall Study|Inappropriate enrollment|0|||
146893971|NCT00944034|529777731|FG007|Overall Study|Inappropriate enrollment|0|||
146893972|NCT00944034|529777732|FG008|Overall Study|Inappropriate enrollment|1|||
146893973|NCT00944034|529777733|FG009|Overall Study|Inappropriate enrollment|1|||
146893974|NCT00944034|529777734|FG010|Overall Study|Inappropriate enrollment|0|||
146893975|NCT00944034|529777735|FG011|Overall Study|Inappropriate enrollment|0|||
146893976|NCT00944034|529777724|FG000|Overall Study|Withdrawal by Subject|3|||
146968196|NCT03917654|530043952|FG010|Year 1|Spouse/Family member request|0|||
146968197|NCT03917654|530043953|FG011|Year 1|Spouse/Family member request|1|||
146968198|NCT03917654|530043942|FG000|Year 1|Death|0|||
146968199|NCT03917654|530043943|FG001|Year 1|Death|0|||
146893977|NCT00944034|529777725|FG001|Overall Study|Withdrawal by Subject|2|||
146893978|NCT00944034|529777726|FG002|Overall Study|Withdrawal by Subject|6|||
146893979|NCT00944034|529777727|FG003|Overall Study|Withdrawal by Subject|2|||
146893980|NCT00944034|529777728|FG004|Overall Study|Withdrawal by Subject|5|||
146893981|NCT00944034|529777729|FG005|Overall Study|Withdrawal by Subject|8|||
146893982|NCT00944034|529777730|FG006|Overall Study|Withdrawal by Subject|2|||
146893983|NCT00944034|529777731|FG007|Overall Study|Withdrawal by Subject|2|||
146893984|NCT00944034|529777732|FG008|Overall Study|Withdrawal by Subject|3|||
146893985|NCT00944034|529777733|FG009|Overall Study|Withdrawal by Subject|4|||
146893986|NCT00944034|529777734|FG010|Overall Study|Withdrawal by Subject|0|||
146893987|NCT00944034|529777735|FG011|Overall Study|Withdrawal by Subject|4|||
146893988|NCT00944034|529777724|FG000|Overall Study|Lost to Follow-up|0|||
146893989|NCT00944034|529777725|FG001|Overall Study|Lost to Follow-up|4|||
146893990|NCT00944034|529777726|FG002|Overall Study|Lost to Follow-up|2|||
146893991|NCT00944034|529777727|FG003|Overall Study|Lost to Follow-up|0|||
146893992|NCT00944034|529777728|FG004|Overall Study|Lost to Follow-up|5|||
146893993|NCT00944034|529777729|FG005|Overall Study|Lost to Follow-up|7|||
146893994|NCT00944034|529777730|FG006|Overall Study|Lost to Follow-up|0|||
146893995|NCT00944034|529777731|FG007|Overall Study|Lost to Follow-up|1|||
146893996|NCT00944034|529777732|FG008|Overall Study|Lost to Follow-up|5|||
146893997|NCT00944034|529777733|FG009|Overall Study|Lost to Follow-up|1|||
146893998|NCT00944034|529777734|FG010|Overall Study|Lost to Follow-up|1|||
146893999|NCT00944034|529777735|FG011|Overall Study|Lost to Follow-up|0|||
146894000|NCT00944034|529777724|FG000|Overall Study|Death|0|||
146894001|NCT00944034|529777725|FG001|Overall Study|Death|0|||
146894002|NCT00944034|529777726|FG002|Overall Study|Death|1|||
146894003|NCT00944034|529777727|FG003|Overall Study|Death|0|||
146894004|NCT00944034|529777728|FG004|Overall Study|Death|0|||
146894005|NCT00944034|529777729|FG005|Overall Study|Death|0|||
146894006|NCT00944034|529777730|FG006|Overall Study|Death|0|||
146894007|NCT00944034|529777731|FG007|Overall Study|Death|0|||
146894008|NCT00944034|529777732|FG008|Overall Study|Death|0|||
146894009|NCT00944034|529777733|FG009|Overall Study|Death|0|||
146894010|NCT00944034|529777734|FG010|Overall Study|Death|0|||
146894011|NCT00944034|529777735|FG011|Overall Study|Death|0|||
146894012|NCT00944034|529777724|FG000|Overall Study|Protocol Violation|2|||
146894013|NCT00944034|529777725|FG001|Overall Study|Protocol Violation|0|||
146894014|NCT00944034|529777726|FG002|Overall Study|Protocol Violation|0|||
146894015|NCT00944034|529777727|FG003|Overall Study|Protocol Violation|1|||
146894016|NCT00944034|529777728|FG004|Overall Study|Protocol Violation|2|||
146894017|NCT00944034|529777729|FG005|Overall Study|Protocol Violation|3|||
146894018|NCT00944034|529777730|FG006|Overall Study|Protocol Violation|0|||
146894019|NCT00944034|529777731|FG007|Overall Study|Protocol Violation|1|||
146894020|NCT00944034|529777732|FG008|Overall Study|Protocol Violation|1|||
146894021|NCT00944034|529777733|FG009|Overall Study|Protocol Violation|4|||
146894022|NCT00944034|529777734|FG010|Overall Study|Protocol Violation|0|||
146894023|NCT00944034|529777735|FG011|Overall Study|Protocol Violation|0|||
146894024|NCT00944034|529777724|FG000|Overall Study|Unable to classify|0|||
146894025|NCT00944034|529777725|FG001|Overall Study|Unable to classify|0|||
146894026|NCT00944034|529777726|FG002|Overall Study|Unable to classify|0|||
146894027|NCT00944034|529777727|FG003|Overall Study|Unable to classify|0|||
146894028|NCT00944034|529777728|FG004|Overall Study|Unable to classify|0|||
146894029|NCT00944034|529777729|FG005|Overall Study|Unable to classify|1|||
146894030|NCT00944034|529777730|FG006|Overall Study|Unable to classify|1|||
146894031|NCT00944034|529777731|FG007|Overall Study|Unable to classify|1|||
146894032|NCT00944034|529777732|FG008|Overall Study|Unable to classify|0|||
146894033|NCT00944034|529777733|FG009|Overall Study|Unable to classify|0|||
146894034|NCT00944034|529777734|FG010|Overall Study|Unable to classify|0|||
146894035|NCT00944034|529777735|FG011|Overall Study|Unable to classify|0|||
146558509|NCT01272219|528554235|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
146894036|NCT00944034|529777724|FG000|Overall Study|Administrative reason|0|||
146894037|NCT00944034|529777725|FG001|Overall Study|Administrative reason|0|||
146894038|NCT00944034|529777726|FG002|Overall Study|Administrative reason|0|||
146894039|NCT00944034|529777727|FG003|Overall Study|Administrative reason|0|||
146894040|NCT00944034|529777728|FG004|Overall Study|Administrative reason|0|||
146894041|NCT00944034|529777729|FG005|Overall Study|Administrative reason|0|||
146894042|NCT00944034|529777730|FG006|Overall Study|Administrative reason|1|||
146894043|NCT00944034|529777731|FG007|Overall Study|Administrative reason|0|||
146894044|NCT00944034|529777732|FG008|Overall Study|Administrative reason|0|||
146968200|NCT03917654|530043944|FG002|Year 1|Death|0|||
146968201|NCT03917654|530043945|FG003|Year 1|Death|0|||
146894045|NCT00944034|529777733|FG009|Overall Study|Administrative reason|0|||
146894046|NCT00944034|529777734|FG010|Overall Study|Administrative reason|0|||
146894047|NCT00944034|529777735|FG011|Overall Study|Administrative reason|0|||
146894048|NCT01596257|529777736|FG000|Overall Study|Inadequate Collection|23|||
146894049|NCT01596257|529777737|FG001|Overall Study|Inadequate Collection|19|||
146894050|NCT01570244|529777738|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
146894051|NCT00531960|529777749|FG000|Overall Study|Adverse Event|5|||
146894052|NCT00531960|529777750|FG001|Overall Study|Adverse Event|4|||
146894053|NCT00531960|529777749|FG000|Overall Study|Death|3|||
146894054|NCT00531960|529777750|FG001|Overall Study|Death|2|||
146894055|NCT00531960|529777749|FG000|Overall Study|Lack of Efficacy|42|||
146894056|NCT00531960|529777750|FG001|Overall Study|Lack of Efficacy|41|||
146894057|NCT00531960|529777749|FG000|Overall Study|Violation of Selection Criteria|2|||
146894058|NCT00531960|529777750|FG001|Overall Study|Violation of Selection Criteria|0|||
146894059|NCT00531960|529777749|FG000|Overall Study|Refused Treatment|5|||
146968202|NCT03917654|530043946|FG004|Year 1|Death|0|||
146894060|NCT00531960|529777750|FG001|Overall Study|Refused Treatment|6|||
146894061|NCT00531960|529777749|FG000|Overall Study|Other|4|||
146894062|NCT00531960|529777750|FG001|Overall Study|Other|10|||
146894063|NCT03157531|529777757|FG000|Overall Study|Death|2|||
146894064|NCT03157531|529777757|FG000|Overall Study|Lost to Follow-up|4|||
146894065|NCT01879410|529777762|FG000|Overall Study|Adverse Event|9|||
146894066|NCT01879410|529777763|FG001|Overall Study|Adverse Event|14|||
146968203|NCT03917654|530043947|FG005|Year 1|Death|0|||
146968204|NCT03917654|530043948|FG006|Year 1|Death|0|||
146968205|NCT03917654|530043949|FG007|Year 1|Death|0|||
146968206|NCT03917654|530043950|FG008|Year 1|Death|1|||
146968207|NCT03917654|530043951|FG009|Year 1|Death|1|||
146968208|NCT03917654|530043952|FG010|Year 1|Death|0|||
146968209|NCT03917654|530043953|FG011|Year 1|Death|0|||
146968210|NCT03917654|530043942|FG000|Year 1|Lost to Follow-up|0|||
146558510|NCT01272219|528554236|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
146558511|NCT01272219|528554237|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
146558512|NCT01272219|528554232|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
146558513|NCT01272219|528554233|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
146558514|NCT01272219|528554234|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
146558515|NCT01272219|528554235|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
146558516|NCT01272219|528554236|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
146558517|NCT01272219|528554237|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
146558518|NCT01272219|528554232|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
146558519|NCT01272219|528554233|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
146558520|NCT01272219|528554234|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
146558521|NCT01272219|528554235|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
146558522|NCT01272219|528554236|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
146558523|NCT01272219|528554237|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
146558524|NCT01272219|528554232|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
146558525|NCT01272219|528554233|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
146558526|NCT01272219|528554234|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
146558527|NCT01272219|528554235|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
146558528|NCT01272219|528554236|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
146558529|NCT01272219|528554237|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
146558530|NCT01272219|528554232|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
146558531|NCT01272219|528554233|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
146558532|NCT01272219|528554234|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
146558533|NCT01272219|528554235|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
146558534|NCT01272219|528554236|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
146558535|NCT01272219|528554237|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
146558536|NCT01272219|528554232|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
146558537|NCT01272219|528554233|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
146558538|NCT01272219|528554234|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
146558539|NCT01272219|528554235|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
146558540|NCT01272219|528554236|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
146558541|NCT01272219|528554237|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
146558542|NCT03131479|528554238|FG000|Overall Study|Adverse Event|0|||
146558543|NCT03131479|528554239|FG001|Overall Study|Adverse Event|0|||
146558544|NCT03131479|528554240|FG002|Overall Study|Adverse Event|1|||
146558545|NCT03131479|528554241|FG003|Overall Study|Adverse Event|1|||
146558546|NCT03131479|528554242|FG004|Overall Study|Adverse Event|0|||
146558547|NCT03131479|528554238|FG000|Overall Study|Subject/Guardian Decision|0|||
146558548|NCT03131479|528554239|FG001|Overall Study|Subject/Guardian Decision|0|||
146558549|NCT03131479|528554240|FG002|Overall Study|Subject/Guardian Decision|0|||
146558550|NCT03131479|528554241|FG003|Overall Study|Subject/Guardian Decision|1|||
146558551|NCT03131479|528554242|FG004|Overall Study|Subject/Guardian Decision|0|||
146558552|NCT01491919|528554243|FG000|Overall Study|Insufficient PK sampling|1|||
146558553|NCT01491919|528554244|FG001|Overall Study|Insufficient PK sampling|2|||
146558554|NCT01491919|528554245|FG002|Overall Study|Insufficient PK sampling|1|||
146558555|NCT04003389|528554246|FG000|Overall Study|Adverse Event|27|||
146558556|NCT04003389|528554247|FG001|Overall Study|Adverse Event|34|||
146558557|NCT04003389|528554248|FG002|Overall Study|Adverse Event|28|||
146558558|NCT04003389|528554246|FG000|Overall Study|Lost to Follow-up|39|||
146558559|NCT04003389|528554247|FG001|Overall Study|Lost to Follow-up|30|||
146558560|NCT04003389|528554248|FG002|Overall Study|Lost to Follow-up|33|||
146558561|NCT04003389|528554246|FG000|Overall Study|Protocol Violation|1|||
146558562|NCT04003389|528554247|FG001|Overall Study|Protocol Violation|6|||
146558563|NCT04003389|528554248|FG002|Overall Study|Protocol Violation|5|||
146894067|NCT01879410|529777762|FG000|Overall Study|Lack of Efficacy|4|||
146968211|NCT03917654|530043943|FG001|Year 1|Lost to Follow-up|0|||
146558564|NCT04003389|528554246|FG000|Overall Study|Withdrawal by Subject|119|||
146894068|NCT01879410|529777763|FG001|Overall Study|Lack of Efficacy|6|||
146968212|NCT03917654|530043944|FG002|Year 1|Lost to Follow-up|0|||
146968213|NCT03917654|530043945|FG003|Year 1|Lost to Follow-up|0|||
146894069|NCT01879410|529777762|FG000|Overall Study|Protocol Violation|1|||
146894070|NCT01879410|529777763|FG001|Overall Study|Protocol Violation|7|||
146894071|NCT01879410|529777762|FG000|Overall Study|Lost to Follow-up|2|||
146894072|NCT01879410|529777763|FG001|Overall Study|Lost to Follow-up|1|||
146968214|NCT03917654|530043946|FG004|Year 1|Lost to Follow-up|0|||
146968215|NCT03917654|530043947|FG005|Year 1|Lost to Follow-up|0|||
146637902|NCT00611026|528848798|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
146637903|NCT00611026|528848799|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
146637904|NCT00611026|528848800|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
146637905|NCT00611026|528848798|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
146637906|NCT00611026|528848799|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
146637907|NCT00611026|528848800|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
146637908|NCT00611026|528848798|FG000|Double-blind Treatment Period|Other|13|||
146637909|NCT00611026|528848799|FG001|Double-blind Treatment Period|Other|20|||
146637910|NCT00611026|528848800|FG002|Double-blind Treatment Period|Other|18|||
146637911|NCT01147874|528848802|FG000|Overall Study|Adverse Event|5|||
146637912|NCT01147874|528848802|FG000|Overall Study|Investigator's Request|1|||
146637913|NCT01147874|528848802|FG000|Overall Study|Lost to Follow-up|25|||
146637914|NCT01147874|528848802|FG000|Overall Study|Other|5|||
146637915|NCT01147874|528848802|FG000|Overall Study|Protocol Violation|5|||
146637916|NCT01147874|528848802|FG000|Overall Study|Sponsor's Decision|2|||
146637917|NCT01147874|528848802|FG000|Overall Study|Withdrawal by Subject|24|||
146637918|NCT02175030|528848810|FG000|Overall Study|Failed screen after consent|7|||
146637919|NCT02175030|528848811|FG001|Overall Study|Failed screen after consent|6|||
146637920|NCT02175030|528848810|FG000|Overall Study|Failed IUD Insertion|20|||
146637921|NCT02175030|528848811|FG001|Overall Study|Failed IUD Insertion|21|||
146637922|NCT02175030|528848810|FG000|Overall Study|Physician Decision|1|||
146637923|NCT02175030|528848811|FG001|Overall Study|Physician Decision|1|||
146637924|NCT02175030|528848810|FG000|Overall Study|Lost to Follow-up|6|||
146637925|NCT02175030|528848811|FG001|Overall Study|Lost to Follow-up|6|||
146637926|NCT02175030|528848810|FG000|Overall Study|Withdrawal by Subject|1|||
146637927|NCT02175030|528848811|FG001|Overall Study|Withdrawal by Subject|4|||
146637928|NCT02533453|528848812|FG000|Overall Study|Adverse Event|6|||
146637929|NCT02533453|528848812|FG000|Overall Study|Protocol Violation|1|||
146637930|NCT02533453|528848812|FG000|Overall Study|Withdrawal by Subject|2|||
146637931|NCT03892967|528848819|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
146637932|NCT03892967|528848820|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
146637933|NCT03892967|528848821|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
146637934|NCT03892967|528848822|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
146637935|NCT03892967|528848823|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
146637936|NCT03892967|528848819|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
146637937|NCT03892967|528848820|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
146637938|NCT03892967|528848821|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
146637939|NCT03892967|528848822|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
146637940|NCT03892967|528848823|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
146637941|NCT03892967|528848819|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
146637942|NCT03892967|528848820|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
146637943|NCT03892967|528848821|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
146637944|NCT03892967|528848822|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
146637945|NCT03892967|528848823|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
146637946|NCT03892967|528848819|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
146637947|NCT03892967|528848820|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
146637948|NCT03892967|528848821|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
146650225|NCT04966910|528896685|FG002|Baseline|Participant did not complete measure|1|||
146766515|NCT02914522|529312249|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
146894073|NCT01879410|529777762|FG000|Overall Study|Withdrawal by Subject|7|||
146894074|NCT01879410|529777763|FG001|Overall Study|Withdrawal by Subject|8|||
146894075|NCT01879410|529777762|FG000|Overall Study|Randomised in Error|1|||
146894076|NCT01879410|529777763|FG001|Overall Study|Randomised in Error|2|||
146894077|NCT00713219|529777772|FG000|Overall Study|Death|1|||
146894078|NCT00713219|529777772|FG000|Overall Study|Protocol Violation|1|||
146968216|NCT03917654|530043948|FG006|Year 1|Lost to Follow-up|2|||
146637949|NCT03892967|528848822|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
146637950|NCT03892967|528848823|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
146637951|NCT03892967|528848819|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
146637952|NCT03892967|528848820|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
146637953|NCT03892967|528848821|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
146637954|NCT03892967|528848822|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
146650226|NCT04966910|528896686|FG003|Baseline|Participant did not complete measure|0|||
146766516|NCT02914522|529312250|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
146766517|NCT02914522|529312251|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
146766518|NCT02914522|529312252|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
146766519|NCT02914522|529312253|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
146766520|NCT02914522|529312254|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
146766521|NCT02914522|529312255|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
146766522|NCT02914522|529312256|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
146766523|NCT02914522|529312257|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
146766524|NCT02914522|529312247|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
146766525|NCT02914522|529312248|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
146766526|NCT02914522|529312249|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
146766527|NCT02914522|529312250|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
146766528|NCT02914522|529312251|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
146766529|NCT02914522|529312252|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
146766530|NCT02914522|529312253|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
146766531|NCT02914522|529312254|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
146894079|NCT03183128|529777778|FG000|Overall Study|Adverse Event|1|||
146894080|NCT03183128|529777779|FG001|Overall Study|Adverse Event|2|||
146894081|NCT03183128|529777778|FG000|Overall Study|Withdrawal by Subject|1|||
146894082|NCT03183128|529777779|FG001|Overall Study|Withdrawal by Subject|8|||
146894083|NCT03183128|529777778|FG000|Overall Study|Protocol Violation|2|||
146894084|NCT03183128|529777779|FG001|Overall Study|Protocol Violation|0|||
146894085|NCT03183128|529777778|FG000|Overall Study|Lack of Efficacy|4|||
146894086|NCT03183128|529777779|FG001|Overall Study|Lack of Efficacy|27|||
146894087|NCT03183128|529777778|FG000|Overall Study|Lost to Follow-up|1|||
146894088|NCT03183128|529777779|FG001|Overall Study|Lost to Follow-up|0|||
146894089|NCT03183128|529777778|FG000|Overall Study|Death|2|||
146894090|NCT03183128|529777779|FG001|Overall Study|Death|0|||
146894091|NCT03183128|529777778|FG000|Overall Study|Physician Decision|1|||
146894092|NCT03183128|529777779|FG001|Overall Study|Physician Decision|0|||
146894093|NCT02978222|529777782|FG000|Overall Study|Withdrawal by Subject|2|||
146894094|NCT02978222|529777783|FG001|Overall Study|Withdrawal by Subject|2|||
146894095|NCT02978222|529777782|FG000|Overall Study|Physician Decision|2|||
146894096|NCT02978222|529777783|FG001|Overall Study|Physician Decision|0|||
146894097|NCT02978222|529777782|FG000|Overall Study|Adverse Event|0|||
146894098|NCT02978222|529777783|FG001|Overall Study|Adverse Event|1|||
146894099|NCT02978222|529777782|FG000|Overall Study|Death|1|||
146894100|NCT02978222|529777783|FG001|Overall Study|Death|0|||
146894101|NCT02978222|529777782|FG000|Overall Study|Disease Progression|32|||
146894102|NCT02978222|529777783|FG001|Overall Study|Disease Progression|32|||
146894103|NCT02978222|529777782|FG000|Overall Study|Early Study Termination|24|||
146894104|NCT02978222|529777783|FG001|Overall Study|Early Study Termination|21|||
146894105|NCT01686568|529777784|FG000|Main Study|Withdrawal by Subject|1|||
146894106|NCT01686568|529777785|FG001|Main Study|Withdrawal by Subject|3|||
146894107|NCT01686568|529777784|FG000|Main Study|Noncompliance with protocol|0|||
146894108|NCT01686568|529777785|FG001|Main Study|Noncompliance with protocol|1|||
146894109|NCT01686568|529777784|FG000|Main Study|Liver enzymes above range of exclusion|1|||
146894110|NCT01686568|529777785|FG001|Main Study|Liver enzymes above range of exclusion|0|||
146894111|NCT01686568|529777784|FG000|Sub-Study|Not consented for sub-study|2|||
146894112|NCT01686568|529777785|FG001|Sub-Study|Not consented for sub-study|2|||
146894113|NCT03258814|529777786|FG000|Overall Study|Early Termination|4|||
146894114|NCT03258814|529777787|FG001|Overall Study|Early Termination|3|||
146894115|NCT03258814|529777788|FG002|Overall Study|Early Termination|10|||
146894116|NCT01413958|529777789|FG000|Overall Study|Lost to Follow-up|0|||
146894117|NCT01413958|529777790|FG001|Overall Study|Lost to Follow-up|1|||
146894118|NCT01900002|529777791|FG000|Overall Study|Withdrawal by Subject|2|||
146894119|NCT01900002|529777791|FG000|Overall Study|ineligible for Y-90|4|||
146894120|NCT01573910|529777798|FG000|Overall Study|Adverse Event|4|||
146894121|NCT01573910|529777799|FG001|Overall Study|Adverse Event|4|||
146894122|NCT01573910|529777798|FG000|Overall Study|Lost to Follow-up|2|||
146894123|NCT01573910|529777799|FG001|Overall Study|Lost to Follow-up|1|||
146894124|NCT01573910|529777798|FG000|Overall Study|Withdrawal by Subject|0|||
146894125|NCT01573910|529777799|FG001|Overall Study|Withdrawal by Subject|1|||
146894126|NCT01573910|529777798|FG000|Overall Study|Protocol Violation|3|||
146894127|NCT01573910|529777799|FG001|Overall Study|Protocol Violation|0|||
146894128|NCT01573910|529777798|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
146894129|NCT01573910|529777799|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
146894130|NCT00364182|529777800|FG000|First Intervention|Secondary prophylaxis|1|||
146894131|NCT00364182|529777801|FG001|First Intervention|Secondary prophylaxis|0|||
146894132|NCT00364182|529777802|FG002|First Intervention|Secondary prophylaxis|0|||
146894133|NCT00364182|529777800|FG000|First Intervention|Withdrawal by Subject|2|||
146894134|NCT00364182|529777801|FG001|First Intervention|Withdrawal by Subject|0|||
146894135|NCT00364182|529777802|FG002|First Intervention|Withdrawal by Subject|0|||
146894136|NCT00364182|529777800|FG000|Second Intervention|non-compliance|0|||
146894137|NCT00364182|529777801|FG001|Second Intervention|non-compliance|1|||
146894138|NCT00364182|529777802|FG002|Second Intervention|non-compliance|1|||
146968217|NCT03917654|530043949|FG007|Year 1|Lost to Follow-up|0|||
146968218|NCT03917654|530043950|FG008|Year 1|Lost to Follow-up|0|||
146968219|NCT03917654|530043951|FG009|Year 1|Lost to Follow-up|0|||
146968220|NCT03917654|530043952|FG010|Year 1|Lost to Follow-up|0|||
146968221|NCT03917654|530043953|FG011|Year 1|Lost to Follow-up|0|||
146968222|NCT03917654|530043942|FG000|Year 1|Missed visits|0|||
146968223|NCT03917654|530043943|FG001|Year 1|Missed visits|0|||
146968224|NCT03917654|530043944|FG002|Year 1|Missed visits|0|||
146968225|NCT03917654|530043945|FG003|Year 1|Missed visits|0|||
146968226|NCT03917654|530043946|FG004|Year 1|Missed visits|0|||
146968227|NCT03917654|530043947|FG005|Year 1|Missed visits|0|||
146968228|NCT03917654|530043948|FG006|Year 1|Missed visits|0|||
146968229|NCT03917654|530043949|FG007|Year 1|Missed visits|0|||
146968230|NCT03917654|530043950|FG008|Year 1|Missed visits|0|||
146968231|NCT03917654|530043951|FG009|Year 1|Missed visits|0|||
146968232|NCT03917654|530043952|FG010|Year 1|Missed visits|1|||
146968233|NCT03917654|530043953|FG011|Year 1|Missed visits|1|||
146968234|NCT03917654|530043942|FG000|Year 1|Pregnancy|0|||
146968235|NCT03917654|530043943|FG001|Year 1|Pregnancy|0|||
146968236|NCT03917654|530043944|FG002|Year 1|Pregnancy|0|||
146968237|NCT03917654|530043945|FG003|Year 1|Pregnancy|0|||
146968238|NCT03917654|530043946|FG004|Year 1|Pregnancy|0|||
146968239|NCT03917654|530043947|FG005|Year 1|Pregnancy|0|||
146968240|NCT03917654|530043948|FG006|Year 1|Pregnancy|0|||
146968241|NCT03917654|530043949|FG007|Year 1|Pregnancy|1|||
146968242|NCT03917654|530043950|FG008|Year 1|Pregnancy|0|||
146968243|NCT03917654|530043951|FG009|Year 1|Pregnancy|1|||
146968244|NCT03917654|530043952|FG010|Year 1|Pregnancy|0|||
146968245|NCT03917654|530043953|FG011|Year 1|Pregnancy|0|||
146968246|NCT03917654|530043942|FG000|Year 2|Travel|1|||
146968247|NCT03917654|530043943|FG001|Year 2|Travel|0|||
146968248|NCT03917654|530043944|FG002|Year 2|Travel|0|||
146968249|NCT03917654|530043945|FG003|Year 2|Travel|0|||
146968250|NCT03917654|530043946|FG004|Year 2|Travel|1|||
146968251|NCT03917654|530043947|FG005|Year 2|Travel|1|||
146968252|NCT03917654|530043948|FG006|Year 2|Travel|2|||
146968253|NCT03917654|530043949|FG007|Year 2|Travel|1|||
146968254|NCT03917654|530043950|FG008|Year 2|Travel|0|||
146558565|NCT04003389|528554247|FG001|Overall Study|Withdrawal by Subject|79|||
146558566|NCT04003389|528554248|FG002|Overall Study|Withdrawal by Subject|85|||
146558567|NCT04003389|528554246|FG000|Overall Study|Miscellaneous|14|||
146558568|NCT04003389|528554247|FG001|Overall Study|Miscellaneous|11|||
146558569|NCT04003389|528554248|FG002|Overall Study|Miscellaneous|14|||
146558570|NCT04003389|528554246|FG000|Overall Study|Participant did not receive study drug|1|||
146558571|NCT04003389|528554247|FG001|Overall Study|Participant did not receive study drug|0|||
146558572|NCT04003389|528554248|FG002|Overall Study|Participant did not receive study drug|0|||
146558573|NCT04806373|528554254|FG000|Overall Study|Withdrawal by Subject|1|||
146558574|NCT04806373|528554255|FG001|Overall Study|Withdrawal by Subject|1|||
146558575|NCT05810597|528554256|FG000|Period 1|Adverse Event|2|||
146558576|NCT05810597|528554257|FG001|Period 1|Adverse Event|0|||
146558577|NCT05810597|528554256|FG000|Period 1|Physician Decision|1|||
146558578|NCT05810597|528554257|FG001|Period 1|Physician Decision|0|||
146558579|NCT02061085|528554262|FG000|Overall Study|Adverse Event|8|||
146558580|NCT03204812|528554272|FG000|Overall Study|Adverse Event|3|||
146558581|NCT02412436|528554273|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
146558582|NCT02412436|528554273|FG000|Overall Study|Lost to Follow-up|6|||
146558583|NCT02412436|528554273|FG000|Overall Study|Unable to get to clinic|3|||
146558584|NCT02412436|528554273|FG000|Overall Study|Death|1|||
146558585|NCT02412436|528554273|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
146558586|NCT00392288|528554274|FG000|Overall Study|Adverse Event|17|||
146558587|NCT00392288|528554275|FG001|Overall Study|Adverse Event|7|||
146968255|NCT03917654|530043951|FG009|Year 2|Travel|1|||
146968256|NCT03917654|530043952|FG010|Year 2|Travel|0|||
146968257|NCT03917654|530043953|FG011|Year 2|Travel|1|||
146968258|NCT03917654|530043942|FG000|Year 2|Married|1|||
146968259|NCT03917654|530043943|FG001|Year 2|Married|0|||
146968260|NCT03917654|530043944|FG002|Year 2|Married|0|||
146968261|NCT03917654|530043945|FG003|Year 2|Married|0|||
146968262|NCT03917654|530043946|FG004|Year 2|Married|0|||
146968263|NCT03917654|530043947|FG005|Year 2|Married|0|||
146968264|NCT03917654|530043948|FG006|Year 2|Married|1|||
146968265|NCT03917654|530043949|FG007|Year 2|Married|1|||
146968266|NCT03917654|530043950|FG008|Year 2|Married|0|||
146968267|NCT03917654|530043951|FG009|Year 2|Married|0|||
146968268|NCT03917654|530043952|FG010|Year 2|Married|0|||
146637955|NCT03892967|528848823|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
146637956|NCT03892967|528848819|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
146637957|NCT03892967|528848820|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
146637958|NCT03892967|528848821|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
146637959|NCT03892967|528848822|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
146637960|NCT03892967|528848823|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
146637961|NCT04434937|528848824|FG000|Overall Study|Death|4|||
146637962|NCT04434937|528848824|FG000|Overall Study|Withdrawal by Subject|1|||
146637963|NCT04434937|528848824|FG000|Overall Study|Transitioned to Rollover Study|19|||
146637964|NCT04434937|528848824|FG000|Overall Study|Progressive Disease|18|||
146637965|NCT03387085|528848829|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
146637966|NCT04193189|528848830|FG000|Overall Study|Lost to Follow-up|9|||
146637967|NCT04193189|528848831|FG001|Overall Study|Lost to Follow-up|7|||
146637968|NCT04193189|528848832|FG002|Overall Study|Lost to Follow-up|9|||
146637969|NCT04193189|528848833|FG003|Overall Study|Lost to Follow-up|0|||
146637970|NCT04193189|528848830|FG000|Overall Study|Withdrawal by Subject|1|||
146637971|NCT04193189|528848831|FG001|Overall Study|Withdrawal by Subject|2|||
146637972|NCT04193189|528848832|FG002|Overall Study|Withdrawal by Subject|2|||
146637973|NCT04193189|528848833|FG003|Overall Study|Withdrawal by Subject|0|||
146637974|NCT04193189|528848830|FG000|Overall Study|Death|1|||
146637975|NCT04193189|528848831|FG001|Overall Study|Death|1|||
146637976|NCT04193189|528848832|FG002|Overall Study|Death|0|||
146637977|NCT04193189|528848833|FG003|Overall Study|Death|0|||
146637978|NCT04193189|528848830|FG000|Overall Study|Protocol Violation|0|||
146637979|NCT04193189|528848831|FG001|Overall Study|Protocol Violation|0|||
146637980|NCT04193189|528848832|FG002|Overall Study|Protocol Violation|0|||
146637981|NCT04193189|528848833|FG003|Overall Study|Protocol Violation|1|||
146637982|NCT01077050|528850886|FG000|Overall Study|Subjects signed ICF could not be located|1|||
146637983|NCT01077050|528850886|FG000|Overall Study|Screen failure|8|||
146637984|NCT01006291|528850892|FG000|Overall Study|Adverse Event|2|||
146637985|NCT01006291|528850893|FG001|Overall Study|Adverse Event|1|||
146637986|NCT01006291|528850894|FG002|Overall Study|Adverse Event|2|||
146637987|NCT01006291|528850892|FG000|Overall Study|Lack of Efficacy|2|||
146637988|NCT01006291|528850893|FG001|Overall Study|Lack of Efficacy|2|||
146637989|NCT01006291|528850894|FG002|Overall Study|Lack of Efficacy|1|||
146637990|NCT01006291|528850892|FG000|Overall Study|Protocol Violation|3|||
146637991|NCT01006291|528850893|FG001|Overall Study|Protocol Violation|3|||
146637992|NCT01006291|528850894|FG002|Overall Study|Protocol Violation|3|||
146637993|NCT01006291|528850892|FG000|Overall Study|Withdrawal criteria|5|||
146637994|NCT01006291|528850893|FG001|Overall Study|Withdrawal criteria|4|||
146637995|NCT01006291|528850894|FG002|Overall Study|Withdrawal criteria|4|||
146637996|NCT01006291|528850892|FG000|Overall Study|Other|14|||
146637997|NCT01006291|528850893|FG001|Overall Study|Other|14|||
146637998|NCT01006291|528850894|FG002|Overall Study|Other|17|||
146637999|NCT00684060|528850895|FG000|Overall Study|Lost to Follow-up|1|||
146638000|NCT00684060|528850896|FG001|Overall Study|Lost to Follow-up|0|||
146638001|NCT00684060|528850895|FG000|Overall Study|New stenosis identified|1|||
146638002|NCT00684060|528850896|FG001|Overall Study|New stenosis identified|0|||
146638003|NCT00684060|528850895|FG000|Overall Study|Unable to collect MRI|1|||
146638004|NCT00684060|528850896|FG001|Overall Study|Unable to collect MRI|2|||
146638005|NCT00684060|528850895|FG000|Overall Study|Death|0|||
146638006|NCT00684060|528850896|FG001|Overall Study|Death|1|||
146638007|NCT00702715|528850897|FG000|Overall Study|Lost to Follow-up|1|||
146638008|NCT00702715|528850898|FG001|Overall Study|Lost to Follow-up|0|||
146638009|NCT01865552|528850899|FG000|Period 1|Adverse Event|1|||
146638010|NCT01865552|528850900|FG001|Period 1|Adverse Event|0|||
146638011|NCT01865552|528850901|FG002|Period 1|Adverse Event|0|||
146638012|NCT01865552|528850902|FG003|Period 1|Adverse Event|1|||
146638013|NCT01865552|528850903|FG004|Period 1|Adverse Event|1|||
146894139|NCT00364182|529777800|FG000|Second Intervention|Protocol Violation|0|||
146894140|NCT00364182|529777801|FG001|Second Intervention|Protocol Violation|1|||
146894141|NCT00364182|529777802|FG002|Second Intervention|Protocol Violation|0|||
146894142|NCT00364182|529777800|FG000|Second Intervention|Adverse Event|0|||
146894143|NCT00364182|529777801|FG001|Second Intervention|Adverse Event|0|||
146894144|NCT00364182|529777802|FG002|Second Intervention|Adverse Event|1|||
146894145|NCT00364182|529777800|FG000|Third Intervention|non-compliance|0|||
146638014|NCT01865552|528850904|FG005|Period 1|Adverse Event|1|||
146638015|NCT01865552|528850899|FG000|Period 1|Pathological lab|0|||
146638016|NCT01865552|528850900|FG001|Period 1|Pathological lab|0|||
146638017|NCT01865552|528850901|FG002|Period 1|Pathological lab|0|||
146638018|NCT01865552|528850902|FG003|Period 1|Pathological lab|0|||
146638019|NCT01865552|528850903|FG004|Period 1|Pathological lab|1|||
146638020|NCT01865552|528850904|FG005|Period 1|Pathological lab|0|||
146638021|NCT01865552|528850899|FG000|Period 1|Other|0|||
146638022|NCT01865552|528850900|FG001|Period 1|Other|0|||
146638023|NCT01865552|528850901|FG002|Period 1|Other|0|||
146638024|NCT01865552|528850902|FG003|Period 1|Other|0|||
146894146|NCT00364182|529777801|FG001|Third Intervention|non-compliance|1|||
146894147|NCT00364182|529777802|FG002|Third Intervention|non-compliance|0|||
146968269|NCT03917654|530043953|FG011|Year 2|Married|0|||
146968270|NCT03917654|530043942|FG000|Year 2|Subject moved away from site|1|||
146968271|NCT03917654|530043943|FG001|Year 2|Subject moved away from site|0|||
146894148|NCT00364182|529777800|FG000|Third Intervention|Lost to Follow-up|0|||
146894149|NCT00364182|529777801|FG001|Third Intervention|Lost to Follow-up|0|||
146894150|NCT00364182|529777802|FG002|Third Intervention|Lost to Follow-up|1|||
146894151|NCT04062214|529777804|FG000|Week 12|Death|1|||
146894152|NCT04062214|529777805|FG001|Week 12|Death|1|||
146894153|NCT04062214|529777804|FG000|Week 12|Withdrawal by Subject|14|||
146894154|NCT04062214|529777805|FG001|Week 12|Withdrawal by Subject|13|||
146894155|NCT04062214|529777804|FG000|Week 12|Lost to Follow-up|55|||
146894156|NCT04062214|529777805|FG001|Week 12|Lost to Follow-up|68|||
146894157|NCT04062214|529777804|FG000|Week 12|Intermittent missing|31|||
146894158|NCT04062214|529777805|FG001|Week 12|Intermittent missing|29|||
146894159|NCT04062214|529777804|FG000|Week 36|Withdrawal by Subject|4|||
146894160|NCT04062214|529777805|FG001|Week 36|Withdrawal by Subject|5|||
146894161|NCT04062214|529777804|FG000|Week 36|Lost to Follow-up|50|||
146894162|NCT04062214|529777805|FG001|Week 36|Lost to Follow-up|46|||
146894163|NCT04062214|529777804|FG000|Week 36|Death|0|||
146894164|NCT04062214|529777805|FG001|Week 36|Death|1|||
146894165|NCT01356589|529777809|FG000|Overall Study|Enrolled, but not treated|3|||
146894166|NCT01356589|529777809|FG000|Overall Study|Dose data not recorded|2|||
146894167|NCT04343651|529777810|FG000|Overall Study|Physician Decision|2|||
146894168|NCT04343651|529777811|FG001|Overall Study|Physician Decision|1|||
146894169|NCT04343651|529777810|FG000|Overall Study|Lost to Follow-up|2|||
146894170|NCT04343651|529777811|FG001|Overall Study|Lost to Follow-up|1|||
146894171|NCT04343651|529777810|FG000|Overall Study|Protocol Violation|4|||
146894172|NCT04343651|529777811|FG001|Overall Study|Protocol Violation|6|||
146968272|NCT03917654|530043944|FG002|Year 2|Subject moved away from site|0|||
146968273|NCT03917654|530043945|FG003|Year 2|Subject moved away from site|0|||
146968274|NCT03917654|530043946|FG004|Year 2|Subject moved away from site|1|||
146968275|NCT03917654|530043947|FG005|Year 2|Subject moved away from site|0|||
146558588|NCT00392288|528554276|FG002|Overall Study|Adverse Event|8|||
146558589|NCT00392288|528554274|FG000|Overall Study|Lack of Efficacy|8|||
146558590|NCT00392288|528554275|FG001|Overall Study|Lack of Efficacy|5|||
146558591|NCT00392288|528554276|FG002|Overall Study|Lack of Efficacy|3|||
146558592|NCT00392288|528554274|FG000|Overall Study|Protocol Violation|1|||
146558593|NCT00392288|528554275|FG001|Overall Study|Protocol Violation|3|||
146558594|NCT00392288|528554276|FG002|Overall Study|Protocol Violation|1|||
146558595|NCT00392288|528554274|FG000|Overall Study|Lost to Follow-up|1|||
146558596|NCT00392288|528554275|FG001|Overall Study|Lost to Follow-up|1|||
146558597|NCT00392288|528554276|FG002|Overall Study|Lost to Follow-up|1|||
146558598|NCT00392288|528554274|FG000|Overall Study|Withdrawal by Subject|1|||
146558599|NCT00392288|528554275|FG001|Overall Study|Withdrawal by Subject|0|||
146558600|NCT00392288|528554276|FG002|Overall Study|Withdrawal by Subject|2|||
146558601|NCT00392288|528554274|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
146558602|NCT00392288|528554275|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
146558603|NCT00392288|528554276|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
146558604|NCT00392288|528554274|FG000|Overall Study|Other|3|||
146558605|NCT00392288|528554275|FG001|Overall Study|Other|4|||
146558606|NCT00392288|528554276|FG002|Overall Study|Other|1|||
146558607|NCT02544763|528554277|FG000|Overall Study|Adverse Event|8|||
146558608|NCT02544763|528554278|FG001|Overall Study|Adverse Event|8|||
146558609|NCT02544763|528554279|FG002|Overall Study|Adverse Event|0|||
146558610|NCT02544763|528554277|FG000|Overall Study|Withdrawn by parent/guardian|1|||
146558611|NCT02544763|528554278|FG001|Overall Study|Withdrawn by parent/guardian|1|||
146894173|NCT04343651|529777810|FG000|Overall Study|Missing|3|||
146894174|NCT04343651|529777811|FG001|Overall Study|Missing|9|||
146894175|NCT04343651|529777810|FG000|Overall Study|Withdrawal by Subject|0|||
146968276|NCT03917654|530043948|FG006|Year 2|Subject moved away from site|2|||
146968277|NCT03917654|530043949|FG007|Year 2|Subject moved away from site|3|||
146558612|NCT02544763|528554279|FG002|Overall Study|Withdrawn by parent/guardian|1|||
146558613|NCT02544763|528554277|FG000|Overall Study|Met withdrawal criteria|0|||
146558614|NCT02544763|528554278|FG001|Overall Study|Met withdrawal criteria|2|||
146558615|NCT02544763|528554279|FG002|Overall Study|Met withdrawal criteria|0|||
146558616|NCT02544763|528554277|FG000|Overall Study|Physician Decision|0|||
146894176|NCT04343651|529777811|FG001|Overall Study|Withdrawal by Subject|4|||
146894177|NCT04343651|529777810|FG000|Overall Study|Death|0|||
146894178|NCT04343651|529777811|FG001|Overall Study|Death|1|||
146894179|NCT04343651|529777810|FG000|Overall Study|Did not start treatment|1|||
146894180|NCT04343651|529777811|FG001|Overall Study|Did not start treatment|1|||
146558617|NCT02544763|528554278|FG001|Overall Study|Physician Decision|1|||
146894181|NCT04343651|529777810|FG000|Overall Study|Patient did not complete visits 3-6|0|||
146894182|NCT04343651|529777811|FG001|Overall Study|Patient did not complete visits 3-6|1|||
146894183|NCT00821678|529777817|FG000|Overall Study|Withdrawal by Subject|8|||
146894184|NCT00821678|529777818|FG001|Overall Study|Withdrawal by Subject|0|||
146894185|NCT00821678|529777817|FG000|Overall Study|Lost to Follow-up|13|||
146894186|NCT00821678|529777818|FG001|Overall Study|Lost to Follow-up|12|||
146558618|NCT02544763|528554279|FG002|Overall Study|Physician Decision|0|||
146558619|NCT02544763|528554277|FG000|Overall Study|Difficulties taking IMP|1|||
146558620|NCT02544763|528554278|FG001|Overall Study|Difficulties taking IMP|0|||
146558621|NCT02544763|528554279|FG002|Overall Study|Difficulties taking IMP|0|||
146558622|NCT03768336|528555860|FG000|Overall Study|Lost to Follow-up|3|||
146894187|NCT00821678|529777817|FG000|Overall Study|Death|0|||
146894188|NCT00821678|529777818|FG001|Overall Study|Death|2|||
146894189|NCT01974817|529779700|FG000|Overall Study|Death|4|||
146894190|NCT01974817|529779700|FG000|Overall Study|Lost to Follow-up|2|||
146894191|NCT01974817|529779700|FG000|Overall Study|Protocol Violation|2|||
146894192|NCT04047797|529779706|FG000|Overall Study|Progressive Disease|1|||
146894193|NCT01793792|529779707|FG000|Overall Study|Death|5|||
146894194|NCT01793792|529779707|FG000|Overall Study|Lost to Follow-up|5|||
146894195|NCT01793792|529779707|FG000|Overall Study|Withdrawal by Subject|1|||
146894196|NCT01793792|529779707|FG000|Overall Study|Device Not Implanted|1|||
146894197|NCT05742984|529779712|FG000|Overall Study|Adverse Event|0|||
146894198|NCT05742984|529779713|FG001|Overall Study|Adverse Event|0|||
146894199|NCT05742984|529779714|FG002|Overall Study|Adverse Event|1|||
146894200|NCT05742984|529779715|FG003|Overall Study|Adverse Event|0|||
146894201|NCT05742984|529779716|FG004|Overall Study|Adverse Event|1|||
146894202|NCT05742984|529779717|FG005|Overall Study|Adverse Event|1|||
146894203|NCT05742984|529779712|FG000|Overall Study|Withdrawal by Subject|0|||
146894204|NCT05742984|529779713|FG001|Overall Study|Withdrawal by Subject|1|||
146894205|NCT05742984|529779714|FG002|Overall Study|Withdrawal by Subject|0|||
146894206|NCT05742984|529779715|FG003|Overall Study|Withdrawal by Subject|0|||
146894207|NCT05742984|529779716|FG004|Overall Study|Withdrawal by Subject|0|||
146894208|NCT05742984|529779717|FG005|Overall Study|Withdrawal by Subject|2|||
146894209|NCT02162862|529779718|FG000|Overall Study|Lost to Follow-up|0|||
146894210|NCT02162862|529779719|FG001|Overall Study|Lost to Follow-up|11|||
146894211|NCT02162862|529779720|FG002|Overall Study|Lost to Follow-up|0|||
146894212|NCT02162862|529779718|FG000|Overall Study|Subject did not feel the med was needed|0|||
146894213|NCT02162862|529779719|FG001|Overall Study|Subject did not feel the med was needed|0|||
146894214|NCT02162862|529779720|FG002|Overall Study|Subject did not feel the med was needed|4|||
146894215|NCT00988247|529779723|FG000|Overall Study|Adverse Event|17|||
146894216|NCT00988247|529779724|FG001|Overall Study|Adverse Event|3|||
146894217|NCT00988247|529779723|FG000|Overall Study|Withdrawal by Subject|44|||
146894218|NCT00988247|529779724|FG001|Overall Study|Withdrawal by Subject|13|||
146894219|NCT00988247|529779723|FG000|Overall Study|Pregnancy|1|||
146894220|NCT00988247|529779724|FG001|Overall Study|Pregnancy|2|||
146894221|NCT00988247|529779723|FG000|Overall Study|Lost to Follow-up|11|||
146894222|NCT00988247|529779724|FG001|Overall Study|Lost to Follow-up|2|||
146894223|NCT00988247|529779723|FG000|Overall Study|Protocol Violation|4|||
146894224|NCT00988247|529779724|FG001|Overall Study|Protocol Violation|5|||
146894225|NCT00988247|529779723|FG000|Overall Study|Sponsor requested withdrawal|3|||
146894226|NCT00988247|529779724|FG001|Overall Study|Sponsor requested withdrawal|1|||
146894227|NCT00988247|529779723|FG000|Overall Study|Other|3|||
146894228|NCT00988247|529779724|FG001|Overall Study|Other|0|||
146894229|NCT03822884|529779725|FG000|Overall Study|Withdrawal by Subject|0|||
146894230|NCT03822884|529779726|FG001|Overall Study|Withdrawal by Subject|0|||
146894231|NCT03822884|529779727|FG002|Overall Study|Withdrawal by Subject|0|||
146894232|NCT03822884|529779728|FG003|Overall Study|Withdrawal by Subject|0|||
146894233|NCT03822884|529779729|FG004|Overall Study|Withdrawal by Subject|1|||
146894234|NCT03822884|529779730|FG005|Overall Study|Withdrawal by Subject|0|||
146894235|NCT01427309|529779736|FG000|Overall Study|Lost to Follow-up|130|||
146894236|NCT01427309|529779737|FG001|Overall Study|Lost to Follow-up|145|||
146894237|NCT01427309|529779738|FG002|Overall Study|Lost to Follow-up|122|||
146894238|NCT01427309|529779739|FG003|Overall Study|Lost to Follow-up|135|||
146894239|NCT01427309|529779736|FG000|Overall Study|Protocol Violation|42|||
146894240|NCT01427309|529779737|FG001|Overall Study|Protocol Violation|69|||
146894241|NCT01427309|529779738|FG002|Overall Study|Protocol Violation|125|||
146894242|NCT01427309|529779739|FG003|Overall Study|Protocol Violation|124|||
146894243|NCT01427309|529779736|FG000|Overall Study|Adverse Event|0|||
146894244|NCT01427309|529779737|FG001|Overall Study|Adverse Event|0|||
146894245|NCT01427309|529779738|FG002|Overall Study|Adverse Event|3|||
146894246|NCT01427309|529779739|FG003|Overall Study|Adverse Event|1|||
146894247|NCT01427309|529779736|FG000|Overall Study|Serious adverse event|52|||
146894248|NCT01427309|529779737|FG001|Overall Study|Serious adverse event|45|||
146894249|NCT01427309|529779738|FG002|Overall Study|Serious adverse event|50|||
146894250|NCT01427309|529779739|FG003|Overall Study|Serious adverse event|61|||
146558623|NCT03768336|528555861|FG001|Overall Study|Lost to Follow-up|2|||
146558624|NCT03768336|528555860|FG000|Overall Study|Became Ineligible|2|||
146894251|NCT01427309|529779736|FG000|Overall Study|Withdrawal by Subject|148|||
146894252|NCT01427309|529779737|FG001|Overall Study|Withdrawal by Subject|148|||
146558625|NCT03768336|528555861|FG001|Overall Study|Became Ineligible|0|||
146638025|NCT01865552|528850903|FG004|Period 1|Other|1|||
146894253|NCT01427309|529779738|FG002|Overall Study|Withdrawal by Subject|61|||
146894254|NCT01427309|529779739|FG003|Overall Study|Withdrawal by Subject|55|||
146894255|NCT03617705|529779742|FG000|Overall Study|Withdrawal by Subject|2|||
146766532|NCT02914522|529312255|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
146766533|NCT02914522|529312256|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
146894256|NCT03617705|529779742|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
146894257|NCT03617705|529779742|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
146894258|NCT00849017|529779743|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
146638026|NCT01865552|528850904|FG005|Period 1|Other|0|||
146894259|NCT00849017|529779744|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
146638027|NCT03079102|528850905|FG000|Overall Study|Physician Decision|0|||
146638028|NCT03079102|528850906|FG001|Overall Study|Physician Decision|1|||
146638029|NCT02923921|528850907|FG000|Overall Study|Sponsor Decision|39|||
146638030|NCT02923921|528850908|FG001|Overall Study|Sponsor Decision|38|||
146638031|NCT02923921|528850907|FG000|Overall Study|Lost to Follow-up|1|||
146638032|NCT02923921|528850908|FG001|Overall Study|Lost to Follow-up|0|||
146638033|NCT02923921|528850907|FG000|Overall Study|Withdrawal by Subject|6|||
146638034|NCT02923921|528850908|FG001|Overall Study|Withdrawal by Subject|13|||
146638035|NCT02923921|528850907|FG000|Overall Study|Unknown, Not Collected|7|||
146638036|NCT02923921|528850908|FG001|Overall Study|Unknown, Not Collected|6|||
146638037|NCT00854113|528850909|FG000|Overall Study|Adverse Event|0|||
146894260|NCT00849017|529779745|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
146894261|NCT00849017|529779743|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
146894262|NCT00849017|529779744|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
146894263|NCT00849017|529779745|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
146894264|NCT00849017|529779743|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
146894265|NCT00849017|529779744|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
146894266|NCT00849017|529779745|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
146638038|NCT00854113|528850910|FG001|Overall Study|Adverse Event|0|||
146638039|NCT00854113|528850911|FG002|Overall Study|Adverse Event|0|||
146638040|NCT00854113|528850912|FG003|Overall Study|Adverse Event|0|||
146638041|NCT00854113|528850913|FG004|Overall Study|Adverse Event|0|||
146638042|NCT00854113|528850914|FG005|Overall Study|Adverse Event|0|||
146638043|NCT00854113|528850915|FG006|Overall Study|Adverse Event|0|||
146638044|NCT00854113|528850916|FG007|Overall Study|Adverse Event|2|||
146638045|NCT00854113|528850917|FG008|Overall Study|Adverse Event|0|||
146638046|NCT00854113|528850918|FG009|Overall Study|Adverse Event|0|||
146894267|NCT00849017|529779743|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
146894268|NCT00849017|529779744|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
146894269|NCT00849017|529779745|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
146894270|NCT00849017|529779743|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
146894271|NCT00849017|529779744|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
146638047|NCT00854113|528850919|FG010|Overall Study|Adverse Event|0|||
146638048|NCT00854113|528850909|FG000|Overall Study|Withdrawal by Subject|0|||
146638049|NCT00854113|528850910|FG001|Overall Study|Withdrawal by Subject|0|||
146638050|NCT00854113|528850911|FG002|Overall Study|Withdrawal by Subject|0|||
146638051|NCT00854113|528850912|FG003|Overall Study|Withdrawal by Subject|0|||
146638052|NCT00854113|528850913|FG004|Overall Study|Withdrawal by Subject|0|||
146894272|NCT00849017|529779745|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
146894273|NCT00849017|529779743|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
146894274|NCT00849017|529779744|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
146894275|NCT00849017|529779745|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
146894276|NCT00849017|529779743|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
146894277|NCT00849017|529779744|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
146894278|NCT00849017|529779745|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
146894279|NCT00849017|529779743|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
146894280|NCT00849017|529779744|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
146894281|NCT00849017|529779745|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
146894282|NCT00849017|529779743|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
146894283|NCT00849017|529779744|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
146894284|NCT00849017|529779745|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
146894285|NCT00849017|529779743|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
146894286|NCT00849017|529779744|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
146894287|NCT00849017|529779745|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
146894288|NCT00849017|529779743|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
146894289|NCT00849017|529779744|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
146894290|NCT00849017|529779745|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
146894291|NCT00849017|529779743|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
146894292|NCT00849017|529779744|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
146894293|NCT00849017|529779745|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
146894294|NCT00849017|529779743|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
146894295|NCT00849017|529779744|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
146894296|NCT00849017|529779745|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
146638053|NCT00854113|528850914|FG005|Overall Study|Withdrawal by Subject|0|||
146638054|NCT00854113|528850915|FG006|Overall Study|Withdrawal by Subject|0|||
146638055|NCT00854113|528850916|FG007|Overall Study|Withdrawal by Subject|1|||
146638056|NCT00854113|528850917|FG008|Overall Study|Withdrawal by Subject|1|||
146638057|NCT00854113|528850918|FG009|Overall Study|Withdrawal by Subject|0|||
146638058|NCT00854113|528850919|FG010|Overall Study|Withdrawal by Subject|0|||
146638059|NCT01250145|528850922|FG000|Overall Study|Adverse Event|2|||
146638060|NCT01250145|528850923|FG001|Overall Study|Adverse Event|1|||
146638061|NCT01250145|528850922|FG000|Overall Study|Withdrawal by Subject|0|||
146638062|NCT01250145|528850923|FG001|Overall Study|Withdrawal by Subject|4|||
146638063|NCT02741518|528850924|FG000|Overall Study|Withdrawal by Subject|1|||
146638064|NCT02741518|528850925|FG001|Overall Study|Withdrawal by Subject|1|||
146638065|NCT02687191|528850926|FG000|Overall Study|Death|0|||
146638066|NCT02687191|528850927|FG001|Overall Study|Death|1|||
146638067|NCT02687191|528850928|FG002|Overall Study|Death|1|||
146638068|NCT02687191|528850929|FG003|Overall Study|Death|0|||
146638069|NCT02687191|528850930|FG004|Overall Study|Death|1|||
146638070|NCT02687191|528850931|FG005|Overall Study|Death|1|||
146638071|NCT02687191|528850926|FG000|Overall Study|Withdrawal by Subject|0|||
146638072|NCT02687191|528850927|FG001|Overall Study|Withdrawal by Subject|0|||
146638073|NCT02687191|528850928|FG002|Overall Study|Withdrawal by Subject|0|||
146638074|NCT02687191|528850929|FG003|Overall Study|Withdrawal by Subject|1|||
146638075|NCT02687191|528850930|FG004|Overall Study|Withdrawal by Subject|0|||
146638076|NCT02687191|528850931|FG005|Overall Study|Withdrawal by Subject|0|||
146638077|NCT03180840|528850932|FG000|Overall Study|Withdrawal by Subject|1|||
146638078|NCT01788358|528850938|FG000|Overall Study|Other|11|||
146638079|NCT01788358|528850938|FG000|Overall Study|Logistical difficulties|1|||
146638080|NCT01788358|528850938|FG000|Overall Study|Lost to Follow-up|5|||
146638081|NCT01788358|528850938|FG000|Overall Study|Protocol Violation|3|||
146638082|NCT01788358|528850938|FG000|Overall Study|Withdrawal by Subject|26|||
146638083|NCT01788358|528850938|FG000|Overall Study|Lack of Efficacy|1|||
146638084|NCT01788358|528850938|FG000|Overall Study|Adverse Event|51|||
146638085|NCT01168219|528850939|FG000|Overall Study|off study before starting treatment|2|||
146638086|NCT01168219|528850939|FG000|Overall Study|withdrew before transplant|1|||
146638087|NCT01168219|528850939|FG000|Overall Study|ineligible due to CML|2|||
146638088|NCT02563067|528850942|FG000|Overall Study|Subject/guardian decision|14|||
146638089|NCT02563067|528850943|FG001|Overall Study|Subject/guardian decision|20|||
146638090|NCT02563067|528850944|FG002|Overall Study|Subject/guardian decision|16|||
146638091|NCT02563067|528850942|FG000|Overall Study|Physician Decision|0|||
146638092|NCT02563067|528850943|FG001|Overall Study|Physician Decision|1|||
146638093|NCT02563067|528850944|FG002|Overall Study|Physician Decision|3|||
146638094|NCT02563067|528850942|FG000|Overall Study|Lost to Follow-up|1|||
146638095|NCT02563067|528850943|FG001|Overall Study|Lost to Follow-up|2|||
146638096|NCT02563067|528850944|FG002|Overall Study|Lost to Follow-up|0|||
146638097|NCT02563067|528850942|FG000|Overall Study|Technical problems|0|||
146638098|NCT02563067|528850943|FG001|Overall Study|Technical problems|1|||
146638099|NCT02563067|528850944|FG002|Overall Study|Technical problems|0|||
146638100|NCT02563067|528850942|FG000|Overall Study|Lack of Efficacy|1|||
146638101|NCT02563067|528850943|FG001|Overall Study|Lack of Efficacy|0|||
146638102|NCT02563067|528850944|FG002|Overall Study|Lack of Efficacy|0|||
146638103|NCT02563067|528850942|FG000|Overall Study|Death|0|||
146638104|NCT02563067|528850943|FG001|Overall Study|Death|1|||
146638105|NCT02563067|528850944|FG002|Overall Study|Death|1|||
146638106|NCT02563067|528850942|FG000|Overall Study|Adverse Event|2|||
146638107|NCT02563067|528850943|FG001|Overall Study|Adverse Event|1|||
146638108|NCT02563067|528850944|FG002|Overall Study|Adverse Event|0|||
146638109|NCT02563067|528850942|FG000|Overall Study|Death post Treatment/safety period|1|||
146638110|NCT02563067|528850943|FG001|Overall Study|Death post Treatment/safety period|0|||
146638111|NCT02563067|528850944|FG002|Overall Study|Death post Treatment/safety period|0|||
146638112|NCT01039519|528850949|FG000|Treatment|Progressive disease|20|||
146638113|NCT01039519|528850949|FG000|Treatment|Treatment failure|2|||
146638114|NCT01039519|528850949|FG000|Treatment|Adverse Event|3|||
146638115|NCT01039519|528850949|FG000|Treatment|Physician Decision|2|||
146638116|NCT01039519|528850949|FG000|Survival Follow-up|Death|23|||
146638117|NCT01039519|528850949|FG000|Survival Follow-up|Sponsor decision|4|||
146638118|NCT00808080|528850953|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
146638119|NCT00423917|528850954|FG000|Overall Study|Cancel|2|||
146638120|NCT00423917|528850954|FG000|Overall Study|Ineligible|1|||
146638121|NCT00243269|528850955|FG000|Overall Study|Protocol Violation|2|||
146638122|NCT00243269|528850956|FG001|Overall Study|Protocol Violation|1|||
146638123|NCT00243269|528850957|FG002|Overall Study|Protocol Violation|0|||
146638124|NCT00243269|528850958|FG003|Overall Study|Protocol Violation|1|||
146638125|NCT00243269|528850955|FG000|Overall Study|Lost to Follow-up|1|||
146638126|NCT00243269|528850956|FG001|Overall Study|Lost to Follow-up|0|||
146638127|NCT00243269|528850957|FG002|Overall Study|Lost to Follow-up|1|||
146638128|NCT00243269|528850958|FG003|Overall Study|Lost to Follow-up|3|||
146638129|NCT01837823|528850959|FG000|Overall Study|Lost to Follow-up|6|||
146638130|NCT03052400|528850960|FG000|Overall Study|Lost to Follow-up|1|||
146638131|NCT03052400|528850961|FG001|Overall Study|Lost to Follow-up|0|||
146638132|NCT03052400|528850960|FG000|Overall Study|Withdrawal by Subject|0|||
146638133|NCT03052400|528850961|FG001|Overall Study|Withdrawal by Subject|1|||
146638134|NCT00555061|528850962|FG000|Overall Study|Adverse Event|3|||
146638135|NCT00555061|528850962|FG000|Overall Study|Protocol Violation|1|||
146638136|NCT00555061|528850962|FG000|Overall Study|Lost to Follow-up|2|||
146638137|NCT00555061|528850962|FG000|Overall Study|Withdrawal by Subject|2|||
146638138|NCT00555061|528850962|FG000|Overall Study|Participant enrolled, but never treated|1|||
146638139|NCT00337675|528850964|FG000|Overall Study|Adverse Event|10|||
146638140|NCT00337675|528850965|FG001|Overall Study|Adverse Event|9|||
146638141|NCT00337675|528850966|FG002|Overall Study|Adverse Event|19|||
146638142|NCT00337675|528850964|FG000|Overall Study|Lack of Efficacy|10|||
146638143|NCT00337675|528850965|FG001|Overall Study|Lack of Efficacy|7|||
146638144|NCT00337675|528850966|FG002|Overall Study|Lack of Efficacy|9|||
146638145|NCT00337675|528850964|FG000|Overall Study|Lost to Follow-up|22|||
146638146|NCT00337675|528850965|FG001|Overall Study|Lost to Follow-up|19|||
146638147|NCT00337675|528850966|FG002|Overall Study|Lost to Follow-up|17|||
146638148|NCT00337675|528850964|FG000|Overall Study|Physician Decision|9|||
146638149|NCT00337675|528850965|FG001|Overall Study|Physician Decision|17|||
146638150|NCT00337675|528850966|FG002|Overall Study|Physician Decision|14|||
146638151|NCT00337675|528850964|FG000|Overall Study|Protocol Violation|21|||
146638152|NCT00337675|528850965|FG001|Overall Study|Protocol Violation|24|||
146638153|NCT00337675|528850966|FG002|Overall Study|Protocol Violation|19|||
146638154|NCT00337675|528850964|FG000|Overall Study|Withdrawal by Subject|25|||
146638155|NCT00337675|528850965|FG001|Overall Study|Withdrawal by Subject|25|||
146638156|NCT00337675|528850966|FG002|Overall Study|Withdrawal by Subject|19|||
146638157|NCT00337675|528850964|FG000|Overall Study|Progressive Disease|0|||
146638158|NCT00337675|528850965|FG001|Overall Study|Progressive Disease|2|||
146638159|NCT00337675|528850966|FG002|Overall Study|Progressive Disease|0|||
146638160|NCT00337675|528850964|FG000|Overall Study|Trial Terminated|0|||
146766534|NCT02914522|529312257|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
146638161|NCT00337675|528850965|FG001|Overall Study|Trial Terminated|0|||
146638162|NCT00337675|528850966|FG002|Overall Study|Trial Terminated|2|||
146638163|NCT00573144|528850969|FG000|Overall Study|Withdrawal by Subject|2|||
146638164|NCT00573144|528850970|FG001|Overall Study|Withdrawal by Subject|3|||
146638165|NCT00125164|528850975|FG000|Overall Study|Adverse Event|0|||
146638166|NCT00125164|528850976|FG001|Overall Study|Adverse Event|0|||
146638167|NCT00125164|528850977|FG002|Overall Study|Adverse Event|2|||
146968278|NCT03917654|530043950|FG008|Year 2|Subject moved away from site|0|||
146968279|NCT03917654|530043951|FG009|Year 2|Subject moved away from site|2|||
146968280|NCT03917654|530043952|FG010|Year 2|Subject moved away from site|0|||
146968281|NCT03917654|530043953|FG011|Year 2|Subject moved away from site|1|||
146968282|NCT03917654|530043942|FG000|Year 2|Year 2 Screening failure|0|||
146968283|NCT03917654|530043943|FG001|Year 2|Year 2 Screening failure|1|||
146968284|NCT03917654|530043944|FG002|Year 2|Year 2 Screening failure|0|||
146968285|NCT03917654|530043945|FG003|Year 2|Year 2 Screening failure|0|||
146968286|NCT03917654|530043946|FG004|Year 2|Year 2 Screening failure|2|||
146968287|NCT03917654|530043947|FG005|Year 2|Year 2 Screening failure|0|||
146968288|NCT03917654|530043948|FG006|Year 2|Year 2 Screening failure|4|||
146968289|NCT03917654|530043949|FG007|Year 2|Year 2 Screening failure|3|||
146968290|NCT03917654|530043950|FG008|Year 2|Year 2 Screening failure|10|||
146968291|NCT03917654|530043951|FG009|Year 2|Year 2 Screening failure|2|||
146968292|NCT03917654|530043952|FG010|Year 2|Year 2 Screening failure|1|||
146968293|NCT03917654|530043953|FG011|Year 2|Year 2 Screening failure|1|||
146968294|NCT03917654|530043942|FG000|Year 2|Death|0|||
146968295|NCT03917654|530043943|FG001|Year 2|Death|0|||
146968296|NCT03917654|530043944|FG002|Year 2|Death|0|||
146968297|NCT03917654|530043945|FG003|Year 2|Death|0|||
146968298|NCT03917654|530043946|FG004|Year 2|Death|0|||
146968299|NCT03917654|530043947|FG005|Year 2|Death|1|||
146968300|NCT03917654|530043948|FG006|Year 2|Death|0|||
146968301|NCT03917654|530043949|FG007|Year 2|Death|0|||
146638168|NCT00125164|528850978|FG003|Overall Study|Adverse Event|4|||
146638169|NCT00125164|528850975|FG000|Overall Study|Lost to Follow-up|0|||
146638170|NCT00125164|528850976|FG001|Overall Study|Lost to Follow-up|0|||
146638171|NCT00125164|528850977|FG002|Overall Study|Lost to Follow-up|1|||
146638172|NCT00125164|528850978|FG003|Overall Study|Lost to Follow-up|1|||
146638173|NCT00125164|528850975|FG000|Overall Study|Withdrawal by Subject|2|||
146638174|NCT00125164|528850976|FG001|Overall Study|Withdrawal by Subject|0|||
146638175|NCT00125164|528850977|FG002|Overall Study|Withdrawal by Subject|1|||
146638176|NCT00125164|528850978|FG003|Overall Study|Withdrawal by Subject|1|||
146638177|NCT04939415|528850986|FG000|Overall Study|Withdrawal by Subject|1|||
146638178|NCT04939415|528850987|FG001|Overall Study|Withdrawal by Subject|3|||
146638179|NCT04939415|528850986|FG000|Overall Study|Lost to Follow-up|0|||
146638180|NCT04939415|528850987|FG001|Overall Study|Lost to Follow-up|2|||
146638181|NCT04308291|528850988|FG000|Run-In Phase|Withdrawal by Subject|4|||
146638182|NCT04308291|528850988|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
146638183|NCT04308291|528850988|FG000|Study Phase 6-M|Physician Decision|2|||
146638184|NCT04308291|528850988|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
146638185|NCT04308291|528850988|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
146638186|NCT04308291|528850988|FG000|Study Phase 12-M|Physician Decision|2|||
146638187|NCT04308291|528850988|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
146638188|NCT03610269|528850990|FG000|Overall Study|Physician Decision|10|||
146638189|NCT03610269|528850990|FG000|Overall Study|Protocol Violation|1|||
146638190|NCT03610269|528850990|FG000|Overall Study|Unable to draw blood|1|||
146638191|NCT03610269|528850990|FG000|Overall Study|Screen fail|4|||
146638192|NCT00067002|528850993|FG000|Overall Study|Early Death|1|||
146638193|NCT00067002|528850994|FG001|Overall Study|Early Death|2|||
146638194|NCT00067002|528850993|FG000|Overall Study|Delayed|1|||
146638195|NCT00067002|528850994|FG001|Overall Study|Delayed|1|||
146638196|NCT00067002|528850993|FG000|Overall Study|Graft Failure|5|||
146638197|NCT00067002|528850994|FG001|Overall Study|Graft Failure|6|||
146638198|NCT01354314|528850995|FG000|Overall Study|Lost to Follow-up|1|||
146638199|NCT01354314|528850996|FG001|Overall Study|Lost to Follow-up|0|||
146638200|NCT01354314|528850997|FG002|Overall Study|Lost to Follow-up|1|||
146638201|NCT01354314|528850998|FG003|Overall Study|Lost to Follow-up|1|||
146968302|NCT03917654|530043950|FG008|Year 2|Death|1|||
146968303|NCT03917654|530043951|FG009|Year 2|Death|1|||
146968304|NCT03917654|530043952|FG010|Year 2|Death|0|||
146968305|NCT03917654|530043953|FG011|Year 2|Death|0|||
146968306|NCT03917654|530043942|FG000|Year 2|Withdrawal by Subject|0|||
146968307|NCT03917654|530043943|FG001|Year 2|Withdrawal by Subject|0|||
146968308|NCT03917654|530043944|FG002|Year 2|Withdrawal by Subject|0|||
146968309|NCT03917654|530043945|FG003|Year 2|Withdrawal by Subject|0|||
146638202|NCT01354314|528850995|FG000|Overall Study|Withdrawal by Subject|0|||
146638203|NCT01354314|528850996|FG001|Overall Study|Withdrawal by Subject|0|||
146638204|NCT01354314|528850997|FG002|Overall Study|Withdrawal by Subject|1|||
146638205|NCT01354314|528850998|FG003|Overall Study|Withdrawal by Subject|0|||
146638206|NCT01354314|528850995|FG000|Overall Study|Adverse Event|0|||
146638207|NCT01354314|528850996|FG001|Overall Study|Adverse Event|0|||
146638208|NCT01354314|528850997|FG002|Overall Study|Adverse Event|0|||
146968310|NCT03917654|530043946|FG004|Year 2|Withdrawal by Subject|0|||
146638209|NCT01354314|528850998|FG003|Overall Study|Adverse Event|1|||
146968311|NCT03917654|530043947|FG005|Year 2|Withdrawal by Subject|0|||
146968312|NCT03917654|530043948|FG006|Year 2|Withdrawal by Subject|3|||
146968313|NCT03917654|530043949|FG007|Year 2|Withdrawal by Subject|0|||
146968314|NCT03917654|530043950|FG008|Year 2|Withdrawal by Subject|2|||
146968315|NCT03917654|530043951|FG009|Year 2|Withdrawal by Subject|5|||
146968316|NCT03917654|530043952|FG010|Year 2|Withdrawal by Subject|0|||
146968317|NCT03917654|530043953|FG011|Year 2|Withdrawal by Subject|0|||
146968318|NCT03917654|530043942|FG000|Year 2|Spouse/family member request|0|||
146968319|NCT03917654|530043943|FG001|Year 2|Spouse/family member request|0|||
146968320|NCT03917654|530043944|FG002|Year 2|Spouse/family member request|0|||
146968321|NCT03917654|530043945|FG003|Year 2|Spouse/family member request|0|||
146968322|NCT03917654|530043946|FG004|Year 2|Spouse/family member request|0|||
146968323|NCT03917654|530043947|FG005|Year 2|Spouse/family member request|0|||
146968324|NCT03917654|530043948|FG006|Year 2|Spouse/family member request|1|||
146968325|NCT03917654|530043949|FG007|Year 2|Spouse/family member request|0|||
146968326|NCT03917654|530043950|FG008|Year 2|Spouse/family member request|0|||
146968327|NCT03917654|530043951|FG009|Year 2|Spouse/family member request|0|||
146968328|NCT03917654|530043952|FG010|Year 2|Spouse/family member request|0|||
146968329|NCT03917654|530043953|FG011|Year 2|Spouse/family member request|0|||
146968330|NCT03917654|530043942|FG000|Year 2|Lost to Follow-up|0|||
146968331|NCT03917654|530043943|FG001|Year 2|Lost to Follow-up|0|||
146968332|NCT03917654|530043944|FG002|Year 2|Lost to Follow-up|0|||
146968333|NCT03917654|530043945|FG003|Year 2|Lost to Follow-up|0|||
146968334|NCT03917654|530043946|FG004|Year 2|Lost to Follow-up|0|||
146968335|NCT03917654|530043947|FG005|Year 2|Lost to Follow-up|0|||
146968336|NCT03917654|530043948|FG006|Year 2|Lost to Follow-up|1|||
146968337|NCT03917654|530043949|FG007|Year 2|Lost to Follow-up|0|||
146968338|NCT03917654|530043950|FG008|Year 2|Lost to Follow-up|1|||
146968339|NCT03917654|530043951|FG009|Year 2|Lost to Follow-up|0|||
146968340|NCT03917654|530043952|FG010|Year 2|Lost to Follow-up|0|||
146968341|NCT03917654|530043953|FG011|Year 2|Lost to Follow-up|1|||
146968342|NCT03917654|530043942|FG000|Year 2|Adverse Event|0|||
146968343|NCT03917654|530043943|FG001|Year 2|Adverse Event|0|||
146968344|NCT03917654|530043944|FG002|Year 2|Adverse Event|0|||
146968345|NCT03917654|530043945|FG003|Year 2|Adverse Event|0|||
146968346|NCT03917654|530043946|FG004|Year 2|Adverse Event|0|||
146968347|NCT03917654|530043947|FG005|Year 2|Adverse Event|0|||
146968348|NCT03917654|530043948|FG006|Year 2|Adverse Event|0|||
146968349|NCT03917654|530043949|FG007|Year 2|Adverse Event|0|||
146968350|NCT03917654|530043950|FG008|Year 2|Adverse Event|0|||
146968351|NCT03917654|530043951|FG009|Year 2|Adverse Event|1|||
146968352|NCT03917654|530043952|FG010|Year 2|Adverse Event|0|||
146968353|NCT03917654|530043953|FG011|Year 2|Adverse Event|0|||
146968354|NCT02255422|530043954|FG000|Overall Study|Withdrawal by Subject|0|||
146968355|NCT02255422|530043955|FG001|Overall Study|Withdrawal by Subject|0|||
146968356|NCT02255422|530043956|FG002|Overall Study|Withdrawal by Subject|0|||
146968357|NCT02255422|530043957|FG003|Overall Study|Withdrawal by Subject|0|||
146968358|NCT02255422|530043958|FG004|Overall Study|Withdrawal by Subject|0|||
146968359|NCT02255422|530043959|FG005|Overall Study|Withdrawal by Subject|0|||
146968360|NCT02255422|530043960|FG006|Overall Study|Withdrawal by Subject|2|||
146968361|NCT02255422|530043954|FG000|Overall Study|Lost to Follow-up|0|||
146968362|NCT02255422|530043955|FG001|Overall Study|Lost to Follow-up|0|||
146968363|NCT02255422|530043956|FG002|Overall Study|Lost to Follow-up|1|||
146968364|NCT02255422|530043957|FG003|Overall Study|Lost to Follow-up|0|||
146968365|NCT02255422|530043958|FG004|Overall Study|Lost to Follow-up|0|||
146968366|NCT02255422|530043959|FG005|Overall Study|Lost to Follow-up|0|||
146968367|NCT02255422|530043960|FG006|Overall Study|Lost to Follow-up|0|||
146968368|NCT00602667|530043961|FG000|Overall Study|Still on Therapy|0|||
146968369|NCT00602667|530043962|FG001|Overall Study|Still on Therapy|2|||
146968370|NCT00602667|530043963|FG002|Overall Study|Still on Therapy|2|||
146968371|NCT00602667|530043961|FG000|Overall Study|Death|0|||
146968372|NCT00602667|530043962|FG001|Overall Study|Death|1|||
146968373|NCT00602667|530043963|FG002|Overall Study|Death|1|||
146968374|NCT00602667|530043961|FG000|Overall Study|Family request|3|||
146968375|NCT00602667|530043962|FG001|Overall Study|Family request|25|||
146968376|NCT00602667|530043963|FG002|Overall Study|Family request|6|||
146968377|NCT00602667|530043961|FG000|Overall Study|Excessive toxicity|1|||
146968378|NCT00602667|530043962|FG001|Overall Study|Excessive toxicity|1|||
146968379|NCT00602667|530043963|FG002|Overall Study|Excessive toxicity|0|||
146968380|NCT00602667|530043961|FG000|Overall Study|Second malignancy|0|||
146968381|NCT00602667|530043962|FG001|Overall Study|Second malignancy|1|||
146968382|NCT00602667|530043963|FG002|Overall Study|Second malignancy|0|||
146968383|NCT00602667|530043961|FG000|Overall Study|Physician Decision|2|||
146968384|NCT00602667|530043962|FG001|Overall Study|Physician Decision|3|||
146968385|NCT00602667|530043963|FG002|Overall Study|Physician Decision|8|||
146968386|NCT00602667|530043961|FG000|Overall Study|Progressive disease|13|||
146968387|NCT00602667|530043962|FG001|Overall Study|Progressive disease|48|||
146968388|NCT00602667|530043963|FG002|Overall Study|Progressive disease|45|||
146968389|NCT00602667|530043961|FG000|Overall Study|Progressive disease prior to therapy|0|||
146968390|NCT00602667|530043962|FG001|Overall Study|Progressive disease prior to therapy|0|||
146968391|NCT00602667|530043963|FG002|Overall Study|Progressive disease prior to therapy|1|||
146968392|NCT03179462|530043969|FG000|Overall Study|screening failure|1|||
146968393|NCT03179462|530043970|FG001|Overall Study|screening failure|2|||
146968394|NCT03179462|530043971|FG002|Overall Study|screening failure|0|||
146968395|NCT04636437|530043972|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
146968396|NCT04636437|530043973|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
146968397|NCT04636437|530043974|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
146968398|NCT04636437|530043972|FG000|Overall Study|Started weight loss drug/program|2|||
146968399|NCT04636437|530043973|FG001|Overall Study|Started weight loss drug/program|1|||
146968400|NCT04636437|530043974|FG002|Overall Study|Started weight loss drug/program|1|||
146968401|NCT04636437|530043972|FG000|Overall Study|Lost to Follow-up|3|||
146968402|NCT04636437|530043973|FG001|Overall Study|Lost to Follow-up|1|||
146968403|NCT04636437|530043974|FG002|Overall Study|Lost to Follow-up|4|||
146968404|NCT04636437|530043972|FG000|Overall Study|Participant or physician decision|3|||
146968405|NCT04636437|530043973|FG001|Overall Study|Participant or physician decision|1|||
146968406|NCT04636437|530043974|FG002|Overall Study|Participant or physician decision|1|||
146968407|NCT00816166|530043978|FG000|Overall Study|Lost to Follow-up|6|||
146968408|NCT00816166|530043979|FG001|Overall Study|Lost to Follow-up|10|||
146968409|NCT00816166|530043978|FG000|Overall Study|Death|4|||
146968410|NCT00816166|530043979|FG001|Overall Study|Death|2|||
146968411|NCT02851069|530043980|FG000|Overall Study|Failure to Return|3|||
146968412|NCT02851069|530043980|FG000|Overall Study|Other|3|||
146968413|NCT02146365|530043981|FG000|Overall Study|Lost to Follow-up|2|||
146968414|NCT02146365|530043982|FG001|Overall Study|Lost to Follow-up|1|||
146968415|NCT02146365|530043983|FG002|Overall Study|Lost to Follow-up|3|||
146968416|NCT02146365|530043984|FG003|Overall Study|Lost to Follow-up|3|||
146968417|NCT02146365|530043985|FG004|Overall Study|Lost to Follow-up|1|||
146558626|NCT03768336|528555860|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
146558627|NCT03768336|528555861|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
146558628|NCT03768336|528555860|FG000|Overall Study|Missed final survey (post-treatment|0|||
146558629|NCT03768336|528555861|FG001|Overall Study|Missed final survey (post-treatment|1|||
146558630|NCT06790303|528555862|FG000|Overall Study|Study Terminated by sponsor|4|||
146558631|NCT06790303|528555862|FG000|Overall Study|Death|4|||
146558632|NCT00500331|528555865|FG000|Overall Study|Adverse Event|0|||
146558633|NCT00500331|528555866|FG001|Overall Study|Adverse Event|2|||
146638210|NCT01354314|528850995|FG000|Overall Study|Protocol Violation|1|||
146638211|NCT01354314|528850996|FG001|Overall Study|Protocol Violation|1|||
146638212|NCT01354314|528850997|FG002|Overall Study|Protocol Violation|0|||
146638213|NCT01354314|528850998|FG003|Overall Study|Protocol Violation|0|||
146638214|NCT01354314|528850995|FG000|Overall Study|Less than 90% Adherence|4|||
146968418|NCT02146365|530043986|FG005|Overall Study|Lost to Follow-up|1|||
146968419|NCT02146365|530043987|FG006|Overall Study|Lost to Follow-up|0|||
146968420|NCT02146365|530043988|FG007|Overall Study|Lost to Follow-up|1|||
146968421|NCT02146365|530043981|FG000|Overall Study|Withdrawal by Subject|1|||
146968422|NCT02146365|530043982|FG001|Overall Study|Withdrawal by Subject|2|||
146558634|NCT00500331|528555867|FG002|Overall Study|Adverse Event|0|||
146558635|NCT00500331|528555868|FG003|Overall Study|Adverse Event|1|||
146638215|NCT01354314|528850996|FG001|Overall Study|Less than 90% Adherence|2|||
146968423|NCT02146365|530043983|FG002|Overall Study|Withdrawal by Subject|1|||
146968424|NCT02146365|530043984|FG003|Overall Study|Withdrawal by Subject|5|||
146968425|NCT02146365|530043985|FG004|Overall Study|Withdrawal by Subject|1|||
146968426|NCT02146365|530043986|FG005|Overall Study|Withdrawal by Subject|0|||
146558636|NCT00500331|528555869|FG004|Overall Study|Adverse Event|2|||
146638216|NCT01354314|528850997|FG002|Overall Study|Less than 90% Adherence|6|||
146638217|NCT01354314|528850998|FG003|Overall Study|Less than 90% Adherence|4|||
146968427|NCT02146365|530043987|FG006|Overall Study|Withdrawal by Subject|0|||
146638218|NCT00478023|528850999|FG000|Overall Study|Adverse Event|11|||
146638219|NCT00478023|528851000|FG001|Overall Study|Adverse Event|7|||
146638220|NCT00478023|528851001|FG002|Overall Study|Adverse Event|8|||
146638221|NCT00478023|528851002|FG003|Overall Study|Adverse Event|14|||
146638222|NCT00478023|528851003|FG004|Overall Study|Adverse Event|6|||
146638223|NCT00478023|528850999|FG000|Overall Study|Death|1|||
146638224|NCT00478023|528851000|FG001|Overall Study|Death|0|||
146638225|NCT00478023|528851001|FG002|Overall Study|Death|0|||
146638226|NCT00478023|528851002|FG003|Overall Study|Death|0|||
146638227|NCT00478023|528851003|FG004|Overall Study|Death|0|||
146638228|NCT00478023|528850999|FG000|Overall Study|Lack of Efficacy|11|||
146638229|NCT00478023|528851000|FG001|Overall Study|Lack of Efficacy|10|||
146638230|NCT00478023|528851001|FG002|Overall Study|Lack of Efficacy|4|||
146638231|NCT00478023|528851002|FG003|Overall Study|Lack of Efficacy|5|||
146638232|NCT00478023|528851003|FG004|Overall Study|Lack of Efficacy|41|||
146638233|NCT00478023|528850999|FG000|Overall Study|Lost to Follow-up|3|||
146638234|NCT00478023|528851000|FG001|Overall Study|Lost to Follow-up|1|||
146638235|NCT00478023|528851001|FG002|Overall Study|Lost to Follow-up|1|||
146638236|NCT00478023|528851002|FG003|Overall Study|Lost to Follow-up|1|||
146638237|NCT00478023|528851003|FG004|Overall Study|Lost to Follow-up|0|||
146638238|NCT00478023|528850999|FG000|Overall Study|Withdrawal by Subject|2|||
146638239|NCT00478023|528851000|FG001|Overall Study|Withdrawal by Subject|3|||
146638240|NCT00478023|528851001|FG002|Overall Study|Withdrawal by Subject|2|||
146638241|NCT00478023|528851002|FG003|Overall Study|Withdrawal by Subject|4|||
146638242|NCT00478023|528851003|FG004|Overall Study|Withdrawal by Subject|5|||
146638243|NCT00478023|528850999|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
146638244|NCT00478023|528851000|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
146638245|NCT00478023|528851001|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
146638246|NCT00478023|528851002|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
146638247|NCT00478023|528851003|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
146638248|NCT05019521|528851007|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
146638249|NCT05019521|528851008|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
146638250|NCT05019521|528851009|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
146638251|NCT05019521|528851010|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
146638252|NCT05019521|528851011|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
146638253|NCT05019521|528851012|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
146638254|NCT05019521|528851013|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
146638255|NCT05019521|528851007|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
146638256|NCT05019521|528851008|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
146638257|NCT05019521|528851009|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
146638258|NCT05019521|528851010|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
146638259|NCT05019521|528851011|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
146638260|NCT05019521|528851012|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
146638261|NCT05019521|528851013|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
146638262|NCT05019521|528851007|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
146638263|NCT05019521|528851008|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
146638264|NCT05019521|528851009|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
146638265|NCT05019521|528851010|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
146638266|NCT05019521|528851011|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
146638267|NCT05019521|528851012|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
146638268|NCT05019521|528851013|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
146638269|NCT05019521|528851007|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
146638270|NCT05019521|528851008|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
146638271|NCT05019521|528851009|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
146638272|NCT05019521|528851010|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
146638273|NCT05019521|528851011|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
146638274|NCT05019521|528851012|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
146638275|NCT05019521|528851013|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
146638276|NCT05019521|528851007|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
146638277|NCT05019521|528851008|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
146638278|NCT05019521|528851009|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
146638279|NCT05019521|528851010|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
146558637|NCT00500331|528555870|FG005|Overall Study|Adverse Event|2|||
146558638|NCT00500331|528555871|FG006|Overall Study|Adverse Event|0|||
146558639|NCT00500331|528555865|FG000|Overall Study|Lost to Follow-up|1|||
146558640|NCT00500331|528555866|FG001|Overall Study|Lost to Follow-up|1|||
146558641|NCT00500331|528555867|FG002|Overall Study|Lost to Follow-up|1|||
146558642|NCT00500331|528555868|FG003|Overall Study|Lost to Follow-up|2|||
146558643|NCT00500331|528555869|FG004|Overall Study|Lost to Follow-up|1|||
146558644|NCT00500331|528555870|FG005|Overall Study|Lost to Follow-up|0|||
146558645|NCT00500331|528555871|FG006|Overall Study|Lost to Follow-up|0|||
146558646|NCT00500331|528555865|FG000|Overall Study|Protocol Violation|3|||
146558647|NCT00500331|528555866|FG001|Overall Study|Protocol Violation|1|||
146558648|NCT00500331|528555867|FG002|Overall Study|Protocol Violation|1|||
146558649|NCT00500331|528555868|FG003|Overall Study|Protocol Violation|0|||
146558650|NCT00500331|528555869|FG004|Overall Study|Protocol Violation|1|||
146558651|NCT00500331|528555870|FG005|Overall Study|Protocol Violation|1|||
146558652|NCT00500331|528555871|FG006|Overall Study|Protocol Violation|1|||
146558653|NCT00500331|528555865|FG000|Overall Study|Withdrawal by Subject|4|||
146638280|NCT05019521|528851011|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
146638281|NCT05019521|528851012|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
146638282|NCT05019521|528851013|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
146638283|NCT05019521|528851007|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
146638284|NCT05019521|528851008|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146638285|NCT05019521|528851009|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146638286|NCT05019521|528851010|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146638287|NCT05019521|528851011|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146638288|NCT05019521|528851012|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146638289|NCT05019521|528851013|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146638290|NCT05019521|528851007|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
146638291|NCT05019521|528851008|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
146638292|NCT05019521|528851009|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
146638293|NCT05019521|528851010|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
146638294|NCT05019521|528851011|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
146638295|NCT05019521|528851012|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
146638296|NCT05019521|528851013|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
146638297|NCT05019521|528851007|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
146638298|NCT05019521|528851008|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
146638299|NCT05019521|528851009|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
146638300|NCT05019521|528851010|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
146638301|NCT05019521|528851011|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
146638302|NCT05019521|528851012|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
146638303|NCT05019521|528851013|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
146638304|NCT05019521|528851007|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
146638305|NCT05019521|528851008|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
146638306|NCT05019521|528851009|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
146638307|NCT05019521|528851010|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
146638308|NCT05019521|528851011|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
146638309|NCT05019521|528851012|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
146638310|NCT05019521|528851013|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
146894297|NCT00849017|529779743|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
146894298|NCT00849017|529779744|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
146894299|NCT00849017|529779745|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
146894300|NCT00849017|529779743|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
146894301|NCT00849017|529779744|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
146894302|NCT00849017|529779745|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
146894303|NCT00849017|529779743|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
146894304|NCT00849017|529779744|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
146894305|NCT00849017|529779745|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
146894306|NCT00849017|529779743|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
146894307|NCT00849017|529779744|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
146894308|NCT00849017|529779745|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
146894309|NCT00849017|529779743|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
146894310|NCT00849017|529779744|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
146894311|NCT00849017|529779745|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
146894312|NCT00849017|529779743|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
146894313|NCT00849017|529779744|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
146894314|NCT00849017|529779745|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
146894315|NCT00214461|529779746|FG000|Overall Study|Adverse Event|0|||
146894316|NCT00214461|529779747|FG001|Overall Study|Adverse Event|0|||
146894317|NCT00214461|529779748|FG002|Overall Study|Adverse Event|1|||
146894318|NCT00214461|529779749|FG003|Overall Study|Adverse Event|1|||
146894319|NCT00214461|529779746|FG000|Overall Study|Withdrawal by Subject|0|||
146894320|NCT00214461|529779747|FG001|Overall Study|Withdrawal by Subject|0|||
146558654|NCT00500331|528555866|FG001|Overall Study|Withdrawal by Subject|0|||
146558655|NCT00500331|528555867|FG002|Overall Study|Withdrawal by Subject|1|||
146968428|NCT02146365|530043988|FG007|Overall Study|Withdrawal by Subject|0|||
146968429|NCT02146365|530043981|FG000|Overall Study|Unable to Comply with Protocol|0|||
146968430|NCT02146365|530043982|FG001|Overall Study|Unable to Comply with Protocol|1|||
146968431|NCT02146365|530043983|FG002|Overall Study|Unable to Comply with Protocol|1|||
146968432|NCT02146365|530043984|FG003|Overall Study|Unable to Comply with Protocol|0|||
146968433|NCT02146365|530043985|FG004|Overall Study|Unable to Comply with Protocol|0|||
146968434|NCT02146365|530043986|FG005|Overall Study|Unable to Comply with Protocol|0|||
146968435|NCT02146365|530043987|FG006|Overall Study|Unable to Comply with Protocol|0|||
146968436|NCT02146365|530043988|FG007|Overall Study|Unable to Comply with Protocol|0|||
146968437|NCT02146365|530043981|FG000|Overall Study|Other|1|||
146968438|NCT02146365|530043982|FG001|Overall Study|Other|0|||
146968439|NCT02146365|530043983|FG002|Overall Study|Other|2|||
146968440|NCT02146365|530043984|FG003|Overall Study|Other|1|||
146968441|NCT02146365|530043985|FG004|Overall Study|Other|0|||
146968442|NCT02146365|530043986|FG005|Overall Study|Other|0|||
146968443|NCT02146365|530043987|FG006|Overall Study|Other|0|||
146968444|NCT02146365|530043988|FG007|Overall Study|Other|0|||
146968445|NCT03222856|530043989|FG000|Overall Study|Adverse Event|6|||
146968446|NCT03222856|530043989|FG000|Overall Study|Death|1|||
146968447|NCT00648739|530045441|FG000|Overall Study|Adverse Event|1|||
146968448|NCT00648739|530045442|FG001|Overall Study|Adverse Event|0|||
146968449|NCT00648739|530045443|FG002|Overall Study|Adverse Event|1|||
146968450|NCT00648739|530045444|FG003|Overall Study|Adverse Event|2|||
146968451|NCT00648739|530045445|FG004|Overall Study|Adverse Event|1|||
146968452|NCT00648739|530045446|FG005|Overall Study|Adverse Event|0|||
146968453|NCT00648739|530045447|FG006|Overall Study|Adverse Event|0|||
146968454|NCT00648739|530045441|FG000|Overall Study|Withdrawal by Subject|1|||
146968455|NCT00648739|530045442|FG001|Overall Study|Withdrawal by Subject|0|||
146968456|NCT00648739|530045443|FG002|Overall Study|Withdrawal by Subject|1|||
146968457|NCT00648739|530045444|FG003|Overall Study|Withdrawal by Subject|0|||
146968458|NCT00648739|530045445|FG004|Overall Study|Withdrawal by Subject|0|||
146968459|NCT00648739|530045446|FG005|Overall Study|Withdrawal by Subject|2|||
146968460|NCT00648739|530045447|FG006|Overall Study|Withdrawal by Subject|0|||
146968461|NCT00648739|530045441|FG000|Overall Study|Lack of Efficacy|0|||
146968462|NCT00648739|530045442|FG001|Overall Study|Lack of Efficacy|0|||
146968463|NCT00648739|530045443|FG002|Overall Study|Lack of Efficacy|0|||
146968464|NCT00648739|530045444|FG003|Overall Study|Lack of Efficacy|0|||
146968465|NCT00648739|530045445|FG004|Overall Study|Lack of Efficacy|1|||
146968466|NCT00648739|530045446|FG005|Overall Study|Lack of Efficacy|2|||
146968467|NCT00648739|530045447|FG006|Overall Study|Lack of Efficacy|0|||
146968468|NCT00648739|530045441|FG000|Overall Study|Investigator Considered it Advisable|0|||
146968469|NCT00648739|530045442|FG001|Overall Study|Investigator Considered it Advisable|0|||
146968470|NCT00648739|530045443|FG002|Overall Study|Investigator Considered it Advisable|0|||
146968471|NCT00648739|530045444|FG003|Overall Study|Investigator Considered it Advisable|0|||
146968472|NCT00648739|530045445|FG004|Overall Study|Investigator Considered it Advisable|0|||
146968473|NCT00648739|530045446|FG005|Overall Study|Investigator Considered it Advisable|1|||
146770137|NCT00818454|529327377|FG000|Washout Period of 1 Week|Protocol Violation|2|||
146968474|NCT00648739|530045447|FG006|Overall Study|Investigator Considered it Advisable|1|||
146968475|NCT00648739|530045441|FG000|Overall Study|Death|0|||
146968476|NCT00648739|530045442|FG001|Overall Study|Death|1|||
146968477|NCT00648739|530045443|FG002|Overall Study|Death|0|||
146894321|NCT00214461|529779748|FG002|Overall Study|Withdrawal by Subject|1|||
146894322|NCT00214461|529779749|FG003|Overall Study|Withdrawal by Subject|0|||
146894323|NCT02913313|529779750|FG000|Overall Study|DISEASE PROGRESSION|1|||
146894324|NCT02913313|529779751|FG001|Overall Study|DISEASE PROGRESSION|2|||
146894325|NCT02913313|529779752|FG002|Overall Study|DISEASE PROGRESSION|2|||
146894326|NCT02913313|529779753|FG003|Overall Study|DISEASE PROGRESSION|4|||
146894327|NCT02913313|529779754|FG004|Overall Study|DISEASE PROGRESSION|6|||
146894328|NCT02913313|529779755|FG005|Overall Study|DISEASE PROGRESSION|4|||
146894329|NCT02913313|529779756|FG006|Overall Study|DISEASE PROGRESSION|19|||
146894330|NCT02913313|529779757|FG007|Overall Study|DISEASE PROGRESSION|3|||
146894331|NCT02913313|529779758|FG008|Overall Study|DISEASE PROGRESSION|4|||
146894332|NCT02913313|529779759|FG009|Overall Study|DISEASE PROGRESSION|4|||
146894333|NCT02913313|529779760|FG010|Overall Study|DISEASE PROGRESSION|11|||
146894334|NCT02913313|529779761|FG011|Overall Study|DISEASE PROGRESSION|5|||
146894335|NCT02913313|529779762|FG012|Overall Study|DISEASE PROGRESSION|14|||
146894336|NCT02913313|529779763|FG013|Overall Study|DISEASE PROGRESSION|3|||
146894337|NCT02913313|529779750|FG000|Overall Study|Not Reported|0|||
146894338|NCT02913313|529779751|FG001|Overall Study|Not Reported|0|||
146894339|NCT02913313|529779752|FG002|Overall Study|Not Reported|0|||
146894340|NCT02913313|529779753|FG003|Overall Study|Not Reported|0|||
146894341|NCT02913313|529779754|FG004|Overall Study|Not Reported|1|||
146894342|NCT02913313|529779755|FG005|Overall Study|Not Reported|0|||
146894343|NCT02913313|529779756|FG006|Overall Study|Not Reported|0|||
146894344|NCT02913313|529779757|FG007|Overall Study|Not Reported|0|||
146894345|NCT02913313|529779758|FG008|Overall Study|Not Reported|0|||
146894346|NCT02913313|529779759|FG009|Overall Study|Not Reported|0|||
146894347|NCT02913313|529779760|FG010|Overall Study|Not Reported|4|||
146894348|NCT02913313|529779761|FG011|Overall Study|Not Reported|0|||
146894349|NCT02913313|529779762|FG012|Overall Study|Not Reported|0|||
146894350|NCT02913313|529779763|FG013|Overall Study|Not Reported|0|||
146894351|NCT02913313|529779750|FG000|Overall Study|Other reasons|0|||
146894352|NCT02913313|529779751|FG001|Overall Study|Other reasons|0|||
146558656|NCT00500331|528555868|FG003|Overall Study|Withdrawal by Subject|5|||
146558657|NCT00500331|528555869|FG004|Overall Study|Withdrawal by Subject|0|||
146558658|NCT00500331|528555870|FG005|Overall Study|Withdrawal by Subject|1|||
146558659|NCT00500331|528555871|FG006|Overall Study|Withdrawal by Subject|1|||
146558660|NCT00500331|528555865|FG000|Overall Study|Lack of Efficacy|3|||
146558661|NCT00500331|528555866|FG001|Overall Study|Lack of Efficacy|1|||
146558662|NCT00500331|528555867|FG002|Overall Study|Lack of Efficacy|0|||
146558663|NCT00500331|528555868|FG003|Overall Study|Lack of Efficacy|0|||
146558664|NCT00500331|528555869|FG004|Overall Study|Lack of Efficacy|0|||
146558665|NCT00500331|528555870|FG005|Overall Study|Lack of Efficacy|0|||
146558666|NCT00500331|528555871|FG006|Overall Study|Lack of Efficacy|0|||
146558667|NCT00500331|528555865|FG000|Overall Study|Liver function test abnormality|0|||
146558668|NCT00500331|528555866|FG001|Overall Study|Liver function test abnormality|0|||
146558669|NCT00500331|528555867|FG002|Overall Study|Liver function test abnormality|1|||
146558670|NCT00500331|528555868|FG003|Overall Study|Liver function test abnormality|0|||
146558671|NCT00500331|528555869|FG004|Overall Study|Liver function test abnormality|0|||
146558672|NCT00500331|528555870|FG005|Overall Study|Liver function test abnormality|0|||
146558673|NCT00500331|528555871|FG006|Overall Study|Liver function test abnormality|0|||
146558674|NCT00500331|528555865|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
146894353|NCT02913313|529779752|FG002|Overall Study|Other reasons|0|||
146894354|NCT02913313|529779753|FG003|Overall Study|Other reasons|0|||
146894355|NCT02913313|529779754|FG004|Overall Study|Other reasons|1|||
146894356|NCT02913313|529779755|FG005|Overall Study|Other reasons|0|||
146894357|NCT02913313|529779756|FG006|Overall Study|Other reasons|0|||
146558675|NCT00500331|528555866|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
146558676|NCT00500331|528555867|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
146894358|NCT02913313|529779757|FG007|Overall Study|Other reasons|0|||
146894359|NCT02913313|529779758|FG008|Overall Study|Other reasons|0|||
146894360|NCT02913313|529779759|FG009|Overall Study|Other reasons|0|||
146894361|NCT02913313|529779760|FG010|Overall Study|Other reasons|1|||
146894362|NCT02913313|529779761|FG011|Overall Study|Other reasons|0|||
146894363|NCT02913313|529779762|FG012|Overall Study|Other reasons|0|||
146894364|NCT02913313|529779763|FG013|Overall Study|Other reasons|0|||
146894365|NCT02913313|529779750|FG000|Overall Study|Withdrawal by Subject|0|||
146894366|NCT02913313|529779751|FG001|Overall Study|Withdrawal by Subject|0|||
146894367|NCT02913313|529779752|FG002|Overall Study|Withdrawal by Subject|1|||
146894368|NCT02913313|529779753|FG003|Overall Study|Withdrawal by Subject|0|||
146894369|NCT02913313|529779754|FG004|Overall Study|Withdrawal by Subject|0|||
146894370|NCT02913313|529779755|FG005|Overall Study|Withdrawal by Subject|0|||
146894371|NCT02913313|529779756|FG006|Overall Study|Withdrawal by Subject|1|||
146894372|NCT02913313|529779757|FG007|Overall Study|Withdrawal by Subject|1|||
146894373|NCT02913313|529779758|FG008|Overall Study|Withdrawal by Subject|0|||
146894374|NCT02913313|529779759|FG009|Overall Study|Withdrawal by Subject|0|||
146894375|NCT02913313|529779760|FG010|Overall Study|Withdrawal by Subject|1|||
146894376|NCT02913313|529779761|FG011|Overall Study|Withdrawal by Subject|0|||
146894377|NCT02913313|529779762|FG012|Overall Study|Withdrawal by Subject|0|||
146894378|NCT02913313|529779763|FG013|Overall Study|Withdrawal by Subject|0|||
146894379|NCT02913313|529779750|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146894380|NCT02913313|529779751|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146894381|NCT02913313|529779752|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146894382|NCT02913313|529779753|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146894383|NCT02913313|529779754|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146894384|NCT02913313|529779755|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146894385|NCT02913313|529779756|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146894386|NCT02913313|529779757|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146894387|NCT02913313|529779758|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146894388|NCT02913313|529779759|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146894389|NCT02913313|529779760|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
146894390|NCT02913313|529779761|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146894391|NCT02913313|529779762|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
146894392|NCT02913313|529779763|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
146894393|NCT02913313|529779750|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
146638311|NCT05019521|528851007|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
146638312|NCT05019521|528851008|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
146638313|NCT05019521|528851009|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
146638314|NCT05019521|528851010|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
146638315|NCT05019521|528851011|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
146638316|NCT05019521|528851012|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
146638317|NCT05019521|528851013|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
146638318|NCT05019521|528851007|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
146638319|NCT05019521|528851008|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
146638320|NCT05019521|528851009|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
146638321|NCT05019521|528851010|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
146638322|NCT05019521|528851011|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
146638323|NCT05019521|528851012|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
146638324|NCT05019521|528851013|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
146638325|NCT05019521|528851007|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
146894394|NCT02913313|529779751|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
146894395|NCT02913313|529779752|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
146894396|NCT02913313|529779753|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
146894397|NCT02913313|529779754|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
146894398|NCT02913313|529779755|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
146894399|NCT02913313|529779756|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
146894400|NCT02913313|529779757|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
146894401|NCT02913313|529779758|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
146638326|NCT05019521|528851008|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
146638327|NCT05019521|528851009|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
146638328|NCT05019521|528851010|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
146638329|NCT05019521|528851011|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
146638330|NCT05019521|528851012|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
146638331|NCT05019521|528851013|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
146638332|NCT05019521|528851007|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146638333|NCT05019521|528851008|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146638334|NCT05019521|528851009|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146638335|NCT05019521|528851010|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146638336|NCT05019521|528851011|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146638337|NCT05019521|528851012|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
146638338|NCT05019521|528851013|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146638339|NCT05019521|528851007|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
146638340|NCT05019521|528851008|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
146638341|NCT05019521|528851009|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
146638342|NCT05019521|528851010|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
146638343|NCT05019521|528851011|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
146638344|NCT05019521|528851012|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
146638345|NCT05019521|528851013|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
146638346|NCT05019521|528851007|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
146638347|NCT05019521|528851008|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
146638348|NCT05019521|528851009|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
146638349|NCT05019521|528851010|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
146638350|NCT05019521|528851011|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
146638351|NCT05019521|528851012|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
146638352|NCT05019521|528851013|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
146638353|NCT02453711|528851014|FG000|Overall Study|Withdrawal by Subject|5|||
146638354|NCT02453711|528851015|FG001|Overall Study|Withdrawal by Subject|4|||
146638355|NCT02453711|528851016|FG002|Overall Study|Withdrawal by Subject|6|||
146638356|NCT02453711|528851017|FG003|Overall Study|Withdrawal by Subject|4|||
146638357|NCT02453711|528851018|FG004|Overall Study|Withdrawal by Subject|1|||
146638358|NCT02453711|528851019|FG005|Overall Study|Withdrawal by Subject|1|||
146638359|NCT02453711|528851020|FG006|Overall Study|Withdrawal by Subject|0|||
146638360|NCT02453711|528851021|FG007|Overall Study|Withdrawal by Subject|1|||
146638361|NCT02453711|528851022|FG008|Overall Study|Withdrawal by Subject|7|||
146638362|NCT02453711|528851014|FG000|Overall Study|Lost to Follow-up|5|||
146638363|NCT02453711|528851015|FG001|Overall Study|Lost to Follow-up|3|||
146638364|NCT02453711|528851016|FG002|Overall Study|Lost to Follow-up|2|||
146638365|NCT02453711|528851017|FG003|Overall Study|Lost to Follow-up|3|||
146638366|NCT02453711|528851018|FG004|Overall Study|Lost to Follow-up|1|||
146638367|NCT02453711|528851019|FG005|Overall Study|Lost to Follow-up|5|||
146638368|NCT02453711|528851020|FG006|Overall Study|Lost to Follow-up|2|||
146638369|NCT02453711|528851021|FG007|Overall Study|Lost to Follow-up|6|||
146638370|NCT02453711|528851022|FG008|Overall Study|Lost to Follow-up|6|||
146638371|NCT02453711|528851014|FG000|Overall Study|Death|0|||
146638372|NCT02453711|528851015|FG001|Overall Study|Death|0|||
146638373|NCT02453711|528851016|FG002|Overall Study|Death|0|||
146638374|NCT02453711|528851017|FG003|Overall Study|Death|0|||
146638375|NCT02453711|528851018|FG004|Overall Study|Death|0|||
146638376|NCT02453711|528851019|FG005|Overall Study|Death|0|||
146638377|NCT02453711|528851020|FG006|Overall Study|Death|1|||
146638378|NCT02453711|528851021|FG007|Overall Study|Death|0|||
146638379|NCT02453711|528851022|FG008|Overall Study|Death|0|||
146638380|NCT02453711|528851014|FG000|Overall Study|Unclassified|1|||
146638381|NCT02453711|528851015|FG001|Overall Study|Unclassified|0|||
146638382|NCT02453711|528851016|FG002|Overall Study|Unclassified|1|||
146638383|NCT02453711|528851017|FG003|Overall Study|Unclassified|0|||
146638384|NCT02453711|528851018|FG004|Overall Study|Unclassified|0|||
146638385|NCT02453711|528851019|FG005|Overall Study|Unclassified|0|||
146638386|NCT02453711|528851020|FG006|Overall Study|Unclassified|0|||
146638387|NCT02453711|528851021|FG007|Overall Study|Unclassified|0|||
146638388|NCT02453711|528851022|FG008|Overall Study|Unclassified|0|||
146638389|NCT03695367|528851024|FG000|Overall Study|Missed the Day 28 visit.|1|||
146638390|NCT03695367|528851025|FG001|Overall Study|Missed the Day 28 visit.|0|||
146638391|NCT03695367|528851024|FG000|Overall Study|Lost to Follow-up|0|||
146638392|NCT03695367|528851025|FG001|Overall Study|Lost to Follow-up|1|||
146638393|NCT03695367|528851024|FG000|Overall Study|Withdrawal by Subject|0|||
146766535|NCT02914522|529312247|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
146638394|NCT03695367|528851025|FG001|Overall Study|Withdrawal by Subject|1|||
146638395|NCT03695367|528851024|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
146638396|NCT03695367|528851025|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
146638397|NCT00068419|528851026|FG000|Overall Study|Adverse Event|3|||
146638398|NCT00068419|528851026|FG000|Overall Study|Lack of Efficacy|24|||
146638399|NCT00068419|528851026|FG000|Overall Study|Lost to Follow-up|1|||
146638400|NCT00068419|528851026|FG000|Overall Study|Physician Decision|7|||
146638401|NCT00068419|528851026|FG000|Overall Study|Withdrawal by Subject|14|||
146638402|NCT00068419|528851026|FG000|Overall Study|Ineligible|11|||
146894402|NCT02913313|529779759|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
146894403|NCT02913313|529779760|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
146894404|NCT02913313|529779761|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
146894405|NCT02913313|529779762|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
146638403|NCT00396253|528851035|FG000|Overall Study|Protocol Violation|1|||
146638404|NCT00396253|528851035|FG000|Overall Study|Withdrawal by Subject|7|||
146638405|NCT00396253|528851035|FG000|Overall Study|Death|3|||
146638406|NCT00396253|528851035|FG000|Overall Study|Physician Decision|1|||
146638407|NCT00396253|528851035|FG000|Overall Study|Change in eligibility status|1|||
146638408|NCT04672655|528851046|FG000|Overall Study|Lost to Follow-up|12|||
146638409|NCT04672655|528851047|FG001|Overall Study|Lost to Follow-up|17|||
146638410|NCT04672655|528851046|FG000|Overall Study|Withdrawal by Subject|1|||
146638411|NCT04672655|528851047|FG001|Overall Study|Withdrawal by Subject|0|||
146638412|NCT04672655|528851046|FG000|Overall Study|Withdrawal by Study|1|||
146638413|NCT04672655|528851047|FG001|Overall Study|Withdrawal by Study|0|||
146638414|NCT00796419|528852773|FG000|Overall Study|Death|0|||
146638415|NCT00796419|528852774|FG001|Overall Study|Death|1|||
146638416|NCT02840799|528852775|FG000|Phase 1|Physician Decision|1|||
146638417|NCT02840799|528852776|FG001|Phase 1|Physician Decision|3|||
146638418|NCT02840799|528852775|FG000|Phase 1|Withdrawal by Subject|4|||
146638419|NCT02840799|528852776|FG001|Phase 1|Withdrawal by Subject|0|||
146638420|NCT02840799|528852775|FG000|Phase 2 (Crossover)|Adverse Event|0|||
146638421|NCT02840799|528852776|FG001|Phase 2 (Crossover)|Adverse Event|1|||
146638422|NCT02840799|528852775|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
146638423|NCT02840799|528852776|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
146638424|NCT02565784|528852777|FG000|First Treatment|Adverse Event|1|||
146638425|NCT02565784|528852777|FG000|First Treatment|Withdrawal by Subject|1|||
146638426|NCT02565784|528852777|FG000|Second Treatment|Withdrawal by Subject|2|||
146638427|NCT01349049|528852781|FG000|Overall Study|Disease progression|3|||
146638428|NCT01349049|528852782|FG001|Overall Study|Disease progression|5|||
146638429|NCT01349049|528852783|FG002|Overall Study|Disease progression|3|||
146638430|NCT01349049|528852784|FG003|Overall Study|Disease progression|2|||
146638431|NCT01349049|528852785|FG004|Overall Study|Disease progression|2|||
146638432|NCT01349049|528852786|FG005|Overall Study|Disease progression|2|||
146638433|NCT01349049|528852787|FG006|Overall Study|Disease progression|3|||
146638434|NCT01349049|528852788|FG007|Overall Study|Disease progression|2|||
146638435|NCT01349049|528852789|FG008|Overall Study|Disease progression|33|||
146638436|NCT01349049|528852781|FG000|Overall Study|Adverse Event|0|||
146638437|NCT01349049|528852782|FG001|Overall Study|Adverse Event|1|||
146638438|NCT01349049|528852783|FG002|Overall Study|Adverse Event|0|||
146638439|NCT01349049|528852784|FG003|Overall Study|Adverse Event|0|||
146638440|NCT01349049|528852785|FG004|Overall Study|Adverse Event|0|||
146638441|NCT01349049|528852786|FG005|Overall Study|Adverse Event|3|||
146894406|NCT02913313|529779763|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
146638442|NCT01349049|528852787|FG006|Overall Study|Adverse Event|1|||
146638443|NCT01349049|528852788|FG007|Overall Study|Adverse Event|0|||
146638444|NCT01349049|528852789|FG008|Overall Study|Adverse Event|4|||
146638445|NCT01349049|528852781|FG000|Overall Study|Physician Decision|0|||
146638446|NCT01349049|528852782|FG001|Overall Study|Physician Decision|1|||
146638447|NCT01349049|528852783|FG002|Overall Study|Physician Decision|0|||
146638448|NCT01349049|528852784|FG003|Overall Study|Physician Decision|0|||
146638449|NCT01349049|528852785|FG004|Overall Study|Physician Decision|0|||
146638450|NCT01349049|528852786|FG005|Overall Study|Physician Decision|0|||
146638451|NCT01349049|528852787|FG006|Overall Study|Physician Decision|0|||
146638452|NCT01349049|528852788|FG007|Overall Study|Physician Decision|0|||
146638453|NCT01349049|528852789|FG008|Overall Study|Physician Decision|2|||
146638454|NCT01349049|528852781|FG000|Overall Study|Protocol Violation|0|||
146638455|NCT01349049|528852782|FG001|Overall Study|Protocol Violation|0|||
146638456|NCT01349049|528852783|FG002|Overall Study|Protocol Violation|0|||
146894407|NCT06118385|529779764|FG000|Overall Study|Protocol Violation|0|||
146894408|NCT06118385|529779765|FG001|Overall Study|Protocol Violation|0|||
146894409|NCT06118385|529779766|FG002|Overall Study|Protocol Violation|0|||
146894410|NCT06118385|529779767|FG003|Overall Study|Protocol Violation|0|||
146894411|NCT06118385|529779768|FG004|Overall Study|Protocol Violation|0|||
146894412|NCT06118385|529779769|FG005|Overall Study|Protocol Violation|0|||
146638457|NCT01349049|528852784|FG003|Overall Study|Protocol Violation|0|||
146638458|NCT01349049|528852785|FG004|Overall Study|Protocol Violation|0|||
146638459|NCT01349049|528852786|FG005|Overall Study|Protocol Violation|0|||
146638460|NCT01349049|528852787|FG006|Overall Study|Protocol Violation|0|||
146638461|NCT01349049|528852788|FG007|Overall Study|Protocol Violation|0|||
146638462|NCT01349049|528852789|FG008|Overall Study|Protocol Violation|1|||
146558677|NCT00500331|528555868|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
146638463|NCT01349049|528852781|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
146638464|NCT01349049|528852782|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
146638465|NCT01349049|528852783|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
146638466|NCT01349049|528852784|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
146638467|NCT01349049|528852785|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
146638468|NCT01349049|528852786|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
146638469|NCT01349049|528852787|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
146638470|NCT01349049|528852788|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
146638471|NCT01349049|528852789|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
146638472|NCT01349049|528852781|FG000|Overall Study|Other|0|||
146638473|NCT01349049|528852782|FG001|Overall Study|Other|0|||
146638474|NCT01349049|528852783|FG002|Overall Study|Other|0|||
146638475|NCT01349049|528852784|FG003|Overall Study|Other|0|||
146638476|NCT01349049|528852785|FG004|Overall Study|Other|0|||
146638477|NCT01349049|528852786|FG005|Overall Study|Other|1|||
146638478|NCT01349049|528852787|FG006|Overall Study|Other|0|||
146638479|NCT01349049|528852788|FG007|Overall Study|Other|0|||
146638480|NCT01349049|528852789|FG008|Overall Study|Other|4|||
146638481|NCT01349049|528852781|FG000|Overall Study|Death|0|||
146638482|NCT01349049|528852782|FG001|Overall Study|Death|0|||
146638483|NCT01349049|528852783|FG002|Overall Study|Death|0|||
146638484|NCT01349049|528852784|FG003|Overall Study|Death|0|||
146638485|NCT01349049|528852785|FG004|Overall Study|Death|0|||
146638486|NCT01349049|528852786|FG005|Overall Study|Death|0|||
146894413|NCT06118385|529779770|FG006|Overall Study|Protocol Violation|0|||
146894414|NCT06118385|529779771|FG007|Overall Study|Protocol Violation|0|||
146894415|NCT06118385|529779772|FG008|Overall Study|Protocol Violation|1|||
146894416|NCT06118385|529779773|FG009|Overall Study|Protocol Violation|0|||
146558678|NCT00500331|528555869|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
146638487|NCT01349049|528852787|FG006|Overall Study|Death|0|||
146638488|NCT01349049|528852788|FG007|Overall Study|Death|1|||
146638489|NCT01349049|528852789|FG008|Overall Study|Death|5|||
146638490|NCT01349049|528852781|FG000|Overall Study|Non-compliance|0|||
146638491|NCT01349049|528852782|FG001|Overall Study|Non-compliance|0|||
146638492|NCT01349049|528852783|FG002|Overall Study|Non-compliance|0|||
146638493|NCT01349049|528852784|FG003|Overall Study|Non-compliance|1|||
146638494|NCT01349049|528852785|FG004|Overall Study|Non-compliance|0|||
146638495|NCT01349049|528852786|FG005|Overall Study|Non-compliance|0|||
146638496|NCT01349049|528852787|FG006|Overall Study|Non-compliance|0|||
146638497|NCT01349049|528852788|FG007|Overall Study|Non-compliance|0|||
146638498|NCT01349049|528852789|FG008|Overall Study|Non-compliance|0|||
146558679|NCT00500331|528555870|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
146558680|NCT00500331|528555871|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
146558681|NCT00500331|528555865|FG000|Overall Study|Didn't return for continuation of study|1|||
146558682|NCT00500331|528555866|FG001|Overall Study|Didn't return for continuation of study|0|||
146558683|NCT00500331|528555867|FG002|Overall Study|Didn't return for continuation of study|0|||
146558684|NCT00500331|528555868|FG003|Overall Study|Didn't return for continuation of study|0|||
146558685|NCT00500331|528555869|FG004|Overall Study|Didn't return for continuation of study|0|||
146558686|NCT00500331|528555870|FG005|Overall Study|Didn't return for continuation of study|0|||
146558687|NCT00500331|528555871|FG006|Overall Study|Didn't return for continuation of study|0|||
146558688|NCT00500331|528555865|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
146558689|NCT00500331|528555866|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
146558690|NCT00500331|528555867|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
146558691|NCT00500331|528555868|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
146558692|NCT00500331|528555869|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
146558693|NCT00500331|528555870|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
146558694|NCT00500331|528555871|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
146558695|NCT00500331|528555865|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
146558696|NCT00500331|528555866|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
146558697|NCT00500331|528555867|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
146558698|NCT00500331|528555868|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
146558699|NCT00500331|528555869|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
146558700|NCT00500331|528555870|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
146558701|NCT00500331|528555871|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
146558702|NCT00500331|528555865|FG000|Overall Study|Participant was randomized by mistake|1|||
146558703|NCT00500331|528555866|FG001|Overall Study|Participant was randomized by mistake|0|||
146558704|NCT00500331|528555867|FG002|Overall Study|Participant was randomized by mistake|0|||
146638499|NCT01349049|528852781|FG000|Overall Study|Withdrawal by Subject|0|||
146638500|NCT01349049|528852782|FG001|Overall Study|Withdrawal by Subject|0|||
146638501|NCT01349049|528852783|FG002|Overall Study|Withdrawal by Subject|0|||
146638502|NCT01349049|528852784|FG003|Overall Study|Withdrawal by Subject|0|||
146770138|NCT00818454|529327378|FG001|Washout Period of 1 Week|Protocol Violation|0|||
146894417|NCT06118385|529779774|FG010|Overall Study|Protocol Violation|0|||
146638503|NCT01349049|528852785|FG004|Overall Study|Withdrawal by Subject|0|||
146638504|NCT01349049|528852786|FG005|Overall Study|Withdrawal by Subject|0|||
146638505|NCT01349049|528852787|FG006|Overall Study|Withdrawal by Subject|0|||
146638506|NCT01349049|528852788|FG007|Overall Study|Withdrawal by Subject|0|||
146638507|NCT01349049|528852789|FG008|Overall Study|Withdrawal by Subject|6|||
146638508|NCT00552188|528852792|FG000|Overall Study|Adverse Event|0|||
146638509|NCT00552188|528852793|FG001|Overall Study|Adverse Event|2|||
146638510|NCT00552188|528852792|FG000|Overall Study|Lost to Follow-up|2|||
146638511|NCT00552188|528852793|FG001|Overall Study|Lost to Follow-up|1|||
146638512|NCT00552188|528852792|FG000|Overall Study|Withdrawal of consent|0|||
146638513|NCT00552188|528852793|FG001|Overall Study|Withdrawal of consent|1|||
146638514|NCT00552188|528852792|FG000|Overall Study|Subject returned to home country|0|||
146638515|NCT00552188|528852793|FG001|Overall Study|Subject returned to home country|1|||
146638516|NCT03887702|528852794|FG000|Overall Study|Study terminated|0|||
146638517|NCT03887702|528852795|FG001|Overall Study|Study terminated|0|||
146894418|NCT06118385|529779775|FG011|Overall Study|Protocol Violation|0|||
146638518|NCT03887702|528852796|FG002|Overall Study|Study terminated|2|||
146638519|NCT03887702|528852797|FG003|Overall Study|Study terminated|2|||
146638520|NCT01193257|528852803|FG000|Overall Study|Death|202|||
146638521|NCT01193257|528852804|FG001|Overall Study|Death|391|||
146638522|NCT01193257|528852803|FG000|Overall Study|Study termination by sponsor|0|||
146638523|NCT01193257|528852804|FG001|Overall Study|Study termination by sponsor|3|||
146894419|NCT06118385|529779764|FG000|Overall Study|Out-of-range blood tests|0|||
146894420|NCT06118385|529779765|FG001|Overall Study|Out-of-range blood tests|0|||
146894421|NCT06118385|529779766|FG002|Overall Study|Out-of-range blood tests|0|||
146894422|NCT06118385|529779767|FG003|Overall Study|Out-of-range blood tests|0|||
146894423|NCT06118385|529779768|FG004|Overall Study|Out-of-range blood tests|0|||
146894424|NCT06118385|529779769|FG005|Overall Study|Out-of-range blood tests|0|||
146894425|NCT06118385|529779770|FG006|Overall Study|Out-of-range blood tests|0|||
146894426|NCT06118385|529779771|FG007|Overall Study|Out-of-range blood tests|0|||
146894427|NCT06118385|529779772|FG008|Overall Study|Out-of-range blood tests|1|||
146894428|NCT06118385|529779773|FG009|Overall Study|Out-of-range blood tests|0|||
146894429|NCT06118385|529779774|FG010|Overall Study|Out-of-range blood tests|0|||
146894430|NCT06118385|529779775|FG011|Overall Study|Out-of-range blood tests|0|||
146894431|NCT03624946|529779778|FG000|Overall Study|Lost to Follow-up|0|||
146894432|NCT03624946|529779779|FG001|Overall Study|Lost to Follow-up|1|||
146894433|NCT01925209|529779780|FG000|Treatment Epoch|Physician Decision|1|||
146894434|NCT01925209|529779781|FG001|Treatment Epoch|Physician Decision|0|||
146894435|NCT01925209|529779782|FG002|Treatment Epoch|Physician Decision|0|||
146894436|NCT01925209|529779783|FG003|Treatment Epoch|Physician Decision|0|||
146894437|NCT01925209|529779780|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
146894438|NCT01925209|529779781|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
146894439|NCT01925209|529779782|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
146894440|NCT01925209|529779783|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
146894441|NCT01925209|529779780|FG000|Treatment Epoch|Death|1|||
146894442|NCT01925209|529779781|FG001|Treatment Epoch|Death|0|||
146894443|NCT01925209|529779782|FG002|Treatment Epoch|Death|0|||
146894444|NCT01925209|529779783|FG003|Treatment Epoch|Death|0|||
146894445|NCT01925209|529779780|FG000|Treatment Epoch|Protocol deviation|0|||
146894446|NCT01925209|529779781|FG001|Treatment Epoch|Protocol deviation|0|||
146894447|NCT01925209|529779782|FG002|Treatment Epoch|Protocol deviation|1|||
146894448|NCT01925209|529779783|FG003|Treatment Epoch|Protocol deviation|1|||
146894449|NCT01925209|529779780|FG000|Treatment Epoch|Withdrawal by Subject|4|||
146894450|NCT01925209|529779781|FG001|Treatment Epoch|Withdrawal by Subject|3|||
146894451|NCT01925209|529779782|FG002|Treatment Epoch|Withdrawal by Subject|3|||
146894452|NCT01925209|529779783|FG003|Treatment Epoch|Withdrawal by Subject|2|||
146894453|NCT01925209|529779780|FG000|Treatment Epoch|Adverse Event|3|||
146894454|NCT01925209|529779781|FG001|Treatment Epoch|Adverse Event|5|||
146894455|NCT01925209|529779782|FG002|Treatment Epoch|Adverse Event|3|||
146638524|NCT01193257|528852803|FG000|Overall Study|Withdrawal by Subject|26|||
146638525|NCT01193257|528852804|FG001|Overall Study|Withdrawal by Subject|86|||
146638526|NCT01193257|528852803|FG000|Overall Study|Lost to Follow-up|2|||
146638527|NCT01193257|528852804|FG001|Overall Study|Lost to Follow-up|3|||
146638528|NCT01193257|528852803|FG000|Overall Study|Unblinded due to futility|135|||
146638529|NCT01193257|528852804|FG001|Overall Study|Unblinded due to futility|251|||
146638530|NCT01675544|528852812|FG000|Overall Study|Withdrawal by Subject|2|||
146638531|NCT03544333|528852813|FG000|Overall Study|Withdrawal by Subject|1|||
146638532|NCT03544333|528852814|FG001|Overall Study|Withdrawal by Subject|0|||
146894456|NCT01925209|529779783|FG003|Treatment Epoch|Adverse Event|1|||
146894457|NCT01925209|529779780|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
146894458|NCT01925209|529779781|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
146894459|NCT01925209|529779782|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
146894460|NCT01925209|529779783|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
146894461|NCT01925209|529779780|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
146638533|NCT03656562|528852818|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
146638534|NCT03656562|528852819|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
146638535|NCT03656562|528852820|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
146638536|NCT03656562|528852821|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
146638537|NCT03656562|528852818|FG000|Overall Study|Physician Decision|1|||
146638538|NCT03656562|528852819|FG001|Overall Study|Physician Decision|2|||
146638539|NCT03656562|528852820|FG002|Overall Study|Physician Decision|0|||
146638540|NCT03656562|528852821|FG003|Overall Study|Physician Decision|0|||
146638541|NCT03656562|528852818|FG000|Overall Study|Subject Decision|3|||
146894462|NCT01925209|529779781|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
146638542|NCT03656562|528852819|FG001|Overall Study|Subject Decision|5|||
146638543|NCT03656562|528852820|FG002|Overall Study|Subject Decision|0|||
146638544|NCT03656562|528852821|FG003|Overall Study|Subject Decision|2|||
146638545|NCT02136069|528852822|FG000|Overall Study|UC flare-up|1|||
146638546|NCT02136069|528852823|FG001|Overall Study|UC flare-up|0|||
146638547|NCT02136069|528852822|FG000|Overall Study|Adverse Event|6|||
146638548|NCT02136069|528852823|FG001|Overall Study|Adverse Event|8|||
146638549|NCT02136069|528852822|FG000|Overall Study|Death|0|||
146638550|NCT02136069|528852823|FG001|Overall Study|Death|1|||
146894463|NCT01925209|529779782|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
146894464|NCT01925209|529779783|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
146894465|NCT01925209|529779780|FG000|Follow-up|Adverse Event|1|||
146894466|NCT01925209|529779781|FG001|Follow-up|Adverse Event|4|||
146894467|NCT01925209|529779782|FG002|Follow-up|Adverse Event|0|||
146894468|NCT01925209|529779783|FG003|Follow-up|Adverse Event|1|||
146894469|NCT01925209|529779780|FG000|Follow-up|Physician Decision|0|||
146894470|NCT01925209|529779781|FG001|Follow-up|Physician Decision|0|||
146894471|NCT01925209|529779782|FG002|Follow-up|Physician Decision|1|||
146894472|NCT01925209|529779783|FG003|Follow-up|Physician Decision|0|||
146894473|NCT01925209|529779780|FG000|Follow-up|Non-compliance with study treatment|0|||
146894474|NCT01925209|529779781|FG001|Follow-up|Non-compliance with study treatment|0|||
146894475|NCT01925209|529779782|FG002|Follow-up|Non-compliance with study treatment|0|||
146894476|NCT01925209|529779783|FG003|Follow-up|Non-compliance with study treatment|1|||
146894477|NCT01925209|529779780|FG000|Follow-up|Withdrawal by Subject|0|||
146894478|NCT01925209|529779781|FG001|Follow-up|Withdrawal by Subject|2|||
146638551|NCT02136069|528852822|FG000|Overall Study|Lack of Efficacy|10|||
146894479|NCT01925209|529779782|FG002|Follow-up|Withdrawal by Subject|0|||
146894480|NCT01925209|529779783|FG003|Follow-up|Withdrawal by Subject|2|||
146894481|NCT00675025|529779784|FG000|Overall Study|Study Terminated by Sponsor|38|||
146638552|NCT02136069|528852823|FG001|Overall Study|Lack of Efficacy|4|||
146638553|NCT02136069|528852822|FG000|Overall Study|Lost to Follow-up|1|||
146638554|NCT02136069|528852823|FG001|Overall Study|Lost to Follow-up|0|||
146638555|NCT02136069|528852822|FG000|Overall Study|Non-Compliance|1|||
146638556|NCT02136069|528852823|FG001|Overall Study|Non-Compliance|0|||
146894482|NCT00675025|529779785|FG001|Overall Study|Study Terminated by Sponsor|42|||
146894483|NCT00675025|529779784|FG000|Overall Study|Adverse Event|6|||
146894484|NCT00675025|529779785|FG001|Overall Study|Adverse Event|11|||
146894485|NCT00675025|529779784|FG000|Overall Study|Lost to Follow-up|6|||
146894486|NCT00675025|529779785|FG001|Overall Study|Lost to Follow-up|4|||
146894487|NCT00675025|529779784|FG000|Overall Study|Withdrawal by Subject|4|||
146638557|NCT02136069|528852822|FG000|Overall Study|Physician Decision|5|||
146638558|NCT02136069|528852823|FG001|Overall Study|Physician Decision|4|||
146638559|NCT02136069|528852822|FG000|Overall Study|Withdrawal by Subject|10|||
146894488|NCT00675025|529779785|FG001|Overall Study|Withdrawal by Subject|6|||
146638560|NCT02136069|528852823|FG001|Overall Study|Withdrawal by Subject|11|||
146638561|NCT04693234|528852824|FG000|Overall Study|Death|79|||
146638562|NCT04693234|528852825|FG001|Overall Study|Death|19|||
146968478|NCT00648739|530045444|FG003|Overall Study|Death|0|||
146638563|NCT04693234|528852824|FG000|Overall Study|Sponsor Ended Study|47|||
146638564|NCT04693234|528852825|FG001|Overall Study|Sponsor Ended Study|18|||
146638565|NCT04693234|528852824|FG000|Overall Study|Withdrawal by Subject|10|||
146638566|NCT04693234|528852825|FG001|Overall Study|Withdrawal by Subject|2|||
146638567|NCT04693234|528852824|FG000|Overall Study|Lost to Follow-up|2|||
146638568|NCT04693234|528852825|FG001|Overall Study|Lost to Follow-up|1|||
146638569|NCT00459186|528852826|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
146638570|NCT00459186|528852826|FG000|PET Imaging and Assessment|Adverse Event|3|||
146638571|NCT02920242|528852827|FG000|Overall Study|Withdrawal by Subject|1|||
146638572|NCT02920242|528852828|FG001|Overall Study|Withdrawal by Subject|0|||
146638573|NCT02920242|528852829|FG002|Overall Study|Withdrawal by Subject|1|||
146638574|NCT02920242|528852827|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
146638575|NCT02920242|528852828|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
146638576|NCT02920242|528852829|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
146638577|NCT04995419|528852830|FG000|Overall Study|Withdrawal by Subject|3|||
146638578|NCT04995419|528852830|FG000|Overall Study|Progressive Disease|19|||
146638579|NCT04995419|528852830|FG000|Overall Study|Adverse Event|2|||
146638580|NCT04995419|528852830|FG000|Overall Study|Ongoing|16|||
146638581|NCT00441064|528852833|FG000|Overall Study|Adverse Event|1|||
146638582|NCT00441064|528852834|FG001|Overall Study|Adverse Event|0|||
146638583|NCT00441064|528852833|FG000|Overall Study|Abnormal laboratory values|0|||
146638584|NCT00441064|528852834|FG001|Overall Study|Abnormal laboratory values|2|||
146638585|NCT00441064|528852833|FG000|Overall Study|Abnormal test procedure results|0|||
146638586|NCT00441064|528852834|FG001|Overall Study|Abnormal test procedure results|1|||
146638587|NCT00441064|528852833|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146638588|NCT00441064|528852834|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146638589|NCT00441064|528852833|FG000|Overall Study|Protocol Deviation|3|||
146638590|NCT00441064|528852834|FG001|Overall Study|Protocol Deviation|2|||
146638591|NCT00441064|528852833|FG000|Overall Study|Patient withdrew consent|5|||
146638592|NCT00441064|528852834|FG001|Overall Study|Patient withdrew consent|2|||
146638593|NCT03051178|528852835|FG000|Overall Study|Withdrawal by Subject|5|||
146638594|NCT00953056|528852836|FG000|Overall Study|Withdrew Consent|0|||
146638595|NCT00953056|528852837|FG001|Overall Study|Withdrew Consent|0|||
146638596|NCT00953056|528852838|FG002|Overall Study|Withdrew Consent|0|||
146638597|NCT00953056|528852839|FG003|Overall Study|Withdrew Consent|0|||
146638598|NCT00953056|528852840|FG004|Overall Study|Withdrew Consent|2|||
146638599|NCT00953056|528852841|FG005|Overall Study|Withdrew Consent|3|||
146638600|NCT00953056|528852836|FG000|Overall Study|Serious Adverse Event|0|||
146638601|NCT00953056|528852837|FG001|Overall Study|Serious Adverse Event|0|||
146638602|NCT00953056|528852838|FG002|Overall Study|Serious Adverse Event|0|||
146638603|NCT00953056|528852839|FG003|Overall Study|Serious Adverse Event|0|||
146638604|NCT00953056|528852840|FG004|Overall Study|Serious Adverse Event|0|||
146638605|NCT00953056|528852841|FG005|Overall Study|Serious Adverse Event|1|||
146638606|NCT03962504|528852842|FG000|Overall Study|Other|11|||
146638607|NCT03962504|528852843|FG001|Overall Study|Other|32|||
146638608|NCT02813577|528852844|FG000|Overall Study|Study terminated|4|||
146638609|NCT01388335|528852845|FG000|Period 1|Progressive Disease|1|||
146638610|NCT01388335|528852845|FG000|Period 2|Progressive Disease|2|||
146638611|NCT01388335|528852845|FG000|Period 2|Sponsor Decision|1|||
146638612|NCT01388335|528852845|FG000|Safety Extension|Progressive Disease|7|||
146638613|NCT03339219|528852846|FG000|Overall Study|Death|12|||
146638614|NCT03339219|528852846|FG000|Overall Study|Site Terminated by Sponsor|22|||
146638615|NCT03339219|528852846|FG000|Overall Study|Withdrawal by Subject|1|||
146638616|NCT00885534|528852850|FG000|Overall Study|Patient deemed ineligible|1|||
146638617|NCT01032889|528852851|FG000|Overall Study|Adverse Event|2|||
146638618|NCT01032889|528852852|FG001|Overall Study|Adverse Event|2|||
146638619|NCT01032889|528852853|FG002|Overall Study|Adverse Event|0|||
146638620|NCT01032889|528852851|FG000|Overall Study|Withdrawal of Consent|1|||
146638621|NCT01032889|528852852|FG001|Overall Study|Withdrawal of Consent|2|||
146638622|NCT01032889|528852853|FG002|Overall Study|Withdrawal of Consent|1|||
146638623|NCT01032889|528852851|FG000|Overall Study|Patient Request|0|||
146638624|NCT01032889|528852852|FG001|Overall Study|Patient Request|1|||
146638625|NCT01032889|528852853|FG002|Overall Study|Patient Request|0|||
146766536|NCT02914522|529312248|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
146638626|NCT01032889|528852851|FG000|Overall Study|Lost to Follow-up|1|||
146638627|NCT01032889|528852852|FG001|Overall Study|Lost to Follow-up|1|||
146638628|NCT01032889|528852853|FG002|Overall Study|Lost to Follow-up|0|||
146638629|NCT01032889|528852851|FG000|Overall Study|Lack of Submental Fat|2|||
146638630|NCT01032889|528852852|FG001|Overall Study|Lack of Submental Fat|8|||
146766537|NCT02914522|529312249|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
146638631|NCT01032889|528852853|FG002|Overall Study|Lack of Submental Fat|1|||
146638632|NCT01032889|528852851|FG000|Overall Study|Miscellaneous Reasons|2|||
146638633|NCT01032889|528852852|FG001|Overall Study|Miscellaneous Reasons|1|||
146638634|NCT01032889|528852853|FG002|Overall Study|Miscellaneous Reasons|1|||
146638635|NCT01500720|528852855|FG000|Overall Study|Randomized But Not Treated|1|||
146638636|NCT01500720|528852856|FG001|Overall Study|Randomized But Not Treated|1|||
146638637|NCT01500720|528852855|FG000|Overall Study|Other|4|||
146638638|NCT01500720|528852856|FG001|Overall Study|Other|8|||
146638639|NCT00740857|528852857|FG000|Overall Study|Withdrawal by Subject|1|||
146638640|NCT00740857|528852858|FG001|Overall Study|Withdrawal by Subject|0|||
146638641|NCT00740857|528852859|FG002|Overall Study|Withdrawal by Subject|0|||
146968479|NCT00648739|530045445|FG004|Overall Study|Death|0|||
146968480|NCT00648739|530045446|FG005|Overall Study|Death|0|||
146968481|NCT00648739|530045447|FG006|Overall Study|Death|0|||
146968482|NCT00648739|530045441|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
146968483|NCT00648739|530045442|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
146968484|NCT00648739|530045443|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
146968485|NCT00648739|530045444|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
146968486|NCT00648739|530045445|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
146968487|NCT00648739|530045446|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
146968488|NCT00648739|530045447|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
146968489|NCT00648739|530045441|FG000|Overall Study|Follow-up Visits Not Completed|0|||
146968490|NCT00648739|530045442|FG001|Overall Study|Follow-up Visits Not Completed|1|||
146638642|NCT03532451|528852860|FG000|Overall Study|Withdrawal by Subject|0|||
146638643|NCT03532451|528852861|FG001|Overall Study|Withdrawal by Subject|1|||
146638644|NCT03532451|528852860|FG000|Overall Study|Did not undergo surgery|1|||
146638645|NCT03532451|528852861|FG001|Overall Study|Did not undergo surgery|1|||
146638646|NCT02527421|528852862|FG000|Overall Study|Withdrawal by Subject|1|||
146638647|NCT02527421|528852863|FG001|Overall Study|Withdrawal by Subject|0|||
146638648|NCT02541604|528852864|FG000|Overall Study|Death|6|||
146638649|NCT02541604|528852865|FG001|Overall Study|Death|5|||
146638650|NCT02541604|528852866|FG002|Overall Study|Death|7|||
146638651|NCT02541604|528852867|FG003|Overall Study|Death|2|||
146638652|NCT02541604|528852868|FG004|Overall Study|Death|9|||
146638653|NCT02541604|528852869|FG005|Overall Study|Death|8|||
146638654|NCT02541604|528852870|FG006|Overall Study|Death|9|||
146638655|NCT02541604|528852871|FG007|Overall Study|Death|9|||
146638656|NCT02541604|528852872|FG008|Overall Study|Death|3|||
146638657|NCT02541604|528852873|FG009|Overall Study|Death|4|||
146638658|NCT02541604|528852874|FG010|Overall Study|Death|2|||
146638659|NCT02541604|528852875|FG011|Overall Study|Death|3|||
146638660|NCT02541604|528852864|FG000|Overall Study|Lost to Follow-up|2|||
146638661|NCT02541604|528852865|FG001|Overall Study|Lost to Follow-up|0|||
146638662|NCT02541604|528852866|FG002|Overall Study|Lost to Follow-up|1|||
146638663|NCT02541604|528852867|FG003|Overall Study|Lost to Follow-up|0|||
146638664|NCT02541604|528852868|FG004|Overall Study|Lost to Follow-up|0|||
146638665|NCT02541604|528852869|FG005|Overall Study|Lost to Follow-up|1|||
146638666|NCT02541604|528852870|FG006|Overall Study|Lost to Follow-up|1|||
146638667|NCT02541604|528852871|FG007|Overall Study|Lost to Follow-up|0|||
146638668|NCT02541604|528852872|FG008|Overall Study|Lost to Follow-up|0|||
146638669|NCT02541604|528852873|FG009|Overall Study|Lost to Follow-up|0|||
146638670|NCT02541604|528852874|FG010|Overall Study|Lost to Follow-up|0|||
146638671|NCT02541604|528852875|FG011|Overall Study|Lost to Follow-up|0|||
146638672|NCT02541604|528852864|FG000|Overall Study|Withdrawal by Subject|2|||
146766538|NCT02914522|529312250|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
146766539|NCT02914522|529312251|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
146894489|NCT00110994|529779786|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
146894490|NCT00110994|529779787|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
146894491|NCT00110994|529779786|FG000|Double-blind (DB) Treatment|Death|1|||
146894492|NCT00110994|529779787|FG001|Double-blind (DB) Treatment|Death|0|||
146894493|NCT00110994|529779786|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
146894494|NCT00110994|529779787|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
146894495|NCT00110994|529779786|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
146894496|NCT00110994|529779787|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
146894497|NCT00110994|529779786|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
146894498|NCT00110994|529779787|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
146894499|NCT00110994|529779786|FG000|Double-blind (DB) Treatment|other reasons|2|||
146894500|NCT00110994|529779787|FG001|Double-blind (DB) Treatment|other reasons|3|||
146894501|NCT00110994|529779786|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
146894502|NCT00110994|529779787|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
146894503|NCT00110994|529779786|FG000|Active Follow-up|Other reasons|0|||
146894504|NCT00110994|529779787|FG001|Active Follow-up|Other reasons|2|||
146894505|NCT00110994|529779786|FG000|Long Term Follow-up|Death|19|||
146894506|NCT00110994|529779787|FG001|Long Term Follow-up|Death|17|||
146638673|NCT02541604|528852865|FG001|Overall Study|Withdrawal by Subject|0|||
146638674|NCT02541604|528852866|FG002|Overall Study|Withdrawal by Subject|1|||
146638675|NCT02541604|528852867|FG003|Overall Study|Withdrawal by Subject|0|||
146638676|NCT02541604|528852868|FG004|Overall Study|Withdrawal by Subject|1|||
146638677|NCT02541604|528852869|FG005|Overall Study|Withdrawal by Subject|1|||
146638678|NCT02541604|528852870|FG006|Overall Study|Withdrawal by Subject|0|||
146558705|NCT00500331|528555868|FG003|Overall Study|Participant was randomized by mistake|0|||
146558706|NCT00500331|528555869|FG004|Overall Study|Participant was randomized by mistake|0|||
146638679|NCT02541604|528852871|FG007|Overall Study|Withdrawal by Subject|0|||
146638680|NCT02541604|528852872|FG008|Overall Study|Withdrawal by Subject|1|||
146638681|NCT02541604|528852873|FG009|Overall Study|Withdrawal by Subject|0|||
146638682|NCT02541604|528852874|FG010|Overall Study|Withdrawal by Subject|0|||
146638683|NCT02541604|528852875|FG011|Overall Study|Withdrawal by Subject|0|||
146638684|NCT02541604|528852864|FG000|Overall Study|Study Terminated by Sponsor|1|||
146638685|NCT02541604|528852865|FG001|Overall Study|Study Terminated by Sponsor|4|||
146638686|NCT02541604|528852866|FG002|Overall Study|Study Terminated by Sponsor|2|||
146638687|NCT02541604|528852867|FG003|Overall Study|Study Terminated by Sponsor|1|||
146638688|NCT02541604|528852868|FG004|Overall Study|Study Terminated by Sponsor|0|||
146558707|NCT00500331|528555870|FG005|Overall Study|Participant was randomized by mistake|0|||
146558708|NCT00500331|528555871|FG006|Overall Study|Participant was randomized by mistake|0|||
146558709|NCT00500331|528555865|FG000|Overall Study|Diabetologist nurse in the study|0|||
146558710|NCT00500331|528555866|FG001|Overall Study|Diabetologist nurse in the study|0|||
146558711|NCT00500331|528555867|FG002|Overall Study|Diabetologist nurse in the study|1|||
146558712|NCT00500331|528555868|FG003|Overall Study|Diabetologist nurse in the study|0|||
146558713|NCT00500331|528555869|FG004|Overall Study|Diabetologist nurse in the study|0|||
146558714|NCT00500331|528555870|FG005|Overall Study|Diabetologist nurse in the study|0|||
146558715|NCT00500331|528555871|FG006|Overall Study|Diabetologist nurse in the study|0|||
146558716|NCT00500331|528555865|FG000|Overall Study|State ban of biological samples export|0|||
146558717|NCT00500331|528555866|FG001|Overall Study|State ban of biological samples export|0|||
146638689|NCT02541604|528852869|FG005|Overall Study|Study Terminated by Sponsor|0|||
146638690|NCT02541604|528852870|FG006|Overall Study|Study Terminated by Sponsor|0|||
146638691|NCT02541604|528852871|FG007|Overall Study|Study Terminated by Sponsor|0|||
146638692|NCT02541604|528852872|FG008|Overall Study|Study Terminated by Sponsor|0|||
146638693|NCT02541604|528852873|FG009|Overall Study|Study Terminated by Sponsor|0|||
146638694|NCT02541604|528852874|FG010|Overall Study|Study Terminated by Sponsor|0|||
146558718|NCT00500331|528555867|FG002|Overall Study|State ban of biological samples export|0|||
146638695|NCT02541604|528852875|FG011|Overall Study|Study Terminated by Sponsor|0|||
146638696|NCT02541604|528852864|FG000|Overall Study|Medical condition may jeopardize safety|0|||
146638697|NCT02541604|528852865|FG001|Overall Study|Medical condition may jeopardize safety|0|||
146638698|NCT02541604|528852866|FG002|Overall Study|Medical condition may jeopardize safety|0|||
146638699|NCT02541604|528852867|FG003|Overall Study|Medical condition may jeopardize safety|0|||
146638700|NCT02541604|528852868|FG004|Overall Study|Medical condition may jeopardize safety|0|||
146638701|NCT02541604|528852869|FG005|Overall Study|Medical condition may jeopardize safety|0|||
146638702|NCT02541604|528852870|FG006|Overall Study|Medical condition may jeopardize safety|0|||
146638703|NCT02541604|528852871|FG007|Overall Study|Medical condition may jeopardize safety|1|||
146638704|NCT02541604|528852872|FG008|Overall Study|Medical condition may jeopardize safety|0|||
146638705|NCT02541604|528852873|FG009|Overall Study|Medical condition may jeopardize safety|0|||
146638706|NCT02541604|528852874|FG010|Overall Study|Medical condition may jeopardize safety|0|||
146638707|NCT02541604|528852875|FG011|Overall Study|Medical condition may jeopardize safety|0|||
146638708|NCT01615029|528852876|FG000|Overall Study|Adverse Event|0|||
146638709|NCT01615029|528852877|FG001|Overall Study|Adverse Event|0|||
146638710|NCT01615029|528852878|FG002|Overall Study|Adverse Event|0|||
146638711|NCT01615029|528852879|FG003|Overall Study|Adverse Event|0|||
146638712|NCT01615029|528852880|FG004|Overall Study|Adverse Event|1|||
146638713|NCT01615029|528852876|FG000|Overall Study|Death|0|||
146638714|NCT01615029|528852877|FG001|Overall Study|Death|0|||
146638715|NCT01615029|528852878|FG002|Overall Study|Death|0|||
146638716|NCT01615029|528852879|FG003|Overall Study|Death|0|||
146638717|NCT01615029|528852880|FG004|Overall Study|Death|1|||
146638718|NCT01615029|528852876|FG000|Overall Study|Lost to Follow-up|0|||
146638719|NCT01615029|528852877|FG001|Overall Study|Lost to Follow-up|0|||
146638720|NCT01615029|528852878|FG002|Overall Study|Lost to Follow-up|0|||
146638721|NCT01615029|528852879|FG003|Overall Study|Lost to Follow-up|0|||
146638722|NCT01615029|528852880|FG004|Overall Study|Lost to Follow-up|1|||
146638723|NCT01615029|528852876|FG000|Overall Study|Progressive disease|2|||
146638724|NCT01615029|528852877|FG001|Overall Study|Progressive disease|1|||
146638725|NCT01615029|528852878|FG002|Overall Study|Progressive disease|1|||
146638726|NCT01615029|528852879|FG003|Overall Study|Progressive disease|1|||
146638727|NCT01615029|528852880|FG004|Overall Study|Progressive disease|5|||
146638728|NCT01615029|528852876|FG000|Overall Study|Physician Decision|0|||
146638729|NCT01615029|528852877|FG001|Overall Study|Physician Decision|0|||
146638730|NCT01615029|528852878|FG002|Overall Study|Physician Decision|0|||
146638731|NCT01615029|528852879|FG003|Overall Study|Physician Decision|0|||
146638732|NCT01615029|528852880|FG004|Overall Study|Physician Decision|1|||
146638733|NCT01615029|528852876|FG000|Overall Study|Ongoing|1|||
146638734|NCT01615029|528852877|FG001|Overall Study|Ongoing|2|||
146638735|NCT01615029|528852878|FG002|Overall Study|Ongoing|3|||
146638736|NCT01615029|528852879|FG003|Overall Study|Ongoing|2|||
146638737|NCT01615029|528852880|FG004|Overall Study|Ongoing|23|||
146638738|NCT05064358|528852881|FG000|Overall Study|Death|23|||
146638739|NCT05064358|528852882|FG001|Overall Study|Death|23|||
146638740|NCT05064358|528852883|FG002|Overall Study|Death|25|||
146638741|NCT05064358|528852884|FG003|Overall Study|Death|21|||
146638742|NCT05064358|528852885|FG004|Overall Study|Death|5|||
146638743|NCT05064358|528852881|FG000|Overall Study|Lost to Follow-up|1|||
146638744|NCT05064358|528852882|FG001|Overall Study|Lost to Follow-up|2|||
146638745|NCT05064358|528852883|FG002|Overall Study|Lost to Follow-up|0|||
146638746|NCT05064358|528852884|FG003|Overall Study|Lost to Follow-up|2|||
146638747|NCT05064358|528852885|FG004|Overall Study|Lost to Follow-up|0|||
146638748|NCT05064358|528852881|FG000|Overall Study|Physician Decision|1|||
146638749|NCT05064358|528852882|FG001|Overall Study|Physician Decision|1|||
146638750|NCT05064358|528852883|FG002|Overall Study|Physician Decision|2|||
146638751|NCT05064358|528852884|FG003|Overall Study|Physician Decision|0|||
146638752|NCT05064358|528852885|FG004|Overall Study|Physician Decision|0|||
146638753|NCT05064358|528852881|FG000|Overall Study|Withdrawal by Subject|4|||
146638754|NCT05064358|528852882|FG001|Overall Study|Withdrawal by Subject|5|||
146638755|NCT05064358|528852883|FG002|Overall Study|Withdrawal by Subject|3|||
146638756|NCT05064358|528852884|FG003|Overall Study|Withdrawal by Subject|6|||
146638757|NCT05064358|528852885|FG004|Overall Study|Withdrawal by Subject|3|||
146638758|NCT05064358|528852881|FG000|Overall Study|Ongoing at the time of analysis|1|||
146638759|NCT05064358|528852882|FG001|Overall Study|Ongoing at the time of analysis|2|||
146638760|NCT05064358|528852883|FG002|Overall Study|Ongoing at the time of analysis|2|||
146638761|NCT05064358|528852884|FG003|Overall Study|Ongoing at the time of analysis|2|||
146638762|NCT05064358|528852885|FG004|Overall Study|Ongoing at the time of analysis|2|||
146638763|NCT01287741|528852886|FG000|Overall Study|Withdrawal by Subject|35|||
146638764|NCT01287741|528852887|FG001|Overall Study|Withdrawal by Subject|38|||
146638765|NCT01287741|528852886|FG000|Overall Study|Protocol Violation|2|||
146638766|NCT01287741|528852887|FG001|Overall Study|Protocol Violation|0|||
146638767|NCT01287741|528852886|FG000|Overall Study|Physician Decision|15|||
146638768|NCT01287741|528852887|FG001|Overall Study|Physician Decision|23|||
146638769|NCT01287741|528852886|FG000|Overall Study|Non-compliance|8|||
146638770|NCT01287741|528852887|FG001|Overall Study|Non-compliance|6|||
146638771|NCT01287741|528852886|FG000|Overall Study|Lost to Follow-up|10|||
146638772|NCT01287741|528852887|FG001|Overall Study|Lost to Follow-up|8|||
146638773|NCT01287741|528852886|FG000|Overall Study|Death|32|||
146638774|NCT01287741|528852887|FG001|Overall Study|Death|44|||
146638775|NCT01287741|528852886|FG000|Overall Study|Adverse Event|4|||
146638776|NCT01287741|528852887|FG001|Overall Study|Adverse Event|6|||
146638777|NCT01287741|528852886|FG000|Overall Study|Study terminated by Sponsor|307|||
146638778|NCT01287741|528852887|FG001|Overall Study|Study terminated by Sponsor|315|||
146638779|NCT01287741|528852886|FG000|Overall Study|Progressive disease|190|||
146638780|NCT01287741|528852887|FG001|Overall Study|Progressive disease|166|||
146638781|NCT01287741|528852886|FG000|Overall Study|Reason not specified|23|||
146638782|NCT01287741|528852887|FG001|Overall Study|Reason not specified|9|||
146638783|NCT04421027|528852888|FG000|Treatment Period|Adverse Event|5|||
146638784|NCT04421027|528852889|FG001|Treatment Period|Adverse Event|3|||
146638785|NCT04421027|528852890|FG002|Treatment Period|Adverse Event|0|||
146638786|NCT04421027|528852891|FG003|Treatment Period|Adverse Event|0|||
146638787|NCT04421027|528852888|FG000|Treatment Period|Death|98|||
146638788|NCT04421027|528852889|FG001|Treatment Period|Death|61|||
146638789|NCT04421027|528852890|FG002|Treatment Period|Death|0|||
146638790|NCT04421027|528852891|FG003|Treatment Period|Death|0|||
146638791|NCT04421027|528852888|FG000|Treatment Period|Lost to Follow-up|22|||
146638792|NCT04421027|528852889|FG001|Treatment Period|Lost to Follow-up|20|||
146638793|NCT04421027|528852890|FG002|Treatment Period|Lost to Follow-up|0|||
146638794|NCT04421027|528852891|FG003|Treatment Period|Lost to Follow-up|0|||
146638795|NCT04421027|528852888|FG000|Treatment Period|Other-Unknown|15|||
146638796|NCT04421027|528852889|FG001|Treatment Period|Other-Unknown|9|||
146558719|NCT00500331|528555868|FG003|Overall Study|State ban of biological samples export|1|||
146558720|NCT00500331|528555869|FG004|Overall Study|State ban of biological samples export|0|||
146558721|NCT00500331|528555870|FG005|Overall Study|State ban of biological samples export|0|||
146558722|NCT00500331|528555871|FG006|Overall Study|State ban of biological samples export|0|||
146558723|NCT00500331|528555865|FG000|Overall Study|Protocol violated|0|||
146558724|NCT00500331|528555866|FG001|Overall Study|Protocol violated|0|||
146558725|NCT00500331|528555867|FG002|Overall Study|Protocol violated|0|||
146558726|NCT00500331|528555868|FG003|Overall Study|Protocol violated|1|||
146558727|NCT00500331|528555869|FG004|Overall Study|Protocol violated|0|||
146558728|NCT00500331|528555870|FG005|Overall Study|Protocol violated|0|||
146558729|NCT00500331|528555871|FG006|Overall Study|Protocol violated|0|||
146558730|NCT03345550|528555872|FG000|Overall Study|Withdrawal by Subject|1|||
146558731|NCT03345550|528555873|FG001|Overall Study|Withdrawal by Subject|0|||
146558732|NCT03345550|528555872|FG000|Overall Study|Lost to Follow-up|4|||
146558733|NCT03345550|528555873|FG001|Overall Study|Lost to Follow-up|5|||
146558734|NCT03033784|528555877|FG000|Overall Study|Anxiety related to MRI scanner|0|||
146558735|NCT03033784|528555878|FG001|Overall Study|Anxiety related to MRI scanner|1|||
146558736|NCT03033784|528555879|FG002|Overall Study|Anxiety related to MRI scanner|0|||
146558737|NCT03033784|528555880|FG003|Overall Study|Anxiety related to MRI scanner|0|||
146558738|NCT03033784|528555881|FG004|Overall Study|Anxiety related to MRI scanner|0|||
146558739|NCT03033784|528555882|FG005|Overall Study|Anxiety related to MRI scanner|0|||
146558740|NCT03033784|528555883|FG006|Overall Study|Anxiety related to MRI scanner|0|||
146558741|NCT03033784|528555884|FG007|Overall Study|Anxiety related to MRI scanner|0|||
146558742|NCT03033784|528555885|FG008|Overall Study|Anxiety related to MRI scanner|0|||
146638797|NCT04421027|528852890|FG002|Treatment Period|Other-Unknown|0|||
146638798|NCT04421027|528852891|FG003|Treatment Period|Other-Unknown|0|||
146638799|NCT04421027|528852888|FG000|Treatment Period|Physician Decision|1|||
146638800|NCT04421027|528852889|FG001|Treatment Period|Physician Decision|1|||
146638801|NCT04421027|528852890|FG002|Treatment Period|Physician Decision|0|||
146638802|NCT04421027|528852891|FG003|Treatment Period|Physician Decision|0|||
146638803|NCT04421027|528852888|FG000|Treatment Period|Withdrawal by Subject|7|||
146638804|NCT04421027|528852889|FG001|Treatment Period|Withdrawal by Subject|12|||
146638805|NCT04421027|528852890|FG002|Treatment Period|Withdrawal by Subject|0|||
146638806|NCT04421027|528852891|FG003|Treatment Period|Withdrawal by Subject|0|||
146638807|NCT04421027|528852888|FG000|Treatment Period|Randomized Not Dosed|9|||
146638808|NCT04421027|528852889|FG001|Treatment Period|Randomized Not Dosed|14|||
146638809|NCT04421027|528852890|FG002|Treatment Period|Randomized Not Dosed|0|||
146638810|NCT04421027|528852891|FG003|Treatment Period|Randomized Not Dosed|0|||
146638811|NCT04421027|528852888|FG000|Follow-Up Period|Adverse Event|0|||
146638812|NCT04421027|528852889|FG001|Follow-Up Period|Adverse Event|0|||
146638813|NCT04421027|528852890|FG002|Follow-Up Period|Adverse Event|0|||
146638814|NCT04421027|528852891|FG003|Follow-Up Period|Adverse Event|3|||
146638815|NCT04421027|528852888|FG000|Follow-Up Period|Death|0|||
146638816|NCT04421027|528852889|FG001|Follow-Up Period|Death|0|||
146638817|NCT04421027|528852890|FG002|Follow-Up Period|Death|16|||
146638818|NCT04421027|528852891|FG003|Follow-Up Period|Death|17|||
146638819|NCT04421027|528852888|FG000|Follow-Up Period|Lost to Follow-up|0|||
146638820|NCT04421027|528852889|FG001|Follow-Up Period|Lost to Follow-up|0|||
146638821|NCT04421027|528852890|FG002|Follow-Up Period|Lost to Follow-up|7|||
146638822|NCT04421027|528852891|FG003|Follow-Up Period|Lost to Follow-up|7|||
146638823|NCT04421027|528852888|FG000|Follow-Up Period|Protocol Deviation|0|||
146638824|NCT04421027|528852889|FG001|Follow-Up Period|Protocol Deviation|0|||
146638825|NCT04421027|528852890|FG002|Follow-Up Period|Protocol Deviation|1|||
146638826|NCT04421027|528852891|FG003|Follow-Up Period|Protocol Deviation|0|||
146638827|NCT04421027|528852888|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
146638828|NCT04421027|528852889|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
146638829|NCT04421027|528852890|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
146638830|NCT04421027|528852891|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
146638831|NCT04421027|528852888|FG000|Follow-Up Period|Left message, participant did not call back|0|||
146638832|NCT04421027|528852889|FG001|Follow-Up Period|Left message, participant did not call back|0|||
146638833|NCT04421027|528852890|FG002|Follow-Up Period|Left message, participant did not call back|0|||
146638834|NCT04421027|528852891|FG003|Follow-Up Period|Left message, participant did not call back|1|||
146638835|NCT04421027|528852888|FG000|Follow-Up Period|Participant died|0|||
146638836|NCT04421027|528852889|FG001|Follow-Up Period|Participant died|0|||
146638837|NCT04421027|528852890|FG002|Follow-Up Period|Participant died|0|||
146638838|NCT04421027|528852891|FG003|Follow-Up Period|Participant died|1|||
146638839|NCT04421027|528852888|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
146638840|NCT04421027|528852889|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
146638841|NCT04421027|528852890|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
146894507|NCT02928952|529779791|FG000|Overall Study|Lost to Follow-up|5|||
146638842|NCT04421027|528852891|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
146638843|NCT05767749|528852901|FG000|Overall Study|Withdrawal by Subject|0|||
146558743|NCT03033784|528555886|FG009|Overall Study|Anxiety related to MRI scanner|0|||
146558744|NCT03033784|528555887|FG010|Overall Study|Anxiety related to MRI scanner|0|||
146558745|NCT03033784|528555888|FG011|Overall Study|Anxiety related to MRI scanner|0|||
146894508|NCT02928952|529779792|FG001|Overall Study|Lost to Follow-up|5|||
146638844|NCT05767749|528852902|FG001|Overall Study|Withdrawal by Subject|0|||
146638845|NCT05767749|528852903|FG002|Overall Study|Withdrawal by Subject|2|||
146638846|NCT05767749|528852904|FG003|Overall Study|Withdrawal by Subject|2|||
146968491|NCT00648739|530045443|FG002|Overall Study|Follow-up Visits Not Completed|0|||
146968492|NCT00648739|530045444|FG003|Overall Study|Follow-up Visits Not Completed|0|||
146558746|NCT03033784|528555889|FG012|Overall Study|Anxiety related to MRI scanner|0|||
146558747|NCT03033784|528555877|FG000|Overall Study|Withdrawal by Subject|0|||
146558748|NCT03033784|528555878|FG001|Overall Study|Withdrawal by Subject|0|||
146558749|NCT03033784|528555879|FG002|Overall Study|Withdrawal by Subject|0|||
146558750|NCT03033784|528555880|FG003|Overall Study|Withdrawal by Subject|0|||
146558751|NCT03033784|528555881|FG004|Overall Study|Withdrawal by Subject|0|||
146558752|NCT03033784|528555882|FG005|Overall Study|Withdrawal by Subject|0|||
146558753|NCT03033784|528555883|FG006|Overall Study|Withdrawal by Subject|0|||
146558754|NCT03033784|528555884|FG007|Overall Study|Withdrawal by Subject|0|||
146558755|NCT03033784|528555885|FG008|Overall Study|Withdrawal by Subject|0|||
146558756|NCT03033784|528555886|FG009|Overall Study|Withdrawal by Subject|0|||
146558757|NCT03033784|528555887|FG010|Overall Study|Withdrawal by Subject|0|||
146558758|NCT03033784|528555888|FG011|Overall Study|Withdrawal by Subject|0|||
146558759|NCT03033784|528555889|FG012|Overall Study|Withdrawal by Subject|2|||
146558760|NCT01432444|528555890|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
146558761|NCT01432444|528555891|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
146558762|NCT01432444|528555892|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
146558763|NCT01432444|528555890|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
146558764|NCT01432444|528555891|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
146558765|NCT01432444|528555892|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
146558766|NCT01432444|528555890|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
146558767|NCT01432444|528555891|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
146558768|NCT01432444|528555892|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
146558769|NCT01432444|528555890|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
146558770|NCT01432444|528555891|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
146558771|NCT01432444|528555892|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
146558772|NCT01432444|528555890|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
146558773|NCT01432444|528555891|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
146558774|NCT01432444|528555892|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
146558775|NCT01432444|528555890|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
146558776|NCT01432444|528555891|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
146558777|NCT01432444|528555892|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
146558778|NCT01432444|528555890|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
146558779|NCT01432444|528555891|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
146558780|NCT01432444|528555892|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
146558781|NCT01432444|528555890|FG000|Treatment Phase|Lost to Follow-up|0|||
146558782|NCT01432444|528555891|FG001|Treatment Phase|Lost to Follow-up|33|||
146558783|NCT01432444|528555892|FG002|Treatment Phase|Lost to Follow-up|0|||
146558784|NCT01432444|528555890|FG000|Treatment Phase|Adverse Event|0|||
146558785|NCT01432444|528555891|FG001|Treatment Phase|Adverse Event|37|||
146638847|NCT05767749|528852905|FG004|Overall Study|Withdrawal by Subject|2|||
146558786|NCT01432444|528555892|FG002|Treatment Phase|Adverse Event|0|||
146638848|NCT05767749|528852906|FG005|Overall Study|Withdrawal by Subject|2|||
146638849|NCT03083873|528854712|FG000|Overall Study|Death|6|||
146638850|NCT03083873|528854713|FG001|Overall Study|Death|15|||
146638851|NCT03083873|528854714|FG002|Overall Study|Death|13|||
146638852|NCT03083873|528854715|FG003|Overall Study|Death|9|||
146638853|NCT03083873|528854716|FG004|Overall Study|Death|0|||
146638854|NCT03083873|528854712|FG000|Overall Study|Sponsor Terminated Study|0|||
146638855|NCT03083873|528854713|FG001|Overall Study|Sponsor Terminated Study|1|||
146638856|NCT03083873|528854714|FG002|Overall Study|Sponsor Terminated Study|2|||
146638857|NCT03083873|528854715|FG003|Overall Study|Sponsor Terminated Study|3|||
146638858|NCT03083873|528854716|FG004|Overall Study|Sponsor Terminated Study|0|||
146638859|NCT03083873|528854712|FG000|Overall Study|Lost to Follow-up|0|||
146638860|NCT03083873|528854713|FG001|Overall Study|Lost to Follow-up|1|||
146638861|NCT03083873|528854714|FG002|Overall Study|Lost to Follow-up|1|||
146638862|NCT03083873|528854715|FG003|Overall Study|Lost to Follow-up|0|||
146638863|NCT03083873|528854716|FG004|Overall Study|Lost to Follow-up|0|||
146638864|NCT03083873|528854712|FG000|Overall Study|Withdrawal by Subject|2|||
146638865|NCT03083873|528854713|FG001|Overall Study|Withdrawal by Subject|0|||
146638866|NCT03083873|528854714|FG002|Overall Study|Withdrawal by Subject|0|||
146638867|NCT03083873|528854715|FG003|Overall Study|Withdrawal by Subject|0|||
146638868|NCT03083873|528854716|FG004|Overall Study|Withdrawal by Subject|0|||
146638869|NCT03083873|528854712|FG000|Overall Study|Did Not Receive TIL|2|||
146638870|NCT03083873|528854713|FG001|Overall Study|Did Not Receive TIL|5|||
146638871|NCT03083873|528854714|FG002|Overall Study|Did Not Receive TIL|3|||
146638872|NCT03083873|528854715|FG003|Overall Study|Did Not Receive TIL|1|||
146638873|NCT03083873|528854716|FG004|Overall Study|Did Not Receive TIL|0|||
146638874|NCT01677377|528854717|FG000|Overall Study|Protocol Violation|1|||
146638875|NCT01677377|528854718|FG001|Overall Study|Protocol Violation|0|||
146638876|NCT01677377|528854719|FG002|Overall Study|Protocol Violation|0|||
146638877|NCT01677377|528854717|FG000|Overall Study|Lost to Follow-up|0|||
146638878|NCT01677377|528854718|FG001|Overall Study|Lost to Follow-up|1|||
146638879|NCT01677377|528854719|FG002|Overall Study|Lost to Follow-up|1|||
146638880|NCT01677377|528854717|FG000|Overall Study|Withdrawal by Subject|0|||
146638881|NCT01677377|528854718|FG001|Overall Study|Withdrawal by Subject|0|||
146638882|NCT01677377|528854719|FG002|Overall Study|Withdrawal by Subject|3|||
146638883|NCT01677377|528854717|FG000|Overall Study|Lack of Efficacy|0|||
146638884|NCT01677377|528854718|FG001|Overall Study|Lack of Efficacy|0|||
146638885|NCT01677377|528854719|FG002|Overall Study|Lack of Efficacy|1|||
146638886|NCT01677377|528854717|FG000|Overall Study|Pregnancy|0|||
146638887|NCT01677377|528854718|FG001|Overall Study|Pregnancy|0|||
146638888|NCT01677377|528854719|FG002|Overall Study|Pregnancy|1|||
146638889|NCT00479687|528854720|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
146638890|NCT00479687|528854721|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
146638891|NCT00479687|528854722|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
146638892|NCT00479687|528854720|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
146638893|NCT00479687|528854721|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
146638894|NCT00479687|528854722|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
146638895|NCT00479687|528854720|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
146638896|NCT00479687|528854721|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
146638897|NCT00479687|528854722|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
146638898|NCT00479687|528854720|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
146638899|NCT00479687|528854721|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
146638900|NCT00479687|528854722|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
146638901|NCT00479687|528854720|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
146638902|NCT00479687|528854721|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
146766540|NCT02914522|529312252|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
146766541|NCT02914522|529312253|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
146766542|NCT02914522|529312254|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
146766543|NCT02914522|529312255|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
146766544|NCT02914522|529312256|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
146558787|NCT01432444|528555890|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
146558788|NCT01432444|528555891|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
146558789|NCT01432444|528555892|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
146558790|NCT01432444|528555890|FG000|Treatment Phase|Physician Decision|0|||
146558791|NCT01432444|528555891|FG001|Treatment Phase|Physician Decision|5|||
146558792|NCT01432444|528555892|FG002|Treatment Phase|Physician Decision|0|||
146558793|NCT01432444|528555890|FG000|Treatment Phase|Withdrawal by Subject|0|||
146558794|NCT01432444|528555891|FG001|Treatment Phase|Withdrawal by Subject|41|||
146558795|NCT01432444|528555892|FG002|Treatment Phase|Withdrawal by Subject|0|||
146558796|NCT01432444|528555890|FG000|Treatment Phase|Protocol Deviation|0|||
146558797|NCT01432444|528555891|FG001|Treatment Phase|Protocol Deviation|3|||
146558798|NCT01432444|528555892|FG002|Treatment Phase|Protocol Deviation|0|||
146558799|NCT01432444|528555890|FG000|Treatment Phase|Lack of Efficacy|0|||
146558800|NCT01432444|528555891|FG001|Treatment Phase|Lack of Efficacy|10|||
146558801|NCT01432444|528555892|FG002|Treatment Phase|Lack of Efficacy|0|||
146558802|NCT01432444|528555890|FG000|Extension Phase|Lost to Follow-up|0|||
146558803|NCT01432444|528555891|FG001|Extension Phase|Lost to Follow-up|0|||
146558804|NCT01432444|528555892|FG002|Extension Phase|Lost to Follow-up|17|||
146558805|NCT01432444|528555890|FG000|Extension Phase|Adverse Event|0|||
146558806|NCT01432444|528555891|FG001|Extension Phase|Adverse Event|0|||
146558807|NCT01432444|528555892|FG002|Extension Phase|Adverse Event|10|||
146558808|NCT01432444|528555890|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
146558809|NCT01432444|528555891|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
146558810|NCT01432444|528555892|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
146558811|NCT01432444|528555890|FG000|Extension Phase|Met Withdrawal Criteria|0|||
146558812|NCT01432444|528555891|FG001|Extension Phase|Met Withdrawal Criteria|0|||
146558813|NCT01432444|528555892|FG002|Extension Phase|Met Withdrawal Criteria|144|||
146558814|NCT01432444|528555890|FG000|Extension Phase|Physician Decision|0|||
146558815|NCT01432444|528555891|FG001|Extension Phase|Physician Decision|0|||
146558816|NCT01432444|528555892|FG002|Extension Phase|Physician Decision|1|||
146558817|NCT01432444|528555890|FG000|Extension Phase|Withdrawal by Subject|0|||
146558818|NCT01432444|528555891|FG001|Extension Phase|Withdrawal by Subject|0|||
146558819|NCT01432444|528555892|FG002|Extension Phase|Withdrawal by Subject|13|||
146558820|NCT02157610|528555893|FG000|Overall Study|Death|4|||
146558821|NCT02157610|528555894|FG001|Overall Study|Death|4|||
146558822|NCT01946880|528555898|FG000|Overall Study|Lost to Follow-up|1|||
146558823|NCT01946880|528555899|FG001|Overall Study|Lost to Follow-up|0|||
146558824|NCT01946880|528555898|FG000|Overall Study|Physician Decision|1|||
146558825|NCT01946880|528555899|FG001|Overall Study|Physician Decision|1|||
146558826|NCT01946880|528555898|FG000|Overall Study|Withdrawal by Subject|3|||
146558827|NCT01946880|528555899|FG001|Overall Study|Withdrawal by Subject|2|||
146558828|NCT01946880|528555898|FG000|Overall Study|Met Primary Endpoint|1|||
146558829|NCT01946880|528555899|FG001|Overall Study|Met Primary Endpoint|0|||
146558830|NCT01946880|528555898|FG000|Overall Study|Personal and Family Issues|1|||
146558831|NCT01946880|528555899|FG001|Overall Study|Personal and Family Issues|0|||
146558832|NCT03647137|528555900|FG000|Overall Study|Scan Limitation|2|||
146558833|NCT03647137|528555901|FG001|Overall Study|Scan Limitation|1|||
146894509|NCT02928952|529779791|FG000|Overall Study|Withdrawal by Subject|5|||
146894510|NCT02928952|529779792|FG001|Overall Study|Withdrawal by Subject|1|||
146894511|NCT02928952|529779791|FG000|Overall Study|Physician Decision|0|||
146894512|NCT02928952|529779792|FG001|Overall Study|Physician Decision|1|||
146558834|NCT03647137|528555902|FG002|Overall Study|Scan Limitation|1|||
146558835|NCT03647137|528555903|FG003|Overall Study|Scan Limitation|2|||
146558836|NCT01443026|528555904|FG000|Overall Study|Physician Decision|1|||
146558837|NCT01443026|528555905|FG001|Overall Study|Physician Decision|0|||
146558838|NCT01443026|528555904|FG000|Overall Study|Death|0|||
146558839|NCT01443026|528555905|FG001|Overall Study|Death|1|||
146558840|NCT01443026|528555904|FG000|Overall Study|Withdrawal by Subject|0|||
146558841|NCT01443026|528555905|FG001|Overall Study|Withdrawal by Subject|3|||
146558842|NCT01443026|528555904|FG000|Overall Study|Lost to Follow-up|2|||
146558843|NCT01443026|528555905|FG001|Overall Study|Lost to Follow-up|1|||
146558844|NCT02034565|528555906|FG000|Overall Study|Adverse Event|1|||
146638903|NCT00479687|528854722|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
146638904|NCT00479687|528854720|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
146638905|NCT00479687|528854721|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
146638906|NCT00479687|528854722|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
146638907|NCT00479687|528854720|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
146638908|NCT00479687|528854721|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
146638909|NCT00479687|528854722|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
146638910|NCT00479687|528854720|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
146638911|NCT00479687|528854721|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
146638912|NCT00479687|528854722|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
146638913|NCT00479687|528854720|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
146638914|NCT00479687|528854721|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
146558845|NCT02034565|528555907|FG001|Overall Study|Adverse Event|0|||
146558846|NCT00581919|528555908|FG000|Overall Study|Adverse Event|8|||
146558847|NCT00581919|528555908|FG000|Overall Study|Death|1|||
146558848|NCT00581919|528555908|FG000|Overall Study|Disease Progression|10|||
146766545|NCT02914522|529312257|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
146766546|NCT02914522|529312247|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
146558849|NCT00581919|528555908|FG000|Overall Study|Physician Decision|1|||
146558850|NCT00581919|528555908|FG000|Overall Study|Other Complicating Disease|1|||
146558851|NCT00581919|528555908|FG000|Overall Study|Started Non-Protocol Therapy|2|||
146558852|NCT00581919|528555908|FG000|Overall Study|Withdrawal by Subject|1|||
146558853|NCT02655601|528555909|FG000|Overall Study|Adverse Event|0|||
146558854|NCT02655601|528555910|FG001|Overall Study|Adverse Event|0|||
146558855|NCT02655601|528555911|FG002|Overall Study|Adverse Event|0|||
146558856|NCT02655601|528555912|FG003|Overall Study|Adverse Event|1|||
146558857|NCT02655601|528555913|FG004|Overall Study|Adverse Event|1|||
146558858|NCT02655601|528555914|FG005|Overall Study|Adverse Event|0|||
146558859|NCT02655601|528555909|FG000|Overall Study|Physician Decision|0|||
146558860|NCT02655601|528555910|FG001|Overall Study|Physician Decision|0|||
146558861|NCT02655601|528555911|FG002|Overall Study|Physician Decision|0|||
146558862|NCT02655601|528555912|FG003|Overall Study|Physician Decision|0|||
146558863|NCT02655601|528555913|FG004|Overall Study|Physician Decision|1|||
146558864|NCT02655601|528555914|FG005|Overall Study|Physician Decision|1|||
146558865|NCT02655601|528555909|FG000|Overall Study|Withdrawal by Subject|0|||
146638915|NCT00479687|528854722|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
146638916|NCT00295880|528854723|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
146638917|NCT00295880|528854723|FG000|Overall Study|Unit randomization did not occur|1|||
146638918|NCT01474239|528854724|FG000|Overall Study|Disease Progression|37|||
146638919|NCT01474239|528854725|FG001|Overall Study|Disease Progression|25|||
146638920|NCT01474239|528854724|FG000|Overall Study|Adverse Event|12|||
146638921|NCT01474239|528854725|FG001|Overall Study|Adverse Event|3|||
146638922|NCT01474239|528854724|FG000|Overall Study|Withdrawal by Subject|1|||
146638923|NCT01474239|528854725|FG001|Overall Study|Withdrawal by Subject|2|||
146638924|NCT01474239|528854724|FG000|Overall Study|Death|1|||
146638925|NCT01474239|528854725|FG001|Overall Study|Death|1|||
146638926|NCT01474239|528854724|FG000|Overall Study|Clinical Disease Progression|7|||
146638927|NCT01474239|528854725|FG001|Overall Study|Clinical Disease Progression|1|||
146638928|NCT01474239|528854724|FG000|Overall Study|Withdrawal for Economic Reason|1|||
146638929|NCT01474239|528854725|FG001|Overall Study|Withdrawal for Economic Reason|0|||
146638930|NCT02260180|528854729|FG000|Overall Study|Adverse Event|2|||
146638931|NCT02260180|528854730|FG001|Overall Study|Adverse Event|0|||
146638932|NCT02260180|528854731|FG002|Overall Study|Adverse Event|1|||
146894513|NCT00974220|529779793|FG000|Treatment Period 1|Adverse Event|2|||
146894514|NCT00974220|529779794|FG001|Treatment Period 1|Adverse Event|1|||
146894515|NCT00974220|529779793|FG000|Treatment Period 1|noncompliant subjects|0|||
146894516|NCT00974220|529779794|FG001|Treatment Period 1|noncompliant subjects|1|||
146894517|NCT01850615|529779795|FG000|Overall Study|Protocol Violation|4|||
146894518|NCT01850615|529779796|FG001|Overall Study|Protocol Violation|1|||
146638933|NCT03126344|528854738|FG000|Overall Study|Lost to Follow-up|0|||
146638934|NCT03126344|528854739|FG001|Overall Study|Lost to Follow-up|0|||
146638935|NCT03126344|528854740|FG002|Overall Study|Lost to Follow-up|5|||
146638936|NCT01027273|528854741|FG000|Overall Study|Lost to Follow-up|57|||
146638937|NCT01027273|528854742|FG001|Overall Study|Lost to Follow-up|31|||
146638938|NCT01027273|528854741|FG000|Overall Study|Death|2|||
146638939|NCT01027273|528854742|FG001|Overall Study|Death|2|||
146638940|NCT01330108|528854749|FG000|Overall Study|Withdrawal by Subject|4|||
146638941|NCT00485134|528854750|FG000|Overall Study|Lost to Follow-up|1|||
146638942|NCT00485134|528854751|FG001|Overall Study|Lost to Follow-up|0|||
146638943|NCT00485134|528854752|FG002|Overall Study|Lost to Follow-up|0|||
146638944|NCT00485134|528854753|FG003|Overall Study|Lost to Follow-up|0|||
146638945|NCT00485134|528854754|FG004|Overall Study|Lost to Follow-up|0|||
146638946|NCT00485134|528854755|FG005|Overall Study|Lost to Follow-up|0|||
146638947|NCT00485134|528854756|FG006|Overall Study|Lost to Follow-up|0|||
146638948|NCT00485134|528854757|FG007|Overall Study|Lost to Follow-up|0|||
146638949|NCT00485134|528854750|FG000|Overall Study|Withdrawal by Subject|0|||
146638950|NCT00485134|528854751|FG001|Overall Study|Withdrawal by Subject|1|||
146638951|NCT00485134|528854752|FG002|Overall Study|Withdrawal by Subject|0|||
146638952|NCT00485134|528854753|FG003|Overall Study|Withdrawal by Subject|0|||
146638953|NCT00485134|528854754|FG004|Overall Study|Withdrawal by Subject|0|||
146638954|NCT00485134|528854755|FG005|Overall Study|Withdrawal by Subject|0|||
146638955|NCT00485134|528854756|FG006|Overall Study|Withdrawal by Subject|0|||
146894519|NCT01850615|529779795|FG000|Overall Study|Adverse Event|2|||
146894520|NCT01850615|529779796|FG001|Overall Study|Adverse Event|1|||
146638956|NCT00485134|528854757|FG007|Overall Study|Withdrawal by Subject|0|||
146638957|NCT00485134|528854750|FG000|Overall Study|Change in health status|0|||
146638958|NCT00485134|528854751|FG001|Overall Study|Change in health status|1|||
146638959|NCT00485134|528854752|FG002|Overall Study|Change in health status|2|||
146638960|NCT00485134|528854753|FG003|Overall Study|Change in health status|1|||
146638961|NCT00485134|528854754|FG004|Overall Study|Change in health status|0|||
146638962|NCT00485134|528854755|FG005|Overall Study|Change in health status|1|||
146638963|NCT00485134|528854756|FG006|Overall Study|Change in health status|0|||
146638964|NCT00485134|528854757|FG007|Overall Study|Change in health status|0|||
146638965|NCT00485134|528854750|FG000|Overall Study|Withdrew for adverse event|0|||
146638966|NCT00485134|528854751|FG001|Overall Study|Withdrew for adverse event|0|||
146638967|NCT00485134|528854752|FG002|Overall Study|Withdrew for adverse event|1|||
146638968|NCT00485134|528854753|FG003|Overall Study|Withdrew for adverse event|0|||
146638969|NCT00485134|528854754|FG004|Overall Study|Withdrew for adverse event|0|||
146638970|NCT00485134|528854755|FG005|Overall Study|Withdrew for adverse event|0|||
146638971|NCT00485134|528854756|FG006|Overall Study|Withdrew for adverse event|0|||
146638972|NCT00485134|528854757|FG007|Overall Study|Withdrew for adverse event|0|||
146638973|NCT00485134|528854750|FG000|Overall Study|Positive drug test|0|||
146638974|NCT00485134|528854751|FG001|Overall Study|Positive drug test|0|||
146638975|NCT00485134|528854752|FG002|Overall Study|Positive drug test|0|||
146638976|NCT00485134|528854753|FG003|Overall Study|Positive drug test|0|||
146638977|NCT00485134|528854754|FG004|Overall Study|Positive drug test|2|||
146638978|NCT00485134|528854755|FG005|Overall Study|Positive drug test|1|||
146638979|NCT00485134|528854756|FG006|Overall Study|Positive drug test|0|||
146638980|NCT00485134|528854757|FG007|Overall Study|Positive drug test|0|||
146638981|NCT00485134|528854750|FG000|Overall Study|Non-compliance|0|||
146638982|NCT00485134|528854751|FG001|Overall Study|Non-compliance|0|||
146894521|NCT01850615|529779795|FG000|Overall Study|Withdrawal by Subject|3|||
146894522|NCT01850615|529779796|FG001|Overall Study|Withdrawal by Subject|1|||
146894523|NCT01850615|529779795|FG000|Overall Study|Lost to Follow-up|0|||
146894524|NCT01850615|529779796|FG001|Overall Study|Lost to Follow-up|1|||
146894525|NCT01850615|529779795|FG000|Overall Study|Unclassified|0|||
146894526|NCT01850615|529779796|FG001|Overall Study|Unclassified|1|||
146894527|NCT02921425|529779797|FG000|Overall Study|Protocol Violation|9|||
146894528|NCT01227967|529779798|FG000|Overall Study|Protocol Violation|3|||
146894529|NCT01227967|529779799|FG001|Overall Study|Protocol Violation|1|||
146894530|NCT01227967|529779798|FG000|Overall Study|Death|0|||
146894531|NCT01227967|529779799|FG001|Overall Study|Death|1|||
146894532|NCT01227967|529779798|FG000|Overall Study|Lost to Follow-up|8|||
146894533|NCT01227967|529779799|FG001|Overall Study|Lost to Follow-up|3|||
146894534|NCT01227967|529779798|FG000|Overall Study|Withdrawal by Subject|4|||
146894535|NCT01227967|529779799|FG001|Overall Study|Withdrawal by Subject|3|||
146894536|NCT01227967|529779798|FG000|Overall Study|Physician Decision|0|||
146894537|NCT01227967|529779799|FG001|Overall Study|Physician Decision|1|||
146894538|NCT01227967|529779798|FG000|Overall Study|Never Started Treatment|0|||
146894539|NCT01227967|529779799|FG001|Overall Study|Never Started Treatment|4|||
146894540|NCT01227967|529779798|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
146638983|NCT00485134|528854752|FG002|Overall Study|Non-compliance|0|||
146638984|NCT00485134|528854753|FG003|Overall Study|Non-compliance|0|||
146894541|NCT01227967|529779799|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
146894542|NCT03403400|529779800|FG000|Overall Study|Lost to Follow-up|1|||
146894543|NCT03403400|529779801|FG001|Overall Study|Lost to Follow-up|0|||
146894544|NCT03403400|529779802|FG002|Overall Study|Lost to Follow-up|1|||
146894545|NCT03403400|529779800|FG000|Overall Study|Hospitalization|1|||
146894546|NCT03403400|529779801|FG001|Overall Study|Hospitalization|0|||
146894547|NCT03403400|529779802|FG002|Overall Study|Hospitalization|0|||
146894548|NCT03403400|529779800|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
146894549|NCT03403400|529779801|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
146638985|NCT00485134|528854754|FG004|Overall Study|Non-compliance|1|||
146638986|NCT00485134|528854755|FG005|Overall Study|Non-compliance|2|||
146638987|NCT00485134|528854756|FG006|Overall Study|Non-compliance|2|||
146638988|NCT00485134|528854757|FG007|Overall Study|Non-compliance|0|||
146638989|NCT00485134|528854750|FG000|Overall Study|Unable to comply with study schedule|0|||
146894550|NCT03403400|529779802|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
146894551|NCT00565617|529779806|FG000|Overall Study|Withdrawal by Subject|1|||
146894552|NCT01145560|529779807|FG000|Overall Study|Withdrawal by Subject|2|||
146894553|NCT01145560|529779808|FG001|Overall Study|Withdrawal by Subject|1|||
146894554|NCT01145560|529779809|FG002|Overall Study|Withdrawal by Subject|0|||
146894555|NCT01145560|529779807|FG000|Overall Study|Lost to Follow-up|1|||
146894556|NCT01145560|529779808|FG001|Overall Study|Lost to Follow-up|1|||
146638990|NCT00485134|528854751|FG001|Overall Study|Unable to comply with study schedule|0|||
146638991|NCT00485134|528854752|FG002|Overall Study|Unable to comply with study schedule|0|||
146638992|NCT00485134|528854753|FG003|Overall Study|Unable to comply with study schedule|0|||
146638993|NCT00485134|528854754|FG004|Overall Study|Unable to comply with study schedule|0|||
146638994|NCT00485134|528854755|FG005|Overall Study|Unable to comply with study schedule|0|||
146638995|NCT00485134|528854756|FG006|Overall Study|Unable to comply with study schedule|0|||
146638996|NCT00485134|528854757|FG007|Overall Study|Unable to comply with study schedule|1|||
146638997|NCT00485134|528854750|FG000|Overall Study|Pregnancy|0|||
146638998|NCT00485134|528854751|FG001|Overall Study|Pregnancy|0|||
146638999|NCT00485134|528854752|FG002|Overall Study|Pregnancy|0|||
146639000|NCT00485134|528854753|FG003|Overall Study|Pregnancy|0|||
146639001|NCT00485134|528854754|FG004|Overall Study|Pregnancy|0|||
146639002|NCT00485134|528854755|FG005|Overall Study|Pregnancy|0|||
146639003|NCT00485134|528854756|FG006|Overall Study|Pregnancy|1|||
146639004|NCT00485134|528854757|FG007|Overall Study|Pregnancy|0|||
146639005|NCT00970684|528854758|FG000|Overall Study|Lack of Efficacy|5|||
146639006|NCT00970684|528854758|FG000|Overall Study|Adverse Event|4|||
146639007|NCT00970684|528854758|FG000|Overall Study|Withdrawal by Subject|1|||
146639008|NCT00905645|528854760|FG000|Overall Study|Death (not device related)|10|||
146639009|NCT00905645|528854761|FG001|Overall Study|Death (not device related)|4|||
146639010|NCT00905645|528854762|FG002|Overall Study|Death (not device related)|15|||
146639011|NCT00905645|528854763|FG003|Overall Study|Death (not device related)|8|||
146639012|NCT00905645|528854760|FG000|Overall Study|Explantation of study device(s)|78|||
146639013|NCT00905645|528854761|FG001|Overall Study|Explantation of study device(s)|47|||
146639014|NCT00905645|528854762|FG002|Overall Study|Explantation of study device(s)|28|||
146639015|NCT00905645|528854763|FG003|Overall Study|Explantation of study device(s)|21|||
146639016|NCT00905645|528854760|FG000|Overall Study|Subject Request|41|||
146639017|NCT00905645|528854761|FG001|Overall Study|Subject Request|17|||
146639018|NCT00905645|528854762|FG002|Overall Study|Subject Request|13|||
146639019|NCT00905645|528854763|FG003|Overall Study|Subject Request|11|||
146639020|NCT00905645|528854760|FG000|Overall Study|Lost to Follow-up|299|||
146639021|NCT00905645|528854761|FG001|Overall Study|Lost to Follow-up|103|||
146639022|NCT00905645|528854762|FG002|Overall Study|Lost to Follow-up|51|||
146639023|NCT00905645|528854763|FG003|Overall Study|Lost to Follow-up|12|||
146639024|NCT04881942|528854764|FG000|Overall Study|Adverse Event|0|||
146639025|NCT04881942|528854765|FG001|Overall Study|Adverse Event|0|||
146639026|NCT04881942|528854766|FG002|Overall Study|Adverse Event|0|||
146639027|NCT04881942|528854767|FG003|Overall Study|Adverse Event|0|||
146639028|NCT04881942|528854768|FG004|Overall Study|Adverse Event|1|||
146639029|NCT04881942|528854764|FG000|Overall Study|Alternates|0|||
146639030|NCT04881942|528854765|FG001|Overall Study|Alternates|0|||
146639031|NCT04881942|528854766|FG002|Overall Study|Alternates|0|||
146639032|NCT04881942|528854767|FG003|Overall Study|Alternates|0|||
146639033|NCT04881942|528854768|FG004|Overall Study|Alternates|2|||
146639034|NCT00578292|528854769|FG000|Overall Study|Death|1|||
146639035|NCT00578292|528854769|FG000|Overall Study|Graft failure|2|||
146639036|NCT01587014|528854770|FG000|Overall Study|Death|2|||
146639037|NCT02948088|528854771|FG000|Overall Study|Lost to Follow-up|8|||
146894557|NCT01145560|529779809|FG002|Overall Study|Lost to Follow-up|1|||
146894558|NCT01145560|529779807|FG000|Overall Study|No study drug by 24h after organ failure|1|||
146639038|NCT02948088|528854771|FG000|Overall Study|Death|1|||
146639039|NCT02948088|528854771|FG000|Overall Study|Withdrawal by Subject|4|||
146639040|NCT02948088|528854771|FG000|Overall Study|Other|2|||
146639041|NCT01409811|528854772|FG000|Overall Study|Insurance denial|1|||
146639042|NCT00634101|528854773|FG000|Overall Study|Study Terminated|3|||
146639043|NCT00634101|528854774|FG001|Overall Study|Study Terminated|3|||
146639044|NCT00634101|528854773|FG000|Overall Study|Lost to Follow-up|2|||
146639045|NCT00634101|528854774|FG001|Overall Study|Lost to Follow-up|0|||
146639046|NCT00838513|528854776|FG000|Screening Period|Screen Failure|3|||
146639047|NCT00838513|528854776|FG000|Extension Treatment Period|Death|1|||
146639048|NCT00838513|528854776|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
146639049|NCT00139477|528854780|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
146639050|NCT00139477|528854781|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
146639051|NCT00139477|528854780|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
146639052|NCT00139477|528854781|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
146639053|NCT00139477|528854780|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
146639054|NCT00139477|528854781|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
146639055|NCT00139477|528854780|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
146639056|NCT00139477|528854781|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
146639057|NCT00139477|528854780|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
146639058|NCT00139477|528854781|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
146639059|NCT00139477|528854780|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
146894559|NCT01145560|529779808|FG001|Overall Study|No study drug by 24h after organ failure|0|||
146894560|NCT01145560|529779809|FG002|Overall Study|No study drug by 24h after organ failure|0|||
146894561|NCT01145560|529779807|FG000|Overall Study|Accidental unblinding of study treatment|0|||
146894562|NCT01145560|529779808|FG001|Overall Study|Accidental unblinding of study treatment|1|||
146894563|NCT01145560|529779809|FG002|Overall Study|Accidental unblinding of study treatment|0|||
146894564|NCT01145560|529779807|FG000|Overall Study|False insurance information|0|||
146894565|NCT01145560|529779808|FG001|Overall Study|False insurance information|1|||
146894566|NCT01145560|529779809|FG002|Overall Study|False insurance information|0|||
146639060|NCT00139477|528854781|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
146639061|NCT00139477|528854780|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
146639062|NCT00139477|528854781|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
146639063|NCT00975780|528854782|FG000|Follow Up|Death|88|||
146894567|NCT01145560|529779807|FG000|Overall Study|Withdrawal of therapy|0|||
146894568|NCT01145560|529779808|FG001|Overall Study|Withdrawal of therapy|0|||
146894569|NCT01145560|529779809|FG002|Overall Study|Withdrawal of therapy|1|||
146894570|NCT00712348|529779810|FG000|Overall Study|Withdrawal by Subject|1|||
146639064|NCT00975780|528854783|FG001|Follow Up|Death|122|||
146639065|NCT00975780|528854782|FG000|Follow Up|Facility Withdrawal|7|||
146639066|NCT00975780|528854783|FG001|Follow Up|Facility Withdrawal|23|||
146639067|NCT00975780|528854782|FG000|Follow Up|Discharged from Facility|7|||
146639068|NCT00975780|528854783|FG001|Follow Up|Discharged from Facility|12|||
146639069|NCT01077076|528854784|FG000|First Intervention|Withdrawal by Subject|1|||
146766547|NCT02914522|529312248|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
146766548|NCT02914522|529312249|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
146766549|NCT02914522|529312250|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
146766550|NCT02914522|529312251|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
146639070|NCT01077076|528854785|FG001|First Intervention|Withdrawal by Subject|0|||
146639071|NCT01077076|528854786|FG002|First Intervention|Withdrawal by Subject|0|||
146639072|NCT01077076|528854787|FG003|First Intervention|Withdrawal by Subject|0|||
146766551|NCT02914522|529312252|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
146968493|NCT00648739|530045445|FG004|Overall Study|Follow-up Visits Not Completed|0|||
146639073|NCT01077076|528854788|FG004|First Intervention|Withdrawal by Subject|0|||
146639074|NCT01077076|528854789|FG005|First Intervention|Withdrawal by Subject|0|||
146639075|NCT01077076|528854784|FG000|Third Intervention|Death in the participant's family|0|||
146639076|NCT01077076|528854785|FG001|Third Intervention|Death in the participant's family|0|||
146639077|NCT01077076|528854786|FG002|Third Intervention|Death in the participant's family|0|||
146639078|NCT01077076|528854787|FG003|Third Intervention|Death in the participant's family|0|||
146639079|NCT01077076|528854788|FG004|Third Intervention|Death in the participant's family|0|||
146639080|NCT01077076|528854789|FG005|Third Intervention|Death in the participant's family|1|||
146639081|NCT01976741|528854790|FG000|Overall Study|Withdrawal by Subject|1|||
146639082|NCT01976741|528854791|FG001|Overall Study|Withdrawal by Subject|0|||
146639083|NCT01976741|528854792|FG002|Overall Study|Withdrawal by Subject|1|||
146639084|NCT01976741|528854793|FG003|Overall Study|Withdrawal by Subject|1|||
146639085|NCT01976741|528854794|FG004|Overall Study|Withdrawal by Subject|0|||
146639086|NCT01976741|528854795|FG005|Overall Study|Withdrawal by Subject|0|||
146639087|NCT01976741|528854796|FG006|Overall Study|Withdrawal by Subject|1|||
146639088|NCT01976741|528854797|FG007|Overall Study|Withdrawal by Subject|4|||
146639089|NCT01976741|528854798|FG008|Overall Study|Withdrawal by Subject|0|||
146639090|NCT01976741|528854799|FG009|Overall Study|Withdrawal by Subject|0|||
146639091|NCT01976741|528854790|FG000|Overall Study|Adverse Event|0|||
146639092|NCT01976741|528854791|FG001|Overall Study|Adverse Event|0|||
146639093|NCT01976741|528854792|FG002|Overall Study|Adverse Event|2|||
146639094|NCT01976741|528854793|FG003|Overall Study|Adverse Event|0|||
146639095|NCT01976741|528854794|FG004|Overall Study|Adverse Event|0|||
146639096|NCT01976741|528854795|FG005|Overall Study|Adverse Event|0|||
146639097|NCT01976741|528854796|FG006|Overall Study|Adverse Event|3|||
146639098|NCT01976741|528854797|FG007|Overall Study|Adverse Event|8|||
146639099|NCT01976741|528854798|FG008|Overall Study|Adverse Event|1|||
146639100|NCT01976741|528854799|FG009|Overall Study|Adverse Event|4|||
146639101|NCT01415882|528854800|FG000|Overall Study|Ineligible|1|||
146639102|NCT01415882|528854801|FG001|Overall Study|Ineligible|0|||
146639103|NCT01415882|528854802|FG002|Overall Study|Ineligible|0|||
146639104|NCT01415882|528854803|FG003|Overall Study|Ineligible|3|||
146639105|NCT01415882|528854804|FG004|Overall Study|Ineligible|0|||
146639106|NCT01415882|528854800|FG000|Overall Study|Withdrawal by Subject|0|||
146639107|NCT01415882|528854801|FG001|Overall Study|Withdrawal by Subject|1|||
146639108|NCT01415882|528854802|FG002|Overall Study|Withdrawal by Subject|0|||
146639109|NCT01415882|528854803|FG003|Overall Study|Withdrawal by Subject|1|||
146639110|NCT01415882|528854804|FG004|Overall Study|Withdrawal by Subject|0|||
146639111|NCT00670306|528854805|FG000|Overall Study|Adverse Event|8|||
146639112|NCT00670306|528854805|FG000|Overall Study|Lack of Efficacy|10|||
146639113|NCT00670306|528854805|FG000|Overall Study|Withdrawal by Subject|9|||
146639114|NCT00670306|528854805|FG000|Overall Study|Physician Decision|1|||
146639115|NCT00670306|528854805|FG000|Overall Study|Lost to Follow-up|8|||
146639116|NCT00670306|528854805|FG000|Overall Study|incl/excl criterias did not meet|19|||
146639117|NCT00845897|528854806|FG000|Overall Study|Lost to Follow-up|1|||
146639118|NCT00845897|528854807|FG001|Overall Study|Lost to Follow-up|1|||
146766552|NCT02914522|529312253|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
146766553|NCT02914522|529312254|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
146639119|NCT00845897|528854808|FG002|Overall Study|Lost to Follow-up|0|||
146639120|NCT00845897|528854806|FG000|Overall Study|Withdrawal by Subject|0|||
146639121|NCT00845897|528854807|FG001|Overall Study|Withdrawal by Subject|3|||
146639122|NCT00845897|528854808|FG002|Overall Study|Withdrawal by Subject|2|||
146639123|NCT00845897|528854806|FG000|Overall Study|Ulcer did not heal|1|||
146639124|NCT00845897|528854807|FG001|Overall Study|Ulcer did not heal|0|||
146639125|NCT00845897|528854808|FG002|Overall Study|Ulcer did not heal|1|||
146639126|NCT00845897|528854806|FG000|Overall Study|Too ill to participate|0|||
146639127|NCT00845897|528854807|FG001|Overall Study|Too ill to participate|1|||
146639128|NCT00845897|528854808|FG002|Overall Study|Too ill to participate|0|||
146639129|NCT02722499|528854809|FG000|Overall Study|Lost to Follow-up|2|||
146639130|NCT02722499|528854810|FG001|Overall Study|Lost to Follow-up|0|||
146766554|NCT02914522|529312255|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
146558866|NCT02655601|528555910|FG001|Overall Study|Withdrawal by Subject|0|||
146894571|NCT01273064|529779813|FG000|Overall Study|Adverse Event|5|||
146639131|NCT02722499|528854811|FG002|Overall Study|Lost to Follow-up|1|||
146639132|NCT00369265|528854821|FG000|Overall Study|Study terminated|4|||
146639133|NCT00369265|528854822|FG001|Overall Study|Study terminated|7|||
146639134|NCT01192191|528854823|FG000|Overall Study|Adverse Event|7|||
146639135|NCT01192191|528854824|FG001|Overall Study|Adverse Event|12|||
146639136|NCT01192191|528854823|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
146639137|NCT01192191|528854824|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
146639138|NCT01192191|528854823|FG000|Overall Study|Lost to Follow-up|0|||
146639139|NCT01192191|528854824|FG001|Overall Study|Lost to Follow-up|1|||
146639140|NCT01192191|528854823|FG000|Overall Study|Withdrawal by Subject|1|||
146639141|NCT01192191|528854824|FG001|Overall Study|Withdrawal by Subject|6|||
146639142|NCT00467753|528854825|FG000|Overall Study|Lost to Follow-up|1|||
146639143|NCT00467753|528854826|FG001|Overall Study|Lost to Follow-up|2|||
146639144|NCT00467753|528854825|FG000|Overall Study|Adverse Event|2|||
146639145|NCT00467753|528854826|FG001|Overall Study|Adverse Event|0|||
146639146|NCT02817464|528854832|FG000|Overall Study|Lost to Follow-up|1|||
146639147|NCT02817464|528854833|FG001|Overall Study|Lost to Follow-up|0|||
146639148|NCT02817464|528854832|FG000|Overall Study|Discontinued early due to personal decision|1|||
146639149|NCT02817464|528854833|FG001|Overall Study|Discontinued early due to personal decision|1|||
146639150|NCT01273519|528854835|FG000|Overall Study|Adverse Event|3|||
146639151|NCT01273519|528854836|FG001|Overall Study|Adverse Event|0|||
146639152|NCT01273519|528854837|FG002|Overall Study|Adverse Event|0|||
146639153|NCT01273519|528854835|FG000|Overall Study|Lost to Follow-up|2|||
146639154|NCT01273519|528854836|FG001|Overall Study|Lost to Follow-up|1|||
146639155|NCT01273519|528854837|FG002|Overall Study|Lost to Follow-up|3|||
146639156|NCT01273519|528854835|FG000|Overall Study|Lack of Efficacy|8|||
146639157|NCT01273519|528854836|FG001|Overall Study|Lack of Efficacy|3|||
146639158|NCT01273519|528854837|FG002|Overall Study|Lack of Efficacy|4|||
146639159|NCT01273519|528854835|FG000|Overall Study|Other|6|||
146639160|NCT01273519|528854836|FG001|Overall Study|Other|1|||
146639161|NCT01273519|528854837|FG002|Overall Study|Other|1|||
146639162|NCT04292899|528854838|FG000|Overall Study|Death|21|||
146639163|NCT04292899|528854839|FG001|Overall Study|Death|28|||
146639164|NCT04292899|528854840|FG002|Overall Study|Death|188|||
146639165|NCT04292899|528854841|FG003|Overall Study|Death|371|||
146639166|NCT04292899|528854838|FG000|Overall Study|Lost to Follow-up|8|||
146639167|NCT04292899|528854839|FG001|Overall Study|Lost to Follow-up|4|||
146639168|NCT04292899|528854840|FG002|Overall Study|Lost to Follow-up|22|||
146639169|NCT04292899|528854841|FG003|Overall Study|Lost to Follow-up|235|||
146639170|NCT04292899|528854838|FG000|Overall Study|Withdrew consent|1|||
146639171|NCT04292899|528854839|FG001|Overall Study|Withdrew consent|0|||
146639172|NCT04292899|528854840|FG002|Overall Study|Withdrew consent|11|||
146766555|NCT02914522|529312256|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
146766556|NCT02914522|529312257|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
146766557|NCT02914522|529312247|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
146766558|NCT02914522|529312248|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
146766559|NCT02914522|529312249|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
146639173|NCT04292899|528854841|FG003|Overall Study|Withdrew consent|32|||
146639174|NCT04292899|528854838|FG000|Overall Study|Adverse Event|2|||
146639175|NCT04292899|528854839|FG001|Overall Study|Adverse Event|1|||
146766560|NCT02914522|529312250|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
146766561|NCT02914522|529312251|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
146766562|NCT02914522|529312252|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
146766563|NCT02914522|529312253|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
146639176|NCT04292899|528854840|FG002|Overall Study|Adverse Event|2|||
146639177|NCT04292899|528854841|FG003|Overall Study|Adverse Event|2|||
146639178|NCT04292899|528854838|FG000|Overall Study|Investigator's Discretion|0|||
146639179|NCT04292899|528854839|FG001|Overall Study|Investigator's Discretion|0|||
146639180|NCT04292899|528854840|FG002|Overall Study|Investigator's Discretion|0|||
146639181|NCT04292899|528854841|FG003|Overall Study|Investigator's Discretion|3|||
146639182|NCT04292899|528854838|FG000|Overall Study|Non-compliance With Study Drug|0|||
146639183|NCT04292899|528854839|FG001|Overall Study|Non-compliance With Study Drug|0|||
146639184|NCT04292899|528854840|FG002|Overall Study|Non-compliance With Study Drug|0|||
146639185|NCT04292899|528854841|FG003|Overall Study|Non-compliance With Study Drug|1|||
146639186|NCT04292899|528854838|FG000|Overall Study|Protocol Violation|0|||
146639187|NCT04292899|528854839|FG001|Overall Study|Protocol Violation|0|||
146639188|NCT04292899|528854840|FG002|Overall Study|Protocol Violation|0|||
146639189|NCT04292899|528854841|FG003|Overall Study|Protocol Violation|1|||
146558867|NCT02655601|528555911|FG002|Overall Study|Withdrawal by Subject|0|||
146558868|NCT02655601|528555912|FG003|Overall Study|Withdrawal by Subject|0|||
146558869|NCT02655601|528555913|FG004|Overall Study|Withdrawal by Subject|4|||
146558870|NCT02655601|528555914|FG005|Overall Study|Withdrawal by Subject|8|||
146558871|NCT02655601|528555909|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
146558872|NCT02655601|528555910|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
146558873|NCT02655601|528555911|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
146558874|NCT02655601|528555912|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
146558875|NCT02655601|528555913|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
146558876|NCT02655601|528555914|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
146558877|NCT00829868|528555915|FG000|Washout|Physician Decision|1|||
146558878|NCT00829868|528555916|FG001|Washout|Physician Decision|0|||
146558879|NCT01969409|528555917|FG000|Overall Study|Death|2|||
146558880|NCT01969409|528555918|FG001|Overall Study|Death|2|||
146558881|NCT01969409|528555917|FG000|Overall Study|Transplant|1|||
146558882|NCT01969409|528555918|FG001|Overall Study|Transplant|1|||
146558883|NCT01969409|528555917|FG000|Overall Study|Withdrawal by Subject|0|||
146558884|NCT01969409|528555918|FG001|Overall Study|Withdrawal by Subject|1|||
146558885|NCT02799043|528555920|FG000|Overall Study|Adverse Event|0|||
146558886|NCT02799043|528555921|FG001|Overall Study|Adverse Event|1|||
146558887|NCT02799043|528555920|FG000|Overall Study|Death|1|||
146558888|NCT02799043|528555921|FG001|Overall Study|Death|1|||
146558889|NCT02799043|528555920|FG000|Overall Study|Lost to Follow-up|3|||
146558890|NCT02799043|528555921|FG001|Overall Study|Lost to Follow-up|6|||
146558891|NCT02799043|528555920|FG000|Overall Study|Withdrawal by Subject|4|||
146558892|NCT02799043|528555921|FG001|Overall Study|Withdrawal by Subject|4|||
146558893|NCT02799043|528555920|FG000|Overall Study|Moved to different country|0|||
146558894|NCT02799043|528555921|FG001|Overall Study|Moved to different country|1|||
146558895|NCT02799043|528555920|FG000|Overall Study|Trial Screen Failure|1|||
146558896|NCT02799043|528555921|FG001|Overall Study|Trial Screen Failure|0|||
146558897|NCT02799043|528555920|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
146558898|NCT02799043|528555921|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
146639190|NCT00828204|528854846|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
146639191|NCT00828204|528854847|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
146766564|NCT02914522|529312254|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
146766565|NCT02914522|529312255|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
146558899|NCT01554904|528555924|FG000|Overall Study|Withdrawal by Subject|3|||
146558900|NCT01554904|528555924|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
146558901|NCT01051661|528555927|FG000|Overall Study|Adverse Event|1|||
146558902|NCT01051661|528555928|FG001|Overall Study|Adverse Event|1|||
146558903|NCT01051661|528555929|FG002|Overall Study|Adverse Event|1|||
146558904|NCT01051661|528555930|FG003|Overall Study|Adverse Event|1|||
146558905|NCT01051661|528555931|FG004|Overall Study|Adverse Event|0|||
146558906|NCT01051661|528555932|FG005|Overall Study|Adverse Event|0|||
146558907|NCT01051661|528555927|FG000|Overall Study|Lost to Follow-up|13|||
146558908|NCT01051661|528555928|FG001|Overall Study|Lost to Follow-up|22|||
146558909|NCT01051661|528555929|FG002|Overall Study|Lost to Follow-up|15|||
146639192|NCT00828204|528854846|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
146639193|NCT00828204|528854847|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
146639194|NCT00828204|528854846|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
146639195|NCT00828204|528854847|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
146639196|NCT00828204|528854846|FG000|Main Study: After Study Restart|Adverse Event|0|||
146639197|NCT00828204|528854847|FG001|Main Study: After Study Restart|Adverse Event|2|||
146639198|NCT00828204|528854846|FG000|Main Study: After Study Restart|Noncompliance|0|||
146639199|NCT00828204|528854847|FG001|Main Study: After Study Restart|Noncompliance|1|||
146639200|NCT00828204|528854846|FG000|Extension Study|Lost to Follow-up|0|||
146639201|NCT00828204|528854847|FG001|Extension Study|Lost to Follow-up|1|||
146639202|NCT00828204|528854846|FG000|Extension Study|Physician Decision|0|||
146639203|NCT00828204|528854847|FG001|Extension Study|Physician Decision|2|||
146639204|NCT01704599|528854854|FG000|Overall Study|Adverse Event|1|||
146639205|NCT02840461|528854855|FG000|Overall Study|Adverse Event|1|||
146639206|NCT02840461|528854856|FG001|Overall Study|Adverse Event|5|||
146639207|NCT02840461|528854857|FG002|Overall Study|Adverse Event|3|||
146639208|NCT02840461|528854855|FG000|Overall Study|Lost to Follow-up|10|||
146639209|NCT02840461|528854856|FG001|Overall Study|Lost to Follow-up|7|||
146639210|NCT02840461|528854857|FG002|Overall Study|Lost to Follow-up|6|||
146639211|NCT02840461|528854855|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
146639212|NCT02840461|528854856|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
146639213|NCT02840461|528854857|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
146639214|NCT02840461|528854855|FG000|Overall Study|Protocol Violation|2|||
146639215|NCT02840461|528854856|FG001|Overall Study|Protocol Violation|3|||
146639216|NCT02840461|528854857|FG002|Overall Study|Protocol Violation|1|||
146639217|NCT02840461|528854855|FG000|Overall Study|Withdrawal by Subject|10|||
146639218|NCT02840461|528854856|FG001|Overall Study|Withdrawal by Subject|6|||
146639219|NCT02840461|528854857|FG002|Overall Study|Withdrawal by Subject|2|||
146639220|NCT02840461|528854855|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
146639221|NCT02840461|528854856|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
146639222|NCT02840461|528854857|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
146639223|NCT01737502|528854860|FG000|Phase I|Disease progression|2|||
146639224|NCT01737502|528854861|FG001|Phase I|Disease progression|3|||
146894572|NCT01273064|529779814|FG001|Overall Study|Adverse Event|1|||
146894573|NCT01273064|529779815|FG002|Overall Study|Adverse Event|3|||
146894574|NCT01273064|529779816|FG003|Overall Study|Adverse Event|2|||
146894575|NCT01273064|529779817|FG004|Overall Study|Adverse Event|1|||
146894576|NCT01273064|529779813|FG000|Overall Study|Withdrawal by Subject|4|||
146894577|NCT01273064|529779814|FG001|Overall Study|Withdrawal by Subject|2|||
146894578|NCT01273064|529779815|FG002|Overall Study|Withdrawal by Subject|2|||
146639225|NCT01737502|528854860|FG000|Phase I|Complicating disease|1|||
146639226|NCT01737502|528854861|FG001|Phase I|Complicating disease|0|||
146639227|NCT01737502|528854860|FG000|Phase II|Adverse Event|0|||
146639228|NCT01737502|528854861|FG001|Phase II|Adverse Event|3|||
146639229|NCT01737502|528854860|FG000|Phase II|Disease progression|0|||
146639230|NCT01737502|528854861|FG001|Phase II|Disease progression|18|||
146639231|NCT01737502|528854860|FG000|Phase II|Death|0|||
146639232|NCT01737502|528854861|FG001|Phase II|Death|1|||
146639233|NCT01737502|528854860|FG000|Phase II|Transition to hospice care|0|||
146639234|NCT01737502|528854861|FG001|Phase II|Transition to hospice care|1|||
146639235|NCT02003924|528854872|FG000|Double-blind Phase|Lost to Follow-up|2|||
146639236|NCT02003924|528854873|FG001|Double-blind Phase|Lost to Follow-up|1|||
146639237|NCT02003924|528854874|FG002|Double-blind Phase|Lost to Follow-up|0|||
146639238|NCT02003924|528854872|FG000|Double-blind Phase|Protocol Violation|1|||
146639239|NCT02003924|528854873|FG001|Double-blind Phase|Protocol Violation|2|||
146639240|NCT02003924|528854874|FG002|Double-blind Phase|Protocol Violation|0|||
146639241|NCT02003924|528854872|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
146639242|NCT02003924|528854873|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
146639243|NCT02003924|528854874|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
146894579|NCT01273064|529779816|FG003|Overall Study|Withdrawal by Subject|2|||
146639244|NCT02003924|528854872|FG000|Double-blind Phase|Disease Progression|229|||
146639245|NCT02003924|528854873|FG001|Double-blind Phase|Disease Progression|247|||
146639246|NCT02003924|528854874|FG002|Double-blind Phase|Disease Progression|0|||
146639247|NCT02003924|528854872|FG000|Double-blind Phase|Adverse Event|120|||
146639248|NCT02003924|528854873|FG001|Double-blind Phase|Adverse Event|31|||
146639249|NCT02003924|528854874|FG002|Double-blind Phase|Adverse Event|0|||
146639250|NCT02003924|528854872|FG000|Double-blind Phase|Randomized But not Treated|3|||
146639251|NCT02003924|528854873|FG001|Double-blind Phase|Randomized But not Treated|3|||
146639252|NCT02003924|528854874|FG002|Double-blind Phase|Randomized But not Treated|0|||
146894580|NCT01273064|529779817|FG004|Overall Study|Withdrawal by Subject|0|||
146766566|NCT02914522|529312256|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
146766567|NCT02914522|529312257|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
146639253|NCT02003924|528854872|FG000|Double-blind Phase|Other|29|||
146639254|NCT02003924|528854873|FG001|Double-blind Phase|Other|50|||
146639255|NCT02003924|528854874|FG002|Double-blind Phase|Other|0|||
146639256|NCT02003924|528854872|FG000|Open-label Phase|Lost to Follow-up|0|||
146639257|NCT02003924|528854873|FG001|Open-label Phase|Lost to Follow-up|0|||
146639258|NCT02003924|528854874|FG002|Open-label Phase|Lost to Follow-up|1|||
146639259|NCT02003924|528854872|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
146639260|NCT02003924|528854873|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
146639261|NCT02003924|528854874|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
146639262|NCT02003924|528854872|FG000|Open-label Phase|Disease Progression|59|||
146639263|NCT02003924|528854873|FG001|Open-label Phase|Disease Progression|0|||
146639264|NCT02003924|528854874|FG002|Open-label Phase|Disease Progression|5|||
146894581|NCT01273064|529779813|FG000|Overall Study|Study Termination|13|||
146894582|NCT01273064|529779814|FG001|Overall Study|Study Termination|27|||
146894583|NCT01273064|529779815|FG002|Overall Study|Study Termination|26|||
146894584|NCT01273064|529779816|FG003|Overall Study|Study Termination|16|||
146894585|NCT01273064|529779817|FG004|Overall Study|Study Termination|8|||
146894586|NCT01273064|529779813|FG000|Overall Study|Lost to Follow-up|1|||
146894587|NCT01273064|529779814|FG001|Overall Study|Lost to Follow-up|0|||
146894588|NCT01273064|529779815|FG002|Overall Study|Lost to Follow-up|0|||
146894589|NCT01273064|529779816|FG003|Overall Study|Lost to Follow-up|0|||
146894590|NCT01273064|529779817|FG004|Overall Study|Lost to Follow-up|0|||
146639265|NCT02003924|528854872|FG000|Open-label Phase|Adverse Event|25|||
146639266|NCT02003924|528854873|FG001|Open-label Phase|Adverse Event|0|||
146639267|NCT02003924|528854874|FG002|Open-label Phase|Adverse Event|10|||
146639268|NCT02003924|528854872|FG000|Open-label Phase|Other|7|||
146894591|NCT01273064|529779813|FG000|Overall Study|Physician Decision|0|||
146894592|NCT01273064|529779814|FG001|Overall Study|Physician Decision|0|||
146894593|NCT01273064|529779815|FG002|Overall Study|Physician Decision|0|||
146968494|NCT00648739|530045446|FG005|Overall Study|Follow-up Visits Not Completed|0|||
146968495|NCT00648739|530045447|FG006|Overall Study|Follow-up Visits Not Completed|0|||
146639269|NCT02003924|528854873|FG001|Open-label Phase|Other|0|||
146639270|NCT02003924|528854874|FG002|Open-label Phase|Other|0|||
146639271|NCT02003924|528854872|FG000|Long-term Follow-up Phase|Death|288|||
146639272|NCT02003924|528854873|FG001|Long-term Follow-up Phase|Death|174|||
146894594|NCT01273064|529779816|FG003|Overall Study|Physician Decision|0|||
146894595|NCT01273064|529779817|FG004|Overall Study|Physician Decision|1|||
146766568|NCT02914522|529312247|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
146766569|NCT02914522|529312248|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
146766570|NCT02914522|529312249|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
146766571|NCT02914522|529312250|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
146766572|NCT02914522|529312251|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
146766573|NCT02914522|529312252|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
146766574|NCT02914522|529312253|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
146766575|NCT02914522|529312254|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
146766576|NCT02914522|529312255|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
146766577|NCT02914522|529312256|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
146766578|NCT02914522|529312257|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
146766579|NCT02914522|529312247|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
146766580|NCT02914522|529312248|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
146766581|NCT02914522|529312249|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
146766582|NCT02914522|529312250|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
146766583|NCT02914522|529312251|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
146766584|NCT02914522|529312252|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
146766585|NCT02914522|529312253|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
146766586|NCT02914522|529312254|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
146766587|NCT02914522|529312255|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
146766588|NCT02914522|529312256|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
146766589|NCT02914522|529312257|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
146766590|NCT02914522|529312247|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146894596|NCT01375764|529779818|FG000|Overall Study|Lost to Follow-up|0|||
146894597|NCT01375764|529779819|FG001|Overall Study|Lost to Follow-up|1|||
146894598|NCT01375764|529779820|FG002|Overall Study|Lost to Follow-up|0|||
146894599|NCT01375764|529779821|FG003|Overall Study|Lost to Follow-up|0|||
146894600|NCT01375764|529779822|FG004|Overall Study|Lost to Follow-up|0|||
146639273|NCT02003924|528854874|FG002|Long-term Follow-up Phase|Death|4|||
146639274|NCT02003924|528854872|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
146639275|NCT02003924|528854873|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
146639276|NCT02003924|528854874|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
146639277|NCT02003924|528854872|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
146639278|NCT02003924|528854873|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
146639279|NCT02003924|528854874|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
146639280|NCT02003924|528854872|FG000|Long-term Follow-up Phase|Other|5|||
146639281|NCT02003924|528854873|FG001|Long-term Follow-up Phase|Other|2|||
146639282|NCT02003924|528854874|FG002|Long-term Follow-up Phase|Other|1|||
146639283|NCT00124306|528854878|FG000|Overall Study|Adverse Event|7|||
146639284|NCT00124306|528854879|FG001|Overall Study|Adverse Event|2|||
146639285|NCT00124306|528854878|FG000|Overall Study|Lost to Follow-up|10|||
146639286|NCT00124306|528854879|FG001|Overall Study|Lost to Follow-up|6|||
146639287|NCT00124306|528854878|FG000|Overall Study|Lack of Efficacy|3|||
146639288|NCT00124306|528854879|FG001|Overall Study|Lack of Efficacy|6|||
146639289|NCT00124306|528854878|FG000|Overall Study|Personal constraints|0|||
146639290|NCT00124306|528854879|FG001|Overall Study|Personal constraints|2|||
146639291|NCT00124306|528854878|FG000|Overall Study|Use of unacceptable medication|1|||
146639292|NCT00124306|528854879|FG001|Overall Study|Use of unacceptable medication|0|||
146639293|NCT00124306|528854878|FG000|Overall Study|Abnormal lab result|0|||
146639294|NCT00124306|528854879|FG001|Overall Study|Abnormal lab result|1|||
146639295|NCT00124306|528854878|FG000|Overall Study|Other|2|||
146639296|NCT00124306|528854879|FG001|Overall Study|Other|0|||
146639297|NCT00560352|528854881|FG000|Overall Study|Adverse event unrelated to study drug|2|||
146639298|NCT00560352|528854882|FG001|Overall Study|Adverse event unrelated to study drug|1|||
146639299|NCT00560352|528854883|FG002|Overall Study|Adverse event unrelated to study drug|1|||
146766591|NCT02914522|529312248|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146766592|NCT02914522|529312249|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146766593|NCT02914522|529312250|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146766594|NCT02914522|529312251|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146766595|NCT02914522|529312252|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146766596|NCT02914522|529312253|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146766597|NCT02914522|529312254|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
146766598|NCT02914522|529312255|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
146766599|NCT02914522|529312256|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146766600|NCT02914522|529312257|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146766601|NCT02914522|529312247|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146894601|NCT01375764|529779818|FG000|Overall Study|Withdrawal by Subject|2|||
146639300|NCT00560352|528854881|FG000|Overall Study|Study drug toxicity|3|||
146639301|NCT00560352|528854882|FG001|Overall Study|Study drug toxicity|0|||
146639302|NCT00560352|528854883|FG002|Overall Study|Study drug toxicity|1|||
146639303|NCT00560352|528854881|FG000|Overall Study|Disease progression|0|||
146968496|NCT03606109|530045452|FG000|Overall Study|Lost to Follow-up|2|||
146968497|NCT03606109|530045453|FG001|Overall Study|Lost to Follow-up|1|||
146968498|NCT03669640|530045454|FG000|Overall Study|Study Terminated by Sponsor|0|||
146968499|NCT03669640|530045455|FG001|Overall Study|Study Terminated by Sponsor|0|||
146968500|NCT03669640|530045456|FG002|Overall Study|Study Terminated by Sponsor|0|||
146968501|NCT03669640|530045457|FG003|Overall Study|Study Terminated by Sponsor|0|||
146766602|NCT02914522|529312248|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146766603|NCT02914522|529312249|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146766604|NCT02914522|529312250|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146968502|NCT03669640|530045458|FG004|Overall Study|Study Terminated by Sponsor|1|||
146968503|NCT03669640|530045459|FG005|Overall Study|Study Terminated by Sponsor|0|||
146968504|NCT03669640|530045454|FG000|Overall Study|Lost to Follow-up|0|||
146968505|NCT03669640|530045455|FG001|Overall Study|Lost to Follow-up|0|||
146968506|NCT03669640|530045456|FG002|Overall Study|Lost to Follow-up|2|||
146558910|NCT01051661|528555930|FG003|Overall Study|Lost to Follow-up|17|||
146558911|NCT01051661|528555931|FG004|Overall Study|Lost to Follow-up|10|||
146558912|NCT01051661|528555932|FG005|Overall Study|Lost to Follow-up|24|||
146558913|NCT01051661|528555927|FG000|Overall Study|Migrated/moved from study area|1|||
146558914|NCT01051661|528555928|FG001|Overall Study|Migrated/moved from study area|6|||
146558915|NCT01051661|528555929|FG002|Overall Study|Migrated/moved from study area|6|||
146558916|NCT01051661|528555930|FG003|Overall Study|Migrated/moved from study area|8|||
146558917|NCT01051661|528555931|FG004|Overall Study|Migrated/moved from study area|7|||
146766605|NCT02914522|529312251|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146558918|NCT01051661|528555932|FG005|Overall Study|Migrated/moved from study area|3|||
146558919|NCT01051661|528555927|FG000|Overall Study|Refused blood sampling|0|||
146558920|NCT01051661|528555928|FG001|Overall Study|Refused blood sampling|0|||
146558921|NCT01051661|528555929|FG002|Overall Study|Refused blood sampling|0|||
146639304|NCT00560352|528854882|FG001|Overall Study|Disease progression|1|||
146639305|NCT00560352|528854883|FG002|Overall Study|Disease progression|1|||
146639306|NCT00560352|528854881|FG000|Overall Study|Withdrawal by Subject|1|||
146639307|NCT00560352|528854882|FG001|Overall Study|Withdrawal by Subject|1|||
146639308|NCT00560352|528854883|FG002|Overall Study|Withdrawal by Subject|1|||
146639309|NCT00560352|528854881|FG000|Overall Study|Maximum clinical benefit|1|||
146639310|NCT00560352|528854882|FG001|Overall Study|Maximum clinical benefit|0|||
146639311|NCT00560352|528854883|FG002|Overall Study|Maximum clinical benefit|0|||
146639312|NCT00114517|528854884|FG000|Overall Study|Adverse Event|6|||
146639313|NCT00114517|528854885|FG001|Overall Study|Adverse Event|1|||
146639314|NCT00114517|528854886|FG002|Overall Study|Adverse Event|6|||
146639315|NCT00114517|528854887|FG003|Overall Study|Adverse Event|3|||
146639316|NCT00114517|528854884|FG000|Overall Study|Lost to Follow-up|2|||
146639317|NCT00114517|528854885|FG001|Overall Study|Lost to Follow-up|2|||
146639318|NCT00114517|528854886|FG002|Overall Study|Lost to Follow-up|2|||
146639319|NCT00114517|528854887|FG003|Overall Study|Lost to Follow-up|1|||
146639320|NCT00114517|528854884|FG000|Overall Study|Too busy|3|||
146639321|NCT00114517|528854885|FG001|Overall Study|Too busy|1|||
146639322|NCT00114517|528854886|FG002|Overall Study|Too busy|1|||
146639323|NCT00114517|528854887|FG003|Overall Study|Too busy|2|||
146639324|NCT00114517|528854884|FG000|Overall Study|Moved from area|0|||
146639325|NCT00114517|528854885|FG001|Overall Study|Moved from area|3|||
146639326|NCT00114517|528854886|FG002|Overall Study|Moved from area|2|||
146639327|NCT00114517|528854887|FG003|Overall Study|Moved from area|1|||
146639328|NCT00114517|528854884|FG000|Overall Study|Did not want estradiol|1|||
146639329|NCT00114517|528854885|FG001|Overall Study|Did not want estradiol|1|||
146639330|NCT00114517|528854886|FG002|Overall Study|Did not want estradiol|0|||
146639331|NCT00114517|528854887|FG003|Overall Study|Did not want estradiol|0|||
146639332|NCT00114517|528854884|FG000|Overall Study|Armed-services duty|0|||
146639333|NCT00114517|528854885|FG001|Overall Study|Armed-services duty|1|||
146639334|NCT00114517|528854886|FG002|Overall Study|Armed-services duty|0|||
146639335|NCT00114517|528854887|FG003|Overall Study|Armed-services duty|1|||
146639336|NCT00114517|528854884|FG000|Overall Study|Competing family issue|0|||
146639337|NCT00114517|528854885|FG001|Overall Study|Competing family issue|1|||
146639338|NCT00114517|528854886|FG002|Overall Study|Competing family issue|0|||
146639339|NCT00114517|528854887|FG003|Overall Study|Competing family issue|1|||
146639340|NCT00114517|528854884|FG000|Overall Study|Physician Decision|0|||
146639341|NCT00114517|528854885|FG001|Overall Study|Physician Decision|1|||
146639342|NCT00114517|528854886|FG002|Overall Study|Physician Decision|0|||
146639343|NCT00114517|528854887|FG003|Overall Study|Physician Decision|0|||
146639344|NCT00114517|528854884|FG000|Overall Study|Lost interest|0|||
146639345|NCT00114517|528854885|FG001|Overall Study|Lost interest|0|||
146639346|NCT00114517|528854886|FG002|Overall Study|Lost interest|1|||
146639347|NCT00114517|528854887|FG003|Overall Study|Lost interest|0|||
146639348|NCT00114517|528854884|FG000|Overall Study|Weight increase|0|||
146639349|NCT00114517|528854885|FG001|Overall Study|Weight increase|0|||
146639350|NCT00114517|528854886|FG002|Overall Study|Weight increase|1|||
146639351|NCT00114517|528854887|FG003|Overall Study|Weight increase|0|||
146639352|NCT00114517|528854884|FG000|Overall Study|Concern about blood clots|0|||
146639353|NCT00114517|528854885|FG001|Overall Study|Concern about blood clots|0|||
146639354|NCT00114517|528854886|FG002|Overall Study|Concern about blood clots|1|||
146639355|NCT00114517|528854887|FG003|Overall Study|Concern about blood clots|0|||
146639356|NCT00114517|528854884|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
146639357|NCT00114517|528854885|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
146639358|NCT00114517|528854886|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
146639359|NCT00114517|528854887|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
146639360|NCT00539864|528856464|FG000|Overall Study|Lost to Follow-up|0|||
146639361|NCT00539864|528856465|FG001|Overall Study|Lost to Follow-up|1|||
146639362|NCT00539864|528856464|FG000|Overall Study|Withdrawal by Subject|1|||
146639363|NCT00539864|528856465|FG001|Overall Study|Withdrawal by Subject|1|||
146639364|NCT00943072|528856471|FG000|Overall Study|Adverse Event|0|||
146639365|NCT00943072|528856472|FG001|Overall Study|Adverse Event|3|||
146639366|NCT00943072|528856471|FG000|Overall Study|Death|0|||
146639367|NCT00943072|528856472|FG001|Overall Study|Death|2|||
146639368|NCT00943072|528856471|FG000|Overall Study|Withdrawal by Subject|3|||
146639369|NCT00943072|528856472|FG001|Overall Study|Withdrawal by Subject|1|||
146639370|NCT00943072|528856471|FG000|Overall Study|Protocol Violation|0|||
146639371|NCT00943072|528856472|FG001|Overall Study|Protocol Violation|1|||
146639372|NCT00943072|528856471|FG000|Overall Study|Lost to Follow-up|1|||
146639373|NCT00943072|528856472|FG001|Overall Study|Lost to Follow-up|2|||
146639374|NCT00943072|528856471|FG000|Overall Study|Lack of Efficacy|0|||
146639375|NCT00943072|528856472|FG001|Overall Study|Lack of Efficacy|4|||
146639376|NCT00943072|528856471|FG000|Overall Study|Other|1|||
146639377|NCT00943072|528856472|FG001|Overall Study|Other|1|||
146639378|NCT03860818|528856478|FG000|Overall Study|Death|144|||
146639379|NCT03860818|528856479|FG001|Overall Study|Death|195|||
146639380|NCT03860818|528856478|FG000|Overall Study|Graft Loss|32|||
146639381|NCT03860818|528856479|FG001|Overall Study|Graft Loss|45|||
146639382|NCT00792571|528856480|FG000|Overall Study|Death|1|||
146639383|NCT00792571|528856480|FG000|Overall Study|Adverse Event|4|||
146639384|NCT00792571|528856480|FG000|Overall Study|Withdrawal by Subject|1|||
146639385|NCT00792571|528856480|FG000|Overall Study|Other|4|||
146639386|NCT02600819|528856481|FG000|GEN Phase|Adverse Event|2|||
146639387|NCT02600819|528856482|FG001|GEN Phase|Adverse Event|0|||
146639388|NCT02600819|528856481|FG000|GEN Phase|Death|2|||
146639389|NCT02600819|528856482|FG001|GEN Phase|Death|0|||
146639390|NCT02600819|528856481|FG000|GEN Phase|Investigator's Discretion|4|||
146639391|NCT02600819|528856482|FG001|GEN Phase|Investigator's Discretion|0|||
146639392|NCT02600819|528856481|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
146639393|NCT02600819|528856482|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
146639394|NCT02600819|528856481|FG000|GEN Phase|Withdrew Consent|5|||
146639395|NCT02600819|528856482|FG001|GEN Phase|Withdrew Consent|0|||
146639396|NCT02600819|528856481|FG000|GEN Phase|Lost to Follow-up|2|||
146639397|NCT02600819|528856482|FG001|GEN Phase|Lost to Follow-up|0|||
146639398|NCT01715857|528856483|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
146639399|NCT00505778|528856484|FG000|Overall Study|Adverse Event|2|||
146639400|NCT00505778|528856485|FG001|Overall Study|Adverse Event|7|||
146639401|NCT00505778|528856484|FG000|Overall Study|Physician Decision|8|||
146639402|NCT00505778|528856485|FG001|Overall Study|Physician Decision|14|||
146639403|NCT00505778|528856484|FG000|Overall Study|Lost to Follow-up|17|||
146639404|NCT00505778|528856485|FG001|Overall Study|Lost to Follow-up|23|||
146639405|NCT00505778|528856484|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
146639406|NCT00505778|528856485|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
146639407|NCT00505778|528856484|FG000|Overall Study|Protocol Violation|7|||
146639408|NCT00505778|528856485|FG001|Overall Study|Protocol Violation|9|||
146639409|NCT00505778|528856484|FG000|Overall Study|Withdrawal by Subject|29|||
146639410|NCT00505778|528856485|FG001|Overall Study|Withdrawal by Subject|14|||
146639411|NCT00505778|528856484|FG000|Overall Study|Relapse|65|||
146639412|NCT00505778|528856485|FG001|Overall Study|Relapse|65|||
146639413|NCT00505778|528856484|FG000|Overall Study|Took No Study Drug|2|||
146639414|NCT00505778|528856485|FG001|Overall Study|Took No Study Drug|2|||
146639415|NCT03790696|528856488|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
146639416|NCT03790696|528856489|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
146639417|NCT00481091|528856496|FG000|Overall Study|Withdrawal by Subject|0|||
146639418|NCT00481091|528856497|FG001|Overall Study|Withdrawal by Subject|1|||
146639419|NCT00481091|528856498|FG002|Overall Study|Withdrawal by Subject|1|||
146639420|NCT00481091|528856499|FG003|Overall Study|Withdrawal by Subject|0|||
146639421|NCT00481091|528856500|FG004|Overall Study|Withdrawal by Subject|0|||
146639422|NCT00481091|528856501|FG005|Overall Study|Withdrawal by Subject|0|||
146639423|NCT00481091|528856502|FG006|Overall Study|Withdrawal by Subject|0|||
146639424|NCT00481091|528856503|FG007|Overall Study|Withdrawal by Subject|0|||
146639425|NCT00481091|528856504|FG008|Overall Study|Withdrawal by Subject|1|||
146639426|NCT00481091|528856505|FG009|Overall Study|Withdrawal by Subject|6|||
146639427|NCT00481091|528856496|FG000|Overall Study|Other, Not Specified|0|||
146639428|NCT00481091|528856497|FG001|Overall Study|Other, Not Specified|1|||
146639429|NCT00481091|528856498|FG002|Overall Study|Other, Not Specified|1|||
146639430|NCT00481091|528856499|FG003|Overall Study|Other, Not Specified|0|||
146639431|NCT00481091|528856500|FG004|Overall Study|Other, Not Specified|0|||
146639432|NCT00481091|528856501|FG005|Overall Study|Other, Not Specified|1|||
146639433|NCT00481091|528856502|FG006|Overall Study|Other, Not Specified|0|||
146639434|NCT00481091|528856503|FG007|Overall Study|Other, Not Specified|0|||
146639435|NCT00481091|528856504|FG008|Overall Study|Other, Not Specified|0|||
146639436|NCT00481091|528856505|FG009|Overall Study|Other, Not Specified|4|||
146639437|NCT00481091|528856496|FG000|Overall Study|Adverse Event|1|||
146639438|NCT00481091|528856497|FG001|Overall Study|Adverse Event|2|||
146639439|NCT00481091|528856498|FG002|Overall Study|Adverse Event|0|||
146639440|NCT00481091|528856499|FG003|Overall Study|Adverse Event|1|||
146639441|NCT00481091|528856500|FG004|Overall Study|Adverse Event|1|||
146639442|NCT00481091|528856501|FG005|Overall Study|Adverse Event|1|||
146639443|NCT00481091|528856502|FG006|Overall Study|Adverse Event|2|||
146639444|NCT00481091|528856503|FG007|Overall Study|Adverse Event|1|||
146639445|NCT00481091|528856504|FG008|Overall Study|Adverse Event|1|||
146639446|NCT00481091|528856505|FG009|Overall Study|Adverse Event|6|||
146639447|NCT00481091|528856496|FG000|Overall Study|Progressive disease clinical|0|||
146639448|NCT00481091|528856497|FG001|Overall Study|Progressive disease clinical|0|||
146639449|NCT00481091|528856498|FG002|Overall Study|Progressive disease clinical|0|||
146639450|NCT00481091|528856499|FG003|Overall Study|Progressive disease clinical|0|||
146639451|NCT00481091|528856500|FG004|Overall Study|Progressive disease clinical|0|||
146639452|NCT00481091|528856501|FG005|Overall Study|Progressive disease clinical|0|||
146639453|NCT00481091|528856502|FG006|Overall Study|Progressive disease clinical|0|||
146639454|NCT00481091|528856503|FG007|Overall Study|Progressive disease clinical|0|||
146639455|NCT00481091|528856504|FG008|Overall Study|Progressive disease clinical|1|||
146639456|NCT00481091|528856505|FG009|Overall Study|Progressive disease clinical|7|||
146639457|NCT00481091|528856496|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
146639458|NCT00481091|528856497|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
146639459|NCT00481091|528856498|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
146639460|NCT00481091|528856499|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
146639461|NCT00481091|528856500|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
146639462|NCT00481091|528856501|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
146639463|NCT00481091|528856502|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
146639464|NCT00481091|528856503|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
146639465|NCT00481091|528856504|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
146639466|NCT00481091|528856505|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
146639467|NCT00481091|528856496|FG000|Overall Study|Progressive disease other|1|||
146639468|NCT00481091|528856497|FG001|Overall Study|Progressive disease other|1|||
146639469|NCT00481091|528856498|FG002|Overall Study|Progressive disease other|0|||
146639470|NCT00481091|528856499|FG003|Overall Study|Progressive disease other|1|||
146639471|NCT00481091|528856500|FG004|Overall Study|Progressive disease other|1|||
146639472|NCT00481091|528856501|FG005|Overall Study|Progressive disease other|1|||
146639473|NCT00481091|528856502|FG006|Overall Study|Progressive disease other|0|||
146639474|NCT00481091|528856503|FG007|Overall Study|Progressive disease other|2|||
146639475|NCT00481091|528856504|FG008|Overall Study|Progressive disease other|0|||
146639476|NCT00481091|528856505|FG009|Overall Study|Progressive disease other|0|||
146639477|NCT00481091|528856496|FG000|Overall Study|No reason given|0|||
146639478|NCT00481091|528856497|FG001|Overall Study|No reason given|0|||
146639479|NCT00481091|528856498|FG002|Overall Study|No reason given|1|||
146639480|NCT00481091|528856499|FG003|Overall Study|No reason given|1|||
146639481|NCT00481091|528856500|FG004|Overall Study|No reason given|1|||
146639482|NCT00481091|528856501|FG005|Overall Study|No reason given|0|||
146639483|NCT00481091|528856502|FG006|Overall Study|No reason given|1|||
146639484|NCT00481091|528856503|FG007|Overall Study|No reason given|1|||
146639485|NCT00481091|528856504|FG008|Overall Study|No reason given|1|||
146639486|NCT00481091|528856505|FG009|Overall Study|No reason given|4|||
146639487|NCT00475306|528856506|FG000|Overall Study|Protocol Violation|1|||
146639488|NCT00475306|528856507|FG001|Overall Study|Protocol Violation|1|||
146639489|NCT00475306|528856508|FG002|Overall Study|Protocol Violation|0|||
146639490|NCT00475306|528856509|FG003|Overall Study|Protocol Violation|1|||
146639491|NCT04294680|528856510|FG000|Overall Study|Withdrawal by Subject|2|||
146639492|NCT04294680|528856511|FG001|Overall Study|Withdrawal by Subject|1|||
146639493|NCT04294680|528856510|FG000|Overall Study|Follow-up visits completed outside of window|1|||
146639494|NCT04294680|528856511|FG001|Overall Study|Follow-up visits completed outside of window|0|||
146639495|NCT02881567|528856512|FG000|Overall Study|Adverse Event|1|||
146639496|NCT02881567|528856512|FG000|Overall Study|Lost to Follow-up|3|||
146639497|NCT02881567|528856512|FG000|Overall Study|Consent withdrawn|1|||
146639498|NCT02881567|528856512|FG000|Overall Study|Investigator decision|1|||
146639499|NCT02881567|528856512|FG000|Overall Study|Study terminated by sponsor|9|||
146766606|NCT02914522|529312252|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146639500|NCT02881567|528856512|FG000|Overall Study|Reason not Specified|3|||
146639501|NCT02405442|528856513|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
146639502|NCT02405442|528856514|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
146639503|NCT02405442|528856515|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
146639504|NCT02405442|528856516|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
146639505|NCT02405442|528856513|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
146968507|NCT03669640|530045457|FG003|Overall Study|Lost to Follow-up|0|||
146639506|NCT02405442|528856514|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
146639507|NCT02405442|528856515|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
146639508|NCT02405442|528856516|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
146639509|NCT02405442|528856513|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
146766607|NCT02914522|529312253|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146766608|NCT02914522|529312254|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146766609|NCT02914522|529312255|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
146766610|NCT02914522|529312256|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
146766611|NCT02914522|529312257|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146766612|NCT02914522|529312247|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146766613|NCT02914522|529312248|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146766614|NCT02914522|529312249|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146766615|NCT02914522|529312250|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146639510|NCT02405442|528856514|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
146639511|NCT02405442|528856515|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
146766616|NCT02914522|529312251|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146639512|NCT02405442|528856516|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
146639513|NCT02405442|528856513|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
146639514|NCT02405442|528856514|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
146639515|NCT02405442|528856515|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
146639516|NCT02405442|528856516|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
146639517|NCT02405442|528856513|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
146639518|NCT02405442|528856514|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
146639519|NCT02405442|528856515|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
146968508|NCT03669640|530045458|FG004|Overall Study|Lost to Follow-up|0|||
146639520|NCT02405442|528856516|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
146639521|NCT02405442|528856513|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
146639522|NCT02405442|528856514|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
146639523|NCT02405442|528856515|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
146639524|NCT02405442|528856516|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
146639525|NCT02405442|528856513|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
146639526|NCT02405442|528856514|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
146639527|NCT02405442|528856515|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
146639528|NCT02405442|528856516|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
146639529|NCT02405442|528856513|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
146639530|NCT02405442|528856514|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
146639531|NCT02405442|528856515|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
146639532|NCT02405442|528856516|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
146639533|NCT02405442|528856513|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
146639534|NCT02405442|528856514|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
146639535|NCT02405442|528856515|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
146639536|NCT02405442|528856516|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
146639537|NCT02405442|528856513|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
146639538|NCT02405442|528856514|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
146639539|NCT02405442|528856515|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
146639540|NCT02405442|528856516|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
146639541|NCT02405442|528856513|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
146639542|NCT02405442|528856514|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
146639543|NCT02405442|528856515|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
146639544|NCT02405442|528856516|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
146639545|NCT02405442|528856513|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
146639546|NCT02405442|528856514|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
146639547|NCT02405442|528856515|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
146639548|NCT02405442|528856516|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
146639549|NCT02405442|528856513|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
146639550|NCT02405442|528856514|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
146639551|NCT02405442|528856515|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
146639552|NCT02405442|528856516|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
146639553|NCT02405442|528856513|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
146639554|NCT02405442|528856514|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
146639555|NCT02405442|528856515|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
146639556|NCT02405442|528856516|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
146639557|NCT00373113|528856517|FG000|Overall Study|Death|1|||
146894602|NCT01375764|529779819|FG001|Overall Study|Withdrawal by Subject|0|||
146894603|NCT01375764|529779820|FG002|Overall Study|Withdrawal by Subject|0|||
146639558|NCT00373113|528856518|FG001|Overall Study|Death|7|||
146639559|NCT00373113|528856517|FG000|Overall Study|Adverse Event|38|||
146639560|NCT00373113|528856518|FG001|Overall Study|Adverse Event|24|||
146639561|NCT00373113|528856517|FG000|Overall Study|Study terminated by sponsor|9|||
146639562|NCT00373113|528856518|FG001|Overall Study|Study terminated by sponsor|1|||
146639563|NCT00373113|528856517|FG000|Overall Study|Global deterioration of health status|10|||
146639564|NCT00373113|528856518|FG001|Overall Study|Global deterioration of health status|7|||
146639565|NCT00373113|528856517|FG000|Overall Study|Lost to Follow-up|1|||
146639566|NCT00373113|528856518|FG001|Overall Study|Lost to Follow-up|3|||
146639567|NCT00373113|528856517|FG000|Overall Study|Objective progression or relapse|150|||
146639568|NCT00373113|528856518|FG001|Overall Study|Objective progression or relapse|169|||
146639569|NCT00373113|528856517|FG000|Overall Study|Other|14|||
146639570|NCT00373113|528856518|FG001|Overall Study|Other|17|||
146639571|NCT00373113|528856517|FG000|Overall Study|Protocol Violation|5|||
146639572|NCT00373113|528856518|FG001|Overall Study|Protocol Violation|1|||
146639573|NCT00373113|528856517|FG000|Overall Study|Withdrawal by Subject|10|||
146639574|NCT00373113|528856518|FG001|Overall Study|Withdrawal by Subject|15|||
146639575|NCT02078960|528856519|FG000|Treatment Period|Other|0|||
146639576|NCT02078960|528856520|FG001|Treatment Period|Other|0|||
146639577|NCT02078960|528856521|FG002|Treatment Period|Other|1|||
146639578|NCT02078960|528856519|FG000|Treatment Period|Lack of Efficacy|0|||
146639579|NCT02078960|528856520|FG001|Treatment Period|Lack of Efficacy|1|||
146639580|NCT02078960|528856521|FG002|Treatment Period|Lack of Efficacy|0|||
146639581|NCT02078960|528856519|FG000|Treatment Period|Disease progression - accelerated phase|0|||
146639582|NCT02078960|528856520|FG001|Treatment Period|Disease progression - accelerated phase|1|||
146639583|NCT02078960|528856521|FG002|Treatment Period|Disease progression - accelerated phase|0|||
146639584|NCT02078960|528856519|FG000|Treatment Period|Disease progression - blast phase|1|||
146639585|NCT02078960|528856520|FG001|Treatment Period|Disease progression - blast phase|0|||
146639586|NCT02078960|528856521|FG002|Treatment Period|Disease progression - blast phase|0|||
146639587|NCT02078960|528856519|FG000|Treatment Period|Withdrawal by Subject|0|||
146639588|NCT02078960|528856520|FG001|Treatment Period|Withdrawal by Subject|1|||
146639589|NCT02078960|528856521|FG002|Treatment Period|Withdrawal by Subject|1|||
146639590|NCT02078960|528856519|FG000|Treatment Period|Adverse Event|1|||
146639591|NCT02078960|528856520|FG001|Treatment Period|Adverse Event|0|||
146639592|NCT02078960|528856521|FG002|Treatment Period|Adverse Event|0|||
146639593|NCT02078960|528856519|FG000|Treatment Period|Death|0|||
146639594|NCT02078960|528856520|FG001|Treatment Period|Death|0|||
146639595|NCT02078960|528856521|FG002|Treatment Period|Death|1|||
146639596|NCT02078960|528856519|FG000|Follow-up Period|Death|2|||
146639597|NCT02078960|528856520|FG001|Follow-up Period|Death|0|||
146639598|NCT02078960|528856521|FG002|Follow-up Period|Death|0|||
146639599|NCT02078960|528856519|FG000|Follow-up Period|Lost to Follow-up|0|||
146639600|NCT02078960|528856520|FG001|Follow-up Period|Lost to Follow-up|1|||
146639601|NCT02078960|528856521|FG002|Follow-up Period|Lost to Follow-up|0|||
146639602|NCT03275350|528856522|FG000|Overall Study|Lost to Follow-up|4|||
146639603|NCT03275350|528856523|FG001|Overall Study|Lost to Follow-up|6|||
146639604|NCT03275350|528856522|FG000|Overall Study|Death|2|||
146639605|NCT03275350|528856523|FG001|Overall Study|Death|1|||
146639606|NCT03275350|528856522|FG000|Overall Study|Physician Decision|1|||
146639607|NCT03275350|528856523|FG001|Overall Study|Physician Decision|0|||
146639608|NCT03275350|528856522|FG000|Overall Study|Incarcerated|1|||
146639609|NCT03275350|528856523|FG001|Overall Study|Incarcerated|1|||
146639610|NCT04661579|528856526|FG000|Overall Study|Lost to Follow-up|19|||
146639611|NCT04661579|528856527|FG001|Overall Study|Lost to Follow-up|10|||
146639612|NCT04661579|528856528|FG002|Overall Study|Lost to Follow-up|2|||
146639613|NCT04661579|528856529|FG003|Overall Study|Lost to Follow-up|7|||
146639614|NCT04661579|528856530|FG004|Overall Study|Lost to Follow-up|11|||
146639615|NCT04661579|528856526|FG000|Overall Study|Physician Decision|2|||
146639616|NCT04661579|528856527|FG001|Overall Study|Physician Decision|0|||
146639617|NCT04661579|528856528|FG002|Overall Study|Physician Decision|0|||
146639618|NCT04661579|528856529|FG003|Overall Study|Physician Decision|1|||
146639619|NCT04661579|528856530|FG004|Overall Study|Physician Decision|0|||
146639620|NCT04661579|528856526|FG000|Overall Study|Withdrawal by Subject|1|||
146639621|NCT04661579|528856527|FG001|Overall Study|Withdrawal by Subject|4|||
146639622|NCT04661579|528856528|FG002|Overall Study|Withdrawal by Subject|0|||
146639623|NCT04661579|528856529|FG003|Overall Study|Withdrawal by Subject|2|||
146639624|NCT04661579|528856530|FG004|Overall Study|Withdrawal by Subject|0|||
146639625|NCT04661579|528856526|FG000|Overall Study|Death|1|||
146968509|NCT03669640|530045459|FG005|Overall Study|Lost to Follow-up|0|||
146968510|NCT03669640|530045454|FG000|Overall Study|Death|0|||
146968511|NCT03669640|530045455|FG001|Overall Study|Death|0|||
146968512|NCT03669640|530045456|FG002|Overall Study|Death|1|||
146968513|NCT03669640|530045457|FG003|Overall Study|Death|0|||
146968514|NCT03669640|530045458|FG004|Overall Study|Death|0|||
146968515|NCT03669640|530045459|FG005|Overall Study|Death|0|||
146968516|NCT03669640|530045454|FG000|Overall Study|Withdrawal by Subject|1|||
146968517|NCT03669640|530045455|FG001|Overall Study|Withdrawal by Subject|2|||
146968518|NCT03669640|530045456|FG002|Overall Study|Withdrawal by Subject|1|||
146968519|NCT03669640|530045457|FG003|Overall Study|Withdrawal by Subject|0|||
146968520|NCT03669640|530045458|FG004|Overall Study|Withdrawal by Subject|1|||
146639626|NCT04661579|528856527|FG001|Overall Study|Death|0|||
146639627|NCT04661579|528856528|FG002|Overall Study|Death|0|||
146639628|NCT04661579|528856529|FG003|Overall Study|Death|0|||
146968521|NCT03669640|530045459|FG005|Overall Study|Withdrawal by Subject|3|||
146968522|NCT03669640|530045454|FG000|Overall Study|Protocol Violation|1|||
146968523|NCT03669640|530045455|FG001|Overall Study|Protocol Violation|0|||
146968524|NCT03669640|530045456|FG002|Overall Study|Protocol Violation|0|||
146968525|NCT03669640|530045457|FG003|Overall Study|Protocol Violation|0|||
146968526|NCT03669640|530045458|FG004|Overall Study|Protocol Violation|0|||
146968527|NCT03669640|530045459|FG005|Overall Study|Protocol Violation|0|||
146639629|NCT04661579|528856530|FG004|Overall Study|Death|0|||
146639630|NCT04661579|528856526|FG000|Overall Study|Other|1|||
146639631|NCT04661579|528856527|FG001|Overall Study|Other|2|||
146639632|NCT04661579|528856528|FG002|Overall Study|Other|1|||
146639633|NCT04661579|528856529|FG003|Overall Study|Other|1|||
146639634|NCT04661579|528856530|FG004|Overall Study|Other|1|||
146639635|NCT04661579|528856526|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
146639636|NCT04661579|528856527|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
146894604|NCT01375764|529779821|FG003|Overall Study|Withdrawal by Subject|0|||
146894605|NCT01375764|529779822|FG004|Overall Study|Withdrawal by Subject|1|||
146894606|NCT01375764|529779818|FG000|Overall Study|Other|0|||
146894607|NCT01375764|529779819|FG001|Overall Study|Other|0|||
146894608|NCT01375764|529779820|FG002|Overall Study|Other|0|||
146894609|NCT01375764|529779821|FG003|Overall Study|Other|1|||
146894610|NCT01375764|529779822|FG004|Overall Study|Other|0|||
146894611|NCT02867761|529779826|FG000|Overall Study|Participant withdrawn by investigator|0|||
146894612|NCT02867761|529779827|FG001|Overall Study|Participant withdrawn by investigator|1|||
146894613|NCT02867761|529779826|FG000|Overall Study|Lost to Follow-up|25|||
146894614|NCT02867761|529779827|FG001|Overall Study|Lost to Follow-up|18|||
146894615|NCT02867761|529779826|FG000|Overall Study|Unable to complete protocol|3|||
146894616|NCT02867761|529779827|FG001|Overall Study|Unable to complete protocol|7|||
146894617|NCT03595280|529779828|FG000|Overall Study|Lost to Follow-up|6|||
146894618|NCT03595280|529779829|FG001|Overall Study|Lost to Follow-up|9|||
146894619|NCT03595280|529779830|FG002|Overall Study|Lost to Follow-up|15|||
146894620|NCT01512264|529779831|FG000|Overall Study|Lost to Follow-up|0|||
146894621|NCT01512264|529779832|FG001|Overall Study|Lost to Follow-up|0|||
146894622|NCT01512264|529779833|FG002|Overall Study|Lost to Follow-up|0|||
146894623|NCT01512264|529779834|FG003|Overall Study|Lost to Follow-up|1|||
146894624|NCT01194440|529779835|FG000|Baseline (First Dose)|Reason not specified|4|||
146894625|NCT01194440|529779835|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
146639637|NCT04661579|528856528|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
146968528|NCT03669640|530045454|FG000|Overall Study|Physician Decision|0|||
146968529|NCT03669640|530045455|FG001|Overall Study|Physician Decision|2|||
146968530|NCT03669640|530045456|FG002|Overall Study|Physician Decision|0|||
146968531|NCT03669640|530045457|FG003|Overall Study|Physician Decision|0|||
146968532|NCT03669640|530045458|FG004|Overall Study|Physician Decision|0|||
146639638|NCT04661579|528856529|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
146894626|NCT01194440|529779835|FG000|Baseline (First Dose)|Change in therapy|1|||
146894627|NCT01194440|529779835|FG000|Baseline (First Dose)|Adverse Event|1|||
146894628|NCT01194440|529779835|FG000|6-months (2nd Dose)|Change in therapy|4|||
146894629|NCT00854828|529779836|FG000|Overall Study|Death|1|||
146894630|NCT00854828|529779837|FG001|Overall Study|Death|0|||
146894631|NCT00854828|529779838|FG002|Overall Study|Death|0|||
146894632|NCT00854828|529779839|FG003|Overall Study|Death|0|||
146894633|NCT00854828|529779836|FG000|Overall Study|Withdrawal by Subject|1|||
146894634|NCT00854828|529779837|FG001|Overall Study|Withdrawal by Subject|1|||
146968533|NCT03669640|530045459|FG005|Overall Study|Physician Decision|0|||
146894635|NCT00854828|529779838|FG002|Overall Study|Withdrawal by Subject|0|||
146894636|NCT00854828|529779839|FG003|Overall Study|Withdrawal by Subject|9|||
146894637|NCT00854828|529779836|FG000|Overall Study|Missed 24mo visit|1|||
146894638|NCT00854828|529779837|FG001|Overall Study|Missed 24mo visit|1|||
146894639|NCT00854828|529779838|FG002|Overall Study|Missed 24mo visit|8|||
146894640|NCT00854828|529779839|FG003|Overall Study|Missed 24mo visit|8|||
146894641|NCT01931059|529779840|FG000|Day 1|Pregnancy|0|||
146894642|NCT01931059|529779841|FG001|Day 1|Pregnancy|1|||
146894643|NCT01931059|529779840|FG000|Day3|Lost to Follow-up|1|||
146894644|NCT01931059|529779841|FG001|Day3|Lost to Follow-up|0|||
146894645|NCT02675075|529779842|FG000|Overall Study|Lost to Follow-up|3|||
146894646|NCT02675075|529779843|FG001|Overall Study|Lost to Follow-up|0|||
146894647|NCT02292212|529779844|FG000|ViE Phase|Withdrawal by Subject|1|||
146894648|NCT02292212|529779844|FG000|ViE Phase|Protocol Violation|2|||
146894649|NCT02411747|529779845|FG000|Overall Study|Withdrawal by Subject|1|||
146894650|NCT02411747|529779846|FG001|Overall Study|Withdrawal by Subject|0|||
146894651|NCT02411747|529779845|FG000|Overall Study|Protocol Violation|2|||
146894652|NCT02411747|529779846|FG001|Overall Study|Protocol Violation|4|||
146894653|NCT02149810|529779847|FG000|Overall Study|Physician Decision|1|||
146894654|NCT02149810|529779848|FG001|Overall Study|Physician Decision|2|||
146894655|NCT02149810|529779847|FG000|Overall Study|Lost to Follow-up|2|||
146894656|NCT02149810|529779848|FG001|Overall Study|Lost to Follow-up|1|||
146894657|NCT02149810|529779847|FG000|Overall Study|Withdrawal by Subject|5|||
146639639|NCT04661579|528856530|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
146639640|NCT01396447|528856531|FG000|Overall Study|Did Not Receive Treatment|3|||
146894658|NCT02149810|529779848|FG001|Overall Study|Withdrawal by Subject|1|||
146894659|NCT01176916|529779849|FG000|Overall Study|Adverse Event|61|||
146894660|NCT01176916|529779849|FG000|Overall Study|Death|1|||
146894661|NCT01176916|529779849|FG000|Overall Study|Lost to Follow-up|15|||
146894662|NCT01176916|529779849|FG000|Overall Study|Objective progression or relapse|17|||
146894663|NCT01176916|529779849|FG000|Overall Study|Protocol Violation|24|||
146894664|NCT01176916|529779849|FG000|Overall Study|Withdrawal by Subject|37|||
146639641|NCT01396447|528856532|FG001|Overall Study|Did Not Receive Treatment|2|||
146639642|NCT01396447|528856533|FG002|Overall Study|Did Not Receive Treatment|1|||
146639643|NCT01396447|528856534|FG003|Overall Study|Did Not Receive Treatment|0|||
146639644|NCT01396447|528856531|FG000|Overall Study|Adverse Event|15|||
146894665|NCT01176916|529779849|FG000|Overall Study|Other|6|||
146894666|NCT01176916|529779849|FG000|Overall Study|Withdrawal prior to Treatment|6|||
146894667|NCT00675597|529779850|FG000|Overall Study|Withdrawal by Subject|3|||
146894668|NCT03158220|529779851|FG000|Overall Study|Screen Failure|0|||
146894669|NCT03158220|529779852|FG001|Overall Study|Screen Failure|1|||
146894670|NCT03158220|529779851|FG000|Overall Study|Withdrawal by Subject|8|||
146894671|NCT03158220|529779852|FG001|Overall Study|Withdrawal by Subject|9|||
146894672|NCT03158220|529779851|FG000|Overall Study|Status unknown|0|||
146894673|NCT03158220|529779852|FG001|Overall Study|Status unknown|1|||
146894674|NCT03158220|529779851|FG000|Overall Study|Lost to Follow-up|8|||
146894675|NCT03158220|529779852|FG001|Overall Study|Lost to Follow-up|5|||
146639645|NCT01396447|528856532|FG001|Overall Study|Adverse Event|12|||
146639646|NCT01396447|528856533|FG002|Overall Study|Adverse Event|12|||
146639647|NCT01396447|528856534|FG003|Overall Study|Adverse Event|17|||
146639648|NCT01396447|528856531|FG000|Overall Study|Insufficient Therapeutic Response|5|||
146639649|NCT01396447|528856532|FG001|Overall Study|Insufficient Therapeutic Response|5|||
146639650|NCT01396447|528856533|FG002|Overall Study|Insufficient Therapeutic Response|2|||
146639651|NCT01396447|528856534|FG003|Overall Study|Insufficient Therapeutic Response|4|||
146639652|NCT01396447|528856531|FG000|Overall Study|Protocol Violation|5|||
146639653|NCT01396447|528856532|FG001|Overall Study|Protocol Violation|2|||
146639654|NCT01396447|528856533|FG002|Overall Study|Protocol Violation|3|||
146639655|NCT01396447|528856534|FG003|Overall Study|Protocol Violation|7|||
146639656|NCT01396447|528856531|FG000|Overall Study|Withdrawal of Consent|11|||
146639657|NCT01396447|528856532|FG001|Overall Study|Withdrawal of Consent|9|||
146639658|NCT01396447|528856533|FG002|Overall Study|Withdrawal of Consent|4|||
146639659|NCT01396447|528856534|FG003|Overall Study|Withdrawal of Consent|15|||
146639660|NCT01396447|528856531|FG000|Overall Study|Lost to Follow-up|4|||
146639661|NCT01396447|528856532|FG001|Overall Study|Lost to Follow-up|8|||
146639662|NCT01396447|528856533|FG002|Overall Study|Lost to Follow-up|7|||
146639663|NCT01396447|528856534|FG003|Overall Study|Lost to Follow-up|9|||
146639664|NCT01396447|528856531|FG000|Overall Study|Other Miscellaneous Reasons|0|||
146639665|NCT01396447|528856532|FG001|Overall Study|Other Miscellaneous Reasons|2|||
146639666|NCT01396447|528856533|FG002|Overall Study|Other Miscellaneous Reasons|1|||
146639667|NCT01396447|528856534|FG003|Overall Study|Other Miscellaneous Reasons|0|||
146639668|NCT01402102|528856536|FG000|Overall Study|Protocol Violation|1|||
146639669|NCT01402102|528856537|FG001|Overall Study|Protocol Violation|0|||
146639670|NCT01402102|528856536|FG000|Overall Study|Insufficiency of compliance|1|||
146639671|NCT01402102|528856537|FG001|Overall Study|Insufficiency of compliance|1|||
146894676|NCT03158220|529779851|FG000|Overall Study|Physician Decision|1|||
146894677|NCT03158220|529779852|FG001|Overall Study|Physician Decision|0|||
146894678|NCT00848120|529779855|FG000|Overall Study|Adverse Event|1|||
146894679|NCT00560755|529779856|FG000|Overall Study|Protocol Violation|15|||
146558922|NCT01051661|528555930|FG003|Overall Study|Refused blood sampling|0|||
146558923|NCT01051661|528555931|FG004|Overall Study|Refused blood sampling|0|||
146558924|NCT01051661|528555932|FG005|Overall Study|Refused blood sampling|1|||
146558925|NCT01051661|528555927|FG000|Overall Study|Data not reliable|1|||
146558926|NCT01051661|528555928|FG001|Overall Study|Data not reliable|0|||
146558927|NCT01051661|528555929|FG002|Overall Study|Data not reliable|0|||
146558928|NCT01051661|528555930|FG003|Overall Study|Data not reliable|0|||
146558929|NCT01051661|528555931|FG004|Overall Study|Data not reliable|0|||
146558930|NCT01051661|528555932|FG005|Overall Study|Data not reliable|1|||
146558931|NCT01051661|528555927|FG000|Overall Study|Unable to attend visit(s)|2|||
146558932|NCT01051661|528555928|FG001|Overall Study|Unable to attend visit(s)|4|||
146558933|NCT01051661|528555929|FG002|Overall Study|Unable to attend visit(s)|2|||
146558934|NCT01051661|528555930|FG003|Overall Study|Unable to attend visit(s)|1|||
146558935|NCT01051661|528555931|FG004|Overall Study|Unable to attend visit(s)|3|||
146558936|NCT01051661|528555932|FG005|Overall Study|Unable to attend visit(s)|2|||
146558937|NCT01051661|528555927|FG000|Overall Study|Consent not received from both parents|0|||
146558938|NCT01051661|528555928|FG001|Overall Study|Consent not received from both parents|0|||
146558939|NCT01051661|528555929|FG002|Overall Study|Consent not received from both parents|0|||
146558940|NCT01051661|528555930|FG003|Overall Study|Consent not received from both parents|0|||
146558941|NCT01051661|528555931|FG004|Overall Study|Consent not received from both parents|0|||
146558942|NCT01051661|528555932|FG005|Overall Study|Consent not received from both parents|1|||
146558943|NCT01051661|528555927|FG000|Overall Study|Failure to comply with protocol|0|||
146558944|NCT01051661|528555928|FG001|Overall Study|Failure to comply with protocol|0|||
146558945|NCT01051661|528555929|FG002|Overall Study|Failure to comply with protocol|2|||
146894680|NCT00560755|529779856|FG000|Overall Study|Withdrawal by Subject|26|||
146894681|NCT00560755|529779856|FG000|Overall Study|Lost to Follow-up|9|||
146894682|NCT00560755|529779856|FG000|Overall Study|Adverse Event|8|||
146558946|NCT01051661|528555930|FG003|Overall Study|Failure to comply with protocol|0|||
146558947|NCT01051661|528555931|FG004|Overall Study|Failure to comply with protocol|0|||
146558948|NCT01051661|528555932|FG005|Overall Study|Failure to comply with protocol|0|||
146894683|NCT00560755|529779856|FG000|Overall Study|Physician Decision|2|||
146968534|NCT03669640|530045454|FG000|Overall Study|Disease Relapse|1|||
146968535|NCT03669640|530045455|FG001|Overall Study|Disease Relapse|0|||
146968536|NCT03669640|530045456|FG002|Overall Study|Disease Relapse|0|||
146968537|NCT03669640|530045457|FG003|Overall Study|Disease Relapse|0|||
146968538|NCT03669640|530045458|FG004|Overall Study|Disease Relapse|0|||
146968539|NCT03669640|530045459|FG005|Overall Study|Disease Relapse|0|||
146968540|NCT03669640|530045454|FG000|Overall Study|Adverse Event|2|||
146968541|NCT03669640|530045455|FG001|Overall Study|Adverse Event|1|||
146968542|NCT03669640|530045456|FG002|Overall Study|Adverse Event|0|||
146968543|NCT03669640|530045457|FG003|Overall Study|Adverse Event|0|||
146968544|NCT03669640|530045458|FG004|Overall Study|Adverse Event|1|||
146968545|NCT03669640|530045459|FG005|Overall Study|Adverse Event|0|||
146639672|NCT01402102|528856536|FG000|Overall Study|Withdrawal by Subject|0|||
146894684|NCT01961115|529779867|FG000|Overall Study|Disease Progression|1|||
146894685|NCT01961115|529779868|FG001|Overall Study|Disease Progression|0|||
146894686|NCT01961115|529779869|FG002|Overall Study|Disease Progression|3|||
146894687|NCT01961115|529779867|FG000|Overall Study|Adverse Event|1|||
146894688|NCT01961115|529779868|FG001|Overall Study|Adverse Event|0|||
146894689|NCT01961115|529779869|FG002|Overall Study|Adverse Event|1|||
146894690|NCT01439945|529779882|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
146894691|NCT01439945|529779883|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
146894692|NCT01439945|529779884|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
146894693|NCT01439945|529779885|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
146894694|NCT01439945|529779882|FG000|Double-Blind Treatment Phase|Ineligible|1|||
146894695|NCT01439945|529779883|FG001|Double-Blind Treatment Phase|Ineligible|2|||
146894696|NCT01439945|529779884|FG002|Double-Blind Treatment Phase|Ineligible|0|||
146894697|NCT01439945|529779885|FG003|Double-Blind Treatment Phase|Ineligible|1|||
146639673|NCT01402102|528856537|FG001|Overall Study|Withdrawal by Subject|2|||
146894698|NCT04082663|529779886|FG000|Overall Study|Adverse Event|6|||
146968546|NCT00826176|530045462|FG000|Overall Study|Lost to Follow-up|1|||
146968547|NCT00826176|530045463|FG001|Overall Study|Lost to Follow-up|0|||
146968548|NCT00826176|530045462|FG000|Overall Study|Subject Withdrew Consent|3|||
146968549|NCT00826176|530045463|FG001|Overall Study|Subject Withdrew Consent|0|||
146968550|NCT00826176|530045462|FG000|Overall Study|Administrative|9|||
146968551|NCT00826176|530045463|FG001|Overall Study|Administrative|0|||
146639674|NCT01386970|528856538|FG000|Overall Study|Withdrawal by Subject|0|||
146639675|NCT01386970|528856539|FG001|Overall Study|Withdrawal by Subject|1|||
146639676|NCT01386970|528856538|FG000|Overall Study|Adverse Event|4|||
146639677|NCT01386970|528856539|FG001|Overall Study|Adverse Event|1|||
146639678|NCT02423902|528856541|FG000|Overall Study|Disease progression|1|||
146639679|NCT02423902|528856542|FG001|Overall Study|Disease progression|4|||
146639680|NCT04329806|528856543|FG000|Overall Study|Physician Decision|3|||
146639681|NCT04329806|528856544|FG001|Overall Study|Physician Decision|4|||
146639682|NCT04838626|528856545|FG000|Overall Study|Adverse Event|2|||
146639683|NCT04838626|528856545|FG000|Overall Study|Physician Decision|6|||
146639684|NCT04838626|528856545|FG000|Overall Study|Protocol Violation|3|||
146639685|NCT04838626|528856545|FG000|Overall Study|Withdrawal by Subject|9|||
146639686|NCT04838626|528856545|FG000|Overall Study|Technical Problems|2|||
146639687|NCT02867384|528856546|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
146639688|NCT02867384|528856547|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
146639689|NCT02867384|528856548|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
146639690|NCT02867384|528856546|FG000|Overall Study|Progression/ Relapse|15|||
146639691|NCT02867384|528856547|FG001|Overall Study|Progression/ Relapse|19|||
146639692|NCT02867384|528856548|FG002|Overall Study|Progression/ Relapse|0|||
146639693|NCT02867384|528856546|FG000|Overall Study|Adverse Event|13|||
146639694|NCT02867384|528856547|FG001|Overall Study|Adverse Event|1|||
146639695|NCT02867384|528856548|FG002|Overall Study|Adverse Event|0|||
146639696|NCT02867384|528856546|FG000|Overall Study|Withdrawal by Subject|6|||
146639697|NCT02867384|528856547|FG001|Overall Study|Withdrawal by Subject|5|||
146639698|NCT02867384|528856548|FG002|Overall Study|Withdrawal by Subject|0|||
146639699|NCT02867384|528856546|FG000|Overall Study|Physician Decision|1|||
146639700|NCT02867384|528856547|FG001|Overall Study|Physician Decision|2|||
146968552|NCT00388674|530045465|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
146968553|NCT00388674|530045466|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
146968554|NCT00388674|530045465|FG000|Initial Treatment|Adverse Event|22|||
146639701|NCT02867384|528856548|FG002|Overall Study|Physician Decision|0|||
146639702|NCT02867384|528856546|FG000|Overall Study|Patient compliance|1|||
146639703|NCT02867384|528856547|FG001|Overall Study|Patient compliance|0|||
146766617|NCT02914522|529312252|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146766618|NCT02914522|529312253|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146766619|NCT02914522|529312254|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146968555|NCT00388674|530045466|FG001|Initial Treatment|Adverse Event|87|||
146894699|NCT04082663|529779886|FG000|Overall Study|Lost to Follow-up|1|||
146894700|NCT05501119|529779889|FG000|Overall Study|Withdrawal by Subject|2|||
146894701|NCT05501119|529779889|FG000|Overall Study|Lost to Follow-up|5|||
146894702|NCT01752023|529779890|FG000|Overall Study|Physician Decision|2|||
146894703|NCT01752023|529779891|FG001|Overall Study|Physician Decision|1|||
146894704|NCT01445678|529779892|FG000|Overall Study|Adverse Event|12|||
146894705|NCT01445678|529779893|FG001|Overall Study|Adverse Event|8|||
146894706|NCT01445678|529779892|FG000|Overall Study|Lack of Efficacy|0|||
146894707|NCT01445678|529779893|FG001|Overall Study|Lack of Efficacy|2|||
146894708|NCT01445678|529779892|FG000|Overall Study|Lost to Follow-up|8|||
146894709|NCT01445678|529779893|FG001|Overall Study|Lost to Follow-up|5|||
146894710|NCT01445678|529779892|FG000|Overall Study|Protocol Violation|1|||
146894711|NCT01445678|529779893|FG001|Overall Study|Protocol Violation|1|||
146894712|NCT01445678|529779892|FG000|Overall Study|Withdrawal by Subject|9|||
146894713|NCT01445678|529779893|FG001|Overall Study|Withdrawal by Subject|5|||
146894714|NCT00393718|529781787|FG000|Overall Study|Adverse Event|20|||
146894715|NCT00393718|529781788|FG001|Overall Study|Adverse Event|8|||
146894716|NCT00393718|529781787|FG000|Overall Study|Protocol Violation|1|||
146894717|NCT00393718|529781788|FG001|Overall Study|Protocol Violation|2|||
146894718|NCT00393718|529781787|FG000|Overall Study|Lack of Efficacy|10|||
146894719|NCT00393718|529781788|FG001|Overall Study|Lack of Efficacy|9|||
146894720|NCT00393718|529781787|FG000|Overall Study|Hypoglycaemia|3|||
146894721|NCT00393718|529781788|FG001|Overall Study|Hypoglycaemia|2|||
146894722|NCT00393718|529781787|FG000|Overall Study|Subject decision|5|||
146894723|NCT00393718|529781788|FG001|Overall Study|Subject decision|0|||
146894724|NCT00393718|529781787|FG000|Overall Study|Withdrawal of consent|2|||
146894725|NCT00393718|529781788|FG001|Overall Study|Withdrawal of consent|1|||
146894726|NCT00393718|529781787|FG000|Overall Study|Missed measurement|1|||
146894727|NCT00393718|529781788|FG001|Overall Study|Missed measurement|0|||
146894728|NCT00393718|529781787|FG000|Overall Study|Move|1|||
146894729|NCT00393718|529781788|FG001|Overall Study|Move|0|||
146894730|NCT01084551|529781793|FG000|Overall Study|Adverse Event|2|||
146894731|NCT01084551|529781794|FG001|Overall Study|Adverse Event|9|||
146894732|NCT01084551|529781795|FG002|Overall Study|Adverse Event|4|||
146894733|NCT01084551|529781793|FG000|Overall Study|Lack of Efficacy|2|||
146894734|NCT01084551|529781794|FG001|Overall Study|Lack of Efficacy|0|||
146894735|NCT01084551|529781795|FG002|Overall Study|Lack of Efficacy|1|||
146894736|NCT01084551|529781793|FG000|Overall Study|Withdrawal by Subject|2|||
146894737|NCT01084551|529781794|FG001|Overall Study|Withdrawal by Subject|1|||
146558949|NCT01051661|528555927|FG000|Overall Study|Subject lost legal representation|0|||
146558950|NCT01051661|528555928|FG001|Overall Study|Subject lost legal representation|0|||
146558951|NCT01051661|528555929|FG002|Overall Study|Subject lost legal representation|0|||
146558952|NCT01051661|528555930|FG003|Overall Study|Subject lost legal representation|0|||
146894738|NCT01084551|529781795|FG002|Overall Study|Withdrawal by Subject|0|||
146894739|NCT01084551|529781793|FG000|Overall Study|Protocol Violation|2|||
146894740|NCT01084551|529781794|FG001|Overall Study|Protocol Violation|4|||
146894741|NCT01084551|529781795|FG002|Overall Study|Protocol Violation|0|||
146894742|NCT01084551|529781793|FG000|Overall Study|Lost to Follow-up|0|||
146894743|NCT01084551|529781794|FG001|Overall Study|Lost to Follow-up|0|||
146894744|NCT01084551|529781795|FG002|Overall Study|Lost to Follow-up|3|||
146894745|NCT01084551|529781793|FG000|Overall Study|Physician Decision|1|||
146894746|NCT01084551|529781794|FG001|Overall Study|Physician Decision|0|||
146894747|NCT01084551|529781795|FG002|Overall Study|Physician Decision|0|||
146894748|NCT03575104|529781796|FG000|Overall Study|Adverse Event|4|||
146894749|NCT03575104|529781797|FG001|Overall Study|Adverse Event|3|||
146894750|NCT03575104|529781798|FG002|Overall Study|Adverse Event|4|||
146894751|NCT03575104|529781796|FG000|Overall Study|Withdrawal by Subject|13|||
146894752|NCT03575104|529781797|FG001|Overall Study|Withdrawal by Subject|16|||
146894753|NCT03575104|529781798|FG002|Overall Study|Withdrawal by Subject|11|||
146894754|NCT03575104|529781796|FG000|Overall Study|Other reasons|6|||
146894755|NCT03575104|529781797|FG001|Overall Study|Other reasons|8|||
146894756|NCT03575104|529781798|FG002|Overall Study|Other reasons|6|||
146894757|NCT03575104|529781796|FG000|Overall Study|Lost to Follow-up|1|||
146894758|NCT03575104|529781797|FG001|Overall Study|Lost to Follow-up|2|||
146894759|NCT03575104|529781798|FG002|Overall Study|Lost to Follow-up|1|||
146894760|NCT04684420|529781799|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146894761|NCT04684420|529781800|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146894762|NCT04684420|529781801|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
146894763|NCT04684420|529781802|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
146894764|NCT04684420|529781799|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
146894765|NCT04684420|529781800|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
146894766|NCT04684420|529781801|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
146894767|NCT04684420|529781802|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
146894768|NCT00463476|529781803|FG000|Overall Study|Withdrawal by Subject|1|||
146894769|NCT00463476|529781804|FG001|Overall Study|Withdrawal by Subject|2|||
146894770|NCT00463476|529781803|FG000|Overall Study|Lost to Follow-up|1|||
146894771|NCT00463476|529781804|FG001|Overall Study|Lost to Follow-up|1|||
146894772|NCT01409928|529781807|FG000|Overall Study|Physician Decision|12|||
146894773|NCT01703000|529781808|FG000|Overall Study|Death|1|||
146894774|NCT01279057|529781809|FG000|Overall Study|Adverse Event|1|||
146894775|NCT01279057|529781810|FG001|Overall Study|Adverse Event|0|||
146894776|NCT01279057|529781811|FG002|Overall Study|Adverse Event|1|||
146894777|NCT01279057|529781809|FG000|Overall Study|Insufficient therapeutic response|0|||
146894778|NCT01279057|529781810|FG001|Overall Study|Insufficient therapeutic response|0|||
146894779|NCT01279057|529781811|FG002|Overall Study|Insufficient therapeutic response|1|||
146894780|NCT01279057|529781809|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
146894781|NCT01279057|529781810|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
146894782|NCT01279057|529781811|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
146894783|NCT01279057|529781809|FG000|Overall Study|Withdrew consent|2|||
146894784|NCT01279057|529781810|FG001|Overall Study|Withdrew consent|0|||
146894785|NCT01279057|529781811|FG002|Overall Study|Withdrew consent|1|||
146894786|NCT01279057|529781809|FG000|Overall Study|Pregnancy|0|||
146894787|NCT01279057|529781810|FG001|Overall Study|Pregnancy|1|||
146894788|NCT01279057|529781811|FG002|Overall Study|Pregnancy|0|||
146894789|NCT01279057|529781809|FG000|Overall Study|Other|3|||
146894790|NCT01279057|529781810|FG001|Overall Study|Other|3|||
146894791|NCT01279057|529781811|FG002|Overall Study|Other|0|||
146894792|NCT03502187|529781814|FG000|Overall Study|Withdrawal by Subject|4|||
146894793|NCT03502187|529781815|FG001|Overall Study|Withdrawal by Subject|3|||
146894794|NCT03502187|529781816|FG002|Overall Study|Withdrawal by Subject|3|||
146894795|NCT03502187|529781814|FG000|Overall Study|Lost to Follow-up|5|||
146894796|NCT03502187|529781815|FG001|Overall Study|Lost to Follow-up|4|||
146894797|NCT03502187|529781816|FG002|Overall Study|Lost to Follow-up|5|||
146894798|NCT02411448|529781820|FG000|Overall Study|Withdrawal by Subject|1|||
146558953|NCT01051661|528555931|FG004|Overall Study|Subject lost legal representation|1|||
146894799|NCT02411448|529781821|FG001|Overall Study|Withdrawal by Subject|14|||
146894800|NCT02411448|529781822|FG002|Overall Study|Withdrawal by Subject|9|||
146894801|NCT02411448|529781820|FG000|Overall Study|Other|0|||
146894802|NCT02411448|529781821|FG001|Overall Study|Other|2|||
146894803|NCT02411448|529781822|FG002|Overall Study|Other|0|||
146894804|NCT02411448|529781820|FG000|Overall Study|Did not receive study treatment|0|||
146894805|NCT02411448|529781821|FG001|Overall Study|Did not receive study treatment|3|||
146894806|NCT02411448|529781822|FG002|Overall Study|Did not receive study treatment|0|||
146894807|NCT02411448|529781820|FG000|Overall Study|Alive on study treatment|3|||
146894808|NCT02411448|529781821|FG001|Overall Study|Alive on study treatment|64|||
146894809|NCT02411448|529781822|FG002|Overall Study|Alive on study treatment|43|||
146894810|NCT01848145|529781823|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
146894811|NCT01848145|529781823|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
146894812|NCT01848145|529781823|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
146894813|NCT01848145|529781823|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
146894814|NCT01848145|529781823|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
146894815|NCT01848145|529781823|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
146766620|NCT02914522|529312255|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146894816|NCT01848145|529781823|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
146894817|NCT01728779|529781824|FG000|Overall Study|Withdrawal by Subject|1|||
146558954|NCT01051661|528555932|FG005|Overall Study|Subject lost legal representation|0|||
146558955|NCT01051661|528555927|FG000|Overall Study|Protocol Violation|0|||
146558956|NCT01051661|528555928|FG001|Overall Study|Protocol Violation|0|||
146558957|NCT01051661|528555929|FG002|Overall Study|Protocol Violation|0|||
146558958|NCT01051661|528555930|FG003|Overall Study|Protocol Violation|1|||
146558959|NCT01051661|528555931|FG004|Overall Study|Protocol Violation|2|||
146558960|NCT01051661|528555932|FG005|Overall Study|Protocol Violation|1|||
146558961|NCT01051661|528555927|FG000|Overall Study|Withdrawal by Subject|16|||
146558962|NCT01051661|528555928|FG001|Overall Study|Withdrawal by Subject|30|||
146558963|NCT01051661|528555929|FG002|Overall Study|Withdrawal by Subject|13|||
146558964|NCT01051661|528555930|FG003|Overall Study|Withdrawal by Subject|28|||
146766621|NCT02914522|529312256|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
146766622|NCT02914522|529312257|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146558965|NCT01051661|528555931|FG004|Overall Study|Withdrawal by Subject|12|||
146639704|NCT02867384|528856548|FG002|Overall Study|Patient compliance|0|||
146968556|NCT00388674|530045465|FG000|Initial Treatment|Death|215|||
146968557|NCT00388674|530045466|FG001|Initial Treatment|Death|216|||
146968558|NCT00388674|530045465|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
146968559|NCT00388674|530045466|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
146968560|NCT00388674|530045465|FG000|Initial Treatment|HCC|12|||
146968561|NCT00388674|530045466|FG001|Initial Treatment|HCC|20|||
146968562|NCT00388674|530045465|FG000|Initial Treatment|Lost to Follow-up|526|||
146968563|NCT00388674|530045466|FG001|Initial Treatment|Lost to Follow-up|624|||
146968564|NCT00388674|530045465|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
146968565|NCT00388674|530045466|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
146968566|NCT00388674|530045465|FG000|Initial Treatment|Never Treated with Study Medication|1|||
146968567|NCT00388674|530045466|FG001|Initial Treatment|Never Treated with Study Medication|7|||
146968568|NCT00388674|530045465|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
146968569|NCT00388674|530045466|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
146968570|NCT00388674|530045465|FG000|Initial Treatment|Not Defined|125|||
146968571|NCT00388674|530045466|FG001|Initial Treatment|Not Defined|172|||
146968572|NCT00388674|530045465|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
146968573|NCT00388674|530045466|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
146968574|NCT00388674|530045465|FG000|Initial Treatment|Pregnancy|26|||
146558966|NCT01051661|528555932|FG005|Overall Study|Withdrawal by Subject|34|||
146558967|NCT01916226|528555933|FG000|Overall Study|Adverse Event|1|||
146558968|NCT01916226|528555934|FG001|Overall Study|Adverse Event|0|||
146558969|NCT01916226|528555935|FG002|Overall Study|Adverse Event|1|||
146558970|NCT01916226|528555936|FG003|Overall Study|Adverse Event|1|||
146558971|NCT01916226|528555933|FG000|Overall Study|Lack of Efficacy|0|||
146558972|NCT01916226|528555934|FG001|Overall Study|Lack of Efficacy|0|||
146558973|NCT01916226|528555935|FG002|Overall Study|Lack of Efficacy|2|||
146558974|NCT01916226|528555936|FG003|Overall Study|Lack of Efficacy|1|||
146968575|NCT00388674|530045466|FG001|Initial Treatment|Pregnancy|16|||
146558975|NCT01916226|528555933|FG000|Overall Study|Protocol Violation|0|||
146968576|NCT00388674|530045465|FG000|Initial Treatment|Study Drug Toxicity|5|||
146558976|NCT01916226|528555934|FG001|Overall Study|Protocol Violation|1|||
146558977|NCT01916226|528555935|FG002|Overall Study|Protocol Violation|0|||
146558978|NCT01916226|528555936|FG003|Overall Study|Protocol Violation|1|||
146968577|NCT00388674|530045466|FG001|Initial Treatment|Study Drug Toxicity|92|||
146968578|NCT00388674|530045465|FG000|Initial Treatment|Participant Request|501|||
146558979|NCT01916226|528555933|FG000|Overall Study|Physician Decision|0|||
146894818|NCT00624520|529781825|FG000|Overall Study|Withdrawal by Subject|12|||
146894819|NCT00624520|529781826|FG001|Overall Study|Withdrawal by Subject|7|||
146894820|NCT00624520|529781825|FG000|Overall Study|Death|0|||
146894821|NCT00624520|529781826|FG001|Overall Study|Death|1|||
146894822|NCT01551693|529781833|FG000|Overall Study|Disease Progression|1|||
146894823|NCT01551693|529781834|FG001|Overall Study|Disease Progression|0|||
146894824|NCT01551693|529781833|FG000|Overall Study|Adverse Event|0|||
146894825|NCT01551693|529781834|FG001|Overall Study|Adverse Event|1|||
146894826|NCT01551693|529781833|FG000|Overall Study|Withdrawal by Subject|0|||
146894827|NCT01551693|529781834|FG001|Overall Study|Withdrawal by Subject|1|||
146894828|NCT04134494|529781835|FG000|Overall Study|Lost to Follow-up|2|||
146894829|NCT01950819|529781836|FG000|Overall Study|Graft Loss|35|||
146894830|NCT01950819|529781837|FG001|Overall Study|Graft Loss|30|||
146894831|NCT01950819|529781836|FG000|Overall Study|Death|29|||
146894832|NCT01950819|529781837|FG001|Overall Study|Death|34|||
146894833|NCT01950819|529781836|FG000|Overall Study|Subject / Gardian decision|54|||
146894834|NCT01950819|529781837|FG001|Overall Study|Subject / Gardian decision|51|||
146894835|NCT01950819|529781836|FG000|Overall Study|technical problems|2|||
146894836|NCT01950819|529781837|FG001|Overall Study|technical problems|0|||
146894837|NCT01950819|529781836|FG000|Overall Study|Pregnancy|0|||
146894838|NCT01950819|529781837|FG001|Overall Study|Pregnancy|2|||
146894839|NCT01950819|529781836|FG000|Overall Study|Lost to Follow-up|9|||
146894840|NCT01950819|529781837|FG001|Overall Study|Lost to Follow-up|17|||
146894841|NCT00781365|529781838|FG000|Overall Study|Withdrawal by Subject|13|||
146894842|NCT00781365|529781839|FG001|Overall Study|Withdrawal by Subject|8|||
146894843|NCT00781365|529781838|FG000|Overall Study|Did Not Attend Visit|20|||
146894844|NCT00781365|529781839|FG001|Overall Study|Did Not Attend Visit|28|||
146894845|NCT00781365|529781838|FG000|Overall Study|Language barrier|1|||
146894846|NCT00781365|529781839|FG001|Overall Study|Language barrier|0|||
146894847|NCT02649634|529781840|FG000|Overall Study|Withdrawal by Subject|3|||
146894848|NCT02649634|529781841|FG001|Overall Study|Withdrawal by Subject|5|||
146894849|NCT02649634|529781840|FG000|Overall Study|Lost to Follow-up|0|||
146894850|NCT02649634|529781841|FG001|Overall Study|Lost to Follow-up|1|||
146894851|NCT00238264|529781842|FG000|Overall Study|Death|7|||
146894852|NCT00238264|529781842|FG000|Overall Study|Lost to Follow-up|18|||
146894853|NCT00238264|529781842|FG000|Overall Study|Withdrawal by Subject|4|||
146894854|NCT00238264|529781842|FG000|Overall Study|Ineligible|7|||
146894855|NCT01756456|529781845|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
146894856|NCT01756456|529781846|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
146894857|NCT01756456|529781847|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
146894858|NCT01756456|529781848|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
146894859|NCT01756456|529781849|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
146894860|NCT01756456|529781850|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
146894861|NCT01756456|529781845|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
146894862|NCT01756456|529781846|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
146894863|NCT01756456|529781847|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
146894864|NCT01756456|529781848|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
146894865|NCT01756456|529781849|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
146894866|NCT01756456|529781850|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
146894867|NCT01756456|529781845|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
146894868|NCT01756456|529781846|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
146894869|NCT01756456|529781847|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
146894870|NCT01756456|529781848|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
146894871|NCT01756456|529781849|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
146894872|NCT01756456|529781850|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
146894873|NCT01756456|529781845|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
146894874|NCT01756456|529781846|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
146894875|NCT01756456|529781847|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
146894876|NCT01756456|529781848|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
146894877|NCT01756456|529781849|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
146894878|NCT01756456|529781850|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
146894879|NCT01756456|529781845|FG000|Treatment Period: Phase I/II|Other causes|0|||
146558980|NCT01916226|528555934|FG001|Overall Study|Physician Decision|0|||
146894880|NCT01756456|529781846|FG001|Treatment Period: Phase I/II|Other causes|0|||
146968579|NCT00388674|530045466|FG001|Initial Treatment|Participant Request|673|||
146968580|NCT00388674|530045465|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
146558981|NCT01916226|528555935|FG002|Overall Study|Physician Decision|0|||
146558982|NCT01916226|528555936|FG003|Overall Study|Physician Decision|1|||
146894881|NCT01756456|529781847|FG002|Treatment Period: Phase I/II|Other causes|0|||
146894882|NCT01756456|529781848|FG003|Treatment Period: Phase I/II|Other causes|1|||
146894883|NCT01756456|529781849|FG004|Treatment Period: Phase I/II|Other causes|2|||
146894884|NCT01756456|529781850|FG005|Treatment Period: Phase I/II|Other causes|2|||
146968581|NCT00388674|530045466|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
146968582|NCT00388674|530045465|FG000|Initial Treatment|Not Reported|10|||
146968583|NCT00388674|530045466|FG001|Initial Treatment|Not Reported|12|||
146894885|NCT01756456|529781845|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
146894886|NCT01756456|529781846|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
146894887|NCT01756456|529781847|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
146894888|NCT01756456|529781848|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
146894889|NCT01756456|529781849|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
146894890|NCT01756456|529781850|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
146894891|NCT01756456|529781845|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
146894892|NCT01756456|529781846|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
146894893|NCT01756456|529781847|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
146894894|NCT01756456|529781848|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
146894895|NCT01756456|529781849|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
146894896|NCT01756456|529781850|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
146894897|NCT01756456|529781845|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
146894898|NCT01756456|529781846|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
146894899|NCT01756456|529781847|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
146894900|NCT01756456|529781848|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
146894901|NCT01756456|529781849|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
146894902|NCT01756456|529781850|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
146894903|NCT01756456|529781845|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
146894904|NCT01756456|529781846|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
146894905|NCT01756456|529781847|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
146894906|NCT01756456|529781848|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
146894907|NCT01756456|529781849|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
146894908|NCT01756456|529781850|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
146894909|NCT01756456|529781845|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
146894910|NCT01756456|529781846|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
146894911|NCT01756456|529781847|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
146894912|NCT01756456|529781848|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
146894913|NCT01756456|529781849|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
146894914|NCT01756456|529781850|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
146894915|NCT01756456|529781845|FG000|Follow Up Period Phase I/II|Other causes|0|||
146894916|NCT01756456|529781846|FG001|Follow Up Period Phase I/II|Other causes|0|||
146894917|NCT01756456|529781847|FG002|Follow Up Period Phase I/II|Other causes|0|||
146894918|NCT01756456|529781848|FG003|Follow Up Period Phase I/II|Other causes|1|||
146894919|NCT01756456|529781849|FG004|Follow Up Period Phase I/II|Other causes|3|||
146894920|NCT01756456|529781850|FG005|Follow Up Period Phase I/II|Other causes|5|||
146894921|NCT01838044|529781851|FG000|Overall Study|Adverse Event|4|||
146894922|NCT01838044|529781852|FG001|Overall Study|Adverse Event|6|||
146894923|NCT01838044|529781851|FG000|Overall Study|Protocol Violation|3|||
146894924|NCT01838044|529781852|FG001|Overall Study|Protocol Violation|3|||
146894925|NCT01838044|529781851|FG000|Overall Study|Withdrawal by Subject|0|||
146894926|NCT01838044|529781852|FG001|Overall Study|Withdrawal by Subject|2|||
146894927|NCT01838044|529781851|FG000|Overall Study|Insufficient clinical response|1|||
146894928|NCT01838044|529781852|FG001|Overall Study|Insufficient clinical response|2|||
146894929|NCT01838044|529781851|FG000|Overall Study|Medication error without associated AE|0|||
146894930|NCT01838044|529781852|FG001|Overall Study|Medication error without associated AE|1|||
146894931|NCT01838044|529781851|FG000|Overall Study|Lost to Follow-up|0|||
146894932|NCT01838044|529781852|FG001|Overall Study|Lost to Follow-up|2|||
146894933|NCT01662648|529781853|FG000|Overall Study|Death|1|||
146894934|NCT01662648|529781854|FG001|Overall Study|Death|3|||
146894935|NCT01662648|529781853|FG000|Overall Study|Adverse Event|40|||
146894936|NCT01662648|529781854|FG001|Overall Study|Adverse Event|37|||
146894937|NCT01662648|529781853|FG000|Overall Study|Lack of Efficacy|17|||
146894938|NCT01662648|529781854|FG001|Overall Study|Lack of Efficacy|16|||
146894939|NCT01662648|529781853|FG000|Overall Study|Participant ineligible to continue trial|1|||
146894940|NCT01662648|529781854|FG001|Overall Study|Participant ineligible to continue trial|1|||
146894941|NCT01662648|529781853|FG000|Overall Study|Lost to Follow-up|24|||
146894942|NCT01662648|529781854|FG001|Overall Study|Lost to Follow-up|36|||
146894943|NCT01662648|529781853|FG000|Overall Study|Withdrawal by Subject|36|||
146894944|NCT01662648|529781854|FG001|Overall Study|Withdrawal by Subject|53|||
146894945|NCT01662648|529781853|FG000|Overall Study|Participant non-compliant|16|||
146894946|NCT01662648|529781854|FG001|Overall Study|Participant non-compliant|20|||
146894947|NCT01662648|529781853|FG000|Overall Study|Other|8|||
146894948|NCT01662648|529781854|FG001|Overall Study|Other|11|||
146894949|NCT01662648|529781853|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
146894950|NCT01662648|529781854|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
146894951|NCT01662648|529781853|FG000|Overall Study|LOE and other reason unspecified|1|||
146894952|NCT01662648|529781854|FG001|Overall Study|LOE and other reason unspecified|0|||
146894953|NCT01662648|529781853|FG000|Overall Study|LOE and Participant non-compliant|0|||
146766623|NCT00177216|529312258|FG000|Overall Study|Withdrawal by Subject|6|||
146558983|NCT00680914|528555939|FG000|Overall Study|Consent withdrawal|6|||
146894954|NCT01662648|529781854|FG001|Overall Study|LOE and Participant non-compliant|1|||
146639705|NCT02867384|528856546|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
146639706|NCT02867384|528856547|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
146894955|NCT00706628|529781855|FG000|Overall Study|Other Adverse Event|16|||
146894956|NCT00706628|529781856|FG001|Overall Study|Other Adverse Event|5|||
146894957|NCT00706628|529781857|FG002|Overall Study|Other Adverse Event|5|||
146558984|NCT00680914|528555940|FG001|Overall Study|Consent withdrawal|3|||
146558985|NCT00680914|528555939|FG000|Overall Study|Lost to Follow-up|4|||
146558986|NCT00680914|528555940|FG001|Overall Study|Lost to Follow-up|0|||
146558987|NCT00680914|528555939|FG000|Overall Study|serious adverse event (SAE)|0|||
146894958|NCT00706628|529781858|FG003|Overall Study|Other Adverse Event|2|||
146558988|NCT00680914|528555940|FG001|Overall Study|serious adverse event (SAE)|1|||
146894959|NCT00706628|529781855|FG000|Overall Study|Non compliant with protocol|0|||
146894960|NCT00706628|529781856|FG001|Overall Study|Non compliant with protocol|1|||
146894961|NCT00706628|529781857|FG002|Overall Study|Non compliant with protocol|0|||
146894962|NCT00706628|529781858|FG003|Overall Study|Non compliant with protocol|0|||
146894963|NCT00706628|529781855|FG000|Overall Study|Consent withdrawn|6|||
146894964|NCT00706628|529781856|FG001|Overall Study|Consent withdrawn|1|||
146894965|NCT00706628|529781857|FG002|Overall Study|Consent withdrawn|3|||
146894966|NCT00706628|529781858|FG003|Overall Study|Consent withdrawn|0|||
146894967|NCT00706628|529781855|FG000|Overall Study|Progressive disease|20|||
146894968|NCT00706628|529781856|FG001|Overall Study|Progressive disease|13|||
146894969|NCT00706628|529781857|FG002|Overall Study|Progressive disease|8|||
146894970|NCT00706628|529781858|FG003|Overall Study|Progressive disease|1|||
146894971|NCT00706628|529781855|FG000|Overall Study|Other than those stated above|4|||
146894972|NCT00706628|529781856|FG001|Overall Study|Other than those stated above|0|||
146894973|NCT00706628|529781857|FG002|Overall Study|Other than those stated above|0|||
146894974|NCT00706628|529781858|FG003|Overall Study|Other than those stated above|0|||
146894975|NCT00706628|529781855|FG000|Overall Study|Not treated|1|||
146894976|NCT00706628|529781856|FG001|Overall Study|Not treated|1|||
146894977|NCT00706628|529781857|FG002|Overall Study|Not treated|0|||
146894978|NCT00706628|529781858|FG003|Overall Study|Not treated|0|||
146894979|NCT02266433|529781862|FG000|Overall Study|Lost to Follow-up|54|||
146894980|NCT02266433|529781863|FG001|Overall Study|Lost to Follow-up|46|||
146894981|NCT02266433|529781862|FG000|Overall Study|Withdrawal by Subject|5|||
146894982|NCT02266433|529781863|FG001|Overall Study|Withdrawal by Subject|7|||
146894983|NCT02658812|529781869|FG000|Overall Study|Disease Progression|7|||
146894984|NCT02658812|529781869|FG000|Overall Study|Unrelated to study treatment|1|||
146894985|NCT02658812|529781869|FG000|Overall Study|Adverse Event|1|||
146894986|NCT00896532|529781878|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146894987|NCT00896532|529781879|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146894988|NCT00896532|529781880|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146894989|NCT00896532|529781881|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
146894990|NCT00896532|529781882|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146894991|NCT00896532|529781883|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
146894992|NCT00896532|529781884|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146894993|NCT00896532|529781885|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146894994|NCT00896532|529781886|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146894995|NCT00896532|529781887|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146894996|NCT00896532|529781888|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146894997|NCT00896532|529781889|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146894998|NCT00896532|529781890|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146894999|NCT00896532|529781891|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146895000|NCT00896532|529781892|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146895001|NCT00896532|529781893|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146895002|NCT00896532|529781894|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146895003|NCT00896532|529781895|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146895004|NCT00896532|529781896|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146895005|NCT00896532|529781897|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146895006|NCT00896532|529781898|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146895007|NCT00896532|529781899|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146895008|NCT00896532|529781900|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146895009|NCT00896532|529781878|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
146895010|NCT00896532|529781879|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
146895011|NCT00896532|529781880|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
146895012|NCT00896532|529781881|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
146895013|NCT00896532|529781882|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
146895014|NCT00896532|529781883|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
146895015|NCT00896532|529781884|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
146895016|NCT00896532|529781885|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146895017|NCT00896532|529781886|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146895018|NCT00896532|529781887|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146895019|NCT00896532|529781888|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146895020|NCT00896532|529781889|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146895021|NCT00896532|529781890|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146895022|NCT00896532|529781891|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146895023|NCT00896532|529781892|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146968584|NCT00388674|530045465|FG000|End of Study|Administrative Reason By Sponsor|299|||
146968585|NCT00388674|530045466|FG001|End of Study|Administrative Reason By Sponsor|253|||
146968586|NCT00388674|530045465|FG000|End of Study|Death|239|||
146968587|NCT00388674|530045466|FG001|End of Study|Death|262|||
146968588|NCT00388674|530045465|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
146968589|NCT00388674|530045466|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
146968590|NCT00388674|530045465|FG000|End of Study|HCC|8|||
146968591|NCT00388674|530045466|FG001|End of Study|HCC|7|||
146968592|NCT00388674|530045465|FG000|End of Study|Lost to Follow-up|587|||
146968593|NCT00388674|530045466|FG001|End of Study|Lost to Follow-up|715|||
146968594|NCT00388674|530045465|FG000|End of Study|Malignancy (Non-HCC)|1|||
146968595|NCT00388674|530045466|FG001|End of Study|Malignancy (Non-HCC)|1|||
146639707|NCT02867384|528856548|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
146639708|NCT02867384|528856546|FG000|Overall Study|Never start treatment|3|||
146895024|NCT00896532|529781893|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146895025|NCT00896532|529781894|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146895026|NCT00896532|529781895|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146895027|NCT00896532|529781896|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146895028|NCT00896532|529781897|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146895029|NCT00896532|529781898|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146895030|NCT00896532|529781899|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146895031|NCT00896532|529781900|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146895032|NCT00896532|529781878|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
146895033|NCT00896532|529781879|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
146895034|NCT00896532|529781880|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
146895035|NCT00896532|529781881|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
146895036|NCT00896532|529781882|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
146895037|NCT00896532|529781883|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
146895038|NCT00896532|529781884|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
146895039|NCT00896532|529781885|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
146968596|NCT00388674|530045465|FG000|End of Study|Non-Study Related Comorbidities|3|||
146968597|NCT00388674|530045466|FG001|End of Study|Non-Study Related Comorbidities|4|||
146968598|NCT00388674|530045465|FG000|End of Study|Not Defined|135|||
146558989|NCT01848457|528555941|FG000|Overall Study|Death|1|||
146558990|NCT01848457|528555942|FG001|Overall Study|Death|0|||
146558991|NCT01848457|528555943|FG002|Overall Study|Death|0|||
146558992|NCT01848457|528555944|FG003|Overall Study|Death|0|||
146558993|NCT01813357|528555948|FG000|Overall Study|Lost to Follow-up|5|||
146558994|NCT01813357|528555949|FG001|Overall Study|Lost to Follow-up|6|||
146895040|NCT00896532|529781886|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146895041|NCT00896532|529781887|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146895042|NCT00896532|529781888|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146895043|NCT00896532|529781889|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146895044|NCT00896532|529781890|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146895045|NCT00896532|529781891|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146895046|NCT00896532|529781892|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146895047|NCT00896532|529781893|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146895048|NCT00896532|529781894|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146895049|NCT00896532|529781895|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146895050|NCT00896532|529781896|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146895051|NCT00896532|529781897|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146895052|NCT00896532|529781898|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146895053|NCT00896532|529781899|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146895054|NCT00896532|529781900|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146895055|NCT00896532|529781878|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895056|NCT00896532|529781879|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895057|NCT00896532|529781880|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
146895058|NCT00896532|529781881|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895059|NCT00896532|529781882|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
146895060|NCT00896532|529781883|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895061|NCT00896532|529781884|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895062|NCT00896532|529781885|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895063|NCT00896532|529781886|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146558995|NCT04903093|528555950|FG000|Overall Study|Withdrawal by Subject|0|||
146558996|NCT04903093|528555951|FG001|Overall Study|Withdrawal by Subject|0|||
146558997|NCT04903093|528555952|FG002|Overall Study|Withdrawal by Subject|0|||
146558998|NCT04903093|528555953|FG003|Overall Study|Withdrawal by Subject|1|||
146558999|NCT04903093|528555954|FG004|Overall Study|Withdrawal by Subject|0|||
146559000|NCT04903093|528555955|FG005|Overall Study|Withdrawal by Subject|0|||
146559001|NCT01111552|528555956|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
146559002|NCT01111552|528555957|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
146559003|NCT01111552|528555958|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
146559004|NCT01111552|528555959|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
146559005|NCT01111552|528555960|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
146895064|NCT00896532|529781887|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146559006|NCT01111552|528555956|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
146895065|NCT00896532|529781888|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895066|NCT00896532|529781889|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146968599|NCT00388674|530045466|FG001|End of Study|Not Defined|214|||
146968600|NCT00388674|530045465|FG000|End of Study|Participant Withdrew Consent|437|||
146968601|NCT00388674|530045466|FG001|End of Study|Participant Withdrew Consent|673|||
146968602|NCT00388674|530045465|FG000|End of Study|No Off-Treatment Status Data|22|||
146968603|NCT00388674|530045466|FG001|End of Study|No Off-Treatment Status Data|30|||
146968604|NCT00388674|530045465|FG000|End of Study|Not Reported|0|||
146968605|NCT00388674|530045466|FG001|End of Study|Not Reported|1|||
146968606|NCT03576131|530045467|FG000|Overall Study|Investigator decision|0|||
146968607|NCT03576131|530045468|FG001|Overall Study|Investigator decision|0|||
146968608|NCT03576131|530045469|FG002|Overall Study|Investigator decision|0|||
146968609|NCT03576131|530045470|FG003|Overall Study|Investigator decision|1|||
146968610|NCT03576131|530045471|FG004|Overall Study|Investigator decision|0|||
146968611|NCT03576131|530045472|FG005|Overall Study|Investigator decision|1|||
146968612|NCT03576131|530045473|FG006|Overall Study|Investigator decision|0|||
146968613|NCT03576131|530045474|FG007|Overall Study|Investigator decision|0|||
146968614|NCT03576131|530045467|FG000|Overall Study|Withdrawal by Subject|1|||
146968615|NCT03576131|530045468|FG001|Overall Study|Withdrawal by Subject|1|||
146968616|NCT03576131|530045469|FG002|Overall Study|Withdrawal by Subject|0|||
146968617|NCT03576131|530045470|FG003|Overall Study|Withdrawal by Subject|1|||
146968618|NCT03576131|530045471|FG004|Overall Study|Withdrawal by Subject|2|||
146968619|NCT03576131|530045472|FG005|Overall Study|Withdrawal by Subject|3|||
146968620|NCT03576131|530045473|FG006|Overall Study|Withdrawal by Subject|1|||
146968621|NCT03576131|530045474|FG007|Overall Study|Withdrawal by Subject|0|||
146968622|NCT03576131|530045467|FG000|Overall Study|Death|3|||
146968623|NCT03576131|530045468|FG001|Overall Study|Death|3|||
146968624|NCT03576131|530045469|FG002|Overall Study|Death|1|||
146968625|NCT03576131|530045470|FG003|Overall Study|Death|5|||
146968626|NCT03576131|530045471|FG004|Overall Study|Death|4|||
146968627|NCT03576131|530045472|FG005|Overall Study|Death|1|||
146968628|NCT03576131|530045473|FG006|Overall Study|Death|0|||
146968629|NCT03576131|530045474|FG007|Overall Study|Death|1|||
146968630|NCT03576131|530045467|FG000|Overall Study|New anti-cancer treatment|5|||
146968631|NCT03576131|530045468|FG001|Overall Study|New anti-cancer treatment|1|||
146968632|NCT03576131|530045469|FG002|Overall Study|New anti-cancer treatment|2|||
146968633|NCT03576131|530045470|FG003|Overall Study|New anti-cancer treatment|3|||
146968634|NCT03576131|530045471|FG004|Overall Study|New anti-cancer treatment|0|||
146968635|NCT03576131|530045472|FG005|Overall Study|New anti-cancer treatment|0|||
146968636|NCT03576131|530045473|FG006|Overall Study|New anti-cancer treatment|0|||
146968637|NCT03576131|530045474|FG007|Overall Study|New anti-cancer treatment|0|||
146968638|NCT03576131|530045467|FG000|Overall Study|Unspecified reason|0|||
146968639|NCT03576131|530045468|FG001|Overall Study|Unspecified reason|0|||
146968640|NCT03576131|530045469|FG002|Overall Study|Unspecified reason|1|||
146968641|NCT03576131|530045470|FG003|Overall Study|Unspecified reason|1|||
146968642|NCT03576131|530045471|FG004|Overall Study|Unspecified reason|1|||
146968643|NCT03576131|530045472|FG005|Overall Study|Unspecified reason|1|||
146968644|NCT03576131|530045473|FG006|Overall Study|Unspecified reason|0|||
146968645|NCT03576131|530045474|FG007|Overall Study|Unspecified reason|0|||
146968646|NCT03576131|530045467|FG000|Overall Study|Subject non-compliance|0|||
146968647|NCT03576131|530045468|FG001|Overall Study|Subject non-compliance|0|||
146968648|NCT03576131|530045469|FG002|Overall Study|Subject non-compliance|0|||
146968649|NCT03576131|530045470|FG003|Overall Study|Subject non-compliance|0|||
146968650|NCT03576131|530045471|FG004|Overall Study|Subject non-compliance|0|||
146895067|NCT00896532|529781890|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895068|NCT00896532|529781891|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895069|NCT00896532|529781892|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895070|NCT00896532|529781893|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895071|NCT00896532|529781894|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895072|NCT00896532|529781895|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146559007|NCT01111552|528555957|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
146895073|NCT00896532|529781896|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895074|NCT00896532|529781897|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895075|NCT00896532|529781898|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895076|NCT00896532|529781899|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895077|NCT00896532|529781900|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146895078|NCT00896532|529781878|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
146895079|NCT00896532|529781879|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895080|NCT00896532|529781880|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895081|NCT00896532|529781881|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
146895082|NCT00896532|529781882|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895083|NCT00896532|529781883|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895084|NCT00896532|529781884|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895085|NCT00896532|529781885|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895086|NCT00896532|529781886|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895087|NCT00896532|529781887|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895088|NCT00896532|529781888|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895089|NCT00896532|529781889|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895090|NCT00896532|529781890|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895091|NCT00896532|529781891|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895092|NCT00896532|529781892|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895093|NCT00896532|529781893|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895094|NCT00896532|529781894|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895095|NCT00896532|529781895|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895096|NCT00896532|529781896|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895097|NCT00896532|529781897|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895098|NCT00896532|529781898|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895099|NCT00896532|529781899|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895100|NCT00896532|529781900|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146895101|NCT00896532|529781878|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895102|NCT00896532|529781879|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895103|NCT00896532|529781880|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
146895104|NCT00896532|529781881|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895105|NCT00896532|529781882|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895106|NCT00896532|529781883|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895107|NCT00896532|529781884|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895108|NCT00896532|529781885|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895109|NCT00896532|529781886|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895110|NCT00896532|529781887|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895111|NCT00896532|529781888|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895112|NCT00896532|529781889|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895113|NCT00896532|529781890|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895114|NCT00896532|529781891|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895115|NCT00896532|529781892|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895116|NCT00896532|529781893|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895117|NCT00896532|529781894|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895118|NCT00896532|529781895|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895119|NCT00896532|529781896|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895120|NCT00896532|529781897|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895121|NCT00896532|529781898|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895122|NCT00896532|529781899|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895123|NCT00896532|529781900|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146895124|NCT00896532|529781878|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895125|NCT00896532|529781879|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895126|NCT00896532|529781880|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
146895127|NCT00896532|529781881|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895128|NCT00896532|529781882|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895129|NCT00896532|529781883|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146559008|NCT01111552|528555958|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
146559009|NCT01111552|528555959|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
146559010|NCT01111552|528555960|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
146559011|NCT01111552|528555956|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
146559012|NCT01111552|528555957|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
146559013|NCT01111552|528555958|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
146559014|NCT01111552|528555959|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
146559015|NCT01111552|528555960|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
146559016|NCT01111552|528555956|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
146559017|NCT01111552|528555957|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
146559018|NCT01111552|528555958|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
146559019|NCT01111552|528555959|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
146559020|NCT01111552|528555960|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
146559021|NCT01111552|528555956|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
146895130|NCT00896532|529781884|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895131|NCT00896532|529781885|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895132|NCT00896532|529781886|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895133|NCT00896532|529781887|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146559022|NCT01111552|528555957|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
146559023|NCT01111552|528555958|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
146639709|NCT02867384|528856547|FG001|Overall Study|Never start treatment|0|||
146639710|NCT02867384|528856548|FG002|Overall Study|Never start treatment|0|||
146639711|NCT03901469|528856549|FG000|Overall Study|Radiographic Progression|4|||
146895134|NCT00896532|529781888|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895135|NCT00896532|529781889|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895136|NCT00896532|529781890|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146968651|NCT03576131|530045472|FG005|Overall Study|Subject non-compliance|1|||
146968652|NCT03576131|530045473|FG006|Overall Study|Subject non-compliance|0|||
146639712|NCT03901469|528856550|FG001|Overall Study|Radiographic Progression|6|||
146639713|NCT03901469|528856551|FG002|Overall Study|Radiographic Progression|3|||
146639714|NCT03901469|528856552|FG003|Overall Study|Radiographic Progression|30|||
146639715|NCT03901469|528856553|FG004|Overall Study|Radiographic Progression|7|||
146639716|NCT03901469|528856554|FG005|Overall Study|Radiographic Progression|2|||
146639717|NCT03901469|528856555|FG006|Overall Study|Radiographic Progression|11|||
146639718|NCT03901469|528856549|FG000|Overall Study|Clinical Progression|0|||
146895137|NCT00896532|529781891|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895138|NCT00896532|529781892|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146559024|NCT01111552|528555959|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
146895139|NCT00896532|529781893|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895140|NCT00896532|529781894|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146559025|NCT01111552|528555960|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
146559026|NCT01111552|528555956|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
146559027|NCT01111552|528555957|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
146559028|NCT01111552|528555958|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
146559029|NCT01111552|528555959|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
146559030|NCT01111552|528555960|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
146559031|NCT01111552|528555956|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
146559032|NCT01111552|528555957|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
146559033|NCT01111552|528555958|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
146559034|NCT01111552|528555959|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
146559035|NCT01111552|528555960|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
146559036|NCT01111552|528555956|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
146559037|NCT01111552|528555957|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
146559038|NCT01111552|528555958|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
146559039|NCT01111552|528555959|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
146559040|NCT01111552|528555960|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
146559041|NCT01111552|528555956|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
146559042|NCT01111552|528555957|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
146559043|NCT01111552|528555958|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
146559044|NCT01111552|528555959|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
146559045|NCT01111552|528555960|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
146559046|NCT01111552|528555956|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
146559047|NCT01111552|528555957|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
146559048|NCT01111552|528555958|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
146639719|NCT03901469|528856550|FG001|Overall Study|Clinical Progression|2|||
146639720|NCT03901469|528856551|FG002|Overall Study|Clinical Progression|0|||
146639721|NCT03901469|528856552|FG003|Overall Study|Clinical Progression|7|||
146639722|NCT03901469|528856553|FG004|Overall Study|Clinical Progression|6|||
146895141|NCT00896532|529781895|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895142|NCT00896532|529781896|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895143|NCT00896532|529781897|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895144|NCT00896532|529781898|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895145|NCT00896532|529781899|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895146|NCT00896532|529781900|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146895147|NCT00896532|529781878|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895148|NCT00896532|529781879|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895149|NCT00896532|529781880|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895150|NCT00896532|529781881|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
146895151|NCT00896532|529781882|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895152|NCT00896532|529781883|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895153|NCT00896532|529781884|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895154|NCT00896532|529781885|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895155|NCT00896532|529781886|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895156|NCT00896532|529781887|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895157|NCT00896532|529781888|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895158|NCT00896532|529781889|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895159|NCT00896532|529781890|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895160|NCT00896532|529781891|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895161|NCT00896532|529781892|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895162|NCT00896532|529781893|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895163|NCT00896532|529781894|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895164|NCT00896532|529781895|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895165|NCT00896532|529781896|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895166|NCT00896532|529781897|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895167|NCT00896532|529781898|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146914683|NCT03303339|529850044|FG002|Overall Study|Safety/Non-compliance|0|||
146639723|NCT03901469|528856554|FG005|Overall Study|Clinical Progression|0|||
146639724|NCT03901469|528856555|FG006|Overall Study|Clinical Progression|2|||
146639725|NCT03901469|528856549|FG000|Overall Study|Adverse Event|1|||
146639726|NCT03901469|528856550|FG001|Overall Study|Adverse Event|0|||
146639727|NCT03901469|528856551|FG002|Overall Study|Adverse Event|0|||
146639728|NCT03901469|528856552|FG003|Overall Study|Adverse Event|0|||
146639729|NCT03901469|528856553|FG004|Overall Study|Adverse Event|0|||
146639730|NCT03901469|528856554|FG005|Overall Study|Adverse Event|0|||
146639731|NCT03901469|528856555|FG006|Overall Study|Adverse Event|9|||
146639732|NCT03901469|528856549|FG000|Overall Study|Physician Decision|0|||
146639733|NCT03901469|528856550|FG001|Overall Study|Physician Decision|0|||
146639734|NCT03901469|528856551|FG002|Overall Study|Physician Decision|0|||
146639735|NCT03901469|528856552|FG003|Overall Study|Physician Decision|1|||
146639736|NCT03901469|528856553|FG004|Overall Study|Physician Decision|0|||
146639737|NCT03901469|528856554|FG005|Overall Study|Physician Decision|0|||
146639738|NCT03901469|528856555|FG006|Overall Study|Physician Decision|0|||
146639739|NCT03901469|528856549|FG000|Overall Study|Withdrawal by Subject|0|||
146639740|NCT03901469|528856550|FG001|Overall Study|Withdrawal by Subject|0|||
146639741|NCT03901469|528856551|FG002|Overall Study|Withdrawal by Subject|0|||
146639742|NCT03901469|528856552|FG003|Overall Study|Withdrawal by Subject|0|||
146639743|NCT03901469|528856553|FG004|Overall Study|Withdrawal by Subject|2|||
146639744|NCT03901469|528856554|FG005|Overall Study|Withdrawal by Subject|0|||
146639745|NCT03901469|528856555|FG006|Overall Study|Withdrawal by Subject|8|||
146639746|NCT03901469|528856549|FG000|Overall Study|Death|0|||
146895168|NCT00896532|529781899|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895169|NCT00896532|529781900|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146895170|NCT00896532|529781878|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895171|NCT00896532|529781879|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
146895172|NCT00896532|529781880|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895173|NCT00896532|529781881|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
146895174|NCT00896532|529781882|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
146895175|NCT00896532|529781883|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895176|NCT00896532|529781884|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895177|NCT00896532|529781885|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895178|NCT00896532|529781886|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895179|NCT00896532|529781887|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895180|NCT00896532|529781888|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895181|NCT00896532|529781889|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895182|NCT00896532|529781890|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895183|NCT00896532|529781891|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895184|NCT00896532|529781892|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895185|NCT00896532|529781893|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895186|NCT00896532|529781894|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895187|NCT00896532|529781895|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895188|NCT00896532|529781896|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895189|NCT00896532|529781897|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895190|NCT00896532|529781898|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895191|NCT00896532|529781899|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895192|NCT00896532|529781900|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146895193|NCT00896532|529781878|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895194|NCT00896532|529781879|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895195|NCT00896532|529781880|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895196|NCT00896532|529781881|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895197|NCT00896532|529781882|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895198|NCT00896532|529781883|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895199|NCT00896532|529781884|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895200|NCT00896532|529781885|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895201|NCT00896532|529781886|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
146895202|NCT00896532|529781887|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895203|NCT00896532|529781888|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895204|NCT00896532|529781889|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895205|NCT00896532|529781890|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895206|NCT00896532|529781891|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895207|NCT00896532|529781892|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895208|NCT00896532|529781893|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895209|NCT00896532|529781894|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895210|NCT00896532|529781895|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895211|NCT00896532|529781896|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895212|NCT00896532|529781897|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895213|NCT00896532|529781898|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895214|NCT00896532|529781899|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895215|NCT00896532|529781900|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146895216|NCT00896532|529781878|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895217|NCT00896532|529781879|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895218|NCT00896532|529781880|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895219|NCT00896532|529781881|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895220|NCT00896532|529781882|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895221|NCT00896532|529781883|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895222|NCT00896532|529781884|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895223|NCT00896532|529781885|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895224|NCT00896532|529781886|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895225|NCT00896532|529781887|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895226|NCT00896532|529781888|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895227|NCT00896532|529781889|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895228|NCT00896532|529781890|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
146895229|NCT00896532|529781891|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146559049|NCT01111552|528555959|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
146559050|NCT01111552|528555960|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
146559051|NCT01111552|528555956|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
146559052|NCT01111552|528555957|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
146559053|NCT01111552|528555958|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
146559054|NCT01111552|528555959|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
146559055|NCT01111552|528555960|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
146559056|NCT01111552|528555956|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
146559057|NCT01111552|528555957|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
146559058|NCT01111552|528555958|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
146559059|NCT01111552|528555959|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
146559060|NCT01111552|528555960|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
146559061|NCT01111552|528555956|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
146559062|NCT01111552|528555957|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
146559063|NCT01111552|528555958|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
146559064|NCT01111552|528555959|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
146559065|NCT01111552|528555960|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
146639747|NCT03901469|528856550|FG001|Overall Study|Death|0|||
146559066|NCT01111552|528555956|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
146639748|NCT03901469|528856551|FG002|Overall Study|Death|0|||
146639749|NCT03901469|528856552|FG003|Overall Study|Death|3|||
146639750|NCT03901469|528856553|FG004|Overall Study|Death|5|||
146639751|NCT03901469|528856554|FG005|Overall Study|Death|0|||
146639752|NCT03901469|528856555|FG006|Overall Study|Death|1|||
146639753|NCT03901469|528856549|FG000|Overall Study|Termination of study by sponsor|0|||
146639754|NCT03901469|528856550|FG001|Overall Study|Termination of study by sponsor|0|||
146639755|NCT03901469|528856551|FG002|Overall Study|Termination of study by sponsor|0|||
146639756|NCT03901469|528856552|FG003|Overall Study|Termination of study by sponsor|0|||
146639757|NCT03901469|528856553|FG004|Overall Study|Termination of study by sponsor|1|||
146895230|NCT00896532|529781892|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895231|NCT00896532|529781893|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895232|NCT00896532|529781894|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146766624|NCT00177216|529312259|FG001|Overall Study|Withdrawal by Subject|3|||
146766625|NCT00177216|529312260|FG002|Overall Study|Withdrawal by Subject|1|||
146968653|NCT03576131|530045474|FG007|Overall Study|Subject non-compliance|0|||
146968654|NCT00996632|530045479|FG000|Overall Study|Physician Decision|0|||
146968655|NCT00996632|530045480|FG001|Overall Study|Physician Decision|0|||
146968656|NCT04484805|530045491|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
146968657|NCT04484805|530045492|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
146968658|NCT04484805|530045491|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
146968659|NCT04484805|530045492|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
146968660|NCT02118896|530045493|FG000|Overall Study|Death|4|||
146968661|NCT02118896|530045494|FG001|Overall Study|Death|0|||
146968662|NCT02118896|530045495|FG002|Overall Study|Death|4|||
146968663|NCT02118896|530045496|FG003|Overall Study|Death|6|||
146968664|NCT02118896|530045497|FG004|Overall Study|Death|3|||
146968665|NCT02118896|530045498|FG005|Overall Study|Death|1|||
146968666|NCT02118896|530045499|FG006|Overall Study|Death|0|||
146968667|NCT02118896|530045500|FG007|Overall Study|Death|0|||
146968668|NCT02118896|530045501|FG008|Overall Study|Death|0|||
146968669|NCT02118896|530045502|FG009|Overall Study|Death|0|||
146968670|NCT02118896|530045493|FG000|Overall Study|Adverse Event|5|||
146968671|NCT02118896|530045494|FG001|Overall Study|Adverse Event|4|||
146968672|NCT02118896|530045495|FG002|Overall Study|Adverse Event|4|||
146968673|NCT02118896|530045496|FG003|Overall Study|Adverse Event|5|||
146968674|NCT02118896|530045497|FG004|Overall Study|Adverse Event|5|||
146968675|NCT02118896|530045498|FG005|Overall Study|Adverse Event|9|||
146968676|NCT02118896|530045499|FG006|Overall Study|Adverse Event|1|||
146968677|NCT02118896|530045500|FG007|Overall Study|Adverse Event|1|||
146968678|NCT02118896|530045501|FG008|Overall Study|Adverse Event|4|||
146639758|NCT03901469|528856554|FG005|Overall Study|Termination of study by sponsor|1|||
146639759|NCT03901469|528856555|FG006|Overall Study|Termination of study by sponsor|0|||
146968679|NCT02118896|530045502|FG009|Overall Study|Adverse Event|0|||
146968680|NCT02118896|530045493|FG000|Overall Study|Consent withdrawn|2|||
146968681|NCT02118896|530045494|FG001|Overall Study|Consent withdrawn|0|||
146639760|NCT03901469|528856549|FG000|Overall Study|Not Reported|1|||
146639761|NCT03901469|528856550|FG001|Overall Study|Not Reported|0|||
146639762|NCT03901469|528856551|FG002|Overall Study|Not Reported|0|||
146639763|NCT03901469|528856552|FG003|Overall Study|Not Reported|1|||
146639764|NCT03901469|528856553|FG004|Overall Study|Not Reported|0|||
146639765|NCT03901469|528856554|FG005|Overall Study|Not Reported|0|||
146639766|NCT03901469|528856555|FG006|Overall Study|Not Reported|1|||
146639767|NCT03710083|528856556|FG000|Overall Study|Withdrawal by Subject|2|||
146639768|NCT03710083|528856556|FG000|Overall Study|Unsuccessful Procedure|1|||
146639769|NCT01727024|528856557|FG000|Period 1|Lost to Follow-up|1|||
146766626|NCT01264718|529312267|FG000|Overall Study|Lost to Follow-up|3|||
146766627|NCT01264718|529312268|FG001|Overall Study|Lost to Follow-up|2|||
146766628|NCT01264718|529312267|FG000|Overall Study|Withdrawal by Subject|9|||
146766629|NCT01264718|529312268|FG001|Overall Study|Withdrawal by Subject|15|||
146766630|NCT01264718|529312267|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
146968682|NCT02118896|530045495|FG002|Overall Study|Consent withdrawn|3|||
146968683|NCT02118896|530045496|FG003|Overall Study|Consent withdrawn|4|||
146968684|NCT02118896|530045497|FG004|Overall Study|Consent withdrawn|1|||
146968685|NCT02118896|530045498|FG005|Overall Study|Consent withdrawn|4|||
146968686|NCT02118896|530045499|FG006|Overall Study|Consent withdrawn|0|||
146968687|NCT02118896|530045500|FG007|Overall Study|Consent withdrawn|0|||
146968688|NCT02118896|530045501|FG008|Overall Study|Consent withdrawn|0|||
146639770|NCT01727024|528856558|FG001|Period 1|Lost to Follow-up|1|||
146968689|NCT02118896|530045502|FG009|Overall Study|Consent withdrawn|0|||
146968690|NCT02118896|530045493|FG000|Overall Study|Non-compliance|2|||
146968691|NCT02118896|530045494|FG001|Overall Study|Non-compliance|1|||
146895233|NCT00896532|529781895|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895234|NCT00896532|529781896|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895235|NCT00896532|529781897|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895236|NCT00896532|529781898|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895237|NCT00896532|529781899|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146895238|NCT00896532|529781900|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146639771|NCT01727024|528856557|FG000|Period 1|Withdrawal by Subject|2|||
146895239|NCT00896532|529781878|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895240|NCT00896532|529781879|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895241|NCT00896532|529781880|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895242|NCT00896532|529781881|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146968692|NCT02118896|530045495|FG002|Overall Study|Non-compliance|1|||
146968693|NCT02118896|530045496|FG003|Overall Study|Non-compliance|5|||
146639772|NCT01727024|528856558|FG001|Period 1|Withdrawal by Subject|3|||
146895243|NCT00896532|529781882|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895244|NCT00896532|529781883|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895245|NCT00896532|529781884|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895246|NCT00896532|529781885|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895247|NCT00896532|529781886|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895248|NCT00896532|529781887|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895249|NCT00896532|529781888|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
146895250|NCT00896532|529781889|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895251|NCT00896532|529781890|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
146895252|NCT00896532|529781891|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895253|NCT00896532|529781892|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895254|NCT00896532|529781893|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895255|NCT00896532|529781894|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895256|NCT00896532|529781895|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895257|NCT00896532|529781896|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895258|NCT00896532|529781897|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895259|NCT00896532|529781898|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895260|NCT00896532|529781899|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895261|NCT00896532|529781900|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146895262|NCT00896532|529781878|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895263|NCT00896532|529781879|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895264|NCT00896532|529781880|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895265|NCT00896532|529781881|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895266|NCT00896532|529781882|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895267|NCT00896532|529781883|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895268|NCT00896532|529781884|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895269|NCT00896532|529781885|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895270|NCT00896532|529781886|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895271|NCT00896532|529781887|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895272|NCT00896532|529781888|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895273|NCT00896532|529781889|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895274|NCT00896532|529781890|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
146895275|NCT00896532|529781891|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
146895276|NCT00896532|529781892|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895277|NCT00896532|529781893|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895278|NCT00896532|529781894|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895279|NCT00896532|529781895|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895280|NCT00896532|529781896|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895281|NCT00896532|529781897|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895282|NCT00896532|529781898|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895283|NCT00896532|529781899|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146895284|NCT00896532|529781900|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146968694|NCT02118896|530045497|FG004|Overall Study|Non-compliance|0|||
146968695|NCT02118896|530045498|FG005|Overall Study|Non-compliance|1|||
146968696|NCT02118896|530045499|FG006|Overall Study|Non-compliance|0|||
146968697|NCT02118896|530045500|FG007|Overall Study|Non-compliance|1|||
146968698|NCT02118896|530045501|FG008|Overall Study|Non-compliance|0|||
146968699|NCT02118896|530045502|FG009|Overall Study|Non-compliance|0|||
146968700|NCT02118896|530045493|FG000|Overall Study|Pregnancy|1|||
146968701|NCT02118896|530045494|FG001|Overall Study|Pregnancy|1|||
146559067|NCT01111552|528555957|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
146559068|NCT01111552|528555958|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
146559069|NCT01111552|528555959|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
146559070|NCT01111552|528555960|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
146968702|NCT02118896|530045495|FG002|Overall Study|Pregnancy|0|||
146895285|NCT00896532|529781878|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
146895286|NCT00896532|529781879|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
146895287|NCT00896532|529781880|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
146895288|NCT00896532|529781881|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
146895289|NCT00896532|529781882|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
146895290|NCT00896532|529781883|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
146895291|NCT00896532|529781884|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
146895292|NCT00896532|529781885|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
146895293|NCT00896532|529781886|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
146895294|NCT00896532|529781887|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
146895295|NCT00896532|529781888|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
146895296|NCT00896532|529781889|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
146895297|NCT00896532|529781890|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
146895298|NCT00896532|529781891|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
146895299|NCT00896532|529781892|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
146895300|NCT00896532|529781893|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
146895301|NCT00896532|529781894|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
146895302|NCT00896532|529781895|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
146895303|NCT00896532|529781896|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
146895304|NCT00896532|529781897|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
146895305|NCT00896532|529781898|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
146895306|NCT00896532|529781899|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
146895307|NCT00896532|529781900|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
146895308|NCT00896532|529781878|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895309|NCT00896532|529781879|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895310|NCT00896532|529781880|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895311|NCT00896532|529781881|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895312|NCT00896532|529781882|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895313|NCT00896532|529781883|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895314|NCT00896532|529781884|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895315|NCT00896532|529781885|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895316|NCT00896532|529781886|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895317|NCT00896532|529781887|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146559071|NCT01027351|528555961|FG000|Overall Study|Withdrawal by Subject|1|||
146559072|NCT01027351|528555962|FG001|Overall Study|Withdrawal by Subject|0|||
146559073|NCT01027351|528555963|FG002|Overall Study|Withdrawal by Subject|1|||
146559074|NCT01027351|528555964|FG003|Overall Study|Withdrawal by Subject|0|||
146559075|NCT01027351|528555965|FG004|Overall Study|Withdrawal by Subject|3|||
146559076|NCT01027351|528555966|FG005|Overall Study|Withdrawal by Subject|5|||
146559077|NCT01027351|528555961|FG000|Overall Study|Lost to Follow-up|1|||
146559078|NCT01027351|528555962|FG001|Overall Study|Lost to Follow-up|1|||
146559079|NCT01027351|528555963|FG002|Overall Study|Lost to Follow-up|0|||
146559080|NCT01027351|528555964|FG003|Overall Study|Lost to Follow-up|1|||
146559081|NCT01027351|528555965|FG004|Overall Study|Lost to Follow-up|6|||
146559082|NCT01027351|528555966|FG005|Overall Study|Lost to Follow-up|0|||
146559083|NCT01027351|528555961|FG000|Overall Study|Inappropriate enrollment|0|||
146559084|NCT01027351|528555962|FG001|Overall Study|Inappropriate enrollment|0|||
146559085|NCT01027351|528555963|FG002|Overall Study|Inappropriate enrollment|0|||
146559086|NCT01027351|528555964|FG003|Overall Study|Inappropriate enrollment|0|||
146559087|NCT01027351|528555965|FG004|Overall Study|Inappropriate enrollment|1|||
146559088|NCT01027351|528555966|FG005|Overall Study|Inappropriate enrollment|0|||
146559089|NCT01027351|528555961|FG000|Overall Study|Protocol Violation|1|||
146559090|NCT01027351|528555962|FG001|Overall Study|Protocol Violation|0|||
146559091|NCT01027351|528555963|FG002|Overall Study|Protocol Violation|0|||
146559092|NCT01027351|528555964|FG003|Overall Study|Protocol Violation|1|||
146559093|NCT01027351|528555965|FG004|Overall Study|Protocol Violation|1|||
146559094|NCT01027351|528555966|FG005|Overall Study|Protocol Violation|0|||
146559095|NCT04650893|528555967|FG000|Overall Study|Lost to Follow-up|11|||
146559096|NCT04650893|528555968|FG001|Overall Study|Lost to Follow-up|10|||
146559097|NCT04650893|528555969|FG002|Overall Study|Lost to Follow-up|11|||
146639773|NCT01485172|528856559|FG000|Overall Study|Adverse Event|2|||
146895318|NCT00896532|529781888|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895319|NCT00896532|529781889|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895320|NCT00896532|529781890|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895321|NCT00896532|529781891|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895322|NCT00896532|529781892|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146559098|NCT04090749|528555972|FG000|Open Label Pilot|Lost to Follow-up|1|||
146559099|NCT04090749|528555973|FG001|Open Label Pilot|Lost to Follow-up|0|||
146559100|NCT04090749|528555974|FG002|Open Label Pilot|Lost to Follow-up|0|||
146559101|NCT04090749|528555972|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
146559102|NCT04090749|528555973|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
146559103|NCT04090749|528555974|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
146766631|NCT01264718|529312268|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
146766632|NCT03545984|529312269|FG000|Overall Study|CSF cases not present during rotation|11|||
146766633|NCT03545984|529312270|FG001|Overall Study|CSF cases not present during rotation|9|||
146766634|NCT01768676|529312271|FG000|Overall Study|Adverse Event|3|||
146766635|NCT01768676|529312272|FG001|Overall Study|Adverse Event|3|||
146766636|NCT01768676|529312271|FG000|Overall Study|Lost to Follow-up|13|||
146766637|NCT01768676|529312272|FG001|Overall Study|Lost to Follow-up|16|||
146766638|NCT01768676|529312271|FG000|Overall Study|Protocol Violation|1|||
146766639|NCT01768676|529312272|FG001|Overall Study|Protocol Violation|1|||
146766640|NCT01768676|529312271|FG000|Overall Study|Physician Decision|4|||
146766641|NCT01768676|529312272|FG001|Overall Study|Physician Decision|1|||
146766642|NCT01768676|529312271|FG000|Overall Study|Withdrawal by Subject|3|||
146766643|NCT01768676|529312272|FG001|Overall Study|Withdrawal by Subject|10|||
146766644|NCT02812966|529312275|FG000|Overall Study|Death|1|||
146766645|NCT02812966|529312276|FG001|Overall Study|Death|0|||
146766646|NCT02577523|529314560|FG000|Overall Study|Adverse Event|1|||
146766647|NCT02577523|529314561|FG001|Overall Study|Adverse Event|1|||
146766648|NCT02577523|529314560|FG000|Overall Study|Lack of Efficacy|1|||
146766649|NCT02577523|529314561|FG001|Overall Study|Lack of Efficacy|1|||
146766650|NCT02577523|529314560|FG000|Overall Study|Withdrawal by Subject|1|||
146766651|NCT02577523|529314561|FG001|Overall Study|Withdrawal by Subject|0|||
146766652|NCT00028769|529314563|FG000|Overall Study|Adverse Event|2|||
146766653|NCT00028769|529314563|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
146766654|NCT00028769|529314563|FG000|Overall Study|Progression or Death|31|||
146766655|NCT00028769|529314563|FG000|Overall Study|Other - Not Protocol Specified|1|||
146766656|NCT00028769|529314563|FG000|Overall Study|Ineligible|5|||
146766657|NCT00028769|529314563|FG000|Overall Study|Not Analyzable|1|||
146766658|NCT01198275|529314566|FG000|Overall Study|Adverse Event|2|||
146766659|NCT01198275|529314567|FG001|Overall Study|Adverse Event|3|||
146766660|NCT01198275|529314566|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
146766661|NCT01198275|529314567|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
146766662|NCT00150176|529314568|FG000|Overall Study|Adverse Event|16|||
146766663|NCT00150176|529314569|FG001|Overall Study|Adverse Event|53|||
146766664|NCT00150176|529314568|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
146766665|NCT00150176|529314569|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
146895323|NCT00896532|529781893|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
146895324|NCT00896532|529781894|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
146766666|NCT00150176|529314568|FG000|Overall Study|Withdrawal by Subject|19|||
146766667|NCT00150176|529314569|FG001|Overall Study|Withdrawal by Subject|12|||
146766668|NCT00150176|529314568|FG000|Overall Study|Lost to Follow-up|3|||
146766669|NCT00150176|529314569|FG001|Overall Study|Lost to Follow-up|3|||
146766670|NCT00150176|529314568|FG000|Overall Study|OTHER|11|||
146766671|NCT00150176|529314569|FG001|Overall Study|OTHER|13|||
146895325|NCT00896532|529781895|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895326|NCT00896532|529781896|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895327|NCT00896532|529781897|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895328|NCT00896532|529781898|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895329|NCT00896532|529781899|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146895330|NCT00896532|529781900|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146766672|NCT02385669|529314572|FG000|Overall Study|Adverse Event|2|||
146766673|NCT00970307|529314573|FG000|Overall Study|Serious Adverse Event|1|||
146895331|NCT00896532|529781878|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146766674|NCT00970307|529314574|FG001|Overall Study|Serious Adverse Event|0|||
146766675|NCT00970307|529314575|FG002|Overall Study|Serious Adverse Event|0|||
146766676|NCT00970307|529314573|FG000|Overall Study|Withdrawal by Subject|2|||
146766677|NCT00970307|529314574|FG001|Overall Study|Withdrawal by Subject|3|||
146895332|NCT00896532|529781879|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895333|NCT00896532|529781880|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146559104|NCT04090749|528555972|FG000|Pilot Trial|Lost to Follow-up|0|||
146559105|NCT04090749|528555973|FG001|Pilot Trial|Lost to Follow-up|1|||
146559106|NCT04090749|528555974|FG002|Pilot Trial|Lost to Follow-up|1|||
146559107|NCT02528305|528555975|FG000|Overall Study|Withdrawal by Subject|1|||
146559108|NCT02528305|528555975|FG000|Overall Study|Adverse Event|1|||
146559109|NCT02528305|528555975|FG000|Overall Study|Physician Decision|1|||
146559110|NCT00421408|528555976|FG000|Overall Study|Lost to Follow-up|30|||
146559111|NCT00421408|528555977|FG001|Overall Study|Lost to Follow-up|20|||
146559112|NCT00421408|528555976|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
146559113|NCT00421408|528555977|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
146559114|NCT00787800|528555980|FG000|Overall Study|Withdrawal by Subject|3|||
146559115|NCT00787800|528555981|FG001|Overall Study|Withdrawal by Subject|5|||
146895334|NCT00896532|529781881|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895335|NCT00896532|529781882|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895336|NCT00896532|529781883|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146559116|NCT00787800|528555980|FG000|Overall Study|Death|0|||
146559117|NCT00787800|528555981|FG001|Overall Study|Death|2|||
146559118|NCT04309500|528555985|FG000|Overall Study|Lost to Follow-up|1|||
146559119|NCT04309500|528555986|FG001|Overall Study|Lost to Follow-up|0|||
146559120|NCT04309500|528555987|FG002|Overall Study|Lost to Follow-up|0|||
146895337|NCT00896532|529781884|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895338|NCT00896532|529781885|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895339|NCT00896532|529781886|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895340|NCT00896532|529781887|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895341|NCT00896532|529781888|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895342|NCT00896532|529781889|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895343|NCT00896532|529781890|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895344|NCT00896532|529781891|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895345|NCT00896532|529781892|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895346|NCT00896532|529781893|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
146895347|NCT00896532|529781894|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
146895348|NCT00896532|529781895|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
146895349|NCT00896532|529781896|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895350|NCT00896532|529781897|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895351|NCT00896532|529781898|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895352|NCT00896532|529781899|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895353|NCT00896532|529781900|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146895354|NCT00896532|529781878|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895355|NCT00896532|529781879|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895356|NCT00896532|529781880|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895357|NCT00896532|529781881|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895358|NCT00896532|529781882|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895359|NCT00896532|529781883|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895360|NCT00896532|529781884|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895361|NCT00896532|529781885|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895362|NCT00896532|529781886|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895363|NCT00896532|529781887|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895364|NCT00896532|529781888|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895365|NCT00896532|529781889|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895366|NCT00896532|529781890|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895367|NCT00896532|529781891|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895368|NCT00896532|529781892|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895369|NCT00896532|529781893|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895370|NCT00896532|529781894|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
146895371|NCT00896532|529781895|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895372|NCT00896532|529781896|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895373|NCT00896532|529781897|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895374|NCT00896532|529781898|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895375|NCT00896532|529781899|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895376|NCT00896532|529781900|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146895377|NCT00896532|529781878|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
146559121|NCT04309500|528555988|FG003|Overall Study|Lost to Follow-up|0|||
146559122|NCT00913835|528555990|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
146559123|NCT00913835|528555991|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
146559124|NCT00913835|528555990|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
146559125|NCT00913835|528555991|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
146559126|NCT00913835|528555990|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
146559127|NCT00913835|528555991|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
146559128|NCT00913835|528555990|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
146895378|NCT00896532|529781879|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
146895379|NCT00896532|529781880|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
146895380|NCT00896532|529781881|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
146895381|NCT00896532|529781882|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
146895382|NCT00896532|529781883|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
146895383|NCT00896532|529781884|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
146895384|NCT00896532|529781885|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
146895385|NCT00896532|529781886|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
146895386|NCT00896532|529781887|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
146895387|NCT00896532|529781888|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
146968703|NCT02118896|530045496|FG003|Overall Study|Pregnancy|0|||
146895388|NCT00896532|529781889|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
146968704|NCT02118896|530045497|FG004|Overall Study|Pregnancy|1|||
146895389|NCT00896532|529781890|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
146895390|NCT00896532|529781891|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
146895391|NCT00896532|529781892|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
146895392|NCT00896532|529781893|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
146895393|NCT00896532|529781894|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
146895394|NCT00896532|529781895|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
146895395|NCT00896532|529781896|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
146895396|NCT00896532|529781897|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
146895397|NCT00896532|529781898|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
146895398|NCT00896532|529781899|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
146895399|NCT00896532|529781900|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
146895400|NCT00896532|529781878|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895401|NCT00896532|529781879|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895402|NCT00896532|529781880|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895403|NCT00896532|529781881|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895404|NCT00896532|529781882|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895405|NCT00896532|529781883|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146559129|NCT00913835|528555991|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
146559130|NCT00913835|528555990|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
146559131|NCT00913835|528555991|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
146559132|NCT00773461|528555992|FG000|Overall Study|Adverse Event|1|||
146559133|NCT00773461|528555993|FG001|Overall Study|Adverse Event|3|||
146559134|NCT00773461|528555992|FG000|Overall Study|Withdrawal by Subject|4|||
146559135|NCT00773461|528555993|FG001|Overall Study|Withdrawal by Subject|1|||
146559136|NCT00637156|528555996|FG000|Overall Study|Withdrawal by Subject|0|||
146559137|NCT00637156|528555997|FG001|Overall Study|Withdrawal by Subject|7|||
146559138|NCT00637156|528555996|FG000|Overall Study|Death|0|||
146559139|NCT00637156|528555997|FG001|Overall Study|Death|1|||
146559140|NCT00637156|528555996|FG000|Overall Study|Lost to Follow-up|10|||
146559141|NCT00637156|528555997|FG001|Overall Study|Lost to Follow-up|16|||
146559142|NCT02374255|528557322|FG000|Overall Study|Withdrawal by Subject|2|||
146559143|NCT02374255|528557323|FG001|Overall Study|Withdrawal by Subject|0|||
146559144|NCT02374255|528557324|FG002|Overall Study|Withdrawal by Subject|0|||
146559145|NCT02374255|528557325|FG003|Overall Study|Withdrawal by Subject|0|||
146559146|NCT03332056|528557326|FG000|Overall Study|Incomplete questionnaires|8|||
146559147|NCT03332056|528557327|FG001|Overall Study|Incomplete questionnaires|9|||
146559148|NCT03332056|528557326|FG000|Overall Study|Passed stone prior to surgery date|1|||
146559149|NCT03332056|528557327|FG001|Overall Study|Passed stone prior to surgery date|0|||
146559150|NCT03332056|528557326|FG000|Overall Study|Did not require a ureteral stent|0|||
146968705|NCT02118896|530045498|FG005|Overall Study|Pregnancy|3|||
146968706|NCT02118896|530045499|FG006|Overall Study|Pregnancy|1|||
146968707|NCT02118896|530045500|FG007|Overall Study|Pregnancy|0|||
146968708|NCT02118896|530045501|FG008|Overall Study|Pregnancy|0|||
146968709|NCT02118896|530045502|FG009|Overall Study|Pregnancy|0|||
146968710|NCT02118896|530045493|FG000|Overall Study|Lost to Follow-up|1|||
146968711|NCT02118896|530045494|FG001|Overall Study|Lost to Follow-up|2|||
146968712|NCT02118896|530045495|FG002|Overall Study|Lost to Follow-up|1|||
146895406|NCT00896532|529781884|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895407|NCT00896532|529781885|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895408|NCT00896532|529781886|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895409|NCT00896532|529781887|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895410|NCT00896532|529781888|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895411|NCT00896532|529781889|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146968713|NCT02118896|530045496|FG003|Overall Study|Lost to Follow-up|0|||
146968714|NCT02118896|530045497|FG004|Overall Study|Lost to Follow-up|2|||
146968715|NCT02118896|530045498|FG005|Overall Study|Lost to Follow-up|1|||
146968716|NCT02118896|530045499|FG006|Overall Study|Lost to Follow-up|0|||
146968717|NCT02118896|530045500|FG007|Overall Study|Lost to Follow-up|0|||
146968718|NCT02118896|530045501|FG008|Overall Study|Lost to Follow-up|0|||
146968719|NCT02118896|530045502|FG009|Overall Study|Lost to Follow-up|0|||
146968720|NCT02118896|530045493|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
146968721|NCT02118896|530045494|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
146968722|NCT02118896|530045495|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
146968723|NCT02118896|530045496|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
146968724|NCT02118896|530045497|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
146968725|NCT02118896|530045498|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
146968726|NCT02118896|530045499|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
146968727|NCT02118896|530045500|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
146968728|NCT02118896|530045501|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
146968729|NCT02118896|530045502|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
146968730|NCT02118896|530045493|FG000|Overall Study|Prohibited medication|0|||
146968731|NCT02118896|530045494|FG001|Overall Study|Prohibited medication|0|||
146968732|NCT02118896|530045495|FG002|Overall Study|Prohibited medication|0|||
146639774|NCT01485172|528856560|FG001|Overall Study|Adverse Event|1|||
146639775|NCT01485172|528856561|FG002|Overall Study|Adverse Event|2|||
146639776|NCT01485172|528856562|FG003|Overall Study|Adverse Event|2|||
146639777|NCT01485172|528856563|FG004|Overall Study|Adverse Event|1|||
146895412|NCT00896532|529781890|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895413|NCT00896532|529781891|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895414|NCT00896532|529781892|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895415|NCT00896532|529781893|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895416|NCT00896532|529781894|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
146895417|NCT00896532|529781895|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895418|NCT00896532|529781896|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895419|NCT00896532|529781897|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895420|NCT00896532|529781898|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895421|NCT00896532|529781899|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895422|NCT00896532|529781900|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146895423|NCT00896532|529781878|FG000|Months 48-72: Follow-on Phase|Death|0|||
146895424|NCT00896532|529781879|FG001|Months 48-72: Follow-on Phase|Death|0|||
146895425|NCT00896532|529781880|FG002|Months 48-72: Follow-on Phase|Death|0|||
146895426|NCT00896532|529781881|FG003|Months 48-72: Follow-on Phase|Death|0|||
146968733|NCT02118896|530045496|FG003|Overall Study|Prohibited medication|0|||
146968734|NCT02118896|530045497|FG004|Overall Study|Prohibited medication|1|||
146639778|NCT01485172|528856564|FG005|Overall Study|Adverse Event|2|||
146639779|NCT01485172|528856559|FG000|Overall Study|Lack of Efficacy|2|||
146639780|NCT01485172|528856560|FG001|Overall Study|Lack of Efficacy|0|||
146639781|NCT01485172|528856561|FG002|Overall Study|Lack of Efficacy|0|||
146639782|NCT01485172|528856562|FG003|Overall Study|Lack of Efficacy|0|||
146639783|NCT01485172|528856563|FG004|Overall Study|Lack of Efficacy|0|||
146639784|NCT01485172|528856564|FG005|Overall Study|Lack of Efficacy|0|||
146968735|NCT02118896|530045498|FG005|Overall Study|Prohibited medication|3|||
146968736|NCT02118896|530045499|FG006|Overall Study|Prohibited medication|0|||
146639785|NCT01485172|528856559|FG000|Overall Study|Protocol Violation|0|||
146639786|NCT01485172|528856560|FG001|Overall Study|Protocol Violation|0|||
146639787|NCT01485172|528856561|FG002|Overall Study|Protocol Violation|4|||
146968737|NCT02118896|530045500|FG007|Overall Study|Prohibited medication|0|||
146968738|NCT02118896|530045501|FG008|Overall Study|Prohibited medication|0|||
146639788|NCT01485172|528856562|FG003|Overall Study|Protocol Violation|5|||
146639789|NCT01485172|528856563|FG004|Overall Study|Protocol Violation|1|||
146559151|NCT03332056|528557327|FG001|Overall Study|Did not require a ureteral stent|1|||
146559152|NCT02093520|528557328|FG000|Overall Study|Not treated|6|||
146559153|NCT02093520|528557329|FG001|Overall Study|Not treated|22|||
146559154|NCT03014089|528557330|FG000|Overall Study|Withdrawal by Subject|0|||
146559155|NCT03014089|528557331|FG001|Overall Study|Withdrawal by Subject|1|||
146559156|NCT03014089|528557332|FG002|Overall Study|Withdrawal by Subject|1|||
146559157|NCT03014089|528557333|FG003|Overall Study|Withdrawal by Subject|1|||
146559158|NCT03014089|528557330|FG000|Overall Study|Lost to Follow-up|1|||
146559159|NCT03014089|528557331|FG001|Overall Study|Lost to Follow-up|0|||
146559160|NCT03014089|528557332|FG002|Overall Study|Lost to Follow-up|0|||
146895427|NCT00896532|529781882|FG004|Months 48-72: Follow-on Phase|Death|0|||
146895428|NCT00896532|529781883|FG005|Months 48-72: Follow-on Phase|Death|0|||
146895429|NCT00896532|529781884|FG006|Months 48-72: Follow-on Phase|Death|0|||
146895430|NCT00896532|529781885|FG007|Months 48-72: Follow-on Phase|Death|0|||
146895431|NCT00896532|529781886|FG008|Months 48-72: Follow-on Phase|Death|0|||
146895432|NCT00896532|529781887|FG009|Months 48-72: Follow-on Phase|Death|0|||
146895433|NCT00896532|529781888|FG010|Months 48-72: Follow-on Phase|Death|0|||
146895434|NCT00896532|529781889|FG011|Months 48-72: Follow-on Phase|Death|0|||
146895435|NCT00896532|529781890|FG012|Months 48-72: Follow-on Phase|Death|0|||
146895436|NCT00896532|529781891|FG013|Months 48-72: Follow-on Phase|Death|0|||
146895437|NCT00896532|529781892|FG014|Months 48-72: Follow-on Phase|Death|0|||
146895438|NCT00896532|529781893|FG015|Months 48-72: Follow-on Phase|Death|0|||
146895439|NCT00896532|529781894|FG016|Months 48-72: Follow-on Phase|Death|0|||
146895440|NCT00896532|529781895|FG017|Months 48-72: Follow-on Phase|Death|0|||
146895441|NCT00896532|529781896|FG018|Months 48-72: Follow-on Phase|Death|1|||
146895442|NCT00896532|529781897|FG019|Months 48-72: Follow-on Phase|Death|0|||
146895443|NCT00896532|529781898|FG020|Months 48-72: Follow-on Phase|Death|0|||
146895444|NCT00896532|529781899|FG021|Months 48-72: Follow-on Phase|Death|0|||
146895445|NCT00896532|529781900|FG022|Months 48-72: Follow-on Phase|Death|0|||
146895446|NCT00896532|529781878|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895447|NCT00896532|529781879|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895448|NCT00896532|529781880|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895449|NCT00896532|529781881|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895450|NCT00896532|529781882|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895451|NCT00896532|529781883|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895452|NCT00896532|529781884|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895453|NCT00896532|529781885|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895454|NCT00896532|529781886|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895455|NCT00896532|529781887|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895456|NCT00896532|529781888|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146639790|NCT01485172|528856564|FG005|Overall Study|Protocol Violation|0|||
146639791|NCT01485172|528856559|FG000|Overall Study|Protocol defined stopping criteria|1|||
146639792|NCT01485172|528856560|FG001|Overall Study|Protocol defined stopping criteria|0|||
146639793|NCT01485172|528856561|FG002|Overall Study|Protocol defined stopping criteria|0|||
146639794|NCT01485172|528856562|FG003|Overall Study|Protocol defined stopping criteria|0|||
146639795|NCT01485172|528856563|FG004|Overall Study|Protocol defined stopping criteria|1|||
146639796|NCT01485172|528856564|FG005|Overall Study|Protocol defined stopping criteria|0|||
146639797|NCT01485172|528856559|FG000|Overall Study|Lost to Follow-up|0|||
146639798|NCT01485172|528856560|FG001|Overall Study|Lost to Follow-up|0|||
146639799|NCT01485172|528856561|FG002|Overall Study|Lost to Follow-up|1|||
146639800|NCT01485172|528856562|FG003|Overall Study|Lost to Follow-up|0|||
146639801|NCT01485172|528856563|FG004|Overall Study|Lost to Follow-up|0|||
146639802|NCT01485172|528856564|FG005|Overall Study|Lost to Follow-up|1|||
146639803|NCT01485172|528856559|FG000|Overall Study|Physician Decision|0|||
146639804|NCT01485172|528856560|FG001|Overall Study|Physician Decision|0|||
146639805|NCT01485172|528856561|FG002|Overall Study|Physician Decision|0|||
146639806|NCT01485172|528856562|FG003|Overall Study|Physician Decision|0|||
146639807|NCT01485172|528856563|FG004|Overall Study|Physician Decision|1|||
146639808|NCT01485172|528856564|FG005|Overall Study|Physician Decision|0|||
146639809|NCT01485172|528856559|FG000|Overall Study|Withdrawal by Subject|2|||
146639810|NCT01485172|528856560|FG001|Overall Study|Withdrawal by Subject|0|||
146639811|NCT01485172|528856561|FG002|Overall Study|Withdrawal by Subject|0|||
146639812|NCT01485172|528856562|FG003|Overall Study|Withdrawal by Subject|1|||
146639813|NCT01485172|528856563|FG004|Overall Study|Withdrawal by Subject|1|||
146639814|NCT01485172|528856564|FG005|Overall Study|Withdrawal by Subject|1|||
146639815|NCT01301027|528856572|FG000|Overall Study|Physician Decision|2|||
146639816|NCT01301027|528856573|FG001|Overall Study|Physician Decision|0|||
146639817|NCT01301027|528856572|FG000|Overall Study|Withdrawal by Subject|2|||
146639818|NCT01301027|528856573|FG001|Overall Study|Withdrawal by Subject|3|||
146639819|NCT01301027|528856572|FG000|Overall Study|Adverse Event|0|||
146639820|NCT01301027|528856573|FG001|Overall Study|Adverse Event|2|||
146639821|NCT01301027|528856572|FG000|Overall Study|Fracture|1|||
146895457|NCT00896532|529781889|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895458|NCT00896532|529781890|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895459|NCT00896532|529781891|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895460|NCT00896532|529781892|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895461|NCT00896532|529781893|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895462|NCT00896532|529781894|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895463|NCT00896532|529781895|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895464|NCT00896532|529781896|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895465|NCT00896532|529781897|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895466|NCT00896532|529781898|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895467|NCT00896532|529781899|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
146895468|NCT00896532|529781900|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146895469|NCT00896532|529781878|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895470|NCT00896532|529781879|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895471|NCT00896532|529781880|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895472|NCT00896532|529781881|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895473|NCT00896532|529781882|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146639822|NCT01301027|528856573|FG001|Overall Study|Fracture|3|||
146559161|NCT03014089|528557333|FG003|Overall Study|Lost to Follow-up|0|||
146559162|NCT03014089|528557330|FG000|Overall Study|Adverse Event|1|||
146559163|NCT03014089|528557331|FG001|Overall Study|Adverse Event|0|||
146559164|NCT03014089|528557332|FG002|Overall Study|Adverse Event|1|||
146559165|NCT03014089|528557333|FG003|Overall Study|Adverse Event|0|||
146559166|NCT00851084|528557334|FG000|Overall Study|Randomized but not treated|1|||
146559167|NCT00851084|528557335|FG001|Overall Study|Randomized but not treated|0|||
146895474|NCT00896532|529781883|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895475|NCT00896532|529781884|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895476|NCT00896532|529781885|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146559168|NCT00851084|528557334|FG000|Overall Study|Adverse Event|26|||
146559169|NCT00851084|528557335|FG001|Overall Study|Adverse Event|36|||
146559170|NCT00851084|528557334|FG000|Overall Study|Disease progression|52|||
146766678|NCT00970307|529314575|FG002|Overall Study|Withdrawal by Subject|2|||
146895477|NCT00896532|529781886|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895478|NCT00896532|529781887|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895479|NCT00896532|529781888|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895480|NCT00896532|529781889|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895481|NCT00896532|529781890|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895482|NCT00896532|529781891|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895483|NCT00896532|529781892|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895484|NCT00896532|529781893|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146559171|NCT00851084|528557335|FG001|Overall Study|Disease progression|47|||
146559172|NCT00851084|528557334|FG000|Overall Study|Poor compliance to protocol|1|||
146559173|NCT00851084|528557335|FG001|Overall Study|Poor compliance to protocol|1|||
146559174|NCT00851084|528557334|FG000|Overall Study|Physician Decision|13|||
146559175|NCT00851084|528557335|FG001|Overall Study|Physician Decision|14|||
146559176|NCT00851084|528557334|FG000|Overall Study|Consent withdrawn|0|||
146559177|NCT00851084|528557335|FG001|Overall Study|Consent withdrawn|2|||
146559178|NCT00851084|528557334|FG000|Overall Study|Withdrawal by Subject|11|||
146559179|NCT00851084|528557335|FG001|Overall Study|Withdrawal by Subject|12|||
146559180|NCT00851084|528557334|FG000|Overall Study|Metastatic surgery|6|||
146559181|NCT00851084|528557335|FG001|Overall Study|Metastatic surgery|6|||
146559182|NCT00851084|528557334|FG000|Overall Study|Other|7|||
146766679|NCT02810080|529314576|FG000|Overall Study|Adverse Event|3|||
146968739|NCT02118896|530045502|FG009|Overall Study|Prohibited medication|0|||
146968740|NCT02118896|530045493|FG000|Overall Study|Miscellaneous|1|||
146968741|NCT02118896|530045494|FG001|Overall Study|Miscellaneous|2|||
146559183|NCT00851084|528557335|FG001|Overall Study|Other|1|||
146559184|NCT00321932|528557336|FG000|Overall Study|Death|3|||
146559185|NCT00321932|528557337|FG001|Overall Study|Death|6|||
146895485|NCT00896532|529781894|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146559186|NCT00321932|528557336|FG000|Overall Study|Withdrawal by Subject|3|||
146559187|NCT00321932|528557337|FG001|Overall Study|Withdrawal by Subject|6|||
146639823|NCT01301027|528856572|FG000|Overall Study|Transplant|0|||
146639824|NCT01301027|528856573|FG001|Overall Study|Transplant|2|||
146639825|NCT01301027|528856572|FG000|Overall Study|Volume Overload|3|||
146639826|NCT01301027|528856573|FG001|Overall Study|Volume Overload|0|||
146639827|NCT03566485|528856574|FG000|Overall Study|Disease progression|5|||
146639828|NCT03566485|528856575|FG001|Overall Study|Disease progression|4|||
146639829|NCT03566485|528856574|FG000|Overall Study|Clinical progression|0|||
146639830|NCT03566485|528856575|FG001|Overall Study|Clinical progression|1|||
146639831|NCT03566485|528856574|FG000|Overall Study|Toxicity|0|||
146639832|NCT03566485|528856575|FG001|Overall Study|Toxicity|2|||
146639833|NCT01047553|528856576|FG000|Overall Study|Adverse Event|10|||
146639834|NCT01047553|528856577|FG001|Overall Study|Adverse Event|5|||
146639835|NCT01047553|528856576|FG000|Overall Study|Withdrawal by Subject|4|||
146639836|NCT01047553|528856577|FG001|Overall Study|Withdrawal by Subject|2|||
146895486|NCT00896532|529781895|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895487|NCT00896532|529781896|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146559188|NCT00321932|528557336|FG000|Overall Study|Early relapse|2|||
146559189|NCT00321932|528557337|FG001|Overall Study|Early relapse|8|||
146559190|NCT00321932|528557336|FG000|Overall Study|Missing data|2|||
146766680|NCT02810080|529314577|FG001|Overall Study|Adverse Event|0|||
146766681|NCT02810080|529314576|FG000|Overall Study|Death|0|||
146559191|NCT00321932|528557337|FG001|Overall Study|Missing data|1|||
146766682|NCT02810080|529314577|FG001|Overall Study|Death|2|||
146559192|NCT00734032|528557338|FG000|Overall Study|Adverse Event|0|||
146766683|NCT02810080|529314576|FG000|Overall Study|Physician Decision|4|||
146559193|NCT00734032|528557339|FG001|Overall Study|Adverse Event|1|||
146559194|NCT00734032|528557340|FG002|Overall Study|Adverse Event|0|||
146895488|NCT00896532|529781897|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895489|NCT00896532|529781898|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895490|NCT00896532|529781899|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
146895491|NCT00896532|529781900|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146895492|NCT01282229|529781901|FG000|Overall Study|Protocol Violation|2|||
146895493|NCT01988090|529781906|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
146895494|NCT01988090|529781907|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
146895495|NCT01988090|529781906|FG000|Start Treament After Randomization|Protocol Violation|0|||
146895496|NCT01988090|529781907|FG001|Start Treament After Randomization|Protocol Violation|1|||
146895497|NCT01988090|529781906|FG000|Complete Study After Start|Withdrawal by Subject|2|||
146895498|NCT01988090|529781907|FG001|Complete Study After Start|Withdrawal by Subject|0|||
146895499|NCT01988090|529781906|FG000|Complete Study After Start|Protocol Violation|1|||
146895500|NCT01988090|529781907|FG001|Complete Study After Start|Protocol Violation|1|||
146895501|NCT03887130|529781913|FG000|Overall Study|Progressive disease|23|||
146895502|NCT03887130|529781914|FG001|Overall Study|Progressive disease|14|||
146895503|NCT03887130|529781915|FG002|Overall Study|Progressive disease|7|||
146895504|NCT03887130|529781913|FG000|Overall Study|Protocol Violation|3|||
146895505|NCT03887130|529781914|FG001|Overall Study|Protocol Violation|1|||
146895506|NCT03887130|529781915|FG002|Overall Study|Protocol Violation|2|||
146895507|NCT03887130|529781913|FG000|Overall Study|Drug related toxicity|7|||
146895508|NCT03887130|529781914|FG001|Overall Study|Drug related toxicity|7|||
146895509|NCT03887130|529781915|FG002|Overall Study|Drug related toxicity|13|||
146895510|NCT03887130|529781913|FG000|Overall Study|Non drug related toxicity|3|||
146895511|NCT03887130|529781914|FG001|Overall Study|Non drug related toxicity|0|||
146895512|NCT03887130|529781915|FG002|Overall Study|Non drug related toxicity|0|||
146895513|NCT03887130|529781913|FG000|Overall Study|Death|2|||
146895514|NCT03887130|529781914|FG001|Overall Study|Death|2|||
146895515|NCT03887130|529781915|FG002|Overall Study|Death|1|||
146895516|NCT03887130|529781913|FG000|Overall Study|Withdrawal by Subject|7|||
146895517|NCT03887130|529781914|FG001|Overall Study|Withdrawal by Subject|6|||
146639837|NCT01047553|528856576|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
146639838|NCT01047553|528856577|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
146639839|NCT01047553|528856576|FG000|Overall Study|Lost to Follow-up|1|||
146639840|NCT01047553|528856577|FG001|Overall Study|Lost to Follow-up|0|||
146639841|NCT01047553|528856576|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
146639842|NCT01047553|528856577|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
146639843|NCT01047553|528856576|FG000|Overall Study|PI's decision|0|||
146639844|NCT01047553|528856577|FG001|Overall Study|PI's decision|1|||
146639845|NCT00948441|528856578|FG000|Overall Study|no longer meet inclusion criteria|1|||
146639846|NCT00948441|528856579|FG001|Overall Study|no longer meet inclusion criteria|4|||
146639847|NCT00104520|528856581|FG000|Overall Study|Unrelated adverse event|34|||
146639848|NCT00104520|528856582|FG001|Overall Study|Unrelated adverse event|47|||
146639849|NCT00104520|528856581|FG000|Overall Study|Study drug intolerance|0|||
146639850|NCT00104520|528856582|FG001|Overall Study|Study drug intolerance|1|||
146639851|NCT00104520|528856581|FG000|Overall Study|Related adverse event|13|||
146639852|NCT00104520|528856582|FG001|Overall Study|Related adverse event|15|||
146639853|NCT00104520|528856581|FG000|Overall Study|Lost to Follow-up|1|||
146639854|NCT00104520|528856582|FG001|Overall Study|Lost to Follow-up|0|||
146639855|NCT00104520|528856581|FG000|Overall Study|Noncompliance|0|||
146639856|NCT00104520|528856582|FG001|Overall Study|Noncompliance|2|||
146639857|NCT00104520|528856581|FG000|Overall Study|Personal/administrative|1|||
146895518|NCT03887130|529781915|FG002|Overall Study|Withdrawal by Subject|11|||
146895519|NCT03887130|529781913|FG000|Overall Study|other reason|6|||
146895520|NCT03887130|529781914|FG001|Overall Study|other reason|20|||
146639858|NCT00104520|528856582|FG001|Overall Study|Personal/administrative|1|||
146639859|NCT00104520|528856581|FG000|Overall Study|Other|1|||
146639860|NCT00104520|528856582|FG001|Overall Study|Other|5|||
146639861|NCT01026324|528856583|FG000|Follow up/Survival|Withdrawal by Subject|1|||
146639862|NCT01026324|528856584|FG001|Follow up/Survival|Withdrawal by Subject|0|||
146639863|NCT01026324|528856585|FG002|Follow up/Survival|Withdrawal by Subject|0|||
146639864|NCT02442804|528856586|FG000|Overall Study|Withdrawal by Subject|0|||
146639865|NCT02442804|528856587|FG001|Overall Study|Withdrawal by Subject|1|||
146639866|NCT02442804|528856586|FG000|Overall Study|Adverse Event|1|||
146639867|NCT02442804|528856587|FG001|Overall Study|Adverse Event|0|||
146639868|NCT02624986|528856591|FG000|Overall Study|Death|0|||
146639869|NCT02624986|528856592|FG001|Overall Study|Death|1|||
146639870|NCT02624986|528856593|FG002|Overall Study|Death|2|||
146639871|NCT02624986|528856594|FG003|Overall Study|Death|2|||
146639872|NCT02624986|528856595|FG004|Overall Study|Death|2|||
146639873|NCT02624986|528856596|FG005|Overall Study|Death|0|||
146639874|NCT02624986|528856597|FG006|Overall Study|Death|0|||
146639875|NCT02624986|528856598|FG007|Overall Study|Death|1|||
146639876|NCT02624986|528856591|FG000|Overall Study|Study Terminated by Sponsor|1|||
146639877|NCT02624986|528856592|FG001|Overall Study|Study Terminated by Sponsor|1|||
146639878|NCT02624986|528856593|FG002|Overall Study|Study Terminated by Sponsor|0|||
146639879|NCT02624986|528856594|FG003|Overall Study|Study Terminated by Sponsor|1|||
146639880|NCT02624986|528856595|FG004|Overall Study|Study Terminated by Sponsor|2|||
146639881|NCT02624986|528856596|FG005|Overall Study|Study Terminated by Sponsor|2|||
146639882|NCT02624986|528856597|FG006|Overall Study|Study Terminated by Sponsor|4|||
146639883|NCT02624986|528856598|FG007|Overall Study|Study Terminated by Sponsor|3|||
146639884|NCT02624986|528856591|FG000|Overall Study|Progressive Disease|0|||
146639885|NCT02624986|528856592|FG001|Overall Study|Progressive Disease|1|||
146639886|NCT02624986|528856593|FG002|Overall Study|Progressive Disease|0|||
146895521|NCT03887130|529781915|FG002|Overall Study|other reason|17|||
146895522|NCT00705263|529781916|FG000|Overall Study|Withdrawal by Subject|2|||
146895523|NCT02440581|529781919|FG000|Overall Study|Death|0|||
146895524|NCT02440581|529781920|FG001|Overall Study|Death|0|||
146895525|NCT02440581|529781921|FG002|Overall Study|Death|7|||
146895526|NCT02440581|529781922|FG003|Overall Study|Death|5|||
146895527|NCT02440581|529781919|FG000|Overall Study|Transplanted|1|||
146895528|NCT02440581|529781920|FG001|Overall Study|Transplanted|0|||
146895529|NCT02440581|529781921|FG002|Overall Study|Transplanted|3|||
146895530|NCT02440581|529781922|FG003|Overall Study|Transplanted|2|||
146895531|NCT02440581|529781919|FG000|Overall Study|Withdrawal by Subject|4|||
146895532|NCT02440581|529781920|FG001|Overall Study|Withdrawal by Subject|11|||
146895533|NCT02440581|529781921|FG002|Overall Study|Withdrawal by Subject|3|||
146895534|NCT02440581|529781922|FG003|Overall Study|Withdrawal by Subject|7|||
146639887|NCT02624986|528856594|FG003|Overall Study|Progressive Disease|0|||
146639888|NCT02624986|528856595|FG004|Overall Study|Progressive Disease|0|||
146639889|NCT02624986|528856596|FG005|Overall Study|Progressive Disease|0|||
146639890|NCT02624986|528856597|FG006|Overall Study|Progressive Disease|0|||
146895535|NCT05032950|529781924|FG000|Overall Study|Adverse Event|0|||
146895536|NCT05032950|529781925|FG001|Overall Study|Adverse Event|0|||
146895537|NCT05032950|529781926|FG002|Overall Study|Adverse Event|1|||
146639891|NCT02624986|528856598|FG007|Overall Study|Progressive Disease|0|||
146639892|NCT02624986|528856591|FG000|Overall Study|Protocol Violation|1|||
146639893|NCT02624986|528856592|FG001|Overall Study|Protocol Violation|0|||
146895538|NCT05032950|529781927|FG003|Overall Study|Adverse Event|1|||
146895539|NCT05032950|529781928|FG004|Overall Study|Adverse Event|0|||
146639894|NCT02624986|528856593|FG002|Overall Study|Protocol Violation|0|||
146639895|NCT02624986|528856594|FG003|Overall Study|Protocol Violation|0|||
146639896|NCT02624986|528856595|FG004|Overall Study|Protocol Violation|0|||
146639897|NCT02624986|528856596|FG005|Overall Study|Protocol Violation|0|||
146639898|NCT02624986|528856597|FG006|Overall Study|Protocol Violation|0|||
146639899|NCT02624986|528856598|FG007|Overall Study|Protocol Violation|0|||
146639900|NCT02624986|528856591|FG000|Overall Study|Withdrawal by Subject|0|||
146968742|NCT02118896|530045495|FG002|Overall Study|Miscellaneous|0|||
146968743|NCT02118896|530045496|FG003|Overall Study|Miscellaneous|2|||
146968744|NCT02118896|530045497|FG004|Overall Study|Miscellaneous|0|||
146968745|NCT02118896|530045498|FG005|Overall Study|Miscellaneous|4|||
146968746|NCT02118896|530045499|FG006|Overall Study|Miscellaneous|0|||
146968747|NCT02118896|530045500|FG007|Overall Study|Miscellaneous|0|||
146968748|NCT02118896|530045501|FG008|Overall Study|Miscellaneous|0|||
146968749|NCT02118896|530045502|FG009|Overall Study|Miscellaneous|0|||
146968750|NCT02329834|530045504|FG000|Overall Study|Physician Decision|1|||
146968751|NCT02329834|530045505|FG001|Overall Study|Physician Decision|0|||
146968752|NCT00578448|530045506|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
146968753|NCT00578448|530045506|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
146968754|NCT00578448|530045506|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
146968755|NCT00578448|530045506|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
146968756|NCT01317199|530045507|FG000|Dose-escalation Phase 1|Physician Decision|5|||
146968757|NCT01317199|530045508|FG001|Dose-escalation Phase 1|Physician Decision|0|||
146968758|NCT01317199|530045509|FG002|Dose-escalation Phase 1|Physician Decision|0|||
146968759|NCT01317199|530045510|FG003|Dose-escalation Phase 1|Physician Decision|0|||
146968760|NCT01317199|530045507|FG000|Dose-escalation Phase 1|Disease progression|1|||
146968761|NCT01317199|530045508|FG001|Dose-escalation Phase 1|Disease progression|0|||
146968762|NCT01317199|530045509|FG002|Dose-escalation Phase 1|Disease progression|0|||
146968763|NCT01317199|530045510|FG003|Dose-escalation Phase 1|Disease progression|0|||
146968764|NCT01317199|530045507|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
146968765|NCT01317199|530045508|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
146968766|NCT01317199|530045509|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
146968767|NCT01317199|530045510|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
146968768|NCT01317199|530045507|FG000|Randomized Phase 2|Disease progression|0|||
146968769|NCT01317199|530045508|FG001|Randomized Phase 2|Disease progression|3|||
146968770|NCT01317199|530045509|FG002|Randomized Phase 2|Disease progression|7|||
146968771|NCT01317199|530045510|FG003|Randomized Phase 2|Disease progression|5|||
146968772|NCT01317199|530045507|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
146968773|NCT01317199|530045508|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
146968774|NCT01317199|530045509|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
146968775|NCT01317199|530045510|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
146968776|NCT01317199|530045507|FG000|Randomized Phase 2|Adverse Event|0|||
146968777|NCT01317199|530045508|FG001|Randomized Phase 2|Adverse Event|0|||
146968778|NCT01317199|530045509|FG002|Randomized Phase 2|Adverse Event|0|||
146968779|NCT01317199|530045510|FG003|Randomized Phase 2|Adverse Event|1|||
146968780|NCT01317199|530045507|FG000|Randomized Phase 2|Comorbidities|0|||
146968781|NCT01317199|530045508|FG001|Randomized Phase 2|Comorbidities|2|||
146968782|NCT01317199|530045509|FG002|Randomized Phase 2|Comorbidities|2|||
146968783|NCT01317199|530045510|FG003|Randomized Phase 2|Comorbidities|2|||
146968784|NCT01317199|530045507|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
146968785|NCT01317199|530045508|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
146968786|NCT01317199|530045509|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
146968787|NCT01317199|530045510|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
146968788|NCT01317199|530045507|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
146968789|NCT01317199|530045508|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
146968790|NCT01317199|530045509|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
146968791|NCT01317199|530045510|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
146968792|NCT01317199|530045507|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
146968793|NCT01317199|530045508|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
146968794|NCT01317199|530045509|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
146639901|NCT02624986|528856592|FG001|Overall Study|Withdrawal by Subject|0|||
146766684|NCT02810080|529314577|FG001|Overall Study|Physician Decision|0|||
146766685|NCT02810080|529314576|FG000|Overall Study|Withdrawal by Subject|0|||
146968795|NCT01317199|530045510|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
146639902|NCT02624986|528856593|FG002|Overall Study|Withdrawal by Subject|0|||
146639903|NCT02624986|528856594|FG003|Overall Study|Withdrawal by Subject|0|||
146639904|NCT02624986|528856595|FG004|Overall Study|Withdrawal by Subject|0|||
146968796|NCT01317199|530045507|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
146968797|NCT01317199|530045508|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
146968798|NCT01317199|530045509|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
146968799|NCT01317199|530045510|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
146968800|NCT04221373|530045513|FG000|Overall Study|Physician Decision|4|||
146968801|NCT04221373|530045514|FG001|Overall Study|Physician Decision|0|||
146968802|NCT00627094|530045517|FG000|Overall Study|Adverse Event|8|||
146968803|NCT00627094|530045518|FG001|Overall Study|Adverse Event|7|||
146968804|NCT00627094|530045517|FG000|Overall Study|Lost to Follow-up|1|||
146968805|NCT00627094|530045518|FG001|Overall Study|Lost to Follow-up|0|||
146968806|NCT00627094|530045517|FG000|Overall Study|Withdrawal by Subject|1|||
146968807|NCT00627094|530045518|FG001|Overall Study|Withdrawal by Subject|1|||
146968808|NCT00627094|530045517|FG000|Overall Study|ulcer healed|1|||
146968809|NCT00627094|530045518|FG001|Overall Study|ulcer healed|7|||
146968810|NCT00627094|530045517|FG000|Overall Study|Other reason|1|||
146968811|NCT00627094|530045518|FG001|Overall Study|Other reason|0|||
146968812|NCT01965431|530045526|FG000|Overall Study|Adverse Event|0|||
146968813|NCT01965431|530045527|FG001|Overall Study|Adverse Event|1|||
146968814|NCT01965431|530045528|FG002|Overall Study|Adverse Event|0|||
146968815|NCT01965431|530045529|FG003|Overall Study|Adverse Event|0|||
146968816|NCT01965431|530045530|FG004|Overall Study|Adverse Event|0|||
146968817|NCT01965431|530045531|FG005|Overall Study|Adverse Event|0|||
146968818|NCT01965431|530045526|FG000|Overall Study|Other than stated above|6|||
146968819|NCT01965431|530045527|FG001|Overall Study|Other than stated above|5|||
146968820|NCT01965431|530045528|FG002|Overall Study|Other than stated above|6|||
146968821|NCT01965431|530045529|FG003|Overall Study|Other than stated above|6|||
146968822|NCT01965431|530045530|FG004|Overall Study|Other than stated above|6|||
146968823|NCT01965431|530045531|FG005|Overall Study|Other than stated above|6|||
146968824|NCT00577031|530045532|FG000|Overall Study|Adverse Event|52|||
146968825|NCT00577031|530045532|FG000|Overall Study|Progression of disease|93|||
146968826|NCT00577031|530045532|FG000|Overall Study|Protocol Violation|5|||
146968827|NCT00577031|530045532|FG000|Overall Study|Participant withdrew consent|13|||
146968828|NCT00577031|530045532|FG000|Overall Study|Participant non-compliance|5|||
146968829|NCT00577031|530045532|FG000|Overall Study|Need for surgery|17|||
146968830|NCT00577031|530045532|FG000|Overall Study|Medical decision|14|||
146968831|NCT00577031|530045532|FG000|Overall Study|Death|6|||
146968832|NCT04635631|530045533|FG000|Overall Study|Adverse Event|1|||
146968833|NCT04635631|530045533|FG000|Overall Study|Progressive disease|13|||
146968834|NCT04635631|530045533|FG000|Overall Study|Withdrawal by Subject|1|||
146968835|NCT01067339|530045536|FG000|Overall Study|Withdrawal by Subject|6|||
146968836|NCT01067339|530045537|FG001|Overall Study|Withdrawal by Subject|5|||
146968837|NCT00769132|530045538|FG000|Period 1|Adverse Event|1|||
146968838|NCT00769132|530045539|FG001|Period 1|Adverse Event|0|||
146968839|NCT00769132|530045540|FG002|Period 1|Adverse Event|0|||
146968840|NCT00769132|530045541|FG003|Period 1|Adverse Event|1|||
146559195|NCT00734032|528557341|FG003|Overall Study|Adverse Event|0|||
146559196|NCT02301897|528557346|FG000|Treatment Course 1|Non-Compliance|0|||
146559197|NCT02301897|528557347|FG001|Treatment Course 1|Non-Compliance|0|||
146559198|NCT02301897|528557348|FG002|Treatment Course 1|Non-Compliance|1|||
146559199|NCT02301897|528557346|FG000|Treatment Course 1|Adverse Event|1|||
146559200|NCT02301897|528557347|FG001|Treatment Course 1|Adverse Event|1|||
146559201|NCT02301897|528557348|FG002|Treatment Course 1|Adverse Event|0|||
146559202|NCT02301897|528557346|FG000|Treatment Course 1|Lost to Follow-up|1|||
146895540|NCT05032950|529781929|FG005|Overall Study|Adverse Event|0|||
146559203|NCT02301897|528557347|FG001|Treatment Course 1|Lost to Follow-up|2|||
146559204|NCT02301897|528557348|FG002|Treatment Course 1|Lost to Follow-up|1|||
146559205|NCT02301897|528557346|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
146559206|NCT02301897|528557347|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
146559207|NCT02301897|528557348|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
146559208|NCT02301897|528557346|FG000|Treatment Course 1|Withdrawal by Subject|0|||
146559209|NCT02301897|528557347|FG001|Treatment Course 1|Withdrawal by Subject|0|||
146895541|NCT02959814|529781930|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
146895542|NCT02959814|529781930|FG000|Overall Study|Excluded based on anatomical criteria|2|||
146895543|NCT02959814|529781930|FG000|Overall Study|Protocol Violation|7|||
146559210|NCT02301897|528557348|FG002|Treatment Course 1|Withdrawal by Subject|2|||
146559211|NCT02301897|528557346|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
146559212|NCT02301897|528557347|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
146895544|NCT02959814|529781930|FG000|Overall Study|FFR not measured|2|||
146559213|NCT02301897|528557348|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
146968841|NCT00769132|530045538|FG000|Period 2|Withdrawal by Subject|0|||
146559214|NCT02301897|528557346|FG000|Treatment Course 2|Lost to Follow-up|0|||
146559215|NCT02301897|528557347|FG001|Treatment Course 2|Lost to Follow-up|2|||
146559216|NCT02301897|528557348|FG002|Treatment Course 2|Lost to Follow-up|0|||
146559217|NCT02301897|528557346|FG000|Treatment Course 2|Pregnancy|0|||
146559218|NCT02301897|528557347|FG001|Treatment Course 2|Pregnancy|1|||
146559219|NCT02301897|528557348|FG002|Treatment Course 2|Pregnancy|1|||
146559220|NCT02301897|528557346|FG000|Treatment Course 2|Withdrawal by Subject|0|||
146559221|NCT02301897|528557347|FG001|Treatment Course 2|Withdrawal by Subject|2|||
146559222|NCT02301897|528557348|FG002|Treatment Course 2|Withdrawal by Subject|0|||
146559223|NCT02301897|528557346|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
146559224|NCT02301897|528557347|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
146559225|NCT02301897|528557348|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
146559226|NCT00337168|528557349|FG000|Overall Study|Death|5|||
146895545|NCT02959814|529781930|FG000|Overall Study|In-procedure QFR not computed|6|||
146895546|NCT02959814|529781930|FG000|Overall Study|Excluded by FFR core-lab|24|||
146895547|NCT01245673|529781931|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
146895548|NCT01078805|529781941|FG000|Overall Study|Clinically significant abnormal lab|5|||
146895549|NCT01078805|529781941|FG000|Overall Study|Death|134|||
146895550|NCT01078805|529781941|FG000|Overall Study|Lost to Follow-up|676|||
146895551|NCT01078805|529781941|FG000|Overall Study|Physician Decision|169|||
146639905|NCT02624986|528856596|FG005|Overall Study|Withdrawal by Subject|0|||
146639906|NCT02624986|528856597|FG006|Overall Study|Withdrawal by Subject|0|||
146639907|NCT02624986|528856598|FG007|Overall Study|Withdrawal by Subject|1|||
146639908|NCT02116205|528856599|FG000|Overall Study|Withdrawal by Subject|2|||
146639909|NCT02116205|528856600|FG001|Overall Study|Withdrawal by Subject|4|||
146639910|NCT02116205|528856601|FG002|Overall Study|Withdrawal by Subject|1|||
146639911|NCT02116205|528856602|FG003|Overall Study|Withdrawal by Subject|3|||
146639912|NCT02116205|528856599|FG000|Overall Study|Lost to Follow-up|0|||
146968842|NCT00769132|530045539|FG001|Period 2|Withdrawal by Subject|0|||
146968843|NCT00769132|530045540|FG002|Period 2|Withdrawal by Subject|0|||
146639913|NCT02116205|528856600|FG001|Overall Study|Lost to Follow-up|2|||
146559227|NCT00337168|528557349|FG000|Overall Study|Not protocol specified|2|||
146559228|NCT00337168|528557349|FG000|Overall Study|Did not start therapy|1|||
146559229|NCT01225952|528557350|FG000|Overall Study|Lost to Follow-up|1|||
146559230|NCT01225952|528557351|FG001|Overall Study|Lost to Follow-up|0|||
146559231|NCT01225952|528557352|FG002|Overall Study|Lost to Follow-up|0|||
146559232|NCT01225952|528557350|FG000|Overall Study|Study Eye Explanted|0|||
146559233|NCT01225952|528557351|FG001|Overall Study|Study Eye Explanted|0|||
146559234|NCT01225952|528557352|FG002|Overall Study|Study Eye Explanted|1|||
146895552|NCT01078805|529781941|FG000|Overall Study|Serious adverse event|26|||
146895553|NCT01078805|529781941|FG000|Overall Study|Sponsor decision|46|||
146895554|NCT01078805|529781941|FG000|Overall Study|Withdrawal by Subject|739|||
146895555|NCT01078805|529781941|FG000|Overall Study|Other|173|||
146895556|NCT01078805|529781941|FG000|Overall Study|Didn't take study drug|82|||
146895557|NCT02246621|529781952|FG000|Overall Study|Withdrawal by Subject|28|||
146895558|NCT02246621|529781953|FG001|Overall Study|Withdrawal by Subject|16|||
146895559|NCT02246621|529781952|FG000|Overall Study|Lost to Follow-up|1|||
146895560|NCT02246621|529781953|FG001|Overall Study|Lost to Follow-up|0|||
146895561|NCT02246621|529781952|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
146895562|NCT02246621|529781953|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
146895563|NCT01292057|529781956|FG000|Overall Study|Protocol Violation|1|||
146895564|NCT01292057|529781957|FG001|Overall Study|Protocol Violation|1|||
146895565|NCT01292057|529781956|FG000|Overall Study|Lost to Follow-up|1|||
146895566|NCT01292057|529781957|FG001|Overall Study|Lost to Follow-up|1|||
146895567|NCT01459614|529781958|FG000|Overall Study|Adverse Event|1|||
146895568|NCT01459614|529781959|FG001|Overall Study|Adverse Event|0|||
146895569|NCT00630331|529781963|FG000|Overall Study|Death|2|||
146895570|NCT00630331|529781964|FG001|Overall Study|Death|1|||
146895571|NCT00630331|529781965|FG002|Overall Study|Death|1|||
146895572|NCT00630331|529781963|FG000|Overall Study|Adverse Event|1|||
146895573|NCT00630331|529781964|FG001|Overall Study|Adverse Event|0|||
146895574|NCT00630331|529781965|FG002|Overall Study|Adverse Event|0|||
146895575|NCT00630331|529781963|FG000|Overall Study|Withdrawal by Subject|12|||
146895576|NCT00630331|529781964|FG001|Overall Study|Withdrawal by Subject|7|||
146895577|NCT00630331|529781965|FG002|Overall Study|Withdrawal by Subject|5|||
146895578|NCT00630331|529781963|FG000|Overall Study|Lost to Follow-up|175|||
146895579|NCT00630331|529781964|FG001|Overall Study|Lost to Follow-up|143|||
146895580|NCT00630331|529781965|FG002|Overall Study|Lost to Follow-up|170|||
146895581|NCT00630331|529781963|FG000|Overall Study|Inappropriate enrollment|3|||
146895582|NCT00630331|529781964|FG001|Overall Study|Inappropriate enrollment|6|||
146895583|NCT00630331|529781965|FG002|Overall Study|Inappropriate enrollment|3|||
146895584|NCT00630331|529781963|FG000|Overall Study|Unable to classify|9|||
146895585|NCT00630331|529781964|FG001|Overall Study|Unable to classify|4|||
146895586|NCT00630331|529781965|FG002|Overall Study|Unable to classify|3|||
146895587|NCT00630331|529781963|FG000|Overall Study|Protocol Violation|4|||
146895588|NCT00630331|529781964|FG001|Overall Study|Protocol Violation|5|||
146895589|NCT00630331|529781965|FG002|Overall Study|Protocol Violation|6|||
146895590|NCT02425098|529781972|FG000|Overall Study|Lost to Follow-up|7|||
146968844|NCT00769132|530045541|FG003|Period 2|Withdrawal by Subject|1|||
146895591|NCT02425098|529781973|FG001|Overall Study|Lost to Follow-up|7|||
146895592|NCT02425098|529781972|FG000|Overall Study|Withdrawal by Subject|4|||
146895593|NCT02425098|529781973|FG001|Overall Study|Withdrawal by Subject|8|||
146895594|NCT02425098|529781972|FG000|Overall Study|Pregnancy|2|||
146895595|NCT02425098|529781973|FG001|Overall Study|Pregnancy|0|||
146895596|NCT02425098|529781972|FG000|Overall Study|Reason not Specified|0|||
146895597|NCT02425098|529781973|FG001|Overall Study|Reason not Specified|1|||
146895598|NCT02078219|529781974|FG000|Overall Study|Other|2|||
146895599|NCT02078219|529781975|FG001|Overall Study|Other|2|||
146895600|NCT02078219|529781976|FG002|Overall Study|Other|3|||
146895601|NCT02078219|529781977|FG003|Overall Study|Other|0|||
146895602|NCT02078219|529781978|FG004|Overall Study|Other|1|||
146895603|NCT02078219|529781974|FG000|Overall Study|Withdrawal by Subject|0|||
146895604|NCT02078219|529781975|FG001|Overall Study|Withdrawal by Subject|1|||
146895605|NCT02078219|529781976|FG002|Overall Study|Withdrawal by Subject|0|||
146895606|NCT02078219|529781977|FG003|Overall Study|Withdrawal by Subject|1|||
146895607|NCT02078219|529781978|FG004|Overall Study|Withdrawal by Subject|1|||
146895608|NCT02078219|529781974|FG000|Overall Study|Protocol Violation|0|||
146895609|NCT02078219|529781975|FG001|Overall Study|Protocol Violation|0|||
146895610|NCT02078219|529781976|FG002|Overall Study|Protocol Violation|0|||
146895611|NCT02078219|529781977|FG003|Overall Study|Protocol Violation|1|||
146895612|NCT02078219|529781978|FG004|Overall Study|Protocol Violation|0|||
146895613|NCT02078219|529781974|FG000|Overall Study|Death|0|||
146895614|NCT02078219|529781975|FG001|Overall Study|Death|0|||
146895615|NCT02078219|529781976|FG002|Overall Study|Death|0|||
146895616|NCT02078219|529781977|FG003|Overall Study|Death|1|||
146895617|NCT02078219|529781978|FG004|Overall Study|Death|0|||
146895618|NCT02078219|529781974|FG000|Overall Study|Adverse Event|1|||
146895619|NCT02078219|529781975|FG001|Overall Study|Adverse Event|1|||
146895620|NCT02078219|529781976|FG002|Overall Study|Adverse Event|3|||
146895621|NCT02078219|529781977|FG003|Overall Study|Adverse Event|1|||
146895622|NCT02078219|529781978|FG004|Overall Study|Adverse Event|0|||
146895623|NCT03136107|529781985|FG000|Overall Study|Other (Not specified)|1|||
146895624|NCT03283085|529781986|FG000|Overall Study|Adverse Event|18|||
146895625|NCT03283085|529781987|FG001|Overall Study|Adverse Event|3|||
146895626|NCT03283085|529781988|FG002|Overall Study|Adverse Event|13|||
146895627|NCT03283085|529781989|FG003|Overall Study|Adverse Event|0|||
146895628|NCT03283085|529781990|FG004|Overall Study|Adverse Event|0|||
146895629|NCT03283085|529781991|FG005|Overall Study|Adverse Event|5|||
146895630|NCT03283085|529781986|FG000|Overall Study|Death|0|||
146895631|NCT03283085|529781987|FG001|Overall Study|Death|0|||
146895632|NCT03283085|529781988|FG002|Overall Study|Death|3|||
146895633|NCT03283085|529781989|FG003|Overall Study|Death|1|||
146895634|NCT03283085|529781990|FG004|Overall Study|Death|0|||
146895635|NCT03283085|529781991|FG005|Overall Study|Death|0|||
146895636|NCT03283085|529781986|FG000|Overall Study|Withdrawal by Subject|42|||
146895637|NCT03283085|529781987|FG001|Overall Study|Withdrawal by Subject|21|||
146895638|NCT03283085|529781988|FG002|Overall Study|Withdrawal by Subject|66|||
146895639|NCT03283085|529781989|FG003|Overall Study|Withdrawal by Subject|3|||
146895640|NCT03283085|529781990|FG004|Overall Study|Withdrawal by Subject|3|||
146895641|NCT03283085|529781991|FG005|Overall Study|Withdrawal by Subject|5|||
146895642|NCT03283085|529781986|FG000|Overall Study|Physician Decision|14|||
146895643|NCT03283085|529781987|FG001|Overall Study|Physician Decision|8|||
146895644|NCT03283085|529781988|FG002|Overall Study|Physician Decision|19|||
146895645|NCT03283085|529781989|FG003|Overall Study|Physician Decision|0|||
146895646|NCT03283085|529781990|FG004|Overall Study|Physician Decision|0|||
146895647|NCT03283085|529781991|FG005|Overall Study|Physician Decision|2|||
146895648|NCT03283085|529781986|FG000|Overall Study|Site Terminated by Sponsor|1|||
146895649|NCT03283085|529781987|FG001|Overall Study|Site Terminated by Sponsor|0|||
146895650|NCT03283085|529781988|FG002|Overall Study|Site Terminated by Sponsor|3|||
146895651|NCT03283085|529781989|FG003|Overall Study|Site Terminated by Sponsor|0|||
146895652|NCT03283085|529781990|FG004|Overall Study|Site Terminated by Sponsor|0|||
146895653|NCT03283085|529781991|FG005|Overall Study|Site Terminated by Sponsor|0|||
146895654|NCT03283085|529781986|FG000|Overall Study|Lost to Follow-up|2|||
146895655|NCT03283085|529781987|FG001|Overall Study|Lost to Follow-up|0|||
146895656|NCT03283085|529781988|FG002|Overall Study|Lost to Follow-up|2|||
146639914|NCT02116205|528856601|FG002|Overall Study|Lost to Follow-up|1|||
146895657|NCT03283085|529781989|FG003|Overall Study|Lost to Follow-up|0|||
146895658|NCT03283085|529781990|FG004|Overall Study|Lost to Follow-up|0|||
146895659|NCT03283085|529781991|FG005|Overall Study|Lost to Follow-up|1|||
146895660|NCT03283085|529781986|FG000|Overall Study|Pregnancy|0|||
146639915|NCT02116205|528856602|FG003|Overall Study|Lost to Follow-up|2|||
146895661|NCT03283085|529781987|FG001|Overall Study|Pregnancy|0|||
146895662|NCT03283085|529781988|FG002|Overall Study|Pregnancy|1|||
146895663|NCT03283085|529781989|FG003|Overall Study|Pregnancy|0|||
146895664|NCT03283085|529781990|FG004|Overall Study|Pregnancy|0|||
146895665|NCT03283085|529781991|FG005|Overall Study|Pregnancy|0|||
146895666|NCT03283085|529781986|FG000|Overall Study|Lack of Efficacy|12|||
146895667|NCT03283085|529781987|FG001|Overall Study|Lack of Efficacy|6|||
146895668|NCT03283085|529781988|FG002|Overall Study|Lack of Efficacy|24|||
146895669|NCT03283085|529781989|FG003|Overall Study|Lack of Efficacy|1|||
146895670|NCT03283085|529781990|FG004|Overall Study|Lack of Efficacy|1|||
146895671|NCT03283085|529781991|FG005|Overall Study|Lack of Efficacy|0|||
146895672|NCT03283085|529781986|FG000|Overall Study|Reason not Specified|0|||
146895673|NCT03283085|529781987|FG001|Overall Study|Reason not Specified|4|||
146895674|NCT03283085|529781988|FG002|Overall Study|Reason not Specified|8|||
146895675|NCT03283085|529781989|FG003|Overall Study|Reason not Specified|0|||
146895676|NCT03283085|529781990|FG004|Overall Study|Reason not Specified|0|||
146895677|NCT03283085|529781991|FG005|Overall Study|Reason not Specified|1|||
146895678|NCT03641560|529781992|FG000|Overall Study|Withdrawal by Subject|6|||
146895679|NCT03641560|529781992|FG000|Overall Study|Progressive disease|40|||
146895680|NCT03641560|529781992|FG000|Overall Study|Death|6|||
146895681|NCT03219164|529784187|FG000|Overall Study|Study Terminated by Sponsor|16|||
146895682|NCT03219164|529784188|FG001|Overall Study|Study Terminated by Sponsor|12|||
146895683|NCT03219164|529784187|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
146895684|NCT03219164|529784188|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
146895685|NCT03219164|529784187|FG000|Overall Study|Lost to Follow-up|1|||
146895686|NCT03219164|529784188|FG001|Overall Study|Lost to Follow-up|1|||
146895687|NCT03219164|529784187|FG000|Overall Study|Adverse Event|1|||
146895688|NCT03219164|529784188|FG001|Overall Study|Adverse Event|0|||
146895689|NCT03219164|529784187|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146895690|NCT03219164|529784188|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146895691|NCT03219164|529784187|FG000|Overall Study|Protocol Violation|0|||
146895692|NCT03219164|529784188|FG001|Overall Study|Protocol Violation|1|||
146895693|NCT03219164|529784187|FG000|Overall Study|Withdrew Assent|1|||
146895694|NCT03219164|529784188|FG001|Overall Study|Withdrew Assent|0|||
146895695|NCT02689492|529784189|FG000|Overall Study|Lost to Follow-up|61|||
146895696|NCT02689492|529784189|FG000|Overall Study|Withdrawal by Subject|11|||
146895697|NCT02689492|529784189|FG000|Overall Study|Death|9|||
146895698|NCT02689492|529784189|FG000|Overall Study|Physician Decision|2|||
146895699|NCT02689492|529784189|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
146895700|NCT02689492|529784189|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
146895701|NCT02689492|529784189|FG000|Overall Study|Other than listed|1|||
146895702|NCT02732951|529784190|FG000|Overall Study|Other than listed|1|||
146895703|NCT02732951|529784191|FG001|Overall Study|Other than listed|0|||
146895704|NCT02732951|529784190|FG000|Overall Study|Lost to Follow-up|0|||
146895705|NCT02732951|529784191|FG001|Overall Study|Lost to Follow-up|1|||
146895706|NCT02732951|529784190|FG000|Overall Study|Adverse Event|4|||
146895707|NCT02732951|529784191|FG001|Overall Study|Adverse Event|4|||
146895708|NCT02732951|529784190|FG000|Overall Study|Protocol Violation|0|||
146895709|NCT02732951|529784191|FG001|Overall Study|Protocol Violation|1|||
146895710|NCT01750918|529784192|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
146895711|NCT01750918|529784193|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
146895712|NCT01750918|529784194|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
146895713|NCT01750918|529784195|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
146895714|NCT01750918|529784196|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
146895715|NCT01750918|529784197|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
146895716|NCT01750918|529784198|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
146895717|NCT01750918|529784199|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
146895718|NCT01750918|529784192|FG000|Overall Study|Lost to Follow-up|0|||
146895719|NCT01750918|529784193|FG001|Overall Study|Lost to Follow-up|0|||
146895720|NCT01750918|529784194|FG002|Overall Study|Lost to Follow-up|2|||
146895721|NCT01750918|529784195|FG003|Overall Study|Lost to Follow-up|2|||
146895722|NCT01750918|529784196|FG004|Overall Study|Lost to Follow-up|0|||
146895723|NCT01750918|529784197|FG005|Overall Study|Lost to Follow-up|0|||
146895724|NCT01750918|529784198|FG006|Overall Study|Lost to Follow-up|0|||
146895725|NCT01750918|529784199|FG007|Overall Study|Lost to Follow-up|1|||
146895726|NCT01750918|529784192|FG000|Overall Study|Withdrawal by Subject|0|||
146895727|NCT01750918|529784193|FG001|Overall Study|Withdrawal by Subject|0|||
146895728|NCT01750918|529784194|FG002|Overall Study|Withdrawal by Subject|1|||
146895729|NCT01750918|529784195|FG003|Overall Study|Withdrawal by Subject|2|||
146895730|NCT01750918|529784196|FG004|Overall Study|Withdrawal by Subject|1|||
146895731|NCT01750918|529784197|FG005|Overall Study|Withdrawal by Subject|1|||
146895732|NCT01750918|529784198|FG006|Overall Study|Withdrawal by Subject|2|||
146895733|NCT01750918|529784199|FG007|Overall Study|Withdrawal by Subject|2|||
146895734|NCT00110305|529784205|FG000|Overall Study|Adverse Event|46|||
146895735|NCT00110305|529784206|FG001|Overall Study|Adverse Event|13|||
146895736|NCT00110305|529784205|FG000|Overall Study|Sponsors Decision|1|||
146895737|NCT00110305|529784206|FG001|Overall Study|Sponsors Decision|0|||
146895738|NCT00110305|529784205|FG000|Overall Study|Subject Non-Compliant|9|||
146895739|NCT00110305|529784206|FG001|Overall Study|Subject Non-Compliant|2|||
146895740|NCT00110305|529784205|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
146895741|NCT00110305|529784206|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
146895742|NCT00110305|529784205|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
146895743|NCT00110305|529784206|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
146895744|NCT00110305|529784205|FG000|Overall Study|Protocol Violation|0|||
146895745|NCT00110305|529784206|FG001|Overall Study|Protocol Violation|1|||
146895746|NCT00110305|529784205|FG000|Overall Study|Withdrawal by Subject|7|||
146895747|NCT00110305|529784206|FG001|Overall Study|Withdrawal by Subject|7|||
146895748|NCT00110305|529784205|FG000|Overall Study|Lost to Follow-up|20|||
146895749|NCT00110305|529784206|FG001|Overall Study|Lost to Follow-up|3|||
146895750|NCT00110305|529784205|FG000|Overall Study|Other|8|||
146895751|NCT00110305|529784206|FG001|Overall Study|Other|2|||
146895752|NCT05047523|529784217|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
146895753|NCT05047523|529784218|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
146895754|NCT05047523|529784219|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
146895755|NCT05047523|529784220|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
146895756|NCT05047523|529784221|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
146895757|NCT05047523|529784222|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
146895758|NCT05047523|529784217|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
146895759|NCT05047523|529784218|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
146895760|NCT05047523|529784219|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
146895761|NCT05047523|529784220|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
146895762|NCT05047523|529784221|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
146895763|NCT05047523|529784222|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
146895764|NCT05047523|529784217|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
146895765|NCT05047523|529784218|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
146895766|NCT05047523|529784219|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
146895767|NCT05047523|529784220|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
146895768|NCT05047523|529784221|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
146895769|NCT05047523|529784222|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
146895770|NCT05047523|529784217|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
146895771|NCT05047523|529784218|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146895772|NCT05047523|529784219|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146895773|NCT05047523|529784220|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146895774|NCT05047523|529784221|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146895775|NCT05047523|529784222|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146895776|NCT05047523|529784217|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
146895777|NCT05047523|529784218|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
146895778|NCT05047523|529784219|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
146895779|NCT05047523|529784220|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
146895780|NCT05047523|529784221|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
146766686|NCT02810080|529314577|FG001|Overall Study|Withdrawal by Subject|2|||
146766687|NCT03923491|529314578|FG000|Overall Study|Lost to Follow-up|5|||
146766688|NCT03923491|529314579|FG001|Overall Study|Lost to Follow-up|8|||
146766689|NCT03923491|529314578|FG000|Overall Study|Withdrawal by Subject|4|||
146766690|NCT03923491|529314579|FG001|Overall Study|Withdrawal by Subject|6|||
146766691|NCT00964366|529314580|FG000|Overall Study|Did not qualify at Day 1|1|||
146766692|NCT00964366|529314581|FG001|Overall Study|Did not qualify at Day 1|0|||
146766693|NCT00964366|529314580|FG000|Overall Study|Withdrawal by Subject|0|||
146766694|NCT00964366|529314581|FG001|Overall Study|Withdrawal by Subject|1|||
146766695|NCT02393716|529314582|FG000|Overall Study|Death|29|||
146766696|NCT02393716|529314582|FG000|Overall Study|Withdrawal by Subject|8|||
146766697|NCT02393716|529314582|FG000|Overall Study|Device Explanted|8|||
146766698|NCT02393716|529314582|FG000|Overall Study|Missed visit|16|||
146766699|NCT01119950|529314584|FG000|Overall Study|Adverse Event|25|||
146766700|NCT01119950|529314584|FG000|Overall Study|Withdrawal by Subject|9|||
146895781|NCT05047523|529784222|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
146766701|NCT01119950|529314584|FG000|Overall Study|Protocol Violation|5|||
146766702|NCT01119950|529314584|FG000|Overall Study|Lost to Follow-up|4|||
146766703|NCT01119950|529314584|FG000|Overall Study|Administrative|2|||
146895782|NCT05047523|529784217|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
146895783|NCT05047523|529784218|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
146895784|NCT05047523|529784219|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
146895785|NCT05047523|529784220|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
146895786|NCT05047523|529784221|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
146968845|NCT00769132|530045538|FG000|Period 3|Withdrawal by Subject|1|||
146895787|NCT05047523|529784222|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
146895788|NCT00224016|529784224|FG000|Titration Period|Withdrawal by Subject|0|||
146895789|NCT00224016|529784225|FG001|Titration Period|Withdrawal by Subject|1|||
146895790|NCT00224016|529784224|FG000|Titration Period|Lost to Follow-up|1|||
146639916|NCT02116205|528856599|FG000|Overall Study|Physician Decision|0|||
146639917|NCT02116205|528856600|FG001|Overall Study|Physician Decision|1|||
146639918|NCT02116205|528856601|FG002|Overall Study|Physician Decision|1|||
146639919|NCT02116205|528856602|FG003|Overall Study|Physician Decision|1|||
146639920|NCT02116205|528856599|FG000|Overall Study|Exclusion criteria|0|||
146639921|NCT02116205|528856600|FG001|Overall Study|Exclusion criteria|0|||
146639922|NCT02116205|528856601|FG002|Overall Study|Exclusion criteria|1|||
146639923|NCT02116205|528856602|FG003|Overall Study|Exclusion criteria|0|||
146639924|NCT04200352|528856608|FG000|Overall Study|Death|1|||
146639925|NCT04200352|528856608|FG000|Overall Study|Adverse Event|6|||
146639926|NCT04200352|528856608|FG000|Overall Study|Withdrawal by parent/guardian|6|||
146639927|NCT04200352|528856608|FG000|Overall Study|Lack of Efficacy|1|||
146639928|NCT04200352|528856608|FG000|Overall Study|Other than specified|6|||
146639929|NCT00806819|528856609|FG000|Overall Study|progressive disease (modified RECIST )|217|||
146639930|NCT00806819|528856610|FG001|Overall Study|progressive disease (modified RECIST )|216|||
146639931|NCT00806819|528856609|FG000|Overall Study|Worsening or AE of underlying disease|18|||
146639932|NCT00806819|528856610|FG001|Overall Study|Worsening or AE of underlying disease|25|||
146639933|NCT00806819|528856609|FG000|Overall Study|Other AE|38|||
146639934|NCT00806819|528856610|FG001|Overall Study|Other AE|40|||
146639935|NCT00806819|528856609|FG000|Overall Study|Protocol Violation|9|||
146639936|NCT00806819|528856610|FG001|Overall Study|Protocol Violation|4|||
146639937|NCT00806819|528856609|FG000|Overall Study|Lost to Follow-up|1|||
146639938|NCT00806819|528856610|FG001|Overall Study|Lost to Follow-up|0|||
146639939|NCT00806819|528856609|FG000|Overall Study|Withdrawal by Subject|32|||
146639940|NCT00806819|528856610|FG001|Overall Study|Withdrawal by Subject|29|||
146639941|NCT00806819|528856609|FG000|Overall Study|Not treated|6|||
146639942|NCT00806819|528856610|FG001|Overall Study|Not treated|3|||
146639943|NCT00806819|528856609|FG000|Overall Study|Reasons other than stated above|25|||
146639944|NCT00806819|528856610|FG001|Overall Study|Reasons other than stated above|41|||
146639945|NCT00912197|528856617|FG000|Overall Study|Withdrawal by Subject|3|||
146639946|NCT00912197|528856618|FG001|Overall Study|Withdrawal by Subject|3|||
146639947|NCT01326104|528856624|FG000|Overall Study|progressed prior to vaccine|0|||
146639948|NCT01326104|528856625|FG001|Overall Study|progressed prior to vaccine|2|||
146639949|NCT01326104|528856624|FG000|Overall Study|unable to make vaccine|0|||
146639950|NCT01326104|528856625|FG001|Overall Study|unable to make vaccine|2|||
146639951|NCT00494676|528856628|FG000|Allocation|Withdrawal by Subject|2|||
146639952|NCT00494676|528856629|FG001|Allocation|Withdrawal by Subject|4|||
146639953|NCT00494676|528856628|FG000|First Intervention|Withdrawal by Subject|1|||
146639954|NCT00494676|528856629|FG001|First Intervention|Withdrawal by Subject|3|||
146639955|NCT00494676|528856628|FG000|Second Intervention|Withdrawal by Subject|1|||
146639956|NCT00494676|528856629|FG001|Second Intervention|Withdrawal by Subject|1|||
146639957|NCT00775593|528857817|FG000|Overall Study|Unmet eligibility criteria|6|||
146639958|NCT00775593|528857817|FG000|Overall Study|Death|1|||
146639959|NCT02067676|528857818|FG000|Overall Study|Withdrawal by Subject|1|||
146639960|NCT02067676|528857819|FG001|Overall Study|Withdrawal by Subject|0|||
146639961|NCT02067676|528857820|FG002|Overall Study|Withdrawal by Subject|0|||
146639962|NCT02067676|528857821|FG003|Overall Study|Withdrawal by Subject|0|||
146639963|NCT02067676|528857822|FG004|Overall Study|Withdrawal by Subject|0|||
146639964|NCT02067676|528857823|FG005|Overall Study|Withdrawal by Subject|0|||
146895791|NCT00224016|529784225|FG001|Titration Period|Lost to Follow-up|0|||
146895792|NCT00224016|529784224|FG000|Maintenance Period|Withdrawal by Subject|2|||
146895793|NCT00224016|529784225|FG001|Maintenance Period|Withdrawal by Subject|0|||
146895794|NCT00224016|529784224|FG000|Maintenance Period|Lost to Follow-up|0|||
146895795|NCT00224016|529784225|FG001|Maintenance Period|Lost to Follow-up|1|||
146895796|NCT01524991|529784228|FG000|Overall Study|Adverse Event|12|||
146895797|NCT01524991|529784228|FG000|Overall Study|Death|1|||
146639965|NCT00996333|528857824|FG000|Overall Study|Screen failure|1|||
146639966|NCT00996333|528857824|FG000|Overall Study|Withdrawal by Subject|1|||
146895798|NCT01524991|529784228|FG000|Overall Study|Disease ProgressionDu|17|||
146639967|NCT00996333|528857824|FG000|Overall Study|Death|4|||
146639968|NCT00996333|528857824|FG000|Overall Study|Adverse Event|1|||
146639969|NCT00996333|528857824|FG000|Overall Study|Physician Decision|1|||
146639970|NCT00996333|528857824|FG000|Overall Study|Other|5|||
146639971|NCT01327482|528857825|FG000|Overall Study|Adverse Event|1|||
146639972|NCT00476229|528857826|FG000|Overall Study|Progressive shortness of breath|1|||
146639973|NCT02164461|528857827|FG000|Overall Study|Adverse Event|0|||
146895799|NCT01524991|529784228|FG000|Overall Study|Other complicating disease|1|||
146895800|NCT01524991|529784228|FG000|Overall Study|Withdrawal by Subject|2|||
146895801|NCT01524991|529784228|FG000|Overall Study|Symptomatic Deterioration|1|||
146895802|NCT01805180|529784229|FG000|Lead-in Donor Phase|screen failure|1|||
146895803|NCT01805180|529784230|FG001|Lead-in Donor Phase|screen failure|0|||
146895804|NCT01805180|529784231|FG002|Lead-in Donor Phase|screen failure|0|||
146895805|NCT04574999|529784234|FG000|Overall Study|Adverse Event|1|||
146895806|NCT04574999|529784235|FG001|Overall Study|Adverse Event|0|||
146895807|NCT04574999|529784234|FG000|Overall Study|Lack of Efficacy|2|||
146895808|NCT04574999|529784235|FG001|Overall Study|Lack of Efficacy|3|||
146895809|NCT04574999|529784234|FG000|Overall Study|Protocol Violation|1|||
146895810|NCT04574999|529784235|FG001|Overall Study|Protocol Violation|0|||
146895811|NCT04574999|529784234|FG000|Overall Study|Withdrawal by Subject|2|||
146895812|NCT04574999|529784235|FG001|Overall Study|Withdrawal by Subject|2|||
146895813|NCT04574999|529784234|FG000|Overall Study|Lost to Follow-up|1|||
146895814|NCT04574999|529784235|FG001|Overall Study|Lost to Follow-up|0|||
146895815|NCT04574999|529784234|FG000|Overall Study|Personal problems|1|||
146895816|NCT04574999|529784235|FG001|Overall Study|Personal problems|0|||
146895817|NCT04574999|529784234|FG000|Overall Study|Previous planned surgery|1|||
146895818|NCT04574999|529784235|FG001|Overall Study|Previous planned surgery|0|||
146895819|NCT00206726|529784239|FG000|Overall Study|Delayed recovery of blood counts|1|||
146895820|NCT00206726|529784239|FG000|Overall Study|Progressive disease or relapsed disease|18|||
146895821|NCT00206726|529784239|FG000|Overall Study|Placed on new protocol|1|||
146895822|NCT00206726|529784239|FG000|Overall Study|Bone marrow transplant|1|||
146895823|NCT00206726|529784239|FG000|Overall Study|Adverse Event|17|||
146895824|NCT00206726|529784239|FG000|Overall Study|Death|4|||
146895825|NCT00206726|529784239|FG000|Overall Study|Protocol Violation|1|||
146895826|NCT00206726|529784239|FG000|Overall Study|Withdrawal by Subject|8|||
146895827|NCT00008385|529784256|FG000|Overall Study|Off treatment reasons not reported|79|||
146895828|NCT00008385|529784257|FG001|Overall Study|Off treatment reasons not reported|70|||
146895829|NCT00008385|529784256|FG000|Overall Study|Progressive disease|52|||
146895830|NCT00008385|529784257|FG001|Overall Study|Progressive disease|117|||
146895831|NCT00008385|529784256|FG000|Overall Study|Adverse Event|8|||
146895832|NCT00008385|529784257|FG001|Overall Study|Adverse Event|20|||
146639974|NCT02164461|528857828|FG001|Overall Study|Adverse Event|0|||
146639975|NCT02164461|528857829|FG002|Overall Study|Adverse Event|1|||
146639976|NCT02164461|528857827|FG000|Overall Study|Disease Progression|1|||
146639977|NCT02164461|528857828|FG001|Overall Study|Disease Progression|3|||
146639978|NCT02164461|528857829|FG002|Overall Study|Disease Progression|4|||
146639979|NCT02164461|528857827|FG000|Overall Study|Withdrawal by Subject|0|||
146639980|NCT02164461|528857828|FG001|Overall Study|Withdrawal by Subject|3|||
146895833|NCT00008385|529784256|FG000|Overall Study|Death|12|||
146895834|NCT00008385|529784257|FG001|Overall Study|Death|18|||
146895835|NCT00008385|529784256|FG000|Overall Study|Withdrawal by Subject|67|||
146895836|NCT00008385|529784257|FG001|Overall Study|Withdrawal by Subject|157|||
146895837|NCT00008385|529784256|FG000|Overall Study|Start non-protocol therapy|3|||
146895838|NCT00008385|529784257|FG001|Overall Study|Start non-protocol therapy|1|||
146895839|NCT00008385|529784256|FG000|Overall Study|Other complicating disease|17|||
146895840|NCT00008385|529784257|FG001|Overall Study|Other complicating disease|30|||
146895841|NCT00008385|529784256|FG000|Overall Study|Maximum dose reached|0|||
146895842|NCT00008385|529784257|FG001|Overall Study|Maximum dose reached|2|||
146895843|NCT00008385|529784256|FG000|Overall Study|Other|105|||
146895844|NCT00008385|529784257|FG001|Overall Study|Other|212|||
146895845|NCT00008385|529784256|FG000|Overall Study|Not start protocol therapy|44|||
146895846|NCT00008385|529784257|FG001|Overall Study|Not start protocol therapy|175|||
146895847|NCT05148884|529784258|FG000|Overall Study|Withdrawal by Subject|3|||
146895848|NCT05148884|529784259|FG001|Overall Study|Withdrawal by Subject|0|||
146895849|NCT05148884|529784258|FG000|Overall Study|Deep brain stimulation operation|0|||
146895850|NCT05148884|529784259|FG001|Overall Study|Deep brain stimulation operation|1|||
146895851|NCT00582556|529784260|FG000|Overall Study|Withdrawal by Subject|0|||
146895852|NCT00582556|529784261|FG001|Overall Study|Withdrawal by Subject|1|||
146895853|NCT00582556|529784262|FG002|Overall Study|Withdrawal by Subject|1|||
146895854|NCT00582556|529784260|FG000|Overall Study|Physician Decision|0|||
146895855|NCT00582556|529784261|FG001|Overall Study|Physician Decision|0|||
146895856|NCT00582556|529784262|FG002|Overall Study|Physician Decision|1|||
146639981|NCT02164461|528857829|FG002|Overall Study|Withdrawal by Subject|0|||
146895857|NCT01993888|529784265|FG000|Overall Study|Death|1|||
146895858|NCT01993888|529784266|FG001|Overall Study|Death|1|||
146895859|NCT01993888|529784265|FG000|Overall Study|Lost to Follow-up|1|||
146895860|NCT01993888|529784266|FG001|Overall Study|Lost to Follow-up|1|||
146895861|NCT01993888|529784265|FG000|Overall Study|Withdrawal by Subject|0|||
146895862|NCT01993888|529784266|FG001|Overall Study|Withdrawal by Subject|1|||
146895863|NCT01341457|529784267|FG000|Overall Study|Adverse Event|2|||
146895864|NCT01341457|529784268|FG001|Overall Study|Adverse Event|0|||
146895865|NCT00365989|529784269|FG000|Overall Study|Withdrawal by Subject|1|||
146895866|NCT00365989|529784269|FG000|Overall Study|Non-compliance|1|||
146895867|NCT00832819|529784274|FG000|Overall Study|Adverse Event|0|||
146895868|NCT00832819|529784275|FG001|Overall Study|Adverse Event|1|||
146895869|NCT00832819|529784276|FG002|Overall Study|Adverse Event|0|||
146895870|NCT00832819|529784274|FG000|Overall Study|Protocol Violation|0|||
146895871|NCT00832819|529784275|FG001|Overall Study|Protocol Violation|0|||
146895872|NCT00832819|529784276|FG002|Overall Study|Protocol Violation|1|||
146895873|NCT00317044|529784277|FG000|Overall Study|Protocol Violation|28|||
146895874|NCT00317044|529784278|FG001|Overall Study|Protocol Violation|22|||
146895875|NCT00317044|529784279|FG002|Overall Study|Protocol Violation|20|||
146895876|NCT00317044|529784277|FG000|Overall Study|Adverse Event|4|||
146895877|NCT00317044|529784278|FG001|Overall Study|Adverse Event|7|||
146895878|NCT00317044|529784279|FG002|Overall Study|Adverse Event|4|||
146895879|NCT00317044|529784277|FG000|Overall Study|Withdrawal by Subject|10|||
146895880|NCT00317044|529784278|FG001|Overall Study|Withdrawal by Subject|7|||
146895881|NCT00317044|529784279|FG002|Overall Study|Withdrawal by Subject|12|||
146895882|NCT00317044|529784277|FG000|Overall Study|Lost to Follow-up|0|||
146895883|NCT00317044|529784278|FG001|Overall Study|Lost to Follow-up|2|||
146895884|NCT00317044|529784279|FG002|Overall Study|Lost to Follow-up|3|||
146895885|NCT00317044|529784277|FG000|Overall Study|Multiple Reasons|6|||
146895886|NCT00317044|529784278|FG001|Overall Study|Multiple Reasons|2|||
146895887|NCT00317044|529784279|FG002|Overall Study|Multiple Reasons|6|||
146895888|NCT02318095|529784282|FG000|Overall Study|Adverse Event|1|||
146895889|NCT01717638|529784283|FG000|Overall Study|Lost to Follow-up|0|||
146968846|NCT00769132|530045539|FG001|Period 3|Withdrawal by Subject|0|||
146968847|NCT00769132|530045540|FG002|Period 3|Withdrawal by Subject|0|||
146968848|NCT00769132|530045541|FG003|Period 3|Withdrawal by Subject|0|||
146968849|NCT00769132|530045538|FG000|Period 4|Withdrawal by Subject|0|||
146968850|NCT00769132|530045539|FG001|Period 4|Withdrawal by Subject|1|||
146968851|NCT00769132|530045540|FG002|Period 4|Withdrawal by Subject|0|||
146968852|NCT00769132|530045541|FG003|Period 4|Withdrawal by Subject|0|||
146968853|NCT00877799|530045543|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
146968854|NCT00877799|530045544|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
146968855|NCT00877799|530045545|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
146968856|NCT00877799|530045546|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
146968857|NCT00877799|530045547|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
146968858|NCT00877799|530045543|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
146968859|NCT00877799|530045544|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
146895890|NCT01717638|529784284|FG001|Overall Study|Lost to Follow-up|0|||
146895891|NCT01717638|529784285|FG002|Overall Study|Lost to Follow-up|0|||
146895892|NCT01717638|529784286|FG003|Overall Study|Lost to Follow-up|0|||
146895893|NCT01717638|529784287|FG004|Overall Study|Lost to Follow-up|0|||
146895894|NCT01717638|529784288|FG005|Overall Study|Lost to Follow-up|1|||
146895895|NCT01717638|529784289|FG006|Overall Study|Lost to Follow-up|0|||
146639982|NCT02100696|528857831|FG000|Induction Phase|Adverse Event|0|||
146639983|NCT02100696|528857832|FG001|Induction Phase|Adverse Event|0|||
146639984|NCT02100696|528857833|FG002|Induction Phase|Adverse Event|1|||
146639985|NCT02100696|528857834|FG003|Induction Phase|Adverse Event|0|||
146639986|NCT02100696|528857835|FG004|Induction Phase|Adverse Event|0|||
146639987|NCT02100696|528857836|FG005|Induction Phase|Adverse Event|0|||
146639988|NCT02100696|528857831|FG000|Induction Phase|Lost to Follow-up|1|||
146639989|NCT02100696|528857832|FG001|Induction Phase|Lost to Follow-up|0|||
146639990|NCT02100696|528857833|FG002|Induction Phase|Lost to Follow-up|1|||
146639991|NCT02100696|528857834|FG003|Induction Phase|Lost to Follow-up|0|||
146639992|NCT02100696|528857835|FG004|Induction Phase|Lost to Follow-up|0|||
146895896|NCT01717638|529784290|FG007|Overall Study|Lost to Follow-up|0|||
146895897|NCT01717638|529784291|FG008|Overall Study|Lost to Follow-up|0|||
146895898|NCT01717638|529784292|FG009|Overall Study|Lost to Follow-up|0|||
146895899|NCT01717638|529784293|FG010|Overall Study|Lost to Follow-up|0|||
146895900|NCT01717638|529784294|FG011|Overall Study|Lost to Follow-up|0|||
146895901|NCT01717638|529784295|FG012|Overall Study|Lost to Follow-up|0|||
146895902|NCT01717638|529784283|FG000|Overall Study|Father in hospital|0|||
146895903|NCT01717638|529784284|FG001|Overall Study|Father in hospital|0|||
146895904|NCT01717638|529784285|FG002|Overall Study|Father in hospital|0|||
146895905|NCT01717638|529784286|FG003|Overall Study|Father in hospital|0|||
146895906|NCT01717638|529784287|FG004|Overall Study|Father in hospital|0|||
146895907|NCT01717638|529784288|FG005|Overall Study|Father in hospital|0|||
146895908|NCT01717638|529784289|FG006|Overall Study|Father in hospital|0|||
146895909|NCT01717638|529784290|FG007|Overall Study|Father in hospital|0|||
146895910|NCT01717638|529784291|FG008|Overall Study|Father in hospital|0|||
146895911|NCT01717638|529784292|FG009|Overall Study|Father in hospital|0|||
146895912|NCT01717638|529784293|FG010|Overall Study|Father in hospital|0|||
146895913|NCT01717638|529784294|FG011|Overall Study|Father in hospital|0|||
146895914|NCT01717638|529784295|FG012|Overall Study|Father in hospital|1|||
146895915|NCT01717638|529784283|FG000|Overall Study|Withdrawal by Subject|0|||
146895916|NCT01717638|529784284|FG001|Overall Study|Withdrawal by Subject|1|||
146895917|NCT01717638|529784285|FG002|Overall Study|Withdrawal by Subject|1|||
146895918|NCT01717638|529784286|FG003|Overall Study|Withdrawal by Subject|0|||
146895919|NCT01717638|529784287|FG004|Overall Study|Withdrawal by Subject|1|||
146895920|NCT01717638|529784288|FG005|Overall Study|Withdrawal by Subject|0|||
146895921|NCT01717638|529784289|FG006|Overall Study|Withdrawal by Subject|2|||
146895922|NCT01717638|529784290|FG007|Overall Study|Withdrawal by Subject|1|||
146895923|NCT01717638|529784291|FG008|Overall Study|Withdrawal by Subject|2|||
146895924|NCT01717638|529784292|FG009|Overall Study|Withdrawal by Subject|1|||
146895925|NCT01717638|529784293|FG010|Overall Study|Withdrawal by Subject|0|||
146895926|NCT01717638|529784294|FG011|Overall Study|Withdrawal by Subject|0|||
146895927|NCT01717638|529784295|FG012|Overall Study|Withdrawal by Subject|18|||
146895928|NCT01719757|529784297|FG000|Overall Study|Adverse Event|38|||
146895929|NCT01719757|529784297|FG000|Overall Study|Withdrawal by Subject|15|||
146895930|NCT01719757|529784297|FG000|Overall Study|Lost to Follow-up|20|||
146895931|NCT01719757|529784297|FG000|Overall Study|Protocol Violation|1|||
146895932|NCT01719757|529784297|FG000|Overall Study|well controlled pain|27|||
146895933|NCT02626338|529784298|FG000|Overall Study|Lack of Efficacy|3|||
146895934|NCT02626338|529784299|FG001|Overall Study|Lack of Efficacy|2|||
146895935|NCT02626338|529784300|FG002|Overall Study|Lack of Efficacy|0|||
146895936|NCT01901224|529784301|FG000|Overall Study|study was not funded and terminated|2|||
146895937|NCT02300129|529784302|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
146895938|NCT02300129|529784303|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
146895939|NCT02300129|529784304|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
146895940|NCT02300129|529784305|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
146895941|NCT02300129|529784302|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
146895942|NCT02300129|529784303|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
146968860|NCT00877799|530045545|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
146639993|NCT02100696|528857836|FG005|Induction Phase|Lost to Follow-up|0|||
146639994|NCT02100696|528857831|FG000|Induction Phase|Protocol Violation|0|||
146639995|NCT02100696|528857832|FG001|Induction Phase|Protocol Violation|1|||
146639996|NCT02100696|528857833|FG002|Induction Phase|Protocol Violation|1|||
146639997|NCT02100696|528857834|FG003|Induction Phase|Protocol Violation|0|||
146639998|NCT02100696|528857835|FG004|Induction Phase|Protocol Violation|0|||
146639999|NCT02100696|528857836|FG005|Induction Phase|Protocol Violation|0|||
146640000|NCT02100696|528857831|FG000|Induction Phase|Withdrawal by Subject|8|||
146766704|NCT01119950|529314584|FG000|Overall Study|Abnormal lab value|1|||
146895943|NCT02300129|529784304|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
146895944|NCT02300129|529784305|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
146895945|NCT02300129|529784302|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
146895946|NCT02300129|529784303|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
146895947|NCT02300129|529784304|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
146895948|NCT02300129|529784305|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
146895949|NCT00522392|529784309|FG000|Overall Study|Disease progression|0|||
146895950|NCT00522392|529784310|FG001|Overall Study|Disease progression|3|||
146895951|NCT00522392|529784309|FG000|Overall Study|Adverse Event|7|||
146895952|NCT00522392|529784310|FG001|Overall Study|Adverse Event|7|||
146895953|NCT00522392|529784309|FG000|Overall Study|Withdrawal by Subject|1|||
146895954|NCT00522392|529784310|FG001|Overall Study|Withdrawal by Subject|1|||
146895955|NCT00522392|529784309|FG000|Overall Study|Physician Decision|0|||
146895956|NCT00522392|529784310|FG001|Overall Study|Physician Decision|1|||
146895957|NCT00522392|529784309|FG000|Overall Study|Non-compliance|0|||
146895958|NCT00522392|529784310|FG001|Overall Study|Non-compliance|1|||
146895959|NCT00430755|529784318|FG000|Overall Study|Withdrawal by Subject|53|||
146895960|NCT00103012|529784319|FG000|Overall Study|Withdrawal by Subject|2|||
146895961|NCT00103012|529784320|FG001|Overall Study|Withdrawal by Subject|1|||
146895962|NCT00103012|529784321|FG002|Overall Study|Withdrawal by Subject|2|||
146895963|NCT00103012|529784319|FG000|Overall Study|Pregnancy|1|||
146895964|NCT00103012|529784320|FG001|Overall Study|Pregnancy|0|||
146895965|NCT00103012|529784321|FG002|Overall Study|Pregnancy|0|||
146895966|NCT00103012|529784319|FG000|Overall Study|Adverse Event|0|||
146895967|NCT00103012|529784320|FG001|Overall Study|Adverse Event|0|||
146895968|NCT00103012|529784321|FG002|Overall Study|Adverse Event|1|||
146895969|NCT00103012|529784319|FG000|Overall Study|Subject non-compliant with medications|0|||
146895970|NCT00103012|529784320|FG001|Overall Study|Subject non-compliant with medications|0|||
146895971|NCT00103012|529784321|FG002|Overall Study|Subject non-compliant with medications|1|||
146895972|NCT05211336|529784326|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
146895973|NCT05211336|529784327|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
146895974|NCT05211336|529784326|FG000|Overall Study|Progressive disease|0|||
146895975|NCT05211336|529784327|FG001|Overall Study|Progressive disease|4|||
146895976|NCT05211336|529784326|FG000|Overall Study|Death due to myocardial infarction|0|||
146895977|NCT05211336|529784327|FG001|Overall Study|Death due to myocardial infarction|1|||
146895978|NCT05211336|529784326|FG000|Overall Study|Death due to unknown cause|0|||
146895979|NCT05211336|529784327|FG001|Overall Study|Death due to unknown cause|1|||
146895980|NCT05211336|529784326|FG000|Overall Study|Worsening kidney function and quality of response|0|||
146895981|NCT05211336|529784327|FG001|Overall Study|Worsening kidney function and quality of response|1|||
146895982|NCT03902080|529784332|FG000|Overall Study|Adverse Event|17|||
146895983|NCT03902080|529784333|FG001|Overall Study|Adverse Event|15|||
146895984|NCT03902080|529784332|FG000|Overall Study|Withdrawal by Subject|28|||
146895985|NCT03902080|529784333|FG001|Overall Study|Withdrawal by Subject|35|||
146895986|NCT03902080|529784332|FG000|Overall Study|Lost to Follow-up|6|||
146895987|NCT03902080|529784333|FG001|Overall Study|Lost to Follow-up|7|||
146895988|NCT03902080|529784332|FG000|Overall Study|Other|3|||
146895989|NCT03902080|529784333|FG001|Overall Study|Other|5|||
146895990|NCT03902080|529784332|FG000|Overall Study|Non compliance|4|||
146895991|NCT03902080|529784333|FG001|Overall Study|Non compliance|3|||
146895992|NCT03902080|529784332|FG000|Overall Study|Physician Decision|5|||
146895993|NCT03902080|529784333|FG001|Overall Study|Physician Decision|1|||
146895994|NCT03902080|529784332|FG000|Overall Study|Protocol Violation|3|||
146895995|NCT03902080|529784333|FG001|Overall Study|Protocol Violation|3|||
146895996|NCT03902080|529784332|FG000|Overall Study|Lack of Efficacy|1|||
146895997|NCT03902080|529784333|FG001|Overall Study|Lack of Efficacy|3|||
146895998|NCT03902080|529784332|FG000|Overall Study|Withdrawn prior to dosing|0|||
146895999|NCT03902080|529784333|FG001|Overall Study|Withdrawn prior to dosing|1|||
146896000|NCT02661594|529784334|FG000|Overall Study|Protocol Violation|1|||
146896001|NCT02661594|529784335|FG001|Overall Study|Protocol Violation|0|||
146896002|NCT02661594|529784336|FG002|Overall Study|Protocol Violation|1|||
146896003|NCT02661594|529784337|FG003|Overall Study|Protocol Violation|0|||
146896004|NCT00434967|529784340|FG000|Overall Study|Adverse Event|2|||
146896005|NCT00434967|529784341|FG001|Overall Study|Adverse Event|4|||
146896006|NCT00434967|529784342|FG002|Overall Study|Adverse Event|3|||
146896007|NCT00434967|529784343|FG003|Overall Study|Adverse Event|3|||
146896008|NCT00434967|529784340|FG000|Overall Study|Lost to Follow-up|0|||
146896009|NCT00434967|529784341|FG001|Overall Study|Lost to Follow-up|0|||
146896010|NCT00434967|529784342|FG002|Overall Study|Lost to Follow-up|1|||
146896011|NCT00434967|529784343|FG003|Overall Study|Lost to Follow-up|0|||
146896012|NCT00434967|529784340|FG000|Overall Study|Withdrawal by Subject|2|||
146896013|NCT00434967|529784341|FG001|Overall Study|Withdrawal by Subject|2|||
146559235|NCT01225952|528557350|FG000|Overall Study|Withdrawal by Subject|4|||
146559236|NCT01225952|528557351|FG001|Overall Study|Withdrawal by Subject|4|||
146559237|NCT01225952|528557352|FG002|Overall Study|Withdrawal by Subject|5|||
146559238|NCT01225952|528557350|FG000|Overall Study|Surgical complications|1|||
146896014|NCT00434967|529784342|FG002|Overall Study|Withdrawal by Subject|4|||
146896015|NCT00434967|529784343|FG003|Overall Study|Withdrawal by Subject|6|||
146896016|NCT00434967|529784340|FG000|Overall Study|Randomized in error|0|||
146896017|NCT00434967|529784341|FG001|Overall Study|Randomized in error|0|||
146896018|NCT00434967|529784342|FG002|Overall Study|Randomized in error|0|||
146896019|NCT00434967|529784343|FG003|Overall Study|Randomized in error|1|||
146896020|NCT00434967|529784340|FG000|Overall Study|Protocol Violation|0|||
146896021|NCT00434967|529784341|FG001|Overall Study|Protocol Violation|1|||
146896022|NCT00434967|529784342|FG002|Overall Study|Protocol Violation|0|||
146896023|NCT00434967|529784343|FG003|Overall Study|Protocol Violation|1|||
146896024|NCT00434967|529784340|FG000|Overall Study|Physician Decision|1|||
146896025|NCT00434967|529784341|FG001|Overall Study|Physician Decision|1|||
146896026|NCT00434967|529784342|FG002|Overall Study|Physician Decision|1|||
146896027|NCT00434967|529784343|FG003|Overall Study|Physician Decision|0|||
146896028|NCT00434967|529784340|FG000|Overall Study|Patient Disposition Challenges|2|||
146896029|NCT00434967|529784341|FG001|Overall Study|Patient Disposition Challenges|0|||
146896030|NCT00434967|529784342|FG002|Overall Study|Patient Disposition Challenges|0|||
146896031|NCT00434967|529784343|FG003|Overall Study|Patient Disposition Challenges|3|||
146896032|NCT01169779|529784344|FG000|Overall Study|Adverse Event|3|||
146896033|NCT01169779|529784345|FG001|Overall Study|Adverse Event|11|||
146896034|NCT01169779|529784344|FG000|Overall Study|Lack of Efficacy|1|||
146896035|NCT01169779|529784345|FG001|Overall Study|Lack of Efficacy|0|||
146896036|NCT01169779|529784344|FG000|Overall Study|Protocol Violation|1|||
146896037|NCT01169779|529784345|FG001|Overall Study|Protocol Violation|1|||
146896038|NCT01169779|529784344|FG000|Overall Study|Withdrawal by Subject|3|||
146896039|NCT01169779|529784345|FG001|Overall Study|Withdrawal by Subject|2|||
146896040|NCT01169779|529784344|FG000|Overall Study|Familial and personal reasons|3|||
146896041|NCT01169779|529784345|FG001|Overall Study|Familial and personal reasons|3|||
146896042|NCT00928070|529784346|FG000|Overall Study|Lost to Follow-up|1|||
146896043|NCT00928070|529784347|FG001|Overall Study|Lost to Follow-up|2|||
146896044|NCT00928070|529784346|FG000|Overall Study|Withdrawal by Subject|10|||
146896045|NCT00928070|529784347|FG001|Overall Study|Withdrawal by Subject|3|||
146896046|NCT00928070|529784346|FG000|Overall Study|Adverse Event|14|||
146896047|NCT00928070|529784347|FG001|Overall Study|Adverse Event|26|||
146896048|NCT00928070|529784346|FG000|Overall Study|Lack of Efficacy|9|||
146896049|NCT00928070|529784347|FG001|Overall Study|Lack of Efficacy|5|||
146896050|NCT00928070|529784346|FG000|Overall Study|Did not meet entrance criteria|16|||
146896051|NCT00928070|529784347|FG001|Overall Study|Did not meet entrance criteria|9|||
146896052|NCT00928070|529784346|FG000|Overall Study|Protocol Violation|6|||
146896053|NCT00928070|529784347|FG001|Overall Study|Protocol Violation|5|||
146896054|NCT00928070|529784346|FG000|Overall Study|Randomized but not treated|2|||
146896055|NCT00928070|529784347|FG001|Overall Study|Randomized but not treated|2|||
146896056|NCT00928070|529784346|FG000|Overall Study|Other|5|||
146896057|NCT00928070|529784347|FG001|Overall Study|Other|5|||
146896058|NCT00191854|529784348|FG000|Overall Study|Death|26|||
146896059|NCT00191854|529784349|FG001|Overall Study|Death|23|||
146896060|NCT00191854|529784350|FG002|Overall Study|Death|29|||
146896061|NCT00191854|529784348|FG000|Overall Study|Lost to Follow-up|7|||
146896062|NCT00191854|529784349|FG001|Overall Study|Lost to Follow-up|5|||
146896063|NCT00191854|529784350|FG002|Overall Study|Lost to Follow-up|5|||
146896064|NCT00191854|529784348|FG000|Overall Study|Withdrawal by Subject|4|||
146896065|NCT00191854|529784349|FG001|Overall Study|Withdrawal by Subject|2|||
146896066|NCT00191854|529784350|FG002|Overall Study|Withdrawal by Subject|3|||
146896067|NCT00191854|529784348|FG000|Overall Study|Sponsor Decision|0|||
146896068|NCT00191854|529784349|FG001|Overall Study|Sponsor Decision|0|||
146896069|NCT00191854|529784350|FG002|Overall Study|Sponsor Decision|1|||
146896070|NCT00191854|529784348|FG000|Overall Study|Screen Failure|0|||
146896071|NCT00191854|529784349|FG001|Overall Study|Screen Failure|0|||
146896072|NCT00191854|529784350|FG002|Overall Study|Screen Failure|1|||
146896073|NCT00556426|529784352|FG000|Overall Study|Withdrawal by Subject|3|||
146896074|NCT00556426|529784352|FG000|Overall Study|Death|6|||
146896075|NCT01671280|529784355|FG000|Overall Study|Withdrawal by Subject|2|||
146896076|NCT00996203|529784356|FG000|Overall Study|Adverse Event|3|||
146896077|NCT00996203|529784356|FG000|Overall Study|Lost to Follow-up|1|||
146896078|NCT00996203|529784356|FG000|Overall Study|Lack of Efficacy|1|||
146896079|NCT00996203|529784356|FG000|Overall Study|Protocol Violation|2|||
146896080|NCT01959165|529784357|FG000|Overall Study|Adverse Event|0|||
146896081|NCT01959165|529784358|FG001|Overall Study|Adverse Event|0|||
146896082|NCT01959165|529784359|FG002|Overall Study|Adverse Event|0|||
146896083|NCT01959165|529784360|FG003|Overall Study|Adverse Event|1|||
146896084|NCT01959165|529784357|FG000|Overall Study|Lack of Efficacy|1|||
146896085|NCT01959165|529784358|FG001|Overall Study|Lack of Efficacy|0|||
146896086|NCT01959165|529784359|FG002|Overall Study|Lack of Efficacy|0|||
146896087|NCT01959165|529784360|FG003|Overall Study|Lack of Efficacy|0|||
146896088|NCT01959165|529784357|FG000|Overall Study|overdose|0|||
146896089|NCT01959165|529784358|FG001|Overall Study|overdose|0|||
146968861|NCT00877799|530045546|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
146968862|NCT00877799|530045547|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
146559239|NCT01225952|528557351|FG001|Overall Study|Surgical complications|0|||
146896090|NCT01959165|529784359|FG002|Overall Study|overdose|0|||
146559240|NCT01225952|528557352|FG002|Overall Study|Surgical complications|0|||
146559241|NCT01217892|528557356|FG000|Overall Study|Adverse Event|1|||
146559242|NCT01217892|528557357|FG001|Overall Study|Adverse Event|1|||
146896091|NCT01959165|529784360|FG003|Overall Study|overdose|1|||
146559243|NCT01217892|528557358|FG002|Overall Study|Adverse Event|1|||
146896092|NCT01959165|529784357|FG000|Overall Study|Welfare recipient|0|||
146896093|NCT01959165|529784358|FG001|Overall Study|Welfare recipient|1|||
146896094|NCT01959165|529784359|FG002|Overall Study|Welfare recipient|0|||
146896095|NCT01959165|529784360|FG003|Overall Study|Welfare recipient|0|||
146896096|NCT03686969|529784361|FG000|Overall Study|Study terminated|1|||
146896097|NCT03686969|529784362|FG001|Overall Study|Study terminated|0|||
146896098|NCT03094195|529784363|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
146896099|NCT03094195|529784364|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
146896100|NCT03094195|529784365|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
146896101|NCT03094195|529784366|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
146896102|NCT03094195|529784367|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
146896103|NCT03094195|529784368|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
146896104|NCT03094195|529784369|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
146896105|NCT03094195|529784370|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
146896106|NCT03094195|529784363|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
146896107|NCT03094195|529784364|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
146896108|NCT03094195|529784365|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
146896109|NCT03094195|529784366|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
146896110|NCT03094195|529784367|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
146896111|NCT03094195|529784368|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
146896112|NCT03094195|529784369|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
146896113|NCT03094195|529784370|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
146896114|NCT03094195|529784363|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
146896115|NCT03094195|529784364|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
146896116|NCT03094195|529784365|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
146896117|NCT03094195|529784366|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
146896118|NCT03094195|529784367|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
146896119|NCT03094195|529784368|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
146896120|NCT03094195|529784369|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
146896121|NCT03094195|529784370|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
146896122|NCT03094195|529784363|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
146896123|NCT03094195|529784364|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
146896124|NCT03094195|529784365|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
146896125|NCT03094195|529784366|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
146896126|NCT03094195|529784367|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
146896127|NCT03094195|529784368|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
146896128|NCT03094195|529784369|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
146896129|NCT03094195|529784370|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
146896130|NCT00927563|529784375|FG000|Overall Study|Lost to Follow-up|1|||
146896131|NCT00927563|529784375|FG000|Overall Study|Withdrawal by Subject|1|||
146896132|NCT00787787|529784379|FG000|Overall Study|Lack of Efficacy|4|||
146896133|NCT00787787|529784379|FG000|Overall Study|Adverse Event|3|||
146896134|NCT01468987|529784380|FG000|Overall Study|Adverse Event|12|||
146896135|NCT01468987|529784381|FG001|Overall Study|Adverse Event|9|||
146896136|NCT01468987|529784380|FG000|Overall Study|Death|4|||
146896137|NCT01468987|529784381|FG001|Overall Study|Death|1|||
146896138|NCT01468987|529784380|FG000|Overall Study|Lost to Follow-up|10|||
146896139|NCT01468987|529784381|FG001|Overall Study|Lost to Follow-up|5|||
146896140|NCT01468987|529784380|FG000|Overall Study|Protocol Violation|8|||
146896141|NCT01468987|529784381|FG001|Overall Study|Protocol Violation|2|||
146896142|NCT01468987|529784380|FG000|Overall Study|Withdrawal by Subject|28|||
146896143|NCT01468987|529784381|FG001|Overall Study|Withdrawal by Subject|28|||
146896144|NCT01468987|529784380|FG000|Overall Study|Physician Decision|8|||
146896145|NCT01468987|529784381|FG001|Overall Study|Physician Decision|15|||
146896146|NCT01468987|529784380|FG000|Overall Study|Sponsor Decision|1|||
146896147|NCT01468987|529784381|FG001|Overall Study|Sponsor Decision|0|||
146896148|NCT03430986|529784383|FG000|24-week Control Period|Adverse Event|1|||
146896149|NCT03430986|529784384|FG001|24-week Control Period|Adverse Event|0|||
146896150|NCT03430986|529784383|FG000|24-week Control Period|Lost to Follow-up|2|||
146896151|NCT03430986|529784384|FG001|24-week Control Period|Lost to Follow-up|2|||
146896152|NCT03430986|529784383|FG000|24-week Control Period|Withdrawal by Participant|5|||
146896153|NCT03430986|529784384|FG001|24-week Control Period|Withdrawal by Participant|0|||
146896154|NCT03430986|529784383|FG000|24-week Control Period|Protocol Deviation|0|||
146896155|NCT03430986|529784384|FG001|24-week Control Period|Protocol Deviation|2|||
146896156|NCT03430986|529784383|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
146559244|NCT01217892|528557359|FG003|Overall Study|Adverse Event|0|||
146559245|NCT01217892|528557356|FG000|Overall Study|Withdrawal by Subject|0|||
146559246|NCT01217892|528557357|FG001|Overall Study|Withdrawal by Subject|2|||
146559247|NCT01217892|528557358|FG002|Overall Study|Withdrawal by Subject|1|||
146559248|NCT01217892|528557359|FG003|Overall Study|Withdrawal by Subject|0|||
146559249|NCT01217892|528557356|FG000|Overall Study|Lab value|1|||
146559250|NCT01217892|528557357|FG001|Overall Study|Lab value|0|||
146896157|NCT03430986|529784384|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
146896158|NCT03430986|529784383|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
146896159|NCT03430986|529784384|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
146896160|NCT00961961|529784388|FG000|Phase I|Withdrawal by Subject|7|||
146896161|NCT00961961|529784389|FG001|Phase I|Withdrawal by Subject|0|||
146896162|NCT00961961|529784390|FG002|Phase I|Withdrawal by Subject|0|||
146896163|NCT00961961|529784391|FG003|Phase I|Withdrawal by Subject|0|||
146896164|NCT00961961|529784388|FG000|Phase I|Lost to Follow-up|10|||
146896165|NCT00961961|529784389|FG001|Phase I|Lost to Follow-up|0|||
146896166|NCT00961961|529784390|FG002|Phase I|Lost to Follow-up|0|||
146896167|NCT00961961|529784391|FG003|Phase I|Lost to Follow-up|0|||
146896168|NCT00961961|529784388|FG000|Phase I|Lack of Efficacy|94|||
146896169|NCT00961961|529784389|FG001|Phase I|Lack of Efficacy|0|||
146896170|NCT00961961|529784390|FG002|Phase I|Lack of Efficacy|0|||
146896171|NCT00961961|529784391|FG003|Phase I|Lack of Efficacy|0|||
146896172|NCT00961961|529784388|FG000|Phase I|Adverse Event|7|||
146896173|NCT00961961|529784389|FG001|Phase I|Adverse Event|0|||
146559251|NCT01217892|528557358|FG002|Overall Study|Lab value|1|||
146559252|NCT01217892|528557359|FG003|Overall Study|Lab value|0|||
146559253|NCT01217892|528557356|FG000|Overall Study|Subject no longer meets study criteria|5|||
146559254|NCT01217892|528557357|FG001|Overall Study|Subject no longer meets study criteria|2|||
146559255|NCT01217892|528557358|FG002|Overall Study|Subject no longer meets study criteria|4|||
146559256|NCT01217892|528557359|FG003|Overall Study|Subject no longer meets study criteria|8|||
146559257|NCT01217892|528557356|FG000|Overall Study|Incorrect enrollment|0|||
146896174|NCT00961961|529784390|FG002|Phase I|Adverse Event|0|||
146896175|NCT00961961|529784391|FG003|Phase I|Adverse Event|0|||
146896176|NCT00961961|529784388|FG000|Phase I|Physician Decision|8|||
146896177|NCT00961961|529784389|FG001|Phase I|Physician Decision|0|||
146896178|NCT00961961|529784390|FG002|Phase I|Physician Decision|0|||
146896179|NCT00961961|529784391|FG003|Phase I|Physician Decision|0|||
146896180|NCT00961961|529784388|FG000|Phase II|Lost to Follow-up|0|||
146896181|NCT00961961|529784389|FG001|Phase II|Lost to Follow-up|0|||
146896182|NCT00961961|529784390|FG002|Phase II|Lost to Follow-up|10|||
146896183|NCT00961961|529784391|FG003|Phase II|Lost to Follow-up|7|||
146896184|NCT00961961|529784388|FG000|Phase II|Adverse Event|0|||
146896185|NCT00961961|529784389|FG001|Phase II|Adverse Event|0|||
146896186|NCT00961961|529784390|FG002|Phase II|Adverse Event|0|||
146896187|NCT00961961|529784391|FG003|Phase II|Adverse Event|1|||
146896188|NCT00961961|529784388|FG000|Phase II|Physician Decision|0|||
146896189|NCT00961961|529784389|FG001|Phase II|Physician Decision|0|||
146896190|NCT00961961|529784390|FG002|Phase II|Physician Decision|1|||
146896191|NCT00961961|529784391|FG003|Phase II|Physician Decision|0|||
146896192|NCT00961961|529784388|FG000|Phase II|Withdrawal by Subject|0|||
146896193|NCT00961961|529784389|FG001|Phase II|Withdrawal by Subject|0|||
146896194|NCT00961961|529784390|FG002|Phase II|Withdrawal by Subject|1|||
146896195|NCT00961961|529784391|FG003|Phase II|Withdrawal by Subject|0|||
146896196|NCT01412957|529784392|FG000|Overall Study|Withdrawal by Subject|6|||
146896197|NCT01412957|529784393|FG001|Overall Study|Withdrawal by Subject|22|||
146896198|NCT01412957|529784392|FG000|Overall Study|Lost to Follow-up|7|||
146896199|NCT01412957|529784393|FG001|Overall Study|Lost to Follow-up|2|||
146896200|NCT01412957|529784392|FG000|Overall Study|Death|136|||
146896201|NCT01412957|529784393|FG001|Overall Study|Death|133|||
146896202|NCT04722991|529784394|FG000|Overall Study|Adverse Event|12|||
146896203|NCT04722991|529784395|FG001|Overall Study|Adverse Event|4|||
146896204|NCT04722991|529784394|FG000|Overall Study|Death|2|||
146896205|NCT04722991|529784395|FG001|Overall Study|Death|0|||
146896206|NCT04722991|529784394|FG000|Overall Study|Lost to Follow-up|1|||
146896207|NCT04722991|529784395|FG001|Overall Study|Lost to Follow-up|1|||
146896208|NCT04722991|529784394|FG000|Overall Study|Withdrawal cirterion met|2|||
146896209|NCT04722991|529784395|FG001|Overall Study|Withdrawal cirterion met|2|||
146896210|NCT04722991|529784394|FG000|Overall Study|Other|1|||
146896211|NCT04722991|529784395|FG001|Overall Study|Other|0|||
146896212|NCT04722991|529784394|FG000|Overall Study|Non-compliance|0|||
146896213|NCT04722991|529784395|FG001|Overall Study|Non-compliance|1|||
146896214|NCT04722991|529784394|FG000|Overall Study|Withdrawal by Subject|0|||
146896215|NCT04722991|529784395|FG001|Overall Study|Withdrawal by Subject|1|||
146896216|NCT03186989|529784396|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
146896217|NCT03186989|529784397|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
146559258|NCT01217892|528557357|FG001|Overall Study|Incorrect enrollment|1|||
146896218|NCT03186989|529784398|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
146896219|NCT03186989|529784399|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
146896220|NCT03186989|529784400|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
146896221|NCT03186989|529784401|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
146559259|NCT01217892|528557358|FG002|Overall Study|Incorrect enrollment|1|||
146896222|NCT03186989|529784402|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
146896223|NCT03186989|529784403|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
146896224|NCT03186989|529784404|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
146896225|NCT03186989|529784405|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
146896226|NCT03186989|529784406|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
146896227|NCT03186989|529784396|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146896228|NCT03186989|529784397|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146896229|NCT03186989|529784398|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146896230|NCT03186989|529784399|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146896231|NCT03186989|529784400|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146896232|NCT03186989|529784401|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
146896233|NCT03186989|529784402|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146896234|NCT03186989|529784403|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146896235|NCT03186989|529784404|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146896236|NCT03186989|529784405|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146896237|NCT03186989|529784406|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146896238|NCT03186989|529784396|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146896239|NCT03186989|529784397|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146896240|NCT03186989|529784398|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146896241|NCT03186989|529784399|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146896242|NCT03186989|529784400|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146896243|NCT03186989|529784401|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146896244|NCT03186989|529784402|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
146896245|NCT03186989|529784403|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146896246|NCT03186989|529784404|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146896247|NCT03186989|529784405|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146896248|NCT03186989|529784406|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146896249|NCT03186989|529784396|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
146896250|NCT03186989|529784397|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
146896251|NCT03186989|529784398|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
146896252|NCT03186989|529784399|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
146896253|NCT03186989|529784400|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
146896254|NCT03186989|529784401|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
146896255|NCT03186989|529784402|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
146896256|NCT03186989|529784403|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
146896257|NCT03186989|529784404|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
146896258|NCT03186989|529784405|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
146896259|NCT03186989|529784406|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
146896260|NCT02292771|529784407|FG000|Overall Study|Withdrawal by Subject|2|||
146896261|NCT02292771|529784408|FG001|Overall Study|Withdrawal by Subject|1|||
146896262|NCT02292771|529784407|FG000|Overall Study|Lost to Follow-up|2|||
146896263|NCT02292771|529784408|FG001|Overall Study|Lost to Follow-up|1|||
146896264|NCT01468311|529784409|FG000|Overall Study|mobilization failure|1|||
146896265|NCT01468311|529784409|FG000|Overall Study|Withdrawal by Subject|1|||
146896266|NCT04840667|529786214|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
146896267|NCT03658889|529786216|FG000|Overall Study|Protocol Violation|2|||
146896268|NCT03658889|529786217|FG001|Overall Study|Protocol Violation|0|||
146896269|NCT02347631|529786218|FG000|First Intervention (2 Months)|Adverse Event|1|||
146896270|NCT02347631|529786219|FG001|First Intervention (2 Months)|Adverse Event|1|||
146896271|NCT02347631|529786218|FG000|First Intervention (2 Months)|Pregnancy|1|||
146896272|NCT02347631|529786219|FG001|First Intervention (2 Months)|Pregnancy|0|||
146896273|NCT02347631|529786218|FG000|First Intervention (2 Months)|Moved out of area|0|||
146896274|NCT02347631|529786219|FG001|First Intervention (2 Months)|Moved out of area|2|||
146896275|NCT02347631|529786218|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
146896276|NCT02347631|529786219|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
146896277|NCT02347631|529786218|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
146896278|NCT02347631|529786219|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
146896279|NCT02347631|529786218|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
146896280|NCT02347631|529786219|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
146896281|NCT02347631|529786218|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
146896282|NCT02347631|529786219|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
146896283|NCT02347631|529786218|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
146896284|NCT02347631|529786219|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
146896285|NCT00934102|529786221|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
146896286|NCT00934102|529786222|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
146896287|NCT00934102|529786223|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
146896288|NCT02318784|529786224|FG000|Overall Study|Adverse Event|13|||
146896289|NCT02318784|529786224|FG000|Overall Study|Death|2|||
146896290|NCT02318784|529786224|FG000|Overall Study|Progressive Disease|37|||
146896291|NCT02318784|529786224|FG000|Overall Study|Withdrawal by Subject|10|||
146896292|NCT02304926|529786225|FG000|Overall Study|Lost to Follow-up|2|||
146896293|NCT02304926|529786226|FG001|Overall Study|Lost to Follow-up|1|||
146559260|NCT01217892|528557359|FG003|Overall Study|Incorrect enrollment|0|||
146559261|NCT01217892|528557356|FG000|Overall Study|Poor/Non-Compliance|0|||
146896294|NCT02388295|529786227|FG000|Dose Escalation Week 1|Adverse Event|1|||
146896295|NCT02388295|529786228|FG001|Dose Escalation Week 1|Adverse Event|2|||
146896296|NCT02388295|529786229|FG002|Dose Escalation Week 1|Adverse Event|1|||
146896297|NCT02388295|529786227|FG000|Dose Escalation Week 1|Determined not eligible|1|||
146896298|NCT02388295|529786228|FG001|Dose Escalation Week 1|Determined not eligible|1|||
146896299|NCT02388295|529786229|FG002|Dose Escalation Week 1|Determined not eligible|1|||
146896300|NCT02388295|529786227|FG000|Dose Escalation Week 2|Protocol Violation|0|||
146896301|NCT02388295|529786228|FG001|Dose Escalation Week 2|Protocol Violation|1|||
146896302|NCT02388295|529786229|FG002|Dose Escalation Week 2|Protocol Violation|0|||
146896303|NCT02388295|529786227|FG000|Dose Escalation Week 2|Determined not eligible|1|||
146896304|NCT02388295|529786228|FG001|Dose Escalation Week 2|Determined not eligible|1|||
146896305|NCT02388295|529786229|FG002|Dose Escalation Week 2|Determined not eligible|1|||
146896306|NCT02388295|529786227|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
146896307|NCT02388295|529786228|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
146896308|NCT02388295|529786229|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
146896309|NCT04007159|529786230|FG000|Induction Phase|(missed study visits)|16|||
146896310|NCT04007159|529786230|FG000|Induction Phase|Withdrawal by Subject|4|||
146896311|NCT04007159|529786230|FG000|Induction Phase|Adverse Event|2|||
146896312|NCT04007159|529786230|FG000|Challenge Phase|missed study visits|3|||
146896313|NCT04258579|529786231|FG000|Overall Study|Withdrawal by Subject|7|||
146896314|NCT04258579|529786231|FG000|Overall Study|Lost to Follow-up|3|||
146896315|NCT04258579|529786231|FG000|Overall Study|Protocol Violation|2|||
146896316|NCT04258579|529786231|FG000|Overall Study|Adverse Event|1|||
146896317|NCT02076165|529786233|FG000|Overall Study|Lost to Follow-up|7|||
146896318|NCT02076165|529786234|FG001|Overall Study|Lost to Follow-up|5|||
146896319|NCT02076165|529786233|FG000|Overall Study|Refused follow-up assessment|1|||
146896320|NCT02076165|529786234|FG001|Overall Study|Refused follow-up assessment|1|||
146896321|NCT03804684|529786235|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
146896322|NCT03804684|529786236|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
146896323|NCT02429856|529786237|FG000|Overall Study|Death|12|||
146896324|NCT02429856|529786238|FG001|Overall Study|Death|13|||
146896325|NCT02429856|529786237|FG000|Overall Study|Lost to Follow-up|6|||
146896326|NCT02429856|529786238|FG001|Overall Study|Lost to Follow-up|5|||
146896327|NCT02429856|529786237|FG000|Overall Study|Withdrawal by Subject|1|||
146896328|NCT02429856|529786238|FG001|Overall Study|Withdrawal by Subject|1|||
146896329|NCT00486603|529786240|FG000|Overall Study|Withdrawal by Subject|1|||
146896330|NCT00486603|529786241|FG001|Overall Study|Withdrawal by Subject|0|||
146896331|NCT00486603|529786242|FG002|Overall Study|Withdrawal by Subject|0|||
146896332|NCT00486603|529786243|FG003|Overall Study|Withdrawal by Subject|0|||
146896333|NCT00486603|529786244|FG004|Overall Study|Withdrawal by Subject|0|||
146896334|NCT00486603|529786240|FG000|Overall Study|Physician Decision|0|||
146896335|NCT00486603|529786241|FG001|Overall Study|Physician Decision|1|||
146896336|NCT00486603|529786242|FG002|Overall Study|Physician Decision|0|||
146896337|NCT00486603|529786243|FG003|Overall Study|Physician Decision|0|||
146896338|NCT00486603|529786244|FG004|Overall Study|Physician Decision|0|||
146896339|NCT00763009|529786245|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
146896340|NCT01355289|529786246|FG000|Core Study|Adverse Event, Non-Fatal|1|||
146896341|NCT01355289|529786247|FG001|Core Study|Adverse Event, Non-Fatal|0|||
146896342|NCT01355289|529786248|FG002|Core Study|Adverse Event, Non-Fatal|0|||
146896343|NCT01355289|529786249|FG003|Core Study|Adverse Event, Non-Fatal|0|||
146896344|NCT01355289|529786250|FG004|Core Study|Adverse Event, Non-Fatal|0|||
146896345|NCT01355289|529786246|FG000|Core Study|Inadequate Therapeutic Effect|0|||
146896346|NCT01355289|529786247|FG001|Core Study|Inadequate Therapeutic Effect|0|||
146896347|NCT01355289|529786248|FG002|Core Study|Inadequate Therapeutic Effect|0|||
146896348|NCT01355289|529786249|FG003|Core Study|Inadequate Therapeutic Effect|1|||
146896349|NCT01355289|529786250|FG004|Core Study|Inadequate Therapeutic Effect|0|||
146896350|NCT01355289|529786246|FG000|Core Study|Other|0|||
146896351|NCT01355289|529786247|FG001|Core Study|Other|0|||
146896352|NCT01355289|529786248|FG002|Core Study|Other|0|||
146896353|NCT01355289|529786249|FG003|Core Study|Other|1|||
146896354|NCT01355289|529786250|FG004|Core Study|Other|0|||
146896355|NCT01355289|529786246|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
146896356|NCT01355289|529786247|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
146896357|NCT01355289|529786248|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
146896358|NCT01355289|529786249|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
146896359|NCT01355289|529786250|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
146896360|NCT01355289|529786246|FG000|Open Label Extension|Lost to Follow-up|0|||
146896361|NCT01355289|529786247|FG001|Open Label Extension|Lost to Follow-up|0|||
146896362|NCT01355289|529786248|FG002|Open Label Extension|Lost to Follow-up|0|||
146896363|NCT01355289|529786249|FG003|Open Label Extension|Lost to Follow-up|0|||
146896364|NCT01355289|529786250|FG004|Open Label Extension|Lost to Follow-up|1|||
146896365|NCT01355289|529786246|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
146896366|NCT01355289|529786247|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
146896367|NCT01355289|529786248|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
146896368|NCT01355289|529786249|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
146896369|NCT01355289|529786250|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
146896370|NCT01355289|529786246|FG000|Open Label Extension|Other|0|||
146896371|NCT01355289|529786247|FG001|Open Label Extension|Other|0|||
146896372|NCT01355289|529786248|FG002|Open Label Extension|Other|0|||
146896373|NCT01355289|529786249|FG003|Open Label Extension|Other|0|||
146896374|NCT01355289|529786250|FG004|Open Label Extension|Other|3|||
146896375|NCT02706938|529786258|FG000|First Period, 6 Weeks|Adverse Event|8|||
146896376|NCT02706938|529786259|FG001|First Period, 6 Weeks|Adverse Event|0|||
146896377|NCT02706938|529786258|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
146896378|NCT02706938|529786259|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
146896379|NCT02706938|529786258|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
146896380|NCT02706938|529786259|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
146896381|NCT02706938|529786258|FG000|Second Period, 6 Weeks|Adverse Event|0|||
146896382|NCT02706938|529786259|FG001|Second Period, 6 Weeks|Adverse Event|7|||
146766705|NCT01119950|529314584|FG000|Overall Study|Death|1|||
146896383|NCT02706938|529786258|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
146896384|NCT02706938|529786259|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
146896385|NCT03838484|529786265|FG000|Overall Study|Lost to Follow-up|0|||
146896386|NCT03838484|529786266|FG001|Overall Study|Lost to Follow-up|1|||
146896387|NCT03838484|529786267|FG002|Overall Study|Lost to Follow-up|0|||
146766706|NCT00139737|529314585|FG000|Overall Study|Withdrawal by Subject|190|||
146766707|NCT00139737|529314585|FG000|Overall Study|Adverse Event|58|||
146766708|NCT00139737|529314585|FG000|Overall Study|Lack of Efficacy|40|||
146766709|NCT00139737|529314585|FG000|Overall Study|Lost to Follow-up|8|||
146766710|NCT00139737|529314585|FG000|Overall Study|Death|3|||
146766711|NCT00139737|529314585|FG000|Overall Study|Laboratory Abnormality|2|||
146766712|NCT00139737|529314585|FG000|Overall Study|Protocol Violation|18|||
146766713|NCT00139737|529314585|FG000|Overall Study|Withdrew During Screening Phase|8|||
146766714|NCT00139737|529314585|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
146766715|NCT00139737|529314585|FG000|Overall Study|Screened, Not Treated|13|||
146766716|NCT00758602|529314591|FG000|Overall Study|Adverse Event|11|||
146766717|NCT00758602|529314592|FG001|Overall Study|Adverse Event|10|||
146766718|NCT00758602|529314591|FG000|Overall Study|Lost to Follow-up|4|||
146766719|NCT00758602|529314592|FG001|Overall Study|Lost to Follow-up|3|||
146766720|NCT00758602|529314591|FG000|Overall Study|Withdrawal by Subject|1|||
146766721|NCT00758602|529314592|FG001|Overall Study|Withdrawal by Subject|3|||
146766722|NCT00758602|529314591|FG000|Overall Study|Protocol Violation|0|||
146766723|NCT00758602|529314592|FG001|Overall Study|Protocol Violation|2|||
146766724|NCT00758602|529314591|FG000|Overall Study|Death|0|||
146766725|NCT00758602|529314592|FG001|Overall Study|Death|1|||
146766726|NCT00758602|529314591|FG000|Overall Study|Reason not specified|3|||
146766727|NCT00758602|529314592|FG001|Overall Study|Reason not specified|3|||
146766728|NCT05046132|529314593|FG000|Overall Study|Adverse Event|4|||
146766729|NCT05046132|529314594|FG001|Overall Study|Adverse Event|0|||
146766730|NCT05046132|529314595|FG002|Overall Study|Adverse Event|0|||
146766731|NCT05046132|529314593|FG000|Overall Study|Withdrawal by Subject|3|||
146766732|NCT05046132|529314594|FG001|Overall Study|Withdrawal by Subject|0|||
146766733|NCT05046132|529314595|FG002|Overall Study|Withdrawal by Subject|0|||
146766734|NCT05046132|529314593|FG000|Overall Study|Positive Covid19 Result.|0|||
146896388|NCT03838484|529786268|FG003|Overall Study|Lost to Follow-up|0|||
146896389|NCT00813995|529786269|FG000|Overall Study|Clinical adverse event|9|||
146896390|NCT00813995|529786270|FG001|Overall Study|Clinical adverse event|3|||
146896391|NCT00813995|529786269|FG000|Overall Study|Laboratory adverse event|0|||
146896392|NCT00813995|529786270|FG001|Overall Study|Laboratory adverse event|2|||
146896393|NCT00813995|529786269|FG000|Overall Study|Lack of Efficacy|1|||
146896394|NCT00813995|529786270|FG001|Overall Study|Lack of Efficacy|0|||
146896395|NCT00813995|529786269|FG000|Overall Study|Lost to Follow-up|4|||
146896396|NCT00813995|529786270|FG001|Overall Study|Lost to Follow-up|2|||
146896397|NCT00813995|529786269|FG000|Overall Study|Other reason|2|||
146896398|NCT00813995|529786270|FG001|Overall Study|Other reason|2|||
146896399|NCT00813995|529786269|FG000|Overall Study|Protocol Violation|3|||
146896400|NCT00813995|529786270|FG001|Overall Study|Protocol Violation|2|||
146896401|NCT00813995|529786269|FG000|Overall Study|Subject moved|4|||
146896402|NCT00813995|529786270|FG001|Overall Study|Subject moved|0|||
146766735|NCT05046132|529314594|FG001|Overall Study|Positive Covid19 Result.|1|||
146766736|NCT05046132|529314595|FG002|Overall Study|Positive Covid19 Result.|0|||
146766737|NCT02148133|529314597|FG000|Overall Study|Investigator discretion|1|||
146766738|NCT02148133|529314597|FG000|Overall Study|Lack of Efficacy|1|||
146766739|NCT02148133|529314597|FG000|Overall Study|Protocol deviation|1|||
146896403|NCT00813995|529786269|FG000|Overall Study|Withdrawal by Subject|0|||
146896404|NCT00813995|529786270|FG001|Overall Study|Withdrawal by Subject|5|||
146896405|NCT02507349|529786271|FG000|Overall Study|Death|12|||
146766740|NCT02148133|529314597|FG000|Overall Study|Protocol-defined stopping criteria|2|||
146766741|NCT00855465|529314598|FG000|Treatment Period|Adverse Event|4|||
146766742|NCT00855465|529314599|FG001|Treatment Period|Adverse Event|2|||
146896406|NCT02507349|529786272|FG001|Overall Study|Death|16|||
146766743|NCT00855465|529314598|FG000|Treatment Period|Death|2|||
146766744|NCT00855465|529314599|FG001|Treatment Period|Death|2|||
146766745|NCT00855465|529314598|FG000|Treatment Period|Lack of Efficacy|2|||
146896407|NCT02507349|529786271|FG000|Overall Study|Withdrawal by Subject|1|||
146896408|NCT02507349|529786272|FG001|Overall Study|Withdrawal by Subject|1|||
146896409|NCT02507349|529786271|FG000|Overall Study|Lost to Follow-up|174|||
146896410|NCT02507349|529786272|FG001|Overall Study|Lost to Follow-up|144|||
146896411|NCT01614964|529786275|FG000|Overall Study|Withdrawal by Subject|2|||
146896412|NCT01614964|529786276|FG001|Overall Study|Withdrawal by Subject|0|||
146896413|NCT01614964|529786275|FG000|Overall Study|Lost to Follow-up|3|||
146896414|NCT01614964|529786276|FG001|Overall Study|Lost to Follow-up|0|||
146896415|NCT00860470|529786285|FG000|Overall Study|Death|6|||
146896416|NCT00860470|529786286|FG001|Overall Study|Death|10|||
146896417|NCT00860470|529786285|FG000|Overall Study|Moved away|8|||
146896418|NCT00860470|529786286|FG001|Overall Study|Moved away|10|||
146896419|NCT00860470|529786285|FG000|Overall Study|Lost to Follow-up|34|||
146896420|NCT00860470|529786286|FG001|Overall Study|Lost to Follow-up|39|||
146896421|NCT00888238|529786288|FG000|Washout Period After Period 2|Adverse Event|0|||
146896422|NCT00888238|529786289|FG001|Washout Period After Period 2|Adverse Event|0|||
146896423|NCT00888238|529786290|FG002|Washout Period After Period 2|Adverse Event|1|||
146896424|NCT02700984|529786291|FG000|Overall Study|Death|2|||
146896425|NCT02700984|529786292|FG001|Overall Study|Death|1|||
146896426|NCT02700984|529786291|FG000|Overall Study|Lost to Follow-up|2|||
146896427|NCT02700984|529786292|FG001|Overall Study|Lost to Follow-up|1|||
146896428|NCT02700984|529786291|FG000|Overall Study|Physician Decision|0|||
146896429|NCT02700984|529786292|FG001|Overall Study|Physician Decision|1|||
146896430|NCT02700984|529786291|FG000|Overall Study|Withdrawal by Subject|8|||
146896431|NCT02700984|529786292|FG001|Overall Study|Withdrawal by Subject|9|||
146896432|NCT02700984|529786291|FG000|Overall Study|Reason not specified|3|||
146896433|NCT02700984|529786292|FG001|Overall Study|Reason not specified|2|||
146896434|NCT01032629|529786294|FG000|Overall Study|Closed Site|21|||
146896435|NCT01032629|529786295|FG001|Overall Study|Closed Site|18|||
146896436|NCT01032629|529786296|FG002|Overall Study|Closed Site|16|||
146896437|NCT01032629|529786294|FG000|Overall Study|Withdrawal by Subject|50|||
146896438|NCT01032629|529786295|FG001|Overall Study|Withdrawal by Subject|36|||
146896439|NCT01032629|529786296|FG002|Overall Study|Withdrawal by Subject|35|||
146896440|NCT01032629|529786294|FG000|Overall Study|Lost to Follow-up|74|||
146896441|NCT01032629|529786295|FG001|Overall Study|Lost to Follow-up|47|||
146896442|NCT01032629|529786296|FG002|Overall Study|Lost to Follow-up|37|||
146896443|NCT00348140|529786297|FG000|Overall Study|Adverse Event|46|||
146896444|NCT00348140|529786298|FG001|Overall Study|Adverse Event|49|||
146896445|NCT00348140|529786299|FG002|Overall Study|Adverse Event|78|||
146896446|NCT00348140|529786297|FG000|Overall Study|Lost to Follow-up|4|||
146896447|NCT00348140|529786298|FG001|Overall Study|Lost to Follow-up|4|||
146896448|NCT00348140|529786299|FG002|Overall Study|Lost to Follow-up|4|||
146896449|NCT00348140|529786297|FG000|Overall Study|Protocol Violation|12|||
146896450|NCT00348140|529786298|FG001|Overall Study|Protocol Violation|13|||
146896451|NCT00348140|529786299|FG002|Overall Study|Protocol Violation|14|||
146896452|NCT00348140|529786297|FG000|Overall Study|Withdrawal by Subject|32|||
146896453|NCT00348140|529786298|FG001|Overall Study|Withdrawal by Subject|40|||
146896454|NCT00348140|529786299|FG002|Overall Study|Withdrawal by Subject|40|||
146896455|NCT00348140|529786297|FG000|Overall Study|Non-compliance|8|||
146896456|NCT00348140|529786298|FG001|Overall Study|Non-compliance|13|||
146896457|NCT00348140|529786299|FG002|Overall Study|Non-compliance|5|||
146896458|NCT00348140|529786297|FG000|Overall Study|Participant at risk due to study drug|2|||
146896459|NCT00348140|529786298|FG001|Overall Study|Participant at risk due to study drug|0|||
146896460|NCT00348140|529786299|FG002|Overall Study|Participant at risk due to study drug|0|||
146896461|NCT00348140|529786297|FG000|Overall Study|Conditional medication increased dose|1|||
146896462|NCT00348140|529786298|FG001|Overall Study|Conditional medication increased dose|0|||
146896463|NCT00348140|529786299|FG002|Overall Study|Conditional medication increased dose|0|||
146896464|NCT00348140|529786297|FG000|Overall Study|Caregiver related|4|||
146896465|NCT00348140|529786298|FG001|Overall Study|Caregiver related|7|||
146896466|NCT00348140|529786299|FG002|Overall Study|Caregiver related|3|||
146896467|NCT00348140|529786297|FG000|Overall Study|Participant hospitalised|3|||
146896468|NCT00348140|529786298|FG001|Overall Study|Participant hospitalised|0|||
146896469|NCT00348140|529786299|FG002|Overall Study|Participant hospitalised|0|||
146896470|NCT00348140|529786297|FG000|Overall Study|Efficacy related|1|||
146896471|NCT00348140|529786298|FG001|Overall Study|Efficacy related|1|||
146896472|NCT00348140|529786299|FG002|Overall Study|Efficacy related|0|||
146896473|NCT00348140|529786297|FG000|Overall Study|Administration related|3|||
146896474|NCT00348140|529786298|FG001|Overall Study|Administration related|1|||
146896475|NCT00348140|529786299|FG002|Overall Study|Administration related|1|||
146896476|NCT00348140|529786297|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
146896477|NCT00348140|529786298|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
146896478|NCT00348140|529786299|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
146896479|NCT00348140|529786297|FG000|Overall Study|Participant unwell|1|||
146896480|NCT00348140|529786298|FG001|Overall Study|Participant unwell|0|||
146896481|NCT00348140|529786299|FG002|Overall Study|Participant unwell|0|||
146896482|NCT00348140|529786297|FG000|Overall Study|Screen failure|1|||
146896483|NCT00348140|529786298|FG001|Overall Study|Screen failure|0|||
146896484|NCT00348140|529786299|FG002|Overall Study|Screen failure|0|||
146896485|NCT00348140|529786297|FG000|Overall Study|Investigator decided to discontinue|4|||
146896486|NCT00348140|529786298|FG001|Overall Study|Investigator decided to discontinue|1|||
146896487|NCT00348140|529786299|FG002|Overall Study|Investigator decided to discontinue|4|||
146896488|NCT00348140|529786297|FG000|Overall Study|Decided to discontinue on their own|1|||
146896489|NCT00348140|529786298|FG001|Overall Study|Decided to discontinue on their own|4|||
146896490|NCT00348140|529786299|FG002|Overall Study|Decided to discontinue on their own|1|||
146896491|NCT00348140|529786297|FG000|Overall Study|Use of prohibited drug|1|||
146896492|NCT00348140|529786298|FG001|Overall Study|Use of prohibited drug|0|||
146896493|NCT00348140|529786299|FG002|Overall Study|Use of prohibited drug|2|||
146896494|NCT00348140|529786297|FG000|Overall Study|Disease progression|1|||
146896495|NCT00348140|529786298|FG001|Overall Study|Disease progression|2|||
146896496|NCT00348140|529786299|FG002|Overall Study|Disease progression|5|||
146896497|NCT00348140|529786297|FG000|Overall Study|Increased risk of cardiac infarction|0|||
146896498|NCT00348140|529786298|FG001|Overall Study|Increased risk of cardiac infarction|1|||
146896499|NCT00348140|529786299|FG002|Overall Study|Increased risk of cardiac infarction|0|||
146896500|NCT00348140|529786297|FG000|Overall Study|Serious adverse event|0|||
146896501|NCT00348140|529786298|FG001|Overall Study|Serious adverse event|1|||
146896502|NCT00348140|529786299|FG002|Overall Study|Serious adverse event|0|||
146896503|NCT00348140|529786297|FG000|Overall Study|Abnormal ECG|0|||
146896504|NCT00348140|529786298|FG001|Overall Study|Abnormal ECG|1|||
146896505|NCT00348140|529786299|FG002|Overall Study|Abnormal ECG|3|||
146896506|NCT00348140|529786297|FG000|Overall Study|Participant died|0|||
146896507|NCT00348140|529786298|FG001|Overall Study|Participant died|1|||
146896508|NCT00348140|529786299|FG002|Overall Study|Participant died|0|||
146896509|NCT00348140|529786297|FG000|Overall Study|Exclusion criteria met|0|||
146896510|NCT00348140|529786298|FG001|Overall Study|Exclusion criteria met|0|||
146896511|NCT00348140|529786299|FG002|Overall Study|Exclusion criteria met|1|||
146896512|NCT00348140|529786297|FG000|Overall Study|Memory declined|0|||
146896513|NCT00348140|529786298|FG001|Overall Study|Memory declined|0|||
146896514|NCT00348140|529786299|FG002|Overall Study|Memory declined|1|||
146896515|NCT02868892|529786302|FG000|Overall Study|Investigator left site and no follow-up|6|||
146896516|NCT00619957|529786303|FG000|Month 24 Double-Blind|Adverse Event|9|||
146896517|NCT00619957|529786304|FG001|Month 24 Double-Blind|Adverse Event|7|||
146896518|NCT00619957|529786303|FG000|Month 24 Double-Blind|Protocol Violation|1|||
146896519|NCT00619957|529786304|FG001|Month 24 Double-Blind|Protocol Violation|0|||
146896520|NCT00619957|529786303|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
146896521|NCT00619957|529786304|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
146896522|NCT00619957|529786303|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
146896523|NCT00619957|529786304|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
146896524|NCT00619957|529786303|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
146896525|NCT00619957|529786304|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
146896526|NCT00619957|529786303|FG000|Month 48 Open-Label|Adverse Event|4|||
146896527|NCT00619957|529786304|FG001|Month 48 Open-Label|Adverse Event|4|||
146896528|NCT00619957|529786303|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
146896529|NCT00619957|529786304|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
146896530|NCT00619957|529786303|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
146896531|NCT00619957|529786304|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
146896532|NCT00723957|529786305|FG000|Overall Study|Adverse event unrelated to study drug|1|||
146896533|NCT00723957|529786306|FG001|Overall Study|Adverse event unrelated to study drug|4|||
146896534|NCT00723957|529786305|FG000|Overall Study|Death|3|||
146896535|NCT00723957|529786306|FG001|Overall Study|Death|4|||
146896536|NCT00723957|529786305|FG000|Overall Study|Disease progression|27|||
146896537|NCT00723957|529786306|FG001|Overall Study|Disease progression|25|||
146896538|NCT00723957|529786305|FG000|Overall Study|Maximum clinical benefit|4|||
146896539|NCT00723957|529786306|FG001|Overall Study|Maximum clinical benefit|5|||
146896540|NCT00723957|529786305|FG000|Overall Study|Investigator decision|1|||
146896541|NCT00723957|529786306|FG001|Overall Study|Investigator decision|1|||
146896542|NCT00723957|529786305|FG000|Overall Study|Study drug toxicity|4|||
146896543|NCT00723957|529786306|FG001|Overall Study|Study drug toxicity|6|||
146896544|NCT00723957|529786305|FG000|Overall Study|Withdrawal by Subject|7|||
146896545|NCT00723957|529786306|FG001|Overall Study|Withdrawal by Subject|5|||
146896546|NCT00723957|529786305|FG000|Overall Study|Reason not analyzed|1|||
146896547|NCT00723957|529786306|FG001|Overall Study|Reason not analyzed|0|||
146896548|NCT00723957|529786305|FG000|Overall Study|Never received treatment|3|||
146896549|NCT00723957|529786306|FG001|Overall Study|Never received treatment|3|||
146896550|NCT00868790|529786308|FG000|Period 1|Adverse Event|1|||
146896551|NCT00868790|529786309|FG001|Period 1|Adverse Event|0|||
146896552|NCT00868790|529786310|FG002|Period 1|Adverse Event|0|||
146896553|NCT00868790|529786311|FG003|Period 1|Adverse Event|0|||
146896554|NCT00868790|529786312|FG004|Period 1|Adverse Event|0|||
146896555|NCT00868790|529786313|FG005|Period 1|Adverse Event|0|||
146896556|NCT00868790|529786314|FG006|Period 1|Adverse Event|0|||
146896557|NCT00868790|529786315|FG007|Period 1|Adverse Event|3|||
146896558|NCT00868790|529786316|FG008|Period 1|Adverse Event|1|||
146896559|NCT00868790|529786317|FG009|Period 1|Adverse Event|0|||
146896560|NCT00868790|529786318|FG010|Period 1|Adverse Event|0|||
146896561|NCT00868790|529786319|FG011|Period 1|Adverse Event|0|||
146896562|NCT00868790|529786320|FG012|Period 1|Adverse Event|0|||
146896563|NCT00868790|529786321|FG013|Period 1|Adverse Event|1|||
146896564|NCT00868790|529786308|FG000|Period 1|Protocol Violation|1|||
146896565|NCT00868790|529786309|FG001|Period 1|Protocol Violation|0|||
146640001|NCT02100696|528857832|FG001|Induction Phase|Withdrawal by Subject|2|||
146896566|NCT00868790|529786310|FG002|Period 1|Protocol Violation|0|||
146896567|NCT00868790|529786311|FG003|Period 1|Protocol Violation|0|||
146896568|NCT00868790|529786312|FG004|Period 1|Protocol Violation|0|||
146896569|NCT00868790|529786313|FG005|Period 1|Protocol Violation|0|||
146896570|NCT00868790|529786314|FG006|Period 1|Protocol Violation|0|||
146896571|NCT00868790|529786315|FG007|Period 1|Protocol Violation|0|||
146896572|NCT00868790|529786316|FG008|Period 1|Protocol Violation|0|||
146896573|NCT00868790|529786317|FG009|Period 1|Protocol Violation|0|||
146896574|NCT00868790|529786318|FG010|Period 1|Protocol Violation|0|||
146896575|NCT00868790|529786319|FG011|Period 1|Protocol Violation|0|||
146896576|NCT00868790|529786320|FG012|Period 1|Protocol Violation|0|||
146896577|NCT00868790|529786321|FG013|Period 1|Protocol Violation|0|||
146896578|NCT00868790|529786308|FG000|Period 1|Withdrawal by Subject|0|||
146896579|NCT00868790|529786309|FG001|Period 1|Withdrawal by Subject|1|||
146896580|NCT00868790|529786310|FG002|Period 1|Withdrawal by Subject|0|||
146896581|NCT00868790|529786311|FG003|Period 1|Withdrawal by Subject|0|||
146896582|NCT00868790|529786312|FG004|Period 1|Withdrawal by Subject|0|||
146896583|NCT00868790|529786313|FG005|Period 1|Withdrawal by Subject|0|||
146896584|NCT00868790|529786314|FG006|Period 1|Withdrawal by Subject|0|||
146896585|NCT00868790|529786315|FG007|Period 1|Withdrawal by Subject|0|||
146896586|NCT00868790|529786316|FG008|Period 1|Withdrawal by Subject|0|||
146896587|NCT00868790|529786317|FG009|Period 1|Withdrawal by Subject|0|||
146896588|NCT00868790|529786318|FG010|Period 1|Withdrawal by Subject|0|||
146896589|NCT00868790|529786319|FG011|Period 1|Withdrawal by Subject|0|||
146896590|NCT00868790|529786320|FG012|Period 1|Withdrawal by Subject|0|||
146896591|NCT00868790|529786321|FG013|Period 1|Withdrawal by Subject|1|||
146896592|NCT00868790|529786308|FG000|Period 1|Abnormal Triglycerides|0|||
146896593|NCT00868790|529786309|FG001|Period 1|Abnormal Triglycerides|0|||
146896594|NCT00868790|529786310|FG002|Period 1|Abnormal Triglycerides|0|||
146896595|NCT00868790|529786311|FG003|Period 1|Abnormal Triglycerides|0|||
146896596|NCT00868790|529786312|FG004|Period 1|Abnormal Triglycerides|1|||
146896597|NCT00868790|529786313|FG005|Period 1|Abnormal Triglycerides|0|||
146896598|NCT00868790|529786314|FG006|Period 1|Abnormal Triglycerides|0|||
146896599|NCT00868790|529786315|FG007|Period 1|Abnormal Triglycerides|0|||
146896600|NCT00868790|529786316|FG008|Period 1|Abnormal Triglycerides|0|||
146896601|NCT00868790|529786317|FG009|Period 1|Abnormal Triglycerides|0|||
146896602|NCT00868790|529786318|FG010|Period 1|Abnormal Triglycerides|0|||
146896603|NCT00868790|529786319|FG011|Period 1|Abnormal Triglycerides|0|||
146896604|NCT00868790|529786320|FG012|Period 1|Abnormal Triglycerides|0|||
146896605|NCT00868790|529786321|FG013|Period 1|Abnormal Triglycerides|0|||
146896606|NCT00868790|529786308|FG000|Period 1|Lost to Follow-up|0|||
146896607|NCT00868790|529786309|FG001|Period 1|Lost to Follow-up|0|||
146896608|NCT00868790|529786310|FG002|Period 1|Lost to Follow-up|0|||
146896609|NCT00868790|529786311|FG003|Period 1|Lost to Follow-up|0|||
146896610|NCT00868790|529786312|FG004|Period 1|Lost to Follow-up|0|||
146896611|NCT00868790|529786313|FG005|Period 1|Lost to Follow-up|1|||
146896612|NCT00868790|529786314|FG006|Period 1|Lost to Follow-up|0|||
146896613|NCT00868790|529786315|FG007|Period 1|Lost to Follow-up|0|||
146896614|NCT00868790|529786316|FG008|Period 1|Lost to Follow-up|0|||
146896615|NCT00868790|529786317|FG009|Period 1|Lost to Follow-up|0|||
146896616|NCT00868790|529786318|FG010|Period 1|Lost to Follow-up|0|||
146896617|NCT00868790|529786319|FG011|Period 1|Lost to Follow-up|0|||
146896618|NCT00868790|529786320|FG012|Period 1|Lost to Follow-up|0|||
146896619|NCT00868790|529786321|FG013|Period 1|Lost to Follow-up|0|||
146896620|NCT00868790|529786308|FG000|Period 2|Adverse Event|0|||
146896621|NCT00868790|529786309|FG001|Period 2|Adverse Event|0|||
146896622|NCT00868790|529786310|FG002|Period 2|Adverse Event|0|||
146896623|NCT00868790|529786311|FG003|Period 2|Adverse Event|0|||
146896624|NCT00868790|529786312|FG004|Period 2|Adverse Event|0|||
146896625|NCT00868790|529786313|FG005|Period 2|Adverse Event|0|||
146896626|NCT00868790|529786314|FG006|Period 2|Adverse Event|0|||
146896627|NCT00868790|529786315|FG007|Period 2|Adverse Event|0|||
146896628|NCT00868790|529786316|FG008|Period 2|Adverse Event|1|||
146896629|NCT00868790|529786317|FG009|Period 2|Adverse Event|0|||
146896630|NCT00868790|529786318|FG010|Period 2|Adverse Event|0|||
146896631|NCT00868790|529786319|FG011|Period 2|Adverse Event|0|||
146896632|NCT00868790|529786320|FG012|Period 2|Adverse Event|0|||
146896633|NCT00868790|529786321|FG013|Period 2|Adverse Event|0|||
146896634|NCT00868790|529786308|FG000|Period 2|Lost to Follow-up|0|||
146896635|NCT00868790|529786309|FG001|Period 2|Lost to Follow-up|1|||
146896636|NCT00868790|529786310|FG002|Period 2|Lost to Follow-up|0|||
146896637|NCT00868790|529786311|FG003|Period 2|Lost to Follow-up|0|||
146896638|NCT00868790|529786312|FG004|Period 2|Lost to Follow-up|0|||
146896639|NCT00868790|529786313|FG005|Period 2|Lost to Follow-up|1|||
146896640|NCT00868790|529786314|FG006|Period 2|Lost to Follow-up|0|||
146896641|NCT00868790|529786315|FG007|Period 2|Lost to Follow-up|0|||
146896642|NCT00868790|529786316|FG008|Period 2|Lost to Follow-up|0|||
146896643|NCT00868790|529786317|FG009|Period 2|Lost to Follow-up|0|||
146896644|NCT00868790|529786318|FG010|Period 2|Lost to Follow-up|0|||
146896645|NCT00868790|529786319|FG011|Period 2|Lost to Follow-up|0|||
146896646|NCT00868790|529786320|FG012|Period 2|Lost to Follow-up|0|||
146896647|NCT00868790|529786321|FG013|Period 2|Lost to Follow-up|0|||
146896648|NCT00868790|529786308|FG000|Period 2|Withdrawal by Subject|0|||
146896649|NCT00868790|529786309|FG001|Period 2|Withdrawal by Subject|0|||
146896650|NCT00868790|529786310|FG002|Period 2|Withdrawal by Subject|0|||
146896651|NCT00868790|529786311|FG003|Period 2|Withdrawal by Subject|0|||
146896652|NCT00868790|529786312|FG004|Period 2|Withdrawal by Subject|0|||
146896653|NCT00868790|529786313|FG005|Period 2|Withdrawal by Subject|0|||
146896654|NCT00868790|529786314|FG006|Period 2|Withdrawal by Subject|0|||
146896655|NCT00868790|529786315|FG007|Period 2|Withdrawal by Subject|0|||
146896656|NCT00868790|529786316|FG008|Period 2|Withdrawal by Subject|1|||
146896657|NCT00868790|529786317|FG009|Period 2|Withdrawal by Subject|0|||
146896658|NCT00868790|529786318|FG010|Period 2|Withdrawal by Subject|0|||
146896659|NCT00868790|529786319|FG011|Period 2|Withdrawal by Subject|0|||
146896660|NCT00868790|529786320|FG012|Period 2|Withdrawal by Subject|0|||
146896661|NCT00868790|529786321|FG013|Period 2|Withdrawal by Subject|1|||
146896662|NCT00868790|529786308|FG000|Period 3|Adverse Event|0|||
146896663|NCT00868790|529786309|FG001|Period 3|Adverse Event|0|||
146896664|NCT00868790|529786310|FG002|Period 3|Adverse Event|0|||
146896665|NCT00868790|529786311|FG003|Period 3|Adverse Event|0|||
146896666|NCT00868790|529786312|FG004|Period 3|Adverse Event|0|||
146896667|NCT00868790|529786313|FG005|Period 3|Adverse Event|0|||
146896668|NCT00868790|529786314|FG006|Period 3|Adverse Event|0|||
146896669|NCT00868790|529786315|FG007|Period 3|Adverse Event|0|||
146896670|NCT00868790|529786316|FG008|Period 3|Adverse Event|0|||
146896671|NCT00868790|529786317|FG009|Period 3|Adverse Event|1|||
146896672|NCT00868790|529786318|FG010|Period 3|Adverse Event|0|||
146896673|NCT00868790|529786319|FG011|Period 3|Adverse Event|0|||
146896674|NCT00868790|529786320|FG012|Period 3|Adverse Event|0|||
146896675|NCT00868790|529786321|FG013|Period 3|Adverse Event|0|||
146896676|NCT00868790|529786308|FG000|Period 3|Protocol Violation|0|||
146896677|NCT00868790|529786309|FG001|Period 3|Protocol Violation|0|||
146896678|NCT00868790|529786310|FG002|Period 3|Protocol Violation|0|||
146896679|NCT00868790|529786311|FG003|Period 3|Protocol Violation|0|||
146896680|NCT00868790|529786312|FG004|Period 3|Protocol Violation|0|||
146896681|NCT00868790|529786313|FG005|Period 3|Protocol Violation|0|||
146896682|NCT00868790|529786314|FG006|Period 3|Protocol Violation|0|||
146896683|NCT00868790|529786315|FG007|Period 3|Protocol Violation|0|||
146896684|NCT00868790|529786316|FG008|Period 3|Protocol Violation|0|||
146896685|NCT00868790|529786317|FG009|Period 3|Protocol Violation|0|||
146896686|NCT00868790|529786318|FG010|Period 3|Protocol Violation|1|||
146896687|NCT00868790|529786319|FG011|Period 3|Protocol Violation|0|||
146896688|NCT00868790|529786320|FG012|Period 3|Protocol Violation|0|||
146896689|NCT00868790|529786321|FG013|Period 3|Protocol Violation|0|||
146896690|NCT00868790|529786308|FG000|Period 3|Study Terminated by Sponsor|0|||
146896691|NCT00868790|529786309|FG001|Period 3|Study Terminated by Sponsor|0|||
146896692|NCT00868790|529786310|FG002|Period 3|Study Terminated by Sponsor|0|||
146896693|NCT00868790|529786311|FG003|Period 3|Study Terminated by Sponsor|1|||
146896694|NCT00868790|529786312|FG004|Period 3|Study Terminated by Sponsor|0|||
146896695|NCT00868790|529786313|FG005|Period 3|Study Terminated by Sponsor|0|||
146896696|NCT00868790|529786314|FG006|Period 3|Study Terminated by Sponsor|0|||
146896697|NCT00868790|529786315|FG007|Period 3|Study Terminated by Sponsor|0|||
146896698|NCT00868790|529786316|FG008|Period 3|Study Terminated by Sponsor|0|||
146896699|NCT00868790|529786317|FG009|Period 3|Study Terminated by Sponsor|0|||
146896700|NCT00868790|529786318|FG010|Period 3|Study Terminated by Sponsor|0|||
146896701|NCT00868790|529786319|FG011|Period 3|Study Terminated by Sponsor|0|||
146896702|NCT00868790|529786320|FG012|Period 3|Study Terminated by Sponsor|0|||
146896703|NCT00868790|529786321|FG013|Period 3|Study Terminated by Sponsor|0|||
146896704|NCT00868790|529786308|FG000|Period 4|Adverse Event|0|||
146896705|NCT00868790|529786309|FG001|Period 4|Adverse Event|0|||
146896706|NCT00868790|529786310|FG002|Period 4|Adverse Event|0|||
146896707|NCT00868790|529786311|FG003|Period 4|Adverse Event|0|||
146896708|NCT00868790|529786312|FG004|Period 4|Adverse Event|0|||
146896709|NCT00868790|529786313|FG005|Period 4|Adverse Event|0|||
146896710|NCT00868790|529786314|FG006|Period 4|Adverse Event|0|||
146896711|NCT00868790|529786315|FG007|Period 4|Adverse Event|1|||
146896712|NCT00868790|529786316|FG008|Period 4|Adverse Event|0|||
146896713|NCT00868790|529786317|FG009|Period 4|Adverse Event|0|||
146896714|NCT00868790|529786318|FG010|Period 4|Adverse Event|1|||
146896715|NCT00868790|529786319|FG011|Period 4|Adverse Event|0|||
146896716|NCT00868790|529786320|FG012|Period 4|Adverse Event|1|||
146896717|NCT00868790|529786321|FG013|Period 4|Adverse Event|0|||
146896718|NCT00868790|529786308|FG000|Period 4|Lost to Follow-up|0|||
146896719|NCT00868790|529786309|FG001|Period 4|Lost to Follow-up|0|||
146896720|NCT00868790|529786310|FG002|Period 4|Lost to Follow-up|0|||
146896721|NCT00868790|529786311|FG003|Period 4|Lost to Follow-up|0|||
146896722|NCT00868790|529786312|FG004|Period 4|Lost to Follow-up|0|||
146896723|NCT00868790|529786313|FG005|Period 4|Lost to Follow-up|0|||
146896724|NCT00868790|529786314|FG006|Period 4|Lost to Follow-up|0|||
146896725|NCT00868790|529786315|FG007|Period 4|Lost to Follow-up|1|||
146896726|NCT00868790|529786316|FG008|Period 4|Lost to Follow-up|0|||
146896727|NCT00868790|529786317|FG009|Period 4|Lost to Follow-up|0|||
146896728|NCT00868790|529786318|FG010|Period 4|Lost to Follow-up|0|||
146896729|NCT00868790|529786319|FG011|Period 4|Lost to Follow-up|0|||
146896730|NCT00868790|529786320|FG012|Period 4|Lost to Follow-up|0|||
146896731|NCT00868790|529786321|FG013|Period 4|Lost to Follow-up|0|||
146896732|NCT00868790|529786308|FG000|Period 4|Study Terminated by Sponsor|2|||
146896733|NCT00868790|529786309|FG001|Period 4|Study Terminated by Sponsor|0|||
146896734|NCT00868790|529786310|FG002|Period 4|Study Terminated by Sponsor|0|||
146896735|NCT00868790|529786311|FG003|Period 4|Study Terminated by Sponsor|0|||
146896736|NCT00868790|529786312|FG004|Period 4|Study Terminated by Sponsor|0|||
146896737|NCT00868790|529786313|FG005|Period 4|Study Terminated by Sponsor|0|||
146896738|NCT00868790|529786314|FG006|Period 4|Study Terminated by Sponsor|0|||
146896739|NCT00868790|529786315|FG007|Period 4|Study Terminated by Sponsor|1|||
146896740|NCT00868790|529786316|FG008|Period 4|Study Terminated by Sponsor|2|||
146896741|NCT00868790|529786317|FG009|Period 4|Study Terminated by Sponsor|0|||
146896742|NCT00868790|529786318|FG010|Period 4|Study Terminated by Sponsor|2|||
146896743|NCT00868790|529786319|FG011|Period 4|Study Terminated by Sponsor|1|||
146896744|NCT00868790|529786320|FG012|Period 4|Study Terminated by Sponsor|0|||
146896745|NCT00868790|529786321|FG013|Period 4|Study Terminated by Sponsor|1|||
146896746|NCT00868790|529786308|FG000|Period 4|Abnormal ALT/AST|0|||
146896747|NCT00868790|529786309|FG001|Period 4|Abnormal ALT/AST|0|||
146896748|NCT00868790|529786310|FG002|Period 4|Abnormal ALT/AST|1|||
146896749|NCT00868790|529786311|FG003|Period 4|Abnormal ALT/AST|0|||
146896750|NCT00868790|529786312|FG004|Period 4|Abnormal ALT/AST|0|||
146896751|NCT00868790|529786313|FG005|Period 4|Abnormal ALT/AST|0|||
146896752|NCT00868790|529786314|FG006|Period 4|Abnormal ALT/AST|0|||
146896753|NCT00868790|529786315|FG007|Period 4|Abnormal ALT/AST|0|||
146896754|NCT00868790|529786316|FG008|Period 4|Abnormal ALT/AST|0|||
146896755|NCT00868790|529786317|FG009|Period 4|Abnormal ALT/AST|0|||
146896756|NCT00868790|529786318|FG010|Period 4|Abnormal ALT/AST|0|||
146896757|NCT00868790|529786319|FG011|Period 4|Abnormal ALT/AST|0|||
146896758|NCT00868790|529786320|FG012|Period 4|Abnormal ALT/AST|0|||
146896759|NCT00868790|529786321|FG013|Period 4|Abnormal ALT/AST|0|||
146896760|NCT00868790|529786308|FG000|Post-study|Withdrawal by Subject|0|||
146896761|NCT00868790|529786309|FG001|Post-study|Withdrawal by Subject|0|||
146896762|NCT00868790|529786310|FG002|Post-study|Withdrawal by Subject|0|||
146896763|NCT00868790|529786311|FG003|Post-study|Withdrawal by Subject|0|||
146896764|NCT00868790|529786312|FG004|Post-study|Withdrawal by Subject|1|||
146896765|NCT00868790|529786313|FG005|Post-study|Withdrawal by Subject|0|||
146896766|NCT00868790|529786314|FG006|Post-study|Withdrawal by Subject|0|||
146896767|NCT00868790|529786315|FG007|Post-study|Withdrawal by Subject|0|||
146896768|NCT00868790|529786316|FG008|Post-study|Withdrawal by Subject|0|||
146896769|NCT00868790|529786317|FG009|Post-study|Withdrawal by Subject|0|||
146896770|NCT00868790|529786318|FG010|Post-study|Withdrawal by Subject|0|||
146896771|NCT00868790|529786319|FG011|Post-study|Withdrawal by Subject|0|||
146896772|NCT00868790|529786320|FG012|Post-study|Withdrawal by Subject|0|||
146896773|NCT00868790|529786321|FG013|Post-study|Withdrawal by Subject|0|||
146896774|NCT00868790|529786308|FG000|Post-study|Excluded Medication|0|||
146896775|NCT00868790|529786309|FG001|Post-study|Excluded Medication|0|||
146896776|NCT00868790|529786310|FG002|Post-study|Excluded Medication|0|||
146896777|NCT00868790|529786311|FG003|Post-study|Excluded Medication|0|||
146896778|NCT00868790|529786312|FG004|Post-study|Excluded Medication|0|||
146896779|NCT00868790|529786313|FG005|Post-study|Excluded Medication|0|||
146896780|NCT00868790|529786314|FG006|Post-study|Excluded Medication|0|||
146896781|NCT00868790|529786315|FG007|Post-study|Excluded Medication|2|||
146896782|NCT00868790|529786316|FG008|Post-study|Excluded Medication|0|||
146896783|NCT00868790|529786317|FG009|Post-study|Excluded Medication|1|||
146896784|NCT00868790|529786318|FG010|Post-study|Excluded Medication|0|||
146896785|NCT00868790|529786319|FG011|Post-study|Excluded Medication|0|||
146896786|NCT00868790|529786320|FG012|Post-study|Excluded Medication|0|||
146896787|NCT00868790|529786321|FG013|Post-study|Excluded Medication|0|||
146896788|NCT01763164|529786322|FG000|Treatment Phase|Participant/Guardian decision|26|||
146896789|NCT01763164|529786323|FG001|Treatment Phase|Participant/Guardian decision|14|||
146896790|NCT01763164|529786322|FG000|Treatment Phase|Protocol Violation|1|||
146896791|NCT01763164|529786323|FG001|Treatment Phase|Protocol Violation|1|||
146896792|NCT01763164|529786322|FG000|Treatment Phase|Progressive Disease|142|||
146896793|NCT01763164|529786323|FG001|Treatment Phase|Progressive Disease|76|||
146896794|NCT01763164|529786322|FG000|Treatment Phase|Physician Decision|24|||
146896795|NCT01763164|529786323|FG001|Treatment Phase|Physician Decision|13|||
146896796|NCT01763164|529786322|FG000|Treatment Phase|Death|10|||
146896797|NCT01763164|529786323|FG001|Treatment Phase|Death|1|||
146896798|NCT01763164|529786322|FG000|Treatment Phase|Adverse Event|66|||
146896799|NCT01763164|529786323|FG001|Treatment Phase|Adverse Event|8|||
146896800|NCT01763164|529786322|FG000|Treatment Phase|Randomized but not Treated|0|||
146896801|NCT01763164|529786323|FG001|Treatment Phase|Randomized but not Treated|19|||
146896802|NCT01763164|529786322|FG000|Treatment Phase|Other|0|||
146896803|NCT01763164|529786323|FG001|Treatment Phase|Other|1|||
146896804|NCT01763164|529786322|FG000|Follow up Phase|New therapy for study indication|12|||
146896805|NCT01763164|529786323|FG001|Follow up Phase|New therapy for study indication|3|||
146896806|NCT01763164|529786322|FG000|Follow up Phase|Death|21|||
146896807|NCT01763164|529786323|FG001|Follow up Phase|Death|4|||
146896808|NCT01763164|529786322|FG000|Follow up Phase|Subject/guardian decision|9|||
146896809|NCT01763164|529786323|FG001|Follow up Phase|Subject/guardian decision|2|||
146896810|NCT01763164|529786322|FG000|Follow up Phase|Progressive disease|127|||
146896811|NCT01763164|529786323|FG001|Follow up Phase|Progressive disease|62|||
146896812|NCT01763164|529786322|FG000|Follow up Phase|Physician Decision|10|||
146896813|NCT01763164|529786323|FG001|Follow up Phase|Physician Decision|3|||
146896814|NCT01763164|529786322|FG000|Follow up Phase|Lost to Follow-up|1|||
146896815|NCT01763164|529786323|FG001|Follow up Phase|Lost to Follow-up|0|||
146640002|NCT02100696|528857833|FG002|Induction Phase|Withdrawal by Subject|13|||
146896816|NCT01763164|529786322|FG000|Follow up Phase|Adverse Event|17|||
146896817|NCT01763164|529786323|FG001|Follow up Phase|Adverse Event|1|||
146896818|NCT03377634|529786324|FG000|Study Period|Adverse Event|1|||
146640003|NCT02100696|528857834|FG003|Induction Phase|Withdrawal by Subject|0|||
146896819|NCT03377634|529786325|FG001|Study Period|Adverse Event|0|||
146896820|NCT03377634|529786324|FG000|Study Period|Withdrawal by Subject|1|||
146896821|NCT03377634|529786325|FG001|Study Period|Withdrawal by Subject|0|||
146896822|NCT01264939|529786326|FG000|Overall Study|Adverse Event|1|||
146896823|NCT01264939|529786327|FG001|Overall Study|Adverse Event|3|||
146896824|NCT01264939|529786326|FG000|Overall Study|Lost to Follow-up|0|||
146896825|NCT01264939|529786327|FG001|Overall Study|Lost to Follow-up|3|||
146896826|NCT01264939|529786326|FG000|Overall Study|Physician Decision|1|||
146896827|NCT01264939|529786327|FG001|Overall Study|Physician Decision|1|||
146896828|NCT01264939|529786326|FG000|Overall Study|Patient/Guardian Decision|8|||
146896829|NCT01264939|529786327|FG001|Overall Study|Patient/Guardian Decision|10|||
146896830|NCT01264939|529786326|FG000|Overall Study|Disease Progression|8|||
146896831|NCT01264939|529786327|FG001|Overall Study|Disease Progression|11|||
146896832|NCT01384292|529786335|FG000|Part B|Severe non-compliance to protocol|1|||
146896833|NCT01384292|529786336|FG001|Part B|Severe non-compliance to protocol|0|||
146896834|NCT01384292|529786337|FG002|Part B|Severe non-compliance to protocol|0|||
146896835|NCT01171612|529786339|FG000|Overall Study|Lost to Follow-up|51|||
146896836|NCT00737529|529786340|FG000|Overall Study|Disease Progression|95|||
146896837|NCT00737529|529786340|FG000|Overall Study|Adverse Event|24|||
146896838|NCT00737529|529786340|FG000|Overall Study|Withdrawal by Subject|5|||
146896839|NCT00737529|529786340|FG000|Overall Study|Death|4|||
146896840|NCT00737529|529786340|FG000|Overall Study|Protocol Violation|1|||
146896841|NCT00737529|529786340|FG000|Overall Study|Other|4|||
146896842|NCT04666038|529786341|FG000|Overall Study|Progressive Disease|2|||
146896843|NCT04666038|529786342|FG001|Overall Study|Progressive Disease|0|||
146896844|NCT04666038|529786341|FG000|Overall Study|Death|38|||
146896845|NCT04666038|529786342|FG001|Overall Study|Death|32|||
146896846|NCT04666038|529786341|FG000|Overall Study|Withdrawal by Subject|10|||
146896847|NCT04666038|529786342|FG001|Overall Study|Withdrawal by Subject|19|||
146896848|NCT04666038|529786341|FG000|Overall Study|Lost to Follow-up|0|||
146896849|NCT04666038|529786342|FG001|Overall Study|Lost to Follow-up|2|||
146896850|NCT04666038|529786341|FG000|Overall Study|On Study Treatment|46|||
146896851|NCT04666038|529786342|FG001|Overall Study|On Study Treatment|5|||
146896852|NCT04666038|529786341|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
146896853|NCT04666038|529786342|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
146896854|NCT04957290|529786344|FG000|Overall Study|Progressive disease|3|||
146896855|NCT04957290|529786345|FG001|Overall Study|Progressive disease|3|||
146896856|NCT04957290|529786346|FG002|Overall Study|Progressive disease|2|||
146896857|NCT04957290|529786347|FG003|Overall Study|Progressive disease|0|||
146896858|NCT04957290|529786348|FG004|Overall Study|Progressive disease|0|||
146896859|NCT04957290|529786349|FG005|Overall Study|Progressive disease|0|||
146896860|NCT04957290|529786344|FG000|Overall Study|Withdrawal by Subject|1|||
146896861|NCT04957290|529786345|FG001|Overall Study|Withdrawal by Subject|0|||
146896862|NCT04957290|529786346|FG002|Overall Study|Withdrawal by Subject|1|||
146896863|NCT04957290|529786347|FG003|Overall Study|Withdrawal by Subject|0|||
146896864|NCT04957290|529786348|FG004|Overall Study|Withdrawal by Subject|0|||
146896865|NCT04957290|529786349|FG005|Overall Study|Withdrawal by Subject|0|||
146896866|NCT04957290|529786344|FG000|Overall Study|Death|0|||
146896867|NCT04957290|529786345|FG001|Overall Study|Death|2|||
146896868|NCT04957290|529786346|FG002|Overall Study|Death|1|||
146896869|NCT04957290|529786347|FG003|Overall Study|Death|0|||
146896870|NCT04957290|529786348|FG004|Overall Study|Death|0|||
146896871|NCT04957290|529786349|FG005|Overall Study|Death|0|||
146896872|NCT04957290|529786344|FG000|Overall Study|non compliance with study drug|0|||
146896873|NCT04957290|529786345|FG001|Overall Study|non compliance with study drug|1|||
146896874|NCT04957290|529786346|FG002|Overall Study|non compliance with study drug|0|||
146896875|NCT04957290|529786347|FG003|Overall Study|non compliance with study drug|0|||
146896876|NCT04957290|529786348|FG004|Overall Study|non compliance with study drug|0|||
146896877|NCT04957290|529786349|FG005|Overall Study|non compliance with study drug|0|||
146896878|NCT04957290|529786344|FG000|Overall Study|none specified.|0|||
146896879|NCT04957290|529786345|FG001|Overall Study|none specified.|1|||
146896880|NCT04957290|529786346|FG002|Overall Study|none specified.|2|||
146896881|NCT04957290|529786347|FG003|Overall Study|none specified.|0|||
146896882|NCT04957290|529786348|FG004|Overall Study|none specified.|0|||
146896883|NCT04957290|529786349|FG005|Overall Study|none specified.|0|||
146896884|NCT04957290|529786344|FG000|Overall Study|unacceptable toxicity|0|||
146896885|NCT04957290|529786345|FG001|Overall Study|unacceptable toxicity|0|||
146896886|NCT04957290|529786346|FG002|Overall Study|unacceptable toxicity|1|||
146896887|NCT04957290|529786347|FG003|Overall Study|unacceptable toxicity|0|||
146896888|NCT04957290|529786348|FG004|Overall Study|unacceptable toxicity|0|||
146896889|NCT04957290|529786349|FG005|Overall Study|unacceptable toxicity|0|||
146896890|NCT04957290|529786344|FG000|Overall Study|Adverse Event|0|||
146896891|NCT04957290|529786345|FG001|Overall Study|Adverse Event|0|||
146896892|NCT04957290|529786346|FG002|Overall Study|Adverse Event|1|||
146896893|NCT04957290|529786347|FG003|Overall Study|Adverse Event|0|||
146896894|NCT04957290|529786348|FG004|Overall Study|Adverse Event|0|||
146896895|NCT04957290|529786349|FG005|Overall Study|Adverse Event|0|||
146896896|NCT04957290|529786344|FG000|Overall Study|study terminated by sponsor|0|||
146896897|NCT04957290|529786345|FG001|Overall Study|study terminated by sponsor|0|||
146896898|NCT04957290|529786346|FG002|Overall Study|study terminated by sponsor|2|||
146896899|NCT04957290|529786347|FG003|Overall Study|study terminated by sponsor|0|||
146896900|NCT04957290|529786348|FG004|Overall Study|study terminated by sponsor|0|||
146896901|NCT04957290|529786349|FG005|Overall Study|study terminated by sponsor|0|||
146896902|NCT02497001|529786350|FG000|Overall Study|Lost to Follow-up|10|||
146896903|NCT02497001|529786351|FG001|Overall Study|Lost to Follow-up|2|||
146896904|NCT02497001|529786352|FG002|Overall Study|Lost to Follow-up|0|||
146896905|NCT02497001|529786353|FG003|Overall Study|Lost to Follow-up|2|||
146896906|NCT02497001|529786350|FG000|Overall Study|Adverse Event|28|||
146896907|NCT02497001|529786351|FG001|Overall Study|Adverse Event|30|||
146896908|NCT02497001|529786352|FG002|Overall Study|Adverse Event|11|||
146896909|NCT02497001|529786353|FG003|Overall Study|Adverse Event|11|||
146896910|NCT02497001|529786350|FG000|Overall Study|Withdrawal by Subject|14|||
146896911|NCT02497001|529786351|FG001|Overall Study|Withdrawal by Subject|37|||
146896912|NCT02497001|529786352|FG002|Overall Study|Withdrawal by Subject|19|||
146896913|NCT02497001|529786353|FG003|Overall Study|Withdrawal by Subject|15|||
146896914|NCT02497001|529786350|FG000|Overall Study|Physician Decision|5|||
146896915|NCT02497001|529786351|FG001|Overall Study|Physician Decision|11|||
146896916|NCT02497001|529786352|FG002|Overall Study|Physician Decision|5|||
146896917|NCT02497001|529786353|FG003|Overall Study|Physician Decision|1|||
146896918|NCT02497001|529786350|FG000|Overall Study|subjects that were not treated|1|||
146896919|NCT02497001|529786351|FG001|Overall Study|subjects that were not treated|2|||
146896920|NCT02497001|529786352|FG002|Overall Study|subjects that were not treated|2|||
146896921|NCT02497001|529786353|FG003|Overall Study|subjects that were not treated|1|||
146896922|NCT02497001|529786350|FG000|Overall Study|Major Protocol Deviation|3|||
146896923|NCT02497001|529786351|FG001|Overall Study|Major Protocol Deviation|4|||
146896924|NCT02497001|529786352|FG002|Overall Study|Major Protocol Deviation|4|||
146896925|NCT02497001|529786353|FG003|Overall Study|Major Protocol Deviation|4|||
146896926|NCT02497001|529786350|FG000|Overall Study|Lack of Efficacy|10|||
146896927|NCT02497001|529786351|FG001|Overall Study|Lack of Efficacy|16|||
146896928|NCT02497001|529786352|FG002|Overall Study|Lack of Efficacy|6|||
146896929|NCT02497001|529786353|FG003|Overall Study|Lack of Efficacy|6|||
146896930|NCT02497001|529786350|FG000|Overall Study|Protocol Violation|3|||
146896931|NCT02497001|529786351|FG001|Overall Study|Protocol Violation|1|||
146896932|NCT02497001|529786352|FG002|Overall Study|Protocol Violation|3|||
146896933|NCT02497001|529786353|FG003|Overall Study|Protocol Violation|1|||
146896934|NCT02899156|529786354|FG000|Overall Study|Death|1|||
146896935|NCT02899156|529786355|FG001|Overall Study|Death|0|||
146896936|NCT02899156|529786354|FG000|Overall Study|Physician Decision|0|||
146896937|NCT02899156|529786355|FG001|Overall Study|Physician Decision|1|||
146896938|NCT02116621|529786356|FG000|Baseline|Withdrawal by Subject|0|||
146896939|NCT02116621|529786357|FG001|Baseline|Withdrawal by Subject|4|||
146896940|NCT02116621|529786356|FG000|Three Month Follow-up|Death|1|||
146896941|NCT02116621|529786357|FG001|Three Month Follow-up|Death|1|||
146896942|NCT02116621|529786356|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
146896943|NCT02116621|529786357|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
146896944|NCT02116621|529786356|FG000|Three Month Follow-up|Lost to Follow-up|0|||
146896945|NCT02116621|529786357|FG001|Three Month Follow-up|Lost to Follow-up|1|||
146896946|NCT02116621|529786356|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
146896947|NCT02116621|529786357|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
146896948|NCT02116621|529786356|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
146896949|NCT02116621|529786357|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
146896950|NCT02116621|529786356|FG000|Six Month Follow-up|Lost to Follow-up|2|||
146896951|NCT02116621|529786357|FG001|Six Month Follow-up|Lost to Follow-up|1|||
146896952|NCT02116621|529786356|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
146896953|NCT02116621|529786357|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
146896954|NCT02116621|529786356|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
146896955|NCT02116621|529786357|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
146896956|NCT02116621|529786356|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
146896957|NCT02116621|529786357|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
146896958|NCT02116621|529786356|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
146766746|NCT00855465|529314599|FG001|Treatment Period|Lack of Efficacy|1|||
146896959|NCT02116621|529786357|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
146896960|NCT02116621|529786356|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
146896961|NCT02116621|529786357|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
146896962|NCT01889602|529786358|FG000|First Intervention|Adverse Event|1|||
146896963|NCT01889602|529786359|FG001|First Intervention|Adverse Event|1|||
146896964|NCT01889602|529786360|FG002|First Intervention|Adverse Event|1|||
146896965|NCT01889602|529786358|FG000|First Intervention|Protocol Violation|0|||
146896966|NCT01889602|529786359|FG001|First Intervention|Protocol Violation|1|||
146896967|NCT01889602|529786360|FG002|First Intervention|Protocol Violation|1|||
146896968|NCT01889602|529786358|FG000|First Intervention|Study ending|0|||
146896969|NCT01889602|529786359|FG001|First Intervention|Study ending|1|||
146896970|NCT01889602|529786360|FG002|First Intervention|Study ending|0|||
146896971|NCT01889602|529786358|FG000|Second Intervention|Adverse Event|0|||
146896972|NCT01889602|529786359|FG001|Second Intervention|Adverse Event|0|||
146896973|NCT01889602|529786360|FG002|Second Intervention|Adverse Event|1|||
146896974|NCT01889602|529786358|FG000|Second Intervention|Study ending|1|||
146766747|NCT00855465|529314598|FG000|Treatment Period|Non-compliance|1|||
146896975|NCT01889602|529786359|FG001|Second Intervention|Study ending|0|||
146896976|NCT01889602|529786360|FG002|Second Intervention|Study ending|0|||
146896977|NCT01889602|529786358|FG000|Second Intervention|Withdrawal by Subject|0|||
146766748|NCT00855465|529314599|FG001|Treatment Period|Non-compliance|0|||
146896978|NCT01889602|529786359|FG001|Second Intervention|Withdrawal by Subject|0|||
146896979|NCT01889602|529786360|FG002|Second Intervention|Withdrawal by Subject|1|||
146896980|NCT01889602|529786358|FG000|Third Intervention|Protocol Violation|1|||
146896981|NCT01889602|529786359|FG001|Third Intervention|Protocol Violation|0|||
146896982|NCT01889602|529786360|FG002|Third Intervention|Protocol Violation|0|||
146896983|NCT01889602|529786358|FG000|Third Intervention|Withdrawal by Subject|2|||
146896984|NCT01889602|529786359|FG001|Third Intervention|Withdrawal by Subject|2|||
146896985|NCT01889602|529786360|FG002|Third Intervention|Withdrawal by Subject|0|||
146896986|NCT00484315|529786361|FG000|12-Month Clinical Follow-up|Death|6|||
146896987|NCT00484315|529786362|FG001|12-Month Clinical Follow-up|Death|2|||
146896988|NCT00484315|529786361|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
146896989|NCT00484315|529786362|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
146896990|NCT00484315|529786361|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
146896991|NCT00484315|529786362|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
146896992|NCT00484315|529786361|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
146896993|NCT00484315|529786362|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
146896994|NCT00484315|529786361|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
146896995|NCT00484315|529786362|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
146896996|NCT00484315|529786361|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
146896997|NCT00484315|529786362|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
146896998|NCT00484315|529786361|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
146896999|NCT00484315|529786362|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
146897000|NCT00943683|529786363|FG000|Overall Study|Adverse Event|3|||
146897001|NCT00943683|529786364|FG001|Overall Study|Adverse Event|3|||
146897002|NCT00943683|529786363|FG000|Overall Study|Lost to Follow-up|1|||
146897003|NCT00943683|529786364|FG001|Overall Study|Lost to Follow-up|1|||
146897004|NCT00943683|529786363|FG000|Overall Study|Protocol Violation|1|||
146897005|NCT00943683|529786364|FG001|Overall Study|Protocol Violation|2|||
146897006|NCT00943683|529786363|FG000|Overall Study|Withdrawal by Subject|1|||
146897007|NCT00943683|529786364|FG001|Overall Study|Withdrawal by Subject|0|||
146897008|NCT00943683|529786363|FG000|Overall Study|Patient Moved|1|||
146897009|NCT00943683|529786364|FG001|Overall Study|Patient Moved|0|||
146897010|NCT00413959|529786373|FG000|Overall Study|Pt had only one cycle.|1|||
146897011|NCT03538743|529786374|FG000|Overall Study|Adverse Event|0|||
146897012|NCT03538743|529786375|FG001|Overall Study|Adverse Event|0|||
146897013|NCT03538743|529786376|FG002|Overall Study|Adverse Event|1|||
146897014|NCT03538743|529786377|FG003|Overall Study|Adverse Event|1|||
146897015|NCT03538743|529786378|FG004|Overall Study|Adverse Event|0|||
146897016|NCT03538743|529786379|FG005|Overall Study|Adverse Event|0|||
146897017|NCT03538743|529786380|FG006|Overall Study|Adverse Event|0|||
146897018|NCT03538743|529786381|FG007|Overall Study|Adverse Event|0|||
146897019|NCT03538743|529786382|FG008|Overall Study|Adverse Event|0|||
146897020|NCT03538743|529786374|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
146897021|NCT03538743|529786375|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
146897022|NCT03538743|529786376|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
146897023|NCT03538743|529786377|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
146897024|NCT03538743|529786378|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
146897025|NCT03538743|529786379|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
146897026|NCT03538743|529786380|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
146897027|NCT03538743|529786381|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
146897028|NCT03538743|529786382|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
146897029|NCT03538743|529786374|FG000|Overall Study|Withdrawal by Subject|0|||
146897030|NCT03538743|529786375|FG001|Overall Study|Withdrawal by Subject|0|||
146897031|NCT03538743|529786376|FG002|Overall Study|Withdrawal by Subject|0|||
146897032|NCT03538743|529786377|FG003|Overall Study|Withdrawal by Subject|1|||
146897033|NCT03538743|529786378|FG004|Overall Study|Withdrawal by Subject|0|||
146897034|NCT03538743|529786379|FG005|Overall Study|Withdrawal by Subject|0|||
146897035|NCT03538743|529786380|FG006|Overall Study|Withdrawal by Subject|0|||
146897036|NCT03538743|529786381|FG007|Overall Study|Withdrawal by Subject|0|||
146897037|NCT03538743|529786382|FG008|Overall Study|Withdrawal by Subject|0|||
146640004|NCT02100696|528857835|FG004|Induction Phase|Withdrawal by Subject|0|||
146640005|NCT02100696|528857836|FG005|Induction Phase|Withdrawal by Subject|0|||
146897038|NCT01565980|529786383|FG000|Overall Study|Death|1|||
146897039|NCT01565980|529786384|FG001|Overall Study|Death|0|||
146897040|NCT01565980|529786383|FG000|Overall Study|Lost to Follow-up|1|||
146897041|NCT01565980|529786384|FG001|Overall Study|Lost to Follow-up|0|||
146897042|NCT01565980|529786383|FG000|Overall Study|health complications|1|||
146897043|NCT01565980|529786384|FG001|Overall Study|health complications|1|||
146897044|NCT01565980|529786383|FG000|Overall Study|stopped medical treatment|1|||
146897045|NCT01565980|529786384|FG001|Overall Study|stopped medical treatment|0|||
146897046|NCT01565980|529786383|FG000|Overall Study|Withdrawal by Subject|0|||
146897047|NCT01565980|529786384|FG001|Overall Study|Withdrawal by Subject|3|||
146897048|NCT01929135|529786387|FG000|Overall Study|Lost to Follow-up|1|||
146897049|NCT01929135|529786388|FG001|Overall Study|Lost to Follow-up|1|||
146897050|NCT06001307|529788125|FG000|Overall Study|Lost to Follow-up|1|||
146897051|NCT06001307|529788126|FG001|Overall Study|Lost to Follow-up|2|||
146897052|NCT03532100|529788127|FG000|Overall Study|Intervention malfunction|1|||
146897053|NCT04439279|529788128|FG000|Overall Study|Adverse Event|7|||
146897054|NCT04439279|529788128|FG000|Overall Study|Death|4|||
146897055|NCT04439279|529788128|FG000|Overall Study|Disease progression|17|||
146897056|NCT04439279|529788128|FG000|Overall Study|Complicating disease|3|||
146897057|NCT04439279|529788128|FG000|Overall Study|Withdrawal by Subject|2|||
146897058|NCT04439279|529788128|FG000|Overall Study|Ineligible|1|||
146897059|NCT04439279|529788128|FG000|Overall Study|Treatment still ongoing|1|||
146897060|NCT02031679|529788129|FG000|Overall Study|Protocol Violation|0|||
146897061|NCT02031679|529788130|FG001|Overall Study|Protocol Violation|1|||
146897062|NCT02031679|529788129|FG000|Overall Study|Lack of Efficacy|0|||
146897063|NCT02031679|529788130|FG001|Overall Study|Lack of Efficacy|1|||
146897064|NCT00023322|529788131|FG000|Overall Study|Lost to Follow-up|1|||
146897065|NCT04317690|529788134|FG000|Overall Study|did not have complete information for primary outcome|0|||
146897066|NCT04317690|529788135|FG001|Overall Study|did not have complete information for primary outcome|4|||
146897067|NCT04317690|529788136|FG002|Overall Study|did not have complete information for primary outcome|0|||
146897068|NCT04317690|529788137|FG003|Overall Study|did not have complete information for primary outcome|2|||
146897069|NCT04317690|529788138|FG004|Overall Study|did not have complete information for primary outcome|0|||
146897070|NCT03312218|529788144|FG000|Overall Study|Never signed in to access the app|54|||
146897071|NCT03312218|529788145|FG001|Overall Study|Never signed in to access the app|58|||
146897072|NCT02747927|529788146|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
146897073|NCT02747927|529788147|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
146897074|NCT02747927|529788146|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
146897075|NCT02747927|529788147|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
146897076|NCT02747927|529788146|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
146897077|NCT02747927|529788147|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
146897078|NCT02747927|529788146|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
146897079|NCT02747927|529788147|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
146897080|NCT02747927|529788146|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
146897081|NCT02747927|529788147|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
146897082|NCT02747927|529788146|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
146897083|NCT02747927|529788147|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
146897084|NCT02747927|529788146|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
146897085|NCT02747927|529788147|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
146897086|NCT02747927|529788146|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
146897087|NCT02747927|529788147|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
146640006|NCT02100696|528857831|FG000|Induction Phase|Physician Decision|1|||
146640007|NCT02100696|528857832|FG001|Induction Phase|Physician Decision|0|||
146640008|NCT02100696|528857833|FG002|Induction Phase|Physician Decision|2|||
146640009|NCT02100696|528857834|FG003|Induction Phase|Physician Decision|0|||
146640010|NCT02100696|528857835|FG004|Induction Phase|Physician Decision|0|||
146640011|NCT02100696|528857836|FG005|Induction Phase|Physician Decision|0|||
146640012|NCT02100696|528857831|FG000|Induction Phase|Multiple Reasons|5|||
146640013|NCT02100696|528857832|FG001|Induction Phase|Multiple Reasons|2|||
146640014|NCT02100696|528857833|FG002|Induction Phase|Multiple Reasons|8|||
146897088|NCT02747927|529788146|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
146897089|NCT02747927|529788147|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
146897090|NCT02747927|529788146|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
146897091|NCT02747927|529788147|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
146640015|NCT02100696|528857834|FG003|Induction Phase|Multiple Reasons|0|||
146640016|NCT02100696|528857835|FG004|Induction Phase|Multiple Reasons|0|||
146640017|NCT02100696|528857836|FG005|Induction Phase|Multiple Reasons|0|||
146640018|NCT02100696|528857831|FG000|Maintenance Phase|Adverse Event|0|||
146897092|NCT02747927|529788146|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
146640019|NCT02100696|528857832|FG001|Maintenance Phase|Adverse Event|0|||
146766749|NCT00855465|529314598|FG000|Treatment Period|Protocol Violation|2|||
146766750|NCT00855465|529314599|FG001|Treatment Period|Protocol Violation|0|||
146766751|NCT00855465|529314598|FG000|Treatment Period|Withdrawal by Subject|2|||
146766752|NCT00855465|529314599|FG001|Treatment Period|Withdrawal by Subject|0|||
146766753|NCT00855465|529314598|FG000|Treatment Period|Not treated|1|||
146766754|NCT00855465|529314599|FG001|Treatment Period|Not treated|0|||
146766755|NCT00855465|529314598|FG000|Follow-up Period (FUP)|Adverse Event|0|||
146766756|NCT00855465|529314599|FG001|Follow-up Period (FUP)|Adverse Event|1|||
146766757|NCT00855465|529314598|FG000|Follow-up Period (FUP)|Death|0|||
146766758|NCT00855465|529314599|FG001|Follow-up Period (FUP)|Death|1|||
146766759|NCT00855465|529314598|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
146766760|NCT00855465|529314599|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
146766761|NCT00855465|529314598|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
146766762|NCT00855465|529314599|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
146766763|NCT00855465|529314598|FG000|Follow-up Period (FUP)|Missing|1|||
146766764|NCT00855465|529314599|FG001|Follow-up Period (FUP)|Missing|0|||
146766765|NCT00079183|529314600|FG000|Overall Study|Withdrawal by Subject|4|||
146766766|NCT00079183|529314600|FG000|Overall Study|Study medication non-compliance|2|||
146766767|NCT00079183|529314600|FG000|Overall Study|Specimen collection non-compliance|1|||
146766768|NCT01157182|529314601|FG000|Washout of 28 Days|Adverse Event|2|||
146766769|NCT01157182|529314602|FG001|Washout of 28 Days|Adverse Event|0|||
146766770|NCT03743246|529314603|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
146766771|NCT03743246|529314604|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
146766772|NCT03743246|529314605|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
146766773|NCT03743246|529314606|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
146766774|NCT03743246|529314603|FG000|Pre-Treatment Period|Death|0|||
146766775|NCT03743246|529314604|FG001|Pre-Treatment Period|Death|1|||
146766776|NCT03743246|529314605|FG002|Pre-Treatment Period|Death|0|||
146766777|NCT03743246|529314606|FG003|Pre-Treatment Period|Death|1|||
146766778|NCT03743246|529314603|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
146766779|NCT03743246|529314604|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
146766780|NCT03743246|529314605|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
146766781|NCT03743246|529314606|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
146766782|NCT03743246|529314603|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
146766783|NCT03743246|529314604|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
146766784|NCT03743246|529314605|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
146766785|NCT03743246|529314606|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
146766786|NCT03743246|529314603|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
146766787|NCT03743246|529314604|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
146766788|NCT03743246|529314605|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
146766789|NCT03743246|529314606|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
146766790|NCT03743246|529314603|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
146766791|NCT03743246|529314604|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
146766792|NCT03743246|529314605|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
146766793|NCT03743246|529314606|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
146766794|NCT03743246|529314603|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
146766795|NCT03743246|529314604|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
146766796|NCT03743246|529314605|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
146766797|NCT03743246|529314606|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
146766798|NCT03743246|529314603|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
146766799|NCT03743246|529314604|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
146766800|NCT03743246|529314605|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
146766801|NCT03743246|529314606|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
146766802|NCT03743246|529314603|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
146766803|NCT03743246|529314604|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
146766804|NCT03743246|529314605|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
146766805|NCT03743246|529314606|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
146766806|NCT00530842|529314607|FG000|Overall Study|Adverse Event|10|||
146766807|NCT00530842|529314608|FG001|Overall Study|Adverse Event|6|||
146766808|NCT00530842|529314607|FG000|Overall Study|Lack of Efficacy|2|||
146766809|NCT00530842|529314608|FG001|Overall Study|Lack of Efficacy|1|||
146766810|NCT00530842|529314607|FG000|Overall Study|Lost to Follow-up|0|||
146766811|NCT00530842|529314608|FG001|Overall Study|Lost to Follow-up|4|||
146766812|NCT00530842|529314607|FG000|Overall Study|Protocol Violation|3|||
146766813|NCT00530842|529314608|FG001|Overall Study|Protocol Violation|2|||
146766814|NCT00530842|529314607|FG000|Overall Study|Withdrawal by Subject|4|||
146766815|NCT00530842|529314608|FG001|Overall Study|Withdrawal by Subject|5|||
146766816|NCT00530842|529314607|FG000|Overall Study|Individual different reasons|4|||
146766817|NCT00530842|529314608|FG001|Overall Study|Individual different reasons|3|||
146766818|NCT00530842|529314607|FG000|Period 1|Adverse Event|7|||
146766819|NCT00530842|529314608|FG001|Period 1|Adverse Event|3|||
146766820|NCT00530842|529314607|FG000|Period 1|Lack of Efficacy|1|||
146766821|NCT00530842|529314608|FG001|Period 1|Lack of Efficacy|1|||
146897093|NCT02747927|529788147|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
146897094|NCT02747927|529788146|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
146897095|NCT02747927|529788147|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
146897096|NCT02747927|529788146|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
146897097|NCT02747927|529788147|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
146897098|NCT02747927|529788146|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
146897099|NCT02747927|529788147|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
146897100|NCT02747927|529788146|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
146897101|NCT02747927|529788147|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
146897102|NCT02747927|529788146|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
146897103|NCT02747927|529788147|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
146897104|NCT02747927|529788146|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
146897105|NCT02747927|529788147|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
146897106|NCT02747927|529788146|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
146897107|NCT02747927|529788147|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
146897108|NCT02747927|529788146|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
146897109|NCT02747927|529788147|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
146897110|NCT02747927|529788146|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
146897111|NCT02747927|529788147|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
146897112|NCT02747927|529788146|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
146897113|NCT02747927|529788147|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
146897114|NCT02747927|529788146|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
146897115|NCT02747927|529788147|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
146897116|NCT02747927|529788146|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
146897117|NCT02747927|529788147|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
146897118|NCT02747927|529788146|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
146897119|NCT02747927|529788147|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
146897120|NCT02747927|529788146|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
146897121|NCT02747927|529788147|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
146897122|NCT02747927|529788146|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
146897123|NCT02747927|529788147|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
146897124|NCT02747927|529788146|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
146897125|NCT02747927|529788147|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
146897126|NCT02747927|529788146|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
146897127|NCT02747927|529788147|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
146897128|NCT02747927|529788146|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
146897129|NCT02747927|529788147|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
146897130|NCT02747927|529788146|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
146897131|NCT02747927|529788147|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
146897132|NCT02747927|529788146|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
146897133|NCT02747927|529788147|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
146897134|NCT02747927|529788146|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
146897135|NCT02747927|529788147|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
146897136|NCT01154101|529788148|FG000|Overall Study|Adverse Event|0|||
146897137|NCT01154101|529788149|FG001|Overall Study|Adverse Event|2|||
146897138|NCT01154101|529788150|FG002|Overall Study|Adverse Event|1|||
146897139|NCT01154101|529788151|FG003|Overall Study|Adverse Event|1|||
146897140|NCT01154101|529788152|FG004|Overall Study|Adverse Event|0|||
146897141|NCT01154101|529788148|FG000|Overall Study|Lost to Follow-up|0|||
146897142|NCT01154101|529788149|FG001|Overall Study|Lost to Follow-up|1|||
146640020|NCT02100696|528857833|FG002|Maintenance Phase|Adverse Event|0|||
146640021|NCT02100696|528857834|FG003|Maintenance Phase|Adverse Event|0|||
146640022|NCT02100696|528857835|FG004|Maintenance Phase|Adverse Event|0|||
146640023|NCT02100696|528857836|FG005|Maintenance Phase|Adverse Event|2|||
146640024|NCT02100696|528857831|FG000|Maintenance Phase|Lost to Follow-up|0|||
146640025|NCT02100696|528857832|FG001|Maintenance Phase|Lost to Follow-up|0|||
146640026|NCT02100696|528857833|FG002|Maintenance Phase|Lost to Follow-up|0|||
146640027|NCT02100696|528857834|FG003|Maintenance Phase|Lost to Follow-up|0|||
146640028|NCT02100696|528857835|FG004|Maintenance Phase|Lost to Follow-up|1|||
146640029|NCT02100696|528857836|FG005|Maintenance Phase|Lost to Follow-up|0|||
146640030|NCT02100696|528857831|FG000|Maintenance Phase|Protocol Violation|0|||
146640031|NCT02100696|528857832|FG001|Maintenance Phase|Protocol Violation|0|||
146640032|NCT02100696|528857833|FG002|Maintenance Phase|Protocol Violation|0|||
146640033|NCT02100696|528857834|FG003|Maintenance Phase|Protocol Violation|0|||
146640034|NCT02100696|528857835|FG004|Maintenance Phase|Protocol Violation|1|||
146640035|NCT02100696|528857836|FG005|Maintenance Phase|Protocol Violation|0|||
146897143|NCT01154101|529788150|FG002|Overall Study|Lost to Follow-up|0|||
146897144|NCT01154101|529788151|FG003|Overall Study|Lost to Follow-up|1|||
146897145|NCT01154101|529788152|FG004|Overall Study|Lost to Follow-up|0|||
146897146|NCT01154101|529788148|FG000|Overall Study|Withdrawal by Subject|0|||
146897147|NCT01154101|529788149|FG001|Overall Study|Withdrawal by Subject|1|||
146897148|NCT01154101|529788150|FG002|Overall Study|Withdrawal by Subject|2|||
146897149|NCT01154101|529788151|FG003|Overall Study|Withdrawal by Subject|0|||
146897150|NCT01154101|529788152|FG004|Overall Study|Withdrawal by Subject|1|||
146897151|NCT05019131|529788153|FG000|Overall Study|Lost to Follow-up|0|||
146897152|NCT05019131|529788154|FG001|Overall Study|Lost to Follow-up|3|||
146897153|NCT00432237|529788155|FG000|Overall Study|Adverse Event|0|||
146897154|NCT00432237|529788156|FG001|Overall Study|Adverse Event|0|||
146897155|NCT00432237|529788157|FG002|Overall Study|Adverse Event|0|||
146897156|NCT00432237|529788158|FG003|Overall Study|Adverse Event|1|||
146897157|NCT00432237|529788155|FG000|Overall Study|Lack of Efficacy|0|||
146897158|NCT00432237|529788156|FG001|Overall Study|Lack of Efficacy|0|||
146897159|NCT00432237|529788157|FG002|Overall Study|Lack of Efficacy|0|||
146897160|NCT00432237|529788158|FG003|Overall Study|Lack of Efficacy|1|||
146897161|NCT00432237|529788155|FG000|Overall Study|Lost to Follow-up|10|||
146897162|NCT00432237|529788156|FG001|Overall Study|Lost to Follow-up|10|||
146897163|NCT00432237|529788157|FG002|Overall Study|Lost to Follow-up|18|||
146897164|NCT00432237|529788158|FG003|Overall Study|Lost to Follow-up|18|||
146897165|NCT00432237|529788155|FG000|Overall Study|Physician Decision|1|||
146897166|NCT00432237|529788156|FG001|Overall Study|Physician Decision|3|||
146897167|NCT00432237|529788157|FG002|Overall Study|Physician Decision|2|||
146897168|NCT00432237|529788158|FG003|Overall Study|Physician Decision|1|||
146897169|NCT00432237|529788155|FG000|Overall Study|Pregnancy|0|||
146897170|NCT00432237|529788156|FG001|Overall Study|Pregnancy|1|||
146897171|NCT00432237|529788157|FG002|Overall Study|Pregnancy|0|||
146897172|NCT00432237|529788158|FG003|Overall Study|Pregnancy|0|||
146897173|NCT00432237|529788155|FG000|Overall Study|Protocol Violation|13|||
146897174|NCT00432237|529788156|FG001|Overall Study|Protocol Violation|10|||
146897175|NCT00432237|529788157|FG002|Overall Study|Protocol Violation|11|||
146897176|NCT00432237|529788158|FG003|Overall Study|Protocol Violation|8|||
146897177|NCT00432237|529788155|FG000|Overall Study|Withdrawal by Subject|5|||
146897178|NCT00432237|529788156|FG001|Overall Study|Withdrawal by Subject|6|||
146897179|NCT00432237|529788157|FG002|Overall Study|Withdrawal by Subject|9|||
146897180|NCT00432237|529788158|FG003|Overall Study|Withdrawal by Subject|11|||
146897181|NCT00432237|529788155|FG000|Overall Study|Lack of Qualifying Event|38|||
146897182|NCT00432237|529788156|FG001|Overall Study|Lack of Qualifying Event|71|||
146897183|NCT00432237|529788157|FG002|Overall Study|Lack of Qualifying Event|69|||
146897184|NCT00432237|529788158|FG003|Overall Study|Lack of Qualifying Event|84|||
146897185|NCT01354132|529788159|FG000|Randomization|Physician Decision|1|||
146897186|NCT01354132|529788160|FG001|Randomization|Physician Decision|0|||
146897187|NCT01354132|529788159|FG000|Randomization|Withdrawal by Subject|0|||
146897188|NCT01354132|529788160|FG001|Randomization|Withdrawal by Subject|1|||
146897189|NCT01354132|529788159|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
146897190|NCT01354132|529788160|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
146897191|NCT01354132|529788159|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
146897192|NCT01354132|529788160|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
146897193|NCT01354132|529788159|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
146897194|NCT01354132|529788160|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
146897195|NCT02360098|529788163|FG000|Overall Study|Physician Decision|7|||
146897196|NCT03293654|529788169|FG000|Overall Study|Lost to Follow-up|0|||
146897197|NCT03293654|529788170|FG001|Overall Study|Lost to Follow-up|1|||
146897198|NCT03293654|529788171|FG002|Overall Study|Lost to Follow-up|0|||
146897199|NCT01919307|529788172|FG000|Overall Study|Withdrawal by Subject|9|||
146897200|NCT02275533|529788174|FG000|Overall Study|Protocol Violation|2|||
146897201|NCT02275533|529788175|FG001|Overall Study|Protocol Violation|0|||
146897202|NCT02275533|529788174|FG000|Overall Study|Never received study treatment|1|||
146897203|NCT02275533|529788175|FG001|Overall Study|Never received study treatment|0|||
146897204|NCT02157883|529788179|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
146897205|NCT02157883|529788179|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
146766822|NCT00530842|529314607|FG000|Period 1|Protocol Violation|2|||
146766823|NCT00530842|529314608|FG001|Period 1|Protocol Violation|1|||
146766824|NCT00530842|529314607|FG000|Period 1|Withdrawal by Subject|2|||
146766825|NCT00530842|529314608|FG001|Period 1|Withdrawal by Subject|3|||
146897206|NCT02157883|529788179|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
146897207|NCT02157883|529788179|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
146897208|NCT02157883|529788179|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
146897209|NCT01323478|529788180|FG000|Overall Study|Adverse Event|7|||
146897210|NCT01323478|529788180|FG000|Overall Study|Lack of Efficacy|4|||
146897211|NCT01323478|529788180|FG000|Overall Study|Non-compliance With Study Product|3|||
146897212|NCT01323478|529788180|FG000|Overall Study|Protocol Violation|1|||
146897213|NCT01323478|529788180|FG000|Overall Study|Withdrawal of Consent|1|||
146897214|NCT01323478|529788180|FG000|Overall Study|Administrative or Other Reasons|8|||
146766826|NCT00530842|529314607|FG000|Period 1|Individual different reasons|2|||
146897215|NCT04067518|529788183|FG000|Overall Study|Adverse Event|1|||
146897216|NCT04067518|529788184|FG001|Overall Study|Adverse Event|3|||
146897217|NCT04067518|529788183|FG000|Overall Study|Screen failures|0|||
146897218|NCT04067518|529788184|FG001|Overall Study|Screen failures|1|||
146897219|NCT04067518|529788183|FG000|Overall Study|Enrolled but not treated|0|||
146897220|NCT04067518|529788184|FG001|Overall Study|Enrolled but not treated|1|||
146897221|NCT02771522|529788185|FG000|Overall Study|Lost to Follow-up|3|||
146897222|NCT02771522|529788185|FG000|Overall Study|Withdrawal by Subject|2|||
146897223|NCT02771522|529788185|FG000|Overall Study|No white spot lesions|3|||
146897224|NCT00862251|529788186|FG000|Overall Study|Adverse Event|8|||
146897225|NCT00862251|529788187|FG001|Overall Study|Adverse Event|3|||
146897226|NCT00862251|529788188|FG002|Overall Study|Adverse Event|1|||
146897227|NCT00862251|529788186|FG000|Overall Study|Lost to Follow-up|0|||
146897228|NCT00862251|529788187|FG001|Overall Study|Lost to Follow-up|0|||
146897229|NCT00862251|529788188|FG002|Overall Study|Lost to Follow-up|1|||
146897230|NCT00862251|529788186|FG000|Overall Study|Protocol Violation|2|||
146897231|NCT00862251|529788187|FG001|Overall Study|Protocol Violation|0|||
146897232|NCT00862251|529788188|FG002|Overall Study|Protocol Violation|1|||
146897233|NCT00862251|529788186|FG000|Overall Study|Withdrawal by Subject|9|||
146897234|NCT00862251|529788187|FG001|Overall Study|Withdrawal by Subject|2|||
146897235|NCT00862251|529788188|FG002|Overall Study|Withdrawal by Subject|6|||
146897236|NCT02054702|529788195|FG000|Overall Study|Lost to Follow-up|3|||
146897237|NCT02054702|529788196|FG001|Overall Study|Lost to Follow-up|5|||
146897238|NCT02054702|529788195|FG000|Overall Study|Adverse Event|3|||
146897239|NCT02054702|529788196|FG001|Overall Study|Adverse Event|1|||
146897240|NCT02054702|529788195|FG000|Overall Study|Met Withdrawal Criteria|4|||
146897241|NCT02054702|529788196|FG001|Overall Study|Met Withdrawal Criteria|1|||
146897242|NCT02054702|529788195|FG000|Overall Study|Physician Decision|0|||
146897243|NCT02054702|529788196|FG001|Overall Study|Physician Decision|1|||
146897244|NCT02054702|529788195|FG000|Overall Study|Withdrawal by Subject|14|||
146897245|NCT02054702|529788196|FG001|Overall Study|Withdrawal by Subject|4|||
146897246|NCT04525703|529788205|FG000|Overall Study|Lost to Follow-up|6|||
146897247|NCT04525703|529788206|FG001|Overall Study|Lost to Follow-up|15|||
146897248|NCT04525703|529788207|FG002|Overall Study|Lost to Follow-up|8|||
146897249|NCT01957137|529788208|FG000|Randomized Portion|Adverse Event|1|||
146897250|NCT01957137|529788208|FG000|Randomized Portion|Withdrawal by Subject|1|||
146897251|NCT03898063|529788211|FG000|Overall Study|Withdrawal by Subject|10|||
146897252|NCT03898063|529788212|FG001|Overall Study|Withdrawal by Subject|8|||
146897253|NCT01651780|529788213|FG000|Overall Study|Physician decision: No 30-day visit|2|||
146897254|NCT01651780|529788214|FG001|Overall Study|Physician decision: No 30-day visit|1|||
146897255|NCT01651780|529788213|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
146897256|NCT01651780|529788214|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
146897257|NCT01651780|529788213|FG000|Overall Study|Withdrawal by Subject|2|||
146897258|NCT01651780|529788214|FG001|Overall Study|Withdrawal by Subject|0|||
146897259|NCT01651780|529788213|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
146897260|NCT01651780|529788214|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146897261|NCT01651780|529788213|FG000|Overall Study|Lost to Follow-up|1|||
146897262|NCT01651780|529788214|FG001|Overall Study|Lost to Follow-up|2|||
146897263|NCT01651780|529788213|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
146897264|NCT01651780|529788214|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
146897265|NCT00054132|529788215|FG000|Overall Study|Not Treated|1|||
146897266|NCT03952559|529788218|FG000|Double Blind Treatment Period|Adverse Event|0|||
146897267|NCT03952559|529788219|FG001|Double Blind Treatment Period|Adverse Event|2|||
146897268|NCT03952559|529788220|FG002|Double Blind Treatment Period|Adverse Event|1|||
146897269|NCT03952559|529788221|FG003|Double Blind Treatment Period|Adverse Event|0|||
146897270|NCT03952559|529788222|FG004|Double Blind Treatment Period|Adverse Event|1|||
146897271|NCT03952559|529788218|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
146897272|NCT03952559|529788219|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
146897273|NCT03952559|529788220|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
146897274|NCT03952559|529788221|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
146897275|NCT03952559|529788222|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
146640036|NCT02100696|528857831|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146640037|NCT02100696|528857832|FG001|Maintenance Phase|Withdrawal by Subject|0|||
146640038|NCT02100696|528857833|FG002|Maintenance Phase|Withdrawal by Subject|0|||
146640039|NCT02100696|528857834|FG003|Maintenance Phase|Withdrawal by Subject|1|||
146897276|NCT03952559|529788218|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
146897277|NCT03952559|529788219|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
146897278|NCT03952559|529788220|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
146897279|NCT03952559|529788221|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
146897280|NCT03952559|529788222|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
146897281|NCT03952559|529788218|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
146897282|NCT03952559|529788219|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
146897283|NCT03952559|529788220|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
146897284|NCT03952559|529788221|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
146897285|NCT03952559|529788222|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
146897286|NCT02875223|529788223|FG000|Overall Study|Other reasons|0|||
146897287|NCT02875223|529788224|FG001|Overall Study|Other reasons|0|||
146897288|NCT02875223|529788225|FG002|Overall Study|Other reasons|1|||
146897289|NCT02875223|529788226|FG003|Overall Study|Other reasons|0|||
146897290|NCT02875223|529788227|FG004|Overall Study|Other reasons|1|||
146897291|NCT02875223|529788228|FG005|Overall Study|Other reasons|2|||
146897292|NCT02875223|529788229|FG006|Overall Study|Other reasons|0|||
146897293|NCT02875223|529788230|FG007|Overall Study|Other reasons|2|||
146897294|NCT02875223|529788231|FG008|Overall Study|Other reasons|0|||
146897295|NCT02875223|529788232|FG009|Overall Study|Other reasons|0|||
146897296|NCT02875223|529788233|FG010|Overall Study|Other reasons|0|||
146897297|NCT02875223|529788234|FG011|Overall Study|Other reasons|0|||
146897298|NCT02875223|529788235|FG012|Overall Study|Other reasons|0|||
146897299|NCT02875223|529788223|FG000|Overall Study|Withdrawal by Subject|0|||
146897300|NCT02875223|529788224|FG001|Overall Study|Withdrawal by Subject|0|||
146897301|NCT02875223|529788225|FG002|Overall Study|Withdrawal by Subject|0|||
146897302|NCT02875223|529788226|FG003|Overall Study|Withdrawal by Subject|0|||
146897303|NCT02875223|529788227|FG004|Overall Study|Withdrawal by Subject|1|||
146897304|NCT02875223|529788228|FG005|Overall Study|Withdrawal by Subject|1|||
146897305|NCT02875223|529788229|FG006|Overall Study|Withdrawal by Subject|0|||
146897306|NCT02875223|529788230|FG007|Overall Study|Withdrawal by Subject|0|||
146897307|NCT02875223|529788231|FG008|Overall Study|Withdrawal by Subject|1|||
146897308|NCT02875223|529788232|FG009|Overall Study|Withdrawal by Subject|0|||
146897309|NCT02875223|529788233|FG010|Overall Study|Withdrawal by Subject|0|||
146897310|NCT02875223|529788234|FG011|Overall Study|Withdrawal by Subject|0|||
146897311|NCT02875223|529788235|FG012|Overall Study|Withdrawal by Subject|0|||
146897312|NCT02875223|529788223|FG000|Overall Study|Progressive disease|0|||
146897313|NCT02875223|529788224|FG001|Overall Study|Progressive disease|0|||
146897314|NCT02875223|529788225|FG002|Overall Study|Progressive disease|1|||
146897315|NCT02875223|529788226|FG003|Overall Study|Progressive disease|0|||
146897316|NCT02875223|529788227|FG004|Overall Study|Progressive disease|0|||
146897317|NCT02875223|529788228|FG005|Overall Study|Progressive disease|0|||
146897318|NCT02875223|529788229|FG006|Overall Study|Progressive disease|0|||
146897319|NCT02875223|529788230|FG007|Overall Study|Progressive disease|0|||
146897320|NCT02875223|529788231|FG008|Overall Study|Progressive disease|0|||
146897321|NCT02875223|529788232|FG009|Overall Study|Progressive disease|12|||
146897322|NCT02875223|529788233|FG010|Overall Study|Progressive disease|2|||
146897323|NCT02875223|529788234|FG011|Overall Study|Progressive disease|3|||
146897324|NCT02875223|529788235|FG012|Overall Study|Progressive disease|6|||
146897325|NCT02875223|529788223|FG000|Overall Study|Death|4|||
146897326|NCT02875223|529788224|FG001|Overall Study|Death|4|||
146897327|NCT02875223|529788225|FG002|Overall Study|Death|3|||
146897328|NCT02875223|529788226|FG003|Overall Study|Death|4|||
146897329|NCT02875223|529788227|FG004|Overall Study|Death|2|||
146897330|NCT02875223|529788228|FG005|Overall Study|Death|3|||
146897331|NCT02875223|529788229|FG006|Overall Study|Death|5|||
146897332|NCT02875223|529788230|FG007|Overall Study|Death|7|||
146897333|NCT02875223|529788231|FG008|Overall Study|Death|3|||
146897334|NCT02875223|529788232|FG009|Overall Study|Death|2|||
146897335|NCT02875223|529788233|FG010|Overall Study|Death|0|||
146897336|NCT02875223|529788234|FG011|Overall Study|Death|0|||
146897337|NCT02875223|529788235|FG012|Overall Study|Death|0|||
146897338|NCT02875223|529788223|FG000|Overall Study|Lost to Follow-up|0|||
146897339|NCT02875223|529788224|FG001|Overall Study|Lost to Follow-up|1|||
146897340|NCT02875223|529788225|FG002|Overall Study|Lost to Follow-up|1|||
146897341|NCT02875223|529788226|FG003|Overall Study|Lost to Follow-up|0|||
146897342|NCT02875223|529788227|FG004|Overall Study|Lost to Follow-up|1|||
146897343|NCT02875223|529788228|FG005|Overall Study|Lost to Follow-up|0|||
146897344|NCT02875223|529788229|FG006|Overall Study|Lost to Follow-up|1|||
146897345|NCT02875223|529788230|FG007|Overall Study|Lost to Follow-up|1|||
146897346|NCT02875223|529788231|FG008|Overall Study|Lost to Follow-up|0|||
146897347|NCT02875223|529788232|FG009|Overall Study|Lost to Follow-up|0|||
146897348|NCT02875223|529788233|FG010|Overall Study|Lost to Follow-up|0|||
146897349|NCT02875223|529788234|FG011|Overall Study|Lost to Follow-up|0|||
146897350|NCT02875223|529788235|FG012|Overall Study|Lost to Follow-up|0|||
146897351|NCT01870739|529788236|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
146897352|NCT01870739|529788237|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
146897353|NCT01870739|529788236|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
146640040|NCT02100696|528857835|FG004|Maintenance Phase|Withdrawal by Subject|4|||
146897354|NCT01870739|529788237|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
146897355|NCT01870739|529788236|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
146897356|NCT01870739|529788237|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
146897357|NCT01870739|529788236|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
146897358|NCT01870739|529788237|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
146897359|NCT01870739|529788236|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
146897360|NCT01870739|529788237|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
146897361|NCT01870739|529788236|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
146897362|NCT01870739|529788237|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
146897363|NCT01870739|529788236|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
146897364|NCT01870739|529788237|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
146897365|NCT01986062|529788238|FG000|Overall Study|Lost to Follow-up|1|||
146897366|NCT01986062|529788239|FG001|Overall Study|Lost to Follow-up|0|||
146897367|NCT01986062|529788238|FG000|Overall Study|Withdrawal by Subject|0|||
146897368|NCT01986062|529788239|FG001|Overall Study|Withdrawal by Subject|1|||
146897369|NCT01926626|529788241|FG000|Overall Study|Withdrawal by Subject|15|||
146897370|NCT01926626|529788241|FG000|Overall Study|Lost to Follow-up|7|||
146897371|NCT01817790|529788242|FG000|Overall Study|Adverse Event|0|||
146897372|NCT01817790|529788243|FG001|Overall Study|Adverse Event|2|||
146897373|NCT01817790|529788242|FG000|Overall Study|Lost to Follow-up|0|||
146897374|NCT01817790|529788243|FG001|Overall Study|Lost to Follow-up|1|||
146897375|NCT01817790|529788242|FG000|Overall Study|Protocol Violation|2|||
146897376|NCT01817790|529788243|FG001|Overall Study|Protocol Violation|1|||
146897377|NCT01817790|529788242|FG000|Overall Study|Withdrawal by Subject|1|||
146897378|NCT01817790|529788243|FG001|Overall Study|Withdrawal by Subject|3|||
146897379|NCT01817790|529788242|FG000|Overall Study|Other: Could not attend appointment|1|||
146897380|NCT01817790|529788243|FG001|Overall Study|Other: Could not attend appointment|1|||
146897381|NCT01671345|529788244|FG000|Overall Study|Lost to Follow-up|10|||
146897382|NCT01671345|529788245|FG001|Overall Study|Lost to Follow-up|6|||
146897383|NCT01671345|529788244|FG000|Overall Study|visit with non-participating physician|3|||
146897384|NCT01671345|529788245|FG001|Overall Study|visit with non-participating physician|3|||
146897385|NCT03636906|529788246|FG000|Overall Study|Adverse Event|0|||
146897386|NCT03636906|529788247|FG001|Overall Study|Adverse Event|0|||
146897387|NCT03636906|529788248|FG002|Overall Study|Adverse Event|1|||
146897388|NCT03636906|529788246|FG000|Overall Study|Lost to Follow-up|1|||
146897389|NCT03636906|529788247|FG001|Overall Study|Lost to Follow-up|0|||
146897390|NCT03636906|529788248|FG002|Overall Study|Lost to Follow-up|0|||
146897391|NCT03636906|529788246|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
146897392|NCT03636906|529788247|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
146897393|NCT03636906|529788248|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
146897394|NCT03636906|529788246|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
146897395|NCT03636906|529788247|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
146897396|NCT03636906|529788248|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
146897397|NCT03636906|529788246|FG000|Overall Study|Other|0|||
146897398|NCT03636906|529788247|FG001|Overall Study|Other|0|||
146897399|NCT03636906|529788248|FG002|Overall Study|Other|1|||
146897400|NCT00891202|529788249|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
146897401|NCT00891202|529788250|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
146897402|NCT00891202|529788251|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
146640041|NCT02100696|528857836|FG005|Maintenance Phase|Withdrawal by Subject|2|||
146640042|NCT02100696|528857831|FG000|Maintenance Phase|Physician Decision|0|||
146640043|NCT02100696|528857832|FG001|Maintenance Phase|Physician Decision|0|||
146640044|NCT02100696|528857833|FG002|Maintenance Phase|Physician Decision|0|||
146640045|NCT02100696|528857834|FG003|Maintenance Phase|Physician Decision|0|||
146640046|NCT02100696|528857835|FG004|Maintenance Phase|Physician Decision|1|||
146640047|NCT02100696|528857836|FG005|Maintenance Phase|Physician Decision|0|||
146640048|NCT02100696|528857831|FG000|Maintenance Phase|Multiple Reasons|0|||
146640049|NCT02100696|528857832|FG001|Maintenance Phase|Multiple Reasons|0|||
146640050|NCT02100696|528857833|FG002|Maintenance Phase|Multiple Reasons|0|||
146640051|NCT02100696|528857834|FG003|Maintenance Phase|Multiple Reasons|0|||
146640052|NCT02100696|528857835|FG004|Maintenance Phase|Multiple Reasons|2|||
146640053|NCT02100696|528857836|FG005|Maintenance Phase|Multiple Reasons|1|||
146640054|NCT03865381|528857840|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
146640055|NCT03865381|528857840|FG000|Overall Study|Withdrawal by Subject|2|||
146640056|NCT04999852|528857841|FG000|Overall Study|Withdrawal by Subject|11|||
146640057|NCT04999852|528857842|FG001|Overall Study|Withdrawal by Subject|1|||
146897403|NCT00891202|529788252|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
146897404|NCT00891202|529788249|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
146640058|NCT04999852|528857841|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
146640059|NCT04999852|528857842|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
146897405|NCT00891202|529788250|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
146897406|NCT00891202|529788251|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
146897407|NCT00891202|529788252|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
146897408|NCT00891202|529788249|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
146897409|NCT00891202|529788250|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
146897410|NCT00891202|529788251|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
146766827|NCT00530842|529314608|FG001|Period 1|Individual different reasons|3|||
146766828|NCT00530842|529314607|FG000|Period 2|Adverse Event|3|||
146766829|NCT00530842|529314608|FG001|Period 2|Adverse Event|3|||
146766830|NCT00530842|529314607|FG000|Period 2|Lack of Efficacy|1|||
146766831|NCT00530842|529314608|FG001|Period 2|Lack of Efficacy|0|||
146766832|NCT00530842|529314607|FG000|Period 2|Lost to Follow-up|0|||
146766833|NCT00530842|529314608|FG001|Period 2|Lost to Follow-up|4|||
146766834|NCT00530842|529314607|FG000|Period 2|Protocol Violation|1|||
146766835|NCT00530842|529314608|FG001|Period 2|Protocol Violation|0|||
146766836|NCT00530842|529314607|FG000|Period 2|Withdrawal by Subject|1|||
146897411|NCT00891202|529788252|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
146897412|NCT00891202|529788249|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
146897413|NCT00891202|529788250|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
146897414|NCT00891202|529788251|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
146897415|NCT00891202|529788252|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
146897416|NCT03690869|529788254|FG000|Overall Study|Adverse Event|0|||
146897417|NCT03690869|529788255|FG001|Overall Study|Adverse Event|0|||
146897418|NCT03690869|529788256|FG002|Overall Study|Adverse Event|0|||
146897419|NCT03690869|529788257|FG003|Overall Study|Adverse Event|1|||
146897420|NCT03690869|529788258|FG004|Overall Study|Adverse Event|0|||
146897421|NCT03690869|529788259|FG005|Overall Study|Adverse Event|0|||
146897422|NCT03690869|529788260|FG006|Overall Study|Adverse Event|0|||
146897423|NCT03690869|529788261|FG007|Overall Study|Adverse Event|1|||
146897424|NCT03690869|529788262|FG008|Overall Study|Adverse Event|0|||
146897425|NCT03690869|529788263|FG009|Overall Study|Adverse Event|1|||
146897426|NCT03690869|529788254|FG000|Overall Study|Death|1|||
146897427|NCT03690869|529788255|FG001|Overall Study|Death|1|||
146897428|NCT03690869|529788256|FG002|Overall Study|Death|1|||
146897429|NCT03690869|529788257|FG003|Overall Study|Death|4|||
146897430|NCT03690869|529788258|FG004|Overall Study|Death|2|||
146897431|NCT03690869|529788259|FG005|Overall Study|Death|5|||
146897432|NCT03690869|529788260|FG006|Overall Study|Death|3|||
146897433|NCT03690869|529788261|FG007|Overall Study|Death|2|||
146897434|NCT03690869|529788262|FG008|Overall Study|Death|0|||
146897435|NCT03690869|529788263|FG009|Overall Study|Death|3|||
146897436|NCT03690869|529788254|FG000|Overall Study|Lost to Follow-up|0|||
146897437|NCT03690869|529788255|FG001|Overall Study|Lost to Follow-up|0|||
146897438|NCT03690869|529788256|FG002|Overall Study|Lost to Follow-up|1|||
146897439|NCT03690869|529788257|FG003|Overall Study|Lost to Follow-up|0|||
146897440|NCT03690869|529788258|FG004|Overall Study|Lost to Follow-up|0|||
146897441|NCT03690869|529788259|FG005|Overall Study|Lost to Follow-up|0|||
146897442|NCT03690869|529788260|FG006|Overall Study|Lost to Follow-up|0|||
146897443|NCT03690869|529788261|FG007|Overall Study|Lost to Follow-up|0|||
146897444|NCT03690869|529788262|FG008|Overall Study|Lost to Follow-up|0|||
146897445|NCT03690869|529788263|FG009|Overall Study|Lost to Follow-up|0|||
146897446|NCT03690869|529788254|FG000|Overall Study|Other Treatment|1|||
146897447|NCT03690869|529788255|FG001|Overall Study|Other Treatment|1|||
146897448|NCT03690869|529788256|FG002|Overall Study|Other Treatment|1|||
146897449|NCT03690869|529788257|FG003|Overall Study|Other Treatment|2|||
146897450|NCT03690869|529788258|FG004|Overall Study|Other Treatment|3|||
146897451|NCT03690869|529788259|FG005|Overall Study|Other Treatment|1|||
146968863|NCT00877799|530045543|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
146968864|NCT00877799|530045544|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
146968865|NCT00877799|530045545|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
146968866|NCT00877799|530045546|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
146640060|NCT05626322|528857843|FG000|Overall Study|Death|2|||
146640061|NCT05626322|528857844|FG001|Overall Study|Death|0|||
146640062|NCT05626322|528857845|FG002|Overall Study|Death|0|||
146640063|NCT05626322|528857843|FG000|Overall Study|Physician Decision|1|||
146640064|NCT05626322|528857844|FG001|Overall Study|Physician Decision|0|||
146640065|NCT05626322|528857845|FG002|Overall Study|Physician Decision|0|||
146640066|NCT05626322|528857843|FG000|Overall Study|Progressive Disease|0|||
146640067|NCT05626322|528857844|FG001|Overall Study|Progressive Disease|1|||
146897452|NCT03690869|529788260|FG006|Overall Study|Other Treatment|2|||
146897453|NCT03690869|529788261|FG007|Overall Study|Other Treatment|7|||
146897454|NCT03690869|529788262|FG008|Overall Study|Other Treatment|0|||
146897455|NCT03690869|529788263|FG009|Overall Study|Other Treatment|3|||
146897456|NCT03690869|529788254|FG000|Overall Study|Physician Decision|0|||
146897457|NCT03690869|529788255|FG001|Overall Study|Physician Decision|1|||
146897458|NCT03690869|529788256|FG002|Overall Study|Physician Decision|0|||
146897459|NCT03690869|529788257|FG003|Overall Study|Physician Decision|0|||
146897460|NCT03690869|529788258|FG004|Overall Study|Physician Decision|0|||
146897461|NCT03690869|529788259|FG005|Overall Study|Physician Decision|0|||
146640068|NCT05626322|528857845|FG002|Overall Study|Progressive Disease|1|||
146640069|NCT05626322|528857843|FG000|Overall Study|Study terminated by sponsor|0|||
146640070|NCT05626322|528857844|FG001|Overall Study|Study terminated by sponsor|1|||
146640071|NCT05626322|528857845|FG002|Overall Study|Study terminated by sponsor|0|||
146897462|NCT03690869|529788260|FG006|Overall Study|Physician Decision|0|||
146897463|NCT03690869|529788261|FG007|Overall Study|Physician Decision|0|||
146897464|NCT03690869|529788262|FG008|Overall Study|Physician Decision|0|||
146897465|NCT03690869|529788263|FG009|Overall Study|Physician Decision|0|||
146897466|NCT03690869|529788254|FG000|Overall Study|Progressive Disease|1|||
146897467|NCT03690869|529788255|FG001|Overall Study|Progressive Disease|2|||
146897468|NCT03690869|529788256|FG002|Overall Study|Progressive Disease|0|||
146897469|NCT03690869|529788257|FG003|Overall Study|Progressive Disease|1|||
146897470|NCT03690869|529788258|FG004|Overall Study|Progressive Disease|0|||
146897471|NCT03690869|529788259|FG005|Overall Study|Progressive Disease|0|||
146897472|NCT03690869|529788260|FG006|Overall Study|Progressive Disease|0|||
146897473|NCT03690869|529788261|FG007|Overall Study|Progressive Disease|0|||
146897474|NCT03690869|529788262|FG008|Overall Study|Progressive Disease|1|||
146897475|NCT03690869|529788263|FG009|Overall Study|Progressive Disease|1|||
146897476|NCT03690869|529788254|FG000|Overall Study|Subject Decision|0|||
146897477|NCT03690869|529788255|FG001|Overall Study|Subject Decision|0|||
146897478|NCT03690869|529788256|FG002|Overall Study|Subject Decision|0|||
146897479|NCT03690869|529788257|FG003|Overall Study|Subject Decision|1|||
146897480|NCT03690869|529788258|FG004|Overall Study|Subject Decision|0|||
146897481|NCT03690869|529788259|FG005|Overall Study|Subject Decision|0|||
146897482|NCT03690869|529788260|FG006|Overall Study|Subject Decision|0|||
146897483|NCT03690869|529788261|FG007|Overall Study|Subject Decision|1|||
146897484|NCT03690869|529788262|FG008|Overall Study|Subject Decision|0|||
146897485|NCT03690869|529788263|FG009|Overall Study|Subject Decision|0|||
146897486|NCT04280081|529788265|FG000|Overall Study|Adverse Event|4|||
146897487|NCT04280081|529788265|FG000|Overall Study|Death|2|||
146897488|NCT04280081|529788265|FG000|Overall Study|Progressive Disease|6|||
146897489|NCT03263806|529789871|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
146897490|NCT03263806|529789872|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
146897491|NCT03263806|529789871|FG000|Overall Study|Withdrawal by Subject|0|||
146897492|NCT03263806|529789872|FG001|Overall Study|Withdrawal by Subject|1|||
146897493|NCT03263806|529789871|FG000|Overall Study|Study Termination|5|||
146897494|NCT03263806|529789872|FG001|Overall Study|Study Termination|6|||
146897495|NCT02338843|529789879|FG000|Overall Study|Adverse Event|2|||
146897496|NCT02338843|529789880|FG001|Overall Study|Adverse Event|1|||
146897497|NCT02338843|529789879|FG000|Overall Study|Death|40|||
146897498|NCT02338843|529789880|FG001|Overall Study|Death|53|||
146897499|NCT02338843|529789879|FG000|Overall Study|Physician Decision|1|||
146897500|NCT02338843|529789880|FG001|Overall Study|Physician Decision|0|||
146897501|NCT02338843|529789879|FG000|Overall Study|Withdrawal by Subject|0|||
146897502|NCT02338843|529789880|FG001|Overall Study|Withdrawal by Subject|2|||
146897503|NCT02338843|529789879|FG000|Overall Study|Subject Recovered|0|||
146897504|NCT02338843|529789880|FG001|Overall Study|Subject Recovered|2|||
146897505|NCT02338843|529789879|FG000|Overall Study|Discontinued prior to randomizat|1|||
146897506|NCT02338843|529789880|FG001|Overall Study|Discontinued prior to randomizat|0|||
146897507|NCT01609933|529789885|FG000|Overall Study|Adverse Event|1|||
146897508|NCT01609933|529789885|FG000|Overall Study|Withdrawal by Subject|3|||
146897509|NCT01252966|529789886|FG000|Overall Study|Lost to Follow-up|16|||
146897510|NCT01252966|529789887|FG001|Overall Study|Lost to Follow-up|10|||
146897511|NCT01252966|529789886|FG000|Overall Study|Withdrawal by Subject|7|||
146897512|NCT01252966|529789887|FG001|Overall Study|Withdrawal by Subject|3|||
146897513|NCT05194345|529789892|FG000|Overall Study|Withdrawal by Subject|6|||
146897514|NCT05194345|529789893|FG001|Overall Study|Withdrawal by Subject|4|||
146897515|NCT05194345|529789894|FG002|Overall Study|Withdrawal by Subject|0|||
146559262|NCT01217892|528557357|FG001|Overall Study|Poor/Non-Compliance|0|||
146559263|NCT01217892|528557358|FG002|Overall Study|Poor/Non-Compliance|1|||
146559264|NCT01217892|528557359|FG003|Overall Study|Poor/Non-Compliance|0|||
146559265|NCT01052779|528557360|FG000|Overall Study|Adverse Event|1|||
146897516|NCT05194345|529789892|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
146897517|NCT05194345|529789893|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
146897518|NCT05194345|529789894|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
146897519|NCT04854499|529789895|FG000|Overall Study|Study Terminated by Sponsor|5|||
146897520|NCT04854499|529789896|FG001|Overall Study|Study Terminated by Sponsor|27|||
146897521|NCT04854499|529789897|FG002|Overall Study|Study Terminated by Sponsor|28|||
146897522|NCT04854499|529789898|FG003|Overall Study|Study Terminated by Sponsor|19|||
146897523|NCT04854499|529789899|FG004|Overall Study|Study Terminated by Sponsor|1|||
146897524|NCT04854499|529789900|FG005|Overall Study|Study Terminated by Sponsor|10|||
146897525|NCT04854499|529789895|FG000|Overall Study|Death|1|||
146897526|NCT04854499|529789896|FG001|Overall Study|Death|23|||
146897527|NCT04854499|529789897|FG002|Overall Study|Death|21|||
146897528|NCT04854499|529789898|FG003|Overall Study|Death|7|||
146897529|NCT04854499|529789899|FG004|Overall Study|Death|6|||
146897530|NCT04854499|529789900|FG005|Overall Study|Death|24|||
146897531|NCT04854499|529789895|FG000|Overall Study|Investigator's Discretion|0|||
146897532|NCT04854499|529789896|FG001|Overall Study|Investigator's Discretion|1|||
146559266|NCT01052779|528557361|FG001|Overall Study|Adverse Event|4|||
146897533|NCT04854499|529789897|FG002|Overall Study|Investigator's Discretion|3|||
146897534|NCT04854499|529789898|FG003|Overall Study|Investigator's Discretion|4|||
146559267|NCT01052779|528557360|FG000|Overall Study|Withdrawal by Subject|1|||
146897535|NCT04854499|529789899|FG004|Overall Study|Investigator's Discretion|1|||
146766837|NCT00530842|529314608|FG001|Period 2|Withdrawal by Subject|2|||
146766838|NCT00530842|529314607|FG000|Period 2|Individual different reasons|2|||
146766839|NCT00530842|529314608|FG001|Period 2|Individual different reasons|0|||
146766840|NCT02534350|529314609|FG000|Overall Study|Randomized But Not Treated|1|||
146766841|NCT02534350|529314610|FG001|Overall Study|Randomized But Not Treated|0|||
146766842|NCT02534350|529314609|FG000|Overall Study|Protocol Violation|1|||
146766843|NCT02534350|529314610|FG001|Overall Study|Protocol Violation|0|||
146766844|NCT02534350|529314609|FG000|Overall Study|Withdrew Consent|2|||
146766845|NCT02534350|529314610|FG001|Overall Study|Withdrew Consent|0|||
146766846|NCT01161498|529314611|FG000|Overall Study|Disease Progression|0|||
146766847|NCT01161498|529314612|FG001|Overall Study|Disease Progression|1|||
146766848|NCT02807493|529314613|FG000|Overall Study|Adverse Event|5|||
146766849|NCT02807493|529314614|FG001|Overall Study|Adverse Event|2|||
146766850|NCT02807493|529314613|FG000|Overall Study|Lost to Follow-up|6|||
146766851|NCT02807493|529314614|FG001|Overall Study|Lost to Follow-up|0|||
146766852|NCT02807493|529314613|FG000|Overall Study|Physician Decision|4|||
146766853|NCT02807493|529314614|FG001|Overall Study|Physician Decision|1|||
146766854|NCT02807493|529314613|FG000|Overall Study|Protocol Violation|7|||
146766855|NCT02807493|529314614|FG001|Overall Study|Protocol Violation|0|||
146766856|NCT02807493|529314613|FG000|Overall Study|Withdrawal by Subject|17|||
146766857|NCT02807493|529314614|FG001|Overall Study|Withdrawal by Subject|10|||
146766858|NCT02807493|529314613|FG000|Overall Study|Other withdrawal|17|||
146766859|NCT02807493|529314614|FG001|Overall Study|Other withdrawal|0|||
146766860|NCT02807493|529314613|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
146766861|NCT02807493|529314614|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
146766862|NCT01493778|529314615|FG000|Overall Study|Withdrawal by Subject|8|||
146766863|NCT01227707|529314616|FG000|Overall Study|Adverse Event|10|||
146766864|NCT01227707|529314616|FG000|Overall Study|Progression of disease|3|||
146766865|NCT01227707|529314616|FG000|Overall Study|Withdrawal by Subject|1|||
146766866|NCT01227707|529314616|FG000|Overall Study|Patient non-compliance|3|||
146766867|NCT01227707|529314616|FG000|Overall Study|Medical decision|6|||
146766868|NCT01227707|529314616|FG000|Overall Study|Death|1|||
146766869|NCT00823979|529314629|FG000|Overall Study|Lack of Efficacy|13|||
146766870|NCT00823979|529314630|FG001|Overall Study|Lack of Efficacy|16|||
146766871|NCT00823979|529314631|FG002|Overall Study|Lack of Efficacy|9|||
146766872|NCT00823979|529314629|FG000|Overall Study|Lost to Follow-up|2|||
146640072|NCT03776812|528857846|FG000|Overall Study|Death|53|||
146640073|NCT03776812|528857847|FG001|Overall Study|Death|49|||
146640074|NCT03776812|528857848|FG002|Overall Study|Death|56|||
146640075|NCT03776812|528857846|FG000|Overall Study|Withdrawal by Subject|1|||
146640076|NCT03776812|528857847|FG001|Overall Study|Withdrawal by Subject|7|||
146640077|NCT03776812|528857848|FG002|Overall Study|Withdrawal by Subject|2|||
146640078|NCT03776812|528857846|FG000|Overall Study|Lost to Follow-up|1|||
146640079|NCT03776812|528857847|FG001|Overall Study|Lost to Follow-up|1|||
146640080|NCT03776812|528857848|FG002|Overall Study|Lost to Follow-up|0|||
146640081|NCT03776812|528857846|FG000|Overall Study|Did not enter long-term follow-up|3|||
146640082|NCT03776812|528857847|FG001|Overall Study|Did not enter long-term follow-up|3|||
146640083|NCT03776812|528857848|FG002|Overall Study|Did not enter long-term follow-up|2|||
146640084|NCT04758637|528857851|FG000|Overall Study|Lost to Follow-up|0|||
146640085|NCT04758637|528857852|FG001|Overall Study|Lost to Follow-up|1|||
146640086|NCT04758637|528857853|FG002|Overall Study|Lost to Follow-up|0|||
146640087|NCT04758637|528857854|FG003|Overall Study|Lost to Follow-up|0|||
146640088|NCT03350672|528857860|FG000|Overall Study|Withdrawal by Subject|7|||
146640089|NCT03350672|528857861|FG001|Overall Study|Withdrawal by Subject|0|||
146640090|NCT03350672|528857862|FG002|Overall Study|Withdrawal by Subject|0|||
146766873|NCT00823979|529314630|FG001|Overall Study|Lost to Follow-up|1|||
146897536|NCT04854499|529789900|FG005|Overall Study|Investigator's Discretion|5|||
146897537|NCT04854499|529789895|FG000|Overall Study|Withdrew Consent|0|||
146897538|NCT04854499|529789896|FG001|Overall Study|Withdrew Consent|1|||
146897539|NCT04854499|529789897|FG002|Overall Study|Withdrew Consent|2|||
146897540|NCT04854499|529789898|FG003|Overall Study|Withdrew Consent|2|||
146897541|NCT04854499|529789899|FG004|Overall Study|Withdrew Consent|0|||
146640091|NCT00048074|528857865|FG000|Overall Study|Adverse Event|46|||
146640092|NCT00048074|528857866|FG001|Overall Study|Adverse Event|41|||
146766874|NCT00823979|529314631|FG002|Overall Study|Lost to Follow-up|0|||
146640093|NCT00048074|528857867|FG002|Overall Study|Adverse Event|53|||
146897542|NCT04854499|529789900|FG005|Overall Study|Withdrew Consent|1|||
146897543|NCT04854499|529789895|FG000|Overall Study|Lost to Follow-up|0|||
146640094|NCT00048074|528857865|FG000|Overall Study|Death|3|||
146640095|NCT00048074|528857866|FG001|Overall Study|Death|3|||
146640096|NCT00048074|528857867|FG002|Overall Study|Death|2|||
146766875|NCT00823979|529314629|FG000|Overall Study|Withdrawal by Subject|2|||
146766876|NCT00823979|529314630|FG001|Overall Study|Withdrawal by Subject|3|||
146766877|NCT00823979|529314631|FG002|Overall Study|Withdrawal by Subject|2|||
146766878|NCT00823979|529314629|FG000|Overall Study|Protocol Violation|1|||
146766879|NCT00823979|529314630|FG001|Overall Study|Protocol Violation|1|||
146897544|NCT04854499|529789896|FG001|Overall Study|Lost to Follow-up|0|||
146897545|NCT04854499|529789897|FG002|Overall Study|Lost to Follow-up|0|||
146897546|NCT04854499|529789898|FG003|Overall Study|Lost to Follow-up|0|||
146897547|NCT04854499|529789899|FG004|Overall Study|Lost to Follow-up|0|||
146897548|NCT04854499|529789900|FG005|Overall Study|Lost to Follow-up|1|||
146897549|NCT05415449|529789901|FG000|Overall Study|Lost to Follow-up|2|||
146897550|NCT05415449|529789901|FG000|Overall Study|Withdrawal by Subject|4|||
146897551|NCT02185521|529789905|FG000|Overall Study|Withdrawal by Subject|1|||
146897552|NCT02185521|529789905|FG000|Overall Study|Protocol Violation|1|||
146897553|NCT00398112|529789906|FG000|Overall Study|Adverse Event|4|||
146897554|NCT00398112|529789906|FG000|Overall Study|Disease progression|9|||
146897555|NCT00398112|529789906|FG000|Overall Study|Alternative treatment|1|||
146897556|NCT00398112|529789906|FG000|Overall Study|Withdrawal by Subject|3|||
146897557|NCT00398112|529789906|FG000|Overall Study|Death|1|||
146897558|NCT01887912|529789908|FG000|Overall Study|Serious adverse event|400|||
146897559|NCT01887912|529789909|FG001|Overall Study|Serious adverse event|198|||
146897560|NCT01887912|529789908|FG000|Overall Study|Other Adverse Event|34|||
146897561|NCT01887912|529789909|FG001|Overall Study|Other Adverse Event|15|||
146897562|NCT01887912|529789908|FG000|Overall Study|Protocol Violation|67|||
146897563|NCT01887912|529789909|FG001|Overall Study|Protocol Violation|37|||
146897564|NCT01887912|529789908|FG000|Overall Study|Lost to Follow-up|163|||
146897565|NCT01887912|529789909|FG001|Overall Study|Lost to Follow-up|74|||
146897566|NCT01887912|529789908|FG000|Overall Study|Withdrawal by Subject|606|||
146897567|NCT01887912|529789909|FG001|Overall Study|Withdrawal by Subject|349|||
146897568|NCT01887912|529789908|FG000|Overall Study|Other|122|||
146897569|NCT01887912|529789909|FG001|Overall Study|Other|58|||
146897570|NCT03932812|529789913|FG000|Overall Study|Lost to Follow-up|12|||
146897571|NCT03932812|529789914|FG001|Overall Study|Lost to Follow-up|14|||
146897572|NCT03932812|529789913|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
146897573|NCT03932812|529789914|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
146897574|NCT06161012|529789915|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
146897575|NCT06161012|529789916|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
146897576|NCT01933932|529789917|FG000|Overall Study|Death|173|||
146897577|NCT01933932|529789918|FG001|Overall Study|Death|163|||
146897578|NCT01933932|529789917|FG000|Overall Study|Withdrawal by Subject|11|||
146897579|NCT01933932|529789918|FG001|Overall Study|Withdrawal by Subject|14|||
146897580|NCT01933932|529789917|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146897581|NCT01933932|529789918|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146897582|NCT00408005|529789919|FG000|Induction|Adverse Event|19|||
146897583|NCT00408005|529789920|FG001|Induction|Adverse Event|3|||
146897584|NCT00408005|529789921|FG002|Induction|Adverse Event|0|||
146897585|NCT00408005|529789922|FG003|Induction|Adverse Event|0|||
146897586|NCT00408005|529789923|FG004|Induction|Adverse Event|0|||
146640097|NCT00048074|528857865|FG000|Overall Study|Lost to Follow-up|2|||
146640098|NCT00048074|528857866|FG001|Overall Study|Lost to Follow-up|6|||
146640099|NCT00048074|528857867|FG002|Overall Study|Lost to Follow-up|6|||
146640100|NCT00048074|528857865|FG000|Overall Study|Withdrawal by Subject|28|||
146640101|NCT00048074|528857866|FG001|Overall Study|Withdrawal by Subject|30|||
146640102|NCT00048074|528857867|FG002|Overall Study|Withdrawal by Subject|35|||
146640103|NCT00048074|528857865|FG000|Overall Study|Protocol Violation|1|||
146640104|NCT00048074|528857866|FG001|Overall Study|Protocol Violation|3|||
146640105|NCT00048074|528857867|FG002|Overall Study|Protocol Violation|0|||
146640106|NCT00048074|528857865|FG000|Overall Study|Study participation was terminated|0|||
146640107|NCT00048074|528857866|FG001|Overall Study|Study participation was terminated|1|||
146640108|NCT00048074|528857867|FG002|Overall Study|Study participation was terminated|0|||
146640109|NCT00048074|528857865|FG000|Overall Study|Husband ill|0|||
146640110|NCT00048074|528857866|FG001|Overall Study|Husband ill|1|||
146640111|NCT00048074|528857867|FG002|Overall Study|Husband ill|0|||
146640112|NCT00048074|528857865|FG000|Overall Study|Poor compliance|0|||
146640113|NCT00048074|528857866|FG001|Overall Study|Poor compliance|1|||
146640114|NCT00048074|528857867|FG002|Overall Study|Poor compliance|0|||
146640115|NCT00048074|528857865|FG000|Overall Study|Out of station|0|||
146897587|NCT00408005|529789924|FG005|Induction|Adverse Event|0|||
146640116|NCT00048074|528857866|FG001|Overall Study|Out of station|1|||
146897588|NCT00408005|529789925|FG006|Induction|Adverse Event|0|||
146640117|NCT00048074|528857867|FG002|Overall Study|Out of station|1|||
146640118|NCT00048074|528857865|FG000|Overall Study|Social reasons|1|||
146640119|NCT00048074|528857866|FG001|Overall Study|Social reasons|0|||
146897589|NCT00408005|529789926|FG007|Induction|Adverse Event|0|||
146897590|NCT00408005|529789919|FG000|Induction|Death|6|||
146640120|NCT00048074|528857867|FG002|Overall Study|Social reasons|0|||
146640121|NCT02873377|528857868|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
146640122|NCT02873377|528857869|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
146897591|NCT00408005|529789920|FG001|Induction|Death|0|||
146897592|NCT00408005|529789921|FG002|Induction|Death|0|||
146897593|NCT00408005|529789922|FG003|Induction|Death|0|||
146897594|NCT00408005|529789923|FG004|Induction|Death|0|||
146897595|NCT00408005|529789924|FG005|Induction|Death|0|||
146766880|NCT00823979|529314631|FG002|Overall Study|Protocol Violation|0|||
146897596|NCT00408005|529789925|FG006|Induction|Death|0|||
146897597|NCT00408005|529789926|FG007|Induction|Death|0|||
146897598|NCT00408005|529789919|FG000|Induction|Physician Decision|83|||
146897599|NCT00408005|529789920|FG001|Induction|Physician Decision|9|||
146640123|NCT02873377|528857868|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
146640124|NCT02873377|528857869|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
146640125|NCT01583296|528857872|FG000|Overall Study|Withdrawal by Subject|11|||
146640126|NCT01583296|528857873|FG001|Overall Study|Withdrawal by Subject|10|||
146640127|NCT01063283|528857874|FG000|Cycle 1|Adverse Event|2|||
146640128|NCT01063283|528857875|FG001|Cycle 1|Adverse Event|0|||
146640129|NCT01063283|528857876|FG002|Cycle 1|Adverse Event|0|||
146640130|NCT01063283|528857874|FG000|Cycle 1|Technical failure in data collection|1|||
146640131|NCT01063283|528857875|FG001|Cycle 1|Technical failure in data collection|0|||
146640132|NCT01063283|528857876|FG002|Cycle 1|Technical failure in data collection|0|||
146640133|NCT03237286|528857879|FG000|Overall Study|Withdrawal by Subject|1|||
146640134|NCT03237286|528857880|FG001|Overall Study|Withdrawal by Subject|0|||
146640135|NCT03237286|528857881|FG002|Overall Study|Withdrawal by Subject|2|||
146640136|NCT03237286|528857879|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
146640137|NCT03237286|528857880|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
146640138|NCT03237286|528857881|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
146640139|NCT02792829|528857882|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
146640140|NCT02792829|528857883|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
146640141|NCT02792829|528857884|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
146640142|NCT02792829|528857885|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
146640143|NCT02792829|528857886|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
146640144|NCT02792829|528857887|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
146640145|NCT02792829|528857888|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
146640146|NCT02792829|528857889|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
146640147|NCT02792829|528857882|FG000|Treatment Period 2|Adverse Event|0|||
146640148|NCT02792829|528857883|FG001|Treatment Period 2|Adverse Event|0|||
146640149|NCT02792829|528857884|FG002|Treatment Period 2|Adverse Event|0|||
146640150|NCT02792829|528857885|FG003|Treatment Period 2|Adverse Event|0|||
146640151|NCT02792829|528857886|FG004|Treatment Period 2|Adverse Event|1|||
146640152|NCT02792829|528857887|FG005|Treatment Period 2|Adverse Event|0|||
146640153|NCT02792829|528857888|FG006|Treatment Period 2|Adverse Event|1|||
146640154|NCT02792829|528857889|FG007|Treatment Period 2|Adverse Event|1|||
146640155|NCT02792829|528857882|FG000|Treatment Period 2|Use of proscribed medications|0|||
146640156|NCT02792829|528857883|FG001|Treatment Period 2|Use of proscribed medications|0|||
146640157|NCT02792829|528857884|FG002|Treatment Period 2|Use of proscribed medications|0|||
146640158|NCT02792829|528857885|FG003|Treatment Period 2|Use of proscribed medications|0|||
146640159|NCT02792829|528857886|FG004|Treatment Period 2|Use of proscribed medications|0|||
146640160|NCT02792829|528857887|FG005|Treatment Period 2|Use of proscribed medications|0|||
146640161|NCT02792829|528857888|FG006|Treatment Period 2|Use of proscribed medications|0|||
146640162|NCT02792829|528857889|FG007|Treatment Period 2|Use of proscribed medications|1|||
146640163|NCT01668589|528857895|FG000|Overall Study|Lost to Follow-up|29|||
146640164|NCT01668589|528857896|FG001|Overall Study|Lost to Follow-up|37|||
146640165|NCT01668589|528857897|FG002|Overall Study|Lost to Follow-up|15|||
146640166|NCT01668589|528857898|FG003|Overall Study|Lost to Follow-up|5|||
146640167|NCT01668589|528857895|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
146640168|NCT01668589|528857896|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
146640169|NCT01668589|528857897|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
146640170|NCT01668589|528857898|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
146640171|NCT01668589|528857895|FG000|Overall Study|Death|12|||
146640172|NCT01668589|528857896|FG001|Overall Study|Death|3|||
146640173|NCT01668589|528857897|FG002|Overall Study|Death|2|||
146640174|NCT01668589|528857898|FG003|Overall Study|Death|11|||
146640175|NCT01668589|528857895|FG000|Overall Study|Other|44|||
146640176|NCT01668589|528857896|FG001|Overall Study|Other|10|||
146640177|NCT01668589|528857897|FG002|Overall Study|Other|7|||
146640178|NCT01668589|528857898|FG003|Overall Study|Other|15|||
146640179|NCT00993148|528857899|FG000|Overall Study|Lost to Follow-up|2|||
146640180|NCT00993148|528857899|FG000|Overall Study|never initiated treatment|1|||
146640181|NCT02302339|528857900|FG000|Overall Study|Lost to Follow-up|1|||
146640182|NCT02302339|528857901|FG001|Overall Study|Lost to Follow-up|0|||
146897600|NCT00408005|529789921|FG002|Induction|Physician Decision|0|||
146640183|NCT02302339|528857902|FG002|Overall Study|Lost to Follow-up|0|||
146640184|NCT02302339|528857903|FG003|Overall Study|Lost to Follow-up|0|||
146640185|NCT02302339|528857900|FG000|Overall Study|Withdrawal by Subject|0|||
146640186|NCT02302339|528857901|FG001|Overall Study|Withdrawal by Subject|2|||
146640187|NCT02302339|528857902|FG002|Overall Study|Withdrawal by Subject|1|||
146640188|NCT02302339|528857903|FG003|Overall Study|Withdrawal by Subject|0|||
146897601|NCT00408005|529789922|FG003|Induction|Physician Decision|0|||
146640189|NCT02752165|528857904|FG000|Overall Study|Withdrawal by Subject|6|||
146640190|NCT02752165|528857905|FG001|Overall Study|Withdrawal by Subject|6|||
146640191|NCT02752165|528857904|FG000|Overall Study|Protocol Violation|6|||
146640192|NCT02752165|528857905|FG001|Overall Study|Protocol Violation|5|||
146640193|NCT02752165|528857904|FG000|Overall Study|Lost to Follow-up|33|||
146640194|NCT02752165|528857905|FG001|Overall Study|Lost to Follow-up|38|||
146897602|NCT00408005|529789923|FG004|Induction|Physician Decision|0|||
146640195|NCT04073225|528857909|FG000|Overall Study|Lost to Follow-up|4|||
146640196|NCT04073225|528857910|FG001|Overall Study|Lost to Follow-up|3|||
146640197|NCT03568461|528857915|FG000|Overall Study|Death|7|||
146640198|NCT03568461|528857915|FG000|Overall Study|Physician Decision|5|||
146640199|NCT03568461|528857915|FG000|Overall Study|Subject decision|5|||
146640200|NCT03568461|528857915|FG000|Overall Study|Lost to Follow-up|1|||
146640201|NCT04695977|528857916|FG000|Overall Study|Sponsor Decision|9|||
146640202|NCT04695977|528857917|FG001|Overall Study|Sponsor Decision|4|||
146640203|NCT04695977|528857916|FG000|Overall Study|Death|2|||
146640204|NCT04695977|528857917|FG001|Overall Study|Death|5|||
146640205|NCT02175199|528859143|FG000|Overall Study|Withdrawal by Subject|1|||
146640206|NCT02175199|528859144|FG001|Overall Study|Withdrawal by Subject|5|||
146640207|NCT02175199|528859143|FG000|Overall Study|Randomized in Error|1|||
146640208|NCT02175199|528859144|FG001|Overall Study|Randomized in Error|0|||
146640209|NCT02175199|528859143|FG000|Overall Study|Sponsor Decision|1|||
146640210|NCT02175199|528859144|FG001|Overall Study|Sponsor Decision|0|||
146640211|NCT03983317|528859147|FG000|Overall Study|Physician Decision|5|||
146640212|NCT01761162|528859148|FG000|Overall Study|Withdrawal by Subject|3|||
146640213|NCT04681352|528859149|FG000|Overall Study|Lost to Follow-up|2|||
146640214|NCT04681352|528859149|FG000|Overall Study|Withdrawal by Subject|22|||
146640215|NCT01643772|528859150|FG000|Overall Study|Protocol Violation|0|||
146897603|NCT00408005|529789924|FG005|Induction|Physician Decision|0|||
146897604|NCT00408005|529789925|FG006|Induction|Physician Decision|0|||
146640216|NCT01643772|528859151|FG001|Overall Study|Protocol Violation|0|||
146640217|NCT01643772|528859152|FG002|Overall Study|Protocol Violation|0|||
146640218|NCT01643772|528859153|FG003|Overall Study|Protocol Violation|1|||
146640219|NCT01643772|528859150|FG000|Overall Study|Adverse Event|0|||
146640220|NCT01643772|528859151|FG001|Overall Study|Adverse Event|0|||
146640221|NCT01643772|528859152|FG002|Overall Study|Adverse Event|0|||
146640222|NCT01643772|528859153|FG003|Overall Study|Adverse Event|1|||
146640223|NCT01296672|528859154|FG000|Overall Study|Lost to Follow-up|73|||
146640224|NCT01296672|528859155|FG001|Overall Study|Lost to Follow-up|18|||
146640225|NCT01716052|528859156|FG000|Overall Study|Withdrawal of funding|1|||
146640226|NCT01716052|528859157|FG001|Overall Study|Withdrawal of funding|1|||
146640227|NCT00975689|528859160|FG000|Overall Study|Adverse Event|0|||
146640228|NCT00975689|528859161|FG001|Overall Study|Adverse Event|3|||
146640229|NCT00975689|528859160|FG000|Overall Study|Withdrawal by Subject|1|||
146640230|NCT00975689|528859161|FG001|Overall Study|Withdrawal by Subject|0|||
146640231|NCT00975689|528859160|FG000|Overall Study|Physician Decision|1|||
146640232|NCT00975689|528859161|FG001|Overall Study|Physician Decision|0|||
146640233|NCT04335136|528859162|FG000|Overall Study|Death|8|||
146640234|NCT04335136|528859163|FG001|Overall Study|Death|4|||
146640235|NCT04335136|528859162|FG000|Overall Study|Lost to Follow-up|2|||
146640236|NCT04335136|528859163|FG001|Overall Study|Lost to Follow-up|0|||
146640237|NCT04335136|528859162|FG000|Overall Study|Protocol Violation|1|||
146640238|NCT04335136|528859163|FG001|Overall Study|Protocol Violation|0|||
146640239|NCT04335136|528859162|FG000|Overall Study|Withdrawal by Subject|1|||
146640240|NCT04335136|528859163|FG001|Overall Study|Withdrawal by Subject|1|||
146640241|NCT04335136|528859162|FG000|Overall Study|Health-threatening condition|0|||
146640242|NCT04335136|528859163|FG001|Overall Study|Health-threatening condition|1|||
146640243|NCT04335136|528859162|FG000|Overall Study|Adverse Event|0|||
146640244|NCT04335136|528859163|FG001|Overall Study|Adverse Event|1|||
146640245|NCT04335136|528859162|FG000|Overall Study|Erroneously randomized|2|||
146640246|NCT04335136|528859163|FG001|Overall Study|Erroneously randomized|0|||
146640247|NCT01305577|528859167|FG000|Overall Study|Adverse Event|2|||
146640248|NCT01305577|528859168|FG001|Overall Study|Adverse Event|2|||
146640249|NCT01305577|528859169|FG002|Overall Study|Adverse Event|1|||
146766881|NCT00823979|529314629|FG000|Overall Study|Pregnancy|0|||
146897605|NCT00408005|529789926|FG007|Induction|Physician Decision|0|||
146897606|NCT00408005|529789919|FG000|Induction|Withdrawal by Subject|2|||
146897607|NCT00408005|529789920|FG001|Induction|Withdrawal by Subject|4|||
146640250|NCT01305577|528859167|FG000|Overall Study|Withdrawal by Subject|7|||
146640251|NCT01305577|528859168|FG001|Overall Study|Withdrawal by Subject|5|||
146766882|NCT00823979|529314630|FG001|Overall Study|Pregnancy|1|||
146640252|NCT01305577|528859169|FG002|Overall Study|Withdrawal by Subject|6|||
146640253|NCT01305577|528859167|FG000|Overall Study|Lost to Follow-up|4|||
146640254|NCT01305577|528859168|FG001|Overall Study|Lost to Follow-up|3|||
146640255|NCT01305577|528859169|FG002|Overall Study|Lost to Follow-up|2|||
146640256|NCT01305577|528859167|FG000|Overall Study|Protocol Deviation|0|||
146640257|NCT01305577|528859168|FG001|Overall Study|Protocol Deviation|1|||
146640258|NCT01305577|528859169|FG002|Overall Study|Protocol Deviation|1|||
146640259|NCT00796978|528859170|FG000|Overall Study|Cardiac adverse event|5|||
146640260|NCT00796978|528859170|FG000|Overall Study|Adverse Event|4|||
146640261|NCT00796978|528859170|FG000|Overall Study|Withdrawal by Subject|3|||
146640262|NCT01092546|528859174|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
146640263|NCT00622440|528859187|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
146640264|NCT00622440|528859188|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
146897608|NCT00408005|529789921|FG002|Induction|Withdrawal by Subject|0|||
146897609|NCT00408005|529789922|FG003|Induction|Withdrawal by Subject|0|||
146897610|NCT00408005|529789923|FG004|Induction|Withdrawal by Subject|0|||
146897611|NCT00408005|529789924|FG005|Induction|Withdrawal by Subject|0|||
146897612|NCT00408005|529789925|FG006|Induction|Withdrawal by Subject|0|||
146897613|NCT00408005|529789926|FG007|Induction|Withdrawal by Subject|0|||
146897614|NCT00408005|529789919|FG000|Induction|Ineligible|33|||
146897615|NCT00408005|529789920|FG001|Induction|Ineligible|14|||
146897616|NCT00408005|529789921|FG002|Induction|Ineligible|0|||
146897617|NCT00408005|529789922|FG003|Induction|Ineligible|0|||
146897618|NCT00408005|529789923|FG004|Induction|Ineligible|0|||
146897619|NCT00408005|529789924|FG005|Induction|Ineligible|0|||
146897620|NCT00408005|529789925|FG006|Induction|Ineligible|0|||
146897621|NCT00408005|529789926|FG007|Induction|Ineligible|0|||
146897622|NCT00408005|529789919|FG000|Induction|Refusal of Further Protocol Therapy|225|||
146897623|NCT00408005|529789920|FG001|Induction|Refusal of Further Protocol Therapy|44|||
146897624|NCT00408005|529789921|FG002|Induction|Refusal of Further Protocol Therapy|0|||
146897625|NCT00408005|529789922|FG003|Induction|Refusal of Further Protocol Therapy|0|||
146897626|NCT00408005|529789923|FG004|Induction|Refusal of Further Protocol Therapy|0|||
146897627|NCT00408005|529789924|FG005|Induction|Refusal of Further Protocol Therapy|0|||
146897628|NCT00408005|529789925|FG006|Induction|Refusal of Further Protocol Therapy|0|||
146897629|NCT00408005|529789926|FG007|Induction|Refusal of Further Protocol Therapy|0|||
146897630|NCT00408005|529789919|FG000|Induction|Entered another COG therapeutic protocol|4|||
146897631|NCT00408005|529789920|FG001|Induction|Entered another COG therapeutic protocol|0|||
146897632|NCT00408005|529789921|FG002|Induction|Entered another COG therapeutic protocol|0|||
146897633|NCT00408005|529789922|FG003|Induction|Entered another COG therapeutic protocol|0|||
146897634|NCT00408005|529789923|FG004|Induction|Entered another COG therapeutic protocol|0|||
146897635|NCT00408005|529789924|FG005|Induction|Entered another COG therapeutic protocol|0|||
146897636|NCT00408005|529789925|FG006|Induction|Entered another COG therapeutic protocol|0|||
146897637|NCT00408005|529789926|FG007|Induction|Entered another COG therapeutic protocol|0|||
146897638|NCT00408005|529789919|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
146897639|NCT00408005|529789920|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
146897640|NCT00408005|529789921|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
146897641|NCT00408005|529789922|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
146897642|NCT00408005|529789923|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
146897643|NCT00408005|529789924|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
146897644|NCT00408005|529789925|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
146897645|NCT00408005|529789926|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
146897646|NCT00408005|529789919|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
146897647|NCT00408005|529789920|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
146897648|NCT00408005|529789921|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
146897649|NCT00408005|529789922|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
146897650|NCT00408005|529789923|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
146897651|NCT00408005|529789924|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
146897652|NCT00408005|529789925|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
146897653|NCT00408005|529789926|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
146897654|NCT00408005|529789919|FG000|Induction|Progressive Disease|0|||
146897655|NCT00408005|529789920|FG001|Induction|Progressive Disease|1|||
146897656|NCT00408005|529789921|FG002|Induction|Progressive Disease|0|||
146897657|NCT00408005|529789922|FG003|Induction|Progressive Disease|0|||
146897658|NCT00408005|529789923|FG004|Induction|Progressive Disease|0|||
146897659|NCT00408005|529789924|FG005|Induction|Progressive Disease|0|||
146897660|NCT00408005|529789925|FG006|Induction|Progressive Disease|0|||
146897661|NCT00408005|529789926|FG007|Induction|Progressive Disease|0|||
146897662|NCT00408005|529789919|FG000|Induction|Inevaluable|18|||
146897663|NCT00408005|529789920|FG001|Induction|Inevaluable|14|||
146897664|NCT00408005|529789921|FG002|Induction|Inevaluable|0|||
146897665|NCT00408005|529789922|FG003|Induction|Inevaluable|0|||
146897666|NCT00408005|529789923|FG004|Induction|Inevaluable|0|||
146897667|NCT00408005|529789924|FG005|Induction|Inevaluable|0|||
146897668|NCT00408005|529789925|FG006|Induction|Inevaluable|0|||
146968867|NCT00877799|530045547|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
146897669|NCT00408005|529789926|FG007|Induction|Inevaluable|0|||
146897670|NCT00408005|529789919|FG000|Induction|Failed to Complete Randomization|3|||
146897671|NCT00408005|529789920|FG001|Induction|Failed to Complete Randomization|2|||
146897672|NCT00408005|529789921|FG002|Induction|Failed to Complete Randomization|0|||
146897673|NCT00408005|529789922|FG003|Induction|Failed to Complete Randomization|0|||
146897674|NCT00408005|529789923|FG004|Induction|Failed to Complete Randomization|0|||
146897675|NCT00408005|529789924|FG005|Induction|Failed to Complete Randomization|0|||
146897676|NCT00408005|529789925|FG006|Induction|Failed to Complete Randomization|0|||
146897677|NCT00408005|529789926|FG007|Induction|Failed to Complete Randomization|0|||
146897678|NCT00408005|529789919|FG000|Induction|Protocol Deviation|3|||
146897679|NCT00408005|529789920|FG001|Induction|Protocol Deviation|1|||
146897680|NCT00408005|529789921|FG002|Induction|Protocol Deviation|0|||
146897681|NCT00408005|529789922|FG003|Induction|Protocol Deviation|0|||
146897682|NCT00408005|529789923|FG004|Induction|Protocol Deviation|0|||
146897683|NCT00408005|529789924|FG005|Induction|Protocol Deviation|0|||
146897684|NCT00408005|529789925|FG006|Induction|Protocol Deviation|0|||
146897685|NCT00408005|529789926|FG007|Induction|Protocol Deviation|0|||
146897686|NCT00408005|529789919|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
146897687|NCT00408005|529789920|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
146897688|NCT00408005|529789921|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
146897689|NCT00408005|529789922|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
146897690|NCT00408005|529789923|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
146897691|NCT00408005|529789924|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
146897692|NCT00408005|529789925|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
146897693|NCT00408005|529789926|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
146897694|NCT00408005|529789919|FG000|Induction|Recurrent leukemia|1|||
146897695|NCT00408005|529789920|FG001|Induction|Recurrent leukemia|0|||
146897696|NCT00408005|529789921|FG002|Induction|Recurrent leukemia|0|||
146897697|NCT00408005|529789922|FG003|Induction|Recurrent leukemia|0|||
146897698|NCT00408005|529789923|FG004|Induction|Recurrent leukemia|0|||
146897699|NCT00408005|529789924|FG005|Induction|Recurrent leukemia|0|||
146897700|NCT00408005|529789925|FG006|Induction|Recurrent leukemia|0|||
146897701|NCT00408005|529789926|FG007|Induction|Recurrent leukemia|0|||
146897702|NCT00408005|529789919|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
146897703|NCT00408005|529789920|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
146897704|NCT00408005|529789921|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
146897705|NCT00408005|529789922|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
146897706|NCT00408005|529789923|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
146897707|NCT00408005|529789924|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
146897708|NCT00408005|529789925|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
146897709|NCT00408005|529789926|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
146897710|NCT00408005|529789919|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
146897711|NCT00408005|529789920|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
146897712|NCT00408005|529789921|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
146897713|NCT00408005|529789922|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
146897714|NCT00408005|529789923|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
146897715|NCT00408005|529789924|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
146897716|NCT00408005|529789925|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
146897717|NCT00408005|529789926|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
146897718|NCT00408005|529789919|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
146897719|NCT00408005|529789920|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
146897720|NCT00408005|529789921|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
146897721|NCT00408005|529789922|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
146897722|NCT00408005|529789923|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
146897723|NCT00408005|529789924|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
146897724|NCT00408005|529789925|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
146897725|NCT00408005|529789926|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
146897726|NCT00408005|529789919|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
146897727|NCT00408005|529789920|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
146897728|NCT00408005|529789921|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
146897729|NCT00408005|529789922|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
146897730|NCT00408005|529789923|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
146897731|NCT00408005|529789924|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
146897732|NCT00408005|529789925|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
146897733|NCT00408005|529789926|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
146897734|NCT00408005|529789919|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
146897735|NCT00408005|529789920|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
146897736|NCT00408005|529789921|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
146897737|NCT00408005|529789922|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
146968868|NCT00877799|530045543|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
146897738|NCT00408005|529789923|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
146897739|NCT00408005|529789924|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
146766883|NCT00823979|529314631|FG002|Overall Study|Pregnancy|0|||
146766884|NCT00823979|529314629|FG000|Overall Study|Adverse Event|0|||
146766885|NCT00823979|529314630|FG001|Overall Study|Adverse Event|2|||
146766886|NCT00823979|529314631|FG002|Overall Study|Adverse Event|4|||
146766887|NCT00823979|529314629|FG000|Overall Study|Other|2|||
146766888|NCT00823979|529314630|FG001|Overall Study|Other|0|||
146766889|NCT00823979|529314631|FG002|Overall Study|Other|1|||
146766890|NCT00823979|529314629|FG000|Overall Study|Randomized but not Treated|4|||
146897740|NCT00408005|529789925|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
146897741|NCT00408005|529789926|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
146897742|NCT00408005|529789919|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
146897743|NCT00408005|529789920|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
146897744|NCT00408005|529789921|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
146897745|NCT00408005|529789922|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
146897746|NCT00408005|529789923|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
146897747|NCT00408005|529789924|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
146897748|NCT00408005|529789925|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
146897749|NCT00408005|529789926|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
146897750|NCT00408005|529789919|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
146897751|NCT00408005|529789920|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
146897752|NCT00408005|529789921|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
146897753|NCT00408005|529789922|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
146897754|NCT00408005|529789923|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
146897755|NCT00408005|529789924|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
146897756|NCT00408005|529789925|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
146897757|NCT00408005|529789926|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
146897758|NCT00408005|529789919|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
146897759|NCT00408005|529789920|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
146897760|NCT00408005|529789921|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
146897761|NCT00408005|529789922|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
146897762|NCT00408005|529789923|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
146897763|NCT00408005|529789924|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
146897764|NCT00408005|529789925|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
146897765|NCT00408005|529789926|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
146897766|NCT00408005|529789919|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
146897767|NCT00408005|529789920|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
146897768|NCT00408005|529789921|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
146897769|NCT00408005|529789922|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
146897770|NCT00408005|529789923|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
146897771|NCT00408005|529789924|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
146897772|NCT00408005|529789925|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
146897773|NCT00408005|529789926|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
146897774|NCT00408005|529789919|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
146897775|NCT00408005|529789920|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
146897776|NCT00408005|529789921|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
146897777|NCT00408005|529789922|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
146897778|NCT00408005|529789923|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
146897779|NCT00408005|529789924|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
146897780|NCT00408005|529789925|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
146897781|NCT00408005|529789926|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
146897782|NCT00408005|529789919|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
146897783|NCT00408005|529789920|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
146897784|NCT00408005|529789921|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
146897785|NCT00408005|529789922|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
146897786|NCT00408005|529789923|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
146897787|NCT00408005|529789924|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
146766891|NCT00823979|529314630|FG001|Overall Study|Randomized but not Treated|3|||
146766892|NCT00823979|529314631|FG002|Overall Study|Randomized but not Treated|1|||
146766893|NCT00823979|529314629|FG000|Overall Study|Study Terminated by Sponsor|5|||
146766894|NCT00823979|529314630|FG001|Overall Study|Study Terminated by Sponsor|5|||
146766895|NCT00823979|529314631|FG002|Overall Study|Study Terminated by Sponsor|7|||
146766896|NCT03523091|529314632|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
146766897|NCT03523091|529314633|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
146766898|NCT03523091|529314632|FG000|Overall Study|Withdrawal by Subject|0|||
146766899|NCT03523091|529314633|FG001|Overall Study|Withdrawal by Subject|3|||
146766900|NCT03523091|529314632|FG000|Overall Study|Increase Botox dose|0|||
146766901|NCT03523091|529314633|FG001|Overall Study|Increase Botox dose|1|||
146766902|NCT00741988|529314634|FG000|Overall Study|Adverse Event|2|||
146766903|NCT00741988|529314635|FG001|Overall Study|Adverse Event|4|||
146766904|NCT00741988|529314634|FG000|Overall Study|Lack of Efficacy|2|||
146766905|NCT00741988|529314635|FG001|Overall Study|Lack of Efficacy|0|||
146766906|NCT02685488|529314642|FG000|Overall Study|Withdrawal by Subject|0|||
146766907|NCT02685488|529314643|FG001|Overall Study|Withdrawal by Subject|1|||
146766908|NCT05019729|529314644|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
146766909|NCT05019729|529314645|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
146766910|NCT05019729|529314646|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
146766911|NCT05019729|529314647|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
146897788|NCT00408005|529789925|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
146897789|NCT00408005|529789926|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
146897790|NCT00408005|529789919|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
146897791|NCT00408005|529789920|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
146897792|NCT00408005|529789921|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
146897793|NCT00408005|529789922|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
146897794|NCT00408005|529789923|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
146897795|NCT00408005|529789924|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
146897796|NCT00408005|529789925|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
146897797|NCT00408005|529789926|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
146897798|NCT00408005|529789919|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
146897799|NCT00408005|529789920|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
146897800|NCT00408005|529789921|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
146897801|NCT00408005|529789922|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
146897802|NCT00408005|529789923|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
146897803|NCT00408005|529789924|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
146897804|NCT00408005|529789925|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
146897805|NCT00408005|529789926|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
146897806|NCT00408005|529789919|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
146897807|NCT00408005|529789920|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
146897808|NCT00408005|529789921|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
146897809|NCT00408005|529789922|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
146897810|NCT00408005|529789923|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
146897811|NCT00408005|529789924|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
146897812|NCT00408005|529789925|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
146897813|NCT00408005|529789926|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
146897814|NCT04454489|529789927|FG000|Overall Study|Disease progression|12|||
146897815|NCT04454489|529789927|FG000|Overall Study|Death|4|||
146897816|NCT04454489|529789927|FG000|Overall Study|Adverse Event|1|||
146897817|NCT04454489|529789927|FG000|Overall Study|Physician Decision|1|||
146897818|NCT03155997|529789928|FG000|Overall Study|Withdrawal by Subject|119|||
146897819|NCT03155997|529789929|FG001|Overall Study|Withdrawal by Subject|134|||
146897820|NCT03155997|529789928|FG000|Overall Study|Lost to Follow-up|12|||
146897821|NCT03155997|529789929|FG001|Overall Study|Lost to Follow-up|13|||
146897822|NCT03155997|529789928|FG000|Overall Study|Missing disposition data|0|||
146897823|NCT03155997|529789929|FG001|Overall Study|Missing disposition data|1|||
146897824|NCT03155997|529789928|FG000|Overall Study|On study treatment|2027|||
146897825|NCT03155997|529789929|FG001|Overall Study|On study treatment|2074|||
146897826|NCT02796755|529789932|FG000|Overall Study|Adverse Event|2|||
146897827|NCT02796755|529789933|FG001|Overall Study|Adverse Event|0|||
146897828|NCT01756274|529789937|FG000|Overall Study|Protocol Violation|2|||
146897829|NCT01756274|529789937|FG000|Overall Study|Laboratory error|1|||
146897830|NCT01111604|529789942|FG000|Overall Study|Lost to Follow-up|0|||
146897831|NCT01111604|529789943|FG001|Overall Study|Lost to Follow-up|0|||
146897832|NCT01111604|529789944|FG002|Overall Study|Lost to Follow-up|1|||
146897833|NCT01111604|529789942|FG000|Overall Study|Withdrew Consent|3|||
146897834|NCT01111604|529789943|FG001|Overall Study|Withdrew Consent|0|||
146897835|NCT01111604|529789944|FG002|Overall Study|Withdrew Consent|2|||
146897836|NCT01111604|529789942|FG000|Overall Study|Withdrawal by Subject|2|||
146897837|NCT01111604|529789943|FG001|Overall Study|Withdrawal by Subject|0|||
146897838|NCT01111604|529789944|FG002|Overall Study|Withdrawal by Subject|0|||
146897839|NCT01111604|529789942|FG000|Overall Study|Death|1|||
146897840|NCT01111604|529789943|FG001|Overall Study|Death|0|||
146897841|NCT01111604|529789944|FG002|Overall Study|Death|0|||
146897842|NCT01111604|529789942|FG000|Overall Study|Met Exclusion Criteria|2|||
146897843|NCT01111604|529789943|FG001|Overall Study|Met Exclusion Criteria|0|||
146897844|NCT01111604|529789944|FG002|Overall Study|Met Exclusion Criteria|0|||
146897845|NCT01295125|529789946|FG000|Overall Study|Study stopped prematurely|9|||
146897846|NCT03371355|529789947|FG000|Overall Study|Investigator judgment|0|||
146897847|NCT03371355|529789948|FG001|Overall Study|Investigator judgment|0|||
146897848|NCT03371355|529789949|FG002|Overall Study|Investigator judgment|1|||
146897849|NCT03371355|529789950|FG003|Overall Study|Investigator judgment|1|||
146897850|NCT03371355|529789947|FG000|Overall Study|Voluntary withdrawal|1|||
146897851|NCT03371355|529789948|FG001|Overall Study|Voluntary withdrawal|0|||
146897852|NCT03371355|529789949|FG002|Overall Study|Voluntary withdrawal|1|||
146897853|NCT03371355|529789950|FG003|Overall Study|Voluntary withdrawal|2|||
146897854|NCT03371355|529789947|FG000|Overall Study|Adverse Event|0|||
146897855|NCT03371355|529789948|FG001|Overall Study|Adverse Event|1|||
146897856|NCT03371355|529789949|FG002|Overall Study|Adverse Event|2|||
146897857|NCT03371355|529789950|FG003|Overall Study|Adverse Event|3|||
146897858|NCT03371355|529789947|FG000|Overall Study|Reason not Specified|0|||
146897859|NCT03371355|529789948|FG001|Overall Study|Reason not Specified|1|||
146897860|NCT03371355|529789949|FG002|Overall Study|Reason not Specified|0|||
146559268|NCT01052779|528557361|FG001|Overall Study|Withdrawal by Subject|2|||
146559269|NCT01052779|528557360|FG000|Overall Study|Other-Protocol Violation|1|||
146559270|NCT01052779|528557361|FG001|Overall Study|Other-Protocol Violation|1|||
146559271|NCT01052779|528557360|FG000|Overall Study|Other-Surgery|0|||
146559272|NCT01052779|528557361|FG001|Overall Study|Other-Surgery|2|||
146559273|NCT01052779|528557360|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
146897861|NCT03371355|529789950|FG003|Overall Study|Reason not Specified|1|||
146897862|NCT01360996|529789956|FG000|Overall Study|Withdrawal by Subject|4|||
146897863|NCT01360996|529789957|FG001|Overall Study|Withdrawal by Subject|3|||
146897864|NCT01360996|529789958|FG002|Overall Study|Withdrawal by Subject|2|||
146897865|NCT01360996|529789956|FG000|Overall Study|Noncompliant|2|||
146897866|NCT01360996|529789957|FG001|Overall Study|Noncompliant|0|||
146897867|NCT01360996|529789958|FG002|Overall Study|Noncompliant|0|||
146897868|NCT01454076|529789959|FG000|Overall Study|Other|2|||
146897869|NCT01454076|529789960|FG001|Overall Study|Other|0|||
146897870|NCT01454076|529789961|FG002|Overall Study|Other|0|||
146897871|NCT01454076|529789962|FG003|Overall Study|Other|1|||
146897872|NCT01454076|529789963|FG004|Overall Study|Other|2|||
146559274|NCT01052779|528557361|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
146897873|NCT01454076|529789959|FG000|Overall Study|Withdrawal by Subject|3|||
146897874|NCT01454076|529789960|FG001|Overall Study|Withdrawal by Subject|4|||
146897875|NCT01454076|529789961|FG002|Overall Study|Withdrawal by Subject|2|||
146897876|NCT01454076|529789962|FG003|Overall Study|Withdrawal by Subject|1|||
146640265|NCT00622440|528859187|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
146640266|NCT00622440|528859188|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
146640267|NCT00622440|528859187|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
146640268|NCT00622440|528859188|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
146897877|NCT01454076|529789963|FG004|Overall Study|Withdrawal by Subject|2|||
146897878|NCT01454076|529789959|FG000|Overall Study|Adverse Event|8|||
146897879|NCT01454076|529789960|FG001|Overall Study|Adverse Event|2|||
146897880|NCT01454076|529789961|FG002|Overall Study|Adverse Event|7|||
146897881|NCT01454076|529789962|FG003|Overall Study|Adverse Event|0|||
146897882|NCT01454076|529789963|FG004|Overall Study|Adverse Event|2|||
146897883|NCT02965378|529789964|FG000|Overall Study|Progression|16|||
146897884|NCT02965378|529789965|FG001|Overall Study|Progression|4|||
146897885|NCT02965378|529789964|FG000|Overall Study|Adverse Event|5|||
146897886|NCT02965378|529789965|FG001|Overall Study|Adverse Event|2|||
146897887|NCT02965378|529789964|FG000|Overall Study|Death|2|||
146897888|NCT02965378|529789965|FG001|Overall Study|Death|0|||
146897889|NCT02965378|529789964|FG000|Overall Study|Refusal|2|||
146897890|NCT02965378|529789965|FG001|Overall Study|Refusal|1|||
146897891|NCT02965378|529789964|FG000|Overall Study|Not protocol specified|0|||
146897892|NCT02965378|529789965|FG001|Overall Study|Not protocol specified|2|||
146897893|NCT04964258|529789966|FG000|Overall Study|Lost to Follow-up|1|||
146897894|NCT04964258|529789967|FG001|Overall Study|Lost to Follow-up|0|||
146897895|NCT04964258|529789968|FG002|Overall Study|Lost to Follow-up|0|||
146897896|NCT04964258|529789969|FG003|Overall Study|Lost to Follow-up|0|||
146897897|NCT04964258|529789970|FG004|Overall Study|Lost to Follow-up|0|||
146897898|NCT04964258|529789971|FG005|Overall Study|Lost to Follow-up|1|||
146897899|NCT04964258|529789972|FG006|Overall Study|Lost to Follow-up|0|||
146897900|NCT04964258|529789973|FG007|Overall Study|Lost to Follow-up|0|||
146897901|NCT04964258|529789974|FG008|Overall Study|Lost to Follow-up|0|||
146897902|NCT04964258|529789975|FG009|Overall Study|Lost to Follow-up|0|||
146897903|NCT04964258|529789976|FG010|Overall Study|Lost to Follow-up|0|||
146897904|NCT03040024|529789977|FG000|Overall Study|Adverse Event|0|||
146897905|NCT03040024|529789978|FG001|Overall Study|Adverse Event|1|||
146897906|NCT03040024|529789979|FG002|Overall Study|Adverse Event|0|||
146897907|NCT03040024|529789977|FG000|Overall Study|Death|0|||
146897908|NCT03040024|529789978|FG001|Overall Study|Death|1|||
146897909|NCT03040024|529789979|FG002|Overall Study|Death|0|||
146897910|NCT03040024|529789977|FG000|Overall Study|Physician Decision|0|||
146897911|NCT03040024|529789978|FG001|Overall Study|Physician Decision|0|||
146897912|NCT03040024|529789979|FG002|Overall Study|Physician Decision|1|||
146897913|NCT00291551|529789985|FG000|Overall Study|Death|7|||
146897914|NCT00291551|529789985|FG000|Overall Study|Withdrawal by Subject|6|||
146897915|NCT02452762|529789986|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
146897916|NCT02452762|529789987|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
146897917|NCT02452762|529789986|FG000|Overall Study|Withdrawal by Subject|1|||
146897918|NCT02452762|529789987|FG001|Overall Study|Withdrawal by Subject|0|||
146897919|NCT00584870|529789988|FG000|Overall Study|Adverse Event|4|||
146897920|NCT00584870|529789989|FG001|Overall Study|Adverse Event|3|||
146897921|NCT00584870|529789990|FG002|Overall Study|Adverse Event|2|||
146897922|NCT00584870|529789988|FG000|Overall Study|Lost to Follow-up|4|||
146897923|NCT00584870|529789989|FG001|Overall Study|Lost to Follow-up|1|||
146897924|NCT00584870|529789990|FG002|Overall Study|Lost to Follow-up|1|||
146897925|NCT00584870|529789988|FG000|Overall Study|Lack of Efficacy|7|||
146897926|NCT00584870|529789989|FG001|Overall Study|Lack of Efficacy|14|||
146897927|NCT00584870|529789990|FG002|Overall Study|Lack of Efficacy|8|||
146897928|NCT00584870|529789988|FG000|Overall Study|Withdrawal by Subject|10|||
146897929|NCT00584870|529789989|FG001|Overall Study|Withdrawal by Subject|5|||
146897930|NCT00584870|529789990|FG002|Overall Study|Withdrawal by Subject|3|||
146897931|NCT00584870|529789988|FG000|Overall Study|Protocol Violation|1|||
146897932|NCT00584870|529789989|FG001|Overall Study|Protocol Violation|1|||
146897933|NCT00584870|529789990|FG002|Overall Study|Protocol Violation|2|||
146897934|NCT00584870|529789988|FG000|Overall Study|Did not met entrance criteria|1|||
146897935|NCT00584870|529789989|FG001|Overall Study|Did not met entrance criteria|0|||
146897936|NCT00584870|529789990|FG002|Overall Study|Did not met entrance criteria|0|||
146897937|NCT00584870|529789988|FG000|Overall Study|Other|2|||
146897938|NCT00584870|529789989|FG001|Overall Study|Other|0|||
146897939|NCT00584870|529789990|FG002|Overall Study|Other|0|||
146897940|NCT00584870|529789988|FG000|Overall Study|Randomized but not treated|0|||
146897941|NCT00584870|529789989|FG001|Overall Study|Randomized but not treated|1|||
146897942|NCT00584870|529789990|FG002|Overall Study|Randomized but not treated|2|||
146897943|NCT03682120|529789991|FG000|Overall Study|Lost to Follow-up|11|||
146897944|NCT03682120|529789992|FG001|Overall Study|Lost to Follow-up|4|||
146897945|NCT03682120|529789993|FG002|Overall Study|Lost to Follow-up|5|||
146897946|NCT03682120|529789994|FG003|Overall Study|Lost to Follow-up|2|||
146897947|NCT03682120|529789991|FG000|Overall Study|Physician Decision|1|||
146968869|NCT00877799|530045544|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
146968870|NCT00877799|530045545|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
146968871|NCT00877799|530045546|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
146968872|NCT00877799|530045547|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
146968873|NCT00877799|530045543|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
146968874|NCT00877799|530045544|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
146968875|NCT00877799|530045545|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
146968876|NCT00877799|530045546|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
146968877|NCT00877799|530045547|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
146968878|NCT00127192|530045548|FG000|Overall Study|Adverse Event|0|||
146968879|NCT00127192|530045549|FG001|Overall Study|Adverse Event|1|||
146968880|NCT00127192|530045550|FG002|Overall Study|Adverse Event|1|||
146968881|NCT00127192|530045551|FG003|Overall Study|Adverse Event|1|||
146640269|NCT00622440|528859187|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
146640270|NCT00622440|528859188|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
146640271|NCT00771953|528859189|FG000|Overall Study|Adverse Event|5|||
146968882|NCT00127192|530045552|FG004|Overall Study|Adverse Event|0|||
146968883|NCT00127192|530045548|FG000|Overall Study|Lack of Efficacy|2|||
146968884|NCT00127192|530045549|FG001|Overall Study|Lack of Efficacy|0|||
146559275|NCT03663582|528557362|FG000|Overall Study|Physician Decision|1|||
146559276|NCT02367885|528557363|FG000|Overall Study|Lost to Follow-up|1|||
146559277|NCT02367885|528557364|FG001|Overall Study|Lost to Follow-up|0|||
146559278|NCT02367885|528557365|FG002|Overall Study|Lost to Follow-up|0|||
146559279|NCT02367885|528557363|FG000|Overall Study|Withdrawal by Subject|1|||
146559280|NCT02367885|528557364|FG001|Overall Study|Withdrawal by Subject|0|||
146559281|NCT02367885|528557365|FG002|Overall Study|Withdrawal by Subject|0|||
146559282|NCT01602484|528557366|FG000|Overall Study|Airway issues unrelated to study|0|||
146559283|NCT01602484|528557367|FG001|Overall Study|Airway issues unrelated to study|1|||
146559284|NCT01378195|528557368|FG000|Overall Study|Lost to Follow-up|29|||
146559285|NCT01378195|528557369|FG001|Overall Study|Lost to Follow-up|18|||
146968885|NCT00127192|530045550|FG002|Overall Study|Lack of Efficacy|0|||
146968886|NCT00127192|530045551|FG003|Overall Study|Lack of Efficacy|0|||
146968887|NCT00127192|530045552|FG004|Overall Study|Lack of Efficacy|2|||
146968888|NCT00127192|530045548|FG000|Overall Study|Withdrawal by Subject|0|||
146968889|NCT00127192|530045549|FG001|Overall Study|Withdrawal by Subject|0|||
146968890|NCT00127192|530045550|FG002|Overall Study|Withdrawal by Subject|1|||
146968891|NCT00127192|530045551|FG003|Overall Study|Withdrawal by Subject|0|||
146968892|NCT00127192|530045552|FG004|Overall Study|Withdrawal by Subject|3|||
146968893|NCT00127192|530045548|FG000|Overall Study|Adverse event in pre-treatment period|1|||
146968894|NCT00127192|530045549|FG001|Overall Study|Adverse event in pre-treatment period|0|||
146968895|NCT00127192|530045550|FG002|Overall Study|Adverse event in pre-treatment period|0|||
146968896|NCT00127192|530045551|FG003|Overall Study|Adverse event in pre-treatment period|0|||
146968897|NCT00127192|530045552|FG004|Overall Study|Adverse event in pre-treatment period|0|||
146968898|NCT00203892|530045553|FG000|Overall Study|Physician Decision|1|||
146968899|NCT00203892|530045554|FG001|Overall Study|Physician Decision|2|||
146968900|NCT00203892|530045555|FG002|Overall Study|Physician Decision|0|||
146968901|NCT00203892|530045553|FG000|Overall Study|Death|1|||
146968902|NCT00203892|530045554|FG001|Overall Study|Death|0|||
146968903|NCT00203892|530045555|FG002|Overall Study|Death|0|||
146968904|NCT00806416|530045558|FG000|Period 1 - Part I|Adverse Event|0|||
146968905|NCT00806416|530045559|FG001|Period 1 - Part I|Adverse Event|1|||
146968906|NCT00806416|530045560|FG002|Period 1 - Part I|Adverse Event|0|||
146968907|NCT00806416|530045561|FG003|Period 1 - Part I|Adverse Event|0|||
146968908|NCT00806416|530045558|FG000|Period 1 - Part I|Lost to Follow-up|0|||
146968909|NCT00806416|530045559|FG001|Period 1 - Part I|Lost to Follow-up|2|||
146968910|NCT00806416|530045560|FG002|Period 1 - Part I|Lost to Follow-up|0|||
146968911|NCT00806416|530045561|FG003|Period 1 - Part I|Lost to Follow-up|0|||
146968912|NCT00806416|530045558|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
146968913|NCT00806416|530045559|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
146968914|NCT00806416|530045560|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
146968915|NCT00806416|530045561|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
146968916|NCT00806416|530045558|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
146968917|NCT00806416|530045559|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
146968918|NCT00806416|530045560|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
146640272|NCT00771953|528859190|FG001|Overall Study|Adverse Event|3|||
146968919|NCT00806416|530045561|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
146968920|NCT01102972|530045566|FG000|Overall Study|Adverse Event|8|||
146968921|NCT01102972|530045567|FG001|Overall Study|Adverse Event|2|||
146968922|NCT01102972|530045566|FG000|Overall Study|Lack of Efficacy|2|||
146968923|NCT01102972|530045567|FG001|Overall Study|Lack of Efficacy|1|||
146897948|NCT03682120|529789992|FG001|Overall Study|Physician Decision|0|||
146559286|NCT03427619|528557370|FG000|Overall Study|Physician Decision|3|||
146559287|NCT03427619|528557370|FG000|Overall Study|Withdrawal by Subject|4|||
146559288|NCT03427619|528557370|FG000|Overall Study|Lost to Follow-up|5|||
146559289|NCT03427619|528557370|FG000|Overall Study|Administrative|4|||
146559290|NCT03427619|528557370|FG000|Overall Study|Other|2|||
146559291|NCT03427619|528557370|FG000|Overall Study|Unknown or Missing Completion Status|48|||
146559292|NCT05763381|528557376|FG000|Overall Study|Lost to Follow-up|2|||
146559293|NCT05763381|528557377|FG001|Overall Study|Lost to Follow-up|3|||
146559294|NCT05763381|528557376|FG000|Overall Study|Withdrawal by Subject|1|||
146559295|NCT05763381|528557377|FG001|Overall Study|Withdrawal by Subject|2|||
146559296|NCT02853136|528557378|FG000|Wash-out|Adverse Event|0|||
146559297|NCT02853136|528557379|FG001|Wash-out|Adverse Event|0|||
146559298|NCT02853136|528557380|FG002|Wash-out|Adverse Event|0|||
146559299|NCT02853136|528557381|FG003|Wash-out|Adverse Event|1|||
146559300|NCT00841815|528557382|FG000|Washout|Withdrawal by Subject|0|||
146559301|NCT00841815|528557383|FG001|Washout|Withdrawal by Subject|1|||
146559302|NCT03729609|528557384|FG000|Overall Study|Protocol Violation|1|||
146559303|NCT03787615|528557390|FG000|Overall Study|Withdrawal by Subject|2|||
146559304|NCT03787615|528557390|FG000|Overall Study|Lost to Follow-up|2|||
146559305|NCT03412929|528557393|FG000|Overall Study|Protocol Violation|3|||
146559306|NCT00605189|528557394|FG000|Overall Study|Adverse Event|1|||
146559307|NCT00605189|528557395|FG001|Overall Study|Adverse Event|0|||
146559308|NCT00605189|528557396|FG002|Overall Study|Adverse Event|0|||
146559309|NCT00605189|528557394|FG000|Overall Study|Other|2|||
146559310|NCT00605189|528557395|FG001|Overall Study|Other|2|||
146559311|NCT00605189|528557396|FG002|Overall Study|Other|0|||
146897949|NCT03682120|529789993|FG002|Overall Study|Physician Decision|0|||
146559312|NCT02697448|528557397|FG000|Overall Study|Protocol Violation|2|||
146559313|NCT02697448|528557398|FG001|Overall Study|Protocol Violation|4|||
146559314|NCT02697448|528557397|FG000|Overall Study|Clinical concerns during ablation|1|||
146559315|NCT02697448|528557398|FG001|Overall Study|Clinical concerns during ablation|1|||
146559316|NCT02697448|528557397|FG000|Overall Study|No data collected|2|||
146559317|NCT02697448|528557398|FG001|Overall Study|No data collected|0|||
146559318|NCT05418426|528557400|FG000|Overall Study|Adverse Event|0|||
146559319|NCT05418426|528557401|FG001|Overall Study|Adverse Event|1|||
146559320|NCT05418426|528557402|FG002|Overall Study|Adverse Event|0|||
146559321|NCT05418426|528557400|FG000|Overall Study|Withdrawal by Subject|0|||
146559322|NCT05418426|528557401|FG001|Overall Study|Withdrawal by Subject|1|||
146559323|NCT05418426|528557402|FG002|Overall Study|Withdrawal by Subject|0|||
146559324|NCT05418426|528557400|FG000|Overall Study|Protocol Violation|0|||
146559325|NCT05418426|528557401|FG001|Overall Study|Protocol Violation|0|||
146559326|NCT05418426|528557402|FG002|Overall Study|Protocol Violation|1|||
146559327|NCT01674062|528557403|FG000|Overall Study|Insufficient Therapeutic Response|56|||
146559328|NCT01674062|528557404|FG001|Overall Study|Insufficient Therapeutic Response|26|||
146559329|NCT01674062|528557403|FG000|Overall Study|Other|8|||
146559330|NCT01674062|528557404|FG001|Overall Study|Other|1|||
146559331|NCT01674062|528557403|FG000|Overall Study|Adverse Event|1|||
146559332|NCT01674062|528557404|FG001|Overall Study|Adverse Event|1|||
146559333|NCT01674062|528557403|FG000|Overall Study|Death|0|||
146559334|NCT01674062|528557404|FG001|Overall Study|Death|1|||
146559335|NCT01674062|528557403|FG000|Overall Study|Programming Error|1|||
146559336|NCT01674062|528557404|FG001|Overall Study|Programming Error|0|||
146559337|NCT04620668|528557405|FG000|Overall Study|Withdrawal by Subject|2|||
146559338|NCT04620668|528557406|FG001|Overall Study|Withdrawal by Subject|0|||
146559339|NCT04620668|528557405|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
146559340|NCT04620668|528557406|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
146559341|NCT04620668|528557405|FG000|Overall Study|Removed before analysis: missing data|2|||
146559342|NCT04620668|528557406|FG001|Overall Study|Removed before analysis: missing data|0|||
146559343|NCT04620668|528557405|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
146559344|NCT04620668|528557406|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
146559345|NCT04620668|528557405|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
146559346|NCT04620668|528557406|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
146559347|NCT02298946|528557409|FG000|Overall Study|Did not receive treatment|2|||
146559348|NCT02298946|528557410|FG001|Overall Study|Did not receive treatment|0|||
146559349|NCT02298946|528557409|FG000|Overall Study|Unevaluable|2|||
146559350|NCT02298946|528557410|FG001|Overall Study|Unevaluable|1|||
146559351|NCT00050011|528557411|FG000|Overall Study|Adverse Event|41|||
146559352|NCT00050011|528557412|FG001|Overall Study|Adverse Event|46|||
146559353|NCT00050011|528557411|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146559354|NCT00050011|528557412|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146897950|NCT03682120|529789994|FG003|Overall Study|Physician Decision|0|||
146640273|NCT00771953|528859189|FG000|Overall Study|Death|2|||
146897951|NCT03682120|529789991|FG000|Overall Study|Withdrawal by Subject|1|||
146897952|NCT03682120|529789992|FG001|Overall Study|Withdrawal by Subject|2|||
146897953|NCT03682120|529789993|FG002|Overall Study|Withdrawal by Subject|3|||
146897954|NCT03682120|529789994|FG003|Overall Study|Withdrawal by Subject|0|||
146640274|NCT00771953|528859190|FG001|Overall Study|Death|2|||
146897955|NCT03682120|529789991|FG000|Overall Study|Death|0|||
146897956|NCT03682120|529789992|FG001|Overall Study|Death|1|||
146509196|NCT00435487|528367761|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
146640275|NCT00771953|528859189|FG000|Overall Study|Progression before active Tx|1|||
146640276|NCT00771953|528859190|FG001|Overall Study|Progression before active Tx|2|||
146640277|NCT00771953|528859189|FG000|Overall Study|Sponsor decision|1|||
146640278|NCT00771953|528859190|FG001|Overall Study|Sponsor decision|0|||
146640279|NCT00771953|528859189|FG000|Overall Study|Other complicating disease|1|||
146640280|NCT00771953|528859190|FG001|Overall Study|Other complicating disease|0|||
146640281|NCT00771953|528859189|FG000|Overall Study|Withdrawal by Subject|0|||
146640282|NCT00771953|528859190|FG001|Overall Study|Withdrawal by Subject|3|||
146640283|NCT00947193|528859193|FG000|Overall Study|Lost to Follow-up|1|||
146640284|NCT00947193|528859194|FG001|Overall Study|Lost to Follow-up|0|||
146640285|NCT00947193|528859193|FG000|Overall Study|Withdrawal by Subject|1|||
146640286|NCT00947193|528859194|FG001|Overall Study|Withdrawal by Subject|0|||
146640287|NCT00947193|528859193|FG000|Overall Study|Factor VIII >1%|1|||
146640288|NCT00947193|528859194|FG001|Overall Study|Factor VIII >1%|0|||
146897957|NCT03682120|529789993|FG002|Overall Study|Death|0|||
146897958|NCT03682120|529789994|FG003|Overall Study|Death|0|||
146897959|NCT03682120|529789991|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
146897960|NCT03682120|529789992|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
146640289|NCT01652534|528859195|FG000|Overall Study|Lack of Efficacy|1|||
146640290|NCT01652534|528859196|FG001|Overall Study|Lack of Efficacy|0|||
146640291|NCT00811018|528859197|FG000|Overall Study|Additional Chronic Treatment|31|||
146640292|NCT00811018|528859197|FG000|Overall Study|Adverse Event|79|||
146640293|NCT00811018|528859197|FG000|Overall Study|Death|147|||
146559355|NCT00050011|528557411|FG000|Overall Study|Abnormal test procedure results|0|||
146559356|NCT00050011|528557412|FG001|Overall Study|Abnormal test procedure results|1|||
146559357|NCT00050011|528557411|FG000|Overall Study|Lack of Efficacy|16|||
146559358|NCT00050011|528557412|FG001|Overall Study|Lack of Efficacy|21|||
146559359|NCT00050011|528557411|FG000|Overall Study|Participant condition no longer required|1|||
146559360|NCT00050011|528557412|FG001|Overall Study|Participant condition no longer required|0|||
146559361|NCT00050011|528557411|FG000|Overall Study|Protocol Violation|4|||
146559362|NCT00050011|528557412|FG001|Overall Study|Protocol Violation|10|||
146559363|NCT00050011|528557411|FG000|Overall Study|Withdrawal by Subject|34|||
146559364|NCT00050011|528557412|FG001|Overall Study|Withdrawal by Subject|26|||
146559365|NCT00050011|528557411|FG000|Overall Study|Lost to Follow-up|7|||
146897961|NCT03682120|529789993|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
146897962|NCT03682120|529789994|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
146897963|NCT01015833|529789995|FG000|Overall Study|Death|1|||
146897964|NCT01015833|529789996|FG001|Overall Study|Death|0|||
146897965|NCT01015833|529789995|FG000|Overall Study|Withdrawal by Subject|3|||
146897966|NCT01015833|529789996|FG001|Overall Study|Withdrawal by Subject|2|||
146897967|NCT01015833|529789995|FG000|Overall Study|Adverse Event|0|||
146897968|NCT01015833|529789996|FG001|Overall Study|Adverse Event|1|||
146897969|NCT01015833|529789995|FG000|Overall Study|Physician Decision|2|||
146897970|NCT01015833|529789996|FG001|Overall Study|Physician Decision|0|||
146897971|NCT01015833|529789995|FG000|Overall Study|Symptomatic deterioration|0|||
146897972|NCT01015833|529789996|FG001|Overall Study|Symptomatic deterioration|1|||
146897973|NCT01015833|529789995|FG000|Overall Study|Other|5|||
146897974|NCT01015833|529789996|FG001|Overall Study|Other|1|||
146897975|NCT01015833|529789995|FG000|Overall Study|Motor Vehicle Accidents|1|||
146897976|NCT01015833|529789996|FG001|Overall Study|Motor Vehicle Accidents|0|||
146897977|NCT01015833|529789995|FG000|Overall Study|Did not start treatment|1|||
146897978|NCT01015833|529789996|FG001|Overall Study|Did not start treatment|0|||
146897979|NCT03529409|529790008|FG000|Randomized|Lost to Follow-up|0|||
146559366|NCT00050011|528557412|FG001|Overall Study|Lost to Follow-up|9|||
146897980|NCT03529409|529790009|FG001|Randomized|Lost to Follow-up|0|||
146897981|NCT03529409|529790010|FG002|Randomized|Lost to Follow-up|4|||
146897982|NCT03529409|529790008|FG000|Randomized|Excluded|0|||
146897983|NCT03529409|529790009|FG001|Randomized|Excluded|0|||
146559367|NCT00050011|528557411|FG000|Overall Study|Administrative problems|10|||
146559368|NCT00050011|528557412|FG001|Overall Study|Administrative problems|6|||
146559369|NCT00050011|528557411|FG000|Overall Study|Death|7|||
146559370|NCT00050011|528557412|FG001|Overall Study|Death|4|||
146559371|NCT00050011|528557411|FG000|Overall Study|Unknown - Reason is missing|0|||
146559372|NCT00050011|528557412|FG001|Overall Study|Unknown - Reason is missing|2|||
146559373|NCT05535972|528557413|FG000|Overall Study|Withdrawal by Subject|31|||
146559374|NCT05535972|528557413|FG000|Overall Study|Lost to Follow-up|5|||
146559375|NCT05535972|528557413|FG000|Overall Study|Adverse Event|6|||
146968924|NCT01102972|530045566|FG000|Overall Study|Protocol Violation|1|||
146968925|NCT01102972|530045567|FG001|Overall Study|Protocol Violation|0|||
146968926|NCT01102972|530045566|FG000|Overall Study|Lost to Follow-up|10|||
146968927|NCT01102972|530045567|FG001|Overall Study|Lost to Follow-up|5|||
146968928|NCT01102972|530045566|FG000|Overall Study|Investigator Discretion|2|||
146968929|NCT01102972|530045567|FG001|Overall Study|Investigator Discretion|0|||
146968930|NCT01102972|530045566|FG000|Overall Study|Withdrawal by Subject|6|||
146968931|NCT01102972|530045567|FG001|Overall Study|Withdrawal by Subject|6|||
146968932|NCT04935931|530045568|FG000|Overall Study|Withdrawal by Subject|1|||
146968933|NCT01360021|530045569|FG000|Overall Study|Eligibility criteria + other|2|||
146968934|NCT01360021|530045570|FG001|Overall Study|Eligibility criteria + other|1|||
146968935|NCT01360021|530045571|FG002|Overall Study|Eligibility criteria + other|1|||
146968936|NCT01360021|530045569|FG000|Overall Study|Protocol Violation|0|||
146968937|NCT01360021|530045570|FG001|Overall Study|Protocol Violation|0|||
146968938|NCT01360021|530045571|FG002|Overall Study|Protocol Violation|1|||
146968939|NCT01360021|530045569|FG000|Overall Study|Withdrawal by Subject|4|||
146968940|NCT01360021|530045570|FG001|Overall Study|Withdrawal by Subject|0|||
146968941|NCT01360021|530045571|FG002|Overall Study|Withdrawal by Subject|2|||
146968942|NCT01360021|530045569|FG000|Overall Study|Adverse Event|2|||
146968943|NCT01360021|530045570|FG001|Overall Study|Adverse Event|3|||
146968944|NCT01360021|530045571|FG002|Overall Study|Adverse Event|3|||
146968945|NCT02596009|530045574|FG000|Overall Study|Administrative problems|0|||
146968946|NCT02596009|530045575|FG001|Overall Study|Administrative problems|1|||
146968947|NCT02596009|530045576|FG002|Overall Study|Administrative problems|0|||
146968948|NCT02596009|530045577|FG003|Overall Study|Administrative problems|0|||
146968949|NCT02596009|530045578|FG004|Overall Study|Administrative problems|0|||
146968950|NCT02596009|530045579|FG005|Overall Study|Administrative problems|0|||
146968951|NCT01071278|530045580|FG000|Overall Study|Premature Discontinuation|254|||
146968952|NCT01071278|530045580|FG000|Overall Study|Completion Status Unknown|459|||
146968953|NCT00903409|530045581|FG000|Overall Study|Adverse Event|11|||
146968954|NCT00903409|530045582|FG001|Overall Study|Adverse Event|9|||
146968955|NCT00903409|530045581|FG000|Overall Study|Non-compliance with Protocol|1|||
146968956|NCT00903409|530045582|FG001|Overall Study|Non-compliance with Protocol|1|||
146968957|NCT00903409|530045581|FG000|Overall Study|Laboratory Abnormality|2|||
146968958|NCT00903409|530045582|FG001|Overall Study|Laboratory Abnormality|0|||
146968959|NCT00903409|530045581|FG000|Overall Study|Withdrawal by Subject|8|||
146968960|NCT00903409|530045582|FG001|Overall Study|Withdrawal by Subject|8|||
146968961|NCT00903409|530045581|FG000|Overall Study|Other|2|||
146968962|NCT00903409|530045582|FG001|Overall Study|Other|3|||
146968963|NCT00903409|530045581|FG000|Overall Study|Lost to Follow-up|2|||
146968964|NCT00903409|530045582|FG001|Overall Study|Lost to Follow-up|6|||
146968965|NCT03539952|530045584|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
146968966|NCT03539952|530045585|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
146968967|NCT03539952|530045584|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
146968968|NCT03539952|530045585|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
146559376|NCT05535972|528557413|FG000|Overall Study|Protocol Deviation|2|||
146559377|NCT04197583|528557416|FG000|Overall Study|Study Stent Replacement|34|||
146559378|NCT04197583|528557417|FG001|Overall Study|Study Stent Replacement|8|||
146559379|NCT04197583|528557416|FG000|Overall Study|Lost to Follow-up|14|||
146559380|NCT04197583|528557417|FG001|Overall Study|Lost to Follow-up|3|||
146968969|NCT03539952|530045584|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
146968970|NCT03539952|530045585|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
146968971|NCT03539952|530045584|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
146968972|NCT03539952|530045585|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
146968973|NCT03539952|530045584|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
146559381|NCT04197583|528557416|FG000|Overall Study|Death|3|||
146968974|NCT03539952|530045585|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
146968975|NCT03539952|530045584|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
146559382|NCT04197583|528557417|FG001|Overall Study|Death|0|||
146559383|NCT04197583|528557416|FG000|Overall Study|Physician Decision|1|||
146559384|NCT04197583|528557417|FG001|Overall Study|Physician Decision|0|||
146559385|NCT04197583|528557416|FG000|Overall Study|Withdrawal by Subject|1|||
146559386|NCT04197583|528557417|FG001|Overall Study|Withdrawal by Subject|1|||
146559387|NCT04197583|528557416|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
146559388|NCT04197583|528557417|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
146559389|NCT04197583|528557416|FG000|Overall Study|Screen Failure|0|||
146559390|NCT04197583|528557417|FG001|Overall Study|Screen Failure|20|||
146559391|NCT04629196|528557418|FG000|Overall Study|Subject discontinued study drug|1|||
146559392|NCT04629196|528557419|FG001|Overall Study|Subject discontinued study drug|0|||
146559393|NCT04629196|528557418|FG000|Overall Study|Subject study drug dosing increased|1|||
146559394|NCT04629196|528557419|FG001|Overall Study|Subject study drug dosing increased|1|||
146559395|NCT04629196|528557418|FG000|Overall Study|Withdrawal by Subject|1|||
146559396|NCT04629196|528557419|FG001|Overall Study|Withdrawal by Subject|2|||
146559397|NCT01450631|528557423|FG000|Overall Study|Lost to Follow-up|2|||
146559398|NCT01450631|528557424|FG001|Overall Study|Lost to Follow-up|4|||
146559399|NCT01450631|528557423|FG000|Overall Study|Withdrawal by Subject|1|||
146559400|NCT01450631|528557424|FG001|Overall Study|Withdrawal by Subject|0|||
146559401|NCT00461812|528557427|FG000|Overall Study|study terminated|10|||
146559402|NCT01308788|528557428|FG000|2-year Treatment|medication change by treating physician|4|||
146559403|NCT01308788|528557429|FG001|2-year Treatment|medication change by treating physician|11|||
146559404|NCT00322218|528557430|FG000|Overall Study|Death|3|||
146559405|NCT00322218|528557431|FG001|Overall Study|Death|6|||
146897984|NCT03529409|529790010|FG002|Randomized|Excluded|1|||
146897985|NCT03529409|529790008|FG000|Post-treatment Assessment|Death|1|||
146897986|NCT03529409|529790009|FG001|Post-treatment Assessment|Death|0|||
146897987|NCT03529409|529790010|FG002|Post-treatment Assessment|Death|0|||
146897988|NCT03529409|529790008|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
146897989|NCT03529409|529790009|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
146897990|NCT03529409|529790010|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
146897991|NCT03529409|529790008|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
146897992|NCT03529409|529790009|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
146897993|NCT03529409|529790010|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
146897994|NCT03529409|529790008|FG000|Follow-up Assessment|Death|1|||
146897995|NCT03529409|529790009|FG001|Follow-up Assessment|Death|0|||
146897996|NCT03529409|529790010|FG002|Follow-up Assessment|Death|0|||
146897997|NCT03529409|529790008|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
146897998|NCT03529409|529790009|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
146897999|NCT03529409|529790010|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
146898000|NCT01497262|529790011|FG000|Overall Study|Abnormal Lab Values|4|||
146898001|NCT01497262|529790011|FG000|Overall Study|Abnormal Test Procedure Result|1|||
146898002|NCT01497262|529790011|FG000|Overall Study|Physician Decision|1|||
146898003|NCT01497262|529790011|FG000|Overall Study|Withdrawal by Subject|2|||
146898004|NCT01497262|529790011|FG000|Overall Study|Adverse Event|2|||
146898005|NCT01497262|529790011|FG000|Overall Study|Protocol Violation|1|||
146898006|NCT02949830|529790012|FG000|Overall Study|Adverse Event|1|||
146898007|NCT02949830|529790012|FG000|Overall Study|Withdrawal by Subject|1|||
146898008|NCT01290887|529790013|FG000|Overall Study|Adverse Event|6|||
146898009|NCT01290887|529790014|FG001|Overall Study|Adverse Event|11|||
146898010|NCT01290887|529790013|FG000|Overall Study|Lack of Efficacy|4|||
146898011|NCT01290887|529790014|FG001|Overall Study|Lack of Efficacy|5|||
146898012|NCT01290887|529790013|FG000|Overall Study|Withdrawal by Subject|26|||
146559406|NCT03193437|528557438|FG000|Overall Study|Adverse Event|4|||
146559407|NCT03193437|528557438|FG000|Overall Study|Withdrawal by Subject|2|||
146559408|NCT03193437|528557438|FG000|Overall Study|Disease Progression|2|||
146559409|NCT02414841|528557441|FG000|Overall Study|Withdrawal by Subject|7|||
146898013|NCT01290887|529790014|FG001|Overall Study|Withdrawal by Subject|32|||
146559410|NCT02414841|528557442|FG001|Overall Study|Withdrawal by Subject|5|||
146559411|NCT02414841|528557441|FG000|Overall Study|Lost to Follow-up|13|||
146559412|NCT02414841|528557442|FG001|Overall Study|Lost to Follow-up|6|||
146559413|NCT02414841|528557441|FG000|Overall Study|Death|17|||
146898014|NCT01290887|529790013|FG000|Overall Study|Protocol Violation|2|||
146898015|NCT01290887|529790014|FG001|Overall Study|Protocol Violation|1|||
146898016|NCT01290887|529790013|FG000|Overall Study|Lost to Follow-up|4|||
146898017|NCT01290887|529790014|FG001|Overall Study|Lost to Follow-up|4|||
146898018|NCT01290887|529790013|FG000|Overall Study|Non-compliance to study procedures|0|||
146559414|NCT02414841|528557442|FG001|Overall Study|Death|14|||
146559415|NCT02414841|528557441|FG000|Overall Study|Received a Kidney Transplant|13|||
146559416|NCT02414841|528557442|FG001|Overall Study|Received a Kidney Transplant|4|||
146559417|NCT02414841|528557441|FG000|Overall Study|Randomized But Not Treated|6|||
146559418|NCT02414841|528557442|FG001|Overall Study|Randomized But Not Treated|4|||
146898019|NCT01290887|529790014|FG001|Overall Study|Non-compliance to study procedures|1|||
146898020|NCT01290887|529790013|FG000|Overall Study|Non-compliance to study medications|1|||
146559419|NCT02613507|528557458|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
146559420|NCT02613507|528557459|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
146559421|NCT02613507|528557458|FG000|Pre-Treamtent|Participant withdrew consent|0|||
146898021|NCT01290887|529790014|FG001|Overall Study|Non-compliance to study medications|0|||
146559422|NCT02613507|528557459|FG001|Pre-Treamtent|Participant withdrew consent|4|||
146640294|NCT00811018|528859197|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
146898022|NCT01290887|529790013|FG000|Overall Study|Sponsor closure of study|420|||
146898023|NCT01290887|529790014|FG001|Overall Study|Sponsor closure of study|476|||
146898024|NCT01290887|529790013|FG000|Overall Study|Other|3|||
146898025|NCT01290887|529790014|FG001|Overall Study|Other|6|||
146898026|NCT01628926|529790015|FG000|Overall Study|Adverse Event|13|||
146898027|NCT01628926|529790016|FG001|Overall Study|Adverse Event|11|||
146898028|NCT01628926|529790017|FG002|Overall Study|Adverse Event|9|||
146898029|NCT01628926|529790015|FG000|Overall Study|Lack of Efficacy|2|||
146898030|NCT01628926|529790016|FG001|Overall Study|Lack of Efficacy|1|||
146898031|NCT01628926|529790017|FG002|Overall Study|Lack of Efficacy|5|||
146898032|NCT01628926|529790015|FG000|Overall Study|Withdrawal by Subject|6|||
146898033|NCT01628926|529790016|FG001|Overall Study|Withdrawal by Subject|4|||
146898034|NCT01628926|529790017|FG002|Overall Study|Withdrawal by Subject|2|||
146898035|NCT01628926|529790015|FG000|Overall Study|Protocol Violation|0|||
146898036|NCT01628926|529790016|FG001|Overall Study|Protocol Violation|1|||
146898037|NCT01628926|529790017|FG002|Overall Study|Protocol Violation|0|||
146898038|NCT01628926|529790015|FG000|Overall Study|Discontinuation criteria|3|||
146898039|NCT01628926|529790016|FG001|Overall Study|Discontinuation criteria|4|||
146898040|NCT01628926|529790017|FG002|Overall Study|Discontinuation criteria|0|||
146898041|NCT01628926|529790015|FG000|Overall Study|Physician Decision|2|||
146898042|NCT01628926|529790016|FG001|Overall Study|Physician Decision|2|||
146898043|NCT01628926|529790017|FG002|Overall Study|Physician Decision|1|||
146898044|NCT03437447|529790020|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146898045|NCT03437447|529790021|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146898046|NCT03437447|529790022|FG002|Treatment Period 1|Withdrawal by Subject|1|||
146898047|NCT01551745|529790023|FG000|Overall Study|Withdrawal by Subject|1|||
146898048|NCT01551745|529790023|FG000|Overall Study|Disease Progression|2|||
146898049|NCT02764541|529790024|FG000|Overall Study|Withdrawal by Subject|0|||
146898050|NCT02764541|529790025|FG001|Overall Study|Withdrawal by Subject|0|||
146898051|NCT02764541|529790026|FG002|Overall Study|Withdrawal by Subject|0|||
146898052|NCT02764541|529790027|FG003|Overall Study|Withdrawal by Subject|0|||
146968976|NCT03539952|530045585|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
146968977|NCT03539952|530045584|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
146968978|NCT03539952|530045585|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
146968979|NCT02184988|530045586|FG000|Overall Study|Pregnancy|2|||
146898053|NCT02764541|529790028|FG004|Overall Study|Withdrawal by Subject|1|||
146898054|NCT02764541|529790029|FG005|Overall Study|Withdrawal by Subject|1|||
146898055|NCT02764541|529790030|FG006|Overall Study|Withdrawal by Subject|0|||
146898056|NCT02764541|529790031|FG007|Overall Study|Withdrawal by Subject|1|||
146898057|NCT02764541|529790024|FG000|Overall Study|Adverse Event|1|||
146898058|NCT02764541|529790025|FG001|Overall Study|Adverse Event|0|||
146898059|NCT02764541|529790026|FG002|Overall Study|Adverse Event|0|||
146968980|NCT02184988|530045586|FG000|Overall Study|Adverse Event|2|||
146898060|NCT02764541|529790027|FG003|Overall Study|Adverse Event|0|||
146898061|NCT02764541|529790028|FG004|Overall Study|Adverse Event|0|||
146898062|NCT02764541|529790029|FG005|Overall Study|Adverse Event|0|||
146898063|NCT02764541|529790030|FG006|Overall Study|Adverse Event|1|||
146898064|NCT02764541|529790031|FG007|Overall Study|Adverse Event|0|||
146898065|NCT02764541|529790024|FG000|Overall Study|Metastasis|1|||
146898066|NCT02764541|529790025|FG001|Overall Study|Metastasis|0|||
146898067|NCT02764541|529790026|FG002|Overall Study|Metastasis|0|||
146898068|NCT02764541|529790027|FG003|Overall Study|Metastasis|0|||
146898069|NCT02764541|529790028|FG004|Overall Study|Metastasis|0|||
146898070|NCT02764541|529790029|FG005|Overall Study|Metastasis|0|||
146898071|NCT02764541|529790030|FG006|Overall Study|Metastasis|0|||
146968981|NCT02184988|530045586|FG000|Overall Study|moving away/travelling/unable to complet|6|||
146968982|NCT02184988|530045586|FG000|Overall Study|work scheduling issues|4|||
146898072|NCT02764541|529790031|FG007|Overall Study|Metastasis|0|||
146898073|NCT02764541|529790024|FG000|Overall Study|Disease progression|1|||
146898074|NCT02764541|529790025|FG001|Overall Study|Disease progression|1|||
146898075|NCT02764541|529790026|FG002|Overall Study|Disease progression|0|||
146898076|NCT02764541|529790027|FG003|Overall Study|Disease progression|0|||
146898077|NCT02764541|529790028|FG004|Overall Study|Disease progression|0|||
146898078|NCT02764541|529790029|FG005|Overall Study|Disease progression|0|||
146898079|NCT02764541|529790030|FG006|Overall Study|Disease progression|0|||
146898080|NCT02764541|529790031|FG007|Overall Study|Disease progression|1|||
146898081|NCT02764541|529790024|FG000|Overall Study|Protocol Violation|0|||
146898082|NCT02764541|529790025|FG001|Overall Study|Protocol Violation|0|||
146898083|NCT02764541|529790026|FG002|Overall Study|Protocol Violation|0|||
146898084|NCT02764541|529790027|FG003|Overall Study|Protocol Violation|1|||
146559423|NCT02613507|528557458|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
146559424|NCT02613507|528557459|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
146559425|NCT02613507|528557458|FG000|Treatment|Not reported|3|||
146559426|NCT02613507|528557459|FG001|Treatment|Not reported|0|||
146559427|NCT02613507|528557458|FG000|Treatment|Other reasons|8|||
146559428|NCT02613507|528557459|FG001|Treatment|Other reasons|0|||
146559429|NCT02613507|528557458|FG000|Treatment|Participant no longer meets criteria|3|||
146559430|NCT02613507|528557459|FG001|Treatment|Participant no longer meets criteria|0|||
146559431|NCT02613507|528557458|FG000|Treatment|Maximum clinical benefit|5|||
146559432|NCT02613507|528557459|FG001|Treatment|Maximum clinical benefit|10|||
146559433|NCT02613507|528557458|FG000|Treatment|Lost to Follow-up|1|||
146559434|NCT02613507|528557459|FG001|Treatment|Lost to Follow-up|0|||
146898085|NCT02764541|529790028|FG004|Overall Study|Protocol Violation|0|||
146898086|NCT02764541|529790029|FG005|Overall Study|Protocol Violation|1|||
146898087|NCT02764541|529790030|FG006|Overall Study|Protocol Violation|0|||
146898088|NCT02764541|529790031|FG007|Overall Study|Protocol Violation|0|||
146898089|NCT02764541|529790024|FG000|Overall Study|Physician Decision|0|||
146898090|NCT02764541|529790025|FG001|Overall Study|Physician Decision|0|||
146898091|NCT02764541|529790026|FG002|Overall Study|Physician Decision|0|||
146898092|NCT02764541|529790027|FG003|Overall Study|Physician Decision|1|||
146898093|NCT02764541|529790028|FG004|Overall Study|Physician Decision|0|||
146898094|NCT02764541|529790029|FG005|Overall Study|Physician Decision|0|||
146898095|NCT02764541|529790030|FG006|Overall Study|Physician Decision|0|||
146898096|NCT02764541|529790031|FG007|Overall Study|Physician Decision|1|||
146898097|NCT02764541|529790024|FG000|Overall Study|Three Cycles completed before surgery|0|||
146898098|NCT02764541|529790025|FG001|Overall Study|Three Cycles completed before surgery|0|||
146898099|NCT02764541|529790026|FG002|Overall Study|Three Cycles completed before surgery|0|||
146898100|NCT02764541|529790027|FG003|Overall Study|Three Cycles completed before surgery|1|||
146898101|NCT02764541|529790028|FG004|Overall Study|Three Cycles completed before surgery|0|||
146898102|NCT02764541|529790029|FG005|Overall Study|Three Cycles completed before surgery|0|||
146898103|NCT02764541|529790030|FG006|Overall Study|Three Cycles completed before surgery|0|||
146898104|NCT02764541|529790031|FG007|Overall Study|Three Cycles completed before surgery|0|||
146898105|NCT02764541|529790024|FG000|Overall Study|Patient Compliance|0|||
146898106|NCT02764541|529790025|FG001|Overall Study|Patient Compliance|0|||
146898107|NCT02764541|529790026|FG002|Overall Study|Patient Compliance|1|||
146898108|NCT02764541|529790027|FG003|Overall Study|Patient Compliance|0|||
146898109|NCT02764541|529790028|FG004|Overall Study|Patient Compliance|0|||
146898110|NCT02764541|529790029|FG005|Overall Study|Patient Compliance|0|||
146898111|NCT02764541|529790030|FG006|Overall Study|Patient Compliance|0|||
146898112|NCT02764541|529790031|FG007|Overall Study|Patient Compliance|0|||
146559435|NCT02613507|528557458|FG000|Treatment|Participant withdrew consent|0|||
146559436|NCT02613507|528557459|FG001|Treatment|Participant withdrew consent|2|||
146559437|NCT02613507|528557458|FG000|Treatment|Participant request to discontinue study treatment|13|||
146898113|NCT02764541|529790024|FG000|Overall Study|Death|0|||
146898114|NCT02764541|529790025|FG001|Overall Study|Death|0|||
146898115|NCT02764541|529790026|FG002|Overall Study|Death|0|||
146898116|NCT02764541|529790027|FG003|Overall Study|Death|0|||
146898117|NCT02764541|529790028|FG004|Overall Study|Death|0|||
146898118|NCT02764541|529790029|FG005|Overall Study|Death|0|||
146898119|NCT02764541|529790030|FG006|Overall Study|Death|1|||
146898120|NCT02764541|529790031|FG007|Overall Study|Death|0|||
146898121|NCT02764541|529790024|FG000|Overall Study|Insurance reasons|0|||
146898122|NCT02764541|529790025|FG001|Overall Study|Insurance reasons|0|||
146968983|NCT02184988|530045586|FG000|Overall Study|various other reasons|9|||
146968984|NCT02184988|530045586|FG000|Overall Study|Lost to Follow-up|32|||
146898123|NCT02764541|529790026|FG002|Overall Study|Insurance reasons|0|||
146898124|NCT02764541|529790027|FG003|Overall Study|Insurance reasons|0|||
146898125|NCT02764541|529790028|FG004|Overall Study|Insurance reasons|0|||
146559438|NCT02613507|528557459|FG001|Treatment|Participant request to discontinue study treatment|17|||
146559439|NCT02613507|528557458|FG000|Treatment|Adverse event unrelated to study drug|20|||
146559440|NCT02613507|528557459|FG001|Treatment|Adverse event unrelated to study drug|3|||
146559441|NCT02613507|528557458|FG000|Treatment|Death|2|||
146559442|NCT02613507|528557459|FG001|Treatment|Death|0|||
146559443|NCT02613507|528557458|FG000|Treatment|Study drug toxicity|19|||
146559444|NCT02613507|528557459|FG001|Treatment|Study drug toxicity|14|||
146559445|NCT02613507|528557458|FG000|Treatment|Disease progression|263|||
146559446|NCT02613507|528557459|FG001|Treatment|Disease progression|110|||
146559447|NCT03941093|528557460|FG000|Overall Study|Protocol Violation|0|||
146559448|NCT03941093|528557461|FG001|Overall Study|Protocol Violation|1|||
146559449|NCT03941093|528557460|FG000|Overall Study|Withdrawal by Subject|9|||
146559450|NCT03941093|528557461|FG001|Overall Study|Withdrawal by Subject|6|||
146559451|NCT04191135|528557471|FG000|Induction Treatment|Not Treated|2|||
146559452|NCT04191135|528557472|FG001|Induction Treatment|Not Treated|0|||
146559453|NCT04191135|528557473|FG002|Induction Treatment|Not Treated|0|||
146559454|NCT04191135|528557471|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
146559455|NCT04191135|528557472|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
146559456|NCT04191135|528557473|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
146559457|NCT04191135|528557471|FG000|Induction Treatment|Adverse Event|25|||
146559458|NCT04191135|528557472|FG001|Induction Treatment|Adverse Event|0|||
146559459|NCT04191135|528557473|FG002|Induction Treatment|Adverse Event|0|||
146559460|NCT04191135|528557471|FG000|Induction Treatment|Clinical Progression|8|||
146559461|NCT04191135|528557472|FG001|Induction Treatment|Clinical Progression|0|||
146559462|NCT04191135|528557473|FG002|Induction Treatment|Clinical Progression|0|||
146559463|NCT04191135|528557471|FG000|Induction Treatment|Excluded Medication|1|||
146559464|NCT04191135|528557472|FG001|Induction Treatment|Excluded Medication|0|||
146559465|NCT04191135|528557473|FG002|Induction Treatment|Excluded Medication|0|||
146559466|NCT04191135|528557471|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
146559467|NCT04191135|528557472|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
146559468|NCT04191135|528557473|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
146898126|NCT02764541|529790029|FG005|Overall Study|Insurance reasons|0|||
146898127|NCT02764541|529790030|FG006|Overall Study|Insurance reasons|1|||
146898128|NCT02764541|529790031|FG007|Overall Study|Insurance reasons|0|||
146898129|NCT02330419|529790034|FG000|Overall Study|Lost to Follow-up|3|||
146898130|NCT02330419|529790035|FG001|Overall Study|Lost to Follow-up|7|||
146898131|NCT01955707|529790040|FG000|Overall Study|Adverse Event|1|||
146898132|NCT01955707|529790041|FG001|Overall Study|Adverse Event|2|||
146898133|NCT01955707|529790040|FG000|Overall Study|Lost to Follow-up|2|||
146898134|NCT01955707|529790041|FG001|Overall Study|Lost to Follow-up|1|||
146898135|NCT01955707|529790040|FG000|Overall Study|Withdrawal by Subject|0|||
146898136|NCT01955707|529790041|FG001|Overall Study|Withdrawal by Subject|3|||
146898137|NCT01955707|529790040|FG000|Overall Study|Death|13|||
146898138|NCT01955707|529790041|FG001|Overall Study|Death|14|||
146898139|NCT01955707|529790040|FG000|Overall Study|Other|4|||
146898140|NCT01955707|529790041|FG001|Overall Study|Other|2|||
146898141|NCT04167345|529790046|FG000|Overall Study|Other|1|||
146898142|NCT04167345|529790047|FG001|Overall Study|Other|1|||
146898143|NCT04167345|529790048|FG002|Overall Study|Other|0|||
146898144|NCT04167345|529790049|FG003|Overall Study|Other|0|||
146898145|NCT04167345|529790050|FG004|Overall Study|Other|0|||
146898146|NCT03896581|529791251|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
146898147|NCT03896581|529791252|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
146898148|NCT03896581|529791251|FG000|Overall Study|Withdrawal by Subject|4|||
146898149|NCT03896581|529791252|FG001|Overall Study|Withdrawal by Subject|1|||
146898150|NCT03896581|529791251|FG000|Overall Study|Lost to Follow-up|1|||
146898151|NCT03896581|529791252|FG001|Overall Study|Lost to Follow-up|0|||
146898152|NCT03896581|529791251|FG000|Overall Study|Lack of Efficacy|2|||
146898153|NCT03896581|529791252|FG001|Overall Study|Lack of Efficacy|1|||
146898154|NCT03896581|529791251|FG000|Overall Study|Adverse event, non-fatal|0|||
146898155|NCT03896581|529791252|FG001|Overall Study|Adverse event, non-fatal|2|||
146898156|NCT04063384|529791253|FG000|Overall Study|placebo manipulation issue|1|||
146898157|NCT04063384|529791254|FG001|Overall Study|placebo manipulation issue|2|||
146898158|NCT04063384|529791255|FG002|Overall Study|placebo manipulation issue|1|||
146898159|NCT04063384|529791256|FG003|Overall Study|placebo manipulation issue|1|||
146898160|NCT00450580|529791259|FG000|Overall Study|Adverse Event|5|||
146898161|NCT00450580|529791260|FG001|Overall Study|Adverse Event|7|||
146898162|NCT00450580|529791259|FG000|Overall Study|Lost to Follow-up|4|||
146898163|NCT00450580|529791260|FG001|Overall Study|Lost to Follow-up|5|||
146898164|NCT00450580|529791259|FG000|Overall Study|Withdrawal by Subject|2|||
146898165|NCT00450580|529791260|FG001|Overall Study|Withdrawal by Subject|2|||
146898166|NCT00450580|529791259|FG000|Overall Study|Protocol Violation|1|||
146898167|NCT00450580|529791260|FG001|Overall Study|Protocol Violation|1|||
146898168|NCT00450580|529791259|FG000|Overall Study|Protocol-defined virologic failure|1|||
146968985|NCT01821391|530045587|FG000|Overall Study|Adverse Event|1|||
146640295|NCT00811018|528859197|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
146640296|NCT00811018|528859197|FG000|Overall Study|Investigator Decision|57|||
146640297|NCT00811018|528859197|FG000|Overall Study|Lost to Follow-up|19|||
146898169|NCT00450580|529791260|FG001|Overall Study|Protocol-defined virologic failure|0|||
146640298|NCT00811018|528859197|FG000|Overall Study|Pregnancy|6|||
146640299|NCT00811018|528859197|FG000|Overall Study|Sponsor Decision|450|||
146898170|NCT00450580|529791259|FG000|Overall Study|Could not comply with scheduled visits|1|||
146898171|NCT00450580|529791260|FG001|Overall Study|Could not comply with scheduled visits|0|||
146898172|NCT00450580|529791259|FG000|Overall Study|Patient went to Brazil|1|||
146898173|NCT00450580|529791260|FG001|Overall Study|Patient went to Brazil|0|||
146968986|NCT01821391|530045588|FG001|Overall Study|Adverse Event|0|||
146898174|NCT00450580|529791259|FG000|Overall Study|Patient could not swallow Norvir|1|||
146898175|NCT00450580|529791260|FG001|Overall Study|Patient could not swallow Norvir|0|||
146898176|NCT00450580|529791259|FG000|Overall Study|Withdrawal due to pregnancy|0|||
146898177|NCT00450580|529791260|FG001|Overall Study|Withdrawal due to pregnancy|1|||
146898178|NCT04572633|529791267|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
146898179|NCT00332709|529791268|FG000|Overall Study|Adverse Event|11|||
146898180|NCT00332709|529791269|FG001|Overall Study|Adverse Event|14|||
146898181|NCT00332709|529791268|FG000|Overall Study|Withdrawal by Subject|2|||
146898182|NCT00332709|529791269|FG001|Overall Study|Withdrawal by Subject|3|||
146898183|NCT00332709|529791268|FG000|Overall Study|Lost to Follow-up|2|||
146898184|NCT00332709|529791269|FG001|Overall Study|Lost to Follow-up|0|||
146898185|NCT00332709|529791268|FG000|Overall Study|Administrative Problems|0|||
146898186|NCT00332709|529791269|FG001|Overall Study|Administrative Problems|3|||
146898187|NCT00332709|529791268|FG000|Overall Study|Abnormal test procedure result|1|||
146898188|NCT00332709|529791269|FG001|Overall Study|Abnormal test procedure result|0|||
146898189|NCT05424276|529791270|FG000|Overall Study|Adverse Event|1|||
146898190|NCT05424276|529791271|FG001|Overall Study|Adverse Event|0|||
146898191|NCT05424276|529791272|FG002|Overall Study|Adverse Event|0|||
146898192|NCT05424276|529791273|FG003|Overall Study|Adverse Event|2|||
146898193|NCT05424276|529791270|FG000|Overall Study|Withdrawal by Subject|0|||
146898194|NCT05424276|529791271|FG001|Overall Study|Withdrawal by Subject|0|||
146898195|NCT05424276|529791272|FG002|Overall Study|Withdrawal by Subject|2|||
146898196|NCT05424276|529791273|FG003|Overall Study|Withdrawal by Subject|0|||
146898197|NCT05424276|529791270|FG000|Overall Study|Protocol Violation|0|||
146898198|NCT05424276|529791271|FG001|Overall Study|Protocol Violation|1|||
146898199|NCT05424276|529791272|FG002|Overall Study|Protocol Violation|0|||
146898200|NCT05424276|529791273|FG003|Overall Study|Protocol Violation|0|||
146898201|NCT05424276|529791270|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
146898202|NCT05424276|529791271|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
146898203|NCT05424276|529791272|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
146898204|NCT05424276|529791273|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
146898205|NCT01701258|529791275|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
146898206|NCT01701258|529791276|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
146898207|NCT01701258|529791277|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
146898208|NCT01701258|529791278|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
146898209|NCT01701258|529791279|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
146898210|NCT01701258|529791280|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
146898211|NCT01701258|529791281|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
146898212|NCT01701258|529791282|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
146898213|NCT01701258|529791283|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
146898214|NCT01701258|529791284|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
146898215|NCT01701258|529791285|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
146898216|NCT01701258|529791286|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
146898217|NCT01701258|529791287|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
146898218|NCT01701258|529791275|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
146898219|NCT01701258|529791276|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
146898220|NCT01701258|529791277|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
146898221|NCT01701258|529791278|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
146898222|NCT01701258|529791279|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
146898223|NCT01701258|529791280|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
146898224|NCT01701258|529791281|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
146898225|NCT01701258|529791282|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
146898226|NCT01701258|529791283|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
146898227|NCT01701258|529791284|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
146898228|NCT01701258|529791285|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
146898229|NCT01701258|529791286|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
146898230|NCT01701258|529791287|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
146898231|NCT01701258|529791275|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
146898232|NCT01701258|529791276|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
146640300|NCT00811018|528859197|FG000|Overall Study|Withdrawal by Subject|70|||
146640301|NCT00811018|528859197|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
146640302|NCT00811018|528859197|FG000|Overall Study|Other|26|||
146640303|NCT02722304|528859201|FG000|Overall Study|Study Terminated by Sponsor|1|||
146898233|NCT01701258|529791277|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
146898234|NCT01701258|529791278|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
146898235|NCT01701258|529791279|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
146898236|NCT01701258|529791280|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
146898237|NCT01701258|529791281|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
146898238|NCT01701258|529791282|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
146898239|NCT01701258|529791283|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
146898240|NCT01701258|529791284|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
146766912|NCT05019729|529314648|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
146766913|NCT05019729|529314649|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
146766914|NCT03254394|529314652|FG000|Overall Study|Withdrawal by Subject|0|||
146766915|NCT03254394|529314653|FG001|Overall Study|Withdrawal by Subject|2|||
146766916|NCT02351180|529314656|FG000|Overall Study|Withdrawal by Subject|1|||
146766917|NCT02351180|529314657|FG001|Overall Study|Withdrawal by Subject|0|||
146766918|NCT00208767|529314664|FG000|Overall Study|Adverse Event|9|||
146766919|NCT00208767|529314665|FG001|Overall Study|Adverse Event|1|||
146766920|NCT00208767|529314664|FG000|Overall Study|Withdrawal by Subject|14|||
146766921|NCT00208767|529314665|FG001|Overall Study|Withdrawal by Subject|3|||
146766922|NCT00208767|529314664|FG000|Overall Study|Death|1|||
146559469|NCT04191135|528557471|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
146559470|NCT04191135|528557472|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
146766923|NCT00208767|529314665|FG001|Overall Study|Death|0|||
146766924|NCT00208767|529314664|FG000|Overall Study|Lost to Follow-up|3|||
146766925|NCT00208767|529314665|FG001|Overall Study|Lost to Follow-up|3|||
146559471|NCT04191135|528557473|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
146559472|NCT04191135|528557471|FG000|Induction Treatment|Physician Decision|2|||
146559473|NCT04191135|528557472|FG001|Induction Treatment|Physician Decision|0|||
146766926|NCT00536380|529314666|FG000|Overall Study|Adverse Event|0|||
146766927|NCT00536380|529314667|FG001|Overall Study|Adverse Event|2|||
146766928|NCT00536380|529314668|FG002|Overall Study|Adverse Event|2|||
146766929|NCT00536380|529314666|FG000|Overall Study|Lost to Follow-up|0|||
146766930|NCT00536380|529314667|FG001|Overall Study|Lost to Follow-up|0|||
146898241|NCT01701258|529791285|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
146898242|NCT01701258|529791286|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
146898243|NCT01701258|529791287|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
146898244|NCT01701258|529791275|FG000|Assessment and Scheduling|Investigator Terminated|2|||
146898245|NCT01701258|529791276|FG001|Assessment and Scheduling|Investigator Terminated|0|||
146898246|NCT01701258|529791277|FG002|Assessment and Scheduling|Investigator Terminated|0|||
146898247|NCT01701258|529791278|FG003|Assessment and Scheduling|Investigator Terminated|0|||
146898248|NCT01701258|529791279|FG004|Assessment and Scheduling|Investigator Terminated|0|||
146898249|NCT01701258|529791280|FG005|Assessment and Scheduling|Investigator Terminated|0|||
146898250|NCT01701258|529791281|FG006|Assessment and Scheduling|Investigator Terminated|0|||
146898251|NCT01701258|529791282|FG007|Assessment and Scheduling|Investigator Terminated|0|||
146898252|NCT01701258|529791283|FG008|Assessment and Scheduling|Investigator Terminated|0|||
146898253|NCT01701258|529791284|FG009|Assessment and Scheduling|Investigator Terminated|0|||
146898254|NCT01701258|529791285|FG010|Assessment and Scheduling|Investigator Terminated|0|||
146898255|NCT01701258|529791286|FG011|Assessment and Scheduling|Investigator Terminated|0|||
146898256|NCT01701258|529791287|FG012|Assessment and Scheduling|Investigator Terminated|0|||
146898257|NCT03049449|529791288|FG000|Overall Study|Did not receive treatment.|0|||
146898258|NCT03049449|529791289|FG001|Overall Study|Did not receive treatment.|0|||
146898259|NCT03049449|529791290|FG002|Overall Study|Did not receive treatment.|0|||
146898260|NCT03049449|529791291|FG003|Overall Study|Did not receive treatment.|0|||
146898261|NCT03049449|529791292|FG004|Overall Study|Did not receive treatment.|0|||
146898262|NCT03049449|529791293|FG005|Overall Study|Did not receive treatment.|0|||
146898263|NCT03049449|529791294|FG006|Overall Study|Did not receive treatment.|0|||
146898264|NCT03049449|529791295|FG007|Overall Study|Did not receive treatment.|0|||
146559474|NCT04191135|528557473|FG002|Induction Treatment|Physician Decision|0|||
146766931|NCT00536380|529314668|FG002|Overall Study|Lost to Follow-up|1|||
146766932|NCT00536380|529314666|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
146766933|NCT00536380|529314667|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
146766934|NCT00536380|529314668|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
146766935|NCT00536380|529314666|FG000|Overall Study|Withdrawal related to study drug|7|||
146898265|NCT03049449|529791296|FG008|Overall Study|Did not receive treatment.|1|||
146898266|NCT03049449|529791297|FG009|Overall Study|Did not receive treatment.|0|||
146898267|NCT03049449|529791288|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
146898268|NCT03049449|529791289|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
146640304|NCT02722304|528859202|FG001|Overall Study|Study Terminated by Sponsor|0|||
146640305|NCT02722304|528859203|FG002|Overall Study|Study Terminated by Sponsor|2|||
146640306|NCT02722304|528859204|FG003|Overall Study|Study Terminated by Sponsor|1|||
146640307|NCT02722304|528859205|FG004|Overall Study|Study Terminated by Sponsor|1|||
146640308|NCT02722304|528859201|FG000|Overall Study|Other|0|||
146640309|NCT02722304|528859202|FG001|Overall Study|Other|0|||
146640310|NCT02722304|528859203|FG002|Overall Study|Other|0|||
146898269|NCT03049449|529791290|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
146898270|NCT03049449|529791291|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
146898271|NCT03049449|529791292|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
146898272|NCT03049449|529791293|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
146898273|NCT03049449|529791294|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
146898274|NCT03049449|529791295|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
146898275|NCT03049449|529791296|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
146898276|NCT03049449|529791297|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
146898277|NCT03049449|529791288|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
146898278|NCT03049449|529791289|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
146898279|NCT03049449|529791290|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
146898280|NCT03049449|529791291|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
146898281|NCT03049449|529791292|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
146898282|NCT03049449|529791293|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
146898283|NCT03049449|529791294|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
146559475|NCT04191135|528557471|FG000|Induction Treatment|Progressive Disease|135|||
146559476|NCT04191135|528557472|FG001|Induction Treatment|Progressive Disease|0|||
146559477|NCT04191135|528557473|FG002|Induction Treatment|Progressive Disease|0|||
146559478|NCT04191135|528557471|FG000|Induction Treatment|Protocol Violation|10|||
146559479|NCT04191135|528557472|FG001|Induction Treatment|Protocol Violation|0|||
146559480|NCT04191135|528557473|FG002|Induction Treatment|Protocol Violation|0|||
146559481|NCT04191135|528557471|FG000|Induction Treatment|Withdrawal by Subject|4|||
146559482|NCT04191135|528557472|FG001|Induction Treatment|Withdrawal by Subject|0|||
146559483|NCT04191135|528557473|FG002|Induction Treatment|Withdrawal by Subject|0|||
146640311|NCT02722304|528859204|FG003|Overall Study|Other|1|||
146640312|NCT02722304|528859205|FG004|Overall Study|Other|1|||
146640313|NCT04380519|528859208|FG000|Overall Study|Withdrawal by Subject|4|||
146968987|NCT01843660|530045589|FG000|Overall Study|Other|30|||
146968988|NCT01977482|530045590|FG000|Overall Study|Adverse Event|0|||
146968989|NCT01977482|530045591|FG001|Overall Study|Adverse Event|1|||
146968990|NCT01977482|530045592|FG002|Overall Study|Adverse Event|1|||
146968991|NCT01977482|530045593|FG003|Overall Study|Adverse Event|0|||
146968992|NCT01977482|530045594|FG004|Overall Study|Adverse Event|2|||
146968993|NCT01977482|530045595|FG005|Overall Study|Adverse Event|0|||
146968994|NCT01977482|530045590|FG000|Overall Study|Lost to Follow-up|1|||
146968995|NCT01977482|530045591|FG001|Overall Study|Lost to Follow-up|0|||
146968996|NCT01977482|530045592|FG002|Overall Study|Lost to Follow-up|0|||
146968997|NCT01977482|530045593|FG003|Overall Study|Lost to Follow-up|0|||
146968998|NCT01977482|530045594|FG004|Overall Study|Lost to Follow-up|0|||
146968999|NCT01977482|530045595|FG005|Overall Study|Lost to Follow-up|0|||
146969000|NCT01977482|530045590|FG000|Overall Study|Physician Decision|0|||
146969001|NCT01977482|530045591|FG001|Overall Study|Physician Decision|1|||
146969002|NCT01977482|530045592|FG002|Overall Study|Physician Decision|0|||
146969003|NCT01977482|530045593|FG003|Overall Study|Physician Decision|0|||
146969004|NCT01977482|530045594|FG004|Overall Study|Physician Decision|0|||
146969005|NCT01977482|530045595|FG005|Overall Study|Physician Decision|0|||
146969006|NCT01977482|530045590|FG000|Overall Study|Protocol Violation|0|||
146969007|NCT01977482|530045591|FG001|Overall Study|Protocol Violation|0|||
146969008|NCT01977482|530045592|FG002|Overall Study|Protocol Violation|1|||
146969009|NCT01977482|530045593|FG003|Overall Study|Protocol Violation|0|||
146969010|NCT01977482|530045594|FG004|Overall Study|Protocol Violation|0|||
146969011|NCT01977482|530045595|FG005|Overall Study|Protocol Violation|0|||
146969012|NCT01977482|530045590|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
146969013|NCT01977482|530045591|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
146969014|NCT01977482|530045592|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
146969015|NCT01977482|530045593|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
146969016|NCT01977482|530045594|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
146969017|NCT01977482|530045595|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
146969018|NCT01977482|530045590|FG000|Overall Study|Withdrawal by Subject|2|||
146969019|NCT01977482|530045591|FG001|Overall Study|Withdrawal by Subject|4|||
146969020|NCT01977482|530045592|FG002|Overall Study|Withdrawal by Subject|1|||
146969021|NCT01977482|530045593|FG003|Overall Study|Withdrawal by Subject|3|||
146969022|NCT01977482|530045594|FG004|Overall Study|Withdrawal by Subject|1|||
146969023|NCT01977482|530045595|FG005|Overall Study|Withdrawal by Subject|5|||
146969024|NCT00209560|530045596|FG000|Overall Study|Lack of Efficacy|1|||
146969025|NCT00209560|530045597|FG001|Overall Study|Lack of Efficacy|0|||
146969026|NCT01608321|530045604|FG000|Overall Study|Withdrawal by Subject|1|||
146969027|NCT01608321|530045605|FG001|Overall Study|Withdrawal by Subject|0|||
146969028|NCT01721369|530045606|FG000|Overall Study|Not initial etiological diagnosis|12|||
146969029|NCT03505606|530047271|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
146640314|NCT04380519|528859209|FG001|Overall Study|Withdrawal by Subject|0|||
146640315|NCT04380519|528859210|FG002|Overall Study|Withdrawal by Subject|1|||
146640316|NCT04380519|528859208|FG000|Overall Study|Death|14|||
146640317|NCT04380519|528859209|FG001|Overall Study|Death|9|||
146969030|NCT03505606|530047272|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
146559484|NCT04191135|528557471|FG000|Randomized Treatment|Death|0|||
146640318|NCT04380519|528859210|FG002|Overall Study|Death|6|||
146640319|NCT04380519|528859208|FG000|Overall Study|Adverse Event|0|||
146640320|NCT04380519|528859209|FG001|Overall Study|Adverse Event|1|||
146640321|NCT04380519|528859210|FG002|Overall Study|Adverse Event|0|||
146640322|NCT04380519|528859208|FG000|Overall Study|relatives' decision|0|||
146969031|NCT03505606|530047273|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
146969032|NCT03505606|530047271|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
146969033|NCT03505606|530047272|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
146969034|NCT03505606|530047273|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
146969035|NCT03505606|530047271|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
146969036|NCT03505606|530047272|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
146559485|NCT04191135|528557472|FG001|Randomized Treatment|Death|50|||
146640323|NCT04380519|528859209|FG001|Overall Study|relatives' decision|1|||
146640324|NCT04380519|528859210|FG002|Overall Study|relatives' decision|0|||
146559486|NCT04191135|528557473|FG002|Randomized Treatment|Death|54|||
146559487|NCT04191135|528557471|FG000|Randomized Treatment|Lost to Follow-up|0|||
146559488|NCT04191135|528557472|FG001|Randomized Treatment|Lost to Follow-up|0|||
146559489|NCT04191135|528557473|FG002|Randomized Treatment|Lost to Follow-up|1|||
146559490|NCT04191135|528557471|FG000|Randomized Treatment|Withdrawal by Subject|0|||
146559491|NCT04191135|528557472|FG001|Randomized Treatment|Withdrawal by Subject|2|||
146559492|NCT04191135|528557473|FG002|Randomized Treatment|Withdrawal by Subject|0|||
146559493|NCT04191135|528557471|FG000|Randomized Treatment|Ongoing in Trial|0|||
146559494|NCT04191135|528557472|FG001|Randomized Treatment|Ongoing in Trial|83|||
146559495|NCT04191135|528557473|FG002|Randomized Treatment|Ongoing in Trial|81|||
146559496|NCT03514134|528559296|FG000|Overall Study|Lost to Follow-up|0|||
146559497|NCT03514134|528559297|FG001|Overall Study|Lost to Follow-up|1|||
146559498|NCT00003645|528559298|FG000|Overall Study|Death|4|||
146559499|NCT00003645|528559299|FG001|Overall Study|Death|1|||
146559500|NCT00003645|528559298|FG000|Overall Study|Lost to Follow-up|7|||
146559501|NCT00003645|528559299|FG001|Overall Study|Lost to Follow-up|8|||
146559502|NCT00003645|528559298|FG000|Overall Study|Withdrawal by Subject|1|||
146559503|NCT00003645|528559299|FG001|Overall Study|Withdrawal by Subject|3|||
146559504|NCT00363298|528559310|FG000|First Study Week|Lack of Efficacy|6|||
146559505|NCT00363298|528559311|FG001|First Study Week|Lack of Efficacy|5|||
146559506|NCT00363298|528559310|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
146559507|NCT00363298|528559311|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
146559508|NCT03360344|528559316|FG000|Overall Study|Withdrawal by Subject|0|||
146559509|NCT03360344|528559317|FG001|Overall Study|Withdrawal by Subject|1|||
146559510|NCT03360344|528559318|FG002|Overall Study|Withdrawal by Subject|1|||
146559511|NCT00133705|528559323|FG000|Overall Study|Withdrawal by Subject|2|||
146559512|NCT00133705|528559324|FG001|Overall Study|Withdrawal by Subject|3|||
146898284|NCT03049449|529791295|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
146898285|NCT03049449|529791296|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
146898286|NCT03049449|529791297|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
146898287|NCT01262898|529791300|FG000|Overall Study|Protocol Violation|1|||
146898288|NCT01262898|529791301|FG001|Overall Study|Protocol Violation|1|||
146898289|NCT01262898|529791302|FG002|Overall Study|Protocol Violation|0|||
146898290|NCT01262898|529791303|FG003|Overall Study|Protocol Violation|0|||
146898291|NCT01262898|529791300|FG000|Overall Study|Lost to Follow-up|1|||
146898292|NCT01262898|529791301|FG001|Overall Study|Lost to Follow-up|0|||
146898293|NCT01262898|529791302|FG002|Overall Study|Lost to Follow-up|0|||
146898294|NCT01262898|529791303|FG003|Overall Study|Lost to Follow-up|0|||
146898295|NCT01262898|529791300|FG000|Overall Study|Withdrawal by Subject|1|||
146898296|NCT01262898|529791301|FG001|Overall Study|Withdrawal by Subject|1|||
146898297|NCT01262898|529791302|FG002|Overall Study|Withdrawal by Subject|0|||
146898298|NCT01262898|529791303|FG003|Overall Study|Withdrawal by Subject|0|||
146898299|NCT00792298|529791304|FG000|Treatment Period 1|Adverse Event|0|||
146898300|NCT00792298|529791305|FG001|Treatment Period 1|Adverse Event|1|||
146898301|NCT00792298|529791306|FG002|Treatment Period 1|Adverse Event|0|||
146898302|NCT00792298|529791307|FG003|Treatment Period 1|Adverse Event|1|||
146898303|NCT00792298|529791308|FG004|Treatment Period 1|Adverse Event|0|||
146898304|NCT00792298|529791309|FG005|Treatment Period 1|Adverse Event|1|||
146898305|NCT00792298|529791310|FG006|Treatment Period 1|Adverse Event|1|||
146898306|NCT00792298|529791311|FG007|Treatment Period 1|Adverse Event|0|||
146898307|NCT00792298|529791304|FG000|Treatment Period 1|Lack of Efficacy|0|||
146898308|NCT00792298|529791305|FG001|Treatment Period 1|Lack of Efficacy|0|||
146898309|NCT00792298|529791306|FG002|Treatment Period 1|Lack of Efficacy|1|||
146898310|NCT00792298|529791307|FG003|Treatment Period 1|Lack of Efficacy|0|||
146898311|NCT00792298|529791308|FG004|Treatment Period 1|Lack of Efficacy|0|||
146898312|NCT00792298|529791309|FG005|Treatment Period 1|Lack of Efficacy|0|||
146898313|NCT00792298|529791310|FG006|Treatment Period 1|Lack of Efficacy|0|||
146898314|NCT00792298|529791311|FG007|Treatment Period 1|Lack of Efficacy|0|||
146898315|NCT00792298|529791304|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146898316|NCT00792298|529791305|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146898317|NCT00792298|529791306|FG002|Treatment Period 1|Withdrawal by Subject|1|||
146898318|NCT00792298|529791307|FG003|Treatment Period 1|Withdrawal by Subject|2|||
146898319|NCT00792298|529791308|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146898320|NCT00792298|529791309|FG005|Treatment Period 1|Withdrawal by Subject|2|||
146898321|NCT00792298|529791310|FG006|Treatment Period 1|Withdrawal by Subject|1|||
146898322|NCT00792298|529791311|FG007|Treatment Period 1|Withdrawal by Subject|0|||
146898323|NCT00792298|529791304|FG000|Treatment Period 1|Lost to Follow-up|0|||
146898324|NCT00792298|529791305|FG001|Treatment Period 1|Lost to Follow-up|0|||
146898325|NCT00792298|529791306|FG002|Treatment Period 1|Lost to Follow-up|0|||
146559513|NCT00959049|528559325|FG000|Overall Study|Adverse Event|1|||
146559514|NCT00959049|528559326|FG001|Overall Study|Adverse Event|0|||
146559515|NCT00959049|528559327|FG002|Overall Study|Adverse Event|0|||
146559516|NCT00959049|528559328|FG003|Overall Study|Adverse Event|0|||
146559517|NCT00959049|528559329|FG004|Overall Study|Adverse Event|0|||
146898326|NCT00792298|529791307|FG003|Treatment Period 1|Lost to Follow-up|0|||
146898327|NCT00792298|529791308|FG004|Treatment Period 1|Lost to Follow-up|0|||
146898328|NCT00792298|529791309|FG005|Treatment Period 1|Lost to Follow-up|0|||
146898329|NCT00792298|529791310|FG006|Treatment Period 1|Lost to Follow-up|1|||
146898330|NCT00792298|529791311|FG007|Treatment Period 1|Lost to Follow-up|0|||
146898331|NCT00792298|529791304|FG000|Treatment Period 1|Physician Decision|0|||
146898332|NCT00792298|529791305|FG001|Treatment Period 1|Physician Decision|0|||
146898333|NCT00792298|529791306|FG002|Treatment Period 1|Physician Decision|0|||
146898334|NCT00792298|529791307|FG003|Treatment Period 1|Physician Decision|1|||
146898335|NCT00792298|529791308|FG004|Treatment Period 1|Physician Decision|0|||
146898336|NCT00792298|529791309|FG005|Treatment Period 1|Physician Decision|0|||
146898337|NCT00792298|529791310|FG006|Treatment Period 1|Physician Decision|1|||
146898338|NCT00792298|529791311|FG007|Treatment Period 1|Physician Decision|0|||
146898339|NCT00792298|529791304|FG000|Treatment Period 1|Protocol Violation|0|||
146898340|NCT00792298|529791305|FG001|Treatment Period 1|Protocol Violation|0|||
146898341|NCT00792298|529791306|FG002|Treatment Period 1|Protocol Violation|0|||
146898342|NCT00792298|529791307|FG003|Treatment Period 1|Protocol Violation|0|||
146898343|NCT00792298|529791308|FG004|Treatment Period 1|Protocol Violation|0|||
146898344|NCT00792298|529791309|FG005|Treatment Period 1|Protocol Violation|0|||
146898345|NCT00792298|529791310|FG006|Treatment Period 1|Protocol Violation|0|||
146898346|NCT00792298|529791311|FG007|Treatment Period 1|Protocol Violation|1|||
146898347|NCT00792298|529791304|FG000|Washout|Adverse Event|0|||
146898348|NCT00792298|529791305|FG001|Washout|Adverse Event|0|||
146898349|NCT00792298|529791306|FG002|Washout|Adverse Event|0|||
146898350|NCT00792298|529791307|FG003|Washout|Adverse Event|0|||
146898351|NCT00792298|529791308|FG004|Washout|Adverse Event|0|||
146898352|NCT00792298|529791309|FG005|Washout|Adverse Event|1|||
146898353|NCT00792298|529791310|FG006|Washout|Adverse Event|0|||
146898354|NCT00792298|529791311|FG007|Washout|Adverse Event|0|||
146898355|NCT00792298|529791304|FG000|Washout|Withdrawal by Subject|0|||
146898356|NCT00792298|529791305|FG001|Washout|Withdrawal by Subject|0|||
146898357|NCT00792298|529791306|FG002|Washout|Withdrawal by Subject|1|||
146898358|NCT00792298|529791307|FG003|Washout|Withdrawal by Subject|0|||
146898359|NCT00792298|529791308|FG004|Washout|Withdrawal by Subject|0|||
146898360|NCT00792298|529791309|FG005|Washout|Withdrawal by Subject|1|||
146898361|NCT00792298|529791310|FG006|Washout|Withdrawal by Subject|0|||
146898362|NCT00792298|529791311|FG007|Washout|Withdrawal by Subject|0|||
146898363|NCT00792298|529791304|FG000|Treatment Period 2|Lack of Efficacy|0|||
146898364|NCT00792298|529791305|FG001|Treatment Period 2|Lack of Efficacy|0|||
146898365|NCT00792298|529791306|FG002|Treatment Period 2|Lack of Efficacy|0|||
146898366|NCT00792298|529791307|FG003|Treatment Period 2|Lack of Efficacy|0|||
146898367|NCT00792298|529791308|FG004|Treatment Period 2|Lack of Efficacy|1|||
146898368|NCT00792298|529791309|FG005|Treatment Period 2|Lack of Efficacy|0|||
146898369|NCT00792298|529791310|FG006|Treatment Period 2|Lack of Efficacy|0|||
146898370|NCT00792298|529791311|FG007|Treatment Period 2|Lack of Efficacy|0|||
146898371|NCT00792298|529791304|FG000|Treatment Period 2|Physician Decision|0|||
146898372|NCT00792298|529791305|FG001|Treatment Period 2|Physician Decision|0|||
146898373|NCT00792298|529791306|FG002|Treatment Period 2|Physician Decision|0|||
146898374|NCT00792298|529791307|FG003|Treatment Period 2|Physician Decision|0|||
146898375|NCT00792298|529791308|FG004|Treatment Period 2|Physician Decision|0|||
146898376|NCT00792298|529791309|FG005|Treatment Period 2|Physician Decision|0|||
146898377|NCT00792298|529791310|FG006|Treatment Period 2|Physician Decision|1|||
146898378|NCT00792298|529791311|FG007|Treatment Period 2|Physician Decision|0|||
146898379|NCT00792298|529791304|FG000|Treatment Period 2|Pregnancy|0|||
146898380|NCT00792298|529791305|FG001|Treatment Period 2|Pregnancy|0|||
146898381|NCT00792298|529791306|FG002|Treatment Period 2|Pregnancy|1|||
146559518|NCT00959049|528559330|FG005|Overall Study|Adverse Event|0|||
146559519|NCT00959049|528559325|FG000|Overall Study|Lost to Follow-up|17|||
146559520|NCT00959049|528559326|FG001|Overall Study|Lost to Follow-up|5|||
146559521|NCT00959049|528559327|FG002|Overall Study|Lost to Follow-up|1|||
146559522|NCT00959049|528559328|FG003|Overall Study|Lost to Follow-up|10|||
146559523|NCT00959049|528559329|FG004|Overall Study|Lost to Follow-up|9|||
146559524|NCT00959049|528559330|FG005|Overall Study|Lost to Follow-up|1|||
146559525|NCT00959049|528559325|FG000|Overall Study|Contraindicated medication|0|||
146559526|NCT00959049|528559326|FG001|Overall Study|Contraindicated medication|0|||
146898382|NCT00792298|529791307|FG003|Treatment Period 2|Pregnancy|0|||
146898383|NCT00792298|529791308|FG004|Treatment Period 2|Pregnancy|0|||
146898384|NCT00792298|529791309|FG005|Treatment Period 2|Pregnancy|0|||
146898385|NCT00792298|529791310|FG006|Treatment Period 2|Pregnancy|0|||
146559527|NCT00959049|528559327|FG002|Overall Study|Contraindicated medication|0|||
146559528|NCT00959049|528559328|FG003|Overall Study|Contraindicated medication|1|||
146898386|NCT00792298|529791311|FG007|Treatment Period 2|Pregnancy|0|||
146898387|NCT00792298|529791304|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146898388|NCT00792298|529791305|FG001|Treatment Period 2|Withdrawal by Subject|1|||
146898389|NCT00792298|529791306|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146559529|NCT00959049|528559329|FG004|Overall Study|Contraindicated medication|0|||
146559530|NCT00959049|528559330|FG005|Overall Study|Contraindicated medication|0|||
146898390|NCT00792298|529791307|FG003|Treatment Period 2|Withdrawal by Subject|2|||
146898391|NCT00792298|529791308|FG004|Treatment Period 2|Withdrawal by Subject|1|||
146898392|NCT00792298|529791309|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146559531|NCT00959049|528559325|FG000|Overall Study|Withdrawal by Subject|0|||
146559532|NCT00959049|528559326|FG001|Overall Study|Withdrawal by Subject|2|||
146898393|NCT00792298|529791310|FG006|Treatment Period 2|Withdrawal by Subject|0|||
146898394|NCT00792298|529791311|FG007|Treatment Period 2|Withdrawal by Subject|2|||
146898395|NCT03304522|529791312|FG000|Overall Study|Adverse Event|0|||
146898396|NCT03304522|529791313|FG001|Overall Study|Adverse Event|4|||
146898397|NCT03304522|529791312|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
146898398|NCT03304522|529791313|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
146898399|NCT03304522|529791312|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
146898400|NCT03304522|529791313|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
146898401|NCT03304522|529791312|FG000|Overall Study|Other|0|||
146898402|NCT03304522|529791313|FG001|Overall Study|Other|1|||
146898403|NCT00473876|529791319|FG000|Overall Study|Lost to Follow-up|3|||
146898404|NCT00473876|529791320|FG001|Overall Study|Lost to Follow-up|1|||
146898405|NCT03751111|529791326|FG000|Overall Study|Lack of Efficacy|9|||
146898406|NCT03751111|529791327|FG001|Overall Study|Lack of Efficacy|30|||
146898407|NCT03751111|529791326|FG000|Overall Study|Adverse Event|3|||
146898408|NCT03751111|529791327|FG001|Overall Study|Adverse Event|2|||
146898409|NCT00755079|529791328|FG000|Overall Study|Lost to Follow-up|1|||
146898410|NCT00755079|529791329|FG001|Overall Study|Lost to Follow-up|3|||
146898411|NCT00755079|529791328|FG000|Overall Study|Adverse Event|0|||
146898412|NCT00755079|529791329|FG001|Overall Study|Adverse Event|1|||
146898413|NCT00755079|529791328|FG000|Overall Study|Withdrawal by Subject|0|||
146898414|NCT00755079|529791329|FG001|Overall Study|Withdrawal by Subject|2|||
146898415|NCT01285349|529791330|FG000|Overall Study|Lost to Follow-up|27|||
146898416|NCT01285349|529791331|FG001|Overall Study|Lost to Follow-up|20|||
146898417|NCT01285349|529791332|FG002|Overall Study|Lost to Follow-up|27|||
146898418|NCT02909153|529791333|FG000|Overall Study|Withdrawal by Subject|0|||
146898419|NCT02909153|529791334|FG001|Overall Study|Withdrawal by Subject|1|||
146898420|NCT02909153|529791335|FG002|Overall Study|Withdrawal by Subject|0|||
146898421|NCT02909153|529791336|FG003|Overall Study|Withdrawal by Subject|0|||
146898422|NCT02909153|529791337|FG004|Overall Study|Withdrawal by Subject|0|||
146898423|NCT01526148|529791339|FG000|Overall Study|Adverse Event|6|||
146898424|NCT01526148|529791340|FG001|Overall Study|Adverse Event|5|||
146898425|NCT01526148|529791339|FG000|Overall Study|Lost to Follow-up|3|||
146898426|NCT01526148|529791340|FG001|Overall Study|Lost to Follow-up|6|||
146898427|NCT01526148|529791339|FG000|Overall Study|Withdrawal by Subject|2|||
146898428|NCT01526148|529791340|FG001|Overall Study|Withdrawal by Subject|0|||
146898429|NCT01526148|529791339|FG000|Overall Study|Unstable Medical Condition|1|||
146898430|NCT01526148|529791340|FG001|Overall Study|Unstable Medical Condition|0|||
146898431|NCT01526148|529791339|FG000|Overall Study|Unable to discontinue concomitant med|1|||
146898432|NCT01526148|529791340|FG001|Overall Study|Unable to discontinue concomitant med|0|||
146898433|NCT01526148|529791339|FG000|Overall Study|Moved out of state|1|||
146898434|NCT01526148|529791340|FG001|Overall Study|Moved out of state|0|||
146898435|NCT01526148|529791339|FG000|Overall Study|Incarcerated|0|||
146898436|NCT01526148|529791340|FG001|Overall Study|Incarcerated|2|||
146898437|NCT01173653|529791341|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
146898438|NCT01173653|529791342|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
146898439|NCT03308188|529791343|FG000|Overall Study|Withdrawal by Subject|0|||
146898440|NCT03308188|529791344|FG001|Overall Study|Withdrawal by Subject|3|||
146898441|NCT03308188|529791343|FG000|Overall Study|Death|0|||
146898442|NCT03308188|529791344|FG001|Overall Study|Death|1|||
146898443|NCT01791855|529791345|FG000|Overall Study|Adverse Event|0|||
146898444|NCT01791855|529791346|FG001|Overall Study|Adverse Event|0|||
146898445|NCT01791855|529791347|FG002|Overall Study|Adverse Event|0|||
146898446|NCT01791855|529791348|FG003|Overall Study|Adverse Event|1|||
146898447|NCT01791855|529791345|FG000|Overall Study|Randomized, not treated|0|||
146898448|NCT01791855|529791346|FG001|Overall Study|Randomized, not treated|1|||
146898449|NCT01791855|529791347|FG002|Overall Study|Randomized, not treated|0|||
146898450|NCT01791855|529791348|FG003|Overall Study|Randomized, not treated|0|||
146898451|NCT00772447|529791349|FG000|Overall Study|Withdrawal by Subject|9|||
146898452|NCT00772447|529791350|FG001|Overall Study|Withdrawal by Subject|5|||
146898453|NCT00772447|529791349|FG000|Overall Study|Physician Decision|4|||
146898454|NCT00772447|529791350|FG001|Overall Study|Physician Decision|8|||
146898455|NCT00772447|529791349|FG000|Overall Study|Lost to Follow-up|2|||
146898456|NCT00772447|529791350|FG001|Overall Study|Lost to Follow-up|4|||
146898457|NCT00772447|529791349|FG000|Overall Study|incorrect enrolment|3|||
146898458|NCT00772447|529791350|FG001|Overall Study|incorrect enrolment|4|||
146898459|NCT00772447|529791349|FG000|Overall Study|Protocol Violation|0|||
146898460|NCT00772447|529791350|FG001|Overall Study|Protocol Violation|1|||
146559533|NCT00959049|528559327|FG002|Overall Study|Withdrawal by Subject|0|||
146898461|NCT00772447|529791349|FG000|Overall Study|all others|2|||
146898462|NCT00772447|529791350|FG001|Overall Study|all others|2|||
146898463|NCT00454207|529791353|FG000|Overall Study|Adverse Event|3|||
146898464|NCT00454207|529791354|FG001|Overall Study|Adverse Event|1|||
146898465|NCT00454207|529791353|FG000|Overall Study|Lack of Efficacy|1|||
146898466|NCT00454207|529791354|FG001|Overall Study|Lack of Efficacy|0|||
146898467|NCT00454207|529791353|FG000|Overall Study|Protocol Violation|0|||
146969037|NCT03505606|530047273|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
146969038|NCT03505606|530047271|FG000|Overall Study|Poor compliance with refractive correction|0|||
146969039|NCT03505606|530047272|FG001|Overall Study|Poor compliance with refractive correction|0|||
146969040|NCT03505606|530047273|FG002|Overall Study|Poor compliance with refractive correction|1|||
146640325|NCT02147561|528859215|FG000|Overall Study|Lost to Follow-up|3|||
146640326|NCT02147561|528859215|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
146640327|NCT00393861|528859216|FG000|Overall Study|Adverse Event|2|||
146640328|NCT00393861|528859216|FG000|Overall Study|Disease Progression|24|||
146898468|NCT00454207|529791354|FG001|Overall Study|Protocol Violation|1|||
146898469|NCT01672957|529791355|FG000|Overall Study|Protocol Violation|48|||
146898470|NCT01672957|529791355|FG000|Overall Study|Death|2|||
146898471|NCT01672957|529791355|FG000|Overall Study|ICF Signed After Transplantation|5|||
146898472|NCT01795547|529791358|FG000|Overall Study|Adverse Event|16|||
146898473|NCT01795547|529791359|FG001|Overall Study|Adverse Event|27|||
146898474|NCT01795547|529791358|FG000|Overall Study|Lack of Efficacy|8|||
146898475|NCT01795547|529791359|FG001|Overall Study|Lack of Efficacy|3|||
146559534|NCT00959049|528559328|FG003|Overall Study|Withdrawal by Subject|0|||
146898476|NCT01795547|529791358|FG000|Overall Study|Protocol Violation|6|||
146898477|NCT01795547|529791359|FG001|Overall Study|Protocol Violation|4|||
146898478|NCT01795547|529791358|FG000|Overall Study|Lost to Follow-up|2|||
146898479|NCT01795547|529791359|FG001|Overall Study|Lost to Follow-up|5|||
146898480|NCT01795547|529791358|FG000|Overall Study|Withdrawal of consent|7|||
146898481|NCT01795547|529791359|FG001|Overall Study|Withdrawal of consent|12|||
146898482|NCT01795547|529791358|FG000|Overall Study|Not Treated|4|||
146898483|NCT01795547|529791359|FG001|Overall Study|Not Treated|10|||
146898484|NCT01795547|529791358|FG000|Overall Study|Non-compliance with IMP|1|||
146898485|NCT01795547|529791359|FG001|Overall Study|Non-compliance with IMP|1|||
146898486|NCT01795547|529791358|FG000|Overall Study|Others|4|||
146898487|NCT01795547|529791359|FG001|Overall Study|Others|1|||
146898488|NCT01795547|529791358|FG000|Overall Study|Not stated|0|||
146898489|NCT01795547|529791359|FG001|Overall Study|Not stated|1|||
146898490|NCT00151892|529791360|FG000|Overall Study|Lack of Efficacy|50|||
146898491|NCT00151892|529791361|FG001|Overall Study|Lack of Efficacy|57|||
146898492|NCT00151892|529791360|FG000|Overall Study|Patient request|10|||
146898493|NCT00151892|529791361|FG001|Overall Study|Patient request|7|||
146898494|NCT00151892|529791360|FG000|Overall Study|Lost to Follow-up|5|||
146898495|NCT00151892|529791361|FG001|Overall Study|Lost to Follow-up|10|||
146559535|NCT00959049|528559329|FG004|Overall Study|Withdrawal by Subject|0|||
146559536|NCT00959049|528559330|FG005|Overall Study|Withdrawal by Subject|0|||
146559537|NCT01892189|528559335|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
146559538|NCT01892189|528559336|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
146559539|NCT01892189|528559337|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
146559540|NCT01892189|528559338|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
146559541|NCT01892189|528559339|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
146559542|NCT01892189|528559340|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
146559543|NCT01892189|528559341|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
146559544|NCT01892189|528559342|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
146559545|NCT01892189|528559343|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
146559546|NCT01892189|528559335|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146559547|NCT01892189|528559336|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146559548|NCT01892189|528559337|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
146559549|NCT01892189|528559338|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
146559550|NCT01892189|528559339|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146559551|NCT01892189|528559340|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146559552|NCT01892189|528559341|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
146559553|NCT01892189|528559342|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146559554|NCT01892189|528559343|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
146559555|NCT01892189|528559335|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
146559556|NCT01892189|528559336|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
146559557|NCT01892189|528559337|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
146559558|NCT01892189|528559338|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
146559559|NCT01892189|528559339|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
146559560|NCT01892189|528559340|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
146559561|NCT01892189|528559341|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
146559562|NCT01892189|528559342|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
146559563|NCT01892189|528559343|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
146559564|NCT01992757|528559346|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
146559565|NCT03440411|528559347|FG000|Overall Study|Adverse Event|0|||
146559566|NCT03440411|528559348|FG001|Overall Study|Adverse Event|0|||
146898496|NCT00151892|529791360|FG000|Overall Study|Adverse Event|6|||
146969041|NCT03505606|530047271|FG000|Overall Study|Insufficient anisometropia|0|||
146559567|NCT03440411|528559349|FG002|Overall Study|Adverse Event|1|||
146559568|NCT03440411|528559350|FG003|Overall Study|Adverse Event|0|||
146559569|NCT03440411|528559347|FG000|Overall Study|PD|2|||
146898497|NCT00151892|529791361|FG001|Overall Study|Adverse Event|3|||
146898498|NCT00151892|529791360|FG000|Overall Study|Protocol Violation|3|||
146898499|NCT00151892|529791361|FG001|Overall Study|Protocol Violation|3|||
146969042|NCT03505606|530047272|FG001|Overall Study|Insufficient anisometropia|0|||
146969043|NCT03505606|530047273|FG002|Overall Study|Insufficient anisometropia|2|||
146969044|NCT03505606|530047271|FG000|Overall Study|Ectopia Lentis|0|||
146559570|NCT03440411|528559348|FG001|Overall Study|PD|1|||
146559571|NCT03440411|528559349|FG002|Overall Study|PD|1|||
146559572|NCT03440411|528559350|FG003|Overall Study|PD|1|||
146898500|NCT00151892|529791360|FG000|Overall Study|Non-compliance|0|||
146898501|NCT00151892|529791361|FG001|Overall Study|Non-compliance|1|||
146969045|NCT03505606|530047272|FG001|Overall Study|Ectopia Lentis|0|||
146969046|NCT03505606|530047273|FG002|Overall Study|Ectopia Lentis|1|||
146969047|NCT03505606|530047271|FG000|Overall Study|alternation of amblyopic eye|0|||
146969048|NCT03505606|530047272|FG001|Overall Study|alternation of amblyopic eye|1|||
146969049|NCT03505606|530047273|FG002|Overall Study|alternation of amblyopic eye|0|||
146969050|NCT02087865|530047275|FG000|Overall Study|Withdrawal by Subject|6|||
146969051|NCT02087865|530047276|FG001|Overall Study|Withdrawal by Subject|0|||
146969052|NCT02087865|530047277|FG002|Overall Study|Withdrawal by Subject|1|||
146969053|NCT02087865|530047275|FG000|Overall Study|Lost to Follow-up|0|||
146969054|NCT02087865|530047276|FG001|Overall Study|Lost to Follow-up|0|||
146969055|NCT02087865|530047277|FG002|Overall Study|Lost to Follow-up|1|||
146969056|NCT02087865|530047275|FG000|Overall Study|Drug Non-compliance|0|||
146969057|NCT02087865|530047276|FG001|Overall Study|Drug Non-compliance|2|||
146969058|NCT02087865|530047277|FG002|Overall Study|Drug Non-compliance|0|||
146969059|NCT02087865|530047275|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
146969060|NCT02087865|530047276|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
146969061|NCT02087865|530047277|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
146969062|NCT01392469|530047280|FG000|Overall Study|Adverse Event|2|||
146969063|NCT01392469|530047280|FG000|Overall Study|Withdrawal by Subject|1|||
146969064|NCT01392469|530047280|FG000|Overall Study|Protocol Violation|1|||
146969065|NCT01017731|530047282|FG000|Overall Study|Lost to Follow-up|2|||
146969066|NCT01017731|530047282|FG000|Overall Study|Withdrawal by Subject|3|||
146969067|NCT01017731|530047282|FG000|Overall Study|Physician Decision|2|||
146969068|NCT01017731|530047282|FG000|Overall Study|Adverse Event|1|||
146969069|NCT00564486|530047286|FG000|Overall Study|Adverse Event|0|||
146969070|NCT00564486|530047287|FG001|Overall Study|Adverse Event|1|||
146969071|NCT00564486|530047288|FG002|Overall Study|Adverse Event|0|||
146969072|NCT00564486|530047289|FG003|Overall Study|Adverse Event|0|||
146969073|NCT00564486|530047286|FG000|Overall Study|Withdrawal by Subject|4|||
146969074|NCT00564486|530047287|FG001|Overall Study|Withdrawal by Subject|0|||
146969075|NCT00564486|530047288|FG002|Overall Study|Withdrawal by Subject|0|||
146969076|NCT00564486|530047289|FG003|Overall Study|Withdrawal by Subject|5|||
146969077|NCT00564486|530047286|FG000|Overall Study|Subject refused to have blood drawn|0|||
146969078|NCT00564486|530047287|FG001|Overall Study|Subject refused to have blood drawn|0|||
146969079|NCT00564486|530047288|FG002|Overall Study|Subject refused to have blood drawn|1|||
146969080|NCT00564486|530047289|FG003|Overall Study|Subject refused to have blood drawn|0|||
146969081|NCT00564486|530047286|FG000|Overall Study|Lost to Follow-up|3|||
146969082|NCT00564486|530047287|FG001|Overall Study|Lost to Follow-up|0|||
146969083|NCT00564486|530047288|FG002|Overall Study|Lost to Follow-up|2|||
146969084|NCT00564486|530047289|FG003|Overall Study|Lost to Follow-up|2|||
146969085|NCT04362761|530047294|FG000|Part A (48 Weeks)|Adverse Event|2|||
146969086|NCT04362761|530047294|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
146969087|NCT04362761|530047294|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
146969088|NCT04362761|530047294|FG000|Part A (48 Weeks)|Other|5|||
146969089|NCT04362761|530047294|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
146969090|NCT04362761|530047294|FG000|Part B (86 Weeks)|Other|4|||
146969091|NCT01819467|530047295|FG000|Overall Study|Physician Decision|20|||
146969092|NCT01819467|530047296|FG001|Overall Study|Physician Decision|9|||
146969093|NCT03926728|530047299|FG000|Overall Study|Withdrawal by Subject|0|||
146969094|NCT03926728|530047300|FG001|Overall Study|Withdrawal by Subject|1|||
146969095|NCT03926728|530047301|FG002|Overall Study|Withdrawal by Subject|1|||
146969096|NCT03926728|530047302|FG003|Overall Study|Withdrawal by Subject|0|||
146969097|NCT03926728|530047303|FG004|Overall Study|Withdrawal by Subject|0|||
146640329|NCT05300763|528859217|FG000|Overall Study|Adverse Event|0|||
146640330|NCT05300763|528859218|FG001|Overall Study|Adverse Event|1|||
146969098|NCT03926728|530047304|FG005|Overall Study|Withdrawal by Subject|1|||
146969099|NCT03926728|530047305|FG006|Overall Study|Withdrawal by Subject|1|||
146969100|NCT03926728|530047306|FG007|Overall Study|Withdrawal by Subject|0|||
146969101|NCT03926728|530047307|FG008|Overall Study|Withdrawal by Subject|0|||
146969102|NCT03926728|530047308|FG009|Overall Study|Withdrawal by Subject|1|||
146640331|NCT05300763|528859217|FG000|Overall Study|Major Protocol Deviation|1|||
146640332|NCT05300763|528859218|FG001|Overall Study|Major Protocol Deviation|0|||
146969103|NCT03926728|530047309|FG010|Overall Study|Withdrawal by Subject|0|||
146969104|NCT03926728|530047310|FG011|Overall Study|Withdrawal by Subject|0|||
146898502|NCT00151892|529791360|FG000|Overall Study|Pregnancy|0|||
146898503|NCT00151892|529791361|FG001|Overall Study|Pregnancy|1|||
146898504|NCT00151892|529791360|FG000|Overall Study|Did not return for a visit|1|||
146898505|NCT00151892|529791361|FG001|Overall Study|Did not return for a visit|0|||
146898506|NCT00151892|529791360|FG000|Overall Study|Used prohibited corticosteroids|1|||
146898507|NCT00151892|529791361|FG001|Overall Study|Used prohibited corticosteroids|0|||
146898508|NCT00151892|529791360|FG000|Overall Study|Lack of study medication at center|0|||
146898509|NCT00151892|529791361|FG001|Overall Study|Lack of study medication at center|1|||
146898510|NCT00749190|529791362|FG000|Overall Study|Adverse Event|0|||
146898511|NCT00749190|529791363|FG001|Overall Study|Adverse Event|2|||
146898512|NCT00749190|529791364|FG002|Overall Study|Adverse Event|0|||
146898513|NCT00749190|529791365|FG003|Overall Study|Adverse Event|4|||
146898514|NCT00749190|529791366|FG004|Overall Study|Adverse Event|0|||
146898515|NCT00749190|529791367|FG005|Overall Study|Adverse Event|3|||
146898516|NCT00749190|529791368|FG006|Overall Study|Adverse Event|0|||
146898517|NCT00749190|529791362|FG000|Overall Study|Lack of Efficacy|3|||
146898518|NCT00749190|529791363|FG001|Overall Study|Lack of Efficacy|1|||
146898519|NCT00749190|529791364|FG002|Overall Study|Lack of Efficacy|1|||
146898520|NCT00749190|529791365|FG003|Overall Study|Lack of Efficacy|0|||
146898521|NCT00749190|529791366|FG004|Overall Study|Lack of Efficacy|0|||
146898522|NCT00749190|529791367|FG005|Overall Study|Lack of Efficacy|1|||
146898523|NCT00749190|529791368|FG006|Overall Study|Lack of Efficacy|0|||
146898524|NCT00749190|529791362|FG000|Overall Study|Withdrawal by Subject|2|||
146898525|NCT00749190|529791363|FG001|Overall Study|Withdrawal by Subject|1|||
146898526|NCT00749190|529791364|FG002|Overall Study|Withdrawal by Subject|0|||
146898527|NCT00749190|529791365|FG003|Overall Study|Withdrawal by Subject|0|||
146898528|NCT00749190|529791366|FG004|Overall Study|Withdrawal by Subject|0|||
146898529|NCT00749190|529791367|FG005|Overall Study|Withdrawal by Subject|1|||
146898530|NCT00749190|529791368|FG006|Overall Study|Withdrawal by Subject|0|||
146898531|NCT00749190|529791362|FG000|Overall Study|Protocol Violation|0|||
146898532|NCT00749190|529791363|FG001|Overall Study|Protocol Violation|1|||
146898533|NCT00749190|529791364|FG002|Overall Study|Protocol Violation|0|||
146898534|NCT00749190|529791365|FG003|Overall Study|Protocol Violation|0|||
146898535|NCT00749190|529791366|FG004|Overall Study|Protocol Violation|0|||
146898536|NCT00749190|529791367|FG005|Overall Study|Protocol Violation|0|||
146898537|NCT00749190|529791368|FG006|Overall Study|Protocol Violation|1|||
146898538|NCT00749190|529791362|FG000|Overall Study|Other reason not defined above|0|||
146898539|NCT00749190|529791363|FG001|Overall Study|Other reason not defined above|0|||
146898540|NCT00749190|529791364|FG002|Overall Study|Other reason not defined above|0|||
146898541|NCT00749190|529791365|FG003|Overall Study|Other reason not defined above|1|||
146898542|NCT00749190|529791366|FG004|Overall Study|Other reason not defined above|0|||
146898543|NCT00749190|529791367|FG005|Overall Study|Other reason not defined above|0|||
146898544|NCT00749190|529791368|FG006|Overall Study|Other reason not defined above|0|||
146898545|NCT00784758|529791369|FG000|Overall Study|Withdrawal by Subject|3|||
146898546|NCT00784758|529791370|FG001|Overall Study|Withdrawal by Subject|0|||
146898547|NCT00784758|529791369|FG000|Overall Study|Adverse Event|1|||
146898548|NCT00784758|529791370|FG001|Overall Study|Adverse Event|0|||
146898549|NCT02040142|529791371|FG000|Overall Study|Lost to Follow-up|5|||
146898550|NCT02040142|529791371|FG000|Overall Study|Death|17|||
146898551|NCT02040142|529791371|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
146898552|NCT04752384|529791372|FG000|Overall Study|Withdrawal by Subject|1|||
146898553|NCT04752384|529791372|FG000|Overall Study|Death|1|||
146898554|NCT01445171|529792218|FG000|Overall Study|Lost to Follow-up|11|||
146898555|NCT01445171|529792218|FG000|Overall Study|Withdrawal by Subject|16|||
146898556|NCT01445171|529792218|FG000|Overall Study|Death|51|||
146898557|NCT01445171|529792218|FG000|Overall Study|Subjects declined to return for followup|9|||
146898558|NCT01445171|529792218|FG000|Overall Study|Consented but did not receive device|8|||
146898559|NCT03480802|529792220|FG000|Overall Study|Lost to Follow-up|5|||
146898560|NCT03480802|529792221|FG001|Overall Study|Lost to Follow-up|1|||
146898561|NCT03480802|529792220|FG000|Overall Study|Withdrawal by Subject|2|||
146898562|NCT03480802|529792221|FG001|Overall Study|Withdrawal by Subject|1|||
146898563|NCT03480802|529792220|FG000|Overall Study|Relocated|0|||
146898564|NCT03480802|529792221|FG001|Overall Study|Relocated|1|||
146898565|NCT01562028|529792227|FG000|Overall Study|Withdrawal by Subject|1|||
146898566|NCT01562028|529792228|FG001|Overall Study|Withdrawal by Subject|1|||
146898567|NCT01562028|529792227|FG000|Overall Study|Lost to Follow-up|2|||
146898568|NCT01562028|529792228|FG001|Overall Study|Lost to Follow-up|1|||
146898569|NCT04439266|529792229|FG000|Overall Study|Ineligible|1|||
146898570|NCT04439266|529792229|FG000|Overall Study|Adverse Event|1|||
146898571|NCT04439266|529792229|FG000|Overall Study|Death|1|||
146898572|NCT04439266|529792229|FG000|Overall Study|Disease progression|1|||
146898573|NCT04439266|529792229|FG000|Overall Study|Still on treatment|1|||
146898574|NCT05052723|529792232|FG000|Overall Study|Death|19|||
146898575|NCT05540652|529792233|FG000|Overall Study|Withdrawal by Subject|1|||
146640333|NCT05300763|528859217|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
146898576|NCT02542267|529792234|FG000|Overall Study|Withdrawal by Subject|10|||
146898577|NCT02542267|529792234|FG000|Overall Study|Physician Decision|6|||
146898578|NCT02542267|529792234|FG000|Overall Study|Lost to Follow-up|4|||
146898579|NCT02542267|529792234|FG000|Overall Study|Death|13|||
146898580|NCT02542267|529792234|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
146898581|NCT02542267|529792234|FG000|Overall Study|Other|9|||
146898582|NCT00442598|529792235|FG000|Overall Study|Adverse Event|1|||
146898583|NCT00442598|529792236|FG001|Overall Study|Adverse Event|0|||
146898584|NCT00442598|529792237|FG002|Overall Study|Adverse Event|0|||
146898585|NCT00442598|529792235|FG000|Overall Study|Tumor progression|3|||
146898586|NCT00442598|529792236|FG001|Overall Study|Tumor progression|4|||
146898587|NCT00442598|529792237|FG002|Overall Study|Tumor progression|0|||
146898588|NCT00442598|529792235|FG000|Overall Study|Clinical deterioration|1|||
146898589|NCT00442598|529792236|FG001|Overall Study|Clinical deterioration|2|||
146559573|NCT03440411|528559347|FG000|Overall Study|Withdrawal by Subject|1|||
146559574|NCT03440411|528559348|FG001|Overall Study|Withdrawal by Subject|0|||
146559575|NCT03440411|528559349|FG002|Overall Study|Withdrawal by Subject|0|||
146559576|NCT03440411|528559350|FG003|Overall Study|Withdrawal by Subject|0|||
146559577|NCT03440411|528559347|FG000|Overall Study|Closed study by sponsor|0|||
146559578|NCT03440411|528559348|FG001|Overall Study|Closed study by sponsor|0|||
146559579|NCT03440411|528559349|FG002|Overall Study|Closed study by sponsor|0|||
146559580|NCT03440411|528559350|FG003|Overall Study|Closed study by sponsor|1|||
146559581|NCT01344356|528559351|FG000|Overall Study|Physician Decision|0|||
146559582|NCT01344356|528559352|FG001|Overall Study|Physician Decision|3|||
146559583|NCT01344356|528559351|FG000|Overall Study|Lost to Follow-up|0|||
146559584|NCT01344356|528559352|FG001|Overall Study|Lost to Follow-up|6|||
146559585|NCT00095576|528559353|FG000|Overall Study|Adverse Event|5|||
146559586|NCT00095576|528559354|FG001|Overall Study|Adverse Event|3|||
146559587|NCT00095576|528559353|FG000|Overall Study|Lost to Follow-up|233|||
146898590|NCT00442598|529792237|FG002|Overall Study|Clinical deterioration|0|||
146898591|NCT00442598|529792235|FG000|Overall Study|CA125 progression|0|||
146898592|NCT00442598|529792236|FG001|Overall Study|CA125 progression|1|||
146898593|NCT00442598|529792237|FG002|Overall Study|CA125 progression|0|||
146898594|NCT00442598|529792235|FG000|Overall Study|Reduced creatinine clearance|1|||
146898595|NCT00442598|529792236|FG001|Overall Study|Reduced creatinine clearance|0|||
146898596|NCT00442598|529792237|FG002|Overall Study|Reduced creatinine clearance|0|||
146898597|NCT00442598|529792235|FG000|Overall Study|Death|0|||
146898598|NCT00442598|529792236|FG001|Overall Study|Death|1|||
146898599|NCT00442598|529792237|FG002|Overall Study|Death|0|||
146898600|NCT00501228|529792238|FG000|Overall Study|Withdrawal by Subject|1|||
146898601|NCT01670994|529792243|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
146898602|NCT01670994|529792244|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
146898603|NCT01670994|529792243|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
146898604|NCT01670994|529792244|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
146898605|NCT01670994|529792243|FG000|Overall Study|Patient experienced DLT|0|||
146898606|NCT01670994|529792244|FG001|Overall Study|Patient experienced DLT|1|||
146898607|NCT00891735|529792246|FG000|Overall Study|Adverse Event|2|||
146898608|NCT00891735|529792247|FG001|Overall Study|Adverse Event|0|||
146898609|NCT00891735|529792248|FG002|Overall Study|Adverse Event|2|||
146898610|NCT00891735|529792249|FG003|Overall Study|Adverse Event|0|||
146898611|NCT00891735|529792246|FG000|Overall Study|Death|8|||
146898612|NCT00891735|529792247|FG001|Overall Study|Death|5|||
146898613|NCT00891735|529792248|FG002|Overall Study|Death|4|||
146898614|NCT00891735|529792249|FG003|Overall Study|Death|5|||
146898615|NCT00891735|529792246|FG000|Overall Study|Lost to Follow-up|2|||
146898616|NCT00891735|529792247|FG001|Overall Study|Lost to Follow-up|2|||
146898617|NCT00891735|529792248|FG002|Overall Study|Lost to Follow-up|2|||
146898618|NCT00891735|529792249|FG003|Overall Study|Lost to Follow-up|2|||
146898619|NCT00891735|529792246|FG000|Overall Study|Physician's decision to withdraw patient|1|||
146898620|NCT00891735|529792247|FG001|Overall Study|Physician's decision to withdraw patient|0|||
146898621|NCT00891735|529792248|FG002|Overall Study|Physician's decision to withdraw patient|0|||
146898622|NCT00891735|529792249|FG003|Overall Study|Physician's decision to withdraw patient|0|||
146898623|NCT00891735|529792246|FG000|Overall Study|Patient's decision to withdraw|4|||
146898624|NCT00891735|529792247|FG001|Overall Study|Patient's decision to withdraw|9|||
146898625|NCT00891735|529792248|FG002|Overall Study|Patient's decision to withdraw|4|||
146898626|NCT00891735|529792249|FG003|Overall Study|Patient's decision to withdraw|8|||
146898627|NCT00885365|529792250|FG000|4 Weeks ON Treatment|Adverse Event|2|||
146898628|NCT00885365|529792251|FG001|4 Weeks ON Treatment|Adverse Event|4|||
146898629|NCT00885365|529792250|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
146898630|NCT00885365|529792251|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
146898631|NCT00885365|529792250|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
146559588|NCT00095576|528559354|FG001|Overall Study|Lost to Follow-up|229|||
146559589|NCT00095576|528559353|FG000|Overall Study|Protocol Violation|1|||
146559590|NCT00095576|528559354|FG001|Overall Study|Protocol Violation|0|||
146559591|NCT00095576|528559353|FG000|Overall Study|Withdrawal by Subject|34|||
146898632|NCT00885365|529792251|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
146898633|NCT01824979|529792252|FG000|Overall Study|Withdrawal by Subject|5|||
146898634|NCT01824979|529792253|FG001|Overall Study|Withdrawal by Subject|0|||
146640334|NCT05300763|528859218|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
146898635|NCT01824979|529792252|FG000|Overall Study|Physician Decision|2|||
146898636|NCT01824979|529792253|FG001|Overall Study|Physician Decision|0|||
146898637|NCT01824979|529792252|FG000|Overall Study|Protocol Violation|6|||
146898638|NCT01824979|529792253|FG001|Overall Study|Protocol Violation|13|||
146898639|NCT01818297|529792259|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
146898640|NCT01818297|529792260|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
146898641|NCT01818297|529792259|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
146640335|NCT02283762|528859222|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
146640336|NCT02283762|528859223|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
146640337|NCT02283762|528859222|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
146640338|NCT02283762|528859223|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
146640339|NCT02283762|528859222|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
146640340|NCT02283762|528859223|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
146640341|NCT02283762|528859222|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
146640342|NCT02283762|528859223|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
146640343|NCT02283762|528859222|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
146640344|NCT02283762|528859223|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
146640345|NCT02283762|528859222|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
146640346|NCT02283762|528859223|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
146640347|NCT02283762|528859222|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
146640348|NCT02283762|528859223|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
146640349|NCT02283762|528859222|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
146640350|NCT02283762|528859223|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
146898642|NCT01818297|529792260|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
146898643|NCT01818297|529792259|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
146898644|NCT01818297|529792260|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
146898645|NCT00631137|529792261|FG000|Overall Study|Withdrawal by Subject|1|||
146898646|NCT00631137|529792262|FG001|Overall Study|Withdrawal by Subject|0|||
146898647|NCT00481065|529792263|FG000|Overall Study|Adverse event or death|1|||
146898648|NCT00481065|529792264|FG001|Overall Study|Adverse event or death|1|||
146898649|NCT00481065|529792265|FG002|Overall Study|Adverse event or death|3|||
146898650|NCT00481065|529792266|FG003|Overall Study|Adverse event or death|0|||
146898651|NCT00481065|529792267|FG004|Overall Study|Adverse event or death|2|||
146898652|NCT00481065|529792268|FG005|Overall Study|Adverse event or death|0|||
146898653|NCT00481065|529792269|FG006|Overall Study|Adverse event or death|1|||
146898654|NCT00481065|529792270|FG007|Overall Study|Adverse event or death|1|||
146898655|NCT00481065|529792263|FG000|Overall Study|Withdrawal by Subject|11|||
146898656|NCT00481065|529792264|FG001|Overall Study|Withdrawal by Subject|12|||
146898657|NCT00481065|529792265|FG002|Overall Study|Withdrawal by Subject|7|||
146898658|NCT00481065|529792266|FG003|Overall Study|Withdrawal by Subject|11|||
146898659|NCT00481065|529792267|FG004|Overall Study|Withdrawal by Subject|13|||
146898660|NCT00481065|529792268|FG005|Overall Study|Withdrawal by Subject|12|||
146898661|NCT00481065|529792269|FG006|Overall Study|Withdrawal by Subject|9|||
146898662|NCT00481065|529792270|FG007|Overall Study|Withdrawal by Subject|10|||
146898663|NCT00481065|529792263|FG000|Overall Study|Lost to Follow-up|4|||
146898664|NCT00481065|529792264|FG001|Overall Study|Lost to Follow-up|2|||
146898665|NCT00481065|529792265|FG002|Overall Study|Lost to Follow-up|4|||
146898666|NCT00481065|529792266|FG003|Overall Study|Lost to Follow-up|3|||
146898667|NCT00481065|529792267|FG004|Overall Study|Lost to Follow-up|3|||
146898668|NCT00481065|529792268|FG005|Overall Study|Lost to Follow-up|3|||
146898669|NCT00481065|529792269|FG006|Overall Study|Lost to Follow-up|2|||
146898670|NCT00481065|529792270|FG007|Overall Study|Lost to Follow-up|5|||
146898671|NCT00481065|529792263|FG000|Overall Study|Inappropriate enrollment|4|||
146898672|NCT00481065|529792264|FG001|Overall Study|Inappropriate enrollment|0|||
146898673|NCT00481065|529792265|FG002|Overall Study|Inappropriate enrollment|2|||
146898674|NCT00481065|529792266|FG003|Overall Study|Inappropriate enrollment|0|||
146898675|NCT00481065|529792267|FG004|Overall Study|Inappropriate enrollment|2|||
146898676|NCT00481065|529792268|FG005|Overall Study|Inappropriate enrollment|1|||
146898677|NCT00481065|529792269|FG006|Overall Study|Inappropriate enrollment|0|||
146898678|NCT00481065|529792270|FG007|Overall Study|Inappropriate enrollment|1|||
146898679|NCT00481065|529792263|FG000|Overall Study|Administrative reason|0|||
146640351|NCT02283762|528859222|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
146640352|NCT02283762|528859223|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
146640353|NCT02283762|528859222|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
146898680|NCT00481065|529792264|FG001|Overall Study|Administrative reason|0|||
146898681|NCT00481065|529792265|FG002|Overall Study|Administrative reason|0|||
146898682|NCT00481065|529792266|FG003|Overall Study|Administrative reason|0|||
146898683|NCT00481065|529792267|FG004|Overall Study|Administrative reason|0|||
146898684|NCT00481065|529792268|FG005|Overall Study|Administrative reason|2|||
146898685|NCT00481065|529792269|FG006|Overall Study|Administrative reason|1|||
146898686|NCT00481065|529792270|FG007|Overall Study|Administrative reason|0|||
146898687|NCT00481065|529792263|FG000|Overall Study|Protocol Violation|2|||
146898688|NCT00481065|529792264|FG001|Overall Study|Protocol Violation|1|||
146898689|NCT00481065|529792265|FG002|Overall Study|Protocol Violation|1|||
146898690|NCT00481065|529792266|FG003|Overall Study|Protocol Violation|1|||
146898691|NCT00481065|529792267|FG004|Overall Study|Protocol Violation|2|||
146898692|NCT00481065|529792268|FG005|Overall Study|Protocol Violation|6|||
146898693|NCT00481065|529792269|FG006|Overall Study|Protocol Violation|3|||
146898694|NCT00481065|529792270|FG007|Overall Study|Protocol Violation|2|||
146898695|NCT00481065|529792263|FG000|Overall Study|Unable to classify|0|||
146898696|NCT00481065|529792264|FG001|Overall Study|Unable to classify|1|||
146898697|NCT00481065|529792265|FG002|Overall Study|Unable to classify|2|||
146898698|NCT00481065|529792266|FG003|Overall Study|Unable to classify|0|||
146898699|NCT00481065|529792267|FG004|Overall Study|Unable to classify|1|||
146898700|NCT00481065|529792268|FG005|Overall Study|Unable to classify|0|||
146898701|NCT00481065|529792269|FG006|Overall Study|Unable to classify|0|||
146898702|NCT00481065|529792270|FG007|Overall Study|Unable to classify|0|||
146898703|NCT04439344|529792271|FG000|Overall Study|Never started threapy|3|||
146898704|NCT04439344|529792271|FG000|Overall Study|Ineligible|3|||
146898705|NCT04439344|529792271|FG000|Overall Study|Adverse Event|13|||
146898706|NCT04439344|529792271|FG000|Overall Study|Death|2|||
146898707|NCT04439344|529792271|FG000|Overall Study|Disease progression|29|||
146898708|NCT04439344|529792271|FG000|Overall Study|Withdrawal by Subject|2|||
146898709|NCT04439344|529792271|FG000|Overall Study|Alternative therapy|1|||
146898710|NCT03770403|529792272|FG000|Overall Study|Adverse Event|8|||
146898711|NCT03770403|529792272|FG000|Overall Study|Death|5|||
146898712|NCT03770403|529792272|FG000|Overall Study|Physician Decision|1|||
146898713|NCT03770403|529792272|FG000|Overall Study|Sponsor decision|1|||
146898714|NCT03770403|529792272|FG000|Overall Study|Study terminated by Sponsor|1|||
146898715|NCT03770403|529792272|FG000|Overall Study|Withdrawal by Subject|13|||
146898716|NCT03770403|529792272|FG000|Overall Study|Other|88|||
146898717|NCT04373460|529792273|FG000|Overall Study|Did not receive tranfusion|18|||
146898718|NCT04373460|529792274|FG001|Overall Study|Did not receive tranfusion|26|||
146898719|NCT00591734|529792277|FG000|Overall Study|Lack of Efficacy|35|||
146898720|NCT00591734|529792277|FG000|Overall Study|Adverse Event|5|||
146898721|NCT00591734|529792277|FG000|Overall Study|Physician Decision|5|||
146898722|NCT00591734|529792277|FG000|Overall Study|Intercurrent Illness|8|||
146559592|NCT00095576|528559354|FG001|Overall Study|Withdrawal by Subject|47|||
146559593|NCT00095576|528559353|FG000|Overall Study|Option to switch to a rollover study|1097|||
146559594|NCT00095576|528559354|FG001|Overall Study|Option to switch to a rollover study|1099|||
146559595|NCT00095576|528559353|FG000|Overall Study|Site terminated|75|||
146559596|NCT00095576|528559354|FG001|Overall Study|Site terminated|67|||
146559597|NCT00095576|528559353|FG000|Overall Study|Subject moved|30|||
146559598|NCT00095576|528559354|FG001|Overall Study|Subject moved|36|||
146559599|NCT03685149|528559355|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
146559600|NCT03685149|528559356|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
146559601|NCT03685149|528559355|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
146559602|NCT03685149|528559356|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
146559603|NCT03685149|528559355|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
146559604|NCT03685149|528559356|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
146559605|NCT01922895|528559358|FG000|Overall Study|Death|0|||
146559606|NCT01922895|528559359|FG001|Overall Study|Death|1|||
146559607|NCT01922895|528559358|FG000|Overall Study|Withdrawal by Subject|1|||
146559608|NCT01922895|528559359|FG001|Overall Study|Withdrawal by Subject|2|||
146559609|NCT01922895|528559358|FG000|Overall Study|Lost to Follow-up|5|||
146559610|NCT01922895|528559359|FG001|Overall Study|Lost to Follow-up|11|||
146559611|NCT02796651|528559363|FG000|Overall Study|Adverse Event|6|||
146559612|NCT02796651|528559363|FG000|Overall Study|Lost to Follow-up|1|||
146559613|NCT02796651|528559363|FG000|Overall Study|Withdrawal by Subject|4|||
146559614|NCT02796651|528559363|FG000|Overall Study|Protocol Violation|4|||
146559615|NCT02796651|528559363|FG000|Overall Study|Lack of Efficacy|1|||
146559616|NCT02796651|528559363|FG000|Overall Study|Other|10|||
146898723|NCT05775289|529792281|FG000|Overall Study|Study Ongoing|20|||
146898724|NCT05775289|529792282|FG001|Overall Study|Study Ongoing|53|||
146898725|NCT05775289|529792283|FG002|Overall Study|Study Ongoing|15|||
146898726|NCT05775289|529792284|FG003|Overall Study|Study Ongoing|55|||
146898727|NCT05775289|529792281|FG000|Overall Study|Death|4|||
146898728|NCT05775289|529792282|FG001|Overall Study|Death|11|||
146559617|NCT05360784|528559364|FG000|Overall Study|Discontinued|25|||
146559618|NCT05360784|528559365|FG001|Overall Study|Discontinued|11|||
146559619|NCT05142306|528559369|FG000|Overall Study|Withdrawal by Subject|0|||
146559620|NCT05142306|528559370|FG001|Overall Study|Withdrawal by Subject|0|||
146559621|NCT05142306|528559371|FG002|Overall Study|Withdrawal by Subject|1|||
146898729|NCT05775289|529792283|FG002|Overall Study|Death|8|||
146898730|NCT05775289|529792284|FG003|Overall Study|Death|12|||
146898731|NCT05775289|529792281|FG000|Overall Study|Lost to Follow-up|0|||
146898732|NCT05775289|529792282|FG001|Overall Study|Lost to Follow-up|1|||
146559622|NCT02251041|528559372|FG000|Overall Study|Did not receive intervention|15|||
146559623|NCT02251041|528559373|FG001|Overall Study|Did not receive intervention|4|||
146898733|NCT05775289|529792283|FG002|Overall Study|Lost to Follow-up|0|||
146898734|NCT05775289|529792284|FG003|Overall Study|Lost to Follow-up|0|||
146898735|NCT05775289|529792281|FG000|Overall Study|Progressive Disease|0|||
146898736|NCT05775289|529792282|FG001|Overall Study|Progressive Disease|0|||
146898737|NCT05775289|529792283|FG002|Overall Study|Progressive Disease|1|||
146898738|NCT05775289|529792284|FG003|Overall Study|Progressive Disease|0|||
146898739|NCT05775289|529792281|FG000|Overall Study|Withdrawal by Subject|1|||
146898740|NCT05775289|529792282|FG001|Overall Study|Withdrawal by Subject|1|||
146898741|NCT05775289|529792283|FG002|Overall Study|Withdrawal by Subject|0|||
146898742|NCT05775289|529792284|FG003|Overall Study|Withdrawal by Subject|0|||
146898743|NCT04439331|529792285|FG000|Overall Study|Never Start Protocol Therapy|2|||
146898744|NCT04439331|529792285|FG000|Overall Study|Ineligible|2|||
146898745|NCT04439331|529792285|FG000|Overall Study|Mutation Status Not Confirmed|1|||
146898746|NCT04439331|529792285|FG000|Overall Study|Adverse Event|1|||
146898747|NCT04439331|529792285|FG000|Overall Study|Death|1|||
146898748|NCT04439331|529792285|FG000|Overall Study|Disease Progression|20|||
146898749|NCT04439331|529792285|FG000|Overall Study|Withdrawal by Subject|6|||
146898750|NCT04439331|529792285|FG000|Overall Study|Physician Decision|1|||
146898751|NCT04439331|529792285|FG000|Overall Study|Other Complicating Disease|1|||
146898752|NCT03726268|529792286|FG000|Overall Study|Physician Decision|2|||
146898753|NCT03726268|529792287|FG001|Overall Study|Physician Decision|8|||
146898754|NCT03726268|529792288|FG002|Overall Study|Physician Decision|6|||
146898755|NCT03726268|529792289|FG003|Overall Study|Physician Decision|3|||
146898756|NCT03726268|529792286|FG000|Overall Study|Withdrawal by Subject|11|||
146898757|NCT03726268|529792287|FG001|Overall Study|Withdrawal by Subject|5|||
146898758|NCT03726268|529792288|FG002|Overall Study|Withdrawal by Subject|9|||
146898759|NCT03726268|529792289|FG003|Overall Study|Withdrawal by Subject|8|||
146898760|NCT04370509|529792293|FG000|Overall Study|Adverse Event|1|||
146898761|NCT04370509|529792294|FG001|Overall Study|Adverse Event|0|||
146898762|NCT04370509|529792293|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
146898763|NCT04370509|529792294|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
146898764|NCT04696861|529792295|FG000|Overall Study|Death|1|||
146898765|NCT04696861|529792296|FG001|Overall Study|Death|0|||
146898766|NCT04696861|529792295|FG000|Overall Study|Lost to Follow-up|3|||
146898767|NCT04696861|529792296|FG001|Overall Study|Lost to Follow-up|0|||
146898768|NCT01827384|529792297|FG000|Overall Study|Switched to alternative treatment|0|||
146898769|NCT01827384|529792298|FG001|Overall Study|Switched to alternative treatment|0|||
146898770|NCT01827384|529792299|FG002|Overall Study|Switched to alternative treatment|0|||
146898771|NCT01827384|529792300|FG003|Overall Study|Switched to alternative treatment|0|||
146898772|NCT01827384|529792301|FG004|Overall Study|Switched to alternative treatment|0|||
146898773|NCT01827384|529792302|FG005|Overall Study|Switched to alternative treatment|0|||
146898774|NCT01827384|529792303|FG006|Overall Study|Switched to alternative treatment|0|||
146898775|NCT01827384|529792304|FG007|Overall Study|Switched to alternative treatment|0|||
146898776|NCT01827384|529792305|FG008|Overall Study|Switched to alternative treatment|0|||
146898777|NCT01827384|529792306|FG009|Overall Study|Switched to alternative treatment|0|||
146898778|NCT01827384|529792307|FG010|Overall Study|Switched to alternative treatment|0|||
146898779|NCT01827384|529792308|FG011|Overall Study|Switched to alternative treatment|0|||
146898780|NCT01827384|529792309|FG012|Overall Study|Switched to alternative treatment|0|||
146969105|NCT03993288|530047311|FG000|Overall Study|Lost to Follow-up|2|||
146898781|NCT01827384|529792310|FG013|Overall Study|Switched to alternative treatment|2|||
146559624|NCT04079920|528559374|FG000|Overall Study|Adverse event, not related to study drug|2|||
146559625|NCT04079920|528559374|FG000|Overall Study|Adverse event related to study drug|10|||
146559626|NCT04079920|528559374|FG000|Overall Study|Death|2|||
146559627|NCT04079920|528559374|FG000|Overall Study|Lost to Follow-up|22|||
146559628|NCT04079920|528559374|FG000|Overall Study|Physician Decision|1|||
146559629|NCT04079920|528559374|FG000|Overall Study|Withdrawal by Subject|11|||
146559630|NCT04918771|528559375|FG000|Overall Study|Withdrawal by Subject|4|||
146640354|NCT02283762|528859223|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
146640355|NCT02283762|528859222|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
146640356|NCT02283762|528859223|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
146640357|NCT02283762|528859222|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
146898782|NCT01827384|529792297|FG000|Overall Study|Disease progression before treatment|0|||
146898783|NCT01827384|529792298|FG001|Overall Study|Disease progression before treatment|0|||
146898784|NCT01827384|529792299|FG002|Overall Study|Disease progression before treatment|0|||
146898785|NCT01827384|529792300|FG003|Overall Study|Disease progression before treatment|0|||
146898786|NCT01827384|529792301|FG004|Overall Study|Disease progression before treatment|0|||
146898787|NCT01827384|529792302|FG005|Overall Study|Disease progression before treatment|0|||
146898788|NCT01827384|529792303|FG006|Overall Study|Disease progression before treatment|0|||
146898789|NCT01827384|529792304|FG007|Overall Study|Disease progression before treatment|0|||
146898790|NCT01827384|529792305|FG008|Overall Study|Disease progression before treatment|0|||
146898791|NCT01827384|529792306|FG009|Overall Study|Disease progression before treatment|0|||
146898792|NCT01827384|529792307|FG010|Overall Study|Disease progression before treatment|0|||
146898793|NCT01827384|529792308|FG011|Overall Study|Disease progression before treatment|0|||
146898794|NCT01827384|529792309|FG012|Overall Study|Disease progression before treatment|0|||
146898795|NCT01827384|529792310|FG013|Overall Study|Disease progression before treatment|4|||
146898796|NCT01827384|529792297|FG000|Overall Study|Ineligible|0|||
146898797|NCT01827384|529792298|FG001|Overall Study|Ineligible|0|||
146898798|NCT01827384|529792299|FG002|Overall Study|Ineligible|0|||
146898799|NCT01827384|529792300|FG003|Overall Study|Ineligible|0|||
146898800|NCT01827384|529792301|FG004|Overall Study|Ineligible|0|||
146898801|NCT01827384|529792302|FG005|Overall Study|Ineligible|0|||
146898802|NCT01827384|529792303|FG006|Overall Study|Ineligible|0|||
146898803|NCT01827384|529792304|FG007|Overall Study|Ineligible|0|||
146898804|NCT01827384|529792305|FG008|Overall Study|Ineligible|0|||
146898805|NCT01827384|529792306|FG009|Overall Study|Ineligible|0|||
146898806|NCT01827384|529792307|FG010|Overall Study|Ineligible|0|||
146898807|NCT01827384|529792308|FG011|Overall Study|Ineligible|0|||
146898808|NCT01827384|529792309|FG012|Overall Study|Ineligible|0|||
146898809|NCT01827384|529792310|FG013|Overall Study|Ineligible|19|||
146898810|NCT01827384|529792297|FG000|Overall Study|Participant died before treatment|0|||
146898811|NCT01827384|529792298|FG001|Overall Study|Participant died before treatment|0|||
146898812|NCT01827384|529792299|FG002|Overall Study|Participant died before treatment|0|||
146898813|NCT01827384|529792300|FG003|Overall Study|Participant died before treatment|0|||
146898814|NCT01827384|529792301|FG004|Overall Study|Participant died before treatment|0|||
146898815|NCT01827384|529792302|FG005|Overall Study|Participant died before treatment|0|||
146898816|NCT01827384|529792303|FG006|Overall Study|Participant died before treatment|0|||
146898817|NCT01827384|529792304|FG007|Overall Study|Participant died before treatment|0|||
146898818|NCT01827384|529792305|FG008|Overall Study|Participant died before treatment|0|||
146898819|NCT01827384|529792306|FG009|Overall Study|Participant died before treatment|0|||
146898820|NCT01827384|529792307|FG010|Overall Study|Participant died before treatment|0|||
146898821|NCT01827384|529792308|FG011|Overall Study|Participant died before treatment|0|||
146898822|NCT01827384|529792309|FG012|Overall Study|Participant died before treatment|0|||
146898823|NCT01827384|529792310|FG013|Overall Study|Participant died before treatment|5|||
146898824|NCT01827384|529792297|FG000|Overall Study|Insufficient tumor cells|0|||
146898825|NCT01827384|529792298|FG001|Overall Study|Insufficient tumor cells|0|||
146898826|NCT01827384|529792299|FG002|Overall Study|Insufficient tumor cells|0|||
146898827|NCT01827384|529792300|FG003|Overall Study|Insufficient tumor cells|0|||
146898828|NCT01827384|529792301|FG004|Overall Study|Insufficient tumor cells|0|||
146898829|NCT01827384|529792302|FG005|Overall Study|Insufficient tumor cells|0|||
146898830|NCT01827384|529792303|FG006|Overall Study|Insufficient tumor cells|0|||
146969106|NCT03993288|530047312|FG001|Overall Study|Lost to Follow-up|1|||
146559631|NCT04918771|528559376|FG001|Overall Study|Withdrawal by Subject|5|||
146559632|NCT04918771|528559375|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
146559633|NCT04918771|528559376|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
146559634|NCT05014919|528559379|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
146640358|NCT02283762|528859223|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
146898831|NCT01827384|529792304|FG007|Overall Study|Insufficient tumor cells|0|||
146898832|NCT01827384|529792305|FG008|Overall Study|Insufficient tumor cells|0|||
146898833|NCT01827384|529792306|FG009|Overall Study|Insufficient tumor cells|0|||
146898834|NCT01827384|529792307|FG010|Overall Study|Insufficient tumor cells|0|||
146898835|NCT01827384|529792308|FG011|Overall Study|Insufficient tumor cells|0|||
146898836|NCT01827384|529792309|FG012|Overall Study|Insufficient tumor cells|0|||
146898837|NCT01827384|529792310|FG013|Overall Study|Insufficient tumor cells|13|||
146898838|NCT01827384|529792297|FG000|Overall Study|No actionable mutation|0|||
146898839|NCT01827384|529792298|FG001|Overall Study|No actionable mutation|0|||
146898840|NCT01827384|529792299|FG002|Overall Study|No actionable mutation|0|||
146898841|NCT01827384|529792300|FG003|Overall Study|No actionable mutation|0|||
146898842|NCT01827384|529792301|FG004|Overall Study|No actionable mutation|0|||
146898843|NCT01827384|529792302|FG005|Overall Study|No actionable mutation|0|||
146898844|NCT01827384|529792303|FG006|Overall Study|No actionable mutation|0|||
146898845|NCT01827384|529792304|FG007|Overall Study|No actionable mutation|0|||
146898846|NCT01827384|529792305|FG008|Overall Study|No actionable mutation|0|||
146898847|NCT01827384|529792306|FG009|Overall Study|No actionable mutation|0|||
146898848|NCT01827384|529792307|FG010|Overall Study|No actionable mutation|0|||
146898849|NCT01827384|529792308|FG011|Overall Study|No actionable mutation|0|||
146898850|NCT01827384|529792309|FG012|Overall Study|No actionable mutation|0|||
146898851|NCT01827384|529792310|FG013|Overall Study|No actionable mutation|73|||
146898852|NCT01827384|529792297|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
146898853|NCT01827384|529792298|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
146898854|NCT01827384|529792299|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
146898855|NCT01827384|529792300|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
146898856|NCT01827384|529792301|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
146898857|NCT01827384|529792302|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
146898858|NCT01827384|529792303|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
146898859|NCT01827384|529792304|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
146898860|NCT01827384|529792305|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
146898861|NCT01827384|529792306|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
146898862|NCT01827384|529792307|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
146898863|NCT01827384|529792308|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
146898864|NCT01827384|529792309|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
146898865|NCT01827384|529792310|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
146898866|NCT03498521|529792313|FG000|Overall Study|Death|227|||
146898867|NCT03498521|529792314|FG001|Overall Study|Death|79|||
146898868|NCT03498521|529792315|FG002|Overall Study|Death|84|||
146898869|NCT03498521|529792313|FG000|Overall Study|Exclusion criteria|1|||
146898870|NCT03498521|529792314|FG001|Overall Study|Exclusion criteria|0|||
146898871|NCT03498521|529792315|FG002|Overall Study|Exclusion criteria|0|||
146898872|NCT03498521|529792313|FG000|Overall Study|Lost to Follow-up|4|||
146898873|NCT03498521|529792314|FG001|Overall Study|Lost to Follow-up|3|||
146898874|NCT03498521|529792315|FG002|Overall Study|Lost to Follow-up|3|||
146898875|NCT03498521|529792313|FG000|Overall Study|No profile due to technical failure|1|||
146898876|NCT03498521|529792314|FG001|Overall Study|No profile due to technical failure|0|||
146898877|NCT03498521|529792315|FG002|Overall Study|No profile due to technical failure|0|||
146898878|NCT03498521|529792313|FG000|Overall Study|Physician Decision|3|||
146898879|NCT03498521|529792314|FG001|Overall Study|Physician Decision|1|||
146898880|NCT03498521|529792315|FG002|Overall Study|Physician Decision|0|||
146898881|NCT03498521|529792313|FG000|Overall Study|Withdrawal by Subject|11|||
146898882|NCT03498521|529792314|FG001|Overall Study|Withdrawal by Subject|6|||
146898883|NCT03498521|529792315|FG002|Overall Study|Withdrawal by Subject|2|||
146898884|NCT03498521|529792313|FG000|Overall Study|Study terminated by sponsor|79|||
146898885|NCT03498521|529792314|FG001|Overall Study|Study terminated by sponsor|21|||
146898886|NCT03498521|529792315|FG002|Overall Study|Study terminated by sponsor|4|||
146898887|NCT02029976|529794133|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
146898888|NCT02029976|529794134|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
146898889|NCT02029976|529794133|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
146898890|NCT02029976|529794134|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
146898891|NCT02029976|529794133|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
146898892|NCT02029976|529794134|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
146898893|NCT02029976|529794133|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
146898894|NCT02029976|529794134|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
146766936|NCT00536380|529314667|FG001|Overall Study|Withdrawal related to study drug|5|||
146898895|NCT02660580|529794137|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
146898896|NCT02660580|529794138|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
146898897|NCT02660580|529794139|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
146898898|NCT02660580|529794140|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
146898899|NCT02660580|529794141|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
146898900|NCT02660580|529794137|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
146898901|NCT02660580|529794138|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
146898902|NCT02660580|529794139|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
146898903|NCT02660580|529794140|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
146898904|NCT02660580|529794141|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
146898905|NCT02660580|529794137|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
146898906|NCT02660580|529794138|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
146898907|NCT02660580|529794139|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
146898908|NCT02660580|529794140|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
146898909|NCT02660580|529794141|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
146898910|NCT02660580|529794137|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
146898911|NCT02660580|529794138|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
146898912|NCT02660580|529794139|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
146898913|NCT02660580|529794140|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
146898914|NCT02660580|529794141|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
146898915|NCT02660580|529794137|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
146898916|NCT02660580|529794138|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
146898917|NCT02660580|529794139|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
146898918|NCT02660580|529794140|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
146898919|NCT02660580|529794141|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
146898920|NCT02660580|529794137|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
146898921|NCT02660580|529794138|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
146898922|NCT02660580|529794139|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
146898923|NCT02660580|529794140|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
146898924|NCT02660580|529794141|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
146898925|NCT02660580|529794137|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
146898926|NCT02660580|529794138|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
146898927|NCT02660580|529794139|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
146898928|NCT02660580|529794140|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
146898929|NCT02660580|529794141|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
146898930|NCT02660580|529794137|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
146898931|NCT02660580|529794138|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
146898932|NCT02660580|529794139|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
146898933|NCT02660580|529794140|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
146898934|NCT02660580|529794141|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
146898935|NCT02660580|529794137|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
146898936|NCT02660580|529794138|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
146898937|NCT02660580|529794139|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
146898938|NCT02660580|529794140|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
146898939|NCT02660580|529794141|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
146898940|NCT02660580|529794137|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
146898941|NCT02660580|529794138|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
146898942|NCT02660580|529794139|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
146898943|NCT02660580|529794140|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
146898944|NCT02660580|529794141|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
146898945|NCT02660580|529794137|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
146898946|NCT02660580|529794138|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
146969107|NCT03993288|530047311|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
146559635|NCT05014919|528559380|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
146559636|NCT05014919|528559381|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
146559637|NCT05014919|528559379|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
146559638|NCT05014919|528559380|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
146559639|NCT05014919|528559381|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
146559640|NCT05014919|528559379|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
146559641|NCT05014919|528559380|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
146559642|NCT05014919|528559381|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
146559643|NCT05014919|528559379|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
146559644|NCT05014919|528559380|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
146898947|NCT02660580|529794139|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
146898948|NCT02660580|529794140|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
146898949|NCT02660580|529794141|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
146898950|NCT02660580|529794137|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
146898951|NCT02660580|529794138|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
146898952|NCT02660580|529794139|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
146898953|NCT02660580|529794140|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
146898954|NCT02660580|529794141|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
146898955|NCT02660580|529794137|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
146898956|NCT02660580|529794138|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
146898957|NCT02660580|529794139|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
146969108|NCT03993288|530047312|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
146969109|NCT03993288|530047311|FG000|Overall Study|wrong randomization|0|||
146969110|NCT03993288|530047312|FG001|Overall Study|wrong randomization|1|||
146969111|NCT03993288|530047311|FG000|Overall Study|improper enrollment|0|||
146969112|NCT03993288|530047312|FG001|Overall Study|improper enrollment|1|||
146969113|NCT03993288|530047311|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
146969114|NCT03993288|530047312|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
146969115|NCT03993288|530047311|FG000|Overall Study|developed SAE|2|||
146969116|NCT03993288|530047312|FG001|Overall Study|developed SAE|0|||
146969117|NCT03993288|530047311|FG000|Overall Study|consent withdrawal|1|||
146559645|NCT05014919|528559381|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
146559646|NCT05014919|528559379|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
146559647|NCT05014919|528559380|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
146559648|NCT05014919|528559381|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
146559649|NCT05014919|528559379|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
146559650|NCT05014919|528559380|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
146559651|NCT05014919|528559381|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
146559652|NCT05014919|528559379|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
146559653|NCT05014919|528559380|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
146559654|NCT05014919|528559381|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
146559655|NCT05014919|528559379|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
146559656|NCT05014919|528559380|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
146559657|NCT05014919|528559381|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
146559658|NCT02971163|528559382|FG000|Overall Study|Lost to Follow-up|4|||
146559659|NCT02971163|528559383|FG001|Overall Study|Lost to Follow-up|2|||
146559660|NCT02940223|528559392|FG000|Overall Study|Failed Requirement|2|||
146559661|NCT02940223|528559393|FG001|Overall Study|Failed Requirement|0|||
146559662|NCT05305651|528559394|FG000|Overall Study|Death|1|||
146559663|NCT05305651|528559394|FG000|Overall Study|Withdrawal by Subject|4|||
146898958|NCT02660580|529794140|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
146969118|NCT03993288|530047312|FG001|Overall Study|consent withdrawal|0|||
146969119|NCT03993288|530047311|FG000|Overall Study|did not follow the treatment schedule|1|||
146969120|NCT03993288|530047312|FG001|Overall Study|did not follow the treatment schedule|0|||
146969121|NCT03993288|530047311|FG000|Overall Study|did not follow the treatment regimen|1|||
146969122|NCT03993288|530047312|FG001|Overall Study|did not follow the treatment regimen|0|||
146969123|NCT03993288|530047311|FG000|Overall Study|Adverse Event|1|||
146969124|NCT03993288|530047312|FG001|Overall Study|Adverse Event|0|||
146969125|NCT03993288|530047311|FG000|Overall Study|Withdrawal by Subject|1|||
146969126|NCT03993288|530047312|FG001|Overall Study|Withdrawal by Subject|1|||
146969127|NCT02729545|530047313|FG000|Overall Study|Pregnancy|1|||
146969128|NCT02729545|530047314|FG001|Overall Study|Pregnancy|1|||
146969129|NCT02729545|530047313|FG000|Overall Study|Lost to Follow-up|0|||
146969130|NCT02729545|530047314|FG001|Overall Study|Lost to Follow-up|1|||
146969131|NCT02729545|530047313|FG000|Overall Study|Withdrawal by Subject|2|||
146969132|NCT02729545|530047314|FG001|Overall Study|Withdrawal by Subject|3|||
146969133|NCT00915473|530047315|FG000|Screening|Withdrawal by Subject|1|||
146969134|NCT00915473|530047316|FG001|Screening|Withdrawal by Subject|0|||
146969135|NCT00915473|530047315|FG000|4-week Follow Up|Lost to Follow-up|1|||
146969136|NCT00915473|530047316|FG001|4-week Follow Up|Lost to Follow-up|5|||
146969137|NCT01389024|530047317|FG000|Overall Study|Withdrawal by Subject|0|||
146969138|NCT01389024|530047318|FG001|Overall Study|Withdrawal by Subject|1|||
146969139|NCT01389024|530047317|FG000|Overall Study|Lost to Follow-up|1|||
146969140|NCT01389024|530047318|FG001|Overall Study|Lost to Follow-up|0|||
146969141|NCT00529802|530047322|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
146969142|NCT00529802|530047322|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
146969143|NCT00529802|530047322|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
146969144|NCT00529802|530047322|FG000|Evaluable for Primary Endpoint|Death|1|||
146969145|NCT00529802|530047322|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
146969146|NCT00529802|530047322|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
146969147|NCT00529802|530047322|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
146969148|NCT03286400|530047326|FG000|Overall Study|Death|10|||
146969149|NCT03286400|530047326|FG000|Overall Study|Lost to Follow-up|10|||
146969150|NCT03286400|530047326|FG000|Overall Study|Physician Decision|1|||
146969151|NCT03286400|530047326|FG000|Overall Study|Scheduling difficulty|4|||
146969152|NCT00740480|530047331|FG000|Overall Study|Adverse Event|1|||
146969153|NCT00740480|530047331|FG000|Overall Study|Physician Decision|1|||
146969154|NCT01325701|530047336|FG000|Overall Study|Adverse Event|12|||
146969155|NCT01325701|530047337|FG001|Overall Study|Adverse Event|0|||
146640359|NCT01598506|528859226|FG000|Overall Study|Withdrawal by Subject|2|||
146969156|NCT01325701|530047336|FG000|Overall Study|Protocol Violation|1|||
146640360|NCT02367833|528859227|FG000|Overall Study|Withdrawal by Subject|1|||
146640361|NCT02367833|528859228|FG001|Overall Study|Withdrawal by Subject|1|||
146640362|NCT02367833|528859229|FG002|Overall Study|Withdrawal by Subject|0|||
146640363|NCT00889720|528859232|FG000|Overall Study|Withdrawal by Subject|4|||
146640364|NCT00889720|528859232|FG000|Overall Study|Other|4|||
146640365|NCT02504216|528859233|FG000|Overall Study|Lost to Follow-up|3|||
146640366|NCT02504216|528859234|FG001|Overall Study|Lost to Follow-up|3|||
146640367|NCT02504216|528859233|FG000|Overall Study|Withdrawal by Subject|8|||
146640368|NCT02504216|528859234|FG001|Overall Study|Withdrawal by Subject|12|||
146640369|NCT00223080|528859235|FG000|Overall Study|Withdrawal by Subject|253|||
146640370|NCT00223080|528859236|FG001|Overall Study|Withdrawal by Subject|232|||
146969157|NCT01325701|530047337|FG001|Overall Study|Protocol Violation|0|||
146969158|NCT01325701|530047336|FG000|Overall Study|Physician Decision|2|||
146969159|NCT01325701|530047337|FG001|Overall Study|Physician Decision|2|||
146969160|NCT01325701|530047336|FG000|Overall Study|Withdrawal by Subject|2|||
146969161|NCT01325701|530047337|FG001|Overall Study|Withdrawal by Subject|1|||
146969162|NCT01325701|530047336|FG000|Overall Study|Rollerover Extension Study|4|||
146969163|NCT01325701|530047337|FG001|Overall Study|Rollerover Extension Study|0|||
146969164|NCT00568776|530047339|FG000|Overall Study|Adverse Event|8|||
146969165|NCT00568776|530047340|FG001|Overall Study|Adverse Event|8|||
146640371|NCT00223080|528859235|FG000|Overall Study|Required contraindicated med|0|||
146640372|NCT00223080|528859236|FG001|Overall Study|Required contraindicated med|1|||
146640373|NCT00223080|528859235|FG000|Overall Study|Non-compliant|7|||
146640374|NCT00223080|528859236|FG001|Overall Study|Non-compliant|7|||
146640375|NCT00223080|528859235|FG000|Overall Study|Moved from study area|37|||
146640376|NCT00223080|528859236|FG001|Overall Study|Moved from study area|47|||
146640377|NCT00223080|528859235|FG000|Overall Study|Lost to Follow-up|259|||
146640378|NCT00223080|528859236|FG001|Overall Study|Lost to Follow-up|284|||
146969166|NCT00568776|530047341|FG002|Overall Study|Adverse Event|10|||
146969167|NCT00568776|530047342|FG003|Overall Study|Adverse Event|8|||
146969168|NCT00568776|530047339|FG000|Overall Study|Death|0|||
146969169|NCT00568776|530047340|FG001|Overall Study|Death|1|||
146969170|NCT00568776|530047341|FG002|Overall Study|Death|4|||
146969171|NCT00568776|530047342|FG003|Overall Study|Death|3|||
146969172|NCT00568776|530047339|FG000|Overall Study|Physician Decision|0|||
146969173|NCT00568776|530047340|FG001|Overall Study|Physician Decision|2|||
146969174|NCT00568776|530047341|FG002|Overall Study|Physician Decision|0|||
146898959|NCT02660580|529794141|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
146898960|NCT03124459|529794147|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
146898961|NCT03124459|529794148|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
146898962|NCT03124459|529794149|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
146898963|NCT03124459|529794150|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
146898964|NCT03124459|529794151|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
146898965|NCT03124459|529794152|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
146898966|NCT03124459|529794147|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
146898967|NCT03124459|529794148|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
146898968|NCT03124459|529794149|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
146898969|NCT03124459|529794150|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
146898970|NCT03124459|529794151|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
146898971|NCT03124459|529794152|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
146898972|NCT03124459|529794147|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
146898973|NCT03124459|529794148|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
146898974|NCT03124459|529794149|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
146898975|NCT03124459|529794150|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
146898976|NCT03124459|529794151|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
146898977|NCT03124459|529794152|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
146898978|NCT03124459|529794147|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
146898979|NCT03124459|529794148|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
146898980|NCT03124459|529794149|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
146898981|NCT03124459|529794150|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
146898982|NCT03124459|529794151|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
146898983|NCT03124459|529794152|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
146898984|NCT03124459|529794147|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
146898985|NCT03124459|529794148|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
146898986|NCT03124459|529794149|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
146898987|NCT03124459|529794150|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
146898988|NCT03124459|529794151|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
146898989|NCT03124459|529794152|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
146898990|NCT03124459|529794147|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
146898991|NCT03124459|529794148|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
146898992|NCT03124459|529794149|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
146898993|NCT03124459|529794150|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
146898994|NCT03124459|529794151|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
146898995|NCT03124459|529794152|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
146898996|NCT01028352|529794153|FG000|Overall Study|Ineligible due to baseline average pain|5|||
146898997|NCT01028352|529794153|FG000|Overall Study|Withdrawal by Subject|1|||
146898998|NCT01903876|529794154|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
146898999|NCT01903876|529794155|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
146899000|NCT01903876|529794154|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
146899001|NCT01903876|529794155|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
146899002|NCT02612909|529794156|FG000|Phase 2|Withdrawal by Subject|2|||
146640379|NCT00223080|528859235|FG000|Overall Study|Death|85|||
146899003|NCT02612909|529794157|FG001|Phase 2|Withdrawal by Subject|5|||
146899004|NCT02612909|529794158|FG002|Phase 2|Withdrawal by Subject|0|||
146899005|NCT02612909|529794159|FG003|Phase 2|Withdrawal by Subject|0|||
146899006|NCT02612909|529794160|FG004|Phase 2|Withdrawal by Subject|0|||
146899007|NCT02612909|529794156|FG000|Phase 2|Pregnancy|0|||
146899008|NCT02612909|529794157|FG001|Phase 2|Pregnancy|0|||
146899009|NCT02612909|529794158|FG002|Phase 2|Pregnancy|1|||
146899010|NCT02612909|529794159|FG003|Phase 2|Pregnancy|0|||
146899011|NCT02612909|529794160|FG004|Phase 2|Pregnancy|0|||
146899012|NCT02612909|529794156|FG000|Phase 3|Withdrawal by Subject|0|||
146899013|NCT02612909|529794157|FG001|Phase 3|Withdrawal by Subject|0|||
146899014|NCT02612909|529794158|FG002|Phase 3|Withdrawal by Subject|0|||
146899015|NCT02612909|529794159|FG003|Phase 3|Withdrawal by Subject|1|||
146899016|NCT02612909|529794160|FG004|Phase 3|Withdrawal by Subject|0|||
146899017|NCT05224258|529794161|FG000|Overall Study|Withdrawal by Subject|1|||
146899018|NCT05224258|529794162|FG001|Overall Study|Withdrawal by Subject|1|||
146899019|NCT05224258|529794161|FG000|Overall Study|Physician Decision|1|||
146899020|NCT05224258|529794162|FG001|Overall Study|Physician Decision|1|||
146899021|NCT05224258|529794161|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146899022|NCT05224258|529794162|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146899023|NCT05224258|529794161|FG000|Overall Study|Study Product No Longer in Use|1|||
146899024|NCT05224258|529794162|FG001|Overall Study|Study Product No Longer in Use|0|||
146640380|NCT00223080|528859236|FG001|Overall Study|Death|74|||
146640381|NCT00223080|528859235|FG000|Overall Study|Other|14|||
146899025|NCT05224258|529794161|FG000|Overall Study|Adverse Event|0|||
146899026|NCT05224258|529794162|FG001|Overall Study|Adverse Event|1|||
146899027|NCT05224258|529794161|FG000|Overall Study|Protocol Deviation|0|||
146899028|NCT05224258|529794162|FG001|Overall Study|Protocol Deviation|1|||
146899029|NCT05067127|529794163|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
146899030|NCT05067127|529794164|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
146899031|NCT05067127|529794165|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
146899032|NCT05067127|529794166|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
146899033|NCT05067127|529794163|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
146899034|NCT05067127|529794164|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
146899035|NCT05067127|529794165|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
146899036|NCT05067127|529794166|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
146899037|NCT05067127|529794163|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
146899038|NCT05067127|529794164|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
146899039|NCT05067127|529794165|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
146899040|NCT05067127|529794166|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
146899041|NCT05067127|529794163|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
146899042|NCT05067127|529794164|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
146899043|NCT05067127|529794165|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
146899044|NCT05067127|529794166|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
146899045|NCT05067127|529794163|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
146899046|NCT05067127|529794164|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
146899047|NCT05067127|529794165|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
146899048|NCT05067127|529794166|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
146766937|NCT00536380|529314668|FG002|Overall Study|Withdrawal related to study drug|2|||
146899049|NCT05067127|529794163|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
146899050|NCT05067127|529794164|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
146899051|NCT05067127|529794165|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
146899052|NCT05067127|529794166|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
146899053|NCT05067127|529794163|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
146899054|NCT05067127|529794164|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
146899055|NCT05067127|529794165|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
146899056|NCT05067127|529794166|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
146899057|NCT04462536|529794167|FG000|Overall Study|Withdrawal by Subject|3|||
146899058|NCT04462536|529794168|FG001|Overall Study|Withdrawal by Subject|9|||
146899059|NCT04462536|529794167|FG000|Overall Study|Lost to Follow-up|2|||
146899060|NCT04462536|529794168|FG001|Overall Study|Lost to Follow-up|4|||
146899061|NCT00603239|529794170|FG000|Overall Study|Adverse Event|4|||
146899062|NCT00603239|529794171|FG001|Overall Study|Adverse Event|1|||
146899063|NCT00603239|529794170|FG000|Overall Study|Entry criteria not met|0|||
146899064|NCT00603239|529794171|FG001|Overall Study|Entry criteria not met|1|||
146899065|NCT00603239|529794170|FG000|Overall Study|Loss of glucose control|3|||
146899066|NCT00603239|529794171|FG001|Overall Study|Loss of glucose control|0|||
146899067|NCT00603239|529794170|FG000|Overall Study|Lost to Follow-up|2|||
146899068|NCT00603239|529794171|FG001|Overall Study|Lost to Follow-up|1|||
146899069|NCT00603239|529794170|FG000|Overall Study|Physician Decision|2|||
146899070|NCT00603239|529794171|FG001|Overall Study|Physician Decision|0|||
146899071|NCT00603239|529794170|FG000|Overall Study|Protocol Violation|2|||
146899072|NCT00603239|529794171|FG001|Overall Study|Protocol Violation|0|||
146899073|NCT00603239|529794170|FG000|Overall Study|Subject decision|2|||
146899074|NCT00603239|529794171|FG001|Overall Study|Subject decision|1|||
146899075|NCT02601950|529794172|FG000|Overall Study|Participant enrolled in rollover study|0|||
146899076|NCT02601950|529794173|FG001|Overall Study|Participant enrolled in rollover study|0|||
146899077|NCT02601950|529794174|FG002|Overall Study|Participant enrolled in rollover study|1|||
146899078|NCT02601950|529794175|FG003|Overall Study|Participant enrolled in rollover study|0|||
146899079|NCT02601950|529794176|FG004|Overall Study|Participant enrolled in rollover study|1|||
146899080|NCT02601950|529794177|FG005|Overall Study|Participant enrolled in rollover study|1|||
146899081|NCT02601950|529794178|FG006|Overall Study|Participant enrolled in rollover study|1|||
146899082|NCT02601950|529794179|FG007|Overall Study|Participant enrolled in rollover study|0|||
146899083|NCT02601950|529794172|FG000|Overall Study|Disease progression - radiological|21|||
146899084|NCT02601950|529794173|FG001|Overall Study|Disease progression - radiological|26|||
146899085|NCT02601950|529794174|FG002|Overall Study|Disease progression - radiological|22|||
146899086|NCT02601950|529794175|FG003|Overall Study|Disease progression - radiological|11|||
146899087|NCT02601950|529794176|FG004|Overall Study|Disease progression - radiological|46|||
146899088|NCT02601950|529794177|FG005|Overall Study|Disease progression - radiological|52|||
146969175|NCT00568776|530047342|FG003|Overall Study|Physician Decision|0|||
146899089|NCT02601950|529794178|FG006|Overall Study|Disease progression - radiological|7|||
146899090|NCT02601950|529794179|FG007|Overall Study|Disease progression - radiological|5|||
146899091|NCT02601950|529794172|FG000|Overall Study|Disease progression - clinical|3|||
146899092|NCT02601950|529794173|FG001|Overall Study|Disease progression - clinical|5|||
146899093|NCT02601950|529794174|FG002|Overall Study|Disease progression - clinical|4|||
146899094|NCT02601950|529794175|FG003|Overall Study|Disease progression - clinical|2|||
146899095|NCT02601950|529794176|FG004|Overall Study|Disease progression - clinical|6|||
146899096|NCT02601950|529794177|FG005|Overall Study|Disease progression - clinical|6|||
146899097|NCT02601950|529794178|FG006|Overall Study|Disease progression - clinical|5|||
146899098|NCT02601950|529794179|FG007|Overall Study|Disease progression - clinical|1|||
146899099|NCT02601950|529794172|FG000|Overall Study|Death|6|||
146899100|NCT02601950|529794173|FG001|Overall Study|Death|0|||
146899101|NCT02601950|529794174|FG002|Overall Study|Death|3|||
146899102|NCT02601950|529794175|FG003|Overall Study|Death|1|||
146899103|NCT02601950|529794176|FG004|Overall Study|Death|4|||
146899104|NCT02601950|529794177|FG005|Overall Study|Death|1|||
146899105|NCT02601950|529794178|FG006|Overall Study|Death|0|||
146899106|NCT02601950|529794179|FG007|Overall Study|Death|0|||
146899107|NCT02601950|529794172|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
146899108|NCT02601950|529794173|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
146899109|NCT02601950|529794174|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
146899110|NCT02601950|529794175|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
146899111|NCT02601950|529794176|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
146899112|NCT02601950|529794177|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
146559664|NCT05305651|528559394|FG000|Overall Study|Lost to Follow-up|4|||
146559665|NCT00526799|528559395|FG000|Overall Study|Withdrawal by Subject|1|||
146559666|NCT00526799|528559396|FG001|Overall Study|Withdrawal by Subject|0|||
146559667|NCT00526799|528559395|FG000|Overall Study|Intercurrent Complicating Disease|0|||
146559668|NCT00526799|528559396|FG001|Overall Study|Intercurrent Complicating Disease|1|||
146559669|NCT00522379|528559399|FG000|Overall Study|Adverse Event|12|||
146559670|NCT00522379|528559400|FG001|Overall Study|Adverse Event|15|||
146559671|NCT00522379|528559401|FG002|Overall Study|Adverse Event|12|||
146559672|NCT00522379|528559402|FG003|Overall Study|Adverse Event|5|||
146559673|NCT00522379|528559403|FG004|Overall Study|Adverse Event|17|||
146559674|NCT00522379|528559399|FG000|Overall Study|Lack of Efficacy|3|||
146559675|NCT00522379|528559400|FG001|Overall Study|Lack of Efficacy|0|||
146559676|NCT00522379|528559401|FG002|Overall Study|Lack of Efficacy|2|||
146559677|NCT00522379|528559402|FG003|Overall Study|Lack of Efficacy|2|||
146559678|NCT00522379|528559403|FG004|Overall Study|Lack of Efficacy|7|||
146899113|NCT02601950|529794178|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
146899114|NCT02601950|529794179|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
146899115|NCT02601950|529794172|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
146899116|NCT02601950|529794173|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
146899117|NCT02601950|529794174|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
146899118|NCT02601950|529794175|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
146899119|NCT02601950|529794176|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
146899120|NCT02601950|529794177|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
146899121|NCT02601950|529794178|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
146899122|NCT02601950|529794179|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
146899123|NCT02601950|529794172|FG000|Overall Study|Non-compliance|0|||
146899124|NCT02601950|529794173|FG001|Overall Study|Non-compliance|1|||
146899125|NCT02601950|529794174|FG002|Overall Study|Non-compliance|0|||
146899126|NCT02601950|529794175|FG003|Overall Study|Non-compliance|0|||
146899127|NCT02601950|529794176|FG004|Overall Study|Non-compliance|0|||
146899128|NCT02601950|529794177|FG005|Overall Study|Non-compliance|1|||
146899129|NCT02601950|529794178|FG006|Overall Study|Non-compliance|1|||
146899130|NCT02601950|529794179|FG007|Overall Study|Non-compliance|0|||
146899131|NCT02601950|529794172|FG000|Overall Study|Participant refused further study treatment|0|||
146899132|NCT02601950|529794173|FG001|Overall Study|Participant refused further study treatment|1|||
146899133|NCT02601950|529794174|FG002|Overall Study|Participant refused further study treatment|1|||
146899134|NCT02601950|529794175|FG003|Overall Study|Participant refused further study treatment|0|||
146899135|NCT02601950|529794176|FG004|Overall Study|Participant refused further study treatment|2|||
146899136|NCT02601950|529794177|FG005|Overall Study|Participant refused further study treatment|2|||
146899137|NCT02601950|529794178|FG006|Overall Study|Participant refused further study treatment|2|||
146899138|NCT02601950|529794179|FG007|Overall Study|Participant refused further study treatment|1|||
146899139|NCT02601950|529794172|FG000|Overall Study|Investigator discretion|1|||
146899140|NCT02601950|529794173|FG001|Overall Study|Investigator discretion|0|||
146899141|NCT02601950|529794174|FG002|Overall Study|Investigator discretion|1|||
146899142|NCT02601950|529794175|FG003|Overall Study|Investigator discretion|0|||
146899143|NCT02601950|529794176|FG004|Overall Study|Investigator discretion|1|||
146899144|NCT02601950|529794177|FG005|Overall Study|Investigator discretion|1|||
146899145|NCT02601950|529794178|FG006|Overall Study|Investigator discretion|1|||
146899146|NCT02601950|529794179|FG007|Overall Study|Investigator discretion|0|||
146899147|NCT02601950|529794172|FG000|Overall Study|Other|0|||
146559679|NCT00522379|528559399|FG000|Overall Study|Withdrawal by Subject|2|||
146559680|NCT00522379|528559400|FG001|Overall Study|Withdrawal by Subject|3|||
146640382|NCT00223080|528859236|FG001|Overall Study|Other|11|||
146899148|NCT02601950|529794173|FG001|Overall Study|Other|0|||
146899149|NCT02601950|529794174|FG002|Overall Study|Other|0|||
146899150|NCT02601950|529794175|FG003|Overall Study|Other|0|||
146559681|NCT00522379|528559401|FG002|Overall Study|Withdrawal by Subject|1|||
146559682|NCT00522379|528559402|FG003|Overall Study|Withdrawal by Subject|2|||
146899151|NCT02601950|529794176|FG004|Overall Study|Other|2|||
146899152|NCT02601950|529794177|FG005|Overall Study|Other|2|||
146899153|NCT02601950|529794178|FG006|Overall Study|Other|1|||
146899154|NCT02601950|529794179|FG007|Overall Study|Other|0|||
146899155|NCT05113940|529794180|FG000|Part A (18 Days)|Adverse Event|0|||
146899156|NCT05113940|529794181|FG001|Part A (18 Days)|Adverse Event|0|||
146899157|NCT05113940|529794182|FG002|Part A (18 Days)|Adverse Event|1|||
146899158|NCT05113940|529794183|FG003|Part A (18 Days)|Adverse Event|1|||
146899159|NCT05113940|529794184|FG004|Part A (18 Days)|Adverse Event|1|||
146899160|NCT05113940|529794185|FG005|Part A (18 Days)|Adverse Event|0|||
146899161|NCT05113940|529794186|FG006|Part A (18 Days)|Adverse Event|0|||
146899162|NCT05113940|529794187|FG007|Part A (18 Days)|Adverse Event|0|||
146899163|NCT05113940|529794188|FG008|Part A (18 Days)|Adverse Event|0|||
146899164|NCT05113940|529794189|FG009|Part A (18 Days)|Adverse Event|0|||
146899165|NCT05113940|529794190|FG010|Part A (18 Days)|Adverse Event|0|||
146899166|NCT05113940|529794191|FG011|Part A (18 Days)|Adverse Event|2|||
146899167|NCT05113940|529794192|FG012|Part A (18 Days)|Adverse Event|0|||
146899168|NCT05113940|529794193|FG013|Part A (18 Days)|Adverse Event|0|||
146899169|NCT05113940|529794194|FG014|Part A (18 Days)|Adverse Event|0|||
146899170|NCT05113940|529794180|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
146899171|NCT05113940|529794181|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
146899172|NCT05113940|529794182|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
146899173|NCT05113940|529794183|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
146899174|NCT05113940|529794184|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
146899175|NCT05113940|529794185|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
146899176|NCT05113940|529794186|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
146899177|NCT05113940|529794187|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
146899178|NCT05113940|529794188|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
146899179|NCT05113940|529794189|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
146899180|NCT05113940|529794190|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
146899181|NCT05113940|529794191|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
146899182|NCT05113940|529794192|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
146899183|NCT05113940|529794193|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
146899184|NCT05113940|529794194|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
146899185|NCT01147926|529794197|FG000|Overall Study|Subject Withdrew Consent|9|||
146899186|NCT01147926|529794198|FG001|Overall Study|Subject Withdrew Consent|10|||
146899187|NCT01147926|529794197|FG000|Overall Study|Adverse Event|7|||
146899188|NCT01147926|529794198|FG001|Overall Study|Adverse Event|6|||
146899189|NCT01147926|529794197|FG000|Overall Study|Subject Non-Compliant|5|||
146899190|NCT01147926|529794198|FG001|Overall Study|Subject Non-Compliant|4|||
146899191|NCT01147926|529794197|FG000|Overall Study|Principal investigator left hospital|1|||
146899192|NCT01147926|529794198|FG001|Overall Study|Principal investigator left hospital|3|||
146899193|NCT01147926|529794197|FG000|Overall Study|Selection criteria not met|3|||
146899194|NCT01147926|529794198|FG001|Overall Study|Selection criteria not met|1|||
146899195|NCT01147926|529794197|FG000|Overall Study|Lost to Follow-up|0|||
146899196|NCT01147926|529794198|FG001|Overall Study|Lost to Follow-up|2|||
146899197|NCT01147926|529794197|FG000|Overall Study|Sponsor's Decision|0|||
146899198|NCT01147926|529794198|FG001|Overall Study|Sponsor's Decision|1|||
146899199|NCT01147926|529794197|FG000|Overall Study|Lack of Efficacy|1|||
146899200|NCT01147926|529794198|FG001|Overall Study|Lack of Efficacy|0|||
146899201|NCT01147926|529794197|FG000|Overall Study|Too busy, no time for study|1|||
146899202|NCT01147926|529794198|FG001|Overall Study|Too busy, no time for study|0|||
146899203|NCT01147926|529794197|FG000|Overall Study|Went on holiday|0|||
146899204|NCT01147926|529794198|FG001|Overall Study|Went on holiday|1|||
146899205|NCT01147926|529794197|FG000|Overall Study|Colonoscopy result|0|||
146899206|NCT01147926|529794198|FG001|Overall Study|Colonoscopy result|1|||
146899207|NCT02013544|529794200|FG000|Overall Study|Adverse Event|5|||
146899208|NCT02013544|529794201|FG001|Overall Study|Adverse Event|5|||
146899209|NCT02013544|529794200|FG000|Overall Study|Lost to Follow-up|2|||
146899210|NCT02013544|529794201|FG001|Overall Study|Lost to Follow-up|3|||
146899211|NCT02013544|529794200|FG000|Overall Study|Withdrawal by Subject|2|||
146899212|NCT02013544|529794201|FG001|Overall Study|Withdrawal by Subject|8|||
146899213|NCT02013544|529794200|FG000|Overall Study|Physician Decision|0|||
146899214|NCT02013544|529794201|FG001|Overall Study|Physician Decision|1|||
146899215|NCT02013544|529794200|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
146899216|NCT02013544|529794201|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
146899217|NCT03514914|529794202|FG000|Overall Study|Death|3|||
146899218|NCT03514914|529794203|FG001|Overall Study|Death|3|||
146899219|NCT03514914|529794202|FG000|Overall Study|Lost to Follow-up|117|||
146899220|NCT03514914|529794203|FG001|Overall Study|Lost to Follow-up|89|||
146899221|NCT00826514|529794204|FG000|Overall Study|Adverse Event|1|||
146899222|NCT00826514|529794205|FG001|Overall Study|Adverse Event|1|||
146899223|NCT00826514|529794204|FG000|Overall Study|Lack of Efficacy|0|||
146899224|NCT00826514|529794205|FG001|Overall Study|Lack of Efficacy|1|||
146899225|NCT00826514|529794204|FG000|Overall Study|Withdrawal by Subject|2|||
146899226|NCT00826514|529794205|FG001|Overall Study|Withdrawal by Subject|3|||
146899227|NCT01276288|529794211|FG000|Overall Study|Adverse Event|1|||
146899228|NCT01276288|529794212|FG001|Overall Study|Adverse Event|1|||
146899229|NCT01276288|529794213|FG002|Overall Study|Adverse Event|0|||
146899230|NCT01276288|529794214|FG003|Overall Study|Adverse Event|0|||
146899231|NCT01276288|529794211|FG000|Overall Study|not treated|1|||
146899232|NCT01276288|529794212|FG001|Overall Study|not treated|0|||
146969176|NCT00568776|530047339|FG000|Overall Study|Lack of Efficacy|2|||
146969177|NCT00568776|530047340|FG001|Overall Study|Lack of Efficacy|2|||
146969178|NCT00568776|530047341|FG002|Overall Study|Lack of Efficacy|2|||
146969179|NCT00568776|530047342|FG003|Overall Study|Lack of Efficacy|4|||
146969180|NCT00568776|530047339|FG000|Overall Study|Lost to Follow-up|1|||
146969181|NCT00568776|530047340|FG001|Overall Study|Lost to Follow-up|1|||
146969182|NCT00568776|530047341|FG002|Overall Study|Lost to Follow-up|1|||
146969183|NCT00568776|530047342|FG003|Overall Study|Lost to Follow-up|1|||
146969184|NCT00568776|530047339|FG000|Overall Study|Protocol Violation|1|||
146969185|NCT00568776|530047340|FG001|Overall Study|Protocol Violation|0|||
146969186|NCT00568776|530047341|FG002|Overall Study|Protocol Violation|1|||
146969187|NCT00568776|530047342|FG003|Overall Study|Protocol Violation|1|||
146969188|NCT00568776|530047339|FG000|Overall Study|Withdrawal by Subject|13|||
146969189|NCT00568776|530047340|FG001|Overall Study|Withdrawal by Subject|15|||
146969190|NCT00568776|530047341|FG002|Overall Study|Withdrawal by Subject|13|||
146969191|NCT00568776|530047342|FG003|Overall Study|Withdrawal by Subject|7|||
146969192|NCT00568776|530047339|FG000|Overall Study|Loss of Caregiver|0|||
146969193|NCT00568776|530047340|FG001|Overall Study|Loss of Caregiver|2|||
146969194|NCT00568776|530047341|FG002|Overall Study|Loss of Caregiver|1|||
146969195|NCT00568776|530047342|FG003|Overall Study|Loss of Caregiver|2|||
146969196|NCT00568776|530047339|FG000|Overall Study|Sponsor Decision|2|||
146969197|NCT00568776|530047340|FG001|Overall Study|Sponsor Decision|2|||
146969198|NCT00568776|530047341|FG002|Overall Study|Sponsor Decision|41|||
146969199|NCT00568776|530047342|FG003|Overall Study|Sponsor Decision|42|||
146969200|NCT00568776|530047339|FG000|Overall Study|Miscellaeneous|3|||
146969201|NCT00568776|530047340|FG001|Overall Study|Miscellaeneous|3|||
146969202|NCT00568776|530047341|FG002|Overall Study|Miscellaeneous|1|||
146969203|NCT00568776|530047342|FG003|Overall Study|Miscellaeneous|4|||
146969204|NCT01005680|530047343|FG000|Overall Study|Lost to Follow-up|4|||
146969205|NCT01005680|530047344|FG001|Overall Study|Lost to Follow-up|6|||
146969206|NCT01005680|530047343|FG000|Overall Study|Withdrawal by Subject|1|||
146969207|NCT01005680|530047344|FG001|Overall Study|Withdrawal by Subject|4|||
146969208|NCT01005680|530047343|FG000|Overall Study|Physician Decision|1|||
146969209|NCT01005680|530047344|FG001|Overall Study|Physician Decision|1|||
146969210|NCT00539006|530047357|FG000|Pre-treatment|Other|0|||
146969211|NCT00539006|530047358|FG001|Pre-treatment|Other|1|||
146969212|NCT00539006|530047359|FG002|Pre-treatment|Other|0|||
146969213|NCT00539006|530047360|FG003|Pre-treatment|Other|0|||
146969214|NCT00539006|530047357|FG000|Treatment Period 1|Lost to Follow-up|0|||
146969215|NCT00539006|530047358|FG001|Treatment Period 1|Lost to Follow-up|0|||
146969216|NCT00539006|530047359|FG002|Treatment Period 1|Lost to Follow-up|1|||
146969217|NCT00539006|530047360|FG003|Treatment Period 1|Lost to Follow-up|0|||
146969218|NCT00539006|530047357|FG000|Treatment Period 1|Protocol Violation|0|||
146969219|NCT00539006|530047358|FG001|Treatment Period 1|Protocol Violation|0|||
146969220|NCT00539006|530047359|FG002|Treatment Period 1|Protocol Violation|1|||
146969221|NCT00539006|530047360|FG003|Treatment Period 1|Protocol Violation|0|||
146969222|NCT00539006|530047357|FG000|Treatment Period 1|Lack of Efficacy|0|||
146899233|NCT01276288|529794213|FG002|Overall Study|not treated|0|||
146899234|NCT01276288|529794214|FG003|Overall Study|not treated|0|||
146899235|NCT00629083|529794219|FG000|Overall Study|Adverse Event|0|||
146899236|NCT00629083|529794220|FG001|Overall Study|Adverse Event|2|||
146899237|NCT00629083|529794219|FG000|Overall Study|Lack of Efficacy|3|||
146899238|NCT00629083|529794220|FG001|Overall Study|Lack of Efficacy|1|||
146899239|NCT00629083|529794219|FG000|Overall Study|Withdrawal by Subject|10|||
146899240|NCT00629083|529794220|FG001|Overall Study|Withdrawal by Subject|2|||
146899241|NCT00629083|529794219|FG000|Overall Study|Lost to Follow-up|12|||
146899242|NCT00629083|529794220|FG001|Overall Study|Lost to Follow-up|8|||
146899243|NCT00629083|529794219|FG000|Overall Study|Moved out of country/state|2|||
146899244|NCT00629083|529794220|FG001|Overall Study|Moved out of country/state|1|||
146899245|NCT00629083|529794219|FG000|Overall Study|Refused to return for 12 month visit|1|||
146969223|NCT00539006|530047358|FG001|Treatment Period 1|Lack of Efficacy|0|||
146969224|NCT00539006|530047359|FG002|Treatment Period 1|Lack of Efficacy|0|||
146969225|NCT00539006|530047360|FG003|Treatment Period 1|Lack of Efficacy|1|||
146969226|NCT00539006|530047357|FG000|Washout|Adverse Event|2|||
146969227|NCT00539006|530047358|FG001|Washout|Adverse Event|1|||
146969228|NCT00539006|530047359|FG002|Washout|Adverse Event|0|||
146969229|NCT00539006|530047360|FG003|Washout|Adverse Event|0|||
146969230|NCT00539006|530047357|FG000|Washout|Protocol Violation|1|||
146969231|NCT00539006|530047358|FG001|Washout|Protocol Violation|1|||
146969232|NCT00539006|530047359|FG002|Washout|Protocol Violation|0|||
146969233|NCT00539006|530047360|FG003|Washout|Protocol Violation|0|||
146969234|NCT00539006|530047357|FG000|Washout|Withdrawal by Subject|0|||
146969235|NCT00539006|530047358|FG001|Washout|Withdrawal by Subject|2|||
146969236|NCT00539006|530047359|FG002|Washout|Withdrawal by Subject|0|||
146899246|NCT00629083|529794220|FG001|Overall Study|Refused to return for 12 month visit|0|||
146899247|NCT01193686|529794221|FG000|Overall Study|Withdrawal by Subject|4|||
146899248|NCT01193686|529794222|FG001|Overall Study|Withdrawal by Subject|1|||
146899249|NCT01193686|529794221|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
146899250|NCT01193686|529794222|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
146899251|NCT03401749|529794223|FG000|Overall Study|Lost to Follow-up|20|||
146899252|NCT03401749|529794224|FG001|Overall Study|Lost to Follow-up|16|||
146899253|NCT03401749|529794225|FG002|Overall Study|Lost to Follow-up|26|||
146899254|NCT03406962|529794228|FG000|Overall Study|Death|2|||
146899255|NCT03406962|529794228|FG000|Overall Study|Adverse Event|1|||
146899256|NCT03853694|529794229|FG000|Overall Study|Protocol Violation|3|||
146899257|NCT03853694|529794230|FG001|Overall Study|Protocol Violation|5|||
146899258|NCT03853694|529794231|FG002|Overall Study|Protocol Violation|3|||
146899259|NCT03853694|529794229|FG000|Overall Study|Delivered early|0|||
146899260|NCT03853694|529794230|FG001|Overall Study|Delivered early|1|||
146899261|NCT03853694|529794231|FG002|Overall Study|Delivered early|0|||
146899262|NCT03853694|529794229|FG000|Overall Study|not suitable to proceed|0|||
146899263|NCT03853694|529794230|FG001|Overall Study|not suitable to proceed|1|||
146899264|NCT03853694|529794231|FG002|Overall Study|not suitable to proceed|0|||
146899265|NCT03853694|529794229|FG000|Overall Study|difficult surgery|0|||
146899266|NCT03853694|529794230|FG001|Overall Study|difficult surgery|0|||
146899267|NCT03853694|529794231|FG002|Overall Study|difficult surgery|1|||
146899268|NCT03853694|529794229|FG000|Overall Study|Lost to Follow-up|0|||
146899269|NCT03853694|529794230|FG001|Overall Study|Lost to Follow-up|1|||
146899270|NCT03853694|529794231|FG002|Overall Study|Lost to Follow-up|0|||
146899271|NCT03853694|529794229|FG000|Overall Study|Withdrawal by Subject|0|||
146899272|NCT03853694|529794230|FG001|Overall Study|Withdrawal by Subject|1|||
146899273|NCT03853694|529794231|FG002|Overall Study|Withdrawal by Subject|0|||
146899274|NCT02209766|529794232|FG000|Overall Study|Withdrawal by Subject|0|||
146899275|NCT02209766|529794233|FG001|Overall Study|Withdrawal by Subject|0|||
146899276|NCT02209766|529794234|FG002|Overall Study|Withdrawal by Subject|0|||
146899277|NCT02209766|529794235|FG003|Overall Study|Withdrawal by Subject|1|||
146899278|NCT02209766|529794236|FG004|Overall Study|Withdrawal by Subject|0|||
146899279|NCT03896295|529794237|FG000|Overall Study|Adverse Event|0|||
146899280|NCT03896295|529794238|FG001|Overall Study|Adverse Event|1|||
146899281|NCT03896295|529794237|FG000|Overall Study|COVID-19|7|||
146899282|NCT03896295|529794238|FG001|Overall Study|COVID-19|29|||
146899283|NCT03029832|529794239|FG000|Overall Study|Safety Follow-Up Completed|2|||
146899284|NCT03029832|529794240|FG001|Overall Study|Safety Follow-Up Completed|0|||
146899285|NCT03029832|529794239|FG000|Overall Study|Death due to Disease Progression|1|||
146899286|NCT03029832|529794240|FG001|Overall Study|Death due to Disease Progression|0|||
146899287|NCT03029832|529794239|FG000|Overall Study|Study Terminated By Sponsor|1|||
146899288|NCT03029832|529794240|FG001|Overall Study|Study Terminated By Sponsor|1|||
146899289|NCT01412229|529794241|FG000|Overall Study|Physician Decision|1|||
146899290|NCT00700804|529794244|FG000|Overall Study|Withdrawal by Subject|1|||
146899291|NCT00700804|529794245|FG001|Overall Study|Withdrawal by Subject|2|||
146899292|NCT00700804|529794244|FG000|Overall Study|Protocol Violation|1|||
146899293|NCT00700804|529794245|FG001|Overall Study|Protocol Violation|1|||
146899294|NCT00700804|529794244|FG000|Overall Study|Loose Stools|1|||
146899295|NCT00700804|529794245|FG001|Overall Study|Loose Stools|1|||
146899296|NCT02901431|529794246|FG000|PK Part|Adverse Event|0|||
146899297|NCT02901431|529794247|FG001|PK Part|Adverse Event|1|||
146899298|NCT02901431|529794248|FG002|PK Part|Adverse Event|0|||
146899299|NCT02901431|529794249|FG003|PK Part|Adverse Event|0|||
146559683|NCT00522379|528559403|FG004|Overall Study|Withdrawal by Subject|0|||
146559684|NCT00522379|528559399|FG000|Overall Study|Protocol Violation|1|||
146559685|NCT00522379|528559400|FG001|Overall Study|Protocol Violation|1|||
146559686|NCT00522379|528559401|FG002|Overall Study|Protocol Violation|2|||
146559687|NCT00522379|528559402|FG003|Overall Study|Protocol Violation|0|||
146559688|NCT00522379|528559403|FG004|Overall Study|Protocol Violation|0|||
146559689|NCT00522379|528559399|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
146559690|NCT00522379|528559400|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
146559691|NCT00522379|528559401|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
146559692|NCT00522379|528559402|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
146559693|NCT00522379|528559403|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
146559694|NCT00522379|528559399|FG000|Overall Study|Lost to Follow-up|1|||
146559695|NCT00522379|528559400|FG001|Overall Study|Lost to Follow-up|0|||
146559696|NCT00522379|528559401|FG002|Overall Study|Lost to Follow-up|4|||
146899300|NCT02901431|529794250|FG004|PK Part|Adverse Event|0|||
146899301|NCT02901431|529794251|FG005|PK Part|Adverse Event|0|||
146559697|NCT00522379|528559402|FG003|Overall Study|Lost to Follow-up|2|||
146640383|NCT00223080|528859235|FG000|Overall Study|Reason not provided|141|||
146640384|NCT00223080|528859236|FG001|Overall Study|Reason not provided|140|||
146899302|NCT02901431|529794252|FG006|PK Part|Adverse Event|0|||
146899303|NCT02901431|529794253|FG007|PK Part|Adverse Event|0|||
146899304|NCT02901431|529794254|FG008|PK Part|Adverse Event|0|||
146899305|NCT02901431|529794255|FG009|PK Part|Adverse Event|0|||
146899306|NCT02901431|529794256|FG010|PK Part|Adverse Event|0|||
146899307|NCT02901431|529794257|FG011|PK Part|Adverse Event|0|||
146899308|NCT02901431|529794258|FG012|PK Part|Adverse Event|0|||
146899309|NCT02901431|529794246|FG000|PK Part|Lost to Follow-up|0|||
146899310|NCT02901431|529794247|FG001|PK Part|Lost to Follow-up|0|||
146899311|NCT02901431|529794248|FG002|PK Part|Lost to Follow-up|1|||
146899312|NCT02901431|529794249|FG003|PK Part|Lost to Follow-up|0|||
146640385|NCT00223080|528859235|FG000|Overall Study|Adverse Event|0|||
146640386|NCT00223080|528859236|FG001|Overall Study|Adverse Event|1|||
146640387|NCT02598583|528859237|FG000|Extension Period|Withdrawal by Subject|1|||
146640388|NCT02598583|528859238|FG001|Extension Period|Withdrawal by Subject|0|||
146640389|NCT00947882|528859246|FG000|Overall Study|Adverse Event|0|||
146640390|NCT00947882|528859247|FG001|Overall Study|Adverse Event|1|||
146640391|NCT00947882|528859248|FG002|Overall Study|Adverse Event|4|||
146640392|NCT00947882|528859249|FG003|Overall Study|Adverse Event|4|||
146640393|NCT00947882|528859246|FG000|Overall Study|Withdrawal by Subject|2|||
146640394|NCT00947882|528859247|FG001|Overall Study|Withdrawal by Subject|0|||
146640395|NCT00947882|528859248|FG002|Overall Study|Withdrawal by Subject|8|||
146640396|NCT00947882|528859249|FG003|Overall Study|Withdrawal by Subject|2|||
146640397|NCT00947882|528859246|FG000|Overall Study|Protocol Violation|0|||
146640398|NCT00947882|528859247|FG001|Overall Study|Protocol Violation|0|||
146640399|NCT00947882|528859248|FG002|Overall Study|Protocol Violation|1|||
146640400|NCT00947882|528859249|FG003|Overall Study|Protocol Violation|0|||
146640401|NCT00947882|528859246|FG000|Overall Study|Lost to Follow-up|0|||
146640402|NCT00947882|528859247|FG001|Overall Study|Lost to Follow-up|2|||
146640403|NCT00947882|528859248|FG002|Overall Study|Lost to Follow-up|1|||
146640404|NCT00947882|528859249|FG003|Overall Study|Lost to Follow-up|0|||
146640405|NCT00947882|528859246|FG000|Overall Study|Other/Unknown|10|||
146640406|NCT00947882|528859247|FG001|Overall Study|Other/Unknown|13|||
146640407|NCT00947882|528859248|FG002|Overall Study|Other/Unknown|3|||
146640408|NCT00947882|528859249|FG003|Overall Study|Other/Unknown|6|||
146640409|NCT00947882|528859246|FG000|Overall Study|Trial Terminated by Sponsor|62|||
146899313|NCT02901431|529794250|FG004|PK Part|Lost to Follow-up|0|||
146899314|NCT02901431|529794251|FG005|PK Part|Lost to Follow-up|0|||
146899315|NCT02901431|529794252|FG006|PK Part|Lost to Follow-up|0|||
146899316|NCT02901431|529794253|FG007|PK Part|Lost to Follow-up|0|||
146899317|NCT02901431|529794254|FG008|PK Part|Lost to Follow-up|0|||
146899318|NCT02901431|529794255|FG009|PK Part|Lost to Follow-up|0|||
146899319|NCT02901431|529794256|FG010|PK Part|Lost to Follow-up|0|||
146899320|NCT02901431|529794257|FG011|PK Part|Lost to Follow-up|0|||
146899321|NCT02901431|529794258|FG012|PK Part|Lost to Follow-up|0|||
146899322|NCT02901431|529794246|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
146899323|NCT02901431|529794247|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146899324|NCT02901431|529794248|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146899325|NCT02901431|529794249|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146899326|NCT02901431|529794250|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146899327|NCT02901431|529794251|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146899328|NCT02901431|529794252|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146899329|NCT02901431|529794253|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146899330|NCT02901431|529794254|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146899331|NCT02901431|529794255|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146899332|NCT02901431|529794256|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146899333|NCT02901431|529794257|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146899334|NCT02901431|529794258|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146899335|NCT02901431|529794246|FG000|PK Part|Pending dose confirmation|0|||
146899336|NCT02901431|529794247|FG001|PK Part|Pending dose confirmation|1|||
146899337|NCT02901431|529794248|FG002|PK Part|Pending dose confirmation|0|||
146899338|NCT02901431|529794249|FG003|PK Part|Pending dose confirmation|0|||
146899339|NCT02901431|529794250|FG004|PK Part|Pending dose confirmation|0|||
146899340|NCT02901431|529794251|FG005|PK Part|Pending dose confirmation|0|||
146640410|NCT00947882|528859247|FG001|Overall Study|Trial Terminated by Sponsor|61|||
146640411|NCT00947882|528859248|FG002|Overall Study|Trial Terminated by Sponsor|62|||
146640412|NCT00947882|528859249|FG003|Overall Study|Trial Terminated by Sponsor|70|||
146899341|NCT02901431|529794252|FG006|PK Part|Pending dose confirmation|0|||
146899342|NCT02901431|529794253|FG007|PK Part|Pending dose confirmation|0|||
146899343|NCT02901431|529794254|FG008|PK Part|Pending dose confirmation|0|||
146899344|NCT02901431|529794255|FG009|PK Part|Pending dose confirmation|0|||
146899345|NCT02901431|529794256|FG010|PK Part|Pending dose confirmation|0|||
146899346|NCT02901431|529794257|FG011|PK Part|Pending dose confirmation|0|||
146899347|NCT02901431|529794258|FG012|PK Part|Pending dose confirmation|0|||
146899348|NCT02901431|529794246|FG000|PK Part|8 weeks of treatment ran out|2|||
146640413|NCT01262820|528859250|FG000|Overall Study|Adverse Event|5|||
146640414|NCT01262820|528859250|FG000|Overall Study|Lack of Efficacy|9|||
146899349|NCT02901431|529794247|FG001|PK Part|8 weeks of treatment ran out|0|||
146899350|NCT02901431|529794248|FG002|PK Part|8 weeks of treatment ran out|0|||
146899351|NCT02901431|529794249|FG003|PK Part|8 weeks of treatment ran out|0|||
146899352|NCT02901431|529794250|FG004|PK Part|8 weeks of treatment ran out|0|||
146899353|NCT02901431|529794251|FG005|PK Part|8 weeks of treatment ran out|0|||
146899354|NCT02901431|529794252|FG006|PK Part|8 weeks of treatment ran out|0|||
146899355|NCT02901431|529794253|FG007|PK Part|8 weeks of treatment ran out|0|||
146899356|NCT02901431|529794254|FG008|PK Part|8 weeks of treatment ran out|0|||
146899357|NCT02901431|529794255|FG009|PK Part|8 weeks of treatment ran out|0|||
146640415|NCT01262820|528859250|FG000|Overall Study|Drug held for 21+ days|1|||
146640416|NCT00452361|528859251|FG000|Overall Study|Adverse Event|8|||
146899358|NCT02901431|529794256|FG010|PK Part|8 weeks of treatment ran out|0|||
146640417|NCT00452361|528859252|FG001|Overall Study|Adverse Event|0|||
146640418|NCT00452361|528859251|FG000|Overall Study|Withdrawal by Subject|0|||
146640419|NCT00452361|528859252|FG001|Overall Study|Withdrawal by Subject|1|||
146640420|NCT00452361|528859251|FG000|Overall Study|Premature termination|13|||
146640421|NCT00452361|528859252|FG001|Overall Study|Premature termination|9|||
146640422|NCT05188053|528859253|FG000|Overall Study|Lost to Follow-up|23|||
146640423|NCT05188053|528859254|FG001|Overall Study|Lost to Follow-up|30|||
146640424|NCT05188053|528859253|FG000|Overall Study|Protocol Violation|16|||
146640425|NCT05188053|528859254|FG001|Overall Study|Protocol Violation|16|||
146640426|NCT05188053|528859253|FG000|Overall Study|Physician Decision|3|||
146640427|NCT05188053|528859254|FG001|Overall Study|Physician Decision|0|||
146640428|NCT05188053|528859253|FG000|Overall Study|Withdrawal by Subject|0|||
146640429|NCT05188053|528859254|FG001|Overall Study|Withdrawal by Subject|1|||
146899359|NCT02901431|529794257|FG011|PK Part|8 weeks of treatment ran out|0|||
146899360|NCT02901431|529794258|FG012|PK Part|8 weeks of treatment ran out|0|||
146899361|NCT02901431|529794246|FG000|PK Part|Stopped treatment after 8 weeks|1|||
146899362|NCT02901431|529794247|FG001|PK Part|Stopped treatment after 8 weeks|0|||
146899363|NCT02901431|529794248|FG002|PK Part|Stopped treatment after 8 weeks|1|||
146899364|NCT02901431|529794249|FG003|PK Part|Stopped treatment after 8 weeks|0|||
146899365|NCT02901431|529794250|FG004|PK Part|Stopped treatment after 8 weeks|0|||
146899366|NCT02901431|529794251|FG005|PK Part|Stopped treatment after 8 weeks|0|||
146899367|NCT02901431|529794252|FG006|PK Part|Stopped treatment after 8 weeks|0|||
146899368|NCT02901431|529794253|FG007|PK Part|Stopped treatment after 8 weeks|0|||
146899369|NCT02901431|529794254|FG008|PK Part|Stopped treatment after 8 weeks|0|||
146899370|NCT02901431|529794255|FG009|PK Part|Stopped treatment after 8 weeks|0|||
146899371|NCT02901431|529794256|FG010|PK Part|Stopped treatment after 8 weeks|0|||
146899372|NCT02901431|529794257|FG011|PK Part|Stopped treatment after 8 weeks|0|||
146899373|NCT02901431|529794258|FG012|PK Part|Stopped treatment after 8 weeks|0|||
146899374|NCT02901431|529794246|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
146899375|NCT02901431|529794247|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146899376|NCT02901431|529794248|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
146899377|NCT02901431|529794249|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146899378|NCT02901431|529794250|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146899379|NCT02901431|529794251|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146899380|NCT02901431|529794252|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146899381|NCT02901431|529794253|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146899382|NCT02901431|529794254|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146899383|NCT02901431|529794255|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146899384|NCT02901431|529794256|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146899385|NCT02901431|529794257|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146899386|NCT02901431|529794258|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146899387|NCT02901431|529794246|FG000|PK Part|Discontinued per Sponsor|0|||
146899388|NCT02901431|529794247|FG001|PK Part|Discontinued per Sponsor|3|||
146899389|NCT02901431|529794248|FG002|PK Part|Discontinued per Sponsor|0|||
146899390|NCT02901431|529794249|FG003|PK Part|Discontinued per Sponsor|0|||
146899391|NCT02901431|529794250|FG004|PK Part|Discontinued per Sponsor|0|||
146899392|NCT02901431|529794251|FG005|PK Part|Discontinued per Sponsor|0|||
146899393|NCT02901431|529794252|FG006|PK Part|Discontinued per Sponsor|0|||
146899394|NCT02901431|529794253|FG007|PK Part|Discontinued per Sponsor|0|||
146899395|NCT02901431|529794254|FG008|PK Part|Discontinued per Sponsor|0|||
146899396|NCT02901431|529794255|FG009|PK Part|Discontinued per Sponsor|0|||
146899397|NCT02901431|529794256|FG010|PK Part|Discontinued per Sponsor|0|||
146899398|NCT02901431|529794257|FG011|PK Part|Discontinued per Sponsor|0|||
146899399|NCT02901431|529794258|FG012|PK Part|Discontinued per Sponsor|0|||
146899400|NCT02901431|529794246|FG000|PK Part|Withdrawal by Subject|1|||
146899401|NCT02901431|529794247|FG001|PK Part|Withdrawal by Subject|1|||
146899402|NCT02901431|529794248|FG002|PK Part|Withdrawal by Subject|3|||
146899403|NCT02901431|529794249|FG003|PK Part|Withdrawal by Subject|0|||
146899404|NCT02901431|529794250|FG004|PK Part|Withdrawal by Subject|0|||
146899405|NCT02901431|529794251|FG005|PK Part|Withdrawal by Subject|0|||
146899406|NCT02901431|529794252|FG006|PK Part|Withdrawal by Subject|0|||
146899407|NCT02901431|529794253|FG007|PK Part|Withdrawal by Subject|0|||
146899408|NCT02901431|529794254|FG008|PK Part|Withdrawal by Subject|0|||
146899409|NCT02901431|529794255|FG009|PK Part|Withdrawal by Subject|0|||
146899410|NCT02901431|529794256|FG010|PK Part|Withdrawal by Subject|0|||
146899411|NCT02901431|529794257|FG011|PK Part|Withdrawal by Subject|0|||
146899412|NCT02901431|529794258|FG012|PK Part|Withdrawal by Subject|0|||
146899413|NCT02901431|529794246|FG000|Main Treatment Part|Adverse Event|0|||
146899414|NCT02901431|529794247|FG001|Main Treatment Part|Adverse Event|0|||
146899415|NCT02901431|529794248|FG002|Main Treatment Part|Adverse Event|0|||
146899416|NCT02901431|529794249|FG003|Main Treatment Part|Adverse Event|3|||
146899417|NCT02901431|529794250|FG004|Main Treatment Part|Adverse Event|3|||
146899418|NCT02901431|529794251|FG005|Main Treatment Part|Adverse Event|4|||
146899419|NCT02901431|529794252|FG006|Main Treatment Part|Adverse Event|1|||
146640430|NCT01010867|528859258|FG000|Overall Study|< 50% adherence to probiotic|1|||
146899420|NCT02901431|529794253|FG007|Main Treatment Part|Adverse Event|0|||
146899421|NCT02901431|529794254|FG008|Main Treatment Part|Adverse Event|0|||
146899422|NCT02901431|529794255|FG009|Main Treatment Part|Adverse Event|0|||
146899423|NCT02901431|529794256|FG010|Main Treatment Part|Adverse Event|0|||
146899424|NCT02901431|529794257|FG011|Main Treatment Part|Adverse Event|0|||
146899425|NCT02901431|529794258|FG012|Main Treatment Part|Adverse Event|0|||
146899426|NCT02901431|529794246|FG000|Main Treatment Part|Lack of Efficacy|0|||
146899427|NCT02901431|529794247|FG001|Main Treatment Part|Lack of Efficacy|0|||
146899428|NCT02901431|529794248|FG002|Main Treatment Part|Lack of Efficacy|0|||
146899429|NCT02901431|529794249|FG003|Main Treatment Part|Lack of Efficacy|1|||
146899430|NCT02901431|529794250|FG004|Main Treatment Part|Lack of Efficacy|0|||
146899431|NCT02901431|529794251|FG005|Main Treatment Part|Lack of Efficacy|0|||
146899432|NCT02901431|529794252|FG006|Main Treatment Part|Lack of Efficacy|0|||
146899433|NCT02901431|529794253|FG007|Main Treatment Part|Lack of Efficacy|0|||
146899434|NCT02901431|529794254|FG008|Main Treatment Part|Lack of Efficacy|0|||
146899435|NCT02901431|529794255|FG009|Main Treatment Part|Lack of Efficacy|0|||
146899436|NCT02901431|529794256|FG010|Main Treatment Part|Lack of Efficacy|0|||
146899437|NCT02901431|529794257|FG011|Main Treatment Part|Lack of Efficacy|0|||
146899438|NCT02901431|529794258|FG012|Main Treatment Part|Lack of Efficacy|0|||
146899439|NCT02901431|529794246|FG000|Main Treatment Part|Lost to Follow-up|0|||
146899440|NCT02901431|529794247|FG001|Main Treatment Part|Lost to Follow-up|0|||
146899441|NCT02901431|529794248|FG002|Main Treatment Part|Lost to Follow-up|0|||
146899442|NCT02901431|529794249|FG003|Main Treatment Part|Lost to Follow-up|3|||
146899443|NCT02901431|529794250|FG004|Main Treatment Part|Lost to Follow-up|1|||
146899444|NCT02901431|529794251|FG005|Main Treatment Part|Lost to Follow-up|2|||
146899445|NCT02901431|529794252|FG006|Main Treatment Part|Lost to Follow-up|3|||
146899446|NCT02901431|529794253|FG007|Main Treatment Part|Lost to Follow-up|0|||
146899447|NCT02901431|529794254|FG008|Main Treatment Part|Lost to Follow-up|0|||
146899448|NCT02901431|529794255|FG009|Main Treatment Part|Lost to Follow-up|0|||
146899449|NCT02901431|529794256|FG010|Main Treatment Part|Lost to Follow-up|0|||
146899450|NCT02901431|529794257|FG011|Main Treatment Part|Lost to Follow-up|0|||
146899451|NCT02901431|529794258|FG012|Main Treatment Part|Lost to Follow-up|0|||
146899452|NCT02901431|529794246|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
146899453|NCT02901431|529794247|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
146899454|NCT02901431|529794248|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
146899455|NCT02901431|529794249|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
146899456|NCT02901431|529794250|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
146899457|NCT02901431|529794251|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
146899458|NCT02901431|529794252|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
146899459|NCT02901431|529794253|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
146899460|NCT02901431|529794254|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
146899461|NCT02901431|529794255|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
146899462|NCT02901431|529794256|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
146899463|NCT02901431|529794257|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
146899464|NCT02901431|529794258|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
146899465|NCT02901431|529794246|FG000|Main Treatment Part|Physician Decision|0|||
146899466|NCT02901431|529794247|FG001|Main Treatment Part|Physician Decision|0|||
146899467|NCT02901431|529794248|FG002|Main Treatment Part|Physician Decision|0|||
146899468|NCT02901431|529794249|FG003|Main Treatment Part|Physician Decision|1|||
146899469|NCT02901431|529794250|FG004|Main Treatment Part|Physician Decision|0|||
146899470|NCT02901431|529794251|FG005|Main Treatment Part|Physician Decision|0|||
146899471|NCT02901431|529794252|FG006|Main Treatment Part|Physician Decision|1|||
146899472|NCT02901431|529794253|FG007|Main Treatment Part|Physician Decision|0|||
146899473|NCT02901431|529794254|FG008|Main Treatment Part|Physician Decision|0|||
146899474|NCT02901431|529794255|FG009|Main Treatment Part|Physician Decision|0|||
146899475|NCT02901431|529794256|FG010|Main Treatment Part|Physician Decision|0|||
146899476|NCT02901431|529794257|FG011|Main Treatment Part|Physician Decision|0|||
146899477|NCT02901431|529794258|FG012|Main Treatment Part|Physician Decision|0|||
146899478|NCT02901431|529794246|FG000|Main Treatment Part|Withdrawal by Subject|0|||
146899479|NCT02901431|529794247|FG001|Main Treatment Part|Withdrawal by Subject|0|||
146899480|NCT02901431|529794248|FG002|Main Treatment Part|Withdrawal by Subject|0|||
146899481|NCT02901431|529794249|FG003|Main Treatment Part|Withdrawal by Subject|18|||
146899482|NCT02901431|529794250|FG004|Main Treatment Part|Withdrawal by Subject|3|||
146899483|NCT02901431|529794251|FG005|Main Treatment Part|Withdrawal by Subject|5|||
146899484|NCT02901431|529794252|FG006|Main Treatment Part|Withdrawal by Subject|6|||
146899485|NCT02901431|529794253|FG007|Main Treatment Part|Withdrawal by Subject|0|||
146899486|NCT02901431|529794254|FG008|Main Treatment Part|Withdrawal by Subject|0|||
146899487|NCT02901431|529794255|FG009|Main Treatment Part|Withdrawal by Subject|0|||
146899488|NCT02901431|529794256|FG010|Main Treatment Part|Withdrawal by Subject|0|||
146899489|NCT02901431|529794257|FG011|Main Treatment Part|Withdrawal by Subject|0|||
146899490|NCT02901431|529794258|FG012|Main Treatment Part|Withdrawal by Subject|0|||
146899491|NCT02901431|529794246|FG000|Open Label Part|Adverse Event|0|||
146899492|NCT02901431|529794247|FG001|Open Label Part|Adverse Event|0|||
146899493|NCT02901431|529794248|FG002|Open Label Part|Adverse Event|0|||
146899494|NCT02901431|529794249|FG003|Open Label Part|Adverse Event|0|||
146899495|NCT02901431|529794250|FG004|Open Label Part|Adverse Event|0|||
146899496|NCT02901431|529794251|FG005|Open Label Part|Adverse Event|0|||
146899497|NCT02901431|529794252|FG006|Open Label Part|Adverse Event|0|||
146899498|NCT02901431|529794253|FG007|Open Label Part|Adverse Event|0|||
146899499|NCT02901431|529794254|FG008|Open Label Part|Adverse Event|4|||
146899500|NCT02901431|529794255|FG009|Open Label Part|Adverse Event|4|||
146899501|NCT02901431|529794256|FG010|Open Label Part|Adverse Event|0|||
146899502|NCT02901431|529794257|FG011|Open Label Part|Adverse Event|4|||
146899503|NCT02901431|529794258|FG012|Open Label Part|Adverse Event|1|||
146899504|NCT02901431|529794246|FG000|Open Label Part|Lost to Follow-up|0|||
146899505|NCT02901431|529794247|FG001|Open Label Part|Lost to Follow-up|0|||
146899506|NCT02901431|529794248|FG002|Open Label Part|Lost to Follow-up|0|||
146899507|NCT02901431|529794249|FG003|Open Label Part|Lost to Follow-up|0|||
146899508|NCT02901431|529794250|FG004|Open Label Part|Lost to Follow-up|0|||
146899509|NCT02901431|529794251|FG005|Open Label Part|Lost to Follow-up|0|||
146899510|NCT02901431|529794252|FG006|Open Label Part|Lost to Follow-up|0|||
146899511|NCT02901431|529794253|FG007|Open Label Part|Lost to Follow-up|0|||
146899512|NCT02901431|529794254|FG008|Open Label Part|Lost to Follow-up|2|||
146899513|NCT02901431|529794255|FG009|Open Label Part|Lost to Follow-up|2|||
146899514|NCT02901431|529794256|FG010|Open Label Part|Lost to Follow-up|1|||
146899515|NCT02901431|529794257|FG011|Open Label Part|Lost to Follow-up|1|||
146899516|NCT02901431|529794258|FG012|Open Label Part|Lost to Follow-up|1|||
146899517|NCT02901431|529794246|FG000|Open Label Part|Physician Decision|0|||
146899518|NCT02901431|529794247|FG001|Open Label Part|Physician Decision|0|||
146899519|NCT02901431|529794248|FG002|Open Label Part|Physician Decision|0|||
146899520|NCT02901431|529794249|FG003|Open Label Part|Physician Decision|0|||
146899521|NCT02901431|529794250|FG004|Open Label Part|Physician Decision|0|||
146899522|NCT02901431|529794251|FG005|Open Label Part|Physician Decision|0|||
146899523|NCT02901431|529794252|FG006|Open Label Part|Physician Decision|0|||
146899524|NCT02901431|529794253|FG007|Open Label Part|Physician Decision|0|||
146899525|NCT02901431|529794254|FG008|Open Label Part|Physician Decision|1|||
146899526|NCT02901431|529794255|FG009|Open Label Part|Physician Decision|1|||
146899527|NCT02901431|529794256|FG010|Open Label Part|Physician Decision|0|||
146899528|NCT02901431|529794257|FG011|Open Label Part|Physician Decision|0|||
146899529|NCT02901431|529794258|FG012|Open Label Part|Physician Decision|0|||
146899530|NCT02901431|529794246|FG000|Open Label Part|Study Terminated By Sponsor|0|||
146899531|NCT02901431|529794247|FG001|Open Label Part|Study Terminated By Sponsor|0|||
146899532|NCT02901431|529794248|FG002|Open Label Part|Study Terminated By Sponsor|0|||
146899533|NCT02901431|529794249|FG003|Open Label Part|Study Terminated By Sponsor|0|||
146899534|NCT02901431|529794250|FG004|Open Label Part|Study Terminated By Sponsor|0|||
146899535|NCT02901431|529794251|FG005|Open Label Part|Study Terminated By Sponsor|0|||
146899536|NCT02901431|529794252|FG006|Open Label Part|Study Terminated By Sponsor|0|||
146899537|NCT02901431|529794253|FG007|Open Label Part|Study Terminated By Sponsor|0|||
146899538|NCT02901431|529794254|FG008|Open Label Part|Study Terminated By Sponsor|35|||
146899539|NCT02901431|529794255|FG009|Open Label Part|Study Terminated By Sponsor|12|||
146899540|NCT02901431|529794256|FG010|Open Label Part|Study Terminated By Sponsor|21|||
146899541|NCT02901431|529794257|FG011|Open Label Part|Study Terminated By Sponsor|31|||
146899542|NCT02901431|529794258|FG012|Open Label Part|Study Terminated By Sponsor|0|||
146899543|NCT02901431|529794246|FG000|Open Label Part|Withdrawal by Subject|0|||
146899544|NCT02901431|529794247|FG001|Open Label Part|Withdrawal by Subject|0|||
146899545|NCT02901431|529794248|FG002|Open Label Part|Withdrawal by Subject|0|||
146899546|NCT02901431|529794249|FG003|Open Label Part|Withdrawal by Subject|0|||
146899547|NCT02901431|529794250|FG004|Open Label Part|Withdrawal by Subject|0|||
146899548|NCT02901431|529794251|FG005|Open Label Part|Withdrawal by Subject|0|||
146899549|NCT02901431|529794252|FG006|Open Label Part|Withdrawal by Subject|0|||
146899550|NCT02901431|529794253|FG007|Open Label Part|Withdrawal by Subject|0|||
146899551|NCT02901431|529794254|FG008|Open Label Part|Withdrawal by Subject|6|||
146899552|NCT02901431|529794255|FG009|Open Label Part|Withdrawal by Subject|5|||
146899553|NCT02901431|529794256|FG010|Open Label Part|Withdrawal by Subject|7|||
146899554|NCT02901431|529794257|FG011|Open Label Part|Withdrawal by Subject|3|||
146899555|NCT02901431|529794258|FG012|Open Label Part|Withdrawal by Subject|1|||
146899556|NCT04223609|529794259|FG000|Overall Study|Adverse Event|0|||
146899557|NCT04223609|529794260|FG001|Overall Study|Adverse Event|1|||
146899558|NCT04223609|529794259|FG000|Overall Study|Missed last visit|0|||
146899559|NCT04223609|529794260|FG001|Overall Study|Missed last visit|1|||
146899560|NCT03440944|529794261|FG000|Overall Study|Physician Decision|1|||
146899561|NCT03440944|529794262|FG001|Overall Study|Physician Decision|0|||
146899562|NCT03440944|529794261|FG000|Overall Study|No Acceptable Vasculature|0|||
146899563|NCT03440944|529794262|FG001|Overall Study|No Acceptable Vasculature|1|||
146899564|NCT04672083|529794263|FG000|Overall Study|Lost to Follow-up|1|||
146899565|NCT04672083|529794264|FG001|Overall Study|Lost to Follow-up|0|||
146899566|NCT04672083|529794265|FG002|Overall Study|Lost to Follow-up|0|||
146899567|NCT04672083|529794266|FG003|Overall Study|Lost to Follow-up|0|||
146899568|NCT04672083|529794267|FG004|Overall Study|Lost to Follow-up|0|||
146899569|NCT02500537|529794268|FG000|Overall Study|Death|2|||
146899570|NCT02500537|529794269|FG001|Overall Study|Death|0|||
146899571|NCT02500537|529794268|FG000|Overall Study|Lost to Follow-up|0|||
146899572|NCT02500537|529794269|FG001|Overall Study|Lost to Follow-up|1|||
146899573|NCT02500537|529794268|FG000|Overall Study|Withdrawal by Subject|1|||
146899574|NCT02500537|529794269|FG001|Overall Study|Withdrawal by Subject|0|||
146899575|NCT01661790|529794270|FG000|Overall Study|Lost to Follow-up|0|||
146899576|NCT01661790|529794271|FG001|Overall Study|Lost to Follow-up|2|||
146899577|NCT00355121|529794276|FG000|Overall Study|Did not receive study vaccine|1|||
146899578|NCT00355121|529794277|FG001|Overall Study|Did not receive study vaccine|0|||
146899579|NCT00355121|529794278|FG002|Overall Study|Did not receive study vaccine|1|||
146899580|NCT00355121|529794276|FG000|Overall Study|Adverse Event|0|||
146899581|NCT00355121|529794277|FG001|Overall Study|Adverse Event|1|||
146899582|NCT00355121|529794278|FG002|Overall Study|Adverse Event|0|||
146559698|NCT00522379|528559403|FG004|Overall Study|Lost to Follow-up|2|||
146899583|NCT00355121|529794276|FG000|Overall Study|Protocol Violation|7|||
146899584|NCT00355121|529794277|FG001|Overall Study|Protocol Violation|9|||
146899585|NCT00355121|529794278|FG002|Overall Study|Protocol Violation|1|||
146899586|NCT00355121|529794276|FG000|Overall Study|Lost to Follow-up|4|||
146899587|NCT00355121|529794277|FG001|Overall Study|Lost to Follow-up|7|||
146899588|NCT00355121|529794278|FG002|Overall Study|Lost to Follow-up|1|||
146899589|NCT00355121|529794276|FG000|Overall Study|Withdrawal by Subject|9|||
146899590|NCT00355121|529794277|FG001|Overall Study|Withdrawal by Subject|10|||
146899591|NCT00355121|529794278|FG002|Overall Study|Withdrawal by Subject|2|||
146899592|NCT00355121|529794276|FG000|Overall Study|Serious adverse events|0|||
146899593|NCT00355121|529794277|FG001|Overall Study|Serious adverse events|2|||
146899594|NCT00355121|529794278|FG002|Overall Study|Serious adverse events|0|||
146899595|NCT04743856|529794280|FG000|Overall Study|Lost to Follow-up|6|||
146899596|NCT04743856|529794281|FG001|Overall Study|Lost to Follow-up|7|||
146899597|NCT04743856|529794280|FG000|Overall Study|Withdrawal by Subject|1|||
146899598|NCT04743856|529794281|FG001|Overall Study|Withdrawal by Subject|0|||
146899599|NCT04439188|529794282|FG000|Overall Study|Ineligible|3|||
146559699|NCT00522379|528559399|FG000|Overall Study|Randomization error|0|||
146559700|NCT00522379|528559400|FG001|Overall Study|Randomization error|0|||
146559701|NCT00522379|528559401|FG002|Overall Study|Randomization error|0|||
146559702|NCT00522379|528559402|FG003|Overall Study|Randomization error|0|||
146559703|NCT00522379|528559403|FG004|Overall Study|Randomization error|1|||
146559704|NCT00522379|528559399|FG000|Overall Study|Dispensing error|1|||
146559705|NCT00522379|528559400|FG001|Overall Study|Dispensing error|0|||
146559706|NCT00522379|528559401|FG002|Overall Study|Dispensing error|0|||
146559707|NCT00522379|528559402|FG003|Overall Study|Dispensing error|1|||
146559708|NCT00522379|528559403|FG004|Overall Study|Dispensing error|0|||
146559709|NCT00522379|528559399|FG000|Overall Study|Subject Moved|1|||
146559710|NCT00522379|528559400|FG001|Overall Study|Subject Moved|1|||
146559711|NCT00522379|528559401|FG002|Overall Study|Subject Moved|0|||
146559712|NCT00522379|528559402|FG003|Overall Study|Subject Moved|0|||
146559713|NCT00522379|528559403|FG004|Overall Study|Subject Moved|0|||
146559714|NCT00522379|528559399|FG000|Overall Study|Sponsor Request|0|||
146559715|NCT00522379|528559400|FG001|Overall Study|Sponsor Request|1|||
146559716|NCT00522379|528559401|FG002|Overall Study|Sponsor Request|0|||
146559717|NCT00522379|528559402|FG003|Overall Study|Sponsor Request|0|||
146559718|NCT00522379|528559403|FG004|Overall Study|Sponsor Request|0|||
146559719|NCT00522379|528559399|FG000|Overall Study|Family Problem|0|||
146559720|NCT00522379|528559400|FG001|Overall Study|Family Problem|0|||
146559721|NCT00522379|528559401|FG002|Overall Study|Family Problem|1|||
146559722|NCT00522379|528559402|FG003|Overall Study|Family Problem|0|||
146559723|NCT00522379|528559403|FG004|Overall Study|Family Problem|0|||
146559724|NCT00522379|528559399|FG000|Overall Study|Site Closed|0|||
146559725|NCT00522379|528559400|FG001|Overall Study|Site Closed|0|||
146559726|NCT00522379|528559401|FG002|Overall Study|Site Closed|0|||
146559727|NCT00522379|528559402|FG003|Overall Study|Site Closed|1|||
146559728|NCT00522379|528559403|FG004|Overall Study|Site Closed|0|||
146559729|NCT00522379|528559399|FG000|Overall Study|Subject Withdrawal|0|||
146559730|NCT00522379|528559400|FG001|Overall Study|Subject Withdrawal|0|||
146559731|NCT00522379|528559401|FG002|Overall Study|Subject Withdrawal|0|||
146640431|NCT01120964|528859262|FG000|Overall Study|Did not receive full treatment|1|||
146559732|NCT00522379|528559402|FG003|Overall Study|Subject Withdrawal|1|||
146559733|NCT00522379|528559403|FG004|Overall Study|Subject Withdrawal|0|||
146559734|NCT00967499|528559408|FG000|Overall Study|Adverse Event|0|||
146559735|NCT00967499|528559409|FG001|Overall Study|Adverse Event|1|||
146559736|NCT00967499|528559408|FG000|Overall Study|Protocol Violation|1|||
146559737|NCT00967499|528559409|FG001|Overall Study|Protocol Violation|0|||
146559738|NCT00967499|528559408|FG000|Overall Study|Sponsor Decision|1|||
146640432|NCT01120964|528859263|FG001|Overall Study|Did not receive full treatment|0|||
146899600|NCT04439188|529794282|FG000|Overall Study|Adverse Event|4|||
146899601|NCT04439188|529794282|FG000|Overall Study|Death|1|||
146559739|NCT00967499|528559409|FG001|Overall Study|Sponsor Decision|0|||
146559740|NCT00967499|528559408|FG000|Overall Study|Randomized but not treated|63|||
146559741|NCT00967499|528559409|FG001|Overall Study|Randomized but not treated|59|||
146899602|NCT04439188|529794282|FG000|Overall Study|Disease Progression|25|||
146899603|NCT04439188|529794282|FG000|Overall Study|Withdrawal by Subject|2|||
146899604|NCT01813890|529794285|FG000|Overall Study|Adverse Event|0|||
146559742|NCT04134936|528559411|FG000|Overall Study|Adverse Event|3|||
146969237|NCT00539006|530047360|FG003|Washout|Withdrawal by Subject|0|||
146969238|NCT00539006|530047357|FG000|Washout|Failed to meet continuation criteria|16|||
146969239|NCT00539006|530047358|FG001|Washout|Failed to meet continuation criteria|5|||
146969240|NCT00539006|530047359|FG002|Washout|Failed to meet continuation criteria|14|||
146969241|NCT00539006|530047360|FG003|Washout|Failed to meet continuation criteria|6|||
146969242|NCT00539006|530047357|FG000|Washout|Other|1|||
146969243|NCT00539006|530047358|FG001|Washout|Other|1|||
146969244|NCT00539006|530047359|FG002|Washout|Other|2|||
146969245|NCT00539006|530047360|FG003|Washout|Other|3|||
146969246|NCT00539006|530047357|FG000|Treatment Period 2|Protocol Violation|1|||
146969247|NCT00539006|530047358|FG001|Treatment Period 2|Protocol Violation|0|||
146969248|NCT00539006|530047359|FG002|Treatment Period 2|Protocol Violation|0|||
146969249|NCT00539006|530047360|FG003|Treatment Period 2|Protocol Violation|0|||
146969250|NCT00539006|530047357|FG000|Treatment Period 2|Other|0|||
146969251|NCT00539006|530047358|FG001|Treatment Period 2|Other|1|||
146969252|NCT00539006|530047359|FG002|Treatment Period 2|Other|0|||
146969253|NCT00539006|530047360|FG003|Treatment Period 2|Other|0|||
146969254|NCT01179191|530047361|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
146969255|NCT01179191|530047361|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
146969256|NCT01179191|530047361|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
146969257|NCT01179191|530047361|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
146969258|NCT01179191|530047361|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
146969259|NCT01179191|530047361|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
146969260|NCT01179191|530047361|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
146969261|NCT01179191|530047361|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
146969262|NCT01179191|530047361|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
146969263|NCT01179191|530047361|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
146969264|NCT01179191|530047361|FG000|Maintenance Phase (8 Weeks)|Other|66|||
146969265|NCT00572910|530047362|FG000|Overall Study|Adverse Event|1|||
146969266|NCT00572910|530047363|FG001|Overall Study|Adverse Event|2|||
146969267|NCT00572910|530047364|FG002|Overall Study|Adverse Event|0|||
146969268|NCT00572910|530047365|FG003|Overall Study|Adverse Event|2|||
146969269|NCT00572910|530047366|FG004|Overall Study|Adverse Event|0|||
146969270|NCT00572910|530047367|FG005|Overall Study|Adverse Event|0|||
146969271|NCT00572910|530047368|FG006|Overall Study|Adverse Event|4|||
146969272|NCT00572910|530047369|FG007|Overall Study|Adverse Event|2|||
146969273|NCT00572910|530047370|FG008|Overall Study|Adverse Event|1|||
146969274|NCT00572910|530047371|FG009|Overall Study|Adverse Event|3|||
146969275|NCT00572910|530047372|FG010|Overall Study|Adverse Event|2|||
146969276|NCT00572910|530047362|FG000|Overall Study|Lost to Follow-up|0|||
146969277|NCT00572910|530047363|FG001|Overall Study|Lost to Follow-up|1|||
146969278|NCT00572910|530047364|FG002|Overall Study|Lost to Follow-up|1|||
146969279|NCT00572910|530047365|FG003|Overall Study|Lost to Follow-up|2|||
146969280|NCT00572910|530047366|FG004|Overall Study|Lost to Follow-up|1|||
146969281|NCT00572910|530047367|FG005|Overall Study|Lost to Follow-up|0|||
146969282|NCT00572910|530047368|FG006|Overall Study|Lost to Follow-up|0|||
146969283|NCT00572910|530047369|FG007|Overall Study|Lost to Follow-up|0|||
146969284|NCT00572910|530047370|FG008|Overall Study|Lost to Follow-up|0|||
146969285|NCT00572910|530047371|FG009|Overall Study|Lost to Follow-up|1|||
146899605|NCT01813890|529794286|FG001|Overall Study|Adverse Event|3|||
146899606|NCT01813890|529794287|FG002|Overall Study|Adverse Event|4|||
146899607|NCT01813890|529794285|FG000|Overall Study|Lack of Efficacy|9|||
146899608|NCT01813890|529794286|FG001|Overall Study|Lack of Efficacy|1|||
146899609|NCT01813890|529794287|FG002|Overall Study|Lack of Efficacy|2|||
146899610|NCT04482647|529794288|FG000|Overall Study|Time constraints|2|||
146899611|NCT04482647|529794288|FG000|Overall Study|Health issues|1|||
146899612|NCT04482647|529794288|FG000|Overall Study|Death in the family|1|||
146899613|NCT04482647|529794288|FG000|Overall Study|Disliked the intervention|1|||
146899614|NCT04482647|529794288|FG000|Overall Study|No reasons specified|7|||
146899615|NCT01707992|529794292|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
146899616|NCT01707992|529794293|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
146899617|NCT01707992|529794294|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
146899618|NCT01707992|529794295|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
146899619|NCT01707992|529794296|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
146899620|NCT01707992|529794297|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
146899621|NCT01707992|529794292|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
146969286|NCT00572910|530047372|FG010|Overall Study|Lost to Follow-up|0|||
146969287|NCT00572910|530047362|FG000|Overall Study|Withdrawal by Subject|3|||
146969288|NCT00572910|530047363|FG001|Overall Study|Withdrawal by Subject|0|||
146969289|NCT00572910|530047364|FG002|Overall Study|Withdrawal by Subject|1|||
146969290|NCT00572910|530047365|FG003|Overall Study|Withdrawal by Subject|0|||
146969291|NCT00572910|530047366|FG004|Overall Study|Withdrawal by Subject|1|||
146899622|NCT01707992|529794293|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
146899623|NCT01707992|529794294|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
146969292|NCT00572910|530047367|FG005|Overall Study|Withdrawal by Subject|3|||
146969293|NCT00572910|530047368|FG006|Overall Study|Withdrawal by Subject|0|||
146899624|NCT01707992|529794295|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
146899625|NCT01707992|529794296|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
146899626|NCT01707992|529794297|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
146899627|NCT01707992|529794292|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
146899628|NCT01707992|529794293|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
146766938|NCT00536380|529314666|FG000|Overall Study|Noncompliance with protocol|3|||
146766939|NCT00536380|529314667|FG001|Overall Study|Noncompliance with protocol|2|||
146899629|NCT01707992|529794294|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
146899630|NCT01707992|529794295|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
146899631|NCT01707992|529794296|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
146899632|NCT01707992|529794297|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
146899633|NCT01707992|529794292|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
146899634|NCT01707992|529794293|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
146899635|NCT01707992|529794294|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
146899636|NCT01707992|529794295|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
146899637|NCT01707992|529794296|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
146899638|NCT01707992|529794297|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
146899639|NCT01707992|529794292|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
146899640|NCT01707992|529794293|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
146899641|NCT01707992|529794294|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
146899642|NCT01707992|529794295|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
146899643|NCT01707992|529794296|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
146766940|NCT00536380|529314668|FG002|Overall Study|Noncompliance with protocol|2|||
146766941|NCT00536380|529314666|FG000|Overall Study|Did not meet protocol eligibility|0|||
146766942|NCT00536380|529314667|FG001|Overall Study|Did not meet protocol eligibility|0|||
146766943|NCT00536380|529314668|FG002|Overall Study|Did not meet protocol eligibility|1|||
146766944|NCT00536380|529314666|FG000|Overall Study|Administrative|0|||
146766945|NCT00536380|529314667|FG001|Overall Study|Administrative|0|||
146766946|NCT00536380|529314668|FG002|Overall Study|Administrative|1|||
146766947|NCT00387465|529314669|FG000|Overall Study|Withdrawal by Subject|0|||
146766948|NCT00387465|529314670|FG001|Overall Study|Withdrawal by Subject|1|||
146766949|NCT00387465|529314671|FG002|Overall Study|Withdrawal by Subject|0|||
146766950|NCT03418324|529314673|FG000|Overall Study|Death|0|||
146766951|NCT03418324|529314674|FG001|Overall Study|Death|1|||
146766952|NCT03418324|529314673|FG000|Overall Study|Physician Decision|1|||
146766953|NCT03418324|529314674|FG001|Overall Study|Physician Decision|1|||
146766954|NCT00290706|529314677|FG000|Overall Study|Withdrawal by Subject|2|||
146766955|NCT00290706|529314678|FG001|Overall Study|Withdrawal by Subject|0|||
146766956|NCT00290706|529314679|FG002|Overall Study|Withdrawal by Subject|0|||
146766957|NCT00290706|529314680|FG003|Overall Study|Withdrawal by Subject|0|||
146766958|NCT00290706|529314677|FG000|Overall Study|Progressive Disease|3|||
146766959|NCT00290706|529314678|FG001|Overall Study|Progressive Disease|5|||
146766960|NCT00290706|529314679|FG002|Overall Study|Progressive Disease|4|||
146766961|NCT00290706|529314680|FG003|Overall Study|Progressive Disease|10|||
146766962|NCT00290706|529314677|FG000|Overall Study|Adverse Event|0|||
146766963|NCT00290706|529314678|FG001|Overall Study|Adverse Event|1|||
146766964|NCT00290706|529314679|FG002|Overall Study|Adverse Event|2|||
146766965|NCT00290706|529314680|FG003|Overall Study|Adverse Event|0|||
146766966|NCT00290706|529314677|FG000|Overall Study|Receive auto transplant or radiation|0|||
146766967|NCT00290706|529314678|FG001|Overall Study|Receive auto transplant or radiation|0|||
146766968|NCT00290706|529314679|FG002|Overall Study|Receive auto transplant or radiation|0|||
146766969|NCT00290706|529314680|FG003|Overall Study|Receive auto transplant or radiation|1|||
146766970|NCT00290706|529314677|FG000|Overall Study|Physician Decision|0|||
146766971|NCT00290706|529314678|FG001|Overall Study|Physician Decision|0|||
146766972|NCT00290706|529314679|FG002|Overall Study|Physician Decision|0|||
146766973|NCT00290706|529314680|FG003|Overall Study|Physician Decision|1|||
146766974|NCT00605033|529314682|FG000|Overall Study|Adverse Event|2|||
146899644|NCT01707992|529794297|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
146899645|NCT01707992|529794292|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
146899646|NCT01707992|529794293|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
146766975|NCT00605033|529314683|FG001|Overall Study|Adverse Event|2|||
146766976|NCT00605033|529314682|FG000|Overall Study|Lost to Follow-up|1|||
146766977|NCT00605033|529314683|FG001|Overall Study|Lost to Follow-up|1|||
146766978|NCT00605033|529314682|FG000|Overall Study|Withdrawal by Subject|3|||
146766979|NCT00605033|529314683|FG001|Overall Study|Withdrawal by Subject|4|||
146766980|NCT00605033|529314682|FG000|Overall Study|Protocol Violation|1|||
146899647|NCT01707992|529794294|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
146899648|NCT01707992|529794295|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
146899649|NCT01707992|529794296|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
146766981|NCT00605033|529314683|FG001|Overall Study|Protocol Violation|1|||
146766982|NCT01196429|529314684|FG000|Overall Study|Ineligible - inadequate pathology|1|||
146766983|NCT01196429|529314685|FG001|Overall Study|Ineligible - inadequate pathology|0|||
146640433|NCT02621151|528859264|FG000|Overall Study|Not eligible for trial|6|||
146640434|NCT04198714|528859265|FG000|Overall Study|Physician Decision|0|||
146640435|NCT04198714|528859266|FG001|Overall Study|Physician Decision|1|||
146640436|NCT04238819|528859267|FG000|Overall Study|Ongoing Treatment|0|||
146640437|NCT04238819|528859268|FG001|Overall Study|Ongoing Treatment|0|||
146640438|NCT04238819|528859269|FG002|Overall Study|Ongoing Treatment|0|||
146640439|NCT04238819|528859270|FG003|Overall Study|Ongoing Treatment|0|||
146640440|NCT04238819|528859271|FG004|Overall Study|Ongoing Treatment|1|||
146640441|NCT04238819|528859272|FG005|Overall Study|Ongoing Treatment|4|||
146640442|NCT04238819|528859273|FG006|Overall Study|Ongoing Treatment|0|||
146640443|NCT04238819|528859267|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
146640444|NCT04238819|528859268|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
146899650|NCT01707992|529794297|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
146899651|NCT01707992|529794292|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
146899652|NCT01707992|529794293|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
146899653|NCT01707992|529794294|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
146899654|NCT01707992|529794295|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
146899655|NCT01707992|529794296|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
146899656|NCT01707992|529794297|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
146899657|NCT01707992|529794292|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
146899658|NCT01707992|529794293|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
146899659|NCT01707992|529794294|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
146899660|NCT01707992|529794295|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
146899661|NCT01707992|529794296|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
146899662|NCT01707992|529794297|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
146899663|NCT01707992|529794292|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
146899664|NCT01707992|529794293|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
146899665|NCT01707992|529794294|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
146899666|NCT01707992|529794295|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
146899667|NCT01707992|529794296|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
146899668|NCT01707992|529794297|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
146899669|NCT01707992|529794292|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
146899670|NCT01707992|529794293|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
146899671|NCT01707992|529794294|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
146899672|NCT01707992|529794295|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
146899673|NCT01707992|529794296|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
146899674|NCT01707992|529794297|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
146899675|NCT01707992|529794292|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
146899676|NCT01707992|529794293|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
146899677|NCT01707992|529794294|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
146899678|NCT01707992|529794295|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
146899679|NCT01707992|529794296|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
146899680|NCT01707992|529794297|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
146899681|NCT01707992|529794292|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
146899682|NCT01707992|529794293|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
146899683|NCT01707992|529794294|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
146899684|NCT01707992|529794295|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
146640445|NCT04238819|528859269|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
146640446|NCT04238819|528859270|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
146640447|NCT04238819|528859271|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
146640448|NCT04238819|528859272|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
146640449|NCT04238819|528859273|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
146640450|NCT02529553|528859274|FG000|Overall Study|Progressive Disease|1|||
146640451|NCT02529553|528859275|FG001|Overall Study|Progressive Disease|0|||
146640452|NCT02529553|528859276|FG002|Overall Study|Progressive Disease|1|||
146640453|NCT02529553|528859277|FG003|Overall Study|Progressive Disease|3|||
146640454|NCT02529553|528859278|FG004|Overall Study|Progressive Disease|2|||
146640455|NCT02529553|528859279|FG005|Overall Study|Progressive Disease|3|||
146640456|NCT02529553|528859280|FG006|Overall Study|Progressive Disease|3|||
146640457|NCT02529553|528859281|FG007|Overall Study|Progressive Disease|5|||
146640458|NCT02529553|528859282|FG008|Overall Study|Progressive Disease|3|||
146766984|NCT01196429|529314684|FG000|Overall Study|Ineligible - wrong cell type|1|||
146899685|NCT01707992|529794296|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
146640459|NCT02529553|528859274|FG000|Overall Study|Physician Decision|0|||
146640460|NCT02529553|528859275|FG001|Overall Study|Physician Decision|1|||
146640461|NCT02529553|528859276|FG002|Overall Study|Physician Decision|0|||
146640462|NCT02529553|528859277|FG003|Overall Study|Physician Decision|0|||
146640463|NCT02529553|528859278|FG004|Overall Study|Physician Decision|1|||
146640464|NCT02529553|528859279|FG005|Overall Study|Physician Decision|0|||
146640465|NCT02529553|528859280|FG006|Overall Study|Physician Decision|0|||
146766985|NCT01196429|529314685|FG001|Overall Study|Ineligible - wrong cell type|0|||
146766986|NCT01196429|529314684|FG000|Overall Study|Refused - Never Treated|1|||
146766987|NCT01196429|529314685|FG001|Overall Study|Refused - Never Treated|0|||
146766988|NCT03768206|529314686|FG000|Overall Study|Lost to Follow-up|2|||
146766989|NCT03768206|529314687|FG001|Overall Study|Lost to Follow-up|1|||
146766990|NCT03768206|529314686|FG000|Overall Study|Withdrawal by Subject|0|||
146766991|NCT03768206|529314687|FG001|Overall Study|Withdrawal by Subject|1|||
146766992|NCT02299336|529314690|FG000|Overall Study|Withdrawal by Subject|11|||
146766993|NCT02299336|529314690|FG000|Overall Study|Adverse Event|1|||
146766994|NCT02299336|529314690|FG000|Overall Study|Death|1|||
146766995|NCT02299336|529314690|FG000|Overall Study|Lost to Follow-up|1|||
146766996|NCT02106442|529314693|FG000|Overall Study|Case Report Forms Uncollected|7|||
146766997|NCT02106442|529314693|FG000|Overall Study|Protocol Deviation|30|||
146766998|NCT01212757|529314696|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
146766999|NCT01212757|529314697|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
146767000|NCT01212757|529314698|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
146767001|NCT01212757|529314699|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146767002|NCT01212757|529314700|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146767003|NCT01212757|529314701|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146767004|NCT01212757|529314702|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146767005|NCT01212757|529314703|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146767006|NCT01212757|529314704|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146767007|NCT01212757|529314696|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
146767008|NCT01212757|529314697|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
146767009|NCT01212757|529314698|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
146767010|NCT01212757|529314699|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146767011|NCT01212757|529314700|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146767012|NCT01212757|529314701|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146767013|NCT01212757|529314702|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146767014|NCT01212757|529314703|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146767015|NCT01212757|529314704|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146767016|NCT01212757|529314696|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
146767017|NCT01212757|529314697|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
146767018|NCT01212757|529314698|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
146767019|NCT01212757|529314699|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146767020|NCT01212757|529314700|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146767021|NCT01212757|529314701|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146767022|NCT01212757|529314702|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146767023|NCT01212757|529314703|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146767024|NCT01212757|529314704|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146767025|NCT01212757|529314696|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
146767026|NCT01212757|529314697|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146767027|NCT01212757|529314698|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
146767028|NCT01212757|529314699|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146767029|NCT01212757|529314700|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146767030|NCT01212757|529314701|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146767031|NCT01212757|529314702|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146767032|NCT01212757|529314703|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146767033|NCT01212757|529314704|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146767034|NCT01212757|529314696|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
146767035|NCT01212757|529314697|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
146767036|NCT01212757|529314698|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
146899686|NCT01707992|529794297|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
146899687|NCT01707992|529794292|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
146899688|NCT01707992|529794293|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
146899689|NCT01707992|529794294|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
146899690|NCT01707992|529794295|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
146899691|NCT01707992|529794296|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
146899692|NCT01707992|529794297|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
146899693|NCT01707992|529794292|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
146899694|NCT01707992|529794293|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
146899695|NCT01707992|529794294|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
146899696|NCT01707992|529794295|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
146899697|NCT01707992|529794296|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
146899698|NCT01707992|529794297|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
146899699|NCT01707992|529794292|FG000|Active Treatment Phase (24 Months)|Death|0|||
146899700|NCT01707992|529794293|FG001|Active Treatment Phase (24 Months)|Death|0|||
146767037|NCT01212757|529314699|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146899701|NCT01707992|529794294|FG002|Active Treatment Phase (24 Months)|Death|0|||
146767038|NCT01212757|529314700|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146899702|NCT01707992|529794295|FG003|Active Treatment Phase (24 Months)|Death|2|||
146899703|NCT01707992|529794296|FG004|Active Treatment Phase (24 Months)|Death|0|||
146899704|NCT01707992|529794297|FG005|Active Treatment Phase (24 Months)|Death|0|||
146899705|NCT01707992|529794292|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
146899706|NCT01707992|529794293|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
146899707|NCT01707992|529794294|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
146899708|NCT01707992|529794295|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
146899709|NCT01707992|529794296|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
146899710|NCT01707992|529794297|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
146899711|NCT01707992|529794292|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
146899712|NCT01707992|529794293|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
146899713|NCT01707992|529794294|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
146899714|NCT01707992|529794295|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
146899715|NCT01707992|529794296|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
146899716|NCT01707992|529794297|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
146899717|NCT01707992|529794292|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
146899718|NCT01707992|529794293|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
146899719|NCT01707992|529794294|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
146899720|NCT01707992|529794295|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
146899721|NCT01707992|529794296|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
146899722|NCT01707992|529794297|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
146899723|NCT01707992|529794292|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
146899724|NCT01707992|529794293|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
146899725|NCT01707992|529794294|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
146899726|NCT01707992|529794295|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
146899727|NCT01707992|529794296|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
146899728|NCT01707992|529794297|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
146899729|NCT00998738|529794299|FG000|Overall Study|Uknown|1|||
146899730|NCT04211337|529794300|FG000|Overall Study|On Treatment|175|||
146899731|NCT04211337|529794301|FG001|Overall Study|On Treatment|40|||
146899732|NCT04211337|529794300|FG000|Overall Study|Withdrawal by Subject|0|||
146899733|NCT04211337|529794301|FG001|Overall Study|Withdrawal by Subject|2|||
146899734|NCT00960076|529796358|FG000|Overall Study|Adverse Event|1|||
146899735|NCT00960076|529796359|FG001|Overall Study|Adverse Event|7|||
146899736|NCT00960076|529796358|FG000|Overall Study|No longer met study criteria|1|||
146899737|NCT00960076|529796359|FG001|Overall Study|No longer met study criteria|5|||
146899738|NCT00960076|529796358|FG000|Overall Study|Withdrawal by Subject|1|||
146899739|NCT00960076|529796359|FG001|Overall Study|Withdrawal by Subject|2|||
146899740|NCT00960076|529796358|FG000|Overall Study|Lost to Follow-up|3|||
146899741|NCT00960076|529796359|FG001|Overall Study|Lost to Follow-up|3|||
146899742|NCT00960076|529796358|FG000|Overall Study|Severe non-compliance to protocol|1|||
146899743|NCT00960076|529796359|FG001|Overall Study|Severe non-compliance to protocol|2|||
146899744|NCT00960076|529796358|FG000|Overall Study|Hyperglycemia|1|||
146899745|NCT00960076|529796359|FG001|Overall Study|Hyperglycemia|5|||
146899746|NCT00960076|529796358|FG000|Overall Study|Did not attend the termination visit|0|||
146899747|NCT00960076|529796359|FG001|Overall Study|Did not attend the termination visit|1|||
146899748|NCT00500266|529796360|FG000|Overall Study|Death|3|||
146899749|NCT00500266|529796360|FG000|Overall Study|Lost to Follow-up|3|||
146899750|NCT00500266|529796360|FG000|Overall Study|Withdrawal by Subject|3|||
146899751|NCT00500266|529796360|FG000|Overall Study|Assigned, not treated|4|||
146899752|NCT01431287|529796361|FG000|Overall Study|not treated|0|||
146767039|NCT01212757|529314701|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146767040|NCT01212757|529314702|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146767041|NCT01212757|529314703|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146767042|NCT01212757|529314704|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146767043|NCT01212757|529314696|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146767044|NCT01212757|529314697|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
146767045|NCT01212757|529314698|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
146899753|NCT01431287|529796362|FG001|Overall Study|not treated|0|||
146899754|NCT01431287|529796363|FG002|Overall Study|not treated|1|||
146899755|NCT01431287|529796364|FG003|Overall Study|not treated|0|||
146899756|NCT01431287|529796365|FG004|Overall Study|not treated|0|||
146899757|NCT01431287|529796361|FG000|Overall Study|Adverse Event|59|||
146899758|NCT01431287|529796362|FG001|Overall Study|Adverse Event|57|||
146767046|NCT01212757|529314699|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146899759|NCT01431287|529796363|FG002|Overall Study|Adverse Event|53|||
146899760|NCT01431287|529796364|FG003|Overall Study|Adverse Event|33|||
146767047|NCT01212757|529314700|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146767048|NCT01212757|529314701|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146767049|NCT01212757|529314702|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146767050|NCT01212757|529314703|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146767051|NCT01212757|529314704|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146767052|NCT01212757|529314696|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
146767053|NCT01212757|529314697|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
146767054|NCT01212757|529314698|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146899761|NCT01431287|529796365|FG004|Overall Study|Adverse Event|41|||
146899762|NCT01431287|529796361|FG000|Overall Study|Non compliant with protocol|6|||
146899763|NCT01431287|529796362|FG001|Overall Study|Non compliant with protocol|6|||
146899764|NCT01431287|529796363|FG002|Overall Study|Non compliant with protocol|5|||
146899765|NCT01431287|529796364|FG003|Overall Study|Non compliant with protocol|6|||
146899766|NCT01431287|529796365|FG004|Overall Study|Non compliant with protocol|5|||
146899767|NCT01431287|529796361|FG000|Overall Study|Lost to Follow-up|0|||
146899768|NCT01431287|529796362|FG001|Overall Study|Lost to Follow-up|3|||
146899769|NCT01431287|529796363|FG002|Overall Study|Lost to Follow-up|2|||
146899770|NCT01431287|529796364|FG003|Overall Study|Lost to Follow-up|3|||
146899771|NCT01431287|529796365|FG004|Overall Study|Lost to Follow-up|1|||
146899772|NCT01431287|529796361|FG000|Overall Study|Consent withdrawn not due to AE|29|||
146899773|NCT01431287|529796362|FG001|Overall Study|Consent withdrawn not due to AE|30|||
146899774|NCT01431287|529796363|FG002|Overall Study|Consent withdrawn not due to AE|34|||
146899775|NCT01431287|529796364|FG003|Overall Study|Consent withdrawn not due to AE|19|||
146899776|NCT01431287|529796365|FG004|Overall Study|Consent withdrawn not due to AE|29|||
146899777|NCT01431287|529796361|FG000|Overall Study|not stated above|4|||
146899778|NCT01431287|529796362|FG001|Overall Study|not stated above|2|||
146899779|NCT01431287|529796363|FG002|Overall Study|not stated above|2|||
146899780|NCT01431287|529796364|FG003|Overall Study|not stated above|2|||
146899781|NCT01431287|529796365|FG004|Overall Study|not stated above|1|||
146899782|NCT00162773|529796366|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
146899783|NCT00278629|529796369|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
146899784|NCT00826748|529796372|FG000|Overall Study|Withdrawal by Subject|0|||
146899785|NCT00826748|529796373|FG001|Overall Study|Withdrawal by Subject|0|||
146899786|NCT00826748|529796374|FG002|Overall Study|Withdrawal by Subject|2|||
146899787|NCT00826748|529796372|FG000|Overall Study|Physician Decision|0|||
146899788|NCT00826748|529796373|FG001|Overall Study|Physician Decision|0|||
146899789|NCT00826748|529796374|FG002|Overall Study|Physician Decision|1|||
146899790|NCT00826748|529796372|FG000|Overall Study|Samples Did Not pass QC|0|||
146899791|NCT00826748|529796373|FG001|Overall Study|Samples Did Not pass QC|0|||
146899792|NCT00826748|529796374|FG002|Overall Study|Samples Did Not pass QC|1|||
146899793|NCT00824564|529796377|FG000|Overall Study|Lost to Follow-up|5|||
146899794|NCT00824564|529796378|FG001|Overall Study|Lost to Follow-up|7|||
146899795|NCT00824564|529796377|FG000|Overall Study|Withdrawal by Subject|1|||
146899796|NCT00824564|529796378|FG001|Overall Study|Withdrawal by Subject|1|||
146899797|NCT00824564|529796377|FG000|Overall Study|Other|1|||
146899798|NCT00824564|529796378|FG001|Overall Study|Other|2|||
146899799|NCT00824564|529796377|FG000|Overall Study|Randomized, but not treated|1|||
146899800|NCT00824564|529796378|FG001|Overall Study|Randomized, but not treated|0|||
146899801|NCT00391976|529796379|FG000|Overall Study|Adverse Event|0|||
146899802|NCT00391976|529796380|FG001|Overall Study|Adverse Event|0|||
146899803|NCT00391976|529796381|FG002|Overall Study|Adverse Event|1|||
146899804|NCT00391976|529796379|FG000|Overall Study|Withdrawal of consent|0|||
146899805|NCT00391976|529796380|FG001|Overall Study|Withdrawal of consent|1|||
146899806|NCT00391976|529796381|FG002|Overall Study|Withdrawal of consent|1|||
146899807|NCT00391976|529796379|FG000|Overall Study|Lost to Follow-up|1|||
146899808|NCT00391976|529796380|FG001|Overall Study|Lost to Follow-up|2|||
146899809|NCT00391976|529796381|FG002|Overall Study|Lost to Follow-up|0|||
146899810|NCT00391976|529796379|FG000|Overall Study|Inappropriate enrollment|1|||
146899811|NCT00391976|529796380|FG001|Overall Study|Inappropriate enrollment|1|||
146899812|NCT00391976|529796381|FG002|Overall Study|Inappropriate enrollment|0|||
146899813|NCT00391976|529796379|FG000|Overall Study|Protocol deviation/violation|4|||
146899814|NCT00391976|529796380|FG001|Overall Study|Protocol deviation/violation|2|||
146899815|NCT00391976|529796381|FG002|Overall Study|Protocol deviation/violation|1|||
146899816|NCT00391976|529796379|FG000|Overall Study|Recurrence/no eradication of infection|21|||
146899817|NCT00391976|529796380|FG001|Overall Study|Recurrence/no eradication of infection|19|||
146899818|NCT00391976|529796381|FG002|Overall Study|Recurrence/no eradication of infection|0|||
146899819|NCT00391976|529796379|FG000|Overall Study|Unable to classify|0|||
146899820|NCT00391976|529796380|FG001|Overall Study|Unable to classify|0|||
146767055|NCT01212757|529314699|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146899821|NCT00391976|529796381|FG002|Overall Study|Unable to classify|1|||
146899822|NCT00391976|529796379|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
146899823|NCT00391976|529796380|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
146899824|NCT00391976|529796381|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
146899825|NCT03367871|529796391|FG000|Overall Study|Lost to Follow-up|1|||
146899826|NCT01773473|529796392|FG000|Overall Study|Adverse Event|3|||
146767056|NCT01212757|529314700|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146899827|NCT01773473|529796393|FG001|Overall Study|Adverse Event|2|||
146899828|NCT01773473|529796392|FG000|Overall Study|Protocol Violation|0|||
146899829|NCT01773473|529796393|FG001|Overall Study|Protocol Violation|4|||
146899830|NCT01773473|529796392|FG000|Overall Study|Physician Decision|3|||
146899831|NCT01773473|529796393|FG001|Overall Study|Physician Decision|5|||
146899832|NCT01773473|529796392|FG000|Overall Study|Sponsor Decision|2|||
146899833|NCT01773473|529796393|FG001|Overall Study|Sponsor Decision|0|||
146899834|NCT01773473|529796392|FG000|Overall Study|Lack of Efficacy|0|||
146899835|NCT01773473|529796393|FG001|Overall Study|Lack of Efficacy|1|||
146899836|NCT01773473|529796392|FG000|Overall Study|Non-Compliance with study drug|1|||
146899837|NCT01773473|529796393|FG001|Overall Study|Non-Compliance with study drug|4|||
146899838|NCT01773473|529796392|FG000|Overall Study|Withdrawal by Subject|5|||
146899839|NCT01773473|529796393|FG001|Overall Study|Withdrawal by Subject|3|||
146899840|NCT01773473|529796392|FG000|Overall Study|Lost to Follow-up|2|||
146899841|NCT01773473|529796393|FG001|Overall Study|Lost to Follow-up|0|||
146767057|NCT01212757|529314701|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146767058|NCT01212757|529314702|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146767059|NCT01212757|529314703|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146767060|NCT01212757|529314704|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146767061|NCT01212757|529314696|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
146767062|NCT01212757|529314697|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
146767063|NCT01212757|529314698|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
146767064|NCT01212757|529314699|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
146767065|NCT01212757|529314700|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
146767066|NCT01212757|529314701|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
146767067|NCT01212757|529314702|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
146767068|NCT01212757|529314703|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
146767069|NCT01212757|529314704|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
146767070|NCT01212757|529314696|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
146767071|NCT01212757|529314697|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
146767072|NCT01212757|529314698|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
146767073|NCT01212757|529314699|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
146767074|NCT01212757|529314700|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
146767075|NCT01212757|529314701|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
146767076|NCT01212757|529314702|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
146767077|NCT01212757|529314703|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
146767078|NCT01212757|529314704|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
146767079|NCT01212757|529314696|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
146767080|NCT01212757|529314697|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
146767081|NCT01212757|529314698|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
146767082|NCT01212757|529314699|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
146767083|NCT01212757|529314700|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
146767084|NCT01212757|529314701|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
146767085|NCT01212757|529314702|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
146767086|NCT01212757|529314703|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
146767087|NCT01212757|529314704|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
146767088|NCT01212757|529314696|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
146767089|NCT01212757|529314697|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
146767090|NCT01212757|529314698|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
146767091|NCT01212757|529314699|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
146767092|NCT01212757|529314700|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
146767093|NCT01212757|529314701|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
146767094|NCT01212757|529314702|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
146767095|NCT01212757|529314703|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
146767096|NCT01212757|529314704|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
146767097|NCT01212757|529314696|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
146767098|NCT01212757|529314697|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
146767099|NCT01212757|529314698|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
146899842|NCT01085682|529796394|FG000|Overall Study|Withdrawal by Subject|25|||
146899843|NCT01085682|529796395|FG001|Overall Study|Withdrawal by Subject|25|||
146899844|NCT01451645|529796396|FG000|Overall Study|Protocol Violation|1|||
146899845|NCT01451645|529796397|FG001|Overall Study|Protocol Violation|0|||
146899846|NCT01451645|529796396|FG000|Overall Study|Adverse Event|0|||
146899847|NCT01451645|529796397|FG001|Overall Study|Adverse Event|3|||
146899848|NCT01451645|529796396|FG000|Overall Study|Withdrawal by Subject|4|||
146899849|NCT01451645|529796397|FG001|Overall Study|Withdrawal by Subject|2|||
146899850|NCT01451645|529796396|FG000|Overall Study|Lost to Follow-up|4|||
146899851|NCT01451645|529796397|FG001|Overall Study|Lost to Follow-up|3|||
146899852|NCT02207907|529796408|FG000|Overall Study|Lost to Follow-up|3|||
146899853|NCT02207907|529796409|FG001|Overall Study|Lost to Follow-up|1|||
146899854|NCT02207907|529796408|FG000|Overall Study|Withdrawal by Subject|5|||
146899855|NCT02207907|529796409|FG001|Overall Study|Withdrawal by Subject|6|||
146899856|NCT02207907|529796408|FG000|Overall Study|Did not meet study criteria|3|||
146899857|NCT02207907|529796409|FG001|Overall Study|Did not meet study criteria|0|||
146899858|NCT02207907|529796408|FG000|Overall Study|Pregnancy|0|||
146899859|NCT02207907|529796409|FG001|Overall Study|Pregnancy|1|||
146899860|NCT02209506|529796412|FG000|Overall Study|Withdrawal by Subject|0|||
146899861|NCT02209506|529796413|FG001|Overall Study|Withdrawal by Subject|0|||
146899862|NCT02209506|529796414|FG002|Overall Study|Withdrawal by Subject|0|||
146899863|NCT02209506|529796415|FG003|Overall Study|Withdrawal by Subject|0|||
146899864|NCT02209506|529796416|FG004|Overall Study|Withdrawal by Subject|1|||
146899865|NCT01147809|529796419|FG000|Phase I (168 Days)|Adverse Event|0|||
146899866|NCT01147809|529796420|FG001|Phase I (168 Days)|Adverse Event|0|||
146899867|NCT01147809|529796421|FG002|Phase I (168 Days)|Adverse Event|0|||
146899868|NCT01147809|529796422|FG003|Phase I (168 Days)|Adverse Event|1|||
146899869|NCT01147809|529796423|FG004|Phase I (168 Days)|Adverse Event|0|||
146899870|NCT01147809|529796424|FG005|Phase I (168 Days)|Adverse Event|0|||
146899871|NCT01147809|529796419|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
146899872|NCT01147809|529796420|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
146899873|NCT01147809|529796421|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
146899874|NCT01147809|529796422|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
146899875|NCT01147809|529796423|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
146899876|NCT01147809|529796424|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
146899877|NCT01147809|529796419|FG000|Phase I (168 Days)|Physician Decision|0|||
146899878|NCT01147809|529796420|FG001|Phase I (168 Days)|Physician Decision|1|||
146899879|NCT01147809|529796421|FG002|Phase I (168 Days)|Physician Decision|2|||
146899880|NCT01147809|529796422|FG003|Phase I (168 Days)|Physician Decision|0|||
146899881|NCT01147809|529796423|FG004|Phase I (168 Days)|Physician Decision|0|||
146899882|NCT01147809|529796424|FG005|Phase I (168 Days)|Physician Decision|0|||
146899883|NCT01147809|529796419|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
146899884|NCT01147809|529796420|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
146899885|NCT01147809|529796421|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
146899886|NCT01147809|529796422|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
146899887|NCT01147809|529796423|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
146899888|NCT01147809|529796424|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
146899889|NCT01147809|529796419|FG000|Phase II (168 Days)|Adverse Event|0|||
146899890|NCT01147809|529796420|FG001|Phase II (168 Days)|Adverse Event|0|||
146899891|NCT01147809|529796421|FG002|Phase II (168 Days)|Adverse Event|0|||
146899892|NCT01147809|529796422|FG003|Phase II (168 Days)|Adverse Event|0|||
146899893|NCT01147809|529796423|FG004|Phase II (168 Days)|Adverse Event|3|||
146899894|NCT01147809|529796424|FG005|Phase II (168 Days)|Adverse Event|6|||
146899895|NCT01147809|529796419|FG000|Phase II (168 Days)|Protocol Violation|0|||
146899896|NCT01147809|529796420|FG001|Phase II (168 Days)|Protocol Violation|0|||
146899897|NCT01147809|529796421|FG002|Phase II (168 Days)|Protocol Violation|0|||
146899898|NCT01147809|529796422|FG003|Phase II (168 Days)|Protocol Violation|0|||
146899899|NCT01147809|529796423|FG004|Phase II (168 Days)|Protocol Violation|0|||
146899900|NCT01147809|529796424|FG005|Phase II (168 Days)|Protocol Violation|1|||
146899901|NCT01147809|529796419|FG000|Phase II (168 Days)|Physician Decision|0|||
146899902|NCT01147809|529796420|FG001|Phase II (168 Days)|Physician Decision|0|||
146899903|NCT01147809|529796421|FG002|Phase II (168 Days)|Physician Decision|0|||
146899904|NCT01147809|529796422|FG003|Phase II (168 Days)|Physician Decision|0|||
146899905|NCT01147809|529796423|FG004|Phase II (168 Days)|Physician Decision|5|||
146899906|NCT01147809|529796424|FG005|Phase II (168 Days)|Physician Decision|11|||
146899907|NCT01147809|529796419|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
146899908|NCT01147809|529796420|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
146899909|NCT01147809|529796421|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
146899910|NCT01147809|529796422|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
146899911|NCT01147809|529796423|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
146899912|NCT01147809|529796424|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
146899913|NCT01147809|529796419|FG000|Phase II (168 Days)|Ongoing|0|||
146899914|NCT01147809|529796420|FG001|Phase II (168 Days)|Ongoing|0|||
146899915|NCT01147809|529796421|FG002|Phase II (168 Days)|Ongoing|0|||
146899916|NCT01147809|529796422|FG003|Phase II (168 Days)|Ongoing|0|||
146899917|NCT01147809|529796423|FG004|Phase II (168 Days)|Ongoing|1|||
146899918|NCT01147809|529796424|FG005|Phase II (168 Days)|Ongoing|0|||
146899919|NCT01307423|529796425|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
146899920|NCT01307423|529796426|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
146899921|NCT01307423|529796427|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
146899922|NCT01307423|529796428|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146899923|NCT01307423|529796429|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146899924|NCT01307423|529796430|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146899925|NCT01307423|529796431|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146899926|NCT01307423|529796432|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146899927|NCT01307423|529796433|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146899928|NCT01307423|529796425|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
146899929|NCT01307423|529796426|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
146899930|NCT01307423|529796427|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
146899931|NCT01307423|529796428|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146899932|NCT01307423|529796429|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146899933|NCT01307423|529796430|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146899934|NCT01307423|529796431|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146899935|NCT01307423|529796432|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146899936|NCT01307423|529796433|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146899937|NCT01307423|529796425|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
146899938|NCT01307423|529796426|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
146899939|NCT01307423|529796427|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
146899940|NCT01307423|529796428|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146899941|NCT01307423|529796429|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146899942|NCT01307423|529796430|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146899943|NCT01307423|529796431|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146899944|NCT01307423|529796432|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146899945|NCT01307423|529796433|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146899946|NCT01307423|529796425|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146899947|NCT01307423|529796426|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146899948|NCT01307423|529796427|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
146899949|NCT01307423|529796428|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146899950|NCT01307423|529796429|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146899951|NCT01307423|529796430|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146899952|NCT01307423|529796431|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146899953|NCT01307423|529796432|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146899954|NCT01307423|529796433|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146899955|NCT01307423|529796425|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
146899956|NCT01307423|529796426|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
146899957|NCT01307423|529796427|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
146899958|NCT01307423|529796428|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146899959|NCT01307423|529796429|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146899960|NCT01307423|529796430|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146899961|NCT01307423|529796431|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146899962|NCT01307423|529796432|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146899963|NCT01307423|529796433|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146899964|NCT01307423|529796425|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
146899965|NCT01307423|529796426|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146899966|NCT01307423|529796427|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146899967|NCT01307423|529796428|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146899968|NCT01307423|529796429|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146899969|NCT01307423|529796430|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146899970|NCT01307423|529796431|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146899971|NCT01307423|529796432|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146559743|NCT04134936|528559412|FG001|Overall Study|Adverse Event|2|||
146559744|NCT04134936|528559411|FG000|Overall Study|Withdrawal by Subject|2|||
146559745|NCT04134936|528559412|FG001|Overall Study|Withdrawal by Subject|3|||
146899972|NCT01307423|529796433|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146899973|NCT01307423|529796425|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
146899974|NCT01307423|529796426|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
146899975|NCT01307423|529796427|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146899976|NCT01307423|529796428|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146899977|NCT01307423|529796429|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146899978|NCT01307423|529796430|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146899979|NCT01307423|529796431|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146899980|NCT01307423|529796432|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146899981|NCT01307423|529796433|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146899982|NCT01307423|529796425|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
146899983|NCT01307423|529796426|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
146899984|NCT01307423|529796427|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
146559746|NCT04134936|528559411|FG000|Overall Study|Physician Decision|0|||
146559747|NCT04134936|528559412|FG001|Overall Study|Physician Decision|1|||
146559748|NCT04134936|528559411|FG000|Overall Study|Progressive disease, joined another trial|1|||
146969294|NCT00572910|530047369|FG007|Overall Study|Withdrawal by Subject|2|||
146969295|NCT00572910|530047370|FG008|Overall Study|Withdrawal by Subject|2|||
146969296|NCT00572910|530047371|FG009|Overall Study|Withdrawal by Subject|2|||
146969297|NCT00572910|530047372|FG010|Overall Study|Withdrawal by Subject|1|||
146969298|NCT02230332|530047373|FG000|Overall Study|Adverse Event|2|||
146969299|NCT02230332|530047374|FG001|Overall Study|Adverse Event|1|||
146969300|NCT02230332|530047373|FG000|Overall Study|Lost to Follow-up|1|||
146969301|NCT02230332|530047374|FG001|Overall Study|Lost to Follow-up|0|||
146969302|NCT02230332|530047373|FG000|Overall Study|Protocol Violation|1|||
146969303|NCT02230332|530047374|FG001|Overall Study|Protocol Violation|0|||
146969304|NCT01260194|530047375|FG000|Overall Study|Withdrawal of Consent|1|||
146969305|NCT00592007|530047376|FG000|Overall Study|Withdrawal by Subject|1|||
146969306|NCT00592007|530047376|FG000|Overall Study|patient ineligible (out of lab range)|1|||
146969307|NCT04054011|530047377|FG000|Overall Study|COVID|3|||
146969308|NCT00595127|530047378|FG000|Overall Study|Death|6|||
146969309|NCT00595127|530047378|FG000|Overall Study|Relapsed|3|||
146969310|NCT00595127|530047378|FG000|Overall Study|joined another trial|1|||
146969311|NCT00538473|530047379|FG000|Overall Study|Adverse Event|1|||
146969312|NCT00538473|530047380|FG001|Overall Study|Adverse Event|0|||
146969313|NCT01569074|530047381|FG000|Overall Study|Study stopped|6|||
146767100|NCT01212757|529314699|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
146767101|NCT01212757|529314700|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
146767102|NCT01212757|529314701|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
146969314|NCT01569074|530047382|FG001|Overall Study|Study stopped|6|||
146969315|NCT01569074|530047383|FG002|Overall Study|Study stopped|8|||
146969316|NCT01569074|530047384|FG003|Overall Study|Study stopped|7|||
146969317|NCT01569074|530047385|FG004|Overall Study|Study stopped|7|||
146969318|NCT01569074|530047381|FG000|Overall Study|Study-specific discontinuation criteria|0|||
146969319|NCT01569074|530047382|FG001|Overall Study|Study-specific discontinuation criteria|1|||
146969320|NCT01569074|530047383|FG002|Overall Study|Study-specific discontinuation criteria|0|||
146969321|NCT01569074|530047384|FG003|Overall Study|Study-specific discontinuation criteria|0|||
146969322|NCT01569074|530047385|FG004|Overall Study|Study-specific discontinuation criteria|0|||
146969323|NCT01569074|530047381|FG000|Overall Study|Severe non-compliance to protocol|0|||
146969324|NCT01569074|530047382|FG001|Overall Study|Severe non-compliance to protocol|0|||
146899985|NCT01307423|529796428|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
146899986|NCT01307423|529796429|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
146899987|NCT01307423|529796430|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
146899988|NCT01307423|529796431|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
146899989|NCT01307423|529796432|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
146899990|NCT01307423|529796433|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
146899991|NCT01307423|529796425|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
146899992|NCT01307423|529796426|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
146899993|NCT01307423|529796427|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
146899994|NCT01307423|529796428|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
146899995|NCT01307423|529796429|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
146899996|NCT01307423|529796430|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
146899997|NCT01307423|529796431|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
146899998|NCT01307423|529796432|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
146899999|NCT01307423|529796433|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
146900000|NCT01307423|529796425|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
146900001|NCT01307423|529796426|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
146900002|NCT01307423|529796427|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
146900003|NCT01307423|529796428|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
146900004|NCT01307423|529796429|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
146900005|NCT01307423|529796430|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
146900006|NCT01307423|529796431|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
146900007|NCT01307423|529796432|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
146900008|NCT01307423|529796433|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
146900009|NCT01307423|529796425|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
146900010|NCT01307423|529796426|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
146900011|NCT01307423|529796427|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
146900012|NCT01307423|529796428|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
146900013|NCT01307423|529796429|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
146969325|NCT01569074|530047383|FG002|Overall Study|Severe non-compliance to protocol|1|||
146969326|NCT01569074|530047384|FG003|Overall Study|Severe non-compliance to protocol|0|||
146767103|NCT01212757|529314702|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
146969327|NCT01569074|530047385|FG004|Overall Study|Severe non-compliance to protocol|0|||
146969328|NCT01569074|530047381|FG000|Overall Study|eg change in circumstances|0|||
146969329|NCT01569074|530047382|FG001|Overall Study|eg change in circumstances|2|||
146900014|NCT01307423|529796430|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
146900015|NCT01307423|529796431|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
146900016|NCT01307423|529796432|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
146900017|NCT01307423|529796433|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
146900018|NCT01307423|529796425|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
146900019|NCT01307423|529796426|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
146900020|NCT01307423|529796427|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
146900021|NCT01307423|529796428|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
146900022|NCT01307423|529796429|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
146900023|NCT01307423|529796430|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
146900024|NCT01307423|529796431|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
146900025|NCT01307423|529796432|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
146900026|NCT01307423|529796433|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
146900027|NCT01307423|529796425|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
146900028|NCT01307423|529796426|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
146900029|NCT01307423|529796427|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
146900030|NCT01307423|529796428|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
146900031|NCT01307423|529796429|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
146900032|NCT01307423|529796430|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
146900033|NCT01307423|529796431|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
146900034|NCT01307423|529796432|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
146900035|NCT01307423|529796433|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
146900036|NCT01307423|529796425|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
146900037|NCT01307423|529796426|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
146900038|NCT01307423|529796427|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
146900039|NCT01307423|529796428|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
146900040|NCT01307423|529796429|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
146900041|NCT01307423|529796430|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
146900042|NCT01307423|529796431|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
146900043|NCT01307423|529796432|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
146900044|NCT01307423|529796433|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
146900045|NCT01307423|529796425|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
146900046|NCT01307423|529796426|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
146900047|NCT01307423|529796427|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
146900048|NCT01307423|529796428|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
146900049|NCT01307423|529796429|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
146900050|NCT01307423|529796430|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
146900051|NCT01307423|529796431|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
146900052|NCT01307423|529796432|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
146900053|NCT01307423|529796433|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
146900054|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146900055|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
146900056|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
146900057|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146900058|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146900059|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146900060|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146900061|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
146900062|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
146900063|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146900064|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
146900065|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
146900066|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146900067|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146900068|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146900069|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146900070|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
146900071|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
146900072|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
146900073|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
146900074|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
146900075|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
146900076|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
146900077|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
146900078|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
146559749|NCT04134936|528559412|FG001|Overall Study|Progressive disease, joined another trial|0|||
146900079|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
146900080|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
146900081|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146900082|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
146900083|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
146900084|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146900085|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146900086|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146900087|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146900088|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
146900089|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
146900090|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146900091|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
146900092|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146900093|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146900094|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146900095|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146900096|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146900097|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
146900098|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
146900099|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146900100|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
146900101|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
146900102|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146900103|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146900104|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146900105|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146900106|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
146900107|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
146900108|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146900109|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
146900110|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
146900111|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146900112|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146900113|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146900114|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146969330|NCT01569074|530047383|FG002|Overall Study|eg change in circumstances|0|||
146559750|NCT04134936|528559411|FG000|Overall Study|Progressive disease|1|||
146559751|NCT04134936|528559412|FG001|Overall Study|Progressive disease|0|||
146559752|NCT03518060|528559413|FG000|Overall Study|Death|1|||
146559753|NCT03518060|528559413|FG000|Overall Study|Poor adherence|1|||
146559754|NCT03518060|528559413|FG000|Overall Study|Withdrawal of informed consent|2|||
146969331|NCT01569074|530047384|FG003|Overall Study|eg change in circumstances|1|||
146969332|NCT01569074|530047385|FG004|Overall Study|eg change in circumstances|1|||
146969333|NCT01569074|530047381|FG000|Overall Study|Adverse Event|1|||
146969334|NCT01569074|530047382|FG001|Overall Study|Adverse Event|0|||
146969335|NCT01569074|530047383|FG002|Overall Study|Adverse Event|3|||
146969336|NCT01569074|530047384|FG003|Overall Study|Adverse Event|0|||
146969337|NCT01569074|530047385|FG004|Overall Study|Adverse Event|0|||
146969338|NCT01036594|530047391|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
146969339|NCT01036594|530047392|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
146969340|NCT01036594|530047391|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
146969341|NCT01036594|530047392|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
146969342|NCT01036594|530047391|FG000|Week 12 Evaluation|Adverse Event|5|||
146969343|NCT01036594|530047392|FG001|Week 12 Evaluation|Adverse Event|0|||
146969344|NCT01036594|530047391|FG000|Week 12 Evaluation|Physician Decision|1|||
146969345|NCT01036594|530047392|FG001|Week 12 Evaluation|Physician Decision|0|||
146969346|NCT01036594|530047391|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
146559755|NCT03518060|528559413|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
146559756|NCT03518060|528559413|FG000|Overall Study|Physician Decision|7|||
146559757|NCT03518060|528559413|FG000|Overall Study|Adverse drug reactions|23|||
146640466|NCT02529553|528859281|FG007|Overall Study|Physician Decision|0|||
146969347|NCT01036594|530047392|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
146969348|NCT01036594|530047391|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
146559758|NCT03518060|528559413|FG000|Overall Study|Withdrawal by Subject|25|||
146640467|NCT02529553|528859282|FG008|Overall Study|Physician Decision|0|||
146559759|NCT03518060|528559413|FG000|Overall Study|Lost to Follow-up|13|||
146559760|NCT00323622|528559415|FG000|Overall Study|Other|30|||
146640468|NCT02529553|528859274|FG000|Overall Study|Withdrawal by Subject|0|||
146900115|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
146900116|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
146559761|NCT00323622|528559416|FG001|Overall Study|Other|91|||
146559762|NCT00323622|528559417|FG002|Overall Study|Other|4|||
146559763|NCT00323622|528559418|FG003|Overall Study|Other|12|||
146559764|NCT00323622|528559419|FG004|Overall Study|Other|32|||
146559765|NCT00323622|528559420|FG005|Overall Study|Other|74|||
146767104|NCT01212757|529314703|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
146767105|NCT01212757|529314704|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
146969349|NCT01036594|530047392|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
146900117|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
146969350|NCT01036594|530047391|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
146969351|NCT01036594|530047392|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
146969352|NCT01036594|530047391|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
146969353|NCT01036594|530047392|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
146969354|NCT01036594|530047391|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
146969355|NCT01036594|530047392|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
146969356|NCT00244881|530047393|FG000|Overall Study|Withdrawal by Subject|3|||
146969357|NCT03345485|530047394|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
146969358|NCT03345485|530047395|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
146969359|NCT03345485|530047396|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
146969360|NCT03345485|530047397|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
146969361|NCT03345485|530047398|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
146969362|NCT03345485|530047399|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
146969363|NCT03345485|530047400|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
146969364|NCT03345485|530047401|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
146969365|NCT03345485|530047402|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
146969366|NCT03345485|530047403|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
146900118|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
146900119|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
146900120|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
146900121|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
146900122|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
146900123|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
146900124|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
146900125|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
146900126|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146900127|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
146900128|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
146900129|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146900130|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146900131|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146900132|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146969367|NCT03345485|530047404|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
146969368|NCT03345485|530047405|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
146969369|NCT03345485|530047406|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
146969370|NCT01610284|530047407|FG000|Randomization Phase|Adverse Event|1|||
146969371|NCT01610284|530047408|FG001|Randomization Phase|Adverse Event|0|||
146969372|NCT01610284|530047407|FG000|Randomization Phase|Physician Decision|1|||
146969373|NCT01610284|530047408|FG001|Randomization Phase|Physician Decision|1|||
146969374|NCT01610284|530047407|FG000|Randomization Phase|Death|0|||
146969375|NCT01610284|530047408|FG001|Randomization Phase|Death|1|||
146969376|NCT01610284|530047407|FG000|Treatment Phase|Adverse Event|80|||
146969377|NCT01610284|530047408|FG001|Treatment Phase|Adverse Event|12|||
146969378|NCT01610284|530047407|FG000|Treatment Phase|Lost to Follow-up|1|||
146969379|NCT01610284|530047408|FG001|Treatment Phase|Lost to Follow-up|0|||
146969380|NCT01610284|530047407|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
146969381|NCT01610284|530047408|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
146900133|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
146969382|NCT01610284|530047407|FG000|Treatment Phase|Physician Decision|27|||
146969383|NCT01610284|530047408|FG001|Treatment Phase|Physician Decision|24|||
146559766|NCT00323622|528559421|FG006|Overall Study|Other|5|||
146559767|NCT00323622|528559422|FG007|Overall Study|Other|13|||
146969384|NCT01610284|530047407|FG000|Treatment Phase|Progressive Disease|377|||
146969385|NCT01610284|530047408|FG001|Treatment Phase|Progressive Disease|486|||
146969386|NCT01610284|530047407|FG000|Treatment Phase|Protocol Deviation|2|||
146969387|NCT01610284|530047408|FG001|Treatment Phase|Protocol Deviation|3|||
146969388|NCT01610284|530047407|FG000|Treatment Phase|Study terminated by Sponsor|18|||
146559768|NCT00323622|528559415|FG000|Overall Study|Death|1|||
146559769|NCT00323622|528559416|FG001|Overall Study|Death|1|||
146559770|NCT00323622|528559417|FG002|Overall Study|Death|0|||
146559771|NCT00323622|528559418|FG003|Overall Study|Death|0|||
146559772|NCT00323622|528559419|FG004|Overall Study|Death|7|||
146767106|NCT01212757|529314696|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
146767107|NCT01212757|529314697|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
146767108|NCT01212757|529314698|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
146767109|NCT01212757|529314699|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
146767110|NCT01212757|529314700|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
146767111|NCT01212757|529314701|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
146767112|NCT01212757|529314702|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
146900134|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
146900135|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146900136|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
146900137|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
146900138|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146900139|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146900140|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146900141|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146900142|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
146900143|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
146900144|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146900145|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
146900146|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146900147|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146900148|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146900149|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146900150|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146900151|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
146900152|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146767113|NCT01212757|529314703|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
146767114|NCT01212757|529314704|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
146767115|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
146767116|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
146767117|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
146767118|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
146767119|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
146767120|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
146767121|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
146767122|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
146767123|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
146767124|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
146767125|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
146767126|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
146767127|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
146767128|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
146767129|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
146767130|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
146767131|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
146900153|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146900154|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
146900155|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146900156|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146900157|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146900158|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146900159|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146900160|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146900161|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146900162|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146900163|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
146900164|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146900165|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146900166|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146900167|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146900168|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146900169|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146900170|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
146900171|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146900172|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
146767132|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
146900173|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
146900174|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146900175|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146969389|NCT01610284|530047408|FG001|Treatment Phase|Study terminated by Sponsor|15|||
146969390|NCT01610284|530047407|FG000|Treatment Phase|Subject/Guardian Decision|55|||
146969391|NCT01610284|530047408|FG001|Treatment Phase|Subject/Guardian Decision|23|||
146969392|NCT01610284|530047407|FG000|Treatment Phase|Death|6|||
146969393|NCT01610284|530047408|FG001|Treatment Phase|Death|5|||
146900176|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146900177|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146900178|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
146900179|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
146900180|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146900181|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146900182|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
146900183|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146900184|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146900185|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146900186|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146900187|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146900188|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146900189|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146900190|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146900191|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146900192|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146900193|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146900194|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146900195|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146900196|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
146900197|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146900198|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146900199|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
146900200|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
146900201|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146900202|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146900203|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146900204|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146900205|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146900206|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
146900207|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146900208|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
146900209|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
146900210|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146900211|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146900212|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146900213|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146900214|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146900215|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146900216|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146900217|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
146900218|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
146900219|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146900220|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146900221|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146900222|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146900223|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146900224|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
146900225|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
146900226|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
146900227|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
146900228|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
146900229|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
146900230|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
146969394|NCT01610284|530047407|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
146969395|NCT01610284|530047408|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
146900231|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
146969396|NCT01610284|530047407|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
146900232|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
146900233|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
146900234|NCT01307423|529796425|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146969397|NCT01610284|530047408|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
146969398|NCT01610284|530047407|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
146900235|NCT01307423|529796426|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146900236|NCT01307423|529796427|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
146900237|NCT01307423|529796428|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146900238|NCT01307423|529796429|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146900239|NCT01307423|529796430|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146900240|NCT01307423|529796431|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146767133|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
146767134|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
146767135|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
146767136|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
146767137|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
146767138|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
146767139|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
146767140|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
146767141|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
146767142|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146767143|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
146767144|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
146767145|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146767146|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146767147|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146767148|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146767149|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
146767150|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
146767151|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
146767152|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
146767153|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
146767154|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
146767155|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
146767156|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
146767157|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
146767158|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
146767159|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
146767160|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
146767161|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
146767162|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
146767163|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
146767164|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
146767165|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
146767166|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
146767167|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
146767168|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
146767169|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
146767170|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
146767171|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
146767172|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
146767173|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
146767174|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
146767175|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
146767176|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
146767177|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
146767178|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
146767179|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
146767180|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
146767181|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
146767182|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
146767183|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
146767184|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
146767185|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
146767186|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
146767187|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146767188|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
146767189|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
146767190|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146900241|NCT01307423|529796432|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
146900242|NCT01307423|529796433|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
146900243|NCT01499290|529796434|FG000|Overall Study|Withdrawal by Subject|22|||
146767191|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146559773|NCT00323622|528559420|FG005|Overall Study|Death|0|||
146969399|NCT01610284|530047408|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
146969400|NCT01610284|530047407|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
146969401|NCT01610284|530047408|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
146969402|NCT01610284|530047407|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
146969403|NCT01610284|530047408|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
146969404|NCT01610284|530047407|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
146969405|NCT01610284|530047408|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
146969406|NCT01125358|530047412|FG000|Overall Study|Adverse Event|3|||
146969407|NCT01125358|530047413|FG001|Overall Study|Adverse Event|0|||
146969408|NCT01125358|530047414|FG002|Overall Study|Adverse Event|0|||
146969409|NCT01125358|530047415|FG003|Overall Study|Adverse Event|2|||
146969410|NCT01125358|530047412|FG000|Overall Study|Perceived Lack of Efficacy|6|||
146969411|NCT01125358|530047413|FG001|Overall Study|Perceived Lack of Efficacy|3|||
146969412|NCT01125358|530047414|FG002|Overall Study|Perceived Lack of Efficacy|7|||
146969413|NCT01125358|530047415|FG003|Overall Study|Perceived Lack of Efficacy|4|||
146969414|NCT01125358|530047412|FG000|Overall Study|Protocol Violation|1|||
146969415|NCT01125358|530047413|FG001|Overall Study|Protocol Violation|0|||
146969416|NCT01125358|530047414|FG002|Overall Study|Protocol Violation|0|||
146969417|NCT01125358|530047415|FG003|Overall Study|Protocol Violation|0|||
146969418|NCT01125358|530047412|FG000|Overall Study|Sponsor Decision|0|||
146969419|NCT01125358|530047413|FG001|Overall Study|Sponsor Decision|0|||
146969420|NCT01125358|530047414|FG002|Overall Study|Sponsor Decision|1|||
146969421|NCT01125358|530047415|FG003|Overall Study|Sponsor Decision|1|||
146969422|NCT01125358|530047412|FG000|Overall Study|Withdrawal by Subject|2|||
146969423|NCT01125358|530047413|FG001|Overall Study|Withdrawal by Subject|1|||
146969424|NCT01125358|530047414|FG002|Overall Study|Withdrawal by Subject|1|||
146969425|NCT01125358|530047415|FG003|Overall Study|Withdrawal by Subject|1|||
146969426|NCT01060007|530047416|FG000|Overall Study|Withdrawal by Subject|1|||
146969427|NCT01060007|530047416|FG000|Overall Study|Inevaluable for response at surgery|3|||
146969428|NCT05168657|530047417|FG000|Overall Study|Adverse Event|0|||
146969429|NCT05168657|530047418|FG001|Overall Study|Adverse Event|0|||
146969430|NCT05168657|530047419|FG002|Overall Study|Adverse Event|1|||
146969431|NCT05168657|530047420|FG003|Overall Study|Adverse Event|0|||
146969432|NCT05168657|530047421|FG004|Overall Study|Adverse Event|0|||
146559774|NCT00323622|528559421|FG006|Overall Study|Death|0|||
146559775|NCT00323622|528559422|FG007|Overall Study|Death|2|||
146559776|NCT00835354|528559423|FG000|First Intervention|Adverse Event|0|||
146559777|NCT00835354|528559424|FG001|First Intervention|Adverse Event|1|||
146559778|NCT02097225|528559429|FG000|Dose Level 4|Adverse Event|0|||
146559779|NCT02097225|528559430|FG001|Dose Level 4|Adverse Event|0|||
146559780|NCT02097225|528559431|FG002|Dose Level 4|Adverse Event|0|||
146559781|NCT02097225|528559432|FG003|Dose Level 4|Adverse Event|0|||
146969433|NCT05168657|530047422|FG005|Overall Study|Adverse Event|0|||
146969434|NCT05168657|530047423|FG006|Overall Study|Adverse Event|0|||
146969435|NCT05168657|530047424|FG007|Overall Study|Adverse Event|0|||
146969436|NCT03159611|530047427|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
146969437|NCT03159611|530047428|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
146969438|NCT03159611|530047427|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
146969439|NCT03159611|530047428|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
146969440|NCT03159611|530047427|FG000|Overall Study|Protocol Violation|7|||
146969441|NCT03159611|530047428|FG001|Overall Study|Protocol Violation|4|||
146969442|NCT03159611|530047427|FG000|Overall Study|Adverse Event|1|||
146969443|NCT03159611|530047428|FG001|Overall Study|Adverse Event|0|||
146969444|NCT03159611|530047427|FG000|Overall Study|Withdrawal by Subject|1|||
146969445|NCT03159611|530047428|FG001|Overall Study|Withdrawal by Subject|1|||
146969446|NCT03159611|530047427|FG000|Overall Study|Non-compliance with protocol requirement|3|||
146969447|NCT03159611|530047428|FG001|Overall Study|Non-compliance with protocol requirement|2|||
146969448|NCT03159611|530047427|FG000|Overall Study|Inability to perform procedures|1|||
146969449|NCT03159611|530047428|FG001|Overall Study|Inability to perform procedures|0|||
146969450|NCT01984229|530047429|FG000|Safety Follow-up Period|Adverse Event|1|||
146969451|NCT01984229|530047430|FG001|Safety Follow-up Period|Adverse Event|1|||
146559782|NCT02097225|528559433|FG004|Dose Level 4|Adverse Event|1|||
146559783|NCT01852214|528559435|FG000|Period 1|Adverse Event|1|||
146559784|NCT01852214|528559436|FG001|Period 1|Adverse Event|2|||
146559785|NCT01852214|528559435|FG000|Period 1|Withdrawal by Subject|0|||
146559786|NCT01852214|528559436|FG001|Period 1|Withdrawal by Subject|1|||
146969452|NCT01984229|530047429|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
146969453|NCT01984229|530047430|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
146969454|NCT02072174|530047431|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
146969455|NCT02072174|530047432|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
146969456|NCT02072174|530047431|FG000|Overall Study|Protocol Violation|16|||
146969457|NCT02072174|530047432|FG001|Overall Study|Protocol Violation|23|||
146969458|NCT02072174|530047431|FG000|Overall Study|Physician Decision|0|||
146969459|NCT02072174|530047432|FG001|Overall Study|Physician Decision|1|||
146969460|NCT02072174|530047431|FG000|Overall Study|Non-compliance with protocol requirement|2|||
146900244|NCT01499290|529796435|FG001|Overall Study|Withdrawal by Subject|15|||
146900245|NCT01499290|529796434|FG000|Overall Study|Not specified in study report|11|||
146900246|NCT01499290|529796435|FG001|Overall Study|Not specified in study report|5|||
146767192|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146767193|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146767194|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
146767195|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
146900247|NCT01499290|529796434|FG000|Overall Study|Condition improved/subject recovered|1|||
146900248|NCT01499290|529796435|FG001|Overall Study|Condition improved/subject recovered|0|||
146900249|NCT01499290|529796434|FG000|Overall Study|Lack of Efficacy|7|||
146900250|NCT01499290|529796435|FG001|Overall Study|Lack of Efficacy|8|||
146900251|NCT01499290|529796434|FG000|Overall Study|Adverse Event|14|||
146900252|NCT01499290|529796435|FG001|Overall Study|Adverse Event|7|||
146900253|NCT00327444|529796436|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
146900254|NCT00327444|529796437|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
146900255|NCT00327444|529796436|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
146900256|NCT00327444|529796437|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
146900257|NCT00327444|529796436|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
146900258|NCT00327444|529796437|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
146900259|NCT00327444|529796436|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
146900260|NCT00327444|529796437|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
146900261|NCT00327444|529796436|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
146900262|NCT00327444|529796437|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
146900263|NCT00327444|529796436|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
146900264|NCT00327444|529796437|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
146900265|NCT00327444|529796436|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
146900266|NCT00327444|529796437|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
146900267|NCT00327444|529796436|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
146900268|NCT00327444|529796437|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
146900269|NCT00805207|529796438|FG000|Overall Study|Protocol Violation|0|||
146900270|NCT00805207|529796439|FG001|Overall Study|Protocol Violation|0|||
146900271|NCT00805207|529796440|FG002|Overall Study|Protocol Violation|1|||
146900272|NCT00805207|529796441|FG003|Overall Study|Protocol Violation|0|||
146900273|NCT00805207|529796442|FG004|Overall Study|Protocol Violation|0|||
146900274|NCT00805207|529796443|FG005|Overall Study|Protocol Violation|0|||
146900275|NCT00805207|529796444|FG006|Overall Study|Protocol Violation|0|||
146900276|NCT00805207|529796445|FG007|Overall Study|Protocol Violation|0|||
146900277|NCT00805207|529796446|FG008|Overall Study|Protocol Violation|0|||
146900278|NCT00805207|529796438|FG000|Overall Study|Physician Decision|0|||
146900279|NCT00805207|529796439|FG001|Overall Study|Physician Decision|1|||
146900280|NCT00805207|529796440|FG002|Overall Study|Physician Decision|0|||
146900281|NCT00805207|529796441|FG003|Overall Study|Physician Decision|0|||
146900282|NCT00805207|529796442|FG004|Overall Study|Physician Decision|0|||
146900283|NCT00805207|529796443|FG005|Overall Study|Physician Decision|1|||
146900284|NCT00805207|529796444|FG006|Overall Study|Physician Decision|0|||
146900285|NCT00805207|529796445|FG007|Overall Study|Physician Decision|0|||
146900286|NCT00805207|529796446|FG008|Overall Study|Physician Decision|0|||
146900287|NCT00805207|529796438|FG000|Overall Study|Withdrawal by Subject|0|||
146900288|NCT00805207|529796439|FG001|Overall Study|Withdrawal by Subject|1|||
146767196|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
146767197|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
146767198|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
146767199|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
146767200|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
146767201|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
146767202|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
146767203|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
146767204|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
146767205|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
146767206|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
146767207|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
146767208|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
146900289|NCT00805207|529796440|FG002|Overall Study|Withdrawal by Subject|0|||
146900290|NCT00805207|529796441|FG003|Overall Study|Withdrawal by Subject|0|||
146900291|NCT00805207|529796442|FG004|Overall Study|Withdrawal by Subject|1|||
146900292|NCT00805207|529796443|FG005|Overall Study|Withdrawal by Subject|2|||
146900293|NCT00805207|529796444|FG006|Overall Study|Withdrawal by Subject|0|||
146767209|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
146767210|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
146900294|NCT00805207|529796445|FG007|Overall Study|Withdrawal by Subject|0|||
146900295|NCT00805207|529796446|FG008|Overall Study|Withdrawal by Subject|0|||
146900296|NCT00064701|529796447|FG000|One Year Post-transplant|Did not receive study drug|7|||
146559787|NCT01852214|528559435|FG000|Washout Period|Withdrawal by Subject|0|||
146900297|NCT00064701|529796448|FG001|One Year Post-transplant|Did not receive study drug|12|||
146900298|NCT00064701|529796449|FG002|One Year Post-transplant|Did not receive study drug|11|||
146900299|NCT00064701|529796447|FG000|One Year Post-transplant|Adverse Event|23|||
146900300|NCT00064701|529796448|FG001|One Year Post-transplant|Adverse Event|19|||
146900301|NCT00064701|529796449|FG002|One Year Post-transplant|Adverse Event|37|||
146900302|NCT00064701|529796447|FG000|One Year Post-transplant|Rejection|0|||
146900303|NCT00064701|529796448|FG001|One Year Post-transplant|Rejection|1|||
146900304|NCT00064701|529796449|FG002|One Year Post-transplant|Rejection|16|||
146900305|NCT00064701|529796447|FG000|One Year Post-transplant|Non-compliance|4|||
146900306|NCT00064701|529796448|FG001|One Year Post-transplant|Non-compliance|2|||
146900307|NCT00064701|529796449|FG002|One Year Post-transplant|Non-compliance|5|||
146900308|NCT00064701|529796447|FG000|One Year Post-transplant|Graft Failure|3|||
146900309|NCT00064701|529796448|FG001|One Year Post-transplant|Graft Failure|2|||
146900310|NCT00064701|529796449|FG002|One Year Post-transplant|Graft Failure|1|||
146900311|NCT00064701|529796447|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
146900312|NCT00064701|529796448|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
146900313|NCT00064701|529796449|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
146900314|NCT00064701|529796447|FG000|One Year Post-transplant|Lost to Follow-up|1|||
146900315|NCT00064701|529796448|FG001|One Year Post-transplant|Lost to Follow-up|0|||
146900316|NCT00064701|529796449|FG002|One Year Post-transplant|Lost to Follow-up|0|||
146900317|NCT00064701|529796447|FG000|One Year Post-transplant|Converted to rapamycin|1|||
146900318|NCT00064701|529796448|FG001|One Year Post-transplant|Converted to rapamycin|0|||
146900319|NCT00064701|529796449|FG002|One Year Post-transplant|Converted to rapamycin|0|||
146900320|NCT00064701|529796447|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
146900321|NCT00064701|529796448|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
146900322|NCT00064701|529796449|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
146900323|NCT00064701|529796447|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
146900324|NCT00064701|529796448|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
146900325|NCT00064701|529796449|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
146900326|NCT00064701|529796447|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
146900327|NCT00064701|529796448|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
146900328|NCT00064701|529796449|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
146900329|NCT00064701|529796447|FG000|One Year Post-transplant|Poor absorption|0|||
146900330|NCT00064701|529796448|FG001|One Year Post-transplant|Poor absorption|1|||
146900331|NCT00064701|529796449|FG002|One Year Post-transplant|Poor absorption|0|||
146900332|NCT00064701|529796447|FG000|One Year Post-transplant|Pancreas transplant|0|||
146900333|NCT00064701|529796448|FG001|One Year Post-transplant|Pancreas transplant|0|||
146900334|NCT00064701|529796449|FG002|One Year Post-transplant|Pancreas transplant|1|||
146900335|NCT00064701|529796447|FG000|Clinical Continuation Phase|Adverse Event|12|||
146900336|NCT00064701|529796448|FG001|Clinical Continuation Phase|Adverse Event|21|||
146900337|NCT00064701|529796449|FG002|Clinical Continuation Phase|Adverse Event|14|||
146900338|NCT00064701|529796447|FG000|Clinical Continuation Phase|Non-compliance|8|||
146900339|NCT00064701|529796448|FG001|Clinical Continuation Phase|Non-compliance|6|||
146900340|NCT00064701|529796449|FG002|Clinical Continuation Phase|Non-compliance|7|||
146900341|NCT00064701|529796447|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
146900342|NCT00064701|529796448|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
146900343|NCT00064701|529796449|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
146900344|NCT00064701|529796447|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
146900345|NCT00064701|529796448|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
146900346|NCT00064701|529796449|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
146900347|NCT00064701|529796447|FG000|Clinical Continuation Phase|Graft Failure|5|||
146900348|NCT00064701|529796448|FG001|Clinical Continuation Phase|Graft Failure|5|||
146900349|NCT00064701|529796449|FG002|Clinical Continuation Phase|Graft Failure|2|||
146900350|NCT00064701|529796447|FG000|Clinical Continuation Phase|Rejection|1|||
146900351|NCT00064701|529796448|FG001|Clinical Continuation Phase|Rejection|2|||
146900352|NCT00064701|529796449|FG002|Clinical Continuation Phase|Rejection|2|||
146900353|NCT00064701|529796447|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
146900354|NCT00064701|529796448|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
146900355|NCT00064701|529796449|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
146900356|NCT00064701|529796447|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
146900357|NCT00064701|529796448|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
146900358|NCT00064701|529796449|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
146900359|NCT00064701|529796447|FG000|Clinical Continuation Phase|Physician Decision|1|||
146900360|NCT00064701|529796448|FG001|Clinical Continuation Phase|Physician Decision|3|||
146900361|NCT00064701|529796449|FG002|Clinical Continuation Phase|Physician Decision|0|||
146900362|NCT00064701|529796447|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
146900363|NCT00064701|529796448|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
146559788|NCT01852214|528559436|FG001|Washout Period|Withdrawal by Subject|1|||
146559789|NCT02679274|528559437|FG000|Overall Study|Withdrawal by Subject|1|||
146900364|NCT00064701|529796449|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
146900365|NCT00064701|529796447|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
146900366|NCT00064701|529796448|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
146900367|NCT00064701|529796449|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
146900368|NCT00064701|529796447|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
146900369|NCT00064701|529796448|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
146767211|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
146767212|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
146767213|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
146767214|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
146767215|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
146767216|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
146767217|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
146767218|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
146767219|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
146767220|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
146767221|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
146767222|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
146767223|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
146767224|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
146767225|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
146900370|NCT00064701|529796449|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
146900371|NCT00064701|529796447|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
146900372|NCT00064701|529796448|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
146767226|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
146767227|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
146767228|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
146767229|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
146767230|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
146767231|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
146767232|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
146767233|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
146767234|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
146767235|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
146767236|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
146767237|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
146767238|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
146767239|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
146767240|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
146767241|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
146767242|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
146767243|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
146767244|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
146767245|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
146767246|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
146767247|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
146767248|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
146767249|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
146767250|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146767251|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
146767252|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
146767253|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146767254|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146767255|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146767256|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146767257|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
146767258|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
146767259|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
146767260|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
146767261|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
146767262|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
146767263|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
146767264|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
146767265|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
146767266|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
146767267|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
146767268|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
146900373|NCT00064701|529796449|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
146900374|NCT00064701|529796447|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
146969461|NCT02072174|530047432|FG001|Overall Study|Non-compliance with protocol requirement|0|||
146969462|NCT01418365|530047437|FG000|First Intervention|Withdrawal by Subject|0|||
146969463|NCT01418365|530047438|FG001|First Intervention|Withdrawal by Subject|1|||
146969464|NCT01418365|530047437|FG000|First Intervention|Non-compliance|1|||
146969465|NCT01418365|530047438|FG001|First Intervention|Non-compliance|0|||
146969466|NCT01418365|530047437|FG000|Second Intervention|Withdrawal by Subject|0|||
146969467|NCT01418365|530047438|FG001|Second Intervention|Withdrawal by Subject|1|||
146969468|NCT03319368|530047443|FG000|Overall Study|Discharge swabs not collected from resident|57|||
146969469|NCT03319368|530047444|FG001|Overall Study|Discharge swabs not collected from resident|46|||
146969470|NCT00518011|530047445|FG000|Overall Study|Death|1|||
146969471|NCT00518011|530047446|FG001|Overall Study|Death|1|||
146969472|NCT00518011|530047445|FG000|Overall Study|Adverse Event|2|||
146969473|NCT00518011|530047446|FG001|Overall Study|Adverse Event|3|||
146969474|NCT00518011|530047445|FG000|Overall Study|Disease Progression|2|||
146969475|NCT00518011|530047446|FG001|Overall Study|Disease Progression|2|||
146969476|NCT00518011|530047445|FG000|Overall Study|Other Reasons|3|||
146969477|NCT00518011|530047446|FG001|Overall Study|Other Reasons|2|||
146969478|NCT00518011|530047445|FG000|Overall Study|Withdrawal by Subject|1|||
146969479|NCT00518011|530047446|FG001|Overall Study|Withdrawal by Subject|0|||
146969480|NCT03409328|530047447|FG000|Overall Study|Lost to Follow-up|6|||
146969481|NCT03409328|530047448|FG001|Overall Study|Lost to Follow-up|3|||
146969482|NCT00358670|530047449|FG000|Overall Study|Adverse Event|26|||
146969483|NCT00358670|530047450|FG001|Overall Study|Adverse Event|29|||
146969484|NCT00358670|530047449|FG000|Overall Study|Lack of Efficacy|20|||
146969485|NCT00358670|530047450|FG001|Overall Study|Lack of Efficacy|23|||
146969486|NCT00358670|530047449|FG000|Overall Study|Protocol Violation|6|||
146969487|NCT00358670|530047450|FG001|Overall Study|Protocol Violation|9|||
146969488|NCT00358670|530047449|FG000|Overall Study|Lost to Follow-up|4|||
146969489|NCT00358670|530047450|FG001|Overall Study|Lost to Follow-up|5|||
146969490|NCT00358670|530047449|FG000|Overall Study|Withdrawal by Subject|13|||
146969491|NCT00358670|530047450|FG001|Overall Study|Withdrawal by Subject|24|||
146969492|NCT00358670|530047449|FG000|Overall Study|Protocol Defined Clinical Event|0|||
146969493|NCT00358670|530047450|FG001|Overall Study|Protocol Defined Clinical Event|1|||
146969494|NCT00358670|530047449|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
146969495|NCT00358670|530047450|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
146969496|NCT00358670|530047449|FG000|Overall Study|Administrative|153|||
146969497|NCT00358670|530047450|FG001|Overall Study|Administrative|125|||
146969498|NCT01525407|530047455|FG000|Overall Study|Change in recipient treatment plan|2|||
146969499|NCT01525407|530047456|FG001|Overall Study|Change in recipient treatment plan|2|||
146969500|NCT01525407|530047455|FG000|Overall Study|Withdrawal by Subject|0|||
146969501|NCT01525407|530047456|FG001|Overall Study|Withdrawal by Subject|1|||
146969502|NCT01525407|530047455|FG000|Overall Study|Transplant was delayed|0|||
146969503|NCT01525407|530047456|FG001|Overall Study|Transplant was delayed|1|||
146969504|NCT01525407|530047455|FG000|Overall Study|Delay in Transplant|1|||
146969505|NCT01525407|530047456|FG001|Overall Study|Delay in Transplant|0|||
146969506|NCT03256526|530048839|FG000|Overall Study|Adverse Event|1|||
146969507|NCT03256526|530048840|FG001|Overall Study|Adverse Event|0|||
146969508|NCT03256526|530048841|FG002|Overall Study|Adverse Event|1|||
146969509|NCT03256526|530048839|FG000|Overall Study|Lost to Follow-up|1|||
146969510|NCT03256526|530048840|FG001|Overall Study|Lost to Follow-up|0|||
146969511|NCT03256526|530048841|FG002|Overall Study|Lost to Follow-up|2|||
146969512|NCT01607398|530048842|FG000|Overall Study|Adverse Event|0|||
146969513|NCT01607398|530048843|FG001|Overall Study|Adverse Event|2|||
146900375|NCT00064701|529796448|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
146900376|NCT00064701|529796449|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
146900377|NCT00064701|529796447|FG000|Clinical Continuation Phase|Patient opted out|0|||
146900378|NCT00064701|529796448|FG001|Clinical Continuation Phase|Patient opted out|0|||
146969514|NCT01607398|530048842|FG000|Overall Study|Severe COPD|2|||
146969515|NCT01607398|530048843|FG001|Overall Study|Severe COPD|0|||
146900379|NCT00064701|529796449|FG002|Clinical Continuation Phase|Patient opted out|1|||
146900380|NCT00552110|529796451|FG000|Overall Study|Serious or Life-Threatening AE|0|||
146900381|NCT00552110|529796452|FG001|Overall Study|Serious or Life-Threatening AE|0|||
146969516|NCT03526679|530048847|FG000|Overall Study|still under treatment|2|||
146969517|NCT03443973|530048848|FG000|Double-blind Treatment Period|Adverse Event|5|||
146969518|NCT03443973|530048849|FG001|Double-blind Treatment Period|Adverse Event|19|||
146969519|NCT03443973|530048850|FG002|Double-blind Treatment Period|Adverse Event|0|||
146969520|NCT03443973|530048851|FG003|Double-blind Treatment Period|Adverse Event|0|||
146969521|NCT03443973|530048848|FG000|Double-blind Treatment Period|Death|5|||
146969522|NCT03443973|530048849|FG001|Double-blind Treatment Period|Death|7|||
146969523|NCT03443973|530048850|FG002|Double-blind Treatment Period|Death|0|||
146969524|NCT03443973|530048851|FG003|Double-blind Treatment Period|Death|0|||
146559790|NCT02679274|528559438|FG001|Overall Study|Withdrawal by Subject|0|||
146559791|NCT04976855|528559439|FG000|Part I|Withdrawal by Subject|0|||
146559792|NCT04976855|528559440|FG001|Part I|Withdrawal by Subject|1|||
146969525|NCT03443973|530048848|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
146559793|NCT04976855|528559441|FG002|Part I|Withdrawal by Subject|0|||
146900382|NCT00552110|529796453|FG002|Overall Study|Serious or Life-Threatening AE|1|||
146900383|NCT00552110|529796454|FG003|Overall Study|Serious or Life-Threatening AE|0|||
146900384|NCT00552110|529796455|FG004|Overall Study|Serious or Life-Threatening AE|0|||
146900385|NCT00552110|529796451|FG000|Overall Study|Lack of Efficacy|1|||
146900386|NCT00552110|529796452|FG001|Overall Study|Lack of Efficacy|0|||
146900387|NCT00552110|529796453|FG002|Overall Study|Lack of Efficacy|0|||
146900388|NCT00552110|529796454|FG003|Overall Study|Lack of Efficacy|1|||
146900389|NCT00552110|529796455|FG004|Overall Study|Lack of Efficacy|4|||
146900390|NCT00552110|529796451|FG000|Overall Study|Withdrawal by Subject|0|||
146900391|NCT00552110|529796452|FG001|Overall Study|Withdrawal by Subject|2|||
146900392|NCT00552110|529796453|FG002|Overall Study|Withdrawal by Subject|0|||
146900393|NCT00552110|529796454|FG003|Overall Study|Withdrawal by Subject|3|||
146900394|NCT00552110|529796455|FG004|Overall Study|Withdrawal by Subject|2|||
146900395|NCT00552110|529796451|FG000|Overall Study|Lost to Follow-up|0|||
146900396|NCT00552110|529796452|FG001|Overall Study|Lost to Follow-up|0|||
146559794|NCT04976855|528559442|FG003|Part I|Withdrawal by Subject|0|||
146559795|NCT04976855|528559443|FG004|Part I|Withdrawal by Subject|0|||
146559796|NCT04976855|528559444|FG005|Part I|Withdrawal by Subject|0|||
146559797|NCT04976855|528559445|FG006|Part I|Withdrawal by Subject|0|||
146559798|NCT04976855|528559439|FG000|Part II|Adverse Event|0|||
146559799|NCT04976855|528559440|FG001|Part II|Adverse Event|0|||
146559800|NCT04976855|528559441|FG002|Part II|Adverse Event|0|||
146559801|NCT04976855|528559442|FG003|Part II|Adverse Event|1|||
146559802|NCT04976855|528559443|FG004|Part II|Adverse Event|0|||
146559803|NCT04976855|528559444|FG005|Part II|Adverse Event|0|||
146559804|NCT04976855|528559445|FG006|Part II|Adverse Event|0|||
146559805|NCT04976855|528559439|FG000|Part II|Withdrawal by Subject|0|||
146559806|NCT04976855|528559440|FG001|Part II|Withdrawal by Subject|0|||
146559807|NCT04976855|528559441|FG002|Part II|Withdrawal by Subject|0|||
146559808|NCT04976855|528559442|FG003|Part II|Withdrawal by Subject|0|||
146559809|NCT04976855|528559443|FG004|Part II|Withdrawal by Subject|1|||
146559810|NCT04976855|528559444|FG005|Part II|Withdrawal by Subject|0|||
146559811|NCT04976855|528559445|FG006|Part II|Withdrawal by Subject|0|||
146559812|NCT04976855|528559439|FG000|Part II|Lost to Follow-up|0|||
146559813|NCT04976855|528559440|FG001|Part II|Lost to Follow-up|0|||
146559814|NCT04976855|528559441|FG002|Part II|Lost to Follow-up|0|||
146559815|NCT04976855|528559442|FG003|Part II|Lost to Follow-up|0|||
146559816|NCT04976855|528559443|FG004|Part II|Lost to Follow-up|0|||
146559817|NCT04976855|528559444|FG005|Part II|Lost to Follow-up|1|||
146559818|NCT04976855|528559445|FG006|Part II|Lost to Follow-up|0|||
146559819|NCT05487378|528559446|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
146559820|NCT05487378|528559447|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
146559821|NCT05487378|528559446|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
146559822|NCT05487378|528559447|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
146559823|NCT01385995|528559455|FG000|Period 1, 2 Months|Physician Decision|1|||
146559824|NCT01385995|528559456|FG001|Period 1, 2 Months|Physician Decision|0|||
146559825|NCT00112385|528559457|FG000|Overall Study|Lost to Follow-up|1|||
146559826|NCT00112385|528559458|FG001|Overall Study|Lost to Follow-up|0|||
146559827|NCT00112385|528559457|FG000|Overall Study|Withdrawal by Subject|0|||
146559828|NCT00112385|528559458|FG001|Overall Study|Withdrawal by Subject|1|||
146559829|NCT00835172|528559469|FG000|Washout|Protocol Violation|0|||
146559830|NCT00835172|528559470|FG001|Washout|Protocol Violation|1|||
146559831|NCT03648372|528559478|FG000|Overall Study|Withdrawal by Subject|2|||
146559832|NCT03648372|528559479|FG001|Overall Study|Withdrawal by Subject|0|||
146559833|NCT03648372|528559480|FG002|Overall Study|Withdrawal by Subject|0|||
146559834|NCT03648372|528559481|FG003|Overall Study|Withdrawal by Subject|0|||
146559835|NCT03648372|528559482|FG004|Overall Study|Withdrawal by Subject|0|||
146559836|NCT03648372|528559483|FG005|Overall Study|Withdrawal by Subject|1|||
146559837|NCT03648372|528559484|FG006|Overall Study|Withdrawal by Subject|2|||
146559838|NCT03648372|528559485|FG007|Overall Study|Withdrawal by Subject|0|||
146559839|NCT03648372|528559486|FG008|Overall Study|Withdrawal by Subject|0|||
146559840|NCT03648372|528559487|FG009|Overall Study|Withdrawal by Subject|0|||
146559841|NCT03648372|528559488|FG010|Overall Study|Withdrawal by Subject|2|||
146559842|NCT03648372|528559489|FG011|Overall Study|Withdrawal by Subject|0|||
146559843|NCT03648372|528559490|FG012|Overall Study|Withdrawal by Subject|2|||
146559844|NCT03648372|528559491|FG013|Overall Study|Withdrawal by Subject|0|||
146559845|NCT03648372|528559492|FG014|Overall Study|Withdrawal by Subject|0|||
146559846|NCT03648372|528559493|FG015|Overall Study|Withdrawal by Subject|0|||
146559847|NCT03648372|528559494|FG016|Overall Study|Withdrawal by Subject|1|||
146559848|NCT03648372|528559495|FG017|Overall Study|Withdrawal by Subject|0|||
146559849|NCT03648372|528559496|FG018|Overall Study|Withdrawal by Subject|0|||
146559850|NCT03648372|528559497|FG019|Overall Study|Withdrawal by Subject|0|||
146559851|NCT03648372|528559498|FG020|Overall Study|Withdrawal by Subject|0|||
146559852|NCT03648372|528559478|FG000|Overall Study|Progressive Disease|2|||
146559853|NCT03648372|528559479|FG001|Overall Study|Progressive Disease|3|||
146559854|NCT03648372|528559480|FG002|Overall Study|Progressive Disease|4|||
146640469|NCT02529553|528859275|FG001|Overall Study|Withdrawal by Subject|0|||
146900397|NCT00552110|529796453|FG002|Overall Study|Lost to Follow-up|0|||
146900398|NCT00552110|529796454|FG003|Overall Study|Lost to Follow-up|1|||
146900399|NCT00552110|529796455|FG004|Overall Study|Lost to Follow-up|1|||
146900400|NCT00552110|529796451|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
146900401|NCT00552110|529796452|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
146900402|NCT00552110|529796453|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
146900403|NCT00552110|529796454|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
146900404|NCT00552110|529796455|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
146900405|NCT00552110|529796451|FG000|Overall Study|Withdrawn per Sponsor|0|||
146900406|NCT00552110|529796452|FG001|Overall Study|Withdrawn per Sponsor|1|||
146900407|NCT00552110|529796453|FG002|Overall Study|Withdrawn per Sponsor|0|||
146900408|NCT00552110|529796454|FG003|Overall Study|Withdrawn per Sponsor|0|||
146900409|NCT00552110|529796455|FG004|Overall Study|Withdrawn per Sponsor|1|||
146900410|NCT00552110|529796451|FG000|Overall Study|Use of Prohibited Medication|1|||
146900411|NCT00552110|529796452|FG001|Overall Study|Use of Prohibited Medication|1|||
146900412|NCT00552110|529796453|FG002|Overall Study|Use of Prohibited Medication|0|||
146900413|NCT00552110|529796454|FG003|Overall Study|Use of Prohibited Medication|0|||
146900414|NCT00552110|529796455|FG004|Overall Study|Use of Prohibited Medication|0|||
146900415|NCT00552110|529796451|FG000|Overall Study|Delay of Study due to Relabeling|0|||
146900416|NCT00552110|529796452|FG001|Overall Study|Delay of Study due to Relabeling|0|||
146900417|NCT00552110|529796453|FG002|Overall Study|Delay of Study due to Relabeling|0|||
146900418|NCT00552110|529796454|FG003|Overall Study|Delay of Study due to Relabeling|1|||
146900419|NCT00552110|529796455|FG004|Overall Study|Delay of Study due to Relabeling|0|||
146900420|NCT00552110|529796451|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
146900421|NCT00552110|529796452|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
146900422|NCT00552110|529796453|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
146900423|NCT00552110|529796454|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
146900424|NCT00552110|529796455|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
146900425|NCT00552110|529796451|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
146900426|NCT00552110|529796452|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
146900427|NCT00552110|529796453|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
146900428|NCT00552110|529796454|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
146900429|NCT00552110|529796455|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
146900430|NCT02048904|529796467|FG000|Overall Study|Withdrawal by Subject|7|||
146767269|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
146767270|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
146767271|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
146767272|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
146767273|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
146767274|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
146767275|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
146767276|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
146767277|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146767278|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
146767279|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
146900431|NCT02048904|529796467|FG000|Overall Study|Physician Decision|70|||
146900432|NCT03832387|529796468|FG000|Overall Study|Protocol Violation|2|||
146900433|NCT03832387|529796469|FG001|Overall Study|Protocol Violation|6|||
146900434|NCT03832387|529796468|FG000|Overall Study|EXCLUSION CRITERIA|3|||
146900435|NCT03832387|529796469|FG001|Overall Study|EXCLUSION CRITERIA|1|||
146900436|NCT00490542|529796470|FG000|Overall Study|Lost to Follow-up|3|||
146900437|NCT00490542|529796471|FG001|Overall Study|Lost to Follow-up|0|||
146767280|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146767281|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146767282|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146767283|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146767284|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
146767285|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
146767286|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
146900438|NCT00490542|529796470|FG000|Overall Study|Adverse Event|3|||
146559855|NCT03648372|528559481|FG003|Overall Study|Progressive Disease|3|||
146559856|NCT03648372|528559482|FG004|Overall Study|Progressive Disease|2|||
146559857|NCT03648372|528559483|FG005|Overall Study|Progressive Disease|2|||
146559858|NCT03648372|528559484|FG006|Overall Study|Progressive Disease|3|||
146900439|NCT00490542|529796471|FG001|Overall Study|Adverse Event|3|||
146767287|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
146767288|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
146900440|NCT00490542|529796470|FG000|Overall Study|Lack of Efficacy|1|||
146900441|NCT00490542|529796471|FG001|Overall Study|Lack of Efficacy|1|||
146900442|NCT00655928|529796472|FG000|Overall Study|Withdrawal by Subject|2|||
146767289|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
146900443|NCT00655928|529796473|FG001|Overall Study|Withdrawal by Subject|1|||
146900444|NCT00655928|529796472|FG000|Overall Study|Physician Decision|1|||
146559859|NCT03648372|528559485|FG007|Overall Study|Progressive Disease|3|||
146900445|NCT00655928|529796473|FG001|Overall Study|Physician Decision|1|||
146900446|NCT01587989|529796474|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
146900447|NCT01587989|529796475|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
146900448|NCT01587989|529796476|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
146900449|NCT01587989|529796474|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
146900450|NCT01587989|529796475|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
146900451|NCT01587989|529796476|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
146900452|NCT01587989|529796474|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
146900453|NCT01587989|529796475|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
146900454|NCT01587989|529796476|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
146969526|NCT03443973|530048849|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
146969527|NCT03443973|530048850|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
146969528|NCT03443973|530048851|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
146969529|NCT03443973|530048848|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
146969530|NCT03443973|530048849|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
146969531|NCT03443973|530048850|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
146969532|NCT03443973|530048851|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
146969533|NCT03443973|530048848|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
146969534|NCT03443973|530048849|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
146969535|NCT03443973|530048850|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
146969536|NCT03443973|530048851|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
146969537|NCT03443973|530048848|FG000|Double-blind Treatment Period|Physician Decision|5|||
146969538|NCT03443973|530048849|FG001|Double-blind Treatment Period|Physician Decision|6|||
146969539|NCT03443973|530048850|FG002|Double-blind Treatment Period|Physician Decision|0|||
146969540|NCT03443973|530048851|FG003|Double-blind Treatment Period|Physician Decision|0|||
146969541|NCT03443973|530048848|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
146969542|NCT03443973|530048849|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
146969543|NCT03443973|530048850|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
146969544|NCT03443973|530048851|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
146969545|NCT03443973|530048848|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
146969546|NCT03443973|530048849|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
146969547|NCT03443973|530048850|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146969548|NCT03443973|530048851|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
146969549|NCT03443973|530048848|FG000|Open-label Extension Period|Reason Not Specified|0|||
146969550|NCT03443973|530048849|FG001|Open-label Extension Period|Reason Not Specified|0|||
146969551|NCT03443973|530048850|FG002|Open-label Extension Period|Reason Not Specified|3|||
146969552|NCT03443973|530048851|FG003|Open-label Extension Period|Reason Not Specified|0|||
146969553|NCT03443973|530048848|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
146969554|NCT03443973|530048849|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
146969555|NCT03443973|530048850|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
146969556|NCT03443973|530048851|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
146969557|NCT00398632|530048854|FG000|Overall Study|Withdrawal by Subject|1|||
146969558|NCT00398632|530048854|FG000|Overall Study|Lack of Efficacy|1|||
146969559|NCT00267020|530048855|FG000|Overall Study|Adverse Event|22|||
146900455|NCT01587989|529796474|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
146900456|NCT01587989|529796475|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
146900457|NCT01587989|529796476|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
146900458|NCT01587989|529796474|FG000|Randomized Study Treatment|Screening failure|0|||
146900459|NCT01587989|529796475|FG001|Randomized Study Treatment|Screening failure|1|||
146900460|NCT01587989|529796476|FG002|Randomized Study Treatment|Screening failure|0|||
146900461|NCT01587989|529796474|FG000|Randomized Study Treatment|Physician Decision|0|||
146900462|NCT01587989|529796475|FG001|Randomized Study Treatment|Physician Decision|0|||
146969560|NCT00267020|530048856|FG001|Overall Study|Adverse Event|5|||
146969561|NCT00267020|530048855|FG000|Overall Study|Death|2|||
146969562|NCT00267020|530048856|FG001|Overall Study|Death|1|||
146969563|NCT00267020|530048855|FG000|Overall Study|Withdrawal by Subject|17|||
146969564|NCT00267020|530048856|FG001|Overall Study|Withdrawal by Subject|7|||
146969565|NCT00267020|530048855|FG000|Overall Study|Physician Decision|3|||
146969566|NCT00267020|530048856|FG001|Overall Study|Physician Decision|2|||
146969567|NCT00267020|530048855|FG000|Overall Study|Disease Progression|39|||
146767290|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
146900463|NCT01587989|529796476|FG002|Randomized Study Treatment|Physician Decision|1|||
146969568|NCT00267020|530048856|FG001|Overall Study|Disease Progression|25|||
146969569|NCT00267020|530048855|FG000|Overall Study|Unrelated Complication|1|||
146969570|NCT00267020|530048856|FG001|Overall Study|Unrelated Complication|1|||
146969571|NCT00267020|530048855|FG000|Overall Study|Sponsor Request|1|||
146969572|NCT00267020|530048856|FG001|Overall Study|Sponsor Request|0|||
146969573|NCT00267020|530048855|FG000|Overall Study|Other|1|||
146969574|NCT00267020|530048856|FG001|Overall Study|Other|2|||
146969575|NCT00640614|530048857|FG000|Overall Study|Lost to Follow-up|1|||
146900464|NCT03313050|529796478|FG000|Stage 2: 12 Months|Adverse Event|0|||
146900465|NCT03313050|529796479|FG001|Stage 2: 12 Months|Adverse Event|0|||
146559860|NCT03648372|528559486|FG008|Overall Study|Progressive Disease|5|||
146559861|NCT03648372|528559487|FG009|Overall Study|Progressive Disease|5|||
146559862|NCT03648372|528559488|FG010|Overall Study|Progressive Disease|2|||
146559863|NCT03648372|528559489|FG011|Overall Study|Progressive Disease|3|||
146559864|NCT03648372|528559490|FG012|Overall Study|Progressive Disease|3|||
146559865|NCT03648372|528559491|FG013|Overall Study|Progressive Disease|3|||
146559866|NCT03648372|528559492|FG014|Overall Study|Progressive Disease|6|||
146559867|NCT03648372|528559493|FG015|Overall Study|Progressive Disease|0|||
146559868|NCT03648372|528559494|FG016|Overall Study|Progressive Disease|0|||
146900466|NCT03313050|529796480|FG002|Stage 2: 12 Months|Adverse Event|0|||
146900467|NCT03313050|529796481|FG003|Stage 2: 12 Months|Adverse Event|1|||
146900468|NCT03313050|529796478|FG000|Stage 2: 12 Months|Death|0|||
146900469|NCT03313050|529796479|FG001|Stage 2: 12 Months|Death|0|||
146900470|NCT03313050|529796480|FG002|Stage 2: 12 Months|Death|3|||
146900471|NCT03313050|529796481|FG003|Stage 2: 12 Months|Death|0|||
146900472|NCT03313050|529796478|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
146900473|NCT03313050|529796479|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
146900474|NCT03313050|529796480|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
146900475|NCT03313050|529796481|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
146900476|NCT03313050|529796478|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
146900477|NCT03313050|529796479|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
146900478|NCT03313050|529796480|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
146900479|NCT03313050|529796481|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
146900480|NCT03313050|529796478|FG000|Stage 2: 12 Months|Protocol deviation|0|||
146900481|NCT03313050|529796479|FG001|Stage 2: 12 Months|Protocol deviation|0|||
146900482|NCT03313050|529796480|FG002|Stage 2: 12 Months|Protocol deviation|7|||
146900483|NCT03313050|529796481|FG003|Stage 2: 12 Months|Protocol deviation|7|||
146900484|NCT03313050|529796478|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
146900485|NCT03313050|529796479|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
146900486|NCT03313050|529796480|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
146900487|NCT03313050|529796481|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
146900488|NCT03313050|529796478|FG000|Stage 2: 12 Months|Other|0|||
146900489|NCT03313050|529796479|FG001|Stage 2: 12 Months|Other|0|||
146900490|NCT03313050|529796480|FG002|Stage 2: 12 Months|Other|0|||
146900491|NCT03313050|529796481|FG003|Stage 2: 12 Months|Other|1|||
146900492|NCT01291017|529796488|FG000|Overall Study|Lost to Follow-up|2|||
146900493|NCT01291017|529796488|FG000|Overall Study|Withdrawal by Subject|3|||
146900494|NCT02847598|529796489|FG000|Overall Study|Adverse Event|0|||
146900495|NCT02847598|529796490|FG001|Overall Study|Adverse Event|0|||
146900496|NCT02847598|529796491|FG002|Overall Study|Adverse Event|0|||
146900497|NCT02847598|529796492|FG003|Overall Study|Adverse Event|0|||
146900498|NCT02847598|529796493|FG004|Overall Study|Adverse Event|0|||
146900499|NCT02847598|529796494|FG005|Overall Study|Adverse Event|0|||
146900500|NCT02847598|529796495|FG006|Overall Study|Adverse Event|0|||
146900501|NCT02847598|529796496|FG007|Overall Study|Adverse Event|1|||
146900502|NCT02847598|529796489|FG000|Overall Study|Consent withdrawn|2|||
146900503|NCT02847598|529796490|FG001|Overall Study|Consent withdrawn|0|||
146900504|NCT02847598|529796491|FG002|Overall Study|Consent withdrawn|0|||
146900505|NCT02847598|529796492|FG003|Overall Study|Consent withdrawn|4|||
146900506|NCT02847598|529796493|FG004|Overall Study|Consent withdrawn|3|||
146900507|NCT02847598|529796494|FG005|Overall Study|Consent withdrawn|2|||
146900508|NCT02847598|529796495|FG006|Overall Study|Consent withdrawn|1|||
146900509|NCT02847598|529796496|FG007|Overall Study|Consent withdrawn|3|||
146900510|NCT02847598|529796489|FG000|Overall Study|Death|3|||
146900511|NCT02847598|529796490|FG001|Overall Study|Death|0|||
146900512|NCT02847598|529796491|FG002|Overall Study|Death|0|||
146900513|NCT02847598|529796492|FG003|Overall Study|Death|0|||
146900514|NCT02847598|529796493|FG004|Overall Study|Death|0|||
146900515|NCT02847598|529796494|FG005|Overall Study|Death|0|||
146900516|NCT02847598|529796495|FG006|Overall Study|Death|0|||
146900517|NCT02847598|529796496|FG007|Overall Study|Death|0|||
146900518|NCT02847598|529796489|FG000|Overall Study|Lost to Follow-up|0|||
146900519|NCT02847598|529796490|FG001|Overall Study|Lost to Follow-up|0|||
146900520|NCT02847598|529796491|FG002|Overall Study|Lost to Follow-up|0|||
146900521|NCT02847598|529796492|FG003|Overall Study|Lost to Follow-up|0|||
146900522|NCT02847598|529796493|FG004|Overall Study|Lost to Follow-up|0|||
146900523|NCT02847598|529796494|FG005|Overall Study|Lost to Follow-up|1|||
146900524|NCT02847598|529796495|FG006|Overall Study|Lost to Follow-up|1|||
146900525|NCT02847598|529796496|FG007|Overall Study|Lost to Follow-up|0|||
146900526|NCT02848833|529796497|FG000|Overall Study|subject who are duplicated|1|||
146900527|NCT02848833|529796497|FG000|Overall Study|have not taken the study drug|11|||
146900528|NCT02848833|529796497|FG000|Overall Study|follow-up failure|6|||
146900529|NCT02848833|529796497|FG000|Overall Study|Protocol Violation|119|||
146900530|NCT04980391|529796498|FG000|Overall Study|Death|0|||
146900531|NCT04980391|529796499|FG001|Overall Study|Death|0|||
146900532|NCT04980391|529796500|FG002|Overall Study|Death|1|||
146900533|NCT04980391|529796501|FG003|Overall Study|Death|1|||
146900534|NCT04980391|529796498|FG000|Overall Study|Lost to Follow-up|3|||
146900535|NCT04980391|529796499|FG001|Overall Study|Lost to Follow-up|3|||
146900536|NCT04980391|529796500|FG002|Overall Study|Lost to Follow-up|2|||
146900537|NCT04980391|529796501|FG003|Overall Study|Lost to Follow-up|3|||
146900538|NCT04980391|529796498|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
146900539|NCT04980391|529796499|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
146900540|NCT04980391|529796500|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
146900541|NCT04980391|529796501|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
146900542|NCT04980391|529796498|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146900543|NCT04980391|529796499|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146900544|NCT04980391|529796500|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
146559869|NCT03648372|528559495|FG017|Overall Study|Progressive Disease|0|||
146559870|NCT03648372|528559496|FG018|Overall Study|Progressive Disease|0|||
146559871|NCT03648372|528559497|FG019|Overall Study|Progressive Disease|0|||
146559872|NCT03648372|528559498|FG020|Overall Study|Progressive Disease|0|||
146559873|NCT03648372|528559478|FG000|Overall Study|Other|0|||
146559874|NCT03648372|528559479|FG001|Overall Study|Other|0|||
146559875|NCT03648372|528559480|FG002|Overall Study|Other|0|||
146559876|NCT03648372|528559481|FG003|Overall Study|Other|0|||
146559877|NCT03648372|528559482|FG004|Overall Study|Other|1|||
146559878|NCT03648372|528559483|FG005|Overall Study|Other|0|||
146559879|NCT03648372|528559484|FG006|Overall Study|Other|0|||
146559880|NCT03648372|528559485|FG007|Overall Study|Other|0|||
146559881|NCT03648372|528559486|FG008|Overall Study|Other|0|||
146559882|NCT03648372|528559487|FG009|Overall Study|Other|0|||
146559883|NCT03648372|528559488|FG010|Overall Study|Other|1|||
146559884|NCT03648372|528559489|FG011|Overall Study|Other|2|||
146559885|NCT03648372|528559490|FG012|Overall Study|Other|1|||
146559886|NCT03648372|528559491|FG013|Overall Study|Other|3|||
146559887|NCT03648372|528559492|FG014|Overall Study|Other|0|||
146559888|NCT03648372|528559493|FG015|Overall Study|Other|5|||
146559889|NCT03648372|528559494|FG016|Overall Study|Other|1|||
146559890|NCT03648372|528559495|FG017|Overall Study|Other|5|||
146559891|NCT03648372|528559496|FG018|Overall Study|Other|0|||
146559892|NCT03648372|528559497|FG019|Overall Study|Other|1|||
146559893|NCT03648372|528559498|FG020|Overall Study|Other|0|||
146559894|NCT03648372|528559478|FG000|Overall Study|Lost to Follow-up|0|||
146559895|NCT03648372|528559479|FG001|Overall Study|Lost to Follow-up|0|||
146559896|NCT03648372|528559480|FG002|Overall Study|Lost to Follow-up|0|||
146559897|NCT03648372|528559481|FG003|Overall Study|Lost to Follow-up|0|||
146559898|NCT03648372|528559482|FG004|Overall Study|Lost to Follow-up|0|||
146559899|NCT03648372|528559483|FG005|Overall Study|Lost to Follow-up|0|||
146559900|NCT03648372|528559484|FG006|Overall Study|Lost to Follow-up|0|||
146559901|NCT03648372|528559485|FG007|Overall Study|Lost to Follow-up|0|||
146559902|NCT03648372|528559486|FG008|Overall Study|Lost to Follow-up|0|||
146559903|NCT03648372|528559487|FG009|Overall Study|Lost to Follow-up|0|||
146559904|NCT03648372|528559488|FG010|Overall Study|Lost to Follow-up|0|||
146559905|NCT03648372|528559489|FG011|Overall Study|Lost to Follow-up|0|||
146559906|NCT03648372|528559490|FG012|Overall Study|Lost to Follow-up|0|||
146559907|NCT03648372|528559491|FG013|Overall Study|Lost to Follow-up|1|||
146559908|NCT03648372|528559492|FG014|Overall Study|Lost to Follow-up|0|||
146559909|NCT03648372|528559493|FG015|Overall Study|Lost to Follow-up|1|||
146559910|NCT03648372|528559494|FG016|Overall Study|Lost to Follow-up|0|||
146559911|NCT03648372|528559495|FG017|Overall Study|Lost to Follow-up|1|||
146900545|NCT04980391|529796501|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146900546|NCT04980391|529796498|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
146900547|NCT04980391|529796499|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
146900548|NCT04980391|529796500|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
146900549|NCT04980391|529796501|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
146900550|NCT03797001|529798634|FG000|Overall Study|Withdrawn due to COVID19|4|||
146900551|NCT03797001|529798635|FG001|Overall Study|Withdrawn due to COVID19|0|||
146900552|NCT03797001|529798634|FG000|Overall Study|Withdrawal by Subject|7|||
146900553|NCT03797001|529798635|FG001|Overall Study|Withdrawal by Subject|6|||
146900554|NCT03797001|529798634|FG000|Overall Study|Adverse Event|0|||
146900555|NCT03797001|529798635|FG001|Overall Study|Adverse Event|1|||
146900556|NCT05630846|529798638|FG000|Overall Study|Death|1|||
146900557|NCT05630846|529798639|FG001|Overall Study|Death|0|||
146900558|NCT05630846|529798640|FG002|Overall Study|Death|0|||
146559912|NCT03648372|528559496|FG018|Overall Study|Lost to Follow-up|0|||
146559913|NCT03648372|528559497|FG019|Overall Study|Lost to Follow-up|0|||
146559914|NCT03648372|528559498|FG020|Overall Study|Lost to Follow-up|0|||
146559915|NCT03648372|528559478|FG000|Overall Study|Start of a New Systemic Treatment|0|||
146559916|NCT03648372|528559479|FG001|Overall Study|Start of a New Systemic Treatment|0|||
146559917|NCT03648372|528559480|FG002|Overall Study|Start of a New Systemic Treatment|0|||
146559918|NCT03648372|528559481|FG003|Overall Study|Start of a New Systemic Treatment|0|||
146559919|NCT03648372|528559482|FG004|Overall Study|Start of a New Systemic Treatment|0|||
146900559|NCT05630846|529798641|FG003|Overall Study|Death|0|||
146900560|NCT05630846|529798638|FG000|Overall Study|Withdrawal by Subject|3|||
146559920|NCT03648372|528559483|FG005|Overall Study|Start of a New Systemic Treatment|0|||
146559921|NCT03648372|528559484|FG006|Overall Study|Start of a New Systemic Treatment|0|||
146559922|NCT03648372|528559485|FG007|Overall Study|Start of a New Systemic Treatment|2|||
146559923|NCT03648372|528559486|FG008|Overall Study|Start of a New Systemic Treatment|0|||
146767291|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
146767292|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
146767293|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
146767294|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
146767295|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
146767296|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
146767297|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
146767298|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
146767299|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
146767300|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
146767301|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
146767302|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
146767303|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
146767304|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
146767305|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
146767306|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
146767307|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
146767308|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
146767309|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
146767310|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
146767311|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
146767312|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
146767313|NCT01212757|529314696|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
146767314|NCT01212757|529314697|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
146767315|NCT01212757|529314698|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
146767316|NCT01212757|529314699|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
146767317|NCT01212757|529314700|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
146767318|NCT01212757|529314701|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
146767319|NCT01212757|529314702|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
146767320|NCT01212757|529314703|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
146767321|NCT01212757|529314704|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
146767322|NCT00573833|529314705|FG000|Overall Study|Not Treated|2|||
146767323|NCT04493242|529314706|FG000|Overall Study|Death|10|||
146767324|NCT04493242|529314707|FG001|Overall Study|Death|14|||
146767325|NCT04493242|529314708|FG002|Overall Study|Death|16|||
146767326|NCT04493242|529314706|FG000|Overall Study|Lost to Follow-up|1|||
146767327|NCT04493242|529314707|FG001|Overall Study|Lost to Follow-up|1|||
146767328|NCT04493242|529314708|FG002|Overall Study|Lost to Follow-up|0|||
146767329|NCT04493242|529314706|FG000|Overall Study|Withdrawal by Subject|1|||
146767330|NCT04493242|529314707|FG001|Overall Study|Withdrawal by Subject|0|||
146767331|NCT04493242|529314708|FG002|Overall Study|Withdrawal by Subject|0|||
146767332|NCT04493242|529314706|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
146767333|NCT04493242|529314707|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
146767334|NCT04493242|529314708|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
146767335|NCT04493242|529314706|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
146767336|NCT04493242|529314707|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
146767337|NCT04493242|529314708|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
146767338|NCT00849147|529314709|FG000|Overall Study|Withdrawal by Subject|1|||
146767339|NCT00849147|529314709|FG000|Overall Study|Protocol Violation|2|||
146767340|NCT00849147|529314709|FG000|Overall Study|Disease Relapse/Progression|2|||
146767341|NCT04517864|529317290|FG000|Placebo-Controlled Phase|Adverse Event|1|||
146767342|NCT04517864|529317291|FG001|Placebo-Controlled Phase|Adverse Event|0|||
146767343|NCT04517864|529317292|FG002|Placebo-Controlled Phase|Adverse Event|0|||
146767344|NCT04517864|529317290|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
146767345|NCT04517864|529317291|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
146767346|NCT04517864|529317292|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
146767347|NCT04517864|529317290|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
146767348|NCT04517864|529317291|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
146767349|NCT04517864|529317292|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
146767350|NCT04517864|529317290|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
146900561|NCT05630846|529798639|FG001|Overall Study|Withdrawal by Subject|3|||
146900562|NCT05630846|529798640|FG002|Overall Study|Withdrawal by Subject|4|||
146900563|NCT05630846|529798641|FG003|Overall Study|Withdrawal by Subject|1|||
146900564|NCT05630846|529798638|FG000|Overall Study|Lost to Follow-up|6|||
146900565|NCT05630846|529798639|FG001|Overall Study|Lost to Follow-up|5|||
146767351|NCT04517864|529317291|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
146767352|NCT04517864|529317292|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
146767353|NCT04517864|529317290|FG000|Active Therapy Extension Phase|Adverse Event|1|||
146900566|NCT05630846|529798640|FG002|Overall Study|Lost to Follow-up|2|||
146900567|NCT05630846|529798641|FG003|Overall Study|Lost to Follow-up|5|||
146900568|NCT05630846|529798638|FG000|Overall Study|Other|1|||
146900569|NCT05630846|529798639|FG001|Overall Study|Other|0|||
146900570|NCT05630846|529798640|FG002|Overall Study|Other|0|||
146969576|NCT00640614|530048858|FG001|Overall Study|Lost to Follow-up|0|||
146969577|NCT02209454|530048861|FG000|Second Period|Adverse Event|1|||
146969578|NCT02209454|530048862|FG001|Second Period|Adverse Event|0|||
146969579|NCT02545868|530048863|FG000|Overall Study|Lack of Efficacy|1|||
146969580|NCT02545868|530048864|FG001|Overall Study|Lack of Efficacy|1|||
146969581|NCT02545868|530048865|FG002|Overall Study|Lack of Efficacy|0|||
146969582|NCT02545868|530048863|FG000|Overall Study|Lost to Follow-up|1|||
146969583|NCT02545868|530048864|FG001|Overall Study|Lost to Follow-up|5|||
146969584|NCT02545868|530048865|FG002|Overall Study|Lost to Follow-up|1|||
146969585|NCT02545868|530048863|FG000|Overall Study|Non-compliance|1|||
146969586|NCT02545868|530048864|FG001|Overall Study|Non-compliance|1|||
146969587|NCT02545868|530048865|FG002|Overall Study|Non-compliance|1|||
146900571|NCT05630846|529798641|FG003|Overall Study|Other|0|||
146900572|NCT05556616|529798642|FG000|Overall Study|Withdrawal by Subject|1|||
146900573|NCT05556616|529798643|FG001|Overall Study|Withdrawal by Subject|0|||
146900574|NCT05556616|529798644|FG002|Overall Study|Withdrawal by Subject|0|||
146900575|NCT05556616|529798645|FG003|Overall Study|Withdrawal by Subject|0|||
146969588|NCT02545868|530048863|FG000|Overall Study|Treatment change|21|||
146969589|NCT02545868|530048864|FG001|Overall Study|Treatment change|19|||
146969590|NCT02545868|530048865|FG002|Overall Study|Treatment change|22|||
146969591|NCT02545868|530048863|FG000|Overall Study|Physician Decision|1|||
146969592|NCT02545868|530048864|FG001|Overall Study|Physician Decision|1|||
146969593|NCT02545868|530048865|FG002|Overall Study|Physician Decision|1|||
146969594|NCT02545868|530048863|FG000|Overall Study|Withdrawal by Subject|6|||
146969595|NCT02545868|530048864|FG001|Overall Study|Withdrawal by Subject|7|||
146969596|NCT02545868|530048865|FG002|Overall Study|Withdrawal by Subject|9|||
146969597|NCT01777191|530048866|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
146969598|NCT01777191|530048867|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
146969599|NCT01777191|530048866|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
146969600|NCT01777191|530048867|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
146969601|NCT01777191|530048866|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
146969602|NCT01777191|530048867|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
146969603|NCT01777191|530048866|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
146969604|NCT01777191|530048867|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
146969605|NCT01777191|530048866|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
146969606|NCT01777191|530048867|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
146969607|NCT01777191|530048866|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
146969608|NCT01777191|530048867|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
146969609|NCT01777191|530048866|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
146969610|NCT01777191|530048867|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
146969611|NCT01777191|530048866|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
146969612|NCT01777191|530048867|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
146969613|NCT01777191|530048866|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
146969614|NCT01777191|530048867|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
146969615|NCT01777191|530048866|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
146900576|NCT05556616|529798646|FG004|Overall Study|Withdrawal by Subject|0|||
146900577|NCT05556616|529798647|FG005|Overall Study|Withdrawal by Subject|0|||
146900578|NCT05556616|529798648|FG006|Overall Study|Withdrawal by Subject|0|||
146900579|NCT05556616|529798642|FG000|Overall Study|Death|0|||
146900580|NCT05556616|529798643|FG001|Overall Study|Death|0|||
146900581|NCT05556616|529798644|FG002|Overall Study|Death|2|||
146900582|NCT05556616|529798645|FG003|Overall Study|Death|1|||
146900583|NCT05556616|529798646|FG004|Overall Study|Death|0|||
146900584|NCT05556616|529798647|FG005|Overall Study|Death|0|||
146900585|NCT05556616|529798648|FG006|Overall Study|Death|0|||
146900586|NCT05556616|529798642|FG000|Overall Study|Study Terminated by Sponsor|0|||
146900587|NCT05556616|529798643|FG001|Overall Study|Study Terminated by Sponsor|3|||
146900588|NCT05556616|529798644|FG002|Overall Study|Study Terminated by Sponsor|0|||
146900589|NCT05556616|529798645|FG003|Overall Study|Study Terminated by Sponsor|0|||
146900590|NCT05556616|529798646|FG004|Overall Study|Study Terminated by Sponsor|0|||
146969616|NCT01777191|530048867|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
146969617|NCT01777191|530048866|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
146969618|NCT01777191|530048867|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
146969619|NCT04465916|530048872|FG000|Overall Study|Withdrawal by Subject|0|||
146900591|NCT05556616|529798647|FG005|Overall Study|Study Terminated by Sponsor|0|||
146900592|NCT05556616|529798648|FG006|Overall Study|Study Terminated by Sponsor|0|||
146900593|NCT00075881|529798650|FG000|Overall Study|Lack of Efficacy|18|||
146900594|NCT00075881|529798650|FG000|Overall Study|Adverse Event|7|||
146900595|NCT00075881|529798650|FG000|Overall Study|Death|1|||
146900596|NCT00075881|529798650|FG000|Overall Study|Withdrawal by Subject|2|||
146900597|NCT00075881|529798650|FG000|Overall Study|Protocol Violation|4|||
146969620|NCT04465916|530048873|FG001|Overall Study|Withdrawal by Subject|1|||
146900598|NCT00075881|529798650|FG000|Overall Study|other complicating disease|3|||
146900599|NCT00075881|529798650|FG000|Overall Study|other|4|||
146900600|NCT00075881|529798650|FG000|Overall Study|missing data|2|||
146900601|NCT00075881|529798650|FG000|Overall Study|Ineligible|1|||
146900602|NCT00075881|529798650|FG000|Overall Study|never start protocol therapy|1|||
146900603|NCT02224664|529798651|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
146900604|NCT02224664|529798652|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
146900605|NCT02224664|529798653|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
146900606|NCT02224664|529798654|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
146900607|NCT02224664|529798655|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
146900608|NCT02224664|529798651|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
146900609|NCT02224664|529798652|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
146900610|NCT02224664|529798653|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
146900611|NCT02224664|529798654|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
146900612|NCT02224664|529798655|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
146900613|NCT02224664|529798651|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
146900614|NCT02224664|529798652|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
146900615|NCT02224664|529798653|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
146900616|NCT02224664|529798654|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
146900617|NCT02224664|529798655|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
146900618|NCT03019549|529798656|FG000|Washout|DId not meet genotype criteria|11|||
146900619|NCT03019549|529798656|FG000|Period 2|Adverse Event|2|||
146900620|NCT03019549|529798656|FG000|Period 2|Physician Decision|2|||
146900621|NCT03019549|529798656|FG000|Period 2|Withdrawal by Subject|1|||
146900622|NCT03195894|529798659|FG000|Overall Study|"An example is Started other treatment."|4|||
146900623|NCT03195894|529798660|FG001|Overall Study|"An example is Started other treatment."|5|||
146900624|NCT03195894|529798659|FG000|Overall Study|Withdrawal by Subject|15|||
146900625|NCT03195894|529798660|FG001|Overall Study|Withdrawal by Subject|4|||
146900626|NCT03195894|529798659|FG000|Overall Study|Lost to Follow-up|14|||
146900627|NCT03195894|529798660|FG001|Overall Study|Lost to Follow-up|19|||
146900628|NCT02251743|529798662|FG000|Overall Study|Withdrawal by Subject|1|||
146900629|NCT02251743|529798663|FG001|Overall Study|Withdrawal by Subject|1|||
146900630|NCT00215150|529798664|FG000|Open Label Phase|Lost to Follow-up|7|||
146900631|NCT00215150|529798664|FG000|Open Label Phase|Withdrawal by Subject|1|||
146900632|NCT00215150|529798664|FG000|Open Label Phase|Did not complete a post base visit|13|||
146900633|NCT00215150|529798664|FG000|Open Label Phase|Did not meet randomization criteria|9|||
146900634|NCT00215150|529798664|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
146900635|NCT00215150|529798664|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
146900636|NCT00215150|529798664|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
146900637|NCT00496366|529798665|FG000|Overall Study|Death|1|||
146900638|NCT03323749|529798680|FG000|Double-blind Period|Lost to Follow-up|4|||
146900639|NCT03323749|529798681|FG001|Double-blind Period|Lost to Follow-up|5|||
146900640|NCT03323749|529798680|FG000|Double-blind Period|Adverse Event|3|||
146900641|NCT03323749|529798681|FG001|Double-blind Period|Adverse Event|1|||
146900642|NCT03323749|529798680|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
146900643|NCT03323749|529798681|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
146900644|NCT03323749|529798680|FG000|Open-Label Period|Adverse Event|3|||
146900645|NCT03323749|529798681|FG001|Open-Label Period|Adverse Event|10|||
146900646|NCT03323749|529798680|FG000|Open-Label Period|Withdrawal by Subject|7|||
146900647|NCT03323749|529798681|FG001|Open-Label Period|Withdrawal by Subject|5|||
146900648|NCT00506389|529798686|FG000|In-treatment Period|Other|3|||
146900649|NCT00506389|529798687|FG001|In-treatment Period|Other|3|||
146900650|NCT00506389|529798688|FG002|In-treatment Period|Other|4|||
146900651|NCT00506389|529798686|FG000|In-treatment Period|Lost to Follow-up|0|||
146900652|NCT00506389|529798687|FG001|In-treatment Period|Lost to Follow-up|0|||
146900653|NCT00506389|529798688|FG002|In-treatment Period|Lost to Follow-up|1|||
146900654|NCT00506389|529798686|FG000|In-treatment Period|Lack of compliance|1|||
146900655|NCT00506389|529798687|FG001|In-treatment Period|Lack of compliance|0|||
146900656|NCT00506389|529798688|FG002|In-treatment Period|Lack of compliance|0|||
146900657|NCT00506389|529798686|FG000|In-treatment Period|Reasons not related to trial|4|||
146900658|NCT00506389|529798687|FG001|In-treatment Period|Reasons not related to trial|1|||
146900659|NCT00506389|529798688|FG002|In-treatment Period|Reasons not related to trial|0|||
146900660|NCT00506389|529798686|FG000|In-treatment Period|Withdrawal by Subject|3|||
146900661|NCT00506389|529798687|FG001|In-treatment Period|Withdrawal by Subject|3|||
146900662|NCT00506389|529798688|FG002|In-treatment Period|Withdrawal by Subject|4|||
146900663|NCT00506389|529798686|FG000|In-treatment Period|Lack of Efficacy|0|||
146900664|NCT00506389|529798687|FG001|In-treatment Period|Lack of Efficacy|2|||
146900665|NCT00506389|529798688|FG002|In-treatment Period|Lack of Efficacy|0|||
146900666|NCT00506389|529798686|FG000|In-treatment Period|Adverse Event|11|||
146900667|NCT00506389|529798687|FG001|In-treatment Period|Adverse Event|5|||
146900668|NCT00506389|529798688|FG002|In-treatment Period|Adverse Event|2|||
146900669|NCT00506389|529798686|FG000|In-treatment Period|Randomized but not treated|4|||
146559924|NCT03648372|528559487|FG009|Overall Study|Start of a New Systemic Treatment|0|||
146559925|NCT03648372|528559488|FG010|Overall Study|Start of a New Systemic Treatment|1|||
146559926|NCT03648372|528559489|FG011|Overall Study|Start of a New Systemic Treatment|0|||
146559927|NCT03648372|528559490|FG012|Overall Study|Start of a New Systemic Treatment|0|||
146559928|NCT03648372|528559491|FG013|Overall Study|Start of a New Systemic Treatment|0|||
146559929|NCT03648372|528559492|FG014|Overall Study|Start of a New Systemic Treatment|0|||
146559930|NCT03648372|528559493|FG015|Overall Study|Start of a New Systemic Treatment|0|||
146559931|NCT03648372|528559494|FG016|Overall Study|Start of a New Systemic Treatment|0|||
146559932|NCT03648372|528559495|FG017|Overall Study|Start of a New Systemic Treatment|0|||
146559933|NCT03648372|528559496|FG018|Overall Study|Start of a New Systemic Treatment|0|||
146559934|NCT03648372|528559497|FG019|Overall Study|Start of a New Systemic Treatment|0|||
146559935|NCT03648372|528559498|FG020|Overall Study|Start of a New Systemic Treatment|0|||
146559936|NCT00688740|528560691|FG000|Overall Study|Adverse Event|45|||
146900670|NCT00506389|529798687|FG001|In-treatment Period|Randomized but not treated|1|||
146900671|NCT00506389|529798688|FG002|In-treatment Period|Randomized but not treated|1|||
146559937|NCT00688740|528560692|FG001|Overall Study|Adverse Event|8|||
146559938|NCT00688740|528560691|FG000|Overall Study|Death|2|||
146900672|NCT02665689|529798690|FG000|Overall Study|Adverse Event|1|||
146559939|NCT00688740|528560692|FG001|Overall Study|Death|2|||
146559940|NCT00688740|528560691|FG000|Overall Study|Lost to Follow-up|0|||
146559941|NCT00688740|528560692|FG001|Overall Study|Lost to Follow-up|1|||
146559942|NCT00688740|528560691|FG000|Overall Study|Consent Withdrawn|17|||
146559943|NCT00688740|528560692|FG001|Overall Study|Consent Withdrawn|17|||
146559944|NCT00688740|528560691|FG000|Overall Study|Breast Cancer Relapse|1|||
146559945|NCT00688740|528560692|FG001|Overall Study|Breast Cancer Relapse|4|||
146559946|NCT00688740|528560691|FG000|Overall Study|Violation of Inclusion Criteria|1|||
146559947|NCT00688740|528560692|FG001|Overall Study|Violation of Inclusion Criteria|3|||
146559948|NCT00856557|528560695|FG000|Overall Study|No patients with contextual flags|12|||
146559949|NCT00856557|528560696|FG001|Overall Study|No patients with contextual flags|16|||
146559950|NCT03673176|528560697|FG000|Overall Study|Death prior to intervention|1|||
146559951|NCT03673176|528560697|FG000|Overall Study|Death following intervention|3|||
146559952|NCT03673176|528560697|FG000|Overall Study|Withdrawal by Subject|1|||
146559953|NCT02378480|528560698|FG000|Overall Study|Physician Decision|1|||
146559954|NCT02378480|528560699|FG001|Overall Study|Physician Decision|1|||
146559955|NCT02378480|528560698|FG000|Overall Study|Death|1|||
146559956|NCT02378480|528560699|FG001|Overall Study|Death|2|||
146559957|NCT02378480|528560698|FG000|Overall Study|Randomized, but Not Treated|6|||
146559958|NCT02378480|528560699|FG001|Overall Study|Randomized, but Not Treated|4|||
146559959|NCT02378480|528560698|FG000|Overall Study|Adverse Event|0|||
146559960|NCT02378480|528560699|FG001|Overall Study|Adverse Event|1|||
146559961|NCT02378480|528560698|FG000|Overall Study|Missed EOT/PTE Visit|1|||
146559962|NCT02378480|528560699|FG001|Overall Study|Missed EOT/PTE Visit|2|||
146559963|NCT02378480|528560698|FG000|Overall Study|Withdrawal by Subject|9|||
146559964|NCT02378480|528560699|FG001|Overall Study|Withdrawal by Subject|4|||
146559965|NCT02378480|528560698|FG000|Overall Study|Lost to Follow-up|10|||
146559966|NCT02378480|528560699|FG001|Overall Study|Lost to Follow-up|18|||
146559967|NCT01285102|528560702|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
146559968|NCT00557440|528560712|FG000|Treatment Period 1|Adverse Event|0|||
146559969|NCT00557440|528560713|FG001|Treatment Period 1|Adverse Event|0|||
146559970|NCT00557440|528560714|FG002|Treatment Period 1|Adverse Event|1|||
146559971|NCT03524157|528560715|FG000|Overall Study|cytology not readable|0|||
146559972|NCT03524157|528560716|FG001|Overall Study|cytology not readable|0|||
146559973|NCT03524157|528560717|FG002|Overall Study|cytology not readable|1|||
146559974|NCT04507763|528560718|FG000|Overall Study|Participants did not meet entrance criteria|201|||
146559975|NCT03322566|528560719|FG000|Overall Study|Death|34|||
146559976|NCT03322566|528560720|FG001|Overall Study|Death|35|||
146900673|NCT02665689|529798691|FG001|Overall Study|Adverse Event|0|||
146900674|NCT02665689|529798690|FG000|Overall Study|Trial termination|1|||
146900675|NCT02665689|529798691|FG001|Overall Study|Trial termination|1|||
146900676|NCT02665689|529798690|FG000|Overall Study|Lost to Follow-up|0|||
146900677|NCT02665689|529798691|FG001|Overall Study|Lost to Follow-up|1|||
146900678|NCT03895203|529798696|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
146900679|NCT03895203|529798697|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
146900680|NCT03895203|529798698|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
146900681|NCT03895203|529798699|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
146900682|NCT03895203|529798700|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
146900683|NCT03895203|529798701|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
146900684|NCT03895203|529798696|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
146900685|NCT03895203|529798697|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
146559977|NCT03322566|528560721|FG002|Overall Study|Death|23|||
146559978|NCT03322566|528560719|FG000|Overall Study|Physician Decision|6|||
146559979|NCT03322566|528560720|FG001|Overall Study|Physician Decision|7|||
146900686|NCT03895203|529798698|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
146900687|NCT03895203|529798699|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
146969621|NCT01856686|530048874|FG000|Overall Study|Lost to Follow-up|5|||
146969622|NCT01856686|530048875|FG001|Overall Study|Lost to Follow-up|11|||
146969623|NCT00602979|530048876|FG000|Overall Study|Lost to Follow-up|3|||
146969624|NCT00602979|530048877|FG001|Overall Study|Lost to Follow-up|2|||
146969625|NCT00602979|530048878|FG002|Overall Study|Lost to Follow-up|3|||
146969626|NCT00602979|530048879|FG003|Overall Study|Lost to Follow-up|2|||
146969627|NCT00602979|530048880|FG004|Overall Study|Lost to Follow-up|3|||
146969628|NCT00602979|530048876|FG000|Overall Study|Failed Intubation|0|||
146969629|NCT00602979|530048877|FG001|Overall Study|Failed Intubation|1|||
146969630|NCT00602979|530048878|FG002|Overall Study|Failed Intubation|0|||
146969631|NCT00602979|530048879|FG003|Overall Study|Failed Intubation|1|||
146969632|NCT00602979|530048880|FG004|Overall Study|Failed Intubation|0|||
146969633|NCT00468312|530048881|FG000|Overall Study|Adverse Event|2|||
146969634|NCT00468312|530048882|FG001|Overall Study|Adverse Event|1|||
146969635|NCT00468312|530048881|FG000|Overall Study|Lack of Efficacy|0|||
146969636|NCT00468312|530048882|FG001|Overall Study|Lack of Efficacy|1|||
146969637|NCT00468312|530048881|FG000|Overall Study|Withdrawal by Subject|0|||
146969638|NCT00468312|530048882|FG001|Overall Study|Withdrawal by Subject|1|||
146969639|NCT00468312|530048881|FG000|Overall Study|Protocol Violation|2|||
146969640|NCT00468312|530048882|FG001|Overall Study|Protocol Violation|1|||
146969641|NCT00468312|530048881|FG000|Overall Study|Did not meet protocol eligibility|0|||
146969642|NCT00468312|530048882|FG001|Overall Study|Did not meet protocol eligibility|1|||
146969643|NCT00916617|530048889|FG000|Overall Study|Adverse Event|3|||
146969644|NCT00916617|530048890|FG001|Overall Study|Adverse Event|2|||
146969645|NCT00916617|530048891|FG002|Overall Study|Adverse Event|6|||
146969646|NCT00916617|530048892|FG003|Overall Study|Adverse Event|3|||
146969647|NCT00916617|530048889|FG000|Overall Study|Withdrawal by Subject|3|||
146969648|NCT00916617|530048890|FG001|Overall Study|Withdrawal by Subject|2|||
146969649|NCT00916617|530048891|FG002|Overall Study|Withdrawal by Subject|0|||
146969650|NCT00916617|530048892|FG003|Overall Study|Withdrawal by Subject|1|||
146969651|NCT00916617|530048889|FG000|Overall Study|Caregiver Request|3|||
146969652|NCT00916617|530048890|FG001|Overall Study|Caregiver Request|2|||
146969653|NCT00916617|530048891|FG002|Overall Study|Caregiver Request|1|||
146969654|NCT00916617|530048892|FG003|Overall Study|Caregiver Request|0|||
146969655|NCT00916617|530048889|FG000|Overall Study|Physician Decision|1|||
146969656|NCT00916617|530048890|FG001|Overall Study|Physician Decision|1|||
146969657|NCT00916617|530048891|FG002|Overall Study|Physician Decision|0|||
146969658|NCT00916617|530048892|FG003|Overall Study|Physician Decision|0|||
146969659|NCT00916617|530048889|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
146969660|NCT00916617|530048890|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
146969661|NCT00916617|530048891|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
146969662|NCT00916617|530048892|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
146969663|NCT00916617|530048889|FG000|Overall Study|Lost to Follow-up|2|||
146969664|NCT00916617|530048890|FG001|Overall Study|Lost to Follow-up|1|||
146969665|NCT00916617|530048891|FG002|Overall Study|Lost to Follow-up|0|||
146969666|NCT00916617|530048892|FG003|Overall Study|Lost to Follow-up|0|||
146969667|NCT00916617|530048889|FG000|Overall Study|Lack of Efficacy|1|||
146969668|NCT00916617|530048890|FG001|Overall Study|Lack of Efficacy|0|||
146969669|NCT00916617|530048891|FG002|Overall Study|Lack of Efficacy|0|||
146969670|NCT00916617|530048892|FG003|Overall Study|Lack of Efficacy|0|||
146969671|NCT00916617|530048889|FG000|Overall Study|Other|2|||
146969672|NCT00916617|530048890|FG001|Overall Study|Other|0|||
146969673|NCT00916617|530048891|FG002|Overall Study|Other|0|||
146969674|NCT00916617|530048892|FG003|Overall Study|Other|2|||
146969675|NCT00566631|530048894|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
146969676|NCT00566631|530048894|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
146969677|NCT00566631|530048894|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
146969678|NCT00566631|530048894|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
146969679|NCT00566631|530048894|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
146969680|NCT00566631|530048894|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
146559980|NCT03322566|528560721|FG002|Overall Study|Physician Decision|2|||
146559981|NCT03322566|528560719|FG000|Overall Study|Withdrawal by Subject|4|||
146969681|NCT00566631|530048894|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
146969682|NCT00566631|530048894|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
146969683|NCT00566631|530048894|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
146969684|NCT00566631|530048894|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
146969685|NCT00566631|530048894|FG000|Part 2: Extension Phase|Adverse Event|11|||
146969686|NCT00566631|530048894|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
146969687|NCT00566631|530048894|FG000|Part 2: Extension Phase|Death|1|||
146969688|NCT00566631|530048894|FG000|Part 2: Extension Phase|Other|5|||
146969689|NCT02723786|530048895|FG000|Overall Study|Lost to Follow-up|1|||
146969690|NCT03170271|530048898|FG000|Overall Study|Adverse Event|7|||
146969691|NCT03170271|530048899|FG001|Overall Study|Adverse Event|2|||
146969692|NCT03170271|530048898|FG000|Overall Study|Lost to Follow-up|0|||
146969693|NCT03170271|530048899|FG001|Overall Study|Lost to Follow-up|1|||
146969694|NCT03170271|530048898|FG000|Overall Study|Physician Decision|1|||
146969695|NCT03170271|530048899|FG001|Overall Study|Physician Decision|0|||
146969696|NCT03170271|530048898|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
146969697|NCT03170271|530048899|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
146969698|NCT03170271|530048898|FG000|Overall Study|Withdrawal by Subject|17|||
146969699|NCT03170271|530048899|FG001|Overall Study|Withdrawal by Subject|5|||
146969700|NCT03170271|530048898|FG000|Overall Study|Other|2|||
146969701|NCT03170271|530048899|FG001|Overall Study|Other|2|||
146969702|NCT03170271|530048898|FG000|Overall Study|Randomized in error|4|||
146969703|NCT03170271|530048899|FG001|Overall Study|Randomized in error|0|||
146969704|NCT03466060|530048909|FG000|Period 1|Test Lens Damage|0|||
146969705|NCT03466060|530048910|FG001|Period 1|Test Lens Damage|2|||
146969706|NCT03466060|530048911|FG002|Period 1|Test Lens Damage|0|||
146969707|NCT03466060|530048912|FG003|Period 1|Test Lens Damage|0|||
146969708|NCT03466060|530048913|FG004|Period 1|Test Lens Damage|0|||
146969709|NCT03466060|530048914|FG005|Period 1|Test Lens Damage|0|||
146969710|NCT03466060|530048909|FG000|Period 1|Withdrawal by Subject|0|||
146969711|NCT03466060|530048910|FG001|Period 1|Withdrawal by Subject|0|||
146969712|NCT03466060|530048911|FG002|Period 1|Withdrawal by Subject|2|||
146900688|NCT03895203|529798700|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
146900689|NCT03895203|529798701|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
146900690|NCT03895203|529798696|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
146900691|NCT03895203|529798697|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
146900692|NCT03895203|529798698|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
146900693|NCT03895203|529798699|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
146640470|NCT02529553|528859276|FG002|Overall Study|Withdrawal by Subject|0|||
146640471|NCT02529553|528859277|FG003|Overall Study|Withdrawal by Subject|0|||
146640472|NCT02529553|528859278|FG004|Overall Study|Withdrawal by Subject|0|||
146640473|NCT02529553|528859279|FG005|Overall Study|Withdrawal by Subject|1|||
146640474|NCT02529553|528859280|FG006|Overall Study|Withdrawal by Subject|0|||
146640475|NCT02529553|528859281|FG007|Overall Study|Withdrawal by Subject|1|||
146640476|NCT02529553|528859282|FG008|Overall Study|Withdrawal by Subject|0|||
146640477|NCT02355184|528859284|FG000|Overall Study|Lost to Follow-up|2|||
146640478|NCT02355184|528859284|FG000|Overall Study|Study Terminated|10|||
146640479|NCT01124864|528860841|FG000|Overall Study|Follow up phase competed as per protocol|18|||
146900694|NCT03895203|529798700|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
146900695|NCT03895203|529798701|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
146900696|NCT03895203|529798696|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
146900697|NCT03895203|529798697|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
146900698|NCT03895203|529798698|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
146900699|NCT03895203|529798699|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
146900700|NCT03895203|529798700|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
146900701|NCT03895203|529798701|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
146900702|NCT03895203|529798696|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
146640480|NCT01124864|528860842|FG001|Overall Study|Follow up phase competed as per protocol|22|||
146900703|NCT03895203|529798697|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
146969713|NCT03466060|530048912|FG003|Period 1|Withdrawal by Subject|0|||
146969714|NCT03466060|530048913|FG004|Period 1|Withdrawal by Subject|0|||
146969715|NCT03466060|530048914|FG005|Period 1|Withdrawal by Subject|0|||
146640481|NCT01124864|528860843|FG002|Overall Study|Follow up phase competed as per protocol|24|||
146640482|NCT01124864|528860844|FG003|Overall Study|Follow up phase competed as per protocol|18|||
146640483|NCT01124864|528860845|FG004|Overall Study|Follow up phase competed as per protocol|26|||
146640484|NCT01124864|528860846|FG005|Overall Study|Follow up phase competed as per protocol|2|||
146640485|NCT01124864|528860841|FG000|Overall Study|Death|6|||
146640486|NCT01124864|528860842|FG001|Overall Study|Death|9|||
146640487|NCT01124864|528860843|FG002|Overall Study|Death|6|||
146640488|NCT01124864|528860844|FG003|Overall Study|Death|2|||
146640489|NCT01124864|528860845|FG004|Overall Study|Death|1|||
146640490|NCT01124864|528860846|FG005|Overall Study|Death|0|||
146640491|NCT01124864|528860841|FG000|Overall Study|Withdrawal by Subject|2|||
146640492|NCT01124864|528860842|FG001|Overall Study|Withdrawal by Subject|3|||
146640493|NCT01124864|528860843|FG002|Overall Study|Withdrawal by Subject|4|||
146640494|NCT01124864|528860844|FG003|Overall Study|Withdrawal by Subject|0|||
146640495|NCT01124864|528860845|FG004|Overall Study|Withdrawal by Subject|2|||
146640496|NCT01124864|528860846|FG005|Overall Study|Withdrawal by Subject|1|||
146640497|NCT01124864|528860841|FG000|Overall Study|Lost to Follow-up|1|||
146640498|NCT01124864|528860842|FG001|Overall Study|Lost to Follow-up|1|||
146640499|NCT01124864|528860843|FG002|Overall Study|Lost to Follow-up|0|||
146640500|NCT01124864|528860844|FG003|Overall Study|Lost to Follow-up|1|||
146969716|NCT03466060|530048909|FG000|Period 1|Lost to Follow-up|0|||
146640501|NCT01124864|528860845|FG004|Overall Study|Lost to Follow-up|0|||
146640502|NCT01124864|528860846|FG005|Overall Study|Lost to Follow-up|0|||
146640503|NCT01124864|528860841|FG000|Overall Study|Protocol Violation|1|||
146640504|NCT01124864|528860842|FG001|Overall Study|Protocol Violation|0|||
146640505|NCT01124864|528860843|FG002|Overall Study|Protocol Violation|0|||
146640506|NCT01124864|528860844|FG003|Overall Study|Protocol Violation|0|||
146900704|NCT03895203|529798698|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
146640507|NCT01124864|528860845|FG004|Overall Study|Protocol Violation|1|||
146900705|NCT03895203|529798699|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
146900706|NCT03895203|529798700|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
146900707|NCT03895203|529798701|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
146900708|NCT03895203|529798696|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
146900709|NCT03895203|529798697|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
146900710|NCT03895203|529798698|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
146900711|NCT03895203|529798699|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
146900712|NCT03895203|529798700|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
146900713|NCT03895203|529798701|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
146900714|NCT03895203|529798696|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
146900715|NCT03895203|529798697|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
146900716|NCT03895203|529798698|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
146900717|NCT03895203|529798699|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
146900718|NCT03895203|529798700|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
146900719|NCT03895203|529798701|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
146900720|NCT03895203|529798696|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
146900721|NCT03895203|529798697|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
146900722|NCT03895203|529798698|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
146900723|NCT03895203|529798699|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
146900724|NCT03895203|529798700|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
146900725|NCT03895203|529798701|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
146900726|NCT03895203|529798696|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
146900727|NCT03895203|529798697|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
146900728|NCT03895203|529798698|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
146900729|NCT03895203|529798699|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
146900730|NCT03895203|529798700|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
146900731|NCT03895203|529798701|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
146900732|NCT03895203|529798696|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
146900733|NCT03895203|529798697|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
146900734|NCT03895203|529798698|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
146900735|NCT03895203|529798699|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
146900736|NCT03895203|529798700|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
146900737|NCT03895203|529798701|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
146900738|NCT03895203|529798696|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
146900739|NCT03895203|529798697|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
146900740|NCT03895203|529798698|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
146900741|NCT03895203|529798699|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
146900742|NCT03895203|529798700|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
146900743|NCT03895203|529798701|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
146900744|NCT03895203|529798696|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
146900745|NCT03895203|529798697|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
146900746|NCT03895203|529798698|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
146900747|NCT03895203|529798699|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
146900748|NCT03895203|529798700|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
146900749|NCT03895203|529798701|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
146900750|NCT03895203|529798696|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
146900751|NCT03895203|529798697|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
146900752|NCT03895203|529798698|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
146900753|NCT03895203|529798699|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
146900754|NCT03895203|529798700|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
146900755|NCT03895203|529798701|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
146900756|NCT03895203|529798696|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
146900757|NCT03895203|529798697|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
146900758|NCT03895203|529798698|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
146900759|NCT03895203|529798699|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
146900760|NCT03895203|529798700|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
146900761|NCT03895203|529798701|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
146900762|NCT04125680|529798702|FG000|Overall Study|Lost to Follow-up|15|||
146900763|NCT04938648|529798703|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
146900764|NCT04938648|529798704|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
146640508|NCT01124864|528860846|FG005|Overall Study|Protocol Violation|0|||
146640509|NCT01243242|528860847|FG000|Overall Study|Adverse Event|1|||
146640510|NCT01243242|528860848|FG001|Overall Study|Adverse Event|1|||
146640511|NCT01243242|528860847|FG000|Overall Study|Withdrawal by Subject|1|||
146640512|NCT01243242|528860848|FG001|Overall Study|Withdrawal by Subject|1|||
146640513|NCT01243242|528860847|FG000|Overall Study|Physician Decision|0|||
146640514|NCT01243242|528860848|FG001|Overall Study|Physician Decision|1|||
146640515|NCT01243242|528860847|FG000|Overall Study|sponsor decision|0|||
146640516|NCT01243242|528860848|FG001|Overall Study|sponsor decision|1|||
146640517|NCT01243242|528860847|FG000|Overall Study|non compliance|1|||
146640518|NCT01243242|528860848|FG001|Overall Study|non compliance|0|||
146640519|NCT01256294|528860857|FG000|Overall Study|Adverse Event|1|||
146640520|NCT01256294|528860858|FG001|Overall Study|Adverse Event|0|||
146640521|NCT01256294|528860857|FG000|Overall Study|Withdrawal by Subject|1|||
146640522|NCT01256294|528860858|FG001|Overall Study|Withdrawal by Subject|1|||
146640523|NCT01256294|528860857|FG000|Overall Study|Protocol deviation|2|||
146640524|NCT01256294|528860858|FG001|Overall Study|Protocol deviation|1|||
146640525|NCT02160899|528860859|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
146640526|NCT02160899|528860860|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
146640527|NCT02160899|528860861|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
146640528|NCT02160899|528860862|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
146640529|NCT02160899|528860863|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
146640530|NCT02160899|528860864|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
146640531|NCT04129151|528860865|FG000|Overall Study|Adverse Event|1|||
146640532|NCT04129151|528860865|FG000|Overall Study|Disease Progression|7|||
146640533|NCT04129151|528860865|FG000|Overall Study|Study closure|1|||
146640534|NCT00724711|528860867|FG000|Overall Study|Adverse Event|7|||
146640535|NCT00724711|528860868|FG001|Overall Study|Adverse Event|3|||
146640536|NCT00724711|528860867|FG000|Overall Study|Pregnancy|0|||
146640537|NCT00724711|528860868|FG001|Overall Study|Pregnancy|1|||
146640538|NCT00724711|528860867|FG000|Overall Study|Lack of Efficacy|0|||
146640539|NCT00724711|528860868|FG001|Overall Study|Lack of Efficacy|1|||
146640540|NCT00724711|528860867|FG000|Overall Study|Physician Decision|0|||
146640541|NCT00724711|528860868|FG001|Overall Study|Physician Decision|3|||
146640542|NCT00724711|528860867|FG000|Overall Study|Withdrawal by Subject|5|||
146640543|NCT00724711|528860868|FG001|Overall Study|Withdrawal by Subject|4|||
146640544|NCT00724711|528860867|FG000|Overall Study|Lost to Follow-up|4|||
146640545|NCT00724711|528860868|FG001|Overall Study|Lost to Follow-up|5|||
146640546|NCT00724711|528860867|FG000|Overall Study|Protocol Violation|1|||
146640547|NCT00724711|528860868|FG001|Overall Study|Protocol Violation|0|||
146640548|NCT01088048|528860870|FG000|Overall Study|Adverse Event|7|||
146640549|NCT01088048|528860871|FG001|Overall Study|Adverse Event|9|||
146900765|NCT04938648|529798703|FG000|Overall Study|Patient too ill|0|||
146900766|NCT04938648|529798704|FG001|Overall Study|Patient too ill|1|||
146900767|NCT04938648|529798703|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
146900768|NCT04938648|529798704|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
146900769|NCT04938648|529798703|FG000|Overall Study|Patient did not have memory problems|1|||
146900770|NCT04938648|529798704|FG001|Overall Study|Patient did not have memory problems|1|||
146900771|NCT04938648|529798703|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
146900772|NCT04938648|529798704|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
146900773|NCT04938648|529798703|FG000|Overall Study|Care partner could not be reached|0|||
146900774|NCT04938648|529798704|FG001|Overall Study|Care partner could not be reached|1|||
146900775|NCT04938648|529798703|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
146969717|NCT03466060|530048910|FG001|Period 1|Lost to Follow-up|0|||
146969718|NCT03466060|530048911|FG002|Period 1|Lost to Follow-up|0|||
146640550|NCT01088048|528860872|FG002|Overall Study|Adverse Event|7|||
146640551|NCT01088048|528860873|FG003|Overall Study|Adverse Event|5|||
146640552|NCT01088048|528860874|FG004|Overall Study|Adverse Event|6|||
146640553|NCT01088048|528860875|FG005|Overall Study|Adverse Event|3|||
146640554|NCT01088048|528860876|FG006|Overall Study|Adverse Event|3|||
146640555|NCT01088048|528860877|FG007|Overall Study|Adverse Event|0|||
146640556|NCT01088048|528860878|FG008|Overall Study|Adverse Event|2|||
146640557|NCT01088048|528860879|FG009|Overall Study|Adverse Event|2|||
146640558|NCT01088048|528860870|FG000|Overall Study|Withdrew Consent|1|||
146640559|NCT01088048|528860871|FG001|Overall Study|Withdrew Consent|1|||
146640560|NCT01088048|528860872|FG002|Overall Study|Withdrew Consent|1|||
146640561|NCT01088048|528860873|FG003|Overall Study|Withdrew Consent|1|||
146640562|NCT01088048|528860874|FG004|Overall Study|Withdrew Consent|2|||
146640563|NCT01088048|528860875|FG005|Overall Study|Withdrew Consent|1|||
146640564|NCT01088048|528860876|FG006|Overall Study|Withdrew Consent|0|||
146640565|NCT01088048|528860877|FG007|Overall Study|Withdrew Consent|2|||
146640566|NCT01088048|528860878|FG008|Overall Study|Withdrew Consent|2|||
146640567|NCT01088048|528860879|FG009|Overall Study|Withdrew Consent|1|||
146640568|NCT01088048|528860870|FG000|Overall Study|Concomitant Medication Prohibited|1|||
146640569|NCT01088048|528860871|FG001|Overall Study|Concomitant Medication Prohibited|0|||
146640570|NCT01088048|528860872|FG002|Overall Study|Concomitant Medication Prohibited|0|||
146640571|NCT01088048|528860873|FG003|Overall Study|Concomitant Medication Prohibited|0|||
146900776|NCT04938648|529798704|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
146900777|NCT04938648|529798703|FG000|Overall Study|Withdrawal by Subject|2|||
146900778|NCT04938648|529798704|FG001|Overall Study|Withdrawal by Subject|1|||
146900779|NCT00364793|529798705|FG000|Overall Study|Adverse Event|2|||
146900780|NCT00364793|529798706|FG001|Overall Study|Adverse Event|0|||
146900781|NCT00364793|529798707|FG002|Overall Study|Adverse Event|0|||
146900782|NCT00364793|529798708|FG003|Overall Study|Adverse Event|0|||
146900783|NCT00364793|529798705|FG000|Overall Study|Death|1|||
146900784|NCT00364793|529798706|FG001|Overall Study|Death|0|||
146900785|NCT00364793|529798707|FG002|Overall Study|Death|1|||
146900786|NCT00364793|529798708|FG003|Overall Study|Death|0|||
146900787|NCT00364793|529798705|FG000|Overall Study|Lack of Efficacy|3|||
146900788|NCT00364793|529798706|FG001|Overall Study|Lack of Efficacy|3|||
146900789|NCT00364793|529798707|FG002|Overall Study|Lack of Efficacy|1|||
146900790|NCT00364793|529798708|FG003|Overall Study|Lack of Efficacy|1|||
146900791|NCT00364793|529798705|FG000|Overall Study|Lost to Follow-up|1|||
146900792|NCT00364793|529798706|FG001|Overall Study|Lost to Follow-up|0|||
146900793|NCT00364793|529798707|FG002|Overall Study|Lost to Follow-up|2|||
146900794|NCT00364793|529798708|FG003|Overall Study|Lost to Follow-up|0|||
146900795|NCT00364793|529798705|FG000|Overall Study|Poor or non-compliance|1|||
146900796|NCT00364793|529798706|FG001|Overall Study|Poor or non-compliance|1|||
146900797|NCT00364793|529798707|FG002|Overall Study|Poor or non-compliance|0|||
146900798|NCT00364793|529798708|FG003|Overall Study|Poor or non-compliance|1|||
146900799|NCT00364793|529798705|FG000|Overall Study|No longer meets criteria|0|||
146900800|NCT00364793|529798706|FG001|Overall Study|No longer meets criteria|0|||
146900801|NCT00364793|529798707|FG002|Overall Study|No longer meets criteria|0|||
146900802|NCT00364793|529798708|FG003|Overall Study|No longer meets criteria|1|||
146900803|NCT00364793|529798705|FG000|Overall Study|Withdrawal by Subject|0|||
146900804|NCT00364793|529798706|FG001|Overall Study|Withdrawal by Subject|1|||
146900805|NCT00364793|529798707|FG002|Overall Study|Withdrawal by Subject|0|||
146900806|NCT00364793|529798708|FG003|Overall Study|Withdrawal by Subject|0|||
146900807|NCT00049127|529798709|FG000|Overall Study|Withdrawal by Subject|0|||
146900808|NCT00049127|529798710|FG001|Overall Study|Withdrawal by Subject|0|||
146900809|NCT00049127|529798711|FG002|Overall Study|Withdrawal by Subject|1|||
146900810|NCT00049127|529798712|FG003|Overall Study|Withdrawal by Subject|0|||
146900811|NCT00049127|529798713|FG004|Overall Study|Withdrawal by Subject|0|||
146900812|NCT01287754|529798716|FG000|Overall Study|Death|2|||
146900813|NCT01287754|529798717|FG001|Overall Study|Death|12|||
146900814|NCT01287754|529798716|FG000|Overall Study|Lost to Follow-up|1|||
146640572|NCT01088048|528860874|FG004|Overall Study|Concomitant Medication Prohibited|0|||
146640573|NCT01088048|528860875|FG005|Overall Study|Concomitant Medication Prohibited|0|||
146767354|NCT04517864|529317291|FG001|Active Therapy Extension Phase|Adverse Event|0|||
146900815|NCT01287754|529798717|FG001|Overall Study|Lost to Follow-up|6|||
146900816|NCT01287754|529798716|FG000|Overall Study|Protocol Violation|0|||
146900817|NCT01287754|529798717|FG001|Overall Study|Protocol Violation|3|||
146900818|NCT00001337|529798728|FG000|Overall Study|Switched to alternate treatment|2|||
146900819|NCT00001337|529798729|FG001|Overall Study|Switched to alternate treatment|2|||
146900820|NCT00001337|529798730|FG002|Overall Study|Switched to alternate treatment|0|||
146900821|NCT00001337|529798728|FG000|Overall Study|Refused further treatment|2|||
146900822|NCT00001337|529798729|FG001|Overall Study|Refused further treatment|1|||
146900823|NCT00001337|529798730|FG002|Overall Study|Refused further treatment|0|||
146900824|NCT00001337|529798728|FG000|Overall Study|Began other Tx|1|||
146900825|NCT00001337|529798729|FG001|Overall Study|Began other Tx|0|||
146900826|NCT00001337|529798730|FG002|Overall Study|Began other Tx|0|||
146900827|NCT00001337|529798728|FG000|Overall Study|Physician Decision|3|||
146900828|NCT00001337|529798729|FG001|Overall Study|Physician Decision|1|||
146900829|NCT00001337|529798730|FG002|Overall Study|Physician Decision|0|||
146900830|NCT00001337|529798728|FG000|Overall Study|Doesn't have NHL|0|||
146900831|NCT00001337|529798729|FG001|Overall Study|Doesn't have NHL|1|||
146900832|NCT00001337|529798730|FG002|Overall Study|Doesn't have NHL|0|||
146900833|NCT00001337|529798728|FG000|Overall Study|Non protocol tx needed|3|||
146900834|NCT00001337|529798729|FG001|Overall Study|Non protocol tx needed|1|||
146900835|NCT00001337|529798730|FG002|Overall Study|Non protocol tx needed|0|||
146900836|NCT00001337|529798728|FG000|Overall Study|Protocol change|1|||
146900837|NCT00001337|529798729|FG001|Overall Study|Protocol change|0|||
146900838|NCT00001337|529798730|FG002|Overall Study|Protocol change|0|||
146900839|NCT00001337|529798728|FG000|Overall Study|2nd primary disease|0|||
146900840|NCT00001337|529798729|FG001|Overall Study|2nd primary disease|0|||
146900841|NCT00001337|529798730|FG002|Overall Study|2nd primary disease|1|||
146900842|NCT00001337|529798728|FG000|Overall Study|Death during follow up period|9|||
146900843|NCT00001337|529798729|FG001|Overall Study|Death during follow up period|4|||
146969719|NCT03466060|530048912|FG003|Period 1|Lost to Follow-up|1|||
146900844|NCT00001337|529798730|FG002|Overall Study|Death during follow up period|0|||
146900845|NCT00001337|529798728|FG000|Overall Study|Death on study|19|||
146900846|NCT00001337|529798729|FG001|Overall Study|Death on study|9|||
146900847|NCT00001337|529798730|FG002|Overall Study|Death on study|0|||
146900848|NCT00001337|529798728|FG000|Overall Study|Disease progression during follow-up period|3|||
146969720|NCT03466060|530048913|FG004|Period 1|Lost to Follow-up|0|||
146900849|NCT00001337|529798729|FG001|Overall Study|Disease progression during follow-up period|1|||
146900850|NCT00001337|529798730|FG002|Overall Study|Disease progression during follow-up period|0|||
146900851|NCT00001337|529798728|FG000|Overall Study|Disease progression on study|33|||
146900852|NCT00001337|529798729|FG001|Overall Study|Disease progression on study|41|||
146900853|NCT00001337|529798730|FG002|Overall Study|Disease progression on study|0|||
146900854|NCT00001337|529798728|FG000|Overall Study|Lost to further follow-up|10|||
146969721|NCT03466060|530048914|FG005|Period 1|Lost to Follow-up|0|||
146969722|NCT03466060|530048909|FG000|Period 1|Grade 2 Conjunctivitis|0|||
146969723|NCT03466060|530048910|FG001|Period 1|Grade 2 Conjunctivitis|0|||
146969724|NCT03466060|530048911|FG002|Period 1|Grade 2 Conjunctivitis|1|||
146969725|NCT03466060|530048912|FG003|Period 1|Grade 2 Conjunctivitis|0|||
146969726|NCT03466060|530048913|FG004|Period 1|Grade 2 Conjunctivitis|0|||
146969727|NCT03466060|530048914|FG005|Period 1|Grade 2 Conjunctivitis|0|||
146969728|NCT03466060|530048909|FG000|Period 2|Lens Handling Difficulties|0|||
146969729|NCT03466060|530048910|FG001|Period 2|Lens Handling Difficulties|0|||
146969730|NCT03466060|530048911|FG002|Period 2|Lens Handling Difficulties|1|||
146969731|NCT03466060|530048912|FG003|Period 2|Lens Handling Difficulties|0|||
146969732|NCT03466060|530048913|FG004|Period 2|Lens Handling Difficulties|0|||
146969733|NCT03466060|530048914|FG005|Period 2|Lens Handling Difficulties|0|||
146969734|NCT00824993|530048919|FG000|Overall Study|Withdrawal by Subject|1|||
146969735|NCT00824993|530048920|FG001|Overall Study|Withdrawal by Subject|1|||
146969736|NCT00824993|530048919|FG000|Overall Study|Malignancy Relapse|9|||
146969737|NCT00824993|530048920|FG001|Overall Study|Malignancy Relapse|10|||
146969738|NCT00824993|530048919|FG000|Overall Study|Rapid Bone Loss|0|||
146969739|NCT00824993|530048920|FG001|Overall Study|Rapid Bone Loss|1|||
146767355|NCT04517864|529317292|FG002|Active Therapy Extension Phase|Adverse Event|0|||
146767356|NCT04517864|529317290|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
146767357|NCT04517864|529317291|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
146767358|NCT04517864|529317292|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
146767359|NCT04517864|529317290|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
146767360|NCT04517864|529317291|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
146767361|NCT04517864|529317292|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
146767362|NCT04517864|529317290|FG000|Active Therapy Extension Phase|Physician Decision|1|||
146900855|NCT00001337|529798729|FG001|Overall Study|Lost to further follow-up|6|||
146900856|NCT00001337|529798730|FG002|Overall Study|Lost to further follow-up|0|||
146900857|NCT00001337|529798728|FG000|Overall Study|2nd malignancy|1|||
146900858|NCT00001337|529798729|FG001|Overall Study|2nd malignancy|0|||
146969740|NCT00824993|530048919|FG000|Overall Study|Non-Compliant|2|||
146969741|NCT00824993|530048920|FG001|Overall Study|Non-Compliant|1|||
146969742|NCT00824993|530048919|FG000|Overall Study|Insurance Issue|2|||
146969743|NCT00824993|530048920|FG001|Overall Study|Insurance Issue|1|||
146969744|NCT00824993|530048919|FG000|Overall Study|Death|0|||
146969745|NCT00824993|530048920|FG001|Overall Study|Death|3|||
146969746|NCT02998645|530048921|FG000|Treatment Period 1|Adverse Event|6|||
146969747|NCT02998645|530048921|FG000|Treatment Period 1|Death|5|||
146969748|NCT02998645|530048921|FG000|Treatment Period 1|Technical Problems|4|||
146969749|NCT02998645|530048921|FG000|Treatment Period 1|Lack of Efficacy|2|||
146969750|NCT02998645|530048921|FG000|Treatment Period 1|Progressive disease|1|||
146900859|NCT00001337|529798730|FG002|Overall Study|2nd malignancy|0|||
146969751|NCT02998645|530048921|FG000|Treatment Period 1|Subject/guardian decision|1|||
146969752|NCT02998645|530048921|FG000|Treatment Period 2|Lack of Efficacy|5|||
146969753|NCT02998645|530048921|FG000|Treatment Period 2|Adverse Event|2|||
146969754|NCT02998645|530048921|FG000|Treatment Period 2|Progressive disease|2|||
146969755|NCT02998645|530048921|FG000|Treatment Period 2|Physician Decision|1|||
146969756|NCT03701516|530048922|FG000|Period 1|Lost to Follow-up|0|||
146969757|NCT03701516|530048923|FG001|Period 1|Lost to Follow-up|1|||
146969758|NCT03701516|530048922|FG000|Period 1|Adverse Event|0|||
146969759|NCT03701516|530048923|FG001|Period 1|Adverse Event|2|||
146969760|NCT03701516|530048922|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
146767363|NCT04517864|529317291|FG001|Active Therapy Extension Phase|Physician Decision|0|||
146900860|NCT00001337|529798728|FG000|Overall Study|Treatment for second lymphoma|0|||
146900861|NCT00001337|529798729|FG001|Overall Study|Treatment for second lymphoma|1|||
146767364|NCT04517864|529317292|FG002|Active Therapy Extension Phase|Physician Decision|0|||
146900862|NCT00001337|529798730|FG002|Overall Study|Treatment for second lymphoma|0|||
146900863|NCT00001337|529798728|FG000|Overall Study|Transfer to transplant|0|||
146900864|NCT00001337|529798729|FG001|Overall Study|Transfer to transplant|1|||
146900865|NCT00001337|529798730|FG002|Overall Study|Transfer to transplant|0|||
146900866|NCT05817045|529798731|FG000|Overall Study|Protocol Violation|0|||
146900867|NCT05817045|529798732|FG001|Overall Study|Protocol Violation|3|||
146900868|NCT05817045|529798731|FG000|Overall Study|Withdrawal by Subject|10|||
146969761|NCT03701516|530048923|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
146969762|NCT03701516|530048922|FG000|Period 1|Non Compliance to Protocol|2|||
146969763|NCT03701516|530048923|FG001|Period 1|Non Compliance to Protocol|1|||
146969764|NCT03701516|530048922|FG000|Period 1|Withdrawal by Subject|0|||
146969765|NCT03701516|530048923|FG001|Period 1|Withdrawal by Subject|1|||
146969766|NCT03701516|530048922|FG000|Period 2|failed to meet all eligibility creiteria|1|||
146900869|NCT05817045|529798732|FG001|Overall Study|Withdrawal by Subject|7|||
146900870|NCT05817045|529798731|FG000|Overall Study|Physician Decision|3|||
146900871|NCT05817045|529798732|FG001|Overall Study|Physician Decision|0|||
146900872|NCT05817045|529798731|FG000|Overall Study|Lost to Follow-up|0|||
146900873|NCT05817045|529798732|FG001|Overall Study|Lost to Follow-up|1|||
146900874|NCT05817045|529798731|FG000|Overall Study|Device Deficiency|1|||
146900875|NCT05817045|529798732|FG001|Overall Study|Device Deficiency|0|||
146900876|NCT05817045|529798731|FG000|Overall Study|System Error|1|||
146900877|NCT05817045|529798732|FG001|Overall Study|System Error|0|||
146900878|NCT00382967|529798733|FG000|Overall Study|Protocol Violation|1|||
146900879|NCT00382967|529798734|FG001|Overall Study|Protocol Violation|1|||
146900880|NCT03093402|529798735|FG000|Overall Study|Lost to Follow-up|1|||
146900881|NCT03093402|529798736|FG001|Overall Study|Lost to Follow-up|0|||
146900882|NCT03093402|529798737|FG002|Overall Study|Lost to Follow-up|0|||
146900883|NCT03093402|529798738|FG003|Overall Study|Lost to Follow-up|0|||
146900884|NCT03093402|529798735|FG000|Overall Study|Withdrawal by Subject|3|||
146900885|NCT03093402|529798736|FG001|Overall Study|Withdrawal by Subject|3|||
146900886|NCT03093402|529798737|FG002|Overall Study|Withdrawal by Subject|0|||
146900887|NCT03093402|529798738|FG003|Overall Study|Withdrawal by Subject|1|||
146900888|NCT03093402|529798735|FG000|Overall Study|Withdrew prior to dosing|2|||
146900889|NCT03093402|529798736|FG001|Overall Study|Withdrew prior to dosing|1|||
146900890|NCT03093402|529798737|FG002|Overall Study|Withdrew prior to dosing|2|||
146900891|NCT03093402|529798738|FG003|Overall Study|Withdrew prior to dosing|3|||
146900892|NCT03093402|529798735|FG000|Overall Study|Ineligible for study|1|||
146900893|NCT03093402|529798736|FG001|Overall Study|Ineligible for study|0|||
146900894|NCT03093402|529798737|FG002|Overall Study|Ineligible for study|0|||
146900895|NCT03093402|529798738|FG003|Overall Study|Ineligible for study|0|||
146900896|NCT03093402|529798735|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
146900897|NCT03093402|529798736|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
146900898|NCT03093402|529798737|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
146900899|NCT03093402|529798738|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
146900900|NCT02886702|529798739|FG000|Overall Study|Other|4|||
146900901|NCT02886702|529798740|FG001|Overall Study|Other|3|||
146900902|NCT02886702|529798741|FG002|Overall Study|Other|9|||
146900903|NCT02886702|529798739|FG000|Overall Study|Withdrawal by Subject|24|||
146900904|NCT02886702|529798740|FG001|Overall Study|Withdrawal by Subject|18|||
146900905|NCT02886702|529798741|FG002|Overall Study|Withdrawal by Subject|22|||
146900906|NCT02886702|529798739|FG000|Overall Study|Significant Worsening of Condition|0|||
146900907|NCT02886702|529798740|FG001|Overall Study|Significant Worsening of Condition|1|||
146900908|NCT02886702|529798741|FG002|Overall Study|Significant Worsening of Condition|0|||
146900909|NCT02886702|529798739|FG000|Overall Study|Protocol Violation|2|||
146900910|NCT02886702|529798740|FG001|Overall Study|Protocol Violation|2|||
146900911|NCT02886702|529798741|FG002|Overall Study|Protocol Violation|1|||
146900912|NCT02886702|529798739|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146900913|NCT02886702|529798740|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146900914|NCT02886702|529798741|FG002|Overall Study|Non-Compliance With Study Drug|4|||
146900915|NCT02886702|529798739|FG000|Overall Study|Lost to Follow-up|11|||
146900916|NCT02886702|529798740|FG001|Overall Study|Lost to Follow-up|13|||
146900917|NCT02886702|529798741|FG002|Overall Study|Lost to Follow-up|8|||
146900918|NCT02886702|529798739|FG000|Overall Study|Lack of Efficacy|3|||
146900919|NCT02886702|529798740|FG001|Overall Study|Lack of Efficacy|4|||
146900920|NCT02886702|529798741|FG002|Overall Study|Lack of Efficacy|5|||
146900921|NCT02886702|529798739|FG000|Overall Study|Adverse Event|4|||
146900922|NCT02886702|529798740|FG001|Overall Study|Adverse Event|9|||
146900923|NCT02886702|529798741|FG002|Overall Study|Adverse Event|3|||
146900924|NCT02886702|529798739|FG000|Overall Study|Administrative Reasons|0|||
146900925|NCT02886702|529798740|FG001|Overall Study|Administrative Reasons|0|||
146900926|NCT02886702|529798741|FG002|Overall Study|Administrative Reasons|1|||
146900927|NCT01147497|529798744|FG000|Overall Study|failed insertion|2|||
146900928|NCT01147497|529798745|FG001|Overall Study|failed insertion|0|||
146900929|NCT02731742|529798746|FG000|Overall Study|Death|1|||
146900930|NCT02731742|529798747|FG001|Overall Study|Death|2|||
146900931|NCT02731742|529798748|FG002|Overall Study|Death|5|||
146900932|NCT02731742|529798749|FG003|Overall Study|Death|0|||
146900933|NCT02731742|529798746|FG000|Overall Study|Physician Decision|0|||
146900934|NCT02731742|529798747|FG001|Overall Study|Physician Decision|0|||
146900935|NCT02731742|529798748|FG002|Overall Study|Physician Decision|0|||
146900936|NCT02731742|529798749|FG003|Overall Study|Physician Decision|1|||
146900937|NCT02731742|529798746|FG000|Overall Study|Study Terminated by Sponsor|2|||
146900938|NCT02731742|529798747|FG001|Overall Study|Study Terminated by Sponsor|1|||
146969767|NCT03701516|530048923|FG001|Period 2|failed to meet all eligibility creiteria|0|||
146900939|NCT02731742|529798748|FG002|Overall Study|Study Terminated by Sponsor|1|||
146900940|NCT02731742|529798749|FG003|Overall Study|Study Terminated by Sponsor|1|||
146900941|NCT04026568|529798750|FG000|Overall Study|study terminated|0|||
146900942|NCT04026568|529798751|FG001|Overall Study|study terminated|1|||
146900943|NCT00331760|529798754|FG000|Overall Study|Ineligible / no protocol treatment|15|||
146900944|NCT00331760|529798755|FG001|Overall Study|Ineligible / no protocol treatment|8|||
146900945|NCT00461175|529798756|FG000|Overall Study|Protocol Violation|522|||
146900946|NCT00461175|529798757|FG001|Overall Study|Protocol Violation|365|||
146900947|NCT03093155|529798759|FG000|Overall Study|Not Eligible|1|||
146900948|NCT03093155|529798760|FG001|Overall Study|Not Eligible|0|||
146900949|NCT03093155|529798759|FG000|Overall Study|Withdrawal by Subject|0|||
146900950|NCT03093155|529798760|FG001|Overall Study|Withdrawal by Subject|1|||
146900951|NCT03417440|529798761|FG000|Overall Study|Lost to Follow-up|0|||
146900952|NCT03417440|529798762|FG001|Overall Study|Lost to Follow-up|1|||
146900953|NCT03417440|529798763|FG002|Overall Study|Lost to Follow-up|0|||
146900954|NCT03417440|529798764|FG003|Overall Study|Lost to Follow-up|0|||
146900955|NCT03417440|529798765|FG004|Overall Study|Lost to Follow-up|1|||
146900956|NCT03417440|529798766|FG005|Overall Study|Lost to Follow-up|0|||
146900957|NCT03417440|529798767|FG006|Overall Study|Lost to Follow-up|0|||
146900958|NCT03417440|529798768|FG007|Overall Study|Lost to Follow-up|0|||
146900959|NCT03417440|529798761|FG000|Overall Study|Withdrawal by Subject|2|||
146900960|NCT03417440|529798762|FG001|Overall Study|Withdrawal by Subject|0|||
146900961|NCT03417440|529798763|FG002|Overall Study|Withdrawal by Subject|2|||
146900962|NCT03417440|529798764|FG003|Overall Study|Withdrawal by Subject|1|||
146900963|NCT03417440|529798765|FG004|Overall Study|Withdrawal by Subject|1|||
146900964|NCT03417440|529798766|FG005|Overall Study|Withdrawal by Subject|0|||
146900965|NCT03417440|529798767|FG006|Overall Study|Withdrawal by Subject|0|||
146900966|NCT03417440|529798768|FG007|Overall Study|Withdrawal by Subject|1|||
146900967|NCT02786901|529798769|FG000|Overall Study|Adverse Event|1|||
146900968|NCT02786901|529798770|FG001|Overall Study|Adverse Event|1|||
146900969|NCT02786901|529798771|FG002|Overall Study|Adverse Event|2|||
146900970|NCT02786901|529798769|FG000|Overall Study|Physician Decision|1|||
146900971|NCT02786901|529798770|FG001|Overall Study|Physician Decision|0|||
146900972|NCT02786901|529798771|FG002|Overall Study|Physician Decision|0|||
146900973|NCT02786901|529798769|FG000|Overall Study|Rescue Therapy Use|71|||
146900974|NCT02786901|529798770|FG001|Overall Study|Rescue Therapy Use|49|||
146900975|NCT02786901|529798771|FG002|Overall Study|Rescue Therapy Use|33|||
146900976|NCT02786901|529798769|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
146900977|NCT02786901|529798770|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
146900978|NCT02786901|529798771|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
146900979|NCT02786901|529798769|FG000|Overall Study|Disallowed medication|1|||
146900980|NCT02786901|529798770|FG001|Overall Study|Disallowed medication|1|||
146900981|NCT02786901|529798771|FG002|Overall Study|Disallowed medication|0|||
146900982|NCT02786901|529798769|FG000|Overall Study|Randomized in error|2|||
146900983|NCT02786901|529798770|FG001|Overall Study|Randomized in error|0|||
146900984|NCT02786901|529798771|FG002|Overall Study|Randomized in error|1|||
146900985|NCT00607048|529798773|FG000|Overall Study|Adverse Event|0|||
146900986|NCT00607048|529798774|FG001|Overall Study|Adverse Event|1|||
146900987|NCT00607048|529798775|FG002|Overall Study|Adverse Event|0|||
146900988|NCT00607048|529798776|FG003|Overall Study|Adverse Event|0|||
146900989|NCT00607048|529798777|FG004|Overall Study|Adverse Event|4|||
146900990|NCT00607048|529798778|FG005|Overall Study|Adverse Event|0|||
146900991|NCT00607048|529798773|FG000|Overall Study|Global deterioration of health|1|||
146900992|NCT00607048|529798774|FG001|Overall Study|Global deterioration of health|0|||
146900993|NCT00607048|529798775|FG002|Overall Study|Global deterioration of health|0|||
146900994|NCT00607048|529798776|FG003|Overall Study|Global deterioration of health|0|||
146900995|NCT00607048|529798777|FG004|Overall Study|Global deterioration of health|0|||
146900996|NCT00607048|529798778|FG005|Overall Study|Global deterioration of health|0|||
146900997|NCT00607048|529798773|FG000|Overall Study|Objective disease progression - relapse|1|||
146900998|NCT00607048|529798774|FG001|Overall Study|Objective disease progression - relapse|2|||
146900999|NCT00607048|529798775|FG002|Overall Study|Objective disease progression - relapse|4|||
146901000|NCT00607048|529798776|FG003|Overall Study|Objective disease progression - relapse|2|||
146901001|NCT00607048|529798777|FG004|Overall Study|Objective disease progression - relapse|2|||
146767365|NCT04517864|529317290|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
146767366|NCT04517864|529317291|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
146767367|NCT04517864|529317292|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
146767368|NCT04517864|529317290|FG000|Extension Phase|Adverse Event|0|||
146767369|NCT04517864|529317291|FG001|Extension Phase|Adverse Event|0|||
146767370|NCT04517864|529317292|FG002|Extension Phase|Adverse Event|1|||
146767371|NCT04517864|529317290|FG000|Extension Phase|Lack of Efficacy|0|||
146767372|NCT04517864|529317291|FG001|Extension Phase|Lack of Efficacy|0|||
146901002|NCT00607048|529798778|FG005|Overall Study|Objective disease progression - relapse|2|||
146901003|NCT00607048|529798773|FG000|Overall Study|Withdrawal by Subject|0|||
146640574|NCT01088048|528860876|FG006|Overall Study|Concomitant Medication Prohibited|0|||
146640575|NCT01088048|528860877|FG007|Overall Study|Concomitant Medication Prohibited|0|||
146901004|NCT00607048|529798774|FG001|Overall Study|Withdrawal by Subject|0|||
146901005|NCT00607048|529798775|FG002|Overall Study|Withdrawal by Subject|0|||
146767373|NCT04517864|529317292|FG002|Extension Phase|Lack of Efficacy|2|||
146901006|NCT00607048|529798776|FG003|Overall Study|Withdrawal by Subject|1|||
146640576|NCT01088048|528860878|FG008|Overall Study|Concomitant Medication Prohibited|0|||
146901007|NCT00607048|529798777|FG004|Overall Study|Withdrawal by Subject|0|||
146901008|NCT00607048|529798778|FG005|Overall Study|Withdrawal by Subject|2|||
146901009|NCT00607048|529798773|FG000|Overall Study|Other|1|||
146901010|NCT00607048|529798774|FG001|Overall Study|Other|1|||
146901011|NCT00607048|529798775|FG002|Overall Study|Other|0|||
146901012|NCT00607048|529798776|FG003|Overall Study|Other|0|||
146901013|NCT00607048|529798777|FG004|Overall Study|Other|0|||
146901014|NCT00607048|529798778|FG005|Overall Study|Other|1|||
146901015|NCT04336163|529798779|FG000|Overall Study|Lost to Follow-up|55|||
146901016|NCT04336163|529798780|FG001|Overall Study|Lost to Follow-up|0|||
146901017|NCT03926143|529798783|FG000|Overall Study|Physician Decision|3|||
146901018|NCT03926143|529798783|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
146901019|NCT03926143|529798783|FG000|Overall Study|Adverse Event|2|||
146901020|NCT03926143|529798783|FG000|Overall Study|Progressive disease|3|||
146901021|NCT01071070|529798784|FG000|Overall Study|Adverse Event|0|||
146901022|NCT01071070|529798785|FG001|Overall Study|Adverse Event|3|||
146901023|NCT01071070|529798784|FG000|Overall Study|Withdrawal by Subject|1|||
146901024|NCT01071070|529798785|FG001|Overall Study|Withdrawal by Subject|0|||
146901025|NCT01071070|529798784|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
146901026|NCT01071070|529798785|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
146901027|NCT01071070|529798784|FG000|Overall Study|Hypercalcemia|1|||
146901028|NCT01071070|529798785|FG001|Overall Study|Hypercalcemia|0|||
146901029|NCT00158184|529798786|FG000|Overall Study|personal issues|3|||
146901030|NCT00158184|529798787|FG001|Overall Study|personal issues|1|||
146901031|NCT00158184|529798786|FG000|Overall Study|failed for follow unit/study rules|2|||
146901032|NCT00158184|529798787|FG001|Overall Study|failed for follow unit/study rules|0|||
146901033|NCT00158184|529798786|FG000|Overall Study|Adverse Event|1|||
146901034|NCT00158184|529798787|FG001|Overall Study|Adverse Event|1|||
146901035|NCT02620020|529798798|FG000|Overall Study|Adverse Event|8|||
146901036|NCT02620020|529798799|FG001|Overall Study|Adverse Event|4|||
146901037|NCT02620020|529798800|FG002|Overall Study|Adverse Event|3|||
146901038|NCT02620020|529798801|FG003|Overall Study|Adverse Event|5|||
146901039|NCT02620020|529798798|FG000|Overall Study|Lost to Follow-up|4|||
146901040|NCT02620020|529798799|FG001|Overall Study|Lost to Follow-up|8|||
146901041|NCT02620020|529798800|FG002|Overall Study|Lost to Follow-up|1|||
146901042|NCT02620020|529798801|FG003|Overall Study|Lost to Follow-up|4|||
146901043|NCT02620020|529798798|FG000|Overall Study|Physician Decision|7|||
146901044|NCT02620020|529798799|FG001|Overall Study|Physician Decision|4|||
146901045|NCT02620020|529798800|FG002|Overall Study|Physician Decision|3|||
146901046|NCT02620020|529798801|FG003|Overall Study|Physician Decision|4|||
146901047|NCT02620020|529798798|FG000|Overall Study|Protocol Violation|5|||
146901048|NCT02620020|529798799|FG001|Overall Study|Protocol Violation|2|||
146901049|NCT02620020|529798800|FG002|Overall Study|Protocol Violation|1|||
146901050|NCT02620020|529798801|FG003|Overall Study|Protocol Violation|1|||
146901051|NCT02620020|529798798|FG000|Overall Study|Withdrawal by Subject|20|||
146901052|NCT02620020|529798799|FG001|Overall Study|Withdrawal by Subject|16|||
146901053|NCT02620020|529798800|FG002|Overall Study|Withdrawal by Subject|17|||
146901054|NCT02620020|529798801|FG003|Overall Study|Withdrawal by Subject|12|||
146901055|NCT02620020|529798798|FG000|Overall Study|Death|0|||
146901056|NCT02620020|529798799|FG001|Overall Study|Death|1|||
146901057|NCT02620020|529798800|FG002|Overall Study|Death|0|||
146901058|NCT02620020|529798801|FG003|Overall Study|Death|0|||
146901059|NCT01025635|529798805|FG000|Overall Study|Withdrawal by Subject|6|||
146901060|NCT01025635|529798806|FG001|Overall Study|Withdrawal by Subject|7|||
146901061|NCT01025635|529798805|FG000|Overall Study|Protocol Violation|4|||
146901062|NCT01025635|529798806|FG001|Overall Study|Protocol Violation|2|||
146901063|NCT01025635|529798805|FG000|Overall Study|Lack of Efficacy|0|||
146901064|NCT01025635|529798806|FG001|Overall Study|Lack of Efficacy|1|||
146901065|NCT01025635|529798805|FG000|Overall Study|Lost to Follow-up|9|||
146901066|NCT01025635|529798806|FG001|Overall Study|Lost to Follow-up|13|||
146901067|NCT01025635|529798805|FG000|Overall Study|Reason not known|4|||
146901068|NCT01025635|529798806|FG001|Overall Study|Reason not known|2|||
146901069|NCT02393209|529798807|FG000|Overall Study|Study Terminated by Sponsor|1|||
146901070|NCT02393209|529798808|FG001|Overall Study|Study Terminated by Sponsor|1|||
146901071|NCT02393209|529798809|FG002|Overall Study|Study Terminated by Sponsor|0|||
146901072|NCT02393209|529798810|FG003|Overall Study|Study Terminated by Sponsor|0|||
146901073|NCT02393209|529798807|FG000|Overall Study|Withdrawal by Patient|1|||
146901074|NCT02393209|529798808|FG001|Overall Study|Withdrawal by Patient|0|||
146901075|NCT02393209|529798809|FG002|Overall Study|Withdrawal by Patient|0|||
146901076|NCT02393209|529798810|FG003|Overall Study|Withdrawal by Patient|0|||
146901077|NCT02393209|529798807|FG000|Overall Study|Death|2|||
146901078|NCT02393209|529798808|FG001|Overall Study|Death|2|||
146901079|NCT02393209|529798809|FG002|Overall Study|Death|0|||
146901080|NCT02393209|529798810|FG003|Overall Study|Death|0|||
146901081|NCT02393209|529798807|FG000|Overall Study|Death due to Disease Progression|2|||
146901082|NCT02393209|529798808|FG001|Overall Study|Death due to Disease Progression|2|||
146901083|NCT02393209|529798809|FG002|Overall Study|Death due to Disease Progression|0|||
146901084|NCT02393209|529798810|FG003|Overall Study|Death due to Disease Progression|0|||
146901085|NCT02393209|529798807|FG000|Overall Study|Death from Legionella Infection|0|||
146901086|NCT02393209|529798808|FG001|Overall Study|Death from Legionella Infection|1|||
146901087|NCT02393209|529798809|FG002|Overall Study|Death from Legionella Infection|0|||
146901088|NCT02393209|529798810|FG003|Overall Study|Death from Legionella Infection|0|||
146901089|NCT02393209|529798807|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
146901090|NCT02393209|529798808|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
146901091|NCT02393209|529798809|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
146901092|NCT02393209|529798810|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
146901093|NCT02393209|529798807|FG000|Overall Study|Lost to Follow-up|0|||
146901094|NCT02393209|529798808|FG001|Overall Study|Lost to Follow-up|1|||
146901095|NCT02393209|529798809|FG002|Overall Study|Lost to Follow-up|0|||
146901096|NCT02393209|529798810|FG003|Overall Study|Lost to Follow-up|0|||
146901097|NCT00727402|529798811|FG000|Overall Study|Physician Decision|116|||
146901098|NCT03545282|529798812|FG000|Overall Study|Lost to Follow-up|15|||
146901099|NCT03545282|529798813|FG001|Overall Study|Lost to Follow-up|10|||
146901100|NCT03545282|529798812|FG000|Overall Study|Withdrawal by Subject|2|||
146901101|NCT03545282|529798813|FG001|Overall Study|Withdrawal by Subject|2|||
146901102|NCT02582671|529798814|FG000|Overall Study|Failure to return|1|||
146901103|NCT02582671|529798814|FG000|Overall Study|Other, not specified|1|||
146901104|NCT02537678|529798819|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
146901105|NCT02537678|529798820|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
146901106|NCT02537678|529798819|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
146901107|NCT02537678|529798820|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
146901108|NCT02537678|529798819|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
146901109|NCT02537678|529798820|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
146901110|NCT02537678|529798819|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
146901111|NCT02537678|529798820|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
146901112|NCT02537678|529798819|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
146901113|NCT02537678|529798820|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
146901114|NCT02537678|529798819|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
146901115|NCT02537678|529798820|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
146901116|NCT02537678|529798819|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
146901117|NCT02537678|529798820|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
146901118|NCT03168867|529798821|FG000|Overall Study|Withdrawal by Subject|1|||
146901119|NCT03168867|529798822|FG001|Overall Study|Withdrawal by Subject|5|||
146901120|NCT04348851|529798823|FG000|Post-Test 1|Withdrawal by Subject|0|||
146901121|NCT04348851|529798824|FG001|Post-Test 1|Withdrawal by Subject|1|||
146901122|NCT04348851|529798825|FG002|Post-Test 1|Withdrawal by Subject|0|||
146901123|NCT04348851|529798826|FG003|Post-Test 1|Withdrawal by Subject|0|||
146901124|NCT04348851|529798823|FG000|Post-Test 1|Lost to Follow-up|0|||
146901125|NCT04348851|529798824|FG001|Post-Test 1|Lost to Follow-up|1|||
146901126|NCT04348851|529798825|FG002|Post-Test 1|Lost to Follow-up|0|||
146901127|NCT04348851|529798826|FG003|Post-Test 1|Lost to Follow-up|0|||
146901128|NCT04348851|529798823|FG000|Post-Test 2|Stroke survivor death|0|||
146901129|NCT04348851|529798824|FG001|Post-Test 2|Stroke survivor death|1|||
146901130|NCT04348851|529798825|FG002|Post-Test 2|Stroke survivor death|0|||
146901131|NCT04348851|529798826|FG003|Post-Test 2|Stroke survivor death|1|||
146901132|NCT00195650|529798827|FG000|Overall Study|Adverse Event|194|||
146901133|NCT00195650|529798827|FG000|Overall Study|Lack of Efficacy|99|||
146901134|NCT00195650|529798827|FG000|Overall Study|Withdrawal by Subject|67|||
146901135|NCT00195650|529798827|FG000|Overall Study|Lost to Follow-up|44|||
146901136|NCT00195650|529798827|FG000|Overall Study|Death|23|||
146901137|NCT00195650|529798827|FG000|Overall Study|Protocol Violation|15|||
146969768|NCT03701516|530048922|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
146969769|NCT03701516|530048923|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
146969770|NCT03930615|530048925|FG000|Overall Study|Death|9|||
146969771|NCT03930615|530048926|FG001|Overall Study|Death|3|||
146969772|NCT03930615|530048925|FG000|Overall Study|Lost to Follow-up|1|||
146969773|NCT03930615|530048926|FG001|Overall Study|Lost to Follow-up|2|||
146969774|NCT03930615|530048925|FG000|Overall Study|Physician Decision|3|||
146969775|NCT03930615|530048926|FG001|Overall Study|Physician Decision|4|||
146901138|NCT00195650|529798827|FG000|Overall Study|Administrative reasons|83|||
146901139|NCT01478958|529798828|FG000|Overall Study|Withdrawal by Subject|1|||
146901140|NCT01478958|529798829|FG001|Overall Study|Withdrawal by Subject|1|||
146901141|NCT01478958|529798830|FG002|Overall Study|Withdrawal by Subject|1|||
146901142|NCT01478958|529798828|FG000|Overall Study|Weight loss|1|||
146901143|NCT01478958|529798829|FG001|Overall Study|Weight loss|0|||
146901144|NCT01478958|529798830|FG002|Overall Study|Weight loss|0|||
146901145|NCT01478958|529798828|FG000|Overall Study|Re-located|0|||
146969776|NCT03930615|530048925|FG000|Overall Study|Withdrawal by Subject|13|||
146901146|NCT01478958|529798829|FG001|Overall Study|Re-located|1|||
146901147|NCT01478958|529798830|FG002|Overall Study|Re-located|0|||
146901148|NCT01478958|529798828|FG000|Overall Study|Unable to comply|0|||
146901149|NCT01478958|529798829|FG001|Overall Study|Unable to comply|0|||
146969777|NCT03930615|530048926|FG001|Overall Study|Withdrawal by Subject|2|||
146901150|NCT01478958|529798830|FG002|Overall Study|Unable to comply|2|||
146901151|NCT04640766|529798831|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
146901152|NCT02654002|529798834|FG000|Overall Study|Adverse Event|0|||
146901153|NCT02654002|529798835|FG001|Overall Study|Adverse Event|0|||
146901154|NCT02654002|529798836|FG002|Overall Study|Adverse Event|0|||
146901155|NCT02654002|529798837|FG003|Overall Study|Adverse Event|0|||
146559982|NCT03322566|528560720|FG001|Overall Study|Withdrawal by Subject|3|||
146559983|NCT03322566|528560721|FG002|Overall Study|Withdrawal by Subject|6|||
146559984|NCT03322566|528560719|FG000|Overall Study|Lost to Follow-up|0|||
146559985|NCT03322566|528560720|FG001|Overall Study|Lost to Follow-up|0|||
146559986|NCT03322566|528560721|FG002|Overall Study|Lost to Follow-up|1|||
146559987|NCT03322566|528560719|FG000|Overall Study|Study terminated by sponsor|1|||
146559988|NCT03322566|528560720|FG001|Overall Study|Study terminated by sponsor|0|||
146559989|NCT03322566|528560721|FG002|Overall Study|Study terminated by sponsor|1|||
146559990|NCT01905540|528560722|FG000|Period 3|Other|1|||
146559991|NCT01905540|528560723|FG001|Period 3|Other|0|||
146767374|NCT04517864|529317290|FG000|Extension Phase|Study Terminated By Sponsor|0|||
146767375|NCT04517864|529317291|FG001|Extension Phase|Study Terminated By Sponsor|0|||
146901156|NCT02654002|529798838|FG004|Overall Study|Adverse Event|0|||
146901157|NCT02654002|529798839|FG005|Overall Study|Adverse Event|0|||
146901158|NCT02654002|529798840|FG006|Overall Study|Adverse Event|1|||
146901159|NCT02654002|529798841|FG007|Overall Study|Adverse Event|0|||
146901160|NCT02654002|529798842|FG008|Overall Study|Adverse Event|0|||
146901161|NCT02654002|529798834|FG000|Overall Study|Withdrew Consent|0|||
146901162|NCT02654002|529798835|FG001|Overall Study|Withdrew Consent|0|||
146901163|NCT02654002|529798836|FG002|Overall Study|Withdrew Consent|0|||
146901164|NCT02654002|529798837|FG003|Overall Study|Withdrew Consent|0|||
146901165|NCT02654002|529798838|FG004|Overall Study|Withdrew Consent|0|||
146901166|NCT02654002|529798839|FG005|Overall Study|Withdrew Consent|1|||
146901167|NCT02654002|529798840|FG006|Overall Study|Withdrew Consent|0|||
146901168|NCT02654002|529798841|FG007|Overall Study|Withdrew Consent|1|||
146901169|NCT02654002|529798842|FG008|Overall Study|Withdrew Consent|0|||
146901170|NCT06119191|529798843|FG000|Overall Study|Adverse Event|0|||
146901171|NCT06119191|529798844|FG001|Overall Study|Adverse Event|1|||
146901172|NCT06119191|529798843|FG000|Overall Study|Protocol Violation|1|||
146901173|NCT06119191|529798844|FG001|Overall Study|Protocol Violation|0|||
146901174|NCT04375761|529801322|FG000|Overall Study|Death|1|||
146901175|NCT04375761|529801323|FG001|Overall Study|Death|2|||
146901176|NCT04375761|529801322|FG000|Overall Study|Lost to Follow-up|203|||
146901177|NCT04375761|529801323|FG001|Overall Study|Lost to Follow-up|380|||
146901178|NCT04375761|529801322|FG000|Overall Study|Withdrawal by Subject|47|||
146901179|NCT04375761|529801323|FG001|Overall Study|Withdrawal by Subject|98|||
146901180|NCT04375761|529801322|FG000|Overall Study|Noncompliance with study procedure|121|||
146901181|NCT04375761|529801323|FG001|Overall Study|Noncompliance with study procedure|251|||
146901182|NCT04375761|529801322|FG000|Overall Study|Reimbursement not enough|1|||
146901183|NCT04375761|529801323|FG001|Overall Study|Reimbursement not enough|2|||
146901184|NCT04375761|529801322|FG000|Overall Study|Unforeseen family circumstances|1|||
146901185|NCT04375761|529801323|FG001|Overall Study|Unforeseen family circumstances|3|||
146901186|NCT04375761|529801322|FG000|Overall Study|Test too painful|1|||
146901187|NCT04375761|529801323|FG001|Overall Study|Test too painful|1|||
146901188|NCT04375761|529801322|FG000|Overall Study|Moved|0|||
146901189|NCT04375761|529801323|FG001|Overall Study|Moved|2|||
146901190|NCT04375761|529801322|FG000|Overall Study|Nonresponsive|0|||
146901191|NCT04375761|529801323|FG001|Overall Study|Nonresponsive|5|||
146767376|NCT04517864|529317292|FG002|Extension Phase|Study Terminated By Sponsor|32|||
146901192|NCT04030195|529801325|FG000|Overall Study|Withdrawal by Subject|2|||
146901193|NCT04030195|529801326|FG001|Overall Study|Withdrawal by Subject|0|||
146901194|NCT04030195|529801327|FG002|Overall Study|Withdrawal by Subject|0|||
146901195|NCT01412879|529801328|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
146901196|NCT01412879|529801329|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
146901197|NCT01412879|529801330|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
146901198|NCT01412879|529801328|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
146767377|NCT04517864|529317290|FG000|Extension Phase|Withdrawal by Subject|0|||
146901199|NCT01412879|529801329|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
146901200|NCT01412879|529801330|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
146901201|NCT01412879|529801328|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
146901202|NCT01412879|529801329|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
146901203|NCT01412879|529801330|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
146901204|NCT01412879|529801328|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
146559992|NCT01905540|528560724|FG002|Period 3|Other|1|||
146559993|NCT01905540|528560725|FG003|Period 3|Other|1|||
146559994|NCT03847519|528560726|FG000|Overall Study|Death|5|||
146901205|NCT01412879|529801329|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
146901206|NCT01412879|529801330|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
146559995|NCT03847519|528560727|FG001|Overall Study|Death|8|||
146901207|NCT01412879|529801328|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
146901208|NCT01412879|529801329|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
146901209|NCT01412879|529801330|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
146901210|NCT01056107|529801334|FG000|Overall Study|Withdrawal by Subject|0|||
146901211|NCT01056107|529801335|FG001|Overall Study|Withdrawal by Subject|1|||
146901212|NCT01056107|529801336|FG002|Overall Study|Withdrawal by Subject|3|||
146901213|NCT01056107|529801337|FG003|Overall Study|Withdrawal by Subject|0|||
146901214|NCT00260208|529801343|FG000|Overall Study|Subject withdrew consent|11|||
146901215|NCT00260208|529801344|FG001|Overall Study|Subject withdrew consent|7|||
146901216|NCT00260208|529801343|FG000|Overall Study|Lost to Follow-up|6|||
146901217|NCT00260208|529801344|FG001|Overall Study|Lost to Follow-up|1|||
146901218|NCT00260208|529801343|FG000|Overall Study|Death|12|||
146901219|NCT00260208|529801344|FG001|Overall Study|Death|10|||
146901220|NCT00260208|529801343|FG000|Overall Study|Missing|18|||
146901221|NCT00260208|529801344|FG001|Overall Study|Missing|16|||
146901222|NCT02091440|529801345|FG000|Overall Study|Death|2|||
146901223|NCT00768222|529801346|FG000|Overall Study|Lost to Follow-up|1|||
146901224|NCT00768222|529801347|FG001|Overall Study|Lost to Follow-up|1|||
146901225|NCT00768222|529801346|FG000|Overall Study|Withdrawal by Subject|3|||
146901226|NCT00768222|529801347|FG001|Overall Study|Withdrawal by Subject|1|||
146901227|NCT00768222|529801346|FG000|Overall Study|Protocol Violation|0|||
146901228|NCT00768222|529801347|FG001|Overall Study|Protocol Violation|2|||
146901229|NCT03263091|529801348|FG000|OL Component|Withdrawal by Subject|1|||
146901230|NCT03263091|529801349|FG001|OL Component|Withdrawal by Subject|1|||
146901231|NCT03263091|529801350|FG002|OL Component|Withdrawal by Subject|0|||
146901232|NCT03263091|529801351|FG003|OL Component|Withdrawal by Subject|0|||
146901233|NCT03263091|529801352|FG004|OL Component|Withdrawal by Subject|0|||
146901234|NCT03263091|529801353|FG005|OL Component|Withdrawal by Subject|0|||
146901235|NCT03263091|529801348|FG000|OL Component|Physician Decision|0|||
146901236|NCT03263091|529801349|FG001|OL Component|Physician Decision|1|||
146901237|NCT03263091|529801350|FG002|OL Component|Physician Decision|2|||
146901238|NCT03263091|529801351|FG003|OL Component|Physician Decision|0|||
146901239|NCT03263091|529801352|FG004|OL Component|Physician Decision|0|||
146901240|NCT03263091|529801353|FG005|OL Component|Physician Decision|0|||
146901241|NCT03263091|529801348|FG000|OL Component|Death|1|||
146901242|NCT03263091|529801349|FG001|OL Component|Death|0|||
146901243|NCT03263091|529801350|FG002|OL Component|Death|0|||
146901244|NCT03263091|529801351|FG003|OL Component|Death|0|||
146901245|NCT03263091|529801352|FG004|OL Component|Death|0|||
146901246|NCT03263091|529801353|FG005|OL Component|Death|0|||
146901247|NCT03263091|529801348|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
146901248|NCT03263091|529801349|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
146901249|NCT03263091|529801350|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
146901250|NCT03263091|529801351|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
146901251|NCT03263091|529801352|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
146901252|NCT03263091|529801353|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
146901253|NCT03263091|529801348|FG000|OL High-EPO Component|Physician Decision|0|||
146901254|NCT03263091|529801349|FG001|OL High-EPO Component|Physician Decision|0|||
146901255|NCT03263091|529801350|FG002|OL High-EPO Component|Physician Decision|0|||
146901256|NCT03263091|529801351|FG003|OL High-EPO Component|Physician Decision|1|||
146901257|NCT03263091|529801352|FG004|OL High-EPO Component|Physician Decision|0|||
146901258|NCT03263091|529801353|FG005|OL High-EPO Component|Physician Decision|0|||
146901259|NCT03263091|529801348|FG000|OL High-EPO Component|Death|0|||
146901260|NCT03263091|529801349|FG001|OL High-EPO Component|Death|0|||
146901261|NCT03263091|529801350|FG002|OL High-EPO Component|Death|0|||
146901262|NCT03263091|529801351|FG003|OL High-EPO Component|Death|3|||
146901263|NCT03263091|529801352|FG004|OL High-EPO Component|Death|0|||
146901264|NCT03263091|529801353|FG005|OL High-EPO Component|Death|0|||
146901265|NCT03263091|529801348|FG000|DB Component|Withdrawal by Subject|0|||
146901266|NCT03263091|529801349|FG001|DB Component|Withdrawal by Subject|0|||
146901267|NCT03263091|529801350|FG002|DB Component|Withdrawal by Subject|0|||
146901268|NCT03263091|529801351|FG003|DB Component|Withdrawal by Subject|0|||
146901269|NCT03263091|529801352|FG004|DB Component|Withdrawal by Subject|22|||
146767378|NCT04517864|529317291|FG001|Extension Phase|Withdrawal by Subject|0|||
146767379|NCT04517864|529317292|FG002|Extension Phase|Withdrawal by Subject|3|||
146767380|NCT04517864|529317290|FG000|Extension Phase|Approved Drug Available for Indication|0|||
146767381|NCT04517864|529317291|FG001|Extension Phase|Approved Drug Available for Indication|0|||
146901270|NCT03263091|529801353|FG005|DB Component|Withdrawal by Subject|8|||
146901271|NCT03263091|529801348|FG000|DB Component|Physician Decision|0|||
146901272|NCT03263091|529801349|FG001|DB Component|Physician Decision|0|||
146901273|NCT03263091|529801350|FG002|DB Component|Physician Decision|0|||
146901274|NCT03263091|529801351|FG003|DB Component|Physician Decision|0|||
146901275|NCT03263091|529801352|FG004|DB Component|Physician Decision|3|||
146901276|NCT03263091|529801353|FG005|DB Component|Physician Decision|1|||
146901277|NCT03263091|529801348|FG000|DB Component|Adverse Event|0|||
146901278|NCT03263091|529801349|FG001|DB Component|Adverse Event|0|||
146901279|NCT03263091|529801350|FG002|DB Component|Adverse Event|0|||
146640577|NCT01088048|528860879|FG009|Overall Study|Concomitant Medication Prohibited|0|||
146640578|NCT01088048|528860870|FG000|Overall Study|Investigator Request|2|||
146640579|NCT01088048|528860871|FG001|Overall Study|Investigator Request|2|||
146640580|NCT01088048|528860872|FG002|Overall Study|Investigator Request|0|||
146640581|NCT01088048|528860873|FG003|Overall Study|Investigator Request|0|||
146640582|NCT01088048|528860874|FG004|Overall Study|Investigator Request|3|||
146901280|NCT03263091|529801351|FG003|DB Component|Adverse Event|0|||
146901281|NCT03263091|529801352|FG004|DB Component|Adverse Event|2|||
146901282|NCT03263091|529801353|FG005|DB Component|Adverse Event|1|||
146901283|NCT03263091|529801348|FG000|DB Component|Lost to Follow-up|0|||
146901284|NCT03263091|529801349|FG001|DB Component|Lost to Follow-up|0|||
146901285|NCT03263091|529801350|FG002|DB Component|Lost to Follow-up|0|||
146901286|NCT03263091|529801351|FG003|DB Component|Lost to Follow-up|0|||
146901287|NCT03263091|529801352|FG004|DB Component|Lost to Follow-up|2|||
146901288|NCT03263091|529801353|FG005|DB Component|Lost to Follow-up|1|||
146901289|NCT03263091|529801348|FG000|DB Component|Death|0|||
146901290|NCT03263091|529801349|FG001|DB Component|Death|0|||
146901291|NCT03263091|529801350|FG002|DB Component|Death|0|||
146901292|NCT03263091|529801351|FG003|DB Component|Death|0|||
146901293|NCT03263091|529801352|FG004|DB Component|Death|7|||
146901294|NCT03263091|529801353|FG005|DB Component|Death|4|||
146901295|NCT03263091|529801348|FG000|DB Component|Other than specified|0|||
146901296|NCT03263091|529801349|FG001|DB Component|Other than specified|0|||
146901297|NCT03263091|529801350|FG002|DB Component|Other than specified|0|||
146901298|NCT03263091|529801351|FG003|DB Component|Other than specified|0|||
146901299|NCT03263091|529801352|FG004|DB Component|Other than specified|8|||
146901300|NCT03263091|529801353|FG005|DB Component|Other than specified|6|||
146901301|NCT01821963|529801354|FG000|Overall Study|Adverse Event|1|||
146901302|NCT03095703|529801355|FG000|Overall Study|Withdrawal by Subject|1|||
146901303|NCT03539432|529801356|FG000|Overall Study|Lost to Follow-up|0|||
146901304|NCT03539432|529801357|FG001|Overall Study|Lost to Follow-up|1|||
146901305|NCT01381094|529801358|FG000|Overall Study|Adverse Event|1|||
146901306|NCT01381094|529801359|FG001|Overall Study|Adverse Event|2|||
146901307|NCT01381094|529801360|FG002|Overall Study|Adverse Event|0|||
146901308|NCT01381094|529801361|FG003|Overall Study|Adverse Event|1|||
146901309|NCT01381094|529801362|FG004|Overall Study|Adverse Event|0|||
146901310|NCT01381094|529801358|FG000|Overall Study|Lost to Follow-up|0|||
146901311|NCT01381094|529801359|FG001|Overall Study|Lost to Follow-up|0|||
146901312|NCT01381094|529801360|FG002|Overall Study|Lost to Follow-up|0|||
146901313|NCT01381094|529801361|FG003|Overall Study|Lost to Follow-up|0|||
146901314|NCT01381094|529801362|FG004|Overall Study|Lost to Follow-up|1|||
146901315|NCT01381094|529801358|FG000|Overall Study|Withdrawal of informed consent|0|||
146901316|NCT01381094|529801359|FG001|Overall Study|Withdrawal of informed consent|1|||
146901317|NCT01381094|529801360|FG002|Overall Study|Withdrawal of informed consent|0|||
146901318|NCT01381094|529801361|FG003|Overall Study|Withdrawal of informed consent|0|||
146901319|NCT01381094|529801362|FG004|Overall Study|Withdrawal of informed consent|0|||
146901320|NCT01381094|529801358|FG000|Overall Study|Participant given Aranesp injection|1|||
146901321|NCT01381094|529801359|FG001|Overall Study|Participant given Aranesp injection|0|||
146901322|NCT01381094|529801360|FG002|Overall Study|Participant given Aranesp injection|0|||
146901323|NCT01381094|529801361|FG003|Overall Study|Participant given Aranesp injection|0|||
146901324|NCT01381094|529801362|FG004|Overall Study|Participant given Aranesp injection|0|||
146901325|NCT02443402|529801365|FG000|Overall Study|Withdrawal by Subject|3|||
146901326|NCT02443402|529801366|FG001|Overall Study|Withdrawal by Subject|1|||
146901327|NCT02443402|529801365|FG000|Overall Study|Screen Failure|1|||
146901328|NCT02443402|529801366|FG001|Overall Study|Screen Failure|2|||
146901329|NCT01934504|529801370|FG000|Overall Study|Protocol Deviation|0|||
146901330|NCT01934504|529801371|FG001|Overall Study|Protocol Deviation|0|||
146640583|NCT01088048|528860875|FG005|Overall Study|Investigator Request|1|||
146640584|NCT01088048|528860876|FG006|Overall Study|Investigator Request|1|||
146640585|NCT01088048|528860877|FG007|Overall Study|Investigator Request|0|||
146640586|NCT01088048|528860878|FG008|Overall Study|Investigator Request|0|||
146901331|NCT01934504|529801372|FG002|Overall Study|Protocol Deviation|0|||
146901332|NCT01934504|529801373|FG003|Overall Study|Protocol Deviation|2|||
146901333|NCT01934504|529801370|FG000|Overall Study|Study Terminated by Sponsor|1|||
146901334|NCT01934504|529801371|FG001|Overall Study|Study Terminated by Sponsor|0|||
146901335|NCT01934504|529801372|FG002|Overall Study|Study Terminated by Sponsor|5|||
146901336|NCT01934504|529801373|FG003|Overall Study|Study Terminated by Sponsor|5|||
146901337|NCT00486902|529801380|FG000|Overall Study|Withdrawal by Subject|1|||
146901338|NCT00486902|529801381|FG001|Overall Study|Withdrawal by Subject|2|||
146901339|NCT00486902|529801380|FG000|Overall Study|decision for postpartum tubal ligation|3|||
146901340|NCT00486902|529801381|FG001|Overall Study|decision for postpartum tubal ligation|1|||
146901341|NCT00486902|529801380|FG000|Overall Study|spinal anesthetic protocal violation|1|||
146901342|NCT00486902|529801381|FG001|Overall Study|spinal anesthetic protocal violation|1|||
146901343|NCT00486902|529801380|FG000|Overall Study|Did not meet inclusion criteria|1|||
146901344|NCT00486902|529801381|FG001|Overall Study|Did not meet inclusion criteria|0|||
146640587|NCT01088048|528860879|FG009|Overall Study|Investigator Request|0|||
146640588|NCT01088048|528860870|FG000|Overall Study|Patient Non-compliance|0|||
146901345|NCT00486902|529801380|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
146901346|NCT00486902|529801381|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
146901347|NCT01217606|529801382|FG000|Initial Treatment Phase|Other Reasons|0|||
146901348|NCT01217606|529801383|FG001|Initial Treatment Phase|Other Reasons|2|||
146901349|NCT01217606|529801382|FG000|Initial Treatment Phase|Protocol Violation|3|||
146901350|NCT01217606|529801383|FG001|Initial Treatment Phase|Protocol Violation|2|||
146901351|NCT01217606|529801382|FG000|Initial Treatment Phase|Personal Reasons|0|||
146901352|NCT01217606|529801383|FG001|Initial Treatment Phase|Personal Reasons|2|||
146901353|NCT01217606|529801382|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
146901354|NCT01217606|529801383|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
146901355|NCT01217606|529801382|FG000|Initial Treatment Phase|Adverse Event|10|||
146901356|NCT01217606|529801383|FG001|Initial Treatment Phase|Adverse Event|6|||
146901357|NCT01217606|529801382|FG000|9-Month Masked Extension|Adverse Event|3|||
146901358|NCT01217606|529801383|FG001|9-Month Masked Extension|Adverse Event|6|||
146901359|NCT01217606|529801382|FG000|9-Month Masked Extension|Other Reasons|4|||
146901360|NCT01217606|529801383|FG001|9-Month Masked Extension|Other Reasons|4|||
146901361|NCT01217606|529801382|FG000|9-Month Masked Extension|Personal Reasons|2|||
146901362|NCT01217606|529801383|FG001|9-Month Masked Extension|Personal Reasons|1|||
146901363|NCT01217606|529801382|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
146901364|NCT01217606|529801383|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
146901365|NCT01217606|529801382|FG000|9-Month Masked Extension|Pregnancy|1|||
146901366|NCT01217606|529801383|FG001|9-Month Masked Extension|Pregnancy|0|||
146901367|NCT01217606|529801382|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
146901368|NCT01217606|529801383|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
146901369|NCT03615222|529801396|FG000|Overall Study|Ineligible|26|||
146901370|NCT03615222|529801396|FG000|Overall Study|Withdrawal by Subject|7|||
146901371|NCT03615222|529801396|FG000|Overall Study|Death|1|||
146901372|NCT01552057|529801397|FG000|Overall Study|Adverse Event|14|||
146901373|NCT01552057|529801398|FG001|Overall Study|Adverse Event|15|||
146901374|NCT01552057|529801397|FG000|Overall Study|Lack of Efficacy|8|||
146901375|NCT01552057|529801398|FG001|Overall Study|Lack of Efficacy|23|||
146901376|NCT01552057|529801397|FG000|Overall Study|Withdrawal by Subject|5|||
146901377|NCT01552057|529801398|FG001|Overall Study|Withdrawal by Subject|8|||
146901378|NCT01552057|529801397|FG000|Overall Study|Entry Criteria Not Met|2|||
146901379|NCT01552057|529801398|FG001|Overall Study|Entry Criteria Not Met|2|||
146901380|NCT01552057|529801397|FG000|Overall Study|Physician Decision|1|||
146901381|NCT01552057|529801398|FG001|Overall Study|Physician Decision|0|||
146901382|NCT00476086|529801399|FG000|Overall Study|Alternative therapy|1|||
146901383|NCT00476086|529801399|FG000|Overall Study|Progressive Disease|4|||
146901384|NCT02900092|529801400|FG000|Overall Study|Adverse Event|1|||
146901385|NCT04178590|529801401|FG000|Overall Study|Pregnancy|1|||
146901386|NCT04178590|529801401|FG000|Overall Study|Lost to Follow-up|1|||
146901387|NCT01389245|529801402|FG000|Overall Study|Protocol Violation|10|||
146901388|NCT01389245|529801402|FG000|Overall Study|Lost to Follow-up|3|||
146901389|NCT01389245|529801402|FG000|Overall Study|Withdrawal by Subject|2|||
146901390|NCT02292849|529801403|FG000|Overall Study|Lost to Follow-up|0|||
146901391|NCT02292849|529801404|FG001|Overall Study|Lost to Follow-up|2|||
146901392|NCT02292849|529801405|FG002|Overall Study|Lost to Follow-up|2|||
146901393|NCT02292849|529801403|FG000|Overall Study|Physician Decision|4|||
146901394|NCT02292849|529801404|FG001|Overall Study|Physician Decision|0|||
146901395|NCT02292849|529801405|FG002|Overall Study|Physician Decision|0|||
146901396|NCT00097539|529801406|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
146901397|NCT00097539|529801407|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
146901398|NCT00097539|529801408|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
146901399|NCT00097539|529801409|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
146901400|NCT00097539|529801410|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
146901401|NCT00097539|529801411|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
146901402|NCT00097539|529801412|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
146901403|NCT00097539|529801406|FG000|Overall Study|Withdrawal by Subject|925|||
146901404|NCT00097539|529801407|FG001|Overall Study|Withdrawal by Subject|323|||
146901405|NCT00097539|529801408|FG002|Overall Study|Withdrawal by Subject|346|||
146901406|NCT00097539|529801409|FG003|Overall Study|Withdrawal by Subject|217|||
146901407|NCT00097539|529801410|FG004|Overall Study|Withdrawal by Subject|68|||
146901408|NCT00097539|529801411|FG005|Overall Study|Withdrawal by Subject|229|||
146969778|NCT03930615|530048925|FG000|Overall Study|Not treated|1|||
146559996|NCT03847519|528560728|FG002|Overall Study|Death|1|||
146559997|NCT03847519|528560726|FG000|Overall Study|Lost to Follow-up|1|||
146559998|NCT03847519|528560727|FG001|Overall Study|Lost to Follow-up|2|||
146559999|NCT03847519|528560728|FG002|Overall Study|Lost to Follow-up|0|||
146560000|NCT03847519|528560726|FG000|Overall Study|Study Terminated by Sponsor|0|||
146560001|NCT03847519|528560727|FG001|Overall Study|Study Terminated by Sponsor|3|||
146560002|NCT03847519|528560728|FG002|Overall Study|Study Terminated by Sponsor|2|||
146560003|NCT02743962|528560729|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
146560004|NCT02743962|528560730|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
146560005|NCT00725985|528560734|FG000|ITP- Treatment Disposition|Adverse Event|20|||
146560006|NCT00725985|528560735|FG001|ITP- Treatment Disposition|Adverse Event|10|||
146901409|NCT00097539|529801412|FG006|Overall Study|Withdrawal by Subject|3|||
146901410|NCT00097539|529801406|FG000|Overall Study|Participant Non-compliant|2140|||
146901411|NCT00097539|529801407|FG001|Overall Study|Participant Non-compliant|567|||
146901412|NCT00097539|529801408|FG002|Overall Study|Participant Non-compliant|1067|||
146901413|NCT00097539|529801409|FG003|Overall Study|Participant Non-compliant|353|||
146901414|NCT00097539|529801410|FG004|Overall Study|Participant Non-compliant|136|||
146901415|NCT00097539|529801411|FG005|Overall Study|Participant Non-compliant|543|||
146901416|NCT00097539|529801412|FG006|Overall Study|Participant Non-compliant|18|||
146901417|NCT00097539|529801406|FG000|Overall Study|Lack of Efficacy|249|||
146901418|NCT00097539|529801407|FG001|Overall Study|Lack of Efficacy|122|||
146901419|NCT00097539|529801408|FG002|Overall Study|Lack of Efficacy|202|||
146901420|NCT00097539|529801409|FG003|Overall Study|Lack of Efficacy|105|||
146901421|NCT00097539|529801410|FG004|Overall Study|Lack of Efficacy|45|||
146901422|NCT00097539|529801411|FG005|Overall Study|Lack of Efficacy|228|||
146901423|NCT00097539|529801412|FG006|Overall Study|Lack of Efficacy|5|||
146901424|NCT00097539|529801406|FG000|Overall Study|Adverse Event|78|||
146901425|NCT00097539|529801407|FG001|Overall Study|Adverse Event|133|||
146901426|NCT00097539|529801408|FG002|Overall Study|Adverse Event|37|||
146901427|NCT00097539|529801409|FG003|Overall Study|Adverse Event|27|||
146901428|NCT00097539|529801410|FG004|Overall Study|Adverse Event|30|||
146901429|NCT00097539|529801411|FG005|Overall Study|Adverse Event|59|||
146901430|NCT00097539|529801412|FG006|Overall Study|Adverse Event|1|||
146901431|NCT00097539|529801406|FG000|Overall Study|Death|2|||
146901432|NCT00097539|529801407|FG001|Overall Study|Death|7|||
146901433|NCT00097539|529801408|FG002|Overall Study|Death|0|||
146901434|NCT00097539|529801409|FG003|Overall Study|Death|0|||
146901435|NCT00097539|529801410|FG004|Overall Study|Death|1|||
146901436|NCT00097539|529801411|FG005|Overall Study|Death|3|||
146901437|NCT00097539|529801412|FG006|Overall Study|Death|0|||
146901438|NCT00097539|529801406|FG000|Overall Study|Reasons Other Than Above|3602|||
146901439|NCT00097539|529801407|FG001|Overall Study|Reasons Other Than Above|1382|||
146901440|NCT00097539|529801408|FG002|Overall Study|Reasons Other Than Above|1757|||
146901441|NCT00097539|529801409|FG003|Overall Study|Reasons Other Than Above|692|||
146901442|NCT00097539|529801410|FG004|Overall Study|Reasons Other Than Above|361|||
146901443|NCT00097539|529801411|FG005|Overall Study|Reasons Other Than Above|1244|||
146901444|NCT00097539|529801412|FG006|Overall Study|Reasons Other Than Above|34|||
146901445|NCT00097539|529801406|FG000|Overall Study|Reason not Specified|111|||
146901446|NCT00097539|529801407|FG001|Overall Study|Reason not Specified|49|||
146901447|NCT00097539|529801408|FG002|Overall Study|Reason not Specified|53|||
146901448|NCT00097539|529801409|FG003|Overall Study|Reason not Specified|21|||
146901449|NCT00097539|529801410|FG004|Overall Study|Reason not Specified|11|||
146901450|NCT00097539|529801411|FG005|Overall Study|Reason not Specified|40|||
146901451|NCT00097539|529801412|FG006|Overall Study|Reason not Specified|2|||
146901452|NCT05127486|529801413|FG000|Overall Study|Adverse Event|2|||
146901453|NCT05127486|529801414|FG001|Overall Study|Adverse Event|4|||
146901454|NCT05127486|529801413|FG000|Overall Study|Lack of Efficacy|1|||
146901455|NCT05127486|529801414|FG001|Overall Study|Lack of Efficacy|0|||
146901456|NCT05127486|529801413|FG000|Overall Study|Pregnancy|0|||
146901457|NCT05127486|529801414|FG001|Overall Study|Pregnancy|1|||
146901458|NCT05127486|529801413|FG000|Overall Study|Physician Decision|4|||
146901459|NCT05127486|529801414|FG001|Overall Study|Physician Decision|1|||
146901460|NCT05127486|529801413|FG000|Overall Study|Withdrawal by Subject|14|||
146901461|NCT05127486|529801414|FG001|Overall Study|Withdrawal by Subject|13|||
146901462|NCT05127486|529801413|FG000|Overall Study|Lost to Follow-up|5|||
146901463|NCT05127486|529801414|FG001|Overall Study|Lost to Follow-up|8|||
146901464|NCT02582515|529801415|FG000|Overall Study|Withdrawal by Subject|0|||
146901465|NCT02582515|529801416|FG001|Overall Study|Withdrawal by Subject|1|||
146901466|NCT00775021|529801417|FG000|First Intervention|Lost to Follow-up|1|||
146901467|NCT00775021|529801418|FG001|First Intervention|Lost to Follow-up|0|||
146901468|NCT00775021|529801417|FG000|Second Intervention|Adverse Event|0|||
146901469|NCT00775021|529801418|FG001|Second Intervention|Adverse Event|1|||
146901470|NCT00363415|529801419|FG000|Overall Study|Progressive Disease|196|||
146901471|NCT00363415|529801420|FG001|Overall Study|Progressive Disease|107|||
146901472|NCT00363415|529801419|FG000|Overall Study|Sponsor Decision|67|||
146901473|NCT00363415|529801420|FG001|Overall Study|Sponsor Decision|31|||
146901474|NCT00363415|529801419|FG000|Overall Study|Death|32|||
146901475|NCT00363415|529801420|FG001|Overall Study|Death|29|||
146901476|NCT00363415|529801419|FG000|Overall Study|Adverse Event|24|||
146901477|NCT00363415|529801420|FG001|Overall Study|Adverse Event|15|||
146901478|NCT00363415|529801419|FG000|Overall Study|Physician Decision|18|||
146901479|NCT00363415|529801420|FG001|Overall Study|Physician Decision|35|||
146901480|NCT00363415|529801419|FG000|Overall Study|Entry Criteria Not Met|11|||
146901481|NCT00363415|529801420|FG001|Overall Study|Entry Criteria Not Met|10|||
146901482|NCT00363415|529801419|FG000|Overall Study|Withdrawal by Subject|9|||
146901483|NCT00363415|529801420|FG001|Overall Study|Withdrawal by Subject|15|||
146901484|NCT00363415|529801419|FG000|Overall Study|Lost to Follow-up|3|||
146901485|NCT00363415|529801420|FG001|Overall Study|Lost to Follow-up|3|||
146901486|NCT00363415|529801419|FG000|Overall Study|Protocol Violation|1|||
146901487|NCT00363415|529801420|FG001|Overall Study|Protocol Violation|4|||
146901488|NCT05027802|529801423|FG000|Overall Study|Adverse Event|2|||
146901489|NCT05027802|529801423|FG000|Overall Study|Withdrawal by Subject|18|||
146901490|NCT05027802|529801423|FG000|Overall Study|Death|2|||
146901491|NCT05027802|529801423|FG000|Overall Study|Other|1|||
146901492|NCT01506141|529801432|FG000|Overall Study|Adverse Event|0|||
146901493|NCT01506141|529801433|FG001|Overall Study|Adverse Event|2|||
146901494|NCT01506141|529801432|FG000|Overall Study|Participation Terminated by Investigator|1|||
146901495|NCT01506141|529801433|FG001|Overall Study|Participation Terminated by Investigator|1|||
146901496|NCT01506141|529801432|FG000|Overall Study|Site Terminated by Sponsor|2|||
146901497|NCT01506141|529801433|FG001|Overall Study|Site Terminated by Sponsor|0|||
146901498|NCT01506141|529801432|FG000|Overall Study|Reason Not Specified|4|||
146901499|NCT01506141|529801433|FG001|Overall Study|Reason Not Specified|2|||
146901500|NCT04889209|529801434|FG000|All Cohorts Except 15E|Adverse Event|0|||
146901501|NCT04889209|529801435|FG001|All Cohorts Except 15E|Adverse Event|0|||
146901502|NCT04889209|529801436|FG002|All Cohorts Except 15E|Adverse Event|0|||
146901503|NCT04889209|529801437|FG003|All Cohorts Except 15E|Adverse Event|0|||
146901504|NCT04889209|529801438|FG004|All Cohorts Except 15E|Adverse Event|0|||
146901505|NCT04889209|529801439|FG005|All Cohorts Except 15E|Adverse Event|0|||
146901506|NCT04889209|529801440|FG006|All Cohorts Except 15E|Adverse Event|1|||
146901507|NCT04889209|529801441|FG007|All Cohorts Except 15E|Adverse Event|0|||
146901508|NCT04889209|529801442|FG008|All Cohorts Except 15E|Adverse Event|0|||
146901509|NCT04889209|529801443|FG009|All Cohorts Except 15E|Adverse Event|0|||
146901510|NCT04889209|529801444|FG010|All Cohorts Except 15E|Adverse Event|0|||
146901511|NCT04889209|529801445|FG011|All Cohorts Except 15E|Adverse Event|0|||
146901512|NCT04889209|529801446|FG012|All Cohorts Except 15E|Adverse Event|0|||
146901513|NCT04889209|529801447|FG013|All Cohorts Except 15E|Adverse Event|0|||
146901514|NCT04889209|529801448|FG014|All Cohorts Except 15E|Adverse Event|0|||
146901515|NCT04889209|529801449|FG015|All Cohorts Except 15E|Adverse Event|0|||
146901516|NCT04889209|529801450|FG016|All Cohorts Except 15E|Adverse Event|0|||
146901517|NCT04889209|529801451|FG017|All Cohorts Except 15E|Adverse Event|0|||
146901518|NCT04889209|529801434|FG000|All Cohorts Except 15E|Death|0|||
146901519|NCT04889209|529801435|FG001|All Cohorts Except 15E|Death|1|||
146901520|NCT04889209|529801436|FG002|All Cohorts Except 15E|Death|0|||
146901521|NCT04889209|529801437|FG003|All Cohorts Except 15E|Death|0|||
146901522|NCT04889209|529801438|FG004|All Cohorts Except 15E|Death|0|||
146901523|NCT04889209|529801439|FG005|All Cohorts Except 15E|Death|0|||
146901524|NCT04889209|529801440|FG006|All Cohorts Except 15E|Death|0|||
146901525|NCT04889209|529801441|FG007|All Cohorts Except 15E|Death|0|||
146901526|NCT04889209|529801442|FG008|All Cohorts Except 15E|Death|0|||
146901527|NCT04889209|529801443|FG009|All Cohorts Except 15E|Death|0|||
146901528|NCT04889209|529801444|FG010|All Cohorts Except 15E|Death|0|||
146901529|NCT04889209|529801445|FG011|All Cohorts Except 15E|Death|0|||
146901530|NCT04889209|529801446|FG012|All Cohorts Except 15E|Death|0|||
146901531|NCT04889209|529801447|FG013|All Cohorts Except 15E|Death|0|||
146901532|NCT04889209|529801448|FG014|All Cohorts Except 15E|Death|0|||
146901533|NCT04889209|529801449|FG015|All Cohorts Except 15E|Death|0|||
146901534|NCT04889209|529801450|FG016|All Cohorts Except 15E|Death|0|||
146901535|NCT04889209|529801451|FG017|All Cohorts Except 15E|Death|0|||
146901536|NCT04889209|529801434|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
146901537|NCT04889209|529801435|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
146901538|NCT04889209|529801436|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
146901539|NCT04889209|529801437|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
146901540|NCT04889209|529801438|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
146901541|NCT04889209|529801439|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
146901542|NCT04889209|529801440|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
146901543|NCT04889209|529801441|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
146901544|NCT04889209|529801442|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
146901545|NCT04889209|529801443|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
146901546|NCT04889209|529801444|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
146901547|NCT04889209|529801445|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
146901548|NCT04889209|529801446|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
146901549|NCT04889209|529801447|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
146901550|NCT04889209|529801448|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
146901551|NCT04889209|529801449|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
146901552|NCT04889209|529801450|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
146901553|NCT04889209|529801451|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
146901554|NCT04889209|529801434|FG000|All Cohorts Except 15E|Physician Decision|0|||
146901555|NCT04889209|529801435|FG001|All Cohorts Except 15E|Physician Decision|0|||
146901556|NCT04889209|529801436|FG002|All Cohorts Except 15E|Physician Decision|0|||
146901557|NCT04889209|529801437|FG003|All Cohorts Except 15E|Physician Decision|0|||
146901558|NCT04889209|529801438|FG004|All Cohorts Except 15E|Physician Decision|1|||
146901559|NCT04889209|529801439|FG005|All Cohorts Except 15E|Physician Decision|0|||
146901560|NCT04889209|529801440|FG006|All Cohorts Except 15E|Physician Decision|0|||
146901561|NCT04889209|529801441|FG007|All Cohorts Except 15E|Physician Decision|1|||
146901562|NCT04889209|529801442|FG008|All Cohorts Except 15E|Physician Decision|0|||
146901563|NCT04889209|529801443|FG009|All Cohorts Except 15E|Physician Decision|1|||
146901564|NCT04889209|529801444|FG010|All Cohorts Except 15E|Physician Decision|0|||
146901565|NCT04889209|529801445|FG011|All Cohorts Except 15E|Physician Decision|1|||
146901566|NCT04889209|529801446|FG012|All Cohorts Except 15E|Physician Decision|1|||
146901567|NCT04889209|529801447|FG013|All Cohorts Except 15E|Physician Decision|0|||
146901568|NCT04889209|529801448|FG014|All Cohorts Except 15E|Physician Decision|0|||
146901569|NCT04889209|529801449|FG015|All Cohorts Except 15E|Physician Decision|0|||
146901570|NCT04889209|529801450|FG016|All Cohorts Except 15E|Physician Decision|0|||
146901571|NCT04889209|529801451|FG017|All Cohorts Except 15E|Physician Decision|0|||
146901572|NCT04889209|529801434|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
146901573|NCT04889209|529801435|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
146901574|NCT04889209|529801436|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
146901575|NCT04889209|529801437|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
146901576|NCT04889209|529801438|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
146901577|NCT04889209|529801439|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
146901578|NCT04889209|529801440|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
146901579|NCT04889209|529801441|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
146901580|NCT04889209|529801442|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
146901581|NCT04889209|529801443|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
146901582|NCT04889209|529801444|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
146901583|NCT04889209|529801445|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
146901584|NCT04889209|529801446|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
146901585|NCT04889209|529801447|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
146901586|NCT04889209|529801448|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
146901587|NCT04889209|529801449|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
146901588|NCT04889209|529801450|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
146901589|NCT04889209|529801451|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
146901590|NCT04889209|529801434|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
146901591|NCT04889209|529801435|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
146901592|NCT04889209|529801436|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146901593|NCT04889209|529801437|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146901594|NCT04889209|529801438|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146901595|NCT04889209|529801439|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
146901596|NCT04889209|529801440|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146901597|NCT04889209|529801441|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
146901598|NCT04889209|529801442|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146901599|NCT04889209|529801443|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
146901600|NCT04889209|529801444|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146901601|NCT04889209|529801445|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146901602|NCT04889209|529801446|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146901603|NCT04889209|529801447|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146901604|NCT04889209|529801448|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146901605|NCT04889209|529801449|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146901606|NCT04889209|529801450|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146901607|NCT04889209|529801451|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
146901608|NCT04889209|529801434|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146560007|NCT00725985|528560736|FG002|ITP- Treatment Disposition|Adverse Event|5|||
146560008|NCT00725985|528560737|FG003|ITP- Treatment Disposition|Adverse Event|0|||
146560009|NCT00725985|528560738|FG004|ITP- Treatment Disposition|Adverse Event|0|||
146560010|NCT00725985|528560739|FG005|ITP- Treatment Disposition|Adverse Event|0|||
146901609|NCT04889209|529801435|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146901610|NCT04889209|529801436|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146560011|NCT00725985|528560740|FG006|ITP- Treatment Disposition|Adverse Event|0|||
146560012|NCT00725985|528560741|FG007|ITP- Treatment Disposition|Adverse Event|0|||
146560013|NCT00725985|528560742|FG008|ITP- Treatment Disposition|Adverse Event|0|||
146901611|NCT04889209|529801437|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
146901612|NCT04889209|529801438|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146901613|NCT04889209|529801439|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146901614|NCT04889209|529801440|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146901615|NCT04889209|529801441|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146901616|NCT04889209|529801442|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146901617|NCT04889209|529801443|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146901618|NCT04889209|529801444|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146901619|NCT04889209|529801445|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146969779|NCT03930615|530048926|FG001|Overall Study|Not treated|1|||
146640589|NCT01088048|528860871|FG001|Overall Study|Patient Non-compliance|1|||
146640590|NCT01088048|528860872|FG002|Overall Study|Patient Non-compliance|0|||
146640591|NCT01088048|528860873|FG003|Overall Study|Patient Non-compliance|0|||
146640592|NCT01088048|528860874|FG004|Overall Study|Patient Non-compliance|0|||
146640593|NCT01088048|528860875|FG005|Overall Study|Patient Non-compliance|0|||
146640594|NCT01088048|528860876|FG006|Overall Study|Patient Non-compliance|0|||
146640595|NCT01088048|528860877|FG007|Overall Study|Patient Non-compliance|0|||
146640596|NCT01088048|528860878|FG008|Overall Study|Patient Non-compliance|0|||
146640597|NCT01088048|528860879|FG009|Overall Study|Patient Non-compliance|0|||
146640598|NCT01088048|528860870|FG000|Overall Study|Disease Progression|7|||
146640599|NCT01088048|528860871|FG001|Overall Study|Disease Progression|4|||
146640600|NCT01088048|528860872|FG002|Overall Study|Disease Progression|3|||
146640601|NCT01088048|528860873|FG003|Overall Study|Disease Progression|5|||
146640602|NCT01088048|528860874|FG004|Overall Study|Disease Progression|3|||
146640603|NCT01088048|528860875|FG005|Overall Study|Disease Progression|3|||
146640604|NCT01088048|528860876|FG006|Overall Study|Disease Progression|2|||
146640605|NCT01088048|528860877|FG007|Overall Study|Disease Progression|1|||
146640606|NCT01088048|528860878|FG008|Overall Study|Disease Progression|0|||
146640607|NCT01088048|528860879|FG009|Overall Study|Disease Progression|0|||
146640608|NCT01088048|528860870|FG000|Overall Study|Death|1|||
146640609|NCT01088048|528860871|FG001|Overall Study|Death|5|||
146640610|NCT01088048|528860872|FG002|Overall Study|Death|3|||
146640611|NCT01088048|528860873|FG003|Overall Study|Death|3|||
146640612|NCT01088048|528860874|FG004|Overall Study|Death|1|||
146640613|NCT01088048|528860875|FG005|Overall Study|Death|3|||
146640614|NCT01088048|528860876|FG006|Overall Study|Death|0|||
146640615|NCT01088048|528860877|FG007|Overall Study|Death|0|||
146640616|NCT01088048|528860878|FG008|Overall Study|Death|3|||
146640617|NCT01088048|528860879|FG009|Overall Study|Death|1|||
146640618|NCT01088048|528860870|FG000|Overall Study|Other|3|||
146640619|NCT01088048|528860871|FG001|Overall Study|Other|5|||
146640620|NCT01088048|528860872|FG002|Overall Study|Other|0|||
146640621|NCT01088048|528860873|FG003|Overall Study|Other|0|||
146640622|NCT01088048|528860874|FG004|Overall Study|Other|2|||
146640623|NCT01088048|528860875|FG005|Overall Study|Other|0|||
146640624|NCT01088048|528860876|FG006|Overall Study|Other|0|||
146640625|NCT01088048|528860877|FG007|Overall Study|Other|2|||
146560014|NCT00725985|528560743|FG009|ITP- Treatment Disposition|Adverse Event|0|||
146560015|NCT00725985|528560744|FG010|ITP- Treatment Disposition|Adverse Event|0|||
146560016|NCT00725985|528560745|FG011|ITP- Treatment Disposition|Adverse Event|0|||
146560017|NCT00725985|528560734|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
146560018|NCT00725985|528560735|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
146560019|NCT00725985|528560736|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
146560020|NCT00725985|528560737|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
146560021|NCT00725985|528560738|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
146560022|NCT00725985|528560739|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
146560023|NCT00725985|528560740|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
146560024|NCT00725985|528560741|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
146560025|NCT00725985|528560742|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
146560026|NCT00725985|528560743|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
146560027|NCT00725985|528560744|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
146560028|NCT00725985|528560745|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
146560029|NCT00725985|528560734|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
146560030|NCT00725985|528560735|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
146560031|NCT00725985|528560736|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
146560032|NCT00725985|528560737|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
146640626|NCT01088048|528860878|FG008|Overall Study|Other|0|||
146640627|NCT01088048|528860879|FG009|Overall Study|Other|0|||
146640628|NCT01621802|528860880|FG000|Overall Study|Protocol Violation|0|||
146640629|NCT01621802|528860881|FG001|Overall Study|Protocol Violation|0|||
146640630|NCT01621802|528860882|FG002|Overall Study|Protocol Violation|0|||
146640631|NCT01621802|528860883|FG003|Overall Study|Protocol Violation|0|||
146640632|NCT01621802|528860884|FG004|Overall Study|Protocol Violation|0|||
146640633|NCT01621802|528860885|FG005|Overall Study|Protocol Violation|1|||
146901620|NCT04889209|529801446|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146901621|NCT04889209|529801447|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146901622|NCT04889209|529801448|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146901623|NCT04889209|529801449|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146901624|NCT04889209|529801450|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146901625|NCT04889209|529801451|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146901626|NCT04889209|529801434|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146901627|NCT04889209|529801435|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146901628|NCT04889209|529801436|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146901629|NCT04889209|529801437|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146901630|NCT04889209|529801438|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
146901631|NCT04889209|529801439|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146901632|NCT04889209|529801440|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
146901633|NCT04889209|529801441|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
146901634|NCT04889209|529801442|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146901635|NCT04889209|529801443|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
146901636|NCT04889209|529801444|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
146640634|NCT01621802|528860880|FG000|Overall Study|Withdrawal by Subject|8|||
146640635|NCT01621802|528860881|FG001|Overall Study|Withdrawal by Subject|4|||
146640636|NCT01621802|528860882|FG002|Overall Study|Withdrawal by Subject|4|||
146640637|NCT01621802|528860883|FG003|Overall Study|Withdrawal by Subject|2|||
146640638|NCT01621802|528860884|FG004|Overall Study|Withdrawal by Subject|2|||
146640639|NCT01621802|528860885|FG005|Overall Study|Withdrawal by Subject|0|||
146640640|NCT01621802|528860880|FG000|Overall Study|Migrated/moved from study area|0|||
146640641|NCT01621802|528860881|FG001|Overall Study|Migrated/moved from study area|0|||
146640642|NCT01621802|528860882|FG002|Overall Study|Migrated/moved from study area|2|||
146640643|NCT01621802|528860883|FG003|Overall Study|Migrated/moved from study area|0|||
146640644|NCT01621802|528860884|FG004|Overall Study|Migrated/moved from study area|1|||
146640645|NCT01621802|528860885|FG005|Overall Study|Migrated/moved from study area|0|||
146640646|NCT01621802|528860880|FG000|Overall Study|Others|3|||
146640647|NCT01621802|528860881|FG001|Overall Study|Others|3|||
146640648|NCT01621802|528860882|FG002|Overall Study|Others|3|||
146640649|NCT01621802|528860883|FG003|Overall Study|Others|2|||
146640650|NCT01621802|528860884|FG004|Overall Study|Others|1|||
146901637|NCT04889209|529801445|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146901638|NCT04889209|529801446|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
146901639|NCT04889209|529801447|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146901640|NCT04889209|529801448|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146901641|NCT04889209|529801449|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146901642|NCT04889209|529801450|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
146560033|NCT00725985|528560738|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
146560034|NCT00725985|528560739|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
146560035|NCT00725985|528560740|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
146560036|NCT00725985|528560741|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
146560037|NCT00725985|528560742|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
146560038|NCT00725985|528560743|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
146560039|NCT00725985|528560744|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
146640651|NCT01621802|528860885|FG005|Overall Study|Others|0|||
146640652|NCT01621802|528860880|FG000|Overall Study|Lost to Follow-up|36|||
146901643|NCT04889209|529801451|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146901644|NCT04889209|529801434|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146901645|NCT04889209|529801435|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146901646|NCT04889209|529801436|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146901647|NCT04889209|529801437|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146901648|NCT04889209|529801438|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146901649|NCT04889209|529801439|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146901650|NCT04889209|529801440|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146901651|NCT04889209|529801441|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146901652|NCT04889209|529801442|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146901653|NCT04889209|529801443|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146975336|NCT00572156|530073539|FG000|Overall Study|Patient/Parent Decision|1|||
146640653|NCT01621802|528860881|FG001|Overall Study|Lost to Follow-up|16|||
146560040|NCT00725985|528560745|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
146640654|NCT01621802|528860882|FG002|Overall Study|Lost to Follow-up|24|||
146640655|NCT01621802|528860883|FG003|Overall Study|Lost to Follow-up|7|||
146560041|NCT00725985|528560734|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
146560042|NCT00725985|528560735|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
146560043|NCT00725985|528560736|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
146560044|NCT00725985|528560737|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
146560045|NCT00725985|528560738|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
146560046|NCT00725985|528560739|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
146560047|NCT00725985|528560740|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
146560048|NCT00725985|528560741|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
146560049|NCT00725985|528560742|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
146560050|NCT00725985|528560743|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
146560051|NCT00725985|528560744|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
146560052|NCT00725985|528560745|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
146901654|NCT04889209|529801444|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146901655|NCT04889209|529801445|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146901656|NCT04889209|529801446|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146901657|NCT04889209|529801447|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146901658|NCT04889209|529801448|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146901659|NCT04889209|529801449|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146901660|NCT04889209|529801450|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146901661|NCT04889209|529801451|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
146901662|NCT04889209|529801434|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901663|NCT04889209|529801435|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901664|NCT04889209|529801436|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901665|NCT04889209|529801437|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901666|NCT04889209|529801438|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901667|NCT04889209|529801439|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901668|NCT04889209|529801440|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901669|NCT04889209|529801441|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901670|NCT04889209|529801442|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901671|NCT04889209|529801443|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901672|NCT04889209|529801444|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901673|NCT04889209|529801445|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901674|NCT04889209|529801446|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901675|NCT04889209|529801447|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901676|NCT04889209|529801448|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901677|NCT04889209|529801449|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901678|NCT04889209|529801450|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146901679|NCT04889209|529801451|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
146901680|NCT04889209|529801434|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901681|NCT04889209|529801435|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901682|NCT04889209|529801436|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901683|NCT04889209|529801437|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901684|NCT04889209|529801438|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901685|NCT04889209|529801439|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901686|NCT04889209|529801440|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901687|NCT04889209|529801441|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901688|NCT04889209|529801442|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901689|NCT04889209|529801443|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901690|NCT04889209|529801444|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901691|NCT04889209|529801445|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901692|NCT04889209|529801446|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901693|NCT04889209|529801447|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901694|NCT04889209|529801448|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
146560053|NCT00725985|528560734|FG000|ITP- Treatment Disposition|Other|50|||
146560054|NCT00725985|528560735|FG001|ITP- Treatment Disposition|Other|38|||
146560055|NCT00725985|528560736|FG002|ITP- Treatment Disposition|Other|24|||
146560056|NCT00725985|528560737|FG003|ITP- Treatment Disposition|Other|0|||
146560057|NCT00725985|528560738|FG004|ITP- Treatment Disposition|Other|0|||
146560058|NCT00725985|528560739|FG005|ITP- Treatment Disposition|Other|0|||
146560059|NCT00725985|528560740|FG006|ITP- Treatment Disposition|Other|0|||
146560060|NCT00725985|528560741|FG007|ITP- Treatment Disposition|Other|0|||
146560061|NCT00725985|528560742|FG008|ITP- Treatment Disposition|Other|0|||
146560062|NCT00725985|528560743|FG009|ITP- Treatment Disposition|Other|0|||
146560063|NCT00725985|528560744|FG010|ITP- Treatment Disposition|Other|0|||
146560064|NCT00725985|528560745|FG011|ITP- Treatment Disposition|Other|0|||
146560065|NCT00725985|528560734|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
146767382|NCT04517864|529317292|FG002|Extension Phase|Approved Drug Available for Indication|7|||
146901695|NCT04889209|529801449|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901696|NCT04889209|529801450|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901697|NCT04889209|529801451|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146901698|NCT04607408|529801452|FG000|Overall Study|Lost to Follow-up|0|||
146901699|NCT04607408|529801453|FG001|Overall Study|Lost to Follow-up|0|||
146901700|NCT04607408|529801454|FG002|Overall Study|Lost to Follow-up|0|||
146901701|NCT04607408|529801455|FG003|Overall Study|Lost to Follow-up|1|||
146901702|NCT04607408|529801456|FG004|Overall Study|Lost to Follow-up|0|||
146901703|NCT04607408|529801452|FG000|Overall Study|Withdrawal by Subject|0|||
146901704|NCT04607408|529801453|FG001|Overall Study|Withdrawal by Subject|1|||
146901705|NCT04607408|529801454|FG002|Overall Study|Withdrawal by Subject|0|||
146901706|NCT04607408|529801455|FG003|Overall Study|Withdrawal by Subject|1|||
146901707|NCT04607408|529801456|FG004|Overall Study|Withdrawal by Subject|0|||
146901708|NCT01725165|529801467|FG000|Overall Study|Death|11|||
146901709|NCT01725165|529801468|FG001|Overall Study|Death|18|||
146901710|NCT05590377|529801469|FG000|Overall Study|Death|1|||
146901711|NCT05590377|529801470|FG001|Overall Study|Death|1|||
146901712|NCT05590377|529801471|FG002|Overall Study|Death|2|||
146901713|NCT05590377|529801472|FG003|Overall Study|Death|0|||
146901714|NCT05590377|529801473|FG004|Overall Study|Death|0|||
146901715|NCT05590377|529801469|FG000|Overall Study|Study Terminated by Sponsor|1|||
146901716|NCT05590377|529801470|FG001|Overall Study|Study Terminated by Sponsor|5|||
146901717|NCT05590377|529801471|FG002|Overall Study|Study Terminated by Sponsor|4|||
146901718|NCT05590377|529801472|FG003|Overall Study|Study Terminated by Sponsor|0|||
146901719|NCT05590377|529801473|FG004|Overall Study|Study Terminated by Sponsor|0|||
146901720|NCT05590377|529801469|FG000|Overall Study|Withdrawal by Subject|1|||
146901721|NCT05590377|529801470|FG001|Overall Study|Withdrawal by Subject|0|||
146901722|NCT05590377|529801471|FG002|Overall Study|Withdrawal by Subject|0|||
146901723|NCT05590377|529801472|FG003|Overall Study|Withdrawal by Subject|0|||
146901724|NCT05590377|529801473|FG004|Overall Study|Withdrawal by Subject|0|||
146901725|NCT02688647|529801474|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
146901726|NCT02688647|529801475|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
146901727|NCT02688647|529801474|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
146901728|NCT02688647|529801475|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
146901729|NCT02688647|529801474|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
146901730|NCT02688647|529801475|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
146901731|NCT02688647|529801474|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
146901732|NCT02688647|529801475|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
146901733|NCT02688647|529801474|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
146901734|NCT02688647|529801475|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
146901735|NCT02688647|529801474|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
146901736|NCT02688647|529801475|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
146901737|NCT02688647|529801474|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
146901738|NCT02688647|529801475|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
146901739|NCT03619213|529801476|FG000|Overall Study|Lost to Follow-up|2|||
146901740|NCT03619213|529801477|FG001|Overall Study|Lost to Follow-up|1|||
146901741|NCT03619213|529801476|FG000|Overall Study|Withdrawal by Subject|8|||
146901742|NCT03619213|529801477|FG001|Overall Study|Withdrawal by Subject|10|||
146901743|NCT00809133|529801485|FG000|Overall Study|Progressive disease|2|||
146901744|NCT00809133|529801486|FG001|Overall Study|Progressive disease|5|||
146901745|NCT00809133|529801487|FG002|Overall Study|Progressive disease|5|||
146901746|NCT00809133|529801488|FG003|Overall Study|Progressive disease|3|||
146901747|NCT00809133|529801489|FG004|Overall Study|Progressive disease|4|||
146901748|NCT00809133|529801490|FG005|Overall Study|Progressive disease|1|||
146901749|NCT00809133|529801491|FG006|Overall Study|Progressive disease|3|||
146901750|NCT00809133|529801492|FG007|Overall Study|Progressive disease|3|||
146901751|NCT00809133|529801493|FG008|Overall Study|Progressive disease|3|||
146640656|NCT01621802|528860884|FG004|Overall Study|Lost to Follow-up|31|||
146901752|NCT00809133|529801494|FG009|Overall Study|Progressive disease|9|||
146901753|NCT00809133|529801495|FG010|Overall Study|Progressive disease|5|||
146901754|NCT00809133|529801496|FG011|Overall Study|Progressive disease|7|||
146901755|NCT00809133|529801497|FG012|Overall Study|Progressive disease|5|||
146901756|NCT00809133|529801498|FG013|Overall Study|Progressive disease|4|||
146901757|NCT00809133|529801485|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146901758|NCT00809133|529801486|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146901759|NCT00809133|529801487|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146640657|NCT01621802|528860885|FG005|Overall Study|Lost to Follow-up|11|||
146640658|NCT01149148|528860886|FG000|Overall Study|Lost to Follow-up|1|||
146901760|NCT00809133|529801488|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146901761|NCT00809133|529801489|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146901762|NCT00809133|529801490|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
146901763|NCT00809133|529801491|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
146901764|NCT00809133|529801492|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
146901765|NCT00809133|529801493|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146640659|NCT01149148|528860887|FG001|Overall Study|Lost to Follow-up|2|||
146901766|NCT00809133|529801494|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146901767|NCT00809133|529801495|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146901768|NCT00809133|529801496|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146901769|NCT00809133|529801497|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146901770|NCT00809133|529801498|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
146901771|NCT00809133|529801485|FG000|Overall Study|Other adverse event|1|||
146901772|NCT00809133|529801486|FG001|Overall Study|Other adverse event|1|||
146901773|NCT00809133|529801487|FG002|Overall Study|Other adverse event|1|||
146901774|NCT00809133|529801488|FG003|Overall Study|Other adverse event|0|||
146901775|NCT00809133|529801489|FG004|Overall Study|Other adverse event|0|||
146901776|NCT00809133|529801490|FG005|Overall Study|Other adverse event|3|||
146901777|NCT00809133|529801491|FG006|Overall Study|Other adverse event|2|||
146901778|NCT00809133|529801492|FG007|Overall Study|Other adverse event|4|||
146901779|NCT00809133|529801493|FG008|Overall Study|Other adverse event|0|||
146901780|NCT00809133|529801494|FG009|Overall Study|Other adverse event|0|||
146901781|NCT00809133|529801495|FG010|Overall Study|Other adverse event|1|||
146901782|NCT00809133|529801496|FG011|Overall Study|Other adverse event|1|||
146901783|NCT00809133|529801497|FG012|Overall Study|Other adverse event|0|||
146901784|NCT00809133|529801498|FG013|Overall Study|Other adverse event|1|||
146901785|NCT00809133|529801485|FG000|Overall Study|Lost to Follow-up|0|||
146901786|NCT00809133|529801486|FG001|Overall Study|Lost to Follow-up|0|||
146901787|NCT00809133|529801487|FG002|Overall Study|Lost to Follow-up|0|||
146901788|NCT00809133|529801488|FG003|Overall Study|Lost to Follow-up|0|||
146901789|NCT00809133|529801489|FG004|Overall Study|Lost to Follow-up|0|||
146901790|NCT00809133|529801490|FG005|Overall Study|Lost to Follow-up|1|||
146901791|NCT00809133|529801491|FG006|Overall Study|Lost to Follow-up|0|||
146901792|NCT00809133|529801492|FG007|Overall Study|Lost to Follow-up|0|||
146901793|NCT00809133|529801493|FG008|Overall Study|Lost to Follow-up|0|||
146901794|NCT00809133|529801494|FG009|Overall Study|Lost to Follow-up|0|||
146901795|NCT00809133|529801495|FG010|Overall Study|Lost to Follow-up|0|||
146901796|NCT00809133|529801496|FG011|Overall Study|Lost to Follow-up|0|||
146901797|NCT00809133|529801497|FG012|Overall Study|Lost to Follow-up|0|||
146901798|NCT00809133|529801498|FG013|Overall Study|Lost to Follow-up|0|||
146901799|NCT00809133|529801485|FG000|Overall Study|Consent withdrawn|0|||
146901800|NCT00809133|529801486|FG001|Overall Study|Consent withdrawn|0|||
146901801|NCT00809133|529801487|FG002|Overall Study|Consent withdrawn|0|||
146901802|NCT00809133|529801488|FG003|Overall Study|Consent withdrawn|0|||
146901803|NCT00809133|529801489|FG004|Overall Study|Consent withdrawn|1|||
146901804|NCT00809133|529801490|FG005|Overall Study|Consent withdrawn|0|||
146901805|NCT00809133|529801491|FG006|Overall Study|Consent withdrawn|0|||
146901806|NCT00809133|529801492|FG007|Overall Study|Consent withdrawn|0|||
146901807|NCT00809133|529801493|FG008|Overall Study|Consent withdrawn|0|||
146901808|NCT00809133|529801494|FG009|Overall Study|Consent withdrawn|0|||
146901809|NCT00809133|529801495|FG010|Overall Study|Consent withdrawn|0|||
146901810|NCT00809133|529801496|FG011|Overall Study|Consent withdrawn|0|||
146901811|NCT00809133|529801497|FG012|Overall Study|Consent withdrawn|0|||
146901812|NCT00809133|529801498|FG013|Overall Study|Consent withdrawn|0|||
146901813|NCT00809133|529801485|FG000|Overall Study|Other not mentioned above|0|||
146901814|NCT00809133|529801486|FG001|Overall Study|Other not mentioned above|1|||
146901815|NCT00809133|529801487|FG002|Overall Study|Other not mentioned above|0|||
146901816|NCT00809133|529801488|FG003|Overall Study|Other not mentioned above|0|||
146901817|NCT00809133|529801489|FG004|Overall Study|Other not mentioned above|0|||
146901818|NCT00809133|529801490|FG005|Overall Study|Other not mentioned above|1|||
146901819|NCT00809133|529801491|FG006|Overall Study|Other not mentioned above|0|||
146901820|NCT00809133|529801492|FG007|Overall Study|Other not mentioned above|0|||
146901821|NCT00809133|529801493|FG008|Overall Study|Other not mentioned above|0|||
146901822|NCT00809133|529801494|FG009|Overall Study|Other not mentioned above|0|||
146640660|NCT01149148|528860886|FG000|Overall Study|Death|1|||
146640661|NCT01149148|528860887|FG001|Overall Study|Death|0|||
146640662|NCT03436082|528860888|FG000|Overall Study|Did not undergo procedure|1|||
146901823|NCT00809133|529801495|FG010|Overall Study|Other not mentioned above|0|||
146901824|NCT00809133|529801496|FG011|Overall Study|Other not mentioned above|0|||
146640663|NCT03436082|528860889|FG001|Overall Study|Did not undergo procedure|0|||
146640664|NCT00950859|528860890|FG000|Overall Study|Adverse Event|3|||
146640665|NCT00950859|528860891|FG001|Overall Study|Adverse Event|3|||
146901825|NCT00809133|529801497|FG012|Overall Study|Other not mentioned above|0|||
146901826|NCT00809133|529801498|FG013|Overall Study|Other not mentioned above|0|||
146901827|NCT00316264|529801499|FG000|Overall Study|Lost to Follow-up|0|||
146901828|NCT00316264|529801500|FG001|Overall Study|Lost to Follow-up|1|||
146901829|NCT00316264|529801501|FG002|Overall Study|Lost to Follow-up|0|||
146901830|NCT00316264|529801499|FG000|Overall Study|Withdrawal of Consent|3|||
146901831|NCT00316264|529801500|FG001|Overall Study|Withdrawal of Consent|5|||
146901832|NCT00316264|529801501|FG002|Overall Study|Withdrawal of Consent|6|||
146901833|NCT00316264|529801499|FG000|Overall Study|Death|2|||
146901834|NCT00316264|529801500|FG001|Overall Study|Death|0|||
146767383|NCT01049503|529317293|FG000|Overall Study|Lost to Follow-up|11|||
146901835|NCT00316264|529801501|FG002|Overall Study|Death|0|||
146901836|NCT00316264|529801499|FG000|Overall Study|Other|1|||
146901837|NCT00316264|529801500|FG001|Overall Study|Other|1|||
146901838|NCT00316264|529801501|FG002|Overall Study|Other|0|||
146901839|NCT03663166|529801502|FG000|Overall Study|Withdrawal by Subject|1|||
146901840|NCT02561156|529801509|FG000|Part 2|Adverse Event|0|||
146901841|NCT02561156|529801510|FG001|Part 2|Adverse Event|0|||
146901842|NCT02561156|529801511|FG002|Part 2|Adverse Event|0|||
146901843|NCT02561156|529801512|FG003|Part 2|Adverse Event|0|||
146901844|NCT02561156|529801513|FG004|Part 2|Adverse Event|0|||
146901845|NCT02561156|529801514|FG005|Part 2|Adverse Event|0|||
146901846|NCT02561156|529801515|FG006|Part 2|Adverse Event|0|||
146901847|NCT02561156|529801516|FG007|Part 2|Adverse Event|0|||
146901848|NCT02561156|529801517|FG008|Part 2|Adverse Event|0|||
146901849|NCT02561156|529801518|FG009|Part 2|Adverse Event|0|||
146901850|NCT02561156|529801519|FG010|Part 2|Adverse Event|0|||
146901851|NCT02561156|529801520|FG011|Part 2|Adverse Event|1|||
146901852|NCT02561156|529801521|FG012|Part 2|Adverse Event|0|||
146901853|NCT04927312|529801522|FG000|Overall Study|Adverse Event|1|||
146901854|NCT04927312|529801522|FG000|Overall Study|Death|1|||
146901855|NCT04927312|529801522|FG000|Overall Study|Withdrawal by Subject|1|||
146901856|NCT04927312|529801522|FG000|Overall Study|Other|1|||
146901857|NCT04919564|529801524|FG000|Overall Study|Lost to Follow-up|1|||
146901858|NCT04919564|529801525|FG001|Overall Study|Lost to Follow-up|0|||
146901859|NCT04919564|529801524|FG000|Overall Study|Physician Decision|1|||
146901860|NCT04919564|529801525|FG001|Overall Study|Physician Decision|1|||
146901861|NCT00684814|529801526|FG000|Washout Period of 7 Days|Adverse Event|1|||
146901862|NCT00684814|529801527|FG001|Washout Period of 7 Days|Adverse Event|2|||
146901863|NCT00684814|529801526|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
146901864|NCT00684814|529801527|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
146901865|NCT00684814|529801526|FG000|Second Intervention|Adverse Event|1|||
146901866|NCT00684814|529801527|FG001|Second Intervention|Adverse Event|0|||
146901867|NCT05292755|529801528|FG000|Overall Study|Lost to Follow-up|5|||
146901868|NCT05292755|529801529|FG001|Overall Study|Lost to Follow-up|9|||
146901869|NCT00519077|529801530|FG000|Overall Study|Death|6|||
146901870|NCT00519077|529801530|FG000|Overall Study|Other|2|||
146901871|NCT00642642|529801531|FG000|Treatment & Follow Up|Adverse Event|2|||
146901872|NCT00642642|529801531|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
146901873|NCT00642642|529801531|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
146901874|NCT02109029|529803604|FG000|Part B|Adverse Event|0|||
146901875|NCT02109029|529803605|FG001|Part B|Adverse Event|0|||
146901876|NCT02109029|529803606|FG002|Part B|Adverse Event|0|||
146901877|NCT02109029|529803607|FG003|Part B|Adverse Event|0|||
146901878|NCT02109029|529803608|FG004|Part B|Adverse Event|1|||
146901879|NCT02109029|529803609|FG005|Part B|Adverse Event|1|||
146901880|NCT00783289|529803613|FG000|Overall Study|Protocol Violation|0|||
146901881|NCT00783289|529803614|FG001|Overall Study|Protocol Violation|1|||
146901882|NCT00783289|529803615|FG002|Overall Study|Protocol Violation|0|||
146901883|NCT00783289|529803616|FG003|Overall Study|Protocol Violation|0|||
146901884|NCT00996840|529803622|FG000|Overall Study|Adverse Event|0|||
146901885|NCT00996840|529803623|FG001|Overall Study|Adverse Event|1|||
146901886|NCT00996840|529803624|FG002|Overall Study|Adverse Event|0|||
146901887|NCT00996840|529803625|FG003|Overall Study|Adverse Event|0|||
146901888|NCT00996840|529803626|FG004|Overall Study|Adverse Event|0|||
146901889|NCT00996840|529803622|FG000|Overall Study|Physician Decision|0|||
146901890|NCT00996840|529803623|FG001|Overall Study|Physician Decision|0|||
146901891|NCT00996840|529803624|FG002|Overall Study|Physician Decision|1|||
146901892|NCT00996840|529803625|FG003|Overall Study|Physician Decision|1|||
146640666|NCT00950859|528860890|FG000|Overall Study|Insufficient Viral Load Response|12|||
146640667|NCT00950859|528860891|FG001|Overall Study|Insufficient Viral Load Response|3|||
146640668|NCT00950859|528860890|FG000|Overall Study|Protocol Violation|1|||
146901893|NCT00996840|529803626|FG004|Overall Study|Physician Decision|2|||
146901894|NCT00996840|529803622|FG000|Overall Study|Withdrawal by Subject|1|||
146901895|NCT00996840|529803623|FG001|Overall Study|Withdrawal by Subject|1|||
146901896|NCT00996840|529803624|FG002|Overall Study|Withdrawal by Subject|0|||
146901897|NCT00996840|529803625|FG003|Overall Study|Withdrawal by Subject|0|||
146901898|NCT00996840|529803626|FG004|Overall Study|Withdrawal by Subject|0|||
146901899|NCT02725788|529803629|FG000|Overall Study|Lost to Follow-up|1|||
146901900|NCT02725788|529803630|FG001|Overall Study|Lost to Follow-up|1|||
146901901|NCT02725788|529803629|FG000|Overall Study|Protocol Violation|0|||
146901902|NCT02725788|529803630|FG001|Overall Study|Protocol Violation|1|||
146901903|NCT00474240|529803631|FG000|Overall Study|Withdrawal by Subject|1|||
146901904|NCT00474240|529803632|FG001|Overall Study|Withdrawal by Subject|1|||
146901905|NCT00474240|529803633|FG002|Overall Study|Withdrawal by Subject|0|||
146901906|NCT00474240|529803634|FG003|Overall Study|Withdrawal by Subject|2|||
146901907|NCT00474240|529803635|FG004|Overall Study|Withdrawal by Subject|3|||
146901908|NCT00474240|529803636|FG005|Overall Study|Withdrawal by Subject|1|||
146901909|NCT00474240|529803631|FG000|Overall Study|Adverse Event|0|||
146901910|NCT00474240|529803632|FG001|Overall Study|Adverse Event|0|||
146901911|NCT00474240|529803633|FG002|Overall Study|Adverse Event|9|||
146901912|NCT00474240|529803634|FG003|Overall Study|Adverse Event|14|||
146901913|NCT00474240|529803635|FG004|Overall Study|Adverse Event|5|||
146901914|NCT00474240|529803636|FG005|Overall Study|Adverse Event|16|||
146901915|NCT00474240|529803631|FG000|Overall Study|Removed due to lab value|0|||
146901916|NCT00474240|529803632|FG001|Overall Study|Removed due to lab value|0|||
146901917|NCT00474240|529803633|FG002|Overall Study|Removed due to lab value|0|||
146901918|NCT00474240|529803634|FG003|Overall Study|Removed due to lab value|0|||
146901919|NCT00474240|529803635|FG004|Overall Study|Removed due to lab value|0|||
146901920|NCT00474240|529803636|FG005|Overall Study|Removed due to lab value|1|||
146901921|NCT00833092|529803637|FG000|Overall Study|Withdrawal by Subject|2|||
146901922|NCT00833092|529803638|FG001|Overall Study|Withdrawal by Subject|3|||
146901923|NCT00833092|529803637|FG000|Overall Study|Protocol Violation|2|||
146901924|NCT00833092|529803638|FG001|Overall Study|Protocol Violation|1|||
146901925|NCT00833092|529803637|FG000|Overall Study|Diarrhea|0|||
146969780|NCT03644927|530048929|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
146969781|NCT03644927|530048930|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
146969782|NCT00956813|530048931|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
146901926|NCT00833092|529803638|FG001|Overall Study|Diarrhea|2|||
146901927|NCT00833092|529803637|FG000|Overall Study|constipation|0|||
146901928|NCT00833092|529803638|FG001|Overall Study|constipation|1|||
146901929|NCT00619229|529803639|FG000|Overall Study|Withdrawal by Subject|1|||
146901930|NCT00619229|529803640|FG001|Overall Study|Withdrawal by Subject|1|||
146901931|NCT00619229|529803639|FG000|Overall Study|Lost to Follow-up|1|||
146901932|NCT00619229|529803640|FG001|Overall Study|Lost to Follow-up|0|||
146901933|NCT00619229|529803639|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
146901934|NCT00619229|529803640|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
146901935|NCT00619229|529803639|FG000|Overall Study|Investigator planned Cataract Operation|1|||
146901936|NCT00619229|529803640|FG001|Overall Study|Investigator planned Cataract Operation|0|||
146901937|NCT01700829|529803641|FG000|Overall Study|Withdrawal by Subject|1|||
146901938|NCT01700829|529803642|FG001|Overall Study|Withdrawal by Subject|1|||
146901939|NCT01075178|529803643|FG000|Subject Matching|eligible but not matched|130|||
146901940|NCT01075178|529803644|FG001|Subject Matching|eligible but not matched|403|||
146901941|NCT01075178|529803643|FG000|Subject Chart Review|died before chart review period|0|||
146640669|NCT00950859|528860891|FG001|Overall Study|Protocol Violation|1|||
146640670|NCT00950859|528860890|FG000|Overall Study|Lost to Follow-up|0|||
146640671|NCT00950859|528860891|FG001|Overall Study|Lost to Follow-up|3|||
146640672|NCT04896086|528860892|FG000|Overall Study|Lost to Follow-up|0|||
146640673|NCT04896086|528860893|FG001|Overall Study|Lost to Follow-up|2|||
146640674|NCT04896086|528860894|FG002|Overall Study|Lost to Follow-up|1|||
146640675|NCT04896086|528860895|FG003|Overall Study|Lost to Follow-up|0|||
146640676|NCT04896086|528860896|FG004|Overall Study|Lost to Follow-up|0|||
146640677|NCT04896086|528860892|FG000|Overall Study|Physician Decision|0|||
146640678|NCT04896086|528860893|FG001|Overall Study|Physician Decision|1|||
146640679|NCT04896086|528860894|FG002|Overall Study|Physician Decision|0|||
146640680|NCT04896086|528860895|FG003|Overall Study|Physician Decision|0|||
146640681|NCT04896086|528860896|FG004|Overall Study|Physician Decision|0|||
146640682|NCT04896086|528860892|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
146640683|NCT04896086|528860893|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
146640684|NCT04896086|528860894|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
146640685|NCT04896086|528860895|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
146640686|NCT04896086|528860896|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
146640687|NCT04896086|528860892|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
146640688|NCT04896086|528860893|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
146901942|NCT01075178|529803644|FG001|Subject Chart Review|died before chart review period|2|||
146901943|NCT01075178|529803643|FG000|Subject Chart Review|no data collected due to site closure|3|||
146969783|NCT00956813|530048932|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
146969784|NCT00956813|530048931|FG000|Flaxseed and Placebo|Ineligible|3|||
146901944|NCT01075178|529803644|FG001|Subject Chart Review|no data collected due to site closure|4|||
146901945|NCT01075178|529803643|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
146901946|NCT01075178|529803644|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
146901947|NCT02983604|529803645|FG000|Overall Study|Enrolled but not Treated|0|||
146901948|NCT02983604|529803646|FG001|Overall Study|Enrolled but not Treated|0|||
146901949|NCT02983604|529803647|FG002|Overall Study|Enrolled but not Treated|1|||
146901950|NCT02983604|529803648|FG003|Overall Study|Enrolled but not Treated|0|||
146969785|NCT00956813|530048932|FG001|Flaxseed and Placebo|Ineligible|1|||
146901951|NCT00355264|529803649|FG000|Extension (Variable Duration)|Adverse Event|1|||
146901952|NCT00355264|529803649|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
146901953|NCT00699192|529803650|FG000|Overall Study|Missing|1|||
146901954|NCT00699192|529803651|FG001|Overall Study|Missing|1|||
146901955|NCT00699192|529803652|FG002|Overall Study|Missing|1|||
146901956|NCT00699192|529803650|FG000|Overall Study|Adverse Event|9|||
146901957|NCT00699192|529803651|FG001|Overall Study|Adverse Event|4|||
146901958|NCT00699192|529803652|FG002|Overall Study|Adverse Event|3|||
146901959|NCT00699192|529803650|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146901960|NCT00699192|529803651|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146901961|NCT00699192|529803652|FG002|Overall Study|Abnormal test procedure result(s)|1|||
146901962|NCT00699192|529803650|FG000|Overall Study|Lack of Efficacy|0|||
146901963|NCT00699192|529803651|FG001|Overall Study|Lack of Efficacy|0|||
146901964|NCT00699192|529803652|FG002|Overall Study|Lack of Efficacy|1|||
146901965|NCT00699192|529803650|FG000|Overall Study|Withdrawal by Subject|3|||
146901966|NCT00699192|529803651|FG001|Overall Study|Withdrawal by Subject|2|||
146901967|NCT00699192|529803652|FG002|Overall Study|Withdrawal by Subject|4|||
146901968|NCT00699192|529803650|FG000|Overall Study|Administrative problems|1|||
146901969|NCT00699192|529803651|FG001|Overall Study|Administrative problems|3|||
146901970|NCT00699192|529803652|FG002|Overall Study|Administrative problems|1|||
146901971|NCT00699192|529803650|FG000|Overall Study|Protocol Violation|2|||
146901972|NCT00699192|529803651|FG001|Overall Study|Protocol Violation|2|||
146901973|NCT00699192|529803652|FG002|Overall Study|Protocol Violation|0|||
146901974|NCT00929240|529803655|FG000|Initial Treatment Phase|Adverse Event|31|||
146901975|NCT00929240|529803656|FG001|Initial Treatment Phase|Adverse Event|0|||
146901976|NCT00929240|529803657|FG002|Initial Treatment Phase|Adverse Event|0|||
146901977|NCT00929240|529803655|FG000|Initial Treatment Phase|Disease progression|41|||
146901978|NCT00929240|529803656|FG001|Initial Treatment Phase|Disease progression|0|||
146901979|NCT00929240|529803657|FG002|Initial Treatment Phase|Disease progression|0|||
146901980|NCT00929240|529803655|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
146901981|NCT00929240|529803656|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
146901982|NCT00929240|529803657|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
146901983|NCT00929240|529803655|FG000|Initial Treatment Phase|Protocol Violation|5|||
146901984|NCT00929240|529803656|FG001|Initial Treatment Phase|Protocol Violation|0|||
146901985|NCT00929240|529803657|FG002|Initial Treatment Phase|Protocol Violation|0|||
146901986|NCT00929240|529803655|FG000|Initial Treatment Phase|Death|2|||
146901987|NCT00929240|529803656|FG001|Initial Treatment Phase|Death|0|||
146901988|NCT00929240|529803657|FG002|Initial Treatment Phase|Death|0|||
146901989|NCT00929240|529803655|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
146901990|NCT00929240|529803656|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
146901991|NCT00929240|529803657|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
146901992|NCT00929240|529803655|FG000|Initial Treatment Phase|Physician Decision|4|||
146901993|NCT00929240|529803656|FG001|Initial Treatment Phase|Physician Decision|0|||
146901994|NCT00929240|529803657|FG002|Initial Treatment Phase|Physician Decision|0|||
146901995|NCT00929240|529803655|FG000|Maintenance Phase|Disease progression|0|||
146901996|NCT00929240|529803656|FG001|Maintenance Phase|Disease progression|73|||
146901997|NCT00929240|529803657|FG002|Maintenance Phase|Disease progression|60|||
146901998|NCT00929240|529803655|FG000|Maintenance Phase|Adverse Event|0|||
146901999|NCT00929240|529803656|FG001|Maintenance Phase|Adverse Event|9|||
146902000|NCT00929240|529803657|FG002|Maintenance Phase|Adverse Event|12|||
146902001|NCT00929240|529803655|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146902002|NCT00929240|529803656|FG001|Maintenance Phase|Withdrawal by Subject|2|||
146902003|NCT00929240|529803657|FG002|Maintenance Phase|Withdrawal by Subject|6|||
146902004|NCT00929240|529803655|FG000|Maintenance Phase|Protocol Violation|0|||
146902005|NCT00929240|529803656|FG001|Maintenance Phase|Protocol Violation|1|||
146902006|NCT00929240|529803657|FG002|Maintenance Phase|Protocol Violation|0|||
146902007|NCT00929240|529803655|FG000|Maintenance Phase|Health authority/Study termination|0|||
146902008|NCT00929240|529803656|FG001|Maintenance Phase|Health authority/Study termination|1|||
146902009|NCT00929240|529803657|FG002|Maintenance Phase|Health authority/Study termination|2|||
146902010|NCT00929240|529803655|FG000|Maintenance Phase|Physician Decision|0|||
146902011|NCT00929240|529803656|FG001|Maintenance Phase|Physician Decision|2|||
146902012|NCT00929240|529803657|FG002|Maintenance Phase|Physician Decision|1|||
146902013|NCT00929240|529803655|FG000|Maintenance Phase|Change of treatment|0|||
146902014|NCT00929240|529803656|FG001|Maintenance Phase|Change of treatment|4|||
146902015|NCT00929240|529803657|FG002|Maintenance Phase|Change of treatment|0|||
146902016|NCT00929240|529803655|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
146560066|NCT00725985|528560735|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
146560067|NCT00725985|528560736|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
146560068|NCT00725985|528560737|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
146560069|NCT00725985|528560738|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
146560070|NCT00725985|528560739|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
146902017|NCT00929240|529803656|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
146902018|NCT00929240|529803657|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
146902019|NCT00929240|529803655|FG000|Maintenance Phase|Participant not treated|0|||
146902020|NCT00929240|529803656|FG001|Maintenance Phase|Participant not treated|2|||
146902021|NCT00929240|529803657|FG002|Maintenance Phase|Participant not treated|0|||
146560071|NCT00725985|528560740|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
146560072|NCT00725985|528560741|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
146902022|NCT01287104|529803658|FG000|Overall Study|Patient developed progressive disease|1|||
146902023|NCT01287104|529803659|FG001|Overall Study|Patient developed progressive disease|1|||
146902024|NCT01287104|529803660|FG002|Overall Study|Patient developed progressive disease|3|||
146902025|NCT01287104|529803661|FG003|Overall Study|Patient developed progressive disease|2|||
146560073|NCT00725985|528560742|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
146560074|NCT00725985|528560743|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
146560075|NCT00725985|528560744|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
146560076|NCT00725985|528560745|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
146560077|NCT00725985|528560734|FG000|OLMP (Up to 96 Weeks)|Death|0|||
146560078|NCT00725985|528560735|FG001|OLMP (Up to 96 Weeks)|Death|0|||
146560079|NCT00725985|528560736|FG002|OLMP (Up to 96 Weeks)|Death|0|||
146560080|NCT00725985|528560737|FG003|OLMP (Up to 96 Weeks)|Death|0|||
146560081|NCT00725985|528560738|FG004|OLMP (Up to 96 Weeks)|Death|1|||
146560082|NCT00725985|528560739|FG005|OLMP (Up to 96 Weeks)|Death|0|||
146560083|NCT00725985|528560740|FG006|OLMP (Up to 96 Weeks)|Death|0|||
146560084|NCT00725985|528560741|FG007|OLMP (Up to 96 Weeks)|Death|0|||
146560085|NCT00725985|528560742|FG008|OLMP (Up to 96 Weeks)|Death|0|||
146560086|NCT00725985|528560743|FG009|OLMP (Up to 96 Weeks)|Death|0|||
146560087|NCT00725985|528560744|FG010|OLMP (Up to 96 Weeks)|Death|0|||
146560088|NCT00725985|528560745|FG011|OLMP (Up to 96 Weeks)|Death|0|||
146560089|NCT00725985|528560734|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
146902026|NCT01287104|529803658|FG000|Overall Study|Donor anaphylaxis|0|||
146902027|NCT01287104|529803659|FG001|Overall Study|Donor anaphylaxis|1|||
146902028|NCT01287104|529803660|FG002|Overall Study|Donor anaphylaxis|0|||
146902029|NCT01287104|529803661|FG003|Overall Study|Donor anaphylaxis|1|||
146902030|NCT01287104|529803658|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
146902031|NCT01287104|529803659|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
146902032|NCT01287104|529803660|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
146902033|NCT01287104|529803661|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
146902034|NCT01287104|529803658|FG000|Overall Study|Low donor chimerism|0|||
146902035|NCT01287104|529803659|FG001|Overall Study|Low donor chimerism|1|||
146902036|NCT01287104|529803660|FG002|Overall Study|Low donor chimerism|0|||
146902037|NCT01287104|529803661|FG003|Overall Study|Low donor chimerism|0|||
146902038|NCT01287104|529803658|FG000|Overall Study|NK cells did not meet release criteria|0|||
146902039|NCT01287104|529803659|FG001|Overall Study|NK cells did not meet release criteria|1|||
146902040|NCT01287104|529803660|FG002|Overall Study|NK cells did not meet release criteria|0|||
146902041|NCT01287104|529803661|FG003|Overall Study|NK cells did not meet release criteria|0|||
146902042|NCT00098787|529803664|FG000|Overall Study|Never started treatment|3|||
146902043|NCT00098787|529803665|FG001|Overall Study|Never started treatment|2|||
146902044|NCT00098787|529803666|FG002|Overall Study|Never started treatment|1|||
146902045|NCT00098787|529803664|FG000|Overall Study|Ineligible|9|||
146902046|NCT00098787|529803665|FG001|Overall Study|Ineligible|7|||
146902047|NCT00098787|529803666|FG002|Overall Study|Ineligible|3|||
146902048|NCT00098787|529803664|FG000|Overall Study|Disease progression|28|||
146902049|NCT00098787|529803665|FG001|Overall Study|Disease progression|17|||
146902050|NCT00098787|529803666|FG002|Overall Study|Disease progression|23|||
146902051|NCT00098787|529803664|FG000|Overall Study|Adverse Event|8|||
146902052|NCT00098787|529803665|FG001|Overall Study|Adverse Event|17|||
146902053|NCT00098787|529803666|FG002|Overall Study|Adverse Event|8|||
146902054|NCT00098787|529803664|FG000|Overall Study|Death|6|||
146902055|NCT00098787|529803665|FG001|Overall Study|Death|1|||
146902056|NCT00098787|529803666|FG002|Overall Study|Death|0|||
146902057|NCT00098787|529803664|FG000|Overall Study|Withdrawal by Subject|4|||
146902058|NCT00098787|529803665|FG001|Overall Study|Withdrawal by Subject|12|||
146902059|NCT00098787|529803666|FG002|Overall Study|Withdrawal by Subject|6|||
146902060|NCT00098787|529803664|FG000|Overall Study|Alternative therapy|8|||
146902061|NCT00098787|529803665|FG001|Overall Study|Alternative therapy|13|||
146902062|NCT00098787|529803666|FG002|Overall Study|Alternative therapy|13|||
146902063|NCT00098787|529803664|FG000|Overall Study|Other|7|||
146902064|NCT00098787|529803665|FG001|Overall Study|Other|6|||
146902065|NCT00098787|529803666|FG002|Overall Study|Other|9|||
146902066|NCT02203149|529803669|FG000|Part 1|Adverse Event|0|||
146902067|NCT02203149|529803670|FG001|Part 1|Adverse Event|1|||
146560090|NCT00725985|528560735|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
146560091|NCT00725985|528560736|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
146560092|NCT00725985|528560737|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
146560093|NCT00725985|528560738|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
146560094|NCT00725985|528560739|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
146560095|NCT00725985|528560740|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
146902068|NCT02203149|529803671|FG002|Part 1|Adverse Event|0|||
146902069|NCT02203149|529803672|FG003|Part 1|Adverse Event|0|||
146560096|NCT00725985|528560741|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
146560097|NCT00725985|528560742|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
146560098|NCT00725985|528560743|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
146560099|NCT00725985|528560744|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
146902070|NCT02203149|529803673|FG004|Part 1|Adverse Event|0|||
146902071|NCT02203149|529803669|FG000|Part 2|Death|0|||
146902072|NCT02203149|529803670|FG001|Part 2|Death|0|||
146902073|NCT02203149|529803671|FG002|Part 2|Death|1|||
146902074|NCT02203149|529803672|FG003|Part 2|Death|1|||
146902075|NCT02203149|529803673|FG004|Part 2|Death|0|||
146902076|NCT02203149|529803669|FG000|Part 2|Withdrawal by Subject|0|||
146902077|NCT02203149|529803670|FG001|Part 2|Withdrawal by Subject|0|||
146902078|NCT02203149|529803671|FG002|Part 2|Withdrawal by Subject|0|||
146902079|NCT02203149|529803672|FG003|Part 2|Withdrawal by Subject|1|||
146902080|NCT02203149|529803673|FG004|Part 2|Withdrawal by Subject|0|||
146902081|NCT02203149|529803669|FG000|Part 2|Adverse Event|0|||
146902082|NCT02203149|529803670|FG001|Part 2|Adverse Event|0|||
146902083|NCT02203149|529803671|FG002|Part 2|Adverse Event|0|||
146902084|NCT02203149|529803672|FG003|Part 2|Adverse Event|1|||
146902085|NCT02203149|529803673|FG004|Part 2|Adverse Event|1|||
146902086|NCT00446030|529803674|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
146902087|NCT00446030|529803675|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
146902088|NCT00446030|529803674|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
146902089|NCT00446030|529803675|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
146902090|NCT00446030|529803674|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
146902091|NCT00446030|529803675|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
146902092|NCT00446030|529803674|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
146902093|NCT00446030|529803675|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
146902094|NCT00446030|529803674|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
146902095|NCT00446030|529803675|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
146902096|NCT00446030|529803674|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
146902097|NCT00446030|529803675|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
146902098|NCT00446030|529803674|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
146902099|NCT00446030|529803675|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
146902100|NCT00446030|529803674|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
146902101|NCT00446030|529803675|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
146902102|NCT00446030|529803674|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
146902103|NCT00446030|529803675|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
146902104|NCT00446030|529803674|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
146902105|NCT00446030|529803675|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
146902106|NCT00446030|529803674|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
146902107|NCT00446030|529803675|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
146902108|NCT00446030|529803674|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
146902109|NCT00446030|529803675|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
146902110|NCT00446030|529803674|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
146902111|NCT00446030|529803675|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
146902112|NCT00446030|529803674|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
146902113|NCT00446030|529803675|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
146902114|NCT00446030|529803674|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
146902115|NCT00446030|529803675|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
146902116|NCT00446030|529803674|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
146902117|NCT00446030|529803675|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
146902118|NCT00446030|529803674|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
146902119|NCT00446030|529803675|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
146902120|NCT00446030|529803674|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
146902121|NCT00446030|529803675|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
146902122|NCT00446030|529803674|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
146902123|NCT00446030|529803675|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
146902124|NCT00858832|529803678|FG000|Overall Study|became ineligible: delivered vaginally|1|||
146902125|NCT00858832|529803679|FG001|Overall Study|became ineligible: delivered vaginally|0|||
146902126|NCT00858832|529803678|FG000|Overall Study|Adverse Event|0|||
146902127|NCT00858832|529803679|FG001|Overall Study|Adverse Event|1|||
146902128|NCT00432809|529803680|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
146902129|NCT00432809|529803681|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
146902130|NCT00432809|529803682|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
146902131|NCT00432809|529803680|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
146902132|NCT00432809|529803681|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
146902133|NCT00432809|529803682|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
146902134|NCT04052139|529803683|FG000|Overall Study|Lost to Follow-up|2|||
146902135|NCT04052139|529803684|FG001|Overall Study|Lost to Follow-up|0|||
146902136|NCT04052139|529803685|FG002|Overall Study|Lost to Follow-up|0|||
146902137|NCT04052139|529803683|FG000|Overall Study|Withdrawal by Subject|1|||
146902138|NCT04052139|529803684|FG001|Overall Study|Withdrawal by Subject|0|||
146902139|NCT04052139|529803685|FG002|Overall Study|Withdrawal by Subject|0|||
146902140|NCT00707577|529803686|FG000|Overall Study|Withdrawal by Subject|3|||
146902141|NCT00707577|529803687|FG001|Overall Study|Withdrawal by Subject|2|||
146902142|NCT00707577|529803686|FG000|Overall Study|Lost to Follow-up|34|||
146902143|NCT00707577|529803687|FG001|Overall Study|Lost to Follow-up|25|||
146902144|NCT00707577|529803686|FG000|Overall Study|Left employment|13|||
146902145|NCT00707577|529803687|FG001|Overall Study|Left employment|10|||
146902146|NCT00707577|529803686|FG000|Overall Study|Pregnancy|4|||
146902147|NCT00707577|529803687|FG001|Overall Study|Pregnancy|1|||
146902148|NCT01967225|529803688|FG000|Overall Study|Adverse Event|3|||
146902149|NCT01967225|529803689|FG001|Overall Study|Adverse Event|1|||
146902150|NCT01967225|529803688|FG000|Overall Study|Withdrawal by Subject|2|||
146902151|NCT01967225|529803689|FG001|Overall Study|Withdrawal by Subject|1|||
146902152|NCT01967225|529803688|FG000|Overall Study|Lack of Efficacy|1|||
146902153|NCT01967225|529803689|FG001|Overall Study|Lack of Efficacy|1|||
146902154|NCT01967225|529803688|FG000|Overall Study|Switching to other therapy|2|||
146902155|NCT01967225|529803689|FG001|Overall Study|Switching to other therapy|0|||
146902156|NCT01967225|529803688|FG000|Overall Study|Protocol driven decision point|1|||
146902157|NCT01967225|529803689|FG001|Overall Study|Protocol driven decision point|0|||
146902158|NCT01967225|529803688|FG000|Overall Study|Logistical difficulties|1|||
146902159|NCT01967225|529803689|FG001|Overall Study|Logistical difficulties|0|||
146902160|NCT01967225|529803688|FG000|Overall Study|Protocol Violation|2|||
146902161|NCT01967225|529803689|FG001|Overall Study|Protocol Violation|0|||
146902162|NCT01709331|529803690|FG000|Overall Study|Adverse Event|1|||
146902163|NCT02305563|529803692|FG000|Treatment Period|Disease progression|0|||
146902164|NCT02305563|529803693|FG001|Treatment Period|Disease progression|0|||
146902165|NCT02305563|529803694|FG002|Treatment Period|Disease progression|15|||
146902166|NCT02305563|529803695|FG003|Treatment Period|Disease progression|6|||
146902167|NCT02305563|529803696|FG004|Treatment Period|Disease progression|6|||
146902168|NCT02305563|529803692|FG000|Treatment Period|Study drug toxicity|0|||
146902169|NCT02305563|529803693|FG001|Treatment Period|Study drug toxicity|0|||
146902170|NCT02305563|529803694|FG002|Treatment Period|Study drug toxicity|0|||
146902171|NCT02305563|529803695|FG003|Treatment Period|Study drug toxicity|1|||
146902172|NCT02305563|529803696|FG004|Treatment Period|Study drug toxicity|2|||
146902173|NCT02305563|529803692|FG000|Treatment Period|Death|0|||
146902174|NCT02305563|529803693|FG001|Treatment Period|Death|0|||
146902175|NCT02305563|529803694|FG002|Treatment Period|Death|1|||
146902176|NCT02305563|529803695|FG003|Treatment Period|Death|2|||
146902177|NCT02305563|529803696|FG004|Treatment Period|Death|1|||
146902178|NCT02305563|529803692|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
146902179|NCT02305563|529803693|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
146902180|NCT02305563|529803694|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
146902181|NCT02305563|529803695|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
146902182|NCT02305563|529803696|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
146902183|NCT02305563|529803692|FG000|Treatment Period|Participant request to stop therapy|0|||
146902184|NCT02305563|529803693|FG001|Treatment Period|Participant request to stop therapy|2|||
146902185|NCT02305563|529803694|FG002|Treatment Period|Participant request to stop therapy|0|||
146902186|NCT02305563|529803695|FG003|Treatment Period|Participant request to stop therapy|1|||
146902187|NCT02305563|529803696|FG004|Treatment Period|Participant request to stop therapy|0|||
146902188|NCT02305563|529803692|FG000|Treatment Period|Participant withdrew consent|0|||
146902189|NCT02305563|529803693|FG001|Treatment Period|Participant withdrew consent|0|||
146902190|NCT02305563|529803694|FG002|Treatment Period|Participant withdrew consent|1|||
146902191|NCT02305563|529803695|FG003|Treatment Period|Participant withdrew consent|1|||
146902192|NCT02305563|529803696|FG004|Treatment Period|Participant withdrew consent|1|||
146902193|NCT02305563|529803692|FG000|Treatment Period|Maximum clinical benefit|0|||
146902194|NCT02305563|529803693|FG001|Treatment Period|Maximum clinical benefit|0|||
146902195|NCT02305563|529803694|FG002|Treatment Period|Maximum clinical benefit|0|||
146902196|NCT02305563|529803695|FG003|Treatment Period|Maximum clinical benefit|0|||
146902197|NCT02305563|529803696|FG004|Treatment Period|Maximum clinical benefit|1|||
146902198|NCT02305563|529803692|FG000|Treatment Period|Poor/non-compliance|0|||
146902199|NCT02305563|529803693|FG001|Treatment Period|Poor/non-compliance|0|||
146902200|NCT02305563|529803694|FG002|Treatment Period|Poor/non-compliance|0|||
146902201|NCT02305563|529803695|FG003|Treatment Period|Poor/non-compliance|0|||
146902202|NCT02305563|529803696|FG004|Treatment Period|Poor/non-compliance|1|||
146902203|NCT02305563|529803692|FG000|Treatment Period|Administrative reason by Sponsor|0|||
146902204|NCT02305563|529803693|FG001|Treatment Period|Administrative reason by Sponsor|0|||
146902205|NCT02305563|529803694|FG002|Treatment Period|Administrative reason by Sponsor|0|||
146902206|NCT02305563|529803695|FG003|Treatment Period|Administrative reason by Sponsor|0|||
146902207|NCT02305563|529803696|FG004|Treatment Period|Administrative reason by Sponsor|1|||
146902208|NCT02305563|529803692|FG000|Treatment Period|other reason|2|||
146902209|NCT02305563|529803693|FG001|Treatment Period|other reason|0|||
146902210|NCT02305563|529803694|FG002|Treatment Period|other reason|2|||
146902211|NCT02305563|529803695|FG003|Treatment Period|other reason|2|||
146902212|NCT02305563|529803696|FG004|Treatment Period|other reason|1|||
146902213|NCT02305563|529803692|FG000|Treatment Period|Randomized but not treated|0|||
146902214|NCT02305563|529803693|FG001|Treatment Period|Randomized but not treated|0|||
146902215|NCT02305563|529803694|FG002|Treatment Period|Randomized but not treated|0|||
146902216|NCT02305563|529803695|FG003|Treatment Period|Randomized but not treated|0|||
146902217|NCT02305563|529803696|FG004|Treatment Period|Randomized but not treated|2|||
146902218|NCT02305563|529803692|FG000|Treatment Period|added ULO, then disease progression|0|||
146902219|NCT02305563|529803693|FG001|Treatment Period|added ULO, then disease progression|0|||
146902220|NCT02305563|529803694|FG002|Treatment Period|added ULO, then disease progression|0|||
146902221|NCT02305563|529803695|FG003|Treatment Period|added ULO, then disease progression|0|||
146902222|NCT02305563|529803696|FG004|Treatment Period|added ULO, then disease progression|4|||
146902223|NCT02305563|529803692|FG000|Treatment Period|added ULO; then other reason|0|||
146902224|NCT02305563|529803693|FG001|Treatment Period|added ULO; then other reason|0|||
146560100|NCT00725985|528560745|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
146560101|NCT00725985|528560734|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
146560102|NCT00725985|528560735|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
146560103|NCT00725985|528560736|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
146560104|NCT00725985|528560737|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
146560105|NCT00725985|528560738|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
146560106|NCT00725985|528560739|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
146560107|NCT00725985|528560740|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
146560108|NCT00725985|528560741|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
146560109|NCT00725985|528560742|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
146560110|NCT00725985|528560743|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
146560111|NCT00725985|528560744|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
146560112|NCT00725985|528560745|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
146560113|NCT00725985|528560734|FG000|OLMP (Up to 96 Weeks)|Other|0|||
146560114|NCT00725985|528560735|FG001|OLMP (Up to 96 Weeks)|Other|0|||
146560115|NCT00725985|528560736|FG002|OLMP (Up to 96 Weeks)|Other|0|||
146560116|NCT00725985|528560737|FG003|OLMP (Up to 96 Weeks)|Other|15|||
146560117|NCT00725985|528560738|FG004|OLMP (Up to 96 Weeks)|Other|20|||
146560118|NCT00725985|528560739|FG005|OLMP (Up to 96 Weeks)|Other|44|||
146560119|NCT00725985|528560740|FG006|OLMP (Up to 96 Weeks)|Other|0|||
146560120|NCT00725985|528560741|FG007|OLMP (Up to 96 Weeks)|Other|0|||
146560121|NCT00725985|528560742|FG008|OLMP (Up to 96 Weeks)|Other|0|||
146560122|NCT00725985|528560743|FG009|OLMP (Up to 96 Weeks)|Other|0|||
146560123|NCT00725985|528560744|FG010|OLMP (Up to 96 Weeks)|Other|0|||
146767384|NCT01049503|529317294|FG001|Overall Study|Lost to Follow-up|12|||
146767385|NCT01049503|529317295|FG002|Overall Study|Lost to Follow-up|24|||
146560124|NCT00725985|528560745|FG011|OLMP (Up to 96 Weeks)|Other|0|||
146560125|NCT00725985|528560734|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
146767386|NCT01049503|529317296|FG003|Overall Study|Lost to Follow-up|26|||
146767387|NCT01049503|529317297|FG004|Overall Study|Lost to Follow-up|27|||
146560126|NCT00725985|528560735|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
146560127|NCT00725985|528560736|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
146560128|NCT00725985|528560737|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
146560129|NCT00725985|528560738|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
146560130|NCT00725985|528560739|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
146560131|NCT00725985|528560740|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
146560132|NCT00725985|528560741|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
146560133|NCT00725985|528560742|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
146902225|NCT02305563|529803694|FG002|Treatment Period|added ULO; then other reason|0|||
146902226|NCT02305563|529803695|FG003|Treatment Period|added ULO; then other reason|0|||
146902227|NCT02305563|529803696|FG004|Treatment Period|added ULO; then other reason|1|||
146560134|NCT00725985|528560743|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
146560135|NCT00725985|528560744|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
146560136|NCT00725985|528560745|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
146560137|NCT00725985|528560734|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
146560138|NCT00725985|528560735|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
146560139|NCT00725985|528560736|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
146560140|NCT00725985|528560737|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
146560141|NCT00725985|528560738|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
146560142|NCT00725985|528560739|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
146560143|NCT00725985|528560740|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
146560144|NCT00725985|528560741|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
146560145|NCT00725985|528560742|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
146560146|NCT00725985|528560743|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
146560147|NCT00725985|528560744|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
146560148|NCT00725985|528560745|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
146560149|NCT00725985|528560734|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
146560150|NCT00725985|528560735|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
146560151|NCT00725985|528560736|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
146969786|NCT04797637|530048933|FG000|Overall Study|Lost to Follow-up|23|||
146969787|NCT04797637|530048934|FG001|Overall Study|Lost to Follow-up|32|||
146969788|NCT04797637|530048933|FG000|Overall Study|Withdrawal by Subject|0|||
146969789|NCT04797637|530048934|FG001|Overall Study|Withdrawal by Subject|1|||
146969790|NCT02864953|530048935|FG000|Overall Study|Adverse Event|22|||
146969791|NCT02864953|530048936|FG001|Overall Study|Adverse Event|19|||
146969792|NCT02864953|530048935|FG000|Overall Study|Withdrawal by Subject|1|||
146969793|NCT02864953|530048936|FG001|Overall Study|Withdrawal by Subject|0|||
146969794|NCT02864953|530048935|FG000|Overall Study|Physician Decision|4|||
146969795|NCT02864953|530048936|FG001|Overall Study|Physician Decision|2|||
146969796|NCT02864953|530048935|FG000|Overall Study|Death|3|||
146969797|NCT02864953|530048936|FG001|Overall Study|Death|13|||
146969798|NCT02864953|530048935|FG000|Overall Study|Reason not specified|14|||
146969799|NCT02864953|530048936|FG001|Overall Study|Reason not specified|12|||
146969800|NCT02864953|530048935|FG000|Overall Study|Withdrew Prior to Dosing|9|||
146969801|NCT02864953|530048936|FG001|Overall Study|Withdrew Prior to Dosing|8|||
146969802|NCT00981019|530048937|FG000|Overall Study|Did not respond|65|||
146969803|NCT00981019|530048937|FG000|Overall Study|Did not match target population|94|||
146969804|NCT00981019|530048937|FG000|Overall Study|Inadvertent exclusion|239|||
146969805|NCT00981019|530048937|FG000|Overall Study|Hit the survey after closure|79|||
146969806|NCT05083559|530048938|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
146640689|NCT04896086|528860894|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
146969807|NCT05083559|530048939|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
146969808|NCT05083559|530048938|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
146969809|NCT05083559|530048939|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
146640690|NCT04896086|528860895|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
146640691|NCT04896086|528860896|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
146640692|NCT02249832|528860899|FG000|Overall Study|Withdrawal by Subject|3|||
146640693|NCT02249832|528860899|FG000|Overall Study|Lost to Follow-up|10|||
146902228|NCT02305563|529803692|FG000|Treatment Period|added ULO, then request to stop|0|||
146640694|NCT00724867|528860904|FG000|Overall Study|Adverse Event|25|||
146902229|NCT02305563|529803693|FG001|Treatment Period|added ULO, then request to stop|0|||
146902230|NCT02305563|529803694|FG002|Treatment Period|added ULO, then request to stop|0|||
146902231|NCT02305563|529803695|FG003|Treatment Period|added ULO, then request to stop|0|||
146902232|NCT02305563|529803696|FG004|Treatment Period|added ULO, then request to stop|1|||
146902233|NCT02305563|529803692|FG000|Follow-up Period|Death|0|||
146902234|NCT02305563|529803693|FG001|Follow-up Period|Death|0|||
146902235|NCT02305563|529803694|FG002|Follow-up Period|Death|5|||
146560152|NCT00725985|528560737|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
146902236|NCT02305563|529803695|FG003|Follow-up Period|Death|4|||
146902237|NCT02305563|529803696|FG004|Follow-up Period|Death|7|||
146902238|NCT02305563|529803692|FG000|Follow-up Period|Participant withdrew consent|0|||
146902239|NCT02305563|529803693|FG001|Follow-up Period|Participant withdrew consent|0|||
146902240|NCT02305563|529803694|FG002|Follow-up Period|Participant withdrew consent|2|||
146902241|NCT02305563|529803695|FG003|Follow-up Period|Participant withdrew consent|1|||
146902242|NCT02305563|529803696|FG004|Follow-up Period|Participant withdrew consent|0|||
146902243|NCT02305563|529803692|FG000|Follow-up Period|other reason|0|||
146902244|NCT02305563|529803693|FG001|Follow-up Period|other reason|0|||
146902245|NCT02305563|529803694|FG002|Follow-up Period|other reason|0|||
146902246|NCT02305563|529803695|FG003|Follow-up Period|other reason|0|||
146902247|NCT02305563|529803696|FG004|Follow-up Period|other reason|1|||
146902248|NCT02305563|529803692|FG000|Follow-up Period|Followup no longer required per protocol|3|||
146640695|NCT00724867|528860904|FG000|Overall Study|Lack of Efficacy|14|||
146640696|NCT00724867|528860904|FG000|Overall Study|Lost to Follow-up|12|||
146640697|NCT00724867|528860904|FG000|Overall Study|Non-compliance with study drug|6|||
146640698|NCT00724867|528860904|FG000|Overall Study|Physician Decision|17|||
146640699|NCT00724867|528860904|FG000|Overall Study|Protocol Violation|1|||
146640700|NCT00724867|528860904|FG000|Overall Study|Withdrawal by Subject|31|||
146640701|NCT00724867|528860904|FG000|Overall Study|Sponsor decision to end study|14|||
146640702|NCT00724867|528860904|FG000|Overall Study|Subject incarcerated|1|||
146640703|NCT00724867|528860904|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
146560153|NCT00725985|528560738|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
146560154|NCT00725985|528560739|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
146560155|NCT00725985|528560740|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
146560156|NCT00725985|528560741|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
146560157|NCT00725985|528560742|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
146560158|NCT00725985|528560743|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
146560159|NCT00725985|528560744|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
146560160|NCT00725985|528560745|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
146560161|NCT00725985|528560734|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
146560162|NCT00725985|528560735|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
146560163|NCT00725985|528560736|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
146640704|NCT00724867|528860904|FG000|Overall Study|Subject moved out of state|1|||
146640705|NCT00724867|528860904|FG000|Overall Study|Elected to exit due to site closure|2|||
146640706|NCT00436345|528860905|FG000|Overall Study|ICU resident beyond follow-up period|3|||
146640707|NCT00436345|528860906|FG001|Overall Study|ICU resident beyond follow-up period|0|||
146640708|NCT01175083|528860907|FG000|Primary Epoch|Withdrawal by Subject|0|||
146640709|NCT01175083|528860908|FG001|Primary Epoch|Withdrawal by Subject|0|||
146640710|NCT01175083|528860909|FG002|Primary Epoch|Withdrawal by Subject|0|||
146640711|NCT01175083|528860910|FG003|Primary Epoch|Withdrawal by Subject|0|||
146640712|NCT01175083|528860911|FG004|Primary Epoch|Withdrawal by Subject|0|||
146640713|NCT01175083|528860912|FG005|Primary Epoch|Withdrawal by Subject|2|||
146640714|NCT01175083|528860907|FG000|Primary Epoch|Lost to Follow-up|0|||
146640715|NCT01175083|528860908|FG001|Primary Epoch|Lost to Follow-up|0|||
146640716|NCT01175083|528860909|FG002|Primary Epoch|Lost to Follow-up|0|||
146902249|NCT02305563|529803693|FG001|Follow-up Period|Followup no longer required per protocol|3|||
146902250|NCT02305563|529803694|FG002|Follow-up Period|Followup no longer required per protocol|4|||
146902251|NCT02305563|529803695|FG003|Follow-up Period|Followup no longer required per protocol|1|||
146902252|NCT02305563|529803696|FG004|Follow-up Period|Followup no longer required per protocol|4|||
146902253|NCT01275222|529803701|FG000|Phase l by Treatment|Adverse Event|1|||
146560164|NCT00725985|528560737|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
146560165|NCT00725985|528560738|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
146640717|NCT01175083|528860910|FG003|Primary Epoch|Lost to Follow-up|0|||
146640718|NCT01175083|528860911|FG004|Primary Epoch|Lost to Follow-up|0|||
146640719|NCT01175083|528860912|FG005|Primary Epoch|Lost to Follow-up|1|||
146640720|NCT01175083|528860907|FG000|Booster Epoch|Death|0|||
146640721|NCT01175083|528860908|FG001|Booster Epoch|Death|0|||
146640722|NCT01175083|528860909|FG002|Booster Epoch|Death|1|||
146640723|NCT01175083|528860910|FG003|Booster Epoch|Death|0|||
146640724|NCT01175083|528860911|FG004|Booster Epoch|Death|0|||
146640725|NCT01175083|528860912|FG005|Booster Epoch|Death|0|||
146640726|NCT01175083|528860907|FG000|Booster Epoch|Withdrawal by Subject|0|||
146640727|NCT01175083|528860908|FG001|Booster Epoch|Withdrawal by Subject|0|||
146767388|NCT01049503|529317298|FG005|Overall Study|Lost to Follow-up|8|||
146640728|NCT01175083|528860909|FG002|Booster Epoch|Withdrawal by Subject|0|||
146640729|NCT01175083|528860910|FG003|Booster Epoch|Withdrawal by Subject|1|||
146902254|NCT01275222|529803702|FG001|Phase l by Treatment|Adverse Event|4|||
146902255|NCT01275222|529803703|FG002|Phase l by Treatment|Adverse Event|2|||
146902256|NCT01275222|529803704|FG003|Phase l by Treatment|Adverse Event|3|||
146902257|NCT01275222|529803705|FG004|Phase l by Treatment|Adverse Event|0|||
146902258|NCT01275222|529803706|FG005|Phase l by Treatment|Adverse Event|0|||
146902259|NCT01275222|529803701|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
146902260|NCT01275222|529803702|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
146767389|NCT02974634|529317299|FG000|Overall Study|Advanced disease|12|||
146767390|NCT02974634|529317300|FG001|Overall Study|Advanced disease|3|||
146902261|NCT01275222|529803703|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
146902262|NCT01275222|529803704|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
146902263|NCT01275222|529803705|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
146902264|NCT01275222|529803706|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
146902265|NCT01275222|529803701|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
146902266|NCT01275222|529803702|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
146560166|NCT00725985|528560739|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
146560167|NCT00725985|528560740|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
146560168|NCT00725985|528560741|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
146560169|NCT00725985|528560742|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
146560170|NCT00725985|528560743|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
146767391|NCT02974634|529317299|FG000|Overall Study|Noncompliance|3|||
146902267|NCT01275222|529803703|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
146902268|NCT01275222|529803704|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
146902269|NCT01275222|529803705|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
146902270|NCT01275222|529803706|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
146767392|NCT02974634|529317300|FG001|Overall Study|Noncompliance|7|||
146560171|NCT00725985|528560744|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
146560172|NCT00725985|528560745|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
146560173|NCT03931330|528560747|FG000|Overall Study|Physician Decision|1|||
146560174|NCT01381679|528560752|FG000|Overall Study|Adverse Event|3|||
146560175|NCT01381679|528560752|FG000|Overall Study|Lost to Follow-up|885|||
146560176|NCT04023487|528560753|FG000|Overall Study|Lost to Follow-up|5|||
146560177|NCT04023487|528560754|FG001|Overall Study|Lost to Follow-up|4|||
146560178|NCT04023487|528560753|FG000|Overall Study|Pregnancy|1|||
146560179|NCT04023487|528560754|FG001|Overall Study|Pregnancy|2|||
146560180|NCT04023487|528560753|FG000|Overall Study|Withdrawal by Subject|4|||
146902271|NCT01275222|529803701|FG000|Phase l by Treatment|Disease progression|12|||
146560181|NCT04023487|528560754|FG001|Overall Study|Withdrawal by Subject|5|||
146560182|NCT04023487|528560753|FG000|Overall Study|Partially completed testing|8|||
146767393|NCT02974634|529317299|FG000|Overall Study|intervention technology related issues|5|||
146969810|NCT05083559|530048938|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
146969811|NCT05083559|530048939|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
146969812|NCT00905437|530048942|FG000|Overall Study|Adverse Event|3|||
146969813|NCT00905437|530048943|FG001|Overall Study|Adverse Event|2|||
146969814|NCT00905437|530048942|FG000|Overall Study|Lost to Follow-up|0|||
146969815|NCT00905437|530048943|FG001|Overall Study|Lost to Follow-up|1|||
146969816|NCT00905437|530048942|FG000|Overall Study|Withdrawal by Subject|0|||
146969817|NCT00905437|530048943|FG001|Overall Study|Withdrawal by Subject|1|||
146969818|NCT00905437|530048942|FG000|Overall Study|Other|5|||
146969819|NCT00905437|530048943|FG001|Overall Study|Other|6|||
146969820|NCT03252015|530048944|FG000|Overall Study|Withdrawal by Subject|0|||
146969821|NCT03252015|530048945|FG001|Overall Study|Withdrawal by Subject|1|||
146969822|NCT03252015|530048946|FG002|Overall Study|Withdrawal by Subject|1|||
146969823|NCT03252015|530048947|FG003|Overall Study|Withdrawal by Subject|0|||
146969824|NCT03252015|530048944|FG000|Overall Study|Adverse Event|1|||
146969825|NCT03252015|530048945|FG001|Overall Study|Adverse Event|0|||
146969826|NCT03252015|530048946|FG002|Overall Study|Adverse Event|0|||
146969827|NCT03252015|530048947|FG003|Overall Study|Adverse Event|1|||
146969828|NCT03128931|530048948|FG000|Overall Study|Physician Decision|1|||
146969829|NCT03128931|530048948|FG000|Overall Study|Equipment Issues|3|||
146969830|NCT04993339|530048949|FG000|Overall Study|Lost to Follow-up|0|||
146560183|NCT04023487|528560754|FG001|Overall Study|Partially completed testing|4|||
146560184|NCT05473715|528560757|FG000|Overall Study|Trial terminate|2|||
146560185|NCT05473715|528560758|FG001|Overall Study|Trial terminate|1|||
146560186|NCT02592863|528560760|FG000|Overall Study|Withdrawal by Subject|2|||
146560187|NCT02592863|528560761|FG001|Overall Study|Withdrawal by Subject|2|||
146560188|NCT02592863|528560760|FG000|Overall Study|Lost to Follow-up|1|||
146560189|NCT02592863|528560761|FG001|Overall Study|Lost to Follow-up|1|||
146969831|NCT04993339|530048950|FG001|Overall Study|Lost to Follow-up|1|||
146560190|NCT02743221|528560762|FG000|Overall Study|Progressive disease|29|||
146560191|NCT02743221|528560763|FG001|Overall Study|Progressive disease|38|||
146560192|NCT02743221|528560762|FG000|Overall Study|Adverse Event|17|||
146560193|NCT02743221|528560763|FG001|Overall Study|Adverse Event|14|||
146560194|NCT02743221|528560762|FG000|Overall Study|non medical reason|8|||
146560195|NCT02743221|528560763|FG001|Overall Study|non medical reason|2|||
146560196|NCT02743221|528560762|FG000|Overall Study|Physician Decision|2|||
146560197|NCT02743221|528560763|FG001|Overall Study|Physician Decision|5|||
146560198|NCT02743221|528560762|FG000|Overall Study|Patient not eligible, not treated|0|||
146560199|NCT02743221|528560763|FG001|Overall Study|Patient not eligible, not treated|1|||
146560200|NCT03528902|528560766|FG000|Overall Study|Adverse Event|1|||
146560201|NCT03528902|528560767|FG001|Overall Study|Adverse Event|0|||
146560202|NCT03411044|528560768|FG000|Overall Study|Death|30|||
146969832|NCT04993339|530048949|FG000|Overall Study|no MRI scan|3|||
146969833|NCT04993339|530048950|FG001|Overall Study|no MRI scan|1|||
146969834|NCT03075215|530048953|FG000|12-Month Primary Endpoint|Death|152|||
146969835|NCT03075215|530048953|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
146969836|NCT03075215|530048953|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
146902272|NCT01275222|529803702|FG001|Phase l by Treatment|Disease progression|8|||
146902273|NCT01275222|529803703|FG002|Phase l by Treatment|Disease progression|2|||
146902274|NCT01275222|529803704|FG003|Phase l by Treatment|Disease progression|5|||
146902275|NCT01275222|529803705|FG004|Phase l by Treatment|Disease progression|0|||
146902276|NCT01275222|529803706|FG005|Phase l by Treatment|Disease progression|0|||
146902277|NCT01275222|529803701|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
146902278|NCT01275222|529803702|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
146902279|NCT01275222|529803703|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
146902280|NCT01275222|529803704|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
146902281|NCT01275222|529803705|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
146560203|NCT03411044|528560768|FG000|Overall Study|Withdrawal by Subject|48|||
146902282|NCT01275222|529803706|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
146902283|NCT01275222|529803701|FG000|Phase l by Treatment|Death|0|||
146902284|NCT01275222|529803702|FG001|Phase l by Treatment|Death|1|||
146902285|NCT01275222|529803703|FG002|Phase l by Treatment|Death|0|||
146902286|NCT01275222|529803704|FG003|Phase l by Treatment|Death|1|||
146902287|NCT01275222|529803705|FG004|Phase l by Treatment|Death|0|||
146902288|NCT01275222|529803706|FG005|Phase l by Treatment|Death|0|||
146902289|NCT01275222|529803701|FG000|Phase ll by Stratum|Adverse Event|0|||
146902290|NCT01275222|529803702|FG001|Phase ll by Stratum|Adverse Event|0|||
146902291|NCT01275222|529803703|FG002|Phase ll by Stratum|Adverse Event|0|||
146902292|NCT01275222|529803704|FG003|Phase ll by Stratum|Adverse Event|0|||
146902293|NCT01275222|529803705|FG004|Phase ll by Stratum|Adverse Event|2|||
146902294|NCT01275222|529803706|FG005|Phase ll by Stratum|Adverse Event|10|||
146902295|NCT01275222|529803701|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
146902296|NCT01275222|529803702|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
146902297|NCT01275222|529803703|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
146902298|NCT01275222|529803704|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
146902299|NCT01275222|529803705|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
146902300|NCT01275222|529803706|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
146902301|NCT01275222|529803701|FG000|Phase ll by Stratum|Disease progression|0|||
146902302|NCT01275222|529803702|FG001|Phase ll by Stratum|Disease progression|0|||
146902303|NCT01275222|529803703|FG002|Phase ll by Stratum|Disease progression|0|||
146902304|NCT01275222|529803704|FG003|Phase ll by Stratum|Disease progression|0|||
146902305|NCT01275222|529803705|FG004|Phase ll by Stratum|Disease progression|23|||
146902306|NCT01275222|529803706|FG005|Phase ll by Stratum|Disease progression|31|||
146902307|NCT01275222|529803701|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
146902308|NCT01275222|529803702|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
146902309|NCT01275222|529803703|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
146902310|NCT01275222|529803704|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
146902311|NCT01275222|529803705|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
146902312|NCT01275222|529803706|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
146902313|NCT01275222|529803701|FG000|Phase ll by Stratum|Death|0|||
146902314|NCT01275222|529803702|FG001|Phase ll by Stratum|Death|0|||
146902315|NCT01275222|529803703|FG002|Phase ll by Stratum|Death|0|||
146902316|NCT01275222|529803704|FG003|Phase ll by Stratum|Death|0|||
146902317|NCT01275222|529803705|FG004|Phase ll by Stratum|Death|1|||
146902318|NCT01275222|529803706|FG005|Phase ll by Stratum|Death|1|||
146560204|NCT03411044|528560768|FG000|Overall Study|Lost to Follow-up|78|||
146902319|NCT01511445|529803707|FG000|Overall Study|Lost to Follow-up|3|||
146902320|NCT01511445|529803708|FG001|Overall Study|Lost to Follow-up|1|||
146902321|NCT01511445|529803707|FG000|Overall Study|Protocol Violation|1|||
146902322|NCT01511445|529803708|FG001|Overall Study|Protocol Violation|3|||
146902323|NCT01511445|529803707|FG000|Overall Study|Protocol Violation|1|||
146902324|NCT01511445|529803708|FG001|Overall Study|Protocol Violation|0|||
146902325|NCT01856114|529803710|FG000|Overall Study|Withdrawal by Subject|1|||
146902326|NCT01856114|529803711|FG001|Overall Study|Withdrawal by Subject|0|||
146902327|NCT01856114|529803710|FG000|Overall Study|Adverse Event|1|||
146902328|NCT01856114|529803711|FG001|Overall Study|Adverse Event|0|||
146902329|NCT00144170|529803712|FG000|Overall Study|Adverse Event|84|||
146902330|NCT00144170|529803713|FG001|Overall Study|Adverse Event|41|||
146902331|NCT00144170|529803712|FG000|Overall Study|Protocol Violation|23|||
146902332|NCT00144170|529803713|FG001|Overall Study|Protocol Violation|16|||
146902333|NCT00144170|529803712|FG000|Overall Study|Lost to Follow-up|5|||
146902334|NCT00144170|529803713|FG001|Overall Study|Lost to Follow-up|10|||
146902335|NCT00144170|529803712|FG000|Overall Study|Withdrawal by Subject|29|||
146902336|NCT00144170|529803713|FG001|Overall Study|Withdrawal by Subject|13|||
146902337|NCT00144170|529803712|FG000|Overall Study|Other reason not defined above|211|||
146902338|NCT00144170|529803713|FG001|Overall Study|Other reason not defined above|316|||
146902339|NCT00957853|529803714|FG000|Overall Study|Withdrawal by Subject|1|||
146902340|NCT00957853|529803715|FG001|Overall Study|Withdrawal by Subject|0|||
146902341|NCT00957853|529803716|FG002|Overall Study|Withdrawal by Subject|0|||
146902342|NCT00818259|529803717|FG000|Part I|Withdrawal by Subject|1|||
146902343|NCT00818259|529803718|FG001|Part I|Withdrawal by Subject|0|||
146902344|NCT00818259|529803719|FG002|Part I|Withdrawal by Subject|0|||
146902345|NCT00818259|529803720|FG003|Part I|Withdrawal by Subject|0|||
146902346|NCT00818259|529803721|FG004|Part I|Withdrawal by Subject|0|||
146902347|NCT00818259|529803722|FG005|Part I|Withdrawal by Subject|0|||
146902348|NCT00818259|529803723|FG006|Part I|Withdrawal by Subject|0|||
146902349|NCT00818259|529803724|FG007|Part I|Withdrawal by Subject|0|||
146902350|NCT00818259|529803725|FG008|Part I|Withdrawal by Subject|0|||
146902351|NCT00818259|529803717|FG000|Part II|Physician Decision|0|||
146902352|NCT00818259|529803718|FG001|Part II|Physician Decision|0|||
146902353|NCT00818259|529803719|FG002|Part II|Physician Decision|1|||
146902354|NCT00818259|529803720|FG003|Part II|Physician Decision|0|||
146902355|NCT00818259|529803721|FG004|Part II|Physician Decision|0|||
146902356|NCT00818259|529803722|FG005|Part II|Physician Decision|0|||
146902357|NCT00818259|529803723|FG006|Part II|Physician Decision|0|||
146902358|NCT00818259|529803724|FG007|Part II|Physician Decision|0|||
146902359|NCT00818259|529803725|FG008|Part II|Physician Decision|0|||
146902360|NCT00818259|529803717|FG000|Part II|Lack of Efficacy|0|||
146902361|NCT00818259|529803718|FG001|Part II|Lack of Efficacy|0|||
146902362|NCT00818259|529803719|FG002|Part II|Lack of Efficacy|0|||
146902363|NCT00818259|529803720|FG003|Part II|Lack of Efficacy|1|||
146902364|NCT00818259|529803721|FG004|Part II|Lack of Efficacy|0|||
146902365|NCT00818259|529803722|FG005|Part II|Lack of Efficacy|0|||
146902366|NCT00818259|529803723|FG006|Part II|Lack of Efficacy|0|||
146902367|NCT00818259|529803724|FG007|Part II|Lack of Efficacy|0|||
146902368|NCT00818259|529803725|FG008|Part II|Lack of Efficacy|0|||
146902369|NCT00818259|529803717|FG000|Part II|Not Treated|0|||
146902370|NCT00818259|529803718|FG001|Part II|Not Treated|0|||
146902371|NCT00818259|529803719|FG002|Part II|Not Treated|0|||
146902372|NCT00818259|529803720|FG003|Part II|Not Treated|1|||
146902373|NCT00818259|529803721|FG004|Part II|Not Treated|0|||
146902374|NCT00818259|529803722|FG005|Part II|Not Treated|0|||
146902375|NCT00818259|529803723|FG006|Part II|Not Treated|0|||
146902376|NCT00818259|529803724|FG007|Part II|Not Treated|0|||
146902377|NCT00818259|529803725|FG008|Part II|Not Treated|0|||
146902378|NCT00818259|529803717|FG000|Part IV|Physician Decision|0|||
146902379|NCT00818259|529803718|FG001|Part IV|Physician Decision|0|||
146902380|NCT00818259|529803719|FG002|Part IV|Physician Decision|0|||
146902381|NCT00818259|529803720|FG003|Part IV|Physician Decision|0|||
146902382|NCT00818259|529803721|FG004|Part IV|Physician Decision|0|||
146902383|NCT00818259|529803722|FG005|Part IV|Physician Decision|1|||
146902384|NCT00818259|529803723|FG006|Part IV|Physician Decision|0|||
146902385|NCT00818259|529803724|FG007|Part IV|Physician Decision|0|||
146902386|NCT00818259|529803725|FG008|Part IV|Physician Decision|0|||
146902387|NCT00818259|529803717|FG000|Part V|Adverse Event|0|||
146902388|NCT00818259|529803718|FG001|Part V|Adverse Event|0|||
146902389|NCT00818259|529803719|FG002|Part V|Adverse Event|0|||
146902390|NCT00818259|529803720|FG003|Part V|Adverse Event|0|||
146902391|NCT00818259|529803721|FG004|Part V|Adverse Event|0|||
146902392|NCT00818259|529803722|FG005|Part V|Adverse Event|0|||
146902393|NCT00818259|529803723|FG006|Part V|Adverse Event|0|||
146902394|NCT00818259|529803724|FG007|Part V|Adverse Event|1|||
146902395|NCT00818259|529803725|FG008|Part V|Adverse Event|0|||
146902396|NCT00686543|529803726|FG000|Overall Study|Adverse Event|9|||
146902397|NCT00686543|529803727|FG001|Overall Study|Adverse Event|1|||
146902398|NCT00686543|529803728|FG002|Overall Study|Adverse Event|3|||
146902399|NCT00686543|529803729|FG003|Overall Study|Adverse Event|2|||
146902400|NCT00686543|529803726|FG000|Overall Study|Withdrawal by Subject|2|||
146902401|NCT00686543|529803727|FG001|Overall Study|Withdrawal by Subject|0|||
146902402|NCT00686543|529803728|FG002|Overall Study|Withdrawal by Subject|0|||
146902403|NCT00686543|529803729|FG003|Overall Study|Withdrawal by Subject|0|||
146902404|NCT00686543|529803726|FG000|Overall Study|Protocol Violation|3|||
146902405|NCT00686543|529803727|FG001|Overall Study|Protocol Violation|0|||
146902406|NCT00686543|529803728|FG002|Overall Study|Protocol Violation|2|||
146902407|NCT00686543|529803729|FG003|Overall Study|Protocol Violation|1|||
146902408|NCT01237951|529803730|FG000|Overall Study|Death|1|||
146902409|NCT00924703|529803733|FG000|Overall Study|Withdrawal by Subject|11|||
146902410|NCT00924703|529803733|FG000|Overall Study|Physician Decision|5|||
146902411|NCT00924703|529803733|FG000|Overall Study|Lost to Follow-up|3|||
146902412|NCT00924703|529803733|FG000|Overall Study|Adverse Event|2|||
146902413|NCT00924703|529803733|FG000|Overall Study|Withdrawal by Sponsor|1|||
146902414|NCT00666562|529803734|FG000|Overall Study|Withdrawal by Subject|0|||
146902415|NCT00666562|529803735|FG001|Overall Study|Withdrawal by Subject|1|||
146902416|NCT00666562|529803736|FG002|Overall Study|Withdrawal by Subject|0|||
146902417|NCT00666562|529803734|FG000|Overall Study|Concomitant Medication|0|||
146902418|NCT00666562|529803735|FG001|Overall Study|Concomitant Medication|1|||
146902419|NCT00666562|529803736|FG002|Overall Study|Concomitant Medication|0|||
146902420|NCT04906707|529803737|FG000|Overall Study|Withdrawal by Subject|2|||
146902421|NCT04906707|529803738|FG001|Overall Study|Withdrawal by Subject|0|||
146902422|NCT04906707|529803737|FG000|Overall Study|Withdrawal due to PI decision|1|||
146902423|NCT04906707|529803738|FG001|Overall Study|Withdrawal due to PI decision|0|||
146902424|NCT04906707|529803737|FG000|Overall Study|Lost to Follow-up|0|||
146902425|NCT04906707|529803738|FG001|Overall Study|Lost to Follow-up|1|||
146902426|NCT01976806|529803739|FG000|Overall Study|Lost to Follow-up|1|||
146902427|NCT01976806|529803740|FG001|Overall Study|Lost to Follow-up|4|||
146902428|NCT01976806|529803739|FG000|Overall Study|Adverse Event|1|||
146902429|NCT01976806|529803740|FG001|Overall Study|Adverse Event|1|||
146902430|NCT01976806|529803739|FG000|Overall Study|Withdrawal by Subject|1|||
146969837|NCT03075215|530048953|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
146969838|NCT00690573|530048962|FG000|Overall Study|Lack of Efficacy|8|||
146902431|NCT01976806|529803740|FG001|Overall Study|Withdrawal by Subject|1|||
146902432|NCT04429022|529803744|FG000|Overall Study|Protocol Violation|18|||
146902433|NCT04429022|529803745|FG001|Overall Study|Protocol Violation|1|||
146560205|NCT03411044|528560768|FG000|Overall Study|Adverse Event|30|||
146902434|NCT01769105|529803750|FG000|First Intervention|Protocol Violation|2|||
146902435|NCT01769105|529803751|FG001|First Intervention|Protocol Violation|2|||
146902436|NCT01769105|529803750|FG000|Cross-over|Lost to Follow-up|5|||
146902437|NCT01769105|529803751|FG001|Cross-over|Lost to Follow-up|0|||
146902438|NCT00963807|529803752|FG000|Overall Study|Physician Decision|2|||
146902439|NCT00963807|529803752|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
146560206|NCT03411044|528560768|FG000|Overall Study|Missing status|4|||
146560207|NCT02609503|528560776|FG000|Overall Study|Adverse Event|1|||
146560208|NCT02609503|528560776|FG000|Overall Study|Death|1|||
146560209|NCT02609503|528560776|FG000|Overall Study|Withdrawal by Subject|1|||
146560210|NCT02609503|528560776|FG000|Overall Study|Disease progression|1|||
146560211|NCT05889468|528560777|FG000|Overall Study|Lost to Follow-up|9|||
146902440|NCT00963807|529803752|FG000|Overall Study|Disease progression|15|||
146902441|NCT00684177|529803754|FG000|Overall Study|Adverse Event|4|||
146902442|NCT00684177|529803755|FG001|Overall Study|Adverse Event|3|||
146902443|NCT00684177|529803754|FG000|Overall Study|Lack of Efficacy|10|||
146902444|NCT00684177|529803755|FG001|Overall Study|Lack of Efficacy|15|||
146902445|NCT00684177|529803754|FG000|Overall Study|Protocol Violation|1|||
146902446|NCT00684177|529803755|FG001|Overall Study|Protocol Violation|0|||
146902447|NCT00684177|529803754|FG000|Overall Study|Lost to Follow-up|2|||
146902448|NCT00684177|529803755|FG001|Overall Study|Lost to Follow-up|1|||
146902449|NCT00684177|529803754|FG000|Overall Study|Physician Decision|2|||
146902450|NCT00684177|529803755|FG001|Overall Study|Physician Decision|0|||
146902451|NCT00684177|529803754|FG000|Overall Study|Withdrawal by Subject|1|||
146902452|NCT00684177|529803755|FG001|Overall Study|Withdrawal by Subject|2|||
146902453|NCT00684177|529803754|FG000|Overall Study|Other|1|||
146902454|NCT00684177|529803755|FG001|Overall Study|Other|2|||
146902455|NCT02432807|529805144|FG000|Overall Study|Adverse Event|0|||
146902456|NCT02432807|529805145|FG001|Overall Study|Adverse Event|2|||
146902457|NCT02432807|529805144|FG000|Overall Study|Lost to Follow-up|1|||
146902458|NCT02432807|529805145|FG001|Overall Study|Lost to Follow-up|0|||
146902459|NCT02432807|529805144|FG000|Overall Study|Withdrawal by Subject|1|||
146902460|NCT02432807|529805145|FG001|Overall Study|Withdrawal by Subject|1|||
146902461|NCT02432807|529805144|FG000|Overall Study|Other|1|||
146902462|NCT02432807|529805145|FG001|Overall Study|Other|1|||
146902463|NCT00828464|529805146|FG000|Overall Study|Withdrawal by Subject|1|||
146902464|NCT02197377|529805147|FG000|Overall Study|Insertion Failure|0|||
146902465|NCT02197377|529805148|FG001|Overall Study|Insertion Failure|3|||
146902466|NCT00502840|529805149|FG000|Overall Study|Adverse Event|5|||
146902467|NCT00502840|529805149|FG000|Overall Study|Additional or changed therapy|48|||
146560212|NCT05889468|528560778|FG001|Overall Study|Lost to Follow-up|2|||
146560213|NCT05889468|528560777|FG000|Overall Study|Withdrawal by Subject|2|||
146902468|NCT00502840|529805149|FG000|Overall Study|Lack of Efficacy|11|||
146902469|NCT00502840|529805149|FG000|Overall Study|Protocol Violation|4|||
146902470|NCT00502840|529805149|FG000|Overall Study|Withdrawal by Subject|5|||
146902471|NCT00502840|529805149|FG000|Overall Study|Lost to Follow-up|6|||
146969839|NCT00690573|530048962|FG000|Overall Study|Withdrawal by Subject|1|||
146969840|NCT01298661|530048963|FG000|Overall Study|Withdrawal by Subject|2|||
146969841|NCT01298661|530048964|FG001|Overall Study|Withdrawal by Subject|0|||
146969842|NCT01298661|530048965|FG002|Overall Study|Withdrawal by Subject|2|||
146969843|NCT00526227|530048966|FG000|Overall Study|Device not implanted|1|||
146969844|NCT00526227|530048966|FG000|Overall Study|Death|1|||
146969845|NCT05378269|530050690|FG000|Overall Study|Protocol Violation|1|||
146969846|NCT05378269|530050691|FG001|Overall Study|Protocol Violation|0|||
146969847|NCT05378269|530050692|FG002|Overall Study|Protocol Violation|2|||
146969848|NCT05378269|530050693|FG003|Overall Study|Protocol Violation|0|||
146969849|NCT05378269|530050694|FG004|Overall Study|Protocol Violation|0|||
146969850|NCT00684645|530050695|FG000|Overall Study|Death|2|||
146969851|NCT00684645|530050695|FG000|Overall Study|Progressive disease|67|||
146969852|NCT00684645|530050695|FG000|Overall Study|Adverse Event|27|||
146969853|NCT00684645|530050695|FG000|Overall Study|Lost to Follow-up|3|||
146560214|NCT05889468|528560778|FG001|Overall Study|Withdrawal by Subject|2|||
146560215|NCT02457065|528560787|FG000|Overall Study|Lost to Follow-up|9|||
146560216|NCT02457065|528560788|FG001|Overall Study|Lost to Follow-up|11|||
146560217|NCT04642079|528560794|FG000|Overall Study|Lost to Follow-up|2|||
146560218|NCT04642079|528560795|FG001|Overall Study|Lost to Follow-up|5|||
146560219|NCT04642079|528560796|FG002|Overall Study|Lost to Follow-up|2|||
146560220|NCT04642079|528560797|FG003|Overall Study|Lost to Follow-up|0|||
146560221|NCT04642079|528560794|FG000|Overall Study|Withdrawal by Subject|0|||
146560222|NCT04642079|528560795|FG001|Overall Study|Withdrawal by Subject|4|||
146560223|NCT04642079|528560796|FG002|Overall Study|Withdrawal by Subject|1|||
146560224|NCT04642079|528560797|FG003|Overall Study|Withdrawal by Subject|2|||
146560225|NCT04642079|528560794|FG000|Overall Study|Other|0|||
146560226|NCT04642079|528560795|FG001|Overall Study|Other|0|||
146560227|NCT04642079|528560796|FG002|Overall Study|Other|0|||
146560228|NCT04642079|528560797|FG003|Overall Study|Other|1|||
146560229|NCT04642079|528560794|FG000|Overall Study|No longer met eligibility criteria|1|||
146560230|NCT04642079|528560795|FG001|Overall Study|No longer met eligibility criteria|0|||
146560231|NCT04642079|528560796|FG002|Overall Study|No longer met eligibility criteria|1|||
146560232|NCT04642079|528560797|FG003|Overall Study|No longer met eligibility criteria|1|||
146969854|NCT00684645|530050695|FG000|Overall Study|Other|15|||
146969855|NCT01186744|530050696|FG000|Overall Study|Lack of Efficacy|156|||
146969856|NCT01186744|530050697|FG001|Overall Study|Lack of Efficacy|99|||
146969857|NCT01186744|530050698|FG002|Overall Study|Lack of Efficacy|0|||
146969858|NCT01186744|530050699|FG003|Overall Study|Lack of Efficacy|2|||
146902472|NCT00502840|529805149|FG000|Overall Study|Administrative problems|1|||
146902473|NCT00502840|529805149|FG000|Overall Study|Other|20|||
146902474|NCT01974323|529805150|FG000|Overall Study|Other Reasons|25|||
146902475|NCT01974323|529805151|FG001|Overall Study|Other Reasons|28|||
146902476|NCT01974323|529805150|FG000|Overall Study|Protocol Violation|2|||
146902477|NCT01974323|529805151|FG001|Overall Study|Protocol Violation|2|||
146902478|NCT01974323|529805150|FG000|Overall Study|Personal Reasons|15|||
146560233|NCT02226653|528560800|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
146560234|NCT02226653|528560801|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
146560235|NCT02226653|528560800|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
146560236|NCT02226653|528560801|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
146560237|NCT00209131|528560809|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
146560238|NCT00209131|528560810|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
146560239|NCT02871219|528560816|FG000|Overall Study|Adverse Event|15|||
146560240|NCT02871219|528560816|FG000|Overall Study|Death|3|||
146560241|NCT02871219|528560816|FG000|Overall Study|Progression|3|||
146560242|NCT02871219|528560816|FG000|Overall Study|Infections|7|||
146560243|NCT02871219|528560816|FG000|Overall Study|Infusion Related|4|||
146560244|NCT03034044|528560817|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
146560245|NCT00791648|528562030|FG000|Overall Study|Physician Decision|0|||
146560246|NCT00791648|528562031|FG001|Overall Study|Physician Decision|1|||
146560247|NCT00791648|528562030|FG000|Overall Study|Withdrawal by Subject|0|||
146560248|NCT00791648|528562031|FG001|Overall Study|Withdrawal by Subject|1|||
146560249|NCT00462826|528562032|FG000|Overall Study|Ineligible - second primary|1|||
146560250|NCT00462826|528562032|FG000|Overall Study|Ineligible - wrong cell type|1|||
146560251|NCT00462826|528562032|FG000|Overall Study|Ineligible - wrong primary|2|||
146560252|NCT00462826|528562032|FG000|Overall Study|Never treated|1|||
146560253|NCT01373281|528562034|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
146560254|NCT01373281|528562035|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
146560255|NCT01373281|528562034|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
146560256|NCT01373281|528562035|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
146560257|NCT01373281|528562034|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
146560258|NCT01373281|528562035|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
146560259|NCT01373281|528562034|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
146560260|NCT01373281|528562035|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
146560261|NCT01373281|528562034|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
146560262|NCT01373281|528562035|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
146560263|NCT01373281|528562034|FG000|Surveillance Expansion Period|Protocol Violation|9|||
146560264|NCT01373281|528562035|FG001|Surveillance Expansion Period|Protocol Violation|1|||
146560265|NCT01373281|528562034|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
146560266|NCT01373281|528562035|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
146560267|NCT01373281|528562034|FG000|Surveillance Expansion Period|Serious adverse event|3|||
146560268|NCT01373281|528562035|FG001|Surveillance Expansion Period|Serious adverse event|4|||
146560269|NCT01397253|528562036|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
146560270|NCT01397253|528562037|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
146560271|NCT03502681|528562040|FG000|Overall Study|Adverse Event|1|||
146560272|NCT03502681|528562041|FG001|Overall Study|Adverse Event|1|||
146560273|NCT03502681|528562040|FG000|Overall Study|Disease Progression|2|||
146560274|NCT03502681|528562041|FG001|Overall Study|Disease Progression|1|||
146902479|NCT01974323|529805151|FG001|Overall Study|Personal Reasons|19|||
146902480|NCT01974323|529805150|FG000|Overall Study|Lost to Follow-up|45|||
146902481|NCT01974323|529805151|FG001|Overall Study|Lost to Follow-up|40|||
146902482|NCT01974323|529805150|FG000|Overall Study|Pregnancy|2|||
146902483|NCT01974323|529805151|FG001|Overall Study|Pregnancy|1|||
146902484|NCT01974323|529805150|FG000|Overall Study|Lack of Efficacy|1|||
146902485|NCT01974323|529805151|FG001|Overall Study|Lack of Efficacy|1|||
146902486|NCT01974323|529805150|FG000|Overall Study|Adverse Event|2|||
146560275|NCT00488293|528562042|FG000|Overall Study|Lost to Follow-up|28|||
146560276|NCT00488293|528562043|FG001|Overall Study|Lost to Follow-up|25|||
146560277|NCT00488293|528562042|FG000|Overall Study|Withdrawal by Subject|5|||
146560278|NCT00488293|528562043|FG001|Overall Study|Withdrawal by Subject|3|||
146560279|NCT00488293|528562042|FG000|Overall Study|Death|2|||
146560280|NCT00488293|528562043|FG001|Overall Study|Death|1|||
146902487|NCT01974323|529805151|FG001|Overall Study|Adverse Event|2|||
146969859|NCT01186744|530050700|FG004|Overall Study|Lack of Efficacy|2|||
146969860|NCT01186744|530050701|FG005|Overall Study|Lack of Efficacy|5|||
146969861|NCT01186744|530050696|FG000|Overall Study|Protocol Violation|1|||
146969862|NCT01186744|530050697|FG001|Overall Study|Protocol Violation|2|||
146969863|NCT01186744|530050698|FG002|Overall Study|Protocol Violation|0|||
146969864|NCT01186744|530050699|FG003|Overall Study|Protocol Violation|1|||
146969865|NCT01186744|530050700|FG004|Overall Study|Protocol Violation|1|||
146969866|NCT01186744|530050701|FG005|Overall Study|Protocol Violation|2|||
146969867|NCT01186744|530050696|FG000|Overall Study|Lost to Follow-up|15|||
146969868|NCT01186744|530050697|FG001|Overall Study|Lost to Follow-up|16|||
146969869|NCT01186744|530050698|FG002|Overall Study|Lost to Follow-up|2|||
146969870|NCT01186744|530050699|FG003|Overall Study|Lost to Follow-up|1|||
146969871|NCT01186744|530050700|FG004|Overall Study|Lost to Follow-up|1|||
146560281|NCT00488293|528562042|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
146560282|NCT00488293|528562043|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
146560283|NCT03436732|528562044|FG000|Overall Study|Not treated-enrolled in different study|1|||
146560284|NCT03436732|528562045|FG001|Overall Study|Not treated-enrolled in different study|0|||
146560285|NCT03436732|528562044|FG000|Overall Study|Off study after cycle 1|1|||
146560286|NCT03436732|528562045|FG001|Overall Study|Off study after cycle 1|0|||
146560287|NCT03436732|528562044|FG000|Overall Study|Adverse Event|2|||
146969872|NCT01186744|530050701|FG005|Overall Study|Lost to Follow-up|4|||
146969873|NCT01186744|530050696|FG000|Overall Study|Screen failure|1|||
146969874|NCT01186744|530050697|FG001|Overall Study|Screen failure|1|||
146969875|NCT01186744|530050698|FG002|Overall Study|Screen failure|0|||
146560288|NCT03436732|528562045|FG001|Overall Study|Adverse Event|0|||
146969876|NCT01186744|530050699|FG003|Overall Study|Screen failure|1|||
146902488|NCT01241786|529805157|FG000|Overall Study|Lack of Efficacy|5|||
146902489|NCT05340504|529805162|FG000|Overall Study|Withdrawal by Subject|1|||
146902490|NCT05340504|529805163|FG001|Overall Study|Withdrawal by Subject|0|||
146902491|NCT03068715|529805164|FG000|Overall Study|No longer met inclusion criteria|1|||
146902492|NCT03068715|529805165|FG001|Overall Study|No longer met inclusion criteria|0|||
146902493|NCT00503399|529805166|FG000|Overall Study|Death|2|||
146902494|NCT00503399|529805167|FG001|Overall Study|Death|1|||
146902495|NCT00503399|529805166|FG000|Overall Study|Protocol Violation|1|||
146902496|NCT00503399|529805167|FG001|Overall Study|Protocol Violation|0|||
146902497|NCT00503399|529805166|FG000|Overall Study|Withdrawal by Subject|4|||
146560289|NCT03436732|528562044|FG000|Overall Study|Death|0|||
146560290|NCT03436732|528562045|FG001|Overall Study|Death|1|||
146560291|NCT00939185|528562046|FG000|Overall Study|Adverse Event|3|||
146560292|NCT00939185|528562046|FG000|Overall Study|Lack of Efficacy|1|||
146560293|NCT00939185|528562046|FG000|Overall Study|Lost to Follow-up|6|||
146560294|NCT00939185|528562046|FG000|Overall Study|Other|3|||
146560295|NCT00939185|528562046|FG000|Overall Study|Withdrawal by Subject|2|||
146560296|NCT00939185|528562046|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
146560297|NCT03552029|528562050|FG000|Overall Study|Death|3|||
146560298|NCT03552029|528562051|FG001|Overall Study|Death|0|||
146560299|NCT03552029|528562050|FG000|Overall Study|Adverse Event|1|||
146902498|NCT00503399|529805167|FG001|Overall Study|Withdrawal by Subject|2|||
146902499|NCT00503399|529805166|FG000|Overall Study|Adverse Event|0|||
146560300|NCT03552029|528562051|FG001|Overall Study|Adverse Event|0|||
146560301|NCT03552029|528562050|FG000|Overall Study|Lack of Efficacy|0|||
146902500|NCT00503399|529805167|FG001|Overall Study|Adverse Event|3|||
146902501|NCT00503399|529805166|FG000|Overall Study|Lost to Follow-up|0|||
146902502|NCT00503399|529805167|FG001|Overall Study|Lost to Follow-up|2|||
146902503|NCT03075839|529805168|FG000|Overall Study|Lost to Follow-up|4|||
146902504|NCT04433117|529805169|FG000|Overall Study|Withdrawal by Subject|1|||
146902505|NCT04433117|529805170|FG001|Overall Study|Withdrawal by Subject|0|||
146902506|NCT00190775|529805171|FG000|Overall Study|Adverse Event|57|||
146902507|NCT00190775|529805172|FG001|Overall Study|Adverse Event|22|||
146902508|NCT00190775|529805171|FG000|Overall Study|Satisfactory Response|1|||
146902509|NCT00190775|529805172|FG001|Overall Study|Satisfactory Response|0|||
146902510|NCT00190775|529805171|FG000|Overall Study|Lack of Efficacy|28|||
146902511|NCT00190775|529805172|FG001|Overall Study|Lack of Efficacy|32|||
146902512|NCT00190775|529805171|FG000|Overall Study|Lost to Follow-up|31|||
146902513|NCT00190775|529805172|FG001|Overall Study|Lost to Follow-up|23|||
146902514|NCT00190775|529805171|FG000|Overall Study|Participant Moved|0|||
146902515|NCT00190775|529805172|FG001|Overall Study|Participant Moved|1|||
146902516|NCT00190775|529805171|FG000|Overall Study|Withdrawal by Subject|24|||
146902517|NCT00190775|529805172|FG001|Overall Study|Withdrawal by Subject|13|||
146902518|NCT00190775|529805171|FG000|Overall Study|Sponsor Decision|1|||
146902519|NCT00190775|529805172|FG001|Overall Study|Sponsor Decision|0|||
146902520|NCT00190775|529805171|FG000|Overall Study|Physician Decision|3|||
146902521|NCT00190775|529805172|FG001|Overall Study|Physician Decision|0|||
146902522|NCT00190775|529805171|FG000|Overall Study|Noncompliance|3|||
146902523|NCT00190775|529805172|FG001|Overall Study|Noncompliance|5|||
146902524|NCT00190775|529805171|FG000|Overall Study|Protocol Violation|0|||
146902525|NCT00190775|529805172|FG001|Overall Study|Protocol Violation|1|||
146902526|NCT00190775|529805171|FG000|Overall Study|Exclusion Criteria Met|1|||
146902527|NCT00190775|529805172|FG001|Overall Study|Exclusion Criteria Met|3|||
146902528|NCT01794780|529805173|FG000|Overall Study|Adverse Event|0|||
146902529|NCT01794780|529805174|FG001|Overall Study|Adverse Event|1|||
146902530|NCT01794780|529805175|FG002|Overall Study|Adverse Event|2|||
146902531|NCT01794780|529805176|FG003|Overall Study|Adverse Event|0|||
146902532|NCT01794780|529805177|FG004|Overall Study|Adverse Event|0|||
146902533|NCT01794780|529805178|FG005|Overall Study|Adverse Event|0|||
146902534|NCT01794780|529805179|FG006|Overall Study|Adverse Event|0|||
146902535|NCT01794780|529805180|FG007|Overall Study|Adverse Event|0|||
146902536|NCT01794780|529805173|FG000|Overall Study|Death|0|||
146902537|NCT01794780|529805174|FG001|Overall Study|Death|2|||
146902538|NCT01794780|529805175|FG002|Overall Study|Death|14|||
146902539|NCT01794780|529805176|FG003|Overall Study|Death|1|||
146902540|NCT01794780|529805177|FG004|Overall Study|Death|0|||
146902541|NCT01794780|529805178|FG005|Overall Study|Death|9|||
146902542|NCT01794780|529805179|FG006|Overall Study|Death|4|||
146902543|NCT01794780|529805180|FG007|Overall Study|Death|0|||
146902544|NCT01794780|529805173|FG000|Overall Study|Lost to Follow-up|10|||
146902545|NCT01794780|529805174|FG001|Overall Study|Lost to Follow-up|64|||
146902546|NCT01794780|529805175|FG002|Overall Study|Lost to Follow-up|165|||
146902547|NCT01794780|529805176|FG003|Overall Study|Lost to Follow-up|53|||
146902548|NCT01794780|529805177|FG004|Overall Study|Lost to Follow-up|2|||
146902549|NCT01794780|529805178|FG005|Overall Study|Lost to Follow-up|99|||
146902550|NCT01794780|529805179|FG006|Overall Study|Lost to Follow-up|30|||
146902551|NCT01794780|529805180|FG007|Overall Study|Lost to Follow-up|5|||
146902552|NCT01794780|529805173|FG000|Overall Study|Withdrew informed consent|7|||
146902553|NCT01794780|529805174|FG001|Overall Study|Withdrew informed consent|17|||
146902554|NCT01794780|529805175|FG002|Overall Study|Withdrew informed consent|36|||
146902555|NCT01794780|529805176|FG003|Overall Study|Withdrew informed consent|9|||
146902556|NCT01794780|529805177|FG004|Overall Study|Withdrew informed consent|0|||
146902557|NCT01794780|529805178|FG005|Overall Study|Withdrew informed consent|48|||
146902558|NCT01794780|529805179|FG006|Overall Study|Withdrew informed consent|4|||
146902559|NCT01794780|529805180|FG007|Overall Study|Withdrew informed consent|3|||
146902560|NCT01794780|529805173|FG000|Overall Study|Other|0|||
146902561|NCT01794780|529805174|FG001|Overall Study|Other|12|||
146902562|NCT01794780|529805175|FG002|Overall Study|Other|25|||
146902563|NCT01794780|529805176|FG003|Overall Study|Other|20|||
146902564|NCT01794780|529805177|FG004|Overall Study|Other|1|||
146902565|NCT01794780|529805178|FG005|Overall Study|Other|24|||
146902566|NCT01794780|529805179|FG006|Overall Study|Other|4|||
146969877|NCT01186744|530050700|FG004|Overall Study|Screen failure|0|||
146969878|NCT01186744|530050701|FG005|Overall Study|Screen failure|0|||
146969879|NCT01186744|530050696|FG000|Overall Study|Withdrawal by Subject|14|||
146969880|NCT01186744|530050697|FG001|Overall Study|Withdrawal by Subject|10|||
146969881|NCT01186744|530050698|FG002|Overall Study|Withdrawal by Subject|2|||
146969882|NCT01186744|530050699|FG003|Overall Study|Withdrawal by Subject|5|||
146969883|NCT01186744|530050700|FG004|Overall Study|Withdrawal by Subject|0|||
146969884|NCT01186744|530050701|FG005|Overall Study|Withdrawal by Subject|6|||
146969885|NCT01186744|530050696|FG000|Overall Study|Study terminated by Sponsor|1|||
146969886|NCT01186744|530050697|FG001|Overall Study|Study terminated by Sponsor|0|||
146969887|NCT01186744|530050698|FG002|Overall Study|Study terminated by Sponsor|0|||
146969888|NCT01186744|530050699|FG003|Overall Study|Study terminated by Sponsor|0|||
146969889|NCT01186744|530050700|FG004|Overall Study|Study terminated by Sponsor|0|||
146969890|NCT01186744|530050701|FG005|Overall Study|Study terminated by Sponsor|0|||
146969891|NCT01186744|530050696|FG000|Overall Study|Other|9|||
146969892|NCT01186744|530050697|FG001|Overall Study|Other|10|||
146969893|NCT01186744|530050698|FG002|Overall Study|Other|1|||
146969894|NCT01186744|530050699|FG003|Overall Study|Other|2|||
146969895|NCT01186744|530050700|FG004|Overall Study|Other|1|||
146969896|NCT01186744|530050701|FG005|Overall Study|Other|5|||
146969897|NCT01186744|530050696|FG000|Overall Study|Adverse Event|10|||
146969898|NCT01186744|530050697|FG001|Overall Study|Adverse Event|14|||
146969899|NCT01186744|530050698|FG002|Overall Study|Adverse Event|1|||
146969900|NCT01186744|530050699|FG003|Overall Study|Adverse Event|0|||
146969901|NCT01186744|530050700|FG004|Overall Study|Adverse Event|1|||
146969902|NCT01186744|530050701|FG005|Overall Study|Adverse Event|4|||
146969903|NCT01186744|530050696|FG000|Overall Study|Death|1|||
146969904|NCT01186744|530050697|FG001|Overall Study|Death|0|||
146969905|NCT01186744|530050698|FG002|Overall Study|Death|0|||
146969906|NCT01186744|530050699|FG003|Overall Study|Death|0|||
146969907|NCT01186744|530050700|FG004|Overall Study|Death|0|||
146969908|NCT01186744|530050701|FG005|Overall Study|Death|0|||
146969909|NCT02325401|530050704|FG000|Overall Study|Withdrawal by Subject|0|||
146969910|NCT02325401|530050705|FG001|Overall Study|Withdrawal by Subject|1|||
146969911|NCT02325401|530050706|FG002|Overall Study|Withdrawal by Subject|1|||
146969912|NCT01956123|530050707|FG000|COS Cycle 2|Protocol Violation|8|||
146969913|NCT01956123|530050708|FG001|COS Cycle 2|Protocol Violation|3|||
146969914|NCT01956123|530050709|FG002|COS Cycle 2|Protocol Violation|0|||
146969915|NCT01956123|530050710|FG003|COS Cycle 2|Protocol Violation|0|||
146969916|NCT01956123|530050707|FG000|COS Cycle 2|Adverse Event|3|||
146969917|NCT01956123|530050708|FG001|COS Cycle 2|Adverse Event|4|||
146969918|NCT01956123|530050709|FG002|COS Cycle 2|Adverse Event|0|||
146969919|NCT01956123|530050710|FG003|COS Cycle 2|Adverse Event|0|||
146969920|NCT01956123|530050707|FG000|COS Cycle 2|Personal Reasons|2|||
146969921|NCT01956123|530050708|FG001|COS Cycle 2|Personal Reasons|0|||
146969922|NCT01956123|530050709|FG002|COS Cycle 2|Personal Reasons|0|||
146969923|NCT01956123|530050710|FG003|COS Cycle 2|Personal Reasons|0|||
146969924|NCT01956123|530050707|FG000|COS Cycle 2|Withdrawal by Subject|1|||
146969925|NCT01956123|530050708|FG001|COS Cycle 2|Withdrawal by Subject|0|||
146969926|NCT01956123|530050709|FG002|COS Cycle 2|Withdrawal by Subject|0|||
146969927|NCT01956123|530050710|FG003|COS Cycle 2|Withdrawal by Subject|0|||
146969928|NCT01956123|530050707|FG000|COS Cycle 3|Protocol Violation|0|||
146969929|NCT01956123|530050708|FG001|COS Cycle 3|Protocol Violation|0|||
146902567|NCT01794780|529805180|FG007|Overall Study|Other|1|||
146902568|NCT02469246|529805181|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
146902569|NCT02469246|529805182|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
146969930|NCT01956123|530050709|FG002|COS Cycle 3|Protocol Violation|2|||
146969931|NCT01956123|530050710|FG003|COS Cycle 3|Protocol Violation|1|||
146969932|NCT01956123|530050707|FG000|COS Cycle 3|Adverse Event|0|||
146969933|NCT01956123|530050708|FG001|COS Cycle 3|Adverse Event|0|||
146969934|NCT01956123|530050709|FG002|COS Cycle 3|Adverse Event|3|||
146969935|NCT01956123|530050710|FG003|COS Cycle 3|Adverse Event|0|||
146969936|NCT01956123|530050707|FG000|COS Cycle 3|Personal Reasons|0|||
146969937|NCT01956123|530050708|FG001|COS Cycle 3|Personal Reasons|0|||
146969938|NCT01956123|530050709|FG002|COS Cycle 3|Personal Reasons|1|||
146969939|NCT01956123|530050710|FG003|COS Cycle 3|Personal Reasons|0|||
146969940|NCT01956123|530050707|FG000|COS Cycle 3|Withdrawal by Subject|0|||
146969941|NCT01956123|530050708|FG001|COS Cycle 3|Withdrawal by Subject|0|||
146902570|NCT02469246|529805181|FG000|Double-Blind Phase|Adverse Event|12|||
146902571|NCT02469246|529805182|FG001|Double-Blind Phase|Adverse Event|9|||
146969942|NCT01956123|530050709|FG002|COS Cycle 3|Withdrawal by Subject|0|||
146969943|NCT01956123|530050710|FG003|COS Cycle 3|Withdrawal by Subject|1|||
146969944|NCT01461369|530050711|FG000|Overall Study|Lack of Efficacy|2|||
146969945|NCT01461369|530050712|FG001|Overall Study|Lack of Efficacy|0|||
146969946|NCT01461369|530050713|FG002|Overall Study|Lack of Efficacy|6|||
146969947|NCT01461369|530050711|FG000|Overall Study|Lost to Follow-up|0|||
146969948|NCT01461369|530050712|FG001|Overall Study|Lost to Follow-up|0|||
146969949|NCT01461369|530050713|FG002|Overall Study|Lost to Follow-up|3|||
146969950|NCT01461369|530050711|FG000|Overall Study|Adverse Event|9|||
146969951|NCT01461369|530050712|FG001|Overall Study|Adverse Event|12|||
146969952|NCT01461369|530050713|FG002|Overall Study|Adverse Event|4|||
146969953|NCT01461369|530050711|FG000|Overall Study|Protocol Violation|1|||
146969954|NCT01461369|530050712|FG001|Overall Study|Protocol Violation|2|||
146969955|NCT01461369|530050713|FG002|Overall Study|Protocol Violation|2|||
146969956|NCT01461369|530050711|FG000|Overall Study|Withdrawal by Subject|1|||
146969957|NCT01461369|530050712|FG001|Overall Study|Withdrawal by Subject|3|||
146969958|NCT01461369|530050713|FG002|Overall Study|Withdrawal by Subject|2|||
146969959|NCT02886494|530050724|FG000|Overall Study|Adverse Event|1|||
146969960|NCT02886494|530050725|FG001|Overall Study|Adverse Event|0|||
146969961|NCT02886494|530050724|FG000|Overall Study|Withdrawal by Subject|12|||
146969962|NCT02886494|530050725|FG001|Overall Study|Withdrawal by Subject|3|||
146969963|NCT02886494|530050724|FG000|Overall Study|Protocol Violation|4|||
146969964|NCT02886494|530050725|FG001|Overall Study|Protocol Violation|1|||
146969965|NCT00499252|530050731|FG000|Overall Study|Adverse Event|3|||
146969966|NCT00499252|530050731|FG000|Overall Study|Refused further treatment|2|||
146969967|NCT00499252|530050731|FG000|Overall Study|Ineligible|4|||
146969968|NCT00499252|530050731|FG000|Overall Study|<no further label>|3|||
146969969|NCT01612780|530050747|FG000|Overall Study|Treatment not completed|1|||
146969970|NCT01612780|530050747|FG000|Overall Study|Withdrawal by Subject|5|||
146969971|NCT00556166|530050748|FG000|Overall Study|Withdrawal by Subject|1|||
146969972|NCT02985515|530050751|FG000|Olfaction Testing|Lost to Follow-up|0|||
146969973|NCT02985515|530050752|FG001|Olfaction Testing|Lost to Follow-up|5|||
146969974|NCT02985515|530050751|FG000|Olfaction Testing|Protocol Violation|0|||
146969975|NCT02985515|530050752|FG001|Olfaction Testing|Protocol Violation|3|||
146969976|NCT03359473|530050753|FG000|Overall Study|Adverse Event|0|||
146969977|NCT03359473|530050754|FG001|Overall Study|Adverse Event|2|||
146969978|NCT03359473|530050755|FG002|Overall Study|Adverse Event|5|||
146969979|NCT03359473|530050756|FG003|Overall Study|Adverse Event|3|||
146969980|NCT03359473|530050753|FG000|Overall Study|Lost to Follow-up|0|||
146969981|NCT03359473|530050754|FG001|Overall Study|Lost to Follow-up|1|||
146969982|NCT03359473|530050755|FG002|Overall Study|Lost to Follow-up|0|||
146969983|NCT03359473|530050756|FG003|Overall Study|Lost to Follow-up|0|||
146969984|NCT03359473|530050753|FG000|Overall Study|Physician Decision|0|||
146969985|NCT03359473|530050754|FG001|Overall Study|Physician Decision|1|||
146969986|NCT03359473|530050755|FG002|Overall Study|Physician Decision|0|||
146969987|NCT03359473|530050756|FG003|Overall Study|Physician Decision|1|||
146969988|NCT03359473|530050753|FG000|Overall Study|Withdrawal by Subject|1|||
146560302|NCT03552029|528562051|FG001|Overall Study|Lack of Efficacy|2|||
146560303|NCT03552029|528562050|FG000|Overall Study|Physician Decision|0|||
146560304|NCT03552029|528562051|FG001|Overall Study|Physician Decision|1|||
146560305|NCT03552029|528562050|FG000|Overall Study|Study terminated by Sponsor|0|||
146560306|NCT03552029|528562051|FG001|Overall Study|Study terminated by Sponsor|1|||
146560307|NCT03552029|528562050|FG000|Overall Study|Other|0|||
146560308|NCT03552029|528562051|FG001|Overall Study|Other|2|||
146560309|NCT03468998|528562053|FG000|Overall Study|Withdrawal by Subject|1|||
146560310|NCT03468998|528562054|FG001|Overall Study|Withdrawal by Subject|1|||
146560311|NCT03468998|528562055|FG002|Overall Study|Withdrawal by Subject|0|||
146560312|NCT03468998|528562056|FG003|Overall Study|Withdrawal by Subject|4|||
146560313|NCT03468998|528562057|FG004|Overall Study|Withdrawal by Subject|1|||
146560314|NCT03468998|528562058|FG005|Overall Study|Withdrawal by Subject|0|||
146560315|NCT00836706|528562059|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
146560316|NCT00836706|528562060|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
146560317|NCT02989857|528562061|FG000|Randomization Phase|Not Treated|3|||
146560318|NCT02989857|528562062|FG001|Randomization Phase|Not Treated|2|||
146560319|NCT02989857|528562063|FG002|Randomization Phase|Not Treated|0|||
146560320|NCT00633126|528562066|FG000|Overall Study|Did not receive full dose|1|||
146560321|NCT00567502|528562072|FG000|Overall Study|Lost to Follow-up|91|||
146560322|NCT00567502|528562073|FG001|Overall Study|Lost to Follow-up|14|||
146560323|NCT00567502|528562074|FG002|Overall Study|Lost to Follow-up|351|||
146560324|NCT00567502|528562075|FG003|Overall Study|Lost to Follow-up|2|||
146560325|NCT00567502|528562072|FG000|Overall Study|Death|65|||
146560326|NCT00567502|528562073|FG001|Overall Study|Death|16|||
146560327|NCT00567502|528562074|FG002|Overall Study|Death|360|||
146560328|NCT00567502|528562075|FG003|Overall Study|Death|5|||
146560329|NCT00567502|528562072|FG000|Overall Study|Other|64|||
146560330|NCT00567502|528562073|FG001|Overall Study|Other|2|||
146560331|NCT00567502|528562074|FG002|Overall Study|Other|134|||
146560332|NCT00567502|528562075|FG003|Overall Study|Other|6|||
146560333|NCT00567502|528562072|FG000|Overall Study|Participant request|12|||
146560334|NCT00567502|528562073|FG001|Overall Study|Participant request|1|||
146560335|NCT00567502|528562074|FG002|Overall Study|Participant request|33|||
146560336|NCT00567502|528562075|FG003|Overall Study|Participant request|1|||
146560337|NCT00567502|528562072|FG000|Overall Study|Sponsor request|9|||
146560338|NCT00567502|528562073|FG001|Overall Study|Sponsor request|0|||
146560339|NCT00567502|528562074|FG002|Overall Study|Sponsor request|30|||
146560340|NCT00567502|528562075|FG003|Overall Study|Sponsor request|1|||
146560341|NCT00567502|528562072|FG000|Overall Study|Never Initiated Treatment|0|||
146560342|NCT00567502|528562073|FG001|Overall Study|Never Initiated Treatment|0|||
146560343|NCT00567502|528562074|FG002|Overall Study|Never Initiated Treatment|0|||
146560344|NCT00567502|528562075|FG003|Overall Study|Never Initiated Treatment|72|||
146560345|NCT00023595|528562077|FG000|5 Year Follow up|Lost to Follow-up|2|||
146560346|NCT00023595|528562078|FG001|5 Year Follow up|Lost to Follow-up|2|||
146560347|NCT00023595|528562079|FG002|5 Year Follow up|Lost to Follow-up|1|||
146560348|NCT00023595|528562080|FG003|5 Year Follow up|Lost to Follow-up|7|||
146560349|NCT00023595|528562081|FG004|5 Year Follow up|Lost to Follow-up|3|||
146902572|NCT02469246|529805181|FG000|Double-Blind Phase|Death|2|||
146902573|NCT02469246|529805182|FG001|Double-Blind Phase|Death|0|||
146902574|NCT02469246|529805181|FG000|Double-Blind Phase|Lack of Efficacy|2|||
146902575|NCT02469246|529805182|FG001|Double-Blind Phase|Lack of Efficacy|1|||
146902576|NCT02469246|529805181|FG000|Double-Blind Phase|Investigator's Discretion|8|||
146902577|NCT02469246|529805182|FG001|Double-Blind Phase|Investigator's Discretion|8|||
146902578|NCT02469246|529805181|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
146902579|NCT02469246|529805182|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
146902580|NCT02469246|529805181|FG000|Double-Blind Phase|Protocol Violation|1|||
146902581|NCT02469246|529805182|FG001|Double-Blind Phase|Protocol Violation|1|||
146902582|NCT02469246|529805181|FG000|Double-Blind Phase|Withdrew Consent|25|||
146902583|NCT02469246|529805182|FG001|Double-Blind Phase|Withdrew Consent|25|||
146902584|NCT02469246|529805181|FG000|Double-Blind Phase|Lost to Follow-up|9|||
146902585|NCT02469246|529805182|FG001|Double-Blind Phase|Lost to Follow-up|5|||
146902586|NCT01658514|529805188|FG000|Overall Study|Protocol Violation|1|||
146902587|NCT01658514|529805189|FG001|Overall Study|Protocol Violation|0|||
146902588|NCT01658514|529805190|FG002|Overall Study|Protocol Violation|2|||
146902589|NCT02337387|529805191|FG000|Overall Study|Adverse Event|0|||
146902590|NCT02337387|529805192|FG001|Overall Study|Adverse Event|1|||
146902591|NCT02337387|529805193|FG002|Overall Study|Adverse Event|0|||
146902592|NCT02337387|529805194|FG003|Overall Study|Adverse Event|0|||
146902593|NCT02337387|529805191|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
146902594|NCT02337387|529805192|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
146902595|NCT02337387|529805193|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
146902596|NCT02337387|529805194|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
146902597|NCT02853760|529805195|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
146902598|NCT02853760|529805196|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
146902599|NCT02853760|529805197|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
146902600|NCT02853760|529805198|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
146902601|NCT02853760|529805199|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
146902602|NCT02853760|529805200|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
146902603|NCT01642212|529805201|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
146902604|NCT01642212|529805202|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
146902605|NCT01642212|529805203|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
146902606|NCT01642212|529805204|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
146902607|NCT01642212|529805205|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
146902608|NCT01642212|529805201|FG000|Double-blind Treatment|Other|0|||
146902609|NCT01642212|529805202|FG001|Double-blind Treatment|Other|2|||
146902610|NCT01642212|529805203|FG002|Double-blind Treatment|Other|1|||
146902611|NCT01642212|529805204|FG003|Double-blind Treatment|Other|0|||
146902612|NCT01642212|529805205|FG004|Double-blind Treatment|Other|0|||
146902613|NCT01642212|529805201|FG000|Double-blind Treatment|Non-compliance|0|||
146902614|NCT01642212|529805202|FG001|Double-blind Treatment|Non-compliance|1|||
146902615|NCT01642212|529805203|FG002|Double-blind Treatment|Non-compliance|0|||
146902616|NCT01642212|529805204|FG003|Double-blind Treatment|Non-compliance|0|||
146902617|NCT01642212|529805205|FG004|Double-blind Treatment|Non-compliance|0|||
146902618|NCT01642212|529805201|FG000|Double-blind Treatment|Adverse Event|0|||
146902619|NCT01642212|529805202|FG001|Double-blind Treatment|Adverse Event|0|||
146902620|NCT01642212|529805203|FG002|Double-blind Treatment|Adverse Event|1|||
146902621|NCT01642212|529805204|FG003|Double-blind Treatment|Adverse Event|0|||
146902622|NCT01642212|529805205|FG004|Double-blind Treatment|Adverse Event|0|||
146902623|NCT01642212|529805201|FG000|Open-label Extension|Adverse Event|0|||
146902624|NCT01642212|529805202|FG001|Open-label Extension|Adverse Event|0|||
146902625|NCT01642212|529805203|FG002|Open-label Extension|Adverse Event|0|||
146902626|NCT01642212|529805204|FG003|Open-label Extension|Adverse Event|3|||
146902627|NCT01642212|529805205|FG004|Open-label Extension|Adverse Event|0|||
146767394|NCT02974634|529317300|FG001|Overall Study|intervention technology related issues|0|||
146902628|NCT01642212|529805201|FG000|Open-label Extension|Sponsor Decision|0|||
146902629|NCT01642212|529805202|FG001|Open-label Extension|Sponsor Decision|0|||
146902630|NCT01642212|529805203|FG002|Open-label Extension|Sponsor Decision|0|||
146902631|NCT01642212|529805204|FG003|Open-label Extension|Sponsor Decision|7|||
146902632|NCT01642212|529805205|FG004|Open-label Extension|Sponsor Decision|4|||
146902633|NCT01642212|529805201|FG000|Open-label Extension|Consent Withdrawn|0|||
146902634|NCT01642212|529805202|FG001|Open-label Extension|Consent Withdrawn|0|||
146902635|NCT01642212|529805203|FG002|Open-label Extension|Consent Withdrawn|0|||
146560350|NCT00023595|528562077|FG000|10 Year Follow up|Lost to Follow-up|12|||
146560351|NCT00023595|528562078|FG001|10 Year Follow up|Lost to Follow-up|10|||
146560352|NCT00023595|528562079|FG002|10 Year Follow up|Lost to Follow-up|3|||
146560353|NCT00023595|528562080|FG003|10 Year Follow up|Lost to Follow-up|0|||
146560354|NCT00023595|528562081|FG004|10 Year Follow up|Lost to Follow-up|0|||
146560355|NCT03900650|528562084|FG000|Overall Study|Withdrawal by Subject|1|||
146560356|NCT03900650|528562085|FG001|Overall Study|Withdrawal by Subject|1|||
146560357|NCT03900650|528562086|FG002|Overall Study|Withdrawal by Subject|0|||
146560358|NCT03900650|528562087|FG003|Overall Study|Withdrawal by Subject|0|||
146560359|NCT03900650|528562084|FG000|Overall Study|Withdrawn by staff|1|||
146560360|NCT03900650|528562085|FG001|Overall Study|Withdrawn by staff|0|||
146560361|NCT03900650|528562086|FG002|Overall Study|Withdrawn by staff|0|||
146560362|NCT03900650|528562087|FG003|Overall Study|Withdrawn by staff|0|||
146560363|NCT02014376|528562090|FG000|Overall Study|Adverse Event|1|||
146560364|NCT02014376|528562091|FG001|Overall Study|Adverse Event|1|||
146560365|NCT02014376|528562092|FG002|Overall Study|Adverse Event|0|||
146560366|NCT02014376|528562090|FG000|Overall Study|Lost to Follow-up|2|||
146560367|NCT02014376|528562091|FG001|Overall Study|Lost to Follow-up|0|||
146560368|NCT02014376|528562092|FG002|Overall Study|Lost to Follow-up|0|||
146560369|NCT00721110|528562097|FG000|Overall Study|Ultram use|1|||
146560370|NCT00721110|528562098|FG001|Overall Study|Ultram use|0|||
146560371|NCT00721110|528562099|FG002|Overall Study|Ultram use|0|||
146560372|NCT00721110|528562100|FG003|Overall Study|Ultram use|0|||
146560373|NCT00721110|528562097|FG000|Overall Study|vertical incision|0|||
146560374|NCT00721110|528562098|FG001|Overall Study|vertical incision|0|||
146560375|NCT00721110|528562099|FG002|Overall Study|vertical incision|1|||
146560376|NCT00721110|528562100|FG003|Overall Study|vertical incision|0|||
146560377|NCT00635050|528562103|FG000|Overall Study|Withdrawal by Subject|1|||
146560378|NCT00086515|528562108|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
146560379|NCT00086515|528562109|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
146560380|NCT00086515|528562108|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
146560381|NCT00086515|528562109|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
146902636|NCT01642212|529805204|FG003|Open-label Extension|Consent Withdrawn|0|||
146902637|NCT01642212|529805205|FG004|Open-label Extension|Consent Withdrawn|2|||
146902638|NCT01642212|529805201|FG000|Open-label Extension|Lost to Follow-up|0|||
146902639|NCT01642212|529805202|FG001|Open-label Extension|Lost to Follow-up|0|||
146902640|NCT01642212|529805203|FG002|Open-label Extension|Lost to Follow-up|0|||
146902641|NCT01642212|529805204|FG003|Open-label Extension|Lost to Follow-up|0|||
146560382|NCT00086515|528562108|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
146560383|NCT00086515|528562109|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
146560384|NCT00086515|528562108|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
146560385|NCT00086515|528562109|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
146560386|NCT00086515|528562108|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
146560387|NCT00086515|528562109|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
146560388|NCT00086515|528562108|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
146560389|NCT00086515|528562109|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
146560390|NCT00086515|528562108|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
146560391|NCT00086515|528562109|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
146560392|NCT00086515|528562108|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
146560393|NCT00086515|528562109|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
146560394|NCT00086515|528562108|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
146560395|NCT00086515|528562109|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
146560396|NCT00086515|528562108|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
146560397|NCT00086515|528562109|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
146560398|NCT00086515|528562108|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
146560399|NCT00086515|528562109|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
146560400|NCT00086515|528562108|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
146560401|NCT00086515|528562109|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
146560402|NCT00086515|528562108|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
146560403|NCT00086515|528562109|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
146560404|NCT00086515|528562108|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
146560405|NCT00086515|528562109|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
146560406|NCT00086515|528562108|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
146560407|NCT00086515|528562109|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
146560408|NCT00086515|528562108|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
146560409|NCT00086515|528562109|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
146902642|NCT01642212|529805205|FG004|Open-label Extension|Lost to Follow-up|1|||
146560410|NCT00086515|528562108|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
146560411|NCT00086515|528562109|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
146902643|NCT01642212|529805201|FG000|Open-label Extension|Other|0|||
146560412|NCT00086515|528562108|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
146560413|NCT00086515|528562109|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
146969989|NCT03359473|530050754|FG001|Overall Study|Withdrawal by Subject|2|||
146969990|NCT03359473|530050755|FG002|Overall Study|Withdrawal by Subject|1|||
146969991|NCT03359473|530050756|FG003|Overall Study|Withdrawal by Subject|0|||
146969992|NCT03359473|530050753|FG000|Overall Study|Protocol-defined stopping criteria|1|||
146969993|NCT03359473|530050754|FG001|Overall Study|Protocol-defined stopping criteria|0|||
146969994|NCT03359473|530050755|FG002|Overall Study|Protocol-defined stopping criteria|0|||
146969995|NCT03359473|530050756|FG003|Overall Study|Protocol-defined stopping criteria|1|||
146969996|NCT05302414|530050757|FG000|Pretest to Posttest|Lost to Follow-up|12|||
146969997|NCT05302414|530050758|FG001|Pretest to Posttest|Lost to Follow-up|8|||
146969998|NCT05302414|530050759|FG002|Pretest to Posttest|Lost to Follow-up|8|||
146969999|NCT05302414|530050757|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
146970000|NCT05302414|530050758|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
146970001|NCT05302414|530050759|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
146970002|NCT00424632|530050762|FG000|Overall Study|Death|0|||
146970003|NCT00424632|530050763|FG001|Overall Study|Death|0|||
146970004|NCT00424632|530050764|FG002|Overall Study|Death|0|||
146970005|NCT00424632|530050765|FG003|Overall Study|Death|0|||
146970006|NCT00424632|530050766|FG004|Overall Study|Death|0|||
146970007|NCT00424632|530050767|FG005|Overall Study|Death|2|||
146970008|NCT00424632|530050768|FG006|Overall Study|Death|0|||
146970009|NCT00424632|530050769|FG007|Overall Study|Death|0|||
146970010|NCT00424632|530050770|FG008|Overall Study|Death|0|||
146970011|NCT00424632|530050771|FG009|Overall Study|Death|0|||
146970012|NCT00424632|530050762|FG000|Overall Study|Adverse Event|0|||
146970013|NCT00424632|530050763|FG001|Overall Study|Adverse Event|0|||
146970014|NCT00424632|530050764|FG002|Overall Study|Adverse Event|0|||
146970015|NCT00424632|530050765|FG003|Overall Study|Adverse Event|0|||
146970016|NCT00424632|530050766|FG004|Overall Study|Adverse Event|0|||
146970017|NCT00424632|530050767|FG005|Overall Study|Adverse Event|0|||
146970018|NCT00424632|530050768|FG006|Overall Study|Adverse Event|0|||
146970019|NCT00424632|530050769|FG007|Overall Study|Adverse Event|0|||
146970020|NCT00424632|530050770|FG008|Overall Study|Adverse Event|3|||
146970021|NCT00424632|530050771|FG009|Overall Study|Adverse Event|2|||
146970022|NCT00424632|530050762|FG000|Overall Study|Global deterioration of health status|0|||
146970023|NCT00424632|530050763|FG001|Overall Study|Global deterioration of health status|0|||
146970024|NCT00424632|530050764|FG002|Overall Study|Global deterioration of health status|0|||
146970025|NCT00424632|530050765|FG003|Overall Study|Global deterioration of health status|1|||
146970026|NCT00424632|530050766|FG004|Overall Study|Global deterioration of health status|1|||
146970027|NCT00424632|530050767|FG005|Overall Study|Global deterioration of health status|0|||
146970028|NCT00424632|530050768|FG006|Overall Study|Global deterioration of health status|0|||
146970029|NCT00424632|530050769|FG007|Overall Study|Global deterioration of health status|0|||
146970030|NCT00424632|530050770|FG008|Overall Study|Global deterioration of health status|0|||
146970031|NCT00424632|530050771|FG009|Overall Study|Global deterioration of health status|0|||
146970032|NCT00424632|530050762|FG000|Overall Study|Objective progression or relapse|1|||
146970033|NCT00424632|530050763|FG001|Overall Study|Objective progression or relapse|1|||
146970034|NCT00424632|530050764|FG002|Overall Study|Objective progression or relapse|1|||
146970035|NCT00424632|530050765|FG003|Overall Study|Objective progression or relapse|2|||
146970036|NCT00424632|530050766|FG004|Overall Study|Objective progression or relapse|2|||
146970037|NCT00424632|530050767|FG005|Overall Study|Objective progression or relapse|13|||
146970038|NCT00424632|530050768|FG006|Overall Study|Objective progression or relapse|7|||
146970039|NCT00424632|530050769|FG007|Overall Study|Objective progression or relapse|3|||
146970040|NCT00424632|530050770|FG008|Overall Study|Objective progression or relapse|12|||
146970041|NCT00424632|530050771|FG009|Overall Study|Objective progression or relapse|4|||
146970042|NCT00424632|530050762|FG000|Overall Study|Other|0|||
146970043|NCT00424632|530050763|FG001|Overall Study|Other|0|||
146970044|NCT00424632|530050764|FG002|Overall Study|Other|0|||
146970045|NCT00424632|530050765|FG003|Overall Study|Other|1|||
146970046|NCT00424632|530050766|FG004|Overall Study|Other|0|||
146970047|NCT00424632|530050767|FG005|Overall Study|Other|0|||
146970048|NCT00424632|530050768|FG006|Overall Study|Other|0|||
146970049|NCT00424632|530050769|FG007|Overall Study|Other|0|||
146970050|NCT00424632|530050770|FG008|Overall Study|Other|1|||
146970051|NCT00424632|530050771|FG009|Overall Study|Other|0|||
146970052|NCT02628418|530050772|FG000|Overall Study|Lost to Follow-up|1|||
146970053|NCT02628418|530050773|FG001|Overall Study|Lost to Follow-up|2|||
146970054|NCT01071083|530050777|FG000|Overall Study|Adverse Event|1|||
146970055|NCT01071083|530050778|FG001|Overall Study|Adverse Event|0|||
146970056|NCT01071083|530050779|FG002|Overall Study|Adverse Event|1|||
146902644|NCT01642212|529805202|FG001|Open-label Extension|Other|0|||
146902645|NCT01642212|529805203|FG002|Open-label Extension|Other|0|||
146767395|NCT02974634|529317299|FG000|Overall Study|Death|8|||
146767396|NCT02974634|529317300|FG001|Overall Study|Death|11|||
146767397|NCT04860258|529317303|FG000|Overall Study|Withdrawal by Subject|0|||
146902646|NCT01642212|529805204|FG003|Open-label Extension|Other|0|||
146902647|NCT01642212|529805205|FG004|Open-label Extension|Other|1|||
146902648|NCT00981526|529805206|FG000|Overall Study|Withdrawal by Subject|0|||
146902649|NCT00981526|529805207|FG001|Overall Study|Withdrawal by Subject|2|||
146902650|NCT00981526|529805206|FG000|Overall Study|Physician Decision|4|||
146902651|NCT00981526|529805207|FG001|Overall Study|Physician Decision|4|||
146902652|NCT01243268|529805208|FG000|Overall Study|Lost to Follow-up|4|||
146902653|NCT01243268|529805208|FG000|Overall Study|Protocol Violation|51|||
146902654|NCT01243268|529805208|FG000|Overall Study|Deviation with contract date|7|||
146902655|NCT01243268|529805208|FG000|Overall Study|Duplicate subject|2|||
146902656|NCT01564784|529805209|FG000|Overall Study|Other|1|||
146902657|NCT01564784|529805210|FG001|Overall Study|Other|0|||
146902658|NCT01564784|529805209|FG000|Overall Study|Subject refused further follow-up|1|||
146902659|NCT01564784|529805210|FG001|Overall Study|Subject refused further follow-up|6|||
146902660|NCT01564784|529805209|FG000|Overall Study|Lost to Follow-up|1|||
146902661|NCT01564784|529805210|FG001|Overall Study|Lost to Follow-up|1|||
146902662|NCT01564784|529805209|FG000|Overall Study|Death|131|||
146902663|NCT01564784|529805210|FG001|Overall Study|Death|126|||
146902664|NCT02272790|529805211|FG000|Overall Study|Physician Decision|0|||
146902665|NCT02272790|529805212|FG001|Overall Study|Physician Decision|1|||
146902666|NCT02272790|529805213|FG002|Overall Study|Physician Decision|0|||
146902667|NCT02272790|529805214|FG003|Overall Study|Physician Decision|0|||
146902668|NCT02272790|529805215|FG004|Overall Study|Physician Decision|0|||
146902669|NCT02272790|529805216|FG005|Overall Study|Physician Decision|0|||
146902670|NCT00332202|529805217|FG000|Overall Study|Adverse Event|72|||
146902671|NCT00332202|529805218|FG001|Overall Study|Adverse Event|28|||
146902672|NCT00332202|529805217|FG000|Overall Study|Lost to Follow-up|2|||
146902673|NCT00332202|529805218|FG001|Overall Study|Lost to Follow-up|1|||
146902674|NCT00332202|529805217|FG000|Overall Study|Physician Decision|6|||
146902675|NCT00332202|529805218|FG001|Overall Study|Physician Decision|8|||
146902676|NCT00332202|529805217|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
146902677|NCT00332202|529805218|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
146902678|NCT00332202|529805217|FG000|Overall Study|Protocol Violation|7|||
146902679|NCT00332202|529805218|FG001|Overall Study|Protocol Violation|2|||
146902680|NCT00332202|529805217|FG000|Overall Study|Sponsor Decision|1|||
146902681|NCT00332202|529805218|FG001|Overall Study|Sponsor Decision|2|||
146767398|NCT04860258|529317304|FG001|Overall Study|Withdrawal by Subject|0|||
146767399|NCT04860258|529317305|FG002|Overall Study|Withdrawal by Subject|4|||
146902682|NCT00332202|529805217|FG000|Overall Study|Withdrawal by Subject|36|||
146902683|NCT00332202|529805218|FG001|Overall Study|Withdrawal by Subject|17|||
146902684|NCT00332202|529805217|FG000|Overall Study|Progressive Disease|106|||
146767400|NCT04860258|529317306|FG003|Overall Study|Withdrawal by Subject|1|||
146902685|NCT00332202|529805218|FG001|Overall Study|Progressive Disease|60|||
146902686|NCT00332202|529805217|FG000|Overall Study|Death|5|||
146902687|NCT00332202|529805218|FG001|Overall Study|Death|2|||
146902688|NCT05202808|529805221|FG000|Overall Study|Lost to Follow-up|3|||
146902689|NCT05202808|529805222|FG001|Overall Study|Lost to Follow-up|1|||
146902690|NCT04091217|529805223|FG000|Overall Study|Lost to Follow-up|2|||
146902691|NCT00100048|529805224|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
146902692|NCT00100048|529805225|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
146902693|NCT00100048|529805226|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
146902694|NCT00100048|529805227|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
146902695|NCT00100048|529805228|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
146902696|NCT00100048|529805229|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
146902697|NCT00100048|529805224|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
146902698|NCT00100048|529805225|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
146902699|NCT00100048|529805226|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
146902700|NCT00100048|529805227|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
146902701|NCT00100048|529805228|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
146902702|NCT00100048|529805229|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
146902703|NCT00100048|529805224|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
146902704|NCT00100048|529805225|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
146902705|NCT00100048|529805226|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
146902706|NCT00100048|529805227|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
146902707|NCT00100048|529805228|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
146902708|NCT00100048|529805229|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
146902709|NCT00100048|529805224|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
146902710|NCT00100048|529805225|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
146902711|NCT00100048|529805226|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
146902712|NCT00100048|529805227|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
146902713|NCT00100048|529805228|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
146902714|NCT00100048|529805229|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
146902715|NCT00100048|529805224|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
146902716|NCT00100048|529805225|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
146902717|NCT00100048|529805226|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
146902718|NCT00100048|529805227|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
146902719|NCT00100048|529805228|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
146902720|NCT00100048|529805229|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
146902721|NCT00100048|529805224|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
146902722|NCT00100048|529805225|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
146902723|NCT00100048|529805226|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
146902724|NCT00100048|529805227|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
146902725|NCT00100048|529805228|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
146902726|NCT00100048|529805229|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
146902727|NCT00100048|529805224|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
146902728|NCT00100048|529805225|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
146902729|NCT00100048|529805226|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
146902730|NCT00100048|529805227|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
146902731|NCT00100048|529805228|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
146902732|NCT00100048|529805229|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
146902733|NCT00100048|529805224|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
146902734|NCT00100048|529805225|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
146902735|NCT00100048|529805226|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
146902736|NCT00100048|529805227|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
146902737|NCT00100048|529805228|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
146970057|NCT01071083|530050780|FG003|Overall Study|Adverse Event|0|||
146640730|NCT01175083|528860911|FG004|Booster Epoch|Withdrawal by Subject|0|||
146914684|NCT03303339|529850045|FG003|Overall Study|Safety/Non-compliance|0|||
146902738|NCT00100048|529805229|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
146902739|NCT01822561|529805232|FG000|Overall Study|Withdrawal by Subject|2|||
146902740|NCT02747004|529805233|FG000|Overall Study|Withdrawal by Subject|8|||
146902741|NCT02747004|529805234|FG001|Overall Study|Withdrawal by Subject|5|||
146902742|NCT02747004|529805235|FG002|Overall Study|Withdrawal by Subject|4|||
146902743|NCT02747004|529805233|FG000|Overall Study|Lost to Follow-up|1|||
146902744|NCT02747004|529805234|FG001|Overall Study|Lost to Follow-up|2|||
146560414|NCT00086515|528562108|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
146560415|NCT00086515|528562109|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
146560416|NCT00086515|528562108|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
146560417|NCT00086515|528562109|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
146560418|NCT00086515|528562108|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
146560419|NCT00086515|528562109|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
146560420|NCT00086515|528562108|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
146560421|NCT00086515|528562109|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
146560422|NCT00086515|528562108|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
146560423|NCT00086515|528562109|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
146560424|NCT00086515|528562108|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
146902745|NCT02747004|529805235|FG002|Overall Study|Lost to Follow-up|2|||
146902746|NCT02747004|529805233|FG000|Overall Study|on study treatment/follow-up|48|||
146970058|NCT01071083|530050781|FG004|Overall Study|Adverse Event|1|||
146902747|NCT02747004|529805234|FG001|Overall Study|on study treatment/follow-up|42|||
146902748|NCT02747004|529805235|FG002|Overall Study|on study treatment/follow-up|41|||
146560425|NCT00086515|528562109|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
146560426|NCT00086515|528562108|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
146640731|NCT01175083|528860912|FG005|Booster Epoch|Withdrawal by Subject|0|||
146640732|NCT04027608|528860913|FG000|Overall Study|Withdrawal by Subject|13|||
146640733|NCT04027608|528860914|FG001|Overall Study|Withdrawal by Subject|2|||
146902749|NCT05087030|529805236|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
146902750|NCT05087030|529805237|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
146902751|NCT05087030|529805238|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
146902752|NCT05087030|529805239|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
146902753|NCT05087030|529805240|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
146560427|NCT00086515|528562109|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
146767401|NCT04860258|529317307|FG004|Overall Study|Withdrawal by Subject|4|||
146970059|NCT01071083|530050777|FG000|Overall Study|Withdrawal by Subject|3|||
146970060|NCT01071083|530050778|FG001|Overall Study|Withdrawal by Subject|0|||
146970061|NCT01071083|530050779|FG002|Overall Study|Withdrawal by Subject|2|||
146970062|NCT01071083|530050780|FG003|Overall Study|Withdrawal by Subject|0|||
146970063|NCT01071083|530050781|FG004|Overall Study|Withdrawal by Subject|3|||
146970064|NCT01071083|530050777|FG000|Overall Study|Physician Decision|1|||
146970065|NCT01071083|530050778|FG001|Overall Study|Physician Decision|0|||
146560428|NCT00086515|528562108|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
146560429|NCT00086515|528562109|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
146560430|NCT00086515|528562108|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
146560431|NCT00086515|528562109|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
146560432|NCT00086515|528562108|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
146560433|NCT00086515|528562109|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
146560434|NCT00086515|528562108|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
146970066|NCT01071083|530050779|FG002|Overall Study|Physician Decision|0|||
146970067|NCT01071083|530050780|FG003|Overall Study|Physician Decision|1|||
146902754|NCT05087030|529805236|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
146902755|NCT05087030|529805237|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
146902756|NCT05087030|529805238|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
146902757|NCT05087030|529805239|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
146560435|NCT00086515|528562109|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
146560436|NCT00086515|528562108|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
146560437|NCT00086515|528562109|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
146560438|NCT00086515|528562108|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
146560439|NCT00086515|528562109|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
146560440|NCT03485157|528562110|FG000|Double Blind Phase|Lost to Follow-up|4|||
146970068|NCT01071083|530050781|FG004|Overall Study|Physician Decision|1|||
146560441|NCT03485157|528562111|FG001|Double Blind Phase|Lost to Follow-up|4|||
146970069|NCT01071083|530050777|FG000|Overall Study|Early Rescue|1|||
146560442|NCT03485157|528562110|FG000|Double Blind Phase|Adverse Event|2|||
146560443|NCT03485157|528562111|FG001|Double Blind Phase|Adverse Event|1|||
146560444|NCT03485157|528562110|FG000|Double Blind Phase|Withdrawal by Subject|6|||
146560445|NCT03485157|528562111|FG001|Double Blind Phase|Withdrawal by Subject|9|||
146560446|NCT03485157|528562110|FG000|Double Blind Phase|Removal by PI|3|||
146560447|NCT03485157|528562111|FG001|Double Blind Phase|Removal by PI|7|||
146560448|NCT03485157|528562110|FG000|Open Label Phase|Lost to Follow-up|1|||
146560449|NCT03485157|528562111|FG001|Open Label Phase|Lost to Follow-up|2|||
146560450|NCT03485157|528562110|FG000|Open Label Phase|Adverse Event|0|||
146560451|NCT03485157|528562111|FG001|Open Label Phase|Adverse Event|1|||
146560452|NCT03485157|528562110|FG000|Open Label Phase|Withdrawal by Subject|1|||
146560453|NCT03485157|528562111|FG001|Open Label Phase|Withdrawal by Subject|2|||
146560454|NCT03485157|528562110|FG000|Open Label Phase|Removal by PI|2|||
146560455|NCT03485157|528562111|FG001|Open Label Phase|Removal by PI|0|||
146560456|NCT01849276|528562112|FG000|Followed for Survival for 5 Years|Death|1|||
146560457|NCT01849276|528562112|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
146560458|NCT00539500|528562113|FG000|Overall Study|Disease Progression|1|||
146560459|NCT00539500|528562113|FG000|Overall Study|Lost to Follow-up|2|||
146560460|NCT00980798|528562115|FG000|Overall Study|Adverse Event|7|||
146560461|NCT00980798|528562116|FG001|Overall Study|Adverse Event|36|||
146902758|NCT05087030|529805240|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
146902759|NCT05087030|529805236|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
146902760|NCT05087030|529805237|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
146902761|NCT05087030|529805238|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
146902762|NCT05087030|529805239|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
146902763|NCT05087030|529805240|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
146560462|NCT00980798|528562115|FG000|Overall Study|Lack of Efficacy|16|||
146560463|NCT00980798|528562116|FG001|Overall Study|Lack of Efficacy|5|||
146560464|NCT00980798|528562115|FG000|Overall Study|Lost to Follow-up|0|||
146560465|NCT00980798|528562116|FG001|Overall Study|Lost to Follow-up|1|||
146640734|NCT04027608|528860913|FG000|Overall Study|Protocol Violation|2|||
146640735|NCT04027608|528860914|FG001|Overall Study|Protocol Violation|1|||
146970070|NCT01071083|530050778|FG001|Overall Study|Early Rescue|0|||
146560466|NCT00980798|528562115|FG000|Overall Study|Physician Decision|2|||
146560467|NCT00980798|528562116|FG001|Overall Study|Physician Decision|1|||
146560468|NCT00980798|528562115|FG000|Overall Study|Withdrawal by Subject|8|||
146560469|NCT00980798|528562116|FG001|Overall Study|Withdrawal by Subject|11|||
146560470|NCT00980798|528562115|FG000|Overall Study|Other|0|||
146560471|NCT00980798|528562116|FG001|Overall Study|Other|1|||
146560472|NCT05081843|528562117|FG000|Overall Study|Lost to Follow-up|135|||
146560473|NCT05081843|528562118|FG001|Overall Study|Lost to Follow-up|145|||
146560474|NCT02402647|528562119|FG000|Overall Study|Lost to Follow-up|13|||
146560475|NCT02402647|528562120|FG001|Overall Study|Lost to Follow-up|7|||
146560476|NCT02402647|528562119|FG000|Overall Study|Protocol Violation|1|||
146560477|NCT02402647|528562120|FG001|Overall Study|Protocol Violation|1|||
146560478|NCT02402647|528562119|FG000|Overall Study|scheduled and timed out|2|||
146560479|NCT02402647|528562120|FG001|Overall Study|scheduled and timed out|1|||
146560480|NCT02402647|528562119|FG000|Overall Study|medical illness|2|||
146560481|NCT02402647|528562120|FG001|Overall Study|medical illness|4|||
146560482|NCT02402647|528562119|FG000|Overall Study|Moved|2|||
146560483|NCT02402647|528562120|FG001|Overall Study|Moved|0|||
146640736|NCT04027608|528860913|FG000|Overall Study|Physician Decision|1|||
146640737|NCT04027608|528860914|FG001|Overall Study|Physician Decision|0|||
146640738|NCT04027608|528860913|FG000|Overall Study|Lost to Follow-up|20|||
146640739|NCT04027608|528860914|FG001|Overall Study|Lost to Follow-up|4|||
146640740|NCT04364984|528860921|FG000|Overall Study|Death|2|||
146640741|NCT04364984|528860922|FG001|Overall Study|Death|2|||
146640742|NCT04364984|528860923|FG002|Overall Study|Death|0|||
146640743|NCT01349959|528860924|FG000|Overall Study|Adverse Event|7|||
146640744|NCT02675634|528860925|FG000|Test Period 1|Adverse Event|0|||
146640745|NCT02675634|528860926|FG001|Test Period 1|Adverse Event|1|||
146640746|NCT02675634|528860927|FG002|Test Period 1|Adverse Event|0|||
146640747|NCT02675634|528860928|FG003|Test Period 1|Adverse Event|1|||
146640748|NCT02675634|528860929|FG004|Test Period 1|Adverse Event|0|||
146640749|NCT02675634|528860930|FG005|Test Period 1|Adverse Event|0|||
146640750|NCT02675634|528860925|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
146640751|NCT02675634|528860926|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
146640752|NCT02675634|528860927|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
146640753|NCT02675634|528860928|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
146640754|NCT02675634|528860929|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
146640755|NCT02675634|528860930|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
146640756|NCT02675634|528860925|FG000|Test Period 2|Lack of Efficacy|1|||
146640757|NCT02675634|528860926|FG001|Test Period 2|Lack of Efficacy|0|||
146640758|NCT02675634|528860927|FG002|Test Period 2|Lack of Efficacy|0|||
146640759|NCT02675634|528860928|FG003|Test Period 2|Lack of Efficacy|0|||
146640760|NCT02675634|528860929|FG004|Test Period 2|Lack of Efficacy|0|||
146640761|NCT02675634|528860930|FG005|Test Period 2|Lack of Efficacy|0|||
146640762|NCT02675634|528860925|FG000|Test Period 2|Adverse Event|0|||
146640763|NCT02675634|528860926|FG001|Test Period 2|Adverse Event|0|||
146640764|NCT02675634|528860927|FG002|Test Period 2|Adverse Event|0|||
146640765|NCT02675634|528860928|FG003|Test Period 2|Adverse Event|0|||
146640766|NCT02675634|528860929|FG004|Test Period 2|Adverse Event|0|||
146640767|NCT02675634|528860930|FG005|Test Period 2|Adverse Event|1|||
146640768|NCT01941186|528860931|FG000|Follow-up|Lost to Follow-up|1|||
146640769|NCT01941186|528860932|FG001|Follow-up|Lost to Follow-up|0|||
146560484|NCT02402647|528562119|FG000|Overall Study|loved one illness|1|||
146560485|NCT02402647|528562120|FG001|Overall Study|loved one illness|0|||
146560486|NCT02402647|528562119|FG000|Overall Study|deceased preexisting condition|2|||
146560487|NCT02402647|528562120|FG001|Overall Study|deceased preexisting condition|0|||
146560488|NCT02402647|528562119|FG000|Overall Study|Other|2|||
146560489|NCT02402647|528562120|FG001|Overall Study|Other|1|||
146560490|NCT03211416|528562121|FG000|Overall Study|Adverse Event|7|||
146560491|NCT03211416|528562121|FG000|Overall Study|Lack of Efficacy|2|||
146560492|NCT03211416|528562121|FG000|Overall Study|Physician Decision|1|||
146560493|NCT03709472|528562125|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
146560494|NCT03709472|528562126|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
146560495|NCT03709472|528562125|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
146560496|NCT03709472|528562126|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
146560497|NCT03559556|528562127|FG000|Overall Study|Withdrawal by Subject|1|||
146560498|NCT01969058|528562131|FG000|Overall Study|Withdrawal by Subject|2|||
146560499|NCT01969058|528562132|FG001|Overall Study|Withdrawal by Subject|0|||
146560500|NCT01969058|528562131|FG000|Overall Study|Adverse Event|1|||
146560501|NCT01969058|528562132|FG001|Overall Study|Adverse Event|0|||
146560502|NCT02038036|528562137|FG000|Core Study|Adverse Event|7|||
146560503|NCT02038036|528562138|FG001|Core Study|Adverse Event|7|||
146560504|NCT02038036|528562137|FG000|Core Study|Death|1|||
146560505|NCT02038036|528562138|FG001|Core Study|Death|1|||
146560506|NCT02038036|528562137|FG000|Core Study|Disease progression|2|||
146560507|NCT02038036|528562138|FG001|Core Study|Disease progression|2|||
146560508|NCT02038036|528562137|FG000|Core Study|Lost to Follow-up|0|||
146560509|NCT02038036|528562138|FG001|Core Study|Lost to Follow-up|1|||
146560510|NCT02038036|528562137|FG000|Core Study|Physician Decision|2|||
146560511|NCT02038036|528562138|FG001|Core Study|Physician Decision|1|||
146560512|NCT02038036|528562137|FG000|Core Study|Subject/guardian decision|0|||
146560513|NCT02038036|528562138|FG001|Core Study|Subject/guardian decision|1|||
146560514|NCT02038036|528562137|FG000|Core Study|Withdrawal by Subject|3|||
146560515|NCT02038036|528562138|FG001|Core Study|Withdrawal by Subject|1|||
146560516|NCT02038036|528562137|FG000|Crossover Period|Withdrawal by Subject|0|||
146560517|NCT02038036|528562138|FG001|Crossover Period|Withdrawal by Subject|3|||
146560518|NCT02038036|528562137|FG000|Crossover Period|Adverse Event|0|||
146560519|NCT02038036|528562138|FG001|Crossover Period|Adverse Event|9|||
146560520|NCT02038036|528562137|FG000|Crossover Period|Death|0|||
146560521|NCT02038036|528562138|FG001|Crossover Period|Death|2|||
146560522|NCT02038036|528562137|FG000|Crossover Period|Disease progression|0|||
146560523|NCT02038036|528562138|FG001|Crossover Period|Disease progression|3|||
146560524|NCT02038036|528562137|FG000|Crossover Period|Lost to Follow-up|0|||
146560525|NCT02038036|528562138|FG001|Crossover Period|Lost to Follow-up|1|||
146560526|NCT02038036|528562137|FG000|Crossover Period|Physician Decision|0|||
146560527|NCT02038036|528562138|FG001|Crossover Period|Physician Decision|2|||
146560528|NCT00964678|528562146|FG000|Overall Study|Physician Decision|4|||
146560529|NCT03359395|528562147|FG000|First Intervention A / B|Withdrawal by Subject|1|||
146560530|NCT03359395|528562148|FG001|First Intervention A / B|Withdrawal by Subject|0|||
146560531|NCT03359395|528562147|FG000|First Intervention A / B|Lost to Follow-up|2|||
146560532|NCT03359395|528562148|FG001|First Intervention A / B|Lost to Follow-up|3|||
146560533|NCT03359395|528562147|FG000|Second Intervention B/A|Exclusion criteria|0|||
146560534|NCT03359395|528562148|FG001|Second Intervention B/A|Exclusion criteria|1|||
146560535|NCT03359395|528562147|FG000|Second Intervention B/A|Lost to Follow-up|3|||
146560536|NCT03359395|528562148|FG001|Second Intervention B/A|Lost to Follow-up|2|||
146560537|NCT03243084|528563972|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
146560538|NCT03243084|528563973|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
146560539|NCT00863304|528563978|FG000|Overall Study|Adverse Event|10|||
146560540|NCT00863304|528563979|FG001|Overall Study|Adverse Event|4|||
146560541|NCT00863304|528563980|FG002|Overall Study|Adverse Event|14|||
146560542|NCT00863304|528563981|FG003|Overall Study|Adverse Event|16|||
146970071|NCT01071083|530050779|FG002|Overall Study|Early Rescue|0|||
146902764|NCT05087030|529805236|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
146902765|NCT05087030|529805237|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
146902766|NCT05087030|529805238|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
146902767|NCT05087030|529805239|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
146902768|NCT05087030|529805240|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
146902769|NCT05087030|529805236|FG000|Main Period (Week 0 to Week 52)|Death|0|||
146970072|NCT01071083|530050780|FG003|Overall Study|Early Rescue|0|||
146560543|NCT00863304|528563978|FG000|Overall Study|Lost to Follow-up|1|||
146970073|NCT01071083|530050781|FG004|Overall Study|Early Rescue|1|||
146970074|NCT01071083|530050777|FG000|Overall Study|Subject Moved|0|||
146970075|NCT01071083|530050778|FG001|Overall Study|Subject Moved|1|||
146970076|NCT01071083|530050779|FG002|Overall Study|Subject Moved|0|||
146970077|NCT01071083|530050780|FG003|Overall Study|Subject Moved|0|||
146970078|NCT01071083|530050781|FG004|Overall Study|Subject Moved|0|||
146970079|NCT01071083|530050777|FG000|Overall Study|Images Not Usable (Motion)|0|||
146560544|NCT00863304|528563979|FG001|Overall Study|Lost to Follow-up|5|||
146560545|NCT00863304|528563980|FG002|Overall Study|Lost to Follow-up|4|||
146560546|NCT00863304|528563981|FG003|Overall Study|Lost to Follow-up|2|||
146902770|NCT05087030|529805237|FG001|Main Period (Week 0 to Week 52)|Death|1|||
146902771|NCT05087030|529805238|FG002|Main Period (Week 0 to Week 52)|Death|0|||
146640770|NCT02105961|528860933|FG000|Overall Study|Adverse Event|18|||
146640771|NCT02105961|528860934|FG001|Overall Study|Adverse Event|7|||
146902772|NCT05087030|529805239|FG003|Main Period (Week 0 to Week 52)|Death|0|||
146902773|NCT05087030|529805240|FG004|Main Period (Week 0 to Week 52)|Death|0|||
146902774|NCT05087030|529805236|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
146902775|NCT05087030|529805237|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
146902776|NCT05087030|529805238|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
146902777|NCT05087030|529805239|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
146640772|NCT02105961|528860935|FG002|Overall Study|Adverse Event|13|||
146560547|NCT00863304|528563978|FG000|Overall Study|Lack of Efficacy|57|||
146902778|NCT05087030|529805240|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
146902779|NCT05087030|529805236|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
146560548|NCT00863304|528563979|FG001|Overall Study|Lack of Efficacy|26|||
146560549|NCT00863304|528563980|FG002|Overall Study|Lack of Efficacy|30|||
146560550|NCT00863304|528563981|FG003|Overall Study|Lack of Efficacy|28|||
146560551|NCT00863304|528563978|FG000|Overall Study|Withdrawal by Subject|19|||
146560552|NCT00863304|528563979|FG001|Overall Study|Withdrawal by Subject|14|||
146560553|NCT00863304|528563980|FG002|Overall Study|Withdrawal by Subject|20|||
146560554|NCT00863304|528563981|FG003|Overall Study|Withdrawal by Subject|18|||
146560555|NCT00863304|528563978|FG000|Overall Study|Other|1|||
146560556|NCT00863304|528563979|FG001|Overall Study|Other|0|||
146560557|NCT00863304|528563980|FG002|Overall Study|Other|0|||
146560558|NCT00863304|528563981|FG003|Overall Study|Other|1|||
146560559|NCT00863304|528563978|FG000|Overall Study|Protocol Violation|2|||
146560560|NCT00863304|528563979|FG001|Overall Study|Protocol Violation|6|||
146560561|NCT00863304|528563980|FG002|Overall Study|Protocol Violation|2|||
146560562|NCT00863304|528563981|FG003|Overall Study|Protocol Violation|0|||
146560563|NCT00863304|528563978|FG000|Overall Study|Randomized, but not Treated|3|||
146560564|NCT00863304|528563979|FG001|Overall Study|Randomized, but not Treated|1|||
146560565|NCT00863304|528563980|FG002|Overall Study|Randomized, but not Treated|4|||
146560566|NCT00863304|528563981|FG003|Overall Study|Randomized, but not Treated|1|||
146560567|NCT00863304|528563978|FG000|Overall Study|Entered extension study|101|||
146560568|NCT00863304|528563979|FG001|Overall Study|Entered extension study|129|||
146560569|NCT00863304|528563980|FG002|Overall Study|Entered extension study|113|||
146560570|NCT00863304|528563981|FG003|Overall Study|Entered extension study|125|||
146560571|NCT02327169|528563982|FG000|Overall Study|Progressive Disease|1|||
146560572|NCT02327169|528563983|FG001|Overall Study|Progressive Disease|3|||
146560573|NCT02327169|528563984|FG002|Overall Study|Progressive Disease|4|||
146560574|NCT02327169|528563985|FG003|Overall Study|Progressive Disease|3|||
146560575|NCT02327169|528563986|FG004|Overall Study|Progressive Disease|4|||
146560576|NCT02327169|528563987|FG005|Overall Study|Progressive Disease|3|||
146560577|NCT02327169|528563988|FG006|Overall Study|Progressive Disease|3|||
146560578|NCT02327169|528563989|FG007|Overall Study|Progressive Disease|3|||
146560579|NCT02327169|528563990|FG008|Overall Study|Progressive Disease|4|||
146560580|NCT02327169|528563991|FG009|Overall Study|Progressive Disease|4|||
146560581|NCT02327169|528563992|FG010|Overall Study|Progressive Disease|4|||
146560582|NCT02327169|528563993|FG011|Overall Study|Progressive Disease|3|||
146560583|NCT02327169|528563994|FG012|Overall Study|Progressive Disease|1|||
146560584|NCT02327169|528563995|FG013|Overall Study|Progressive Disease|3|||
146560585|NCT02327169|528563996|FG014|Overall Study|Progressive Disease|3|||
146560586|NCT02327169|528563982|FG000|Overall Study|Adverse Event|2|||
146560587|NCT02327169|528563983|FG001|Overall Study|Adverse Event|0|||
146560588|NCT02327169|528563984|FG002|Overall Study|Adverse Event|1|||
146560589|NCT02327169|528563985|FG003|Overall Study|Adverse Event|0|||
146560590|NCT02327169|528563986|FG004|Overall Study|Adverse Event|1|||
146560591|NCT02327169|528563987|FG005|Overall Study|Adverse Event|0|||
146560592|NCT02327169|528563988|FG006|Overall Study|Adverse Event|0|||
146560593|NCT02327169|528563989|FG007|Overall Study|Adverse Event|0|||
146560594|NCT02327169|528563990|FG008|Overall Study|Adverse Event|0|||
146560595|NCT02327169|528563991|FG009|Overall Study|Adverse Event|2|||
146560596|NCT02327169|528563992|FG010|Overall Study|Adverse Event|0|||
146560597|NCT02327169|528563993|FG011|Overall Study|Adverse Event|3|||
146560598|NCT02327169|528563994|FG012|Overall Study|Adverse Event|0|||
146560599|NCT02327169|528563995|FG013|Overall Study|Adverse Event|2|||
146560600|NCT02327169|528563996|FG014|Overall Study|Adverse Event|1|||
146560601|NCT02327169|528563982|FG000|Overall Study|Symptomatic Deterioration|0|||
146560602|NCT02327169|528563983|FG001|Overall Study|Symptomatic Deterioration|0|||
146560603|NCT02327169|528563984|FG002|Overall Study|Symptomatic Deterioration|1|||
146560604|NCT02327169|528563985|FG003|Overall Study|Symptomatic Deterioration|0|||
146560605|NCT02327169|528563986|FG004|Overall Study|Symptomatic Deterioration|1|||
146560606|NCT02327169|528563987|FG005|Overall Study|Symptomatic Deterioration|1|||
146560607|NCT02327169|528563988|FG006|Overall Study|Symptomatic Deterioration|0|||
146560608|NCT02327169|528563989|FG007|Overall Study|Symptomatic Deterioration|0|||
146560609|NCT02327169|528563990|FG008|Overall Study|Symptomatic Deterioration|2|||
146560610|NCT02327169|528563991|FG009|Overall Study|Symptomatic Deterioration|1|||
146640773|NCT02105961|528860933|FG000|Overall Study|Lack of Efficacy|3|||
146640774|NCT02105961|528860934|FG001|Overall Study|Lack of Efficacy|0|||
146640775|NCT02105961|528860935|FG002|Overall Study|Lack of Efficacy|3|||
146640776|NCT02105961|528860933|FG000|Overall Study|Lost to Follow-up|2|||
146640777|NCT02105961|528860934|FG001|Overall Study|Lost to Follow-up|0|||
146640778|NCT02105961|528860935|FG002|Overall Study|Lost to Follow-up|1|||
146640779|NCT02105961|528860933|FG000|Overall Study|Physician Decision|3|||
146640780|NCT02105961|528860934|FG001|Overall Study|Physician Decision|3|||
146640781|NCT02105961|528860935|FG002|Overall Study|Physician Decision|2|||
146640782|NCT02105961|528860933|FG000|Overall Study|Withdrawal by Subject|15|||
146640783|NCT02105961|528860934|FG001|Overall Study|Withdrawal by Subject|7|||
146560611|NCT02327169|528563992|FG010|Overall Study|Symptomatic Deterioration|0|||
146560612|NCT02327169|528563993|FG011|Overall Study|Symptomatic Deterioration|0|||
146560613|NCT02327169|528563994|FG012|Overall Study|Symptomatic Deterioration|0|||
146560614|NCT02327169|528563995|FG013|Overall Study|Symptomatic Deterioration|2|||
146560615|NCT02327169|528563996|FG014|Overall Study|Symptomatic Deterioration|1|||
146560616|NCT02327169|528563982|FG000|Overall Study|Reason Not Specified|0|||
146560617|NCT02327169|528563983|FG001|Overall Study|Reason Not Specified|0|||
146560618|NCT02327169|528563984|FG002|Overall Study|Reason Not Specified|1|||
146560619|NCT02327169|528563985|FG003|Overall Study|Reason Not Specified|0|||
146560620|NCT02327169|528563986|FG004|Overall Study|Reason Not Specified|0|||
146560621|NCT02327169|528563987|FG005|Overall Study|Reason Not Specified|0|||
146560622|NCT02327169|528563988|FG006|Overall Study|Reason Not Specified|0|||
146560623|NCT02327169|528563989|FG007|Overall Study|Reason Not Specified|0|||
146560624|NCT02327169|528563990|FG008|Overall Study|Reason Not Specified|0|||
146560625|NCT02327169|528563991|FG009|Overall Study|Reason Not Specified|1|||
146560626|NCT02327169|528563992|FG010|Overall Study|Reason Not Specified|2|||
146560627|NCT02327169|528563993|FG011|Overall Study|Reason Not Specified|1|||
146560628|NCT02327169|528563994|FG012|Overall Study|Reason Not Specified|0|||
146560629|NCT02327169|528563995|FG013|Overall Study|Reason Not Specified|0|||
146767402|NCT04860258|529317308|FG005|Overall Study|Withdrawal by Subject|1|||
146560630|NCT02327169|528563996|FG014|Overall Study|Reason Not Specified|2|||
146902780|NCT05087030|529805237|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
146902781|NCT05087030|529805238|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
146902782|NCT05087030|529805239|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
146902783|NCT05087030|529805240|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
146902784|NCT05087030|529805236|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
146902785|NCT05087030|529805237|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
146902786|NCT05087030|529805238|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
146902787|NCT05087030|529805239|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
146902788|NCT05087030|529805240|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
146902789|NCT05087030|529805236|FG000|Main Period (Week 0 to Week 52)|Other|1|||
146902790|NCT05087030|529805237|FG001|Main Period (Week 0 to Week 52)|Other|2|||
146902791|NCT05087030|529805238|FG002|Main Period (Week 0 to Week 52)|Other|0|||
146902792|NCT05087030|529805239|FG003|Main Period (Week 0 to Week 52)|Other|0|||
146902793|NCT05087030|529805240|FG004|Main Period (Week 0 to Week 52)|Other|0|||
146902794|NCT05087030|529805236|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
146902795|NCT05087030|529805237|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
146902796|NCT05087030|529805238|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
146902797|NCT05087030|529805239|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
146902798|NCT05087030|529805240|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
146902799|NCT02722044|529805241|FG000|Overall Study|Adverse Event|2|||
146902800|NCT02722044|529805241|FG000|Overall Study|Physician Decision|1|||
146767403|NCT04860258|529317309|FG006|Overall Study|Withdrawal by Subject|0|||
146902801|NCT02722044|529805241|FG000|Overall Study|Withdrawal by Subject|1|||
146560631|NCT02327169|528563982|FG000|Overall Study|Withdrawal by Subject|1|||
146560632|NCT02327169|528563983|FG001|Overall Study|Withdrawal by Subject|0|||
146560633|NCT02327169|528563984|FG002|Overall Study|Withdrawal by Subject|0|||
146560634|NCT02327169|528563985|FG003|Overall Study|Withdrawal by Subject|0|||
146560635|NCT02327169|528563986|FG004|Overall Study|Withdrawal by Subject|1|||
146560636|NCT02327169|528563987|FG005|Overall Study|Withdrawal by Subject|0|||
146560637|NCT02327169|528563988|FG006|Overall Study|Withdrawal by Subject|0|||
146902802|NCT02722044|529805241|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
146902803|NCT03372941|529805245|FG000|Overall Study|Lost to Follow-up|2|||
146902804|NCT03372941|529805246|FG001|Overall Study|Lost to Follow-up|4|||
146902805|NCT00741819|529805247|FG000|Overall Study|Adverse Event|3|||
146767404|NCT02496702|529317310|FG000|Overall Study|Lost to Follow-up|8|||
146767405|NCT02496702|529317311|FG001|Overall Study|Lost to Follow-up|6|||
146902806|NCT00741819|529805247|FG000|Overall Study|Withdrawal by Subject|3|||
146902807|NCT00741819|529805247|FG000|Overall Study|Death|1|||
146902808|NCT00741819|529805247|FG000|Overall Study|Disease progression|1|||
146902809|NCT00609622|529805250|FG000|Overall Study|Adverse Event|14|||
146902810|NCT00609622|529805251|FG001|Overall Study|Adverse Event|10|||
146902811|NCT00609622|529805250|FG000|Overall Study|Withdrawal by Subject|4|||
146902812|NCT00609622|529805251|FG001|Overall Study|Withdrawal by Subject|20|||
146902813|NCT00609622|529805250|FG000|Overall Study|Death|1|||
146902814|NCT00609622|529805251|FG001|Overall Study|Death|4|||
146902815|NCT00609622|529805250|FG000|Overall Study|Protocol Violation|1|||
146902816|NCT00609622|529805251|FG001|Overall Study|Protocol Violation|1|||
146902817|NCT00609622|529805250|FG000|Overall Study|Objective progression or relapse|47|||
146902818|NCT00609622|529805251|FG001|Overall Study|Objective progression or relapse|41|||
146902819|NCT00609622|529805250|FG000|Overall Study|Study terminated by sponsor|16|||
146902820|NCT00609622|529805251|FG001|Overall Study|Study terminated by sponsor|3|||
146902821|NCT00609622|529805250|FG000|Overall Study|Other|7|||
146902822|NCT00609622|529805251|FG001|Overall Study|Other|14|||
146902823|NCT00609622|529805250|FG000|Overall Study|Global deterioration of health status|6|||
146902824|NCT00609622|529805251|FG001|Overall Study|Global deterioration of health status|2|||
146902825|NCT00752986|529805254|FG000|Overall Study|Withdrawal by Subject|2|||
146902826|NCT00752986|529805255|FG001|Overall Study|Withdrawal by Subject|1|||
146902827|NCT00752986|529805256|FG002|Overall Study|Withdrawal by Subject|2|||
146902828|NCT00752986|529805254|FG000|Overall Study|Protocol Violation|3|||
146902829|NCT00752986|529805255|FG001|Overall Study|Protocol Violation|0|||
146902830|NCT00752986|529805256|FG002|Overall Study|Protocol Violation|0|||
146902831|NCT01697345|529805260|FG000|Overall Study|Withdrawal by Subject|1|||
146902832|NCT02970929|529805261|FG000|Overall Study|Adverse Event|18|||
146902833|NCT02970929|529805261|FG000|Overall Study|Lack of Efficacy|8|||
146902834|NCT02970929|529805261|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
146902835|NCT02970929|529805261|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
146902836|NCT02970929|529805261|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
146902837|NCT02970929|529805261|FG000|Overall Study|LOST TO FOLLOWUP|6|||
146902838|NCT02970929|529805261|FG000|Overall Study|MOVED OUT OF STATE|1|||
146902839|NCT02970929|529805261|FG000|Overall Study|Withdrawal by Subject|16|||
146902840|NCT02382133|529805262|FG000|Overall Study|Death|22|||
146902841|NCT02382133|529805262|FG000|Overall Study|transfer out of ICU|4|||
146902842|NCT02382133|529805262|FG000|Overall Study|Physician Decision|2|||
146902843|NCT02382133|529805262|FG000|Overall Study|arterial catheter loss|4|||
146902844|NCT02382133|529805262|FG000|Overall Study|pressure injury both sites|1|||
146902845|NCT02370121|529805269|FG000|Overall Study|Lost to Follow-up|1|||
146902846|NCT02370121|529805270|FG001|Overall Study|Lost to Follow-up|1|||
146902847|NCT01523873|529805271|FG000|Overall Study|Protocol Violation|422|||
146902848|NCT00275561|529805274|FG000|Overall Study|Withdrawal by Subject|0|||
146902849|NCT00275561|529805275|FG001|Overall Study|Withdrawal by Subject|1|||
146970080|NCT01071083|530050778|FG001|Overall Study|Images Not Usable (Motion)|1|||
146970081|NCT01071083|530050779|FG002|Overall Study|Images Not Usable (Motion)|0|||
146970082|NCT01071083|530050780|FG003|Overall Study|Images Not Usable (Motion)|0|||
146970083|NCT01071083|530050781|FG004|Overall Study|Images Not Usable (Motion)|0|||
146970084|NCT01071083|530050777|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
146970085|NCT01071083|530050778|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
146970086|NCT01071083|530050779|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
146970087|NCT01071083|530050780|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
146970088|NCT01071083|530050781|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
146970089|NCT01071083|530050777|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
146970090|NCT01071083|530050778|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
146970091|NCT01071083|530050779|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
146970092|NCT01071083|530050780|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
146970093|NCT01071083|530050781|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
146970094|NCT01071083|530050777|FG000|Overall Study|Subject Refused to Continue|1|||
146970095|NCT01071083|530050778|FG001|Overall Study|Subject Refused to Continue|0|||
146970096|NCT01071083|530050779|FG002|Overall Study|Subject Refused to Continue|0|||
146560638|NCT02327169|528563989|FG007|Overall Study|Withdrawal by Subject|1|||
146902850|NCT00275561|529805274|FG000|Overall Study|Travel|1|||
146902851|NCT00275561|529805275|FG001|Overall Study|Travel|1|||
146560639|NCT02327169|528563990|FG008|Overall Study|Withdrawal by Subject|0|||
146560640|NCT02327169|528563991|FG009|Overall Study|Withdrawal by Subject|0|||
146902852|NCT00275561|529805274|FG000|Overall Study|Scheduling|1|||
146902853|NCT00275561|529805275|FG001|Overall Study|Scheduling|2|||
146902854|NCT00275561|529805274|FG000|Overall Study|Family Issues|0|||
146902855|NCT00275561|529805275|FG001|Overall Study|Family Issues|2|||
146902856|NCT02582658|529805280|FG000|Overall Study|Failure to Return|10|||
146902857|NCT02582658|529805280|FG000|Overall Study|Insufficient Virological Response|2|||
146902858|NCT02582658|529805280|FG000|Overall Study|Withdrawn Consent|1|||
146902859|NCT02582658|529805280|FG000|Overall Study|Death|1|||
146902860|NCT02582658|529805280|FG000|Overall Study|Not further specified|11|||
146902861|NCT00377962|529806778|FG000|Core Study: 0-12 Months|Adverse Event|18|||
146902862|NCT00377962|529806779|FG001|Core Study: 0-12 Months|Adverse Event|2|||
146902863|NCT00377962|529806778|FG000|Core Study: 0-12 Months|Death|3|||
146902864|NCT00377962|529806779|FG001|Core Study: 0-12 Months|Death|0|||
146902865|NCT00377962|529806778|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
146902866|NCT00377962|529806779|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
146902867|NCT00377962|529806778|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
146902868|NCT00377962|529806779|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
146902869|NCT00377962|529806778|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
146902870|NCT00377962|529806779|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
146902871|NCT00377962|529806778|FG000|Extension Study: 12-24 Months|Death|1|||
146902872|NCT00377962|529806779|FG001|Extension Study: 12-24 Months|Death|1|||
146970097|NCT01071083|530050780|FG003|Overall Study|Subject Refused to Continue|0|||
146902873|NCT00377962|529806778|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
146970098|NCT01071083|530050781|FG004|Overall Study|Subject Refused to Continue|0|||
146902874|NCT00377962|529806779|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
146902875|NCT00377962|529806778|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
146902876|NCT00377962|529806779|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
146902877|NCT00377962|529806778|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
146902878|NCT00377962|529806779|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
146902879|NCT00686205|529806783|FG000|Overall Study|Protocol Violation|127|||
146902880|NCT00686205|529806784|FG001|Overall Study|Protocol Violation|0|||
146902881|NCT00686205|529806783|FG000|Overall Study|Withdrawal by Subject|2|||
146902882|NCT00686205|529806784|FG001|Overall Study|Withdrawal by Subject|0|||
146902883|NCT00686205|529806783|FG000|Overall Study|Specimen handling procedure altered|5878|||
146902884|NCT00686205|529806784|FG001|Overall Study|Specimen handling procedure altered|0|||
146902885|NCT00686205|529806783|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
146902886|NCT00686205|529806784|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
146902887|NCT00265941|529806785|FG000|Overall Study|Protocol Violation|22|||
146902888|NCT00265941|529806786|FG001|Overall Study|Protocol Violation|25|||
146902889|NCT00265941|529806785|FG000|Overall Study|Lost to Follow-up|1|||
146902890|NCT00265941|529806786|FG001|Overall Study|Lost to Follow-up|1|||
146902891|NCT02966314|529806789|FG000|Overall Study|Lost to Follow-up|1|||
146902892|NCT02966314|529806790|FG001|Overall Study|Lost to Follow-up|0|||
146902893|NCT02015819|529806793|FG000|Overall Study|Rickham catheter was misaligned|0|||
146902894|NCT02015819|529806794|FG001|Overall Study|Rickham catheter was misaligned|0|||
146902895|NCT02015819|529806795|FG002|Overall Study|Rickham catheter was misaligned|0|||
146902896|NCT02015819|529806796|FG003|Overall Study|Rickham catheter was misaligned|1|||
146902897|NCT01697215|529806799|FG000|Overall Study|Physician Decision|5|||
146902898|NCT01697215|529806799|FG000|Overall Study|Malfunction|9|||
146902899|NCT01697215|529806799|FG000|Overall Study|CXR not available|9|||
146902900|NCT00466505|529806801|FG000|Overall Study|disease progression|13|||
146902901|NCT00466505|529806801|FG000|Overall Study|Adverse Event|4|||
146902902|NCT02886715|529806802|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146902903|NCT02886715|529806803|FG001|Overall Study|Non-Compliance With Study Drug|2|||
146902904|NCT02886715|529806804|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146902905|NCT02886715|529806802|FG000|Overall Study|Adverse Event|4|||
146902906|NCT02886715|529806803|FG001|Overall Study|Adverse Event|2|||
146902907|NCT02886715|529806804|FG002|Overall Study|Adverse Event|0|||
146902908|NCT02886715|529806802|FG000|Overall Study|Lack of Efficacy|0|||
146902909|NCT02886715|529806803|FG001|Overall Study|Lack of Efficacy|2|||
146902910|NCT02886715|529806804|FG002|Overall Study|Lack of Efficacy|1|||
146902911|NCT02886715|529806802|FG000|Overall Study|Lost to Follow-up|29|||
146902912|NCT02886715|529806803|FG001|Overall Study|Lost to Follow-up|26|||
146902913|NCT02886715|529806804|FG002|Overall Study|Lost to Follow-up|10|||
146902914|NCT02886715|529806802|FG000|Overall Study|Pregnancy|1|||
146902915|NCT02886715|529806803|FG001|Overall Study|Pregnancy|1|||
146902916|NCT02886715|529806804|FG002|Overall Study|Pregnancy|1|||
146902917|NCT02886715|529806802|FG000|Overall Study|Protocol Violation|3|||
146902918|NCT02886715|529806803|FG001|Overall Study|Protocol Violation|2|||
146902919|NCT02886715|529806804|FG002|Overall Study|Protocol Violation|1|||
146902920|NCT02886715|529806802|FG000|Overall Study|Withdrawal by Subject|20|||
146902921|NCT02886715|529806803|FG001|Overall Study|Withdrawal by Subject|18|||
146902922|NCT02886715|529806804|FG002|Overall Study|Withdrawal by Subject|5|||
146902923|NCT02886715|529806802|FG000|Overall Study|missing|7|||
146767406|NCT02496702|529317310|FG000|Overall Study|Only partially tested|0|||
146902924|NCT02886715|529806803|FG001|Overall Study|missing|2|||
146767407|NCT02496702|529317311|FG001|Overall Study|Only partially tested|2|||
146902925|NCT02886715|529806804|FG002|Overall Study|missing|2|||
146902926|NCT01676961|529806805|FG000|Overall Study|Death|3|||
146902927|NCT01676961|529806805|FG000|Overall Study|Lost to Follow-up|1|||
146902928|NCT01676961|529806805|FG000|Overall Study|Withdrawal by Subject|1|||
146902929|NCT00768560|529806808|FG000|Intervention Set 1|Adverse Event|0|||
146902930|NCT00768560|529806809|FG001|Intervention Set 1|Adverse Event|1|||
146902931|NCT00768560|529806810|FG002|Intervention Set 1|Adverse Event|0|||
146902932|NCT00768560|529806811|FG003|Intervention Set 1|Adverse Event|0|||
146902933|NCT00768560|529806812|FG004|Intervention Set 1|Adverse Event|0|||
146902934|NCT00768560|529806813|FG005|Intervention Set 1|Adverse Event|0|||
146902935|NCT00117312|529806814|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
146902936|NCT00117312|529806815|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
146902937|NCT00117312|529806816|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
146902938|NCT00117312|529806817|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
146902939|NCT00117312|529806814|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
146902940|NCT00117312|529806815|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
146902941|NCT00117312|529806816|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
146902942|NCT00117312|529806817|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
146902943|NCT00117312|529806814|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
146902944|NCT00117312|529806815|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
146902945|NCT00117312|529806816|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
146902946|NCT00117312|529806817|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
146902947|NCT00117312|529806814|FG000|Overall Study|Other|0|||
146902948|NCT00117312|529806815|FG001|Overall Study|Other|1|||
146902949|NCT00117312|529806816|FG002|Overall Study|Other|3|||
146902950|NCT00117312|529806817|FG003|Overall Study|Other|1|||
146902951|NCT00117312|529806814|FG000|Overall Study|Patient choice|0|||
146902952|NCT00117312|529806815|FG001|Overall Study|Patient choice|0|||
146902953|NCT00117312|529806816|FG002|Overall Study|Patient choice|2|||
146902954|NCT00117312|529806817|FG003|Overall Study|Patient choice|1|||
146902955|NCT00117312|529806814|FG000|Overall Study|Adverse Event|0|||
146902956|NCT00117312|529806815|FG001|Overall Study|Adverse Event|2|||
146902957|NCT00117312|529806816|FG002|Overall Study|Adverse Event|0|||
146902958|NCT00117312|529806817|FG003|Overall Study|Adverse Event|0|||
146902959|NCT00117312|529806814|FG000|Overall Study|Protocol Violation|0|||
146902960|NCT00117312|529806815|FG001|Overall Study|Protocol Violation|1|||
146902961|NCT00117312|529806816|FG002|Overall Study|Protocol Violation|3|||
146902962|NCT00117312|529806817|FG003|Overall Study|Protocol Violation|0|||
146902963|NCT00117312|529806814|FG000|Overall Study|PSA decrease <=50%|0|||
146902964|NCT00117312|529806815|FG001|Overall Study|PSA decrease <=50%|2|||
146902965|NCT00117312|529806816|FG002|Overall Study|PSA decrease <=50%|2|||
146902966|NCT00117312|529806817|FG003|Overall Study|PSA decrease <=50%|4|||
146902967|NCT00117312|529806814|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
146902968|NCT00117312|529806815|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
146902969|NCT00117312|529806816|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
146902970|NCT00117312|529806817|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
146902971|NCT00117312|529806814|FG000|Overall Study|Hepatic abnormality|0|||
146902972|NCT00117312|529806815|FG001|Overall Study|Hepatic abnormality|1|||
146902973|NCT00117312|529806816|FG002|Overall Study|Hepatic abnormality|0|||
146902974|NCT00117312|529806817|FG003|Overall Study|Hepatic abnormality|1|||
146902975|NCT00117312|529806814|FG000|Overall Study|Withdrawal by Subject|0|||
146902976|NCT00117312|529806815|FG001|Overall Study|Withdrawal by Subject|2|||
146902977|NCT00117312|529806816|FG002|Overall Study|Withdrawal by Subject|0|||
146902978|NCT00117312|529806817|FG003|Overall Study|Withdrawal by Subject|0|||
146902979|NCT05089708|529806818|FG000|Overall Study|Lost to Follow-up|9|||
146902980|NCT05089708|529806819|FG001|Overall Study|Lost to Follow-up|7|||
146902981|NCT05089708|529806818|FG000|Overall Study|Withdrawal by Subject|3|||
146902982|NCT05089708|529806819|FG001|Overall Study|Withdrawal by Subject|1|||
146902983|NCT05089708|529806818|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
146902984|NCT05089708|529806819|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
146902985|NCT05089708|529806818|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
146902986|NCT05089708|529806819|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
146902987|NCT01440101|529806820|FG000|Overall Study|Adverse Event|2|||
146902988|NCT01440101|529806821|FG001|Overall Study|Adverse Event|0|||
146902989|NCT01440101|529806822|FG002|Overall Study|Adverse Event|0|||
146902990|NCT01440101|529806820|FG000|Overall Study|Withdrawal by Subject|0|||
146902991|NCT01440101|529806821|FG001|Overall Study|Withdrawal by Subject|3|||
146560641|NCT02327169|528563992|FG010|Overall Study|Withdrawal by Subject|0|||
146560642|NCT02327169|528563993|FG011|Overall Study|Withdrawal by Subject|0|||
146560643|NCT02327169|528563994|FG012|Overall Study|Withdrawal by Subject|0|||
146560644|NCT02327169|528563995|FG013|Overall Study|Withdrawal by Subject|0|||
146560645|NCT02327169|528563996|FG014|Overall Study|Withdrawal by Subject|3|||
146560646|NCT02327169|528563982|FG000|Overall Study|Lost to Follow-up|0|||
146560647|NCT02327169|528563983|FG001|Overall Study|Lost to Follow-up|0|||
146560648|NCT02327169|528563984|FG002|Overall Study|Lost to Follow-up|0|||
146560649|NCT02327169|528563985|FG003|Overall Study|Lost to Follow-up|0|||
146560650|NCT02327169|528563986|FG004|Overall Study|Lost to Follow-up|1|||
146560651|NCT02327169|528563987|FG005|Overall Study|Lost to Follow-up|0|||
146560652|NCT02327169|528563988|FG006|Overall Study|Lost to Follow-up|0|||
146902992|NCT01440101|529806822|FG002|Overall Study|Withdrawal by Subject|1|||
146902993|NCT01440101|529806820|FG000|Overall Study|Other|0|||
146902994|NCT01440101|529806821|FG001|Overall Study|Other|1|||
146902995|NCT01440101|529806822|FG002|Overall Study|Other|0|||
146902996|NCT00659438|529806823|FG000|Overall Study|Withdrawal by Subject|2|||
146902997|NCT00659438|529806824|FG001|Overall Study|Withdrawal by Subject|2|||
146902998|NCT00659438|529806823|FG000|Overall Study|Death|11|||
146560653|NCT02327169|528563989|FG007|Overall Study|Lost to Follow-up|0|||
146560654|NCT02327169|528563990|FG008|Overall Study|Lost to Follow-up|0|||
146560655|NCT02327169|528563991|FG009|Overall Study|Lost to Follow-up|0|||
146560656|NCT02327169|528563992|FG010|Overall Study|Lost to Follow-up|0|||
146902999|NCT00659438|529806824|FG001|Overall Study|Death|6|||
146560657|NCT02327169|528563993|FG011|Overall Study|Lost to Follow-up|0|||
146903000|NCT00659438|529806823|FG000|Overall Study|Lost to Follow-up|1|||
146903001|NCT00659438|529806824|FG001|Overall Study|Lost to Follow-up|0|||
146903002|NCT00201851|529806825|FG000|Overall Study|Lost to Follow-up|2|||
146903003|NCT00201851|529806826|FG001|Overall Study|Lost to Follow-up|1|||
146903004|NCT00201851|529806827|FG002|Overall Study|Lost to Follow-up|0|||
146903005|NCT00201851|529806825|FG000|Overall Study|Ineligible post enrollment|6|||
146903006|NCT00201851|529806826|FG001|Overall Study|Ineligible post enrollment|1|||
146903007|NCT00201851|529806827|FG002|Overall Study|Ineligible post enrollment|1|||
146903008|NCT01491945|529806831|FG000|Overall Study|Death|30|||
146903009|NCT01491945|529806831|FG000|Overall Study|Withdrwan/LTF|16|||
146903010|NCT01491945|529806831|FG000|Overall Study|Conversion|4|||
146903011|NCT01491945|529806831|FG000|Overall Study|Missed Visit|1|||
146903012|NCT00636818|529806832|FG000|Overall Study|Adverse Event|1|||
146903013|NCT00636818|529806832|FG000|Overall Study|Lost to Follow-up|2|||
146903014|NCT00636818|529806832|FG000|Overall Study|Entry Criteria Exclusion|3|||
146903015|NCT00636818|529806832|FG000|Overall Study|Protocol Violation|1|||
146903016|NCT00636818|529806832|FG000|Overall Study|Withdrawal by Subject|4|||
146903017|NCT00404092|529806833|FG000|Overall Study|Death|1|||
146903018|NCT00404092|529806834|FG001|Overall Study|Death|0|||
146903019|NCT00404092|529806835|FG002|Overall Study|Death|0|||
146903020|NCT00404092|529806836|FG003|Overall Study|Death|0|||
146903021|NCT00404092|529806833|FG000|Overall Study|Adverse Event|0|||
146903022|NCT00404092|529806834|FG001|Overall Study|Adverse Event|0|||
146903023|NCT00404092|529806835|FG002|Overall Study|Adverse Event|1|||
146903024|NCT00404092|529806836|FG003|Overall Study|Adverse Event|0|||
146903025|NCT00749203|529806837|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
146903026|NCT00749203|529806838|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
146903027|NCT00749203|529806837|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
146903028|NCT00749203|529806838|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
146903029|NCT00749203|529806837|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
146903030|NCT00749203|529806838|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
146903031|NCT00749203|529806837|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
146903032|NCT00749203|529806838|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
146903033|NCT00749203|529806837|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
146903034|NCT00749203|529806838|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
146903035|NCT00749203|529806837|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
146903036|NCT00749203|529806838|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
146903037|NCT02344576|529806842|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
146903038|NCT02344576|529806843|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
146903039|NCT02344576|529806844|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
146903040|NCT02344576|529806845|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
146903041|NCT02344576|529806842|FG000|1-Month Follow-Up|Death|13|||
146903042|NCT02344576|529806843|FG001|1-Month Follow-Up|Death|8|||
146903043|NCT02344576|529806844|FG002|1-Month Follow-Up|Death|0|||
146903044|NCT02344576|529806845|FG003|1-Month Follow-Up|Death|0|||
146903045|NCT02344576|529806842|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
146903046|NCT02344576|529806843|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
146903047|NCT02344576|529806844|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
146903048|NCT02344576|529806845|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
146903049|NCT02344576|529806842|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
146903050|NCT02344576|529806843|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
146903051|NCT02344576|529806844|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
146903052|NCT02344576|529806845|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
146903053|NCT02344576|529806842|FG000|6-Month Follow-Up|Death|14|||
146903054|NCT02344576|529806843|FG001|6-Month Follow-Up|Death|14|||
146903055|NCT02344576|529806844|FG002|6-Month Follow-Up|Death|0|||
146903056|NCT02344576|529806845|FG003|6-Month Follow-Up|Death|0|||
146903057|NCT02344576|529806842|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
146903058|NCT02344576|529806843|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
146903059|NCT02344576|529806844|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
146903060|NCT02344576|529806845|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
146903061|NCT02344576|529806842|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
146903062|NCT02344576|529806843|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
146903063|NCT02344576|529806844|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
146903064|NCT02344576|529806845|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
146903065|NCT04233424|529806847|FG000|Overall Study|Death|15|||
146903066|NCT04233424|529806848|FG001|Overall Study|Death|16|||
146903067|NCT04233424|529806847|FG000|Overall Study|Withdrawal by Subject|2|||
146903068|NCT04233424|529806848|FG001|Overall Study|Withdrawal by Subject|8|||
146903069|NCT04233424|529806847|FG000|Overall Study|Physician Decision|1|||
146903070|NCT04233424|529806848|FG001|Overall Study|Physician Decision|3|||
146903071|NCT04233424|529806847|FG000|Overall Study|Protocol Violation|3|||
146903072|NCT04233424|529806848|FG001|Overall Study|Protocol Violation|1|||
146903073|NCT04233424|529806847|FG000|Overall Study|Lost to Follow-up|1|||
146903074|NCT04233424|529806848|FG001|Overall Study|Lost to Follow-up|3|||
146903075|NCT04233424|529806847|FG000|Overall Study|subject refuse to visit site|2|||
146903076|NCT04233424|529806848|FG001|Overall Study|subject refuse to visit site|0|||
146903077|NCT02698189|529806849|FG000|Overall Study|Physician Decision|3|||
146903078|NCT02698189|529806850|FG001|Overall Study|Physician Decision|0|||
146903079|NCT02698189|529806849|FG000|Overall Study|Progressive disease|0|||
146903080|NCT02698189|529806850|FG001|Overall Study|Progressive disease|5|||
146903081|NCT02698189|529806849|FG000|Overall Study|Study terminated by sponsor|0|||
146903082|NCT02698189|529806850|FG001|Overall Study|Study terminated by sponsor|1|||
146903083|NCT04325503|529806864|FG000|Overall Study|Withdrawal by Subject|1|||
146903084|NCT04325503|529806864|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
146903085|NCT00702143|529806865|FG000|Overall Study|Lost to Follow-up|0|||
146903086|NCT00702143|529806866|FG001|Overall Study|Lost to Follow-up|0|||
146903087|NCT00702143|529806867|FG002|Overall Study|Lost to Follow-up|1|||
146903088|NCT03871491|529806872|FG000|Overall Study|Withdrawal by Subject|14|||
146903089|NCT03871491|529806873|FG001|Overall Study|Withdrawal by Subject|14|||
146903090|NCT03871491|529806874|FG002|Overall Study|Withdrawal by Subject|14|||
146903091|NCT03871491|529806875|FG003|Overall Study|Withdrawal by Subject|14|||
146903092|NCT03871491|529806872|FG000|Overall Study|Physician Decision|0|||
146903093|NCT03871491|529806873|FG001|Overall Study|Physician Decision|0|||
146903094|NCT03871491|529806874|FG002|Overall Study|Physician Decision|1|||
146903095|NCT03871491|529806875|FG003|Overall Study|Physician Decision|1|||
146903096|NCT03871491|529806872|FG000|Overall Study|Lost to Follow-up|50|||
146903097|NCT03871491|529806873|FG001|Overall Study|Lost to Follow-up|15|||
146903098|NCT03871491|529806874|FG002|Overall Study|Lost to Follow-up|36|||
146903099|NCT03871491|529806875|FG003|Overall Study|Lost to Follow-up|11|||
146903100|NCT04996797|529806876|FG000|Overall Study|Adverse Event|0|||
146903101|NCT04996797|529806877|FG001|Overall Study|Adverse Event|2|||
146903102|NCT04996797|529806878|FG002|Overall Study|Adverse Event|0|||
146903103|NCT04996797|529806879|FG003|Overall Study|Adverse Event|1|||
146903104|NCT04996797|529806876|FG000|Overall Study|Lack of Efficacy|0|||
146903105|NCT04996797|529806877|FG001|Overall Study|Lack of Efficacy|2|||
146903106|NCT04996797|529806878|FG002|Overall Study|Lack of Efficacy|0|||
146903107|NCT04996797|529806879|FG003|Overall Study|Lack of Efficacy|0|||
146903108|NCT04996797|529806876|FG000|Overall Study|Prohibited Medication|0|||
146903109|NCT04996797|529806877|FG001|Overall Study|Prohibited Medication|1|||
146903110|NCT04996797|529806878|FG002|Overall Study|Prohibited Medication|0|||
146903111|NCT04996797|529806879|FG003|Overall Study|Prohibited Medication|0|||
146903112|NCT04996797|529806876|FG000|Overall Study|Ongoing|68|||
146903113|NCT04996797|529806877|FG001|Overall Study|Ongoing|60|||
146903114|NCT04996797|529806878|FG002|Overall Study|Ongoing|22|||
146903115|NCT04996797|529806879|FG003|Overall Study|Ongoing|20|||
146903116|NCT04996797|529806876|FG000|Overall Study|Withdrawal by Subject|0|||
146903117|NCT04996797|529806877|FG001|Overall Study|Withdrawal by Subject|2|||
146903118|NCT04996797|529806878|FG002|Overall Study|Withdrawal by Subject|0|||
146903119|NCT04996797|529806879|FG003|Overall Study|Withdrawal by Subject|0|||
146903120|NCT02793544|529806880|FG000|Overall Study|Death|10|||
146903121|NCT02793544|529806881|FG001|Overall Study|Death|8|||
146903122|NCT02793544|529806880|FG000|Overall Study|Lost to Follow-up|2|||
146903123|NCT02793544|529806881|FG001|Overall Study|Lost to Follow-up|0|||
146903124|NCT02793544|529806880|FG000|Overall Study|Withdrawal by Subject|1|||
146903125|NCT02793544|529806881|FG001|Overall Study|Withdrawal by Subject|0|||
146903126|NCT02495948|529806886|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
146903127|NCT02495948|529806887|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
146903128|NCT02495948|529806886|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
146903129|NCT02495948|529806887|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
146903130|NCT01624142|529806888|FG000|Overall Study|Withdrawal by Subject|14|||
146903131|NCT01624142|529806889|FG001|Overall Study|Withdrawal by Subject|4|||
146903132|NCT01624142|529806888|FG000|Overall Study|Death|3|||
146903133|NCT01624142|529806889|FG001|Overall Study|Death|6|||
146903134|NCT01624142|529806888|FG000|Overall Study|Study Closure|12|||
146903135|NCT01624142|529806889|FG001|Overall Study|Study Closure|6|||
146903136|NCT01624142|529806888|FG000|Overall Study|Lost to Follow-up|2|||
146903137|NCT01624142|529806889|FG001|Overall Study|Lost to Follow-up|0|||
146903138|NCT01624142|529806888|FG000|Overall Study|Other|1|||
146903139|NCT01624142|529806889|FG001|Overall Study|Other|0|||
146903140|NCT01444300|529806890|FG000|Overall Study|Adverse Event|4|||
146903141|NCT01444300|529806891|FG001|Overall Study|Adverse Event|0|||
146903142|NCT04826900|529806892|FG000|Overall Study|Family factor|1|||
146903143|NCT04826900|529806893|FG001|Overall Study|Family factor|1|||
146903144|NCT04885257|529806894|FG000|Overall Study|Withdrawal by Subject|1|||
146903145|NCT04885257|529806895|FG001|Overall Study|Withdrawal by Subject|0|||
146903146|NCT02597062|529806896|FG000|Overall Study|Ineligible|1|||
146903147|NCT01053429|529806897|FG000|Overall Study|Adverse Event|64|||
146903148|NCT01053429|529806897|FG000|Overall Study|Other|309|||
146903149|NCT01708057|529806898|FG000|Overall Study|Withdrawal due to study termination.|1|||
146903150|NCT01708057|529806899|FG001|Overall Study|Withdrawal due to study termination.|1|||
146903151|NCT01708057|529806900|FG002|Overall Study|Withdrawal due to study termination.|1|||
146903152|NCT03929250|529806907|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
146903153|NCT03929250|529806908|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
146903154|NCT05262764|529806910|FG000|Overall Study|Case report form not collected|9|||
146903155|NCT05262764|529806910|FG000|Overall Study|No patient visits after entry|23|||
146903156|NCT05262764|529806910|FG000|Overall Study|Registration rule not followed|2|||
146903157|NCT05262764|529806910|FG000|Overall Study|Patient of non-chronic heart failure|1|||
146903158|NCT01392183|529806911|FG000|First Drug Administration|Adverse Event|3|||
146903159|NCT01392183|529806912|FG001|First Drug Administration|Adverse Event|2|||
146903160|NCT01392183|529806911|FG000|First Drug Administration|Death|1|||
146903161|NCT01392183|529806912|FG001|First Drug Administration|Death|0|||
146903162|NCT01392183|529806911|FG000|First Drug Administration|Withdrawal by Subject|10|||
146903163|NCT01392183|529806912|FG001|First Drug Administration|Withdrawal by Subject|17|||
146903164|NCT03972488|529806914|FG000|Overall Study|Progressive disease|42|||
146903165|NCT03972488|529806915|FG001|Overall Study|Progressive disease|44|||
146903166|NCT03972488|529806914|FG000|Overall Study|Physician Decision|13|||
146903167|NCT03972488|529806915|FG001|Overall Study|Physician Decision|7|||
146903168|NCT03972488|529806914|FG000|Overall Study|Adverse Event|8|||
146903169|NCT03972488|529806915|FG001|Overall Study|Adverse Event|1|||
146903170|NCT03972488|529806914|FG000|Overall Study|Death|4|||
146903171|NCT03972488|529806915|FG001|Overall Study|Death|4|||
146903172|NCT03972488|529806914|FG000|Overall Study|Withdrawal by Subject|3|||
146903173|NCT03972488|529806915|FG001|Overall Study|Withdrawal by Subject|4|||
146903174|NCT03972488|529806914|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
146903175|NCT03972488|529806915|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
146903176|NCT00045032|529806920|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
146903177|NCT00045032|529806921|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
146903178|NCT00045032|529806922|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
146903179|NCT00045032|529806920|FG000|Overall Study|Death|22|||
146903180|NCT00045032|529806921|FG001|Overall Study|Death|24|||
146903181|NCT00045032|529806922|FG002|Overall Study|Death|17|||
146903182|NCT00045032|529806920|FG000|Overall Study|Insufficient Therapeutic Response|542|||
146903183|NCT00045032|529806921|FG001|Overall Study|Insufficient Therapeutic Response|437|||
146903184|NCT00045032|529806922|FG002|Overall Study|Insufficient Therapeutic Response|445|||
146903185|NCT00045032|529806920|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
146903186|NCT00045032|529806921|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
146903187|NCT00045032|529806922|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
146903188|NCT00045032|529806920|FG000|Overall Study|Other Protocol Violation|2|||
146903189|NCT00045032|529806921|FG001|Overall Study|Other Protocol Violation|0|||
146903190|NCT00045032|529806922|FG002|Overall Study|Other Protocol Violation|1|||
146903191|NCT00045032|529806920|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
146903192|NCT00045032|529806921|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
146903193|NCT00045032|529806922|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
146903194|NCT00045032|529806920|FG000|Overall Study|Failure to Return|57|||
146903195|NCT00045032|529806921|FG001|Overall Study|Failure to Return|62|||
146903196|NCT00045032|529806922|FG002|Overall Study|Failure to Return|61|||
146903197|NCT00045032|529806920|FG000|Overall Study|Other|93|||
146903198|NCT00045032|529806921|FG001|Overall Study|Other|84|||
146903199|NCT00045032|529806922|FG002|Overall Study|Other|105|||
146903200|NCT02770807|529806923|FG000|Overall Study|Adverse Event|3|||
146903201|NCT02770807|529806924|FG001|Overall Study|Adverse Event|3|||
146903202|NCT02770807|529806925|FG002|Overall Study|Adverse Event|1|||
146903203|NCT02770807|529806923|FG000|Overall Study|Withdrawal by Subject|7|||
146903204|NCT02770807|529806924|FG001|Overall Study|Withdrawal by Subject|3|||
146903205|NCT02770807|529806925|FG002|Overall Study|Withdrawal by Subject|4|||
146903206|NCT02770807|529806923|FG000|Overall Study|Other|0|||
146903207|NCT02770807|529806924|FG001|Overall Study|Other|1|||
146903208|NCT02770807|529806925|FG002|Overall Study|Other|0|||
146903209|NCT02770807|529806923|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
146903210|NCT02770807|529806924|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
146903211|NCT02770807|529806925|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
146903212|NCT02770807|529806923|FG000|Overall Study|Physician Decision|0|||
146903213|NCT02770807|529806924|FG001|Overall Study|Physician Decision|0|||
146903214|NCT02770807|529806925|FG002|Overall Study|Physician Decision|1|||
146903215|NCT00222105|529806928|FG000|Overall Study|Removed due to wrong diagnosis|1|||
146903216|NCT00222105|529806928|FG000|Overall Study|Withdrawal by Subject|1|||
146903217|NCT00222105|529806928|FG000|Overall Study|Adverse Event|8|||
146903218|NCT00222105|529806928|FG000|Overall Study|Treatment delays|2|||
146903219|NCT00222105|529806928|FG000|Overall Study|Death|2|||
146903220|NCT03277196|529806929|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
146903221|NCT03277196|529806929|FG000|Overall Study|Lost to Follow-up|3|||
146903222|NCT03277196|529806929|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
146903223|NCT03277196|529806929|FG000|Overall Study|Other|2|||
146903224|NCT01024244|529808409|FG000|Overall Study|Adverse Event|1|||
146903225|NCT01024244|529808410|FG001|Overall Study|Adverse Event|2|||
146903226|NCT01024244|529808411|FG002|Overall Study|Adverse Event|0|||
146903227|NCT01024244|529808412|FG003|Overall Study|Adverse Event|1|||
146903228|NCT01024244|529808413|FG004|Overall Study|Adverse Event|2|||
146903229|NCT01024244|529808409|FG000|Overall Study|Entry Criteria Not Met|0|||
146903230|NCT01024244|529808410|FG001|Overall Study|Entry Criteria Not Met|1|||
146903231|NCT01024244|529808411|FG002|Overall Study|Entry Criteria Not Met|0|||
146903232|NCT01024244|529808412|FG003|Overall Study|Entry Criteria Not Met|0|||
146903233|NCT01024244|529808413|FG004|Overall Study|Entry Criteria Not Met|0|||
146903234|NCT01024244|529808409|FG000|Overall Study|Lack of Efficacy|1|||
146903235|NCT01024244|529808410|FG001|Overall Study|Lack of Efficacy|0|||
146903236|NCT01024244|529808411|FG002|Overall Study|Lack of Efficacy|0|||
146903237|NCT01024244|529808412|FG003|Overall Study|Lack of Efficacy|0|||
146903238|NCT01024244|529808413|FG004|Overall Study|Lack of Efficacy|0|||
146903239|NCT01024244|529808409|FG000|Overall Study|Protocol Violation|1|||
146903240|NCT01024244|529808410|FG001|Overall Study|Protocol Violation|0|||
146903241|NCT01024244|529808411|FG002|Overall Study|Protocol Violation|0|||
146903242|NCT01024244|529808412|FG003|Overall Study|Protocol Violation|0|||
146903243|NCT01024244|529808413|FG004|Overall Study|Protocol Violation|2|||
146903244|NCT01024244|529808409|FG000|Overall Study|Sponsor Decision|14|||
146903245|NCT01024244|529808410|FG001|Overall Study|Sponsor Decision|7|||
146903246|NCT01024244|529808411|FG002|Overall Study|Sponsor Decision|14|||
146903247|NCT01024244|529808412|FG003|Overall Study|Sponsor Decision|12|||
146903248|NCT01024244|529808413|FG004|Overall Study|Sponsor Decision|10|||
146903249|NCT01024244|529808409|FG000|Overall Study|Withdrawal by Subject|0|||
146903250|NCT01024244|529808410|FG001|Overall Study|Withdrawal by Subject|1|||
146903251|NCT01024244|529808411|FG002|Overall Study|Withdrawal by Subject|0|||
146903252|NCT01024244|529808412|FG003|Overall Study|Withdrawal by Subject|0|||
146903253|NCT01024244|529808413|FG004|Overall Study|Withdrawal by Subject|0|||
146903254|NCT00374556|529808414|FG000|Overall Study|Lost to Follow-up|1|||
146903255|NCT00374556|529808415|FG001|Overall Study|Lost to Follow-up|0|||
146903256|NCT00374556|529808414|FG000|Overall Study|Removed at baseline due to medical cond|0|||
146903257|NCT00374556|529808415|FG001|Overall Study|Removed at baseline due to medical cond|1|||
146903258|NCT00541307|529808419|FG000|Overall Study|Death|5|||
146903259|NCT00541307|529808419|FG000|Overall Study|Physician Decision|3|||
146903260|NCT00541307|529808419|FG000|Overall Study|Withdrawal by Subject|6|||
146903261|NCT00541307|529808419|FG000|Overall Study|Lost to Follow-up|4|||
146903262|NCT00541307|529808419|FG000|Overall Study|Subject returned early (outside window)|1|||
146903263|NCT00541307|529808419|FG000|Overall Study|Surgical Bypass|5|||
146903264|NCT04723537|529808420|FG000|Overall Study|Withdrawal by Subject|3|||
146903265|NCT04723537|529808421|FG001|Overall Study|Withdrawal by Subject|0|||
146903266|NCT04723537|529808422|FG002|Overall Study|Withdrawal by Subject|0|||
146903267|NCT04723537|529808420|FG000|Overall Study|Physician Decision|0|||
146903268|NCT04723537|529808421|FG001|Overall Study|Physician Decision|0|||
146903269|NCT04723537|529808422|FG002|Overall Study|Physician Decision|1|||
146903270|NCT04723537|529808420|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
146903271|NCT04723537|529808421|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
146903272|NCT04723537|529808422|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
146903273|NCT03976401|529808429|FG000|Overall Study|Adverse Event|2|||
146903274|NCT03976401|529808430|FG001|Overall Study|Adverse Event|0|||
146560658|NCT02327169|528563994|FG012|Overall Study|Lost to Follow-up|0|||
146903275|NCT03976401|529808431|FG002|Overall Study|Adverse Event|4|||
146903276|NCT03976401|529808432|FG003|Overall Study|Adverse Event|1|||
146903277|NCT03976401|529808433|FG004|Overall Study|Adverse Event|1|||
146903278|NCT03976401|529808434|FG005|Overall Study|Adverse Event|0|||
146903279|NCT03976401|529808429|FG000|Overall Study|Withdrawal by Subject|0|||
146903280|NCT03976401|529808430|FG001|Overall Study|Withdrawal by Subject|1|||
146903281|NCT03976401|529808431|FG002|Overall Study|Withdrawal by Subject|0|||
146903282|NCT03976401|529808432|FG003|Overall Study|Withdrawal by Subject|0|||
146903283|NCT03976401|529808433|FG004|Overall Study|Withdrawal by Subject|0|||
146903284|NCT03976401|529808434|FG005|Overall Study|Withdrawal by Subject|1|||
146903285|NCT03976401|529808429|FG000|Overall Study|Physician Decision|0|||
146903286|NCT03976401|529808430|FG001|Overall Study|Physician Decision|0|||
146903287|NCT03976401|529808431|FG002|Overall Study|Physician Decision|1|||
146903288|NCT03976401|529808432|FG003|Overall Study|Physician Decision|0|||
146903289|NCT03976401|529808433|FG004|Overall Study|Physician Decision|0|||
146903290|NCT03976401|529808434|FG005|Overall Study|Physician Decision|0|||
146903291|NCT03976401|529808429|FG000|Overall Study|Lost to Follow-up|1|||
146903292|NCT03976401|529808430|FG001|Overall Study|Lost to Follow-up|2|||
146903293|NCT03976401|529808431|FG002|Overall Study|Lost to Follow-up|0|||
146903294|NCT03976401|529808432|FG003|Overall Study|Lost to Follow-up|0|||
146903295|NCT03976401|529808433|FG004|Overall Study|Lost to Follow-up|0|||
146903296|NCT03976401|529808434|FG005|Overall Study|Lost to Follow-up|0|||
146903297|NCT03976401|529808429|FG000|Overall Study|Protocol Violation|0|||
146903298|NCT03976401|529808430|FG001|Overall Study|Protocol Violation|1|||
146903299|NCT03976401|529808431|FG002|Overall Study|Protocol Violation|0|||
146903300|NCT03976401|529808432|FG003|Overall Study|Protocol Violation|0|||
146903301|NCT03976401|529808433|FG004|Overall Study|Protocol Violation|0|||
146903302|NCT03976401|529808434|FG005|Overall Study|Protocol Violation|0|||
146903303|NCT03976401|529808429|FG000|Overall Study|Withdrew Consent|0|||
146903304|NCT03976401|529808430|FG001|Overall Study|Withdrew Consent|0|||
146903305|NCT03976401|529808431|FG002|Overall Study|Withdrew Consent|0|||
146903306|NCT03976401|529808432|FG003|Overall Study|Withdrew Consent|1|||
146903307|NCT03976401|529808433|FG004|Overall Study|Withdrew Consent|0|||
146903308|NCT03976401|529808434|FG005|Overall Study|Withdrew Consent|0|||
146903309|NCT04645797|529808435|FG000|Overall Study|Disease Progression|3|||
146903310|NCT04645797|529808436|FG001|Overall Study|Disease Progression|3|||
146903311|NCT04645797|529808437|FG002|Overall Study|Disease Progression|1|||
146903312|NCT04645797|529808438|FG003|Overall Study|Disease Progression|0|||
146903313|NCT04645797|529808439|FG004|Overall Study|Disease Progression|0|||
146903314|NCT04645797|529808440|FG005|Overall Study|Disease Progression|0|||
146903315|NCT04645797|529808441|FG006|Overall Study|Disease Progression|0|||
146903316|NCT04645797|529808435|FG000|Overall Study|Death|3|||
146903317|NCT04645797|529808436|FG001|Overall Study|Death|1|||
146903318|NCT04645797|529808437|FG002|Overall Study|Death|0|||
146903319|NCT04645797|529808438|FG003|Overall Study|Death|0|||
146903320|NCT04645797|529808439|FG004|Overall Study|Death|0|||
146903321|NCT04645797|529808440|FG005|Overall Study|Death|0|||
146903322|NCT04645797|529808441|FG006|Overall Study|Death|0|||
146903323|NCT00942409|529808444|FG000|Overall Study|Lack of Efficacy|1|||
146903324|NCT00942409|529808444|FG000|Overall Study|study drug unavailable|2|||
146903325|NCT00500071|529808448|FG000|Screening and Washout Phase|Protocol Violation|1|||
146903326|NCT00500071|529808448|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
146903327|NCT00500071|529808448|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
146903328|NCT00500071|529808448|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
146903329|NCT00500071|529808448|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
146903330|NCT00500071|529808448|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
146903331|NCT00500071|529808448|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
146903332|NCT01122927|529808449|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
146903333|NCT01122927|529808450|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
146903334|NCT01122927|529808449|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
146903335|NCT01122927|529808450|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
146903336|NCT01122927|529808449|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
146903337|NCT01122927|529808450|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
146903338|NCT01122927|529808449|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
146903339|NCT01122927|529808450|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
146903340|NCT01122927|529808449|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
146903341|NCT01122927|529808450|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
146903342|NCT01122927|529808449|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
146903343|NCT01122927|529808450|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
146903344|NCT01122927|529808449|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
146903345|NCT01122927|529808450|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
146903346|NCT01122927|529808449|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
146903347|NCT01122927|529808450|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
146903348|NCT01122927|529808449|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
146903349|NCT01122927|529808450|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
146903350|NCT01122927|529808449|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
146903351|NCT01122927|529808450|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
146767408|NCT01499134|529317312|FG000|Overall Study|Withdrawal by Subject|0|||
146903352|NCT01122927|529808449|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
146903353|NCT01122927|529808450|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
146903354|NCT01122927|529808449|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
146903355|NCT01122927|529808450|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
146903356|NCT03182738|529808451|FG000|Overall Study|Lost to Follow-up|9|||
146903357|NCT03182738|529808452|FG001|Overall Study|Lost to Follow-up|3|||
146903358|NCT03182738|529808451|FG000|Overall Study|Pregnancy|0|||
146903359|NCT03182738|529808452|FG001|Overall Study|Pregnancy|1|||
146903360|NCT03182738|529808451|FG000|Overall Study|Withdrawal by Subject|0|||
146903361|NCT03182738|529808452|FG001|Overall Study|Withdrawal by Subject|1|||
146903362|NCT03584009|529808453|FG000|Overall Study|Death|25|||
146903363|NCT03584009|529808454|FG001|Overall Study|Death|18|||
146903364|NCT03584009|529808453|FG000|Overall Study|Lost to Follow-up|0|||
146903365|NCT03584009|529808454|FG001|Overall Study|Lost to Follow-up|1|||
146903366|NCT03584009|529808453|FG000|Overall Study|Physician Decision|1|||
146903367|NCT03584009|529808454|FG001|Overall Study|Physician Decision|1|||
146903368|NCT03584009|529808453|FG000|Overall Study|Study Terminated by Sponsor|22|||
146903369|NCT03584009|529808454|FG001|Overall Study|Study Terminated by Sponsor|30|||
146903370|NCT03584009|529808453|FG000|Overall Study|Withdrawal by Subject|3|||
146903371|NCT03584009|529808454|FG001|Overall Study|Withdrawal by Subject|2|||
146903372|NCT03812510|529808455|FG000|Overall Study|Lost to Follow-up|39|||
146903373|NCT03812510|529808455|FG000|Overall Study|Withdrawal by Subject|42|||
146903374|NCT03812510|529808455|FG000|Overall Study|Physician Decision|2|||
146903375|NCT03812510|529808455|FG000|Overall Study|Study Terminated by Sponsor|9|||
146903376|NCT03812510|529808455|FG000|Overall Study|Did Not Start Study Medication|55|||
146903377|NCT03812510|529808455|FG000|Overall Study|Adverse Event|5|||
146903378|NCT01128387|529808456|FG000|Overall Study|Physician Decision|0|||
146903379|NCT01128387|529808457|FG001|Overall Study|Physician Decision|1|||
146903380|NCT02635204|529808458|FG000|Overall Study|Adverse Event|1|||
146903381|NCT02635204|529808459|FG001|Overall Study|Adverse Event|0|||
146903382|NCT02635204|529808458|FG000|Overall Study|Lost to Follow-up|1|||
146903383|NCT02635204|529808459|FG001|Overall Study|Lost to Follow-up|1|||
146903384|NCT01535235|529808460|FG000|Overall Study|Adverse Event|1|||
146903385|NCT01535235|529808461|FG001|Overall Study|Adverse Event|0|||
146903386|NCT00389207|529808463|FG000|Overall Study|Adverse Event|26|||
146903387|NCT00389207|529808464|FG001|Overall Study|Adverse Event|32|||
146903388|NCT00389207|529808465|FG002|Overall Study|Adverse Event|10|||
146903389|NCT00389207|529808463|FG000|Overall Study|Protocol Violation|3|||
146903390|NCT00389207|529808464|FG001|Overall Study|Protocol Violation|1|||
146903391|NCT00389207|529808465|FG002|Overall Study|Protocol Violation|4|||
146903392|NCT00389207|529808463|FG000|Overall Study|Lost to Follow-up|12|||
146903393|NCT00389207|529808464|FG001|Overall Study|Lost to Follow-up|9|||
146903394|NCT00389207|529808465|FG002|Overall Study|Lost to Follow-up|7|||
146903395|NCT00389207|529808463|FG000|Overall Study|Withdrawal by Subject|5|||
146903396|NCT00389207|529808464|FG001|Overall Study|Withdrawal by Subject|7|||
146903397|NCT00389207|529808465|FG002|Overall Study|Withdrawal by Subject|11|||
146903398|NCT00389207|529808463|FG000|Overall Study|Other|17|||
146903399|NCT00389207|529808464|FG001|Overall Study|Other|23|||
146903400|NCT00389207|529808465|FG002|Overall Study|Other|9|||
146903401|NCT00509106|529808468|FG000|Overall Study|Adverse Event|3|||
146560659|NCT02327169|528563995|FG013|Overall Study|Lost to Follow-up|0|||
146560660|NCT02327169|528563996|FG014|Overall Study|Lost to Follow-up|0|||
146560661|NCT03766399|528563999|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560662|NCT03766399|528564000|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560663|NCT03766399|528564001|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560664|NCT03766399|528564002|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560665|NCT03766399|528564003|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560666|NCT03766399|528564004|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560667|NCT03766399|528564005|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560668|NCT03766399|528564006|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560669|NCT03766399|528564007|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560670|NCT03766399|528564008|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560671|NCT03766399|528564009|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560672|NCT03766399|528564010|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560673|NCT03766399|528564011|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560674|NCT03766399|528564012|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
146560675|NCT03766399|528564013|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560676|NCT03766399|528564014|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560677|NCT03766399|528564015|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560678|NCT03766399|528564016|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146560679|NCT05030766|528564017|FG000|Phase 1 Participants|Lost to Follow-up|12|||
146560680|NCT05030766|528564018|FG001|Phase 1 Participants|Lost to Follow-up|22|||
146560681|NCT05030766|528564019|FG002|Phase 1 Participants|Lost to Follow-up|0|||
146560682|NCT05030766|528564020|FG003|Phase 1 Participants|Lost to Follow-up|0|||
146560683|NCT05030766|528564017|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
146560684|NCT05030766|528564018|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
146903402|NCT00509106|529808469|FG001|Overall Study|Adverse Event|2|||
146903403|NCT00509106|529808468|FG000|Overall Study|Noncompliance|0|||
146903404|NCT00509106|529808469|FG001|Overall Study|Noncompliance|1|||
146903405|NCT00509106|529808468|FG000|Overall Study|At the request of sponsor/investigator|1|||
146903406|NCT00509106|529808469|FG001|Overall Study|At the request of sponsor/investigator|2|||
146903407|NCT00509106|529808468|FG000|Overall Study|Withdrew consent|4|||
146903408|NCT00509106|529808469|FG001|Overall Study|Withdrew consent|8|||
146903409|NCT00509106|529808468|FG000|Overall Study|Lost to Follow-up|16|||
146903410|NCT00509106|529808469|FG001|Overall Study|Lost to Follow-up|10|||
146903411|NCT00509106|529808468|FG000|Overall Study|Other|1|||
146903412|NCT00509106|529808469|FG001|Overall Study|Other|0|||
146560685|NCT05030766|528564019|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
146560686|NCT05030766|528564020|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
146560687|NCT05030766|528564017|FG000|Phase 2 Participants|Lost to Follow-up|0|||
146560688|NCT05030766|528564018|FG001|Phase 2 Participants|Lost to Follow-up|0|||
146560689|NCT05030766|528564019|FG002|Phase 2 Participants|Lost to Follow-up|6|||
146560690|NCT05030766|528564020|FG003|Phase 2 Participants|Lost to Follow-up|2|||
146640784|NCT02105961|528860935|FG002|Overall Study|Withdrawal by Subject|11|||
146640785|NCT03860259|528860936|FG000|Overall Study|Lost to Follow-up|5|||
146640786|NCT03860259|528860937|FG001|Overall Study|Lost to Follow-up|5|||
146640787|NCT03860259|528860936|FG000|Overall Study|Protocol Violation|1|||
146640788|NCT03860259|528860937|FG001|Overall Study|Protocol Violation|0|||
146640789|NCT00934362|528860938|FG000|Overall Study|Adverse Event|1|||
146640790|NCT00934362|528860939|FG001|Overall Study|Adverse Event|0|||
146640791|NCT04154189|528860940|FG000|Overall Study|Withdrawal by Subject|4|||
146640792|NCT04154189|528860941|FG001|Overall Study|Withdrawal by Subject|6|||
146640793|NCT04154189|528860940|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
146640794|NCT04154189|528860941|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
146640795|NCT04154189|528860940|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
146640796|NCT04154189|528860941|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
146640797|NCT04154189|528860940|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
146640798|NCT04154189|528860941|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
146640799|NCT04154189|528860940|FG000|Overall Study|Death|25|||
146767409|NCT01499134|529317313|FG001|Overall Study|Withdrawal by Subject|1|||
146767410|NCT01400776|529317314|FG000|Overall Study|Adverse Event|7|||
146903413|NCT00509106|529808468|FG000|Overall Study|Death|6|||
146903414|NCT00509106|529808469|FG001|Overall Study|Death|6|||
146903415|NCT00824421|529808479|FG000|Overall Study|Adverse Event|6|||
146903416|NCT00824421|529808480|FG001|Overall Study|Adverse Event|6|||
146903417|NCT00824421|529808481|FG002|Overall Study|Adverse Event|6|||
146903418|NCT00824421|529808479|FG000|Overall Study|Death|0|||
146903419|NCT00824421|529808480|FG001|Overall Study|Death|1|||
146903420|NCT00824421|529808481|FG002|Overall Study|Death|0|||
146560691|NCT00645658|528564021|FG000|Overall Study|Withdrawal by Subject|1|||
146560692|NCT00645658|528564022|FG001|Overall Study|Withdrawal by Subject|0|||
146560693|NCT00645658|528564021|FG000|Overall Study|Did not complete all assesments|0|||
146560694|NCT00645658|528564022|FG001|Overall Study|Did not complete all assesments|2|||
146560695|NCT03895372|528564025|FG000|Investigational Treatment Period|Adverse Event|1|||
146560696|NCT03895372|528564026|FG001|Investigational Treatment Period|Adverse Event|0|||
146560697|NCT03895372|528564027|FG002|Investigational Treatment Period|Adverse Event|0|||
146560698|NCT03895372|528564028|FG003|Investigational Treatment Period|Adverse Event|0|||
146560699|NCT03895372|528564029|FG004|Investigational Treatment Period|Adverse Event|0|||
146560700|NCT03895372|528564030|FG005|Investigational Treatment Period|Adverse Event|0|||
146560701|NCT03895372|528564031|FG006|Investigational Treatment Period|Adverse Event|4|||
146560702|NCT03895372|528564032|FG007|Investigational Treatment Period|Adverse Event|3|||
146560703|NCT03895372|528564025|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
146560704|NCT03895372|528564026|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
146560705|NCT03895372|528564027|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
146560706|NCT03895372|528564028|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
146560707|NCT03895372|528564029|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
146560708|NCT03895372|528564030|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
146560709|NCT03895372|528564031|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
146560710|NCT03895372|528564032|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
146560711|NCT03895372|528564025|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
146560712|NCT03895372|528564026|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
146560713|NCT03895372|528564027|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
146560714|NCT03895372|528564028|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
146560715|NCT03895372|528564029|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
146560716|NCT03895372|528564030|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
146560717|NCT03895372|528564031|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
146560718|NCT03895372|528564032|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
146560719|NCT03895372|528564025|FG000|Investigational Treatment Period|Other|0|||
146560720|NCT03895372|528564026|FG001|Investigational Treatment Period|Other|0|||
146560721|NCT03895372|528564027|FG002|Investigational Treatment Period|Other|0|||
146560722|NCT03895372|528564028|FG003|Investigational Treatment Period|Other|0|||
146560723|NCT03895372|528564029|FG004|Investigational Treatment Period|Other|0|||
146560724|NCT03895372|528564030|FG005|Investigational Treatment Period|Other|1|||
146560725|NCT03895372|528564031|FG006|Investigational Treatment Period|Other|0|||
146560726|NCT03895372|528564032|FG007|Investigational Treatment Period|Other|2|||
146560727|NCT03895372|528564025|FG000|Investigational Treatment Period|Protocol Violation|0|||
146640800|NCT04154189|528860941|FG001|Overall Study|Death|25|||
146903421|NCT00824421|529808479|FG000|Overall Study|Lack of Efficacy|5|||
146903422|NCT00824421|529808480|FG001|Overall Study|Lack of Efficacy|7|||
146903423|NCT00824421|529808481|FG002|Overall Study|Lack of Efficacy|4|||
146903424|NCT00824421|529808479|FG000|Overall Study|Lost to Follow-up|2|||
146903425|NCT00824421|529808480|FG001|Overall Study|Lost to Follow-up|3|||
146903426|NCT00824421|529808481|FG002|Overall Study|Lost to Follow-up|0|||
146903427|NCT00824421|529808479|FG000|Overall Study|Pregnancy|1|||
146903428|NCT00824421|529808480|FG001|Overall Study|Pregnancy|0|||
146903429|NCT00824421|529808481|FG002|Overall Study|Pregnancy|1|||
146903430|NCT00824421|529808479|FG000|Overall Study|Withdrawal by Subject|2|||
146903431|NCT00824421|529808480|FG001|Overall Study|Withdrawal by Subject|3|||
146903432|NCT00824421|529808481|FG002|Overall Study|Withdrawal by Subject|3|||
146903433|NCT00824421|529808479|FG000|Overall Study|Randomized but not Treated|1|||
146903434|NCT00824421|529808480|FG001|Overall Study|Randomized but not Treated|1|||
146903435|NCT00824421|529808481|FG002|Overall Study|Randomized but not Treated|0|||
146903436|NCT00824421|529808479|FG000|Overall Study|Other|0|||
146903437|NCT00824421|529808480|FG001|Overall Study|Other|1|||
146903438|NCT00824421|529808481|FG002|Overall Study|Other|0|||
146903439|NCT02499952|529808483|FG000|Overall Study|Lost to Follow-up|1|||
146903440|NCT02499952|529808483|FG000|Overall Study|Death|9|||
146903441|NCT02120417|529808484|FG000|Overall Study|Death|5|||
146903442|NCT02120417|529808485|FG001|Overall Study|Death|1|||
146903443|NCT02120417|529808484|FG000|Overall Study|Adverse Event|3|||
146903444|NCT02120417|529808485|FG001|Overall Study|Adverse Event|9|||
146903445|NCT02120417|529808484|FG000|Overall Study|Participant decision|4|||
146903446|NCT02120417|529808485|FG001|Overall Study|Participant decision|4|||
146903447|NCT02120417|529808484|FG000|Overall Study|Disease progression|41|||
146903448|NCT02120417|529808485|FG001|Overall Study|Disease progression|45|||
146903449|NCT02120417|529808484|FG000|Overall Study|Noncompliance with study treatment|0|||
146903450|NCT02120417|529808485|FG001|Overall Study|Noncompliance with study treatment|2|||
146903451|NCT02120417|529808484|FG000|Overall Study|Physician Decision|2|||
146903452|NCT02120417|529808485|FG001|Overall Study|Physician Decision|3|||
146903453|NCT02120417|529808484|FG000|Overall Study|Other unspecified|5|||
146903454|NCT02120417|529808485|FG001|Overall Study|Other unspecified|4|||
146903455|NCT02286102|529808486|FG000|Overall Study|Screen Failure|1|||
146903456|NCT02286102|529808487|FG001|Overall Study|Screen Failure|1|||
146903457|NCT00927485|529808488|FG000|Overall Study|Adverse Event|4|||
146903458|NCT00927485|529808489|FG001|Overall Study|Adverse Event|2|||
146903459|NCT00927485|529808488|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
146903460|NCT00927485|529808489|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
146903461|NCT00594399|529808490|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
146903462|NCT00594399|529808491|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
146903463|NCT00594399|529808492|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
146903464|NCT00594399|529808490|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
146903465|NCT00594399|529808491|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
146903466|NCT00594399|529808492|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
146903467|NCT00594399|529808490|FG000|Initial 3 Month Counseling|Personal issues|2|||
146903468|NCT00594399|529808491|FG001|Initial 3 Month Counseling|Personal issues|0|||
146903469|NCT00594399|529808492|FG002|Initial 3 Month Counseling|Personal issues|0|||
146903470|NCT00594399|529808490|FG000|Initial 3 Month Counseling|Too busy|7|||
146903471|NCT00594399|529808491|FG001|Initial 3 Month Counseling|Too busy|1|||
146903472|NCT00594399|529808492|FG002|Initial 3 Month Counseling|Too busy|0|||
146903473|NCT00594399|529808490|FG000|Initial 3 Month Counseling|Pain|2|||
146903474|NCT00594399|529808491|FG001|Initial 3 Month Counseling|Pain|0|||
146903475|NCT00594399|529808492|FG002|Initial 3 Month Counseling|Pain|0|||
146903476|NCT00594399|529808490|FG000|Initial 3 Month Counseling|Moved|1|||
146903477|NCT00594399|529808491|FG001|Initial 3 Month Counseling|Moved|0|||
146903478|NCT00594399|529808492|FG002|Initial 3 Month Counseling|Moved|0|||
146640801|NCT02280408|528860942|FG000|Overall Study|Lost to Follow-up|0|||
146903479|NCT00594399|529808490|FG000|Initial 3 Month Counseling|Family illness|1|||
146903480|NCT00594399|529808491|FG001|Initial 3 Month Counseling|Family illness|0|||
146903481|NCT00594399|529808492|FG002|Initial 3 Month Counseling|Family illness|0|||
146903482|NCT00594399|529808490|FG000|Rerandomization Arm 1 Only|Death|2|||
146903483|NCT00594399|529808491|FG001|Rerandomization Arm 1 Only|Death|1|||
146903484|NCT00594399|529808492|FG002|Rerandomization Arm 1 Only|Death|0|||
146903485|NCT00594399|529808490|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
146903486|NCT00594399|529808491|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
146903487|NCT00594399|529808492|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
146903488|NCT03830281|529808493|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
146640802|NCT02280408|528860943|FG001|Overall Study|Lost to Follow-up|2|||
146903489|NCT03830281|529808494|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
146903490|NCT03830281|529808493|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
146903491|NCT03830281|529808494|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
146903492|NCT03830281|529808493|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
146903493|NCT03830281|529808494|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
146903494|NCT03830281|529808493|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
146903495|NCT03830281|529808494|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
146903496|NCT03830281|529808493|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
146903497|NCT03830281|529808494|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
146903498|NCT03830281|529808493|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
146903499|NCT03830281|529808494|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
146903500|NCT03830281|529808493|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
146903501|NCT03830281|529808494|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
146903502|NCT03830281|529808493|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
146903503|NCT03830281|529808494|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
146903504|NCT03830281|529808493|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
146903505|NCT03830281|529808494|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
146903506|NCT03293680|529808496|FG000|Overall Study|Death|1|||
146903507|NCT03293680|529808496|FG000|Overall Study|Did not meet inclusion criteria|8|||
146903508|NCT00922935|529808497|FG000|Overall Study|Protocol Violation|0|||
146903509|NCT00922935|529808498|FG001|Overall Study|Protocol Violation|3|||
146903510|NCT00922935|529808499|FG002|Overall Study|Protocol Violation|0|||
146903511|NCT00922935|529808497|FG000|Overall Study|Physician Decision|1|||
146903512|NCT00922935|529808498|FG001|Overall Study|Physician Decision|1|||
146903513|NCT00922935|529808499|FG002|Overall Study|Physician Decision|0|||
146903514|NCT00922935|529808497|FG000|Overall Study|Lost to Follow-up|0|||
146903515|NCT00922935|529808498|FG001|Overall Study|Lost to Follow-up|1|||
146903516|NCT00922935|529808499|FG002|Overall Study|Lost to Follow-up|0|||
146903517|NCT02201940|529808500|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
146903518|NCT02201940|529808501|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
146903519|NCT02201940|529808500|FG000|Overall Study|Lack of Efficacy|2|||
146903520|NCT02201940|529808501|FG001|Overall Study|Lack of Efficacy|113|||
146903521|NCT02201940|529808500|FG000|Overall Study|Lost to Follow-up|5|||
146903522|NCT02201940|529808501|FG001|Overall Study|Lost to Follow-up|0|||
146903523|NCT02201940|529808500|FG000|Overall Study|Withdrew Consent|2|||
146903524|NCT02201940|529808501|FG001|Overall Study|Withdrew Consent|1|||
146903525|NCT02201940|529808500|FG000|Overall Study|Investigator's Discretion|1|||
146903526|NCT02201940|529808501|FG001|Overall Study|Investigator's Discretion|1|||
146903527|NCT02201940|529808500|FG000|Overall Study|Death|1|||
146903528|NCT02201940|529808501|FG001|Overall Study|Death|0|||
146903529|NCT02201940|529808500|FG000|Overall Study|Adverse Event|0|||
146903530|NCT02201940|529808501|FG001|Overall Study|Adverse Event|1|||
146903531|NCT00074958|529808503|FG000|Overall Study|Adverse Event|1|||
146903532|NCT02690701|529808507|FG000|Treatment Period 1|Adverse Event|2|||
146903533|NCT02690701|529808508|FG001|Treatment Period 1|Adverse Event|2|||
146903534|NCT02690701|529808507|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146903535|NCT02690701|529808508|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146903536|NCT02690701|529808507|FG000|Treatment Period 2|Adverse Event|2|||
146903537|NCT02690701|529808508|FG001|Treatment Period 2|Adverse Event|0|||
146903538|NCT02690701|529808507|FG000|Treatment Period 2|Lack of Efficacy|1|||
146903539|NCT02690701|529808508|FG001|Treatment Period 2|Lack of Efficacy|0|||
146903540|NCT02690701|529808507|FG000|Treatment Period 2|Lost to Follow-up|0|||
146903541|NCT02690701|529808508|FG001|Treatment Period 2|Lost to Follow-up|2|||
146903542|NCT02690701|529808507|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146903543|NCT02690701|529808508|FG001|Treatment Period 2|Withdrawal by Subject|2|||
146903544|NCT02690701|529808507|FG000|Treatment Period 2|Protocol Violation|0|||
146903545|NCT02690701|529808508|FG001|Treatment Period 2|Protocol Violation|1|||
146903546|NCT02700451|529808509|FG000|Overall Study|Protocol Violation|2|||
146903547|NCT02700451|529808510|FG001|Overall Study|Protocol Violation|2|||
146903548|NCT02700451|529808511|FG002|Overall Study|Protocol Violation|3|||
146903549|NCT02700451|529808509|FG000|Overall Study|Discontinued intervention|14|||
146903550|NCT02700451|529808510|FG001|Overall Study|Discontinued intervention|15|||
146903551|NCT02700451|529808511|FG002|Overall Study|Discontinued intervention|14|||
146903552|NCT02115308|529808517|FG000|Overall Study|Safety Screening|2|||
146903553|NCT02115308|529808518|FG001|Overall Study|Safety Screening|2|||
146903554|NCT01126580|529808519|FG000|Overall Study|Adverse Event|14|||
146903555|NCT01126580|529808520|FG001|Overall Study|Adverse Event|8|||
146903556|NCT01126580|529808521|FG002|Overall Study|Adverse Event|12|||
146903557|NCT01126580|529808519|FG000|Overall Study|Withdrawal by Subject|11|||
146903558|NCT01126580|529808520|FG001|Overall Study|Withdrawal by Subject|19|||
146903559|NCT01126580|529808521|FG002|Overall Study|Withdrawal by Subject|14|||
146903560|NCT01126580|529808519|FG000|Overall Study|Sponsor Decision|5|||
146903561|NCT01126580|529808520|FG001|Overall Study|Sponsor Decision|4|||
146903562|NCT01126580|529808521|FG002|Overall Study|Sponsor Decision|7|||
146903563|NCT01126580|529808519|FG000|Overall Study|Physician Decision|1|||
146903564|NCT01126580|529808520|FG001|Overall Study|Physician Decision|1|||
146903565|NCT01126580|529808521|FG002|Overall Study|Physician Decision|2|||
146903566|NCT01126580|529808519|FG000|Overall Study|Entry Criteria Not Met|1|||
146903567|NCT01126580|529808520|FG001|Overall Study|Entry Criteria Not Met|1|||
146903568|NCT01126580|529808521|FG002|Overall Study|Entry Criteria Not Met|2|||
146903569|NCT01126580|529808519|FG000|Overall Study|Lack of Efficacy|2|||
146903570|NCT01126580|529808520|FG001|Overall Study|Lack of Efficacy|3|||
146903571|NCT01126580|529808521|FG002|Overall Study|Lack of Efficacy|4|||
146903572|NCT01126580|529808519|FG000|Overall Study|Protocol Violation|0|||
146903573|NCT01126580|529808520|FG001|Overall Study|Protocol Violation|1|||
146560728|NCT03895372|528564026|FG001|Investigational Treatment Period|Protocol Violation|0|||
146560729|NCT03895372|528564027|FG002|Investigational Treatment Period|Protocol Violation|0|||
146903574|NCT01126580|529808521|FG002|Overall Study|Protocol Violation|2|||
146903575|NCT01126580|529808519|FG000|Overall Study|Lost to Follow-up|15|||
146903576|NCT01126580|529808520|FG001|Overall Study|Lost to Follow-up|13|||
146903577|NCT01126580|529808521|FG002|Overall Study|Lost to Follow-up|9|||
146903578|NCT01126580|529808519|FG000|Overall Study|Treatment Non-compliance|0|||
146903579|NCT01126580|529808520|FG001|Overall Study|Treatment Non-compliance|2|||
146903580|NCT01126580|529808521|FG002|Overall Study|Treatment Non-compliance|3|||
146903581|NCT01731002|529808522|FG000|Overall Study|Adverse Event|0|||
146903582|NCT01731002|529808523|FG001|Overall Study|Adverse Event|2|||
146903583|NCT01731002|529808524|FG002|Overall Study|Adverse Event|2|||
146903584|NCT01731002|529808522|FG000|Overall Study|Non-Compliant|0|||
146903585|NCT01731002|529808523|FG001|Overall Study|Non-Compliant|1|||
146903586|NCT01731002|529808524|FG002|Overall Study|Non-Compliant|0|||
146903587|NCT01731002|529808522|FG000|Overall Study|Lost to Follow-up|1|||
146903588|NCT01731002|529808523|FG001|Overall Study|Lost to Follow-up|0|||
146903589|NCT01731002|529808524|FG002|Overall Study|Lost to Follow-up|0|||
146903590|NCT01731002|529808522|FG000|Overall Study|Test Agent Discontinuation|0|||
146903591|NCT01731002|529808523|FG001|Overall Study|Test Agent Discontinuation|1|||
146903592|NCT01731002|529808524|FG002|Overall Study|Test Agent Discontinuation|0|||
146903593|NCT01731002|529808522|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
146560730|NCT03895372|528564028|FG003|Investigational Treatment Period|Protocol Violation|1|||
146903594|NCT01731002|529808523|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
146903595|NCT01731002|529808524|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
146903596|NCT01731002|529808522|FG000|Overall Study|Elevated IOP|1|||
146903597|NCT01731002|529808523|FG001|Overall Study|Elevated IOP|0|||
146903598|NCT01731002|529808524|FG002|Overall Study|Elevated IOP|0|||
146903599|NCT01731002|529808522|FG000|Overall Study|Inappropriate use of study medications|0|||
146903600|NCT01731002|529808523|FG001|Overall Study|Inappropriate use of study medications|0|||
146903601|NCT01731002|529808524|FG002|Overall Study|Inappropriate use of study medications|1|||
146903602|NCT00947349|529808525|FG000|Triple Treatment Combination Period|Adverse Event|0|||
146903603|NCT00947349|529808526|FG001|Triple Treatment Combination Period|Adverse Event|1|||
146903604|NCT00947349|529808527|FG002|Triple Treatment Combination Period|Adverse Event|0|||
146903605|NCT00947349|529808528|FG003|Triple Treatment Combination Period|Adverse Event|0|||
146903606|NCT00947349|529808525|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
146903607|NCT00947349|529808526|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
146903608|NCT00947349|529808527|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
146903609|NCT00947349|529808528|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
146903610|NCT00947349|529808525|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
146903611|NCT00947349|529808526|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
146903612|NCT00947349|529808527|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
146903613|NCT00947349|529808528|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
146903614|NCT00947349|529808525|FG000|Overall Study Standard of Care|Other|0|||
146903615|NCT00947349|529808526|FG001|Overall Study Standard of Care|Other|0|||
146903616|NCT00947349|529808527|FG002|Overall Study Standard of Care|Other|0|||
146903617|NCT00947349|529808528|FG003|Overall Study Standard of Care|Other|1|||
146903618|NCT00473694|529810953|FG000|Overall Study|Adverse Event|0|||
146903619|NCT00473694|529810954|FG001|Overall Study|Adverse Event|1|||
146903620|NCT00473694|529810955|FG002|Overall Study|Adverse Event|0|||
146903621|NCT00473694|529810956|FG003|Overall Study|Adverse Event|0|||
146903622|NCT00473694|529810953|FG000|Overall Study|Participants did not receive treatment|11|||
146903623|NCT00473694|529810954|FG001|Overall Study|Participants did not receive treatment|3|||
146903624|NCT00473694|529810955|FG002|Overall Study|Participants did not receive treatment|5|||
146903625|NCT00473694|529810956|FG003|Overall Study|Participants did not receive treatment|6|||
146903626|NCT00473694|529810953|FG000|Overall Study|Lost to Follow-up|0|||
146903627|NCT00473694|529810954|FG001|Overall Study|Lost to Follow-up|0|||
146903628|NCT00473694|529810955|FG002|Overall Study|Lost to Follow-up|0|||
146903629|NCT00473694|529810956|FG003|Overall Study|Lost to Follow-up|1|||
146903630|NCT02468193|529810957|FG000|Overall Study|Adverse Event|4|||
146903631|NCT02468193|529810957|FG000|Overall Study|Subject/ Guardian decision|2|||
146903632|NCT00742781|529810958|FG000|Overall Study|Withdrawal by Subject|3|||
146903633|NCT01416181|529810959|FG000|Part 1|Other|10|||
146903634|NCT01416181|529810960|FG001|Part 1|Other|24|||
146903635|NCT01416181|529810959|FG000|Part 1|Death|0|||
146903636|NCT01416181|529810960|FG001|Part 1|Death|1|||
146903637|NCT01416181|529810959|FG000|Part 1|Investigator Decision|7|||
146903638|NCT01416181|529810960|FG001|Part 1|Investigator Decision|6|||
146903639|NCT01416181|529810959|FG000|Part 1|Withdrawal by Subject|74|||
146903640|NCT01416181|529810960|FG001|Part 1|Withdrawal by Subject|48|||
146903641|NCT01416181|529810959|FG000|Part 1|Lack of Efficacy|16|||
146903642|NCT01416181|529810960|FG001|Part 1|Lack of Efficacy|8|||
146903643|NCT01416181|529810959|FG000|Part 1|Lost to Follow-up|1|||
146903644|NCT01416181|529810960|FG001|Part 1|Lost to Follow-up|1|||
146903645|NCT01416181|529810959|FG000|Part 1|Adverse Event|15|||
146903646|NCT01416181|529810960|FG001|Part 1|Adverse Event|18|||
146903647|NCT01416181|529810959|FG000|Part 1|Ongoing in Follow-Up|14|||
146903648|NCT01416181|529810960|FG001|Part 1|Ongoing in Follow-Up|8|||
146903649|NCT01416181|529810959|FG000|Part 2|Adverse Event|11|||
146903650|NCT01416181|529810960|FG001|Part 2|Adverse Event|4|||
146560731|NCT03895372|528564029|FG004|Investigational Treatment Period|Protocol Violation|0|||
146903651|NCT01416181|529810959|FG000|Part 2|Other|234|||
146903652|NCT01416181|529810960|FG001|Part 2|Other|267|||
146903653|NCT01416181|529810959|FG000|Part 2|Investigator Decision|6|||
146903654|NCT01416181|529810960|FG001|Part 2|Investigator Decision|7|||
146903655|NCT01416181|529810959|FG000|Part 2|Withdrawal by Subject|14|||
146903656|NCT01416181|529810960|FG001|Part 2|Withdrawal by Subject|5|||
146903657|NCT01416181|529810959|FG000|Part 2|Lack of Efficacy|4|||
146903658|NCT01416181|529810960|FG001|Part 2|Lack of Efficacy|1|||
146903659|NCT01416181|529810959|FG000|Part 2|Lost to Follow-up|2|||
146560732|NCT03895372|528564030|FG005|Investigational Treatment Period|Protocol Violation|0|||
146903660|NCT01416181|529810960|FG001|Part 2|Lost to Follow-up|2|||
146903661|NCT03874234|529810961|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146903662|NCT03874234|529810962|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146903663|NCT03874234|529810963|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146903664|NCT03874234|529810964|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
146903665|NCT03874234|529810965|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146903666|NCT03874234|529810966|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146903667|NCT03874234|529810967|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146903668|NCT03874234|529810968|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146903669|NCT03874234|529810969|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146903670|NCT03874234|529810970|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146903671|NCT03874234|529810971|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146903672|NCT03874234|529810972|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146903673|NCT03874234|529810973|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146903674|NCT03874234|529810961|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
146903675|NCT03874234|529810962|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146903676|NCT03874234|529810963|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146903677|NCT03874234|529810964|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146640803|NCT02280408|528860944|FG002|Overall Study|Lost to Follow-up|0|||
146903678|NCT03874234|529810965|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146903679|NCT03874234|529810966|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146903680|NCT03874234|529810967|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146903681|NCT03874234|529810968|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146903682|NCT03874234|529810969|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146903683|NCT03874234|529810970|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146640804|NCT02280408|528860945|FG003|Overall Study|Lost to Follow-up|0|||
146640805|NCT01092117|528860946|FG000|Index Procedure to 1 Month|Death|1|||
146640806|NCT01092117|528860946|FG000|1 Month|Death|1|||
146640807|NCT01092117|528860946|FG000|1 Month|Withdrawal by Subject|1|||
146640808|NCT01092117|528860946|FG000|1 Month|Lost to Follow-up|1|||
146640809|NCT01092117|528860946|FG000|6 Months|Death|2|||
146640810|NCT01092117|528860946|FG000|6 Months|Withdrawal by Subject|3|||
146640811|NCT01092117|528860946|FG000|12 Month|Death|11|||
146640812|NCT01092117|528860946|FG000|12 Month|Withdrawal by Subject|2|||
146640813|NCT01092117|528860946|FG000|12 Month|Lost to Follow-up|1|||
146640814|NCT01092117|528860946|FG000|Year 2|Death|5|||
146640815|NCT01092117|528860946|FG000|Year 2|Withdrawal by Subject|4|||
146640816|NCT01092117|528860946|FG000|Year 2|Lost to Follow-up|1|||
146640817|NCT01092117|528860946|FG000|Year 3|Death|7|||
146640818|NCT01092117|528860946|FG000|Year 3|Withdrawal by Subject|9|||
146640819|NCT01092117|528860946|FG000|Year 3|Lost to Follow-up|3|||
146767411|NCT01400776|529317315|FG001|Overall Study|Adverse Event|2|||
146767412|NCT01400776|529317316|FG002|Overall Study|Adverse Event|9|||
146767413|NCT01400776|529317317|FG003|Overall Study|Adverse Event|2|||
146903684|NCT03874234|529810971|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146903685|NCT03874234|529810972|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146903686|NCT03874234|529810973|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146903687|NCT03874234|529810961|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146640820|NCT01092117|528860946|FG000|Year 4|Death|8|||
146640821|NCT01092117|528860946|FG000|Year 4|Withdrawal by Subject|4|||
146640822|NCT01092117|528860946|FG000|Year 4|Lost to Follow-up|4|||
146767414|NCT01400776|529317314|FG000|Overall Study|Lost to Follow-up|1|||
146903688|NCT03874234|529810962|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146903689|NCT03874234|529810963|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146903690|NCT03874234|529810964|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
146903691|NCT03874234|529810965|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146903692|NCT03874234|529810966|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146903693|NCT03874234|529810967|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146903694|NCT03874234|529810968|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146903695|NCT03874234|529810969|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146903696|NCT03874234|529810970|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146903697|NCT03874234|529810971|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146903698|NCT03874234|529810972|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146903699|NCT03874234|529810973|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146903700|NCT03874234|529810961|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146903701|NCT03874234|529810962|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146903702|NCT03874234|529810963|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146903703|NCT03874234|529810964|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146560733|NCT03895372|528564031|FG006|Investigational Treatment Period|Protocol Violation|0|||
146560734|NCT03895372|528564032|FG007|Investigational Treatment Period|Protocol Violation|0|||
146560735|NCT03895372|528564025|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
146560736|NCT03895372|528564026|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
146560737|NCT03895372|528564027|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
146560738|NCT03895372|528564028|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
146560739|NCT03895372|528564029|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
146560740|NCT03895372|528564030|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
146560741|NCT03895372|528564031|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
146560742|NCT03895372|528564032|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
146560743|NCT03895372|528564025|FG000|Extension Treatment Period|Adverse Event|0|||
146560744|NCT03895372|528564026|FG001|Extension Treatment Period|Adverse Event|1|||
146560745|NCT03895372|528564027|FG002|Extension Treatment Period|Adverse Event|0|||
146560746|NCT03895372|528564028|FG003|Extension Treatment Period|Adverse Event|1|||
146560747|NCT03895372|528564029|FG004|Extension Treatment Period|Adverse Event|0|||
146560748|NCT03895372|528564030|FG005|Extension Treatment Period|Adverse Event|0|||
146560749|NCT03895372|528564031|FG006|Extension Treatment Period|Adverse Event|3|||
146560750|NCT03895372|528564032|FG007|Extension Treatment Period|Adverse Event|3|||
146560751|NCT03895372|528564025|FG000|Extension Treatment Period|Other|1|||
146560752|NCT03895372|528564026|FG001|Extension Treatment Period|Other|3|||
146560753|NCT03895372|528564027|FG002|Extension Treatment Period|Other|0|||
146560754|NCT03895372|528564028|FG003|Extension Treatment Period|Other|0|||
146560755|NCT03895372|528564029|FG004|Extension Treatment Period|Other|1|||
146560756|NCT03895372|528564030|FG005|Extension Treatment Period|Other|0|||
146560757|NCT03895372|528564031|FG006|Extension Treatment Period|Other|0|||
146560758|NCT03895372|528564032|FG007|Extension Treatment Period|Other|2|||
146560759|NCT03895372|528564025|FG000|Extension Treatment Period|Pregnancy|0|||
146560760|NCT03895372|528564026|FG001|Extension Treatment Period|Pregnancy|0|||
146560761|NCT03895372|528564027|FG002|Extension Treatment Period|Pregnancy|0|||
146560762|NCT03895372|528564028|FG003|Extension Treatment Period|Pregnancy|0|||
146560763|NCT03895372|528564029|FG004|Extension Treatment Period|Pregnancy|1|||
146560764|NCT03895372|528564030|FG005|Extension Treatment Period|Pregnancy|0|||
146560765|NCT03895372|528564031|FG006|Extension Treatment Period|Pregnancy|0|||
146560766|NCT03895372|528564032|FG007|Extension Treatment Period|Pregnancy|0|||
146560767|NCT03895372|528564025|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
146560768|NCT03895372|528564026|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
146560769|NCT03895372|528564027|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
146560770|NCT03895372|528564028|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
146560771|NCT03895372|528564029|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
146560772|NCT03895372|528564030|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
146560773|NCT03895372|528564031|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
146560774|NCT03895372|528564032|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
146560775|NCT03559530|528564033|FG000|Overall Study|non-location of medical records|44|||
146560776|NCT03559530|528564034|FG001|Overall Study|non-location of medical records|0|||
146560777|NCT03559530|528564033|FG000|Overall Study|culture results not considered for treat|29|||
146560778|NCT03559530|528564034|FG001|Overall Study|culture results not considered for treat|0|||
146560779|NCT03559530|528564033|FG000|Overall Study|duplicate cases|8|||
146560780|NCT03559530|528564034|FG001|Overall Study|duplicate cases|0|||
146560781|NCT03559530|528564033|FG000|Overall Study|other species of Acinetobacte|7|||
146560782|NCT03559530|528564034|FG001|Overall Study|other species of Acinetobacte|0|||
146560783|NCT03559530|528564033|FG000|Overall Study|contamination / colonization|3|||
146560784|NCT03559530|528564034|FG001|Overall Study|contamination / colonization|0|||
146560785|NCT01309230|528564037|FG000|Overall Study|Withdrawal by Subject|0|||
146560786|NCT01309230|528564038|FG001|Overall Study|Withdrawal by Subject|2|||
146560787|NCT01309230|528564037|FG000|Overall Study|Observation arm closed|0|||
146560788|NCT01309230|528564038|FG001|Overall Study|Observation arm closed|2|||
146560789|NCT00427700|528564039|FG000|Overall Study|Lost to Follow-up|2|||
146560790|NCT00427700|528564040|FG001|Overall Study|Lost to Follow-up|5|||
146560791|NCT00427700|528564039|FG000|Overall Study|no induction of menses|1|||
146560792|NCT00427700|528564040|FG001|Overall Study|no induction of menses|4|||
146560793|NCT00427700|528564039|FG000|Overall Study|Pregnancy|0|||
146560794|NCT00427700|528564040|FG001|Overall Study|Pregnancy|2|||
146560795|NCT01362790|528564043|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
146560796|NCT01362790|528564044|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
146560797|NCT01362790|528564045|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
146560798|NCT01362790|528564046|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
146560799|NCT01362790|528564047|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
146640823|NCT02474069|528860947|FG000|Selection Phase (SP)|Adverse Event|8|||
146767415|NCT01400776|529317315|FG001|Overall Study|Lost to Follow-up|0|||
146767416|NCT01400776|529317316|FG002|Overall Study|Lost to Follow-up|4|||
146640824|NCT02474069|528860948|FG001|Selection Phase (SP)|Adverse Event|0|||
146640825|NCT02474069|528860949|FG002|Selection Phase (SP)|Adverse Event|0|||
146767417|NCT01400776|529317317|FG003|Overall Study|Lost to Follow-up|1|||
146903704|NCT03874234|529810965|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
146903705|NCT03874234|529810966|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146903706|NCT03874234|529810967|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146903707|NCT03874234|529810968|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146903708|NCT03874234|529810969|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146903709|NCT03874234|529810970|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146903710|NCT03874234|529810971|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146903711|NCT03874234|529810972|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146903712|NCT03874234|529810973|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146903713|NCT03874234|529810961|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146903714|NCT03874234|529810962|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146903715|NCT03874234|529810963|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146903716|NCT03874234|529810964|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146903717|NCT03874234|529810965|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146903718|NCT03874234|529810966|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146903719|NCT03874234|529810967|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146903720|NCT03874234|529810968|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
146903721|NCT03874234|529810969|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146903722|NCT03874234|529810970|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146903723|NCT03874234|529810971|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146903724|NCT03874234|529810972|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146903725|NCT03874234|529810973|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146903726|NCT03874234|529810961|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146903727|NCT03874234|529810962|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146903728|NCT03874234|529810963|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146903729|NCT03874234|529810964|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146903730|NCT03874234|529810965|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
146903731|NCT03874234|529810966|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
146903732|NCT03874234|529810967|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146903733|NCT03874234|529810968|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146903734|NCT03874234|529810969|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146903735|NCT03874234|529810970|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146903736|NCT03874234|529810971|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146903737|NCT03874234|529810972|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146903738|NCT03874234|529810973|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146903739|NCT03874234|529810961|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146903740|NCT03874234|529810962|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146903741|NCT03874234|529810963|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146903742|NCT03874234|529810964|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146903743|NCT03874234|529810965|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146903744|NCT03874234|529810966|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146903745|NCT03874234|529810967|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
146903746|NCT03874234|529810968|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146903747|NCT03874234|529810969|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146903748|NCT03874234|529810970|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146903749|NCT03874234|529810971|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146903750|NCT03874234|529810972|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146903751|NCT03874234|529810973|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146903752|NCT03874234|529810961|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146903753|NCT03874234|529810962|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146903754|NCT03874234|529810963|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146903755|NCT03874234|529810964|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146903756|NCT03874234|529810965|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
146903757|NCT03874234|529810966|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146903758|NCT03874234|529810967|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146903759|NCT03874234|529810968|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146903760|NCT03874234|529810969|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146903761|NCT03874234|529810970|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146903762|NCT03874234|529810971|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146903763|NCT03874234|529810972|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146903764|NCT03874234|529810973|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146903765|NCT01896232|529810976|FG000|Overall Study|Death|6|||
146903766|NCT01896232|529810977|FG001|Overall Study|Death|10|||
146903767|NCT01896232|529810976|FG000|Overall Study|Withdrawal by Subject|32|||
146903768|NCT01896232|529810977|FG001|Overall Study|Withdrawal by Subject|31|||
146903769|NCT01896232|529810976|FG000|Overall Study|Sponsor Decision|2|||
146903770|NCT01896232|529810977|FG001|Overall Study|Sponsor Decision|0|||
146903771|NCT01896232|529810976|FG000|Overall Study|Lost to Follow-up|9|||
146560800|NCT01362790|528564048|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
146560801|NCT01362790|528564049|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
146903772|NCT01896232|529810977|FG001|Overall Study|Lost to Follow-up|12|||
146903773|NCT03816995|529810988|FG000|Overall Study|Withdrawal by Subject|3|||
146903774|NCT03816995|529810989|FG001|Overall Study|Withdrawal by Subject|1|||
146903775|NCT03816995|529810988|FG000|Overall Study|Cancelled Surgery|8|||
146903776|NCT03816995|529810989|FG001|Overall Study|Cancelled Surgery|12|||
146560802|NCT01362790|528564043|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
146903777|NCT03816995|529810988|FG000|Overall Study|No wound protector used|11|||
146903778|NCT03816995|529810989|FG001|Overall Study|No wound protector used|17|||
146903779|NCT03816995|529810988|FG000|Overall Study|Protocol Violation|2|||
146903780|NCT03816995|529810989|FG001|Overall Study|Protocol Violation|3|||
146903781|NCT01324830|529810990|FG000|Overall Study|Progressive Disease|3|||
146903782|NCT01324830|529810991|FG001|Overall Study|Progressive Disease|2|||
146560803|NCT01362790|528564044|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
146560804|NCT01362790|528564045|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
146560805|NCT01362790|528564046|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
146560806|NCT01362790|528564047|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
146560807|NCT01362790|528564048|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
146560808|NCT01362790|528564049|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
146560809|NCT01362790|528564043|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
146560810|NCT01362790|528564044|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
146560811|NCT01362790|528564045|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
146560812|NCT01362790|528564046|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
146560813|NCT01362790|528564047|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
146560814|NCT01362790|528564048|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
146560815|NCT01362790|528564049|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
146560816|NCT01362790|528564043|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
146560817|NCT01362790|528564044|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
146560818|NCT01362790|528564045|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
146560819|NCT01362790|528564046|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
146560820|NCT01362790|528564047|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
146560821|NCT01362790|528564048|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
146560822|NCT01362790|528564049|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
146560823|NCT01362790|528564043|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
146560824|NCT01362790|528564044|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
146560825|NCT01362790|528564045|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
146560826|NCT01362790|528564046|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
146560827|NCT01362790|528564047|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
146560828|NCT01362790|528564048|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
146560829|NCT01362790|528564049|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
146560830|NCT01362790|528564043|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
146560831|NCT01362790|528564044|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
146560832|NCT01362790|528564045|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
146560833|NCT01362790|528564046|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
146560834|NCT01362790|528564047|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
146560835|NCT01362790|528564048|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
146560836|NCT01362790|528564049|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
146560837|NCT01362790|528564043|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
146560838|NCT01362790|528564044|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
146560839|NCT01362790|528564045|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
146560840|NCT01362790|528564046|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
146560841|NCT01362790|528564047|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
146560842|NCT01362790|528564048|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
146560843|NCT01362790|528564049|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
146560844|NCT01362790|528564043|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
146560845|NCT01362790|528564044|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
146560846|NCT01362790|528564045|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
146560847|NCT01362790|528564046|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
146560848|NCT01362790|528564047|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
146560849|NCT01362790|528564048|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
146560850|NCT01362790|528564049|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
146560851|NCT01362790|528564043|FG000|Pilot Phase & Phase 2|Death on study|0|||
146560852|NCT01362790|528564044|FG001|Pilot Phase & Phase 2|Death on study|0|||
146903783|NCT01324830|529810992|FG002|Overall Study|Progressive Disease|3|||
146903784|NCT01324830|529810993|FG003|Overall Study|Progressive Disease|3|||
146903785|NCT01324830|529810994|FG004|Overall Study|Progressive Disease|6|||
146903786|NCT01324830|529810995|FG005|Overall Study|Progressive Disease|6|||
146560853|NCT01362790|528564045|FG002|Pilot Phase & Phase 2|Death on study|0|||
146560854|NCT01362790|528564046|FG003|Pilot Phase & Phase 2|Death on study|1|||
146560855|NCT01362790|528564047|FG004|Pilot Phase & Phase 2|Death on study|0|||
146560856|NCT01362790|528564048|FG005|Pilot Phase & Phase 2|Death on study|0|||
146560857|NCT01362790|528564049|FG006|Pilot Phase & Phase 2|Death on study|0|||
146560858|NCT01362790|528564043|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
146560859|NCT01362790|528564044|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
146560860|NCT01362790|528564045|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
146560861|NCT01362790|528564046|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
146560862|NCT01362790|528564047|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
146560863|NCT01362790|528564048|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
146560864|NCT01362790|528564049|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
146560865|NCT01362790|528564043|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
146560866|NCT01362790|528564044|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
146560867|NCT01362790|528564045|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
146560868|NCT01362790|528564046|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
146903787|NCT01324830|529810996|FG006|Overall Study|Progressive Disease|3|||
146903788|NCT01324830|529810997|FG007|Overall Study|Progressive Disease|3|||
146903789|NCT01324830|529810998|FG008|Overall Study|Progressive Disease|3|||
146903790|NCT01324830|529810999|FG009|Overall Study|Progressive Disease|6|||
146903791|NCT01324830|529811000|FG010|Overall Study|Progressive Disease|2|||
146903792|NCT01324830|529811001|FG011|Overall Study|Progressive Disease|1|||
146903793|NCT01324830|529811002|FG012|Overall Study|Progressive Disease|1|||
146903794|NCT01324830|529811003|FG013|Overall Study|Progressive Disease|1|||
146903795|NCT01324830|529811004|FG014|Overall Study|Progressive Disease|1|||
146903796|NCT01324830|529811005|FG015|Overall Study|Progressive Disease|3|||
146903797|NCT01324830|529811006|FG016|Overall Study|Progressive Disease|2|||
146903798|NCT01324830|529811007|FG017|Overall Study|Progressive Disease|3|||
146903799|NCT01324830|529811008|FG018|Overall Study|Progressive Disease|4|||
146903800|NCT01324830|529810990|FG000|Overall Study|Dose limiting toxicity|0|||
146903801|NCT01324830|529810991|FG001|Overall Study|Dose limiting toxicity|0|||
146903802|NCT01324830|529810992|FG002|Overall Study|Dose limiting toxicity|0|||
146903803|NCT01324830|529810993|FG003|Overall Study|Dose limiting toxicity|0|||
146903804|NCT01324830|529810994|FG004|Overall Study|Dose limiting toxicity|1|||
146903805|NCT01324830|529810995|FG005|Overall Study|Dose limiting toxicity|0|||
146903806|NCT01324830|529810996|FG006|Overall Study|Dose limiting toxicity|0|||
146903807|NCT01324830|529810997|FG007|Overall Study|Dose limiting toxicity|0|||
146903808|NCT01324830|529810998|FG008|Overall Study|Dose limiting toxicity|0|||
146903809|NCT01324830|529810999|FG009|Overall Study|Dose limiting toxicity|0|||
146903810|NCT01324830|529811000|FG010|Overall Study|Dose limiting toxicity|0|||
146903811|NCT01324830|529811001|FG011|Overall Study|Dose limiting toxicity|0|||
146903812|NCT01324830|529811002|FG012|Overall Study|Dose limiting toxicity|0|||
146903813|NCT01324830|529811003|FG013|Overall Study|Dose limiting toxicity|0|||
146903814|NCT01324830|529811004|FG014|Overall Study|Dose limiting toxicity|0|||
146903815|NCT01324830|529811005|FG015|Overall Study|Dose limiting toxicity|0|||
146903816|NCT01324830|529811006|FG016|Overall Study|Dose limiting toxicity|1|||
146903817|NCT01324830|529811007|FG017|Overall Study|Dose limiting toxicity|1|||
146903818|NCT01324830|529811008|FG018|Overall Study|Dose limiting toxicity|1|||
146903819|NCT01324830|529810990|FG000|Overall Study|Reason not mentioned above|0|||
146903820|NCT01324830|529810991|FG001|Overall Study|Reason not mentioned above|0|||
146903821|NCT01324830|529810992|FG002|Overall Study|Reason not mentioned above|0|||
146903822|NCT01324830|529810993|FG003|Overall Study|Reason not mentioned above|0|||
146903823|NCT01324830|529810994|FG004|Overall Study|Reason not mentioned above|0|||
146903824|NCT01324830|529810995|FG005|Overall Study|Reason not mentioned above|0|||
146903825|NCT01324830|529810996|FG006|Overall Study|Reason not mentioned above|0|||
146903826|NCT01324830|529810997|FG007|Overall Study|Reason not mentioned above|0|||
146903827|NCT01324830|529810998|FG008|Overall Study|Reason not mentioned above|0|||
146903828|NCT01324830|529810999|FG009|Overall Study|Reason not mentioned above|0|||
146903829|NCT01324830|529811000|FG010|Overall Study|Reason not mentioned above|0|||
146903830|NCT01324830|529811001|FG011|Overall Study|Reason not mentioned above|0|||
146903831|NCT01324830|529811002|FG012|Overall Study|Reason not mentioned above|0|||
146903832|NCT01324830|529811003|FG013|Overall Study|Reason not mentioned above|0|||
146903833|NCT01324830|529811004|FG014|Overall Study|Reason not mentioned above|0|||
146903834|NCT01324830|529811005|FG015|Overall Study|Reason not mentioned above|0|||
146903835|NCT01324830|529811006|FG016|Overall Study|Reason not mentioned above|0|||
146903836|NCT01324830|529811007|FG017|Overall Study|Reason not mentioned above|1|||
146903837|NCT01324830|529811008|FG018|Overall Study|Reason not mentioned above|0|||
146903838|NCT01324830|529810990|FG000|Overall Study|Adverse Event, serious fatal|0|||
146903839|NCT01324830|529810991|FG001|Overall Study|Adverse Event, serious fatal|1|||
146903840|NCT01324830|529810992|FG002|Overall Study|Adverse Event, serious fatal|0|||
146903841|NCT01324830|529810993|FG003|Overall Study|Adverse Event, serious fatal|0|||
146903842|NCT01324830|529810994|FG004|Overall Study|Adverse Event, serious fatal|0|||
146903843|NCT01324830|529810995|FG005|Overall Study|Adverse Event, serious fatal|0|||
146903844|NCT01324830|529810996|FG006|Overall Study|Adverse Event, serious fatal|0|||
146903845|NCT01324830|529810997|FG007|Overall Study|Adverse Event, serious fatal|0|||
146903846|NCT01324830|529810998|FG008|Overall Study|Adverse Event, serious fatal|0|||
146903847|NCT01324830|529810999|FG009|Overall Study|Adverse Event, serious fatal|0|||
146903848|NCT01324830|529811000|FG010|Overall Study|Adverse Event, serious fatal|0|||
146903849|NCT01324830|529811001|FG011|Overall Study|Adverse Event, serious fatal|0|||
146903850|NCT01324830|529811002|FG012|Overall Study|Adverse Event, serious fatal|0|||
146903851|NCT01324830|529811003|FG013|Overall Study|Adverse Event, serious fatal|0|||
146903852|NCT01324830|529811004|FG014|Overall Study|Adverse Event, serious fatal|0|||
146903853|NCT01324830|529811005|FG015|Overall Study|Adverse Event, serious fatal|0|||
146903854|NCT01324830|529811006|FG016|Overall Study|Adverse Event, serious fatal|0|||
146903855|NCT01324830|529811007|FG017|Overall Study|Adverse Event, serious fatal|0|||
146903856|NCT01324830|529811008|FG018|Overall Study|Adverse Event, serious fatal|0|||
146903857|NCT01324830|529810990|FG000|Overall Study|Adverse Event, non-fatal|0|||
146903858|NCT01324830|529810991|FG001|Overall Study|Adverse Event, non-fatal|0|||
146903859|NCT01324830|529810992|FG002|Overall Study|Adverse Event, non-fatal|0|||
146903860|NCT01324830|529810993|FG003|Overall Study|Adverse Event, non-fatal|0|||
146903861|NCT01324830|529810994|FG004|Overall Study|Adverse Event, non-fatal|0|||
146903862|NCT01324830|529810995|FG005|Overall Study|Adverse Event, non-fatal|0|||
146903863|NCT01324830|529810996|FG006|Overall Study|Adverse Event, non-fatal|0|||
146903864|NCT01324830|529810997|FG007|Overall Study|Adverse Event, non-fatal|0|||
146903865|NCT01324830|529810998|FG008|Overall Study|Adverse Event, non-fatal|2|||
146903866|NCT01324830|529810999|FG009|Overall Study|Adverse Event, non-fatal|0|||
146903867|NCT01324830|529811000|FG010|Overall Study|Adverse Event, non-fatal|1|||
146903868|NCT01324830|529811001|FG011|Overall Study|Adverse Event, non-fatal|0|||
146903869|NCT01324830|529811002|FG012|Overall Study|Adverse Event, non-fatal|0|||
146903870|NCT01324830|529811003|FG013|Overall Study|Adverse Event, non-fatal|0|||
146903871|NCT01324830|529811004|FG014|Overall Study|Adverse Event, non-fatal|0|||
146903872|NCT01324830|529811005|FG015|Overall Study|Adverse Event, non-fatal|0|||
146903873|NCT01324830|529811006|FG016|Overall Study|Adverse Event, non-fatal|0|||
146903874|NCT01324830|529811007|FG017|Overall Study|Adverse Event, non-fatal|1|||
146903875|NCT01324830|529811008|FG018|Overall Study|Adverse Event, non-fatal|0|||
146903876|NCT01324830|529810990|FG000|Overall Study|Withdrawal by Subject|0|||
146640826|NCT02474069|528860947|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
146903877|NCT01324830|529810991|FG001|Overall Study|Withdrawal by Subject|0|||
146903878|NCT01324830|529810992|FG002|Overall Study|Withdrawal by Subject|0|||
146640827|NCT02474069|528860948|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
146903879|NCT01324830|529810993|FG003|Overall Study|Withdrawal by Subject|0|||
146903880|NCT01324830|529810994|FG004|Overall Study|Withdrawal by Subject|0|||
146560869|NCT01362790|528564047|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
146560870|NCT01362790|528564048|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
146560871|NCT01362790|528564049|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
146560872|NCT01362790|528564043|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
146767418|NCT01400776|529317314|FG000|Overall Study|Withdrew Consent|4|||
146767419|NCT01400776|529317315|FG001|Overall Study|Withdrew Consent|2|||
146767420|NCT01400776|529317316|FG002|Overall Study|Withdrew Consent|6|||
146767421|NCT01400776|529317317|FG003|Overall Study|Withdrew Consent|1|||
146767422|NCT01400776|529317314|FG000|Overall Study|Protocol Deviation|6|||
146767423|NCT01400776|529317315|FG001|Overall Study|Protocol Deviation|1|||
146767424|NCT01400776|529317316|FG002|Overall Study|Protocol Deviation|5|||
146767425|NCT01400776|529317317|FG003|Overall Study|Protocol Deviation|2|||
146767426|NCT01400776|529317314|FG000|Overall Study|Reason not Specified|3|||
146767427|NCT01400776|529317315|FG001|Overall Study|Reason not Specified|0|||
146767428|NCT01400776|529317316|FG002|Overall Study|Reason not Specified|4|||
146767429|NCT01400776|529317317|FG003|Overall Study|Reason not Specified|3|||
146767430|NCT00391846|529317318|FG000|Overall Study|Adverse Event|4|||
146767431|NCT00391846|529317319|FG001|Overall Study|Adverse Event|1|||
146767432|NCT00391846|529317318|FG000|Overall Study|Did not meet the required elig. crit|2|||
146767433|NCT00391846|529317319|FG001|Overall Study|Did not meet the required elig. crit|2|||
146767434|NCT00391846|529317318|FG000|Overall Study|Withdrawal by Subject|2|||
146767435|NCT00391846|529317319|FG001|Overall Study|Withdrawal by Subject|3|||
146767436|NCT00391846|529317318|FG000|Overall Study|Developed study specific DC criteria|0|||
146767437|NCT00391846|529317319|FG001|Overall Study|Developed study specific DC criteria|1|||
146767438|NCT04035668|529317320|FG000|Overall Study|Adverse Event|3|||
146767439|NCT04035668|529317321|FG001|Overall Study|Adverse Event|4|||
146767440|NCT04035668|529317322|FG002|Overall Study|Adverse Event|2|||
146767441|NCT04035668|529317320|FG000|Overall Study|Lost to Follow-up|0|||
146560873|NCT01362790|528564044|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
146767442|NCT04035668|529317321|FG001|Overall Study|Lost to Follow-up|1|||
146767443|NCT04035668|529317322|FG002|Overall Study|Lost to Follow-up|0|||
146767444|NCT04035668|529317320|FG000|Overall Study|Physician Decision|2|||
146767445|NCT04035668|529317321|FG001|Overall Study|Physician Decision|1|||
146767446|NCT04035668|529317322|FG002|Overall Study|Physician Decision|1|||
146767447|NCT04035668|529317320|FG000|Overall Study|Subject Decision|2|||
146767448|NCT04035668|529317321|FG001|Overall Study|Subject Decision|2|||
146767449|NCT04035668|529317322|FG002|Overall Study|Subject Decision|0|||
146767450|NCT02937831|529317324|FG000|Overall Study|Protocol Violation|4|||
146767451|NCT01376089|529317325|FG000|Overall Study|Patient received no contrast media|3|||
146767452|NCT01376089|529317326|FG001|Overall Study|Patient received no contrast media|4|||
146767453|NCT00419094|529317329|FG000|Overall Study|Adverse Event|3|||
146767454|NCT00419094|529317330|FG001|Overall Study|Adverse Event|7|||
146767455|NCT00419094|529317329|FG000|Overall Study|Lack of Efficacy|1|||
146767456|NCT00419094|529317330|FG001|Overall Study|Lack of Efficacy|0|||
146767457|NCT00419094|529317329|FG000|Overall Study|Lost to Follow-up|0|||
146767458|NCT00419094|529317330|FG001|Overall Study|Lost to Follow-up|2|||
146767459|NCT00419094|529317329|FG000|Overall Study|Protocol Violation|1|||
146767460|NCT00419094|529317330|FG001|Overall Study|Protocol Violation|14|||
146767461|NCT00419094|529317329|FG000|Overall Study|Withdrawal of consent|1|||
146767462|NCT00419094|529317330|FG001|Overall Study|Withdrawal of consent|5|||
146767463|NCT00419094|529317329|FG000|Overall Study|Other: Error determining exit criteria|1|||
146767464|NCT00419094|529317330|FG001|Overall Study|Other: Error determining exit criteria|0|||
146767465|NCT00419094|529317329|FG000|Overall Study|Other: Patient non-compliant|0|||
146767466|NCT00419094|529317330|FG001|Overall Study|Other: Patient non-compliant|1|||
146767467|NCT00419094|529317329|FG000|Overall Study|Other: No contact for extended period|0|||
146767468|NCT00419094|529317330|FG001|Overall Study|Other: No contact for extended period|1|||
146767469|NCT01811706|529317331|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
146767470|NCT01811706|529317332|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
146767471|NCT03020745|529317333|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
146767472|NCT03020745|529317334|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
146767473|NCT03020745|529317335|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
146767474|NCT03020745|529317336|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
146767475|NCT03020745|529317337|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
146767476|NCT03020745|529317338|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
146767477|NCT03020745|529317339|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
146767478|NCT03020745|529317340|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
146767479|NCT03020745|529317341|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
146767480|NCT03020745|529317342|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
146767481|NCT03020745|529317333|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146767482|NCT03020745|529317334|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146767483|NCT03020745|529317335|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146767484|NCT03020745|529317336|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146767485|NCT03020745|529317337|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146767486|NCT03020745|529317338|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146767487|NCT03020745|529317339|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146767488|NCT03020745|529317340|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
146767489|NCT03020745|529317341|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146767490|NCT03020745|529317342|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146767491|NCT03020745|529317333|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
146767492|NCT03020745|529317334|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
146767493|NCT03020745|529317335|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
146767494|NCT03020745|529317336|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
146767495|NCT03020745|529317337|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
146767496|NCT03020745|529317338|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
146767497|NCT03020745|529317339|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
146767498|NCT03020745|529317340|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
146767499|NCT03020745|529317341|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
146767500|NCT03020745|529317342|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
146767501|NCT03020745|529317333|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146767502|NCT03020745|529317334|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146560874|NCT01362790|528564045|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
146560875|NCT01362790|528564046|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
146560876|NCT01362790|528564047|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
146560877|NCT01362790|528564048|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
146560878|NCT01362790|528564049|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
146560879|NCT03038087|528564050|FG000|Overall Study|lost data|1|||
146560880|NCT00759395|528564052|FG000|Overall Study|Adverse Event|1|||
146767503|NCT03020745|529317335|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146767504|NCT03020745|529317336|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146767505|NCT03020745|529317337|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146767506|NCT03020745|529317338|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146767507|NCT03020745|529317339|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146767508|NCT03020745|529317340|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146767509|NCT03020745|529317341|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
146560881|NCT00759395|528564053|FG001|Overall Study|Adverse Event|0|||
146767510|NCT03020745|529317342|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146767511|NCT02057692|529317347|FG000|Overall Study|Adverse Event|1|||
146767512|NCT02057692|529317348|FG001|Overall Study|Adverse Event|0|||
146767513|NCT02057692|529317349|FG002|Overall Study|Adverse Event|0|||
146767514|NCT02057692|529317350|FG003|Overall Study|Adverse Event|0|||
146767515|NCT02057692|529317347|FG000|Overall Study|Lost to Follow-up|0|||
146767516|NCT02057692|529317348|FG001|Overall Study|Lost to Follow-up|0|||
146767517|NCT02057692|529317349|FG002|Overall Study|Lost to Follow-up|0|||
146767518|NCT02057692|529317350|FG003|Overall Study|Lost to Follow-up|1|||
146767519|NCT03823300|529317357|FG000|Overall Study|Withdrawal by Subject|16|||
146767520|NCT03823300|529317358|FG001|Overall Study|Withdrawal by Subject|22|||
146767521|NCT03823300|529317357|FG000|Overall Study|Death|10|||
146767522|NCT03823300|529317358|FG001|Overall Study|Death|14|||
146767523|NCT03823300|529317357|FG000|Overall Study|Adverse Event|3|||
146767524|NCT03823300|529317358|FG001|Overall Study|Adverse Event|5|||
146767525|NCT03823300|529317357|FG000|Overall Study|Physician Decision|1|||
146767526|NCT03823300|529317358|FG001|Overall Study|Physician Decision|7|||
146767527|NCT03823300|529317357|FG000|Overall Study|Lost to Follow-up|1|||
146767528|NCT03823300|529317358|FG001|Overall Study|Lost to Follow-up|3|||
146767529|NCT03823300|529317357|FG000|Overall Study|Protocol Violation|1|||
146767530|NCT03823300|529317358|FG001|Overall Study|Protocol Violation|1|||
146767531|NCT03823300|529317357|FG000|Overall Study|Lack of Efficacy|1|||
146767532|NCT03823300|529317358|FG001|Overall Study|Lack of Efficacy|1|||
146767533|NCT03823300|529317357|FG000|Overall Study|Not Eligible|0|||
146767534|NCT03823300|529317358|FG001|Overall Study|Not Eligible|1|||
146767535|NCT03823300|529317357|FG000|Overall Study|Other|1|||
146767536|NCT03823300|529317358|FG001|Overall Study|Other|0|||
146767537|NCT00241644|529317360|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
146767538|NCT00241644|529317361|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
146767539|NCT00241644|529317362|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
146767540|NCT00241644|529317363|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
146767541|NCT00241644|529317360|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
146767542|NCT00241644|529317361|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
146767543|NCT00241644|529317362|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
146767544|NCT00241644|529317363|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
146767545|NCT00241644|529317360|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
146767546|NCT00241644|529317361|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
146767547|NCT00241644|529317362|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
146767548|NCT00241644|529317363|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
146767549|NCT00241644|529317360|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
146767550|NCT00241644|529317361|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
146767551|NCT00241644|529317362|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
146767552|NCT00241644|529317363|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
146767553|NCT00241644|529317360|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
146767554|NCT00241644|529317361|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
146767555|NCT00241644|529317362|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
146767556|NCT00241644|529317363|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
146767557|NCT00241644|529317360|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
146767558|NCT00241644|529317361|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
146767559|NCT00241644|529317362|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
146767560|NCT00241644|529317363|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
146767561|NCT00241644|529317360|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
146767562|NCT00241644|529317361|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
146767563|NCT00241644|529317362|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
146767564|NCT00241644|529317363|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
146767565|NCT00241644|529317360|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
146767566|NCT00241644|529317361|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
146560882|NCT00759395|528564052|FG000|Overall Study|Withdrawal by Subject|1|||
146560883|NCT00759395|528564053|FG001|Overall Study|Withdrawal by Subject|0|||
146560884|NCT00759395|528564052|FG000|Overall Study|Lack of Efficacy|0|||
146560885|NCT00759395|528564053|FG001|Overall Study|Lack of Efficacy|2|||
146560886|NCT01435356|528564054|FG000|Overall Study|Adverse Event|2|||
146767567|NCT00241644|529317362|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
146560887|NCT01435356|528564055|FG001|Overall Study|Adverse Event|0|||
146560888|NCT01435356|528564054|FG000|Overall Study|Disease progression/recurrence|17|||
146560889|NCT01435356|528564055|FG001|Overall Study|Disease progression/recurrence|10|||
146767568|NCT00241644|529317363|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
146767569|NCT00241644|529317360|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
146560890|NCT01435356|528564054|FG000|Overall Study|Protocol Violation|0|||
146767570|NCT00241644|529317361|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
146767571|NCT00241644|529317362|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
146767572|NCT00241644|529317363|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
146560891|NCT01435356|528564055|FG001|Overall Study|Protocol Violation|1|||
146640828|NCT02474069|528860949|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
146640829|NCT02474069|528860947|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
146640830|NCT02474069|528860948|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
146640831|NCT02474069|528860949|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
146640832|NCT02474069|528860947|FG000|Selection Phase (SP)|Physician Decision|1|||
146640833|NCT02474069|528860948|FG001|Selection Phase (SP)|Physician Decision|0|||
146640834|NCT02474069|528860949|FG002|Selection Phase (SP)|Physician Decision|0|||
146640835|NCT02474069|528860947|FG000|Selection Phase (SP)|Protocol Violation|1|||
146640836|NCT02474069|528860948|FG001|Selection Phase (SP)|Protocol Violation|0|||
146640837|NCT02474069|528860949|FG002|Selection Phase (SP)|Protocol Violation|0|||
146640838|NCT02474069|528860947|FG000|Selection Phase (SP)|No longer requires treatment|1|||
146640839|NCT02474069|528860948|FG001|Selection Phase (SP)|No longer requires treatment|0|||
146640840|NCT02474069|528860949|FG002|Selection Phase (SP)|No longer requires treatment|0|||
146640841|NCT02474069|528860947|FG000|Selection Phase (SP)|Technical Problem|1|||
146640842|NCT02474069|528860948|FG001|Selection Phase (SP)|Technical Problem|0|||
146640843|NCT02474069|528860949|FG002|Selection Phase (SP)|Technical Problem|0|||
146640844|NCT02474069|528860947|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
146640845|NCT02474069|528860948|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
146640846|NCT02474069|528860949|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
146640847|NCT02474069|528860947|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
146640848|NCT02474069|528860948|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
146640849|NCT02474069|528860949|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
146640850|NCT02474069|528860947|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
146903881|NCT01324830|529810995|FG005|Overall Study|Withdrawal by Subject|1|||
146903882|NCT01324830|529810996|FG006|Overall Study|Withdrawal by Subject|0|||
146903883|NCT01324830|529810997|FG007|Overall Study|Withdrawal by Subject|0|||
146903884|NCT01324830|529810998|FG008|Overall Study|Withdrawal by Subject|0|||
146903885|NCT01324830|529810999|FG009|Overall Study|Withdrawal by Subject|0|||
146903886|NCT01324830|529811000|FG010|Overall Study|Withdrawal by Subject|1|||
146903887|NCT01324830|529811001|FG011|Overall Study|Withdrawal by Subject|0|||
146903888|NCT01324830|529811002|FG012|Overall Study|Withdrawal by Subject|0|||
146903889|NCT01324830|529811003|FG013|Overall Study|Withdrawal by Subject|0|||
146903890|NCT01324830|529811004|FG014|Overall Study|Withdrawal by Subject|0|||
146903891|NCT01324830|529811005|FG015|Overall Study|Withdrawal by Subject|0|||
146903892|NCT01324830|529811006|FG016|Overall Study|Withdrawal by Subject|0|||
146903893|NCT01324830|529811007|FG017|Overall Study|Withdrawal by Subject|0|||
146903894|NCT01324830|529811008|FG018|Overall Study|Withdrawal by Subject|1|||
146903895|NCT01485614|529811009|FG000|Randomization|Not Treated|1|||
146903896|NCT01485614|529811010|FG001|Randomization|Not Treated|0|||
146903897|NCT01485614|529811011|FG002|Randomization|Not Treated|0|||
146903898|NCT01485614|529811012|FG003|Randomization|Not Treated|0|||
146903899|NCT01485614|529811009|FG000|Weeks 0-20|Lost to Follow-up|2|||
146903900|NCT01485614|529811010|FG001|Weeks 0-20|Lost to Follow-up|0|||
146903901|NCT01485614|529811011|FG002|Weeks 0-20|Lost to Follow-up|0|||
146903902|NCT01485614|529811012|FG003|Weeks 0-20|Lost to Follow-up|0|||
146903903|NCT01485614|529811009|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
146903904|NCT01485614|529811010|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
146903905|NCT01485614|529811011|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
146560892|NCT01435356|528564054|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
146767573|NCT00241644|529317360|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
146767574|NCT00241644|529317361|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
146903906|NCT01485614|529811012|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
146903907|NCT01485614|529811009|FG000|Weeks 0-20|Withdrawal by Subject|3|||
146903908|NCT01485614|529811010|FG001|Weeks 0-20|Withdrawal by Subject|2|||
146903909|NCT01485614|529811011|FG002|Weeks 0-20|Withdrawal by Subject|1|||
146903910|NCT01485614|529811012|FG003|Weeks 0-20|Withdrawal by Subject|0|||
146903911|NCT01485614|529811009|FG000|Weeks 20-54|Lost to Follow-up|4|||
146903912|NCT01485614|529811010|FG001|Weeks 20-54|Lost to Follow-up|3|||
146560893|NCT01435356|528564055|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
146903913|NCT01485614|529811011|FG002|Weeks 20-54|Lost to Follow-up|1|||
146903914|NCT01485614|529811012|FG003|Weeks 20-54|Lost to Follow-up|0|||
146903915|NCT01485614|529811009|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
146903916|NCT01485614|529811010|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
146903917|NCT01485614|529811011|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
146903918|NCT01485614|529811012|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
146903919|NCT01485614|529811009|FG000|Weeks 20-54|Withdrawal by Subject|5|||
146903920|NCT01485614|529811010|FG001|Weeks 20-54|Withdrawal by Subject|3|||
146903921|NCT01485614|529811011|FG002|Weeks 20-54|Withdrawal by Subject|0|||
146903922|NCT01485614|529811012|FG003|Weeks 20-54|Withdrawal by Subject|0|||
146903923|NCT00733902|529811013|FG000|Overall Study|Death|0|||
146903924|NCT00733902|529811014|FG001|Overall Study|Death|0|||
146903925|NCT00733902|529811015|FG002|Overall Study|Death|0|||
146903926|NCT00733902|529811016|FG003|Overall Study|Death|1|||
146903927|NCT00733902|529811013|FG000|Overall Study|Adverse Event|3|||
146903928|NCT00733902|529811014|FG001|Overall Study|Adverse Event|4|||
146903929|NCT00733902|529811015|FG002|Overall Study|Adverse Event|7|||
146903930|NCT00733902|529811016|FG003|Overall Study|Adverse Event|11|||
146903931|NCT00733902|529811013|FG000|Overall Study|Lack of Efficacy|56|||
146903932|NCT00733902|529811014|FG001|Overall Study|Lack of Efficacy|21|||
146903933|NCT00733902|529811015|FG002|Overall Study|Lack of Efficacy|34|||
146903934|NCT00733902|529811016|FG003|Overall Study|Lack of Efficacy|23|||
146903935|NCT00733902|529811013|FG000|Overall Study|Protocol Violation|4|||
146903936|NCT00733902|529811014|FG001|Overall Study|Protocol Violation|6|||
146903937|NCT00733902|529811015|FG002|Overall Study|Protocol Violation|3|||
146903938|NCT00733902|529811016|FG003|Overall Study|Protocol Violation|3|||
146903939|NCT00733902|529811013|FG000|Overall Study|Withdrawal by Subject|10|||
146903940|NCT00733902|529811014|FG001|Overall Study|Withdrawal by Subject|5|||
146903941|NCT00733902|529811015|FG002|Overall Study|Withdrawal by Subject|4|||
146903942|NCT00733902|529811016|FG003|Overall Study|Withdrawal by Subject|16|||
146903943|NCT00733902|529811013|FG000|Overall Study|Entered extension study|89|||
146903944|NCT00733902|529811014|FG001|Overall Study|Entered extension study|124|||
146903945|NCT00733902|529811015|FG002|Overall Study|Entered extension study|111|||
146903946|NCT00733902|529811016|FG003|Overall Study|Entered extension study|109|||
146560894|NCT01435356|528564054|FG000|Overall Study|Withdrawal by Subject|1|||
146903947|NCT00733902|529811013|FG000|Overall Study|Randomized but not treated|2|||
146560895|NCT01435356|528564055|FG001|Overall Study|Withdrawal by Subject|1|||
146560896|NCT01435356|528564054|FG000|Overall Study|Facial palsy|1|||
146560897|NCT01435356|528564055|FG001|Overall Study|Facial palsy|0|||
146560898|NCT01435356|528564054|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
146903948|NCT00733902|529811014|FG001|Overall Study|Randomized but not treated|2|||
146560899|NCT01435356|528564055|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
146560900|NCT01435356|528564054|FG000|Overall Study|Physician Decision|1|||
146560901|NCT01435356|528564055|FG001|Overall Study|Physician Decision|0|||
146560902|NCT01435356|528564054|FG000|Overall Study|Patient decision|3|||
146560903|NCT01435356|528564055|FG001|Overall Study|Patient decision|0|||
146560904|NCT01435356|528564054|FG000|Overall Study|Patient moved to another city|1|||
146903949|NCT00733902|529811015|FG002|Overall Study|Randomized but not treated|2|||
146903950|NCT00733902|529811016|FG003|Overall Study|Randomized but not treated|1|||
146903951|NCT02210780|529811017|FG000|Overall Study|Adverse Event|0|||
146903952|NCT02210780|529811018|FG001|Overall Study|Adverse Event|5|||
146903953|NCT02210780|529811017|FG000|Overall Study|Lost to Follow-up|2|||
146903954|NCT02210780|529811018|FG001|Overall Study|Lost to Follow-up|1|||
146903955|NCT02210780|529811017|FG000|Overall Study|Withdrawal by Subject|1|||
146903956|NCT02210780|529811018|FG001|Overall Study|Withdrawal by Subject|1|||
146903957|NCT02210780|529811017|FG000|Overall Study|Physician Decision|1|||
146903958|NCT02210780|529811018|FG001|Overall Study|Physician Decision|0|||
146903959|NCT02210780|529811017|FG000|Overall Study|Protocol Violation|1|||
146903960|NCT02210780|529811018|FG001|Overall Study|Protocol Violation|0|||
146903961|NCT02210780|529811017|FG000|Overall Study|Other than specified above|0|||
146903962|NCT02210780|529811018|FG001|Overall Study|Other than specified above|1|||
146903963|NCT01503021|529811023|FG000|Overall Study|Adverse Event|7|||
146903964|NCT01503021|529811024|FG001|Overall Study|Adverse Event|6|||
146903965|NCT01503021|529811023|FG000|Overall Study|Death|0|||
146903966|NCT01503021|529811024|FG001|Overall Study|Death|2|||
146903967|NCT01503021|529811023|FG000|Overall Study|Lost to Follow-up|2|||
146903968|NCT01503021|529811024|FG001|Overall Study|Lost to Follow-up|0|||
146903969|NCT01503021|529811023|FG000|Overall Study|Physician Decision|3|||
146903970|NCT01503021|529811024|FG001|Overall Study|Physician Decision|0|||
146903971|NCT01503021|529811023|FG000|Overall Study|Protocol Violation|1|||
146903972|NCT01503021|529811024|FG001|Overall Study|Protocol Violation|3|||
146903973|NCT01503021|529811023|FG000|Overall Study|Withdrawal by Subject|9|||
146903974|NCT01503021|529811024|FG001|Overall Study|Withdrawal by Subject|8|||
146903975|NCT01503021|529811023|FG000|Overall Study|Moved, received transplant, etc.|5|||
146903976|NCT01503021|529811024|FG001|Overall Study|Moved, received transplant, etc.|7|||
146903977|NCT01242111|529811025|FG000|Overall Study|Adverse Event|1|||
146903978|NCT01242111|529811025|FG000|Overall Study|Withdrawal by Subject|1|||
146903979|NCT01242111|529811025|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
146903980|NCT01929083|529811028|FG000|Intervention 1|Lost to Follow-up|2|||
146903981|NCT01929083|529811029|FG001|Intervention 1|Lost to Follow-up|0|||
146903982|NCT01929083|529811028|FG000|Intervention 1|Nonadherent to study medications|1|||
146903983|NCT01929083|529811029|FG001|Intervention 1|Nonadherent to study medications|0|||
146903984|NCT01929083|529811028|FG000|Intervention 2|Adverse Event|0|||
146903985|NCT01929083|529811029|FG001|Intervention 2|Adverse Event|1|||
146903986|NCT02599402|529811030|FG000|Overall Study|Disease progression|153|||
146903987|NCT02599402|529811030|FG000|Overall Study|Study drug toxicity|201|||
146903988|NCT02599402|529811030|FG000|Overall Study|Death|26|||
146903989|NCT02599402|529811030|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
146903990|NCT02599402|529811030|FG000|Overall Study|Participant request to discontinue study treatment|13|||
146903991|NCT02599402|529811030|FG000|Overall Study|Participant withdrew consent|5|||
146903992|NCT02599402|529811030|FG000|Overall Study|Lost to Follow-up|1|||
146903993|NCT02599402|529811030|FG000|Overall Study|Maximum Clinical Benefit|7|||
146903994|NCT02599402|529811030|FG000|Overall Study|Poor/non-compliance|1|||
146903995|NCT02599402|529811030|FG000|Overall Study|Pregnancy|1|||
146903996|NCT02599402|529811030|FG000|Overall Study|Participant no longer met study criteria|7|||
146903997|NCT02599402|529811030|FG000|Overall Study|Other Reasons|95|||
146903998|NCT01486264|529811037|FG000|Overall Study|Death|1|||
146903999|NCT01486264|529811038|FG001|Overall Study|Death|1|||
146904000|NCT01486264|529811037|FG000|Overall Study|Adverse Event|3|||
146904001|NCT01486264|529811038|FG001|Overall Study|Adverse Event|3|||
146904002|NCT01486264|529811037|FG000|Overall Study|Lack of Efficacy|6|||
146904003|NCT01486264|529811038|FG001|Overall Study|Lack of Efficacy|10|||
146904004|NCT01486264|529811037|FG000|Overall Study|Withdrawal by Subject|7|||
146904005|NCT01486264|529811038|FG001|Overall Study|Withdrawal by Subject|18|||
146904006|NCT01486264|529811037|FG000|Overall Study|Physician Decision|1|||
146904007|NCT01486264|529811038|FG001|Overall Study|Physician Decision|1|||
146904008|NCT01486264|529811037|FG000|Overall Study|Protocol Violation|3|||
146904009|NCT01486264|529811038|FG001|Overall Study|Protocol Violation|0|||
146904010|NCT01486264|529811037|FG000|Overall Study|Lost to Follow-up|3|||
146904011|NCT01486264|529811038|FG001|Overall Study|Lost to Follow-up|2|||
146640851|NCT02474069|528860948|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
146640852|NCT02474069|528860949|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
146904012|NCT01486264|529811037|FG000|Overall Study|Other|5|||
146904013|NCT01486264|529811038|FG001|Overall Study|Other|11|||
146904014|NCT01486264|529811037|FG000|Overall Study|Not treated|0|||
146904015|NCT01486264|529811038|FG001|Overall Study|Not treated|1|||
146904016|NCT00283387|529811039|FG000|First Intervention|Subject non-compliant|1|||
146904017|NCT00283387|529811040|FG001|First Intervention|Subject non-compliant|1|||
146904018|NCT00283387|529811039|FG000|First Intervention|Withdrawal by Subject|0|||
146904019|NCT00283387|529811040|FG001|First Intervention|Withdrawal by Subject|1|||
146904020|NCT02371629|529811052|FG000|Overall Study|Patient decision|14|||
146904021|NCT02371629|529811053|FG001|Overall Study|Patient decision|10|||
146904022|NCT02371629|529811052|FG000|Overall Study|Adverse Event|8|||
146904023|NCT02371629|529811053|FG001|Overall Study|Adverse Event|8|||
146904024|NCT02371629|529811052|FG000|Overall Study|Physician Decision|2|||
146904025|NCT02371629|529811053|FG001|Overall Study|Physician Decision|3|||
146904026|NCT02371629|529811052|FG000|Overall Study|Death|1|||
146904027|NCT02371629|529811053|FG001|Overall Study|Death|1|||
146904028|NCT02371629|529811052|FG000|Overall Study|Noncompliance with study treatment|1|||
146904029|NCT02371629|529811053|FG001|Overall Study|Noncompliance with study treatment|0|||
146904030|NCT02371629|529811052|FG000|Overall Study|Lack of Efficacy|0|||
146904031|NCT02371629|529811053|FG001|Overall Study|Lack of Efficacy|2|||
146904032|NCT02371629|529811052|FG000|Overall Study|Protocol deviation|0|||
146904033|NCT02371629|529811053|FG001|Overall Study|Protocol deviation|1|||
146904034|NCT01073943|529811054|FG000|Overall Study|Withdrawal by Subject|8|||
146904035|NCT01073943|529811055|FG001|Overall Study|Withdrawal by Subject|2|||
146904036|NCT01073943|529811054|FG000|Overall Study|Protocol Violation|2|||
146904037|NCT01073943|529811055|FG001|Overall Study|Protocol Violation|1|||
146904038|NCT01073943|529811054|FG000|Overall Study|Adverse Event|1|||
146904039|NCT01073943|529811055|FG001|Overall Study|Adverse Event|1|||
146904040|NCT01073943|529811054|FG000|Overall Study|Lost to Follow-up|0|||
146904041|NCT01073943|529811055|FG001|Overall Study|Lost to Follow-up|2|||
146904042|NCT01073943|529811054|FG000|Overall Study|Power outage; colonoscopy not done|1|||
146904043|NCT01073943|529811055|FG001|Overall Study|Power outage; colonoscopy not done|0|||
146904044|NCT01073943|529811054|FG000|Overall Study|Subject forgot|0|||
146904045|NCT01073943|529811055|FG001|Overall Study|Subject forgot|1|||
146904046|NCT01073943|529811054|FG000|Overall Study|Unable to return for follow-up|0|||
146904047|NCT01073943|529811055|FG001|Overall Study|Unable to return for follow-up|1|||
146904048|NCT01073943|529811054|FG000|Overall Study|Could not tolerate prep|1|||
146904049|NCT01073943|529811055|FG001|Overall Study|Could not tolerate prep|0|||
146904050|NCT01051739|529811061|FG000|Overall Study|Death|3|||
146904051|NCT01051739|529811062|FG001|Overall Study|Death|3|||
146904052|NCT01051739|529811061|FG000|Overall Study|Withdrawal by Subject|25|||
146904053|NCT01051739|529811062|FG001|Overall Study|Withdrawal by Subject|10|||
146904054|NCT03527043|529811064|FG000|Overall Study|Withdrawal by Subject|1|||
146904055|NCT03527043|529811065|FG001|Overall Study|Withdrawal by Subject|0|||
146904056|NCT00424398|529811068|FG000|Overall Study|Withdrawal by Subject|2|||
146904057|NCT00424398|529811069|FG001|Overall Study|Withdrawal by Subject|1|||
146904058|NCT00424398|529811070|FG002|Overall Study|Withdrawal by Subject|0|||
146904059|NCT00424398|529811068|FG000|Overall Study|Subject met exclusion criteria|1|||
146904060|NCT00424398|529811069|FG001|Overall Study|Subject met exclusion criteria|0|||
146904061|NCT00424398|529811070|FG002|Overall Study|Subject met exclusion criteria|0|||
146904062|NCT01309737|529811072|FG000|Week 0 to 16|Death|1|||
146904063|NCT01309737|529811073|FG001|Week 0 to 16|Death|0|||
146904064|NCT01309737|529811074|FG002|Week 0 to 16|Death|1|||
146904065|NCT01309737|529811075|FG003|Week 0 to 16|Death|0|||
146904066|NCT01309737|529811076|FG004|Week 0 to 16|Death|0|||
146904067|NCT01309737|529811072|FG000|Week 0 to 16|Adverse Event|11|||
146904068|NCT01309737|529811073|FG001|Week 0 to 16|Adverse Event|10|||
146904069|NCT01309737|529811074|FG002|Week 0 to 16|Adverse Event|5|||
146904070|NCT01309737|529811075|FG003|Week 0 to 16|Adverse Event|0|||
146904071|NCT01309737|529811076|FG004|Week 0 to 16|Adverse Event|0|||
146904072|NCT01309737|529811072|FG000|Week 0 to 16|Lack of Efficacy|15|||
146904073|NCT01309737|529811073|FG001|Week 0 to 16|Lack of Efficacy|2|||
146904074|NCT01309737|529811074|FG002|Week 0 to 16|Lack of Efficacy|24|||
146904075|NCT01309737|529811075|FG003|Week 0 to 16|Lack of Efficacy|0|||
146904076|NCT01309737|529811076|FG004|Week 0 to 16|Lack of Efficacy|0|||
146904077|NCT01309737|529811072|FG000|Week 0 to 16|Lost to Follow-up|7|||
146904078|NCT01309737|529811073|FG001|Week 0 to 16|Lost to Follow-up|8|||
146904079|NCT01309737|529811074|FG002|Week 0 to 16|Lost to Follow-up|3|||
146904080|NCT01309737|529811075|FG003|Week 0 to 16|Lost to Follow-up|0|||
146904081|NCT01309737|529811076|FG004|Week 0 to 16|Lost to Follow-up|0|||
146904082|NCT01309737|529811072|FG000|Week 0 to 16|Withdrawal by Subject|7|||
146904083|NCT01309737|529811073|FG001|Week 0 to 16|Withdrawal by Subject|6|||
146904084|NCT01309737|529811074|FG002|Week 0 to 16|Withdrawal by Subject|7|||
146904085|NCT01309737|529811075|FG003|Week 0 to 16|Withdrawal by Subject|0|||
146904086|NCT01309737|529811076|FG004|Week 0 to 16|Withdrawal by Subject|0|||
146904087|NCT01309737|529811072|FG000|Week 0 to 16|Other|10|||
146904088|NCT01309737|529811073|FG001|Week 0 to 16|Other|14|||
146904089|NCT01309737|529811074|FG002|Week 0 to 16|Other|4|||
146904090|NCT01309737|529811075|FG003|Week 0 to 16|Other|0|||
146904091|NCT01309737|529811076|FG004|Week 0 to 16|Other|0|||
146904092|NCT01309737|529811072|FG000|Week 0 to 16|Randomized, but not treated|1|||
146904093|NCT01309737|529811073|FG001|Week 0 to 16|Randomized, but not treated|0|||
146904094|NCT01309737|529811074|FG002|Week 0 to 16|Randomized, but not treated|0|||
146904095|NCT01309737|529811075|FG003|Week 0 to 16|Randomized, but not treated|0|||
146904096|NCT01309737|529811076|FG004|Week 0 to 16|Randomized, but not treated|0|||
146904097|NCT01309737|529811072|FG000|Week 16 to 52|Death|0|||
146904098|NCT01309737|529811073|FG001|Week 16 to 52|Death|0|||
146904099|NCT01309737|529811074|FG002|Week 16 to 52|Death|0|||
146904100|NCT01309737|529811075|FG003|Week 16 to 52|Death|0|||
146904101|NCT01309737|529811076|FG004|Week 16 to 52|Death|1|||
146904102|NCT01309737|529811072|FG000|Week 16 to 52|Adverse Event|7|||
146904103|NCT01309737|529811073|FG001|Week 16 to 52|Adverse Event|7|||
146904104|NCT01309737|529811074|FG002|Week 16 to 52|Adverse Event|0|||
146904105|NCT01309737|529811075|FG003|Week 16 to 52|Adverse Event|6|||
146904106|NCT01309737|529811076|FG004|Week 16 to 52|Adverse Event|5|||
146904107|NCT01309737|529811072|FG000|Week 16 to 52|Lack of Efficacy|107|||
146904108|NCT01309737|529811073|FG001|Week 16 to 52|Lack of Efficacy|76|||
146904109|NCT01309737|529811074|FG002|Week 16 to 52|Lack of Efficacy|0|||
146904110|NCT01309737|529811075|FG003|Week 16 to 52|Lack of Efficacy|25|||
146904111|NCT01309737|529811076|FG004|Week 16 to 52|Lack of Efficacy|21|||
146904112|NCT01309737|529811072|FG000|Week 16 to 52|Lost to Follow-up|4|||
146904113|NCT01309737|529811073|FG001|Week 16 to 52|Lost to Follow-up|2|||
146904114|NCT01309737|529811074|FG002|Week 16 to 52|Lost to Follow-up|0|||
146904115|NCT01309737|529811075|FG003|Week 16 to 52|Lost to Follow-up|1|||
146904116|NCT01309737|529811076|FG004|Week 16 to 52|Lost to Follow-up|4|||
146904117|NCT01309737|529811072|FG000|Week 16 to 52|Withdrawal by Subject|5|||
146904118|NCT01309737|529811073|FG001|Week 16 to 52|Withdrawal by Subject|6|||
146904119|NCT01309737|529811074|FG002|Week 16 to 52|Withdrawal by Subject|0|||
146904120|NCT01309737|529811075|FG003|Week 16 to 52|Withdrawal by Subject|0|||
146904121|NCT01309737|529811076|FG004|Week 16 to 52|Withdrawal by Subject|2|||
146904122|NCT01309737|529811072|FG000|Week 16 to 52|Other|10|||
146904123|NCT01309737|529811073|FG001|Week 16 to 52|Other|12|||
146904124|NCT01309737|529811074|FG002|Week 16 to 52|Other|0|||
146904125|NCT01309737|529811075|FG003|Week 16 to 52|Other|2|||
146904126|NCT01309737|529811076|FG004|Week 16 to 52|Other|0|||
146904127|NCT02240706|529811083|FG000|Overall Study|Lack of Efficacy|2|||
146904128|NCT02240706|529811084|FG001|Overall Study|Lack of Efficacy|2|||
146904129|NCT02240706|529811085|FG002|Overall Study|Lack of Efficacy|2|||
146904130|NCT02240706|529811086|FG003|Overall Study|Lack of Efficacy|2|||
146904131|NCT02240706|529811087|FG004|Overall Study|Lack of Efficacy|5|||
146904132|NCT02240706|529811088|FG005|Overall Study|Lack of Efficacy|0|||
146904133|NCT02240706|529811089|FG006|Overall Study|Lack of Efficacy|0|||
146904134|NCT02240706|529811083|FG000|Overall Study|Adverse Event|1|||
146904135|NCT02240706|529811084|FG001|Overall Study|Adverse Event|0|||
146904136|NCT02240706|529811085|FG002|Overall Study|Adverse Event|1|||
146904137|NCT02240706|529811086|FG003|Overall Study|Adverse Event|0|||
146904138|NCT02240706|529811087|FG004|Overall Study|Adverse Event|2|||
146904139|NCT02240706|529811088|FG005|Overall Study|Adverse Event|0|||
146904140|NCT02240706|529811089|FG006|Overall Study|Adverse Event|0|||
146904141|NCT02240706|529811083|FG000|Overall Study|Progressive disease|0|||
146904142|NCT02240706|529811084|FG001|Overall Study|Progressive disease|0|||
146904143|NCT02240706|529811085|FG002|Overall Study|Progressive disease|0|||
146904144|NCT02240706|529811086|FG003|Overall Study|Progressive disease|0|||
146904145|NCT02240706|529811087|FG004|Overall Study|Progressive disease|1|||
146904146|NCT02240706|529811088|FG005|Overall Study|Progressive disease|0|||
146904147|NCT02240706|529811089|FG006|Overall Study|Progressive disease|0|||
146904148|NCT02240706|529811083|FG000|Overall Study|Dose limiting toxicity|0|||
146904149|NCT02240706|529811084|FG001|Overall Study|Dose limiting toxicity|0|||
146904150|NCT02240706|529811085|FG002|Overall Study|Dose limiting toxicity|0|||
146904151|NCT02240706|529811086|FG003|Overall Study|Dose limiting toxicity|0|||
146904152|NCT02240706|529811087|FG004|Overall Study|Dose limiting toxicity|1|||
146904153|NCT02240706|529811088|FG005|Overall Study|Dose limiting toxicity|0|||
146904154|NCT02240706|529811089|FG006|Overall Study|Dose limiting toxicity|0|||
146904155|NCT02240706|529811083|FG000|Overall Study|Refused to continue taking medication|0|||
146904156|NCT02240706|529811084|FG001|Overall Study|Refused to continue taking medication|1|||
146904157|NCT02240706|529811085|FG002|Overall Study|Refused to continue taking medication|3|||
146904158|NCT02240706|529811086|FG003|Overall Study|Refused to continue taking medication|1|||
146904159|NCT02240706|529811087|FG004|Overall Study|Refused to continue taking medication|2|||
146560905|NCT01435356|528564055|FG001|Overall Study|Patient moved to another city|1|||
146560906|NCT00437073|528564056|FG000|Overall Study|Sponsor Terminated Study|1|||
146560907|NCT00437073|528564057|FG001|Overall Study|Sponsor Terminated Study|0|||
146560908|NCT00437073|528564056|FG000|Overall Study|Physician Decision|0|||
146560909|NCT00437073|528564057|FG001|Overall Study|Physician Decision|1|||
146560910|NCT05205616|528564058|FG000|Overall Study|Lost to Follow-up|4|||
146560911|NCT05205616|528564059|FG001|Overall Study|Lost to Follow-up|4|||
146560912|NCT04875533|528564060|FG000|Overall Study|Adverse Event|6|||
146560913|NCT04875533|528564061|FG001|Overall Study|Adverse Event|4|||
146560914|NCT04875533|528564060|FG000|Overall Study|Protocol Violation|4|||
146560915|NCT04875533|528564061|FG001|Overall Study|Protocol Violation|0|||
146904160|NCT02240706|529811088|FG005|Overall Study|Refused to continue taking medication|0|||
146904161|NCT02240706|529811089|FG006|Overall Study|Refused to continue taking medication|0|||
146904162|NCT02240706|529811083|FG000|Overall Study|Insurance billing concerns|0|||
146904163|NCT02240706|529811084|FG001|Overall Study|Insurance billing concerns|0|||
146904164|NCT02240706|529811085|FG002|Overall Study|Insurance billing concerns|0|||
146904165|NCT02240706|529811086|FG003|Overall Study|Insurance billing concerns|1|||
146904166|NCT02240706|529811087|FG004|Overall Study|Insurance billing concerns|0|||
146904167|NCT02240706|529811088|FG005|Overall Study|Insurance billing concerns|0|||
146904168|NCT02240706|529811089|FG006|Overall Study|Insurance billing concerns|0|||
146904169|NCT03022461|529811095|FG000|Overall Study|Death|3|||
146904170|NCT03459040|529811096|FG000|Overall Study|Death|8|||
146560916|NCT04875533|528564060|FG000|Overall Study|Withdrawal by Subject|8|||
146560917|NCT04875533|528564061|FG001|Overall Study|Withdrawal by Subject|5|||
146904171|NCT03459040|529811096|FG000|Overall Study|Withdrawal by Subject|1|||
146904172|NCT00986349|529811097|FG000|Overall Study|Unsuccessful implant procedure|3|||
146904173|NCT00986349|529811097|FG000|Overall Study|Adverse Event|2|||
146904174|NCT00986349|529811097|FG000|Overall Study|Physician Decision|1|||
146904175|NCT00986349|529811097|FG000|Overall Study|device migration|1|||
146904176|NCT02299934|529811098|FG000|Overall Study|Termination of study|13|||
146904177|NCT03815175|529811099|FG000|Overall Study|Subject Lost to Follow-up|6|||
146904178|NCT03815175|529811099|FG000|Overall Study|Subject Withdrew Consent|48|||
146904179|NCT03815175|529811099|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
146904180|NCT03815175|529811099|FG000|Overall Study|Death|86|||
146904181|NCT03815175|529811099|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
146904182|NCT03815175|529811099|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
146904183|NCT03815175|529811099|FG000|Overall Study|Other Status Change Reason|1|||
146904184|NCT03815175|529811099|FG000|Overall Study|Missed Visit|12|||
146904185|NCT03577990|529811100|FG000|Overall Study|Lost to Follow-up|4|||
146904186|NCT03577990|529811101|FG001|Overall Study|Lost to Follow-up|6|||
146904187|NCT03577990|529811100|FG000|Overall Study|Withdrawal by Subject|4|||
146904188|NCT03577990|529811101|FG001|Overall Study|Withdrawal by Subject|7|||
146904189|NCT00538681|529811113|FG000|Overall Study|Progressive Disease|7|||
146904190|NCT00538681|529811114|FG001|Overall Study|Progressive Disease|0|||
146904191|NCT00538681|529811115|FG002|Overall Study|Progressive Disease|1|||
146904192|NCT00538681|529811116|FG003|Overall Study|Progressive Disease|0|||
146904193|NCT00538681|529811113|FG000|Overall Study|Sponsor Decision|1|||
146904194|NCT00538681|529811114|FG001|Overall Study|Sponsor Decision|3|||
146904195|NCT00538681|529811115|FG002|Overall Study|Sponsor Decision|8|||
146904196|NCT00538681|529811116|FG003|Overall Study|Sponsor Decision|9|||
146904197|NCT00538681|529811113|FG000|Overall Study|Adverse Event|1|||
146904198|NCT00538681|529811114|FG001|Overall Study|Adverse Event|1|||
146904199|NCT00538681|529811115|FG002|Overall Study|Adverse Event|1|||
146904200|NCT00538681|529811116|FG003|Overall Study|Adverse Event|0|||
146904201|NCT00538681|529811113|FG000|Overall Study|Death|0|||
146904202|NCT00538681|529811114|FG001|Overall Study|Death|0|||
146904203|NCT00538681|529811115|FG002|Overall Study|Death|1|||
146904204|NCT00538681|529811116|FG003|Overall Study|Death|1|||
146904205|NCT00538681|529811113|FG000|Overall Study|Investigator Decision|0|||
146904206|NCT00538681|529811114|FG001|Overall Study|Investigator Decision|0|||
146904207|NCT00538681|529811115|FG002|Overall Study|Investigator Decision|0|||
146904208|NCT00538681|529811116|FG003|Overall Study|Investigator Decision|1|||
146904209|NCT00628355|529811119|FG000|Overall Study|Withdrawal by Subject|1|||
146904210|NCT00628355|529811120|FG001|Overall Study|Withdrawal by Subject|1|||
146904211|NCT00140855|529811121|FG000|Overall Study|Progressive disease|2|||
146904212|NCT03430310|529811125|FG000|Overall Study|Protocol Violation|2|||
146904213|NCT03430310|529811126|FG001|Overall Study|Protocol Violation|0|||
146904214|NCT03430310|529811125|FG000|Overall Study|Withdrawal by Subject|3|||
146904215|NCT03430310|529811126|FG001|Overall Study|Withdrawal by Subject|2|||
146904216|NCT03430310|529811125|FG000|Overall Study|COVID shutdown March 2020|0|||
146904217|NCT03430310|529811126|FG001|Overall Study|COVID shutdown March 2020|1|||
146904218|NCT01446809|529811127|FG000|Overall Study|Adverse Event|0|||
146904219|NCT01446809|529811128|FG001|Overall Study|Adverse Event|0|||
146904220|NCT01446809|529811129|FG002|Overall Study|Adverse Event|1|||
146904221|NCT01446809|529811127|FG000|Overall Study|Failure to complete study procedures|0|||
146904222|NCT01446809|529811128|FG001|Overall Study|Failure to complete study procedures|0|||
146904223|NCT01446809|529811129|FG002|Overall Study|Failure to complete study procedures|1|||
146904224|NCT01331161|529811130|FG000|Overall Study|Physician Decision|1|||
146904225|NCT01331161|529811131|FG001|Overall Study|Physician Decision|0|||
146904226|NCT01331161|529811130|FG000|Overall Study|Lost to Follow-up|0|||
146904227|NCT01331161|529811131|FG001|Overall Study|Lost to Follow-up|1|||
146904228|NCT01331161|529811130|FG000|Overall Study|Pregnancy|0|||
146640853|NCT02474069|528860947|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
146640854|NCT02474069|528860948|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
146640855|NCT02474069|528860949|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
146640856|NCT02474069|528860947|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
146904229|NCT01331161|529811131|FG001|Overall Study|Pregnancy|1|||
146904230|NCT02581995|529811132|FG000|Overall Study|Unspecified other|3|||
146904231|NCT02581995|529811132|FG000|Overall Study|Adverse Event|6|||
146904232|NCT02581995|529811132|FG000|Overall Study|Lost to Follow-up|5|||
146904233|NCT02581995|529811132|FG000|Overall Study|Withdrawal by participant|12|||
146904234|NCT02581995|529811132|FG000|Overall Study|Physician Decision|1|||
146904235|NCT02581995|529811132|FG000|Overall Study|Death|4|||
146904236|NCT00817414|529812636|FG000|Overall Study|Adverse Event|1|||
146904237|NCT00817414|529812637|FG001|Overall Study|Adverse Event|1|||
146904238|NCT00817414|529812638|FG002|Overall Study|Adverse Event|1|||
146904239|NCT00817414|529812639|FG003|Overall Study|Adverse Event|0|||
146904240|NCT00817414|529812640|FG004|Overall Study|Adverse Event|0|||
146904241|NCT00817414|529812636|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
146640857|NCT02474069|528860948|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
146904242|NCT00817414|529812637|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
146560918|NCT04875533|528564060|FG000|Overall Study|No longer meets eligibility criteria|1|||
146560919|NCT04875533|528564061|FG001|Overall Study|No longer meets eligibility criteria|0|||
146560920|NCT04875533|528564060|FG000|Overall Study|Other|0|||
146560921|NCT04875533|528564061|FG001|Overall Study|Other|2|||
146560922|NCT02657343|528564066|FG000|Overall Study|Death|0|||
146560923|NCT02657343|528564067|FG001|Overall Study|Death|2|||
146560924|NCT02657343|528564068|FG002|Overall Study|Death|0|||
146560925|NCT02657343|528564069|FG003|Overall Study|Death|0|||
146560926|NCT02657343|528564070|FG004|Overall Study|Death|0|||
146560927|NCT02657343|528564071|FG005|Overall Study|Death|0|||
146560928|NCT02657343|528564066|FG000|Overall Study|Patient went to hospice|1|||
146560929|NCT02657343|528564067|FG001|Overall Study|Patient went to hospice|0|||
146560930|NCT02657343|528564068|FG002|Overall Study|Patient went to hospice|0|||
146560931|NCT02657343|528564069|FG003|Overall Study|Patient went to hospice|0|||
146560932|NCT02657343|528564070|FG004|Overall Study|Patient went to hospice|0|||
146560933|NCT02657343|528564071|FG005|Overall Study|Patient went to hospice|0|||
146560934|NCT02657343|528564066|FG000|Overall Study|Withdrawal by Subject|0|||
146560935|NCT02657343|528564067|FG001|Overall Study|Withdrawal by Subject|0|||
146560936|NCT02657343|528564068|FG002|Overall Study|Withdrawal by Subject|0|||
146560937|NCT02657343|528564069|FG003|Overall Study|Withdrawal by Subject|0|||
146560938|NCT02657343|528564070|FG004|Overall Study|Withdrawal by Subject|1|||
146560939|NCT02657343|528564071|FG005|Overall Study|Withdrawal by Subject|0|||
146560940|NCT02011542|528564072|FG000|Overall Study|Physician Decision|1|||
146560941|NCT01299961|528564073|FG000|Overall Study|Adverse Event|3|||
146560942|NCT01299961|528564073|FG000|Overall Study|Lack of Efficacy|2|||
146560943|NCT01299961|528564073|FG000|Overall Study|Lost to Follow-up|1|||
146560944|NCT02904096|528564074|FG000|Overall Study|Adverse Event|1|||
146560945|NCT02904096|528564075|FG001|Overall Study|Adverse Event|0|||
146560946|NCT02904096|528564074|FG000|Overall Study|Withdrawal by Subject|4|||
146560947|NCT02904096|528564075|FG001|Overall Study|Withdrawal by Subject|3|||
146560948|NCT02904096|528564074|FG000|Overall Study|Lost to Follow-up|10|||
146560949|NCT02904096|528564075|FG001|Overall Study|Lost to Follow-up|17|||
146560950|NCT02904096|528564074|FG000|Overall Study|Non-compliant|3|||
146560951|NCT02904096|528564075|FG001|Overall Study|Non-compliant|1|||
146560952|NCT02904096|528564074|FG000|Overall Study|Sponsor instructed|1|||
146640858|NCT02474069|528860949|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
146640859|NCT02474069|528860947|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
146767575|NCT00241644|529317362|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
146767576|NCT00241644|529317363|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
146904243|NCT00817414|529812638|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
146904244|NCT00817414|529812639|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
146904245|NCT00817414|529812640|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
146904246|NCT00817414|529812636|FG000|Overall Study|Withdrawal by Subject|1|||
146904247|NCT00817414|529812637|FG001|Overall Study|Withdrawal by Subject|1|||
146904248|NCT00817414|529812638|FG002|Overall Study|Withdrawal by Subject|0|||
146904249|NCT00817414|529812639|FG003|Overall Study|Withdrawal by Subject|0|||
146904250|NCT00817414|529812640|FG004|Overall Study|Withdrawal by Subject|0|||
146904251|NCT00817414|529812636|FG000|Overall Study|Lost to Follow-up|0|||
146904252|NCT00817414|529812637|FG001|Overall Study|Lost to Follow-up|0|||
146904253|NCT00817414|529812638|FG002|Overall Study|Lost to Follow-up|1|||
146904254|NCT00817414|529812639|FG003|Overall Study|Lost to Follow-up|1|||
146904255|NCT00817414|529812640|FG004|Overall Study|Lost to Follow-up|1|||
146904256|NCT00817414|529812636|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
146904257|NCT00817414|529812637|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
146904258|NCT00817414|529812638|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
146904259|NCT00817414|529812639|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
146904260|NCT00817414|529812640|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
146904261|NCT00817414|529812636|FG000|Overall Study|Protocol Violation|0|||
146904262|NCT00817414|529812637|FG001|Overall Study|Protocol Violation|0|||
146904263|NCT00817414|529812638|FG002|Overall Study|Protocol Violation|0|||
146904264|NCT00817414|529812639|FG003|Overall Study|Protocol Violation|0|||
146904265|NCT00817414|529812640|FG004|Overall Study|Protocol Violation|1|||
146904266|NCT00886938|529812641|FG000|Overall Study|Adverse Event|1|||
146904267|NCT00886938|529812641|FG000|Overall Study|Withdrawal by Subject|1|||
146904268|NCT03941548|529812645|FG000|Overall Study|Adverse Event|0|||
146904269|NCT03941548|529812646|FG001|Overall Study|Adverse Event|1|||
146904270|NCT03941548|529812645|FG000|Overall Study|Lost to Follow-up|0|||
146904271|NCT03941548|529812646|FG001|Overall Study|Lost to Follow-up|1|||
146904272|NCT03941548|529812645|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
146904273|NCT03941548|529812646|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
146904274|NCT00870688|529812647|FG000|Overall Study|Lost to Follow-up|2|||
146560953|NCT02904096|528564075|FG001|Overall Study|Sponsor instructed|0|||
146560954|NCT00663260|528564077|FG000|Overall Study|Lack of Efficacy|2|||
146904275|NCT00870688|529812647|FG000|Overall Study|Death, Unrelated|1|||
146904276|NCT00870688|529812647|FG000|Overall Study|Granules in the Stools|1|||
146904277|NCT03872180|529812648|FG000|Overall Study|Adverse Event|4|||
146904278|NCT03872180|529812648|FG000|Overall Study|Lack of Efficacy|2|||
146904279|NCT02945657|529812649|FG000|Overall Study|Adverse Event|1|||
146904280|NCT02945657|529812649|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
146904281|NCT00087438|529812650|FG000|Overall Study|Ineligible / No protocol treatment|4|||
146904282|NCT01157117|529812651|FG000|Overall Study|Dosing Symptoms|0|||
146904283|NCT01157117|529812652|FG001|Overall Study|Dosing Symptoms|4|||
146904284|NCT01157117|529812653|FG002|Overall Study|Dosing Symptoms|0|||
146904285|NCT01157117|529812651|FG000|Overall Study|Withdrawal by Subject|4|||
146904286|NCT01157117|529812652|FG001|Overall Study|Withdrawal by Subject|1|||
146904287|NCT01157117|529812653|FG002|Overall Study|Withdrawal by Subject|1|||
146904288|NCT01157117|529812651|FG000|Overall Study|Lack of Efficacy|1|||
146904289|NCT01157117|529812652|FG001|Overall Study|Lack of Efficacy|1|||
146904290|NCT01157117|529812653|FG002|Overall Study|Lack of Efficacy|0|||
146904291|NCT01157117|529812651|FG000|Overall Study|Lost to Follow-up|0|||
146904292|NCT01157117|529812652|FG001|Overall Study|Lost to Follow-up|0|||
146904293|NCT01157117|529812653|FG002|Overall Study|Lost to Follow-up|1|||
146904294|NCT01157117|529812651|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
146904295|NCT01157117|529812652|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
146904296|NCT01157117|529812653|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
146904297|NCT03215277|529812654|FG000|Overall Study|Adverse Event|2|||
146904298|NCT03215277|529812655|FG001|Overall Study|Adverse Event|3|||
146904299|NCT03215277|529812654|FG000|Overall Study|Death|1|||
146904300|NCT03215277|529812655|FG001|Overall Study|Death|0|||
146970099|NCT01523301|530050782|FG000|Overall Study|Adverse Event|25|||
146970100|NCT01523301|530050783|FG001|Overall Study|Adverse Event|16|||
146970101|NCT01523301|530050782|FG000|Overall Study|Lack of Efficacy|0|||
146970102|NCT01523301|530050783|FG001|Overall Study|Lack of Efficacy|2|||
146970103|NCT01523301|530050782|FG000|Overall Study|Protocol Violation|3|||
146904301|NCT03215277|529812654|FG000|Overall Study|Lost to Follow-up|0|||
146904302|NCT03215277|529812655|FG001|Overall Study|Lost to Follow-up|1|||
146904303|NCT03215277|529812654|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
146904304|NCT03215277|529812655|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
146904305|NCT00728416|529812665|FG000|Overall Study|Adverse Event|1|||
146904306|NCT00728416|529812666|FG001|Overall Study|Adverse Event|1|||
146904307|NCT00728416|529812665|FG000|Overall Study|Treatment Failure|0|||
146904308|NCT00728416|529812666|FG001|Overall Study|Treatment Failure|1|||
146904309|NCT00728416|529812665|FG000|Overall Study|Withdrawal by Subject|1|||
146904310|NCT00728416|529812666|FG001|Overall Study|Withdrawal by Subject|0|||
146904311|NCT03596164|529812667|FG000|Overall Study|Adverse Event|0|||
146904312|NCT03596164|529812668|FG001|Overall Study|Adverse Event|1|||
146904313|NCT03596164|529812667|FG000|Overall Study|Death|1|||
146904314|NCT03596164|529812668|FG001|Overall Study|Death|0|||
146904315|NCT01120626|529812669|FG000|Overall Study|Withdrawal by Subject|1|||
146904316|NCT01120626|529812670|FG001|Overall Study|Withdrawal by Subject|0|||
146904317|NCT01772134|529812676|FG000|Overall Study|Adverse Event|6|||
146904318|NCT01772134|529812677|FG001|Overall Study|Adverse Event|5|||
146904319|NCT01772134|529812678|FG002|Overall Study|Adverse Event|10|||
146904320|NCT01772134|529812676|FG000|Overall Study|Withdrew Consent|3|||
146904321|NCT01772134|529812677|FG001|Overall Study|Withdrew Consent|1|||
146904322|NCT01772134|529812678|FG002|Overall Study|Withdrew Consent|5|||
146904323|NCT01772134|529812676|FG000|Overall Study|Lost to Follow-up|2|||
146904324|NCT01772134|529812677|FG001|Overall Study|Lost to Follow-up|0|||
146904325|NCT01772134|529812678|FG002|Overall Study|Lost to Follow-up|0|||
146904326|NCT01772134|529812676|FG000|Overall Study|Protocol Deviation|4|||
146904327|NCT01772134|529812677|FG001|Overall Study|Protocol Deviation|3|||
146904328|NCT01772134|529812678|FG002|Overall Study|Protocol Deviation|3|||
146904329|NCT01772134|529812676|FG000|Overall Study|Lack of Efficacy|11|||
146904330|NCT01772134|529812677|FG001|Overall Study|Lack of Efficacy|5|||
146904331|NCT01772134|529812678|FG002|Overall Study|Lack of Efficacy|3|||
146904332|NCT01772134|529812676|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
146904333|NCT01772134|529812677|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
146904334|NCT01772134|529812678|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
146904335|NCT01772134|529812676|FG000|Overall Study|Randomized Study Medication Not Received|2|||
146904336|NCT01772134|529812677|FG001|Overall Study|Randomized Study Medication Not Received|0|||
146904337|NCT01772134|529812678|FG002|Overall Study|Randomized Study Medication Not Received|1|||
146904338|NCT02500550|529812679|FG000|Overall Study|Death|7|||
146904339|NCT01023789|529812684|FG000|3 - Year Visit|Death|29|||
146904340|NCT01023789|529812684|FG000|3 - Year Visit|Withdrawal of consent|1|||
146904341|NCT01023789|529812684|FG000|3 - Year Visit|Lost to Follow-up|13|||
146904342|NCT02034123|529812686|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146904343|NCT02034123|529812687|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146904344|NCT02034123|529812688|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146904345|NCT02034123|529812689|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146904346|NCT02034123|529812690|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
146904347|NCT02034123|529812691|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146904348|NCT02034123|529812692|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146904349|NCT02034123|529812693|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
146904350|NCT02034123|529812694|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
146904351|NCT02034123|529812695|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146904352|NCT02034123|529812696|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146904353|NCT02034123|529812697|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146904354|NCT02034123|529812698|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146904355|NCT02034123|529812699|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146904356|NCT02034123|529812700|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146904357|NCT02034123|529812701|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146904358|NCT02034123|529812702|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146904359|NCT02034123|529812703|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146904360|NCT02034123|529812686|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904361|NCT02034123|529812687|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904362|NCT02034123|529812688|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904363|NCT02034123|529812689|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
146904364|NCT02034123|529812690|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904365|NCT02034123|529812691|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904366|NCT02034123|529812692|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904367|NCT02034123|529812693|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904368|NCT02034123|529812694|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904369|NCT02034123|529812695|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904370|NCT02034123|529812696|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904371|NCT02034123|529812697|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904372|NCT02034123|529812698|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904373|NCT02034123|529812699|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904374|NCT02034123|529812700|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904375|NCT02034123|529812701|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904376|NCT02034123|529812702|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904377|NCT02034123|529812703|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146904378|NCT02034123|529812686|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904379|NCT02034123|529812687|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904380|NCT02034123|529812688|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904381|NCT02034123|529812689|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904382|NCT02034123|529812690|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904383|NCT02034123|529812691|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904384|NCT02034123|529812692|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904385|NCT02034123|529812693|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904386|NCT02034123|529812694|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
146904387|NCT02034123|529812695|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904388|NCT02034123|529812696|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904389|NCT02034123|529812697|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904390|NCT02034123|529812698|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904391|NCT02034123|529812699|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904392|NCT02034123|529812700|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904393|NCT02034123|529812701|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904394|NCT02034123|529812702|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904395|NCT02034123|529812703|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146904396|NCT02034123|529812686|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146904397|NCT02034123|529812687|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146904398|NCT02034123|529812688|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146904399|NCT02034123|529812689|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
146904400|NCT02034123|529812690|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
146904401|NCT02034123|529812691|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146904402|NCT02034123|529812692|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146904403|NCT02034123|529812693|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146904404|NCT02034123|529812694|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146904405|NCT02034123|529812695|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146904406|NCT02034123|529812696|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146904407|NCT02034123|529812697|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146904408|NCT02034123|529812698|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146904409|NCT02034123|529812699|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146904410|NCT02034123|529812700|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146904411|NCT02034123|529812701|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146904412|NCT02034123|529812702|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146904413|NCT02034123|529812703|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146904414|NCT00246259|529812704|FG000|Overall Study|Other|3|||
146904415|NCT00246259|529812705|FG001|Overall Study|Other|3|||
146904416|NCT00246259|529812704|FG000|Overall Study|Not stable by Week 18|2|||
146904417|NCT00246259|529812705|FG001|Overall Study|Not stable by Week 18|1|||
146904418|NCT00246259|529812704|FG000|Overall Study|Participant non-compliant|4|||
146904419|NCT00246259|529812705|FG001|Overall Study|Participant non-compliant|9|||
146904420|NCT00246259|529812704|FG000|Overall Study|Lack of Efficacy|2|||
146904421|NCT00246259|529812705|FG001|Overall Study|Lack of Efficacy|2|||
146904422|NCT00246259|529812704|FG000|Overall Study|Investigator withdrew participant|2|||
146970104|NCT01523301|530050783|FG001|Overall Study|Protocol Violation|4|||
146560955|NCT00663260|528564078|FG001|Overall Study|Lack of Efficacy|0|||
146560956|NCT00663260|528564079|FG002|Overall Study|Lack of Efficacy|0|||
146560957|NCT00663260|528564077|FG000|Overall Study|Adverse Event|12|||
146560958|NCT00663260|528564078|FG001|Overall Study|Adverse Event|7|||
146560959|NCT00663260|528564079|FG002|Overall Study|Adverse Event|6|||
146560960|NCT00663260|528564077|FG000|Overall Study|Withdrawal by Subject|3|||
146560961|NCT00663260|528564078|FG001|Overall Study|Withdrawal by Subject|1|||
146560962|NCT00663260|528564079|FG002|Overall Study|Withdrawal by Subject|6|||
146904423|NCT00246259|529812705|FG001|Overall Study|Investigator withdrew participant|0|||
146904424|NCT00246259|529812704|FG000|Overall Study|Adverse Event|5|||
146904425|NCT00246259|529812705|FG001|Overall Study|Adverse Event|0|||
146904426|NCT00246259|529812704|FG000|Overall Study|Lost to Follow-up|3|||
146904427|NCT00246259|529812705|FG001|Overall Study|Lost to Follow-up|4|||
146904428|NCT00246259|529812704|FG000|Overall Study|Withdrawal by Subject|5|||
146904429|NCT00246259|529812705|FG001|Overall Study|Withdrawal by Subject|1|||
146904430|NCT00246259|529812704|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
146904431|NCT00246259|529812705|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
146904432|NCT02333227|529812709|FG000|Overall Study|Lost to Follow-up|137|||
146904433|NCT02333227|529812710|FG001|Overall Study|Lost to Follow-up|106|||
146904434|NCT02333227|529812709|FG000|Overall Study|Pregnancy Interrupted|42|||
146904435|NCT02333227|529812710|FG001|Overall Study|Pregnancy Interrupted|89|||
146904436|NCT02333227|529812709|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
146904437|NCT02333227|529812710|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
146904438|NCT01076179|529812711|FG000|Overall Study|Withdrawal by Subject|1|||
146904439|NCT03934684|529812712|FG000|Overall Study|Participants continuing in study|11|||
146904440|NCT03934684|529812713|FG001|Overall Study|Participants continuing in study|4|||
146904441|NCT03934684|529812712|FG000|Overall Study|Discontinuation of carfilzomib|20|||
146904442|NCT03934684|529812713|FG001|Overall Study|Discontinuation of carfilzomib|30|||
146904443|NCT03934684|529812712|FG000|Overall Study|Death|2|||
146904444|NCT03934684|529812713|FG001|Overall Study|Death|2|||
146904445|NCT03934684|529812712|FG000|Overall Study|Lost to Follow-up|2|||
146904446|NCT03934684|529812713|FG001|Overall Study|Lost to Follow-up|5|||
146904447|NCT03934684|529812712|FG000|Overall Study|Withdrawal by Subject|7|||
146904448|NCT03934684|529812713|FG001|Overall Study|Withdrawal by Subject|8|||
146904449|NCT05300087|529812714|FG000|Overall Study|Withdrawal by Subject|0|||
146904450|NCT05300087|529812715|FG001|Overall Study|Withdrawal by Subject|1|||
146904451|NCT05662332|529812716|FG000|Overall Study|Death|3|||
146904452|NCT05662332|529812717|FG001|Overall Study|Death|3|||
146904453|NCT05662332|529812716|FG000|Overall Study|Lost to Follow-up|3|||
146904454|NCT05662332|529812717|FG001|Overall Study|Lost to Follow-up|8|||
146904455|NCT05662332|529812716|FG000|Overall Study|Physician Decision|1|||
146904456|NCT05662332|529812717|FG001|Overall Study|Physician Decision|2|||
146904457|NCT05662332|529812716|FG000|Overall Study|Protocol Deviation|2|||
146904458|NCT05662332|529812717|FG001|Overall Study|Protocol Deviation|1|||
146904459|NCT05662332|529812716|FG000|Overall Study|Withdrawal by Subject|14|||
146904460|NCT05662332|529812717|FG001|Overall Study|Withdrawal by Subject|14|||
146904461|NCT05662332|529812716|FG000|Overall Study|Assigned Treatment by Mistake|5|||
146904462|NCT05662332|529812717|FG001|Overall Study|Assigned Treatment by Mistake|7|||
146904463|NCT05662332|529812716|FG000|Overall Study|Non-compliance with study drug|4|||
146904464|NCT05662332|529812717|FG001|Overall Study|Non-compliance with study drug|1|||
146904465|NCT05662332|529812716|FG000|Overall Study|Due to Bariatric surgery|1|||
146904466|NCT05662332|529812717|FG001|Overall Study|Due to Bariatric surgery|0|||
146904467|NCT05662332|529812716|FG000|Overall Study|Subject Moving out of State|0|||
146904468|NCT05662332|529812717|FG001|Overall Study|Subject Moving out of State|1|||
146904469|NCT05662332|529812716|FG000|Overall Study|Subject Missed the Schedule|1|||
146904470|NCT05662332|529812717|FG001|Overall Study|Subject Missed the Schedule|0|||
146904471|NCT05662332|529812716|FG000|Overall Study|The Patient Moved to Another City|1|||
146904472|NCT05662332|529812717|FG001|Overall Study|The Patient Moved to Another City|0|||
146904473|NCT03248128|529812718|FG000|Overall Study|Lost to Follow-up|1|||
146904474|NCT03248128|529812719|FG001|Overall Study|Lost to Follow-up|0|||
146904475|NCT03248128|529812718|FG000|Overall Study|Withdrawal by Subject|16|||
146904476|NCT03248128|529812719|FG001|Overall Study|Withdrawal by Subject|14|||
146904477|NCT03248128|529812718|FG000|Overall Study|Site Closed|4|||
146904478|NCT03248128|529812719|FG001|Overall Study|Site Closed|3|||
146904479|NCT03248128|529812718|FG000|Overall Study|Randomized, but did not receive treatment|1|||
146560963|NCT00663260|528564077|FG000|Overall Study|Death|1|||
146904480|NCT03248128|529812719|FG001|Overall Study|Randomized, but did not receive treatment|3|||
146904481|NCT01914679|529812720|FG000|Overall Study|Lack of Efficacy|1|||
146904482|NCT01914679|529812720|FG000|Overall Study|Sponsor terminated study|4|||
146904483|NCT00256295|529812723|FG000|Overall Study|Withdrawal by Subject|3|||
146904484|NCT00256295|529812723|FG000|Overall Study|Death|1|||
146904485|NCT05369806|529812727|FG000|Overall Study|Lost to Follow-up|1|||
146904486|NCT03542682|529812729|FG000|Overall Study|COVID-19 Protocol|0|||
146904487|NCT03542682|529812730|FG001|Overall Study|COVID-19 Protocol|1|||
146904488|NCT04321343|529812732|FG000|Overall Study|Adverse Event|0|||
146904489|NCT04321343|529812733|FG001|Overall Study|Adverse Event|0|||
146904490|NCT04321343|529812734|FG002|Overall Study|Adverse Event|1|||
146904491|NCT04321343|529812735|FG003|Overall Study|Adverse Event|0|||
146560964|NCT00663260|528564078|FG001|Overall Study|Death|0|||
146560965|NCT00663260|528564079|FG002|Overall Study|Death|1|||
146904492|NCT04321343|529812732|FG000|Overall Study|Death|0|||
146904493|NCT04321343|529812733|FG001|Overall Study|Death|0|||
146904494|NCT04321343|529812734|FG002|Overall Study|Death|0|||
146904495|NCT04321343|529812735|FG003|Overall Study|Death|1|||
146904496|NCT04321343|529812732|FG000|Overall Study|Pregnancy|1|||
146904497|NCT04321343|529812733|FG001|Overall Study|Pregnancy|0|||
146560966|NCT00663260|528564077|FG000|Overall Study|Lost to Follow-up|0|||
146904498|NCT04321343|529812734|FG002|Overall Study|Pregnancy|0|||
146904499|NCT04321343|529812735|FG003|Overall Study|Pregnancy|0|||
146904500|NCT04321343|529812732|FG000|Overall Study|Protocol Violation|1|||
146904501|NCT04321343|529812733|FG001|Overall Study|Protocol Violation|1|||
146904502|NCT04321343|529812734|FG002|Overall Study|Protocol Violation|1|||
146904503|NCT04321343|529812735|FG003|Overall Study|Protocol Violation|1|||
146904504|NCT04321343|529812732|FG000|Overall Study|Withdrawal by Subject|0|||
146904505|NCT04321343|529812733|FG001|Overall Study|Withdrawal by Subject|6|||
146904506|NCT04321343|529812734|FG002|Overall Study|Withdrawal by Subject|0|||
146904507|NCT04321343|529812735|FG003|Overall Study|Withdrawal by Subject|2|||
146904508|NCT04321343|529812732|FG000|Overall Study|Lost to Follow-up|2|||
146904509|NCT04321343|529812733|FG001|Overall Study|Lost to Follow-up|2|||
146904510|NCT04321343|529812734|FG002|Overall Study|Lost to Follow-up|1|||
146904511|NCT04321343|529812735|FG003|Overall Study|Lost to Follow-up|3|||
146904512|NCT01097044|529812740|FG000|Overall Study|Withdrawal by Subject|4|||
146904513|NCT01097044|529812741|FG001|Overall Study|Withdrawal by Subject|4|||
146904514|NCT01097044|529812740|FG000|Overall Study|Lost to Follow-up|1|||
146904515|NCT01097044|529812741|FG001|Overall Study|Lost to Follow-up|0|||
146904516|NCT01097044|529812740|FG000|Overall Study|Withdrawal by Sponsor|0|||
146904517|NCT01097044|529812741|FG001|Overall Study|Withdrawal by Sponsor|1|||
146904518|NCT04865731|529812749|FG000|Overall Study|Physician Decision|2|||
146904519|NCT04865731|529812750|FG001|Overall Study|Physician Decision|1|||
146904520|NCT04865731|529812749|FG000|Overall Study|Adverse Event|1|||
146904521|NCT04865731|529812750|FG001|Overall Study|Adverse Event|0|||
146904522|NCT04865731|529812749|FG000|Overall Study|Withdrawal by Subject|0|||
146904523|NCT04865731|529812750|FG001|Overall Study|Withdrawal by Subject|1|||
146904524|NCT01672892|529814340|FG000|Overall Study|Protocol Violation|7|||
146904525|NCT01672892|529814341|FG001|Overall Study|Protocol Violation|3|||
146904526|NCT02017444|529814345|FG000|Overall Study|Physician Decision|1|||
146904527|NCT02017444|529814346|FG001|Overall Study|Physician Decision|0|||
146904528|NCT02017444|529814345|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
146904529|NCT02017444|529814346|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
146904530|NCT01614457|529814347|FG000|Overall Study|Non-Compliance|1|||
146904531|NCT01614457|529814348|FG001|Overall Study|Non-Compliance|0|||
146904532|NCT01614457|529814347|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
146904533|NCT01614457|529814348|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
146904534|NCT02342171|529814349|FG000|Overall Study|Death|4|||
146904535|NCT02342171|529814350|FG001|Overall Study|Death|87|||
146904536|NCT02342171|529814349|FG000|Overall Study|Received favipiravir|10|||
146904537|NCT02342171|529814350|FG001|Overall Study|Received favipiravir|0|||
146904538|NCT02342171|529814349|FG000|Overall Study|Missing cycle treshold value|1|||
146904539|NCT02342171|529814350|FG001|Overall Study|Missing cycle treshold value|0|||
146904540|NCT02342171|529814349|FG000|Overall Study|Unknown outcome|0|||
146904541|NCT02342171|529814350|FG001|Overall Study|Unknown outcome|1|||
146904542|NCT02342171|529814349|FG000|Overall Study|Missing age data|0|||
146904543|NCT02342171|529814350|FG001|Overall Study|Missing age data|1|||
146904544|NCT00886821|529814353|FG000|Stage 2|Adverse Event|0|||
146904545|NCT00886821|529814354|FG001|Stage 2|Adverse Event|0|||
146904546|NCT00886821|529814355|FG002|Stage 2|Adverse Event|0|||
146904547|NCT00886821|529814356|FG003|Stage 2|Adverse Event|0|||
146904548|NCT00886821|529814357|FG004|Stage 2|Adverse Event|0|||
146904549|NCT00886821|529814358|FG005|Stage 2|Adverse Event|0|||
146904550|NCT00886821|529814359|FG006|Stage 2|Adverse Event|0|||
146904551|NCT00886821|529814360|FG007|Stage 2|Adverse Event|0|||
146904552|NCT00886821|529814361|FG008|Stage 2|Adverse Event|0|||
146904553|NCT00886821|529814362|FG009|Stage 2|Adverse Event|0|||
146904554|NCT00886821|529814363|FG010|Stage 2|Adverse Event|0|||
146904555|NCT00886821|529814364|FG011|Stage 2|Adverse Event|1|||
146904556|NCT00886821|529814365|FG012|Stage 2|Adverse Event|3|||
146904557|NCT00886821|529814366|FG013|Stage 2|Adverse Event|0|||
146904558|NCT00886821|529814353|FG000|Stage 2|Lost to Follow-up|0|||
146904559|NCT00886821|529814354|FG001|Stage 2|Lost to Follow-up|0|||
146904560|NCT00886821|529814355|FG002|Stage 2|Lost to Follow-up|0|||
146904561|NCT00886821|529814356|FG003|Stage 2|Lost to Follow-up|0|||
146904562|NCT00886821|529814357|FG004|Stage 2|Lost to Follow-up|0|||
146904563|NCT00886821|529814358|FG005|Stage 2|Lost to Follow-up|0|||
146904564|NCT00886821|529814359|FG006|Stage 2|Lost to Follow-up|0|||
146904565|NCT00886821|529814360|FG007|Stage 2|Lost to Follow-up|0|||
146904566|NCT00886821|529814361|FG008|Stage 2|Lost to Follow-up|0|||
146904567|NCT00886821|529814362|FG009|Stage 2|Lost to Follow-up|0|||
146904568|NCT00886821|529814363|FG010|Stage 2|Lost to Follow-up|0|||
146904569|NCT00886821|529814364|FG011|Stage 2|Lost to Follow-up|0|||
146904570|NCT00886821|529814365|FG012|Stage 2|Lost to Follow-up|2|||
146904571|NCT00886821|529814366|FG013|Stage 2|Lost to Follow-up|1|||
146904572|NCT03311126|529814367|FG000|Induction|Death|1|||
146904573|NCT03311126|529814367|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
146904574|NCT00942162|529814368|FG000|Overall Study|Death|45|||
146904575|NCT00942162|529814369|FG001|Overall Study|Death|35|||
146904576|NCT00942162|529814370|FG002|Overall Study|Death|0|||
146904577|NCT00942162|529814368|FG000|Overall Study|Withdrawal by Subject|7|||
146904578|NCT00942162|529814369|FG001|Overall Study|Withdrawal by Subject|2|||
146904579|NCT00942162|529814370|FG002|Overall Study|Withdrawal by Subject|0|||
146904580|NCT00942162|529814368|FG000|Overall Study|Lost to Follow-up|4|||
146904581|NCT00942162|529814369|FG001|Overall Study|Lost to Follow-up|0|||
146904582|NCT00942162|529814370|FG002|Overall Study|Lost to Follow-up|0|||
146904583|NCT00942162|529814368|FG000|Overall Study|Other|14|||
146904584|NCT00942162|529814369|FG001|Overall Study|Other|13|||
146904585|NCT00942162|529814370|FG002|Overall Study|Other|2|||
146904586|NCT00698516|529814371|FG000|Overall Study|Study Termination|2|||
146904587|NCT00698516|529814371|FG000|Overall Study|Withdrawal by Subject|3|||
146904588|NCT03090191|529814372|FG000|Overall Study|Adverse Event|90|||
146904589|NCT03090191|529814373|FG001|Overall Study|Adverse Event|72|||
146904590|NCT03090191|529814372|FG000|Overall Study|Death|365|||
146904591|NCT03090191|529814373|FG001|Overall Study|Death|358|||
146904592|NCT03090191|529814372|FG000|Overall Study|Lost to Follow-up|382|||
146904593|NCT03090191|529814373|FG001|Overall Study|Lost to Follow-up|394|||
146904594|NCT03090191|529814372|FG000|Overall Study|Physician Decision|77|||
146904595|NCT03090191|529814373|FG001|Overall Study|Physician Decision|66|||
146904596|NCT03090191|529814372|FG000|Overall Study|Protocol Violation|43|||
146904597|NCT03090191|529814373|FG001|Overall Study|Protocol Violation|52|||
146904598|NCT03090191|529814372|FG000|Overall Study|Withdrawal by Subject|2160|||
146904599|NCT03090191|529814373|FG001|Overall Study|Withdrawal by Subject|2133|||
146904600|NCT03090191|529814372|FG000|Overall Study|Site terminated|7|||
146904601|NCT03090191|529814373|FG001|Overall Study|Site terminated|8|||
146904602|NCT03090191|529814372|FG000|Overall Study|Other|66|||
146904603|NCT03090191|529814373|FG001|Overall Study|Other|60|||
146904604|NCT03090191|529814372|FG000|Overall Study|Withdrawn before any study vaccination|43|||
146904605|NCT03090191|529814373|FG001|Overall Study|Withdrawn before any study vaccination|52|||
146904606|NCT01931865|529814383|FG000|Overall Study|Lost to Follow-up|2|||
146904607|NCT01931865|529814383|FG000|Overall Study|Withdrawal by Subject|2|||
146904608|NCT01531725|529814387|FG000|Overall Study|Protocol Violation|5|||
146904609|NCT00472303|529814388|FG000|Titration Phase|Adverse Event|22|||
146904610|NCT00472303|529814389|FG001|Titration Phase|Adverse Event|12|||
146904611|NCT00472303|529814390|FG002|Titration Phase|Adverse Event|0|||
146904612|NCT00472303|529814388|FG000|Titration Phase|Death|4|||
146904613|NCT00472303|529814389|FG001|Titration Phase|Death|2|||
146904614|NCT00472303|529814390|FG002|Titration Phase|Death|0|||
146904615|NCT00472303|529814388|FG000|Titration Phase|Lack of Efficacy|10|||
146904616|NCT00472303|529814389|FG001|Titration Phase|Lack of Efficacy|0|||
146904617|NCT00472303|529814390|FG002|Titration Phase|Lack of Efficacy|0|||
146904618|NCT00472303|529814388|FG000|Titration Phase|Withdrawal by Subject|16|||
146904619|NCT00472303|529814389|FG001|Titration Phase|Withdrawal by Subject|13|||
146904620|NCT00472303|529814390|FG002|Titration Phase|Withdrawal by Subject|0|||
146904621|NCT00472303|529814388|FG000|Titration Phase|Trial Medication non-compliant|4|||
146904622|NCT00472303|529814389|FG001|Titration Phase|Trial Medication non-compliant|1|||
146904623|NCT00472303|529814390|FG002|Titration Phase|Trial Medication non-compliant|0|||
146904624|NCT00472303|529814388|FG000|Titration Phase|Other|3|||
146904625|NCT00472303|529814389|FG001|Titration Phase|Other|1|||
146904626|NCT00472303|529814390|FG002|Titration Phase|Other|0|||
146904627|NCT00472303|529814388|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
146904628|NCT00472303|529814389|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
146904629|NCT00472303|529814390|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
146904630|NCT00472303|529814388|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
146904631|NCT00472303|529814389|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
146904632|NCT00472303|529814390|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
146904633|NCT00472303|529814388|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
146904634|NCT00472303|529814389|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
146904635|NCT00472303|529814390|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
146904636|NCT00472303|529814388|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
146904637|NCT00472303|529814389|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
146904638|NCT00472303|529814390|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
146904639|NCT00472303|529814388|FG000|Discontinuations After Titration Phase|Other|5|||
146904640|NCT00472303|529814389|FG001|Discontinuations After Titration Phase|Other|0|||
146904641|NCT00472303|529814390|FG002|Discontinuations After Titration Phase|Other|0|||
146904642|NCT00472303|529814388|FG000|Maintenance Phase|Adverse Event|5|||
146904643|NCT00472303|529814389|FG001|Maintenance Phase|Adverse Event|6|||
146904644|NCT00472303|529814390|FG002|Maintenance Phase|Adverse Event|6|||
146904645|NCT00472303|529814388|FG000|Maintenance Phase|Death|3|||
146904646|NCT00472303|529814389|FG001|Maintenance Phase|Death|0|||
146904647|NCT00472303|529814390|FG002|Maintenance Phase|Death|2|||
146904648|NCT00472303|529814388|FG000|Maintenance Phase|Lack of Efficacy|2|||
146904649|NCT00472303|529814389|FG001|Maintenance Phase|Lack of Efficacy|2|||
146904650|NCT00472303|529814390|FG002|Maintenance Phase|Lack of Efficacy|4|||
146904651|NCT00472303|529814388|FG000|Maintenance Phase|Withdrawal by Subject|6|||
146904652|NCT00472303|529814389|FG001|Maintenance Phase|Withdrawal by Subject|7|||
146904653|NCT00472303|529814390|FG002|Maintenance Phase|Withdrawal by Subject|3|||
146904654|NCT00472303|529814388|FG000|Maintenance Phase|Trial medication non-compliant|0|||
146904655|NCT00472303|529814389|FG001|Maintenance Phase|Trial medication non-compliant|0|||
146904656|NCT00472303|529814390|FG002|Maintenance Phase|Trial medication non-compliant|1|||
146904657|NCT00472303|529814388|FG000|Maintenance Phase|Resolution of pain|0|||
146904658|NCT00472303|529814389|FG001|Maintenance Phase|Resolution of pain|0|||
146904659|NCT00472303|529814390|FG002|Maintenance Phase|Resolution of pain|1|||
146904660|NCT00472303|529814388|FG000|Maintenance Phase|Other|1|||
146904661|NCT00472303|529814389|FG001|Maintenance Phase|Other|1|||
146904662|NCT00472303|529814390|FG002|Maintenance Phase|Other|0|||
146904663|NCT04112914|529814392|FG000|Overall Study|Lost to Follow-up|13|||
146904664|NCT04112914|529814393|FG001|Overall Study|Lost to Follow-up|9|||
146904665|NCT04112914|529814392|FG000|Overall Study|Withdrawal by Subject|1|||
146904666|NCT04112914|529814393|FG001|Overall Study|Withdrawal by Subject|0|||
146904667|NCT02835495|529814404|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
146904668|NCT02835495|529814405|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
146904669|NCT02835495|529814404|FG000|Overall Study|Declined in-person follow-up visit|4|||
146904670|NCT02835495|529814405|FG001|Overall Study|Declined in-person follow-up visit|2|||
146904671|NCT00356915|529814407|FG000|Overall Study|Non compliance|1|||
146904672|NCT00356915|529814408|FG001|Overall Study|Non compliance|2|||
146904673|NCT00356915|529814409|FG002|Overall Study|Non compliance|1|||
146904674|NCT00356915|529814407|FG000|Overall Study|Protocol Violation|2|||
146904675|NCT00356915|529814408|FG001|Overall Study|Protocol Violation|3|||
146904676|NCT00356915|529814409|FG002|Overall Study|Protocol Violation|2|||
146904677|NCT00356915|529814407|FG000|Overall Study|Withdrawal by Subject|14|||
146904678|NCT00356915|529814408|FG001|Overall Study|Withdrawal by Subject|14|||
146904679|NCT00356915|529814409|FG002|Overall Study|Withdrawal by Subject|10|||
146904680|NCT00356915|529814407|FG000|Overall Study|Lack of Efficacy|0|||
146904681|NCT00356915|529814408|FG001|Overall Study|Lack of Efficacy|0|||
146904682|NCT00356915|529814409|FG002|Overall Study|Lack of Efficacy|3|||
146904683|NCT00356915|529814407|FG000|Overall Study|Lost to Follow-up|27|||
146904684|NCT00356915|529814408|FG001|Overall Study|Lost to Follow-up|34|||
146904685|NCT00356915|529814409|FG002|Overall Study|Lost to Follow-up|14|||
146904686|NCT00356915|529814407|FG000|Overall Study|Administrative Decision|0|||
146904687|NCT00356915|529814408|FG001|Overall Study|Administrative Decision|0|||
146970105|NCT01523301|530050782|FG000|Overall Study|Lost to Follow-up|1|||
146970106|NCT01523301|530050783|FG001|Overall Study|Lost to Follow-up|0|||
146904688|NCT00356915|529814409|FG002|Overall Study|Administrative Decision|1|||
146904689|NCT00356915|529814407|FG000|Overall Study|Physician Decision|0|||
146904690|NCT00356915|529814408|FG001|Overall Study|Physician Decision|2|||
146970107|NCT01523301|530050782|FG000|Overall Study|Withdrawal by Subject|6|||
146904691|NCT00356915|529814409|FG002|Overall Study|Physician Decision|0|||
146904692|NCT00356915|529814407|FG000|Overall Study|Adverse Event|21|||
146904693|NCT00356915|529814408|FG001|Overall Study|Adverse Event|31|||
146904694|NCT00356915|529814409|FG002|Overall Study|Adverse Event|8|||
146904695|NCT00356915|529814407|FG000|Overall Study|Miscellaneous reasons|11|||
146904696|NCT00356915|529814408|FG001|Overall Study|Miscellaneous reasons|8|||
146904697|NCT00356915|529814409|FG002|Overall Study|Miscellaneous reasons|3|||
146904698|NCT00488631|529814410|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
146904699|NCT00488631|529814411|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
146904700|NCT00488631|529814412|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
146904701|NCT00488631|529814413|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
146904702|NCT00488631|529814414|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
146904703|NCT00488631|529814415|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
146904704|NCT00488631|529814416|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
146904705|NCT00488631|529814417|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
146904706|NCT00488631|529814418|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
146904707|NCT00488631|529814419|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
146904708|NCT00488631|529814410|FG000|Double Blind Period (Week 0-54)|Death|0|||
146904709|NCT00488631|529814411|FG001|Double Blind Period (Week 0-54)|Death|0|||
146904710|NCT00488631|529814412|FG002|Double Blind Period (Week 0-54)|Death|0|||
146904711|NCT00488631|529814413|FG003|Double Blind Period (Week 0-54)|Death|0|||
146904712|NCT00488631|529814414|FG004|Double Blind Period (Week 0-54)|Death|0|||
146904713|NCT00488631|529814415|FG005|Double Blind Period (Week 0-54)|Death|1|||
146904714|NCT00488631|529814416|FG006|Double Blind Period (Week 0-54)|Death|0|||
146904715|NCT00488631|529814417|FG007|Double Blind Period (Week 0-54)|Death|0|||
146904716|NCT00488631|529814418|FG008|Double Blind Period (Week 0-54)|Death|0|||
146904717|NCT00488631|529814419|FG009|Double Blind Period (Week 0-54)|Death|0|||
146904718|NCT00488631|529814410|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
146904719|NCT00488631|529814411|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
146904720|NCT00488631|529814412|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
146904721|NCT00488631|529814413|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
146904722|NCT00488631|529814414|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
146904723|NCT00488631|529814415|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
146904724|NCT00488631|529814416|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
146904725|NCT00488631|529814417|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
146904726|NCT00488631|529814418|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
146904727|NCT00488631|529814419|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
146904728|NCT00488631|529814410|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
146904729|NCT00488631|529814411|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
146904730|NCT00488631|529814412|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
146904731|NCT00488631|529814413|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
146904732|NCT00488631|529814414|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
146904733|NCT00488631|529814415|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
146904734|NCT00488631|529814416|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
146904735|NCT00488631|529814417|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
146904736|NCT00488631|529814418|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
146904737|NCT00488631|529814419|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
146904738|NCT00488631|529814410|FG000|Double Blind Period (Week 0-54)|Other|6|||
146904739|NCT00488631|529814411|FG001|Double Blind Period (Week 0-54)|Other|12|||
146904740|NCT00488631|529814412|FG002|Double Blind Period (Week 0-54)|Other|10|||
146904741|NCT00488631|529814413|FG003|Double Blind Period (Week 0-54)|Other|11|||
146904742|NCT00488631|529814414|FG004|Double Blind Period (Week 0-54)|Other|14|||
146904743|NCT00488631|529814415|FG005|Double Blind Period (Week 0-54)|Other|34|||
146904744|NCT00488631|529814416|FG006|Double Blind Period (Week 0-54)|Other|0|||
146904745|NCT00488631|529814417|FG007|Double Blind Period (Week 0-54)|Other|0|||
146904746|NCT00488631|529814418|FG008|Double Blind Period (Week 0-54)|Other|0|||
146904747|NCT00488631|529814419|FG009|Double Blind Period (Week 0-54)|Other|0|||
146904748|NCT00488631|529814410|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
146904749|NCT00488631|529814411|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
146904750|NCT00488631|529814412|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
146904751|NCT00488631|529814413|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
146904752|NCT00488631|529814414|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
146904753|NCT00488631|529814415|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
146904754|NCT00488631|529814416|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
146904755|NCT00488631|529814417|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
146904756|NCT00488631|529814418|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
146904757|NCT00488631|529814419|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
146560967|NCT00663260|528564078|FG001|Overall Study|Lost to Follow-up|1|||
146560968|NCT00663260|528564079|FG002|Overall Study|Lost to Follow-up|0|||
146560969|NCT00663260|528564077|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
146560970|NCT00663260|528564078|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
146904758|NCT00488631|529814410|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
146904759|NCT00488631|529814411|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
146904760|NCT00488631|529814412|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
146904761|NCT00488631|529814413|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
146904762|NCT00488631|529814414|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
146904763|NCT00488631|529814415|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
146904764|NCT00488631|529814416|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
146904765|NCT00488631|529814417|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
146904766|NCT00488631|529814418|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
146904767|NCT00488631|529814419|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
146904768|NCT00488631|529814410|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
146904769|NCT00488631|529814411|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
146904770|NCT00488631|529814412|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
146904771|NCT00488631|529814413|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
146904772|NCT00488631|529814414|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
146904773|NCT00488631|529814415|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
146904774|NCT00488631|529814416|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
146904775|NCT00488631|529814417|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
146904776|NCT00488631|529814418|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
146904777|NCT00488631|529814419|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
146904778|NCT00488631|529814410|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
146904779|NCT00488631|529814411|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
146904780|NCT00488631|529814412|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
146904781|NCT00488631|529814413|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
146560971|NCT00663260|528564079|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
146560972|NCT01979185|528564083|FG000|Period 2|Other|0|||
146560973|NCT01979185|528564084|FG001|Period 2|Other|1|||
146560974|NCT02607722|528564085|FG000|Overall Study|No data reliability|1|||
146560975|NCT02607722|528564085|FG000|Overall Study|no patient visit|18|||
146560976|NCT02607722|528564085|FG000|Overall Study|missing info in CRF|13|||
146560977|NCT02607722|528564085|FG000|Overall Study|Withdrawal by Subject|616|||
146560978|NCT02607722|528564085|FG000|Overall Study|Lost to Follow-up|312|||
146560979|NCT02607722|528564085|FG000|Overall Study|Improved|22|||
146560980|NCT02607722|528564085|FG000|Overall Study|Lack of Efficacy|316|||
146560981|NCT02607722|528564085|FG000|Overall Study|Adverse Event|2553|||
146560982|NCT02607722|528564085|FG000|Overall Study|Not treated|1|||
146560983|NCT02607722|528564085|FG000|Overall Study|No CRF collected|138|||
146560984|NCT02607722|528564085|FG000|Overall Study|without CRF|4225|||
146560985|NCT02607722|528564085|FG000|Overall Study|Physician Decision|367|||
146904782|NCT00488631|529814414|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
146904783|NCT00488631|529814415|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
146904784|NCT00488631|529814416|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
146970108|NCT01523301|530050783|FG001|Overall Study|Withdrawal by Subject|8|||
146970109|NCT01523301|530050782|FG000|Overall Study|Other Reason|0|||
146560986|NCT02135133|528564086|FG000|Overall Study|Adverse Event|10|||
146560987|NCT02135133|528564086|FG000|Overall Study|regulatory mandate|5|||
146560988|NCT03238196|528564087|FG000|Overall Study|Adverse Event|3|||
146560989|NCT03238196|528564088|FG001|Overall Study|Adverse Event|0|||
146560990|NCT03238196|528564089|FG002|Overall Study|Adverse Event|2|||
146560991|NCT03238196|528564090|FG003|Overall Study|Adverse Event|2|||
146560992|NCT03238196|528564087|FG000|Overall Study|Withdrawal by Subject|4|||
146560993|NCT03238196|528564088|FG001|Overall Study|Withdrawal by Subject|1|||
146560994|NCT03238196|528564089|FG002|Overall Study|Withdrawal by Subject|1|||
146560995|NCT03238196|528564090|FG003|Overall Study|Withdrawal by Subject|0|||
146560996|NCT03238196|528564087|FG000|Overall Study|Disease progression|14|||
146560997|NCT03238196|528564088|FG001|Overall Study|Disease progression|2|||
146560998|NCT03238196|528564089|FG002|Overall Study|Disease progression|3|||
146560999|NCT03238196|528564090|FG003|Overall Study|Disease progression|2|||
146561000|NCT03238196|528564087|FG000|Overall Study|Still on treatment|1|||
146561001|NCT03238196|528564088|FG001|Overall Study|Still on treatment|0|||
146561002|NCT03238196|528564089|FG002|Overall Study|Still on treatment|0|||
146561003|NCT03238196|528564090|FG003|Overall Study|Still on treatment|0|||
146561004|NCT00847730|528564091|FG000|Overall Study|Multiple interruptions in therapy|8|||
146561005|NCT02496000|528564104|FG000|Overall Study|Withdrawal by Subject|1|||
146561006|NCT02496000|528564105|FG001|Overall Study|Withdrawal by Subject|2|||
146561007|NCT02496000|528564106|FG002|Overall Study|Withdrawal by Subject|0|||
146561008|NCT02496000|528564104|FG000|Overall Study|Lost to Follow-up|1|||
146561009|NCT02496000|528564105|FG001|Overall Study|Lost to Follow-up|0|||
146561010|NCT02496000|528564106|FG002|Overall Study|Lost to Follow-up|1|||
146561011|NCT02496000|528564104|FG000|Overall Study|Protocol Violation|0|||
146561012|NCT02496000|528564105|FG001|Overall Study|Protocol Violation|0|||
146561013|NCT02496000|528564106|FG002|Overall Study|Protocol Violation|1|||
146561014|NCT02496000|528564104|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
146561015|NCT02496000|528564105|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
146561016|NCT02496000|528564106|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
146561017|NCT02496000|528564104|FG000|Overall Study|undetermined|0|||
146561018|NCT02496000|528564105|FG001|Overall Study|undetermined|1|||
146561019|NCT02496000|528564106|FG002|Overall Study|undetermined|0|||
146561020|NCT02255656|528564107|FG000|Overall Study|Adverse Event|11|||
146561021|NCT02255656|528564107|FG000|Overall Study|Poor compliance to protocol|3|||
146561022|NCT02255656|528564107|FG000|Overall Study|Lost to Follow-up|30|||
146561023|NCT02255656|528564107|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
146561024|NCT02255656|528564107|FG000|Overall Study|Other|126|||
146561025|NCT01877278|528564108|FG000|Overall Study|Lost to Follow-up|3|||
146561026|NCT01877278|528564109|FG001|Overall Study|Lost to Follow-up|3|||
146561027|NCT04727151|528564110|FG000|Overall Study|Death|0|||
146561028|NCT04727151|528564111|FG001|Overall Study|Death|0|||
146561029|NCT04727151|528564112|FG002|Overall Study|Death|0|||
146561030|NCT04727151|528564113|FG003|Overall Study|Death|0|||
146561031|NCT04727151|528564114|FG004|Overall Study|Death|3|||
146561032|NCT04727151|528564110|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
146561033|NCT04727151|528564111|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
146561034|NCT04727151|528564112|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
146561035|NCT04727151|528564113|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
146561036|NCT04727151|528564114|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
146561037|NCT03510715|528564115|FG000|Overall Study|Adverse Event|1|||
146561038|NCT03510715|528564116|FG001|Overall Study|Adverse Event|0|||
146561039|NCT05318287|528564121|FG000|Overall Study|Lost to Follow-up|8|||
146561040|NCT04144517|528564124|FG000|Overall Study|Physician Decision|0|||
146561041|NCT04144517|528564125|FG001|Overall Study|Physician Decision|1|||
146904785|NCT00488631|529814417|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
146904786|NCT00488631|529814418|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
146904787|NCT00488631|529814419|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
146904788|NCT00488631|529814410|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
146904789|NCT00488631|529814411|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
146904790|NCT00488631|529814412|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
146904791|NCT00488631|529814413|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
146561042|NCT04144517|528564124|FG000|Overall Study|Other|2|||
146561043|NCT04144517|528564125|FG001|Overall Study|Other|2|||
146561044|NCT04144517|528564124|FG000|Overall Study|Death|6|||
146561045|NCT04144517|528564125|FG001|Overall Study|Death|3|||
146561046|NCT02757768|528564129|FG000|Overall Study|Randomized Never Received Study Drug|3|||
146561047|NCT02757768|528564130|FG001|Overall Study|Randomized Never Received Study Drug|4|||
146561048|NCT02757768|528564129|FG000|Overall Study|Adverse Event|5|||
146561049|NCT02757768|528564130|FG001|Overall Study|Adverse Event|3|||
146561050|NCT02757768|528564129|FG000|Overall Study|Lack of Efficacy|2|||
146561051|NCT02757768|528564130|FG001|Overall Study|Lack of Efficacy|1|||
146561052|NCT02757768|528564129|FG000|Overall Study|Lost to Follow-up|1|||
146561053|NCT02757768|528564130|FG001|Overall Study|Lost to Follow-up|0|||
146561054|NCT02757768|528564129|FG000|Overall Study|Protocol Deviation|2|||
146561055|NCT02757768|528564130|FG001|Overall Study|Protocol Deviation|9|||
146561056|NCT02757768|528564129|FG000|Overall Study|Withdrawal by Subject|16|||
146561057|NCT02757768|528564130|FG001|Overall Study|Withdrawal by Subject|9|||
146561058|NCT02757768|528564129|FG000|Overall Study|Miscellaneous|4|||
146561059|NCT02757768|528564130|FG001|Overall Study|Miscellaneous|2|||
146561060|NCT02495883|528564137|FG000|Overall Study|Excessive head motion|1|||
146561061|NCT02495883|528564138|FG001|Overall Study|Excessive head motion|0|||
146561062|NCT03557502|528564139|FG000|Protocol 2|Withdrawal by Subject|1|||
146561063|NCT03557502|528564140|FG001|Protocol 2|Withdrawal by Subject|1|||
146561064|NCT03557502|528564139|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
146561065|NCT03557502|528564140|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
146561066|NCT03164356|528564142|FG000|Overall Study|Lost to Follow-up|1|||
146561067|NCT03164356|528564143|FG001|Overall Study|Lost to Follow-up|1|||
146561068|NCT03164356|528564144|FG002|Overall Study|Lost to Follow-up|2|||
146561069|NCT03164356|528564145|FG003|Overall Study|Lost to Follow-up|1|||
146561070|NCT03164356|528564142|FG000|Overall Study|Physician Decision|0|||
146561071|NCT03164356|528564143|FG001|Overall Study|Physician Decision|0|||
146561072|NCT03164356|528564144|FG002|Overall Study|Physician Decision|3|||
146561073|NCT03164356|528564145|FG003|Overall Study|Physician Decision|0|||
146561074|NCT03164356|528564142|FG000|Overall Study|Protocol Violation|2|||
146561075|NCT03164356|528564143|FG001|Overall Study|Protocol Violation|1|||
146561076|NCT03164356|528564144|FG002|Overall Study|Protocol Violation|0|||
146561077|NCT03164356|528564145|FG003|Overall Study|Protocol Violation|0|||
146561078|NCT03164356|528564142|FG000|Overall Study|Withdrawal by Subject|1|||
146561079|NCT03164356|528564143|FG001|Overall Study|Withdrawal by Subject|0|||
146561080|NCT03164356|528564144|FG002|Overall Study|Withdrawal by Subject|0|||
146561081|NCT03164356|528564145|FG003|Overall Study|Withdrawal by Subject|0|||
146561082|NCT03164356|528564142|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
146561083|NCT03164356|528564143|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
146561084|NCT03164356|528564144|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
146561085|NCT03164356|528564145|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
146561086|NCT03164356|528564142|FG000|Overall Study|Subject Incarcerated|0|||
146561087|NCT03164356|528564143|FG001|Overall Study|Subject Incarcerated|1|||
146561088|NCT03164356|528564144|FG002|Overall Study|Subject Incarcerated|0|||
146561089|NCT03164356|528564145|FG003|Overall Study|Subject Incarcerated|0|||
146561090|NCT03164356|528564142|FG000|Overall Study|Prosthetist unable to participate|0|||
146561091|NCT03164356|528564143|FG001|Overall Study|Prosthetist unable to participate|2|||
146561092|NCT03164356|528564144|FG002|Overall Study|Prosthetist unable to participate|1|||
146561093|NCT03164356|528564145|FG003|Overall Study|Prosthetist unable to participate|0|||
146561094|NCT02520154|528564152|FG000|Overall Study|Death|1|||
146561095|NCT02520154|528564152|FG000|Overall Study|Withdrawal by Subject|2|||
146561096|NCT02520154|528564152|FG000|Overall Study|Physician Decision|2|||
146561097|NCT05943990|528564156|FG000|Overall Study|Study Terminated by Sponsor|0|||
146561098|NCT05943990|528564157|FG001|Overall Study|Study Terminated by Sponsor|0|||
146561099|NCT05943990|528564158|FG002|Overall Study|Study Terminated by Sponsor|1|||
146561100|NCT03977155|528565902|FG000|Overall Study|Adverse Event|3|||
146561101|NCT03977155|528565903|FG001|Overall Study|Adverse Event|0|||
146904792|NCT00488631|529814414|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
146904793|NCT00488631|529814415|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
146904794|NCT00488631|529814416|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
146904795|NCT00488631|529814417|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
146904796|NCT00488631|529814418|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
146904797|NCT00488631|529814419|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
146904798|NCT05421754|529814420|FG000|Overall Study|Technical issue with sensor|1|||
146904799|NCT02604264|529814422|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
146904800|NCT02604264|529814423|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
146904801|NCT03192904|529814424|FG000|Overall Study|Physician Decision|3|||
146904802|NCT03192904|529814425|FG001|Overall Study|Physician Decision|1|||
146904803|NCT03192904|529814424|FG000|Overall Study|Lost to Follow-up|0|||
146904804|NCT03192904|529814425|FG001|Overall Study|Lost to Follow-up|1|||
146904805|NCT00709202|529814428|FG000|Overall Study|Withdrawal by Subject|6|||
146904806|NCT00709202|529814429|FG001|Overall Study|Withdrawal by Subject|6|||
146904807|NCT03301857|529814430|FG000|Overall Study|Death|0|||
146904808|NCT03301857|529814431|FG001|Overall Study|Death|2|||
146904809|NCT03301857|529814430|FG000|Overall Study|Lost to Follow-up|4|||
146904810|NCT03301857|529814431|FG001|Overall Study|Lost to Follow-up|2|||
146904811|NCT03301857|529814430|FG000|Overall Study|Decision by Sponsor|6|||
146904812|NCT03301857|529814431|FG001|Overall Study|Decision by Sponsor|0|||
146904813|NCT03301857|529814430|FG000|Overall Study|Withdrawal by Subject|12|||
146767577|NCT00241644|529317360|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
146904814|NCT03301857|529814431|FG001|Overall Study|Withdrawal by Subject|4|||
146904815|NCT00855439|529814436|FG000|Overall Study|Withdrawal by Subject|2|||
146904816|NCT00855439|529814437|FG001|Overall Study|Withdrawal by Subject|0|||
146904817|NCT00855439|529814436|FG000|Overall Study|Pregnancy|1|||
146904818|NCT00855439|529814437|FG001|Overall Study|Pregnancy|0|||
146904819|NCT05502289|529814438|FG000|Period 1|Out Of Window|1|||
146904820|NCT05502289|529814439|FG001|Period 1|Out Of Window|0|||
146904821|NCT01982630|529814442|FG000|Overall Study|Adverse Event|2|||
146904822|NCT01982630|529814443|FG001|Overall Study|Adverse Event|0|||
146904823|NCT01982630|529814444|FG002|Overall Study|Adverse Event|1|||
146904824|NCT01982630|529814445|FG003|Overall Study|Adverse Event|0|||
146904825|NCT01982630|529814446|FG004|Overall Study|Adverse Event|1|||
146904826|NCT01982630|529814447|FG005|Overall Study|Adverse Event|2|||
146767578|NCT00241644|529317361|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
146904827|NCT01982630|529814448|FG006|Overall Study|Adverse Event|1|||
146904828|NCT01982630|529814449|FG007|Overall Study|Adverse Event|0|||
146904829|NCT01982630|529814442|FG000|Overall Study|Physician Decision|1|||
146904830|NCT01982630|529814443|FG001|Overall Study|Physician Decision|0|||
146904831|NCT01982630|529814444|FG002|Overall Study|Physician Decision|2|||
146904832|NCT01982630|529814445|FG003|Overall Study|Physician Decision|1|||
146767579|NCT00241644|529317362|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
146767580|NCT00241644|529317363|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
146767581|NCT00241644|529317360|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
146904833|NCT01982630|529814446|FG004|Overall Study|Physician Decision|2|||
146904834|NCT01982630|529814447|FG005|Overall Study|Physician Decision|0|||
146970110|NCT01523301|530050783|FG001|Overall Study|Other Reason|2|||
146970111|NCT01339000|530050784|FG000|Overall Study|study closed due to lack of drug supply|1|||
146970112|NCT01339000|530050785|FG001|Overall Study|study closed due to lack of drug supply|0|||
146970113|NCT00728988|530050786|FG000|Overall Study|Not Treated|2|||
146970114|NCT00728988|530050787|FG001|Overall Study|Not Treated|2|||
146970115|NCT00728988|530050786|FG000|Overall Study|Death|1|||
146970116|NCT00728988|530050787|FG001|Overall Study|Death|1|||
146904835|NCT01982630|529814448|FG006|Overall Study|Physician Decision|0|||
146904836|NCT01982630|529814449|FG007|Overall Study|Physician Decision|0|||
146904837|NCT01982630|529814442|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
146970117|NCT00728988|530050786|FG000|Overall Study|Adverse Event|3|||
146970118|NCT00728988|530050787|FG001|Overall Study|Adverse Event|2|||
146904838|NCT01982630|529814443|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
146970119|NCT00728988|530050786|FG000|Overall Study|Other|85|||
146970120|NCT00728988|530050787|FG001|Overall Study|Other|77|||
146904839|NCT01982630|529814444|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
146904840|NCT01982630|529814445|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
146904841|NCT01982630|529814446|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
146904842|NCT01982630|529814447|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
146904843|NCT01982630|529814448|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
146904844|NCT01982630|529814449|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
146904845|NCT01982630|529814442|FG000|Overall Study|Withdrawal by Subject|0|||
146904846|NCT01982630|529814443|FG001|Overall Study|Withdrawal by Subject|0|||
146904847|NCT01982630|529814444|FG002|Overall Study|Withdrawal by Subject|0|||
146904848|NCT01982630|529814445|FG003|Overall Study|Withdrawal by Subject|0|||
146904849|NCT01982630|529814446|FG004|Overall Study|Withdrawal by Subject|0|||
146904850|NCT01982630|529814447|FG005|Overall Study|Withdrawal by Subject|1|||
146904851|NCT01982630|529814448|FG006|Overall Study|Withdrawal by Subject|0|||
146904852|NCT01982630|529814449|FG007|Overall Study|Withdrawal by Subject|0|||
146904853|NCT00561353|529814450|FG000|Overall Study|Subject reached a virologic endpoint|2|||
146904854|NCT00561353|529814451|FG001|Overall Study|Subject reached a virologic endpoint|1|||
146904855|NCT00561353|529814452|FG002|Overall Study|Subject reached a virologic endpoint|1|||
146904856|NCT00561353|529814453|FG003|Overall Study|Subject reached a virologic endpoint|4|||
146904857|NCT00561353|529814454|FG004|Overall Study|Subject reached a virologic endpoint|1|||
146904858|NCT00561353|529814455|FG005|Overall Study|Subject reached a virologic endpoint|3|||
146904859|NCT00561353|529814456|FG006|Overall Study|Subject reached a virologic endpoint|4|||
146904860|NCT00561353|529814457|FG007|Overall Study|Subject reached a virologic endpoint|4|||
146904861|NCT00561353|529814458|FG008|Overall Study|Subject reached a virologic endpoint|5|||
146904862|NCT00561353|529814459|FG009|Overall Study|Subject reached a virologic endpoint|0|||
146904863|NCT00561353|529814450|FG000|Overall Study|Subject ineligible to continue the trial|0|||
146904864|NCT00561353|529814451|FG001|Overall Study|Subject ineligible to continue the trial|0|||
146904865|NCT00561353|529814452|FG002|Overall Study|Subject ineligible to continue the trial|0|||
146904866|NCT00561353|529814453|FG003|Overall Study|Subject ineligible to continue the trial|0|||
146904867|NCT00561353|529814454|FG004|Overall Study|Subject ineligible to continue the trial|0|||
146904868|NCT00561353|529814455|FG005|Overall Study|Subject ineligible to continue the trial|1|||
146904869|NCT00561353|529814456|FG006|Overall Study|Subject ineligible to continue the trial|1|||
146904870|NCT00561353|529814457|FG007|Overall Study|Subject ineligible to continue the trial|0|||
146904871|NCT00561353|529814458|FG008|Overall Study|Subject ineligible to continue the trial|2|||
146904872|NCT00561353|529814459|FG009|Overall Study|Subject ineligible to continue the trial|1|||
146904873|NCT00561353|529814450|FG000|Overall Study|Other|1|||
146904874|NCT00561353|529814451|FG001|Overall Study|Other|0|||
146904875|NCT00561353|529814452|FG002|Overall Study|Other|1|||
146904876|NCT00561353|529814453|FG003|Overall Study|Other|0|||
146904877|NCT00561353|529814454|FG004|Overall Study|Other|0|||
146904878|NCT00561353|529814455|FG005|Overall Study|Other|2|||
146904879|NCT00561353|529814456|FG006|Overall Study|Other|0|||
146904880|NCT00561353|529814457|FG007|Overall Study|Other|0|||
146904881|NCT00561353|529814458|FG008|Overall Study|Other|0|||
146904882|NCT00561353|529814459|FG009|Overall Study|Other|0|||
146904883|NCT00561353|529814450|FG000|Overall Study|Adverse Event|0|||
146904884|NCT00561353|529814451|FG001|Overall Study|Adverse Event|0|||
146904885|NCT00561353|529814452|FG002|Overall Study|Adverse Event|0|||
146904886|NCT00561353|529814453|FG003|Overall Study|Adverse Event|2|||
146904887|NCT00561353|529814454|FG004|Overall Study|Adverse Event|0|||
146904888|NCT00561353|529814455|FG005|Overall Study|Adverse Event|0|||
146904889|NCT00561353|529814456|FG006|Overall Study|Adverse Event|1|||
146904890|NCT00561353|529814457|FG007|Overall Study|Adverse Event|0|||
146904891|NCT00561353|529814458|FG008|Overall Study|Adverse Event|0|||
146904892|NCT00561353|529814459|FG009|Overall Study|Adverse Event|1|||
146904893|NCT00561353|529814450|FG000|Overall Study|Lost to Follow-up|2|||
146904894|NCT00561353|529814451|FG001|Overall Study|Lost to Follow-up|0|||
146904895|NCT00561353|529814452|FG002|Overall Study|Lost to Follow-up|1|||
146904896|NCT00561353|529814453|FG003|Overall Study|Lost to Follow-up|0|||
146904897|NCT00561353|529814454|FG004|Overall Study|Lost to Follow-up|0|||
146904898|NCT00561353|529814455|FG005|Overall Study|Lost to Follow-up|0|||
146904899|NCT00561353|529814456|FG006|Overall Study|Lost to Follow-up|0|||
146904900|NCT00561353|529814457|FG007|Overall Study|Lost to Follow-up|0|||
146904901|NCT00561353|529814458|FG008|Overall Study|Lost to Follow-up|0|||
146904902|NCT00561353|529814459|FG009|Overall Study|Lost to Follow-up|0|||
146904903|NCT00561353|529814450|FG000|Overall Study|Withdrawal by Subject|0|||
146904904|NCT00561353|529814451|FG001|Overall Study|Withdrawal by Subject|2|||
146904905|NCT00561353|529814452|FG002|Overall Study|Withdrawal by Subject|0|||
146904906|NCT00561353|529814453|FG003|Overall Study|Withdrawal by Subject|0|||
146904907|NCT00561353|529814454|FG004|Overall Study|Withdrawal by Subject|0|||
146904908|NCT00561353|529814455|FG005|Overall Study|Withdrawal by Subject|0|||
146904909|NCT00561353|529814456|FG006|Overall Study|Withdrawal by Subject|0|||
146904910|NCT00561353|529814457|FG007|Overall Study|Withdrawal by Subject|0|||
146904911|NCT00561353|529814458|FG008|Overall Study|Withdrawal by Subject|0|||
146904912|NCT00561353|529814459|FG009|Overall Study|Withdrawal by Subject|0|||
146904913|NCT01273818|529814460|FG000|Overall Study|Physician Decision|13|||
146904914|NCT01273818|529814461|FG001|Overall Study|Physician Decision|2|||
146904915|NCT01273818|529814462|FG002|Overall Study|Physician Decision|9|||
146904916|NCT00761215|529814463|FG000|Overall Study|Randomized but didn't receive drug|1|||
146904917|NCT00761215|529814464|FG001|Overall Study|Randomized but didn't receive drug|1|||
146904918|NCT00761215|529814465|FG002|Overall Study|Randomized but didn't receive drug|2|||
146904919|NCT00761215|529814463|FG000|Overall Study|Lost to Follow-up|6|||
146904920|NCT00761215|529814464|FG001|Overall Study|Lost to Follow-up|3|||
146904921|NCT00761215|529814465|FG002|Overall Study|Lost to Follow-up|6|||
146904922|NCT00761215|529814463|FG000|Overall Study|Withdrawal by Subject|1|||
146904923|NCT00761215|529814464|FG001|Overall Study|Withdrawal by Subject|0|||
146904924|NCT00761215|529814465|FG002|Overall Study|Withdrawal by Subject|0|||
146904925|NCT00761215|529814463|FG000|Overall Study|Bacteremia|1|||
146904926|NCT00761215|529814464|FG001|Overall Study|Bacteremia|0|||
146904927|NCT00761215|529814465|FG002|Overall Study|Bacteremia|0|||
146904928|NCT00519532|529814466|FG000|Overall Study|Adverse Event|11|||
146904929|NCT00519532|529814466|FG000|Overall Study|Withdrawal by Subject|5|||
146904930|NCT00519532|529814466|FG000|Overall Study|Lost to Follow-up|2|||
146904931|NCT00667277|529814467|FG000|Overall Study|Withdrawal by Subject|2|||
146904932|NCT01682044|529814469|FG000|Overall Study|Death|1|||
146904933|NCT01682044|529814469|FG000|Overall Study|Progression|3|||
146904934|NCT03232073|529814473|FG000|Overall Study|Death|1|||
146904935|NCT03232073|529814474|FG001|Overall Study|Death|0|||
146904936|NCT03232073|529814473|FG000|Overall Study|Adverse Event|7|||
146904937|NCT03232073|529814474|FG001|Overall Study|Adverse Event|12|||
146904938|NCT03232073|529814473|FG000|Overall Study|Lost to Follow-up|6|||
146904939|NCT03232073|529814474|FG001|Overall Study|Lost to Follow-up|6|||
146904940|NCT03232073|529814473|FG000|Overall Study|Lack of Efficacy|10|||
146904941|NCT03232073|529814474|FG001|Overall Study|Lack of Efficacy|8|||
146904942|NCT03232073|529814473|FG000|Overall Study|Physician Decision|9|||
146904943|NCT03232073|529814474|FG001|Overall Study|Physician Decision|2|||
146904944|NCT03232073|529814473|FG000|Overall Study|Withdrawal by Subject|54|||
146904945|NCT03232073|529814474|FG001|Overall Study|Withdrawal by Subject|39|||
146904946|NCT04909463|529815863|FG000|Overall Study|Withdrawal by Subject|0|||
146904947|NCT04909463|529815864|FG001|Overall Study|Withdrawal by Subject|1|||
146904948|NCT04909463|529815865|FG002|Overall Study|Withdrawal by Subject|0|||
146904949|NCT04909463|529815866|FG003|Overall Study|Withdrawal by Subject|0|||
146904950|NCT04909463|529815863|FG000|Overall Study|Lost to Follow-up|2|||
146904951|NCT04909463|529815864|FG001|Overall Study|Lost to Follow-up|1|||
146904952|NCT04909463|529815865|FG002|Overall Study|Lost to Follow-up|1|||
146904953|NCT04909463|529815866|FG003|Overall Study|Lost to Follow-up|0|||
146904954|NCT03528681|529815878|FG000|Open-Label Phase|Physician Decision|2|||
146904955|NCT03528681|529815879|FG001|Open-Label Phase|Physician Decision|0|||
146904956|NCT03528681|529815880|FG002|Open-Label Phase|Physician Decision|0|||
146904957|NCT03528681|529815881|FG003|Open-Label Phase|Physician Decision|0|||
146904958|NCT03528681|529815878|FG000|Open-Label Phase|Withdrawal by Subject|8|||
146904959|NCT03528681|529815879|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146904960|NCT03528681|529815880|FG002|Open-Label Phase|Withdrawal by Subject|0|||
146904961|NCT03528681|529815881|FG003|Open-Label Phase|Withdrawal by Subject|0|||
146904962|NCT03528681|529815878|FG000|Open-Label Phase|(Not collected)|4|||
146904963|NCT03528681|529815879|FG001|Open-Label Phase|(Not collected)|0|||
146904964|NCT03528681|529815880|FG002|Open-Label Phase|(Not collected)|0|||
146904965|NCT03528681|529815881|FG003|Open-Label Phase|(Not collected)|0|||
146904966|NCT03528681|529815878|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
146904967|NCT03528681|529815879|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
146904968|NCT03528681|529815880|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
146904969|NCT03528681|529815881|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
146904970|NCT03528681|529815878|FG000|Randomized Treatment Phase|Physician Decision|0|||
146904971|NCT03528681|529815879|FG001|Randomized Treatment Phase|Physician Decision|5|||
146904972|NCT03528681|529815880|FG002|Randomized Treatment Phase|Physician Decision|1|||
146904973|NCT03528681|529815881|FG003|Randomized Treatment Phase|Physician Decision|2|||
146904974|NCT03528681|529815878|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
146904975|NCT03528681|529815879|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
146904976|NCT03528681|529815880|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
146904977|NCT03528681|529815881|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
146904978|NCT03528681|529815878|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
146904979|NCT03528681|529815879|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
146904980|NCT03528681|529815880|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
146904981|NCT03528681|529815881|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
146904982|NCT03528681|529815878|FG000|Randomized Treatment Phase|(Not collected)|0|||
146904983|NCT03528681|529815879|FG001|Randomized Treatment Phase|(Not collected)|4|||
146904984|NCT03528681|529815880|FG002|Randomized Treatment Phase|(Not collected)|6|||
146904985|NCT03528681|529815881|FG003|Randomized Treatment Phase|(Not collected)|5|||
146904986|NCT03518840|529815890|FG000|Overall Study|Lost to Follow-up|6|||
146904987|NCT00875420|529815893|FG000|Overall Study|Adverse Event|0|||
146904988|NCT00875420|529815894|FG001|Overall Study|Adverse Event|1|||
146904989|NCT00875420|529815895|FG002|Overall Study|Adverse Event|1|||
146904990|NCT00875420|529815896|FG003|Overall Study|Adverse Event|0|||
146904991|NCT00875420|529815897|FG004|Overall Study|Adverse Event|0|||
146904992|NCT00875420|529815893|FG000|Overall Study|Inability to complete study procedures|1|||
146904993|NCT00875420|529815894|FG001|Overall Study|Inability to complete study procedures|0|||
146904994|NCT00875420|529815895|FG002|Overall Study|Inability to complete study procedures|1|||
146904995|NCT00875420|529815896|FG003|Overall Study|Inability to complete study procedures|1|||
146904996|NCT00875420|529815897|FG004|Overall Study|Inability to complete study procedures|1|||
146904997|NCT00875420|529815893|FG000|Overall Study|Lost to Follow-up|1|||
146904998|NCT00875420|529815894|FG001|Overall Study|Lost to Follow-up|0|||
146904999|NCT00875420|529815895|FG002|Overall Study|Lost to Follow-up|0|||
146905000|NCT00875420|529815896|FG003|Overall Study|Lost to Follow-up|0|||
146905001|NCT00875420|529815897|FG004|Overall Study|Lost to Follow-up|0|||
146905002|NCT00875420|529815893|FG000|Overall Study|Personal reason|0|||
146905003|NCT00875420|529815894|FG001|Overall Study|Personal reason|0|||
146905004|NCT00875420|529815895|FG002|Overall Study|Personal reason|0|||
146905005|NCT00875420|529815896|FG003|Overall Study|Personal reason|0|||
146905006|NCT00875420|529815897|FG004|Overall Study|Personal reason|1|||
146905007|NCT00875420|529815893|FG000|Overall Study|Prohibited medication|0|||
146905008|NCT00875420|529815894|FG001|Overall Study|Prohibited medication|0|||
146905009|NCT00875420|529815895|FG002|Overall Study|Prohibited medication|0|||
146905010|NCT00875420|529815896|FG003|Overall Study|Prohibited medication|1|||
146905011|NCT00875420|529815897|FG004|Overall Study|Prohibited medication|0|||
146905012|NCT00875420|529815893|FG000|Overall Study|Sponsor decision|0|||
146905013|NCT00875420|529815894|FG001|Overall Study|Sponsor decision|1|||
146905014|NCT00875420|529815895|FG002|Overall Study|Sponsor decision|0|||
146905015|NCT00875420|529815896|FG003|Overall Study|Sponsor decision|0|||
146905016|NCT00875420|529815897|FG004|Overall Study|Sponsor decision|0|||
146905017|NCT00875420|529815893|FG000|Overall Study|Withdrawal by Subject|0|||
146905018|NCT00875420|529815894|FG001|Overall Study|Withdrawal by Subject|0|||
146905019|NCT00875420|529815895|FG002|Overall Study|Withdrawal by Subject|1|||
146905020|NCT00875420|529815896|FG003|Overall Study|Withdrawal by Subject|0|||
146905021|NCT00875420|529815897|FG004|Overall Study|Withdrawal by Subject|0|||
146905022|NCT00914628|529815898|FG000|Overall Study|Death|35|||
146905023|NCT00914628|529815899|FG001|Overall Study|Death|17|||
146905024|NCT00914628|529815898|FG000|Overall Study|Medical decision|4|||
146905025|NCT00914628|529815899|FG001|Overall Study|Medical decision|0|||
146905026|NCT00914628|529815898|FG000|Overall Study|Protocol Violation|1|||
146561102|NCT03977155|528565904|FG002|Overall Study|Adverse Event|0|||
146905027|NCT00914628|529815899|FG001|Overall Study|Protocol Violation|0|||
146905028|NCT00914628|529815898|FG000|Overall Study|Lack of Efficacy|1|||
146905029|NCT00914628|529815899|FG001|Overall Study|Lack of Efficacy|0|||
146561103|NCT03977155|528565902|FG000|Overall Study|Lost to Follow-up|0|||
146905030|NCT00914628|529815898|FG000|Overall Study|non-randomized|1|||
146905031|NCT00914628|529815899|FG001|Overall Study|non-randomized|0|||
146905032|NCT00914628|529815898|FG000|Overall Study|Relapse|1|||
146561104|NCT03977155|528565903|FG001|Overall Study|Lost to Follow-up|1|||
146561105|NCT03977155|528565904|FG002|Overall Study|Lost to Follow-up|0|||
146905033|NCT00914628|529815899|FG001|Overall Study|Relapse|2|||
146905034|NCT00914628|529815898|FG000|Overall Study|Study terminated by Sponsor|14|||
146905035|NCT00914628|529815899|FG001|Overall Study|Study terminated by Sponsor|8|||
146905036|NCT00914628|529815898|FG000|Overall Study|Patients who did not receive a single dose|7|||
146905037|NCT00914628|529815899|FG001|Overall Study|Patients who did not receive a single dose|1|||
146905038|NCT02799381|529815900|FG000|Overall Study|Withdrew consent|3|||
146905039|NCT02799381|529815901|FG001|Overall Study|Withdrew consent|2|||
146905040|NCT02799381|529815900|FG000|Overall Study|Adverse Event|0|||
146905041|NCT02799381|529815901|FG001|Overall Study|Adverse Event|1|||
146905042|NCT02799381|529815900|FG000|Overall Study|Participant did not take any study drug|1|||
146905043|NCT02799381|529815901|FG001|Overall Study|Participant did not take any study drug|0|||
146905044|NCT03368859|529815902|FG000|Overall Study|Withdrew Consent|5|||
146905045|NCT03368859|529815903|FG001|Overall Study|Withdrew Consent|4|||
146905046|NCT03368859|529815902|FG000|Overall Study|Death|12|||
146905047|NCT03368859|529815903|FG001|Overall Study|Death|6|||
146905048|NCT03368859|529815902|FG000|Overall Study|Study terminated by Sponsor|18|||
146905049|NCT03368859|529815903|FG001|Overall Study|Study terminated by Sponsor|23|||
146905050|NCT03368859|529815902|FG000|Overall Study|Other|1|||
146905051|NCT03368859|529815903|FG001|Overall Study|Other|1|||
146905052|NCT02698410|529815904|FG000|Overall Study|Adverse Event|2|||
146905053|NCT02698410|529815904|FG000|Overall Study|Withdrawal by Subject|1|||
146905054|NCT02698410|529815904|FG000|Overall Study|Other|1|||
146905055|NCT01713348|529815905|FG000|Overall Study|Withdrawal by Subject|3|||
146905056|NCT01713348|529815906|FG001|Overall Study|Withdrawal by Subject|2|||
146905057|NCT01713348|529815907|FG002|Overall Study|Withdrawal by Subject|2|||
146905058|NCT01713348|529815908|FG003|Overall Study|Withdrawal by Subject|0|||
146905059|NCT01713348|529815905|FG000|Overall Study|Lost to Follow-up|1|||
146905060|NCT01713348|529815906|FG001|Overall Study|Lost to Follow-up|0|||
146905061|NCT01713348|529815907|FG002|Overall Study|Lost to Follow-up|0|||
146905062|NCT01713348|529815908|FG003|Overall Study|Lost to Follow-up|0|||
146905063|NCT00621023|529815909|FG000|Overall Study|Death|5|||
146905064|NCT00621023|529815909|FG000|Overall Study|Follow up discontinued|1|||
146905065|NCT04331899|529815919|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
146905066|NCT04331899|529815920|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
146905067|NCT02424539|529815923|FG000|Overall Study|Adverse Event|0|||
146905068|NCT02424539|529815924|FG001|Overall Study|Adverse Event|0|||
146905069|NCT02424539|529815925|FG002|Overall Study|Adverse Event|1|||
146905070|NCT02424539|529815923|FG000|Overall Study|Physician Decision|0|||
146905071|NCT02424539|529815924|FG001|Overall Study|Physician Decision|0|||
146905072|NCT02424539|529815925|FG002|Overall Study|Physician Decision|1|||
146905073|NCT02424539|529815923|FG000|Overall Study|Withdrawal by Subject|3|||
146905074|NCT02424539|529815924|FG001|Overall Study|Withdrawal by Subject|1|||
146905075|NCT02424539|529815925|FG002|Overall Study|Withdrawal by Subject|0|||
146905076|NCT02424539|529815923|FG000|Overall Study|Other: Reached stopping criteria|11|||
146905077|NCT02424539|529815924|FG001|Overall Study|Other: Reached stopping criteria|7|||
146905078|NCT02424539|529815925|FG002|Overall Study|Other: Reached stopping criteria|6|||
146905079|NCT00719810|529815926|FG000|Overall Study|Adverse Event|0|||
146905080|NCT00719810|529815927|FG001|Overall Study|Adverse Event|2|||
146905081|NCT00719810|529815928|FG002|Overall Study|Adverse Event|3|||
146905082|NCT00719810|529815926|FG000|Overall Study|Lost to Follow-up|2|||
146905083|NCT00719810|529815927|FG001|Overall Study|Lost to Follow-up|0|||
146905084|NCT00719810|529815928|FG002|Overall Study|Lost to Follow-up|3|||
146905085|NCT00719810|529815926|FG000|Overall Study|Physician Decision|0|||
146905086|NCT00719810|529815927|FG001|Overall Study|Physician Decision|1|||
146905087|NCT00719810|529815928|FG002|Overall Study|Physician Decision|0|||
146905088|NCT00719810|529815926|FG000|Overall Study|Withdrawal by Subject|1|||
146905089|NCT00719810|529815927|FG001|Overall Study|Withdrawal by Subject|1|||
146905090|NCT00719810|529815928|FG002|Overall Study|Withdrawal by Subject|2|||
146905091|NCT04893265|529815931|FG000|Overall Study|Withdrawal by Subject|2|||
146905092|NCT04893265|529815932|FG001|Overall Study|Withdrawal by Subject|5|||
146905093|NCT04893265|529815931|FG000|Overall Study|Lost to Follow-up|0|||
146905094|NCT04893265|529815932|FG001|Overall Study|Lost to Follow-up|4|||
146905095|NCT00573131|529815934|FG000|Overall Study|Withdrawal by Subject|10|||
146640860|NCT02474069|528860948|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
146640861|NCT02474069|528860949|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
146640862|NCT04173494|528860950|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
146640863|NCT04173494|528860951|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
146640864|NCT04173494|528860950|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
146640865|NCT04173494|528860951|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
146640866|NCT04173494|528860950|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
146905096|NCT00573131|529815935|FG001|Overall Study|Withdrawal by Subject|8|||
146905097|NCT00893789|529815936|FG000|Overall Study|Withdrawal by Subject|3|||
146905098|NCT00893789|529815937|FG001|Overall Study|Withdrawal by Subject|1|||
146905099|NCT00893789|529815938|FG002|Overall Study|Withdrawal by Subject|3|||
146905100|NCT00893789|529815939|FG003|Overall Study|Withdrawal by Subject|1|||
146905101|NCT00893789|529815936|FG000|Overall Study|Noncompliance With Study Drug|1|||
146905102|NCT00893789|529815937|FG001|Overall Study|Noncompliance With Study Drug|0|||
146905103|NCT00893789|529815938|FG002|Overall Study|Noncompliance With Study Drug|1|||
146905104|NCT00893789|529815939|FG003|Overall Study|Noncompliance With Study Drug|2|||
146905105|NCT00893789|529815936|FG000|Overall Study|Noncompliance With Study Procedures|1|||
146905106|NCT00893789|529815937|FG001|Overall Study|Noncompliance With Study Procedures|0|||
146905107|NCT00893789|529815938|FG002|Overall Study|Noncompliance With Study Procedures|0|||
146905108|NCT00893789|529815939|FG003|Overall Study|Noncompliance With Study Procedures|0|||
146905109|NCT00893789|529815936|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
146905110|NCT00893789|529815937|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
146905111|NCT00893789|529815938|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
146905112|NCT00893789|529815939|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
146905113|NCT00893789|529815936|FG000|Overall Study|Adverse Event|0|||
146905114|NCT00893789|529815937|FG001|Overall Study|Adverse Event|2|||
146905115|NCT00893789|529815938|FG002|Overall Study|Adverse Event|1|||
146905116|NCT00893789|529815939|FG003|Overall Study|Adverse Event|5|||
146905117|NCT00893789|529815936|FG000|Overall Study|Protocol Violation|0|||
146905118|NCT00893789|529815937|FG001|Overall Study|Protocol Violation|1|||
146905119|NCT00893789|529815938|FG002|Overall Study|Protocol Violation|1|||
146905120|NCT00893789|529815939|FG003|Overall Study|Protocol Violation|4|||
146905121|NCT00893789|529815936|FG000|Overall Study|Lost to Follow-up|0|||
146905122|NCT00893789|529815937|FG001|Overall Study|Lost to Follow-up|0|||
146905123|NCT00893789|529815938|FG002|Overall Study|Lost to Follow-up|0|||
146905124|NCT00893789|529815939|FG003|Overall Study|Lost to Follow-up|1|||
146905125|NCT02024464|529815940|FG000|Overall Study|Discontinued|5|||
146905126|NCT02024464|529815941|FG001|Overall Study|Discontinued|4|||
146905127|NCT02024464|529815940|FG000|Overall Study|Missed Visits|1|||
146905128|NCT02024464|529815941|FG001|Overall Study|Missed Visits|0|||
146905129|NCT02024464|529815940|FG000|Overall Study|Lost to Follow-up|4|||
146905130|NCT02024464|529815941|FG001|Overall Study|Lost to Follow-up|7|||
146905131|NCT00900796|529815944|FG000|Phase 1|Lacked sufficient information|4|||
146905132|NCT00900796|529815944|FG000|Phase 1|Missing information at Week 16|7|||
146905133|NCT00900796|529815944|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
146905134|NCT00900796|529815944|FG000|Phase 2|Lost to Follow-up|5|||
146905135|NCT02586805|529815947|FG000|Overall Study|Withdrawal by Subject|3|||
146905136|NCT02586805|529815948|FG001|Overall Study|Withdrawal by Subject|1|||
146905137|NCT02586805|529815949|FG002|Overall Study|Withdrawal by Subject|1|||
146905138|NCT02586805|529815950|FG003|Overall Study|Withdrawal by Subject|2|||
146905139|NCT02586805|529815947|FG000|Overall Study|Adverse Event|2|||
146905140|NCT02586805|529815948|FG001|Overall Study|Adverse Event|0|||
146905141|NCT02586805|529815949|FG002|Overall Study|Adverse Event|1|||
146905142|NCT02586805|529815950|FG003|Overall Study|Adverse Event|0|||
146905143|NCT02586805|529815947|FG000|Overall Study|Lost to Follow-up|0|||
146905144|NCT02586805|529815948|FG001|Overall Study|Lost to Follow-up|0|||
146905145|NCT02586805|529815949|FG002|Overall Study|Lost to Follow-up|1|||
146905146|NCT02586805|529815950|FG003|Overall Study|Lost to Follow-up|0|||
146905147|NCT02586805|529815947|FG000|Overall Study|Physician Decision|1|||
146905148|NCT02586805|529815948|FG001|Overall Study|Physician Decision|0|||
146905149|NCT02586805|529815949|FG002|Overall Study|Physician Decision|0|||
146905150|NCT02586805|529815950|FG003|Overall Study|Physician Decision|0|||
146905151|NCT01859403|529815951|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
146905152|NCT01859403|529815952|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
146905153|NCT01859403|529815951|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
146905154|NCT01859403|529815952|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
146905155|NCT01859403|529815951|FG000|Primary Endpoint Measure|Physician Decision|0|||
146905156|NCT01859403|529815952|FG001|Primary Endpoint Measure|Physician Decision|1|||
146905157|NCT01859403|529815951|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
146905158|NCT01859403|529815952|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
146905159|NCT00811252|529815953|FG000|Overall Study|Adverse Event|6|||
146905160|NCT00811252|529815954|FG001|Overall Study|Adverse Event|10|||
146905161|NCT00811252|529815955|FG002|Overall Study|Adverse Event|15|||
146905162|NCT00811252|529815953|FG000|Overall Study|Lack of Efficacy|7|||
146905163|NCT00811252|529815954|FG001|Overall Study|Lack of Efficacy|2|||
146905164|NCT00811252|529815955|FG002|Overall Study|Lack of Efficacy|0|||
146905165|NCT00811252|529815953|FG000|Overall Study|Protocol Violation|3|||
146905166|NCT00811252|529815954|FG001|Overall Study|Protocol Violation|3|||
146905167|NCT00811252|529815955|FG002|Overall Study|Protocol Violation|2|||
146905168|NCT00811252|529815953|FG000|Overall Study|Withdrawal of Consent|1|||
146905169|NCT00811252|529815954|FG001|Overall Study|Withdrawal of Consent|2|||
146905170|NCT00811252|529815955|FG002|Overall Study|Withdrawal of Consent|2|||
146905171|NCT00811252|529815953|FG000|Overall Study|Lost to Follow-up|0|||
146905172|NCT00811252|529815954|FG001|Overall Study|Lost to Follow-up|0|||
146905173|NCT00811252|529815955|FG002|Overall Study|Lost to Follow-up|2|||
146905174|NCT00811252|529815953|FG000|Overall Study|Administrative or Other Reasons|0|||
146905175|NCT00811252|529815954|FG001|Overall Study|Administrative or Other Reasons|3|||
146905176|NCT00811252|529815955|FG002|Overall Study|Administrative or Other Reasons|2|||
146905177|NCT00813748|529815957|FG000|Skin Test Substudy|Physician Decision|0|||
146905178|NCT00813748|529815958|FG001|Skin Test Substudy|Physician Decision|1|||
146905179|NCT03185130|529815961|FG000|Overall Study|Withdrawal by Subject|0|||
146905180|NCT03185130|529815962|FG001|Overall Study|Withdrawal by Subject|2|||
146905181|NCT01244737|529815972|FG000|Overall Study|Physician Decision|2|||
146970121|NCT00728988|530050786|FG000|Overall Study|Withdrawal by Subject|2|||
146970122|NCT00728988|530050787|FG001|Overall Study|Withdrawal by Subject|6|||
146970123|NCT05674721|530050790|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
146905182|NCT01244737|529815973|FG001|Overall Study|Physician Decision|18|||
146905183|NCT01244737|529815974|FG002|Overall Study|Physician Decision|5|||
146905184|NCT01244737|529815972|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
146905185|NCT01244737|529815973|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
146905186|NCT01244737|529815974|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
146905187|NCT01244737|529815972|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
146905188|NCT01244737|529815973|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
146905189|NCT01244737|529815974|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
146905190|NCT01244737|529815972|FG000|Overall Study|MIB immunopathology results not available|3|||
146905191|NCT01244737|529815973|FG001|Overall Study|MIB immunopathology results not available|2|||
146905192|NCT01244737|529815974|FG002|Overall Study|MIB immunopathology results not available|0|||
146905193|NCT01244737|529815972|FG000|Overall Study|PET data failure|0|||
146905194|NCT01244737|529815973|FG001|Overall Study|PET data failure|1|||
146905195|NCT01244737|529815974|FG002|Overall Study|PET data failure|0|||
146905196|NCT01244737|529815972|FG000|Overall Study|Withdrawal by Subject|0|||
146905197|NCT01244737|529815973|FG001|Overall Study|Withdrawal by Subject|0|||
146905198|NCT01244737|529815974|FG002|Overall Study|Withdrawal by Subject|1|||
146905199|NCT00465569|529815977|FG000|Overall Study|persistent eczema during dose escalation|1|||
146905200|NCT00465569|529815978|FG001|Overall Study|persistent eczema during dose escalation|0|||
146905201|NCT03826914|529815979|FG000|Overall Study|Withdrawal by Subject|1|||
146905202|NCT03826914|529815980|FG001|Overall Study|Withdrawal by Subject|1|||
146905203|NCT05139030|529815983|FG000|Overall Study|Withdrawal by Subject|1|||
146905204|NCT05139030|529815984|FG001|Overall Study|Withdrawal by Subject|3|||
146905205|NCT05139030|529815983|FG000|Overall Study|Adverse Event|0|||
146905206|NCT05139030|529815984|FG001|Overall Study|Adverse Event|1|||
146905207|NCT05139030|529815983|FG000|Overall Study|Failure to meet continuation criteria|0|||
146905208|NCT05139030|529815984|FG001|Overall Study|Failure to meet continuation criteria|1|||
146905209|NCT01442181|529815990|FG000|Overall Study|patient refused surgery|1|||
146905210|NCT01442181|529815991|FG001|Overall Study|patient refused surgery|0|||
146905211|NCT01442181|529815990|FG000|Overall Study|no insurance for surgery|1|||
146905212|NCT01442181|529815991|FG001|Overall Study|no insurance for surgery|0|||
146905213|NCT01442181|529815990|FG000|Overall Study|low ejection factor|0|||
146905214|NCT01442181|529815991|FG001|Overall Study|low ejection factor|1|||
146905215|NCT01442181|529815990|FG000|Overall Study|Lost to Follow-up|1|||
146905216|NCT01442181|529815991|FG001|Overall Study|Lost to Follow-up|1|||
146905217|NCT01442181|529815990|FG000|Overall Study|patient in an additional study|1|||
146905218|NCT01442181|529815991|FG001|Overall Study|patient in an additional study|0|||
146905219|NCT01442181|529815990|FG000|Overall Study|atrial fibrillation not noted|0|||
146905220|NCT01442181|529815991|FG001|Overall Study|atrial fibrillation not noted|1|||
146905221|NCT03133767|529815992|FG000|Overall Study|Lost to Follow-up|38|||
146905222|NCT03133767|529815993|FG001|Overall Study|Lost to Follow-up|24|||
146905223|NCT03133767|529815992|FG000|Overall Study|Protocol Violation|0|||
146905224|NCT03133767|529815993|FG001|Overall Study|Protocol Violation|1|||
146905225|NCT00613626|529815994|FG000|Overall Study|Ineligible|0|||
146905226|NCT00613626|529815995|FG001|Overall Study|Ineligible|1|||
146905227|NCT00613626|529815996|FG002|Overall Study|Ineligible|0|||
146905228|NCT04375878|529815999|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
146970124|NCT05674721|530050791|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
146970125|NCT05674721|530050790|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
146970126|NCT05674721|530050791|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
146970127|NCT05013749|530050797|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
146970128|NCT05013749|530050798|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
146970129|NCT05013749|530050797|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
146970130|NCT05013749|530050798|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
146970131|NCT02017535|530050801|FG000|Overall Study|Withdrawal by Subject|1|||
146970132|NCT02017535|530050802|FG001|Overall Study|Withdrawal by Subject|0|||
146970133|NCT02017535|530050803|FG002|Overall Study|Withdrawal by Subject|0|||
146905229|NCT04375878|529816000|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
146561106|NCT03977155|528565902|FG000|Overall Study|Withdrawal by Subject|1|||
146561107|NCT03977155|528565903|FG001|Overall Study|Withdrawal by Subject|1|||
146905230|NCT04375878|529816001|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
146905231|NCT04375878|529816002|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
146905232|NCT04375878|529816003|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
146905233|NCT04375878|529816004|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
146905234|NCT04375878|529815999|FG000|Crossover First and Second Interventions|Adverse Event|0|||
146905235|NCT04375878|529816000|FG001|Crossover First and Second Interventions|Adverse Event|0|||
146905236|NCT04375878|529816001|FG002|Crossover First and Second Interventions|Adverse Event|1|||
146905237|NCT04375878|529816002|FG003|Crossover First and Second Interventions|Adverse Event|0|||
146905238|NCT04375878|529816003|FG004|Crossover First and Second Interventions|Adverse Event|0|||
146905239|NCT04375878|529816004|FG005|Crossover First and Second Interventions|Adverse Event|0|||
146905240|NCT04375878|529815999|FG000|Extension Phase|Withdrawal by Subject|0|||
146905241|NCT04375878|529816000|FG001|Extension Phase|Withdrawal by Subject|0|||
146905242|NCT04375878|529816001|FG002|Extension Phase|Withdrawal by Subject|0|||
146905243|NCT04375878|529816002|FG003|Extension Phase|Withdrawal by Subject|0|||
146905244|NCT04375878|529816003|FG004|Extension Phase|Withdrawal by Subject|1|||
146905245|NCT04375878|529816004|FG005|Extension Phase|Withdrawal by Subject|0|||
146905246|NCT00816036|529816007|FG000|Overall Study|Death|47|||
146905247|NCT00816036|529816008|FG001|Overall Study|Death|28|||
146905248|NCT00816036|529816007|FG000|Overall Study|Lost to Follow-up|75|||
146905249|NCT00816036|529816008|FG001|Overall Study|Lost to Follow-up|57|||
146905250|NCT00816036|529816007|FG000|Overall Study|Withdrawal by Subject|54|||
146905251|NCT00816036|529816008|FG001|Overall Study|Withdrawal by Subject|23|||
146905252|NCT00004980|529816009|FG000|Overall Study|Withdrawal by Subject|1|||
146905253|NCT00004980|529816010|FG001|Overall Study|Withdrawal by Subject|0|||
146905254|NCT00004980|529816009|FG000|Overall Study|memory difficulties|1|||
146905255|NCT00004980|529816010|FG001|Overall Study|memory difficulties|1|||
146905256|NCT00004980|529816009|FG000|Overall Study|Physician Decision|0|||
146905257|NCT00004980|529816010|FG001|Overall Study|Physician Decision|1|||
146905258|NCT01299025|529816011|FG000|Overall Study|Withdrawal by Subject|2|||
146905259|NCT01299025|529816012|FG001|Overall Study|Withdrawal by Subject|1|||
146905260|NCT01299025|529816011|FG000|Overall Study|Lost to Follow-up|1|||
146905261|NCT01299025|529816012|FG001|Overall Study|Lost to Follow-up|0|||
146905262|NCT01624194|529816013|FG000|Overall Study|Lost to Follow-up|1|||
146905263|NCT01624194|529816014|FG001|Overall Study|Lost to Follow-up|0|||
146905264|NCT01624194|529816013|FG000|Overall Study|Withdrawal by Subject|1|||
146905265|NCT01624194|529816014|FG001|Overall Study|Withdrawal by Subject|0|||
146905266|NCT03212261|529816015|FG000|Overall Study|Became ineligible d/t tech|2|||
146905267|NCT03212261|529816015|FG000|Overall Study|Tech Trouble- No first study visit|1|||
146905268|NCT03212261|529816015|FG000|Overall Study|Lost to Follow-up|7|||
146905269|NCT03212261|529816015|FG000|Overall Study|Family Emergency|1|||
146905270|NCT03212261|529816015|FG000|Overall Study|Too busy/ No time|5|||
146905271|NCT05480514|529816016|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
146905272|NCT05480514|529816017|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
146905273|NCT05480514|529816016|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
146905274|NCT05480514|529816017|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
146905275|NCT05480514|529816016|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
146905276|NCT05480514|529816017|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
146905277|NCT05480514|529816016|FG000|Period 1|Covid-19 Related|1|||
146905278|NCT05480514|529816017|FG001|Period 1|Covid-19 Related|0|||
146905279|NCT05480514|529816016|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
146905280|NCT05480514|529816017|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
146905281|NCT00820040|529816018|FG000|Overall Study|Death|1|||
146905282|NCT00820040|529816018|FG000|Overall Study|Sponsor terminated study|1|||
146905283|NCT00820040|529816018|FG000|Overall Study|Screen failure|1|||
146905284|NCT01259466|529816023|FG000|Overall Study|Withdrawal by Subject|1|||
146905285|NCT01259466|529816024|FG001|Overall Study|Withdrawal by Subject|9|||
146905286|NCT02296840|529816025|FG000|Overall Study|Adverse Event|1|||
146905287|NCT02296840|529816026|FG001|Overall Study|Adverse Event|1|||
146905288|NCT02296840|529816025|FG000|Overall Study|Protocol Violation|2|||
146905289|NCT02296840|529816026|FG001|Overall Study|Protocol Violation|1|||
146905290|NCT02296840|529816025|FG000|Overall Study|Lost to Follow-up|6|||
146905291|NCT02296840|529816026|FG001|Overall Study|Lost to Follow-up|17|||
146905292|NCT00814710|529816031|FG000|Overall Study|Adverse Event|1|||
146905293|NCT00814710|529816032|FG001|Overall Study|Adverse Event|0|||
146905294|NCT00814710|529816031|FG000|Overall Study|Lost to Follow-up|7|||
146905295|NCT00814710|529816032|FG001|Overall Study|Lost to Follow-up|3|||
146905296|NCT03885284|529816033|FG000|Overall Study|Disease Progression|1|||
146905297|NCT03885284|529816034|FG001|Overall Study|Disease Progression|3|||
146905298|NCT03885284|529816033|FG000|Overall Study|Physician Decision|0|||
146905299|NCT03885284|529816034|FG001|Overall Study|Physician Decision|1|||
146905300|NCT00002850|529816039|FG000|Overall Study|Death|4|||
146905301|NCT00002850|529816040|FG001|Overall Study|Death|1|||
146905302|NCT00002850|529816041|FG002|Overall Study|Death|3|||
146905303|NCT00002850|529816039|FG000|Overall Study|Protocol Violation|1|||
146905304|NCT00002850|529816040|FG001|Overall Study|Protocol Violation|0|||
146905305|NCT00002850|529816041|FG002|Overall Study|Protocol Violation|1|||
146905306|NCT00002850|529816039|FG000|Overall Study|Withdrawal by Subject|0|||
146905307|NCT00002850|529816040|FG001|Overall Study|Withdrawal by Subject|1|||
146905308|NCT00002850|529816041|FG002|Overall Study|Withdrawal by Subject|0|||
146905309|NCT02932267|529816042|FG000|Overall Study|Withdrawal by Subject|3|||
146905310|NCT02932267|529816042|FG000|Overall Study|Lost to Follow-up|4|||
146905311|NCT02932267|529816042|FG000|Overall Study|Pregnancy|1|||
146905312|NCT03476239|529816043|FG000|Overall Study|Withdrawal by Subject|10|||
146905313|NCT03476239|529816043|FG000|Overall Study|Death|80|||
146905314|NCT03476239|529816043|FG000|Overall Study|Lost to Follow-up|8|||
146905315|NCT05405166|529818320|FG000|Overall Study|Death|49|||
146905316|NCT05405166|529818321|FG001|Overall Study|Death|50|||
146905317|NCT05405166|529818320|FG000|Overall Study|Withdrawal by Subject|10|||
146905318|NCT05405166|529818321|FG001|Overall Study|Withdrawal by Subject|3|||
146905319|NCT05405166|529818320|FG000|Overall Study|Ongoing at the time of PCD|209|||
146905320|NCT05405166|529818321|FG001|Overall Study|Ongoing at the time of PCD|210|||
146905321|NCT01386385|529818322|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
146905322|NCT01386385|529818323|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
146905323|NCT01386385|529818324|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
146905324|NCT01386385|529818325|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
146905325|NCT01386385|529818326|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
146905326|NCT01386385|529818327|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
146905327|NCT01386385|529818328|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
146905328|NCT01386385|529818329|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
146905329|NCT01386385|529818322|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
146905330|NCT01386385|529818323|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
146905331|NCT01386385|529818324|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
146905332|NCT01386385|529818325|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
146905333|NCT01386385|529818326|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
146905334|NCT01386385|529818327|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
146905335|NCT01386385|529818328|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
146905336|NCT01386385|529818329|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
146905337|NCT01386385|529818322|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
146905338|NCT01386385|529818323|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
146905339|NCT01386385|529818324|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
146905340|NCT01386385|529818325|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
146905341|NCT01386385|529818326|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
146905342|NCT01386385|529818327|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
146905343|NCT01386385|529818328|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
146905344|NCT01386385|529818329|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
146905345|NCT01386385|529818322|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
146905346|NCT01386385|529818323|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
146905347|NCT01386385|529818324|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
146905348|NCT01386385|529818325|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
146905349|NCT01386385|529818326|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
146905350|NCT01386385|529818327|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
146905351|NCT01386385|529818328|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
146905352|NCT01386385|529818329|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
146905353|NCT01386385|529818322|FG000|Phase II Concurrent CRT|Adverse Event|0|||
146905354|NCT01386385|529818323|FG001|Phase II Concurrent CRT|Adverse Event|0|||
146905355|NCT01386385|529818324|FG002|Phase II Concurrent CRT|Adverse Event|0|||
146905356|NCT01386385|529818325|FG003|Phase II Concurrent CRT|Adverse Event|0|||
146905357|NCT01386385|529818326|FG004|Phase II Concurrent CRT|Adverse Event|0|||
146905358|NCT01386385|529818327|FG005|Phase II Concurrent CRT|Adverse Event|0|||
146905359|NCT01386385|529818328|FG006|Phase II Concurrent CRT|Adverse Event|3|||
146905360|NCT01386385|529818329|FG007|Phase II Concurrent CRT|Adverse Event|3|||
146905361|NCT01386385|529818322|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
146905362|NCT01386385|529818323|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
146905363|NCT01386385|529818324|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
146905364|NCT01386385|529818325|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
146905365|NCT01386385|529818326|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
146905366|NCT01386385|529818327|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
146905367|NCT01386385|529818328|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
146905368|NCT01386385|529818329|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
146905369|NCT01386385|529818322|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
146905370|NCT01386385|529818323|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
146905371|NCT01386385|529818324|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
146905372|NCT01386385|529818325|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
146905373|NCT01386385|529818326|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
146905374|NCT01386385|529818327|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
146905375|NCT01386385|529818328|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
146905376|NCT01386385|529818329|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
146905377|NCT01386385|529818322|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
146905378|NCT01386385|529818323|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
146905379|NCT01386385|529818324|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
146905380|NCT01386385|529818325|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
146905381|NCT01386385|529818326|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
146905382|NCT01386385|529818327|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
146905383|NCT01386385|529818328|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
146905384|NCT01386385|529818329|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
146905385|NCT01386385|529818322|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
146905386|NCT01386385|529818323|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
146905387|NCT01386385|529818324|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
146905388|NCT01386385|529818325|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
146905389|NCT01386385|529818326|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
146905390|NCT01386385|529818327|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
146905391|NCT01386385|529818328|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
146905392|NCT01386385|529818329|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
146905393|NCT01084252|529818330|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146905394|NCT01084252|529818331|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146905395|NCT01084252|529818332|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146905396|NCT01084252|529818333|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146905397|NCT01084252|529818334|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146905398|NCT01084252|529818335|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146905399|NCT01084252|529818336|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146905400|NCT01084252|529818337|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146905401|NCT01084252|529818338|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146905402|NCT01084252|529818339|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146905403|NCT01084252|529818340|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146905404|NCT01084252|529818341|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146905405|NCT01084252|529818342|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
146905406|NCT01084252|529818343|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146905407|NCT03395210|529818344|FG000|Overall Study|Other|0|||
146905408|NCT03395210|529818345|FG001|Overall Study|Other|0|||
146905409|NCT03395210|529818346|FG002|Overall Study|Other|0|||
146905410|NCT03395210|529818347|FG003|Overall Study|Other|0|||
146905411|NCT03395210|529818348|FG004|Overall Study|Other|1|||
146905412|NCT03395210|529818344|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
146905413|NCT03395210|529818345|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
146905414|NCT03395210|529818346|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
146905415|NCT03395210|529818347|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
146905416|NCT03395210|529818348|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
146905417|NCT03395210|529818344|FG000|Overall Study|Adverse Event|1|||
146905418|NCT03395210|529818345|FG001|Overall Study|Adverse Event|0|||
146905419|NCT03395210|529818346|FG002|Overall Study|Adverse Event|2|||
146905420|NCT03395210|529818347|FG003|Overall Study|Adverse Event|4|||
146905421|NCT03395210|529818348|FG004|Overall Study|Adverse Event|3|||
146905422|NCT03395210|529818344|FG000|Overall Study|Need of Rescue Medication|1|||
146905423|NCT03395210|529818345|FG001|Overall Study|Need of Rescue Medication|0|||
146905424|NCT03395210|529818346|FG002|Overall Study|Need of Rescue Medication|1|||
146905425|NCT03395210|529818347|FG003|Overall Study|Need of Rescue Medication|4|||
146905426|NCT03395210|529818348|FG004|Overall Study|Need of Rescue Medication|0|||
146905427|NCT03395210|529818344|FG000|Overall Study|Lack of Response|0|||
146905428|NCT03395210|529818345|FG001|Overall Study|Lack of Response|0|||
146905429|NCT03395210|529818346|FG002|Overall Study|Lack of Response|0|||
146905430|NCT03395210|529818347|FG003|Overall Study|Lack of Response|5|||
146905431|NCT03395210|529818348|FG004|Overall Study|Lack of Response|5|||
146905432|NCT03395210|529818344|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
146905433|NCT03395210|529818345|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
146905434|NCT03395210|529818346|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
146905435|NCT03395210|529818347|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
146905436|NCT03395210|529818348|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
146905437|NCT03395210|529818344|FG000|Overall Study|Participant Decision|1|||
146905438|NCT03395210|529818345|FG001|Overall Study|Participant Decision|1|||
146905439|NCT03395210|529818346|FG002|Overall Study|Participant Decision|0|||
146905440|NCT03395210|529818347|FG003|Overall Study|Participant Decision|4|||
146905441|NCT03395210|529818348|FG004|Overall Study|Participant Decision|0|||
146905442|NCT03395210|529818344|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
146905443|NCT03395210|529818345|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
146905444|NCT03395210|529818346|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
146905445|NCT03395210|529818347|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
146905446|NCT03395210|529818348|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
146905447|NCT00853632|529818349|FG000|Overall Study|Death|88|||
146905448|NCT00853632|529818349|FG000|Overall Study|Withdrawal by Subject|45|||
146905449|NCT00853632|529818349|FG000|Overall Study|Lost to Follow-up|30|||
146905450|NCT00853632|529818349|FG000|Overall Study|Reoperation/Explant|17|||
146905451|NCT00853632|529818349|FG000|Overall Study|Exit with other reason|22|||
146905452|NCT04364854|529818350|FG000|Overall Study|Withdrawal by Subject|1|||
146905453|NCT04364854|529818351|FG001|Overall Study|Withdrawal by Subject|0|||
146905454|NCT04364854|529818352|FG002|Overall Study|Withdrawal by Subject|1|||
146905455|NCT04364854|529818353|FG003|Overall Study|Withdrawal by Subject|3|||
146905456|NCT04364854|529818350|FG000|Overall Study|Death|1|||
146905457|NCT04364854|529818351|FG001|Overall Study|Death|0|||
146905458|NCT04364854|529818352|FG002|Overall Study|Death|0|||
146905459|NCT04364854|529818353|FG003|Overall Study|Death|0|||
146905460|NCT04364854|529818350|FG000|Overall Study|Lost to Follow-up|0|||
146905461|NCT04364854|529818351|FG001|Overall Study|Lost to Follow-up|0|||
146905462|NCT04364854|529818352|FG002|Overall Study|Lost to Follow-up|0|||
146905463|NCT04364854|529818353|FG003|Overall Study|Lost to Follow-up|1|||
146905464|NCT04493619|529818355|FG000|Overall Study|Death|4|||
146905465|NCT04493619|529818356|FG001|Overall Study|Death|3|||
146905466|NCT04493619|529818357|FG002|Overall Study|Death|3|||
146905467|NCT04493619|529818358|FG003|Overall Study|Death|4|||
146905468|NCT04493619|529818355|FG000|Overall Study|Study discontinued early|10|||
146905469|NCT04493619|529818356|FG001|Overall Study|Study discontinued early|0|||
146905470|NCT04493619|529818357|FG002|Overall Study|Study discontinued early|4|||
146905471|NCT04493619|529818358|FG003|Overall Study|Study discontinued early|8|||
146905472|NCT04493619|529818355|FG000|Overall Study|Lost to Follow-up|0|||
146905473|NCT04493619|529818356|FG001|Overall Study|Lost to Follow-up|0|||
146905474|NCT04493619|529818357|FG002|Overall Study|Lost to Follow-up|0|||
146905475|NCT04493619|529818358|FG003|Overall Study|Lost to Follow-up|1|||
146905476|NCT03716726|529818360|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
146905477|NCT03716726|529818361|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
146905478|NCT03716726|529818360|FG000|12 Months Followup|Lost to Follow-up|10|||
146905479|NCT03716726|529818361|FG001|12 Months Followup|Lost to Follow-up|17|||
146905480|NCT02579603|529818362|FG000|Overall Study|Not treated|1|||
146905481|NCT02579603|529818363|FG001|Overall Study|Not treated|0|||
146905482|NCT02579603|529818362|FG000|Overall Study|Adverse Event|2|||
146905483|NCT02579603|529818363|FG001|Overall Study|Adverse Event|2|||
146905484|NCT02579603|529818362|FG000|Overall Study|Other than stated|1|||
146905485|NCT02579603|529818363|FG001|Overall Study|Other than stated|0|||
146905486|NCT00469079|529818364|FG000|Overall Study|Lack of Efficacy|3|||
146905487|NCT00469079|529818365|FG001|Overall Study|Lack of Efficacy|8|||
146905488|NCT00469079|529818366|FG002|Overall Study|Lack of Efficacy|5|||
146905489|NCT00469079|529818364|FG000|Overall Study|Adverse Event|1|||
146905490|NCT00469079|529818365|FG001|Overall Study|Adverse Event|3|||
146905491|NCT00469079|529818366|FG002|Overall Study|Adverse Event|2|||
146905492|NCT00469079|529818364|FG000|Overall Study|Lost to Follow-up|4|||
146905493|NCT00469079|529818365|FG001|Overall Study|Lost to Follow-up|8|||
146905494|NCT00469079|529818366|FG002|Overall Study|Lost to Follow-up|10|||
146905495|NCT00469079|529818364|FG000|Overall Study|Withdrawal by Subject|1|||
146905496|NCT00469079|529818365|FG001|Overall Study|Withdrawal by Subject|2|||
146905497|NCT00469079|529818366|FG002|Overall Study|Withdrawal by Subject|2|||
146905498|NCT00469079|529818364|FG000|Overall Study|Ineligible|0|||
146905499|NCT00469079|529818365|FG001|Overall Study|Ineligible|1|||
146905500|NCT00469079|529818366|FG002|Overall Study|Ineligible|0|||
146905501|NCT01006356|529818367|FG000|Overall Study|Adverse Event|6|||
146905502|NCT01006356|529818367|FG000|Overall Study|Physician Decision|1|||
146905503|NCT01006356|529818367|FG000|Overall Study|Paticipants did not cooperate|6|||
146905504|NCT01006356|529818367|FG000|Overall Study|Withdrawal by Subject|1|||
146905505|NCT01006356|529818367|FG000|Overall Study|Choice by participants|2|||
146905506|NCT01006356|529818367|FG000|Overall Study|Protocol Violation|3|||
146905507|NCT01006356|529818367|FG000|Overall Study|Other|23|||
146905508|NCT01756157|529818372|FG000|First Intervention Period|Withdrawal by Subject|1|||
146905509|NCT01756157|529818373|FG001|First Intervention Period|Withdrawal by Subject|0|||
146905510|NCT01756157|529818372|FG000|First Intervention Period|Lost to Follow-up|0|||
146905511|NCT01756157|529818373|FG001|First Intervention Period|Lost to Follow-up|2|||
146640867|NCT04173494|528860951|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
146640868|NCT04173494|528860950|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
146640869|NCT04173494|528860951|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
146905512|NCT03952130|529818377|FG000|Overall Study|Adverse Event|0|||
146905513|NCT03952130|529818378|FG001|Overall Study|Adverse Event|1|||
146905514|NCT03952130|529818377|FG000|Overall Study|Lost to Follow-up|1|||
146905515|NCT03952130|529818378|FG001|Overall Study|Lost to Follow-up|0|||
146905516|NCT03952130|529818377|FG000|Overall Study|Withdrawal by Subject|1|||
146905517|NCT03952130|529818378|FG001|Overall Study|Withdrawal by Subject|5|||
146905518|NCT02638012|529818379|FG000|Overall Study|Lost to Follow-up|1|||
146905519|NCT02559505|529818381|FG000|Overall Study|Lost to Follow-up|23|||
146905520|NCT02559505|529818382|FG001|Overall Study|Lost to Follow-up|20|||
146905521|NCT02559505|529818381|FG000|Overall Study|Withdrawal by Subject|4|||
146905522|NCT02559505|529818382|FG001|Overall Study|Withdrawal by Subject|2|||
146905523|NCT03523585|529818383|FG000|Overall Study|Progressive Disease|174|||
146905524|NCT03523585|529818384|FG001|Overall Study|Progressive Disease|64|||
146905525|NCT03523585|529818385|FG002|Overall Study|Progressive Disease|77|||
146905526|NCT03523585|529818383|FG000|Overall Study|Adverse Event|74|||
146905527|NCT03523585|529818384|FG001|Overall Study|Adverse Event|5|||
146905528|NCT03523585|529818385|FG002|Overall Study|Adverse Event|9|||
146905529|NCT03523585|529818383|FG000|Overall Study|Withdrawal by Subject|30|||
146905530|NCT03523585|529818384|FG001|Overall Study|Withdrawal by Subject|11|||
146905531|NCT03523585|529818385|FG002|Overall Study|Withdrawal by Subject|6|||
146905532|NCT03523585|529818383|FG000|Overall Study|Clinical Progression|23|||
146905533|NCT03523585|529818384|FG001|Overall Study|Clinical Progression|5|||
146905534|NCT03523585|529818385|FG002|Overall Study|Clinical Progression|10|||
146905535|NCT03523585|529818383|FG000|Overall Study|Death|4|||
146905536|NCT03523585|529818384|FG001|Overall Study|Death|0|||
146905537|NCT03523585|529818385|FG002|Overall Study|Death|1|||
146905538|NCT03523585|529818383|FG000|Overall Study|Physician Decision|2|||
146905539|NCT03523585|529818384|FG001|Overall Study|Physician Decision|1|||
146905540|NCT03523585|529818385|FG002|Overall Study|Physician Decision|0|||
146905541|NCT03523585|529818383|FG000|Overall Study|Lost to Follow-up|1|||
146905542|NCT03523585|529818384|FG001|Overall Study|Lost to Follow-up|0|||
146905543|NCT03523585|529818385|FG002|Overall Study|Lost to Follow-up|0|||
146905544|NCT03523585|529818383|FG000|Overall Study|Miscellaneous|1|||
146905545|NCT03523585|529818384|FG001|Overall Study|Miscellaneous|0|||
146905546|NCT03523585|529818385|FG002|Overall Study|Miscellaneous|0|||
146905547|NCT03523585|529818383|FG000|Overall Study|Protocol Deviation|1|||
146905548|NCT03523585|529818384|FG001|Overall Study|Protocol Deviation|0|||
146905549|NCT03523585|529818385|FG002|Overall Study|Protocol Deviation|1|||
146640870|NCT04173494|528860950|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
146640871|NCT04173494|528860951|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
146640872|NCT04173494|528860950|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
146767582|NCT00241644|529317361|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
146905550|NCT03523585|529818383|FG000|Overall Study|Randomized But Not Treated|2|||
146905551|NCT03523585|529818384|FG001|Overall Study|Randomized But Not Treated|4|||
146905552|NCT03523585|529818385|FG002|Overall Study|Randomized But Not Treated|3|||
146905553|NCT01473004|529818386|FG000|Overall Study|Incomplete Lobar Treatment|1|||
146905554|NCT01473004|529818387|FG001|Overall Study|Incomplete Lobar Treatment|0|||
146905555|NCT05882890|529818388|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
146905556|NCT01584024|529818395|FG000|Overall Study|Lost to Follow-up|10|||
146905557|NCT01584024|529818395|FG000|Overall Study|Withdrawal by Subject|3|||
146905558|NCT00613314|529818396|FG000|Overall Study|Adverse Event|5|||
146561108|NCT03977155|528565904|FG002|Overall Study|Withdrawal by Subject|2|||
146905559|NCT00613314|529818396|FG000|Overall Study|Protocol Violation|14|||
146905560|NCT00613314|529818396|FG000|Overall Study|Lost to Follow-up|46|||
146905561|NCT00613314|529818396|FG000|Overall Study|Other reason not defined above|90|||
146905562|NCT01062399|529818399|FG000|Overall Study|Protocol Violation|0|||
146905563|NCT01062399|529818400|FG001|Overall Study|Protocol Violation|1|||
146905564|NCT01062399|529818401|FG002|Overall Study|Protocol Violation|0|||
146905565|NCT01062399|529818402|FG003|Overall Study|Protocol Violation|6|||
146905566|NCT01062399|529818403|FG004|Overall Study|Protocol Violation|4|||
146561109|NCT03977155|528565902|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
146905567|NCT04419506|529818424|FG000|Overall Study|Adverse Event|0|||
146561110|NCT03977155|528565903|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
146905568|NCT04419506|529818425|FG001|Overall Study|Adverse Event|10|||
146905569|NCT04419506|529818426|FG002|Overall Study|Adverse Event|0|||
146905570|NCT04419506|529818427|FG003|Overall Study|Adverse Event|3|||
146905571|NCT04419506|529818424|FG000|Overall Study|Withdrawal by Subject|0|||
146640873|NCT04173494|528860951|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
146640874|NCT04173494|528860950|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
146640875|NCT04173494|528860951|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
146640876|NCT04173494|528860950|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
146640877|NCT04173494|528860951|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
146640878|NCT04173494|528860950|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
146640879|NCT04173494|528860951|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
146640880|NCT04173494|528860950|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
146640881|NCT04173494|528860951|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
146640882|NCT04173494|528860950|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
146640883|NCT04173494|528860951|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
146640884|NCT04173494|528860950|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
146640885|NCT04173494|528860951|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
146767583|NCT00241644|529317362|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
146767584|NCT00241644|529317363|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
146767585|NCT00241644|529317360|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
146905572|NCT04419506|529818425|FG001|Overall Study|Withdrawal by Subject|0|||
146905573|NCT04419506|529818426|FG002|Overall Study|Withdrawal by Subject|0|||
146905574|NCT04419506|529818427|FG003|Overall Study|Withdrawal by Subject|1|||
146905575|NCT04419506|529818424|FG000|Overall Study|poor-compliance|0|||
146905576|NCT04419506|529818425|FG001|Overall Study|poor-compliance|0|||
146905577|NCT04419506|529818426|FG002|Overall Study|poor-compliance|0|||
146905578|NCT04419506|529818427|FG003|Overall Study|poor-compliance|1|||
146905579|NCT01845025|529818428|FG000|Overall Study|Adverse Event|6|||
146905580|NCT01845025|529818429|FG001|Overall Study|Adverse Event|3|||
146905581|NCT01845025|529818428|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146905582|NCT01845025|529818429|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146905583|NCT01845025|529818428|FG000|Overall Study|Withdrawal by Subject|48|||
146905584|NCT01845025|529818429|FG001|Overall Study|Withdrawal by Subject|44|||
146905585|NCT01845025|529818428|FG000|Overall Study|Lost to Follow-up|13|||
146905586|NCT01845025|529818429|FG001|Overall Study|Lost to Follow-up|13|||
146905587|NCT01845025|529818428|FG000|Overall Study|Administrative problems|8|||
146905588|NCT01845025|529818429|FG001|Overall Study|Administrative problems|8|||
146905589|NCT01845025|529818428|FG000|Overall Study|Death|2|||
146905590|NCT01845025|529818429|FG001|Overall Study|Death|0|||
146905591|NCT01845025|529818428|FG000|Overall Study|Protocol deviation|3|||
146905592|NCT01845025|529818429|FG001|Overall Study|Protocol deviation|6|||
146905593|NCT01845025|529818428|FG000|Overall Study|Missing|1|||
146905594|NCT01845025|529818429|FG001|Overall Study|Missing|1|||
146905595|NCT01973283|529818430|FG000|Overall Study|Lost to Follow-up|4|||
146905596|NCT01126619|529818431|FG000|Overall Study|Not eligible for the study|2|||
146905597|NCT01126619|529818431|FG000|Overall Study|Investigator decision|4|||
146905598|NCT01126619|529818431|FG000|Overall Study|Serious adverse event|1|||
146905599|NCT01126619|529818431|FG000|Overall Study|Withdrawal by Subject|9|||
146905600|NCT01126619|529818431|FG000|Overall Study|Non-compliance|1|||
146905601|NCT00947154|529818432|FG000|Overall Study|Lost to Follow-up|1|||
146905602|NCT01121406|529818436|FG000|Overall Study|Progressive disease RECIST|44|||
146905603|NCT01121406|529818437|FG001|Overall Study|Progressive disease RECIST|28|||
146905604|NCT01121406|529818436|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
146905605|NCT01121406|529818437|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
146905606|NCT01121406|529818436|FG000|Overall Study|Other AE|3|||
146905607|NCT01121406|529818437|FG001|Overall Study|Other AE|10|||
146905608|NCT01121406|529818436|FG000|Overall Study|Non-compliant with protocol|0|||
146905609|NCT01121406|529818437|FG001|Overall Study|Non-compliant with protocol|2|||
146905610|NCT01121406|529818436|FG000|Overall Study|Lost to Follow-up|0|||
146905611|NCT01121406|529818437|FG001|Overall Study|Lost to Follow-up|1|||
146640886|NCT04173494|528860950|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
146905612|NCT01121406|529818436|FG000|Overall Study|Refused continuation of study med.|1|||
146905613|NCT01121406|529818437|FG001|Overall Study|Refused continuation of study med.|2|||
146905614|NCT01121406|529818436|FG000|Overall Study|Reason other than specified above|2|||
146905615|NCT01121406|529818437|FG001|Overall Study|Reason other than specified above|6|||
146905616|NCT01121406|529818436|FG000|Overall Study|Not treated|1|||
146905617|NCT01121406|529818437|FG001|Overall Study|Not treated|0|||
146905618|NCT01829048|529818438|FG000|Overall Study|Withdrawal by Subject|0|||
146905619|NCT01829048|529818439|FG001|Overall Study|Withdrawal by Subject|0|||
146905620|NCT01829048|529818440|FG002|Overall Study|Withdrawal by Subject|0|||
146905621|NCT01829048|529818441|FG003|Overall Study|Withdrawal by Subject|2|||
146905622|NCT01829048|529818442|FG004|Overall Study|Withdrawal by Subject|0|||
146905623|NCT00892437|529818443|FG000|Randomized Phase|Randomized but not treated|6|||
146905624|NCT00892437|529818444|FG001|Randomized Phase|Randomized but not treated|0|||
146905625|NCT00892437|529818443|FG000|Randomized Phase|Adverse Event|2|||
146905626|NCT00892437|529818444|FG001|Randomized Phase|Adverse Event|2|||
146905627|NCT00892437|529818443|FG000|Randomized Phase|Lost to Follow-up|1|||
146905628|NCT00892437|529818444|FG001|Randomized Phase|Lost to Follow-up|3|||
146905629|NCT00892437|529818443|FG000|Randomized Phase|Investigator's Discretion|1|||
146905630|NCT00892437|529818444|FG001|Randomized Phase|Investigator's Discretion|0|||
146905631|NCT00892437|529818443|FG000|Randomized Phase|Withdrew Consent|1|||
146905632|NCT00892437|529818444|FG001|Randomized Phase|Withdrew Consent|0|||
146905633|NCT00892437|529818443|FG000|Open-Label Extension Phase|Adverse Event|4|||
146905634|NCT00892437|529818444|FG001|Open-Label Extension Phase|Adverse Event|2|||
146905635|NCT00892437|529818443|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
146905636|NCT00892437|529818444|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
146905637|NCT00892437|529818443|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
146905638|NCT00892437|529818444|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
146905639|NCT00892437|529818443|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
146905640|NCT00892437|529818444|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
146905641|NCT00892437|529818443|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
146905642|NCT00892437|529818444|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
146905643|NCT00504257|529818445|FG000|Overall Study|Withdrawal by Subject|2|||
146905644|NCT00504257|529818445|FG000|Overall Study|ineligible histology|2|||
146905645|NCT02750410|529818448|FG000|Double-Blind Treatment Period|Adverse Event|2|||
146905646|NCT02750410|529818449|FG001|Double-Blind Treatment Period|Adverse Event|2|||
146905647|NCT02750410|529818448|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146905648|NCT02750410|529818449|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146905649|NCT02750410|529818448|FG000|Open-Label Extension Period|Adverse Event|5|||
146905650|NCT02750410|529818449|FG001|Open-Label Extension Period|Adverse Event|3|||
146905651|NCT02750410|529818448|FG000|Open-Label Extension Period|Protocol Violation|0|||
146905652|NCT02750410|529818449|FG001|Open-Label Extension Period|Protocol Violation|1|||
146905653|NCT02750410|529818448|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
146905654|NCT02750410|529818449|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
146905655|NCT02504541|529818450|FG000|Overall Study|Adverse Event|4|||
146905656|NCT02504541|529818450|FG000|Overall Study|Withdrawal by Subject|4|||
146905657|NCT02504541|529818450|FG000|Overall Study|Lost to Follow-up|1|||
146905658|NCT02504541|529818450|FG000|Overall Study|Met Stopping Criteria|1|||
146905659|NCT02504541|529818450|FG000|Overall Study|Protocol Violation|2|||
146905660|NCT02504541|529818450|FG000|Overall Study|Termination by Sponsor|1|||
146905661|NCT02504541|529818450|FG000|Overall Study|Other|2|||
146905662|NCT02504541|529818450|FG000|Overall Study|Multiple|5|||
146905663|NCT02318602|529818454|FG000|Overall Study|Adverse Event|0|||
146905664|NCT02318602|529818455|FG001|Overall Study|Adverse Event|1|||
146905665|NCT02318602|529818456|FG002|Overall Study|Adverse Event|1|||
146905666|NCT02318602|529818454|FG000|Overall Study|Withdrawal by Subject|0|||
146905667|NCT02318602|529818455|FG001|Overall Study|Withdrawal by Subject|3|||
146905668|NCT02318602|529818456|FG002|Overall Study|Withdrawal by Subject|0|||
146905669|NCT02318602|529818454|FG000|Overall Study|Death|1|||
146905670|NCT02318602|529818455|FG001|Overall Study|Death|0|||
146905671|NCT02318602|529818456|FG002|Overall Study|Death|0|||
146905672|NCT02318602|529818454|FG000|Overall Study|Guardian decision to withdraw|0|||
146905673|NCT02318602|529818455|FG001|Overall Study|Guardian decision to withdraw|0|||
146905674|NCT02318602|529818456|FG002|Overall Study|Guardian decision to withdraw|1|||
146905675|NCT02580058|529818457|FG000|Overall Study|Adverse Event|16|||
146905676|NCT02580058|529818458|FG001|Overall Study|Adverse Event|30|||
146905677|NCT02580058|529818459|FG002|Overall Study|Adverse Event|20|||
146905678|NCT02580058|529818457|FG000|Overall Study|Death|4|||
146905679|NCT02580058|529818458|FG001|Overall Study|Death|4|||
146905680|NCT02580058|529818459|FG002|Overall Study|Death|5|||
146905681|NCT02580058|529818457|FG000|Overall Study|Physician Decision|1|||
146905682|NCT02580058|529818458|FG001|Overall Study|Physician Decision|3|||
146905683|NCT02580058|529818459|FG002|Overall Study|Physician Decision|11|||
146905684|NCT02580058|529818457|FG000|Overall Study|Other|5|||
146905685|NCT02580058|529818458|FG001|Overall Study|Other|1|||
146905686|NCT02580058|529818459|FG002|Overall Study|Other|3|||
146905687|NCT02580058|529818457|FG000|Overall Study|Withdrawal by Subject|4|||
146905688|NCT02580058|529818458|FG001|Overall Study|Withdrawal by Subject|7|||
146905689|NCT02580058|529818459|FG002|Overall Study|Withdrawal by Subject|31|||
146905690|NCT02580058|529818457|FG000|Overall Study|Global Deterioration of Health Status|19|||
146905691|NCT02580058|529818458|FG001|Overall Study|Global Deterioration of Health Status|18|||
146905692|NCT02580058|529818459|FG002|Overall Study|Global Deterioration of Health Status|24|||
146905693|NCT02580058|529818457|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
146905694|NCT02580058|529818458|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146905695|NCT02580058|529818459|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
146905696|NCT02580058|529818457|FG000|Overall Study|Progressive Disease|137|||
146905697|NCT02580058|529818458|FG001|Overall Study|Progressive Disease|125|||
146905698|NCT02580058|529818459|FG002|Overall Study|Progressive Disease|94|||
146905699|NCT02580058|529818457|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146905700|NCT02580058|529818458|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146905701|NCT02580058|529818459|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146905702|NCT00730236|529818460|FG000|Overall Study|Adverse Event|4|||
146905703|NCT00730236|529818460|FG000|Overall Study|Withdrawal by Subject|1|||
146905704|NCT00730236|529818460|FG000|Overall Study|Non-compliance|1|||
146905705|NCT03486314|529818462|FG000|Part A|Adverse Event|1|||
146640887|NCT04173494|528860951|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
146905706|NCT03486314|529818463|FG001|Part A|Adverse Event|0|||
146905707|NCT03486314|529818464|FG002|Part A|Adverse Event|0|||
146905708|NCT03486314|529818462|FG000|Part A|Symptomatic Deterioration|2|||
146905709|NCT03486314|529818463|FG001|Part A|Symptomatic Deterioration|0|||
146561111|NCT03977155|528565904|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
146905710|NCT03486314|529818464|FG002|Part A|Symptomatic Deterioration|0|||
146905711|NCT00482001|529818466|FG000|Overall Study|Protocol Violation|1|||
146905712|NCT00482001|529818467|FG001|Overall Study|Protocol Violation|1|||
146561112|NCT00936936|528565905|FG000|Overall Study|Adverse Event|7|||
146561113|NCT00936936|528565906|FG001|Overall Study|Adverse Event|1|||
146905713|NCT01985321|529818468|FG000|Overall Study|Protocol Violation|4|||
146905714|NCT01985321|529818469|FG001|Overall Study|Protocol Violation|3|||
146905715|NCT01985321|529818468|FG000|Overall Study|Withdrawal by Subject|1|||
146905716|NCT01985321|529818469|FG001|Overall Study|Withdrawal by Subject|0|||
146905717|NCT01985321|529818468|FG000|Overall Study|Lost to Follow-up|5|||
146905718|NCT01985321|529818469|FG001|Overall Study|Lost to Follow-up|2|||
146905719|NCT01985321|529818468|FG000|Overall Study|Subject treated wrong type of sore|1|||
146905720|NCT01985321|529818469|FG001|Overall Study|Subject treated wrong type of sore|0|||
146905721|NCT00542828|529818476|FG000|Overall Study|Physician Decision|1|||
146905722|NCT00542828|529818476|FG000|Overall Study|Need for Prohibited Treatment|3|||
146561114|NCT00936936|528565905|FG000|Overall Study|Disease Progression|2|||
146561115|NCT00936936|528565906|FG001|Overall Study|Disease Progression|2|||
146561116|NCT00936936|528565905|FG000|Overall Study|Unrelated|3|||
146561117|NCT00936936|528565906|FG001|Overall Study|Unrelated|1|||
146561118|NCT02278003|528565907|FG000|Overall Study|Withdrawal by Subject|11|||
146561119|NCT02278003|528565908|FG001|Overall Study|Withdrawal by Subject|0|||
146561120|NCT02278003|528565907|FG000|Overall Study|Not Treated|1|||
146561121|NCT02278003|528565908|FG001|Overall Study|Not Treated|0|||
146561122|NCT02278003|528565907|FG000|Overall Study|Recognition task improperly completed|7|||
146561123|NCT02278003|528565908|FG001|Overall Study|Recognition task improperly completed|0|||
146561124|NCT02296476|528565909|FG000|Overall Study|Disease Progression|6|||
146561125|NCT02296476|528565910|FG001|Overall Study|Disease Progression|4|||
146561126|NCT02296476|528565911|FG002|Overall Study|Disease Progression|2|||
146561127|NCT03440385|528565913|FG000|Overall Study|Other Reason|4|||
146561128|NCT03440385|528565914|FG001|Overall Study|Other Reason|1|||
146561129|NCT03440385|528565913|FG000|Overall Study|Site Closed|1|||
146561130|NCT03440385|528565914|FG001|Overall Study|Site Closed|0|||
146561131|NCT03440385|528565913|FG000|Overall Study|Lost to Follow-up|2|||
146561132|NCT03440385|528565914|FG001|Overall Study|Lost to Follow-up|0|||
146561133|NCT03440385|528565913|FG000|Overall Study|Withdrawal by Subject|12|||
146561134|NCT03440385|528565914|FG001|Overall Study|Withdrawal by Subject|6|||
146561135|NCT03440385|528565913|FG000|Overall Study|Lack of Efficacy|9|||
146561136|NCT03440385|528565914|FG001|Overall Study|Lack of Efficacy|2|||
146561137|NCT03440385|528565913|FG000|Overall Study|Adverse Event|15|||
146561138|NCT03440385|528565914|FG001|Overall Study|Adverse Event|11|||
146561139|NCT00730327|528565916|FG000|Overall Study|Lost to Follow-up|14|||
146905723|NCT00542828|529818476|FG000|Overall Study|Study Prematurely Discontinued|7|||
146905724|NCT00542828|529818476|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
146905725|NCT00095303|529818477|FG000|Main Study|Lost to Follow-up|91|||
146905726|NCT00095303|529818478|FG001|Main Study|Lost to Follow-up|87|||
146970134|NCT02017535|530050804|FG003|Overall Study|Withdrawal by Subject|0|||
146561140|NCT00730327|528565917|FG001|Overall Study|Lost to Follow-up|16|||
146561141|NCT00730327|528565916|FG000|Overall Study|Adverse Event|8|||
146561142|NCT00730327|528565917|FG001|Overall Study|Adverse Event|1|||
146561143|NCT00730327|528565916|FG000|Overall Study|Withdrawal by Subject|3|||
146905727|NCT00095303|529818477|FG000|Follow Up Study|Lost to Follow-up|59|||
146905728|NCT00095303|529818478|FG001|Follow Up Study|Lost to Follow-up|58|||
146767586|NCT00241644|529317361|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
146905729|NCT01364467|529818481|FG000|Overall Study|Lost to Follow-up|1|||
146905730|NCT01364467|529818482|FG001|Overall Study|Lost to Follow-up|2|||
146905731|NCT03228186|529818483|FG000|Overall Study|Patient never started treatment|1|||
146905732|NCT01634243|529818486|FG000|Overall Study|Adverse Event|5|||
146561144|NCT00730327|528565917|FG001|Overall Study|Withdrawal by Subject|13|||
146905733|NCT01634243|529818487|FG001|Overall Study|Adverse Event|5|||
146905734|NCT01634243|529818486|FG000|Overall Study|Lack of Efficacy|1|||
146905735|NCT01634243|529818487|FG001|Overall Study|Lack of Efficacy|0|||
146905736|NCT03953118|529818488|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
146905737|NCT03953118|529818489|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
146905738|NCT04283461|529818490|FG000|Overall Study|Enrolled in separate trial|0|||
146905739|NCT04283461|529818491|FG001|Overall Study|Enrolled in separate trial|0|||
146905740|NCT04283461|529818492|FG002|Overall Study|Enrolled in separate trial|8|||
146905741|NCT04283461|529818493|FG003|Overall Study|Enrolled in separate trial|13|||
146767587|NCT00241644|529317362|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
146767588|NCT00241644|529317363|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
146767589|NCT00943735|529317364|FG000|Overall Study|Adverse Event|12|||
146905742|NCT04283461|529818494|FG004|Overall Study|Enrolled in separate trial|12|||
146905743|NCT04283461|529818495|FG005|Overall Study|Enrolled in separate trial|0|||
146905744|NCT04283461|529818496|FG006|Overall Study|Enrolled in separate trial|0|||
146905745|NCT04283461|529818497|FG007|Overall Study|Enrolled in separate trial|8|||
146905746|NCT04283461|529818498|FG008|Overall Study|Enrolled in separate trial|0|||
146970135|NCT03506425|530050805|FG000|Overall Study|Adverse Event|1|||
146905747|NCT04283461|529818499|FG009|Overall Study|Enrolled in separate trial|0|||
146640888|NCT04173494|528860950|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
146640889|NCT04173494|528860951|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
146640890|NCT04173494|528860950|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
146640891|NCT04173494|528860951|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
146640892|NCT04173494|528860950|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
146640893|NCT04173494|528860951|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
146640894|NCT01623050|528860952|FG000|Overall Study|Lost to Follow-up|9|||
146767590|NCT00943735|529317364|FG000|Overall Study|Withdrawal by Subject|8|||
146767591|NCT00943735|529317364|FG000|Overall Study|Death|1|||
146767592|NCT00943735|529317364|FG000|Overall Study|Other|8|||
146905748|NCT04283461|529818500|FG010|Overall Study|Enrolled in separate trial|0|||
146767593|NCT00943735|529317364|FG000|Overall Study|Other|3|||
146561145|NCT00730327|528565916|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
146561146|NCT00730327|528565917|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
146561147|NCT02332928|528565923|FG000|Overall Study|Withdrawal by Subject|0|||
146561148|NCT02332928|528565924|FG001|Overall Study|Withdrawal by Subject|2|||
146561149|NCT02332928|528565923|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
146561150|NCT02332928|528565924|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
146561151|NCT04484857|528565930|FG000|Overall Study|Adverse Event|2|||
146561152|NCT04484857|528565930|FG000|Overall Study|Death|10|||
146561153|NCT04484857|528565930|FG000|Overall Study|Withdrawal by Subject|3|||
146561154|NCT04484857|528565930|FG000|Overall Study|Transferred/Relocation|5|||
146561155|NCT04484857|528565930|FG000|Overall Study|Kidney Transplant|7|||
146561156|NCT04484857|528565930|FG000|Overall Study|Other than specified|4|||
146561157|NCT04484857|528565930|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
146561158|NCT01425814|528565931|FG000|Period 1|Stability criteria not fulfilled|0|||
146561159|NCT01425814|528565932|FG001|Period 1|Stability criteria not fulfilled|1|||
146561160|NCT01425814|528565933|FG002|Period 1|Stability criteria not fulfilled|0|||
146561161|NCT01425814|528565934|FG003|Period 1|Stability criteria not fulfilled|0|||
146561162|NCT01425814|528565935|FG004|Period 1|Stability criteria not fulfilled|0|||
146561163|NCT01425814|528565936|FG005|Period 1|Stability criteria not fulfilled|0|||
146561164|NCT01425814|528565931|FG000|Period 2|Stability criteria not fulfilled|0|||
146561165|NCT01425814|528565932|FG001|Period 2|Stability criteria not fulfilled|1|||
146561166|NCT01425814|528565933|FG002|Period 2|Stability criteria not fulfilled|0|||
146561167|NCT01425814|528565934|FG003|Period 2|Stability criteria not fulfilled|0|||
146561168|NCT01425814|528565935|FG004|Period 2|Stability criteria not fulfilled|0|||
146561169|NCT01425814|528565936|FG005|Period 2|Stability criteria not fulfilled|0|||
146561170|NCT01425814|528565931|FG000|Period 3|Adverse Event|0|||
146561171|NCT01425814|528565932|FG001|Period 3|Adverse Event|0|||
146561172|NCT01425814|528565933|FG002|Period 3|Adverse Event|0|||
146561173|NCT01425814|528565934|FG003|Period 3|Adverse Event|0|||
146767594|NCT00486330|529317365|FG000|Overall Study|Adverse Event|2|||
146905749|NCT04283461|529818501|FG011|Overall Study|Enrolled in separate trial|7|||
146905750|NCT04283461|529818502|FG012|Overall Study|Enrolled in separate trial|0|||
146905751|NCT02502864|529818508|FG000|Overall Study|Withdrawal by Subject|1|||
146561174|NCT01425814|528565935|FG004|Period 3|Adverse Event|0|||
146561175|NCT01425814|528565936|FG005|Period 3|Adverse Event|1|||
146561176|NCT01425814|528565931|FG000|Period 4|Adverse Event|1|||
146561177|NCT01425814|528565932|FG001|Period 4|Adverse Event|0|||
146561178|NCT01425814|528565933|FG002|Period 4|Adverse Event|1|||
146561179|NCT01425814|528565934|FG003|Period 4|Adverse Event|0|||
146561180|NCT01425814|528565935|FG004|Period 4|Adverse Event|0|||
146561181|NCT01425814|528565936|FG005|Period 4|Adverse Event|0|||
146561182|NCT01425814|528565931|FG000|Period 5|Stability criteria not fulfilled|0|||
146640895|NCT01191762|528860953|FG000|Overall Study|Adverse Event|1|||
146640896|NCT01191762|528860954|FG001|Overall Study|Adverse Event|0|||
146640897|NCT01519869|528860957|FG000|Overall Study|Lost to Follow-up|1|||
146640898|NCT03023813|528860958|FG000|Overall Study|Lost to Follow-up|1|||
146640899|NCT03023813|528860959|FG001|Overall Study|Lost to Follow-up|2|||
146640900|NCT03023813|528860960|FG002|Overall Study|Lost to Follow-up|0|||
146640901|NCT00202878|528860961|FG000|Overall Study|Death|964|||
146640902|NCT00202878|528860962|FG001|Overall Study|Death|968|||
146640903|NCT00202878|528860961|FG000|Overall Study|Only Vital Status Known|357|||
146640904|NCT00202878|528860962|FG001|Overall Study|Only Vital Status Known|356|||
146640905|NCT00202878|528860961|FG000|Overall Study|Lost to Follow-up|44|||
146640906|NCT00202878|528860962|FG001|Overall Study|Lost to Follow-up|49|||
146640907|NCT00202878|528860961|FG000|Overall Study|Site Closure|39|||
146640908|NCT00202878|528860962|FG001|Overall Study|Site Closure|36|||
146640909|NCT00202878|528860961|FG000|Overall Study|Withdrawal by Subject|795|||
146640910|NCT00202878|528860962|FG001|Overall Study|Withdrawal by Subject|808|||
146640911|NCT02123472|528860964|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
146640912|NCT02123472|528860965|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
146640913|NCT02433080|528860967|FG000|Overall Study|Lost to Follow-up|1|||
146640914|NCT02433080|528860968|FG001|Overall Study|Lost to Follow-up|2|||
146640915|NCT02433080|528860967|FG000|Overall Study|Withdrawal by Subject|0|||
146640916|NCT02433080|528860968|FG001|Overall Study|Withdrawal by Subject|2|||
146640917|NCT03801031|528860969|FG000|Overall Study|Lost to Follow-up|1|||
146640918|NCT03801031|528860970|FG001|Overall Study|Lost to Follow-up|0|||
146640919|NCT03801031|528860969|FG000|Overall Study|Unable to comply|1|||
146640920|NCT03801031|528860970|FG001|Overall Study|Unable to comply|0|||
146640921|NCT03801031|528860969|FG000|Overall Study|Withdrawal by Subject|0|||
146640922|NCT03801031|528860970|FG001|Overall Study|Withdrawal by Subject|1|||
146905752|NCT00104871|529818519|FG000|Overall Study|Not evaluable|1|||
146905753|NCT00457639|529818523|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
146905754|NCT00457639|529818524|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
146905755|NCT00457639|529818523|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
146905756|NCT00457639|529818524|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
146905757|NCT00457639|529818523|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
146905758|NCT00457639|529818524|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
146905759|NCT02117687|529818525|FG000|Overall Study|Lost to Follow-up|0|||
146905760|NCT02117687|529818526|FG001|Overall Study|Lost to Follow-up|1|||
146905761|NCT02117687|529818525|FG000|Overall Study|Adverse Event|0|||
146905762|NCT02117687|529818526|FG001|Overall Study|Adverse Event|2|||
146905763|NCT02117687|529818525|FG000|Overall Study|Other Reasons|1|||
146905764|NCT02117687|529818526|FG001|Overall Study|Other Reasons|1|||
146905765|NCT00618956|529818527|FG000|Overall Study|Adverse Event|10|||
146905766|NCT00618956|529818528|FG001|Overall Study|Adverse Event|34|||
146905767|NCT00618956|529818527|FG000|Overall Study|Lack of Efficacy|2|||
146905768|NCT00618956|529818528|FG001|Overall Study|Lack of Efficacy|1|||
146905769|NCT00618956|529818527|FG000|Overall Study|Withdrawal by Subject|5|||
146905770|NCT00618956|529818528|FG001|Overall Study|Withdrawal by Subject|7|||
146905771|NCT00618956|529818527|FG000|Overall Study|Lost to Follow-up|4|||
146905772|NCT00618956|529818528|FG001|Overall Study|Lost to Follow-up|5|||
146640943|NCT00126490|528860979|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
146640944|NCT02087423|528860980|FG000|Overall Study|Withdrawal by Subject|20|||
146640945|NCT02087423|528860981|FG001|Overall Study|Withdrawal by Subject|20|||
146640946|NCT02087423|528860982|FG002|Overall Study|Withdrawal by Subject|3|||
146640947|NCT02087423|528860980|FG000|Overall Study|Death|68|||
146640948|NCT02087423|528860981|FG001|Overall Study|Death|207|||
146640949|NCT02087423|528860982|FG002|Overall Study|Death|40|||
146640950|NCT02087423|528860980|FG000|Overall Study|Lost to Follow-up|0|||
146640951|NCT02087423|528860981|FG001|Overall Study|Lost to Follow-up|2|||
146640952|NCT02087423|528860982|FG002|Overall Study|Lost to Follow-up|0|||
146640953|NCT02087423|528860980|FG000|Overall Study|Terminated from study at final DCO|23|||
146640954|NCT02087423|528860981|FG001|Overall Study|Terminated from study at final DCO|36|||
146640955|NCT02087423|528860982|FG002|Overall Study|Terminated from study at final DCO|25|||
146640956|NCT02762370|528860985|FG000|Overall Study|Protocol Violation|1|||
146640957|NCT02762370|528860986|FG001|Overall Study|Protocol Violation|0|||
146640958|NCT04393454|528860990|FG000|Overall Study|Death|1|||
146640959|NCT04393454|528860990|FG000|Overall Study|Lost to Follow-up|1|||
146640960|NCT03304249|528860992|FG000|Overall Study|Lost to Follow-up|8|||
146640961|NCT03304249|528860993|FG001|Overall Study|Lost to Follow-up|10|||
146640962|NCT03304249|528860992|FG000|Overall Study|Withdrawal by Subject|12|||
146640963|NCT03304249|528860993|FG001|Overall Study|Withdrawal by Subject|2|||
146640964|NCT03304249|528860992|FG000|Overall Study|Moved Out of District|4|||
146640965|NCT03304249|528860993|FG001|Overall Study|Moved Out of District|2|||
146640966|NCT00924027|528860994|FG000|Overall Study|Lost to Further Follow-Up|4|||
146640967|NCT00924027|528860995|FG001|Overall Study|Lost to Further Follow-Up|0|||
146640968|NCT00924027|528860996|FG002|Overall Study|Lost to Further Follow-Up|0|||
146640969|NCT00924027|528860997|FG003|Overall Study|Lost to Further Follow-Up|0|||
146640970|NCT00924027|528860994|FG000|Overall Study|Physician Decision|1|||
146640971|NCT00924027|528860995|FG001|Overall Study|Physician Decision|0|||
146640972|NCT00924027|528860996|FG002|Overall Study|Physician Decision|0|||
146640973|NCT00924027|528860997|FG003|Overall Study|Physician Decision|1|||
146640974|NCT00924027|528860994|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
146640975|NCT00924027|528860995|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
146640976|NCT00924027|528860996|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
146640977|NCT00924027|528860997|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
146640978|NCT00924027|528860994|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
146640979|NCT00924027|528860995|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
146640980|NCT00924027|528860996|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
146640981|NCT00924027|528860997|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
146640982|NCT00924027|528860994|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
146640983|NCT00924027|528860995|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
146640984|NCT00924027|528860996|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
146905773|NCT00618956|529818527|FG000|Overall Study|Protocol Violation|2|||
146905774|NCT00618956|529818528|FG001|Overall Study|Protocol Violation|2|||
146905775|NCT00618956|529818527|FG000|Overall Study|did not meet criteria, non-compliance|2|||
146905776|NCT00618956|529818528|FG001|Overall Study|did not meet criteria, non-compliance|1|||
146905777|NCT00630032|529818529|FG000|Overall Study|Death|55|||
146905778|NCT00630032|529818530|FG001|Overall Study|Death|49|||
146905779|NCT00630032|529818529|FG000|Overall Study|Withdrawal by Subject|3|||
146905780|NCT00630032|529818530|FG001|Overall Study|Withdrawal by Subject|2|||
146905781|NCT00630032|529818529|FG000|Overall Study|Lost to Follow-up|18|||
146905782|NCT00630032|529818530|FG001|Overall Study|Lost to Follow-up|31|||
146905783|NCT00630032|529818529|FG000|Overall Study|Protocol Violation|1|||
146905784|NCT00630032|529818530|FG001|Overall Study|Protocol Violation|0|||
146905785|NCT00630032|529818529|FG000|Overall Study|Patient has moved|1|||
146905786|NCT00630032|529818530|FG001|Overall Study|Patient has moved|1|||
146905787|NCT00630032|529818529|FG000|Overall Study|Disease progression|1|||
146905788|NCT00630032|529818530|FG001|Overall Study|Disease progression|1|||
146905789|NCT00630032|529818529|FG000|Overall Study|End of monitoring in US centers|11|||
146905790|NCT00630032|529818530|FG001|Overall Study|End of monitoring in US centers|11|||
146905791|NCT03746080|529820311|FG000|Overall Study|In follow up|2|||
146905792|NCT03746080|529820311|FG000|Overall Study|Death|15|||
146905793|NCT01826214|529820315|FG000|Overall Study|Adverse Event|7|||
146905794|NCT01826214|529820316|FG001|Overall Study|Adverse Event|6|||
146905795|NCT01826214|529820315|FG000|Overall Study|Death|3|||
146905796|NCT01826214|529820316|FG001|Overall Study|Death|1|||
146905797|NCT01826214|529820315|FG000|Overall Study|Lost to Follow-up|1|||
146905798|NCT01826214|529820316|FG001|Overall Study|Lost to Follow-up|0|||
146905799|NCT01826214|529820315|FG000|Overall Study|Physician Decision|0|||
146905800|NCT01826214|529820316|FG001|Overall Study|Physician Decision|2|||
146905801|NCT01826214|529820315|FG000|Overall Study|Progressive disease|22|||
146905802|NCT01826214|529820316|FG001|Overall Study|Progressive disease|21|||
146905803|NCT01826214|529820315|FG000|Overall Study|Study terminated by Sponsor|0|||
146905804|NCT01826214|529820316|FG001|Overall Study|Study terminated by Sponsor|1|||
146905805|NCT01826214|529820315|FG000|Overall Study|Subject/guardian decision|2|||
146905806|NCT01826214|529820316|FG001|Overall Study|Subject/guardian decision|3|||
146905807|NCT00955110|529820317|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
146905808|NCT00955110|529820317|FG000|Treatment Phase|Adverse Event|2|||
146640985|NCT00924027|528860997|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
146640986|NCT04549545|528862900|FG000|Initial Period|Withdrawal by Subject|4|||
146640987|NCT04549545|528862901|FG001|Initial Period|Withdrawal by Subject|0|||
146640988|NCT04549545|528862900|FG000|Initial Period|Additional ENT Procedure|3|||
146640989|NCT04549545|528862901|FG001|Initial Period|Additional ENT Procedure|0|||
146640990|NCT04549545|528862900|FG000|Initial Period|Lost to Follow-up|3|||
146640991|NCT04549545|528862901|FG001|Initial Period|Lost to Follow-up|1|||
146640992|NCT04549545|528862900|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
146640993|NCT04549545|528862901|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
146640994|NCT04549545|528862900|FG000|Crossover Period|Additional ENT Procedure|0|||
146640995|NCT04549545|528862901|FG001|Crossover Period|Additional ENT Procedure|6|||
146640996|NCT04549545|528862900|FG000|Crossover Period|Lost to Follow-up|0|||
146767595|NCT03804918|529317366|FG000|Overall Study|Participant did not use the app|1|||
146767596|NCT00813904|529317367|FG000|Overall Study|Death|1|||
146640997|NCT04549545|528862901|FG001|Crossover Period|Lost to Follow-up|1|||
146640998|NCT04549545|528862900|FG000|Crossover Period|Withdrawal by Subject|0|||
146767597|NCT01087762|529317368|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
146905809|NCT00955110|529820317|FG000|Treatment Phase|Administrative reasons|2|||
146905810|NCT00955110|529820317|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
146905811|NCT00955110|529820317|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
146905812|NCT02128490|529820318|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
146767598|NCT01087762|529317369|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
146905813|NCT02128490|529820319|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
146905814|NCT02128490|529820320|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
146561183|NCT01425814|528565932|FG001|Period 5|Stability criteria not fulfilled|0|||
146561184|NCT01425814|528565933|FG002|Period 5|Stability criteria not fulfilled|1|||
146561185|NCT01425814|528565934|FG003|Period 5|Stability criteria not fulfilled|0|||
146561186|NCT01425814|528565935|FG004|Period 5|Stability criteria not fulfilled|0|||
146561187|NCT01425814|528565936|FG005|Period 5|Stability criteria not fulfilled|1|||
146561188|NCT02095106|528565945|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
146561189|NCT02095106|528565946|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
146561190|NCT02546323|528565947|FG000|Overall Study|Withdrawal by Subject|36|||
146561191|NCT02546323|528565948|FG001|Overall Study|Withdrawal by Subject|33|||
146561192|NCT02546323|528565947|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
146561193|NCT02546323|528565948|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
146561194|NCT02546323|528565947|FG000|Overall Study|Adverse Event|17|||
146905815|NCT02128490|529820321|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
146905816|NCT02128490|529820322|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
146905817|NCT02128490|529820318|FG000|Overall Study|Major Protocol Deviation|1|||
146905818|NCT02128490|529820319|FG001|Overall Study|Major Protocol Deviation|2|||
146905819|NCT02128490|529820320|FG002|Overall Study|Major Protocol Deviation|0|||
146905820|NCT02128490|529820321|FG003|Overall Study|Major Protocol Deviation|2|||
146905821|NCT02128490|529820322|FG004|Overall Study|Major Protocol Deviation|2|||
146905822|NCT02128490|529820318|FG000|Overall Study|Lost to Follow-up|0|||
146905823|NCT02128490|529820319|FG001|Overall Study|Lost to Follow-up|0|||
146905824|NCT02128490|529820320|FG002|Overall Study|Lost to Follow-up|1|||
146905825|NCT02128490|529820321|FG003|Overall Study|Lost to Follow-up|1|||
146905826|NCT02128490|529820322|FG004|Overall Study|Lost to Follow-up|1|||
146905827|NCT02128490|529820318|FG000|Overall Study|Voluntary Withdrawal|3|||
146905828|NCT02128490|529820319|FG001|Overall Study|Voluntary Withdrawal|3|||
146905829|NCT02128490|529820320|FG002|Overall Study|Voluntary Withdrawal|1|||
146905830|NCT02128490|529820321|FG003|Overall Study|Voluntary Withdrawal|1|||
146905831|NCT02128490|529820322|FG004|Overall Study|Voluntary Withdrawal|2|||
146905832|NCT02128490|529820318|FG000|Overall Study|Lack of Efficacy|0|||
146905833|NCT02128490|529820319|FG001|Overall Study|Lack of Efficacy|1|||
146905834|NCT02128490|529820320|FG002|Overall Study|Lack of Efficacy|0|||
146905835|NCT02128490|529820321|FG003|Overall Study|Lack of Efficacy|0|||
146905836|NCT02128490|529820322|FG004|Overall Study|Lack of Efficacy|0|||
146905837|NCT02128490|529820318|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
146905838|NCT02128490|529820319|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
146905839|NCT02128490|529820320|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
146905840|NCT02128490|529820321|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
146767599|NCT01087762|529317370|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
146767600|NCT01087762|529317371|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
146767601|NCT01087762|529317372|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
146767602|NCT01087762|529317368|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
146640999|NCT04549545|528862901|FG001|Crossover Period|Withdrawal by Subject|4|||
146641000|NCT01395524|528862906|FG000|Overall Study|Non-compliance with study schedule|1|||
146641001|NCT01395524|528862907|FG001|Overall Study|Non-compliance with study schedule|0|||
146641002|NCT01395524|528862908|FG002|Overall Study|Non-compliance with study schedule|1|||
146641003|NCT01395524|528862906|FG000|Overall Study|Lost to Follow-up|3|||
146641004|NCT01395524|528862907|FG001|Overall Study|Lost to Follow-up|1|||
146641005|NCT01395524|528862908|FG002|Overall Study|Lost to Follow-up|1|||
146641006|NCT01395524|528862906|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
146641007|NCT01395524|528862907|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
146641008|NCT01395524|528862908|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
146641009|NCT01395524|528862906|FG000|Overall Study|Severe noncompliance with protocol|1|||
146767603|NCT01087762|529317369|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
146767604|NCT01087762|529317370|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
146767605|NCT01087762|529317371|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
146905841|NCT02128490|529820322|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
146905842|NCT02128490|529820318|FG000|Overall Study|Other Miscellaneous Reasons|0|||
146905843|NCT02128490|529820319|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146905844|NCT02128490|529820320|FG002|Overall Study|Other Miscellaneous Reasons|2|||
146905845|NCT02128490|529820321|FG003|Overall Study|Other Miscellaneous Reasons|1|||
146905846|NCT02128490|529820322|FG004|Overall Study|Other Miscellaneous Reasons|1|||
146905847|NCT02243176|529820323|FG000|Overall Study|Other reason|1|||
146905848|NCT02243176|529820324|FG001|Overall Study|Other reason|2|||
146905849|NCT02243176|529820323|FG000|Overall Study|protocol specified withdrawal critera|1|||
146905850|NCT02243176|529820324|FG001|Overall Study|protocol specified withdrawal critera|3|||
146905851|NCT02243176|529820323|FG000|Overall Study|Protocol Violation|2|||
146905852|NCT02243176|529820324|FG001|Overall Study|Protocol Violation|1|||
146905853|NCT02243176|529820323|FG000|Overall Study|Withdrawal by Subject|8|||
146905854|NCT02243176|529820324|FG001|Overall Study|Withdrawal by Subject|7|||
146905855|NCT02243176|529820323|FG000|Overall Study|Adverse Event|2|||
146905856|NCT02243176|529820324|FG001|Overall Study|Adverse Event|2|||
146641010|NCT01395524|528862907|FG001|Overall Study|Severe noncompliance with protocol|0|||
146905857|NCT02981472|529820330|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
146905858|NCT02981472|529820331|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
146905859|NCT02981472|529820330|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
146905860|NCT02981472|529820331|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146905861|NCT02981472|529820330|FG000|Treatment Period|Adverse Event|6|||
146641011|NCT01395524|528862908|FG002|Overall Study|Severe noncompliance with protocol|0|||
146561195|NCT02546323|528565948|FG001|Overall Study|Adverse Event|11|||
146561196|NCT02546323|528565947|FG000|Overall Study|Patient Specific Reasons|1|||
146561197|NCT02546323|528565948|FG001|Overall Study|Patient Specific Reasons|2|||
146561198|NCT02546323|528565947|FG000|Overall Study|Lost to Follow-up|2|||
146561199|NCT02546323|528565948|FG001|Overall Study|Lost to Follow-up|3|||
146561200|NCT02546323|528565947|FG000|Overall Study|Non-compliance with Study Drug|2|||
146561201|NCT02546323|528565948|FG001|Overall Study|Non-compliance with Study Drug|2|||
146561202|NCT02546323|528565947|FG000|Overall Study|Met Withdrawal Criteria|2|||
146561203|NCT02546323|528565948|FG001|Overall Study|Met Withdrawal Criteria|14|||
146561204|NCT04476784|528565949|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
146561205|NCT04476784|528565950|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
146561206|NCT00478257|528565951|FG000|Overall Study|Withdrawal by Subject|8|||
146561207|NCT00478257|528565952|FG001|Overall Study|Withdrawal by Subject|3|||
146561208|NCT01055028|528565954|FG000|Screening|Screen Failure|1|||
146561209|NCT01055028|528565955|FG001|Screening|Screen Failure|1|||
146561210|NCT01055028|528565954|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
146561211|NCT01055028|528565955|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
146767606|NCT01087762|529317372|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
146767607|NCT01087762|529317368|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
146767608|NCT01087762|529317369|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
146767609|NCT01087762|529317370|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
146767610|NCT01087762|529317371|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
146561212|NCT01055028|528565954|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
146641012|NCT01395524|528862906|FG000|Overall Study|Adverse Event|4|||
146641013|NCT01395524|528862907|FG001|Overall Study|Adverse Event|4|||
146641014|NCT01395524|528862908|FG002|Overall Study|Adverse Event|3|||
146641015|NCT01395524|528862906|FG000|Overall Study|Death|1|||
146641016|NCT01395524|528862907|FG001|Overall Study|Death|0|||
146641017|NCT01395524|528862908|FG002|Overall Study|Death|0|||
146641018|NCT01395524|528862906|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
146641019|NCT01395524|528862907|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
146641020|NCT01395524|528862908|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
146641021|NCT01395524|528862906|FG000|Overall Study|Withdrawal by Subject|4|||
146641022|NCT01395524|528862907|FG001|Overall Study|Withdrawal by Subject|8|||
146641023|NCT01395524|528862908|FG002|Overall Study|Withdrawal by Subject|8|||
146641024|NCT01395524|528862906|FG000|Overall Study|Did not receive treatment|1|||
146641025|NCT01395524|528862907|FG001|Overall Study|Did not receive treatment|1|||
146641026|NCT01395524|528862908|FG002|Overall Study|Did not receive treatment|3|||
146641027|NCT01395524|528862906|FG000|Overall Study|Subject had spinal surgery|0|||
146641028|NCT01395524|528862907|FG001|Overall Study|Subject had spinal surgery|0|||
146641029|NCT01395524|528862908|FG002|Overall Study|Subject had spinal surgery|1|||
146641030|NCT01657461|528862909|FG000|Overall Study|Death|9|||
146905862|NCT02981472|529820331|FG001|Treatment Period|Adverse Event|1|||
146561213|NCT01055028|528565955|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
146641031|NCT01657461|528862910|FG001|Overall Study|Death|12|||
146641032|NCT01657461|528862909|FG000|Overall Study|Lost to Follow-up|0|||
146641033|NCT01657461|528862910|FG001|Overall Study|Lost to Follow-up|3|||
146641034|NCT01657461|528862909|FG000|Overall Study|Physician Decision|0|||
146641035|NCT01657461|528862910|FG001|Overall Study|Physician Decision|2|||
146641036|NCT01657461|528862909|FG000|Overall Study|Withdrawal by Subject|1|||
146561214|NCT01055028|528565954|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
146641037|NCT01657461|528862910|FG001|Overall Study|Withdrawal by Subject|3|||
146767611|NCT01087762|529317372|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
146767612|NCT01087762|529317368|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
146767613|NCT01087762|529317369|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
146767614|NCT01087762|529317370|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
146767615|NCT01087762|529317371|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
146767616|NCT01087762|529317372|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
146767617|NCT01087762|529317368|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
146767618|NCT01087762|529317369|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
146767619|NCT01087762|529317370|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
146767620|NCT01087762|529317371|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
146767621|NCT01087762|529317372|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
146767622|NCT01087762|529317368|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
146767623|NCT01087762|529317369|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
146767624|NCT01087762|529317370|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
146767625|NCT01087762|529317371|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
146767626|NCT01087762|529317372|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
146767627|NCT01087762|529317368|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
146767628|NCT01087762|529317369|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
146767629|NCT01087762|529317370|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
146767630|NCT01087762|529317371|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
146767631|NCT01087762|529317372|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
146767632|NCT01087762|529317368|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
146767633|NCT01087762|529317369|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
146767634|NCT01087762|529317370|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
146767635|NCT01087762|529317371|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
146767636|NCT01087762|529317372|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
146767637|NCT01087762|529317368|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
146767638|NCT01087762|529317369|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
146970136|NCT03506425|530050806|FG001|Overall Study|Adverse Event|3|||
146970137|NCT03506425|530050807|FG002|Overall Study|Adverse Event|0|||
146970138|NCT03506425|530050805|FG000|Overall Study|Death|1|||
146641038|NCT01868542|528862911|FG000|Overall Study|Protocol Violation|0|||
146641039|NCT01868542|528862912|FG001|Overall Study|Protocol Violation|1|||
146641040|NCT01868542|528862911|FG000|Overall Study|Unclassified|0|||
146641041|NCT01868542|528862912|FG001|Overall Study|Unclassified|1|||
146641042|NCT00130247|528862913|FG000|Overall Study|Pregnancy|1|||
146641043|NCT00130247|528862914|FG001|Overall Study|Pregnancy|0|||
146641044|NCT00130247|528862913|FG000|Overall Study|Post-randomization exclusion|1|||
146641045|NCT00130247|528862914|FG001|Overall Study|Post-randomization exclusion|2|||
146641046|NCT00130247|528862913|FG000|Overall Study|Not compliant with DOT|0|||
146641047|NCT00130247|528862914|FG001|Overall Study|Not compliant with DOT|2|||
146641048|NCT00843284|528862919|FG000|Overall Study|Adverse Event|39|||
146641049|NCT00843284|528862919|FG000|Overall Study|Lack of Efficacy|5|||
146641050|NCT00843284|528862919|FG000|Overall Study|Lost to Follow-up|11|||
146641051|NCT00843284|528862919|FG000|Overall Study|Other|10|||
146641052|NCT00843284|528862919|FG000|Overall Study|Withdrawal by Subject|4|||
146641053|NCT00843284|528862919|FG000|Overall Study|Death|3|||
146641054|NCT00122980|528862920|FG000|Overall Study|Death|0|||
146641055|NCT00122980|528862921|FG001|Overall Study|Death|1|||
146641056|NCT00122980|528862920|FG000|Overall Study|Physician Decision|2|||
146641057|NCT00122980|528862921|FG001|Overall Study|Physician Decision|0|||
146641058|NCT00122980|528862920|FG000|Overall Study|Protocol Violation|5|||
146641059|NCT00122980|528862921|FG001|Overall Study|Protocol Violation|1|||
146641060|NCT00122980|528862920|FG000|Overall Study|Withdrawal by Subject|2|||
146641061|NCT00122980|528862921|FG001|Overall Study|Withdrawal by Subject|3|||
146641062|NCT00122980|528862920|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
146905863|NCT02981472|529820330|FG000|Treatment Period|Participant withdrew consent|1|||
146905864|NCT02981472|529820331|FG001|Treatment Period|Participant withdrew consent|0|||
146905865|NCT02981472|529820330|FG000|Treatment Period|Lost to Follow-up|0|||
146905866|NCT02981472|529820331|FG001|Treatment Period|Lost to Follow-up|1|||
146905867|NCT03199911|529820341|FG000|Overall Study|Lost to Follow-up|5|||
146905868|NCT03199911|529820342|FG001|Overall Study|Lost to Follow-up|5|||
146905869|NCT03199911|529820341|FG000|Overall Study|Did not proceed with surgery|2|||
146641063|NCT00122980|528862921|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
146641064|NCT00122980|528862920|FG000|Overall Study|Study termination|27|||
146641065|NCT00122980|528862921|FG001|Overall Study|Study termination|35|||
146641066|NCT03844945|528862922|FG000|Overall Study|Adverse Event|1|||
146641067|NCT03844945|528862923|FG001|Overall Study|Adverse Event|1|||
146767639|NCT01087762|529317370|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
146641068|NCT03844945|528862924|FG002|Overall Study|Adverse Event|4|||
146641069|NCT03844945|528862925|FG003|Overall Study|Adverse Event|0|||
146641070|NCT03844945|528862922|FG000|Overall Study|Withdrawal by Subject|0|||
146905870|NCT03199911|529820342|FG001|Overall Study|Did not proceed with surgery|1|||
146905871|NCT05309668|529820344|FG000|Overall Study|Ongoing at data cut-off|14|||
146905872|NCT05309668|529820345|FG001|Overall Study|Ongoing at data cut-off|17|||
146905873|NCT05309668|529820346|FG002|Overall Study|Ongoing at data cut-off|4|||
146905874|NCT02465034|529820350|FG000|Overall Study|Withdrawal by Subject|1|||
146905875|NCT02465034|529820351|FG001|Overall Study|Withdrawal by Subject|1|||
146905876|NCT02465034|529820350|FG000|Overall Study|Screen fail|2|||
146905877|NCT02465034|529820351|FG001|Overall Study|Screen fail|0|||
146905878|NCT02465034|529820350|FG000|Overall Study|Could not be scheduled for study visit|0|||
146905879|NCT02465034|529820351|FG001|Overall Study|Could not be scheduled for study visit|5|||
146905880|NCT02401256|529820354|FG000|Overall Study|Adverse Event|5|||
146905881|NCT02401256|529820354|FG000|Overall Study|Withdrawal by Subject|12|||
146905882|NCT05408858|529820357|FG000|Overall Study|no longer met eligibility criteria|1|||
146905883|NCT01021007|529820366|FG000|Overall Study|Lost to Follow-up|1|||
146905884|NCT01021007|529820367|FG001|Overall Study|Lost to Follow-up|1|||
146905885|NCT01021007|529820366|FG000|Overall Study|Adverse Event|1|||
146905886|NCT01021007|529820367|FG001|Overall Study|Adverse Event|3|||
146905887|NCT03293030|529820372|FG000|Overall Study|Withdrawal by Subject|3|||
146905888|NCT04899271|529820373|FG000|Overall Study|Lost to Follow-up|1|||
146905889|NCT04899271|529820374|FG001|Overall Study|Lost to Follow-up|0|||
146905890|NCT04899271|529820373|FG000|Overall Study|Subject request/consent withdrawal|2|||
146905891|NCT04899271|529820374|FG001|Overall Study|Subject request/consent withdrawal|0|||
146905892|NCT01193335|529820377|FG000|After Infant Series|Lost to Follow-up|1|||
146905893|NCT01193335|529820378|FG001|After Infant Series|Lost to Follow-up|2|||
146905894|NCT01193335|529820377|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
146905895|NCT01193335|529820378|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
146905896|NCT01193335|529820377|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
146905897|NCT01193335|529820378|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
146905898|NCT01193335|529820377|FG000|1-Year Follow-up|Lost to Follow-up|4|||
146767640|NCT01087762|529317371|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
146767641|NCT01087762|529317372|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
146767642|NCT01087762|529317368|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
146767643|NCT01087762|529317369|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
146767644|NCT01087762|529317370|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
146767645|NCT01087762|529317371|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
146767646|NCT01087762|529317372|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
146767647|NCT01087762|529317368|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
146767648|NCT01087762|529317369|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
146767649|NCT01087762|529317370|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
146767650|NCT01087762|529317371|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
146767651|NCT01087762|529317372|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
146767652|NCT01087762|529317368|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
146767653|NCT01087762|529317369|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
146767654|NCT01087762|529317370|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
146767655|NCT01087762|529317371|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
146767656|NCT01087762|529317372|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
146767657|NCT01087762|529317368|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
146767658|NCT01087762|529317369|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
146767659|NCT01087762|529317370|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
146767660|NCT01087762|529317371|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
146767661|NCT01087762|529317372|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
146767662|NCT01405924|529317373|FG000|Overall Study|Protocol Violation|8|||
146767663|NCT01405924|529317373|FG000|Overall Study|Missing/Incomplete Data|2|||
146767664|NCT02506257|529317374|FG000|Overall Study|Adverse Event|0|||
146767665|NCT02506257|529317375|FG001|Overall Study|Adverse Event|2|||
146767666|NCT02506257|529317376|FG002|Overall Study|Adverse Event|3|||
146767667|NCT02506257|529317377|FG003|Overall Study|Adverse Event|0|||
146767668|NCT02506257|529317374|FG000|Overall Study|Protocol Violation|0|||
146767669|NCT02506257|529317375|FG001|Overall Study|Protocol Violation|0|||
146767670|NCT02506257|529317376|FG002|Overall Study|Protocol Violation|1|||
146767671|NCT02506257|529317377|FG003|Overall Study|Protocol Violation|0|||
146767672|NCT01924767|529317380|FG000|Overall Study|Adverse Event|1|||
146767673|NCT01924767|529317381|FG001|Overall Study|Adverse Event|0|||
146767674|NCT01924767|529317382|FG002|Overall Study|Adverse Event|1|||
146767675|NCT01924767|529317383|FG003|Overall Study|Adverse Event|0|||
146767676|NCT01924767|529317384|FG004|Overall Study|Adverse Event|0|||
146767677|NCT01193153|529317385|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
146905899|NCT01193335|529820378|FG001|1-Year Follow-up|Lost to Follow-up|0|||
146905900|NCT01193335|529820377|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
146905901|NCT01193335|529820378|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
146905902|NCT01193335|529820377|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
146905903|NCT01193335|529820378|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
146905904|NCT01733329|529820379|FG000|Overall Study|Protocol Violation|1|||
146905905|NCT01733329|529820380|FG001|Overall Study|Protocol Violation|1|||
146905906|NCT01733329|529820379|FG000|Overall Study|Uterine artery injury|1|||
146905907|NCT01733329|529820380|FG001|Overall Study|Uterine artery injury|0|||
146905908|NCT02388776|529820385|FG000|Overall Study|Death|1|||
146561215|NCT01055028|528565955|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
146561216|NCT06582732|528565956|FG000|Initial Study Period|Adverse Event|0|||
146561217|NCT06582732|528565957|FG001|Initial Study Period|Adverse Event|0|||
146561218|NCT06582732|528565958|FG002|Initial Study Period|Adverse Event|0|||
146561219|NCT06582732|528565959|FG003|Initial Study Period|Adverse Event|2|||
146561220|NCT06582732|528565960|FG004|Initial Study Period|Adverse Event|0|||
146905909|NCT02388776|529820385|FG000|Overall Study|Lost to Follow-up|1|||
146905910|NCT05490771|529820386|FG000|Overall Study|Disease progression|18|||
146905911|NCT05490771|529820386|FG000|Overall Study|Adverse Event|3|||
146905912|NCT05490771|529820386|FG000|Overall Study|Other complicating disease|1|||
146905913|NCT05490771|529820386|FG000|Overall Study|Withdrawal by Subject|3|||
146561221|NCT06582732|528565961|FG005|Initial Study Period|Adverse Event|0|||
146561222|NCT06582732|528565962|FG006|Initial Study Period|Adverse Event|0|||
146561223|NCT06582732|528565956|FG000|Initial Study Period|Death|1|||
146561224|NCT06582732|528565957|FG001|Initial Study Period|Death|0|||
146561225|NCT06582732|528565958|FG002|Initial Study Period|Death|0|||
146561226|NCT06582732|528565959|FG003|Initial Study Period|Death|0|||
146561227|NCT06582732|528565960|FG004|Initial Study Period|Death|1|||
146641071|NCT03844945|528862923|FG001|Overall Study|Withdrawal by Subject|0|||
146905914|NCT05490771|529820386|FG000|Overall Study|Physician Decision|1|||
146905915|NCT05490771|529820386|FG000|Overall Study|Still on treatment|2|||
146905916|NCT05490771|529820386|FG000|Overall Study|Never start protocol therapy|5|||
146905917|NCT05490771|529820386|FG000|Overall Study|Ineligible|2|||
146641072|NCT03844945|528862924|FG002|Overall Study|Withdrawal by Subject|1|||
146641073|NCT03844945|528862925|FG003|Overall Study|Withdrawal by Subject|0|||
146641074|NCT03844945|528862922|FG000|Overall Study|Lack of Efficacy|0|||
146641075|NCT03844945|528862923|FG001|Overall Study|Lack of Efficacy|0|||
146641076|NCT03844945|528862924|FG002|Overall Study|Lack of Efficacy|0|||
146641077|NCT03844945|528862925|FG003|Overall Study|Lack of Efficacy|1|||
146641078|NCT01139008|528862935|FG000|Overall Study|Withdrawal by Subject|5|||
146641079|NCT01139008|528862935|FG000|Overall Study|Non-compliant, lost product|1|||
146641080|NCT00545272|528862941|FG000|Overall Study|Protocol deviation|0|||
146641081|NCT00545272|528862942|FG001|Overall Study|Protocol deviation|1|||
146641082|NCT00545272|528862943|FG002|Overall Study|Protocol deviation|0|||
146641083|NCT00545272|528862944|FG003|Overall Study|Protocol deviation|1|||
146641084|NCT00545272|528862945|FG004|Overall Study|Protocol deviation|0|||
146641085|NCT00545272|528862946|FG005|Overall Study|Protocol deviation|1|||
146641086|NCT00545272|528862941|FG000|Overall Study|Adverse Event|0|||
146641087|NCT00545272|528862942|FG001|Overall Study|Adverse Event|0|||
146641088|NCT00545272|528862943|FG002|Overall Study|Adverse Event|1|||
146641089|NCT00545272|528862944|FG003|Overall Study|Adverse Event|0|||
146641090|NCT00545272|528862945|FG004|Overall Study|Adverse Event|0|||
146641091|NCT00545272|528862946|FG005|Overall Study|Adverse Event|1|||
146641092|NCT00545272|528862941|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146641093|NCT00545272|528862942|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146641094|NCT00545272|528862943|FG002|Overall Study|Abnormal laboratory value(s)|0|||
146641095|NCT00545272|528862944|FG003|Overall Study|Abnormal laboratory value(s)|0|||
146641096|NCT00545272|528862945|FG004|Overall Study|Abnormal laboratory value(s)|0|||
146641097|NCT00545272|528862946|FG005|Overall Study|Abnormal laboratory value(s)|1|||
146641098|NCT00545272|528862941|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146641099|NCT00545272|528862942|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146641100|NCT00545272|528862943|FG002|Overall Study|Abnormal test procedure result(s)|0|||
146641101|NCT00545272|528862944|FG003|Overall Study|Abnormal test procedure result(s)|0|||
146641102|NCT00545272|528862945|FG004|Overall Study|Abnormal test procedure result(s)|1|||
146641103|NCT00545272|528862946|FG005|Overall Study|Abnormal test procedure result(s)|0|||
146905918|NCT04246047|529820387|FG000|Overall Study|Death|50|||
146905919|NCT04246047|529820388|FG001|Overall Study|Death|77|||
146641104|NCT00545272|528862941|FG000|Overall Study|Lost to Follow-up|0|||
146641105|NCT00545272|528862942|FG001|Overall Study|Lost to Follow-up|0|||
146641106|NCT00545272|528862943|FG002|Overall Study|Lost to Follow-up|0|||
146641107|NCT00545272|528862944|FG003|Overall Study|Lost to Follow-up|0|||
146641108|NCT00545272|528862945|FG004|Overall Study|Lost to Follow-up|1|||
146641109|NCT00545272|528862946|FG005|Overall Study|Lost to Follow-up|0|||
146641110|NCT02934503|528862947|FG000|Overall Study|progression of disease|3|||
146641111|NCT02934503|528862947|FG000|Overall Study|Withdrawal by Subject|1|||
146767678|NCT01193153|529317386|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
146767679|NCT01193153|529317385|FG000|Open-label Lead in Period|Pregnancy|1|||
146767680|NCT01193153|529317386|FG001|Open-label Lead in Period|Pregnancy|0|||
146767681|NCT01193153|529317385|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
146767682|NCT01193153|529317386|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
146767683|NCT01193153|529317385|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
146767684|NCT01193153|529317386|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
146905920|NCT04246047|529820387|FG000|Overall Study|Lost to Follow-up|1|||
146905921|NCT04246047|529820388|FG001|Overall Study|Lost to Follow-up|3|||
146905922|NCT04246047|529820387|FG000|Overall Study|Physician Decision|4|||
146905923|NCT04246047|529820388|FG001|Overall Study|Physician Decision|10|||
146905924|NCT04246047|529820387|FG000|Overall Study|Withdrawal by Subject|19|||
146905925|NCT04246047|529820388|FG001|Overall Study|Withdrawal by Subject|26|||
146905926|NCT04246047|529820387|FG000|Overall Study|Ongoing|169|||
146561228|NCT06582732|528565961|FG005|Initial Study Period|Death|0|||
146905927|NCT04246047|529820388|FG001|Overall Study|Ongoing|135|||
146561229|NCT06582732|528565962|FG006|Initial Study Period|Death|0|||
146561230|NCT06582732|528565956|FG000|Initial Study Period|Lost to Follow-up|0|||
146905928|NCT01824602|529820390|FG000|Overall Study|Withdrawal by Subject|0|||
146561231|NCT06582732|528565957|FG001|Initial Study Period|Lost to Follow-up|0|||
146561232|NCT06582732|528565958|FG002|Initial Study Period|Lost to Follow-up|2|||
146970139|NCT03506425|530050806|FG001|Overall Study|Death|0|||
146561233|NCT06582732|528565959|FG003|Initial Study Period|Lost to Follow-up|0|||
146561234|NCT06582732|528565960|FG004|Initial Study Period|Lost to Follow-up|0|||
146561235|NCT06582732|528565961|FG005|Initial Study Period|Lost to Follow-up|0|||
146561236|NCT06582732|528565962|FG006|Initial Study Period|Lost to Follow-up|0|||
146561237|NCT06582732|528565956|FG000|Initial Study Period|Withdrawal by Subject|0|||
146561238|NCT06582732|528565957|FG001|Initial Study Period|Withdrawal by Subject|1|||
146561239|NCT06582732|528565958|FG002|Initial Study Period|Withdrawal by Subject|0|||
146970140|NCT03506425|530050807|FG002|Overall Study|Death|0|||
146970141|NCT03506425|530050805|FG000|Overall Study|Withdrawal by Subject|0|||
146970142|NCT03506425|530050806|FG001|Overall Study|Withdrawal by Subject|0|||
146970143|NCT03506425|530050807|FG002|Overall Study|Withdrawal by Subject|1|||
146970144|NCT02380248|530050810|FG000|Overall Study|Lost to Follow-up|11|||
146970145|NCT02380248|530050810|FG000|Overall Study|Withdrawal by Subject|3|||
146970146|NCT02392377|530050816|FG000|Overall Study|Withdrawal by Subject|0|||
146561240|NCT06582732|528565959|FG003|Initial Study Period|Withdrawal by Subject|1|||
146561241|NCT06582732|528565960|FG004|Initial Study Period|Withdrawal by Subject|3|||
146561242|NCT06582732|528565961|FG005|Initial Study Period|Withdrawal by Subject|1|||
146561243|NCT06582732|528565962|FG006|Initial Study Period|Withdrawal by Subject|2|||
146561244|NCT06582732|528565956|FG000|Initial Study Period|Moved Away|0|||
146561245|NCT06582732|528565957|FG001|Initial Study Period|Moved Away|0|||
146561246|NCT06582732|528565958|FG002|Initial Study Period|Moved Away|0|||
146561247|NCT06582732|528565959|FG003|Initial Study Period|Moved Away|0|||
146561248|NCT06582732|528565960|FG004|Initial Study Period|Moved Away|1|||
146561249|NCT06582732|528565961|FG005|Initial Study Period|Moved Away|0|||
146561250|NCT06582732|528565962|FG006|Initial Study Period|Moved Away|0|||
146561251|NCT01182350|528565963|FG000|Overall Study|Adverse Event|5|||
146561252|NCT01182350|528565964|FG001|Overall Study|Adverse Event|0|||
146561253|NCT01182350|528565965|FG002|Overall Study|Adverse Event|0|||
146561254|NCT01182350|528565966|FG003|Overall Study|Adverse Event|0|||
146561255|NCT01182350|528565967|FG004|Overall Study|Adverse Event|0|||
146561256|NCT01182350|528565963|FG000|Overall Study|Disease Progression|15|||
146561257|NCT01182350|528565964|FG001|Overall Study|Disease Progression|12|||
146561258|NCT01182350|528565965|FG002|Overall Study|Disease Progression|0|||
146561259|NCT01182350|528565966|FG003|Overall Study|Disease Progression|1|||
146561260|NCT01182350|528565967|FG004|Overall Study|Disease Progression|0|||
146561261|NCT01182350|528565963|FG000|Overall Study|Death|0|||
146561262|NCT01182350|528565964|FG001|Overall Study|Death|1|||
146561263|NCT01182350|528565965|FG002|Overall Study|Death|1|||
146561264|NCT01182350|528565966|FG003|Overall Study|Death|0|||
146561265|NCT01182350|528565967|FG004|Overall Study|Death|0|||
146561266|NCT01182350|528565963|FG000|Overall Study|Withdrawal by Subject|3|||
146561267|NCT01182350|528565964|FG001|Overall Study|Withdrawal by Subject|1|||
146561268|NCT01182350|528565965|FG002|Overall Study|Withdrawal by Subject|0|||
146561269|NCT01182350|528565966|FG003|Overall Study|Withdrawal by Subject|1|||
146561270|NCT01182350|528565967|FG004|Overall Study|Withdrawal by Subject|0|||
146561271|NCT01182350|528565963|FG000|Overall Study|Alternative Therapy|2|||
146561272|NCT01182350|528565964|FG001|Overall Study|Alternative Therapy|0|||
146561273|NCT01182350|528565965|FG002|Overall Study|Alternative Therapy|1|||
146561274|NCT01182350|528565966|FG003|Overall Study|Alternative Therapy|0|||
146561275|NCT01182350|528565967|FG004|Overall Study|Alternative Therapy|0|||
146561276|NCT01182350|528565963|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
146561277|NCT01182350|528565964|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
146561278|NCT01182350|528565965|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
146561279|NCT01182350|528565966|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
146561280|NCT01182350|528565967|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
146561281|NCT01182350|528565963|FG000|Overall Study|Unevaluable for Biopsy|0|||
146561282|NCT01182350|528565964|FG001|Overall Study|Unevaluable for Biopsy|0|||
146561283|NCT01182350|528565965|FG002|Overall Study|Unevaluable for Biopsy|0|||
146561284|NCT01182350|528565966|FG003|Overall Study|Unevaluable for Biopsy|0|||
146561285|NCT01182350|528565967|FG004|Overall Study|Unevaluable for Biopsy|3|||
146561286|NCT02919618|528565968|FG000|Overall Study|Death|1|||
146561287|NCT04770285|528565970|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
146561288|NCT04770285|528565971|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
146561289|NCT04770285|528565970|FG000|Overall Study|Lack of Efficacy|0|||
146561290|NCT04770285|528565971|FG001|Overall Study|Lack of Efficacy|1|||
146970147|NCT02392377|530050817|FG001|Overall Study|Withdrawal by Subject|1|||
146561291|NCT04770285|528565970|FG000|Overall Study|Lost to Follow-up|11|||
146561292|NCT04770285|528565971|FG001|Overall Study|Lost to Follow-up|8|||
146561293|NCT04770285|528565970|FG000|Overall Study|Protocol Deviation|6|||
146561294|NCT04770285|528565971|FG001|Overall Study|Protocol Deviation|6|||
146561295|NCT04770285|528565970|FG000|Overall Study|Technical Problem|0|||
146561296|NCT04770285|528565971|FG001|Overall Study|Technical Problem|1|||
146561297|NCT04770285|528565970|FG000|Overall Study|Withdrawal by Subject|9|||
146641112|NCT04248491|528862948|FG000|Overall Study|Lost to Follow-up|1|||
146561298|NCT04770285|528565971|FG001|Overall Study|Withdrawal by Subject|8|||
146561299|NCT04770285|528565970|FG000|Overall Study|Reason Not Specified|0|||
146561300|NCT04770285|528565971|FG001|Overall Study|Reason Not Specified|1|||
146561301|NCT03605693|528565972|FG000|Overall Study|Lost to Follow-up|4|||
146561302|NCT03605693|528565973|FG001|Overall Study|Lost to Follow-up|0|||
146561303|NCT03605693|528565972|FG000|Overall Study|Physician Decision|1|||
146561304|NCT03605693|528565973|FG001|Overall Study|Physician Decision|0|||
146561305|NCT03093415|528565974|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
146561306|NCT03093415|528565975|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
146561307|NCT03093415|528565976|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
146561308|NCT03093415|528565974|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
146561309|NCT03093415|528565975|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
146561310|NCT03093415|528565976|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
146561311|NCT03093415|528565974|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
146561312|NCT03093415|528565975|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
146561313|NCT03093415|528565976|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
146561314|NCT03093415|528565974|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
146561315|NCT03093415|528565975|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
146561316|NCT03093415|528565976|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
146561317|NCT03093415|528565974|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
146561318|NCT03093415|528565975|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
146561319|NCT03093415|528565976|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
146561320|NCT03093415|528565974|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
146561321|NCT03093415|528565975|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
146561322|NCT03093415|528565976|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
146561323|NCT03093415|528565974|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
146561324|NCT03093415|528565975|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
146561325|NCT03093415|528565976|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
146561326|NCT03093415|528565974|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
146561327|NCT03093415|528565975|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
146561328|NCT03093415|528565976|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
146561329|NCT03093415|528565974|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
146561330|NCT03093415|528565975|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
146561331|NCT03093415|528565976|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
146561332|NCT03093415|528565974|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
146561333|NCT03093415|528565975|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
146561334|NCT03093415|528565976|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
146561335|NCT03093415|528565974|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
146561336|NCT03093415|528565975|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
146561337|NCT03093415|528565976|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
146561338|NCT01646827|528565979|FG000|Overall Study|Lost to Follow-up|0|||
146561339|NCT01646827|528565980|FG001|Overall Study|Lost to Follow-up|3|||
146561340|NCT01646827|528565979|FG000|Overall Study|Physician Decision|1|||
146561341|NCT01646827|528565980|FG001|Overall Study|Physician Decision|2|||
146767685|NCT01193153|529317385|FG000|Open-label Lead in Period|Other|14|||
146767686|NCT01193153|529317386|FG001|Open-label Lead in Period|Other|0|||
146767687|NCT01193153|529317385|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
146905929|NCT01824602|529820391|FG001|Overall Study|Withdrawal by Subject|0|||
146905930|NCT01824602|529820392|FG002|Overall Study|Withdrawal by Subject|1|||
146905931|NCT01824602|529820393|FG003|Overall Study|Withdrawal by Subject|2|||
146561342|NCT01646827|528565979|FG000|Overall Study|Withdrawal by Subject|1|||
146561343|NCT01646827|528565980|FG001|Overall Study|Withdrawal by Subject|0|||
146561344|NCT01472185|528565985|FG000|Overall Study|Randomized but Not Treated|0|||
146561345|NCT01472185|528565986|FG001|Overall Study|Randomized but Not Treated|1|||
146561346|NCT01472185|528565985|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
146561347|NCT01472185|528565986|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
146905932|NCT01824602|529820390|FG000|Overall Study|Patient non-compliance|0|||
146905933|NCT01824602|529820391|FG001|Overall Study|Patient non-compliance|0|||
146905934|NCT01824602|529820392|FG002|Overall Study|Patient non-compliance|1|||
146905935|NCT01824602|529820393|FG003|Overall Study|Patient non-compliance|0|||
146905936|NCT01824602|529820390|FG000|Overall Study|Adverse Event|1|||
146905937|NCT01824602|529820391|FG001|Overall Study|Adverse Event|0|||
146905938|NCT01824602|529820392|FG002|Overall Study|Adverse Event|2|||
146905939|NCT01824602|529820393|FG003|Overall Study|Adverse Event|2|||
146905940|NCT01824602|529820390|FG000|Overall Study|Treatment failure|0|||
146905941|NCT01824602|529820391|FG001|Overall Study|Treatment failure|0|||
146905942|NCT01824602|529820392|FG002|Overall Study|Treatment failure|0|||
146905943|NCT01824602|529820393|FG003|Overall Study|Treatment failure|1|||
146561348|NCT01472185|528565985|FG000|Overall Study|Hyperglycemia|5|||
146561349|NCT01472185|528565986|FG001|Overall Study|Hyperglycemia|2|||
146561350|NCT01472185|528565985|FG000|Overall Study|Investigator's Discretion|3|||
146561351|NCT01472185|528565986|FG001|Overall Study|Investigator's Discretion|1|||
146561352|NCT01472185|528565985|FG000|Overall Study|Lost to Follow-up|4|||
146561353|NCT01472185|528565986|FG001|Overall Study|Lost to Follow-up|1|||
146561354|NCT01472185|528565985|FG000|Overall Study|Protocol Violation|5|||
146561355|NCT01472185|528565986|FG001|Overall Study|Protocol Violation|1|||
146561356|NCT01472185|528565985|FG000|Overall Study|Subject Noncompliance|8|||
146561357|NCT01472185|528565986|FG001|Overall Study|Subject Noncompliance|15|||
146905944|NCT02485717|529820396|FG000|Overall Study|Lost to Follow-up|6|||
146561358|NCT01472185|528565985|FG000|Overall Study|Subject Withdrew Consent|6|||
146561359|NCT01472185|528565986|FG001|Overall Study|Subject Withdrew Consent|3|||
146561360|NCT00815633|528565987|FG000|Overall Study|study terminated|1|||
146561361|NCT02038647|528565988|FG000|Overall Study|Progressive Disease|50|||
146561362|NCT02038647|528565989|FG001|Overall Study|Progressive Disease|59|||
146561363|NCT02038647|528565988|FG000|Overall Study|Adverse Event|18|||
146561364|NCT02038647|528565989|FG001|Overall Study|Adverse Event|10|||
146561365|NCT02038647|528565988|FG000|Overall Study|Symptomatic Deterioration|7|||
146561366|NCT02038647|528565989|FG001|Overall Study|Symptomatic Deterioration|7|||
146561367|NCT02038647|528565988|FG000|Overall Study|Withdrawal by Subject|5|||
146561368|NCT02038647|528565989|FG001|Overall Study|Withdrawal by Subject|2|||
146561369|NCT02038647|528565988|FG000|Overall Study|Not Reported|0|||
146561370|NCT02038647|528565989|FG001|Overall Study|Not Reported|1|||
146561371|NCT02038647|528565988|FG000|Overall Study|Ongoing at Datacut|9|||
146561372|NCT02038647|528565989|FG001|Overall Study|Ongoing at Datacut|10|||
146561373|NCT03078868|528565990|FG000|Overall Study|Physician Decision|3|||
146561374|NCT04380142|528565993|FG000|LD/CD Stabilization Period|Adverse Event|3|||
146561375|NCT04380142|528565994|FG001|LD/CD Stabilization Period|Adverse Event|0|||
146561376|NCT04380142|528565995|FG002|LD/CD Stabilization Period|Adverse Event|0|||
146561377|NCT04380142|528565993|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
146561378|NCT04380142|528565994|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
146905945|NCT02485717|529820397|FG001|Overall Study|Lost to Follow-up|0|||
146905946|NCT02485717|529820398|FG002|Overall Study|Lost to Follow-up|0|||
146905947|NCT02485717|529820396|FG000|Overall Study|Withdrawal by Subject|0|||
146905948|NCT02485717|529820397|FG001|Overall Study|Withdrawal by Subject|0|||
146905949|NCT02485717|529820398|FG002|Overall Study|Withdrawal by Subject|1|||
146561379|NCT04380142|528565995|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
146561380|NCT04380142|528565993|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
146561381|NCT04380142|528565994|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
146561382|NCT04380142|528565995|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
146561383|NCT04380142|528565993|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
146561384|NCT04380142|528565994|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
146641113|NCT04248491|528862949|FG001|Overall Study|Lost to Follow-up|0|||
146905950|NCT02485717|529820396|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
146905951|NCT02485717|529820397|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
146905952|NCT02485717|529820398|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
146905953|NCT02485717|529820396|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
146905954|NCT02485717|529820397|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
146905955|NCT02485717|529820398|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
146905956|NCT02192359|529820401|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
146905957|NCT02192359|529820402|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
146905958|NCT02192359|529820403|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
146905959|NCT02192359|529820404|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
146905960|NCT02192359|529820401|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
146905961|NCT02192359|529820402|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
146905962|NCT02192359|529820403|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
146905963|NCT02192359|529820404|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
146905964|NCT02192359|529820401|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
146905965|NCT02192359|529820402|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
146905966|NCT02192359|529820403|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
146905967|NCT02192359|529820404|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
146905968|NCT01450540|529820405|FG000|Overall Study|Withdrawal by Subject|19|||
146905969|NCT01450540|529820406|FG001|Overall Study|Withdrawal by Subject|13|||
146905970|NCT01450540|529820405|FG000|Overall Study|protocol deviation|3|||
146905971|NCT01450540|529820406|FG001|Overall Study|protocol deviation|23|||
146905972|NCT01687673|529820418|FG000|Overall Study|Physician Decision|1|||
146905973|NCT02234622|529820419|FG000|Overall Study|Withdrawal by Subject|16|||
146905974|NCT02234622|529820420|FG001|Overall Study|Withdrawal by Subject|22|||
146905975|NCT02234622|529820419|FG000|Overall Study|Lost to Follow-up|27|||
146905976|NCT02234622|529820420|FG001|Overall Study|Lost to Follow-up|14|||
146905977|NCT03598777|529820421|FG000|Overall Study|Study Terminated by Sponsor|3|||
146905978|NCT03598777|529820422|FG001|Overall Study|Study Terminated by Sponsor|0|||
146905979|NCT03598777|529820423|FG002|Overall Study|Study Terminated by Sponsor|0|||
146905980|NCT03598777|529820424|FG003|Overall Study|Study Terminated by Sponsor|0|||
146905981|NCT03598777|529820425|FG004|Overall Study|Study Terminated by Sponsor|15|||
146905982|NCT03598777|529820421|FG000|Overall Study|Withdrawal by Subject|1|||
146905983|NCT03598777|529820422|FG001|Overall Study|Withdrawal by Subject|1|||
146905984|NCT03598777|529820423|FG002|Overall Study|Withdrawal by Subject|0|||
146905985|NCT03598777|529820424|FG003|Overall Study|Withdrawal by Subject|0|||
146905986|NCT03598777|529820425|FG004|Overall Study|Withdrawal by Subject|0|||
146905987|NCT03598777|529820421|FG000|Overall Study|Adverse Event|1|||
146905988|NCT03598777|529820422|FG001|Overall Study|Adverse Event|0|||
146905989|NCT03598777|529820423|FG002|Overall Study|Adverse Event|0|||
146905990|NCT03598777|529820424|FG003|Overall Study|Adverse Event|0|||
146905991|NCT03598777|529820425|FG004|Overall Study|Adverse Event|0|||
146905992|NCT03598777|529820421|FG000|Overall Study|Lost to Follow-up|1|||
146905993|NCT03598777|529820422|FG001|Overall Study|Lost to Follow-up|0|||
146905994|NCT03598777|529820423|FG002|Overall Study|Lost to Follow-up|0|||
146905995|NCT03598777|529820424|FG003|Overall Study|Lost to Follow-up|0|||
146905996|NCT03598777|529820425|FG004|Overall Study|Lost to Follow-up|0|||
146905997|NCT02006576|529820426|FG000|Overall Study|Withdrawal by Subject|4|||
146905998|NCT02006576|529820427|FG001|Overall Study|Withdrawal by Subject|6|||
146905999|NCT02006576|529820428|FG002|Overall Study|Withdrawal by Subject|2|||
146906000|NCT02006576|529820426|FG000|Overall Study|Death|0|||
146906001|NCT02006576|529820427|FG001|Overall Study|Death|0|||
146906002|NCT02006576|529820428|FG002|Overall Study|Death|1|||
146906003|NCT02006576|529820426|FG000|Overall Study|Lost to Follow-up|1|||
146906004|NCT02006576|529820427|FG001|Overall Study|Lost to Follow-up|0|||
146906005|NCT02006576|529820428|FG002|Overall Study|Lost to Follow-up|1|||
146906006|NCT02006576|529820426|FG000|Overall Study|Screen Failure, too sick, other|13|||
146906007|NCT02006576|529820427|FG001|Overall Study|Screen Failure, too sick, other|1|||
146906008|NCT02006576|529820428|FG002|Overall Study|Screen Failure, too sick, other|13|||
146906009|NCT00785577|529820429|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
146906010|NCT00785577|529820430|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
146906011|NCT00785577|529820431|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
146906012|NCT00785577|529820432|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
146906013|NCT00785577|529820433|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
146906014|NCT00785577|529820429|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
146561385|NCT04380142|528565995|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
146561386|NCT04380142|528565993|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
146561387|NCT04380142|528565994|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
146906015|NCT00785577|529820430|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
146970148|NCT01126359|530050820|FG000|First Intervention (20-minutes)|Physician Decision|0|||
146561388|NCT04380142|528565995|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
146906016|NCT00785577|529820431|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
146906017|NCT00785577|529820432|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
146906018|NCT00785577|529820433|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
146906019|NCT00785577|529820429|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
146906020|NCT00785577|529820430|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
146906021|NCT00785577|529820431|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
146906022|NCT00785577|529820432|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
146906023|NCT00785577|529820433|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
146906024|NCT00785577|529820429|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
146906025|NCT00785577|529820430|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
146906026|NCT00785577|529820431|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
146906027|NCT00785577|529820432|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
146906028|NCT00785577|529820433|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
146906029|NCT00785577|529820429|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
146906030|NCT00785577|529820430|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
146906031|NCT00785577|529820431|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
146906032|NCT00785577|529820432|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
146906033|NCT00785577|529820433|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
146906034|NCT00785577|529820429|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
146906035|NCT00785577|529820430|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
146906036|NCT00785577|529820431|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
146906037|NCT00785577|529820432|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
146906038|NCT00785577|529820433|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
146906039|NCT00785577|529820429|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
146906040|NCT00785577|529820430|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
146906041|NCT00785577|529820431|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
146906042|NCT00785577|529820432|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
146906043|NCT00785577|529820433|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
146906044|NCT00785577|529820429|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
146906045|NCT00785577|529820430|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
146906046|NCT00785577|529820431|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
146561389|NCT04380142|528565993|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
146561390|NCT04380142|528565994|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
146561391|NCT04380142|528565995|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
146561392|NCT04380142|528565993|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146561393|NCT04380142|528565994|FG001|Double-Blind Treatment Period|Adverse Event|1|||
146561394|NCT04380142|528565995|FG002|Double-Blind Treatment Period|Adverse Event|14|||
146561395|NCT04380142|528565993|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
146561396|NCT04380142|528565994|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
146561397|NCT04380142|528565995|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
146561398|NCT04380142|528565993|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
146561399|NCT04380142|528565994|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
146561400|NCT04380142|528565995|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
146561401|NCT04380142|528565993|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
146561402|NCT04380142|528565994|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
146561403|NCT04380142|528565995|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
146561404|NCT04380142|528565993|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
146561405|NCT04380142|528565994|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
146561406|NCT04380142|528565995|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
146561407|NCT04380142|528565993|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
146561408|NCT04380142|528565994|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
146561409|NCT04380142|528565995|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
146561410|NCT04347538|528565996|FG000|Overall Study|Lost to Follow-up|4|||
146561411|NCT04347538|528565997|FG001|Overall Study|Lost to Follow-up|5|||
146561412|NCT04347538|528565998|FG002|Overall Study|Lost to Follow-up|7|||
146561413|NCT02259231|528565999|FG000|Overall Study|Adverse Event|1|||
146561414|NCT02259231|528566000|FG001|Overall Study|Adverse Event|1|||
146561415|NCT02259231|528566001|FG002|Overall Study|Adverse Event|2|||
146561416|NCT02259231|528566002|FG003|Overall Study|Adverse Event|0|||
146641114|NCT01311024|528862952|FG000|Overall Study|Protocol Violation|35|||
146641115|NCT01311024|528862953|FG001|Overall Study|Protocol Violation|22|||
146906047|NCT00785577|529820432|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
146906048|NCT00785577|529820433|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
146906049|NCT00785577|529820429|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
146906050|NCT00785577|529820430|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
146906051|NCT00785577|529820431|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
146561417|NCT02259231|528566003|FG004|Overall Study|Adverse Event|0|||
146561418|NCT02259231|528566004|FG005|Overall Study|Adverse Event|0|||
146561419|NCT02259231|528566005|FG006|Overall Study|Adverse Event|0|||
146641116|NCT01652469|528862954|FG000|Overall Study|Withdrawal by Subject|1|||
146906052|NCT00785577|529820432|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
146906053|NCT00785577|529820433|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
146906054|NCT00785577|529820429|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
146906055|NCT00785577|529820430|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
146906056|NCT00785577|529820431|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
146906057|NCT00785577|529820432|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
146906058|NCT00785577|529820433|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
146906059|NCT01650805|529820434|FG000|Overall Study|Withdrawal by Subject|1|||
146906060|NCT01650805|529820435|FG001|Overall Study|Withdrawal by Subject|0|||
146906061|NCT02452359|529820438|FG000|Overall Study|Adverse Event|1|||
146906062|NCT02452359|529820438|FG000|Overall Study|Lost to Follow-up|15|||
146906063|NCT02452359|529820438|FG000|Overall Study|Pregnancy|1|||
146906064|NCT02452359|529820438|FG000|Overall Study|Withdrawal by Subject|4|||
146906065|NCT01887210|529820439|FG000|Overall Study|Withdrawal by Subject|1|||
146906066|NCT01887210|529820440|FG001|Overall Study|Withdrawal by Subject|3|||
146906067|NCT01887210|529820439|FG000|Overall Study|Lost to Follow-up|0|||
146906068|NCT01887210|529820440|FG001|Overall Study|Lost to Follow-up|1|||
146906069|NCT02515669|529820445|FG000|228 Week Open-Label Phase|Other|0|||
146906070|NCT02515669|529820446|FG001|228 Week Open-Label Phase|Other|0|||
146906071|NCT02515669|529820447|FG002|228 Week Open-Label Phase|Other|1|||
146906072|NCT02515669|529820448|FG003|228 Week Open-Label Phase|Other|4|||
146906073|NCT02515669|529820445|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
146906074|NCT02515669|529820446|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
146906075|NCT02515669|529820447|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
146906076|NCT02515669|529820448|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
146641117|NCT01652469|528862955|FG001|Overall Study|Withdrawal by Subject|4|||
146641118|NCT01652469|528862954|FG000|Overall Study|Lost to Follow-up|0|||
146641119|NCT01652469|528862955|FG001|Overall Study|Lost to Follow-up|2|||
146641120|NCT02834793|528862956|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
146641121|NCT02834793|528862957|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
146641122|NCT02834793|528862958|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
146641123|NCT02834793|528862959|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
146641124|NCT02834793|528862956|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
146641125|NCT02834793|528862957|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
146641126|NCT02834793|528862958|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
146641127|NCT02834793|528862959|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
146641128|NCT02834793|528862956|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
146641129|NCT02834793|528862957|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
146641130|NCT02834793|528862958|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
146641131|NCT02834793|528862959|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
146641132|NCT02834793|528862956|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
146641133|NCT02834793|528862957|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
146641134|NCT02834793|528862958|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
146641135|NCT02834793|528862959|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
146641136|NCT02834793|528862956|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
146641137|NCT02834793|528862957|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
146641138|NCT02834793|528862958|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
146906077|NCT02515669|529820445|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
146906078|NCT02515669|529820446|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
146906079|NCT02515669|529820447|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
146641139|NCT02834793|528862959|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
146641140|NCT02834793|528862956|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
146641141|NCT02834793|528862957|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
146906080|NCT02515669|529820448|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
146906081|NCT02515669|529820445|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
146906082|NCT02515669|529820446|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
146906083|NCT02515669|529820447|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
146906084|NCT02515669|529820448|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
146906085|NCT02515669|529820445|FG000|228 Week Open-Label Phase|Missing|0|||
146906086|NCT02515669|529820446|FG001|228 Week Open-Label Phase|Missing|2|||
146906087|NCT02515669|529820447|FG002|228 Week Open-Label Phase|Missing|2|||
146906088|NCT02515669|529820448|FG003|228 Week Open-Label Phase|Missing|2|||
146906089|NCT05738486|529821986|FG000|Overall Study|Continuing Study|194|||
146906090|NCT05738486|529821987|FG001|Overall Study|Continuing Study|196|||
146906091|NCT05738486|529821988|FG002|Overall Study|Continuing Study|193|||
146906092|NCT05738486|529821989|FG003|Overall Study|Continuing Study|191|||
146906093|NCT05738486|529821986|FG000|Overall Study|Withdrawal by Subject|8|||
146906094|NCT05738486|529821987|FG001|Overall Study|Withdrawal by Subject|5|||
146906095|NCT05738486|529821988|FG002|Overall Study|Withdrawal by Subject|7|||
146906096|NCT05738486|529821989|FG003|Overall Study|Withdrawal by Subject|13|||
146906097|NCT05738486|529821986|FG000|Overall Study|Adverse Event|4|||
146906098|NCT05738486|529821987|FG001|Overall Study|Adverse Event|6|||
146906099|NCT05738486|529821988|FG002|Overall Study|Adverse Event|4|||
146906100|NCT05738486|529821989|FG003|Overall Study|Adverse Event|5|||
146906101|NCT05738486|529821986|FG000|Overall Study|Physician Decision|0|||
146906102|NCT05738486|529821987|FG001|Overall Study|Physician Decision|2|||
146906103|NCT05738486|529821988|FG002|Overall Study|Physician Decision|4|||
146906104|NCT05738486|529821989|FG003|Overall Study|Physician Decision|1|||
146906105|NCT05738486|529821986|FG000|Overall Study|Lost to Follow-up|1|||
146906106|NCT05738486|529821987|FG001|Overall Study|Lost to Follow-up|1|||
146906107|NCT05738486|529821988|FG002|Overall Study|Lost to Follow-up|2|||
146906108|NCT05738486|529821989|FG003|Overall Study|Lost to Follow-up|1|||
146906109|NCT05738486|529821986|FG000|Overall Study|Participant was Non-ambulatory|0|||
146906110|NCT05738486|529821987|FG001|Overall Study|Participant was Non-ambulatory|0|||
146906111|NCT05738486|529821988|FG002|Overall Study|Participant was Non-ambulatory|1|||
146906112|NCT05738486|529821989|FG003|Overall Study|Participant was Non-ambulatory|0|||
146906113|NCT05738486|529821986|FG000|Overall Study|Participant had Poor Venous Access|0|||
146906114|NCT05738486|529821987|FG001|Overall Study|Participant had Poor Venous Access|0|||
146906115|NCT05738486|529821988|FG002|Overall Study|Participant had Poor Venous Access|0|||
146906116|NCT05738486|529821989|FG003|Overall Study|Participant had Poor Venous Access|1|||
146906117|NCT05738486|529821986|FG000|Overall Study|Assigned Treatment by Mistake|0|||
146906118|NCT05738486|529821987|FG001|Overall Study|Assigned Treatment by Mistake|0|||
146906119|NCT05738486|529821988|FG002|Overall Study|Assigned Treatment by Mistake|0|||
146906120|NCT05738486|529821989|FG003|Overall Study|Assigned Treatment by Mistake|1|||
146906121|NCT05738486|529821986|FG000|Overall Study|Death|0|||
146906122|NCT05738486|529821987|FG001|Overall Study|Death|0|||
146906123|NCT05738486|529821988|FG002|Overall Study|Death|1|||
146561420|NCT02259231|528565999|FG000|Overall Study|Progressive Disease|4|||
146561421|NCT02259231|528566000|FG001|Overall Study|Progressive Disease|5|||
146561422|NCT02259231|528566001|FG002|Overall Study|Progressive Disease|4|||
146561423|NCT02259231|528566002|FG003|Overall Study|Progressive Disease|5|||
146561424|NCT02259231|528566003|FG004|Overall Study|Progressive Disease|4|||
146561425|NCT02259231|528566004|FG005|Overall Study|Progressive Disease|5|||
146561426|NCT02259231|528566005|FG006|Overall Study|Progressive Disease|4|||
146561427|NCT02259231|528565999|FG000|Overall Study|Sponsor termination of study|1|||
146561428|NCT02259231|528566000|FG001|Overall Study|Sponsor termination of study|0|||
146561429|NCT02259231|528566001|FG002|Overall Study|Sponsor termination of study|0|||
146561430|NCT02259231|528566002|FG003|Overall Study|Sponsor termination of study|1|||
146561431|NCT02259231|528566003|FG004|Overall Study|Sponsor termination of study|2|||
146561432|NCT02259231|528566004|FG005|Overall Study|Sponsor termination of study|1|||
146561433|NCT02259231|528566005|FG006|Overall Study|Sponsor termination of study|1|||
146561434|NCT04562090|528566006|FG000|Overall Study|Withdrawal by Subject|3|||
146561435|NCT04562090|528566007|FG001|Overall Study|Withdrawal by Subject|4|||
146561436|NCT04562090|528566006|FG000|Overall Study|Protocol Violation|2|||
146561437|NCT04562090|528566007|FG001|Overall Study|Protocol Violation|0|||
146561438|NCT04562090|528566006|FG000|Overall Study|Lack of Efficacy|0|||
146561439|NCT04562090|528566007|FG001|Overall Study|Lack of Efficacy|1|||
146561440|NCT04562090|528566006|FG000|Overall Study|Adverse Event|1|||
146561441|NCT04562090|528566007|FG001|Overall Study|Adverse Event|4|||
146561442|NCT04562090|528566006|FG000|Overall Study|Miscellaneous|0|||
146561443|NCT04562090|528566007|FG001|Overall Study|Miscellaneous|3|||
146561444|NCT04938427|528566008|FG000|Overall Study|Adverse Event|5|||
146561445|NCT04938427|528566009|FG001|Overall Study|Adverse Event|19|||
146561446|NCT04938427|528566008|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
146561447|NCT04938427|528566009|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146561448|NCT04938427|528566008|FG000|Overall Study|Withdrawal by Subject|1|||
146561449|NCT04938427|528566009|FG001|Overall Study|Withdrawal by Subject|0|||
146561450|NCT04938427|528566008|FG000|Overall Study|Reason Not Specified|2|||
146641142|NCT02834793|528862958|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
146906124|NCT05738486|529821989|FG003|Overall Study|Death|0|||
146561451|NCT04938427|528566009|FG001|Overall Study|Reason Not Specified|1|||
146641143|NCT02834793|528862959|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
146641144|NCT02834793|528862956|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
146561452|NCT03633058|528566018|FG000|Overall Study|Adverse Event|0|||
146561453|NCT03633058|528566019|FG001|Overall Study|Adverse Event|0|||
146561454|NCT03633058|528566020|FG002|Overall Study|Adverse Event|1|||
146561455|NCT03633058|528566021|FG003|Overall Study|Adverse Event|0|||
146641145|NCT02834793|528862957|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
146641146|NCT02834793|528862958|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
146641147|NCT02834793|528862959|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
146641148|NCT02834793|528862956|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
146641149|NCT02834793|528862957|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
146641150|NCT02834793|528862958|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
146641151|NCT02834793|528862959|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
146641152|NCT02834793|528862956|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
146641153|NCT02834793|528862957|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
146641154|NCT02834793|528862958|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
146970149|NCT01126359|530050821|FG001|First Intervention (20-minutes)|Physician Decision|1|||
146970150|NCT00902486|530050822|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
146641155|NCT02834793|528862959|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
146641156|NCT02834793|528862956|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
146641157|NCT02834793|528862957|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
146641158|NCT02834793|528862958|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
146641159|NCT02834793|528862959|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
146970151|NCT00902486|530050823|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
146906125|NCT05738486|529821986|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
146906126|NCT05738486|529821987|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
146906127|NCT05738486|529821988|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
146906128|NCT05738486|529821989|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
146906129|NCT03113500|529821990|FG000|Overall Study|Withdrawal by Subject|1|||
146906130|NCT02517515|529821993|FG000|Overall Study|Adverse Event|0|||
146906131|NCT02517515|529821994|FG001|Overall Study|Adverse Event|1|||
146906132|NCT02517515|529821993|FG000|Overall Study|Withdrew Consent|0|||
146906133|NCT02517515|529821994|FG001|Overall Study|Withdrew Consent|1|||
146906134|NCT02517515|529821993|FG000|Overall Study|Lost to Follow-up|1|||
146906135|NCT02517515|529821994|FG001|Overall Study|Lost to Follow-up|0|||
146906136|NCT02517515|529821993|FG000|Overall Study|Other|1|||
146906137|NCT02517515|529821994|FG001|Overall Study|Other|0|||
146906138|NCT06400238|529821997|FG000|Overall Study|Started Protocol Therapy|2|||
146906139|NCT06400238|529821997|FG000|Overall Study|Adverse Event|1|||
146906140|NCT06400238|529821997|FG000|Overall Study|Death|1|||
146906141|NCT06400238|529821997|FG000|Overall Study|Disease Progression|27|||
146906142|NCT06400238|529821997|FG000|Overall Study|Withdrawal by Subject|2|||
146906143|NCT06400238|529821997|FG000|Overall Study|Physician Decision|2|||
146906144|NCT01981187|529822002|FG000|Overall Study|Participant/guardian decision|2|||
146906145|NCT01981187|529822002|FG000|Overall Study|Physician Decision|1|||
146906146|NCT01981187|529822002|FG000|Overall Study|Disease progression|2|||
146906147|NCT01981187|529822002|FG000|Overall Study|Adverse Event|7|||
146561456|NCT03312543|528566024|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
146561457|NCT03312543|528566025|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
146561458|NCT03312543|528566024|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
146561459|NCT03312543|528566025|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
146561460|NCT03312543|528566024|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
146561461|NCT03312543|528566025|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
146561462|NCT03312543|528566024|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
146561463|NCT03312543|528566025|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
146561464|NCT03312543|528566024|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
146561465|NCT03312543|528566025|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
146561466|NCT03312543|528566024|FG000|Regression (Week 12 to Week 24)|Death|0|||
146561467|NCT03312543|528566025|FG001|Regression (Week 12 to Week 24)|Death|1|||
146561468|NCT04507269|528566026|FG000|Overall Study|Withdrawal by Subject|1|||
146561469|NCT04507269|528566027|FG001|Overall Study|Withdrawal by Subject|1|||
146561470|NCT04507269|528566028|FG002|Overall Study|Withdrawal by Subject|0|||
146561471|NCT04507269|528566029|FG003|Overall Study|Withdrawal by Subject|0|||
146561472|NCT04507269|528566030|FG004|Overall Study|Withdrawal by Subject|0|||
146561473|NCT04507269|528566031|FG005|Overall Study|Withdrawal by Subject|0|||
146561474|NCT04507269|528566026|FG000|Overall Study|Lost to Follow-up|0|||
146561475|NCT04507269|528566027|FG001|Overall Study|Lost to Follow-up|0|||
146561476|NCT04507269|528566028|FG002|Overall Study|Lost to Follow-up|0|||
146561477|NCT04507269|528566029|FG003|Overall Study|Lost to Follow-up|0|||
146561478|NCT04507269|528566030|FG004|Overall Study|Lost to Follow-up|1|||
146561479|NCT04507269|528566031|FG005|Overall Study|Lost to Follow-up|0|||
146561480|NCT05852340|528566032|FG000|Period 5|Not completing the meal|0|||
146561481|NCT05852340|528566033|FG001|Period 5|Not completing the meal|1|||
146561482|NCT05852340|528566034|FG002|Period 5|Not completing the meal|0|||
146561483|NCT05852340|528566035|FG003|Period 5|Not completing the meal|0|||
146561484|NCT05852340|528566032|FG000|Period 5|Adverse Event|0|||
146561485|NCT05852340|528566033|FG001|Period 5|Adverse Event|0|||
146561486|NCT05852340|528566034|FG002|Period 5|Adverse Event|0|||
146561487|NCT05852340|528566035|FG003|Period 5|Adverse Event|1|||
146561488|NCT01722669|528566038|FG000|Overall Study|Withdrawal by Subject|0|||
146561489|NCT01722669|528566039|FG001|Overall Study|Withdrawal by Subject|0|||
146561490|NCT01722669|528566040|FG002|Overall Study|Withdrawal by Subject|0|||
146561491|NCT01722669|528566041|FG003|Overall Study|Withdrawal by Subject|0|||
146561492|NCT01722669|528566042|FG004|Overall Study|Withdrawal by Subject|0|||
146561493|NCT01722669|528566043|FG005|Overall Study|Withdrawal by Subject|2|||
146561494|NCT02420717|528566044|FG000|Overall Study|Did not receive all study medication|2|||
146561495|NCT02420717|528566045|FG001|Overall Study|Did not receive all study medication|0|||
146561496|NCT02420717|528566046|FG002|Overall Study|Did not receive all study medication|0|||
146906148|NCT01362322|529822003|FG000|Overall Study|Withdrawal by Subject|3|||
146906149|NCT01362322|529822004|FG001|Overall Study|Withdrawal by Subject|1|||
146906150|NCT01362322|529822003|FG000|Overall Study|Lost to Follow-up|2|||
146561497|NCT04116489|528566047|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
146561498|NCT04116489|528566047|FG000|Overall Study|Withdrawal by Subject|1|||
146561499|NCT03781570|528566048|FG000|Overall Study|Technical Issues (equipment failure)|31|||
146561500|NCT03781570|528566048|FG000|Overall Study|Withdrawal by Subject|7|||
146906151|NCT01362322|529822004|FG001|Overall Study|Lost to Follow-up|6|||
146906152|NCT01009463|529822005|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
146906153|NCT01009463|529822006|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
146906154|NCT01009463|529822007|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
146906155|NCT01009463|529822008|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
146906156|NCT01009463|529822009|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
146641160|NCT02834793|528862956|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
146906157|NCT01009463|529822005|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
146906158|NCT01009463|529822006|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
146561501|NCT03781570|528566048|FG000|Overall Study|Physical Constraints|11|||
146561502|NCT01107496|528566049|FG000|Overall Study|Adverse Event|1|||
146561503|NCT01107496|528566050|FG001|Overall Study|Adverse Event|0|||
146561504|NCT01107496|528566049|FG000|Overall Study|Lack of Efficacy|1|||
146561505|NCT01107496|528566050|FG001|Overall Study|Lack of Efficacy|0|||
146561506|NCT01107496|528566049|FG000|Overall Study|Protocol Violation|0|||
146561507|NCT01107496|528566050|FG001|Overall Study|Protocol Violation|1|||
146561508|NCT01107496|528566049|FG000|Overall Study|Lost to Follow-up|0|||
146561509|NCT01107496|528566050|FG001|Overall Study|Lost to Follow-up|1|||
146561510|NCT01346592|528566051|FG000|Overall Study|Lost to Follow-up|62|||
146561511|NCT01346592|528566052|FG001|Overall Study|Lost to Follow-up|29|||
146561512|NCT01346592|528566053|FG002|Overall Study|Lost to Follow-up|29|||
146561513|NCT01346592|528566051|FG000|Overall Study|Protocol Violation|2|||
146561514|NCT01346592|528566052|FG001|Overall Study|Protocol Violation|1|||
146561515|NCT01346592|528566053|FG002|Overall Study|Protocol Violation|0|||
146561516|NCT01346592|528566051|FG000|Overall Study|Death|1|||
146561517|NCT01346592|528566052|FG001|Overall Study|Death|3|||
146561518|NCT01346592|528566053|FG002|Overall Study|Death|4|||
146561519|NCT01346592|528566051|FG000|Overall Study|Adverse Event|0|||
146561520|NCT01346592|528566052|FG001|Overall Study|Adverse Event|1|||
146561521|NCT01346592|528566053|FG002|Overall Study|Adverse Event|0|||
146561522|NCT01346592|528566051|FG000|Overall Study|Withdrawal by Subject|77|||
146561523|NCT01346592|528566052|FG001|Overall Study|Withdrawal by Subject|51|||
146561524|NCT01346592|528566053|FG002|Overall Study|Withdrawal by Subject|38|||
146561525|NCT01346592|528566051|FG000|Overall Study|Inappropriate enrollment|3|||
146561526|NCT01346592|528566052|FG001|Overall Study|Inappropriate enrollment|1|||
146561527|NCT01346592|528566053|FG002|Overall Study|Inappropriate enrollment|1|||
146561528|NCT01346592|528566051|FG000|Overall Study|Administrative reason|1|||
146561529|NCT01346592|528566052|FG001|Overall Study|Administrative reason|0|||
146561530|NCT01346592|528566053|FG002|Overall Study|Administrative reason|0|||
146561531|NCT01346592|528566051|FG000|Overall Study|Unable to Classify|7|||
146561532|NCT01346592|528566052|FG001|Overall Study|Unable to Classify|3|||
146561533|NCT01346592|528566053|FG002|Overall Study|Unable to Classify|6|||
146561534|NCT02457793|528566054|FG000|Overall Study|Reason not specified|0|||
146561535|NCT02457793|528566055|FG001|Overall Study|Reason not specified|0|||
146561536|NCT02457793|528566056|FG002|Overall Study|Reason not specified|0|||
146561537|NCT02457793|528566057|FG003|Overall Study|Reason not specified|1|||
146561538|NCT02457793|528566058|FG004|Overall Study|Reason not specified|1|||
146561539|NCT02457793|528566059|FG005|Overall Study|Reason not specified|1|||
146561540|NCT02457793|528566054|FG000|Overall Study|Withdrawal by Subject|0|||
146561541|NCT02457793|528566055|FG001|Overall Study|Withdrawal by Subject|4|||
146561542|NCT02457793|528566056|FG002|Overall Study|Withdrawal by Subject|2|||
146561543|NCT02457793|528566057|FG003|Overall Study|Withdrawal by Subject|2|||
146561544|NCT02457793|528566058|FG004|Overall Study|Withdrawal by Subject|2|||
146906159|NCT01009463|529822007|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
146561545|NCT02457793|528566059|FG005|Overall Study|Withdrawal by Subject|2|||
146561546|NCT02457793|528566054|FG000|Overall Study|Adverse Event|0|||
146561547|NCT02457793|528566055|FG001|Overall Study|Adverse Event|0|||
146561548|NCT02457793|528566056|FG002|Overall Study|Adverse Event|0|||
146561549|NCT02457793|528566057|FG003|Overall Study|Adverse Event|1|||
146561550|NCT02457793|528566058|FG004|Overall Study|Adverse Event|0|||
146561551|NCT02457793|528566059|FG005|Overall Study|Adverse Event|0|||
146561552|NCT02457793|528566054|FG000|Overall Study|Physician Decision|1|||
146561553|NCT02457793|528566055|FG001|Overall Study|Physician Decision|0|||
146561554|NCT02457793|528566056|FG002|Overall Study|Physician Decision|1|||
146561555|NCT02457793|528566057|FG003|Overall Study|Physician Decision|1|||
146906160|NCT01009463|529822008|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
146906161|NCT01009463|529822009|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
146906162|NCT01009463|529822005|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
146906163|NCT01009463|529822006|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
146906164|NCT01009463|529822007|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
146906165|NCT01009463|529822008|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
146906166|NCT01009463|529822009|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
146906167|NCT01009463|529822005|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
146906168|NCT01009463|529822006|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
146906169|NCT01009463|529822007|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
146906170|NCT01009463|529822008|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
146906171|NCT01009463|529822009|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
146906172|NCT01009463|529822005|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
146906173|NCT01009463|529822006|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
146906174|NCT01009463|529822007|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
146906175|NCT01009463|529822008|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
146906176|NCT01009463|529822009|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
146906177|NCT01009463|529822005|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
146906178|NCT01009463|529822006|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
146906179|NCT01009463|529822007|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
146906180|NCT01009463|529822008|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
146906181|NCT01009463|529822009|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
146906182|NCT01009463|529822005|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
146641161|NCT02834793|528862957|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
146641162|NCT02834793|528862958|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
146641163|NCT02834793|528862959|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
146641164|NCT02834793|528862956|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
146641165|NCT02834793|528862957|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
146641166|NCT02834793|528862958|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
146641167|NCT02834793|528862959|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
146641168|NCT02834793|528862956|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
146641169|NCT02834793|528862957|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
146641170|NCT02834793|528862958|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
146641171|NCT02834793|528862959|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
146641172|NCT02834793|528862956|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
146641173|NCT02834793|528862957|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
146641174|NCT02834793|528862958|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
146641175|NCT02834793|528862959|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
146641176|NCT02834793|528862956|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
146641177|NCT02834793|528862957|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
146641178|NCT02834793|528862958|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
146641179|NCT02834793|528862959|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
146641180|NCT02364336|528862960|FG000|Overall Study|Adverse Event|0|||
146641181|NCT02364336|528862961|FG001|Overall Study|Adverse Event|1|||
146641182|NCT01731938|528862962|FG000|Preliminary Part I|Withdrawal by Subject|2|||
146641183|NCT01731938|528862963|FG001|Preliminary Part I|Withdrawal by Subject|2|||
146641184|NCT01731938|528862962|FG000|Preliminary Part I|Physician Decision|1|||
146906183|NCT01009463|529822006|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
146906184|NCT01009463|529822007|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
146906185|NCT01009463|529822008|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
146906186|NCT01009463|529822009|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
146906187|NCT01009463|529822005|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
146970152|NCT00902486|530050824|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
146767688|NCT01193153|529317386|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
146767689|NCT01193153|529317385|FG000|Open-label Lead in Period|Adverse Event|41|||
146767690|NCT01193153|529317386|FG001|Open-label Lead in Period|Adverse Event|0|||
146767691|NCT01193153|529317385|FG000|Open-label Lead in Period|Death|1|||
146767692|NCT01193153|529317386|FG001|Open-label Lead in Period|Death|0|||
146767693|NCT01193153|529317385|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
146767694|NCT01193153|529317386|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
146767695|NCT01193153|529317385|FG000|Open-label Stabilization Period|Adverse Event|9|||
146767696|NCT01193153|529317386|FG001|Open-label Stabilization Period|Adverse Event|0|||
146767697|NCT01193153|529317385|FG000|Open-label Stabilization Period|Death|2|||
146767698|NCT01193153|529317386|FG001|Open-label Stabilization Period|Death|0|||
146767699|NCT01193153|529317385|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
146767700|NCT01193153|529317386|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
146767701|NCT01193153|529317385|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
146767702|NCT01193153|529317386|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
146767703|NCT01193153|529317385|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
146767704|NCT01193153|529317386|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
146767705|NCT01193153|529317385|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
146767706|NCT01193153|529317386|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
146767707|NCT01193153|529317385|FG000|Open-label Stabilization Period|Other|8|||
146767708|NCT01193153|529317386|FG001|Open-label Stabilization Period|Other|0|||
146767709|NCT01193153|529317385|FG000|Double Blind Relapse Prevention Period|Other|2|||
146767710|NCT01193153|529317386|FG001|Double Blind Relapse Prevention Period|Other|3|||
146767711|NCT01193153|529317385|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
146767712|NCT01193153|529317386|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
146767713|NCT01193153|529317385|FG000|Double Blind Relapse Prevention Period|Death|2|||
146767714|NCT01193153|529317386|FG001|Double Blind Relapse Prevention Period|Death|0|||
146767715|NCT01193153|529317385|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
146767716|NCT01193153|529317386|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
146767717|NCT01193153|529317385|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
146767718|NCT01193153|529317386|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
146767719|NCT01193153|529317385|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
146767720|NCT01193153|529317386|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
146767721|NCT01193153|529317385|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
146767722|NCT01193153|529317386|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
146767723|NCT01193153|529317385|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
146767724|NCT01193153|529317386|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
146767725|NCT01648140|529317387|FG000|Overall Study|Physician Decision|1|||
146767726|NCT01648140|529317388|FG001|Overall Study|Physician Decision|0|||
146767727|NCT01648140|529317389|FG002|Overall Study|Physician Decision|0|||
146767728|NCT01648140|529317390|FG003|Overall Study|Physician Decision|0|||
146767729|NCT01648140|529317387|FG000|Overall Study|Lack of Efficacy|4|||
146767730|NCT01648140|529317388|FG001|Overall Study|Lack of Efficacy|7|||
146767731|NCT01648140|529317389|FG002|Overall Study|Lack of Efficacy|1|||
146767732|NCT01648140|529317390|FG003|Overall Study|Lack of Efficacy|0|||
146767733|NCT01648140|529317387|FG000|Overall Study|Adverse Event|3|||
146767734|NCT01648140|529317388|FG001|Overall Study|Adverse Event|1|||
146767735|NCT01648140|529317389|FG002|Overall Study|Adverse Event|2|||
146767736|NCT01648140|529317390|FG003|Overall Study|Adverse Event|0|||
146767737|NCT01648140|529317387|FG000|Overall Study|Withdrawal by Subject|2|||
146767738|NCT01648140|529317388|FG001|Overall Study|Withdrawal by Subject|3|||
146906188|NCT01009463|529822006|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
146767739|NCT01648140|529317389|FG002|Overall Study|Withdrawal by Subject|3|||
146767740|NCT01648140|529317390|FG003|Overall Study|Withdrawal by Subject|2|||
146767741|NCT01648140|529317387|FG000|Overall Study|Lost to Follow-up|2|||
146767742|NCT01648140|529317388|FG001|Overall Study|Lost to Follow-up|1|||
146767743|NCT01648140|529317389|FG002|Overall Study|Lost to Follow-up|2|||
146767744|NCT01648140|529317390|FG003|Overall Study|Lost to Follow-up|0|||
146767745|NCT01988233|529317397|FG000|Overall Study|Lost to Follow-up|64|||
146767746|NCT01988233|529317398|FG001|Overall Study|Lost to Follow-up|51|||
146561556|NCT02457793|528566058|FG004|Overall Study|Physician Decision|1|||
146561557|NCT02457793|528566059|FG005|Overall Study|Physician Decision|3|||
146561558|NCT03814044|528566064|FG000|Overall Study|Protocol deviation|1|||
146561559|NCT00835367|528566076|FG000|Washout|Adverse Event|2|||
146561560|NCT00835367|528566077|FG001|Washout|Adverse Event|0|||
146561561|NCT00835367|528566076|FG000|Washout|Withdrawal by Subject|1|||
146561562|NCT00835367|528566077|FG001|Washout|Withdrawal by Subject|0|||
146561563|NCT00835367|528566076|FG000|Second Intervention|Adverse Event|1|||
146561564|NCT00835367|528566077|FG001|Second Intervention|Adverse Event|1|||
146561565|NCT05929326|528566078|FG000|Overall Study|unqualified sample|2|||
146561566|NCT05929326|528566079|FG001|Overall Study|unqualified sample|3|||
146561567|NCT05929326|528566080|FG002|Overall Study|unqualified sample|7|||
146561568|NCT04890509|528566081|FG000|Overall Study|Death|4|||
146561569|NCT04890509|528566082|FG001|Overall Study|Death|4|||
146561570|NCT04976777|528568204|FG000|Overall Study|COVID-19 Infection|1|||
146561571|NCT04976777|528568205|FG001|Overall Study|COVID-19 Infection|0|||
146561572|NCT00442702|528568208|FG000|Titration Period|Adverse Event|2|||
146561573|NCT00442702|528568209|FG001|Titration Period|Adverse Event|0|||
146561574|NCT00442702|528568208|FG000|Titration Period|Death|3|||
146561575|NCT00442702|528568209|FG001|Titration Period|Death|2|||
146561576|NCT00442702|528568208|FG000|Titration Period|Insufficient Therapeutic Response|1|||
146561577|NCT00442702|528568209|FG001|Titration Period|Insufficient Therapeutic Response|0|||
146561578|NCT00442702|528568208|FG000|Titration Period|Refused Treatment|4|||
146561579|NCT00442702|528568209|FG001|Titration Period|Refused Treatment|1|||
146641185|NCT01731938|528862963|FG001|Preliminary Part I|Physician Decision|0|||
146641186|NCT01731938|528862962|FG000|Preliminary Part I|Lost to Follow-up|0|||
146641187|NCT01731938|528862963|FG001|Preliminary Part I|Lost to Follow-up|3|||
146641188|NCT01731938|528862962|FG000|Preliminary Part I|Missed Week 6 visit|0|||
146641189|NCT01731938|528862963|FG001|Preliminary Part I|Missed Week 6 visit|3|||
146641190|NCT01731938|528862962|FG000|Primary Part II|Withdrawal by Subject|5|||
146641191|NCT01731938|528862963|FG001|Primary Part II|Withdrawal by Subject|4|||
146641192|NCT01731938|528862962|FG000|Primary Part II|Lost to Follow-up|4|||
146641193|NCT01731938|528862963|FG001|Primary Part II|Lost to Follow-up|5|||
146641194|NCT01731938|528862962|FG000|Primary Part II|Death|2|||
146641195|NCT01731938|528862963|FG001|Primary Part II|Death|1|||
146641196|NCT01731938|528862962|FG000|Primary Part II|Missed Week 6 visit|2|||
146641197|NCT01731938|528862963|FG001|Primary Part II|Missed Week 6 visit|3|||
146641198|NCT04931888|528862964|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
146641199|NCT04931888|528862965|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
146641200|NCT04931888|528862966|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
146641201|NCT04931888|528862967|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
146641202|NCT01049009|528862968|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
146641203|NCT01049009|528862969|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
146641204|NCT01049009|528862968|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146641205|NCT01049009|528862969|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
146641206|NCT01049009|528862968|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
146641207|NCT01049009|528862969|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
146641208|NCT01049009|528862968|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
146641209|NCT01049009|528862969|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
146641210|NCT03179202|528862970|FG000|Overall Study|Screen Failure|67|||
146641211|NCT03179202|528862970|FG000|Overall Study|Subject Lost to Follow Up|12|||
146641212|NCT03179202|528862970|FG000|Overall Study|Withdrawal by Subject|7|||
146641213|NCT03179202|528862970|FG000|Overall Study|Adverse Event|3|||
146641214|NCT03179202|528862970|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
146641215|NCT03179202|528862970|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
146561580|NCT00442702|528568208|FG000|Titration Period|Failure to return|1|||
146906189|NCT01009463|529822007|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
146906190|NCT01009463|529822008|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
146906191|NCT01009463|529822009|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
146906192|NCT01009463|529822005|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
146906193|NCT01009463|529822006|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
146906194|NCT01009463|529822007|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
146906195|NCT01009463|529822008|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
146906196|NCT01009463|529822009|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
146906197|NCT01009463|529822005|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
146906198|NCT01009463|529822006|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
146906199|NCT01009463|529822007|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
146906200|NCT01009463|529822008|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
146906201|NCT01009463|529822009|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
146906202|NCT01009463|529822005|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
146906203|NCT01009463|529822006|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
146906204|NCT01009463|529822007|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
146906205|NCT01009463|529822008|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
146906206|NCT01009463|529822009|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
146970153|NCT00902486|530050825|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
146970154|NCT00902486|530050826|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
146561581|NCT00442702|528568209|FG001|Titration Period|Failure to return|0|||
146641216|NCT00859638|528862971|FG000|Overall Study|Lost to Follow-up|6|||
146906207|NCT01009463|529822005|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146906208|NCT01009463|529822006|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
146906209|NCT01009463|529822007|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
146906210|NCT01009463|529822008|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
146906211|NCT01009463|529822009|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
146906212|NCT01009463|529822005|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
146906213|NCT01009463|529822006|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
146906214|NCT01009463|529822007|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
146906215|NCT01009463|529822008|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
146906216|NCT01009463|529822009|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
146906217|NCT04430348|529822010|FG000|Overall Study|Death|3|||
146906218|NCT04430348|529822011|FG001|Overall Study|Death|2|||
146906219|NCT04430348|529822012|FG002|Overall Study|Death|2|||
146906220|NCT04430348|529822013|FG003|Overall Study|Death|2|||
146906221|NCT04430348|529822014|FG004|Overall Study|Death|2|||
146906222|NCT04430348|529822015|FG005|Overall Study|Death|3|||
146906223|NCT04430348|529822010|FG000|Overall Study|Lost to Follow-up|0|||
146906224|NCT04430348|529822011|FG001|Overall Study|Lost to Follow-up|0|||
146906225|NCT04430348|529822012|FG002|Overall Study|Lost to Follow-up|0|||
146906226|NCT04430348|529822013|FG003|Overall Study|Lost to Follow-up|1|||
146906227|NCT04430348|529822014|FG004|Overall Study|Lost to Follow-up|0|||
146906228|NCT04430348|529822015|FG005|Overall Study|Lost to Follow-up|0|||
146906229|NCT04430348|529822010|FG000|Overall Study|Adverse Event|0|||
146906230|NCT04430348|529822011|FG001|Overall Study|Adverse Event|0|||
146906231|NCT04430348|529822012|FG002|Overall Study|Adverse Event|0|||
146906232|NCT04430348|529822013|FG003|Overall Study|Adverse Event|0|||
146906233|NCT04430348|529822014|FG004|Overall Study|Adverse Event|0|||
146906234|NCT04430348|529822015|FG005|Overall Study|Adverse Event|1|||
146906235|NCT04430348|529822010|FG000|Overall Study|Withdrawal by Subject|0|||
146906236|NCT04430348|529822011|FG001|Overall Study|Withdrawal by Subject|1|||
146906237|NCT04430348|529822012|FG002|Overall Study|Withdrawal by Subject|0|||
146906238|NCT04430348|529822013|FG003|Overall Study|Withdrawal by Subject|0|||
146906239|NCT04430348|529822014|FG004|Overall Study|Withdrawal by Subject|0|||
146906240|NCT04430348|529822015|FG005|Overall Study|Withdrawal by Subject|1|||
146906241|NCT04430348|529822010|FG000|Overall Study|Study Terminated by Sponsor|0|||
146906242|NCT04430348|529822011|FG001|Overall Study|Study Terminated by Sponsor|0|||
146906243|NCT04430348|529822012|FG002|Overall Study|Study Terminated by Sponsor|2|||
146906244|NCT04430348|529822013|FG003|Overall Study|Study Terminated by Sponsor|0|||
146906245|NCT04430348|529822014|FG004|Overall Study|Study Terminated by Sponsor|1|||
146561582|NCT00442702|528568208|FG000|Titration Period|Hospitalized in another hospital|1|||
146561583|NCT00442702|528568209|FG001|Titration Period|Hospitalized in another hospital|0|||
146561584|NCT00442702|528568208|FG000|Evaluation Period|Adverse Event|1|||
146561585|NCT00442702|528568209|FG001|Evaluation Period|Adverse Event|0|||
146561586|NCT00442702|528568208|FG000|Evaluation Period|Death|1|||
146561587|NCT00442702|528568209|FG001|Evaluation Period|Death|1|||
146561588|NCT00442702|528568208|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
146906246|NCT04430348|529822015|FG005|Overall Study|Study Terminated by Sponsor|1|||
146906247|NCT02874794|529822018|FG000|Overall Study|Physician Decision|3|||
146906248|NCT02874794|529822019|FG001|Overall Study|Physician Decision|2|||
146906249|NCT02874794|529822018|FG000|Overall Study|Withdrawal by Subject|2|||
146906250|NCT02874794|529822019|FG001|Overall Study|Withdrawal by Subject|8|||
146906251|NCT02874794|529822018|FG000|Overall Study|Death|2|||
146906252|NCT02874794|529822019|FG001|Overall Study|Death|1|||
146906253|NCT03839524|529822021|FG000|Overall Study|Adverse Event|1|||
146906254|NCT03715465|529822024|FG000|Overall Study|Withdrawal by Subject|1|||
146906255|NCT03715465|529822025|FG001|Overall Study|Withdrawal by Subject|2|||
146906256|NCT04329949|529822034|FG000|Overall Study|Death|36|||
146906257|NCT04329949|529822034|FG000|Overall Study|Withdrawal by Subject|4|||
146906258|NCT04329949|529822034|FG000|Overall Study|Termination of study by sponsor|3|||
146906259|NCT00917384|529822039|FG000|Overall Study|Lost to Follow-up|4|||
146906260|NCT00917384|529822040|FG001|Overall Study|Lost to Follow-up|2|||
146906261|NCT00917384|529822039|FG000|Overall Study|Withdrawal by Subject|10|||
146906262|NCT00917384|529822040|FG001|Overall Study|Withdrawal by Subject|2|||
146906263|NCT01451515|529822043|FG000|Overall Study|Death|0|||
146906264|NCT01451515|529822044|FG001|Overall Study|Death|1|||
146906265|NCT01451515|529822045|FG002|Overall Study|Death|0|||
146906266|NCT01451515|529822043|FG000|Overall Study|Withdrawal by Subject|0|||
146906267|NCT01451515|529822044|FG001|Overall Study|Withdrawal by Subject|1|||
146906268|NCT01451515|529822045|FG002|Overall Study|Withdrawal by Subject|0|||
146906269|NCT01451515|529822043|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
146561589|NCT00442702|528568209|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
146561590|NCT00442702|528568208|FG000|Evaluation Period|Refused treatment|1|||
146561591|NCT00442702|528568209|FG001|Evaluation Period|Refused treatment|1|||
146561592|NCT00442702|528568208|FG000|Evaluation Period|Renal transplant|0|||
146561593|NCT00442702|528568209|FG001|Evaluation Period|Renal transplant|1|||
146561594|NCT00442702|528568208|FG000|Evaluation Period|Failure to return|1|||
146561595|NCT00442702|528568209|FG001|Evaluation Period|Failure to return|0|||
146561596|NCT00442702|528568208|FG000|Evaluation Period|Site closure|0|||
146561597|NCT00442702|528568209|FG001|Evaluation Period|Site closure|1|||
146561598|NCT04123704|528568220|FG000|Overall Study|Disease progression|2|||
146561599|NCT03122184|528568221|FG000|Overall Study|Lost to Follow-up|4|||
146561600|NCT03122184|528568222|FG001|Overall Study|Lost to Follow-up|6|||
146561601|NCT03122184|528568221|FG000|Overall Study|Withdrawal by Subject|3|||
146561602|NCT03122184|528568222|FG001|Overall Study|Withdrawal by Subject|0|||
146561603|NCT03122184|528568221|FG000|Overall Study|Terminated due to cognitive problem|1|||
146561604|NCT03122184|528568222|FG001|Overall Study|Terminated due to cognitive problem|0|||
146561605|NCT01497197|528568228|FG000|Overall Study|Lost to Follow-up|1|||
146561606|NCT01497197|528568229|FG001|Overall Study|Lost to Follow-up|0|||
146561607|NCT01497197|528568228|FG000|Overall Study|Protocol Violation|0|||
146561608|NCT01497197|528568229|FG001|Overall Study|Protocol Violation|2|||
146561609|NCT01497197|528568228|FG000|Overall Study|Withdrawal by Subject|2|||
146561610|NCT01497197|528568229|FG001|Overall Study|Withdrawal by Subject|1|||
146561611|NCT01497197|528568228|FG000|Overall Study|Excessive/lack of response to treatment|1|||
146561612|NCT01497197|528568229|FG001|Overall Study|Excessive/lack of response to treatment|0|||
146561613|NCT01497197|528568228|FG000|Overall Study|Risk of OHSS|1|||
146906270|NCT01451515|529822044|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
146906271|NCT01451515|529822045|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
146906272|NCT01451515|529822043|FG000|Overall Study|Relapse (except CNS)|1|||
146906273|NCT01451515|529822044|FG001|Overall Study|Relapse (except CNS)|1|||
146906274|NCT01451515|529822045|FG002|Overall Study|Relapse (except CNS)|0|||
146906275|NCT03717922|529822046|FG000|Overall Study|Lost to Follow-up|2|||
146561614|NCT01497197|528568229|FG001|Overall Study|Risk of OHSS|0|||
146561615|NCT01497197|528568228|FG000|Overall Study|No oocytes retrieved|3|||
146767747|NCT03781336|529317403|FG000|Overall Study|Withdrawal by Subject|2|||
146767748|NCT03781336|529317404|FG001|Overall Study|Withdrawal by Subject|2|||
146767749|NCT03987451|529317405|FG000|Overall Study|Lost to Follow-up|1|||
146767750|NCT03987451|529317406|FG001|Overall Study|Lost to Follow-up|0|||
146906276|NCT03717922|529822047|FG001|Overall Study|Lost to Follow-up|2|||
146906277|NCT01458340|529822050|FG000|Overall Study|Adverse Event|5|||
146641217|NCT00859638|528862972|FG001|Overall Study|Lost to Follow-up|1|||
146641218|NCT00859638|528862971|FG000|Overall Study|Withdrawal by Subject|3|||
146641219|NCT00859638|528862972|FG001|Overall Study|Withdrawal by Subject|2|||
146641220|NCT00859638|528862971|FG000|Overall Study|Ill health|1|||
146641221|NCT00859638|528862972|FG001|Overall Study|Ill health|1|||
146641222|NCT02969408|528862974|FG000|Overall Study|Adverse Event|2|||
146641223|NCT02969408|528862974|FG000|Overall Study|Withdrawal by Subject|8|||
146906278|NCT01458340|529822051|FG001|Overall Study|Adverse Event|4|||
146906279|NCT01458340|529822052|FG002|Overall Study|Adverse Event|2|||
146906280|NCT01458340|529822050|FG000|Overall Study|Lost to Follow-up|3|||
146906281|NCT01458340|529822051|FG001|Overall Study|Lost to Follow-up|3|||
146906282|NCT01458340|529822052|FG002|Overall Study|Lost to Follow-up|10|||
146906283|NCT01458340|529822050|FG000|Overall Study|Miscellaneous|0|||
146906284|NCT01458340|529822051|FG001|Overall Study|Miscellaneous|1|||
146906285|NCT01458340|529822052|FG002|Overall Study|Miscellaneous|0|||
146906286|NCT01458340|529822050|FG000|Overall Study|Physician Decision|1|||
146906287|NCT01458340|529822051|FG001|Overall Study|Physician Decision|1|||
146641224|NCT02969408|528862974|FG000|Overall Study|Lost to Follow-up|4|||
146906288|NCT01458340|529822052|FG002|Overall Study|Physician Decision|2|||
146906289|NCT01458340|529822050|FG000|Overall Study|Protocol Violation|6|||
146906290|NCT01458340|529822051|FG001|Overall Study|Protocol Violation|6|||
146641225|NCT02969408|528862974|FG000|Overall Study|Protocol Violation|1|||
146641226|NCT02969408|528862974|FG000|Overall Study|Other than specified|1|||
146641227|NCT04643158|528862975|FG000|Overall Study|Study terminated by sponsor|0|||
146641228|NCT04643158|528862976|FG001|Overall Study|Study terminated by sponsor|0|||
146641229|NCT04643158|528862977|FG002|Overall Study|Study terminated by sponsor|1|||
146641230|NCT04643158|528862978|FG003|Overall Study|Study terminated by sponsor|0|||
146641231|NCT04643158|528862979|FG004|Overall Study|Study terminated by sponsor|0|||
146641232|NCT04643158|528862980|FG005|Overall Study|Study terminated by sponsor|1|||
146641233|NCT04643158|528862981|FG006|Overall Study|Study terminated by sponsor|0|||
146641234|NCT04643158|528862975|FG000|Overall Study|Global/country situation|0|||
146641235|NCT04643158|528862976|FG001|Overall Study|Global/country situation|0|||
146641236|NCT04643158|528862977|FG002|Overall Study|Global/country situation|1|||
146641237|NCT04643158|528862978|FG003|Overall Study|Global/country situation|0|||
146641238|NCT04643158|528862979|FG004|Overall Study|Global/country situation|0|||
146641239|NCT04643158|528862980|FG005|Overall Study|Global/country situation|0|||
146641240|NCT04643158|528862981|FG006|Overall Study|Global/country situation|0|||
146641241|NCT04643158|528862975|FG000|Overall Study|Withdrawal by Subject|0|||
146641242|NCT04643158|528862976|FG001|Overall Study|Withdrawal by Subject|0|||
146641243|NCT04643158|528862977|FG002|Overall Study|Withdrawal by Subject|0|||
146641244|NCT04643158|528862978|FG003|Overall Study|Withdrawal by Subject|0|||
146641245|NCT04643158|528862979|FG004|Overall Study|Withdrawal by Subject|0|||
146641246|NCT04643158|528862980|FG005|Overall Study|Withdrawal by Subject|1|||
146641247|NCT04643158|528862981|FG006|Overall Study|Withdrawal by Subject|0|||
146641248|NCT01068600|528862982|FG000|Overall Study|Withdrawal by Subject|5|||
146641249|NCT01068600|528862983|FG001|Overall Study|Withdrawal by Subject|6|||
146641250|NCT01068600|528862982|FG000|Overall Study|Adverse Event|3|||
146641251|NCT01068600|528862983|FG001|Overall Study|Adverse Event|3|||
146641252|NCT01068600|528862982|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146906291|NCT01458340|529822052|FG002|Overall Study|Protocol Violation|5|||
146906292|NCT01458340|529822050|FG000|Overall Study|Withdrawal by Subject|12|||
146906293|NCT01458340|529822051|FG001|Overall Study|Withdrawal by Subject|6|||
146906294|NCT01458340|529822052|FG002|Overall Study|Withdrawal by Subject|4|||
146906295|NCT01575548|529822059|FG000|Overall Study|Adverse Event|15|||
146641253|NCT01068600|528862983|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146767751|NCT03987451|529317405|FG000|Overall Study|Withdrawal by Subject|1|||
146906296|NCT01575548|529822060|FG001|Overall Study|Adverse Event|2|||
146906297|NCT01575548|529822059|FG000|Overall Study|Disease progression|12|||
146641254|NCT01068600|528862982|FG000|Overall Study|Lost to Follow-up|1|||
146641255|NCT01068600|528862983|FG001|Overall Study|Lost to Follow-up|2|||
146906298|NCT01575548|529822060|FG001|Overall Study|Disease progression|25|||
146641256|NCT01068600|528862982|FG000|Overall Study|Protocol deviation|1|||
146641257|NCT01068600|528862983|FG001|Overall Study|Protocol deviation|1|||
146641258|NCT01068600|528862982|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146906299|NCT01575548|529822059|FG000|Overall Study|Death|1|||
146906300|NCT01575548|529822060|FG001|Overall Study|Death|0|||
146906301|NCT01575548|529822059|FG000|Overall Study|Other complicating disease|1|||
146906302|NCT01575548|529822060|FG001|Overall Study|Other complicating disease|0|||
146906303|NCT01575548|529822059|FG000|Overall Study|Withdrawal by Subject|7|||
146641259|NCT01068600|528862983|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
146641260|NCT01068600|528862982|FG000|Overall Study|Administrative problems|0|||
146767752|NCT03987451|529317406|FG001|Overall Study|Withdrawal by Subject|1|||
146767753|NCT01183780|529317409|FG000|Overall Study|Withdrawal by Subject|25|||
146767754|NCT01183780|529317410|FG001|Overall Study|Withdrawal by Subject|14|||
146906304|NCT01575548|529822060|FG001|Overall Study|Withdrawal by Subject|3|||
146906305|NCT01575548|529822059|FG000|Overall Study|Noncompliance|1|||
146906306|NCT01575548|529822060|FG001|Overall Study|Noncompliance|0|||
146906307|NCT01575548|529822059|FG000|Overall Study|Anticipated surgery|0|||
146906308|NCT01575548|529822060|FG001|Overall Study|Anticipated surgery|1|||
146906309|NCT01575548|529822059|FG000|Overall Study|Never started protocol therapy|3|||
146906310|NCT01575548|529822060|FG001|Overall Study|Never started protocol therapy|2|||
146906311|NCT01702805|529822067|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
146641261|NCT01068600|528862983|FG001|Overall Study|Administrative problems|1|||
146641262|NCT01474018|528862984|FG000|Overall Study|Lost to Follow-up|0|||
146641263|NCT01474018|528862985|FG001|Overall Study|Lost to Follow-up|1|||
146641264|NCT01474018|528862984|FG000|Overall Study|Withdrawal by Subject|0|||
146641265|NCT01474018|528862985|FG001|Overall Study|Withdrawal by Subject|2|||
146641266|NCT00486291|528862990|FG000|Overall Study|Adverse Event|3|||
146641267|NCT00486291|528862991|FG001|Overall Study|Adverse Event|4|||
146641268|NCT00486291|528862990|FG000|Overall Study|Lost to Follow-up|3|||
146641269|NCT00486291|528862991|FG001|Overall Study|Lost to Follow-up|7|||
146641270|NCT00486291|528862990|FG000|Overall Study|protocol non-compliance|10|||
146641271|NCT00486291|528862991|FG001|Overall Study|protocol non-compliance|15|||
146641272|NCT00486291|528862990|FG000|Overall Study|requirement for restricted medication|0|||
146641273|NCT00486291|528862991|FG001|Overall Study|requirement for restricted medication|3|||
146641274|NCT03462511|528862995|FG000|Overall Study|Withdrawal by Subject|2|||
146641275|NCT03462511|528862996|FG001|Overall Study|Withdrawal by Subject|3|||
146641276|NCT02925416|528862997|FG000|Overall Study|Adverse Event|2|||
146641277|NCT02925416|528862998|FG001|Overall Study|Adverse Event|0|||
146641278|NCT02625909|528862999|FG000|Overall Study|Death|2|||
146641279|NCT02625909|528863000|FG001|Overall Study|Death|0|||
146641280|NCT02625909|528862999|FG000|Overall Study|Lost to Follow-up|3|||
146641281|NCT02625909|528863000|FG001|Overall Study|Lost to Follow-up|5|||
146641282|NCT02625909|528862999|FG000|Overall Study|Lack of Efficacy|9|||
146641283|NCT02625909|528863000|FG001|Overall Study|Lack of Efficacy|2|||
146906312|NCT01702805|529822068|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
146906313|NCT01702805|529822067|FG000|Overall Study|Incomplete Follow-up|18|||
146906314|NCT01702805|529822068|FG001|Overall Study|Incomplete Follow-up|15|||
146906315|NCT01702805|529822067|FG000|Overall Study|Vital Status Assessment Only|40|||
146906316|NCT01702805|529822068|FG001|Overall Study|Vital Status Assessment Only|39|||
146906317|NCT01702805|529822067|FG000|Overall Study|Lost to Follow-up|5|||
146906318|NCT01702805|529822068|FG001|Overall Study|Lost to Follow-up|5|||
146906319|NCT04876391|529822069|FG000|Overall Study|Withdrawal by Subject|1|||
146906320|NCT04876391|529822070|FG001|Overall Study|Withdrawal by Subject|10|||
146906321|NCT04876391|529822069|FG000|Overall Study|Lost to Follow-up|2|||
146906322|NCT04876391|529822070|FG001|Overall Study|Lost to Follow-up|4|||
146906323|NCT04876391|529822069|FG000|Overall Study|Lack of Efficacy|0|||
146906324|NCT04876391|529822070|FG001|Overall Study|Lack of Efficacy|2|||
146906325|NCT04876391|529822069|FG000|Overall Study|Adverse Event|3|||
146906326|NCT04876391|529822070|FG001|Overall Study|Adverse Event|1|||
146906327|NCT04876391|529822069|FG000|Overall Study|Patient non-compliance|0|||
146906328|NCT04876391|529822070|FG001|Overall Study|Patient non-compliance|1|||
146906329|NCT04876391|529822069|FG000|Overall Study|Personal reasons|0|||
146641284|NCT02625909|528862999|FG000|Overall Study|Reinfection|3|||
146641285|NCT02625909|528863000|FG001|Overall Study|Reinfection|2|||
146641286|NCT00200356|528863001|FG000|Overall Study|Lack of Efficacy|3|||
146767755|NCT01183780|529317409|FG000|Overall Study|Lost to Follow-up|6|||
146641287|NCT00200356|528863002|FG001|Overall Study|Lack of Efficacy|3|||
146641288|NCT00200356|528863001|FG000|Overall Study|Protocol Violation|4|||
146641289|NCT00200356|528863002|FG001|Overall Study|Protocol Violation|4|||
146641290|NCT00200356|528863001|FG000|Overall Study|Nontreatment|1|||
146641291|NCT00200356|528863002|FG001|Overall Study|Nontreatment|0|||
146767756|NCT01183780|529317410|FG001|Overall Study|Lost to Follow-up|11|||
146906330|NCT04876391|529822070|FG001|Overall Study|Personal reasons|1|||
146906331|NCT04876391|529822069|FG000|Overall Study|Withdrawn as per protocol|2|||
146906332|NCT04876391|529822070|FG001|Overall Study|Withdrawn as per protocol|2|||
146906333|NCT02286960|529822071|FG000|Overall Study|Lost to Follow-up|3|||
146906334|NCT02286960|529822072|FG001|Overall Study|Lost to Follow-up|3|||
146970155|NCT00902486|530050827|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
146641292|NCT00035932|528863009|FG000|Overall Study|Adverse Event|10|||
146641293|NCT00035932|528863010|FG001|Overall Study|Adverse Event|9|||
146641294|NCT00035932|528863011|FG002|Overall Study|Adverse Event|9|||
146641295|NCT00035932|528863009|FG000|Overall Study|Death|0|||
146641296|NCT00035932|528863010|FG001|Overall Study|Death|0|||
146641297|NCT00035932|528863011|FG002|Overall Study|Death|1|||
146906335|NCT02317510|529822074|FG000|Overall Study|Adverse Event|0|||
146906336|NCT02317510|529822075|FG001|Overall Study|Adverse Event|1|||
146641298|NCT00035932|528863009|FG000|Overall Study|Disease Progression / Relapse|1|||
146641299|NCT00035932|528863010|FG001|Overall Study|Disease Progression / Relapse|1|||
146641300|NCT00035932|528863011|FG002|Overall Study|Disease Progression / Relapse|0|||
146641301|NCT00035932|528863009|FG000|Overall Study|Lost to Follow-up|4|||
146641302|NCT00035932|528863010|FG001|Overall Study|Lost to Follow-up|4|||
146641303|NCT00035932|528863011|FG002|Overall Study|Lost to Follow-up|3|||
146641304|NCT00035932|528863009|FG000|Overall Study|Noncompliance|6|||
146641305|NCT00035932|528863010|FG001|Overall Study|Noncompliance|7|||
146641306|NCT00035932|528863011|FG002|Overall Study|Noncompliance|6|||
146641307|NCT00035932|528863009|FG000|Overall Study|Protocol Violation While on Study|0|||
146906337|NCT03427073|529822076|FG000|Overall Study|Disease Progression|1|||
146906338|NCT03427073|529822077|FG001|Overall Study|Disease Progression|1|||
146906339|NCT03427073|529822078|FG002|Overall Study|Disease Progression|1|||
146906340|NCT03427073|529822079|FG003|Overall Study|Disease Progression|3|||
146906341|NCT03427073|529822080|FG004|Overall Study|Disease Progression|3|||
146641308|NCT00035932|528863010|FG001|Overall Study|Protocol Violation While on Study|1|||
146906342|NCT03427073|529822081|FG005|Overall Study|Disease Progression|4|||
146906343|NCT03427073|529822082|FG006|Overall Study|Disease Progression|2|||
146906344|NCT03427073|529822083|FG007|Overall Study|Disease Progression|3|||
146906345|NCT03427073|529822076|FG000|Overall Study|Physician Decision|0|||
146906346|NCT03427073|529822077|FG001|Overall Study|Physician Decision|0|||
146906347|NCT03427073|529822078|FG002|Overall Study|Physician Decision|0|||
146641309|NCT00035932|528863011|FG002|Overall Study|Protocol Violation While on Study|2|||
146641310|NCT00035932|528863009|FG000|Overall Study|Withdrawal by Subject|1|||
146641311|NCT00035932|528863010|FG001|Overall Study|Withdrawal by Subject|5|||
146641312|NCT00035932|528863011|FG002|Overall Study|Withdrawal by Subject|0|||
146641313|NCT00035932|528863009|FG000|Overall Study|Study Termination by Sponsor|1|||
146641314|NCT00035932|528863010|FG001|Overall Study|Study Termination by Sponsor|0|||
146641315|NCT00035932|528863011|FG002|Overall Study|Study Termination by Sponsor|0|||
146641316|NCT00035932|528863009|FG000|Overall Study|Lack of Efficacy|33|||
146641317|NCT00035932|528863010|FG001|Overall Study|Lack of Efficacy|33|||
146641318|NCT00035932|528863011|FG002|Overall Study|Lack of Efficacy|28|||
146641319|NCT01297491|528863012|FG000|Overall Study|Adverse Event|11|||
146641320|NCT01297491|528863013|FG001|Overall Study|Adverse Event|6|||
146641321|NCT01297491|528863012|FG000|Overall Study|Physician Decision|3|||
146641322|NCT01297491|528863013|FG001|Overall Study|Physician Decision|2|||
146641323|NCT01297491|528863012|FG000|Overall Study|Progressive disease|11|||
146641324|NCT01297491|528863013|FG001|Overall Study|Progressive disease|20|||
146641325|NCT01297491|528863012|FG000|Overall Study|Patient/Guardian decision|3|||
146641326|NCT01297491|528863013|FG001|Overall Study|Patient/Guardian decision|4|||
146641327|NCT01297491|528863012|FG000|Overall Study|Death|2|||
146641328|NCT01297491|528863013|FG001|Overall Study|Death|1|||
146641329|NCT04413617|528863017|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
146641330|NCT04413617|528863018|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
146641331|NCT04413617|528863019|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
146641332|NCT04413617|528863020|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
146641333|NCT04413617|528863021|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
146641334|NCT04413617|528863017|FG000|Overall Study|Protocol Violation|0|||
146641335|NCT04413617|528863018|FG001|Overall Study|Protocol Violation|1|||
146641336|NCT04413617|528863019|FG002|Overall Study|Protocol Violation|0|||
146641337|NCT04413617|528863020|FG003|Overall Study|Protocol Violation|0|||
146641338|NCT04413617|528863021|FG004|Overall Study|Protocol Violation|1|||
146767757|NCT00770965|529317411|FG000|Safety Set|Withdrawal by Subject|0|||
146767758|NCT00770965|529317412|FG001|Safety Set|Withdrawal by Subject|0|||
146906348|NCT03427073|529822079|FG003|Overall Study|Physician Decision|0|||
146906349|NCT03427073|529822080|FG004|Overall Study|Physician Decision|0|||
146767759|NCT00770965|529317413|FG002|Safety Set|Withdrawal by Subject|0|||
146767760|NCT00770965|529317414|FG003|Safety Set|Withdrawal by Subject|1|||
146767761|NCT00770965|529317411|FG000|Safety Set|Protocol deviation|0|||
146641339|NCT04413617|528863017|FG000|Overall Study|Lack of Efficacy|2|||
146641340|NCT04413617|528863018|FG001|Overall Study|Lack of Efficacy|0|||
146641341|NCT04413617|528863019|FG002|Overall Study|Lack of Efficacy|2|||
146641342|NCT04413617|528863020|FG003|Overall Study|Lack of Efficacy|1|||
146641343|NCT04413617|528863021|FG004|Overall Study|Lack of Efficacy|0|||
146641344|NCT04413617|528863017|FG000|Overall Study|Withdrawal by Subject|3|||
146641345|NCT04413617|528863018|FG001|Overall Study|Withdrawal by Subject|4|||
146641346|NCT04413617|528863019|FG002|Overall Study|Withdrawal by Subject|2|||
146641347|NCT04413617|528863020|FG003|Overall Study|Withdrawal by Subject|5|||
146641348|NCT04413617|528863021|FG004|Overall Study|Withdrawal by Subject|3|||
146641349|NCT04413617|528863017|FG000|Overall Study|Death|1|||
146641350|NCT04413617|528863018|FG001|Overall Study|Death|0|||
146641351|NCT04413617|528863019|FG002|Overall Study|Death|0|||
146641352|NCT04413617|528863020|FG003|Overall Study|Death|0|||
146641353|NCT04413617|528863021|FG004|Overall Study|Death|0|||
146641354|NCT04413617|528863017|FG000|Overall Study|Adverse Event|1|||
146641355|NCT04413617|528863018|FG001|Overall Study|Adverse Event|0|||
146641356|NCT04413617|528863019|FG002|Overall Study|Adverse Event|0|||
146641357|NCT04413617|528863020|FG003|Overall Study|Adverse Event|1|||
146641358|NCT04413617|528863021|FG004|Overall Study|Adverse Event|1|||
146641359|NCT04413617|528863017|FG000|Overall Study|COVID-19|0|||
146641360|NCT04413617|528863018|FG001|Overall Study|COVID-19|1|||
146641361|NCT04413617|528863019|FG002|Overall Study|COVID-19|0|||
146641362|NCT04413617|528863020|FG003|Overall Study|COVID-19|0|||
146641363|NCT04413617|528863021|FG004|Overall Study|COVID-19|0|||
146641364|NCT00312195|528863022|FG000|Overall Study|Adverse Event|4|||
146641365|NCT00312195|528863023|FG001|Overall Study|Adverse Event|6|||
146641366|NCT00312195|528863022|FG000|Overall Study|Lost to Follow-up|1|||
146641367|NCT00312195|528863023|FG001|Overall Study|Lost to Follow-up|0|||
146641368|NCT00312195|528863022|FG000|Overall Study|Protocol Violation|1|||
146641369|NCT00312195|528863023|FG001|Overall Study|Protocol Violation|0|||
146641370|NCT02511106|528863026|FG000|Overall Study|Lost to Follow-up|6|||
146641371|NCT02511106|528863027|FG001|Overall Study|Lost to Follow-up|4|||
146641372|NCT02511106|528863026|FG000|Overall Study|Withdrawal by Subject|24|||
146641373|NCT02511106|528863027|FG001|Overall Study|Withdrawal by Subject|21|||
146641374|NCT02511106|528863026|FG000|Overall Study|Death|42|||
146641375|NCT02511106|528863027|FG001|Overall Study|Death|82|||
146641376|NCT02511106|528863026|FG000|Overall Study|Ongoing study at data cut-off|3|||
146641377|NCT02511106|528863027|FG001|Overall Study|Ongoing study at data cut-off|2|||
146641378|NCT02511106|528863026|FG000|Overall Study|Without specified reason|3|||
146906350|NCT03427073|529822081|FG005|Overall Study|Physician Decision|0|||
146906351|NCT03427073|529822082|FG006|Overall Study|Physician Decision|1|||
146906352|NCT03427073|529822083|FG007|Overall Study|Physician Decision|1|||
146906353|NCT01486238|529822086|FG000|Overall Study|Death|0|||
146906354|NCT01486238|529822087|FG001|Overall Study|Death|2|||
146906355|NCT01486238|529822086|FG000|Overall Study|Withdrawal by Subject|2|||
146906356|NCT01486238|529822087|FG001|Overall Study|Withdrawal by Subject|1|||
146906357|NCT01486238|529822086|FG000|Overall Study|Lost to Follow-up|0|||
146906358|NCT01486238|529822087|FG001|Overall Study|Lost to Follow-up|3|||
146906359|NCT00693706|529822092|FG000|Overall Study|Protocol Violation|0|||
146509197|NCT00835679|528367762|FG000|Overall Study|Withdrawal by Subject|1|||
146906360|NCT00693706|529822093|FG001|Overall Study|Protocol Violation|1|||
146906361|NCT04786210|529822095|FG000|Overall Study|Lost to Follow-up|2|||
146906362|NCT04786210|529822095|FG000|Overall Study|Withdrawal by Subject|4|||
146906363|NCT04334148|529822096|FG000|Overall Study|positive nasal swab at baseline|0|||
146906364|NCT04334148|529822097|FG001|Overall Study|positive nasal swab at baseline|1|||
146906365|NCT00498173|529822098|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
146906366|NCT00498173|529822099|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
146906367|NCT00498173|529822100|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
146561616|NCT01497197|528568229|FG001|Overall Study|No oocytes retrieved|2|||
146561617|NCT01497197|528568228|FG000|Overall Study|No fertilisation|6|||
146561618|NCT01497197|528568229|FG001|Overall Study|No fertilisation|5|||
146561619|NCT01497197|528568228|FG000|Overall Study|Intention to freeze all embryos|0|||
146561620|NCT01497197|528568229|FG001|Overall Study|Intention to freeze all embryos|1|||
146767762|NCT00770965|529317412|FG001|Safety Set|Protocol deviation|0|||
146767763|NCT00770965|529317413|FG002|Safety Set|Protocol deviation|1|||
146767764|NCT00770965|529317414|FG003|Safety Set|Protocol deviation|0|||
146767765|NCT00770965|529317411|FG000|Excluded Set|Administrative problems|14|||
146561621|NCT01497197|528568228|FG000|Overall Study|All embryos discarded|0|||
146561622|NCT01497197|528568229|FG001|Overall Study|All embryos discarded|3|||
146561623|NCT01497197|528568228|FG000|Overall Study|Other|3|||
146561624|NCT01497197|528568229|FG001|Overall Study|Other|1|||
146906368|NCT00258154|529822101|FG000|Overall Study|Adverse Event|1|||
146561625|NCT04734210|528568230|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
146561626|NCT04734210|528568231|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
146561627|NCT04734210|528568232|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
146561628|NCT04734210|528568230|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
146561629|NCT04734210|528568231|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
146767766|NCT00770965|529317412|FG001|Excluded Set|Administrative problems|12|||
146906369|NCT00258154|529822102|FG001|Overall Study|Adverse Event|0|||
146906370|NCT00258154|529822101|FG000|Overall Study|Lost to Follow-up|0|||
146561630|NCT04734210|528568232|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
146906371|NCT00258154|529822102|FG001|Overall Study|Lost to Follow-up|1|||
146561631|NCT04734210|528568230|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
146561632|NCT04734210|528568231|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
146561633|NCT04734210|528568232|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
146561634|NCT04734210|528568230|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
146970156|NCT00902486|530050822|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
146561635|NCT04734210|528568231|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
146561636|NCT04734210|528568232|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
146561637|NCT02684461|528568233|FG000|Overall Study|Adverse Event|1|||
146561638|NCT02684461|528568234|FG001|Overall Study|Adverse Event|0|||
146561639|NCT02684461|528568235|FG002|Overall Study|Adverse Event|0|||
146561640|NCT02684461|528568233|FG000|Overall Study|Lack of Efficacy|1|||
146561641|NCT02684461|528568234|FG001|Overall Study|Lack of Efficacy|2|||
146561642|NCT02684461|528568235|FG002|Overall Study|Lack of Efficacy|0|||
146561643|NCT02390076|528568236|FG000|Overall Study|Lost to Follow-up|2|||
146561644|NCT02390076|528568237|FG001|Overall Study|Lost to Follow-up|1|||
146561645|NCT02390076|528568238|FG002|Overall Study|Lost to Follow-up|4|||
146561646|NCT01206517|528568241|FG000|Overall Study|Withdrawal by Subject|0|||
146561647|NCT01206517|528568242|FG001|Overall Study|Withdrawal by Subject|0|||
146561648|NCT01206517|528568243|FG002|Overall Study|Withdrawal by Subject|2|||
146561649|NCT01206517|528568244|FG003|Overall Study|Withdrawal by Subject|0|||
146561650|NCT01206517|528568245|FG004|Overall Study|Withdrawal by Subject|1|||
146561651|NCT01206517|528568246|FG005|Overall Study|Withdrawal by Subject|0|||
146561652|NCT03493958|528568247|FG000|Overall Study|Withdrawal by Subject|6|||
146561653|NCT03493958|528568247|FG000|Overall Study|Lost to Follow-up|7|||
146561654|NCT03493958|528568247|FG000|Overall Study|Did not complete all required study procedures|2|||
146561655|NCT01029535|528568248|FG000|Overall Study|Lost to Follow-up|24|||
146561656|NCT01029535|528568248|FG000|Overall Study|Protocol Violation|2|||
146561657|NCT01029535|528568248|FG000|Overall Study|Participant Withdrew Consent|2|||
146561658|NCT01029535|528568248|FG000|Overall Study|Adverse Event|1|||
146561659|NCT01029535|528568248|FG000|Overall Study|Use of Another Treatment|1|||
146561660|NCT01029535|528568248|FG000|Overall Study|Death|1|||
146641379|NCT02511106|528863027|FG001|Overall Study|Without specified reason|0|||
146641380|NCT01015638|528863028|FG000|Overall Study|Withdrawal by Subject|1|||
146561661|NCT01358734|528568251|FG000|Overall Study|Adverse Event|4|||
146561662|NCT01358734|528568252|FG001|Overall Study|Adverse Event|7|||
146641381|NCT01015638|528863029|FG001|Overall Study|Withdrawal by Subject|0|||
146906372|NCT00258154|529822101|FG000|Overall Study|Protocol Violation|2|||
146906373|NCT00258154|529822102|FG001|Overall Study|Protocol Violation|1|||
146906374|NCT00258154|529822101|FG000|Overall Study|Withdrawal by Subject|3|||
146906375|NCT00258154|529822102|FG001|Overall Study|Withdrawal by Subject|4|||
146906376|NCT00258154|529822101|FG000|Overall Study|Patient Moved|3|||
146906377|NCT00258154|529822102|FG001|Overall Study|Patient Moved|1|||
146906378|NCT03772327|529822103|FG000|Overall Study|Lost to Follow-up|3|||
146906379|NCT03772327|529822104|FG001|Overall Study|Lost to Follow-up|4|||
146906380|NCT03772327|529822103|FG000|Overall Study|Withdrawal by Subject|2|||
146906381|NCT03772327|529822104|FG001|Overall Study|Withdrawal by Subject|3|||
146906382|NCT04689828|529822105|FG000|Overall Study|Subject decision|5|||
146906383|NCT04689828|529822106|FG001|Overall Study|Subject decision|5|||
146906384|NCT04689828|529822105|FG000|Overall Study|Adverse Event|12|||
146906385|NCT04689828|529822106|FG001|Overall Study|Adverse Event|12|||
146906386|NCT04689828|529822105|FG000|Overall Study|Physician Decision|24|||
146906387|NCT04689828|529822106|FG001|Overall Study|Physician Decision|32|||
146906388|NCT04689828|529822105|FG000|Overall Study|Progressive disease|54|||
146906389|NCT04689828|529822106|FG001|Overall Study|Progressive disease|173|||
146906390|NCT04689828|529822105|FG000|Overall Study|Death|0|||
146906391|NCT04689828|529822106|FG001|Overall Study|Death|1|||
146906392|NCT04689828|529822105|FG000|Overall Study|Lost to Follow-up|1|||
146906393|NCT04689828|529822106|FG001|Overall Study|Lost to Follow-up|0|||
146906394|NCT04689828|529822105|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
146906395|NCT04689828|529822106|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
146906396|NCT04689828|529822105|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
146906397|NCT04689828|529822106|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
146641382|NCT01703754|528863032|FG000|Overall Study|Clinically significant disease progression|2|||
146906398|NCT04689828|529822105|FG000|Overall Study|Participants not treated|7|||
146906399|NCT04689828|529822106|FG001|Overall Study|Participants not treated|2|||
146906400|NCT00754390|529822107|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
146906401|NCT00754390|529822107|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
146561663|NCT01358734|528568253|FG002|Overall Study|Adverse Event|3|||
146561664|NCT01358734|528568251|FG000|Overall Study|Lack of Efficacy|0|||
146561665|NCT01358734|528568252|FG001|Overall Study|Lack of Efficacy|1|||
146561666|NCT01358734|528568253|FG002|Overall Study|Lack of Efficacy|3|||
146561667|NCT01358734|528568251|FG000|Overall Study|Withdrawal by Subject|1|||
146561668|NCT01358734|528568252|FG001|Overall Study|Withdrawal by Subject|6|||
146561669|NCT01358734|528568253|FG002|Overall Study|Withdrawal by Subject|3|||
146561670|NCT01358734|528568251|FG000|Overall Study|Death|3|||
146561671|NCT01358734|528568252|FG001|Overall Study|Death|7|||
146561672|NCT01358734|528568253|FG002|Overall Study|Death|2|||
146561673|NCT01358734|528568251|FG000|Overall Study|Progressive Disease|5|||
146561674|NCT01358734|528568252|FG001|Overall Study|Progressive Disease|13|||
146561675|NCT01358734|528568253|FG002|Overall Study|Progressive Disease|16|||
146561676|NCT01358734|528568251|FG000|Overall Study|Non-compliance with study drug|0|||
146561677|NCT01358734|528568252|FG001|Overall Study|Non-compliance with study drug|0|||
146561678|NCT01358734|528568253|FG002|Overall Study|Non-compliance with study drug|1|||
146561679|NCT01358734|528568251|FG000|Overall Study|Other|2|||
146561680|NCT01358734|528568252|FG001|Overall Study|Other|5|||
146561681|NCT01358734|528568253|FG002|Overall Study|Other|4|||
146561682|NCT01358734|528568251|FG000|Overall Study|Protocol Violation|0|||
146561683|NCT01358734|528568252|FG001|Overall Study|Protocol Violation|0|||
146561684|NCT01358734|528568253|FG002|Overall Study|Protocol Violation|2|||
146561685|NCT01822925|528568254|FG000|Overall Study|Adverse Event|1|||
146906402|NCT00754390|529822107|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
146641383|NCT01703754|528863033|FG001|Overall Study|Clinically significant disease progression|2|||
146641384|NCT01703754|528863034|FG002|Overall Study|Clinically significant disease progression|1|||
146641385|NCT01703754|528863032|FG000|Overall Study|Adverse Event|1|||
146641386|NCT01703754|528863033|FG001|Overall Study|Adverse Event|1|||
146641387|NCT01703754|528863034|FG002|Overall Study|Adverse Event|0|||
146641388|NCT01703754|528863032|FG000|Overall Study|Withdrawal by Subject|2|||
146641389|NCT01703754|528863033|FG001|Overall Study|Withdrawal by Subject|0|||
146641390|NCT01703754|528863034|FG002|Overall Study|Withdrawal by Subject|0|||
146767767|NCT00770965|529317413|FG002|Excluded Set|Administrative problems|12|||
146767768|NCT00770965|529317414|FG003|Excluded Set|Administrative problems|10|||
146906403|NCT00754390|529822107|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
146906404|NCT00847613|529822108|FG000|Overall Study|Ongoing at cut-off date|250|||
146906405|NCT00847613|529822109|FG001|Overall Study|Ongoing at cut-off date|265|||
146906406|NCT00847613|529822110|FG002|Overall Study|Ongoing at cut-off date|64|||
146906407|NCT00847613|529822111|FG003|Overall Study|Ongoing at cut-off date|64|||
146906408|NCT00847613|529822108|FG000|Overall Study|Death|1|||
146906409|NCT00847613|529822109|FG001|Overall Study|Death|1|||
146906410|NCT00847613|529822110|FG002|Overall Study|Death|0|||
146906411|NCT00847613|529822111|FG003|Overall Study|Death|0|||
146906412|NCT00847613|529822108|FG000|Overall Study|Adverse Event|36|||
146906413|NCT00847613|529822109|FG001|Overall Study|Adverse Event|26|||
146906414|NCT00847613|529822110|FG002|Overall Study|Adverse Event|5|||
146906415|NCT00847613|529822111|FG003|Overall Study|Adverse Event|6|||
146906416|NCT00847613|529822108|FG000|Overall Study|Lack of Efficacy|7|||
146641391|NCT01459497|528863038|FG000|Overall Study|Inability to meet trial constraints.|1|||
146641392|NCT01459497|528863039|FG001|Overall Study|Inability to meet trial constraints.|0|||
146641393|NCT01459497|528863038|FG000|Overall Study|Physician Decision|1|||
146641394|NCT01459497|528863039|FG001|Overall Study|Physician Decision|1|||
146641395|NCT01459497|528863038|FG000|Overall Study|Hospitalization.|0|||
146641396|NCT01459497|528863039|FG001|Overall Study|Hospitalization.|3|||
146641397|NCT01459497|528863038|FG000|Overall Study|Disease progression.|0|||
146641398|NCT01459497|528863039|FG001|Overall Study|Disease progression.|1|||
146641399|NCT03530124|528863040|FG000|Overall Study|Withdrawal by Subject|0|||
146641400|NCT03530124|528863041|FG001|Overall Study|Withdrawal by Subject|1|||
146641401|NCT03530124|528863040|FG000|Overall Study|Protocol Violation|1|||
146641402|NCT03530124|528863041|FG001|Overall Study|Protocol Violation|0|||
146641403|NCT03530124|528863040|FG000|Overall Study|Discharged prior to study completion|1|||
146641404|NCT03530124|528863041|FG001|Overall Study|Discharged prior to study completion|0|||
146641405|NCT03179319|528863042|FG000|Overall Study|Lost to Follow-up|6|||
146641406|NCT03179319|528863043|FG001|Overall Study|Lost to Follow-up|0|||
146641407|NCT01120717|528863044|FG000|Overall Study|Withdrawal by Subject|11|||
146641408|NCT01120717|528863045|FG001|Overall Study|Withdrawal by Subject|6|||
146641409|NCT01120717|528863044|FG000|Overall Study|Adverse Event|10|||
146641410|NCT01120717|528863045|FG001|Overall Study|Adverse Event|6|||
146641411|NCT01120717|528863044|FG000|Overall Study|Protocol Deviation|2|||
146641412|NCT01120717|528863045|FG001|Overall Study|Protocol Deviation|5|||
146767769|NCT00770965|529317411|FG000|Excluded Set|Withdrawal by Subject|1|||
146906417|NCT00847613|529822109|FG001|Overall Study|Lack of Efficacy|3|||
146906418|NCT00847613|529822110|FG002|Overall Study|Lack of Efficacy|3|||
146906419|NCT00847613|529822111|FG003|Overall Study|Lack of Efficacy|1|||
146906420|NCT00847613|529822108|FG000|Overall Study|Study terminated by Sponsor|1|||
146641413|NCT01120717|528863044|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
146906421|NCT00847613|529822109|FG001|Overall Study|Study terminated by Sponsor|0|||
146906422|NCT00847613|529822110|FG002|Overall Study|Study terminated by Sponsor|2|||
146906423|NCT00847613|529822111|FG003|Overall Study|Study terminated by Sponsor|1|||
146906424|NCT00847613|529822108|FG000|Overall Study|Lost to Follow-up|5|||
146906425|NCT00847613|529822109|FG001|Overall Study|Lost to Follow-up|0|||
146906426|NCT00847613|529822110|FG002|Overall Study|Lost to Follow-up|0|||
146906427|NCT00847613|529822111|FG003|Overall Study|Lost to Follow-up|3|||
146906428|NCT00847613|529822108|FG000|Overall Study|Protocol Violation|6|||
146906429|NCT00847613|529822109|FG001|Overall Study|Protocol Violation|6|||
146906430|NCT00847613|529822110|FG002|Overall Study|Protocol Violation|3|||
146906431|NCT00847613|529822111|FG003|Overall Study|Protocol Violation|1|||
146906432|NCT00847613|529822108|FG000|Overall Study|Pregnancy|1|||
146906433|NCT00847613|529822109|FG001|Overall Study|Pregnancy|1|||
146906434|NCT00847613|529822110|FG002|Overall Study|Pregnancy|0|||
146906435|NCT00847613|529822111|FG003|Overall Study|Pregnancy|0|||
146906436|NCT00847613|529822108|FG000|Overall Study|Site closure|1|||
146906437|NCT00847613|529822109|FG001|Overall Study|Site closure|0|||
146906438|NCT00847613|529822110|FG002|Overall Study|Site closure|0|||
146906439|NCT00847613|529822111|FG003|Overall Study|Site closure|1|||
146906440|NCT00847613|529822108|FG000|Overall Study|Withdrawal by Subject|8|||
146906441|NCT00847613|529822109|FG001|Overall Study|Withdrawal by Subject|11|||
146906442|NCT00847613|529822110|FG002|Overall Study|Withdrawal by Subject|2|||
146906443|NCT00847613|529822111|FG003|Overall Study|Withdrawal by Subject|2|||
146906444|NCT00847613|529822108|FG000|Overall Study|Participant moved|4|||
146906445|NCT00847613|529822109|FG001|Overall Study|Participant moved|1|||
146906446|NCT00847613|529822110|FG002|Overall Study|Participant moved|0|||
146906447|NCT00847613|529822111|FG003|Overall Study|Participant moved|0|||
146906448|NCT00847613|529822108|FG000|Overall Study|Sponsor request|0|||
146906449|NCT00847613|529822109|FG001|Overall Study|Sponsor request|1|||
146906450|NCT00847613|529822110|FG002|Overall Study|Sponsor request|0|||
146906451|NCT00847613|529822111|FG003|Overall Study|Sponsor request|0|||
146906452|NCT00847613|529822108|FG000|Overall Study|Randomized, but not treated|0|||
146906453|NCT00847613|529822109|FG001|Overall Study|Randomized, but not treated|3|||
146906454|NCT00847613|529822110|FG002|Overall Study|Randomized, but not treated|0|||
146906455|NCT00847613|529822111|FG003|Overall Study|Randomized, but not treated|0|||
146906456|NCT00847613|529822108|FG000|Overall Study|Other|1|||
146906457|NCT00847613|529822109|FG001|Overall Study|Other|1|||
146906458|NCT00847613|529822110|FG002|Overall Study|Other|2|||
146906459|NCT00847613|529822111|FG003|Overall Study|Other|0|||
146906460|NCT02493751|529822115|FG000|Overall Study|Withdrawal by Subject|2|||
146906461|NCT02493751|529822116|FG001|Overall Study|Withdrawal by Subject|8|||
146906462|NCT02493751|529822115|FG000|Overall Study|Death|6|||
146906463|NCT02493751|529822116|FG001|Overall Study|Death|13|||
146906464|NCT02493751|529822115|FG000|Overall Study|Lost to Follow-up|2|||
146906465|NCT02493751|529822116|FG001|Overall Study|Lost to Follow-up|3|||
146906466|NCT02493751|529822115|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
146906467|NCT02493751|529822116|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
146906468|NCT00184054|529822117|FG000|Overall Study|Adverse Event|1|||
146906469|NCT02332915|529822120|FG000|Overall Study|Moved out of region|3|||
146906470|NCT02332915|529822121|FG001|Overall Study|Moved out of region|0|||
146906471|NCT02332915|529822120|FG000|Overall Study|Unrelated illness|1|||
146906472|NCT02332915|529822121|FG001|Overall Study|Unrelated illness|1|||
146906473|NCT02332915|529822120|FG000|Overall Study|Travel distance prohibitive|0|||
146906474|NCT02332915|529822121|FG001|Overall Study|Travel distance prohibitive|1|||
146906475|NCT02332915|529822120|FG000|Overall Study|did not meet inclusion criteria|2|||
146906476|NCT02332915|529822121|FG001|Overall Study|did not meet inclusion criteria|4|||
146906477|NCT01901328|529822125|FG000|Overall Study|Lost to Follow-up|1|||
146906478|NCT01901328|529822126|FG001|Overall Study|Lost to Follow-up|0|||
146906479|NCT01901328|529822125|FG000|Overall Study|Physician Decision|0|||
146906480|NCT01901328|529822126|FG001|Overall Study|Physician Decision|1|||
146906481|NCT01901328|529822125|FG000|Overall Study|Protocol Violation|1|||
146906482|NCT01901328|529822126|FG001|Overall Study|Protocol Violation|1|||
146906483|NCT01901328|529822125|FG000|Overall Study|Study Terminated by Sponsor|19|||
146906484|NCT01901328|529822126|FG001|Overall Study|Study Terminated by Sponsor|16|||
146906485|NCT01901328|529822125|FG000|Overall Study|Withdrawal by Subject|1|||
146906486|NCT01901328|529822126|FG001|Overall Study|Withdrawal by Subject|2|||
146906487|NCT01901328|529822125|FG000|Overall Study|Lack of Efficacy|0|||
146906488|NCT01901328|529822126|FG001|Overall Study|Lack of Efficacy|1|||
146906489|NCT05847881|529822129|FG000|Overall Study|Principal Investigator Decision|8|||
146906490|NCT05847881|529822129|FG000|Overall Study|Withdrawal by Subject|2|||
146906491|NCT03439345|529823571|FG000|Overall Study|Lost to Follow-up|0|||
146906492|NCT03439345|529823572|FG001|Overall Study|Lost to Follow-up|1|||
146906493|NCT03439345|529823571|FG000|Overall Study|Consent withdrawn|0|||
146906494|NCT03439345|529823572|FG001|Overall Study|Consent withdrawn|1|||
146906495|NCT05781542|529823573|FG000|Overall Study|Lost to Follow-up|1|||
146906496|NCT05781542|529823574|FG001|Overall Study|Lost to Follow-up|0|||
146906497|NCT05781542|529823575|FG002|Overall Study|Lost to Follow-up|1|||
146906498|NCT01843374|529823578|FG000|Overall Study|Death|155|||
146906499|NCT01843374|529823579|FG001|Overall Study|Death|313|||
146906500|NCT01843374|529823578|FG000|Overall Study|Withdrawal by Subject|14|||
146906501|NCT01843374|529823579|FG001|Overall Study|Withdrawal by Subject|20|||
146906502|NCT01843374|529823578|FG000|Overall Study|Withdrawing due to Other reason|20|||
146906503|NCT01843374|529823579|FG001|Overall Study|Withdrawing due to Other reason|46|||
146906504|NCT03704051|529823580|FG000|Overall Study|Withdrawal by Subject|4|||
146906505|NCT03704051|529823581|FG001|Overall Study|Withdrawal by Subject|0|||
146906506|NCT02495077|529823582|FG000|Overall Study|Adverse Event|0|||
146906507|NCT02495077|529823583|FG001|Overall Study|Adverse Event|1|||
146561686|NCT01822925|528568255|FG001|Overall Study|Adverse Event|1|||
146561687|NCT01822925|528568256|FG002|Overall Study|Adverse Event|1|||
146561688|NCT01822925|528568257|FG003|Overall Study|Adverse Event|1|||
146561689|NCT01822925|528568254|FG000|Overall Study|Lost to Follow-up|0|||
146906508|NCT02495077|529823584|FG002|Overall Study|Adverse Event|1|||
146906509|NCT02495077|529823585|FG003|Overall Study|Adverse Event|0|||
146906510|NCT02495077|529823582|FG000|Overall Study|Death|3|||
146906511|NCT02495077|529823583|FG001|Overall Study|Death|5|||
146906512|NCT02495077|529823584|FG002|Overall Study|Death|0|||
146906513|NCT02495077|529823585|FG003|Overall Study|Death|0|||
146906514|NCT02495077|529823582|FG000|Overall Study|Lost to Follow-up|6|||
146906515|NCT02495077|529823583|FG001|Overall Study|Lost to Follow-up|4|||
146906516|NCT02495077|529823584|FG002|Overall Study|Lost to Follow-up|0|||
146561690|NCT01822925|528568255|FG001|Overall Study|Lost to Follow-up|1|||
146561691|NCT01822925|528568256|FG002|Overall Study|Lost to Follow-up|0|||
146561692|NCT01822925|528568257|FG003|Overall Study|Lost to Follow-up|0|||
146561693|NCT01822925|528568254|FG000|Overall Study|Protocol Violation|1|||
146906517|NCT02495077|529823585|FG003|Overall Study|Lost to Follow-up|0|||
146906518|NCT02495077|529823582|FG000|Overall Study|Physician Decision|2|||
146906519|NCT02495077|529823583|FG001|Overall Study|Physician Decision|1|||
146906520|NCT02495077|529823584|FG002|Overall Study|Physician Decision|4|||
146906521|NCT02495077|529823585|FG003|Overall Study|Physician Decision|0|||
146906522|NCT02495077|529823582|FG000|Overall Study|Protocol Violation|0|||
146906523|NCT02495077|529823583|FG001|Overall Study|Protocol Violation|1|||
146906524|NCT02495077|529823584|FG002|Overall Study|Protocol Violation|0|||
146906525|NCT02495077|529823585|FG003|Overall Study|Protocol Violation|0|||
146906526|NCT02495077|529823582|FG000|Overall Study|Screen Failure|0|||
146906527|NCT02495077|529823583|FG001|Overall Study|Screen Failure|0|||
146906528|NCT02495077|529823584|FG002|Overall Study|Screen Failure|0|||
146906529|NCT02495077|529823585|FG003|Overall Study|Screen Failure|48|||
146906530|NCT02495077|529823582|FG000|Overall Study|Withdrawal by Subject|7|||
146906531|NCT02495077|529823583|FG001|Overall Study|Withdrawal by Subject|7|||
146906532|NCT02495077|529823584|FG002|Overall Study|Withdrawal by Subject|7|||
146906533|NCT02495077|529823585|FG003|Overall Study|Withdrawal by Subject|0|||
146906534|NCT02495077|529823582|FG000|Overall Study|Covid-19 research restrictions|1|||
146906535|NCT02495077|529823583|FG001|Overall Study|Covid-19 research restrictions|0|||
146906536|NCT02495077|529823584|FG002|Overall Study|Covid-19 research restrictions|0|||
146906537|NCT02495077|529823585|FG003|Overall Study|Covid-19 research restrictions|0|||
146906538|NCT02495077|529823582|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
146906539|NCT02495077|529823583|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
146561694|NCT01822925|528568255|FG001|Overall Study|Protocol Violation|0|||
146906540|NCT02495077|529823584|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
146906541|NCT02495077|529823585|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
146906542|NCT02495077|529823582|FG000|Overall Study|Incarcerated|0|||
146906543|NCT02495077|529823583|FG001|Overall Study|Incarcerated|1|||
146906544|NCT02495077|529823584|FG002|Overall Study|Incarcerated|0|||
146906545|NCT02495077|529823585|FG003|Overall Study|Incarcerated|0|||
146561695|NCT01822925|528568256|FG002|Overall Study|Protocol Violation|0|||
146561696|NCT01822925|528568257|FG003|Overall Study|Protocol Violation|1|||
146906546|NCT02495077|529823582|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
146906547|NCT02495077|529823583|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
146906548|NCT02495077|529823584|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
146906549|NCT02495077|529823585|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
146906550|NCT02495077|529823582|FG000|Overall Study|Timing of transplant and randomization|0|||
146906551|NCT02495077|529823583|FG001|Overall Study|Timing of transplant and randomization|0|||
146906552|NCT02495077|529823584|FG002|Overall Study|Timing of transplant and randomization|5|||
146906553|NCT02495077|529823585|FG003|Overall Study|Timing of transplant and randomization|0|||
146641414|NCT01120717|528863045|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
146641415|NCT01120717|528863044|FG000|Overall Study|Lost to Follow-up|2|||
146641416|NCT01120717|528863045|FG001|Overall Study|Lost to Follow-up|3|||
146641417|NCT01120717|528863044|FG000|Overall Study|Death|3|||
146641418|NCT01120717|528863045|FG001|Overall Study|Death|1|||
146641419|NCT01120717|528863044|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
146641420|NCT01120717|528863045|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
146641421|NCT02379637|528863050|FG000|Overall Study|Protocol Violation|0|||
146641422|NCT02379637|528863051|FG001|Overall Study|Protocol Violation|1|||
146906554|NCT00430781|529823586|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
146906555|NCT00430781|529823587|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
146906556|NCT00430781|529823588|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
146906557|NCT00430781|529823586|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
146906558|NCT00430781|529823587|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
146906559|NCT00430781|529823588|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
146906560|NCT00430781|529823586|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
146906561|NCT00430781|529823587|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
146641423|NCT02379637|528863050|FG000|Overall Study|Adverse Event|1|||
146641424|NCT02379637|528863051|FG001|Overall Study|Adverse Event|0|||
146641425|NCT02379637|528863050|FG000|Overall Study|Withdrawal by Subject|1|||
146641426|NCT02379637|528863051|FG001|Overall Study|Withdrawal by Subject|0|||
146641427|NCT01309282|528863053|FG000|Overall Study|Lost to Follow-up|1|||
146906562|NCT00430781|529823588|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
146906563|NCT00430781|529823586|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
146906564|NCT00430781|529823587|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
146906565|NCT00430781|529823588|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
146906566|NCT00430781|529823586|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
146906567|NCT00430781|529823587|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
146906568|NCT00430781|529823588|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
146906569|NCT00430781|529823586|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
146641428|NCT02445794|528863054|FG000|Overall Study|Adverse Event|0|||
146641429|NCT02445794|528863055|FG001|Overall Study|Adverse Event|0|||
146906570|NCT00430781|529823587|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
146906571|NCT00430781|529823588|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
146906572|NCT00430781|529823586|FG000|Interim Analysis; 11 February 2008|Death|0|||
146906573|NCT00430781|529823587|FG001|Interim Analysis; 11 February 2008|Death|1|||
146906574|NCT00430781|529823588|FG002|Interim Analysis; 11 February 2008|Death|0|||
146906575|NCT00430781|529823586|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
146906576|NCT00430781|529823587|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
146906577|NCT00430781|529823588|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
146906578|NCT00430781|529823586|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
146906579|NCT00430781|529823587|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
146906580|NCT00430781|529823588|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
146906581|NCT00430781|529823586|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
146906582|NCT00430781|529823587|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
146906583|NCT00430781|529823588|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
146641430|NCT02445794|528863056|FG002|Overall Study|Adverse Event|2|||
146641431|NCT02445794|528863057|FG003|Overall Study|Adverse Event|0|||
146906584|NCT00430781|529823586|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
146906585|NCT00430781|529823587|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
146561697|NCT01822925|528568254|FG000|Overall Study|Withdrawal by Subject|2|||
146561698|NCT01822925|528568255|FG001|Overall Study|Withdrawal by Subject|0|||
146561699|NCT01822925|528568256|FG002|Overall Study|Withdrawal by Subject|2|||
146561700|NCT01822925|528568257|FG003|Overall Study|Withdrawal by Subject|2|||
146561701|NCT01822925|528568254|FG000|Overall Study|Taking prohibited medication|2|||
146561702|NCT01822925|528568255|FG001|Overall Study|Taking prohibited medication|0|||
146561703|NCT01822925|528568256|FG002|Overall Study|Taking prohibited medication|0|||
146561704|NCT01822925|528568257|FG003|Overall Study|Taking prohibited medication|1|||
146561705|NCT00553254|528568262|FG000|Overall Study|Death|3|||
146561706|NCT00553254|528568263|FG001|Overall Study|Death|6|||
146561707|NCT00553254|528568264|FG002|Overall Study|Death|25|||
146561708|NCT00553254|528568262|FG000|Overall Study|Lost to Follow-up|0|||
146561709|NCT00553254|528568263|FG001|Overall Study|Lost to Follow-up|0|||
146561710|NCT00553254|528568264|FG002|Overall Study|Lost to Follow-up|2|||
146561711|NCT00553254|528568262|FG000|Overall Study|Withdrawal by Subject|2|||
146767770|NCT00770965|529317412|FG001|Excluded Set|Withdrawal by Subject|1|||
146561712|NCT00553254|528568263|FG001|Overall Study|Withdrawal by Subject|0|||
146561713|NCT00553254|528568264|FG002|Overall Study|Withdrawal by Subject|2|||
146767771|NCT00770965|529317413|FG002|Excluded Set|Withdrawal by Subject|2|||
146906586|NCT00430781|529823588|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
146906587|NCT00430781|529823586|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
146906588|NCT00430781|529823587|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
146906589|NCT00430781|529823588|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
146906590|NCT00430781|529823586|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
146561714|NCT00553254|528568262|FG000|Overall Study|Study terminated by Sponsor|0|||
146906591|NCT00430781|529823587|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
146906592|NCT00430781|529823588|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
146767772|NCT00770965|529317414|FG003|Excluded Set|Withdrawal by Subject|3|||
146906593|NCT00430781|529823586|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
146906594|NCT00430781|529823587|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
146906595|NCT00430781|529823588|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
146906596|NCT00430781|529823586|FG000|Final Analysis; 31 July 2008|Other|0|||
146561715|NCT00553254|528568263|FG001|Overall Study|Study terminated by Sponsor|0|||
146767773|NCT00880048|529317431|FG000|Overall Study|Adverse Event|2|||
146970157|NCT00902486|530050823|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
146561716|NCT00553254|528568264|FG002|Overall Study|Study terminated by Sponsor|1|||
146561717|NCT00553254|528568262|FG000|Overall Study|Other|1|||
146561718|NCT00553254|528568263|FG001|Overall Study|Other|0|||
146561719|NCT00553254|528568264|FG002|Overall Study|Other|13|||
146561720|NCT02314923|528568267|FG000|Overall Study|Death|0|||
146561721|NCT02314923|528568268|FG001|Overall Study|Death|0|||
146561722|NCT02314923|528568269|FG002|Overall Study|Death|0|||
146561723|NCT02314923|528568270|FG003|Overall Study|Death|1|||
146561724|NCT02314923|528568271|FG004|Overall Study|Death|0|||
146561725|NCT02314923|528568272|FG005|Overall Study|Death|0|||
146561726|NCT02314923|528568273|FG006|Overall Study|Death|0|||
146561727|NCT02314923|528568274|FG007|Overall Study|Death|0|||
146561728|NCT02314923|528568275|FG008|Overall Study|Death|0|||
146561729|NCT02314923|528568276|FG009|Overall Study|Death|0|||
146561730|NCT02314923|528568267|FG000|Overall Study|Lost to Follow-up|2|||
146561731|NCT02314923|528568268|FG001|Overall Study|Lost to Follow-up|3|||
146561732|NCT02314923|528568269|FG002|Overall Study|Lost to Follow-up|1|||
146561733|NCT02314923|528568270|FG003|Overall Study|Lost to Follow-up|0|||
146561734|NCT02314923|528568271|FG004|Overall Study|Lost to Follow-up|0|||
146561735|NCT02314923|528568272|FG005|Overall Study|Lost to Follow-up|0|||
146906597|NCT00430781|529823587|FG001|Final Analysis; 31 July 2008|Other|1|||
146561736|NCT02314923|528568273|FG006|Overall Study|Lost to Follow-up|3|||
146561737|NCT02314923|528568274|FG007|Overall Study|Lost to Follow-up|4|||
146561738|NCT02314923|528568275|FG008|Overall Study|Lost to Follow-up|2|||
146561739|NCT02314923|528568276|FG009|Overall Study|Lost to Follow-up|0|||
146561740|NCT02314923|528568267|FG000|Overall Study|Withdrawal by Subject|0|||
146561741|NCT02314923|528568268|FG001|Overall Study|Withdrawal by Subject|0|||
146561742|NCT02314923|528568269|FG002|Overall Study|Withdrawal by Subject|1|||
146561743|NCT02314923|528568270|FG003|Overall Study|Withdrawal by Subject|0|||
146561744|NCT02314923|528568271|FG004|Overall Study|Withdrawal by Subject|1|||
146561745|NCT02314923|528568272|FG005|Overall Study|Withdrawal by Subject|0|||
146561746|NCT02314923|528568273|FG006|Overall Study|Withdrawal by Subject|1|||
146561747|NCT02314923|528568274|FG007|Overall Study|Withdrawal by Subject|0|||
146561748|NCT02314923|528568275|FG008|Overall Study|Withdrawal by Subject|0|||
146561749|NCT02314923|528568276|FG009|Overall Study|Withdrawal by Subject|0|||
146906598|NCT00430781|529823588|FG002|Final Analysis; 31 July 2008|Other|0|||
146561750|NCT02314923|528568267|FG000|Overall Study|Physician Decision|0|||
146561751|NCT02314923|528568268|FG001|Overall Study|Physician Decision|1|||
146561752|NCT02314923|528568269|FG002|Overall Study|Physician Decision|0|||
146561753|NCT02314923|528568270|FG003|Overall Study|Physician Decision|0|||
146561754|NCT02314923|528568271|FG004|Overall Study|Physician Decision|0|||
146561755|NCT02314923|528568272|FG005|Overall Study|Physician Decision|0|||
146561756|NCT02314923|528568273|FG006|Overall Study|Physician Decision|0|||
146561757|NCT02314923|528568274|FG007|Overall Study|Physician Decision|0|||
146561758|NCT02314923|528568275|FG008|Overall Study|Physician Decision|0|||
146561759|NCT02314923|528568276|FG009|Overall Study|Physician Decision|0|||
146561760|NCT02314923|528568267|FG000|Overall Study|Participant unavailable|0|||
146561761|NCT02314923|528568268|FG001|Overall Study|Participant unavailable|0|||
146561762|NCT02314923|528568269|FG002|Overall Study|Participant unavailable|0|||
146561763|NCT02314923|528568270|FG003|Overall Study|Participant unavailable|0|||
146561764|NCT02314923|528568271|FG004|Overall Study|Participant unavailable|0|||
146561765|NCT02314923|528568272|FG005|Overall Study|Participant unavailable|1|||
146561766|NCT02314923|528568273|FG006|Overall Study|Participant unavailable|0|||
146561767|NCT02314923|528568274|FG007|Overall Study|Participant unavailable|0|||
146561768|NCT02314923|528568275|FG008|Overall Study|Participant unavailable|0|||
146561769|NCT02314923|528568276|FG009|Overall Study|Participant unavailable|0|||
146561770|NCT02314923|528568267|FG000|Overall Study|Screen failure|0|||
146561771|NCT02314923|528568268|FG001|Overall Study|Screen failure|0|||
146561772|NCT02314923|528568269|FG002|Overall Study|Screen failure|0|||
146561773|NCT02314923|528568270|FG003|Overall Study|Screen failure|0|||
146561774|NCT02314923|528568271|FG004|Overall Study|Screen failure|0|||
146561775|NCT02314923|528568272|FG005|Overall Study|Screen failure|0|||
146561776|NCT02314923|528568273|FG006|Overall Study|Screen failure|1|||
146561777|NCT02314923|528568274|FG007|Overall Study|Screen failure|0|||
146561778|NCT02314923|528568275|FG008|Overall Study|Screen failure|0|||
146561779|NCT02314923|528568276|FG009|Overall Study|Screen failure|0|||
146561780|NCT02314923|528568267|FG000|Overall Study|Participant relocation|1|||
146561781|NCT02314923|528568268|FG001|Overall Study|Participant relocation|0|||
146561782|NCT02314923|528568269|FG002|Overall Study|Participant relocation|0|||
146561783|NCT02314923|528568270|FG003|Overall Study|Participant relocation|0|||
146561784|NCT02314923|528568271|FG004|Overall Study|Participant relocation|0|||
146561785|NCT02314923|528568272|FG005|Overall Study|Participant relocation|0|||
146561786|NCT02314923|528568273|FG006|Overall Study|Participant relocation|0|||
146561787|NCT02314923|528568274|FG007|Overall Study|Participant relocation|1|||
146561788|NCT02314923|528568275|FG008|Overall Study|Participant relocation|0|||
146561789|NCT02314923|528568276|FG009|Overall Study|Participant relocation|0|||
146641432|NCT01136785|528863058|FG000|Overall Study|Protocol Violation|2|||
146641433|NCT01136785|528863059|FG001|Overall Study|Protocol Violation|1|||
146641434|NCT00233064|528863060|FG000|Overall Study|Lost to Follow-up|7|||
146641435|NCT00233064|528863061|FG001|Overall Study|Lost to Follow-up|7|||
146641436|NCT00233064|528863060|FG000|Overall Study|Withdrawal by Subject|5|||
146641437|NCT00233064|528863061|FG001|Overall Study|Withdrawal by Subject|3|||
146641438|NCT00233064|528863060|FG000|Overall Study|Death|0|||
146641439|NCT00233064|528863061|FG001|Overall Study|Death|1|||
146641440|NCT00233064|528863060|FG000|Overall Study|Relocation|0|||
146641441|NCT00233064|528863061|FG001|Overall Study|Relocation|1|||
146641442|NCT00233064|528863060|FG000|Overall Study|Protocol Violation|1|||
146641443|NCT00233064|528863061|FG001|Overall Study|Protocol Violation|0|||
146641444|NCT00233064|528863060|FG000|Overall Study|Moved to Dom. Republic|1|||
146641445|NCT00233064|528863061|FG001|Overall Study|Moved to Dom. Republic|0|||
146641446|NCT04976192|528863064|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146641447|NCT04976192|528863065|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
146641448|NCT04976192|528863066|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146641449|NCT04976192|528863067|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146641450|NCT04976192|528863068|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146641451|NCT04976192|528863069|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146641452|NCT04976192|528863070|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146641453|NCT04976192|528863071|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146641454|NCT04976192|528863072|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146641455|NCT04976192|528863073|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146641456|NCT04976192|528863064|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
146641457|NCT04976192|528863065|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
146641458|NCT04976192|528863066|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
146641459|NCT04976192|528863067|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
146641460|NCT04976192|528863068|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146641461|NCT04976192|528863069|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146641462|NCT04976192|528863070|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146641463|NCT04976192|528863071|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146641464|NCT04976192|528863072|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146641465|NCT04976192|528863073|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146641466|NCT04976192|528863064|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
146641467|NCT04976192|528863065|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
146641468|NCT04976192|528863066|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
146641469|NCT04976192|528863067|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
146641470|NCT04976192|528863068|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
146641471|NCT04976192|528863069|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
146641472|NCT04976192|528863070|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
146641473|NCT04976192|528863071|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
146641474|NCT04976192|528863072|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
146641475|NCT04976192|528863073|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
146641476|NCT04976192|528863064|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146641477|NCT04976192|528863065|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146641478|NCT04976192|528863066|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146561790|NCT05134649|528568277|FG000|Overall Study|Lost to Follow-up|12|||
146641479|NCT04976192|528863067|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146641480|NCT04976192|528863068|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
146641481|NCT04976192|528863069|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
146641482|NCT04976192|528863070|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
146767774|NCT00880048|529317432|FG001|Overall Study|Adverse Event|3|||
146561791|NCT05134649|528568277|FG000|Overall Study|Withdrawal by Subject|14|||
146561792|NCT05134649|528568277|FG000|Overall Study|Pregnancy|1|||
146561793|NCT05134649|528568277|FG000|Overall Study|Other, not specified|3|||
146561794|NCT03232567|528568281|FG000|Overall Study|Withdrawal by Subject|0|||
146561795|NCT03232567|528568282|FG001|Overall Study|Withdrawal by Subject|1|||
146561796|NCT03232567|528568283|FG002|Overall Study|Withdrawal by Subject|0|||
146561797|NCT03232567|528568284|FG003|Overall Study|Withdrawal by Subject|0|||
146561798|NCT01153516|528568285|FG000|Overall Study|Both subjects refused surgery|2|||
146561799|NCT01153516|528568286|FG001|Overall Study|Both subjects refused surgery|0|||
146561800|NCT05837481|528568287|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
146561801|NCT05837481|528568288|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
146561802|NCT04581395|528568289|FG000|Overall Study|Protocol Violation|4|||
146561803|NCT04581395|528568290|FG001|Overall Study|Protocol Violation|3|||
146561804|NCT04581395|528568291|FG002|Overall Study|Protocol Violation|2|||
146561805|NCT04581395|528568289|FG000|Overall Study|Physician Decision|0|||
146561806|NCT04581395|528568290|FG001|Overall Study|Physician Decision|1|||
146906599|NCT00430781|529823586|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
146906600|NCT00430781|529823587|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
146906601|NCT00430781|529823588|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
146906602|NCT00430781|529823586|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
146906603|NCT00430781|529823587|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
146906604|NCT00430781|529823588|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
146906605|NCT00430781|529823586|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
146906606|NCT00430781|529823587|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
146906607|NCT00430781|529823588|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
146906608|NCT00430781|529823586|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
146906609|NCT00430781|529823587|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
146906610|NCT00430781|529823588|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
146906611|NCT00430781|529823586|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
146906612|NCT00430781|529823587|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
146906613|NCT00430781|529823588|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
146906614|NCT00430781|529823586|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
146906615|NCT00430781|529823587|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
146906616|NCT00430781|529823588|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
146906617|NCT00430781|529823586|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
146906618|NCT00430781|529823587|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
146906619|NCT00430781|529823588|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
146906620|NCT03230097|529823589|FG000|Overall Study|Adverse Event|2|||
146906621|NCT03230097|529823590|FG001|Overall Study|Adverse Event|1|||
146906622|NCT03230097|529823589|FG000|Overall Study|non-compliance|0|||
146906623|NCT03230097|529823590|FG001|Overall Study|non-compliance|1|||
146906624|NCT03230097|529823589|FG000|Overall Study|Lost to Follow-up|2|||
146906625|NCT03230097|529823590|FG001|Overall Study|Lost to Follow-up|4|||
146906626|NCT03230097|529823589|FG000|Overall Study|Withdrawal by Subject|7|||
146906627|NCT03230097|529823590|FG001|Overall Study|Withdrawal by Subject|3|||
146906628|NCT03230097|529823589|FG000|Overall Study|Trial termination|4|||
146906629|NCT03230097|529823590|FG001|Overall Study|Trial termination|5|||
146906630|NCT03230097|529823589|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
146906631|NCT03230097|529823590|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
146906632|NCT03230097|529823589|FG000|Overall Study|outcome event|0|||
146906633|NCT03230097|529823590|FG001|Overall Study|outcome event|1|||
146906634|NCT03056287|529823591|FG000|Overall Study|Withdrawal by Subject|0|||
146561807|NCT04581395|528568291|FG002|Overall Study|Physician Decision|0|||
146561808|NCT01605097|528568292|FG000|Overall Study|Protocol Violation|1|||
146561809|NCT03038620|528568293|FG000|Overall Study|Lost to Follow-up|18|||
146561810|NCT03038620|528568294|FG001|Overall Study|Lost to Follow-up|23|||
146641483|NCT04976192|528863071|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
146641484|NCT04976192|528863072|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
146641485|NCT04976192|528863073|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
146641486|NCT04976192|528863064|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146641487|NCT04976192|528863065|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146641488|NCT04976192|528863066|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146641489|NCT04976192|528863067|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146641490|NCT04976192|528863068|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
146641491|NCT04976192|528863069|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146767775|NCT00880048|529317433|FG002|Overall Study|Adverse Event|5|||
146767776|NCT00880048|529317431|FG000|Overall Study|Lack of Efficacy|1|||
146767777|NCT00880048|529317432|FG001|Overall Study|Lack of Efficacy|2|||
146767778|NCT00880048|529317433|FG002|Overall Study|Lack of Efficacy|2|||
146767779|NCT00880048|529317431|FG000|Overall Study|Protocol Violation|4|||
146767780|NCT00880048|529317432|FG001|Overall Study|Protocol Violation|6|||
146767781|NCT00880048|529317433|FG002|Overall Study|Protocol Violation|5|||
146767782|NCT00880048|529317431|FG000|Overall Study|Lost to Follow-up|6|||
146767783|NCT00880048|529317432|FG001|Overall Study|Lost to Follow-up|6|||
146767784|NCT00880048|529317433|FG002|Overall Study|Lost to Follow-up|5|||
146767785|NCT00880048|529317431|FG000|Overall Study|Physician Decision|1|||
146906635|NCT03056287|529823592|FG001|Overall Study|Withdrawal by Subject|1|||
146906636|NCT03056287|529823593|FG002|Overall Study|Withdrawal by Subject|0|||
146906637|NCT03056287|529823594|FG003|Overall Study|Withdrawal by Subject|0|||
146561811|NCT03038620|528568293|FG000|Overall Study|Withdrawal by Subject|0|||
146561812|NCT03038620|528568294|FG001|Overall Study|Withdrawal by Subject|15|||
146561813|NCT03038620|528568293|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
146561814|NCT03038620|528568294|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
146561815|NCT02106832|528568301|FG000|Overall Study|Adverse Event|1|||
146561816|NCT02106832|528568302|FG001|Overall Study|Adverse Event|2|||
146561817|NCT02106832|528568303|FG002|Overall Study|Adverse Event|3|||
146561818|NCT02106832|528568304|FG003|Overall Study|Adverse Event|0|||
146561819|NCT02106832|528568301|FG000|Overall Study|Death|4|||
146561820|NCT02106832|528568302|FG001|Overall Study|Death|4|||
146561821|NCT02106832|528568303|FG002|Overall Study|Death|1|||
146561822|NCT02106832|528568304|FG003|Overall Study|Death|4|||
146561823|NCT02106832|528568301|FG000|Overall Study|Deterioration of general conditions|0|||
146561824|NCT02106832|528568302|FG001|Overall Study|Deterioration of general conditions|0|||
146561825|NCT02106832|528568303|FG002|Overall Study|Deterioration of general conditions|1|||
146561826|NCT02106832|528568304|FG003|Overall Study|Deterioration of general conditions|0|||
146561827|NCT02106832|528568301|FG000|Overall Study|Lost to Follow-up|0|||
146561828|NCT02106832|528568302|FG001|Overall Study|Lost to Follow-up|1|||
146561829|NCT02106832|528568303|FG002|Overall Study|Lost to Follow-up|1|||
146561830|NCT02106832|528568304|FG003|Overall Study|Lost to Follow-up|3|||
146561831|NCT02106832|528568301|FG000|Overall Study|Physician Decision|1|||
146561832|NCT02106832|528568302|FG001|Overall Study|Physician Decision|0|||
146561833|NCT02106832|528568303|FG002|Overall Study|Physician Decision|0|||
146561834|NCT02106832|528568304|FG003|Overall Study|Physician Decision|0|||
146561835|NCT02106832|528568301|FG000|Overall Study|Protocol Violation|0|||
146561836|NCT02106832|528568302|FG001|Overall Study|Protocol Violation|0|||
146561837|NCT02106832|528568303|FG002|Overall Study|Protocol Violation|0|||
146561838|NCT02106832|528568304|FG003|Overall Study|Protocol Violation|1|||
146561839|NCT02106832|528568301|FG000|Overall Study|Withdrawal by Subject|17|||
146561840|NCT02106832|528568302|FG001|Overall Study|Withdrawal by Subject|17|||
146561841|NCT02106832|528568303|FG002|Overall Study|Withdrawal by Subject|10|||
146561842|NCT02106832|528568304|FG003|Overall Study|Withdrawal by Subject|7|||
146561843|NCT02106832|528568301|FG000|Overall Study|Technical problems|0|||
146561844|NCT02106832|528568302|FG001|Overall Study|Technical problems|1|||
146561845|NCT02106832|528568303|FG002|Overall Study|Technical problems|0|||
146906638|NCT03056287|529823591|FG000|Overall Study|move out of area|0|||
146906639|NCT03056287|529823592|FG001|Overall Study|move out of area|0|||
146906640|NCT03056287|529823593|FG002|Overall Study|move out of area|1|||
146906641|NCT03056287|529823594|FG003|Overall Study|move out of area|1|||
146906642|NCT01238120|529823603|FG000|Overall Study|Withdrawal by Subject|4|||
146906643|NCT01238120|529823604|FG001|Overall Study|Withdrawal by Subject|1|||
146906644|NCT01238120|529823605|FG002|Overall Study|Withdrawal by Subject|2|||
146906645|NCT01238120|529823606|FG003|Overall Study|Withdrawal by Subject|5|||
146906646|NCT01238120|529823603|FG000|Overall Study|Lost to Follow-up|2|||
146906647|NCT01238120|529823604|FG001|Overall Study|Lost to Follow-up|0|||
146906648|NCT01238120|529823605|FG002|Overall Study|Lost to Follow-up|1|||
146906649|NCT01238120|529823606|FG003|Overall Study|Lost to Follow-up|1|||
146906650|NCT01238120|529823603|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
146906651|NCT01238120|529823604|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
146906652|NCT01238120|529823605|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
146906653|NCT01238120|529823606|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
146906654|NCT00881205|529823607|FG000|Overall Study|Adverse Event|8|||
146906655|NCT00881205|529823608|FG001|Overall Study|Adverse Event|3|||
146906656|NCT00881205|529823607|FG000|Overall Study|Withdrawal by Subject|1|||
146906657|NCT00881205|529823608|FG001|Overall Study|Withdrawal by Subject|2|||
146906658|NCT00881205|529823607|FG000|Overall Study|Lost to Follow-up|0|||
146906659|NCT00881205|529823608|FG001|Overall Study|Lost to Follow-up|1|||
146906660|NCT00881205|529823607|FG000|Overall Study|Administrative problems|1|||
146906661|NCT00881205|529823608|FG001|Overall Study|Administrative problems|1|||
146906662|NCT00881205|529823607|FG000|Overall Study|Condition no longer requires drug|1|||
146906663|NCT00881205|529823608|FG001|Overall Study|Condition no longer requires drug|0|||
146906664|NCT02498652|529823611|FG000|Overall Study|Protocol Violation|0|||
146906665|NCT02498652|529823612|FG001|Overall Study|Protocol Violation|1|||
146906666|NCT06129487|529823613|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
146906667|NCT06129487|529823614|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
146906668|NCT01480180|529823621|FG000|Main Phase|Withdrawal criteria|12|||
146906669|NCT01480180|529823622|FG001|Main Phase|Withdrawal criteria|1|||
146906670|NCT01480180|529823623|FG002|Main Phase|Withdrawal criteria|0|||
146906671|NCT01480180|529823624|FG003|Main Phase|Withdrawal criteria|0|||
146906672|NCT01480180|529823625|FG004|Main Phase|Withdrawal criteria|0|||
146906673|NCT01480180|529823626|FG005|Main Phase|Withdrawal criteria|0|||
146906674|NCT01480180|529823621|FG000|Main Phase|Lack of Efficacy|1|||
146906675|NCT01480180|529823622|FG001|Main Phase|Lack of Efficacy|0|||
146906676|NCT01480180|529823623|FG002|Main Phase|Lack of Efficacy|0|||
146906677|NCT01480180|529823624|FG003|Main Phase|Lack of Efficacy|0|||
146906678|NCT01480180|529823625|FG004|Main Phase|Lack of Efficacy|0|||
146906679|NCT01480180|529823626|FG005|Main Phase|Lack of Efficacy|0|||
146906680|NCT01480180|529823621|FG000|Main Phase|Non-compliance|3|||
146906681|NCT01480180|529823622|FG001|Main Phase|Non-compliance|0|||
146906682|NCT01480180|529823623|FG002|Main Phase|Non-compliance|0|||
146906683|NCT01480180|529823624|FG003|Main Phase|Non-compliance|0|||
146906684|NCT01480180|529823625|FG004|Main Phase|Non-compliance|0|||
146906685|NCT01480180|529823626|FG005|Main Phase|Non-compliance|0|||
146906686|NCT01480180|529823621|FG000|Main Phase|Unclassified|3|||
146561846|NCT02106832|528568304|FG003|Overall Study|Technical problems|0|||
146561847|NCT01968980|528568325|FG000|Overall Study|Death|0|||
146906687|NCT01480180|529823622|FG001|Main Phase|Unclassified|0|||
146561848|NCT01968980|528568326|FG001|Overall Study|Death|1|||
146561849|NCT01968980|528568325|FG000|Overall Study|Adverse Event|1|||
146906688|NCT01480180|529823623|FG002|Main Phase|Unclassified|0|||
146906689|NCT01480180|529823624|FG003|Main Phase|Unclassified|0|||
146906690|NCT01480180|529823625|FG004|Main Phase|Unclassified|0|||
146906691|NCT01480180|529823626|FG005|Main Phase|Unclassified|0|||
146906692|NCT01480180|529823621|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
146906693|NCT01480180|529823622|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
146906694|NCT01480180|529823623|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
146906695|NCT01480180|529823624|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
146906696|NCT01480180|529823625|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
146906697|NCT01480180|529823626|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
146906698|NCT01480180|529823621|FG000|Extension Phase, Part 1|Unclassified|0|||
146906699|NCT01480180|529823622|FG001|Extension Phase, Part 1|Unclassified|0|||
146906700|NCT01480180|529823623|FG002|Extension Phase, Part 1|Unclassified|1|||
146906701|NCT01480180|529823624|FG003|Extension Phase, Part 1|Unclassified|0|||
146906702|NCT01480180|529823625|FG004|Extension Phase, Part 1|Unclassified|0|||
146906703|NCT01480180|529823626|FG005|Extension Phase, Part 1|Unclassified|0|||
146906704|NCT01480180|529823621|FG000|Extension Phase, Part 1|Adverse Event|0|||
146906705|NCT01480180|529823622|FG001|Extension Phase, Part 1|Adverse Event|0|||
146906706|NCT01480180|529823623|FG002|Extension Phase, Part 1|Adverse Event|4|||
146561850|NCT01968980|528568326|FG001|Overall Study|Adverse Event|3|||
146641492|NCT04976192|528863070|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146561851|NCT01968980|528568325|FG000|Overall Study|Does not meet entry criteria|1|||
146561852|NCT01968980|528568326|FG001|Overall Study|Does not meet entry criteria|3|||
146561853|NCT01968980|528568325|FG000|Overall Study|Withdrawal by Subject|13|||
146561854|NCT01968980|528568326|FG001|Overall Study|Withdrawal by Subject|5|||
146561855|NCT01968980|528568325|FG000|Overall Study|Other unspecified|1|||
146561856|NCT01968980|528568326|FG001|Overall Study|Other unspecified|2|||
146561857|NCT00265122|528568327|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
146561858|NCT00265122|528568328|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
146561859|NCT00265122|528568329|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
146561860|NCT00265122|528568330|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
146561861|NCT00265122|528568331|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
146561862|NCT00265122|528568332|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
146561863|NCT00265122|528568327|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
146561864|NCT00265122|528568328|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
146561865|NCT00265122|528568329|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
146561866|NCT00265122|528568330|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
146561867|NCT00265122|528568331|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
146561868|NCT00265122|528568332|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
146561869|NCT00265122|528568327|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
146561870|NCT00265122|528568328|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
146561871|NCT00265122|528568329|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
146561872|NCT00265122|528568330|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
146561873|NCT00265122|528568331|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
146561874|NCT00265122|528568332|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
146561875|NCT00265122|528568327|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
146561876|NCT00265122|528568328|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
146561877|NCT00265122|528568329|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
146561878|NCT00265122|528568330|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
146561879|NCT00265122|528568331|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
146561880|NCT00265122|528568332|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
146561881|NCT00265122|528568327|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
146561882|NCT00265122|528568328|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
146561883|NCT00265122|528568329|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
146561884|NCT00265122|528568330|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
146561885|NCT00265122|528568331|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
146561886|NCT00265122|528568332|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
146561887|NCT00265122|528568327|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
146561888|NCT00265122|528568328|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
146561889|NCT00265122|528568329|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
146561890|NCT00265122|528568330|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
146561891|NCT00265122|528568331|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
146641493|NCT04976192|528863071|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146906707|NCT01480180|529823624|FG003|Extension Phase, Part 1|Adverse Event|1|||
146641494|NCT04976192|528863072|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146641495|NCT04976192|528863073|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146641496|NCT04976192|528863064|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146641497|NCT04976192|528863065|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146641498|NCT04976192|528863066|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146641499|NCT04976192|528863067|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146641500|NCT04976192|528863068|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146641501|NCT04976192|528863069|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
146641502|NCT04976192|528863070|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146641503|NCT04976192|528863071|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146641504|NCT04976192|528863072|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146641505|NCT04976192|528863073|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146641506|NCT01925131|528865052|FG000|Overall Study|Death|0|||
146641507|NCT01925131|528865053|FG001|Overall Study|Death|0|||
146641508|NCT01925131|528865054|FG002|Overall Study|Death|1|||
146641509|NCT01925131|528865055|FG003|Overall Study|Death|0|||
146641510|NCT01925131|528865056|FG004|Overall Study|Death|0|||
146641511|NCT01925131|528865057|FG005|Overall Study|Death|0|||
146641512|NCT01925131|528865052|FG000|Overall Study|Progression/Relapse|1|||
146641513|NCT01925131|528865053|FG001|Overall Study|Progression/Relapse|1|||
146641514|NCT01925131|528865054|FG002|Overall Study|Progression/Relapse|4|||
146641515|NCT01925131|528865055|FG003|Overall Study|Progression/Relapse|0|||
146641516|NCT01925131|528865056|FG004|Overall Study|Progression/Relapse|0|||
146641517|NCT01925131|528865057|FG005|Overall Study|Progression/Relapse|1|||
146641518|NCT01925131|528865052|FG000|Overall Study|Patient Refusal|1|||
146641519|NCT01925131|528865053|FG001|Overall Study|Patient Refusal|0|||
146641520|NCT01925131|528865054|FG002|Overall Study|Patient Refusal|0|||
146641521|NCT01925131|528865055|FG003|Overall Study|Patient Refusal|0|||
146641522|NCT01925131|528865056|FG004|Overall Study|Patient Refusal|0|||
146641523|NCT01925131|528865057|FG005|Overall Study|Patient Refusal|0|||
146641524|NCT01925131|528865052|FG000|Overall Study|Adverse Event|0|||
146641525|NCT01925131|528865053|FG001|Overall Study|Adverse Event|0|||
146641526|NCT01925131|528865054|FG002|Overall Study|Adverse Event|2|||
146641527|NCT01925131|528865055|FG003|Overall Study|Adverse Event|0|||
146641528|NCT01925131|528865056|FG004|Overall Study|Adverse Event|1|||
146641529|NCT01925131|528865057|FG005|Overall Study|Adverse Event|3|||
146641530|NCT01925131|528865052|FG000|Overall Study|Other - Not Protocol Specified|3|||
146641531|NCT01925131|528865053|FG001|Overall Study|Other - Not Protocol Specified|1|||
146641532|NCT01925131|528865054|FG002|Overall Study|Other - Not Protocol Specified|2|||
146641533|NCT01925131|528865055|FG003|Overall Study|Other - Not Protocol Specified|5|||
146641534|NCT01925131|528865056|FG004|Overall Study|Other - Not Protocol Specified|10|||
146641535|NCT01925131|528865057|FG005|Overall Study|Other - Not Protocol Specified|6|||
146641536|NCT04838977|528865058|FG000|Overall Study|Lost to Follow-up|2|||
146641537|NCT04838977|528865059|FG001|Overall Study|Lost to Follow-up|3|||
146641538|NCT04838977|528865058|FG000|Overall Study|Withdrawal by Subject|1|||
146641539|NCT04838977|528865059|FG001|Overall Study|Withdrawal by Subject|1|||
146641540|NCT00265148|528865060|FG000|Overall Study|Adverse Event|2|||
146641541|NCT00265148|528865061|FG001|Overall Study|Adverse Event|2|||
146641542|NCT00265148|528865060|FG000|Overall Study|Lack of Efficacy|0|||
146641543|NCT00265148|528865061|FG001|Overall Study|Lack of Efficacy|2|||
146641544|NCT00265148|528865060|FG000|Overall Study|Protocol Violation|3|||
146641545|NCT00265148|528865061|FG001|Overall Study|Protocol Violation|2|||
146641546|NCT00265148|528865060|FG000|Overall Study|Lost to Follow-up|0|||
146641547|NCT00265148|528865061|FG001|Overall Study|Lost to Follow-up|1|||
146641548|NCT00265148|528865060|FG000|Overall Study|Withdrawal by Subject|2|||
146641549|NCT00265148|528865061|FG001|Overall Study|Withdrawal by Subject|1|||
146641550|NCT00265148|528865060|FG000|Overall Study|Physician Decision|1|||
146906708|NCT01480180|529823625|FG004|Extension Phase, Part 1|Adverse Event|0|||
146906709|NCT01480180|529823626|FG005|Extension Phase, Part 1|Adverse Event|0|||
146906710|NCT01480180|529823621|FG000|Extension Phase, Part 1|Change of treatment|0|||
146906711|NCT01480180|529823622|FG001|Extension Phase, Part 1|Change of treatment|0|||
146906712|NCT01480180|529823623|FG002|Extension Phase, Part 1|Change of treatment|0|||
146906713|NCT01480180|529823624|FG003|Extension Phase, Part 1|Change of treatment|9|||
146641551|NCT00265148|528865061|FG001|Overall Study|Physician Decision|0|||
146641552|NCT00265148|528865060|FG000|Overall Study|Increasing frailty|0|||
146767786|NCT00880048|529317432|FG001|Overall Study|Physician Decision|1|||
146767787|NCT00880048|529317433|FG002|Overall Study|Physician Decision|7|||
146767788|NCT00880048|529317431|FG000|Overall Study|Withdrawal by Subject|5|||
146767789|NCT00880048|529317432|FG001|Overall Study|Withdrawal by Subject|8|||
146767790|NCT00880048|529317433|FG002|Overall Study|Withdrawal by Subject|5|||
146767791|NCT00880048|529317431|FG000|Overall Study|Study closed/terminated|9|||
146767792|NCT00880048|529317432|FG001|Overall Study|Study closed/terminated|7|||
146767793|NCT00880048|529317433|FG002|Overall Study|Study closed/terminated|6|||
146767794|NCT01069341|529317434|FG000|Overall Study|Lost to Follow-up|1|||
146767795|NCT02950558|529317438|FG000|Overall Study|Lost to Follow-up|2|||
146767796|NCT02950558|529317439|FG001|Overall Study|Lost to Follow-up|0|||
146767797|NCT01184508|529317440|FG000|Overall Study|Adverse Event|4|||
146767798|NCT01184508|529317441|FG001|Overall Study|Adverse Event|6|||
146767799|NCT01184508|529317440|FG000|Overall Study|Lack of Efficacy|1|||
146767800|NCT01184508|529317441|FG001|Overall Study|Lack of Efficacy|1|||
146767801|NCT01184508|529317440|FG000|Overall Study|Lost to Follow-up|1|||
146767802|NCT01184508|529317441|FG001|Overall Study|Lost to Follow-up|1|||
146767803|NCT01184508|529317440|FG000|Overall Study|Physician Decision|1|||
146767804|NCT01184508|529317441|FG001|Overall Study|Physician Decision|0|||
146767805|NCT01184508|529317440|FG000|Overall Study|Protocol Violation|3|||
146767806|NCT01184508|529317441|FG001|Overall Study|Protocol Violation|1|||
146767807|NCT01184508|529317440|FG000|Overall Study|Sponsor Decision|5|||
146767808|NCT01184508|529317441|FG001|Overall Study|Sponsor Decision|2|||
146767809|NCT01184508|529317440|FG000|Overall Study|Withdrawal by Subject|1|||
146767810|NCT01184508|529317441|FG001|Overall Study|Withdrawal by Subject|3|||
146767811|NCT01184508|529317440|FG000|Overall Study|Randomized, Not Treated|0|||
146767812|NCT01184508|529317441|FG001|Overall Study|Randomized, Not Treated|1|||
146767813|NCT00319436|529317447|FG000|Overall Study|Withdrawal by Subject|6|||
146767814|NCT00319436|529317448|FG001|Overall Study|Withdrawal by Subject|7|||
146767815|NCT00790790|529317449|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
146767816|NCT00790790|529317450|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
146767817|NCT00790790|529317451|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
146767818|NCT00790790|529317449|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
146767819|NCT00790790|529317450|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
146767820|NCT00790790|529317451|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
146767821|NCT00790790|529317449|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
146767822|NCT00790790|529317450|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
146767823|NCT00790790|529317451|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
146767824|NCT00790790|529317449|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
146767825|NCT00790790|529317450|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
146767826|NCT00790790|529317451|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
146767827|NCT00790790|529317449|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
146767828|NCT00790790|529317450|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
146767829|NCT00790790|529317451|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
146767830|NCT02808338|529317453|FG000|Screening|Screen Failure|10|||
146767831|NCT02808338|529317453|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
146767832|NCT02808338|529317453|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
146767833|NCT02194933|529317454|FG000|Overall Study|Lost to Follow-up|1|||
146767834|NCT02194933|529317455|FG001|Overall Study|Lost to Follow-up|2|||
146767835|NCT02194933|529317454|FG000|Overall Study|Participant met withdrawal criteria|1|||
146767836|NCT02194933|529317455|FG001|Overall Study|Participant met withdrawal criteria|3|||
146767837|NCT02194933|529317454|FG000|Overall Study|Withdrawal by Subject|0|||
146767838|NCT02194933|529317455|FG001|Overall Study|Withdrawal by Subject|2|||
146767839|NCT02194933|529317454|FG000|Overall Study|Lack of Efficacy|1|||
146767840|NCT02194933|529317455|FG001|Overall Study|Lack of Efficacy|2|||
146767841|NCT02000817|529317458|FG000|Overall Study|Withdrawal by Subject|2|||
146767842|NCT02000817|529317459|FG001|Overall Study|Withdrawal by Subject|0|||
146767843|NCT02000817|529317460|FG002|Overall Study|Withdrawal by Subject|0|||
146767844|NCT02000817|529317461|FG003|Overall Study|Withdrawal by Subject|0|||
146767845|NCT02000817|529317458|FG000|Overall Study|Adverse Event|0|||
146767846|NCT02000817|529317459|FG001|Overall Study|Adverse Event|1|||
146767847|NCT02000817|529317460|FG002|Overall Study|Adverse Event|0|||
146767848|NCT02000817|529317461|FG003|Overall Study|Adverse Event|0|||
146767849|NCT02000817|529317458|FG000|Overall Study|Lost to Follow-up|0|||
146767850|NCT02000817|529317459|FG001|Overall Study|Lost to Follow-up|0|||
146767851|NCT02000817|529317460|FG002|Overall Study|Lost to Follow-up|1|||
146767852|NCT02000817|529317461|FG003|Overall Study|Lost to Follow-up|0|||
146767853|NCT04210180|529317468|FG000|Overall Study|Withdrawal by Subject|2|||
146767854|NCT03538054|529317469|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
146767855|NCT03538054|529317469|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
146906714|NCT01480180|529823625|FG004|Extension Phase, Part 1|Change of treatment|0|||
146906715|NCT01480180|529823626|FG005|Extension Phase, Part 1|Change of treatment|0|||
146906716|NCT01480180|529823621|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
146906717|NCT01480180|529823622|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
146906718|NCT01480180|529823623|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
146906719|NCT01480180|529823624|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
146906720|NCT01480180|529823625|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
146906721|NCT01480180|529823626|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
146906722|NCT01480180|529823621|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
146906723|NCT01480180|529823622|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
146906724|NCT01480180|529823623|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
146906725|NCT01480180|529823624|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
146906726|NCT01480180|529823625|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
146906727|NCT01480180|529823626|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
146906728|NCT01480180|529823621|FG000|Extension Phase, Part 2|Unclassified|0|||
146906729|NCT01480180|529823622|FG001|Extension Phase, Part 2|Unclassified|0|||
146906730|NCT01480180|529823623|FG002|Extension Phase, Part 2|Unclassified|3|||
146906731|NCT01480180|529823624|FG003|Extension Phase, Part 2|Unclassified|1|||
146906732|NCT01480180|529823625|FG004|Extension Phase, Part 2|Unclassified|1|||
146906733|NCT01480180|529823626|FG005|Extension Phase, Part 2|Unclassified|0|||
146906734|NCT03256539|529823631|FG000|Overall Study|Withdrawal by Subject|0|||
146906735|NCT03256539|529823632|FG001|Overall Study|Withdrawal by Subject|3|||
146906736|NCT03256539|529823631|FG000|Overall Study|Unexpected closure of study components|8|||
146906737|NCT03256539|529823632|FG001|Overall Study|Unexpected closure of study components|4|||
146906738|NCT00828451|529823633|FG000|Overall Study|Death|2|||
146906739|NCT00828451|529823633|FG000|Overall Study|Lack of intravenous line|7|||
146906740|NCT00828451|529823633|FG000|Overall Study|Withdrawal by Subject|1|||
146906741|NCT00828451|529823633|FG000|Overall Study|Deterioration in clinical status|1|||
146906742|NCT02827877|529823634|FG000|Overall Study|Withdrawal by Subject|1|||
146906743|NCT05755438|529823635|FG000|12-week DBVC Period|Adverse Event|4|||
146906744|NCT05755438|529823636|FG001|12-week DBVC Period|Adverse Event|1|||
146906745|NCT05755438|529823635|FG000|12-week DBVC Period|Physician Decision|1|||
146906746|NCT05755438|529823636|FG001|12-week DBVC Period|Physician Decision|1|||
146906747|NCT05755438|529823635|FG000|12-week DBVC Period|Protocol Violation|4|||
146906748|NCT05755438|529823636|FG001|12-week DBVC Period|Protocol Violation|2|||
146906749|NCT05755438|529823635|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
146906750|NCT05755438|529823636|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
146906751|NCT05755438|529823635|FG000|12-week DBVC Period|Sponsor Decision|1|||
146906752|NCT05755438|529823636|FG001|12-week DBVC Period|Sponsor Decision|0|||
146906753|NCT05755438|529823635|FG000|40-week OLE Period|Adverse Event|0|||
146906754|NCT05755438|529823636|FG001|40-week OLE Period|Adverse Event|2|||
146906755|NCT05755438|529823635|FG000|40-week OLE Period|Lack of Efficacy|1|||
146906756|NCT05755438|529823636|FG001|40-week OLE Period|Lack of Efficacy|1|||
146906757|NCT05755438|529823635|FG000|40-week OLE Period|Lost to Follow-up|1|||
146906758|NCT05755438|529823636|FG001|40-week OLE Period|Lost to Follow-up|0|||
146906759|NCT05755438|529823635|FG000|40-week OLE Period|Physician Decision|1|||
146906760|NCT05755438|529823636|FG001|40-week OLE Period|Physician Decision|1|||
146906761|NCT05755438|529823635|FG000|40-week OLE Period|Protocol Violation|1|||
146906762|NCT05755438|529823636|FG001|40-week OLE Period|Protocol Violation|1|||
146906763|NCT05755438|529823635|FG000|40-week OLE Period|Withdrawal by Subject|6|||
146906764|NCT05755438|529823636|FG001|40-week OLE Period|Withdrawal by Subject|6|||
146906765|NCT05755438|529823635|FG000|40-week OLE Period|Sponsor Decision|3|||
146561892|NCT00265122|528568332|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
146561893|NCT04716894|528568333|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
146561894|NCT04716894|528568333|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
146561895|NCT00982280|528568359|FG000|Observation Period|Not eligible to be dosed|19|||
146561896|NCT00982280|528568359|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
146561897|NCT00982280|528568359|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
146561898|NCT00982280|528568359|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
146561899|NCT00982280|528568359|FG000|Maintenance Period|Adverse Event|1|||
146561900|NCT01506726|528568360|FG000|Overall Study|Adverse Event|1|||
146561901|NCT01506726|528568361|FG001|Overall Study|Adverse Event|2|||
146561902|NCT02231580|528568362|FG000|Overall Study|Adverse Event|5|||
146561903|NCT02231580|528568363|FG001|Overall Study|Adverse Event|0|||
146561904|NCT04724837|528568364|FG000|Overall Study|Other|4|||
146561905|NCT04724837|528568365|FG001|Overall Study|Other|16|||
146561906|NCT04724837|528568366|FG002|Overall Study|Other|0|||
146561907|NCT04724837|528568364|FG000|Overall Study|Withdrawal by Subject|2|||
146561908|NCT04724837|528568365|FG001|Overall Study|Withdrawal by Subject|9|||
146561909|NCT04724837|528568366|FG002|Overall Study|Withdrawal by Subject|9|||
146561910|NCT04724837|528568364|FG000|Overall Study|Adverse Event|2|||
146561911|NCT04724837|528568365|FG001|Overall Study|Adverse Event|7|||
146561912|NCT04724837|528568366|FG002|Overall Study|Adverse Event|4|||
146561913|NCT04724837|528568364|FG000|Overall Study|Lost to Follow-up|0|||
146561914|NCT04724837|528568365|FG001|Overall Study|Lost to Follow-up|1|||
146561915|NCT04724837|528568366|FG002|Overall Study|Lost to Follow-up|3|||
146561916|NCT04724837|528568364|FG000|Overall Study|Physician Decision|1|||
146561917|NCT04724837|528568365|FG001|Overall Study|Physician Decision|2|||
146561918|NCT04724837|528568366|FG002|Overall Study|Physician Decision|0|||
146561919|NCT04724837|528568364|FG000|Overall Study|Death|0|||
146561920|NCT04724837|528568365|FG001|Overall Study|Death|0|||
146561921|NCT04724837|528568366|FG002|Overall Study|Death|1|||
146561922|NCT04724837|528568364|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
146561923|NCT04724837|528568365|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
146561924|NCT04724837|528568366|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
146561925|NCT04724837|528568364|FG000|Overall Study|Study Terminated by Sponsor|0|||
146561926|NCT04724837|528568365|FG001|Overall Study|Study Terminated by Sponsor|1|||
146561927|NCT04724837|528568366|FG002|Overall Study|Study Terminated by Sponsor|0|||
146561928|NCT03620981|528568367|FG000|Overall Study|Adverse Event|14|||
146561929|NCT03620981|528568368|FG001|Overall Study|Adverse Event|38|||
146561930|NCT03620981|528568369|FG002|Overall Study|Adverse Event|25|||
146561931|NCT03620981|528568367|FG000|Overall Study|Lack of Efficacy|2|||
146561932|NCT03620981|528568368|FG001|Overall Study|Lack of Efficacy|1|||
146561933|NCT03620981|528568369|FG002|Overall Study|Lack of Efficacy|1|||
146561934|NCT03620981|528568367|FG000|Overall Study|Physician Decision|7|||
146561935|NCT03620981|528568368|FG001|Overall Study|Physician Decision|4|||
146561936|NCT03620981|528568369|FG002|Overall Study|Physician Decision|4|||
146561937|NCT03620981|528568367|FG000|Overall Study|Protocol Violation|1|||
146561938|NCT03620981|528568368|FG001|Overall Study|Protocol Violation|2|||
146561939|NCT03620981|528568369|FG002|Overall Study|Protocol Violation|1|||
146561940|NCT03620981|528568367|FG000|Overall Study|Withdrawal by Legal Representative|2|||
146561941|NCT03620981|528568368|FG001|Overall Study|Withdrawal by Legal Representative|1|||
146561942|NCT03620981|528568369|FG002|Overall Study|Withdrawal by Legal Representative|1|||
146641553|NCT00265148|528865061|FG001|Overall Study|Increasing frailty|1|||
146561943|NCT03620981|528568367|FG000|Overall Study|Withdrawal by Care Giver|2|||
146767856|NCT03538054|529317469|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
146767857|NCT02754479|529317470|FG000|Overall Study|Lost to Follow-up|1|||
146767858|NCT04722003|529319400|FG000|Overall Study|Lost to Follow-up|2|||
146767859|NCT04722003|529319401|FG001|Overall Study|Lost to Follow-up|0|||
146767860|NCT04722003|529319400|FG000|Overall Study|Physician Decision|1|||
146767861|NCT04722003|529319401|FG001|Overall Study|Physician Decision|0|||
146767862|NCT03351075|529319402|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
146767863|NCT03351075|529319403|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
146767864|NCT03351075|529319402|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
146767865|NCT03351075|529319403|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
146767866|NCT03351075|529319402|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
146767867|NCT03351075|529319403|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
146767868|NCT03351075|529319402|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
146767869|NCT03351075|529319403|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
146767870|NCT03175172|529319404|FG000|Overall Study|Death|3|||
146767871|NCT03175172|529319404|FG000|Overall Study|Withdrawal by Subject|3|||
146767872|NCT03175172|529319404|FG000|Overall Study|Lost to Follow-up|1|||
146767873|NCT03175172|529319404|FG000|Overall Study|Study Terminated by Sponsor|3|||
146767874|NCT03169244|529319405|FG000|Overall Study|Lost to Follow-up|1|||
146767875|NCT03169244|529319406|FG001|Overall Study|Lost to Follow-up|2|||
146767876|NCT03169244|529319405|FG000|Overall Study|Adverse Event|1|||
146767877|NCT03169244|529319406|FG001|Overall Study|Adverse Event|0|||
146767878|NCT03169244|529319405|FG000|Overall Study|Withdrawal by Subject|2|||
146767879|NCT03169244|529319406|FG001|Overall Study|Withdrawal by Subject|2|||
146767880|NCT03169244|529319405|FG000|Overall Study|Physician Decision|1|||
146767881|NCT03169244|529319406|FG001|Overall Study|Physician Decision|0|||
146767882|NCT02027558|529319409|FG000|Overall Study|Death|0|||
146767883|NCT02027558|529319410|FG001|Overall Study|Death|1|||
146767884|NCT02027558|529319409|FG000|Overall Study|Withdrawal by Subject|2|||
146767885|NCT02027558|529319410|FG001|Overall Study|Withdrawal by Subject|0|||
146767886|NCT02027558|529319409|FG000|Overall Study|Lost to Follow-up|4|||
146767887|NCT02027558|529319410|FG001|Overall Study|Lost to Follow-up|1|||
146767888|NCT02027558|529319409|FG000|Overall Study|Refused assessment|3|||
146767889|NCT02027558|529319410|FG001|Overall Study|Refused assessment|0|||
146767890|NCT00114244|529319415|FG000|Overall Study|Adverse Event|2|||
146767891|NCT00114244|529319416|FG001|Overall Study|Adverse Event|5|||
146767892|NCT00114244|529319415|FG000|Overall Study|Withdrawal by Subject|0|||
146767893|NCT00114244|529319416|FG001|Overall Study|Withdrawal by Subject|2|||
146767894|NCT02694978|529319417|FG000|Overall Study|Adverse Event|10|||
146906766|NCT05755438|529823636|FG001|40-week OLE Period|Sponsor Decision|0|||
146906767|NCT05755438|529823635|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
146906768|NCT05755438|529823636|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
146906769|NCT05755438|529823635|FG000|40-week OLE Period|Ongoing|46|||
146906770|NCT05755438|529823636|FG001|40-week OLE Period|Ongoing|58|||
146906771|NCT03914300|529823638|FG000|Overall Study|Adverse Event|1|||
146906772|NCT05445843|529823644|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
146906773|NCT05445843|529823645|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
146906774|NCT05445843|529823644|FG000|Overall Study|Progressive disease|17|||
146906775|NCT05445843|529823645|FG001|Overall Study|Progressive disease|9|||
146561944|NCT03620981|528568368|FG001|Overall Study|Withdrawal by Care Giver|0|||
146561945|NCT03620981|528568369|FG002|Overall Study|Withdrawal by Care Giver|1|||
146561946|NCT03620981|528568367|FG000|Overall Study|Non-compliance with Study Drug|1|||
146561947|NCT03620981|528568368|FG001|Overall Study|Non-compliance with Study Drug|1|||
146561948|NCT03620981|528568369|FG002|Overall Study|Non-compliance with Study Drug|0|||
146561949|NCT05185453|528568376|FG000|Overall Study|Lost to Follow-up|13|||
146561950|NCT05185453|528568377|FG001|Overall Study|Lost to Follow-up|3|||
146561951|NCT03537508|528568390|FG000|Overall Study|Adverse Event|2|||
146561952|NCT03537508|528568391|FG001|Overall Study|Adverse Event|1|||
146561953|NCT03537508|528568390|FG000|Overall Study|Protocol Violation|65|||
146561954|NCT03537508|528568391|FG001|Overall Study|Protocol Violation|48|||
146561955|NCT03537508|528568390|FG000|Overall Study|Lost to Follow-up|86|||
146561956|NCT03537508|528568391|FG001|Overall Study|Lost to Follow-up|60|||
146561957|NCT03537508|528568390|FG000|Overall Study|Withdrawal by parent/guardian|263|||
146767895|NCT02694978|529319418|FG001|Overall Study|Adverse Event|9|||
146767896|NCT02694978|529319417|FG000|Overall Study|Withdrawal by Subject|22|||
146767897|NCT02694978|529319418|FG001|Overall Study|Withdrawal by Subject|19|||
146767898|NCT02694978|529319417|FG000|Overall Study|Lost to Follow-up|14|||
146767899|NCT02694978|529319418|FG001|Overall Study|Lost to Follow-up|17|||
146767900|NCT02694978|529319417|FG000|Overall Study|Death|4|||
146767901|NCT02694978|529319418|FG001|Overall Study|Death|1|||
146767902|NCT02694978|529319417|FG000|Overall Study|Other-Decision of Participant|6|||
146906776|NCT05445843|529823644|FG000|Overall Study|Physician Decision|16|||
146561958|NCT03537508|528568391|FG001|Overall Study|Withdrawal by parent/guardian|149|||
146561959|NCT01972659|528568392|FG000|Overall Study|Protocol Violation|2|||
146561960|NCT01972659|528568393|FG001|Overall Study|Protocol Violation|2|||
146906777|NCT05445843|529823645|FG001|Overall Study|Physician Decision|4|||
146906778|NCT05445843|529823644|FG000|Overall Study|Death|6|||
146906779|NCT05445843|529823645|FG001|Overall Study|Death|3|||
146906780|NCT05445843|529823644|FG000|Overall Study|Subject decision|6|||
146906781|NCT05445843|529823645|FG001|Overall Study|Subject decision|2|||
146906782|NCT05445843|529823644|FG000|Overall Study|Adverse Event|2|||
146906783|NCT05445843|529823645|FG001|Overall Study|Adverse Event|0|||
146906784|NCT01919411|529823653|FG000|Overall Study|Lost to Follow-up|2|||
146906785|NCT01919411|529823654|FG001|Overall Study|Lost to Follow-up|4|||
146906786|NCT01919411|529823653|FG000|Overall Study|Physician Decision|1|||
146906787|NCT01919411|529823654|FG001|Overall Study|Physician Decision|0|||
146906788|NCT01919411|529823653|FG000|Overall Study|Protocol Violation|2|||
146906789|NCT01919411|529823654|FG001|Overall Study|Protocol Violation|1|||
146906790|NCT03478683|529823655|FG000|Overall Study|Adverse Event|5|||
146906791|NCT03478683|529823656|FG001|Overall Study|Adverse Event|3|||
146906792|NCT03478683|529823655|FG000|Overall Study|Lost to Follow-up|0|||
146906793|NCT03478683|529823656|FG001|Overall Study|Lost to Follow-up|5|||
146906794|NCT03478683|529823655|FG000|Overall Study|Physician Decision|1|||
146906795|NCT03478683|529823656|FG001|Overall Study|Physician Decision|3|||
146906796|NCT03478683|529823655|FG000|Overall Study|Withdrawal by Subject|7|||
146906797|NCT03478683|529823656|FG001|Overall Study|Withdrawal by Subject|7|||
146906798|NCT04090164|529823659|FG000|Overall Study|incomplete data on file|245|||
146906799|NCT04090164|529823660|FG001|Overall Study|incomplete data on file|0|||
146906800|NCT00840463|529823666|FG000|Overall Study|Adverse Event|1|||
146906801|NCT00840463|529823667|FG001|Overall Study|Adverse Event|0|||
146906802|NCT03414359|529823668|FG000|Overall Study|Lack of Efficacy|1|||
146906803|NCT03414359|529823669|FG001|Overall Study|Lack of Efficacy|1|||
146906804|NCT03414359|529823668|FG000|Overall Study|Protocol Violation|0|||
146906805|NCT03414359|529823669|FG001|Overall Study|Protocol Violation|1|||
146906806|NCT03750838|529823674|FG000|Overall Study|Lost to Follow-up|10|||
146906807|NCT03750838|529823675|FG001|Overall Study|Lost to Follow-up|6|||
146906808|NCT02462889|529823676|FG000|Overall Study|Withdrawal by Subject|2|||
146906809|NCT02462889|529823677|FG001|Overall Study|Withdrawal by Subject|6|||
146906810|NCT02462889|529823676|FG000|Overall Study|Death|1|||
146906811|NCT02462889|529823677|FG001|Overall Study|Death|5|||
146906812|NCT03497689|529823683|FG000|Overall Study|Adverse Event|2|||
146906813|NCT03497689|529823683|FG000|Overall Study|Death|1|||
146906814|NCT03497689|529823683|FG000|Overall Study|Physician Decision|1|||
146906815|NCT03497689|529823683|FG000|Overall Study|Withdrawal by Subject|1|||
146906816|NCT03497689|529823683|FG000|Overall Study|Protocol Violation|2|||
146906817|NCT02032875|529823684|FG000|Treatment Period|Adverse Event|1|||
146906818|NCT02032875|529823685|FG001|Treatment Period|Adverse Event|0|||
146906819|NCT02032875|529823684|FG000|Treatment Period|Liver transplant, No extension needed|0|||
146906820|NCT02032875|529823685|FG001|Treatment Period|Liver transplant, No extension needed|1|||
146906821|NCT02032875|529823684|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
146906822|NCT02032875|529823685|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
146906823|NCT02032875|529823684|FG000|Follow-up Period|Death|0|||
146906824|NCT02032875|529823685|FG001|Follow-up Period|Death|1|||
146906825|NCT02032875|529823684|FG000|Follow-up Period|Virologic Relapse|3|||
146906826|NCT02032875|529823685|FG001|Follow-up Period|Virologic Relapse|10|||
146906827|NCT04636177|529823690|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
146906828|NCT04636177|529823691|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
146906829|NCT04636177|529823690|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
146906830|NCT04636177|529823691|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
146906831|NCT04636177|529823690|FG000|Single-arm portion|Withdrawal by Subject|1|||
146906832|NCT04636177|529823691|FG001|Single-arm portion|Withdrawal by Subject|0|||
146906833|NCT04636177|529823690|FG000|Single-arm portion|Adverse Event|1|||
146906834|NCT04636177|529823691|FG001|Single-arm portion|Adverse Event|0|||
146906835|NCT03191786|529823692|FG000|Overall Study|Death|236|||
146641554|NCT00265148|528865060|FG000|Overall Study|Subject chose to change of the dose|1|||
146906836|NCT03191786|529823693|FG001|Overall Study|Death|127|||
146906837|NCT03191786|529823692|FG000|Overall Study|Lost to Follow-up|9|||
146906838|NCT03191786|529823693|FG001|Overall Study|Lost to Follow-up|3|||
146970158|NCT00902486|530050824|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
146906839|NCT03191786|529823692|FG000|Overall Study|Physician Decision|1|||
146906840|NCT03191786|529823693|FG001|Overall Study|Physician Decision|0|||
146906841|NCT03191786|529823692|FG000|Overall Study|Moved to Post Trial Access Program|30|||
146906842|NCT03191786|529823693|FG001|Overall Study|Moved to Post Trial Access Program|5|||
146906843|NCT03191786|529823692|FG000|Overall Study|Withdrawal by Subject|26|||
146906844|NCT03191786|529823693|FG001|Overall Study|Withdrawal by Subject|16|||
146561961|NCT01972659|528568392|FG000|Overall Study|problems realted to acceleromyograph|2|||
146561962|NCT01972659|528568393|FG001|Overall Study|problems realted to acceleromyograph|1|||
146561963|NCT02552225|528569868|FG000|Overall Study|Withdrawal by Subject|1|||
146561964|NCT02552225|528569869|FG001|Overall Study|Withdrawal by Subject|0|||
146561965|NCT01168596|528569870|FG000|Overall Study|Withdrawal by Subject|3|||
146561966|NCT01168596|528569871|FG001|Overall Study|Withdrawal by Subject|1|||
146561967|NCT02297516|528569874|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
146561968|NCT02297516|528569875|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
146561969|NCT02297516|528569874|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
146561970|NCT02297516|528569875|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
146561971|NCT02297516|528569874|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
146561972|NCT02297516|528569875|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
146561973|NCT00710593|528569876|FG000|Overall Study|Incarceration|1|||
146561974|NCT00710593|528569877|FG001|Overall Study|Incarceration|0|||
146561975|NCT00710593|528569876|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
146561976|NCT00710593|528569877|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
146561977|NCT00710593|528569876|FG000|Overall Study|Lost to Follow-up|3|||
146561978|NCT00710593|528569877|FG001|Overall Study|Lost to Follow-up|1|||
146561979|NCT00710593|528569876|FG000|Overall Study|Moved out of area|1|||
146561980|NCT00710593|528569877|FG001|Overall Study|Moved out of area|0|||
146561981|NCT00710593|528569876|FG000|Overall Study|Failure to adhere or complete study eval|1|||
146561982|NCT00710593|528569877|FG001|Overall Study|Failure to adhere or complete study eval|1|||
146561983|NCT00710593|528569876|FG000|Overall Study|Protocol Violation|1|||
146561984|NCT00710593|528569877|FG001|Overall Study|Protocol Violation|1|||
146561985|NCT00710593|528569876|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
146561986|NCT00710593|528569877|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
146561987|NCT04490278|528569878|FG000|Overall Study|Lost to Follow-up|6|||
146561988|NCT00366457|528569881|FG000|Overall Study|never began study therapy|2|||
146561989|NCT02829996|528569882|FG000|Overall Study|Withdrawal by Subject|1|||
146561990|NCT02829996|528569883|FG001|Overall Study|Withdrawal by Subject|0|||
146561991|NCT02829996|528569884|FG002|Overall Study|Withdrawal by Subject|0|||
146561992|NCT02829996|528569885|FG003|Overall Study|Withdrawal by Subject|0|||
146561993|NCT02829996|528569886|FG004|Overall Study|Withdrawal by Subject|0|||
146561994|NCT00189423|528569887|FG000|Overall Study|Death|746|||
146561995|NCT00189423|528569888|FG001|Overall Study|Death|747|||
146561996|NCT00189423|528569887|FG000|Overall Study|Withdrawal by Subject|9|||
146561997|NCT00189423|528569888|FG001|Overall Study|Withdrawal by Subject|9|||
146561998|NCT00189423|528569887|FG000|Overall Study|Lost to Follow-up|10|||
146561999|NCT00189423|528569888|FG001|Overall Study|Lost to Follow-up|10|||
146562000|NCT00565747|528569898|FG000|Overall Study|No embryo transfer|67|||
146562001|NCT00565747|528569899|FG001|Overall Study|No embryo transfer|73|||
146562002|NCT00183248|528569900|FG000|Overall Study|Lost to Follow-up|0|||
146562003|NCT00183248|528569901|FG001|Overall Study|Lost to Follow-up|1|||
146562004|NCT00183248|528569900|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
146562005|NCT00183248|528569901|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
146562006|NCT04507204|528569904|FG000|Overall Study|Adverse Event|8|||
146562007|NCT04507204|528569905|FG001|Overall Study|Adverse Event|13|||
146562008|NCT04507204|528569904|FG000|Overall Study|Death|0|||
146562009|NCT04507204|528569905|FG001|Overall Study|Death|1|||
146562010|NCT04507204|528569904|FG000|Overall Study|Lost to Follow-up|15|||
146562011|NCT04507204|528569905|FG001|Overall Study|Lost to Follow-up|14|||
146562012|NCT04507204|528569904|FG000|Overall Study|Poor Compliance with Protocol|2|||
146562013|NCT04507204|528569905|FG001|Overall Study|Poor Compliance with Protocol|4|||
146562014|NCT04507204|528569904|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
146641555|NCT00265148|528865061|FG001|Overall Study|Subject chose to change of the dose|0|||
146562015|NCT04507204|528569905|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
146641556|NCT01463007|528865062|FG000|Overall Study|Physician Decision|1|||
146641557|NCT00942994|528865063|FG000|Overall Study|Adverse Event|7|||
146641558|NCT00942994|528865064|FG001|Overall Study|Adverse Event|4|||
146641559|NCT00942994|528865063|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146641560|NCT00942994|528865064|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146641561|NCT00942994|528865063|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146641562|NCT00942994|528865064|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146641563|NCT00942994|528865063|FG000|Overall Study|Patient withdrew consent|5|||
146641564|NCT00942994|528865064|FG001|Overall Study|Patient withdrew consent|8|||
146641565|NCT00942994|528865063|FG000|Overall Study|Lost to Follow-up|1|||
146641566|NCT00942994|528865064|FG001|Overall Study|Lost to Follow-up|4|||
146641567|NCT00942994|528865063|FG000|Overall Study|Protocol deviation|1|||
146641568|NCT00942994|528865064|FG001|Overall Study|Protocol deviation|2|||
146641569|NCT03583385|528865065|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146641570|NCT03583385|528865066|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146641571|NCT03583385|528865065|FG000|Treatment Period 2|Adverse Event|1|||
146641572|NCT03583385|528865066|FG001|Treatment Period 2|Adverse Event|0|||
146641573|NCT00095940|528865067|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
146641574|NCT00095940|528865068|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
146641575|NCT00095940|528865069|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
146641576|NCT00095940|528865070|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
146641577|NCT00095940|528865071|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
146641578|NCT00095940|528865072|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
146641579|NCT00095940|528865073|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
146641580|NCT00095940|528865074|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
146641581|NCT00095940|528865075|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
146641582|NCT00095940|528865067|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
146641583|NCT00095940|528865068|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
146641584|NCT00095940|528865069|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
146641585|NCT00095940|528865070|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
146641586|NCT00095940|528865071|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
146641587|NCT00095940|528865072|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
146641588|NCT00095940|528865073|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
146641589|NCT00095940|528865074|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
146641590|NCT00095940|528865075|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
146641591|NCT00095940|528865067|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
146641592|NCT00095940|528865068|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
146641593|NCT00095940|528865069|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
146641594|NCT00095940|528865070|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
146641595|NCT00095940|528865071|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
146641596|NCT00095940|528865072|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
146641597|NCT00095940|528865073|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
146641598|NCT00095940|528865074|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
146970159|NCT00902486|530050825|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
146767903|NCT02694978|529319418|FG001|Overall Study|Other-Decision of Participant|1|||
146767904|NCT02694978|529319417|FG000|Overall Study|Other-Investigator's decision|1|||
146767905|NCT02694978|529319418|FG001|Overall Study|Other-Investigator's decision|0|||
146767906|NCT02694978|529319417|FG000|Overall Study|Other-Unable to be reached|0|||
146767907|NCT02694978|529319418|FG001|Overall Study|Other-Unable to be reached|1|||
146767908|NCT02694978|529319417|FG000|Overall Study|Other-Protocol noncompliant|2|||
146767909|NCT02694978|529319418|FG001|Overall Study|Other-Protocol noncompliant|1|||
146767910|NCT02694978|529319417|FG000|Overall Study|Other-Personal reasons|3|||
146767911|NCT02694978|529319418|FG001|Overall Study|Other-Personal reasons|3|||
146767912|NCT02694978|529319417|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
146767913|NCT02694978|529319418|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
146767914|NCT01613716|529319419|FG000|Overall Study|screen failures|3|||
146767915|NCT01613716|529319419|FG000|Overall Study|Lost to Follow-up|4|||
146767916|NCT03262935|529319421|FG000|Overall Study|Withdrawal by Subject|6|||
146906845|NCT02277444|529823695|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
146906846|NCT02277444|529823695|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
146767917|NCT03262935|529319422|FG001|Overall Study|Withdrawal by Subject|7|||
146906847|NCT02277444|529823695|FG000|Treatment Period (Week 0-52)|Other|1|||
146906848|NCT02277444|529823695|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
146767918|NCT03262935|529319421|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
146767919|NCT03262935|529319422|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
146767920|NCT03262935|529319421|FG000|Overall Study|Death|181|||
146767921|NCT03262935|529319422|FG001|Overall Study|Death|94|||
146906849|NCT02277444|529823695|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
146767922|NCT03262935|529319421|FG000|Overall Study|Lost to Follow-up|9|||
146767923|NCT03262935|529319422|FG001|Overall Study|Lost to Follow-up|4|||
146767924|NCT03262935|529319421|FG000|Overall Study|Other reason|5|||
146767925|NCT03262935|529319422|FG001|Overall Study|Other reason|0|||
146767926|NCT00743444|529319425|FG000|First Intervention|Catheter placement problems|0|||
146767927|NCT00743444|529319426|FG001|First Intervention|Catheter placement problems|1|||
146767928|NCT00743444|529319425|FG000|Washout Period|Adverse Event|0|||
146767929|NCT00743444|529319426|FG001|Washout Period|Adverse Event|1|||
146767930|NCT02567656|529319429|FG000|Overall Study|Premature discontinuation due to PD|1|||
146767931|NCT02567656|529319430|FG001|Overall Study|Premature discontinuation due to PD|1|||
146767932|NCT02567656|529319431|FG002|Overall Study|Premature discontinuation due to PD|2|||
146767933|NCT02567656|529319432|FG003|Overall Study|Premature discontinuation due to PD|0|||
146767934|NCT02567656|529319433|FG004|Overall Study|Premature discontinuation due to PD|0|||
146767935|NCT02567656|529319434|FG005|Overall Study|Premature discontinuation due to PD|0|||
146767936|NCT03287622|529319435|FG000|Overall Study|Withdrawal by Subject|1|||
146767937|NCT03287622|529319436|FG001|Overall Study|Withdrawal by Subject|0|||
146767938|NCT03287622|529319435|FG000|Overall Study|Lost to Follow-up|27|||
146767939|NCT03287622|529319436|FG001|Overall Study|Lost to Follow-up|15|||
146767940|NCT03287622|529319435|FG000|Overall Study|No prescripion after surgery|28|||
146767941|NCT03287622|529319436|FG001|Overall Study|No prescripion after surgery|31|||
146767942|NCT03287622|529319435|FG000|Overall Study|prolonged Length of stay|2|||
146767943|NCT03287622|529319436|FG001|Overall Study|prolonged Length of stay|0|||
146767944|NCT03287622|529319435|FG000|Overall Study|surgery related|0|||
146767945|NCT03287622|529319436|FG001|Overall Study|surgery related|2|||
146767946|NCT03622580|529319439|FG000|Overall Study|Death|16|||
146767947|NCT03622580|529319440|FG001|Overall Study|Death|21|||
146767948|NCT03622580|529319441|FG002|Overall Study|Death|13|||
146767949|NCT03622580|529319439|FG000|Overall Study|Adverse Event|6|||
146767950|NCT03622580|529319440|FG001|Overall Study|Adverse Event|6|||
146767951|NCT03622580|529319441|FG002|Overall Study|Adverse Event|5|||
146767952|NCT03622580|529319439|FG000|Overall Study|Withdrawal by Subject|12|||
146767953|NCT03622580|529319440|FG001|Overall Study|Withdrawal by Subject|7|||
146767954|NCT03622580|529319441|FG002|Overall Study|Withdrawal by Subject|19|||
146767955|NCT03622580|529319439|FG000|Overall Study|Lost to Follow-up|12|||
146767956|NCT03622580|529319440|FG001|Overall Study|Lost to Follow-up|9|||
146767957|NCT03622580|529319441|FG002|Overall Study|Lost to Follow-up|9|||
146767958|NCT03622580|529319439|FG000|Overall Study|Protocol Violation|1|||
146767959|NCT03622580|529319440|FG001|Overall Study|Protocol Violation|0|||
146767960|NCT03622580|529319441|FG002|Overall Study|Protocol Violation|1|||
146767961|NCT03622580|529319439|FG000|Overall Study|Physician Decision|3|||
146767962|NCT03622580|529319440|FG001|Overall Study|Physician Decision|0|||
146767963|NCT03622580|529319441|FG002|Overall Study|Physician Decision|1|||
146767964|NCT03622580|529319439|FG000|Overall Study|Pregnancy|0|||
146767965|NCT03622580|529319440|FG001|Overall Study|Pregnancy|1|||
146767966|NCT03622580|529319441|FG002|Overall Study|Pregnancy|0|||
146767967|NCT03622580|529319439|FG000|Overall Study|Lack of Efficacy|0|||
146767968|NCT03622580|529319440|FG001|Overall Study|Lack of Efficacy|0|||
146767969|NCT03622580|529319441|FG002|Overall Study|Lack of Efficacy|1|||
146767970|NCT03622580|529319439|FG000|Overall Study|Other|2|||
146767971|NCT03622580|529319440|FG001|Overall Study|Other|0|||
146767972|NCT03622580|529319441|FG002|Overall Study|Other|3|||
146767973|NCT01930045|529319444|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
146767974|NCT01930045|529319445|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
146767975|NCT01930045|529319446|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
146767976|NCT01930045|529319447|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
146767977|NCT01930045|529319448|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
146767978|NCT01930045|529319449|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
146767979|NCT01930045|529319444|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
146767980|NCT01930045|529319445|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
146767981|NCT01930045|529319446|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
146767982|NCT01930045|529319447|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
146767983|NCT01930045|529319448|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
146767984|NCT01930045|529319449|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
146767985|NCT01563354|529319452|FG000|Core Phase|Adverse Event|5|||
146767986|NCT01563354|529319453|FG001|Core Phase|Adverse Event|15|||
146767987|NCT01563354|529319454|FG002|Core Phase|Adverse Event|13|||
146767988|NCT01563354|529319452|FG000|Core Phase|Withdrawal by Subject|1|||
146767989|NCT01563354|529319453|FG001|Core Phase|Withdrawal by Subject|0|||
146767990|NCT01563354|529319454|FG002|Core Phase|Withdrawal by Subject|3|||
146767991|NCT01563354|529319452|FG000|Core Phase|Lost to Follow-up|1|||
146767992|NCT01563354|529319453|FG001|Core Phase|Lost to Follow-up|0|||
146767993|NCT01563354|529319454|FG002|Core Phase|Lost to Follow-up|0|||
146767994|NCT01563354|529319452|FG000|Core Phase|Death|1|||
146767995|NCT01563354|529319453|FG001|Core Phase|Death|5|||
146767996|NCT01563354|529319454|FG002|Core Phase|Death|2|||
146767997|NCT01563354|529319452|FG000|Core Phase|Diseasse progression|18|||
146767998|NCT01563354|529319453|FG001|Core Phase|Diseasse progression|7|||
146767999|NCT01563354|529319454|FG002|Core Phase|Diseasse progression|8|||
146768000|NCT01563354|529319452|FG000|Core Phase|Protocol deviation|2|||
146562016|NCT04507204|528569904|FG000|Overall Study|Withdrawal of Patient Consent|21|||
146562017|NCT04507204|528569905|FG001|Overall Study|Withdrawal of Patient Consent|13|||
146562018|NCT03580044|528569906|FG000|Overall Study|Death|2|||
146562019|NCT03580044|528569907|FG001|Overall Study|Death|1|||
146562020|NCT03580044|528569906|FG000|Overall Study|Withdrawal by Subject|1|||
146562021|NCT03580044|528569907|FG001|Overall Study|Withdrawal by Subject|1|||
146562022|NCT00904371|528569913|FG000|Overall Study|Adverse Event|2|||
146562023|NCT00904371|528569913|FG000|Overall Study|Lost to Follow-up|4|||
146562024|NCT00904371|528569913|FG000|Overall Study|Discontinued at target blood pressure|2|||
146562025|NCT00904371|528569913|FG000|Overall Study|Continued with Tritace|1|||
146562026|NCT02300233|528569925|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
146562027|NCT02300233|528569926|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
146562028|NCT02300233|528569927|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
146562029|NCT02300233|528569925|FG000|Overall Study|Withdrawal by Subject|1|||
146562030|NCT02300233|528569926|FG001|Overall Study|Withdrawal by Subject|0|||
146562031|NCT02300233|528569927|FG002|Overall Study|Withdrawal by Subject|3|||
146562032|NCT02300233|528569925|FG000|Overall Study|Investigator Judgement|0|||
146562033|NCT02300233|528569926|FG001|Overall Study|Investigator Judgement|0|||
146562034|NCT02300233|528569927|FG002|Overall Study|Investigator Judgement|1|||
146562035|NCT02300233|528569925|FG000|Overall Study|Reason Not Specified|0|||
146562036|NCT02300233|528569926|FG001|Overall Study|Reason Not Specified|0|||
146562037|NCT02300233|528569927|FG002|Overall Study|Reason Not Specified|5|||
146562038|NCT02836249|528569928|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
146562039|NCT02836249|528569929|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
146562040|NCT02836249|528569930|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
146562041|NCT02836249|528569931|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
146562042|NCT02836249|528569928|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
146562043|NCT02836249|528569929|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
146562044|NCT02836249|528569930|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
146562045|NCT02836249|528569931|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
146562046|NCT02836249|528569928|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
146562047|NCT02836249|528569929|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
146562048|NCT02836249|528569930|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
146562049|NCT02836249|528569931|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
146562050|NCT02836249|528569928|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146562051|NCT02836249|528569929|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
146562052|NCT02836249|528569930|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146562053|NCT02836249|528569931|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146562054|NCT02836249|528569928|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
146562055|NCT02836249|528569929|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
146562056|NCT02836249|528569930|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
146562057|NCT02836249|528569931|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
146562058|NCT02836249|528569928|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
146562059|NCT02836249|528569929|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
146562060|NCT02836249|528569930|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
146562061|NCT02836249|528569931|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
146562062|NCT02836249|528569928|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
146562063|NCT02836249|528569929|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
146562064|NCT02836249|528569930|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
146562065|NCT02836249|528569931|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
146562066|NCT02836249|528569928|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
146562067|NCT02836249|528569929|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
146562068|NCT02836249|528569930|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
146562069|NCT02836249|528569931|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
146562070|NCT02836249|528569928|FG000|Open-Label TAF Treatment Phase|Death|0|||
146562071|NCT02836249|528569929|FG001|Open-Label TAF Treatment Phase|Death|0|||
146562072|NCT02836249|528569930|FG002|Open-Label TAF Treatment Phase|Death|1|||
146970160|NCT00902486|530050826|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
146970161|NCT00902486|530050827|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
146970162|NCT00902486|530050822|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
146970163|NCT00902486|530050823|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
146970164|NCT00902486|530050824|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
146970165|NCT00902486|530050825|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
146970166|NCT00902486|530050826|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
146562073|NCT02836249|528569931|FG003|Open-Label TAF Treatment Phase|Death|0|||
146562074|NCT02836249|528569928|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
146562075|NCT02836249|528569929|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
146562076|NCT02836249|528569930|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
146562077|NCT02836249|528569931|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
146562078|NCT02836249|528569928|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
146562079|NCT02836249|528569929|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
146562080|NCT02836249|528569930|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
146562081|NCT02836249|528569931|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
146562082|NCT04752566|528569932|FG000|Overall Study|Protocol Violation|0|||
146562083|NCT04752566|528569933|FG001|Overall Study|Protocol Violation|1|||
146562084|NCT04752566|528569932|FG000|Overall Study|Death|1|||
146562085|NCT04752566|528569933|FG001|Overall Study|Death|0|||
146562086|NCT04752566|528569932|FG000|Overall Study|Adverse Event|1|||
146562087|NCT04752566|528569933|FG001|Overall Study|Adverse Event|0|||
146562088|NCT04752566|528569932|FG000|Overall Study|Withdrawal by Subject|2|||
146562089|NCT04752566|528569933|FG001|Overall Study|Withdrawal by Subject|0|||
146562090|NCT04752566|528569932|FG000|Overall Study|Physician Decision|1|||
146562091|NCT04752566|528569933|FG001|Overall Study|Physician Decision|1|||
146562092|NCT03331354|528569934|FG000|Overall Study|Withdrawal by Subject|1|||
146562093|NCT03331354|528569935|FG001|Overall Study|Withdrawal by Subject|3|||
146562094|NCT03331354|528569934|FG000|Overall Study|Lost to Follow-up|3|||
146562095|NCT03331354|528569935|FG001|Overall Study|Lost to Follow-up|3|||
146562096|NCT03331354|528569934|FG000|Overall Study|Found employment before initiated active intervention|0|||
146562097|NCT03331354|528569935|FG001|Overall Study|Found employment before initiated active intervention|4|||
146562098|NCT00928668|528569936|FG000|Overall Study|Adverse Event|1|||
146562099|NCT00928668|528569937|FG001|Overall Study|Adverse Event|0|||
146562100|NCT00928668|528569938|FG002|Overall Study|Adverse Event|0|||
146562101|NCT00928668|528569939|FG003|Overall Study|Adverse Event|0|||
146562102|NCT00928668|528569940|FG004|Overall Study|Adverse Event|0|||
146562103|NCT00928668|528569936|FG000|Overall Study|Protocol Violation|0|||
146562104|NCT00928668|528569937|FG001|Overall Study|Protocol Violation|0|||
146562105|NCT00928668|528569938|FG002|Overall Study|Protocol Violation|0|||
146562106|NCT00928668|528569939|FG003|Overall Study|Protocol Violation|0|||
146562107|NCT00928668|528569940|FG004|Overall Study|Protocol Violation|1|||
146562108|NCT00928668|528569936|FG000|Overall Study|Withdrawal by Subject|0|||
146562109|NCT00928668|528569937|FG001|Overall Study|Withdrawal by Subject|1|||
146562110|NCT00928668|528569938|FG002|Overall Study|Withdrawal by Subject|1|||
146562111|NCT00928668|528569939|FG003|Overall Study|Withdrawal by Subject|0|||
146562112|NCT00928668|528569940|FG004|Overall Study|Withdrawal by Subject|0|||
146562113|NCT00928668|528569936|FG000|Overall Study|Other reasons not listed above|0|||
146562114|NCT00928668|528569937|FG001|Overall Study|Other reasons not listed above|0|||
146562115|NCT00928668|528569938|FG002|Overall Study|Other reasons not listed above|0|||
146562116|NCT00928668|528569939|FG003|Overall Study|Other reasons not listed above|1|||
146768001|NCT01563354|529319453|FG001|Core Phase|Protocol deviation|0|||
146906850|NCT02277444|529823695|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
146906851|NCT02277444|529823695|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
146906852|NCT02277444|529823695|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
146906853|NCT02277444|529823695|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
146906854|NCT05278104|529823696|FG000|Overall Study|Not treated|1|||
146906855|NCT05278104|529823697|FG001|Overall Study|Not treated|0|||
146906856|NCT05278104|529823696|FG000|Overall Study|Adverse Event|2|||
146906857|NCT05278104|529823697|FG001|Overall Study|Adverse Event|1|||
146906858|NCT05278104|529823696|FG000|Overall Study|Exclusion criteria not met|1|||
146906859|NCT05278104|529823697|FG001|Overall Study|Exclusion criteria not met|0|||
146906860|NCT01943539|529825442|FG000|Overall Study|Non-compliance with at-home intervention|4|||
146906861|NCT01943539|529825443|FG001|Overall Study|Non-compliance with at-home intervention|0|||
146906862|NCT02333331|529825444|FG000|Overall Study|Adverse Event|1|||
146906863|NCT02333331|529825445|FG001|Overall Study|Adverse Event|0|||
146906864|NCT02333331|529825446|FG002|Overall Study|Adverse Event|4|||
146906865|NCT02333331|529825447|FG003|Overall Study|Adverse Event|1|||
146906866|NCT02333331|529825444|FG000|Overall Study|Death|0|||
146906867|NCT02333331|529825445|FG001|Overall Study|Death|0|||
146906868|NCT02333331|529825446|FG002|Overall Study|Death|2|||
146906869|NCT02333331|529825447|FG003|Overall Study|Death|0|||
146906870|NCT02333331|529825444|FG000|Overall Study|Lost to Follow-up|0|||
146906871|NCT02333331|529825445|FG001|Overall Study|Lost to Follow-up|0|||
146906872|NCT02333331|529825446|FG002|Overall Study|Lost to Follow-up|1|||
146906873|NCT02333331|529825447|FG003|Overall Study|Lost to Follow-up|0|||
146906874|NCT02333331|529825444|FG000|Overall Study|Physician Decision|0|||
146906875|NCT02333331|529825445|FG001|Overall Study|Physician Decision|1|||
146906876|NCT02333331|529825446|FG002|Overall Study|Physician Decision|0|||
146906877|NCT02333331|529825447|FG003|Overall Study|Physician Decision|0|||
146906878|NCT02333331|529825444|FG000|Overall Study|Protocol Deviation|0|||
146906879|NCT02333331|529825445|FG001|Overall Study|Protocol Deviation|3|||
146906880|NCT02333331|529825446|FG002|Overall Study|Protocol Deviation|2|||
146906881|NCT02333331|529825447|FG003|Overall Study|Protocol Deviation|1|||
146906882|NCT02333331|529825444|FG000|Overall Study|Patient/Guardian Decision|1|||
146906883|NCT02333331|529825445|FG001|Overall Study|Patient/Guardian Decision|2|||
146906884|NCT02333331|529825446|FG002|Overall Study|Patient/Guardian Decision|9|||
146906885|NCT02333331|529825447|FG003|Overall Study|Patient/Guardian Decision|1|||
146906886|NCT02158533|529825452|FG000|Stage 1|Adverse Event|6|||
146906887|NCT02158533|529825453|FG001|Stage 1|Adverse Event|4|||
146641599|NCT00095940|528865075|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
146641600|NCT02314637|528865078|FG000|Overall Study|Adverse Event|4|||
146641601|NCT02314637|528865079|FG001|Overall Study|Adverse Event|8|||
146641602|NCT02314637|528865078|FG000|Overall Study|Lack of Efficacy|1|||
146641603|NCT02314637|528865079|FG001|Overall Study|Lack of Efficacy|0|||
146641604|NCT02314637|528865078|FG000|Overall Study|Physician Decision|5|||
146768002|NCT01563354|529319454|FG002|Core Phase|Protocol deviation|0|||
146768003|NCT01563354|529319452|FG000|Core Phase|PI decision - did not enter extension|0|||
146768004|NCT01563354|529319453|FG001|Core Phase|PI decision - did not enter extension|1|||
146768005|NCT01563354|529319454|FG002|Core Phase|PI decision - did not enter extension|0|||
146906888|NCT02158533|529825454|FG002|Stage 1|Adverse Event|7|||
146906889|NCT02158533|529825455|FG003|Stage 1|Adverse Event|0|||
146906890|NCT02158533|529825456|FG004|Stage 1|Adverse Event|0|||
146906891|NCT02158533|529825457|FG005|Stage 1|Adverse Event|0|||
146906892|NCT02158533|529825452|FG000|Stage 1|Withdrawal by Subject|3|||
146906893|NCT02158533|529825453|FG001|Stage 1|Withdrawal by Subject|2|||
146906894|NCT02158533|529825454|FG002|Stage 1|Withdrawal by Subject|1|||
146906895|NCT02158533|529825455|FG003|Stage 1|Withdrawal by Subject|0|||
146906896|NCT02158533|529825456|FG004|Stage 1|Withdrawal by Subject|0|||
146906897|NCT02158533|529825457|FG005|Stage 1|Withdrawal by Subject|0|||
146562117|NCT00928668|528569940|FG004|Overall Study|Other reasons not listed above|0|||
146562118|NCT04392154|528569941|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
146562119|NCT04392154|528569942|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
146562120|NCT04392154|528569943|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
146562121|NCT04392154|528569944|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
146562122|NCT04392154|528569941|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
146562123|NCT04392154|528569942|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
146562124|NCT04392154|528569943|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
146562125|NCT04392154|528569944|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
146562126|NCT04392154|528569941|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
146562127|NCT04392154|528569942|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
146562128|NCT04392154|528569943|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
146562129|NCT04392154|528569944|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
146562130|NCT04392154|528569941|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
146562131|NCT04392154|528569942|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
146562132|NCT04392154|528569943|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
146562133|NCT04392154|528569944|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
146562134|NCT04392154|528569941|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
146562135|NCT04392154|528569942|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
146562136|NCT04392154|528569943|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
146562137|NCT04392154|528569944|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
146562138|NCT04392154|528569941|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
146562139|NCT04392154|528569942|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
146562140|NCT04392154|528569943|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
146562141|NCT04392154|528569944|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
146562142|NCT04392154|528569941|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
146562143|NCT04392154|528569942|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
146562144|NCT04392154|528569943|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
146562145|NCT04392154|528569944|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
146562146|NCT04392154|528569941|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
146562147|NCT04392154|528569942|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
146562148|NCT04392154|528569943|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
146562149|NCT04392154|528569944|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
146562150|NCT04392154|528569941|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
146562151|NCT04392154|528569942|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
146562152|NCT04392154|528569943|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
146562153|NCT04392154|528569944|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
146562154|NCT04392154|528569941|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
146562155|NCT04392154|528569942|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
146562156|NCT04392154|528569943|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
146641605|NCT02314637|528865079|FG001|Overall Study|Physician Decision|2|||
146906898|NCT02158533|529825452|FG000|Stage 1|Lack of Efficacy|1|||
146906899|NCT02158533|529825453|FG001|Stage 1|Lack of Efficacy|0|||
146906900|NCT02158533|529825454|FG002|Stage 1|Lack of Efficacy|0|||
146906901|NCT02158533|529825455|FG003|Stage 1|Lack of Efficacy|0|||
146906902|NCT02158533|529825456|FG004|Stage 1|Lack of Efficacy|0|||
146906903|NCT02158533|529825457|FG005|Stage 1|Lack of Efficacy|0|||
146906904|NCT02158533|529825452|FG000|Stage 1|Lost to Follow-up|3|||
146906905|NCT02158533|529825453|FG001|Stage 1|Lost to Follow-up|1|||
146906906|NCT02158533|529825454|FG002|Stage 1|Lost to Follow-up|0|||
146906907|NCT02158533|529825455|FG003|Stage 1|Lost to Follow-up|0|||
146906908|NCT02158533|529825456|FG004|Stage 1|Lost to Follow-up|0|||
146906909|NCT02158533|529825457|FG005|Stage 1|Lost to Follow-up|0|||
146906910|NCT02158533|529825452|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
146906911|NCT02158533|529825453|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
146906912|NCT02158533|529825454|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
146906913|NCT02158533|529825455|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
146906914|NCT02158533|529825456|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
146906915|NCT02158533|529825457|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
146906916|NCT02158533|529825452|FG000|Stage 1|Non-compliance with study visits|1|||
146906917|NCT02158533|529825453|FG001|Stage 1|Non-compliance with study visits|0|||
146906918|NCT02158533|529825454|FG002|Stage 1|Non-compliance with study visits|0|||
146906919|NCT02158533|529825455|FG003|Stage 1|Non-compliance with study visits|0|||
146906920|NCT02158533|529825456|FG004|Stage 1|Non-compliance with study visits|0|||
146906921|NCT02158533|529825457|FG005|Stage 1|Non-compliance with study visits|0|||
146906922|NCT02158533|529825452|FG000|Stage 2|Adverse Event|0|||
146906923|NCT02158533|529825453|FG001|Stage 2|Adverse Event|0|||
146906924|NCT02158533|529825454|FG002|Stage 2|Adverse Event|0|||
146906925|NCT02158533|529825455|FG003|Stage 2|Adverse Event|0|||
146906926|NCT02158533|529825456|FG004|Stage 2|Adverse Event|0|||
146906927|NCT02158533|529825457|FG005|Stage 2|Adverse Event|1|||
146906928|NCT02158533|529825452|FG000|Stage 2|Lack of Efficacy|0|||
146768006|NCT01563354|529319452|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
146768007|NCT01563354|529319453|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
146768008|NCT01563354|529319454|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
146768009|NCT01563354|529319452|FG000|Extension Phase|Adverse Event|0|||
146906929|NCT02158533|529825453|FG001|Stage 2|Lack of Efficacy|0|||
146906930|NCT02158533|529825454|FG002|Stage 2|Lack of Efficacy|0|||
146768010|NCT01563354|529319453|FG001|Extension Phase|Adverse Event|3|||
146768011|NCT01563354|529319454|FG002|Extension Phase|Adverse Event|2|||
146768012|NCT01563354|529319452|FG000|Extension Phase|Withdrawal by Subject|0|||
146768013|NCT01563354|529319453|FG001|Extension Phase|Withdrawal by Subject|1|||
146768014|NCT01563354|529319454|FG002|Extension Phase|Withdrawal by Subject|0|||
146768015|NCT01563354|529319452|FG000|Extension Phase|Administration problems|3|||
146768016|NCT01563354|529319453|FG001|Extension Phase|Administration problems|2|||
146768017|NCT01563354|529319454|FG002|Extension Phase|Administration problems|3|||
146768018|NCT01563354|529319452|FG000|Extension Phase|Disease progression|9|||
146768019|NCT01563354|529319453|FG001|Extension Phase|Disease progression|8|||
146768020|NCT01563354|529319454|FG002|Extension Phase|Disease progression|10|||
146768021|NCT03621761|529319456|FG000|Overall Study|Lost to Follow-up|1|||
146768022|NCT03621761|529319457|FG001|Overall Study|Lost to Follow-up|1|||
146768023|NCT03621761|529319458|FG002|Overall Study|Lost to Follow-up|2|||
146768024|NCT03621761|529319456|FG000|Overall Study|Withdrawal by Subject|2|||
146768025|NCT03621761|529319457|FG001|Overall Study|Withdrawal by Subject|1|||
146768026|NCT03621761|529319458|FG002|Overall Study|Withdrawal by Subject|1|||
146768027|NCT03621761|529319456|FG000|Overall Study|Became Ineligible|0|||
146768028|NCT03621761|529319457|FG001|Overall Study|Became Ineligible|2|||
146768029|NCT03621761|529319458|FG002|Overall Study|Became Ineligible|0|||
146768030|NCT01050569|529319459|FG000|Overall Study|Lost to Follow-up|20|||
146768031|NCT01050569|529319460|FG001|Overall Study|Lost to Follow-up|14|||
146768032|NCT01050569|529319461|FG002|Overall Study|Lost to Follow-up|16|||
146768033|NCT01050569|529319459|FG000|Overall Study|Withdrawal by Subject|9|||
146768034|NCT01050569|529319460|FG001|Overall Study|Withdrawal by Subject|3|||
146768035|NCT01050569|529319461|FG002|Overall Study|Withdrawal by Subject|11|||
146768036|NCT01050569|529319459|FG000|Overall Study|Lack of Efficacy|5|||
146906931|NCT02158533|529825455|FG003|Stage 2|Lack of Efficacy|0|||
146768037|NCT01050569|529319460|FG001|Overall Study|Lack of Efficacy|4|||
146906932|NCT02158533|529825456|FG004|Stage 2|Lack of Efficacy|1|||
146906933|NCT02158533|529825457|FG005|Stage 2|Lack of Efficacy|0|||
146906934|NCT02158533|529825452|FG000|Stage 2|Lost to Follow-up|0|||
146906935|NCT02158533|529825453|FG001|Stage 2|Lost to Follow-up|0|||
146768038|NCT01050569|529319461|FG002|Overall Study|Lack of Efficacy|3|||
146906936|NCT02158533|529825454|FG002|Stage 2|Lost to Follow-up|0|||
146906937|NCT02158533|529825455|FG003|Stage 2|Lost to Follow-up|1|||
146906938|NCT02158533|529825456|FG004|Stage 2|Lost to Follow-up|1|||
146906939|NCT02158533|529825457|FG005|Stage 2|Lost to Follow-up|2|||
146906940|NCT02158533|529825452|FG000|Stage 2|Withdrawal by Subject|0|||
146906941|NCT02158533|529825453|FG001|Stage 2|Withdrawal by Subject|0|||
146768039|NCT01050569|529319459|FG000|Overall Study|Adverse Event|1|||
146906942|NCT02158533|529825454|FG002|Stage 2|Withdrawal by Subject|0|||
146906943|NCT02158533|529825455|FG003|Stage 2|Withdrawal by Subject|0|||
146906944|NCT02158533|529825456|FG004|Stage 2|Withdrawal by Subject|1|||
146906945|NCT02158533|529825457|FG005|Stage 2|Withdrawal by Subject|2|||
146906946|NCT02158533|529825452|FG000|Stage 2|Physician Decision|0|||
146906947|NCT02158533|529825453|FG001|Stage 2|Physician Decision|0|||
146906948|NCT02158533|529825454|FG002|Stage 2|Physician Decision|0|||
146906949|NCT02158533|529825455|FG003|Stage 2|Physician Decision|0|||
146906950|NCT02158533|529825456|FG004|Stage 2|Physician Decision|1|||
146906951|NCT02158533|529825457|FG005|Stage 2|Physician Decision|0|||
146906952|NCT02158533|529825452|FG000|Stage 2|Pregnancy|0|||
146906953|NCT02158533|529825453|FG001|Stage 2|Pregnancy|0|||
146906954|NCT02158533|529825454|FG002|Stage 2|Pregnancy|0|||
146906955|NCT02158533|529825455|FG003|Stage 2|Pregnancy|1|||
146906956|NCT02158533|529825456|FG004|Stage 2|Pregnancy|0|||
146906957|NCT02158533|529825457|FG005|Stage 2|Pregnancy|0|||
146906958|NCT02158533|529825452|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
146906959|NCT02158533|529825453|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
146906960|NCT02158533|529825454|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
146906961|NCT02158533|529825455|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
146906962|NCT02158533|529825456|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
146906963|NCT02158533|529825457|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
146906964|NCT02158533|529825452|FG000|Stage 2|Non-adherence with study visits|0|||
146906965|NCT02158533|529825453|FG001|Stage 2|Non-adherence with study visits|0|||
146906966|NCT02158533|529825454|FG002|Stage 2|Non-adherence with study visits|0|||
146906967|NCT02158533|529825455|FG003|Stage 2|Non-adherence with study visits|0|||
146906968|NCT02158533|529825456|FG004|Stage 2|Non-adherence with study visits|0|||
146906969|NCT02158533|529825457|FG005|Stage 2|Non-adherence with study visits|1|||
146906970|NCT02037919|529825462|FG000|Overall Study|Lost to Follow-up|30|||
146906971|NCT02037919|529825463|FG001|Overall Study|Lost to Follow-up|45|||
146906972|NCT00345605|529825464|FG000|Arm 1|Adverse Event|0|||
146906973|NCT00345605|529825465|FG001|Arm 1|Adverse Event|1|||
146906974|NCT00345605|529825464|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
146906975|NCT00345605|529825465|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
146906976|NCT01335971|529825466|FG000|Overall Study|Withdrawal by Subject|1|||
146906977|NCT01335971|529825467|FG001|Overall Study|Withdrawal by Subject|0|||
146641606|NCT02314637|528865078|FG000|Overall Study|Withdrawal by Subject|5|||
146641607|NCT02314637|528865079|FG001|Overall Study|Withdrawal by Subject|4|||
146641608|NCT02314637|528865078|FG000|Overall Study|Other Reason|1|||
146641609|NCT02314637|528865079|FG001|Overall Study|Other Reason|0|||
146641610|NCT02597478|528865096|FG000|Overall Study|Withdrawal by Subject|2|||
146641611|NCT02597478|528865097|FG001|Overall Study|Withdrawal by Subject|0|||
146641612|NCT02597478|528865096|FG000|Overall Study|Change of opioid dose|1|||
146641613|NCT02597478|528865097|FG001|Overall Study|Change of opioid dose|0|||
146641614|NCT02597478|528865096|FG000|Overall Study|Insufficient exertional dyspnea|0|||
146641615|NCT02597478|528865097|FG001|Overall Study|Insufficient exertional dyspnea|1|||
146641616|NCT01256190|528865099|FG000|Overall Study|Lost to Follow-up|2|||
146641617|NCT01256190|528865100|FG001|Overall Study|Lost to Follow-up|0|||
146641618|NCT02350478|528865101|FG000|Overall Study|Lost to Follow-up|5|||
146641619|NCT02350478|528865102|FG001|Overall Study|Lost to Follow-up|1|||
146641620|NCT02779556|528865103|FG000|Baseline|Partial baseline interview completed|1|||
146641621|NCT02779556|528865104|FG001|Baseline|Partial baseline interview completed|0|||
146641622|NCT02779556|528865103|FG000|3 Months|Lost to Follow-up|40|||
146641623|NCT02779556|528865104|FG001|3 Months|Lost to Follow-up|29|||
146641624|NCT02779556|528865103|FG000|3 Months|Missed 3 month clinic visit|27|||
146641625|NCT02779556|528865104|FG001|3 Months|Missed 3 month clinic visit|19|||
146641626|NCT02779556|528865103|FG000|6 Month|Lost to Follow-up|33|||
146641627|NCT02779556|528865104|FG001|6 Month|Lost to Follow-up|39|||
146641628|NCT02779556|528865103|FG000|6 Month HbA1c|No value collected during window|69|||
146641629|NCT02779556|528865104|FG001|6 Month HbA1c|No value collected during window|50|||
146641630|NCT02779556|528865103|FG000|12 Month HbA1c|No value collected during window|138|||
146641631|NCT02779556|528865104|FG001|12 Month HbA1c|No value collected during window|102|||
146641632|NCT03110770|528865106|FG000|Overall Study|Death|1|||
146641633|NCT03110770|528865107|FG001|Overall Study|Death|0|||
146641634|NCT03110770|528865108|FG002|Overall Study|Death|0|||
146641635|NCT03110770|528865109|FG003|Overall Study|Death|1|||
146641636|NCT03110770|528865110|FG004|Overall Study|Death|0|||
146641637|NCT03110770|528865106|FG000|Overall Study|Enrolled but did not receive product|0|||
146906978|NCT01335971|529825468|FG002|Overall Study|Withdrawal by Subject|0|||
146641638|NCT03110770|528865107|FG001|Overall Study|Enrolled but did not receive product|0|||
146641639|NCT03110770|528865108|FG002|Overall Study|Enrolled but did not receive product|0|||
146906979|NCT01335971|529825466|FG000|Overall Study|Did not complete bronchoscopy|1|||
146641640|NCT03110770|528865109|FG003|Overall Study|Enrolled but did not receive product|8|||
146641641|NCT03110770|528865110|FG004|Overall Study|Enrolled but did not receive product|7|||
146641642|NCT03110770|528865106|FG000|Overall Study|Lost to Follow-up|0|||
146641643|NCT03110770|528865107|FG001|Overall Study|Lost to Follow-up|0|||
146641644|NCT03110770|528865108|FG002|Overall Study|Lost to Follow-up|0|||
146906980|NCT01335971|529825467|FG001|Overall Study|Did not complete bronchoscopy|1|||
146906981|NCT01335971|529825468|FG002|Overall Study|Did not complete bronchoscopy|1|||
146906982|NCT00384956|529825469|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
146906983|NCT01059812|529825470|FG000|Overall Study|Adverse Event|9|||
146906984|NCT01059812|529825471|FG001|Overall Study|Adverse Event|5|||
146906985|NCT01059812|529825470|FG000|Overall Study|Lack of Efficacy|2|||
146906986|NCT01059812|529825471|FG001|Overall Study|Lack of Efficacy|2|||
146562157|NCT04392154|528569944|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
146562158|NCT04392154|528569941|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
146562159|NCT04392154|528569942|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
146562160|NCT04392154|528569943|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
146768040|NCT01050569|529319460|FG001|Overall Study|Adverse Event|0|||
146768041|NCT01050569|529319461|FG002|Overall Study|Adverse Event|0|||
146906987|NCT01059812|529825470|FG000|Overall Study|Protocol Violation|3|||
146906988|NCT01059812|529825471|FG001|Overall Study|Protocol Violation|1|||
146906989|NCT01059812|529825470|FG000|Overall Study|Withdrawal Criteria|9|||
146906990|NCT01059812|529825471|FG001|Overall Study|Withdrawal Criteria|4|||
146906991|NCT01059812|529825470|FG000|Overall Study|Unclassified|14|||
146906992|NCT01059812|529825471|FG001|Overall Study|Unclassified|4|||
146906993|NCT03180736|529825472|FG000|Overall Study|Adverse Event|3|||
146906994|NCT03180736|529825473|FG001|Overall Study|Adverse Event|4|||
146906995|NCT03180736|529825472|FG000|Overall Study|Death|10|||
146906996|NCT03180736|529825473|FG001|Overall Study|Death|7|||
146906997|NCT03180736|529825472|FG000|Overall Study|Withdrawal by Subject|5|||
146906998|NCT03180736|529825473|FG001|Overall Study|Withdrawal by Subject|12|||
146906999|NCT03180736|529825472|FG000|Overall Study|Lost to Follow-up|1|||
146907000|NCT03180736|529825473|FG001|Overall Study|Lost to Follow-up|0|||
146907001|NCT03180736|529825472|FG000|Overall Study|Lack of Efficacy|66|||
146907002|NCT03180736|529825473|FG001|Overall Study|Lack of Efficacy|87|||
146907003|NCT03180736|529825472|FG000|Overall Study|Physician Decision|4|||
146907004|NCT03180736|529825473|FG001|Overall Study|Physician Decision|7|||
146907005|NCT03180736|529825472|FG000|Overall Study|randomized but not treated|2|||
146907006|NCT03180736|529825473|FG001|Overall Study|randomized but not treated|3|||
146907007|NCT01389128|529825474|FG000|Overall Study|Fetal distress|1|||
146768042|NCT01050569|529319459|FG000|Overall Study|Physician Decision|3|||
146907008|NCT01389128|529825475|FG001|Overall Study|Fetal distress|0|||
146907009|NCT01389128|529825474|FG000|Overall Study|Cervix dilation stop|1|||
146562161|NCT04392154|528569944|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
146562162|NCT04392154|528569941|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
146562163|NCT04392154|528569942|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
146562164|NCT04392154|528569943|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
146562165|NCT04392154|528569944|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
146562166|NCT04392154|528569941|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
146562167|NCT04392154|528569942|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
146562168|NCT04392154|528569943|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
146562169|NCT04392154|528569944|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
146562170|NCT04392154|528569941|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
146562171|NCT04392154|528569942|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
146562172|NCT04392154|528569943|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
146562173|NCT04392154|528569944|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
146562174|NCT02958865|528569945|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
146562175|NCT02958865|528569946|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
146562176|NCT02958865|528569947|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
146562177|NCT02958865|528569948|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
146562178|NCT02958865|528569949|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
146562179|NCT02958865|528569950|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
146562180|NCT02958865|528569951|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
146562181|NCT02958865|528569952|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
146768043|NCT01050569|529319460|FG001|Overall Study|Physician Decision|3|||
146907010|NCT01389128|529825475|FG001|Overall Study|Cervix dilation stop|2|||
146907011|NCT01389128|529825474|FG000|Overall Study|Rapid labor evolution|3|||
146907012|NCT01389128|529825475|FG001|Overall Study|Rapid labor evolution|2|||
146907013|NCT01389128|529825474|FG000|Overall Study|Intolerance to procedure|0|||
146907014|NCT01389128|529825475|FG001|Overall Study|Intolerance to procedure|2|||
146907015|NCT00174941|529825478|FG000|Overall Study|Adverse Event|1|||
146907016|NCT00174941|529825479|FG001|Overall Study|Adverse Event|10|||
146907017|NCT00174941|529825480|FG002|Overall Study|Adverse Event|2|||
146907018|NCT00174941|529825481|FG003|Overall Study|Adverse Event|13|||
146907019|NCT00174941|529825478|FG000|Overall Study|Protocol Violation|0|||
146907020|NCT00174941|529825479|FG001|Overall Study|Protocol Violation|1|||
146907021|NCT00174941|529825480|FG002|Overall Study|Protocol Violation|0|||
146907022|NCT00174941|529825481|FG003|Overall Study|Protocol Violation|1|||
146907023|NCT00174941|529825478|FG000|Overall Study|Lost to Follow-up|0|||
146907024|NCT00174941|529825479|FG001|Overall Study|Lost to Follow-up|3|||
146907025|NCT00174941|529825480|FG002|Overall Study|Lost to Follow-up|2|||
146907026|NCT00174941|529825481|FG003|Overall Study|Lost to Follow-up|5|||
146907027|NCT00174941|529825478|FG000|Overall Study|Personal Reason(s)|0|||
146907028|NCT00174941|529825479|FG001|Overall Study|Personal Reason(s)|14|||
146907029|NCT00174941|529825480|FG002|Overall Study|Personal Reason(s)|8|||
146907030|NCT00174941|529825481|FG003|Overall Study|Personal Reason(s)|22|||
146907031|NCT00174941|529825478|FG000|Overall Study|Gout Flare|0|||
146907032|NCT00174941|529825479|FG001|Overall Study|Gout Flare|4|||
146907033|NCT00174941|529825480|FG002|Overall Study|Gout Flare|4|||
146907034|NCT00174941|529825481|FG003|Overall Study|Gout Flare|8|||
146907035|NCT00174941|529825478|FG000|Overall Study|Reason Not Specified|1|||
146907036|NCT00174941|529825479|FG001|Overall Study|Reason Not Specified|6|||
146907037|NCT00174941|529825480|FG002|Overall Study|Reason Not Specified|2|||
146907038|NCT00174941|529825481|FG003|Overall Study|Reason Not Specified|9|||
146907039|NCT03126227|529825482|FG000|Overall Study|Adverse Event|43|||
146907040|NCT03126227|529825483|FG001|Overall Study|Adverse Event|4|||
146907041|NCT03126227|529825482|FG000|Overall Study|Death|0|||
146907042|NCT03126227|529825483|FG001|Overall Study|Death|1|||
146907043|NCT03126227|529825482|FG000|Overall Study|Lost to Follow-up|0|||
146562182|NCT02958865|528569953|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
146907044|NCT03126227|529825483|FG001|Overall Study|Lost to Follow-up|1|||
146907045|NCT03126227|529825482|FG000|Overall Study|Physician Decision|2|||
146907046|NCT03126227|529825483|FG001|Overall Study|Physician Decision|0|||
146907047|NCT03126227|529825482|FG000|Overall Study|Protocol Violation|1|||
146907048|NCT03126227|529825483|FG001|Overall Study|Protocol Violation|0|||
146562183|NCT02958865|528569954|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
146907049|NCT03126227|529825482|FG000|Overall Study|Withdrawal by Subject|19|||
146907050|NCT03126227|529825483|FG001|Overall Study|Withdrawal by Subject|3|||
146562184|NCT02958865|528569955|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
146768044|NCT01050569|529319461|FG002|Overall Study|Physician Decision|3|||
146907051|NCT03126227|529825482|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
146907052|NCT03126227|529825483|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
146907053|NCT03126227|529825482|FG000|Overall Study|Lack of dosing compliance|2|||
146562185|NCT02958865|528569956|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
146562186|NCT02958865|528569957|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
146562187|NCT02958865|528569958|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
146562188|NCT02958865|528569959|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
146562189|NCT02958865|528569960|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
146562190|NCT02958865|528569945|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
146562191|NCT02958865|528569946|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
146562192|NCT02958865|528569947|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
146562193|NCT02958865|528569948|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
146562194|NCT02958865|528569949|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
146562195|NCT02958865|528569950|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
146562196|NCT02958865|528569951|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
146562197|NCT02958865|528569952|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
146562198|NCT02958865|528569953|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
146562199|NCT02958865|528569954|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
146562200|NCT02958865|528569955|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
146562201|NCT02958865|528569956|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
146562202|NCT02958865|528569957|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
146562203|NCT02958865|528569958|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
146562204|NCT02958865|528569959|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
146562205|NCT02958865|528569960|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
146562206|NCT02958865|528569945|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
146562207|NCT02958865|528569946|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
146562208|NCT02958865|528569947|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
146562209|NCT02958865|528569948|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
146562210|NCT02958865|528569949|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
146562211|NCT02958865|528569950|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
146562212|NCT02958865|528569951|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
146562213|NCT02958865|528569952|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
146562214|NCT02958865|528569953|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
146562215|NCT02958865|528569954|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
146562216|NCT02958865|528569955|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
146562217|NCT02958865|528569956|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
146562218|NCT02958865|528569957|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
146562219|NCT02958865|528569958|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
146562220|NCT02958865|528569959|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
146562221|NCT02958865|528569960|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
146562222|NCT02958865|528569945|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
146562223|NCT02958865|528569946|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146562224|NCT02958865|528569947|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
146562225|NCT02958865|528569948|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
146562226|NCT02958865|528569949|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
146562227|NCT02958865|528569950|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
146562228|NCT02958865|528569951|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
146562229|NCT02958865|528569952|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146562230|NCT02958865|528569953|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146562231|NCT02958865|528569954|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146562232|NCT02958865|528569955|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146562233|NCT02958865|528569956|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146562234|NCT02958865|528569957|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146562235|NCT02958865|528569958|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146562236|NCT02958865|528569959|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146562237|NCT02958865|528569960|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146562238|NCT02958865|528569945|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
146562239|NCT02958865|528569946|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
146562240|NCT02958865|528569947|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
146562241|NCT02958865|528569948|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
146562242|NCT02958865|528569949|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
146562243|NCT02958865|528569950|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
146562244|NCT02958865|528569951|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
146562245|NCT02958865|528569952|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
146562246|NCT02958865|528569953|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
146562247|NCT02958865|528569954|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
146562248|NCT02958865|528569955|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
146907054|NCT03126227|529825483|FG001|Overall Study|Lack of dosing compliance|0|||
146907055|NCT03126227|529825482|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
146907056|NCT03126227|529825483|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
146907057|NCT03126227|529825482|FG000|Overall Study|Scheduling conflict|1|||
146907058|NCT03126227|529825483|FG001|Overall Study|Scheduling conflict|0|||
146907059|NCT00635102|529825488|FG000|Overall Study|Withdrawal by Subject|7|||
146907060|NCT00635102|529825489|FG001|Overall Study|Withdrawal by Subject|8|||
146907061|NCT00440401|529825491|FG000|Overall Study|Adverse Event|2|||
146907062|NCT00440401|529825492|FG001|Overall Study|Adverse Event|1|||
146907063|NCT00440401|529825491|FG000|Overall Study|Other|2|||
146907064|NCT00440401|529825492|FG001|Overall Study|Other|5|||
146907065|NCT01938625|529825493|FG000|Overall Study|Withdrawal by Subject|0|||
146907066|NCT01938625|529825494|FG001|Overall Study|Withdrawal by Subject|1|||
146907067|NCT01938625|529825493|FG000|Overall Study|Adverse Event|0|||
146907068|NCT01938625|529825494|FG001|Overall Study|Adverse Event|1|||
146907069|NCT01937312|529825495|FG000|Overall Study|Adverse Event|10|||
146907070|NCT01937312|529825496|FG001|Overall Study|Adverse Event|1|||
146907071|NCT01937312|529825495|FG000|Overall Study|Lack of Efficacy|0|||
146907072|NCT01937312|529825496|FG001|Overall Study|Lack of Efficacy|1|||
146907073|NCT01937312|529825495|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
146907074|NCT01937312|529825496|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
146907075|NCT01165229|529825497|FG000|Overall Study|Serious Adverse Event|456|||
146907076|NCT01165229|529825498|FG001|Overall Study|Serious Adverse Event|487|||
146907077|NCT01165229|529825497|FG000|Overall Study|Non-Serious Adverse Event|47|||
146907078|NCT01165229|529825498|FG001|Overall Study|Non-Serious Adverse Event|15|||
146907079|NCT01165229|529825497|FG000|Overall Study|Protocol Violation|6|||
146907080|NCT01165229|529825498|FG001|Overall Study|Protocol Violation|8|||
146907081|NCT01165229|529825497|FG000|Overall Study|Withdrawal by Subject|387|||
146907082|NCT01165229|529825498|FG001|Overall Study|Withdrawal by Subject|396|||
146907083|NCT01165229|529825497|FG000|Overall Study|Migrated/moved from study area|51|||
146907084|NCT01165229|529825498|FG001|Overall Study|Migrated/moved from study area|46|||
146907085|NCT01165229|529825497|FG000|Overall Study|Lost to Follow-up|123|||
146907086|NCT01165229|529825498|FG001|Overall Study|Lost to Follow-up|133|||
146907087|NCT01165229|529825497|FG000|Overall Study|Suspected HZ Episode|2|||
146907088|NCT01165229|529825498|FG001|Overall Study|Suspected HZ Episode|2|||
146907089|NCT01165229|529825497|FG000|Overall Study|No reason from the subject|108|||
146907090|NCT01165229|529825498|FG001|Overall Study|No reason from the subject|102|||
146907091|NCT01165229|529825497|FG000|Overall Study|Unknown completion status|0|||
146907092|NCT01165229|529825498|FG001|Overall Study|Unknown completion status|1|||
146907093|NCT00550238|529825502|FG000|Overall Study|Adverse Event|88|||
146907094|NCT00550238|529825502|FG000|Overall Study|Death|34|||
146907095|NCT00550238|529825502|FG000|Overall Study|Disease progression|46|||
146907096|NCT00550238|529825502|FG000|Overall Study|Withdrawal by Subject|167|||
146562249|NCT02958865|528569956|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
146907097|NCT00550238|529825502|FG000|Overall Study|Physician Decision|31|||
146768045|NCT02441036|529319466|FG000|Overall Study|No tissue resected|0|||
146907098|NCT00550238|529825502|FG000|Overall Study|Patient noncompliance|25|||
146907099|NCT00550238|529825502|FG000|Overall Study|Lost to Follow-up|13|||
146907100|NCT00550238|529825502|FG000|Overall Study|Sponsor decision|55|||
146907101|NCT05370157|529825505|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
146907102|NCT05370157|529825506|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
146907103|NCT05370157|529825505|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
146907104|NCT05370157|529825506|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
146907105|NCT01508676|529825507|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
146907106|NCT01508676|529825508|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
146907107|NCT01508676|529825507|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
146907108|NCT01508676|529825508|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
146907109|NCT01508676|529825507|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
146907110|NCT01508676|529825508|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
146907111|NCT01508676|529825507|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
146907112|NCT01508676|529825508|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
146907113|NCT01508676|529825507|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
146562250|NCT02958865|528569957|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
146907114|NCT01508676|529825508|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
146907115|NCT03700892|529825509|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
146907116|NCT03700892|529825510|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
146907117|NCT03700892|529825511|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
146907118|NCT00849212|529825513|FG000|Overall Study|Lack of Efficacy|1|||
146907119|NCT00849212|529825513|FG000|Overall Study|Withdrawal by Subject|3|||
146907120|NCT00849212|529825513|FG000|Overall Study|Adverse Event|2|||
146907121|NCT00849212|529825513|FG000|Overall Study|Miscellaneous|1|||
146907122|NCT04407507|529825514|FG000|Overall Study|Withdrawal by Subject|0|||
146907123|NCT04407507|529825515|FG001|Overall Study|Withdrawal by Subject|1|||
146907124|NCT01499576|529825516|FG000|Overall Study|Physician Decision|12|||
146907125|NCT01499576|529825516|FG000|Overall Study|Withdrawal by Subject|9|||
146907126|NCT00845429|529825521|FG000|Overall Study|Protocol Violation|5|||
146907127|NCT00845429|529825522|FG001|Overall Study|Protocol Violation|4|||
146907128|NCT00845429|529825523|FG002|Overall Study|Protocol Violation|7|||
146907129|NCT00845429|529825521|FG000|Overall Study|Lost to Follow-up|7|||
146907130|NCT00845429|529825522|FG001|Overall Study|Lost to Follow-up|9|||
146907131|NCT00845429|529825523|FG002|Overall Study|Lost to Follow-up|10|||
146907132|NCT00845429|529825521|FG000|Overall Study|Withdrawal by Subject|2|||
146907133|NCT00845429|529825522|FG001|Overall Study|Withdrawal by Subject|2|||
146907134|NCT00845429|529825523|FG002|Overall Study|Withdrawal by Subject|2|||
146907135|NCT00845429|529825521|FG000|Overall Study|Serious adverse event|0|||
146907136|NCT00845429|529825522|FG001|Overall Study|Serious adverse event|0|||
146907137|NCT00845429|529825523|FG002|Overall Study|Serious adverse event|1|||
146907138|NCT00587223|529825529|FG000|Overall Study|Adverse Event|1|||
146907139|NCT00195351|529825530|FG000|Overall Study|Lost to Follow-up|9|||
146907140|NCT00195351|529825531|FG001|Overall Study|Lost to Follow-up|9|||
146907141|NCT00195351|529825530|FG000|Overall Study|Withdrawal by Subject|6|||
146907142|NCT00195351|529825531|FG001|Overall Study|Withdrawal by Subject|3|||
146907143|NCT00195351|529825530|FG000|Overall Study|Protocol Deviation|3|||
146907144|NCT00195351|529825531|FG001|Overall Study|Protocol Deviation|2|||
146907145|NCT00195351|529825530|FG000|Overall Study|Death|3|||
146907146|NCT00195351|529825531|FG001|Overall Study|Death|1|||
146907147|NCT00195351|529825530|FG000|Overall Study|Lack of Efficacy|0|||
146907148|NCT00195351|529825531|FG001|Overall Study|Lack of Efficacy|1|||
146907149|NCT02111369|529825532|FG000|Overall Study|Lost to Follow-up|2|||
146907150|NCT02111369|529825532|FG000|Overall Study|Withdrawal by Subject|1|||
146907151|NCT04332419|529825538|FG000|Overall Study|Withdrawal by Subject|1|||
146907152|NCT00971321|529825539|FG000|Up to Month 7|Withdrawal by Subject|1|||
146907153|NCT00971321|529825540|FG001|Up to Month 7|Withdrawal by Subject|0|||
146907154|NCT00971321|529825539|FG000|Up to Month 7|Migrated/moved from study area|3|||
146907155|NCT00971321|529825540|FG001|Up to Month 7|Migrated/moved from study area|2|||
146907156|NCT00971321|529825539|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
146907157|NCT00971321|529825540|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
146907158|NCT00971321|529825539|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
146907159|NCT00971321|529825540|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
146907160|NCT00971321|529825539|FG000|Up to Month 11-12|Lost to Follow-up|1|||
146907161|NCT00971321|529825540|FG001|Up to Month 11-12|Lost to Follow-up|0|||
146907162|NCT00519623|529825541|FG000|Overall Study|Adverse Event|1|||
146562251|NCT02958865|528569958|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
146562252|NCT02958865|528569959|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
146562253|NCT02958865|528569960|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
146562254|NCT02958865|528569945|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
146562255|NCT02958865|528569946|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
146562256|NCT02958865|528569947|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
146907163|NCT04222725|529825542|FG000|Overall Study|Adverse Event|0|||
146907164|NCT04222725|529825543|FG001|Overall Study|Adverse Event|1|||
146907165|NCT04222725|529825544|FG002|Overall Study|Adverse Event|0|||
146907166|NCT04222725|529825545|FG003|Overall Study|Adverse Event|0|||
146907167|NCT03819140|529825546|FG000|Overall Study|Lost to Follow-up|1|||
146907168|NCT03819140|529825547|FG001|Overall Study|Lost to Follow-up|2|||
146970167|NCT00902486|530050827|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
146907169|NCT03819140|529825546|FG000|Overall Study|Withdrawal by Subject|3|||
146907170|NCT03819140|529825547|FG001|Overall Study|Withdrawal by Subject|2|||
146907171|NCT03819140|529825546|FG000|Overall Study|Adverse Event|0|||
146907172|NCT03819140|529825547|FG001|Overall Study|Adverse Event|1|||
146907173|NCT03819140|529825546|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
146907174|NCT03819140|529825547|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
146907175|NCT03819140|529825546|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
146907176|NCT03819140|529825547|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
146907177|NCT00658333|529825548|FG000|Overall Study|Adverse Event|2|||
146907178|NCT00658333|529825549|FG001|Overall Study|Adverse Event|1|||
146907179|NCT03519178|529825550|FG000|PF-06873600 Treatment|Adverse Event|0|||
146907180|NCT03519178|529825551|FG001|PF-06873600 Treatment|Adverse Event|0|||
146907181|NCT03519178|529825552|FG002|PF-06873600 Treatment|Adverse Event|0|||
146907182|NCT03519178|529825553|FG003|PF-06873600 Treatment|Adverse Event|0|||
146907183|NCT03519178|529825554|FG004|PF-06873600 Treatment|Adverse Event|0|||
146907184|NCT03519178|529825555|FG005|PF-06873600 Treatment|Adverse Event|0|||
146907185|NCT03519178|529825556|FG006|PF-06873600 Treatment|Adverse Event|0|||
146907186|NCT03519178|529825557|FG007|PF-06873600 Treatment|Adverse Event|2|||
146907187|NCT03519178|529825558|FG008|PF-06873600 Treatment|Adverse Event|1|||
146907188|NCT03519178|529825559|FG009|PF-06873600 Treatment|Adverse Event|0|||
146907189|NCT03519178|529825560|FG010|PF-06873600 Treatment|Adverse Event|0|||
146907190|NCT03519178|529825561|FG011|PF-06873600 Treatment|Adverse Event|0|||
146907191|NCT03519178|529825562|FG012|PF-06873600 Treatment|Adverse Event|1|||
146907192|NCT03519178|529825563|FG013|PF-06873600 Treatment|Adverse Event|3|||
146907193|NCT03519178|529825564|FG014|PF-06873600 Treatment|Adverse Event|2|||
146907194|NCT03519178|529825550|FG000|PF-06873600 Treatment|Death|0|||
146907195|NCT03519178|529825551|FG001|PF-06873600 Treatment|Death|0|||
146907196|NCT03519178|529825552|FG002|PF-06873600 Treatment|Death|0|||
146907197|NCT03519178|529825553|FG003|PF-06873600 Treatment|Death|0|||
146907198|NCT03519178|529825554|FG004|PF-06873600 Treatment|Death|0|||
146907199|NCT03519178|529825555|FG005|PF-06873600 Treatment|Death|0|||
146907200|NCT03519178|529825556|FG006|PF-06873600 Treatment|Death|0|||
146907201|NCT03519178|529825557|FG007|PF-06873600 Treatment|Death|0|||
146907202|NCT03519178|529825558|FG008|PF-06873600 Treatment|Death|1|||
146907203|NCT03519178|529825559|FG009|PF-06873600 Treatment|Death|1|||
146907204|NCT03519178|529825560|FG010|PF-06873600 Treatment|Death|0|||
146907205|NCT03519178|529825561|FG011|PF-06873600 Treatment|Death|0|||
146907206|NCT03519178|529825562|FG012|PF-06873600 Treatment|Death|0|||
146907207|NCT03519178|529825563|FG013|PF-06873600 Treatment|Death|0|||
146907208|NCT03519178|529825564|FG014|PF-06873600 Treatment|Death|1|||
146907209|NCT03519178|529825550|FG000|PF-06873600 Treatment|Physician Decision|0|||
146907210|NCT03519178|529825551|FG001|PF-06873600 Treatment|Physician Decision|0|||
146907211|NCT03519178|529825552|FG002|PF-06873600 Treatment|Physician Decision|0|||
146907212|NCT03519178|529825553|FG003|PF-06873600 Treatment|Physician Decision|0|||
146907213|NCT03519178|529825554|FG004|PF-06873600 Treatment|Physician Decision|0|||
146907214|NCT03519178|529825555|FG005|PF-06873600 Treatment|Physician Decision|0|||
146907215|NCT03519178|529825556|FG006|PF-06873600 Treatment|Physician Decision|0|||
146907216|NCT03519178|529825557|FG007|PF-06873600 Treatment|Physician Decision|1|||
146907217|NCT03519178|529825558|FG008|PF-06873600 Treatment|Physician Decision|0|||
146907218|NCT03519178|529825559|FG009|PF-06873600 Treatment|Physician Decision|0|||
146907219|NCT03519178|529825560|FG010|PF-06873600 Treatment|Physician Decision|1|||
146907220|NCT03519178|529825561|FG011|PF-06873600 Treatment|Physician Decision|0|||
146907221|NCT03519178|529825562|FG012|PF-06873600 Treatment|Physician Decision|0|||
146907222|NCT03519178|529825563|FG013|PF-06873600 Treatment|Physician Decision|4|||
146907223|NCT03519178|529825564|FG014|PF-06873600 Treatment|Physician Decision|1|||
146907224|NCT03519178|529825550|FG000|PF-06873600 Treatment|Progressive disease|1|||
146907225|NCT03519178|529825551|FG001|PF-06873600 Treatment|Progressive disease|1|||
146907226|NCT03519178|529825552|FG002|PF-06873600 Treatment|Progressive disease|1|||
146907227|NCT03519178|529825553|FG003|PF-06873600 Treatment|Progressive disease|1|||
146907228|NCT03519178|529825554|FG004|PF-06873600 Treatment|Progressive disease|6|||
146907229|NCT03519178|529825555|FG005|PF-06873600 Treatment|Progressive disease|7|||
146907230|NCT03519178|529825556|FG006|PF-06873600 Treatment|Progressive disease|3|||
146907231|NCT03519178|529825557|FG007|PF-06873600 Treatment|Progressive disease|7|||
146907232|NCT03519178|529825558|FG008|PF-06873600 Treatment|Progressive disease|3|||
146907233|NCT03519178|529825559|FG009|PF-06873600 Treatment|Progressive disease|5|||
146907234|NCT03519178|529825560|FG010|PF-06873600 Treatment|Progressive disease|4|||
146907235|NCT03519178|529825561|FG011|PF-06873600 Treatment|Progressive disease|3|||
146907236|NCT03519178|529825562|FG012|PF-06873600 Treatment|Progressive disease|4|||
146907237|NCT03519178|529825563|FG013|PF-06873600 Treatment|Progressive disease|28|||
146907238|NCT03519178|529825564|FG014|PF-06873600 Treatment|Progressive disease|8|||
146907239|NCT03519178|529825550|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
146907240|NCT03519178|529825551|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
146907241|NCT03519178|529825552|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
146907242|NCT03519178|529825553|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
146907243|NCT03519178|529825554|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
146907244|NCT03519178|529825555|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
146562257|NCT02958865|528569948|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
146562258|NCT02958865|528569949|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
146562259|NCT02958865|528569950|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
146562260|NCT02958865|528569951|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
146562261|NCT02958865|528569952|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
146562262|NCT02958865|528569953|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
146562263|NCT02958865|528569954|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
146562264|NCT02958865|528569955|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
146562265|NCT02958865|528569956|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
146562266|NCT02958865|528569957|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
146562267|NCT02958865|528569958|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
146562268|NCT02958865|528569959|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
146562269|NCT02958865|528569960|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
146562270|NCT02958865|528569945|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
146562271|NCT02958865|528569946|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
146562272|NCT02958865|528569947|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
146562273|NCT02958865|528569948|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146562274|NCT02958865|528569949|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146562275|NCT02958865|528569950|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146562276|NCT02958865|528569951|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146562277|NCT02958865|528569952|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146562278|NCT02958865|528569953|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146562279|NCT02958865|528569954|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146562280|NCT02958865|528569955|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146562281|NCT02958865|528569956|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146562282|NCT02958865|528569957|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146562283|NCT02958865|528569958|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146562284|NCT02958865|528569959|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146562285|NCT02958865|528569960|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146562286|NCT02958865|528569945|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
146562287|NCT02958865|528569946|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
146562288|NCT02958865|528569947|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
146562289|NCT02958865|528569948|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
146768046|NCT02441036|529319467|FG001|Overall Study|No tissue resected|1|||
146562290|NCT02958865|528569949|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
146641645|NCT03110770|528865109|FG003|Overall Study|Lost to Follow-up|53|||
146907245|NCT03519178|529825556|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
146907246|NCT03519178|529825557|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
146562291|NCT02958865|528569950|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
146641646|NCT03110770|528865110|FG004|Overall Study|Lost to Follow-up|45|||
146907247|NCT03519178|529825558|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
146907248|NCT03519178|529825559|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
146907249|NCT03519178|529825560|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
146907250|NCT03519178|529825561|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
146907251|NCT03519178|529825562|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
146907252|NCT03519178|529825563|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
146562292|NCT02958865|528569951|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
146562293|NCT02958865|528569952|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
146562294|NCT02958865|528569953|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
146562295|NCT02958865|528569954|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
146562296|NCT02958865|528569955|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
146562297|NCT02958865|528569956|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
146562298|NCT02958865|528569957|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
146562299|NCT02958865|528569958|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
146562300|NCT02958865|528569959|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
146562301|NCT02958865|528569960|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
146562302|NCT02958865|528569945|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146562303|NCT02958865|528569946|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146562304|NCT02958865|528569947|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146562305|NCT02958865|528569948|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146562306|NCT02958865|528569949|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
146562307|NCT02958865|528569950|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146562308|NCT02958865|528569951|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146562309|NCT02958865|528569952|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146562310|NCT02958865|528569953|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146562311|NCT02958865|528569954|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146562312|NCT02958865|528569955|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146562313|NCT02958865|528569956|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146562314|NCT02958865|528569957|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146562315|NCT02958865|528569958|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146562316|NCT02958865|528569959|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146562317|NCT02958865|528569960|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146562318|NCT02958865|528569945|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
146562319|NCT02958865|528569946|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
146562320|NCT02958865|528569947|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
146562321|NCT02958865|528569948|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
146562322|NCT02958865|528569949|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
146562323|NCT02958865|528569950|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
146562324|NCT02958865|528569951|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
146562325|NCT02958865|528569952|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
146562326|NCT02958865|528569953|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
146562327|NCT02958865|528569954|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
146562328|NCT02958865|528569955|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
146562329|NCT02958865|528569956|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
146907253|NCT03519178|529825564|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
146907254|NCT03519178|529825550|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
146907255|NCT03519178|529825551|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
146907256|NCT03519178|529825552|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
146907257|NCT03519178|529825553|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
146562330|NCT02958865|528569957|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
146562331|NCT02958865|528569958|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
146562332|NCT02958865|528569959|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
146562333|NCT02958865|528569960|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
146562334|NCT02958865|528569945|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
146768047|NCT02441036|529319468|FG002|Overall Study|No tissue resected|0|||
146768048|NCT02441036|529319469|FG003|Overall Study|No tissue resected|1|||
146907258|NCT03519178|529825554|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
146970168|NCT00902486|530050822|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
146970169|NCT00902486|530050823|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
146970170|NCT00902486|530050824|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
146907259|NCT03519178|529825555|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
146907260|NCT03519178|529825556|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
146907261|NCT03519178|529825557|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
146907262|NCT03519178|529825558|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
146907263|NCT03519178|529825559|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
146907264|NCT03519178|529825560|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
146907265|NCT03519178|529825561|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
146907266|NCT03519178|529825562|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
146907267|NCT03519178|529825563|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
146641647|NCT03110770|528865106|FG000|Overall Study|Investigator Decision|0|||
146907268|NCT03519178|529825564|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
146970171|NCT00902486|530050825|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
146768049|NCT02441036|529319470|FG004|Overall Study|No tissue resected|0|||
146641648|NCT03110770|528865107|FG001|Overall Study|Investigator Decision|0|||
146907269|NCT03519178|529825550|FG000|PF-06873600 Treatment|Refused further treatment|0|||
146907270|NCT03519178|529825551|FG001|PF-06873600 Treatment|Refused further treatment|1|||
146907271|NCT03519178|529825552|FG002|PF-06873600 Treatment|Refused further treatment|0|||
146907272|NCT03519178|529825553|FG003|PF-06873600 Treatment|Refused further treatment|0|||
146907273|NCT03519178|529825554|FG004|PF-06873600 Treatment|Refused further treatment|1|||
146907274|NCT03519178|529825555|FG005|PF-06873600 Treatment|Refused further treatment|0|||
146907275|NCT03519178|529825556|FG006|PF-06873600 Treatment|Refused further treatment|0|||
146907276|NCT03519178|529825557|FG007|PF-06873600 Treatment|Refused further treatment|0|||
146907277|NCT03519178|529825558|FG008|PF-06873600 Treatment|Refused further treatment|0|||
146907278|NCT03519178|529825559|FG009|PF-06873600 Treatment|Refused further treatment|0|||
146907279|NCT03519178|529825560|FG010|PF-06873600 Treatment|Refused further treatment|0|||
146907280|NCT03519178|529825561|FG011|PF-06873600 Treatment|Refused further treatment|0|||
146907281|NCT03519178|529825562|FG012|PF-06873600 Treatment|Refused further treatment|0|||
146907282|NCT03519178|529825563|FG013|PF-06873600 Treatment|Refused further treatment|0|||
146907283|NCT03519178|529825564|FG014|PF-06873600 Treatment|Refused further treatment|1|||
146907284|NCT03519178|529825550|FG000|PF-06873600 Treatment|Other|0|||
146907285|NCT03519178|529825551|FG001|PF-06873600 Treatment|Other|0|||
146907286|NCT03519178|529825552|FG002|PF-06873600 Treatment|Other|0|||
146907287|NCT03519178|529825553|FG003|PF-06873600 Treatment|Other|0|||
146907288|NCT03519178|529825554|FG004|PF-06873600 Treatment|Other|0|||
146907289|NCT03519178|529825555|FG005|PF-06873600 Treatment|Other|0|||
146907290|NCT03519178|529825556|FG006|PF-06873600 Treatment|Other|0|||
146907291|NCT03519178|529825557|FG007|PF-06873600 Treatment|Other|0|||
146907292|NCT03519178|529825558|FG008|PF-06873600 Treatment|Other|1|||
146907293|NCT03519178|529825559|FG009|PF-06873600 Treatment|Other|0|||
146907294|NCT03519178|529825560|FG010|PF-06873600 Treatment|Other|0|||
146907295|NCT03519178|529825561|FG011|PF-06873600 Treatment|Other|0|||
146907296|NCT03519178|529825562|FG012|PF-06873600 Treatment|Other|0|||
146907297|NCT03519178|529825563|FG013|PF-06873600 Treatment|Other|1|||
146907298|NCT03519178|529825564|FG014|PF-06873600 Treatment|Other|3|||
146907299|NCT03519178|529825550|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
146907300|NCT03519178|529825551|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
146907301|NCT03519178|529825552|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
146907302|NCT03519178|529825553|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
146907303|NCT03519178|529825554|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
146907304|NCT03519178|529825555|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
146768050|NCT00756730|529319473|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
146907305|NCT03519178|529825556|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
146907306|NCT03519178|529825557|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
146907307|NCT03519178|529825558|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
146907308|NCT03519178|529825559|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
146907309|NCT03519178|529825560|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
146907310|NCT03519178|529825561|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
146907311|NCT03519178|529825562|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
146907312|NCT03519178|529825563|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
146907313|NCT03519178|529825564|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
146907314|NCT03519178|529825550|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
146907315|NCT03519178|529825551|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
146907316|NCT03519178|529825552|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
146907317|NCT03519178|529825553|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
146907318|NCT03519178|529825554|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
146907319|NCT03519178|529825555|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
146907320|NCT03519178|529825556|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
146907321|NCT03519178|529825557|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
146907322|NCT03519178|529825558|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
146907323|NCT03519178|529825559|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
146907324|NCT03519178|529825560|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
146562335|NCT02958865|528569946|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
146562336|NCT02958865|528569947|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
146562337|NCT02958865|528569948|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
146562338|NCT02958865|528569949|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
146562339|NCT02958865|528569950|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
146562340|NCT02958865|528569951|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
146562341|NCT02958865|528569952|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
146562342|NCT02958865|528569953|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
146768051|NCT00756730|529319474|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
146907325|NCT03519178|529825561|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
146907326|NCT03519178|529825562|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
146907327|NCT03519178|529825563|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
146768052|NCT00756730|529319473|FG000|Overall Study|persistent low-level viremmia|0|||
146768053|NCT00756730|529319474|FG001|Overall Study|persistent low-level viremmia|1|||
146970172|NCT00902486|530050826|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
146768054|NCT03383146|529319476|FG000|Overall Study|Screen Failure|1|||
146768055|NCT03383146|529319477|FG001|Overall Study|Screen Failure|0|||
146768056|NCT03383146|529319476|FG000|Overall Study|Adverse Event|6|||
146768057|NCT03383146|529319477|FG001|Overall Study|Adverse Event|18|||
146768058|NCT03383146|529319476|FG000|Overall Study|Lack of Efficacy|0|||
146768059|NCT03383146|529319477|FG001|Overall Study|Lack of Efficacy|3|||
146768060|NCT03383146|529319476|FG000|Overall Study|Withdrawal by Subject|20|||
146768061|NCT03383146|529319477|FG001|Overall Study|Withdrawal by Subject|36|||
146768062|NCT03383146|529319476|FG000|Overall Study|Lost to Follow-up|5|||
146768063|NCT03383146|529319477|FG001|Overall Study|Lost to Follow-up|15|||
146768064|NCT03383146|529319476|FG000|Overall Study|Death|0|||
146768065|NCT03383146|529319477|FG001|Overall Study|Death|2|||
146768066|NCT03383146|529319476|FG000|Overall Study|Physician Decision|0|||
146768067|NCT03383146|529319477|FG001|Overall Study|Physician Decision|1|||
146768068|NCT03383146|529319476|FG000|Overall Study|Protocol Deviation|1|||
146768069|NCT03383146|529319477|FG001|Overall Study|Protocol Deviation|8|||
146768070|NCT03383146|529319476|FG000|Overall Study|Study Terminated by the Sponsor|48|||
146768071|NCT03383146|529319477|FG001|Overall Study|Study Terminated by the Sponsor|95|||
146768072|NCT03383146|529319476|FG000|Overall Study|Reason not Specified|4|||
146768073|NCT03383146|529319477|FG001|Overall Study|Reason not Specified|6|||
146768074|NCT05382104|529319478|FG000|Period 2 (2 Days)|Adverse Event|0|||
146768075|NCT05382104|529319479|FG001|Period 2 (2 Days)|Adverse Event|1|||
146768076|NCT05382104|529319480|FG002|Period 2 (2 Days)|Adverse Event|0|||
146768077|NCT05382104|529319481|FG003|Period 2 (2 Days)|Adverse Event|0|||
146768078|NCT05382104|529319482|FG004|Period 2 (2 Days)|Adverse Event|0|||
146768079|NCT05382104|529319483|FG005|Period 2 (2 Days)|Adverse Event|0|||
146768080|NCT00639002|529319484|FG000|Overall Study|Death|1|||
146768081|NCT00639002|529319484|FG000|Overall Study|Adverse Event|1|||
146768082|NCT00639002|529319484|FG000|Overall Study|Protocol Violation|1|||
146768083|NCT00639002|529319484|FG000|Overall Study|Disease progression|3|||
146768084|NCT00639002|529319484|FG000|Overall Study|Physician Decision|6|||
146768085|NCT00639002|529319484|FG000|Overall Study|Lack of Efficacy|1|||
146768086|NCT01317420|529319490|FG000|Overall Study|Progressive disease according to RECIST|2|||
146768087|NCT01317420|529319491|FG001|Overall Study|Progressive disease according to RECIST|3|||
146768088|NCT01317420|529319492|FG002|Overall Study|Progressive disease according to RECIST|3|||
146768089|NCT01317420|529319493|FG003|Overall Study|Progressive disease according to RECIST|3|||
146768090|NCT01317420|529319494|FG004|Overall Study|Progressive disease according to RECIST|3|||
146768091|NCT01317420|529319495|FG005|Overall Study|Progressive disease according to RECIST|3|||
146768092|NCT01317420|529319496|FG006|Overall Study|Progressive disease according to RECIST|3|||
146768093|NCT01317420|529319497|FG007|Overall Study|Progressive disease according to RECIST|3|||
146768094|NCT01317420|529319498|FG008|Overall Study|Progressive disease according to RECIST|3|||
146562343|NCT02958865|528569954|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
146768095|NCT01317420|529319499|FG009|Overall Study|Progressive disease according to RECIST|2|||
146768096|NCT01317420|529319500|FG010|Overall Study|Progressive disease according to RECIST|3|||
146768097|NCT01317420|529319501|FG011|Overall Study|Progressive disease according to RECIST|11|||
146768098|NCT01317420|529319502|FG012|Overall Study|Progressive disease according to RECIST|16|||
146768099|NCT01317420|529319490|FG000|Overall Study|Other adverse event|1|||
146768100|NCT01317420|529319491|FG001|Overall Study|Other adverse event|0|||
146768101|NCT01317420|529319492|FG002|Overall Study|Other adverse event|0|||
146768102|NCT01317420|529319493|FG003|Overall Study|Other adverse event|0|||
146768103|NCT01317420|529319494|FG004|Overall Study|Other adverse event|0|||
146768104|NCT01317420|529319495|FG005|Overall Study|Other adverse event|0|||
146562344|NCT02958865|528569955|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
146562345|NCT02958865|528569956|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
146562346|NCT02958865|528569957|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
146562347|NCT02958865|528569958|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
146562348|NCT02958865|528569959|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
146562349|NCT02958865|528569960|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
146562350|NCT02958865|528569945|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
146562351|NCT02958865|528569946|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
146562352|NCT02958865|528569947|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
146562353|NCT02958865|528569948|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
146562354|NCT02958865|528569949|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
146562355|NCT02958865|528569950|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
146768105|NCT01317420|529319496|FG006|Overall Study|Other adverse event|0|||
146768106|NCT01317420|529319497|FG007|Overall Study|Other adverse event|0|||
146562356|NCT02958865|528569951|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
146768107|NCT01317420|529319498|FG008|Overall Study|Other adverse event|0|||
146768108|NCT01317420|529319499|FG009|Overall Study|Other adverse event|0|||
146768109|NCT01317420|529319500|FG010|Overall Study|Other adverse event|0|||
146768110|NCT01317420|529319501|FG011|Overall Study|Other adverse event|0|||
146768111|NCT01317420|529319502|FG012|Overall Study|Other adverse event|2|||
146768112|NCT01317420|529319490|FG000|Overall Study|Non-compliant with protocol|0|||
146768113|NCT01317420|529319491|FG001|Overall Study|Non-compliant with protocol|0|||
146768114|NCT01317420|529319492|FG002|Overall Study|Non-compliant with protocol|0|||
146907328|NCT03519178|529825564|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
146907329|NCT03519178|529825550|FG000|Fulvestrant. Treatment|Adverse Event|0|||
146907330|NCT03519178|529825551|FG001|Fulvestrant. Treatment|Adverse Event|0|||
146907331|NCT03519178|529825552|FG002|Fulvestrant. Treatment|Adverse Event|0|||
146907332|NCT03519178|529825553|FG003|Fulvestrant. Treatment|Adverse Event|0|||
146907333|NCT03519178|529825554|FG004|Fulvestrant. Treatment|Adverse Event|0|||
146907334|NCT03519178|529825555|FG005|Fulvestrant. Treatment|Adverse Event|0|||
146907335|NCT03519178|529825556|FG006|Fulvestrant. Treatment|Adverse Event|0|||
146907336|NCT03519178|529825557|FG007|Fulvestrant. Treatment|Adverse Event|0|||
146907337|NCT03519178|529825558|FG008|Fulvestrant. Treatment|Adverse Event|0|||
146907338|NCT03519178|529825559|FG009|Fulvestrant. Treatment|Adverse Event|0|||
146907339|NCT03519178|529825560|FG010|Fulvestrant. Treatment|Adverse Event|0|||
146907340|NCT03519178|529825561|FG011|Fulvestrant. Treatment|Adverse Event|0|||
146907341|NCT03519178|529825562|FG012|Fulvestrant. Treatment|Adverse Event|0|||
146907342|NCT03519178|529825563|FG013|Fulvestrant. Treatment|Adverse Event|1|||
146907343|NCT03519178|529825564|FG014|Fulvestrant. Treatment|Adverse Event|0|||
146907344|NCT03519178|529825550|FG000|Fulvestrant. Treatment|Death|0|||
146907345|NCT03519178|529825551|FG001|Fulvestrant. Treatment|Death|0|||
146907346|NCT03519178|529825552|FG002|Fulvestrant. Treatment|Death|0|||
146907347|NCT03519178|529825553|FG003|Fulvestrant. Treatment|Death|0|||
146907348|NCT03519178|529825554|FG004|Fulvestrant. Treatment|Death|0|||
146907349|NCT03519178|529825555|FG005|Fulvestrant. Treatment|Death|0|||
146907350|NCT03519178|529825556|FG006|Fulvestrant. Treatment|Death|0|||
146907351|NCT03519178|529825557|FG007|Fulvestrant. Treatment|Death|0|||
146907352|NCT03519178|529825558|FG008|Fulvestrant. Treatment|Death|0|||
146907353|NCT03519178|529825559|FG009|Fulvestrant. Treatment|Death|1|||
146907354|NCT03519178|529825560|FG010|Fulvestrant. Treatment|Death|0|||
146907355|NCT03519178|529825561|FG011|Fulvestrant. Treatment|Death|0|||
146907356|NCT03519178|529825562|FG012|Fulvestrant. Treatment|Death|0|||
146907357|NCT03519178|529825563|FG013|Fulvestrant. Treatment|Death|0|||
146907358|NCT03519178|529825564|FG014|Fulvestrant. Treatment|Death|1|||
146907359|NCT03519178|529825550|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
146907360|NCT03519178|529825551|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
146907361|NCT03519178|529825552|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
146907362|NCT03519178|529825553|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
146907363|NCT03519178|529825554|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
146907364|NCT03519178|529825555|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
146907365|NCT03519178|529825556|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
146907366|NCT03519178|529825557|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
146907367|NCT03519178|529825558|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
146768115|NCT01317420|529319493|FG003|Overall Study|Non-compliant with protocol|0|||
146768116|NCT01317420|529319494|FG004|Overall Study|Non-compliant with protocol|0|||
146768117|NCT01317420|529319495|FG005|Overall Study|Non-compliant with protocol|0|||
146768118|NCT01317420|529319496|FG006|Overall Study|Non-compliant with protocol|0|||
146907368|NCT03519178|529825559|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
146907369|NCT03519178|529825560|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
146907370|NCT03519178|529825561|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
146907371|NCT03519178|529825562|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
146907372|NCT03519178|529825563|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
146907373|NCT03519178|529825564|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
146907374|NCT03519178|529825550|FG000|Fulvestrant. Treatment|Physician Decision|0|||
146907375|NCT03519178|529825551|FG001|Fulvestrant. Treatment|Physician Decision|0|||
146907376|NCT03519178|529825552|FG002|Fulvestrant. Treatment|Physician Decision|0|||
146907377|NCT03519178|529825553|FG003|Fulvestrant. Treatment|Physician Decision|0|||
146907378|NCT03519178|529825554|FG004|Fulvestrant. Treatment|Physician Decision|0|||
146907379|NCT03519178|529825555|FG005|Fulvestrant. Treatment|Physician Decision|0|||
146907380|NCT03519178|529825556|FG006|Fulvestrant. Treatment|Physician Decision|0|||
146907381|NCT03519178|529825557|FG007|Fulvestrant. Treatment|Physician Decision|0|||
146907382|NCT03519178|529825558|FG008|Fulvestrant. Treatment|Physician Decision|0|||
146907383|NCT03519178|529825559|FG009|Fulvestrant. Treatment|Physician Decision|0|||
146907384|NCT03519178|529825560|FG010|Fulvestrant. Treatment|Physician Decision|0|||
146907385|NCT03519178|529825561|FG011|Fulvestrant. Treatment|Physician Decision|0|||
146907386|NCT03519178|529825562|FG012|Fulvestrant. Treatment|Physician Decision|0|||
146907387|NCT03519178|529825563|FG013|Fulvestrant. Treatment|Physician Decision|4|||
146907388|NCT03519178|529825564|FG014|Fulvestrant. Treatment|Physician Decision|2|||
146907389|NCT03519178|529825550|FG000|Fulvestrant. Treatment|Progressive disease|0|||
146907390|NCT03519178|529825551|FG001|Fulvestrant. Treatment|Progressive disease|0|||
146907391|NCT03519178|529825552|FG002|Fulvestrant. Treatment|Progressive disease|0|||
146907392|NCT03519178|529825553|FG003|Fulvestrant. Treatment|Progressive disease|0|||
146907393|NCT03519178|529825554|FG004|Fulvestrant. Treatment|Progressive disease|0|||
146907394|NCT03519178|529825555|FG005|Fulvestrant. Treatment|Progressive disease|0|||
146907395|NCT03519178|529825556|FG006|Fulvestrant. Treatment|Progressive disease|0|||
146907396|NCT03519178|529825557|FG007|Fulvestrant. Treatment|Progressive disease|0|||
146907397|NCT03519178|529825558|FG008|Fulvestrant. Treatment|Progressive disease|0|||
146907398|NCT03519178|529825559|FG009|Fulvestrant. Treatment|Progressive disease|5|||
146907399|NCT03519178|529825560|FG010|Fulvestrant. Treatment|Progressive disease|0|||
146907400|NCT03519178|529825561|FG011|Fulvestrant. Treatment|Progressive disease|0|||
146907401|NCT03519178|529825562|FG012|Fulvestrant. Treatment|Progressive disease|0|||
146907402|NCT03519178|529825563|FG013|Fulvestrant. Treatment|Progressive disease|30|||
146907403|NCT03519178|529825564|FG014|Fulvestrant. Treatment|Progressive disease|8|||
146907404|NCT03519178|529825550|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146907405|NCT03519178|529825551|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146907406|NCT03519178|529825552|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146907407|NCT03519178|529825553|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146907408|NCT03519178|529825554|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146907409|NCT03519178|529825555|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146907410|NCT03519178|529825556|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146907411|NCT03519178|529825557|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146907412|NCT03519178|529825558|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146907413|NCT03519178|529825559|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146907414|NCT03519178|529825560|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146907415|NCT03519178|529825561|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146907416|NCT03519178|529825562|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146907417|NCT03519178|529825563|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
146907418|NCT03519178|529825564|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
146907419|NCT03519178|529825550|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146907420|NCT03519178|529825551|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146907421|NCT03519178|529825552|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146907422|NCT03519178|529825553|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146907423|NCT03519178|529825554|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146907424|NCT03519178|529825555|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146907425|NCT03519178|529825556|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146907426|NCT03519178|529825557|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146907427|NCT03519178|529825558|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146907428|NCT03519178|529825559|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
146907429|NCT03519178|529825560|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146562357|NCT02958865|528569952|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
146562358|NCT02958865|528569953|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
146562359|NCT02958865|528569954|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
146562360|NCT02958865|528569955|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
146562361|NCT02958865|528569956|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
146562362|NCT02958865|528569957|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
146562363|NCT02958865|528569958|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
146562364|NCT02958865|528569959|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
146562365|NCT02958865|528569960|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
146562366|NCT02958865|528569945|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
146562367|NCT02958865|528569946|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
146562368|NCT02958865|528569947|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
146562369|NCT02958865|528569948|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
146562370|NCT02958865|528569949|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
146562371|NCT02958865|528569950|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
146562372|NCT02958865|528569951|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
146562373|NCT02958865|528569952|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
146562374|NCT02958865|528569953|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
146562375|NCT02958865|528569954|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
146562376|NCT02958865|528569955|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
146562377|NCT02958865|528569956|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
146562378|NCT02958865|528569957|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
146562379|NCT02958865|528569958|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
146562380|NCT02958865|528569959|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
146562381|NCT02958865|528569960|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
146562382|NCT02958865|528569945|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
146562383|NCT02958865|528569946|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
146562384|NCT02958865|528569947|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
146562385|NCT02958865|528569948|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
146562386|NCT02958865|528569949|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
146562387|NCT02958865|528569950|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
146562388|NCT02958865|528569951|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
146562389|NCT02958865|528569952|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
146562390|NCT02958865|528569953|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
146562391|NCT02958865|528569954|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
146562392|NCT02958865|528569955|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
146562393|NCT02958865|528569956|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
146562394|NCT02958865|528569957|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
146562395|NCT02958865|528569958|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
146907430|NCT03519178|529825561|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146907431|NCT03519178|529825562|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146562396|NCT02958865|528569959|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
146562397|NCT02958865|528569960|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
146562398|NCT02958865|528569945|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
146562399|NCT02958865|528569946|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
146562400|NCT02958865|528569947|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
146562401|NCT02958865|528569948|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
146907432|NCT03519178|529825563|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
146907433|NCT03519178|529825564|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
146907434|NCT03519178|529825550|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
146907435|NCT03519178|529825551|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
146907436|NCT03519178|529825552|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
146907437|NCT03519178|529825553|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
146907438|NCT03519178|529825554|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
146907439|NCT03519178|529825555|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
146907440|NCT03519178|529825556|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
146907441|NCT03519178|529825557|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
146907442|NCT03519178|529825558|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
146907443|NCT03519178|529825559|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
146907444|NCT03519178|529825560|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
146907445|NCT03519178|529825561|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
146562402|NCT02958865|528569949|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
146562403|NCT02958865|528569950|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
146562404|NCT02958865|528569951|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
146907446|NCT03519178|529825562|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
146907447|NCT03519178|529825563|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
146907448|NCT03519178|529825564|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
146907449|NCT03519178|529825550|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
146907450|NCT03519178|529825551|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
146907451|NCT03519178|529825552|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
146907452|NCT03519178|529825553|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
146907453|NCT03519178|529825554|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
146907454|NCT03519178|529825555|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
146907455|NCT03519178|529825556|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
146907456|NCT03519178|529825557|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
146907457|NCT03519178|529825558|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
146907458|NCT03519178|529825559|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
146907459|NCT03519178|529825560|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
146907460|NCT03519178|529825561|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
146907461|NCT03519178|529825562|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
146907462|NCT03519178|529825563|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
146907463|NCT03519178|529825564|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
146907464|NCT03519178|529825550|FG000|Fulvestrant. Treatment|Other|0|||
146907465|NCT03519178|529825551|FG001|Fulvestrant. Treatment|Other|0|||
146907466|NCT03519178|529825552|FG002|Fulvestrant. Treatment|Other|0|||
146907467|NCT03519178|529825553|FG003|Fulvestrant. Treatment|Other|0|||
146907468|NCT03519178|529825554|FG004|Fulvestrant. Treatment|Other|0|||
146907469|NCT03519178|529825555|FG005|Fulvestrant. Treatment|Other|0|||
146907470|NCT03519178|529825556|FG006|Fulvestrant. Treatment|Other|0|||
146907471|NCT03519178|529825557|FG007|Fulvestrant. Treatment|Other|0|||
146907472|NCT03519178|529825558|FG008|Fulvestrant. Treatment|Other|0|||
146907473|NCT03519178|529825559|FG009|Fulvestrant. Treatment|Other|0|||
146907474|NCT03519178|529825560|FG010|Fulvestrant. Treatment|Other|0|||
146907475|NCT03519178|529825561|FG011|Fulvestrant. Treatment|Other|0|||
146907476|NCT03519178|529825562|FG012|Fulvestrant. Treatment|Other|0|||
146907477|NCT03519178|529825563|FG013|Fulvestrant. Treatment|Other|1|||
146907478|NCT03519178|529825564|FG014|Fulvestrant. Treatment|Other|3|||
146907479|NCT03519178|529825550|FG000|Letrozole Treatment|Physician Decision|0|||
146907480|NCT03519178|529825551|FG001|Letrozole Treatment|Physician Decision|0|||
146907481|NCT03519178|529825552|FG002|Letrozole Treatment|Physician Decision|0|||
146907482|NCT03519178|529825553|FG003|Letrozole Treatment|Physician Decision|0|||
146907483|NCT03519178|529825554|FG004|Letrozole Treatment|Physician Decision|0|||
146907484|NCT03519178|529825555|FG005|Letrozole Treatment|Physician Decision|0|||
146907485|NCT03519178|529825556|FG006|Letrozole Treatment|Physician Decision|0|||
146907486|NCT03519178|529825557|FG007|Letrozole Treatment|Physician Decision|0|||
146907487|NCT03519178|529825558|FG008|Letrozole Treatment|Physician Decision|0|||
146907488|NCT03519178|529825559|FG009|Letrozole Treatment|Physician Decision|0|||
146907489|NCT03519178|529825560|FG010|Letrozole Treatment|Physician Decision|1|||
146907490|NCT03519178|529825561|FG011|Letrozole Treatment|Physician Decision|0|||
146907491|NCT03519178|529825562|FG012|Letrozole Treatment|Physician Decision|0|||
146907492|NCT03519178|529825563|FG013|Letrozole Treatment|Physician Decision|0|||
146907493|NCT03519178|529825564|FG014|Letrozole Treatment|Physician Decision|0|||
146907494|NCT03519178|529825550|FG000|Letrozole Treatment|Progressive disease|0|||
146907495|NCT03519178|529825551|FG001|Letrozole Treatment|Progressive disease|0|||
146907496|NCT03519178|529825552|FG002|Letrozole Treatment|Progressive disease|0|||
146907497|NCT03519178|529825553|FG003|Letrozole Treatment|Progressive disease|0|||
146907498|NCT03519178|529825554|FG004|Letrozole Treatment|Progressive disease|0|||
146907499|NCT03519178|529825555|FG005|Letrozole Treatment|Progressive disease|0|||
146907500|NCT03519178|529825556|FG006|Letrozole Treatment|Progressive disease|0|||
146907501|NCT03519178|529825557|FG007|Letrozole Treatment|Progressive disease|0|||
146562405|NCT02958865|528569952|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
146907502|NCT03519178|529825558|FG008|Letrozole Treatment|Progressive disease|0|||
146907503|NCT03519178|529825559|FG009|Letrozole Treatment|Progressive disease|0|||
146907504|NCT03519178|529825560|FG010|Letrozole Treatment|Progressive disease|4|||
146907505|NCT03519178|529825561|FG011|Letrozole Treatment|Progressive disease|0|||
146907506|NCT03519178|529825562|FG012|Letrozole Treatment|Progressive disease|0|||
146907507|NCT03519178|529825563|FG013|Letrozole Treatment|Progressive disease|0|||
146907508|NCT03519178|529825564|FG014|Letrozole Treatment|Progressive disease|0|||
146907509|NCT03519178|529825550|FG000|Letrozole Treatment|Global deterioration of health status|0|||
146907510|NCT03519178|529825551|FG001|Letrozole Treatment|Global deterioration of health status|0|||
146768119|NCT01317420|529319497|FG007|Overall Study|Non-compliant with protocol|0|||
146768120|NCT01317420|529319498|FG008|Overall Study|Non-compliant with protocol|0|||
146768121|NCT01317420|529319499|FG009|Overall Study|Non-compliant with protocol|0|||
146768122|NCT01317420|529319500|FG010|Overall Study|Non-compliant with protocol|0|||
146768123|NCT01317420|529319501|FG011|Overall Study|Non-compliant with protocol|0|||
146768124|NCT01317420|529319502|FG012|Overall Study|Non-compliant with protocol|1|||
146907511|NCT03519178|529825552|FG002|Letrozole Treatment|Global deterioration of health status|0|||
146907512|NCT03519178|529825553|FG003|Letrozole Treatment|Global deterioration of health status|0|||
146907513|NCT03519178|529825554|FG004|Letrozole Treatment|Global deterioration of health status|0|||
146907514|NCT03519178|529825555|FG005|Letrozole Treatment|Global deterioration of health status|0|||
146907515|NCT03519178|529825556|FG006|Letrozole Treatment|Global deterioration of health status|0|||
146907516|NCT03519178|529825557|FG007|Letrozole Treatment|Global deterioration of health status|0|||
146907517|NCT03519178|529825558|FG008|Letrozole Treatment|Global deterioration of health status|0|||
146907518|NCT03519178|529825559|FG009|Letrozole Treatment|Global deterioration of health status|0|||
146907519|NCT03519178|529825560|FG010|Letrozole Treatment|Global deterioration of health status|2|||
146907520|NCT03519178|529825561|FG011|Letrozole Treatment|Global deterioration of health status|0|||
146907521|NCT03519178|529825562|FG012|Letrozole Treatment|Global deterioration of health status|0|||
146907522|NCT03519178|529825563|FG013|Letrozole Treatment|Global deterioration of health status|0|||
146907523|NCT03519178|529825564|FG014|Letrozole Treatment|Global deterioration of health status|0|||
146907524|NCT03519178|529825550|FG000|Follow-Up|Death|0|||
146907525|NCT03519178|529825551|FG001|Follow-Up|Death|0|||
146907526|NCT03519178|529825552|FG002|Follow-Up|Death|0|||
146907527|NCT03519178|529825553|FG003|Follow-Up|Death|0|||
146907528|NCT03519178|529825554|FG004|Follow-Up|Death|0|||
146907529|NCT03519178|529825555|FG005|Follow-Up|Death|0|||
146907530|NCT03519178|529825556|FG006|Follow-Up|Death|0|||
146907531|NCT03519178|529825557|FG007|Follow-Up|Death|0|||
146907532|NCT03519178|529825558|FG008|Follow-Up|Death|3|||
146907533|NCT03519178|529825559|FG009|Follow-Up|Death|1|||
146907534|NCT03519178|529825560|FG010|Follow-Up|Death|0|||
146907535|NCT03519178|529825561|FG011|Follow-Up|Death|0|||
146907536|NCT03519178|529825562|FG012|Follow-Up|Death|2|||
146907537|NCT03519178|529825563|FG013|Follow-Up|Death|0|||
146907538|NCT03519178|529825564|FG014|Follow-Up|Death|0|||
146907539|NCT03519178|529825550|FG000|Follow-Up|Lost to Follow-up|0|||
146907540|NCT03519178|529825551|FG001|Follow-Up|Lost to Follow-up|0|||
146907541|NCT03519178|529825552|FG002|Follow-Up|Lost to Follow-up|0|||
146907542|NCT03519178|529825553|FG003|Follow-Up|Lost to Follow-up|0|||
146907543|NCT03519178|529825554|FG004|Follow-Up|Lost to Follow-up|0|||
146907544|NCT03519178|529825555|FG005|Follow-Up|Lost to Follow-up|3|||
146907545|NCT03519178|529825556|FG006|Follow-Up|Lost to Follow-up|1|||
146907546|NCT03519178|529825557|FG007|Follow-Up|Lost to Follow-up|4|||
146907547|NCT03519178|529825558|FG008|Follow-Up|Lost to Follow-up|1|||
146907548|NCT03519178|529825559|FG009|Follow-Up|Lost to Follow-up|0|||
146907549|NCT03519178|529825560|FG010|Follow-Up|Lost to Follow-up|0|||
146907550|NCT03519178|529825561|FG011|Follow-Up|Lost to Follow-up|0|||
146907551|NCT03519178|529825562|FG012|Follow-Up|Lost to Follow-up|0|||
146907552|NCT03519178|529825563|FG013|Follow-Up|Lost to Follow-up|0|||
146907553|NCT03519178|529825564|FG014|Follow-Up|Lost to Follow-up|0|||
146907554|NCT03519178|529825550|FG000|Follow-Up|Withdrawal by Subject|1|||
146907555|NCT03519178|529825551|FG001|Follow-Up|Withdrawal by Subject|2|||
146907556|NCT03519178|529825552|FG002|Follow-Up|Withdrawal by Subject|2|||
146907557|NCT03519178|529825553|FG003|Follow-Up|Withdrawal by Subject|3|||
146907558|NCT03519178|529825554|FG004|Follow-Up|Withdrawal by Subject|5|||
146907559|NCT03519178|529825555|FG005|Follow-Up|Withdrawal by Subject|1|||
146907560|NCT03519178|529825556|FG006|Follow-Up|Withdrawal by Subject|2|||
146907561|NCT03519178|529825557|FG007|Follow-Up|Withdrawal by Subject|6|||
146907562|NCT03519178|529825558|FG008|Follow-Up|Withdrawal by Subject|5|||
146907563|NCT03519178|529825559|FG009|Follow-Up|Withdrawal by Subject|2|||
146907564|NCT03519178|529825560|FG010|Follow-Up|Withdrawal by Subject|3|||
146907565|NCT03519178|529825561|FG011|Follow-Up|Withdrawal by Subject|5|||
146907566|NCT03519178|529825562|FG012|Follow-Up|Withdrawal by Subject|2|||
146907567|NCT03519178|529825563|FG013|Follow-Up|Withdrawal by Subject|0|||
146907568|NCT03519178|529825564|FG014|Follow-Up|Withdrawal by Subject|0|||
146907569|NCT03519178|529825550|FG000|Follow-Up|Other|0|||
146907570|NCT03519178|529825551|FG001|Follow-Up|Other|0|||
146907571|NCT03519178|529825552|FG002|Follow-Up|Other|0|||
146907572|NCT03519178|529825553|FG003|Follow-Up|Other|0|||
146907573|NCT03519178|529825554|FG004|Follow-Up|Other|0|||
146907574|NCT03519178|529825555|FG005|Follow-Up|Other|0|||
146907575|NCT03519178|529825556|FG006|Follow-Up|Other|0|||
146907576|NCT03519178|529825557|FG007|Follow-Up|Other|1|||
146907577|NCT03519178|529825558|FG008|Follow-Up|Other|0|||
146907578|NCT03519178|529825559|FG009|Follow-Up|Other|0|||
146970173|NCT00902486|530050827|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
146768125|NCT01317420|529319490|FG000|Overall Study|Refused to cont. taking trial medication|0|||
146907579|NCT03519178|529825560|FG010|Follow-Up|Other|0|||
146907580|NCT03519178|529825561|FG011|Follow-Up|Other|0|||
146907581|NCT03519178|529825562|FG012|Follow-Up|Other|0|||
146907582|NCT03519178|529825563|FG013|Follow-Up|Other|0|||
146907583|NCT03519178|529825564|FG014|Follow-Up|Other|0|||
146907584|NCT03519178|529825550|FG000|Long-term Follow-up|Death|0|||
146562406|NCT02958865|528569953|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
146562407|NCT02958865|528569954|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
146562408|NCT02958865|528569955|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
146562409|NCT02958865|528569956|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
146562410|NCT02958865|528569957|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
146562411|NCT02958865|528569958|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
146562412|NCT02958865|528569959|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
146562413|NCT02958865|528569960|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
146562414|NCT02958865|528569945|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
146562415|NCT02958865|528569946|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
146562416|NCT02958865|528569947|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
146562417|NCT02958865|528569948|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
146562418|NCT02958865|528569949|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
146562419|NCT02958865|528569950|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
146562420|NCT02958865|528569951|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
146562421|NCT02958865|528569952|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
146562422|NCT02958865|528569953|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
146562423|NCT02958865|528569954|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
146562424|NCT02958865|528569955|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
146562425|NCT02958865|528569956|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
146562426|NCT02958865|528569957|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
146562427|NCT02958865|528569958|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
146562428|NCT02958865|528569959|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
146562429|NCT02958865|528569960|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
146562430|NCT02958865|528569945|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
146562431|NCT02958865|528569946|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
146562432|NCT02958865|528569947|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
146562433|NCT02958865|528569948|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
146562434|NCT02958865|528569949|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
146562435|NCT02958865|528569950|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
146562436|NCT02958865|528569951|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
146562437|NCT02958865|528569952|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
146562438|NCT02958865|528569953|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
146562439|NCT02958865|528569954|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
146562440|NCT02958865|528569955|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
146562441|NCT02958865|528569956|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
146562442|NCT02958865|528569957|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
146562443|NCT02958865|528569958|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
146562444|NCT02958865|528569959|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
146562445|NCT02958865|528569960|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
146562446|NCT01767987|528569961|FG000|Overall Study|Physician Decision|4|||
146562447|NCT01767987|528569962|FG001|Overall Study|Physician Decision|1|||
146562448|NCT00654355|528569973|FG000|Overall Study|Lost to Follow-up|2|||
146562449|NCT00654355|528569974|FG001|Overall Study|Lost to Follow-up|2|||
146562450|NCT05805150|528569979|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
146562451|NCT05805150|528569980|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
146562452|NCT02284893|528569981|FG000|26 Week (Short Term)|Adverse Event|1|||
146562453|NCT02284893|528569982|FG001|26 Week (Short Term)|Adverse Event|9|||
146562454|NCT02284893|528569981|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
146562455|NCT02284893|528569982|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
146562456|NCT02284893|528569981|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
146562457|NCT02284893|528569982|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
146562458|NCT02284893|528569981|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
146562459|NCT02284893|528569982|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
146562460|NCT02284893|528569981|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
146562461|NCT02284893|528569982|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
146562462|NCT02284893|528569981|FG000|26 Week (Short Term)|Other|1|||
146562463|NCT02284893|528569982|FG001|26 Week (Short Term)|Other|1|||
146562464|NCT02284893|528569981|FG000|52 Week (Long Term)|Adverse Event|3|||
146562465|NCT02284893|528569982|FG001|52 Week (Long Term)|Adverse Event|1|||
146562466|NCT02284893|528569981|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
146562467|NCT02284893|528569982|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
146562468|NCT02284893|528569981|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
146562469|NCT02284893|528569982|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
146641649|NCT03110770|528865108|FG002|Overall Study|Investigator Decision|0|||
146641650|NCT03110770|528865109|FG003|Overall Study|Investigator Decision|5|||
146641651|NCT03110770|528865110|FG004|Overall Study|Investigator Decision|3|||
146641652|NCT03110770|528865106|FG000|Overall Study|Withdrawal by Subject|0|||
146641653|NCT03110770|528865107|FG001|Overall Study|Withdrawal by Subject|0|||
146641654|NCT03110770|528865108|FG002|Overall Study|Withdrawal by Subject|0|||
146641655|NCT03110770|528865109|FG003|Overall Study|Withdrawal by Subject|24|||
146641656|NCT03110770|528865110|FG004|Overall Study|Withdrawal by Subject|24|||
146641657|NCT03110770|528865106|FG000|Overall Study|Moved from area|5|||
146641658|NCT03110770|528865107|FG001|Overall Study|Moved from area|0|||
146641659|NCT03110770|528865108|FG002|Overall Study|Moved from area|2|||
146641660|NCT03110770|528865109|FG003|Overall Study|Moved from area|42|||
146641661|NCT03110770|528865110|FG004|Overall Study|Moved from area|43|||
146641662|NCT03110770|528865106|FG000|Overall Study|Illness/Injury unrelated to product|0|||
146641663|NCT03110770|528865107|FG001|Overall Study|Illness/Injury unrelated to product|0|||
146641664|NCT03110770|528865108|FG002|Overall Study|Illness/Injury unrelated to product|0|||
146641665|NCT03110770|528865109|FG003|Overall Study|Illness/Injury unrelated to product|0|||
146641666|NCT03110770|528865110|FG004|Overall Study|Illness/Injury unrelated to product|1|||
146641667|NCT01667419|528865111|FG000|Overall Study|Reason Not Specified|1|||
146641668|NCT01667419|528865112|FG001|Overall Study|Reason Not Specified|0|||
146641669|NCT01667419|528865113|FG002|Overall Study|Reason Not Specified|0|||
146641670|NCT01667419|528865114|FG003|Overall Study|Reason Not Specified|0|||
146641671|NCT01667419|528865111|FG000|Overall Study|Withdrawal by Subject|16|||
146641672|NCT01667419|528865112|FG001|Overall Study|Withdrawal by Subject|8|||
146641673|NCT01667419|528865113|FG002|Overall Study|Withdrawal by Subject|9|||
146641674|NCT01667419|528865114|FG003|Overall Study|Withdrawal by Subject|8|||
146641675|NCT01667419|528865111|FG000|Overall Study|Non-compliance|0|||
146641676|NCT01667419|528865112|FG001|Overall Study|Non-compliance|0|||
146641677|NCT01667419|528865113|FG002|Overall Study|Non-compliance|0|||
146641678|NCT01667419|528865114|FG003|Overall Study|Non-compliance|1|||
146641679|NCT01667419|528865111|FG000|Overall Study|Protocol Violation|1|||
146641680|NCT01667419|528865112|FG001|Overall Study|Protocol Violation|0|||
146641681|NCT01667419|528865113|FG002|Overall Study|Protocol Violation|0|||
146641682|NCT01667419|528865114|FG003|Overall Study|Protocol Violation|0|||
146907585|NCT03519178|529825551|FG001|Long-term Follow-up|Death|0|||
146907586|NCT03519178|529825552|FG002|Long-term Follow-up|Death|0|||
146907587|NCT03519178|529825553|FG003|Long-term Follow-up|Death|0|||
146907588|NCT03519178|529825554|FG004|Long-term Follow-up|Death|0|||
146907589|NCT03519178|529825555|FG005|Long-term Follow-up|Death|0|||
146641683|NCT01667419|528865111|FG000|Overall Study|Lost to Follow-up|7|||
146641684|NCT01667419|528865112|FG001|Overall Study|Lost to Follow-up|6|||
146641685|NCT01667419|528865113|FG002|Overall Study|Lost to Follow-up|2|||
146641686|NCT01667419|528865114|FG003|Overall Study|Lost to Follow-up|4|||
146641687|NCT01667419|528865111|FG000|Overall Study|Death|18|||
146641688|NCT01667419|528865112|FG001|Overall Study|Death|33|||
146641689|NCT01667419|528865113|FG002|Overall Study|Death|25|||
146641690|NCT01667419|528865114|FG003|Overall Study|Death|26|||
146641691|NCT00856518|528865115|FG000|Overall Study|Lost to Follow-up|4|||
146562470|NCT02284893|528569981|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
146562471|NCT02284893|528569982|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
146562472|NCT02284893|528569981|FG000|52 Week (Long Term)|Non-Compliance|2|||
146562473|NCT02284893|528569982|FG001|52 Week (Long Term)|Non-Compliance|3|||
146562474|NCT02757430|528569983|FG000|Overall Study|Physician Decision|6|||
146562475|NCT02757430|528569983|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
146562476|NCT02757430|528569983|FG000|Overall Study|No informed consent|1|||
146562477|NCT02757430|528569983|FG000|Overall Study|No procedure performed|2|||
146562478|NCT00071032|528569987|FG000|Overall Study|Lost to Follow-up|1|||
146562479|NCT00071032|528569988|FG001|Overall Study|Lost to Follow-up|1|||
146562480|NCT00071032|528569987|FG000|Overall Study|Withdrawal by Subject|8|||
146562481|NCT00071032|528569988|FG001|Overall Study|Withdrawal by Subject|6|||
146562482|NCT00071032|528569987|FG000|Overall Study|Missing Primary Outcome|0|||
146562483|NCT00071032|528569988|FG001|Overall Study|Missing Primary Outcome|1|||
146562484|NCT05852470|528569989|FG000|Overall Study|Withdrawal by Subject|0|||
146562485|NCT05852470|528569990|FG001|Overall Study|Withdrawal by Subject|1|||
146562486|NCT06071104|528569991|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
146562487|NCT01903863|528569992|FG000|Overall Study|Physician Decision|2|||
146562488|NCT01903863|528569993|FG001|Overall Study|Physician Decision|0|||
146562489|NCT03636022|528569996|FG000|Overall Study|Withdrawal by Subject|1|||
146641692|NCT00856518|528865116|FG001|Overall Study|Lost to Follow-up|2|||
146641693|NCT02082340|528865118|FG000|Overall Study|Lost to Follow-up|1|||
146641694|NCT02082340|528865119|FG001|Overall Study|Lost to Follow-up|1|||
146641695|NCT02644109|528865126|FG000|Overall Study|Adverse Event|0|||
146641696|NCT02644109|528865127|FG001|Overall Study|Adverse Event|4|||
146641697|NCT04195893|528865130|FG000|Second Intervention|Withdrawal by Subject|1|||
146641698|NCT04195893|528865131|FG001|Second Intervention|Withdrawal by Subject|0|||
146641699|NCT00918736|528865134|FG000|Overall Study|Withdrawal by Subject|4|||
146641700|NCT01942733|528865135|FG000|Overall Study|Lost to Follow-up|1|||
146641701|NCT01942733|528865135|FG000|Overall Study|Non-compliance with IMP|1|||
146641702|NCT01942733|528865135|FG000|Overall Study|Administrative|1|||
146641703|NCT04080167|528865139|FG000|Overall Study|Lost to Follow-up-Patients|7|||
146641704|NCT04080167|528865140|FG001|Overall Study|Lost to Follow-up-Patients|14|||
146641705|NCT04080167|528865141|FG002|Overall Study|Lost to Follow-up-Patients|0|||
146641706|NCT04080167|528865139|FG000|Overall Study|Lost to Follow-up-Providers|2|||
146641707|NCT04080167|528865140|FG001|Overall Study|Lost to Follow-up-Providers|2|||
146641708|NCT04080167|528865141|FG002|Overall Study|Lost to Follow-up-Providers|0|||
146641709|NCT04080167|528865139|FG000|Overall Study|Withdrawal by Subject|1|||
146641710|NCT04080167|528865140|FG001|Overall Study|Withdrawal by Subject|2|||
146641711|NCT04080167|528865141|FG002|Overall Study|Withdrawal by Subject|0|||
146641712|NCT04080167|528865139|FG000|Overall Study|Withdrawal by Provider|0|||
146641713|NCT04080167|528865140|FG001|Overall Study|Withdrawal by Provider|0|||
146641714|NCT04080167|528865141|FG002|Overall Study|Withdrawal by Provider|4|||
146641715|NCT04080167|528865139|FG000|Overall Study|Death-Patient|2|||
146641716|NCT04080167|528865140|FG001|Overall Study|Death-Patient|1|||
146641717|NCT04080167|528865141|FG002|Overall Study|Death-Patient|0|||
146641718|NCT04080167|528865139|FG000|Overall Study|Hydroxyurea New Starts|0|||
146641719|NCT04080167|528865140|FG001|Overall Study|Hydroxyurea New Starts|0|||
146641720|NCT04080167|528865141|FG002|Overall Study|Hydroxyurea New Starts|1|||
146641721|NCT04080167|528865139|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
146641722|NCT04080167|528865140|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
146641723|NCT04080167|528865141|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
146641724|NCT02167139|528865142|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
146641725|NCT02167139|528865143|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
146641726|NCT02167139|528865144|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
146641727|NCT02167139|528865145|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
146562490|NCT03636022|528569997|FG001|Overall Study|Withdrawal by Subject|3|||
146562491|NCT05715827|528570010|FG000|Overall Study|Physician Decision|0|||
146562492|NCT05715827|528570011|FG001|Overall Study|Physician Decision|1|||
146562493|NCT05715827|528570010|FG000|Overall Study|console communication error|0|||
146562494|NCT05715827|528570011|FG001|Overall Study|console communication error|1|||
146562495|NCT04569084|528570012|FG000|Overall Study|Adverse Event|10|||
146562496|NCT04569084|528570013|FG001|Overall Study|Adverse Event|14|||
146641728|NCT02167139|528865142|FG000|Randomised, Double-blind|Adverse Event|2|||
146641729|NCT02167139|528865143|FG001|Randomised, Double-blind|Adverse Event|9|||
146641730|NCT02167139|528865144|FG002|Randomised, Double-blind|Adverse Event|0|||
146641731|NCT02167139|528865145|FG003|Randomised, Double-blind|Adverse Event|0|||
146641732|NCT02167139|528865142|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
146641733|NCT02167139|528865143|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
146641734|NCT02167139|528865144|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
146641735|NCT02167139|528865145|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
146641736|NCT02167139|528865142|FG000|Randomised, Double-blind|Other|3|||
146641737|NCT02167139|528865143|FG001|Randomised, Double-blind|Other|0|||
146641738|NCT02167139|528865144|FG002|Randomised, Double-blind|Other|0|||
146641739|NCT02167139|528865145|FG003|Randomised, Double-blind|Other|0|||
146641740|NCT02167139|528865142|FG000|Transition-extension|Adverse Event|2|||
146907590|NCT03519178|529825556|FG006|Long-term Follow-up|Death|0|||
146907591|NCT03519178|529825557|FG007|Long-term Follow-up|Death|0|||
146907592|NCT03519178|529825558|FG008|Long-term Follow-up|Death|0|||
146907593|NCT03519178|529825559|FG009|Long-term Follow-up|Death|0|||
146641741|NCT02167139|528865143|FG001|Transition-extension|Adverse Event|0|||
146641742|NCT02167139|528865144|FG002|Transition-extension|Adverse Event|2|||
146641743|NCT02167139|528865145|FG003|Transition-extension|Adverse Event|3|||
146641744|NCT02167139|528865142|FG000|Transition-extension|Withdrawal by Subject|2|||
146641745|NCT02167139|528865143|FG001|Transition-extension|Withdrawal by Subject|0|||
146641746|NCT02167139|528865144|FG002|Transition-extension|Withdrawal by Subject|4|||
146641747|NCT02167139|528865145|FG003|Transition-extension|Withdrawal by Subject|1|||
146641748|NCT02167139|528865142|FG000|Transition-extension|Lack of Efficacy|0|||
146641749|NCT02167139|528865143|FG001|Transition-extension|Lack of Efficacy|0|||
146641750|NCT02167139|528865144|FG002|Transition-extension|Lack of Efficacy|1|||
146641751|NCT02167139|528865145|FG003|Transition-extension|Lack of Efficacy|1|||
146641752|NCT02167139|528865142|FG000|Transition-extension|Other|1|||
146641753|NCT02167139|528865143|FG001|Transition-extension|Other|0|||
146641754|NCT02167139|528865144|FG002|Transition-extension|Other|1|||
146641755|NCT02167139|528865145|FG003|Transition-extension|Other|0|||
146641756|NCT02167139|528865142|FG000|Transition-extension|Lost to Follow-up|1|||
146641757|NCT02167139|528865143|FG001|Transition-extension|Lost to Follow-up|0|||
146641758|NCT02167139|528865144|FG002|Transition-extension|Lost to Follow-up|0|||
146641759|NCT02167139|528865145|FG003|Transition-extension|Lost to Follow-up|0|||
146641760|NCT00984620|528865148|FG000|Overall Study|Adverse Event|5|||
146641761|NCT00984620|528865149|FG001|Overall Study|Adverse Event|5|||
146641762|NCT00984620|528865148|FG000|Overall Study|Lost to Follow-up|1|||
146641763|NCT00984620|528865149|FG001|Overall Study|Lost to Follow-up|1|||
146641764|NCT00984620|528865148|FG000|Overall Study|Withdrawal by Subject|0|||
146641765|NCT00984620|528865149|FG001|Overall Study|Withdrawal by Subject|2|||
146641766|NCT00984620|528865148|FG000|Overall Study|reason other than listed above|0|||
146641767|NCT00984620|528865149|FG001|Overall Study|reason other than listed above|4|||
146641768|NCT00344487|528865152|FG000|Overall Study|immunologic failure|1|||
146641769|NCT02791763|528865156|FG000|Overall Study|Protocol Violation|0|||
146641770|NCT02791763|528865157|FG001|Overall Study|Protocol Violation|0|||
146641771|NCT02791763|528865158|FG002|Overall Study|Protocol Violation|1|||
146641772|NCT02791763|528865156|FG000|Overall Study|Withdrawal by Subject|5|||
146641773|NCT02791763|528865157|FG001|Overall Study|Withdrawal by Subject|1|||
146641774|NCT02791763|528865158|FG002|Overall Study|Withdrawal by Subject|0|||
146641775|NCT02791763|528865156|FG000|Overall Study|Physician Decision|0|||
146641776|NCT02791763|528865157|FG001|Overall Study|Physician Decision|1|||
146641777|NCT02791763|528865158|FG002|Overall Study|Physician Decision|0|||
146641778|NCT02791763|528865156|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
146641779|NCT02791763|528865157|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
146641780|NCT02791763|528865158|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
146641781|NCT02791763|528865156|FG000|Overall Study|Cancer event|1|||
146641782|NCT02791763|528865157|FG001|Overall Study|Cancer event|3|||
146641783|NCT02791763|528865158|FG002|Overall Study|Cancer event|0|||
146641784|NCT02791763|528865156|FG000|Overall Study|Participant had renal transplant|3|||
146641785|NCT02791763|528865157|FG001|Overall Study|Participant had renal transplant|0|||
146641786|NCT02791763|528865158|FG002|Overall Study|Participant had renal transplant|0|||
146641787|NCT02791763|528865156|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
146641788|NCT02791763|528865157|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
146641789|NCT02791763|528865158|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
146641790|NCT02791763|528865156|FG000|Overall Study|Adverse Event|12|||
146641791|NCT02791763|528865157|FG001|Overall Study|Adverse Event|13|||
146641792|NCT02791763|528865158|FG002|Overall Study|Adverse Event|7|||
146641793|NCT01561313|528865164|FG000|Overall Study|Withdrawal by Subject|1|||
146641794|NCT01561313|528865165|FG001|Overall Study|Withdrawal by Subject|0|||
146641795|NCT01561313|528865164|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
146641796|NCT01561313|528865165|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
146641797|NCT04535453|528865166|FG000|Overall Study|Death|0|||
146641798|NCT04535453|528865167|FG001|Overall Study|Death|1|||
146641799|NCT04535453|528865168|FG002|Overall Study|Death|0|||
146641800|NCT04535453|528865169|FG003|Overall Study|Death|0|||
146907594|NCT03519178|529825560|FG010|Long-term Follow-up|Death|0|||
146907595|NCT03519178|529825561|FG011|Long-term Follow-up|Death|0|||
146907596|NCT03519178|529825562|FG012|Long-term Follow-up|Death|0|||
146907597|NCT03519178|529825563|FG013|Long-term Follow-up|Death|4|||
146907598|NCT03519178|529825564|FG014|Long-term Follow-up|Death|4|||
146907599|NCT03519178|529825550|FG000|Long-term Follow-up|Lost to Follow-up|0|||
146907600|NCT03519178|529825551|FG001|Long-term Follow-up|Lost to Follow-up|0|||
146907601|NCT03519178|529825552|FG002|Long-term Follow-up|Lost to Follow-up|0|||
146907602|NCT03519178|529825553|FG003|Long-term Follow-up|Lost to Follow-up|0|||
146907603|NCT03519178|529825554|FG004|Long-term Follow-up|Lost to Follow-up|0|||
146907604|NCT03519178|529825555|FG005|Long-term Follow-up|Lost to Follow-up|0|||
146907605|NCT03519178|529825556|FG006|Long-term Follow-up|Lost to Follow-up|0|||
146907606|NCT03519178|529825557|FG007|Long-term Follow-up|Lost to Follow-up|0|||
146907607|NCT03519178|529825558|FG008|Long-term Follow-up|Lost to Follow-up|0|||
146907608|NCT03519178|529825559|FG009|Long-term Follow-up|Lost to Follow-up|0|||
146907609|NCT03519178|529825560|FG010|Long-term Follow-up|Lost to Follow-up|0|||
146907610|NCT03519178|529825561|FG011|Long-term Follow-up|Lost to Follow-up|0|||
146907611|NCT03519178|529825562|FG012|Long-term Follow-up|Lost to Follow-up|0|||
146907612|NCT03519178|529825563|FG013|Long-term Follow-up|Lost to Follow-up|1|||
146907613|NCT03519178|529825564|FG014|Long-term Follow-up|Lost to Follow-up|1|||
146907614|NCT03519178|529825550|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
146907615|NCT03519178|529825551|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
146907616|NCT03519178|529825552|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
146907617|NCT03519178|529825553|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
146907618|NCT03519178|529825554|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
146907619|NCT03519178|529825555|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
146907620|NCT03519178|529825556|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
146907621|NCT03519178|529825557|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
146907622|NCT03519178|529825558|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
146907623|NCT03519178|529825559|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
146907624|NCT03519178|529825560|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
146907625|NCT03519178|529825561|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
146907626|NCT03519178|529825562|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
146907627|NCT03519178|529825563|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
146907628|NCT03519178|529825564|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
146907629|NCT03519178|529825550|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
146907630|NCT03519178|529825551|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
146907631|NCT03519178|529825552|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
146907632|NCT03519178|529825553|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
146907633|NCT03519178|529825554|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
146907634|NCT03519178|529825555|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
146907635|NCT03519178|529825556|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
146907636|NCT03519178|529825557|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
146907637|NCT03519178|529825558|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
146907638|NCT03519178|529825559|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
146907639|NCT03519178|529825560|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
146907640|NCT03519178|529825561|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
146907641|NCT03519178|529825562|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
146907642|NCT03519178|529825563|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
146907643|NCT03519178|529825564|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
146907644|NCT03519178|529825550|FG000|Long-term Follow-up|Other|0|||
146907645|NCT03519178|529825551|FG001|Long-term Follow-up|Other|0|||
146907646|NCT03519178|529825552|FG002|Long-term Follow-up|Other|0|||
146907647|NCT03519178|529825553|FG003|Long-term Follow-up|Other|0|||
146907648|NCT03519178|529825554|FG004|Long-term Follow-up|Other|0|||
146907649|NCT03519178|529825555|FG005|Long-term Follow-up|Other|0|||
146907650|NCT03519178|529825556|FG006|Long-term Follow-up|Other|0|||
146907651|NCT03519178|529825557|FG007|Long-term Follow-up|Other|0|||
146907652|NCT03519178|529825558|FG008|Long-term Follow-up|Other|0|||
146907653|NCT03519178|529825559|FG009|Long-term Follow-up|Other|0|||
146907654|NCT03519178|529825560|FG010|Long-term Follow-up|Other|0|||
146907655|NCT03519178|529825561|FG011|Long-term Follow-up|Other|0|||
146907656|NCT03519178|529825562|FG012|Long-term Follow-up|Other|0|||
146907657|NCT03519178|529825563|FG013|Long-term Follow-up|Other|0|||
146907658|NCT03519178|529825564|FG014|Long-term Follow-up|Other|1|||
146907659|NCT03519178|529825550|FG000|Long-term Follow-up|Global deterioration of health status|0|||
146907660|NCT03519178|529825551|FG001|Long-term Follow-up|Global deterioration of health status|0|||
146562497|NCT04569084|528570012|FG000|Overall Study|Death|2|||
146562498|NCT04569084|528570013|FG001|Overall Study|Death|3|||
146562499|NCT04569084|528570012|FG000|Overall Study|Lost to Follow-up|1|||
146562500|NCT04569084|528570013|FG001|Overall Study|Lost to Follow-up|1|||
146562501|NCT04569084|528570012|FG000|Overall Study|Physician Decision|3|||
146562502|NCT04569084|528570013|FG001|Overall Study|Physician Decision|3|||
146562503|NCT04569084|528570012|FG000|Overall Study|Protocol Violation|2|||
146562504|NCT04569084|528570013|FG001|Overall Study|Protocol Violation|1|||
146562505|NCT04569084|528570012|FG000|Overall Study|Withdrawal by Subject|20|||
146562506|NCT04569084|528570013|FG001|Overall Study|Withdrawal by Subject|21|||
146562507|NCT04569084|528570012|FG000|Overall Study|Study terminated by sponsor|26|||
146562508|NCT04569084|528570013|FG001|Overall Study|Study terminated by sponsor|23|||
146562509|NCT04569084|528570012|FG000|Overall Study|Other|3|||
146562510|NCT04569084|528570013|FG001|Overall Study|Other|5|||
146562511|NCT03274466|528570014|FG000|Overall Study|Withdrawal by Subject|7|||
146562512|NCT03274466|528570015|FG001|Overall Study|Withdrawal by Subject|3|||
146562513|NCT03274466|528570014|FG000|Overall Study|Protocol Specified Withdrawal|5|||
146562514|NCT03274466|528570015|FG001|Overall Study|Protocol Specified Withdrawal|11|||
146562515|NCT03274466|528570014|FG000|Overall Study|Lost to Follow-up|5|||
146562516|NCT03274466|528570015|FG001|Overall Study|Lost to Follow-up|7|||
146562517|NCT03274466|528570014|FG000|Overall Study|Subject Non-compliance|0|||
146562518|NCT03274466|528570015|FG001|Overall Study|Subject Non-compliance|1|||
146562519|NCT03274466|528570014|FG000|Overall Study|Adverse Event|3|||
146562520|NCT03274466|528570015|FG001|Overall Study|Adverse Event|3|||
146562521|NCT03274466|528570014|FG000|Overall Study|Physician Decision|0|||
146562522|NCT03274466|528570015|FG001|Overall Study|Physician Decision|1|||
146562523|NCT03274466|528570014|FG000|Overall Study|Protocol Violation|3|||
146562524|NCT03274466|528570015|FG001|Overall Study|Protocol Violation|3|||
146562525|NCT06022107|528570019|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
146562526|NCT06022107|528570019|FG000|Overall Study|Dropped out of study for higher level of care|1|||
146562527|NCT06022107|528570019|FG000|Overall Study|Lost to Follow-up|2|||
146562528|NCT02333799|528571688|FG000|Treatment Period|Withdrawal by Subject|1|||
146562529|NCT02333799|528571688|FG000|Treatment Period|Death|6|||
146562530|NCT02333799|528571688|FG000|6 Month Follow Up Period|Physician Decision|1|||
146562531|NCT02333799|528571688|FG000|6 Month Follow Up Period|Death|1|||
146562532|NCT02333799|528571688|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
146562533|NCT02333799|528571688|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
146562534|NCT05484895|528571689|FG000|Overall Study|Lost to Follow-up|63|||
146907661|NCT03519178|529825552|FG002|Long-term Follow-up|Global deterioration of health status|0|||
146907662|NCT03519178|529825553|FG003|Long-term Follow-up|Global deterioration of health status|0|||
146907663|NCT03519178|529825554|FG004|Long-term Follow-up|Global deterioration of health status|0|||
146907664|NCT03519178|529825555|FG005|Long-term Follow-up|Global deterioration of health status|0|||
146907665|NCT03519178|529825556|FG006|Long-term Follow-up|Global deterioration of health status|0|||
146907666|NCT03519178|529825557|FG007|Long-term Follow-up|Global deterioration of health status|0|||
146907667|NCT03519178|529825558|FG008|Long-term Follow-up|Global deterioration of health status|0|||
146562535|NCT05484895|528571690|FG001|Overall Study|Lost to Follow-up|64|||
146562536|NCT03396445|528571691|FG000|Treatment Period|Death|2|||
146907668|NCT03519178|529825559|FG009|Long-term Follow-up|Global deterioration of health status|0|||
146562537|NCT03396445|528571692|FG001|Treatment Period|Death|2|||
146562538|NCT03396445|528571693|FG002|Treatment Period|Death|1|||
146907669|NCT03519178|529825560|FG010|Long-term Follow-up|Global deterioration of health status|0|||
146562539|NCT03396445|528571694|FG003|Treatment Period|Death|1|||
146562540|NCT03396445|528571695|FG004|Treatment Period|Death|3|||
146562541|NCT03396445|528571696|FG005|Treatment Period|Death|2|||
146562542|NCT03396445|528571697|FG006|Treatment Period|Death|5|||
146562543|NCT03396445|528571698|FG007|Treatment Period|Death|3|||
146562544|NCT03396445|528571699|FG008|Treatment Period|Death|3|||
146562545|NCT03396445|528571700|FG009|Treatment Period|Death|3|||
146562546|NCT03396445|528571701|FG010|Treatment Period|Death|7|||
146562547|NCT03396445|528571702|FG011|Treatment Period|Death|12|||
146562548|NCT03396445|528571703|FG012|Treatment Period|Death|28|||
146562549|NCT03396445|528571704|FG013|Treatment Period|Death|14|||
146562550|NCT03396445|528571705|FG014|Treatment Period|Death|10|||
146562551|NCT03396445|528571706|FG015|Treatment Period|Death|8|||
146562552|NCT03396445|528571707|FG016|Treatment Period|Death|18|||
146562553|NCT03396445|528571708|FG017|Treatment Period|Death|0|||
146562554|NCT03396445|528571709|FG018|Treatment Period|Death|0|||
146562555|NCT03396445|528571710|FG019|Treatment Period|Death|0|||
146562556|NCT03396445|528571711|FG020|Treatment Period|Death|0|||
146562557|NCT03396445|528571712|FG021|Treatment Period|Death|0|||
146562558|NCT03396445|528571713|FG022|Treatment Period|Death|0|||
146562559|NCT03396445|528571714|FG023|Treatment Period|Death|0|||
146562560|NCT03396445|528571715|FG024|Treatment Period|Death|0|||
146562561|NCT03396445|528571716|FG025|Treatment Period|Death|0|||
146562562|NCT03396445|528571691|FG000|Treatment Period|Lost to Follow-up|0|||
146562563|NCT03396445|528571692|FG001|Treatment Period|Lost to Follow-up|0|||
146562564|NCT03396445|528571693|FG002|Treatment Period|Lost to Follow-up|0|||
146562565|NCT03396445|528571694|FG003|Treatment Period|Lost to Follow-up|0|||
146562566|NCT03396445|528571695|FG004|Treatment Period|Lost to Follow-up|0|||
146562567|NCT03396445|528571696|FG005|Treatment Period|Lost to Follow-up|0|||
146562568|NCT03396445|528571697|FG006|Treatment Period|Lost to Follow-up|0|||
146562569|NCT03396445|528571698|FG007|Treatment Period|Lost to Follow-up|0|||
146562570|NCT03396445|528571699|FG008|Treatment Period|Lost to Follow-up|0|||
146562571|NCT03396445|528571700|FG009|Treatment Period|Lost to Follow-up|0|||
146562572|NCT03396445|528571701|FG010|Treatment Period|Lost to Follow-up|0|||
146562573|NCT03396445|528571702|FG011|Treatment Period|Lost to Follow-up|0|||
146562574|NCT03396445|528571703|FG012|Treatment Period|Lost to Follow-up|1|||
146562575|NCT03396445|528571704|FG013|Treatment Period|Lost to Follow-up|0|||
146907670|NCT03519178|529825561|FG011|Long-term Follow-up|Global deterioration of health status|0|||
146907671|NCT03519178|529825562|FG012|Long-term Follow-up|Global deterioration of health status|0|||
146907672|NCT03519178|529825563|FG013|Long-term Follow-up|Global deterioration of health status|1|||
146907673|NCT03519178|529825564|FG014|Long-term Follow-up|Global deterioration of health status|0|||
146907674|NCT01548638|529825567|FG000|Overall Study|Protocol Violation|3|||
146907675|NCT01548638|529825567|FG000|Overall Study|Withdrawal by Subject|1|||
146562576|NCT03396445|528571705|FG014|Treatment Period|Lost to Follow-up|1|||
146562577|NCT03396445|528571706|FG015|Treatment Period|Lost to Follow-up|0|||
146562578|NCT03396445|528571707|FG016|Treatment Period|Lost to Follow-up|0|||
146562579|NCT03396445|528571708|FG017|Treatment Period|Lost to Follow-up|0|||
146562580|NCT03396445|528571709|FG018|Treatment Period|Lost to Follow-up|0|||
146562581|NCT03396445|528571710|FG019|Treatment Period|Lost to Follow-up|0|||
146562582|NCT03396445|528571711|FG020|Treatment Period|Lost to Follow-up|0|||
146907676|NCT00144300|529825573|FG000|Overall Study|Adverse Event|18|||
146562583|NCT03396445|528571712|FG021|Treatment Period|Lost to Follow-up|0|||
146562584|NCT03396445|528571713|FG022|Treatment Period|Lost to Follow-up|0|||
146562585|NCT03396445|528571714|FG023|Treatment Period|Lost to Follow-up|0|||
146562586|NCT03396445|528571715|FG024|Treatment Period|Lost to Follow-up|0|||
146562587|NCT03396445|528571716|FG025|Treatment Period|Lost to Follow-up|0|||
146907677|NCT00144300|529825574|FG001|Overall Study|Adverse Event|16|||
146907678|NCT00144300|529825573|FG000|Overall Study|Protocol Violation|1|||
146562588|NCT03396445|528571691|FG000|Treatment Period|Physician Decision|0|||
146562589|NCT03396445|528571692|FG001|Treatment Period|Physician Decision|0|||
146562590|NCT03396445|528571693|FG002|Treatment Period|Physician Decision|0|||
146907679|NCT00144300|529825574|FG001|Overall Study|Protocol Violation|3|||
146907680|NCT00144300|529825573|FG000|Overall Study|Lost to Follow-up|3|||
146907681|NCT00144300|529825574|FG001|Overall Study|Lost to Follow-up|0|||
146907682|NCT00144300|529825573|FG000|Overall Study|Withdrawal by Subject|6|||
146907683|NCT00144300|529825574|FG001|Overall Study|Withdrawal by Subject|6|||
146907684|NCT00144300|529825573|FG000|Overall Study|Other reason (not specified)|1|||
146907685|NCT00144300|529825574|FG001|Overall Study|Other reason (not specified)|3|||
146907686|NCT02426086|529825577|FG000|Overall Study|Death|33|||
146907687|NCT02426086|529825578|FG001|Overall Study|Death|36|||
146907688|NCT02426086|529825577|FG000|Overall Study|Lost to Follow-up|2|||
146907689|NCT02426086|529825578|FG001|Overall Study|Lost to Follow-up|0|||
146907690|NCT02426086|529825577|FG000|Overall Study|Study Terminated by Sponsor|5|||
146907691|NCT02426086|529825578|FG001|Overall Study|Study Terminated by Sponsor|14|||
146907692|NCT02426086|529825577|FG000|Overall Study|Withdrawal by Subject|8|||
146907693|NCT02426086|529825578|FG001|Overall Study|Withdrawal by Subject|9|||
146907694|NCT00524303|529825579|FG000|Overall Study|Lost to Follow-up|6|||
146907695|NCT00524303|529825580|FG001|Overall Study|Lost to Follow-up|0|||
146907696|NCT00524303|529825581|FG002|Overall Study|Lost to Follow-up|3|||
146907697|NCT00524303|529825579|FG000|Overall Study|Protocol Violation|0|||
146907698|NCT00524303|529825580|FG001|Overall Study|Protocol Violation|1|||
146907699|NCT00524303|529825581|FG002|Overall Study|Protocol Violation|1|||
146907700|NCT00524303|529825579|FG000|Overall Study|Withdrawal by Subject|3|||
146562591|NCT03396445|528571694|FG003|Treatment Period|Physician Decision|0|||
146562592|NCT03396445|528571695|FG004|Treatment Period|Physician Decision|1|||
146907701|NCT00524303|529825580|FG001|Overall Study|Withdrawal by Subject|0|||
146907702|NCT00524303|529825581|FG002|Overall Study|Withdrawal by Subject|4|||
146907703|NCT00524303|529825579|FG000|Overall Study|Death|0|||
146907704|NCT00524303|529825580|FG001|Overall Study|Death|2|||
146907705|NCT00524303|529825581|FG002|Overall Study|Death|3|||
146907706|NCT00524303|529825579|FG000|Overall Study|Adverse Event|1|||
146907707|NCT00524303|529825580|FG001|Overall Study|Adverse Event|2|||
146907708|NCT00524303|529825581|FG002|Overall Study|Adverse Event|3|||
146907709|NCT00524303|529825579|FG000|Overall Study|Did not Complete Study Dosing|1|||
146907710|NCT00524303|529825580|FG001|Overall Study|Did not Complete Study Dosing|0|||
146907711|NCT00524303|529825581|FG002|Overall Study|Did not Complete Study Dosing|0|||
146907712|NCT00524303|529825579|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
146907713|NCT00524303|529825580|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
146562593|NCT03396445|528571696|FG005|Treatment Period|Physician Decision|0|||
146562594|NCT03396445|528571697|FG006|Treatment Period|Physician Decision|0|||
146562595|NCT03396445|528571698|FG007|Treatment Period|Physician Decision|0|||
146907714|NCT00524303|529825581|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
146907715|NCT00524303|529825579|FG000|Overall Study|Disease Progression|0|||
146907716|NCT00524303|529825580|FG001|Overall Study|Disease Progression|4|||
146907717|NCT00524303|529825581|FG002|Overall Study|Disease Progression|1|||
146907718|NCT00524303|529825579|FG000|Overall Study|Disease Recurrence|0|||
146907719|NCT00524303|529825580|FG001|Overall Study|Disease Recurrence|1|||
146907720|NCT00524303|529825581|FG002|Overall Study|Disease Recurrence|0|||
146907721|NCT00524303|529825579|FG000|Overall Study|Sponsor Request|0|||
146907722|NCT00524303|529825580|FG001|Overall Study|Sponsor Request|0|||
146907723|NCT00524303|529825581|FG002|Overall Study|Sponsor Request|1|||
146907724|NCT00524303|529825579|FG000|Overall Study|Physician Decision|0|||
146907725|NCT00524303|529825580|FG001|Overall Study|Physician Decision|0|||
146907726|NCT00524303|529825581|FG002|Overall Study|Physician Decision|1|||
146907727|NCT00524303|529825579|FG000|Overall Study|Completed 5 years|0|||
146907728|NCT00524303|529825580|FG001|Overall Study|Completed 5 years|0|||
146907729|NCT00524303|529825581|FG002|Overall Study|Completed 5 years|1|||
146907730|NCT01877655|529825584|FG000|Overall Study|Death|57|||
146907731|NCT01877655|529825585|FG001|Overall Study|Death|52|||
146907732|NCT01877655|529825584|FG000|Overall Study|Withdrawal by Subject|18|||
146907733|NCT01877655|529825585|FG001|Overall Study|Withdrawal by Subject|26|||
146907734|NCT01877655|529825584|FG000|Overall Study|Physician Decision|11|||
146907735|NCT01877655|529825585|FG001|Overall Study|Physician Decision|10|||
146907736|NCT01877655|529825584|FG000|Overall Study|Miscellaneous|4|||
146907737|NCT01877655|529825585|FG001|Overall Study|Miscellaneous|4|||
146907738|NCT01877655|529825584|FG000|Overall Study|Randomized but Never Received Drug|8|||
146907739|NCT01877655|529825585|FG001|Overall Study|Randomized but Never Received Drug|5|||
146562596|NCT03396445|528571699|FG008|Treatment Period|Physician Decision|0|||
146562597|NCT03396445|528571700|FG009|Treatment Period|Physician Decision|1|||
146562598|NCT03396445|528571701|FG010|Treatment Period|Physician Decision|0|||
146562599|NCT03396445|528571702|FG011|Treatment Period|Physician Decision|0|||
146562600|NCT03396445|528571703|FG012|Treatment Period|Physician Decision|0|||
146562601|NCT03396445|528571704|FG013|Treatment Period|Physician Decision|0|||
146562602|NCT03396445|528571705|FG014|Treatment Period|Physician Decision|0|||
146562603|NCT03396445|528571706|FG015|Treatment Period|Physician Decision|0|||
146562604|NCT03396445|528571707|FG016|Treatment Period|Physician Decision|0|||
146907740|NCT00095121|529825588|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
146907741|NCT00095121|529825589|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
146907742|NCT00095121|529825588|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
146907743|NCT00095121|529825589|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
146907744|NCT04070378|529825592|FG000|Overall Study|Withdrawal by Subject|2|||
146907745|NCT04070378|529825592|FG000|Overall Study|Screen Failure|6|||
146907746|NCT04070378|529825592|FG000|Overall Study|Physician Decision|1|||
146907747|NCT04070378|529825592|FG000|Overall Study|Adverse Event|1|||
146914685|NCT03303339|529850046|FG004|Overall Study|Safety/Non-compliance|0|||
146562605|NCT03396445|528571708|FG017|Treatment Period|Physician Decision|0|||
146562606|NCT03396445|528571709|FG018|Treatment Period|Physician Decision|0|||
146562607|NCT03396445|528571710|FG019|Treatment Period|Physician Decision|0|||
146562608|NCT03396445|528571711|FG020|Treatment Period|Physician Decision|0|||
146562609|NCT03396445|528571712|FG021|Treatment Period|Physician Decision|0|||
146562610|NCT03396445|528571713|FG022|Treatment Period|Physician Decision|0|||
146562611|NCT03396445|528571714|FG023|Treatment Period|Physician Decision|0|||
146562612|NCT03396445|528571715|FG024|Treatment Period|Physician Decision|0|||
146768126|NCT01317420|529319491|FG001|Overall Study|Refused to cont. taking trial medication|0|||
146914686|NCT03303339|529850047|FG005|Overall Study|Safety/Non-compliance|0|||
146914687|NCT03303339|529850048|FG006|Overall Study|Safety/Non-compliance|0|||
146914688|NCT03303339|529850049|FG007|Overall Study|Safety/Non-compliance|0|||
146914689|NCT03303339|529850050|FG008|Overall Study|Safety/Non-compliance|0|||
146907748|NCT02742649|529826823|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
146907749|NCT02742649|529826824|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
146907750|NCT02742649|529826825|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
146907751|NCT02742649|529826826|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
146907752|NCT02742649|529826827|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
146907753|NCT02742649|529826823|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146641801|NCT04535453|528865170|FG004|Overall Study|Death|0|||
146641802|NCT04535453|528865171|FG005|Overall Study|Death|0|||
146641803|NCT04535453|528865172|FG006|Overall Study|Death|0|||
146641804|NCT04535453|528865173|FG007|Overall Study|Death|0|||
146641805|NCT04535453|528865174|FG008|Overall Study|Death|0|||
146641806|NCT04535453|528865175|FG009|Overall Study|Death|0|||
146641807|NCT04535453|528865176|FG010|Overall Study|Death|0|||
146641808|NCT04535453|528865177|FG011|Overall Study|Death|0|||
146641809|NCT04535453|528865166|FG000|Overall Study|Lost to Follow-up|1|||
146641810|NCT04535453|528865167|FG001|Overall Study|Lost to Follow-up|1|||
146641811|NCT04535453|528865168|FG002|Overall Study|Lost to Follow-up|1|||
146641812|NCT04535453|528865169|FG003|Overall Study|Lost to Follow-up|0|||
146641813|NCT04535453|528865170|FG004|Overall Study|Lost to Follow-up|3|||
146641814|NCT04535453|528865171|FG005|Overall Study|Lost to Follow-up|1|||
146641815|NCT04535453|528865172|FG006|Overall Study|Lost to Follow-up|0|||
146907754|NCT02742649|529826824|FG001|Double-Blind Treatment Period|Adverse Event|1|||
146907755|NCT02742649|529826825|FG002|Double-Blind Treatment Period|Adverse Event|0|||
146907756|NCT02742649|529826826|FG003|Double-Blind Treatment Period|Adverse Event|0|||
146641816|NCT04535453|528865173|FG007|Overall Study|Lost to Follow-up|0|||
146641817|NCT04535453|528865174|FG008|Overall Study|Lost to Follow-up|1|||
146907757|NCT02742649|529826827|FG004|Double-Blind Treatment Period|Adverse Event|0|||
146907758|NCT02742649|529826823|FG000|Open-Label Period|Lost to Follow-up|0|||
146907759|NCT02742649|529826824|FG001|Open-Label Period|Lost to Follow-up|0|||
146907760|NCT02742649|529826825|FG002|Open-Label Period|Lost to Follow-up|0|||
146907761|NCT02742649|529826826|FG003|Open-Label Period|Lost to Follow-up|0|||
146907762|NCT02742649|529826827|FG004|Open-Label Period|Lost to Follow-up|1|||
146907763|NCT03167619|529826834|FG000|Overall Study|Death|11|||
146907764|NCT03167619|529826835|FG001|Overall Study|Death|8|||
146907765|NCT03167619|529826834|FG000|Overall Study|Withdrawal by Subject|1|||
146907766|NCT03167619|529826835|FG001|Overall Study|Withdrawal by Subject|2|||
146907767|NCT03167619|529826834|FG000|Overall Study|Physician Decision|0|||
146907768|NCT03167619|529826835|FG001|Overall Study|Physician Decision|1|||
146907769|NCT01348919|529826839|FG000|Overall Study|Adverse Event|3|||
146907770|NCT01348919|529826840|FG001|Overall Study|Adverse Event|1|||
146907771|NCT01348919|529826841|FG002|Overall Study|Adverse Event|0|||
146907772|NCT01348919|529826839|FG000|Overall Study|Withdrawal by Subject|0|||
146907773|NCT01348919|529826840|FG001|Overall Study|Withdrawal by Subject|1|||
146907774|NCT01348919|529826841|FG002|Overall Study|Withdrawal by Subject|0|||
146907775|NCT01348919|529826839|FG000|Overall Study|Disease progression|0|||
146907776|NCT01348919|529826840|FG001|Overall Study|Disease progression|1|||
146907777|NCT01348919|529826841|FG002|Overall Study|Disease progression|1|||
146907778|NCT02082184|529826843|FG000|Overall Study|Adverse Event|1|||
146907779|NCT02082184|529826844|FG001|Overall Study|Adverse Event|0|||
146907780|NCT02082184|529826843|FG000|Overall Study|Medical diagnosis|1|||
146907781|NCT02082184|529826844|FG001|Overall Study|Medical diagnosis|2|||
146907782|NCT02082184|529826843|FG000|Overall Study|Device associated symptoms|5|||
146907783|NCT02082184|529826844|FG001|Overall Study|Device associated symptoms|0|||
146907784|NCT02082184|529826843|FG000|Overall Study|Withdrawal by Subject|3|||
146907785|NCT02082184|529826844|FG001|Overall Study|Withdrawal by Subject|2|||
146907786|NCT02082184|529826843|FG000|Overall Study|Protocol Violation|0|||
146907787|NCT02082184|529826844|FG001|Overall Study|Protocol Violation|6|||
146907788|NCT02082184|529826843|FG000|Overall Study|Lost to Follow-up|0|||
146907789|NCT02082184|529826844|FG001|Overall Study|Lost to Follow-up|2|||
146907790|NCT02082184|529826843|FG000|Overall Study|Subject non-compliance|0|||
146907791|NCT02082184|529826844|FG001|Overall Study|Subject non-compliance|1|||
146907792|NCT00443560|529826845|FG000|Overall Study|No intrathecal dose|58|||
146907793|NCT00443560|529826846|FG001|Overall Study|No intrathecal dose|26|||
146907794|NCT00443560|529826845|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
146907795|NCT00443560|529826846|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
146907796|NCT00537940|529826851|FG000|Overall Study|Adverse Event|20|||
146907797|NCT00537940|529826852|FG001|Overall Study|Adverse Event|19|||
146907798|NCT00537940|529826851|FG000|Overall Study|Lack of Efficacy|8|||
146907799|NCT00537940|529826852|FG001|Overall Study|Lack of Efficacy|16|||
146907800|NCT00537940|529826851|FG000|Overall Study|Lost to Follow-up|23|||
146907801|NCT00537940|529826852|FG001|Overall Study|Lost to Follow-up|29|||
146907802|NCT00537940|529826851|FG000|Overall Study|Withdrawal by Subject|113|||
146907803|NCT00537940|529826852|FG001|Overall Study|Withdrawal by Subject|95|||
146907804|NCT00537940|529826851|FG000|Overall Study|Protocol Violation|6|||
146907805|NCT00537940|529826852|FG001|Overall Study|Protocol Violation|4|||
146907806|NCT00537940|529826851|FG000|Overall Study|Pregnancy|1|||
146907807|NCT00537940|529826852|FG001|Overall Study|Pregnancy|1|||
146907808|NCT00537940|529826851|FG000|Overall Study|Study terminated by sponsor|2|||
146907809|NCT00537940|529826852|FG001|Overall Study|Study terminated by sponsor|3|||
146907810|NCT00537940|529826851|FG000|Overall Study|Other|10|||
146907811|NCT00537940|529826852|FG001|Overall Study|Other|12|||
146907812|NCT01978912|529826856|FG000|Overall Study|Adverse Event|0|||
146907813|NCT01978912|529826857|FG001|Overall Study|Adverse Event|1|||
146907814|NCT01978912|529826858|FG002|Overall Study|Adverse Event|0|||
146907815|NCT01978912|529826859|FG003|Overall Study|Adverse Event|0|||
146907816|NCT01978912|529826856|FG000|Overall Study|Lost to Follow-up|1|||
146907817|NCT01978912|529826857|FG001|Overall Study|Lost to Follow-up|1|||
146907818|NCT01978912|529826858|FG002|Overall Study|Lost to Follow-up|0|||
146907819|NCT01978912|529826859|FG003|Overall Study|Lost to Follow-up|1|||
146907820|NCT01978912|529826856|FG000|Overall Study|Withdrawal by Subject|1|||
146907821|NCT01978912|529826857|FG001|Overall Study|Withdrawal by Subject|0|||
146907822|NCT01978912|529826858|FG002|Overall Study|Withdrawal by Subject|2|||
146907823|NCT01978912|529826859|FG003|Overall Study|Withdrawal by Subject|2|||
146907824|NCT01978912|529826856|FG000|Overall Study|Lumbar Surgery|1|||
146907825|NCT01978912|529826857|FG001|Overall Study|Lumbar Surgery|0|||
146907826|NCT01978912|529826858|FG002|Overall Study|Lumbar Surgery|1|||
146907827|NCT01978912|529826859|FG003|Overall Study|Lumbar Surgery|0|||
146907828|NCT01978912|529826856|FG000|Overall Study|Intradiscal Steroid Injection|0|||
146907829|NCT01978912|529826857|FG001|Overall Study|Intradiscal Steroid Injection|1|||
146907830|NCT01978912|529826858|FG002|Overall Study|Intradiscal Steroid Injection|0|||
146907831|NCT01978912|529826859|FG003|Overall Study|Intradiscal Steroid Injection|0|||
146907832|NCT00077623|529826865|FG000|Overall Study|Adverse Event|1|||
146907833|NCT00077623|529826866|FG001|Overall Study|Adverse Event|0|||
146907834|NCT00077623|529826867|FG002|Overall Study|Adverse Event|1|||
146907835|NCT00077623|529826865|FG000|Overall Study|Withdrawal by Subject|2|||
146907836|NCT00077623|529826866|FG001|Overall Study|Withdrawal by Subject|10|||
146907837|NCT00077623|529826867|FG002|Overall Study|Withdrawal by Subject|1|||
146907838|NCT00077623|529826865|FG000|Overall Study|Other-Non safety reason|18|||
146907839|NCT00077623|529826866|FG001|Overall Study|Other-Non safety reason|15|||
146907840|NCT00077623|529826867|FG002|Overall Study|Other-Non safety reason|19|||
146907841|NCT00077623|529826865|FG000|Overall Study|Insufficient therapeutic response|2|||
146907842|NCT00077623|529826866|FG001|Overall Study|Insufficient therapeutic response|0|||
146907843|NCT00077623|529826867|FG002|Overall Study|Insufficient therapeutic response|0|||
146970174|NCT00902486|530050822|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
146970175|NCT00902486|530050823|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
146970176|NCT00902486|530050824|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
146970177|NCT00902486|530050825|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
146970178|NCT00902486|530050826|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
146970179|NCT00902486|530050827|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
146970180|NCT00902486|530050822|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
146970181|NCT00902486|530050823|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
146970182|NCT00902486|530050824|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
146641818|NCT04535453|528865175|FG009|Overall Study|Lost to Follow-up|1|||
146970183|NCT00902486|530050825|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
146970184|NCT00902486|530050826|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
146970185|NCT00902486|530050827|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
146970186|NCT00902486|530050822|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
146970187|NCT00902486|530050823|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
146970188|NCT00902486|530050824|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
146970189|NCT00902486|530050825|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
146970190|NCT00902486|530050826|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
146970191|NCT00902486|530050827|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
146970192|NCT00902486|530050822|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
146970193|NCT00902486|530050823|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
146970194|NCT00902486|530050824|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
146970195|NCT00902486|530050825|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
146970196|NCT00902486|530050826|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
146970197|NCT00902486|530050827|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
146970198|NCT00902486|530050822|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
146970199|NCT00902486|530050823|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
146970200|NCT00902486|530050824|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
146970201|NCT00902486|530050825|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
146641819|NCT04535453|528865176|FG010|Overall Study|Lost to Follow-up|0|||
146641820|NCT04535453|528865177|FG011|Overall Study|Lost to Follow-up|0|||
146641821|NCT04535453|528865166|FG000|Overall Study|Physician Decision|0|||
146641822|NCT04535453|528865167|FG001|Overall Study|Physician Decision|0|||
146907844|NCT00077623|529826865|FG000|Overall Study|Death|12|||
146907845|NCT00077623|529826866|FG001|Overall Study|Death|18|||
146907846|NCT00077623|529826867|FG002|Overall Study|Death|11|||
146907847|NCT00077623|529826865|FG000|Overall Study|Failure to return|1|||
146907848|NCT00077623|529826866|FG001|Overall Study|Failure to return|0|||
146970202|NCT00902486|530050826|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
146970203|NCT00902486|530050827|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
146907849|NCT00077623|529826867|FG002|Overall Study|Failure to return|0|||
146907850|NCT00882713|529826868|FG000|Overall Study|Adverse Event|2|||
146907851|NCT00882713|529826868|FG000|Overall Study|Death|3|||
146907852|NCT00882713|529826868|FG000|Overall Study|Administrative reasons|4|||
146907853|NCT00882713|529826868|FG000|Overall Study|refused treatment/withdrew consent|4|||
146641823|NCT04535453|528865168|FG002|Overall Study|Physician Decision|0|||
146641824|NCT04535453|528865169|FG003|Overall Study|Physician Decision|1|||
146641825|NCT04535453|528865170|FG004|Overall Study|Physician Decision|0|||
146641826|NCT04535453|528865171|FG005|Overall Study|Physician Decision|0|||
146641827|NCT04535453|528865172|FG006|Overall Study|Physician Decision|0|||
146641828|NCT04535453|528865173|FG007|Overall Study|Physician Decision|0|||
146641829|NCT04535453|528865174|FG008|Overall Study|Physician Decision|0|||
146641830|NCT04535453|528865175|FG009|Overall Study|Physician Decision|0|||
146641831|NCT04535453|528865176|FG010|Overall Study|Physician Decision|0|||
146641832|NCT04535453|528865177|FG011|Overall Study|Physician Decision|0|||
146641833|NCT04535453|528865166|FG000|Overall Study|Withdrawal by Subject|3|||
146641834|NCT04535453|528865167|FG001|Overall Study|Withdrawal by Subject|6|||
146641835|NCT04535453|528865168|FG002|Overall Study|Withdrawal by Subject|3|||
146641836|NCT04535453|528865169|FG003|Overall Study|Withdrawal by Subject|3|||
146641837|NCT04535453|528865170|FG004|Overall Study|Withdrawal by Subject|2|||
146641838|NCT04535453|528865171|FG005|Overall Study|Withdrawal by Subject|1|||
146641839|NCT04535453|528865172|FG006|Overall Study|Withdrawal by Subject|1|||
146641840|NCT04535453|528865173|FG007|Overall Study|Withdrawal by Subject|1|||
146641841|NCT04535453|528865174|FG008|Overall Study|Withdrawal by Subject|1|||
146641842|NCT04535453|528865175|FG009|Overall Study|Withdrawal by Subject|1|||
146641843|NCT04535453|528865176|FG010|Overall Study|Withdrawal by Subject|0|||
146641844|NCT04535453|528865177|FG011|Overall Study|Withdrawal by Subject|1|||
146641845|NCT04535453|528865166|FG000|Overall Study|Other|0|||
146641846|NCT04535453|528865167|FG001|Overall Study|Other|0|||
146641847|NCT04535453|528865168|FG002|Overall Study|Other|1|||
146641848|NCT04535453|528865169|FG003|Overall Study|Other|0|||
146641849|NCT04535453|528865170|FG004|Overall Study|Other|1|||
146641850|NCT04535453|528865171|FG005|Overall Study|Other|0|||
146641851|NCT04535453|528865172|FG006|Overall Study|Other|1|||
146641852|NCT04535453|528865173|FG007|Overall Study|Other|1|||
146641853|NCT04535453|528865174|FG008|Overall Study|Other|1|||
146641854|NCT04535453|528865175|FG009|Overall Study|Other|0|||
146641855|NCT04535453|528865176|FG010|Overall Study|Other|0|||
146641856|NCT04535453|528865177|FG011|Overall Study|Other|0|||
146641857|NCT01742286|528865178|FG000|Escalation Phase|Administrative problems|1|||
146641858|NCT01742286|528865179|FG001|Escalation Phase|Administrative problems|1|||
146641859|NCT01742286|528865180|FG002|Escalation Phase|Administrative problems|0|||
146641860|NCT01742286|528865181|FG003|Escalation Phase|Administrative problems|0|||
146641861|NCT01742286|528865182|FG004|Escalation Phase|Administrative problems|0|||
146641862|NCT01742286|528865183|FG005|Escalation Phase|Administrative problems|0|||
146641863|NCT01742286|528865184|FG006|Escalation Phase|Administrative problems|2|||
146970204|NCT00902486|530050822|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
146970205|NCT00902486|530050823|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
146970206|NCT00902486|530050824|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
146970207|NCT00902486|530050825|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
146970208|NCT00902486|530050826|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
146970209|NCT00902486|530050827|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
146970210|NCT00902486|530050822|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
146970211|NCT00902486|530050823|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
146970212|NCT00902486|530050824|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
146970213|NCT00902486|530050825|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
146970214|NCT00902486|530050826|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
146970215|NCT00902486|530050827|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
146970216|NCT02332655|530050828|FG000|Overall Study|Lack of Efficacy|1|||
146970217|NCT00734617|530052560|FG000|Overall Study|Adverse Event|4|||
146970218|NCT00734617|530052561|FG001|Overall Study|Adverse Event|7|||
146970219|NCT00734617|530052560|FG000|Overall Study|Withdrawal by Subject|103|||
146970220|NCT00734617|530052561|FG001|Overall Study|Withdrawal by Subject|95|||
146970221|NCT00537056|530052565|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
146970222|NCT01257737|530052566|FG000|Overall Study|Lost to Follow-up|1|||
146970223|NCT01257737|530052567|FG001|Overall Study|Lost to Follow-up|2|||
146970224|NCT01257737|530052566|FG000|Overall Study|Liver transplant|1|||
146970225|NCT01257737|530052567|FG001|Overall Study|Liver transplant|0|||
146907854|NCT00882713|529826868|FG000|Overall Study|Blood transfusion|2|||
146562613|NCT03396445|528571716|FG025|Treatment Period|Physician Decision|0|||
146907855|NCT00882713|529826868|FG000|Overall Study|Insufficient therapeutic response|3|||
146907856|NCT00882713|529826868|FG000|Overall Study|Failure to return|2|||
146907857|NCT00882713|529826868|FG000|Overall Study|Other - Reasons|2|||
146907858|NCT00401973|529826871|FG000|Overall Study|Adverse Event|2|||
146907859|NCT00401973|529826872|FG001|Overall Study|Adverse Event|8|||
146907860|NCT00401973|529826873|FG002|Overall Study|Adverse Event|4|||
146907861|NCT00401973|529826871|FG000|Overall Study|Clinical Relapse|0|||
146907862|NCT00401973|529826872|FG001|Overall Study|Clinical Relapse|1|||
146562614|NCT03396445|528571691|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562615|NCT03396445|528571692|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562616|NCT03396445|528571693|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146907863|NCT00401973|529826873|FG002|Overall Study|Clinical Relapse|1|||
146970226|NCT01257737|530052566|FG000|Overall Study|Relocation out of the country|0|||
146970227|NCT01257737|530052567|FG001|Overall Study|Relocation out of the country|1|||
146970228|NCT01257737|530052566|FG000|Overall Study|Withdrew from study|0|||
146907864|NCT00401973|529826871|FG000|Overall Study|Lack of Efficacy|0|||
146907865|NCT00401973|529826872|FG001|Overall Study|Lack of Efficacy|0|||
146562617|NCT03396445|528571694|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562618|NCT03396445|528571695|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562619|NCT03396445|528571696|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562620|NCT03396445|528571697|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562621|NCT03396445|528571698|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562622|NCT03396445|528571699|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562623|NCT03396445|528571700|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562624|NCT03396445|528571701|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562625|NCT03396445|528571702|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562626|NCT03396445|528571703|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
146562627|NCT03396445|528571704|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562628|NCT03396445|528571705|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
146562629|NCT03396445|528571706|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562630|NCT03396445|528571707|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562631|NCT03396445|528571708|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562632|NCT03396445|528571709|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562633|NCT03396445|528571710|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562634|NCT03396445|528571711|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146641864|NCT01742286|528865178|FG000|Escalation Phase|Adverse Event|0|||
146641865|NCT01742286|528865179|FG001|Escalation Phase|Adverse Event|1|||
146641866|NCT01742286|528865180|FG002|Escalation Phase|Adverse Event|2|||
146641867|NCT01742286|528865181|FG003|Escalation Phase|Adverse Event|0|||
146641868|NCT01742286|528865182|FG004|Escalation Phase|Adverse Event|0|||
146641869|NCT01742286|528865183|FG005|Escalation Phase|Adverse Event|1|||
146641870|NCT01742286|528865184|FG006|Escalation Phase|Adverse Event|0|||
146641871|NCT01742286|528865178|FG000|Escalation Phase|Disease progression|3|||
146641872|NCT01742286|528865179|FG001|Escalation Phase|Disease progression|7|||
146641873|NCT01742286|528865180|FG002|Escalation Phase|Disease progression|4|||
146641874|NCT01742286|528865181|FG003|Escalation Phase|Disease progression|1|||
146641875|NCT01742286|528865182|FG004|Escalation Phase|Disease progression|4|||
146641876|NCT01742286|528865183|FG005|Escalation Phase|Disease progression|3|||
146641877|NCT01742286|528865184|FG006|Escalation Phase|Disease progression|2|||
146641878|NCT01742286|528865178|FG000|Escalation Phase|Death|0|||
146641879|NCT01742286|528865179|FG001|Escalation Phase|Death|0|||
146641880|NCT01742286|528865180|FG002|Escalation Phase|Death|0|||
146641881|NCT01742286|528865181|FG003|Escalation Phase|Death|0|||
146641882|NCT01742286|528865182|FG004|Escalation Phase|Death|0|||
146907866|NCT00401973|529826873|FG002|Overall Study|Lack of Efficacy|3|||
146907867|NCT00401973|529826871|FG000|Overall Study|Lost to Follow-up|2|||
146907868|NCT00401973|529826872|FG001|Overall Study|Lost to Follow-up|2|||
146907869|NCT00401973|529826873|FG002|Overall Study|Lost to Follow-up|2|||
146907870|NCT00401973|529826871|FG000|Overall Study|Physician Decision|2|||
146907871|NCT00401973|529826872|FG001|Overall Study|Physician Decision|0|||
146907872|NCT00401973|529826873|FG002|Overall Study|Physician Decision|1|||
146907873|NCT00401973|529826871|FG000|Overall Study|Protocol Violation|1|||
146907874|NCT00401973|529826872|FG001|Overall Study|Protocol Violation|2|||
146907875|NCT00401973|529826873|FG002|Overall Study|Protocol Violation|3|||
146907876|NCT00401973|529826871|FG000|Overall Study|Sponsor Decision|0|||
146907877|NCT00401973|529826872|FG001|Overall Study|Sponsor Decision|1|||
146907878|NCT00401973|529826873|FG002|Overall Study|Sponsor Decision|0|||
146907879|NCT00401973|529826871|FG000|Overall Study|Withdrawal by Subject|4|||
146907880|NCT00401973|529826872|FG001|Overall Study|Withdrawal by Subject|12|||
146907881|NCT00401973|529826873|FG002|Overall Study|Withdrawal by Subject|9|||
146907882|NCT01408537|529826874|FG000|Overall Study|Withdrawal by Subject|2|||
146907883|NCT01408537|529826874|FG000|Overall Study|Protocol Violation|3|||
146907884|NCT01408537|529826874|FG000|Overall Study|Lost to Follow-up|3|||
146907885|NCT05523362|529826877|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
146907886|NCT05523362|529826877|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
146907887|NCT05523362|529826877|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
146907888|NCT05523362|529826877|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
146907889|NCT05299892|529826882|FG000|Overall Study|Withdrawal by Subject|2|||
146907890|NCT00149214|529826887|FG000|Overall Study|Adverse Event|12|||
146907891|NCT00149214|529826888|FG001|Overall Study|Adverse Event|9|||
146907892|NCT00149214|529826887|FG000|Overall Study|Withdrawal by Subject|4|||
146907893|NCT00149214|529826888|FG001|Overall Study|Withdrawal by Subject|1|||
146907894|NCT00149214|529826887|FG000|Overall Study|Physician Decision|3|||
146907895|NCT00149214|529826888|FG001|Overall Study|Physician Decision|3|||
146907896|NCT00149214|529826887|FG000|Overall Study|Sponsor Decision|0|||
146907897|NCT00149214|529826888|FG001|Overall Study|Sponsor Decision|1|||
146907898|NCT00149214|529826887|FG000|Overall Study|Progressive Disease|7|||
146907899|NCT00149214|529826888|FG001|Overall Study|Progressive Disease|3|||
146907900|NCT00756002|529826889|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
146907901|NCT00756002|529826890|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
146907902|NCT00756002|529826889|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146907903|NCT00756002|529826890|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
146907904|NCT00756002|529826889|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
146907905|NCT00756002|529826890|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
146641883|NCT01742286|528865183|FG005|Escalation Phase|Death|1|||
146641884|NCT01742286|528865184|FG006|Escalation Phase|Death|0|||
146641885|NCT01742286|528865178|FG000|Escalation Phase|Physician Decision|0|||
146641886|NCT01742286|528865179|FG001|Escalation Phase|Physician Decision|3|||
146641887|NCT01742286|528865180|FG002|Escalation Phase|Physician Decision|0|||
146641888|NCT01742286|528865181|FG003|Escalation Phase|Physician Decision|1|||
146641889|NCT01742286|528865182|FG004|Escalation Phase|Physician Decision|0|||
146641890|NCT01742286|528865183|FG005|Escalation Phase|Physician Decision|0|||
146641891|NCT01742286|528865184|FG006|Escalation Phase|Physician Decision|2|||
146641892|NCT01742286|528865178|FG000|Escalation Phase|Subject/guardian decision|1|||
146641893|NCT01742286|528865179|FG001|Escalation Phase|Subject/guardian decision|0|||
146641894|NCT01742286|528865180|FG002|Escalation Phase|Subject/guardian decision|0|||
146641895|NCT01742286|528865181|FG003|Escalation Phase|Subject/guardian decision|0|||
146641896|NCT01742286|528865182|FG004|Escalation Phase|Subject/guardian decision|0|||
146641897|NCT01742286|528865183|FG005|Escalation Phase|Subject/guardian decision|0|||
146641898|NCT01742286|528865184|FG006|Escalation Phase|Subject/guardian decision|0|||
146641899|NCT01742286|528865178|FG000|Expansion Phase|Administrative problems|0|||
146641900|NCT01742286|528865179|FG001|Expansion Phase|Administrative problems|0|||
146641901|NCT01742286|528865180|FG002|Expansion Phase|Administrative problems|0|||
146641902|NCT01742286|528865181|FG003|Expansion Phase|Administrative problems|0|||
146641903|NCT01742286|528865182|FG004|Expansion Phase|Administrative problems|0|||
146641904|NCT01742286|528865183|FG005|Expansion Phase|Administrative problems|0|||
146641905|NCT01742286|528865184|FG006|Expansion Phase|Administrative problems|5|||
146641906|NCT01742286|528865178|FG000|Expansion Phase|Physician Decision|0|||
146641907|NCT01742286|528865179|FG001|Expansion Phase|Physician Decision|0|||
146641908|NCT01742286|528865180|FG002|Expansion Phase|Physician Decision|4|||
146641909|NCT01742286|528865181|FG003|Expansion Phase|Physician Decision|0|||
146641910|NCT01742286|528865182|FG004|Expansion Phase|Physician Decision|0|||
146641911|NCT01742286|528865183|FG005|Expansion Phase|Physician Decision|0|||
146641912|NCT01742286|528865184|FG006|Expansion Phase|Physician Decision|9|||
146641913|NCT01742286|528865178|FG000|Expansion Phase|Adverse Event|0|||
146641914|NCT01742286|528865179|FG001|Expansion Phase|Adverse Event|0|||
146641915|NCT01742286|528865180|FG002|Expansion Phase|Adverse Event|0|||
146641916|NCT01742286|528865181|FG003|Expansion Phase|Adverse Event|0|||
146641917|NCT01742286|528865182|FG004|Expansion Phase|Adverse Event|0|||
146641918|NCT01742286|528865183|FG005|Expansion Phase|Adverse Event|0|||
146641919|NCT01742286|528865184|FG006|Expansion Phase|Adverse Event|6|||
146641920|NCT01742286|528865178|FG000|Expansion Phase|Disease progression|0|||
146641921|NCT01742286|528865179|FG001|Expansion Phase|Disease progression|0|||
146641922|NCT01742286|528865180|FG002|Expansion Phase|Disease progression|3|||
146641923|NCT01742286|528865181|FG003|Expansion Phase|Disease progression|0|||
146641924|NCT01742286|528865182|FG004|Expansion Phase|Disease progression|0|||
146641925|NCT01742286|528865183|FG005|Expansion Phase|Disease progression|0|||
146641926|NCT01742286|528865184|FG006|Expansion Phase|Disease progression|15|||
146641927|NCT01742286|528865178|FG000|Expansion Phase|Withdrawal by Subject|0|||
146641928|NCT01742286|528865179|FG001|Expansion Phase|Withdrawal by Subject|0|||
146641929|NCT01742286|528865180|FG002|Expansion Phase|Withdrawal by Subject|0|||
146641930|NCT01742286|528865181|FG003|Expansion Phase|Withdrawal by Subject|0|||
146641931|NCT01742286|528865182|FG004|Expansion Phase|Withdrawal by Subject|0|||
146641932|NCT01742286|528865183|FG005|Expansion Phase|Withdrawal by Subject|0|||
146641933|NCT01742286|528865184|FG006|Expansion Phase|Withdrawal by Subject|1|||
146641934|NCT04530136|528865185|FG000|Overall Study|Lost to Follow-up|2|||
146641935|NCT04530136|528865186|FG001|Overall Study|Lost to Follow-up|3|||
146641936|NCT04530136|528865185|FG000|Overall Study|Withdrawal by Subject|1|||
146641937|NCT04530136|528865186|FG001|Overall Study|Withdrawal by Subject|0|||
146641938|NCT04530136|528865185|FG000|Overall Study|Death|0|||
146641939|NCT04530136|528865186|FG001|Overall Study|Death|1|||
146641940|NCT01387542|528865187|FG000|Overall Study|Adverse Event|3|||
146641941|NCT01387542|528865187|FG000|Overall Study|Withdrawal by Subject|1|||
146641942|NCT01387542|528865187|FG000|Overall Study|Changed diagnosis|1|||
146641943|NCT01387542|528865187|FG000|Overall Study|Insufficient response|1|||
146641944|NCT01387542|528865187|FG000|Overall Study|Non-compliant|1|||
146641945|NCT01387542|528865187|FG000|Overall Study|Lost to Follow-up|1|||
146641946|NCT01233232|528865188|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
146641947|NCT01233232|528865189|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
146641948|NCT01233232|528865190|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
146641949|NCT02633020|528865196|FG000|Overall Study|Adverse Event|1|||
146641950|NCT02633020|528865197|FG001|Overall Study|Adverse Event|0|||
146641951|NCT00934440|528865198|FG000|Overall Study|Lost to Follow-up|1|||
146641952|NCT02152956|528865199|FG000|Overall Study|Adverse Event|0|||
146641953|NCT02152956|528865200|FG001|Overall Study|Adverse Event|0|||
146641954|NCT02152956|528865201|FG002|Overall Study|Adverse Event|0|||
146641955|NCT02152956|528865202|FG003|Overall Study|Adverse Event|0|||
146641956|NCT02152956|528865203|FG004|Overall Study|Adverse Event|0|||
146641957|NCT02152956|528865204|FG005|Overall Study|Adverse Event|0|||
146641958|NCT02152956|528865205|FG006|Overall Study|Adverse Event|0|||
146641959|NCT02152956|528865206|FG007|Overall Study|Adverse Event|0|||
146641960|NCT02152956|528865207|FG008|Overall Study|Adverse Event|0|||
146641961|NCT02152956|528865208|FG009|Overall Study|Adverse Event|0|||
146970229|NCT01257737|530052567|FG001|Overall Study|Withdrew from study|1|||
146970230|NCT03020966|530052570|FG000|Overall Study|Withdrawal by Subject|2|||
146970231|NCT03020966|530052571|FG001|Overall Study|Withdrawal by Subject|0|||
146970232|NCT00962013|530052577|FG000|Overall Study|Did not have surgery|1|||
146970233|NCT00962013|530052577|FG000|Overall Study|Death|8|||
146970234|NCT00962013|530052577|FG000|Overall Study|Lost to Follow-up|12|||
146970235|NCT00962013|530052577|FG000|Overall Study|Unable/Unwilling to return|6|||
146970236|NCT00962013|530052577|FG000|Overall Study|Withdrawal by Subject|8|||
146970237|NCT00962013|530052577|FG000|Overall Study|Removal of study device|3|||
146970238|NCT00962013|530052577|FG000|Overall Study|Site Termination|24|||
146970239|NCT00962013|530052577|FG000|Overall Study|No 5 year evaluation|6|||
146970240|NCT00445458|530052584|FG000|Overall Study|Disease Progression|3|||
146562635|NCT03396445|528571712|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146768127|NCT01317420|529319492|FG002|Overall Study|Refused to cont. taking trial medication|0|||
146768128|NCT01317420|529319493|FG003|Overall Study|Refused to cont. taking trial medication|0|||
146768129|NCT01317420|529319494|FG004|Overall Study|Refused to cont. taking trial medication|0|||
146970241|NCT00445458|530052585|FG001|Overall Study|Disease Progression|4|||
146970242|NCT00445458|530052586|FG002|Overall Study|Disease Progression|54|||
146562636|NCT03396445|528571713|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562637|NCT03396445|528571714|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146907906|NCT00756002|529826889|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
146907907|NCT00756002|529826890|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
146907908|NCT00756002|529826889|FG000|Double-Blind Treatment Period|Other|2|||
146907909|NCT00756002|529826890|FG001|Double-Blind Treatment Period|Other|2|||
146907910|NCT04329923|529826894|FG000|Overall Study|Withdrawal by Subject|1|||
146907911|NCT04329923|529826895|FG001|Overall Study|Withdrawal by Subject|4|||
146907912|NCT04329923|529826896|FG002|Overall Study|Withdrawal by Subject|1|||
146907913|NCT04329923|529826897|FG003|Overall Study|Withdrawal by Subject|1|||
146907914|NCT04329923|529826898|FG004|Overall Study|Withdrawal by Subject|1|||
146907915|NCT04329923|529826899|FG005|Overall Study|Withdrawal by Subject|1|||
146907916|NCT04329923|529826894|FG000|Overall Study|early termination of study|0|||
146907917|NCT04329923|529826895|FG001|Overall Study|early termination of study|0|||
146907918|NCT04329923|529826896|FG002|Overall Study|early termination of study|0|||
146907919|NCT04329923|529826897|FG003|Overall Study|early termination of study|0|||
146907920|NCT04329923|529826898|FG004|Overall Study|early termination of study|1|||
146907921|NCT04329923|529826899|FG005|Overall Study|early termination of study|2|||
146907922|NCT04329923|529826894|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
146768130|NCT01317420|529319495|FG005|Overall Study|Refused to cont. taking trial medication|0|||
146768131|NCT01317420|529319496|FG006|Overall Study|Refused to cont. taking trial medication|0|||
146768132|NCT01317420|529319497|FG007|Overall Study|Refused to cont. taking trial medication|0|||
146907923|NCT04329923|529826895|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
146907924|NCT04329923|529826896|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
146907925|NCT04329923|529826897|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
146907926|NCT04329923|529826898|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
146768133|NCT01317420|529319498|FG008|Overall Study|Refused to cont. taking trial medication|0|||
146907927|NCT04329923|529826899|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
146970243|NCT00445458|530052587|FG003|Overall Study|Disease Progression|27|||
146907928|NCT01844076|529826911|FG000|Overall Study|Adverse Event|1|||
146907929|NCT01844076|529826912|FG001|Overall Study|Adverse Event|0|||
146907930|NCT01844076|529826913|FG002|Overall Study|Adverse Event|0|||
146907931|NCT01844076|529826914|FG003|Overall Study|Adverse Event|0|||
146907932|NCT01844076|529826911|FG000|Overall Study|Withdrawal by Subject|1|||
146907933|NCT01844076|529826912|FG001|Overall Study|Withdrawal by Subject|0|||
146907934|NCT01844076|529826913|FG002|Overall Study|Withdrawal by Subject|0|||
146907935|NCT01844076|529826914|FG003|Overall Study|Withdrawal by Subject|0|||
146907936|NCT01925703|529826923|FG000|Overall Study|Physician Decision|1|||
146907937|NCT01925703|529826923|FG000|Overall Study|Lost to Follow-up|2|||
146907938|NCT01925703|529826923|FG000|Overall Study|Discharge prior to full iron repletion|1|||
146907939|NCT05309083|529826924|FG000|Overall Study|Withdrawal by Subject|2|||
146907940|NCT00474253|529826925|FG000|Overall Study|Withdrew consent|2|||
146907941|NCT00474253|529826926|FG001|Overall Study|Withdrew consent|0|||
146970244|NCT00445458|530052584|FG000|Overall Study|Withdrawal by Subject|0|||
146970245|NCT00445458|530052585|FG001|Overall Study|Withdrawal by Subject|0|||
146970246|NCT00445458|530052586|FG002|Overall Study|Withdrawal by Subject|7|||
146970247|NCT00445458|530052587|FG003|Overall Study|Withdrawal by Subject|0|||
146970248|NCT00445458|530052584|FG000|Overall Study|Adverse Event|0|||
146970249|NCT00445458|530052585|FG001|Overall Study|Adverse Event|0|||
146768134|NCT01317420|529319499|FG009|Overall Study|Refused to cont. taking trial medication|0|||
146970250|NCT00445458|530052586|FG002|Overall Study|Adverse Event|3|||
146970251|NCT00445458|530052587|FG003|Overall Study|Adverse Event|0|||
146970252|NCT00445458|530052584|FG000|Overall Study|Death|0|||
146970253|NCT00445458|530052585|FG001|Overall Study|Death|1|||
146970254|NCT00445458|530052586|FG002|Overall Study|Death|2|||
146970255|NCT00445458|530052587|FG003|Overall Study|Death|0|||
146970256|NCT00445458|530052584|FG000|Overall Study|Physician Decision|0|||
146970257|NCT00445458|530052585|FG001|Overall Study|Physician Decision|0|||
146970258|NCT00445458|530052586|FG002|Overall Study|Physician Decision|1|||
146970259|NCT00445458|530052587|FG003|Overall Study|Physician Decision|1|||
146970260|NCT00445458|530052584|FG000|Overall Study|Surgery|0|||
146970261|NCT00445458|530052585|FG001|Overall Study|Surgery|0|||
146970262|NCT00445458|530052586|FG002|Overall Study|Surgery|1|||
146970263|NCT00445458|530052587|FG003|Overall Study|Surgery|0|||
146970264|NCT03972709|530052590|FG000|Overall Study|Withdrawal by Subject|18|||
146768135|NCT01317420|529319500|FG010|Overall Study|Refused to cont. taking trial medication|0|||
146907942|NCT00474253|529826925|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
146907943|NCT00474253|529826926|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
146907944|NCT00474253|529826925|FG000|Overall Study|Lost to Follow-up|1|||
146907945|NCT00474253|529826926|FG001|Overall Study|Lost to Follow-up|0|||
146907946|NCT00474253|529826925|FG000|Overall Study|Discharged prior to study completion|0|||
146907947|NCT00474253|529826926|FG001|Overall Study|Discharged prior to study completion|1|||
146907948|NCT03133481|529826927|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
146907949|NCT03133481|529826928|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
146907950|NCT01184989|529826933|FG000|Overall Study|Adverse Event|11|||
146907951|NCT01184989|529826933|FG000|Overall Study|Withdrawal by Subject|1|||
146907952|NCT01570491|529826934|FG000|Overall Study|Lost to Follow-up|3|||
146970265|NCT03972709|530052591|FG001|Overall Study|Withdrawal by Subject|7|||
146970266|NCT03972709|530052592|FG002|Overall Study|Withdrawal by Subject|14|||
146970267|NCT03972709|530052590|FG000|Overall Study|Study Terminated by Sponsor|48|||
146970268|NCT03972709|530052591|FG001|Overall Study|Study Terminated by Sponsor|25|||
146562638|NCT03396445|528571715|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562639|NCT03396445|528571716|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146562640|NCT03396445|528571691|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
146562641|NCT03396445|528571692|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
146562642|NCT03396445|528571693|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
146768136|NCT01317420|529319501|FG011|Overall Study|Refused to cont. taking trial medication|0|||
146907953|NCT01570491|529826935|FG001|Overall Study|Lost to Follow-up|1|||
146768137|NCT01317420|529319502|FG012|Overall Study|Refused to cont. taking trial medication|1|||
146768138|NCT01317420|529319490|FG000|Overall Study|Reason other than those specified|0|||
146768139|NCT01317420|529319491|FG001|Overall Study|Reason other than those specified|0|||
146768140|NCT01317420|529319492|FG002|Overall Study|Reason other than those specified|0|||
146768141|NCT01317420|529319493|FG003|Overall Study|Reason other than those specified|0|||
146768142|NCT01317420|529319494|FG004|Overall Study|Reason other than those specified|0|||
146768143|NCT01317420|529319495|FG005|Overall Study|Reason other than those specified|0|||
146768144|NCT01317420|529319496|FG006|Overall Study|Reason other than those specified|0|||
146768145|NCT01317420|529319497|FG007|Overall Study|Reason other than those specified|0|||
146768146|NCT01317420|529319498|FG008|Overall Study|Reason other than those specified|0|||
146768147|NCT01317420|529319499|FG009|Overall Study|Reason other than those specified|1|||
146768148|NCT01317420|529319500|FG010|Overall Study|Reason other than those specified|0|||
146768149|NCT01317420|529319501|FG011|Overall Study|Reason other than those specified|0|||
146768150|NCT01317420|529319502|FG012|Overall Study|Reason other than those specified|0|||
146768151|NCT05686421|529319503|FG000|Overall Study|Screen failure|22|||
146907954|NCT01570491|529826934|FG000|Overall Study|treatment: not given or discontinued|2|||
146907955|NCT01570491|529826935|FG001|Overall Study|treatment: not given or discontinued|0|||
146907956|NCT01254344|529826939|FG000|Overall Study|Adverse Event|2|||
146907957|NCT01254344|529826940|FG001|Overall Study|Adverse Event|5|||
146907958|NCT01254344|529826939|FG000|Overall Study|Physician Decision|7|||
146907959|NCT01254344|529826940|FG001|Overall Study|Physician Decision|4|||
146907960|NCT01254344|529826939|FG000|Overall Study|Protocol Violation|1|||
146907961|NCT01254344|529826940|FG001|Overall Study|Protocol Violation|4|||
146907962|NCT01254344|529826939|FG000|Overall Study|Withdrawal by Subject|3|||
146907963|NCT01254344|529826940|FG001|Overall Study|Withdrawal by Subject|6|||
146907964|NCT03249350|529826941|FG000|Overall Study|Participant did not initiate treatment|5|||
146907965|NCT03249350|529826942|FG001|Overall Study|Participant did not initiate treatment|8|||
146907966|NCT01591330|529826943|FG000|Period 1|Adverse Event|1|||
146907967|NCT01591330|529826944|FG001|Period 1|Adverse Event|0|||
146907968|NCT01591330|529826945|FG002|Period 1|Adverse Event|0|||
146907969|NCT01591330|529826946|FG003|Period 1|Adverse Event|0|||
146907970|NCT01591330|529826943|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
146907971|NCT01591330|529826944|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
146907972|NCT01591330|529826945|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
146907973|NCT01591330|529826946|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
146907974|NCT01591330|529826943|FG000|Period 2|Adverse Event|1|||
146907975|NCT01591330|529826944|FG001|Period 2|Adverse Event|0|||
146907976|NCT01591330|529826945|FG002|Period 2|Adverse Event|0|||
146907977|NCT01591330|529826946|FG003|Period 2|Adverse Event|0|||
146907978|NCT01450137|529826947|FG000|Up to Week 12|Adverse Event|2|||
146907979|NCT01450137|529826948|FG001|Up to Week 12|Adverse Event|1|||
146907980|NCT01450137|529826947|FG000|Up to Week 12|Withdrawal by Subject|0|||
146907981|NCT01450137|529826948|FG001|Up to Week 12|Withdrawal by Subject|2|||
146907982|NCT01450137|529826947|FG000|Week 12 to Study End|Death|0|||
146907983|NCT01450137|529826948|FG001|Week 12 to Study End|Death|1|||
146907984|NCT01450137|529826947|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
146907985|NCT01450137|529826948|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
146907986|NCT01769404|529826949|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
146768152|NCT05686421|529319504|FG001|Overall Study|Screen failure|0|||
146768153|NCT05686421|529319505|FG002|Overall Study|Screen failure|0|||
146768154|NCT05686421|529319506|FG003|Overall Study|Screen failure|0|||
146768156|NCT00857649|529319508|FG000|Overall Study|Adverse Event|15|||
146907987|NCT01769404|529826950|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
146907988|NCT01769404|529826949|FG000|Treatment Period 1|Withdrawal by Subject|3|||
146907989|NCT01769404|529826950|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146907990|NCT01769404|529826949|FG000|Treatment Period 1|Sponsor decision|1|||
146907991|NCT01769404|529826950|FG001|Treatment Period 1|Sponsor decision|0|||
146907992|NCT01769404|529826949|FG000|Treatment Period 2|Sponsor decision|7|||
146907993|NCT01769404|529826950|FG001|Treatment Period 2|Sponsor decision|0|||
146907994|NCT00538733|529826951|FG000|Overall Study|Adverse Event|8|||
146907995|NCT00538733|529826951|FG000|Overall Study|Death|1|||
146907996|NCT00538733|529826951|FG000|Overall Study|declined to participate|2|||
146907997|NCT00538733|529826951|FG000|Overall Study|still on therapy|1|||
146907998|NCT02413255|529829337|FG000|Overall Study|Voluntary Withdrawal|0|||
146907999|NCT02413255|529829338|FG001|Overall Study|Voluntary Withdrawal|0|||
146908000|NCT02413255|529829339|FG002|Overall Study|Voluntary Withdrawal|0|||
146908001|NCT02413255|529829340|FG003|Overall Study|Voluntary Withdrawal|0|||
146908002|NCT02413255|529829341|FG004|Overall Study|Voluntary Withdrawal|0|||
146908003|NCT02413255|529829342|FG005|Overall Study|Voluntary Withdrawal|0|||
146908004|NCT02413255|529829343|FG006|Overall Study|Voluntary Withdrawal|0|||
146908005|NCT02413255|529829344|FG007|Overall Study|Voluntary Withdrawal|0|||
146908006|NCT02413255|529829345|FG008|Overall Study|Voluntary Withdrawal|0|||
146908007|NCT02413255|529829346|FG009|Overall Study|Voluntary Withdrawal|0|||
146908008|NCT02413255|529829347|FG010|Overall Study|Voluntary Withdrawal|0|||
146908009|NCT02413255|529829348|FG011|Overall Study|Voluntary Withdrawal|0|||
146908010|NCT02413255|529829349|FG012|Overall Study|Voluntary Withdrawal|0|||
146908011|NCT02413255|529829350|FG013|Overall Study|Voluntary Withdrawal|0|||
146908012|NCT02413255|529829351|FG014|Overall Study|Voluntary Withdrawal|1|||
146908013|NCT02413255|529829352|FG015|Overall Study|Voluntary Withdrawal|0|||
146908014|NCT02413255|529829353|FG016|Overall Study|Voluntary Withdrawal|0|||
146908015|NCT02413398|529829354|FG000|Overall Study|Lost to Follow-up|2|||
146908016|NCT02413398|529829355|FG001|Overall Study|Lost to Follow-up|4|||
146908017|NCT02413398|529829354|FG000|Overall Study|Withdrawal by Subject|1|||
146908018|NCT02413398|529829355|FG001|Overall Study|Withdrawal by Subject|1|||
146908019|NCT02413398|529829354|FG000|Overall Study|Other Eligibility criteria|1|||
146908020|NCT02413398|529829355|FG001|Overall Study|Other Eligibility criteria|2|||
146908021|NCT01494038|529829356|FG000|Overall Study|Protocol Violation|1|||
146908022|NCT01494038|529829357|FG001|Overall Study|Protocol Violation|1|||
146908023|NCT01494038|529829356|FG000|Overall Study|Lost to Follow-up|18|||
146908024|NCT01494038|529829357|FG001|Overall Study|Lost to Follow-up|20|||
146908025|NCT01494038|529829356|FG000|Overall Study|Withdrawal by Subject|44|||
146908026|NCT01494038|529829357|FG001|Overall Study|Withdrawal by Subject|34|||
146908027|NCT01494038|529829356|FG000|Overall Study|Not able to get to clinic|21|||
146908028|NCT01494038|529829357|FG001|Overall Study|Not able to get to clinic|15|||
146908029|NCT01494038|529829356|FG000|Overall Study|Not willing to adhere to reqs|2|||
146908030|NCT01494038|529829357|FG001|Overall Study|Not willing to adhere to reqs|9|||
146908031|NCT01494038|529829356|FG000|Overall Study|Death|2|||
146908032|NCT01494038|529829357|FG001|Overall Study|Death|4|||
146908033|NCT00685178|529829364|FG000|Overall Study|Adverse Event|1|||
146908034|NCT00685178|529829365|FG001|Overall Study|Adverse Event|5|||
146908035|NCT00685178|529829366|FG002|Overall Study|Adverse Event|2|||
146908036|NCT00685178|529829367|FG003|Overall Study|Adverse Event|4|||
146908037|NCT00685178|529829364|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
146908038|NCT00685178|529829365|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
146908039|NCT00685178|529829366|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
146908040|NCT00685178|529829367|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
146908041|NCT00685178|529829364|FG000|Overall Study|voluntary study discharge|4|||
146908042|NCT00685178|529829365|FG001|Overall Study|voluntary study discharge|5|||
146908043|NCT00685178|529829366|FG002|Overall Study|voluntary study discharge|1|||
146970269|NCT03972709|530052592|FG002|Overall Study|Study Terminated by Sponsor|50|||
146970270|NCT03972709|530052590|FG000|Overall Study|Physician Decision|1|||
146970271|NCT03972709|530052591|FG001|Overall Study|Physician Decision|0|||
146970272|NCT03972709|530052592|FG002|Overall Study|Physician Decision|0|||
146970273|NCT03972709|530052590|FG000|Overall Study|COVID-19|0|||
146970274|NCT03972709|530052591|FG001|Overall Study|COVID-19|1|||
146970275|NCT03972709|530052592|FG002|Overall Study|COVID-19|1|||
146908044|NCT00685178|529829367|FG003|Overall Study|voluntary study discharge|1|||
146908045|NCT00685178|529829364|FG000|Overall Study|incarcerated|1|||
146908046|NCT00685178|529829365|FG001|Overall Study|incarcerated|3|||
146908047|NCT00685178|529829366|FG002|Overall Study|incarcerated|7|||
146908048|NCT00685178|529829367|FG003|Overall Study|incarcerated|0|||
146908049|NCT00685178|529829364|FG000|Overall Study|administrative (disciplinary) discharge|0|||
146908050|NCT00685178|529829365|FG001|Overall Study|administrative (disciplinary) discharge|1|||
146908051|NCT00685178|529829366|FG002|Overall Study|administrative (disciplinary) discharge|0|||
146908052|NCT00685178|529829367|FG003|Overall Study|administrative (disciplinary) discharge|2|||
146908053|NCT00685178|529829364|FG000|Overall Study|Pregnancy|0|||
146908054|NCT00685178|529829365|FG001|Overall Study|Pregnancy|0|||
146970276|NCT03972709|530052590|FG000|Overall Study|Lost to Follow-up|6|||
146908055|NCT00685178|529829366|FG002|Overall Study|Pregnancy|0|||
146908056|NCT00685178|529829367|FG003|Overall Study|Pregnancy|1|||
146908057|NCT01334125|529829368|FG000|Overall Study|Lost to Follow-up|3|||
146908058|NCT01334125|529829369|FG001|Overall Study|Lost to Follow-up|3|||
146970277|NCT03972709|530052591|FG001|Overall Study|Lost to Follow-up|1|||
146562643|NCT03396445|528571694|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
146562644|NCT03396445|528571695|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
146562645|NCT03396445|528571696|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562646|NCT03396445|528571697|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
146562647|NCT03396445|528571698|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562648|NCT03396445|528571699|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562649|NCT03396445|528571700|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146768157|NCT00857649|529319509|FG001|Overall Study|Adverse Event|10|||
146562650|NCT03396445|528571701|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562651|NCT03396445|528571702|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562652|NCT03396445|528571703|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562653|NCT03396445|528571704|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562654|NCT03396445|528571705|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562655|NCT03396445|528571706|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562656|NCT03396445|528571707|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562657|NCT03396445|528571708|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562658|NCT03396445|528571709|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562659|NCT03396445|528571710|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562660|NCT03396445|528571711|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562661|NCT03396445|528571712|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562662|NCT03396445|528571713|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562663|NCT03396445|528571714|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562664|NCT03396445|528571715|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562665|NCT03396445|528571716|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
146562666|NCT03396445|528571691|FG000|Treatment Period|Withdrawal by Subject|0|||
146562667|NCT03396445|528571692|FG001|Treatment Period|Withdrawal by Subject|0|||
146562668|NCT03396445|528571693|FG002|Treatment Period|Withdrawal by Subject|0|||
146562669|NCT03396445|528571694|FG003|Treatment Period|Withdrawal by Subject|0|||
146562670|NCT03396445|528571695|FG004|Treatment Period|Withdrawal by Subject|0|||
146562671|NCT03396445|528571696|FG005|Treatment Period|Withdrawal by Subject|0|||
146908059|NCT02138110|529829373|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
146908060|NCT02138110|529829373|FG000|Overall Scaffold Implantation|Death|3|||
146908061|NCT04075604|529829377|FG000|Overall Study|Adverse Event|0|||
146562672|NCT03396445|528571697|FG006|Treatment Period|Withdrawal by Subject|0|||
146562673|NCT03396445|528571698|FG007|Treatment Period|Withdrawal by Subject|0|||
146562674|NCT03396445|528571699|FG008|Treatment Period|Withdrawal by Subject|0|||
146562675|NCT03396445|528571700|FG009|Treatment Period|Withdrawal by Subject|0|||
146908062|NCT04075604|529829378|FG001|Overall Study|Adverse Event|0|||
146768158|NCT00857649|529319508|FG000|Overall Study|Non-compliance|1|||
146768159|NCT00857649|529319509|FG001|Overall Study|Non-compliance|1|||
146768160|NCT00857649|529319508|FG000|Overall Study|Protocol Violation|2|||
146768161|NCT00857649|529319509|FG001|Overall Study|Protocol Violation|2|||
146768162|NCT00857649|529319508|FG000|Overall Study|Withdrawal of Consent|10|||
146768163|NCT00857649|529319509|FG001|Overall Study|Withdrawal of Consent|7|||
146768164|NCT00857649|529319508|FG000|Overall Study|Nursing Home Placement|2|||
146768165|NCT00857649|529319509|FG001|Overall Study|Nursing Home Placement|9|||
146768166|NCT00857649|529319508|FG000|Overall Study|Other Reasons|1|||
146768167|NCT00857649|529319509|FG001|Overall Study|Other Reasons|3|||
146768168|NCT05190419|529319510|FG000|Overall Study|Lack of Efficacy|8|||
146768169|NCT05190419|529319511|FG001|Overall Study|Lack of Efficacy|0|||
146768170|NCT05190419|529319512|FG002|Overall Study|Lack of Efficacy|1|||
146768171|NCT05190419|529319513|FG003|Overall Study|Lack of Efficacy|0|||
146768172|NCT05190419|529319510|FG000|Overall Study|Withdrawal by Subject|7|||
146768173|NCT05190419|529319511|FG001|Overall Study|Withdrawal by Subject|1|||
146768174|NCT05190419|529319512|FG002|Overall Study|Withdrawal by Subject|2|||
146768175|NCT05190419|529319513|FG003|Overall Study|Withdrawal by Subject|2|||
146768176|NCT05190419|529319510|FG000|Overall Study|Adverse Event|2|||
146768177|NCT05190419|529319511|FG001|Overall Study|Adverse Event|10|||
146768178|NCT05190419|529319512|FG002|Overall Study|Adverse Event|11|||
146768179|NCT05190419|529319513|FG003|Overall Study|Adverse Event|21|||
146768180|NCT05190419|529319510|FG000|Overall Study|Lost to Follow-up|1|||
146768181|NCT05190419|529319511|FG001|Overall Study|Lost to Follow-up|2|||
146768182|NCT05190419|529319512|FG002|Overall Study|Lost to Follow-up|3|||
146768183|NCT05190419|529319513|FG003|Overall Study|Lost to Follow-up|1|||
146768184|NCT05190419|529319510|FG000|Overall Study|Other|1|||
146768185|NCT05190419|529319511|FG001|Overall Study|Other|1|||
146768186|NCT05190419|529319512|FG002|Overall Study|Other|0|||
146768187|NCT05190419|529319513|FG003|Overall Study|Other|3|||
146768188|NCT00367055|529319516|FG000|Overall Study|Adverse Event|6|||
146768189|NCT00367055|529319517|FG001|Overall Study|Adverse Event|3|||
146768190|NCT00367055|529319516|FG000|Overall Study|Patient's Willing|3|||
146768191|NCT00367055|529319517|FG001|Overall Study|Patient's Willing|2|||
146768192|NCT00367055|529319516|FG000|Overall Study|Lack of Efficacy|1|||
146768193|NCT00367055|529319517|FG001|Overall Study|Lack of Efficacy|2|||
146768194|NCT00367055|529319516|FG000|Overall Study|Lost to Follow-up|1|||
146768195|NCT00367055|529319517|FG001|Overall Study|Lost to Follow-up|1|||
146768196|NCT00367055|529319516|FG000|Overall Study|Protocol Violation|0|||
146768197|NCT00367055|529319517|FG001|Overall Study|Protocol Violation|1|||
146768198|NCT00367055|529319516|FG000|Overall Study|Stopping Criterion Met|0|||
146768199|NCT00367055|529319517|FG001|Overall Study|Stopping Criterion Met|1|||
146768200|NCT00367055|529319516|FG000|Overall Study|Participant Living too Far from Hospital|0|||
146768201|NCT00367055|529319517|FG001|Overall Study|Participant Living too Far from Hospital|1|||
146768202|NCT03210402|529319518|FG000|Overall Study|Withdrawal by Subject|0|||
146768203|NCT03210402|529319519|FG001|Overall Study|Withdrawal by Subject|1|||
146768204|NCT02517307|529319534|FG000|Overall Study|Withdrawal by Subject|1|||
146768205|NCT02517307|529319535|FG001|Overall Study|Withdrawal by Subject|0|||
146768206|NCT02517307|529319536|FG002|Overall Study|Withdrawal by Subject|1|||
146768207|NCT02517307|529319537|FG003|Overall Study|Withdrawal by Subject|0|||
146768208|NCT02517307|529319534|FG000|Overall Study|Protocol Violation|0|||
146768209|NCT02517307|529319535|FG001|Overall Study|Protocol Violation|0|||
146768210|NCT02517307|529319536|FG002|Overall Study|Protocol Violation|1|||
146768211|NCT02517307|529319537|FG003|Overall Study|Protocol Violation|1|||
146768212|NCT03586544|529319538|FG000|First Intervention|Adverse Event|0|||
146768213|NCT03586544|529319539|FG001|First Intervention|Adverse Event|1|||
146768214|NCT03586544|529319538|FG000|Second Intervention|Withdrawal by Subject|0|||
146908063|NCT04075604|529829379|FG002|Overall Study|Adverse Event|3|||
146908064|NCT04075604|529829377|FG000|Overall Study|Participant request to discontinue study treatment|0|||
146908065|NCT04075604|529829378|FG001|Overall Study|Participant request to discontinue study treatment|0|||
146908066|NCT04075604|529829379|FG002|Overall Study|Participant request to discontinue study treatment|1|||
146908067|NCT04075604|529829377|FG000|Overall Study|Participant withdrew consent|0|||
146908068|NCT04075604|529829378|FG001|Overall Study|Participant withdrew consent|0|||
146908069|NCT04075604|529829379|FG002|Overall Study|Participant withdrew consent|1|||
146908070|NCT04075604|529829377|FG000|Overall Study|Other reasons|1|||
146908071|NCT04075604|529829378|FG001|Overall Study|Other reasons|0|||
146908072|NCT04075604|529829379|FG002|Overall Study|Other reasons|0|||
146908073|NCT04075604|529829377|FG000|Overall Study|Disease progression|0|||
146908074|NCT04075604|529829378|FG001|Overall Study|Disease progression|1|||
146970278|NCT03972709|530052592|FG002|Overall Study|Lost to Follow-up|2|||
146970279|NCT03972709|530052590|FG000|Overall Study|Death|5|||
146970280|NCT03972709|530052591|FG001|Overall Study|Death|1|||
146970281|NCT03972709|530052592|FG002|Overall Study|Death|4|||
146562676|NCT03396445|528571701|FG010|Treatment Period|Withdrawal by Subject|0|||
146562677|NCT03396445|528571702|FG011|Treatment Period|Withdrawal by Subject|0|||
146562678|NCT03396445|528571703|FG012|Treatment Period|Withdrawal by Subject|0|||
146562679|NCT03396445|528571704|FG013|Treatment Period|Withdrawal by Subject|0|||
146908075|NCT04075604|529829379|FG002|Overall Study|Disease progression|0|||
146562680|NCT03396445|528571705|FG014|Treatment Period|Withdrawal by Subject|1|||
146908076|NCT04075604|529829377|FG000|Overall Study|Study drug toxicity|0|||
146970282|NCT03972709|530052590|FG000|Overall Study|Adverse Event|3|||
146970283|NCT03972709|530052591|FG001|Overall Study|Adverse Event|1|||
146970284|NCT03972709|530052592|FG002|Overall Study|Adverse Event|4|||
146970285|NCT03972709|530052590|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
146970286|NCT03972709|530052591|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
146768215|NCT03586544|529319539|FG001|Second Intervention|Withdrawal by Subject|1|||
146768216|NCT03863834|529319543|FG000|Overall Study|Lost to Follow-up|3|||
146768217|NCT02770248|529319545|FG000|Overall Study|Adverse Event|0|||
146768218|NCT02770248|529319546|FG001|Overall Study|Adverse Event|1|||
146768219|NCT02770248|529319545|FG000|Overall Study|Randomized in error, prior to treatment|0|||
146768220|NCT02770248|529319546|FG001|Overall Study|Randomized in error, prior to treatment|1|||
146768221|NCT01837641|529319547|FG000|Overall Study|Sponsor decision|1|||
146768222|NCT01837641|529319548|FG001|Overall Study|Sponsor decision|0|||
146768223|NCT01837641|529319549|FG002|Overall Study|Sponsor decision|0|||
146768224|NCT01837641|529319550|FG003|Overall Study|Sponsor decision|0|||
146768225|NCT01837641|529319551|FG004|Overall Study|Sponsor decision|0|||
146768226|NCT01837641|529319552|FG005|Overall Study|Sponsor decision|1|||
146768227|NCT01837641|529319553|FG006|Overall Study|Sponsor decision|0|||
146768228|NCT01837641|529319554|FG007|Overall Study|Sponsor decision|0|||
146768229|NCT01837641|529319547|FG000|Overall Study|Adverse Event|0|||
146768230|NCT01837641|529319548|FG001|Overall Study|Adverse Event|0|||
146768231|NCT01837641|529319549|FG002|Overall Study|Adverse Event|0|||
146970287|NCT03972709|530052592|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
146970288|NCT03972709|530052590|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
146970289|NCT03972709|530052591|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
146970290|NCT03972709|530052592|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
146970291|NCT03972709|530052590|FG000|Overall Study|Subject Unable to be Contacted|0|||
146768232|NCT01837641|529319550|FG003|Overall Study|Adverse Event|0|||
146768233|NCT01837641|529319551|FG004|Overall Study|Adverse Event|0|||
146768234|NCT01837641|529319552|FG005|Overall Study|Adverse Event|1|||
146768235|NCT01837641|529319553|FG006|Overall Study|Adverse Event|0|||
146768236|NCT01837641|529319554|FG007|Overall Study|Adverse Event|0|||
146768237|NCT01837641|529319547|FG000|Overall Study|Withdrawal by Subject|0|||
146768238|NCT01837641|529319548|FG001|Overall Study|Withdrawal by Subject|0|||
146768239|NCT01837641|529319549|FG002|Overall Study|Withdrawal by Subject|0|||
146908077|NCT04075604|529829378|FG001|Overall Study|Study drug toxicity|5|||
146908078|NCT04075604|529829379|FG002|Overall Study|Study drug toxicity|1|||
146908079|NCT02760602|529829380|FG000|Overall Study|Withdrawal by Subject|1|||
146908080|NCT02760602|529829381|FG001|Overall Study|Withdrawal by Subject|0|||
146908081|NCT02760602|529829380|FG000|Overall Study|Terminated by sponsor|12|||
146908082|NCT02760602|529829381|FG001|Overall Study|Terminated by sponsor|13|||
146908083|NCT01260181|529829386|FG000|Overall Study|Decision of Investigator|1|||
146908084|NCT01588197|529829389|FG000|Overall Study|Lack of Efficacy|0|||
146908085|NCT01588197|529829390|FG001|Overall Study|Lack of Efficacy|1|||
146908086|NCT01588197|529829389|FG000|Overall Study|No MRI|1|||
146908087|NCT01588197|529829390|FG001|Overall Study|No MRI|0|||
146908088|NCT03351244|529829391|FG000|Overall Study|Adverse Event|7|||
146908089|NCT03351244|529829392|FG001|Overall Study|Adverse Event|11|||
146908090|NCT03351244|529829393|FG002|Overall Study|Adverse Event|12|||
146908091|NCT03351244|529829391|FG000|Overall Study|Investigator's decision|0|||
146908092|NCT03351244|529829392|FG001|Overall Study|Investigator's decision|0|||
146908093|NCT03351244|529829393|FG002|Overall Study|Investigator's decision|2|||
146908094|NCT03351244|529829391|FG000|Overall Study|System error|0|||
146908095|NCT03351244|529829392|FG001|Overall Study|System error|0|||
146908096|NCT03351244|529829393|FG002|Overall Study|System error|2|||
146908097|NCT03351244|529829391|FG000|Overall Study|COVID-19 restrictions|3|||
146908098|NCT03351244|529829392|FG001|Overall Study|COVID-19 restrictions|0|||
146908099|NCT03351244|529829393|FG002|Overall Study|COVID-19 restrictions|1|||
146908100|NCT03351244|529829391|FG000|Overall Study|Non-compliance|2|||
146908101|NCT03351244|529829392|FG001|Overall Study|Non-compliance|5|||
146908102|NCT03351244|529829393|FG002|Overall Study|Non-compliance|0|||
146908103|NCT03351244|529829391|FG000|Overall Study|Withdrawal by Subject|11|||
146908104|NCT03351244|529829392|FG001|Overall Study|Withdrawal by Subject|16|||
146908105|NCT03351244|529829393|FG002|Overall Study|Withdrawal by Subject|13|||
146908106|NCT03351244|529829391|FG000|Overall Study|Lost to Follow-up|2|||
146908107|NCT03351244|529829392|FG001|Overall Study|Lost to Follow-up|6|||
146908108|NCT03351244|529829393|FG002|Overall Study|Lost to Follow-up|4|||
146908109|NCT03351244|529829391|FG000|Overall Study|Protocol Violation|2|||
146908110|NCT03351244|529829392|FG001|Overall Study|Protocol Violation|2|||
146641962|NCT02152956|528865209|FG010|Overall Study|Adverse Event|0|||
146641963|NCT02152956|528865210|FG011|Overall Study|Adverse Event|4|||
146641964|NCT02152956|528865211|FG012|Overall Study|Adverse Event|0|||
146641965|NCT02152956|528865199|FG000|Overall Study|Death|0|||
146641966|NCT02152956|528865200|FG001|Overall Study|Death|3|||
146641967|NCT02152956|528865201|FG002|Overall Study|Death|3|||
146641968|NCT02152956|528865202|FG003|Overall Study|Death|4|||
146641969|NCT02152956|528865203|FG004|Overall Study|Death|1|||
146641970|NCT02152956|528865204|FG005|Overall Study|Death|2|||
146641971|NCT02152956|528865205|FG006|Overall Study|Death|6|||
146641972|NCT02152956|528865206|FG007|Overall Study|Death|6|||
146641973|NCT02152956|528865207|FG008|Overall Study|Death|4|||
146641974|NCT02152956|528865208|FG009|Overall Study|Death|5|||
146641975|NCT02152956|528865209|FG010|Overall Study|Death|3|||
146641976|NCT02152956|528865210|FG011|Overall Study|Death|143|||
146641977|NCT02152956|528865211|FG012|Overall Study|Death|12|||
146908111|NCT03351244|529829393|FG002|Overall Study|Protocol Violation|0|||
146908112|NCT00091793|529829397|FG000|Overall Study|Adverse Event|1|||
146908113|NCT00091793|529829398|FG001|Overall Study|Adverse Event|2|||
146908114|NCT00091793|529829397|FG000|Overall Study|Withdrawal by Subject|10|||
146908115|NCT00091793|529829398|FG001|Overall Study|Withdrawal by Subject|15|||
146908116|NCT00091793|529829397|FG000|Overall Study|Ineligibility determined|2|||
146908117|NCT00091793|529829398|FG001|Overall Study|Ineligibility determined|0|||
146908118|NCT00091793|529829397|FG000|Overall Study|Lost to Follow-up|7|||
146908119|NCT00091793|529829398|FG001|Overall Study|Lost to Follow-up|5|||
146908120|NCT00091793|529829397|FG000|Overall Study|Noncompliance|2|||
146641978|NCT02152956|528865199|FG000|Overall Study|Lost to Follow-up|0|||
146908121|NCT00091793|529829398|FG001|Overall Study|Noncompliance|0|||
146908122|NCT00091793|529829397|FG000|Overall Study|Other|2|||
146908123|NCT00091793|529829398|FG001|Overall Study|Other|0|||
146908124|NCT01025336|529829399|FG000|Overall Study|Protocol Violation|0|||
146908125|NCT01025336|529829400|FG001|Overall Study|Protocol Violation|0|||
146641979|NCT02152956|528865200|FG001|Overall Study|Lost to Follow-up|1|||
146641980|NCT02152956|528865201|FG002|Overall Study|Lost to Follow-up|0|||
146641981|NCT02152956|528865202|FG003|Overall Study|Lost to Follow-up|0|||
146641982|NCT02152956|528865203|FG004|Overall Study|Lost to Follow-up|0|||
146908126|NCT01025336|529829401|FG002|Overall Study|Protocol Violation|0|||
146908127|NCT01025336|529829402|FG003|Overall Study|Protocol Violation|2|||
146641983|NCT02152956|528865204|FG005|Overall Study|Lost to Follow-up|0|||
146641984|NCT02152956|528865205|FG006|Overall Study|Lost to Follow-up|0|||
146641985|NCT02152956|528865206|FG007|Overall Study|Lost to Follow-up|0|||
146908128|NCT01025336|529829403|FG004|Overall Study|Protocol Violation|0|||
146908129|NCT03794986|529829404|FG000|Overall Study|0 Sessions Attended|34|||
146908130|NCT03794986|529829405|FG001|Overall Study|0 Sessions Attended|37|||
146908131|NCT03794986|529829404|FG000|Overall Study|Withdrawal by Subject|4|||
146908132|NCT03794986|529829405|FG001|Overall Study|Withdrawal by Subject|6|||
146908133|NCT03794986|529829404|FG000|Overall Study|Protocol Violation|1|||
146908134|NCT03794986|529829405|FG001|Overall Study|Protocol Violation|0|||
146908135|NCT03000452|529829406|FG000|Treatment Period|Death|1|||
146908136|NCT03000452|529829406|FG000|Treatment Period|Progressive Disease (PD)|14|||
146908137|NCT03000452|529829406|FG000|Treatment Period|Physician Decision|1|||
146908138|NCT03000452|529829406|FG000|Treatment Period|Miscellaneous|2|||
146908139|NCT03000452|529829406|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
146908140|NCT03000452|529829406|FG000|Follow-Up Period|Death|3|||
146908141|NCT03000452|529829406|FG000|Follow-Up Period|Withdrawal by Subject|3|||
146908142|NCT05372315|529829409|FG000|Overall Study|Withdrawal by Subject|1|||
146908143|NCT05372315|529829410|FG001|Overall Study|Withdrawal by Subject|0|||
146908144|NCT00537745|529829411|FG000|Overall Study|Did not meet eligibility criteria|2|||
146908145|NCT00537745|529829411|FG000|Overall Study|Withdrawal by Subject|2|||
146908146|NCT00537745|529829411|FG000|Overall Study|Subject unable to provide Interlock info|1|||
146908147|NCT01512368|529829412|FG000|Overall Study|Protocol Violation|3|||
146908148|NCT00650585|529829415|FG000|Overall Study|Lost to Follow-up|505|||
146908149|NCT00650585|529829416|FG001|Overall Study|Lost to Follow-up|482|||
146908150|NCT00650585|529829415|FG000|Overall Study|No parental consent|935|||
146908151|NCT00650585|529829416|FG001|Overall Study|No parental consent|866|||
146908152|NCT00650585|529829415|FG000|Overall Study|Excluded/ruled ineligible|357|||
146908153|NCT00650585|529829416|FG001|Overall Study|Excluded/ruled ineligible|129|||
146908154|NCT02532543|529829417|FG000|Overall Study|Lost to Follow-up|0|||
146908155|NCT02532543|529829418|FG001|Overall Study|Lost to Follow-up|0|||
146908156|NCT02532543|529829419|FG002|Overall Study|Lost to Follow-up|1|||
146908157|NCT02532543|529829420|FG003|Overall Study|Lost to Follow-up|0|||
146908158|NCT02640612|529829421|FG000|Overall Study|Adverse Event|6|||
146908159|NCT02640612|529829422|FG001|Overall Study|Adverse Event|7|||
146908160|NCT02640612|529829423|FG002|Overall Study|Adverse Event|2|||
146908161|NCT02640612|529829421|FG000|Overall Study|Death|1|||
146908162|NCT02640612|529829422|FG001|Overall Study|Death|0|||
146908163|NCT02640612|529829423|FG002|Overall Study|Death|0|||
146908164|NCT02640612|529829421|FG000|Overall Study|Withdrawal by Subject|10|||
146908165|NCT02640612|529829422|FG001|Overall Study|Withdrawal by Subject|3|||
146908166|NCT02640612|529829423|FG002|Overall Study|Withdrawal by Subject|3|||
146908167|NCT02640612|529829421|FG000|Overall Study|Lost to Follow-up|4|||
146908168|NCT02640612|529829422|FG001|Overall Study|Lost to Follow-up|1|||
146908169|NCT02640612|529829423|FG002|Overall Study|Lost to Follow-up|1|||
146908170|NCT02640612|529829421|FG000|Overall Study|Protocol Violation|0|||
146908171|NCT02640612|529829422|FG001|Overall Study|Protocol Violation|2|||
146908172|NCT02640612|529829423|FG002|Overall Study|Protocol Violation|0|||
146908173|NCT02640612|529829421|FG000|Overall Study|Lack of Efficacy|1|||
146908174|NCT02640612|529829422|FG001|Overall Study|Lack of Efficacy|1|||
146908175|NCT02640612|529829423|FG002|Overall Study|Lack of Efficacy|0|||
146908176|NCT00923091|529829434|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
146908177|NCT00923091|529829435|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
146908178|NCT00923091|529829436|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
146908179|NCT00923091|529829437|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
146908180|NCT00923091|529829438|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
146908181|NCT00923091|529829439|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
146641986|NCT02152956|528865207|FG008|Overall Study|Lost to Follow-up|0|||
146641987|NCT02152956|528865208|FG009|Overall Study|Lost to Follow-up|0|||
146641988|NCT02152956|528865209|FG010|Overall Study|Lost to Follow-up|0|||
146641989|NCT02152956|528865210|FG011|Overall Study|Lost to Follow-up|3|||
146641990|NCT02152956|528865211|FG012|Overall Study|Lost to Follow-up|0|||
146641991|NCT02152956|528865199|FG000|Overall Study|Withdrawal by Subject|1|||
146641992|NCT02152956|528865200|FG001|Overall Study|Withdrawal by Subject|0|||
146641993|NCT02152956|528865201|FG002|Overall Study|Withdrawal by Subject|1|||
146641994|NCT02152956|528865202|FG003|Overall Study|Withdrawal by Subject|0|||
146641995|NCT02152956|528865203|FG004|Overall Study|Withdrawal by Subject|2|||
146641996|NCT02152956|528865204|FG005|Overall Study|Withdrawal by Subject|2|||
146641997|NCT02152956|528865205|FG006|Overall Study|Withdrawal by Subject|0|||
146641998|NCT02152956|528865206|FG007|Overall Study|Withdrawal by Subject|0|||
146641999|NCT02152956|528865207|FG008|Overall Study|Withdrawal by Subject|1|||
146642000|NCT02152956|528865208|FG009|Overall Study|Withdrawal by Subject|0|||
146642001|NCT02152956|528865209|FG010|Overall Study|Withdrawal by Subject|0|||
146642002|NCT02152956|528865210|FG011|Overall Study|Withdrawal by Subject|4|||
146642003|NCT02152956|528865211|FG012|Overall Study|Withdrawal by Subject|0|||
146642004|NCT02152956|528865199|FG000|Overall Study|Physician Decision|0|||
146642005|NCT02152956|528865200|FG001|Overall Study|Physician Decision|0|||
146642006|NCT02152956|528865201|FG002|Overall Study|Physician Decision|0|||
146642007|NCT02152956|528865202|FG003|Overall Study|Physician Decision|0|||
146642008|NCT02152956|528865203|FG004|Overall Study|Physician Decision|0|||
146642009|NCT02152956|528865204|FG005|Overall Study|Physician Decision|0|||
146642010|NCT02152956|528865205|FG006|Overall Study|Physician Decision|0|||
146642011|NCT02152956|528865206|FG007|Overall Study|Physician Decision|0|||
146642012|NCT02152956|528865207|FG008|Overall Study|Physician Decision|0|||
146642013|NCT02152956|528865208|FG009|Overall Study|Physician Decision|0|||
146642014|NCT02152956|528865209|FG010|Overall Study|Physician Decision|0|||
146642015|NCT02152956|528865210|FG011|Overall Study|Physician Decision|1|||
146642016|NCT02152956|528865211|FG012|Overall Study|Physician Decision|0|||
146642017|NCT02152956|528865199|FG000|Overall Study|Study terminated by sponsor|0|||
146642018|NCT02152956|528865200|FG001|Overall Study|Study terminated by sponsor|0|||
146642019|NCT02152956|528865201|FG002|Overall Study|Study terminated by sponsor|0|||
146642020|NCT02152956|528865202|FG003|Overall Study|Study terminated by sponsor|0|||
146642021|NCT02152956|528865203|FG004|Overall Study|Study terminated by sponsor|0|||
146642022|NCT02152956|528865204|FG005|Overall Study|Study terminated by sponsor|0|||
146642023|NCT02152956|528865205|FG006|Overall Study|Study terminated by sponsor|0|||
146642024|NCT02152956|528865206|FG007|Overall Study|Study terminated by sponsor|0|||
146642025|NCT02152956|528865207|FG008|Overall Study|Study terminated by sponsor|0|||
146642026|NCT02152956|528865208|FG009|Overall Study|Study terminated by sponsor|0|||
146642027|NCT02152956|528865209|FG010|Overall Study|Study terminated by sponsor|0|||
146642028|NCT02152956|528865210|FG011|Overall Study|Study terminated by sponsor|29|||
146642029|NCT02152956|528865211|FG012|Overall Study|Study terminated by sponsor|0|||
146908182|NCT00923091|529829440|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
146642030|NCT02152956|528865199|FG000|Overall Study|progressive disease|0|||
146642031|NCT02152956|528865200|FG001|Overall Study|progressive disease|0|||
146642032|NCT02152956|528865201|FG002|Overall Study|progressive disease|0|||
146642033|NCT02152956|528865202|FG003|Overall Study|progressive disease|0|||
146642034|NCT02152956|528865203|FG004|Overall Study|progressive disease|0|||
146642035|NCT02152956|528865204|FG005|Overall Study|progressive disease|0|||
146642036|NCT02152956|528865205|FG006|Overall Study|progressive disease|0|||
146642037|NCT02152956|528865206|FG007|Overall Study|progressive disease|0|||
146642038|NCT02152956|528865207|FG008|Overall Study|progressive disease|1|||
146642039|NCT02152956|528865208|FG009|Overall Study|progressive disease|0|||
146642040|NCT02152956|528865209|FG010|Overall Study|progressive disease|0|||
146642041|NCT02152956|528865210|FG011|Overall Study|progressive disease|1|||
146908183|NCT00923091|529829441|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
146908184|NCT00923091|529829442|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
146908185|NCT00923091|529829443|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
146908186|NCT00923091|529829444|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
146908187|NCT00923091|529829445|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
146908188|NCT00923091|529829446|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
146562681|NCT03396445|528571706|FG015|Treatment Period|Withdrawal by Subject|0|||
146908189|NCT00923091|529829434|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
146562682|NCT03396445|528571707|FG016|Treatment Period|Withdrawal by Subject|1|||
146908190|NCT00923091|529829435|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
146908191|NCT00923091|529829436|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
146908192|NCT00923091|529829437|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
146908193|NCT00923091|529829438|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
146908194|NCT00923091|529829439|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
146908195|NCT00923091|529829440|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
146908196|NCT00923091|529829441|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
146908197|NCT00923091|529829442|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
146908198|NCT00923091|529829443|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
146908199|NCT00923091|529829444|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
146908200|NCT00923091|529829445|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
146908201|NCT00923091|529829446|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
146908202|NCT00923091|529829434|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
146908203|NCT00923091|529829435|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
146908204|NCT00923091|529829436|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
146908205|NCT00923091|529829437|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
146908206|NCT00923091|529829438|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
146908207|NCT00923091|529829439|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
146908208|NCT00923091|529829440|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
146908209|NCT00923091|529829441|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
146908210|NCT00923091|529829442|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
146908211|NCT00923091|529829443|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
146908212|NCT00923091|529829444|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
146908213|NCT00923091|529829445|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
146908214|NCT00923091|529829446|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
146908215|NCT00923091|529829434|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146908216|NCT00923091|529829435|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146908217|NCT00923091|529829436|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146908218|NCT00923091|529829437|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146908219|NCT00923091|529829438|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146908220|NCT00923091|529829439|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
146908221|NCT00923091|529829440|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146908222|NCT00923091|529829441|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146908223|NCT00923091|529829442|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146908224|NCT00923091|529829443|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146908225|NCT00923091|529829444|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146908226|NCT00923091|529829445|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146908227|NCT00923091|529829446|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146908228|NCT00923091|529829434|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146908229|NCT00923091|529829435|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
146908230|NCT00923091|529829436|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146908231|NCT00923091|529829437|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
146908232|NCT00923091|529829438|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146908233|NCT00923091|529829439|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
146908234|NCT00923091|529829440|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146908235|NCT00923091|529829441|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146908236|NCT00923091|529829442|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146908237|NCT00923091|529829443|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146908238|NCT00923091|529829444|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146908239|NCT00923091|529829445|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146908240|NCT00923091|529829446|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146908241|NCT00923091|529829434|FG000|Period III (Single-Blind)|Adverse Event|5|||
146908242|NCT00923091|529829435|FG001|Period III (Single-Blind)|Adverse Event|0|||
146908243|NCT00923091|529829436|FG002|Period III (Single-Blind)|Adverse Event|0|||
146908244|NCT00923091|529829437|FG003|Period III (Single-Blind)|Adverse Event|0|||
146908245|NCT00923091|529829438|FG004|Period III (Single-Blind)|Adverse Event|0|||
146908246|NCT00923091|529829439|FG005|Period III (Single-Blind)|Adverse Event|0|||
146908247|NCT00923091|529829440|FG006|Period III (Single-Blind)|Adverse Event|0|||
146908248|NCT00923091|529829441|FG007|Period III (Single-Blind)|Adverse Event|0|||
146908249|NCT00923091|529829442|FG008|Period III (Single-Blind)|Adverse Event|0|||
146908250|NCT00923091|529829443|FG009|Period III (Single-Blind)|Adverse Event|0|||
146908251|NCT00923091|529829444|FG010|Period III (Single-Blind)|Adverse Event|0|||
146908252|NCT00923091|529829445|FG011|Period III (Single-Blind)|Adverse Event|0|||
146908253|NCT00923091|529829446|FG012|Period III (Single-Blind)|Adverse Event|0|||
146908254|NCT00923091|529829434|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
146908255|NCT00923091|529829435|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
146562683|NCT03396445|528571708|FG017|Treatment Period|Withdrawal by Subject|0|||
146562684|NCT03396445|528571709|FG018|Treatment Period|Withdrawal by Subject|0|||
146908256|NCT00923091|529829436|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
146562685|NCT03396445|528571710|FG019|Treatment Period|Withdrawal by Subject|0|||
146562686|NCT03396445|528571711|FG020|Treatment Period|Withdrawal by Subject|0|||
146562687|NCT03396445|528571712|FG021|Treatment Period|Withdrawal by Subject|0|||
146562688|NCT03396445|528571713|FG022|Treatment Period|Withdrawal by Subject|0|||
146562689|NCT03396445|528571714|FG023|Treatment Period|Withdrawal by Subject|0|||
146562690|NCT03396445|528571715|FG024|Treatment Period|Withdrawal by Subject|0|||
146562691|NCT03396445|528571716|FG025|Treatment Period|Withdrawal by Subject|0|||
146562692|NCT03396445|528571691|FG000|Switch-over Period|Death|0|||
146562693|NCT03396445|528571692|FG001|Switch-over Period|Death|0|||
146562694|NCT03396445|528571693|FG002|Switch-over Period|Death|0|||
146562695|NCT03396445|528571694|FG003|Switch-over Period|Death|0|||
146562696|NCT03396445|528571695|FG004|Switch-over Period|Death|0|||
146562697|NCT03396445|528571696|FG005|Switch-over Period|Death|0|||
146562698|NCT03396445|528571697|FG006|Switch-over Period|Death|0|||
146562699|NCT03396445|528571698|FG007|Switch-over Period|Death|0|||
146562700|NCT03396445|528571699|FG008|Switch-over Period|Death|0|||
146562701|NCT03396445|528571700|FG009|Switch-over Period|Death|0|||
146562702|NCT03396445|528571701|FG010|Switch-over Period|Death|0|||
146562703|NCT03396445|528571702|FG011|Switch-over Period|Death|0|||
146562704|NCT03396445|528571703|FG012|Switch-over Period|Death|0|||
146562705|NCT03396445|528571704|FG013|Switch-over Period|Death|0|||
146562706|NCT03396445|528571705|FG014|Switch-over Period|Death|0|||
146562707|NCT03396445|528571706|FG015|Switch-over Period|Death|0|||
146562708|NCT03396445|528571707|FG016|Switch-over Period|Death|0|||
146562709|NCT03396445|528571708|FG017|Switch-over Period|Death|0|||
146562710|NCT03396445|528571709|FG018|Switch-over Period|Death|1|||
146562711|NCT03396445|528571710|FG019|Switch-over Period|Death|2|||
146562712|NCT03396445|528571711|FG020|Switch-over Period|Death|2|||
146562713|NCT03396445|528571712|FG021|Switch-over Period|Death|1|||
146562714|NCT03396445|528571713|FG022|Switch-over Period|Death|2|||
146562715|NCT03396445|528571714|FG023|Switch-over Period|Death|0|||
146562716|NCT03396445|528571715|FG024|Switch-over Period|Death|1|||
146562717|NCT03396445|528571716|FG025|Switch-over Period|Death|6|||
146562718|NCT03396445|528571691|FG000|Switch-over Period|Lost to Follow-up|0|||
146562719|NCT03396445|528571692|FG001|Switch-over Period|Lost to Follow-up|0|||
146562720|NCT03396445|528571693|FG002|Switch-over Period|Lost to Follow-up|0|||
146562721|NCT03396445|528571694|FG003|Switch-over Period|Lost to Follow-up|0|||
146562722|NCT03396445|528571695|FG004|Switch-over Period|Lost to Follow-up|0|||
146562723|NCT03396445|528571696|FG005|Switch-over Period|Lost to Follow-up|0|||
146908257|NCT00923091|529829437|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
146908258|NCT00923091|529829438|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
146562724|NCT03396445|528571697|FG006|Switch-over Period|Lost to Follow-up|0|||
146562725|NCT03396445|528571698|FG007|Switch-over Period|Lost to Follow-up|0|||
146908259|NCT00923091|529829439|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
146562726|NCT03396445|528571699|FG008|Switch-over Period|Lost to Follow-up|0|||
146562727|NCT03396445|528571700|FG009|Switch-over Period|Lost to Follow-up|0|||
146908260|NCT00923091|529829440|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
146908261|NCT00923091|529829441|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
146908262|NCT00923091|529829442|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
146908263|NCT00923091|529829443|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
146908264|NCT00923091|529829444|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
146908265|NCT00923091|529829445|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
146908266|NCT00923091|529829446|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
146908267|NCT00923091|529829434|FG000|Period III (Single-Blind)|Protocol Violation|3|||
146908268|NCT00923091|529829435|FG001|Period III (Single-Blind)|Protocol Violation|0|||
146908269|NCT00923091|529829436|FG002|Period III (Single-Blind)|Protocol Violation|0|||
146908270|NCT00923091|529829437|FG003|Period III (Single-Blind)|Protocol Violation|0|||
146908271|NCT00923091|529829438|FG004|Period III (Single-Blind)|Protocol Violation|0|||
146908272|NCT00923091|529829439|FG005|Period III (Single-Blind)|Protocol Violation|0|||
146908273|NCT00923091|529829440|FG006|Period III (Single-Blind)|Protocol Violation|0|||
146908274|NCT00923091|529829441|FG007|Period III (Single-Blind)|Protocol Violation|0|||
146908275|NCT00923091|529829442|FG008|Period III (Single-Blind)|Protocol Violation|0|||
146908276|NCT00923091|529829443|FG009|Period III (Single-Blind)|Protocol Violation|0|||
146908277|NCT00923091|529829444|FG010|Period III (Single-Blind)|Protocol Violation|0|||
146908278|NCT00923091|529829445|FG011|Period III (Single-Blind)|Protocol Violation|0|||
146908279|NCT00923091|529829446|FG012|Period III (Single-Blind)|Protocol Violation|0|||
146908280|NCT00923091|529829434|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
146908281|NCT00923091|529829435|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
146908282|NCT00923091|529829436|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
146908283|NCT00923091|529829437|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
146908284|NCT00923091|529829438|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
146908285|NCT00923091|529829439|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
146908286|NCT00923091|529829440|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
146908287|NCT00923091|529829441|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
146908288|NCT00923091|529829442|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
146908289|NCT00923091|529829443|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
146908290|NCT00923091|529829444|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
146908291|NCT00923091|529829445|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
146908292|NCT00923091|529829446|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
146908293|NCT00923091|529829434|FG000|Period IV (Double-Blind)|Adverse Event|2|||
146908294|NCT00923091|529829435|FG001|Period IV (Double-Blind)|Adverse Event|0|||
146908295|NCT00923091|529829436|FG002|Period IV (Double-Blind)|Adverse Event|0|||
146908296|NCT00923091|529829437|FG003|Period IV (Double-Blind)|Adverse Event|0|||
146562728|NCT03396445|528571701|FG010|Switch-over Period|Lost to Follow-up|0|||
146562729|NCT03396445|528571702|FG011|Switch-over Period|Lost to Follow-up|0|||
146562730|NCT03396445|528571703|FG012|Switch-over Period|Lost to Follow-up|0|||
146562731|NCT03396445|528571704|FG013|Switch-over Period|Lost to Follow-up|0|||
146908297|NCT00923091|529829438|FG004|Period IV (Double-Blind)|Adverse Event|0|||
146908298|NCT00923091|529829439|FG005|Period IV (Double-Blind)|Adverse Event|0|||
146908299|NCT00923091|529829440|FG006|Period IV (Double-Blind)|Adverse Event|0|||
146908300|NCT00923091|529829441|FG007|Period IV (Double-Blind)|Adverse Event|0|||
146562732|NCT03396445|528571705|FG014|Switch-over Period|Lost to Follow-up|0|||
146562733|NCT03396445|528571706|FG015|Switch-over Period|Lost to Follow-up|0|||
146642042|NCT02152956|528865211|FG012|Overall Study|progressive disease|0|||
146642043|NCT05661851|528865212|FG000|Overall Study|Protocol Violation|1|||
146642044|NCT05661851|528865213|FG001|Overall Study|Protocol Violation|1|||
146642045|NCT05661851|528865212|FG000|Overall Study|Covid-19 Related|3|||
146642046|NCT05661851|528865213|FG001|Overall Study|Covid-19 Related|4|||
146642047|NCT05661851|528865212|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
146642048|NCT05661851|528865213|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
146642049|NCT05661851|528865212|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
146642050|NCT05661851|528865213|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
146642051|NCT00530816|528865214|FG000|Overall Study|Progressive Disease|16|||
146642052|NCT00530816|528865215|FG001|Overall Study|Progressive Disease|24|||
146642053|NCT00530816|528865216|FG002|Overall Study|Progressive Disease|24|||
146642054|NCT00530816|528865214|FG000|Overall Study|Adverse Event|6|||
146642055|NCT00530816|528865215|FG001|Overall Study|Adverse Event|13|||
146642056|NCT00530816|528865216|FG002|Overall Study|Adverse Event|7|||
146642057|NCT00530816|528865214|FG000|Overall Study|Other|3|||
146642058|NCT00530816|528865215|FG001|Overall Study|Other|3|||
146642059|NCT00530816|528865216|FG002|Overall Study|Other|4|||
146642060|NCT00530816|528865214|FG000|Overall Study|Withdrawal by Subject|1|||
146642061|NCT00530816|528865215|FG001|Overall Study|Withdrawal by Subject|2|||
146642062|NCT00530816|528865216|FG002|Overall Study|Withdrawal by Subject|6|||
146642063|NCT01014910|528865217|FG000|Overall Study|Withdrawal by Subject|0|||
146642064|NCT01014910|528865218|FG001|Overall Study|Withdrawal by Subject|2|||
146642065|NCT01388985|528865219|FG000|Overall Study|Death|0|||
146642066|NCT01388985|528865220|FG001|Overall Study|Death|1|||
146642067|NCT01388985|528865219|FG000|Overall Study|Lost to Follow-up|30|||
146642068|NCT01388985|528865220|FG001|Overall Study|Lost to Follow-up|30|||
146642069|NCT01388985|528865219|FG000|Overall Study|Withdrawal by Subject|13|||
146642070|NCT01388985|528865220|FG001|Overall Study|Withdrawal by Subject|4|||
146642071|NCT01388985|528865219|FG000|Overall Study|Subject unavailable|1|||
146642072|NCT01388985|528865220|FG001|Overall Study|Subject unavailable|1|||
146642073|NCT01388985|528865219|FG000|Overall Study|Other (no reason)|0|||
146642074|NCT01388985|528865220|FG001|Overall Study|Other (no reason)|1|||
146642075|NCT01388985|528865219|FG000|Overall Study|Error of nurse|5|||
146642076|NCT01388985|528865220|FG001|Overall Study|Error of nurse|1|||
146642077|NCT01057589|528865221|FG000|Overall Study|Disease Progression|35|||
146908301|NCT00923091|529829442|FG008|Period IV (Double-Blind)|Adverse Event|0|||
146908302|NCT00923091|529829443|FG009|Period IV (Double-Blind)|Adverse Event|0|||
146908303|NCT00923091|529829444|FG010|Period IV (Double-Blind)|Adverse Event|0|||
146908304|NCT00923091|529829445|FG011|Period IV (Double-Blind)|Adverse Event|0|||
146908305|NCT00923091|529829446|FG012|Period IV (Double-Blind)|Adverse Event|0|||
146562734|NCT03396445|528571707|FG016|Switch-over Period|Lost to Follow-up|0|||
146562735|NCT03396445|528571708|FG017|Switch-over Period|Lost to Follow-up|0|||
146562736|NCT03396445|528571709|FG018|Switch-over Period|Lost to Follow-up|0|||
146908306|NCT00923091|529829434|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146908307|NCT00923091|529829435|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
146908308|NCT00923091|529829436|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146908309|NCT00923091|529829437|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146908310|NCT00923091|529829438|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146908311|NCT00923091|529829439|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146908312|NCT00923091|529829440|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146908313|NCT00923091|529829441|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146908314|NCT00923091|529829442|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146908315|NCT00923091|529829443|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146908316|NCT00923091|529829444|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146908317|NCT00923091|529829445|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146908318|NCT00923091|529829446|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146908319|NCT00923091|529829434|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
146908320|NCT00923091|529829435|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
146908321|NCT00923091|529829436|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
146908322|NCT00923091|529829437|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
146908323|NCT00923091|529829438|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
146908324|NCT00923091|529829439|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
146908325|NCT00923091|529829440|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
146908326|NCT00923091|529829441|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
146908327|NCT00923091|529829442|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
146908328|NCT00923091|529829443|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
146908329|NCT00923091|529829444|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
146908330|NCT00923091|529829445|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
146908331|NCT00923091|529829446|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
146908332|NCT00923091|529829434|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
146908333|NCT00923091|529829435|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
146908334|NCT00923091|529829436|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
146908335|NCT00923091|529829437|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
146908336|NCT00923091|529829438|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
146908337|NCT00923091|529829439|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
146908338|NCT00923091|529829440|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
146908339|NCT00923091|529829441|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
146908340|NCT00923091|529829442|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
146908341|NCT00923091|529829443|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
146908342|NCT00923091|529829444|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
146908343|NCT00923091|529829445|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
146908344|NCT00923091|529829446|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
146908345|NCT00923091|529829434|FG000|Period V (Double -Blind)|Protocol Violation|0|||
146908346|NCT00923091|529829435|FG001|Period V (Double -Blind)|Protocol Violation|0|||
146908347|NCT00923091|529829436|FG002|Period V (Double -Blind)|Protocol Violation|0|||
146908348|NCT00923091|529829437|FG003|Period V (Double -Blind)|Protocol Violation|0|||
146908349|NCT00923091|529829438|FG004|Period V (Double -Blind)|Protocol Violation|0|||
146908350|NCT00923091|529829439|FG005|Period V (Double -Blind)|Protocol Violation|0|||
146908351|NCT00923091|529829440|FG006|Period V (Double -Blind)|Protocol Violation|0|||
146908352|NCT00923091|529829441|FG007|Period V (Double -Blind)|Protocol Violation|0|||
146908353|NCT00923091|529829442|FG008|Period V (Double -Blind)|Protocol Violation|0|||
146908354|NCT00923091|529829443|FG009|Period V (Double -Blind)|Protocol Violation|0|||
146908355|NCT00923091|529829444|FG010|Period V (Double -Blind)|Protocol Violation|0|||
146908356|NCT00923091|529829445|FG011|Period V (Double -Blind)|Protocol Violation|0|||
146908357|NCT00923091|529829446|FG012|Period V (Double -Blind)|Protocol Violation|1|||
146908358|NCT00923091|529829434|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
146908359|NCT00923091|529829435|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
146908360|NCT00923091|529829436|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
146908361|NCT00923091|529829437|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
146908362|NCT00923091|529829438|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
146908363|NCT00923091|529829439|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
146908364|NCT00923091|529829440|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
146908365|NCT00923091|529829441|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
146908366|NCT00923091|529829442|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
146908367|NCT00923091|529829443|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
146908368|NCT00923091|529829444|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
146908369|NCT00923091|529829445|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
146908370|NCT00923091|529829446|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
146908371|NCT00923091|529829434|FG000|Period VI (Open-Label)|Adverse Event|17|||
146908372|NCT00923091|529829435|FG001|Period VI (Open-Label)|Adverse Event|0|||
146908373|NCT00923091|529829436|FG002|Period VI (Open-Label)|Adverse Event|4|||
146908374|NCT00923091|529829437|FG003|Period VI (Open-Label)|Adverse Event|1|||
146908375|NCT00923091|529829438|FG004|Period VI (Open-Label)|Adverse Event|1|||
146908376|NCT00923091|529829439|FG005|Period VI (Open-Label)|Adverse Event|0|||
146908377|NCT00923091|529829440|FG006|Period VI (Open-Label)|Adverse Event|0|||
146908378|NCT00923091|529829441|FG007|Period VI (Open-Label)|Adverse Event|0|||
146908379|NCT00923091|529829442|FG008|Period VI (Open-Label)|Adverse Event|0|||
146908380|NCT00923091|529829443|FG009|Period VI (Open-Label)|Adverse Event|0|||
146908381|NCT00923091|529829444|FG010|Period VI (Open-Label)|Adverse Event|0|||
146908382|NCT00923091|529829445|FG011|Period VI (Open-Label)|Adverse Event|0|||
146908383|NCT00923091|529829446|FG012|Period VI (Open-Label)|Adverse Event|0|||
146908384|NCT00923091|529829434|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
146908385|NCT00923091|529829435|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
146908386|NCT00923091|529829436|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
146908387|NCT00923091|529829437|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
146908388|NCT00923091|529829438|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
146908389|NCT00923091|529829439|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
146908390|NCT00923091|529829440|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
146908391|NCT00923091|529829441|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
146908392|NCT00923091|529829442|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
146908393|NCT00923091|529829443|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
146908394|NCT00923091|529829444|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
146908395|NCT00923091|529829445|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
146908396|NCT00923091|529829446|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
146908397|NCT00923091|529829434|FG000|Period VI (Open-Label)|Protocol Violation|6|||
146908398|NCT00923091|529829435|FG001|Period VI (Open-Label)|Protocol Violation|1|||
146908399|NCT00923091|529829436|FG002|Period VI (Open-Label)|Protocol Violation|3|||
146908400|NCT00923091|529829437|FG003|Period VI (Open-Label)|Protocol Violation|1|||
146908401|NCT00923091|529829438|FG004|Period VI (Open-Label)|Protocol Violation|4|||
146908402|NCT00923091|529829439|FG005|Period VI (Open-Label)|Protocol Violation|0|||
146908403|NCT00923091|529829440|FG006|Period VI (Open-Label)|Protocol Violation|0|||
146908404|NCT00923091|529829441|FG007|Period VI (Open-Label)|Protocol Violation|0|||
146908405|NCT00923091|529829442|FG008|Period VI (Open-Label)|Protocol Violation|0|||
146908406|NCT00923091|529829443|FG009|Period VI (Open-Label)|Protocol Violation|0|||
146908407|NCT00923091|529829444|FG010|Period VI (Open-Label)|Protocol Violation|0|||
146908408|NCT00923091|529829445|FG011|Period VI (Open-Label)|Protocol Violation|0|||
146908409|NCT00923091|529829446|FG012|Period VI (Open-Label)|Protocol Violation|0|||
146908410|NCT00923091|529829434|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
146908411|NCT00923091|529829435|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
146908412|NCT00923091|529829436|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
146908413|NCT00923091|529829437|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
146908414|NCT00923091|529829438|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
146908415|NCT00923091|529829439|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
146908416|NCT00923091|529829440|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
146908417|NCT00923091|529829441|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
146908418|NCT00923091|529829442|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
146908419|NCT00923091|529829443|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
146908420|NCT00923091|529829444|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
146908421|NCT00923091|529829445|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
146908422|NCT00923091|529829446|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
146908423|NCT00923091|529829434|FG000|Period VI (Open-Label)|Other Reason|0|||
146908424|NCT00923091|529829435|FG001|Period VI (Open-Label)|Other Reason|0|||
146908425|NCT00923091|529829436|FG002|Period VI (Open-Label)|Other Reason|0|||
146908426|NCT00923091|529829437|FG003|Period VI (Open-Label)|Other Reason|1|||
146908427|NCT00923091|529829438|FG004|Period VI (Open-Label)|Other Reason|1|||
146908428|NCT00923091|529829439|FG005|Period VI (Open-Label)|Other Reason|0|||
146908429|NCT00923091|529829440|FG006|Period VI (Open-Label)|Other Reason|0|||
146908430|NCT00923091|529829441|FG007|Period VI (Open-Label)|Other Reason|0|||
146908431|NCT00923091|529829442|FG008|Period VI (Open-Label)|Other Reason|0|||
146908432|NCT00923091|529829443|FG009|Period VI (Open-Label)|Other Reason|0|||
146908433|NCT00923091|529829444|FG010|Period VI (Open-Label)|Other Reason|0|||
146908434|NCT00923091|529829445|FG011|Period VI (Open-Label)|Other Reason|0|||
146908435|NCT00923091|529829446|FG012|Period VI (Open-Label)|Other Reason|0|||
146908436|NCT02460822|529829449|FG000|Overall Study|Withdrawal by Subject|1|||
146908437|NCT00467649|529829450|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
146908438|NCT00467649|529829451|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
146908439|NCT00467649|529829452|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
146908440|NCT00467649|529829453|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
146908441|NCT00467649|529829454|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
146908442|NCT00467649|529829455|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
146908443|NCT00467649|529829450|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
146908444|NCT00467649|529829451|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
146908445|NCT00467649|529829452|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
146908446|NCT00467649|529829453|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
146908447|NCT00467649|529829454|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
146908448|NCT00467649|529829455|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
146908449|NCT00467649|529829450|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
146908450|NCT00467649|529829451|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
146908451|NCT00467649|529829452|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
146908452|NCT00467649|529829453|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
146908453|NCT00467649|529829454|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
146908454|NCT00467649|529829455|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
146908455|NCT00467649|529829450|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
146908456|NCT00467649|529829451|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
146908457|NCT00467649|529829452|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
146908458|NCT00467649|529829453|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
146908459|NCT00467649|529829454|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
146908460|NCT00467649|529829455|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
146562737|NCT03396445|528571710|FG019|Switch-over Period|Lost to Follow-up|0|||
146562738|NCT03396445|528571711|FG020|Switch-over Period|Lost to Follow-up|0|||
146562739|NCT03396445|528571712|FG021|Switch-over Period|Lost to Follow-up|0|||
146562740|NCT03396445|528571713|FG022|Switch-over Period|Lost to Follow-up|0|||
146562741|NCT03396445|528571714|FG023|Switch-over Period|Lost to Follow-up|1|||
146908461|NCT00467649|529829450|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
146908462|NCT00467649|529829451|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
146908463|NCT00467649|529829452|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
146908464|NCT00467649|529829453|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
146908465|NCT00467649|529829454|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
146908466|NCT00467649|529829455|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
146908467|NCT00467649|529829450|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
146908468|NCT00467649|529829451|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
146908469|NCT00467649|529829452|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
146908470|NCT00467649|529829453|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
146908471|NCT00467649|529829454|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
146908472|NCT00467649|529829455|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
146908473|NCT00467649|529829450|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
146908474|NCT00467649|529829451|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
146908475|NCT00467649|529829452|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
146908476|NCT00467649|529829453|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
146908477|NCT00467649|529829454|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
146908478|NCT00467649|529829455|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
146908479|NCT03240081|529829456|FG000|Overall Study|Withdrawal by Subject|0|||
146908480|NCT03240081|529829457|FG001|Overall Study|Withdrawal by Subject|2|||
146908481|NCT03240081|529829456|FG000|Overall Study|Lost to Follow-up|0|||
146908482|NCT03240081|529829457|FG001|Overall Study|Lost to Follow-up|1|||
146908483|NCT04925570|529829460|FG000|Overall Study|Protocol Violation|24|||
146908484|NCT04925570|529829461|FG001|Overall Study|Protocol Violation|30|||
146908485|NCT04925570|529829460|FG000|Overall Study|Withdrawal by Subject|0|||
146908486|NCT04925570|529829461|FG001|Overall Study|Withdrawal by Subject|2|||
146908487|NCT00624338|529829465|FG000|Overall Study|Adverse Event|14|||
146908488|NCT00624338|529829466|FG001|Overall Study|Adverse Event|14|||
146908489|NCT00624338|529829467|FG002|Overall Study|Adverse Event|18|||
146908490|NCT00624338|529829465|FG000|Overall Study|Lost to Follow-up|1|||
146908491|NCT00624338|529829466|FG001|Overall Study|Lost to Follow-up|0|||
146908492|NCT00624338|529829467|FG002|Overall Study|Lost to Follow-up|0|||
146908493|NCT00624338|529829465|FG000|Overall Study|Lack of Efficacy|11|||
146908494|NCT00624338|529829466|FG001|Overall Study|Lack of Efficacy|3|||
146908495|NCT00624338|529829467|FG002|Overall Study|Lack of Efficacy|14|||
146908496|NCT00624338|529829465|FG000|Overall Study|Protocol Violation|3|||
146908497|NCT00624338|529829466|FG001|Overall Study|Protocol Violation|3|||
146908498|NCT00624338|529829467|FG002|Overall Study|Protocol Violation|2|||
146908499|NCT00624338|529829465|FG000|Overall Study|Death|0|||
146908500|NCT00624338|529829466|FG001|Overall Study|Death|2|||
146908501|NCT00624338|529829467|FG002|Overall Study|Death|0|||
146908502|NCT00624338|529829465|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
146908503|NCT00624338|529829466|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
146908504|NCT00624338|529829467|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
146908505|NCT00624338|529829465|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
146908506|NCT00624338|529829466|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
146908507|NCT00624338|529829467|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
146908508|NCT00624338|529829465|FG000|Overall Study|Other|15|||
146908509|NCT00624338|529829466|FG001|Overall Study|Other|5|||
146908510|NCT00624338|529829467|FG002|Overall Study|Other|9|||
146908511|NCT00624338|529829465|FG000|Overall Study|Randomized but not treated|2|||
146908512|NCT00624338|529829466|FG001|Overall Study|Randomized but not treated|1|||
146908513|NCT00624338|529829467|FG002|Overall Study|Randomized but not treated|3|||
146908514|NCT01476787|529829468|FG000|Treatment|Progression|64|||
146908515|NCT01476787|529829469|FG001|Treatment|Progression|71|||
146908516|NCT01476787|529829468|FG000|Treatment|Toxicity|44|||
146908517|NCT01476787|529829469|FG001|Treatment|Toxicity|16|||
146908518|NCT01476787|529829468|FG000|Treatment|Death|0|||
146908519|NCT01476787|529829469|FG001|Treatment|Death|1|||
146908520|NCT01476787|529829468|FG000|Treatment|Withdrawal by Subject|3|||
146908521|NCT01476787|529829469|FG001|Treatment|Withdrawal by Subject|14|||
146908522|NCT01476787|529829468|FG000|Treatment|Major protocol violation|1|||
146908523|NCT01476787|529829469|FG001|Treatment|Major protocol violation|6|||
146908524|NCT01476787|529829468|FG000|Treatment|Other reasons|10|||
146908525|NCT01476787|529829469|FG001|Treatment|Other reasons|22|||
146908526|NCT01476787|529829468|FG000|Treatment|Concurrent illness|12|||
146908527|NCT01476787|529829469|FG001|Treatment|Concurrent illness|9|||
146908528|NCT01476787|529829468|FG000|Treatment|Insufficient response|15|||
146908529|NCT01476787|529829469|FG001|Treatment|Insufficient response|3|||
146908530|NCT01476787|529829468|FG000|Treatment|Voluntary treatment discontinuation|8|||
146908531|NCT01476787|529829469|FG001|Treatment|Voluntary treatment discontinuation|4|||
146908532|NCT02782715|529829470|FG000|Overall Study|Withdrawal by Subject|1|||
146908533|NCT02986373|529829471|FG000|Overall Study|Adverse Event|4|||
146908534|NCT02986373|529829471|FG000|Overall Study|Lost to Follow-up|1|||
146908535|NCT02986373|529829471|FG000|Overall Study|Withdrawal by Subject|10|||
146908536|NCT02986373|529829471|FG000|Overall Study|Other|24|||
146908537|NCT01662999|529829480|FG000|Period 3|Withdrawal by Subject|0|||
146908538|NCT01662999|529829481|FG001|Period 3|Withdrawal by Subject|1|||
146908539|NCT01662999|529829482|FG002|Period 3|Withdrawal by Subject|0|||
146908540|NCT01662999|529829483|FG003|Period 3|Withdrawal by Subject|0|||
146908541|NCT01662999|529829484|FG004|Period 3|Withdrawal by Subject|0|||
146908542|NCT01662999|529829485|FG005|Period 3|Withdrawal by Subject|0|||
146908543|NCT01151137|529829492|FG000|Overall Study|Death|15|||
146908544|NCT01151137|529829493|FG001|Overall Study|Death|27|||
146908545|NCT01151137|529829492|FG000|Overall Study|Lost to Follow-up|1|||
146908546|NCT01151137|529829493|FG001|Overall Study|Lost to Follow-up|1|||
146908547|NCT01933672|529829495|FG000|Metformin Run-in Period|Adverse Event|1|||
146908548|NCT01933672|529829496|FG001|Metformin Run-in Period|Adverse Event|0|||
146908549|NCT01933672|529829497|FG002|Metformin Run-in Period|Adverse Event|0|||
146908550|NCT01933672|529829498|FG003|Metformin Run-in Period|Adverse Event|0|||
146908551|NCT01933672|529829499|FG004|Metformin Run-in Period|Adverse Event|0|||
146908552|NCT01933672|529829500|FG005|Metformin Run-in Period|Adverse Event|0|||
146908553|NCT01933672|529829501|FG006|Metformin Run-in Period|Adverse Event|0|||
146908554|NCT01933672|529829495|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
146908555|NCT01933672|529829496|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
146908556|NCT01933672|529829497|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
146908557|NCT01933672|529829498|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
146908558|NCT01933672|529829499|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
146908559|NCT01933672|529829500|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
146908560|NCT01933672|529829501|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
146908561|NCT01933672|529829495|FG000|Metformin Run-in Period|Other|5|||
146908562|NCT01933672|529829496|FG001|Metformin Run-in Period|Other|0|||
146908563|NCT01933672|529829497|FG002|Metformin Run-in Period|Other|0|||
146768240|NCT01837641|529319550|FG003|Overall Study|Withdrawal by Subject|0|||
146768241|NCT01837641|529319551|FG004|Overall Study|Withdrawal by Subject|1|||
146908564|NCT01933672|529829498|FG003|Metformin Run-in Period|Other|0|||
146908565|NCT01933672|529829499|FG004|Metformin Run-in Period|Other|0|||
146908566|NCT01933672|529829500|FG005|Metformin Run-in Period|Other|0|||
146908567|NCT01933672|529829501|FG006|Metformin Run-in Period|Other|0|||
146908568|NCT01933672|529829495|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146908569|NCT01933672|529829496|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146908570|NCT01933672|529829497|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146908571|NCT01933672|529829498|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146562742|NCT03396445|528571715|FG024|Switch-over Period|Lost to Follow-up|0|||
146562743|NCT03396445|528571716|FG025|Switch-over Period|Lost to Follow-up|0|||
146562744|NCT00876447|528571720|FG000|Overall Study|Other miscellaneous reasons|3|||
146562745|NCT00876447|528571721|FG001|Overall Study|Other miscellaneous reasons|8|||
146562746|NCT00876447|528571720|FG000|Overall Study|Site closure|19|||
146562747|NCT00876447|528571721|FG001|Overall Study|Site closure|14|||
146562748|NCT00876447|528571720|FG000|Overall Study|Protocol Violation|9|||
146562749|NCT00876447|528571721|FG001|Overall Study|Protocol Violation|3|||
146562750|NCT00876447|528571720|FG000|Overall Study|Personal reasons|30|||
146562751|NCT00876447|528571721|FG001|Overall Study|Personal reasons|28|||
146562752|NCT00876447|528571720|FG000|Overall Study|Lost to Follow-up|6|||
146562753|NCT00876447|528571721|FG001|Overall Study|Lost to Follow-up|15|||
146562754|NCT00876447|528571720|FG000|Overall Study|Pregnancy|4|||
146562755|NCT00876447|528571721|FG001|Overall Study|Pregnancy|2|||
146562756|NCT00876447|528571720|FG000|Overall Study|Lack of Efficacy|5|||
146562757|NCT00876447|528571721|FG001|Overall Study|Lack of Efficacy|3|||
146642078|NCT01057589|528865221|FG000|Overall Study|Adverse Event|10|||
146642079|NCT01057589|528865221|FG000|Overall Study|Physician Decision|8|||
146562758|NCT00876447|528571720|FG000|Overall Study|Adverse Event|4|||
146562759|NCT00876447|528571721|FG001|Overall Study|Adverse Event|8|||
146562760|NCT02538614|528571722|FG000|Overall Study|Progressive Disease|2|||
146562761|NCT01517984|528571731|FG000|Overall Study|Lost to Follow-up|0|||
146562762|NCT01517984|528571732|FG001|Overall Study|Lost to Follow-up|1|||
146908572|NCT01933672|529829499|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
146908573|NCT01933672|529829500|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146908574|NCT01933672|529829501|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146908575|NCT01933672|529829495|FG000|First Intervention Period (12-16 Days)|Other|0|||
146908576|NCT01933672|529829496|FG001|First Intervention Period (12-16 Days)|Other|0|||
146908577|NCT01933672|529829497|FG002|First Intervention Period (12-16 Days)|Other|1|||
146562763|NCT01517984|528571733|FG002|Overall Study|Lost to Follow-up|0|||
146562764|NCT01517984|528571734|FG003|Overall Study|Lost to Follow-up|0|||
146562765|NCT01517984|528571731|FG000|Overall Study|Withdrawal by Subject|1|||
146562766|NCT01517984|528571732|FG001|Overall Study|Withdrawal by Subject|8|||
146562767|NCT01517984|528571733|FG002|Overall Study|Withdrawal by Subject|4|||
146562768|NCT01517984|528571734|FG003|Overall Study|Withdrawal by Subject|1|||
146562769|NCT01517984|528571731|FG000|Overall Study|Screen Failure|4|||
146562770|NCT01517984|528571732|FG001|Overall Study|Screen Failure|0|||
146562771|NCT01517984|528571733|FG002|Overall Study|Screen Failure|0|||
146562772|NCT01517984|528571734|FG003|Overall Study|Screen Failure|0|||
146562773|NCT01517984|528571731|FG000|Overall Study|Ineligible for randomization|0|||
146562774|NCT01517984|528571732|FG001|Overall Study|Ineligible for randomization|14|||
146562775|NCT01517984|528571733|FG002|Overall Study|Ineligible for randomization|0|||
146562776|NCT01517984|528571734|FG003|Overall Study|Ineligible for randomization|0|||
146562777|NCT04903288|528571735|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
146562778|NCT04903288|528571735|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
146562779|NCT04903288|528571735|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
146562780|NCT04903288|528571735|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
146562781|NCT04617860|528571738|FG000|Overall Study|Adverse Event|0|||
146562782|NCT04617860|528571739|FG001|Overall Study|Adverse Event|2|||
146562783|NCT04617860|528571740|FG002|Overall Study|Adverse Event|2|||
146562784|NCT04617860|528571738|FG000|Overall Study|Withdrawal by Subject|0|||
146562785|NCT04617860|528571739|FG001|Overall Study|Withdrawal by Subject|0|||
146562786|NCT04617860|528571740|FG002|Overall Study|Withdrawal by Subject|2|||
146562787|NCT04617860|528571738|FG000|Overall Study|Physician Decision|0|||
146562788|NCT04617860|528571739|FG001|Overall Study|Physician Decision|1|||
146562789|NCT04617860|528571740|FG002|Overall Study|Physician Decision|0|||
146562790|NCT04617860|528571738|FG000|Overall Study|Sponsor Decision|0|||
146562791|NCT04617860|528571739|FG001|Overall Study|Sponsor Decision|3|||
146562792|NCT04617860|528571740|FG002|Overall Study|Sponsor Decision|1|||
146562793|NCT04617860|528571738|FG000|Overall Study|Termination of Study by Sponsor|8|||
146562794|NCT04617860|528571739|FG001|Overall Study|Termination of Study by Sponsor|4|||
146562795|NCT04617860|528571740|FG002|Overall Study|Termination of Study by Sponsor|13|||
146562796|NCT03898180|528571741|FG000|Overall Study|Death|178|||
146562797|NCT03898180|528571742|FG001|Overall Study|Death|173|||
146562798|NCT03898180|528571741|FG000|Overall Study|Physician Decision|1|||
146562799|NCT03898180|528571742|FG001|Overall Study|Physician Decision|0|||
146562800|NCT03898180|528571741|FG000|Overall Study|Sponsor Decision|3|||
146562801|NCT03898180|528571742|FG001|Overall Study|Sponsor Decision|0|||
146562802|NCT03898180|528571741|FG000|Overall Study|Lost to Follow-up|1|||
146562803|NCT03898180|528571742|FG001|Overall Study|Lost to Follow-up|0|||
146562804|NCT03898180|528571741|FG000|Overall Study|Withdrawal by Subject|5|||
146562805|NCT03898180|528571742|FG001|Overall Study|Withdrawal by Subject|4|||
146562806|NCT02507934|528571743|FG000|Overall Study|Lost to Follow-up|2|||
146562807|NCT02507934|528571744|FG001|Overall Study|Lost to Follow-up|0|||
146562808|NCT02507934|528571743|FG000|Overall Study|Withdrawal by Subject|2|||
146562809|NCT02507934|528571744|FG001|Overall Study|Withdrawal by Subject|0|||
146562810|NCT01559935|528571745|FG000|Car Phase|Toxicity|4|||
146562811|NCT01559935|528571745|FG000|Car Phase|Death|1|||
146562812|NCT01559935|528571745|FG000|Car Phase|Lack of Efficacy|2|||
146562813|NCT01559935|528571745|FG000|Car Phase|Lost to Follow-up|1|||
146562814|NCT01559935|528571745|FG000|Car Phase|Physician Decision|1|||
146562815|NCT01559935|528571745|FG000|Car Phase|Withdrawal by Subject|2|||
146562816|NCT01559935|528571745|FG000|Car Phase|Per protocol|1|||
146562817|NCT01559935|528571745|FG000|Car Phase|Insurance|1|||
146562818|NCT01559935|528571745|FG000|Car Phase|non-compliance|1|||
146562819|NCT01559935|528571745|FG000|BiRD Phase|Toxicity|1|||
146562820|NCT01559935|528571745|FG000|BiRD Phase|Lack of Efficacy|1|||
146642080|NCT01057589|528865221|FG000|Overall Study|Withdrawal by Subject|3|||
146642081|NCT01057589|528865221|FG000|Overall Study|Sponsor Decision|1|||
146642082|NCT01057589|528865221|FG000|Overall Study|Death|8|||
146642083|NCT01057589|528865221|FG000|Overall Study|Lost to Follow-up|1|||
146562821|NCT01559935|528571745|FG000|BiRD Phase|Withdrawal by Subject|2|||
146562822|NCT01559935|528571745|FG000|Maintenance Phase|Remains on study|28|||
146562823|NCT01559935|528571745|FG000|Maintenance Phase|Toxicity|1|||
146562824|NCT01559935|528571745|FG000|Maintenance Phase|Lack of Efficacy|18|||
146562825|NCT01559935|528571745|FG000|Maintenance Phase|Withdrawal by Subject|5|||
146562826|NCT01559935|528571745|FG000|Maintenance Phase|Non-compliance|2|||
146562827|NCT02661815|528571746|FG000|Overall Study|Withdrawal by Subject|1|||
146562828|NCT02661815|528571747|FG001|Overall Study|Withdrawal by Subject|0|||
146562829|NCT02661815|528571748|FG002|Overall Study|Withdrawal by Subject|0|||
146562830|NCT02661815|528571749|FG003|Overall Study|Withdrawal by Subject|0|||
146562831|NCT01983111|528571752|FG000|Overall Study|Withdrawal by Subject|8|||
146562832|NCT01983111|528571753|FG001|Overall Study|Withdrawal by Subject|6|||
146562833|NCT01983111|528571752|FG000|Overall Study|Adverse Event|4|||
146562834|NCT01983111|528571753|FG001|Overall Study|Adverse Event|0|||
146562835|NCT01983111|528571752|FG000|Overall Study|Protocol Violation|0|||
146562836|NCT01983111|528571753|FG001|Overall Study|Protocol Violation|1|||
146908578|NCT01933672|529829498|FG003|First Intervention Period (12-16 Days)|Other|0|||
146908579|NCT01933672|529829499|FG004|First Intervention Period (12-16 Days)|Other|0|||
146908580|NCT01933672|529829500|FG005|First Intervention Period (12-16 Days)|Other|1|||
146908581|NCT01933672|529829501|FG006|First Intervention Period (12-16 Days)|Other|0|||
146908582|NCT01933672|529829495|FG000|Second Intervention Period (12-16 Days)|Other|0|||
146908583|NCT01933672|529829496|FG001|Second Intervention Period (12-16 Days)|Other|1|||
146908584|NCT01933672|529829497|FG002|Second Intervention Period (12-16 Days)|Other|1|||
146908585|NCT01933672|529829498|FG003|Second Intervention Period (12-16 Days)|Other|0|||
146908586|NCT01933672|529829499|FG004|Second Intervention Period (12-16 Days)|Other|0|||
146908587|NCT01933672|529829500|FG005|Second Intervention Period (12-16 Days)|Other|0|||
146908588|NCT01933672|529829501|FG006|Second Intervention Period (12-16 Days)|Other|0|||
146908589|NCT01933672|529829495|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146908590|NCT01933672|529829496|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146908591|NCT01933672|529829497|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146908592|NCT01933672|529829498|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
146908593|NCT01933672|529829499|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146908594|NCT01933672|529829500|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146908595|NCT01933672|529829501|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146908596|NCT01933672|529829495|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
146908597|NCT01933672|529829496|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
146908598|NCT01933672|529829497|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
146908599|NCT01933672|529829498|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
146908600|NCT01933672|529829499|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
146908601|NCT01933672|529829500|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
146908602|NCT01933672|529829501|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
146908603|NCT01607892|529829504|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
146908604|NCT01607892|529829505|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
146908605|NCT01607892|529829506|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
146908606|NCT01607892|529829507|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
146908607|NCT01607892|529829508|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
146908608|NCT01607892|529829504|FG000|Overall Study|Death|4|||
146908609|NCT01607892|529829505|FG001|Overall Study|Death|2|||
146908610|NCT01607892|529829506|FG002|Overall Study|Death|8|||
146908611|NCT01607892|529829507|FG003|Overall Study|Death|10|||
146908612|NCT01607892|529829508|FG004|Overall Study|Death|3|||
146908613|NCT01607892|529829504|FG000|Overall Study|Investigator discretion|2|||
146908614|NCT01607892|529829505|FG001|Overall Study|Investigator discretion|4|||
146908615|NCT01607892|529829506|FG002|Overall Study|Investigator discretion|4|||
146908616|NCT01607892|529829507|FG003|Overall Study|Investigator discretion|8|||
146908617|NCT01607892|529829508|FG004|Overall Study|Investigator discretion|0|||
146908618|NCT01607892|529829504|FG000|Overall Study|Other treatments became available|1|||
146908619|NCT01607892|529829505|FG001|Overall Study|Other treatments became available|1|||
146562837|NCT00855335|528571754|FG000|Overall Study|Lost to Follow-up|0|||
146908620|NCT01607892|529829506|FG002|Overall Study|Other treatments became available|0|||
146562838|NCT00855335|528571755|FG001|Overall Study|Lost to Follow-up|0|||
146562839|NCT00855335|528571756|FG002|Overall Study|Lost to Follow-up|3|||
146562840|NCT00855335|528571757|FG003|Overall Study|Lost to Follow-up|1|||
146908621|NCT01607892|529829507|FG003|Overall Study|Other treatments became available|0|||
146908622|NCT01607892|529829508|FG004|Overall Study|Other treatments became available|2|||
146908623|NCT01607892|529829504|FG000|Overall Study|Intercurrent illness|1|||
146908624|NCT01607892|529829505|FG001|Overall Study|Intercurrent illness|0|||
146908625|NCT01607892|529829506|FG002|Overall Study|Intercurrent illness|0|||
146908626|NCT01607892|529829507|FG003|Overall Study|Intercurrent illness|3|||
146908627|NCT01607892|529829508|FG004|Overall Study|Intercurrent illness|0|||
146908628|NCT01607892|529829504|FG000|Overall Study|Non-Compliance with study procedures|0|||
146908629|NCT01607892|529829505|FG001|Overall Study|Non-Compliance with study procedures|0|||
146908630|NCT01607892|529829506|FG002|Overall Study|Non-Compliance with study procedures|1|||
146908631|NCT01607892|529829507|FG003|Overall Study|Non-Compliance with study procedures|0|||
146908632|NCT01607892|529829508|FG004|Overall Study|Non-Compliance with study procedures|0|||
146908633|NCT01607892|529829504|FG000|Overall Study|Consent withdrawn by participant|9|||
146908634|NCT01607892|529829505|FG001|Overall Study|Consent withdrawn by participant|4|||
146908635|NCT01607892|529829506|FG002|Overall Study|Consent withdrawn by participant|24|||
146908636|NCT01607892|529829507|FG003|Overall Study|Consent withdrawn by participant|14|||
146908637|NCT01607892|529829508|FG004|Overall Study|Consent withdrawn by participant|4|||
146908638|NCT01607892|529829504|FG000|Overall Study|Disease progression|38|||
146908639|NCT01607892|529829505|FG001|Overall Study|Disease progression|13|||
146908640|NCT01607892|529829506|FG002|Overall Study|Disease progression|37|||
146908641|NCT01607892|529829507|FG003|Overall Study|Disease progression|57|||
146908642|NCT01607892|529829508|FG004|Overall Study|Disease progression|9|||
146908643|NCT01607892|529829504|FG000|Overall Study|Incidence or severity of Adverse events|3|||
146908644|NCT01607892|529829505|FG001|Overall Study|Incidence or severity of Adverse events|3|||
146908645|NCT01607892|529829506|FG002|Overall Study|Incidence or severity of Adverse events|7|||
146908646|NCT01607892|529829507|FG003|Overall Study|Incidence or severity of Adverse events|2|||
146908647|NCT01607892|529829508|FG004|Overall Study|Incidence or severity of Adverse events|6|||
146908648|NCT02273973|529829511|FG000|Overall Study|Adverse Event|4|||
146908649|NCT02273973|529829512|FG001|Overall Study|Adverse Event|0|||
146908650|NCT02273973|529829511|FG000|Overall Study|Withdrawal by Subject|2|||
146908651|NCT02273973|529829512|FG001|Overall Study|Withdrawal by Subject|3|||
146908652|NCT02273973|529829511|FG000|Overall Study|Death|1|||
146908653|NCT02273973|529829512|FG001|Overall Study|Death|0|||
146908654|NCT02273973|529829511|FG000|Overall Study|Non-compliance|1|||
146908655|NCT02273973|529829512|FG001|Overall Study|Non-compliance|0|||
146908656|NCT02273973|529829511|FG000|Overall Study|Protocol Violation|1|||
146908657|NCT02273973|529829512|FG001|Overall Study|Protocol Violation|0|||
146908658|NCT02273973|529829511|FG000|Overall Study|Progression of disease|0|||
146908659|NCT02273973|529829512|FG001|Overall Study|Progression of disease|2|||
146908660|NCT02273973|529829511|FG000|Overall Study|Lost to Follow-up|0|||
146908661|NCT02273973|529829512|FG001|Overall Study|Lost to Follow-up|1|||
146908662|NCT02273973|529829511|FG000|Overall Study|Physician Decision|0|||
146908663|NCT02273973|529829512|FG001|Overall Study|Physician Decision|1|||
146642084|NCT02954172|528865224|FG000|Overall Study|Protocol Violation|3|||
146908664|NCT02273973|529829511|FG000|Overall Study|Reason not specified|0|||
146908665|NCT02273973|529829512|FG001|Overall Study|Reason not specified|1|||
146908666|NCT03022422|529829514|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
146908667|NCT03022422|529829515|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
146908668|NCT03022422|529829516|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
146908669|NCT03022422|529829517|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
146908670|NCT03022422|529829518|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
146908671|NCT03022422|529829519|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
146908672|NCT01282814|529829520|FG000|First Intervention|Emesis During Dosing Interval|0|||
146908673|NCT01282814|529829521|FG001|First Intervention|Emesis During Dosing Interval|3|||
146908674|NCT01282814|529829520|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
146908675|NCT01282814|529829521|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
146908676|NCT00957372|529829522|FG000|PART I|Lost to Follow-up|0|||
146908677|NCT00957372|529829523|FG001|PART I|Lost to Follow-up|0|||
146908678|NCT00957372|529829524|FG002|PART I|Lost to Follow-up|1|||
146908679|NCT00957372|529829525|FG003|PART I|Lost to Follow-up|0|||
146908680|NCT00957372|529829522|FG000|PART II|Withdrawal by Subject|0|||
146908681|NCT00957372|529829523|FG001|PART II|Withdrawal by Subject|0|||
146908682|NCT00957372|529829524|FG002|PART II|Withdrawal by Subject|0|||
146908683|NCT00957372|529829525|FG003|PART II|Withdrawal by Subject|8|||
146908684|NCT00957372|529829522|FG000|PART II|Physician Decision|0|||
146908685|NCT00957372|529829523|FG001|PART II|Physician Decision|0|||
146908686|NCT00957372|529829524|FG002|PART II|Physician Decision|0|||
146908687|NCT00957372|529829525|FG003|PART II|Physician Decision|1|||
146908688|NCT00957372|529829522|FG000|PART II|Pregnancy|0|||
146908689|NCT00957372|529829523|FG001|PART II|Pregnancy|0|||
146908690|NCT00957372|529829524|FG002|PART II|Pregnancy|0|||
146908691|NCT00957372|529829525|FG003|PART II|Pregnancy|1|||
146908692|NCT00957372|529829522|FG000|PART II|Not Know|0|||
146908693|NCT00957372|529829523|FG001|PART II|Not Know|0|||
146908694|NCT00957372|529829524|FG002|PART II|Not Know|0|||
146908695|NCT00957372|529829525|FG003|PART II|Not Know|20|||
146562841|NCT00855335|528571758|FG004|Overall Study|Lost to Follow-up|0|||
146562842|NCT00855335|528571754|FG000|Overall Study|Withdrawal by Subject|0|||
146562843|NCT00855335|528571755|FG001|Overall Study|Withdrawal by Subject|0|||
146562844|NCT00855335|528571756|FG002|Overall Study|Withdrawal by Subject|0|||
146562845|NCT00855335|528571757|FG003|Overall Study|Withdrawal by Subject|1|||
146562846|NCT00855335|528571758|FG004|Overall Study|Withdrawal by Subject|0|||
146562847|NCT00855335|528571754|FG000|Overall Study|Adverse Event|2|||
146562848|NCT00855335|528571755|FG001|Overall Study|Adverse Event|0|||
146562849|NCT00855335|528571756|FG002|Overall Study|Adverse Event|0|||
146562850|NCT00855335|528571757|FG003|Overall Study|Adverse Event|0|||
146562851|NCT00855335|528571758|FG004|Overall Study|Adverse Event|0|||
146562852|NCT00855335|528571754|FG000|Overall Study|Physician Decision|1|||
146562853|NCT00855335|528571755|FG001|Overall Study|Physician Decision|1|||
146562854|NCT00855335|528571756|FG002|Overall Study|Physician Decision|0|||
146908696|NCT00957372|529829522|FG000|PART II|Adverse Event|0|||
146908697|NCT00957372|529829523|FG001|PART II|Adverse Event|0|||
146908698|NCT00957372|529829524|FG002|PART II|Adverse Event|0|||
146908699|NCT00957372|529829525|FG003|PART II|Adverse Event|10|||
146908700|NCT00957372|529829522|FG000|PART II|Patient non-compliance|0|||
146908701|NCT00957372|529829523|FG001|PART II|Patient non-compliance|0|||
146908702|NCT00957372|529829524|FG002|PART II|Patient non-compliance|0|||
146908703|NCT00957372|529829525|FG003|PART II|Patient non-compliance|4|||
146908704|NCT02403206|529829526|FG000|Overall Study|Lost to Follow-up|4|||
146908705|NCT02403206|529829527|FG001|Overall Study|Lost to Follow-up|3|||
146908706|NCT02403206|529829526|FG000|Overall Study|Physician Decision|2|||
146908707|NCT02403206|529829527|FG001|Overall Study|Physician Decision|0|||
146908708|NCT02403206|529829526|FG000|Overall Study|Withdrawal by Subject|3|||
146908709|NCT02403206|529829527|FG001|Overall Study|Withdrawal by Subject|3|||
146908710|NCT02403206|529829526|FG000|Overall Study|Reason not given|2|||
146908711|NCT02403206|529829527|FG001|Overall Study|Reason not given|4|||
146908712|NCT01444391|529829530|FG000|Overall Study|Death|1|||
146908713|NCT01287117|529829531|FG000|Overall Study|Adverse Event|2|||
146908714|NCT01287117|529829532|FG001|Overall Study|Adverse Event|1|||
146908715|NCT01287117|529829533|FG002|Overall Study|Adverse Event|1|||
146908716|NCT01287117|529829534|FG003|Overall Study|Adverse Event|1|||
146908717|NCT01287117|529829531|FG000|Overall Study|Lost to Follow-up|1|||
146908718|NCT01287117|529829532|FG001|Overall Study|Lost to Follow-up|1|||
146908719|NCT01287117|529829533|FG002|Overall Study|Lost to Follow-up|0|||
146908720|NCT01287117|529829534|FG003|Overall Study|Lost to Follow-up|0|||
146908721|NCT01287117|529829531|FG000|Overall Study|Physician Decision|0|||
146908722|NCT01287117|529829532|FG001|Overall Study|Physician Decision|1|||
146908723|NCT01287117|529829533|FG002|Overall Study|Physician Decision|1|||
146908724|NCT01287117|529829534|FG003|Overall Study|Physician Decision|1|||
146908725|NCT01287117|529829531|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
146908726|NCT01287117|529829532|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
146908727|NCT01287117|529829533|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
146642085|NCT02954172|528865225|FG001|Overall Study|Protocol Violation|0|||
146642086|NCT02954172|528865224|FG000|Overall Study|allergic reaction|2|||
146642087|NCT02954172|528865225|FG001|Overall Study|allergic reaction|1|||
146642088|NCT02954172|528865224|FG000|Overall Study|non-measurable lesions at baseline|1|||
146642089|NCT02954172|528865225|FG001|Overall Study|non-measurable lesions at baseline|2|||
146642090|NCT01519167|528865226|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
146642091|NCT01519167|528865227|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
146908728|NCT01287117|529829534|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
146642092|NCT01519167|528865226|FG000|Overall Study|Adverse Event|0|||
146642093|NCT01519167|528865227|FG001|Overall Study|Adverse Event|1|||
146908729|NCT01287117|529829531|FG000|Overall Study|Disease Progression|10|||
146908730|NCT01287117|529829532|FG001|Overall Study|Disease Progression|5|||
146908731|NCT01287117|529829533|FG002|Overall Study|Disease Progression|6|||
146642094|NCT01519167|528865226|FG000|Overall Study|Lack of Efficacy|0|||
146642095|NCT01519167|528865227|FG001|Overall Study|Lack of Efficacy|1|||
146908732|NCT01287117|529829534|FG003|Overall Study|Disease Progression|5|||
146908733|NCT01676116|529829535|FG000|Overall Study|Withdrawal criteria|2|||
146908734|NCT01676116|529829536|FG001|Overall Study|Withdrawal criteria|14|||
146908735|NCT01676116|529829535|FG000|Overall Study|Adverse Event|1|||
146642096|NCT01519167|528865226|FG000|Overall Study|Medical condition changes&deep sedation|0|||
146642097|NCT01519167|528865227|FG001|Overall Study|Medical condition changes&deep sedation|2|||
146642098|NCT01519167|528865226|FG000|Overall Study|Physician Decision|0|||
146642099|NCT01519167|528865227|FG001|Overall Study|Physician Decision|1|||
146642100|NCT00870584|528865228|FG000|Overall Study|Adverse Event|3|||
146642101|NCT00870584|528865229|FG001|Overall Study|Adverse Event|3|||
146642102|NCT00870584|528865228|FG000|Overall Study|Withdrawal by Subject|6|||
146642103|NCT00870584|528865229|FG001|Overall Study|Withdrawal by Subject|7|||
146642104|NCT00870584|528865228|FG000|Overall Study|Lost to Follow-up|5|||
146642105|NCT00870584|528865229|FG001|Overall Study|Lost to Follow-up|1|||
146642106|NCT00870584|528865228|FG000|Overall Study|Protocol Deviation|2|||
146908736|NCT01676116|529829536|FG001|Overall Study|Adverse Event|2|||
146908737|NCT01676116|529829535|FG000|Overall Study|Unclassified|4|||
146642107|NCT00870584|528865229|FG001|Overall Study|Protocol Deviation|2|||
146908738|NCT01676116|529829536|FG001|Overall Study|Unclassified|10|||
146642108|NCT01497366|528865230|FG000|Overall Study|Virologic failure|2|||
146908739|NCT01676116|529829535|FG000|Overall Study|Protocol Violation|9|||
146642109|NCT01497366|528865231|FG001|Overall Study|Virologic failure|50|||
146908740|NCT01676116|529829536|FG001|Overall Study|Protocol Violation|3|||
146908741|NCT02032524|529829544|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
146642110|NCT01497366|528865230|FG000|Overall Study|Lost to Follow-up|11|||
146642111|NCT01497366|528865231|FG001|Overall Study|Lost to Follow-up|10|||
146642112|NCT01497366|528865230|FG000|Overall Study|Withdrawal by Subject|6|||
146642113|NCT01497366|528865231|FG001|Overall Study|Withdrawal by Subject|6|||
146642114|NCT01497366|528865230|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
146642115|NCT01497366|528865231|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
146642116|NCT01497366|528865230|FG000|Overall Study|Other|5|||
146642117|NCT01497366|528865231|FG001|Overall Study|Other|0|||
146642118|NCT01497366|528865230|FG000|Overall Study|Death|1|||
146642119|NCT01497366|528865231|FG001|Overall Study|Death|1|||
146642120|NCT01497366|528865230|FG000|Overall Study|Randomized but not treated|7|||
146642121|NCT01497366|528865231|FG001|Overall Study|Randomized but not treated|21|||
146642122|NCT00472030|528865243|FG000|Overall Study|Physician Decision|1|||
146642123|NCT00472030|528865244|FG001|Overall Study|Physician Decision|0|||
146642124|NCT00829504|528865245|FG000|First Intervention|Adverse Event|1|||
146642125|NCT00829504|528865246|FG001|First Intervention|Adverse Event|0|||
146642126|NCT00829504|528865245|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
146642127|NCT00829504|528865246|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
146642128|NCT00829504|528865245|FG000|Second Intervention|Physician Decision|1|||
146642129|NCT00829504|528865246|FG001|Second Intervention|Physician Decision|0|||
146642130|NCT04189224|528865247|FG000|Period 2|Adverse Event|0|||
146642131|NCT04189224|528865248|FG001|Period 2|Adverse Event|1|||
146642132|NCT04236141|528867794|FG000|Overall Study|Death|18|||
146642133|NCT04236141|528867795|FG001|Overall Study|Death|10|||
146642134|NCT04236141|528867794|FG000|Overall Study|Withdrawal by Participant|1|||
146642135|NCT04236141|528867795|FG001|Overall Study|Withdrawal by Participant|0|||
146642136|NCT04236141|528867794|FG000|Overall Study|Reason not Specified|1|||
146642137|NCT04236141|528867795|FG001|Overall Study|Reason not Specified|0|||
146642138|NCT04236141|528867794|FG000|Overall Study|Study terminated by Sponsor|8|||
146642139|NCT04236141|528867795|FG001|Overall Study|Study terminated by Sponsor|4|||
146642140|NCT01217307|528867799|FG000|Overall Study|Withdrawal by Subject|0|||
146642141|NCT01217307|528867800|FG001|Overall Study|Withdrawal by Subject|1|||
146642142|NCT01888432|528867805|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
146642143|NCT01888432|528867806|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
146642144|NCT01888432|528867805|FG000|12-month Analysis (FAS)|Physician Decision|1|||
146908742|NCT02032524|529829545|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
146642145|NCT01888432|528867806|FG001|12-month Analysis (FAS)|Physician Decision|1|||
146642146|NCT01888432|528867805|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
146642147|NCT01888432|528867806|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
146642148|NCT01888432|528867805|FG000|12-month Analysis (FAS)|Death|4|||
146642149|NCT01888432|528867806|FG001|12-month Analysis (FAS)|Death|3|||
146642150|NCT01888432|528867805|FG000|24-month Analysis (FAS)|Graft loss|0|||
146642151|NCT01888432|528867806|FG001|24-month Analysis (FAS)|Graft loss|1|||
146642152|NCT01888432|528867805|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
146642153|NCT01888432|528867806|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
146642154|NCT01888432|528867805|FG000|24-month Analysis (FAS)|Physician Decision|2|||
146642155|NCT01888432|528867806|FG001|24-month Analysis (FAS)|Physician Decision|4|||
146642156|NCT01888432|528867805|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
146642157|NCT01888432|528867806|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
146642158|NCT01888432|528867805|FG000|24-month Analysis (FAS)|Death|8|||
146642159|NCT01888432|528867806|FG001|24-month Analysis (FAS)|Death|4|||
146642160|NCT01888432|528867805|FG000|36-month Analysis (Extension)|Death|1|||
146642161|NCT01888432|528867806|FG001|36-month Analysis (Extension)|Death|0|||
146642162|NCT01696929|528867809|FG000|Overall Study|Physician Decision|1|||
146642163|NCT04473235|528867812|FG000|Overall Study|Lost to Follow-up|6|||
146642164|NCT04473235|528867813|FG001|Overall Study|Lost to Follow-up|5|||
146642165|NCT04473235|528867812|FG000|Overall Study|Declined continuation|2|||
146642166|NCT04473235|528867813|FG001|Overall Study|Declined continuation|0|||
146642167|NCT04473235|528867812|FG000|Overall Study|Physician Decision|1|||
146642168|NCT04473235|528867813|FG001|Overall Study|Physician Decision|1|||
146642169|NCT04473235|528867812|FG000|Overall Study|Protocol Violation|10|||
146642170|NCT04473235|528867813|FG001|Overall Study|Protocol Violation|6|||
146642171|NCT00798759|528867816|FG000|Overall Study|Adverse Event|3|||
146642172|NCT00798759|528867817|FG001|Overall Study|Adverse Event|3|||
146642173|NCT00798759|528867816|FG000|Overall Study|Lost to Follow-up|1|||
146642174|NCT00798759|528867817|FG001|Overall Study|Lost to Follow-up|1|||
146642175|NCT00798759|528867816|FG000|Overall Study|Protocol Violation|4|||
146642176|NCT00798759|528867817|FG001|Overall Study|Protocol Violation|8|||
146642177|NCT00798759|528867816|FG000|Overall Study|Other|0|||
146642178|NCT00798759|528867817|FG001|Overall Study|Other|1|||
146642179|NCT02156271|528867818|FG000|Overall Study|Physician Decision|4|||
146642180|NCT02156271|528867819|FG001|Overall Study|Physician Decision|3|||
146642181|NCT00955305|528867820|FG000|Overall Study|Disease progression|39|||
146642182|NCT00955305|528867821|FG001|Overall Study|Disease progression|41|||
146642183|NCT00955305|528867820|FG000|Overall Study|Adverse Event|22|||
146642184|NCT00955305|528867821|FG001|Overall Study|Adverse Event|22|||
146642185|NCT00955305|528867820|FG000|Overall Study|Death|2|||
146642186|NCT00955305|528867821|FG001|Overall Study|Death|1|||
146642187|NCT00955305|528867820|FG000|Overall Study|Withdrawal by Subject|5|||
146642188|NCT00955305|528867821|FG001|Overall Study|Withdrawal by Subject|4|||
146642189|NCT00955305|528867820|FG000|Overall Study|Alternative therapy|4|||
146642190|NCT00955305|528867821|FG001|Overall Study|Alternative therapy|0|||
146642191|NCT00955305|528867820|FG000|Overall Study|Other complicating disease|2|||
146642192|NCT00955305|528867821|FG001|Overall Study|Other complicating disease|4|||
146642193|NCT00955305|528867820|FG000|Overall Study|Physician Decision|1|||
146642194|NCT00955305|528867821|FG001|Overall Study|Physician Decision|0|||
146642195|NCT00955305|528867820|FG000|Overall Study|Continued presence of residual disease|0|||
146642196|NCT00955305|528867821|FG001|Overall Study|Continued presence of residual disease|1|||
146642197|NCT00955305|528867820|FG000|Overall Study|Functional decline|2|||
146642198|NCT00955305|528867821|FG001|Overall Study|Functional decline|0|||
146642199|NCT00955305|528867820|FG000|Overall Study|Maximum response achieved|0|||
146642200|NCT00955305|528867821|FG001|Overall Study|Maximum response achieved|1|||
146642201|NCT00955305|528867820|FG000|Overall Study|Lost to Follow-up|0|||
146642202|NCT00955305|528867821|FG001|Overall Study|Lost to Follow-up|1|||
146642203|NCT00955305|528867820|FG000|Overall Study|No off-treatment reason submitted|1|||
146642204|NCT00955305|528867821|FG001|Overall Study|No off-treatment reason submitted|0|||
146642205|NCT00955305|528867820|FG000|Overall Study|Never started protocol treatment|5|||
146642206|NCT00955305|528867821|FG001|Overall Study|Never started protocol treatment|5|||
146642207|NCT00955305|528867820|FG000|Overall Study|Ineligible|5|||
146642208|NCT00955305|528867821|FG001|Overall Study|Ineligible|7|||
146642209|NCT03387111|528867822|FG000|Overall Study|Progressive Disease|3|||
146642210|NCT03387111|528867822|FG000|Overall Study|Other|1|||
146908743|NCT02032524|529829546|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
146908744|NCT02032524|529829547|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
146642211|NCT01945710|528867826|FG000|Overall Study|Progressive Disease|5|||
146642212|NCT01945710|528867827|FG001|Overall Study|Progressive Disease|4|||
146642213|NCT01945710|528867828|FG002|Overall Study|Progressive Disease|3|||
146642214|NCT01945710|528867829|FG003|Overall Study|Progressive Disease|2|||
146642215|NCT01945710|528867830|FG004|Overall Study|Progressive Disease|7|||
146642216|NCT01945710|528867831|FG005|Overall Study|Progressive Disease|3|||
146642217|NCT01945710|528867832|FG006|Overall Study|Progressive Disease|19|||
146642218|NCT01945710|528867826|FG000|Overall Study|Adverse Event|0|||
146642219|NCT01945710|528867827|FG001|Overall Study|Adverse Event|1|||
146908745|NCT02032524|529829548|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
146908746|NCT02032524|529829549|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
146908747|NCT02032524|529829544|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
146908748|NCT02032524|529829545|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
146908749|NCT02032524|529829546|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
146908750|NCT02032524|529829547|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
146908751|NCT02032524|529829548|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
146908752|NCT02032524|529829549|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
146908753|NCT02032524|529829544|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
146908754|NCT02032524|529829545|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
146908755|NCT02032524|529829546|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
146908756|NCT02032524|529829547|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
146908757|NCT02032524|529829548|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
146908758|NCT02032524|529829549|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
146908759|NCT02032524|529829544|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
146908760|NCT02032524|529829545|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
146908761|NCT02032524|529829546|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
146908762|NCT02032524|529829547|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
146908763|NCT02032524|529829548|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
146908764|NCT02032524|529829549|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
146908765|NCT02032524|529829544|FG000|Period 2: LTS13769 Study|Other|0|||
146908766|NCT02032524|529829545|FG001|Period 2: LTS13769 Study|Other|0|||
146908767|NCT02032524|529829546|FG002|Period 2: LTS13769 Study|Other|0|||
146908768|NCT02032524|529829547|FG003|Period 2: LTS13769 Study|Other|0|||
146908769|NCT02032524|529829548|FG004|Period 2: LTS13769 Study|Other|0|||
146908770|NCT02032524|529829549|FG005|Period 2: LTS13769 Study|Other|1|||
146908771|NCT03567187|529829550|FG000|Overall Study|Lost to Follow-up|18|||
146908772|NCT03596645|529829553|FG000|Overall Study|Adverse Event|17|||
146908773|NCT03596645|529829554|FG001|Overall Study|Adverse Event|0|||
146908774|NCT03596645|529829553|FG000|Overall Study|Lack of Efficacy|8|||
146908775|NCT03596645|529829554|FG001|Overall Study|Lack of Efficacy|0|||
146908776|NCT03596645|529829553|FG000|Overall Study|Lost to Follow-up|1|||
146562855|NCT00855335|528571757|FG003|Overall Study|Physician Decision|0|||
146908777|NCT03596645|529829554|FG001|Overall Study|Lost to Follow-up|1|||
146908778|NCT03596645|529829553|FG000|Overall Study|Physician Decision|1|||
146908779|NCT03596645|529829554|FG001|Overall Study|Physician Decision|1|||
146908780|NCT03596645|529829553|FG000|Overall Study|Protocol Violation|1|||
146908781|NCT03596645|529829554|FG001|Overall Study|Protocol Violation|0|||
146908782|NCT03596645|529829553|FG000|Overall Study|Initiated Prohibited Medication|1|||
146908783|NCT03596645|529829554|FG001|Overall Study|Initiated Prohibited Medication|0|||
146908784|NCT03596645|529829553|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146908785|NCT03596645|529829554|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146908786|NCT03596645|529829553|FG000|Overall Study|No mucosal healing achieved|1|||
146908787|NCT03596645|529829554|FG001|Overall Study|No mucosal healing achieved|0|||
146908788|NCT03596645|529829553|FG000|Overall Study|Disease progression|1|||
146908789|NCT03596645|529829554|FG001|Overall Study|Disease progression|0|||
146908790|NCT03596645|529829553|FG000|Overall Study|Ongoing|37|||
146908791|NCT03596645|529829554|FG001|Overall Study|Ongoing|12|||
146908792|NCT03596645|529829553|FG000|Overall Study|Randomized but not treated|0|||
146908793|NCT03596645|529829554|FG001|Overall Study|Randomized but not treated|1|||
146908794|NCT04358458|529829555|FG000|Overall Study|Death|1|||
146908795|NCT04358458|529829556|FG001|Overall Study|Death|1|||
146908796|NCT04358458|529829557|FG002|Overall Study|Death|3|||
146908797|NCT04358458|529829558|FG003|Overall Study|Death|8|||
146908798|NCT04358458|529829559|FG004|Overall Study|Death|1|||
146908799|NCT04358458|529829560|FG005|Overall Study|Death|6|||
146908800|NCT04358458|529829561|FG006|Overall Study|Death|2|||
146908801|NCT04358458|529829562|FG007|Overall Study|Death|3|||
146908802|NCT04358458|529829555|FG000|Overall Study|Lost to Follow-up|0|||
146908803|NCT04358458|529829556|FG001|Overall Study|Lost to Follow-up|0|||
146908804|NCT04358458|529829557|FG002|Overall Study|Lost to Follow-up|0|||
146908805|NCT04358458|529829558|FG003|Overall Study|Lost to Follow-up|0|||
146908806|NCT04358458|529829559|FG004|Overall Study|Lost to Follow-up|0|||
146908807|NCT04358458|529829560|FG005|Overall Study|Lost to Follow-up|0|||
146908808|NCT04358458|529829561|FG006|Overall Study|Lost to Follow-up|0|||
146908809|NCT04358458|529829562|FG007|Overall Study|Lost to Follow-up|1|||
146908810|NCT04358458|529829555|FG000|Overall Study|Site is closing study participation|0|||
146908811|NCT04358458|529829556|FG001|Overall Study|Site is closing study participation|0|||
146908812|NCT04358458|529829557|FG002|Overall Study|Site is closing study participation|0|||
146908813|NCT04358458|529829558|FG003|Overall Study|Site is closing study participation|1|||
146908814|NCT04358458|529829559|FG004|Overall Study|Site is closing study participation|0|||
146908815|NCT04358458|529829560|FG005|Overall Study|Site is closing study participation|0|||
146908816|NCT04358458|529829561|FG006|Overall Study|Site is closing study participation|0|||
146908817|NCT04358458|529829562|FG007|Overall Study|Site is closing study participation|0|||
146908818|NCT04358458|529829555|FG000|Overall Study|Sponsor request|2|||
146908819|NCT04358458|529829556|FG001|Overall Study|Sponsor request|3|||
146908820|NCT04358458|529829557|FG002|Overall Study|Sponsor request|3|||
146908821|NCT04358458|529829558|FG003|Overall Study|Sponsor request|0|||
146908822|NCT04358458|529829559|FG004|Overall Study|Sponsor request|2|||
146908823|NCT04358458|529829560|FG005|Overall Study|Sponsor request|3|||
146908824|NCT04358458|529829561|FG006|Overall Study|Sponsor request|1|||
146908825|NCT04358458|529829562|FG007|Overall Study|Sponsor request|1|||
146908826|NCT04358458|529829555|FG000|Overall Study|Withdrawal by Subject|0|||
146908827|NCT04358458|529829556|FG001|Overall Study|Withdrawal by Subject|0|||
146908828|NCT04358458|529829557|FG002|Overall Study|Withdrawal by Subject|1|||
146908829|NCT04358458|529829558|FG003|Overall Study|Withdrawal by Subject|1|||
146908830|NCT04358458|529829559|FG004|Overall Study|Withdrawal by Subject|0|||
146908831|NCT04358458|529829560|FG005|Overall Study|Withdrawal by Subject|1|||
146908832|NCT04358458|529829561|FG006|Overall Study|Withdrawal by Subject|0|||
146908833|NCT04358458|529829562|FG007|Overall Study|Withdrawal by Subject|1|||
146908834|NCT04513158|529829563|FG000|Overall Study|Screen Failure|1|||
146908835|NCT05165394|529831295|FG000|Overall Study|Withdrawal by Subject|5|||
146908836|NCT05165394|529831296|FG001|Overall Study|Withdrawal by Subject|1|||
146908837|NCT05165394|529831295|FG000|Overall Study|Lost to Follow-up|1|||
146908838|NCT05165394|529831296|FG001|Overall Study|Lost to Follow-up|2|||
146908839|NCT05165394|529831295|FG000|Overall Study|Other Than Specified|0|||
146908840|NCT05165394|529831296|FG001|Overall Study|Other Than Specified|1|||
146908841|NCT02629393|529831297|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
146908842|NCT02629393|529831297|FG000|Overall Study|Physician Decision|1|||
146908843|NCT03937986|529831298|FG000|Overall Study|COVID-19 Pandemic|1|||
146970292|NCT03972709|530052591|FG001|Overall Study|Subject Unable to be Contacted|1|||
146562856|NCT00855335|528571758|FG004|Overall Study|Physician Decision|0|||
146562857|NCT00855335|528571754|FG000|Overall Study|Other|2|||
146562858|NCT00855335|528571755|FG001|Overall Study|Other|1|||
146562859|NCT00855335|528571756|FG002|Overall Study|Other|2|||
146642220|NCT01945710|528867828|FG002|Overall Study|Adverse Event|0|||
146642221|NCT01945710|528867829|FG003|Overall Study|Adverse Event|0|||
146642222|NCT01945710|528867830|FG004|Overall Study|Adverse Event|0|||
146642223|NCT01945710|528867831|FG005|Overall Study|Adverse Event|0|||
146642224|NCT01945710|528867832|FG006|Overall Study|Adverse Event|0|||
146642225|NCT01945710|528867826|FG000|Overall Study|Other|2|||
146642226|NCT01945710|528867827|FG001|Overall Study|Other|0|||
146642227|NCT01945710|528867828|FG002|Overall Study|Other|3|||
146642228|NCT01945710|528867829|FG003|Overall Study|Other|1|||
146642229|NCT01945710|528867830|FG004|Overall Study|Other|1|||
146642230|NCT01945710|528867831|FG005|Overall Study|Other|0|||
146642231|NCT01945710|528867832|FG006|Overall Study|Other|4|||
146642232|NCT01945710|528867826|FG000|Overall Study|Withdrawal by Subject|0|||
146642233|NCT01945710|528867827|FG001|Overall Study|Withdrawal by Subject|1|||
146642234|NCT01945710|528867828|FG002|Overall Study|Withdrawal by Subject|1|||
146642235|NCT01945710|528867829|FG003|Overall Study|Withdrawal by Subject|0|||
146642236|NCT01945710|528867830|FG004|Overall Study|Withdrawal by Subject|1|||
146642237|NCT01945710|528867831|FG005|Overall Study|Withdrawal by Subject|0|||
146642238|NCT01945710|528867832|FG006|Overall Study|Withdrawal by Subject|0|||
146642239|NCT02730195|528867833|FG000|Overall Study|Withdrawal by Subject|1|||
146642240|NCT00375609|528867834|FG000|Overall Study|Did not receive treatment|1|||
146642241|NCT00375609|528867835|FG001|Overall Study|Did not receive treatment|0|||
146642242|NCT00375609|528867836|FG002|Overall Study|Did not receive treatment|0|||
146562860|NCT00855335|528571757|FG003|Overall Study|Other|5|||
146562861|NCT00855335|528571758|FG004|Overall Study|Other|1|||
146562862|NCT02526290|528571759|FG000|Overall Study|Adverse Event|3|||
146562863|NCT02526290|528571759|FG000|Overall Study|Withdrawal by Subject|4|||
146562864|NCT02526290|528571759|FG000|Overall Study|Physician Decision|1|||
146562865|NCT02082977|528571760|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
146562866|NCT02082977|528571761|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
146562867|NCT02082977|528571762|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
146562868|NCT02082977|528571763|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
146642243|NCT00375609|528867834|FG000|Overall Study|Adverse Event|0|||
146642244|NCT00375609|528867835|FG001|Overall Study|Adverse Event|3|||
146642245|NCT00375609|528867836|FG002|Overall Study|Adverse Event|0|||
146908844|NCT01853228|529831299|FG000|Phase 1|Lack of Efficacy|8|||
146642246|NCT00375609|528867834|FG000|Overall Study|Lost to Follow-up|1|||
146908845|NCT01853228|529831300|FG001|Phase 1|Lack of Efficacy|0|||
146562869|NCT02082977|528571764|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
146562870|NCT02082977|528571765|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
146562871|NCT02082977|528571766|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
146562872|NCT02082977|528571767|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
146562873|NCT02082977|528571768|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
146562874|NCT02082977|528571769|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
146562875|NCT02082977|528571760|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
146562876|NCT02082977|528571761|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
146562877|NCT02082977|528571762|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
146562878|NCT02082977|528571763|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
146562879|NCT02082977|528571764|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
146562880|NCT02082977|528571765|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
146562881|NCT02082977|528571766|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
146562882|NCT02082977|528571767|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
146562883|NCT02082977|528571768|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
146562884|NCT02082977|528571769|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
146562885|NCT02082977|528571760|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
146562886|NCT02082977|528571761|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
146562887|NCT02082977|528571762|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
146562888|NCT02082977|528571763|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
146562889|NCT02082977|528571764|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
146562890|NCT02082977|528571765|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
146562891|NCT02082977|528571766|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
146562892|NCT02082977|528571767|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
146562893|NCT02082977|528571768|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
146562894|NCT02082977|528571769|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
146562895|NCT02082977|528571760|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
146562896|NCT02082977|528571761|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
146562897|NCT02082977|528571762|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
146562898|NCT02082977|528571763|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
146562899|NCT02082977|528571764|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
146562900|NCT02082977|528571765|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
146562901|NCT02082977|528571766|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
146562902|NCT02082977|528571767|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
146562903|NCT02082977|528571768|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
146562904|NCT02082977|528571769|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
146562905|NCT02082977|528571760|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
146562906|NCT02082977|528571761|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
146562907|NCT02082977|528571762|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
146562908|NCT02082977|528571763|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
146562909|NCT02082977|528571764|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
146562910|NCT02082977|528571765|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
146562911|NCT02082977|528571766|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
146562912|NCT02082977|528571767|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
146562913|NCT02082977|528571768|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
146562914|NCT02082977|528571769|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
146562915|NCT00049543|528571773|FG000|Overall Study|still on treatment|2|||
146562916|NCT00049543|528571774|FG001|Overall Study|still on treatment|9|||
146562917|NCT00105066|528571775|FG000|Overall Study|Adverse Event|2|||
146562918|NCT00105066|528571776|FG001|Overall Study|Adverse Event|5|||
146562919|NCT01467466|528571777|FG000|Overall Study|Withdrawal by Subject|15|||
146562920|NCT01467466|528571778|FG001|Overall Study|Withdrawal by Subject|18|||
146562921|NCT01467466|528571779|FG002|Overall Study|Withdrawal by Subject|13|||
146562922|NCT01467466|528571780|FG003|Overall Study|Withdrawal by Subject|11|||
146562923|NCT01467466|528571777|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
146562924|NCT01467466|528571778|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
146642247|NCT00375609|528867835|FG001|Overall Study|Lost to Follow-up|0|||
146642248|NCT00375609|528867836|FG002|Overall Study|Lost to Follow-up|0|||
146642249|NCT00375609|528867834|FG000|Overall Study|Physician Decision|0|||
146642250|NCT00375609|528867835|FG001|Overall Study|Physician Decision|0|||
146970293|NCT03972709|530052592|FG002|Overall Study|Subject Unable to be Contacted|0|||
146562925|NCT01467466|528571779|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
146562926|NCT01467466|528571780|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
146562927|NCT01467466|528571777|FG000|Overall Study|Procedure Cancelled|46|||
146562928|NCT01467466|528571778|FG001|Overall Study|Procedure Cancelled|45|||
146562929|NCT01467466|528571779|FG002|Overall Study|Procedure Cancelled|25|||
146562930|NCT01467466|528571780|FG003|Overall Study|Procedure Cancelled|29|||
146562931|NCT01467466|528571777|FG000|Overall Study|No Endpoint Blood Draw|38|||
146908846|NCT01853228|529831299|FG000|Phase 1|Other|1|||
146908847|NCT01853228|529831300|FG001|Phase 1|Other|0|||
146908848|NCT01853228|529831299|FG000|Phase 2|Physician Decision|0|||
146908849|NCT01853228|529831300|FG001|Phase 2|Physician Decision|1|||
146908850|NCT01853228|529831299|FG000|Phase 2|Proceed To Transplant|0|||
146908851|NCT01853228|529831300|FG001|Phase 2|Proceed To Transplant|3|||
146908852|NCT01853228|529831299|FG000|Phase 2|Lack of Efficacy|0|||
146908853|NCT01853228|529831300|FG001|Phase 2|Lack of Efficacy|4|||
146908854|NCT01123889|529831302|FG000|Overall Study|Lost to Follow-up|3|||
146908855|NCT01123889|529831303|FG001|Overall Study|Lost to Follow-up|1|||
146908856|NCT02786537|529831304|FG000|As Randomized|Adverse Event|0|||
146908857|NCT02786537|529831305|FG001|As Randomized|Adverse Event|11|||
146908858|NCT02786537|529831306|FG002|As Randomized|Adverse Event|0|||
146908859|NCT02786537|529831307|FG003|As Randomized|Adverse Event|4|||
146908860|NCT02786537|529831308|FG004|As Randomized|Adverse Event|6|||
146908861|NCT02786537|529831309|FG005|As Randomized|Adverse Event|2|||
146908862|NCT02786537|529831304|FG000|As Randomized|Lack of Efficacy|0|||
146908863|NCT02786537|529831305|FG001|As Randomized|Lack of Efficacy|0|||
146908864|NCT02786537|529831306|FG002|As Randomized|Lack of Efficacy|0|||
146908865|NCT02786537|529831307|FG003|As Randomized|Lack of Efficacy|1|||
146908866|NCT02786537|529831308|FG004|As Randomized|Lack of Efficacy|0|||
146908867|NCT02786537|529831309|FG005|As Randomized|Lack of Efficacy|0|||
146908868|NCT02786537|529831304|FG000|As Randomized|Withdrawal by Subject|1|||
146908869|NCT02786537|529831305|FG001|As Randomized|Withdrawal by Subject|2|||
146908870|NCT02786537|529831306|FG002|As Randomized|Withdrawal by Subject|0|||
146908871|NCT02786537|529831307|FG003|As Randomized|Withdrawal by Subject|1|||
146908872|NCT02786537|529831308|FG004|As Randomized|Withdrawal by Subject|1|||
146908873|NCT02786537|529831309|FG005|As Randomized|Withdrawal by Subject|0|||
146908874|NCT02786537|529831304|FG000|As Randomized|Death|0|||
146908875|NCT02786537|529831305|FG001|As Randomized|Death|2|||
146908876|NCT02786537|529831306|FG002|As Randomized|Death|0|||
146908877|NCT02786537|529831307|FG003|As Randomized|Death|3|||
146908878|NCT02786537|529831308|FG004|As Randomized|Death|1|||
146908879|NCT02786537|529831309|FG005|As Randomized|Death|0|||
146908880|NCT02786537|529831304|FG000|As Randomized|Non-compliance with study drug|1|||
146908881|NCT02786537|529831305|FG001|As Randomized|Non-compliance with study drug|11|||
146908882|NCT02786537|529831306|FG002|As Randomized|Non-compliance with study drug|0|||
146908883|NCT02786537|529831307|FG003|As Randomized|Non-compliance with study drug|1|||
146908884|NCT02786537|529831308|FG004|As Randomized|Non-compliance with study drug|0|||
146908885|NCT02786537|529831309|FG005|As Randomized|Non-compliance with study drug|1|||
146908886|NCT02786537|529831304|FG000|As Randomized|Lost to treatment follow-up|4|||
146908887|NCT02786537|529831305|FG001|As Randomized|Lost to treatment follow-up|32|||
146908888|NCT02786537|529831306|FG002|As Randomized|Lost to treatment follow-up|0|||
146908889|NCT02786537|529831307|FG003|As Randomized|Lost to treatment follow-up|24|||
146908890|NCT02786537|529831308|FG004|As Randomized|Lost to treatment follow-up|4|||
146908891|NCT02786537|529831309|FG005|As Randomized|Lost to treatment follow-up|4|||
146908892|NCT02786537|529831304|FG000|As Randomized|Incarceration|0|||
146908893|NCT02786537|529831305|FG001|As Randomized|Incarceration|1|||
146908894|NCT02786537|529831306|FG002|As Randomized|Incarceration|0|||
146908895|NCT02786537|529831307|FG003|As Randomized|Incarceration|0|||
146908896|NCT02786537|529831308|FG004|As Randomized|Incarceration|0|||
146908897|NCT02786537|529831309|FG005|As Randomized|Incarceration|0|||
146908898|NCT02786537|529831304|FG000|As Randomized|Opiate Dependency Relapse|0|||
146908899|NCT02786537|529831305|FG001|As Randomized|Opiate Dependency Relapse|1|||
146908900|NCT02786537|529831306|FG002|As Randomized|Opiate Dependency Relapse|0|||
146908901|NCT02786537|529831307|FG003|As Randomized|Opiate Dependency Relapse|0|||
146908902|NCT02786537|529831308|FG004|As Randomized|Opiate Dependency Relapse|0|||
146908903|NCT02786537|529831309|FG005|As Randomized|Opiate Dependency Relapse|0|||
146908904|NCT02786537|529831304|FG000|As Randomized|HCV drugs stolen from pt|0|||
146908905|NCT02786537|529831305|FG001|As Randomized|HCV drugs stolen from pt|1|||
146908906|NCT02786537|529831306|FG002|As Randomized|HCV drugs stolen from pt|0|||
146908907|NCT02786537|529831307|FG003|As Randomized|HCV drugs stolen from pt|0|||
146908908|NCT02786537|529831308|FG004|As Randomized|HCV drugs stolen from pt|0|||
146908909|NCT02786537|529831309|FG005|As Randomized|HCV drugs stolen from pt|0|||
146908910|NCT02786537|529831304|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
146908911|NCT02786537|529831305|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
146908912|NCT02786537|529831306|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
146908913|NCT02786537|529831307|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
146908914|NCT02786537|529831308|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
146908915|NCT02786537|529831309|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
146642251|NCT00375609|528867836|FG002|Overall Study|Physician Decision|1|||
146642252|NCT00375609|528867834|FG000|Overall Study|Withdrawal by Subject|1|||
146642253|NCT00375609|528867835|FG001|Overall Study|Withdrawal by Subject|4|||
146642254|NCT00375609|528867836|FG002|Overall Study|Withdrawal by Subject|0|||
146642255|NCT00375609|528867834|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
146642256|NCT00375609|528867835|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
146642257|NCT00375609|528867836|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
146642258|NCT01368562|528867837|FG000|Overall Study|Adverse Event|1|||
146642259|NCT01368562|528867837|FG000|Overall Study|Disease progression|1|||
146642260|NCT01368562|528867837|FG000|Overall Study|Lost to Follow-up|1|||
146908916|NCT02786537|529831304|FG000|As Randomized|Subject lost insurance|0|||
146908917|NCT02786537|529831305|FG001|As Randomized|Subject lost insurance|0|||
146908918|NCT02786537|529831306|FG002|As Randomized|Subject lost insurance|0|||
146908919|NCT02786537|529831307|FG003|As Randomized|Subject lost insurance|1|||
146908920|NCT02786537|529831308|FG004|As Randomized|Subject lost insurance|0|||
146908921|NCT02786537|529831309|FG005|As Randomized|Subject lost insurance|0|||
146908922|NCT02786537|529831304|FG000|As Treated|Adverse Event|0|||
146908923|NCT02786537|529831305|FG001|As Treated|Adverse Event|11|||
146908924|NCT02786537|529831306|FG002|As Treated|Adverse Event|0|||
146908925|NCT02786537|529831307|FG003|As Treated|Adverse Event|4|||
146908926|NCT02786537|529831308|FG004|As Treated|Adverse Event|6|||
146908927|NCT02786537|529831309|FG005|As Treated|Adverse Event|2|||
146908928|NCT02786537|529831304|FG000|As Treated|Death|0|||
146908929|NCT02786537|529831305|FG001|As Treated|Death|2|||
146908930|NCT02786537|529831306|FG002|As Treated|Death|0|||
146908931|NCT02786537|529831307|FG003|As Treated|Death|3|||
146908932|NCT02786537|529831308|FG004|As Treated|Death|1|||
146908933|NCT02786537|529831309|FG005|As Treated|Death|0|||
146908934|NCT02786537|529831304|FG000|As Treated|Lack of Efficacy|0|||
146908935|NCT02786537|529831305|FG001|As Treated|Lack of Efficacy|0|||
146908936|NCT02786537|529831306|FG002|As Treated|Lack of Efficacy|0|||
146908937|NCT02786537|529831307|FG003|As Treated|Lack of Efficacy|1|||
146908938|NCT02786537|529831308|FG004|As Treated|Lack of Efficacy|0|||
146908939|NCT02786537|529831309|FG005|As Treated|Lack of Efficacy|0|||
146908940|NCT02786537|529831304|FG000|As Treated|Lost to Follow-up|4|||
146908941|NCT02786537|529831305|FG001|As Treated|Lost to Follow-up|32|||
146562932|NCT01467466|528571778|FG001|Overall Study|No Endpoint Blood Draw|32|||
146562933|NCT01467466|528571779|FG002|Overall Study|No Endpoint Blood Draw|51|||
146562934|NCT01467466|528571780|FG003|Overall Study|No Endpoint Blood Draw|43|||
146562935|NCT00787150|528571781|FG000|Overall Study|Adverse Event|4|||
146562936|NCT00787150|528571782|FG001|Overall Study|Adverse Event|4|||
146562937|NCT00787150|528571783|FG002|Overall Study|Adverse Event|4|||
146562938|NCT00787150|528571781|FG000|Overall Study|Physician Decision|1|||
146562939|NCT00787150|528571782|FG001|Overall Study|Physician Decision|2|||
146562940|NCT00787150|528571783|FG002|Overall Study|Physician Decision|1|||
146562941|NCT00787150|528571781|FG000|Overall Study|Withdrawal by Subject|2|||
146562942|NCT00787150|528571782|FG001|Overall Study|Withdrawal by Subject|1|||
146562943|NCT00787150|528571783|FG002|Overall Study|Withdrawal by Subject|0|||
146562944|NCT00787150|528571781|FG000|Overall Study|Dosing incorrect study durg|2|||
146562945|NCT00787150|528571782|FG001|Overall Study|Dosing incorrect study durg|0|||
146562946|NCT00787150|528571783|FG002|Overall Study|Dosing incorrect study durg|0|||
146562947|NCT03261505|528571784|FG000|Overall Study|Withdrawal by Subject|2|||
146562948|NCT03261505|528571785|FG001|Overall Study|Withdrawal by Subject|3|||
146562949|NCT03261505|528571786|FG002|Overall Study|Withdrawal by Subject|4|||
146562950|NCT03261505|528571787|FG003|Overall Study|Withdrawal by Subject|3|||
146562951|NCT03261505|528571784|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
146562952|NCT03261505|528571785|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
146562953|NCT03261505|528571786|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
146562954|NCT03261505|528571787|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
146562955|NCT03261505|528571784|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
146562956|NCT03261505|528571785|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
146642261|NCT01368562|528867837|FG000|Overall Study|Death|6|||
146908942|NCT02786537|529831306|FG002|As Treated|Lost to Follow-up|0|||
146908943|NCT02786537|529831307|FG003|As Treated|Lost to Follow-up|25|||
146908944|NCT02786537|529831308|FG004|As Treated|Lost to Follow-up|4|||
146908945|NCT02786537|529831309|FG005|As Treated|Lost to Follow-up|4|||
146908946|NCT02786537|529831304|FG000|As Treated|Non-compliance with study drug|1|||
146908947|NCT02786537|529831305|FG001|As Treated|Non-compliance with study drug|11|||
146908948|NCT02786537|529831306|FG002|As Treated|Non-compliance with study drug|0|||
146908949|NCT02786537|529831307|FG003|As Treated|Non-compliance with study drug|1|||
146908950|NCT02786537|529831308|FG004|As Treated|Non-compliance with study drug|0|||
146562957|NCT03261505|528571786|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
146908951|NCT02786537|529831309|FG005|As Treated|Non-compliance with study drug|1|||
146908952|NCT02786537|529831304|FG000|As Treated|Lost insurance|0|||
146562958|NCT03261505|528571787|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
146908953|NCT02786537|529831305|FG001|As Treated|Lost insurance|0|||
146908954|NCT02786537|529831306|FG002|As Treated|Lost insurance|0|||
146908955|NCT02786537|529831307|FG003|As Treated|Lost insurance|1|||
146642262|NCT01368562|528867837|FG000|Overall Study|Unresponsive to treatment|5|||
146642263|NCT01368562|528867837|FG000|Overall Study|Other|3|||
146642264|NCT01368562|528867837|FG000|Overall Study|Other than specified|2|||
146642265|NCT02810444|528867839|FG000|Overall Study|Screen Failures|14|||
146642266|NCT02810444|528867839|FG000|Overall Study|Withdrawal by Subject|4|||
146642267|NCT02810444|528867839|FG000|Overall Study|Adverse Event|3|||
146642268|NCT00745849|528867840|FG000|First Intervention|Withdrawal by Subject|0|||
146908956|NCT02786537|529831308|FG004|As Treated|Lost insurance|0|||
146562959|NCT03261505|528571784|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
146562960|NCT03261505|528571785|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
146562961|NCT03261505|528571786|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
146562962|NCT03261505|528571787|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
146562963|NCT03773484|528571798|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
146562964|NCT04079738|528571799|FG000|Study Treatment|Death|1|||
146562965|NCT04079738|528571800|FG001|Study Treatment|Death|0|||
146562966|NCT04079738|528571801|FG002|Study Treatment|Death|0|||
146562967|NCT04079738|528571802|FG003|Study Treatment|Death|0|||
146562968|NCT04079738|528571799|FG000|Study Treatment|Adverse Event|2|||
146562969|NCT04079738|528571800|FG001|Study Treatment|Adverse Event|0|||
146562970|NCT04079738|528571801|FG002|Study Treatment|Adverse Event|0|||
146908957|NCT02786537|529831309|FG005|As Treated|Lost insurance|0|||
146908958|NCT02786537|529831304|FG000|As Treated|Withdrawal by Subject|1|||
146908959|NCT02786537|529831305|FG001|As Treated|Withdrawal by Subject|2|||
146908960|NCT02786537|529831306|FG002|As Treated|Withdrawal by Subject|0|||
146908961|NCT02786537|529831307|FG003|As Treated|Withdrawal by Subject|0|||
146908962|NCT02786537|529831308|FG004|As Treated|Withdrawal by Subject|1|||
146908963|NCT02786537|529831309|FG005|As Treated|Withdrawal by Subject|0|||
146908964|NCT02786537|529831304|FG000|As Treated|Incarceration|0|||
146908965|NCT02786537|529831305|FG001|As Treated|Incarceration|1|||
146908966|NCT02786537|529831306|FG002|As Treated|Incarceration|0|||
146908967|NCT02786537|529831307|FG003|As Treated|Incarceration|0|||
146908968|NCT02786537|529831308|FG004|As Treated|Incarceration|0|||
146908969|NCT02786537|529831309|FG005|As Treated|Incarceration|0|||
146908970|NCT02786537|529831304|FG000|As Treated|Opiate dependency relapse|0|||
146908971|NCT02786537|529831305|FG001|As Treated|Opiate dependency relapse|1|||
146908972|NCT02786537|529831306|FG002|As Treated|Opiate dependency relapse|0|||
146908973|NCT02786537|529831307|FG003|As Treated|Opiate dependency relapse|0|||
146908974|NCT02786537|529831308|FG004|As Treated|Opiate dependency relapse|0|||
146908975|NCT02786537|529831309|FG005|As Treated|Opiate dependency relapse|0|||
146908976|NCT02786537|529831304|FG000|As Treated|Drugs stolen from patient|0|||
146908977|NCT02786537|529831305|FG001|As Treated|Drugs stolen from patient|1|||
146908978|NCT02786537|529831306|FG002|As Treated|Drugs stolen from patient|0|||
146908979|NCT02786537|529831307|FG003|As Treated|Drugs stolen from patient|0|||
146908980|NCT02786537|529831308|FG004|As Treated|Drugs stolen from patient|0|||
146908981|NCT02786537|529831309|FG005|As Treated|Drugs stolen from patient|0|||
146908982|NCT02786537|529831304|FG000|As Treated|Advised to stop tx after loss of meds|0|||
146908983|NCT02786537|529831305|FG001|As Treated|Advised to stop tx after loss of meds|1|||
146908984|NCT02786537|529831306|FG002|As Treated|Advised to stop tx after loss of meds|0|||
146908985|NCT02786537|529831307|FG003|As Treated|Advised to stop tx after loss of meds|0|||
146908986|NCT02786537|529831308|FG004|As Treated|Advised to stop tx after loss of meds|0|||
146908987|NCT02786537|529831309|FG005|As Treated|Advised to stop tx after loss of meds|0|||
146908988|NCT01330381|529831310|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
146908989|NCT01330381|529831311|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
146908990|NCT01330381|529831312|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
146908991|NCT01330381|529831310|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
146908992|NCT01330381|529831311|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
146908993|NCT01330381|529831312|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
146908994|NCT01330381|529831310|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
146908995|NCT01330381|529831311|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
146908996|NCT01330381|529831312|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
146908997|NCT01330381|529831310|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
146908998|NCT01330381|529831311|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
146908999|NCT01330381|529831312|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
146909000|NCT01330381|529831310|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
146909001|NCT01330381|529831311|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
146909002|NCT01330381|529831312|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
146909003|NCT01330381|529831310|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
146909004|NCT01330381|529831311|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
146909005|NCT01330381|529831312|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
146909006|NCT01330381|529831310|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
146909007|NCT01330381|529831311|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
146909008|NCT01330381|529831312|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
146909009|NCT01330381|529831310|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
146909010|NCT01330381|529831311|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
146909011|NCT01330381|529831312|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
146909012|NCT01330381|529831310|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
146909013|NCT01330381|529831311|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
146562971|NCT04079738|528571802|FG003|Study Treatment|Adverse Event|0|||
146909014|NCT01330381|529831312|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
146909015|NCT01330381|529831310|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
146909016|NCT01330381|529831311|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
146909017|NCT01330381|529831312|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
146562972|NCT04079738|528571799|FG000|Study Treatment|withdrawal before treatment|1|||
146562973|NCT04079738|528571800|FG001|Study Treatment|withdrawal before treatment|0|||
146562974|NCT04079738|528571801|FG002|Study Treatment|withdrawal before treatment|0|||
146562975|NCT04079738|528571802|FG003|Study Treatment|withdrawal before treatment|0|||
146562976|NCT04079738|528571799|FG000|Study Treatment|symptomatic deterioration|2|||
146562977|NCT04079738|528571800|FG001|Study Treatment|symptomatic deterioration|0|||
146562978|NCT04079738|528571801|FG002|Study Treatment|symptomatic deterioration|0|||
146562979|NCT04079738|528571802|FG003|Study Treatment|symptomatic deterioration|0|||
146562980|NCT04079738|528571799|FG000|Study Treatment|Disease Progression|1|||
146562981|NCT04079738|528571800|FG001|Study Treatment|Disease Progression|0|||
146562982|NCT04079738|528571801|FG002|Study Treatment|Disease Progression|0|||
146562983|NCT04079738|528571802|FG003|Study Treatment|Disease Progression|0|||
146562984|NCT04079738|528571799|FG000|Study Treatment|withdrawal after treatment|1|||
146562985|NCT04079738|528571800|FG001|Study Treatment|withdrawal after treatment|0|||
146562986|NCT04079738|528571801|FG002|Study Treatment|withdrawal after treatment|0|||
146562987|NCT04079738|528571802|FG003|Study Treatment|withdrawal after treatment|0|||
146562988|NCT04079738|528571799|FG000|Follow up|Withdrawal by Subject|3|||
146562989|NCT04079738|528571800|FG001|Follow up|Withdrawal by Subject|0|||
146562990|NCT04079738|528571801|FG002|Follow up|Withdrawal by Subject|0|||
146562991|NCT04079738|528571802|FG003|Follow up|Withdrawal by Subject|0|||
146562992|NCT04079738|528571799|FG000|Follow up|Death|5|||
146562993|NCT04079738|528571800|FG001|Follow up|Death|0|||
146562994|NCT04079738|528571801|FG002|Follow up|Death|0|||
146562995|NCT04079738|528571802|FG003|Follow up|Death|0|||
146909018|NCT01272180|529831314|FG000|Overall Study|Adverse Event|0|||
146562996|NCT05552859|528571803|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
146562997|NCT05552859|528571804|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
146562998|NCT04251533|528571805|FG000|Overall Study|Progressive disease|33|||
146562999|NCT04251533|528571806|FG001|Overall Study|Progressive disease|29|||
146768242|NCT01837641|529319552|FG005|Overall Study|Withdrawal by Subject|0|||
146909019|NCT01272180|529831315|FG001|Overall Study|Adverse Event|0|||
146909020|NCT01272180|529831316|FG002|Overall Study|Adverse Event|1|||
146909021|NCT01272180|529831317|FG003|Overall Study|Adverse Event|0|||
146909022|NCT01272180|529831314|FG000|Overall Study|Withdrawal by Subject|2|||
146909023|NCT01272180|529831315|FG001|Overall Study|Withdrawal by Subject|6|||
146909024|NCT01272180|529831316|FG002|Overall Study|Withdrawal by Subject|3|||
146909025|NCT01272180|529831317|FG003|Overall Study|Withdrawal by Subject|2|||
146909026|NCT01272180|529831314|FG000|Overall Study|Lost to Follow-up|15|||
146909027|NCT01272180|529831315|FG001|Overall Study|Lost to Follow-up|14|||
146909028|NCT01272180|529831316|FG002|Overall Study|Lost to Follow-up|8|||
146909029|NCT01272180|529831317|FG003|Overall Study|Lost to Follow-up|10|||
146909030|NCT01272180|529831314|FG000|Overall Study|Inappropriate enrollment|0|||
146909031|NCT01272180|529831315|FG001|Overall Study|Inappropriate enrollment|0|||
146909032|NCT01272180|529831316|FG002|Overall Study|Inappropriate enrollment|1|||
146909033|NCT01272180|529831317|FG003|Overall Study|Inappropriate enrollment|1|||
146909034|NCT01272180|529831314|FG000|Overall Study|Protocol Violation|0|||
146563000|NCT04251533|528571807|FG002|Overall Study|Progressive disease|22|||
146563001|NCT04251533|528571805|FG000|Overall Study|Death|5|||
146563002|NCT04251533|528571806|FG001|Overall Study|Death|1|||
146563003|NCT04251533|528571807|FG002|Overall Study|Death|3|||
146563004|NCT04251533|528571805|FG000|Overall Study|Physician Decision|3|||
146563005|NCT04251533|528571806|FG001|Overall Study|Physician Decision|2|||
146563006|NCT04251533|528571807|FG002|Overall Study|Physician Decision|4|||
146642269|NCT00745849|528867841|FG001|First Intervention|Withdrawal by Subject|1|||
146768243|NCT01837641|529319553|FG006|Overall Study|Withdrawal by Subject|1|||
146768244|NCT01837641|529319554|FG007|Overall Study|Withdrawal by Subject|0|||
146768245|NCT01579916|529319555|FG000|Overall Study|Lost to Follow-up|6|||
146768246|NCT01579916|529319556|FG001|Overall Study|Lost to Follow-up|1|||
146909035|NCT01272180|529831315|FG001|Overall Study|Protocol Violation|1|||
146909036|NCT01272180|529831316|FG002|Overall Study|Protocol Violation|0|||
146909037|NCT01272180|529831317|FG003|Overall Study|Protocol Violation|1|||
146909038|NCT03334214|529831318|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
146563007|NCT04251533|528571805|FG000|Overall Study|Participant decision|1|||
146563008|NCT04251533|528571806|FG001|Overall Study|Participant decision|3|||
146563009|NCT04251533|528571807|FG002|Overall Study|Participant decision|1|||
146768247|NCT01579916|529319555|FG000|Overall Study|Withdrawal by Subject|1|||
146768248|NCT01579916|529319556|FG001|Overall Study|Withdrawal by Subject|1|||
146768249|NCT01579916|529319555|FG000|Overall Study|Death|1|||
146768250|NCT01579916|529319556|FG001|Overall Study|Death|0|||
146768251|NCT03264456|529319557|FG000|Overall Study|Withdrawal by Subject|3|||
146768252|NCT03264456|529319557|FG000|Overall Study|Lost to Follow-up|1|||
146768253|NCT01123083|529319560|FG000|Overall Study|Investigator recommendation|1|||
146768254|NCT01123083|529319561|FG001|Overall Study|Investigator recommendation|1|||
146768255|NCT01123083|529319560|FG000|Overall Study|Administrative reasons|0|||
146768256|NCT01123083|529319561|FG001|Overall Study|Administrative reasons|4|||
146768257|NCT01123083|529319560|FG000|Overall Study|Lost to Follow-up|2|||
146768258|NCT01123083|529319561|FG001|Overall Study|Lost to Follow-up|6|||
146768259|NCT01123083|529319560|FG000|Overall Study|Adverse Event|1|||
146768260|NCT01123083|529319561|FG001|Overall Study|Adverse Event|0|||
146768261|NCT01123083|529319560|FG000|Overall Study|Withdrew for another reason not covered|0|||
146768262|NCT01123083|529319561|FG001|Overall Study|Withdrew for another reason not covered|1|||
146768263|NCT01123083|529319560|FG000|Overall Study|Participant/legal representative request|7|||
146768264|NCT01123083|529319561|FG001|Overall Study|Participant/legal representative request|3|||
146563010|NCT04251533|528571805|FG000|Overall Study|Adverse Event|2|||
146563011|NCT04251533|528571806|FG001|Overall Study|Adverse Event|1|||
146563012|NCT04251533|528571807|FG002|Overall Study|Adverse Event|1|||
146563013|NCT00210132|528571812|FG000|Overall Study|Protocol Violation|1|||
146563014|NCT00210132|528571813|FG001|Overall Study|Protocol Violation|4|||
146563015|NCT02711202|528571814|FG000|Overall Study|Adverse Event|3|||
146563016|NCT02711202|528571815|FG001|Overall Study|Adverse Event|0|||
146563017|NCT02711202|528571814|FG000|Overall Study|graft loss|1|||
146563018|NCT02711202|528571815|FG001|Overall Study|graft loss|0|||
146563019|NCT00432965|528571816|FG000|Overall Study|Lost to Follow-up|22|||
146563020|NCT00432965|528571817|FG001|Overall Study|Lost to Follow-up|19|||
146563021|NCT00432965|528571816|FG000|Overall Study|Withdrawal by Subject|13|||
146563022|NCT00432965|528571817|FG001|Overall Study|Withdrawal by Subject|13|||
146563023|NCT00432965|528571816|FG000|Overall Study|Physician Decision|14|||
146563024|NCT00432965|528571817|FG001|Overall Study|Physician Decision|13|||
146563025|NCT00432965|528571816|FG000|Overall Study|Lack of Efficacy|8|||
146563026|NCT00432965|528571817|FG001|Overall Study|Lack of Efficacy|13|||
146563027|NCT00432965|528571816|FG000|Overall Study|Non-compliance|7|||
146563028|NCT00432965|528571817|FG001|Overall Study|Non-compliance|0|||
146563029|NCT00432965|528571816|FG000|Overall Study|Adverse Event|22|||
146563030|NCT00432965|528571817|FG001|Overall Study|Adverse Event|19|||
146563031|NCT00432965|528571816|FG000|Overall Study|Death|3|||
146563032|NCT00432965|528571817|FG001|Overall Study|Death|4|||
146768265|NCT00961636|529319562|FG000|Overall Study|Adverse Event|35|||
146768266|NCT00961636|529319563|FG001|Overall Study|Adverse Event|54|||
146768267|NCT00961636|529319564|FG002|Overall Study|Adverse Event|13|||
146563033|NCT00432965|528571816|FG000|Overall Study|Exclusionary Methods|1|||
146563034|NCT00432965|528571817|FG001|Overall Study|Exclusionary Methods|2|||
146563035|NCT00432965|528571816|FG000|Overall Study|Incomplete Data|4|||
146563036|NCT00432965|528571817|FG001|Overall Study|Incomplete Data|3|||
146563037|NCT01889251|528571818|FG000|Overall Study|Adverse Event|1|||
146563038|NCT01889251|528571819|FG001|Overall Study|Adverse Event|0|||
146563039|NCT03448393|528571822|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
146563040|NCT03448393|528571823|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
146563041|NCT03448393|528571824|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
146563042|NCT03448393|528571825|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
146563043|NCT03448393|528571826|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
146563044|NCT03448393|528571827|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
146563045|NCT03448393|528571828|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
146563046|NCT03448393|528571829|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
146563047|NCT03448393|528571830|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
146563048|NCT03448393|528571822|FG000|Dose Expansion|Not treated - screen failure|0|||
146563049|NCT03448393|528571823|FG001|Dose Expansion|Not treated - screen failure|0|||
146563050|NCT03448393|528571824|FG002|Dose Expansion|Not treated - screen failure|0|||
146563051|NCT03448393|528571825|FG003|Dose Expansion|Not treated - screen failure|0|||
146563052|NCT03448393|528571826|FG004|Dose Expansion|Not treated - screen failure|0|||
146563053|NCT03448393|528571827|FG005|Dose Expansion|Not treated - screen failure|0|||
146563054|NCT03448393|528571828|FG006|Dose Expansion|Not treated - screen failure|0|||
146563055|NCT03448393|528571829|FG007|Dose Expansion|Not treated - screen failure|0|||
146563056|NCT03448393|528571830|FG008|Dose Expansion|Not treated - screen failure|7|||
146563057|NCT01587196|528571831|FG000|Overall Study|Lost to Follow-up|50|||
146563058|NCT01587196|528571831|FG000|Overall Study|Withdrawal by Subject|4|||
146563059|NCT00642759|528571832|FG000|Overall Study|Protocol Violation|1|||
146563060|NCT00643279|528571837|FG000|Overall Study|Death|13|||
146563061|NCT00643279|528571838|FG001|Overall Study|Death|11|||
146563062|NCT00643279|528571837|FG000|Overall Study|Withdrawal by Subject|3|||
146563063|NCT00643279|528571838|FG001|Overall Study|Withdrawal by Subject|0|||
146563064|NCT00643279|528571837|FG000|Overall Study|Lost to Follow-up|0|||
146563065|NCT00643279|528571838|FG001|Overall Study|Lost to Follow-up|1|||
146563066|NCT00643279|528571837|FG000|Overall Study|Physician Decision|0|||
146563067|NCT00643279|528571838|FG001|Overall Study|Physician Decision|1|||
146563068|NCT03612570|528571839|FG000|Overall Study|Lost to Follow-up|1|||
146563069|NCT05212168|528571840|FG000|Overall Study|Lost to Follow-up|0|||
146563070|NCT05212168|528571841|FG001|Overall Study|Lost to Follow-up|3|||
146563071|NCT05212168|528571840|FG000|Overall Study|Study terminated by sponsor|30|||
146563072|NCT05212168|528571841|FG001|Overall Study|Study terminated by sponsor|27|||
146563073|NCT05212168|528571840|FG000|Overall Study|Other|4|||
146909039|NCT03334214|529831319|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
146909040|NCT03334214|529831318|FG000|Overall Study|Withdrawal by Subject|0|||
146909041|NCT03334214|529831319|FG001|Overall Study|Withdrawal by Subject|1|||
146563074|NCT05212168|528571841|FG001|Overall Study|Other|7|||
146563075|NCT00618787|528571843|FG000|Overall Study|Adverse Event|0|||
146563076|NCT00618787|528571844|FG001|Overall Study|Adverse Event|1|||
146563077|NCT00618787|528571843|FG000|Overall Study|Withdrawal by Subject|2|||
146563078|NCT00618787|528571844|FG001|Overall Study|Withdrawal by Subject|1|||
146563079|NCT00618787|528571843|FG000|Overall Study|Lost to Follow-up|1|||
146563080|NCT00618787|528571844|FG001|Overall Study|Lost to Follow-up|0|||
146563081|NCT01107886|528571845|FG000|Overall Study|Lost to Follow-up|15|||
146563082|NCT01107886|528571846|FG001|Overall Study|Lost to Follow-up|13|||
146563083|NCT01107886|528571845|FG000|Overall Study|Withdrawal by Subject|180|||
146563084|NCT01107886|528571846|FG001|Overall Study|Withdrawal by Subject|196|||
146563085|NCT01107886|528571845|FG000|Overall Study|Administrative withdrawal of consent|7|||
146563086|NCT01107886|528571846|FG001|Overall Study|Administrative withdrawal of consent|5|||
146563087|NCT01994876|528571847|FG000|Test Period 1|Withdrawal by Subject|0|||
146563088|NCT01994876|528571848|FG001|Test Period 1|Withdrawal by Subject|1|||
146563089|NCT01994876|528571847|FG000|Test Period 1|Adverse Event|0|||
146563090|NCT01994876|528571848|FG001|Test Period 1|Adverse Event|1|||
146563091|NCT01994876|528571847|FG000|Test Period 2|Adverse Event|1|||
146563092|NCT01994876|528571848|FG001|Test Period 2|Adverse Event|0|||
146563093|NCT01994876|528571847|FG000|Test Period 2|Protocol Violation|0|||
146563094|NCT01994876|528571848|FG001|Test Period 2|Protocol Violation|1|||
146563095|NCT01346176|528571849|FG000|Recruited|Protocol Violation|1|||
146909042|NCT03334214|529831318|FG000|Overall Study|Other|1|||
146909043|NCT03334214|529831319|FG001|Overall Study|Other|0|||
146909044|NCT02088034|529831321|FG000|Overall Study|Lost to Follow-up|1|||
146563096|NCT01346176|528571850|FG001|Recruited|Protocol Violation|0|||
146563097|NCT01346176|528571851|FG002|Recruited|Protocol Violation|0|||
146563098|NCT01346176|528571849|FG000|Completed Advance Directive|Death|3|||
146563099|NCT01346176|528571850|FG001|Completed Advance Directive|Death|2|||
146563100|NCT01346176|528571851|FG002|Completed Advance Directive|Death|2|||
146563101|NCT01346176|528571849|FG000|Completed Advance Directive|Became Ineligible|3|||
146563102|NCT01346176|528571850|FG001|Completed Advance Directive|Became Ineligible|0|||
146563103|NCT01346176|528571851|FG002|Completed Advance Directive|Became Ineligible|1|||
146563104|NCT01346176|528571849|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
146563105|NCT01346176|528571850|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
146563106|NCT01346176|528571851|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
146563107|NCT01346176|528571849|FG000|Completed Satisfaction Survey|Death|3|||
146563108|NCT01346176|528571850|FG001|Completed Satisfaction Survey|Death|0|||
146563109|NCT01346176|528571851|FG002|Completed Satisfaction Survey|Death|2|||
146909045|NCT02088034|529831322|FG001|Overall Study|Lost to Follow-up|1|||
146909046|NCT02088034|529831323|FG002|Overall Study|Lost to Follow-up|0|||
146909047|NCT02088034|529831321|FG000|Overall Study|Pregnancy|2|||
146642270|NCT00745849|528867840|FG000|First Intervention|Lost to Follow-up|1|||
146642271|NCT00745849|528867841|FG001|First Intervention|Lost to Follow-up|1|||
146642272|NCT00745849|528867840|FG000|Second Intervention|Lost to Follow-up|2|||
146642273|NCT00745849|528867841|FG001|Second Intervention|Lost to Follow-up|1|||
146909048|NCT02088034|529831322|FG001|Overall Study|Pregnancy|1|||
146909049|NCT02088034|529831323|FG002|Overall Study|Pregnancy|2|||
146909050|NCT00308620|529831326|FG000|Overall Study|Death|1|||
146563110|NCT01346176|528571849|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
146909051|NCT00308620|529831327|FG001|Overall Study|Death|1|||
146909052|NCT00308620|529831328|FG002|Overall Study|Death|0|||
146909053|NCT00308620|529831326|FG000|Overall Study|Lost to Follow-up|0|||
146909054|NCT00308620|529831327|FG001|Overall Study|Lost to Follow-up|0|||
146909055|NCT00308620|529831328|FG002|Overall Study|Lost to Follow-up|1|||
146909056|NCT00637728|529831333|FG000|Double-blind Phase|Adverse Event|1|||
146970294|NCT03972709|530052590|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
146970295|NCT03972709|530052591|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
146975337|NCT00572156|530073540|FG001|Overall Study|Patient/Parent Decision|6|||
146509128|NCT00454818|528367736|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
146509129|NCT00454818|528367737|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
146509130|NCT00454818|528367738|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
146509131|NCT00454818|528367739|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
146509132|NCT00454818|528367740|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
146509133|NCT00454818|528367736|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
146509134|NCT00454818|528367737|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
146509135|NCT00454818|528367738|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
146509136|NCT00454818|528367739|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
146509137|NCT00454818|528367740|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
146509138|NCT00454818|528367736|FG000|Phase 2: Randomized Double-blind|Death|0|||
146509139|NCT00454818|528367737|FG001|Phase 2: Randomized Double-blind|Death|1|||
146509140|NCT00454818|528367738|FG002|Phase 2: Randomized Double-blind|Death|0|||
146509141|NCT00454818|528367739|FG003|Phase 2: Randomized Double-blind|Death|0|||
146509142|NCT00454818|528367740|FG004|Phase 2: Randomized Double-blind|Death|1|||
146509143|NCT00454818|528367736|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
146509144|NCT00454818|528367737|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
146509145|NCT00454818|528367738|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
146509146|NCT00454818|528367739|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
146509147|NCT00454818|528367740|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
146509148|NCT00454818|528367736|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
146509149|NCT00454818|528367737|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
146509150|NCT00454818|528367738|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
146509151|NCT00454818|528367739|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
146509152|NCT00454818|528367740|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
146509153|NCT03488225|528367744|FG000|Overall Study|Off Protocol Therapy|2|||
146509154|NCT03488225|528367744|FG000|Overall Study|Stem Cell Transplant|2|||
146509155|NCT03448939|528367745|FG000|Overall Study|Adverse Event|5|||
146509156|NCT03448939|528367746|FG001|Overall Study|Adverse Event|1|||
146509157|NCT03448939|528367745|FG000|Overall Study|Lost to Follow-up|6|||
146509158|NCT03448939|528367746|FG001|Overall Study|Lost to Follow-up|6|||
146509159|NCT03448939|528367745|FG000|Overall Study|Pregnancy|1|||
146509160|NCT03448939|528367746|FG001|Overall Study|Pregnancy|1|||
146509161|NCT03448939|528367745|FG000|Overall Study|Withdrawal by Subject|9|||
146563111|NCT01346176|528571850|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
146509162|NCT03448939|528367746|FG001|Overall Study|Withdrawal by Subject|3|||
146509163|NCT01472965|528367747|FG000|Overall Study|Withdrawal by Subject|1|||
146509164|NCT01472965|528367748|FG001|Overall Study|Withdrawal by Subject|0|||
146509165|NCT04631107|528367751|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
146509166|NCT04631107|528367751|FG000|Second Intervention (1 Night)|Adverse Event|1|||
146509167|NCT04631107|528367751|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
146509168|NCT04631107|528367751|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
146509169|NCT00096993|528367756|FG000|Overall Study|Death|1|||
146509170|NCT00096993|528367757|FG001|Overall Study|Death|0|||
146509171|NCT00096993|528367756|FG000|Overall Study|Disease progression|56|||
146509172|NCT00096993|528367757|FG001|Overall Study|Disease progression|53|||
146509173|NCT00096993|528367756|FG000|Overall Study|Adverse Event|2|||
146509174|NCT00096993|528367757|FG001|Overall Study|Adverse Event|8|||
146509175|NCT00096993|528367756|FG000|Overall Study|Subject's decision|3|||
146509176|NCT00096993|528367757|FG001|Overall Study|Subject's decision|1|||
146563112|NCT01346176|528571851|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
146563113|NCT05819398|528571852|FG000|Overall Study|Withdrawal by Subject|11|||
146563114|NCT05819398|528571853|FG001|Overall Study|Withdrawal by Subject|7|||
146563115|NCT05819398|528571854|FG002|Overall Study|Withdrawal by Subject|6|||
146563116|NCT05819398|528571855|FG003|Overall Study|Withdrawal by Subject|6|||
146563117|NCT05819398|528571852|FG000|Overall Study|Lost to Follow-up|0|||
146563118|NCT05819398|528571853|FG001|Overall Study|Lost to Follow-up|2|||
146563119|NCT05819398|528571854|FG002|Overall Study|Lost to Follow-up|0|||
146563120|NCT05819398|528571855|FG003|Overall Study|Lost to Follow-up|1|||
146563121|NCT05819398|528571852|FG000|Overall Study|Adverse Event|1|||
146563122|NCT05819398|528571853|FG001|Overall Study|Adverse Event|3|||
146563123|NCT05819398|528571854|FG002|Overall Study|Adverse Event|4|||
146563124|NCT05819398|528571855|FG003|Overall Study|Adverse Event|5|||
146563125|NCT05819398|528571852|FG000|Overall Study|Other than listed|0|||
146563126|NCT05819398|528571853|FG001|Overall Study|Other than listed|2|||
146563127|NCT05819398|528571854|FG002|Overall Study|Other than listed|2|||
146563128|NCT05819398|528571855|FG003|Overall Study|Other than listed|0|||
146563129|NCT05819398|528571852|FG000|Overall Study|Lack of Efficacy|0|||
146768268|NCT00961636|529319562|FG000|Overall Study|Flushing Symptoms|29|||
146768269|NCT00961636|529319563|FG001|Overall Study|Flushing Symptoms|46|||
146768270|NCT00961636|529319564|FG002|Overall Study|Flushing Symptoms|3|||
146768271|NCT00961636|529319562|FG000|Overall Study|Lost to Follow-up|2|||
146909057|NCT00637728|529831334|FG001|Double-blind Phase|Adverse Event|0|||
146909058|NCT00637728|529831335|FG002|Double-blind Phase|Adverse Event|0|||
146909059|NCT00637728|529831333|FG000|Double-blind Phase|Non-compliance|2|||
146909060|NCT00637728|529831334|FG001|Double-blind Phase|Non-compliance|0|||
146909061|NCT00637728|529831335|FG002|Double-blind Phase|Non-compliance|0|||
146909062|NCT00637728|529831333|FG000|Double-blind Phase|Study Discontinued|1|||
146909063|NCT00637728|529831334|FG001|Double-blind Phase|Study Discontinued|1|||
146909064|NCT00637728|529831335|FG002|Double-blind Phase|Study Discontinued|0|||
146909065|NCT01050062|529831338|FG000|Overall Study|Adverse Event|75|||
146909066|NCT01050062|529831339|FG001|Overall Study|Adverse Event|22|||
146909067|NCT01050062|529831338|FG000|Overall Study|Lost to Follow-up|83|||
146909068|NCT01050062|529831339|FG001|Overall Study|Lost to Follow-up|35|||
146909069|NCT01050062|529831338|FG000|Overall Study|Lack of Efficacy|22|||
146909070|NCT01050062|529831339|FG001|Overall Study|Lack of Efficacy|35|||
146909071|NCT01050062|529831338|FG000|Overall Study|Physician Decision|74|||
146909072|NCT01050062|529831339|FG001|Overall Study|Physician Decision|9|||
146563130|NCT05819398|528571853|FG001|Overall Study|Lack of Efficacy|1|||
146563131|NCT05819398|528571854|FG002|Overall Study|Lack of Efficacy|0|||
146563132|NCT05819398|528571855|FG003|Overall Study|Lack of Efficacy|0|||
146768272|NCT00961636|529319563|FG001|Overall Study|Lost to Follow-up|3|||
146768273|NCT00961636|529319564|FG002|Overall Study|Lost to Follow-up|1|||
146768274|NCT00961636|529319562|FG000|Overall Study|Physician Decision|3|||
146768275|NCT00961636|529319563|FG001|Overall Study|Physician Decision|1|||
146909073|NCT01050062|529831338|FG000|Overall Study|Others|17|||
146563133|NCT05819398|528571852|FG000|Overall Study|Study terminated by sponsor|20|||
146909074|NCT01050062|529831339|FG001|Overall Study|Others|11|||
146909075|NCT01873950|529831340|FG000|Period 5|Withdrawal by Subject|0|||
146909076|NCT01873950|529831341|FG001|Period 5|Withdrawal by Subject|0|||
146909077|NCT01873950|529831342|FG002|Period 5|Withdrawal by Subject|0|||
146909078|NCT01873950|529831343|FG003|Period 5|Withdrawal by Subject|1|||
146563134|NCT05819398|528571853|FG001|Overall Study|Study terminated by sponsor|18|||
146563135|NCT05819398|528571854|FG002|Overall Study|Study terminated by sponsor|20|||
146563136|NCT05819398|528571855|FG003|Overall Study|Study terminated by sponsor|22|||
146563137|NCT04522973|528571856|FG000|Overall Study|Lost to Follow-up|4|||
146563138|NCT04522973|528571856|FG000|Overall Study|Could not adhere to study schedule|1|||
146563139|NCT04795531|528574406|FG000|Overall Study|Withdrawal by Subject|4|||
146563140|NCT04795531|528574407|FG001|Overall Study|Withdrawal by Subject|4|||
146563141|NCT04795531|528574406|FG000|Overall Study|Lost to Follow-up|0|||
146563142|NCT04795531|528574407|FG001|Overall Study|Lost to Follow-up|1|||
146563143|NCT04795531|528574406|FG000|Overall Study|Physician Decision|0|||
146563144|NCT04795531|528574407|FG001|Overall Study|Physician Decision|2|||
146563145|NCT04795531|528574406|FG000|Overall Study|Death|2|||
146563146|NCT04795531|528574407|FG001|Overall Study|Death|1|||
146563147|NCT04887831|528574408|FG000|Overall Study|Death|26|||
146563148|NCT04887831|528574409|FG001|Overall Study|Death|26|||
146563149|NCT04887831|528574408|FG000|Overall Study|Lost to Follow-up|0|||
146563150|NCT04887831|528574409|FG001|Overall Study|Lost to Follow-up|1|||
146563151|NCT04887831|528574408|FG000|Overall Study|Withdrawal by Subject|2|||
146563152|NCT04887831|528574409|FG001|Overall Study|Withdrawal by Subject|1|||
146563153|NCT04887831|528574408|FG000|Overall Study|Study Terminated by Sponsor|18|||
146563154|NCT04887831|528574409|FG001|Overall Study|Study Terminated by Sponsor|17|||
146563155|NCT04887831|528574408|FG000|Overall Study|Other|1|||
146563156|NCT04887831|528574409|FG001|Overall Study|Other|0|||
146563157|NCT04622592|528574410|FG000|Overall Study|Death|0|||
146563158|NCT04622592|528574411|FG001|Overall Study|Death|0|||
146563159|NCT04622592|528574412|FG002|Overall Study|Death|1|||
146563160|NCT04622592|528574413|FG003|Overall Study|Death|0|||
146563161|NCT04622592|528574414|FG004|Overall Study|Death|0|||
146563162|NCT04622592|528574415|FG005|Overall Study|Death|0|||
146563163|NCT04622592|528574416|FG006|Overall Study|Death|0|||
146563164|NCT04622592|528574417|FG007|Overall Study|Death|1|||
146563165|NCT04622592|528574410|FG000|Overall Study|Lost to Follow-up|0|||
146563166|NCT04622592|528574411|FG001|Overall Study|Lost to Follow-up|0|||
146563167|NCT04622592|528574412|FG002|Overall Study|Lost to Follow-up|0|||
146563168|NCT04622592|528574413|FG003|Overall Study|Lost to Follow-up|3|||
146563169|NCT04622592|528574414|FG004|Overall Study|Lost to Follow-up|1|||
146563170|NCT04622592|528574415|FG005|Overall Study|Lost to Follow-up|0|||
146563171|NCT04622592|528574416|FG006|Overall Study|Lost to Follow-up|2|||
146563172|NCT04622592|528574417|FG007|Overall Study|Lost to Follow-up|2|||
146563173|NCT04622592|528574410|FG000|Overall Study|Physician Decision|0|||
146563174|NCT04622592|528574411|FG001|Overall Study|Physician Decision|0|||
146563175|NCT04622592|528574412|FG002|Overall Study|Physician Decision|0|||
146563176|NCT04622592|528574413|FG003|Overall Study|Physician Decision|0|||
146563177|NCT04622592|528574414|FG004|Overall Study|Physician Decision|1|||
146563178|NCT04622592|528574415|FG005|Overall Study|Physician Decision|0|||
146563179|NCT04622592|528574416|FG006|Overall Study|Physician Decision|0|||
146563180|NCT04622592|528574417|FG007|Overall Study|Physician Decision|0|||
146563181|NCT04622592|528574410|FG000|Overall Study|Withdrawal by Subject|1|||
146563182|NCT04622592|528574411|FG001|Overall Study|Withdrawal by Subject|0|||
146563183|NCT04622592|528574412|FG002|Overall Study|Withdrawal by Subject|2|||
146563184|NCT04622592|528574413|FG003|Overall Study|Withdrawal by Subject|0|||
146563185|NCT04622592|528574414|FG004|Overall Study|Withdrawal by Subject|0|||
146563186|NCT04622592|528574415|FG005|Overall Study|Withdrawal by Subject|0|||
146563187|NCT04622592|528574416|FG006|Overall Study|Withdrawal by Subject|1|||
146563188|NCT04622592|528574417|FG007|Overall Study|Withdrawal by Subject|4|||
146563189|NCT04622592|528574410|FG000|Overall Study|Other than specified above|0|||
146563190|NCT04622592|528574411|FG001|Overall Study|Other than specified above|0|||
146563191|NCT04622592|528574412|FG002|Overall Study|Other than specified above|1|||
146563192|NCT04622592|528574413|FG003|Overall Study|Other than specified above|0|||
146909079|NCT01873950|529831344|FG004|Period 5|Withdrawal by Subject|0|||
146909080|NCT03894540|529831345|FG000|Overall Study|Adverse Event|0|||
146909081|NCT03894540|529831346|FG001|Overall Study|Adverse Event|0|||
146909082|NCT03894540|529831347|FG002|Overall Study|Adverse Event|0|||
146768276|NCT00961636|529319564|FG002|Overall Study|Physician Decision|1|||
146768277|NCT00961636|529319562|FG000|Overall Study|Protocol Violation|9|||
146768278|NCT00961636|529319563|FG001|Overall Study|Protocol Violation|5|||
146768279|NCT00961636|529319564|FG002|Overall Study|Protocol Violation|1|||
146909083|NCT03894540|529831348|FG003|Overall Study|Adverse Event|0|||
146909084|NCT03894540|529831349|FG004|Overall Study|Adverse Event|1|||
146509177|NCT00096993|528367756|FG000|Overall Study|Physician Decision|2|||
146642274|NCT01754727|528867844|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
146909085|NCT03894540|529831350|FG005|Overall Study|Adverse Event|0|||
146563193|NCT04622592|528574414|FG004|Overall Study|Other than specified above|0|||
146563194|NCT04622592|528574415|FG005|Overall Study|Other than specified above|0|||
146563195|NCT04622592|528574416|FG006|Overall Study|Other than specified above|0|||
146563196|NCT04622592|528574417|FG007|Overall Study|Other than specified above|0|||
146563197|NCT01664624|528574418|FG000|Overall Study|Adverse Event|0|||
146768280|NCT00961636|529319562|FG000|Overall Study|Withdrawal by Subject|29|||
146563198|NCT01664624|528574419|FG001|Overall Study|Adverse Event|1|||
146563199|NCT01664624|528574420|FG002|Overall Study|Adverse Event|0|||
146563200|NCT01664624|528574421|FG003|Overall Study|Adverse Event|0|||
146563201|NCT00573768|528574425|FG000|Overall Study|Adverse Event|1|||
146563202|NCT00573768|528574426|FG001|Overall Study|Adverse Event|1|||
146563203|NCT00573768|528574427|FG002|Overall Study|Adverse Event|2|||
146563204|NCT00573768|528574425|FG000|Overall Study|Protocol Violation|1|||
146563205|NCT00573768|528574426|FG001|Overall Study|Protocol Violation|0|||
146563206|NCT00573768|528574427|FG002|Overall Study|Protocol Violation|1|||
146563207|NCT00573768|528574425|FG000|Overall Study|Withdrawal by Subject|0|||
146563208|NCT00573768|528574426|FG001|Overall Study|Withdrawal by Subject|1|||
146563209|NCT00573768|528574427|FG002|Overall Study|Withdrawal by Subject|0|||
146563210|NCT00573768|528574425|FG000|Overall Study|Lost to Follow-up|0|||
146563211|NCT00573768|528574426|FG001|Overall Study|Lost to Follow-up|0|||
146563212|NCT00573768|528574427|FG002|Overall Study|Lost to Follow-up|1|||
146563213|NCT00583219|528574430|FG000|Phase 2|Withdrawal by Subject|1|||
146563214|NCT03502200|528574438|FG000|Overall Study|Adverse Event|1|||
146563215|NCT03502200|528574439|FG001|Overall Study|Adverse Event|0|||
146563216|NCT03502200|528574438|FG000|Overall Study|Lost to Follow-up|36|||
146563217|NCT03502200|528574439|FG001|Overall Study|Lost to Follow-up|38|||
146563218|NCT03502200|528574438|FG000|Overall Study|Study Team Decision|1|||
146563219|NCT03502200|528574439|FG001|Overall Study|Study Team Decision|1|||
146563220|NCT03502200|528574438|FG000|Overall Study|Withdrawal by Subject|5|||
146563221|NCT03502200|528574439|FG001|Overall Study|Withdrawal by Subject|7|||
146768281|NCT00961636|529319563|FG001|Overall Study|Withdrawal by Subject|22|||
146768282|NCT00961636|529319564|FG002|Overall Study|Withdrawal by Subject|13|||
146563222|NCT03502200|528574438|FG000|Overall Study|Death|0|||
146563223|NCT03502200|528574439|FG001|Overall Study|Death|2|||
146563224|NCT04138056|528574450|FG000|Primary Study|Lost to Follow-up|3|||
146563225|NCT04138056|528574451|FG001|Primary Study|Lost to Follow-up|4|||
146563226|NCT04138056|528574452|FG002|Primary Study|Lost to Follow-up|1|||
146563227|NCT04138056|528574453|FG003|Primary Study|Lost to Follow-up|1|||
146909086|NCT03894540|529831345|FG000|Overall Study|Withdrawal by Subject|0|||
146909087|NCT03894540|529831346|FG001|Overall Study|Withdrawal by Subject|0|||
146909088|NCT03894540|529831347|FG002|Overall Study|Withdrawal by Subject|0|||
146909089|NCT03894540|529831348|FG003|Overall Study|Withdrawal by Subject|0|||
146909090|NCT03894540|529831349|FG004|Overall Study|Withdrawal by Subject|1|||
146909091|NCT03894540|529831350|FG005|Overall Study|Withdrawal by Subject|0|||
146909092|NCT03894540|529831345|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
146909093|NCT03894540|529831346|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
146909094|NCT03894540|529831347|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
146909095|NCT03894540|529831348|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
146909096|NCT03894540|529831349|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
146909097|NCT03894540|529831350|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
146909098|NCT03894540|529831345|FG000|Overall Study|Progressive Disease Clinical|1|||
146909099|NCT03894540|529831346|FG001|Overall Study|Progressive Disease Clinical|1|||
146909100|NCT03894540|529831347|FG002|Overall Study|Progressive Disease Clinical|0|||
146909101|NCT03894540|529831348|FG003|Overall Study|Progressive Disease Clinical|1|||
146909102|NCT03894540|529831349|FG004|Overall Study|Progressive Disease Clinical|5|||
146909103|NCT03894540|529831350|FG005|Overall Study|Progressive Disease Clinical|1|||
146909104|NCT03894540|529831345|FG000|Overall Study|Study termination by sponsor|0|||
146909105|NCT03894540|529831346|FG001|Overall Study|Study termination by sponsor|0|||
146909106|NCT03894540|529831347|FG002|Overall Study|Study termination by sponsor|0|||
146909107|NCT03894540|529831348|FG003|Overall Study|Study termination by sponsor|0|||
146909108|NCT03894540|529831349|FG004|Overall Study|Study termination by sponsor|2|||
146909109|NCT03894540|529831350|FG005|Overall Study|Study termination by sponsor|0|||
146909110|NCT03043365|529831351|FG000|Weeks 0 to Week 8|Adverse Event|1|||
146909111|NCT03043365|529831352|FG001|Weeks 0 to Week 8|Adverse Event|3|||
146909112|NCT03043365|529831351|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
146909113|NCT03043365|529831352|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
146909114|NCT03043365|529831351|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
146909115|NCT03043365|529831352|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
146909116|NCT00593112|529831353|FG000|Overall Study|Scan Anxiety|3|||
146909117|NCT00593112|529831354|FG001|Overall Study|Scan Anxiety|0|||
146970296|NCT03972709|530052592|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
146970297|NCT03972709|530052590|FG000|Overall Study|Subject Moved|0|||
146909118|NCT00593112|529831353|FG000|Overall Study|Abnormal Scan|1|||
146909119|NCT00593112|529831354|FG001|Overall Study|Abnormal Scan|0|||
146909120|NCT00593112|529831353|FG000|Overall Study|Unreadable Scan|1|||
146768283|NCT02486588|529319567|FG000|Overall Study|Randomized in error- ineligible|738|||
146768284|NCT02486588|529319568|FG001|Overall Study|Randomized in error- ineligible|750|||
146563228|NCT04138056|528574454|FG004|Primary Study|Lost to Follow-up|4|||
146563229|NCT04138056|528574450|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
146768285|NCT02486588|529319569|FG002|Overall Study|Randomized in error- ineligible|755|||
146768286|NCT02486588|529319570|FG003|Overall Study|Randomized in error- ineligible|738|||
146563230|NCT04138056|528574451|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
146563231|NCT04138056|528574452|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
146563232|NCT04138056|528574453|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
146563233|NCT04138056|528574454|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
146563234|NCT04138056|528574450|FG000|Extension Study|Lost to Follow-up|1|||
146563235|NCT04138056|528574451|FG001|Extension Study|Lost to Follow-up|2|||
146563236|NCT04138056|528574452|FG002|Extension Study|Lost to Follow-up|1|||
146563237|NCT04138056|528574453|FG003|Extension Study|Lost to Follow-up|0|||
146563238|NCT04138056|528574454|FG004|Extension Study|Lost to Follow-up|1|||
146563239|NCT02706392|528574459|FG000|Overall Study|Death|1|||
146563240|NCT02706392|528574460|FG001|Overall Study|Death|0|||
146563241|NCT02706392|528574461|FG002|Overall Study|Death|2|||
146563242|NCT02706392|528574462|FG003|Overall Study|Death|2|||
146563243|NCT02706392|528574463|FG004|Overall Study|Death|5|||
146563244|NCT02706392|528574464|FG005|Overall Study|Death|2|||
146563245|NCT01276106|528574474|FG000|Overall Study|Adverse Event|3|||
146563246|NCT01276106|528574475|FG001|Overall Study|Adverse Event|3|||
146563247|NCT01276106|528574476|FG002|Overall Study|Adverse Event|11|||
146563248|NCT01276106|528574477|FG003|Overall Study|Adverse Event|3|||
146563249|NCT01276106|528574474|FG000|Overall Study|Withdrawal by Subject|6|||
146563250|NCT01276106|528574475|FG001|Overall Study|Withdrawal by Subject|3|||
146563251|NCT01276106|528574476|FG002|Overall Study|Withdrawal by Subject|1|||
146563252|NCT01276106|528574477|FG003|Overall Study|Withdrawal by Subject|6|||
146563253|NCT01276106|528574474|FG000|Overall Study|Lack of Efficacy|0|||
146563254|NCT01276106|528574475|FG001|Overall Study|Lack of Efficacy|1|||
146563255|NCT01276106|528574476|FG002|Overall Study|Lack of Efficacy|0|||
146563256|NCT01276106|528574477|FG003|Overall Study|Lack of Efficacy|1|||
146563257|NCT01276106|528574474|FG000|Overall Study|Lost to Follow-up|2|||
146563258|NCT01276106|528574475|FG001|Overall Study|Lost to Follow-up|1|||
146563259|NCT01276106|528574476|FG002|Overall Study|Lost to Follow-up|1|||
146563260|NCT01276106|528574477|FG003|Overall Study|Lost to Follow-up|0|||
146563261|NCT01276106|528574474|FG000|Overall Study|Physician Decision|0|||
146563262|NCT01276106|528574475|FG001|Overall Study|Physician Decision|0|||
146563263|NCT01276106|528574476|FG002|Overall Study|Physician Decision|1|||
146563264|NCT01276106|528574477|FG003|Overall Study|Physician Decision|1|||
146563265|NCT01276106|528574474|FG000|Overall Study|Protocol Violation|1|||
146563266|NCT01276106|528574475|FG001|Overall Study|Protocol Violation|1|||
146563267|NCT01276106|528574476|FG002|Overall Study|Protocol Violation|0|||
146563268|NCT01276106|528574477|FG003|Overall Study|Protocol Violation|2|||
146563269|NCT01276106|528574474|FG000|Overall Study|Insufficient therapeutic effects|0|||
146563270|NCT01276106|528574475|FG001|Overall Study|Insufficient therapeutic effects|0|||
146768287|NCT02486588|529319571|FG004|Overall Study|Randomized in error- ineligible|746|||
146768288|NCT02486588|529319572|FG005|Overall Study|Randomized in error- ineligible|746|||
146563271|NCT01276106|528574476|FG002|Overall Study|Insufficient therapeutic effects|2|||
146563272|NCT01276106|528574477|FG003|Overall Study|Insufficient therapeutic effects|0|||
146563273|NCT01242514|528574480|FG000|Overall Study|e.g., project closure|1042|||
146563274|NCT01242514|528574481|FG001|Overall Study|e.g., project closure|305|||
146563275|NCT01242514|528574482|FG002|Overall Study|e.g., project closure|171|||
146563276|NCT01242514|528574480|FG000|Overall Study|Subject decision|33|||
146563277|NCT01242514|528574481|FG001|Overall Study|Subject decision|8|||
146563278|NCT01242514|528574482|FG002|Overall Study|Subject decision|2|||
146563279|NCT01242514|528574480|FG000|Overall Study|Severe non-compliance to protocol|5|||
146563280|NCT01242514|528574481|FG001|Overall Study|Severe non-compliance to protocol|2|||
146563281|NCT01242514|528574482|FG002|Overall Study|Severe non-compliance to protocol|1|||
146563282|NCT01242514|528574480|FG000|Overall Study|Lack of therapeutic response|99|||
146563283|NCT01242514|528574481|FG001|Overall Study|Lack of therapeutic response|16|||
146563284|NCT01242514|528574482|FG002|Overall Study|Lack of therapeutic response|10|||
146563285|NCT01242514|528574480|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
146563286|NCT01242514|528574481|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
146563287|NCT01242514|528574482|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
146563288|NCT01242514|528574480|FG000|Overall Study|Lost to Follow-up|14|||
146563289|NCT01242514|528574481|FG001|Overall Study|Lost to Follow-up|5|||
146563290|NCT01242514|528574482|FG002|Overall Study|Lost to Follow-up|4|||
146563291|NCT01242514|528574480|FG000|Overall Study|Adverse Event|129|||
146563292|NCT01242514|528574481|FG001|Overall Study|Adverse Event|18|||
146563293|NCT01242514|528574482|FG002|Overall Study|Adverse Event|19|||
146563294|NCT00862940|528574484|FG000|Overall Study|Adverse Event|15|||
146563295|NCT00862940|528574485|FG001|Overall Study|Adverse Event|12|||
146563296|NCT00862940|528574484|FG000|Overall Study|Lack of Efficacy|1|||
146909121|NCT00593112|529831354|FG001|Overall Study|Unreadable Scan|0|||
146909122|NCT00593112|529831353|FG000|Overall Study|Withdrawal by Subject|5|||
146768289|NCT02551055|529319575|FG000|Overall Study|Death|2|||
146909123|NCT00593112|529831354|FG001|Overall Study|Withdrawal by Subject|0|||
146909124|NCT02723630|529831355|FG000|Intervention Period 1|Adverse Event|1|||
146909125|NCT02723630|529831356|FG001|Intervention Period 1|Adverse Event|0|||
146909126|NCT02723630|529831357|FG002|Intervention Period 1|Adverse Event|0|||
146909127|NCT02723630|529831358|FG003|Intervention Period 1|Adverse Event|0|||
146909128|NCT02723630|529831359|FG004|Intervention Period 1|Adverse Event|0|||
146909129|NCT02723630|529831360|FG005|Intervention Period 1|Adverse Event|0|||
146909130|NCT02723630|529831355|FG000|Intervention Period 3|consumption of restricted item|0|||
146563297|NCT00862940|528574485|FG001|Overall Study|Lack of Efficacy|3|||
146563298|NCT00862940|528574484|FG000|Overall Study|Protocol Violation|2|||
146563299|NCT00862940|528574485|FG001|Overall Study|Protocol Violation|5|||
146563300|NCT00862940|528574484|FG000|Overall Study|Withdrawal by Subject|4|||
146563301|NCT00862940|528574485|FG001|Overall Study|Withdrawal by Subject|6|||
146563302|NCT00862940|528574484|FG000|Overall Study|Non-compliance|4|||
146563303|NCT00862940|528574485|FG001|Overall Study|Non-compliance|0|||
146563304|NCT00862940|528574484|FG000|Overall Study|Lost to Follow-up|0|||
146563305|NCT00862940|528574485|FG001|Overall Study|Lost to Follow-up|1|||
146563306|NCT00862940|528574484|FG000|Overall Study|Administrative or other reason(s)|4|||
146563307|NCT00862940|528574485|FG001|Overall Study|Administrative or other reason(s)|3|||
146768290|NCT02551055|529319576|FG001|Overall Study|Death|4|||
146768291|NCT02551055|529319577|FG002|Overall Study|Death|2|||
146768292|NCT02551055|529319578|FG003|Overall Study|Death|2|||
146563308|NCT00879398|528574486|FG000|Overall Study|Visit Stop|399|||
146563309|NCT00879398|528574486|FG000|Overall Study|Lack of Efficacy|64|||
146970298|NCT03972709|530052591|FG001|Overall Study|Subject Moved|1|||
146563310|NCT00879398|528574486|FG000|Overall Study|Adverse Event|41|||
146563311|NCT00879398|528574486|FG000|Overall Study|Other Reasons|171|||
146563312|NCT01380080|528574488|FG000|Overall Study|Death|36|||
146563313|NCT01380080|528574489|FG001|Overall Study|Death|44|||
146563314|NCT01380080|528574488|FG000|Overall Study|Site is closing|28|||
146563315|NCT01380080|528574489|FG001|Overall Study|Site is closing|31|||
146563316|NCT01380080|528574488|FG000|Overall Study|Not able to get to clinic|7|||
146563317|NCT01380080|528574489|FG001|Overall Study|Not able to get to clinic|1|||
146563318|NCT01380080|528574488|FG000|Overall Study|Not willing to adhere to requirements|6|||
146563319|NCT01380080|528574489|FG001|Overall Study|Not willing to adhere to requirements|2|||
146563320|NCT01380080|528574488|FG000|Overall Study|Withdrawal by Subject|5|||
146563321|NCT01380080|528574489|FG001|Overall Study|Withdrawal by Subject|2|||
146563322|NCT01380080|528574488|FG000|Overall Study|Lost to Follow-up|3|||
146563323|NCT01380080|528574489|FG001|Overall Study|Lost to Follow-up|3|||
146563324|NCT05901636|528574490|FG000|Overall Study|Lost to Follow-up|0|||
146563325|NCT05901636|528574491|FG001|Overall Study|Lost to Follow-up|1|||
146563326|NCT05901636|528574492|FG002|Overall Study|Lost to Follow-up|0|||
146563327|NCT05901636|528574493|FG003|Overall Study|Lost to Follow-up|1|||
146563328|NCT05901636|528574494|FG004|Overall Study|Lost to Follow-up|1|||
146563329|NCT05901636|528574495|FG005|Overall Study|Lost to Follow-up|3|||
146563330|NCT05901636|528574496|FG006|Overall Study|Lost to Follow-up|1|||
146563331|NCT05901636|528574490|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
146563332|NCT05901636|528574491|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
146563333|NCT05901636|528574492|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
146563334|NCT05901636|528574493|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
146563335|NCT05901636|528574494|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
146909131|NCT02723630|529831356|FG001|Intervention Period 3|consumption of restricted item|1|||
146909132|NCT02723630|529831357|FG002|Intervention Period 3|consumption of restricted item|0|||
146909133|NCT02723630|529831358|FG003|Intervention Period 3|consumption of restricted item|0|||
146909134|NCT02723630|529831359|FG004|Intervention Period 3|consumption of restricted item|0|||
146909135|NCT02723630|529831360|FG005|Intervention Period 3|consumption of restricted item|0|||
146909136|NCT00852930|529831361|FG000|Overall Study|Withdrawal by Subject|1|||
146909137|NCT00852930|529831362|FG001|Overall Study|Withdrawal by Subject|1|||
146909138|NCT00852930|529831363|FG002|Overall Study|Withdrawal by Subject|1|||
146909139|NCT00852930|529831361|FG000|Overall Study|Physician Decision|0|||
146909140|NCT00852930|529831362|FG001|Overall Study|Physician Decision|0|||
146909141|NCT00852930|529831363|FG002|Overall Study|Physician Decision|1|||
146909142|NCT00779038|529831364|FG000|Overall Study|Study Prematurely Terminated|13|||
146909143|NCT03114969|529831365|FG000|Overall Study|Lost to Follow-up|0|||
146909144|NCT03114969|529831366|FG001|Overall Study|Lost to Follow-up|0|||
146909145|NCT03114969|529831367|FG002|Overall Study|Lost to Follow-up|3|||
146909146|NCT03114969|529831368|FG003|Overall Study|Lost to Follow-up|2|||
146909147|NCT03114969|529831369|FG004|Overall Study|Lost to Follow-up|0|||
146909148|NCT03114969|529831370|FG005|Overall Study|Lost to Follow-up|0|||
146909149|NCT03114969|529831371|FG006|Overall Study|Lost to Follow-up|0|||
146909150|NCT03114969|529831372|FG007|Overall Study|Lost to Follow-up|0|||
146909151|NCT03114969|529831373|FG008|Overall Study|Lost to Follow-up|0|||
146909152|NCT03114969|529831365|FG000|Overall Study|Adverse Event|0|||
146909153|NCT03114969|529831366|FG001|Overall Study|Adverse Event|0|||
146909154|NCT03114969|529831367|FG002|Overall Study|Adverse Event|1|||
146563336|NCT05901636|528574495|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
146563337|NCT05901636|528574496|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
146563338|NCT05901636|528574490|FG000|Overall Study|Withdrawal by Subject|1|||
146563339|NCT05901636|528574491|FG001|Overall Study|Withdrawal by Subject|1|||
146563340|NCT05901636|528574492|FG002|Overall Study|Withdrawal by Subject|0|||
146563341|NCT05901636|528574493|FG003|Overall Study|Withdrawal by Subject|0|||
146563342|NCT05901636|528574494|FG004|Overall Study|Withdrawal by Subject|1|||
146563343|NCT05901636|528574495|FG005|Overall Study|Withdrawal by Subject|1|||
146563344|NCT05901636|528574496|FG006|Overall Study|Withdrawal by Subject|0|||
146563345|NCT05901636|528574490|FG000|Overall Study|Other|0|||
146563346|NCT05901636|528574491|FG001|Overall Study|Other|0|||
146563347|NCT05901636|528574492|FG002|Overall Study|Other|1|||
146563348|NCT05901636|528574493|FG003|Overall Study|Other|1|||
146563349|NCT05901636|528574494|FG004|Overall Study|Other|0|||
146563350|NCT05901636|528574495|FG005|Overall Study|Other|0|||
146563351|NCT05901636|528574496|FG006|Overall Study|Other|0|||
146563352|NCT02303821|528574497|FG000|Overall Study|Withdrawal by Subject|0|||
146563353|NCT02303821|528574498|FG001|Overall Study|Withdrawal by Subject|0|||
146563354|NCT02303821|528574499|FG002|Overall Study|Withdrawal by Subject|0|||
146563355|NCT02303821|528574500|FG003|Overall Study|Withdrawal by Subject|0|||
146563356|NCT02303821|528574501|FG004|Overall Study|Withdrawal by Subject|0|||
146563357|NCT02303821|528574502|FG005|Overall Study|Withdrawal by Subject|0|||
146563358|NCT02303821|528574503|FG006|Overall Study|Withdrawal by Subject|0|||
146563359|NCT02303821|528574504|FG007|Overall Study|Withdrawal by Subject|2|||
146563360|NCT02303821|528574497|FG000|Overall Study|Death|0|||
146563361|NCT02303821|528574498|FG001|Overall Study|Death|2|||
146563362|NCT02303821|528574499|FG002|Overall Study|Death|0|||
146563363|NCT02303821|528574500|FG003|Overall Study|Death|0|||
146563364|NCT02303821|528574501|FG004|Overall Study|Death|0|||
146563365|NCT02303821|528574502|FG005|Overall Study|Death|3|||
146563366|NCT02303821|528574503|FG006|Overall Study|Death|41|||
146563367|NCT02303821|528574504|FG007|Overall Study|Death|29|||
146563368|NCT02303821|528574497|FG000|Overall Study|Lost to Follow-up|0|||
146563369|NCT02303821|528574498|FG001|Overall Study|Lost to Follow-up|0|||
146563370|NCT02303821|528574499|FG002|Overall Study|Lost to Follow-up|0|||
146563371|NCT02303821|528574500|FG003|Overall Study|Lost to Follow-up|0|||
146563372|NCT02303821|528574501|FG004|Overall Study|Lost to Follow-up|0|||
146563373|NCT02303821|528574502|FG005|Overall Study|Lost to Follow-up|0|||
146563374|NCT02303821|528574503|FG006|Overall Study|Lost to Follow-up|1|||
146909155|NCT03114969|529831368|FG003|Overall Study|Adverse Event|0|||
146909156|NCT03114969|529831369|FG004|Overall Study|Adverse Event|0|||
146563375|NCT02303821|528574504|FG007|Overall Study|Lost to Follow-up|0|||
146563376|NCT02303821|528574497|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
146563377|NCT02303821|528574498|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
146909157|NCT03114969|529831370|FG005|Overall Study|Adverse Event|1|||
146909158|NCT03114969|529831371|FG006|Overall Study|Adverse Event|1|||
146563378|NCT02303821|528574499|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
146563379|NCT02303821|528574500|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
146563380|NCT02303821|528574501|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
146563381|NCT02303821|528574502|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
146563382|NCT02303821|528574503|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
146563383|NCT02303821|528574504|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
146563384|NCT02303821|528574497|FG000|Overall Study|Decision by sponsor|0|||
146563385|NCT02303821|528574498|FG001|Overall Study|Decision by sponsor|0|||
146563386|NCT02303821|528574499|FG002|Overall Study|Decision by sponsor|0|||
146563387|NCT02303821|528574500|FG003|Overall Study|Decision by sponsor|0|||
146563388|NCT02303821|528574501|FG004|Overall Study|Decision by sponsor|0|||
146563389|NCT02303821|528574502|FG005|Overall Study|Decision by sponsor|1|||
146563390|NCT02303821|528574503|FG006|Overall Study|Decision by sponsor|0|||
146563391|NCT02303821|528574504|FG007|Overall Study|Decision by sponsor|0|||
146563392|NCT02303821|528574497|FG000|Overall Study|Protocol-specified criteria|0|||
146563393|NCT02303821|528574498|FG001|Overall Study|Protocol-specified criteria|1|||
146563394|NCT02303821|528574499|FG002|Overall Study|Protocol-specified criteria|0|||
146563395|NCT02303821|528574500|FG003|Overall Study|Protocol-specified criteria|0|||
146563396|NCT02303821|528574501|FG004|Overall Study|Protocol-specified criteria|0|||
146563397|NCT02303821|528574502|FG005|Overall Study|Protocol-specified criteria|1|||
146909159|NCT03114969|529831372|FG007|Overall Study|Adverse Event|0|||
146563398|NCT02303821|528574503|FG006|Overall Study|Protocol-specified criteria|0|||
146563399|NCT02303821|528574504|FG007|Overall Study|Protocol-specified criteria|0|||
146563400|NCT01344226|528574507|FG000|Overall Study|Protocol Violation|2|||
146563401|NCT01344226|528574507|FG000|Overall Study|Withdrawal by Subject|3|||
146563402|NCT01344226|528574507|FG000|Overall Study|Lack of Efficacy|3|||
146563403|NCT02302222|528574514|FG000|Overall Study|Physician Decision|0|||
146563404|NCT02302222|528574515|FG001|Overall Study|Physician Decision|4|||
146768293|NCT02551055|529319579|FG004|Overall Study|Death|2|||
146563405|NCT02302222|528574514|FG000|Overall Study|Lost to Follow-up|1|||
146563406|NCT02302222|528574515|FG001|Overall Study|Lost to Follow-up|0|||
146563407|NCT02302222|528574514|FG000|Overall Study|Treatment discontinued before day 5|0|||
146563408|NCT02302222|528574515|FG001|Overall Study|Treatment discontinued before day 5|1|||
146563409|NCT02302222|528574514|FG000|Overall Study|Withdrawn prior to any treatment|0|||
146563410|NCT02302222|528574515|FG001|Overall Study|Withdrawn prior to any treatment|1|||
146563411|NCT03193801|528574516|FG000|Overall Study|Physician Decision|2|||
146563412|NCT03193801|528574516|FG000|Overall Study|Withdrawal by Subject|1|||
146563413|NCT03138564|528574517|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
146563414|NCT03138564|528574518|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
146563415|NCT03138564|528574517|FG000|Overall Study|Lost to Follow-up|16|||
146563416|NCT03138564|528574518|FG001|Overall Study|Lost to Follow-up|2|||
146563417|NCT03138564|528574517|FG000|Overall Study|Withdrawal by Subject|48|||
146563418|NCT03138564|528574518|FG001|Overall Study|Withdrawal by Subject|4|||
146563419|NCT03138564|528574517|FG000|Overall Study|No longer met eligibility criteria|2|||
146563420|NCT03138564|528574518|FG001|Overall Study|No longer met eligibility criteria|0|||
146563421|NCT03138564|528574517|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
146563422|NCT03138564|528574518|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
146563423|NCT03138564|528574517|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
146563424|NCT03138564|528574518|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
146563425|NCT03138564|528574517|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
146563426|NCT03138564|528574518|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
146563427|NCT03138564|528574517|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
146563428|NCT03138564|528574518|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
146563429|NCT03909971|528574520|FG000|Overall Study|Participant transition to rollover study|26|||
146563430|NCT03909971|528574521|FG001|Overall Study|Participant transition to rollover study|9|||
146563431|NCT03909971|528574520|FG000|Overall Study|Global Deterioration of Health Status|2|||
146563432|NCT03909971|528574521|FG001|Overall Study|Global Deterioration of Health Status|2|||
146563433|NCT03909971|528574520|FG000|Overall Study|Progressive Disease|28|||
146563434|NCT03909971|528574521|FG001|Overall Study|Progressive Disease|21|||
146563435|NCT03909971|528574520|FG000|Overall Study|Death|6|||
146563436|NCT03909971|528574521|FG001|Overall Study|Death|6|||
146563437|NCT03909971|528574520|FG000|Overall Study|Adverse Event|1|||
146563438|NCT03909971|528574521|FG001|Overall Study|Adverse Event|2|||
146563439|NCT03909971|528574520|FG000|Overall Study|Withdrawal by Subject|2|||
146563440|NCT03909971|528574521|FG001|Overall Study|Withdrawal by Subject|1|||
146563441|NCT03909971|528574520|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
146563442|NCT03909971|528574521|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
146563443|NCT03909971|528574520|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
146563444|NCT03909971|528574521|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
146563445|NCT05177354|528574522|FG000|Implant to 30-day Visit|Physician Decision|1|||
146563446|NCT05177354|528574522|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
146563447|NCT05177354|528574522|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
146563448|NCT05177354|528574522|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
146563449|NCT03734536|528574523|FG000|Overall Study|Withdrew Consent|1|||
146563450|NCT03734536|528574524|FG001|Overall Study|Withdrew Consent|5|||
146563451|NCT03734536|528574523|FG000|Overall Study|Lost to Follow-up|10|||
146563452|NCT03734536|528574524|FG001|Overall Study|Lost to Follow-up|7|||
146563453|NCT06028464|528574528|FG000|Washout|Positive drug test.|1|||
146563454|NCT03330847|528574529|FG000|Overall Study|Patients ongoing study|62|||
146563455|NCT03330847|528574530|FG001|Overall Study|Patients ongoing study|65|||
146563456|NCT03330847|528574531|FG002|Overall Study|Patients ongoing study|15|||
146563457|NCT05211596|528574534|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
146563458|NCT05211596|528574534|FG000|Baseline to 6 Months|Death|1|||
146563459|NCT05211596|528574534|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
146563460|NCT05211596|528574534|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
146563461|NCT04846868|528574535|FG000|Overall Study|Adverse Event|12|||
146563462|NCT04846868|528574536|FG001|Overall Study|Adverse Event|11|||
146563463|NCT04846868|528574535|FG000|Overall Study|Protocol deviation|6|||
146563464|NCT04846868|528574536|FG001|Overall Study|Protocol deviation|2|||
146563465|NCT04846868|528574535|FG000|Overall Study|Perceived lack of efficacy|3|||
146563466|NCT04846868|528574536|FG001|Overall Study|Perceived lack of efficacy|2|||
146563467|NCT04846868|528574535|FG000|Overall Study|Change of residence|2|||
146563468|NCT04846868|528574536|FG001|Overall Study|Change of residence|3|||
146563469|NCT04846868|528574535|FG000|Overall Study|Burden of study procedures|1|||
146563470|NCT04846868|528574536|FG001|Overall Study|Burden of study procedures|1|||
146563471|NCT04846868|528574535|FG000|Overall Study|No reason available|2|||
146563472|NCT04846868|528574536|FG001|Overall Study|No reason available|5|||
146909160|NCT03114969|529831373|FG008|Overall Study|Adverse Event|2|||
146909161|NCT05121103|529831376|FG000|Overall Study|Progressive disease|2|||
146642275|NCT02785770|528867845|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
146642276|NCT02785770|528867846|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
146642277|NCT02785770|528867847|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
146642278|NCT02785770|528867848|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
146642279|NCT02785770|528867845|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
146642280|NCT02785770|528867846|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
146909162|NCT05121103|529831377|FG001|Overall Study|Progressive disease|1|||
146909163|NCT05121103|529831378|FG002|Overall Study|Progressive disease|6|||
146563473|NCT04846868|528574535|FG000|Overall Study|Other reason listed|20|||
146563474|NCT04846868|528574536|FG001|Overall Study|Other reason listed|10|||
146563475|NCT04846868|528574535|FG000|Overall Study|Not treated|0|||
146563476|NCT04846868|528574536|FG001|Overall Study|Not treated|1|||
146563477|NCT04116853|528574537|FG000|Overall Study|Adverse Event|1|||
146563478|NCT04116853|528574538|FG001|Overall Study|Adverse Event|3|||
146563479|NCT04116853|528574537|FG000|Overall Study|Lost to Follow-up|2|||
146563480|NCT04116853|528574538|FG001|Overall Study|Lost to Follow-up|0|||
146563481|NCT04116853|528574537|FG000|Overall Study|Incarceration|0|||
146563482|NCT04116853|528574538|FG001|Overall Study|Incarceration|1|||
146563483|NCT04116853|528574537|FG000|Overall Study|Pregnancy|1|||
146563484|NCT04116853|528574538|FG001|Overall Study|Pregnancy|1|||
146563485|NCT04116853|528574537|FG000|Overall Study|Began Other Weight Loss program|4|||
146563486|NCT04116853|528574538|FG001|Overall Study|Began Other Weight Loss program|8|||
146563487|NCT04116853|528574537|FG000|Overall Study|Began Anti-Obesity Medication|3|||
146563488|NCT04116853|528574538|FG001|Overall Study|Began Anti-Obesity Medication|3|||
146563489|NCT04116853|528574537|FG000|Overall Study|Protocol Violation|0|||
146563490|NCT04116853|528574538|FG001|Overall Study|Protocol Violation|1|||
146563491|NCT01649869|528574539|FG000|Overall Study|Family member illness|1|||
146563492|NCT01649869|528574540|FG001|Overall Study|Family member illness|0|||
146563493|NCT01649869|528574539|FG000|Overall Study|Required treatment outside protocol|1|||
146563494|NCT01649869|528574540|FG001|Overall Study|Required treatment outside protocol|0|||
146563495|NCT01649869|528574539|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
146563496|NCT01649869|528574540|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
146563497|NCT02776735|528574541|FG000|Overall Study|Adverse Event|0|||
146563498|NCT02776735|528574542|FG001|Overall Study|Adverse Event|0|||
146563499|NCT02776735|528574543|FG002|Overall Study|Adverse Event|0|||
146563500|NCT02776735|528574544|FG003|Overall Study|Adverse Event|1|||
146563501|NCT02776735|528574545|FG004|Overall Study|Adverse Event|0|||
146563502|NCT02776735|528574546|FG005|Overall Study|Adverse Event|1|||
146563503|NCT02776735|528574541|FG000|Overall Study|Lost to Follow-up|0|||
146563504|NCT02776735|528574542|FG001|Overall Study|Lost to Follow-up|0|||
146563505|NCT02776735|528574543|FG002|Overall Study|Lost to Follow-up|0|||
146563506|NCT02776735|528574544|FG003|Overall Study|Lost to Follow-up|1|||
146563507|NCT02776735|528574545|FG004|Overall Study|Lost to Follow-up|0|||
146563508|NCT02776735|528574546|FG005|Overall Study|Lost to Follow-up|0|||
146563509|NCT02776735|528574541|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146563510|NCT02776735|528574542|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146563511|NCT02776735|528574543|FG002|Overall Study|Withdrawal by parent/guardian|2|||
146563512|NCT02776735|528574544|FG003|Overall Study|Withdrawal by parent/guardian|2|||
146563513|NCT02776735|528574545|FG004|Overall Study|Withdrawal by parent/guardian|0|||
146642281|NCT02785770|528867847|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
146642282|NCT02785770|528867848|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
146642283|NCT02785770|528867845|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
146642284|NCT02785770|528867846|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
146642285|NCT02785770|528867847|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
146642286|NCT02785770|528867848|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
146642287|NCT02338882|528867854|FG000|Overall Study|Death|1|||
146642288|NCT02338882|528867855|FG001|Overall Study|Death|0|||
146642289|NCT02338882|528867854|FG000|Overall Study|Lost to Follow-up|6|||
146642290|NCT02338882|528867855|FG001|Overall Study|Lost to Follow-up|3|||
146642291|NCT01904773|528867858|FG000|Screen|Screen failure|3|||
146642292|NCT01904773|528867859|FG001|Screen|Screen failure|0|||
146642293|NCT01904773|528867860|FG002|Screen|Screen failure|0|||
146768294|NCT02551055|529319580|FG005|Overall Study|Death|1|||
146768295|NCT02551055|529319581|FG006|Overall Study|Death|2|||
146563514|NCT02776735|528574546|FG005|Overall Study|Withdrawal by parent/guardian|0|||
146563515|NCT02776735|528574541|FG000|Overall Study|Withdrawal by Subject|1|||
146563516|NCT02776735|528574542|FG001|Overall Study|Withdrawal by Subject|0|||
146909164|NCT05121103|529831376|FG000|Overall Study|Physician Decision|2|||
146563517|NCT02776735|528574543|FG002|Overall Study|Withdrawal by Subject|0|||
146563518|NCT02776735|528574544|FG003|Overall Study|Withdrawal by Subject|0|||
146563519|NCT02776735|528574545|FG004|Overall Study|Withdrawal by Subject|0|||
146563520|NCT02776735|528574546|FG005|Overall Study|Withdrawal by Subject|1|||
146642294|NCT01904773|528867861|FG003|Screen|Screen failure|0|||
146642295|NCT01904773|528867862|FG004|Screen|Screen failure|0|||
146642296|NCT01904773|528867863|FG005|Screen|Screen failure|0|||
146642297|NCT01904773|528867864|FG006|Screen|Screen failure|0|||
146642298|NCT01904773|528867865|FG007|Screen|Screen failure|0|||
146642299|NCT01904773|528867866|FG008|Screen|Screen failure|0|||
146642300|NCT01904773|528867858|FG000|Screen|Withdrawal by Subject|1|||
146642301|NCT01904773|528867859|FG001|Screen|Withdrawal by Subject|0|||
146642302|NCT01904773|528867860|FG002|Screen|Withdrawal by Subject|0|||
146642303|NCT01904773|528867861|FG003|Screen|Withdrawal by Subject|0|||
146642304|NCT01904773|528867862|FG004|Screen|Withdrawal by Subject|0|||
146642305|NCT01904773|528867863|FG005|Screen|Withdrawal by Subject|0|||
146642306|NCT01904773|528867864|FG006|Screen|Withdrawal by Subject|0|||
146642307|NCT01904773|528867865|FG007|Screen|Withdrawal by Subject|0|||
146642308|NCT01904773|528867866|FG008|Screen|Withdrawal by Subject|0|||
146642309|NCT01904773|528867858|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
146642310|NCT01904773|528867859|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
146642311|NCT01904773|528867860|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
146642312|NCT01904773|528867861|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
146642313|NCT01904773|528867862|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
146642314|NCT01904773|528867863|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
146642315|NCT01904773|528867864|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
146642316|NCT01904773|528867865|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
146642317|NCT01904773|528867866|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
146909165|NCT05121103|529831377|FG001|Overall Study|Physician Decision|1|||
146909166|NCT05121103|529831378|FG002|Overall Study|Physician Decision|0|||
146909167|NCT05121103|529831376|FG000|Overall Study|Withdrawal by Subject|0|||
146909168|NCT05121103|529831377|FG001|Overall Study|Withdrawal by Subject|1|||
146909169|NCT05121103|529831378|FG002|Overall Study|Withdrawal by Subject|0|||
146909170|NCT03443024|529831380|FG000|Overall Study|Adverse Event|2|||
146563521|NCT02776735|528574541|FG000|Overall Study|Other|0|||
146909171|NCT03443024|529831381|FG001|Overall Study|Adverse Event|4|||
146909172|NCT03443024|529831382|FG002|Overall Study|Adverse Event|3|||
146909173|NCT03443024|529831383|FG003|Overall Study|Adverse Event|1|||
146909174|NCT03443024|529831380|FG000|Overall Study|Lost to Follow-up|9|||
146909175|NCT03443024|529831381|FG001|Overall Study|Lost to Follow-up|9|||
146909176|NCT03443024|529831382|FG002|Overall Study|Lost to Follow-up|7|||
146909177|NCT03443024|529831383|FG003|Overall Study|Lost to Follow-up|5|||
146909178|NCT03443024|529831380|FG000|Overall Study|Withdrawal by Subject|8|||
146909179|NCT03443024|529831381|FG001|Overall Study|Withdrawal by Subject|15|||
146909180|NCT03443024|529831382|FG002|Overall Study|Withdrawal by Subject|9|||
146909181|NCT03443024|529831383|FG003|Overall Study|Withdrawal by Subject|23|||
146909182|NCT03443024|529831380|FG000|Overall Study|Physician Decision|1|||
146909183|NCT03443024|529831381|FG001|Overall Study|Physician Decision|2|||
146909184|NCT03443024|529831382|FG002|Overall Study|Physician Decision|0|||
146909185|NCT03443024|529831383|FG003|Overall Study|Physician Decision|1|||
146909186|NCT03443024|529831380|FG000|Overall Study|Sponsor Decision|1|||
146909187|NCT03443024|529831381|FG001|Overall Study|Sponsor Decision|1|||
146909188|NCT03443024|529831382|FG002|Overall Study|Sponsor Decision|0|||
146909189|NCT03443024|529831383|FG003|Overall Study|Sponsor Decision|0|||
146909190|NCT03443024|529831380|FG000|Overall Study|Protocol Deviation|0|||
146909191|NCT03443024|529831381|FG001|Overall Study|Protocol Deviation|0|||
146909192|NCT03443024|529831382|FG002|Overall Study|Protocol Deviation|0|||
146909193|NCT03443024|529831383|FG003|Overall Study|Protocol Deviation|2|||
146909194|NCT01359982|529831384|FG000|Overall Study|Adverse Event|2|||
146909195|NCT01359982|529831385|FG001|Overall Study|Adverse Event|0|||
146909196|NCT01359982|529831386|FG002|Overall Study|Adverse Event|0|||
146909197|NCT01359982|529831387|FG003|Overall Study|Adverse Event|1|||
146909198|NCT01359982|529831388|FG004|Overall Study|Adverse Event|0|||
146909199|NCT01359982|529831389|FG005|Overall Study|Adverse Event|0|||
146909200|NCT01359982|529831384|FG000|Overall Study|Death|1|||
146909201|NCT01359982|529831385|FG001|Overall Study|Death|0|||
146909202|NCT01359982|529831386|FG002|Overall Study|Death|0|||
146909203|NCT01359982|529831387|FG003|Overall Study|Death|0|||
146909204|NCT01359982|529831388|FG004|Overall Study|Death|0|||
146909205|NCT01359982|529831389|FG005|Overall Study|Death|0|||
146909206|NCT05593432|529831390|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
146909207|NCT05593432|529831391|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
146909208|NCT05593432|529831392|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
146909209|NCT05593432|529831393|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
146909210|NCT05593432|529831390|FG000|16-Week OLE Period|Lack of Efficacy|0|||
146909211|NCT05593432|529831391|FG001|16-Week OLE Period|Lack of Efficacy|0|||
146909212|NCT05593432|529831392|FG002|16-Week OLE Period|Lack of Efficacy|0|||
146909213|NCT05593432|529831393|FG003|16-Week OLE Period|Lack of Efficacy|1|||
146909214|NCT05593432|529831390|FG000|16-Week OLE Period|Lost to Follow-up|0|||
146909215|NCT05593432|529831391|FG001|16-Week OLE Period|Lost to Follow-up|0|||
146909216|NCT05593432|529831392|FG002|16-Week OLE Period|Lost to Follow-up|1|||
146909217|NCT05593432|529831393|FG003|16-Week OLE Period|Lost to Follow-up|2|||
146909218|NCT05593432|529831390|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
146909219|NCT05593432|529831391|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
146909220|NCT05593432|529831392|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
146909221|NCT05593432|529831393|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
146909222|NCT05897853|529831394|FG000|Overall Study|Lost to Follow-up|2|||
146909223|NCT05897853|529831395|FG001|Overall Study|Lost to Follow-up|0|||
146909224|NCT05897853|529831394|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
146909225|NCT05897853|529831395|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
146909226|NCT04458857|529831402|FG000|Overall Study|Adverse Event|0|||
146909227|NCT04458857|529831403|FG001|Overall Study|Adverse Event|1|||
146909228|NCT04458857|529831404|FG002|Overall Study|Adverse Event|0|||
146970299|NCT03972709|530052592|FG002|Overall Study|Subject Moved|0|||
146563522|NCT02776735|528574542|FG001|Overall Study|Other|0|||
146768296|NCT02551055|529319582|FG007|Overall Study|Death|0|||
146768297|NCT02551055|529319575|FG000|Overall Study|Study Terminated by Sponsor|1|||
146909229|NCT04458857|529831402|FG000|Overall Study|Withdrawal by Subject|2|||
146909230|NCT04458857|529831403|FG001|Overall Study|Withdrawal by Subject|0|||
146909231|NCT04458857|529831404|FG002|Overall Study|Withdrawal by Subject|0|||
146909232|NCT04458857|529831402|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146909233|NCT04458857|529831403|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146909234|NCT04458857|529831404|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146909235|NCT04458857|529831402|FG000|Overall Study|Non-compliance with study drug|0|||
146970300|NCT03972709|530052590|FG000|Overall Study|Missed Study Visits|1|||
146909236|NCT04458857|529831403|FG001|Overall Study|Non-compliance with study drug|1|||
146909237|NCT04458857|529831404|FG002|Overall Study|Non-compliance with study drug|0|||
146909238|NCT04458857|529831402|FG000|Overall Study|Lost to Follow-up|4|||
146909239|NCT04458857|529831403|FG001|Overall Study|Lost to Follow-up|1|||
146909240|NCT04458857|529831404|FG002|Overall Study|Lost to Follow-up|0|||
146909241|NCT04800315|529831406|FG000|Randomization|Did not receive study treatment|1|||
146909242|NCT04800315|529831407|FG001|Randomization|Did not receive study treatment|0|||
146909243|NCT04800315|529831408|FG002|Randomization|Did not receive study treatment|0|||
146909244|NCT04800315|529831409|FG003|Randomization|Did not receive study treatment|0|||
146909245|NCT04800315|529831406|FG000|Treatment Period|Adverse Event|4|||
146909246|NCT04800315|529831407|FG001|Treatment Period|Adverse Event|2|||
146909247|NCT04800315|529831408|FG002|Treatment Period|Adverse Event|1|||
146909248|NCT04800315|529831409|FG003|Treatment Period|Adverse Event|2|||
146909249|NCT04800315|529831406|FG000|Treatment Period|Lack of Efficacy|1|||
146909250|NCT04800315|529831407|FG001|Treatment Period|Lack of Efficacy|0|||
146909251|NCT04800315|529831408|FG002|Treatment Period|Lack of Efficacy|0|||
146909252|NCT04800315|529831409|FG003|Treatment Period|Lack of Efficacy|3|||
146909253|NCT04800315|529831406|FG000|Treatment Period|Lost to Follow-up|0|||
146909254|NCT04800315|529831407|FG001|Treatment Period|Lost to Follow-up|1|||
146563523|NCT02776735|528574543|FG002|Overall Study|Other|3|||
146909255|NCT04800315|529831408|FG002|Treatment Period|Lost to Follow-up|2|||
146909256|NCT04800315|529831409|FG003|Treatment Period|Lost to Follow-up|2|||
146563524|NCT02776735|528574544|FG003|Overall Study|Other|0|||
146563525|NCT02776735|528574545|FG004|Overall Study|Other|0|||
146909257|NCT04800315|529831406|FG000|Treatment Period|Withdrawal by participant|0|||
146909258|NCT04800315|529831407|FG001|Treatment Period|Withdrawal by participant|0|||
146909259|NCT04800315|529831408|FG002|Treatment Period|Withdrawal by participant|0|||
146563526|NCT02776735|528574546|FG005|Overall Study|Other|0|||
146563527|NCT05847686|528576120|FG000|Overall Study|Withdrawal by Subject|3|||
146909260|NCT04800315|529831409|FG003|Treatment Period|Withdrawal by participant|4|||
146909261|NCT04800315|529831406|FG000|Treatment Period|Other Reasons|0|||
146563528|NCT03716830|528576121|FG000|Overall Study|Withdrawal by Subject|2|||
146768298|NCT02551055|529319576|FG001|Overall Study|Study Terminated by Sponsor|1|||
146768299|NCT02551055|529319577|FG002|Overall Study|Study Terminated by Sponsor|0|||
146768300|NCT02551055|529319578|FG003|Overall Study|Study Terminated by Sponsor|2|||
146909262|NCT04800315|529831407|FG001|Treatment Period|Other Reasons|2|||
146509178|NCT00096993|528367757|FG001|Overall Study|Physician Decision|1|||
146768301|NCT02551055|529319579|FG004|Overall Study|Study Terminated by Sponsor|2|||
146909263|NCT04800315|529831408|FG002|Treatment Period|Other Reasons|0|||
146563529|NCT03716830|528576122|FG001|Overall Study|Withdrawal by Subject|2|||
146563530|NCT03716830|528576123|FG002|Overall Study|Withdrawal by Subject|6|||
146563531|NCT03716830|528576124|FG003|Overall Study|Withdrawal by Subject|5|||
146563532|NCT03716830|528576121|FG000|Overall Study|Adverse Event|1|||
146563533|NCT03716830|528576122|FG001|Overall Study|Adverse Event|2|||
146563534|NCT03716830|528576123|FG002|Overall Study|Adverse Event|0|||
146563535|NCT03716830|528576124|FG003|Overall Study|Adverse Event|1|||
146563536|NCT03716830|528576121|FG000|Overall Study|Lost to Follow-up|1|||
146563537|NCT03716830|528576122|FG001|Overall Study|Lost to Follow-up|1|||
146563538|NCT03716830|528576123|FG002|Overall Study|Lost to Follow-up|0|||
146563539|NCT03716830|528576124|FG003|Overall Study|Lost to Follow-up|0|||
146563540|NCT03021486|528576125|FG000|Overall Study|Withdrawal by Subject|1|||
146563541|NCT03021486|528576126|FG001|Overall Study|Withdrawal by Subject|1|||
146563542|NCT03021486|528576127|FG002|Overall Study|Withdrawal by Subject|3|||
146563543|NCT03021486|528576125|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
146563544|NCT03021486|528576126|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
146563545|NCT03021486|528576127|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
146563546|NCT03309202|528576130|FG000|Overall Study|Lost to Follow-up|1|||
146563547|NCT03309202|528576131|FG001|Overall Study|Lost to Follow-up|0|||
146563548|NCT03309202|528576132|FG002|Overall Study|Lost to Follow-up|0|||
146563549|NCT03309202|528576133|FG003|Overall Study|Lost to Follow-up|0|||
146563550|NCT01209767|528576134|FG000|Overall Study|Withdrawal by Subject|1|||
146563551|NCT01209767|528576134|FG000|Overall Study|Lost to Follow-up|3|||
146563552|NCT01702298|528576135|FG000|Overall Study|Withdrawal by Subject|1|||
146563553|NCT02090764|528576139|FG000|Overall Study|Adverse Event|1|||
146563554|NCT02090764|528576140|FG001|Overall Study|Adverse Event|3|||
146563555|NCT02090764|528576139|FG000|Overall Study|Lack of Efficacy|0|||
146563556|NCT02090764|528576140|FG001|Overall Study|Lack of Efficacy|13|||
146563557|NCT02090764|528576139|FG000|Overall Study|Withdrawal by Subject|2|||
146563558|NCT02090764|528576140|FG001|Overall Study|Withdrawal by Subject|1|||
146563559|NCT02090764|528576139|FG000|Overall Study|Intercurrent illness and other|1|||
146563560|NCT02090764|528576140|FG001|Overall Study|Intercurrent illness and other|1|||
146563561|NCT02090764|528576139|FG000|Overall Study|Lost to Follow-up|2|||
146563562|NCT02090764|528576140|FG001|Overall Study|Lost to Follow-up|2|||
146563563|NCT02037529|528576141|FG000|Overall Study|Withdrawal by Subject|1|||
146563564|NCT02037529|528576142|FG001|Overall Study|Withdrawal by Subject|3|||
146563565|NCT02037529|528576141|FG000|Overall Study|Adverse Event|0|||
146563566|NCT02037529|528576142|FG001|Overall Study|Adverse Event|1|||
146563567|NCT02131766|528576143|FG000|Overall Study|Withdrawal by Subject|4|||
146563568|NCT00718315|528576145|FG000|Overall Study|Adverse Event|1|||
146563569|NCT00718315|528576146|FG001|Overall Study|Adverse Event|2|||
146563570|NCT00718315|528576147|FG002|Overall Study|Adverse Event|3|||
146563571|NCT00718315|528576145|FG000|Overall Study|Death|6|||
146563572|NCT00718315|528576146|FG001|Overall Study|Death|6|||
146563573|NCT00718315|528576147|FG002|Overall Study|Death|5|||
146563574|NCT00718315|528576145|FG000|Overall Study|Lost to Follow-up|2|||
146563575|NCT00718315|528576146|FG001|Overall Study|Lost to Follow-up|3|||
146563576|NCT00718315|528576147|FG002|Overall Study|Lost to Follow-up|4|||
146563577|NCT00718315|528576145|FG000|Overall Study|Protocol Violation|5|||
146563578|NCT00718315|528576146|FG001|Overall Study|Protocol Violation|5|||
146563579|NCT00718315|528576147|FG002|Overall Study|Protocol Violation|3|||
146563580|NCT00718315|528576145|FG000|Overall Study|Erlotinib dose decreased|4|||
146563581|NCT00718315|528576146|FG001|Overall Study|Erlotinib dose decreased|3|||
146563582|NCT00718315|528576147|FG002|Overall Study|Erlotinib dose decreased|1|||
146563583|NCT00718315|528576145|FG000|Overall Study|Use of Minocyclin|1|||
146563584|NCT00718315|528576146|FG001|Overall Study|Use of Minocyclin|1|||
146563585|NCT00718315|528576147|FG002|Overall Study|Use of Minocyclin|1|||
146563586|NCT00718315|528576145|FG000|Overall Study|Disease progression|0|||
146563587|NCT00718315|528576146|FG001|Overall Study|Disease progression|1|||
146563588|NCT00718315|528576147|FG002|Overall Study|Disease progression|1|||
146563589|NCT00718315|528576145|FG000|Overall Study|Other|0|||
146563590|NCT00718315|528576146|FG001|Overall Study|Other|0|||
146563591|NCT00718315|528576147|FG002|Overall Study|Other|1|||
146563592|NCT00718315|528576145|FG000|Overall Study|Use of ATB and Corticoids|0|||
146563593|NCT00718315|528576146|FG001|Overall Study|Use of ATB and Corticoids|1|||
146563594|NCT00718315|528576147|FG002|Overall Study|Use of ATB and Corticoids|2|||
146563595|NCT00806585|528576148|FG000|Overall Study|Study terminated by Sponsor|0|||
146563596|NCT00806585|528576149|FG001|Overall Study|Study terminated by Sponsor|0|||
146563597|NCT00806585|528576150|FG002|Overall Study|Study terminated by Sponsor|1|||
146563598|NCT00806585|528576151|FG003|Overall Study|Study terminated by Sponsor|2|||
146563599|NCT00806585|528576152|FG004|Overall Study|Study terminated by Sponsor|0|||
146563600|NCT00806585|528576148|FG000|Overall Study|Protocol Violation|3|||
146563601|NCT00806585|528576149|FG001|Overall Study|Protocol Violation|1|||
146563602|NCT00806585|528576150|FG002|Overall Study|Protocol Violation|2|||
146563603|NCT00806585|528576151|FG003|Overall Study|Protocol Violation|0|||
146563604|NCT00806585|528576152|FG004|Overall Study|Protocol Violation|0|||
146563605|NCT00806585|528576148|FG000|Overall Study|Physician Decision|0|||
146563606|NCT00806585|528576149|FG001|Overall Study|Physician Decision|2|||
146909264|NCT04800315|529831409|FG003|Treatment Period|Other Reasons|1|||
146909265|NCT00753922|529831410|FG000|Overall Study|Lost to Follow-up|155|||
146909266|NCT00753922|529831411|FG001|Overall Study|Lost to Follow-up|24|||
146909267|NCT00753922|529831412|FG002|Overall Study|Lost to Follow-up|28|||
146909268|NCT00753922|529831413|FG003|Overall Study|Lost to Follow-up|5|||
146909269|NCT00753922|529831410|FG000|Overall Study|Withdrawal by Subject|9|||
146909270|NCT00753922|529831411|FG001|Overall Study|Withdrawal by Subject|11|||
146909271|NCT00753922|529831412|FG002|Overall Study|Withdrawal by Subject|4|||
146909272|NCT00753922|529831413|FG003|Overall Study|Withdrawal by Subject|2|||
146909273|NCT00753922|529831410|FG000|Overall Study|Patient Non-compliance|55|||
146909274|NCT00753922|529831411|FG001|Overall Study|Patient Non-compliance|22|||
146909275|NCT00753922|529831412|FG002|Overall Study|Patient Non-compliance|14|||
146642318|NCT01904773|528867858|FG000|First Intervention|Adverse Event|0|||
146642319|NCT01904773|528867859|FG001|First Intervention|Adverse Event|0|||
146642320|NCT01904773|528867860|FG002|First Intervention|Adverse Event|0|||
146642321|NCT01904773|528867861|FG003|First Intervention|Adverse Event|0|||
146642322|NCT01904773|528867862|FG004|First Intervention|Adverse Event|0|||
146642323|NCT01904773|528867863|FG005|First Intervention|Adverse Event|0|||
146642324|NCT01904773|528867864|FG006|First Intervention|Adverse Event|1|||
146642325|NCT01904773|528867865|FG007|First Intervention|Adverse Event|0|||
146642326|NCT01904773|528867866|FG008|First Intervention|Adverse Event|0|||
146768302|NCT02551055|529319580|FG005|Overall Study|Study Terminated by Sponsor|0|||
146768303|NCT02551055|529319581|FG006|Overall Study|Study Terminated by Sponsor|0|||
146970301|NCT03972709|530052591|FG001|Overall Study|Missed Study Visits|0|||
146642327|NCT01904773|528867858|FG000|Placebo Washout First Intervention|Condition worsened|0|||
146563607|NCT00806585|528576150|FG002|Overall Study|Physician Decision|3|||
146970302|NCT03972709|530052592|FG002|Overall Study|Missed Study Visits|0|||
146970303|NCT04732728|530052593|FG000|Overall Study|Death|12|||
146970304|NCT04732728|530052593|FG000|Overall Study|Withdrawn|136|||
146970305|NCT01393626|530052602|FG000|Overall Study|Adverse Event|2|||
146563608|NCT00806585|528576151|FG003|Overall Study|Physician Decision|0|||
146563609|NCT00806585|528576152|FG004|Overall Study|Physician Decision|1|||
146563610|NCT00806585|528576148|FG000|Overall Study|Lost to Follow-up|2|||
146563611|NCT00806585|528576149|FG001|Overall Study|Lost to Follow-up|1|||
146970306|NCT01393626|530052603|FG001|Overall Study|Adverse Event|1|||
146563612|NCT00806585|528576150|FG002|Overall Study|Lost to Follow-up|2|||
146563613|NCT00806585|528576151|FG003|Overall Study|Lost to Follow-up|2|||
146563614|NCT00806585|528576152|FG004|Overall Study|Lost to Follow-up|5|||
146563615|NCT00806585|528576148|FG000|Overall Study|Lack of Efficacy|1|||
146563616|NCT00806585|528576149|FG001|Overall Study|Lack of Efficacy|0|||
146563617|NCT00806585|528576150|FG002|Overall Study|Lack of Efficacy|0|||
146563618|NCT00806585|528576151|FG003|Overall Study|Lack of Efficacy|0|||
146563619|NCT00806585|528576152|FG004|Overall Study|Lack of Efficacy|0|||
146563620|NCT00806585|528576148|FG000|Overall Study|Adverse Event|1|||
146642328|NCT01904773|528867859|FG001|Placebo Washout First Intervention|Condition worsened|1|||
146642329|NCT01904773|528867860|FG002|Placebo Washout First Intervention|Condition worsened|0|||
146642330|NCT01904773|528867861|FG003|Placebo Washout First Intervention|Condition worsened|0|||
146563621|NCT00806585|528576149|FG001|Overall Study|Adverse Event|5|||
146563622|NCT00806585|528576150|FG002|Overall Study|Adverse Event|3|||
146563623|NCT00806585|528576151|FG003|Overall Study|Adverse Event|4|||
146563624|NCT00806585|528576152|FG004|Overall Study|Adverse Event|2|||
146563625|NCT00806585|528576148|FG000|Overall Study|Withdrawal by Subject|10|||
146563626|NCT00806585|528576149|FG001|Overall Study|Withdrawal by Subject|8|||
146563627|NCT00806585|528576150|FG002|Overall Study|Withdrawal by Subject|9|||
146563628|NCT00806585|528576151|FG003|Overall Study|Withdrawal by Subject|3|||
146563629|NCT00806585|528576152|FG004|Overall Study|Withdrawal by Subject|11|||
146563630|NCT00806585|528576148|FG000|Overall Study|Completion status unknown|15|||
146563631|NCT00806585|528576149|FG001|Overall Study|Completion status unknown|14|||
146563632|NCT00806585|528576150|FG002|Overall Study|Completion status unknown|12|||
146563633|NCT00806585|528576151|FG003|Overall Study|Completion status unknown|4|||
146563634|NCT00806585|528576152|FG004|Overall Study|Completion status unknown|12|||
146563635|NCT00673920|528576160|FG000|Baseline up to Week 48|Withdrew consent|1|||
146563636|NCT00673920|528576161|FG001|Baseline up to Week 48|Withdrew consent|0|||
146563637|NCT00673920|528576162|FG002|Baseline up to Week 48|Withdrew consent|2|||
146563638|NCT00673920|528576163|FG003|Baseline up to Week 48|Withdrew consent|0|||
146563639|NCT00673920|528576164|FG004|Baseline up to Week 48|Withdrew consent|0|||
146563640|NCT00673920|528576165|FG005|Baseline up to Week 48|Withdrew consent|0|||
146563641|NCT00673920|528576166|FG006|Baseline up to Week 48|Withdrew consent|0|||
146563642|NCT00673920|528576167|FG007|Baseline up to Week 48|Withdrew consent|0|||
146563643|NCT00673920|528576160|FG000|Baseline up to Week 48|Refused treatment|1|||
146563644|NCT00673920|528576161|FG001|Baseline up to Week 48|Refused treatment|0|||
146563645|NCT00673920|528576162|FG002|Baseline up to Week 48|Refused treatment|0|||
146563646|NCT00673920|528576163|FG003|Baseline up to Week 48|Refused treatment|0|||
146563647|NCT00673920|528576164|FG004|Baseline up to Week 48|Refused treatment|0|||
146563648|NCT00673920|528576165|FG005|Baseline up to Week 48|Refused treatment|0|||
146563649|NCT00673920|528576166|FG006|Baseline up to Week 48|Refused treatment|0|||
146563650|NCT00673920|528576167|FG007|Baseline up to Week 48|Refused treatment|0|||
146563651|NCT00673920|528576160|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
146563652|NCT00673920|528576161|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
146563653|NCT00673920|528576162|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
146563654|NCT00673920|528576163|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
146563655|NCT00673920|528576164|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
146563656|NCT00673920|528576165|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
146563657|NCT00673920|528576166|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
146909276|NCT00753922|529831413|FG003|Overall Study|Patient Non-compliance|11|||
146909277|NCT00753922|529831410|FG000|Overall Study|Patients Not Completing Visit|11|||
146909278|NCT00753922|529831411|FG001|Overall Study|Patients Not Completing Visit|0|||
146909279|NCT00753922|529831412|FG002|Overall Study|Patients Not Completing Visit|1|||
146909280|NCT00753922|529831413|FG003|Overall Study|Patients Not Completing Visit|0|||
146909281|NCT00753922|529831410|FG000|Overall Study|Death|2|||
146909282|NCT00753922|529831411|FG001|Overall Study|Death|23|||
146909283|NCT00753922|529831412|FG002|Overall Study|Death|2|||
146909284|NCT00753922|529831413|FG003|Overall Study|Death|1|||
146909285|NCT00753922|529831410|FG000|Overall Study|Discontinuation Due to Explantation|14|||
146909286|NCT00753922|529831411|FG001|Overall Study|Discontinuation Due to Explantation|14|||
146909287|NCT00753922|529831412|FG002|Overall Study|Discontinuation Due to Explantation|14|||
146909288|NCT00753922|529831413|FG003|Overall Study|Discontinuation Due to Explantation|4|||
146909289|NCT00196937|529831414|FG000|Overall Study|Serious Adverse Event|1|||
146909290|NCT00196937|529831415|FG001|Overall Study|Serious Adverse Event|0|||
146909291|NCT00196937|529831416|FG002|Overall Study|Serious Adverse Event|0|||
146909292|NCT00196937|529831414|FG000|Overall Study|Non-serious adverse event|1|||
146909293|NCT00196937|529831415|FG001|Overall Study|Non-serious adverse event|1|||
146909294|NCT00196937|529831416|FG002|Overall Study|Non-serious adverse event|1|||
146909295|NCT00196937|529831414|FG000|Overall Study|Withdrawal by Subject|0|||
146909296|NCT00196937|529831415|FG001|Overall Study|Withdrawal by Subject|0|||
146909297|NCT00196937|529831416|FG002|Overall Study|Withdrawal by Subject|2|||
146909298|NCT00196937|529831414|FG000|Overall Study|Lost to Follow-up|4|||
146909299|NCT00196937|529831415|FG001|Overall Study|Lost to Follow-up|3|||
146909300|NCT00196937|529831416|FG002|Overall Study|Lost to Follow-up|3|||
146909301|NCT00196937|529831414|FG000|Overall Study|Other|3|||
146909302|NCT00196937|529831415|FG001|Overall Study|Other|1|||
146909303|NCT00196937|529831416|FG002|Overall Study|Other|1|||
146909304|NCT03368404|529831424|FG000|Overall Study|Adverse Event|2|||
146909305|NCT03368404|529831425|FG001|Overall Study|Adverse Event|1|||
146909306|NCT03368404|529831424|FG000|Overall Study|Withdrawal by Subject|1|||
146909307|NCT03368404|529831425|FG001|Overall Study|Withdrawal by Subject|1|||
146909308|NCT02983292|529831426|FG000|Overall Study|Participant unwell & cannot travel|2|||
146909309|NCT02983292|529831426|FG000|Overall Study|Lost to Follow-up|3|||
146909310|NCT02983292|529831426|FG000|Overall Study|Participant withdrew consent|2|||
146563658|NCT00673920|528576167|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
146563659|NCT00673920|528576160|FG000|Baseline up to Week 48|Protocol Violation|0|||
146563660|NCT00673920|528576161|FG001|Baseline up to Week 48|Protocol Violation|0|||
146768304|NCT02551055|529319582|FG007|Overall Study|Study Terminated by Sponsor|0|||
146768305|NCT02551055|529319575|FG000|Overall Study|Withdrawal by Subject|1|||
146768306|NCT02551055|529319576|FG001|Overall Study|Withdrawal by Subject|1|||
146768307|NCT02551055|529319577|FG002|Overall Study|Withdrawal by Subject|0|||
146768308|NCT02551055|529319578|FG003|Overall Study|Withdrawal by Subject|1|||
146768309|NCT02551055|529319579|FG004|Overall Study|Withdrawal by Subject|2|||
146768310|NCT02551055|529319580|FG005|Overall Study|Withdrawal by Subject|0|||
146768311|NCT02551055|529319581|FG006|Overall Study|Withdrawal by Subject|0|||
146768312|NCT02551055|529319582|FG007|Overall Study|Withdrawal by Subject|0|||
146768313|NCT02551055|529319575|FG000|Overall Study|Reason not specified|0|||
146768314|NCT02551055|529319576|FG001|Overall Study|Reason not specified|0|||
146768315|NCT02551055|529319577|FG002|Overall Study|Reason not specified|0|||
146768316|NCT02551055|529319578|FG003|Overall Study|Reason not specified|0|||
146768317|NCT02551055|529319579|FG004|Overall Study|Reason not specified|1|||
146768318|NCT02551055|529319580|FG005|Overall Study|Reason not specified|0|||
146768319|NCT02551055|529319581|FG006|Overall Study|Reason not specified|1|||
146768320|NCT02551055|529319582|FG007|Overall Study|Reason not specified|0|||
146768321|NCT00430300|529319583|FG000|Overall Study|Adverse Event|0|||
146768322|NCT00430300|529319584|FG001|Overall Study|Adverse Event|2|||
146768323|NCT00430300|529319585|FG002|Overall Study|Adverse Event|1|||
146768324|NCT00430300|529319586|FG003|Overall Study|Adverse Event|1|||
146909311|NCT02983292|529831426|FG000|Overall Study|Revision|7|||
146909312|NCT02983292|529831426|FG000|Overall Study|Death|1|||
146909313|NCT02983292|529831426|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
146909314|NCT02983292|529831426|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
146768325|NCT00430300|529319583|FG000|Overall Study|Withdrawal by Subject|1|||
146768326|NCT00430300|529319584|FG001|Overall Study|Withdrawal by Subject|0|||
146768327|NCT00430300|529319585|FG002|Overall Study|Withdrawal by Subject|5|||
146768328|NCT00430300|529319586|FG003|Overall Study|Withdrawal by Subject|0|||
146768329|NCT00430300|529319583|FG000|Overall Study|Laboratory abnormality|1|||
146768330|NCT00430300|529319584|FG001|Overall Study|Laboratory abnormality|0|||
146768331|NCT00430300|529319585|FG002|Overall Study|Laboratory abnormality|0|||
146509179|NCT00096993|528367756|FG000|Overall Study|Non-compliance|0|||
146909315|NCT02983292|529831426|FG000|Overall Study|Participant relocation|1|||
146909316|NCT00586690|529831431|FG000|Overall Study|Death|2|||
146909317|NCT00586690|529831432|FG001|Overall Study|Death|0|||
146909318|NCT00586690|529831431|FG000|Overall Study|Disease Progression|10|||
146909319|NCT00586690|529831432|FG001|Overall Study|Disease Progression|0|||
146909320|NCT00586690|529831431|FG000|Overall Study|Adverse Event|1|||
146909321|NCT00586690|529831432|FG001|Overall Study|Adverse Event|0|||
146909322|NCT00586690|529831431|FG000|Overall Study|Lack of Efficacy|2|||
146909323|NCT00586690|529831432|FG001|Overall Study|Lack of Efficacy|0|||
146909324|NCT00586690|529831431|FG000|Overall Study|Lab can't accommodate|1|||
146909325|NCT00586690|529831432|FG001|Overall Study|Lab can't accommodate|0|||
146909326|NCT01751646|529831433|FG000|Overall Study|Lost to Follow-up|5|||
146909327|NCT01751646|529831434|FG001|Overall Study|Lost to Follow-up|1|||
146909328|NCT01751646|529831433|FG000|Overall Study|Withdrawal by Subject|0|||
146909329|NCT01751646|529831434|FG001|Overall Study|Withdrawal by Subject|4|||
146909330|NCT01751646|529831433|FG000|Overall Study|Starting hormone therapy|1|||
146909331|NCT01751646|529831434|FG001|Overall Study|Starting hormone therapy|0|||
146909332|NCT01751646|529831433|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
146909333|NCT01751646|529831434|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
146909334|NCT01751646|529831433|FG000|Overall Study|Inadvertent enrollment|1|||
146909335|NCT01751646|529831434|FG001|Overall Study|Inadvertent enrollment|1|||
146909336|NCT01751646|529831433|FG000|Overall Study|Moved out of the area|1|||
146909337|NCT01751646|529831434|FG001|Overall Study|Moved out of the area|5|||
146909338|NCT01751646|529831433|FG000|Overall Study|Inability to attend required visits|0|||
146909339|NCT01751646|529831434|FG001|Overall Study|Inability to attend required visits|1|||
146909340|NCT01751646|529831433|FG000|Overall Study|Off study due to multiple obligations|0|||
146909341|NCT01751646|529831434|FG001|Overall Study|Off study due to multiple obligations|1|||
146909342|NCT01751646|529831433|FG000|Overall Study|Fails to comply with study requirements|0|||
146909343|NCT01751646|529831434|FG001|Overall Study|Fails to comply with study requirements|1|||
146909344|NCT01751646|529831433|FG000|Overall Study|Childcare issues|1|||
146909345|NCT01751646|529831434|FG001|Overall Study|Childcare issues|1|||
146909346|NCT02190591|529831435|FG000|Overall Study|Withdrawal by Subject|1|||
146909347|NCT02190591|529831436|FG001|Overall Study|Withdrawal by Subject|8|||
146909348|NCT02190591|529831435|FG000|Overall Study|Protocol Violation|1|||
146909349|NCT02190591|529831436|FG001|Overall Study|Protocol Violation|0|||
146909350|NCT02190591|529831435|FG000|Overall Study|did not use peanut ball as instructed|0|||
146909351|NCT02190591|529831436|FG001|Overall Study|did not use peanut ball as instructed|2|||
146909352|NCT02190591|529831435|FG000|Overall Study|face presentation so she was ineligible|0|||
146909353|NCT02190591|529831436|FG001|Overall Study|face presentation so she was ineligible|1|||
146909354|NCT01524289|529831437|FG000|Overall Study|Lost to Follow-up|0|||
146909355|NCT01524289|529831438|FG001|Overall Study|Lost to Follow-up|1|||
146909356|NCT01524289|529831437|FG000|Overall Study|Physician Decision|1|||
146909357|NCT01524289|529831438|FG001|Overall Study|Physician Decision|0|||
146909358|NCT01524289|529831437|FG000|Overall Study|Protocol Violation|5|||
146909359|NCT01524289|529831438|FG001|Overall Study|Protocol Violation|1|||
146909360|NCT01524289|529831437|FG000|Overall Study|Withdrawal by Subject|11|||
146642331|NCT01904773|528867862|FG004|Placebo Washout First Intervention|Condition worsened|0|||
146642332|NCT01904773|528867863|FG005|Placebo Washout First Intervention|Condition worsened|0|||
146642333|NCT01904773|528867864|FG006|Placebo Washout First Intervention|Condition worsened|0|||
146909361|NCT01524289|529831438|FG001|Overall Study|Withdrawal by Subject|7|||
146642334|NCT01904773|528867865|FG007|Placebo Washout First Intervention|Condition worsened|0|||
146909362|NCT01524289|529831437|FG000|Overall Study|Adverse Event|12|||
146909363|NCT01524289|529831438|FG001|Overall Study|Adverse Event|5|||
146909364|NCT01524289|529831437|FG000|Overall Study|Did not take study medication|1|||
146909365|NCT01524289|529831438|FG001|Overall Study|Did not take study medication|0|||
146970307|NCT01393626|530052604|FG002|Overall Study|Adverse Event|5|||
146970308|NCT01393626|530052605|FG003|Overall Study|Adverse Event|0|||
146970309|NCT01393626|530052602|FG000|Overall Study|Did not meet entrance criteria|1|||
146642335|NCT01904773|528867866|FG008|Placebo Washout First Intervention|Condition worsened|0|||
146642336|NCT01904773|528867858|FG000|Fifth Intervention|Adverse Event|0|||
146642337|NCT01904773|528867859|FG001|Fifth Intervention|Adverse Event|0|||
146642338|NCT01904773|528867860|FG002|Fifth Intervention|Adverse Event|0|||
146642339|NCT01904773|528867861|FG003|Fifth Intervention|Adverse Event|0|||
146642340|NCT01904773|528867862|FG004|Fifth Intervention|Adverse Event|0|||
146642341|NCT01904773|528867863|FG005|Fifth Intervention|Adverse Event|0|||
146642342|NCT01904773|528867864|FG006|Fifth Intervention|Adverse Event|0|||
146642343|NCT01904773|528867865|FG007|Fifth Intervention|Adverse Event|1|||
146642344|NCT01904773|528867866|FG008|Fifth Intervention|Adverse Event|0|||
146642345|NCT01904773|528867858|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
146642346|NCT01904773|528867859|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
146642347|NCT01904773|528867860|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
146642348|NCT01904773|528867861|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
146642349|NCT01904773|528867862|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
146642350|NCT01904773|528867863|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
146642351|NCT01904773|528867864|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
146642352|NCT01904773|528867865|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
146642353|NCT01904773|528867866|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
146642354|NCT04518995|528867867|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
146642355|NCT04518995|528867868|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
146642356|NCT04518995|528867869|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
146642357|NCT04518995|528867867|FG000|Overall Study|Lack of Efficacy|2|||
146642358|NCT04518995|528867868|FG001|Overall Study|Lack of Efficacy|1|||
146642359|NCT04518995|528867869|FG002|Overall Study|Lack of Efficacy|0|||
146642360|NCT04518995|528867867|FG000|Overall Study|Non-compliance With Study Drug|0|||
146642361|NCT04518995|528867868|FG001|Overall Study|Non-compliance With Study Drug|3|||
146642362|NCT04518995|528867869|FG002|Overall Study|Non-compliance With Study Drug|2|||
146642363|NCT04518995|528867867|FG000|Overall Study|Pregnancy|0|||
146642364|NCT04518995|528867868|FG001|Overall Study|Pregnancy|0|||
146642365|NCT04518995|528867869|FG002|Overall Study|Pregnancy|1|||
146642366|NCT04518995|528867867|FG000|Overall Study|Protocol Violation|2|||
146642367|NCT04518995|528867868|FG001|Overall Study|Protocol Violation|0|||
146642368|NCT04518995|528867869|FG002|Overall Study|Protocol Violation|1|||
146642369|NCT04518995|528867867|FG000|Overall Study|Reason not Specified|4|||
146642370|NCT04518995|528867868|FG001|Overall Study|Reason not Specified|11|||
146642371|NCT04518995|528867869|FG002|Overall Study|Reason not Specified|2|||
146642372|NCT04518995|528867867|FG000|Overall Study|Lost to Follow-up|1|||
146642373|NCT04518995|528867868|FG001|Overall Study|Lost to Follow-up|10|||
146642374|NCT04518995|528867869|FG002|Overall Study|Lost to Follow-up|6|||
146642375|NCT00669409|528867872|FG000|Part 2|Withdrawal by Subject|0|||
146642376|NCT00669409|528867873|FG001|Part 2|Withdrawal by Subject|0|||
146642377|NCT00669409|528867874|FG002|Part 2|Withdrawal by Subject|0|||
146642378|NCT00669409|528867875|FG003|Part 2|Withdrawal by Subject|0|||
146642379|NCT00669409|528867876|FG004|Part 2|Withdrawal by Subject|0|||
146642380|NCT00669409|528867877|FG005|Part 2|Withdrawal by Subject|0|||
146909366|NCT01821677|529831442|FG000|Overall Study|Adverse Event|4|||
146909367|NCT01821677|529831443|FG001|Overall Study|Adverse Event|6|||
146909368|NCT01821677|529831444|FG002|Overall Study|Adverse Event|5|||
146909369|NCT01821677|529831442|FG000|Overall Study|Physician Decision|1|||
146909370|NCT01821677|529831443|FG001|Overall Study|Physician Decision|4|||
146909371|NCT01821677|529831444|FG002|Overall Study|Physician Decision|1|||
146909372|NCT01821677|529831442|FG000|Overall Study|Non-compliance|0|||
146909373|NCT01821677|529831443|FG001|Overall Study|Non-compliance|1|||
146909374|NCT01821677|529831444|FG002|Overall Study|Non-compliance|2|||
146909375|NCT01821677|529831442|FG000|Overall Study|Lost to Follow-up|2|||
146909376|NCT01821677|529831443|FG001|Overall Study|Lost to Follow-up|1|||
146909377|NCT01821677|529831444|FG002|Overall Study|Lost to Follow-up|3|||
146642381|NCT00669409|528867878|FG006|Part 2|Withdrawal by Subject|0|||
146909378|NCT01821677|529831442|FG000|Overall Study|Protocol Violation|0|||
146909379|NCT01821677|529831443|FG001|Overall Study|Protocol Violation|0|||
146642382|NCT00669409|528867879|FG007|Part 2|Withdrawal by Subject|0|||
146642383|NCT00669409|528867880|FG008|Part 2|Withdrawal by Subject|0|||
146642384|NCT00669409|528867881|FG009|Part 2|Withdrawal by Subject|1|||
146642385|NCT00669409|528867882|FG010|Part 2|Withdrawal by Subject|0|||
146642386|NCT00813943|528867883|FG000|Overall Study|Ongoing at cut-off date|5|||
146642387|NCT00813943|528867884|FG001|Overall Study|Ongoing at cut-off date|5|||
146909380|NCT01821677|529831444|FG002|Overall Study|Protocol Violation|2|||
146642388|NCT00813943|528867885|FG002|Overall Study|Ongoing at cut-off date|3|||
146642389|NCT05367492|528867886|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
146642390|NCT05367492|528867887|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
146642391|NCT05367492|528867888|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
146642392|NCT05367492|528867886|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
146642393|NCT05367492|528867887|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
146642394|NCT05367492|528867888|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
146642395|NCT05367492|528867886|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
146970310|NCT01393626|530052603|FG001|Overall Study|Did not meet entrance criteria|0|||
146563661|NCT00673920|528576162|FG002|Baseline up to Week 48|Protocol Violation|1|||
146563662|NCT00673920|528576163|FG003|Baseline up to Week 48|Protocol Violation|0|||
146563663|NCT00673920|528576164|FG004|Baseline up to Week 48|Protocol Violation|0|||
146563664|NCT00673920|528576165|FG005|Baseline up to Week 48|Protocol Violation|0|||
146563665|NCT00673920|528576166|FG006|Baseline up to Week 48|Protocol Violation|0|||
146563666|NCT00673920|528576167|FG007|Baseline up to Week 48|Protocol Violation|0|||
146563667|NCT00673920|528576160|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
146563668|NCT00673920|528576161|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
146563669|NCT00673920|528576162|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
146563670|NCT00673920|528576163|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
146563671|NCT00673920|528576164|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
146563672|NCT00673920|528576165|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
146563673|NCT00673920|528576166|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
146563674|NCT00673920|528576167|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
146563675|NCT00673920|528576160|FG000|Baseline up to Week 48|Administrative/Other|0|||
146563676|NCT00673920|528576161|FG001|Baseline up to Week 48|Administrative/Other|1|||
146563677|NCT00673920|528576162|FG002|Baseline up to Week 48|Administrative/Other|2|||
146563678|NCT00673920|528576163|FG003|Baseline up to Week 48|Administrative/Other|0|||
146563679|NCT00673920|528576164|FG004|Baseline up to Week 48|Administrative/Other|0|||
146563680|NCT00673920|528576165|FG005|Baseline up to Week 48|Administrative/Other|0|||
146563681|NCT00673920|528576166|FG006|Baseline up to Week 48|Administrative/Other|0|||
146563682|NCT00673920|528576167|FG007|Baseline up to Week 48|Administrative/Other|0|||
146563683|NCT00673920|528576160|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
146563684|NCT00673920|528576161|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
146563685|NCT00673920|528576162|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
146563686|NCT00673920|528576163|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
146563687|NCT00673920|528576164|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
146563688|NCT00673920|528576165|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
146563689|NCT00673920|528576166|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
146563690|NCT00673920|528576167|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
146563691|NCT00673920|528576160|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
146563692|NCT00673920|528576161|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
146563693|NCT00673920|528576162|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
146563694|NCT00673920|528576163|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
146563695|NCT00673920|528576164|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
146563696|NCT00673920|528576165|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
146970311|NCT01393626|530052604|FG002|Overall Study|Did not meet entrance criteria|0|||
146970312|NCT01393626|530052605|FG003|Overall Study|Did not meet entrance criteria|0|||
146970313|NCT01393626|530052602|FG000|Overall Study|Lack of Efficacy|6|||
146970314|NCT01393626|530052603|FG001|Overall Study|Lack of Efficacy|6|||
146970315|NCT01393626|530052604|FG002|Overall Study|Lack of Efficacy|4|||
146970316|NCT01393626|530052605|FG003|Overall Study|Lack of Efficacy|1|||
146970317|NCT01393626|530052602|FG000|Overall Study|Lost to Follow-up|1|||
146970318|NCT01393626|530052603|FG001|Overall Study|Lost to Follow-up|1|||
146970319|NCT01393626|530052604|FG002|Overall Study|Lost to Follow-up|1|||
146970320|NCT01393626|530052605|FG003|Overall Study|Lost to Follow-up|0|||
146970321|NCT01393626|530052602|FG000|Overall Study|Withdrawal by Subject|6|||
146970322|NCT01393626|530052603|FG001|Overall Study|Withdrawal by Subject|4|||
146970323|NCT01393626|530052604|FG002|Overall Study|Withdrawal by Subject|0|||
146563697|NCT00673920|528576166|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
146563698|NCT00673920|528576167|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
146563699|NCT00673920|528576160|FG000|Week 24 to Week 48|Failure to return|0|||
146563700|NCT00673920|528576161|FG001|Week 24 to Week 48|Failure to return|0|||
146563701|NCT00673920|528576162|FG002|Week 24 to Week 48|Failure to return|0|||
146909381|NCT01821677|529831442|FG000|Overall Study|Withdrawal by Subject|7|||
146909382|NCT01821677|529831443|FG001|Overall Study|Withdrawal by Subject|3|||
146909383|NCT01821677|529831444|FG002|Overall Study|Withdrawal by Subject|2|||
146909384|NCT01821677|529831442|FG000|Overall Study|Other|9|||
146909385|NCT01821677|529831443|FG001|Overall Study|Other|0|||
146909386|NCT01821677|529831444|FG002|Overall Study|Other|0|||
146909387|NCT01855789|529831453|FG000|1) Baseline up to Week 24|Adverse Event|37|||
146909388|NCT01855789|529831454|FG001|1) Baseline up to Week 24|Adverse Event|0|||
146909389|NCT01855789|529831455|FG002|1) Baseline up to Week 24|Adverse Event|0|||
146909390|NCT01855789|529831456|FG003|1) Baseline up to Week 24|Adverse Event|0|||
146909391|NCT01855789|529831453|FG000|1) Baseline up to Week 24|Death|2|||
146909392|NCT01855789|529831454|FG001|1) Baseline up to Week 24|Death|0|||
146909393|NCT01855789|529831455|FG002|1) Baseline up to Week 24|Death|0|||
146909394|NCT01855789|529831456|FG003|1) Baseline up to Week 24|Death|0|||
146909395|NCT01855789|529831453|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
146909396|NCT01855789|529831454|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
146909397|NCT01855789|529831455|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
146909398|NCT01855789|529831456|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
146909399|NCT01855789|529831453|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
146909400|NCT01855789|529831454|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
146909401|NCT01855789|529831455|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
146909402|NCT01855789|529831456|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
146909403|NCT01855789|529831453|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
146909404|NCT01855789|529831454|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
146909405|NCT01855789|529831455|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
146909406|NCT01855789|529831456|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
146909407|NCT01855789|529831453|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
146909408|NCT01855789|529831454|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
146909409|NCT01855789|529831455|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
146909410|NCT01855789|529831456|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
146909411|NCT01855789|529831453|FG000|1) Baseline up to Week 24|Physician Decision|4|||
146909412|NCT01855789|529831454|FG001|1) Baseline up to Week 24|Physician Decision|0|||
146909413|NCT01855789|529831455|FG002|1) Baseline up to Week 24|Physician Decision|0|||
146909414|NCT01855789|529831456|FG003|1) Baseline up to Week 24|Physician Decision|0|||
146909415|NCT01855789|529831453|FG000|1) Baseline up to Week 24|Pregnancy|1|||
146909416|NCT01855789|529831454|FG001|1) Baseline up to Week 24|Pregnancy|0|||
146909417|NCT01855789|529831455|FG002|1) Baseline up to Week 24|Pregnancy|0|||
146909418|NCT01855789|529831456|FG003|1) Baseline up to Week 24|Pregnancy|0|||
146909419|NCT01855789|529831453|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
146909420|NCT01855789|529831454|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
146909421|NCT01855789|529831455|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
146642396|NCT05367492|528867887|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
146642397|NCT05367492|528867888|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
146642398|NCT05367492|528867886|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
146642399|NCT05367492|528867887|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
146642400|NCT05367492|528867888|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
146642401|NCT02891070|528867894|FG000|Overall Study|Adverse Event|1|||
146642402|NCT02891070|528867895|FG001|Overall Study|Adverse Event|0|||
146642403|NCT02891070|528867894|FG000|Overall Study|Physician Decision|0|||
146909422|NCT01855789|529831456|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
146909423|NCT01855789|529831453|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
146909424|NCT01855789|529831454|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
146909425|NCT01855789|529831455|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
146642404|NCT02891070|528867895|FG001|Overall Study|Physician Decision|1|||
146642405|NCT02891070|528867894|FG000|Overall Study|Lost to Follow-up|4|||
146970324|NCT01393626|530052605|FG003|Overall Study|Withdrawal by Subject|0|||
146970325|NCT01393626|530052602|FG000|Overall Study|Other|1|||
146970326|NCT01393626|530052603|FG001|Overall Study|Other|0|||
146970327|NCT01393626|530052604|FG002|Overall Study|Other|0|||
146970328|NCT01393626|530052605|FG003|Overall Study|Other|0|||
146970329|NCT01393626|530052602|FG000|Overall Study|Protocol Violation|1|||
146970330|NCT01393626|530052603|FG001|Overall Study|Protocol Violation|0|||
146970331|NCT01393626|530052604|FG002|Overall Study|Protocol Violation|2|||
146970332|NCT01393626|530052605|FG003|Overall Study|Protocol Violation|0|||
146970333|NCT02426125|530052606|FG000|Overall Study|Lost to Follow-up|14|||
146970334|NCT02426125|530052607|FG001|Overall Study|Lost to Follow-up|12|||
146563702|NCT00673920|528576163|FG003|Week 24 to Week 48|Failure to return|0|||
146563703|NCT00673920|528576164|FG004|Week 24 to Week 48|Failure to return|0|||
146563704|NCT00673920|528576165|FG005|Week 24 to Week 48|Failure to return|1|||
146563705|NCT00673920|528576166|FG006|Week 24 to Week 48|Failure to return|0|||
146563706|NCT00673920|528576167|FG007|Week 24 to Week 48|Failure to return|0|||
146563707|NCT00673920|528576160|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
146563708|NCT00673920|528576161|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
146563709|NCT00673920|528576162|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
146563710|NCT00673920|528576163|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
146642406|NCT02891070|528867895|FG001|Overall Study|Lost to Follow-up|4|||
146642407|NCT02891070|528867894|FG000|Overall Study|Other|1|||
146642408|NCT02891070|528867895|FG001|Overall Study|Other|0|||
146970335|NCT02426125|530052606|FG000|Overall Study|Withdrawal by Subject|13|||
146970336|NCT02426125|530052607|FG001|Overall Study|Withdrawal by Subject|14|||
146970337|NCT02426125|530052606|FG000|Overall Study|Death|185|||
146970338|NCT02426125|530052607|FG001|Overall Study|Death|200|||
146970339|NCT02426125|530052606|FG000|Overall Study|Randomized, But Never Treated|5|||
146970340|NCT02426125|530052607|FG001|Overall Study|Randomized, But Never Treated|2|||
146970341|NCT02858076|530052608|FG000|Overall Study|Death|6|||
146970342|NCT02858076|530052609|FG001|Overall Study|Death|3|||
146970343|NCT02858076|530052608|FG000|Overall Study|Withdrawal by Subject|1|||
146970344|NCT02858076|530052609|FG001|Overall Study|Withdrawal by Subject|5|||
146970345|NCT02858076|530052608|FG000|Overall Study|Lost to Follow-up|2|||
146970346|NCT02858076|530052609|FG001|Overall Study|Lost to Follow-up|7|||
146970347|NCT02858076|530052608|FG000|Overall Study|Completed Out of Window|1|||
146970348|NCT02858076|530052609|FG001|Overall Study|Completed Out of Window|3|||
146970349|NCT00938015|530052614|FG000|Overall Study|Death|2|||
146970350|NCT00938015|530052614|FG000|Overall Study|Lost to Follow-up|32|||
146970351|NCT00938015|530052614|FG000|Overall Study|Adverse Event|32|||
146970352|NCT00938015|530052614|FG000|Overall Study|Non-responder|52|||
146970353|NCT00938015|530052614|FG000|Overall Study|Reason not related to Etanercept|29|||
146642409|NCT02891070|528867894|FG000|Overall Study|Protocol Violation|0|||
146642410|NCT02891070|528867895|FG001|Overall Study|Protocol Violation|1|||
146642411|NCT02891070|528867894|FG000|Overall Study|Withdrawal by Subject|1|||
146642412|NCT02891070|528867895|FG001|Overall Study|Withdrawal by Subject|2|||
146642413|NCT02891070|528867894|FG000|Overall Study|Death|3|||
146642414|NCT02891070|528867895|FG001|Overall Study|Death|0|||
146642415|NCT04491604|528867902|FG000|Overall Study|Withdrawal by Subject|3|||
146642416|NCT01523275|528867907|FG000|Overall Study|Lost to Follow-up|1|||
146642417|NCT01523275|528867908|FG001|Overall Study|Lost to Follow-up|2|||
146642418|NCT01523275|528867907|FG000|Overall Study|Withdrawal by Subject|1|||
146642419|NCT01523275|528867908|FG001|Overall Study|Withdrawal by Subject|0|||
146642420|NCT02888119|528867913|FG000|Overall Study|Lost to Follow-up|5|||
146642421|NCT02888119|528867914|FG001|Overall Study|Lost to Follow-up|4|||
146642422|NCT02888119|528867915|FG002|Overall Study|Lost to Follow-up|0|||
146642423|NCT01767142|528867916|FG000|Overall Study|Lost to Follow-up|3|||
146642424|NCT00926029|528867922|FG000|Overall Study|Lost to Follow-up|2|||
146642425|NCT00926029|528867923|FG001|Overall Study|Lost to Follow-up|1|||
146642426|NCT00926029|528867924|FG002|Overall Study|Lost to Follow-up|1|||
146970354|NCT02341482|530052615|FG000|Overall Study|Adverse Event|1|||
146970355|NCT03186794|530052616|FG000|Overall Study|Physician Decision|2|||
146970356|NCT03186794|530052616|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
146642427|NCT03206788|528867925|FG000|Overall Study|Withdrawal by Subject|0|||
146970357|NCT00664066|530052621|FG000|Overall Study|Study terminated|3|||
146970358|NCT02180659|530052624|FG000|Overall Study|Adverse Event|1|||
146970359|NCT02180659|530052625|FG001|Overall Study|Adverse Event|0|||
146970360|NCT02180659|530052624|FG000|Overall Study|Lost to Follow-up|4|||
146970361|NCT02180659|530052625|FG001|Overall Study|Lost to Follow-up|2|||
146970362|NCT02180659|530052624|FG000|Overall Study|Subject incarcerated during conduct|1|||
146970363|NCT02180659|530052625|FG001|Overall Study|Subject incarcerated during conduct|0|||
146970364|NCT02180659|530052624|FG000|Overall Study|Withdrawal by Subject|0|||
146970365|NCT02180659|530052625|FG001|Overall Study|Withdrawal by Subject|2|||
146563711|NCT00673920|528576164|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
146563712|NCT00673920|528576165|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
146642428|NCT03206788|528867926|FG001|Overall Study|Withdrawal by Subject|1|||
146970366|NCT02180659|530052624|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
146970367|NCT02180659|530052625|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
146909426|NCT01855789|529831456|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
146909427|NCT01855789|529831453|FG000|1) Baseline up to Week 24|Other|4|||
146909428|NCT01855789|529831454|FG001|1) Baseline up to Week 24|Other|0|||
146909429|NCT01855789|529831455|FG002|1) Baseline up to Week 24|Other|0|||
146909430|NCT01855789|529831456|FG003|1) Baseline up to Week 24|Other|0|||
146509180|NCT00096993|528367757|FG001|Overall Study|Non-compliance|1|||
146909431|NCT01855789|529831453|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
146909432|NCT01855789|529831454|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
146909433|NCT01855789|529831455|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
146909434|NCT01855789|529831456|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
146909435|NCT01855789|529831453|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
146909436|NCT01855789|529831454|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
146909437|NCT01855789|529831455|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
146909438|NCT01855789|529831456|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
146909439|NCT01855789|529831453|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
146909440|NCT01855789|529831454|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
146909441|NCT01855789|529831455|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
146909442|NCT01855789|529831456|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
146909443|NCT01855789|529831453|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
146909444|NCT01855789|529831454|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
146909445|NCT01855789|529831455|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
146909446|NCT01855789|529831456|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
146909447|NCT01855789|529831453|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
146909448|NCT01855789|529831454|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
146909449|NCT01855789|529831455|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
146909450|NCT01855789|529831456|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
146909451|NCT01855789|529831453|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
146909452|NCT01855789|529831454|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
146909453|NCT01855789|529831455|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
146909454|NCT01855789|529831456|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
146909455|NCT01855789|529831453|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
146909456|NCT01855789|529831454|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
146909457|NCT01855789|529831455|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
146909458|NCT01855789|529831456|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
146909459|NCT01855789|529831453|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
146768332|NCT00430300|529319586|FG003|Overall Study|Laboratory abnormality|0|||
146768333|NCT00430300|529319583|FG000|Overall Study|Other|0|||
146768334|NCT00430300|529319584|FG001|Overall Study|Other|0|||
146768335|NCT00430300|529319585|FG002|Overall Study|Other|0|||
146768336|NCT00430300|529319586|FG003|Overall Study|Other|1|||
146768337|NCT02041104|529319589|FG000|Overall Study|Lost to Follow-up|1|||
146768338|NCT02041104|529319590|FG001|Overall Study|Lost to Follow-up|4|||
146768339|NCT02041104|529319589|FG000|Overall Study|discomfort during OGTT|0|||
146768340|NCT02041104|529319590|FG001|Overall Study|discomfort during OGTT|3|||
146768341|NCT00546871|529319591|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
146768342|NCT00546871|529319592|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
146768343|NCT00546871|529319591|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
146768344|NCT00546871|529319592|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
146768345|NCT00546871|529319591|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
146768346|NCT00546871|529319592|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
146768347|NCT00546871|529319591|FG000|Study Extension Period|Protocol Violation|1|||
146768348|NCT00546871|529319592|FG001|Study Extension Period|Protocol Violation|0|||
146909460|NCT01855789|529831454|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
146909461|NCT01855789|529831455|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
146909462|NCT01855789|529831456|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
146909463|NCT01855789|529831453|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
146909464|NCT01855789|529831454|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
146909465|NCT01855789|529831455|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
146909466|NCT01855789|529831456|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
146768349|NCT00546871|529319591|FG000|Study Extension Period|Withdrawal by Subject|0|||
146909467|NCT01855789|529831453|FG000|2) Week 24 up to End of Study|Other|0|||
146909468|NCT01855789|529831454|FG001|2) Week 24 up to End of Study|Other|0|||
146909469|NCT01855789|529831455|FG002|2) Week 24 up to End of Study|Other|0|||
146909470|NCT01855789|529831456|FG003|2) Week 24 up to End of Study|Other|1|||
146970368|NCT03000075|530052626|FG000|Part A|Adverse Event|4|||
146642429|NCT03206788|528867925|FG000|Overall Study|Adverse Event|0|||
146768350|NCT00546871|529319592|FG001|Study Extension Period|Withdrawal by Subject|1|||
146509181|NCT00096993|528367756|FG000|Overall Study|Other unspecified|1|||
146970369|NCT03000075|530052627|FG001|Part A|Adverse Event|0|||
146970370|NCT03000075|530052628|FG002|Part A|Adverse Event|0|||
146970371|NCT03000075|530052629|FG003|Part A|Adverse Event|0|||
146970372|NCT03000075|530052630|FG004|Part A|Adverse Event|0|||
146970373|NCT03000075|530052631|FG005|Part A|Adverse Event|0|||
146970374|NCT03000075|530052632|FG006|Part A|Adverse Event|0|||
146970375|NCT03000075|530052626|FG000|Part B|Not dosed due to AE|0|||
146909471|NCT01863758|529831457|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
146909472|NCT01863758|529831457|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
146909473|NCT02606877|529831458|FG000|Overall Study|Adverse Event|3|||
146909474|NCT02606877|529831459|FG001|Overall Study|Adverse Event|0|||
146909475|NCT02606877|529831458|FG000|Overall Study|Non-compliance with protocol|0|||
146909476|NCT02606877|529831459|FG001|Overall Study|Non-compliance with protocol|1|||
146909477|NCT02606877|529831458|FG000|Overall Study|Other than listed above|1|||
146909478|NCT02606877|529831459|FG001|Overall Study|Other than listed above|0|||
146909479|NCT04952389|529831462|FG000|Overall Study|Withdrawal by Subject|8|||
146909480|NCT04952389|529831463|FG001|Overall Study|Withdrawal by Subject|4|||
146909481|NCT00778999|529831464|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
146909482|NCT00778999|529831465|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
146909483|NCT00778999|529831464|FG000|Overall Study|Did not receive recFSH|14|||
146909484|NCT00778999|529831465|FG001|Overall Study|Did not receive recFSH|20|||
146909485|NCT05635838|529832762|FG000|16-Week DBVC Period|Adverse Event|2|||
146909486|NCT05635838|529832763|FG001|16-Week DBVC Period|Adverse Event|0|||
146909487|NCT05635838|529832764|FG002|16-Week DBVC Period|Adverse Event|0|||
146909488|NCT05635838|529832765|FG003|16-Week DBVC Period|Adverse Event|0|||
146909489|NCT05635838|529832762|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
146909490|NCT05635838|529832763|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
146909491|NCT05635838|529832764|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
146909492|NCT05635838|529832765|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
146909493|NCT05635838|529832762|FG000|16-Week DBVC Period|Physician Decision|0|||
146909494|NCT05635838|529832763|FG001|16-Week DBVC Period|Physician Decision|1|||
146909495|NCT05635838|529832764|FG002|16-Week DBVC Period|Physician Decision|0|||
146970376|NCT03000075|530052627|FG001|Part B|Not dosed due to AE|0|||
146970377|NCT03000075|530052628|FG002|Part B|Not dosed due to AE|0|||
146970378|NCT03000075|530052629|FG003|Part B|Not dosed due to AE|0|||
146970379|NCT03000075|530052630|FG004|Part B|Not dosed due to AE|0|||
146970380|NCT03000075|530052631|FG005|Part B|Not dosed due to AE|2|||
146970381|NCT03000075|530052632|FG006|Part B|Not dosed due to AE|1|||
146970382|NCT03000075|530052626|FG000|Part B|Adverse Event|0|||
146970383|NCT03000075|530052627|FG001|Part B|Adverse Event|0|||
146970384|NCT03000075|530052628|FG002|Part B|Adverse Event|0|||
146970385|NCT03000075|530052629|FG003|Part B|Adverse Event|0|||
146970386|NCT03000075|530052630|FG004|Part B|Adverse Event|1|||
146970387|NCT03000075|530052631|FG005|Part B|Adverse Event|0|||
146970388|NCT03000075|530052632|FG006|Part B|Adverse Event|0|||
146970389|NCT00111007|530052633|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
146970390|NCT00111007|530052634|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
146970391|NCT00111007|530052633|FG000|Double-blind (DB) Treatment|Death|5|||
146970392|NCT00111007|530052634|FG001|Double-blind (DB) Treatment|Death|2|||
146970393|NCT00111007|530052633|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
146970394|NCT00111007|530052634|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
146970395|NCT00111007|530052633|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
146970396|NCT00111007|530052634|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
146970397|NCT00111007|530052633|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
146970398|NCT00111007|530052634|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
146970399|NCT00111007|530052633|FG000|Double-blind (DB) Treatment|Relapse|1|||
146970400|NCT00111007|530052634|FG001|Double-blind (DB) Treatment|Relapse|0|||
146970401|NCT00111007|530052633|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
146642430|NCT03206788|528867926|FG001|Overall Study|Adverse Event|1|||
146642431|NCT03206788|528867925|FG000|Overall Study|Physician Decision|0|||
146642432|NCT03206788|528867926|FG001|Overall Study|Physician Decision|1|||
146642433|NCT02471612|528867927|FG000|Overall Study|Lost to Follow-up|2|||
146642434|NCT05573386|528867928|FG000|Overall Study|Withdrawal by Subject|3|||
146642435|NCT05573386|528867929|FG001|Overall Study|Withdrawal by Subject|2|||
146642436|NCT05246514|528867930|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
146642437|NCT05246514|528867930|FG000|Overall Study|Withdrawal by Subject|1|||
146642438|NCT05246514|528867930|FG000|Overall Study|Death|13|||
146642439|NCT03646123|528867931|FG000|Overall Study|Withdrawal by Subject|2|||
146642440|NCT03646123|528867932|FG001|Overall Study|Withdrawal by Subject|2|||
146642441|NCT03646123|528867933|FG002|Overall Study|Withdrawal by Subject|3|||
146909496|NCT05635838|529832765|FG003|16-Week DBVC Period|Physician Decision|0|||
146909497|NCT05635838|529832762|FG000|16-Week DBVC Period|Protocol Violation|1|||
146909498|NCT05635838|529832763|FG001|16-Week DBVC Period|Protocol Violation|0|||
146909499|NCT05635838|529832764|FG002|16-Week DBVC Period|Protocol Violation|0|||
146909500|NCT05635838|529832765|FG003|16-Week DBVC Period|Protocol Violation|0|||
146909501|NCT05635838|529832762|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
146642442|NCT03646123|528867931|FG000|Overall Study|Study termination by sponsor|0|||
146642443|NCT03646123|528867932|FG001|Overall Study|Study termination by sponsor|45|||
146642444|NCT03646123|528867933|FG002|Overall Study|Study termination by sponsor|139|||
146642445|NCT03646123|528867931|FG000|Overall Study|Lost to Follow-up|4|||
146642446|NCT03646123|528867932|FG001|Overall Study|Lost to Follow-up|10|||
146642447|NCT03646123|528867933|FG002|Overall Study|Lost to Follow-up|10|||
146642448|NCT03646123|528867931|FG000|Overall Study|Death|2|||
146642449|NCT03646123|528867932|FG001|Overall Study|Death|1|||
146642450|NCT03646123|528867933|FG002|Overall Study|Death|1|||
146642451|NCT03646123|528867931|FG000|Overall Study|Other|2|||
146642452|NCT03646123|528867932|FG001|Overall Study|Other|0|||
146642453|NCT03646123|528867933|FG002|Overall Study|Other|2|||
146642454|NCT01802073|528867936|FG000|Overall Study|Lost to Follow-up|0|||
146642455|NCT01802073|528867937|FG001|Overall Study|Lost to Follow-up|1|||
146642456|NCT01802073|528867936|FG000|Overall Study|Non-compliant|4|||
146909502|NCT05635838|529832763|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
146909503|NCT05635838|529832764|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
146909504|NCT05635838|529832765|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
146909505|NCT05635838|529832762|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
146970402|NCT00111007|530052634|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
146970403|NCT00111007|530052633|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
146970404|NCT00111007|530052634|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
146970405|NCT00111007|530052633|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
146970406|NCT00111007|530052634|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
146642457|NCT01802073|528867937|FG001|Overall Study|Non-compliant|2|||
146642458|NCT01802073|528867936|FG000|Overall Study|Withdrawal by Subject|1|||
146642459|NCT01802073|528867937|FG001|Overall Study|Withdrawal by Subject|1|||
146970407|NCT00111007|530052633|FG000|Active Follow-up|Adverse Event|1|||
146642460|NCT01802073|528867936|FG000|Overall Study|Physician Decision|0|||
146642461|NCT01802073|528867937|FG001|Overall Study|Physician Decision|7|||
146642462|NCT02657408|528867941|FG000|Overall Study|Adverse Event|3|||
146642463|NCT02657408|528867942|FG001|Overall Study|Adverse Event|7|||
146642464|NCT00324961|528867943|FG000|Overall Study|Adverse Event|5|||
146970408|NCT00111007|530052634|FG001|Active Follow-up|Adverse Event|0|||
146768351|NCT01713946|529319593|FG000|Overall Study|Death|0|||
146768352|NCT01713946|529319594|FG001|Overall Study|Death|2|||
146768353|NCT01713946|529319595|FG002|Overall Study|Death|2|||
146768354|NCT01713946|529319593|FG000|Overall Study|Adverse Event|19|||
146768355|NCT01713946|529319594|FG001|Overall Study|Adverse Event|14|||
146768356|NCT01713946|529319595|FG002|Overall Study|Adverse Event|13|||
146768357|NCT01713946|529319593|FG000|Overall Study|Withdrawal by Subject|12|||
146768358|NCT01713946|529319594|FG001|Overall Study|Withdrawal by Subject|12|||
146768359|NCT01713946|529319595|FG002|Overall Study|Withdrawal by Subject|8|||
146768360|NCT01713946|529319593|FG000|Overall Study|Lack of Efficacy|8|||
146768361|NCT01713946|529319594|FG001|Overall Study|Lack of Efficacy|8|||
146768362|NCT01713946|529319595|FG002|Overall Study|Lack of Efficacy|14|||
146768363|NCT01713946|529319593|FG000|Overall Study|Protocol Violation|2|||
146768364|NCT01713946|529319594|FG001|Overall Study|Protocol Violation|4|||
146768365|NCT01713946|529319595|FG002|Overall Study|Protocol Violation|1|||
146768366|NCT01713946|529319593|FG000|Overall Study|Lost to Follow-up|0|||
146768367|NCT01713946|529319594|FG001|Overall Study|Lost to Follow-up|0|||
146768368|NCT01713946|529319595|FG002|Overall Study|Lost to Follow-up|1|||
146768369|NCT01713946|529319593|FG000|Overall Study|Administrative problems|1|||
146768370|NCT01713946|529319594|FG001|Overall Study|Administrative problems|0|||
146768371|NCT01713946|529319595|FG002|Overall Study|Administrative problems|0|||
146768372|NCT01713946|529319593|FG000|Overall Study|Did not continue in Ext|0|||
146768373|NCT01713946|529319594|FG001|Overall Study|Did not continue in Ext|3|||
146768374|NCT01713946|529319595|FG002|Overall Study|Did not continue in Ext|0|||
146768375|NCT01713946|529319593|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
146768376|NCT01713946|529319594|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
146768377|NCT01713946|529319595|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
146768378|NCT01713946|529319593|FG000|Overall Study|Patients never switched to everolimus|0|||
146768379|NCT01713946|529319594|FG001|Overall Study|Patients never switched to everolimus|0|||
146768380|NCT01713946|529319595|FG002|Overall Study|Patients never switched to everolimus|5|||
146768381|NCT05328297|529321658|FG000|Overall Study|Adverse Event|5|||
146768382|NCT05328297|529321659|FG001|Overall Study|Adverse Event|7|||
146768383|NCT05328297|529321658|FG000|Overall Study|Withdrawal by Subject|4|||
146768384|NCT05328297|529321659|FG001|Overall Study|Withdrawal by Subject|3|||
146768385|NCT05328297|529321658|FG000|Overall Study|Lack of Efficacy|1|||
146909506|NCT05635838|529832763|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
146909507|NCT05635838|529832764|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
146909508|NCT05635838|529832765|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
146909509|NCT05635838|529832762|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
146909510|NCT05635838|529832763|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
146909511|NCT05635838|529832764|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
146768386|NCT05328297|529321659|FG001|Overall Study|Lack of Efficacy|0|||
146768387|NCT05328297|529321658|FG000|Overall Study|Lost to Follow-up|1|||
146768388|NCT05328297|529321659|FG001|Overall Study|Lost to Follow-up|0|||
146768389|NCT05328297|529321658|FG000|Overall Study|Protocol Violation|1|||
146768390|NCT05328297|529321659|FG001|Overall Study|Protocol Violation|0|||
146768391|NCT05328297|529321658|FG000|Overall Study|Randomized but not treated|1|||
146768392|NCT05328297|529321659|FG001|Overall Study|Randomized but not treated|1|||
146768393|NCT04513522|529321660|FG000|Overall Study|Other reasons|1|||
146768394|NCT04513522|529321660|FG000|Overall Study|Adverse event unrelated to study drug|9|||
146970409|NCT00111007|530052633|FG000|Active Follow-up|Death|2|||
146970410|NCT00111007|530052634|FG001|Active Follow-up|Death|0|||
146642465|NCT00324961|528867943|FG000|Overall Study|Consent Withdrawn|11|||
146642466|NCT00324961|528867943|FG000|Overall Study|Lost to Follow-up|22|||
146642467|NCT00324961|528867943|FG000|Overall Study|Protocol Violation|3|||
146642468|NCT00324961|528867943|FG000|Overall Study|Other|2|||
146642469|NCT05343624|528867944|FG000|Overall Study|Chart review not completed|1|||
146642470|NCT02447302|528867945|FG000|Overall Study|Physician Decision|1|||
146642471|NCT02447302|528867946|FG001|Overall Study|Physician Decision|0|||
146642472|NCT02447302|528867947|FG002|Overall Study|Physician Decision|0|||
146642473|NCT02447302|528867945|FG000|Overall Study|Adverse Event|4|||
146642474|NCT02447302|528867946|FG001|Overall Study|Adverse Event|3|||
146642475|NCT02447302|528867947|FG002|Overall Study|Adverse Event|0|||
146642476|NCT02447302|528867945|FG000|Overall Study|Withdrawal by Subject|0|||
146642477|NCT02447302|528867946|FG001|Overall Study|Withdrawal by Subject|1|||
146642478|NCT02447302|528867947|FG002|Overall Study|Withdrawal by Subject|5|||
146642479|NCT02447302|528867945|FG000|Overall Study|Sponsor Decision|0|||
146642480|NCT02447302|528867946|FG001|Overall Study|Sponsor Decision|0|||
146642481|NCT02447302|528867947|FG002|Overall Study|Sponsor Decision|1|||
146642482|NCT05334212|528867952|FG000|Overall Study|Study terminated prematurely|7|||
146642483|NCT00910299|528867953|FG000|Overall Study|Withdrawal by Subject|16|||
146642484|NCT00910299|528867954|FG001|Overall Study|Withdrawal by Subject|13|||
146642485|NCT00910299|528867953|FG000|Overall Study|Sponsor Decision|58|||
146642486|NCT00910299|528867954|FG001|Overall Study|Sponsor Decision|60|||
146642487|NCT00910299|528867953|FG000|Overall Study|Didn't receive any study drug|2|||
146642488|NCT00910299|528867954|FG001|Overall Study|Didn't receive any study drug|1|||
146768395|NCT04513522|529321660|FG000|Overall Study|Study drug toxicity|14|||
146642489|NCT01456897|528867955|FG000|Overall Study|Adverse Event|19|||
146642490|NCT01456897|528867956|FG001|Overall Study|Adverse Event|22|||
146768396|NCT04513522|529321660|FG000|Overall Study|Disease progression|39|||
146768397|NCT04513522|529321660|FG000|Overall Study|Participants withdrew consent|2|||
146768398|NCT05219253|529321672|FG000|Overall Study|Withdrawal by Subject|1|||
146768399|NCT05219253|529321673|FG001|Overall Study|Withdrawal by Subject|2|||
146768400|NCT03086369|529321674|FG000|Overall Study|Lost to Follow-up|1|||
146768401|NCT03086369|529321675|FG001|Overall Study|Lost to Follow-up|0|||
146768402|NCT03086369|529321676|FG002|Overall Study|Lost to Follow-up|0|||
146768403|NCT03086369|529321677|FG003|Overall Study|Lost to Follow-up|2|||
146768404|NCT03086369|529321678|FG004|Overall Study|Lost to Follow-up|1|||
146768405|NCT03086369|529321674|FG000|Overall Study|Physician Decision|0|||
146768406|NCT03086369|529321675|FG001|Overall Study|Physician Decision|0|||
146768407|NCT03086369|529321676|FG002|Overall Study|Physician Decision|0|||
146768408|NCT03086369|529321677|FG003|Overall Study|Physician Decision|1|||
146768409|NCT03086369|529321678|FG004|Overall Study|Physician Decision|2|||
146768410|NCT03086369|529321674|FG000|Overall Study|Withdrawal by Subject|0|||
146768411|NCT03086369|529321675|FG001|Overall Study|Withdrawal by Subject|0|||
146768412|NCT03086369|529321676|FG002|Overall Study|Withdrawal by Subject|0|||
146768413|NCT03086369|529321677|FG003|Overall Study|Withdrawal by Subject|5|||
146768414|NCT03086369|529321678|FG004|Overall Study|Withdrawal by Subject|3|||
146768415|NCT03086369|529321674|FG000|Overall Study|Progressive Disease|0|||
146768416|NCT03086369|529321675|FG001|Overall Study|Progressive Disease|0|||
146768417|NCT03086369|529321676|FG002|Overall Study|Progressive Disease|0|||
146768418|NCT03086369|529321677|FG003|Overall Study|Progressive Disease|1|||
146768419|NCT03086369|529321678|FG004|Overall Study|Progressive Disease|1|||
146768420|NCT04668339|529321679|FG000|Overall Study|Physician Decision|1|||
146768421|NCT04668339|529321680|FG001|Overall Study|Physician Decision|0|||
146768422|NCT04668339|529321681|FG002|Overall Study|Physician Decision|1|||
146768423|NCT04668339|529321682|FG003|Overall Study|Physician Decision|1|||
146768424|NCT04668339|529321679|FG000|Overall Study|Lost to Follow-up|14|||
146768425|NCT04668339|529321680|FG001|Overall Study|Lost to Follow-up|12|||
146768426|NCT04668339|529321681|FG002|Overall Study|Lost to Follow-up|8|||
146768427|NCT04668339|529321682|FG003|Overall Study|Lost to Follow-up|5|||
146768428|NCT04668339|529321679|FG000|Overall Study|Adverse Event|0|||
146768429|NCT04668339|529321680|FG001|Overall Study|Adverse Event|0|||
146768430|NCT04668339|529321681|FG002|Overall Study|Adverse Event|1|||
146768431|NCT04668339|529321682|FG003|Overall Study|Adverse Event|0|||
146768432|NCT04668339|529321679|FG000|Overall Study|Other than specified|3|||
146768433|NCT04668339|529321680|FG001|Overall Study|Other than specified|0|||
146768434|NCT04668339|529321681|FG002|Overall Study|Other than specified|1|||
146768435|NCT04668339|529321682|FG003|Overall Study|Other than specified|0|||
146768436|NCT04668339|529321679|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
146768437|NCT04668339|529321680|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
146768438|NCT04668339|529321681|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
146768439|NCT04668339|529321682|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
146768440|NCT04668339|529321679|FG000|Overall Study|Vaccine not Administered|0|||
146768441|NCT04668339|529321680|FG001|Overall Study|Vaccine not Administered|0|||
146768442|NCT04668339|529321681|FG002|Overall Study|Vaccine not Administered|1|||
146768443|NCT04668339|529321682|FG003|Overall Study|Vaccine not Administered|0|||
146768444|NCT04668339|529321679|FG000|Overall Study|Protocol Violation|18|||
146768445|NCT04668339|529321680|FG001|Overall Study|Protocol Violation|23|||
146768446|NCT04668339|529321681|FG002|Overall Study|Protocol Violation|12|||
146768447|NCT04668339|529321682|FG003|Overall Study|Protocol Violation|20|||
146768448|NCT04668339|529321679|FG000|Overall Study|Withdrawal by Subject|45|||
146970411|NCT00111007|530052633|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
146768449|NCT04668339|529321680|FG001|Overall Study|Withdrawal by Subject|46|||
146768450|NCT04668339|529321681|FG002|Overall Study|Withdrawal by Subject|46|||
146768451|NCT04668339|529321682|FG003|Overall Study|Withdrawal by Subject|27|||
146768452|NCT04668339|529321679|FG000|Overall Study|Study Terminated by Sponsor|59|||
146768453|NCT04668339|529321680|FG001|Overall Study|Study Terminated by Sponsor|59|||
146768454|NCT04668339|529321681|FG002|Overall Study|Study Terminated by Sponsor|71|||
146768455|NCT04668339|529321682|FG003|Overall Study|Study Terminated by Sponsor|1|||
146768456|NCT00178399|529321686|FG000|Overall Study|Physician Decision|4|||
146768457|NCT00178399|529321686|FG000|Overall Study|Withdrawal by Subject|8|||
146768458|NCT00178399|529321686|FG000|Overall Study|Lost to Follow-up|1|||
146509182|NCT00096993|528367757|FG001|Overall Study|Other unspecified|1|||
146768459|NCT01134562|529321689|FG000|Overall Study|Adverse Event|0|||
146970412|NCT00111007|530052634|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
146970413|NCT00111007|530052633|FG000|Long Term Follow-up|Death|34|||
146970414|NCT00111007|530052634|FG001|Long Term Follow-up|Death|39|||
146970415|NCT00111007|530052633|FG000|Long Term Follow-up|Lost to Follow-up|1|||
146970416|NCT00111007|530052634|FG001|Long Term Follow-up|Lost to Follow-up|1|||
146970417|NCT00111007|530052633|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
146970418|NCT00111007|530052634|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
146970419|NCT00111007|530052633|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
146970420|NCT00111007|530052634|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
146970421|NCT00111007|530052633|FG000|Long Term Follow-up|Missing|10|||
146970422|NCT00111007|530052634|FG001|Long Term Follow-up|Missing|3|||
146970423|NCT01495793|530052635|FG000|Overall Study|Lost to Follow-up|1|||
146970424|NCT01495793|530052635|FG000|Overall Study|Violation of inclusion criteria|1|||
146970425|NCT00440193|530052636|FG000|Treatment Period|Adverse Event|74|||
146970426|NCT00440193|530052637|FG001|Treatment Period|Adverse Event|67|||
146970427|NCT00440193|530052636|FG000|Treatment Period|Death|19|||
146970428|NCT00440193|530052637|FG001|Treatment Period|Death|22|||
146970429|NCT00440193|530052636|FG000|Treatment Period|Lack of Efficacy|0|||
146970430|NCT00440193|530052637|FG001|Treatment Period|Lack of Efficacy|1|||
146970431|NCT00440193|530052636|FG000|Treatment Period|Lost to Follow-up|12|||
146909512|NCT05635838|529832765|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
146909513|NCT05635838|529832762|FG000|16-Week OLE Period|Adverse Event|0|||
146909514|NCT05635838|529832763|FG001|16-Week OLE Period|Adverse Event|0|||
146909515|NCT05635838|529832764|FG002|16-Week OLE Period|Adverse Event|0|||
146909516|NCT05635838|529832765|FG003|16-Week OLE Period|Adverse Event|2|||
146909517|NCT05635838|529832762|FG000|16-Week OLE Period|Lost to Follow-up|0|||
146909518|NCT05635838|529832763|FG001|16-Week OLE Period|Lost to Follow-up|0|||
146909519|NCT05635838|529832764|FG002|16-Week OLE Period|Lost to Follow-up|1|||
146909520|NCT05635838|529832765|FG003|16-Week OLE Period|Lost to Follow-up|3|||
146909521|NCT05635838|529832762|FG000|16-Week OLE Period|Physician Decision|0|||
146909522|NCT05635838|529832763|FG001|16-Week OLE Period|Physician Decision|0|||
146909523|NCT05635838|529832764|FG002|16-Week OLE Period|Physician Decision|0|||
146909524|NCT05635838|529832765|FG003|16-Week OLE Period|Physician Decision|1|||
146909525|NCT05635838|529832762|FG000|16-Week OLE Period|Protocol Violation|0|||
146909526|NCT05635838|529832763|FG001|16-Week OLE Period|Protocol Violation|0|||
146909527|NCT05635838|529832764|FG002|16-Week OLE Period|Protocol Violation|1|||
146909528|NCT05635838|529832765|FG003|16-Week OLE Period|Protocol Violation|1|||
146909529|NCT05635838|529832762|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
146909530|NCT05635838|529832763|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
146909531|NCT05635838|529832764|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
146909532|NCT05635838|529832765|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
146909533|NCT05635838|529832762|FG000|16-Week OLE Period|Pregnancy|0|||
146563713|NCT00673920|528576166|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
146563714|NCT00673920|528576167|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
146563715|NCT00673920|528576160|FG000|Week 24 to Week 48|Death|0|||
146563716|NCT00673920|528576161|FG001|Week 24 to Week 48|Death|0|||
146563717|NCT00673920|528576162|FG002|Week 24 to Week 48|Death|0|||
146563718|NCT00673920|528576163|FG003|Week 24 to Week 48|Death|0|||
146563719|NCT00673920|528576164|FG004|Week 24 to Week 48|Death|0|||
146563720|NCT00673920|528576165|FG005|Week 24 to Week 48|Death|1|||
146563721|NCT00673920|528576166|FG006|Week 24 to Week 48|Death|0|||
146563722|NCT00673920|528576167|FG007|Week 24 to Week 48|Death|0|||
146563723|NCT00673920|528576160|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
146563724|NCT00673920|528576161|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
146563725|NCT00673920|528576162|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
146563726|NCT00673920|528576163|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
146563727|NCT00673920|528576164|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
146563728|NCT00673920|528576165|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
146563729|NCT00673920|528576166|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
146563730|NCT00673920|528576167|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
146563731|NCT00833690|528576171|FG000|Overall Study|Withdrawal by Subject|1|||
146563732|NCT00833690|528576172|FG001|Overall Study|Withdrawal by Subject|0|||
146563733|NCT00833690|528576173|FG002|Overall Study|Withdrawal by Subject|0|||
146563734|NCT00833690|528576171|FG000|Overall Study|Discontinued study drug|3|||
146563735|NCT00833690|528576172|FG001|Overall Study|Discontinued study drug|2|||
146563736|NCT00833690|528576173|FG002|Overall Study|Discontinued study drug|0|||
146563737|NCT04562116|528576179|FG000|Overall Study|Lost to Follow-up|1|||
146563738|NCT04562116|528576179|FG000|Overall Study|Withdrawal by Subject|3|||
146563739|NCT04462471|528576182|FG000|Overall Study|Adverse Event|0|||
146563740|NCT04462471|528576183|FG001|Overall Study|Adverse Event|1|||
146563741|NCT04462471|528576184|FG002|Overall Study|Adverse Event|0|||
146768460|NCT01134562|529321690|FG001|Overall Study|Adverse Event|1|||
146909534|NCT05635838|529832763|FG001|16-Week OLE Period|Pregnancy|0|||
146909535|NCT05635838|529832764|FG002|16-Week OLE Period|Pregnancy|1|||
146909536|NCT05635838|529832765|FG003|16-Week OLE Period|Pregnancy|0|||
146909537|NCT02031146|529832768|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
146909538|NCT02031146|529832769|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
146909539|NCT02031146|529832770|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
146909540|NCT02031146|529832771|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
146909541|NCT02031146|529832772|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
146909542|NCT02031146|529832773|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
146909543|NCT02031146|529832774|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
146909544|NCT00001259|529832777|FG000|Study 2|Adverse Event|0|||
146909545|NCT00001259|529832778|FG001|Study 2|Adverse Event|0|||
146909546|NCT00001259|529832779|FG002|Study 2|Adverse Event|0|||
146909547|NCT00001259|529832780|FG003|Study 2|Adverse Event|0|||
146909548|NCT00001259|529832781|FG004|Study 2|Adverse Event|2|||
146909549|NCT00001259|529832782|FG005|Study 2|Adverse Event|0|||
146909550|NCT00001259|529832783|FG006|Study 2|Adverse Event|0|||
146563742|NCT04462471|528576185|FG003|Overall Study|Adverse Event|0|||
146563743|NCT04462471|528576182|FG000|Overall Study|Disease progression|1|||
146563744|NCT04462471|528576183|FG001|Overall Study|Disease progression|0|||
146563745|NCT04462471|528576184|FG002|Overall Study|Disease progression|0|||
146563746|NCT04462471|528576185|FG003|Overall Study|Disease progression|0|||
146563747|NCT03097289|528576186|FG000|Overall Study|Adverse Event|1|||
146563748|NCT03097289|528576186|FG000|Overall Study|Equipment failure|2|||
146909551|NCT03705494|529832784|FG000|Overall Study|Lost to Follow-up|2|||
146909552|NCT03705494|529832785|FG001|Overall Study|Lost to Follow-up|1|||
146909553|NCT03705494|529832784|FG000|Overall Study|Withdrawal by Subject|5|||
146909554|NCT03705494|529832785|FG001|Overall Study|Withdrawal by Subject|2|||
146909555|NCT01582282|529832786|FG000|Overall Study|Adverse Event|1|||
146563749|NCT03097289|528576186|FG000|Overall Study|Collected platelet product unusable|3|||
146563750|NCT00619866|528576187|FG000|Weeks 1 - 12|Adverse Event|0|||
146563751|NCT00619866|528576188|FG001|Weeks 1 - 12|Adverse Event|1|||
146563752|NCT00619866|528576189|FG002|Weeks 1 - 12|Adverse Event|2|||
146563753|NCT00619866|528576190|FG003|Weeks 1 - 12|Adverse Event|0|||
146563754|NCT00619866|528576191|FG004|Weeks 1 - 12|Adverse Event|0|||
146563755|NCT00619866|528576187|FG000|Weeks 1 - 12|Non-compliance|0|||
146563756|NCT00619866|528576188|FG001|Weeks 1 - 12|Non-compliance|0|||
146563757|NCT00619866|528576189|FG002|Weeks 1 - 12|Non-compliance|1|||
146563758|NCT00619866|528576190|FG003|Weeks 1 - 12|Non-compliance|0|||
146909556|NCT01582282|529832787|FG001|Overall Study|Adverse Event|1|||
146909557|NCT01582282|529832788|FG002|Overall Study|Adverse Event|0|||
146909558|NCT01582282|529832786|FG000|Overall Study|Lost to Follow-up|1|||
146909559|NCT01582282|529832787|FG001|Overall Study|Lost to Follow-up|0|||
146909560|NCT01582282|529832788|FG002|Overall Study|Lost to Follow-up|0|||
146909561|NCT01582282|529832786|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
146909562|NCT01582282|529832787|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
146909563|NCT01582282|529832788|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
146909564|NCT02839746|529832790|FG000|Overall Study|Not met selection criteria|12|||
146909565|NCT02089737|529832791|FG000|Overall Study|Survey form not completed|5|||
146909566|NCT02089737|529832791|FG000|Overall Study|Not treated|1|||
146909567|NCT01300286|529832792|FG000|Overall Study|did not get dosed|1|||
146909568|NCT02767570|529832793|FG000|Overall Study|Lost to Follow-up|3|||
146909569|NCT02767570|529832794|FG001|Overall Study|Lost to Follow-up|0|||
146909570|NCT02767570|529832793|FG000|Overall Study|COVID shutdown|2|||
146909571|NCT02767570|529832794|FG001|Overall Study|COVID shutdown|5|||
146909572|NCT02767570|529832793|FG000|Overall Study|Increased pain|2|||
146909573|NCT02767570|529832794|FG001|Overall Study|Increased pain|0|||
146909574|NCT02767570|529832793|FG000|Overall Study|Withdrawal by Subject|1|||
146909575|NCT02767570|529832794|FG001|Overall Study|Withdrawal by Subject|3|||
146909576|NCT02767570|529832793|FG000|Overall Study|Unrelated medical issue|1|||
146909577|NCT02767570|529832794|FG001|Overall Study|Unrelated medical issue|1|||
146909578|NCT02767570|529832793|FG000|Overall Study|Received intra-articular injection|0|||
146909579|NCT02767570|529832794|FG001|Overall Study|Received intra-articular injection|1|||
146909580|NCT04426630|529832795|FG000|Overall Study|Death|4|||
146909581|NCT04426630|529832795|FG000|Overall Study|Lost to Follow-up|2|||
146909582|NCT01357239|529832798|FG000|Stratum: All Patients|Adverse Event|0|||
146909583|NCT01357239|529832799|FG001|Stratum: All Patients|Adverse Event|0|||
146563759|NCT00619866|528576191|FG004|Weeks 1 - 12|Non-compliance|0|||
146563760|NCT00619866|528576187|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
146909584|NCT01357239|529832800|FG002|Stratum: All Patients|Adverse Event|1|||
146909585|NCT01357239|529832801|FG003|Stratum: All Patients|Adverse Event|1|||
146909586|NCT01357239|529832798|FG000|Stratum: All Patients|Subject withdrew consent|0|||
146909587|NCT01357239|529832799|FG001|Stratum: All Patients|Subject withdrew consent|0|||
146909588|NCT01357239|529832800|FG002|Stratum: All Patients|Subject withdrew consent|1|||
146909589|NCT01357239|529832801|FG003|Stratum: All Patients|Subject withdrew consent|1|||
146909590|NCT01357239|529832798|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
146909591|NCT01357239|529832799|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
146909592|NCT01357239|529832800|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
146909593|NCT01357239|529832801|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
146909594|NCT01357239|529832798|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
146909595|NCT01357239|529832799|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
146909596|NCT01357239|529832800|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
146909597|NCT01357239|529832801|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
146909598|NCT01357239|529832798|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
146909599|NCT01357239|529832799|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
146909600|NCT01357239|529832800|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
146909601|NCT01357239|529832801|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
146909602|NCT03455543|529832806|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
146909603|NCT03455543|529832807|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
146909604|NCT03455543|529832808|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
146909605|NCT03455543|529832806|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
146909606|NCT03455543|529832807|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
146909607|NCT03455543|529832808|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
146909608|NCT03455543|529832806|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
146563761|NCT00619866|528576188|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
146563762|NCT00619866|528576189|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
146563763|NCT00619866|528576190|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
146563764|NCT00619866|528576191|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
146563765|NCT00619866|528576187|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
146563766|NCT00619866|528576188|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
146563767|NCT00619866|528576189|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
146563768|NCT00619866|528576190|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
146563769|NCT00619866|528576191|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
146563770|NCT00619866|528576187|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
146563771|NCT00619866|528576188|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
146563772|NCT00619866|528576189|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
146768461|NCT01134562|529321691|FG002|Overall Study|Adverse Event|0|||
146970432|NCT00440193|530052637|FG001|Treatment Period|Lost to Follow-up|18|||
146563773|NCT00619866|528576190|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
146909609|NCT03455543|529832807|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
146909610|NCT03455543|529832808|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
146909611|NCT03455543|529832806|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
146909612|NCT03455543|529832807|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
146909613|NCT03455543|529832808|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
146909614|NCT03455543|529832806|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
146909615|NCT03455543|529832807|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
146909616|NCT03455543|529832808|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
146909617|NCT03455543|529832806|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
146909618|NCT03455543|529832807|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
146909619|NCT03455543|529832808|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
146909620|NCT03455543|529832806|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
146909621|NCT03455543|529832807|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
146909622|NCT03455543|529832808|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
146909623|NCT03455543|529832806|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
146909624|NCT03455543|529832807|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
146909625|NCT03455543|529832808|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
146909626|NCT03455543|529832806|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
146909627|NCT03455543|529832807|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
146909628|NCT03455543|529832808|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
146909629|NCT01221233|529832811|FG000|Overall Study|Withdrawal by Subject|3|||
146909630|NCT01221233|529832812|FG001|Overall Study|Withdrawal by Subject|1|||
146909631|NCT01645280|529832814|FG000|Overall Study|Death|0|||
146909632|NCT01645280|529832815|FG001|Overall Study|Death|1|||
146970433|NCT00440193|530052636|FG000|Treatment Period|Physician Decision|3|||
146909633|NCT01645280|529832816|FG002|Overall Study|Death|0|||
146909634|NCT01645280|529832817|FG003|Overall Study|Death|0|||
146909635|NCT01645280|529832818|FG004|Overall Study|Death|0|||
146909636|NCT01645280|529832814|FG000|Overall Study|Withdrawal by Subject|4|||
146909637|NCT01645280|529832815|FG001|Overall Study|Withdrawal by Subject|0|||
146768462|NCT01134562|529321692|FG003|Overall Study|Adverse Event|0|||
146768463|NCT01134562|529321693|FG004|Overall Study|Adverse Event|0|||
146768464|NCT00768664|529321696|FG000|Overall Study|Death|57|||
146768465|NCT00768664|529321696|FG000|Overall Study|Lost to Follow-up|2|||
146768466|NCT00768664|529321696|FG000|Overall Study|Other|9|||
146768467|NCT00768664|529321696|FG000|Overall Study|Participant refused|1|||
146768468|NCT00708032|529321699|FG000|Overall Study|Adverse Event|0|||
146768469|NCT00708032|529321700|FG001|Overall Study|Adverse Event|2|||
146909638|NCT01645280|529832816|FG002|Overall Study|Withdrawal by Subject|2|||
146909639|NCT01645280|529832817|FG003|Overall Study|Withdrawal by Subject|4|||
146768470|NCT00708032|529321699|FG000|Overall Study|Lost to Follow-up|1|||
146768471|NCT00708032|529321700|FG001|Overall Study|Lost to Follow-up|2|||
146909640|NCT01645280|529832818|FG004|Overall Study|Withdrawal by Subject|5|||
146909641|NCT01645280|529832814|FG000|Overall Study|Lost to Follow-up|0|||
146909642|NCT01645280|529832815|FG001|Overall Study|Lost to Follow-up|0|||
146909643|NCT01645280|529832816|FG002|Overall Study|Lost to Follow-up|0|||
146909644|NCT01645280|529832817|FG003|Overall Study|Lost to Follow-up|2|||
146909645|NCT01645280|529832818|FG004|Overall Study|Lost to Follow-up|1|||
146909646|NCT01645280|529832814|FG000|Overall Study|Other|1|||
146909647|NCT01645280|529832815|FG001|Overall Study|Other|1|||
146909648|NCT01645280|529832816|FG002|Overall Study|Other|2|||
146909649|NCT01645280|529832817|FG003|Overall Study|Other|0|||
146909650|NCT01645280|529832818|FG004|Overall Study|Other|0|||
146909651|NCT01645280|529832814|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
146909652|NCT01645280|529832815|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
146909653|NCT01645280|529832816|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
146909654|NCT01645280|529832817|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
146909655|NCT01645280|529832818|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
146909656|NCT00234104|529832823|FG000|Overall Study|Adverse Event|4|||
146909657|NCT00234104|529832824|FG001|Overall Study|Adverse Event|0|||
146909658|NCT00234104|529832825|FG002|Overall Study|Adverse Event|3|||
146909659|NCT00234104|529832826|FG003|Overall Study|Adverse Event|5|||
146909660|NCT00234104|529832823|FG000|Overall Study|Protocol Violation|0|||
146768472|NCT00708032|529321699|FG000|Overall Study|Pregnancy|0|||
146768473|NCT00708032|529321700|FG001|Overall Study|Pregnancy|1|||
146768474|NCT00708032|529321699|FG000|Overall Study|Poor vision|0|||
146909661|NCT00234104|529832824|FG001|Overall Study|Protocol Violation|0|||
146909662|NCT00234104|529832825|FG002|Overall Study|Protocol Violation|0|||
146909663|NCT00234104|529832826|FG003|Overall Study|Protocol Violation|1|||
146909664|NCT00234104|529832823|FG000|Overall Study|Physician Decision|0|||
146768475|NCT00708032|529321700|FG001|Overall Study|Poor vision|6|||
146768476|NCT00708032|529321699|FG000|Overall Study|Visit out of range at month 12|4|||
146909665|NCT00234104|529832824|FG001|Overall Study|Physician Decision|1|||
146909666|NCT00234104|529832825|FG002|Overall Study|Physician Decision|2|||
146909667|NCT00234104|529832826|FG003|Overall Study|Physician Decision|2|||
146909668|NCT00546819|529832829|FG000|Overall Study|Adverse Event|2|||
146909669|NCT00546819|529832830|FG001|Overall Study|Adverse Event|3|||
146909670|NCT00546819|529832829|FG000|Overall Study|Lost to Follow-up|2|||
146909671|NCT00546819|529832830|FG001|Overall Study|Lost to Follow-up|1|||
146909672|NCT00546819|529832829|FG000|Overall Study|Withdrawal by Subject|4|||
146909673|NCT00546819|529832830|FG001|Overall Study|Withdrawal by Subject|2|||
146909674|NCT04045613|529832831|FG000|Overall Study|Adverse Event|2|||
146909675|NCT04045613|529832832|FG001|Overall Study|Adverse Event|2|||
146909676|NCT04045613|529832833|FG002|Overall Study|Adverse Event|1|||
146642491|NCT01456897|528867955|FG000|Overall Study|Protocol Violation|3|||
146642492|NCT01456897|528867956|FG001|Overall Study|Protocol Violation|4|||
146642493|NCT01456897|528867955|FG000|Overall Study|Physician Decision|5|||
146642494|NCT01456897|528867956|FG001|Overall Study|Physician Decision|3|||
146642495|NCT01456897|528867955|FG000|Overall Study|Withdrawal by Subject|44|||
146642496|NCT01456897|528867956|FG001|Overall Study|Withdrawal by Subject|17|||
146642497|NCT01456897|528867955|FG000|Overall Study|Lack of Efficacy|4|||
146642498|NCT01456897|528867956|FG001|Overall Study|Lack of Efficacy|11|||
146642499|NCT01396070|528867958|FG000|Overall Study|Withdrawal by Subject|2|||
146642500|NCT01396070|528867958|FG000|Overall Study|Death|2|||
146642501|NCT01396070|528867958|FG000|Overall Study|Adverse Event|8|||
146642502|NCT01396070|528867958|FG000|Overall Study|Physician Decision|3|||
146642503|NCT01396070|528867958|FG000|Overall Study|Lack of Efficacy|4|||
146642504|NCT04254913|528867959|FG000|Overall Study|Adverse Event|1|||
146642505|NCT01396057|528867960|FG000|Overall Study|Adverse Event|2|||
146642506|NCT01396057|528867961|FG001|Overall Study|Adverse Event|6|||
146642507|NCT01396057|528867960|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146642508|NCT01396057|528867961|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
146909677|NCT04045613|529832834|FG003|Overall Study|Adverse Event|1|||
146909678|NCT04045613|529832835|FG004|Overall Study|Adverse Event|0|||
146642509|NCT01396057|528867960|FG000|Overall Study|Protocol deviation|4|||
146642510|NCT01396057|528867961|FG001|Overall Study|Protocol deviation|4|||
146642511|NCT01396057|528867960|FG000|Overall Study|Consent withdrawn|3|||
146642512|NCT01396057|528867961|FG001|Overall Study|Consent withdrawn|2|||
146909679|NCT04045613|529832836|FG005|Overall Study|Adverse Event|0|||
146909680|NCT04045613|529832837|FG006|Overall Study|Adverse Event|1|||
146642513|NCT02695420|528867962|FG000|Overall Study|Death|0|||
146642514|NCT02695420|528867963|FG001|Overall Study|Death|1|||
146642515|NCT02695420|528867964|FG002|Overall Study|Death|0|||
146642516|NCT02695420|528867965|FG003|Overall Study|Death|0|||
146642517|NCT02929407|528867968|FG000|Overall Study|Adverse Event|1|||
146642518|NCT00916929|528867969|FG000|Overall Study|Lost to Follow-up|1|||
146642519|NCT00916929|528867970|FG001|Overall Study|Lost to Follow-up|3|||
146642520|NCT00916929|528867969|FG000|Overall Study|Death|5|||
146642521|NCT00916929|528867970|FG001|Overall Study|Death|10|||
146642522|NCT00916929|528867969|FG000|Overall Study|Withdrawal by Subject|1|||
146642523|NCT00916929|528867970|FG001|Overall Study|Withdrawal by Subject|5|||
146642524|NCT00916929|528867969|FG000|Overall Study|Left ventricular epicardial lead|1|||
146642525|NCT00916929|528867970|FG001|Overall Study|Left ventricular epicardial lead|2|||
146642526|NCT00916929|528867969|FG000|Overall Study|Transferred to hospice care|1|||
146642527|NCT00916929|528867970|FG001|Overall Study|Transferred to hospice care|1|||
146642528|NCT00916929|528867969|FG000|Overall Study|System explant|1|||
146642529|NCT00916929|528867970|FG001|Overall Study|System explant|0|||
146642530|NCT00916929|528867969|FG000|Overall Study|Moved to another state|0|||
146642531|NCT00916929|528867970|FG001|Overall Study|Moved to another state|1|||
146642532|NCT00916929|528867969|FG000|Overall Study|Device unable to process impedance data|0|||
146642533|NCT00916929|528867970|FG001|Overall Study|Device unable to process impedance data|7|||
146642534|NCT02878798|528867973|FG000|Overall Study|Withdrawal by Subject|5|||
146642535|NCT02878798|528867974|FG001|Overall Study|Withdrawal by Subject|4|||
146642536|NCT02878798|528867973|FG000|Overall Study|Lost to Follow-up|2|||
146642537|NCT02878798|528867974|FG001|Overall Study|Lost to Follow-up|2|||
146642538|NCT02878798|528867973|FG000|Overall Study|Protocol Violation|0|||
146563774|NCT00619866|528576191|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
146970434|NCT00440193|530052637|FG001|Treatment Period|Physician Decision|6|||
146970435|NCT00440193|530052636|FG000|Treatment Period|Protocol Violation|16|||
146970436|NCT00440193|530052637|FG001|Treatment Period|Protocol Violation|19|||
146970437|NCT00440193|530052636|FG000|Treatment Period|Withdrawal by Subject|36|||
146970438|NCT00440193|530052637|FG001|Treatment Period|Withdrawal by Subject|77|||
146909681|NCT04045613|529832831|FG000|Overall Study|Withdrawal by Subject|0|||
146909682|NCT04045613|529832832|FG001|Overall Study|Withdrawal by Subject|5|||
146909683|NCT04045613|529832833|FG002|Overall Study|Withdrawal by Subject|0|||
146909684|NCT04045613|529832834|FG003|Overall Study|Withdrawal by Subject|0|||
146909685|NCT04045613|529832835|FG004|Overall Study|Withdrawal by Subject|0|||
146970439|NCT00440193|530052636|FG000|Treatment Period|Clinical endpoint reached|28|||
146970440|NCT00440193|530052637|FG001|Treatment Period|Clinical endpoint reached|25|||
146970441|NCT00440193|530052636|FG000|Treatment Period|Study terminated by sponsor|102|||
146970442|NCT00440193|530052637|FG001|Treatment Period|Study terminated by sponsor|94|||
146970443|NCT00440193|530052636|FG000|Treatment Period|Protocol driven decision point|2|||
146970444|NCT00440193|530052637|FG001|Treatment Period|Protocol driven decision point|2|||
146642539|NCT02878798|528867974|FG001|Overall Study|Protocol Violation|1|||
146642540|NCT03500224|528867975|FG000|Overall Study|Withdrawal by Subject|2|||
146642541|NCT01324401|528867976|FG000|Overall Study|Withdrawn before any treatment|0|||
146642542|NCT01324401|528867977|FG001|Overall Study|Withdrawn before any treatment|3|||
146642543|NCT01324401|528867976|FG000|Overall Study|Adverse Event|1|||
146642544|NCT01324401|528867977|FG001|Overall Study|Adverse Event|3|||
146642545|NCT01708902|528867979|FG000|Overall Study|Adverse Event|3|||
146642546|NCT01708902|528867980|FG001|Overall Study|Adverse Event|4|||
146642547|NCT01708902|528867981|FG002|Overall Study|Adverse Event|9|||
146642548|NCT01708902|528867982|FG003|Overall Study|Adverse Event|2|||
146642549|NCT01708902|528867983|FG004|Overall Study|Adverse Event|7|||
146642550|NCT01708902|528867984|FG005|Overall Study|Adverse Event|3|||
146642551|NCT01708902|528867985|FG006|Overall Study|Adverse Event|5|||
146642552|NCT01708902|528867979|FG000|Overall Study|Lack of Efficacy|3|||
146642553|NCT01708902|528867980|FG001|Overall Study|Lack of Efficacy|1|||
146642554|NCT01708902|528867981|FG002|Overall Study|Lack of Efficacy|0|||
146768477|NCT00708032|529321700|FG001|Overall Study|Visit out of range at month 12|1|||
146768478|NCT00708032|529321699|FG000|Overall Study|Did not meet protocol criteria|1|||
146768479|NCT00708032|529321700|FG001|Overall Study|Did not meet protocol criteria|2|||
146768480|NCT00708032|529321699|FG000|Overall Study|Protocol Violation|4|||
146563775|NCT00619866|528576187|FG000|Weeks 1 - 12|Sponsor Decision|0|||
146563776|NCT00619866|528576188|FG001|Weeks 1 - 12|Sponsor Decision|1|||
146970445|NCT00440193|530052636|FG000|Treatment Period|Switch to commercial drug|0|||
146970446|NCT00440193|530052637|FG001|Treatment Period|Switch to commercial drug|2|||
146970447|NCT00440193|530052636|FG000|Treatment Period|Technical problems|1|||
146970448|NCT00440193|530052637|FG001|Treatment Period|Technical problems|1|||
146970449|NCT00440193|530052636|FG000|Treatment Period|Participant convenience|5|||
146970450|NCT00440193|530052637|FG001|Treatment Period|Participant convenience|2|||
146970451|NCT00440193|530052636|FG000|Treatment Period|Participant did not receive treatment|7|||
146970452|NCT00440193|530052637|FG001|Treatment Period|Participant did not receive treatment|13|||
146970453|NCT00440193|530052636|FG000|Treatment Period|Site closed by investigator|0|||
146970454|NCT00440193|530052637|FG001|Treatment Period|Site closed by investigator|2|||
146970455|NCT00440193|530052636|FG000|Observational Period|Adverse Event|2|||
146970456|NCT00440193|530052637|FG001|Observational Period|Adverse Event|2|||
146970457|NCT00440193|530052636|FG000|Observational Period|Death|15|||
146970458|NCT00440193|530052637|FG001|Observational Period|Death|20|||
146970459|NCT00440193|530052636|FG000|Observational Period|Lost to Follow-up|12|||
146970460|NCT00440193|530052637|FG001|Observational Period|Lost to Follow-up|8|||
146970461|NCT00440193|530052636|FG000|Observational Period|Protocol Violation|1|||
146970462|NCT00440193|530052637|FG001|Observational Period|Protocol Violation|0|||
146970463|NCT00440193|530052636|FG000|Observational Period|Withdrawal by Subject|11|||
146970464|NCT00440193|530052637|FG001|Observational Period|Withdrawal by Subject|8|||
146970465|NCT00440193|530052636|FG000|Observational Period|Physician Decision|1|||
146970466|NCT00440193|530052637|FG001|Observational Period|Physician Decision|0|||
146970467|NCT00440193|530052636|FG000|Observational Period|Clinical endpoint reached|1|||
146970468|NCT00440193|530052637|FG001|Observational Period|Clinical endpoint reached|0|||
146970469|NCT00440193|530052636|FG000|Observational Period|Participant convenience|2|||
146970470|NCT00440193|530052637|FG001|Observational Period|Participant convenience|0|||
146970471|NCT00834366|530052638|FG000|Treatment Period 1|Adverse Event|1|||
146970472|NCT00834366|530052639|FG001|Treatment Period 1|Adverse Event|1|||
146970473|NCT03014570|530052640|FG000|Overall Study|COVID-19 Restrictions|38|||
146970474|NCT03014570|530052641|FG001|Overall Study|COVID-19 Restrictions|24|||
146970475|NCT03014570|530052640|FG000|Overall Study|Death|70|||
146970476|NCT03014570|530052641|FG001|Overall Study|Death|79|||
146970477|NCT03014570|530052640|FG000|Overall Study|Transfer from facility|11|||
146970478|NCT03014570|530052641|FG001|Overall Study|Transfer from facility|14|||
146563777|NCT00619866|528576189|FG002|Weeks 1 - 12|Sponsor Decision|0|||
146563778|NCT00619866|528576190|FG003|Weeks 1 - 12|Sponsor Decision|0|||
146768481|NCT00708032|529321700|FG001|Overall Study|Protocol Violation|1|||
146970479|NCT03014570|530052640|FG000|Overall Study|Hospitalized|5|||
146970480|NCT03014570|530052641|FG001|Overall Study|Hospitalized|3|||
146970481|NCT03014570|530052640|FG000|Overall Study|Transfer within facility|1|||
146970482|NCT03014570|530052641|FG001|Overall Study|Transfer within facility|0|||
146970483|NCT03014570|530052640|FG000|Overall Study|Site refusal|0|||
146970484|NCT03014570|530052641|FG001|Overall Study|Site refusal|11|||
146970485|NCT01154673|530052642|FG000|Overall Study|Lost to Follow-up|1|||
146970486|NCT01154673|530052643|FG001|Overall Study|Lost to Follow-up|0|||
146563779|NCT00619866|528576191|FG004|Weeks 1 - 12|Sponsor Decision|0|||
146909686|NCT04045613|529832836|FG005|Overall Study|Withdrawal by Subject|1|||
146909687|NCT04045613|529832837|FG006|Overall Study|Withdrawal by Subject|0|||
146909688|NCT04045613|529832831|FG000|Overall Study|Physician Decision|2|||
146909689|NCT04045613|529832832|FG001|Overall Study|Physician Decision|0|||
146909690|NCT04045613|529832833|FG002|Overall Study|Physician Decision|0|||
146909691|NCT04045613|529832834|FG003|Overall Study|Physician Decision|0|||
146909692|NCT04045613|529832835|FG004|Overall Study|Physician Decision|1|||
146909693|NCT04045613|529832836|FG005|Overall Study|Physician Decision|0|||
146909694|NCT04045613|529832837|FG006|Overall Study|Physician Decision|0|||
146909695|NCT04045613|529832831|FG000|Overall Study|Death|3|||
146909696|NCT04045613|529832832|FG001|Overall Study|Death|0|||
146909697|NCT04045613|529832833|FG002|Overall Study|Death|0|||
146909698|NCT04045613|529832834|FG003|Overall Study|Death|0|||
146909699|NCT04045613|529832835|FG004|Overall Study|Death|0|||
146909700|NCT04045613|529832836|FG005|Overall Study|Death|0|||
146909701|NCT04045613|529832837|FG006|Overall Study|Death|1|||
146909702|NCT04045613|529832831|FG000|Overall Study|Other reasons|0|||
146909703|NCT04045613|529832832|FG001|Overall Study|Other reasons|1|||
146909704|NCT04045613|529832833|FG002|Overall Study|Other reasons|0|||
146909705|NCT04045613|529832834|FG003|Overall Study|Other reasons|0|||
146909706|NCT04045613|529832835|FG004|Overall Study|Other reasons|0|||
146909707|NCT04045613|529832836|FG005|Overall Study|Other reasons|0|||
146909708|NCT04045613|529832837|FG006|Overall Study|Other reasons|1|||
146909709|NCT04045613|529832831|FG000|Overall Study|Progressive disease: Clinical progression|1|||
146909710|NCT04045613|529832832|FG001|Overall Study|Progressive disease: Clinical progression|0|||
146909711|NCT04045613|529832833|FG002|Overall Study|Progressive disease: Clinical progression|3|||
146909712|NCT04045613|529832834|FG003|Overall Study|Progressive disease: Clinical progression|1|||
146909713|NCT04045613|529832835|FG004|Overall Study|Progressive disease: Clinical progression|1|||
146909714|NCT04045613|529832836|FG005|Overall Study|Progressive disease: Clinical progression|3|||
146909715|NCT04045613|529832837|FG006|Overall Study|Progressive disease: Clinical progression|3|||
146909716|NCT04045613|529832831|FG000|Overall Study|Progressive disease: Radiological progression|24|||
146909717|NCT04045613|529832832|FG001|Overall Study|Progressive disease: Radiological progression|6|||
146909718|NCT04045613|529832833|FG002|Overall Study|Progressive disease: Radiological progression|8|||
146909719|NCT04045613|529832834|FG003|Overall Study|Progressive disease: Radiological progression|0|||
146909720|NCT04045613|529832835|FG004|Overall Study|Progressive disease: Radiological progression|6|||
146909721|NCT04045613|529832836|FG005|Overall Study|Progressive disease: Radiological progression|6|||
146909722|NCT04045613|529832837|FG006|Overall Study|Progressive disease: Radiological progression|11|||
146909723|NCT01633060|529832844|FG000|Randomization Phase|Protocol deviation|1|||
146909724|NCT01633060|529832845|FG001|Randomization Phase|Protocol deviation|2|||
146909725|NCT01633060|529832844|FG000|Randomization Phase|Technical problem|0|||
146909726|NCT01633060|529832845|FG001|Randomization Phase|Technical problem|1|||
146909727|NCT01633060|529832844|FG000|Treatment Phase|Adverse Event|24|||
146909728|NCT01633060|529832845|FG001|Treatment Phase|Adverse Event|3|||
146909729|NCT01633060|529832844|FG000|Treatment Phase|Lost to Follow-up|1|||
146909730|NCT01633060|529832845|FG001|Treatment Phase|Lost to Follow-up|0|||
146909731|NCT01633060|529832844|FG000|Treatment Phase|Physician Decision|16|||
146563780|NCT00619866|528576187|FG000|Weeks 13 - 24|Adverse Event|0|||
146563781|NCT00619866|528576188|FG001|Weeks 13 - 24|Adverse Event|0|||
146563782|NCT00619866|528576189|FG002|Weeks 13 - 24|Adverse Event|2|||
146563783|NCT00619866|528576190|FG003|Weeks 13 - 24|Adverse Event|1|||
146970487|NCT01154673|530052642|FG000|Overall Study|moved out of province|1|||
146970488|NCT01154673|530052643|FG001|Overall Study|moved out of province|0|||
146970489|NCT00090259|530052644|FG000|Overall Study|Lost to Follow-up|30|||
146970490|NCT00090259|530052645|FG001|Overall Study|Lost to Follow-up|26|||
146970491|NCT00090259|530052644|FG000|Overall Study|Withdrawal by Subject|21|||
146970492|NCT00090259|530052645|FG001|Overall Study|Withdrawal by Subject|15|||
146970493|NCT00090259|530052644|FG000|Overall Study|Investigator site closed|11|||
146563784|NCT00619866|528576191|FG004|Weeks 13 - 24|Adverse Event|0|||
146563785|NCT00619866|528576187|FG000|Weeks 13 - 24|Protocol Deviation|0|||
146970494|NCT00090259|530052645|FG001|Overall Study|Investigator site closed|7|||
146563786|NCT00619866|528576188|FG001|Weeks 13 - 24|Protocol Deviation|0|||
146768482|NCT00708032|529321699|FG000|Overall Study|Withdrawal by Subject|0|||
146768483|NCT00708032|529321700|FG001|Overall Study|Withdrawal by Subject|1|||
146768484|NCT02320123|529321704|FG000|Overall Study|Lost to Follow-up|4|||
146768485|NCT02320123|529321705|FG001|Overall Study|Lost to Follow-up|6|||
146768486|NCT02320123|529321704|FG000|Overall Study|Death|6|||
146768487|NCT02320123|529321705|FG001|Overall Study|Death|5|||
146768488|NCT00941655|529321714|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
146768489|NCT00941655|529321715|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
146768490|NCT00941655|529321714|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
146768491|NCT00941655|529321715|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
146768492|NCT00941655|529321714|FG000|Overall Study|progressed while on chemo|0|||
146768493|NCT00941655|529321715|FG001|Overall Study|progressed while on chemo|2|||
146768494|NCT00941655|529321714|FG000|Overall Study|refused further treatment|0|||
146768495|NCT00941655|529321715|FG001|Overall Study|refused further treatment|1|||
146768496|NCT00941655|529321714|FG000|Overall Study|withdrew consent|0|||
146768497|NCT00941655|529321715|FG001|Overall Study|withdrew consent|1|||
146768498|NCT00941655|529321714|FG000|Overall Study|non-compliant|0|||
146768499|NCT00941655|529321715|FG001|Overall Study|non-compliant|1|||
146768500|NCT02477670|529321716|FG000|Stage 1|Adverse Event|2|||
146768501|NCT02477670|529321717|FG001|Stage 1|Adverse Event|7|||
146768502|NCT02477670|529321718|FG002|Stage 1|Adverse Event|0|||
146768503|NCT02477670|529321719|FG003|Stage 1|Adverse Event|0|||
146768504|NCT02477670|529321720|FG004|Stage 1|Adverse Event|0|||
146768505|NCT02477670|529321721|FG005|Stage 1|Adverse Event|0|||
146768506|NCT02477670|529321722|FG006|Stage 1|Adverse Event|0|||
146768507|NCT02477670|529321716|FG000|Stage 1|Lost to Follow-up|0|||
146768508|NCT02477670|529321717|FG001|Stage 1|Lost to Follow-up|2|||
146768509|NCT02477670|529321718|FG002|Stage 1|Lost to Follow-up|0|||
146642555|NCT01708902|528867982|FG003|Overall Study|Lack of Efficacy|0|||
146768510|NCT02477670|529321719|FG003|Stage 1|Lost to Follow-up|0|||
146768511|NCT02477670|529321720|FG004|Stage 1|Lost to Follow-up|0|||
146768512|NCT02477670|529321721|FG005|Stage 1|Lost to Follow-up|0|||
146768513|NCT02477670|529321722|FG006|Stage 1|Lost to Follow-up|0|||
146768514|NCT02477670|529321716|FG000|Stage 1|Withdrawal by Subject|1|||
146768515|NCT02477670|529321717|FG001|Stage 1|Withdrawal by Subject|2|||
146768516|NCT02477670|529321718|FG002|Stage 1|Withdrawal by Subject|0|||
146768517|NCT02477670|529321719|FG003|Stage 1|Withdrawal by Subject|0|||
146768518|NCT02477670|529321720|FG004|Stage 1|Withdrawal by Subject|0|||
146768519|NCT02477670|529321721|FG005|Stage 1|Withdrawal by Subject|0|||
146768520|NCT02477670|529321722|FG006|Stage 1|Withdrawal by Subject|0|||
146768521|NCT02477670|529321716|FG000|Stage 1|Non-compliance with Study Drug|1|||
146768522|NCT02477670|529321717|FG001|Stage 1|Non-compliance with Study Drug|2|||
146768523|NCT02477670|529321718|FG002|Stage 1|Non-compliance with Study Drug|0|||
146768524|NCT02477670|529321719|FG003|Stage 1|Non-compliance with Study Drug|0|||
146768525|NCT02477670|529321720|FG004|Stage 1|Non-compliance with Study Drug|0|||
146768526|NCT02477670|529321721|FG005|Stage 1|Non-compliance with Study Drug|0|||
146909732|NCT01633060|529832845|FG001|Treatment Phase|Physician Decision|7|||
146909733|NCT01633060|529832844|FG000|Treatment Phase|Progressive Disease|210|||
146909734|NCT01633060|529832845|FG001|Treatment Phase|Progressive Disease|120|||
146909735|NCT01633060|529832844|FG000|Treatment Phase|Protocol Deviation|1|||
146909736|NCT01633060|529832845|FG001|Treatment Phase|Protocol Deviation|0|||
146909737|NCT01633060|529832844|FG000|Treatment Phase|Study Terminated by sponsor|7|||
146909738|NCT01633060|529832845|FG001|Treatment Phase|Study Terminated by sponsor|3|||
146909739|NCT01633060|529832844|FG000|Treatment Phase|Subject/guardian decision|25|||
146909740|NCT01633060|529832845|FG001|Treatment Phase|Subject/guardian decision|4|||
146563787|NCT00619866|528576189|FG002|Weeks 13 - 24|Protocol Deviation|0|||
146909741|NCT01633060|529832844|FG000|Treatment Phase|Death|4|||
146909742|NCT01633060|529832845|FG001|Treatment Phase|Death|3|||
146909743|NCT01633060|529832844|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
146563788|NCT00619866|528576190|FG003|Weeks 13 - 24|Protocol Deviation|1|||
146563789|NCT00619866|528576191|FG004|Weeks 13 - 24|Protocol Deviation|0|||
146768527|NCT02477670|529321722|FG006|Stage 1|Non-compliance with Study Drug|0|||
146768528|NCT02477670|529321716|FG000|Stage 2|Adverse Event|0|||
146563790|NCT00619866|528576187|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
146642556|NCT01708902|528867983|FG004|Overall Study|Lack of Efficacy|0|||
146642557|NCT01708902|528867984|FG005|Overall Study|Lack of Efficacy|1|||
146642558|NCT01708902|528867985|FG006|Overall Study|Lack of Efficacy|0|||
146768529|NCT02477670|529321717|FG001|Stage 2|Adverse Event|0|||
146768530|NCT02477670|529321718|FG002|Stage 2|Adverse Event|1|||
146768531|NCT02477670|529321719|FG003|Stage 2|Adverse Event|0|||
146768532|NCT02477670|529321720|FG004|Stage 2|Adverse Event|0|||
146768533|NCT02477670|529321721|FG005|Stage 2|Adverse Event|0|||
146768534|NCT02477670|529321722|FG006|Stage 2|Adverse Event|0|||
146768535|NCT02477670|529321716|FG000|Stage 2|Antipsychotic Medication Changed|0|||
146768536|NCT02477670|529321717|FG001|Stage 2|Antipsychotic Medication Changed|0|||
146768537|NCT02477670|529321718|FG002|Stage 2|Antipsychotic Medication Changed|1|||
146768538|NCT02477670|529321719|FG003|Stage 2|Antipsychotic Medication Changed|0|||
146768539|NCT02477670|529321720|FG004|Stage 2|Antipsychotic Medication Changed|0|||
146768540|NCT02477670|529321721|FG005|Stage 2|Antipsychotic Medication Changed|0|||
146768541|NCT02477670|529321722|FG006|Stage 2|Antipsychotic Medication Changed|0|||
146768542|NCT02477670|529321716|FG000|Stage 2|Withdrawal by Subject|0|||
146768543|NCT02477670|529321717|FG001|Stage 2|Withdrawal by Subject|0|||
146768544|NCT02477670|529321718|FG002|Stage 2|Withdrawal by Subject|0|||
146909744|NCT01633060|529832845|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
146768545|NCT02477670|529321719|FG003|Stage 2|Withdrawal by Subject|1|||
146909745|NCT01633060|529832844|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
146768546|NCT02477670|529321720|FG004|Stage 2|Withdrawal by Subject|0|||
146768547|NCT02477670|529321721|FG005|Stage 2|Withdrawal by Subject|0|||
146768548|NCT02477670|529321722|FG006|Stage 2|Withdrawal by Subject|0|||
146768549|NCT00004124|529321727|FG000|Overall Study|Received no protocol therapy|12|||
146909746|NCT01633060|529832845|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
146909747|NCT01633060|529832844|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
146909748|NCT01633060|529832845|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
146909749|NCT01633060|529832844|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
146909750|NCT01633060|529832845|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
146909751|NCT01633060|529832844|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
146909752|NCT01633060|529832845|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
146909753|NCT01633060|529832844|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
146909754|NCT01633060|529832845|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
146909755|NCT03633331|529832853|FG000|Overall Study|Withdrawal by Subject|1|||
146909756|NCT01009294|529832854|FG000|Overall Study|Study discontinued by Sponsor|6|||
146909757|NCT01856673|529832855|FG000|Overall Study|Withdrawal by Subject|44|||
146909758|NCT01856673|529832856|FG001|Overall Study|Withdrawal by Subject|50|||
146909759|NCT01856673|529832857|FG002|Overall Study|Withdrawal by Subject|33|||
146909760|NCT01856673|529832855|FG000|Overall Study|Lost to Follow-up|31|||
146642559|NCT01708902|528867979|FG000|Overall Study|Non compliance with protocol|0|||
146642560|NCT01708902|528867980|FG001|Overall Study|Non compliance with protocol|2|||
146642561|NCT01708902|528867981|FG002|Overall Study|Non compliance with protocol|1|||
146642562|NCT01708902|528867982|FG003|Overall Study|Non compliance with protocol|3|||
146642563|NCT01708902|528867983|FG004|Overall Study|Non compliance with protocol|0|||
146642564|NCT01708902|528867984|FG005|Overall Study|Non compliance with protocol|0|||
146642565|NCT01708902|528867985|FG006|Overall Study|Non compliance with protocol|0|||
146642566|NCT01708902|528867979|FG000|Overall Study|Lost to Follow-up|2|||
146642567|NCT01708902|528867980|FG001|Overall Study|Lost to Follow-up|1|||
146642568|NCT01708902|528867981|FG002|Overall Study|Lost to Follow-up|2|||
146642569|NCT01708902|528867982|FG003|Overall Study|Lost to Follow-up|2|||
146642570|NCT01708902|528867983|FG004|Overall Study|Lost to Follow-up|0|||
146642571|NCT01708902|528867984|FG005|Overall Study|Lost to Follow-up|0|||
146642572|NCT01708902|528867985|FG006|Overall Study|Lost to Follow-up|1|||
146642573|NCT01708902|528867979|FG000|Overall Study|Refused to continue trial medication|8|||
146642574|NCT01708902|528867980|FG001|Overall Study|Refused to continue trial medication|0|||
146642575|NCT01708902|528867981|FG002|Overall Study|Refused to continue trial medication|4|||
146642576|NCT01708902|528867982|FG003|Overall Study|Refused to continue trial medication|2|||
146642577|NCT01708902|528867983|FG004|Overall Study|Refused to continue trial medication|8|||
146642578|NCT01708902|528867984|FG005|Overall Study|Refused to continue trial medication|1|||
146642579|NCT01708902|528867985|FG006|Overall Study|Refused to continue trial medication|1|||
146642580|NCT01708902|528867979|FG000|Overall Study|Other Reason|1|||
146642581|NCT01708902|528867980|FG001|Overall Study|Other Reason|0|||
146642582|NCT01708902|528867981|FG002|Overall Study|Other Reason|1|||
146642583|NCT01708902|528867982|FG003|Overall Study|Other Reason|1|||
146642584|NCT01708902|528867983|FG004|Overall Study|Other Reason|1|||
146642585|NCT01708902|528867984|FG005|Overall Study|Other Reason|2|||
146909761|NCT01856673|529832856|FG001|Overall Study|Lost to Follow-up|34|||
146909762|NCT01856673|529832857|FG002|Overall Study|Lost to Follow-up|0|||
146909763|NCT01856673|529832855|FG000|Overall Study|Unknown reasons|9|||
146909764|NCT01856673|529832856|FG001|Overall Study|Unknown reasons|0|||
146909765|NCT01856673|529832857|FG002|Overall Study|Unknown reasons|0|||
146909766|NCT01856673|529832855|FG000|Overall Study|Psychologist decision|1|||
146909767|NCT01856673|529832856|FG001|Overall Study|Psychologist decision|0|||
146909768|NCT01856673|529832857|FG002|Overall Study|Psychologist decision|0|||
146909769|NCT01856673|529832855|FG000|Overall Study|Paperwork errors|8|||
146909770|NCT01856673|529832856|FG001|Overall Study|Paperwork errors|0|||
146909771|NCT01856673|529832857|FG002|Overall Study|Paperwork errors|0|||
146909772|NCT01856673|529832855|FG000|Overall Study|Death|1|||
146909773|NCT01856673|529832856|FG001|Overall Study|Death|1|||
146909774|NCT01856673|529832857|FG002|Overall Study|Death|0|||
146909775|NCT01856673|529832855|FG000|Overall Study|Protocol Violation|1|||
146909776|NCT01856673|529832856|FG001|Overall Study|Protocol Violation|0|||
146909777|NCT01856673|529832857|FG002|Overall Study|Protocol Violation|1|||
146909778|NCT01743027|529832866|FG000|Overall Study|Adverse Event|2|||
146909779|NCT01743027|529832867|FG001|Overall Study|Adverse Event|0|||
146909780|NCT01743027|529832868|FG002|Overall Study|Adverse Event|0|||
146909781|NCT01743027|529832869|FG003|Overall Study|Adverse Event|0|||
146909782|NCT01743027|529832866|FG000|Overall Study|Lost to Follow-up|0|||
146909783|NCT01743027|529832867|FG001|Overall Study|Lost to Follow-up|0|||
146909784|NCT01743027|529832868|FG002|Overall Study|Lost to Follow-up|2|||
146909785|NCT01743027|529832869|FG003|Overall Study|Lost to Follow-up|0|||
146909786|NCT01743027|529832866|FG000|Overall Study|Progressive Disease|1|||
146909787|NCT01743027|529832867|FG001|Overall Study|Progressive Disease|4|||
146909788|NCT01743027|529832868|FG002|Overall Study|Progressive Disease|3|||
146909789|NCT01743027|529832869|FG003|Overall Study|Progressive Disease|0|||
146909790|NCT01743027|529832866|FG000|Overall Study|Protocol Violation|1|||
146563791|NCT00619866|528576188|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
146563792|NCT00619866|528576189|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
146563793|NCT00619866|528576190|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
146563794|NCT00619866|528576191|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
146563795|NCT00619866|528576187|FG000|Weeks 13 - 24|Non-compliance|0|||
146563796|NCT00619866|528576188|FG001|Weeks 13 - 24|Non-compliance|1|||
146563797|NCT00619866|528576189|FG002|Weeks 13 - 24|Non-compliance|1|||
146563798|NCT00619866|528576190|FG003|Weeks 13 - 24|Non-compliance|0|||
146563799|NCT00619866|528576191|FG004|Weeks 13 - 24|Non-compliance|0|||
146909791|NCT01743027|529832867|FG001|Overall Study|Protocol Violation|1|||
146563800|NCT00619866|528576187|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
146563801|NCT00619866|528576188|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
146909792|NCT01743027|529832868|FG002|Overall Study|Protocol Violation|1|||
146909793|NCT01743027|529832869|FG003|Overall Study|Protocol Violation|0|||
146909794|NCT01743027|529832866|FG000|Overall Study|Withdrawal by Subject|1|||
146909795|NCT01743027|529832867|FG001|Overall Study|Withdrawal by Subject|0|||
146909796|NCT01743027|529832868|FG002|Overall Study|Withdrawal by Subject|3|||
146909797|NCT01743027|529832869|FG003|Overall Study|Withdrawal by Subject|1|||
146909798|NCT00450866|529832870|FG000|Overall Study|Adverse Event|0|||
146970495|NCT03083639|530052649|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
146563802|NCT00619866|528576189|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
146563803|NCT00619866|528576190|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
146563804|NCT00619866|528576191|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
146563805|NCT00485173|528576195|FG000|Overall Study|Death|4|||
146563806|NCT00485173|528576196|FG001|Overall Study|Death|3|||
146563807|NCT00485173|528576195|FG000|Overall Study|Lost to Follow-up|32|||
146563808|NCT00485173|528576196|FG001|Overall Study|Lost to Follow-up|61|||
146563809|NCT01121757|528576197|FG000|First Drug|Death|1|||
146563810|NCT01121757|528576198|FG001|First Drug|Death|0|||
146563811|NCT01121757|528576197|FG000|First Drug|Disease Progression|0|||
146563812|NCT01121757|528576198|FG001|First Drug|Disease Progression|2|||
146563813|NCT01121757|528576197|FG000|Combination|Physician Decision|0|||
146563814|NCT01121757|528576198|FG001|Combination|Physician Decision|1|||
146563815|NCT01121757|528576197|FG000|Combination|Disease Progression|2|||
146563816|NCT01121757|528576198|FG001|Combination|Disease Progression|0|||
146563817|NCT00829244|528576199|FG000|Overall Study|Adverse Event|1|||
146563818|NCT00829244|528576200|FG001|Overall Study|Adverse Event|3|||
146563819|NCT00829244|528576199|FG000|Overall Study|Protocol Violation|1|||
146563820|NCT00829244|528576200|FG001|Overall Study|Protocol Violation|0|||
146563821|NCT00829244|528576199|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
146563822|NCT00829244|528576200|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
146563823|NCT00829244|528576199|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
146563824|NCT00829244|528576200|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
146563825|NCT00829244|528576199|FG000|Overall Study|No fertilization|2|||
146563826|NCT00829244|528576200|FG001|Overall Study|No fertilization|2|||
146563827|NCT00829244|528576199|FG000|Overall Study|All embryos discarded|0|||
146563828|NCT00829244|528576200|FG001|Overall Study|All embryos discarded|3|||
146563829|NCT00829244|528576199|FG000|Overall Study|No embryo cleavage|0|||
146563830|NCT00829244|528576200|FG001|Overall Study|No embryo cleavage|2|||
146563831|NCT04222673|528576201|FG000|Overall Study|Lost to Follow-up|5|||
146563832|NCT03213509|528576215|FG000|Overall Study|Did not consent for verbal autopsy|4|||
146563833|NCT03213509|528576216|FG001|Overall Study|Did not consent for verbal autopsy|5|||
146563834|NCT02297412|528576217|FG000|Overall Study|Canceled|1|||
146563835|NCT02297412|528576218|FG001|Overall Study|Canceled|1|||
146563836|NCT04583618|528576232|FG000|Overall Study|Adverse Event|0|||
146563837|NCT04583618|528576233|FG001|Overall Study|Adverse Event|0|||
146563838|NCT04583618|528576234|FG002|Overall Study|Adverse Event|1|||
146563839|NCT04583618|528576235|FG003|Overall Study|Adverse Event|0|||
146642586|NCT01708902|528867985|FG006|Overall Study|Other Reason|0|||
146642587|NCT00499590|528867988|FG000|Overall Study|Study Terminated|112|||
146970496|NCT03083639|530052650|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
146970497|NCT03083639|530052649|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
146970498|NCT03083639|530052650|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
146970499|NCT01275170|530052651|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
146970500|NCT01275170|530052652|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
146970501|NCT01275170|530052653|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
146970502|NCT01275170|530052654|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
146563840|NCT04583618|528576236|FG004|Overall Study|Adverse Event|0|||
146563841|NCT04583618|528576232|FG000|Overall Study|Protocol deviation|1|||
146642588|NCT00499590|528867989|FG001|Overall Study|Study Terminated|112|||
146970503|NCT01275170|530052655|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
146970504|NCT01275170|530052656|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
146563842|NCT04583618|528576233|FG001|Overall Study|Protocol deviation|1|||
146563843|NCT04583618|528576234|FG002|Overall Study|Protocol deviation|1|||
146563844|NCT04583618|528576235|FG003|Overall Study|Protocol deviation|0|||
146563845|NCT04583618|528576236|FG004|Overall Study|Protocol deviation|0|||
146563846|NCT04583618|528576232|FG000|Overall Study|Withdrawal by Subject|2|||
146563847|NCT04583618|528576233|FG001|Overall Study|Withdrawal by Subject|1|||
146563848|NCT04583618|528576234|FG002|Overall Study|Withdrawal by Subject|3|||
146563849|NCT04583618|528576235|FG003|Overall Study|Withdrawal by Subject|1|||
146970505|NCT01275170|530052657|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
146970506|NCT01275170|530052658|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
146970507|NCT00960687|530052659|FG000|Washout Period of 7 Days|Adverse Event|3|||
146970508|NCT00960687|530052660|FG001|Washout Period of 7 Days|Adverse Event|2|||
146970509|NCT00960687|530052659|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
146970510|NCT00960687|530052660|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
146970511|NCT02362646|530052661|FG000|Overall Study|Death|15|||
146970512|NCT02362646|530052662|FG001|Overall Study|Death|8|||
146970513|NCT02362646|530052661|FG000|Overall Study|Withdrawal by Subject|2|||
146970514|NCT02362646|530052662|FG001|Overall Study|Withdrawal by Subject|2|||
146970515|NCT02362646|530052661|FG000|Overall Study|received transplant|21|||
146970516|NCT02362646|530052662|FG001|Overall Study|received transplant|14|||
146970517|NCT00865306|530052663|FG000|Controlled Trial|Lost to Follow-up|1|||
146970518|NCT00865306|530052664|FG001|Controlled Trial|Lost to Follow-up|1|||
146970519|NCT00865306|530052663|FG000|Controlled Trial|Difficulty commuting|2|||
146970520|NCT00865306|530052664|FG001|Controlled Trial|Difficulty commuting|0|||
146970521|NCT00865306|530052663|FG000|Controlled Trial|Improved btw baseline and first session|1|||
146970522|NCT00865306|530052664|FG001|Controlled Trial|Improved btw baseline and first session|0|||
146970523|NCT00865306|530052663|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
146970524|NCT00865306|530052664|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
146970525|NCT00865306|530052663|FG000|Controlled Trial|Withdrawal by Subject|0|||
146970526|NCT00865306|530052664|FG001|Controlled Trial|Withdrawal by Subject|1|||
146970527|NCT02704130|530052669|FG000|Overall Study|Physician Decision|5|||
146970528|NCT02704130|530052670|FG001|Overall Study|Physician Decision|3|||
146970529|NCT01216319|530052673|FG000|Overall Study|Lost to Follow-up|2|||
146970530|NCT01216319|530052673|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
146970531|NCT03611751|530052677|FG000|Pre-treatment|Randomized but not treated|1|||
146970532|NCT03611751|530052678|FG001|Pre-treatment|Randomized but not treated|1|||
146970533|NCT03611751|530052679|FG002|Pre-treatment|Randomized but not treated|0|||
146563850|NCT04583618|528576236|FG004|Overall Study|Withdrawal by Subject|1|||
146563851|NCT04583618|528576232|FG000|Overall Study|Lost to Follow-up|0|||
146563852|NCT04583618|528576233|FG001|Overall Study|Lost to Follow-up|1|||
146563853|NCT04583618|528576234|FG002|Overall Study|Lost to Follow-up|3|||
146563854|NCT04583618|528576235|FG003|Overall Study|Lost to Follow-up|1|||
146970534|NCT03611751|530052677|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
146563855|NCT04583618|528576236|FG004|Overall Study|Lost to Follow-up|1|||
146768550|NCT00004124|529321728|FG001|Overall Study|Received no protocol therapy|20|||
146970535|NCT03611751|530052678|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
146970536|NCT03611751|530052679|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
146563856|NCT03189719|528576241|FG000|Overall Study|Death|325|||
146563857|NCT03189719|528576242|FG001|Overall Study|Death|361|||
146909799|NCT00450866|529832871|FG001|Overall Study|Adverse Event|1|||
146909800|NCT00450866|529832870|FG000|Overall Study|Withdrawal by Subject|5|||
146909801|NCT00450866|529832871|FG001|Overall Study|Withdrawal by Subject|2|||
146909802|NCT00450866|529832870|FG000|Overall Study|Death|1|||
146909803|NCT00450866|529832871|FG001|Overall Study|Death|0|||
146909804|NCT00450866|529832870|FG000|Overall Study|Physician Decision|1|||
146909805|NCT00450866|529832871|FG001|Overall Study|Physician Decision|0|||
146909806|NCT02111811|529832872|FG000|Treatment Phase|Lost to Follow-up|22|||
146909807|NCT02111811|529832873|FG001|Treatment Phase|Lost to Follow-up|18|||
146909808|NCT02111811|529832872|FG000|Treatment Phase|Death|2|||
146909809|NCT02111811|529832873|FG001|Treatment Phase|Death|0|||
146909810|NCT02111811|529832872|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
146909811|NCT02111811|529832873|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
146909812|NCT02111811|529832872|FG000|Follow up Period (Aim 2)|Death|2|||
146909813|NCT02111811|529832873|FG001|Follow up Period (Aim 2)|Death|0|||
146909814|NCT01926886|529832879|FG000|Overall Study|Administrative/other|1|||
146909815|NCT01926886|529832880|FG001|Overall Study|Administrative/other|0|||
146909816|NCT01926886|529832879|FG000|Overall Study|Adverse event/intercurrent illness|4|||
146909817|NCT01926886|529832880|FG001|Overall Study|Adverse event/intercurrent illness|0|||
146909818|NCT01926886|529832879|FG000|Overall Study|Disease progression/recurrence|4|||
146909819|NCT01926886|529832880|FG001|Overall Study|Disease progression/recurrence|0|||
146909820|NCT01926886|529832879|FG000|Overall Study|Withdrawal by Subject|15|||
146909821|NCT01926886|529832880|FG001|Overall Study|Withdrawal by Subject|0|||
146909822|NCT01926886|529832879|FG000|Overall Study|Failure to return|3|||
146909823|NCT01926886|529832880|FG001|Overall Study|Failure to return|0|||
146909824|NCT01926886|529832879|FG000|Overall Study|Recurrence of disease|1|||
146909825|NCT01926886|529832880|FG001|Overall Study|Recurrence of disease|0|||
146909826|NCT01926886|529832879|FG000|Overall Study|Progression of disease|2|||
146909827|NCT01926886|529832880|FG001|Overall Study|Progression of disease|0|||
146909828|NCT01926886|529832879|FG000|Overall Study|Death|1|||
146909829|NCT01926886|529832880|FG001|Overall Study|Death|0|||
146909830|NCT01926886|529832879|FG000|Overall Study|Did not cooperate|1|||
146909831|NCT01926886|529832880|FG001|Overall Study|Did not cooperate|0|||
146909832|NCT02609399|529832881|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
146909833|NCT02609399|529832882|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
146642589|NCT00499590|528867990|FG002|Overall Study|Study Terminated|112|||
146642590|NCT00499590|528867988|FG000|Overall Study|Not treated|1|||
146642591|NCT00499590|528867989|FG001|Overall Study|Not treated|0|||
146642592|NCT00499590|528867990|FG002|Overall Study|Not treated|1|||
146642593|NCT01129583|528869566|FG000|Overall Study|Death|1|||
146642594|NCT01129583|528869567|FG001|Overall Study|Death|0|||
146642595|NCT01129583|528869566|FG000|Overall Study|Lost to Follow-up|1|||
146642596|NCT01129583|528869567|FG001|Overall Study|Lost to Follow-up|1|||
146642597|NCT01129583|528869566|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
146642598|NCT01129583|528869567|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
146642599|NCT02052414|528869573|FG000|Overall Study|Adverse Event|12|||
146642600|NCT02052414|528869573|FG000|Overall Study|Lack of Efficacy|2|||
146642601|NCT02052414|528869573|FG000|Overall Study|Withdrawal by Subject|3|||
146642602|NCT01343693|528869577|FG000|Overall Study|Lost to Follow-up|9|||
146642603|NCT02704143|528869578|FG000|Overall Study|disease progression|10|||
146642604|NCT01235598|528869579|FG000|Overall Study|Adverse Event|0|||
146642605|NCT01235598|528869580|FG001|Overall Study|Adverse Event|3|||
146642606|NCT01235598|528869579|FG000|Overall Study|Lack of Efficacy|0|||
146642607|NCT01235598|528869580|FG001|Overall Study|Lack of Efficacy|1|||
146642608|NCT01235598|528869579|FG000|Overall Study|Withdrawal by Subject|1|||
146642609|NCT01235598|528869580|FG001|Overall Study|Withdrawal by Subject|0|||
146909834|NCT02609399|529832881|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
146909835|NCT02609399|529832882|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
146909836|NCT02609399|529832881|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
146909837|NCT02609399|529832882|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
146642610|NCT02551991|528869581|FG000|Overall Study|Death|5|||
146642611|NCT02551991|528869582|FG001|Overall Study|Death|7|||
146642612|NCT02551991|528869583|FG002|Overall Study|Death|8|||
146768551|NCT00446550|529321729|FG000|Overall Study|Adverse Event|1|||
146768552|NCT00446550|529321730|FG001|Overall Study|Adverse Event|0|||
146768553|NCT01759264|529321731|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
146768554|NCT01759264|529321731|FG000|Overall Study|Adverse Event|1|||
146768555|NCT01759264|529321731|FG000|Overall Study|Other|2|||
146768556|NCT01759264|529321731|FG000|Overall Study|Lost to Follow-up|2|||
146909838|NCT04725682|529832888|FG000|Overall Study|Withdrawal by Subject|7|||
146909839|NCT04725682|529832889|FG001|Overall Study|Withdrawal by Subject|5|||
146768557|NCT01759264|529321731|FG000|Overall Study|Withdrawal by Subject|3|||
146909840|NCT04725682|529832888|FG000|Overall Study|Failed to comply with the requirements|2|||
146909841|NCT04725682|529832889|FG001|Overall Study|Failed to comply with the requirements|1|||
146909842|NCT04725682|529832888|FG000|Overall Study|Adverse Event|1|||
146909843|NCT04725682|529832889|FG001|Overall Study|Adverse Event|1|||
146909844|NCT04725682|529832888|FG000|Overall Study|Death|0|||
146909845|NCT04725682|529832889|FG001|Overall Study|Death|1|||
146909846|NCT00964795|529832890|FG000|Overall Study|Withdrawal by Subject|79|||
146909847|NCT00964795|529832890|FG000|Overall Study|Adverse Event|12|||
146909848|NCT00964795|529832890|FG000|Overall Study|Death|14|||
146909849|NCT00964795|529832890|FG000|Overall Study|Lost to Follow-up|7|||
146909850|NCT00964795|529832890|FG000|Overall Study|Termination of Study by Sponsor|169|||
146768558|NCT01759264|529321731|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
146909851|NCT00964795|529832890|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
146909852|NCT00964795|529832890|FG000|Overall Study|Other|23|||
146768559|NCT00612586|529321734|FG000|Overall Study|Adverse Event|6|||
146768560|NCT00612586|529321735|FG001|Overall Study|Adverse Event|2|||
146909853|NCT02453841|529832894|FG000|Overall Study|Protocol Violation|1|||
146642613|NCT02551991|528869584|FG003|Overall Study|Death|7|||
146642614|NCT02551991|528869585|FG004|Overall Study|Death|17|||
146642615|NCT02551991|528869581|FG000|Overall Study|Withdrawal by Subject|1|||
146642616|NCT02551991|528869582|FG001|Overall Study|Withdrawal by Subject|0|||
146909854|NCT02453841|529832894|FG000|Overall Study|Unable to obtain blood samples|2|||
146909855|NCT00857246|529832895|FG000|Induction Regimen|Adverse Event|1|||
146909856|NCT00857246|529832895|FG000|Induction Regimen|disease-related complications|1|||
146909857|NCT00857246|529832895|FG000|Induction Regimen|Withdrawal by Subject|1|||
146909858|NCT00857246|529832895|FG000|Surgery (Curative)|disease progression|6|||
146909859|NCT00857246|529832895|FG000|ChemoRT|Withdrawal by Subject|1|||
146909860|NCT00857246|529832895|FG000|ChemoRT|Adverse Event|2|||
146909861|NCT00072189|529832896|FG000|Overall Study|Withdrawal by Subject|1|||
146909862|NCT02973815|529832897|FG000|Post Intervention|Death|1|||
146909863|NCT02973815|529832898|FG001|Post Intervention|Death|0|||
146909864|NCT02973815|529832897|FG000|Post Intervention|Lost to Follow-up|7|||
146909865|NCT02973815|529832898|FG001|Post Intervention|Lost to Follow-up|24|||
146909866|NCT02973815|529832897|FG000|Follow-up|Lost to Follow-up|2|||
146909867|NCT02973815|529832898|FG001|Follow-up|Lost to Follow-up|0|||
146909868|NCT04542291|529832899|FG000|Overall Study|Adverse Event|1|||
146909869|NCT04542291|529832899|FG000|Overall Study|Physician Decision|2|||
146909870|NCT04579393|529832907|FG000|Overall Study|Withdrawal by Subject|2|||
146909871|NCT04579393|529832908|FG001|Overall Study|Withdrawal by Subject|2|||
146909872|NCT04579393|529832907|FG000|Overall Study|Death|1|||
146909873|NCT04579393|529832908|FG001|Overall Study|Death|3|||
146909874|NCT01333189|529832909|FG000|Overall Study|Time constraints|1|||
146909875|NCT01333189|529832910|FG001|Overall Study|Time constraints|0|||
146909876|NCT01333189|529832909|FG000|Overall Study|Adverse Event|1|||
146909877|NCT01333189|529832910|FG001|Overall Study|Adverse Event|0|||
146909878|NCT01333189|529832909|FG000|Overall Study|Transportation difficulties|0|||
146909879|NCT01333189|529832910|FG001|Overall Study|Transportation difficulties|1|||
146909880|NCT01333189|529832909|FG000|Overall Study|Moved from region|0|||
146909881|NCT01333189|529832910|FG001|Overall Study|Moved from region|1|||
146909882|NCT01739595|529832912|FG000|Overall Study|Adverse Event|3|||
146909883|NCT01739595|529832913|FG001|Overall Study|Adverse Event|0|||
146909884|NCT01739595|529832914|FG002|Overall Study|Adverse Event|0|||
146909885|NCT01739595|529832912|FG000|Overall Study|Lost to Follow-up|2|||
146909886|NCT01739595|529832913|FG001|Overall Study|Lost to Follow-up|0|||
146909887|NCT01739595|529832914|FG002|Overall Study|Lost to Follow-up|0|||
146909888|NCT01739595|529832912|FG000|Overall Study|Withdrawal by Subject|2|||
146909889|NCT01739595|529832913|FG001|Overall Study|Withdrawal by Subject|1|||
146909890|NCT01739595|529832914|FG002|Overall Study|Withdrawal by Subject|2|||
146909891|NCT01739595|529832912|FG000|Overall Study|Eligibility issue|3|||
146909892|NCT01739595|529832913|FG001|Overall Study|Eligibility issue|0|||
146909893|NCT01739595|529832914|FG002|Overall Study|Eligibility issue|0|||
146909894|NCT01739595|529832912|FG000|Overall Study|Protocol Violation|1|||
146909895|NCT01739595|529832913|FG001|Overall Study|Protocol Violation|0|||
146909896|NCT01739595|529832914|FG002|Overall Study|Protocol Violation|0|||
146909897|NCT01739595|529832912|FG000|Overall Study|Lab assessment|1|||
146909898|NCT01739595|529832913|FG001|Overall Study|Lab assessment|0|||
146909899|NCT01739595|529832914|FG002|Overall Study|Lab assessment|0|||
146909900|NCT01739595|529832912|FG000|Overall Study|Drug discrepancy|1|||
146909901|NCT01739595|529832913|FG001|Overall Study|Drug discrepancy|0|||
146909902|NCT01739595|529832914|FG002|Overall Study|Drug discrepancy|0|||
146909903|NCT02104180|529832921|FG000|Overall Study|Protocol Violation|1|||
146909904|NCT02104180|529832922|FG001|Overall Study|Protocol Violation|0|||
146909905|NCT02704429|529832925|FG000|Part A: 24 Weeks|Adverse Event|3|||
146909906|NCT02704429|529832926|FG001|Part A: 24 Weeks|Adverse Event|0|||
146909907|NCT02704429|529832925|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
146909908|NCT02704429|529832926|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
146909909|NCT00104104|529832927|FG000|Overall Study|Adverse Event|8|||
146909910|NCT00104104|529832928|FG001|Overall Study|Adverse Event|8|||
146970537|NCT03611751|530052677|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
146909911|NCT00104104|529832927|FG000|Overall Study|Abnormal laboratory value(s)|20|||
146970538|NCT03611751|530052678|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
146642617|NCT02551991|528869583|FG002|Overall Study|Withdrawal by Subject|0|||
146909912|NCT00104104|529832928|FG001|Overall Study|Abnormal laboratory value(s)|14|||
146909913|NCT00104104|529832927|FG000|Overall Study|Lack of Efficacy|0|||
146909914|NCT00104104|529832928|FG001|Overall Study|Lack of Efficacy|3|||
146909915|NCT00104104|529832927|FG000|Overall Study|Condition no longer requires study drug|7|||
146909916|NCT00104104|529832928|FG001|Overall Study|Condition no longer requires study drug|4|||
146909917|NCT00104104|529832927|FG000|Overall Study|Protocol Violation|5|||
146909918|NCT00104104|529832928|FG001|Overall Study|Protocol Violation|2|||
146909919|NCT00104104|529832927|FG000|Overall Study|Withdrawal by Subject|11|||
146768561|NCT00612586|529321734|FG000|Overall Study|Death|1|||
146768562|NCT00612586|529321735|FG001|Overall Study|Death|0|||
146768563|NCT00612586|529321734|FG000|Overall Study|Entry Criteria Not Met|0|||
146768564|NCT00612586|529321735|FG001|Overall Study|Entry Criteria Not Met|2|||
146768565|NCT00612586|529321734|FG000|Overall Study|Withdrawal by Subject|7|||
146768566|NCT00612586|529321735|FG001|Overall Study|Withdrawal by Subject|9|||
146768567|NCT00612586|529321734|FG000|Overall Study|Physician Decision|1|||
146768568|NCT00612586|529321735|FG001|Overall Study|Physician Decision|2|||
146768569|NCT00612586|529321734|FG000|Overall Study|Sponsor Decision|1|||
146768570|NCT00612586|529321735|FG001|Overall Study|Sponsor Decision|1|||
146768571|NCT00612586|529321734|FG000|Overall Study|Progressive Disease|26|||
146768572|NCT00612586|529321735|FG001|Overall Study|Progressive Disease|24|||
146768573|NCT00612586|529321734|FG000|Overall Study|Randomized and Not Treated|1|||
146768574|NCT00612586|529321735|FG001|Overall Study|Randomized and Not Treated|1|||
146768575|NCT01194154|529321736|FG000|Overall Study|Adverse Event|12|||
146768576|NCT01194154|529321737|FG001|Overall Study|Adverse Event|7|||
146768577|NCT01194154|529321736|FG000|Overall Study|Lost to Follow-up|2|||
146768578|NCT01194154|529321737|FG001|Overall Study|Lost to Follow-up|3|||
146768579|NCT01194154|529321736|FG000|Overall Study|Protocol Violation|0|||
146768580|NCT01194154|529321737|FG001|Overall Study|Protocol Violation|1|||
146768581|NCT01194154|529321736|FG000|Overall Study|Withdrawal by Subject|5|||
146768582|NCT01194154|529321737|FG001|Overall Study|Withdrawal by Subject|6|||
146768583|NCT01194154|529321736|FG000|Overall Study|Blood pressure increase|5|||
146768584|NCT01194154|529321737|FG001|Overall Study|Blood pressure increase|3|||
146768585|NCT01194154|529321736|FG000|Overall Study|Hemoglobin decrease|0|||
146768586|NCT01194154|529321737|FG001|Overall Study|Hemoglobin decrease|1|||
146768587|NCT01194154|529321736|FG000|Overall Study|Hemoglobin increase|12|||
146768588|NCT01194154|529321737|FG001|Overall Study|Hemoglobin increase|3|||
146768589|NCT01194154|529321736|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
146909920|NCT00104104|529832928|FG001|Overall Study|Withdrawal by Subject|15|||
146909921|NCT00104104|529832927|FG000|Overall Study|Lost to Follow-up|3|||
146909922|NCT00104104|529832928|FG001|Overall Study|Lost to Follow-up|7|||
146909923|NCT00104104|529832927|FG000|Overall Study|Administrative problems|12|||
146909924|NCT00104104|529832928|FG001|Overall Study|Administrative problems|13|||
146909925|NCT00104104|529832927|FG000|Overall Study|Death|9|||
146909926|NCT00104104|529832928|FG001|Overall Study|Death|6|||
146909927|NCT00793585|529832929|FG000|Overall Study|Adverse Event|1|||
146909928|NCT00793585|529832930|FG001|Overall Study|Adverse Event|1|||
146909929|NCT00793585|529832929|FG000|Overall Study|Protocol Violation|1|||
146909930|NCT00793585|529832930|FG001|Overall Study|Protocol Violation|2|||
146909931|NCT02209597|529832933|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
146909932|NCT02209597|529832933|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
146909933|NCT02209597|529832933|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
146909934|NCT02209597|529832933|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
146909935|NCT00744055|529834117|FG000|Overall Study|Withdrawal by Subject|6|||
146909936|NCT00744055|529834118|FG001|Overall Study|Withdrawal by Subject|9|||
146909937|NCT00744055|529834117|FG000|Overall Study|Lack of Efficacy|0|||
146909938|NCT00744055|529834118|FG001|Overall Study|Lack of Efficacy|1|||
146909939|NCT00744055|529834117|FG000|Overall Study|Physician Decision|0|||
146909940|NCT00744055|529834118|FG001|Overall Study|Physician Decision|2|||
146909941|NCT00744055|529834117|FG000|Overall Study|Protocol Violation|1|||
146909942|NCT00744055|529834118|FG001|Overall Study|Protocol Violation|1|||
146909943|NCT00744055|529834117|FG000|Overall Study|Lost to Follow-up|0|||
146768590|NCT01194154|529321737|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
146768591|NCT01194154|529321736|FG000|Overall Study|Treatment with prohibited medication|4|||
146909944|NCT00744055|529834118|FG001|Overall Study|Lost to Follow-up|1|||
146909945|NCT03635190|529834119|FG000|Overall Study|Lost to Follow-up|4|||
146768592|NCT01194154|529321737|FG001|Overall Study|Treatment with prohibited medication|5|||
146909946|NCT03635190|529834119|FG000|Overall Study|Death|3|||
146768593|NCT01194154|529321736|FG000|Overall Study|Other|4|||
146768594|NCT01194154|529321737|FG001|Overall Study|Other|0|||
146768595|NCT01194154|529321736|FG000|Overall Study|Did not receive study medication|2|||
146909947|NCT03635190|529834119|FG000|Overall Study|Withdrawal by Subject|1|||
146642618|NCT02551991|528869584|FG003|Overall Study|Withdrawal by Subject|0|||
146642619|NCT02551991|528869585|FG004|Overall Study|Withdrawal by Subject|2|||
146642620|NCT02551991|528869581|FG000|Overall Study|Lost to Follow-up|0|||
146642621|NCT02551991|528869582|FG001|Overall Study|Lost to Follow-up|0|||
146642622|NCT02551991|528869583|FG002|Overall Study|Lost to Follow-up|1|||
146642623|NCT02551991|528869584|FG003|Overall Study|Lost to Follow-up|0|||
146642624|NCT02551991|528869585|FG004|Overall Study|Lost to Follow-up|0|||
146642625|NCT02551991|528869581|FG000|Overall Study|Sponsor Decision|1|||
146642626|NCT02551991|528869582|FG001|Overall Study|Sponsor Decision|0|||
146642627|NCT02551991|528869583|FG002|Overall Study|Sponsor Decision|1|||
146642628|NCT02551991|528869584|FG003|Overall Study|Sponsor Decision|0|||
146642629|NCT02551991|528869585|FG004|Overall Study|Sponsor Decision|5|||
146642630|NCT02551991|528869581|FG000|Overall Study|Other|0|||
146642631|NCT02551991|528869582|FG001|Overall Study|Other|0|||
146642632|NCT02551991|528869583|FG002|Overall Study|Other|0|||
146642633|NCT02551991|528869584|FG003|Overall Study|Other|0|||
146642634|NCT02551991|528869585|FG004|Overall Study|Other|1|||
146642635|NCT00395343|528869586|FG000|Overall Study|Adverse Event|13|||
146642636|NCT00395343|528869587|FG001|Overall Study|Adverse Event|5|||
146642637|NCT00395343|528869586|FG000|Overall Study|Lack of Efficacy|0|||
146642638|NCT00395343|528869587|FG001|Overall Study|Lack of Efficacy|1|||
146642639|NCT00395343|528869586|FG000|Overall Study|Lost to Follow-up|4|||
146642640|NCT00395343|528869587|FG001|Overall Study|Lost to Follow-up|4|||
146909948|NCT03635190|529834119|FG000|Overall Study|Patient moved and did not return for follow up|1|||
146909949|NCT01306058|529834122|FG000|Overall Study|Death|1|||
146909950|NCT01306058|529834122|FG000|Overall Study|Enrolled but did not get treatment|1|||
146909951|NCT00224107|529834123|FG000|Overall Study|Adverse Event|20|||
146909952|NCT00224107|529834124|FG001|Overall Study|Adverse Event|6|||
146909953|NCT00224107|529834123|FG000|Overall Study|Protocol Violation|2|||
146909954|NCT00224107|529834124|FG001|Overall Study|Protocol Violation|3|||
146909955|NCT00224107|529834123|FG000|Overall Study|Withdrawal by Subject|1|||
146909956|NCT00224107|529834124|FG001|Overall Study|Withdrawal by Subject|4|||
146909957|NCT00224107|529834123|FG000|Overall Study|Lack of Efficacy|2|||
146909958|NCT00224107|529834124|FG001|Overall Study|Lack of Efficacy|0|||
146909959|NCT00224107|529834123|FG000|Overall Study|Lost to Follow-up|4|||
146909960|NCT00224107|529834124|FG001|Overall Study|Lost to Follow-up|0|||
146563858|NCT03189719|528576241|FG000|Overall Study|Physician Decision|1|||
146563859|NCT03189719|528576242|FG001|Overall Study|Physician Decision|0|||
146563860|NCT03189719|528576241|FG000|Overall Study|Sponsor Decision|40|||
146563861|NCT03189719|528576242|FG001|Overall Study|Sponsor Decision|12|||
146563862|NCT03189719|528576241|FG000|Overall Study|Withdrawal by Subject|7|||
146563863|NCT03189719|528576242|FG001|Overall Study|Withdrawal by Subject|3|||
146563864|NCT02769481|528576245|FG000|Overall Study|Protocol Violation|1|||
146563865|NCT02769481|528576246|FG001|Overall Study|Protocol Violation|0|||
146563866|NCT02769481|528576245|FG000|Overall Study|Adverse Event|3|||
146563867|NCT02769481|528576246|FG001|Overall Study|Adverse Event|6|||
146563868|NCT02769481|528576245|FG000|Overall Study|Entry Criteria Not Met|1|||
146563869|NCT02769481|528576246|FG001|Overall Study|Entry Criteria Not Met|2|||
146563870|NCT02769481|528576245|FG000|Overall Study|Withdrawal by Subject|14|||
146642641|NCT00395343|528869586|FG000|Overall Study|Physician Decision|2|||
146642642|NCT00395343|528869587|FG001|Overall Study|Physician Decision|4|||
146642643|NCT00395343|528869586|FG000|Overall Study|Protocol Violation|6|||
146642644|NCT00395343|528869587|FG001|Overall Study|Protocol Violation|8|||
146642645|NCT00395343|528869586|FG000|Overall Study|Withdrawal by Subject|11|||
146642646|NCT00395343|528869587|FG001|Overall Study|Withdrawal by Subject|12|||
146642647|NCT00395343|528869586|FG000|Overall Study|Other|5|||
146642648|NCT00395343|528869587|FG001|Overall Study|Other|2|||
146642649|NCT00387790|528869590|FG000|Overall Study|Adverse Event|5|||
146642650|NCT00387790|528869590|FG000|Overall Study|Lack of Efficacy|2|||
146642651|NCT00387790|528869590|FG000|Overall Study|Physician Decision|2|||
146642652|NCT00387790|528869590|FG000|Overall Study|Withdrawal by Subject|3|||
146642653|NCT00387790|528869590|FG000|Overall Study|Ineligible for study|2|||
146642654|NCT01874340|528869591|FG000|Overall Study|Study terminated by Sponsor|6|||
146642655|NCT01874340|528869592|FG001|Overall Study|Study terminated by Sponsor|8|||
146642656|NCT01874340|528869593|FG002|Overall Study|Study terminated by Sponsor|8|||
146642657|NCT01874340|528869594|FG003|Overall Study|Study terminated by Sponsor|4|||
146642658|NCT01874340|528869591|FG000|Overall Study|Withdrawal by Subject|0|||
146642659|NCT01874340|528869592|FG001|Overall Study|Withdrawal by Subject|0|||
146642660|NCT01874340|528869593|FG002|Overall Study|Withdrawal by Subject|0|||
146642661|NCT01874340|528869594|FG003|Overall Study|Withdrawal by Subject|1|||
146642662|NCT03539549|528869595|FG000|Overall Study|Adverse Event|12|||
146642663|NCT03539549|528869595|FG000|Overall Study|Lost to Follow-up|1|||
146642664|NCT03539549|528869595|FG000|Overall Study|Death|2|||
146909961|NCT00224107|529834123|FG000|Overall Study|Physician Decision|1|||
146909962|NCT00224107|529834124|FG001|Overall Study|Physician Decision|0|||
146909963|NCT00224107|529834123|FG000|Overall Study|Other|1|||
146909964|NCT00224107|529834124|FG001|Overall Study|Other|1|||
146909965|NCT03842709|529834125|FG000|Overall Study|Withdrawal by Subject|3|||
146909966|NCT03842709|529834126|FG001|Overall Study|Withdrawal by Subject|3|||
146909967|NCT03842709|529834125|FG000|Overall Study|Lost to Follow-up|1|||
146909968|NCT03842709|529834126|FG001|Overall Study|Lost to Follow-up|0|||
146563871|NCT02769481|528576246|FG001|Overall Study|Withdrawal by Subject|16|||
146563872|NCT02769481|528576245|FG000|Overall Study|Lost to Follow-up|9|||
146563873|NCT02769481|528576246|FG001|Overall Study|Lost to Follow-up|9|||
146563874|NCT02769481|528576245|FG000|Overall Study|Physician Decision|0|||
146909969|NCT00984659|529834127|FG000|2-week Run-in Period|Adverse Event|8|||
146909970|NCT00984659|529834128|FG001|2-week Run-in Period|Adverse Event|0|||
146909971|NCT00984659|529834129|FG002|2-week Run-in Period|Adverse Event|0|||
146563875|NCT02769481|528576246|FG001|Overall Study|Physician Decision|1|||
146563876|NCT02769481|528576245|FG000|Overall Study|Terminated by Sponsor|1|||
146563877|NCT02769481|528576246|FG001|Overall Study|Terminated by Sponsor|0|||
146642665|NCT03539549|528869595|FG000|Overall Study|Progressive Disease|1|||
146642666|NCT03539549|528869595|FG000|Overall Study|Reason not Specified|1|||
146909972|NCT00984659|529834130|FG003|2-week Run-in Period|Adverse Event|0|||
146909973|NCT00984659|529834127|FG000|2-week Run-in Period|Protocol Violation|5|||
146909974|NCT00984659|529834128|FG001|2-week Run-in Period|Protocol Violation|0|||
146909975|NCT00984659|529834129|FG002|2-week Run-in Period|Protocol Violation|0|||
146909976|NCT00984659|529834130|FG003|2-week Run-in Period|Protocol Violation|0|||
146909977|NCT00984659|529834127|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
146909978|NCT00984659|529834128|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
146909979|NCT00984659|529834129|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
146909980|NCT00984659|529834130|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
146909981|NCT00984659|529834127|FG000|2-week Run-in Period|Lost to Follow-up|3|||
146909982|NCT00984659|529834128|FG001|2-week Run-in Period|Lost to Follow-up|0|||
146909983|NCT00984659|529834129|FG002|2-week Run-in Period|Lost to Follow-up|0|||
146909984|NCT00984659|529834130|FG003|2-week Run-in Period|Lost to Follow-up|0|||
146909985|NCT00984659|529834127|FG000|2-week Run-in Period|Physician Decision|10|||
146909986|NCT00984659|529834128|FG001|2-week Run-in Period|Physician Decision|0|||
146909987|NCT00984659|529834129|FG002|2-week Run-in Period|Physician Decision|0|||
146909988|NCT00984659|529834130|FG003|2-week Run-in Period|Physician Decision|0|||
146909989|NCT00984659|529834127|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
146909990|NCT00984659|529834128|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
146909991|NCT00984659|529834129|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
146909992|NCT00984659|529834130|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
146909993|NCT00984659|529834127|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
146909994|NCT00984659|529834128|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
146909995|NCT00984659|529834129|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
146909996|NCT00984659|529834130|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
146909997|NCT00984659|529834127|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
146909998|NCT00984659|529834128|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
146909999|NCT00984659|529834129|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
146910000|NCT00984659|529834130|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
146910001|NCT00984659|529834127|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
146563878|NCT02769481|528576245|FG000|Overall Study|Death|0|||
146910002|NCT00984659|529834128|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
146910003|NCT00984659|529834129|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
146910004|NCT00984659|529834130|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
146563879|NCT02769481|528576246|FG001|Overall Study|Death|1|||
146910005|NCT00984659|529834127|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
146910006|NCT00984659|529834128|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
146910007|NCT00984659|529834129|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
146910008|NCT00984659|529834130|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
146910009|NCT00984659|529834127|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
146910010|NCT00984659|529834128|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
146910011|NCT00984659|529834129|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
146910012|NCT00984659|529834130|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
146910013|NCT00984659|529834127|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
146910014|NCT00984659|529834128|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
146910015|NCT00984659|529834129|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
146910016|NCT00984659|529834130|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
146910017|NCT02424149|529834132|FG000|Overall Study|surgery cancelled|2|||
146910018|NCT02424149|529834133|FG001|Overall Study|surgery cancelled|0|||
146910019|NCT02424149|529834132|FG000|Overall Study|Withdrawal by Subject|0|||
146910020|NCT02424149|529834133|FG001|Overall Study|Withdrawal by Subject|1|||
146910021|NCT03472534|529834137|FG000|Overall Study|Withdrawal by Subject|9|||
146910022|NCT03472534|529834137|FG000|Overall Study|Adverse Event|2|||
146910023|NCT02614794|529834138|FG000|Overall Study|Death|258|||
146910024|NCT02614794|529834139|FG001|Overall Study|Death|151|||
146910025|NCT02614794|529834138|FG000|Overall Study|Study closure by Sponsor|119|||
146910026|NCT02614794|529834139|FG001|Overall Study|Study closure by Sponsor|45|||
146910027|NCT02614794|529834138|FG000|Overall Study|Withdrawal by Subject|24|||
146910028|NCT02614794|529834139|FG001|Overall Study|Withdrawal by Subject|5|||
146910029|NCT02614794|529834138|FG000|Overall Study|Lost to Follow-up|7|||
146910030|NCT02614794|529834139|FG001|Overall Study|Lost to Follow-up|0|||
146910031|NCT02614794|529834138|FG000|Overall Study|Physician Decision|1|||
146910032|NCT02614794|529834139|FG001|Overall Study|Physician Decision|1|||
146910033|NCT02614794|529834138|FG000|Overall Study|Hospital closure|1|||
146910034|NCT02614794|529834139|FG001|Overall Study|Hospital closure|0|||
146910035|NCT03396471|529834144|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
146910036|NCT03396471|529834144|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
146910037|NCT03396471|529834144|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
146910038|NCT03396471|529834144|FG000|Study Treatment - Up to 22 Months|Death|2|||
146910039|NCT03396471|529834144|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
146910040|NCT03396471|529834144|FG000|Follow up - Up to 2 Years|Death|9|||
146910041|NCT03396471|529834144|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
146910042|NCT03396471|529834144|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
146910043|NCT03396471|529834144|FG000|Follow up - Up to 2 Years|study terminated|1|||
146910044|NCT03396471|529834144|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
146910045|NCT03396471|529834144|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
146910046|NCT01319929|529834148|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
146910047|NCT01319929|529834149|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
146910048|NCT01319929|529834148|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
146910049|NCT01319929|529834149|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
146910050|NCT01319929|529834148|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
146910051|NCT01319929|529834149|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
146910052|NCT01319929|529834148|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
146910053|NCT01319929|529834149|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
146910054|NCT01319929|529834148|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
146910055|NCT01319929|529834149|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
146910056|NCT03237845|529834150|FG000|Overall Study|Adverse Event|0|||
146910057|NCT03237845|529834151|FG001|Overall Study|Adverse Event|1|||
146910058|NCT03237845|529834150|FG000|Overall Study|Lost to Follow-up|13|||
146910059|NCT03237845|529834151|FG001|Overall Study|Lost to Follow-up|10|||
146910060|NCT03237845|529834150|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
146910061|NCT03237845|529834151|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
146910062|NCT03237845|529834150|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
146910063|NCT03237845|529834151|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
146910064|NCT03237845|529834150|FG000|Overall Study|Physician Decision|1|||
146910065|NCT03237845|529834151|FG001|Overall Study|Physician Decision|2|||
146509183|NCT00435487|528367760|FG000|Overall Study|Death|3|||
146910066|NCT03237845|529834150|FG000|Overall Study|Pregnancy|1|||
146910067|NCT03237845|529834151|FG001|Overall Study|Pregnancy|0|||
146910068|NCT03237845|529834150|FG000|Overall Study|Protocol Deviation|0|||
146910069|NCT03237845|529834151|FG001|Overall Study|Protocol Deviation|1|||
146910070|NCT03237845|529834150|FG000|Overall Study|Technical Problems|8|||
146910071|NCT03237845|529834151|FG001|Overall Study|Technical Problems|1|||
146910072|NCT03237845|529834150|FG000|Overall Study|Withdrawal by Subject|3|||
146910073|NCT03237845|529834151|FG001|Overall Study|Withdrawal by Subject|3|||
146910074|NCT03237845|529834150|FG000|Overall Study|Other Reasons|4|||
146910075|NCT03237845|529834151|FG001|Overall Study|Other Reasons|0|||
146910076|NCT03865407|529834153|FG000|Overall Study|Adverse Event|1|||
146910077|NCT03865407|529834154|FG001|Overall Study|Adverse Event|0|||
146910078|NCT03865407|529834153|FG000|Overall Study|Withdrawal by Subject|1|||
146910079|NCT03865407|529834154|FG001|Overall Study|Withdrawal by Subject|0|||
146910080|NCT03865407|529834153|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
146910081|NCT03865407|529834154|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
146910082|NCT00883753|529834155|FG000|Overall Study|Adverse Event|37|||
146910083|NCT00883753|529834155|FG000|Overall Study|Death|2|||
146910084|NCT00883753|529834155|FG000|Overall Study|Insufficient therapeutic response|16|||
146910085|NCT00883753|529834155|FG000|Overall Study|Lost to Follow-up|4|||
146910086|NCT00883753|529834155|FG000|Overall Study|Violation of selection criteria at entry|7|||
146910087|NCT00883753|529834155|FG000|Overall Study|Protocol Violation|2|||
146910088|NCT00883753|529834155|FG000|Overall Study|Refused treatment|4|||
146910089|NCT00883753|529834155|FG000|Overall Study|Withdrew consent|10|||
146910090|NCT00883753|529834155|FG000|Overall Study|Investigator's decision|17|||
146910091|NCT00883753|529834155|FG000|Overall Study|Administrative/Other|8|||
146910092|NCT02859415|529834156|FG000|Overall Study|Physician Decision|1|||
146910093|NCT02859415|529834157|FG001|Overall Study|Physician Decision|0|||
146910094|NCT02859415|529834156|FG000|Overall Study|Off treatment due to cardiac event|0|||
146910095|NCT02859415|529834157|FG001|Overall Study|Off treatment due to cardiac event|1|||
146910096|NCT02168946|529834160|FG000|Overall Study|Adverse Event|8|||
146910097|NCT02168946|529834161|FG001|Overall Study|Adverse Event|5|||
146910098|NCT02168946|529834160|FG000|Overall Study|Lost to Follow-up|3|||
146910099|NCT02168946|529834161|FG001|Overall Study|Lost to Follow-up|0|||
146910100|NCT02168946|529834160|FG000|Overall Study|Subject unable to come back for visits|1|||
146910101|NCT02168946|529834161|FG001|Overall Study|Subject unable to come back for visits|0|||
146910102|NCT00138151|529834163|FG000|Overall Study|Withdrawal by Subject|3|||
146910103|NCT00138151|529834163|FG000|Overall Study|Physician Decision|1|||
146910104|NCT02675517|529834166|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
146910105|NCT02675517|529834166|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
146910106|NCT00301067|529834169|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
146910107|NCT00301067|529834170|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
146910108|NCT00301067|529834171|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
146910109|NCT00301067|529834172|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
146910110|NCT00301067|529834169|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
146910111|NCT00301067|529834170|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
146910112|NCT00301067|529834171|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
146910113|NCT00301067|529834172|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
146910114|NCT00301067|529834169|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
146910115|NCT00301067|529834170|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
146910116|NCT00301067|529834171|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
146910117|NCT00301067|529834172|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
146910118|NCT00301067|529834169|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
146970539|NCT03611751|530052679|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
146970540|NCT03611751|530052677|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
146970541|NCT03611751|530052678|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
146970542|NCT03611751|530052679|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
146970543|NCT03611751|530052677|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
146970544|NCT03611751|530052678|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
146970545|NCT03611751|530052679|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
146970546|NCT03611751|530052677|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
146970547|NCT03611751|530052678|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
146970548|NCT03611751|530052679|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
146970549|NCT03611751|530052677|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
146970550|NCT03611751|530052678|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
146970551|NCT03611751|530052679|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
146970552|NCT03611751|530052677|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
146970553|NCT03611751|530052678|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
146970554|NCT03611751|530052679|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
146970555|NCT03611751|530052677|FG000|Treatment Week 0 - Week 16|Death|0|||
146970556|NCT03611751|530052678|FG001|Treatment Week 0 - Week 16|Death|0|||
146970557|NCT03611751|530052679|FG002|Treatment Week 0 - Week 16|Death|1|||
146970558|NCT03611751|530052677|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
146970559|NCT03611751|530052678|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
146970560|NCT03611751|530052679|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
146970561|NCT03611751|530052677|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
146970562|NCT03611751|530052678|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
146970563|NCT03611751|530052679|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
146970564|NCT03611751|530052677|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
146970565|NCT03611751|530052678|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
146970566|NCT03611751|530052679|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
146970567|NCT03611751|530052677|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
146970568|NCT03611751|530052678|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
146970569|NCT03611751|530052679|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
146970570|NCT03611751|530052677|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
146970571|NCT03611751|530052678|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
146970572|NCT03611751|530052679|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
146970573|NCT03611751|530052677|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
146970574|NCT03611751|530052678|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
146970575|NCT03611751|530052679|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
146970576|NCT03611751|530052677|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
146970577|NCT03611751|530052678|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
146970578|NCT03611751|530052679|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
146970579|NCT03611751|530052677|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
146970580|NCT03611751|530052678|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
146970581|NCT03611751|530052679|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
146970582|NCT03611751|530052677|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
146970583|NCT03611751|530052678|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
146970584|NCT03611751|530052679|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
146970585|NCT03611751|530052677|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
146768596|NCT01194154|529321737|FG001|Overall Study|Did not receive study medication|4|||
146768597|NCT01505881|529321738|FG000|Overall Study|Adverse Event|0|||
146970586|NCT03611751|530052678|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
146768598|NCT01505881|529321739|FG001|Overall Study|Adverse Event|1|||
146970587|NCT03611751|530052679|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
146970588|NCT03611751|530052677|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
146970589|NCT03611751|530052678|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
146970590|NCT03611751|530052679|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
146970591|NCT03611751|530052677|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
146970592|NCT03611751|530052678|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
146970593|NCT03611751|530052679|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
146970594|NCT03611751|530052677|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
146970595|NCT03611751|530052678|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
146970596|NCT03611751|530052679|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
146970597|NCT03611751|530052677|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
146970598|NCT03611751|530052678|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
146970599|NCT03611751|530052679|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
146970600|NCT00929864|530052680|FG000|Overall Study|Death|1|||
146970601|NCT00929864|530052681|FG001|Overall Study|Death|1|||
146970602|NCT00929864|530052680|FG000|Overall Study|Adverse Event|11|||
146970603|NCT00929864|530052681|FG001|Overall Study|Adverse Event|30|||
146768599|NCT01505881|529321738|FG000|Overall Study|Lost to Follow-up|2|||
146970604|NCT00929864|530052680|FG000|Overall Study|Lack of Efficacy|19|||
146970605|NCT00929864|530052681|FG001|Overall Study|Lack of Efficacy|16|||
146970606|NCT00929864|530052680|FG000|Overall Study|Lost to Follow-up|7|||
146768600|NCT01505881|529321739|FG001|Overall Study|Lost to Follow-up|0|||
146970607|NCT00929864|530052681|FG001|Overall Study|Lost to Follow-up|12|||
146970608|NCT00929864|530052680|FG000|Overall Study|Withdrawal by Subject|20|||
146970609|NCT00929864|530052681|FG001|Overall Study|Withdrawal by Subject|9|||
146970610|NCT00929864|530052680|FG000|Overall Study|No longer met criteria|2|||
146970611|NCT00929864|530052681|FG001|Overall Study|No longer met criteria|1|||
146970612|NCT00929864|530052680|FG000|Overall Study|Poor or non-compliance|3|||
146970613|NCT00929864|530052681|FG001|Overall Study|Poor or non-compliance|3|||
146970614|NCT00929864|530052680|FG000|Overall Study|Pregnancy|0|||
146970615|NCT00929864|530052681|FG001|Overall Study|Pregnancy|3|||
146970616|NCT00929864|530052680|FG000|Overall Study|Administrative reason by Sponsor|1|||
146970617|NCT00929864|530052681|FG001|Overall Study|Administrative reason by Sponsor|1|||
146970618|NCT00929864|530052680|FG000|Overall Study|Non-specified|2|||
146970619|NCT00929864|530052681|FG001|Overall Study|Non-specified|7|||
146970620|NCT02666768|530052682|FG000|Overall Study|Withdrawal by Subject|4|||
146910119|NCT00301067|529834170|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
146910120|NCT00301067|529834171|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
146910121|NCT00301067|529834172|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
146910122|NCT00301067|529834169|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
146910123|NCT00301067|529834170|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
146910124|NCT00301067|529834171|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
146910125|NCT00301067|529834172|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
146910126|NCT00301067|529834169|FG000|Follow up Until Death|Alive at last data cut point|1|||
146910127|NCT00301067|529834170|FG001|Follow up Until Death|Alive at last data cut point|0|||
146910128|NCT00301067|529834171|FG002|Follow up Until Death|Alive at last data cut point|0|||
146910129|NCT00301067|529834172|FG003|Follow up Until Death|Alive at last data cut point|1|||
146910130|NCT00149825|529834173|FG000|Overall Study|Intolerance to medication side effects|1|||
146910131|NCT00149825|529834174|FG001|Overall Study|Intolerance to medication side effects|2|||
146970621|NCT01023022|530052683|FG000|Overall Study|Death|5|||
146970622|NCT01023022|530052683|FG000|Overall Study|Lost to Follow-up|7|||
146970623|NCT01023022|530052683|FG000|Overall Study|due to technical issues|2|||
146970624|NCT03728257|530052684|FG000|Overall Study|Death|3|||
146970625|NCT03728257|530052685|FG001|Overall Study|Death|0|||
146970626|NCT00621309|530052688|FG000|Overall Study|Withdrawal by Subject|2|||
146970627|NCT00621309|530052689|FG001|Overall Study|Withdrawal by Subject|0|||
146970628|NCT00621309|530052690|FG002|Overall Study|Withdrawal by Subject|1|||
146970629|NCT00621309|530052691|FG003|Overall Study|Withdrawal by Subject|1|||
146970630|NCT00621309|530052692|FG004|Overall Study|Withdrawal by Subject|1|||
146970631|NCT00621309|530052693|FG005|Overall Study|Withdrawal by Subject|1|||
146970632|NCT01306968|530052696|FG000|Overall Study|Lost to Follow-up|1|||
146970633|NCT01306968|530052697|FG001|Overall Study|Lost to Follow-up|1|||
146970634|NCT01306968|530052698|FG002|Overall Study|Lost to Follow-up|0|||
146970635|NCT01306968|530052699|FG003|Overall Study|Lost to Follow-up|0|||
146970636|NCT01306968|530052696|FG000|Overall Study|Physician Decision|0|||
146970637|NCT01306968|530052697|FG001|Overall Study|Physician Decision|1|||
146970638|NCT01306968|530052698|FG002|Overall Study|Physician Decision|0|||
146970639|NCT01306968|530052699|FG003|Overall Study|Physician Decision|0|||
146970640|NCT01306968|530052696|FG000|Overall Study|Relocated and left active duty|0|||
146970641|NCT01306968|530052697|FG001|Overall Study|Relocated and left active duty|1|||
146970642|NCT01306968|530052698|FG002|Overall Study|Relocated and left active duty|1|||
146970643|NCT01306968|530052699|FG003|Overall Study|Relocated and left active duty|1|||
146970644|NCT01306968|530052696|FG000|Overall Study|Withdrew - time commitment|0|||
146970645|NCT01306968|530052697|FG001|Overall Study|Withdrew - time commitment|0|||
146970646|NCT01306968|530052698|FG002|Overall Study|Withdrew - time commitment|0|||
146970647|NCT01306968|530052699|FG003|Overall Study|Withdrew - time commitment|2|||
146970648|NCT01306968|530052696|FG000|Overall Study|Withdrew over privacy concerns|0|||
146970649|NCT01306968|530052697|FG001|Overall Study|Withdrew over privacy concerns|0|||
146970650|NCT01306968|530052698|FG002|Overall Study|Withdrew over privacy concerns|0|||
146970651|NCT01306968|530052699|FG003|Overall Study|Withdrew over privacy concerns|1|||
146970652|NCT01329562|530052700|FG000|Overall Study|Protocol Violation|5|||
146970653|NCT01329562|530052701|FG001|Overall Study|Protocol Violation|3|||
146970654|NCT01329562|530052700|FG000|Overall Study|Lost to Follow-up|1|||
146970655|NCT01329562|530052701|FG001|Overall Study|Lost to Follow-up|1|||
146970656|NCT01329562|530052700|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
146970657|NCT01329562|530052701|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
146970658|NCT01329562|530052700|FG000|Overall Study|Physician Decision|0|||
146970659|NCT01329562|530052701|FG001|Overall Study|Physician Decision|1|||
146970660|NCT00061568|530052702|FG000|Overall Study|Lost to Follow-up|12|||
146970661|NCT00061568|530052703|FG001|Overall Study|Lost to Follow-up|0|||
146970662|NCT00061568|530052702|FG000|Overall Study|Death|6|||
146970663|NCT00061568|530052703|FG001|Overall Study|Death|0|||
146970664|NCT00061568|530052702|FG000|Overall Study|Withdrawal by Subject|1|||
146970665|NCT00061568|530052703|FG001|Overall Study|Withdrawal by Subject|0|||
146970666|NCT01381068|530052704|FG000|Overall Study|Death|1|||
146970667|NCT01381068|530052705|FG001|Overall Study|Death|0|||
146970668|NCT00797316|530052706|FG000|Overall Study|Administrative problems|1|||
146768601|NCT01505881|529321738|FG000|Overall Study|Withdrawal by Subject|2|||
146768602|NCT01505881|529321739|FG001|Overall Study|Withdrawal by Subject|0|||
146910132|NCT00149825|529834173|FG000|Overall Study|Time commitments|2|||
146910133|NCT00149825|529834174|FG001|Overall Study|Time commitments|1|||
146910134|NCT00149825|529834173|FG000|Overall Study|Not liking insomnia therapy|1|||
146910135|NCT00149825|529834174|FG001|Overall Study|Not liking insomnia therapy|0|||
146910136|NCT00149825|529834173|FG000|Overall Study|Other|1|||
146910137|NCT00149825|529834174|FG001|Overall Study|Other|0|||
146910138|NCT00069121|529834175|FG000|Overall Study|Death|286|||
146910139|NCT00069121|529834176|FG001|Overall Study|Death|242|||
146910140|NCT00069121|529834175|FG000|Overall Study|Withdrawal by Subject|18|||
146910141|NCT00069121|529834176|FG001|Overall Study|Withdrawal by Subject|20|||
146910142|NCT00069121|529834175|FG000|Overall Study|Lost to Follow-up|63|||
146910143|NCT00069121|529834176|FG001|Overall Study|Lost to Follow-up|63|||
146910144|NCT00942708|529834177|FG000|Overall Study|Withdrawal by Subject|1|||
146910145|NCT00995371|529834178|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
146910146|NCT00995371|529834179|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
146910147|NCT00673673|529834180|FG000|Overall Study|Progressive disease|27|||
146910148|NCT00673673|529834180|FG000|Overall Study|Adverse Event|4|||
146910149|NCT00673673|529834180|FG000|Overall Study|Withdrawal by Subject|3|||
146910150|NCT00673673|529834180|FG000|Overall Study|Investigators' discretion|2|||
146910151|NCT03851510|529834181|FG000|Overall Study|Screen Fail|1|||
146910152|NCT03851510|529834181|FG000|Overall Study|Adverse Event|1|||
146910153|NCT03851510|529834181|FG000|Overall Study|Withdrawal by Subject|1|||
146910154|NCT02613572|529834182|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
146910155|NCT02613572|529834183|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
146910156|NCT02613572|529834184|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
146910157|NCT02613572|529834182|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
146910158|NCT02613572|529834183|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
146910159|NCT02613572|529834184|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
146910160|NCT00970294|529834190|FG000|Overall Study|Physician Decision|4|||
146910161|NCT00970294|529834190|FG000|Overall Study|Withdrawal by Subject|1|||
146910162|NCT00393458|529834193|FG000|Overall Study|Adverse Event|35|||
146910163|NCT00393458|529834194|FG001|Overall Study|Adverse Event|24|||
146910164|NCT00393458|529834195|FG002|Overall Study|Adverse Event|40|||
146910165|NCT00393458|529834196|FG003|Overall Study|Adverse Event|35|||
146910166|NCT00393458|529834193|FG000|Overall Study|Subject withdrew consent|27|||
146910167|NCT00393458|529834194|FG001|Overall Study|Subject withdrew consent|40|||
146910168|NCT00393458|529834195|FG002|Overall Study|Subject withdrew consent|33|||
146910169|NCT00393458|529834196|FG003|Overall Study|Subject withdrew consent|50|||
146910170|NCT00393458|529834193|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
146910171|NCT00393458|529834194|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
146910172|NCT00393458|529834195|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
146910173|NCT00393458|529834196|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
146910174|NCT00393458|529834193|FG000|Overall Study|Protocol deviation|11|||
146910175|NCT00393458|529834194|FG001|Overall Study|Protocol deviation|11|||
146910176|NCT00393458|529834195|FG002|Overall Study|Protocol deviation|11|||
146910177|NCT00393458|529834196|FG003|Overall Study|Protocol deviation|10|||
146910178|NCT00393458|529834193|FG000|Overall Study|Administrative problems|7|||
146910179|NCT00393458|529834194|FG001|Overall Study|Administrative problems|8|||
146910180|NCT00393458|529834195|FG002|Overall Study|Administrative problems|5|||
146910181|NCT00393458|529834196|FG003|Overall Study|Administrative problems|2|||
146910182|NCT00393458|529834193|FG000|Overall Study|Lost to Follow-up|5|||
146910183|NCT00393458|529834194|FG001|Overall Study|Lost to Follow-up|6|||
146910184|NCT00393458|529834195|FG002|Overall Study|Lost to Follow-up|5|||
146910185|NCT00393458|529834196|FG003|Overall Study|Lost to Follow-up|3|||
146910186|NCT00393458|529834193|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146910187|NCT00393458|529834194|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146910188|NCT00393458|529834195|FG002|Overall Study|Abnormal laboratory value(s)|0|||
146768603|NCT01596504|529321740|FG000|Overall Study|Participant's Private Reason|0|||
146910189|NCT00393458|529834196|FG003|Overall Study|Abnormal laboratory value(s)|0|||
146910190|NCT00393458|529834193|FG000|Overall Study|Death|1|||
146910191|NCT00393458|529834194|FG001|Overall Study|Death|1|||
146642667|NCT02864862|528869597|FG000|Overall Study|Lost to Follow-up|1|||
146910192|NCT00393458|529834195|FG002|Overall Study|Death|5|||
146910193|NCT00393458|529834196|FG003|Overall Study|Death|5|||
146910194|NCT00393458|529834193|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146910195|NCT00393458|529834194|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146910196|NCT00393458|529834195|FG002|Overall Study|Abnormal test procedure result(s)|1|||
146910197|NCT00393458|529834196|FG003|Overall Study|Abnormal test procedure result(s)|2|||
146910198|NCT00393458|529834193|FG000|Overall Study|Subject no longer requires study drug|0|||
146910199|NCT00393458|529834194|FG001|Overall Study|Subject no longer requires study drug|1|||
146910200|NCT00393458|529834195|FG002|Overall Study|Subject no longer requires study drug|0|||
146910201|NCT00393458|529834196|FG003|Overall Study|Subject no longer requires study drug|0|||
146910202|NCT01326962|529834198|FG000|Overall Study|Adverse Event|1|||
146910203|NCT01326962|529834198|FG000|Overall Study|Withdrawal by Subject|1|||
146910204|NCT01326962|529834198|FG000|Overall Study|Lost to Follow-up|3|||
146910205|NCT01326962|529834198|FG000|Overall Study|Other|2|||
146910206|NCT00035815|529834199|FG000|Overall Study|Withdrawal by Subject|17|||
146910207|NCT00035815|529834200|FG001|Overall Study|Withdrawal by Subject|11|||
146910208|NCT02369510|529834203|FG000|Overall Study|Spilled Medication|1|||
146910209|NCT02369510|529834204|FG001|Overall Study|Spilled Medication|2|||
146910210|NCT02369510|529834205|FG002|Overall Study|Spilled Medication|1|||
146910211|NCT02369510|529834203|FG000|Overall Study|Epidural Activation|1|||
146910212|NCT02369510|529834204|FG001|Overall Study|Epidural Activation|1|||
146910213|NCT02369510|529834205|FG002|Overall Study|Epidural Activation|5|||
146910214|NCT04285723|529834212|FG000|Overall Study|Subject decision|1|||
146910215|NCT04285723|529834213|FG001|Overall Study|Subject decision|2|||
146910216|NCT04285723|529834212|FG000|Overall Study|Physician Decision|1|||
146910217|NCT04285723|529834213|FG001|Overall Study|Physician Decision|0|||
146910218|NCT04285723|529834212|FG000|Overall Study|No efficiency|1|||
146910219|NCT04285723|529834213|FG001|Overall Study|No efficiency|0|||
146910220|NCT03067311|529834214|FG000|Overall Study|Lost to Follow-up|1|||
146910221|NCT03067311|529834215|FG001|Overall Study|Lost to Follow-up|1|||
146910222|NCT03067311|529834214|FG000|Overall Study|Moved away|1|||
146910223|NCT03067311|529834215|FG001|Overall Study|Moved away|1|||
146910224|NCT02903511|529834216|FG000|Overall Study|Withdrawal by Subject|1|||
146910225|NCT02903511|529834217|FG001|Overall Study|Withdrawal by Subject|0|||
146910226|NCT02903511|529834216|FG000|Overall Study|Lost to Follow-up|3|||
146910227|NCT02903511|529834217|FG001|Overall Study|Lost to Follow-up|2|||
146910228|NCT01089725|529834221|FG000|Overall Study|Adverse Event|1|||
146910229|NCT01089725|529834222|FG001|Overall Study|Adverse Event|1|||
146910230|NCT01089725|529834223|FG002|Overall Study|Adverse Event|0|||
146910231|NCT01089725|529834224|FG003|Overall Study|Adverse Event|0|||
146910232|NCT01089725|529834225|FG004|Overall Study|Adverse Event|2|||
146910233|NCT01089725|529834221|FG000|Overall Study|Lack of Efficacy|4|||
146910234|NCT01089725|529834222|FG001|Overall Study|Lack of Efficacy|3|||
146910235|NCT01089725|529834223|FG002|Overall Study|Lack of Efficacy|1|||
146910236|NCT01089725|529834224|FG003|Overall Study|Lack of Efficacy|0|||
146910237|NCT01089725|529834225|FG004|Overall Study|Lack of Efficacy|4|||
146910238|NCT01089725|529834221|FG000|Overall Study|Lost to Follow-up|2|||
146910239|NCT01089725|529834222|FG001|Overall Study|Lost to Follow-up|2|||
146910240|NCT01089725|529834223|FG002|Overall Study|Lost to Follow-up|0|||
146910241|NCT01089725|529834224|FG003|Overall Study|Lost to Follow-up|3|||
146910242|NCT01089725|529834225|FG004|Overall Study|Lost to Follow-up|0|||
146910243|NCT01089725|529834221|FG000|Overall Study|Protocol Violation|0|||
146910244|NCT01089725|529834222|FG001|Overall Study|Protocol Violation|0|||
146970669|NCT00797316|530052707|FG001|Overall Study|Administrative problems|0|||
146970670|NCT00797316|530052706|FG000|Overall Study|Adverse Event|5|||
146970671|NCT00797316|530052707|FG001|Overall Study|Adverse Event|3|||
146970672|NCT00797316|530052706|FG000|Overall Study|Lost to Follow-up|4|||
146970673|NCT00797316|530052707|FG001|Overall Study|Lost to Follow-up|8|||
146970674|NCT00797316|530052706|FG000|Overall Study|Protocol Deviation|1|||
146970675|NCT00797316|530052707|FG001|Overall Study|Protocol Deviation|2|||
146970676|NCT00797316|530052706|FG000|Overall Study|Patient withdrew consent|12|||
146970677|NCT00797316|530052707|FG001|Overall Study|Patient withdrew consent|6|||
146970678|NCT00797316|530052706|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146970679|NCT00797316|530052707|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
146970680|NCT03239340|530052714|FG000|Overall Study|Other|26|||
146970681|NCT03239340|530052714|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
146970682|NCT03239340|530052714|FG000|Overall Study|Death|40|||
146970683|NCT03239340|530052714|FG000|Overall Study|Lost to Follow-up|2|||
146970684|NCT03239340|530052714|FG000|Overall Study|Physician Decision|16|||
146970685|NCT03239340|530052714|FG000|Overall Study|Withdrawal by Subject|27|||
146970686|NCT03868059|530052721|FG000|Overall Study|Adverse Event|3|||
146970687|NCT03868059|530052721|FG000|Overall Study|Lost to Follow-up|3|||
146970688|NCT03868059|530052721|FG000|Overall Study|Withdrawal by Subject|6|||
146970689|NCT02061293|530052722|FG000|Overall Study|Elevated Blood Pressure|1|||
146970690|NCT02061293|530052723|FG001|Overall Study|Elevated Blood Pressure|1|||
146970691|NCT03205163|530052724|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
146970692|NCT03205163|530052725|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
146970693|NCT04502862|530052726|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
146970694|NCT04502862|530052727|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
146970695|NCT04502862|530052726|FG000|Overall Study|Withdrawal by Subject|1|||
146642668|NCT02864862|528869598|FG001|Overall Study|Lost to Follow-up|0|||
146642669|NCT02864862|528869599|FG002|Overall Study|Lost to Follow-up|1|||
146910245|NCT01089725|529834223|FG002|Overall Study|Protocol Violation|1|||
146910246|NCT01089725|529834224|FG003|Overall Study|Protocol Violation|1|||
146910247|NCT01089725|529834225|FG004|Overall Study|Protocol Violation|0|||
146910248|NCT01089725|529834221|FG000|Overall Study|Withdrawal by Subject|5|||
146910249|NCT01089725|529834222|FG001|Overall Study|Withdrawal by Subject|5|||
146910250|NCT01089725|529834223|FG002|Overall Study|Withdrawal by Subject|4|||
146910251|NCT01089725|529834224|FG003|Overall Study|Withdrawal by Subject|5|||
146642670|NCT02864862|528869597|FG000|Overall Study|Protocol Violation|0|||
146910252|NCT01089725|529834225|FG004|Overall Study|Withdrawal by Subject|4|||
146910253|NCT01089725|529834221|FG000|Overall Study|Study Terminated by Sponsor|51|||
146910254|NCT01089725|529834222|FG001|Overall Study|Study Terminated by Sponsor|56|||
146910255|NCT01089725|529834223|FG002|Overall Study|Study Terminated by Sponsor|53|||
146910256|NCT01089725|529834224|FG003|Overall Study|Study Terminated by Sponsor|68|||
146970696|NCT04502862|530052727|FG001|Overall Study|Withdrawal by Subject|0|||
146910257|NCT01089725|529834225|FG004|Overall Study|Study Terminated by Sponsor|68|||
146910258|NCT01089725|529834221|FG000|Overall Study|Randomized, but not treated|0|||
146910259|NCT01089725|529834222|FG001|Overall Study|Randomized, but not treated|1|||
146910260|NCT01089725|529834223|FG002|Overall Study|Randomized, but not treated|2|||
146910261|NCT01089725|529834224|FG003|Overall Study|Randomized, but not treated|1|||
146910262|NCT01089725|529834225|FG004|Overall Study|Randomized, but not treated|2|||
146910263|NCT01089725|529834221|FG000|Overall Study|Other|3|||
146910264|NCT01089725|529834222|FG001|Overall Study|Other|0|||
146910265|NCT01089725|529834223|FG002|Overall Study|Other|0|||
146910266|NCT01089725|529834224|FG003|Overall Study|Other|1|||
146910267|NCT01089725|529834225|FG004|Overall Study|Other|0|||
146910268|NCT02452970|529835640|FG000|Overall Study|Adverse Event|1|||
146910269|NCT01266148|529835641|FG000|Overall Study|Adverse Event|2|||
146910270|NCT01266148|529835642|FG001|Overall Study|Adverse Event|0|||
146910271|NCT01266148|529835641|FG000|Overall Study|Ongoing rejection|1|||
146910272|NCT01266148|529835642|FG001|Overall Study|Ongoing rejection|0|||
146910273|NCT01266148|529835641|FG000|Overall Study|2 2R rejections|1|||
146910274|NCT01266148|529835642|FG001|Overall Study|2 2R rejections|0|||
146910275|NCT01266148|529835641|FG000|Overall Study|Death|2|||
146910276|NCT01266148|529835642|FG001|Overall Study|Death|3|||
146910277|NCT01266148|529835641|FG000|Overall Study|missing mGFR value + AE|1|||
146910278|NCT01266148|529835642|FG001|Overall Study|missing mGFR value + AE|0|||
146910279|NCT01269125|529835652|FG000|Overall Study|Adverse Event|3|||
146910280|NCT01269125|529835653|FG001|Overall Study|Adverse Event|5|||
146910281|NCT01269125|529835654|FG002|Overall Study|Adverse Event|0|||
146910282|NCT01269125|529835652|FG000|Overall Study|Lost to Follow-up|4|||
146910283|NCT01269125|529835653|FG001|Overall Study|Lost to Follow-up|0|||
146910284|NCT01269125|529835654|FG002|Overall Study|Lost to Follow-up|0|||
146910285|NCT01040832|529835655|FG000|Overall Study|Adverse Event|4|||
146910286|NCT01040832|529835656|FG001|Overall Study|Adverse Event|5|||
146910287|NCT01040832|529835655|FG000|Overall Study|Death|4|||
146910288|NCT01040832|529835656|FG001|Overall Study|Death|6|||
146910289|NCT01040832|529835655|FG000|Overall Study|Withdrawal by Subject|2|||
146910290|NCT01040832|529835656|FG001|Overall Study|Withdrawal by Subject|3|||
146910291|NCT01040832|529835655|FG000|Overall Study|Progressive disease|32|||
146910292|NCT01040832|529835656|FG001|Overall Study|Progressive disease|17|||
146910293|NCT01040832|529835655|FG000|Overall Study|Symptomatic deterioration|2|||
146910294|NCT01040832|529835656|FG001|Overall Study|Symptomatic deterioration|5|||
146910295|NCT01040832|529835655|FG000|Overall Study|Other|2|||
146910296|NCT01040832|529835656|FG001|Overall Study|Other|1|||
146910297|NCT00417612|529835659|FG000|Overall Study|Errant diagnosis|0|||
146910298|NCT00417612|529835660|FG001|Overall Study|Errant diagnosis|1|||
146910299|NCT00417612|529835659|FG000|Overall Study|Adverse Event|2|||
146910300|NCT00417612|529835660|FG001|Overall Study|Adverse Event|0|||
146910301|NCT00417612|529835659|FG000|Overall Study|Protocol Violation|0|||
146910302|NCT00417612|529835660|FG001|Overall Study|Protocol Violation|2|||
146910303|NCT00417612|529835659|FG000|Overall Study|Lost to Follow-up|1|||
146910304|NCT00417612|529835660|FG001|Overall Study|Lost to Follow-up|0|||
146970697|NCT04502862|530052726|FG000|Overall Study|Adverse Event|1|||
146970698|NCT04502862|530052727|FG001|Overall Study|Adverse Event|1|||
146970699|NCT03284424|530054307|FG000|Overall Study|Death|70|||
146970700|NCT03284424|530054308|FG001|Overall Study|Death|24|||
146970701|NCT03284424|530054307|FG000|Overall Study|Lost to Follow-up|3|||
146970702|NCT03284424|530054308|FG001|Overall Study|Lost to Follow-up|1|||
146970703|NCT03284424|530054307|FG000|Overall Study|Physician Decision|1|||
146970704|NCT03284424|530054308|FG001|Overall Study|Physician Decision|2|||
146970705|NCT03284424|530054307|FG000|Overall Study|Withdrawal by Subject|4|||
146970706|NCT03284424|530054308|FG001|Overall Study|Withdrawal by Subject|5|||
146970707|NCT03284424|530054307|FG000|Overall Study|Sponsor's decision|27|||
146970708|NCT03284424|530054308|FG001|Overall Study|Sponsor's decision|22|||
146642671|NCT02864862|528869598|FG001|Overall Study|Protocol Violation|0|||
146642672|NCT02864862|528869599|FG002|Overall Study|Protocol Violation|1|||
146642673|NCT03263702|528869600|FG000|Overall Study|Lost to Follow-up|2|||
146970709|NCT01563029|530054311|FG000|Overall Study|Adverse Event|1|||
146970710|NCT01563029|530054312|FG001|Overall Study|Adverse Event|0|||
146970711|NCT01563029|530054313|FG002|Overall Study|Adverse Event|1|||
146910305|NCT01712438|529835661|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
146910306|NCT01712438|529835661|FG000|Overall Study|Ongoing ITI treatment|6|||
146910307|NCT01712438|529835661|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
146910308|NCT01712438|529835661|FG000|Overall Study|Prematurely Discontinued|25|||
146910309|NCT03846947|529835664|FG000|Overall Study|technical issues with imaging sequence|2|||
146910310|NCT03216265|529835665|FG000|Overall Study|Adverse Event|2|||
146910311|NCT03216265|529835666|FG001|Overall Study|Adverse Event|0|||
146910312|NCT03216265|529835667|FG002|Overall Study|Adverse Event|2|||
146910313|NCT03216265|529835665|FG000|Overall Study|Lost to Follow-up|0|||
146910314|NCT03216265|529835666|FG001|Overall Study|Lost to Follow-up|1|||
146910315|NCT03216265|529835667|FG002|Overall Study|Lost to Follow-up|0|||
146910316|NCT03216265|529835665|FG000|Overall Study|Withdrawal by Subject|0|||
146910317|NCT03216265|529835666|FG001|Overall Study|Withdrawal by Subject|0|||
146910318|NCT03216265|529835667|FG002|Overall Study|Withdrawal by Subject|1|||
146910319|NCT01539837|529835668|FG000|Overall Study|reduce neutrophil level|0|||
146910320|NCT01539837|529835669|FG001|Overall Study|reduce neutrophil level|1|||
146910321|NCT01539837|529835670|FG002|Overall Study|reduce neutrophil level|1|||
146910322|NCT01539837|529835668|FG000|Overall Study|bad compliance|0|||
146910323|NCT01539837|529835669|FG001|Overall Study|bad compliance|0|||
146910324|NCT01539837|529835670|FG002|Overall Study|bad compliance|1|||
146910325|NCT00849693|529835671|FG000|Acute Treatment Phase|Adverse Event|12|||
146910326|NCT00849693|529835672|FG001|Acute Treatment Phase|Adverse Event|7|||
146910327|NCT00849693|529835673|FG002|Acute Treatment Phase|Adverse Event|6|||
146910328|NCT00849693|529835674|FG003|Acute Treatment Phase|Adverse Event|4|||
146910329|NCT00849693|529835671|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
146910330|NCT00849693|529835672|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
146910331|NCT00849693|529835673|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
146910332|NCT00849693|529835674|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
146910333|NCT00849693|529835671|FG000|Acute Treatment Phase|Protocol Violation|1|||
146910334|NCT00849693|529835672|FG001|Acute Treatment Phase|Protocol Violation|5|||
146910335|NCT00849693|529835673|FG002|Acute Treatment Phase|Protocol Violation|2|||
146910336|NCT00849693|529835674|FG003|Acute Treatment Phase|Protocol Violation|6|||
146910337|NCT00849693|529835671|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
146910338|NCT00849693|529835672|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
146910339|NCT00849693|529835673|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
146910340|NCT00849693|529835674|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
146910341|NCT00849693|529835671|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
146910342|NCT00849693|529835672|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
146910343|NCT00849693|529835673|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
146910344|NCT00849693|529835674|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
146910345|NCT00849693|529835671|FG000|Acute Treatment Phase|Physician Decision|2|||
146910346|NCT00849693|529835672|FG001|Acute Treatment Phase|Physician Decision|1|||
146910347|NCT00849693|529835673|FG002|Acute Treatment Phase|Physician Decision|2|||
146910348|NCT00849693|529835674|FG003|Acute Treatment Phase|Physician Decision|1|||
146910349|NCT00849693|529835671|FG000|Acute Treatment Phase|Sponsor decision|0|||
146910350|NCT00849693|529835672|FG001|Acute Treatment Phase|Sponsor decision|0|||
146910351|NCT00849693|529835673|FG002|Acute Treatment Phase|Sponsor decision|1|||
146910352|NCT00849693|529835674|FG003|Acute Treatment Phase|Sponsor decision|0|||
146910353|NCT00849693|529835671|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
146910354|NCT00849693|529835672|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
146910355|NCT00849693|529835673|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
146910356|NCT00849693|529835674|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
146910357|NCT00849693|529835671|FG000|Extension Phase|Adverse Event|4|||
146910358|NCT00849693|529835672|FG001|Extension Phase|Adverse Event|6|||
146910359|NCT00849693|529835673|FG002|Extension Phase|Adverse Event|3|||
146910360|NCT00849693|529835674|FG003|Extension Phase|Adverse Event|7|||
146910361|NCT00849693|529835671|FG000|Extension Phase|Lost to Follow-up|7|||
146910362|NCT00849693|529835672|FG001|Extension Phase|Lost to Follow-up|5|||
146910363|NCT00849693|529835673|FG002|Extension Phase|Lost to Follow-up|6|||
146910364|NCT00849693|529835674|FG003|Extension Phase|Lost to Follow-up|6|||
146910365|NCT00849693|529835671|FG000|Extension Phase|Protocol Violation|0|||
146910366|NCT00849693|529835672|FG001|Extension Phase|Protocol Violation|3|||
146910367|NCT00849693|529835673|FG002|Extension Phase|Protocol Violation|2|||
146910368|NCT00849693|529835674|FG003|Extension Phase|Protocol Violation|3|||
146910369|NCT00849693|529835671|FG000|Extension Phase|Withdrawal by Subject|6|||
146910370|NCT00849693|529835672|FG001|Extension Phase|Withdrawal by Subject|9|||
146910371|NCT00849693|529835673|FG002|Extension Phase|Withdrawal by Subject|10|||
146910372|NCT00849693|529835674|FG003|Extension Phase|Withdrawal by Subject|15|||
146910373|NCT00849693|529835671|FG000|Extension Phase|Parent or caregiver decision|9|||
146910374|NCT00849693|529835672|FG001|Extension Phase|Parent or caregiver decision|4|||
146910375|NCT00849693|529835673|FG002|Extension Phase|Parent or caregiver decision|10|||
146910376|NCT00849693|529835674|FG003|Extension Phase|Parent or caregiver decision|5|||
146910377|NCT00849693|529835671|FG000|Extension Phase|Physician Decision|1|||
146910378|NCT00849693|529835672|FG001|Extension Phase|Physician Decision|1|||
146910379|NCT00849693|529835673|FG002|Extension Phase|Physician Decision|2|||
146970712|NCT01563029|530054314|FG003|Overall Study|Adverse Event|2|||
146970713|NCT01563029|530054315|FG004|Overall Study|Adverse Event|1|||
146970714|NCT01563029|530054311|FG000|Overall Study|Lack of Efficacy|42|||
146970715|NCT01563029|530054312|FG001|Overall Study|Lack of Efficacy|16|||
146970716|NCT01563029|530054313|FG002|Overall Study|Lack of Efficacy|23|||
146970717|NCT01563029|530054314|FG003|Overall Study|Lack of Efficacy|21|||
146970718|NCT01563029|530054315|FG004|Overall Study|Lack of Efficacy|19|||
146970719|NCT01563029|530054311|FG000|Overall Study|Protocol Violation|1|||
146970720|NCT01563029|530054312|FG001|Overall Study|Protocol Violation|2|||
146970721|NCT01563029|530054313|FG002|Overall Study|Protocol Violation|3|||
146970722|NCT01563029|530054314|FG003|Overall Study|Protocol Violation|1|||
146970723|NCT01563029|530054315|FG004|Overall Study|Protocol Violation|3|||
146970724|NCT01563029|530054311|FG000|Overall Study|Protocol defined stopping criteria|1|||
146970725|NCT01563029|530054312|FG001|Overall Study|Protocol defined stopping criteria|0|||
146970726|NCT01563029|530054313|FG002|Overall Study|Protocol defined stopping criteria|0|||
146970727|NCT01563029|530054314|FG003|Overall Study|Protocol defined stopping criteria|0|||
146970728|NCT01563029|530054315|FG004|Overall Study|Protocol defined stopping criteria|0|||
146970729|NCT01563029|530054311|FG000|Overall Study|Lost to Follow-up|1|||
146970730|NCT01563029|530054312|FG001|Overall Study|Lost to Follow-up|0|||
146970731|NCT01563029|530054313|FG002|Overall Study|Lost to Follow-up|1|||
146970732|NCT01563029|530054314|FG003|Overall Study|Lost to Follow-up|1|||
146910380|NCT00849693|529835674|FG003|Extension Phase|Physician Decision|0|||
146910381|NCT00849693|529835671|FG000|Extension Phase|Sponsor decision|1|||
146910382|NCT00849693|529835672|FG001|Extension Phase|Sponsor decision|0|||
146910383|NCT00849693|529835673|FG002|Extension Phase|Sponsor decision|0|||
146910384|NCT00849693|529835674|FG003|Extension Phase|Sponsor decision|1|||
146910385|NCT00849693|529835671|FG000|Extension Phase|Lack of Efficacy|2|||
146910386|NCT00849693|529835672|FG001|Extension Phase|Lack of Efficacy|2|||
146910387|NCT00849693|529835673|FG002|Extension Phase|Lack of Efficacy|2|||
146910388|NCT00849693|529835674|FG003|Extension Phase|Lack of Efficacy|1|||
146910389|NCT00098345|529835677|FG000|Overall Study|Adverse Event|7|||
146910390|NCT00098345|529835677|FG000|Overall Study|Withdrawal by Subject|2|||
146910391|NCT00098345|529835677|FG000|Overall Study|progression|4|||
146910392|NCT01183858|529835678|FG000|Overall Study|Death not related to Progressive Disease|5|||
146910393|NCT01183858|529835679|FG001|Overall Study|Death not related to Progressive Disease|6|||
146910394|NCT01183858|529835678|FG000|Overall Study|Adverse Event|14|||
146910395|NCT01183858|529835679|FG001|Overall Study|Adverse Event|11|||
146910396|NCT01183858|529835678|FG000|Overall Study|Investigator's Decision|0|||
146910397|NCT01183858|529835679|FG001|Overall Study|Investigator's Decision|3|||
146910398|NCT01183858|529835678|FG000|Overall Study|Insufficient Therapeutic Response|2|||
146910399|NCT01183858|529835679|FG001|Overall Study|Insufficient Therapeutic Response|0|||
146910400|NCT01183858|529835678|FG000|Overall Study|Refused Treatment|1|||
146910401|NCT01183858|529835679|FG001|Overall Study|Refused Treatment|4|||
146910402|NCT01183858|529835678|FG000|Overall Study|Withdrew Consent|4|||
146910403|NCT01183858|529835679|FG001|Overall Study|Withdrew Consent|4|||
146910404|NCT01183858|529835678|FG000|Overall Study|Discontinued Smoking|3|||
146910405|NCT01183858|529835679|FG001|Overall Study|Discontinued Smoking|1|||
146910406|NCT01183858|529835678|FG000|Overall Study|Protocol Violation|1|||
146910407|NCT01183858|529835679|FG001|Overall Study|Protocol Violation|0|||
146910408|NCT01183858|529835678|FG000|Overall Study|Administrative/Other|6|||
146910409|NCT01183858|529835679|FG001|Overall Study|Administrative/Other|6|||
146910410|NCT01183858|529835678|FG000|Overall Study|Progressive Disease|112|||
146910411|NCT01183858|529835679|FG001|Overall Study|Progressive Disease|115|||
146910412|NCT01183858|529835678|FG000|Overall Study|Death related to Progressive Disease|4|||
146910413|NCT01183858|529835679|FG001|Overall Study|Death related to Progressive Disease|5|||
146910414|NCT01183858|529835678|FG000|Overall Study|Lost to Follow-up|1|||
146910415|NCT01183858|529835679|FG001|Overall Study|Lost to Follow-up|1|||
146910416|NCT02046564|529835682|FG000|Overall Study|Adverse Event|6|||
146910417|NCT02046564|529835683|FG001|Overall Study|Adverse Event|3|||
146910418|NCT02046564|529835682|FG000|Overall Study|Physician Decision|0|||
146910419|NCT02046564|529835683|FG001|Overall Study|Physician Decision|1|||
146910420|NCT02046564|529835682|FG000|Overall Study|Protocol Violation|3|||
146910421|NCT02046564|529835683|FG001|Overall Study|Protocol Violation|1|||
146970733|NCT01563029|530054315|FG004|Overall Study|Lost to Follow-up|1|||
146970734|NCT01563029|530054311|FG000|Overall Study|Physician Decision|3|||
146970735|NCT01563029|530054312|FG001|Overall Study|Physician Decision|5|||
146970736|NCT01563029|530054313|FG002|Overall Study|Physician Decision|2|||
146970737|NCT01563029|530054314|FG003|Overall Study|Physician Decision|4|||
146910422|NCT02046564|529835682|FG000|Overall Study|Withdrawal by Subject|4|||
146910423|NCT02046564|529835683|FG001|Overall Study|Withdrawal by Subject|10|||
146910424|NCT02046564|529835682|FG000|Overall Study|Subject met withdrawal criteria|2|||
146910425|NCT02046564|529835683|FG001|Overall Study|Subject met withdrawal criteria|5|||
146910426|NCT01295905|529835686|FG000|Overall Study|Did not meet inclusion criteria|1|||
146910427|NCT01295905|529835687|FG001|Overall Study|Did not meet inclusion criteria|0|||
146910428|NCT01295905|529835686|FG000|Overall Study|Met exclusion criteria|1|||
146970738|NCT01563029|530054315|FG004|Overall Study|Physician Decision|2|||
146910429|NCT01295905|529835687|FG001|Overall Study|Met exclusion criteria|0|||
146642674|NCT03263702|528869601|FG001|Overall Study|Lost to Follow-up|2|||
146910430|NCT03707977|529835688|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
146910431|NCT03707977|529835689|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
146910432|NCT03707977|529835690|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
146910433|NCT03707977|529835688|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
146910434|NCT03707977|529835689|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
146910435|NCT03707977|529835690|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
146910436|NCT00641147|529835691|FG000|Completed 4 Months.|Physician Decision|1|||
146910437|NCT00641147|529835692|FG001|Completed 4 Months.|Physician Decision|0|||
146910438|NCT00641147|529835691|FG000|Completed 4 Months.|Adverse Event|1|||
146910439|NCT00641147|529835692|FG001|Completed 4 Months.|Adverse Event|0|||
146910440|NCT00641147|529835691|FG000|Completed 8 Months.|Physician Decision|2|||
146910441|NCT00641147|529835692|FG001|Completed 8 Months.|Physician Decision|1|||
146910442|NCT00641147|529835691|FG000|Completed 8 Months.|non compliance|1|||
146910443|NCT00641147|529835692|FG001|Completed 8 Months.|non compliance|0|||
146910444|NCT00641147|529835691|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
146910445|NCT00641147|529835692|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
146910446|NCT00641147|529835691|FG000|Completed 12 Months.|Physician Decision|1|||
146910447|NCT00641147|529835692|FG001|Completed 12 Months.|Physician Decision|1|||
146910448|NCT00641147|529835691|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
146910449|NCT00641147|529835692|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
146910450|NCT00641147|529835691|FG000|Completed 16 Months.|Physician Decision|1|||
146910451|NCT00641147|529835692|FG001|Completed 16 Months.|Physician Decision|0|||
146910452|NCT00641147|529835691|FG000|Completed 16 Months.|Lost to Follow-up|1|||
146910453|NCT00641147|529835692|FG001|Completed 16 Months.|Lost to Follow-up|0|||
146910454|NCT00791128|529835693|FG000|Overall Study|Adverse Event|4|||
146910455|NCT00791128|529835693|FG000|Overall Study|Device migration|2|||
146910456|NCT00791128|529835693|FG000|Overall Study|non-compliance by subject|2|||
146910457|NCT00791128|529835693|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
146910458|NCT01629667|529835694|FG000|Overall Study|Lost to Follow-up|0|||
146910459|NCT01629667|529835695|FG001|Overall Study|Lost to Follow-up|1|||
146910460|NCT01629667|529835696|FG002|Overall Study|Lost to Follow-up|1|||
146910461|NCT01629667|529835694|FG000|Overall Study|Withdrawal by Subject|31|||
146910462|NCT01629667|529835695|FG001|Overall Study|Withdrawal by Subject|20|||
146910463|NCT01629667|529835696|FG002|Overall Study|Withdrawal by Subject|28|||
146910464|NCT01629667|529835694|FG000|Overall Study|Death|1|||
146910465|NCT01629667|529835695|FG001|Overall Study|Death|5|||
146910466|NCT01629667|529835696|FG002|Overall Study|Death|3|||
146910467|NCT01629667|529835694|FG000|Overall Study|Randomized, not treated|2|||
146910468|NCT01629667|529835695|FG001|Overall Study|Randomized, not treated|1|||
146910469|NCT01629667|529835696|FG002|Overall Study|Randomized, not treated|0|||
146910470|NCT01629667|529835694|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
146910471|NCT01629667|529835695|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
146910472|NCT01629667|529835696|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
146910473|NCT01629667|529835694|FG000|Overall Study|Requiring lung transplant|2|||
146910474|NCT01629667|529835695|FG001|Overall Study|Requiring lung transplant|1|||
146910475|NCT01629667|529835696|FG002|Overall Study|Requiring lung transplant|3|||
146910476|NCT01629667|529835694|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
146910477|NCT01629667|529835695|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
146642675|NCT03263702|528869600|FG000|Overall Study|Withdrawal by Subject|1|||
146910478|NCT01629667|529835696|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
146910479|NCT01629667|529835694|FG000|Overall Study|Started other medicine|1|||
146910480|NCT01629667|529835695|FG001|Overall Study|Started other medicine|0|||
146642676|NCT03263702|528869601|FG001|Overall Study|Withdrawal by Subject|2|||
146910481|NCT01629667|529835696|FG002|Overall Study|Started other medicine|1|||
146910482|NCT01629667|529835694|FG000|Overall Study|Site error in safety follow-up|0|||
146910483|NCT01629667|529835695|FG001|Overall Study|Site error in safety follow-up|0|||
146910484|NCT01629667|529835696|FG002|Overall Study|Site error in safety follow-up|1|||
146910485|NCT01629667|529835694|FG000|Overall Study|Enrolled in another clinical study|0|||
146910486|NCT01629667|529835695|FG001|Overall Study|Enrolled in another clinical study|1|||
146910487|NCT01629667|529835696|FG002|Overall Study|Enrolled in another clinical study|0|||
146910488|NCT01629667|529835694|FG000|Overall Study|Code break|1|||
146910489|NCT01629667|529835695|FG001|Overall Study|Code break|0|||
146910490|NCT01629667|529835696|FG002|Overall Study|Code break|0|||
146910491|NCT00670111|529835701|FG000|Enrollment to One Month|Testing Failure|0|||
146910492|NCT00670111|529835702|FG001|Enrollment to One Month|Testing Failure|0|||
146910493|NCT00670111|529835703|FG002|Enrollment to One Month|Testing Failure|13|||
146910494|NCT00670111|529835701|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
146910495|NCT00670111|529835702|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
146910496|NCT00670111|529835703|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
146910497|NCT00670111|529835701|FG000|Enrollment to One Month|Physician Decision|1|||
146910498|NCT00670111|529835702|FG001|Enrollment to One Month|Physician Decision|0|||
146910499|NCT00670111|529835703|FG002|Enrollment to One Month|Physician Decision|0|||
146910500|NCT00844883|529835704|FG000|Overall Study|Bridged to liver transplant|3|||
146910501|NCT00844883|529835704|FG000|Overall Study|Bridged to resection|1|||
146910502|NCT00537823|529835707|FG000|Overall Study|Adverse Event|2|||
146910503|NCT00537823|529835708|FG001|Overall Study|Adverse Event|0|||
146910504|NCT02873221|529835709|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
146910505|NCT02873221|529835710|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
146910506|NCT02873221|529835711|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
146910507|NCT02873221|529835709|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
146910508|NCT02873221|529835710|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
146910509|NCT02873221|529835711|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
146910510|NCT02873221|529835709|FG000|Treatment Period|Protocol Violation|2|||
146910511|NCT02873221|529835710|FG001|Treatment Period|Protocol Violation|5|||
146910512|NCT02873221|529835711|FG002|Treatment Period|Protocol Violation|8|||
146910513|NCT02873221|529835709|FG000|Treatment Period|Pregnancy|4|||
146910514|NCT02873221|529835710|FG001|Treatment Period|Pregnancy|6|||
146910515|NCT02873221|529835711|FG002|Treatment Period|Pregnancy|3|||
146910516|NCT02873221|529835709|FG000|Treatment Period|Lack of Qualifying Event|0|||
146910517|NCT02873221|529835710|FG001|Treatment Period|Lack of Qualifying Event|3|||
146910518|NCT02873221|529835711|FG002|Treatment Period|Lack of Qualifying Event|1|||
146910519|NCT02873221|529835709|FG000|Treatment Period|Withdrawal of Consent|52|||
146910520|NCT02873221|529835710|FG001|Treatment Period|Withdrawal of Consent|51|||
146910521|NCT02873221|529835711|FG002|Treatment Period|Withdrawal of Consent|41|||
146910522|NCT02873221|529835709|FG000|Treatment Period|Lack of Efficacy|0|||
146910523|NCT02873221|529835710|FG001|Treatment Period|Lack of Efficacy|17|||
146910524|NCT02873221|529835711|FG002|Treatment Period|Lack of Efficacy|12|||
146910525|NCT02873221|529835709|FG000|Treatment Period|Adverse Event|4|||
146910526|NCT02873221|529835710|FG001|Treatment Period|Adverse Event|9|||
146910527|NCT02873221|529835711|FG002|Treatment Period|Adverse Event|11|||
146910528|NCT02873221|529835709|FG000|Treatment Period|Lost to Follow-up|26|||
146910529|NCT02873221|529835710|FG001|Treatment Period|Lost to Follow-up|30|||
146910530|NCT02873221|529835711|FG002|Treatment Period|Lost to Follow-up|26|||
146910531|NCT02873221|529835709|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
146910532|NCT02873221|529835710|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
146910533|NCT02873221|529835711|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
146910534|NCT02873221|529835709|FG000|Safety Follow-up Period|Protocol Violation|0|||
146910535|NCT02873221|529835710|FG001|Safety Follow-up Period|Protocol Violation|0|||
146910536|NCT02873221|529835711|FG002|Safety Follow-up Period|Protocol Violation|1|||
146910537|NCT02873221|529835709|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
146910538|NCT02873221|529835710|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
146910539|NCT02873221|529835711|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
146910540|NCT02873221|529835709|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
146910541|NCT02873221|529835710|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
146910542|NCT02873221|529835711|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
146910543|NCT00328198|529835718|FG000|Treatment|Adverse Event|21|||
146910544|NCT00328198|529835718|FG000|Treatment|Death|1|||
146910545|NCT00328198|529835718|FG000|Treatment|Physician Decision|5|||
146910546|NCT00328198|529835718|FG000|Treatment|Withdrawal by Subject|5|||
146910547|NCT00328198|529835718|FG000|Treatment|Evidence of disease progression|2|||
146910548|NCT00328198|529835718|FG000|Treatment|Non-compliance|1|||
146910549|NCT00328198|529835718|FG000|Treatment|Confirmed complete response, MRD -|3|||
146910550|NCT00328198|529835718|FG000|Follow-up|Lost to Follow-up|4|||
146910551|NCT00328198|529835718|FG000|Follow-up|Death|31|||
146910552|NCT02717546|529835719|FG000|Overall Study|Lost to Follow-up|12|||
146910553|NCT02052960|529835723|FG000|Overall Study|Adverse Event|19|||
146910554|NCT02052960|529835724|FG001|Overall Study|Adverse Event|17|||
146910555|NCT02052960|529835723|FG000|Overall Study|Protocol Violation|4|||
146910556|NCT02052960|529835724|FG001|Overall Study|Protocol Violation|3|||
146910557|NCT02052960|529835723|FG000|Overall Study|Withdrawal by Subject|6|||
146910558|NCT02052960|529835724|FG001|Overall Study|Withdrawal by Subject|11|||
146910559|NCT02052960|529835723|FG000|Overall Study|Other|25|||
146910560|NCT02052960|529835724|FG001|Overall Study|Other|15|||
146910561|NCT03849560|529835725|FG000|Overall Study|Withdrawal by Subject|1|||
146910562|NCT03849560|529835726|FG001|Overall Study|Withdrawal by Subject|0|||
146910563|NCT03849560|529835727|FG002|Overall Study|Withdrawal by Subject|0|||
146910564|NCT03233048|529835730|FG000|Overall Study|Withdrawal by Subject|1|||
146910565|NCT00491530|529835731|FG000|Overall Study|Adverse Event|6|||
146910566|NCT00491530|529835732|FG001|Overall Study|Adverse Event|1|||
146910567|NCT00491530|529835733|FG002|Overall Study|Adverse Event|2|||
146910568|NCT00491530|529835731|FG000|Overall Study|Withdrawal by Subject|3|||
146910569|NCT00491530|529835732|FG001|Overall Study|Withdrawal by Subject|0|||
146910570|NCT00491530|529835733|FG002|Overall Study|Withdrawal by Subject|0|||
146910571|NCT00491530|529835731|FG000|Overall Study|Lost to Follow-up|3|||
146910572|NCT00491530|529835732|FG001|Overall Study|Lost to Follow-up|2|||
146910573|NCT00491530|529835733|FG002|Overall Study|Lost to Follow-up|2|||
146910574|NCT00491530|529835731|FG000|Overall Study|Lack of Efficacy|0|||
146910575|NCT00491530|529835732|FG001|Overall Study|Lack of Efficacy|1|||
146910576|NCT00491530|529835733|FG002|Overall Study|Lack of Efficacy|0|||
146910577|NCT00491530|529835731|FG000|Overall Study|Investigator Discretion|0|||
146910578|NCT00491530|529835732|FG001|Overall Study|Investigator Discretion|1|||
146563880|NCT02769481|528576245|FG000|Overall Study|Undefined|4|||
146563881|NCT02769481|528576246|FG001|Overall Study|Undefined|1|||
146563882|NCT06272383|528576247|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
146563883|NCT06272383|528576248|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
146563884|NCT04398706|528576249|FG000|Overall Study|Adverse Event|0|||
146563885|NCT04398706|528576250|FG001|Overall Study|Adverse Event|0|||
146563886|NCT04398706|528576251|FG002|Overall Study|Adverse Event|0|||
146563887|NCT04398706|528576252|FG003|Overall Study|Adverse Event|0|||
146563888|NCT04398706|528576253|FG004|Overall Study|Adverse Event|0|||
146563889|NCT04398706|528576254|FG005|Overall Study|Adverse Event|1|||
146563890|NCT04398706|528576255|FG006|Overall Study|Adverse Event|1|||
146563891|NCT04398706|528576256|FG007|Overall Study|Adverse Event|0|||
146563892|NCT04398706|528576249|FG000|Overall Study|Lost to Follow-up|0|||
146563893|NCT04398706|528576250|FG001|Overall Study|Lost to Follow-up|1|||
146563894|NCT04398706|528576251|FG002|Overall Study|Lost to Follow-up|2|||
146563895|NCT04398706|528576252|FG003|Overall Study|Lost to Follow-up|1|||
146563896|NCT04398706|528576253|FG004|Overall Study|Lost to Follow-up|6|||
146563897|NCT04398706|528576254|FG005|Overall Study|Lost to Follow-up|3|||
146563898|NCT04398706|528576255|FG006|Overall Study|Lost to Follow-up|8|||
146563899|NCT04398706|528576256|FG007|Overall Study|Lost to Follow-up|2|||
146563900|NCT04398706|528576249|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146563901|NCT04398706|528576250|FG001|Overall Study|Withdrawal by parent/guardian|2|||
146563902|NCT04398706|528576251|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146563903|NCT04398706|528576252|FG003|Overall Study|Withdrawal by parent/guardian|2|||
146563904|NCT04398706|528576253|FG004|Overall Study|Withdrawal by parent/guardian|19|||
146563905|NCT04398706|528576254|FG005|Overall Study|Withdrawal by parent/guardian|23|||
146563906|NCT04398706|528576255|FG006|Overall Study|Withdrawal by parent/guardian|13|||
146563907|NCT04398706|528576256|FG007|Overall Study|Withdrawal by parent/guardian|11|||
146563908|NCT04398706|528576249|FG000|Overall Study|Protocol deviation|0|||
146563909|NCT04398706|528576250|FG001|Overall Study|Protocol deviation|1|||
146563910|NCT04398706|528576251|FG002|Overall Study|Protocol deviation|0|||
146563911|NCT04398706|528576252|FG003|Overall Study|Protocol deviation|0|||
146563912|NCT04398706|528576253|FG004|Overall Study|Protocol deviation|6|||
146910579|NCT00491530|529835733|FG002|Overall Study|Investigator Discretion|0|||
146910580|NCT00491530|529835731|FG000|Overall Study|Patient Request|0|||
146910581|NCT00491530|529835732|FG001|Overall Study|Patient Request|1|||
146563913|NCT04398706|528576254|FG005|Overall Study|Protocol deviation|4|||
146563914|NCT04398706|528576255|FG006|Overall Study|Protocol deviation|6|||
146910582|NCT00491530|529835733|FG002|Overall Study|Patient Request|0|||
146970739|NCT01563029|530054311|FG000|Overall Study|Withdrawal by Subject|4|||
146970740|NCT01563029|530054312|FG001|Overall Study|Withdrawal by Subject|1|||
146970741|NCT01563029|530054313|FG002|Overall Study|Withdrawal by Subject|3|||
146970742|NCT01563029|530054314|FG003|Overall Study|Withdrawal by Subject|4|||
146970743|NCT01563029|530054315|FG004|Overall Study|Withdrawal by Subject|3|||
146970744|NCT01569594|530054316|FG000|Overall Study|Physician Decision|4|||
146970745|NCT01569594|530054316|FG000|Overall Study|Death|13|||
146970746|NCT01569594|530054316|FG000|Overall Study|Lost to Follow-up|22|||
146970747|NCT01569594|530054316|FG000|Overall Study|Adverse Event|2|||
146970748|NCT01569594|530054316|FG000|Overall Study|Withdrawal by Subject|13|||
146970749|NCT01569594|530054316|FG000|Overall Study|Other|4|||
146970750|NCT01569594|530054316|FG000|Overall Study|No ECM used|9|||
146970751|NCT03069365|530054317|FG000|Overall Study|Adverse Event|1|||
146970752|NCT02861534|530054318|FG000|Overall Study|Death|541|||
146970753|NCT02861534|530054319|FG001|Overall Study|Death|552|||
146970754|NCT02861534|530054318|FG000|Overall Study|Lost to Follow-up|14|||
146970755|NCT02861534|530054319|FG001|Overall Study|Lost to Follow-up|14|||
146970756|NCT02861534|530054318|FG000|Overall Study|Site Terminated by Sponsor|4|||
146970757|NCT02861534|530054319|FG001|Overall Study|Site Terminated by Sponsor|3|||
146970758|NCT02861534|530054318|FG000|Overall Study|Withdrawal by Subject|15|||
146970759|NCT02861534|530054319|FG001|Overall Study|Withdrawal by Subject|18|||
146970760|NCT02780115|530054320|FG000|Overall Study|Withdrawal by Subject|0|||
146970761|NCT02780115|530054321|FG001|Overall Study|Withdrawal by Subject|1|||
146970762|NCT02780115|530054322|FG002|Overall Study|Withdrawal by Subject|1|||
146970763|NCT02780115|530054323|FG003|Overall Study|Withdrawal by Subject|0|||
146970764|NCT02780115|530054324|FG004|Overall Study|Withdrawal by Subject|0|||
146970765|NCT02780115|530054320|FG000|Overall Study|Adverse Event|0|||
146970766|NCT02780115|530054321|FG001|Overall Study|Adverse Event|0|||
146970767|NCT02780115|530054322|FG002|Overall Study|Adverse Event|0|||
146970768|NCT02780115|530054323|FG003|Overall Study|Adverse Event|1|||
146970769|NCT02780115|530054324|FG004|Overall Study|Adverse Event|1|||
146970770|NCT01988337|530054329|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
146970771|NCT02742818|530054330|FG000|Overall Study|Adverse Event|0|||
146970772|NCT02742818|530054331|FG001|Overall Study|Adverse Event|1|||
146970773|NCT02742818|530054330|FG000|Overall Study|Protocol Violation|0|||
146970774|NCT02742818|530054331|FG001|Overall Study|Protocol Violation|1|||
146970775|NCT00457418|530054332|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
146970776|NCT00457418|530054332|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
146970777|NCT00457418|530054332|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
146970778|NCT00457418|530054332|FG000|Post PK Maintenance|Adverse Event|10|||
146970779|NCT00457418|530054332|FG000|Post PK Maintenance|Progression of Disease|6|||
146970780|NCT00457418|530054332|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
146970781|NCT00457418|530054332|FG000|Post PK Maintenance|Lost to Follow-up|1|||
146563915|NCT04398706|528576256|FG007|Overall Study|Protocol deviation|3|||
146563916|NCT05489328|528577832|FG000|Overall Study|Lost to Follow-up|0|||
146563917|NCT05489328|528577833|FG001|Overall Study|Lost to Follow-up|0|||
146563918|NCT05489328|528577834|FG002|Overall Study|Lost to Follow-up|1|||
146563919|NCT05489328|528577835|FG003|Overall Study|Lost to Follow-up|0|||
146970782|NCT01785472|530054333|FG000|Overall Study|Adverse Event|5|||
146970783|NCT01785472|530054334|FG001|Overall Study|Adverse Event|4|||
146970784|NCT01785472|530054335|FG002|Overall Study|Adverse Event|6|||
146970785|NCT01785472|530054333|FG000|Overall Study|Lack of Efficacy|2|||
146970786|NCT01785472|530054334|FG001|Overall Study|Lack of Efficacy|0|||
146970787|NCT01785472|530054335|FG002|Overall Study|Lack of Efficacy|1|||
146970788|NCT01785472|530054333|FG000|Overall Study|Lost to Follow-up|1|||
146970789|NCT01785472|530054334|FG001|Overall Study|Lost to Follow-up|2|||
146970790|NCT01785472|530054335|FG002|Overall Study|Lost to Follow-up|0|||
146970791|NCT01785472|530054333|FG000|Overall Study|Physician Decision|1|||
146970792|NCT01785472|530054334|FG001|Overall Study|Physician Decision|1|||
146970793|NCT01785472|530054335|FG002|Overall Study|Physician Decision|1|||
146970794|NCT01785472|530054333|FG000|Overall Study|Protocol deviation|0|||
146970795|NCT01785472|530054334|FG001|Overall Study|Protocol deviation|2|||
146970796|NCT01785472|530054335|FG002|Overall Study|Protocol deviation|2|||
146970797|NCT01785472|530054333|FG000|Overall Study|Subject/guardian decision|15|||
146970798|NCT01785472|530054334|FG001|Overall Study|Subject/guardian decision|10|||
146970799|NCT01785472|530054335|FG002|Overall Study|Subject/guardian decision|11|||
146970800|NCT01785472|530054333|FG000|Overall Study|Technical problems|0|||
146970801|NCT01785472|530054334|FG001|Overall Study|Technical problems|0|||
146970802|NCT01785472|530054335|FG002|Overall Study|Technical problems|1|||
146970803|NCT02086968|530054337|FG000|Overall Study|Adverse Event|1|||
146970804|NCT02086968|530054338|FG001|Overall Study|Adverse Event|5|||
146970805|NCT02086968|530054337|FG000|Overall Study|Lost to Follow-up|2|||
146970806|NCT02086968|530054338|FG001|Overall Study|Lost to Follow-up|3|||
146970807|NCT02086968|530054337|FG000|Overall Study|Study drug received outside protocol|0|||
146970808|NCT02086968|530054338|FG001|Overall Study|Study drug received outside protocol|1|||
146768604|NCT01596504|529321741|FG001|Overall Study|Participant's Private Reason|1|||
146768605|NCT01596504|529321742|FG002|Overall Study|Participant's Private Reason|0|||
146970809|NCT02086968|530054337|FG000|Overall Study|Physician Decision|4|||
146970810|NCT02086968|530054338|FG001|Overall Study|Physician Decision|0|||
146970811|NCT02086968|530054337|FG000|Overall Study|Withdrawal by Subject|1|||
146970812|NCT02086968|530054338|FG001|Overall Study|Withdrawal by Subject|4|||
146970813|NCT03387735|530054339|FG000|Overall Study|Lost to Follow-up|4|||
146642677|NCT03598114|528869602|FG000|Overall Study|Staff turnover/left the program|3|||
146642678|NCT03598114|528869603|FG001|Overall Study|Staff turnover/left the program|39|||
146642679|NCT01206322|528869604|FG000|Overall Study|Adverse Event|0|||
146642680|NCT01206322|528869605|FG001|Overall Study|Adverse Event|0|||
146642681|NCT01206322|528869606|FG002|Overall Study|Adverse Event|0|||
146642682|NCT01206322|528869607|FG003|Overall Study|Adverse Event|1|||
146642683|NCT00689117|528869608|FG000|Overall Study|Adverse Event|6|||
146642684|NCT00689117|528869609|FG001|Overall Study|Adverse Event|0|||
146642685|NCT00689117|528869610|FG002|Overall Study|Adverse Event|5|||
146642686|NCT00689117|528869611|FG003|Overall Study|Adverse Event|0|||
146642687|NCT00689117|528869608|FG000|Overall Study|Lost to Follow-up|26|||
146642688|NCT00689117|528869609|FG001|Overall Study|Lost to Follow-up|19|||
146910583|NCT00491530|529835731|FG000|Overall Study|Use of Prohibited Medication|0|||
146910584|NCT00491530|529835732|FG001|Overall Study|Use of Prohibited Medication|0|||
146910585|NCT00491530|529835733|FG002|Overall Study|Use of Prohibited Medication|1|||
146910586|NCT01396525|529835734|FG000|Overall Study|Withdrawal by Subject|8|||
146910587|NCT01396525|529835734|FG000|Overall Study|Death|14|||
146910588|NCT01396525|529835734|FG000|Overall Study|Lost to Follow-up|4|||
146910589|NCT00949650|529835735|FG000|Overall Study|Progressive disease|188|||
146910590|NCT00949650|529835736|FG001|Overall Study|Progressive disease|19|||
146910591|NCT00949650|529835735|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
146910592|NCT00949650|529835736|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
146910593|NCT00949650|529835735|FG000|Overall Study|Other Adverse Event (AE)|28|||
146910594|NCT00949650|529835736|FG001|Overall Study|Other Adverse Event (AE)|17|||
146910595|NCT00949650|529835735|FG000|Overall Study|Protocol Violation|1|||
146910596|NCT00949650|529835736|FG001|Overall Study|Protocol Violation|4|||
146910597|NCT00949650|529835735|FG000|Overall Study|Refusal to continue medication|7|||
146910598|NCT00949650|529835736|FG001|Overall Study|Refusal to continue medication|11|||
146910599|NCT00949650|529835735|FG000|Overall Study|Not treated|1|||
146910600|NCT00949650|529835736|FG001|Overall Study|Not treated|4|||
146910601|NCT00949650|529835735|FG000|Overall Study|Other not specified above|5|||
146910602|NCT00949650|529835736|FG001|Overall Study|Other not specified above|0|||
146910603|NCT02436239|529835740|FG000|Open-Lable Treatment Period|Adverse Event|12|||
146910604|NCT02436239|529835741|FG001|Open-Lable Treatment Period|Adverse Event|3|||
146910605|NCT02436239|529835742|FG002|Open-Lable Treatment Period|Adverse Event|4|||
146910606|NCT02436239|529835743|FG003|Open-Lable Treatment Period|Adverse Event|2|||
146910607|NCT02436239|529835740|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
146910608|NCT02436239|529835741|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
146910609|NCT02436239|529835742|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
146910610|NCT02436239|529835743|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
146910611|NCT02436239|529835740|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
146910612|NCT02436239|529835741|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
146910613|NCT02436239|529835742|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
146910614|NCT02436239|529835743|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
146910615|NCT02436239|529835740|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
146910616|NCT02436239|529835741|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
146910617|NCT02436239|529835742|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
146910618|NCT02436239|529835743|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
146910619|NCT02436239|529835740|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
146910620|NCT02436239|529835741|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
146910621|NCT02436239|529835742|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
146910622|NCT02436239|529835743|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
146910623|NCT02436239|529835740|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
146910624|NCT02436239|529835741|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
146910625|NCT02436239|529835742|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
146910626|NCT02436239|529835743|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
146642689|NCT00689117|528869610|FG002|Overall Study|Lost to Follow-up|17|||
146642690|NCT00689117|528869611|FG003|Overall Study|Lost to Follow-up|11|||
146910627|NCT02436239|529835740|FG000|Open-Lable Treatment Period|Other Reason|1|||
146910628|NCT02436239|529835741|FG001|Open-Lable Treatment Period|Other Reason|1|||
146910629|NCT02436239|529835742|FG002|Open-Lable Treatment Period|Other Reason|0|||
146910630|NCT02436239|529835743|FG003|Open-Lable Treatment Period|Other Reason|0|||
146642691|NCT00689117|528869608|FG000|Overall Study|Lack of Efficacy|1|||
146910631|NCT02436239|529835740|FG000|Down-Taper Period|Withdrawal by Subject|4|||
146910632|NCT02436239|529835741|FG001|Down-Taper Period|Withdrawal by Subject|4|||
146910633|NCT02436239|529835742|FG002|Down-Taper Period|Withdrawal by Subject|1|||
146910634|NCT02436239|529835743|FG003|Down-Taper Period|Withdrawal by Subject|2|||
146910635|NCT03671369|529835744|FG000|Overall Study|Other|1|||
146910636|NCT03671369|529835744|FG000|Overall Study|Withdrawal by Subject|289|||
146910637|NCT03671369|529835744|FG000|Overall Study|Not willing to be vaccinated|1|||
146910638|NCT02612077|529835746|FG000|Overall Study|Adverse Event|3|||
146910639|NCT02612077|529835746|FG000|Overall Study|Withdrawal by Subject|9|||
146910640|NCT02612077|529835746|FG000|Overall Study|Protocol Violation|28|||
146910641|NCT02612077|529835746|FG000|Overall Study|Lost to Follow-up|20|||
146910642|NCT02612077|529835746|FG000|Overall Study|Death|377|||
146910643|NCT02612077|529835746|FG000|Overall Study|Moved or Changed Medical Team|23|||
146910644|NCT02612077|529835746|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
146910645|NCT02612077|529835746|FG000|Overall Study|Disease Progression|3|||
146910646|NCT02612077|529835746|FG000|Overall Study|Unknown reason|2|||
146910647|NCT01971476|529835747|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
146910648|NCT01971476|529835748|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
146910649|NCT01971476|529835749|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
146910650|NCT01971476|529835747|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
146910651|NCT01971476|529835748|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
146910652|NCT01971476|529835749|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
146910653|NCT01971476|529835747|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
146910654|NCT01971476|529835748|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
146910655|NCT01971476|529835749|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
146910656|NCT02498821|529835750|FG000|Overall Study|Screen failure|3|||
146970814|NCT03387735|530054340|FG001|Overall Study|Lost to Follow-up|8|||
146910657|NCT02498821|529835751|FG001|Overall Study|Screen failure|5|||
146910658|NCT01716169|529835753|FG000|Overall Study|Adverse Event|1|||
146910659|NCT01716169|529835753|FG000|Overall Study|Lost to Follow-up|1|||
146970815|NCT03387735|530054339|FG000|Overall Study|Death|4|||
146910660|NCT01716169|529835753|FG000|Overall Study|Withdrawal by Subject|1|||
146910661|NCT01716169|529835753|FG000|Overall Study|inconsistent dressing application|1|||
146910662|NCT00306891|529835756|FG000|Part A|Withdrawal by Subject|1|||
146910663|NCT00306891|529835757|FG001|Part A|Withdrawal by Subject|1|||
146910664|NCT00306891|529835758|FG002|Part A|Withdrawal by Subject|0|||
146910665|NCT00306891|529835759|FG003|Part A|Withdrawal by Subject|0|||
146910666|NCT00306891|529835756|FG000|Part A|Condition under investigation worsened|2|||
146910667|NCT00306891|529835757|FG001|Part A|Condition under investigation worsened|2|||
146910668|NCT00306891|529835758|FG002|Part A|Condition under investigation worsened|0|||
146910669|NCT00306891|529835759|FG003|Part A|Condition under investigation worsened|0|||
146910670|NCT00306891|529835756|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
146910671|NCT00306891|529835757|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
146910672|NCT00306891|529835758|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
146910673|NCT00306891|529835759|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
146910674|NCT00306891|529835756|FG000|Part A|Partial bowel obstruction|1|||
146910675|NCT00306891|529835757|FG001|Part A|Partial bowel obstruction|0|||
146970816|NCT03387735|530054340|FG001|Overall Study|Death|8|||
146970817|NCT03099161|530054343|FG000|Overall Study|Adverse Event|0|||
146970818|NCT03099161|530054344|FG001|Overall Study|Adverse Event|0|||
146970819|NCT03099161|530054345|FG002|Overall Study|Adverse Event|2|||
146970820|NCT03099161|530054343|FG000|Overall Study|Physician Decision|2|||
146970821|NCT03099161|530054344|FG001|Overall Study|Physician Decision|0|||
146970822|NCT03099161|530054345|FG002|Overall Study|Physician Decision|0|||
146970823|NCT03099161|530054343|FG000|Overall Study|Progressive Disease|1|||
146970824|NCT03099161|530054344|FG001|Overall Study|Progressive Disease|4|||
146970825|NCT03099161|530054345|FG002|Overall Study|Progressive Disease|1|||
146970826|NCT00110084|530054346|FG000|Overall Study|Adverse Event|9|||
146970827|NCT00110084|530054346|FG000|Overall Study|Death|1|||
146970828|NCT00110084|530054346|FG000|Overall Study|Patient Refusal|10|||
146970829|NCT00110084|530054346|FG000|Overall Study|Alternate Therapy|5|||
146970830|NCT00110084|530054346|FG000|Overall Study|Intercurrent Illness|1|||
146970831|NCT00110084|530054346|FG000|Overall Study|Other|2|||
146970832|NCT04854707|530054348|FG000|Overall Study|Lack of Efficacy|78|||
146970833|NCT04854707|530054349|FG001|Overall Study|Lack of Efficacy|59|||
146970834|NCT04854707|530054350|FG002|Overall Study|Lack of Efficacy|30|||
146970835|NCT00742859|530054352|FG000|Overall Study|Adverse Event|5|||
146970836|NCT00742859|530054353|FG001|Overall Study|Adverse Event|6|||
146970837|NCT00742859|530054354|FG002|Overall Study|Adverse Event|3|||
146970838|NCT00742859|530054355|FG003|Overall Study|Adverse Event|1|||
146970839|NCT00742859|530054352|FG000|Overall Study|Death|1|||
146970840|NCT00742859|530054353|FG001|Overall Study|Death|0|||
146970841|NCT00742859|530054354|FG002|Overall Study|Death|0|||
146970842|NCT00742859|530054355|FG003|Overall Study|Death|1|||
146970843|NCT00742859|530054352|FG000|Overall Study|Physician Decision|1|||
146970844|NCT00742859|530054353|FG001|Overall Study|Physician Decision|2|||
146970845|NCT00742859|530054354|FG002|Overall Study|Physician Decision|0|||
146970846|NCT00742859|530054355|FG003|Overall Study|Physician Decision|0|||
146970847|NCT00742859|530054352|FG000|Overall Study|Withdrawal by Subject|4|||
146970848|NCT00742859|530054353|FG001|Overall Study|Withdrawal by Subject|2|||
146768606|NCT01596504|529321740|FG000|Overall Study|Adverse Event|1|||
146768607|NCT01596504|529321741|FG001|Overall Study|Adverse Event|2|||
146768608|NCT01596504|529321742|FG002|Overall Study|Adverse Event|1|||
146970849|NCT00742859|530054354|FG002|Overall Study|Withdrawal by Subject|4|||
146970850|NCT00742859|530054355|FG003|Overall Study|Withdrawal by Subject|1|||
146970851|NCT00742859|530054352|FG000|Overall Study|Endpoint|0|||
146970852|NCT00742859|530054353|FG001|Overall Study|Endpoint|1|||
146970853|NCT00742859|530054354|FG002|Overall Study|Endpoint|1|||
146970854|NCT00742859|530054355|FG003|Overall Study|Endpoint|2|||
146970855|NCT00742859|530054352|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
146970856|NCT00742859|530054353|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
146970857|NCT00742859|530054354|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
146970858|NCT00742859|530054355|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
146970859|NCT00742859|530054352|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
146970860|NCT00742859|530054353|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
146970861|NCT00742859|530054354|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
146970862|NCT00742859|530054355|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
146768609|NCT01596504|529321740|FG000|Overall Study|Withdrawal by Subject|1|||
146768610|NCT01596504|529321741|FG001|Overall Study|Withdrawal by Subject|0|||
146768611|NCT01596504|529321742|FG002|Overall Study|Withdrawal by Subject|0|||
146768612|NCT01901276|529321743|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
146768613|NCT01901276|529321744|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
146768614|NCT00395018|529321745|FG000|On-Treatment|Death|4|||
146768615|NCT00395018|529321745|FG000|On-Treatment|Other Reason|2|||
146768616|NCT00395018|529321745|FG000|On-Treatment|Poor/non-compliance|2|||
146768617|NCT00395018|529321745|FG000|On-Treatment|Subject no longer meets study criteria|2|||
146768618|NCT00395018|529321745|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
146768619|NCT00395018|529321745|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
146768620|NCT00395018|529321745|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
146768621|NCT02314117|529321746|FG000|Overall Study|Lost to Follow-up|9|||
146768622|NCT02314117|529321747|FG001|Overall Study|Lost to Follow-up|14|||
146768623|NCT02314117|529321746|FG000|Overall Study|Withdrawal by Subject|3|||
146768624|NCT02314117|529321747|FG001|Overall Study|Withdrawal by Subject|2|||
146768625|NCT04439799|529321748|FG000|Overall Study|Lost to Follow-up|6|||
146768626|NCT04439799|529321749|FG001|Overall Study|Lost to Follow-up|6|||
146768627|NCT04439799|529321748|FG000|Overall Study|Withdrawal by Subject|2|||
146768628|NCT04439799|529321749|FG001|Overall Study|Withdrawal by Subject|6|||
146768629|NCT04439799|529321748|FG000|Overall Study|Adverse Event|2|||
146768630|NCT04439799|529321749|FG001|Overall Study|Adverse Event|5|||
146768631|NCT00949975|529321750|FG000|Overall Study|Voluntary discontinuation|6|||
146768632|NCT00949975|529321751|FG001|Overall Study|Voluntary discontinuation|5|||
146768633|NCT00949975|529321752|FG002|Overall Study|Voluntary discontinuation|3|||
146768634|NCT00949975|529321753|FG003|Overall Study|Voluntary discontinuation|6|||
146768635|NCT00949975|529321750|FG000|Overall Study|Adverse Event|11|||
146768636|NCT00949975|529321751|FG001|Overall Study|Adverse Event|11|||
146768637|NCT00949975|529321752|FG002|Overall Study|Adverse Event|10|||
146768638|NCT00949975|529321753|FG003|Overall Study|Adverse Event|10|||
146768639|NCT00949975|529321750|FG000|Overall Study|Safety reason|0|||
146768640|NCT00949975|529321751|FG001|Overall Study|Safety reason|1|||
146768641|NCT00949975|529321752|FG002|Overall Study|Safety reason|0|||
146768642|NCT00949975|529321753|FG003|Overall Study|Safety reason|0|||
146768643|NCT00949975|529321750|FG000|Overall Study|Study-specific criteria|0|||
146768644|NCT00949975|529321751|FG001|Overall Study|Study-specific criteria|1|||
146768645|NCT00949975|529321752|FG002|Overall Study|Study-specific criteria|1|||
146768646|NCT00949975|529321753|FG003|Overall Study|Study-specific criteria|0|||
146768647|NCT00949975|529321750|FG000|Overall Study|Incorrect enrolment|5|||
146768648|NCT00949975|529321751|FG001|Overall Study|Incorrect enrolment|10|||
146910676|NCT00306891|529835758|FG002|Part A|Partial bowel obstruction|0|||
146910677|NCT00306891|529835759|FG003|Part A|Partial bowel obstruction|0|||
146910678|NCT00306891|529835756|FG000|Part A|Reaccumul. of ascites following drainage|0|||
146910679|NCT00306891|529835757|FG001|Part A|Reaccumul. of ascites following drainage|1|||
146910680|NCT00306891|529835758|FG002|Part A|Reaccumul. of ascites following drainage|0|||
146910681|NCT00306891|529835759|FG003|Part A|Reaccumul. of ascites following drainage|0|||
146910682|NCT00306891|529835756|FG000|Part A|Suspicion of second malignancy|0|||
146910683|NCT00306891|529835757|FG001|Part A|Suspicion of second malignancy|1|||
146910684|NCT00306891|529835758|FG002|Part A|Suspicion of second malignancy|0|||
146910685|NCT00306891|529835759|FG003|Part A|Suspicion of second malignancy|0|||
146910686|NCT00306891|529835756|FG000|Part A|QTC interval outwith elig. criteria|1|||
146910687|NCT00306891|529835757|FG001|Part A|QTC interval outwith elig. criteria|0|||
146910688|NCT00306891|529835758|FG002|Part A|QTC interval outwith elig. criteria|0|||
146910689|NCT00306891|529835759|FG003|Part A|QTC interval outwith elig. criteria|0|||
146910690|NCT00306891|529835756|FG000|Part B|Death|0|||
146910691|NCT00306891|529835757|FG001|Part B|Death|0|||
146910692|NCT00306891|529835758|FG002|Part B|Death|1|||
146910693|NCT00306891|529835759|FG003|Part B|Death|2|||
146910694|NCT00306891|529835756|FG000|Part B|Adverse Event|0|||
146910695|NCT00306891|529835757|FG001|Part B|Adverse Event|0|||
146910696|NCT00306891|529835758|FG002|Part B|Adverse Event|5|||
146910697|NCT00306891|529835759|FG003|Part B|Adverse Event|5|||
146910698|NCT00306891|529835756|FG000|Part B|Withdrawal by Subject|0|||
146910699|NCT00306891|529835757|FG001|Part B|Withdrawal by Subject|0|||
146910700|NCT00306891|529835758|FG002|Part B|Withdrawal by Subject|3|||
146910701|NCT00306891|529835759|FG003|Part B|Withdrawal by Subject|1|||
146910702|NCT00306891|529835756|FG000|Part B|Condition under investigation worsened|0|||
146970863|NCT00742859|530054352|FG000|Overall Study|Sponsor request patient out of town|0|||
146768649|NCT00949975|529321752|FG002|Overall Study|Incorrect enrolment|4|||
146768650|NCT00949975|529321753|FG003|Overall Study|Incorrect enrolment|7|||
146768651|NCT00949975|529321750|FG000|Overall Study|Severe non-compliance|3|||
146768652|NCT00949975|529321751|FG001|Overall Study|Severe non-compliance|1|||
146910703|NCT00306891|529835757|FG001|Part B|Condition under investigation worsened|0|||
146910704|NCT00306891|529835758|FG002|Part B|Condition under investigation worsened|2|||
146910705|NCT00306891|529835759|FG003|Part B|Condition under investigation worsened|8|||
146910706|NCT00306891|529835756|FG000|Part B|Development of study specific disc crit.|0|||
146768653|NCT00949975|529321752|FG002|Overall Study|Severe non-compliance|0|||
146910707|NCT00306891|529835757|FG001|Part B|Development of study specific disc crit.|0|||
146970864|NCT00742859|530054353|FG001|Overall Study|Sponsor request patient out of town|0|||
146970865|NCT00742859|530054354|FG002|Overall Study|Sponsor request patient out of town|1|||
146970866|NCT00742859|530054355|FG003|Overall Study|Sponsor request patient out of town|1|||
146970867|NCT00742859|530054352|FG000|Overall Study|Site error|0|||
146970868|NCT00742859|530054353|FG001|Overall Study|Site error|0|||
146970869|NCT00742859|530054354|FG002|Overall Study|Site error|1|||
146970870|NCT00742859|530054355|FG003|Overall Study|Site error|1|||
146970871|NCT00943384|530054367|FG000|Overall Study|Dispositioned prior to treatment|23|||
146970872|NCT00943384|530054367|FG000|Overall Study|Treated off protocol-protocol violation|5|||
146970873|NCT00943384|530054367|FG000|Overall Study|Lost to Follow-up|16|||
146970874|NCT00943384|530054367|FG000|Overall Study|Withdrawal by Subject|5|||
146970875|NCT02575807|530054371|FG000|Overall Study|Death|8|||
146642692|NCT00689117|528869609|FG001|Overall Study|Lack of Efficacy|2|||
146910708|NCT00306891|529835758|FG002|Part B|Development of study specific disc crit.|0|||
146910709|NCT00306891|529835759|FG003|Part B|Development of study specific disc crit.|1|||
146910710|NCT00231478|529835761|FG000|Overall Study|Protocol Violation|3|||
146910711|NCT00231478|529835762|FG001|Overall Study|Protocol Violation|2|||
146910712|NCT00231478|529835761|FG000|Overall Study|Refused Treatment|1|||
146910713|NCT00231478|529835762|FG001|Overall Study|Refused Treatment|1|||
146910714|NCT00231478|529835761|FG000|Overall Study|Withdrawal by Subject|1|||
146910715|NCT00231478|529835762|FG001|Overall Study|Withdrawal by Subject|0|||
146910716|NCT00231478|529835761|FG000|Overall Study|Adverse Event|0|||
146910717|NCT00231478|529835762|FG001|Overall Study|Adverse Event|1|||
146910718|NCT00231478|529835761|FG000|Overall Study|Administrative|3|||
146910719|NCT00231478|529835762|FG001|Overall Study|Administrative|2|||
146910720|NCT04538950|529835763|FG000|Overall Study|Pulmonary Issues|2|||
146910721|NCT04538950|529835763|FG000|Overall Study|illness|2|||
146910722|NCT01707147|529835764|FG000|Overall Study|Administered Trajenta prior to contract|5|||
146910723|NCT01707147|529835764|FG000|Overall Study|Patients who have not taken Trajenta|1|||
146910724|NCT01707147|529835764|FG000|Overall Study|Follow-up failure|17|||
146910725|NCT01707147|529835764|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
146910726|NCT02489630|529835767|FG000|Overall Study|Oversedation|1|||
146910727|NCT02489630|529835768|FG001|Overall Study|Oversedation|1|||
146910728|NCT02489630|529835767|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
146910729|NCT02489630|529835768|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
146910730|NCT02053246|529835770|FG000|Overall Study|Withdrawal by Subject|3|||
146910731|NCT02053246|529835770|FG000|Overall Study|Physician Decision|1|||
146910732|NCT01056523|529835771|FG000|Overall Study|Death|1|||
146910733|NCT01056523|529835772|FG001|Overall Study|Death|0|||
146910734|NCT01056523|529835773|FG002|Overall Study|Death|2|||
146910735|NCT01056523|529835774|FG003|Overall Study|Death|3|||
146910736|NCT01056523|529835775|FG004|Overall Study|Death|0|||
146910737|NCT01056523|529835776|FG005|Overall Study|Death|0|||
146910738|NCT01056523|529835777|FG006|Overall Study|Death|1|||
146910739|NCT03429556|529835778|FG000|Overall Study|Lost to Follow-up|0|||
146910740|NCT03429556|529835779|FG001|Overall Study|Lost to Follow-up|1|||
146910741|NCT03429556|529835780|FG002|Overall Study|Lost to Follow-up|0|||
146910742|NCT03429556|529835781|FG003|Overall Study|Lost to Follow-up|0|||
146910743|NCT00907738|529835782|FG000|Overall Study|Adverse Event|2|||
146910744|NCT00907738|529835783|FG001|Overall Study|Adverse Event|0|||
146910745|NCT00907738|529835784|FG002|Overall Study|Adverse Event|1|||
146910746|NCT00907738|529835785|FG003|Overall Study|Adverse Event|0|||
146910747|NCT00907738|529835786|FG004|Overall Study|Adverse Event|0|||
146910748|NCT00907738|529835782|FG000|Overall Study|not specified or withdrew consent|3|||
146642693|NCT00689117|528869610|FG002|Overall Study|Lack of Efficacy|2|||
146910749|NCT00907738|529835783|FG001|Overall Study|not specified or withdrew consent|0|||
146910750|NCT00907738|529835784|FG002|Overall Study|not specified or withdrew consent|0|||
146970876|NCT02575807|530054372|FG001|Overall Study|Death|3|||
146910751|NCT00907738|529835785|FG003|Overall Study|not specified or withdrew consent|0|||
146910752|NCT00907738|529835786|FG004|Overall Study|not specified or withdrew consent|0|||
146910753|NCT00907738|529835782|FG000|Overall Study|Disease progression|8|||
146910754|NCT00907738|529835783|FG001|Overall Study|Disease progression|1|||
146910755|NCT00907738|529835784|FG002|Overall Study|Disease progression|6|||
146910756|NCT00907738|529835785|FG003|Overall Study|Disease progression|4|||
146970877|NCT02575807|530054373|FG002|Overall Study|Death|7|||
146970878|NCT02575807|530054374|FG003|Overall Study|Death|0|||
146970879|NCT02575807|530054375|FG004|Overall Study|Death|1|||
146970880|NCT02575807|530054371|FG000|Overall Study|Study terminated by Sponsor|0|||
146970881|NCT02575807|530054372|FG001|Overall Study|Study terminated by Sponsor|1|||
146970882|NCT02575807|530054373|FG002|Overall Study|Study terminated by Sponsor|7|||
146970883|NCT02575807|530054374|FG003|Overall Study|Study terminated by Sponsor|0|||
146970884|NCT02575807|530054375|FG004|Overall Study|Study terminated by Sponsor|1|||
146970885|NCT02575807|530054371|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
146970886|NCT02575807|530054372|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
146970887|NCT02575807|530054373|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
146970888|NCT02575807|530054374|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
146970889|NCT02575807|530054375|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
146970890|NCT02575807|530054371|FG000|Overall Study|Terminated due to physician decision|0|||
146970891|NCT02575807|530054372|FG001|Overall Study|Terminated due to physician decision|0|||
146970892|NCT02575807|530054373|FG002|Overall Study|Terminated due to physician decision|1|||
146970893|NCT02575807|530054374|FG003|Overall Study|Terminated due to physician decision|0|||
146970894|NCT02575807|530054375|FG004|Overall Study|Terminated due to physician decision|0|||
146970895|NCT02575807|530054371|FG000|Overall Study|Subject ineligible - medical implant|0|||
146970896|NCT02575807|530054372|FG001|Overall Study|Subject ineligible - medical implant|0|||
146970897|NCT02575807|530054373|FG002|Overall Study|Subject ineligible - medical implant|0|||
146970898|NCT02575807|530054374|FG003|Overall Study|Subject ineligible - medical implant|1|||
146970899|NCT02575807|530054375|FG004|Overall Study|Subject ineligible - medical implant|0|||
146970900|NCT02575807|530054371|FG000|Overall Study|Withdrawal by Subject|0|||
146970901|NCT02575807|530054372|FG001|Overall Study|Withdrawal by Subject|0|||
146970902|NCT02575807|530054373|FG002|Overall Study|Withdrawal by Subject|1|||
146970903|NCT02575807|530054374|FG003|Overall Study|Withdrawal by Subject|1|||
146970904|NCT02575807|530054375|FG004|Overall Study|Withdrawal by Subject|2|||
146970905|NCT00478673|530054383|FG000|30-Days Post-Procedure|Death|2|||
146970906|NCT00478673|530054383|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
146970907|NCT00478673|530054383|FG000|30-Days Post-Procedure|Missed Visit|7|||
146970908|NCT00478673|530054383|FG000|12-Months Post-Procedure|Death|23|||
146970909|NCT00478673|530054383|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
146970910|NCT00478673|530054383|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
146970911|NCT00478673|530054383|FG000|12-Months Post-Procedure|Missed Visit|25|||
146970912|NCT00478673|530054383|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
146970913|NCT03940742|530054389|FG000|Overall Study|Lost to Follow-up|0|||
146970914|NCT03940742|530054390|FG001|Overall Study|Lost to Follow-up|0|||
146910757|NCT00907738|529835786|FG004|Overall Study|Disease progression|2|||
146910758|NCT05363293|529835787|FG000|Overall Study|Withdrawal by Subject|1|||
146910759|NCT05363293|529835788|FG001|Overall Study|Withdrawal by Subject|0|||
146910760|NCT05363293|529835789|FG002|Overall Study|Withdrawal by Subject|0|||
146910761|NCT05363293|529835790|FG003|Overall Study|Withdrawal by Subject|0|||
146642694|NCT00689117|528869611|FG003|Overall Study|Lack of Efficacy|2|||
146642695|NCT00689117|528869608|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
146642696|NCT00689117|528869609|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
146910762|NCT05363293|529835791|FG004|Overall Study|Withdrawal by Subject|0|||
146642697|NCT00689117|528869610|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
146910763|NCT05363293|529835792|FG005|Overall Study|Withdrawal by Subject|0|||
146910764|NCT05363293|529835793|FG006|Overall Study|Withdrawal by Subject|0|||
146642698|NCT00689117|528869611|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
146970915|NCT03940742|530054391|FG002|Overall Study|Lost to Follow-up|0|||
146970916|NCT03940742|530054392|FG003|Overall Study|Lost to Follow-up|1|||
146970917|NCT03428217|530054393|FG000|Overall Study|Death|89|||
146970918|NCT03428217|530054394|FG001|Overall Study|Death|93|||
146970919|NCT03428217|530054393|FG000|Overall Study|Withdrawal by Subject|8|||
146970920|NCT03428217|530054394|FG001|Overall Study|Withdrawal by Subject|7|||
146970921|NCT03428217|530054393|FG000|Overall Study|Lost to Follow-up|1|||
146970922|NCT03428217|530054394|FG001|Overall Study|Lost to Follow-up|3|||
146970923|NCT03428217|530054393|FG000|Overall Study|Study terminated by sponsor|124|||
146970924|NCT03428217|530054394|FG001|Overall Study|Study terminated by sponsor|118|||
146970925|NCT03428217|530054393|FG000|Overall Study|Other, Not Specified|1|||
146970926|NCT03428217|530054394|FG001|Overall Study|Other, Not Specified|0|||
146970927|NCT03889197|530054395|FG000|Overall Study|Withdrawal by Subject|1|||
146970928|NCT03889197|530054396|FG001|Overall Study|Withdrawal by Subject|0|||
146970929|NCT03889197|530054395|FG000|Overall Study|Physician Decision|0|||
146970930|NCT03889197|530054396|FG001|Overall Study|Physician Decision|1|||
146970931|NCT03889197|530054395|FG000|Overall Study|met exclusion criteria|0|||
146970932|NCT03889197|530054396|FG001|Overall Study|met exclusion criteria|1|||
146970933|NCT03889197|530054395|FG000|Overall Study|Protocol Violation|1|||
146970934|NCT03889197|530054396|FG001|Overall Study|Protocol Violation|0|||
146970935|NCT05246111|530054397|FG000|Period 01|NOT ELIGIBLE IC5|1|||
146970936|NCT05246111|530054398|FG001|Period 01|NOT ELIGIBLE IC5|0|||
146970937|NCT03151226|530054399|FG000|Overall Study|Withdrawal by Subject|2|||
146970938|NCT03151226|530054399|FG000|Overall Study|not wear device correctly|1|||
146970939|NCT00402779|530054400|FG000|Overall Study|Screen Failure|77|||
146970940|NCT00402779|530054401|FG001|Overall Study|Screen Failure|76|||
146970941|NCT05004181|530054404|FG000|Overall Study|Withdrawal of consent|0|||
146970942|NCT05004181|530054405|FG001|Overall Study|Withdrawal of consent|0|||
146970943|NCT05004181|530054406|FG002|Overall Study|Withdrawal of consent|1|||
146970944|NCT05004181|530054407|FG003|Overall Study|Withdrawal of consent|3|||
146970945|NCT05004181|530054408|FG004|Overall Study|Withdrawal of consent|3|||
146970946|NCT05004181|530054409|FG005|Overall Study|Withdrawal of consent|0|||
146970947|NCT05004181|530054410|FG006|Overall Study|Withdrawal of consent|30|||
146970948|NCT05004181|530054411|FG007|Overall Study|Withdrawal of consent|9|||
146970949|NCT05004181|530054412|FG008|Overall Study|Withdrawal of consent|3|||
146970950|NCT05004181|530054413|FG009|Overall Study|Withdrawal of consent|2|||
146970951|NCT05004181|530054414|FG010|Overall Study|Withdrawal of consent|5|||
146970952|NCT05004181|530054415|FG011|Overall Study|Withdrawal of consent|1|||
146970953|NCT05004181|530054404|FG000|Overall Study|Lost to Follow-up|2|||
146970954|NCT05004181|530054405|FG001|Overall Study|Lost to Follow-up|4|||
146970955|NCT05004181|530054406|FG002|Overall Study|Lost to Follow-up|2|||
146970956|NCT05004181|530054407|FG003|Overall Study|Lost to Follow-up|3|||
146970957|NCT05004181|530054408|FG004|Overall Study|Lost to Follow-up|5|||
146970958|NCT05004181|530054409|FG005|Overall Study|Lost to Follow-up|2|||
146970959|NCT05004181|530054410|FG006|Overall Study|Lost to Follow-up|15|||
146970960|NCT05004181|530054411|FG007|Overall Study|Lost to Follow-up|12|||
146970961|NCT05004181|530054412|FG008|Overall Study|Lost to Follow-up|38|||
146970962|NCT05004181|530054413|FG009|Overall Study|Lost to Follow-up|6|||
146970963|NCT05004181|530054414|FG010|Overall Study|Lost to Follow-up|6|||
146970964|NCT05004181|530054415|FG011|Overall Study|Lost to Follow-up|0|||
146970965|NCT05004181|530054404|FG000|Overall Study|Death|0|||
146970966|NCT05004181|530054405|FG001|Overall Study|Death|0|||
146970967|NCT05004181|530054406|FG002|Overall Study|Death|0|||
146970968|NCT05004181|530054407|FG003|Overall Study|Death|0|||
146970969|NCT05004181|530054408|FG004|Overall Study|Death|0|||
146970970|NCT05004181|530054409|FG005|Overall Study|Death|0|||
146970971|NCT05004181|530054410|FG006|Overall Study|Death|1|||
146970972|NCT05004181|530054411|FG007|Overall Study|Death|0|||
146970973|NCT05004181|530054412|FG008|Overall Study|Death|2|||
146970974|NCT05004181|530054413|FG009|Overall Study|Death|0|||
146970975|NCT05004181|530054414|FG010|Overall Study|Death|0|||
146970976|NCT05004181|530054415|FG011|Overall Study|Death|0|||
146970977|NCT05004181|530054404|FG000|Overall Study|Physician Decision|0|||
146970978|NCT05004181|530054405|FG001|Overall Study|Physician Decision|0|||
146970979|NCT05004181|530054406|FG002|Overall Study|Physician Decision|0|||
146970980|NCT05004181|530054407|FG003|Overall Study|Physician Decision|0|||
146970981|NCT05004181|530054408|FG004|Overall Study|Physician Decision|0|||
146970982|NCT05004181|530054409|FG005|Overall Study|Physician Decision|0|||
146970983|NCT05004181|530054410|FG006|Overall Study|Physician Decision|2|||
146970984|NCT05004181|530054411|FG007|Overall Study|Physician Decision|0|||
146970985|NCT05004181|530054412|FG008|Overall Study|Physician Decision|7|||
146970986|NCT05004181|530054413|FG009|Overall Study|Physician Decision|0|||
146970987|NCT05004181|530054414|FG010|Overall Study|Physician Decision|0|||
146970988|NCT05004181|530054415|FG011|Overall Study|Physician Decision|0|||
146970989|NCT05004181|530054404|FG000|Overall Study|Withdrawal by Subject|2|||
146970990|NCT05004181|530054405|FG001|Overall Study|Withdrawal by Subject|3|||
146970991|NCT05004181|530054406|FG002|Overall Study|Withdrawal by Subject|2|||
146970992|NCT05004181|530054407|FG003|Overall Study|Withdrawal by Subject|2|||
146970993|NCT05004181|530054408|FG004|Overall Study|Withdrawal by Subject|4|||
146970994|NCT05004181|530054409|FG005|Overall Study|Withdrawal by Subject|2|||
146970995|NCT05004181|530054410|FG006|Overall Study|Withdrawal by Subject|4|||
146970996|NCT05004181|530054411|FG007|Overall Study|Withdrawal by Subject|22|||
146970997|NCT05004181|530054412|FG008|Overall Study|Withdrawal by Subject|8|||
146970998|NCT05004181|530054413|FG009|Overall Study|Withdrawal by Subject|1|||
146970999|NCT05004181|530054414|FG010|Overall Study|Withdrawal by Subject|3|||
146971000|NCT05004181|530054415|FG011|Overall Study|Withdrawal by Subject|2|||
146971001|NCT05004181|530054404|FG000|Overall Study|Protocol Violation|2|||
146971002|NCT05004181|530054405|FG001|Overall Study|Protocol Violation|3|||
146971003|NCT05004181|530054406|FG002|Overall Study|Protocol Violation|0|||
146971004|NCT05004181|530054407|FG003|Overall Study|Protocol Violation|0|||
146971005|NCT05004181|530054408|FG004|Overall Study|Protocol Violation|1|||
146971006|NCT05004181|530054409|FG005|Overall Study|Protocol Violation|0|||
146971007|NCT05004181|530054410|FG006|Overall Study|Protocol Violation|16|||
146971008|NCT05004181|530054411|FG007|Overall Study|Protocol Violation|18|||
146971009|NCT05004181|530054412|FG008|Overall Study|Protocol Violation|2|||
146971010|NCT05004181|530054413|FG009|Overall Study|Protocol Violation|2|||
146971011|NCT05004181|530054414|FG010|Overall Study|Protocol Violation|2|||
146642699|NCT00689117|528869608|FG000|Overall Study|Withdrawal by Subject|19|||
146642700|NCT00689117|528869609|FG001|Overall Study|Withdrawal by Subject|18|||
146642701|NCT00689117|528869610|FG002|Overall Study|Withdrawal by Subject|26|||
146642702|NCT00689117|528869611|FG003|Overall Study|Withdrawal by Subject|13|||
146642703|NCT00689117|528869608|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
146642704|NCT00689117|528869609|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
146642705|NCT00689117|528869610|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
146642706|NCT00689117|528869611|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
146642707|NCT00689117|528869608|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
146642708|NCT00689117|528869609|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
146642709|NCT00689117|528869610|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146642710|NCT00689117|528869611|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146642711|NCT00689117|528869608|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
146642712|NCT00689117|528869609|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
146642713|NCT00689117|528869610|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
146642714|NCT00689117|528869611|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
146642715|NCT00689117|528869608|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
146642716|NCT00689117|528869609|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
146642717|NCT00689117|528869610|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
146642718|NCT00689117|528869611|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
146642719|NCT00689117|528869608|FG000|Overall Study|Use of Prohibitive Medication|2|||
146642720|NCT00689117|528869609|FG001|Overall Study|Use of Prohibitive Medication|1|||
146642721|NCT00689117|528869610|FG002|Overall Study|Use of Prohibitive Medication|3|||
146642722|NCT00689117|528869611|FG003|Overall Study|Use of Prohibitive Medication|0|||
146642723|NCT00689117|528869608|FG000|Overall Study|Pregnancy|0|||
146642724|NCT00689117|528869609|FG001|Overall Study|Pregnancy|2|||
146971012|NCT05004181|530054415|FG011|Overall Study|Protocol Violation|1|||
146642725|NCT00689117|528869610|FG002|Overall Study|Pregnancy|0|||
146971013|NCT05004181|530054404|FG000|Overall Study|Not further specified|1|||
146971014|NCT05004181|530054405|FG001|Overall Study|Not further specified|0|||
146971015|NCT05004181|530054406|FG002|Overall Study|Not further specified|0|||
146971016|NCT05004181|530054407|FG003|Overall Study|Not further specified|0|||
146971017|NCT05004181|530054408|FG004|Overall Study|Not further specified|0|||
146971018|NCT05004181|530054409|FG005|Overall Study|Not further specified|0|||
146971019|NCT05004181|530054410|FG006|Overall Study|Not further specified|1|||
146971020|NCT05004181|530054411|FG007|Overall Study|Not further specified|0|||
146971021|NCT05004181|530054412|FG008|Overall Study|Not further specified|2|||
146910765|NCT05363293|529835794|FG007|Overall Study|Withdrawal by Subject|0|||
146910766|NCT05363293|529835795|FG008|Overall Study|Withdrawal by Subject|0|||
146910767|NCT05363293|529835796|FG009|Overall Study|Withdrawal by Subject|0|||
146910768|NCT05243550|529837284|FG000|Overall Study|Ongoing in the Study|171|||
146910769|NCT05243550|529837284|FG000|Overall Study|Withdrawal by Subject|10|||
146910770|NCT05243550|529837284|FG000|Overall Study|Lost to Follow-up|7|||
146910771|NCT05243550|529837284|FG000|Overall Study|Adverse Event|3|||
146910772|NCT05243550|529837284|FG000|Overall Study|Noncompliance|1|||
146910773|NCT05243550|529837284|FG000|Overall Study|Physician Decision|1|||
146910774|NCT05243550|529837284|FG000|Overall Study|Other Reason|4|||
146910775|NCT01894516|529837285|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
146910776|NCT01894516|529837286|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
146910777|NCT01894516|529837287|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
146910778|NCT01894516|529837288|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
146910779|NCT01894516|529837285|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
146910780|NCT01894516|529837286|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146910781|NCT01894516|529837287|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146910782|NCT01894516|529837288|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146910783|NCT01894516|529837285|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
146910784|NCT01894516|529837286|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
146910785|NCT01894516|529837287|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
146910786|NCT01894516|529837288|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
146910787|NCT01894516|529837285|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
146910788|NCT01894516|529837286|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
146910789|NCT01894516|529837287|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
146910790|NCT01894516|529837288|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
146910791|NCT01894516|529837285|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
146910792|NCT01894516|529837286|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
146910793|NCT01894516|529837287|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
146910794|NCT01894516|529837288|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
146910795|NCT01894516|529837285|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
146910796|NCT01894516|529837286|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
146910797|NCT01894516|529837287|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
146910798|NCT01894516|529837288|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
146910799|NCT01894516|529837285|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
146910800|NCT01894516|529837286|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
146910801|NCT01894516|529837287|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
146910802|NCT01894516|529837288|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
146910803|NCT01894516|529837285|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
146910804|NCT01894516|529837286|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
146910805|NCT01894516|529837287|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
146910806|NCT01894516|529837288|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
146910807|NCT01486316|529837292|FG000|Overall Study|Device explanted with/without re-implant|3|||
146910808|NCT01486316|529837293|FG001|Overall Study|Device explanted with/without re-implant|2|||
146910809|NCT01486316|529837294|FG002|Overall Study|Device explanted with/without re-implant|0|||
146910810|NCT01486316|529837295|FG003|Overall Study|Device explanted with/without re-implant|2|||
146910811|NCT01486316|529837292|FG000|Overall Study|Not meeting eligibility criteria|0|||
146910812|NCT01486316|529837293|FG001|Overall Study|Not meeting eligibility criteria|0|||
146910813|NCT01486316|529837294|FG002|Overall Study|Not meeting eligibility criteria|1|||
146910814|NCT01486316|529837295|FG003|Overall Study|Not meeting eligibility criteria|0|||
146910815|NCT01486316|529837292|FG000|Overall Study|Withdrawal by Subject|1|||
146910816|NCT01486316|529837293|FG001|Overall Study|Withdrawal by Subject|0|||
146910817|NCT01486316|529837294|FG002|Overall Study|Withdrawal by Subject|3|||
146910818|NCT01486316|529837295|FG003|Overall Study|Withdrawal by Subject|0|||
146910819|NCT01486316|529837292|FG000|Overall Study|Physician Decision|0|||
146910820|NCT01486316|529837293|FG001|Overall Study|Physician Decision|0|||
146910821|NCT01486316|529837294|FG002|Overall Study|Physician Decision|1|||
146910822|NCT01486316|529837295|FG003|Overall Study|Physician Decision|0|||
146971022|NCT05004181|530054413|FG009|Overall Study|Not further specified|1|||
146910823|NCT01486316|529837292|FG000|Overall Study|Death|0|||
146910824|NCT01486316|529837293|FG001|Overall Study|Death|1|||
146910825|NCT01486316|529837294|FG002|Overall Study|Death|0|||
146910826|NCT01486316|529837295|FG003|Overall Study|Death|0|||
146910827|NCT00375934|529837304|FG000|Overall Study|Adverse Event|1|||
146910828|NCT00375934|529837305|FG001|Overall Study|Adverse Event|1|||
146910829|NCT00375934|529837304|FG000|Overall Study|Withdrawal by Subject|2|||
146910830|NCT00375934|529837305|FG001|Overall Study|Withdrawal by Subject|2|||
146910831|NCT00375934|529837304|FG000|Overall Study|Lack of Efficacy|0|||
146910832|NCT00375934|529837305|FG001|Overall Study|Lack of Efficacy|2|||
146910833|NCT00375934|529837304|FG000|Overall Study|Physician Decision|0|||
146910834|NCT00375934|529837305|FG001|Overall Study|Physician Decision|1|||
146910835|NCT03191396|529837307|FG000|Overall Study|Lost to Follow-up|0|||
146910836|NCT03191396|529837308|FG001|Overall Study|Lost to Follow-up|3|||
146910837|NCT03191396|529837307|FG000|Overall Study|Withdrawal by Subject|3|||
146910838|NCT03191396|529837308|FG001|Overall Study|Withdrawal by Subject|2|||
146910839|NCT00893113|529837311|FG000|Overall Study|Lost to Follow-up|4|||
146910840|NCT00893113|529837312|FG001|Overall Study|Lost to Follow-up|8|||
146910841|NCT00893113|529837311|FG000|Overall Study|Early Termination|1|||
146910842|NCT00893113|529837312|FG001|Overall Study|Early Termination|1|||
146910843|NCT00893113|529837311|FG000|Overall Study|Withdrew Consent|8|||
146910844|NCT00893113|529837312|FG001|Overall Study|Withdrew Consent|7|||
146910845|NCT03270085|529837315|FG000|Overall Study|Withdrawal by Subject|1|||
146910846|NCT03270085|529837316|FG001|Overall Study|Withdrawal by Subject|0|||
146910847|NCT02114203|529837317|FG000|Overall Study|Adverse Event|0|||
146910848|NCT02114203|529837318|FG001|Overall Study|Adverse Event|1|||
146910849|NCT02114203|529837319|FG002|Overall Study|Adverse Event|0|||
146910850|NCT02114203|529837317|FG000|Overall Study|Withdrawal by Subject|0|||
146910851|NCT02114203|529837318|FG001|Overall Study|Withdrawal by Subject|1|||
146910852|NCT02114203|529837319|FG002|Overall Study|Withdrawal by Subject|0|||
146910853|NCT01518699|529837320|FG000|Period 2|Protocol Violation|1|||
146910854|NCT01518699|529837321|FG001|Period 2|Protocol Violation|1|||
146910855|NCT01518699|529837322|FG002|Period 2|Protocol Violation|0|||
146971023|NCT05004181|530054414|FG010|Overall Study|Not further specified|0|||
146971024|NCT05004181|530054415|FG011|Overall Study|Not further specified|1|||
146971025|NCT04066894|530054416|FG000|Overall Study|Lack of Efficacy|1|||
146971026|NCT04066894|530054416|FG000|Overall Study|Screen Failure|1|||
146971027|NCT04278872|530054417|FG000|Overall Study|Adverse Event|1|||
146971028|NCT04278872|530054418|FG001|Overall Study|Adverse Event|0|||
146971029|NCT04278872|530054417|FG000|Overall Study|Protocol Violation|0|||
146971030|NCT04278872|530054418|FG001|Overall Study|Protocol Violation|1|||
146971031|NCT04278872|530054417|FG000|Overall Study|Study Termination|2|||
146971032|NCT04278872|530054418|FG001|Overall Study|Study Termination|0|||
146971033|NCT00777920|530054423|FG000|Overall Study|Adverse Event|39|||
146971034|NCT00777920|530054423|FG000|Overall Study|Withdrawal of Consent|4|||
146971035|NCT00777920|530054423|FG000|Overall Study|Lost to Follow-up|1|||
146971036|NCT00777920|530054423|FG000|Overall Study|Investigator's discretion|1|||
146971037|NCT00777920|530054423|FG000|Overall Study|Clinical status did not improve|1|||
146971038|NCT00777920|530054423|FG000|Overall Study|Other, not specified|4|||
146971039|NCT00483717|530054424|FG000|Overall Study|Protocol Violation|5|||
146971040|NCT00483717|530054425|FG001|Overall Study|Protocol Violation|7|||
146971041|NCT00483717|530054424|FG000|Overall Study|Time of dosing missing|1|||
146971042|NCT00483717|530054425|FG001|Overall Study|Time of dosing missing|1|||
146971043|NCT00483717|530054424|FG000|Overall Study|No treatment for migraine|16|||
146971044|NCT00483717|530054425|FG001|Overall Study|No treatment for migraine|13|||
146971045|NCT00483717|530054424|FG000|Overall Study|Lost to Follow-up|1|||
146971046|NCT00483717|530054425|FG001|Overall Study|Lost to Follow-up|0|||
146971047|NCT00483717|530054424|FG000|Overall Study|Withdrawal by Subject|1|||
146971048|NCT00483717|530054425|FG001|Overall Study|Withdrawal by Subject|0|||
146971049|NCT03878108|530054426|FG000|Overall Study|Adverse Event|1|||
146971050|NCT03878108|530054427|FG001|Overall Study|Adverse Event|0|||
146971051|NCT00604175|530054434|FG000|Entry Through Week 28|Death|2|||
146971052|NCT00604175|530054435|FG001|Entry Through Week 28|Death|0|||
146971053|NCT00604175|530054436|FG002|Entry Through Week 28|Death|0|||
146971054|NCT00604175|530054434|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
146971055|NCT00604175|530054435|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
146971056|NCT00604175|530054436|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
146971057|NCT00604175|530054434|FG000|Entry Through Week 28|Lost to Follow-up|4|||
146971058|NCT00604175|530054435|FG001|Entry Through Week 28|Lost to Follow-up|3|||
146971059|NCT00604175|530054436|FG002|Entry Through Week 28|Lost to Follow-up|0|||
146971060|NCT00604175|530054434|FG000|Entry Through Week 28|Ineligible|1|||
146642726|NCT00689117|528869611|FG003|Overall Study|Pregnancy|2|||
146642727|NCT00689117|528869608|FG000|Overall Study|Incarceration|2|||
146642728|NCT00689117|528869609|FG001|Overall Study|Incarceration|0|||
146642729|NCT00689117|528869610|FG002|Overall Study|Incarceration|0|||
146642730|NCT00689117|528869611|FG003|Overall Study|Incarceration|0|||
146642731|NCT00689117|528869608|FG000|Overall Study|Fear of Birth Defects|0|||
146971061|NCT00604175|530054435|FG001|Entry Through Week 28|Ineligible|0|||
146971062|NCT00604175|530054436|FG002|Entry Through Week 28|Ineligible|0|||
146642732|NCT00689117|528869609|FG001|Overall Study|Fear of Birth Defects|0|||
146971063|NCT00604175|530054434|FG000|Entry Through Week 28|Did not start intervention|2|||
146642733|NCT00689117|528869610|FG002|Overall Study|Fear of Birth Defects|1|||
146642734|NCT00689117|528869611|FG003|Overall Study|Fear of Birth Defects|0|||
146971064|NCT00604175|530054435|FG001|Entry Through Week 28|Did not start intervention|0|||
146971065|NCT00604175|530054436|FG002|Entry Through Week 28|Did not start intervention|1|||
146971066|NCT00604175|530054434|FG000|Week 29 Through Week 72|Death|0|||
146971067|NCT00604175|530054435|FG001|Week 29 Through Week 72|Death|0|||
146971068|NCT00604175|530054436|FG002|Week 29 Through Week 72|Death|1|||
146971069|NCT00604175|530054434|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
146910856|NCT01518699|529837323|FG003|Period 2|Protocol Violation|0|||
146910857|NCT01518699|529837324|FG004|Period 2|Protocol Violation|0|||
146910858|NCT01518699|529837325|FG005|Period 2|Protocol Violation|0|||
146910859|NCT01518699|529837320|FG000|Period 2|Lost to Follow-up|0|||
146910860|NCT01518699|529837321|FG001|Period 2|Lost to Follow-up|1|||
146910861|NCT01518699|529837322|FG002|Period 2|Lost to Follow-up|0|||
146910862|NCT01518699|529837323|FG003|Period 2|Lost to Follow-up|0|||
146971070|NCT00604175|530054435|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
146971071|NCT00604175|530054436|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
146971072|NCT00604175|530054434|FG000|Week 29 Through Week 72|Site closure|0|||
146971073|NCT00604175|530054435|FG001|Week 29 Through Week 72|Site closure|1|||
146971074|NCT00604175|530054436|FG002|Week 29 Through Week 72|Site closure|0|||
146971075|NCT00604175|530054434|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
146971076|NCT00604175|530054435|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
146971077|NCT00604175|530054436|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
146971078|NCT02044094|530054437|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
146971079|NCT02044094|530054437|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
146971080|NCT02044094|530054437|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
146971081|NCT02044094|530054437|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
146971082|NCT02044094|530054437|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
146971083|NCT02044094|530054437|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
146971084|NCT02044094|530054437|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
146971085|NCT02044094|530054437|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
146971086|NCT03353415|530054438|FG000|Masked CGM Wear|Lost to Follow-up|2|||
146971087|NCT03353415|530054438|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
146971088|NCT00359073|530056226|FG000|Overall Study|Withdrawal by Subject|1|||
146910863|NCT01518699|529837324|FG004|Period 2|Lost to Follow-up|0|||
146642735|NCT00689117|528869608|FG000|Overall Study|Transportation|1|||
146642736|NCT00689117|528869609|FG001|Overall Study|Transportation|0|||
146642737|NCT00689117|528869610|FG002|Overall Study|Transportation|0|||
146642738|NCT00689117|528869611|FG003|Overall Study|Transportation|0|||
146642739|NCT00689117|528869608|FG000|Overall Study|Patient Withdrew from Study|0|||
146642740|NCT00689117|528869609|FG001|Overall Study|Patient Withdrew from Study|0|||
146971089|NCT00359073|530056227|FG001|Overall Study|Withdrawal by Subject|1|||
146971090|NCT00359073|530056226|FG000|Overall Study|Eligibility criteria no longer met|3|||
146642741|NCT00689117|528869610|FG002|Overall Study|Patient Withdrew from Study|0|||
146642742|NCT00689117|528869611|FG003|Overall Study|Patient Withdrew from Study|1|||
146642743|NCT00689117|528869608|FG000|Overall Study|Personal Reason|0|||
146642744|NCT00689117|528869609|FG001|Overall Study|Personal Reason|1|||
146642745|NCT00689117|528869610|FG002|Overall Study|Personal Reason|0|||
146642746|NCT00689117|528869611|FG003|Overall Study|Personal Reason|0|||
146971091|NCT00359073|530056227|FG001|Overall Study|Eligibility criteria no longer met|0|||
146971092|NCT00359073|530056226|FG000|Overall Study|developed RV16 antibody|0|||
146642747|NCT00689117|528869608|FG000|Overall Study|Dispensing Error|0|||
146642748|NCT00689117|528869609|FG001|Overall Study|Dispensing Error|1|||
146642749|NCT00689117|528869610|FG002|Overall Study|Dispensing Error|0|||
146642750|NCT00689117|528869611|FG003|Overall Study|Dispensing Error|0|||
146642751|NCT00444678|528869612|FG000|Overall Study|Toxicity|11|||
146642752|NCT00444678|528869612|FG000|Overall Study|Disease Progression|12|||
146768654|NCT00949975|529321753|FG003|Overall Study|Severe non-compliance|2|||
146768655|NCT00949975|529321750|FG000|Overall Study|Lost to Follow-up|1|||
146768656|NCT00949975|529321751|FG001|Overall Study|Lost to Follow-up|0|||
146910864|NCT01518699|529837325|FG005|Period 2|Lost to Follow-up|0|||
146910865|NCT01518699|529837320|FG000|Period 2|Adverse Event|1|||
146768657|NCT00949975|529321752|FG002|Overall Study|Lost to Follow-up|1|||
146910866|NCT01518699|529837321|FG001|Period 2|Adverse Event|0|||
146910867|NCT01518699|529837322|FG002|Period 2|Adverse Event|0|||
146910868|NCT01518699|529837323|FG003|Period 2|Adverse Event|0|||
146910869|NCT01518699|529837324|FG004|Period 2|Adverse Event|0|||
146910870|NCT01518699|529837325|FG005|Period 2|Adverse Event|0|||
146910871|NCT03692910|529837328|FG000|Overall Study|Lost to Follow-up|4|||
146910872|NCT03692910|529837329|FG001|Overall Study|Lost to Follow-up|0|||
146971093|NCT00359073|530056227|FG001|Overall Study|developed RV16 antibody|1|||
146971094|NCT01371006|530056228|FG000|Overall Study|Adverse Event|1|||
146971095|NCT01371006|530056229|FG001|Overall Study|Adverse Event|0|||
146971096|NCT00891527|530056230|FG000|Overall Study|Withdrawal by Subject|2|||
146971097|NCT03515837|530056232|FG000|Overall Study|Death|219|||
146642753|NCT00444678|528869612|FG000|Overall Study|Death|3|||
146768658|NCT00949975|529321753|FG003|Overall Study|Lost to Follow-up|3|||
146642754|NCT00444678|528869612|FG000|Overall Study|Physician Decision|3|||
146642755|NCT00444678|528869612|FG000|Overall Study|Withdrawal by Subject|2|||
146910873|NCT03692910|529837330|FG002|Overall Study|Lost to Follow-up|0|||
146642756|NCT00329797|528869616|FG000|Overall Study|Protocol Violation|1|||
146910874|NCT03692910|529837328|FG000|Overall Study|Withdrawal by Subject|2|||
146910875|NCT03692910|529837329|FG001|Overall Study|Withdrawal by Subject|0|||
146910876|NCT03692910|529837330|FG002|Overall Study|Withdrawal by Subject|0|||
146910877|NCT00151411|529837333|FG000|Overall Study|Lost to Follow-up|15|||
146910878|NCT00151411|529837334|FG001|Overall Study|Lost to Follow-up|19|||
146910879|NCT00151411|529837333|FG000|Overall Study|Withdrawal by Subject|12|||
146910880|NCT00151411|529837334|FG001|Overall Study|Withdrawal by Subject|20|||
146910881|NCT00151411|529837333|FG000|Overall Study|Adverse Event|6|||
146971098|NCT03515837|530056233|FG001|Overall Study|Death|227|||
146971099|NCT03515837|530056232|FG000|Overall Study|Lost to Follow-up|0|||
146971100|NCT03515837|530056233|FG001|Overall Study|Lost to Follow-up|1|||
146971101|NCT03515837|530056232|FG000|Overall Study|Withdrawal by Subject|0|||
146971102|NCT03515837|530056233|FG001|Overall Study|Withdrawal by Subject|4|||
146971103|NCT03515837|530056232|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
146971104|NCT03515837|530056233|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
146971105|NCT01964898|530056234|FG000|Overall Study|ineligible post-randomization|1|||
146971106|NCT01964898|530056235|FG001|Overall Study|ineligible post-randomization|1|||
146971107|NCT01964898|530056234|FG000|Overall Study|did not receive the allocated interventi|2|||
146642757|NCT00329797|528869617|FG001|Overall Study|Protocol Violation|0|||
146642758|NCT00329797|528869616|FG000|Overall Study|Withdrawal by Subject|6|||
146642759|NCT00329797|528869617|FG001|Overall Study|Withdrawal by Subject|6|||
146642760|NCT01761240|528869626|FG000|Overall Study|Progressive disease:radiology assessment|3|||
146642761|NCT01761240|528869627|FG001|Overall Study|Progressive disease:radiology assessment|3|||
146642762|NCT01761240|528869628|FG002|Overall Study|Progressive disease:radiology assessment|0|||
146642763|NCT01761240|528869629|FG003|Overall Study|Progressive disease:radiology assessment|0|||
146642764|NCT01761240|528869630|FG004|Overall Study|Progressive disease:radiology assessment|0|||
146642765|NCT01761240|528869626|FG000|Overall Study|Progressive disease:clinical assessment|0|||
146642766|NCT01761240|528869627|FG001|Overall Study|Progressive disease:clinical assessment|0|||
146642767|NCT01761240|528869628|FG002|Overall Study|Progressive disease:clinical assessment|3|||
146642768|NCT01761240|528869629|FG003|Overall Study|Progressive disease:clinical assessment|1|||
146642769|NCT01761240|528869630|FG004|Overall Study|Progressive disease:clinical assessment|0|||
146642770|NCT01761240|528869626|FG000|Overall Study|Withdrawal by Subject|0|||
146642771|NCT01761240|528869627|FG001|Overall Study|Withdrawal by Subject|0|||
146642772|NCT01761240|528869628|FG002|Overall Study|Withdrawal by Subject|0|||
146642773|NCT01761240|528869629|FG003|Overall Study|Withdrawal by Subject|3|||
146910882|NCT00151411|529837334|FG001|Overall Study|Adverse Event|0|||
146910883|NCT00151411|529837333|FG000|Overall Study|Pregnancy|0|||
146910884|NCT00151411|529837334|FG001|Overall Study|Pregnancy|4|||
146910885|NCT01283581|529837335|FG000|Overall Study|Lost to Follow-up|8|||
146910886|NCT01283581|529837336|FG001|Overall Study|Lost to Follow-up|6|||
146971108|NCT01964898|530056235|FG001|Overall Study|did not receive the allocated interventi|1|||
146642774|NCT01761240|528869630|FG004|Overall Study|Withdrawal by Subject|1|||
146910887|NCT01283581|529837337|FG002|Overall Study|Lost to Follow-up|8|||
146910888|NCT01283581|529837335|FG000|Overall Study|Withdrawal by Subject|2|||
146509184|NCT00435487|528367761|FG001|Overall Study|Death|4|||
146509185|NCT00435487|528367760|FG000|Overall Study|Adverse Event|0|||
146509186|NCT00435487|528367761|FG001|Overall Study|Adverse Event|3|||
146509187|NCT00435487|528367760|FG000|Overall Study|Lost to Follow-up|2|||
146509188|NCT00435487|528367761|FG001|Overall Study|Lost to Follow-up|2|||
146509189|NCT00435487|528367760|FG000|Overall Study|Other|5|||
146509190|NCT00435487|528367761|FG001|Overall Study|Other|2|||
146509191|NCT00435487|528367760|FG000|Overall Study|Withdrawal by Subject|2|||
146509192|NCT00435487|528367761|FG001|Overall Study|Withdrawal by Subject|1|||
146509193|NCT00435487|528367760|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
146509194|NCT00435487|528367761|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
146509195|NCT00435487|528367760|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
146563920|NCT05489328|528577836|FG004|Overall Study|Lost to Follow-up|2|||
146563921|NCT05489328|528577837|FG005|Overall Study|Lost to Follow-up|0|||
146563922|NCT05489328|528577838|FG006|Overall Study|Lost to Follow-up|0|||
146563923|NCT05489328|528577839|FG007|Overall Study|Lost to Follow-up|1|||
146563924|NCT05489328|528577840|FG008|Overall Study|Lost to Follow-up|0|||
146563925|NCT05489328|528577832|FG000|Overall Study|Withdrawal by Subject|0|||
146563926|NCT05489328|528577833|FG001|Overall Study|Withdrawal by Subject|0|||
146563927|NCT05489328|528577834|FG002|Overall Study|Withdrawal by Subject|0|||
146563928|NCT05489328|528577835|FG003|Overall Study|Withdrawal by Subject|0|||
146563929|NCT05489328|528577836|FG004|Overall Study|Withdrawal by Subject|0|||
146563930|NCT05489328|528577837|FG005|Overall Study|Withdrawal by Subject|0|||
146563931|NCT05489328|528577838|FG006|Overall Study|Withdrawal by Subject|1|||
146563932|NCT05489328|528577839|FG007|Overall Study|Withdrawal by Subject|1|||
146563933|NCT05489328|528577840|FG008|Overall Study|Withdrawal by Subject|0|||
146563934|NCT05489328|528577832|FG000|Overall Study|Other|0|||
146563935|NCT05489328|528577833|FG001|Overall Study|Other|0|||
146563936|NCT05489328|528577834|FG002|Overall Study|Other|0|||
146563937|NCT05489328|528577835|FG003|Overall Study|Other|0|||
146563938|NCT05489328|528577836|FG004|Overall Study|Other|0|||
146563939|NCT05489328|528577837|FG005|Overall Study|Other|0|||
146563940|NCT05489328|528577838|FG006|Overall Study|Other|0|||
146563941|NCT05489328|528577839|FG007|Overall Study|Other|1|||
146910889|NCT01283581|529837336|FG001|Overall Study|Withdrawal by Subject|5|||
146910890|NCT01283581|529837337|FG002|Overall Study|Withdrawal by Subject|2|||
146910891|NCT01283581|529837335|FG000|Overall Study|Adverse Event|1|||
146910892|NCT01283581|529837336|FG001|Overall Study|Adverse Event|1|||
146910893|NCT01283581|529837337|FG002|Overall Study|Adverse Event|4|||
146910894|NCT01283581|529837335|FG000|Overall Study|Physician Decision|0|||
146910895|NCT01283581|529837336|FG001|Overall Study|Physician Decision|1|||
146910896|NCT01283581|529837337|FG002|Overall Study|Physician Decision|2|||
146910897|NCT01283581|529837335|FG000|Overall Study|Protocol Violation|0|||
146910898|NCT01283581|529837336|FG001|Overall Study|Protocol Violation|1|||
146910899|NCT01283581|529837337|FG002|Overall Study|Protocol Violation|2|||
146910900|NCT01283581|529837335|FG000|Overall Study|Noncompliance|1|||
146910901|NCT01283581|529837336|FG001|Overall Study|Noncompliance|0|||
146910902|NCT01283581|529837337|FG002|Overall Study|Noncompliance|0|||
146910903|NCT01283581|529837335|FG000|Overall Study|Investigator unblinded|0|||
146910904|NCT01283581|529837336|FG001|Overall Study|Investigator unblinded|0|||
146910905|NCT01283581|529837337|FG002|Overall Study|Investigator unblinded|1|||
146910906|NCT01283581|529837335|FG000|Overall Study|"Early termination"|0|||
146910907|NCT01283581|529837336|FG001|Overall Study|"Early termination"|0|||
146910908|NCT01283581|529837337|FG002|Overall Study|"Early termination"|1|||
146910909|NCT00486226|529837338|FG000|Overall Study|Death|3|||
146910910|NCT00486226|529837338|FG000|Overall Study|Adverse Event|1|||
146910911|NCT00486226|529837338|FG000|Overall Study|Withdrawal by Subject|1|||
146910912|NCT00486226|529837338|FG000|Overall Study|Lost to Follow-up|8|||
146910913|NCT01259492|529837339|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
146910914|NCT01259492|529837340|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
146910915|NCT01259492|529837341|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
146910916|NCT01259492|529837342|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
146910917|NCT01259492|529837339|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
146910918|NCT01259492|529837340|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
146910919|NCT01259492|529837341|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
146910920|NCT01259492|529837342|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
146910921|NCT01259492|529837339|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
146910922|NCT01259492|529837340|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
146910923|NCT01259492|529837341|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
146910924|NCT01259492|529837342|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
146910925|NCT01259492|529837339|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
146910926|NCT01259492|529837340|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
146910927|NCT01259492|529837341|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
146910928|NCT01259492|529837342|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
146910929|NCT01259492|529837339|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
146910930|NCT01259492|529837340|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
146910931|NCT01259492|529837341|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
146910932|NCT01259492|529837342|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
146910933|NCT01259492|529837339|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
146910934|NCT01259492|529837340|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
146910935|NCT01259492|529837341|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
146910936|NCT01259492|529837342|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
146910937|NCT01259492|529837339|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
146563942|NCT05489328|528577840|FG008|Overall Study|Other|1|||
146563943|NCT01083602|528577841|FG000|Overall Study|Adverse Event|11|||
146910938|NCT01259492|529837340|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
146563944|NCT01083602|528577841|FG000|Overall Study|New Cancer Therapy|2|||
146910939|NCT01259492|529837341|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
146563945|NCT01083602|528577841|FG000|Overall Study|Death|1|||
146563946|NCT01083602|528577841|FG000|Overall Study|Withdrawal by Subject|5|||
146910940|NCT01259492|529837342|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
146910941|NCT01259492|529837339|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
146910942|NCT01259492|529837340|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
146910943|NCT01259492|529837341|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
146910944|NCT01259492|529837342|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
146910945|NCT01259492|529837339|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
146910946|NCT01259492|529837340|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
146910947|NCT01259492|529837341|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
146910948|NCT01259492|529837342|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
146910949|NCT01259492|529837339|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
146910950|NCT01259492|529837340|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
146910951|NCT01259492|529837341|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
146910952|NCT01259492|529837342|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
146910953|NCT01259492|529837339|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
146910954|NCT01259492|529837340|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
146642775|NCT01761240|528869626|FG000|Overall Study|Adverse Event|0|||
146642776|NCT01761240|528869627|FG001|Overall Study|Adverse Event|0|||
146642777|NCT01761240|528869628|FG002|Overall Study|Adverse Event|0|||
146642778|NCT01761240|528869629|FG003|Overall Study|Adverse Event|1|||
146642779|NCT01761240|528869630|FG004|Overall Study|Adverse Event|6|||
146642780|NCT01761240|528869626|FG000|Overall Study|Death|0|||
146642781|NCT01761240|528869627|FG001|Overall Study|Death|1|||
146642782|NCT01761240|528869628|FG002|Overall Study|Death|1|||
146642783|NCT01761240|528869629|FG003|Overall Study|Death|2|||
146642784|NCT01761240|528869630|FG004|Overall Study|Death|1|||
146642785|NCT01761240|528869626|FG000|Overall Study|Non-compliance|0|||
146642786|NCT01761240|528869627|FG001|Overall Study|Non-compliance|0|||
146642787|NCT01761240|528869628|FG002|Overall Study|Non-compliance|1|||
146642788|NCT01761240|528869629|FG003|Overall Study|Non-compliance|0|||
146642789|NCT01761240|528869630|FG004|Overall Study|Non-compliance|0|||
146642790|NCT02055118|528869636|FG000|Overall Study|Withdrawal by Subject|0|||
146642791|NCT02055118|528869637|FG001|Overall Study|Withdrawal by Subject|2|||
146642792|NCT02055118|528869638|FG002|Overall Study|Withdrawal by Subject|0|||
146642793|NCT02281383|528869641|FG000|Overall Study|Progressive Disease|1|||
146642794|NCT02281383|528869641|FG000|Overall Study|Withdrawal by Subject|6|||
146642795|NCT02281383|528869641|FG000|Overall Study|Protocol Violation|2|||
146910955|NCT01259492|529837341|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
146910956|NCT01259492|529837342|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
146910957|NCT01259492|529837339|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
146642796|NCT02281383|528869641|FG000|Overall Study|Death|1|||
146910958|NCT01259492|529837340|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
146910959|NCT01259492|529837341|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
146910960|NCT01259492|529837342|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
146910961|NCT01259492|529837339|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
146910962|NCT01259492|529837340|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
146910963|NCT01259492|529837341|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
146910964|NCT01259492|529837342|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
146910965|NCT01259492|529837339|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
146910966|NCT01259492|529837340|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
146910967|NCT01259492|529837341|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
146910968|NCT01259492|529837342|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
146910969|NCT01259492|529837339|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
146910970|NCT01259492|529837340|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
146910971|NCT01259492|529837341|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
146910972|NCT01259492|529837342|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
146910973|NCT01259492|529837339|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
146910974|NCT01259492|529837340|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
146910975|NCT01259492|529837341|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
146910976|NCT01259492|529837342|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
146642797|NCT02281383|528869641|FG000|Overall Study|Adverse Event|2|||
146768659|NCT00949975|529321750|FG000|Overall Study|Other|1|||
146642798|NCT01215097|528869642|FG000|Overall Study|Adverse Event|1|||
146642799|NCT01215097|528869643|FG001|Overall Study|Adverse Event|3|||
146642800|NCT01215097|528869642|FG000|Overall Study|Protocol Violation|0|||
146642801|NCT01215097|528869643|FG001|Overall Study|Protocol Violation|2|||
146910977|NCT01259492|529837339|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
146910978|NCT01259492|529837340|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
146910979|NCT01259492|529837341|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
146910980|NCT01259492|529837342|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
146910981|NCT01259492|529837339|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
146910982|NCT01259492|529837340|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
146910983|NCT01259492|529837341|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
146910984|NCT01259492|529837342|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
146910985|NCT01259492|529837339|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
146910986|NCT01259492|529837340|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
146910987|NCT01259492|529837341|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
146910988|NCT01259492|529837342|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
146910989|NCT01259492|529837339|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
146910990|NCT01259492|529837340|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
146768660|NCT00949975|529321751|FG001|Overall Study|Other|0|||
146910991|NCT01259492|529837341|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
146910992|NCT01259492|529837342|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
146910993|NCT01981122|529837343|FG000|Overall Study|Withdrawal by Subject|0|||
146910994|NCT01981122|529837344|FG001|Overall Study|Withdrawal by Subject|2|||
146910995|NCT01981122|529837343|FG000|Overall Study|Protocol Violation|0|||
146910996|NCT01981122|529837344|FG001|Overall Study|Protocol Violation|1|||
146910997|NCT01981122|529837343|FG000|Overall Study|Lost to Follow-up|0|||
146910998|NCT01981122|529837344|FG001|Overall Study|Lost to Follow-up|1|||
146910999|NCT01981122|529837343|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
146911000|NCT01981122|529837344|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
146911001|NCT01981122|529837343|FG000|Overall Study|Death|14|||
146911002|NCT01981122|529837344|FG001|Overall Study|Death|15|||
146911003|NCT00521339|529837350|FG000|Treatment Phase|Adverse Event|2|||
146911004|NCT00521339|529837351|FG001|Treatment Phase|Adverse Event|0|||
146911005|NCT00521339|529837352|FG002|Treatment Phase|Adverse Event|0|||
146911006|NCT00521339|529837350|FG000|Treatment Phase|Intolerability to study drug|2|||
146911007|NCT00521339|529837351|FG001|Treatment Phase|Intolerability to study drug|0|||
146911008|NCT00521339|529837352|FG002|Treatment Phase|Intolerability to study drug|0|||
146911009|NCT00521339|529837350|FG000|Treatment Phase|Lack of Efficacy|3|||
146911010|NCT00521339|529837351|FG001|Treatment Phase|Lack of Efficacy|0|||
146911011|NCT00521339|529837352|FG002|Treatment Phase|Lack of Efficacy|0|||
146911012|NCT00521339|529837350|FG000|Treatment Phase|Withdrawal by Subject|3|||
146911013|NCT00521339|529837351|FG001|Treatment Phase|Withdrawal by Subject|0|||
146911014|NCT00521339|529837352|FG002|Treatment Phase|Withdrawal by Subject|0|||
146911015|NCT00521339|529837350|FG000|Treatment Phase|Lost to Follow-up|1|||
146911016|NCT00521339|529837351|FG001|Treatment Phase|Lost to Follow-up|0|||
146911017|NCT00521339|529837352|FG002|Treatment Phase|Lost to Follow-up|0|||
146911018|NCT00521339|529837350|FG000|Treatment Phase|Protocol Violation|1|||
146911019|NCT00521339|529837351|FG001|Treatment Phase|Protocol Violation|0|||
146911020|NCT00521339|529837352|FG002|Treatment Phase|Protocol Violation|0|||
146911021|NCT00521339|529837350|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
146911022|NCT00521339|529837351|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
146911023|NCT00521339|529837352|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
146911024|NCT00521339|529837350|FG000|Treatment Extension Phase|Death|0|||
146911025|NCT00521339|529837351|FG001|Treatment Extension Phase|Death|0|||
146911026|NCT00521339|529837352|FG002|Treatment Extension Phase|Death|1|||
146911027|NCT02940886|529837353|FG000|Overall Study|Adverse Event|7|||
146911028|NCT02940886|529837354|FG001|Overall Study|Adverse Event|3|||
146911029|NCT02940886|529837353|FG000|Overall Study|Protocol Violation|0|||
146971109|NCT01964898|530056234|FG000|Overall Study|Lost to Follow-up|3|||
146563947|NCT01083602|528577841|FG000|Overall Study|Lack of Efficacy|36|||
146642802|NCT01215097|528869642|FG000|Overall Study|Lost to Follow-up|2|||
146642803|NCT01215097|528869643|FG001|Overall Study|Lost to Follow-up|0|||
146642804|NCT01215097|528869642|FG000|Overall Study|Withdrawal by Subject|6|||
146642805|NCT01215097|528869643|FG001|Overall Study|Withdrawal by Subject|3|||
146642806|NCT01215097|528869642|FG000|Overall Study|Lack of Efficacy|0|||
146642807|NCT01215097|528869643|FG001|Overall Study|Lack of Efficacy|3|||
146642808|NCT01215097|528869642|FG000|Overall Study|patient's refusal to come|2|||
146642809|NCT01215097|528869643|FG001|Overall Study|patient's refusal to come|2|||
146642810|NCT01215097|528869642|FG000|Overall Study|patient's private reason|1|||
146642811|NCT01215097|528869643|FG001|Overall Study|patient's private reason|1|||
146642812|NCT02252939|528869644|FG000|Overall Study|Lost to Follow-up|3|||
146642813|NCT01516034|528869646|FG000|Overall Study|Physician Decision|1|||
146642814|NCT01516034|528869646|FG000|Overall Study|Lack of Efficacy|7|||
146642815|NCT01033448|528869647|FG000|Overall Study|Withdrawal by Subject|4|||
146642816|NCT01033448|528869647|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
146642817|NCT01033448|528869647|FG000|Overall Study|Lost to Follow-up|3|||
146642818|NCT01033448|528869647|FG000|Overall Study|Withdrew due to other reasons|3|||
146642819|NCT01033448|528869647|FG000|Overall Study|Unknown disposition|1|||
146642820|NCT02560025|528869653|FG000|Overall Study|Ineligible after consent/ registration|3|||
146642821|NCT02703337|528869654|FG000|Period One (Part A)|Withdrawal by Subject|0|||
146642822|NCT02703337|528869655|FG001|Period One (Part A)|Withdrawal by Subject|0|||
146642823|NCT02703337|528869656|FG002|Period One (Part A)|Withdrawal by Subject|0|||
146642824|NCT02703337|528869657|FG003|Period One (Part A)|Withdrawal by Subject|0|||
146642825|NCT02703337|528869658|FG004|Period One (Part A)|Withdrawal by Subject|1|||
146642826|NCT02703337|528869659|FG005|Period One (Part A)|Withdrawal by Subject|0|||
146768661|NCT00949975|529321752|FG002|Overall Study|Other|0|||
146768662|NCT00949975|529321753|FG003|Overall Study|Other|0|||
146768663|NCT04347954|529321754|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
146768664|NCT04347954|529321755|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
146911030|NCT02940886|529837354|FG001|Overall Study|Protocol Violation|2|||
146911031|NCT02940886|529837353|FG000|Overall Study|Withdrawal by Subject|28|||
146911032|NCT02940886|529837354|FG001|Overall Study|Withdrawal by Subject|20|||
146911033|NCT02940886|529837353|FG000|Overall Study|Death|1|||
146911034|NCT02940886|529837354|FG001|Overall Study|Death|0|||
146911035|NCT02940886|529837353|FG000|Overall Study|Lack of Efficacy|1|||
146911036|NCT02940886|529837354|FG001|Overall Study|Lack of Efficacy|0|||
146911037|NCT02940886|529837353|FG000|Overall Study|Lost to Follow-up|49|||
146911038|NCT02940886|529837354|FG001|Overall Study|Lost to Follow-up|21|||
146911039|NCT02940886|529837353|FG000|Overall Study|Physician Decision|9|||
146911040|NCT02940886|529837354|FG001|Overall Study|Physician Decision|4|||
146911041|NCT02940886|529837353|FG000|Overall Study|Sponsor decision|0|||
146911042|NCT02940886|529837354|FG001|Overall Study|Sponsor decision|1|||
146911043|NCT02940886|529837353|FG000|Overall Study|No treatment|7|||
146911044|NCT02940886|529837354|FG001|Overall Study|No treatment|2|||
146911045|NCT02940886|529837353|FG000|Overall Study|Enrolment error|0|||
146911046|NCT02940886|529837354|FG001|Overall Study|Enrolment error|1|||
146911047|NCT00634543|529837358|FG000|Overall Study|Other|1|||
146911048|NCT00634543|529837359|FG001|Overall Study|Other|2|||
146911049|NCT00634543|529837358|FG000|Overall Study|Protocol Violation|3|||
146911050|NCT00634543|529837359|FG001|Overall Study|Protocol Violation|3|||
146911051|NCT00634543|529837358|FG000|Overall Study|Adverse Event|11|||
146911052|NCT00634543|529837359|FG001|Overall Study|Adverse Event|11|||
146911053|NCT00634543|529837358|FG000|Overall Study|Withdrawal by Subject|4|||
146911054|NCT00634543|529837359|FG001|Overall Study|Withdrawal by Subject|4|||
146911055|NCT00634543|529837358|FG000|Overall Study|Lost to Follow-up|0|||
146911056|NCT00634543|529837359|FG001|Overall Study|Lost to Follow-up|1|||
146911057|NCT03515538|529837360|FG000|Overall Study|Lack of Efficacy|2|||
146911058|NCT03515538|529837361|FG001|Overall Study|Lack of Efficacy|0|||
146911059|NCT03515538|529837362|FG002|Overall Study|Lack of Efficacy|2|||
146911060|NCT03515538|529837363|FG003|Overall Study|Lack of Efficacy|0|||
146911061|NCT03515538|529837360|FG000|Overall Study|Death|0|||
146911062|NCT03515538|529837361|FG001|Overall Study|Death|0|||
146911063|NCT03515538|529837362|FG002|Overall Study|Death|1|||
146911064|NCT03515538|529837363|FG003|Overall Study|Death|0|||
146642827|NCT02703337|528869660|FG006|Period One (Part A)|Withdrawal by Subject|0|||
146971110|NCT01964898|530056235|FG001|Overall Study|Lost to Follow-up|5|||
146642828|NCT02703337|528869661|FG007|Period One (Part A)|Withdrawal by Subject|0|||
146642829|NCT00282308|528869668|FG000|Treatment Period|Lost to Follow-up|1|||
146911065|NCT03515538|529837360|FG000|Overall Study|Protocol Violation|0|||
146911066|NCT03515538|529837361|FG001|Overall Study|Protocol Violation|0|||
146911067|NCT03515538|529837362|FG002|Overall Study|Protocol Violation|0|||
146911068|NCT03515538|529837363|FG003|Overall Study|Protocol Violation|1|||
146911069|NCT03515538|529837360|FG000|Overall Study|Screen failure (baseline dropout)|0|||
146911070|NCT03515538|529837361|FG001|Overall Study|Screen failure (baseline dropout)|1|||
146911071|NCT03515538|529837362|FG002|Overall Study|Screen failure (baseline dropout)|0|||
146911072|NCT03515538|529837363|FG003|Overall Study|Screen failure (baseline dropout)|0|||
146911073|NCT03515538|529837360|FG000|Overall Study|Withdrawal by Subject|2|||
146911074|NCT03515538|529837361|FG001|Overall Study|Withdrawal by Subject|2|||
146911075|NCT03515538|529837362|FG002|Overall Study|Withdrawal by Subject|1|||
146911076|NCT03515538|529837363|FG003|Overall Study|Withdrawal by Subject|3|||
146911077|NCT03515538|529837360|FG000|Overall Study|Physician Decision|1|||
146911078|NCT03515538|529837361|FG001|Overall Study|Physician Decision|0|||
146911079|NCT03515538|529837362|FG002|Overall Study|Physician Decision|0|||
146911080|NCT03515538|529837363|FG003|Overall Study|Physician Decision|1|||
146911081|NCT01650779|529837370|FG000|Overall Study|Withdrawal by Subject|1|||
146911082|NCT02397655|529837377|FG000|Overall Study|data not completed|1301|||
146911083|NCT01736683|529837378|FG000|Overall Study|Disease Relapse|0|||
146911084|NCT01736683|529837379|FG001|Overall Study|Disease Relapse|0|||
146911085|NCT01736683|529837380|FG002|Overall Study|Disease Relapse|2|||
146911086|NCT01736683|529837381|FG003|Overall Study|Disease Relapse|1|||
146911087|NCT01736683|529837382|FG004|Overall Study|Disease Relapse|0|||
146911088|NCT01736683|529837378|FG000|Overall Study|Adverse Event|0|||
146911089|NCT01736683|529837379|FG001|Overall Study|Adverse Event|2|||
146911090|NCT01736683|529837380|FG002|Overall Study|Adverse Event|2|||
146911091|NCT01736683|529837381|FG003|Overall Study|Adverse Event|3|||
146911092|NCT01736683|529837382|FG004|Overall Study|Adverse Event|2|||
146911093|NCT01736683|529837378|FG000|Overall Study|Withdrawal by Subject|0|||
146911094|NCT01736683|529837379|FG001|Overall Study|Withdrawal by Subject|0|||
146911095|NCT01736683|529837380|FG002|Overall Study|Withdrawal by Subject|3|||
146911096|NCT01736683|529837381|FG003|Overall Study|Withdrawal by Subject|1|||
146911097|NCT01736683|529837382|FG004|Overall Study|Withdrawal by Subject|1|||
146911098|NCT01736683|529837378|FG000|Overall Study|Lack of Therapeutic Effect|7|||
146911099|NCT01736683|529837379|FG001|Overall Study|Lack of Therapeutic Effect|4|||
146911100|NCT01736683|529837380|FG002|Overall Study|Lack of Therapeutic Effect|13|||
146911101|NCT01736683|529837381|FG003|Overall Study|Lack of Therapeutic Effect|20|||
146911102|NCT01736683|529837382|FG004|Overall Study|Lack of Therapeutic Effect|1|||
146911103|NCT01736683|529837378|FG000|Overall Study|Progressive Disease|0|||
146911104|NCT01736683|529837379|FG001|Overall Study|Progressive Disease|0|||
146911105|NCT01736683|529837380|FG002|Overall Study|Progressive Disease|0|||
146911106|NCT01736683|529837381|FG003|Overall Study|Progressive Disease|1|||
146911107|NCT01736683|529837382|FG004|Overall Study|Progressive Disease|0|||
146911108|NCT01736683|529837378|FG000|Overall Study|Other|0|||
146911109|NCT01736683|529837379|FG001|Overall Study|Other|0|||
146911110|NCT01736683|529837380|FG002|Overall Study|Other|1|||
146911111|NCT01736683|529837381|FG003|Overall Study|Other|9|||
146911112|NCT01736683|529837382|FG004|Overall Study|Other|1|||
146911113|NCT03069690|529837384|FG000|Pregnancy Intervention|Pregnancy loss|9|||
146911114|NCT03069690|529837385|FG001|Pregnancy Intervention|Pregnancy loss|4|||
146911115|NCT03069690|529837386|FG002|Pregnancy Intervention|Pregnancy loss|0|||
146911116|NCT03069690|529837387|FG003|Pregnancy Intervention|Pregnancy loss|0|||
146911117|NCT03069690|529837388|FG004|Pregnancy Intervention|Pregnancy loss|0|||
146911118|NCT03069690|529837389|FG005|Pregnancy Intervention|Pregnancy loss|0|||
146911119|NCT03069690|529837384|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
146911120|NCT03069690|529837385|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
146911121|NCT03069690|529837386|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
146911122|NCT03069690|529837387|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
146911123|NCT03069690|529837388|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
146911124|NCT03069690|529837389|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
146911125|NCT03069690|529837384|FG000|Postpartum Intervention|Lost to Follow-up|0|||
146911126|NCT03069690|529837385|FG001|Postpartum Intervention|Lost to Follow-up|0|||
146911127|NCT03069690|529837386|FG002|Postpartum Intervention|Lost to Follow-up|5|||
146911128|NCT03069690|529837387|FG003|Postpartum Intervention|Lost to Follow-up|5|||
146911129|NCT03069690|529837388|FG004|Postpartum Intervention|Lost to Follow-up|2|||
146911130|NCT03069690|529837389|FG005|Postpartum Intervention|Lost to Follow-up|4|||
146911131|NCT03988751|529837390|FG000|Overall Study|Withdrawal by Subject|1|||
146911132|NCT03988751|529837391|FG001|Overall Study|Withdrawal by Subject|0|||
146911133|NCT03988751|529837390|FG000|Overall Study|Protocol Violation|0|||
146911134|NCT03988751|529837391|FG001|Overall Study|Protocol Violation|1|||
146911135|NCT02623361|529837392|FG000|Overall Study|Protocol Violation|0|||
146911136|NCT02623361|529837393|FG001|Overall Study|Protocol Violation|1|||
146911137|NCT02623361|529837392|FG000|Overall Study|Withdrawal by Subject|0|||
146911138|NCT02623361|529837393|FG001|Overall Study|Withdrawal by Subject|1|||
146911139|NCT02441803|529837395|FG000|Overall Study|Physician Decision|0|||
146971111|NCT01964898|530056234|FG000|Overall Study|Withdrawal by Subject|1|||
146971112|NCT01964898|530056235|FG001|Overall Study|Withdrawal by Subject|0|||
146971113|NCT02957682|530056238|FG000|Overall Study|Adverse Event|64|||
146971114|NCT02957682|530056239|FG001|Overall Study|Adverse Event|67|||
146971115|NCT02957682|530056238|FG000|Overall Study|Poor Compliance to Protocol|30|||
146971116|NCT02957682|530056239|FG001|Overall Study|Poor Compliance to Protocol|26|||
146971117|NCT02957682|530056238|FG000|Overall Study|Physician Decision|4|||
146971118|NCT02957682|530056239|FG001|Overall Study|Physician Decision|4|||
146971119|NCT02957682|530056238|FG000|Overall Study|Study Terminated by Sponsor|4|||
146971120|NCT02957682|530056239|FG001|Overall Study|Study Terminated by Sponsor|3|||
146971121|NCT02957682|530056238|FG000|Overall Study|Subject Moved|10|||
146971122|NCT02957682|530056239|FG001|Overall Study|Subject Moved|16|||
146971123|NCT02957682|530056238|FG000|Overall Study|Withdrawal by Subject|64|||
146971124|NCT02957682|530056239|FG001|Overall Study|Withdrawal by Subject|33|||
146971125|NCT02957682|530056238|FG000|Overall Study|Related to IMP Administration|3|||
146911140|NCT02441803|529837396|FG001|Overall Study|Physician Decision|2|||
146911141|NCT02441803|529837397|FG002|Overall Study|Physician Decision|2|||
146911142|NCT03065530|529837401|FG000|Overall Study|Lack of Efficacy|1|||
146911143|NCT03065530|529837402|FG001|Overall Study|Lack of Efficacy|1|||
146911144|NCT03065530|529837403|FG002|Overall Study|Lack of Efficacy|0|||
146911145|NCT03065530|529837404|FG003|Overall Study|Lack of Efficacy|1|||
146911146|NCT03065530|529837401|FG000|Overall Study|Protocol Violation|1|||
146911147|NCT03065530|529837402|FG001|Overall Study|Protocol Violation|0|||
146911148|NCT03065530|529837403|FG002|Overall Study|Protocol Violation|1|||
146911149|NCT03065530|529837404|FG003|Overall Study|Protocol Violation|1|||
146911150|NCT01325493|529837405|FG000|Overall Study|Protocol Violation|0|||
146911151|NCT01325493|529837406|FG001|Overall Study|Protocol Violation|1|||
146911152|NCT01325493|529837405|FG000|Overall Study|loss of neuromonitoring signals|0|||
146911153|NCT01325493|529837406|FG001|Overall Study|loss of neuromonitoring signals|2|||
146911154|NCT01325493|529837405|FG000|Overall Study|Allergy|1|||
146911155|NCT01325493|529837406|FG001|Overall Study|Allergy|0|||
146911156|NCT01720667|529837410|FG000|Overall Study|Adverse Event|1|||
146911157|NCT01720667|529837411|FG001|Overall Study|Adverse Event|1|||
146911158|NCT01720667|529837410|FG000|Overall Study|Withdrawal by Subject|3|||
146911159|NCT01720667|529837411|FG001|Overall Study|Withdrawal by Subject|0|||
146971126|NCT02957682|530056239|FG001|Overall Study|Related to IMP Administration|6|||
146971127|NCT02957682|530056238|FG000|Overall Study|Non-disclosed|16|||
146971128|NCT02957682|530056239|FG001|Overall Study|Non-disclosed|12|||
146971129|NCT02957682|530056238|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
146971130|NCT02957682|530056239|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
146642830|NCT00282308|528869669|FG001|Treatment Period|Lost to Follow-up|0|||
146971131|NCT02953262|530056247|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
146971132|NCT02953262|530056248|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
146911160|NCT02117050|529837414|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
146911161|NCT01753518|529837416|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
146911162|NCT01753518|529837417|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
146911163|NCT01753518|529837416|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
146911164|NCT01753518|529837417|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
146911165|NCT01753518|529837416|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
146911166|NCT01753518|529837417|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
146911167|NCT01753518|529837416|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
146911168|NCT01753518|529837417|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
146911169|NCT00940342|529837418|FG000|Overall Study|Adverse Event|0|||
146911170|NCT00940342|529837419|FG001|Overall Study|Adverse Event|2|||
146911171|NCT00940342|529837420|FG002|Overall Study|Adverse Event|1|||
146911172|NCT00553787|529837421|FG000|Overall Study|Adverse Event|34|||
146911173|NCT00553787|529837422|FG001|Overall Study|Adverse Event|21|||
146911174|NCT00553787|529837423|FG002|Overall Study|Adverse Event|67|||
146911175|NCT00553787|529837421|FG000|Overall Study|Lost to Follow-up|132|||
146911176|NCT00553787|529837422|FG001|Overall Study|Lost to Follow-up|44|||
146911177|NCT00553787|529837423|FG002|Overall Study|Lost to Follow-up|78|||
146911178|NCT00553787|529837421|FG000|Overall Study|Withdrawal by Subject|151|||
146911179|NCT00553787|529837422|FG001|Overall Study|Withdrawal by Subject|40|||
146911180|NCT00553787|529837423|FG002|Overall Study|Withdrawal by Subject|83|||
146911181|NCT00553787|529837421|FG000|Overall Study|Lack of Efficacy|31|||
146911182|NCT00553787|529837422|FG001|Overall Study|Lack of Efficacy|1|||
146911183|NCT00553787|529837423|FG002|Overall Study|Lack of Efficacy|3|||
146911184|NCT00553787|529837421|FG000|Overall Study|Pregnancy|0|||
146911185|NCT00553787|529837422|FG001|Overall Study|Pregnancy|1|||
146911186|NCT00553787|529837423|FG002|Overall Study|Pregnancy|2|||
146911187|NCT00553787|529837421|FG000|Overall Study|non compliance|4|||
146911188|NCT00553787|529837422|FG001|Overall Study|non compliance|0|||
146911189|NCT00553787|529837423|FG002|Overall Study|non compliance|11|||
146911190|NCT00553787|529837421|FG000|Overall Study|Requirement for restricted medication|8|||
146911191|NCT00553787|529837422|FG001|Overall Study|Requirement for restricted medication|7|||
146911192|NCT00553787|529837423|FG002|Overall Study|Requirement for restricted medication|5|||
146911193|NCT00553787|529837421|FG000|Overall Study|Other|18|||
146911194|NCT00553787|529837422|FG001|Overall Study|Other|10|||
146911195|NCT00553787|529837423|FG002|Overall Study|Other|13|||
146911196|NCT01088412|529837424|FG000|Overall Study|Adverse Event|38|||
146911197|NCT01088412|529837425|FG001|Overall Study|Adverse Event|0|||
146911198|NCT01088412|529837426|FG002|Overall Study|Adverse Event|0|||
146911199|NCT01088412|529837424|FG000|Overall Study|Death|42|||
146911200|NCT01088412|529837425|FG001|Overall Study|Death|6|||
146911201|NCT01088412|529837426|FG002|Overall Study|Death|0|||
146911202|NCT01088412|529837424|FG000|Overall Study|Other Reason per Case Report Form|2089|||
146911203|NCT01088412|529837425|FG001|Overall Study|Other Reason per Case Report Form|103|||
146911204|NCT01088412|529837426|FG002|Overall Study|Other Reason per Case Report Form|9|||
146911205|NCT01088412|529837424|FG000|Overall Study|Withdrawal by Subject|1761|||
146911206|NCT01088412|529837425|FG001|Overall Study|Withdrawal by Subject|25|||
146911207|NCT01088412|529837426|FG002|Overall Study|Withdrawal by Subject|1|||
146642831|NCT00282308|528869670|FG002|Treatment Period|Lost to Follow-up|0|||
146911208|NCT01088412|529837424|FG000|Overall Study|Received Another GH Product|79|||
146911209|NCT01088412|529837425|FG001|Overall Study|Received Another GH Product|0|||
146911210|NCT01088412|529837426|FG002|Overall Study|Received Another GH Product|0|||
146911211|NCT01088412|529837424|FG000|Overall Study|Participant Moved|601|||
146911212|NCT01088412|529837425|FG001|Overall Study|Participant Moved|21|||
146911213|NCT01088412|529837426|FG002|Overall Study|Participant Moved|2|||
146911214|NCT01088412|529837424|FG000|Overall Study|Physician Decision|1041|||
146911215|NCT01088412|529837425|FG001|Overall Study|Physician Decision|8|||
146911216|NCT01088412|529837426|FG002|Overall Study|Physician Decision|4|||
146911217|NCT01088412|529837424|FG000|Overall Study|Sponsor Decision|4467|||
146911218|NCT01088412|529837425|FG001|Overall Study|Sponsor Decision|79|||
146911219|NCT01088412|529837426|FG002|Overall Study|Sponsor Decision|23|||
146911220|NCT01088412|529837424|FG000|Overall Study|Third Party Required to Change Brand|487|||
146911221|NCT01088412|529837425|FG001|Overall Study|Third Party Required to Change Brand|0|||
146911222|NCT01088412|529837426|FG002|Overall Study|Third Party Required to Change Brand|0|||
146911223|NCT01088412|529837424|FG000|Overall Study|Lost to Follow-up|3052|||
146911224|NCT01088412|529837425|FG001|Overall Study|Lost to Follow-up|130|||
146911225|NCT01088412|529837426|FG002|Overall Study|Lost to Follow-up|11|||
146911226|NCT01088412|529837424|FG000|Overall Study|Study Summary Not Completed|4360|||
146911227|NCT01088412|529837425|FG001|Overall Study|Study Summary Not Completed|64|||
146911228|NCT01088412|529837426|FG002|Overall Study|Study Summary Not Completed|22|||
146911229|NCT00793104|529837427|FG000|Overall Study|Lost to Follow-up|1|||
146971133|NCT02953262|530056249|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
146971134|NCT02953262|530056250|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
146971135|NCT00934622|530056251|FG000|Overall Study|Lost to Follow-up|7|||
146642832|NCT00282308|528869668|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
146642833|NCT00282308|528869669|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
146642834|NCT00282308|528869670|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
146642835|NCT00282308|528869668|FG000|Treatment Period|Adverse Event|0|||
146642836|NCT00282308|528869669|FG001|Treatment Period|Adverse Event|2|||
146642837|NCT00282308|528869670|FG002|Treatment Period|Adverse Event|0|||
146642838|NCT00282308|528869668|FG000|Treatment Period|Not Treated with Study Drug|1|||
146911230|NCT03494725|529837430|FG000|Overall Study|Withdrawal by Subject|0|||
146971136|NCT00934622|530056251|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
146911231|NCT03494725|529837431|FG001|Overall Study|Withdrawal by Subject|2|||
146911232|NCT03494725|529837430|FG000|Overall Study|Antibiotic use|1|||
146971137|NCT03349437|530056252|FG000|Screening|Screen Fail|4|||
146911233|NCT03494725|529837431|FG001|Overall Study|Antibiotic use|0|||
146911234|NCT02619253|529837432|FG000|Overall Study|Adverse Event|0|||
146971138|NCT03349437|530056253|FG001|Screening|Screen Fail|0|||
146971139|NCT03349437|530056254|FG002|Screening|Screen Fail|0|||
146911235|NCT02619253|529837433|FG001|Overall Study|Adverse Event|0|||
146911236|NCT02619253|529837434|FG002|Overall Study|Adverse Event|1|||
146911237|NCT02619253|529837435|FG003|Overall Study|Adverse Event|1|||
146911238|NCT02619253|529837436|FG004|Overall Study|Adverse Event|3|||
146911239|NCT02619253|529837432|FG000|Overall Study|Alternative Therapy|0|||
146911240|NCT02619253|529837433|FG001|Overall Study|Alternative Therapy|0|||
146911241|NCT02619253|529837434|FG002|Overall Study|Alternative Therapy|1|||
146911242|NCT02619253|529837435|FG003|Overall Study|Alternative Therapy|0|||
146911243|NCT02619253|529837436|FG004|Overall Study|Alternative Therapy|0|||
146911244|NCT02619253|529837432|FG000|Overall Study|Death|0|||
146911245|NCT02619253|529837433|FG001|Overall Study|Death|0|||
146911246|NCT02619253|529837434|FG002|Overall Study|Death|0|||
146911247|NCT02619253|529837435|FG003|Overall Study|Death|1|||
146911248|NCT02619253|529837436|FG004|Overall Study|Death|0|||
146911249|NCT02619253|529837432|FG000|Overall Study|Disease Progression|4|||
146911250|NCT02619253|529837433|FG001|Overall Study|Disease Progression|2|||
146911251|NCT02619253|529837434|FG002|Overall Study|Disease Progression|8|||
146911252|NCT02619253|529837435|FG003|Overall Study|Disease Progression|9|||
146911253|NCT02619253|529837436|FG004|Overall Study|Disease Progression|10|||
146911254|NCT02619253|529837432|FG000|Overall Study|Needed a disqualifying therapy|0|||
146911255|NCT02619253|529837433|FG001|Overall Study|Needed a disqualifying therapy|0|||
146911256|NCT02619253|529837434|FG002|Overall Study|Needed a disqualifying therapy|1|||
146911257|NCT02619253|529837435|FG003|Overall Study|Needed a disqualifying therapy|0|||
146911258|NCT02619253|529837436|FG004|Overall Study|Needed a disqualifying therapy|0|||
146911259|NCT02619253|529837432|FG000|Overall Study|Transferred to hospice|0|||
146911260|NCT02619253|529837433|FG001|Overall Study|Transferred to hospice|0|||
146911261|NCT02619253|529837434|FG002|Overall Study|Transferred to hospice|1|||
146911262|NCT02619253|529837435|FG003|Overall Study|Transferred to hospice|0|||
146911263|NCT02619253|529837436|FG004|Overall Study|Transferred to hospice|0|||
146911264|NCT02619253|529837432|FG000|Overall Study|Physician Decision|0|||
146911265|NCT02619253|529837433|FG001|Overall Study|Physician Decision|1|||
146911266|NCT02619253|529837434|FG002|Overall Study|Physician Decision|2|||
146911267|NCT02619253|529837435|FG003|Overall Study|Physician Decision|3|||
146911268|NCT02619253|529837436|FG004|Overall Study|Physician Decision|0|||
146911269|NCT02619253|529837432|FG000|Overall Study|Withdrawal by Subject|0|||
146911270|NCT02619253|529837433|FG001|Overall Study|Withdrawal by Subject|1|||
146911271|NCT02619253|529837434|FG002|Overall Study|Withdrawal by Subject|0|||
146911272|NCT02619253|529837435|FG003|Overall Study|Withdrawal by Subject|0|||
146911273|NCT02619253|529837436|FG004|Overall Study|Withdrawal by Subject|2|||
146971140|NCT03349437|530056252|FG000|Screening|Withdrawn|1|||
146971141|NCT03349437|530056253|FG001|Screening|Withdrawn|0|||
146911274|NCT00514449|529837437|FG000|Overall Study|Withdrawal by Subject|1|||
146911275|NCT00514449|529837438|FG001|Overall Study|Withdrawal by Subject|2|||
146911276|NCT00514449|529837437|FG000|Overall Study|Protocol Violation|1|||
146911277|NCT00514449|529837438|FG001|Overall Study|Protocol Violation|2|||
146911278|NCT00514449|529837437|FG000|Overall Study|Lost to Follow-up|1|||
146911279|NCT00514449|529837438|FG001|Overall Study|Lost to Follow-up|0|||
146911280|NCT00206518|529837448|FG000|Overall Study|Lack of Efficacy|6|||
146911281|NCT00206518|529837449|FG001|Overall Study|Lack of Efficacy|4|||
146911282|NCT00206518|529837448|FG000|Overall Study|Adverse Event|2|||
146911283|NCT00206518|529837449|FG001|Overall Study|Adverse Event|1|||
146911284|NCT00206518|529837448|FG000|Overall Study|Physician Decision|1|||
146911285|NCT00206518|529837449|FG001|Overall Study|Physician Decision|0|||
146911286|NCT00206518|529837448|FG000|Overall Study|Protocol Violation|1|||
146911287|NCT00206518|529837449|FG001|Overall Study|Protocol Violation|1|||
146911288|NCT02335450|529837450|FG000|Overall Study|Pregnancy|1|||
146911289|NCT00847561|529837453|FG000|Overall Study|Withdrawal by Subject|4|||
146911290|NCT00847561|529837454|FG001|Overall Study|Withdrawal by Subject|3|||
146911291|NCT00847561|529837453|FG000|Overall Study|Unable to schedule|9|||
146911292|NCT00847561|529837454|FG001|Overall Study|Unable to schedule|1|||
146911293|NCT03060577|529839780|FG000|Overall Study|Withdrawal by Subject|25|||
146911294|NCT03060577|529839781|FG001|Overall Study|Withdrawal by Subject|5|||
146911295|NCT03060577|529839780|FG000|Overall Study|Physician Decision|4|||
146911296|NCT03060577|529839781|FG001|Overall Study|Physician Decision|3|||
146911297|NCT03060577|529839780|FG000|Overall Study|Lost to Follow-up|3|||
146911298|NCT03060577|529839781|FG001|Overall Study|Lost to Follow-up|0|||
146911299|NCT03060577|529839780|FG000|Overall Study|Death|7|||
146911300|NCT03060577|529839781|FG001|Overall Study|Death|1|||
146911301|NCT03060577|529839780|FG000|Overall Study|Adverse Event|9|||
146911302|NCT03060577|529839781|FG001|Overall Study|Adverse Event|1|||
146911303|NCT03060577|529839780|FG000|Overall Study|Inclusion/Exclusion|1|||
146911304|NCT03060577|529839781|FG001|Overall Study|Inclusion/Exclusion|0|||
146911305|NCT03060577|529839780|FG000|Overall Study|Other|8|||
146911306|NCT03060577|529839781|FG001|Overall Study|Other|2|||
146911307|NCT02584634|529839783|FG000|Overall Study|Adverse Event|3|||
146911308|NCT02584634|529839784|FG001|Overall Study|Adverse Event|5|||
146911309|NCT02584634|529839783|FG000|Overall Study|Death|0|||
146911310|NCT02584634|529839784|FG001|Overall Study|Death|1|||
146911311|NCT02584634|529839783|FG000|Overall Study|Lost to Follow-up|0|||
146911312|NCT02584634|529839784|FG001|Overall Study|Lost to Follow-up|1|||
146911313|NCT02584634|529839783|FG000|Overall Study|Physician Decision|1|||
146911314|NCT02584634|529839784|FG001|Overall Study|Physician Decision|2|||
146911315|NCT02584634|529839783|FG000|Overall Study|Progressive disease|7|||
146911316|NCT02584634|529839784|FG001|Overall Study|Progressive disease|15|||
146911317|NCT02584634|529839783|FG000|Overall Study|Withdrawal by Subject|1|||
146911318|NCT02584634|529839784|FG001|Overall Study|Withdrawal by Subject|1|||
146911319|NCT02584634|529839783|FG000|Overall Study|Other|0|||
146911320|NCT02584634|529839784|FG001|Overall Study|Other|6|||
146911321|NCT00474630|529839785|FG000|Overall Study|Adverse Event|98|||
146971142|NCT03349437|530056254|FG002|Screening|Withdrawn|0|||
146971143|NCT02406742|530056255|FG000|Overall Study|Progression of Disease|5|||
146911322|NCT00474630|529839786|FG001|Overall Study|Adverse Event|26|||
146971144|NCT02406742|530056256|FG001|Overall Study|Progression of Disease|1|||
146971145|NCT02406742|530056257|FG002|Overall Study|Progression of Disease|6|||
146971146|NCT02406742|530056255|FG000|Overall Study|Adverse Event|3|||
146911323|NCT00474630|529839785|FG000|Overall Study|Lost to Follow-up|22|||
146911324|NCT00474630|529839786|FG001|Overall Study|Lost to Follow-up|15|||
146911325|NCT00474630|529839785|FG000|Overall Study|Withdrawal by Subject|21|||
146911326|NCT00474630|529839786|FG001|Overall Study|Withdrawal by Subject|15|||
146971147|NCT02406742|530056256|FG001|Overall Study|Adverse Event|0|||
146563948|NCT01657370|528577842|FG000|Overall Study|Withdrawal by Subject|0|||
146563949|NCT01657370|528577843|FG001|Overall Study|Withdrawal by Subject|0|||
146563950|NCT01657370|528577844|FG002|Overall Study|Withdrawal by Subject|1|||
146563951|NCT01657370|528577845|FG003|Overall Study|Withdrawal by Subject|0|||
146563952|NCT01657370|528577846|FG004|Overall Study|Withdrawal by Subject|0|||
146563953|NCT01657370|528577847|FG005|Overall Study|Withdrawal by Subject|1|||
146971148|NCT02406742|530056257|FG002|Overall Study|Adverse Event|2|||
146971149|NCT02406742|530056255|FG000|Overall Study|Death|1|||
146971150|NCT02406742|530056256|FG001|Overall Study|Death|0|||
146563954|NCT01657370|528577842|FG000|Overall Study|Physician Decision|2|||
146563955|NCT01657370|528577843|FG001|Overall Study|Physician Decision|3|||
146563956|NCT01657370|528577844|FG002|Overall Study|Physician Decision|1|||
146563957|NCT01657370|528577845|FG003|Overall Study|Physician Decision|2|||
146563958|NCT01657370|528577846|FG004|Overall Study|Physician Decision|5|||
146971151|NCT02406742|530056257|FG002|Overall Study|Death|0|||
146971152|NCT02406742|530056255|FG000|Overall Study|Lack of Efficacy|0|||
146563959|NCT01657370|528577847|FG005|Overall Study|Physician Decision|0|||
146563960|NCT01657370|528577842|FG000|Overall Study|Lack of Qualifying Event|1|||
146563961|NCT01657370|528577843|FG001|Overall Study|Lack of Qualifying Event|0|||
146768665|NCT04347954|529321756|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
146768666|NCT04347954|529321754|FG000|Overall Study|Lost to Follow-up|0|||
146768667|NCT04347954|529321755|FG001|Overall Study|Lost to Follow-up|1|||
146768668|NCT04347954|529321756|FG002|Overall Study|Lost to Follow-up|0|||
146768669|NCT03478696|529321760|FG000|Overall Study|Adverse Event|1|||
146768670|NCT03478696|529321761|FG001|Overall Study|Adverse Event|5|||
146768671|NCT03478696|529321760|FG000|Overall Study|Lost to Follow-up|1|||
146768672|NCT03478696|529321761|FG001|Overall Study|Lost to Follow-up|0|||
146768673|NCT03478696|529321760|FG000|Overall Study|Physician Decision|6|||
146768674|NCT03478696|529321761|FG001|Overall Study|Physician Decision|3|||
146768675|NCT03478696|529321760|FG000|Overall Study|Withdrawal by Subject|9|||
146768676|NCT03478696|529321761|FG001|Overall Study|Withdrawal by Subject|4|||
146768677|NCT03257813|529321762|FG000|Overall Study|Protocol Violation|6|||
146768678|NCT03257813|529321763|FG001|Overall Study|Protocol Violation|3|||
146768679|NCT03615924|529321764|FG000|Overall Study|Withdrawal by Subject|2|||
146768680|NCT03615924|529321765|FG001|Overall Study|Withdrawal by Subject|5|||
146768681|NCT03615924|529321764|FG000|Overall Study|Death|3|||
146768682|NCT03615924|529321765|FG001|Overall Study|Death|1|||
146971153|NCT02406742|530056256|FG001|Overall Study|Lack of Efficacy|0|||
146971154|NCT02406742|530056257|FG002|Overall Study|Lack of Efficacy|1|||
146971155|NCT02406742|530056255|FG000|Overall Study|Withdrawal by Participant|1|||
146971156|NCT02406742|530056256|FG001|Overall Study|Withdrawal by Participant|2|||
146971157|NCT02406742|530056257|FG002|Overall Study|Withdrawal by Participant|0|||
146971158|NCT02406742|530056255|FG000|Overall Study|Physician Decision|1|||
146768683|NCT03615924|529321764|FG000|Overall Study|Lost to Follow-up|1|||
146971159|NCT02406742|530056256|FG001|Overall Study|Physician Decision|2|||
146971160|NCT02406742|530056257|FG002|Overall Study|Physician Decision|1|||
146971161|NCT02406742|530056255|FG000|Overall Study|Transition to other treatment|2|||
146971162|NCT02406742|530056256|FG001|Overall Study|Transition to other treatment|0|||
146768684|NCT03615924|529321765|FG001|Overall Study|Lost to Follow-up|0|||
146642839|NCT00282308|528869669|FG001|Treatment Period|Not Treated with Study Drug|0|||
146642840|NCT00282308|528869670|FG002|Treatment Period|Not Treated with Study Drug|0|||
146642841|NCT00282308|528869668|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
146642842|NCT00282308|528869669|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
146768685|NCT03615924|529321764|FG000|Overall Study|Randomized in error|1|||
146971163|NCT02406742|530056257|FG002|Overall Study|Transition to other treatment|1|||
146642843|NCT00282308|528869670|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
146642844|NCT00282308|528869668|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
146642845|NCT00282308|528869669|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
146642846|NCT00282308|528869670|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
146642847|NCT00282308|528869668|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
146642848|NCT00282308|528869669|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
146642849|NCT00282308|528869670|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
146642850|NCT00282308|528869668|FG000|Safety Follow-up Period|Adverse Event|0|||
146642851|NCT00282308|528869669|FG001|Safety Follow-up Period|Adverse Event|0|||
146642852|NCT00282308|528869670|FG002|Safety Follow-up Period|Adverse Event|1|||
146642853|NCT00282308|528869668|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
146642854|NCT00282308|528869669|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
146642855|NCT00282308|528869670|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
146642856|NCT00282308|528869668|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
146642857|NCT00282308|528869669|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
146642858|NCT00282308|528869670|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
146642859|NCT00282308|528869668|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
146642860|NCT00282308|528869669|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
146642861|NCT00282308|528869670|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
146642862|NCT01584440|528869672|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
146642863|NCT01584440|528869673|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
146642864|NCT01584440|528869674|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
146642865|NCT01584440|528869675|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
146642866|NCT01584440|528869676|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
146563962|NCT01657370|528577844|FG002|Overall Study|Lack of Qualifying Event|3|||
146563963|NCT01657370|528577845|FG003|Overall Study|Lack of Qualifying Event|2|||
146563964|NCT01657370|528577846|FG004|Overall Study|Lack of Qualifying Event|1|||
146911327|NCT00474630|529839785|FG000|Overall Study|Protocol Violation|3|||
146911328|NCT00474630|529839786|FG001|Overall Study|Protocol Violation|4|||
146911329|NCT00474630|529839785|FG000|Overall Study|Lack of Efficacy|5|||
146911330|NCT00474630|529839786|FG001|Overall Study|Lack of Efficacy|6|||
146911331|NCT00474630|529839785|FG000|Overall Study|Drug noncompliance, other|11|||
146642867|NCT01584440|528869672|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
146642868|NCT01584440|528869673|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
146642869|NCT01584440|528869674|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
146642870|NCT01584440|528869675|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
146642871|NCT01584440|528869676|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
146642872|NCT01584440|528869672|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
146642873|NCT01584440|528869673|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
146642874|NCT01584440|528869674|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
146642875|NCT01584440|528869675|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
146642876|NCT01584440|528869676|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
146642877|NCT01584440|528869672|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
146642878|NCT01584440|528869673|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
146642879|NCT01584440|528869674|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
146642880|NCT01584440|528869675|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
146642881|NCT01584440|528869676|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
146642882|NCT01584440|528869672|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
146642883|NCT01584440|528869673|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
146642884|NCT01584440|528869674|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
146642885|NCT01584440|528869675|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
146642886|NCT01584440|528869676|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
146642887|NCT01584440|528869672|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
146642888|NCT01584440|528869673|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
146642889|NCT01584440|528869674|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
146642890|NCT01584440|528869675|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
146642891|NCT01584440|528869676|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
146642892|NCT01584440|528869672|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
146642893|NCT01584440|528869673|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
146642894|NCT01584440|528869674|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
146642895|NCT01584440|528869675|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
146642896|NCT01584440|528869676|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
146642897|NCT01584440|528869672|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
146642898|NCT01584440|528869673|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
146642899|NCT01584440|528869674|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
146642900|NCT01584440|528869675|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
146642901|NCT01584440|528869676|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
146642902|NCT01584440|528869672|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
146642903|NCT01584440|528869673|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
146911332|NCT00474630|529839786|FG001|Overall Study|Drug noncompliance, other|4|||
146642904|NCT01584440|528869674|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
146642905|NCT01584440|528869675|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
146911333|NCT00915005|529839788|FG000|Overall Study|Withdrawal by Subject|4|||
146911334|NCT00915005|529839789|FG001|Overall Study|Withdrawal by Subject|4|||
146911335|NCT00915005|529839788|FG000|Overall Study|Patient preferred protons therapy|6|||
146768686|NCT03615924|529321765|FG001|Overall Study|Randomized in error|0|||
146563965|NCT01657370|528577847|FG005|Overall Study|Lack of Qualifying Event|2|||
146563966|NCT01657370|528577842|FG000|Overall Study|Adverse Event|0|||
146563967|NCT01657370|528577843|FG001|Overall Study|Adverse Event|0|||
146563968|NCT01657370|528577844|FG002|Overall Study|Adverse Event|0|||
146563969|NCT01657370|528577845|FG003|Overall Study|Adverse Event|0|||
146563970|NCT01657370|528577846|FG004|Overall Study|Adverse Event|1|||
146563971|NCT01657370|528577847|FG005|Overall Study|Adverse Event|0|||
146563972|NCT01657370|528577842|FG000|Overall Study|Protocol Violation|1|||
146563973|NCT01657370|528577843|FG001|Overall Study|Protocol Violation|1|||
146563974|NCT01657370|528577844|FG002|Overall Study|Protocol Violation|1|||
146642906|NCT01584440|528869676|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
146642907|NCT04237116|528869677|FG000|Overall Study|Adverse Event|0|||
146563975|NCT01657370|528577845|FG003|Overall Study|Protocol Violation|1|||
146642908|NCT04237116|528869678|FG001|Overall Study|Adverse Event|1|||
146642909|NCT04237116|528869677|FG000|Overall Study|Study terminated by Sponsor|4|||
146642910|NCT04237116|528869678|FG001|Overall Study|Study terminated by Sponsor|1|||
146642911|NCT00899431|528869679|FG000|Overall Study|Physician Decision|1|||
146911336|NCT00915005|529839789|FG001|Overall Study|Patient preferred protons therapy|0|||
146911337|NCT00915005|529839788|FG000|Overall Study|Insurance denial|3|||
146911338|NCT00915005|529839789|FG001|Overall Study|Insurance denial|15|||
146911339|NCT02747043|529839792|FG000|Overall Study|Other|1|||
146911340|NCT02747043|529839793|FG001|Overall Study|Other|1|||
146911341|NCT02747043|529839792|FG000|Overall Study|Adverse Event|3|||
146911342|NCT02747043|529839793|FG001|Overall Study|Adverse Event|1|||
146911343|NCT02747043|529839792|FG000|Overall Study|Withdrawal by Subject|1|||
146911344|NCT02747043|529839793|FG001|Overall Study|Withdrawal by Subject|1|||
146911345|NCT02747043|529839792|FG000|Overall Study|Physician Decision|1|||
146911346|NCT02747043|529839793|FG001|Overall Study|Physician Decision|1|||
146911347|NCT02747043|529839792|FG000|Overall Study|Protocol Violation|0|||
146911348|NCT02747043|529839793|FG001|Overall Study|Protocol Violation|1|||
146911349|NCT02747043|529839792|FG000|Overall Study|Disease progression|4|||
146911350|NCT02747043|529839793|FG001|Overall Study|Disease progression|0|||
146911351|NCT02564120|529839800|FG000|Overall Study|Did not return release forms|160|||
146911352|NCT02564120|529839800|FG000|Overall Study|Death|58|||
146911353|NCT02564120|529839800|FG000|Overall Study|Withdrawal by Subject|204|||
146911354|NCT02564120|529839800|FG000|Overall Study|Other medical condition|24|||
146911355|NCT00553059|529839803|FG000|Overall Study|Deemed ineligible|1|||
146911356|NCT00553059|529839804|FG001|Overall Study|Deemed ineligible|1|||
146911357|NCT00553059|529839803|FG000|Overall Study|Drug supply not available|0|||
146911358|NCT00553059|529839804|FG001|Overall Study|Drug supply not available|1|||
146911359|NCT01966731|529839805|FG000|Overall Study|Death|2|||
146911360|NCT01966731|529839805|FG000|Overall Study|Lost to Follow-up|1|||
146911361|NCT01966731|529839805|FG000|Overall Study|Physician Decision|2|||
146911362|NCT01966731|529839805|FG000|Overall Study|Follow up is not complete|600|||
146911363|NCT01966731|529839805|FG000|Overall Study|Screening Failure|29|||
146911364|NCT01966731|529839805|FG000|Overall Study|Found to be ineligible|1|||
146911365|NCT01380093|529839806|FG000|Naloxone Challenge Phase|Screen failures|21|||
146911366|NCT01380093|529839807|FG001|Naloxone Challenge Phase|Screen failures|0|||
146911367|NCT01380093|529839808|FG002|Naloxone Challenge Phase|Screen failures|0|||
146911368|NCT01380093|529839809|FG003|Naloxone Challenge Phase|Screen failures|0|||
146911369|NCT01380093|529839810|FG004|Naloxone Challenge Phase|Screen failures|0|||
146911370|NCT01380093|529839811|FG005|Naloxone Challenge Phase|Screen failures|0|||
146911371|NCT01380093|529839812|FG006|Naloxone Challenge Phase|Screen failures|0|||
146911372|NCT01380093|529839813|FG007|Naloxone Challenge Phase|Screen failures|0|||
146911373|NCT01380093|529839814|FG008|Naloxone Challenge Phase|Screen failures|0|||
146911374|NCT01380093|529839806|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
146911375|NCT01380093|529839807|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
146911376|NCT01380093|529839808|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
146911377|NCT01380093|529839809|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
146563976|NCT01657370|528577846|FG004|Overall Study|Protocol Violation|0|||
146911378|NCT01380093|529839810|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
146911379|NCT01380093|529839811|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
146911380|NCT01380093|529839812|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
146768687|NCT03615924|529321764|FG000|Overall Study|Study termination by Sponsor|94|||
146768688|NCT03615924|529321765|FG001|Overall Study|Study termination by Sponsor|86|||
146768689|NCT00716144|529321766|FG000|Overall Study|Withdrawal by Subject|4|||
146768690|NCT00716144|529321767|FG001|Overall Study|Withdrawal by Subject|2|||
146768691|NCT00716144|529321768|FG002|Overall Study|Withdrawal by Subject|6|||
146768692|NCT00716144|529321769|FG003|Overall Study|Withdrawal by Subject|6|||
146768693|NCT00716144|529321766|FG000|Overall Study|Lost to Follow-up|2|||
146768694|NCT00716144|529321767|FG001|Overall Study|Lost to Follow-up|2|||
146768695|NCT00716144|529321768|FG002|Overall Study|Lost to Follow-up|1|||
146768696|NCT00716144|529321769|FG003|Overall Study|Lost to Follow-up|2|||
146768697|NCT00716144|529321766|FG000|Overall Study|Adverse Event|0|||
146768698|NCT00716144|529321767|FG001|Overall Study|Adverse Event|0|||
146768699|NCT00716144|529321768|FG002|Overall Study|Adverse Event|0|||
146768700|NCT00716144|529321769|FG003|Overall Study|Adverse Event|2|||
146768701|NCT00716144|529321766|FG000|Overall Study|Non-compliance|1|||
146768702|NCT00716144|529321767|FG001|Overall Study|Non-compliance|0|||
146768703|NCT00716144|529321768|FG002|Overall Study|Non-compliance|0|||
146768704|NCT00716144|529321769|FG003|Overall Study|Non-compliance|0|||
146768705|NCT00716144|529321766|FG000|Overall Study|Protocol Violation|2|||
146768706|NCT00716144|529321767|FG001|Overall Study|Protocol Violation|0|||
146768707|NCT00716144|529321768|FG002|Overall Study|Protocol Violation|1|||
146768708|NCT00716144|529321769|FG003|Overall Study|Protocol Violation|0|||
146768709|NCT00716144|529321766|FG000|Overall Study|Physician Decision|0|||
146768710|NCT00716144|529321767|FG001|Overall Study|Physician Decision|1|||
146768711|NCT00716144|529321768|FG002|Overall Study|Physician Decision|2|||
146768712|NCT00716144|529321769|FG003|Overall Study|Physician Decision|2|||
146768713|NCT00716144|529321766|FG000|Overall Study|Intercurrent illness|0|||
146768714|NCT00716144|529321767|FG001|Overall Study|Intercurrent illness|0|||
146768715|NCT00716144|529321768|FG002|Overall Study|Intercurrent illness|1|||
146768716|NCT00716144|529321769|FG003|Overall Study|Intercurrent illness|0|||
146768717|NCT00716144|529321766|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
146768718|NCT00716144|529321767|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
146768719|NCT00716144|529321768|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
146768720|NCT00716144|529321769|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
146911381|NCT01380093|529839813|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
146911382|NCT01380093|529839814|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
146911383|NCT01380093|529839806|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
146911384|NCT01380093|529839807|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
146768721|NCT00716144|529321766|FG000|Overall Study|Adverse event: left foot pain|0|||
146768722|NCT00716144|529321767|FG001|Overall Study|Adverse event: left foot pain|1|||
146768723|NCT00716144|529321768|FG002|Overall Study|Adverse event: left foot pain|0|||
146911385|NCT01380093|529839808|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
146911386|NCT01380093|529839809|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
146911387|NCT01380093|529839810|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
146911388|NCT01380093|529839811|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
146911389|NCT01380093|529839812|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
146911390|NCT01380093|529839813|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
146911391|NCT01380093|529839814|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
146911392|NCT01380093|529839806|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
146911393|NCT01380093|529839807|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
146911394|NCT01380093|529839808|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
146911395|NCT01380093|529839809|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
146911396|NCT01380093|529839810|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
146911397|NCT01380093|529839811|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
146971164|NCT02406742|530056255|FG000|Overall Study|Other Reasons|1|||
146971165|NCT02406742|530056256|FG001|Overall Study|Other Reasons|11|||
146642912|NCT00899431|528869680|FG001|Overall Study|Physician Decision|0|||
146642913|NCT00899431|528869681|FG002|Overall Study|Physician Decision|0|||
146642914|NCT03212144|528869682|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
146642915|NCT03212144|528869683|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
146642916|NCT03212144|528869682|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
146642917|NCT03212144|528869683|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
146642918|NCT00661427|528869684|FG000|Overall Study|Adverse Event|5|||
146642919|NCT00661427|528869685|FG001|Overall Study|Adverse Event|5|||
146642920|NCT00661427|528869684|FG000|Overall Study|Patient not treated|0|||
146642921|NCT00661427|528869685|FG001|Overall Study|Patient not treated|2|||
146642922|NCT00599339|528869686|FG000|Overall Study|Adverse Event|79|||
146642923|NCT00599339|528869686|FG000|Overall Study|Withdrawal by Subject|137|||
146642924|NCT00599339|528869686|FG000|Overall Study|Other Reason|179|||
146971166|NCT02406742|530056257|FG002|Overall Study|Other Reasons|5|||
146971167|NCT00765999|530056258|FG000|Overall Study|Adverse Event|203|||
146971168|NCT00765999|530056258|FG000|Overall Study|Insufficient Therapeutic Response|100|||
146971169|NCT00765999|530056258|FG000|Overall Study|Protocol Violation|95|||
146971170|NCT00765999|530056258|FG000|Overall Study|Consent Withdrawn|202|||
146971171|NCT00765999|530056258|FG000|Overall Study|Lost to Follow-up|131|||
146971172|NCT00765999|530056258|FG000|Overall Study|Study Terminated by Sponsor|2|||
146971173|NCT00765999|530056258|FG000|Overall Study|Other Miscellaneous Reasons|51|||
146971174|NCT02367729|530056259|FG000|Overall Study|Organic disorder diagnosed|2|||
146971175|NCT02367729|530056260|FG001|Overall Study|Organic disorder diagnosed|1|||
146971176|NCT02367729|530056259|FG000|Overall Study|Adverse Event|1|||
146971177|NCT02367729|530056260|FG001|Overall Study|Adverse Event|2|||
146971178|NCT02367729|530056259|FG000|Overall Study|Withdrawal by Subject|0|||
146971179|NCT02367729|530056260|FG001|Overall Study|Withdrawal by Subject|5|||
146971180|NCT00759174|530056265|FG000|Overall Study|Other|0|||
146971181|NCT00759174|530056266|FG001|Overall Study|Other|2|||
146971182|NCT01890109|530056267|FG000|Overall Study|Withdrawal by Subject|0|||
146971183|NCT01890109|530056268|FG001|Overall Study|Withdrawal by Subject|3|||
146971184|NCT01890109|530056267|FG000|Overall Study|Lost to Follow-up|1|||
146563977|NCT01657370|528577847|FG005|Overall Study|Protocol Violation|0|||
146971185|NCT01890109|530056268|FG001|Overall Study|Lost to Follow-up|2|||
146971186|NCT01643928|530056269|FG000|Overall Study|Lost to Follow-up|1|||
146971187|NCT01643928|530056270|FG001|Overall Study|Lost to Follow-up|0|||
146971188|NCT01643928|530056271|FG002|Overall Study|Lost to Follow-up|2|||
146911398|NCT01380093|529839812|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
146911399|NCT01380093|529839813|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
146911400|NCT01380093|529839814|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
146911401|NCT01380093|529839806|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
146971189|NCT01643928|530056272|FG003|Overall Study|Lost to Follow-up|0|||
146563978|NCT01657370|528577842|FG000|Overall Study|Lost to Follow-up|2|||
146563979|NCT01657370|528577843|FG001|Overall Study|Lost to Follow-up|0|||
146563980|NCT01657370|528577844|FG002|Overall Study|Lost to Follow-up|1|||
146563981|NCT01657370|528577845|FG003|Overall Study|Lost to Follow-up|0|||
146563982|NCT01657370|528577846|FG004|Overall Study|Lost to Follow-up|0|||
146563983|NCT01657370|528577847|FG005|Overall Study|Lost to Follow-up|1|||
146563984|NCT04043286|528577849|FG000|Overall Study|Withdrawal by Subject|2|||
146563985|NCT04043286|528577850|FG001|Overall Study|Withdrawal by Subject|2|||
146563986|NCT01323192|528577851|FG000|Overall Study|Adverse Event|6|||
146911402|NCT01380093|529839807|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
146911403|NCT01380093|529839808|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
146642925|NCT00599339|528869686|FG000|Overall Study|Lost to Follow-up|221|||
146642926|NCT00599339|528869686|FG000|Overall Study|No valid data consent|36|||
146642927|NCT00599339|528869686|FG000|Overall Study|Study Termination Status Unknown|12|||
146642928|NCT05564052|528869687|FG000|Overall Study|Withdrawal by Subject|0|||
146642929|NCT05564052|528869688|FG001|Overall Study|Withdrawal by Subject|0|||
146642930|NCT05564052|528869689|FG002|Overall Study|Withdrawal by Subject|0|||
146642931|NCT05564052|528869690|FG003|Overall Study|Withdrawal by Subject|1|||
146642932|NCT01821560|528869691|FG000|Overall Study|Lost to Follow-up|5|||
146642933|NCT01821560|528869692|FG001|Overall Study|Lost to Follow-up|5|||
146642934|NCT01821560|528869691|FG000|Overall Study|Withdrawal by Subject|1|||
146642935|NCT01821560|528869692|FG001|Overall Study|Withdrawal by Subject|1|||
146642936|NCT01821560|528869691|FG000|Overall Study|Protocol Violation|0|||
146768724|NCT00716144|529321769|FG003|Overall Study|Adverse event: left foot pain|0|||
146768725|NCT00716144|529321766|FG000|Overall Study|Clinical Depression|0|||
146768726|NCT00716144|529321767|FG001|Overall Study|Clinical Depression|1|||
146911404|NCT01380093|529839809|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
146768727|NCT00716144|529321768|FG002|Overall Study|Clinical Depression|0|||
146911405|NCT01380093|529839810|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
146971190|NCT01643928|530056273|FG004|Overall Study|Lost to Follow-up|0|||
146642937|NCT01821560|528869692|FG001|Overall Study|Protocol Violation|1|||
146642938|NCT00531427|528869693|FG000|Overall Study|Withdrawal by Subject|7|||
146911406|NCT01380093|529839811|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
146642939|NCT00531427|528869694|FG001|Overall Study|Withdrawal by Subject|13|||
146642940|NCT00531427|528869693|FG000|Overall Study|Adverse Event|44|||
146642941|NCT00531427|528869694|FG001|Overall Study|Adverse Event|30|||
146642942|NCT00531427|528869693|FG000|Overall Study|Lost to Follow-up|4|||
146642943|NCT00531427|528869694|FG001|Overall Study|Lost to Follow-up|3|||
146642944|NCT00531427|528869693|FG000|Overall Study|Lack of Efficacy|14|||
146642945|NCT00531427|528869694|FG001|Overall Study|Lack of Efficacy|39|||
146642946|NCT00531427|528869693|FG000|Overall Study|Administrative|4|||
146642947|NCT00531427|528869694|FG001|Overall Study|Administrative|9|||
146642948|NCT01338298|528869695|FG000|Overall Study|Withdrawal by Subject|1|||
146642949|NCT01338298|528869696|FG001|Overall Study|Withdrawal by Subject|1|||
146911407|NCT01380093|529839812|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
146911408|NCT01380093|529839813|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
146642950|NCT01338298|528869695|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
146911409|NCT01380093|529839814|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
146911410|NCT01380093|529839806|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
146911411|NCT01380093|529839807|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
146911412|NCT01380093|529839808|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
146971191|NCT01643928|530056269|FG000|Overall Study|Withdrawal by Subject|2|||
146911413|NCT01380093|529839809|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
146911414|NCT01380093|529839810|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
146971192|NCT01643928|530056270|FG001|Overall Study|Withdrawal by Subject|0|||
146911415|NCT01380093|529839811|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
146971193|NCT01643928|530056271|FG002|Overall Study|Withdrawal by Subject|0|||
146971194|NCT01643928|530056272|FG003|Overall Study|Withdrawal by Subject|1|||
146971195|NCT01643928|530056273|FG004|Overall Study|Withdrawal by Subject|0|||
146971196|NCT01643928|530056269|FG000|Overall Study|Pregnancy|0|||
146971197|NCT01643928|530056270|FG001|Overall Study|Pregnancy|0|||
146971198|NCT01643928|530056271|FG002|Overall Study|Pregnancy|0|||
146971199|NCT01643928|530056272|FG003|Overall Study|Pregnancy|1|||
146971200|NCT01643928|530056273|FG004|Overall Study|Pregnancy|0|||
146971201|NCT01643928|530056269|FG000|Overall Study|Other|5|||
146971202|NCT01643928|530056270|FG001|Overall Study|Other|1|||
146971203|NCT01643928|530056271|FG002|Overall Study|Other|1|||
146971204|NCT01643928|530056272|FG003|Overall Study|Other|0|||
146971205|NCT01643928|530056273|FG004|Overall Study|Other|0|||
146971206|NCT01643928|530056269|FG000|Overall Study|Adverse Event|2|||
146971207|NCT01643928|530056270|FG001|Overall Study|Adverse Event|1|||
146971208|NCT01643928|530056271|FG002|Overall Study|Adverse Event|0|||
146971209|NCT01643928|530056272|FG003|Overall Study|Adverse Event|1|||
146971210|NCT01643928|530056273|FG004|Overall Study|Adverse Event|2|||
146971211|NCT03692078|530056275|FG000|Overall Study|Adverse Event|0|||
146971212|NCT03692078|530056276|FG001|Overall Study|Adverse Event|0|||
146971213|NCT03692078|530056277|FG002|Overall Study|Adverse Event|0|||
146971214|NCT03692078|530056278|FG003|Overall Study|Adverse Event|0|||
146971215|NCT03692078|530056279|FG004|Overall Study|Adverse Event|0|||
146971216|NCT03692078|530056280|FG005|Overall Study|Adverse Event|1|||
146971217|NCT03692078|530056281|FG006|Overall Study|Adverse Event|0|||
146971218|NCT03692078|530056275|FG000|Overall Study|Enrollment Closed|5|||
146971219|NCT03692078|530056276|FG001|Overall Study|Enrollment Closed|0|||
146971220|NCT03692078|530056277|FG002|Overall Study|Enrollment Closed|0|||
146971221|NCT03692078|530056278|FG003|Overall Study|Enrollment Closed|0|||
146971222|NCT03692078|530056279|FG004|Overall Study|Enrollment Closed|0|||
146971223|NCT03692078|530056280|FG005|Overall Study|Enrollment Closed|0|||
146971224|NCT03692078|530056281|FG006|Overall Study|Enrollment Closed|0|||
146971225|NCT03692078|530056275|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
146971226|NCT03692078|530056276|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
146971227|NCT03692078|530056277|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
146971228|NCT03692078|530056278|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
146971229|NCT03692078|530056279|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
146971230|NCT03692078|530056280|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
146971231|NCT03692078|530056281|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
146971232|NCT03692078|530056275|FG000|Overall Study|Withdrawal by Subject|0|||
146971233|NCT03692078|530056276|FG001|Overall Study|Withdrawal by Subject|2|||
146911416|NCT01380093|529839812|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
146911417|NCT01380093|529839813|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
146911418|NCT01380093|529839814|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
146911419|NCT01380093|529839806|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
146911420|NCT01380093|529839807|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
146911421|NCT01380093|529839808|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
146911422|NCT01380093|529839809|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
146911423|NCT01380093|529839810|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
146911424|NCT01380093|529839811|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
146971234|NCT03692078|530056277|FG002|Overall Study|Withdrawal by Subject|0|||
146971235|NCT03692078|530056278|FG003|Overall Study|Withdrawal by Subject|1|||
146971236|NCT03692078|530056279|FG004|Overall Study|Withdrawal by Subject|5|||
146642951|NCT01338298|528869696|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
146642952|NCT01338298|528869695|FG000|Overall Study|Administrative error|0|||
146642953|NCT01338298|528869696|FG001|Overall Study|Administrative error|1|||
146642954|NCT01338298|528869695|FG000|Overall Study|Positive symptom worsening|1|||
146642955|NCT01338298|528869696|FG001|Overall Study|Positive symptom worsening|0|||
146642956|NCT01338298|528869695|FG000|Overall Study|Depressive symptoms and nausea|1|||
146642957|NCT01338298|528869696|FG001|Overall Study|Depressive symptoms and nausea|0|||
146642958|NCT01338298|528869695|FG000|Overall Study|Non-adherence|1|||
146642959|NCT01338298|528869696|FG001|Overall Study|Non-adherence|0|||
146642960|NCT02872285|528869697|FG000|Overall Study|Withdrawal by Subject|2|||
146642961|NCT02872285|528869698|FG001|Overall Study|Withdrawal by Subject|0|||
146642962|NCT02872285|528869697|FG000|Overall Study|Lost to Follow-up|2|||
146642963|NCT02872285|528869698|FG001|Overall Study|Lost to Follow-up|2|||
146642964|NCT02872285|528869697|FG000|Overall Study|Discontinued due to back surgery|1|||
146642965|NCT02872285|528869698|FG001|Overall Study|Discontinued due to back surgery|0|||
146642966|NCT02660983|528869700|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
146642967|NCT02660983|528869701|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
146642968|NCT02660983|528869700|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
146768728|NCT00716144|529321769|FG003|Overall Study|Clinical Depression|0|||
146768729|NCT00909363|529321770|FG000|Overall Study|Withdrawal by Subject|1|||
146971237|NCT03692078|530056280|FG005|Overall Study|Withdrawal by Subject|3|||
146971238|NCT03692078|530056281|FG006|Overall Study|Withdrawal by Subject|3|||
146971239|NCT05723835|530056284|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
146971240|NCT05723835|530056285|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
146971241|NCT05723835|530056286|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
146971242|NCT05723835|530056287|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
146971243|NCT05723835|530056288|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
146971244|NCT05723835|530056289|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
146971245|NCT05723835|530056290|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
146971246|NCT05723835|530056291|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
146971247|NCT05226286|530056292|FG000|Overall Study|Screen failures prior to implant|62|||
146971248|NCT05226286|530056292|FG000|Overall Study|Withdrawal by Subject|13|||
146642969|NCT02660983|528869701|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
146768730|NCT00909363|529321771|FG001|Overall Study|Withdrawal by Subject|0|||
146768731|NCT00909363|529321772|FG002|Overall Study|Withdrawal by Subject|0|||
146642970|NCT02660983|528869700|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
146768732|NCT00909363|529321770|FG000|Overall Study|Lack of Efficacy|1|||
146971249|NCT05226286|530056292|FG000|Overall Study|Lost to Follow-up|3|||
146971250|NCT05226286|530056292|FG000|Overall Study|Physician Decision|1|||
146971251|NCT05226286|530056292|FG000|Overall Study|Adverse Event|1|||
146971252|NCT05226286|530056292|FG000|Overall Study|Death|1|||
146971253|NCT05226286|530056292|FG000|Overall Study|Device explant with no planned replacement|1|||
146971254|NCT05226286|530056292|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
146971255|NCT05226286|530056292|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
146971256|NCT03395197|530056293|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
146971257|NCT03395197|530056294|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
146971258|NCT03395197|530056295|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
146971259|NCT03395197|530056296|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
146971260|NCT03395197|530056297|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
146971261|NCT03395197|530056298|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
146971262|NCT03395197|530056293|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
146971263|NCT03395197|530056294|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
146971264|NCT03395197|530056295|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
146971265|NCT03395197|530056296|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
146971266|NCT03395197|530056297|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
146971267|NCT03395197|530056298|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
146971268|NCT03395197|530056293|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
146971269|NCT03395197|530056294|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
146971270|NCT03395197|530056295|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
146971271|NCT03395197|530056296|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
146971272|NCT03395197|530056297|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
146971273|NCT03395197|530056298|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
146971274|NCT03395197|530056293|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
146971275|NCT03395197|530056294|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
146971276|NCT03395197|530056295|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
146971277|NCT03395197|530056296|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
146971278|NCT03395197|530056297|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
146971279|NCT03395197|530056298|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
146971280|NCT03395197|530056293|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
146971281|NCT03395197|530056294|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
146971282|NCT03395197|530056295|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
146971283|NCT03395197|530056296|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
146971284|NCT03395197|530056297|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
146971285|NCT03395197|530056298|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
146971286|NCT03395197|530056293|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
146971287|NCT03395197|530056294|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
146971288|NCT03395197|530056295|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
146971289|NCT03395197|530056296|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
146971290|NCT03395197|530056297|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
146971291|NCT03395197|530056298|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
146971292|NCT03395197|530056293|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
146971293|NCT03395197|530056294|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
146971294|NCT03395197|530056295|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
146971295|NCT03395197|530056296|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
146971296|NCT03395197|530056297|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
146971297|NCT03395197|530056298|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
146642971|NCT02660983|528869701|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
146642972|NCT02660983|528869700|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
146911425|NCT01380093|529839812|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
146911426|NCT01380093|529839813|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
146911427|NCT01380093|529839814|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
146911428|NCT01380093|529839806|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
146911429|NCT01380093|529839807|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
146911430|NCT01380093|529839808|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
146911431|NCT01380093|529839809|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
146911432|NCT01380093|529839810|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
146911433|NCT01380093|529839811|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
146911434|NCT01380093|529839812|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
146911435|NCT01380093|529839813|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
146911436|NCT01380093|529839814|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
146911437|NCT01380093|529839806|FG000|Treatment Phase: Second Intervention|Other|0|||
146911438|NCT01380093|529839807|FG001|Treatment Phase: Second Intervention|Other|0|||
146911439|NCT01380093|529839808|FG002|Treatment Phase: Second Intervention|Other|0|||
146911440|NCT01380093|529839809|FG003|Treatment Phase: Second Intervention|Other|1|||
146911441|NCT01380093|529839810|FG004|Treatment Phase: Second Intervention|Other|0|||
146911442|NCT01380093|529839811|FG005|Treatment Phase: Second Intervention|Other|0|||
146911443|NCT01380093|529839812|FG006|Treatment Phase: Second Intervention|Other|0|||
146911444|NCT01380093|529839813|FG007|Treatment Phase: Second Intervention|Other|0|||
146911445|NCT01380093|529839814|FG008|Treatment Phase: Second Intervention|Other|0|||
146911446|NCT01380093|529839806|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
146911447|NCT01380093|529839807|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
146642973|NCT02660983|528869701|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
146642974|NCT02660983|528869700|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
146642975|NCT02660983|528869701|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
146642976|NCT02660983|528869700|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
146642977|NCT02660983|528869701|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
146642978|NCT02660983|528869700|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
146642979|NCT02660983|528869701|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
146911448|NCT01380093|529839808|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
146911449|NCT01380093|529839809|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
146911450|NCT01380093|529839810|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
146911451|NCT01380093|529839811|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
146971298|NCT03395197|530056293|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
146971299|NCT03395197|530056294|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
146971300|NCT03395197|530056295|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
146971301|NCT03395197|530056296|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
146971302|NCT03395197|530056297|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
146971303|NCT03395197|530056298|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
146971304|NCT03395197|530056293|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
146911452|NCT01380093|529839812|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
146911453|NCT01380093|529839813|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
146911454|NCT01380093|529839814|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
146911455|NCT01380093|529839806|FG000|Treatment Phase: Third Intervention|Other|0|||
146911456|NCT01380093|529839807|FG001|Treatment Phase: Third Intervention|Other|0|||
146911457|NCT01380093|529839808|FG002|Treatment Phase: Third Intervention|Other|0|||
146911458|NCT01380093|529839809|FG003|Treatment Phase: Third Intervention|Other|0|||
146911459|NCT01380093|529839810|FG004|Treatment Phase: Third Intervention|Other|0|||
146911460|NCT01380093|529839811|FG005|Treatment Phase: Third Intervention|Other|0|||
146911461|NCT01380093|529839812|FG006|Treatment Phase: Third Intervention|Other|0|||
146911462|NCT01380093|529839813|FG007|Treatment Phase: Third Intervention|Other|0|||
146911463|NCT01380093|529839814|FG008|Treatment Phase: Third Intervention|Other|1|||
146911464|NCT03952650|529839815|FG000|Overall Study|TRAVEL|0|||
146911465|NCT03952650|529839816|FG001|Overall Study|TRAVEL|4|||
146911466|NCT03952650|529839817|FG002|Overall Study|TRAVEL|0|||
146911467|NCT03952650|529839818|FG003|Overall Study|TRAVEL|4|||
146911468|NCT03952650|529839819|FG004|Overall Study|TRAVEL|0|||
146911469|NCT03952650|529839820|FG005|Overall Study|TRAVEL|3|||
146911470|NCT03952650|529839821|FG006|Overall Study|TRAVEL|2|||
146911471|NCT03952650|529839815|FG000|Overall Study|Withdrawal by Subject|0|||
146911472|NCT03952650|529839816|FG001|Overall Study|Withdrawal by Subject|2|||
146911473|NCT03952650|529839817|FG002|Overall Study|Withdrawal by Subject|0|||
146911474|NCT03952650|529839818|FG003|Overall Study|Withdrawal by Subject|3|||
146911475|NCT03952650|529839819|FG004|Overall Study|Withdrawal by Subject|0|||
146911476|NCT03952650|529839820|FG005|Overall Study|Withdrawal by Subject|1|||
146911477|NCT03952650|529839821|FG006|Overall Study|Withdrawal by Subject|1|||
146911478|NCT03952650|529839815|FG000|Overall Study|Lost to Follow-up|0|||
146911479|NCT03952650|529839816|FG001|Overall Study|Lost to Follow-up|1|||
146911480|NCT03952650|529839817|FG002|Overall Study|Lost to Follow-up|0|||
146911481|NCT03952650|529839818|FG003|Overall Study|Lost to Follow-up|0|||
146911482|NCT03952650|529839819|FG004|Overall Study|Lost to Follow-up|0|||
146911483|NCT03952650|529839820|FG005|Overall Study|Lost to Follow-up|1|||
146911484|NCT03952650|529839821|FG006|Overall Study|Lost to Follow-up|1|||
146911485|NCT03952650|529839815|FG000|Overall Study|Received wrong vaccine and travelled|0|||
146911486|NCT03952650|529839816|FG001|Overall Study|Received wrong vaccine and travelled|0|||
146911487|NCT03952650|529839817|FG002|Overall Study|Received wrong vaccine and travelled|0|||
146911488|NCT03952650|529839818|FG003|Overall Study|Received wrong vaccine and travelled|0|||
146911489|NCT03952650|529839819|FG004|Overall Study|Received wrong vaccine and travelled|0|||
146911490|NCT03952650|529839820|FG005|Overall Study|Received wrong vaccine and travelled|1|||
146911491|NCT03952650|529839821|FG006|Overall Study|Received wrong vaccine and travelled|0|||
146911492|NCT03952650|529839815|FG000|Overall Study|Unable to make study visit|0|||
146911493|NCT03952650|529839816|FG001|Overall Study|Unable to make study visit|0|||
146911494|NCT03952650|529839817|FG002|Overall Study|Unable to make study visit|0|||
146911495|NCT03952650|529839818|FG003|Overall Study|Unable to make study visit|0|||
146911496|NCT03952650|529839819|FG004|Overall Study|Unable to make study visit|0|||
146911497|NCT03952650|529839820|FG005|Overall Study|Unable to make study visit|1|||
146911498|NCT03952650|529839821|FG006|Overall Study|Unable to make study visit|0|||
146911499|NCT00592683|529839822|FG000|Overall Study|Found ineligible|0|||
146911500|NCT00592683|529839823|FG001|Overall Study|Found ineligible|1|||
146911501|NCT00592683|529839822|FG000|Overall Study|Withdrawal by Subject|1|||
146911502|NCT00592683|529839823|FG001|Overall Study|Withdrawal by Subject|0|||
146911503|NCT00592683|529839822|FG000|Overall Study|Adverse Event|0|||
146911504|NCT00592683|529839823|FG001|Overall Study|Adverse Event|2|||
146911505|NCT00592683|529839822|FG000|Overall Study|Protocol Violation|1|||
146768733|NCT00909363|529321771|FG001|Overall Study|Lack of Efficacy|0|||
146768734|NCT00909363|529321772|FG002|Overall Study|Lack of Efficacy|0|||
146768735|NCT02954848|529321782|FG000|Overall Study|Randomized but Not Treated|0|||
146768736|NCT02954848|529321783|FG001|Overall Study|Randomized but Not Treated|1|||
146768737|NCT02954848|529321782|FG000|Overall Study|Adverse Event|2|||
146768738|NCT02954848|529321783|FG001|Overall Study|Adverse Event|3|||
146911506|NCT00592683|529839823|FG001|Overall Study|Protocol Violation|0|||
146768739|NCT02954848|529321782|FG000|Overall Study|Withdrawal by Participant|0|||
146642980|NCT01253577|528869705|FG000|Overall Study|Lost to Follow-up|3|||
146642981|NCT00721968|528869706|FG000|Overall Study|Lost to Follow-up|2|||
146911507|NCT00592683|529839822|FG000|Overall Study|Study drug expired|1|||
146911508|NCT00592683|529839823|FG001|Overall Study|Study drug expired|0|||
146911509|NCT00592683|529839822|FG000|Overall Study|Other|1|||
146911510|NCT00592683|529839823|FG001|Overall Study|Other|0|||
146911511|NCT00592683|529839822|FG000|Overall Study|Lost to Follow-up|0|||
146911512|NCT00592683|529839823|FG001|Overall Study|Lost to Follow-up|1|||
146911513|NCT00201201|529839824|FG000|Overall Study|Death|0|||
146911514|NCT00201201|529839825|FG001|Overall Study|Death|2|||
146911515|NCT00201201|529839824|FG000|Overall Study|Withdrawal by Subject|5|||
146911516|NCT00201201|529839825|FG001|Overall Study|Withdrawal by Subject|5|||
146911517|NCT00891657|529839832|FG000|Overall Study|Withdrawal by Subject|1|||
146911518|NCT00891657|529839833|FG001|Overall Study|Withdrawal by Subject|1|||
146911519|NCT00545818|529839834|FG000|Overall Study|Protocol Violation|1|||
146911520|NCT00545818|529839835|FG001|Overall Study|Protocol Violation|0|||
146911521|NCT00545818|529839834|FG000|Overall Study|Adverse Event|1|||
146911522|NCT00545818|529839835|FG001|Overall Study|Adverse Event|1|||
146911523|NCT00545818|529839834|FG000|Overall Study|Lost to Follow-up|1|||
146911524|NCT00545818|529839835|FG001|Overall Study|Lost to Follow-up|6|||
146911525|NCT00609609|529839836|FG000|Overall Study|Withdrawal by Subject|2|||
146911526|NCT00609609|529839837|FG001|Overall Study|Withdrawal by Subject|0|||
146911527|NCT00609609|529839836|FG000|Overall Study|Progression|4|||
146911528|NCT00609609|529839837|FG001|Overall Study|Progression|2|||
146911529|NCT00909090|529839840|FG000|Overall Study|Lost to Follow-up|17|||
146911530|NCT00909090|529839841|FG001|Overall Study|Lost to Follow-up|17|||
146911531|NCT01749735|529839843|FG000|Overall Study|Withdrawal by Subject|1|||
146911532|NCT01749735|529839844|FG001|Overall Study|Withdrawal by Subject|0|||
146911533|NCT02926573|529839845|FG000|Overall Study|Nausea|1|||
146911534|NCT02926573|529839846|FG001|Overall Study|Nausea|0|||
146911535|NCT02926573|529839845|FG000|Overall Study|Remain intubated|2|||
146911536|NCT02926573|529839846|FG001|Overall Study|Remain intubated|2|||
146911537|NCT02926573|529839845|FG000|Overall Study|Change in surgery plan|3|||
146911538|NCT02926573|529839846|FG001|Overall Study|Change in surgery plan|1|||
146911539|NCT02926573|529839845|FG000|Overall Study|Change to outpatient status|5|||
146911540|NCT02926573|529839846|FG001|Overall Study|Change to outpatient status|1|||
146911541|NCT02926573|529839845|FG000|Overall Study|Withdrawal by Subject|0|||
146911542|NCT02926573|529839846|FG001|Overall Study|Withdrawal by Subject|2|||
146971305|NCT03395197|530056294|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
146971306|NCT03395197|530056295|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
146971307|NCT03395197|530056296|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
146971308|NCT03395197|530056297|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
146971309|NCT03395197|530056298|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
146971310|NCT03395197|530056293|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
146642982|NCT00721968|528869707|FG001|Overall Study|Lost to Follow-up|0|||
146642983|NCT05601544|528869708|FG000|Phase 2 Period 1|Adverse Event|0|||
146642984|NCT05601544|528869709|FG001|Phase 2 Period 1|Adverse Event|1|||
146642985|NCT05601544|528869710|FG002|Phase 2 Period 1|Adverse Event|0|||
146971311|NCT03395197|530056294|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
146971312|NCT03395197|530056295|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
146971313|NCT03395197|530056296|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
146971314|NCT03395197|530056297|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
146971315|NCT03395197|530056298|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
146971316|NCT03395197|530056293|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
146971317|NCT03395197|530056294|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
146971318|NCT03395197|530056295|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
146971319|NCT03395197|530056296|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
146971320|NCT03395197|530056297|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
146971321|NCT03395197|530056298|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
146971322|NCT03395197|530056293|FG000|Analysis for DDR-Deficient Participants|Death|0|||
146971323|NCT03395197|530056294|FG001|Analysis for DDR-Deficient Participants|Death|0|||
146971324|NCT03395197|530056295|FG002|Analysis for DDR-Deficient Participants|Death|0|||
146971325|NCT03395197|530056296|FG003|Analysis for DDR-Deficient Participants|Death|0|||
146971326|NCT03395197|530056297|FG004|Analysis for DDR-Deficient Participants|Death|1|||
146971327|NCT03395197|530056298|FG005|Analysis for DDR-Deficient Participants|Death|4|||
146971328|NCT03395197|530056293|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
146971329|NCT03395197|530056294|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
146971330|NCT03395197|530056295|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
146563987|NCT01323192|528577852|FG001|Overall Study|Adverse Event|1|||
146563988|NCT01323192|528577851|FG000|Overall Study|Withdrawal by Subject|3|||
146563989|NCT01323192|528577852|FG001|Overall Study|Withdrawal by Subject|1|||
146563990|NCT01323192|528577851|FG000|Overall Study|Noncompliance with study medication|0|||
146563991|NCT01323192|528577852|FG001|Overall Study|Noncompliance with study medication|3|||
146563992|NCT01323192|528577851|FG000|Overall Study|Nonmedical reasons|0|||
146971331|NCT03395197|530056296|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
146911543|NCT02926573|529839845|FG000|Overall Study|Return to operating room|0|||
146911544|NCT02926573|529839846|FG001|Overall Study|Return to operating room|2|||
146911545|NCT02926573|529839845|FG000|Overall Study|Delirium|0|||
146911546|NCT02926573|529839846|FG001|Overall Study|Delirium|1|||
146768740|NCT02954848|529321783|FG001|Overall Study|Withdrawal by Participant|1|||
146768741|NCT01802632|529321784|FG000|Overall Study|Death|28|||
146768742|NCT01802632|529321785|FG001|Overall Study|Death|1|||
146768743|NCT01802632|529321786|FG002|Overall Study|Death|38|||
146768744|NCT01802632|529321787|FG003|Overall Study|Death|0|||
146768745|NCT01802632|529321788|FG004|Overall Study|Death|2|||
146768746|NCT01802632|529321789|FG005|Overall Study|Death|0|||
146911547|NCT00611455|529839849|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
146911548|NCT00611455|529839850|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
146911549|NCT00611455|529839851|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
146911550|NCT00611455|529839849|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
146642986|NCT05601544|528869711|FG003|Phase 2 Period 1|Adverse Event|0|||
146911551|NCT00611455|529839850|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
146911552|NCT00611455|529839851|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
146911553|NCT00611455|529839849|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
146911554|NCT00611455|529839850|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
146642987|NCT05601544|528869712|FG004|Phase 2 Period 1|Adverse Event|0|||
146642988|NCT05601544|528869713|FG005|Phase 2 Period 1|Adverse Event|0|||
146642989|NCT01064947|528869714|FG000|Overall Study|negative culture|41|||
146642990|NCT06457204|528869715|FG000|Washout|Adverse Event|0|||
146642991|NCT06457204|528869716|FG001|Washout|Adverse Event|2|||
146642992|NCT01601652|528869718|FG000|Overall Study|Death|1|||
146642993|NCT00488683|528869725|FG000|Overall Study|Withdrawal by Subject|1|||
146642994|NCT00488683|528869726|FG001|Overall Study|Withdrawal by Subject|2|||
146642995|NCT00488683|528869727|FG002|Overall Study|Withdrawal by Subject|2|||
146911555|NCT00611455|529839851|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
146911556|NCT00611455|529839849|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
146768747|NCT01802632|529321784|FG000|Overall Study|Withdrawal by Subject|4|||
146911557|NCT00611455|529839850|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
146911558|NCT00611455|529839851|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146768748|NCT01802632|529321785|FG001|Overall Study|Withdrawal by Subject|2|||
146642996|NCT00488683|528869725|FG000|Overall Study|Lost to Follow-up|5|||
146768749|NCT01802632|529321786|FG002|Overall Study|Withdrawal by Subject|7|||
146642997|NCT00488683|528869726|FG001|Overall Study|Lost to Follow-up|3|||
146642998|NCT00488683|528869727|FG002|Overall Study|Lost to Follow-up|0|||
146642999|NCT00488683|528869725|FG000|Overall Study|Protocol Violation|5|||
146643000|NCT00488683|528869726|FG001|Overall Study|Protocol Violation|1|||
146643001|NCT00488683|528869727|FG002|Overall Study|Protocol Violation|0|||
146643002|NCT00488683|528869725|FG000|Overall Study|Unable to Classify|1|||
146643003|NCT00488683|528869726|FG001|Overall Study|Unable to Classify|0|||
146643004|NCT00488683|528869727|FG002|Overall Study|Unable to Classify|0|||
146643005|NCT03818035|528869729|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
146643006|NCT03818035|528869730|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
146643007|NCT03818035|528869731|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
146643008|NCT03818035|528869732|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
146643009|NCT03818035|528869729|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
146643010|NCT03818035|528869730|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
146643011|NCT03818035|528869731|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
146643012|NCT03818035|528869732|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
146643013|NCT03818035|528869729|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
146643014|NCT03818035|528869730|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
146643015|NCT03818035|528869731|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
146643016|NCT03818035|528869732|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
146643017|NCT03818035|528869729|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
146643018|NCT03818035|528869730|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
146643019|NCT03818035|528869731|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
146643020|NCT03818035|528869732|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
146643021|NCT03818035|528869729|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
146643022|NCT03818035|528869730|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
146643023|NCT03818035|528869731|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
146643024|NCT03818035|528869732|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
146643025|NCT03818035|528869729|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
146643026|NCT03818035|528869730|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
146643027|NCT03818035|528869731|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
146643028|NCT03818035|528869732|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
146643029|NCT03818035|528869729|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
146643030|NCT03818035|528869730|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
146643031|NCT03818035|528869731|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
146643032|NCT03818035|528869732|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
146643033|NCT03818035|528869729|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
146643034|NCT03818035|528869730|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
146643035|NCT03818035|528869731|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
146768750|NCT01802632|529321787|FG003|Overall Study|Withdrawal by Subject|3|||
146768751|NCT01802632|529321788|FG004|Overall Study|Withdrawal by Subject|0|||
146643036|NCT03818035|528869732|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
146768752|NCT01802632|529321789|FG005|Overall Study|Withdrawal by Subject|1|||
146768753|NCT01802632|529321784|FG000|Overall Study|Objective Disease Progression|1|||
146768754|NCT01802632|529321785|FG001|Overall Study|Objective Disease Progression|12|||
146768755|NCT01802632|529321786|FG002|Overall Study|Objective Disease Progression|104|||
146768756|NCT01802632|529321787|FG003|Overall Study|Objective Disease Progression|6|||
146768757|NCT01802632|529321788|FG004|Overall Study|Objective Disease Progression|4|||
146768758|NCT01802632|529321789|FG005|Overall Study|Objective Disease Progression|4|||
146768759|NCT01802632|529321784|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
146768760|NCT01802632|529321785|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
146768761|NCT01802632|529321786|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
146971332|NCT03395197|530056297|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
146768762|NCT01802632|529321787|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
146768763|NCT01802632|529321788|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
146768764|NCT01802632|529321789|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
146768765|NCT01802632|529321784|FG000|Overall Study|Other (not specified)|0|||
146768766|NCT01802632|529321785|FG001|Overall Study|Other (not specified)|0|||
146768767|NCT01802632|529321786|FG002|Overall Study|Other (not specified)|7|||
146971333|NCT03395197|530056298|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
146971334|NCT03395197|530056293|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
146971335|NCT03395197|530056294|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
146971336|NCT03395197|530056295|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
146971337|NCT03395197|530056296|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
146643037|NCT03818035|528869729|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
146768768|NCT01802632|529321787|FG003|Overall Study|Other (not specified)|1|||
146768769|NCT01802632|529321788|FG004|Overall Study|Other (not specified)|0|||
146768770|NCT01802632|529321789|FG005|Overall Study|Other (not specified)|1|||
146768771|NCT04707313|529321791|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
146768772|NCT04707313|529321792|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
146768773|NCT04707313|529321793|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
146768774|NCT04707313|529321794|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
146768775|NCT04707313|529321795|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
146768776|NCT04707313|529321796|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
146768777|NCT04707313|529321797|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
146768778|NCT04707313|529321798|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
146768779|NCT04707313|529321799|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
146768780|NCT04707313|529321800|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
146768781|NCT04707313|529321801|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
146768782|NCT04707313|529321802|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
146768783|NCT04707313|529321803|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
146768784|NCT04707313|529321791|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
146768785|NCT04707313|529321792|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
146768786|NCT04707313|529321793|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146768787|NCT04707313|529321794|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146768788|NCT04707313|529321795|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
146768789|NCT04707313|529321796|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146768790|NCT04707313|529321797|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146768791|NCT04707313|529321798|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146768792|NCT04707313|529321799|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146768793|NCT04707313|529321800|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146768794|NCT04707313|529321801|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146768795|NCT04707313|529321802|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146768796|NCT04707313|529321803|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146768797|NCT04707313|529321791|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
146768798|NCT04707313|529321792|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
146768799|NCT04707313|529321793|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
146768800|NCT04707313|529321794|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
146768801|NCT04707313|529321795|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
146971338|NCT03395197|530056297|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
146971339|NCT03395197|530056298|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
146971340|NCT03395197|530056293|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
146971341|NCT03395197|530056294|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
146971342|NCT03395197|530056295|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
146971343|NCT03395197|530056296|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
146971344|NCT03395197|530056297|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
146971345|NCT03395197|530056298|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
146971346|NCT03395197|530056293|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
146971347|NCT03395197|530056294|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
146971348|NCT03395197|530056295|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
146971349|NCT03395197|530056296|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
146643038|NCT03818035|528869730|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
146643039|NCT03818035|528869731|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
146971350|NCT03395197|530056297|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
146643040|NCT03818035|528869732|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
146643041|NCT03818035|528869729|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
146643042|NCT03818035|528869730|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
146643043|NCT03818035|528869731|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
146971351|NCT03395197|530056298|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
146643044|NCT03818035|528869732|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
146643045|NCT03818035|528869729|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
146643046|NCT03818035|528869730|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
146643047|NCT03818035|528869731|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
146643048|NCT03818035|528869732|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
146643049|NCT03818035|528869729|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
146643050|NCT03818035|528869730|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
146643051|NCT03818035|528869731|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
146643052|NCT03818035|528869732|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
146643053|NCT03818035|528869729|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
146643054|NCT03818035|528869730|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
146643055|NCT03818035|528869731|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
146643056|NCT03818035|528869732|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
146643057|NCT03818035|528869729|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
146643058|NCT03818035|528869730|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
146643059|NCT03818035|528869731|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
146643060|NCT03818035|528869732|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
146643061|NCT03818035|528869729|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
146643062|NCT03818035|528869730|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
146643063|NCT03818035|528869731|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
146643064|NCT03818035|528869732|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
146643065|NCT03374202|528869735|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
146643066|NCT03374202|528869736|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
146643067|NCT03374202|528869737|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
146643068|NCT03374202|528869735|FG000|Five Year Long Term Follow Up|Death|0|||
146643069|NCT03374202|528869736|FG001|Five Year Long Term Follow Up|Death|1|||
146643070|NCT03374202|528869737|FG002|Five Year Long Term Follow Up|Death|0|||
146643071|NCT01794338|528872076|FG000|Overall Study|Death|2|||
146643072|NCT01794338|528872077|FG001|Overall Study|Death|0|||
146643073|NCT01794338|528872076|FG000|Overall Study|Lost to Follow-up|6|||
146643074|NCT01794338|528872077|FG001|Overall Study|Lost to Follow-up|9|||
146643075|NCT01754402|528872078|FG000|Overall Study|Death|0|||
146643076|NCT01754402|528872079|FG001|Overall Study|Death|0|||
146643077|NCT01754402|528872080|FG002|Overall Study|Death|1|||
146643078|NCT01754402|528872078|FG000|Overall Study|Adverse Event|2|||
146911559|NCT00611455|529839849|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
146911560|NCT00611455|529839850|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
146911561|NCT00611455|529839851|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
146911562|NCT00611455|529839849|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
146911563|NCT00611455|529839850|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
146911564|NCT00611455|529839851|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
146911565|NCT00611455|529839849|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
146911566|NCT00611455|529839850|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
146971352|NCT03395197|530056293|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
146971353|NCT03395197|530056294|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
146971354|NCT03395197|530056295|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
146971355|NCT03395197|530056296|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
146971356|NCT03395197|530056297|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
146971357|NCT03395197|530056298|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
146971358|NCT03395197|530056293|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
146971359|NCT03395197|530056294|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
146971360|NCT03395197|530056295|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
146971361|NCT03395197|530056296|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
146971362|NCT03395197|530056297|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
146971363|NCT03395197|530056298|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
146971364|NCT03395197|530056293|FG000|Analysis for DDR-Deficient Participants|Other|0|||
146971365|NCT03395197|530056294|FG001|Analysis for DDR-Deficient Participants|Other|0|||
146971366|NCT03395197|530056295|FG002|Analysis for DDR-Deficient Participants|Other|0|||
146971367|NCT03395197|530056296|FG003|Analysis for DDR-Deficient Participants|Other|0|||
146971368|NCT03395197|530056297|FG004|Analysis for DDR-Deficient Participants|Other|3|||
146971369|NCT03395197|530056298|FG005|Analysis for DDR-Deficient Participants|Other|3|||
146971370|NCT03395197|530056293|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
146971371|NCT03395197|530056294|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
146971372|NCT03395197|530056295|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
146971373|NCT03395197|530056296|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
146971374|NCT03395197|530056297|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
146971375|NCT03395197|530056298|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
146971376|NCT04701658|530056299|FG000|Overall Study|Lost to Follow-up|6|||
146971377|NCT01346501|530056301|FG000|Overall Study|Initiated Other Biological Agents|3|||
146971378|NCT01346501|530056302|FG001|Overall Study|Initiated Other Biological Agents|1|||
146971379|NCT01346501|530056301|FG000|Overall Study|Other|8|||
146971380|NCT01346501|530056302|FG001|Overall Study|Other|12|||
146971381|NCT04101721|530056303|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
146971382|NCT04101721|530056304|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
146971383|NCT04101721|530056303|FG000|Overall Study|Death|0|||
146971384|NCT04101721|530056304|FG001|Overall Study|Death|1|||
146971385|NCT04101721|530056303|FG000|Overall Study|Lost to Follow-up|0|||
146971386|NCT04101721|530056304|FG001|Overall Study|Lost to Follow-up|3|||
146971387|NCT02564952|530056305|FG000|Overall Study|Adverse Event|6|||
146971388|NCT02564952|530056305|FG000|Overall Study|Lost to Follow-up|1|||
146971389|NCT02564952|530056305|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
146971390|NCT02564952|530056305|FG000|Overall Study|Withdrawal by Subject|1|||
146971391|NCT02564952|530056305|FG000|Overall Study|Low Efficacy|1|||
146971392|NCT02564952|530056305|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
146971393|NCT00756652|530056306|FG000|Original Phase|Withdrawal by Subject|864|||
146971394|NCT00756652|530056307|FG001|Original Phase|Withdrawal by Subject|23|||
146971395|NCT00756652|530056306|FG000|Original Phase|Lost to Follow-up|601|||
146971396|NCT00756652|530056307|FG001|Original Phase|Lost to Follow-up|0|||
146971397|NCT00756652|530056306|FG000|Original Phase|Other Discontinuation|797|||
146971398|NCT00756652|530056307|FG001|Original Phase|Other Discontinuation|5|||
146971399|NCT00756652|530056306|FG000|Original Phase|Participant Noncompliance|18622|||
146971400|NCT00756652|530056307|FG001|Original Phase|Participant Noncompliance|424|||
146971401|NCT00756652|530056306|FG000|Original Phase|Unknown Discontinuation Reason|2|||
146971402|NCT00756652|530056307|FG001|Original Phase|Unknown Discontinuation Reason|0|||
146971403|NCT00756652|530056306|FG000|Original Phase|Participants without data|3259|||
146971404|NCT00756652|530056307|FG001|Original Phase|Participants without data|466|||
146971405|NCT00756652|530056306|FG000|Original Phase|Death|168|||
146971406|NCT00756652|530056307|FG001|Original Phase|Death|1|||
146971407|NCT00756652|530056306|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
146971408|NCT00756652|530056307|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
146971409|NCT00756652|530056306|FG000|Re-Op Phase|Withdrawal by Subject|62|||
146971410|NCT00756652|530056307|FG001|Re-Op Phase|Withdrawal by Subject|0|||
146971411|NCT00756652|530056306|FG000|Re-Op Phase|Death|6|||
146971412|NCT00756652|530056307|FG001|Re-Op Phase|Death|0|||
146643079|NCT01754402|528872079|FG001|Overall Study|Adverse Event|2|||
146643080|NCT01754402|528872080|FG002|Overall Study|Adverse Event|1|||
146643081|NCT01754402|528872078|FG000|Overall Study|Withdrawal by Subject|0|||
146643082|NCT01754402|528872079|FG001|Overall Study|Withdrawal by Subject|0|||
146643083|NCT01754402|528872080|FG002|Overall Study|Withdrawal by Subject|1|||
146643084|NCT01754402|528872078|FG000|Overall Study|Lack of Efficacy|0|||
146643085|NCT01754402|528872079|FG001|Overall Study|Lack of Efficacy|0|||
146643086|NCT01754402|528872080|FG002|Overall Study|Lack of Efficacy|1|||
146643087|NCT01282463|528872081|FG000|Overall Study|Lost to Follow-up|1|||
146643088|NCT01282463|528872082|FG001|Overall Study|Lost to Follow-up|0|||
146643089|NCT01282463|528872083|FG002|Overall Study|Lost to Follow-up|0|||
146643090|NCT01282463|528872081|FG000|Overall Study|Withdrawal by Subject|6|||
146643091|NCT01282463|528872082|FG001|Overall Study|Withdrawal by Subject|2|||
146768802|NCT04707313|529321796|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
146768803|NCT04707313|529321797|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
146911567|NCT00611455|529839851|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
146911568|NCT00611455|529839849|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
146911569|NCT00611455|529839850|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
146911570|NCT00611455|529839851|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
146911571|NCT00611455|529839849|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
146911572|NCT00611455|529839850|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
146911573|NCT00611455|529839851|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
146911574|NCT00611455|529839849|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
146911575|NCT00611455|529839850|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
146911576|NCT00611455|529839851|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
146911577|NCT00611455|529839849|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
146911578|NCT00611455|529839850|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
146911579|NCT00611455|529839851|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
146911580|NCT00611455|529839849|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
146911581|NCT00611455|529839850|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
146911582|NCT00611455|529839851|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
146911583|NCT00611455|529839849|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
146911584|NCT00611455|529839850|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
146911585|NCT00611455|529839851|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
146911586|NCT00611455|529839849|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
146911587|NCT00611455|529839850|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
146911588|NCT00611455|529839851|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
146911589|NCT00611455|529839849|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
146911590|NCT00611455|529839850|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
146911591|NCT00611455|529839851|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
146911592|NCT00611455|529839849|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
146911593|NCT00611455|529839850|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
146911594|NCT00611455|529839851|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
146911595|NCT00611455|529839849|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
146911596|NCT00611455|529839850|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
146911597|NCT00611455|529839851|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
146643092|NCT01282463|528872083|FG002|Overall Study|Withdrawal by Subject|3|||
146643093|NCT01282463|528872081|FG000|Overall Study|"Never Treated Death"|0|||
146643094|NCT01282463|528872082|FG001|Overall Study|"Never Treated Death"|1|||
146643095|NCT01282463|528872083|FG002|Overall Study|"Never Treated Death"|0|||
146643096|NCT01282463|528872081|FG000|Overall Study|"Never Treated PD"|0|||
146643097|NCT01282463|528872082|FG001|Overall Study|"Never Treated PD"|1|||
146643098|NCT01282463|528872083|FG002|Overall Study|"Never Treated PD"|0|||
146643099|NCT01282463|528872081|FG000|Overall Study|Protocol Violation|0|||
146643100|NCT01282463|528872082|FG001|Overall Study|Protocol Violation|0|||
146643101|NCT01282463|528872083|FG002|Overall Study|Protocol Violation|1|||
146643102|NCT01282463|528872081|FG000|Overall Study|Physician Decision|1|||
146643103|NCT01282463|528872082|FG001|Overall Study|Physician Decision|0|||
146643104|NCT01282463|528872083|FG002|Overall Study|Physician Decision|0|||
146643105|NCT01954927|528872084|FG000|Overall Study|Withdrawal by Subject|3|||
146643106|NCT01954927|528872085|FG001|Overall Study|Withdrawal by Subject|1|||
146643107|NCT03320824|528872086|FG000|Overall Study|Withdrawal by Subject|8|||
146643108|NCT03320824|528872087|FG001|Overall Study|Withdrawal by Subject|1|||
146643109|NCT03320824|528872086|FG000|Overall Study|Lost to Follow-up|10|||
146643110|NCT03320824|528872087|FG001|Overall Study|Lost to Follow-up|1|||
146643111|NCT03320824|528872086|FG000|Overall Study|moved out of state|0|||
146643112|NCT03320824|528872087|FG001|Overall Study|moved out of state|1|||
146643113|NCT03320824|528872086|FG000|Overall Study|could not complete final visit|0|||
146643114|NCT03320824|528872087|FG001|Overall Study|could not complete final visit|1|||
146643115|NCT00109590|528872088|FG000|Overall Study|Lost to Follow-up|1|||
146643116|NCT00109590|528872089|FG001|Overall Study|Lost to Follow-up|0|||
146643117|NCT00109590|528872090|FG002|Overall Study|Lost to Follow-up|1|||
146643118|NCT00109590|528872088|FG000|Overall Study|Never Started Treatment|1|||
146643119|NCT00109590|528872089|FG001|Overall Study|Never Started Treatment|2|||
146643120|NCT00109590|528872090|FG002|Overall Study|Never Started Treatment|3|||
146643121|NCT02123251|528872091|FG000|Overall Study|Death|1|||
146643122|NCT02123251|528872092|FG001|Overall Study|Death|1|||
146768804|NCT04707313|529321798|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
146768805|NCT04707313|529321799|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
146768806|NCT04707313|529321800|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
146768807|NCT04707313|529321801|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
146768808|NCT04707313|529321802|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
146768809|NCT04707313|529321803|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
146768810|NCT04707313|529321791|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146768811|NCT04707313|529321792|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
146768812|NCT04707313|529321793|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
146768813|NCT04707313|529321794|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146768814|NCT04707313|529321795|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
146768815|NCT04707313|529321796|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146768816|NCT04707313|529321797|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146768817|NCT04707313|529321798|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146768818|NCT04707313|529321799|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146768819|NCT04707313|529321800|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146768820|NCT04707313|529321801|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146768821|NCT04707313|529321802|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146768822|NCT04707313|529321803|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146768823|NCT04707313|529321791|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
146911598|NCT00611455|529839849|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
146911599|NCT00611455|529839850|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
146911600|NCT00611455|529839851|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
146911601|NCT00611455|529839849|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
146911602|NCT00611455|529839850|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
146911603|NCT00611455|529839851|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
146911604|NCT00611455|529839849|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
146911605|NCT00611455|529839850|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
146768824|NCT04707313|529321792|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
146768825|NCT04707313|529321793|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
146768826|NCT04707313|529321794|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
146768827|NCT04707313|529321795|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
146768828|NCT04707313|529321796|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
146971413|NCT00756652|530056306|FG000|Re-Op Phase|Lost to Follow-up|340|||
146911606|NCT00611455|529839851|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
146911607|NCT00611455|529839849|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
146911608|NCT00611455|529839850|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
146643123|NCT02123251|528872091|FG000|Overall Study|Withdrawal by Subject|0|||
146643124|NCT02123251|528872092|FG001|Overall Study|Withdrawal by Subject|3|||
146643125|NCT02123251|528872091|FG000|Overall Study|Lost Medicaid eligibility|29|||
146643126|NCT02123251|528872092|FG001|Overall Study|Lost Medicaid eligibility|22|||
146643127|NCT02123251|528872091|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
146643128|NCT02123251|528872092|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
146643129|NCT01221285|528872093|FG000|Overall Study|Withdrawal by Subject|1|||
146643130|NCT00727441|528872096|FG000|Overall Study|Disease Progression|11|||
146643131|NCT00727441|528872097|FG001|Overall Study|Disease Progression|14|||
146643132|NCT00727441|528872098|FG002|Overall Study|Disease Progression|17|||
146643133|NCT00727441|528872096|FG000|Overall Study|Eligibility|7|||
146643134|NCT00727441|528872097|FG001|Overall Study|Eligibility|5|||
146643135|NCT00727441|528872098|FG002|Overall Study|Eligibility|7|||
146643136|NCT00727441|528872096|FG000|Overall Study|Death|0|||
146643137|NCT00727441|528872097|FG001|Overall Study|Death|1|||
146643138|NCT00727441|528872098|FG002|Overall Study|Death|1|||
146643139|NCT00727441|528872096|FG000|Overall Study|Physician Decision|0|||
146911609|NCT00611455|529839851|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
146911610|NCT04601272|529839852|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
146643140|NCT00727441|528872097|FG001|Overall Study|Physician Decision|1|||
146643141|NCT00727441|528872098|FG002|Overall Study|Physician Decision|0|||
146914690|NCT03303339|529850051|FG009|Overall Study|Safety/Non-compliance|0|||
146563993|NCT01323192|528577852|FG001|Overall Study|Nonmedical reasons|1|||
146563994|NCT03698279|528577853|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146563995|NCT03698279|528577854|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146768829|NCT04707313|529321797|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
146768830|NCT04707313|529321798|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
146768831|NCT04707313|529321799|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
146768832|NCT04707313|529321800|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
146768833|NCT04707313|529321801|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
146768834|NCT04707313|529321802|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
146768835|NCT04707313|529321803|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
146768836|NCT04707313|529321791|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
146768837|NCT04707313|529321792|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146911611|NCT04601272|529839853|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
146911612|NCT04601272|529839854|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
146911613|NCT00414440|529839857|FG000|Core Period|Withdrawal by Subject|70|||
146911614|NCT00414440|529839858|FG001|Core Period|Withdrawal by Subject|32|||
146911615|NCT00414440|529839857|FG000|Extension Period|Lost to Follow-up|44|||
146911616|NCT00414440|529839858|FG001|Extension Period|Lost to Follow-up|52|||
146911617|NCT00414440|529839857|FG000|Extension Period|Did not consent to continue follow up|61|||
146911618|NCT00414440|529839858|FG001|Extension Period|Did not consent to continue follow up|54|||
146911619|NCT00414440|529839857|FG000|Extension Period|Other|1|||
146911620|NCT00414440|529839858|FG001|Extension Period|Other|1|||
146911621|NCT00414440|529839857|FG000|Extension Period|Administrative|16|||
146911622|NCT00414440|529839858|FG001|Extension Period|Administrative|16|||
146911623|NCT00414440|529839857|FG000|Extension Period|Death|1|||
146911624|NCT00414440|529839858|FG001|Extension Period|Death|2|||
146911625|NCT00414440|529839857|FG000|Extension Period|Withdrawal by Subject|9|||
146911626|NCT00414440|529839858|FG001|Extension Period|Withdrawal by Subject|7|||
146911627|NCT00414440|529839857|FG000|Extension Period|Not included in follow up period|18|||
146911628|NCT00414440|529839858|FG001|Extension Period|Not included in follow up period|8|||
146911629|NCT04382651|529839859|FG000|Overall Study|Death|26|||
146911630|NCT04382651|529839860|FG001|Overall Study|Death|23|||
146911631|NCT04382651|529839859|FG000|Overall Study|Lost to Follow-up|3|||
146911632|NCT04382651|529839860|FG001|Overall Study|Lost to Follow-up|4|||
146911633|NCT04382651|529839859|FG000|Overall Study|Withdrawal by Subject|2|||
146911634|NCT04382651|529839860|FG001|Overall Study|Withdrawal by Subject|0|||
146911635|NCT04382651|529839859|FG000|Overall Study|Physician Decision|0|||
146911636|NCT04382651|529839860|FG001|Overall Study|Physician Decision|1|||
146911637|NCT02732912|529839861|FG000|Overall Study|Discharged before night|2|||
146911638|NCT02732912|529839862|FG001|Overall Study|Discharged before night|6|||
146911639|NCT02732912|529839861|FG000|Overall Study|Incomplete completion of questionnaire|2|||
146911640|NCT02732912|529839862|FG001|Overall Study|Incomplete completion of questionnaire|3|||
146911641|NCT02732912|529839861|FG000|Overall Study|No outcome; discharged or refused|6|||
146911642|NCT02732912|529839862|FG001|Overall Study|No outcome; discharged or refused|9|||
146911643|NCT01507545|529839863|FG000|Overall Study|Withdrawal by Subject|6|||
146911644|NCT01507545|529839864|FG001|Overall Study|Withdrawal by Subject|2|||
146911645|NCT01507545|529839863|FG000|Overall Study|Lost to Follow-up|1|||
146911646|NCT01507545|529839864|FG001|Overall Study|Lost to Follow-up|0|||
146911647|NCT01507545|529839863|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
146911648|NCT01507545|529839864|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
146911649|NCT01507545|529839863|FG000|Overall Study|Progressive disease|60|||
146911650|NCT01507545|529839864|FG001|Overall Study|Progressive disease|27|||
146911651|NCT01507545|529839863|FG000|Overall Study|Other|6|||
146911652|NCT01507545|529839864|FG001|Overall Study|Other|4|||
146911653|NCT01873742|529839865|FG000|Overall Study|Lost to Follow-up|68|||
146911654|NCT01873742|529839866|FG001|Overall Study|Lost to Follow-up|76|||
146911655|NCT00790296|529839867|FG000|Overall Study|Did not meet study eligibility criteria|1|||
146911656|NCT00790296|529839868|FG001|Overall Study|Did not meet study eligibility criteria|1|||
146911657|NCT00790296|529839867|FG000|Overall Study|Adverse Event|0|||
146911658|NCT00790296|529839868|FG001|Overall Study|Adverse Event|1|||
146911659|NCT01457339|529839878|FG000|Period 3 (100 mg)|Adverse Event|0|||
146911660|NCT01457339|529839879|FG001|Period 3 (100 mg)|Adverse Event|1|||
146911661|NCT01457339|529839878|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
146911662|NCT01457339|529839879|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
146911663|NCT01457339|529839878|FG000|Period 6 (250 mg)|Family Emergency|1|||
146911664|NCT01457339|529839879|FG001|Period 6 (250 mg)|Family Emergency|0|||
146563996|NCT03698279|528577855|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146911665|NCT01457339|529839878|FG000|Period 6 (250 mg)|Personal appointment|0|||
146911666|NCT01457339|529839879|FG001|Period 6 (250 mg)|Personal appointment|1|||
146911667|NCT01164501|529839883|FG000|Overall Study|Not treated|2|||
146911668|NCT01164501|529839884|FG001|Overall Study|Not treated|0|||
146768838|NCT04707313|529321793|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146911669|NCT01164501|529839885|FG002|Overall Study|Not treated|1|||
146911670|NCT01164501|529839883|FG000|Overall Study|Adverse Event|18|||
146911671|NCT01164501|529839884|FG001|Overall Study|Adverse Event|4|||
146643142|NCT00727441|528872096|FG000|Overall Study|Withdrawal by Subject|0|||
146643143|NCT00727441|528872097|FG001|Overall Study|Withdrawal by Subject|1|||
146643144|NCT00727441|528872098|FG002|Overall Study|Withdrawal by Subject|0|||
146643145|NCT01239992|528872099|FG000|Overall Study|Withdrawal by Subject|2|||
146643146|NCT00535288|528872100|FG000|Overall Study|Adverse Event|20|||
146643147|NCT00535288|528872101|FG001|Overall Study|Adverse Event|19|||
146643148|NCT00535288|528872102|FG002|Overall Study|Adverse Event|25|||
146643149|NCT00535288|528872103|FG003|Overall Study|Adverse Event|20|||
146643150|NCT00535288|528872104|FG004|Overall Study|Adverse Event|30|||
146643151|NCT00535288|528872100|FG000|Overall Study|Lost to Follow-up|0|||
146643152|NCT00535288|528872101|FG001|Overall Study|Lost to Follow-up|3|||
146643153|NCT00535288|528872102|FG002|Overall Study|Lost to Follow-up|0|||
146643154|NCT00535288|528872103|FG003|Overall Study|Lost to Follow-up|0|||
146643155|NCT00535288|528872104|FG004|Overall Study|Lost to Follow-up|0|||
146643156|NCT00535288|528872100|FG000|Overall Study|Lack of Efficacy|26|||
146643157|NCT00535288|528872101|FG001|Overall Study|Lack of Efficacy|3|||
146643158|NCT00535288|528872102|FG002|Overall Study|Lack of Efficacy|4|||
146643159|NCT00535288|528872103|FG003|Overall Study|Lack of Efficacy|4|||
146643160|NCT00535288|528872104|FG004|Overall Study|Lack of Efficacy|7|||
146643161|NCT00535288|528872100|FG000|Overall Study|Unwilling to cooperate|6|||
146643162|NCT00535288|528872101|FG001|Overall Study|Unwilling to cooperate|6|||
146643163|NCT00535288|528872102|FG002|Overall Study|Unwilling to cooperate|3|||
146643164|NCT00535288|528872103|FG003|Overall Study|Unwilling to cooperate|3|||
146643165|NCT00535288|528872104|FG004|Overall Study|Unwilling to cooperate|4|||
146643166|NCT00535288|528872100|FG000|Overall Study|Other|2|||
146643167|NCT00535288|528872101|FG001|Overall Study|Other|1|||
146643168|NCT00535288|528872102|FG002|Overall Study|Other|1|||
146643169|NCT00535288|528872103|FG003|Overall Study|Other|2|||
146643170|NCT00535288|528872104|FG004|Overall Study|Other|1|||
146911672|NCT01164501|529839885|FG002|Overall Study|Adverse Event|21|||
146911673|NCT01164501|529839883|FG000|Overall Study|Lack of Efficacy|0|||
146911674|NCT01164501|529839884|FG001|Overall Study|Lack of Efficacy|0|||
146911675|NCT01164501|529839885|FG002|Overall Study|Lack of Efficacy|1|||
146643171|NCT02848729|528872107|FG000|Overall Study|Withdrawal by Subject|1|||
146643172|NCT02848729|528872108|FG001|Overall Study|Withdrawal by Subject|0|||
146643173|NCT02848729|528872107|FG000|Overall Study|Emesis|15|||
146643174|NCT02848729|528872108|FG001|Overall Study|Emesis|11|||
146643175|NCT02617485|528872112|FG000|Treatment and Observation Period|Adverse Event|9|||
146643176|NCT02617485|528872113|FG001|Treatment and Observation Period|Adverse Event|1|||
146643177|NCT02617485|528872112|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
146911676|NCT01164501|529839883|FG000|Overall Study|Non compliant with protocol|1|||
146643178|NCT02617485|528872113|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
146911677|NCT01164501|529839884|FG001|Overall Study|Non compliant with protocol|1|||
146643179|NCT02617485|528872112|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
146911678|NCT01164501|529839885|FG002|Overall Study|Non compliant with protocol|4|||
146911679|NCT01164501|529839883|FG000|Overall Study|Lost to Follow-up|3|||
146911680|NCT01164501|529839884|FG001|Overall Study|Lost to Follow-up|0|||
146911681|NCT01164501|529839885|FG002|Overall Study|Lost to Follow-up|3|||
146911682|NCT01164501|529839883|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
146563997|NCT03698279|528577856|FG003|Overall Study|Withdrawal by parent/guardian|1|||
146563998|NCT03698279|528577857|FG004|Overall Study|Withdrawal by parent/guardian|0|||
146563999|NCT03698279|528577858|FG005|Overall Study|Withdrawal by parent/guardian|0|||
146564000|NCT03698279|528577853|FG000|Overall Study|Protocol deviation|1|||
146564001|NCT03698279|528577854|FG001|Overall Study|Protocol deviation|0|||
146564002|NCT03698279|528577855|FG002|Overall Study|Protocol deviation|1|||
146564003|NCT03698279|528577856|FG003|Overall Study|Protocol deviation|0|||
146564004|NCT03698279|528577857|FG004|Overall Study|Protocol deviation|0|||
146564005|NCT03698279|528577858|FG005|Overall Study|Protocol deviation|0|||
146564006|NCT03698279|528577853|FG000|Overall Study|Withdrawal by Subject|0|||
146564007|NCT03698279|528577854|FG001|Overall Study|Withdrawal by Subject|0|||
146564008|NCT03698279|528577855|FG002|Overall Study|Withdrawal by Subject|1|||
146564009|NCT03698279|528577856|FG003|Overall Study|Withdrawal by Subject|0|||
146564010|NCT03698279|528577857|FG004|Overall Study|Withdrawal by Subject|0|||
146564011|NCT03698279|528577858|FG005|Overall Study|Withdrawal by Subject|0|||
146564012|NCT03698279|528577853|FG000|Overall Study|Lost to Follow-up|3|||
146564013|NCT03698279|528577854|FG001|Overall Study|Lost to Follow-up|1|||
146564014|NCT03698279|528577855|FG002|Overall Study|Lost to Follow-up|4|||
146564015|NCT03698279|528577856|FG003|Overall Study|Lost to Follow-up|5|||
146564016|NCT03698279|528577857|FG004|Overall Study|Lost to Follow-up|0|||
146564017|NCT03698279|528577858|FG005|Overall Study|Lost to Follow-up|0|||
146564018|NCT02276040|528577864|FG000|Overall Study|Physician Decision|15|||
146564019|NCT02835690|528577865|FG000|Overall Study|Death|12|||
146564020|NCT02835690|528577866|FG001|Overall Study|Death|11|||
146564021|NCT02835690|528577867|FG002|Overall Study|Death|13|||
146564022|NCT02835690|528577865|FG000|Overall Study|Transferred to Extension Study|2|||
146564023|NCT02835690|528577866|FG001|Overall Study|Transferred to Extension Study|2|||
146564024|NCT02835690|528577867|FG002|Overall Study|Transferred to Extension Study|1|||
146564025|NCT02835690|528577865|FG000|Overall Study|Did Not Continue on Extension Study|0|||
146564026|NCT02835690|528577866|FG001|Overall Study|Did Not Continue on Extension Study|0|||
146564027|NCT02835690|528577867|FG002|Overall Study|Did Not Continue on Extension Study|1|||
146564028|NCT02835690|528577865|FG000|Overall Study|Not Treated|0|||
146564029|NCT02835690|528577866|FG001|Overall Study|Not Treated|2|||
146564030|NCT02835690|528577867|FG002|Overall Study|Not Treated|0|||
146971414|NCT00756652|530056307|FG001|Re-Op Phase|Lost to Follow-up|0|||
146971415|NCT00756652|530056306|FG000|Re-Op Phase|Site Closed|2454|||
146971416|NCT00756652|530056307|FG001|Re-Op Phase|Site Closed|0|||
146971417|NCT00756652|530056306|FG000|Re-Op Phase|Withdrawn after explant|14|||
146971418|NCT00756652|530056307|FG001|Re-Op Phase|Withdrawn after explant|0|||
146971419|NCT01215955|530056308|FG000|Overall Study|Adverse Event|1|||
146971420|NCT01215955|530056309|FG001|Overall Study|Adverse Event|4|||
146971421|NCT01215955|530056310|FG002|Overall Study|Adverse Event|2|||
146971422|NCT01215955|530056311|FG003|Overall Study|Adverse Event|3|||
146971423|NCT01215955|530056308|FG000|Overall Study|Death|2|||
146971424|NCT01215955|530056309|FG001|Overall Study|Death|0|||
146971425|NCT01215955|530056310|FG002|Overall Study|Death|1|||
146971426|NCT01215955|530056311|FG003|Overall Study|Death|3|||
146971427|NCT01215955|530056308|FG000|Overall Study|Entry Criteria Not Met|1|||
146971428|NCT01215955|530056309|FG001|Overall Study|Entry Criteria Not Met|3|||
146971429|NCT01215955|530056310|FG002|Overall Study|Entry Criteria Not Met|4|||
146971430|NCT01215955|530056311|FG003|Overall Study|Entry Criteria Not Met|7|||
146971431|NCT01215955|530056308|FG000|Overall Study|Lack of Efficacy|1|||
146971432|NCT01215955|530056309|FG001|Overall Study|Lack of Efficacy|2|||
146971433|NCT01215955|530056310|FG002|Overall Study|Lack of Efficacy|1|||
146971434|NCT01215955|530056311|FG003|Overall Study|Lack of Efficacy|0|||
146971435|NCT01215955|530056308|FG000|Overall Study|Lost to Follow-up|4|||
146971436|NCT01215955|530056309|FG001|Overall Study|Lost to Follow-up|4|||
146971437|NCT01215955|530056310|FG002|Overall Study|Lost to Follow-up|8|||
146971438|NCT01215955|530056311|FG003|Overall Study|Lost to Follow-up|9|||
146971439|NCT01215955|530056308|FG000|Overall Study|Physician Decision|4|||
146971440|NCT01215955|530056309|FG001|Overall Study|Physician Decision|10|||
146971441|NCT01215955|530056310|FG002|Overall Study|Physician Decision|8|||
146971442|NCT01215955|530056311|FG003|Overall Study|Physician Decision|11|||
146971443|NCT01215955|530056308|FG000|Overall Study|Protocol Violation|17|||
146971444|NCT01215955|530056309|FG001|Overall Study|Protocol Violation|13|||
146971445|NCT01215955|530056310|FG002|Overall Study|Protocol Violation|8|||
146971446|NCT01215955|530056311|FG003|Overall Study|Protocol Violation|8|||
146971447|NCT01215955|530056308|FG000|Overall Study|Sponsor Decision|1|||
146971448|NCT01215955|530056309|FG001|Overall Study|Sponsor Decision|2|||
146971449|NCT01215955|530056310|FG002|Overall Study|Sponsor Decision|0|||
146971450|NCT01215955|530056311|FG003|Overall Study|Sponsor Decision|1|||
146971451|NCT01215955|530056308|FG000|Overall Study|Withdrawal by Subject|14|||
146971452|NCT01215955|530056309|FG001|Overall Study|Withdrawal by Subject|15|||
146971453|NCT01215955|530056310|FG002|Overall Study|Withdrawal by Subject|13|||
146971454|NCT01215955|530056311|FG003|Overall Study|Withdrawal by Subject|9|||
146971455|NCT01215955|530056308|FG000|Overall Study|Quality Issues|0|||
146911683|NCT01164501|529839884|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
146911684|NCT01164501|529839885|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
146911685|NCT01164501|529839883|FG000|Overall Study|Other reason not defined above|9|||
146911686|NCT01164501|529839884|FG001|Overall Study|Other reason not defined above|1|||
146911687|NCT01164501|529839885|FG002|Overall Study|Other reason not defined above|4|||
146911688|NCT01096667|529839886|FG000|Overall Study|Lost to Follow-up|1|||
146564031|NCT03674281|528577868|FG000|Overall Study|screen failure|2|||
146564032|NCT03674281|528577869|FG001|Overall Study|screen failure|0|||
146564033|NCT03674281|528577870|FG002|Overall Study|screen failure|0|||
146564034|NCT03674281|528577868|FG000|Overall Study|Withdrawal by Subject|1|||
146564035|NCT03674281|528577869|FG001|Overall Study|Withdrawal by Subject|3|||
146564036|NCT03674281|528577870|FG002|Overall Study|Withdrawal by Subject|3|||
146564037|NCT00582907|528577871|FG000|1st Course|Withdrawal by Subject|1|||
146564038|NCT00582907|528577872|FG001|1st Course|Withdrawal by Subject|0|||
146564039|NCT00582907|528577873|FG002|1st Course|Withdrawal by Subject|0|||
146564040|NCT00582907|528577874|FG003|1st Course|Withdrawal by Subject|0|||
146564041|NCT00582907|528577871|FG000|1st Course|Lost to Follow-up|0|||
146564042|NCT00582907|528577872|FG001|1st Course|Lost to Follow-up|0|||
146564043|NCT00582907|528577873|FG002|1st Course|Lost to Follow-up|0|||
146564044|NCT00582907|528577874|FG003|1st Course|Lost to Follow-up|1|||
146564045|NCT00582907|528577871|FG000|2nd Course|Lack of Efficacy|1|||
146564046|NCT00582907|528577872|FG001|2nd Course|Lack of Efficacy|0|||
146564047|NCT00582907|528577873|FG002|2nd Course|Lack of Efficacy|0|||
146564048|NCT00582907|528577874|FG003|2nd Course|Lack of Efficacy|0|||
146564049|NCT01441960|528577875|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
146564050|NCT01441960|528577876|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
146911689|NCT01096667|529839887|FG001|Overall Study|Lost to Follow-up|1|||
146911690|NCT01096667|529839888|FG002|Overall Study|Lost to Follow-up|1|||
146911691|NCT01096667|529839889|FG003|Overall Study|Lost to Follow-up|0|||
146971456|NCT01215955|530056309|FG001|Overall Study|Quality Issues|0|||
146564051|NCT01441960|528577875|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
146971457|NCT01215955|530056310|FG002|Overall Study|Quality Issues|3|||
146971458|NCT01215955|530056311|FG003|Overall Study|Quality Issues|2|||
146564052|NCT01441960|528577876|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
146971459|NCT00038467|530056312|FG000|Overall Study|Adverse Event|170|||
146971460|NCT00038467|530056313|FG001|Overall Study|Adverse Event|145|||
146971461|NCT00038467|530056312|FG000|Overall Study|Withdrawal by Subject|150|||
146971462|NCT00038467|530056313|FG001|Overall Study|Withdrawal by Subject|107|||
146971463|NCT00038467|530056312|FG000|Overall Study|Protocol Violation|19|||
146971464|NCT00038467|530056313|FG001|Overall Study|Protocol Violation|22|||
146971465|NCT00038467|530056312|FG000|Overall Study|Death|22|||
146971466|NCT00038467|530056313|FG001|Overall Study|Death|16|||
146971467|NCT00038467|530056312|FG000|Overall Study|Lost to Follow-up|15|||
146971468|NCT00038467|530056313|FG001|Overall Study|Lost to Follow-up|10|||
146971469|NCT00038467|530056312|FG000|Overall Study|Recurrence|109|||
146971470|NCT00038467|530056313|FG001|Overall Study|Recurrence|179|||
146971471|NCT00038467|530056312|FG000|Overall Study|Randomized, but not treated|31|||
146971472|NCT00038467|530056313|FG001|Overall Study|Randomized, but not treated|35|||
146971473|NCT00038467|530056312|FG000|Overall Study|Other|26|||
146971474|NCT00038467|530056313|FG001|Overall Study|Other|28|||
146971475|NCT01787188|530056314|FG000|Overall Study|Adverse Event|2|||
146971476|NCT01787188|530056315|FG001|Overall Study|Adverse Event|4|||
146971477|NCT01787188|530056316|FG002|Overall Study|Adverse Event|6|||
146971478|NCT01787188|530056314|FG000|Overall Study|Lack of Efficacy|7|||
146971479|NCT01787188|530056315|FG001|Overall Study|Lack of Efficacy|3|||
146971480|NCT01787188|530056316|FG002|Overall Study|Lack of Efficacy|5|||
146971481|NCT01787188|530056314|FG000|Overall Study|Non-compliance with Study Drug|0|||
146971482|NCT01787188|530056315|FG001|Overall Study|Non-compliance with Study Drug|1|||
146971483|NCT01787188|530056316|FG002|Overall Study|Non-compliance with Study Drug|0|||
146971484|NCT01787188|530056314|FG000|Overall Study|Withdrawal by Subject|4|||
146971485|NCT01787188|530056315|FG001|Overall Study|Withdrawal by Subject|3|||
146971486|NCT01787188|530056316|FG002|Overall Study|Withdrawal by Subject|2|||
146971487|NCT01787188|530056314|FG000|Overall Study|Protocol Violation|3|||
146768839|NCT04707313|529321794|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146768840|NCT04707313|529321795|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146768841|NCT04707313|529321796|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
146768842|NCT04707313|529321797|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
146768843|NCT04707313|529321798|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
146768844|NCT04707313|529321799|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146768845|NCT04707313|529321800|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146768846|NCT04707313|529321801|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146768847|NCT04707313|529321802|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146768848|NCT04707313|529321803|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146768849|NCT04707313|529321791|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
146911692|NCT01096667|529839890|FG004|Overall Study|Lost to Follow-up|0|||
146911693|NCT01096667|529839886|FG000|Overall Study|Withdrawal by Subject|1|||
146911694|NCT01096667|529839887|FG001|Overall Study|Withdrawal by Subject|0|||
146911695|NCT01096667|529839888|FG002|Overall Study|Withdrawal by Subject|0|||
146911696|NCT01096667|529839889|FG003|Overall Study|Withdrawal by Subject|1|||
146911697|NCT01096667|529839890|FG004|Overall Study|Withdrawal by Subject|0|||
146911698|NCT01096667|529839886|FG000|Overall Study|Reason not available|0|||
146911699|NCT01096667|529839887|FG001|Overall Study|Reason not available|1|||
146911700|NCT01096667|529839888|FG002|Overall Study|Reason not available|1|||
146911701|NCT01096667|529839889|FG003|Overall Study|Reason not available|1|||
146911702|NCT01096667|529839890|FG004|Overall Study|Reason not available|0|||
146911703|NCT01096667|529839886|FG000|Overall Study|Protocol Violation|0|||
146911704|NCT01096667|529839887|FG001|Overall Study|Protocol Violation|0|||
146911705|NCT01096667|529839888|FG002|Overall Study|Protocol Violation|0|||
146911706|NCT01096667|529839889|FG003|Overall Study|Protocol Violation|1|||
146911707|NCT01096667|529839890|FG004|Overall Study|Protocol Violation|0|||
146911708|NCT01096667|529839886|FG000|Overall Study|Not treated|1|||
146911709|NCT01096667|529839887|FG001|Overall Study|Not treated|0|||
146911710|NCT01096667|529839888|FG002|Overall Study|Not treated|0|||
146911711|NCT01096667|529839889|FG003|Overall Study|Not treated|0|||
146911712|NCT01096667|529839890|FG004|Overall Study|Not treated|0|||
146911713|NCT00853905|529839891|FG000|Overall Study|Lost to Follow-up|1|||
146911714|NCT00853905|529839892|FG001|Overall Study|Lost to Follow-up|3|||
146911715|NCT00853905|529839891|FG000|Overall Study|Withdrawal by Subject|0|||
146768850|NCT04707313|529321792|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
146768851|NCT04707313|529321793|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
146911716|NCT00853905|529839892|FG001|Overall Study|Withdrawal by Subject|1|||
146911717|NCT00853905|529839891|FG000|Overall Study|never had surgery|1|||
146911718|NCT00853905|529839892|FG001|Overall Study|never had surgery|0|||
146911719|NCT00408681|529839898|FG000|Overall Study|Lack of Efficacy|2|||
146911720|NCT00408681|529839898|FG000|Overall Study|Adverse Event|7|||
146911721|NCT00447421|529839902|FG000|Overall Study|Lack of Efficacy|1|||
146911722|NCT00447421|529839902|FG000|Overall Study|Adverse Event|3|||
146564053|NCT01441960|528577875|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
146564054|NCT01441960|528577876|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
146911723|NCT00447421|529839902|FG000|Overall Study|Sponsor Decision|2|||
146911724|NCT01787591|529839903|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
146911725|NCT01787591|529839904|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
146911726|NCT01787591|529839905|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
146911727|NCT01787591|529839906|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
146911728|NCT02725177|529839909|FG000|Overall Study|Physician Decision|4|||
146911729|NCT02725177|529839909|FG000|Overall Study|Adverse Event|1|||
146911730|NCT00377299|529839910|FG000|Overall Study|Lost to Follow-up|14|||
146911731|NCT00377299|529839911|FG001|Overall Study|Lost to Follow-up|19|||
146911732|NCT00377299|529839910|FG000|Overall Study|Adverse Event|0|||
146971488|NCT01787188|530056315|FG001|Overall Study|Protocol Violation|2|||
146971489|NCT01787188|530056316|FG002|Overall Study|Protocol Violation|3|||
146971490|NCT01787188|530056314|FG000|Overall Study|Lost to Follow-up|1|||
146971491|NCT01787188|530056315|FG001|Overall Study|Lost to Follow-up|2|||
146971492|NCT01787188|530056316|FG002|Overall Study|Lost to Follow-up|2|||
146971493|NCT01787188|530056314|FG000|Overall Study|Other, including patient moved|0|||
146971494|NCT01787188|530056315|FG001|Overall Study|Other, including patient moved|3|||
146971495|NCT01787188|530056316|FG002|Overall Study|Other, including patient moved|0|||
146971496|NCT05511428|530056317|FG000|Overall Study|Withdrawal by Subject|1|||
146971497|NCT05511428|530056317|FG000|Overall Study|Adverse Event|1|||
146971498|NCT02643394|530056318|FG000|Overall Study|Protocol Violation|4|||
146971499|NCT02643394|530056319|FG001|Overall Study|Protocol Violation|5|||
146971500|NCT04088734|530056320|FG000|Overall Study|Other, Not Specified|5|||
146971501|NCT00096200|530056321|FG000|Overall Study|Adverse Event|0|||
146971502|NCT00096200|530056322|FG001|Overall Study|Adverse Event|4|||
146971503|NCT00096200|530056323|FG002|Overall Study|Adverse Event|0|||
146971504|NCT00096200|530056321|FG000|Overall Study|Withdrawal by Subject|1|||
146971505|NCT00096200|530056322|FG001|Overall Study|Withdrawal by Subject|2|||
146971506|NCT00096200|530056323|FG002|Overall Study|Withdrawal by Subject|0|||
146971507|NCT00096200|530056321|FG000|Overall Study|Ineligible pathology|0|||
146971508|NCT00096200|530056322|FG001|Overall Study|Ineligible pathology|1|||
146971509|NCT00096200|530056323|FG002|Overall Study|Ineligible pathology|0|||
146971510|NCT00835068|530056324|FG000|Overall Study|Death|1|||
146971511|NCT00835068|530056325|FG001|Overall Study|Death|0|||
146971512|NCT00835068|530056324|FG000|Overall Study|Adverse Event|0|||
146971513|NCT00835068|530056325|FG001|Overall Study|Adverse Event|1|||
146971514|NCT00835068|530056324|FG000|Overall Study|Other|8|||
146971515|NCT00835068|530056325|FG001|Overall Study|Other|0|||
146971516|NCT00835068|530056324|FG000|Overall Study|Withdrawal by Subject|1|||
146971517|NCT00835068|530056325|FG001|Overall Study|Withdrawal by Subject|0|||
146971518|NCT05264506|530056328|FG000|Overall Study|Adverse Event|59|||
146971519|NCT05264506|530056328|FG000|Overall Study|Lost to Follow-up|204|||
146971520|NCT05264506|530056328|FG000|Overall Study|Protocol Violation|185|||
146971521|NCT05264506|530056328|FG000|Overall Study|Pregnancy|60|||
146971522|NCT05264506|530056328|FG000|Overall Study|Physician Decision|6|||
146971523|NCT05264506|530056328|FG000|Overall Study|Non-compliance with Study Drug|29|||
146971524|NCT05264506|530056328|FG000|Overall Study|Study termination|677|||
146971525|NCT05264506|530056328|FG000|Overall Study|Withdrawal by Subject|208|||
146971526|NCT05264506|530056328|FG000|Overall Study|Discontinued prior treatment|89|||
146971527|NCT02032823|530056330|FG000|Overall Study|Death|75|||
146971528|NCT02032823|530056331|FG001|Overall Study|Death|109|||
146971529|NCT02032823|530056330|FG000|Overall Study|Lost to Follow-up|18|||
146971530|NCT02032823|530056331|FG001|Overall Study|Lost to Follow-up|17|||
146971531|NCT02032823|530056330|FG000|Overall Study|Withdrawal by Subject|70|||
146971532|NCT02032823|530056331|FG001|Overall Study|Withdrawal by Subject|53|||
146971533|NCT02032823|530056330|FG000|Overall Study|Ongoing study at data cut-off|755|||
146971534|NCT02032823|530056331|FG001|Overall Study|Ongoing study at data cut-off|731|||
146971535|NCT02032823|530056330|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
146971536|NCT02032823|530056331|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
146971537|NCT02949219|530056333|FG000|Overall Study|Withdrawal by Subject|1|||
146971538|NCT03494816|530056334|FG000|Overall Study|Protocol Violation|2|||
146971539|NCT03494816|530056334|FG000|Overall Study|Physician Decision|2|||
146971540|NCT03494816|530056334|FG000|Overall Study|Did not start trial treatment|1|||
146971541|NCT03494816|530056334|FG000|Overall Study|Adverse Event|1|||
146971542|NCT00096031|530056335|FG000|Overall Study|Adverse Event|3|||
146971543|NCT00096031|530056335|FG000|Overall Study|Lack of Efficacy|42|||
146971544|NCT00096031|530056335|FG000|Overall Study|Death|4|||
146971545|NCT00096031|530056335|FG000|Overall Study|Withdrawal by Subject|1|||
146971546|NCT00096031|530056335|FG000|Overall Study|Ineligible|8|||
146564055|NCT00415636|528577880|FG000|Overall Study|Symptomatic deterioration|1|||
146564056|NCT00415636|528577881|FG001|Overall Study|Symptomatic deterioration|0|||
146971547|NCT00096031|530056335|FG000|Overall Study|Not protocol specified|5|||
146971548|NCT01283282|530056336|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
146564057|NCT00415636|528577882|FG002|Overall Study|Symptomatic deterioration|1|||
146564058|NCT00415636|528577883|FG003|Overall Study|Symptomatic deterioration|2|||
146564059|NCT00415636|528577884|FG004|Overall Study|Symptomatic deterioration|0|||
146564060|NCT00415636|528577885|FG005|Overall Study|Symptomatic deterioration|1|||
146564061|NCT00415636|528577880|FG000|Overall Study|Adverse Event|0|||
146564062|NCT00415636|528577881|FG001|Overall Study|Adverse Event|0|||
146564063|NCT00415636|528577882|FG002|Overall Study|Adverse Event|0|||
146564064|NCT00415636|528577883|FG003|Overall Study|Adverse Event|1|||
146564065|NCT00415636|528577884|FG004|Overall Study|Adverse Event|1|||
146564066|NCT00415636|528577885|FG005|Overall Study|Adverse Event|0|||
146564067|NCT00415636|528577880|FG000|Overall Study|Withdrawal by Subject|0|||
146564068|NCT00415636|528577881|FG001|Overall Study|Withdrawal by Subject|0|||
146564069|NCT00415636|528577882|FG002|Overall Study|Withdrawal by Subject|0|||
146564070|NCT00415636|528577883|FG003|Overall Study|Withdrawal by Subject|0|||
146564071|NCT00415636|528577884|FG004|Overall Study|Withdrawal by Subject|1|||
146564072|NCT00415636|528577885|FG005|Overall Study|Withdrawal by Subject|0|||
146564073|NCT00415636|528577880|FG000|Overall Study|Disease progression|0|||
146564074|NCT00415636|528577881|FG001|Overall Study|Disease progression|0|||
146564075|NCT00415636|528577882|FG002|Overall Study|Disease progression|0|||
146564076|NCT00415636|528577883|FG003|Overall Study|Disease progression|3|||
146564077|NCT00415636|528577884|FG004|Overall Study|Disease progression|0|||
146564078|NCT00415636|528577885|FG005|Overall Study|Disease progression|1|||
146564079|NCT01263119|528577886|FG000|Period 1|Protocol Violation|2|||
146564080|NCT01263119|528577886|FG000|Period 2|Adverse Event|2|||
146564081|NCT02138825|528577887|FG000|Main Study Treatment|Adverse Event|11|||
146564082|NCT02138825|528577888|FG001|Main Study Treatment|Adverse Event|3|||
146564083|NCT02138825|528577887|FG000|Main Study Treatment|Death|1|||
146564084|NCT02138825|528577888|FG001|Main Study Treatment|Death|2|||
146564085|NCT02138825|528577887|FG000|Main Study Treatment|Protocol Violation|2|||
146564086|NCT02138825|528577888|FG001|Main Study Treatment|Protocol Violation|2|||
146564087|NCT02138825|528577887|FG000|Main Study Treatment|Sponsor decision|12|||
146564088|NCT02138825|528577888|FG001|Main Study Treatment|Sponsor decision|18|||
146564089|NCT02138825|528577887|FG000|Main Study Treatment|Study terminated by sponsor|10|||
146564090|NCT02138825|528577888|FG001|Main Study Treatment|Study terminated by sponsor|9|||
146564091|NCT02138825|528577887|FG000|Main Study Treatment|Withdrawal by Subject|3|||
146564092|NCT02138825|528577888|FG001|Main Study Treatment|Withdrawal by Subject|1|||
146564093|NCT02138825|528577887|FG000|Main Study Treatment|Medical decision|1|||
146564094|NCT02138825|528577888|FG001|Main Study Treatment|Medical decision|0|||
146564095|NCT02138825|528577887|FG000|Long-term Extension|Study termination by sponsor|32|||
146564096|NCT02138825|528577888|FG001|Long-term Extension|Study termination by sponsor|38|||
146564097|NCT02138825|528577887|FG000|Safety Follow-up|Adverse Event|4|||
146564098|NCT02138825|528577888|FG001|Safety Follow-up|Adverse Event|3|||
146643180|NCT02617485|528872113|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
146643181|NCT02617485|528872112|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
146643182|NCT02617485|528872113|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
146643183|NCT02617485|528872112|FG000|Treatment and Observation Period|Physician Decision|0|||
146643184|NCT02617485|528872113|FG001|Treatment and Observation Period|Physician Decision|1|||
146643185|NCT02617485|528872112|FG000|Follow-up Period|Adverse Event|1|||
146643186|NCT02617485|528872113|FG001|Follow-up Period|Adverse Event|0|||
146643187|NCT02617485|528872112|FG000|Follow-up Period|Withdrawal by Subject|1|||
146643188|NCT02617485|528872113|FG001|Follow-up Period|Withdrawal by Subject|0|||
146643189|NCT02617485|528872112|FG000|Follow-up Period|Disease progression|2|||
146643190|NCT02617485|528872113|FG001|Follow-up Period|Disease progression|1|||
146643191|NCT02617485|528872112|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
146643192|NCT02617485|528872113|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
146911733|NCT00377299|529839911|FG001|Overall Study|Adverse Event|1|||
146911734|NCT00377299|529839910|FG000|Overall Study|Withdrawal by Subject|5|||
146911735|NCT00377299|529839911|FG001|Overall Study|Withdrawal by Subject|4|||
146911736|NCT00638846|529839912|FG000|Overall Study|Adverse Event|0|||
146911737|NCT00638846|529839913|FG001|Overall Study|Adverse Event|1|||
146643193|NCT02617485|528872112|FG000|Follow-up Period|Patient needed radiotherapy|9|||
146643194|NCT02617485|528872113|FG001|Follow-up Period|Patient needed radiotherapy|5|||
146643195|NCT02617485|528872112|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
146643196|NCT02617485|528872113|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
146643197|NCT00220779|528872114|FG000|Overall Study|Adverse Event|1|||
146643198|NCT00220779|528872115|FG001|Overall Study|Adverse Event|0|||
146643199|NCT00220779|528872116|FG002|Overall Study|Adverse Event|0|||
146643200|NCT00220779|528872114|FG000|Overall Study|Withdrawal by Subject|1|||
146643201|NCT00220779|528872115|FG001|Overall Study|Withdrawal by Subject|4|||
146643202|NCT00220779|528872116|FG002|Overall Study|Withdrawal by Subject|1|||
146643203|NCT00220779|528872114|FG000|Overall Study|Non-compliance|1|||
146643204|NCT00220779|528872115|FG001|Overall Study|Non-compliance|0|||
146643205|NCT00220779|528872116|FG002|Overall Study|Non-compliance|0|||
146643206|NCT00220779|528872114|FG000|Overall Study|Too time consuming|1|||
146643207|NCT00220779|528872115|FG001|Overall Study|Too time consuming|0|||
146643208|NCT00220779|528872116|FG002|Overall Study|Too time consuming|0|||
146643209|NCT00220779|528872114|FG000|Overall Study|Pregnancy|0|||
146643210|NCT00220779|528872115|FG001|Overall Study|Pregnancy|0|||
146643211|NCT00220779|528872116|FG002|Overall Study|Pregnancy|2|||
146643212|NCT00220779|528872114|FG000|Overall Study|Lack of Efficacy|3|||
146643213|NCT00220779|528872115|FG001|Overall Study|Lack of Efficacy|0|||
146643214|NCT00220779|528872116|FG002|Overall Study|Lack of Efficacy|1|||
146643215|NCT00791076|528872117|FG000|Overall Study|Study was terminated,PI left institution|8|||
146643216|NCT02248675|528872124|FG000|Overall Study|Lost to Follow-up|3|||
146643217|NCT02248675|528872125|FG001|Overall Study|Lost to Follow-up|1|||
146643218|NCT03390101|528872128|FG000|Weeks 0-12|Withdrawal by Subject|0|||
146643219|NCT03390101|528872129|FG001|Weeks 0-12|Withdrawal by Subject|1|||
146643220|NCT03390101|528872130|FG002|Weeks 0-12|Withdrawal by Subject|1|||
146643221|NCT03390101|528872128|FG000|Weeks 0-12|Lost to Follow-up|0|||
146643222|NCT03390101|528872129|FG001|Weeks 0-12|Lost to Follow-up|1|||
146643223|NCT03390101|528872130|FG002|Weeks 0-12|Lost to Follow-up|0|||
146643224|NCT03390101|528872128|FG000|Weeks 12-54|Withdrawal by Subject|0|||
146643225|NCT03390101|528872129|FG001|Weeks 12-54|Withdrawal by Subject|3|||
146643226|NCT03390101|528872130|FG002|Weeks 12-54|Withdrawal by Subject|1|||
146643227|NCT03390101|528872128|FG000|Weeks 12-54|Pregnancy|1|||
146643228|NCT03390101|528872129|FG001|Weeks 12-54|Pregnancy|0|||
146643229|NCT03390101|528872130|FG002|Weeks 12-54|Pregnancy|0|||
146643230|NCT03390101|528872128|FG000|Weeks 12-54|Adverse Event|2|||
146643231|NCT03390101|528872129|FG001|Weeks 12-54|Adverse Event|1|||
146643232|NCT03390101|528872130|FG002|Weeks 12-54|Adverse Event|1|||
146768852|NCT04707313|529321794|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
146768853|NCT04707313|529321795|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
146768854|NCT04707313|529321796|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
146768855|NCT04707313|529321797|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
146768856|NCT04707313|529321798|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
146768857|NCT04707313|529321799|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
146768858|NCT04707313|529321800|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
146768859|NCT04707313|529321801|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
146768860|NCT04707313|529321802|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
146768861|NCT04707313|529321803|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
146768862|NCT04707313|529321791|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146768863|NCT04707313|529321792|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146768864|NCT04707313|529321793|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
146911738|NCT00638846|529839912|FG000|Overall Study|Lost to Follow-up|3|||
146911739|NCT00638846|529839913|FG001|Overall Study|Lost to Follow-up|2|||
146911740|NCT00638846|529839912|FG000|Overall Study|lens issue|1|||
146911741|NCT00638846|529839913|FG001|Overall Study|lens issue|3|||
146911742|NCT04799782|529839920|FG000|Washout|Physician Decision|2|||
146911743|NCT04799782|529839921|FG001|Washout|Physician Decision|0|||
146911744|NCT04799782|529839920|FG000|Washout|Withdrawal by Subject|0|||
146911745|NCT04799782|529839921|FG001|Washout|Withdrawal by Subject|2|||
146911746|NCT04799782|529839920|FG000|Washout|Lost to Follow-up|0|||
146911747|NCT04799782|529839921|FG001|Washout|Lost to Follow-up|1|||
146911748|NCT02050048|529839926|FG000|Overall Study|Lost to Follow-up|0|||
146911749|NCT02050048|529839927|FG001|Overall Study|Lost to Follow-up|1|||
146911750|NCT02050048|529839926|FG000|Overall Study|Death|1|||
146911751|NCT02050048|529839927|FG001|Overall Study|Death|0|||
146911752|NCT02050048|529839926|FG000|Overall Study|Ineligible after ERCP|4|||
146911753|NCT02050048|529839927|FG001|Overall Study|Ineligible after ERCP|1|||
146911754|NCT01507246|529839931|FG000|Overall Study|Required different surgical procedures|2|||
146911755|NCT01507246|529839932|FG001|Overall Study|Required different surgical procedures|1|||
146911756|NCT01589094|529839935|FG000|Overall Study|Did not receive treatment|2|||
146911757|NCT02975349|529839936|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146564099|NCT02138825|528577887|FG000|Safety Follow-up|Death|11|||
146564100|NCT02138825|528577888|FG001|Safety Follow-up|Death|5|||
146768865|NCT04707313|529321794|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146768866|NCT04707313|529321795|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146911758|NCT02975349|529839937|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146911759|NCT02975349|529839938|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146911760|NCT02975349|529839939|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
146911761|NCT02975349|529839940|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
146911762|NCT02975349|529839941|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146768867|NCT04707313|529321796|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146768868|NCT04707313|529321797|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146564101|NCT02138825|528577887|FG000|Safety Follow-up|Withdrawal by Subject|5|||
146564102|NCT02138825|528577888|FG001|Safety Follow-up|Withdrawal by Subject|3|||
146564103|NCT02138825|528577887|FG000|Safety Follow-up|clinic worsening|1|||
146564104|NCT02138825|528577888|FG001|Safety Follow-up|clinic worsening|0|||
146564105|NCT02138825|528577887|FG000|Safety Follow-up|withdrawal by PI|1|||
146564106|NCT02138825|528577888|FG001|Safety Follow-up|withdrawal by PI|0|||
146564107|NCT02138825|528577887|FG000|Safety Follow-up|logistical difficulties|0|||
146564108|NCT02138825|528577888|FG001|Safety Follow-up|logistical difficulties|1|||
146564109|NCT02138825|528577887|FG000|Safety Follow-up|progressive disease|0|||
146564110|NCT02138825|528577888|FG001|Safety Follow-up|progressive disease|2|||
146564111|NCT02138825|528577887|FG000|Safety Follow-up|too unwell to attend the visit|0|||
146564112|NCT02138825|528577888|FG001|Safety Follow-up|too unwell to attend the visit|1|||
146564113|NCT02138825|528577887|FG000|Safety Follow-up|treatment unblinded|0|||
146564114|NCT02138825|528577888|FG001|Safety Follow-up|treatment unblinded|1|||
146971549|NCT01283282|530056337|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
146564115|NCT02138825|528577887|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
146564116|NCT02138825|528577888|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
146564117|NCT05201807|528577891|FG000|Overall Study|Adverse Event|1|||
146564118|NCT05201807|528577891|FG000|Overall Study|COVID-19 Related|1|||
146564119|NCT02367456|528577897|FG000|Overall Study|Death|8|||
146564120|NCT02367456|528577898|FG001|Overall Study|Death|24|||
146564121|NCT02367456|528577899|FG002|Overall Study|Death|17|||
146564122|NCT02367456|528577897|FG000|Overall Study|Lost to Follow-up|1|||
146564123|NCT02367456|528577898|FG001|Overall Study|Lost to Follow-up|3|||
146564124|NCT02367456|528577899|FG002|Overall Study|Lost to Follow-up|1|||
146564125|NCT02367456|528577897|FG000|Overall Study|Other reason|3|||
146643233|NCT01511055|528872131|FG000|Overall Study|Withdrawal by Subject|6|||
146564126|NCT02367456|528577898|FG001|Overall Study|Other reason|3|||
146564127|NCT02367456|528577899|FG002|Overall Study|Other reason|9|||
146643234|NCT00830869|528872132|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
146643235|NCT00830869|528872133|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
146643236|NCT00830869|528872134|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
146564128|NCT02367456|528577897|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
146564129|NCT02367456|528577898|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
146564130|NCT02367456|528577899|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
146564131|NCT02862574|528577900|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146564132|NCT02862574|528577901|FG001|Double-Blind Treatment Period|Adverse Event|1|||
146564133|NCT02862574|528577902|FG002|Double-Blind Treatment Period|Adverse Event|0|||
146564134|NCT02862574|528577900|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
146564135|NCT02862574|528577901|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
146643237|NCT00830869|528872135|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
146643238|NCT00830869|528872136|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
146643239|NCT00830869|528872137|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
146643240|NCT00830869|528872138|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
146643241|NCT00830869|528872139|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
146643242|NCT00830869|528872140|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
146643243|NCT00830869|528872141|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
146643244|NCT00830869|528872142|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
146643245|NCT00830869|528872143|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
146643246|NCT00830869|528872132|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
146643247|NCT00830869|528872133|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
146768869|NCT04707313|529321798|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
146564136|NCT02862574|528577902|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
146643248|NCT00830869|528872134|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
146643249|NCT00830869|528872135|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
146643250|NCT00830869|528872136|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
146643251|NCT00830869|528872137|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
146911763|NCT02975349|529839942|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146911764|NCT02975349|529839936|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146564137|NCT02862574|528577900|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
146564138|NCT02862574|528577901|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
146564139|NCT02862574|528577902|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
146564140|NCT04573972|528577903|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
146564141|NCT04573972|528577904|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
146564142|NCT00976456|528577905|FG000|Overall Study|Adverse Event|17|||
146564143|NCT00976456|528577906|FG001|Overall Study|Adverse Event|22|||
146564144|NCT00976456|528577905|FG000|Overall Study|Death|7|||
146911765|NCT02975349|529839937|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146911766|NCT02975349|529839938|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146564145|NCT00976456|528577906|FG001|Overall Study|Death|9|||
146564146|NCT00976456|528577905|FG000|Overall Study|Lack of Efficacy|5|||
146564147|NCT00976456|528577906|FG001|Overall Study|Lack of Efficacy|2|||
146564148|NCT00976456|528577905|FG000|Overall Study|Withdrawal by Subject|3|||
146564149|NCT00976456|528577906|FG001|Overall Study|Withdrawal by Subject|1|||
146564150|NCT00976456|528577905|FG000|Overall Study|screening failure, unknown|11|||
146564151|NCT00976456|528577906|FG001|Overall Study|screening failure, unknown|4|||
146564152|NCT03746015|528577909|FG000|Overall Study|Withdrawal of Consent|1|||
146564153|NCT03746015|528577910|FG001|Overall Study|Withdrawal of Consent|0|||
146564154|NCT03746015|528577911|FG002|Overall Study|Withdrawal of Consent|0|||
146564155|NCT01143402|528577916|FG000|Overall Study|Rapid clinical decline|1|||
146564156|NCT01143402|528577917|FG001|Overall Study|Rapid clinical decline|1|||
146564157|NCT01143402|528577918|FG002|Overall Study|Rapid clinical decline|0|||
146564158|NCT01143402|528577916|FG000|Overall Study|Not Treated|0|||
146564159|NCT01143402|528577917|FG001|Overall Study|Not Treated|0|||
146564160|NCT01143402|528577918|FG002|Overall Study|Not Treated|1|||
146564161|NCT01959932|528577922|FG000|Overall Study|Withdrawal by Subject|1|||
146564162|NCT01959932|528577923|FG001|Overall Study|Withdrawal by Subject|0|||
146564163|NCT01959932|528577924|FG002|Overall Study|Withdrawal by Subject|0|||
146564164|NCT00397540|528577925|FG000|Overall Study|short follow-up duration < 12 months|1|||
146564165|NCT00397540|528577926|FG001|Overall Study|short follow-up duration < 12 months|0|||
146564166|NCT01656161|528577927|FG000|Overall Study|Death|3|||
146564167|NCT01656161|528577927|FG000|Overall Study|Adverse Event|2|||
146564168|NCT01656161|528577927|FG000|Overall Study|Protocol Violation|1|||
146564169|NCT01656161|528577927|FG000|Overall Study|Withdrawal by Subject|1|||
146564170|NCT00776230|528577930|FG000|Overall Study|Lost to Follow-up|2|||
146564171|NCT00776230|528577931|FG001|Overall Study|Lost to Follow-up|1|||
146564172|NCT00776230|528577932|FG002|Overall Study|Lost to Follow-up|5|||
146564173|NCT00776230|528577930|FG000|Overall Study|Not vaccinated at Day 0|1|||
146564174|NCT00776230|528577931|FG001|Overall Study|Not vaccinated at Day 0|0|||
146564175|NCT00776230|528577932|FG002|Overall Study|Not vaccinated at Day 0|0|||
146564176|NCT00776230|528577930|FG000|Overall Study|Withdrawal by Subject|0|||
146564177|NCT00776230|528577931|FG001|Overall Study|Withdrawal by Subject|1|||
146564178|NCT00776230|528577932|FG002|Overall Study|Withdrawal by Subject|0|||
146564179|NCT00776230|528577930|FG000|Overall Study|Subject missed Visit 4|0|||
146564180|NCT00776230|528577931|FG001|Overall Study|Subject missed Visit 4|1|||
146564181|NCT00776230|528577932|FG002|Overall Study|Subject missed Visit 4|0|||
146564182|NCT01215851|528577933|FG000|Treatment Period|Adverse Event|1|||
146564183|NCT01215851|528577934|FG001|Treatment Period|Adverse Event|1|||
146564184|NCT01215851|528577935|FG002|Treatment Period|Adverse Event|1|||
146564185|NCT01215851|528577936|FG003|Treatment Period|Adverse Event|3|||
146564186|NCT01215851|528577937|FG004|Treatment Period|Adverse Event|0|||
146564187|NCT01215851|528577938|FG005|Treatment Period|Adverse Event|1|||
146564188|NCT01215851|528577933|FG000|Follow up Period|Lost to Follow-up|0|||
146564189|NCT01215851|528577934|FG001|Follow up Period|Lost to Follow-up|0|||
146564190|NCT01215851|528577935|FG002|Follow up Period|Lost to Follow-up|0|||
146564191|NCT01215851|528577936|FG003|Follow up Period|Lost to Follow-up|0|||
146564192|NCT01215851|528577937|FG004|Follow up Period|Lost to Follow-up|0|||
146564193|NCT01215851|528577938|FG005|Follow up Period|Lost to Follow-up|1|||
146564194|NCT03510273|528577939|FG000|Overall Study|Withdrawal by Subject|2|||
146564195|NCT03510273|528577939|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
146564196|NCT03510273|528577939|FG000|Overall Study|Moved away from study area|4|||
146564197|NCT02589938|528577942|FG000|Overall Study|Withdrawal by Subject|11|||
146564198|NCT02589938|528577943|FG001|Overall Study|Withdrawal by Subject|5|||
146564199|NCT02589938|528577944|FG002|Overall Study|Withdrawal by Subject|6|||
146564200|NCT02589938|528577942|FG000|Overall Study|Lost to Follow-up|3|||
146564201|NCT02589938|528577943|FG001|Overall Study|Lost to Follow-up|3|||
146564202|NCT02589938|528577944|FG002|Overall Study|Lost to Follow-up|3|||
146564203|NCT02589938|528577942|FG000|Overall Study|Death|1|||
146564204|NCT02589938|528577943|FG001|Overall Study|Death|0|||
146564205|NCT02589938|528577944|FG002|Overall Study|Death|1|||
146564206|NCT02589938|528577942|FG000|Overall Study|Protocol Violation|6|||
146564207|NCT02589938|528577943|FG001|Overall Study|Protocol Violation|2|||
146564208|NCT02589938|528577944|FG002|Overall Study|Protocol Violation|3|||
146564209|NCT02589938|528577942|FG000|Overall Study|Physician Decision|1|||
146564210|NCT02589938|528577943|FG001|Overall Study|Physician Decision|0|||
146564211|NCT02589938|528577944|FG002|Overall Study|Physician Decision|0|||
146564212|NCT02589938|528577942|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
146564213|NCT02589938|528577943|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
146564214|NCT02589938|528577944|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
146564215|NCT00016354|528577947|FG000|Overall Study|Lack of Efficacy|0|||
146564216|NCT00016354|528577948|FG001|Overall Study|Lack of Efficacy|0|||
146564217|NCT00016354|528577949|FG002|Overall Study|Lack of Efficacy|0|||
146564218|NCT00016354|528577950|FG003|Overall Study|Lack of Efficacy|0|||
146564219|NCT00016354|528577951|FG004|Overall Study|Lack of Efficacy|0|||
146564220|NCT00016354|528577952|FG005|Overall Study|Lack of Efficacy|0|||
146911767|NCT02975349|529839939|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146911768|NCT02975349|529839940|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146911769|NCT02975349|529839941|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146911770|NCT02975349|529839942|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146911771|NCT02975349|529839936|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
146911772|NCT02975349|529839937|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
146911773|NCT02975349|529839938|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
146911774|NCT02975349|529839939|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
146564221|NCT00016354|528577953|FG006|Overall Study|Lack of Efficacy|0|||
146911775|NCT02975349|529839940|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
146564222|NCT00016354|528577954|FG007|Overall Study|Lack of Efficacy|1|||
146911776|NCT02975349|529839941|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
146911777|NCT02975349|529839942|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
146911778|NCT02975349|529839936|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
146911779|NCT02975349|529839937|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
146911780|NCT02975349|529839938|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
146911781|NCT02975349|529839939|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
146911782|NCT02975349|529839940|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
146911783|NCT02975349|529839941|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
146911784|NCT02975349|529839942|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
146911785|NCT02975349|529839936|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
146911786|NCT02975349|529839937|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
146911787|NCT02975349|529839938|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
146911788|NCT02975349|529839939|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
146564223|NCT03110562|528577955|FG000|Initial Treatment Period|Disease Progression|1|||
146564224|NCT03110562|528577956|FG001|Initial Treatment Period|Disease Progression|1|||
146564225|NCT03110562|528577957|FG002|Initial Treatment Period|Disease Progression|0|||
146564226|NCT03110562|528577958|FG003|Initial Treatment Period|Disease Progression|0|||
146564227|NCT03110562|528577955|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
146911789|NCT02975349|529839940|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
146911790|NCT02975349|529839941|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
146911791|NCT02975349|529839942|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
146911792|NCT02975349|529839936|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
146911793|NCT02975349|529839937|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
146911794|NCT02975349|529839938|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
146911795|NCT02975349|529839939|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
146911796|NCT02975349|529839940|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
146911797|NCT02975349|529839941|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
146911798|NCT02975349|529839942|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
146911799|NCT02975349|529839936|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
146911800|NCT02975349|529839937|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
146911801|NCT02975349|529839938|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
146911802|NCT02975349|529839939|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
146911803|NCT02975349|529839940|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
146911804|NCT02975349|529839941|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
146911805|NCT02975349|529839942|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
146911806|NCT02975349|529839936|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
146911807|NCT02975349|529839937|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
146911808|NCT02975349|529839938|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
146911809|NCT02975349|529839939|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
146564228|NCT03110562|528577956|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
146564229|NCT03110562|528577957|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
146564230|NCT03110562|528577958|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
146564231|NCT03110562|528577955|FG000|Initial Treatment Period|Adverse Event|1|||
146564232|NCT03110562|528577956|FG001|Initial Treatment Period|Adverse Event|0|||
146564233|NCT03110562|528577957|FG002|Initial Treatment Period|Adverse Event|0|||
146564234|NCT03110562|528577958|FG003|Initial Treatment Period|Adverse Event|0|||
146564235|NCT03110562|528577955|FG000|Initial Treatment Period|Death|74|||
146564236|NCT03110562|528577956|FG001|Initial Treatment Period|Death|82|||
146564237|NCT03110562|528577957|FG002|Initial Treatment Period|Death|0|||
146564238|NCT03110562|528577958|FG003|Initial Treatment Period|Death|0|||
146564239|NCT03110562|528577955|FG000|Initial Treatment Period|Lost to Follow-up|13|||
146564240|NCT03110562|528577956|FG001|Initial Treatment Period|Lost to Follow-up|8|||
146564241|NCT03110562|528577957|FG002|Initial Treatment Period|Lost to Follow-up|0|||
146564242|NCT03110562|528577958|FG003|Initial Treatment Period|Lost to Follow-up|0|||
146564243|NCT03110562|528577955|FG000|Initial Treatment Period|Protocol Deviation|1|||
146564244|NCT03110562|528577956|FG001|Initial Treatment Period|Protocol Deviation|0|||
146564245|NCT03110562|528577957|FG002|Initial Treatment Period|Protocol Deviation|0|||
146564246|NCT03110562|528577958|FG003|Initial Treatment Period|Protocol Deviation|0|||
146564247|NCT03110562|528577955|FG000|Initial Treatment Period|Physician Decision|2|||
146564248|NCT03110562|528577956|FG001|Initial Treatment Period|Physician Decision|1|||
146564249|NCT03110562|528577957|FG002|Initial Treatment Period|Physician Decision|0|||
146564250|NCT03110562|528577958|FG003|Initial Treatment Period|Physician Decision|0|||
146564251|NCT03110562|528577955|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
146564252|NCT03110562|528577956|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
146564253|NCT03110562|528577957|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
146564254|NCT03110562|528577958|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
146564255|NCT03110562|528577955|FG000|Initial Treatment Period|Other|5|||
146564256|NCT03110562|528577956|FG001|Initial Treatment Period|Other|4|||
146564257|NCT03110562|528577957|FG002|Initial Treatment Period|Other|0|||
146564258|NCT03110562|528577958|FG003|Initial Treatment Period|Other|0|||
146564259|NCT03110562|528577955|FG000|Initial Treatment Period|Randomized but never treated|0|||
146564260|NCT03110562|528577956|FG001|Initial Treatment Period|Randomized but never treated|3|||
146564261|NCT03110562|528577957|FG002|Initial Treatment Period|Randomized but never treated|0|||
146564262|NCT03110562|528577958|FG003|Initial Treatment Period|Randomized but never treated|0|||
146564263|NCT03110562|528577955|FG000|Crossover Period|Disease Progression|0|||
146564264|NCT03110562|528577956|FG001|Crossover Period|Disease Progression|0|||
146564265|NCT03110562|528577957|FG002|Crossover Period|Disease Progression|1|||
146564266|NCT03110562|528577958|FG003|Crossover Period|Disease Progression|0|||
146564267|NCT03110562|528577955|FG000|Crossover Period|Withdrawal by Subject|0|||
146564268|NCT03110562|528577956|FG001|Crossover Period|Withdrawal by Subject|0|||
146564269|NCT03110562|528577957|FG002|Crossover Period|Withdrawal by Subject|8|||
146564270|NCT03110562|528577958|FG003|Crossover Period|Withdrawal by Subject|6|||
146564271|NCT03110562|528577955|FG000|Crossover Period|Death|0|||
146564272|NCT03110562|528577956|FG001|Crossover Period|Death|0|||
146564273|NCT03110562|528577957|FG002|Crossover Period|Death|37|||
146564274|NCT03110562|528577958|FG003|Crossover Period|Death|3|||
146564275|NCT03110562|528577955|FG000|Crossover Period|Lost to Follow-up|0|||
146564276|NCT03110562|528577956|FG001|Crossover Period|Lost to Follow-up|0|||
146911810|NCT02975349|529839940|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
146911811|NCT02975349|529839941|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
146911812|NCT02975349|529839942|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
146564277|NCT03110562|528577957|FG002|Crossover Period|Lost to Follow-up|0|||
146564278|NCT03110562|528577958|FG003|Crossover Period|Lost to Follow-up|1|||
146564279|NCT03110562|528577955|FG000|Crossover Period|Other|0|||
146564280|NCT03110562|528577956|FG001|Crossover Period|Other|0|||
146564281|NCT03110562|528577957|FG002|Crossover Period|Other|1|||
146564282|NCT03110562|528577958|FG003|Crossover Period|Other|1|||
146564283|NCT03110562|528577955|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
146564284|NCT03110562|528577956|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
146911813|NCT02975349|529839936|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
146911814|NCT02975349|529839937|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
146768870|NCT04707313|529321799|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146914691|NCT03303339|529850052|FG010|Overall Study|Safety/Non-compliance|0|||
146643252|NCT00830869|528872138|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
146643253|NCT00830869|528872139|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
146643254|NCT00830869|528872140|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
146643255|NCT00830869|528872141|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
146643256|NCT00830869|528872142|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
146643257|NCT00830869|528872143|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
146643258|NCT00830869|528872132|FG000|Period 1: Part 1|Adverse Event|0|||
146643259|NCT00830869|528872133|FG001|Period 1: Part 1|Adverse Event|0|||
146643260|NCT00830869|528872134|FG002|Period 1: Part 1|Adverse Event|0|||
146643261|NCT00830869|528872135|FG003|Period 1: Part 1|Adverse Event|0|||
146643262|NCT00830869|528872136|FG004|Period 1: Part 1|Adverse Event|0|||
146643263|NCT00830869|528872137|FG005|Period 1: Part 1|Adverse Event|1|||
146768871|NCT04707313|529321800|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146768872|NCT04707313|529321801|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146643264|NCT00830869|528872138|FG006|Period 1: Part 1|Adverse Event|1|||
146643265|NCT00830869|528872139|FG007|Period 1: Part 1|Adverse Event|0|||
146643266|NCT00830869|528872140|FG008|Period 1: Part 1|Adverse Event|0|||
146914692|NCT03303339|529850053|FG011|Overall Study|Safety/Non-compliance|1|||
146564285|NCT03110562|528577957|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
146564286|NCT03110562|528577958|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
146564287|NCT03012880|528577962|FG000|Overall Study|Withdrawal by Subject|1|||
146564288|NCT03012880|528577963|FG001|Overall Study|Withdrawal by Subject|0|||
146564289|NCT03012880|528577962|FG000|Overall Study|Ineligible|1|||
146564290|NCT03012880|528577963|FG001|Overall Study|Ineligible|0|||
146564291|NCT01355627|528577964|FG000|Overall Study|Request By the Patient to Discontinue|5|||
146564292|NCT01355627|528577965|FG001|Overall Study|Request By the Patient to Discontinue|7|||
146564293|NCT01355627|528577964|FG000|Overall Study|Lost to Follow-up|8|||
146564294|NCT01355627|528577965|FG001|Overall Study|Lost to Follow-up|7|||
146564295|NCT01355627|528577964|FG000|Overall Study|Fatal Adverse Event|19|||
146564296|NCT01355627|528577965|FG001|Overall Study|Fatal Adverse Event|23|||
146564297|NCT01355627|528577964|FG000|Overall Study|Other|1|||
146564298|NCT01355627|528577965|FG001|Overall Study|Other|1|||
146564299|NCT04532749|528577966|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
146564300|NCT04532749|528577967|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
146564301|NCT04532749|528577966|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
146564302|NCT04532749|528577967|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
146564303|NCT04532749|528577966|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
146564304|NCT04532749|528577967|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
146564305|NCT04532749|528577966|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
146564306|NCT04532749|528577967|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
146564307|NCT04532749|528577966|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
146564308|NCT04532749|528577967|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
146564309|NCT04532749|528577966|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
146564310|NCT04532749|528577967|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
146564311|NCT04532749|528577966|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
146564312|NCT04532749|528577967|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
146564313|NCT04532749|528577966|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
146564314|NCT04532749|528577967|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
146564315|NCT04532749|528577966|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
146564316|NCT04532749|528577967|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
146564317|NCT04532749|528577966|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
146564318|NCT04532749|528577967|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
146564319|NCT04756531|528577970|FG000|Overall Study|Adverse Event|0|||
146564320|NCT04756531|528577971|FG001|Overall Study|Adverse Event|0|||
146564321|NCT04756531|528577972|FG002|Overall Study|Adverse Event|0|||
146564322|NCT04756531|528577973|FG003|Overall Study|Adverse Event|0|||
146564323|NCT04756531|528577974|FG004|Overall Study|Adverse Event|1|||
146564324|NCT04756531|528577975|FG005|Overall Study|Adverse Event|0|||
146564325|NCT04756531|528577976|FG006|Overall Study|Adverse Event|0|||
146564326|NCT04756531|528577977|FG007|Overall Study|Adverse Event|0|||
146564327|NCT04756531|528577978|FG008|Overall Study|Adverse Event|0|||
146564328|NCT04756531|528577979|FG009|Overall Study|Adverse Event|0|||
146564329|NCT04756531|528577980|FG010|Overall Study|Adverse Event|0|||
146564330|NCT04756531|528577981|FG011|Overall Study|Adverse Event|0|||
146564331|NCT04756531|528577982|FG012|Overall Study|Adverse Event|0|||
146564332|NCT04756531|528577983|FG013|Overall Study|Adverse Event|0|||
146564333|NCT04756531|528577984|FG014|Overall Study|Adverse Event|0|||
146564334|NCT04756531|528577985|FG015|Overall Study|Adverse Event|0|||
146564335|NCT04756531|528577986|FG016|Overall Study|Adverse Event|0|||
146564336|NCT04756531|528577987|FG017|Overall Study|Adverse Event|0|||
146564337|NCT04756531|528577970|FG000|Overall Study|Withdrawal by Subject|0|||
146564338|NCT04756531|528577971|FG001|Overall Study|Withdrawal by Subject|0|||
146564339|NCT04756531|528577972|FG002|Overall Study|Withdrawal by Subject|0|||
146564340|NCT04756531|528577973|FG003|Overall Study|Withdrawal by Subject|0|||
146564341|NCT04756531|528577974|FG004|Overall Study|Withdrawal by Subject|0|||
146564342|NCT04756531|528577975|FG005|Overall Study|Withdrawal by Subject|0|||
146564343|NCT04756531|528577976|FG006|Overall Study|Withdrawal by Subject|1|||
146564344|NCT04756531|528577977|FG007|Overall Study|Withdrawal by Subject|0|||
146564345|NCT04756531|528577978|FG008|Overall Study|Withdrawal by Subject|0|||
146564346|NCT04756531|528577979|FG009|Overall Study|Withdrawal by Subject|0|||
146564347|NCT04756531|528577980|FG010|Overall Study|Withdrawal by Subject|0|||
146564348|NCT04756531|528577981|FG011|Overall Study|Withdrawal by Subject|0|||
146564349|NCT04756531|528577982|FG012|Overall Study|Withdrawal by Subject|0|||
146564350|NCT04756531|528577983|FG013|Overall Study|Withdrawal by Subject|0|||
146564351|NCT04756531|528577984|FG014|Overall Study|Withdrawal by Subject|0|||
146564352|NCT04756531|528577985|FG015|Overall Study|Withdrawal by Subject|0|||
146564353|NCT04756531|528577986|FG016|Overall Study|Withdrawal by Subject|0|||
146564354|NCT04756531|528577987|FG017|Overall Study|Withdrawal by Subject|0|||
146911815|NCT02975349|529839938|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
146564355|NCT05239221|528577991|FG000|Overall Study|Adverse Event|0|||
146564356|NCT05239221|528577992|FG001|Overall Study|Adverse Event|0|||
146564357|NCT05239221|528577993|FG002|Overall Study|Adverse Event|0|||
146564358|NCT05239221|528577994|FG003|Overall Study|Adverse Event|0|||
146564359|NCT05239221|528577995|FG004|Overall Study|Adverse Event|0|||
146643267|NCT00830869|528872141|FG009|Period 1: Part 1|Adverse Event|0|||
146643268|NCT00830869|528872142|FG010|Period 1: Part 1|Adverse Event|0|||
146643269|NCT00830869|528872143|FG011|Period 1: Part 1|Adverse Event|0|||
146643270|NCT00830869|528872132|FG000|Period 1: Part 1|Progressive disease|1|||
146643271|NCT00830869|528872133|FG001|Period 1: Part 1|Progressive disease|0|||
146643272|NCT00830869|528872134|FG002|Period 1: Part 1|Progressive disease|1|||
146643273|NCT00830869|528872135|FG003|Period 1: Part 1|Progressive disease|6|||
146643274|NCT00830869|528872136|FG004|Period 1: Part 1|Progressive disease|4|||
146643275|NCT00830869|528872137|FG005|Period 1: Part 1|Progressive disease|4|||
146643276|NCT00830869|528872138|FG006|Period 1: Part 1|Progressive disease|1|||
146643277|NCT00830869|528872139|FG007|Period 1: Part 1|Progressive disease|0|||
146643278|NCT00830869|528872140|FG008|Period 1: Part 1|Progressive disease|0|||
146643279|NCT00830869|528872141|FG009|Period 1: Part 1|Progressive disease|0|||
146643280|NCT00830869|528872142|FG010|Period 1: Part 1|Progressive disease|0|||
146643281|NCT00830869|528872143|FG011|Period 1: Part 1|Progressive disease|0|||
146643282|NCT00830869|528872132|FG000|Period 2: Part 2|Protocol Violation|0|||
146643283|NCT00830869|528872133|FG001|Period 2: Part 2|Protocol Violation|0|||
146643284|NCT00830869|528872134|FG002|Period 2: Part 2|Protocol Violation|0|||
146643285|NCT00830869|528872135|FG003|Period 2: Part 2|Protocol Violation|0|||
146643286|NCT00830869|528872136|FG004|Period 2: Part 2|Protocol Violation|0|||
146643287|NCT00830869|528872137|FG005|Period 2: Part 2|Protocol Violation|0|||
146643288|NCT00830869|528872138|FG006|Period 2: Part 2|Protocol Violation|0|||
146643289|NCT00830869|528872139|FG007|Period 2: Part 2|Protocol Violation|1|||
146643290|NCT00830869|528872140|FG008|Period 2: Part 2|Protocol Violation|0|||
146643291|NCT00830869|528872141|FG009|Period 2: Part 2|Protocol Violation|1|||
146643292|NCT00830869|528872142|FG010|Period 2: Part 2|Protocol Violation|0|||
146643293|NCT00830869|528872143|FG011|Period 2: Part 2|Protocol Violation|0|||
146643294|NCT00830869|528872132|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
146643295|NCT00830869|528872133|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
146643296|NCT00830869|528872134|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
146643297|NCT00830869|528872135|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
146643298|NCT00830869|528872136|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
146643299|NCT00830869|528872137|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
146643300|NCT00830869|528872138|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
146643301|NCT00830869|528872139|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
146643302|NCT00830869|528872140|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
146643303|NCT00830869|528872141|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
146643304|NCT00830869|528872142|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
146643305|NCT00830869|528872143|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
146643306|NCT00830869|528872132|FG000|Period 2: Part 2|Adverse Event|0|||
146643307|NCT00830869|528872133|FG001|Period 2: Part 2|Adverse Event|0|||
146643308|NCT00830869|528872134|FG002|Period 2: Part 2|Adverse Event|0|||
146643309|NCT00830869|528872135|FG003|Period 2: Part 2|Adverse Event|0|||
146643310|NCT00830869|528872136|FG004|Period 2: Part 2|Adverse Event|0|||
146643311|NCT00830869|528872137|FG005|Period 2: Part 2|Adverse Event|0|||
146643312|NCT00830869|528872138|FG006|Period 2: Part 2|Adverse Event|0|||
146643313|NCT00830869|528872139|FG007|Period 2: Part 2|Adverse Event|4|||
146643314|NCT00830869|528872140|FG008|Period 2: Part 2|Adverse Event|3|||
146643315|NCT00830869|528872141|FG009|Period 2: Part 2|Adverse Event|2|||
146911816|NCT02975349|529839939|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
146911817|NCT02975349|529839940|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
146911818|NCT02975349|529839941|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
146643316|NCT00830869|528872142|FG010|Period 2: Part 2|Adverse Event|2|||
146643317|NCT00830869|528872143|FG011|Period 2: Part 2|Adverse Event|0|||
146643318|NCT00830869|528872132|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
146643319|NCT00830869|528872133|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
146643320|NCT00830869|528872134|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
146643321|NCT00830869|528872135|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
146643322|NCT00830869|528872136|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
146643323|NCT00830869|528872137|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
146643324|NCT00830869|528872138|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
146643325|NCT00830869|528872139|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
146643326|NCT00830869|528872140|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
146643327|NCT00830869|528872141|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
146643328|NCT00830869|528872142|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
146643329|NCT00830869|528872143|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
146643330|NCT00830869|528872132|FG000|Period 2: Part 2|Progressive disease|0|||
146643331|NCT00830869|528872133|FG001|Period 2: Part 2|Progressive disease|0|||
146643332|NCT00830869|528872134|FG002|Period 2: Part 2|Progressive disease|0|||
146643333|NCT00830869|528872135|FG003|Period 2: Part 2|Progressive disease|0|||
146643334|NCT00830869|528872136|FG004|Period 2: Part 2|Progressive disease|0|||
146643335|NCT00830869|528872137|FG005|Period 2: Part 2|Progressive disease|0|||
146643336|NCT00830869|528872138|FG006|Period 2: Part 2|Progressive disease|0|||
146643337|NCT00830869|528872139|FG007|Period 2: Part 2|Progressive disease|14|||
146643338|NCT00830869|528872140|FG008|Period 2: Part 2|Progressive disease|11|||
146643339|NCT00830869|528872141|FG009|Period 2: Part 2|Progressive disease|12|||
146643340|NCT00830869|528872142|FG010|Period 2: Part 2|Progressive disease|8|||
146643341|NCT00830869|528872143|FG011|Period 2: Part 2|Progressive disease|15|||
146643342|NCT00830869|528872132|FG000|Period 2: Part 2|Other|0|||
146643343|NCT00830869|528872133|FG001|Period 2: Part 2|Other|0|||
146643344|NCT00830869|528872134|FG002|Period 2: Part 2|Other|0|||
146643345|NCT00830869|528872135|FG003|Period 2: Part 2|Other|0|||
146643346|NCT00830869|528872136|FG004|Period 2: Part 2|Other|0|||
146643347|NCT00830869|528872137|FG005|Period 2: Part 2|Other|0|||
146643348|NCT00830869|528872138|FG006|Period 2: Part 2|Other|0|||
146643349|NCT00830869|528872139|FG007|Period 2: Part 2|Other|0|||
146643350|NCT00830869|528872140|FG008|Period 2: Part 2|Other|0|||
146643351|NCT00830869|528872141|FG009|Period 2: Part 2|Other|1|||
146643352|NCT00830869|528872142|FG010|Period 2: Part 2|Other|0|||
146643353|NCT00830869|528872143|FG011|Period 2: Part 2|Other|0|||
146643354|NCT00281658|528872149|FG000|Randomized Phase|Adverse Event|0|||
146643355|NCT00281658|528872150|FG001|Randomized Phase|Adverse Event|2|||
146643356|NCT00281658|528872151|FG002|Randomized Phase|Adverse Event|0|||
146643357|NCT00281658|528872152|FG003|Randomized Phase|Adverse Event|0|||
146643358|NCT00281658|528872149|FG000|Randomized Phase|Lost to Follow-up|34|||
146643359|NCT00281658|528872150|FG001|Randomized Phase|Lost to Follow-up|27|||
146643360|NCT00281658|528872151|FG002|Randomized Phase|Lost to Follow-up|0|||
146643361|NCT00281658|528872152|FG003|Randomized Phase|Lost to Follow-up|0|||
146643362|NCT00281658|528872149|FG000|Randomized Phase|Withdrawal by Subject|8|||
146643363|NCT00281658|528872150|FG001|Randomized Phase|Withdrawal by Subject|7|||
146643364|NCT00281658|528872151|FG002|Randomized Phase|Withdrawal by Subject|0|||
146643365|NCT00281658|528872152|FG003|Randomized Phase|Withdrawal by Subject|0|||
146643366|NCT00281658|528872149|FG000|Randomized Phase|Study closed/terminated|1|||
146643367|NCT00281658|528872150|FG001|Randomized Phase|Study closed/terminated|1|||
146643368|NCT00281658|528872151|FG002|Randomized Phase|Study closed/terminated|0|||
146643369|NCT00281658|528872152|FG003|Randomized Phase|Study closed/terminated|0|||
146643370|NCT00281658|528872149|FG000|Randomized Phase|Disease progression|36|||
146643371|NCT00281658|528872150|FG001|Randomized Phase|Disease progression|27|||
146643372|NCT00281658|528872151|FG002|Randomized Phase|Disease progression|0|||
146643373|NCT00281658|528872152|FG003|Randomized Phase|Disease progression|0|||
146911819|NCT02975349|529839942|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
146911820|NCT02975349|529839936|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
146911821|NCT02975349|529839937|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
146911822|NCT02975349|529839938|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
146643374|NCT00281658|528872149|FG000|Randomized Phase|Physician Decision|1|||
146643375|NCT00281658|528872150|FG001|Randomized Phase|Physician Decision|1|||
146643376|NCT00281658|528872151|FG002|Randomized Phase|Physician Decision|0|||
146643377|NCT00281658|528872152|FG003|Randomized Phase|Physician Decision|0|||
146643378|NCT00281658|528872149|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
146643379|NCT00281658|528872150|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
146643380|NCT00281658|528872151|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
146643381|NCT00281658|528872152|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
146643382|NCT00281658|528872149|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
146643383|NCT00281658|528872150|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
146643384|NCT00281658|528872151|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
146643385|NCT00281658|528872152|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
146643386|NCT00281658|528872149|FG000|Randomized Phase|Treatment ongoing|1|||
146643387|NCT00281658|528872150|FG001|Randomized Phase|Treatment ongoing|0|||
146643388|NCT00281658|528872151|FG002|Randomized Phase|Treatment ongoing|0|||
146643389|NCT00281658|528872152|FG003|Randomized Phase|Treatment ongoing|0|||
146643390|NCT00281658|528872149|FG000|Open Label Phase|Adverse Event|0|||
146643391|NCT00281658|528872150|FG001|Open Label Phase|Adverse Event|0|||
146643392|NCT00281658|528872151|FG002|Open Label Phase|Adverse Event|1|||
146643393|NCT00281658|528872152|FG003|Open Label Phase|Adverse Event|0|||
146643394|NCT00281658|528872149|FG000|Open Label Phase|Lost to Follow-up|0|||
146911823|NCT02975349|529839939|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
146911824|NCT02975349|529839940|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
146911825|NCT02975349|529839941|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
146911826|NCT02975349|529839942|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
146911827|NCT02975349|529839936|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
146911828|NCT02975349|529839937|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
146911829|NCT02975349|529839938|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
146911830|NCT02975349|529839939|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
146911831|NCT02975349|529839940|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
146911832|NCT02975349|529839941|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
146911833|NCT02975349|529839942|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
146911834|NCT02975349|529839936|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
146911835|NCT02975349|529839937|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
146911836|NCT02975349|529839938|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
146564360|NCT05239221|528577996|FG005|Overall Study|Adverse Event|0|||
146564361|NCT05239221|528577997|FG006|Overall Study|Adverse Event|1|||
146564362|NCT05239221|528577998|FG007|Overall Study|Adverse Event|0|||
146564363|NCT05239221|528577999|FG008|Overall Study|Adverse Event|0|||
146564364|NCT05239221|528578000|FG009|Overall Study|Adverse Event|0|||
146564365|NCT05239221|528578001|FG010|Overall Study|Adverse Event|1|||
146564366|NCT05239221|528578002|FG011|Overall Study|Adverse Event|1|||
146564367|NCT05239221|528578003|FG012|Overall Study|Adverse Event|0|||
146564368|NCT05239221|528578004|FG013|Overall Study|Adverse Event|0|||
146564369|NCT05239221|528578005|FG014|Overall Study|Adverse Event|0|||
146564370|NCT05239221|528578006|FG015|Overall Study|Adverse Event|0|||
146564371|NCT05239221|528577991|FG000|Overall Study|Withdrawal by Subject|0|||
146564372|NCT05239221|528577992|FG001|Overall Study|Withdrawal by Subject|0|||
146564373|NCT05239221|528577993|FG002|Overall Study|Withdrawal by Subject|0|||
146564374|NCT05239221|528577994|FG003|Overall Study|Withdrawal by Subject|0|||
146564375|NCT05239221|528577995|FG004|Overall Study|Withdrawal by Subject|0|||
146564376|NCT05239221|528577996|FG005|Overall Study|Withdrawal by Subject|0|||
146564377|NCT05239221|528577997|FG006|Overall Study|Withdrawal by Subject|0|||
146564378|NCT05239221|528577998|FG007|Overall Study|Withdrawal by Subject|0|||
146564379|NCT05239221|528577999|FG008|Overall Study|Withdrawal by Subject|0|||
146564380|NCT05239221|528578000|FG009|Overall Study|Withdrawal by Subject|0|||
146564381|NCT05239221|528578001|FG010|Overall Study|Withdrawal by Subject|1|||
146564382|NCT05239221|528578002|FG011|Overall Study|Withdrawal by Subject|0|||
146564383|NCT05239221|528578003|FG012|Overall Study|Withdrawal by Subject|0|||
146564384|NCT05239221|528578004|FG013|Overall Study|Withdrawal by Subject|0|||
146564385|NCT05239221|528578005|FG014|Overall Study|Withdrawal by Subject|0|||
146564386|NCT05239221|528578006|FG015|Overall Study|Withdrawal by Subject|1|||
146911837|NCT02975349|529839939|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
146564387|NCT02581930|528578007|FG000|Overall Study|Withdrawal by Subject|1|||
146564388|NCT02581930|528578007|FG000|Overall Study|patient declined further treatment|1|||
146564389|NCT01400412|528578008|FG000|Overall Study|Lost to Follow-up|4|||
146768873|NCT04707313|529321802|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146911838|NCT02975349|529839940|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
146911839|NCT02975349|529839941|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
146911840|NCT02975349|529839942|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
146911841|NCT02975349|529839936|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
146911842|NCT02975349|529839937|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
146911843|NCT02975349|529839938|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
146911844|NCT02975349|529839939|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
146911845|NCT02975349|529839940|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
146911846|NCT02975349|529839941|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
146911847|NCT02975349|529839942|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
146911848|NCT02975349|529839936|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
146911849|NCT02975349|529839937|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
146911850|NCT02975349|529839938|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
146911851|NCT02975349|529839939|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
146911852|NCT02975349|529839940|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
146643395|NCT00281658|528872150|FG001|Open Label Phase|Lost to Follow-up|0|||
146643396|NCT00281658|528872151|FG002|Open Label Phase|Lost to Follow-up|16|||
146643397|NCT00281658|528872152|FG003|Open Label Phase|Lost to Follow-up|2|||
146643398|NCT00281658|528872149|FG000|Open Label Phase|Withdrawal by Subject|0|||
146643399|NCT00281658|528872150|FG001|Open Label Phase|Withdrawal by Subject|0|||
146643400|NCT00281658|528872151|FG002|Open Label Phase|Withdrawal by Subject|3|||
146643401|NCT00281658|528872152|FG003|Open Label Phase|Withdrawal by Subject|2|||
146643402|NCT00281658|528872149|FG000|Open Label Phase|Disease progression|0|||
146768874|NCT04707313|529321803|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146911853|NCT02975349|529839941|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
146911854|NCT02975349|529839942|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
146911855|NCT02975349|529839936|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
146911856|NCT02975349|529839937|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
146911857|NCT02975349|529839938|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
146911858|NCT02975349|529839939|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
146911859|NCT02975349|529839940|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
146911860|NCT02975349|529839941|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
146911861|NCT02975349|529839942|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
146911862|NCT00969618|529839951|FG000|Overall Study|Adverse Event|29|||
146911863|NCT00969618|529839951|FG000|Overall Study|Entry Criteria Not Met|3|||
146643403|NCT00281658|528872150|FG001|Open Label Phase|Disease progression|0|||
146643404|NCT00281658|528872151|FG002|Open Label Phase|Disease progression|18|||
146643405|NCT00281658|528872152|FG003|Open Label Phase|Disease progression|0|||
146643406|NCT00281658|528872149|FG000|Open Label Phase|Physician Decision|0|||
146643407|NCT00281658|528872150|FG001|Open Label Phase|Physician Decision|0|||
146643408|NCT00281658|528872151|FG002|Open Label Phase|Physician Decision|1|||
146911864|NCT00969618|529839951|FG000|Overall Study|Lack of Efficacy|2|||
146911865|NCT00969618|529839951|FG000|Overall Study|Lost to Follow-up|7|||
146643409|NCT00281658|528872152|FG003|Open Label Phase|Physician Decision|0|||
146643410|NCT00281658|528872149|FG000|Open Label Phase|Relocation of patient|0|||
146643411|NCT00281658|528872150|FG001|Open Label Phase|Relocation of patient|0|||
146643412|NCT00281658|528872151|FG002|Open Label Phase|Relocation of patient|1|||
146911866|NCT00969618|529839951|FG000|Overall Study|Physician Decision|1|||
146911867|NCT00969618|529839951|FG000|Overall Study|Protocol Violation|9|||
146911868|NCT00969618|529839951|FG000|Overall Study|Withdrawal by Subject|27|||
146911869|NCT05094154|529841354|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
146643413|NCT00281658|528872152|FG003|Open Label Phase|Relocation of patient|0|||
146911870|NCT05094154|529841355|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
146911871|NCT05094154|529841354|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
146911872|NCT05094154|529841355|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
146564390|NCT01400412|528578009|FG001|Overall Study|Lost to Follow-up|7|||
146564391|NCT01400412|528578008|FG000|Overall Study|Withdrawal by Subject|3|||
146564392|NCT01400412|528578009|FG001|Overall Study|Withdrawal by Subject|4|||
146564393|NCT01400412|528578008|FG000|Overall Study|Unable to complete|3|||
146564394|NCT01400412|528578009|FG001|Overall Study|Unable to complete|3|||
146911873|NCT02100657|529841362|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
146911874|NCT02100657|529841363|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
146911875|NCT02100657|529841364|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
146564395|NCT01400412|528578008|FG000|Overall Study|Never started study treatment|0|||
146564396|NCT01400412|528578009|FG001|Overall Study|Never started study treatment|3|||
146643414|NCT00281658|528872149|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
146643415|NCT00281658|528872150|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
146643416|NCT00281658|528872151|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
146564397|NCT00805389|528579939|FG000|Overall Study|Adverse Event|0|||
146564398|NCT00805389|528579940|FG001|Overall Study|Adverse Event|0|||
146564399|NCT00805389|528579941|FG002|Overall Study|Adverse Event|1|||
146564400|NCT00805389|528579942|FG003|Overall Study|Adverse Event|2|||
146564401|NCT00805389|528579943|FG004|Overall Study|Adverse Event|0|||
146564402|NCT00805389|528579939|FG000|Overall Study|Lost to Follow-up|4|||
146564403|NCT00805389|528579940|FG001|Overall Study|Lost to Follow-up|3|||
146564404|NCT00805389|528579941|FG002|Overall Study|Lost to Follow-up|6|||
146564405|NCT00805389|528579942|FG003|Overall Study|Lost to Follow-up|10|||
146564406|NCT00805389|528579943|FG004|Overall Study|Lost to Follow-up|9|||
146564407|NCT00805389|528579939|FG000|Overall Study|Protocol Violation|0|||
146564408|NCT00805389|528579940|FG001|Overall Study|Protocol Violation|0|||
146564409|NCT00805389|528579941|FG002|Overall Study|Protocol Violation|1|||
146564410|NCT00805389|528579942|FG003|Overall Study|Protocol Violation|0|||
146564411|NCT00805389|528579943|FG004|Overall Study|Protocol Violation|0|||
146564412|NCT00805389|528579939|FG000|Overall Study|Withdrawal by Subject|3|||
146564413|NCT00805389|528579940|FG001|Overall Study|Withdrawal by Subject|2|||
146564414|NCT00805389|528579941|FG002|Overall Study|Withdrawal by Subject|4|||
146564415|NCT00805389|528579942|FG003|Overall Study|Withdrawal by Subject|5|||
146643417|NCT00281658|528872152|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
146643418|NCT04590248|528872153|FG000|Overall Study|Lost to Follow-up|1|||
146643419|NCT04590248|528872153|FG000|Overall Study|Withdrawal by Subject|16|||
146643420|NCT04590248|528872153|FG000|Overall Study|Other|2|||
146643421|NCT02151773|528872161|FG000|Overall Study|Protocol Deviation|64|||
146643422|NCT04605991|528872163|FG000|Overall Study|Adverse Event|5|||
146643423|NCT04605991|528872163|FG000|Overall Study|Lack of Efficacy|1|||
146643424|NCT04605991|528872163|FG000|Overall Study|Lost to Follow-up|8|||
146564416|NCT00805389|528579943|FG004|Overall Study|Withdrawal by Subject|4|||
146564417|NCT00069641|528579946|FG000|Overall Study|Death|1|||
146564418|NCT00069641|528579947|FG001|Overall Study|Death|0|||
146643425|NCT04605991|528872163|FG000|Overall Study|Physician Decision|4|||
146564419|NCT00069641|528579948|FG002|Overall Study|Death|1|||
146643426|NCT04605991|528872163|FG000|Overall Study|Withdrawal by Subject|14|||
146643427|NCT04605991|528872163|FG000|Overall Study|Non-compliance with study|1|||
146643428|NCT02527200|528872164|FG000|Overall Study|Withdrawal by Subject|3|||
146564420|NCT03186638|528579949|FG000|Overall Study|Withdrawal by Subject|4|||
146564421|NCT03186638|528579950|FG001|Overall Study|Withdrawal by Subject|4|||
146564422|NCT03186638|528579949|FG000|Overall Study|Withdrawn due to medical problem|3|||
146564423|NCT03186638|528579950|FG001|Overall Study|Withdrawn due to medical problem|2|||
146564424|NCT03186638|528579949|FG000|Overall Study|Lost to Follow-up|1|||
146564425|NCT03186638|528579950|FG001|Overall Study|Lost to Follow-up|0|||
146911876|NCT02100657|529841362|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
146911877|NCT02100657|529841363|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
146911878|NCT02100657|529841364|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
146911879|NCT02100657|529841362|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
146911880|NCT02100657|529841363|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
146911881|NCT02100657|529841364|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
146911882|NCT02100657|529841362|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
146643429|NCT02527200|528872165|FG001|Overall Study|Withdrawal by Subject|2|||
146911883|NCT02100657|529841363|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
146971550|NCT01283282|530056336|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
146564426|NCT02239926|528579951|FG000|Overall Study|Withdrawal by Subject|0|||
146564427|NCT02239926|528579952|FG001|Overall Study|Withdrawal by Subject|1|||
146564428|NCT04388826|528579953|FG000|Overall Study|Lost to Follow-up|3|||
146564429|NCT04388826|528579954|FG001|Overall Study|Lost to Follow-up|2|||
146564430|NCT04388826|528579953|FG000|Overall Study|Adverse Event|1|||
146564431|NCT04388826|528579954|FG001|Overall Study|Adverse Event|0|||
146564432|NCT04047446|528579955|FG000|Overall Study|Physician Decision|1|||
146564433|NCT04047446|528579956|FG001|Overall Study|Physician Decision|0|||
146564434|NCT00329420|528579957|FG000|Re-induction Phase|Lack of Efficacy|0|||
146564435|NCT00329420|528579958|FG001|Re-induction Phase|Lack of Efficacy|1|||
146564436|NCT00329420|528579959|FG002|Re-induction Phase|Lack of Efficacy|0|||
146564437|NCT00329420|528579957|FG000|Re-induction Phase|Withdrawal of Consent|0|||
146564438|NCT00329420|528579958|FG001|Re-induction Phase|Withdrawal of Consent|0|||
146564439|NCT00329420|528579959|FG002|Re-induction Phase|Withdrawal of Consent|1|||
146564440|NCT00329420|528579957|FG000|Re-induction Phase|Did not respond to re-induction|6|||
146564441|NCT00329420|528579958|FG001|Re-induction Phase|Did not respond to re-induction|5|||
146564442|NCT00329420|528579959|FG002|Re-induction Phase|Did not respond to re-induction|7|||
146564443|NCT00329420|528579957|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
146564444|NCT00329420|528579958|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
146564445|NCT00329420|528579959|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
146564446|NCT00329420|528579957|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
146564447|NCT00329420|528579958|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
146564448|NCT00329420|528579959|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
146564449|NCT00329420|528579957|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
146564450|NCT00329420|528579958|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
146564451|NCT00329420|528579959|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
146564452|NCT03983421|528579961|FG000|Overall Study|Lost to Follow-up|1|||
146564453|NCT03386773|528579962|FG000|Overall Study|Lost to Follow-up|24|||
146564454|NCT03386773|528579963|FG001|Overall Study|Lost to Follow-up|33|||
146564455|NCT03386773|528579962|FG000|Overall Study|Withdrawal by Subject|3|||
146564456|NCT03386773|528579963|FG001|Overall Study|Withdrawal by Subject|2|||
146564457|NCT03639610|528579964|FG000|Overall Study|Adverse Event|7|||
146564458|NCT03639610|528579965|FG001|Overall Study|Adverse Event|1|||
146564459|NCT03639610|528579966|FG002|Overall Study|Adverse Event|0|||
146564460|NCT03639610|528579964|FG000|Overall Study|Physician Decision|3|||
146564461|NCT03639610|528579965|FG001|Overall Study|Physician Decision|1|||
146564462|NCT03639610|528579966|FG002|Overall Study|Physician Decision|0|||
146564463|NCT03639610|528579964|FG000|Overall Study|Disease progression|8|||
146564464|NCT03639610|528579965|FG001|Overall Study|Disease progression|5|||
146564465|NCT03639610|528579966|FG002|Overall Study|Disease progression|3|||
146564466|NCT03639610|528579964|FG000|Overall Study|Study terminated by sponsor|2|||
146564467|NCT03639610|528579965|FG001|Overall Study|Study terminated by sponsor|1|||
146564468|NCT03639610|528579966|FG002|Overall Study|Study terminated by sponsor|1|||
146564469|NCT03639610|528579964|FG000|Overall Study|Patient request to stop treatment|1|||
146564470|NCT03639610|528579965|FG001|Overall Study|Patient request to stop treatment|2|||
146564471|NCT03639610|528579966|FG002|Overall Study|Patient request to stop treatment|0|||
146564472|NCT00892008|528579969|FG000|Overall Study|Death|5|||
146564473|NCT00892008|528579969|FG000|Overall Study|Lack of Efficacy|3|||
146564474|NCT00892008|528579969|FG000|Overall Study|Lost to Follow-up|142|||
146564475|NCT00892008|528579969|FG000|Overall Study|Other|378|||
146564476|NCT00892008|528579969|FG000|Overall Study|Adverse Event|37|||
146564477|NCT02410772|528579973|FG000|Overall Study|Death|3|||
146564478|NCT02410772|528579974|FG001|Overall Study|Death|4|||
146564479|NCT02410772|528579975|FG002|Overall Study|Death|8|||
146564480|NCT02410772|528579973|FG000|Overall Study|Lost to Follow-up|31|||
146564481|NCT02410772|528579974|FG001|Overall Study|Lost to Follow-up|23|||
146564482|NCT02410772|528579975|FG002|Overall Study|Lost to Follow-up|22|||
146564483|NCT02410772|528579973|FG000|Overall Study|Pregnancy|8|||
146564484|NCT02410772|528579974|FG001|Overall Study|Pregnancy|4|||
146564485|NCT02410772|528579975|FG002|Overall Study|Pregnancy|5|||
146564486|NCT02410772|528579973|FG000|Overall Study|Protocol Violation|8|||
146564487|NCT02410772|528579974|FG001|Overall Study|Protocol Violation|8|||
146564488|NCT02410772|528579975|FG002|Overall Study|Protocol Violation|4|||
146564489|NCT02410772|528579973|FG000|Overall Study|Baseline Drug Resistance|49|||
146564490|NCT02410772|528579974|FG001|Overall Study|Baseline Drug Resistance|40|||
146564491|NCT02410772|528579975|FG002|Overall Study|Baseline Drug Resistance|51|||
146564492|NCT02410772|528579973|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
146564493|NCT02410772|528579974|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
146564494|NCT02410772|528579975|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
146564495|NCT02410772|528579973|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
146768875|NCT04707313|529321791|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146768876|NCT04707313|529321792|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146564496|NCT02410772|528579974|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
146564497|NCT02410772|528579975|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
146564498|NCT05067335|528579980|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
146564499|NCT05067335|528579981|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
146564500|NCT05067335|528579982|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
146564501|NCT05067335|528579983|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
146564502|NCT05067335|528579980|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
146564503|NCT05067335|528579981|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
146564504|NCT05067335|528579982|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
146564505|NCT05067335|528579983|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
146564506|NCT05067335|528579980|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
146564507|NCT05067335|528579981|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
146564508|NCT05067335|528579982|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
146643430|NCT02527200|528872166|FG002|Overall Study|Withdrawal by Subject|1|||
146768877|NCT04707313|529321793|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146564509|NCT05067335|528579983|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
146768878|NCT04707313|529321794|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146911884|NCT02100657|529841364|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
146911885|NCT02100657|529841362|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
146911886|NCT02100657|529841363|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
146911887|NCT02100657|529841364|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
146911888|NCT02100657|529841362|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
146911889|NCT02100657|529841363|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
146911890|NCT02100657|529841364|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
146911891|NCT02100657|529841362|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
146911892|NCT02100657|529841363|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
146911893|NCT02100657|529841364|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
146911894|NCT02100657|529841362|FG000|Cohort 3: Dose Level 3|Death|0|||
146911895|NCT02100657|529841363|FG001|Cohort 3: Dose Level 3|Death|0|||
146911896|NCT02100657|529841364|FG002|Cohort 3: Dose Level 3|Death|1|||
146911897|NCT02100657|529841362|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
146643431|NCT02527200|528872167|FG003|Overall Study|Withdrawal by Subject|0|||
146643432|NCT02527200|528872164|FG000|Overall Study|Unclassified|0|||
146643433|NCT02527200|528872165|FG001|Overall Study|Unclassified|1|||
146643434|NCT02527200|528872166|FG002|Overall Study|Unclassified|0|||
146643435|NCT02527200|528872167|FG003|Overall Study|Unclassified|0|||
146643436|NCT02527200|528872164|FG000|Overall Study|Lost to Follow-up|0|||
146643437|NCT02527200|528872165|FG001|Overall Study|Lost to Follow-up|0|||
146643438|NCT02527200|528872166|FG002|Overall Study|Lost to Follow-up|1|||
146643439|NCT02527200|528872167|FG003|Overall Study|Lost to Follow-up|0|||
146643440|NCT00966875|528872169|FG000|Part A|Adverse Event|2|||
146643441|NCT00966875|528872170|FG001|Part A|Adverse Event|1|||
146643442|NCT00966875|528872171|FG002|Part A|Adverse Event|0|||
146643443|NCT00966875|528872172|FG003|Part A|Adverse Event|1|||
146643444|NCT00966875|528872173|FG004|Part A|Adverse Event|0|||
146643445|NCT00966875|528872174|FG005|Part A|Adverse Event|1|||
146643446|NCT00966875|528872175|FG006|Part A|Adverse Event|0|||
146643447|NCT00966875|528872176|FG007|Part A|Adverse Event|3|||
146643448|NCT00966875|528872177|FG008|Part A|Adverse Event|3|||
146768879|NCT04707313|529321795|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146768880|NCT04707313|529321796|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146643449|NCT00966875|528872169|FG000|Part A|Entry Criteria|0|||
146643450|NCT00966875|528872170|FG001|Part A|Entry Criteria|0|||
146643451|NCT00966875|528872171|FG002|Part A|Entry Criteria|0|||
146643452|NCT00966875|528872172|FG003|Part A|Entry Criteria|0|||
146643453|NCT00966875|528872173|FG004|Part A|Entry Criteria|0|||
146564510|NCT05067335|528579980|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
146564511|NCT05067335|528579981|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
146564512|NCT05067335|528579982|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
146643454|NCT00966875|528872174|FG005|Part A|Entry Criteria|2|||
146911898|NCT02100657|529841363|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
146911899|NCT02100657|529841364|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
146911900|NCT02100657|529841362|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
146911901|NCT02100657|529841363|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
146911902|NCT02100657|529841364|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
146911903|NCT02100657|529841362|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
146911904|NCT02100657|529841363|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
146911905|NCT02100657|529841364|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
146911906|NCT02100657|529841362|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
146911907|NCT02100657|529841363|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
146911908|NCT02100657|529841364|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
146911909|NCT02100657|529841362|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
146911910|NCT02100657|529841363|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
146911911|NCT02100657|529841364|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
146911912|NCT02531035|529841365|FG000|Overall Study|Death|0|||
146911913|NCT02531035|529841366|FG001|Overall Study|Death|1|||
146911914|NCT02531035|529841365|FG000|Overall Study|Protocol Violation|1|||
146911915|NCT02531035|529841366|FG001|Overall Study|Protocol Violation|1|||
146911916|NCT02531035|529841365|FG000|Overall Study|Noncompliance with study drug|8|||
146564513|NCT05067335|528579983|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
146564514|NCT05067335|528579980|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
146564515|NCT05067335|528579981|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
146564516|NCT05067335|528579982|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
146564517|NCT05067335|528579983|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
146564518|NCT05067335|528579980|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
146564519|NCT05067335|528579981|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
146564520|NCT05067335|528579982|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
146564521|NCT05067335|528579983|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
146564522|NCT05067335|528579980|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
146564523|NCT05067335|528579981|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
146564524|NCT05067335|528579982|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
146564525|NCT05067335|528579983|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
146564526|NCT05067335|528579980|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
146564527|NCT05067335|528579981|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
146564528|NCT05067335|528579982|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
146564529|NCT05067335|528579983|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
146564530|NCT05067335|528579980|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
146564531|NCT05067335|528579981|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
146564532|NCT05067335|528579982|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
146564533|NCT05067335|528579983|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
146564534|NCT05067335|528579980|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
146568920|NCT00940602|528595502|FG001|Overall Study|Administrative problems|1|||
146911917|NCT02531035|529841366|FG001|Overall Study|Noncompliance with study drug|3|||
146911918|NCT02531035|529841365|FG000|Overall Study|Physician Decision|1|||
146911919|NCT02531035|529841366|FG001|Overall Study|Physician Decision|0|||
146911920|NCT02531035|529841365|FG000|Overall Study|Adverse Event|16|||
146911921|NCT02531035|529841366|FG001|Overall Study|Adverse Event|45|||
146911922|NCT02531035|529841365|FG000|Overall Study|Other|3|||
146911923|NCT02531035|529841366|FG001|Overall Study|Other|2|||
146911924|NCT02531035|529841365|FG000|Overall Study|Withdrawal by Subject|42|||
146911925|NCT02531035|529841366|FG001|Overall Study|Withdrawal by Subject|32|||
146911926|NCT02531035|529841365|FG000|Overall Study|Lost to Follow-up|8|||
146911927|NCT02531035|529841366|FG001|Overall Study|Lost to Follow-up|10|||
146911928|NCT02531035|529841365|FG000|Overall Study|Randomized, not treated|2|||
146911929|NCT02531035|529841366|FG001|Overall Study|Randomized, not treated|1|||
146911930|NCT01543490|529841369|FG000|Overall Study|Adverse Event|4|||
146911931|NCT01543490|529841370|FG001|Overall Study|Adverse Event|0|||
146911932|NCT01543490|529841369|FG000|Overall Study|Physician Decision|1|||
146911933|NCT01543490|529841370|FG001|Overall Study|Physician Decision|0|||
146911934|NCT01543490|529841369|FG000|Overall Study|Lack of Efficacy|3|||
146911935|NCT01543490|529841370|FG001|Overall Study|Lack of Efficacy|3|||
146911936|NCT01543490|529841369|FG000|Overall Study|Lost to Follow-up|5|||
146911937|NCT01543490|529841370|FG001|Overall Study|Lost to Follow-up|0|||
146911938|NCT01543490|529841369|FG000|Overall Study|Withdrawal by Subject|2|||
146911939|NCT01543490|529841370|FG001|Overall Study|Withdrawal by Subject|0|||
146911940|NCT01543490|529841369|FG000|Overall Study|Other-Various Administrative Reasons|1|||
146911941|NCT01543490|529841370|FG001|Overall Study|Other-Various Administrative Reasons|2|||
146911942|NCT04168645|529841376|FG000|Overall Study|Lost to Follow-up|23|||
146911943|NCT04168645|529841377|FG001|Overall Study|Lost to Follow-up|28|||
146911944|NCT04168645|529841378|FG002|Overall Study|Lost to Follow-up|15|||
146911945|NCT04168645|529841379|FG003|Overall Study|Lost to Follow-up|12|||
146911946|NCT04168645|529841376|FG000|Overall Study|Death|1|||
146911947|NCT04168645|529841377|FG001|Overall Study|Death|1|||
146911948|NCT04168645|529841378|FG002|Overall Study|Death|0|||
146911949|NCT04168645|529841379|FG003|Overall Study|Death|0|||
146911950|NCT04168645|529841376|FG000|Overall Study|Withdrawal by Subject|5|||
146911951|NCT04168645|529841377|FG001|Overall Study|Withdrawal by Subject|2|||
146911952|NCT04168645|529841378|FG002|Overall Study|Withdrawal by Subject|2|||
146911953|NCT04168645|529841379|FG003|Overall Study|Withdrawal by Subject|2|||
146911954|NCT04168645|529841376|FG000|Overall Study|Administrative Withdrawal|3|||
146911955|NCT04168645|529841377|FG001|Overall Study|Administrative Withdrawal|1|||
146911956|NCT04168645|529841378|FG002|Overall Study|Administrative Withdrawal|1|||
146911957|NCT04168645|529841379|FG003|Overall Study|Administrative Withdrawal|3|||
146911958|NCT02400346|529841380|FG000|Overall Study|Adverse Event|24|||
146911959|NCT02400346|529841380|FG000|Overall Study|Lack of Efficacy|9|||
146911960|NCT02400346|529841380|FG000|Overall Study|Non-compliance with IMP|1|||
146911961|NCT02400346|529841380|FG000|Overall Study|Withdrawal by Subject|7|||
146643455|NCT00966875|528872175|FG006|Part A|Entry Criteria|0|||
146643456|NCT00966875|528872176|FG007|Part A|Entry Criteria|0|||
146643457|NCT00966875|528872177|FG008|Part A|Entry Criteria|0|||
146643458|NCT00966875|528872169|FG000|Part A|Lack of Efficacy|0|||
146911962|NCT02400346|529841380|FG000|Overall Study|Administrative or other reason(s)|2|||
146911963|NCT02400346|529841380|FG000|Overall Study|Lost to Follow-up|1|||
146564535|NCT05067335|528579981|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
146564536|NCT05067335|528579982|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
146564537|NCT05067335|528579983|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
146564538|NCT02724839|528579984|FG000|Overall Study|Withdrawal by Subject|1|||
146768881|NCT04707313|529321797|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146768882|NCT04707313|529321798|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146768883|NCT04707313|529321799|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146564539|NCT02724839|528579985|FG001|Overall Study|Withdrawal by Subject|1|||
146564540|NCT02724839|528579986|FG002|Overall Study|Withdrawal by Subject|0|||
146564541|NCT02724839|528579984|FG000|Overall Study|Lost to Follow-up|0|||
146564542|NCT02724839|528579985|FG001|Overall Study|Lost to Follow-up|3|||
146564543|NCT02724839|528579986|FG002|Overall Study|Lost to Follow-up|2|||
146564544|NCT02724839|528579984|FG000|Overall Study|Physician Decision|0|||
146564545|NCT02724839|528579985|FG001|Overall Study|Physician Decision|0|||
146564546|NCT02724839|528579986|FG002|Overall Study|Physician Decision|3|||
146564547|NCT01645176|528579988|FG000|Overall Study|Lack of Efficacy|4|||
146564548|NCT01645176|528579988|FG000|Overall Study|did not complete final MRI|1|||
146564549|NCT05878067|528579989|FG000|Overall Study|Lost to Follow-up|2|||
146564550|NCT00949533|528579992|FG000|Overall Study|Lost to Follow-up|0|||
146564551|NCT00949533|528579993|FG001|Overall Study|Lost to Follow-up|1|||
146564552|NCT01198587|528579996|FG000|Overall Study|Lost to Follow-up|8|||
146564553|NCT01198587|528579997|FG001|Overall Study|Lost to Follow-up|0|||
146564554|NCT01198587|528579998|FG002|Overall Study|Lost to Follow-up|9|||
146911964|NCT00500149|529841381|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
146911965|NCT00500149|529841382|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
146911966|NCT00500149|529841381|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
146911967|NCT00500149|529841382|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
146911968|NCT00500149|529841381|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
146911969|NCT00500149|529841382|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
146911970|NCT00500149|529841381|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
146911971|NCT00500149|529841382|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
146911972|NCT00500149|529841381|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
146911973|NCT00500149|529841382|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
146643459|NCT00966875|528872170|FG001|Part A|Lack of Efficacy|1|||
146643460|NCT00966875|528872171|FG002|Part A|Lack of Efficacy|0|||
146643461|NCT00966875|528872172|FG003|Part A|Lack of Efficacy|0|||
146643462|NCT00966875|528872173|FG004|Part A|Lack of Efficacy|0|||
146643463|NCT00966875|528872174|FG005|Part A|Lack of Efficacy|0|||
146643464|NCT00966875|528872175|FG006|Part A|Lack of Efficacy|4|||
146643465|NCT00966875|528872176|FG007|Part A|Lack of Efficacy|0|||
146971551|NCT01283282|530056337|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
146971552|NCT01283282|530056336|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
146971553|NCT01283282|530056337|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
146971554|NCT00083226|530056338|FG000|Overall Study|Lack of Efficacy|19|||
146971555|NCT00083226|530056338|FG000|Overall Study|Adverse Event|9|||
146971556|NCT00083226|530056338|FG000|Overall Study|Death|4|||
146971557|NCT00083226|530056338|FG000|Overall Study|Withdrawal by Subject|4|||
146971558|NCT00083226|530056338|FG000|Overall Study|Other|2|||
146971559|NCT00083226|530056338|FG000|Overall Study|ineligible or not receiving treatment|4|||
146971560|NCT00909857|530056339|FG000|Overall Study|Withdrawal by Subject|6|||
146971561|NCT00909857|530056340|FG001|Overall Study|Withdrawal by Subject|10|||
146971562|NCT00909857|530056339|FG000|Overall Study|Adverse Event|5|||
146971563|NCT00909857|530056340|FG001|Overall Study|Adverse Event|5|||
146971564|NCT00909857|530056339|FG000|Overall Study|Lost to Follow-up|2|||
146971565|NCT00909857|530056340|FG001|Overall Study|Lost to Follow-up|5|||
146971566|NCT00909857|530056339|FG000|Overall Study|Protocol Violation|2|||
146971567|NCT00909857|530056340|FG001|Overall Study|Protocol Violation|1|||
146971568|NCT00909857|530056339|FG000|Overall Study|Pregnancy|1|||
146971569|NCT00909857|530056340|FG001|Overall Study|Pregnancy|0|||
146971570|NCT00909857|530056339|FG000|Overall Study|Other|1|||
146971571|NCT00909857|530056340|FG001|Overall Study|Other|0|||
146971572|NCT00909857|530056339|FG000|Overall Study|Did not receive study medication|19|||
146971573|NCT00909857|530056340|FG001|Overall Study|Did not receive study medication|24|||
146971574|NCT01682681|530056341|FG000|Overall Study|Lack of Efficacy|62|||
146971575|NCT01682681|530056341|FG000|Overall Study|Withdrawal by Subject|1|||
146971576|NCT01682681|530056341|FG000|Overall Study|Moved to other hospital|10|||
146971577|NCT01682681|530056341|FG000|Overall Study|Lost to Follow-up|174|||
146971578|NCT01682681|530056341|FG000|Overall Study|Adverse Event|46|||
146971579|NCT01682681|530056341|FG000|Overall Study|tapering of topiramate|5|||
146971580|NCT01682681|530056341|FG000|Overall Study|Other|21|||
146971581|NCT01682681|530056341|FG000|Overall Study|Low compliance|13|||
146971582|NCT00975000|530056344|FG000|Overall Study|Other|1|||
146971583|NCT00975000|530056345|FG001|Overall Study|Other|0|||
146971584|NCT00975000|530056344|FG000|Overall Study|Adverse Event|1|||
146971585|NCT00975000|530056345|FG001|Overall Study|Adverse Event|1|||
146971586|NCT00975000|530056344|FG000|Overall Study|Withdrawal by Subject|2|||
146971587|NCT00975000|530056345|FG001|Overall Study|Withdrawal by Subject|2|||
146971588|NCT00975000|530056344|FG000|Overall Study|Lost to Follow-up|0|||
146971589|NCT00975000|530056345|FG001|Overall Study|Lost to Follow-up|1|||
146971590|NCT00975000|530056344|FG000|Overall Study|Protocol-specified Criteria|1|||
146971591|NCT00975000|530056345|FG001|Overall Study|Protocol-specified Criteria|0|||
146971592|NCT00975000|530056344|FG000|Overall Study|Non-compliance|0|||
146971593|NCT00975000|530056345|FG001|Overall Study|Non-compliance|1|||
146971594|NCT01652573|530057167|FG000|Overall Study|Adverse Event|0|||
146971595|NCT01652573|530057168|FG001|Overall Study|Adverse Event|1|||
146971596|NCT01052038|530057172|FG000|Overall Study|Lost to Follow-up|2|||
146971597|NCT01052038|530057173|FG001|Overall Study|Lost to Follow-up|3|||
146971598|NCT01052038|530057174|FG002|Overall Study|Lost to Follow-up|1|||
146971599|NCT01052038|530057172|FG000|Overall Study|Protocol Violation|2|||
146971600|NCT01052038|530057173|FG001|Overall Study|Protocol Violation|3|||
146971601|NCT01052038|530057174|FG002|Overall Study|Protocol Violation|3|||
146971602|NCT03976076|530057175|FG000|Overall Study|Withdrawal by Subject|2|||
146971603|NCT00602641|530057177|FG000|Overall Study|Never started protocol therapy|6|||
146971604|NCT00602641|530057178|FG001|Overall Study|Never started protocol therapy|2|||
146971605|NCT00602641|530057177|FG000|Overall Study|Still on treatment at time of analysis|8|||
146971606|NCT00602641|530057178|FG001|Overall Study|Still on treatment at time of analysis|15|||
146971607|NCT00602641|530057177|FG000|Overall Study|Adverse Event|62|||
146971608|NCT00602641|530057178|FG001|Overall Study|Adverse Event|53|||
146971609|NCT00602641|530057177|FG000|Overall Study|Disease progression|38|||
146971610|NCT00602641|530057178|FG001|Overall Study|Disease progression|55|||
146971611|NCT00602641|530057177|FG000|Overall Study|Death|6|||
146971612|NCT00602641|530057178|FG001|Overall Study|Death|5|||
146971613|NCT00602641|530057177|FG000|Overall Study|Withdrawal by Subject|15|||
146643466|NCT00966875|528872177|FG008|Part A|Lack of Efficacy|0|||
146643467|NCT00966875|528872169|FG000|Part A|Lost to Follow-up|2|||
146971614|NCT00602641|530057178|FG001|Overall Study|Withdrawal by Subject|12|||
146971615|NCT00602641|530057177|FG000|Overall Study|Alternative therapy|5|||
146971616|NCT00602641|530057178|FG001|Overall Study|Alternative therapy|2|||
146643468|NCT00966875|528872170|FG001|Part A|Lost to Follow-up|0|||
146971617|NCT00602641|530057177|FG000|Overall Study|Other Complicating Disease|5|||
146971618|NCT00602641|530057178|FG001|Overall Study|Other Complicating Disease|2|||
146971619|NCT00602641|530057177|FG000|Overall Study|Physician Decision|5|||
146971620|NCT00602641|530057178|FG001|Overall Study|Physician Decision|4|||
146971621|NCT00602641|530057177|FG000|Overall Study|Administrative Closure|1|||
146971622|NCT00602641|530057178|FG001|Overall Study|Administrative Closure|1|||
146971623|NCT00602641|530057177|FG000|Overall Study|Other|3|||
146971624|NCT00602641|530057178|FG001|Overall Study|Other|1|||
146971625|NCT03901352|530057180|FG000|Double-blind Phase|Adverse Event|6|||
146971626|NCT03901352|530057181|FG001|Double-blind Phase|Adverse Event|4|||
146971627|NCT03901352|530057180|FG000|Double-blind Phase|Death|1|||
146971628|NCT03901352|530057181|FG001|Double-blind Phase|Death|0|||
146971629|NCT03901352|530057180|FG000|Double-blind Phase|Lack of Efficacy|0|||
146971630|NCT03901352|530057181|FG001|Double-blind Phase|Lack of Efficacy|1|||
146971631|NCT03901352|530057180|FG000|Double-blind Phase|Protocol Violation|0|||
146971632|NCT03901352|530057181|FG001|Double-blind Phase|Protocol Violation|1|||
146971633|NCT03901352|530057180|FG000|Double-blind Phase|Withdrawal by Subject|10|||
146971634|NCT03901352|530057181|FG001|Double-blind Phase|Withdrawal by Subject|8|||
146971635|NCT03901352|530057180|FG000|Open-label Extension Phase|Adverse Event|24|||
146971636|NCT03901352|530057181|FG001|Open-label Extension Phase|Adverse Event|0|||
146971637|NCT03901352|530057180|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
146564555|NCT01198587|528579999|FG003|Overall Study|Lost to Follow-up|0|||
146564556|NCT01493089|528580000|FG000|Overall Study|Protocol Violation|2|||
146564557|NCT01493089|528580001|FG001|Overall Study|Protocol Violation|2|||
146564558|NCT01493089|528580000|FG000|Overall Study|Withdrawal by Subject|1|||
146564559|NCT01493089|528580001|FG001|Overall Study|Withdrawal by Subject|0|||
146564560|NCT01493089|528580000|FG000|Overall Study|Physician Decision|0|||
146564561|NCT01493089|528580001|FG001|Overall Study|Physician Decision|1|||
146564562|NCT01959529|528580002|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
146564563|NCT01959529|528580003|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
146564564|NCT01959529|528580002|FG000|Overall Study|Lost to Follow-up|4|||
146564565|NCT01959529|528580003|FG001|Overall Study|Lost to Follow-up|1|||
146971638|NCT03901352|530057181|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
146971639|NCT03901352|530057180|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
146971640|NCT03901352|530057181|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
146971641|NCT03901352|530057180|FG000|Open-label Extension Phase|Other|1|||
146971642|NCT03901352|530057181|FG001|Open-label Extension Phase|Other|0|||
146971643|NCT01615822|530057184|FG000|Period 1|Withdrawal by Subject|0|||
146971644|NCT01615822|530057185|FG001|Period 1|Withdrawal by Subject|1|||
146971645|NCT01615822|530057186|FG002|Period 1|Withdrawal by Subject|0|||
146971646|NCT01615822|530057184|FG000|Period 1|Adverse Event|1|||
146971647|NCT01615822|530057185|FG001|Period 1|Adverse Event|1|||
146971648|NCT01615822|530057186|FG002|Period 1|Adverse Event|0|||
146971649|NCT01615822|530057184|FG000|Period 2|Lost to Follow-up|0|||
146971650|NCT01615822|530057185|FG001|Period 2|Lost to Follow-up|1|||
146971651|NCT01615822|530057186|FG002|Period 2|Lost to Follow-up|2|||
146494823|NCT02186873|528315994|FG000|Overall Study|Adverse Event|1|||
146494824|NCT02186873|528315995|FG001|Overall Study|Adverse Event|3|||
146494825|NCT02186873|528315994|FG000|Overall Study|Lack of Efficacy|0|||
146971652|NCT03901339|530057187|FG000|Overall Study|Death|220|||
146971653|NCT03901339|530057188|FG001|Overall Study|Death|192|||
146971654|NCT03901339|530057187|FG000|Overall Study|Informed consent withdrawn|13|||
146971655|NCT03901339|530057188|FG001|Overall Study|Informed consent withdrawn|40|||
146971656|NCT03901339|530057187|FG000|Overall Study|Sponsor request|30|||
146971657|NCT03901339|530057188|FG001|Overall Study|Sponsor request|23|||
146971658|NCT03901339|530057187|FG000|Overall Study|Reason not specified|5|||
146971659|NCT03901339|530057188|FG001|Overall Study|Reason not specified|7|||
146971660|NCT03901339|530057187|FG000|Overall Study|Lost to Follow-up|4|||
146971661|NCT03901339|530057188|FG001|Overall Study|Lost to Follow-up|7|||
146971662|NCT03901339|530057187|FG000|Overall Study|Covid19|0|||
146971663|NCT03901339|530057188|FG001|Overall Study|Covid19|2|||
146971664|NCT03981614|530057189|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
146971665|NCT03981614|530057190|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
146971666|NCT03981614|530057191|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
146971667|NCT04971226|530057194|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
146971668|NCT04971226|530057195|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
146971669|NCT04971226|530057196|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
146971670|NCT04971226|530057197|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
146971671|NCT04971226|530057194|FG000|Overall Study|Adverse Event|6|||
146971672|NCT04971226|530057195|FG001|Overall Study|Adverse Event|5|||
146494826|NCT02186873|528315995|FG001|Overall Study|Lack of Efficacy|1|||
146494827|NCT02186873|528315994|FG000|Overall Study|Lost to Follow-up|1|||
146494828|NCT02186873|528315995|FG001|Overall Study|Lost to Follow-up|2|||
146971673|NCT04971226|530057196|FG002|Overall Study|Adverse Event|11|||
146971674|NCT04971226|530057197|FG003|Overall Study|Adverse Event|10|||
146971675|NCT04971226|530057194|FG000|Overall Study|Progressive disease|2|||
146971676|NCT04971226|530057195|FG001|Overall Study|Progressive disease|0|||
146971677|NCT04971226|530057196|FG002|Overall Study|Progressive disease|3|||
146971678|NCT04971226|530057197|FG003|Overall Study|Progressive disease|1|||
146971679|NCT04971226|530057194|FG000|Overall Study|Protocol Deviation|1|||
146971680|NCT04971226|530057195|FG001|Overall Study|Protocol Deviation|0|||
146971681|NCT04971226|530057196|FG002|Overall Study|Protocol Deviation|1|||
146971682|NCT04971226|530057197|FG003|Overall Study|Protocol Deviation|1|||
146971683|NCT04971226|530057194|FG000|Overall Study|Subject Decision|0|||
146971684|NCT04971226|530057195|FG001|Overall Study|Subject Decision|1|||
146494829|NCT02186873|528315994|FG000|Overall Study|Withdrawal by Subject|7|||
146494830|NCT02186873|528315995|FG001|Overall Study|Withdrawal by Subject|2|||
146494831|NCT00347958|528315996|FG000|Overall Study|Adverse Event|1|||
146494832|NCT00347958|528315996|FG000|Overall Study|Protocol Violation|2|||
146494833|NCT00347958|528315996|FG000|Overall Study|Withdrawal by Subject|1|||
146494834|NCT01623310|528316001|FG000|Overall Study|Adverse Event|21|||
146494835|NCT01623310|528316001|FG000|Overall Study|Lost to Follow-up|18|||
146494836|NCT01623310|528316001|FG000|Overall Study|Lack of Efficacy|6|||
146494837|NCT01623310|528316001|FG000|Overall Study|Protocol Violation|6|||
146494838|NCT01623310|528316001|FG000|Overall Study|Withdrawal by Subject|25|||
146494839|NCT01623310|528316001|FG000|Overall Study|Became potentially child-bearing|1|||
146494840|NCT01623310|528316001|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
146494841|NCT01623310|528316001|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
146494842|NCT00356603|528316002|FG000|Overall Study|Other|6|||
146494843|NCT00356603|528316003|FG001|Overall Study|Other|3|||
146494844|NCT00734162|528316005|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
146494845|NCT00734162|528316006|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
146494846|NCT00734162|528316007|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
146494847|NCT00734162|528316008|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
146494848|NCT00734162|528316005|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
146494849|NCT00734162|528316006|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
146494850|NCT00734162|528316007|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
146494851|NCT00734162|528316008|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
146494852|NCT00734162|528316005|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
146494853|NCT00734162|528316006|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
146494854|NCT00734162|528316007|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
146494855|NCT00734162|528316008|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
146494856|NCT00734162|528316005|FG000|Open-Label Phase|Withdrew Consent|1|||
146494857|NCT00734162|528316006|FG001|Open-Label Phase|Withdrew Consent|0|||
146494858|NCT00734162|528316007|FG002|Open-Label Phase|Withdrew Consent|1|||
146494859|NCT00734162|528316008|FG003|Open-Label Phase|Withdrew Consent|1|||
146494860|NCT00734162|528316005|FG000|Open-Label Phase|Lost to Follow-up|1|||
146494861|NCT00734162|528316006|FG001|Open-Label Phase|Lost to Follow-up|2|||
146494862|NCT00734162|528316007|FG002|Open-Label Phase|Lost to Follow-up|0|||
146494863|NCT00734162|528316008|FG003|Open-Label Phase|Lost to Follow-up|1|||
146494864|NCT00734162|528316005|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
146494865|NCT00734162|528316006|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
146494866|NCT00734162|528316007|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
146494867|NCT00734162|528316008|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
146494868|NCT00566020|528316009|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
146494869|NCT00566020|528316010|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
146494870|NCT00566020|528316009|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
146494871|NCT00566020|528316010|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
146494872|NCT00566020|528316009|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
146494873|NCT00566020|528316010|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
146494874|NCT00566020|528316009|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
146494875|NCT00566020|528316010|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
146494876|NCT00566020|528316009|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
146494877|NCT00566020|528316010|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
146494878|NCT00566020|528316009|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
146494879|NCT00566020|528316010|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
146494880|NCT00932373|528316011|FG000|Overall Study|Progressive disease|3|||
146494881|NCT00932373|528316012|FG001|Overall Study|Progressive disease|1|||
146494882|NCT00932373|528316013|FG002|Overall Study|Progressive disease|0|||
146494883|NCT00932373|528316014|FG003|Overall Study|Progressive disease|0|||
146494884|NCT00932373|528316015|FG004|Overall Study|Progressive disease|10|||
146494885|NCT00932373|528316016|FG005|Overall Study|Progressive disease|1|||
146494886|NCT00932373|528316017|FG006|Overall Study|Progressive disease|0|||
146494887|NCT00932373|528316018|FG007|Overall Study|Progressive disease|2|||
146494888|NCT00932373|528316019|FG008|Overall Study|Progressive disease|1|||
146494889|NCT00932373|528316020|FG009|Overall Study|Progressive disease|9|||
146494890|NCT00932373|528316021|FG010|Overall Study|Progressive disease|2|||
146494891|NCT00932373|528316011|FG000|Overall Study|Adverse Event|0|||
146494892|NCT00932373|528316012|FG001|Overall Study|Adverse Event|0|||
146494893|NCT00932373|528316013|FG002|Overall Study|Adverse Event|0|||
146494894|NCT00932373|528316014|FG003|Overall Study|Adverse Event|0|||
146494895|NCT00932373|528316015|FG004|Overall Study|Adverse Event|2|||
146494896|NCT00932373|528316016|FG005|Overall Study|Adverse Event|1|||
146494897|NCT00932373|528316017|FG006|Overall Study|Adverse Event|0|||
146494898|NCT00932373|528316018|FG007|Overall Study|Adverse Event|1|||
146494899|NCT00932373|528316019|FG008|Overall Study|Adverse Event|0|||
146494900|NCT00932373|528316020|FG009|Overall Study|Adverse Event|2|||
146494901|NCT00932373|528316021|FG010|Overall Study|Adverse Event|1|||
146494902|NCT00932373|528316011|FG000|Overall Study|Physician Decision|0|||
146494903|NCT00932373|528316012|FG001|Overall Study|Physician Decision|0|||
146494904|NCT00932373|528316013|FG002|Overall Study|Physician Decision|1|||
146494905|NCT00932373|528316014|FG003|Overall Study|Physician Decision|0|||
146564566|NCT01959529|528580002|FG000|Overall Study|Other|70|||
146564567|NCT01959529|528580003|FG001|Overall Study|Other|68|||
146564568|NCT01959529|528580002|FG000|Overall Study|Hypoglycaemia|1|||
146494906|NCT00932373|528316015|FG004|Overall Study|Physician Decision|2|||
146494907|NCT00932373|528316016|FG005|Overall Study|Physician Decision|0|||
146494908|NCT00932373|528316017|FG006|Overall Study|Physician Decision|0|||
146494909|NCT00932373|528316018|FG007|Overall Study|Physician Decision|0|||
146494910|NCT00932373|528316019|FG008|Overall Study|Physician Decision|0|||
146768884|NCT04707313|529321800|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146494911|NCT00932373|528316020|FG009|Overall Study|Physician Decision|1|||
146494912|NCT00932373|528316021|FG010|Overall Study|Physician Decision|0|||
146494913|NCT00932373|528316011|FG000|Overall Study|Dose limiting toxicity|0|||
146494914|NCT00932373|528316012|FG001|Overall Study|Dose limiting toxicity|0|||
146643469|NCT00966875|528872171|FG002|Part A|Lost to Follow-up|0|||
146643470|NCT00966875|528872172|FG003|Part A|Lost to Follow-up|0|||
146643471|NCT00966875|528872173|FG004|Part A|Lost to Follow-up|0|||
146494915|NCT00932373|528316013|FG002|Overall Study|Dose limiting toxicity|0|||
146494916|NCT00932373|528316014|FG003|Overall Study|Dose limiting toxicity|0|||
146494917|NCT00932373|528316015|FG004|Overall Study|Dose limiting toxicity|0|||
146494918|NCT00932373|528316016|FG005|Overall Study|Dose limiting toxicity|1|||
146494919|NCT00932373|528316017|FG006|Overall Study|Dose limiting toxicity|0|||
146494920|NCT00932373|528316018|FG007|Overall Study|Dose limiting toxicity|0|||
146494921|NCT00932373|528316019|FG008|Overall Study|Dose limiting toxicity|0|||
146494922|NCT00932373|528316020|FG009|Overall Study|Dose limiting toxicity|0|||
146494923|NCT00932373|528316021|FG010|Overall Study|Dose limiting toxicity|0|||
146494924|NCT00932373|528316011|FG000|Overall Study|Withdrawal by Subject|0|||
146494925|NCT00932373|528316012|FG001|Overall Study|Withdrawal by Subject|0|||
146494926|NCT00932373|528316013|FG002|Overall Study|Withdrawal by Subject|0|||
146494927|NCT00932373|528316014|FG003|Overall Study|Withdrawal by Subject|0|||
146494928|NCT00932373|528316015|FG004|Overall Study|Withdrawal by Subject|0|||
146494929|NCT00932373|528316016|FG005|Overall Study|Withdrawal by Subject|0|||
146494930|NCT00932373|528316017|FG006|Overall Study|Withdrawal by Subject|0|||
146494931|NCT00932373|528316018|FG007|Overall Study|Withdrawal by Subject|0|||
146494932|NCT00932373|528316019|FG008|Overall Study|Withdrawal by Subject|1|||
146494933|NCT00932373|528316020|FG009|Overall Study|Withdrawal by Subject|0|||
146494934|NCT00932373|528316021|FG010|Overall Study|Withdrawal by Subject|0|||
146494935|NCT00932373|528316011|FG000|Overall Study|Clinical progression|0|||
146494936|NCT00932373|528316012|FG001|Overall Study|Clinical progression|0|||
146494937|NCT00932373|528316013|FG002|Overall Study|Clinical progression|0|||
146494938|NCT00932373|528316014|FG003|Overall Study|Clinical progression|0|||
146494939|NCT00932373|528316015|FG004|Overall Study|Clinical progression|0|||
146494940|NCT00932373|528316016|FG005|Overall Study|Clinical progression|0|||
146494941|NCT00932373|528316017|FG006|Overall Study|Clinical progression|1|||
146494942|NCT00932373|528316018|FG007|Overall Study|Clinical progression|0|||
146494943|NCT00932373|528316019|FG008|Overall Study|Clinical progression|0|||
146494944|NCT00932373|528316020|FG009|Overall Study|Clinical progression|0|||
146494945|NCT00932373|528316021|FG010|Overall Study|Clinical progression|0|||
146494946|NCT00932373|528316011|FG000|Overall Study|Lack of Efficacy|0|||
146494947|NCT00932373|528316012|FG001|Overall Study|Lack of Efficacy|0|||
146494948|NCT00932373|528316013|FG002|Overall Study|Lack of Efficacy|0|||
146494949|NCT00932373|528316014|FG003|Overall Study|Lack of Efficacy|0|||
146494950|NCT00932373|528316015|FG004|Overall Study|Lack of Efficacy|0|||
146494951|NCT00932373|528316016|FG005|Overall Study|Lack of Efficacy|0|||
146494952|NCT00932373|528316017|FG006|Overall Study|Lack of Efficacy|0|||
146494953|NCT00932373|528316018|FG007|Overall Study|Lack of Efficacy|0|||
146494954|NCT00932373|528316019|FG008|Overall Study|Lack of Efficacy|0|||
146494955|NCT00932373|528316020|FG009|Overall Study|Lack of Efficacy|1|||
146494956|NCT00932373|528316021|FG010|Overall Study|Lack of Efficacy|0|||
146494957|NCT06098339|528316022|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
146494958|NCT06098339|528316023|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
146494959|NCT06098339|528316022|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
146494960|NCT06098339|528316023|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
146494961|NCT03831113|528316026|FG000|Overall Study|Withdrawal by Subject|0|||
146494962|NCT03831113|528316027|FG001|Overall Study|Withdrawal by Subject|2|||
146494963|NCT03831113|528316026|FG000|Overall Study|Protocol Violation|0|||
146494964|NCT03831113|528316027|FG001|Overall Study|Protocol Violation|9|||
146643472|NCT00966875|528872174|FG005|Part A|Lost to Follow-up|1|||
146643473|NCT00966875|528872175|FG006|Part A|Lost to Follow-up|0|||
146971685|NCT04971226|530057196|FG002|Overall Study|Subject Decision|1|||
146643474|NCT00966875|528872176|FG007|Part A|Lost to Follow-up|0|||
146643475|NCT00966875|528872177|FG008|Part A|Lost to Follow-up|0|||
146643476|NCT00966875|528872169|FG000|Part A|Parent/Caregiver Decision|0|||
146643477|NCT00966875|528872170|FG001|Part A|Parent/Caregiver Decision|0|||
146643478|NCT00966875|528872171|FG002|Part A|Parent/Caregiver Decision|0|||
146643479|NCT00966875|528872172|FG003|Part A|Parent/Caregiver Decision|1|||
146643480|NCT00966875|528872173|FG004|Part A|Parent/Caregiver Decision|0|||
146643481|NCT00966875|528872174|FG005|Part A|Parent/Caregiver Decision|0|||
146643482|NCT00966875|528872175|FG006|Part A|Parent/Caregiver Decision|0|||
146495028|NCT03981900|528316043|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
146495029|NCT03981900|528316043|FG000|Overall Study|Adverse Event|5|||
146495030|NCT03981900|528316043|FG000|Overall Study|Protocol Violation|1|||
146495031|NCT03981900|528316043|FG000|Overall Study|Withdrawal by Subject|7|||
146495032|NCT03981900|528316043|FG000|Overall Study|Lost to Follow-up|46|||
146495033|NCT03981900|528316043|FG000|Overall Study|Decision of the researcher|3|||
146495034|NCT03981900|528316043|FG000|Overall Study|Death|3|||
146495035|NCT03981900|528316043|FG000|Overall Study|Other|5|||
146495036|NCT06152224|528316048|FG000|Overall Study|Withdrawal by Subject|1|||
146643483|NCT00966875|528872176|FG007|Part A|Parent/Caregiver Decision|0|||
146643484|NCT00966875|528872177|FG008|Part A|Parent/Caregiver Decision|0|||
146495037|NCT06152224|528316049|FG001|Overall Study|Withdrawal by Subject|0|||
146495038|NCT06152224|528316048|FG000|Overall Study|Lost to Follow-up|0|||
146495039|NCT06152224|528316049|FG001|Overall Study|Lost to Follow-up|1|||
146495040|NCT06152224|528316048|FG000|Overall Study|On Follow Up|18|||
146495041|NCT06152224|528316049|FG001|Overall Study|On Follow Up|18|||
146495042|NCT02509507|528316052|FG000|Overall Study|Death|21|||
146643485|NCT00966875|528872169|FG000|Part A|Physician Decision|0|||
146643486|NCT00966875|528872170|FG001|Part A|Physician Decision|0|||
146495043|NCT02509507|528316053|FG001|Overall Study|Death|3|||
146495044|NCT02509507|528316054|FG002|Overall Study|Death|22|||
146643487|NCT00966875|528872171|FG002|Part A|Physician Decision|0|||
146495045|NCT02509507|528316055|FG003|Overall Study|Death|14|||
146971686|NCT04971226|530057197|FG003|Overall Study|Subject Decision|1|||
146495046|NCT02509507|528316056|FG004|Overall Study|Death|8|||
146495047|NCT02509507|528316057|FG005|Overall Study|Death|12|||
146495048|NCT02509507|528316058|FG006|Overall Study|Death|5|||
146643488|NCT00966875|528872172|FG003|Part A|Physician Decision|0|||
146643489|NCT00966875|528872173|FG004|Part A|Physician Decision|1|||
146643490|NCT00966875|528872174|FG005|Part A|Physician Decision|0|||
146495049|NCT02509507|528316059|FG007|Overall Study|Death|4|||
146495050|NCT02509507|528316060|FG008|Overall Study|Death|8|||
146495051|NCT02509507|528316052|FG000|Overall Study|Lost to Follow-up|0|||
146495052|NCT02509507|528316053|FG001|Overall Study|Lost to Follow-up|1|||
146495053|NCT02509507|528316054|FG002|Overall Study|Lost to Follow-up|0|||
146495054|NCT02509507|528316055|FG003|Overall Study|Lost to Follow-up|0|||
146495055|NCT02509507|528316056|FG004|Overall Study|Lost to Follow-up|0|||
146495056|NCT02509507|528316057|FG005|Overall Study|Lost to Follow-up|2|||
146495057|NCT02509507|528316058|FG006|Overall Study|Lost to Follow-up|0|||
146495058|NCT02509507|528316059|FG007|Overall Study|Lost to Follow-up|0|||
146495059|NCT02509507|528316060|FG008|Overall Study|Lost to Follow-up|0|||
146495060|NCT02509507|528316052|FG000|Overall Study|Withdrawal by Subject|2|||
146495061|NCT02509507|528316053|FG001|Overall Study|Withdrawal by Subject|0|||
146495062|NCT02509507|528316054|FG002|Overall Study|Withdrawal by Subject|1|||
146495063|NCT02509507|528316055|FG003|Overall Study|Withdrawal by Subject|4|||
146495064|NCT02509507|528316056|FG004|Overall Study|Withdrawal by Subject|1|||
146495065|NCT02509507|528316057|FG005|Overall Study|Withdrawal by Subject|3|||
146495066|NCT02509507|528316058|FG006|Overall Study|Withdrawal by Subject|4|||
146495067|NCT02509507|528316059|FG007|Overall Study|Withdrawal by Subject|0|||
146495068|NCT02509507|528316060|FG008|Overall Study|Withdrawal by Subject|1|||
146495069|NCT03337113|528316070|FG000|Overall Study|Adverse Event|1|||
146495070|NCT03337113|528316071|FG001|Overall Study|Adverse Event|1|||
146495071|NCT03337113|528316072|FG002|Overall Study|Adverse Event|0|||
146495072|NCT03337113|528316073|FG003|Overall Study|Adverse Event|1|||
146495073|NCT03337113|528316070|FG000|Overall Study|Physician Decision|0|||
146495074|NCT03337113|528316071|FG001|Overall Study|Physician Decision|2|||
146495075|NCT03337113|528316072|FG002|Overall Study|Physician Decision|0|||
146495076|NCT03337113|528316073|FG003|Overall Study|Physician Decision|1|||
146495077|NCT03337113|528316070|FG000|Overall Study|Withdrawal by Subject|0|||
146495078|NCT03337113|528316071|FG001|Overall Study|Withdrawal by Subject|0|||
146495079|NCT03337113|528316072|FG002|Overall Study|Withdrawal by Subject|1|||
146495080|NCT03337113|528316073|FG003|Overall Study|Withdrawal by Subject|0|||
146495081|NCT02476578|528316082|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
146495082|NCT02476578|528316083|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
146495083|NCT02476578|528316082|FG000|Overall Study|Lost to Follow-up|6|||
146495084|NCT02476578|528316083|FG001|Overall Study|Lost to Follow-up|13|||
146643491|NCT00966875|528872175|FG006|Part A|Physician Decision|1|||
146495167|NCT04015518|528316123|FG000|Overall Study|Adverse Event|6|||
146564569|NCT01959529|528580003|FG001|Overall Study|Hypoglycaemia|1|||
146564570|NCT01959529|528580002|FG000|Overall Study|Lack of glycaemic control|1|||
146564571|NCT01959529|528580003|FG001|Overall Study|Lack of glycaemic control|1|||
146564572|NCT02234362|528580004|FG000|Overall Study|Not eligible after first screening visit|17|||
146564573|NCT02234362|528580004|FG000|Overall Study|Lost to Follow-up|6|||
146564574|NCT02234362|528580004|FG000|Overall Study|Withdrawal by Subject|3|||
146564575|NCT00560417|528580012|FG000|Overall Study|Adverse Event|3|||
146564576|NCT00560417|528580013|FG001|Overall Study|Adverse Event|2|||
146564577|NCT00560417|528580012|FG000|Overall Study|Entry Criteria Not Met|1|||
146971687|NCT04971226|530057194|FG000|Overall Study|Pregnancy|0|||
146971688|NCT04971226|530057195|FG001|Overall Study|Pregnancy|0|||
146971689|NCT04971226|530057196|FG002|Overall Study|Pregnancy|0|||
146971690|NCT04971226|530057197|FG003|Overall Study|Pregnancy|1|||
146971691|NCT04971226|530057194|FG000|Overall Study|Participants not treated|1|||
146971692|NCT04971226|530057195|FG001|Overall Study|Participants not treated|0|||
146971693|NCT04971226|530057196|FG002|Overall Study|Participants not treated|2|||
146971694|NCT04971226|530057197|FG003|Overall Study|Participants not treated|1|||
146971695|NCT04439149|530057198|FG000|Overall Study|Ineligible|1|||
146971696|NCT04439149|530057198|FG000|Overall Study|Never start protocol therapy|1|||
146971697|NCT04439149|530057198|FG000|Overall Study|Adverse Event|4|||
146971698|NCT04439149|530057198|FG000|Overall Study|Disease Progression|14|||
146971699|NCT04439149|530057198|FG000|Overall Study|Complicating disease|1|||
146971700|NCT04439149|530057198|FG000|Overall Study|Withdrawal by Subject|3|||
146971701|NCT05919823|530057205|FG000|Pre-Treatment Period|Screen failure|1|||
146971702|NCT05919823|530057206|FG001|Pre-Treatment Period|Screen failure|0|||
146971703|NCT05919823|530057207|FG002|Pre-Treatment Period|Screen failure|0|||
146495168|NCT04015518|528316124|FG001|Overall Study|Adverse Event|1|||
146971704|NCT05919823|530057208|FG003|Pre-Treatment Period|Screen failure|0|||
146971705|NCT05919823|530057205|FG000|Pre-Treatment Period|Protocol Violation|0|||
146971706|NCT05919823|530057206|FG001|Pre-Treatment Period|Protocol Violation|1|||
146971707|NCT05919823|530057207|FG002|Pre-Treatment Period|Protocol Violation|0|||
146495169|NCT04015518|528316125|FG002|Overall Study|Adverse Event|1|||
146495170|NCT04015518|528316126|FG003|Overall Study|Adverse Event|3|||
146495171|NCT04015518|528316127|FG004|Overall Study|Adverse Event|3|||
146495172|NCT04015518|528316123|FG000|Overall Study|Lack of Efficacy|1|||
146971708|NCT05919823|530057208|FG003|Pre-Treatment Period|Protocol Violation|0|||
146971709|NCT05919823|530057205|FG000|Double-Blind Period|Adverse Event|8|||
146495173|NCT04015518|528316124|FG001|Overall Study|Lack of Efficacy|0|||
146495174|NCT04015518|528316125|FG002|Overall Study|Lack of Efficacy|1|||
146495175|NCT04015518|528316126|FG003|Overall Study|Lack of Efficacy|0|||
146495176|NCT04015518|528316127|FG004|Overall Study|Lack of Efficacy|4|||
146495177|NCT04015518|528316123|FG000|Overall Study|Lost to Follow-up|0|||
146495178|NCT04015518|528316124|FG001|Overall Study|Lost to Follow-up|0|||
146495179|NCT04015518|528316125|FG002|Overall Study|Lost to Follow-up|0|||
146495180|NCT04015518|528316126|FG003|Overall Study|Lost to Follow-up|0|||
146495181|NCT04015518|528316127|FG004|Overall Study|Lost to Follow-up|1|||
146495182|NCT04015518|528316123|FG000|Overall Study|Withdrawal by Subject|0|||
146495183|NCT04015518|528316124|FG001|Overall Study|Withdrawal by Subject|1|||
146495184|NCT04015518|528316125|FG002|Overall Study|Withdrawal by Subject|0|||
146495185|NCT04015518|528316126|FG003|Overall Study|Withdrawal by Subject|1|||
146495186|NCT04015518|528316127|FG004|Overall Study|Withdrawal by Subject|1|||
146495187|NCT04015518|528316123|FG000|Overall Study|Patient did not come for consecutive visits|0|||
146495188|NCT04015518|528316124|FG001|Overall Study|Patient did not come for consecutive visits|1|||
146495189|NCT04015518|528316125|FG002|Overall Study|Patient did not come for consecutive visits|0|||
146495190|NCT04015518|528316126|FG003|Overall Study|Patient did not come for consecutive visits|0|||
146495191|NCT04015518|528316127|FG004|Overall Study|Patient did not come for consecutive visits|0|||
146495192|NCT04015518|528316123|FG000|Overall Study|not willing to travel due to Covid-19|0|||
146495193|NCT04015518|528316124|FG001|Overall Study|not willing to travel due to Covid-19|0|||
146495194|NCT04015518|528316125|FG002|Overall Study|not willing to travel due to Covid-19|1|||
146495195|NCT04015518|528316126|FG003|Overall Study|not willing to travel due to Covid-19|0|||
146495196|NCT04015518|528316127|FG004|Overall Study|not willing to travel due to Covid-19|0|||
146495197|NCT04015518|528316123|FG000|Overall Study|Patient wants to discontinue treatment|0|||
146495198|NCT04015518|528316124|FG001|Overall Study|Patient wants to discontinue treatment|0|||
146495199|NCT04015518|528316125|FG002|Overall Study|Patient wants to discontinue treatment|0|||
146495200|NCT04015518|528316126|FG003|Overall Study|Patient wants to discontinue treatment|1|||
146495201|NCT04015518|528316127|FG004|Overall Study|Patient wants to discontinue treatment|0|||
146495202|NCT04015518|528316123|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
146495203|NCT04015518|528316124|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
146495204|NCT04015518|528316125|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
146495205|NCT04015518|528316126|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
146495206|NCT04015518|528316127|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
146495207|NCT04015518|528316123|FG000|Overall Study|Pregnancy|0|||
146495208|NCT04015518|528316124|FG001|Overall Study|Pregnancy|0|||
146495209|NCT04015518|528316125|FG002|Overall Study|Pregnancy|0|||
146495210|NCT04015518|528316126|FG003|Overall Study|Pregnancy|0|||
146495211|NCT04015518|528316127|FG004|Overall Study|Pregnancy|1|||
146495212|NCT04015518|528316123|FG000|Overall Study|Personal reasons|1|||
146495213|NCT04015518|528316124|FG001|Overall Study|Personal reasons|0|||
146495214|NCT04015518|528316125|FG002|Overall Study|Personal reasons|0|||
146495215|NCT04015518|528316126|FG003|Overall Study|Personal reasons|0|||
146495216|NCT04015518|528316127|FG004|Overall Study|Personal reasons|1|||
146495217|NCT04015518|528316123|FG000|Overall Study|Withdrew consent|1|||
146495218|NCT04015518|528316124|FG001|Overall Study|Withdrew consent|0|||
146495219|NCT04015518|528316125|FG002|Overall Study|Withdrew consent|0|||
146495220|NCT04015518|528316126|FG003|Overall Study|Withdrew consent|0|||
146495221|NCT04015518|528316127|FG004|Overall Study|Withdrew consent|0|||
146495222|NCT04015518|528316123|FG000|Overall Study|Prostate carcinoma|1|||
146495223|NCT04015518|528316124|FG001|Overall Study|Prostate carcinoma|0|||
146495224|NCT04015518|528316125|FG002|Overall Study|Prostate carcinoma|0|||
146495225|NCT04015518|528316126|FG003|Overall Study|Prostate carcinoma|0|||
146495226|NCT04015518|528316127|FG004|Overall Study|Prostate carcinoma|0|||
146495227|NCT04015518|528316123|FG000|Overall Study|Could not keep appointments due to work|1|||
146495228|NCT04015518|528316124|FG001|Overall Study|Could not keep appointments due to work|0|||
146495229|NCT04015518|528316125|FG002|Overall Study|Could not keep appointments due to work|0|||
146495230|NCT04015518|528316126|FG003|Overall Study|Could not keep appointments due to work|0|||
146643492|NCT00966875|528872176|FG007|Part A|Physician Decision|0|||
146643493|NCT00966875|528872177|FG008|Part A|Physician Decision|2|||
146643494|NCT00966875|528872169|FG000|Part A|Sponsor Decision|0|||
146643495|NCT00966875|528872170|FG001|Part A|Sponsor Decision|0|||
146643496|NCT00966875|528872171|FG002|Part A|Sponsor Decision|1|||
146643497|NCT00966875|528872172|FG003|Part A|Sponsor Decision|0|||
146495231|NCT04015518|528316127|FG004|Overall Study|Could not keep appointments due to work|0|||
146495232|NCT00550745|528316128|FG000|Overall Study|Death|20|||
146495233|NCT00550745|528316129|FG001|Overall Study|Death|16|||
146643498|NCT00966875|528872173|FG004|Part A|Sponsor Decision|1|||
146495234|NCT00550745|528316128|FG000|Overall Study|Lost to Follow-up|45|||
146643499|NCT00966875|528872174|FG005|Part A|Sponsor Decision|0|||
146495235|NCT00550745|528316129|FG001|Overall Study|Lost to Follow-up|30|||
146495236|NCT00550745|528316128|FG000|Overall Study|Physician Decision|0|||
146495237|NCT00550745|528316129|FG001|Overall Study|Physician Decision|2|||
146643500|NCT00966875|528872175|FG006|Part A|Sponsor Decision|0|||
146643501|NCT00966875|528872176|FG007|Part A|Sponsor Decision|2|||
146643502|NCT00966875|528872177|FG008|Part A|Sponsor Decision|1|||
146495238|NCT00550745|528316128|FG000|Overall Study|Protocol Violation|4|||
146495239|NCT00550745|528316129|FG001|Overall Study|Protocol Violation|2|||
146495240|NCT00550745|528316128|FG000|Overall Study|Withdrawal by Subject|17|||
146495241|NCT00550745|528316129|FG001|Overall Study|Withdrawal by Subject|10|||
146495242|NCT00550745|528316128|FG000|Overall Study|Screen failure|1|||
146495243|NCT00550745|528316129|FG001|Overall Study|Screen failure|0|||
146495244|NCT00764660|528316130|FG000|Overall Study|Adverse Event|6|||
146495245|NCT00764660|528316131|FG001|Overall Study|Adverse Event|3|||
146495246|NCT00764660|528316130|FG000|Overall Study|Lost to Follow-up|3|||
146495247|NCT00764660|528316131|FG001|Overall Study|Lost to Follow-up|4|||
146495248|NCT00764660|528316130|FG000|Overall Study|Withdrawal by Subject|7|||
146495249|NCT00764660|528316131|FG001|Overall Study|Withdrawal by Subject|3|||
146495250|NCT00764660|528316130|FG000|Overall Study|Noncompliance With Protocol|5|||
146495251|NCT00764660|528316131|FG001|Overall Study|Noncompliance With Protocol|1|||
146495252|NCT00764660|528316130|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
146495253|NCT00764660|528316131|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
146495254|NCT01131455|528316132|FG000|Overall Study|Death of PI|6|||
146495255|NCT01131455|528316133|FG001|Overall Study|Death of PI|4|||
146495256|NCT01131455|528316134|FG002|Overall Study|Death of PI|0|||
146495257|NCT03694002|528317704|FG000|Overall Study|Progression|4|||
146495258|NCT03694002|528317705|FG001|Overall Study|Progression|2|||
146495259|NCT03694002|528317704|FG000|Overall Study|Adverse Event|2|||
146495260|NCT03694002|528317705|FG001|Overall Study|Adverse Event|0|||
146495261|NCT03694002|528317704|FG000|Overall Study|Other not protocol specified|1|||
146495262|NCT03694002|528317705|FG001|Overall Study|Other not protocol specified|0|||
146495263|NCT03694002|528317704|FG000|Overall Study|Ineligible|0|||
146495264|NCT03694002|528317705|FG001|Overall Study|Ineligible|1|||
146495265|NCT03694002|528317704|FG000|Overall Study|Withdrew consent before starting treatment|0|||
146495266|NCT03694002|528317705|FG001|Overall Study|Withdrew consent before starting treatment|3|||
146495267|NCT05678959|528317706|FG000|Overall Study|Study Terminated by Sponsor|76|||
146495268|NCT05678959|528317707|FG001|Overall Study|Study Terminated by Sponsor|76|||
146495269|NCT05678959|528317706|FG000|Overall Study|Physician Decision|2|||
146495270|NCT05678959|528317707|FG001|Overall Study|Physician Decision|3|||
146495271|NCT05678959|528317706|FG000|Overall Study|Adverse Event|1|||
146495272|NCT05678959|528317707|FG001|Overall Study|Adverse Event|1|||
146495273|NCT05678959|528317706|FG000|Overall Study|Guardian Decision|1|||
146495274|NCT05678959|528317707|FG001|Overall Study|Guardian Decision|0|||
146495275|NCT05678959|528317706|FG000|Overall Study|Protocol Deviation|0|||
146495276|NCT05678959|528317707|FG001|Overall Study|Protocol Deviation|1|||
146495277|NCT05678959|528317706|FG000|Overall Study|Subject Decision|1|||
146495278|NCT05678959|528317707|FG001|Overall Study|Subject Decision|0|||
146495279|NCT05678959|528317706|FG000|Overall Study|Technical Problem|0|||
146495280|NCT05678959|528317707|FG001|Overall Study|Technical Problem|1|||
146495281|NCT01481766|528317708|FG000|4 months|Lost to Follow-up|3|||
146495282|NCT01481766|528317709|FG001|4 months|Lost to Follow-up|2|||
146495283|NCT01481766|528317710|FG002|4 months|Lost to Follow-up|1|||
146495284|NCT01481766|528317711|FG003|4 months|Lost to Follow-up|5|||
146495285|NCT01481766|528317708|FG000|12 months|Lost to Follow-up|7|||
146495286|NCT01481766|528317709|FG001|12 months|Lost to Follow-up|8|||
146495287|NCT01481766|528317710|FG002|12 months|Lost to Follow-up|5|||
146495288|NCT01481766|528317711|FG003|12 months|Lost to Follow-up|3|||
146495289|NCT03868930|528317712|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
146495290|NCT03868930|528317713|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
146495291|NCT03868930|528317712|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
146495292|NCT03868930|528317713|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
146495293|NCT03868930|528317712|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
146495294|NCT03868930|528317713|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
146495295|NCT03868930|528317712|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
146495296|NCT03868930|528317713|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
146495297|NCT03868930|528317712|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
146495298|NCT03868930|528317713|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
146495299|NCT00596687|528317716|FG000|Overall Study|< 24 hours of insulin treatment|8|||
146495300|NCT00596687|528317717|FG001|Overall Study|< 24 hours of insulin treatment|6|||
146495301|NCT00596687|528317716|FG000|Overall Study|continuous insulin infusion during TPN|2|||
146495302|NCT00596687|528317717|FG001|Overall Study|continuous insulin infusion during TPN|1|||
146495303|NCT00596687|528317716|FG000|Overall Study|Withdrawal by Subject|3|||
146495304|NCT00596687|528317717|FG001|Overall Study|Withdrawal by Subject|1|||
146495305|NCT00596687|528317716|FG000|Overall Study|cancelled surgery|1|||
146971710|NCT05919823|530057206|FG001|Double-Blind Period|Adverse Event|9|||
146495306|NCT00596687|528317717|FG001|Overall Study|cancelled surgery|1|||
146495307|NCT01262287|528317718|FG000|Overall Study|Lost to Follow-up|2|||
146495308|NCT01262287|528317719|FG001|Overall Study|Lost to Follow-up|1|||
146495309|NCT04134767|528317720|FG000|Overall Study|Death|0|||
146495310|NCT04134767|528317721|FG001|Overall Study|Death|1|||
146495311|NCT04134767|528317720|FG000|Overall Study|Removed for harassing staff|0|||
146643503|NCT00966875|528872169|FG000|Part A|Withdrawal by Subject|2|||
146495312|NCT04134767|528317721|FG001|Overall Study|Removed for harassing staff|1|||
146495313|NCT04134767|528317720|FG000|Overall Study|Lost to Follow-up|44|||
146495314|NCT04134767|528317721|FG001|Overall Study|Lost to Follow-up|40|||
146495315|NCT00638404|528317722|FG000|Overall Study|Physician Decision|8|||
146495316|NCT00638404|528317723|FG001|Overall Study|Physician Decision|0|||
146495317|NCT02492984|528317724|FG000|Overall Study|Adverse Event|1|||
146495318|NCT02492984|528317725|FG001|Overall Study|Adverse Event|0|||
146495319|NCT02492984|528317724|FG000|Overall Study|Protocol Violation|1|||
146495320|NCT02492984|528317725|FG001|Overall Study|Protocol Violation|0|||
146495321|NCT02492984|528317724|FG000|Overall Study|Withdrawal by Subject|1|||
146495322|NCT02492984|528317725|FG001|Overall Study|Withdrawal by Subject|0|||
146495323|NCT02282631|528317727|FG000|Overall Study|Lost to Follow-up|2|||
146495324|NCT02282631|528317728|FG001|Overall Study|Lost to Follow-up|0|||
146495325|NCT01515865|528317729|FG000|Part A (Open-label)|Other|3|||
146495326|NCT01515865|528317730|FG001|Part A (Open-label)|Other|0|||
146495327|NCT01515865|528317731|FG002|Part A (Open-label)|Other|0|||
146495328|NCT01515865|528317729|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
146495329|NCT01515865|528317730|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
146495330|NCT01515865|528317731|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
146495331|NCT01515865|528317729|FG000|Part B (Open-label)|Other|1|||
146495332|NCT01515865|528317730|FG001|Part B (Open-label)|Other|0|||
146495333|NCT01515865|528317731|FG002|Part B (Open-label)|Other|0|||
146495334|NCT02510664|528317736|FG000|Overall Study|Transferred Care|9|||
146495335|NCT02510664|528317737|FG001|Overall Study|Transferred Care|9|||
146495336|NCT02510664|528317738|FG002|Overall Study|Transferred Care|0|||
146495337|NCT02510664|528317736|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
146495338|NCT02510664|528317737|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
146495339|NCT02510664|528317738|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
146495340|NCT02510664|528317736|FG000|Overall Study|Time Constraints|1|||
146495341|NCT02510664|528317737|FG001|Overall Study|Time Constraints|1|||
146495342|NCT02510664|528317738|FG002|Overall Study|Time Constraints|0|||
146495343|NCT02801617|528317740|FG000|Overall Study|Protocol Violation|2|||
146495344|NCT02801617|528317741|FG001|Overall Study|Protocol Violation|6|||
146495345|NCT04090060|528317747|FG000|Overall Study|Lost to Follow-up|76|||
146495346|NCT04090060|528317748|FG001|Overall Study|Lost to Follow-up|77|||
146495347|NCT02490371|528317753|FG000|Overall Study|Lost to Follow-up|1|||
146495348|NCT02490371|528317754|FG001|Overall Study|Lost to Follow-up|1|||
146495349|NCT01718535|528317755|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
146495350|NCT01718535|528317756|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
146495351|NCT01718535|528317757|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
146495352|NCT01718535|528317758|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
146495353|NCT01718535|528317759|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
146495354|NCT01718535|528317760|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
146495355|NCT01718535|528317761|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
146495356|NCT01718535|528317762|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
146495357|NCT01718535|528317763|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
146495358|NCT01718535|528317764|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
146495359|NCT01163851|528317767|FG000|Overall Study|Site Closure|0|||
146564578|NCT00560417|528580013|FG001|Overall Study|Entry Criteria Not Met|0|||
146971711|NCT05919823|530057207|FG002|Double-Blind Period|Adverse Event|0|||
146971712|NCT05919823|530057208|FG003|Double-Blind Period|Adverse Event|0|||
146971713|NCT05919823|530057205|FG000|Double-Blind Period|Protocol Violation|2|||
146971714|NCT05919823|530057206|FG001|Double-Blind Period|Protocol Violation|1|||
146971715|NCT05919823|530057207|FG002|Double-Blind Period|Protocol Violation|0|||
146971716|NCT05919823|530057208|FG003|Double-Blind Period|Protocol Violation|0|||
146971717|NCT05919823|530057205|FG000|Double-Blind Period|Participant withdrew consent|11|||
146971718|NCT05919823|530057206|FG001|Double-Blind Period|Participant withdrew consent|7|||
146971719|NCT05919823|530057207|FG002|Double-Blind Period|Participant withdrew consent|0|||
146971720|NCT05919823|530057208|FG003|Double-Blind Period|Participant withdrew consent|0|||
146971721|NCT05919823|530057205|FG000|Double-Blind Period|Other reasons|2|||
146971722|NCT05919823|530057206|FG001|Double-Blind Period|Other reasons|3|||
146971723|NCT05919823|530057207|FG002|Double-Blind Period|Other reasons|0|||
146971724|NCT05919823|530057208|FG003|Double-Blind Period|Other reasons|0|||
146495360|NCT01163851|528317768|FG001|Overall Study|Site Closure|1|||
146495361|NCT01163851|528317767|FG000|Overall Study|Enrolled but not treated|1|||
146495362|NCT01163851|528317768|FG001|Overall Study|Enrolled but not treated|0|||
146495363|NCT00740792|528317772|FG000|Overall Study|Adverse Event|3|||
146495364|NCT00740792|528317773|FG001|Overall Study|Adverse Event|1|||
146495365|NCT00740792|528317774|FG002|Overall Study|Adverse Event|1|||
146495366|NCT00740792|528317775|FG003|Overall Study|Adverse Event|3|||
146495367|NCT00740792|528317772|FG000|Overall Study|Lack of Efficacy|1|||
146495368|NCT00740792|528317773|FG001|Overall Study|Lack of Efficacy|1|||
146495369|NCT00740792|528317774|FG002|Overall Study|Lack of Efficacy|0|||
146495370|NCT00740792|528317775|FG003|Overall Study|Lack of Efficacy|3|||
146495371|NCT00740792|528317772|FG000|Overall Study|Lost to Follow-up|2|||
146495372|NCT00740792|528317773|FG001|Overall Study|Lost to Follow-up|1|||
146495373|NCT00740792|528317774|FG002|Overall Study|Lost to Follow-up|0|||
146495374|NCT00740792|528317775|FG003|Overall Study|Lost to Follow-up|0|||
146495375|NCT00740792|528317772|FG000|Overall Study|Protocol Violation|0|||
146495376|NCT00740792|528317773|FG001|Overall Study|Protocol Violation|1|||
146495377|NCT00740792|528317774|FG002|Overall Study|Protocol Violation|0|||
146495378|NCT00740792|528317775|FG003|Overall Study|Protocol Violation|2|||
146495379|NCT00740792|528317772|FG000|Overall Study|Withdrawal by Subject|1|||
146495380|NCT00740792|528317773|FG001|Overall Study|Withdrawal by Subject|1|||
146495381|NCT00740792|528317774|FG002|Overall Study|Withdrawal by Subject|0|||
146495382|NCT00740792|528317775|FG003|Overall Study|Withdrawal by Subject|0|||
146495383|NCT00740792|528317772|FG000|Overall Study|administrative|3|||
146495384|NCT00740792|528317773|FG001|Overall Study|administrative|3|||
146495385|NCT00740792|528317774|FG002|Overall Study|administrative|8|||
146495386|NCT00740792|528317775|FG003|Overall Study|administrative|2|||
146495387|NCT03412734|528317782|FG000|Overall Study|Incorrect labeling of samples|2|||
146495388|NCT03412734|528317783|FG001|Overall Study|Incorrect labeling of samples|0|||
146495389|NCT03412734|528317782|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
146495390|NCT03412734|528317783|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
146495391|NCT00423332|528317784|FG000|Overall Study|Adverse Event|6|||
146495392|NCT00423332|528317785|FG001|Overall Study|Adverse Event|2|||
146495393|NCT00423332|528317784|FG000|Overall Study|Withdrawal by Subject|1|||
146495394|NCT00423332|528317785|FG001|Overall Study|Withdrawal by Subject|0|||
146495395|NCT00423332|528317784|FG000|Overall Study|Condition under investigation worsened|1|||
146495396|NCT00423332|528317785|FG001|Overall Study|Condition under investigation worsened|1|||
146495397|NCT00423332|528317784|FG000|Overall Study|Progressive at Week 6|0|||
146495398|NCT00423332|528317785|FG001|Overall Study|Progressive at Week 6|1|||
146495399|NCT00423332|528317784|FG000|Overall Study|Unblinded before 12 weeks|1|||
146495400|NCT00423332|528317785|FG001|Overall Study|Unblinded before 12 weeks|3|||
146495401|NCT02035202|528317787|FG000|Overall Study|Lost to Follow-up|8|||
146495402|NCT02035202|528317788|FG001|Overall Study|Lost to Follow-up|16|||
146495403|NCT02035202|528317789|FG002|Overall Study|Lost to Follow-up|2|||
146495404|NCT00644917|528317790|FG000|Overall Study|Withdrawal by Subject|2|||
146495405|NCT00758485|528317791|FG000|Overall Study|Lost to Follow-up|0|||
146495406|NCT00758485|528317792|FG001|Overall Study|Lost to Follow-up|1|||
146495407|NCT00758485|528317791|FG000|Overall Study|Not Treated|1|||
146495408|NCT00758485|528317792|FG001|Overall Study|Not Treated|2|||
146643504|NCT00966875|528872170|FG001|Part A|Withdrawal by Subject|2|||
146495409|NCT00921557|528317793|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
146495410|NCT00921557|528317794|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
146495411|NCT00921557|528317795|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
146495412|NCT00921557|528317793|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
146495413|NCT00921557|528317794|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
146495414|NCT00921557|528317795|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
146495415|NCT00921557|528317793|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
146495416|NCT00921557|528317794|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
146495417|NCT00921557|528317795|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
146495418|NCT00921557|528317793|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
146495419|NCT00921557|528317794|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
146495420|NCT00921557|528317795|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
146495421|NCT00921557|528317793|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
146495422|NCT00921557|528317794|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
146495423|NCT00921557|528317795|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
146495424|NCT03259425|528317805|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
146495425|NCT02097238|528317815|FG000|Overall Study|Death|1|||
146495426|NCT02097238|528317815|FG000|Overall Study|Physician Decision|1|||
146495427|NCT02097238|528317815|FG000|Overall Study|Progressive Disease|17|||
146495428|NCT01106911|528317816|FG000|Overall Study|Physician Decision|2|||
146495429|NCT01106911|528317816|FG000|Overall Study|deemed ineligible after screening|3|||
146495430|NCT01282372|528317818|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
146495431|NCT01282372|528317818|FG000|Overall Study|Lost to Follow-up|23|||
146495432|NCT01282372|528317818|FG000|Overall Study|Withdrawal by Subject|11|||
146495433|NCT01282372|528317818|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
146971725|NCT05919823|530057205|FG000|Open Label Period|Adverse Event|0|||
146971726|NCT05919823|530057206|FG001|Open Label Period|Adverse Event|0|||
146971727|NCT05919823|530057207|FG002|Open Label Period|Adverse Event|2|||
146971728|NCT05919823|530057208|FG003|Open Label Period|Adverse Event|4|||
146495434|NCT01282372|528317818|FG000|Overall Study|Death|1|||
146495435|NCT01282372|528317818|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
146495436|NCT01282372|528317818|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
146495437|NCT01282372|528317818|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
146495438|NCT01282372|528317818|FG000|Overall Study|Adverse Event|12|||
146495439|NCT01814696|528317819|FG000|Overall Study|Withdrawal by Subject|1|||
146495440|NCT01814696|528317820|FG001|Overall Study|Withdrawal by Subject|0|||
146495441|NCT01814696|528317819|FG000|Overall Study|Randomized to wrong group|1|||
146495442|NCT01814696|528317820|FG001|Overall Study|Randomized to wrong group|0|||
146495443|NCT00713258|528317821|FG000|Overall Study|Adverse Event|2|||
146495444|NCT00713258|528317822|FG001|Overall Study|Adverse Event|4|||
146495445|NCT00713258|528317821|FG000|Overall Study|Non-Compliance|2|||
146495446|NCT00713258|528317822|FG001|Overall Study|Non-Compliance|1|||
146495447|NCT00713258|528317821|FG000|Overall Study|Other|1|||
146495448|NCT00713258|528317822|FG001|Overall Study|Other|1|||
146495449|NCT01322490|528317823|FG000|Treatment Period|Adverse Event|12|||
146495450|NCT01322490|528317824|FG001|Treatment Period|Adverse Event|18|||
146495451|NCT01322490|528317825|FG002|Treatment Period|Adverse Event|15|||
146495452|NCT01322490|528317823|FG000|Treatment Period|Death|5|||
146495453|NCT01322490|528317824|FG001|Treatment Period|Death|7|||
146495454|NCT01322490|528317825|FG002|Treatment Period|Death|3|||
146495455|NCT01322490|528317823|FG000|Treatment Period|Lack of Efficacy|89|||
146495456|NCT01322490|528317824|FG001|Treatment Period|Lack of Efficacy|100|||
146495457|NCT01322490|528317825|FG002|Treatment Period|Lack of Efficacy|112|||
146495458|NCT01322490|528317823|FG000|Treatment Period|Physician Decision|0|||
146495459|NCT01322490|528317824|FG001|Treatment Period|Physician Decision|2|||
146495460|NCT01322490|528317825|FG002|Treatment Period|Physician Decision|1|||
146495461|NCT01322490|528317823|FG000|Treatment Period|Protocol Violation|7|||
146495462|NCT01322490|528317824|FG001|Treatment Period|Protocol Violation|5|||
146495463|NCT01322490|528317825|FG002|Treatment Period|Protocol Violation|4|||
146495464|NCT01322490|528317823|FG000|Treatment Period|Withdrawal by Subject|14|||
146495465|NCT01322490|528317824|FG001|Treatment Period|Withdrawal by Subject|16|||
146495466|NCT01322490|528317825|FG002|Treatment Period|Withdrawal by Subject|11|||
146495467|NCT01322490|528317823|FG000|Treatment Period|Non-compliance with study drug|0|||
146495468|NCT01322490|528317824|FG001|Treatment Period|Non-compliance with study drug|0|||
146495469|NCT01322490|528317825|FG002|Treatment Period|Non-compliance with study drug|1|||
146495470|NCT01322490|528317823|FG000|Treatment Period|Other per report|2|||
146495471|NCT01322490|528317824|FG001|Treatment Period|Other per report|2|||
146495472|NCT01322490|528317825|FG002|Treatment Period|Other per report|1|||
146495473|NCT01322490|528317823|FG000|Treatment Period|Randomized but Not Treated|3|||
146495474|NCT01322490|528317824|FG001|Treatment Period|Randomized but Not Treated|3|||
146495475|NCT01322490|528317825|FG002|Treatment Period|Randomized but Not Treated|5|||
146495476|NCT01322490|528317823|FG000|Long Term Follow-up Period|Death|235|||
146495477|NCT01322490|528317824|FG001|Long Term Follow-up Period|Death|239|||
146495478|NCT01322490|528317825|FG002|Long Term Follow-up Period|Death|236|||
146495479|NCT01322490|528317823|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
146495480|NCT01322490|528317824|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
146495481|NCT01322490|528317825|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
146495482|NCT01322490|528317823|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
146495483|NCT01322490|528317824|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
146495484|NCT01322490|528317825|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
146495485|NCT01322490|528317823|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
146495486|NCT01322490|528317824|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
146495487|NCT01322490|528317825|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
146495488|NCT01322490|528317823|FG000|Long Term Follow-up Period|Other per report|3|||
146495489|NCT01322490|528317824|FG001|Long Term Follow-up Period|Other per report|2|||
146495490|NCT01322490|528317825|FG002|Long Term Follow-up Period|Other per report|2|||
146495491|NCT01322490|528317823|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
146495492|NCT01322490|528317824|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
146495493|NCT01322490|528317825|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
146495494|NCT02199795|528317827|FG000|Overall Study|no longer met inclusion criteria|1|||
146495495|NCT02199795|528317828|FG001|Overall Study|no longer met inclusion criteria|0|||
146495496|NCT02199795|528317827|FG000|Overall Study|withdrew due to shoulder pain|1|||
146495497|NCT02199795|528317828|FG001|Overall Study|withdrew due to shoulder pain|0|||
146643505|NCT00966875|528872171|FG002|Part A|Withdrawal by Subject|1|||
146495498|NCT05310071|528317845|FG000|Overall Study|Death|0|||
146495499|NCT05310071|528317846|FG001|Overall Study|Death|3|||
146495500|NCT05310071|528317845|FG000|Overall Study|Adverse Event|4|||
146495501|NCT05310071|528317846|FG001|Overall Study|Adverse Event|31|||
146495502|NCT05310071|528317845|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
146495503|NCT05310071|528317846|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
146495504|NCT05310071|528317845|FG000|Overall Study|Protocol Deviation|2|||
146495505|NCT05310071|528317846|FG001|Overall Study|Protocol Deviation|0|||
146495506|NCT05310071|528317845|FG000|Overall Study|Randomized by Mistake|0|||
146495507|NCT05310071|528317846|FG001|Overall Study|Randomized by Mistake|1|||
146495508|NCT05310071|528317845|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
146495509|NCT05310071|528317846|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
146495510|NCT05310071|528317845|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
146495511|NCT05310071|528317846|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
146495512|NCT05310071|528317845|FG000|Overall Study|Site Terminated by Sponsor|0|||
146495513|NCT05310071|528317846|FG001|Overall Study|Site Terminated by Sponsor|2|||
146495514|NCT05310071|528317845|FG000|Overall Study|Study Terminated by Sponsor|282|||
146495515|NCT05310071|528317846|FG001|Overall Study|Study Terminated by Sponsor|559|||
146495516|NCT05310071|528317845|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
146495517|NCT05310071|528317846|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
146495518|NCT05310071|528317845|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
146495519|NCT05310071|528317846|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
146495520|NCT05310071|528317845|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
146495521|NCT05310071|528317846|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
146495522|NCT05310071|528317845|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
146495523|NCT05310071|528317846|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
146495524|NCT05310071|528317845|FG000|Overall Study|Withdrawal by Participant - Other|25|||
146495525|NCT05310071|528317846|FG001|Overall Study|Withdrawal by Participant - Other|30|||
146495526|NCT05310071|528317845|FG000|Overall Study|Lost to Follow-up|2|||
146495527|NCT05310071|528317846|FG001|Overall Study|Lost to Follow-up|4|||
146495528|NCT05310071|528317845|FG000|Overall Study|Reason Not Specified|1|||
146495529|NCT05310071|528317846|FG001|Overall Study|Reason Not Specified|3|||
146495530|NCT02418949|528317847|FG000|Overall Study|Withdrawal by Subject|1|||
146495531|NCT02418949|528317848|FG001|Overall Study|Withdrawal by Subject|0|||
146495532|NCT02418949|528317849|FG002|Overall Study|Withdrawal by Subject|1|||
146495533|NCT02418949|528317850|FG003|Overall Study|Withdrawal by Subject|1|||
146495534|NCT02418949|528317847|FG000|Overall Study|Lost to Follow-up|1|||
146495535|NCT02418949|528317848|FG001|Overall Study|Lost to Follow-up|0|||
146495536|NCT02418949|528317849|FG002|Overall Study|Lost to Follow-up|1|||
146495537|NCT02418949|528317850|FG003|Overall Study|Lost to Follow-up|0|||
146495538|NCT02418949|528317847|FG000|Overall Study|Physician Decision|1|||
146495539|NCT02418949|528317848|FG001|Overall Study|Physician Decision|1|||
146643506|NCT00966875|528872172|FG003|Part A|Withdrawal by Subject|1|||
146643507|NCT00966875|528872173|FG004|Part A|Withdrawal by Subject|3|||
146643508|NCT00966875|528872174|FG005|Part A|Withdrawal by Subject|0|||
146495540|NCT02418949|528317849|FG002|Overall Study|Physician Decision|1|||
146495541|NCT02418949|528317850|FG003|Overall Study|Physician Decision|0|||
146495542|NCT00984542|528317855|FG000|Overall Study|disease progression|19|||
146495543|NCT00984542|528317855|FG000|Overall Study|toxicity|7|||
146495544|NCT00984542|528317855|FG000|Overall Study|Death|7|||
146495545|NCT00984542|528317855|FG000|Overall Study|complicating disease|3|||
146495546|NCT00984542|528317855|FG000|Overall Study|Withdrawal by Subject|3|||
146495547|NCT00984542|528317855|FG000|Overall Study|clinical deterioration|2|||
146495548|NCT02343939|528317856|FG000|Overall Study|Death|0|||
146495549|NCT02343939|528317857|FG001|Overall Study|Death|15|||
146495550|NCT02343939|528317858|FG002|Overall Study|Death|4|||
146495551|NCT02343939|528317859|FG003|Overall Study|Death|2|||
146495552|NCT02343939|528317860|FG004|Overall Study|Death|5|||
146495553|NCT02343939|528317861|FG005|Overall Study|Death|11|||
146495554|NCT02343939|528317862|FG006|Overall Study|Death|8|||
146495555|NCT02343939|528317863|FG007|Overall Study|Death|22|||
146495556|NCT02343939|528317864|FG008|Overall Study|Death|1|||
146495557|NCT02343939|528317856|FG000|Overall Study|Study terminated by sponsor|0|||
146495558|NCT02343939|528317857|FG001|Overall Study|Study terminated by sponsor|27|||
146495559|NCT02343939|528317858|FG002|Overall Study|Study terminated by sponsor|0|||
146495560|NCT02343939|528317859|FG003|Overall Study|Study terminated by sponsor|1|||
146495561|NCT02343939|528317860|FG004|Overall Study|Study terminated by sponsor|1|||
146495562|NCT02343939|528317861|FG005|Overall Study|Study terminated by sponsor|5|||
146495563|NCT02343939|528317862|FG006|Overall Study|Study terminated by sponsor|3|||
146495564|NCT02343939|528317863|FG007|Overall Study|Study terminated by sponsor|4|||
146495565|NCT02343939|528317864|FG008|Overall Study|Study terminated by sponsor|0|||
146495566|NCT02343939|528317856|FG000|Overall Study|Withdrew consent|3|||
146495567|NCT02343939|528317857|FG001|Overall Study|Withdrew consent|6|||
146495568|NCT02343939|528317858|FG002|Overall Study|Withdrew consent|1|||
146495569|NCT02343939|528317859|FG003|Overall Study|Withdrew consent|2|||
146495570|NCT02343939|528317860|FG004|Overall Study|Withdrew consent|2|||
146495571|NCT02343939|528317861|FG005|Overall Study|Withdrew consent|0|||
146495572|NCT02343939|528317862|FG006|Overall Study|Withdrew consent|0|||
146495573|NCT02343939|528317863|FG007|Overall Study|Withdrew consent|8|||
146495574|NCT02343939|528317864|FG008|Overall Study|Withdrew consent|6|||
146495575|NCT02343939|528317856|FG000|Overall Study|Treatment failure|0|||
146495576|NCT02343939|528317857|FG001|Overall Study|Treatment failure|0|||
146495577|NCT02343939|528317858|FG002|Overall Study|Treatment failure|0|||
146495578|NCT02343939|528317859|FG003|Overall Study|Treatment failure|0|||
146495579|NCT02343939|528317860|FG004|Overall Study|Treatment failure|0|||
146495580|NCT02343939|528317861|FG005|Overall Study|Treatment failure|0|||
146495581|NCT02343939|528317862|FG006|Overall Study|Treatment failure|2|||
146495582|NCT02343939|528317863|FG007|Overall Study|Treatment failure|1|||
146643509|NCT00966875|528872175|FG006|Part A|Withdrawal by Subject|5|||
146495583|NCT02343939|528317864|FG008|Overall Study|Treatment failure|0|||
146495584|NCT02343939|528317856|FG000|Overall Study|Investigator's discretion|0|||
146495585|NCT02343939|528317857|FG001|Overall Study|Investigator's discretion|0|||
146495586|NCT02343939|528317858|FG002|Overall Study|Investigator's discretion|0|||
146768885|NCT04707313|529321801|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
146768886|NCT04707313|529321802|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
146495587|NCT02343939|528317859|FG003|Overall Study|Investigator's discretion|1|||
146495588|NCT02343939|528317860|FG004|Overall Study|Investigator's discretion|0|||
146495589|NCT02343939|528317861|FG005|Overall Study|Investigator's discretion|0|||
146495590|NCT02343939|528317862|FG006|Overall Study|Investigator's discretion|1|||
146495591|NCT02343939|528317863|FG007|Overall Study|Investigator's discretion|0|||
146495592|NCT02343939|528317864|FG008|Overall Study|Investigator's discretion|0|||
146495593|NCT02343939|528317856|FG000|Overall Study|Adverse Event|0|||
146495594|NCT02343939|528317857|FG001|Overall Study|Adverse Event|0|||
146495595|NCT02343939|528317858|FG002|Overall Study|Adverse Event|0|||
146495596|NCT02343939|528317859|FG003|Overall Study|Adverse Event|0|||
146495597|NCT02343939|528317860|FG004|Overall Study|Adverse Event|0|||
146495598|NCT02343939|528317861|FG005|Overall Study|Adverse Event|1|||
146495599|NCT02343939|528317862|FG006|Overall Study|Adverse Event|0|||
146495600|NCT02343939|528317863|FG007|Overall Study|Adverse Event|0|||
146495601|NCT02343939|528317864|FG008|Overall Study|Adverse Event|0|||
146495602|NCT02343939|528317856|FG000|Overall Study|Never Treated With ENTO|0|||
146495603|NCT02343939|528317857|FG001|Overall Study|Never Treated With ENTO|0|||
146495604|NCT02343939|528317858|FG002|Overall Study|Never Treated With ENTO|0|||
146495605|NCT02343939|528317859|FG003|Overall Study|Never Treated With ENTO|0|||
146495606|NCT02343939|528317860|FG004|Overall Study|Never Treated With ENTO|0|||
146495607|NCT02343939|528317861|FG005|Overall Study|Never Treated With ENTO|0|||
146495608|NCT02343939|528317862|FG006|Overall Study|Never Treated With ENTO|1|||
146495609|NCT02343939|528317863|FG007|Overall Study|Never Treated With ENTO|2|||
146495610|NCT02343939|528317864|FG008|Overall Study|Never Treated With ENTO|0|||
146495611|NCT00460811|528317865|FG000|Overall Study|Adverse Event|4|||
146495612|NCT00460811|528317866|FG001|Overall Study|Adverse Event|6|||
146495613|NCT00460811|528317867|FG002|Overall Study|Adverse Event|3|||
146495614|NCT00460811|528317868|FG003|Overall Study|Adverse Event|10|||
146495615|NCT00460811|528317869|FG004|Overall Study|Adverse Event|2|||
146495616|NCT00460811|528317865|FG000|Overall Study|Noncompliance|1|||
146495617|NCT00460811|528317866|FG001|Overall Study|Noncompliance|0|||
146495618|NCT00460811|528317867|FG002|Overall Study|Noncompliance|0|||
146495619|NCT00460811|528317868|FG003|Overall Study|Noncompliance|2|||
146495620|NCT00460811|528317869|FG004|Overall Study|Noncompliance|1|||
146495621|NCT00460811|528317865|FG000|Overall Study|Withdrawal by Subject|7|||
146495622|NCT00460811|528317866|FG001|Overall Study|Withdrawal by Subject|7|||
146495623|NCT00460811|528317867|FG002|Overall Study|Withdrawal by Subject|6|||
146495624|NCT00460811|528317868|FG003|Overall Study|Withdrawal by Subject|3|||
146495625|NCT00460811|528317869|FG004|Overall Study|Withdrawal by Subject|11|||
146495626|NCT00460811|528317865|FG000|Overall Study|Physician Decision|1|||
146495627|NCT00460811|528317866|FG001|Overall Study|Physician Decision|0|||
146495628|NCT00460811|528317867|FG002|Overall Study|Physician Decision|0|||
146495629|NCT00460811|528317868|FG003|Overall Study|Physician Decision|0|||
146495630|NCT00460811|528317869|FG004|Overall Study|Physician Decision|0|||
146495631|NCT00460811|528317865|FG000|Overall Study|Lost to Follow-up|3|||
146495632|NCT00460811|528317866|FG001|Overall Study|Lost to Follow-up|2|||
146495633|NCT00460811|528317867|FG002|Overall Study|Lost to Follow-up|5|||
146495634|NCT00460811|528317868|FG003|Overall Study|Lost to Follow-up|3|||
146495635|NCT00460811|528317869|FG004|Overall Study|Lost to Follow-up|6|||
146495636|NCT02097745|528317870|FG000|Overall Study|Adverse Event|25|||
146495637|NCT02097745|528317870|FG000|Overall Study|Death|16|||
146971729|NCT05919823|530057205|FG000|Open Label Period|Lost to Follow-up|0|||
146971730|NCT05919823|530057206|FG001|Open Label Period|Lost to Follow-up|0|||
146971731|NCT05919823|530057207|FG002|Open Label Period|Lost to Follow-up|1|||
146971732|NCT05919823|530057208|FG003|Open Label Period|Lost to Follow-up|0|||
146971733|NCT05919823|530057205|FG000|Open Label Period|Protocol Violation|0|||
146971734|NCT05919823|530057206|FG001|Open Label Period|Protocol Violation|0|||
146971735|NCT05919823|530057207|FG002|Open Label Period|Protocol Violation|0|||
146971736|NCT05919823|530057208|FG003|Open Label Period|Protocol Violation|1|||
146971737|NCT05919823|530057205|FG000|Open Label Period|Participant withdrew consent|0|||
146495638|NCT02097745|528317870|FG000|Overall Study|Failure to Return|14|||
146495639|NCT02097745|528317870|FG000|Overall Study|Administrative/Other|27|||
146495640|NCT02097745|528317870|FG000|Overall Study|Reason Not Specified|96|||
146495641|NCT00425750|528317876|FG000|Overall Study|Death|1|||
146971738|NCT05919823|530057206|FG001|Open Label Period|Participant withdrew consent|0|||
146971739|NCT05919823|530057207|FG002|Open Label Period|Participant withdrew consent|8|||
146495642|NCT00425750|528317876|FG000|Overall Study|Withdrawal by Subject|3|||
146495643|NCT00425750|528317876|FG000|Overall Study|Adverse Event|3|||
146495644|NCT00425750|528317876|FG000|Overall Study|Progression of disease|18|||
146971740|NCT05919823|530057208|FG003|Open Label Period|Participant withdrew consent|6|||
146495645|NCT02099110|528317877|FG000|Overall Study|Protocol Violation|2|||
146495646|NCT02099110|528317878|FG001|Overall Study|Protocol Violation|1|||
146495647|NCT02099110|528317879|FG002|Overall Study|Protocol Violation|0|||
146495648|NCT02099110|528317880|FG003|Overall Study|Protocol Violation|3|||
146495649|NCT02099110|528317881|FG004|Overall Study|Protocol Violation|1|||
146495650|NCT02099110|528317877|FG000|Overall Study|Participant moved|1|||
146495651|NCT02099110|528317878|FG001|Overall Study|Participant moved|1|||
146495652|NCT02099110|528317879|FG002|Overall Study|Participant moved|1|||
146495653|NCT02099110|528317880|FG003|Overall Study|Participant moved|0|||
146495654|NCT02099110|528317881|FG004|Overall Study|Participant moved|2|||
146495655|NCT02099110|528317877|FG000|Overall Study|Withdrawal by Subject|7|||
146495656|NCT02099110|528317878|FG001|Overall Study|Withdrawal by Subject|11|||
146495657|NCT02099110|528317879|FG002|Overall Study|Withdrawal by Subject|13|||
146495658|NCT02099110|528317880|FG003|Overall Study|Withdrawal by Subject|9|||
146495659|NCT02099110|528317881|FG004|Overall Study|Withdrawal by Subject|13|||
146495660|NCT02099110|528317877|FG000|Overall Study|Adverse Event|3|||
146495661|NCT02099110|528317878|FG001|Overall Study|Adverse Event|5|||
146495662|NCT02099110|528317879|FG002|Overall Study|Adverse Event|2|||
146495663|NCT02099110|528317880|FG003|Overall Study|Adverse Event|3|||
146495664|NCT02099110|528317881|FG004|Overall Study|Adverse Event|2|||
146495665|NCT02099110|528317877|FG000|Overall Study|Lost to Follow-up|6|||
146495666|NCT02099110|528317878|FG001|Overall Study|Lost to Follow-up|12|||
146495667|NCT02099110|528317879|FG002|Overall Study|Lost to Follow-up|11|||
146495668|NCT02099110|528317880|FG003|Overall Study|Lost to Follow-up|5|||
146495669|NCT02099110|528317881|FG004|Overall Study|Lost to Follow-up|6|||
146495670|NCT02099110|528317877|FG000|Overall Study|Death|0|||
146495671|NCT02099110|528317878|FG001|Overall Study|Death|1|||
146495672|NCT02099110|528317879|FG002|Overall Study|Death|0|||
146495673|NCT02099110|528317880|FG003|Overall Study|Death|0|||
146495674|NCT02099110|528317881|FG004|Overall Study|Death|0|||
146495675|NCT02099110|528317877|FG000|Overall Study|Screen failure|0|||
146495676|NCT02099110|528317878|FG001|Overall Study|Screen failure|0|||
146495677|NCT02099110|528317879|FG002|Overall Study|Screen failure|0|||
146495678|NCT02099110|528317880|FG003|Overall Study|Screen failure|0|||
146495679|NCT02099110|528317881|FG004|Overall Study|Screen failure|1|||
146495680|NCT02099110|528317877|FG000|Overall Study|Non-compliance with study drug|2|||
146495681|NCT02099110|528317878|FG001|Overall Study|Non-compliance with study drug|0|||
146495682|NCT02099110|528317879|FG002|Overall Study|Non-compliance with study drug|0|||
146495683|NCT02099110|528317880|FG003|Overall Study|Non-compliance with study drug|0|||
146495684|NCT02099110|528317881|FG004|Overall Study|Non-compliance with study drug|1|||
146495685|NCT02099110|528317877|FG000|Overall Study|Physician Decision|3|||
146495686|NCT02099110|528317878|FG001|Overall Study|Physician Decision|0|||
146495687|NCT02099110|528317879|FG002|Overall Study|Physician Decision|1|||
146495688|NCT02099110|528317880|FG003|Overall Study|Physician Decision|2|||
146495689|NCT02099110|528317881|FG004|Overall Study|Physician Decision|1|||
146495690|NCT01757184|528317888|FG000|Double-blind Period|Adverse Event|1|||
146495691|NCT01757184|528317889|FG001|Double-blind Period|Adverse Event|0|||
146495692|NCT01757184|528317890|FG002|Double-blind Period|Adverse Event|0|||
146495693|NCT01757184|528317891|FG003|Double-blind Period|Adverse Event|0|||
146495694|NCT01757184|528317888|FG000|Open-label Period|Lost to Follow-up|0|||
146495695|NCT01757184|528317889|FG001|Open-label Period|Lost to Follow-up|0|||
146971741|NCT05919823|530057205|FG000|Open Label Period|Death|0|||
146971742|NCT05919823|530057206|FG001|Open Label Period|Death|0|||
146971743|NCT05919823|530057207|FG002|Open Label Period|Death|0|||
146971744|NCT05919823|530057208|FG003|Open Label Period|Death|1|||
146971745|NCT05919823|530057205|FG000|Open Label Period|Other reasons|0|||
146971746|NCT05919823|530057206|FG001|Open Label Period|Other reasons|0|||
146971747|NCT05919823|530057207|FG002|Open Label Period|Other reasons|9|||
146971748|NCT05919823|530057208|FG003|Open Label Period|Other reasons|5|||
146971749|NCT04521608|530057209|FG000|Overall Study|Death|8|||
146971750|NCT04521608|530057210|FG001|Overall Study|Death|9|||
146971751|NCT04521608|530057209|FG000|Overall Study|Withdrawal by Subject|25|||
146971752|NCT04521608|530057210|FG001|Overall Study|Withdrawal by Subject|18|||
146971753|NCT04521608|530057209|FG000|Overall Study|Disease Progression|3|||
146971754|NCT04521608|530057210|FG001|Overall Study|Disease Progression|10|||
146971755|NCT04521608|530057209|FG000|Overall Study|Complicating Disease|6|||
146971756|NCT04521608|530057210|FG001|Overall Study|Complicating Disease|3|||
146971757|NCT04521608|530057209|FG000|Overall Study|Lost Contact|25|||
146495696|NCT01757184|528317890|FG002|Open-label Period|Lost to Follow-up|2|||
146495697|NCT01757184|528317891|FG003|Open-label Period|Lost to Follow-up|0|||
146495698|NCT01757184|528317888|FG000|Open-label Period|Withdrawal by Subject|0|||
146495699|NCT01757184|528317889|FG001|Open-label Period|Withdrawal by Subject|0|||
146971758|NCT04521608|530057210|FG001|Overall Study|Lost Contact|27|||
146971759|NCT04521608|530057209|FG000|Overall Study|Ineligible|1|||
146564579|NCT00560417|528580012|FG000|Overall Study|Lost to Follow-up|0|||
146564580|NCT00560417|528580013|FG001|Overall Study|Lost to Follow-up|1|||
146564581|NCT00560417|528580012|FG000|Overall Study|Physician Decision|2|||
146495700|NCT01757184|528317890|FG002|Open-label Period|Withdrawal by Subject|1|||
146495701|NCT01757184|528317891|FG003|Open-label Period|Withdrawal by Subject|1|||
146495702|NCT01757184|528317888|FG000|Open-label Period|Discontinued by Sponsor|0|||
146495703|NCT01757184|528317889|FG001|Open-label Period|Discontinued by Sponsor|0|||
146495704|NCT01757184|528317890|FG002|Open-label Period|Discontinued by Sponsor|1|||
146564582|NCT00560417|528580013|FG001|Overall Study|Physician Decision|6|||
146971760|NCT04521608|530057210|FG001|Overall Study|Ineligible|0|||
146971761|NCT04521608|530057209|FG000|Overall Study|Refused Further Study Participation|13|||
146971762|NCT04521608|530057210|FG001|Overall Study|Refused Further Study Participation|7|||
146495705|NCT01757184|528317891|FG003|Open-label Period|Discontinued by Sponsor|2|||
146495706|NCT03515811|528317894|FG000|Overall Study|Lost to Follow-up|2|||
146495707|NCT03515811|528317895|FG001|Overall Study|Lost to Follow-up|1|||
146495708|NCT03515811|528317894|FG000|Overall Study|Protocol Violation|1|||
146495709|NCT03515811|528317895|FG001|Overall Study|Protocol Violation|1|||
146495710|NCT03515811|528317894|FG000|Overall Study|Death|1|||
146495711|NCT03515811|528317895|FG001|Overall Study|Death|1|||
146495712|NCT03515811|528317894|FG000|Overall Study|Withdrawal by Subject|0|||
146495713|NCT03515811|528317895|FG001|Overall Study|Withdrawal by Subject|2|||
146495714|NCT03515811|528317894|FG000|Overall Study|Technical Problems|1|||
146495715|NCT03515811|528317895|FG001|Overall Study|Technical Problems|0|||
146495716|NCT03515811|528317894|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
146495717|NCT03515811|528317895|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
146495718|NCT03515811|528317894|FG000|Overall Study|COVID-19|0|||
146495719|NCT03515811|528317895|FG001|Overall Study|COVID-19|1|||
146495720|NCT02977572|528317896|FG000|Overall Study|Exclusion criterion|2|||
146495721|NCT02977572|528317897|FG001|Overall Study|Exclusion criterion|2|||
146495722|NCT06360588|528319243|FG000|Overall Study|Adverse Event|3|||
146495723|NCT06360588|528319243|FG000|Overall Study|Death|2|||
146495724|NCT06360588|528319243|FG000|Overall Study|Disease Progression|14|||
146495725|NCT06360588|528319243|FG000|Overall Study|Withdrawal by Subject|1|||
146495726|NCT06360588|528319243|FG000|Overall Study|Lack of Efficacy|1|||
146495727|NCT06360588|528319243|FG000|Overall Study|Ineligible|1|||
146495728|NCT00754234|528319244|FG000|Overall Study|Withdrawal by Subject|3|||
146495729|NCT04432831|528319245|FG000|Overall Study|Withdrawal by Subject|24|||
146495730|NCT04432831|528319246|FG001|Overall Study|Withdrawal by Subject|28|||
146495731|NCT04432831|528319247|FG002|Overall Study|Withdrawal by Subject|21|||
146495732|NCT04432831|528319245|FG000|Overall Study|Death|23|||
146495733|NCT04432831|528319246|FG001|Overall Study|Death|23|||
146495734|NCT04432831|528319247|FG002|Overall Study|Death|17|||
146495735|NCT04432831|528319245|FG000|Overall Study|Lost to Follow-up|15|||
146495736|NCT04432831|528319246|FG001|Overall Study|Lost to Follow-up|15|||
146495737|NCT04432831|528319247|FG002|Overall Study|Lost to Follow-up|12|||
146495738|NCT04432831|528319245|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
146495739|NCT04432831|528319246|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
146495740|NCT04432831|528319247|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
146495741|NCT04432831|528319245|FG000|Overall Study|Reason Not Specified|7|||
146495742|NCT04432831|528319246|FG001|Overall Study|Reason Not Specified|11|||
146495743|NCT04432831|528319247|FG002|Overall Study|Reason Not Specified|9|||
146495744|NCT04432831|528319245|FG000|Overall Study|Adverse Event|7|||
146495745|NCT04432831|528319246|FG001|Overall Study|Adverse Event|7|||
146495746|NCT04432831|528319247|FG002|Overall Study|Adverse Event|7|||
146495747|NCT04432831|528319245|FG000|Overall Study|Physician Decision|1|||
146495748|NCT04432831|528319246|FG001|Overall Study|Physician Decision|3|||
146495749|NCT04432831|528319247|FG002|Overall Study|Physician Decision|6|||
146495750|NCT04432831|528319245|FG000|Overall Study|Protocol Violation|1|||
146495751|NCT04432831|528319246|FG001|Overall Study|Protocol Violation|0|||
146495752|NCT04432831|528319247|FG002|Overall Study|Protocol Violation|2|||
146495753|NCT04432831|528319245|FG000|Overall Study|Pregnancy|0|||
146495754|NCT04432831|528319246|FG001|Overall Study|Pregnancy|1|||
146495755|NCT04432831|528319247|FG002|Overall Study|Pregnancy|0|||
146495756|NCT04432831|528319245|FG000|Overall Study|Lack of Efficacy|0|||
146495757|NCT04432831|528319246|FG001|Overall Study|Lack of Efficacy|0|||
146495758|NCT04432831|528319247|FG002|Overall Study|Lack of Efficacy|2|||
146495759|NCT02176655|528319248|FG000|Overall Study|Subjects did not treat|6|||
146495760|NCT06110494|528319249|FG000|Overall Study|Protocol Violation|2|||
146495761|NCT06110494|528319250|FG001|Overall Study|Protocol Violation|0|||
146495762|NCT06110494|528319251|FG002|Overall Study|Protocol Violation|1|||
146495763|NCT06110494|528319249|FG000|Overall Study|Dixon's test for outlier analysis|1|||
146495764|NCT06110494|528319250|FG001|Overall Study|Dixon's test for outlier analysis|1|||
146495765|NCT06110494|528319251|FG002|Overall Study|Dixon's test for outlier analysis|0|||
146495766|NCT01073605|528319252|FG000|Overall Study|Ongoing at Cutoff Date|1|||
146495767|NCT01073605|528319253|FG001|Overall Study|Ongoing at Cutoff Date|1|||
146495768|NCT01073605|528319254|FG002|Overall Study|Ongoing at Cutoff Date|0|||
146495769|NCT01073605|528319252|FG000|Overall Study|Adverse Event|2|||
146495770|NCT01073605|528319253|FG001|Overall Study|Adverse Event|1|||
146495771|NCT01073605|528319254|FG002|Overall Study|Adverse Event|0|||
146495772|NCT01073605|528319252|FG000|Overall Study|Lost to Follow-up|3|||
146495773|NCT01073605|528319253|FG001|Overall Study|Lost to Follow-up|4|||
146495774|NCT01073605|528319254|FG002|Overall Study|Lost to Follow-up|9|||
146495775|NCT01073605|528319252|FG000|Overall Study|Other|25|||
146495776|NCT01073605|528319253|FG001|Overall Study|Other|21|||
146495777|NCT01073605|528319254|FG002|Overall Study|Other|29|||
146495778|NCT01073605|528319252|FG000|Overall Study|Withdrawal by Subject|31|||
146495779|NCT01073605|528319253|FG001|Overall Study|Withdrawal by Subject|39|||
146495780|NCT01073605|528319254|FG002|Overall Study|Withdrawal by Subject|22|||
146495781|NCT01073605|528319252|FG000|Overall Study|Randomized But Not Treated|0|||
146495782|NCT01073605|528319253|FG001|Overall Study|Randomized But Not Treated|1|||
146495783|NCT01073605|528319254|FG002|Overall Study|Randomized But Not Treated|1|||
146495784|NCT03018080|528319255|FG000|Overall Study|Death|12|||
146495785|NCT03018080|528319256|FG001|Overall Study|Death|19|||
146495786|NCT00179660|528319269|FG000|Overall Study|Adverse Event|7|||
146495787|NCT00179660|528319269|FG000|Overall Study|Lack of therapeutic effect|28|||
146495788|NCT00179660|528319269|FG000|Overall Study|Withdrawal by Subject|2|||
146495789|NCT00179660|528319269|FG000|Overall Study|Lost to Follow-up|1|||
146495790|NCT00179660|528319269|FG000|Overall Study|Death|3|||
146495791|NCT00179660|528319269|FG000|Overall Study|Other - Unspecified|9|||
146495792|NCT00402688|528319273|FG000|Overall Study|Adverse Event|12|||
146495793|NCT00402688|528319274|FG001|Overall Study|Adverse Event|9|||
146495794|NCT00402688|528319275|FG002|Overall Study|Adverse Event|3|||
146495795|NCT00402688|528319273|FG000|Overall Study|Withdrawal by Subject|3|||
146495796|NCT00402688|528319274|FG001|Overall Study|Withdrawal by Subject|1|||
146495797|NCT00402688|528319275|FG002|Overall Study|Withdrawal by Subject|1|||
146495798|NCT00402688|528319273|FG000|Overall Study|Physician Decision|0|||
146495799|NCT00402688|528319274|FG001|Overall Study|Physician Decision|0|||
146495800|NCT00402688|528319275|FG002|Overall Study|Physician Decision|1|||
146495801|NCT00402688|528319273|FG000|Overall Study|Lack of Efficacy|4|||
146495802|NCT00402688|528319274|FG001|Overall Study|Lack of Efficacy|4|||
146495803|NCT00402688|528319275|FG002|Overall Study|Lack of Efficacy|5|||
146495804|NCT00402688|528319273|FG000|Overall Study|Protocol Violation|1|||
146495805|NCT00402688|528319274|FG001|Overall Study|Protocol Violation|1|||
146495806|NCT00402688|528319275|FG002|Overall Study|Protocol Violation|1|||
146495807|NCT00402688|528319273|FG000|Overall Study|Lost to Follow-up|1|||
146495808|NCT00402688|528319274|FG001|Overall Study|Lost to Follow-up|0|||
146495809|NCT00402688|528319275|FG002|Overall Study|Lost to Follow-up|2|||
146495810|NCT00402688|528319273|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
146495811|NCT00402688|528319274|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
146495812|NCT00402688|528319275|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
146495813|NCT00402688|528319273|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
146495814|NCT00402688|528319274|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
146495815|NCT00402688|528319275|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
146495816|NCT00402688|528319273|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
146495817|NCT00402688|528319274|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
146495818|NCT00402688|528319275|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
146495819|NCT01431716|528319288|FG000|Overall Study|Withdrawal of consent|1|||
146495820|NCT01053663|528319289|FG000|Overall Study|Death|2|||
146495821|NCT01053663|528319289|FG000|Overall Study|Lost to Follow-up|1|||
146495822|NCT01053663|528319289|FG000|Overall Study|Poor IV Access|1|||
146495823|NCT01053663|528319289|FG000|Overall Study|Transferred to Another Hospital|1|||
146495824|NCT01053663|528319289|FG000|Overall Study|Negative Influenza Diagnosis|1|||
146495825|NCT02737930|528319292|FG000|Overall Study|Withdrawal by Subject|0|||
146495826|NCT02737930|528319293|FG001|Overall Study|Withdrawal by Subject|1|||
146495827|NCT00708214|528319294|FG000|Overall Study|Other Adverse Event|3|||
146495828|NCT00708214|528319295|FG001|Overall Study|Other Adverse Event|6|||
146495829|NCT00708214|528319296|FG002|Overall Study|Other Adverse Event|2|||
146495830|NCT00708214|528319294|FG000|Overall Study|Other|0|||
146495831|NCT00708214|528319295|FG001|Overall Study|Other|1|||
146495832|NCT00708214|528319296|FG002|Overall Study|Other|1|||
146495833|NCT00708214|528319294|FG000|Overall Study|Progressive Disease|4|||
146495834|NCT00708214|528319295|FG001|Overall Study|Progressive Disease|6|||
146495835|NCT00708214|528319296|FG002|Overall Study|Progressive Disease|5|||
146495836|NCT05708976|528319306|FG000|Overall Study|Withdrawal by Subject|0|||
146495837|NCT05708976|528319307|FG001|Overall Study|Withdrawal by Subject|1|||
146495838|NCT00183885|528319310|FG000|Overall Study|Adverse Event|11|||
146495839|NCT00183885|528319310|FG000|Overall Study|Death|1|||
146495840|NCT00183885|528319310|FG000|Overall Study|Lost to Follow-up|3|||
146495841|NCT00183885|528319310|FG000|Overall Study|Physician Decision|6|||
146495842|NCT00183885|528319310|FG000|Overall Study|Withdrawal by Subject|5|||
146495843|NCT00183885|528319310|FG000|Overall Study|Switched to alternative treatment|8|||
146495844|NCT00183885|528319310|FG000|Overall Study|Treatment delayed too long|4|||
146495845|NCT00183885|528319310|FG000|Overall Study|Developed second malignancy|1|||
146495846|NCT00014495|528319311|FG000|Overall Study|Death|0|||
146495847|NCT00014495|528319312|FG001|Overall Study|Death|0|||
146495848|NCT00014495|528319313|FG002|Overall Study|Death|1|||
146495849|NCT00014495|528319314|FG003|Overall Study|Death|0|||
146495850|NCT00014495|528319311|FG000|Overall Study|Clinical deterioration|0|||
146495851|NCT00014495|528319312|FG001|Overall Study|Clinical deterioration|0|||
146495852|NCT00014495|528319313|FG002|Overall Study|Clinical deterioration|0|||
146564583|NCT00560417|528580012|FG000|Overall Study|Protocol Violation|6|||
146495853|NCT00014495|528319314|FG003|Overall Study|Clinical deterioration|1|||
146495854|NCT02929589|528319348|FG000|Overall Study|Withdrawal by Subject|1|||
146495855|NCT02929589|528319349|FG001|Overall Study|Withdrawal by Subject|0|||
146495856|NCT02929589|528319350|FG002|Overall Study|Withdrawal by Subject|0|||
146495857|NCT02929589|528319351|FG003|Overall Study|Withdrawal by Subject|0|||
146495858|NCT02929589|528319348|FG000|Overall Study|Physician Decision|2|||
146495859|NCT02929589|528319349|FG001|Overall Study|Physician Decision|0|||
146495860|NCT02929589|528319350|FG002|Overall Study|Physician Decision|0|||
146495861|NCT02929589|528319351|FG003|Overall Study|Physician Decision|0|||
146495862|NCT02091089|528319352|FG000|Overall Study|Lost to Follow-up|2|||
146495863|NCT01303172|528319358|FG000|Overall Study|Physician Decision|9|||
146495864|NCT01303172|528319359|FG001|Overall Study|Physician Decision|6|||
146495865|NCT01303172|528319358|FG000|Overall Study|Adverse Event|5|||
146495866|NCT01303172|528319359|FG001|Overall Study|Adverse Event|2|||
146495867|NCT01303172|528319358|FG000|Overall Study|Withdrawal by Subject|4|||
146495868|NCT01303172|528319359|FG001|Overall Study|Withdrawal by Subject|2|||
146495869|NCT01303172|528319358|FG000|Overall Study|Death|20|||
146495870|NCT01303172|528319359|FG001|Overall Study|Death|7|||
146495871|NCT01303172|528319358|FG000|Overall Study|Lack of Efficacy|25|||
146495872|NCT01303172|528319359|FG001|Overall Study|Lack of Efficacy|17|||
146495873|NCT00994461|528319362|FG000|Overall Study|Adverse Event|2|||
146495874|NCT00994461|528319363|FG001|Overall Study|Adverse Event|1|||
146495875|NCT00994461|528319364|FG002|Overall Study|Adverse Event|0|||
146495876|NCT00591565|528319369|FG000|Overall Study|lost follow up, withdrawn|5|||
146495877|NCT01863667|528319371|FG000|Overall Study|Adverse Event|1|||
146495878|NCT01863667|528319372|FG001|Overall Study|Adverse Event|0|||
146495879|NCT01863667|528319371|FG000|Overall Study|Study terminated by Sponsor|30|||
146495880|NCT01863667|528319372|FG001|Overall Study|Study terminated by Sponsor|30|||
146495881|NCT01863667|528319371|FG000|Overall Study|Withdrawal by Subject|2|||
146495882|NCT01863667|528319372|FG001|Overall Study|Withdrawal by Subject|2|||
146495883|NCT03627546|528319375|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
146495884|NCT03627546|528319376|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
146495885|NCT03627546|528319377|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
146495886|NCT03627546|528319375|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
146495887|NCT03627546|528319376|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
146495888|NCT03627546|528319377|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
146495889|NCT00615550|528319378|FG000|Overall Study|Lost to Follow-up|6|||
146495890|NCT00615550|528319379|FG001|Overall Study|Lost to Follow-up|1|||
146495891|NCT01537042|528319380|FG000|Overall Study|Adverse Event|0|||
146495892|NCT01537042|528319381|FG001|Overall Study|Adverse Event|2|||
146495893|NCT01537042|528319380|FG000|Overall Study|Lack of Efficacy|0|||
146495894|NCT01537042|528319381|FG001|Overall Study|Lack of Efficacy|1|||
146495895|NCT01537042|528319380|FG000|Overall Study|Protocol Violation|0|||
146495896|NCT01537042|528319381|FG001|Overall Study|Protocol Violation|1|||
146495897|NCT01537042|528319380|FG000|Overall Study|Other|0|||
146495898|NCT01537042|528319381|FG001|Overall Study|Other|1|||
146495899|NCT02741076|528319382|FG000|Overall Study|Adverse Event|0|||
146495900|NCT02741076|528319383|FG001|Overall Study|Adverse Event|1|||
146495901|NCT02741076|528319384|FG002|Overall Study|Adverse Event|1|||
146971763|NCT00285012|530057213|FG000|Assigned to Study Treatment (Tx)|Other|2|||
146971764|NCT00285012|530057214|FG001|Assigned to Study Treatment (Tx)|Other|3|||
146971765|NCT00285012|530057213|FG000|Received Study Tx|Death|2|||
146971766|NCT00285012|530057214|FG001|Received Study Tx|Death|1|||
146971767|NCT00285012|530057213|FG000|Received Study Tx|Adverse Event|5|||
146971768|NCT00285012|530057214|FG001|Received Study Tx|Adverse Event|11|||
146971769|NCT00285012|530057213|FG000|Received Study Tx|Lack of Efficacy|0|||
146971770|NCT00285012|530057214|FG001|Received Study Tx|Lack of Efficacy|3|||
146971771|NCT00285012|530057213|FG000|Received Study Tx|Lost to Follow-up|29|||
146971772|NCT00285012|530057214|FG001|Received Study Tx|Lost to Follow-up|31|||
146971773|NCT00285012|530057213|FG000|Received Study Tx|Withdrawal by Subject|31|||
146971774|NCT00285012|530057214|FG001|Received Study Tx|Withdrawal by Subject|43|||
146971775|NCT00285012|530057213|FG000|Received Study Tx|Other|5|||
146971776|NCT00285012|530057214|FG001|Received Study Tx|Other|5|||
146971777|NCT04050293|530057218|FG000|Overall Study|Lost to Follow-up|1|||
146971778|NCT04050293|530057219|FG001|Overall Study|Lost to Follow-up|2|||
146971779|NCT04050293|530057218|FG000|Overall Study|Withdrawal by Subject|2|||
146971780|NCT04050293|530057219|FG001|Overall Study|Withdrawal by Subject|0|||
146971781|NCT05631093|530057222|FG000|Overall Study|Death|0|||
146971782|NCT05631093|530057223|FG001|Overall Study|Death|1|||
146495902|NCT02741076|528319385|FG003|Overall Study|Adverse Event|0|||
146495903|NCT02741076|528319382|FG000|Overall Study|Lack of Efficacy|1|||
146495904|NCT02741076|528319383|FG001|Overall Study|Lack of Efficacy|0|||
146495905|NCT02741076|528319384|FG002|Overall Study|Lack of Efficacy|0|||
146495906|NCT02741076|528319385|FG003|Overall Study|Lack of Efficacy|0|||
146495907|NCT02741076|528319382|FG000|Overall Study|Withdrawal by Subject|0|||
146495908|NCT02741076|528319383|FG001|Overall Study|Withdrawal by Subject|1|||
146495909|NCT02741076|528319384|FG002|Overall Study|Withdrawal by Subject|0|||
146495910|NCT02741076|528319385|FG003|Overall Study|Withdrawal by Subject|0|||
146495911|NCT02741076|528319382|FG000|Overall Study|Sponsor Request|2|||
146495912|NCT02741076|528319383|FG001|Overall Study|Sponsor Request|3|||
146495913|NCT02741076|528319384|FG002|Overall Study|Sponsor Request|0|||
146495914|NCT02741076|528319385|FG003|Overall Study|Sponsor Request|1|||
146495915|NCT02741076|528319382|FG000|Overall Study|No additional information available|0|||
146971783|NCT05631093|530057222|FG000|Overall Study|Lost to Follow-up|1|||
146971784|NCT05631093|530057223|FG001|Overall Study|Lost to Follow-up|2|||
146971785|NCT05631093|530057222|FG000|Overall Study|Physician Decision|1|||
146971786|NCT05631093|530057223|FG001|Overall Study|Physician Decision|0|||
146643510|NCT00966875|528872176|FG007|Part A|Withdrawal by Subject|1|||
146643511|NCT00966875|528872177|FG008|Part A|Withdrawal by Subject|1|||
146643512|NCT00966875|528872169|FG000|Part A|Protocol Violation|0|||
146643513|NCT00966875|528872170|FG001|Part A|Protocol Violation|0|||
146643514|NCT00966875|528872171|FG002|Part A|Protocol Violation|0|||
146643515|NCT00966875|528872172|FG003|Part A|Protocol Violation|0|||
146643516|NCT00966875|528872173|FG004|Part A|Protocol Violation|0|||
146643517|NCT00966875|528872174|FG005|Part A|Protocol Violation|0|||
146495916|NCT02741076|528319383|FG001|Overall Study|No additional information available|0|||
146495917|NCT02741076|528319384|FG002|Overall Study|No additional information available|1|||
146495918|NCT02741076|528319385|FG003|Overall Study|No additional information available|1|||
146495919|NCT02965573|528319389|FG000|Overall Study|Lack of Efficacy|1|||
146643518|NCT00966875|528872175|FG006|Part A|Protocol Violation|2|||
146643519|NCT00966875|528872176|FG007|Part A|Protocol Violation|1|||
146643520|NCT00966875|528872177|FG008|Part A|Protocol Violation|1|||
146643521|NCT00966875|528872169|FG000|Part B|Adverse Event|0|||
146495920|NCT02965573|528319390|FG001|Overall Study|Lack of Efficacy|0|||
146495921|NCT01779440|528319391|FG000|Overall Study|Withdrawal by Subject|3|||
146495922|NCT01779440|528319392|FG001|Overall Study|Withdrawal by Subject|5|||
146495923|NCT00315458|528319393|FG000|Overall Study|Administrative|0|||
146495924|NCT00315458|528319394|FG001|Overall Study|Administrative|3|||
146495925|NCT00315458|528319395|FG002|Overall Study|Administrative|8|||
146495926|NCT00315458|528319396|FG003|Overall Study|Administrative|21|||
146495927|NCT00315458|528319393|FG000|Overall Study|Adverse Event|2|||
146495928|NCT00315458|528319394|FG001|Overall Study|Adverse Event|4|||
146495929|NCT00315458|528319395|FG002|Overall Study|Adverse Event|23|||
146495930|NCT00315458|528319396|FG003|Overall Study|Adverse Event|3|||
146643522|NCT00966875|528872170|FG001|Part B|Adverse Event|1|||
146495931|NCT00315458|528319393|FG000|Overall Study|Lost to Follow-up|1|||
146495932|NCT00315458|528319394|FG001|Overall Study|Lost to Follow-up|2|||
146495933|NCT00315458|528319395|FG002|Overall Study|Lost to Follow-up|0|||
146495934|NCT00315458|528319396|FG003|Overall Study|Lost to Follow-up|2|||
146495935|NCT00315458|528319393|FG000|Overall Study|Withdrawal by Subject|0|||
146495936|NCT00315458|528319394|FG001|Overall Study|Withdrawal by Subject|3|||
146495937|NCT00315458|528319395|FG002|Overall Study|Withdrawal by Subject|0|||
146495938|NCT00315458|528319396|FG003|Overall Study|Withdrawal by Subject|2|||
146495939|NCT00315458|528319393|FG000|Overall Study|Lack of Efficacy|0|||
146495940|NCT00315458|528319394|FG001|Overall Study|Lack of Efficacy|0|||
146495941|NCT00315458|528319395|FG002|Overall Study|Lack of Efficacy|20|||
146495942|NCT00315458|528319396|FG003|Overall Study|Lack of Efficacy|1|||
146495943|NCT00315458|528319393|FG000|Overall Study|Did not qualify|0|||
146495944|NCT00315458|528319394|FG001|Overall Study|Did not qualify|0|||
146495945|NCT00315458|528319395|FG002|Overall Study|Did not qualify|1|||
146643523|NCT00966875|528872171|FG002|Part B|Adverse Event|1|||
146643524|NCT00966875|528872172|FG003|Part B|Adverse Event|0|||
146643525|NCT00966875|528872173|FG004|Part B|Adverse Event|1|||
146643526|NCT00966875|528872174|FG005|Part B|Adverse Event|0|||
146495946|NCT00315458|528319396|FG003|Overall Study|Did not qualify|0|||
146495947|NCT00523848|528319397|FG000|Overall Study|Adverse Event|11|||
146495948|NCT00523848|528319397|FG000|Overall Study|Withdrawal by Subject|2|||
146495949|NCT00523848|528319397|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
146495950|NCT00523848|528319397|FG000|Overall Study|Disease Progression|5|||
146495951|NCT00523848|528319397|FG000|Overall Study|Other, unspecified|4|||
146495952|NCT00086619|528319398|FG000|Overall Study|Withdrawal by Subject|6|||
146495953|NCT00086619|528319399|FG001|Overall Study|Withdrawal by Subject|6|||
146495954|NCT00086619|528319398|FG000|Overall Study|Adverse Event|8|||
146495955|NCT00086619|528319399|FG001|Overall Study|Adverse Event|10|||
146495956|NCT00086619|528319398|FG000|Overall Study|Protocol Violation|1|||
146495957|NCT00086619|528319399|FG001|Overall Study|Protocol Violation|1|||
146495958|NCT00489918|528319400|FG000|Overall Study|Withdrawal by Subject|2|||
146495959|NCT00489918|528319401|FG001|Overall Study|Withdrawal by Subject|1|||
146495960|NCT00489918|528319402|FG002|Overall Study|Withdrawal by Subject|1|||
146643527|NCT00966875|528872175|FG006|Part B|Adverse Event|5|||
146643528|NCT00966875|528872176|FG007|Part B|Adverse Event|2|||
146643529|NCT00966875|528872177|FG008|Part B|Adverse Event|2|||
146495961|NCT00489918|528319403|FG003|Overall Study|Withdrawal by Subject|0|||
146495962|NCT00489918|528319404|FG004|Overall Study|Withdrawal by Subject|1|||
146495963|NCT00489918|528319400|FG000|Overall Study|Adverse Event|0|||
146495964|NCT00489918|528319401|FG001|Overall Study|Adverse Event|1|||
146495965|NCT00489918|528319402|FG002|Overall Study|Adverse Event|1|||
146495966|NCT00489918|528319403|FG003|Overall Study|Adverse Event|0|||
146495967|NCT00489918|528319404|FG004|Overall Study|Adverse Event|0|||
146495968|NCT00489918|528319400|FG000|Overall Study|Lost to Follow-up|0|||
146643530|NCT00966875|528872169|FG000|Part B|Death|0|||
146643531|NCT00966875|528872170|FG001|Part B|Death|0|||
146643532|NCT00966875|528872171|FG002|Part B|Death|1|||
146643533|NCT00966875|528872172|FG003|Part B|Death|0|||
146643534|NCT00966875|528872173|FG004|Part B|Death|0|||
146643535|NCT00966875|528872174|FG005|Part B|Death|0|||
146643536|NCT00966875|528872175|FG006|Part B|Death|0|||
146643537|NCT00966875|528872176|FG007|Part B|Death|1|||
146643538|NCT00966875|528872177|FG008|Part B|Death|0|||
146971787|NCT05631093|530057222|FG000|Overall Study|Withdrawal by Subject|4|||
146971788|NCT05631093|530057223|FG001|Overall Study|Withdrawal by Subject|1|||
146971789|NCT05631093|530057222|FG000|Overall Study|Ongoing|353|||
146971790|NCT05631093|530057223|FG001|Overall Study|Ongoing|177|||
146971791|NCT05631093|530057222|FG000|Overall Study|Adverse Event|0|||
146971792|NCT05631093|530057223|FG001|Overall Study|Adverse Event|1|||
146971793|NCT00005879|530057237|FG000|Overall Study|Withdrawal by Subject|8|||
146495969|NCT00489918|528319401|FG001|Overall Study|Lost to Follow-up|0|||
146495970|NCT00489918|528319402|FG002|Overall Study|Lost to Follow-up|1|||
146495971|NCT00489918|528319403|FG003|Overall Study|Lost to Follow-up|1|||
146495972|NCT00489918|528319404|FG004|Overall Study|Lost to Follow-up|0|||
146495973|NCT00489918|528319400|FG000|Overall Study|Physician Decision|0|||
146495974|NCT00489918|528319401|FG001|Overall Study|Physician Decision|0|||
146495975|NCT00489918|528319402|FG002|Overall Study|Physician Decision|1|||
146495976|NCT00489918|528319403|FG003|Overall Study|Physician Decision|0|||
146495977|NCT00489918|528319404|FG004|Overall Study|Physician Decision|0|||
146495978|NCT02748213|528319405|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
146495979|NCT02748213|528319406|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
146495980|NCT02748213|528319405|FG000|Overall Study|Abnormal Laboratory Test|1|||
146495981|NCT02748213|528319406|FG001|Overall Study|Abnormal Laboratory Test|0|||
146495982|NCT02748213|528319405|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
146495983|NCT02748213|528319406|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
146495984|NCT02748213|528319405|FG000|Overall Study|Death|5|||
146495985|NCT02748213|528319406|FG001|Overall Study|Death|3|||
146495986|NCT02748213|528319405|FG000|Overall Study|Insufficient Therapeutic Response|56|||
146495987|NCT02748213|528319406|FG001|Overall Study|Insufficient Therapeutic Response|57|||
146495988|NCT02748213|528319405|FG000|Overall Study|Violation of Selection Criteria|2|||
146495989|NCT02748213|528319406|FG001|Overall Study|Violation of Selection Criteria|0|||
146495990|NCT02748213|528319405|FG000|Overall Study|Protocol Violation|6|||
146495991|NCT02748213|528319406|FG001|Overall Study|Protocol Violation|4|||
146495992|NCT02748213|528319405|FG000|Overall Study|Refused Treatment*|6|||
146495993|NCT02748213|528319406|FG001|Overall Study|Refused Treatment*|6|||
146495994|NCT02748213|528319405|FG000|Overall Study|Failure to Return|1|||
146971794|NCT00005879|530057238|FG001|Overall Study|Withdrawal by Subject|10|||
146971795|NCT01238172|530057239|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
146971796|NCT01238172|530057240|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
146971797|NCT01238172|530057239|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
146971798|NCT01238172|530057240|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
146971799|NCT05022121|530057241|FG000|Overall Study|Lack of Efficacy|1|||
146971800|NCT05022121|530057242|FG001|Overall Study|Lack of Efficacy|0|||
146971801|NCT05022121|530057241|FG000|Overall Study|Lost to Follow-up|0|||
146971802|NCT05022121|530057242|FG001|Overall Study|Lost to Follow-up|2|||
146971803|NCT05257109|530057249|FG000|Overall Study|Withdrawal by Subject|1|||
146971804|NCT05257109|530057250|FG001|Overall Study|Withdrawal by Subject|0|||
146971805|NCT05257109|530057251|FG002|Overall Study|Withdrawal by Subject|0|||
146971806|NCT05257109|530057252|FG003|Overall Study|Withdrawal by Subject|0|||
146971807|NCT00391092|530058455|FG000|Overall Study|Death|78|||
146971808|NCT00391092|530058456|FG001|Overall Study|Death|81|||
146971809|NCT00391092|530058455|FG000|Overall Study|Lost to Follow-up|13|||
146971810|NCT00391092|530058456|FG001|Overall Study|Lost to Follow-up|18|||
146971811|NCT00391092|530058455|FG000|Overall Study|Alive on treatment|29|||
146971812|NCT00391092|530058456|FG001|Overall Study|Alive on treatment|33|||
146971813|NCT00391092|530058455|FG000|Overall Study|Alive in follow-up|88|||
146971814|NCT00391092|530058456|FG001|Overall Study|Alive in follow-up|84|||
146971815|NCT00424515|530058459|FG000|Overall Study|Progressive Disease|10|||
146971816|NCT00424515|530058460|FG001|Overall Study|Progressive Disease|11|||
146971817|NCT00424515|530058459|FG000|Overall Study|Adverse Event|0|||
146564584|NCT00560417|528580013|FG001|Overall Study|Protocol Violation|5|||
146564585|NCT00560417|528580012|FG000|Overall Study|Sponsor Decision|2|||
146564586|NCT00560417|528580013|FG001|Overall Study|Sponsor Decision|0|||
146971818|NCT00424515|530058460|FG001|Overall Study|Adverse Event|1|||
146971819|NCT00424515|530058459|FG000|Overall Study|Intercurrent Illness|0|||
146971820|NCT00424515|530058460|FG001|Overall Study|Intercurrent Illness|1|||
146971821|NCT00424515|530058459|FG000|Overall Study|Withdrawal by Subject|1|||
146971822|NCT00424515|530058460|FG001|Overall Study|Withdrawal by Subject|0|||
146495995|NCT02748213|528319406|FG001|Overall Study|Failure to Return|0|||
146495996|NCT02748213|528319405|FG000|Overall Study|Other|30|||
146495997|NCT02748213|528319406|FG001|Overall Study|Other|29|||
146564587|NCT00560417|528580012|FG000|Overall Study|Withdrawal by Subject|3|||
146971823|NCT04071366|530058461|FG000|Part 1: Open-label (29 Days)|Death|4|||
146971824|NCT04071366|530058462|FG001|Part 1: Open-label (29 Days)|Death|2|||
146971825|NCT04071366|530058463|FG002|Part 1: Open-label (29 Days)|Death|8|||
146971826|NCT04071366|530058464|FG003|Part 1: Open-label (29 Days)|Death|0|||
146495998|NCT00961350|528319408|FG000|Overall Study|Adverse Event|18|||
146564588|NCT00560417|528580013|FG001|Overall Study|Withdrawal by Subject|3|||
146971827|NCT04071366|530058465|FG004|Part 1: Open-label (29 Days)|Death|0|||
146971828|NCT04071366|530058461|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
146495999|NCT00961350|528319409|FG001|Overall Study|Adverse Event|33|||
146496000|NCT00961350|528319408|FG000|Overall Study|Withdrawal by Subject|10|||
146496001|NCT00961350|528319409|FG001|Overall Study|Withdrawal by Subject|10|||
146496002|NCT00961350|528319408|FG000|Overall Study|Lost to Follow-up|3|||
146496003|NCT00961350|528319409|FG001|Overall Study|Lost to Follow-up|3|||
146496004|NCT00961350|528319408|FG000|Overall Study|Misc|16|||
146496005|NCT00961350|528319409|FG001|Overall Study|Misc|21|||
146496007|NCT01760655|528321208|FG000|Overall Study|Death|18|||
146496008|NCT01760655|528321208|FG000|Overall Study|Physician Decision|1|||
146496009|NCT03056638|528321221|FG000|Overall Study|Death|1|||
146496010|NCT03056638|528321222|FG001|Overall Study|Death|0|||
146496011|NCT02530125|528321223|FG000|Completed Treatment|Early termination of study|1|||
146496012|NCT02530125|528321223|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
146496013|NCT00468481|528321225|FG000|Overall Study|Adverse Event|13|||
146496014|NCT00468481|528321226|FG001|Overall Study|Adverse Event|3|||
146496015|NCT00468481|528321225|FG000|Overall Study|Lost to Follow-up|25|||
146496016|NCT00468481|528321226|FG001|Overall Study|Lost to Follow-up|8|||
146496017|NCT00468481|528321225|FG000|Overall Study|Pregnancy|2|||
146496018|NCT00468481|528321226|FG001|Overall Study|Pregnancy|0|||
146496019|NCT00468481|528321225|FG000|Overall Study|Protocol Violation|18|||
146496020|NCT00468481|528321226|FG001|Overall Study|Protocol Violation|8|||
146496021|NCT00468481|528321225|FG000|Overall Study|Withdrawal by Subject|12|||
146496022|NCT00468481|528321226|FG001|Overall Study|Withdrawal by Subject|3|||
146496023|NCT00468481|528321225|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
146496024|NCT00468481|528321226|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
146496025|NCT00468481|528321225|FG000|Overall Study|Prohibited Medication|1|||
146496026|NCT00468481|528321226|FG001|Overall Study|Prohibited Medication|1|||
146496027|NCT00468481|528321225|FG000|Overall Study|Egg Donor|1|||
146496028|NCT00468481|528321226|FG001|Overall Study|Egg Donor|0|||
146496029|NCT00468481|528321225|FG000|Overall Study|Moved out of area|4|||
146496030|NCT00468481|528321226|FG001|Overall Study|Moved out of area|1|||
146496031|NCT00468481|528321225|FG000|Overall Study|Non-Compliance|5|||
146496032|NCT00468481|528321226|FG001|Overall Study|Non-Compliance|0|||
146496033|NCT00468481|528321225|FG000|Overall Study|Other|6|||
146496034|NCT00468481|528321226|FG001|Overall Study|Other|0|||
146496035|NCT01568034|528321228|FG000|Overall Study|Withdrawal by Subject|1|||
146496036|NCT01568034|528321229|FG001|Overall Study|Withdrawal by Subject|0|||
146496037|NCT01568034|528321230|FG002|Overall Study|Withdrawal by Subject|0|||
146496038|NCT01568034|528321231|FG003|Overall Study|Withdrawal by Subject|0|||
146496039|NCT00728468|528321232|FG000|Overall Study|Enrolled but not treated|1|||
146496040|NCT00728468|528321232|FG000|Overall Study|Death|1|||
146496041|NCT00728468|528321232|FG000|Overall Study|Protocol Violation|4|||
146496042|NCT00728468|528321232|FG000|Overall Study|Objective progression or relapse|9|||
146496043|NCT00728468|528321232|FG000|Overall Study|Study terminated by sponsor|1|||
146496044|NCT01637922|528321233|FG000|Overall Study|Adverse Event|0|||
146496045|NCT01637922|528321234|FG001|Overall Study|Adverse Event|1|||
146496046|NCT01637922|528321233|FG000|Overall Study|Protocol Violation|0|||
146496047|NCT01637922|528321234|FG001|Overall Study|Protocol Violation|1|||
146496048|NCT01637922|528321233|FG000|Overall Study|Withdrawal by Subject|0|||
146496049|NCT01637922|528321234|FG001|Overall Study|Withdrawal by Subject|3|||
146496050|NCT01637922|528321233|FG000|Overall Study|Lost to Follow-up|2|||
146496051|NCT01637922|528321234|FG001|Overall Study|Lost to Follow-up|0|||
146496052|NCT03656692|528321237|FG000|Overall Study|Worsening of disease activity|2|||
146768887|NCT04707313|529321803|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
146971829|NCT04071366|530058462|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
146496053|NCT03656692|528321237|FG000|Overall Study|Physician Decision|1|||
146496054|NCT02498444|528321238|FG000|Overall Study|Withdrawal by Subject|3|||
146496055|NCT02498444|528321239|FG001|Overall Study|Withdrawal by Subject|0|||
146564589|NCT01870869|528580016|FG000|Overall Study|Implanted with nonstudy device|1|||
146564590|NCT01870869|528580017|FG001|Overall Study|Implanted with nonstudy device|3|||
146564591|NCT01870869|528580018|FG002|Overall Study|Implanted with nonstudy device|14|||
146564592|NCT01870869|528580019|FG003|Overall Study|Implanted with nonstudy device|4|||
146564593|NCT01870869|528580016|FG000|Overall Study|Death|0|||
146564594|NCT01870869|528580017|FG001|Overall Study|Death|0|||
146564595|NCT01870869|528580018|FG002|Overall Study|Death|7|||
146564596|NCT01870869|528580019|FG003|Overall Study|Death|1|||
146564597|NCT01870869|528580016|FG000|Overall Study|Subject choice|6|||
146971830|NCT04071366|530058463|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
146971831|NCT04071366|530058464|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
146496056|NCT02498444|528321238|FG000|Overall Study|Physician Decision|1|||
146496057|NCT02498444|528321239|FG001|Overall Study|Physician Decision|0|||
146496058|NCT01841762|528321240|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
146496059|NCT01841762|528321240|FG000|Treatment Period|Adverse Event|16|||
146496060|NCT01841762|528321240|FG000|Treatment Period|Death|1|||
146496061|NCT01841762|528321240|FG000|Treatment Period|Withdrawal by Subject|7|||
146496062|NCT01841762|528321240|FG000|Treatment Period|Lost to Follow-up|1|||
146496063|NCT01841762|528321240|FG000|Treatment Period|Physician Decision|2|||
146496064|NCT01841762|528321240|FG000|Treatment Period|Other, including non-compliance|5|||
146496065|NCT01841762|528321240|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
146496066|NCT01841762|528321240|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
146496067|NCT01841762|528321240|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
146496068|NCT01841762|528321240|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
146496069|NCT02448537|528321241|FG000|Overall Study|Withdrawal by Subject|1|||
146496070|NCT02448537|528321242|FG001|Overall Study|Withdrawal by Subject|1|||
146496071|NCT02448537|528321243|FG002|Overall Study|Withdrawal by Subject|1|||
146496072|NCT01270464|528321244|FG000|Overall Study|Protocol Violation|4|||
146496073|NCT01270464|528321245|FG001|Overall Study|Protocol Violation|3|||
146496074|NCT01270464|528321246|FG002|Overall Study|Protocol Violation|2|||
146496075|NCT01270464|528321244|FG000|Overall Study|Lack of Efficacy|2|||
146971832|NCT04071366|530058465|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
146971833|NCT04071366|530058461|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
146971834|NCT04071366|530058462|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
146496076|NCT01270464|528321245|FG001|Overall Study|Lack of Efficacy|3|||
146496077|NCT01270464|528321246|FG002|Overall Study|Lack of Efficacy|1|||
146496078|NCT01270464|528321244|FG000|Overall Study|Adverse Event|9|||
146496079|NCT01270464|528321245|FG001|Overall Study|Adverse Event|1|||
146496080|NCT01270464|528321246|FG002|Overall Study|Adverse Event|7|||
146496081|NCT01270464|528321244|FG000|Overall Study|Withdrawal by Subject|2|||
146496082|NCT01270464|528321245|FG001|Overall Study|Withdrawal by Subject|1|||
146496083|NCT01270464|528321246|FG002|Overall Study|Withdrawal by Subject|4|||
146496084|NCT01270464|528321244|FG000|Overall Study|Lost to Follow-up|2|||
146496085|NCT01270464|528321245|FG001|Overall Study|Lost to Follow-up|3|||
146496086|NCT01270464|528321246|FG002|Overall Study|Lost to Follow-up|1|||
146496087|NCT01270464|528321244|FG000|Overall Study|Other|1|||
146496088|NCT01270464|528321245|FG001|Overall Study|Other|1|||
146496089|NCT01270464|528321246|FG002|Overall Study|Other|3|||
146496090|NCT04725812|528321247|FG000|Overall Study|Withdrawal by Subject|1|||
146496091|NCT05656534|528321249|FG000|Overall Study|Withdrawal by Subject|1|||
146496092|NCT05656534|528321250|FG001|Overall Study|Withdrawal by Subject|1|||
146496093|NCT05656534|528321251|FG002|Overall Study|Withdrawal by Subject|0|||
146496094|NCT05656534|528321252|FG003|Overall Study|Withdrawal by Subject|0|||
146496095|NCT05656534|528321249|FG000|Overall Study|Physician Decision|1|||
146496096|NCT05656534|528321250|FG001|Overall Study|Physician Decision|1|||
146496097|NCT05656534|528321251|FG002|Overall Study|Physician Decision|0|||
146496098|NCT05656534|528321252|FG003|Overall Study|Physician Decision|0|||
146496099|NCT00839800|528321254|FG000|Overall Study|Adverse Event|8|||
146496100|NCT00839800|528321255|FG001|Overall Study|Adverse Event|12|||
146496101|NCT00839800|528321254|FG000|Overall Study|Lost to Follow-up|31|||
146496102|NCT00839800|528321255|FG001|Overall Study|Lost to Follow-up|26|||
146496103|NCT00839800|528321254|FG000|Overall Study|Withdrawal by Subject|28|||
146971835|NCT04071366|530058463|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
146971836|NCT04071366|530058464|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
146971837|NCT04071366|530058465|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
146971838|NCT04071366|530058461|FG000|Part 2: Randomized (29 Days)|Death|0|||
146496104|NCT00839800|528321255|FG001|Overall Study|Withdrawal by Subject|34|||
146496105|NCT00839800|528321254|FG000|Overall Study|Incorrect Enrolment|3|||
146496106|NCT00839800|528321255|FG001|Overall Study|Incorrect Enrolment|3|||
146496107|NCT00839800|528321254|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
146496108|NCT00839800|528321255|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
146564598|NCT01870869|528580017|FG001|Overall Study|Subject choice|2|||
146564599|NCT01870869|528580018|FG002|Overall Study|Subject choice|22|||
146564600|NCT01870869|528580019|FG003|Overall Study|Subject choice|8|||
146564601|NCT01870869|528580016|FG000|Overall Study|Lost to Follow-up|10|||
146564602|NCT01870869|528580017|FG001|Overall Study|Lost to Follow-up|2|||
146564603|NCT01870869|528580018|FG002|Overall Study|Lost to Follow-up|25|||
146564604|NCT01870869|528580019|FG003|Overall Study|Lost to Follow-up|3|||
146564605|NCT01870869|528580016|FG000|Overall Study|Reason not Specified|1|||
146564606|NCT01870869|528580017|FG001|Overall Study|Reason not Specified|2|||
146564607|NCT01870869|528580018|FG002|Overall Study|Reason not Specified|20|||
146564608|NCT01870869|528580019|FG003|Overall Study|Reason not Specified|4|||
146564609|NCT01870869|528580016|FG000|Overall Study|Not evaluable|10|||
146564610|NCT01870869|528580017|FG001|Overall Study|Not evaluable|5|||
146564611|NCT01870869|528580018|FG002|Overall Study|Not evaluable|42|||
146564612|NCT01870869|528580019|FG003|Overall Study|Not evaluable|10|||
146564613|NCT00557193|528580020|FG000|Induction|Adverse Event|2|||
146564614|NCT00557193|528580021|FG001|Induction|Adverse Event|0|||
146564615|NCT00557193|528580022|FG002|Induction|Adverse Event|0|||
146564616|NCT00557193|528580023|FG003|Induction|Adverse Event|0|||
146496109|NCT00839800|528321254|FG000|Overall Study|Safety Reasons|2|||
146496110|NCT00839800|528321255|FG001|Overall Study|Safety Reasons|1|||
146496111|NCT00839800|528321254|FG000|Overall Study|Other|8|||
146564617|NCT00557193|528580024|FG004|Induction|Adverse Event|0|||
146564618|NCT00557193|528580025|FG005|Induction|Adverse Event|0|||
146564619|NCT00557193|528580020|FG000|Induction|Death|6|||
146496112|NCT00839800|528321255|FG001|Overall Study|Other|14|||
146496113|NCT00839800|528321254|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
146496114|NCT00839800|528321255|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
146496115|NCT01164579|528321256|FG000|Overall Study|Lack of Efficacy|0|||
146643539|NCT00966875|528872169|FG000|Part B|Lack of Efficacy|2|||
146643540|NCT00966875|528872170|FG001|Part B|Lack of Efficacy|1|||
146643541|NCT00966875|528872171|FG002|Part B|Lack of Efficacy|1|||
146643542|NCT00966875|528872172|FG003|Part B|Lack of Efficacy|1|||
146643543|NCT00966875|528872173|FG004|Part B|Lack of Efficacy|2|||
146971839|NCT04071366|530058462|FG001|Part 2: Randomized (29 Days)|Death|0|||
146496116|NCT01164579|528321257|FG001|Overall Study|Lack of Efficacy|0|||
146496117|NCT01164579|528321258|FG002|Overall Study|Lack of Efficacy|6|||
146496118|NCT01164579|528321256|FG000|Overall Study|Lost to Follow-up|1|||
146496119|NCT01164579|528321257|FG001|Overall Study|Lost to Follow-up|1|||
146496120|NCT01164579|528321258|FG002|Overall Study|Lost to Follow-up|0|||
146496121|NCT01164579|528321256|FG000|Overall Study|Withdrawal by Subject|2|||
146496122|NCT01164579|528321257|FG001|Overall Study|Withdrawal by Subject|5|||
146496123|NCT01164579|528321258|FG002|Overall Study|Withdrawal by Subject|3|||
146496124|NCT01164579|528321256|FG000|Overall Study|Protocol Violation|0|||
146496125|NCT01164579|528321257|FG001|Overall Study|Protocol Violation|1|||
146496126|NCT01164579|528321258|FG002|Overall Study|Protocol Violation|2|||
146496127|NCT01164579|528321256|FG000|Overall Study|Adverse Event|4|||
146496128|NCT01164579|528321257|FG001|Overall Study|Adverse Event|2|||
146496129|NCT01164579|528321258|FG002|Overall Study|Adverse Event|5|||
146496130|NCT01164579|528321256|FG000|Overall Study|Reason not specified|1|||
146496131|NCT01164579|528321257|FG001|Overall Study|Reason not specified|0|||
146496132|NCT01164579|528321258|FG002|Overall Study|Reason not specified|0|||
146496133|NCT00302328|528321262|FG000|Overall Study|Physician Decision|0|||
146496134|NCT00302328|528321263|FG001|Overall Study|Physician Decision|1|||
146496135|NCT00302328|528321264|FG002|Overall Study|Physician Decision|0|||
146496136|NCT01288937|528321265|FG000|Overall Study|Adverse Event|1|||
146496137|NCT01288937|528321266|FG001|Overall Study|Adverse Event|0|||
146496138|NCT00912743|528321270|FG000|Overall Study|Adverse Event|3|||
146496139|NCT00912743|528321271|FG001|Overall Study|Adverse Event|1|||
146496140|NCT00912743|528321270|FG000|Overall Study|Lack of Efficacy|9|||
146496141|NCT00912743|528321271|FG001|Overall Study|Lack of Efficacy|18|||
146496142|NCT00912743|528321270|FG000|Overall Study|Toxicity|0|||
146496143|NCT00912743|528321271|FG001|Overall Study|Toxicity|1|||
146496144|NCT00912743|528321270|FG000|Overall Study|End of treatment form was not collected|1|||
146496145|NCT00912743|528321271|FG001|Overall Study|End of treatment form was not collected|0|||
146496146|NCT04478695|528321272|FG000|Overall Study|Death|1|||
146496147|NCT04478695|528321273|FG001|Overall Study|Death|0|||
146496148|NCT01136356|528321274|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
146496149|NCT01136356|528321275|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
146496150|NCT01136356|528321274|FG000|First 18-day Withdrawal|Physician Decision|1|||
146496151|NCT01136356|528321275|FG001|First 18-day Withdrawal|Physician Decision|0|||
146496152|NCT01136356|528321274|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
146496153|NCT01136356|528321275|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
146496154|NCT00927862|528321276|FG000|Overall Study|Missing data needed for endpt analyses|27|||
146496155|NCT00927862|528321277|FG001|Overall Study|Missing data needed for endpt analyses|45|||
146496156|NCT02347774|528321278|FG000|Study Participation|Lost to Follow-up|3|||
146496157|NCT02347774|528321279|FG001|Study Participation|Lost to Follow-up|6|||
146496158|NCT02347774|528321280|FG002|Study Participation|Lost to Follow-up|2|||
146496159|NCT02347774|528321278|FG000|Study Participation|Withdrawal by Subject|8|||
146496160|NCT02347774|528321279|FG001|Study Participation|Withdrawal by Subject|9|||
146496161|NCT02347774|528321280|FG002|Study Participation|Withdrawal by Subject|15|||
146496162|NCT02347774|528321278|FG000|Study Participation|Adverse Event|1|||
146496163|NCT02347774|528321279|FG001|Study Participation|Adverse Event|4|||
146496164|NCT02347774|528321280|FG002|Study Participation|Adverse Event|6|||
146496165|NCT02347774|528321278|FG000|Study Participation|withdrew consent|1|||
146496166|NCT02347774|528321279|FG001|Study Participation|withdrew consent|1|||
146496167|NCT02347774|528321280|FG002|Study Participation|withdrew consent|1|||
146971840|NCT04071366|530058463|FG002|Part 2: Randomized (29 Days)|Death|0|||
146971841|NCT04071366|530058464|FG003|Part 2: Randomized (29 Days)|Death|2|||
146971842|NCT04071366|530058465|FG004|Part 2: Randomized (29 Days)|Death|2|||
146971843|NCT04071366|530058461|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
146971844|NCT04071366|530058462|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
146496168|NCT02347774|528321278|FG000|Study Participation|Met Prolonged QT criteria|1|||
146496169|NCT02347774|528321279|FG001|Study Participation|Met Prolonged QT criteria|0|||
146496170|NCT02347774|528321280|FG002|Study Participation|Met Prolonged QT criteria|0|||
146971845|NCT04071366|530058463|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
146496171|NCT02347774|528321278|FG000|Study Participation|non-compliance with study drug|0|||
146643544|NCT00966875|528872174|FG005|Part B|Lack of Efficacy|3|||
146643545|NCT00966875|528872175|FG006|Part B|Lack of Efficacy|12|||
146496172|NCT02347774|528321279|FG001|Study Participation|non-compliance with study drug|1|||
146496173|NCT02347774|528321280|FG002|Study Participation|non-compliance with study drug|0|||
146971846|NCT04071366|530058464|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
146971847|NCT04071366|530058465|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
146971848|NCT04071366|530058461|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
146971849|NCT04071366|530058462|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
146971850|NCT04071366|530058463|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
146971851|NCT04071366|530058464|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
146971852|NCT04071366|530058465|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
146971853|NCT04071366|530058461|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
146971854|NCT04071366|530058462|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
146971855|NCT04071366|530058463|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
146971856|NCT04071366|530058464|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
146971857|NCT04071366|530058465|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
146971858|NCT04071366|530058461|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
146971859|NCT04071366|530058462|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
146971860|NCT04071366|530058463|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
146971861|NCT04071366|530058464|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
146971862|NCT04071366|530058465|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
146971863|NCT04071366|530058461|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
146971864|NCT04071366|530058462|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
146971865|NCT04071366|530058463|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
146971866|NCT04071366|530058464|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
146971867|NCT04071366|530058465|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
146971868|NCT04071366|530058461|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
146971869|NCT04071366|530058462|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
146971870|NCT04071366|530058463|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
146971871|NCT04071366|530058464|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
146971872|NCT04071366|530058465|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
146971873|NCT02239692|530058466|FG000|Overall Study|Incomplete colonoscopy|1|||
146971874|NCT02239692|530058467|FG001|Overall Study|Incomplete colonoscopy|2|||
146971875|NCT02239692|530058466|FG000|Overall Study|Adverse Event|0|||
146971876|NCT02239692|530058467|FG001|Overall Study|Adverse Event|1|||
146971877|NCT02239692|530058466|FG000|Overall Study|Physician Decision|0|||
146971878|NCT02239692|530058467|FG001|Overall Study|Physician Decision|1|||
146971879|NCT02239692|530058466|FG000|Overall Study|Lost to Follow-up|1|||
146971880|NCT02239692|530058467|FG001|Overall Study|Lost to Follow-up|4|||
146971881|NCT02239692|530058466|FG000|Overall Study|Withdrawal by Subject|3|||
146971882|NCT02239692|530058467|FG001|Overall Study|Withdrawal by Subject|5|||
146971883|NCT02239692|530058466|FG000|Overall Study|Other reason|1|||
146971884|NCT02239692|530058467|FG001|Overall Study|Other reason|0|||
146971885|NCT00858234|530058468|FG000|Overall Study|Adverse Event|6|||
146971886|NCT00858234|530058468|FG000|Overall Study|Progressive disease|2|||
146971887|NCT00858234|530058468|FG000|Overall Study|Status unknown|1|||
146971888|NCT01678924|530058469|FG000|Overall Study|Adverse Event|1|||
146971889|NCT01678924|530058470|FG001|Overall Study|Adverse Event|1|||
146971890|NCT01678924|530058471|FG002|Overall Study|Adverse Event|0|||
146971891|NCT01678924|530058472|FG003|Overall Study|Adverse Event|1|||
146971892|NCT01678924|530058469|FG000|Overall Study|Lack of Efficacy|7|||
146971893|NCT01678924|530058470|FG001|Overall Study|Lack of Efficacy|2|||
146971894|NCT01678924|530058471|FG002|Overall Study|Lack of Efficacy|0|||
146971895|NCT01678924|530058472|FG003|Overall Study|Lack of Efficacy|5|||
146971896|NCT01678924|530058469|FG000|Overall Study|Lost to Follow-up|0|||
146971897|NCT01678924|530058470|FG001|Overall Study|Lost to Follow-up|4|||
146971898|NCT01678924|530058471|FG002|Overall Study|Lost to Follow-up|0|||
146971899|NCT01678924|530058472|FG003|Overall Study|Lost to Follow-up|2|||
146971900|NCT01678924|530058469|FG000|Overall Study|Personal Reasons|2|||
146971901|NCT01678924|530058470|FG001|Overall Study|Personal Reasons|2|||
146496174|NCT02347774|528321278|FG000|Study Participation|incarceration|1|||
146496175|NCT02347774|528321279|FG001|Study Participation|incarceration|0|||
146496176|NCT02347774|528321280|FG002|Study Participation|incarceration|0|||
146496177|NCT02347774|528321278|FG000|Study Participation|randomized in error|0|||
146496178|NCT02347774|528321279|FG001|Study Participation|randomized in error|0|||
146496179|NCT02347774|528321280|FG002|Study Participation|randomized in error|1|||
146496180|NCT02347774|528321278|FG000|On Study Treatment|Adverse Event|9|||
146496181|NCT02347774|528321279|FG001|On Study Treatment|Adverse Event|15|||
146496182|NCT02347774|528321280|FG002|On Study Treatment|Adverse Event|19|||
146496183|NCT02347774|528321278|FG000|On Study Treatment|Lack of Efficacy|3|||
146971902|NCT01678924|530058471|FG002|Overall Study|Personal Reasons|2|||
146971903|NCT01678924|530058472|FG003|Overall Study|Personal Reasons|7|||
146971904|NCT01678924|530058469|FG000|Overall Study|Withdrawal by Subject|0|||
146971905|NCT01678924|530058470|FG001|Overall Study|Withdrawal by Subject|3|||
146971906|NCT01678924|530058471|FG002|Overall Study|Withdrawal by Subject|0|||
146971907|NCT01678924|530058472|FG003|Overall Study|Withdrawal by Subject|2|||
146971908|NCT01678924|530058469|FG000|Overall Study|Unable to attend scheduled visits|0|||
146496184|NCT02347774|528321279|FG001|On Study Treatment|Lack of Efficacy|0|||
146496185|NCT02347774|528321280|FG002|On Study Treatment|Lack of Efficacy|2|||
146768888|NCT04707313|529321791|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146564620|NCT00557193|528580021|FG001|Induction|Death|0|||
146564621|NCT00557193|528580022|FG002|Induction|Death|0|||
146564622|NCT00557193|528580023|FG003|Induction|Death|0|||
146564623|NCT00557193|528580024|FG004|Induction|Death|0|||
146564624|NCT00557193|528580025|FG005|Induction|Death|0|||
146564625|NCT00557193|528580020|FG000|Induction|Physician Decision|3|||
146564626|NCT00557193|528580021|FG001|Induction|Physician Decision|0|||
146564627|NCT00557193|528580022|FG002|Induction|Physician Decision|0|||
146564628|NCT00557193|528580023|FG003|Induction|Physician Decision|0|||
146564629|NCT00557193|528580024|FG004|Induction|Physician Decision|0|||
146564630|NCT00557193|528580025|FG005|Induction|Physician Decision|0|||
146564631|NCT00557193|528580020|FG000|Induction|Withdrawal by Subject|1|||
146564632|NCT00557193|528580021|FG001|Induction|Withdrawal by Subject|0|||
146564633|NCT00557193|528580022|FG002|Induction|Withdrawal by Subject|0|||
146564634|NCT00557193|528580023|FG003|Induction|Withdrawal by Subject|0|||
146564635|NCT00557193|528580024|FG004|Induction|Withdrawal by Subject|0|||
146564636|NCT00557193|528580025|FG005|Induction|Withdrawal by Subject|0|||
146564637|NCT00557193|528580020|FG000|Induction|Refusal of Further Protocol Therapy|2|||
146564638|NCT00557193|528580021|FG001|Induction|Refusal of Further Protocol Therapy|0|||
146564639|NCT00557193|528580022|FG002|Induction|Refusal of Further Protocol Therapy|0|||
146564640|NCT00557193|528580023|FG003|Induction|Refusal of Further Protocol Therapy|0|||
146564641|NCT00557193|528580024|FG004|Induction|Refusal of Further Protocol Therapy|0|||
146564642|NCT00557193|528580025|FG005|Induction|Refusal of Further Protocol Therapy|0|||
146564643|NCT00557193|528580020|FG000|Induction|Ineligible|8|||
146564644|NCT00557193|528580021|FG001|Induction|Ineligible|0|||
146564645|NCT00557193|528580022|FG002|Induction|Ineligible|0|||
146564646|NCT00557193|528580023|FG003|Induction|Ineligible|0|||
146564647|NCT00557193|528580024|FG004|Induction|Ineligible|0|||
146564648|NCT00557193|528580025|FG005|Induction|Ineligible|0|||
146564649|NCT00557193|528580020|FG000|Induction|Inevaluable for post Induction|2|||
146564650|NCT00557193|528580021|FG001|Induction|Inevaluable for post Induction|0|||
146564651|NCT00557193|528580022|FG002|Induction|Inevaluable for post Induction|0|||
146564652|NCT00557193|528580023|FG003|Induction|Inevaluable for post Induction|0|||
146564653|NCT00557193|528580024|FG004|Induction|Inevaluable for post Induction|0|||
146564654|NCT00557193|528580025|FG005|Induction|Inevaluable for post Induction|0|||
146564655|NCT00557193|528580020|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
146564656|NCT00557193|528580021|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
146564657|NCT00557193|528580022|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
146564658|NCT00557193|528580023|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
146564659|NCT00557193|528580024|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
146564660|NCT00557193|528580025|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
146564661|NCT00557193|528580020|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
146564662|NCT00557193|528580021|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
146911974|NCT00500149|529841381|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
146911975|NCT00500149|529841382|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
146911976|NCT00500149|529841381|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
146911977|NCT00500149|529841382|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
146911978|NCT01058369|529841383|FG000|Overall Study|Adverse Event|1|||
146911979|NCT01058369|529841383|FG000|Overall Study|Early termination study|1|||
146911980|NCT00089843|529841384|FG000|Overall Study|Withdrawal by Subject|1|||
146911981|NCT00089843|529841385|FG001|Overall Study|Withdrawal by Subject|4|||
146911982|NCT00089843|529841386|FG002|Overall Study|Withdrawal by Subject|5|||
146911983|NCT00089843|529841387|FG003|Overall Study|Withdrawal by Subject|6|||
146911984|NCT00089843|529841384|FG000|Overall Study|Physician Decision|1|||
146911985|NCT00089843|529841385|FG001|Overall Study|Physician Decision|0|||
146911986|NCT00089843|529841386|FG002|Overall Study|Physician Decision|0|||
146911987|NCT00089843|529841387|FG003|Overall Study|Physician Decision|1|||
146911988|NCT01157169|529841388|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
146911989|NCT01157169|529841389|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
146911990|NCT01157169|529841388|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
146911991|NCT01157169|529841389|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
146911992|NCT00663858|529841390|FG000|Overall Study|Adverse Event|9|||
146911993|NCT00663858|529841391|FG001|Overall Study|Adverse Event|1|||
146911994|NCT00663858|529841392|FG002|Overall Study|Adverse Event|6|||
146911995|NCT00663858|529841390|FG000|Overall Study|Lack of Efficacy|5|||
146911996|NCT00663858|529841391|FG001|Overall Study|Lack of Efficacy|1|||
146911997|NCT00663858|529841392|FG002|Overall Study|Lack of Efficacy|3|||
146911998|NCT00663858|529841390|FG000|Overall Study|Withdrawal by Subject|7|||
146911999|NCT00663858|529841391|FG001|Overall Study|Withdrawal by Subject|3|||
146912000|NCT00663858|529841392|FG002|Overall Study|Withdrawal by Subject|3|||
146912001|NCT00663858|529841390|FG000|Overall Study|Protocol Violation|5|||
146912002|NCT00663858|529841391|FG001|Overall Study|Protocol Violation|3|||
146768889|NCT04707313|529321792|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146912003|NCT00663858|529841392|FG002|Overall Study|Protocol Violation|4|||
146564663|NCT00557193|528580022|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
146768890|NCT04707313|529321793|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146768891|NCT04707313|529321794|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146971909|NCT01678924|530058470|FG001|Overall Study|Unable to attend scheduled visits|0|||
146971910|NCT01678924|530058471|FG002|Overall Study|Unable to attend scheduled visits|0|||
146971911|NCT01678924|530058472|FG003|Overall Study|Unable to attend scheduled visits|1|||
146971912|NCT02428231|530058477|FG000|Overall Study|Other|10|||
146971913|NCT02428231|530058478|FG001|Overall Study|Other|16|||
146971914|NCT02428231|530058477|FG000|Overall Study|Required Symptomatic Therapy|0|||
146971915|NCT02428231|530058478|FG001|Overall Study|Required Symptomatic Therapy|1|||
146971916|NCT02428231|530058477|FG000|Overall Study|Adverse Event|3|||
146971917|NCT02428231|530058478|FG001|Overall Study|Adverse Event|0|||
146971918|NCT03978117|530058479|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
146971919|NCT03978117|530058480|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
146971920|NCT03978117|530058479|FG000|Overall Study|Lost to Follow-up|4|||
146496186|NCT02347774|528321278|FG000|On Study Treatment|non-complicance with study medication|0|||
146496187|NCT02347774|528321279|FG001|On Study Treatment|non-complicance with study medication|2|||
146496188|NCT02347774|528321280|FG002|On Study Treatment|non-complicance with study medication|0|||
146496189|NCT02347774|528321278|FG000|On Study Treatment|Protocol Violation|0|||
146496190|NCT02347774|528321279|FG001|On Study Treatment|Protocol Violation|0|||
146496191|NCT02347774|528321280|FG002|On Study Treatment|Protocol Violation|1|||
146496192|NCT02347774|528321278|FG000|On Study Treatment|withdrew consent|9|||
146496193|NCT02347774|528321279|FG001|On Study Treatment|withdrew consent|8|||
146496194|NCT02347774|528321280|FG002|On Study Treatment|withdrew consent|12|||
146496195|NCT02347774|528321278|FG000|On Study Treatment|Lost to Follow-up|2|||
146496196|NCT02347774|528321279|FG001|On Study Treatment|Lost to Follow-up|6|||
146496197|NCT02347774|528321280|FG002|On Study Treatment|Lost to Follow-up|1|||
146496198|NCT02347774|528321278|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
146496199|NCT02347774|528321279|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
146496200|NCT02347774|528321280|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
146496201|NCT02347774|528321278|FG000|On Study Treatment|ranomized in error|0|||
146496202|NCT02347774|528321279|FG001|On Study Treatment|ranomized in error|0|||
146496203|NCT02347774|528321280|FG002|On Study Treatment|ranomized in error|1|||
146496204|NCT00820248|528321281|FG000|Overall Study|No treated|4|||
146496205|NCT00820248|528321282|FG001|Overall Study|No treated|1|||
146496206|NCT00619892|528321288|FG000|Overall Study|Adverse Event|3|||
146496207|NCT00619892|528321289|FG001|Overall Study|Adverse Event|0|||
146496208|NCT00619892|528321288|FG000|Overall Study|Lost to Follow-up|0|||
146496209|NCT00619892|528321289|FG001|Overall Study|Lost to Follow-up|1|||
146496210|NCT00619892|528321288|FG000|Overall Study|Intercurrent illness|0|||
146496211|NCT00619892|528321289|FG001|Overall Study|Intercurrent illness|1|||
146496212|NCT03852264|528321290|FG000|Third Research Visit|Lost to Follow-up|1|||
146496213|NCT03852264|528321291|FG001|Third Research Visit|Lost to Follow-up|0|||
146564664|NCT00557193|528580023|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
146564665|NCT00557193|528580024|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
146564666|NCT00557193|528580025|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
146564667|NCT00557193|528580020|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
146564668|NCT00557193|528580021|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
146564669|NCT00557193|528580022|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
146564670|NCT00557193|528580023|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
146564671|NCT00557193|528580024|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
146564672|NCT00557193|528580025|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
146564673|NCT00557193|528580020|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
146564674|NCT00557193|528580021|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
146564675|NCT00557193|528580022|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
146564676|NCT00557193|528580023|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
146564677|NCT00557193|528580024|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
146564678|NCT00557193|528580025|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
146564679|NCT00557193|528580020|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
146564680|NCT00557193|528580021|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
146564681|NCT00557193|528580022|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
146971921|NCT03978117|530058480|FG001|Overall Study|Lost to Follow-up|4|||
146971922|NCT00791154|530058481|FG000|Overall Study|Noncompliance|0|||
146971923|NCT00791154|530058482|FG001|Overall Study|Noncompliance|1|||
146564682|NCT00557193|528580023|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
146768892|NCT04707313|529321795|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146971924|NCT00791154|530058483|FG002|Overall Study|Noncompliance|0|||
146971925|NCT00791154|530058484|FG003|Overall Study|Noncompliance|0|||
146971926|NCT00791154|530058485|FG004|Overall Study|Noncompliance|1|||
146496214|NCT04481789|528321292|FG000|Period 1|Withdrawal by Subject|1|||
146496215|NCT04481789|528321293|FG001|Period 1|Withdrawal by Subject|0|||
146496216|NCT04481789|528321294|FG002|Period 1|Withdrawal by Subject|0|||
146496217|NCT04481789|528321295|FG003|Period 1|Withdrawal by Subject|0|||
146643546|NCT00966875|528872176|FG007|Part B|Lack of Efficacy|9|||
146643547|NCT00966875|528872177|FG008|Part B|Lack of Efficacy|6|||
146643548|NCT00966875|528872169|FG000|Part B|Lost to Follow-up|0|||
146643549|NCT00966875|528872170|FG001|Part B|Lost to Follow-up|0|||
146643550|NCT00966875|528872171|FG002|Part B|Lost to Follow-up|0|||
146643551|NCT00966875|528872172|FG003|Part B|Lost to Follow-up|1|||
146643552|NCT00966875|528872173|FG004|Part B|Lost to Follow-up|0|||
146643553|NCT00966875|528872174|FG005|Part B|Lost to Follow-up|0|||
146643554|NCT00966875|528872175|FG006|Part B|Lost to Follow-up|0|||
146643555|NCT00966875|528872176|FG007|Part B|Lost to Follow-up|0|||
146643556|NCT00966875|528872177|FG008|Part B|Lost to Follow-up|1|||
146643557|NCT00966875|528872169|FG000|Part B|Physician Decision|0|||
146643558|NCT00966875|528872170|FG001|Part B|Physician Decision|0|||
146643559|NCT00966875|528872171|FG002|Part B|Physician Decision|1|||
146643560|NCT00966875|528872172|FG003|Part B|Physician Decision|0|||
146496218|NCT04481789|528321296|FG004|Period 1|Withdrawal by Subject|0|||
146496219|NCT04481789|528321297|FG005|Period 1|Withdrawal by Subject|0|||
146496220|NCT02477332|528321300|FG000|Overall Study|Adverse Event|0|||
146496221|NCT02477332|528321301|FG001|Overall Study|Adverse Event|1|||
146496222|NCT02477332|528321302|FG002|Overall Study|Adverse Event|1|||
146496223|NCT02477332|528321303|FG003|Overall Study|Adverse Event|2|||
146496224|NCT02477332|528321304|FG004|Overall Study|Adverse Event|1|||
146496225|NCT02477332|528321305|FG005|Overall Study|Adverse Event|2|||
146496226|NCT02477332|528321300|FG000|Overall Study|Lack of Efficacy|1|||
146496227|NCT02477332|528321301|FG001|Overall Study|Lack of Efficacy|2|||
146496228|NCT02477332|528321302|FG002|Overall Study|Lack of Efficacy|1|||
146496229|NCT02477332|528321303|FG003|Overall Study|Lack of Efficacy|2|||
146496230|NCT02477332|528321304|FG004|Overall Study|Lack of Efficacy|1|||
146496231|NCT02477332|528321305|FG005|Overall Study|Lack of Efficacy|1|||
146496232|NCT02477332|528321300|FG000|Overall Study|Non-compliance with study treatment|0|||
146496233|NCT02477332|528321301|FG001|Overall Study|Non-compliance with study treatment|1|||
146496234|NCT02477332|528321302|FG002|Overall Study|Non-compliance with study treatment|2|||
146496235|NCT02477332|528321303|FG003|Overall Study|Non-compliance with study treatment|0|||
146496236|NCT02477332|528321304|FG004|Overall Study|Non-compliance with study treatment|0|||
146496237|NCT02477332|528321305|FG005|Overall Study|Non-compliance with study treatment|0|||
146496238|NCT02477332|528321300|FG000|Overall Study|Pregnancy|0|||
146496239|NCT02477332|528321301|FG001|Overall Study|Pregnancy|0|||
146496240|NCT02477332|528321302|FG002|Overall Study|Pregnancy|0|||
146643561|NCT00966875|528872173|FG004|Part B|Physician Decision|2|||
146643562|NCT00966875|528872174|FG005|Part B|Physician Decision|1|||
146643563|NCT00966875|528872175|FG006|Part B|Physician Decision|0|||
146643564|NCT00966875|528872176|FG007|Part B|Physician Decision|0|||
146643565|NCT00966875|528872177|FG008|Part B|Physician Decision|2|||
146643566|NCT00966875|528872169|FG000|Part B|Sponsor Decision|1|||
146643567|NCT00966875|528872170|FG001|Part B|Sponsor Decision|0|||
146643568|NCT00966875|528872171|FG002|Part B|Sponsor Decision|0|||
146643569|NCT00966875|528872172|FG003|Part B|Sponsor Decision|0|||
146643570|NCT00966875|528872173|FG004|Part B|Sponsor Decision|0|||
146643571|NCT00966875|528872174|FG005|Part B|Sponsor Decision|1|||
146643572|NCT00966875|528872175|FG006|Part B|Sponsor Decision|0|||
146643573|NCT00966875|528872176|FG007|Part B|Sponsor Decision|2|||
146643574|NCT00966875|528872177|FG008|Part B|Sponsor Decision|1|||
146643575|NCT00966875|528872169|FG000|Part B|Withdrawal by Subject|2|||
146643576|NCT00966875|528872170|FG001|Part B|Withdrawal by Subject|1|||
146643577|NCT00966875|528872171|FG002|Part B|Withdrawal by Subject|2|||
146643578|NCT00966875|528872172|FG003|Part B|Withdrawal by Subject|1|||
146643579|NCT00966875|528872173|FG004|Part B|Withdrawal by Subject|2|||
146643580|NCT00966875|528872174|FG005|Part B|Withdrawal by Subject|1|||
146643581|NCT00966875|528872175|FG006|Part B|Withdrawal by Subject|4|||
146643582|NCT00966875|528872176|FG007|Part B|Withdrawal by Subject|5|||
146643583|NCT00966875|528872177|FG008|Part B|Withdrawal by Subject|5|||
146643584|NCT00966875|528872169|FG000|Part B|Entry Criteria|0|||
146643585|NCT00966875|528872170|FG001|Part B|Entry Criteria|0|||
146643586|NCT00966875|528872171|FG002|Part B|Entry Criteria|0|||
146496241|NCT02477332|528321303|FG003|Overall Study|Pregnancy|1|||
146496242|NCT02477332|528321304|FG004|Overall Study|Pregnancy|0|||
146496243|NCT02477332|528321305|FG005|Overall Study|Pregnancy|0|||
146496244|NCT02477332|528321300|FG000|Overall Study|Protocol Violation|2|||
146643587|NCT00966875|528872172|FG003|Part B|Entry Criteria|0|||
146643588|NCT00966875|528872173|FG004|Part B|Entry Criteria|0|||
146643589|NCT00966875|528872174|FG005|Part B|Entry Criteria|0|||
146643590|NCT00966875|528872175|FG006|Part B|Entry Criteria|1|||
146643591|NCT00966875|528872176|FG007|Part B|Entry Criteria|0|||
146496245|NCT02477332|528321301|FG001|Overall Study|Protocol Violation|0|||
146496246|NCT02477332|528321302|FG002|Overall Study|Protocol Violation|3|||
146496247|NCT02477332|528321303|FG003|Overall Study|Protocol Violation|3|||
146643592|NCT00966875|528872177|FG008|Part B|Entry Criteria|1|||
146643593|NCT01589653|528872180|FG000|Overall Study|Protocol Violation|3|||
146496248|NCT02477332|528321304|FG004|Overall Study|Protocol Violation|1|||
146643594|NCT01589653|528872181|FG001|Overall Study|Protocol Violation|1|||
146643595|NCT01589653|528872180|FG000|Overall Study|Withdrawal criteria|4|||
146643596|NCT01589653|528872181|FG001|Overall Study|Withdrawal criteria|7|||
146643597|NCT01589653|528872180|FG000|Overall Study|Unclassified|0|||
146643598|NCT01589653|528872181|FG001|Overall Study|Unclassified|3|||
146971927|NCT00791154|530058486|FG005|Overall Study|Noncompliance|1|||
146496249|NCT02477332|528321305|FG005|Overall Study|Protocol Violation|1|||
146496250|NCT02477332|528321300|FG000|Overall Study|Technical problems|0|||
146496251|NCT02477332|528321301|FG001|Overall Study|Technical problems|0|||
146496252|NCT02477332|528321302|FG002|Overall Study|Technical problems|1|||
146496253|NCT02477332|528321303|FG003|Overall Study|Technical problems|0|||
146496254|NCT02477332|528321304|FG004|Overall Study|Technical problems|0|||
146496255|NCT02477332|528321305|FG005|Overall Study|Technical problems|0|||
146496256|NCT02477332|528321300|FG000|Overall Study|Lost to Follow-up|0|||
146496257|NCT02477332|528321301|FG001|Overall Study|Lost to Follow-up|0|||
146496258|NCT02477332|528321302|FG002|Overall Study|Lost to Follow-up|2|||
146496259|NCT02477332|528321303|FG003|Overall Study|Lost to Follow-up|0|||
146496260|NCT02477332|528321304|FG004|Overall Study|Lost to Follow-up|0|||
146496261|NCT02477332|528321305|FG005|Overall Study|Lost to Follow-up|0|||
146496262|NCT02477332|528321300|FG000|Overall Study|Physician Decision|0|||
146496263|NCT02477332|528321301|FG001|Overall Study|Physician Decision|0|||
146496264|NCT02477332|528321302|FG002|Overall Study|Physician Decision|1|||
146496265|NCT02477332|528321303|FG003|Overall Study|Physician Decision|3|||
146496266|NCT02477332|528321304|FG004|Overall Study|Physician Decision|0|||
146496267|NCT02477332|528321305|FG005|Overall Study|Physician Decision|1|||
146496268|NCT02477332|528321300|FG000|Overall Study|Withdrawal by Subject|0|||
146496269|NCT02477332|528321301|FG001|Overall Study|Withdrawal by Subject|3|||
146496270|NCT02477332|528321302|FG002|Overall Study|Withdrawal by Subject|1|||
146496271|NCT02477332|528321303|FG003|Overall Study|Withdrawal by Subject|2|||
146496272|NCT02477332|528321304|FG004|Overall Study|Withdrawal by Subject|1|||
146496273|NCT02477332|528321305|FG005|Overall Study|Withdrawal by Subject|0|||
146496274|NCT00900159|528321310|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
146496275|NCT00900159|528321311|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
146496276|NCT01075256|528321312|FG000|Overall Study|Withdrawal by Subject|1|||
146496277|NCT01075256|528321313|FG001|Overall Study|Withdrawal by Subject|0|||
146496278|NCT01075256|528321314|FG002|Overall Study|Withdrawal by Subject|0|||
146496279|NCT02593097|528321328|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
146496280|NCT02593097|528321329|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
146496281|NCT02593097|528321328|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
146496282|NCT02593097|528321329|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
146496283|NCT02593097|528321328|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
146496284|NCT02593097|528321329|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
146496285|NCT02593097|528321328|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
146496286|NCT02593097|528321329|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
146496287|NCT02593097|528321328|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
146496288|NCT02593097|528321329|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
146564683|NCT00557193|528580024|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
146564684|NCT00557193|528580025|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
146564685|NCT00557193|528580020|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
146564686|NCT00557193|528580021|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
146564687|NCT00557193|528580022|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
146564688|NCT00557193|528580023|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
146564689|NCT00557193|528580024|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
146564690|NCT00557193|528580025|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
146564691|NCT00557193|528580020|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
146564692|NCT00557193|528580021|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
146564693|NCT00557193|528580022|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
146564694|NCT00557193|528580023|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
146564695|NCT00557193|528580024|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
146564696|NCT00557193|528580025|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
146564697|NCT00557193|528580020|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
146564698|NCT00557193|528580021|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
146564699|NCT00557193|528580022|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
146564700|NCT00557193|528580023|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
146564701|NCT00557193|528580024|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
146564702|NCT00557193|528580025|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
146564703|NCT00557193|528580020|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
146643599|NCT01536067|528872182|FG000|Overall Study|Disease Progression|1|||
146496289|NCT03759587|528321330|FG000|Overall Study|Adverse Event|5|||
146496290|NCT03759587|528321330|FG000|Overall Study|Progressive Disease|10|||
146496291|NCT03759587|528321330|FG000|Overall Study|Site Terminated by Sponsor|3|||
146496292|NCT03759587|528321330|FG000|Overall Study|Withdrawal by Subject|1|||
146496293|NCT00665431|528321332|FG000|Overall Study|Adverse Event|16|||
146496294|NCT00665431|528321333|FG001|Overall Study|Adverse Event|22|||
146496295|NCT00665431|528321334|FG002|Overall Study|Adverse Event|6|||
146496296|NCT00665431|528321332|FG000|Overall Study|Withdrawal by Subject|17|||
146496297|NCT00665431|528321333|FG001|Overall Study|Withdrawal by Subject|25|||
146496298|NCT00665431|528321334|FG002|Overall Study|Withdrawal by Subject|15|||
146496299|NCT00665431|528321332|FG000|Overall Study|Lost to Follow-up|3|||
146496300|NCT00665431|528321333|FG001|Overall Study|Lost to Follow-up|3|||
146496301|NCT00665431|528321334|FG002|Overall Study|Lost to Follow-up|1|||
146496302|NCT00665431|528321332|FG000|Overall Study|Other|4|||
146496303|NCT00665431|528321333|FG001|Overall Study|Other|7|||
146496304|NCT00665431|528321334|FG002|Overall Study|Other|2|||
146496305|NCT02837731|528321342|FG000|Allocation|Admitted to General Floor|3|||
146496306|NCT02837731|528321343|FG001|Allocation|Admitted to General Floor|4|||
146496307|NCT02837731|528321342|FG000|Allocation|Immediate surgery/withdrew|2|||
146496308|NCT02837731|528321343|FG001|Allocation|Immediate surgery/withdrew|0|||
146496309|NCT02837731|528321342|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
146496310|NCT02837731|528321343|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
146496311|NCT02837731|528321342|FG000|Allocation|Withdrawal by Subject|2|||
146496312|NCT02837731|528321343|FG001|Allocation|Withdrawal by Subject|0|||
146496313|NCT02837731|528321342|FG000|Allocation|Device not available|1|||
146496314|NCT02837731|528321343|FG001|Allocation|Device not available|0|||
146496315|NCT02837731|528321342|FG000|Allocation|Protocol not implemented|7|||
146496316|NCT02837731|528321343|FG001|Allocation|Protocol not implemented|0|||
146496317|NCT02837731|528321342|FG000|Allocation|Moribund/Do not resuscitate|2|||
146496318|NCT02837731|528321343|FG001|Allocation|Moribund/Do not resuscitate|0|||
146496319|NCT02837731|528321342|FG000|Allocation|Did not meet sepsis criteria|1|||
146496320|NCT02837731|528321343|FG001|Allocation|Did not meet sepsis criteria|2|||
146496321|NCT02837731|528321342|FG000|Allocation|Known aortic abnormalities|0|||
146496322|NCT02837731|528321343|FG001|Allocation|Known aortic abnormalities|1|||
146496323|NCT01119859|528321344|FG000|Overall Study|Adverse Event|9|||
146496324|NCT01119859|528321345|FG001|Overall Study|Adverse Event|10|||
146496325|NCT01119859|528321344|FG000|Overall Study|Death|2|||
146496326|NCT01119859|528321345|FG001|Overall Study|Death|0|||
146496327|NCT01119859|528321344|FG000|Overall Study|Insufficient therapeutic response|7|||
146496328|NCT01119859|528321345|FG001|Overall Study|Insufficient therapeutic response|14|||
146496329|NCT01119859|528321344|FG000|Overall Study|Refused treatment|3|||
146496330|NCT01119859|528321345|FG001|Overall Study|Refused treatment|6|||
146496331|NCT01119859|528321344|FG000|Overall Study|Failure to return|3|||
146496332|NCT01119859|528321345|FG001|Overall Study|Failure to return|0|||
146496333|NCT02644668|528321348|FG000|Overall Study|Adverse Event|2|||
146496334|NCT02644668|528321349|FG001|Overall Study|Adverse Event|0|||
146496335|NCT02644668|528321350|FG002|Overall Study|Adverse Event|1|||
146496336|NCT02644668|528321348|FG000|Overall Study|Protocol Violation|0|||
146496337|NCT02644668|528321349|FG001|Overall Study|Protocol Violation|0|||
146496338|NCT02644668|528321350|FG002|Overall Study|Protocol Violation|1|||
146496339|NCT02644668|528321348|FG000|Overall Study|Withdrawal by Subject|0|||
146496340|NCT02644668|528321349|FG001|Overall Study|Withdrawal by Subject|0|||
146496341|NCT02644668|528321350|FG002|Overall Study|Withdrawal by Subject|1|||
146496342|NCT01209520|528321351|FG000|Overall Study|Withdrawal by Subject|3|||
146496343|NCT03850483|528321355|FG000|Treatment for Stage 1|Adverse Event|1|||
146496344|NCT03850483|528321356|FG001|Treatment for Stage 1|Adverse Event|1|||
146496345|NCT03850483|528321357|FG002|Treatment for Stage 1|Adverse Event|3|||
146496346|NCT03850483|528321358|FG003|Treatment for Stage 1|Adverse Event|0|||
146496347|NCT03850483|528321359|FG004|Treatment for Stage 1|Adverse Event|2|||
146496348|NCT03850483|528321360|FG005|Treatment for Stage 1|Adverse Event|0|||
146496349|NCT03850483|528321361|FG006|Treatment for Stage 1|Adverse Event|2|||
146496350|NCT03850483|528321362|FG007|Treatment for Stage 1|Adverse Event|2|||
146496351|NCT03850483|528321363|FG008|Treatment for Stage 1|Adverse Event|0|||
146496352|NCT03850483|528321364|FG009|Treatment for Stage 1|Adverse Event|0|||
146496353|NCT03850483|528321355|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
146496354|NCT03850483|528321356|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
146496355|NCT03850483|528321357|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
146496356|NCT03850483|528321358|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
146496357|NCT03850483|528321359|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
146496358|NCT03850483|528321360|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
146496359|NCT03850483|528321361|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
146496360|NCT03850483|528321362|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
146496361|NCT03850483|528321363|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
146496362|NCT03850483|528321364|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
146496363|NCT03850483|528321355|FG000|Treatment for Stage 1|Protocol Violation|1|||
146496364|NCT03850483|528321356|FG001|Treatment for Stage 1|Protocol Violation|0|||
146496365|NCT03850483|528321357|FG002|Treatment for Stage 1|Protocol Violation|0|||
146496366|NCT03850483|528321358|FG003|Treatment for Stage 1|Protocol Violation|0|||
146496367|NCT03850483|528321359|FG004|Treatment for Stage 1|Protocol Violation|0|||
146496368|NCT03850483|528321360|FG005|Treatment for Stage 1|Protocol Violation|0|||
146496369|NCT03850483|528321361|FG006|Treatment for Stage 1|Protocol Violation|1|||
146496370|NCT03850483|528321362|FG007|Treatment for Stage 1|Protocol Violation|0|||
146496371|NCT03850483|528321363|FG008|Treatment for Stage 1|Protocol Violation|0|||
146643600|NCT00606905|528872185|FG000|Overall Study|No Pregnancy|9|||
146643601|NCT00606905|528872186|FG001|Overall Study|No Pregnancy|6|||
146643602|NCT00606905|528872185|FG000|Overall Study|Non-Index Pregnancy|1|||
146643603|NCT00606905|528872186|FG001|Overall Study|Non-Index Pregnancy|4|||
146643604|NCT00606905|528872185|FG000|Overall Study|Withdrew|5|||
146643605|NCT00606905|528872186|FG001|Overall Study|Withdrew|5|||
146643606|NCT02386189|528872187|FG000|Overall Study|Lost to Follow-up|2|||
146643607|NCT02386189|528872188|FG001|Overall Study|Lost to Follow-up|3|||
146643608|NCT02386189|528872187|FG000|Overall Study|Withdrawal by Subject|1|||
146643609|NCT02386189|528872188|FG001|Overall Study|Withdrawal by Subject|0|||
146643610|NCT02386189|528872187|FG000|Overall Study|Death|1|||
146643611|NCT02386189|528872188|FG001|Overall Study|Death|0|||
146643612|NCT04657666|528872189|FG000|Period 1|Withdrawal of participant consent|2|||
146643613|NCT04657666|528872190|FG001|Period 1|Withdrawal of participant consent|1|||
146643614|NCT04657666|528872189|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
146643615|NCT04657666|528872190|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
146643616|NCT04657666|528872189|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
146643617|NCT04657666|528872190|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
146643618|NCT04657666|528872189|FG000|Period 2|Other|2|||
146643619|NCT04657666|528872190|FG001|Period 2|Other|0|||
146643620|NCT04657666|528872189|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
146912004|NCT00663858|529841390|FG000|Overall Study|Other|8|||
146912005|NCT00663858|529841391|FG001|Overall Study|Other|2|||
146912006|NCT00663858|529841392|FG002|Overall Study|Other|4|||
146912007|NCT01277289|529841396|FG000|Overall Study|fragile vein|1|||
146912008|NCT01277289|529841397|FG001|Overall Study|fragile vein|0|||
146912009|NCT01277289|529841396|FG000|Overall Study|Physician Decision|1|||
146496372|NCT03850483|528321364|FG009|Treatment for Stage 1|Protocol Violation|0|||
146912010|NCT01277289|529841397|FG001|Overall Study|Physician Decision|0|||
146496373|NCT03850483|528321355|FG000|Treatment for Stage 1|Physician Decision|0|||
146496374|NCT03850483|528321356|FG001|Treatment for Stage 1|Physician Decision|0|||
146496375|NCT03850483|528321357|FG002|Treatment for Stage 1|Physician Decision|0|||
146496376|NCT03850483|528321358|FG003|Treatment for Stage 1|Physician Decision|0|||
146496377|NCT03850483|528321359|FG004|Treatment for Stage 1|Physician Decision|0|||
146496378|NCT03850483|528321360|FG005|Treatment for Stage 1|Physician Decision|1|||
146496379|NCT03850483|528321361|FG006|Treatment for Stage 1|Physician Decision|0|||
146496380|NCT03850483|528321362|FG007|Treatment for Stage 1|Physician Decision|0|||
146496381|NCT03850483|528321363|FG008|Treatment for Stage 1|Physician Decision|0|||
146496382|NCT03850483|528321364|FG009|Treatment for Stage 1|Physician Decision|0|||
146496383|NCT03850483|528321355|FG000|Treatment for Stage 1|Other|0|||
146496384|NCT03850483|528321356|FG001|Treatment for Stage 1|Other|0|||
146496385|NCT03850483|528321357|FG002|Treatment for Stage 1|Other|0|||
146496386|NCT03850483|528321358|FG003|Treatment for Stage 1|Other|0|||
146643621|NCT04657666|528872190|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
146912011|NCT01277289|529841396|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
146912012|NCT01277289|529841397|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
146912013|NCT01277289|529841396|FG000|Overall Study|Protocol Violation|1|||
146912014|NCT01277289|529841397|FG001|Overall Study|Protocol Violation|1|||
146912015|NCT01277289|529841396|FG000|Overall Study|Adverse Event|2|||
146912016|NCT01277289|529841397|FG001|Overall Study|Adverse Event|1|||
146912017|NCT01277289|529841396|FG000|Overall Study|consent withdrawn|1|||
146912018|NCT01277289|529841397|FG001|Overall Study|consent withdrawn|1|||
146912019|NCT01277289|529841396|FG000|Overall Study|premature closure of the study|4|||
146912020|NCT01277289|529841397|FG001|Overall Study|premature closure of the study|2|||
146912021|NCT00950690|529841402|FG000|Overall Study|Death|4|||
146912022|NCT00950690|529841402|FG000|Overall Study|Adverse Event|15|||
146912023|NCT00950690|529841402|FG000|Overall Study|Lack of Efficacy|22|||
146912024|NCT00950690|529841402|FG000|Overall Study|Lost to Follow-up|40|||
146912025|NCT00950690|529841402|FG000|Overall Study|Other|163|||
146912026|NCT00092547|529841403|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
146912027|NCT00092547|529841404|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
146912028|NCT00092547|529841405|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
146912029|NCT00092547|529841403|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
146912030|NCT00092547|529841404|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
146912031|NCT00092547|529841405|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
146912032|NCT00092547|529841403|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
146912033|NCT00092547|529841404|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
146912034|NCT00092547|529841405|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
146912035|NCT00092547|529841403|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
146643622|NCT03120351|528872191|FG000|Overall Study|Physician Decision|1|||
146643623|NCT03120351|528872192|FG001|Overall Study|Physician Decision|1|||
146643624|NCT04250077|528872201|FG000|Overall Study|Withdrawal by Subject|0|||
146643625|NCT04250077|528872202|FG001|Overall Study|Withdrawal by Subject|1|||
146912036|NCT00092547|529841404|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
146912037|NCT00092547|529841405|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
146971928|NCT00791154|530058487|FG006|Overall Study|Noncompliance|1|||
146768893|NCT04707313|529321796|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146768894|NCT04707313|529321797|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146768895|NCT04707313|529321798|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146768896|NCT04707313|529321799|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146768897|NCT04707313|529321800|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
146768898|NCT04707313|529321801|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
146768899|NCT04707313|529321802|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
146768900|NCT04707313|529321803|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146768901|NCT04707313|529321791|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146768902|NCT04707313|529321792|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146496387|NCT03850483|528321359|FG004|Treatment for Stage 1|Other|2|||
146496388|NCT03850483|528321360|FG005|Treatment for Stage 1|Other|1|||
146496389|NCT03850483|528321361|FG006|Treatment for Stage 1|Other|0|||
146496390|NCT03850483|528321362|FG007|Treatment for Stage 1|Other|0|||
146496391|NCT03850483|528321363|FG008|Treatment for Stage 1|Other|0|||
146496392|NCT03850483|528321364|FG009|Treatment for Stage 1|Other|0|||
146496393|NCT03850483|528321355|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
146496394|NCT03850483|528321356|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
146496395|NCT03850483|528321357|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
146496396|NCT03850483|528321358|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
146496397|NCT03850483|528321359|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
146496398|NCT03850483|528321360|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
146496399|NCT03850483|528321361|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
146496400|NCT03850483|528321362|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
146496401|NCT03850483|528321363|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
146496402|NCT03850483|528321364|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
146496403|NCT03850483|528321355|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
146496404|NCT03850483|528321356|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
146496405|NCT03850483|528321357|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
146496406|NCT03850483|528321358|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
146564704|NCT00557193|528580021|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
146564705|NCT00557193|528580022|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
146564706|NCT00557193|528580023|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
146564707|NCT00557193|528580024|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
146564708|NCT00557193|528580025|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
146564709|NCT00261833|528580026|FG000|Overall Study|Death|1|||
146564710|NCT00261833|528580027|FG001|Overall Study|Death|3|||
146564711|NCT00261833|528580026|FG000|Overall Study|Adverse Event|1|||
146564712|NCT00261833|528580027|FG001|Overall Study|Adverse Event|4|||
146564713|NCT00261833|528580026|FG000|Overall Study|Withdrawal by Subject|5|||
146564714|NCT00261833|528580027|FG001|Overall Study|Withdrawal by Subject|7|||
146564715|NCT00261833|528580026|FG000|Overall Study|Protocol Violation|0|||
146564716|NCT00261833|528580027|FG001|Overall Study|Protocol Violation|1|||
146564717|NCT00261833|528580026|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
146564718|NCT00261833|528580027|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
146564719|NCT00261833|528580026|FG000|Overall Study|Lung transplantation|1|||
146564720|NCT00261833|528580027|FG001|Overall Study|Lung transplantation|1|||
146564721|NCT00261833|528580026|FG000|Overall Study|Missing reason|1|||
146564722|NCT00261833|528580027|FG001|Overall Study|Missing reason|0|||
146564723|NCT00261833|528580026|FG000|Overall Study|Not interested in being participant|0|||
146564724|NCT00261833|528580027|FG001|Overall Study|Not interested in being participant|1|||
146564725|NCT00622726|528580028|FG000|March, 2008 to August, 2010|Death|5|||
146564726|NCT00622726|528580029|FG001|March, 2008 to August, 2010|Death|2|||
146564727|NCT00622726|528580028|FG000|August, 2010 to April, 2013|Death|1|||
146564728|NCT00622726|528580029|FG001|August, 2010 to April, 2013|Death|5|||
146564729|NCT01948427|528580032|FG000|Overall Study|Serious Adverse Event|3|||
146564730|NCT01948427|528580033|FG001|Overall Study|Serious Adverse Event|0|||
146564731|NCT01948427|528580034|FG002|Overall Study|Serious Adverse Event|0|||
146564732|NCT01948427|528580035|FG003|Overall Study|Serious Adverse Event|0|||
146564733|NCT01948427|528580036|FG004|Overall Study|Serious Adverse Event|1|||
146564734|NCT01948427|528580032|FG000|Overall Study|Investigator Request|0|||
146564735|NCT01948427|528580033|FG001|Overall Study|Investigator Request|8|||
146564736|NCT01948427|528580034|FG002|Overall Study|Investigator Request|0|||
146564737|NCT01948427|528580035|FG003|Overall Study|Investigator Request|0|||
146564738|NCT01948427|528580036|FG004|Overall Study|Investigator Request|6|||
146564739|NCT01948427|528580032|FG000|Overall Study|Lost to Follow-up|1|||
146564740|NCT01948427|528580033|FG001|Overall Study|Lost to Follow-up|0|||
146564741|NCT01948427|528580034|FG002|Overall Study|Lost to Follow-up|0|||
146564742|NCT01948427|528580035|FG003|Overall Study|Lost to Follow-up|0|||
146564743|NCT01948427|528580036|FG004|Overall Study|Lost to Follow-up|4|||
146564744|NCT01948427|528580032|FG000|Overall Study|Withdrawal by Subject|2|||
146768903|NCT04707313|529321793|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146768904|NCT04707313|529321794|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146643626|NCT04250077|528872203|FG002|Overall Study|Withdrawal by Subject|0|||
146643627|NCT04250077|528872201|FG000|Overall Study|Lost to Follow-up|2|||
146643628|NCT04250077|528872202|FG001|Overall Study|Lost to Follow-up|3|||
146643629|NCT04250077|528872203|FG002|Overall Study|Lost to Follow-up|0|||
146643630|NCT01022398|528872204|FG000|Overall Study|Study terminated|2|||
146643631|NCT01022398|528872205|FG001|Overall Study|Study terminated|2|||
146643632|NCT03319745|528872207|FG000|Overall Study|Death|1|||
146643633|NCT03319745|528872207|FG000|Overall Study|Toxicity Precluding Surgery|1|||
146643634|NCT01317550|528872208|FG000|Overall Study|Withdrawal by Subject|1|||
146643635|NCT01317550|528872209|FG001|Overall Study|Withdrawal by Subject|0|||
146643636|NCT01317550|528872210|FG002|Overall Study|Withdrawal by Subject|0|||
146643637|NCT01317550|528872211|FG003|Overall Study|Withdrawal by Subject|0|||
146643638|NCT01317550|528872208|FG000|Overall Study|Lack of compliance study med|1|||
146643639|NCT01317550|528872209|FG001|Overall Study|Lack of compliance study med|0|||
146643640|NCT01317550|528872210|FG002|Overall Study|Lack of compliance study med|0|||
146643641|NCT01317550|528872211|FG003|Overall Study|Lack of compliance study med|0|||
146643642|NCT00870103|528872212|FG000|Overall Study|Physician Decision|2|||
146643643|NCT00870103|528872212|FG000|Overall Study|Lost to Follow-up|2|||
146643644|NCT03255629|528872213|FG000|Overall Study|Adverse Event|1|||
146643645|NCT03255629|528872214|FG001|Overall Study|Adverse Event|0|||
146643646|NCT03255629|528872213|FG000|Overall Study|did not experience hypoglycemia|2|||
146643647|NCT03255629|528872214|FG001|Overall Study|did not experience hypoglycemia|1|||
146643648|NCT04540198|528872215|FG000|Overall Study|Lost to Follow-up|25|||
146643649|NCT04540198|528872216|FG001|Overall Study|Lost to Follow-up|23|||
146643650|NCT04540198|528872215|FG000|Overall Study|Withdrawal by Subject|15|||
146643651|NCT04540198|528872216|FG001|Overall Study|Withdrawal by Subject|9|||
146643652|NCT04540198|528872215|FG000|Overall Study|Discontinued|1|||
146643653|NCT04540198|528872216|FG001|Overall Study|Discontinued|0|||
146643654|NCT01086358|528872217|FG000|First Intervention|Lost to Follow-up|9|||
146643655|NCT01086358|528872218|FG001|First Intervention|Lost to Follow-up|4|||
146643656|NCT01086358|528872217|FG000|First Intervention|Withdrawal by Subject|0|||
146643657|NCT01086358|528872218|FG001|First Intervention|Withdrawal by Subject|1|||
146643658|NCT01086358|528872217|FG000|Second Intervention|Lost to Follow-up|4|||
146643659|NCT01086358|528872218|FG001|Second Intervention|Lost to Follow-up|4|||
146643660|NCT00833417|528872219|FG000|Overall Study|Adverse Event|5|||
146643661|NCT00833417|528872220|FG001|Overall Study|Adverse Event|16|||
146643662|NCT00833417|528872219|FG000|Overall Study|Death|1|||
146643663|NCT00833417|528872220|FG001|Overall Study|Death|3|||
146643664|NCT00833417|528872219|FG000|Overall Study|Lost to Follow-up|1|||
146643665|NCT00833417|528872220|FG001|Overall Study|Lost to Follow-up|2|||
146643666|NCT00833417|528872219|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
146643667|NCT00833417|528872220|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
146643668|NCT00833417|528872219|FG000|Overall Study|Patient Decision to Withdraw|4|||
146643669|NCT00833417|528872220|FG001|Overall Study|Patient Decision to Withdraw|23|||
146643670|NCT00833417|528872219|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
146643671|NCT00833417|528872220|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
146643672|NCT00833417|528872219|FG000|Overall Study|Disease Progression|18|||
146643673|NCT00833417|528872220|FG001|Overall Study|Disease Progression|17|||
146643674|NCT00833417|528872219|FG000|Overall Study|Reason Not Specified|0|||
146643675|NCT00833417|528872220|FG001|Overall Study|Reason Not Specified|1|||
146643676|NCT03330002|528872221|FG000|Overall Study|Lost to Follow-up|15|||
146643677|NCT03330002|528872221|FG000|Overall Study|Death|7|||
146643678|NCT03679754|528872222|FG000|Overall Study|Investigator request|1|||
146643679|NCT00964171|528872223|FG000|Overall Study|Death|5|||
146643680|NCT02872935|528872224|FG000|Overall Study|Other|0|||
146643681|NCT02872935|528872225|FG001|Overall Study|Other|1|||
146643682|NCT03037580|528872229|FG000|Overall Study|Withdrawal by Subject|3|||
146643683|NCT03037580|528872230|FG001|Overall Study|Withdrawal by Subject|0|||
146971929|NCT00791154|530058481|FG000|Overall Study|Adverse Event|0|||
146971930|NCT00791154|530058482|FG001|Overall Study|Adverse Event|0|||
146971931|NCT00791154|530058483|FG002|Overall Study|Adverse Event|0|||
146971932|NCT00791154|530058484|FG003|Overall Study|Adverse Event|0|||
146971933|NCT00791154|530058485|FG004|Overall Study|Adverse Event|2|||
146971934|NCT00791154|530058486|FG005|Overall Study|Adverse Event|0|||
146971935|NCT00791154|530058487|FG006|Overall Study|Adverse Event|1|||
146971936|NCT00791154|530058481|FG000|Overall Study|Full Consent withdrawn|1|||
146971937|NCT00791154|530058482|FG001|Overall Study|Full Consent withdrawn|3|||
146971938|NCT00791154|530058483|FG002|Overall Study|Full Consent withdrawn|0|||
146971939|NCT00791154|530058484|FG003|Overall Study|Full Consent withdrawn|0|||
146971940|NCT00791154|530058485|FG004|Overall Study|Full Consent withdrawn|1|||
146971941|NCT00791154|530058486|FG005|Overall Study|Full Consent withdrawn|3|||
146971942|NCT00791154|530058487|FG006|Overall Study|Full Consent withdrawn|1|||
146643684|NCT03037580|528872229|FG000|Overall Study|Adverse Event|1|||
146643685|NCT03037580|528872230|FG001|Overall Study|Adverse Event|0|||
146643686|NCT03037580|528872229|FG000|Overall Study|Study Terminated by Sponsor|12|||
146643687|NCT03037580|528872230|FG001|Overall Study|Study Terminated by Sponsor|15|||
146971943|NCT00791154|530058481|FG000|Overall Study|Lost to Follow-up|0|||
146496407|NCT03850483|528321359|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
146496408|NCT03850483|528321360|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
146496409|NCT03850483|528321361|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
146496410|NCT03850483|528321362|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
146496411|NCT03850483|528321363|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
146496412|NCT03850483|528321364|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
146496413|NCT03850483|528321355|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
146496414|NCT03850483|528321356|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
146496415|NCT03850483|528321357|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
146496416|NCT03850483|528321358|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
146496417|NCT03850483|528321359|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
146496418|NCT03850483|528321360|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
146496419|NCT03850483|528321361|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
146496420|NCT03850483|528321362|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
146496421|NCT03850483|528321363|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
146496422|NCT03850483|528321364|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
146496423|NCT03850483|528321355|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
146496424|NCT03850483|528321356|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
146496425|NCT03850483|528321357|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
146496426|NCT03850483|528321358|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
146496427|NCT03850483|528321359|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
146496428|NCT03850483|528321360|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
146496429|NCT03850483|528321361|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
146496430|NCT03850483|528321362|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
146496431|NCT03850483|528321363|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
146496432|NCT03850483|528321364|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
146496433|NCT03850483|528321355|FG000|Treatment for Stage 1|Death|0|||
146496434|NCT03850483|528321356|FG001|Treatment for Stage 1|Death|0|||
146496435|NCT03850483|528321357|FG002|Treatment for Stage 1|Death|0|||
146496436|NCT03850483|528321358|FG003|Treatment for Stage 1|Death|0|||
146496437|NCT03850483|528321359|FG004|Treatment for Stage 1|Death|0|||
146496438|NCT03850483|528321360|FG005|Treatment for Stage 1|Death|1|||
146496439|NCT03850483|528321361|FG006|Treatment for Stage 1|Death|0|||
146496440|NCT03850483|528321362|FG007|Treatment for Stage 1|Death|0|||
146496441|NCT03850483|528321363|FG008|Treatment for Stage 1|Death|0|||
146496442|NCT03850483|528321364|FG009|Treatment for Stage 1|Death|0|||
146496443|NCT03850483|528321355|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
146496444|NCT03850483|528321356|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
146496445|NCT03850483|528321357|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
146496446|NCT03850483|528321358|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
146496447|NCT03850483|528321359|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
146496448|NCT03850483|528321360|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
146496449|NCT03850483|528321361|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
146496450|NCT03850483|528321362|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
146496451|NCT03850483|528321363|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
146496452|NCT03850483|528321364|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
146496453|NCT03850483|528321355|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
146496454|NCT03850483|528321356|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
146496455|NCT03850483|528321357|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
146496456|NCT03850483|528321358|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
146496457|NCT03850483|528321359|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
146496458|NCT03850483|528321360|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
146496459|NCT03850483|528321361|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
146496460|NCT03850483|528321362|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
146496461|NCT03850483|528321363|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
146496462|NCT03850483|528321364|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
146496463|NCT03850483|528321355|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
146496464|NCT03850483|528321356|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
146496465|NCT03850483|528321357|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
146496466|NCT03850483|528321358|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
146496467|NCT03850483|528321359|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
146496468|NCT03850483|528321360|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
146496469|NCT03850483|528321361|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
146496470|NCT03850483|528321362|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
146564745|NCT01948427|528580033|FG001|Overall Study|Withdrawal by Subject|0|||
146564746|NCT01948427|528580034|FG002|Overall Study|Withdrawal by Subject|0|||
146564747|NCT01948427|528580035|FG003|Overall Study|Withdrawal by Subject|0|||
146912038|NCT00092547|529841403|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
146496471|NCT03850483|528321363|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
146496472|NCT03850483|528321364|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
146496473|NCT03850483|528321355|FG000|Follow-up for Stage 1|Physician Decision|0|||
146496474|NCT03850483|528321356|FG001|Follow-up for Stage 1|Physician Decision|0|||
146496475|NCT03850483|528321357|FG002|Follow-up for Stage 1|Physician Decision|0|||
146496476|NCT03850483|528321358|FG003|Follow-up for Stage 1|Physician Decision|0|||
146496477|NCT03850483|528321359|FG004|Follow-up for Stage 1|Physician Decision|1|||
146496478|NCT03850483|528321360|FG005|Follow-up for Stage 1|Physician Decision|0|||
146496479|NCT03850483|528321361|FG006|Follow-up for Stage 1|Physician Decision|1|||
146496480|NCT03850483|528321362|FG007|Follow-up for Stage 1|Physician Decision|0|||
146496481|NCT03850483|528321363|FG008|Follow-up for Stage 1|Physician Decision|0|||
146496482|NCT03850483|528321364|FG009|Follow-up for Stage 1|Physician Decision|0|||
146496483|NCT03850483|528321355|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
146564748|NCT01948427|528580036|FG004|Overall Study|Withdrawal by Subject|1|||
146564749|NCT01948427|528580032|FG000|Overall Study|Other, Not Specified|1|||
146564750|NCT01948427|528580033|FG001|Overall Study|Other, Not Specified|9|||
146564751|NCT01948427|528580034|FG002|Overall Study|Other, Not Specified|0|||
146564752|NCT01948427|528580035|FG003|Overall Study|Other, Not Specified|0|||
146564753|NCT01948427|528580036|FG004|Overall Study|Other, Not Specified|2|||
146564754|NCT00402987|528580037|FG000|Overall Study|Lack of Efficacy|0|||
146564755|NCT00402987|528580038|FG001|Overall Study|Lack of Efficacy|0|||
146564756|NCT00402987|528580039|FG002|Overall Study|Lack of Efficacy|1|||
146564757|NCT00402987|528580040|FG003|Overall Study|Lack of Efficacy|0|||
146564758|NCT02434081|528580041|FG000|Overall Study|Death (never started treatment)|2|||
146564759|NCT02434081|528580041|FG000|Overall Study|Death|2|||
146564760|NCT02434081|528580041|FG000|Overall Study|Progression|20|||
146564761|NCT02434081|528580041|FG000|Overall Study|Adverse Event|20|||
146564762|NCT02434081|528580041|FG000|Overall Study|Physician Decision|2|||
146564763|NCT02434081|528580041|FG000|Overall Study|Withdrawal by Subject|1|||
146564764|NCT02434081|528580041|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
146564765|NCT00419744|528580042|FG000|Overall Study|Adverse Event|39|||
146564766|NCT00419744|528580043|FG001|Overall Study|Adverse Event|40|||
146564767|NCT00419744|528580044|FG002|Overall Study|Adverse Event|50|||
146564768|NCT00419744|528580042|FG000|Overall Study|Withdrawal by Subject|45|||
146564769|NCT00419744|528580043|FG001|Overall Study|Withdrawal by Subject|49|||
146564770|NCT00419744|528580044|FG002|Overall Study|Withdrawal by Subject|52|||
146564771|NCT00419744|528580042|FG000|Overall Study|Lost to Follow-up|8|||
146564772|NCT00419744|528580043|FG001|Overall Study|Lost to Follow-up|10|||
146564773|NCT00419744|528580044|FG002|Overall Study|Lost to Follow-up|6|||
146564774|NCT00419744|528580042|FG000|Overall Study|Protocol Violation|4|||
146564775|NCT00419744|528580043|FG001|Overall Study|Protocol Violation|7|||
146564776|NCT00419744|528580044|FG002|Overall Study|Protocol Violation|8|||
146643688|NCT03037580|528872229|FG000|Overall Study|Death|0|||
146643689|NCT03037580|528872230|FG001|Overall Study|Death|1|||
146643690|NCT02873429|528872231|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
146643691|NCT02873429|528872232|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
146643692|NCT02873429|528872231|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
146643693|NCT02873429|528872232|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
146643694|NCT02873429|528872231|FG000|16 Weeks|Lost to Follow-up|3|||
146643695|NCT02873429|528872232|FG001|16 Weeks|Lost to Follow-up|0|||
146643696|NCT00853567|528872234|FG000|Overall Study|Study prematurely terminated|71|||
146643697|NCT00782834|528872235|FG000|Treatment Phase|fibrous tumor not GIST|1|||
146643698|NCT02259088|528872236|FG000|Overall Study|Adverse Event|6|||
146643699|NCT02259088|528872237|FG001|Overall Study|Adverse Event|4|||
146643700|NCT02259088|528872236|FG000|Overall Study|Lost to Follow-up|2|||
146643701|NCT02259088|528872237|FG001|Overall Study|Lost to Follow-up|0|||
146643702|NCT02259088|528872236|FG000|Overall Study|Death|2|||
146643703|NCT02259088|528872237|FG001|Overall Study|Death|0|||
146643704|NCT02259088|528872236|FG000|Overall Study|Physician Decision|5|||
146643705|NCT02259088|528872237|FG001|Overall Study|Physician Decision|2|||
146643706|NCT02259088|528872236|FG000|Overall Study|Protocol deviation|5|||
146643707|NCT02259088|528872237|FG001|Overall Study|Protocol deviation|0|||
146643708|NCT02259088|528872236|FG000|Overall Study|Subject/guardian decision|8|||
146643709|NCT02259088|528872237|FG001|Overall Study|Subject/guardian decision|8|||
146643710|NCT01818752|528872238|FG000|Overall Study|Adverse Event|64|||
146643711|NCT01818752|528872239|FG001|Overall Study|Adverse Event|74|||
146643712|NCT01818752|528872238|FG000|Overall Study|Death|14|||
146643713|NCT01818752|528872239|FG001|Overall Study|Death|18|||
146643714|NCT01818752|528872238|FG000|Overall Study|Non-compliance|16|||
146643715|NCT01818752|528872239|FG001|Overall Study|Non-compliance|20|||
146564777|NCT00419744|528580042|FG000|Overall Study|Randomized in error|9|||
146564778|NCT00419744|528580043|FG001|Overall Study|Randomized in error|6|||
146643716|NCT01818752|528872238|FG000|Overall Study|Withdrawal by Subject|15|||
146643717|NCT01818752|528872239|FG001|Overall Study|Withdrawal by Subject|14|||
146643718|NCT01818752|528872238|FG000|Overall Study|Physician Decision|9|||
146643719|NCT01818752|528872239|FG001|Overall Study|Physician Decision|8|||
146643720|NCT01818752|528872238|FG000|Overall Study|Disease Progression|54|||
146496484|NCT03850483|528321356|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
146643721|NCT01818752|528872239|FG001|Overall Study|Disease Progression|48|||
146496485|NCT03850483|528321357|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
146496486|NCT03850483|528321358|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
146564779|NCT00419744|528580044|FG002|Overall Study|Randomized in error|7|||
146564780|NCT00419744|528580042|FG000|Overall Study|Moving out of state|2|||
146496487|NCT03850483|528321359|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
146496488|NCT03850483|528321360|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
146496489|NCT03850483|528321361|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
146496490|NCT03850483|528321362|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
146496491|NCT03850483|528321363|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
146496492|NCT03850483|528321364|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
146496493|NCT03850483|528321355|FG000|Follow-up for Stage 1|Adverse Event|0|||
146496494|NCT03850483|528321356|FG001|Follow-up for Stage 1|Adverse Event|0|||
146496495|NCT03850483|528321357|FG002|Follow-up for Stage 1|Adverse Event|1|||
146496496|NCT03850483|528321358|FG003|Follow-up for Stage 1|Adverse Event|0|||
146496497|NCT03850483|528321359|FG004|Follow-up for Stage 1|Adverse Event|0|||
146496498|NCT03850483|528321360|FG005|Follow-up for Stage 1|Adverse Event|1|||
146496499|NCT03850483|528321361|FG006|Follow-up for Stage 1|Adverse Event|0|||
146496500|NCT03850483|528321362|FG007|Follow-up for Stage 1|Adverse Event|0|||
146496501|NCT03850483|528321363|FG008|Follow-up for Stage 1|Adverse Event|0|||
146496502|NCT03850483|528321364|FG009|Follow-up for Stage 1|Adverse Event|0|||
146496503|NCT03850483|528321355|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
146496504|NCT03850483|528321356|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
146496505|NCT03850483|528321357|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
146496506|NCT03850483|528321358|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
146496507|NCT03850483|528321359|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
146496508|NCT03850483|528321360|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
146496509|NCT03850483|528321361|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
146496510|NCT03850483|528321362|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
146496511|NCT03850483|528321363|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
146496512|NCT03850483|528321364|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
146496513|NCT03850483|528321355|FG000|Follow-up for Stage 1|Other|0|||
146496514|NCT03850483|528321356|FG001|Follow-up for Stage 1|Other|2|||
146496515|NCT03850483|528321357|FG002|Follow-up for Stage 1|Other|0|||
146496516|NCT03850483|528321358|FG003|Follow-up for Stage 1|Other|2|||
146496517|NCT03850483|528321359|FG004|Follow-up for Stage 1|Other|0|||
146496518|NCT03850483|528321360|FG005|Follow-up for Stage 1|Other|1|||
146496519|NCT03850483|528321361|FG006|Follow-up for Stage 1|Other|0|||
146496520|NCT03850483|528321362|FG007|Follow-up for Stage 1|Other|0|||
146496521|NCT03850483|528321363|FG008|Follow-up for Stage 1|Other|0|||
146496522|NCT03850483|528321364|FG009|Follow-up for Stage 1|Other|0|||
146496523|NCT03850483|528321355|FG000|Treatment for Stage 2|Adverse Event|0|||
146496524|NCT03850483|528321356|FG001|Treatment for Stage 2|Adverse Event|0|||
146496525|NCT03850483|528321357|FG002|Treatment for Stage 2|Adverse Event|0|||
146496526|NCT03850483|528321358|FG003|Treatment for Stage 2|Adverse Event|0|||
146496527|NCT03850483|528321359|FG004|Treatment for Stage 2|Adverse Event|0|||
146496528|NCT03850483|528321360|FG005|Treatment for Stage 2|Adverse Event|0|||
146496529|NCT03850483|528321361|FG006|Treatment for Stage 2|Adverse Event|0|||
146496530|NCT03850483|528321362|FG007|Treatment for Stage 2|Adverse Event|0|||
146564781|NCT00419744|528580043|FG001|Overall Study|Moving out of state|0|||
146564782|NCT00419744|528580044|FG002|Overall Study|Moving out of state|1|||
146564783|NCT00419744|528580042|FG000|Overall Study|Physician Decision|10|||
146564784|NCT00419744|528580043|FG001|Overall Study|Physician Decision|5|||
146564785|NCT00419744|528580044|FG002|Overall Study|Physician Decision|6|||
146564786|NCT00419744|528580042|FG000|Overall Study|Spirometry mouthpiece issues|0|||
146564787|NCT00419744|528580043|FG001|Overall Study|Spirometry mouthpiece issues|1|||
146564788|NCT00419744|528580044|FG002|Overall Study|Spirometry mouthpiece issues|2|||
146564789|NCT00419744|528580042|FG000|Overall Study|Incorrect medication kit dispensed|0|||
146564790|NCT00419744|528580043|FG001|Overall Study|Incorrect medication kit dispensed|0|||
146564791|NCT00419744|528580044|FG002|Overall Study|Incorrect medication kit dispensed|1|||
146564792|NCT01668004|528580045|FG000|Overall Study|Adverse Event|7|||
146564793|NCT01668004|528580045|FG000|Overall Study|Withdrawal by Subject|2|||
146564794|NCT01668004|528580045|FG000|Overall Study|Lost to Follow-up|5|||
146564795|NCT01668004|528580045|FG000|Overall Study|Lack of Efficacy|9|||
146564796|NCT01668004|528580045|FG000|Overall Study|Non-compliance with treatment|2|||
146564797|NCT02448381|528580053|FG000|Overall Study|Adverse Event|2|||
146564798|NCT02448381|528580054|FG001|Overall Study|Adverse Event|0|||
146564799|NCT02448381|528580053|FG000|Overall Study|Lost to Follow-up|16|||
146564800|NCT02448381|528580054|FG001|Overall Study|Lost to Follow-up|9|||
146564801|NCT02448381|528580053|FG000|Overall Study|Physician Decision|1|||
146564802|NCT02448381|528580054|FG001|Overall Study|Physician Decision|1|||
146496531|NCT03850483|528321363|FG008|Treatment for Stage 2|Adverse Event|0|||
146496532|NCT03850483|528321364|FG009|Treatment for Stage 2|Adverse Event|1|||
146496533|NCT03850483|528321355|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
146496534|NCT03850483|528321356|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
146496535|NCT03850483|528321357|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
146496536|NCT03850483|528321358|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
146564803|NCT02448381|528580053|FG000|Overall Study|Pregnancy|1|||
146564804|NCT02448381|528580054|FG001|Overall Study|Pregnancy|0|||
146564805|NCT02448381|528580053|FG000|Overall Study|Withdrawal by Subject|13|||
146643722|NCT01818752|528872238|FG000|Overall Study|Other|7|||
146912039|NCT00092547|529841404|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
146912040|NCT00092547|529841405|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
146912041|NCT00092547|529841403|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
146912042|NCT00092547|529841404|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
146912043|NCT00092547|529841405|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
146912044|NCT00092547|529841403|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
146643723|NCT01818752|528872239|FG001|Overall Study|Other|8|||
146643724|NCT01818752|528872238|FG000|Overall Study|Continuing Treatment|1|||
146643725|NCT01818752|528872239|FG001|Overall Study|Continuing Treatment|4|||
146643726|NCT01818752|528872238|FG000|Overall Study|Randomized but not Dosed|7|||
146643727|NCT01818752|528872239|FG001|Overall Study|Randomized but not Dosed|4|||
146643728|NCT04270370|528872240|FG000|Overall Study|Lost to Follow-up|1|||
146643729|NCT04270370|528872241|FG001|Overall Study|Lost to Follow-up|0|||
146643730|NCT04270370|528872242|FG002|Overall Study|Lost to Follow-up|0|||
146643731|NCT04270370|528872243|FG003|Overall Study|Lost to Follow-up|0|||
146643732|NCT04270370|528872244|FG004|Overall Study|Lost to Follow-up|0|||
146643733|NCT04270370|528872245|FG005|Overall Study|Lost to Follow-up|0|||
146643734|NCT04270370|528872246|FG006|Overall Study|Lost to Follow-up|0|||
146643735|NCT04270370|528872247|FG007|Overall Study|Lost to Follow-up|0|||
146643736|NCT04270370|528872248|FG008|Overall Study|Lost to Follow-up|1|||
146643737|NCT04270370|528872249|FG009|Overall Study|Lost to Follow-up|0|||
146643738|NCT04270370|528872250|FG010|Overall Study|Lost to Follow-up|0|||
146643739|NCT04270370|528872251|FG011|Overall Study|Lost to Follow-up|0|||
146643740|NCT01324141|528872252|FG000|Overall Study|Declined to participate before treatment started|1|||
146643741|NCT01324141|528872252|FG000|Overall Study|Disease progression on study|1|||
146643742|NCT02745080|528872253|FG000|Overall Study|Adverse Event|13|||
146643743|NCT02745080|528872254|FG001|Overall Study|Adverse Event|21|||
146643744|NCT02745080|528872253|FG000|Overall Study|Lack of Efficacy|11|||
146643745|NCT02745080|528872254|FG001|Overall Study|Lack of Efficacy|23|||
146496537|NCT03850483|528321359|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
146496538|NCT03850483|528321360|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
146496539|NCT03850483|528321361|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
146496540|NCT03850483|528321362|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
146496541|NCT03850483|528321363|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
146496542|NCT03850483|528321364|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
146496543|NCT03850483|528321355|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
146496544|NCT03850483|528321356|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
146496545|NCT03850483|528321357|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
146496546|NCT03850483|528321358|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
146496547|NCT03850483|528321359|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
146496548|NCT03850483|528321360|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
146496549|NCT03850483|528321361|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
146496550|NCT03850483|528321362|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
146768905|NCT04707313|529321795|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146768906|NCT04707313|529321796|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146768907|NCT04707313|529321797|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146768908|NCT04707313|529321798|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146768909|NCT04707313|529321799|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146768910|NCT04707313|529321800|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
146768911|NCT04707313|529321801|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
146768912|NCT04707313|529321802|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
146768913|NCT04707313|529321803|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
146768914|NCT04707313|529321791|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
146768915|NCT04707313|529321792|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
146768916|NCT04707313|529321793|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
146768917|NCT04707313|529321794|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
146768918|NCT04707313|529321795|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
146768919|NCT04707313|529321796|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
146768920|NCT04707313|529321797|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
146768921|NCT04707313|529321798|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
146768922|NCT04707313|529321799|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
146768923|NCT04707313|529321800|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
146912045|NCT00092547|529841404|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
146912046|NCT00092547|529841405|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
146496551|NCT03850483|528321363|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
146496552|NCT03850483|528321364|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
146496553|NCT03850483|528321355|FG000|Treatment for Stage 2|Physician Decision|0|||
146496554|NCT03850483|528321356|FG001|Treatment for Stage 2|Physician Decision|0|||
146643746|NCT02745080|528872253|FG000|Overall Study|Lost to Follow-up|3|||
146768924|NCT04707313|529321801|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
146768925|NCT04707313|529321802|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
146768926|NCT04707313|529321803|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
146643747|NCT02745080|528872254|FG001|Overall Study|Lost to Follow-up|3|||
146643748|NCT02745080|528872253|FG000|Overall Study|Physician Decision|3|||
146643749|NCT02745080|528872254|FG001|Overall Study|Physician Decision|0|||
146643750|NCT02745080|528872253|FG000|Overall Study|Protocol Violation|3|||
146643751|NCT02745080|528872254|FG001|Overall Study|Protocol Violation|1|||
146643752|NCT02745080|528872253|FG000|Overall Study|Withdrawal by Subject|22|||
146643753|NCT02745080|528872254|FG001|Overall Study|Withdrawal by Subject|41|||
146643754|NCT01001325|528872256|FG000|Overall Study|Lost to Follow-up|16|||
146643755|NCT01001325|528872257|FG001|Overall Study|Lost to Follow-up|10|||
146643756|NCT01001325|528872256|FG000|Overall Study|Protocol Violation|2|||
146643757|NCT01001325|528872257|FG001|Overall Study|Protocol Violation|0|||
146643758|NCT02051933|528874259|FG000|Overall Study|Physician Decision|0|||
146643759|NCT02051933|528874260|FG001|Overall Study|Physician Decision|1|||
146643760|NCT03745820|528874265|FG000|Overall Study|Adverse Event|0|||
146643761|NCT03745820|528874266|FG001|Overall Study|Adverse Event|3|||
146643762|NCT03745820|528874267|FG002|Overall Study|Adverse Event|2|||
146643763|NCT03745820|528874265|FG000|Overall Study|Non-Compliance with Study Drug|4|||
146643764|NCT03745820|528874266|FG001|Overall Study|Non-Compliance with Study Drug|3|||
146643765|NCT03745820|528874267|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146643766|NCT03745820|528874265|FG000|Overall Study|Withdrawal by Subject|4|||
146643767|NCT03745820|528874266|FG001|Overall Study|Withdrawal by Subject|4|||
146643768|NCT03745820|528874267|FG002|Overall Study|Withdrawal by Subject|4|||
146643769|NCT03745820|528874265|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
146643770|NCT03745820|528874266|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
146643771|NCT03745820|528874267|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
146643772|NCT03745820|528874265|FG000|Overall Study|Lost to Follow-up|2|||
146643773|NCT03745820|528874266|FG001|Overall Study|Lost to Follow-up|0|||
146643774|NCT03745820|528874267|FG002|Overall Study|Lost to Follow-up|3|||
146643775|NCT03745820|528874265|FG000|Overall Study|Reason not Specified|2|||
146643776|NCT03745820|528874266|FG001|Overall Study|Reason not Specified|4|||
146643777|NCT03745820|528874267|FG002|Overall Study|Reason not Specified|1|||
146643778|NCT00507728|528874268|FG000|Randomization to Month 3|Lost to Follow-up|15|||
146643779|NCT00507728|528874269|FG001|Randomization to Month 3|Lost to Follow-up|14|||
146643780|NCT00507728|528874270|FG002|Randomization to Month 3|Lost to Follow-up|20|||
146643781|NCT00507728|528874268|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
146643782|NCT00507728|528874269|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
146643783|NCT00507728|528874270|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
146643784|NCT01625260|528874275|FG000|Overall Study|Adverse Event|3|||
146643785|NCT01625260|528874276|FG001|Overall Study|Adverse Event|0|||
146643786|NCT01625260|528874275|FG000|Overall Study|Study Terminated by Investigator|2|||
146643787|NCT01625260|528874276|FG001|Overall Study|Study Terminated by Investigator|0|||
146643788|NCT01625260|528874275|FG000|Overall Study|Disease Progression|2|||
146643789|NCT01625260|528874276|FG001|Overall Study|Disease Progression|0|||
146643790|NCT01625260|528874275|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
146643791|NCT01625260|528874276|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
146643792|NCT03899805|528874277|FG000|Overall Study|Physician Decision|3|||
146643793|NCT03899805|528874278|FG001|Overall Study|Physician Decision|0|||
146643794|NCT03899805|528874279|FG002|Overall Study|Physician Decision|2|||
146643795|NCT03899805|528874277|FG000|Overall Study|Withdrawal by Subject|1|||
146643796|NCT03899805|528874278|FG001|Overall Study|Withdrawal by Subject|0|||
146643797|NCT03899805|528874279|FG002|Overall Study|Withdrawal by Subject|2|||
146643798|NCT03899805|528874277|FG000|Overall Study|Progressive Disease|10|||
146643799|NCT03899805|528874278|FG001|Overall Study|Progressive Disease|18|||
146496555|NCT03850483|528321357|FG002|Treatment for Stage 2|Physician Decision|0|||
146496556|NCT03850483|528321358|FG003|Treatment for Stage 2|Physician Decision|0|||
146496557|NCT03850483|528321359|FG004|Treatment for Stage 2|Physician Decision|0|||
146496558|NCT03850483|528321360|FG005|Treatment for Stage 2|Physician Decision|0|||
146496559|NCT03850483|528321361|FG006|Treatment for Stage 2|Physician Decision|0|||
146496560|NCT03850483|528321362|FG007|Treatment for Stage 2|Physician Decision|0|||
146496561|NCT03850483|528321363|FG008|Treatment for Stage 2|Physician Decision|0|||
146496562|NCT03850483|528321364|FG009|Treatment for Stage 2|Physician Decision|1|||
146643800|NCT03899805|528874279|FG002|Overall Study|Progressive Disease|12|||
146643801|NCT03899805|528874277|FG000|Overall Study|Adverse Event|3|||
146643802|NCT03899805|528874278|FG001|Overall Study|Adverse Event|1|||
146643803|NCT03899805|528874279|FG002|Overall Study|Adverse Event|0|||
146643804|NCT03899805|528874277|FG000|Overall Study|Death|2|||
146643805|NCT03899805|528874278|FG001|Overall Study|Death|0|||
146643806|NCT03899805|528874279|FG002|Overall Study|Death|0|||
146643807|NCT03899805|528874277|FG000|Overall Study|Came off for surgery|0|||
146496563|NCT03850483|528321355|FG000|Treatment for Stage 2|Protocol Violation|0|||
146643808|NCT03899805|528874278|FG001|Overall Study|Came off for surgery|0|||
146643809|NCT03899805|528874279|FG002|Overall Study|Came off for surgery|1|||
146643810|NCT03317405|528874280|FG000|Overall Study|Withdrawal by Subject|1|||
146643811|NCT03317405|528874281|FG001|Overall Study|Withdrawal by Subject|0|||
146643812|NCT03317405|528874282|FG002|Overall Study|Withdrawal by Subject|0|||
146643813|NCT03317405|528874280|FG000|Overall Study|Physician Decision|0|||
146643814|NCT03317405|528874281|FG001|Overall Study|Physician Decision|0|||
146971944|NCT00791154|530058482|FG001|Overall Study|Lost to Follow-up|0|||
146971945|NCT00791154|530058483|FG002|Overall Study|Lost to Follow-up|0|||
146971946|NCT00791154|530058484|FG003|Overall Study|Lost to Follow-up|1|||
146971947|NCT00791154|530058485|FG004|Overall Study|Lost to Follow-up|2|||
146971948|NCT00791154|530058486|FG005|Overall Study|Lost to Follow-up|0|||
146971949|NCT00791154|530058487|FG006|Overall Study|Lost to Follow-up|4|||
146971950|NCT00791154|530058481|FG000|Overall Study|Death|5|||
146971951|NCT00791154|530058482|FG001|Overall Study|Death|4|||
146971952|NCT00791154|530058483|FG002|Overall Study|Death|4|||
146971953|NCT00791154|530058484|FG003|Overall Study|Death|7|||
146971954|NCT00791154|530058485|FG004|Overall Study|Death|54|||
146971955|NCT00791154|530058486|FG005|Overall Study|Death|54|||
146971956|NCT00791154|530058487|FG006|Overall Study|Death|52|||
146971957|NCT00791154|530058481|FG000|Overall Study|Other event|0|||
146971958|NCT00791154|530058482|FG001|Overall Study|Other event|0|||
146971959|NCT00791154|530058483|FG002|Overall Study|Other event|2|||
146971960|NCT00791154|530058484|FG003|Overall Study|Other event|0|||
146971961|NCT00791154|530058485|FG004|Overall Study|Other event|2|||
146971962|NCT00791154|530058486|FG005|Overall Study|Other event|4|||
146971963|NCT00791154|530058487|FG006|Overall Study|Other event|2|||
146971964|NCT00817778|530058489|FG000|Overall Study|Adverse Event|1|||
146971965|NCT00817778|530058490|FG001|Overall Study|Adverse Event|0|||
146971966|NCT00817778|530058489|FG000|Overall Study|Withdrawal by Subject|1|||
146971967|NCT00817778|530058490|FG001|Overall Study|Withdrawal by Subject|1|||
146496564|NCT03850483|528321356|FG001|Treatment for Stage 2|Protocol Violation|0|||
146496565|NCT03850483|528321357|FG002|Treatment for Stage 2|Protocol Violation|0|||
146496566|NCT03850483|528321358|FG003|Treatment for Stage 2|Protocol Violation|0|||
146496567|NCT03850483|528321359|FG004|Treatment for Stage 2|Protocol Violation|0|||
146496568|NCT03850483|528321360|FG005|Treatment for Stage 2|Protocol Violation|0|||
146496569|NCT03850483|528321361|FG006|Treatment for Stage 2|Protocol Violation|0|||
146496570|NCT03850483|528321362|FG007|Treatment for Stage 2|Protocol Violation|0|||
146496571|NCT03850483|528321363|FG008|Treatment for Stage 2|Protocol Violation|1|||
146496572|NCT03850483|528321364|FG009|Treatment for Stage 2|Protocol Violation|0|||
146496573|NCT03850483|528321355|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
146496574|NCT03850483|528321356|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
146564806|NCT02448381|528580054|FG001|Overall Study|Withdrawal by Subject|9|||
146564807|NCT02448381|528580053|FG000|Overall Study|Noncompliance with Study Procedures|2|||
146564808|NCT02448381|528580054|FG001|Overall Study|Noncompliance with Study Procedures|0|||
146564809|NCT01500317|528580057|FG000|Overall Study|Withdrawal by Subject|3|||
146564810|NCT01500317|528580058|FG001|Overall Study|Withdrawal by Subject|2|||
146564811|NCT01500317|528580059|FG002|Overall Study|Withdrawal by Subject|0|||
146564812|NCT04856527|528580061|FG000|Overall Study|Unable to complete experimental task|2|||
146564813|NCT04856527|528580062|FG001|Overall Study|Unable to complete experimental task|0|||
146564814|NCT01463527|528580065|FG000|Overall Study|Protocol Violation|1|||
146564815|NCT01463527|528580066|FG001|Overall Study|Protocol Violation|1|||
146564816|NCT01463527|528580065|FG000|Overall Study|Crying >20% of sedation|5|||
146564817|NCT01463527|528580066|FG001|Overall Study|Crying >20% of sedation|6|||
146564818|NCT01493414|528580067|FG000|Overall Study|Adverse Event|405|||
146564819|NCT01493414|528580067|FG000|Overall Study|Disease progression|204|||
146564820|NCT01493414|528580067|FG000|Overall Study|Death|101|||
146564821|NCT01493414|528580067|FG000|Overall Study|Physician Decision|93|||
146564822|NCT01493414|528580067|FG000|Overall Study|Withdrawal by Subject|79|||
146564823|NCT01493414|528580067|FG000|Overall Study|Protocol deviation|27|||
146564824|NCT01493414|528580067|FG000|Overall Study|Administrative problems|25|||
146564825|NCT01493414|528580067|FG000|Overall Study|Lost to Follow-up|16|||
146564826|NCT05448950|528580070|FG000|Overall Study|Death|2|||
146564827|NCT05448950|528580070|FG000|Overall Study|Withdrawal by Subject|1|||
146564828|NCT05448950|528580070|FG000|Overall Study|AVG abandoned|4|||
146564829|NCT02303262|528580071|FG000|Overall Study|Withdrawal by Subject|2|||
146971968|NCT00817778|530058489|FG000|Overall Study|Protocol Violation|0|||
146971969|NCT00817778|530058490|FG001|Overall Study|Protocol Violation|1|||
146971970|NCT00817778|530058489|FG000|Overall Study|Study-specific discontinuation criteria|0|||
146971971|NCT00817778|530058490|FG001|Overall Study|Study-specific discontinuation criteria|1|||
146971972|NCT00817778|530058489|FG000|Overall Study|Poor venous access|1|||
146971973|NCT00817778|530058490|FG001|Overall Study|Poor venous access|0|||
146643815|NCT03317405|528874282|FG002|Overall Study|Physician Decision|1|||
146643816|NCT03317405|528874280|FG000|Overall Study|Surgery Rescheduled|0|||
146643817|NCT03317405|528874281|FG001|Overall Study|Surgery Rescheduled|1|||
146643818|NCT03317405|528874282|FG002|Overall Study|Surgery Rescheduled|0|||
146643819|NCT04075734|528874285|FG000|Overall Study|Lost to Follow-up|1|||
146643820|NCT04075734|528874286|FG001|Overall Study|Lost to Follow-up|1|||
146643821|NCT04075734|528874287|FG002|Overall Study|Lost to Follow-up|0|||
146643822|NCT04075734|528874285|FG000|Overall Study|Withdrawal by Subject|3|||
146496575|NCT03850483|528321357|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
146496576|NCT03850483|528321358|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
146496577|NCT03850483|528321359|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
146496578|NCT03850483|528321360|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
146496579|NCT03850483|528321361|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
146496580|NCT03850483|528321362|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
146496581|NCT03850483|528321363|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
146496582|NCT03850483|528321364|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
146496583|NCT03850483|528321355|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
146496584|NCT03850483|528321356|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
146496585|NCT03850483|528321357|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
146496586|NCT03850483|528321358|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
146496587|NCT03850483|528321359|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
146496588|NCT03850483|528321360|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
146643823|NCT04075734|528874286|FG001|Overall Study|Withdrawal by Subject|0|||
146912047|NCT00092547|529841403|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
146912048|NCT00092547|529841404|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
146912049|NCT00092547|529841405|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
146912050|NCT00092547|529841403|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
146912051|NCT00092547|529841404|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
146912052|NCT00092547|529841405|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
146912053|NCT00092547|529841403|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
146912054|NCT00092547|529841404|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
146912055|NCT00092547|529841405|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
146912056|NCT00092547|529841403|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
146912057|NCT00092547|529841404|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
146912058|NCT00092547|529841405|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
146912059|NCT00092547|529841403|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
146912060|NCT00092547|529841404|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
146643824|NCT04075734|528874287|FG002|Overall Study|Withdrawal by Subject|0|||
146643825|NCT01137604|528874290|FG000|Overall Study|Adverse Event|3|||
146564866|NCT01728246|528580076|FG000|Overall Study|Participant needed rescue medication|1|||
146564867|NCT01728246|528580077|FG001|Overall Study|Participant needed rescue medication|5|||
146564868|NCT01728246|528580076|FG000|Overall Study|Protocol Violation|1|||
146564869|NCT01728246|528580077|FG001|Overall Study|Protocol Violation|0|||
146564870|NCT01728246|528580076|FG000|Overall Study|Withdrawal by Subject|2|||
146564871|NCT01728246|528580077|FG001|Overall Study|Withdrawal by Subject|3|||
146564872|NCT01728246|528580076|FG000|Overall Study|Lost to Follow-up|23|||
146643826|NCT01137604|528874291|FG001|Overall Study|Adverse Event|6|||
146643827|NCT01137604|528874292|FG002|Overall Study|Adverse Event|9|||
146643828|NCT01137604|528874293|FG003|Overall Study|Adverse Event|9|||
146643829|NCT01137604|528874290|FG000|Overall Study|Participant Choice|0|||
146643830|NCT01137604|528874291|FG001|Overall Study|Participant Choice|2|||
146643831|NCT01137604|528874292|FG002|Overall Study|Participant Choice|2|||
146643832|NCT01137604|528874293|FG003|Overall Study|Participant Choice|0|||
146643833|NCT01137604|528874290|FG000|Overall Study|Withdrawal of consent|0|||
146643834|NCT01137604|528874291|FG001|Overall Study|Withdrawal of consent|0|||
146643835|NCT01137604|528874292|FG002|Overall Study|Withdrawal of consent|0|||
146643836|NCT01137604|528874293|FG003|Overall Study|Withdrawal of consent|2|||
146643837|NCT01137604|528874290|FG000|Overall Study|Clinical progression/deterioration|1|||
146643838|NCT01137604|528874291|FG001|Overall Study|Clinical progression/deterioration|2|||
146643839|NCT01137604|528874292|FG002|Overall Study|Clinical progression/deterioration|2|||
146643840|NCT01137604|528874293|FG003|Overall Study|Clinical progression/deterioration|0|||
146643841|NCT00591318|528874294|FG000|Overall Study|Lack of Efficacy|2|||
146643842|NCT00591318|528874295|FG001|Overall Study|Lack of Efficacy|0|||
146643843|NCT00591318|528874294|FG000|Overall Study|Adverse Event|2|||
146643844|NCT00591318|528874295|FG001|Overall Study|Adverse Event|0|||
146643845|NCT01776307|528874296|FG000|Overall Study|Not dosed|0|||
146643846|NCT01776307|528874297|FG001|Overall Study|Not dosed|0|||
146643847|NCT01776307|528874298|FG002|Overall Study|Not dosed|1|||
146643848|NCT01024309|528874304|FG000|Overall Study|Physician Decision|4|||
146643849|NCT01024309|528874305|FG001|Overall Study|Physician Decision|0|||
146643850|NCT01024309|528874304|FG000|Overall Study|Withdrawal by Subject|4|||
146643851|NCT01024309|528874305|FG001|Overall Study|Withdrawal by Subject|4|||
146643852|NCT02745145|528874308|FG000|Overall Study|Adverse Event|1|||
146643853|NCT02745145|528874309|FG001|Overall Study|Adverse Event|0|||
146643854|NCT02745145|528874310|FG002|Overall Study|Adverse Event|0|||
146643855|NCT02745145|528874308|FG000|Overall Study|Death|0|||
146643856|NCT02745145|528874309|FG001|Overall Study|Death|1|||
146643857|NCT02745145|528874310|FG002|Overall Study|Death|0|||
146643858|NCT02745145|528874308|FG000|Overall Study|Progressive disease|0|||
146643859|NCT02745145|528874309|FG001|Overall Study|Progressive disease|0|||
146643860|NCT02745145|528874310|FG002|Overall Study|Progressive disease|1|||
146643861|NCT02745145|528874308|FG000|Overall Study|Withdrew consent|1|||
146643862|NCT02745145|528874309|FG001|Overall Study|Withdrew consent|1|||
146643863|NCT02745145|528874310|FG002|Overall Study|Withdrew consent|1|||
146643864|NCT02745145|528874308|FG000|Overall Study|Study Termination|8|||
146643865|NCT02745145|528874309|FG001|Overall Study|Study Termination|3|||
146643866|NCT02745145|528874310|FG002|Overall Study|Study Termination|7|||
146643867|NCT03083990|528874311|FG000|Overall Study|Adverse Event|1|||
146643868|NCT03083990|528874312|FG001|Overall Study|Adverse Event|0|||
146643869|NCT01018810|528874313|FG000|Overall Study|Withdrawal by Subject|0|||
146643870|NCT01018810|528874314|FG001|Overall Study|Withdrawal by Subject|1|||
146643871|NCT01018810|528874315|FG002|Overall Study|Withdrawal by Subject|0|||
146643872|NCT01018810|528874316|FG003|Overall Study|Withdrawal by Subject|0|||
146643873|NCT01018810|528874317|FG004|Overall Study|Withdrawal by Subject|0|||
146643874|NCT01018810|528874313|FG000|Overall Study|Sponsor Decision|2|||
146643875|NCT01018810|528874314|FG001|Overall Study|Sponsor Decision|0|||
146643876|NCT01018810|528874315|FG002|Overall Study|Sponsor Decision|1|||
146768927|NCT04707313|529321791|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146768928|NCT04707313|529321792|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146643877|NCT01018810|528874316|FG003|Overall Study|Sponsor Decision|1|||
146643878|NCT01018810|528874317|FG004|Overall Study|Sponsor Decision|1|||
146643879|NCT02424578|528874318|FG000|Overall Study|Withdrawal by Subject|0|||
146643880|NCT02424578|528874319|FG001|Overall Study|Withdrawal by Subject|1|||
146643881|NCT02640508|528874325|FG000|Overall Study|Death|19|||
146912061|NCT00092547|529841405|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
146912062|NCT00092547|529841403|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
146643882|NCT02640508|528874325|FG000|Overall Study|Withdrawal by Subject|8|||
146643883|NCT02640508|528874325|FG000|Overall Study|Physician Decision|1|||
146643884|NCT02640508|528874325|FG000|Overall Study|Lost to Follow-up|1|||
146643885|NCT00862082|528874326|FG000|Overall Study|Sponsor decision to terminate the study|5|||
146643886|NCT00862082|528874327|FG001|Overall Study|Sponsor decision to terminate the study|0|||
146643887|NCT00862082|528874326|FG000|Overall Study|Withdrawal by Subject|0|||
146643888|NCT00862082|528874327|FG001|Overall Study|Withdrawal by Subject|1|||
146643889|NCT05405257|528874328|FG000|Overall Study|Withdrawal by Subject|1|||
146643890|NCT00776919|528874329|FG000|Overall Study|Withdrawal by Subject|16|||
146643891|NCT00776919|528874330|FG001|Overall Study|Withdrawal by Subject|14|||
146643892|NCT00776919|528874331|FG002|Overall Study|Withdrawal by Subject|15|||
146643893|NCT00776919|528874332|FG003|Overall Study|Withdrawal by Subject|26|||
146643894|NCT00776919|528874329|FG000|Overall Study|Lost to Follow-up|8|||
146643895|NCT00776919|528874330|FG001|Overall Study|Lost to Follow-up|12|||
146912063|NCT00092547|529841404|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
146643896|NCT00776919|528874331|FG002|Overall Study|Lost to Follow-up|11|||
146912064|NCT00092547|529841405|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
146912065|NCT00092547|529841403|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
146643897|NCT00776919|528874332|FG003|Overall Study|Lost to Follow-up|8|||
146643898|NCT00776919|528874329|FG000|Overall Study|Adverse Event|1|||
146643899|NCT00776919|528874330|FG001|Overall Study|Adverse Event|0|||
146643900|NCT00776919|528874331|FG002|Overall Study|Adverse Event|2|||
146643901|NCT00776919|528874332|FG003|Overall Study|Adverse Event|2|||
146643902|NCT00776919|528874329|FG000|Overall Study|Protocol Violation|1|||
146643903|NCT00776919|528874330|FG001|Overall Study|Protocol Violation|2|||
146643904|NCT00776919|528874331|FG002|Overall Study|Protocol Violation|0|||
146643905|NCT00776919|528874332|FG003|Overall Study|Protocol Violation|1|||
146643906|NCT00776919|528874329|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
146643907|NCT00776919|528874330|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
146643908|NCT00776919|528874331|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
146643909|NCT00776919|528874332|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
146643910|NCT03116152|528874333|FG000|Overall Study|Disease Progression|49|||
146643911|NCT03116152|528874334|FG001|Overall Study|Disease Progression|47|||
146643912|NCT03116152|528874333|FG000|Overall Study|Death|5|||
146496589|NCT03850483|528321361|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
146496590|NCT03850483|528321362|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
146496591|NCT03850483|528321363|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
146496592|NCT03850483|528321364|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
146496593|NCT03850483|528321355|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
146496594|NCT03850483|528321356|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
146643913|NCT03116152|528874334|FG001|Overall Study|Death|2|||
146643914|NCT03116152|528874333|FG000|Overall Study|Adverse Event|21|||
146643915|NCT03116152|528874334|FG001|Overall Study|Adverse Event|7|||
146643916|NCT03116152|528874333|FG000|Overall Study|Protocol Violation|2|||
146643917|NCT03116152|528874334|FG001|Overall Study|Protocol Violation|2|||
146643918|NCT03116152|528874333|FG000|Overall Study|Withdrawal by Subject|0|||
146643919|NCT03116152|528874334|FG001|Overall Study|Withdrawal by Subject|1|||
146643920|NCT03116152|528874333|FG000|Overall Study|Physician Decision|3|||
146643921|NCT03116152|528874334|FG001|Overall Study|Physician Decision|2|||
146643922|NCT03116152|528874333|FG000|Overall Study|other|11|||
146643923|NCT03116152|528874334|FG001|Overall Study|other|34|||
146643924|NCT00862641|528874336|FG000|Overall Study|Randomized, but drug not received|1|||
146643925|NCT00862641|528874337|FG001|Overall Study|Randomized, but drug not received|4|||
146643926|NCT00862641|528874338|FG002|Overall Study|Randomized, but drug not received|1|||
146643927|NCT00862641|528874339|FG003|Overall Study|Randomized, but drug not received|4|||
146643928|NCT03179605|528874340|FG000|Overall Study|Withdrawal by Subject|1|||
146643929|NCT00635999|528874341|FG000|Overall Study|Withdrawal by Subject|4|||
146643930|NCT00635999|528874342|FG001|Overall Study|Withdrawal by Subject|2|||
146643931|NCT00635999|528874343|FG002|Overall Study|Withdrawal by Subject|1|||
146643932|NCT00711477|528874344|FG000|Overall Study|Adverse Event|3|||
146643933|NCT00711477|528874345|FG001|Overall Study|Adverse Event|1|||
146643934|NCT00711477|528874344|FG000|Overall Study|Lost to Follow-up|0|||
146643935|NCT00711477|528874345|FG001|Overall Study|Lost to Follow-up|1|||
146643936|NCT00711477|528874344|FG000|Overall Study|Noncompliance|0|||
146643937|NCT00711477|528874345|FG001|Overall Study|Noncompliance|1|||
146643938|NCT01798849|528874346|FG000|Overall Study|Physician Decision|0|||
146643939|NCT01798849|528874347|FG001|Overall Study|Physician Decision|0|||
146643940|NCT01798849|528874348|FG002|Overall Study|Physician Decision|1|||
146643941|NCT02636361|528874349|FG000|Period 4|Physician Decision|0|||
146643942|NCT02636361|528874350|FG001|Period 4|Physician Decision|0|||
146643943|NCT02636361|528874351|FG002|Period 4|Physician Decision|0|||
146643944|NCT02636361|528874352|FG003|Period 4|Physician Decision|1|||
146643945|NCT02636361|528874353|FG004|Period 4|Physician Decision|0|||
146643946|NCT02410343|528874359|FG000|Core Period (24 Weeks)|Adverse Event|1|||
146643947|NCT02410343|528874360|FG001|Core Period (24 Weeks)|Adverse Event|0|||
146643948|NCT02410343|528874359|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
146643949|NCT02410343|528874360|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
146643950|NCT02410343|528874359|FG000|Extension Period (12 Months)|Adverse Event|1|||
146643951|NCT02410343|528874360|FG001|Extension Period (12 Months)|Adverse Event|0|||
146643952|NCT02410343|528874359|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
146643953|NCT02410343|528874360|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
146643954|NCT02036853|528874361|FG000|Overall Study|Adverse Event|0|||
146643955|NCT02036853|528874362|FG001|Overall Study|Adverse Event|2|||
146643956|NCT02036853|528874361|FG000|Overall Study|Lack of Efficacy|0|||
146643957|NCT02036853|528874362|FG001|Overall Study|Lack of Efficacy|2|||
146643958|NCT02036853|528874361|FG000|Overall Study|Physician Decision|0|||
146643959|NCT02036853|528874362|FG001|Overall Study|Physician Decision|1|||
146643960|NCT02036853|528874361|FG000|Overall Study|Withdrawal by Subject|0|||
146643961|NCT02036853|528874362|FG001|Overall Study|Withdrawal by Subject|1|||
146643962|NCT00228553|528874363|FG000|Overall Study|Adverse Event|112|||
146643963|NCT00228553|528874363|FG000|Overall Study|Lack of Efficacy|34|||
146643964|NCT00228553|528874363|FG000|Overall Study|Lost to Follow-up|67|||
146643965|NCT00228553|528874363|FG000|Overall Study|Physician Decision|48|||
146643966|NCT00228553|528874363|FG000|Overall Study|Protocol Violation|6|||
146643967|NCT00228553|528874363|FG000|Overall Study|Withdrawal by Subject|115|||
146643968|NCT00228553|528874363|FG000|Overall Study|Pregnancy|2|||
146643969|NCT00228553|528874363|FG000|Overall Study|Miscellaneous|46|||
146643970|NCT04556383|528874366|FG000|PCP|Lack of Efficacy|28|||
146643971|NCT04556383|528874367|FG001|PCP|Lack of Efficacy|23|||
146643972|NCT04556383|528874368|FG002|PCP|Lack of Efficacy|23|||
146643973|NCT04556383|528874369|FG003|PCP|Lack of Efficacy|0|||
146643974|NCT04556383|528874366|FG000|PCP|Study terminated by sponsor|15|||
146643975|NCT04556383|528874367|FG001|PCP|Study terminated by sponsor|13|||
146643976|NCT04556383|528874368|FG002|PCP|Study terminated by sponsor|16|||
146643977|NCT04556383|528874369|FG003|PCP|Study terminated by sponsor|0|||
146643978|NCT04556383|528874366|FG000|PCP|Withdrawal by Subject|8|||
146643979|NCT04556383|528874367|FG001|PCP|Withdrawal by Subject|6|||
146643980|NCT04556383|528874368|FG002|PCP|Withdrawal by Subject|6|||
146643981|NCT04556383|528874369|FG003|PCP|Withdrawal by Subject|0|||
146643982|NCT04556383|528874366|FG000|PCP|Adverse Event|1|||
146643983|NCT04556383|528874367|FG001|PCP|Adverse Event|7|||
146643984|NCT04556383|528874368|FG002|PCP|Adverse Event|7|||
146643985|NCT04556383|528874369|FG003|PCP|Adverse Event|0|||
146643986|NCT04556383|528874366|FG000|PCP|Other, Not Specified|1|||
146643987|NCT04556383|528874367|FG001|PCP|Other, Not Specified|2|||
146643988|NCT04556383|528874368|FG002|PCP|Other, Not Specified|1|||
146643989|NCT04556383|528874369|FG003|PCP|Other, Not Specified|0|||
146643990|NCT04556383|528874366|FG000|PCP|Protocol Violation|1|||
146643991|NCT04556383|528874367|FG001|PCP|Protocol Violation|0|||
146643992|NCT04556383|528874368|FG002|PCP|Protocol Violation|1|||
146643993|NCT04556383|528874369|FG003|PCP|Protocol Violation|0|||
146643994|NCT04556383|528874366|FG000|PCP|Lost to Follow-up|1|||
146643995|NCT04556383|528874367|FG001|PCP|Lost to Follow-up|0|||
146643996|NCT04556383|528874368|FG002|PCP|Lost to Follow-up|0|||
146643997|NCT04556383|528874369|FG003|PCP|Lost to Follow-up|0|||
146643998|NCT04556383|528874366|FG000|PCP|Physician Decision|0|||
146643999|NCT04556383|528874367|FG001|PCP|Physician Decision|1|||
146644000|NCT04556383|528874368|FG002|PCP|Physician Decision|0|||
146644001|NCT04556383|528874369|FG003|PCP|Physician Decision|0|||
146644002|NCT04556383|528874366|FG000|PCP|Site terminated by sponsor|0|||
146644003|NCT04556383|528874367|FG001|PCP|Site terminated by sponsor|1|||
146644004|NCT04556383|528874368|FG002|PCP|Site terminated by sponsor|0|||
146644005|NCT04556383|528874369|FG003|PCP|Site terminated by sponsor|0|||
146644006|NCT04556383|528874366|FG000|OLE|Study terminated by sponsor|0|||
146644007|NCT04556383|528874367|FG001|OLE|Study terminated by sponsor|0|||
146644008|NCT04556383|528874368|FG002|OLE|Study terminated by sponsor|0|||
146644009|NCT04556383|528874369|FG003|OLE|Study terminated by sponsor|68|||
146644010|NCT04556383|528874366|FG000|OLE|Withdrawal by Subject|0|||
146644011|NCT04556383|528874367|FG001|OLE|Withdrawal by Subject|0|||
146644012|NCT04556383|528874368|FG002|OLE|Withdrawal by Subject|0|||
146644013|NCT04556383|528874369|FG003|OLE|Withdrawal by Subject|10|||
146644014|NCT04556383|528874366|FG000|OLE|Lack of Efficacy|0|||
146644015|NCT04556383|528874367|FG001|OLE|Lack of Efficacy|0|||
146644016|NCT04556383|528874368|FG002|OLE|Lack of Efficacy|0|||
146644017|NCT04556383|528874369|FG003|OLE|Lack of Efficacy|7|||
146644018|NCT04556383|528874366|FG000|OLE|Adverse Event|0|||
146644019|NCT04556383|528874367|FG001|OLE|Adverse Event|0|||
146644020|NCT04556383|528874368|FG002|OLE|Adverse Event|0|||
146644021|NCT04556383|528874369|FG003|OLE|Adverse Event|2|||
146644022|NCT04556383|528874366|FG000|OLE|Other, Not Specified|0|||
146644023|NCT04556383|528874367|FG001|OLE|Other, Not Specified|0|||
146644024|NCT04556383|528874368|FG002|OLE|Other, Not Specified|0|||
146644025|NCT04556383|528874369|FG003|OLE|Other, Not Specified|2|||
146644026|NCT04556383|528874366|FG000|OLE|Death|0|||
146644027|NCT04556383|528874367|FG001|OLE|Death|0|||
146644028|NCT04556383|528874368|FG002|OLE|Death|0|||
146644029|NCT04556383|528874369|FG003|OLE|Death|1|||
146768929|NCT04707313|529321793|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146496595|NCT03850483|528321357|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
146496596|NCT03850483|528321358|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
146496597|NCT03850483|528321359|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
146496598|NCT03850483|528321360|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
146496599|NCT03850483|528321361|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
146496600|NCT03850483|528321362|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
146644030|NCT04556383|528874366|FG000|OLE|Lost to Follow-up|0|||
146644031|NCT04556383|528874367|FG001|OLE|Lost to Follow-up|0|||
146644032|NCT04556383|528874368|FG002|OLE|Lost to Follow-up|0|||
146644033|NCT04556383|528874369|FG003|OLE|Lost to Follow-up|1|||
146644034|NCT00884741|528874377|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
146644035|NCT00884741|528874378|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
146644036|NCT00884741|528874379|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
146644037|NCT00884741|528874380|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
146644038|NCT00884741|528874377|FG000|Step 1 Registration: Tissue Screening|Death|3|||
146644039|NCT00884741|528874378|FG001|Step 1 Registration: Tissue Screening|Death|0|||
146644040|NCT00884741|528874379|FG002|Step 1 Registration: Tissue Screening|Death|0|||
146644041|NCT00884741|528874380|FG003|Step 1 Registration: Tissue Screening|Death|0|||
146644042|NCT00884741|528874377|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
146644043|NCT00884741|528874378|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
146644044|NCT00884741|528874379|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
146644045|NCT00884741|528874380|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
146496601|NCT03850483|528321363|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
146496602|NCT03850483|528321364|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
146496603|NCT03850483|528321355|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
146496604|NCT03850483|528321356|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
146496605|NCT03850483|528321357|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
146496606|NCT03850483|528321358|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
146496607|NCT03850483|528321359|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
146496608|NCT03850483|528321360|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
146496609|NCT03850483|528321361|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
146496610|NCT03850483|528321362|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
146496611|NCT03850483|528321363|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
146496612|NCT03850483|528321364|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
146496613|NCT03850483|528321355|FG000|Follow-up For Stage 2|Other|0|||
146496614|NCT03850483|528321356|FG001|Follow-up For Stage 2|Other|0|||
146496615|NCT03850483|528321357|FG002|Follow-up For Stage 2|Other|0|||
146564873|NCT01728246|528580077|FG001|Overall Study|Lost to Follow-up|22|||
146564874|NCT01728246|528580076|FG000|Overall Study|Lack of Efficacy|1|||
146564875|NCT01728246|528580077|FG001|Overall Study|Lack of Efficacy|1|||
146564876|NCT01728246|528580076|FG000|Overall Study|Adverse Event|8|||
146564877|NCT01728246|528580077|FG001|Overall Study|Adverse Event|5|||
146564878|NCT05643495|528580084|FG000|Overall Study|Adverse Event|0|||
146564879|NCT05643495|528580085|FG001|Overall Study|Adverse Event|1|||
146564880|NCT05643495|528580084|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
146564881|NCT05643495|528580085|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
146564882|NCT02257528|528580086|FG000|Overall Study|Never received study treatment|1|||
146564883|NCT04237584|528580087|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
146564884|NCT04237584|528580088|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
146564885|NCT04237584|528580089|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
146564886|NCT04237584|528580090|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
146564887|NCT04237584|528580087|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
146564888|NCT04237584|528580088|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
146564889|NCT04237584|528580089|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
146564890|NCT04237584|528580090|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
146564891|NCT04237584|528580087|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
146564892|NCT04237584|528580088|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
146564893|NCT04237584|528580089|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
146564894|NCT04237584|528580090|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
146564895|NCT04237584|528580087|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
146564896|NCT04237584|528580088|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
146564897|NCT04237584|528580089|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
146564898|NCT04237584|528580090|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
146564899|NCT04237584|528580087|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
146564900|NCT04237584|528580088|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
146564901|NCT04237584|528580089|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
146564902|NCT04237584|528580090|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
146564903|NCT04696146|528581284|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
146564904|NCT04696146|528581285|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
146564905|NCT04696146|528581284|FG000|Overall Study|Off hours issue with product|1|||
146564906|NCT04696146|528581285|FG001|Overall Study|Off hours issue with product|0|||
146564907|NCT01334918|528581290|FG000|Overall Study|Did not receive study drug|6|||
146564908|NCT01334918|528581291|FG001|Overall Study|Did not receive study drug|0|||
146564909|NCT01334918|528581290|FG000|Overall Study|Adverse Event|2|||
146564910|NCT01334918|528581291|FG001|Overall Study|Adverse Event|0|||
146564911|NCT01334918|528581290|FG000|Overall Study|Withdrawal by Subject|0|||
146564912|NCT01334918|528581291|FG001|Overall Study|Withdrawal by Subject|1|||
146564913|NCT00529633|528581292|FG000|Overall Study|Withdrawal by Subject|1|||
146564914|NCT00529633|528581293|FG001|Overall Study|Withdrawal by Subject|1|||
146564915|NCT01897493|528581298|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
146564916|NCT02777086|528581300|FG000|Overall Study|Lost to Follow-up|96|||
146564917|NCT02777086|528581301|FG001|Overall Study|Lost to Follow-up|99|||
146564918|NCT01133665|528581302|FG000|Overall Study|Physician Decision|2|||
146564919|NCT01819272|528581303|FG000|Overall Study|Adverse Event|1|||
146564920|NCT01819272|528581304|FG001|Overall Study|Adverse Event|0|||
146564921|NCT01819272|528581305|FG002|Overall Study|Adverse Event|0|||
146564922|NCT01819272|528581306|FG003|Overall Study|Adverse Event|2|||
146564923|NCT01819272|528581307|FG004|Overall Study|Adverse Event|0|||
146564924|NCT01819272|528581308|FG005|Overall Study|Adverse Event|0|||
146564925|NCT01819272|528581303|FG000|Overall Study|Lost to Follow-up|3|||
146564926|NCT01819272|528581304|FG001|Overall Study|Lost to Follow-up|0|||
146564927|NCT01819272|528581305|FG002|Overall Study|Lost to Follow-up|1|||
146496616|NCT03850483|528321358|FG003|Follow-up For Stage 2|Other|0|||
146644046|NCT00884741|528874377|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
146644047|NCT00884741|528874378|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
146644048|NCT00884741|528874379|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
146644049|NCT00884741|528874380|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
146644050|NCT00884741|528874377|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
146644051|NCT00884741|528874378|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
146644052|NCT00884741|528874379|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
146644053|NCT00884741|528874380|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
146644054|NCT00884741|528874377|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
146644055|NCT00884741|528874378|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
146644056|NCT00884741|528874379|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
146644057|NCT00884741|528874380|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
146644058|NCT00884741|528874377|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
146644059|NCT00884741|528874378|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
146644060|NCT00884741|528874379|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
146644061|NCT00884741|528874380|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
146644062|NCT00884741|528874377|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
146644063|NCT00884741|528874378|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
146644064|NCT00884741|528874379|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
146644065|NCT00884741|528874380|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
146644066|NCT00884741|528874377|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
146644067|NCT00884741|528874378|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
146644068|NCT00884741|528874379|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
146644069|NCT00884741|528874380|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
146644070|NCT00884741|528874377|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
146644071|NCT00884741|528874378|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
146644072|NCT00884741|528874379|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
146644073|NCT00884741|528874380|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
146644074|NCT00884741|528874377|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
146644075|NCT00884741|528874378|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
146644076|NCT00884741|528874379|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
146644077|NCT00884741|528874380|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
146644078|NCT00884741|528874377|FG000|Randomization|Protocol Violation|0|||
146644079|NCT00884741|528874378|FG001|Randomization|Protocol Violation|0|||
146644080|NCT00884741|528874379|FG002|Randomization|Protocol Violation|8|||
146644081|NCT00884741|528874380|FG003|Randomization|Protocol Violation|8|||
146644082|NCT00335764|528874381|FG000|Overall Study|wrong histology|1|||
146644083|NCT00335764|528874382|FG001|Overall Study|wrong histology|0|||
146644084|NCT00335764|528874383|FG002|Overall Study|wrong histology|0|||
146644085|NCT00335764|528874384|FG003|Overall Study|wrong histology|0|||
146644086|NCT00335764|528874385|FG004|Overall Study|wrong histology|1|||
146644087|NCT00612807|528874386|FG000|Overall Study|Withdrawal by Subject|2|||
146644088|NCT00612807|528874387|FG001|Overall Study|Withdrawal by Subject|0|||
146644089|NCT00744042|528874390|FG000|Overall Study|Withdrawal by Subject|1|||
146644090|NCT04303195|528874393|FG000|Overall Study|Adverse Event|1|||
146644091|NCT04303195|528874394|FG001|Overall Study|Adverse Event|3|||
146644092|NCT04303195|528874395|FG002|Overall Study|Adverse Event|7|||
146644093|NCT04303195|528874396|FG003|Overall Study|Adverse Event|0|||
146644094|NCT04303195|528874393|FG000|Overall Study|Lost to Follow-up|1|||
146644095|NCT04303195|528874394|FG001|Overall Study|Lost to Follow-up|0|||
146644096|NCT04303195|528874395|FG002|Overall Study|Lost to Follow-up|1|||
146644097|NCT04303195|528874396|FG003|Overall Study|Lost to Follow-up|4|||
146644098|NCT04303195|528874393|FG000|Overall Study|Withdrawal by Subject|3|||
146644099|NCT04303195|528874394|FG001|Overall Study|Withdrawal by Subject|1|||
146644100|NCT04303195|528874395|FG002|Overall Study|Withdrawal by Subject|1|||
146644101|NCT04303195|528874396|FG003|Overall Study|Withdrawal by Subject|1|||
146644102|NCT04303195|528874393|FG000|Overall Study|No study drug administered or protocol deviation|0|||
146644103|NCT04303195|528874394|FG001|Overall Study|No study drug administered or protocol deviation|2|||
146644104|NCT04303195|528874395|FG002|Overall Study|No study drug administered or protocol deviation|0|||
146644105|NCT04303195|528874396|FG003|Overall Study|No study drug administered or protocol deviation|2|||
146644106|NCT02970942|528874397|FG000|Overall Study|Death|0|||
146644107|NCT02970942|528874398|FG001|Overall Study|Death|1|||
146644108|NCT02970942|528874399|FG002|Overall Study|Death|0|||
146644109|NCT02970942|528874400|FG003|Overall Study|Death|0|||
146644110|NCT02970942|528874397|FG000|Overall Study|Lost to Follow-up|1|||
146644111|NCT02970942|528874398|FG001|Overall Study|Lost to Follow-up|0|||
146644112|NCT02970942|528874399|FG002|Overall Study|Lost to Follow-up|2|||
146644113|NCT02970942|528874400|FG003|Overall Study|Lost to Follow-up|1|||
146644114|NCT02970942|528874397|FG000|Overall Study|Withdrawal by Subject|3|||
146644115|NCT02970942|528874398|FG001|Overall Study|Withdrawal by Subject|5|||
146644116|NCT02970942|528874399|FG002|Overall Study|Withdrawal by Subject|3|||
146644117|NCT02970942|528874400|FG003|Overall Study|Withdrawal by Subject|2|||
146564928|NCT01819272|528581306|FG003|Overall Study|Lost to Follow-up|0|||
146564929|NCT01819272|528581307|FG004|Overall Study|Lost to Follow-up|0|||
146564930|NCT01819272|528581308|FG005|Overall Study|Lost to Follow-up|3|||
146564931|NCT01819272|528581303|FG000|Overall Study|Protocol Violation|0|||
146564932|NCT01819272|528581304|FG001|Overall Study|Protocol Violation|0|||
146564933|NCT01819272|528581305|FG002|Overall Study|Protocol Violation|0|||
146496617|NCT03850483|528321359|FG004|Follow-up For Stage 2|Other|0|||
146496618|NCT03850483|528321360|FG005|Follow-up For Stage 2|Other|0|||
146496619|NCT03850483|528321361|FG006|Follow-up For Stage 2|Other|0|||
146496620|NCT03850483|528321362|FG007|Follow-up For Stage 2|Other|0|||
146496621|NCT03850483|528321363|FG008|Follow-up For Stage 2|Other|0|||
146496622|NCT03850483|528321364|FG009|Follow-up For Stage 2|Other|1|||
146496623|NCT02875613|528322887|FG000|Overall Study|Withdrawal by Subject|1|||
146496624|NCT02875613|528322887|FG000|Overall Study|Screen Failure|1|||
146496625|NCT02237196|528322888|FG000|Overall Study|Adverse Event|0|||
146496626|NCT02237196|528322889|FG001|Overall Study|Adverse Event|1|||
146496627|NCT02237196|528322890|FG002|Overall Study|Adverse Event|1|||
146496628|NCT02237196|528322891|FG003|Overall Study|Adverse Event|0|||
146496629|NCT02237196|528322888|FG000|Overall Study|Lost to Follow-up|4|||
146496630|NCT02237196|528322889|FG001|Overall Study|Lost to Follow-up|2|||
146496631|NCT02237196|528322890|FG002|Overall Study|Lost to Follow-up|4|||
146496632|NCT02237196|528322891|FG003|Overall Study|Lost to Follow-up|6|||
146496633|NCT02237196|528322888|FG000|Overall Study|Physician Decision|2|||
146496634|NCT02237196|528322889|FG001|Overall Study|Physician Decision|0|||
146496635|NCT02237196|528322890|FG002|Overall Study|Physician Decision|0|||
146496636|NCT02237196|528322891|FG003|Overall Study|Physician Decision|1|||
146496637|NCT02237196|528322888|FG000|Overall Study|Pregnancy|0|||
146496638|NCT02237196|528322889|FG001|Overall Study|Pregnancy|0|||
146496639|NCT02237196|528322890|FG002|Overall Study|Pregnancy|1|||
146496640|NCT02237196|528322891|FG003|Overall Study|Pregnancy|1|||
146496641|NCT02237196|528322888|FG000|Overall Study|Withdrawal by Subject|1|||
146496642|NCT02237196|528322889|FG001|Overall Study|Withdrawal by Subject|1|||
146496643|NCT02237196|528322890|FG002|Overall Study|Withdrawal by Subject|4|||
146496644|NCT02237196|528322891|FG003|Overall Study|Withdrawal by Subject|1|||
146496645|NCT02237196|528322888|FG000|Overall Study|Site Error|1|||
146496646|NCT02237196|528322889|FG001|Overall Study|Site Error|2|||
146496647|NCT02237196|528322890|FG002|Overall Study|Site Error|0|||
146496648|NCT02237196|528322891|FG003|Overall Study|Site Error|2|||
146496649|NCT04157296|528322892|FG000|Overall Study|Withdrawal by Subject|0|||
146496650|NCT04157296|528322893|FG001|Overall Study|Withdrawal by Subject|1|||
146496651|NCT04157296|528322892|FG000|Overall Study|Did not obtain second fMRI.|0|||
146496652|NCT04157296|528322893|FG001|Overall Study|Did not obtain second fMRI.|1|||
146496653|NCT04157296|528322892|FG000|Overall Study|MRI failed/no second fMRI|0|||
146496654|NCT04157296|528322893|FG001|Overall Study|MRI failed/no second fMRI|1|||
146496655|NCT01057810|528322896|FG000|Overall Study|Disease progression|156|||
146496656|NCT01057810|528322897|FG001|Overall Study|Disease progression|197|||
146496657|NCT01057810|528322896|FG000|Overall Study|Study drug toxicity|5|||
146496658|NCT01057810|528322897|FG001|Overall Study|Study drug toxicity|114|||
146496659|NCT01057810|528322896|FG000|Overall Study|Adverse event unrelated to study drug|13|||
146496660|NCT01057810|528322897|FG001|Overall Study|Adverse event unrelated to study drug|29|||
146496661|NCT01057810|528322896|FG000|Overall Study|Withdrawal by Subject|10|||
146496662|NCT01057810|528322897|FG001|Overall Study|Withdrawal by Subject|25|||
146496663|NCT01057810|528322896|FG000|Overall Study|Death|2|||
146496664|NCT01057810|528322897|FG001|Overall Study|Death|12|||
146496665|NCT01057810|528322896|FG000|Overall Study|Maximum clinical benefit|5|||
146496666|NCT01057810|528322897|FG001|Overall Study|Maximum clinical benefit|5|||
146496667|NCT01057810|528322896|FG000|Overall Study|Poor/non-compliance|0|||
146496668|NCT01057810|528322897|FG001|Overall Study|Poor/non-compliance|1|||
146496669|NCT01057810|528322896|FG000|Overall Study|No longer met study criteria|0|||
146496670|NCT01057810|528322897|FG001|Overall Study|No longer met study criteria|1|||
146496671|NCT01057810|528322896|FG000|Overall Study|Other|7|||
146496672|NCT01057810|528322897|FG001|Overall Study|Other|14|||
146496673|NCT02088905|528322898|FG000|Overall Study|Withdrawal by Subject|5|||
146496674|NCT02088905|528322899|FG001|Overall Study|Withdrawal by Subject|1|||
146496675|NCT00267969|528322900|FG000|Controlled Period|Adverse Event|6|||
146496676|NCT00267969|528322901|FG001|Controlled Period|Adverse Event|0|||
146496677|NCT00267969|528322902|FG002|Controlled Period|Adverse Event|2|||
146496678|NCT00267969|528322903|FG003|Controlled Period|Adverse Event|0|||
146496679|NCT00267969|528322904|FG004|Controlled Period|Adverse Event|0|||
146496680|NCT00267969|528322905|FG005|Controlled Period|Adverse Event|0|||
146496681|NCT00267969|528322906|FG006|Controlled Period|Adverse Event|0|||
146496682|NCT00267969|528322900|FG000|Controlled Period|Lack of Efficacy|3|||
146496683|NCT00267969|528322901|FG001|Controlled Period|Lack of Efficacy|0|||
146496684|NCT00267969|528322902|FG002|Controlled Period|Lack of Efficacy|1|||
146564934|NCT01819272|528581306|FG003|Overall Study|Protocol Violation|1|||
146496685|NCT00267969|528322903|FG003|Controlled Period|Lack of Efficacy|0|||
146564935|NCT01819272|528581307|FG004|Overall Study|Protocol Violation|2|||
146564936|NCT01819272|528581308|FG005|Overall Study|Protocol Violation|3|||
146564937|NCT01819272|528581303|FG000|Overall Study|Physician Decision|0|||
146644118|NCT01065454|528874403|FG000|Treatment|Adverse Event|7|||
146644119|NCT01065454|528874404|FG001|Treatment|Adverse Event|4|||
146644120|NCT01065454|528874405|FG002|Treatment|Adverse Event|3|||
146644121|NCT01065454|528874406|FG003|Treatment|Adverse Event|6|||
146644122|NCT01065454|528874403|FG000|Treatment|Death|1|||
146644123|NCT01065454|528874404|FG001|Treatment|Death|0|||
146644124|NCT01065454|528874405|FG002|Treatment|Death|0|||
146644125|NCT01065454|528874406|FG003|Treatment|Death|0|||
146496686|NCT00267969|528322904|FG004|Controlled Period|Lack of Efficacy|0|||
146496687|NCT00267969|528322905|FG005|Controlled Period|Lack of Efficacy|0|||
146496688|NCT00267969|528322906|FG006|Controlled Period|Lack of Efficacy|0|||
146496689|NCT00267969|528322900|FG000|Controlled Period|Lost to Follow-up|1|||
146496690|NCT00267969|528322901|FG001|Controlled Period|Lost to Follow-up|0|||
146496691|NCT00267969|528322902|FG002|Controlled Period|Lost to Follow-up|1|||
146496692|NCT00267969|528322903|FG003|Controlled Period|Lost to Follow-up|0|||
146496693|NCT00267969|528322904|FG004|Controlled Period|Lost to Follow-up|0|||
146496694|NCT00267969|528322905|FG005|Controlled Period|Lost to Follow-up|0|||
146496695|NCT00267969|528322906|FG006|Controlled Period|Lost to Follow-up|0|||
146496696|NCT00267969|528322900|FG000|Controlled Period|Randomized but not treated|0|||
146496697|NCT00267969|528322901|FG001|Controlled Period|Randomized but not treated|0|||
146496698|NCT00267969|528322902|FG002|Controlled Period|Randomized but not treated|1|||
146496699|NCT00267969|528322903|FG003|Controlled Period|Randomized but not treated|0|||
146496700|NCT00267969|528322904|FG004|Controlled Period|Randomized but not treated|0|||
146496701|NCT00267969|528322905|FG005|Controlled Period|Randomized but not treated|0|||
146496702|NCT00267969|528322906|FG006|Controlled Period|Randomized but not treated|0|||
146496703|NCT00267969|528322900|FG000|Controlled Period|Other|2|||
146496704|NCT00267969|528322901|FG001|Controlled Period|Other|1|||
146496705|NCT00267969|528322902|FG002|Controlled Period|Other|6|||
146496706|NCT00267969|528322903|FG003|Controlled Period|Other|0|||
146496707|NCT00267969|528322904|FG004|Controlled Period|Other|0|||
146496708|NCT00267969|528322905|FG005|Controlled Period|Other|0|||
146496709|NCT00267969|528322906|FG006|Controlled Period|Other|0|||
146644126|NCT01065454|528874403|FG000|Treatment|Non-compliance|1|||
146644127|NCT01065454|528874404|FG001|Treatment|Non-compliance|0|||
146644128|NCT01065454|528874405|FG002|Treatment|Non-compliance|0|||
146644129|NCT01065454|528874406|FG003|Treatment|Non-compliance|1|||
146644130|NCT01065454|528874403|FG000|Treatment|Protocol Decision|0|||
146644131|NCT01065454|528874404|FG001|Treatment|Protocol Decision|0|||
146644132|NCT01065454|528874405|FG002|Treatment|Protocol Decision|3|||
146644133|NCT01065454|528874406|FG003|Treatment|Protocol Decision|2|||
146644134|NCT01065454|528874403|FG000|Treatment|Protocol Violation|1|||
146644135|NCT01065454|528874404|FG001|Treatment|Protocol Violation|0|||
146644136|NCT01065454|528874405|FG002|Treatment|Protocol Violation|1|||
146644137|NCT01065454|528874406|FG003|Treatment|Protocol Violation|0|||
146644138|NCT01065454|528874403|FG000|Treatment|Withdrawal by Subject|3|||
146644139|NCT01065454|528874404|FG001|Treatment|Withdrawal by Subject|1|||
146644140|NCT01065454|528874405|FG002|Treatment|Withdrawal by Subject|2|||
146644141|NCT01065454|528874406|FG003|Treatment|Withdrawal by Subject|3|||
146644142|NCT01065454|528874403|FG000|Follow up|Adverse Event|1|||
146644143|NCT01065454|528874404|FG001|Follow up|Adverse Event|0|||
146644144|NCT01065454|528874405|FG002|Follow up|Adverse Event|0|||
146644145|NCT01065454|528874406|FG003|Follow up|Adverse Event|1|||
146644146|NCT01065454|528874403|FG000|Follow up|Death|0|||
146644147|NCT01065454|528874404|FG001|Follow up|Death|1|||
146644148|NCT01065454|528874405|FG002|Follow up|Death|1|||
146644149|NCT01065454|528874406|FG003|Follow up|Death|0|||
146644150|NCT01065454|528874403|FG000|Follow up|Lost to Follow-up|0|||
146496710|NCT00267969|528322900|FG000|After Controlled Period|Adverse Event|0|||
146496711|NCT00267969|528322901|FG001|After Controlled Period|Adverse Event|0|||
146496712|NCT00267969|528322902|FG002|After Controlled Period|Adverse Event|0|||
146496713|NCT00267969|528322903|FG003|After Controlled Period|Adverse Event|7|||
146644151|NCT01065454|528874404|FG001|Follow up|Lost to Follow-up|0|||
146644152|NCT01065454|528874405|FG002|Follow up|Lost to Follow-up|0|||
146644153|NCT01065454|528874406|FG003|Follow up|Lost to Follow-up|1|||
146644154|NCT01065454|528874403|FG000|Follow up|Progressive disease|0|||
146644155|NCT01065454|528874404|FG001|Follow up|Progressive disease|0|||
146644156|NCT01065454|528874405|FG002|Follow up|Progressive disease|0|||
146644157|NCT01065454|528874406|FG003|Follow up|Progressive disease|1|||
146644158|NCT01065454|528874403|FG000|Follow up|Withdrawal by Subject|1|||
146496714|NCT00267969|528322904|FG004|After Controlled Period|Adverse Event|8|||
146496715|NCT00267969|528322905|FG005|After Controlled Period|Adverse Event|23|||
146496716|NCT00267969|528322906|FG006|After Controlled Period|Adverse Event|21|||
146496717|NCT00267969|528322900|FG000|After Controlled Period|Death|0|||
146496718|NCT00267969|528322901|FG001|After Controlled Period|Death|0|||
146644159|NCT01065454|528874404|FG001|Follow up|Withdrawal by Subject|1|||
146644160|NCT01065454|528874405|FG002|Follow up|Withdrawal by Subject|1|||
146644161|NCT01065454|528874406|FG003|Follow up|Withdrawal by Subject|0|||
146644162|NCT01065454|528874403|FG000|Follow up|study ongoing|37|||
146644163|NCT01065454|528874404|FG001|Follow up|study ongoing|22|||
146644164|NCT01065454|528874405|FG002|Follow up|study ongoing|15|||
146644165|NCT01065454|528874406|FG003|Follow up|study ongoing|41|||
146644166|NCT05688670|528874407|FG000|Overall Study|Change in surgery plan|1|||
146644167|NCT05688670|528874408|FG001|Overall Study|Change in surgery plan|4|||
146644168|NCT05688670|528874407|FG000|Overall Study|Inability to extubate|1|||
146644169|NCT05688670|528874408|FG001|Overall Study|Inability to extubate|2|||
146644170|NCT05688670|528874407|FG000|Overall Study|Day of surgery cancellation|0|||
146644171|NCT05688670|528874408|FG001|Overall Study|Day of surgery cancellation|1|||
146644172|NCT05688670|528874407|FG000|Overall Study|Reintubated on PCICU arrival|0|||
146644173|NCT05688670|528874408|FG001|Overall Study|Reintubated on PCICU arrival|1|||
146644174|NCT02537015|528874415|FG000|Overall Study|Adverse Event|3|||
146644175|NCT02537015|528874415|FG000|Overall Study|Withdrawal by Subject|2|||
146644176|NCT02537015|528874415|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146644177|NCT01097005|528874419|FG000|Overall Study|Case Report Form not collected|18|||
146644178|NCT01097005|528874419|FG000|Overall Study|Subjects cannot visit the hospital|1|||
146644179|NCT01097005|528874419|FG000|Overall Study|Poor medication compliance|1|||
146644180|NCT01097005|528874419|FG000|Overall Study|No examination data available|244|||
146644181|NCT01097005|528874419|FG000|Overall Study|Deviation from exclusion criteria|37|||
146644182|NCT01097005|528874419|FG000|Overall Study|Adverse Event|14|||
146644183|NCT01097005|528874419|FG000|Overall Study|Discontinuance by complication|50|||
146644184|NCT00588861|528875555|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
146644185|NCT00588861|528875556|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
146644186|NCT00588861|528875555|FG000|6 Months|Patients did not return for follow-up|98|||
146644187|NCT00588861|528875556|FG001|6 Months|Patients did not return for follow-up|73|||
146644188|NCT00588861|528875555|FG000|1 Year|Patients did not return for follow-up|89|||
146644189|NCT00588861|528875556|FG001|1 Year|Patients did not return for follow-up|82|||
146644190|NCT00588861|528875555|FG000|2 Years|Patients did not return for follow-up|92|||
146644191|NCT00588861|528875556|FG001|2 Years|Patients did not return for follow-up|87|||
146644192|NCT00588861|528875555|FG000|4 Years|Patients did not return for follow-up|91|||
146644193|NCT00588861|528875556|FG001|4 Years|Patients did not return for follow-up|103|||
146644194|NCT00588861|528875555|FG000|6 Years|Patients did not return for follow-up|104|||
146644195|NCT00588861|528875556|FG001|6 Years|Patients did not return for follow-up|109|||
146644196|NCT00588861|528875555|FG000|8 Years|Patients did not return for follow-up|105|||
146644197|NCT00588861|528875556|FG001|8 Years|Patients did not return for follow-up|114|||
146644198|NCT00588861|528875555|FG000|10 Years|Incomplete due to study termination|107|||
146644199|NCT00588861|528875556|FG001|10 Years|Incomplete due to study termination|114|||
146644200|NCT03254459|528875562|FG000|Overall Study|Adverse Event|7|||
146644201|NCT03254459|528875563|FG001|Overall Study|Adverse Event|20|||
146644202|NCT03254459|528875562|FG000|Overall Study|Withdrawal by Subject Consent|3|||
146644203|NCT03254459|528875563|FG001|Overall Study|Withdrawal by Subject Consent|1|||
146644204|NCT03254459|528875562|FG000|Overall Study|Lost to Follow-up|0|||
146644205|NCT03254459|528875563|FG001|Overall Study|Lost to Follow-up|1|||
146644206|NCT03254459|528875562|FG000|Overall Study|Miscellaneous|0|||
146644207|NCT03254459|528875563|FG001|Overall Study|Miscellaneous|1|||
146496719|NCT00267969|528322902|FG002|After Controlled Period|Death|0|||
146496720|NCT00267969|528322903|FG003|After Controlled Period|Death|1|||
146496721|NCT00267969|528322904|FG004|After Controlled Period|Death|2|||
146496722|NCT00267969|528322905|FG005|After Controlled Period|Death|0|||
146496723|NCT00267969|528322906|FG006|After Controlled Period|Death|1|||
146496724|NCT00267969|528322900|FG000|After Controlled Period|Lack of Efficacy|0|||
146496725|NCT00267969|528322901|FG001|After Controlled Period|Lack of Efficacy|0|||
146496726|NCT00267969|528322902|FG002|After Controlled Period|Lack of Efficacy|0|||
146496727|NCT00267969|528322903|FG003|After Controlled Period|Lack of Efficacy|10|||
146496728|NCT00267969|528322904|FG004|After Controlled Period|Lack of Efficacy|6|||
146496729|NCT00267969|528322905|FG005|After Controlled Period|Lack of Efficacy|28|||
146496730|NCT00267969|528322906|FG006|After Controlled Period|Lack of Efficacy|15|||
146496731|NCT00267969|528322900|FG000|After Controlled Period|Lost to Follow-up|0|||
146496732|NCT00267969|528322901|FG001|After Controlled Period|Lost to Follow-up|0|||
146496733|NCT00267969|528322902|FG002|After Controlled Period|Lost to Follow-up|0|||
146496734|NCT00267969|528322903|FG003|After Controlled Period|Lost to Follow-up|5|||
146496735|NCT00267969|528322904|FG004|After Controlled Period|Lost to Follow-up|8|||
146496736|NCT00267969|528322905|FG005|After Controlled Period|Lost to Follow-up|9|||
146496737|NCT00267969|528322906|FG006|After Controlled Period|Lost to Follow-up|10|||
146496738|NCT00267969|528322900|FG000|After Controlled Period|Other|0|||
146496739|NCT00267969|528322901|FG001|After Controlled Period|Other|0|||
146496740|NCT00267969|528322902|FG002|After Controlled Period|Other|0|||
146496741|NCT00267969|528322903|FG003|After Controlled Period|Other|13|||
146496742|NCT00267969|528322904|FG004|After Controlled Period|Other|11|||
146644208|NCT00617669|528875570|FG000|Overall Study|Withdrawal by Subject|71|||
146644209|NCT00617669|528875571|FG001|Overall Study|Withdrawal by Subject|77|||
146644210|NCT00617669|528875570|FG000|Overall Study|Lost to Follow-up|3|||
146644211|NCT00617669|528875571|FG001|Overall Study|Lost to Follow-up|2|||
146644212|NCT00617669|528875570|FG000|Overall Study|Adverse Event|87|||
146496743|NCT00267969|528322905|FG005|After Controlled Period|Other|22|||
146496744|NCT00267969|528322906|FG006|After Controlled Period|Other|25|||
146496745|NCT04075682|528322907|FG000|Overall Study|Lost to Follow-up|5|||
146644213|NCT00617669|528875571|FG001|Overall Study|Adverse Event|76|||
146644214|NCT00617669|528875570|FG000|Overall Study|Protocol Violation|2|||
146644215|NCT00617669|528875571|FG001|Overall Study|Protocol Violation|3|||
146644216|NCT00617669|528875570|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
146644217|NCT00617669|528875571|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
146644218|NCT00617669|528875570|FG000|Overall Study|Patients randomized but not treated|2|||
146644219|NCT00617669|528875571|FG001|Overall Study|Patients randomized but not treated|3|||
146644220|NCT03680742|528875572|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
146644221|NCT02894502|528875573|FG000|Baseline|Withdrawal by Subject|24|||
146644222|NCT02894502|528875574|FG001|Baseline|Withdrawal by Subject|31|||
146644223|NCT02894502|528875575|FG002|Baseline|Withdrawal by Subject|36|||
146644224|NCT02894502|528875573|FG000|Baseline|Death|3|||
146644225|NCT02894502|528875574|FG001|Baseline|Death|1|||
146644226|NCT02894502|528875575|FG002|Baseline|Death|9|||
146644227|NCT02894502|528875573|FG000|First Follow up|Withdrawal by Subject|32|||
146644228|NCT02894502|528875574|FG001|First Follow up|Withdrawal by Subject|29|||
146644229|NCT02894502|528875575|FG002|First Follow up|Withdrawal by Subject|37|||
146644230|NCT02894502|528875573|FG000|First Follow up|Death|2|||
146644231|NCT02894502|528875574|FG001|First Follow up|Death|2|||
146644232|NCT02894502|528875575|FG002|First Follow up|Death|3|||
146644233|NCT02894502|528875573|FG000|Second Follow up|Withdrawal by Subject|13|||
146644234|NCT02894502|528875574|FG001|Second Follow up|Withdrawal by Subject|15|||
146644235|NCT02894502|528875575|FG002|Second Follow up|Withdrawal by Subject|13|||
146644236|NCT02894502|528875573|FG000|Second Follow up|Death|2|||
146644237|NCT02894502|528875574|FG001|Second Follow up|Death|3|||
146644238|NCT02894502|528875575|FG002|Second Follow up|Death|1|||
146644239|NCT02894502|528875573|FG000|Third Follow up|Withdrawal by Subject|5|||
146644240|NCT02894502|528875574|FG001|Third Follow up|Withdrawal by Subject|6|||
146644241|NCT02894502|528875575|FG002|Third Follow up|Withdrawal by Subject|3|||
146644242|NCT02894502|528875573|FG000|Third Follow up|Death|1|||
146644243|NCT02894502|528875574|FG001|Third Follow up|Death|1|||
146644244|NCT02894502|528875575|FG002|Third Follow up|Death|0|||
146644245|NCT00615901|528875576|FG000|Overall Study|Withdrawal by Subject|2|||
146644246|NCT00615901|528875576|FG000|Overall Study|Adverse Event|7|||
146644247|NCT00796445|528875581|FG000|Overall Study|Protocol Violation|5|||
146644248|NCT00796445|528875582|FG001|Overall Study|Protocol Violation|3|||
146644249|NCT00796445|528875581|FG000|Overall Study|Adverse event, serious fatal|10|||
146644250|NCT00796445|528875582|FG001|Overall Study|Adverse event, serious fatal|5|||
146644251|NCT00796445|528875581|FG000|Overall Study|Adverse event, non-fatal|4|||
146644252|NCT00796445|528875582|FG001|Overall Study|Adverse event, non-fatal|0|||
146644253|NCT00796445|528875581|FG000|Overall Study|Disease progression/recurrence|537|||
146644254|NCT00796445|528875582|FG001|Overall Study|Disease progression/recurrence|268|||
146644255|NCT00796445|528875581|FG000|Overall Study|Other|10|||
146644256|NCT00796445|528875582|FG001|Overall Study|Other|7|||
146644257|NCT00796445|528875581|FG000|Overall Study|Withdrawal by Subject|18|||
146644258|NCT00796445|528875582|FG001|Overall Study|Withdrawal by Subject|9|||
146644259|NCT00796445|528875581|FG000|Overall Study|Invalid Informed Consent Form|1|||
146644260|NCT00796445|528875582|FG001|Overall Study|Invalid Informed Consent Form|0|||
146644261|NCT00388583|528875585|FG000|Overall Study|Protocol Violation|1|||
146644262|NCT00388583|528875586|FG001|Overall Study|Protocol Violation|0|||
146644263|NCT00388583|528875585|FG000|Overall Study|Withdrawal by Subject|3|||
146644264|NCT00388583|528875586|FG001|Overall Study|Withdrawal by Subject|3|||
146644265|NCT00388583|528875585|FG000|Overall Study|Serious Adverse Event|2|||
146644266|NCT00388583|528875586|FG001|Overall Study|Serious Adverse Event|0|||
146644267|NCT00388583|528875585|FG000|Overall Study|Did not receive vaccine|0|||
146644268|NCT00388583|528875586|FG001|Overall Study|Did not receive vaccine|1|||
146644269|NCT05194579|528875587|FG000|Overall Study|Lost to Follow-up|2|||
146644270|NCT05194579|528875588|FG001|Overall Study|Lost to Follow-up|3|||
146644271|NCT05194579|528875587|FG000|Overall Study|Withdrawal by Subject|3|||
146644272|NCT05194579|528875588|FG001|Overall Study|Withdrawal by Subject|4|||
146644273|NCT05194579|528875587|FG000|Overall Study|Refused further study procedures|0|||
146644274|NCT05194579|528875588|FG001|Overall Study|Refused further study procedures|1|||
146644275|NCT05194579|528875587|FG000|Overall Study|Protocol deviation|1|||
146644276|NCT05194579|528875588|FG001|Overall Study|Protocol deviation|0|||
146644277|NCT03595228|528875593|FG000|Overall Study|Death|2|||
146644278|NCT03595228|528875593|FG000|Overall Study|Lack of Efficacy|13|||
146644279|NCT03595228|528875593|FG000|Overall Study|Withdrawal by Subject|3|||
146644280|NCT03595228|528875593|FG000|Overall Study|Withdrawal by Sponsor|1|||
146644281|NCT03232333|528875594|FG000|Overall Study|Infection or Osteomyelitis|9|||
146971974|NCT03343054|530058491|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
146644282|NCT03232333|528875594|FG000|Overall Study|Lost to Follow-up|4|||
146644283|NCT03232333|528875594|FG000|Overall Study|Withdrawal by Subject|2|||
146644284|NCT01087736|528875595|FG000|Overall Study|Lost to Follow-up|1|||
146644285|NCT01087736|528875596|FG001|Overall Study|Lost to Follow-up|0|||
146644286|NCT01087736|528875595|FG000|Overall Study|Death|0|||
146644287|NCT01087736|528875596|FG001|Overall Study|Death|1|||
146971975|NCT03343054|530058492|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
146644288|NCT01087736|528875595|FG000|Overall Study|Withdrawal by Subject|0|||
146644289|NCT01087736|528875596|FG001|Overall Study|Withdrawal by Subject|1|||
146644290|NCT01253811|528875597|FG000|Overall Study|Withdrawal criteria|1|||
146912066|NCT00092547|529841404|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
146912067|NCT00092547|529841405|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
146912068|NCT00092547|529841403|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
146912069|NCT00092547|529841404|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
146912070|NCT00092547|529841405|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
146496746|NCT04075682|528322908|FG001|Overall Study|Lost to Follow-up|5|||
146496747|NCT04075682|528322909|FG002|Overall Study|Lost to Follow-up|2|||
146496748|NCT04075682|528322910|FG003|Overall Study|Lost to Follow-up|2|||
146496749|NCT04075682|528322907|FG000|Overall Study|Withdrawal by Subject|1|||
146496750|NCT04075682|528322908|FG001|Overall Study|Withdrawal by Subject|0|||
146496751|NCT04075682|528322909|FG002|Overall Study|Withdrawal by Subject|1|||
146496752|NCT04075682|528322910|FG003|Overall Study|Withdrawal by Subject|0|||
146496753|NCT04075682|528322907|FG000|Overall Study|Protocol Violation|0|||
146496754|NCT04075682|528322908|FG001|Overall Study|Protocol Violation|1|||
146496755|NCT04075682|528322909|FG002|Overall Study|Protocol Violation|1|||
146496756|NCT04075682|528322910|FG003|Overall Study|Protocol Violation|0|||
146496757|NCT04075682|528322907|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
146496758|NCT04075682|528322908|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
146496759|NCT04075682|528322909|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
146496760|NCT04075682|528322910|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
146496761|NCT04075682|528322907|FG000|Overall Study|Lost study phone the first day of study participation|0|||
146496762|NCT04075682|528322908|FG001|Overall Study|Lost study phone the first day of study participation|1|||
146496763|NCT04075682|528322909|FG002|Overall Study|Lost study phone the first day of study participation|0|||
146496764|NCT04075682|528322910|FG003|Overall Study|Lost study phone the first day of study participation|0|||
146496765|NCT00862823|528322913|FG000|First Intervention|Withdrawal by Subject|1|||
146496766|NCT00862823|528322914|FG001|First Intervention|Withdrawal by Subject|1|||
146496767|NCT00887315|528322915|FG000|Overall Study|Study termination|7|||
146496768|NCT00887315|528322916|FG001|Overall Study|Study termination|4|||
146496769|NCT01562782|528322917|FG000|Overall Study|Withdrawal by Subject|3|||
146496770|NCT01562782|528322918|FG001|Overall Study|Withdrawal by Subject|3|||
146496771|NCT01562782|528322917|FG000|Overall Study|screen failure|1|||
146496772|NCT01562782|528322918|FG001|Overall Study|screen failure|2|||
146496773|NCT00857896|528322924|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
146496774|NCT02308540|528322926|FG000|Overall Study|Lost to Follow-up|0|||
146496775|NCT02308540|528322927|FG001|Overall Study|Lost to Follow-up|0|||
146496776|NCT02308540|528322928|FG002|Overall Study|Lost to Follow-up|0|||
146496777|NCT02308540|528322929|FG003|Overall Study|Lost to Follow-up|0|||
146496778|NCT02308540|528322930|FG004|Overall Study|Lost to Follow-up|0|||
146496779|NCT02308540|528322931|FG005|Overall Study|Lost to Follow-up|1|||
146496780|NCT01091662|528322932|FG000|Overall Study|Adverse Event|1|||
146496781|NCT01091662|528322933|FG001|Overall Study|Adverse Event|9|||
146496782|NCT01091662|528322932|FG000|Overall Study|Physician Decision|1|||
146496783|NCT01091662|528322933|FG001|Overall Study|Physician Decision|1|||
146496784|NCT01091662|528322932|FG000|Overall Study|Withdrawal by Subject|7|||
146496785|NCT01091662|528322933|FG001|Overall Study|Withdrawal by Subject|6|||
146496786|NCT01091662|528322932|FG000|Overall Study|met exit criteria|7|||
146496787|NCT01091662|528322933|FG001|Overall Study|met exit criteria|13|||
146496788|NCT01091662|528322932|FG000|Overall Study|met exclusion criteria|1|||
146496789|NCT01091662|528322933|FG001|Overall Study|met exclusion criteria|0|||
146496790|NCT01091662|528322932|FG000|Overall Study|Lost to Follow-up|0|||
146496791|NCT01091662|528322933|FG001|Overall Study|Lost to Follow-up|1|||
146496792|NCT01091662|528322932|FG000|Overall Study|Pregnancy|0|||
146496793|NCT01091662|528322933|FG001|Overall Study|Pregnancy|1|||
146496794|NCT01091662|528322932|FG000|Overall Study|Protocol Violation|0|||
146496795|NCT01091662|528322933|FG001|Overall Study|Protocol Violation|2|||
146496796|NCT01091662|528322932|FG000|Overall Study|unable to swallow capsule|0|||
146496797|NCT01091662|528322933|FG001|Overall Study|unable to swallow capsule|1|||
146496798|NCT04109391|528322934|FG000|Overall Study|Adverse Event|2|||
146496799|NCT04109391|528322935|FG001|Overall Study|Adverse Event|2|||
146496800|NCT04109391|528322936|FG002|Overall Study|Adverse Event|0|||
146496801|NCT04109391|528322934|FG000|Overall Study|Withdrawal by Subject|2|||
146496802|NCT04109391|528322935|FG001|Overall Study|Withdrawal by Subject|0|||
146496803|NCT04109391|528322936|FG002|Overall Study|Withdrawal by Subject|0|||
146496804|NCT04109391|528322934|FG000|Overall Study|Pregnancy|1|||
146496805|NCT04109391|528322935|FG001|Overall Study|Pregnancy|0|||
146496806|NCT04109391|528322936|FG002|Overall Study|Pregnancy|0|||
146496807|NCT04109391|528322934|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
146496808|NCT04109391|528322935|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
146496809|NCT04109391|528322936|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
146496810|NCT04109391|528322934|FG000|Overall Study|Lost to Follow-up|0|||
146496811|NCT04109391|528322935|FG001|Overall Study|Lost to Follow-up|0|||
146496812|NCT04109391|528322936|FG002|Overall Study|Lost to Follow-up|1|||
146496813|NCT04109391|528322934|FG000|Overall Study|Lack of Efficacy|2|||
146644291|NCT00435045|528875599|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
146644292|NCT00435045|528875600|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
146644293|NCT00435045|528875599|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
146644294|NCT00435045|528875600|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
146644295|NCT00435045|528875599|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
146644296|NCT00435045|528875600|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
146644297|NCT00435045|528875599|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
146644298|NCT00435045|528875600|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
146644299|NCT00435045|528875599|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
146644300|NCT00435045|528875600|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
146644301|NCT00435045|528875599|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
146644302|NCT00435045|528875600|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
146644303|NCT00435045|528875599|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
146644304|NCT00435045|528875600|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
146644305|NCT00435045|528875599|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
146644306|NCT00435045|528875600|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
146644307|NCT00435045|528875599|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
146644308|NCT00435045|528875600|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
146644309|NCT00435045|528875599|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
146644310|NCT00435045|528875600|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
146644311|NCT00435045|528875599|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
146644312|NCT00435045|528875600|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
146644313|NCT00567255|528875601|FG000|Overall Study|Adverse Event|241|||
146644314|NCT00567255|528875602|FG001|Overall Study|Adverse Event|68|||
146644315|NCT00567255|528875601|FG000|Overall Study|Lost to Follow-up|77|||
146644316|NCT00567255|528875602|FG001|Overall Study|Lost to Follow-up|48|||
146644317|NCT00567255|528875601|FG000|Overall Study|Withdrawal by Subject|75|||
146644318|NCT00567255|528875602|FG001|Overall Study|Withdrawal by Subject|56|||
146644319|NCT00567255|528875601|FG000|Overall Study|Lack of Efficacy|19|||
146644320|NCT00567255|528875602|FG001|Overall Study|Lack of Efficacy|33|||
146644321|NCT00567255|528875601|FG000|Overall Study|Protocol Violation|20|||
146644322|NCT00567255|528875602|FG001|Overall Study|Protocol Violation|8|||
146644323|NCT00567255|528875601|FG000|Overall Study|Pregnancy|6|||
146644324|NCT00567255|528875602|FG001|Overall Study|Pregnancy|0|||
146644325|NCT00567255|528875601|FG000|Overall Study|Drug noncompliance,moved,other|25|||
146644326|NCT00567255|528875602|FG001|Overall Study|Drug noncompliance,moved,other|15|||
146644327|NCT01743001|528875605|FG000|Overall Study|Physician Decision|1|||
146644328|NCT01743001|528875606|FG001|Overall Study|Physician Decision|0|||
146644329|NCT01743001|528875605|FG000|Overall Study|Pregnancy|1|||
146644330|NCT01743001|528875606|FG001|Overall Study|Pregnancy|0|||
146644331|NCT01743001|528875605|FG000|Overall Study|Death|1|||
146644332|NCT01743001|528875606|FG001|Overall Study|Death|0|||
146644333|NCT03052426|528875609|FG000|Overall Study|Withdrawal by Subject|0|||
146644334|NCT03052426|528875610|FG001|Overall Study|Withdrawal by Subject|1|||
146644335|NCT03052426|528875611|FG002|Overall Study|Withdrawal by Subject|0|||
146644336|NCT03052426|528875609|FG000|Overall Study|Lost to Follow-up|2|||
146644337|NCT03052426|528875610|FG001|Overall Study|Lost to Follow-up|0|||
146644338|NCT03052426|528875611|FG002|Overall Study|Lost to Follow-up|1|||
146644339|NCT01565343|528875614|FG000|Overall Study|Administrative decision/technical issues|1|||
146644340|NCT01565343|528875615|FG001|Overall Study|Administrative decision/technical issues|0|||
146644341|NCT01565343|528875616|FG002|Overall Study|Administrative decision/technical issues|0|||
146644342|NCT01853839|528875622|FG000|Overall Study|Violated inclusion criteria|2|||
146644343|NCT01853839|528875622|FG000|Overall Study|Not meet ITT population definition|58|||
146644344|NCT01853839|528875622|FG000|Overall Study|End of treatment visit too early|33|||
146644345|NCT01853839|528875622|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
146644346|NCT03672097|528875623|FG000|Period 1|Withdrawal by Subject|2|||
146644347|NCT03672097|528875623|FG000|Period 1|Adverse Event|1|||
146644348|NCT03672097|528875623|FG000|Period 1|Did not receive treatment|1|||
146644349|NCT03672097|528875623|FG000|Period 2|Withdrawal by Subject|3|||
146644350|NCT03672097|528875623|FG000|Period 2|Other|1|||
146644351|NCT03087617|528875625|FG000|Overall Study|Lost to Follow-up|32|||
146644352|NCT03087617|528875626|FG001|Overall Study|Lost to Follow-up|30|||
146644353|NCT03087617|528875627|FG002|Overall Study|Lost to Follow-up|30|||
146644354|NCT03087617|528875628|FG003|Overall Study|Lost to Follow-up|39|||
146644355|NCT02059291|528875632|FG000|Epoch 2|Lack of Efficacy|0|||
146644356|NCT02059291|528875633|FG001|Epoch 2|Lack of Efficacy|0|||
146644357|NCT02059291|528875634|FG002|Epoch 2|Lack of Efficacy|0|||
146644358|NCT02059291|528875635|FG003|Epoch 2|Lack of Efficacy|1|||
146644359|NCT02059291|528875636|FG004|Epoch 2|Lack of Efficacy|0|||
146644360|NCT02059291|528875637|FG005|Epoch 2|Lack of Efficacy|1|||
146644361|NCT02059291|528875638|FG006|Epoch 2|Lack of Efficacy|0|||
146644362|NCT02059291|528875639|FG007|Epoch 2|Lack of Efficacy|0|||
146644363|NCT02059291|528875640|FG008|Epoch 2|Lack of Efficacy|0|||
146644364|NCT02059291|528875641|FG009|Epoch 2|Lack of Efficacy|0|||
146644365|NCT02059291|528875642|FG010|Epoch 2|Lack of Efficacy|0|||
146644366|NCT02059291|528875643|FG011|Epoch 2|Lack of Efficacy|0|||
146644367|NCT02059291|528875644|FG012|Epoch 2|Lack of Efficacy|0|||
146644368|NCT02059291|528875645|FG013|Epoch 2|Lack of Efficacy|0|||
146644369|NCT02059291|528875646|FG014|Epoch 2|Lack of Efficacy|0|||
146644370|NCT02059291|528875647|FG015|Epoch 2|Lack of Efficacy|0|||
146644371|NCT02059291|528875648|FG016|Epoch 2|Lack of Efficacy|0|||
146644372|NCT02059291|528875649|FG017|Epoch 2|Lack of Efficacy|0|||
146644373|NCT02059291|528875650|FG018|Epoch 2|Lack of Efficacy|0|||
146644374|NCT02059291|528875651|FG019|Epoch 2|Lack of Efficacy|0|||
146644375|NCT02059291|528875652|FG020|Epoch 2|Lack of Efficacy|0|||
146644376|NCT02059291|528875653|FG021|Epoch 2|Lack of Efficacy|0|||
146644377|NCT02059291|528875654|FG022|Epoch 2|Lack of Efficacy|0|||
146644378|NCT02059291|528875655|FG023|Epoch 2|Lack of Efficacy|0|||
146644379|NCT02059291|528875656|FG024|Epoch 2|Lack of Efficacy|0|||
146644380|NCT02059291|528875632|FG000|Epoch 2|Adverse Event|0|||
146644381|NCT02059291|528875633|FG001|Epoch 2|Adverse Event|0|||
146644382|NCT02059291|528875634|FG002|Epoch 2|Adverse Event|1|||
146644383|NCT02059291|528875635|FG003|Epoch 2|Adverse Event|1|||
146644384|NCT02059291|528875636|FG004|Epoch 2|Adverse Event|0|||
146644385|NCT02059291|528875637|FG005|Epoch 2|Adverse Event|0|||
146644386|NCT02059291|528875638|FG006|Epoch 2|Adverse Event|0|||
146644387|NCT02059291|528875639|FG007|Epoch 2|Adverse Event|1|||
146644388|NCT02059291|528875640|FG008|Epoch 2|Adverse Event|1|||
146644389|NCT02059291|528875641|FG009|Epoch 2|Adverse Event|0|||
146644390|NCT02059291|528875642|FG010|Epoch 2|Adverse Event|0|||
146644391|NCT02059291|528875643|FG011|Epoch 2|Adverse Event|0|||
146644392|NCT02059291|528875644|FG012|Epoch 2|Adverse Event|0|||
146644393|NCT02059291|528875645|FG013|Epoch 2|Adverse Event|0|||
146644394|NCT02059291|528875646|FG014|Epoch 2|Adverse Event|0|||
146644395|NCT02059291|528875647|FG015|Epoch 2|Adverse Event|0|||
146644396|NCT02059291|528875648|FG016|Epoch 2|Adverse Event|0|||
146644397|NCT02059291|528875649|FG017|Epoch 2|Adverse Event|0|||
146644398|NCT02059291|528875650|FG018|Epoch 2|Adverse Event|0|||
146644399|NCT02059291|528875651|FG019|Epoch 2|Adverse Event|0|||
146644400|NCT02059291|528875652|FG020|Epoch 2|Adverse Event|0|||
146912071|NCT00092547|529841403|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
146912072|NCT00092547|529841404|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
146644401|NCT02059291|528875653|FG021|Epoch 2|Adverse Event|0|||
146644402|NCT02059291|528875654|FG022|Epoch 2|Adverse Event|0|||
146644403|NCT02059291|528875655|FG023|Epoch 2|Adverse Event|0|||
146644404|NCT02059291|528875656|FG024|Epoch 2|Adverse Event|0|||
146644405|NCT02059291|528875632|FG000|Epoch 2|Withdrawal by Subject|0|||
146644406|NCT02059291|528875633|FG001|Epoch 2|Withdrawal by Subject|1|||
146644407|NCT02059291|528875634|FG002|Epoch 2|Withdrawal by Subject|0|||
146644408|NCT02059291|528875635|FG003|Epoch 2|Withdrawal by Subject|0|||
146644409|NCT02059291|528875636|FG004|Epoch 2|Withdrawal by Subject|0|||
146644410|NCT02059291|528875637|FG005|Epoch 2|Withdrawal by Subject|1|||
146644411|NCT02059291|528875638|FG006|Epoch 2|Withdrawal by Subject|0|||
146644412|NCT02059291|528875639|FG007|Epoch 2|Withdrawal by Subject|0|||
146644413|NCT02059291|528875640|FG008|Epoch 2|Withdrawal by Subject|1|||
146644414|NCT02059291|528875641|FG009|Epoch 2|Withdrawal by Subject|0|||
146644415|NCT02059291|528875642|FG010|Epoch 2|Withdrawal by Subject|0|||
146644416|NCT02059291|528875643|FG011|Epoch 2|Withdrawal by Subject|0|||
146644417|NCT02059291|528875644|FG012|Epoch 2|Withdrawal by Subject|0|||
146644418|NCT02059291|528875645|FG013|Epoch 2|Withdrawal by Subject|0|||
146644419|NCT02059291|528875646|FG014|Epoch 2|Withdrawal by Subject|0|||
146644420|NCT02059291|528875647|FG015|Epoch 2|Withdrawal by Subject|0|||
146644421|NCT02059291|528875648|FG016|Epoch 2|Withdrawal by Subject|0|||
146644422|NCT02059291|528875649|FG017|Epoch 2|Withdrawal by Subject|0|||
146644423|NCT02059291|528875650|FG018|Epoch 2|Withdrawal by Subject|0|||
146912073|NCT00092547|529841405|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
146644424|NCT02059291|528875651|FG019|Epoch 2|Withdrawal by Subject|0|||
146644425|NCT02059291|528875652|FG020|Epoch 2|Withdrawal by Subject|0|||
146644426|NCT02059291|528875653|FG021|Epoch 2|Withdrawal by Subject|0|||
146644427|NCT02059291|528875654|FG022|Epoch 2|Withdrawal by Subject|0|||
146644428|NCT02059291|528875655|FG023|Epoch 2|Withdrawal by Subject|0|||
146644429|NCT02059291|528875656|FG024|Epoch 2|Withdrawal by Subject|0|||
146644430|NCT02059291|528875632|FG000|Epoch 3|Physician Decision|0|||
146644431|NCT02059291|528875633|FG001|Epoch 3|Physician Decision|0|||
146644432|NCT02059291|528875634|FG002|Epoch 3|Physician Decision|0|||
146644433|NCT02059291|528875635|FG003|Epoch 3|Physician Decision|0|||
146644434|NCT02059291|528875636|FG004|Epoch 3|Physician Decision|0|||
146644435|NCT02059291|528875637|FG005|Epoch 3|Physician Decision|0|||
146644436|NCT02059291|528875638|FG006|Epoch 3|Physician Decision|0|||
146644437|NCT02059291|528875639|FG007|Epoch 3|Physician Decision|0|||
146644438|NCT02059291|528875640|FG008|Epoch 3|Physician Decision|0|||
146644439|NCT02059291|528875641|FG009|Epoch 3|Physician Decision|0|||
146644440|NCT02059291|528875642|FG010|Epoch 3|Physician Decision|0|||
146644441|NCT02059291|528875643|FG011|Epoch 3|Physician Decision|0|||
146644442|NCT02059291|528875644|FG012|Epoch 3|Physician Decision|0|||
146644443|NCT02059291|528875645|FG013|Epoch 3|Physician Decision|1|||
146644444|NCT02059291|528875646|FG014|Epoch 3|Physician Decision|0|||
146644445|NCT02059291|528875647|FG015|Epoch 3|Physician Decision|1|||
146644446|NCT02059291|528875648|FG016|Epoch 3|Physician Decision|0|||
146644447|NCT02059291|528875649|FG017|Epoch 3|Physician Decision|0|||
146644448|NCT02059291|528875650|FG018|Epoch 3|Physician Decision|0|||
146644449|NCT02059291|528875651|FG019|Epoch 3|Physician Decision|0|||
146644450|NCT02059291|528875652|FG020|Epoch 3|Physician Decision|0|||
146644451|NCT02059291|528875653|FG021|Epoch 3|Physician Decision|0|||
146644452|NCT02059291|528875654|FG022|Epoch 3|Physician Decision|0|||
146644453|NCT02059291|528875655|FG023|Epoch 3|Physician Decision|0|||
146644454|NCT02059291|528875656|FG024|Epoch 3|Physician Decision|0|||
146644455|NCT02059291|528875632|FG000|Epoch 3|Adverse Event|0|||
146644456|NCT02059291|528875633|FG001|Epoch 3|Adverse Event|0|||
146644457|NCT02059291|528875634|FG002|Epoch 3|Adverse Event|0|||
146644458|NCT02059291|528875635|FG003|Epoch 3|Adverse Event|0|||
146644459|NCT02059291|528875636|FG004|Epoch 3|Adverse Event|0|||
146644460|NCT02059291|528875637|FG005|Epoch 3|Adverse Event|0|||
146644461|NCT02059291|528875638|FG006|Epoch 3|Adverse Event|0|||
146644462|NCT02059291|528875639|FG007|Epoch 3|Adverse Event|0|||
146644463|NCT02059291|528875640|FG008|Epoch 3|Adverse Event|0|||
146644464|NCT02059291|528875641|FG009|Epoch 3|Adverse Event|0|||
146644465|NCT02059291|528875642|FG010|Epoch 3|Adverse Event|0|||
146644466|NCT02059291|528875643|FG011|Epoch 3|Adverse Event|0|||
146644467|NCT02059291|528875644|FG012|Epoch 3|Adverse Event|0|||
146644468|NCT02059291|528875645|FG013|Epoch 3|Adverse Event|0|||
146644469|NCT02059291|528875646|FG014|Epoch 3|Adverse Event|0|||
146644470|NCT02059291|528875647|FG015|Epoch 3|Adverse Event|1|||
146644471|NCT02059291|528875648|FG016|Epoch 3|Adverse Event|0|||
146644472|NCT02059291|528875649|FG017|Epoch 3|Adverse Event|0|||
146644473|NCT02059291|528875650|FG018|Epoch 3|Adverse Event|0|||
146644474|NCT02059291|528875651|FG019|Epoch 3|Adverse Event|0|||
146644475|NCT02059291|528875652|FG020|Epoch 3|Adverse Event|0|||
146644476|NCT02059291|528875653|FG021|Epoch 3|Adverse Event|0|||
146644477|NCT02059291|528875654|FG022|Epoch 3|Adverse Event|0|||
146644478|NCT02059291|528875655|FG023|Epoch 3|Adverse Event|0|||
146644479|NCT02059291|528875656|FG024|Epoch 3|Adverse Event|0|||
146644480|NCT02059291|528875632|FG000|Epoch 3|Lack of Efficacy|0|||
146644481|NCT02059291|528875633|FG001|Epoch 3|Lack of Efficacy|0|||
146644482|NCT02059291|528875634|FG002|Epoch 3|Lack of Efficacy|0|||
146644483|NCT02059291|528875635|FG003|Epoch 3|Lack of Efficacy|0|||
146644484|NCT02059291|528875636|FG004|Epoch 3|Lack of Efficacy|0|||
146496814|NCT04109391|528322935|FG001|Overall Study|Lack of Efficacy|2|||
146496815|NCT04109391|528322936|FG002|Overall Study|Lack of Efficacy|3|||
146496816|NCT00443079|528322945|FG000|Overall Study|Lost to Follow-up|0|||
146644485|NCT02059291|528875637|FG005|Epoch 3|Lack of Efficacy|0|||
146644486|NCT02059291|528875638|FG006|Epoch 3|Lack of Efficacy|0|||
146644487|NCT02059291|528875639|FG007|Epoch 3|Lack of Efficacy|0|||
146644488|NCT02059291|528875640|FG008|Epoch 3|Lack of Efficacy|0|||
146644489|NCT02059291|528875641|FG009|Epoch 3|Lack of Efficacy|0|||
146644490|NCT02059291|528875642|FG010|Epoch 3|Lack of Efficacy|0|||
146644491|NCT02059291|528875643|FG011|Epoch 3|Lack of Efficacy|0|||
146644492|NCT02059291|528875644|FG012|Epoch 3|Lack of Efficacy|0|||
146644493|NCT02059291|528875645|FG013|Epoch 3|Lack of Efficacy|0|||
146644494|NCT02059291|528875646|FG014|Epoch 3|Lack of Efficacy|0|||
146644495|NCT02059291|528875647|FG015|Epoch 3|Lack of Efficacy|3|||
146644496|NCT02059291|528875648|FG016|Epoch 3|Lack of Efficacy|0|||
146644497|NCT02059291|528875649|FG017|Epoch 3|Lack of Efficacy|0|||
146644498|NCT02059291|528875650|FG018|Epoch 3|Lack of Efficacy|0|||
146644499|NCT02059291|528875651|FG019|Epoch 3|Lack of Efficacy|0|||
146644500|NCT02059291|528875652|FG020|Epoch 3|Lack of Efficacy|0|||
146644501|NCT02059291|528875653|FG021|Epoch 3|Lack of Efficacy|0|||
146644502|NCT02059291|528875654|FG022|Epoch 3|Lack of Efficacy|0|||
146644503|NCT02059291|528875655|FG023|Epoch 3|Lack of Efficacy|0|||
146644504|NCT02059291|528875656|FG024|Epoch 3|Lack of Efficacy|0|||
146644505|NCT02059291|528875632|FG000|Epoch 3|Withdrawal by Subject|0|||
146644506|NCT02059291|528875633|FG001|Epoch 3|Withdrawal by Subject|0|||
146768930|NCT04707313|529321794|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146496817|NCT00443079|528322946|FG001|Overall Study|Lost to Follow-up|1|||
146496818|NCT01421225|528322947|FG000|Overall Study|Withdrawal by Subject|0|||
146496819|NCT01421225|528322948|FG001|Overall Study|Withdrawal by Subject|1|||
146644507|NCT02059291|528875634|FG002|Epoch 3|Withdrawal by Subject|0|||
146644508|NCT02059291|528875635|FG003|Epoch 3|Withdrawal by Subject|0|||
146644509|NCT02059291|528875636|FG004|Epoch 3|Withdrawal by Subject|0|||
146644510|NCT02059291|528875637|FG005|Epoch 3|Withdrawal by Subject|0|||
146644511|NCT02059291|528875638|FG006|Epoch 3|Withdrawal by Subject|0|||
146644512|NCT02059291|528875639|FG007|Epoch 3|Withdrawal by Subject|0|||
146644513|NCT02059291|528875640|FG008|Epoch 3|Withdrawal by Subject|0|||
146644514|NCT02059291|528875641|FG009|Epoch 3|Withdrawal by Subject|0|||
146644515|NCT02059291|528875642|FG010|Epoch 3|Withdrawal by Subject|0|||
146644516|NCT02059291|528875643|FG011|Epoch 3|Withdrawal by Subject|0|||
146644517|NCT02059291|528875644|FG012|Epoch 3|Withdrawal by Subject|0|||
146644518|NCT02059291|528875645|FG013|Epoch 3|Withdrawal by Subject|0|||
146644519|NCT02059291|528875646|FG014|Epoch 3|Withdrawal by Subject|0|||
146644520|NCT02059291|528875647|FG015|Epoch 3|Withdrawal by Subject|1|||
146644521|NCT02059291|528875648|FG016|Epoch 3|Withdrawal by Subject|0|||
146644522|NCT02059291|528875649|FG017|Epoch 3|Withdrawal by Subject|0|||
146644523|NCT02059291|528875650|FG018|Epoch 3|Withdrawal by Subject|0|||
146768931|NCT04707313|529321795|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146768932|NCT04707313|529321796|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146768933|NCT04707313|529321797|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146768934|NCT04707313|529321798|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146768935|NCT04707313|529321799|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146768936|NCT04707313|529321800|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
146768937|NCT04707313|529321801|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
146768938|NCT04707313|529321802|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146768939|NCT04707313|529321803|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146564938|NCT01819272|528581304|FG001|Overall Study|Physician Decision|1|||
146564939|NCT01819272|528581305|FG002|Overall Study|Physician Decision|0|||
146564940|NCT01819272|528581306|FG003|Overall Study|Physician Decision|0|||
146564941|NCT01819272|528581307|FG004|Overall Study|Physician Decision|0|||
146768940|NCT04707313|529321791|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146768941|NCT04707313|529321792|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146768942|NCT04707313|529321793|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146768943|NCT04707313|529321794|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146768944|NCT04707313|529321795|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146912074|NCT00092547|529841403|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
146912075|NCT00092547|529841404|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
146912076|NCT00092547|529841405|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
146912077|NCT00092547|529841403|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
146912078|NCT00092547|529841404|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
146912079|NCT00092547|529841405|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
146912080|NCT00092547|529841403|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
146564942|NCT01819272|528581308|FG005|Overall Study|Physician Decision|0|||
146564943|NCT01819272|528581303|FG000|Overall Study|Withdrawal of Consent|0|||
146564944|NCT01819272|528581304|FG001|Overall Study|Withdrawal of Consent|1|||
146564945|NCT01819272|528581305|FG002|Overall Study|Withdrawal of Consent|2|||
146564946|NCT01819272|528581306|FG003|Overall Study|Withdrawal of Consent|1|||
146564947|NCT01819272|528581307|FG004|Overall Study|Withdrawal of Consent|0|||
146564948|NCT01819272|528581308|FG005|Overall Study|Withdrawal of Consent|1|||
146564949|NCT01819272|528581303|FG000|Overall Study|Loss of Glucose Control|2|||
146564950|NCT01819272|528581304|FG001|Overall Study|Loss of Glucose Control|1|||
146564951|NCT01819272|528581305|FG002|Overall Study|Loss of Glucose Control|0|||
146564952|NCT01819272|528581306|FG003|Overall Study|Loss of Glucose Control|1|||
146644524|NCT02059291|528875651|FG019|Epoch 3|Withdrawal by Subject|0|||
146644525|NCT02059291|528875652|FG020|Epoch 3|Withdrawal by Subject|0|||
146644526|NCT02059291|528875653|FG021|Epoch 3|Withdrawal by Subject|0|||
146644527|NCT02059291|528875654|FG022|Epoch 3|Withdrawal by Subject|0|||
146644528|NCT02059291|528875655|FG023|Epoch 3|Withdrawal by Subject|0|||
146644529|NCT02059291|528875656|FG024|Epoch 3|Withdrawal by Subject|0|||
146644530|NCT02059291|528875632|FG000|Epoch 4|Adverse Event|0|||
146644531|NCT02059291|528875633|FG001|Epoch 4|Adverse Event|0|||
146644532|NCT02059291|528875634|FG002|Epoch 4|Adverse Event|0|||
146644533|NCT02059291|528875635|FG003|Epoch 4|Adverse Event|0|||
146644534|NCT02059291|528875636|FG004|Epoch 4|Adverse Event|0|||
146644535|NCT02059291|528875637|FG005|Epoch 4|Adverse Event|0|||
146644536|NCT02059291|528875638|FG006|Epoch 4|Adverse Event|0|||
146644537|NCT02059291|528875639|FG007|Epoch 4|Adverse Event|0|||
146644538|NCT02059291|528875640|FG008|Epoch 4|Adverse Event|0|||
146644539|NCT02059291|528875641|FG009|Epoch 4|Adverse Event|0|||
146644540|NCT02059291|528875642|FG010|Epoch 4|Adverse Event|0|||
146644541|NCT02059291|528875643|FG011|Epoch 4|Adverse Event|0|||
146644542|NCT02059291|528875644|FG012|Epoch 4|Adverse Event|0|||
146644543|NCT02059291|528875645|FG013|Epoch 4|Adverse Event|0|||
146644544|NCT02059291|528875646|FG014|Epoch 4|Adverse Event|0|||
146644545|NCT02059291|528875647|FG015|Epoch 4|Adverse Event|0|||
146644546|NCT02059291|528875648|FG016|Epoch 4|Adverse Event|1|||
146644547|NCT02059291|528875649|FG017|Epoch 4|Adverse Event|0|||
146768945|NCT04707313|529321796|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146564953|NCT01819272|528581307|FG004|Overall Study|Loss of Glucose Control|2|||
146564954|NCT01819272|528581308|FG005|Overall Study|Loss of Glucose Control|0|||
146564955|NCT01784029|528581309|FG000|Overall Study|Lost to Follow-up|19|||
146644548|NCT02059291|528875650|FG018|Epoch 4|Adverse Event|0|||
146644549|NCT02059291|528875651|FG019|Epoch 4|Adverse Event|0|||
146644550|NCT02059291|528875652|FG020|Epoch 4|Adverse Event|0|||
146644551|NCT02059291|528875653|FG021|Epoch 4|Adverse Event|0|||
146644552|NCT02059291|528875654|FG022|Epoch 4|Adverse Event|1|||
146644553|NCT02059291|528875655|FG023|Epoch 4|Adverse Event|0|||
146644554|NCT02059291|528875656|FG024|Epoch 4|Adverse Event|0|||
146644555|NCT02059291|528875632|FG000|Epoch 4|Pregnancy|0|||
146644556|NCT02059291|528875633|FG001|Epoch 4|Pregnancy|0|||
146644557|NCT02059291|528875634|FG002|Epoch 4|Pregnancy|0|||
146644558|NCT02059291|528875635|FG003|Epoch 4|Pregnancy|0|||
146644559|NCT02059291|528875636|FG004|Epoch 4|Pregnancy|0|||
146644560|NCT02059291|528875637|FG005|Epoch 4|Pregnancy|0|||
146644561|NCT02059291|528875638|FG006|Epoch 4|Pregnancy|0|||
146644562|NCT02059291|528875639|FG007|Epoch 4|Pregnancy|0|||
146644563|NCT02059291|528875640|FG008|Epoch 4|Pregnancy|0|||
146644564|NCT02059291|528875641|FG009|Epoch 4|Pregnancy|0|||
146644565|NCT02059291|528875642|FG010|Epoch 4|Pregnancy|0|||
146644566|NCT02059291|528875643|FG011|Epoch 4|Pregnancy|0|||
146644567|NCT02059291|528875644|FG012|Epoch 4|Pregnancy|0|||
146644568|NCT02059291|528875645|FG013|Epoch 4|Pregnancy|0|||
146644569|NCT02059291|528875646|FG014|Epoch 4|Pregnancy|0|||
146644570|NCT02059291|528875647|FG015|Epoch 4|Pregnancy|0|||
146644571|NCT02059291|528875648|FG016|Epoch 4|Pregnancy|1|||
146644572|NCT02059291|528875649|FG017|Epoch 4|Pregnancy|0|||
146644573|NCT02059291|528875650|FG018|Epoch 4|Pregnancy|0|||
146644574|NCT02059291|528875651|FG019|Epoch 4|Pregnancy|0|||
146644575|NCT02059291|528875652|FG020|Epoch 4|Pregnancy|0|||
146644576|NCT02059291|528875653|FG021|Epoch 4|Pregnancy|0|||
146644577|NCT02059291|528875654|FG022|Epoch 4|Pregnancy|0|||
146644578|NCT02059291|528875655|FG023|Epoch 4|Pregnancy|0|||
146644579|NCT02059291|528875656|FG024|Epoch 4|Pregnancy|0|||
146644580|NCT02059291|528875632|FG000|Epoch 4|Withdrawal by Subject|0|||
146644581|NCT02059291|528875633|FG001|Epoch 4|Withdrawal by Subject|0|||
146644582|NCT02059291|528875634|FG002|Epoch 4|Withdrawal by Subject|0|||
146644583|NCT02059291|528875635|FG003|Epoch 4|Withdrawal by Subject|0|||
146644584|NCT02059291|528875636|FG004|Epoch 4|Withdrawal by Subject|0|||
146644585|NCT02059291|528875637|FG005|Epoch 4|Withdrawal by Subject|0|||
146644586|NCT02059291|528875638|FG006|Epoch 4|Withdrawal by Subject|0|||
146644587|NCT02059291|528875639|FG007|Epoch 4|Withdrawal by Subject|0|||
146644588|NCT02059291|528875640|FG008|Epoch 4|Withdrawal by Subject|0|||
146644589|NCT02059291|528875641|FG009|Epoch 4|Withdrawal by Subject|0|||
146644590|NCT02059291|528875642|FG010|Epoch 4|Withdrawal by Subject|0|||
146644591|NCT02059291|528875643|FG011|Epoch 4|Withdrawal by Subject|0|||
146644592|NCT02059291|528875644|FG012|Epoch 4|Withdrawal by Subject|0|||
146644593|NCT02059291|528875645|FG013|Epoch 4|Withdrawal by Subject|0|||
146912081|NCT00092547|529841404|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
146912082|NCT00092547|529841405|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
146644594|NCT02059291|528875646|FG014|Epoch 4|Withdrawal by Subject|0|||
146644595|NCT02059291|528875647|FG015|Epoch 4|Withdrawal by Subject|0|||
146644596|NCT02059291|528875648|FG016|Epoch 4|Withdrawal by Subject|0|||
146644597|NCT02059291|528875649|FG017|Epoch 4|Withdrawal by Subject|0|||
146644598|NCT02059291|528875650|FG018|Epoch 4|Withdrawal by Subject|0|||
146644599|NCT02059291|528875651|FG019|Epoch 4|Withdrawal by Subject|0|||
146644600|NCT02059291|528875652|FG020|Epoch 4|Withdrawal by Subject|1|||
146644601|NCT02059291|528875653|FG021|Epoch 4|Withdrawal by Subject|0|||
146644602|NCT02059291|528875654|FG022|Epoch 4|Withdrawal by Subject|0|||
146644603|NCT02059291|528875655|FG023|Epoch 4|Withdrawal by Subject|0|||
146644604|NCT02059291|528875656|FG024|Epoch 4|Withdrawal by Subject|0|||
146644605|NCT02059291|528875632|FG000|Epoch 4|Lack of Efficacy|0|||
146644606|NCT02059291|528875633|FG001|Epoch 4|Lack of Efficacy|0|||
146644607|NCT02059291|528875634|FG002|Epoch 4|Lack of Efficacy|0|||
146644608|NCT02059291|528875635|FG003|Epoch 4|Lack of Efficacy|0|||
146912083|NCT00092547|529841403|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
146912084|NCT00092547|529841404|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
146912085|NCT00092547|529841405|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
146912086|NCT00092547|529841403|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
146912087|NCT00092547|529841404|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
146971976|NCT03343054|530058493|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
146971977|NCT03343054|530058491|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
146644609|NCT02059291|528875636|FG004|Epoch 4|Lack of Efficacy|0|||
146644610|NCT02059291|528875637|FG005|Epoch 4|Lack of Efficacy|0|||
146644611|NCT02059291|528875638|FG006|Epoch 4|Lack of Efficacy|0|||
146644612|NCT02059291|528875639|FG007|Epoch 4|Lack of Efficacy|0|||
146644613|NCT02059291|528875640|FG008|Epoch 4|Lack of Efficacy|0|||
146644614|NCT02059291|528875641|FG009|Epoch 4|Lack of Efficacy|0|||
146644615|NCT02059291|528875642|FG010|Epoch 4|Lack of Efficacy|0|||
146644616|NCT02059291|528875643|FG011|Epoch 4|Lack of Efficacy|0|||
146644617|NCT02059291|528875644|FG012|Epoch 4|Lack of Efficacy|0|||
146644618|NCT02059291|528875645|FG013|Epoch 4|Lack of Efficacy|0|||
146644619|NCT02059291|528875646|FG014|Epoch 4|Lack of Efficacy|0|||
146644620|NCT02059291|528875647|FG015|Epoch 4|Lack of Efficacy|0|||
146644621|NCT02059291|528875648|FG016|Epoch 4|Lack of Efficacy|0|||
146644622|NCT02059291|528875649|FG017|Epoch 4|Lack of Efficacy|0|||
146644623|NCT02059291|528875650|FG018|Epoch 4|Lack of Efficacy|0|||
146644624|NCT02059291|528875651|FG019|Epoch 4|Lack of Efficacy|0|||
146644625|NCT02059291|528875652|FG020|Epoch 4|Lack of Efficacy|0|||
146644626|NCT02059291|528875653|FG021|Epoch 4|Lack of Efficacy|0|||
146644627|NCT02059291|528875654|FG022|Epoch 4|Lack of Efficacy|0|||
146644628|NCT02059291|528875655|FG023|Epoch 4|Lack of Efficacy|1|||
146644629|NCT02059291|528875656|FG024|Epoch 4|Lack of Efficacy|0|||
146644630|NCT00470834|528875657|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
146644631|NCT00470834|528875658|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
146644632|NCT00470834|528875657|FG000|Treatment Period (18 Months)|Adverse Event|7|||
146644633|NCT00470834|528875658|FG001|Treatment Period (18 Months)|Adverse Event|6|||
146644634|NCT00470834|528875657|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
146644635|NCT00470834|528875658|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
146644636|NCT00470834|528875657|FG000|Treatment Period (18 Months)|Physician Decision|4|||
146644637|NCT00470834|528875658|FG001|Treatment Period (18 Months)|Physician Decision|4|||
146644638|NCT00470834|528875657|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
146644639|NCT00470834|528875658|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
146644640|NCT00470834|528875657|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
146644641|NCT00470834|528875658|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
146644642|NCT00470834|528875657|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
146644643|NCT00470834|528875658|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
146644644|NCT00470834|528875657|FG000|Treatment Period (18 Months)|Non-compliance|1|||
146644645|NCT00470834|528875658|FG001|Treatment Period (18 Months)|Non-compliance|0|||
146644646|NCT00470834|528875657|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
146644647|NCT00470834|528875658|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
146644648|NCT00470834|528875657|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
146644649|NCT00470834|528875658|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
146644650|NCT00470834|528875657|FG000|Extension Period (24 Months)|Adverse Event|3|||
146644651|NCT00470834|528875658|FG001|Extension Period (24 Months)|Adverse Event|4|||
146644652|NCT00470834|528875657|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
146644653|NCT00470834|528875658|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
146644654|NCT00470834|528875657|FG000|Extension Period (24 Months)|Physician Decision|4|||
146644655|NCT00470834|528875658|FG001|Extension Period (24 Months)|Physician Decision|3|||
146644656|NCT00470834|528875657|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
146644657|NCT00470834|528875658|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
146644658|NCT00470834|528875657|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
146644659|NCT00470834|528875658|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
146644660|NCT00470834|528875657|FG000|Extension Period (24 Months)|Non-compliance|0|||
146644661|NCT00470834|528875658|FG001|Extension Period (24 Months)|Non-compliance|1|||
146644662|NCT00470834|528875657|FG000|Extension Period (24 Months)|Disease Progression|0|||
146644663|NCT00470834|528875658|FG001|Extension Period (24 Months)|Disease Progression|1|||
146644664|NCT01989208|528875661|FG000|200 mg (7 Days)|Protocol Violation|0|||
146644665|NCT01989208|528875662|FG001|200 mg (7 Days)|Protocol Violation|1|||
146644666|NCT00080899|528875666|FG000|Overall Study|Adverse Event|1|||
146644667|NCT01276054|528875669|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
146644668|NCT01276054|528875670|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
146644669|NCT04343235|528875671|FG000|Overall Study|Lost to Follow-up|3|||
146644670|NCT04343235|528875672|FG001|Overall Study|Lost to Follow-up|2|||
146644671|NCT00787267|528875673|FG000|Overall Study|Screen failure/Ineligible|10|||
146644672|NCT00787267|528875673|FG000|Overall Study|No Reason Provided|1|||
146644673|NCT00787267|528875673|FG000|Overall Study|Withdrawal by Subject|1|||
146644674|NCT01763996|528875674|FG000|Treatment Period 2|Adverse Event|0|||
146644675|NCT01763996|528875675|FG001|Treatment Period 2|Adverse Event|1|||
146644676|NCT00865280|528875676|FG000|Overall Study|Withdrawal by Subject|4|||
146644677|NCT00865280|528875677|FG001|Overall Study|Withdrawal by Subject|1|||
146644678|NCT00865280|528875676|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
146644679|NCT00865280|528875677|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
146644680|NCT00865280|528875676|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
146644681|NCT00865280|528875677|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
146644682|NCT00865280|528875676|FG000|Overall Study|Exclusion Condition|1|||
146644683|NCT00865280|528875677|FG001|Overall Study|Exclusion Condition|0|||
146644684|NCT00865280|528875676|FG000|Overall Study|Adverse Event|0|||
146644685|NCT00865280|528875677|FG001|Overall Study|Adverse Event|1|||
146644686|NCT00743106|528875678|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
146644687|NCT00743106|528875679|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
146644688|NCT00145977|528875680|FG000|Overall Study|Lack of Efficacy|0|||
146912088|NCT00092547|529841405|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
146912089|NCT00084682|529841406|FG000|Overall Study|Withdrawal by Subject|1|||
146644689|NCT00145977|528875681|FG001|Overall Study|Lack of Efficacy|4|||
146644690|NCT00145977|528875680|FG000|Overall Study|Lost to Follow-up|1|||
146644691|NCT00145977|528875681|FG001|Overall Study|Lost to Follow-up|0|||
146644692|NCT00145977|528875680|FG000|Overall Study|Withdrawal by Subject|1|||
146644693|NCT00145977|528875681|FG001|Overall Study|Withdrawal by Subject|0|||
146644694|NCT03060551|528875682|FG000|Overall Study|Withdrawal by Subject|1|||
146644695|NCT03060551|528875682|FG000|Overall Study|Adverse Event|1|||
146644696|NCT04359901|528875687|FG000|Overall Study|Withdrawal by Subject|0|||
146644697|NCT04359901|528875688|FG001|Overall Study|Withdrawal by Subject|1|||
146644698|NCT04359901|528875687|FG000|Overall Study|Death|6|||
146644699|NCT04359901|528875688|FG001|Overall Study|Death|2|||
146644700|NCT04627285|528875695|FG000|Overall Study|Adverse Event|0|||
146644701|NCT04627285|528875696|FG001|Overall Study|Adverse Event|2|||
146644702|NCT04627285|528875695|FG000|Overall Study|Lost to Follow-up|1|||
146644703|NCT04627285|528875696|FG001|Overall Study|Lost to Follow-up|0|||
146644704|NCT04627285|528875695|FG000|Overall Study|Withdrawal by Subject|1|||
146644705|NCT04627285|528875696|FG001|Overall Study|Withdrawal by Subject|1|||
146496820|NCT02049814|528322951|FG000|Overall Study|Reason not Specified|4|||
146496821|NCT02049814|528322952|FG001|Overall Study|Reason not Specified|3|||
146496822|NCT02049814|528322951|FG000|Overall Study|Pregnancy|1|||
146496823|NCT02049814|528322952|FG001|Overall Study|Pregnancy|0|||
146496824|NCT02049814|528322951|FG000|Overall Study|Lost to Follow-up|2|||
146496825|NCT02049814|528322952|FG001|Overall Study|Lost to Follow-up|3|||
146496826|NCT02049814|528322951|FG000|Overall Study|Serious Protocol Violation|5|||
146496827|NCT02049814|528322952|FG001|Overall Study|Serious Protocol Violation|7|||
146496828|NCT02049814|528322951|FG000|Overall Study|Study Termination|0|||
146496829|NCT02049814|528322952|FG001|Overall Study|Study Termination|1|||
146496830|NCT02049814|528322951|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
146496831|NCT02049814|528322952|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
146496832|NCT02049814|528322951|FG000|Overall Study|Voluntary withdrawal|9|||
146496833|NCT02049814|528322952|FG001|Overall Study|Voluntary withdrawal|8|||
146496834|NCT02993250|528322953|FG000|Overall Study|Lost to Follow-up|0|||
146496835|NCT02993250|528322954|FG001|Overall Study|Lost to Follow-up|1|||
146496836|NCT00954941|528322956|FG000|Overall Study|Received treatment at home|1|||
146496837|NCT00954941|528322957|FG001|Overall Study|Received treatment at home|0|||
146496838|NCT00954941|528322956|FG000|Overall Study|Withdrawal by Subject|1|||
146496839|NCT00954941|528322957|FG001|Overall Study|Withdrawal by Subject|0|||
146496840|NCT00954941|528322956|FG000|Overall Study|Insurance Denial|2|||
146496841|NCT00954941|528322957|FG001|Overall Study|Insurance Denial|2|||
146496842|NCT00954941|528322956|FG000|Overall Study|Physician Decision|2|||
146496843|NCT00954941|528322957|FG001|Overall Study|Physician Decision|2|||
146496844|NCT00954941|528322956|FG000|Overall Study|Ineligible|2|||
146496845|NCT00954941|528322957|FG001|Overall Study|Ineligible|2|||
146496846|NCT00954941|528322956|FG000|Overall Study|Adverse Event|0|||
146644706|NCT04627285|528875695|FG000|Overall Study|Sponsor decision|5|||
146496847|NCT00954941|528322957|FG001|Overall Study|Adverse Event|1|||
146496848|NCT00356148|528322960|FG000|Overall Study|Reoperation within 30 days|2|||
146496849|NCT00356148|528322961|FG001|Overall Study|Reoperation within 30 days|1|||
146496850|NCT02484456|528322962|FG000|Washout Period|Withdrawal by Subject|0|||
146496851|NCT02484456|528322963|FG001|Washout Period|Withdrawal by Subject|1|||
146496852|NCT02484456|528322962|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
146496853|NCT02484456|528322963|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
146496854|NCT02484456|528322962|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
146496855|NCT02484456|528322963|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
146496856|NCT02484456|528322962|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
146496857|NCT02484456|528322963|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
146496858|NCT02865499|528322969|FG000|Baseline|Adverse Event|1|||
146496859|NCT02865499|528322969|FG000|Baseline|Withdrawal by Subject|1|||
146496860|NCT02247440|528322970|FG000|Overall Study|Withdrawal by Subject|1|||
146496861|NCT02247440|528322970|FG000|Overall Study|Lack of Efficacy|3|||
146496862|NCT02792192|528322971|FG000|Overall Study|Death|1|||
146496863|NCT02792192|528322972|FG001|Overall Study|Death|0|||
146496864|NCT02792192|528322973|FG002|Overall Study|Death|0|||
146496865|NCT02792192|528322974|FG003|Overall Study|Death|0|||
146496866|NCT02792192|528322971|FG000|Overall Study|Informed Consent Withdrawn|4|||
146496867|NCT02792192|528322972|FG001|Overall Study|Informed Consent Withdrawn|0|||
146496868|NCT02792192|528322973|FG002|Overall Study|Informed Consent Withdrawn|0|||
146496869|NCT02792192|528322974|FG003|Overall Study|Informed Consent Withdrawn|0|||
146496870|NCT02792192|528322971|FG000|Overall Study|Physician Decision|1|||
146496871|NCT02792192|528322972|FG001|Overall Study|Physician Decision|0|||
146496872|NCT02792192|528322973|FG002|Overall Study|Physician Decision|0|||
146496873|NCT02792192|528322974|FG003|Overall Study|Physician Decision|0|||
146496874|NCT02792192|528322971|FG000|Overall Study|Progressive Disease|0|||
146496875|NCT02792192|528322972|FG001|Overall Study|Progressive Disease|1|||
146496876|NCT02792192|528322973|FG002|Overall Study|Progressive Disease|0|||
146496877|NCT02792192|528322974|FG003|Overall Study|Progressive Disease|0|||
146496878|NCT02792192|528322971|FG000|Overall Study|Study Terminated By Sponsor|6|||
146496879|NCT02792192|528322972|FG001|Overall Study|Study Terminated By Sponsor|10|||
146496880|NCT02792192|528322973|FG002|Overall Study|Study Terminated By Sponsor|0|||
146496881|NCT02792192|528322974|FG003|Overall Study|Study Terminated By Sponsor|0|||
146496882|NCT00661609|528322975|FG000|Overall Study|Adverse Event|4|||
146496883|NCT00661609|528322975|FG000|Overall Study|Death|20|||
146496884|NCT00661609|528322975|FG000|Overall Study|Withdrawal by Subject|2|||
146496885|NCT00661609|528322975|FG000|Overall Study|PI Decision|1|||
146496886|NCT00661609|528322975|FG000|Overall Study|Survival follow up stage discontinued|11|||
146496887|NCT00661609|528322975|FG000|Overall Study|Disease progression|3|||
146496888|NCT01430403|528322976|FG000|Overall Study|Lost to Follow-up|5|||
146496889|NCT01430403|528322977|FG001|Overall Study|Lost to Follow-up|5|||
146496890|NCT01430403|528322978|FG002|Overall Study|Lost to Follow-up|3|||
146644707|NCT04627285|528875696|FG001|Overall Study|Sponsor decision|0|||
146496891|NCT01430403|528322976|FG000|Overall Study|Physician Decision|1|||
146496892|NCT01430403|528322977|FG001|Overall Study|Physician Decision|0|||
146496893|NCT01430403|528322978|FG002|Overall Study|Physician Decision|0|||
146496894|NCT01430403|528322976|FG000|Overall Study|Protocol Violation|2|||
146496895|NCT01430403|528322977|FG001|Overall Study|Protocol Violation|3|||
146644708|NCT04627285|528875695|FG000|Overall Study|Participant left country; aunt informed the site|0|||
146644709|NCT04627285|528875696|FG001|Overall Study|Participant left country; aunt informed the site|1|||
146644710|NCT00635219|528877549|FG000|Overall Study|Adverse Event|12|||
146644711|NCT00635219|528877550|FG001|Overall Study|Adverse Event|10|||
146644712|NCT00635219|528877551|FG002|Overall Study|Adverse Event|18|||
146644713|NCT00635219|528877552|FG003|Overall Study|Adverse Event|15|||
146644714|NCT00635219|528877553|FG004|Overall Study|Adverse Event|19|||
146644715|NCT00635219|528877549|FG000|Overall Study|Lack of Efficacy|5|||
146644716|NCT00635219|528877550|FG001|Overall Study|Lack of Efficacy|6|||
146644717|NCT00635219|528877551|FG002|Overall Study|Lack of Efficacy|3|||
146644718|NCT00635219|528877552|FG003|Overall Study|Lack of Efficacy|4|||
146644719|NCT00635219|528877553|FG004|Overall Study|Lack of Efficacy|6|||
146644720|NCT00635219|528877549|FG000|Overall Study|Non-compliance With Study Product|0|||
146644721|NCT00635219|528877550|FG001|Overall Study|Non-compliance With Study Product|0|||
146644722|NCT00635219|528877551|FG002|Overall Study|Non-compliance With Study Product|0|||
146644723|NCT00635219|528877552|FG003|Overall Study|Non-compliance With Study Product|2|||
146644724|NCT00635219|528877553|FG004|Overall Study|Non-compliance With Study Product|1|||
146644725|NCT00635219|528877549|FG000|Overall Study|Protocol Violation|0|||
146644726|NCT00635219|528877550|FG001|Overall Study|Protocol Violation|2|||
146644727|NCT00635219|528877551|FG002|Overall Study|Protocol Violation|3|||
146644728|NCT00635219|528877552|FG003|Overall Study|Protocol Violation|2|||
146644729|NCT00635219|528877553|FG004|Overall Study|Protocol Violation|4|||
146644730|NCT00635219|528877549|FG000|Overall Study|Withdrawal of Consent|8|||
146644731|NCT00635219|528877550|FG001|Overall Study|Withdrawal of Consent|6|||
146644732|NCT00635219|528877551|FG002|Overall Study|Withdrawal of Consent|8|||
146644733|NCT00635219|528877552|FG003|Overall Study|Withdrawal of Consent|11|||
146496896|NCT01430403|528322978|FG002|Overall Study|Protocol Violation|2|||
146496897|NCT01430403|528322976|FG000|Overall Study|Withdrawal by Subject|9|||
146496898|NCT01430403|528322977|FG001|Overall Study|Withdrawal by Subject|1|||
146496899|NCT01430403|528322978|FG002|Overall Study|Withdrawal by Subject|3|||
146496900|NCT03124407|528322981|FG000|Overall Study|Lost to Follow-up|1|||
146496901|NCT03124407|528322982|FG001|Overall Study|Lost to Follow-up|0|||
146496902|NCT03124407|528322983|FG002|Overall Study|Lost to Follow-up|0|||
146496903|NCT03124407|528322984|FG003|Overall Study|Lost to Follow-up|0|||
146496904|NCT03124407|528322981|FG000|Overall Study|Adverse Event|0|||
146496905|NCT03124407|528322982|FG001|Overall Study|Adverse Event|0|||
146496906|NCT03124407|528322983|FG002|Overall Study|Adverse Event|1|||
146496907|NCT03124407|528322984|FG003|Overall Study|Adverse Event|0|||
146496908|NCT00396656|528322989|FG000|First Treatment Period|Withdrawal by Subject|0|||
146496909|NCT00396656|528322990|FG001|First Treatment Period|Withdrawal by Subject|2|||
146496910|NCT00396656|528322989|FG000|Second Treatment Period|Adverse Event|0|||
146496911|NCT00396656|528322990|FG001|Second Treatment Period|Adverse Event|1|||
146496912|NCT02821754|528322991|FG000|Overall Study|Procedure not required prior to amendment change|13|||
146496913|NCT02821754|528322992|FG001|Overall Study|Procedure not required prior to amendment change|11|||
146496914|NCT02821754|528322993|FG002|Overall Study|Procedure not required prior to amendment change|0|||
146644734|NCT00635219|528877553|FG004|Overall Study|Withdrawal of Consent|8|||
146644735|NCT00635219|528877549|FG000|Overall Study|Lost to Follow-up|0|||
146644736|NCT00635219|528877550|FG001|Overall Study|Lost to Follow-up|0|||
146644737|NCT00635219|528877551|FG002|Overall Study|Lost to Follow-up|2|||
146644738|NCT00635219|528877552|FG003|Overall Study|Lost to Follow-up|0|||
146644739|NCT00635219|528877553|FG004|Overall Study|Lost to Follow-up|3|||
146644740|NCT00635219|528877549|FG000|Overall Study|Administrative or Other Reasons|0|||
146496915|NCT02821754|528322991|FG000|Overall Study|Participant's Clinical status|2|||
146496916|NCT02821754|528322992|FG001|Overall Study|Participant's Clinical status|0|||
146644741|NCT00635219|528877550|FG001|Overall Study|Administrative or Other Reasons|1|||
146644742|NCT00635219|528877551|FG002|Overall Study|Administrative or Other Reasons|1|||
146644743|NCT00635219|528877552|FG003|Overall Study|Administrative or Other Reasons|0|||
146644744|NCT00635219|528877553|FG004|Overall Study|Administrative or Other Reasons|1|||
146644745|NCT01639729|528877554|FG000|Overall Study|Withdrawal by Subject|1|||
146644746|NCT01639729|528877555|FG001|Overall Study|Withdrawal by Subject|0|||
146496917|NCT02821754|528322993|FG002|Overall Study|Participant's Clinical status|0|||
146496918|NCT02821754|528322991|FG000|Overall Study|Participant removed for noncompliance|1|||
146496919|NCT02821754|528322992|FG001|Overall Study|Participant removed for noncompliance|0|||
146496920|NCT02821754|528322993|FG002|Overall Study|Participant removed for noncompliance|0|||
146496921|NCT02821754|528322991|FG000|Overall Study|Drug not available.|0|||
146496922|NCT02821754|528322992|FG001|Overall Study|Drug not available.|0|||
146644747|NCT01639729|528877556|FG002|Overall Study|Withdrawal by Subject|1|||
146644748|NCT01639729|528877557|FG003|Overall Study|Withdrawal by Subject|1|||
146644749|NCT01639729|528877558|FG004|Overall Study|Withdrawal by Subject|0|||
146644750|NCT01639729|528877559|FG005|Overall Study|Withdrawal by Subject|0|||
146644751|NCT00759564|528877560|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
146644752|NCT00759564|528877561|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
146644753|NCT00759564|528877562|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
146912090|NCT01013883|529841413|FG000|Overall Study|Lost to Follow-up|2|||
146496923|NCT02821754|528322993|FG002|Overall Study|Drug not available.|1|||
146496924|NCT02821754|528322991|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
146644754|NCT00759564|528877563|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
146644755|NCT00759564|528877564|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
146644756|NCT04145219|528877565|FG000|Overall Study|Adverse Event|18|||
146644757|NCT04145219|528877566|FG001|Overall Study|Adverse Event|6|||
146644758|NCT04145219|528877565|FG000|Overall Study|Lost to Follow-up|2|||
146644759|NCT04145219|528877566|FG001|Overall Study|Lost to Follow-up|3|||
146644760|NCT04145219|528877565|FG000|Overall Study|Physician Decision|0|||
146644761|NCT04145219|528877566|FG001|Overall Study|Physician Decision|2|||
146644762|NCT04145219|528877565|FG000|Overall Study|Withdrawal by Subject|12|||
146644763|NCT04145219|528877566|FG001|Overall Study|Withdrawal by Subject|8|||
146644764|NCT04145219|528877565|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
146644765|NCT04145219|528877566|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
146644766|NCT01640314|528877567|FG000|Overall Study|Protocol Violation|0|||
146644767|NCT01640314|528877568|FG001|Overall Study|Protocol Violation|1|||
146644768|NCT01290796|528877569|FG000|Overall Study|Lost to Follow-up|21|||
146644769|NCT01290796|528877569|FG000|Overall Study|Withdrawal by Subject|4|||
146644770|NCT01290796|528877569|FG000|Overall Study|Physician Decision|2|||
146644771|NCT01290796|528877569|FG000|Overall Study|Secondary Surgical Intervention|2|||
146644772|NCT01290796|528877569|FG000|Overall Study|Withdrawal by Sponsor|1|||
146644773|NCT02709538|528877571|FG000|Overall Study|Adverse Event|13|||
146644774|NCT02709538|528877572|FG001|Overall Study|Adverse Event|2|||
146644775|NCT02709538|528877573|FG002|Overall Study|Adverse Event|3|||
146644776|NCT02709538|528877571|FG000|Overall Study|Lack of Efficacy|1|||
146644777|NCT02709538|528877572|FG001|Overall Study|Lack of Efficacy|0|||
146644778|NCT02709538|528877573|FG002|Overall Study|Lack of Efficacy|0|||
146644779|NCT02709538|528877571|FG000|Overall Study|Lost to Follow-up|24|||
146496925|NCT02821754|528322992|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
146644780|NCT02709538|528877572|FG001|Overall Study|Lost to Follow-up|8|||
146644781|NCT02709538|528877573|FG002|Overall Study|Lost to Follow-up|4|||
146644782|NCT02709538|528877571|FG000|Overall Study|Physician Decision|1|||
146644783|NCT02709538|528877572|FG001|Overall Study|Physician Decision|0|||
146644784|NCT02709538|528877573|FG002|Overall Study|Physician Decision|0|||
146644785|NCT02709538|528877571|FG000|Overall Study|Withdrawal by Subject|40|||
146644786|NCT02709538|528877572|FG001|Overall Study|Withdrawal by Subject|7|||
146644787|NCT02709538|528877573|FG002|Overall Study|Withdrawal by Subject|4|||
146644788|NCT02709538|528877571|FG000|Overall Study|Non-compliance with study procedures|5|||
146644789|NCT02709538|528877572|FG001|Overall Study|Non-compliance with study procedures|0|||
146644790|NCT02709538|528877573|FG002|Overall Study|Non-compliance with study procedures|0|||
146644791|NCT02709538|528877571|FG000|Overall Study|Non-compliance with study drug|2|||
146644792|NCT02709538|528877572|FG001|Overall Study|Non-compliance with study drug|0|||
146644793|NCT02709538|528877573|FG002|Overall Study|Non-compliance with study drug|0|||
146644794|NCT02709538|528877571|FG000|Overall Study|Protocol deviation|10|||
146644795|NCT02709538|528877572|FG001|Overall Study|Protocol deviation|4|||
146644796|NCT02709538|528877573|FG002|Overall Study|Protocol deviation|4|||
146644797|NCT02709538|528877571|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
146644798|NCT02709538|528877572|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
146644799|NCT02709538|528877573|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
146644800|NCT02709538|528877571|FG000|Overall Study|Other|16|||
146644801|NCT02709538|528877572|FG001|Overall Study|Other|7|||
146644802|NCT02709538|528877573|FG002|Overall Study|Other|5|||
146644803|NCT00835211|528877574|FG000|First Intervention|Withdrawal by Subject|0|||
146644804|NCT00835211|528877575|FG001|First Intervention|Withdrawal by Subject|1|||
146644805|NCT00835211|528877574|FG000|Washout: 7 Days|Adverse Event|2|||
146644806|NCT00835211|528877575|FG001|Washout: 7 Days|Adverse Event|1|||
146644807|NCT00835211|528877574|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
146644808|NCT00835211|528877575|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
146644809|NCT02343549|528877577|FG000|Overall Study|Death|11|||
146644810|NCT02343549|528877577|FG000|Overall Study|Withdrawal by Subject|2|||
146644811|NCT02160041|528877578|FG000|Overall Study|Adverse Event|11|||
146644812|NCT02160041|528877578|FG000|Overall Study|Death|2|||
146644813|NCT02160041|528877578|FG000|Overall Study|disease progression|57|||
146644814|NCT02160041|528877578|FG000|Overall Study|Protocol Violation|1|||
146644815|NCT02160041|528877578|FG000|Overall Study|non-compliance with study|1|||
146644816|NCT02160041|528877578|FG000|Overall Study|Physician Decision|3|||
146644817|NCT02160041|528877578|FG000|Overall Study|Withdrawal by Subject|8|||
146644818|NCT02160041|528877578|FG000|Overall Study|study terminated by by sponsor|1|||
146644819|NCT01403948|528877579|FG000|Overall Study|Progressive disease|0|||
146644820|NCT01403948|528877580|FG001|Overall Study|Progressive disease|2|||
146644821|NCT01403948|528877581|FG002|Overall Study|Progressive disease|2|||
146644822|NCT01403948|528877582|FG003|Overall Study|Progressive disease|4|||
146644823|NCT01403948|528877583|FG004|Overall Study|Progressive disease|2|||
146644824|NCT01403948|528877584|FG005|Overall Study|Progressive disease|6|||
146644825|NCT01403948|528877585|FG006|Overall Study|Progressive disease|2|||
146644826|NCT01403948|528877586|FG007|Overall Study|Progressive disease|4|||
146644827|NCT01403948|528877587|FG008|Overall Study|Progressive disease|5|||
146496926|NCT02821754|528322993|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
146496927|NCT00554515|528322997|FG000|Overall Study|Withdrawal by Subject|3|||
146496928|NCT00554515|528322997|FG000|Overall Study|Disease progression|52|||
146496929|NCT00554515|528322997|FG000|Overall Study|Physician Decision|18|||
146496930|NCT00554515|528322997|FG000|Overall Study|Withdrawal by Subject|11|||
146496931|NCT00554515|528322997|FG000|Overall Study|Adverse Event|9|||
146496932|NCT00554515|528322997|FG000|Overall Study|Death|2|||
146496933|NCT00554515|528322997|FG000|Overall Study|Achieved Stable Disease|7|||
146496934|NCT00554515|528322997|FG000|Overall Study|Other|1|||
146496935|NCT00554515|528322997|FG000|Overall Study|Misc|15|||
146496936|NCT00766636|528322998|FG000|Overall Study|Withdrawal by Subject|1|||
146496937|NCT00766636|528322999|FG001|Overall Study|Withdrawal by Subject|1|||
146496938|NCT00766636|528322998|FG000|Overall Study|Incomplete Treatment|0|||
146496939|NCT00766636|528322999|FG001|Overall Study|Incomplete Treatment|1|||
146496940|NCT00766636|528322998|FG000|Overall Study|Adverse Event|1|||
146496941|NCT00766636|528322999|FG001|Overall Study|Adverse Event|0|||
146496942|NCT00766636|528322998|FG000|Overall Study|Disease Progression|1|||
146496943|NCT00766636|528322999|FG001|Overall Study|Disease Progression|0|||
146496944|NCT03340454|528323000|FG000|Overall Study|Lost to Follow-up|0|||
146496945|NCT03340454|528323001|FG001|Overall Study|Lost to Follow-up|4|||
146496946|NCT03682848|528323002|FG000|Overall Study|Withdrawal by Subject|2|||
146496947|NCT03682848|528323002|FG000|Overall Study|Site closed|5|||
146496948|NCT03682848|528323002|FG000|Overall Study|Protocol Deviation|1|||
146496949|NCT03682848|528323002|FG000|Overall Study|Adverse Event|1|||
146496950|NCT01464164|528323003|FG000|Overall Study|Screen failure|0|||
146496951|NCT01464164|528323004|FG001|Overall Study|Screen failure|1|||
146496952|NCT01464164|528323005|FG002|Overall Study|Screen failure|2|||
146496953|NCT01464164|528323006|FG003|Overall Study|Screen failure|0|||
146496954|NCT01464164|528323007|FG004|Overall Study|Screen failure|0|||
146496955|NCT01464164|528323008|FG005|Overall Study|Screen failure|0|||
146496956|NCT01464164|528323009|FG006|Overall Study|Screen failure|0|||
146496957|NCT01464164|528323003|FG000|Overall Study|Physician Decision|0|||
146496958|NCT01464164|528323004|FG001|Overall Study|Physician Decision|1|||
146496959|NCT01464164|528323005|FG002|Overall Study|Physician Decision|0|||
146496960|NCT01464164|528323006|FG003|Overall Study|Physician Decision|0|||
146496961|NCT01464164|528323007|FG004|Overall Study|Physician Decision|0|||
146496962|NCT01464164|528323008|FG005|Overall Study|Physician Decision|0|||
146496963|NCT01464164|528323009|FG006|Overall Study|Physician Decision|2|||
146496964|NCT00454363|528323010|FG000|Overall Study|Adverse Event|1|||
146496965|NCT00454363|528323011|FG001|Overall Study|Adverse Event|2|||
146496966|NCT00454363|528323010|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
146496967|NCT00454363|528323011|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
146496968|NCT01578239|528323012|FG000|Treatment Period|Progressive Disease|19|||
146496969|NCT01578239|528323013|FG001|Treatment Period|Progressive Disease|64|||
146496970|NCT01578239|528323012|FG000|Treatment Period|Physician Decision|17|||
146496971|NCT01578239|528323013|FG001|Treatment Period|Physician Decision|17|||
146496972|NCT01578239|528323012|FG000|Treatment Period|Adverse Event|13|||
146496973|NCT01578239|528323013|FG001|Treatment Period|Adverse Event|10|||
146496974|NCT01578239|528323012|FG000|Treatment Period|Non-compliance|2|||
146496975|NCT01578239|528323013|FG001|Treatment Period|Non-compliance|0|||
146496976|NCT01578239|528323012|FG000|Treatment Period|Withdrawal by Subject|10|||
146496977|NCT01578239|528323013|FG001|Treatment Period|Withdrawal by Subject|9|||
146496978|NCT01578239|528323012|FG000|Treatment Period|Other|6|||
146496979|NCT01578239|528323013|FG001|Treatment Period|Other|1|||
146496980|NCT01578239|528323012|FG000|Long-term Follow-Up Period|Death|69|||
146496981|NCT01578239|528323013|FG001|Long-term Follow-Up Period|Death|64|||
146496982|NCT01578239|528323012|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
146496983|NCT01578239|528323013|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
146496984|NCT01578239|528323012|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
146496985|NCT01578239|528323013|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
146496986|NCT01578239|528323012|FG000|Long-term Follow-Up Period|Other|2|||
146496987|NCT01578239|528323013|FG001|Long-term Follow-Up Period|Other|2|||
146496988|NCT02347813|528323014|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
146496989|NCT02347813|528323015|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
146564956|NCT01784029|528581310|FG001|Overall Study|Lost to Follow-up|20|||
146564957|NCT01784029|528581311|FG002|Overall Study|Lost to Follow-up|22|||
146564958|NCT02704208|528581312|FG000|Overall Study|Lost to Follow-up|42|||
146564959|NCT02704208|528581313|FG001|Overall Study|Lost to Follow-up|37|||
146564960|NCT00560508|528581314|FG000|12 Week Double-blind Period|Adverse Event|3|||
146564961|NCT00560508|528581315|FG001|12 Week Double-blind Period|Adverse Event|2|||
146496990|NCT02347813|528323014|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
146496991|NCT02347813|528323015|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
146496992|NCT01134939|528323016|FG000|Overall Study|Adverse Event|9|||
146496993|NCT01134939|528323017|FG001|Overall Study|Adverse Event|3|||
146496994|NCT01134939|528323018|FG002|Overall Study|Adverse Event|4|||
146496995|NCT01134939|528323019|FG003|Overall Study|Adverse Event|5|||
146496996|NCT01134939|528323020|FG004|Overall Study|Adverse Event|5|||
146564962|NCT00560508|528581314|FG000|12 Week Double-blind Period|Protocol Violation|1|||
146644828|NCT01403948|528877588|FG009|Overall Study|Progressive disease|5|||
146644829|NCT01403948|528877579|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
146644830|NCT01403948|528877580|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
146644831|NCT01403948|528877581|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
146644832|NCT01403948|528877582|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
146644833|NCT01403948|528877583|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
146644834|NCT01403948|528877584|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
146644835|NCT01403948|528877585|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
146644836|NCT01403948|528877586|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
146644837|NCT01403948|528877587|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
146496997|NCT01134939|528323021|FG005|Overall Study|Adverse Event|5|||
146496998|NCT01134939|528323022|FG006|Overall Study|Adverse Event|1|||
146496999|NCT01134939|528323023|FG007|Overall Study|Adverse Event|0|||
146497000|NCT01134939|528323016|FG000|Overall Study|Lack of Efficacy|2|||
146497001|NCT01134939|528323017|FG001|Overall Study|Lack of Efficacy|5|||
146644838|NCT01403948|528877588|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
146644839|NCT01403948|528877579|FG000|Overall Study|Lost to Follow-up|0|||
146644840|NCT01403948|528877580|FG001|Overall Study|Lost to Follow-up|0|||
146497002|NCT01134939|528323018|FG002|Overall Study|Lack of Efficacy|1|||
146497003|NCT01134939|528323019|FG003|Overall Study|Lack of Efficacy|0|||
146497004|NCT01134939|528323020|FG004|Overall Study|Lack of Efficacy|3|||
146497005|NCT01134939|528323021|FG005|Overall Study|Lack of Efficacy|0|||
146497006|NCT01134939|528323022|FG006|Overall Study|Lack of Efficacy|1|||
146497007|NCT01134939|528323023|FG007|Overall Study|Lack of Efficacy|0|||
146497008|NCT01134939|528323016|FG000|Overall Study|Lost to Follow-up|2|||
146497009|NCT01134939|528323017|FG001|Overall Study|Lost to Follow-up|3|||
146497010|NCT01134939|528323018|FG002|Overall Study|Lost to Follow-up|0|||
146497011|NCT01134939|528323019|FG003|Overall Study|Lost to Follow-up|1|||
146497012|NCT01134939|528323020|FG004|Overall Study|Lost to Follow-up|2|||
146497013|NCT01134939|528323021|FG005|Overall Study|Lost to Follow-up|1|||
146497014|NCT01134939|528323022|FG006|Overall Study|Lost to Follow-up|0|||
146497015|NCT01134939|528323023|FG007|Overall Study|Lost to Follow-up|0|||
146497016|NCT01134939|528323016|FG000|Overall Study|Death|0|||
146497017|NCT01134939|528323017|FG001|Overall Study|Death|1|||
146497018|NCT01134939|528323018|FG002|Overall Study|Death|0|||
146564963|NCT00560508|528581315|FG001|12 Week Double-blind Period|Protocol Violation|0|||
146564964|NCT00560508|528581314|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
146564965|NCT00560508|528581315|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
146644841|NCT01403948|528877581|FG002|Overall Study|Lost to Follow-up|0|||
146644842|NCT01403948|528877582|FG003|Overall Study|Lost to Follow-up|0|||
146644843|NCT01403948|528877583|FG004|Overall Study|Lost to Follow-up|0|||
146644844|NCT01403948|528877584|FG005|Overall Study|Lost to Follow-up|0|||
146644845|NCT01403948|528877585|FG006|Overall Study|Lost to Follow-up|0|||
146644846|NCT01403948|528877586|FG007|Overall Study|Lost to Follow-up|0|||
146644847|NCT01403948|528877587|FG008|Overall Study|Lost to Follow-up|0|||
146644848|NCT01403948|528877588|FG009|Overall Study|Lost to Follow-up|1|||
146644849|NCT01403948|528877579|FG000|Overall Study|Refused cont. medication|0|||
146644850|NCT01403948|528877580|FG001|Overall Study|Refused cont. medication|0|||
146644851|NCT01403948|528877581|FG002|Overall Study|Refused cont. medication|0|||
146644852|NCT01403948|528877582|FG003|Overall Study|Refused cont. medication|0|||
146644853|NCT01403948|528877583|FG004|Overall Study|Refused cont. medication|1|||
146644854|NCT01403948|528877584|FG005|Overall Study|Refused cont. medication|0|||
146644855|NCT01403948|528877585|FG006|Overall Study|Refused cont. medication|0|||
146644856|NCT01403948|528877586|FG007|Overall Study|Refused cont. medication|0|||
146644857|NCT01403948|528877587|FG008|Overall Study|Refused cont. medication|0|||
146644858|NCT01403948|528877588|FG009|Overall Study|Refused cont. medication|1|||
146564966|NCT00560508|528581314|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
146564967|NCT00560508|528581315|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
146564968|NCT00560508|528581314|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
146564969|NCT00560508|528581315|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
146564970|NCT00560508|528581314|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
146564971|NCT00560508|528581315|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
146644859|NCT01403948|528877579|FG000|Overall Study|other than above|1|||
146644860|NCT01403948|528877580|FG001|Overall Study|other than above|2|||
146644861|NCT01403948|528877581|FG002|Overall Study|other than above|1|||
146644862|NCT01403948|528877582|FG003|Overall Study|other than above|0|||
146644863|NCT01403948|528877583|FG004|Overall Study|other than above|1|||
146644864|NCT01403948|528877584|FG005|Overall Study|other than above|1|||
146644865|NCT01403948|528877585|FG006|Overall Study|other than above|2|||
146497019|NCT01134939|528323019|FG003|Overall Study|Death|0|||
146497020|NCT01134939|528323020|FG004|Overall Study|Death|0|||
146497021|NCT01134939|528323021|FG005|Overall Study|Death|0|||
146497022|NCT01134939|528323022|FG006|Overall Study|Death|0|||
146564972|NCT00560508|528581314|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
146564973|NCT00560508|528581315|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
146497023|NCT01134939|528323023|FG007|Overall Study|Death|0|||
146497024|NCT01134939|528323016|FG000|Overall Study|Termination page not available|4|||
146497025|NCT01134939|528323017|FG001|Overall Study|Termination page not available|6|||
146497026|NCT01134939|528323018|FG002|Overall Study|Termination page not available|5|||
146497027|NCT01134939|528323019|FG003|Overall Study|Termination page not available|8|||
146497028|NCT01134939|528323020|FG004|Overall Study|Termination page not available|0|||
146497029|NCT01134939|528323021|FG005|Overall Study|Termination page not available|3|||
146497030|NCT01134939|528323022|FG006|Overall Study|Termination page not available|7|||
146497031|NCT01134939|528323023|FG007|Overall Study|Termination page not available|0|||
146497032|NCT03817229|528323026|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
146497033|NCT03817229|528323027|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
146497034|NCT03817229|528323028|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
146497035|NCT03817229|528323029|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
146497036|NCT03817229|528323026|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
146497037|NCT03817229|528323027|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
146497038|NCT03817229|528323028|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
146497039|NCT03817229|528323029|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
146497040|NCT03817229|528323026|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
146497041|NCT03817229|528323027|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
146497042|NCT03817229|528323028|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
146497043|NCT03817229|528323029|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
146497044|NCT03817229|528323026|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
146497045|NCT03817229|528323027|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
146497046|NCT03817229|528323028|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
146497047|NCT03817229|528323029|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
146497048|NCT03817229|528323026|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
146497049|NCT03817229|528323027|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
146497050|NCT03817229|528323028|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
146497051|NCT03817229|528323029|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
146497052|NCT03817229|528323026|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
146497053|NCT03817229|528323027|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
146497054|NCT03817229|528323028|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
146497055|NCT03817229|528323029|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
146497056|NCT03817229|528323026|FG000|Post-Intervention|Withdrawal by Subject|6|||
146497057|NCT03817229|528323027|FG001|Post-Intervention|Withdrawal by Subject|0|||
146497058|NCT03817229|528323028|FG002|Post-Intervention|Withdrawal by Subject|2|||
146497059|NCT03817229|528323029|FG003|Post-Intervention|Withdrawal by Subject|2|||
146497060|NCT03817229|528323026|FG000|Post-Intervention|Withdrawal by Study Team|3|||
146497061|NCT03817229|528323027|FG001|Post-Intervention|Withdrawal by Study Team|1|||
146497062|NCT03817229|528323028|FG002|Post-Intervention|Withdrawal by Study Team|1|||
146497063|NCT03817229|528323029|FG003|Post-Intervention|Withdrawal by Study Team|4|||
146497064|NCT03817229|528323026|FG000|Post-Intervention|Weaned from medication|3|||
146497065|NCT03817229|528323027|FG001|Post-Intervention|Weaned from medication|0|||
146497066|NCT03817229|528323028|FG002|Post-Intervention|Weaned from medication|2|||
146497067|NCT03817229|528323029|FG003|Post-Intervention|Weaned from medication|1|||
146497068|NCT03817229|528323026|FG000|Post-Intervention|Transferred care to another institution|1|||
146497069|NCT03817229|528323027|FG001|Post-Intervention|Transferred care to another institution|0|||
146497070|NCT03817229|528323028|FG002|Post-Intervention|Transferred care to another institution|0|||
146497071|NCT03817229|528323029|FG003|Post-Intervention|Transferred care to another institution|0|||
146497072|NCT03817229|528323026|FG000|Post-Intervention|Change in parental guardianship|0|||
146497073|NCT03817229|528323027|FG001|Post-Intervention|Change in parental guardianship|0|||
146497074|NCT03817229|528323028|FG002|Post-Intervention|Change in parental guardianship|1|||
146497075|NCT03817229|528323029|FG003|Post-Intervention|Change in parental guardianship|0|||
146497076|NCT03817229|528323026|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
146497077|NCT03817229|528323027|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
146497078|NCT03817229|528323028|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
146497079|NCT03817229|528323029|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
146497080|NCT03817229|528323026|FG000|Follow-up 1|Withdrawal by Subject|1|||
146497081|NCT03817229|528323027|FG001|Follow-up 1|Withdrawal by Subject|2|||
146497082|NCT03817229|528323028|FG002|Follow-up 1|Withdrawal by Subject|0|||
146497083|NCT03817229|528323029|FG003|Follow-up 1|Withdrawal by Subject|0|||
146497084|NCT03817229|528323026|FG000|Follow-up 1|Withdrawal by Study Team|3|||
146497085|NCT03817229|528323027|FG001|Follow-up 1|Withdrawal by Study Team|1|||
146497086|NCT03817229|528323028|FG002|Follow-up 1|Withdrawal by Study Team|0|||
146497087|NCT03817229|528323029|FG003|Follow-up 1|Withdrawal by Study Team|0|||
146564974|NCT02164864|528581316|FG000|Overall Study|Trial disease worsening|7|||
146497088|NCT03817229|528323026|FG000|Follow-up 1|Wean from medication|3|||
146497089|NCT03817229|528323027|FG001|Follow-up 1|Wean from medication|4|||
146497090|NCT03817229|528323028|FG002|Follow-up 1|Wean from medication|0|||
146497091|NCT03817229|528323029|FG003|Follow-up 1|Wean from medication|1|||
146497092|NCT03817229|528323026|FG000|Follow-up 1|Transferred care to another hospital|1|||
146497093|NCT03817229|528323027|FG001|Follow-up 1|Transferred care to another hospital|0|||
146497094|NCT03817229|528323028|FG002|Follow-up 1|Transferred care to another hospital|0|||
146497095|NCT03817229|528323029|FG003|Follow-up 1|Transferred care to another hospital|0|||
146497096|NCT03817229|528323026|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
146497097|NCT03817229|528323027|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
146497098|NCT03817229|528323028|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
146497099|NCT03817229|528323029|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
146497100|NCT03817229|528323026|FG000|Follow-up 2|Withdrawal by Subject|2|||
146497101|NCT03817229|528323027|FG001|Follow-up 2|Withdrawal by Subject|0|||
146497102|NCT03817229|528323028|FG002|Follow-up 2|Withdrawal by Subject|1|||
146497103|NCT03817229|528323029|FG003|Follow-up 2|Withdrawal by Subject|1|||
146497104|NCT03817229|528323026|FG000|Follow-up 2|Withdrawal by Study Team|2|||
146497105|NCT03817229|528323027|FG001|Follow-up 2|Withdrawal by Study Team|0|||
146497106|NCT03817229|528323028|FG002|Follow-up 2|Withdrawal by Study Team|1|||
146497107|NCT03817229|528323029|FG003|Follow-up 2|Withdrawal by Study Team|0|||
146497108|NCT03817229|528323026|FG000|Follow-up 2|Wean from medication|1|||
146497109|NCT03817229|528323027|FG001|Follow-up 2|Wean from medication|0|||
146564975|NCT02164864|528581317|FG001|Overall Study|Trial disease worsening|5|||
146564976|NCT02164864|528581318|FG002|Overall Study|Trial disease worsening|1|||
146564977|NCT02164864|528581316|FG000|Overall Study|Other pre-existing disease worsening|6|||
146564978|NCT02164864|528581317|FG001|Overall Study|Other pre-existing disease worsening|4|||
146564979|NCT02164864|528581318|FG002|Overall Study|Other pre-existing disease worsening|9|||
146564980|NCT02164864|528581316|FG000|Overall Study|Other Adverse Event (AE)|52|||
146564981|NCT02164864|528581317|FG001|Overall Study|Other Adverse Event (AE)|32|||
146564982|NCT02164864|528581318|FG002|Overall Study|Other Adverse Event (AE)|49|||
146564983|NCT02164864|528581316|FG000|Overall Study|Protocol Violation|2|||
146564984|NCT02164864|528581317|FG001|Overall Study|Protocol Violation|4|||
146564985|NCT02164864|528581318|FG002|Overall Study|Protocol Violation|1|||
146564986|NCT02164864|528581316|FG000|Overall Study|Lost to Follow-up|4|||
146564987|NCT02164864|528581317|FG001|Overall Study|Lost to Follow-up|3|||
146564988|NCT02164864|528581318|FG002|Overall Study|Lost to Follow-up|2|||
146564989|NCT02164864|528581316|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
146564990|NCT02164864|528581317|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
146564991|NCT02164864|528581318|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
146564992|NCT02164864|528581316|FG000|Overall Study|Other than stated|3|||
146564993|NCT02164864|528581317|FG001|Overall Study|Other than stated|4|||
146564994|NCT02164864|528581318|FG002|Overall Study|Other than stated|14|||
146564995|NCT00652834|528581319|FG000|Overall Study|Withdrawal by Subject|3|||
146564996|NCT00652834|528581319|FG000|Overall Study|Lost to Follow-up|2|||
146564997|NCT02569853|528581320|FG000|Overall Study|Adverse Event|2|||
146564998|NCT02569853|528581321|FG001|Overall Study|Adverse Event|0|||
146564999|NCT02569853|528581320|FG000|Overall Study|Withdrawal by Subject|3|||
146565000|NCT02569853|528581321|FG001|Overall Study|Withdrawal by Subject|2|||
146565001|NCT02569853|528581320|FG000|Overall Study|Lost to Follow-up|3|||
146565002|NCT02569853|528581321|FG001|Overall Study|Lost to Follow-up|3|||
146565003|NCT02569853|528581320|FG000|Overall Study|Protocol Violation|1|||
146565004|NCT02569853|528581321|FG001|Overall Study|Protocol Violation|1|||
146565005|NCT02569853|528581320|FG000|Overall Study|Did not experience migraine attack|10|||
146565006|NCT02569853|528581321|FG001|Overall Study|Did not experience migraine attack|7|||
146565007|NCT02569853|528581320|FG000|Overall Study|Physician Decision|1|||
146565008|NCT02569853|528581321|FG001|Overall Study|Physician Decision|1|||
146565009|NCT00335829|528581322|FG000|Overall Study|Withdrawal by Subject|1|||
146565010|NCT00335829|528581322|FG000|Overall Study|Lost to Follow-up|1|||
146565011|NCT00335829|528581322|FG000|Overall Study|Adverse Event|1|||
146565012|NCT00854360|528581323|FG000|Overall Study|Adverse Event|0|||
146565013|NCT00854360|528581324|FG001|Overall Study|Adverse Event|1|||
146565014|NCT00854360|528581325|FG002|Overall Study|Adverse Event|2|||
146565015|NCT00854360|528581326|FG003|Overall Study|Adverse Event|6|||
146497110|NCT03817229|528323028|FG002|Follow-up 2|Wean from medication|0|||
146497111|NCT03817229|528323029|FG003|Follow-up 2|Wean from medication|0|||
146497112|NCT03817229|528323026|FG000|Follow-up 2|Transferred care|0|||
146565016|NCT00854360|528581323|FG000|Overall Study|Withdrawal by Subject|0|||
146565017|NCT00854360|528581324|FG001|Overall Study|Withdrawal by Subject|0|||
146565018|NCT00854360|528581325|FG002|Overall Study|Withdrawal by Subject|0|||
146497113|NCT03817229|528323027|FG001|Follow-up 2|Transferred care|0|||
146565019|NCT00854360|528581326|FG003|Overall Study|Withdrawal by Subject|1|||
146565020|NCT00854360|528581323|FG000|Overall Study|Pregnancy|0|||
146565021|NCT00854360|528581324|FG001|Overall Study|Pregnancy|1|||
146565022|NCT00854360|528581325|FG002|Overall Study|Pregnancy|0|||
146497114|NCT03817229|528323028|FG002|Follow-up 2|Transferred care|1|||
146497115|NCT03817229|528323029|FG003|Follow-up 2|Transferred care|0|||
146497116|NCT00757042|528323036|FG000|Overall Study|Lost to Follow-up|0|||
146565023|NCT00854360|528581326|FG003|Overall Study|Pregnancy|0|||
146565024|NCT00854360|528581323|FG000|Overall Study|Lack of Efficacy|2|||
146565025|NCT00854360|528581324|FG001|Overall Study|Lack of Efficacy|1|||
146497117|NCT00757042|528323037|FG001|Overall Study|Lost to Follow-up|0|||
146497118|NCT00757042|528323038|FG002|Overall Study|Lost to Follow-up|0|||
146497119|NCT00757042|528323039|FG003|Overall Study|Lost to Follow-up|0|||
146497120|NCT00757042|528323040|FG004|Overall Study|Lost to Follow-up|0|||
146497121|NCT00757042|528323041|FG005|Overall Study|Lost to Follow-up|0|||
146497122|NCT00757042|528323042|FG006|Overall Study|Lost to Follow-up|0|||
146497123|NCT00757042|528323043|FG007|Overall Study|Lost to Follow-up|0|||
146497124|NCT00757042|528323044|FG008|Overall Study|Lost to Follow-up|1|||
146497125|NCT00757042|528323045|FG009|Overall Study|Lost to Follow-up|0|||
146497126|NCT00757042|528323046|FG010|Overall Study|Lost to Follow-up|0|||
146497127|NCT00757042|528323036|FG000|Overall Study|Ineligibility Determined|0|||
146497128|NCT00757042|528323037|FG001|Overall Study|Ineligibility Determined|0|||
146497129|NCT00757042|528323038|FG002|Overall Study|Ineligibility Determined|0|||
146497130|NCT00757042|528323039|FG003|Overall Study|Ineligibility Determined|0|||
146497131|NCT00757042|528323040|FG004|Overall Study|Ineligibility Determined|0|||
146497132|NCT00757042|528323041|FG005|Overall Study|Ineligibility Determined|0|||
146497133|NCT00757042|528323042|FG006|Overall Study|Ineligibility Determined|0|||
146497134|NCT00757042|528323043|FG007|Overall Study|Ineligibility Determined|0|||
146497135|NCT00757042|528323044|FG008|Overall Study|Ineligibility Determined|0|||
146497136|NCT00757042|528323045|FG009|Overall Study|Ineligibility Determined|0|||
146497137|NCT00757042|528323046|FG010|Overall Study|Ineligibility Determined|1|||
146497138|NCT00757042|528323036|FG000|Overall Study|Withdrawal by Subject|0|||
146565026|NCT00854360|528581325|FG002|Overall Study|Lack of Efficacy|0|||
146565027|NCT00854360|528581326|FG003|Overall Study|Lack of Efficacy|0|||
146565028|NCT00854360|528581323|FG000|Overall Study|Other|0|||
146565029|NCT00854360|528581324|FG001|Overall Study|Other|0|||
146565030|NCT00854360|528581325|FG002|Overall Study|Other|0|||
146565031|NCT00854360|528581326|FG003|Overall Study|Other|3|||
146565032|NCT00754572|528581327|FG000|Overall Study|Adverse Event|19|||
146565033|NCT00754572|528581327|FG000|Overall Study|Other|39|||
146565034|NCT00754572|528581327|FG000|Overall Study|Protocol Violation|3|||
146565035|NCT00754572|528581327|FG000|Overall Study|Withdrawal by Subject|3|||
146565036|NCT00754572|528581327|FG000|Overall Study|Lack of Efficacy|2|||
146565037|NCT00754572|528581327|FG000|Overall Study|Death|1|||
146565038|NCT00754572|528581327|FG000|Overall Study|Administrative Reason|3|||
146565039|NCT00754572|528581327|FG000|Overall Study|Lost to Follow-up|1|||
146565040|NCT02271880|528581329|FG000|Overall Study|Premature discontinuation of study|3|||
146565041|NCT02271880|528581330|FG001|Overall Study|Premature discontinuation of study|4|||
146565042|NCT00474903|528581331|FG000|Overall Study|Protocol Violation|1|||
146565043|NCT00474903|528581332|FG001|Overall Study|Protocol Violation|5|||
146565044|NCT00474903|528581333|FG002|Overall Study|Protocol Violation|2|||
146565045|NCT01170663|528581334|FG000|Overall Study|Lost to Follow-up|3|||
146565046|NCT01170663|528581335|FG001|Overall Study|Lost to Follow-up|9|||
146565047|NCT01170663|528581334|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
146565048|NCT01170663|528581335|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
146565049|NCT02006927|528581338|FG000|Overall Study|Adverse Event|2|||
146565050|NCT02006927|528581338|FG000|Overall Study|Withdrawal by Subject|1|||
146565051|NCT02735200|528581341|FG000|Overall Study|Lost to Follow-up|0|||
146565052|NCT02735200|528581342|FG001|Overall Study|Lost to Follow-up|5|||
146565053|NCT02735200|528581341|FG000|Overall Study|Withdrawal by Subject|8|||
146565054|NCT02735200|528581342|FG001|Overall Study|Withdrawal by Subject|0|||
146565055|NCT02746809|528581343|FG000|Enrollment|Inclusion Exclusion not met|9|||
146565056|NCT02746809|528581343|FG000|Enrollment|Withdrawal by Subject|1|||
146565057|NCT02746809|528581343|FG000|Enrollment|Expected Enrollment Met|2|||
146565058|NCT02746809|528581343|FG000|Procedure|Death|1|||
146565059|NCT02746809|528581343|FG000|1-Month|Death|5|||
146565060|NCT02746809|528581343|FG000|6-Month|Death|2|||
146565061|NCT02746809|528581343|FG000|6-Month|Withdrawal by Subject|1|||
146565062|NCT02746809|528581343|FG000|12-Month|Death|3|||
146565063|NCT02746809|528581343|FG000|12-Month|Withdrawal by Subject|2|||
146565064|NCT02746809|528581343|FG000|24-Month|Death|1|||
146565065|NCT02746809|528581343|FG000|24-Month|Withdrawal by Subject|1|||
146565066|NCT02746809|528581343|FG000|36-Month|Death|8|||
146565067|NCT02746809|528581343|FG000|36-Month|Withdrawal by Subject|1|||
146565068|NCT02746809|528581343|FG000|48-Month|Death|7|||
146565069|NCT02746809|528581343|FG000|48-Month|Withdrawal by Subject|1|||
146565070|NCT02746809|528581343|FG000|60-Month|Death|1|||
146565071|NCT02746809|528581343|FG000|60-Month|Lost to Follow-up|2|||
146565072|NCT01164007|528581344|FG000|Overall Study|Adverse Event|5|||
146565073|NCT01164007|528581344|FG000|Overall Study|Progression of Disease|30|||
146565074|NCT01164007|528581344|FG000|Overall Study|Protocol Violation|1|||
146565075|NCT01164007|528581344|FG000|Overall Study|Withdrawal by Subject|1|||
146565076|NCT01164007|528581344|FG000|Overall Study|Medical Decision|3|||
146565077|NCT00894387|528581347|FG000|Overall Study|Adverse Event|44|||
146565078|NCT00894387|528581348|FG001|Overall Study|Adverse Event|45|||
146565079|NCT00894387|528581347|FG000|Overall Study|Abnormal Laboratory values|2|||
146565080|NCT00894387|528581348|FG001|Overall Study|Abnormal Laboratory values|2|||
146565081|NCT00894387|528581347|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146644866|NCT01403948|528877586|FG007|Overall Study|other than above|0|||
146644867|NCT01403948|528877587|FG008|Overall Study|other than above|0|||
146644868|NCT01403948|528877588|FG009|Overall Study|other than above|0|||
146644869|NCT04450381|528877589|FG000|Overall Study|Protocol Violation|4|||
146644870|NCT04450381|528877589|FG000|Overall Study|Wrong device setting|2|||
146644871|NCT01090323|528877590|FG000|Overall Study|Adverse Event|12|||
146644872|NCT01090323|528877591|FG001|Overall Study|Adverse Event|2|||
146644873|NCT01090323|528877590|FG000|Overall Study|Abnormal Lab Values|3|||
146644874|NCT01090323|528877591|FG001|Overall Study|Abnormal Lab Values|1|||
146644875|NCT01090323|528877590|FG000|Overall Study|Abnormal Test Procedure Results|2|||
146644876|NCT01090323|528877591|FG001|Overall Study|Abnormal Test Procedure Results|0|||
146644877|NCT01090323|528877590|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146644878|NCT01090323|528877591|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146644879|NCT01090323|528877590|FG000|Overall Study|Condition no longer requires drug|5|||
146644880|NCT01090323|528877591|FG001|Overall Study|Condition no longer requires drug|4|||
146644881|NCT01090323|528877590|FG000|Overall Study|Protocol Violation|2|||
146644882|NCT01090323|528877591|FG001|Overall Study|Protocol Violation|1|||
146644883|NCT01090323|528877590|FG000|Overall Study|Withdrew consent|33|||
146768946|NCT04707313|529321797|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146497139|NCT00757042|528323037|FG001|Overall Study|Withdrawal by Subject|0|||
146497140|NCT00757042|528323038|FG002|Overall Study|Withdrawal by Subject|0|||
146497141|NCT00757042|528323039|FG003|Overall Study|Withdrawal by Subject|0|||
146497142|NCT00757042|528323040|FG004|Overall Study|Withdrawal by Subject|0|||
146497143|NCT00757042|528323041|FG005|Overall Study|Withdrawal by Subject|0|||
146497144|NCT00757042|528323042|FG006|Overall Study|Withdrawal by Subject|0|||
146497145|NCT00757042|528323043|FG007|Overall Study|Withdrawal by Subject|0|||
146497146|NCT00757042|528323044|FG008|Overall Study|Withdrawal by Subject|0|||
146497147|NCT00757042|528323045|FG009|Overall Study|Withdrawal by Subject|1|||
146497148|NCT00757042|528323046|FG010|Overall Study|Withdrawal by Subject|0|||
146497149|NCT02654977|528323048|FG000|Overall Study|Death|1|||
146497150|NCT02654977|528323048|FG000|Overall Study|Lost to Follow-up|1|||
146497151|NCT02654977|528323048|FG000|Overall Study|Adverse Event|1|||
146497152|NCT02654977|528323048|FG000|Overall Study|Withdrawal by Subject|1|||
146497153|NCT02654977|528323048|FG000|Overall Study|Lack of Efficacy|3|||
146497154|NCT01266291|528323050|FG000|Overall Study|Adverse Event|1|||
146497155|NCT03291431|528323051|FG000|Overall Study|Protocol Violation|2|||
146497156|NCT03291431|528323052|FG001|Overall Study|Protocol Violation|1|||
146497157|NCT03291431|528323051|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
146497158|NCT03291431|528323052|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
146497159|NCT03291431|528323051|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
146497160|NCT03291431|528323052|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
146497161|NCT04402138|528324598|FG000|Overall Study|Progressive Disease|2|||
146497162|NCT04402138|528324598|FG000|Overall Study|Adverse Event|1|||
146497163|NCT04390503|528324599|FG000|Overall Study|Physician Decision|2|||
146497164|NCT04390503|528324600|FG001|Overall Study|Physician Decision|1|||
146497165|NCT04390503|528324599|FG000|Overall Study|Adverse Event|1|||
146497166|NCT04390503|528324600|FG001|Overall Study|Adverse Event|0|||
146497167|NCT03508726|528324601|FG000|Overall Study|Withdrawal by Subject|0|||
146497168|NCT03508726|528324602|FG001|Overall Study|Withdrawal by Subject|1|||
146497169|NCT00384839|528324608|FG000|Overall Study|Adverse Event|4|||
146497170|NCT00384839|528324608|FG000|Overall Study|Investigator Request|1|||
146497171|NCT00384839|528324608|FG000|Overall Study|Patient Request|1|||
146497172|NCT00384839|528324608|FG000|Overall Study|Ineligible|2|||
146497173|NCT02649439|528324609|FG000|Overall Study|Switched to alternative treatment|6|||
146497174|NCT02649439|528324610|FG001|Overall Study|Switched to alternative treatment|4|||
146497175|NCT02649439|528324609|FG000|Overall Study|Patient decision|1|||
146497176|NCT02649439|528324610|FG001|Overall Study|Patient decision|0|||
146497177|NCT02649439|528324609|FG000|Overall Study|Patient going out of country|1|||
146497178|NCT02649439|528324610|FG001|Overall Study|Patient going out of country|0|||
146497179|NCT02649439|528324609|FG000|Overall Study|To start finasteride|1|||
146497180|NCT02649439|528324610|FG001|Overall Study|To start finasteride|0|||
146497181|NCT02649439|528324609|FG000|Overall Study|Physician Decision|1|||
146497182|NCT02649439|528324610|FG001|Overall Study|Physician Decision|0|||
146497183|NCT02649439|528324609|FG000|Overall Study|Disease progression on study|12|||
146497184|NCT02649439|528324610|FG001|Overall Study|Disease progression on study|13|||
146497185|NCT02649439|528324609|FG000|Overall Study|Refused further treatment|1|||
146768947|NCT04707313|529321798|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146768948|NCT04707313|529321799|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146497186|NCT02649439|528324610|FG001|Overall Study|Refused further treatment|0|||
146644884|NCT01090323|528877591|FG001|Overall Study|Withdrew consent|11|||
146644885|NCT01090323|528877590|FG000|Overall Study|Lost to Follow-up|11|||
146644886|NCT01090323|528877591|FG001|Overall Study|Lost to Follow-up|6|||
146644887|NCT01090323|528877590|FG000|Overall Study|Administrative problems|6|||
146768949|NCT04707313|529321800|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
146497187|NCT02649439|528324609|FG000|Overall Study|Refused further follow up|2|||
146497188|NCT02649439|528324610|FG001|Overall Study|Refused further follow up|7|||
146497189|NCT02649439|528324609|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
146497190|NCT02649439|528324610|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
146768950|NCT04707313|529321801|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
146768951|NCT04707313|529321802|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
146497191|NCT02649439|528324609|FG000|Overall Study|No treatment, per protocol|1|||
146497192|NCT02649439|528324610|FG001|Overall Study|No treatment, per protocol|0|||
146497193|NCT02649439|528324609|FG000|Overall Study|PSA DT makes ineligible|0|||
146497194|NCT02649439|528324610|FG001|Overall Study|PSA DT makes ineligible|1|||
146497195|NCT02649439|528324609|FG000|Overall Study|Rising PSA No Mets|0|||
146497196|NCT02649439|528324610|FG001|Overall Study|Rising PSA No Mets|1|||
146497197|NCT02649439|528324609|FG000|Overall Study|Rising PSA|0|||
146497198|NCT02649439|528324610|FG001|Overall Study|Rising PSA|1|||
146497199|NCT02649439|528324609|FG000|Overall Study|Signed follow up protocol|0|||
146497200|NCT02649439|528324610|FG001|Overall Study|Signed follow up protocol|1|||
146565082|NCT00894387|528581348|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146565083|NCT00894387|528581347|FG000|Overall Study|Lost to Follow-up|3|||
146565084|NCT00894387|528581348|FG001|Overall Study|Lost to Follow-up|5|||
146565085|NCT00894387|528581347|FG000|Overall Study|Administrative problems|2|||
146565086|NCT00894387|528581348|FG001|Overall Study|Administrative problems|2|||
146565087|NCT00894387|528581347|FG000|Overall Study|Death|77|||
146565088|NCT00894387|528581348|FG001|Overall Study|Death|76|||
146565089|NCT00894387|528581347|FG000|Overall Study|Protocol Deviation|4|||
146565090|NCT00894387|528581348|FG001|Overall Study|Protocol Deviation|0|||
146565091|NCT00894387|528581347|FG000|Overall Study|Patient's request|25|||
146565092|NCT00894387|528581348|FG001|Overall Study|Patient's request|30|||
146565093|NCT00894387|528581347|FG000|Overall Study|Other (Missing)|5|||
146565094|NCT00894387|528581348|FG001|Overall Study|Other (Missing)|3|||
146565095|NCT00894387|528581347|FG000|Overall Study|Mis-randomized|13|||
146565096|NCT00894387|528581348|FG001|Overall Study|Mis-randomized|9|||
146565097|NCT00894387|528581347|FG000|Overall Study|GCP non-compliance|0|||
146565098|NCT00894387|528581348|FG001|Overall Study|GCP non-compliance|2|||
146565099|NCT00744861|528581349|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
146565100|NCT00744861|528581350|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
146565101|NCT00744861|528581351|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
146565102|NCT00744861|528581352|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
146565103|NCT00744861|528581349|FG000|Feasibility Stage 1|Pregnancy|0|||
146565104|NCT00744861|528581350|FG001|Feasibility Stage 1|Pregnancy|1|||
146565105|NCT00744861|528581351|FG002|Feasibility Stage 1|Pregnancy|0|||
146565106|NCT00744861|528581352|FG003|Feasibility Stage 1|Pregnancy|0|||
146565107|NCT00744861|528581349|FG000|Pivotal Stage 2|Adverse Event|0|||
146565108|NCT00744861|528581350|FG001|Pivotal Stage 2|Adverse Event|0|||
146565109|NCT00744861|528581351|FG002|Pivotal Stage 2|Adverse Event|6|||
146565110|NCT00744861|528581352|FG003|Pivotal Stage 2|Adverse Event|11|||
146565111|NCT00744861|528581349|FG000|Pivotal Stage 2|Death|0|||
146565112|NCT00744861|528581350|FG001|Pivotal Stage 2|Death|0|||
146565113|NCT00744861|528581351|FG002|Pivotal Stage 2|Death|0|||
146565114|NCT00744861|528581352|FG003|Pivotal Stage 2|Death|1|||
146565115|NCT00744861|528581349|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
146565116|NCT00744861|528581350|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
146565117|NCT00744861|528581351|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
146565118|NCT00744861|528581352|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
146565119|NCT00744861|528581349|FG000|Pivotal Stage 2|Physician Decision|0|||
146565120|NCT00744861|528581350|FG001|Pivotal Stage 2|Physician Decision|0|||
146565121|NCT00744861|528581351|FG002|Pivotal Stage 2|Physician Decision|3|||
146565122|NCT00744861|528581352|FG003|Pivotal Stage 2|Physician Decision|1|||
146565123|NCT00744861|528581349|FG000|Pivotal Stage 2|Protocol Violation|0|||
146565124|NCT00744861|528581350|FG001|Pivotal Stage 2|Protocol Violation|0|||
146565125|NCT00744861|528581351|FG002|Pivotal Stage 2|Protocol Violation|0|||
146565126|NCT00744861|528581352|FG003|Pivotal Stage 2|Protocol Violation|1|||
146565127|NCT00744861|528581349|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
146565128|NCT00744861|528581350|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
146565129|NCT00744861|528581351|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
146565130|NCT00744861|528581352|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
146565131|NCT00744861|528581349|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
146565132|NCT00744861|528581350|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
146565133|NCT00744861|528581351|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
146565134|NCT00744861|528581352|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
146565135|NCT02493764|528581353|FG000|Overall Study|Adverse Event|2|||
146565136|NCT02493764|528581354|FG001|Overall Study|Adverse Event|2|||
146565137|NCT02493764|528581353|FG000|Overall Study|Death|44|||
146565138|NCT02493764|528581354|FG001|Overall Study|Death|58|||
146497201|NCT02714595|528324611|FG000|Overall Study|Lost to Follow-up|1|||
146497202|NCT02714595|528324612|FG001|Overall Study|Lost to Follow-up|0|||
146565139|NCT02493764|528581353|FG000|Overall Study|Lost to Follow-up|2|||
146565140|NCT02493764|528581354|FG001|Overall Study|Lost to Follow-up|1|||
146565141|NCT02493764|528581353|FG000|Overall Study|Protocol Violation|6|||
146565142|NCT02493764|528581354|FG001|Overall Study|Protocol Violation|7|||
146565143|NCT02493764|528581353|FG000|Overall Study|Physician Decision|1|||
146565144|NCT02493764|528581354|FG001|Overall Study|Physician Decision|1|||
146565145|NCT02493764|528581353|FG000|Overall Study|Participant moved|17|||
146565146|NCT02493764|528581354|FG001|Overall Study|Participant moved|5|||
146565147|NCT02493764|528581353|FG000|Overall Study|Withdrawal parent/guardian|0|||
146565148|NCT02493764|528581354|FG001|Overall Study|Withdrawal parent/guardian|1|||
146565149|NCT02493764|528581353|FG000|Overall Study|Withdrawal by Subject|11|||
146565150|NCT02493764|528581354|FG001|Overall Study|Withdrawal by Subject|7|||
146565151|NCT01561976|528581355|FG000|Period 1|Adverse Event|0|||
146565152|NCT01561976|528581356|FG001|Period 1|Adverse Event|0|||
146565153|NCT01561976|528581357|FG002|Period 1|Adverse Event|1|||
146565154|NCT01561976|528581358|FG003|Period 1|Adverse Event|0|||
146565155|NCT01561976|528581359|FG004|Period 1|Adverse Event|0|||
146565156|NCT01561976|528581360|FG005|Period 1|Adverse Event|0|||
146565157|NCT01561976|528581355|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
146565158|NCT01561976|528581356|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
146565159|NCT01561976|528581357|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
146565160|NCT01561976|528581358|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
146565161|NCT01561976|528581359|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
146565162|NCT01561976|528581360|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
146565163|NCT01561976|528581355|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146565164|NCT01561976|528581356|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146565165|NCT01561976|528581357|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146565166|NCT01561976|528581358|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146565167|NCT01561976|528581359|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146565168|NCT01561976|528581360|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
146565169|NCT01561976|528581355|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
146565170|NCT01561976|528581356|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
146565171|NCT01561976|528581357|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
146565172|NCT01561976|528581358|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
146565173|NCT01561976|528581359|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
146565174|NCT01561976|528581360|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
146565175|NCT01977222|528581363|FG000|Overall Study|Withdrawal by Subject|1|||
146565176|NCT04165824|528581364|FG000|Overall Study|Adverse Event|23|||
146565177|NCT04165824|528581364|FG000|Overall Study|Physician Decision|1|||
146565178|NCT04165824|528581364|FG000|Overall Study|Withdrawal by Subject|17|||
146565179|NCT04165824|528581364|FG000|Overall Study|Other|5|||
146565180|NCT04403919|528581365|FG000|Overall Study|Lost to Follow-up|0|||
146565181|NCT04403919|528581366|FG001|Overall Study|Lost to Follow-up|0|||
146565182|NCT04403919|528581367|FG002|Overall Study|Lost to Follow-up|0|||
146565183|NCT04403919|528581368|FG003|Overall Study|Lost to Follow-up|1|||
146565184|NCT01612676|528581369|FG000|Overall Study|Adverse Event|2|||
146565185|NCT01612676|528581370|FG001|Overall Study|Adverse Event|3|||
146565186|NCT01612676|528581371|FG002|Overall Study|Adverse Event|1|||
146565187|NCT01612676|528581372|FG003|Overall Study|Adverse Event|3|||
146565188|NCT01612676|528581369|FG000|Overall Study|Protocol Violation|0|||
146565189|NCT01612676|528581370|FG001|Overall Study|Protocol Violation|1|||
146565190|NCT01612676|528581371|FG002|Overall Study|Protocol Violation|0|||
146565191|NCT01612676|528581372|FG003|Overall Study|Protocol Violation|0|||
146565192|NCT04846231|528581379|FG000|Overall Study|Lost to Follow-up|1|||
146565193|NCT04846231|528581380|FG001|Overall Study|Lost to Follow-up|0|||
146565194|NCT04846231|528581381|FG002|Overall Study|Lost to Follow-up|0|||
146565195|NCT04846231|528581382|FG003|Overall Study|Lost to Follow-up|0|||
146565196|NCT04846231|528581383|FG004|Overall Study|Lost to Follow-up|0|||
146565197|NCT04846231|528581384|FG005|Overall Study|Lost to Follow-up|0|||
146565198|NCT04846231|528581385|FG006|Overall Study|Lost to Follow-up|0|||
146565199|NCT04846231|528581386|FG007|Overall Study|Lost to Follow-up|1|||
146565200|NCT04846231|528581379|FG000|Overall Study|Withdrawal by Subject|0|||
146565201|NCT04846231|528581380|FG001|Overall Study|Withdrawal by Subject|1|||
146565202|NCT04846231|528581381|FG002|Overall Study|Withdrawal by Subject|2|||
146565203|NCT04846231|528581382|FG003|Overall Study|Withdrawal by Subject|1|||
146565204|NCT04846231|528581383|FG004|Overall Study|Withdrawal by Subject|0|||
146565205|NCT04846231|528581384|FG005|Overall Study|Withdrawal by Subject|0|||
146565206|NCT04846231|528581385|FG006|Overall Study|Withdrawal by Subject|0|||
146768952|NCT04707313|529321803|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
146565207|NCT04846231|528581386|FG007|Overall Study|Withdrawal by Subject|0|||
146565208|NCT04846231|528581379|FG000|Overall Study|Protocol Violation|0|||
146565209|NCT04846231|528581380|FG001|Overall Study|Protocol Violation|1|||
146565210|NCT04846231|528581381|FG002|Overall Study|Protocol Violation|0|||
146565211|NCT04846231|528581382|FG003|Overall Study|Protocol Violation|0|||
146565212|NCT04846231|528581383|FG004|Overall Study|Protocol Violation|0|||
146565213|NCT04846231|528581384|FG005|Overall Study|Protocol Violation|0|||
146565214|NCT04846231|528581385|FG006|Overall Study|Protocol Violation|0|||
146565215|NCT04846231|528581386|FG007|Overall Study|Protocol Violation|0|||
146565216|NCT04846231|528581379|FG000|Overall Study|Adverse Event|0|||
146565217|NCT04846231|528581380|FG001|Overall Study|Adverse Event|0|||
146497203|NCT02714595|528324611|FG000|Overall Study|Withdrawal by Subject|1|||
146497204|NCT02714595|528324612|FG001|Overall Study|Withdrawal by Subject|2|||
146497205|NCT02714595|528324611|FG000|Overall Study|Lack of Efficacy|0|||
146497206|NCT02714595|528324612|FG001|Overall Study|Lack of Efficacy|1|||
146497207|NCT02714595|528324611|FG000|Overall Study|Death|30|||
146497208|NCT02714595|528324612|FG001|Overall Study|Death|9|||
146497209|NCT02714595|528324611|FG000|Overall Study|Other-Miscellaneous|0|||
146497210|NCT02714595|528324612|FG001|Overall Study|Other-Miscellaneous|1|||
146497211|NCT02257489|528324617|FG000|Overall Study|Withdrawal by Subject|0|||
146497212|NCT02257489|528324618|FG001|Overall Study|Withdrawal by Subject|0|||
146497213|NCT02257489|528324619|FG002|Overall Study|Withdrawal by Subject|0|||
146497214|NCT02257489|528324620|FG003|Overall Study|Withdrawal by Subject|1|||
146497215|NCT02257489|528324621|FG004|Overall Study|Withdrawal by Subject|0|||
146497216|NCT02257489|528324622|FG005|Overall Study|Withdrawal by Subject|0|||
146497217|NCT02257489|528324623|FG006|Overall Study|Withdrawal by Subject|0|||
146497218|NCT02257489|528324624|FG007|Overall Study|Withdrawal by Subject|0|||
146497219|NCT02257489|528324625|FG008|Overall Study|Withdrawal by Subject|0|||
146497220|NCT04606394|528324626|FG000|Overall Study|Withdrawal by Subject|3|||
146497221|NCT04606394|528324626|FG000|Overall Study|Exclusion criteria screen failure|12|||
146497222|NCT01896128|528324627|FG000|Overall Study|Withdrawal by Subject|3|||
146497223|NCT01896128|528324628|FG001|Overall Study|Withdrawal by Subject|3|||
146497224|NCT00955955|528324629|FG000|Overall Study|Lost to Follow-up|2|||
146497225|NCT00955955|528324630|FG001|Overall Study|Lost to Follow-up|0|||
146497226|NCT00955955|528324631|FG002|Overall Study|Lost to Follow-up|0|||
146497227|NCT01996254|528324633|FG000|Overall Study|Change in Eligibility|0|||
146497228|NCT01996254|528324634|FG001|Overall Study|Change in Eligibility|2|||
146497229|NCT01996254|528324635|FG002|Overall Study|Change in Eligibility|0|||
146497230|NCT01996254|528324633|FG000|Overall Study|Withdrawal by Subject|0|||
146497231|NCT01996254|528324634|FG001|Overall Study|Withdrawal by Subject|3|||
146497232|NCT01996254|528324635|FG002|Overall Study|Withdrawal by Subject|4|||
146497233|NCT01996254|528324633|FG000|Overall Study|Lost to Follow-up|1|||
146497234|NCT01996254|528324634|FG001|Overall Study|Lost to Follow-up|0|||
146497235|NCT01996254|528324635|FG002|Overall Study|Lost to Follow-up|4|||
146497236|NCT03423173|528324636|FG000|Overall Study|Randomized but not vaccinated|1|||
146497237|NCT03423173|528324637|FG001|Overall Study|Randomized but not vaccinated|0|||
146497238|NCT03423173|528324638|FG002|Overall Study|Randomized but not vaccinated|2|||
146497239|NCT03423173|528324639|FG003|Overall Study|Randomized but not vaccinated|1|||
146497240|NCT03423173|528324636|FG000|Overall Study|Adverse Event|1|||
146497241|NCT03423173|528324637|FG001|Overall Study|Adverse Event|1|||
146497242|NCT03423173|528324638|FG002|Overall Study|Adverse Event|1|||
146497243|NCT03423173|528324639|FG003|Overall Study|Adverse Event|1|||
146497244|NCT03423173|528324636|FG000|Overall Study|Lost to Follow-up|10|||
146497245|NCT03423173|528324637|FG001|Overall Study|Lost to Follow-up|19|||
146497246|NCT03423173|528324638|FG002|Overall Study|Lost to Follow-up|17|||
146497247|NCT03423173|528324639|FG003|Overall Study|Lost to Follow-up|22|||
146497248|NCT03423173|528324636|FG000|Overall Study|Withdrawal of consent|4|||
146497249|NCT03423173|528324637|FG001|Overall Study|Withdrawal of consent|10|||
146497250|NCT03423173|528324638|FG002|Overall Study|Withdrawal of consent|4|||
146497251|NCT03423173|528324639|FG003|Overall Study|Withdrawal of consent|5|||
146497252|NCT03423173|528324636|FG000|Overall Study|Death|1|||
146497253|NCT03423173|528324637|FG001|Overall Study|Death|0|||
146497254|NCT03423173|528324638|FG002|Overall Study|Death|0|||
146497255|NCT03423173|528324639|FG003|Overall Study|Death|0|||
146497256|NCT03423173|528324636|FG000|Overall Study|Reason not Specified|2|||
146497257|NCT03423173|528324637|FG001|Overall Study|Reason not Specified|5|||
146497258|NCT03423173|528324638|FG002|Overall Study|Reason not Specified|3|||
146497259|NCT03423173|528324639|FG003|Overall Study|Reason not Specified|1|||
146497260|NCT03348930|528324640|FG000|Washout (1 Week)|Lost to Follow-up|1|||
146497261|NCT03348930|528324641|FG001|Washout (1 Week)|Lost to Follow-up|1|||
146497262|NCT03533114|528324642|FG000|Overall|Adverse Event|16|||
146497263|NCT03533114|528324643|FG001|Overall|Adverse Event|11|||
146497264|NCT03533114|528324642|FG000|Overall|Consent Withdrawal by Participant|7|||
146497265|NCT03533114|528324643|FG001|Overall|Consent Withdrawal by Participant|6|||
146497266|NCT03533114|528324642|FG000|Overall|Lack of Efficacy|5|||
146497267|NCT03533114|528324643|FG001|Overall|Lack of Efficacy|3|||
146497268|NCT03533114|528324642|FG000|Overall|Lost to Follow-up|1|||
146497269|NCT03533114|528324643|FG001|Overall|Lost to Follow-up|1|||
146497270|NCT03533114|528324642|FG000|Overall|Physician Decision|0|||
146497271|NCT03533114|528324643|FG001|Overall|Physician Decision|2|||
146497272|NCT03533114|528324642|FG000|Overall|Protocol deviation|1|||
146565218|NCT04846231|528581381|FG002|Overall Study|Adverse Event|0|||
146565219|NCT04846231|528581382|FG003|Overall Study|Adverse Event|0|||
146497273|NCT03533114|528324643|FG001|Overall|Protocol deviation|1|||
146497274|NCT03533114|528324642|FG000|Overall|Failure to meet randomization criteria|1|||
146497275|NCT03533114|528324643|FG001|Overall|Failure to meet randomization criteria|2|||
146497276|NCT03533114|528324642|FG000|Overall|Non-Compliance with study drug|0|||
146497277|NCT03533114|528324643|FG001|Overall|Non-Compliance with study drug|1|||
146565220|NCT04846231|528581383|FG004|Overall Study|Adverse Event|0|||
146644888|NCT01090323|528877591|FG001|Overall Study|Administrative problems|4|||
146644889|NCT01090323|528877590|FG000|Overall Study|Death|1|||
146644890|NCT01090323|528877591|FG001|Overall Study|Death|2|||
146644891|NCT01090323|528877590|FG000|Overall Study|Stopped end of core|7|||
146644892|NCT01090323|528877591|FG001|Overall Study|Stopped end of core|0|||
146644893|NCT01090323|528877590|FG000|Overall Study|Stopped end of extension 1#|3|||
146644894|NCT01090323|528877591|FG001|Overall Study|Stopped end of extension 1#|1|||
146644895|NCT05498701|528877592|FG000|Period 3|Adverse Event|1|||
146644896|NCT05498701|528877593|FG001|Period 3|Adverse Event|0|||
146644897|NCT01864005|528877594|FG000|Overall Study|Protocol Violation|0|||
146644898|NCT01864005|528877595|FG001|Overall Study|Protocol Violation|1|||
146644899|NCT01864005|528877594|FG000|Overall Study|Withdrawal by Subject|0|||
146644900|NCT01864005|528877595|FG001|Overall Study|Withdrawal by Subject|1|||
146644901|NCT01864005|528877594|FG000|Overall Study|Incorrect enrolment|1|||
146644902|NCT01864005|528877595|FG001|Overall Study|Incorrect enrolment|0|||
146644903|NCT01864005|528877594|FG000|Overall Study|Disease need|1|||
146644904|NCT01864005|528877595|FG001|Overall Study|Disease need|1|||
146644905|NCT01864005|528877594|FG000|Overall Study|Need GP IIb/IIIa|1|||
146644906|NCT01864005|528877595|FG001|Overall Study|Need GP IIb/IIIa|3|||
146644907|NCT00763698|528877601|FG000|Overall Study|Unsuccessful Implant|5|||
146644908|NCT00763698|528877601|FG000|Overall Study|Death|4|||
146644909|NCT00763698|528877601|FG000|Overall Study|Withdrawal by Subject|1|||
146644910|NCT02184572|528877602|FG000|Overall Study|Lost to Follow-up|29|||
146644911|NCT02184572|528877603|FG001|Overall Study|Lost to Follow-up|21|||
146644912|NCT02184572|528877602|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
146768953|NCT02459899|529321804|FG000|Overall Study|Adverse Event|1|||
146768954|NCT02459899|529321805|FG001|Overall Study|Adverse Event|1|||
146768955|NCT02459899|529321806|FG002|Overall Study|Adverse Event|0|||
146768956|NCT02459899|529321807|FG003|Overall Study|Adverse Event|0|||
146768957|NCT02459899|529321804|FG000|Overall Study|Lost to Follow-up|1|||
146768958|NCT02459899|529321805|FG001|Overall Study|Lost to Follow-up|2|||
146768959|NCT02459899|529321806|FG002|Overall Study|Lost to Follow-up|0|||
146768960|NCT02459899|529321807|FG003|Overall Study|Lost to Follow-up|1|||
146768961|NCT02459899|529321804|FG000|Overall Study|Non-compliance with the treatment|0|||
146768962|NCT02459899|529321805|FG001|Overall Study|Non-compliance with the treatment|0|||
146768963|NCT02459899|529321806|FG002|Overall Study|Non-compliance with the treatment|0|||
146768964|NCT02459899|529321807|FG003|Overall Study|Non-compliance with the treatment|1|||
146768965|NCT02459899|529321804|FG000|Overall Study|Withdrawal by Subject|1|||
146768966|NCT02459899|529321805|FG001|Overall Study|Withdrawal by Subject|3|||
146768967|NCT02459899|529321806|FG002|Overall Study|Withdrawal by Subject|0|||
146768968|NCT02459899|529321807|FG003|Overall Study|Withdrawal by Subject|0|||
146768969|NCT00539292|529321809|FG000|Overall Study|Physician Decision|1|||
146768970|NCT00539292|529321810|FG001|Overall Study|Physician Decision|0|||
146768971|NCT02020616|529321814|FG000|Overall Study|Adverse Event|0|||
146768972|NCT02020616|529321815|FG001|Overall Study|Adverse Event|0|||
146768973|NCT02020616|529321816|FG002|Overall Study|Adverse Event|0|||
146768974|NCT02020616|529321817|FG003|Overall Study|Adverse Event|0|||
146768975|NCT02020616|529321818|FG004|Overall Study|Adverse Event|0|||
146768976|NCT02020616|529321819|FG005|Overall Study|Adverse Event|1|||
146768977|NCT02020616|529321820|FG006|Overall Study|Adverse Event|1|||
146768978|NCT02020616|529321814|FG000|Overall Study|Physician Decision|0|||
146768979|NCT02020616|529321815|FG001|Overall Study|Physician Decision|0|||
146768980|NCT02020616|529321816|FG002|Overall Study|Physician Decision|0|||
146768981|NCT02020616|529321817|FG003|Overall Study|Physician Decision|0|||
146768982|NCT02020616|529321818|FG004|Overall Study|Physician Decision|0|||
146768983|NCT02020616|529321819|FG005|Overall Study|Physician Decision|1|||
146768984|NCT02020616|529321820|FG006|Overall Study|Physician Decision|2|||
146975338|NCT00572156|530073541|FG002|Overall Study|Patient/Parent Decision|4|||
146644913|NCT02184572|528877603|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
146644914|NCT02184572|528877602|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
146644915|NCT02184572|528877603|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
146644916|NCT02184572|528877602|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
146644917|NCT02184572|528877603|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
146644918|NCT02184572|528877602|FG000|Overall Study|Traveling Outside The Country|1|||
146644919|NCT02184572|528877603|FG001|Overall Study|Traveling Outside The Country|0|||
146644920|NCT02184572|528877602|FG000|Overall Study|Withdrawal by Subject|14|||
146768985|NCT02020616|529321814|FG000|Overall Study|Withdrawal by Subject|0|||
146768986|NCT02020616|529321815|FG001|Overall Study|Withdrawal by Subject|0|||
146768987|NCT02020616|529321816|FG002|Overall Study|Withdrawal by Subject|1|||
146768988|NCT02020616|529321817|FG003|Overall Study|Withdrawal by Subject|0|||
146768989|NCT02020616|529321818|FG004|Overall Study|Withdrawal by Subject|0|||
146768990|NCT02020616|529321819|FG005|Overall Study|Withdrawal by Subject|1|||
146644921|NCT02184572|528877603|FG001|Overall Study|Withdrawal by Subject|9|||
146644922|NCT00006409|528877607|FG000|Baseline|Protocol Violation|48|||
146644923|NCT00006409|528877608|FG001|Baseline|Protocol Violation|70|||
146644924|NCT00006409|528877609|FG002|Baseline|Protocol Violation|0|||
146644925|NCT00006409|528877610|FG003|Baseline|Protocol Violation|0|||
146768991|NCT02020616|529321820|FG006|Overall Study|Withdrawal by Subject|1|||
146644926|NCT00006409|528877611|FG004|Baseline|Protocol Violation|0|||
146644927|NCT00006409|528877612|FG005|Baseline|Protocol Violation|0|||
146644928|NCT00006409|528877607|FG000|Post-2 Year Intervention|Protocol Violation|0|||
146644929|NCT00006409|528877608|FG001|Post-2 Year Intervention|Protocol Violation|0|||
146644930|NCT00006409|528877609|FG002|Post-2 Year Intervention|Protocol Violation|251|||
146565221|NCT04846231|528581384|FG005|Overall Study|Adverse Event|0|||
146565222|NCT04846231|528581385|FG006|Overall Study|Adverse Event|1|||
146565223|NCT04846231|528581386|FG007|Overall Study|Adverse Event|1|||
146565224|NCT02980107|528581387|FG000|Overall Study|Withdrawal by Subject|51|||
146565225|NCT02980107|528581388|FG001|Overall Study|Withdrawal by Subject|62|||
146565226|NCT04064905|528581391|FG000|Overall Study|Lost to Follow-up|0|||
146565227|NCT04064905|528581392|FG001|Overall Study|Lost to Follow-up|3|||
146565228|NCT04064905|528581393|FG002|Overall Study|Lost to Follow-up|1|||
146565229|NCT04064905|528581394|FG003|Overall Study|Lost to Follow-up|4|||
146565230|NCT04064905|528581395|FG004|Overall Study|Lost to Follow-up|2|||
146565231|NCT01038323|528581399|FG000|Overall Study|Withdrawal by Subject|3|||
146565232|NCT01038323|528581400|FG001|Overall Study|Withdrawal by Subject|2|||
146565233|NCT01038323|528581401|FG002|Overall Study|Withdrawal by Subject|4|||
146565234|NCT00789555|528581402|FG000|Overall Study|Protocol Amendment|78|||
146565235|NCT00789555|528581403|FG001|Overall Study|Protocol Amendment|76|||
146565236|NCT00789555|528581404|FG002|Overall Study|Protocol Amendment|80|||
146565237|NCT00789555|528581402|FG000|Overall Study|Adverse Event|17|||
146565238|NCT00789555|528581403|FG001|Overall Study|Adverse Event|7|||
146565239|NCT00789555|528581404|FG002|Overall Study|Adverse Event|10|||
146565240|NCT00789555|528581402|FG000|Overall Study|Lost to Follow-up|9|||
146565241|NCT00789555|528581403|FG001|Overall Study|Lost to Follow-up|10|||
146565242|NCT00789555|528581404|FG002|Overall Study|Lost to Follow-up|18|||
146565243|NCT00789555|528581402|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
146565244|NCT00789555|528581403|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
146565245|NCT00789555|528581404|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
146565246|NCT00789555|528581402|FG000|Overall Study|Treatment failure|11|||
146565247|NCT00789555|528581403|FG001|Overall Study|Treatment failure|8|||
146565248|NCT00789555|528581404|FG002|Overall Study|Treatment failure|12|||
146565249|NCT00789555|528581402|FG000|Overall Study|Protocol Violation|6|||
146565250|NCT00789555|528581403|FG001|Overall Study|Protocol Violation|9|||
146565251|NCT00789555|528581404|FG002|Overall Study|Protocol Violation|13|||
146565252|NCT00698841|528581405|FG000|Overall Study|Withdrawal by Subject|2|||
146565253|NCT00698841|528581405|FG000|Overall Study|Adverse Event|3|||
146565254|NCT00698841|528581405|FG000|Overall Study|Disease progression|7|||
146565255|NCT00698841|528581405|FG000|Overall Study|Failure to meet eligibility criteria|2|||
146565256|NCT00698841|528581405|FG000|Overall Study|Study drug toxicity|2|||
146565257|NCT00698841|528581405|FG000|Overall Study|Other|2|||
146565258|NCT00404248|528581406|FG000|Overall Study|pts declining status|0|||
146565259|NCT00404248|528581407|FG001|Overall Study|pts declining status|1|||
146565260|NCT00404248|528581408|FG002|Overall Study|pts declining status|0|||
146565261|NCT00404248|528581409|FG003|Overall Study|pts declining status|0|||
146565262|NCT00404248|528581410|FG004|Overall Study|pts declining status|0|||
146565263|NCT00404248|528581411|FG005|Overall Study|pts declining status|0|||
146565264|NCT00404248|528581412|FG006|Overall Study|pts declining status|0|||
146565265|NCT00404248|528581413|FG007|Overall Study|pts declining status|0|||
146565266|NCT00404248|528581414|FG008|Overall Study|pts declining status|0|||
146565267|NCT04646005|528581415|FG000|Overall Study|Adverse Event|1|||
146565268|NCT04646005|528581415|FG000|Overall Study|Progressive Disease|71|||
146565269|NCT04646005|528581415|FG000|Overall Study|Death|20|||
146565270|NCT04646005|528581415|FG000|Overall Study|Withdrawal by Subject|12|||
146565271|NCT04646005|528581415|FG000|Overall Study|Sponsor Request|9|||
146565272|NCT01576783|528582498|FG000|Overall Study|Change in Medical Care|1|||
146565273|NCT01576783|528582499|FG001|Overall Study|Change in Medical Care|0|||
146565274|NCT01576783|528582498|FG000|Overall Study|Lost to Follow-up|14|||
146565275|NCT01576783|528582499|FG001|Overall Study|Lost to Follow-up|16|||
146565276|NCT01576783|528582498|FG000|Overall Study|Withdrawal by Subject|5|||
146565277|NCT01576783|528582499|FG001|Overall Study|Withdrawal by Subject|1|||
146565278|NCT01732536|528582502|FG000|Overall Study|Withdrawal by Subject|1|||
146565279|NCT01732536|528582503|FG001|Overall Study|Withdrawal by Subject|1|||
146565280|NCT05111145|528582506|FG000|Overall Study|Commercial drug is available for participant|76|||
146565281|NCT05111145|528582506|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
146565282|NCT01276704|528582509|FG000|Overall Study|Lost to Follow-up|2|||
146565283|NCT01276704|528582510|FG001|Overall Study|Lost to Follow-up|3|||
146565284|NCT01276704|528582509|FG000|Overall Study|Non-compliant|2|||
146565285|NCT01276704|528582510|FG001|Overall Study|Non-compliant|2|||
146565286|NCT01276704|528582509|FG000|Overall Study|Withdrawal by Subject|7|||
146565287|NCT01276704|528582510|FG001|Overall Study|Withdrawal by Subject|1|||
146644931|NCT00006409|528877610|FG003|Post-2 Year Intervention|Protocol Violation|168|||
146644932|NCT00006409|528877611|FG004|Post-2 Year Intervention|Protocol Violation|0|||
146565288|NCT01276704|528582509|FG000|Overall Study|Physician Decision|3|||
146565289|NCT01276704|528582510|FG001|Overall Study|Physician Decision|5|||
146565290|NCT01359956|528582511|FG000|Overall Study|Death|58|||
146644933|NCT00006409|528877612|FG005|Post-2 Year Intervention|Protocol Violation|0|||
146644934|NCT00006409|528877607|FG000|Post-3 Year Intervention|Protocol Violation|0|||
146644935|NCT00006409|528877608|FG001|Post-3 Year Intervention|Protocol Violation|0|||
146644936|NCT00006409|528877609|FG002|Post-3 Year Intervention|Protocol Violation|0|||
146644937|NCT00006409|528877610|FG003|Post-3 Year Intervention|Protocol Violation|0|||
146644938|NCT00006409|528877611|FG004|Post-3 Year Intervention|Protocol Violation|62|||
146644939|NCT00006409|528877612|FG005|Post-3 Year Intervention|Protocol Violation|62|||
146644940|NCT00638183|528877613|FG000|Overall Study|Adverse Event|23|||
146644941|NCT00638183|528877613|FG000|Overall Study|Lack of Efficacy|14|||
146644942|NCT00638183|528877613|FG000|Overall Study|Physician Decision|9|||
146644943|NCT00638183|528877613|FG000|Overall Study|Lost to Follow-up|46|||
146644944|NCT00638183|528877613|FG000|Overall Study|Other reason not defined above|27|||
146644945|NCT01433289|528877614|FG000|Overall Study|Pregnancy|0|||
146644946|NCT01433289|528877615|FG001|Overall Study|Pregnancy|1|||
146644947|NCT01433289|528877616|FG002|Overall Study|Pregnancy|0|||
146644948|NCT01433289|528877617|FG003|Overall Study|Pregnancy|0|||
146644949|NCT04973436|528877621|FG000|Overall Study|Lost to Follow-up|3|||
146644950|NCT04973436|528877621|FG000|Overall Study|Withdrawal by Subject|1|||
146644951|NCT04973436|528877621|FG000|Overall Study|Death|2|||
146644952|NCT01788215|528877625|FG000|Overall Study|Withdrawal by Subject|0|||
146644953|NCT01788215|528877626|FG001|Overall Study|Withdrawal by Subject|1|||
146644954|NCT01788215|528877625|FG000|Overall Study|Lost to Follow-up|2|||
146644955|NCT01788215|528877626|FG001|Overall Study|Lost to Follow-up|0|||
146644956|NCT02365480|528877631|FG000|Overall Study|Withdrawal by Subject|2|||
146644957|NCT02365480|528877632|FG001|Overall Study|Withdrawal by Subject|0|||
146644958|NCT03091348|528877633|FG000|Overall Study|Lost to Follow-up|2|||
146644959|NCT03091348|528877634|FG001|Overall Study|Lost to Follow-up|1|||
146644960|NCT00706342|528877635|FG000|Overall Study|Adverse Event|3|||
146644961|NCT00706342|528877635|FG000|Overall Study|Not responding to treatment|2|||
146644962|NCT00706342|528877635|FG000|Overall Study|Withdrawn due to failure to respond|1|||
146644963|NCT00706342|528877635|FG000|Overall Study|Death|1|||
146644964|NCT00706342|528877635|FG000|Overall Study|Withdrew from the study on his own.|1|||
146644965|NCT00706342|528877635|FG000|Overall Study|Investigator discretion|2|||
146644966|NCT00706342|528877635|FG000|Overall Study|Non-responder Week 12|1|||
146644967|NCT00706342|528877635|FG000|Overall Study|Ongoing|6|||
146644968|NCT00706342|528877635|FG000|Overall Study|WIthdrawal of consent|1|||
146644969|NCT04534686|528877636|FG000|Baseline Measurement|Lost to Follow-up|4|||
146644970|NCT04534686|528877637|FG001|Baseline Measurement|Lost to Follow-up|6|||
146644971|NCT04534686|528877636|FG000|Baseline Measurement|Withdrawal by Subject|3|||
146644972|NCT04534686|528877637|FG001|Baseline Measurement|Withdrawal by Subject|1|||
146644973|NCT04534686|528877636|FG000|Intervention|Withdrawal by Subject|2|||
146644974|NCT04534686|528877637|FG001|Intervention|Withdrawal by Subject|2|||
146644975|NCT01419197|528877642|FG000|Overall Study|Death|247|||
146644976|NCT01419197|528877643|FG001|Overall Study|Death|122|||
146644977|NCT01419197|528877642|FG000|Overall Study|Physician Decision|4|||
146644978|NCT01419197|528877643|FG001|Overall Study|Physician Decision|4|||
146644979|NCT01419197|528877642|FG000|Overall Study|Non-compliance|3|||
146644980|NCT01419197|528877643|FG001|Overall Study|Non-compliance|1|||
146644981|NCT01419197|528877642|FG000|Overall Study|Withdrawal by Subject|33|||
146644982|NCT01419197|528877643|FG001|Overall Study|Withdrawal by Subject|32|||
146644983|NCT01419197|528877642|FG000|Overall Study|Study Completed by Sponsor|103|||
146644984|NCT01419197|528877643|FG001|Overall Study|Study Completed by Sponsor|34|||
146497278|NCT03533114|528324642|FG000|Overall|Other|0|||
146497279|NCT03533114|528324643|FG001|Overall|Other|1|||
146497280|NCT03533114|528324642|FG000|Open Label Titration and Optimization|Adverse Event|11|||
146497281|NCT03533114|528324643|FG001|Open Label Titration and Optimization|Adverse Event|8|||
146497282|NCT03533114|528324642|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
146497283|NCT03533114|528324643|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
146497284|NCT03533114|528324642|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
146497285|NCT03533114|528324643|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
146497286|NCT03533114|528324642|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
146497287|NCT03533114|528324643|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
146497288|NCT03533114|528324642|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
146497289|NCT03533114|528324643|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
146497290|NCT03533114|528324642|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
146497291|NCT03533114|528324643|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
146497292|NCT03533114|528324642|FG000|Stable Dose|Adverse Event|0|||
146497293|NCT03533114|528324643|FG001|Stable Dose|Adverse Event|2|||
146497294|NCT03533114|528324642|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
146497295|NCT03533114|528324643|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
146644985|NCT01419197|528877642|FG000|Overall Study|Reason Not Specified|0|||
146644986|NCT01419197|528877643|FG001|Overall Study|Reason Not Specified|1|||
146644987|NCT01419197|528877642|FG000|Overall Study|Lost to Follow-up|14|||
146497296|NCT03533114|528324642|FG000|Stable Dose|Lack of Efficacy|1|||
146497297|NCT03533114|528324643|FG001|Stable Dose|Lack of Efficacy|0|||
146497298|NCT03533114|528324642|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
146497299|NCT03533114|528324643|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
146497300|NCT03533114|528324642|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
146644988|NCT01419197|528877643|FG001|Overall Study|Lost to Follow-up|4|||
146497301|NCT03533114|528324643|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
146497302|NCT03533114|528324642|FG000|Open-Label Safety Extension|Adverse Event|3|||
146497303|NCT03533114|528324643|FG001|Open-Label Safety Extension|Adverse Event|0|||
146497304|NCT03533114|528324642|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
146497305|NCT03533114|528324643|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
146497306|NCT03533114|528324642|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
146497307|NCT03533114|528324643|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
146497308|NCT03533114|528324642|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
146497309|NCT03533114|528324643|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
146497310|NCT03533114|528324642|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
146497311|NCT03533114|528324643|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
146497312|NCT01028014|528324647|FG000|Overall Study|Lost to Follow-up|1|||
146497313|NCT01028014|528324648|FG001|Overall Study|Lost to Follow-up|2|||
146644989|NCT01781299|528877644|FG000|Overall Study|Withdrawal by Subject|0|||
146644990|NCT01781299|528877645|FG001|Overall Study|Withdrawal by Subject|1|||
146644991|NCT00146848|528877649|FG000|Pre-randomization|Death|19|||
146644992|NCT00146848|528877650|FG001|Pre-randomization|Death|0|||
146644993|NCT00146848|528877651|FG002|Pre-randomization|Death|0|||
146644994|NCT00146848|528877649|FG000|Pre-randomization|Lost to Follow-up|70|||
146644995|NCT00146848|528877650|FG001|Pre-randomization|Lost to Follow-up|0|||
146644996|NCT00146848|528877651|FG002|Pre-randomization|Lost to Follow-up|0|||
146644997|NCT00146848|528877649|FG000|Pre-randomization|Physician Decision|8|||
146644998|NCT00146848|528877650|FG001|Pre-randomization|Physician Decision|0|||
146644999|NCT00146848|528877651|FG002|Pre-randomization|Physician Decision|0|||
146645000|NCT00146848|528877649|FG000|Pre-randomization|Protocol Violation|172|||
146645001|NCT00146848|528877650|FG001|Pre-randomization|Protocol Violation|0|||
146645002|NCT00146848|528877651|FG002|Pre-randomization|Protocol Violation|0|||
146645003|NCT00146848|528877649|FG000|Pre-randomization|Withdrawal by Subject|40|||
146645004|NCT00146848|528877650|FG001|Pre-randomization|Withdrawal by Subject|0|||
146645005|NCT00146848|528877651|FG002|Pre-randomization|Withdrawal by Subject|0|||
146645006|NCT00146848|528877649|FG000|Post-randomization|Lost to Follow-up|12|||
146645007|NCT00146848|528877650|FG001|Post-randomization|Lost to Follow-up|15|||
146645008|NCT00146848|528877651|FG002|Post-randomization|Lost to Follow-up|12|||
146645009|NCT00146848|528877649|FG000|Post-randomization|Withdrawn|26|||
146645010|NCT00146848|528877650|FG001|Post-randomization|Withdrawn|32|||
146645011|NCT00146848|528877651|FG002|Post-randomization|Withdrawn|27|||
146645012|NCT00119678|528877654|FG000|Double-blind Treatment Period|Death|1|||
146645013|NCT00119678|528877655|FG001|Double-blind Treatment Period|Death|0|||
146645014|NCT00119678|528877654|FG000|Double-blind Treatment Period|Adverse Event|7|||
146645015|NCT00119678|528877655|FG001|Double-blind Treatment Period|Adverse Event|1|||
146645016|NCT00119678|528877654|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
146645017|NCT00119678|528877655|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
146645018|NCT00119678|528877654|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
146645019|NCT00119678|528877655|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
146645020|NCT00119678|528877654|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
146645021|NCT00119678|528877655|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
146645022|NCT00119678|528877654|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
146645023|NCT00119678|528877655|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
146645024|NCT00119678|528877654|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
146645025|NCT00119678|528877655|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
146645026|NCT00119678|528877654|FG000|Double-blind Treatment Period|Pregnancy|0|||
146645027|NCT00119678|528877655|FG001|Double-blind Treatment Period|Pregnancy|2|||
146645028|NCT00119678|528877654|FG000|Double-blind Treatment Period|Not treated|1|||
146645029|NCT00119678|528877655|FG001|Double-blind Treatment Period|Not treated|2|||
146497314|NCT01028014|528324649|FG002|Overall Study|Lost to Follow-up|0|||
146497315|NCT01028014|528324650|FG003|Overall Study|Lost to Follow-up|1|||
146645030|NCT00119678|528877654|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
146645031|NCT00119678|528877655|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
146645032|NCT00119678|528877654|FG000|Open-label Treatment Period|Death|1|||
146645033|NCT00119678|528877655|FG001|Open-label Treatment Period|Death|0|||
146645034|NCT00119678|528877654|FG000|Open-label Treatment Period|Adverse Event|3|||
146645035|NCT00119678|528877655|FG001|Open-label Treatment Period|Adverse Event|0|||
146645036|NCT00119678|528877654|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
146645037|NCT00119678|528877655|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
146645038|NCT00119678|528877654|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
146645039|NCT00119678|528877655|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
146497316|NCT01028014|528324651|FG004|Overall Study|Lost to Follow-up|1|||
146497317|NCT01028014|528324652|FG005|Overall Study|Lost to Follow-up|2|||
146768992|NCT02020616|529321814|FG000|Overall Study|Lost to Follow-up|0|||
146497318|NCT02411396|528324653|FG000|Overall Study|Lost to Follow-up|31|||
146497319|NCT02411396|528324653|FG000|Overall Study|Death|10|||
146912091|NCT01013883|529841414|FG001|Overall Study|Lost to Follow-up|2|||
146912092|NCT01371838|529841415|FG000|Overall Study|Withdrawal by Subject|27|||
146912093|NCT01371838|529841416|FG001|Overall Study|Withdrawal by Subject|33|||
146912094|NCT01371838|529841415|FG000|Overall Study|Lost to Follow-up|10|||
146912095|NCT01371838|529841416|FG001|Overall Study|Lost to Follow-up|20|||
146912096|NCT01371838|529841415|FG000|Overall Study|Death|3|||
146912097|NCT01371838|529841416|FG001|Overall Study|Death|4|||
146912098|NCT01371838|529841415|FG000|Overall Study|Protocol Violation|3|||
146912099|NCT01371838|529841416|FG001|Overall Study|Protocol Violation|0|||
146912100|NCT01371838|529841415|FG000|Overall Study|Investigator Decision|3|||
146912101|NCT01371838|529841416|FG001|Overall Study|Investigator Decision|8|||
146912102|NCT01371838|529841415|FG000|Overall Study|Last follow-up visit not conducted|2|||
146912103|NCT01371838|529841416|FG001|Overall Study|Last follow-up visit not conducted|0|||
146912104|NCT01371838|529841415|FG000|Overall Study|Lack of therapeutic response|0|||
146912105|NCT01371838|529841416|FG001|Overall Study|Lack of therapeutic response|1|||
146912106|NCT01371838|529841415|FG000|Overall Study|Surgery|1|||
146912107|NCT01371838|529841416|FG001|Overall Study|Surgery|0|||
146912108|NCT00641043|529841423|FG000|Overall Study|Adverse Event|6|||
146912109|NCT00641043|529841424|FG001|Overall Study|Adverse Event|4|||
146912110|NCT00641043|529841423|FG000|Overall Study|Protocol Violation|2|||
146912111|NCT00641043|529841424|FG001|Overall Study|Protocol Violation|3|||
146912112|NCT00641043|529841423|FG000|Overall Study|Lost to Follow-up|3|||
146912113|NCT00641043|529841424|FG001|Overall Study|Lost to Follow-up|2|||
146497320|NCT02016105|528324660|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
146497321|NCT02016105|528324661|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
146497322|NCT02016105|528324662|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
146497323|NCT02016105|528324663|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
146497324|NCT02016105|528324664|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
146497325|NCT02016105|528324665|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
146497326|NCT02016105|528324660|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
146497327|NCT02016105|528324661|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
146497328|NCT02016105|528324662|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
146497329|NCT02016105|528324663|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
146497330|NCT02016105|528324664|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
146497331|NCT02016105|528324665|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
146497332|NCT02016105|528324660|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
146497333|NCT02016105|528324661|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
146497334|NCT02016105|528324662|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
146497335|NCT02016105|528324663|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
146497336|NCT02016105|528324664|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
146497337|NCT02016105|528324665|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
146497338|NCT02016105|528324660|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
146497339|NCT02016105|528324661|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
146497340|NCT02016105|528324662|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
146497341|NCT02016105|528324663|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
146497342|NCT02016105|528324664|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
146497343|NCT02016105|528324665|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
146497344|NCT02016105|528324660|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
146497345|NCT02016105|528324661|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
146497346|NCT02016105|528324662|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
146497347|NCT02016105|528324663|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
146497348|NCT02016105|528324664|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
146497349|NCT02016105|528324665|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
146497350|NCT02016105|528324660|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
146497351|NCT02016105|528324661|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
146497352|NCT02016105|528324662|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
146497353|NCT02016105|528324663|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
146497354|NCT02016105|528324664|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
146497355|NCT02016105|528324665|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
146497356|NCT02016105|528324660|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
146912114|NCT00641043|529841423|FG000|Overall Study|Withdrawal by Subject|4|||
146912115|NCT00641043|529841424|FG001|Overall Study|Withdrawal by Subject|4|||
146912116|NCT00641043|529841423|FG000|Overall Study|Other incl. lack of efficacy|4|||
146497357|NCT02016105|528324661|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
146497358|NCT02016105|528324662|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
146497359|NCT02016105|528324663|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
146497360|NCT02016105|528324664|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
146497361|NCT02016105|528324665|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
146497362|NCT02016105|528324660|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
146497363|NCT02016105|528324661|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
146497364|NCT02016105|528324662|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
146497365|NCT02016105|528324663|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
146497366|NCT02016105|528324664|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
146497367|NCT02016105|528324665|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
146645040|NCT00119678|528877654|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
146645041|NCT00119678|528877655|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
146645042|NCT00119678|528877654|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
146645043|NCT00119678|528877655|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
146645044|NCT00119678|528877654|FG000|Open-label Treatment Period|Pregnancy|1|||
146645045|NCT00119678|528877655|FG001|Open-label Treatment Period|Pregnancy|0|||
146645046|NCT00119678|528877654|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
146645047|NCT00119678|528877655|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
146645048|NCT03704636|528877656|FG000|Overall Study|Inadequate Venous Flow|3|||
146645049|NCT02720042|528877657|FG000|Overall Study|Death|3|||
146645050|NCT02720042|528877657|FG000|Overall Study|Lost to Follow-up|4|||
146645051|NCT02720042|528877657|FG000|Overall Study|Withdrawal by Subject|1|||
146645052|NCT02720042|528877657|FG000|Overall Study|Physician Decision|3|||
146645053|NCT02720042|528877657|FG000|Overall Study|Phasix Mesh explanted|1|||
146645054|NCT02720042|528877657|FG000|Overall Study|unable due to non-study-related illness|3|||
146645055|NCT01134705|528877662|FG000|Overall Study|Adverse Event|1|||
146645056|NCT01134705|528877663|FG001|Overall Study|Adverse Event|7|||
146645057|NCT01134705|528877662|FG000|Overall Study|Withdrawal by Subject|6|||
146645058|NCT01134705|528877663|FG001|Overall Study|Withdrawal by Subject|6|||
146645059|NCT01134705|528877662|FG000|Overall Study|Pregnancy|1|||
146645060|NCT01134705|528877663|FG001|Overall Study|Pregnancy|0|||
146645061|NCT01134705|528877662|FG000|Overall Study|Lost to Follow-up|5|||
146645062|NCT01134705|528877663|FG001|Overall Study|Lost to Follow-up|2|||
146645063|NCT01134705|528877662|FG000|Overall Study|Protocol Violation|1|||
146645064|NCT01134705|528877663|FG001|Overall Study|Protocol Violation|1|||
146645065|NCT01134705|528877662|FG000|Overall Study|Other|1|||
146645066|NCT01134705|528877663|FG001|Overall Study|Other|6|||
146645067|NCT00509145|528877664|FG000|Overall Study|Death|0|||
146645068|NCT00509145|528877665|FG001|Overall Study|Death|2|||
146645069|NCT00509145|528877664|FG000|Overall Study|Adverse Event|42|||
146645070|NCT00509145|528877665|FG001|Overall Study|Adverse Event|28|||
146645071|NCT00509145|528877664|FG000|Overall Study|Withdrawal by Subject|32|||
146645072|NCT00509145|528877665|FG001|Overall Study|Withdrawal by Subject|38|||
146645073|NCT00509145|528877664|FG000|Overall Study|Physician Decision|11|||
146645074|NCT00509145|528877665|FG001|Overall Study|Physician Decision|14|||
146645075|NCT00509145|528877664|FG000|Overall Study|Protocol Violation|1|||
146645076|NCT00509145|528877665|FG001|Overall Study|Protocol Violation|6|||
146645077|NCT00509145|528877664|FG000|Overall Study|Pregnancy|3|||
146645078|NCT00509145|528877665|FG001|Overall Study|Pregnancy|8|||
146645079|NCT00509145|528877664|FG000|Overall Study|Lost to Follow-up|6|||
146645080|NCT00509145|528877665|FG001|Overall Study|Lost to Follow-up|5|||
146645081|NCT00509145|528877664|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
146645082|NCT00509145|528877665|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
146645083|NCT00509145|528877664|FG000|Overall Study|Other|6|||
146645084|NCT00509145|528877665|FG001|Overall Study|Other|6|||
146645085|NCT00246740|528877666|FG000|Initial Enrollment|Death|1|||
146645086|NCT00246740|528877667|FG001|Initial Enrollment|Death|0|||
146645087|NCT00246740|528877666|FG000|Initial Enrollment|Additional surgery scheduled|0|||
146645088|NCT00246740|528877667|FG001|Initial Enrollment|Additional surgery scheduled|2|||
146645089|NCT00246740|528877666|FG000|Initial Enrollment|Surgery schedule change|4|||
146645090|NCT00246740|528877667|FG001|Initial Enrollment|Surgery schedule change|4|||
146645091|NCT00246740|528877666|FG000|Initial Enrollment|Other|1|||
146645092|NCT00246740|528877667|FG001|Initial Enrollment|Other|2|||
146645093|NCT00101452|528877670|FG000|Overall Study|Adverse Event|2|||
146645094|NCT00101452|528877671|FG001|Overall Study|Adverse Event|0|||
146645095|NCT00101452|528877672|FG002|Overall Study|Adverse Event|1|||
146497368|NCT02016105|528324660|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
146497369|NCT02016105|528324661|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
146497370|NCT02016105|528324662|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
146497371|NCT02016105|528324663|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
146497372|NCT02016105|528324664|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
146497373|NCT02016105|528324665|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
146497374|NCT02016105|528324660|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
146645096|NCT00101452|528877670|FG000|Overall Study|Lost to Follow-up|13|||
146645097|NCT00101452|528877671|FG001|Overall Study|Lost to Follow-up|8|||
146645098|NCT00101452|528877672|FG002|Overall Study|Lost to Follow-up|14|||
146645099|NCT00101452|528877670|FG000|Overall Study|Withdrawal by Subject|10|||
146645100|NCT00101452|528877671|FG001|Overall Study|Withdrawal by Subject|14|||
146645101|NCT00101452|528877672|FG002|Overall Study|Withdrawal by Subject|9|||
146645102|NCT00101452|528877670|FG000|Overall Study|Baseline Fail|2|||
146645103|NCT00101452|528877671|FG001|Overall Study|Baseline Fail|1|||
146645104|NCT00101452|528877672|FG002|Overall Study|Baseline Fail|2|||
146645105|NCT00101452|528877670|FG000|Overall Study|Physician Decision|0|||
146645106|NCT00101452|528877671|FG001|Overall Study|Physician Decision|3|||
146645107|NCT00101452|528877672|FG002|Overall Study|Physician Decision|2|||
146645108|NCT00101452|528877670|FG000|Overall Study|Protocol Violation|2|||
146645109|NCT00101452|528877671|FG001|Overall Study|Protocol Violation|1|||
146645110|NCT00101452|528877672|FG002|Overall Study|Protocol Violation|3|||
146645111|NCT00101452|528877670|FG000|Overall Study|Other|15|||
146645112|NCT00101452|528877671|FG001|Overall Study|Other|16|||
146645113|NCT00101452|528877672|FG002|Overall Study|Other|12|||
146645114|NCT01994889|528877673|FG000|Overall Study|Adverse Event|5|||
146645115|NCT01994889|528877674|FG001|Overall Study|Adverse Event|12|||
146645116|NCT01994889|528877675|FG002|Overall Study|Adverse Event|11|||
146645117|NCT01994889|528877673|FG000|Overall Study|Cardiac Device Implantation|0|||
146645118|NCT01994889|528877674|FG001|Overall Study|Cardiac Device Implantation|2|||
146645119|NCT01994889|528877675|FG002|Overall Study|Cardiac Device Implantation|0|||
146645120|NCT01994889|528877673|FG000|Overall Study|Organ Transplantation|1|||
146645121|NCT01994889|528877674|FG001|Overall Study|Organ Transplantation|5|||
146645122|NCT01994889|528877675|FG002|Overall Study|Organ Transplantation|5|||
146645123|NCT01994889|528877673|FG000|Overall Study|No longer willing to participate|8|||
146645124|NCT01994889|528877674|FG001|Overall Study|No longer willing to participate|17|||
146645125|NCT01994889|528877675|FG002|Overall Study|No longer willing to participate|37|||
146645126|NCT01994889|528877673|FG000|Overall Study|Lost to Follow-up|0|||
146645127|NCT01994889|528877674|FG001|Overall Study|Lost to Follow-up|1|||
146497375|NCT02016105|528324661|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
146497376|NCT02016105|528324662|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
146497377|NCT02016105|528324663|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
146497378|NCT02016105|528324664|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
146645128|NCT01994889|528877675|FG002|Overall Study|Lost to Follow-up|0|||
146645129|NCT01994889|528877673|FG000|Overall Study|Protocol Violation|0|||
146645130|NCT01994889|528877674|FG001|Overall Study|Protocol Violation|1|||
146645131|NCT01994889|528877675|FG002|Overall Study|Protocol Violation|1|||
146645132|NCT01994889|528877673|FG000|Overall Study|Death|14|||
146645133|NCT01994889|528877674|FG001|Overall Study|Death|25|||
146645134|NCT01994889|528877675|FG002|Overall Study|Death|38|||
146645135|NCT02969655|528877676|FG000|Overall Study|Withdrawal by Subject|3|||
146645136|NCT02969655|528877677|FG001|Overall Study|Withdrawal by Subject|2|||
146645137|NCT02969655|528877676|FG000|Overall Study|Physician Decision|4|||
146645138|NCT02969655|528877677|FG001|Overall Study|Physician Decision|3|||
146645139|NCT02969655|528877676|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
146645140|NCT02969655|528877677|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
146645141|NCT02969655|528877676|FG000|Overall Study|Adverse Event|10|||
146645142|NCT02969655|528877677|FG001|Overall Study|Adverse Event|8|||
146645143|NCT02674204|528877678|FG000|Overall Study|Adverse Event|1|||
146645144|NCT02674204|528877679|FG001|Overall Study|Adverse Event|0|||
146645145|NCT02466659|528877682|FG000|Overall Study|Lost to Follow-up|5|||
146645146|NCT02466659|528877683|FG001|Overall Study|Lost to Follow-up|2|||
146645147|NCT01536392|528877684|FG000|Overall Study|Adverse Event|2|||
146645148|NCT01536392|528877685|FG001|Overall Study|Adverse Event|2|||
146645149|NCT01536392|528877684|FG000|Overall Study|Physician Decision|2|||
146645150|NCT01536392|528877685|FG001|Overall Study|Physician Decision|3|||
146645151|NCT01536392|528877684|FG000|Overall Study|Withdrawal by Subject|3|||
146645152|NCT01536392|528877685|FG001|Overall Study|Withdrawal by Subject|6|||
146768993|NCT02020616|529321815|FG001|Overall Study|Lost to Follow-up|1|||
146912117|NCT00641043|529841424|FG001|Overall Study|Other incl. lack of efficacy|2|||
146912118|NCT03088605|529841427|FG000|Overall Study|Withdrawal by Subject|1|||
146912119|NCT03088605|529841428|FG001|Overall Study|Withdrawal by Subject|0|||
146912120|NCT02225223|529841430|FG000|Overall Study|Death|10|||
146912121|NCT02225223|529841431|FG001|Overall Study|Death|1|||
146912122|NCT02225223|529841430|FG000|Overall Study|Lost to Follow-up|5|||
146912123|NCT02225223|529841431|FG001|Overall Study|Lost to Follow-up|0|||
146912124|NCT02225223|529841430|FG000|Overall Study|Other|1|||
146912125|NCT02225223|529841431|FG001|Overall Study|Other|2|||
146912126|NCT02225223|529841430|FG000|Overall Study|Physician Decision|1|||
146912127|NCT02225223|529841431|FG001|Overall Study|Physician Decision|0|||
146912128|NCT02225223|529841430|FG000|Overall Study|Withdrawal by Subject|2|||
146912129|NCT02225223|529841431|FG001|Overall Study|Withdrawal by Subject|2|||
146912130|NCT03567291|529841432|FG000|Period I|Adverse Event|14|||
146912131|NCT03567291|529841433|FG001|Period I|Adverse Event|0|||
146912132|NCT03567291|529841434|FG002|Period I|Adverse Event|0|||
146912133|NCT03567291|529841435|FG003|Period I|Adverse Event|0|||
146975339|NCT00572156|530073542|FG003|Overall Study|Patient/Parent Decision|3|||
146497379|NCT02016105|528324665|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
146645153|NCT01536392|528877684|FG000|Overall Study|Non Compliance|3|||
146645154|NCT01536392|528877685|FG001|Overall Study|Non Compliance|4|||
146645155|NCT01536392|528877684|FG000|Overall Study|Completed therapy early|3|||
146645156|NCT01536392|528877685|FG001|Overall Study|Completed therapy early|0|||
146645157|NCT03753789|528877686|FG000|Overall Study|Withdrawal by Subject|2|||
146645158|NCT04629066|528877692|FG000|Overall Study|Lost to Follow-up|3|||
146645159|NCT04629066|528877693|FG001|Overall Study|Lost to Follow-up|2|||
146645160|NCT01030666|528877694|FG000|Overall Study|Lost to Follow-up|3|||
146645161|NCT01030666|528877695|FG001|Overall Study|Lost to Follow-up|2|||
146645162|NCT04002908|528877698|FG000|Overall Study|Death|41|||
146645163|NCT04002908|528877699|FG001|Overall Study|Death|0|||
146645164|NCT04002908|528877700|FG002|Overall Study|Death|0|||
146912134|NCT03567291|529841432|FG000|Period I|Protocol Violation|1|||
146912135|NCT03567291|529841433|FG001|Period I|Protocol Violation|0|||
146912136|NCT03567291|529841434|FG002|Period I|Protocol Violation|0|||
146912137|NCT03567291|529841435|FG003|Period I|Protocol Violation|0|||
146912138|NCT03567291|529841432|FG000|Period I|Withdrawal by Subject|23|||
146912139|NCT03567291|529841433|FG001|Period I|Withdrawal by Subject|0|||
146497380|NCT02016105|528324660|FG000|TREATMENT PERIOD 2|Death|0|||
146497381|NCT02016105|528324661|FG001|TREATMENT PERIOD 2|Death|0|||
146497382|NCT02016105|528324662|FG002|TREATMENT PERIOD 2|Death|0|||
146497383|NCT02016105|528324663|FG003|TREATMENT PERIOD 2|Death|0|||
146497384|NCT02016105|528324664|FG004|TREATMENT PERIOD 2|Death|0|||
146497385|NCT02016105|528324665|FG005|TREATMENT PERIOD 2|Death|1|||
146497386|NCT02016105|528324660|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
146912140|NCT03567291|529841434|FG002|Period I|Withdrawal by Subject|0|||
146912141|NCT03567291|529841435|FG003|Period I|Withdrawal by Subject|0|||
146497387|NCT02016105|528324661|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
146497388|NCT02016105|528324662|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
146497389|NCT02016105|528324663|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
146497390|NCT02016105|528324664|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
146497391|NCT02016105|528324665|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
146497392|NCT02016105|528324660|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
146497393|NCT02016105|528324661|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
146497394|NCT02016105|528324662|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
146497395|NCT02016105|528324663|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
146497396|NCT02016105|528324664|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
146497397|NCT02016105|528324665|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
146497398|NCT02016105|528324660|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
146497399|NCT02016105|528324661|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
146497400|NCT02016105|528324662|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
146497401|NCT02016105|528324663|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
146497402|NCT02016105|528324664|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
146497403|NCT02016105|528324665|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
146497404|NCT02016105|528324660|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
146497405|NCT02016105|528324661|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
146497406|NCT02016105|528324662|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
146497407|NCT02016105|528324663|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
146497408|NCT02016105|528324664|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
146497409|NCT02016105|528324665|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
146497410|NCT02016105|528324660|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
146497411|NCT02016105|528324661|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
146497412|NCT02016105|528324662|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
146497413|NCT02016105|528324663|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
146497414|NCT02016105|528324664|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
146497415|NCT02016105|528324665|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
146497416|NCT02016105|528324660|FG000|EXTENSION PERIOD|Adverse Event|0|||
146497417|NCT02016105|528324661|FG001|EXTENSION PERIOD|Adverse Event|0|||
146497418|NCT02016105|528324662|FG002|EXTENSION PERIOD|Adverse Event|2|||
146497419|NCT02016105|528324663|FG003|EXTENSION PERIOD|Adverse Event|0|||
146497420|NCT02016105|528324664|FG004|EXTENSION PERIOD|Adverse Event|1|||
146497421|NCT02016105|528324665|FG005|EXTENSION PERIOD|Adverse Event|0|||
146497422|NCT02016105|528324660|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
146497423|NCT02016105|528324661|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
146497424|NCT02016105|528324662|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
146497425|NCT02016105|528324663|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
146497426|NCT02016105|528324664|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
146497427|NCT02016105|528324665|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
146497428|NCT02016105|528324660|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
146497429|NCT02016105|528324661|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
146497430|NCT02016105|528324662|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
146497431|NCT02016105|528324663|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
146497432|NCT02016105|528324664|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
146497433|NCT02016105|528324665|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
146497434|NCT02016105|528324660|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
146497435|NCT02016105|528324661|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
146497436|NCT02016105|528324662|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
146497437|NCT02016105|528324663|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
146497438|NCT02016105|528324664|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
146497439|NCT02016105|528324665|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
146497440|NCT00090493|528324666|FG000|Overall Study|Physician Decision|2|||
146565291|NCT01359956|528582512|FG001|Overall Study|Death|60|||
146497441|NCT02071706|528324667|FG000|Overall Study|Adverse Event|1|||
146497442|NCT02071706|528324667|FG000|Overall Study|Withdrawal by Subject|2|||
146497443|NCT01908829|528324668|FG000|Overall Study|Adverse Event|13|||
146497444|NCT01908829|528324669|FG001|Overall Study|Adverse Event|11|||
146497445|NCT01908829|528324670|FG002|Overall Study|Adverse Event|13|||
146497446|NCT01908829|528324668|FG000|Overall Study|Lost to Follow-up|4|||
146497447|NCT01908829|528324669|FG001|Overall Study|Lost to Follow-up|2|||
146497448|NCT01908829|528324670|FG002|Overall Study|Lost to Follow-up|1|||
146912142|NCT03567291|529841432|FG000|Period I|Lost to Follow-up|2|||
146497449|NCT01908829|528324668|FG000|Overall Study|Randomized no double-blind drug received|1|||
146912143|NCT03567291|529841433|FG001|Period I|Lost to Follow-up|0|||
146912144|NCT03567291|529841434|FG002|Period I|Lost to Follow-up|0|||
146912145|NCT03567291|529841435|FG003|Period I|Lost to Follow-up|0|||
146912146|NCT03567291|529841432|FG000|Period I|Terminated by sponsor|44|||
146912147|NCT03567291|529841433|FG001|Period I|Terminated by sponsor|0|||
146912148|NCT03567291|529841434|FG002|Period I|Terminated by sponsor|0|||
146912149|NCT03567291|529841435|FG003|Period I|Terminated by sponsor|0|||
146912150|NCT03567291|529841432|FG000|Period I|Missing or unknown|7|||
146912151|NCT03567291|529841433|FG001|Period I|Missing or unknown|0|||
146912152|NCT03567291|529841434|FG002|Period I|Missing or unknown|0|||
146497450|NCT01908829|528324669|FG001|Overall Study|Randomized no double-blind drug received|0|||
146497451|NCT01908829|528324670|FG002|Overall Study|Randomized no double-blind drug received|1|||
146497452|NCT01908829|528324668|FG000|Overall Study|Discontinued (no EoT page)|2|||
146497453|NCT01908829|528324669|FG001|Overall Study|Discontinued (no EoT page)|0|||
146497454|NCT01908829|528324670|FG002|Overall Study|Discontinued (no EoT page)|0|||
146497455|NCT01908829|528324668|FG000|Overall Study|Miscellaneous|0|||
146497456|NCT01908829|528324669|FG001|Overall Study|Miscellaneous|2|||
146497457|NCT01908829|528324670|FG002|Overall Study|Miscellaneous|0|||
146497458|NCT01908829|528324668|FG000|Overall Study|Protocol Violation|2|||
146497459|NCT01908829|528324669|FG001|Overall Study|Protocol Violation|2|||
146497460|NCT01908829|528324670|FG002|Overall Study|Protocol Violation|0|||
146497461|NCT01908829|528324668|FG000|Overall Study|Lack of Efficacy|1|||
146497462|NCT01908829|528324669|FG001|Overall Study|Lack of Efficacy|3|||
146497463|NCT01908829|528324670|FG002|Overall Study|Lack of Efficacy|2|||
146497464|NCT01908829|528324668|FG000|Overall Study|Withdrawal by Subject|26|||
146497465|NCT01908829|528324669|FG001|Overall Study|Withdrawal by Subject|29|||
146497466|NCT01908829|528324670|FG002|Overall Study|Withdrawal by Subject|22|||
146497467|NCT02320058|528324671|FG000|Overall Study|Death|25|||
146497468|NCT02320058|528324672|FG001|Overall Study|Death|10|||
146497469|NCT02320058|528324671|FG000|Overall Study|Lost to Follow-up|4|||
146497470|NCT02320058|528324672|FG001|Overall Study|Lost to Follow-up|0|||
146497471|NCT02320058|528324671|FG000|Overall Study|Other reasons|4|||
146497472|NCT02320058|528324672|FG001|Overall Study|Other reasons|1|||
146497473|NCT02320058|528324671|FG000|Overall Study|Withdrawal by Subject|8|||
146497474|NCT02320058|528324672|FG001|Overall Study|Withdrawal by Subject|2|||
146497475|NCT02320058|528324671|FG000|Overall Study|Not reported|1|||
146497476|NCT02320058|528324672|FG001|Overall Study|Not reported|0|||
146497477|NCT01339923|528324673|FG000|Overall Study|Adverse Event|1|||
146497478|NCT01339923|528324674|FG001|Overall Study|Adverse Event|1|||
146497479|NCT01339923|528324675|FG002|Overall Study|Adverse Event|1|||
146497480|NCT01339923|528324676|FG003|Overall Study|Adverse Event|0|||
146497481|NCT01339923|528324677|FG004|Overall Study|Adverse Event|0|||
146497482|NCT01339923|528324678|FG005|Overall Study|Adverse Event|0|||
146497483|NCT01339923|528324679|FG006|Overall Study|Adverse Event|1|||
146497484|NCT01339923|528324673|FG000|Overall Study|Inappropriate Enrollment|1|||
146497485|NCT01339923|528324674|FG001|Overall Study|Inappropriate Enrollment|0|||
146497486|NCT01339923|528324675|FG002|Overall Study|Inappropriate Enrollment|0|||
146497487|NCT01339923|528324676|FG003|Overall Study|Inappropriate Enrollment|0|||
146497488|NCT01339923|528324677|FG004|Overall Study|Inappropriate Enrollment|0|||
146497489|NCT01339923|528324678|FG005|Overall Study|Inappropriate Enrollment|1|||
146497490|NCT01339923|528324679|FG006|Overall Study|Inappropriate Enrollment|0|||
146497491|NCT01339923|528324673|FG000|Overall Study|Lost to Follow-up|4|||
146497492|NCT01339923|528324674|FG001|Overall Study|Lost to Follow-up|4|||
146497493|NCT01339923|528324675|FG002|Overall Study|Lost to Follow-up|0|||
146497494|NCT01339923|528324676|FG003|Overall Study|Lost to Follow-up|3|||
146497495|NCT01339923|528324677|FG004|Overall Study|Lost to Follow-up|1|||
146497496|NCT01339923|528324678|FG005|Overall Study|Lost to Follow-up|1|||
146497497|NCT01339923|528324679|FG006|Overall Study|Lost to Follow-up|5|||
146497498|NCT01339923|528324673|FG000|Overall Study|Protocol Violation|0|||
146497499|NCT01339923|528324674|FG001|Overall Study|Protocol Violation|0|||
146497500|NCT01339923|528324675|FG002|Overall Study|Protocol Violation|0|||
146497501|NCT01339923|528324676|FG003|Overall Study|Protocol Violation|0|||
146497502|NCT01339923|528324677|FG004|Overall Study|Protocol Violation|0|||
146497503|NCT01339923|528324678|FG005|Overall Study|Protocol Violation|3|||
146497504|NCT01339923|528324679|FG006|Overall Study|Protocol Violation|1|||
146497505|NCT01339923|528324673|FG000|Overall Study|Unable to Classify|1|||
146912153|NCT03567291|529841435|FG003|Period I|Missing or unknown|0|||
146912154|NCT03567291|529841432|FG000|Period II|Adverse Event|0|||
146497506|NCT01339923|528324674|FG001|Overall Study|Unable to Classify|0|||
146497507|NCT01339923|528324675|FG002|Overall Study|Unable to Classify|1|||
146497508|NCT01339923|528324676|FG003|Overall Study|Unable to Classify|0|||
146497509|NCT01339923|528324677|FG004|Overall Study|Unable to Classify|0|||
146497510|NCT01339923|528324678|FG005|Overall Study|Unable to Classify|1|||
146497511|NCT01339923|528324679|FG006|Overall Study|Unable to Classify|5|||
146497512|NCT01339923|528324673|FG000|Overall Study|Withdrawal by Subject|7|||
146497513|NCT01339923|528324674|FG001|Overall Study|Withdrawal by Subject|11|||
146912155|NCT03567291|529841433|FG001|Period II|Adverse Event|1|||
146912156|NCT03567291|529841434|FG002|Period II|Adverse Event|0|||
146912157|NCT03567291|529841435|FG003|Period II|Adverse Event|0|||
146768994|NCT02020616|529321816|FG002|Overall Study|Lost to Follow-up|0|||
146768995|NCT02020616|529321817|FG003|Overall Study|Lost to Follow-up|1|||
146768996|NCT02020616|529321818|FG004|Overall Study|Lost to Follow-up|1|||
146912158|NCT03567291|529841432|FG000|Period II|Missing or unknown|0|||
146912159|NCT03567291|529841433|FG001|Period II|Missing or unknown|2|||
146912160|NCT03567291|529841434|FG002|Period II|Missing or unknown|1|||
146912161|NCT03567291|529841435|FG003|Period II|Missing or unknown|0|||
146912162|NCT03567291|529841432|FG000|Period III|Adverse Event|0|||
146912163|NCT03567291|529841433|FG001|Period III|Adverse Event|0|||
146912164|NCT03567291|529841434|FG002|Period III|Adverse Event|0|||
146912165|NCT03567291|529841435|FG003|Period III|Adverse Event|4|||
146912166|NCT03567291|529841432|FG000|Period III|Withdrawal by Subject|0|||
146912167|NCT03567291|529841433|FG001|Period III|Withdrawal by Subject|0|||
146912168|NCT03567291|529841434|FG002|Period III|Withdrawal by Subject|0|||
146912169|NCT03567291|529841435|FG003|Period III|Withdrawal by Subject|4|||
146912170|NCT03567291|529841432|FG000|Period III|Lost to Follow-up|0|||
146497514|NCT01339923|528324675|FG002|Overall Study|Withdrawal by Subject|6|||
146497515|NCT01339923|528324676|FG003|Overall Study|Withdrawal by Subject|1|||
146497516|NCT01339923|528324677|FG004|Overall Study|Withdrawal by Subject|4|||
146497517|NCT01339923|528324678|FG005|Overall Study|Withdrawal by Subject|3|||
146497518|NCT01339923|528324679|FG006|Overall Study|Withdrawal by Subject|2|||
146497519|NCT00637000|528324682|FG000|Overall Study|Withdrawal by Subject|4|||
146497520|NCT00637000|528324683|FG001|Overall Study|Withdrawal by Subject|3|||
146497521|NCT01855243|528324684|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
146497522|NCT01855243|528324685|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
146497523|NCT01855243|528324686|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
146497524|NCT01860040|528324687|FG000|Overall Study|Withdrawal by Subject|1|||
146497525|NCT01860040|528324688|FG001|Overall Study|Withdrawal by Subject|0|||
146497526|NCT01931995|528324689|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
146912171|NCT03567291|529841433|FG001|Period III|Lost to Follow-up|0|||
146497527|NCT01931995|528324690|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
146497528|NCT01931995|528324689|FG000|First Intervention (1 Day)|Physician Decision|1|||
146497529|NCT01931995|528324690|FG001|First Intervention (1 Day)|Physician Decision|1|||
146497530|NCT01931995|528324689|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
146497531|NCT01931995|528324690|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
146497532|NCT02477826|528324709|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
146497533|NCT02477826|528324710|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
146497534|NCT02477826|528324711|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
146497535|NCT02477826|528324712|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
146497536|NCT02477826|528324713|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
146497537|NCT02477826|528324714|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
146497538|NCT02477826|528324715|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
146497539|NCT02477826|528324716|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
146497540|NCT02477826|528324717|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
146497541|NCT02477826|528324718|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
146497542|NCT02477826|528324709|FG000|Pre-Treatment|Other reasons|4|||
146497543|NCT02477826|528324710|FG001|Pre-Treatment|Other reasons|1|||
146497544|NCT02477826|528324711|FG002|Pre-Treatment|Other reasons|4|||
146497545|NCT02477826|528324712|FG003|Pre-Treatment|Other reasons|1|||
146497546|NCT02477826|528324713|FG004|Pre-Treatment|Other reasons|4|||
146497547|NCT02477826|528324714|FG005|Pre-Treatment|Other reasons|2|||
146497548|NCT02477826|528324715|FG006|Pre-Treatment|Other reasons|0|||
146497549|NCT02477826|528324716|FG007|Pre-Treatment|Other reasons|0|||
146497550|NCT02477826|528324717|FG008|Pre-Treatment|Other reasons|0|||
146497551|NCT02477826|528324718|FG009|Pre-Treatment|Other reasons|0|||
146497552|NCT02477826|528324709|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
146497553|NCT02477826|528324710|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
146497554|NCT02477826|528324711|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
146497555|NCT02477826|528324712|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
146497556|NCT02477826|528324713|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
146497557|NCT02477826|528324714|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
146497558|NCT02477826|528324715|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
146497559|NCT02477826|528324716|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
146497560|NCT02477826|528324717|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
146497561|NCT02477826|528324718|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
146912172|NCT03567291|529841434|FG002|Period III|Lost to Follow-up|0|||
146497562|NCT02477826|528324709|FG000|Pre-Treatment|Subject withdrew consent|0|||
146497563|NCT02477826|528324710|FG001|Pre-Treatment|Subject withdrew consent|0|||
146497564|NCT02477826|528324711|FG002|Pre-Treatment|Subject withdrew consent|3|||
146497565|NCT02477826|528324712|FG003|Pre-Treatment|Subject withdrew consent|0|||
146768997|NCT02020616|529321819|FG005|Overall Study|Lost to Follow-up|1|||
146768998|NCT02020616|529321820|FG006|Overall Study|Lost to Follow-up|0|||
146912173|NCT03567291|529841435|FG003|Period III|Lost to Follow-up|1|||
146912174|NCT03567291|529841432|FG000|Period III|Terminated by sponsor|0|||
146497566|NCT02477826|528324713|FG004|Pre-Treatment|Subject withdrew consent|0|||
146497567|NCT02477826|528324714|FG005|Pre-Treatment|Subject withdrew consent|1|||
146497568|NCT02477826|528324715|FG006|Pre-Treatment|Subject withdrew consent|0|||
146497569|NCT02477826|528324716|FG007|Pre-Treatment|Subject withdrew consent|1|||
146497570|NCT02477826|528324717|FG008|Pre-Treatment|Subject withdrew consent|0|||
146497571|NCT02477826|528324718|FG009|Pre-Treatment|Subject withdrew consent|3|||
146497572|NCT02477826|528324709|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
146497573|NCT02477826|528324710|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
146497574|NCT02477826|528324711|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
146497575|NCT02477826|528324712|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
146497576|NCT02477826|528324713|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
146497577|NCT02477826|528324714|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
146497578|NCT02477826|528324715|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
146497579|NCT02477826|528324716|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
146497580|NCT02477826|528324717|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
146497581|NCT02477826|528324718|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
146497582|NCT02477826|528324709|FG000|Pre-Treatment|Death|0|||
146497583|NCT02477826|528324710|FG001|Pre-Treatment|Death|0|||
146497584|NCT02477826|528324711|FG002|Pre-Treatment|Death|0|||
146497585|NCT02477826|528324712|FG003|Pre-Treatment|Death|0|||
146497586|NCT02477826|528324713|FG004|Pre-Treatment|Death|0|||
146497587|NCT02477826|528324714|FG005|Pre-Treatment|Death|0|||
146497588|NCT02477826|528324715|FG006|Pre-Treatment|Death|1|||
146497589|NCT02477826|528324716|FG007|Pre-Treatment|Death|0|||
146497590|NCT02477826|528324717|FG008|Pre-Treatment|Death|0|||
146497591|NCT02477826|528324718|FG009|Pre-Treatment|Death|0|||
146497592|NCT02477826|528324709|FG000|Treatment Period|Not reported|8|||
146497593|NCT02477826|528324710|FG001|Treatment Period|Not reported|6|||
146497594|NCT02477826|528324711|FG002|Treatment Period|Not reported|4|||
146497595|NCT02477826|528324712|FG003|Treatment Period|Not reported|4|||
146497596|NCT02477826|528324713|FG004|Treatment Period|Not reported|2|||
146497597|NCT02477826|528324714|FG005|Treatment Period|Not reported|1|||
146497598|NCT02477826|528324715|FG006|Treatment Period|Not reported|14|||
146497599|NCT02477826|528324716|FG007|Treatment Period|Not reported|8|||
146497600|NCT02477826|528324717|FG008|Treatment Period|Not reported|5|||
146565292|NCT01359956|528582513|FG002|Overall Study|Death|66|||
146912175|NCT03567291|529841433|FG001|Period III|Terminated by sponsor|0|||
146912176|NCT03567291|529841434|FG002|Period III|Terminated by sponsor|0|||
146912177|NCT03567291|529841435|FG003|Period III|Terminated by sponsor|68|||
146912178|NCT03567291|529841432|FG000|Period III|Missing or unknown|0|||
146912179|NCT03567291|529841433|FG001|Period III|Missing or unknown|0|||
146565293|NCT01359956|528582514|FG003|Overall Study|Death|57|||
146565294|NCT01359956|528582511|FG000|Overall Study|Lost to Follow-up|3|||
146565295|NCT01359956|528582512|FG001|Overall Study|Lost to Follow-up|4|||
146565296|NCT01359956|528582513|FG002|Overall Study|Lost to Follow-up|1|||
146565297|NCT01359956|528582514|FG003|Overall Study|Lost to Follow-up|1|||
146565298|NCT03728933|528582515|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
146565299|NCT03728933|528582516|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146565300|NCT03728933|528582517|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146565301|NCT03728933|528582515|FG000|Overall Study|Withdrawal by Subject|0|||
146565302|NCT03728933|528582516|FG001|Overall Study|Withdrawal by Subject|0|||
146565303|NCT03728933|528582517|FG002|Overall Study|Withdrawal by Subject|1|||
146565304|NCT03728933|528582515|FG000|Overall Study|Lost to Follow-up|0|||
146565305|NCT03728933|528582516|FG001|Overall Study|Lost to Follow-up|1|||
146565306|NCT03728933|528582517|FG002|Overall Study|Lost to Follow-up|0|||
146565307|NCT03728933|528582515|FG000|Overall Study|Adverse Event|1|||
146565308|NCT03728933|528582516|FG001|Overall Study|Adverse Event|0|||
146565309|NCT03728933|528582517|FG002|Overall Study|Adverse Event|0|||
146565310|NCT00370292|528582518|FG000|Overall Study|Disease Progression|4|||
146565311|NCT00370292|528582518|FG000|Overall Study|Adverse Event|7|||
146565312|NCT00370292|528582518|FG000|Overall Study|Physician Decision|2|||
146565313|NCT00276419|528582519|FG000|First Intervention|Adverse Event|1|||
146565314|NCT00276419|528582520|FG001|First Intervention|Adverse Event|0|||
146565315|NCT00276419|528582519|FG000|First Intervention|Withdrawal by Subject|0|||
146912180|NCT03567291|529841434|FG002|Period III|Missing or unknown|0|||
146912181|NCT03567291|529841435|FG003|Period III|Missing or unknown|8|||
146971978|NCT03343054|530058492|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
146497601|NCT02477826|528324718|FG009|Treatment Period|Not reported|2|||
146497602|NCT02477826|528324709|FG000|Treatment Period|Other reasons|5|||
146497603|NCT02477826|528324710|FG001|Treatment Period|Other reasons|6|||
146497604|NCT02477826|528324711|FG002|Treatment Period|Other reasons|12|||
146565316|NCT00276419|528582520|FG001|First Intervention|Withdrawal by Subject|2|||
146565317|NCT03801525|528582521|FG000|Overall Study|Adverse Event|17|||
146565318|NCT03801525|528582522|FG001|Overall Study|Adverse Event|1|||
146565319|NCT03801525|528582523|FG002|Overall Study|Adverse Event|0|||
146912182|NCT03666143|529841436|FG000|Overall Study|Death|158|||
146912183|NCT03666143|529841436|FG000|Overall Study|Sponsor Decision|31|||
146497605|NCT02477826|528324712|FG003|Treatment Period|Other reasons|7|||
146497606|NCT02477826|528324713|FG004|Treatment Period|Other reasons|5|||
146497607|NCT02477826|528324714|FG005|Treatment Period|Other reasons|1|||
146497608|NCT02477826|528324715|FG006|Treatment Period|Other reasons|8|||
146497609|NCT02477826|528324716|FG007|Treatment Period|Other reasons|8|||
146497610|NCT02477826|528324717|FG008|Treatment Period|Other reasons|21|||
146497611|NCT02477826|528324718|FG009|Treatment Period|Other reasons|1|||
146497612|NCT02477826|528324709|FG000|Treatment Period|Administrative reason by sponsor|0|||
146497613|NCT02477826|528324710|FG001|Treatment Period|Administrative reason by sponsor|3|||
146497614|NCT02477826|528324711|FG002|Treatment Period|Administrative reason by sponsor|0|||
146497615|NCT02477826|528324712|FG003|Treatment Period|Administrative reason by sponsor|0|||
146497616|NCT02477826|528324713|FG004|Treatment Period|Administrative reason by sponsor|0|||
146497617|NCT02477826|528324714|FG005|Treatment Period|Administrative reason by sponsor|0|||
146497618|NCT02477826|528324715|FG006|Treatment Period|Administrative reason by sponsor|0|||
146497619|NCT02477826|528324716|FG007|Treatment Period|Administrative reason by sponsor|0|||
146497620|NCT02477826|528324717|FG008|Treatment Period|Administrative reason by sponsor|0|||
146497621|NCT02477826|528324718|FG009|Treatment Period|Administrative reason by sponsor|0|||
146497622|NCT02477826|528324709|FG000|Treatment Period|Participant meet no longer study criteria|1|||
146497623|NCT02477826|528324710|FG001|Treatment Period|Participant meet no longer study criteria|1|||
146497624|NCT02477826|528324711|FG002|Treatment Period|Participant meet no longer study criteria|0|||
146497625|NCT02477826|528324712|FG003|Treatment Period|Participant meet no longer study criteria|0|||
146497626|NCT02477826|528324713|FG004|Treatment Period|Participant meet no longer study criteria|1|||
146497627|NCT02477826|528324714|FG005|Treatment Period|Participant meet no longer study criteria|1|||
146497628|NCT02477826|528324715|FG006|Treatment Period|Participant meet no longer study criteria|0|||
146497629|NCT02477826|528324716|FG007|Treatment Period|Participant meet no longer study criteria|1|||
146497630|NCT02477826|528324717|FG008|Treatment Period|Participant meet no longer study criteria|0|||
146497631|NCT02477826|528324718|FG009|Treatment Period|Participant meet no longer study criteria|0|||
146497632|NCT02477826|528324709|FG000|Treatment Period|Poor/Non Compliance|1|||
146497633|NCT02477826|528324710|FG001|Treatment Period|Poor/Non Compliance|0|||
146497634|NCT02477826|528324711|FG002|Treatment Period|Poor/Non Compliance|2|||
146497635|NCT02477826|528324712|FG003|Treatment Period|Poor/Non Compliance|0|||
146497636|NCT02477826|528324713|FG004|Treatment Period|Poor/Non Compliance|0|||
146497637|NCT02477826|528324714|FG005|Treatment Period|Poor/Non Compliance|1|||
146497638|NCT02477826|528324715|FG006|Treatment Period|Poor/Non Compliance|1|||
146497639|NCT02477826|528324716|FG007|Treatment Period|Poor/Non Compliance|0|||
146497640|NCT02477826|528324717|FG008|Treatment Period|Poor/Non Compliance|0|||
146497641|NCT02477826|528324718|FG009|Treatment Period|Poor/Non Compliance|1|||
146497642|NCT02477826|528324709|FG000|Treatment Period|Maximum Clinical Benefit|3|||
146497643|NCT02477826|528324710|FG001|Treatment Period|Maximum Clinical Benefit|3|||
146497644|NCT02477826|528324711|FG002|Treatment Period|Maximum Clinical Benefit|1|||
146497645|NCT02477826|528324712|FG003|Treatment Period|Maximum Clinical Benefit|1|||
146497646|NCT02477826|528324713|FG004|Treatment Period|Maximum Clinical Benefit|3|||
146497647|NCT02477826|528324714|FG005|Treatment Period|Maximum Clinical Benefit|0|||
146497648|NCT02477826|528324715|FG006|Treatment Period|Maximum Clinical Benefit|3|||
146497649|NCT02477826|528324716|FG007|Treatment Period|Maximum Clinical Benefit|2|||
146497650|NCT02477826|528324717|FG008|Treatment Period|Maximum Clinical Benefit|2|||
146497651|NCT02477826|528324718|FG009|Treatment Period|Maximum Clinical Benefit|2|||
146497652|NCT02477826|528324709|FG000|Treatment Period|Lost to Follow-up|0|||
146497653|NCT02477826|528324710|FG001|Treatment Period|Lost to Follow-up|0|||
146497654|NCT02477826|528324711|FG002|Treatment Period|Lost to Follow-up|1|||
146497655|NCT02477826|528324712|FG003|Treatment Period|Lost to Follow-up|1|||
146497656|NCT02477826|528324713|FG004|Treatment Period|Lost to Follow-up|0|||
146497657|NCT02477826|528324714|FG005|Treatment Period|Lost to Follow-up|0|||
146497658|NCT02477826|528324715|FG006|Treatment Period|Lost to Follow-up|2|||
146497659|NCT02477826|528324716|FG007|Treatment Period|Lost to Follow-up|2|||
146497660|NCT02477826|528324717|FG008|Treatment Period|Lost to Follow-up|0|||
146497661|NCT02477826|528324718|FG009|Treatment Period|Lost to Follow-up|0|||
146497662|NCT02477826|528324709|FG000|Treatment Period|Participant withdrew Consent|5|||
146497663|NCT02477826|528324710|FG001|Treatment Period|Participant withdrew Consent|5|||
146497664|NCT02477826|528324711|FG002|Treatment Period|Participant withdrew Consent|3|||
146497665|NCT02477826|528324712|FG003|Treatment Period|Participant withdrew Consent|3|||
146497666|NCT02477826|528324713|FG004|Treatment Period|Participant withdrew Consent|1|||
146497667|NCT02477826|528324714|FG005|Treatment Period|Participant withdrew Consent|3|||
146497668|NCT02477826|528324715|FG006|Treatment Period|Participant withdrew Consent|3|||
146497669|NCT02477826|528324716|FG007|Treatment Period|Participant withdrew Consent|3|||
146497670|NCT02477826|528324717|FG008|Treatment Period|Participant withdrew Consent|2|||
146497671|NCT02477826|528324718|FG009|Treatment Period|Participant withdrew Consent|3|||
146565320|NCT03801525|528582521|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
146565321|NCT03801525|528582522|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
146565322|NCT03801525|528582523|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
146975340|NCT00572156|530073539|FG000|Overall Study|Sponsor Decision|20|||
146645165|NCT04002908|528877701|FG003|Overall Study|Death|0|||
146645166|NCT04002908|528877698|FG000|Overall Study|Withdrawal by Subject|112|||
146645167|NCT04002908|528877699|FG001|Overall Study|Withdrawal by Subject|0|||
146645168|NCT04002908|528877700|FG002|Overall Study|Withdrawal by Subject|0|||
146497672|NCT02477826|528324709|FG000|Treatment Period|Participant request to discontinue treatment|5|||
146497673|NCT02477826|528324710|FG001|Treatment Period|Participant request to discontinue treatment|3|||
146497674|NCT02477826|528324711|FG002|Treatment Period|Participant request to discontinue treatment|15|||
146497675|NCT02477826|528324712|FG003|Treatment Period|Participant request to discontinue treatment|5|||
146497676|NCT02477826|528324713|FG004|Treatment Period|Participant request to discontinue treatment|3|||
146497677|NCT02477826|528324714|FG005|Treatment Period|Participant request to discontinue treatment|6|||
146497678|NCT02477826|528324715|FG006|Treatment Period|Participant request to discontinue treatment|13|||
146497679|NCT02477826|528324716|FG007|Treatment Period|Participant request to discontinue treatment|15|||
146497680|NCT02477826|528324717|FG008|Treatment Period|Participant request to discontinue treatment|4|||
146497681|NCT02477826|528324718|FG009|Treatment Period|Participant request to discontinue treatment|18|||
146497682|NCT02477826|528324709|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
146497683|NCT02477826|528324710|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
146497684|NCT02477826|528324711|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
146497685|NCT02477826|528324712|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
146497686|NCT02477826|528324713|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
146497687|NCT02477826|528324714|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
146497688|NCT02477826|528324715|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
146497689|NCT02477826|528324716|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
146497690|NCT02477826|528324717|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
146497691|NCT02477826|528324718|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
146497692|NCT02477826|528324709|FG000|Treatment Period|Death|4|||
146497693|NCT02477826|528324710|FG001|Treatment Period|Death|7|||
146497694|NCT02477826|528324711|FG002|Treatment Period|Death|0|||
146497695|NCT02477826|528324712|FG003|Treatment Period|Death|0|||
146565323|NCT03801525|528582521|FG000|Overall Study|Death|29|||
146565324|NCT03801525|528582522|FG001|Overall Study|Death|1|||
146565325|NCT03801525|528582523|FG002|Overall Study|Death|4|||
146565326|NCT03801525|528582521|FG000|Overall Study|Disease Progression|6|||
146565327|NCT03801525|528582522|FG001|Overall Study|Disease Progression|0|||
146565328|NCT03801525|528582523|FG002|Overall Study|Disease Progression|1|||
146565329|NCT03801525|528582521|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
146565330|NCT03801525|528582522|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
146565331|NCT03801525|528582523|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
146565332|NCT03801525|528582521|FG000|Overall Study|Investigator Decision|18|||
146565333|NCT03801525|528582522|FG001|Overall Study|Investigator Decision|1|||
146565334|NCT03801525|528582523|FG002|Overall Study|Investigator Decision|0|||
146565335|NCT03801525|528582521|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
146565336|NCT03801525|528582522|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
146565337|NCT03801525|528582523|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
146565338|NCT03801525|528582521|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
146565339|NCT03801525|528582522|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
146565340|NCT03801525|528582523|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
146565341|NCT03801525|528582521|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
146565342|NCT03801525|528582522|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
146565343|NCT03801525|528582523|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
146565344|NCT03801525|528582521|FG000|Overall Study|Withdrawal of Subject Consent|38|||
146565345|NCT03801525|528582522|FG001|Overall Study|Withdrawal of Subject Consent|2|||
146565346|NCT03801525|528582523|FG002|Overall Study|Withdrawal of Subject Consent|1|||
146565347|NCT03801525|528582521|FG000|Overall Study|Reason not Specified|4|||
146565348|NCT03801525|528582522|FG001|Overall Study|Reason not Specified|0|||
146565349|NCT03801525|528582523|FG002|Overall Study|Reason not Specified|4|||
146565350|NCT03545672|528582526|FG000|Overall Study|Uncertain diagnosis|2|||
146565351|NCT03545672|528582527|FG001|Overall Study|Uncertain diagnosis|1|||
146565352|NCT03545672|528582526|FG000|Overall Study|Protocol Violation|2|||
146565353|NCT03545672|528582527|FG001|Overall Study|Protocol Violation|2|||
146565354|NCT01628913|528582528|FG000|Overall Study|Adverse Event|12|||
146565355|NCT01628913|528582529|FG001|Overall Study|Adverse Event|5|||
146565356|NCT01628913|528582528|FG000|Overall Study|Disease Progression|11|||
146645169|NCT04002908|528877701|FG003|Overall Study|Withdrawal by Subject|0|||
146975341|NCT00572156|530073540|FG001|Overall Study|Sponsor Decision|16|||
146565357|NCT01628913|528582529|FG001|Overall Study|Disease Progression|14|||
146565358|NCT01628913|528582528|FG000|Overall Study|Protocol Violation|1|||
146497696|NCT02477826|528324713|FG004|Treatment Period|Death|1|||
146565359|NCT01628913|528582529|FG001|Overall Study|Protocol Violation|0|||
146565360|NCT01628913|528582528|FG000|Overall Study|Death|1|||
146565361|NCT01628913|528582529|FG001|Overall Study|Death|0|||
146645170|NCT04002908|528877698|FG000|Overall Study|Lost to Follow-up|72|||
146645171|NCT04002908|528877699|FG001|Overall Study|Lost to Follow-up|0|||
146645172|NCT04002908|528877700|FG002|Overall Study|Lost to Follow-up|0|||
146645173|NCT04002908|528877701|FG003|Overall Study|Lost to Follow-up|0|||
146645174|NCT04002908|528877698|FG000|Overall Study|Infant died, so mother withdrawn|34|||
146645175|NCT04002908|528877699|FG001|Overall Study|Infant died, so mother withdrawn|0|||
146645176|NCT04002908|528877700|FG002|Overall Study|Infant died, so mother withdrawn|0|||
146645177|NCT04002908|528877701|FG003|Overall Study|Infant died, so mother withdrawn|0|||
146645178|NCT05477108|528877705|FG000|Overall Study|Participants randomized, not treated|1|||
146645179|NCT05477108|528877706|FG001|Overall Study|Participants randomized, not treated|1|||
146645180|NCT05477108|528877707|FG002|Overall Study|Participants randomized, not treated|1|||
146645181|NCT05477108|528877705|FG000|Overall Study|Physician Decision|0|||
146645182|NCT05477108|528877706|FG001|Overall Study|Physician Decision|0|||
146645183|NCT05477108|528877707|FG002|Overall Study|Physician Decision|1|||
146645184|NCT05477108|528877705|FG000|Overall Study|withdrawn from study|0|||
146645185|NCT05477108|528877706|FG001|Overall Study|withdrawn from study|0|||
146645186|NCT05477108|528877707|FG002|Overall Study|withdrawn from study|1|||
146645187|NCT00334113|528877709|FG000|Overall Study|Lost to Follow-up|2|||
146645188|NCT00334113|528877710|FG001|Overall Study|Lost to Follow-up|2|||
146645189|NCT00334113|528877709|FG000|Overall Study|Withdrawal by Subject|0|||
146645190|NCT00334113|528877710|FG001|Overall Study|Withdrawal by Subject|1|||
146645191|NCT02509026|528877715|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
146645192|NCT02509026|528877715|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
146645193|NCT02509026|528877715|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
146645194|NCT02509026|528877715|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
146645195|NCT02509026|528877715|FG000|Induction Period (24 Weeks)|Other|2|||
146645196|NCT02509026|528877715|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
146645197|NCT02509026|528877715|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
146645198|NCT02509026|528877715|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
146645199|NCT02509026|528877715|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
146645200|NCT02509026|528877715|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
146645201|NCT02509026|528877715|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
146645202|NCT02509026|528877715|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
146645203|NCT02509026|528877715|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
146645204|NCT00243841|528877716|FG000|Overall Study|Physician Decision|0|||
146645205|NCT00243841|528877717|FG001|Overall Study|Physician Decision|0|||
146645206|NCT00243841|528877718|FG002|Overall Study|Physician Decision|1|||
146645207|NCT00243841|528877719|FG003|Overall Study|Physician Decision|0|||
146645208|NCT00243841|528877720|FG004|Overall Study|Physician Decision|0|||
146645209|NCT00243841|528877721|FG005|Overall Study|Physician Decision|2|||
146645210|NCT01808092|528877722|FG000|Overall Study|Death|39|||
146645211|NCT01808092|528877723|FG001|Overall Study|Death|29|||
146645212|NCT01808092|528877722|FG000|Overall Study|Lost to Follow-up|3|||
146645213|NCT01808092|528877723|FG001|Overall Study|Lost to Follow-up|7|||
146971979|NCT03343054|530058493|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
146971980|NCT03343054|530058491|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
146497697|NCT02477826|528324714|FG005|Treatment Period|Death|2|||
146645214|NCT01808092|528877722|FG000|Overall Study|Withdrawal by Subject|9|||
146645215|NCT01808092|528877723|FG001|Overall Study|Withdrawal by Subject|4|||
146645216|NCT01808092|528877722|FG000|Overall Study|Other Eligibility criteria|3|||
146971981|NCT03343054|530058492|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
146971982|NCT03343054|530058493|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
146497698|NCT02477826|528324715|FG006|Treatment Period|Death|6|||
146497699|NCT02477826|528324716|FG007|Treatment Period|Death|5|||
146497700|NCT02477826|528324717|FG008|Treatment Period|Death|9|||
146497701|NCT02477826|528324718|FG009|Treatment Period|Death|0|||
146497702|NCT02477826|528324709|FG000|Treatment Period|Study Drug Toxicity|79|||
146497703|NCT02477826|528324710|FG001|Treatment Period|Study Drug Toxicity|51|||
146497704|NCT02477826|528324711|FG002|Treatment Period|Study Drug Toxicity|31|||
146497705|NCT02477826|528324712|FG003|Treatment Period|Study Drug Toxicity|39|||
146497706|NCT02477826|528324713|FG004|Treatment Period|Study Drug Toxicity|12|||
146497707|NCT02477826|528324714|FG005|Treatment Period|Study Drug Toxicity|25|||
146497708|NCT02477826|528324715|FG006|Treatment Period|Study Drug Toxicity|52|||
146645217|NCT01808092|528877723|FG001|Overall Study|Other Eligibility criteria|5|||
146645218|NCT03425253|528877728|FG000|Overall Study|Adverse Event|2|||
146645219|NCT03425253|528877728|FG000|Overall Study|Lost to Follow-up|3|||
146645220|NCT03425253|528877728|FG000|Overall Study|Withdrew Consent|6|||
146645221|NCT03425253|528877728|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
146645222|NCT04614324|528877729|FG000|Overall Study|Lost to Follow-up|3|||
146645223|NCT04614324|528877729|FG000|Overall Study|Physician Decision|1|||
146971983|NCT03343054|530058491|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
146497709|NCT02477826|528324716|FG007|Treatment Period|Study Drug Toxicity|30|||
146497710|NCT02477826|528324717|FG008|Treatment Period|Study Drug Toxicity|20|||
146497711|NCT02477826|528324718|FG009|Treatment Period|Study Drug Toxicity|9|||
146645224|NCT04614324|528877729|FG000|Overall Study|Withdrawal by Subject|2|||
146645225|NCT04614324|528877729|FG000|Overall Study|Remaining in Follow up|123|||
146645226|NCT01031836|528879256|FG000|Stage I|Adverse Event|1|||
146497712|NCT02477826|528324709|FG000|Treatment Period|Disease progression|212|||
146497713|NCT02477826|528324710|FG001|Treatment Period|Disease progression|240|||
146497714|NCT02477826|528324711|FG002|Treatment Period|Disease progression|202|||
146497715|NCT02477826|528324712|FG003|Treatment Period|Disease progression|93|||
146497716|NCT02477826|528324713|FG004|Treatment Period|Disease progression|113|||
146497717|NCT02477826|528324714|FG005|Treatment Period|Disease progression|96|||
146497718|NCT02477826|528324715|FG006|Treatment Period|Disease progression|208|||
146497719|NCT02477826|528324716|FG007|Treatment Period|Disease progression|195|||
146497720|NCT02477826|528324717|FG008|Treatment Period|Disease progression|59|||
146497721|NCT02477826|528324718|FG009|Treatment Period|Disease progression|46|||
146497722|NCT02477826|528324709|FG000|Treatment Period|Pregnancy|0|||
146497723|NCT02477826|528324710|FG001|Treatment Period|Pregnancy|0|||
146497724|NCT02477826|528324711|FG002|Treatment Period|Pregnancy|0|||
146497725|NCT02477826|528324712|FG003|Treatment Period|Pregnancy|0|||
146497726|NCT02477826|528324713|FG004|Treatment Period|Pregnancy|0|||
146497727|NCT02477826|528324714|FG005|Treatment Period|Pregnancy|0|||
146497728|NCT02477826|528324715|FG006|Treatment Period|Pregnancy|0|||
146497729|NCT02477826|528324716|FG007|Treatment Period|Pregnancy|0|||
146497730|NCT02477826|528324717|FG008|Treatment Period|Pregnancy|0|||
146497731|NCT02477826|528324718|FG009|Treatment Period|Pregnancy|1|||
146497732|NCT02477826|528324709|FG000|Treatment Period|Other|0|||
146497733|NCT02477826|528324710|FG001|Treatment Period|Other|0|||
146497734|NCT02477826|528324711|FG002|Treatment Period|Other|0|||
146497735|NCT02477826|528324712|FG003|Treatment Period|Other|0|||
146497736|NCT02477826|528324713|FG004|Treatment Period|Other|0|||
146497737|NCT02477826|528324714|FG005|Treatment Period|Other|0|||
146497738|NCT02477826|528324715|FG006|Treatment Period|Other|0|||
146497739|NCT02477826|528324716|FG007|Treatment Period|Other|0|||
146565362|NCT01628913|528582528|FG000|Overall Study|study terminated by Sponsor|4|||
146565363|NCT01628913|528582529|FG001|Overall Study|study terminated by Sponsor|9|||
146565364|NCT01628913|528582528|FG000|Overall Study|Withdrawal by Subject|1|||
146565365|NCT01628913|528582529|FG001|Overall Study|Withdrawal by Subject|0|||
146565366|NCT01628913|528582528|FG000|Overall Study|Physician Decision|1|||
146565367|NCT01628913|528582529|FG001|Overall Study|Physician Decision|3|||
146565368|NCT01146613|528582531|FG000|Overall Study|Lost to Follow-up|3|||
146565369|NCT01146613|528582532|FG001|Overall Study|Lost to Follow-up|8|||
146565370|NCT01146613|528582531|FG000|Overall Study|Lack of Efficacy|0|||
146565371|NCT01146613|528582532|FG001|Overall Study|Lack of Efficacy|1|||
146565372|NCT01146613|528582531|FG000|Overall Study|Death|1|||
146565373|NCT01146613|528582532|FG001|Overall Study|Death|0|||
146565374|NCT01146613|528582531|FG000|Overall Study|Physician Decision|1|||
146565375|NCT01146613|528582532|FG001|Overall Study|Physician Decision|0|||
146565376|NCT01146613|528582531|FG000|Overall Study|Withdrawal by Subject|0|||
146565377|NCT01146613|528582532|FG001|Overall Study|Withdrawal by Subject|3|||
146565378|NCT01146613|528582531|FG000|Overall Study|schedule conflict|1|||
146565379|NCT01146613|528582532|FG001|Overall Study|schedule conflict|0|||
146565380|NCT01146613|528582531|FG000|Overall Study|Outpatient detox|1|||
146565381|NCT01146613|528582532|FG001|Overall Study|Outpatient detox|0|||
146565382|NCT00320606|528582533|FG000|Overall Study|Adverse Event|1|||
146565383|NCT00320606|528582533|FG000|Overall Study|Protocol Violation|1|||
146565384|NCT00320606|528582533|FG000|Overall Study|Withdrawal by Subject|1|||
146565385|NCT03984825|528582534|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
146565386|NCT03984825|528582534|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
146565387|NCT03984825|528582534|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
146565388|NCT00399529|528582535|FG000|Overall Study|Off Study Prior to Treatment|2|||
146565389|NCT00742625|528582536|FG000|Remission Induction|Progression|6|||
146565390|NCT00742625|528582536|FG000|Remission Induction|Failed induction|8|||
146565391|NCT00742625|528582536|FG000|Remission Induction|Adverse Event|3|||
146565392|NCT00742625|528582536|FG000|Remission Induction|Death|10|||
146565393|NCT00742625|528582536|FG000|Remission Induction|Refusal|5|||
146565394|NCT00742625|528582536|FG000|Remission Induction|Non protocol treatment|17|||
146565395|NCT00742625|528582536|FG000|Remission Induction|Other, not specified|5|||
146565396|NCT00742625|528582536|FG000|Consolidation|Progression|5|||
146565397|NCT00742625|528582536|FG000|Consolidation|Adverse Event|1|||
146768999|NCT02020616|529321814|FG000|Overall Study|Early Termination Criteria Met|0|||
146912184|NCT03666143|529841436|FG000|Overall Study|Withdrawal by Subject|11|||
146497740|NCT02477826|528324717|FG008|Treatment Period|Other|0|||
146497741|NCT02477826|528324718|FG009|Treatment Period|Other|1|||
146497742|NCT00828568|528324719|FG000|Randomized|Withdrawal by Subject|1|||
146497743|NCT00828568|528324720|FG001|Randomized|Withdrawal by Subject|0|||
146565398|NCT00742625|528582536|FG000|Consolidation|Death|1|||
146565399|NCT00742625|528582536|FG000|Consolidation|Refused|1|||
146565400|NCT00742625|528582536|FG000|Consolidation|Non protocol therapy|13|||
146565401|NCT02519842|528582540|FG000|Base Study: Cycle 1|Screening Failure|1|||
146565402|NCT02519842|528582541|FG001|Base Study: Cycle 1|Screening Failure|1|||
146565403|NCT02519842|528582542|FG002|Base Study: Cycle 1|Screening Failure|0|||
146497744|NCT00828568|528324721|FG002|Randomized|Withdrawal by Subject|2|||
146497745|NCT00828568|528324719|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
146497746|NCT00828568|528324720|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
146497747|NCT00828568|528324721|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
146497748|NCT00828568|528324719|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
146497749|NCT00828568|528324720|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
146497750|NCT00828568|528324721|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
146497751|NCT00828568|528324719|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
146497752|NCT00828568|528324720|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
146497753|NCT00828568|528324721|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
146497754|NCT00828568|528324719|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
146497755|NCT00828568|528324720|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
146497756|NCT00828568|528324721|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
146497757|NCT00403481|528324722|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
146497758|NCT00403481|528324722|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
146497759|NCT00403481|528324722|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
146497760|NCT00403481|528324722|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
146497761|NCT00403481|528324722|FG000|Olm 40 mg|Adverse Event|2|||
146497762|NCT00403481|528324722|FG000|Olm 40 mg|Protocol Violation|1|||
146497763|NCT00403481|528324722|FG000|Olm 40 mg|Withdrawal by Subject|1|||
146497764|NCT00403481|528324722|FG000|Olm 40 mg|Other|1|||
146497765|NCT00403481|528324722|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
146497766|NCT00403481|528324722|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
146497767|NCT00403481|528324722|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
146497768|NCT00403481|528324722|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
146497769|NCT00403481|528324722|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
146497770|NCT00403481|528324722|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
146497771|NCT03793842|528324728|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
146497772|NCT03793842|528324729|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
146497773|NCT03793842|528324728|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
146497774|NCT03793842|528324729|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
146565404|NCT02519842|528582540|FG000|Base Study: Cycle 1|Adverse Event|1|||
146565405|NCT02519842|528582541|FG001|Base Study: Cycle 1|Adverse Event|0|||
146565406|NCT02519842|528582542|FG002|Base Study: Cycle 1|Adverse Event|0|||
146565407|NCT02519842|528582540|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
146565408|NCT02519842|528582541|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
146565409|NCT02519842|528582542|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
146565410|NCT02519842|528582540|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
146565411|NCT02519842|528582541|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
146565412|NCT02519842|528582542|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
146565413|NCT02519842|528582540|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
146565414|NCT02519842|528582541|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
146565415|NCT02519842|528582542|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
146565416|NCT02519842|528582540|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
146565417|NCT02519842|528582541|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
146565418|NCT02519842|528582542|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
146565419|NCT02519842|528582540|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
146565420|NCT02519842|528582541|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
146565421|NCT02519842|528582542|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
146565422|NCT02519842|528582540|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
146565423|NCT02519842|528582541|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
146565424|NCT02519842|528582542|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
146565425|NCT02519842|528582540|FG000|Optional Extension: Cycles 2-6|Death|0|||
146565426|NCT02519842|528582541|FG001|Optional Extension: Cycles 2-6|Death|0|||
146565427|NCT02519842|528582542|FG002|Optional Extension: Cycles 2-6|Death|1|||
146565428|NCT02519842|528582540|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
146565429|NCT02519842|528582541|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
146565430|NCT02519842|528582542|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
146565431|NCT02519842|528582540|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
146565432|NCT02519842|528582541|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
146565433|NCT02519842|528582542|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
146565434|NCT02519842|528582540|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
146565435|NCT02519842|528582541|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
146565436|NCT02519842|528582542|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
146565437|NCT02519842|528582540|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
146565438|NCT02519842|528582541|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
146565439|NCT02519842|528582542|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
146565440|NCT01448616|528582546|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
146565441|NCT01448616|528582547|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
146645227|NCT01031836|528879257|FG001|Stage I|Adverse Event|1|||
146497775|NCT04657198|528324730|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
146645228|NCT01031836|528879258|FG002|Stage I|Adverse Event|0|||
146645229|NCT01031836|528879259|FG003|Stage I|Adverse Event|0|||
146497776|NCT04657198|528324731|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
146497777|NCT04657198|528324732|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
146497778|NCT04087720|528324733|FG000|Overall Study|Withdrawal by Subject|2|||
146497779|NCT04087720|528324733|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
146497780|NCT01166438|528324734|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
146497781|NCT01166438|528324735|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
146497782|NCT01166438|528324734|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
146497783|NCT01166438|528324735|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
146497784|NCT01166438|528324734|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
146497785|NCT01166438|528324735|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
146497786|NCT01166438|528324734|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
146497787|NCT01166438|528324735|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
146497788|NCT01166438|528324734|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
146497789|NCT01166438|528324735|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
146497790|NCT01166438|528324734|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
146497791|NCT01166438|528324735|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
146497792|NCT02547220|528324738|FG000|Overall Study|Withdrawal by Subject|1|||
146497793|NCT02547220|528324739|FG001|Overall Study|Withdrawal by Subject|0|||
146497794|NCT02547220|528324738|FG000|Overall Study|Study terminated by sponsor|18|||
146497795|NCT02547220|528324739|FG001|Overall Study|Study terminated by sponsor|20|||
146497796|NCT01031680|528324743|FG000|Overall Study|Adverse Event|8|||
146497797|NCT01031680|528324744|FG001|Overall Study|Adverse Event|3|||
146497798|NCT01031680|528324743|FG000|Overall Study|Lost to Follow-up|2|||
146497799|NCT01031680|528324744|FG001|Overall Study|Lost to Follow-up|10|||
146497800|NCT01031680|528324743|FG000|Overall Study|Withdrawal by Subject|12|||
146497801|NCT01031680|528324744|FG001|Overall Study|Withdrawal by Subject|16|||
146497802|NCT01031680|528324743|FG000|Overall Study|Death|2|||
146497803|NCT01031680|528324744|FG001|Overall Study|Death|1|||
146497804|NCT01031680|528324743|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
146497805|NCT01031680|528324744|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
146497806|NCT01031680|528324743|FG000|Overall Study|Poor/Non-compliance|5|||
146497807|NCT01031680|528324744|FG001|Overall Study|Poor/Non-compliance|6|||
146497808|NCT01031680|528324743|FG000|Overall Study|Safety|1|||
146497809|NCT01031680|528324744|FG001|Overall Study|Safety|0|||
146497810|NCT01031680|528324743|FG000|Overall Study|Incorrect Enrolment|1|||
146497811|NCT01031680|528324744|FG001|Overall Study|Incorrect Enrolment|2|||
146497812|NCT01031680|528324743|FG000|Overall Study|Administrative Reason by Sponsor|0|||
146497813|NCT01031680|528324744|FG001|Overall Study|Administrative Reason by Sponsor|1|||
146497814|NCT01031680|528324743|FG000|Overall Study|Various|0|||
146497815|NCT01031680|528324744|FG001|Overall Study|Various|2|||
146497816|NCT01029782|528324745|FG000|Overall Study|Lost to Follow-up|2|||
146497817|NCT01029782|528324746|FG001|Overall Study|Lost to Follow-up|2|||
146497818|NCT01029782|528324745|FG000|Overall Study|Diagnosis changed|1|||
146497819|NCT01029782|528324746|FG001|Overall Study|Diagnosis changed|1|||
146497820|NCT01029782|528324745|FG000|Overall Study|Adverse Event|0|||
146497821|NCT01029782|528324746|FG001|Overall Study|Adverse Event|1|||
146497822|NCT01029782|528324745|FG000|Overall Study|Physician Decision|0|||
146497823|NCT01029782|528324746|FG001|Overall Study|Physician Decision|1|||
146497824|NCT01029782|528324745|FG000|Overall Study|Protocol Violation|0|||
146497825|NCT01029782|528324746|FG001|Overall Study|Protocol Violation|2|||
146565442|NCT01448616|528582548|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
146565443|NCT01448616|528582549|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
146565444|NCT01448616|528582546|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
146565445|NCT01448616|528582547|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
146565446|NCT01448616|528582548|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
146565447|NCT01448616|528582549|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
146565448|NCT01448616|528582546|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
146565449|NCT01448616|528582547|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
146565450|NCT01448616|528582548|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
146565451|NCT01448616|528582549|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
146565452|NCT01448616|528582546|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
146565453|NCT01448616|528582547|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
146497826|NCT01029782|528324745|FG000|Overall Study|Withdrawal by Subject|0|||
146497827|NCT01029782|528324746|FG001|Overall Study|Withdrawal by Subject|1|||
146497828|NCT01186692|528324750|FG000|Overall Study|Not Catheterized|11|||
146497829|NCT01186692|528324750|FG000|Overall Study|Futher testing contraindicated implant|19|||
146497830|NCT01186692|528324750|FG000|Overall Study|Adverse Event|2|||
146497831|NCT02195869|528324751|FG000|Overall Study|cGVHD Progression|5|||
146497832|NCT02195869|528324751|FG000|Overall Study|Malignancy Progression/relapse|2|||
146565454|NCT01448616|528582548|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
146645230|NCT01031836|528879260|FG004|Stage I|Adverse Event|0|||
146645231|NCT01031836|528879261|FG005|Stage I|Adverse Event|0|||
146645232|NCT01031836|528879256|FG000|Stage I|Other|0|||
146645233|NCT01031836|528879257|FG001|Stage I|Other|1|||
146645234|NCT01031836|528879258|FG002|Stage I|Other|0|||
146645235|NCT01031836|528879259|FG003|Stage I|Other|0|||
146645236|NCT01031836|528879260|FG004|Stage I|Other|0|||
146645237|NCT01031836|528879261|FG005|Stage I|Other|1|||
146645238|NCT01031836|528879256|FG000|Stage II|Adverse Event|0|||
146645239|NCT01031836|528879257|FG001|Stage II|Adverse Event|0|||
146645240|NCT01031836|528879258|FG002|Stage II|Adverse Event|2|||
146645241|NCT01031836|528879259|FG003|Stage II|Adverse Event|2|||
146645242|NCT01031836|528879260|FG004|Stage II|Adverse Event|1|||
146645243|NCT01031836|528879261|FG005|Stage II|Adverse Event|1|||
146645244|NCT01031836|528879256|FG000|Stage II|Other|2|||
146645245|NCT01031836|528879257|FG001|Stage II|Other|0|||
146645246|NCT01031836|528879258|FG002|Stage II|Other|0|||
146645247|NCT01031836|528879259|FG003|Stage II|Other|1|||
146645248|NCT01031836|528879260|FG004|Stage II|Other|1|||
146645249|NCT01031836|528879261|FG005|Stage II|Other|0|||
146645250|NCT00490529|528879262|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
146645251|NCT00490529|528879262|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
146971984|NCT03343054|530058492|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
146971985|NCT03343054|530058493|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
146971986|NCT04256759|530058494|FG000|Overall Study|Physician Decision|1|||
146971987|NCT04256759|530058494|FG000|Overall Study|Lack of Efficacy|1|||
146971988|NCT04075292|530058501|FG000|Overall Study|Withdrawal by Subject|1|||
146971989|NCT04075292|530058502|FG001|Overall Study|Withdrawal by Subject|9|||
146645252|NCT00490529|528879262|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
146645253|NCT00490529|528879262|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
146645254|NCT00490529|528879262|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
146645255|NCT00490529|528879262|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
146645256|NCT01410357|528879263|FG000|Overall Study|Death|2|||
146645257|NCT01410357|528879264|FG001|Overall Study|Death|1|||
146645258|NCT01410357|528879263|FG000|Overall Study|Withdrawal by Subject|1|||
146645259|NCT01410357|528879264|FG001|Overall Study|Withdrawal by Subject|2|||
146645260|NCT01410357|528879263|FG000|Overall Study|Lost to Follow-up|23|||
146645261|NCT01410357|528879264|FG001|Overall Study|Lost to Follow-up|21|||
146645262|NCT03467152|528879269|FG000|Overall Study|Adverse Event|4|||
146645263|NCT03467152|528879270|FG001|Overall Study|Adverse Event|5|||
146645264|NCT03467152|528879271|FG002|Overall Study|Adverse Event|0|||
146645265|NCT03467152|528879269|FG000|Overall Study|Subject Choice|1|||
146645266|NCT03467152|528879270|FG001|Overall Study|Subject Choice|3|||
146645267|NCT03467152|528879271|FG002|Overall Study|Subject Choice|0|||
146645268|NCT03467152|528879269|FG000|Overall Study|Lost to Follow-up|1|||
146645269|NCT03467152|528879270|FG001|Overall Study|Lost to Follow-up|0|||
146645270|NCT03467152|528879271|FG002|Overall Study|Lost to Follow-up|0|||
146645271|NCT03467152|528879269|FG000|Overall Study|Withdrawal by Subject|4|||
146645272|NCT03467152|528879270|FG001|Overall Study|Withdrawal by Subject|2|||
146645273|NCT03467152|528879271|FG002|Overall Study|Withdrawal by Subject|0|||
146645274|NCT03467152|528879269|FG000|Overall Study|Others|3|||
146645275|NCT03467152|528879270|FG001|Overall Study|Others|0|||
146645276|NCT03467152|528879271|FG002|Overall Study|Others|0|||
146645277|NCT03467152|528879269|FG000|Overall Study|Not treated|3|||
146645278|NCT03467152|528879270|FG001|Overall Study|Not treated|1|||
146645279|NCT03467152|528879271|FG002|Overall Study|Not treated|6|||
146645280|NCT00945906|528879273|FG000|Overall Study|Withdrawal by Subject|1|||
146645281|NCT00945906|528879273|FG000|Overall Study|Did not want to return for last visit|2|||
146645282|NCT00945906|528879273|FG000|Overall Study|Unable to return for last visit|2|||
146645283|NCT00945906|528879273|FG000|Overall Study|Moved to another country|2|||
146645284|NCT03700684|528879274|FG000|Overall Study|COVID-19|0|||
146645285|NCT03700684|528879275|FG001|Overall Study|COVID-19|0|||
146645286|NCT03700684|528879276|FG002|Overall Study|COVID-19|2|||
146645287|NCT01120782|528879277|FG000|Overall Study|Test article shipping error|11|||
146645288|NCT04140227|528879278|FG000|Overall Study|Withdrawal by Subject|26|||
146971990|NCT04075292|530058501|FG000|Overall Study|Death|2|||
146645289|NCT04140227|528879278|FG000|Overall Study|Lost to Follow-up|8|||
146645290|NCT04140227|528879278|FG000|Overall Study|Adverse Event|8|||
146645291|NCT04140227|528879278|FG000|Overall Study|Death|1|||
146645292|NCT04140227|528879278|FG000|Overall Study|Other|3|||
146645293|NCT04140227|528879278|FG000|Overall Study|Protocol Violation|2|||
146645294|NCT03180619|528879287|FG000|Overall Study|Withdrew Consent|5|||
146645295|NCT03180619|528879288|FG001|Overall Study|Withdrew Consent|0|||
146645296|NCT03180619|528879289|FG002|Overall Study|Withdrew Consent|2|||
146645297|NCT03180619|528879287|FG000|Overall Study|Death|2|||
146645298|NCT03180619|528879288|FG001|Overall Study|Death|1|||
146645299|NCT03180619|528879289|FG002|Overall Study|Death|2|||
146645300|NCT03180619|528879287|FG000|Overall Study|Adverse Event|2|||
146645301|NCT03180619|528879288|FG001|Overall Study|Adverse Event|0|||
146645302|NCT03180619|528879289|FG002|Overall Study|Adverse Event|1|||
146645303|NCT03180619|528879287|FG000|Overall Study|Investigator's discretion|2|||
146645304|NCT03180619|528879288|FG001|Overall Study|Investigator's discretion|0|||
146497833|NCT02195869|528324751|FG000|Overall Study|Adverse Event|15|||
146497834|NCT02195869|528324751|FG000|Overall Study|Withdrawal by Subject|7|||
146497835|NCT02195869|528324751|FG000|Overall Study|Physician Decision|4|||
146497836|NCT02195869|528324751|FG000|Overall Study|Study Terminated by Sponsor|7|||
146497837|NCT02195869|528324751|FG000|Overall Study|Noncompliance with study drug|2|||
146497838|NCT03319732|528324752|FG000|Overall Study|Adverse Event|40|||
146497839|NCT03319732|528324752|FG000|Overall Study|Withdrawal by Subject|50|||
146497840|NCT03319732|528324752|FG000|Overall Study|MS relapse|10|||
146497841|NCT03319732|528324752|FG000|Overall Study|reason not specified|5|||
146497842|NCT01921101|528324753|FG000|Overall Study|Death|16|||
146497843|NCT01921101|528324754|FG001|Overall Study|Death|6|||
146497844|NCT00767455|528324755|FG000|Overall Study|Investigator error|19|||
146497845|NCT04925557|528325885|FG000|Overall Study|Study closed|5|||
146497846|NCT04925557|528325886|FG001|Overall Study|Study closed|3|||
146497847|NCT05488470|528325887|FG000|Overall Study|Physician Decision|2|||
146497848|NCT05488470|528325887|FG000|Overall Study|Withdrawal by Subject|1|||
146497849|NCT05488470|528325887|FG000|Overall Study|Death|1|||
146497850|NCT00068393|528325892|FG000|Overall Study|Adverse Event|2|||
146497851|NCT00068393|528325892|FG000|Overall Study|Death|3|||
146497852|NCT00068393|528325892|FG000|Overall Study|Withdrawal by Subject|3|||
146497853|NCT00068393|528325892|FG000|Overall Study|Alternative treatment|1|||
146497854|NCT00068393|528325892|FG000|Overall Study|Quality of life worsening|1|||
146497855|NCT01108341|528325897|FG000|Overall Study|Death|2|||
146497856|NCT01108341|528325897|FG000|Overall Study|Withdrawal by Subject|1|||
146497857|NCT01108341|528325897|FG000|Overall Study|Lost to Follow-up|1|||
146497858|NCT01108341|528325897|FG000|Overall Study|Other|1|||
146497859|NCT01068730|528325898|FG000|Period 3|Personal reason|1|||
146497860|NCT01068730|528325899|FG001|Period 3|Personal reason|0|||
146497861|NCT01068730|528325900|FG002|Period 3|Personal reason|0|||
146497862|NCT01068730|528325901|FG003|Period 3|Personal reason|0|||
146497863|NCT01068730|528325898|FG000|Period 4|Family emergency|0|||
146497864|NCT01068730|528325899|FG001|Period 4|Family emergency|1|||
146497865|NCT01068730|528325900|FG002|Period 4|Family emergency|0|||
146497866|NCT01068730|528325901|FG003|Period 4|Family emergency|0|||
146497867|NCT00178685|528325903|FG000|Overall Study|Death|3|||
146497868|NCT00178685|528325904|FG001|Overall Study|Death|3|||
146497869|NCT00178685|528325905|FG002|Overall Study|Death|6|||
146497870|NCT00178685|528325903|FG000|Overall Study|Lost to Follow-up|100|||
146497871|NCT00178685|528325904|FG001|Overall Study|Lost to Follow-up|187|||
146497872|NCT00178685|528325905|FG002|Overall Study|Lost to Follow-up|183|||
146497873|NCT00178685|528325903|FG000|Overall Study|Withdrawal by Subject|8|||
146497874|NCT00178685|528325904|FG001|Overall Study|Withdrawal by Subject|14|||
146497875|NCT00178685|528325905|FG002|Overall Study|Withdrawal by Subject|7|||
146497876|NCT04112043|528325906|FG000|Overall Study|Withdrawal by Subject|1|||
146497877|NCT04112043|528325907|FG001|Overall Study|Withdrawal by Subject|1|||
146497878|NCT04112043|528325908|FG002|Overall Study|Withdrawal by Subject|1|||
146497879|NCT04112043|528325906|FG000|Overall Study|Taking NR supplement|1|||
146497880|NCT04112043|528325907|FG001|Overall Study|Taking NR supplement|0|||
146497881|NCT04112043|528325908|FG002|Overall Study|Taking NR supplement|0|||
146497882|NCT04112043|528325906|FG000|Overall Study|Adverse Event|0|||
146497883|NCT04112043|528325907|FG001|Overall Study|Adverse Event|1|||
146497884|NCT04112043|528325908|FG002|Overall Study|Adverse Event|0|||
146565455|NCT01448616|528582549|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
146497885|NCT01750697|528325911|FG000|Overall Study|Transferred Back to Local Hospital|1|||
146497886|NCT01750697|528325911|FG000|Overall Study|Physician and Family Decision|1|||
146497887|NCT01750697|528325911|FG000|Overall Study|Transferred to Adult Services|5|||
146497888|NCT01750697|528325911|FG000|Overall Study|Physician Decision|1|||
146497889|NCT01750697|528325911|FG000|Overall Study|Withdrawal by Subject|1|||
146497890|NCT00379080|528325914|FG000|Overall Study|Withdrawal by Subject|0|||
146497891|NCT00379080|528325915|FG001|Overall Study|Withdrawal by Subject|4|||
146497892|NCT00379080|528325916|FG002|Overall Study|Withdrawal by Subject|0|||
146497893|NCT01222520|528325917|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
146497894|NCT01222520|528325918|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
146497895|NCT01222520|528325917|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
146497896|NCT01222520|528325918|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
146497897|NCT01222520|528325917|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
146497898|NCT01222520|528325918|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
146497899|NCT01222520|528325917|FG000|Double-blind Period|Adverse Event|0|||
146497900|NCT01222520|528325918|FG001|Double-blind Period|Adverse Event|1|||
146497901|NCT01222520|528325917|FG000|Double-blind Period|Lack of Efficacy|0|||
146497902|NCT01222520|528325918|FG001|Double-blind Period|Lack of Efficacy|1|||
146497903|NCT01222520|528325917|FG000|Double-blind Period|Study medication stolen|1|||
146497904|NCT01222520|528325918|FG001|Double-blind Period|Study medication stolen|0|||
146497905|NCT02285166|528325919|FG000|Overall Study|Case Report Forms Uncollected|564|||
146497906|NCT02285166|528325919|FG000|Overall Study|Protocol Deviation|402|||
146497907|NCT02920008|528325920|FG000|Overall Study|Death|117|||
146565456|NCT01448616|528582546|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
146565457|NCT01448616|528582547|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
146497908|NCT02920008|528325921|FG001|Overall Study|Death|127|||
146497909|NCT02920008|528325920|FG000|Overall Study|Withdrawal by Subject|3|||
146497910|NCT02920008|528325921|FG001|Overall Study|Withdrawal by Subject|6|||
146497911|NCT02920008|528325920|FG000|Overall Study|Lost to Follow-up|0|||
146497912|NCT02920008|528325921|FG001|Overall Study|Lost to Follow-up|1|||
146497913|NCT01862250|528325922|FG000|Overall Study|Adverse Event|4|||
146645305|NCT03180619|528879289|FG002|Overall Study|Investigator's discretion|1|||
146645306|NCT00729469|528879290|FG000|Overall Study|Adverse Event|14|||
146645307|NCT00729469|528879291|FG001|Overall Study|Adverse Event|25|||
146645308|NCT00729469|528879290|FG000|Overall Study|Lost to Follow-up|9|||
146645309|NCT00729469|528879291|FG001|Overall Study|Lost to Follow-up|9|||
146645310|NCT00729469|528879290|FG000|Overall Study|Protocol Violation|2|||
146645311|NCT00729469|528879291|FG001|Overall Study|Protocol Violation|1|||
146645312|NCT00729469|528879290|FG000|Overall Study|Withdrawal by Subject|19|||
146645313|NCT00729469|528879291|FG001|Overall Study|Withdrawal by Subject|8|||
146645314|NCT00729469|528879290|FG000|Overall Study|Other-Not mentioned|9|||
146645315|NCT00729469|528879291|FG001|Overall Study|Other-Not mentioned|4|||
146645316|NCT00561977|528879294|FG000|Overall Study|Withdrawal by Subject|0|||
146645317|NCT00561977|528879295|FG001|Overall Study|Withdrawal by Subject|2|||
146645318|NCT00561977|528879296|FG002|Overall Study|Withdrawal by Subject|1|||
146645319|NCT00561977|528879294|FG000|Overall Study|Pregnancy|0|||
146645320|NCT00561977|528879295|FG001|Overall Study|Pregnancy|1|||
146645321|NCT00561977|528879296|FG002|Overall Study|Pregnancy|1|||
146645322|NCT04975438|528879297|FG000|Overall Study|Lost to Follow-up|1|||
146645323|NCT04975438|528879298|FG001|Overall Study|Lost to Follow-up|0|||
146645324|NCT04975438|528879299|FG002|Overall Study|Lost to Follow-up|1|||
146645325|NCT04975438|528879300|FG003|Overall Study|Lost to Follow-up|0|||
146645326|NCT04975438|528879297|FG000|Overall Study|Withdrawal by Subject|1|||
146645327|NCT04975438|528879298|FG001|Overall Study|Withdrawal by Subject|0|||
146645328|NCT04975438|528879299|FG002|Overall Study|Withdrawal by Subject|0|||
146645329|NCT04975438|528879300|FG003|Overall Study|Withdrawal by Subject|0|||
146645330|NCT00977080|528879301|FG000|Overall Study|Adverse Event|2|||
146645331|NCT00977080|528879302|FG001|Overall Study|Adverse Event|7|||
146645332|NCT00977080|528879303|FG002|Overall Study|Adverse Event|7|||
146645333|NCT00977080|528879304|FG003|Overall Study|Adverse Event|7|||
146645334|NCT00977080|528879301|FG000|Overall Study|Withdrawal by Subject|1|||
146645335|NCT00977080|528879302|FG001|Overall Study|Withdrawal by Subject|5|||
146645336|NCT00977080|528879303|FG002|Overall Study|Withdrawal by Subject|1|||
146645337|NCT00977080|528879304|FG003|Overall Study|Withdrawal by Subject|5|||
146645338|NCT00977080|528879301|FG000|Overall Study|Protocol Violation|7|||
146645339|NCT00977080|528879302|FG001|Overall Study|Protocol Violation|3|||
146645340|NCT00977080|528879303|FG002|Overall Study|Protocol Violation|4|||
146645341|NCT00977080|528879304|FG003|Overall Study|Protocol Violation|3|||
146645342|NCT00977080|528879301|FG000|Overall Study|Noncompliance|0|||
146645343|NCT00977080|528879302|FG001|Overall Study|Noncompliance|2|||
146497914|NCT01598090|528325927|FG000|Treatment Period|Poor/non-compliance|0|||
146497915|NCT01598090|528325928|FG001|Treatment Period|Poor/non-compliance|2|||
146497916|NCT01598090|528325929|FG002|Treatment Period|Poor/non-compliance|0|||
146497917|NCT01598090|528325927|FG000|Treatment Period|No longer meet study criteria|0|||
146497918|NCT01598090|528325928|FG001|Treatment Period|No longer meet study criteria|1|||
146497919|NCT01598090|528325929|FG002|Treatment Period|No longer meet study criteria|0|||
146497920|NCT01598090|528325927|FG000|Treatment Period|Lack of Efficacy|5|||
146497921|NCT01598090|528325928|FG001|Treatment Period|Lack of Efficacy|14|||
146497922|NCT01598090|528325929|FG002|Treatment Period|Lack of Efficacy|6|||
146497923|NCT01598090|528325927|FG000|Treatment Period|Adverse Event|2|||
146497924|NCT01598090|528325928|FG001|Treatment Period|Adverse Event|33|||
146497925|NCT01598090|528325929|FG002|Treatment Period|Adverse Event|17|||
146497926|NCT01598090|528325927|FG000|Treatment Period|Other reasons|0|||
146497927|NCT01598090|528325928|FG001|Treatment Period|Other reasons|4|||
146497928|NCT01598090|528325929|FG002|Treatment Period|Other reasons|1|||
146497929|NCT01598090|528325927|FG000|Treatment Period|Withdrawal by Subject|3|||
146497930|NCT01598090|528325928|FG001|Treatment Period|Withdrawal by Subject|13|||
146497931|NCT01598090|528325929|FG002|Treatment Period|Withdrawal by Subject|10|||
146497932|NCT01598090|528325927|FG000|Treatment Period|Lost to Follow-up|1|||
146645344|NCT00977080|528879303|FG002|Overall Study|Noncompliance|1|||
146645345|NCT00977080|528879304|FG003|Overall Study|Noncompliance|0|||
146645346|NCT00977080|528879301|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
146645347|NCT00977080|528879302|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
146645348|NCT00977080|528879303|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
146645349|NCT00977080|528879304|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
146645350|NCT00977080|528879301|FG000|Overall Study|Required kidney transplantation|1|||
146645351|NCT00977080|528879302|FG001|Overall Study|Required kidney transplantation|3|||
146645352|NCT00977080|528879303|FG002|Overall Study|Required kidney transplantation|3|||
146645353|NCT00977080|528879304|FG003|Overall Study|Required kidney transplantation|1|||
146497933|NCT01598090|528325928|FG001|Treatment Period|Lost to Follow-up|5|||
146497934|NCT01598090|528325929|FG002|Treatment Period|Lost to Follow-up|1|||
146497935|NCT01598090|528325927|FG000|Follow-up Period|Death|0|||
146645354|NCT00977080|528879301|FG000|Overall Study|Travel for family reasons|1|||
146497936|NCT01598090|528325928|FG001|Follow-up Period|Death|1|||
146497937|NCT01598090|528325929|FG002|Follow-up Period|Death|0|||
146497938|NCT01598090|528325927|FG000|Follow-up Period|No longer required per protocol|1|||
146497939|NCT01598090|528325928|FG001|Follow-up Period|No longer required per protocol|3|||
146497940|NCT01598090|528325929|FG002|Follow-up Period|No longer required per protocol|2|||
146497941|NCT01598090|528325927|FG000|Follow-up Period|Not reported|0|||
146497942|NCT01598090|528325928|FG001|Follow-up Period|Not reported|10|||
146497943|NCT01598090|528325929|FG002|Follow-up Period|Not reported|4|||
146497944|NCT01598090|528325927|FG000|Follow-up Period|Withdrawal by Subject|0|||
146497945|NCT01598090|528325928|FG001|Follow-up Period|Withdrawal by Subject|3|||
146497946|NCT01598090|528325929|FG002|Follow-up Period|Withdrawal by Subject|2|||
146497947|NCT01598090|528325927|FG000|Follow-up Period|Other reasons|2|||
146497948|NCT01598090|528325928|FG001|Follow-up Period|Other reasons|8|||
146497949|NCT01598090|528325929|FG002|Follow-up Period|Other reasons|8|||
146497950|NCT01598090|528325927|FG000|Follow-up Period|Lost to Follow-up|2|||
146497951|NCT01598090|528325928|FG001|Follow-up Period|Lost to Follow-up|10|||
146497952|NCT01598090|528325929|FG002|Follow-up Period|Lost to Follow-up|12|||
146497953|NCT02549287|528325932|FG000|Overall Study|Lost to Follow-up|65|||
146497954|NCT02549287|528325933|FG001|Overall Study|Lost to Follow-up|26|||
146497955|NCT02549287|528325932|FG000|Overall Study|Withdrawal by Subject|15|||
146497956|NCT02549287|528325933|FG001|Overall Study|Withdrawal by Subject|6|||
146497957|NCT00520533|528325934|FG000|Overall Study|Death|1|||
146497958|NCT00520533|528325934|FG000|Overall Study|Suspension of the study for safety reasons|1|||
146497959|NCT00520533|528325934|FG000|Overall Study|Withdrawal by Subject|1|||
146497960|NCT00520533|528325934|FG000|Overall Study|Physician Decision|1|||
146497961|NCT01377922|528325935|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
146497962|NCT01377922|528325936|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
146497963|NCT01218087|528325937|FG000|Overall Study|Death|2|||
146497964|NCT01218087|528325938|FG001|Overall Study|Death|1|||
146497965|NCT01218087|528325937|FG000|Overall Study|Withdrawal by Subject|5|||
146497966|NCT01218087|528325938|FG001|Overall Study|Withdrawal by Subject|0|||
146497967|NCT01218087|528325937|FG000|Overall Study|Transferred|8|||
146497968|NCT01218087|528325938|FG001|Overall Study|Transferred|5|||
146497969|NCT02157376|528325941|FG000|Overall Study|Death|10|||
146497970|NCT02157376|528325942|FG001|Overall Study|Death|4|||
146497971|NCT02157376|528325941|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146497972|NCT02157376|528325942|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146497973|NCT02157376|528325941|FG000|Overall Study|Withdrawal by Subject|3|||
146497974|NCT02157376|528325942|FG001|Overall Study|Withdrawal by Subject|8|||
146497975|NCT02157376|528325941|FG000|Overall Study|Not treated|8|||
146497976|NCT02157376|528325942|FG001|Overall Study|Not treated|3|||
146497977|NCT02157376|528325941|FG000|Overall Study|Investigator's misjudgement|1|||
146497978|NCT02157376|528325942|FG001|Overall Study|Investigator's misjudgement|2|||
146497979|NCT00529373|528325949|FG000|Base Study|Adverse Event|525|||
146497980|NCT00529373|528325950|FG001|Base Study|Adverse Event|470|||
146497981|NCT00529373|528325949|FG000|Base Study|Lack of Efficacy|16|||
146497982|NCT00529373|528325950|FG001|Base Study|Lack of Efficacy|75|||
146497983|NCT00529373|528325949|FG000|Base Study|Lost to Follow-up|221|||
146497984|NCT00529373|528325950|FG001|Base Study|Lost to Follow-up|208|||
146497985|NCT00529373|528325949|FG000|Base Study|Other Protocol Specified Criteria|19|||
146497986|NCT00529373|528325950|FG001|Base Study|Other Protocol Specified Criteria|20|||
146497987|NCT00529373|528325949|FG000|Base Study|Physician Decision|60|||
146497988|NCT00529373|528325950|FG001|Base Study|Physician Decision|52|||
146497989|NCT00529373|528325949|FG000|Base Study|Protocol Violation|48|||
146497990|NCT00529373|528325950|FG001|Base Study|Protocol Violation|38|||
146497991|NCT00529373|528325949|FG000|Base Study|Withdrawal by Subject|1062|||
146497992|NCT00529373|528325950|FG001|Base Study|Withdrawal by Subject|967|||
146497993|NCT00529373|528325949|FG000|Base Study|Did not continue into Extension|1795|||
146497994|NCT00529373|528325950|FG001|Base Study|Did not continue into Extension|2238|||
146497995|NCT00529373|528325949|FG000|First Extension Study|Adverse Event|162|||
146497996|NCT00529373|528325950|FG001|First Extension Study|Adverse Event|142|||
146497997|NCT00529373|528325949|FG000|First Extension Study|Lack of Efficacy|65|||
146497998|NCT00529373|528325950|FG001|First Extension Study|Lack of Efficacy|427|||
146497999|NCT00529373|528325949|FG000|First Extension Study|Lost to Follow-up|41|||
146498000|NCT00529373|528325950|FG001|First Extension Study|Lost to Follow-up|37|||
146498001|NCT00529373|528325949|FG000|First Extension Study|Other|27|||
146498002|NCT00529373|528325950|FG001|First Extension Study|Other|47|||
146498003|NCT00529373|528325949|FG000|First Extension Study|Physician Decision|50|||
146498004|NCT00529373|528325950|FG001|First Extension Study|Physician Decision|45|||
146498005|NCT00529373|528325949|FG000|First Extension Study|Protocol Violation|16|||
146498006|NCT00529373|528325950|FG001|First Extension Study|Protocol Violation|13|||
146498007|NCT00529373|528325949|FG000|First Extension Study|Withdrawal by Subject|296|||
146971991|NCT04075292|530058502|FG001|Overall Study|Death|5|||
146498008|NCT00529373|528325950|FG001|First Extension Study|Withdrawal by Subject|287|||
146498009|NCT00529373|528325949|FG000|First Extension Study|Disposition record non-existing|0|||
146498010|NCT00529373|528325950|FG001|First Extension Study|Disposition record non-existing|1|||
146498011|NCT00529373|528325949|FG000|First Extension Study|Discontinued after 5 years completion|208|||
146498012|NCT00529373|528325950|FG001|First Extension Study|Discontinued after 5 years completion|346|||
146498013|NCT00529373|528325949|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
146498014|NCT00529373|528325950|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
146498015|NCT00529373|528325949|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
146498016|NCT00529373|528325950|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
146498017|NCT00529373|528325949|FG000|Second Extension Study|Adverse Event|101|||
146498018|NCT00529373|528325950|FG001|Second Extension Study|Adverse Event|51|||
146498019|NCT00529373|528325949|FG000|Second Extension Study|Lack of Efficacy|7|||
146498020|NCT00529373|528325950|FG001|Second Extension Study|Lack of Efficacy|15|||
146498021|NCT00529373|528325949|FG000|Second Extension Study|Lost to Follow-up|18|||
146498022|NCT00529373|528325950|FG001|Second Extension Study|Lost to Follow-up|12|||
146498023|NCT00529373|528325949|FG000|Second Extension Study|Other|7|||
146498024|NCT00529373|528325950|FG001|Second Extension Study|Other|12|||
146498025|NCT00529373|528325949|FG000|Second Extension Study|Physician Decision|63|||
146498026|NCT00529373|528325950|FG001|Second Extension Study|Physician Decision|26|||
146498027|NCT00529373|528325949|FG000|Second Extension Study|Protocol Violation|2|||
146498028|NCT00529373|528325950|FG001|Second Extension Study|Protocol Violation|1|||
146498029|NCT00529373|528325949|FG000|Second Extension Study|Withdrawal by Subject|97|||
146498030|NCT00529373|528325950|FG001|Second Extension Study|Withdrawal by Subject|75|||
146498031|NCT00529373|528325949|FG000|Second Extension Study|Status Missing|5|||
146498032|NCT00529373|528325950|FG001|Second Extension Study|Status Missing|5|||
146498033|NCT01074268|528325951|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
146498034|NCT01074268|528325952|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
146498035|NCT01074268|528325951|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
146498036|NCT01074268|528325952|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
146498037|NCT01074268|528325951|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
146498038|NCT01074268|528325952|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
146498039|NCT01074268|528325951|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
146498040|NCT01074268|528325952|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
146498041|NCT01074268|528325951|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
146498042|NCT01074268|528325952|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
146498043|NCT01074268|528325951|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
146498044|NCT01074268|528325952|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
146498045|NCT01074268|528325951|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
146498046|NCT01074268|528325952|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
146498047|NCT01074268|528325951|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
146498048|NCT01074268|528325952|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
146498049|NCT01074268|528325951|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
146498050|NCT01074268|528325952|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
146498051|NCT00603473|528325953|FG000|Overall Study|Adverse Event|4|||
146498052|NCT00603473|528325953|FG000|Overall Study|Lack of Efficacy|4|||
146498053|NCT00603473|528325953|FG000|Overall Study|Protocol Violation|1|||
146498054|NCT04200651|528325954|FG000|Overall Study|Moved to another country during follow-up|2|||
146498055|NCT04200651|528325955|FG001|Overall Study|Moved to another country during follow-up|2|||
146498056|NCT04200651|528325954|FG000|Overall Study|Lost to Follow-up|1|||
146498057|NCT04200651|528325955|FG001|Overall Study|Lost to Follow-up|3|||
146498058|NCT00733421|528325959|FG000|Overall Study|Withdrawal by Subject|1|||
146498059|NCT00733421|528325960|FG001|Overall Study|Withdrawal by Subject|1|||
146498060|NCT04185220|528325961|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
146498061|NCT04185220|528325962|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
146498062|NCT04185220|528325961|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
146498063|NCT04185220|528325962|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
146498064|NCT01870973|528325967|FG000|Overall Study|Lost to Follow-up|10|||
146498065|NCT01870973|528325968|FG001|Overall Study|Lost to Follow-up|3|||
146498066|NCT02729051|528325971|FG000|Overall Study|Adverse Event|21|||
146498067|NCT02729051|528325972|FG001|Overall Study|Adverse Event|11|||
146498068|NCT02729051|528325971|FG000|Overall Study|Lack of Efficacy|1|||
146498069|NCT02729051|528325972|FG001|Overall Study|Lack of Efficacy|1|||
146498070|NCT02729051|528325971|FG000|Overall Study|Lost to Follow-up|1|||
146498071|NCT02729051|528325972|FG001|Overall Study|Lost to Follow-up|2|||
146498072|NCT02729051|528325971|FG000|Overall Study|Physician Decision|1|||
146498073|NCT02729051|528325972|FG001|Overall Study|Physician Decision|1|||
146769000|NCT02020616|529321815|FG001|Overall Study|Early Termination Criteria Met|0|||
146769001|NCT02020616|529321816|FG002|Overall Study|Early Termination Criteria Met|1|||
146769002|NCT02020616|529321817|FG003|Overall Study|Early Termination Criteria Met|0|||
146498074|NCT02729051|528325971|FG000|Overall Study|Withdrawal by Subject|6|||
146769003|NCT02020616|529321818|FG004|Overall Study|Early Termination Criteria Met|0|||
146769004|NCT02020616|529321819|FG005|Overall Study|Early Termination Criteria Met|1|||
146769005|NCT02020616|529321820|FG006|Overall Study|Early Termination Criteria Met|0|||
146498075|NCT02729051|528325972|FG001|Overall Study|Withdrawal by Subject|17|||
146498076|NCT02702388|528325973|FG000|Overall Study|Disease Progression|18|||
146498077|NCT02702388|528325974|FG001|Overall Study|Disease Progression|25|||
146498078|NCT02702388|528325973|FG000|Overall Study|Withdrawal by Subject|9|||
146498079|NCT02702388|528325974|FG001|Overall Study|Withdrawal by Subject|7|||
146498080|NCT02702388|528325973|FG000|Overall Study|Adverse Event|11|||
146498081|NCT02702388|528325974|FG001|Overall Study|Adverse Event|15|||
146498082|NCT02702388|528325973|FG000|Overall Study|Other|2|||
146498083|NCT02702388|528325974|FG001|Overall Study|Other|4|||
146498084|NCT00596817|528325975|FG000|Open-label Period|Adverse Event|0|||
146498085|NCT00596817|528325976|FG001|Open-label Period|Adverse Event|49|||
146498086|NCT00596817|528325975|FG000|Open-label Period|Lack of Efficacy|0|||
146498087|NCT00596817|528325976|FG001|Open-label Period|Lack of Efficacy|33|||
146498088|NCT00596817|528325975|FG000|Open-label Period|Other Reasons|0|||
146498089|NCT00596817|528325976|FG001|Open-label Period|Other Reasons|65|||
146498090|NCT00596817|528325975|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
146498091|NCT00596817|528325976|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
146498092|NCT00596817|528325975|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
146498093|NCT00596817|528325976|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
146498094|NCT00596817|528325975|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
146498095|NCT00596817|528325976|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
146498096|NCT00596817|528325975|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
146498097|NCT00596817|528325976|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
146498098|NCT00596817|528325975|FG000|Double-blind Period|Adverse Event|5|||
146498099|NCT00596817|528325976|FG001|Double-blind Period|Adverse Event|16|||
146498100|NCT00596817|528325975|FG000|Double-blind Period|Lack of Efficacy|52|||
146498101|NCT00596817|528325976|FG001|Double-blind Period|Lack of Efficacy|28|||
146498102|NCT00596817|528325975|FG000|Double-blind Period|Non-compliance With Study Product|3|||
146498103|NCT00596817|528325976|FG001|Double-blind Period|Non-compliance With Study Product|4|||
146498104|NCT00596817|528325975|FG000|Double-blind Period|Protocol Violation|11|||
146498105|NCT00596817|528325976|FG001|Double-blind Period|Protocol Violation|8|||
146498106|NCT00596817|528325975|FG000|Double-blind Period|Withdrawal of Consent|7|||
146498107|NCT00596817|528325976|FG001|Double-blind Period|Withdrawal of Consent|3|||
146498108|NCT00596817|528325975|FG000|Double-blind Period|Lost to Follow-up|0|||
146498109|NCT00596817|528325976|FG001|Double-blind Period|Lost to Follow-up|2|||
146498110|NCT00596817|528325975|FG000|Double-blind Period|Other Reasons|10|||
146498111|NCT00596817|528325976|FG001|Double-blind Period|Other Reasons|18|||
146498112|NCT03232931|528327873|FG000|Overall Study|Physician Decision|1|||
146498113|NCT03232931|528327874|FG001|Overall Study|Physician Decision|1|||
146498114|NCT03232931|528327873|FG000|Overall Study|Withdrawal by Subject|6|||
146498115|NCT03232931|528327874|FG001|Overall Study|Withdrawal by Subject|0|||
146498116|NCT03232931|528327873|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
146498117|NCT03232931|528327874|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
146498118|NCT03232931|528327873|FG000|Overall Study|Parent did not record voice|1|||
146498119|NCT03232931|528327874|FG001|Overall Study|Parent did not record voice|2|||
146498120|NCT03232931|528327873|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
146498121|NCT03232931|528327874|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
146498122|NCT01190410|528327875|FG000|Overall Study|Adverse Event|0|||
146498123|NCT01190410|528327876|FG001|Overall Study|Adverse Event|3|||
146498124|NCT01190410|528327875|FG000|Overall Study|Lack of Efficacy|0|||
146498125|NCT01190410|528327876|FG001|Overall Study|Lack of Efficacy|2|||
146498126|NCT01190410|528327875|FG000|Overall Study|Withdrawal by Subject|0|||
146498127|NCT01190410|528327876|FG001|Overall Study|Withdrawal by Subject|2|||
146498128|NCT01190410|528327875|FG000|Overall Study|Administrative decision|1|||
146498129|NCT01190410|528327876|FG001|Overall Study|Administrative decision|0|||
146498130|NCT01190410|528327875|FG000|Overall Study|PI discretion|0|||
146498131|NCT01190410|528327876|FG001|Overall Study|PI discretion|2|||
146498132|NCT03300505|528327881|FG000|Overall Study|Death|0|||
146498133|NCT03300505|528327882|FG001|Overall Study|Death|1|||
146498134|NCT03300505|528327883|FG002|Overall Study|Death|0|||
146498135|NCT03300505|528327881|FG000|Overall Study|Withdrawal by Subject|0|||
146498136|NCT03300505|528327882|FG001|Overall Study|Withdrawal by Subject|1|||
146498137|NCT03300505|528327883|FG002|Overall Study|Withdrawal by Subject|1|||
146498138|NCT03300505|528327881|FG000|Overall Study|Sponsor Termination|0|||
146498139|NCT03300505|528327882|FG001|Overall Study|Sponsor Termination|1|||
146498140|NCT03300505|528327883|FG002|Overall Study|Sponsor Termination|0|||
146498141|NCT03300505|528327881|FG000|Overall Study|Adverse Event|0|||
146565458|NCT01448616|528582548|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
146565459|NCT01448616|528582549|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
146565460|NCT02943473|528582550|FG000|Overall Study|enrolled but not dosed|1|||
146565461|NCT02943473|528582550|FG000|Overall Study|screen failure|1|||
146565462|NCT02943473|528582550|FG000|Overall Study|Physician Decision|4|||
146498142|NCT03300505|528327882|FG001|Overall Study|Adverse Event|0|||
146498143|NCT03300505|528327883|FG002|Overall Study|Adverse Event|2|||
146498144|NCT05119595|528327884|FG000|Overall Study|Death|1|||
146498145|NCT05119595|528327884|FG000|Overall Study|Lost to Follow-up|7|||
146498146|NCT01283334|528327889|FG000|Overall Study|Withdrawal by Subject|1|||
146498147|NCT01283334|528327889|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
146498148|NCT01283334|528327889|FG000|Overall Study|Adverse Event|4|||
146498149|NCT01283334|528327889|FG000|Overall Study|Physician Decision|1|||
146498150|NCT03467217|528327890|FG000|Overall Study|Trial stopped early|5|||
146498151|NCT03467217|528327891|FG001|Overall Study|Trial stopped early|2|||
146498152|NCT03467217|528327890|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
146498153|NCT03467217|528327891|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
146498154|NCT03467217|528327890|FG000|Overall Study|Lost to Follow-up|0|||
146498155|NCT03467217|528327891|FG001|Overall Study|Lost to Follow-up|2|||
146498156|NCT04981470|528327892|FG000|Overall Study|Device failure in all 4 patients|4|||
146498157|NCT00784238|528327893|FG000|Overall Study|Adverse Event|14|||
146498158|NCT00784238|528327893|FG000|Overall Study|Death|2|||
146498159|NCT00784238|528327893|FG000|Overall Study|Lack of Efficacy|33|||
146498160|NCT00784238|528327893|FG000|Overall Study|Lost to Follow-up|29|||
146498161|NCT00784238|528327893|FG000|Overall Study|Pregnancy|1|||
146498162|NCT00784238|528327893|FG000|Overall Study|Withdrawal by Subject|26|||
146498163|NCT00784238|528327893|FG000|Overall Study|Other|14|||
146498164|NCT03806933|528327894|FG000|Main Period|Physician Decision|0|||
146498165|NCT03806933|528327895|FG001|Main Period|Physician Decision|0|||
146498166|NCT03806933|528327896|FG002|Main Period|Physician Decision|0|||
146498167|NCT03806933|528327897|FG003|Main Period|Physician Decision|1|||
146498168|NCT03806933|528327894|FG000|Main Period|Pregnancy|0|||
146498169|NCT03806933|528327895|FG001|Main Period|Pregnancy|0|||
146498170|NCT03806933|528327896|FG002|Main Period|Pregnancy|1|||
146498171|NCT03806933|528327897|FG003|Main Period|Pregnancy|0|||
146498172|NCT03806933|528327894|FG000|Main Period|Withdrawal by Subject|2|||
146498173|NCT03806933|528327895|FG001|Main Period|Withdrawal by Subject|1|||
146498174|NCT03806933|528327896|FG002|Main Period|Withdrawal by Subject|1|||
146498175|NCT03806933|528327897|FG003|Main Period|Withdrawal by Subject|2|||
146498176|NCT03806933|528327894|FG000|Main Period|Lost to Follow-up|2|||
146498177|NCT03806933|528327895|FG001|Main Period|Lost to Follow-up|2|||
146498178|NCT03806933|528327896|FG002|Main Period|Lost to Follow-up|0|||
146498179|NCT03806933|528327897|FG003|Main Period|Lost to Follow-up|0|||
146498180|NCT03806933|528327894|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
146498181|NCT03806933|528327895|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
146498182|NCT03806933|528327896|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
146498183|NCT03806933|528327897|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
146498184|NCT00078767|528327898|FG000|Overall Study|Withdrawal by Subject|1|||
146498185|NCT00078767|528327899|FG001|Overall Study|Withdrawal by Subject|1|||
146498186|NCT01736397|528327902|FG000|Overall Study|Lack of Efficacy|1|||
146498187|NCT01736397|528327903|FG001|Overall Study|Lack of Efficacy|11|||
146498188|NCT01736397|528327902|FG000|Overall Study|Withdrawal by Subject|6|||
146498189|NCT01736397|528327903|FG001|Overall Study|Withdrawal by Subject|5|||
146498190|NCT01736397|528327902|FG000|Overall Study|Lost to Follow-up|0|||
146498191|NCT01736397|528327903|FG001|Overall Study|Lost to Follow-up|1|||
146498192|NCT01736397|528327902|FG000|Overall Study|Adverse Event|6|||
146498193|NCT01736397|528327903|FG001|Overall Study|Adverse Event|3|||
146498194|NCT01736397|528327902|FG000|Overall Study|Not stated|1|||
146498195|NCT01736397|528327903|FG001|Overall Study|Not stated|4|||
146498196|NCT05088603|528327904|FG000|Overall Study|Protocol Violation|6|||
146498197|NCT05088603|528327905|FG001|Overall Study|Protocol Violation|1|||
146498198|NCT01868438|528327908|FG000|First Intervention|Withdrawal by Subject|5|||
146498199|NCT01868438|528327909|FG001|First Intervention|Withdrawal by Subject|1|||
146498200|NCT01868438|528327908|FG000|First Intervention|Lost to Follow-up|2|||
146498201|NCT01868438|528327909|FG001|First Intervention|Lost to Follow-up|3|||
146498202|NCT01868438|528327908|FG000|First Intervention|Meeting the non-redosing criteria|0|||
146498203|NCT01868438|528327909|FG001|First Intervention|Meeting the non-redosing criteria|1|||
146498204|NCT01868438|528327908|FG000|Second Intervention|Adverse Event|3|||
146498205|NCT01868438|528327909|FG001|Second Intervention|Adverse Event|3|||
146498206|NCT03260244|528327910|FG000|Overall Study|Death|19|||
146498207|NCT03260244|528327910|FG000|Overall Study|Lost to Follow-up|60|||
146498208|NCT03260244|528327910|FG000|Overall Study|Withdrawal by Subject|48|||
146498209|NCT03260244|528327910|FG000|Overall Study|Procedure Not Performed|21|||
146498210|NCT03260244|528327910|FG000|Overall Study|Enrollment Criteria Not Met|31|||
146498211|NCT03260244|528327910|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
146498212|NCT03260244|528327910|FG000|Overall Study|Subject Noncompliance|6|||
146498213|NCT03260244|528327910|FG000|Overall Study|No inducible Arrhythmia|2|||
146498214|NCT03260244|528327910|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
146498215|NCT03260244|528327910|FG000|Overall Study|Screen Failure|2|||
146498216|NCT03260244|528327910|FG000|Overall Study|Treated Off Label|69|||
146498217|NCT03260244|528327910|FG000|Overall Study|No Radiofrequency Ablation|14|||
146498218|NCT03233529|528327911|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
146498219|NCT03233529|528327911|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
146498220|NCT01177293|528327915|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
146498221|NCT01177293|528327916|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
146498222|NCT00594100|528327923|FG000|Procedure|Technical Failure|9|||
146498223|NCT00594100|528327923|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
146498224|NCT00594100|528327923|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
146498225|NCT00594100|528327923|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
146498226|NCT00956592|528327924|FG000|Overall Study|Protocol Violation|1|||
146498227|NCT00956592|528327925|FG001|Overall Study|Protocol Violation|3|||
146498228|NCT03528369|528327926|FG000|Overall Study|Withdrawal by Subject|2|||
146971992|NCT04075292|530058501|FG000|Overall Study|Remained on study at time of DCO|74|||
146971993|NCT04075292|530058502|FG001|Overall Study|Remained on study at time of DCO|64|||
146971994|NCT01826201|530058503|FG000|Overall Study|Non compliance with protocol|4|||
146971995|NCT03829462|530058505|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
146971996|NCT03829462|530058506|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
146971997|NCT03829462|530058505|FG000|Overall Study|No treatment due to progression disease|0|||
146971998|NCT03829462|530058506|FG001|Overall Study|No treatment due to progression disease|1|||
146971999|NCT00481871|530058509|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
146498229|NCT03528369|528327927|FG001|Overall Study|Withdrawal by Subject|0|||
146498230|NCT03528369|528327928|FG002|Overall Study|Withdrawal by Subject|0|||
146498231|NCT03528369|528327926|FG000|Overall Study|Lost to Follow-up|1|||
146498232|NCT03528369|528327927|FG001|Overall Study|Lost to Follow-up|0|||
146498233|NCT03528369|528327928|FG002|Overall Study|Lost to Follow-up|0|||
146498234|NCT03528369|528327926|FG000|Overall Study|Adverse Event|0|||
146972000|NCT00481871|530058510|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
146972001|NCT00481871|530058511|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
146972002|NCT00481871|530058512|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
146972003|NCT00481871|530058513|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
146972004|NCT06065176|530058514|FG000|Overall Study|Lost to Follow-up|11|||
146498235|NCT03528369|528327927|FG001|Overall Study|Adverse Event|1|||
146498236|NCT03528369|528327928|FG002|Overall Study|Adverse Event|0|||
146498237|NCT02162719|528327929|FG000|Overall Study|Death|41|||
146498238|NCT02162719|528327930|FG001|Overall Study|Death|46|||
146498239|NCT02162719|528327929|FG000|Overall Study|Lost to Follow-up|1|||
146498240|NCT02162719|528327930|FG001|Overall Study|Lost to Follow-up|3|||
146498241|NCT02162719|528327929|FG000|Overall Study|Disease Progression|2|||
146498242|NCT02162719|528327930|FG001|Overall Study|Disease Progression|1|||
146498243|NCT02162719|528327929|FG000|Overall Study|Withdrawal by Subject|8|||
146498244|NCT02162719|528327930|FG001|Overall Study|Withdrawal by Subject|2|||
146498245|NCT02162719|528327929|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
146498246|NCT02162719|528327930|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
146498247|NCT03555565|528327931|FG000|Overall Study|Case Report Forms Uncollected|2|||
146498248|NCT03555565|528327931|FG000|Overall Study|Protocol Deviation|13|||
146498249|NCT00076752|528327935|FG000|Overall Study|Death|2|||
146498250|NCT00076752|528327935|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
146498251|NCT00394836|528327938|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
146498252|NCT00394836|528327939|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
146498253|NCT00394836|528327938|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
146498254|NCT00394836|528327939|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
146498255|NCT00394836|528327938|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
146498256|NCT00394836|528327939|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
146498257|NCT00394836|528327938|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
146498258|NCT00394836|528327939|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
146498259|NCT00394836|528327938|FG000|Teatment or Follow-up Phase|Death|0|||
146498260|NCT00394836|528327939|FG001|Teatment or Follow-up Phase|Death|1|||
146498261|NCT00394836|528327938|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
146498262|NCT00394836|528327939|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
146498263|NCT00394836|528327938|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
146498264|NCT00394836|528327939|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
146565463|NCT01567722|528582557|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
146565464|NCT01567722|528582558|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
146972005|NCT06065176|530058515|FG001|Overall Study|Lost to Follow-up|11|||
146972006|NCT06065176|530058516|FG002|Overall Study|Lost to Follow-up|10|||
146972007|NCT06065176|530058514|FG000|Overall Study|Withdrawal by Subject|1|||
146972008|NCT06065176|530058515|FG001|Overall Study|Withdrawal by Subject|1|||
146498265|NCT00394836|528327938|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
146498266|NCT00394836|528327939|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
146498267|NCT00394836|528327938|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
146498268|NCT00394836|528327939|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
146498269|NCT00394836|528327938|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
146498270|NCT00394836|528327939|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
146498271|NCT00394836|528327938|FG000|Teatment or Follow-up Phase|Non compliance|0|||
146498272|NCT00394836|528327939|FG001|Teatment or Follow-up Phase|Non compliance|1|||
146498273|NCT00394836|528327938|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
146498274|NCT00394836|528327939|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
146498275|NCT00394836|528327938|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
146498276|NCT00394836|528327939|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
146498277|NCT00394836|528327938|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
146498278|NCT00394836|528327939|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
146498279|NCT00394836|528327938|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
146498280|NCT00394836|528327939|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
146498281|NCT00748189|528327940|FG000|Overall Study|Death|99|||
146498282|NCT00748189|528327941|FG001|Overall Study|Death|84|||
146498283|NCT00748189|528327940|FG000|Overall Study|Withdrawal by Subject|23|||
146498284|NCT00748189|528327941|FG001|Overall Study|Withdrawal by Subject|29|||
146498285|NCT00748189|528327940|FG000|Overall Study|Physician Decision|16|||
146498286|NCT00748189|528327941|FG001|Overall Study|Physician Decision|5|||
146498287|NCT00748189|528327940|FG000|Overall Study|Lost to Follow-up|8|||
146498288|NCT00748189|528327941|FG001|Overall Study|Lost to Follow-up|15|||
146498289|NCT00748189|528327940|FG000|Overall Study|Study terminated by Sponsor|70|||
146498290|NCT00748189|528327941|FG001|Overall Study|Study terminated by Sponsor|79|||
146498291|NCT04696055|528327948|FG000|Overall Study|Adverse Event|10|||
146498292|NCT04696055|528327949|FG001|Overall Study|Adverse Event|2|||
146498293|NCT04696055|528327948|FG000|Overall Study|Death|4|||
146498294|NCT04696055|528327949|FG001|Overall Study|Death|0|||
146498295|NCT04696055|528327948|FG000|Overall Study|Other|7|||
146498296|NCT04696055|528327949|FG001|Overall Study|Other|2|||
146498297|NCT04696055|528327948|FG000|Overall Study|Physician Decision|3|||
146498298|NCT04696055|528327949|FG001|Overall Study|Physician Decision|0|||
146498299|NCT04696055|528327948|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
146498300|NCT04696055|528327949|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
146498301|NCT04696055|528327948|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
146498302|NCT04696055|528327949|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
146498303|NCT04696055|528327948|FG000|Overall Study|Subject Decision|1|||
146498304|NCT04696055|528327949|FG001|Overall Study|Subject Decision|2|||
146498305|NCT03969901|528327950|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146498306|NCT03969901|528327951|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146498307|NCT03969901|528327952|FG002|Overall Study|Withdrawal by parent/guardian|0|||
146498308|NCT03969901|528327953|FG003|Overall Study|Withdrawal by parent/guardian|0|||
146498309|NCT03969901|528327954|FG004|Overall Study|Withdrawal by parent/guardian|1|||
146498310|NCT03969901|528327955|FG005|Overall Study|Withdrawal by parent/guardian|0|||
146498311|NCT03969901|528327956|FG006|Overall Study|Withdrawal by parent/guardian|0|||
146498312|NCT03969901|528327957|FG007|Overall Study|Withdrawal by parent/guardian|1|||
146498313|NCT03969901|528327958|FG008|Overall Study|Withdrawal by parent/guardian|1|||
146498314|NCT03969901|528327959|FG009|Overall Study|Withdrawal by parent/guardian|0|||
146498315|NCT01920958|528327960|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
146498316|NCT00610155|528327961|FG000|Period 1|Withdrawal by Subject|0|||
146498317|NCT00610155|528327962|FG001|Period 1|Withdrawal by Subject|0|||
146498318|NCT00610155|528327963|FG002|Period 1|Withdrawal by Subject|1|||
146498319|NCT00610155|528327964|FG003|Period 1|Withdrawal by Subject|0|||
146498320|NCT00610155|528327965|FG004|Period 1|Withdrawal by Subject|0|||
146498321|NCT00610155|528327966|FG005|Period 1|Withdrawal by Subject|0|||
146498322|NCT00610155|528327961|FG000|Period 3|Adverse Event|1|||
146498323|NCT00610155|528327962|FG001|Period 3|Adverse Event|0|||
146498324|NCT00610155|528327963|FG002|Period 3|Adverse Event|0|||
146498325|NCT00610155|528327964|FG003|Period 3|Adverse Event|0|||
146498326|NCT00610155|528327965|FG004|Period 3|Adverse Event|0|||
146498327|NCT00610155|528327966|FG005|Period 3|Adverse Event|0|||
146498328|NCT01284348|528327967|FG000|Overall Study|Death|1|||
146498329|NCT01284348|528327968|FG001|Overall Study|Death|1|||
146565465|NCT01567722|528582559|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
146565466|NCT01567722|528582557|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
146565467|NCT01567722|528582558|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
146498330|NCT01284348|528327967|FG000|Overall Study|Withdrew consent|0|||
146498331|NCT01284348|528327968|FG001|Overall Study|Withdrew consent|1|||
146498332|NCT01284348|528327967|FG000|Overall Study|Status not recorded|9|||
146565468|NCT01567722|528582559|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
146565469|NCT01567722|528582557|FG000|Overall Study|Protocol closure by the OCG|2|||
146565470|NCT01567722|528582558|FG001|Overall Study|Protocol closure by the OCG|0|||
146565471|NCT01567722|528582559|FG002|Overall Study|Protocol closure by the OCG|0|||
146498333|NCT01284348|528327968|FG001|Overall Study|Status not recorded|10|||
146498334|NCT00083759|528327971|FG000|Overall Study|Adverse Event|5|||
146498335|NCT00083759|528327972|FG001|Overall Study|Adverse Event|3|||
146565472|NCT01567722|528582557|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
146498336|NCT00083759|528327971|FG000|Overall Study|Lost to Follow-up|1|||
146498337|NCT00083759|528327972|FG001|Overall Study|Lost to Follow-up|0|||
146972009|NCT06065176|530058516|FG002|Overall Study|Withdrawal by Subject|2|||
146972010|NCT06065176|530058514|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
146972011|NCT06065176|530058515|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
146972012|NCT06065176|530058516|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
146972013|NCT02588651|530058517|FG000|Overall Study|Adverse Event|1|||
146972014|NCT02588651|530058517|FG000|Overall Study|Withdrawal by Subject|2|||
146498338|NCT00083759|528327971|FG000|Overall Study|Death|1|||
146498339|NCT00083759|528327972|FG001|Overall Study|Death|1|||
146498340|NCT00083759|528327971|FG000|Overall Study|Inadequate Therapeutic Response|32|||
146498341|NCT00083759|528327972|FG001|Overall Study|Inadequate Therapeutic Response|35|||
146498342|NCT00083759|528327971|FG000|Overall Study|Subject Withdrew Consent|2|||
146498343|NCT00083759|528327972|FG001|Overall Study|Subject Withdrew Consent|2|||
146498344|NCT00083759|528327971|FG000|Overall Study|Non-Compliance|1|||
146498345|NCT00083759|528327972|FG001|Overall Study|Non-Compliance|0|||
146498346|NCT00083759|528327971|FG000|Overall Study|Sponsor's Discretion|28|||
146498347|NCT00083759|528327972|FG001|Overall Study|Sponsor's Discretion|29|||
146498348|NCT00083759|528327971|FG000|Overall Study|Other|14|||
146498349|NCT00083759|528327972|FG001|Overall Study|Other|13|||
146498350|NCT03645395|528327973|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
146498351|NCT03645395|528327974|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
146498352|NCT03645395|528327975|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
146498353|NCT03645395|528327976|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
146498354|NCT03645395|528327973|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
146498355|NCT03645395|528327974|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
146498356|NCT03645395|528327975|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
146498357|NCT03645395|528327976|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
146498358|NCT03645395|528327973|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
146498359|NCT03645395|528327974|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
146498360|NCT03645395|528327975|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
146498361|NCT03645395|528327976|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
146498362|NCT03645395|528327973|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
146498363|NCT03645395|528327974|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
146498364|NCT03645395|528327975|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
146498365|NCT03645395|528327976|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
146498366|NCT02564900|528327977|FG000|Dose Escalation|Progressive disease per RECIST|2|||
146498367|NCT02564900|528327978|FG001|Dose Escalation|Progressive disease per RECIST|3|||
146498368|NCT02564900|528327979|FG002|Dose Escalation|Progressive disease per RECIST|3|||
146498369|NCT02564900|528327980|FG003|Dose Escalation|Progressive disease per RECIST|3|||
146498370|NCT02564900|528327981|FG004|Dose Escalation|Progressive disease per RECIST|3|||
146498371|NCT02564900|528327982|FG005|Dose Escalation|Progressive disease per RECIST|1|||
146498372|NCT02564900|528327983|FG006|Dose Escalation|Progressive disease per RECIST|0|||
146498373|NCT02564900|528327984|FG007|Dose Escalation|Progressive disease per RECIST|0|||
146498374|NCT02564900|528327985|FG008|Dose Escalation|Progressive disease per RECIST|0|||
146498375|NCT02564900|528327986|FG009|Dose Escalation|Progressive disease per RECIST|0|||
146498376|NCT02564900|528327987|FG010|Dose Escalation|Progressive disease per RECIST|0|||
146498377|NCT02564900|528327988|FG011|Dose Escalation|Progressive disease per RECIST|0|||
146565473|NCT01567722|528582558|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
146565474|NCT01567722|528582559|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
146565475|NCT00431964|528582560|FG000|Overall Study|Adverse Event|1|||
146565476|NCT00431964|528582561|FG001|Overall Study|Adverse Event|0|||
146565477|NCT00431964|528582560|FG000|Overall Study|Lost to Follow-up|1|||
146565478|NCT00431964|528582561|FG001|Overall Study|Lost to Follow-up|2|||
146565479|NCT00431964|528582560|FG000|Overall Study|Physician Decision|2|||
146565480|NCT00431964|528582561|FG001|Overall Study|Physician Decision|2|||
146565481|NCT00431964|528582560|FG000|Overall Study|Withdrawal by Subject|2|||
146565482|NCT00431964|528582561|FG001|Overall Study|Withdrawal by Subject|1|||
146565483|NCT00431964|528582560|FG000|Overall Study|Parental Consent Withdrawn|0|||
146565484|NCT00431964|528582561|FG001|Overall Study|Parental Consent Withdrawn|2|||
146565485|NCT00431964|528582560|FG000|Overall Study|Due to Unstable Health|0|||
146565486|NCT00431964|528582561|FG001|Overall Study|Due to Unstable Health|1|||
146565487|NCT02170064|528582562|FG000|Overall Study|Withdrawal by Subject|5|||
146565488|NCT02170064|528582563|FG001|Overall Study|Withdrawal by Subject|1|||
146565489|NCT02170064|528582564|FG002|Overall Study|Withdrawal by Subject|1|||
146565490|NCT02170064|528582562|FG000|Overall Study|Physician Decision|1|||
146565491|NCT02170064|528582563|FG001|Overall Study|Physician Decision|1|||
146565492|NCT02170064|528582564|FG002|Overall Study|Physician Decision|0|||
146972015|NCT02588651|530058517|FG000|Overall Study|Death|1|||
146498378|NCT02564900|528327989|FG012|Dose Escalation|Progressive disease per RECIST|0|||
146498379|NCT02564900|528327990|FG013|Dose Escalation|Progressive disease per RECIST|0|||
146498380|NCT02564900|528327991|FG014|Dose Escalation|Progressive disease per RECIST|0|||
146498381|NCT02564900|528327977|FG000|Dose Escalation|Ongoing|1|||
146498382|NCT02564900|528327978|FG001|Dose Escalation|Ongoing|0|||
146565493|NCT04211363|528582565|FG000|Overall Study|Adverse Event|5|||
146565494|NCT04211363|528582566|FG001|Overall Study|Adverse Event|2|||
146565495|NCT04211363|528582565|FG000|Overall Study|Physician Decision|0|||
146565496|NCT04211363|528582566|FG001|Overall Study|Physician Decision|1|||
146565497|NCT04211363|528582565|FG000|Overall Study|Protocol Violation|1|||
146565498|NCT04211363|528582566|FG001|Overall Study|Protocol Violation|0|||
146565499|NCT04211363|528582565|FG000|Overall Study|Pregnancy|1|||
146565500|NCT04211363|528582566|FG001|Overall Study|Pregnancy|0|||
146565501|NCT04211363|528582565|FG000|Overall Study|Lost to Follow-up|12|||
146565502|NCT04211363|528582566|FG001|Overall Study|Lost to Follow-up|4|||
146565503|NCT04211363|528582565|FG000|Overall Study|Withdrawal by Subject|11|||
146565504|NCT04211363|528582566|FG001|Overall Study|Withdrawal by Subject|11|||
146565505|NCT04211363|528582565|FG000|Overall Study|Other|1|||
146565506|NCT04211363|528582566|FG001|Overall Study|Other|2|||
146565507|NCT03961308|528582567|FG000|Overall Study|Withdrawal by Subject|1|||
146565508|NCT03961308|528582568|FG001|Overall Study|Withdrawal by Subject|0|||
146565509|NCT03961308|528582567|FG000|Overall Study|Other|1|||
146565510|NCT03961308|528582568|FG001|Overall Study|Other|0|||
146565511|NCT03961308|528582567|FG000|Overall Study|Lost to Follow-up|0|||
146565512|NCT03961308|528582568|FG001|Overall Study|Lost to Follow-up|1|||
146565513|NCT03961308|528582567|FG000|Overall Study|Adverse Event|0|||
146565514|NCT03961308|528582568|FG001|Overall Study|Adverse Event|1|||
146565515|NCT00659425|528582571|FG000|Overall Study|Disease progression|1|||
146565516|NCT00659425|528582572|FG001|Overall Study|Disease progression|0|||
146565517|NCT00659425|528582573|FG002|Overall Study|Disease progression|0|||
146565518|NCT00659425|528582574|FG003|Overall Study|Disease progression|1|||
146565519|NCT00659425|528582575|FG004|Overall Study|Disease progression|0|||
146565520|NCT00659425|528582576|FG005|Overall Study|Disease progression|2|||
146565521|NCT00659425|528582577|FG006|Overall Study|Disease progression|4|||
146565522|NCT00659425|528582578|FG007|Overall Study|Disease progression|3|||
146565523|NCT00659425|528582579|FG008|Overall Study|Disease progression|5|||
146565524|NCT00659425|528582580|FG009|Overall Study|Disease progression|3|||
146565525|NCT00659425|528582571|FG000|Overall Study|Death|0|||
146565526|NCT00659425|528582572|FG001|Overall Study|Death|0|||
146565527|NCT00659425|528582573|FG002|Overall Study|Death|0|||
146565528|NCT00659425|528582574|FG003|Overall Study|Death|1|||
146565529|NCT00659425|528582575|FG004|Overall Study|Death|0|||
146565530|NCT00659425|528582576|FG005|Overall Study|Death|0|||
146565531|NCT00659425|528582577|FG006|Overall Study|Death|1|||
146565532|NCT00659425|528582578|FG007|Overall Study|Death|0|||
146565533|NCT00659425|528582579|FG008|Overall Study|Death|0|||
146565534|NCT00659425|528582580|FG009|Overall Study|Death|0|||
146565535|NCT00659425|528582571|FG000|Overall Study|Adverse Event|0|||
146645355|NCT00977080|528879302|FG001|Overall Study|Travel for family reasons|0|||
146645356|NCT00977080|528879303|FG002|Overall Study|Travel for family reasons|0|||
146645357|NCT00977080|528879304|FG003|Overall Study|Travel for family reasons|0|||
146498383|NCT02564900|528327979|FG002|Dose Escalation|Ongoing|0|||
146498384|NCT02564900|528327980|FG003|Dose Escalation|Ongoing|2|||
146498385|NCT02564900|528327981|FG004|Dose Escalation|Ongoing|2|||
146498386|NCT02564900|528327982|FG005|Dose Escalation|Ongoing|2|||
146498387|NCT02564900|528327983|FG006|Dose Escalation|Ongoing|0|||
146498388|NCT02564900|528327984|FG007|Dose Escalation|Ongoing|0|||
146498389|NCT02564900|528327985|FG008|Dose Escalation|Ongoing|0|||
146498390|NCT02564900|528327986|FG009|Dose Escalation|Ongoing|0|||
146498391|NCT02564900|528327987|FG010|Dose Escalation|Ongoing|0|||
146498392|NCT02564900|528327988|FG011|Dose Escalation|Ongoing|0|||
146498393|NCT02564900|528327989|FG012|Dose Escalation|Ongoing|0|||
146498394|NCT02564900|528327990|FG013|Dose Escalation|Ongoing|0|||
146498395|NCT02564900|528327991|FG014|Dose Escalation|Ongoing|0|||
146498396|NCT02564900|528327977|FG000|Dose Escalation|Adverse Event|0|||
146498397|NCT02564900|528327978|FG001|Dose Escalation|Adverse Event|0|||
146498398|NCT02564900|528327979|FG002|Dose Escalation|Adverse Event|0|||
146565536|NCT00659425|528582572|FG001|Overall Study|Adverse Event|0|||
146645358|NCT00566696|528879305|FG000|Overall Study|Met Exclusion Criteria|2|||
146498399|NCT02564900|528327980|FG003|Dose Escalation|Adverse Event|1|||
146565537|NCT00659425|528582573|FG002|Overall Study|Adverse Event|0|||
146565538|NCT00659425|528582574|FG003|Overall Study|Adverse Event|0|||
146565539|NCT00659425|528582575|FG004|Overall Study|Adverse Event|0|||
146565540|NCT00659425|528582576|FG005|Overall Study|Adverse Event|1|||
146565541|NCT00659425|528582577|FG006|Overall Study|Adverse Event|0|||
146645359|NCT00566696|528879305|FG000|Overall Study|Muromonab not available|1|||
146498400|NCT02564900|528327981|FG004|Dose Escalation|Adverse Event|1|||
146498401|NCT02564900|528327982|FG005|Dose Escalation|Adverse Event|3|||
146565542|NCT00659425|528582578|FG007|Overall Study|Adverse Event|3|||
146565543|NCT00659425|528582579|FG008|Overall Study|Adverse Event|1|||
146565544|NCT00659425|528582580|FG009|Overall Study|Adverse Event|4|||
146498402|NCT02564900|528327983|FG006|Dose Escalation|Adverse Event|0|||
146498403|NCT02564900|528327984|FG007|Dose Escalation|Adverse Event|0|||
146498404|NCT02564900|528327985|FG008|Dose Escalation|Adverse Event|0|||
146498405|NCT02564900|528327986|FG009|Dose Escalation|Adverse Event|0|||
146565545|NCT00659425|528582571|FG000|Overall Study|Investigator Discretion|0|||
146565546|NCT00659425|528582572|FG001|Overall Study|Investigator Discretion|0|||
146565547|NCT00659425|528582573|FG002|Overall Study|Investigator Discretion|0|||
146769006|NCT02020616|529321814|FG000|Overall Study|Randomized in Error|0|||
146498406|NCT02564900|528327987|FG010|Dose Escalation|Adverse Event|0|||
146498407|NCT02564900|528327988|FG011|Dose Escalation|Adverse Event|0|||
146498408|NCT02564900|528327989|FG012|Dose Escalation|Adverse Event|0|||
146498409|NCT02564900|528327990|FG013|Dose Escalation|Adverse Event|0|||
146498410|NCT02564900|528327991|FG014|Dose Escalation|Adverse Event|0|||
146498411|NCT02564900|528327977|FG000|Dose Expansion|Progressive disease per RECIST|0|||
146498412|NCT02564900|528327978|FG001|Dose Expansion|Progressive disease per RECIST|0|||
146498413|NCT02564900|528327979|FG002|Dose Expansion|Progressive disease per RECIST|0|||
146498414|NCT02564900|528327980|FG003|Dose Expansion|Progressive disease per RECIST|0|||
146498415|NCT02564900|528327981|FG004|Dose Expansion|Progressive disease per RECIST|0|||
146498416|NCT02564900|528327982|FG005|Dose Expansion|Progressive disease per RECIST|0|||
146498417|NCT02564900|528327983|FG006|Dose Expansion|Progressive disease per RECIST|19|||
146498418|NCT02564900|528327984|FG007|Dose Expansion|Progressive disease per RECIST|17|||
146498419|NCT02564900|528327985|FG008|Dose Expansion|Progressive disease per RECIST|8|||
146498420|NCT02564900|528327986|FG009|Dose Expansion|Progressive disease per RECIST|16|||
146498421|NCT02564900|528327987|FG010|Dose Expansion|Progressive disease per RECIST|13|||
146498422|NCT02564900|528327988|FG011|Dose Expansion|Progressive disease per RECIST|19|||
146645360|NCT00566696|528879305|FG000|Overall Study|Health Status Change|1|||
146645361|NCT00566696|528879305|FG000|Overall Study|Physician Decision|1|||
146498423|NCT02564900|528327989|FG012|Dose Expansion|Progressive disease per RECIST|10|||
146498424|NCT02564900|528327990|FG013|Dose Expansion|Progressive disease per RECIST|13|||
146498425|NCT02564900|528327991|FG014|Dose Expansion|Progressive disease per RECIST|11|||
146498426|NCT02564900|528327977|FG000|Dose Expansion|Clinical progression|0|||
146498427|NCT02564900|528327978|FG001|Dose Expansion|Clinical progression|0|||
146498428|NCT02564900|528327979|FG002|Dose Expansion|Clinical progression|0|||
146498429|NCT02564900|528327980|FG003|Dose Expansion|Clinical progression|0|||
146498430|NCT02564900|528327981|FG004|Dose Expansion|Clinical progression|0|||
146498431|NCT02564900|528327982|FG005|Dose Expansion|Clinical progression|0|||
146498432|NCT02564900|528327983|FG006|Dose Expansion|Clinical progression|5|||
146498433|NCT02564900|528327984|FG007|Dose Expansion|Clinical progression|12|||
146498434|NCT02564900|528327985|FG008|Dose Expansion|Clinical progression|0|||
146498435|NCT02564900|528327986|FG009|Dose Expansion|Clinical progression|3|||
146498436|NCT02564900|528327987|FG010|Dose Expansion|Clinical progression|2|||
146498437|NCT02564900|528327988|FG011|Dose Expansion|Clinical progression|0|||
146498438|NCT02564900|528327989|FG012|Dose Expansion|Clinical progression|1|||
146498439|NCT02564900|528327990|FG013|Dose Expansion|Clinical progression|3|||
146498440|NCT02564900|528327991|FG014|Dose Expansion|Clinical progression|1|||
146498441|NCT02564900|528327977|FG000|Dose Expansion|Adverse Event|0|||
146498442|NCT02564900|528327978|FG001|Dose Expansion|Adverse Event|0|||
146498443|NCT02564900|528327979|FG002|Dose Expansion|Adverse Event|0|||
146498444|NCT02564900|528327980|FG003|Dose Expansion|Adverse Event|0|||
146498445|NCT02564900|528327981|FG004|Dose Expansion|Adverse Event|0|||
146498446|NCT02564900|528327982|FG005|Dose Expansion|Adverse Event|0|||
146498447|NCT02564900|528327983|FG006|Dose Expansion|Adverse Event|9|||
146498448|NCT02564900|528327984|FG007|Dose Expansion|Adverse Event|22|||
146498449|NCT02564900|528327985|FG008|Dose Expansion|Adverse Event|0|||
146498450|NCT02564900|528327986|FG009|Dose Expansion|Adverse Event|11|||
146498451|NCT02564900|528327987|FG010|Dose Expansion|Adverse Event|0|||
146498452|NCT02564900|528327988|FG011|Dose Expansion|Adverse Event|5|||
146498453|NCT02564900|528327989|FG012|Dose Expansion|Adverse Event|2|||
146498454|NCT02564900|528327990|FG013|Dose Expansion|Adverse Event|2|||
146498455|NCT02564900|528327991|FG014|Dose Expansion|Adverse Event|1|||
146498456|NCT02564900|528327977|FG000|Dose Expansion|Ongoing|0|||
146498457|NCT02564900|528327978|FG001|Dose Expansion|Ongoing|0|||
146498458|NCT02564900|528327979|FG002|Dose Expansion|Ongoing|0|||
146498459|NCT02564900|528327980|FG003|Dose Expansion|Ongoing|0|||
146498460|NCT02564900|528327981|FG004|Dose Expansion|Ongoing|0|||
146498461|NCT02564900|528327982|FG005|Dose Expansion|Ongoing|0|||
146498462|NCT02564900|528327983|FG006|Dose Expansion|Ongoing|9|||
146498463|NCT02564900|528327984|FG007|Dose Expansion|Ongoing|10|||
146498464|NCT02564900|528327985|FG008|Dose Expansion|Ongoing|11|||
146498465|NCT02564900|528327986|FG009|Dose Expansion|Ongoing|3|||
146498466|NCT02564900|528327987|FG010|Dose Expansion|Ongoing|0|||
146645362|NCT00566696|528879305|FG000|Overall Study|Non-Patient Donors|37|||
146645363|NCT00275340|528879313|FG000|Overall Study|Lost to Follow-up|2|||
146645364|NCT00275340|528879314|FG001|Overall Study|Lost to Follow-up|4|||
146645365|NCT00653939|528879316|FG000|Overall Study|Adverse Event|1|||
146645366|NCT00653939|528879317|FG001|Overall Study|Adverse Event|3|||
146645367|NCT00653939|528879316|FG000|Overall Study|Withdrawal by Subject|3|||
146645368|NCT00653939|528879317|FG001|Overall Study|Withdrawal by Subject|3|||
146498467|NCT02564900|528327988|FG011|Dose Expansion|Ongoing|0|||
146498468|NCT02564900|528327989|FG012|Dose Expansion|Ongoing|4|||
146498469|NCT02564900|528327990|FG013|Dose Expansion|Ongoing|0|||
146498470|NCT02564900|528327991|FG014|Dose Expansion|Ongoing|6|||
146498471|NCT02564900|528327977|FG000|Dose Expansion|Death|0|||
146498472|NCT02564900|528327978|FG001|Dose Expansion|Death|0|||
146498473|NCT02564900|528327979|FG002|Dose Expansion|Death|0|||
146498474|NCT02564900|528327980|FG003|Dose Expansion|Death|0|||
146645369|NCT00653939|528879316|FG000|Overall Study|Physician Decision|4|||
146498475|NCT02564900|528327981|FG004|Dose Expansion|Death|0|||
146498476|NCT02564900|528327982|FG005|Dose Expansion|Death|0|||
146498477|NCT02564900|528327983|FG006|Dose Expansion|Death|1|||
146498478|NCT02564900|528327984|FG007|Dose Expansion|Death|0|||
146498479|NCT02564900|528327985|FG008|Dose Expansion|Death|0|||
146498480|NCT02564900|528327986|FG009|Dose Expansion|Death|0|||
146498481|NCT02564900|528327987|FG010|Dose Expansion|Death|1|||
146498482|NCT02564900|528327988|FG011|Dose Expansion|Death|0|||
146498483|NCT02564900|528327989|FG012|Dose Expansion|Death|1|||
146498484|NCT02564900|528327990|FG013|Dose Expansion|Death|1|||
146498485|NCT02564900|528327991|FG014|Dose Expansion|Death|0|||
146498486|NCT02564900|528327977|FG000|Dose Expansion|Withdrawal by Subject|0|||
146498487|NCT02564900|528327978|FG001|Dose Expansion|Withdrawal by Subject|0|||
146498488|NCT02564900|528327979|FG002|Dose Expansion|Withdrawal by Subject|0|||
146498489|NCT02564900|528327980|FG003|Dose Expansion|Withdrawal by Subject|0|||
146498490|NCT02564900|528327981|FG004|Dose Expansion|Withdrawal by Subject|0|||
146498491|NCT02564900|528327982|FG005|Dose Expansion|Withdrawal by Subject|0|||
146498492|NCT02564900|528327983|FG006|Dose Expansion|Withdrawal by Subject|4|||
146498493|NCT02564900|528327984|FG007|Dose Expansion|Withdrawal by Subject|0|||
146498494|NCT02564900|528327985|FG008|Dose Expansion|Withdrawal by Subject|0|||
146498495|NCT02564900|528327986|FG009|Dose Expansion|Withdrawal by Subject|0|||
146498496|NCT02564900|528327987|FG010|Dose Expansion|Withdrawal by Subject|1|||
146498497|NCT02564900|528327988|FG011|Dose Expansion|Withdrawal by Subject|0|||
146498498|NCT02564900|528327989|FG012|Dose Expansion|Withdrawal by Subject|0|||
146498499|NCT02564900|528327990|FG013|Dose Expansion|Withdrawal by Subject|1|||
146498500|NCT02564900|528327991|FG014|Dose Expansion|Withdrawal by Subject|1|||
146498501|NCT02564900|528327977|FG000|Dose Expansion|Other|0|||
146498502|NCT02564900|528327978|FG001|Dose Expansion|Other|0|||
146498503|NCT02564900|528327979|FG002|Dose Expansion|Other|0|||
146498504|NCT02564900|528327980|FG003|Dose Expansion|Other|0|||
146498505|NCT02564900|528327981|FG004|Dose Expansion|Other|0|||
146498506|NCT02564900|528327982|FG005|Dose Expansion|Other|0|||
146498507|NCT02564900|528327983|FG006|Dose Expansion|Other|1|||
146498508|NCT02564900|528327984|FG007|Dose Expansion|Other|0|||
146498509|NCT02564900|528327985|FG008|Dose Expansion|Other|1|||
146498510|NCT02564900|528327986|FG009|Dose Expansion|Other|0|||
146498511|NCT02564900|528327987|FG010|Dose Expansion|Other|0|||
146498512|NCT02564900|528327988|FG011|Dose Expansion|Other|0|||
146498513|NCT02564900|528327989|FG012|Dose Expansion|Other|0|||
146498514|NCT02564900|528327990|FG013|Dose Expansion|Other|0|||
146498515|NCT02564900|528327991|FG014|Dose Expansion|Other|1|||
146498516|NCT02564900|528327977|FG000|Dose Expansion|Did not receive treatment|0|||
146498517|NCT02564900|528327978|FG001|Dose Expansion|Did not receive treatment|0|||
146498518|NCT02564900|528327979|FG002|Dose Expansion|Did not receive treatment|0|||
146498519|NCT02564900|528327980|FG003|Dose Expansion|Did not receive treatment|0|||
146498520|NCT02564900|528327981|FG004|Dose Expansion|Did not receive treatment|0|||
146498521|NCT02564900|528327982|FG005|Dose Expansion|Did not receive treatment|0|||
146498522|NCT02564900|528327983|FG006|Dose Expansion|Did not receive treatment|1|||
146498523|NCT02564900|528327984|FG007|Dose Expansion|Did not receive treatment|1|||
146498524|NCT02564900|528327985|FG008|Dose Expansion|Did not receive treatment|0|||
146645370|NCT00653939|528879317|FG001|Overall Study|Physician Decision|0|||
146645371|NCT00653939|528879316|FG000|Overall Study|Disease Progression|2|||
146645372|NCT00653939|528879317|FG001|Overall Study|Disease Progression|3|||
146645373|NCT00653939|528879316|FG000|Overall Study|Other|2|||
146645374|NCT00653939|528879317|FG001|Overall Study|Other|6|||
146645375|NCT02032238|528879318|FG000|Overall Study|Lost to Follow-up|2|||
146498525|NCT02564900|528327986|FG009|Dose Expansion|Did not receive treatment|0|||
146498526|NCT02564900|528327987|FG010|Dose Expansion|Did not receive treatment|0|||
146498527|NCT02564900|528327988|FG011|Dose Expansion|Did not receive treatment|0|||
146498528|NCT02564900|528327989|FG012|Dose Expansion|Did not receive treatment|0|||
146498529|NCT02564900|528327990|FG013|Dose Expansion|Did not receive treatment|0|||
146498530|NCT02564900|528327991|FG014|Dose Expansion|Did not receive treatment|1|||
146912185|NCT03666143|529841436|FG000|Overall Study|Lost to Follow-up|5|||
146912186|NCT03666143|529841436|FG000|Overall Study|Physician Decision|1|||
146912187|NCT03666143|529841436|FG000|Overall Study|Rolled into extension study|9|||
146912188|NCT03666143|529841436|FG000|Overall Study|Progressive Disease|1|||
146912189|NCT01103349|529841437|FG000|Overall Study|Adverse Event|8|||
146498531|NCT00892151|528327992|FG000|Overall Study|Protocol Violation|1|||
146498532|NCT01089608|528327993|FG000|Overall Study|Adverse Event|0|||
146498533|NCT01089608|528327994|FG001|Overall Study|Adverse Event|4|||
146645376|NCT02032238|528879319|FG001|Overall Study|Lost to Follow-up|0|||
146912190|NCT01103349|529841438|FG001|Overall Study|Adverse Event|5|||
146498534|NCT01089608|528327993|FG000|Overall Study|Lost to Follow-up|0|||
146498535|NCT01089608|528327994|FG001|Overall Study|Lost to Follow-up|2|||
146498536|NCT00839527|528327995|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
146498537|NCT00839527|528327996|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
146498538|NCT00839527|528327997|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
146498539|NCT00839527|528327995|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
146498540|NCT00839527|528327996|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
146498541|NCT00839527|528327997|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
146498542|NCT00839527|528327995|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
146498543|NCT00839527|528327996|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
146498544|NCT00839527|528327997|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
146498545|NCT00839527|528327995|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
146498546|NCT00839527|528327996|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
146498547|NCT00839527|528327997|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
146498548|NCT00839527|528327995|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
146498549|NCT00839527|528327996|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
146498550|NCT00839527|528327997|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
146498551|NCT00839527|528327995|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
146498552|NCT00839527|528327996|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
146498553|NCT00839527|528327997|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
146498554|NCT00839527|528327995|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
146498555|NCT00839527|528327996|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
146498556|NCT00839527|528327997|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
146498557|NCT00839527|528327995|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
146498558|NCT00839527|528327996|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
146498559|NCT00839527|528327997|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
146498560|NCT00839527|528327995|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
146498561|NCT00839527|528327996|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
146498562|NCT00839527|528327997|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
146498563|NCT00839527|528327995|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
146498564|NCT00839527|528327996|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
146498565|NCT00839527|528327997|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
146498566|NCT00839527|528327995|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
146498567|NCT00839527|528327996|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
146498568|NCT00839527|528327997|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
146498569|NCT00839527|528327995|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
146498570|NCT00839527|528327996|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
146498571|NCT00839527|528327997|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
146498572|NCT00839527|528327995|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
146498573|NCT00839527|528327996|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
146498574|NCT00839527|528327997|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
146498575|NCT00839527|528327995|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
146498576|NCT00839527|528327996|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
146498577|NCT00839527|528327997|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
146498578|NCT00839527|528327995|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
146498579|NCT00839527|528327996|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
146498580|NCT00839527|528327997|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
146498581|NCT00839527|528327995|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
146498582|NCT00839527|528327996|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
146498583|NCT00839527|528327997|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
146498584|NCT00839527|528327995|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
146498585|NCT00839527|528327996|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
146498586|NCT00839527|528327997|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
146498587|NCT00839527|528327995|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
146498588|NCT00839527|528327996|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
146498589|NCT00839527|528327997|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
146498590|NCT00839527|528327995|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
146498591|NCT00839527|528327996|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
146498592|NCT00839527|528327997|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
146498593|NCT00839527|528327995|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
146498594|NCT00839527|528327996|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
146498595|NCT00839527|528327997|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
146498596|NCT00839527|528327995|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
146498597|NCT00839527|528327996|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
146498598|NCT00839527|528327997|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
146498599|NCT00839527|528327995|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
146498600|NCT00839527|528327996|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
146498601|NCT00839527|528327997|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
146498602|NCT00839527|528327995|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
146498603|NCT00839527|528327996|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
146498604|NCT00839527|528327997|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
146498605|NCT00839527|528327995|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
146498606|NCT00839527|528327996|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
146498607|NCT00839527|528327997|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
146498608|NCT02751450|528327998|FG000|Overall Study|Adverse Event|1|||
146498609|NCT02751450|528327999|FG001|Overall Study|Adverse Event|0|||
146498610|NCT00427921|528328003|FG000|Overall Study|Adverse Event|26|||
146498611|NCT00427921|528328003|FG000|Overall Study|Withdrawal by Subject|4|||
146498612|NCT00427921|528328003|FG000|Overall Study|Lost to Follow-up|2|||
146498613|NCT00427921|528328003|FG000|Overall Study|Other reason not specified|10|||
146498614|NCT00427921|528328003|FG000|Overall Study|Adverse Event + Hospitalization|1|||
146498615|NCT00427921|528328003|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
146498616|NCT00427921|528328003|FG000|Overall Study|Adverse Event + No Response|1|||
146498617|NCT00427921|528328003|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
146498618|NCT00427921|528328003|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
146498619|NCT00427921|528328003|FG000|Overall Study|Adverse Event + Lost Response|1|||
146498620|NCT00427921|528328003|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
146498621|NCT00427921|528328003|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
146498622|NCT03502070|528328004|FG000|Overall Study|Withdrawal by Subject|1|||
146498623|NCT03502070|528328004|FG000|Overall Study|Screen Failure|1|||
146498624|NCT02858583|528328005|FG000|Overall Study|Declined consent|1|||
146498625|NCT02858583|528328006|FG001|Overall Study|Declined consent|1|||
146498626|NCT04615403|528328010|FG000|Overall Study|Death|1|||
146498627|NCT03170362|528328011|FG000|Overall Study|Death|2|||
146498628|NCT03170362|528328012|FG001|Overall Study|Death|2|||
146498629|NCT03170362|528328011|FG000|Overall Study|Withdrawal by Subject|23|||
146498630|NCT03170362|528328012|FG001|Overall Study|Withdrawal by Subject|22|||
146498631|NCT03170362|528328011|FG000|Overall Study|Lost to Follow-up|187|||
146498632|NCT03170362|528328012|FG001|Overall Study|Lost to Follow-up|167|||
146498633|NCT01972438|528328013|FG000|Baseline-Month 3 Crossover Period|Death|1|||
146498634|NCT01972438|528328014|FG001|Baseline-Month 3 Crossover Period|Death|0|||
146498635|NCT01972438|528328013|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
146498636|NCT01972438|528328014|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
146498637|NCT01972438|528328013|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
146498638|NCT01972438|528328014|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
146498639|NCT01972438|528328013|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
146498640|NCT01972438|528328014|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
146498641|NCT01972438|528328013|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
146498642|NCT01972438|528328014|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
146498643|NCT01972438|528328013|FG000|Months 6-12 Study Period|Death|1|||
146498644|NCT01972438|528328014|FG001|Months 6-12 Study Period|Death|0|||
146498645|NCT01972438|528328013|FG000|Months 6-12 Study Period|Early Study Closure|2|||
146498646|NCT01972438|528328014|FG001|Months 6-12 Study Period|Early Study Closure|2|||
146498647|NCT01972438|528328013|FG000|Post Month 12 Study Period|Early Study Closure|3|||
146498648|NCT01972438|528328014|FG001|Post Month 12 Study Period|Early Study Closure|4|||
146498649|NCT00697463|528328020|FG000|Overall Study|Withdrawal by Subject|1|||
146498650|NCT03307252|528328021|FG000|Part 2, Period 1|Treatment not received|0|||
146498651|NCT03307252|528328022|FG001|Part 2, Period 1|Treatment not received|0|||
146498652|NCT03307252|528328023|FG002|Part 2, Period 1|Treatment not received|0|||
146498653|NCT03307252|528328024|FG003|Part 2, Period 1|Treatment not received|0|||
146498654|NCT03307252|528328025|FG004|Part 2, Period 1|Treatment not received|0|||
146498655|NCT03307252|528328026|FG005|Part 2, Period 1|Treatment not received|1|||
146498656|NCT03307252|528328027|FG006|Part 2, Period 1|Treatment not received|0|||
146498657|NCT03307252|528328028|FG007|Part 2, Period 1|Treatment not received|0|||
146498658|NCT03307252|528328029|FG008|Part 2, Period 1|Treatment not received|0|||
146498659|NCT03307252|528328030|FG009|Part 2, Period 1|Treatment not received|0|||
146498660|NCT03307252|528328031|FG010|Part 2, Period 1|Treatment not received|0|||
146498661|NCT03307252|528328021|FG000|Part 2, Period 3|Other than listed|0|||
146498662|NCT03307252|528328022|FG001|Part 2, Period 3|Other than listed|0|||
146498663|NCT03307252|528328023|FG002|Part 2, Period 3|Other than listed|0|||
146498664|NCT03307252|528328024|FG003|Part 2, Period 3|Other than listed|0|||
146498665|NCT03307252|528328025|FG004|Part 2, Period 3|Other than listed|1|||
146498666|NCT03307252|528328026|FG005|Part 2, Period 3|Other than listed|0|||
146498667|NCT03307252|528328027|FG006|Part 2, Period 3|Other than listed|0|||
146498668|NCT03307252|528328028|FG007|Part 2, Period 3|Other than listed|0|||
146498669|NCT03307252|528328029|FG008|Part 2, Period 3|Other than listed|0|||
146498670|NCT03307252|528328030|FG009|Part 2, Period 3|Other than listed|0|||
146498671|NCT03307252|528328031|FG010|Part 2, Period 3|Other than listed|0|||
146498672|NCT03307252|528328021|FG000|Part 2, Period 4|Other than listed|0|||
146498673|NCT03307252|528328022|FG001|Part 2, Period 4|Other than listed|0|||
146498674|NCT03307252|528328023|FG002|Part 2, Period 4|Other than listed|0|||
146498675|NCT03307252|528328024|FG003|Part 2, Period 4|Other than listed|0|||
146498676|NCT03307252|528328025|FG004|Part 2, Period 4|Other than listed|0|||
146498677|NCT03307252|528328026|FG005|Part 2, Period 4|Other than listed|0|||
146498678|NCT03307252|528328027|FG006|Part 2, Period 4|Other than listed|1|||
146498679|NCT03307252|528328028|FG007|Part 2, Period 4|Other than listed|0|||
146498680|NCT03307252|528328029|FG008|Part 2, Period 4|Other than listed|0|||
146498681|NCT03307252|528328030|FG009|Part 2, Period 4|Other than listed|0|||
146498682|NCT03307252|528328031|FG010|Part 2, Period 4|Other than listed|0|||
146498683|NCT03307252|528328021|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
146498684|NCT03307252|528328022|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
146498685|NCT03307252|528328023|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
146498686|NCT03307252|528328024|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
146498687|NCT03307252|528328025|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
146498688|NCT03307252|528328026|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
146498689|NCT03307252|528328027|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
146498690|NCT03307252|528328028|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
146498691|NCT03307252|528328029|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
146498692|NCT03307252|528328030|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
146498693|NCT03307252|528328031|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
146498694|NCT03482453|528328032|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
146498695|NCT03482453|528328033|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
146498696|NCT03482453|528328034|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
146498697|NCT03482453|528328035|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
146498698|NCT03482453|528328036|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
146498699|NCT03482453|528328037|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
146498700|NCT03482453|528328038|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
146498701|NCT03482453|528328039|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
146498702|NCT03482453|528328040|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
146498703|NCT03482453|528328041|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
146498704|NCT03482453|528328042|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
146498705|NCT03482453|528328043|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
146498706|NCT02568189|528328044|FG000|Overall Study|Protocol Violation|0|||
146498707|NCT02568189|528328045|FG001|Overall Study|Protocol Violation|0|||
146498708|NCT02568189|528328046|FG002|Overall Study|Protocol Violation|19|||
146498709|NCT02568189|528328047|FG003|Overall Study|Protocol Violation|18|||
146498710|NCT01052480|528328048|FG000|Overall Study|Lost to Follow-up|3|||
146498711|NCT01052480|528328049|FG001|Overall Study|Lost to Follow-up|3|||
146498712|NCT01052480|528328048|FG000|Overall Study|Protocol Violation|1|||
146498713|NCT01052480|528328049|FG001|Overall Study|Protocol Violation|0|||
146498714|NCT01052480|528328048|FG000|Overall Study|Withdrawal by Subject|3|||
146498715|NCT01052480|528328049|FG001|Overall Study|Withdrawal by Subject|7|||
146498716|NCT01052480|528328048|FG000|Overall Study|Physician Decision|0|||
146498717|NCT01052480|528328049|FG001|Overall Study|Physician Decision|2|||
146498718|NCT01052480|528328048|FG000|Overall Study|Death|1|||
146498719|NCT01052480|528328049|FG001|Overall Study|Death|5|||
146498720|NCT02887183|528328057|FG000|Overall Study|Adverse Event|44|||
146498721|NCT02887183|528328057|FG000|Overall Study|Death|30|||
146498722|NCT02887183|528328057|FG000|Overall Study|Pregnancy|1|||
146498723|NCT02887183|528328057|FG000|Overall Study|Protocol Violation|6|||
146498724|NCT02887183|528328057|FG000|Overall Study|Technical Problems|2|||
146498725|NCT02887183|528328057|FG000|Overall Study|Lost to Follow-up|13|||
146498726|NCT02887183|528328057|FG000|Overall Study|Physician Decision|10|||
146498727|NCT02887183|528328057|FG000|Overall Study|Withdrawal by Subject|35|||
146498728|NCT00789698|528328060|FG000|Overall Study|Lack of Efficacy|10|||
146498729|NCT00789698|528328061|FG001|Overall Study|Lack of Efficacy|4|||
146498730|NCT00789698|528328062|FG002|Overall Study|Lack of Efficacy|5|||
146498731|NCT00789698|528328063|FG003|Overall Study|Lack of Efficacy|18|||
146498732|NCT00789698|528328060|FG000|Overall Study|Adverse Event|5|||
146565548|NCT00659425|528582574|FG003|Overall Study|Investigator Discretion|0|||
146565549|NCT00659425|528582575|FG004|Overall Study|Investigator Discretion|0|||
146565550|NCT00659425|528582576|FG005|Overall Study|Investigator Discretion|1|||
146565551|NCT00659425|528582577|FG006|Overall Study|Investigator Discretion|0|||
146498733|NCT00789698|528328061|FG001|Overall Study|Adverse Event|5|||
146498734|NCT00789698|528328062|FG002|Overall Study|Adverse Event|3|||
146498735|NCT00789698|528328063|FG003|Overall Study|Adverse Event|4|||
146565552|NCT00659425|528582578|FG007|Overall Study|Investigator Discretion|3|||
146565553|NCT00659425|528582579|FG008|Overall Study|Investigator Discretion|0|||
146565554|NCT00659425|528582580|FG009|Overall Study|Investigator Discretion|0|||
146565555|NCT00659425|528582571|FG000|Overall Study|Other|0|||
146565556|NCT00659425|528582572|FG001|Overall Study|Other|1|||
146565557|NCT00659425|528582573|FG002|Overall Study|Other|1|||
146498736|NCT00789698|528328060|FG000|Overall Study|Lost to Follow-up|5|||
146498737|NCT00789698|528328061|FG001|Overall Study|Lost to Follow-up|5|||
146498738|NCT00789698|528328062|FG002|Overall Study|Lost to Follow-up|2|||
146498739|NCT00789698|528328063|FG003|Overall Study|Lost to Follow-up|9|||
146498740|NCT00789698|528328060|FG000|Overall Study|Protocol Violation|6|||
146498741|NCT00789698|528328061|FG001|Overall Study|Protocol Violation|1|||
146565558|NCT00659425|528582574|FG003|Overall Study|Other|2|||
146565559|NCT00659425|528582575|FG004|Overall Study|Other|4|||
146565560|NCT00659425|528582576|FG005|Overall Study|Other|0|||
146498742|NCT00789698|528328062|FG002|Overall Study|Protocol Violation|2|||
146498743|NCT00789698|528328063|FG003|Overall Study|Protocol Violation|1|||
146498744|NCT00789698|528328060|FG000|Overall Study|Withdrawal by Subject|14|||
146498745|NCT00789698|528328061|FG001|Overall Study|Withdrawal by Subject|15|||
146498746|NCT00789698|528328062|FG002|Overall Study|Withdrawal by Subject|12|||
146498747|NCT00789698|528328063|FG003|Overall Study|Withdrawal by Subject|19|||
146498748|NCT00789698|528328060|FG000|Overall Study|Administrative|0|||
146498749|NCT00789698|528328061|FG001|Overall Study|Administrative|3|||
146498750|NCT00789698|528328062|FG002|Overall Study|Administrative|3|||
146498751|NCT00789698|528328063|FG003|Overall Study|Administrative|1|||
146498752|NCT03225105|528328064|FG000|Overall Study|Withdrawal by Subject|1|||
146498753|NCT03225105|528328065|FG001|Overall Study|Withdrawal by Subject|0|||
146498754|NCT03225105|528328066|FG002|Overall Study|Withdrawal by Subject|0|||
146498755|NCT03225105|528328067|FG003|Overall Study|Withdrawal by Subject|0|||
146498756|NCT03225105|528328064|FG000|Overall Study|Death|0|||
146498757|NCT03225105|528328065|FG001|Overall Study|Death|4|||
146498758|NCT03225105|528328066|FG002|Overall Study|Death|2|||
146498759|NCT03225105|528328067|FG003|Overall Study|Death|0|||
146498760|NCT03225105|528328064|FG000|Overall Study|Study termination per Sponsor Decision|2|||
146498761|NCT03225105|528328065|FG001|Overall Study|Study termination per Sponsor Decision|0|||
146498762|NCT03225105|528328066|FG002|Overall Study|Study termination per Sponsor Decision|3|||
146498763|NCT03225105|528328067|FG003|Overall Study|Study termination per Sponsor Decision|3|||
146498764|NCT01399047|528329647|FG000|Overall Study|Withdrawal by Subject|0|||
146498765|NCT01399047|528329648|FG001|Overall Study|Withdrawal by Subject|1|||
146498766|NCT03652636|528329656|FG000|Overall Study|Withdrawal by Subject|7|||
146498767|NCT01806961|528329658|FG000|Overall Study|sponsor decision|16|||
146498768|NCT04411810|528329659|FG000|Overall Study|Screen failure|1|||
146498769|NCT04411810|528329659|FG000|Overall Study|Withdrawal by Subject|1|||
146498770|NCT02028767|528329662|FG000|Treatment Period 2|Non compliant with protocol|1|||
146498771|NCT02028767|528329663|FG001|Treatment Period 2|Non compliant with protocol|0|||
146498772|NCT02028767|528329662|FG000|Treatment Period 2|Reason other than those specified above|1|||
146498773|NCT02028767|528329663|FG001|Treatment Period 2|Reason other than those specified above|0|||
146498774|NCT03192306|528329666|FG000|Overall Study|Did not treat cold sore during study|149|||
146498775|NCT03192306|528329667|FG001|Overall Study|Did not treat cold sore during study|143|||
146498776|NCT03192306|528329666|FG000|Overall Study|Withdrawal by Subject|1|||
146498777|NCT03192306|528329667|FG001|Overall Study|Withdrawal by Subject|1|||
146498778|NCT03192306|528329666|FG000|Overall Study|Lost to Follow-up|1|||
146498779|NCT03192306|528329667|FG001|Overall Study|Lost to Follow-up|0|||
146498780|NCT03192306|528329666|FG000|Overall Study|Protocol Violation|1|||
146498781|NCT03192306|528329667|FG001|Overall Study|Protocol Violation|1|||
146498782|NCT02589626|528329677|FG000|Overall Study|Other than the reason specified|1|||
146498783|NCT02589626|528329678|FG001|Overall Study|Other than the reason specified|0|||
146498784|NCT02589626|528329677|FG000|Overall Study|Withdrawal by Subject|1|||
146498785|NCT02589626|528329678|FG001|Overall Study|Withdrawal by Subject|1|||
146498786|NCT02589626|528329677|FG000|Overall Study|Adverse Event|1|||
146498787|NCT02589626|528329678|FG001|Overall Study|Adverse Event|1|||
146498788|NCT05338502|528329679|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
146498789|NCT05338502|528329680|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
146498790|NCT05338502|528329681|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
146498791|NCT05338502|528329679|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
146498792|NCT05338502|528329680|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
146498793|NCT05338502|528329681|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
146498794|NCT03575793|528329682|FG000|Overall Study|Withdrawal by Subject|0|||
146498795|NCT03575793|528329683|FG001|Overall Study|Withdrawal by Subject|1|||
146498796|NCT03575793|528329682|FG000|Overall Study|Never Treated|0|||
146498797|NCT03575793|528329683|FG001|Overall Study|Never Treated|2|||
146498798|NCT01127451|528329684|FG000|Overall Study|Other|2|||
146498799|NCT01127451|528329685|FG001|Overall Study|Other|1|||
146498800|NCT01127451|528329684|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
146498801|NCT01127451|528329685|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
146498802|NCT01127451|528329684|FG000|Overall Study|Death|22|||
146498803|NCT01127451|528329685|FG001|Overall Study|Death|17|||
146498804|NCT01127451|528329684|FG000|Overall Study|Lost to Follow-up|3|||
146498805|NCT01127451|528329685|FG001|Overall Study|Lost to Follow-up|0|||
146498806|NCT01127451|528329684|FG000|Overall Study|Administrative Reason by Sponsor|2|||
146498807|NCT01127451|528329685|FG001|Overall Study|Administrative Reason by Sponsor|2|||
146498808|NCT02111577|528329686|FG000|Overall Study|Protocol Violation|2|||
146498809|NCT02111577|528329687|FG001|Overall Study|Protocol Violation|0|||
146565561|NCT00659425|528582577|FG006|Overall Study|Other|3|||
146565562|NCT00659425|528582578|FG007|Overall Study|Other|2|||
146912191|NCT01103349|529841439|FG002|Overall Study|Adverse Event|3|||
146498810|NCT02111577|528329686|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
146498811|NCT02111577|528329687|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
146498812|NCT02111577|528329686|FG000|Overall Study|Failure to produce study treatment|6|||
146498813|NCT02111577|528329687|FG001|Overall Study|Failure to produce study treatment|0|||
146565563|NCT00659425|528582579|FG008|Overall Study|Other|0|||
146565564|NCT00659425|528582580|FG009|Overall Study|Other|6|||
146565565|NCT03358030|528582581|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
146565566|NCT03358030|528582582|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
146565567|NCT03358030|528582583|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
146565568|NCT03358030|528582584|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
146565569|NCT03358030|528582581|FG000|Overall Study|Ineligibility|0|||
146565570|NCT03358030|528582582|FG001|Overall Study|Ineligibility|0|||
146498814|NCT02111577|528329686|FG000|Overall Study|Death|518|||
146498815|NCT02111577|528329687|FG001|Overall Study|Death|254|||
146498816|NCT02111577|528329686|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
146498817|NCT02111577|528329687|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
146498818|NCT02111577|528329686|FG000|Overall Study|Adverse Event|1|||
146498819|NCT02111577|528329687|FG001|Overall Study|Adverse Event|1|||
146498820|NCT02111577|528329686|FG000|Overall Study|Withdrawal by Subject|51|||
146498821|NCT02111577|528329687|FG001|Overall Study|Withdrawal by Subject|23|||
146498822|NCT02111577|528329686|FG000|Overall Study|Disease progression|0|||
146498823|NCT02111577|528329687|FG001|Overall Study|Disease progression|1|||
146498824|NCT02111577|528329686|FG000|Overall Study|Lost to Follow-up|19|||
146565571|NCT03358030|528582583|FG002|Overall Study|Ineligibility|0|||
146498825|NCT02111577|528329687|FG001|Overall Study|Lost to Follow-up|10|||
146498826|NCT01014988|528329688|FG000|Overall Study|Adverse Event|20|||
146498827|NCT01014988|528329689|FG001|Overall Study|Adverse Event|0|||
146498828|NCT01014988|528329690|FG002|Overall Study|Adverse Event|1|||
146498829|NCT01014988|528329691|FG003|Overall Study|Adverse Event|0|||
146498830|NCT01014988|528329692|FG004|Overall Study|Adverse Event|1|||
146498831|NCT01014988|528329693|FG005|Overall Study|Adverse Event|3|||
146498832|NCT01014988|528329688|FG000|Overall Study|Lost to Follow-up|1|||
146498833|NCT01014988|528329689|FG001|Overall Study|Lost to Follow-up|0|||
146498834|NCT01014988|528329690|FG002|Overall Study|Lost to Follow-up|1|||
146498835|NCT01014988|528329691|FG003|Overall Study|Lost to Follow-up|0|||
146498836|NCT01014988|528329692|FG004|Overall Study|Lost to Follow-up|0|||
146498837|NCT01014988|528329693|FG005|Overall Study|Lost to Follow-up|0|||
146565572|NCT03358030|528582584|FG003|Overall Study|Ineligibility|2|||
146565573|NCT03358030|528582581|FG000|Overall Study|Voluntary Withdrawal|1|||
146565574|NCT03358030|528582582|FG001|Overall Study|Voluntary Withdrawal|1|||
146565575|NCT03358030|528582583|FG002|Overall Study|Voluntary Withdrawal|3|||
146565576|NCT03358030|528582584|FG003|Overall Study|Voluntary Withdrawal|1|||
146565577|NCT03358030|528582581|FG000|Overall Study|Other|0|||
146565578|NCT03358030|528582582|FG001|Overall Study|Other|0|||
146565579|NCT03358030|528582583|FG002|Overall Study|Other|1|||
146565580|NCT03358030|528582584|FG003|Overall Study|Other|0|||
146769007|NCT02020616|529321815|FG001|Overall Study|Randomized in Error|0|||
146769008|NCT02020616|529321816|FG002|Overall Study|Randomized in Error|0|||
146769009|NCT02020616|529321817|FG003|Overall Study|Randomized in Error|1|||
146912192|NCT01103349|529841437|FG000|Overall Study|Consent withdrawn|1|||
146912193|NCT01103349|529841438|FG001|Overall Study|Consent withdrawn|0|||
146498838|NCT01014988|528329688|FG000|Overall Study|Physician Decision|1|||
146498839|NCT01014988|528329689|FG001|Overall Study|Physician Decision|0|||
146498840|NCT01014988|528329690|FG002|Overall Study|Physician Decision|0|||
146498841|NCT01014988|528329691|FG003|Overall Study|Physician Decision|0|||
146498842|NCT01014988|528329692|FG004|Overall Study|Physician Decision|0|||
146498843|NCT01014988|528329693|FG005|Overall Study|Physician Decision|0|||
146498844|NCT01014988|528329688|FG000|Overall Study|Withdrawal by Subject|1|||
146498845|NCT01014988|528329689|FG001|Overall Study|Withdrawal by Subject|0|||
146498846|NCT01014988|528329690|FG002|Overall Study|Withdrawal by Subject|0|||
146498847|NCT01014988|528329691|FG003|Overall Study|Withdrawal by Subject|0|||
146498848|NCT01014988|528329692|FG004|Overall Study|Withdrawal by Subject|0|||
146565581|NCT03342560|528582585|FG000|Overall Study|Lost to Follow-up|2|||
146912194|NCT01103349|529841439|FG002|Overall Study|Consent withdrawn|0|||
146498849|NCT01014988|528329693|FG005|Overall Study|Withdrawal by Subject|0|||
146498850|NCT00729157|528329694|FG000|Overall Study|Withdrawal by Subject|1|||
146565582|NCT02604511|528582586|FG000|Overall Study|Adverse Event|3|||
146565583|NCT02604511|528582586|FG000|Overall Study|Disease Progression|4|||
146769010|NCT02020616|529321818|FG004|Overall Study|Randomized in Error|0|||
146912195|NCT01103349|529841437|FG000|Overall Study|Incorrectly included in the trial|1|||
146912196|NCT01103349|529841438|FG001|Overall Study|Incorrectly included in the trial|0|||
146498851|NCT00886743|528329695|FG000|Overall Study|Adverse Event|3|||
146498852|NCT00886743|528329695|FG000|Overall Study|Other|1|||
146498853|NCT02429778|528329697|FG000|Overall Study|Lost to Follow-up|2|||
146498854|NCT02429778|528329698|FG001|Overall Study|Lost to Follow-up|0|||
146498855|NCT02429778|528329697|FG000|Overall Study|Withdrawal by Subject|5|||
146498856|NCT02429778|528329698|FG001|Overall Study|Withdrawal by Subject|0|||
146498857|NCT02475265|528329699|FG000|Overall Study|Physician Decision|1|||
146498858|NCT02475265|528329699|FG000|Overall Study|Withdrawal by Subject|2|||
146565584|NCT02604511|528582586|FG000|Overall Study|Withdrawal by Subject|3|||
146565585|NCT02604511|528582586|FG000|Overall Study|Participant ineligible|1|||
146645377|NCT00612105|528879320|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
146498859|NCT03063086|528329700|FG000|Overall Study|technical problems|1|||
146498860|NCT03063086|528329701|FG001|Overall Study|technical problems|0|||
146498861|NCT03063086|528329702|FG002|Overall Study|technical problems|0|||
146498862|NCT03063086|528329703|FG003|Overall Study|technical problems|0|||
146498863|NCT03063086|528329704|FG004|Overall Study|technical problems|0|||
146498864|NCT03063086|528329705|FG005|Overall Study|technical problems|0|||
146498865|NCT03063086|528329700|FG000|Overall Study|Adverse Event|1|||
146498866|NCT03063086|528329701|FG001|Overall Study|Adverse Event|1|||
146498867|NCT03063086|528329702|FG002|Overall Study|Adverse Event|1|||
146498868|NCT03063086|528329703|FG003|Overall Study|Adverse Event|1|||
146498869|NCT03063086|528329704|FG004|Overall Study|Adverse Event|0|||
146498870|NCT03063086|528329705|FG005|Overall Study|Adverse Event|0|||
146498871|NCT03063086|528329700|FG000|Overall Study|subject/guardian decision|1|||
146498872|NCT03063086|528329701|FG001|Overall Study|subject/guardian decision|0|||
146498873|NCT03063086|528329702|FG002|Overall Study|subject/guardian decision|0|||
146498874|NCT03063086|528329703|FG003|Overall Study|subject/guardian decision|0|||
146498875|NCT03063086|528329704|FG004|Overall Study|subject/guardian decision|0|||
146498876|NCT03063086|528329705|FG005|Overall Study|subject/guardian decision|0|||
146498877|NCT03063086|528329700|FG000|Overall Study|Non-compliance with study treatment|0|||
146498878|NCT03063086|528329701|FG001|Overall Study|Non-compliance with study treatment|0|||
146498879|NCT03063086|528329702|FG002|Overall Study|Non-compliance with study treatment|0|||
146498880|NCT03063086|528329703|FG003|Overall Study|Non-compliance with study treatment|1|||
146498881|NCT03063086|528329704|FG004|Overall Study|Non-compliance with study treatment|0|||
146498882|NCT03063086|528329705|FG005|Overall Study|Non-compliance with study treatment|1|||
146498883|NCT03063086|528329700|FG000|Overall Study|Physician Decision|0|||
146498884|NCT03063086|528329701|FG001|Overall Study|Physician Decision|0|||
146498885|NCT03063086|528329702|FG002|Overall Study|Physician Decision|0|||
146498886|NCT03063086|528329703|FG003|Overall Study|Physician Decision|1|||
146498887|NCT03063086|528329704|FG004|Overall Study|Physician Decision|0|||
146498888|NCT03063086|528329705|FG005|Overall Study|Physician Decision|0|||
146498889|NCT02244463|528329706|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
146498890|NCT02244463|528329707|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
146498891|NCT02244463|528329708|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
146498892|NCT02244463|528329709|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
146498893|NCT02244463|528329710|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
146498894|NCT02244463|528329711|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
146498895|NCT02244463|528329706|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
146498896|NCT02244463|528329707|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
146498897|NCT02244463|528329708|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
146972016|NCT02588651|530058517|FG000|Overall Study|Lack of Efficacy|13|||
146972017|NCT02588651|530058517|FG000|Overall Study|Lost to Follow-up|1|||
146972018|NCT02588651|530058517|FG000|Overall Study|Physician Decision|1|||
146972019|NCT02588651|530058517|FG000|Overall Study|Disease progression|2|||
146972020|NCT00569127|530058522|FG000|Overall Study|Adverse Event|57|||
146972021|NCT00569127|530058523|FG001|Overall Study|Adverse Event|47|||
146972022|NCT00569127|530058522|FG000|Overall Study|Withdrawal by Subject|13|||
146972023|NCT00569127|530058523|FG001|Overall Study|Withdrawal by Subject|27|||
146972024|NCT00569127|530058522|FG000|Overall Study|Progression|99|||
146972025|NCT00569127|530058523|FG001|Overall Study|Progression|100|||
146972026|NCT00569127|530058522|FG000|Overall Study|Death|4|||
146972027|NCT00569127|530058523|FG001|Overall Study|Death|3|||
146972028|NCT00569127|530058522|FG000|Overall Study|Other|20|||
146972029|NCT00569127|530058523|FG001|Overall Study|Other|19|||
146972030|NCT00569127|530058522|FG000|Overall Study|Lost to Follow-up|0|||
146972031|NCT00569127|530058523|FG001|Overall Study|Lost to Follow-up|3|||
146972032|NCT00569127|530058522|FG000|Overall Study|Not Eligible|14|||
146972033|NCT00569127|530058523|FG001|Overall Study|Not Eligible|11|||
146972034|NCT00569127|530058522|FG000|Overall Study|Still on Treatment|7|||
146972035|NCT00569127|530058523|FG001|Overall Study|Still on Treatment|3|||
146972036|NCT04083378|530058524|FG000|Overall Study|Death|18|||
146972037|NCT04083378|530058525|FG001|Overall Study|Death|4|||
146972038|NCT04083378|530058524|FG000|Overall Study|Lost to Follow-up|4|||
146972039|NCT04083378|530058525|FG001|Overall Study|Lost to Follow-up|0|||
146972040|NCT04803214|530058526|FG000|Overall Study|Adverse Event|1|||
146972041|NCT04803214|530058527|FG001|Overall Study|Adverse Event|0|||
146498898|NCT02244463|528329709|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
146498899|NCT02244463|528329710|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
146498900|NCT02244463|528329711|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
146972042|NCT04803214|530058526|FG000|Overall Study|Withdrawal by Subject|1|||
146972043|NCT04803214|530058527|FG001|Overall Study|Withdrawal by Subject|2|||
146498901|NCT02244463|528329706|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
146498902|NCT02244463|528329707|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
146498903|NCT02244463|528329708|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
146498904|NCT02244463|528329709|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
146498905|NCT02244463|528329710|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
146769011|NCT02020616|529321819|FG005|Overall Study|Randomized in Error|0|||
146972044|NCT04803214|530058526|FG000|Overall Study|Lost to Follow-up|2|||
146972045|NCT04803214|530058527|FG001|Overall Study|Lost to Follow-up|4|||
146972046|NCT04803214|530058526|FG000|Overall Study|Physician Decision|1|||
146972047|NCT04803214|530058527|FG001|Overall Study|Physician Decision|1|||
146972048|NCT04803214|530058526|FG000|Overall Study|Missed 12 month visit|0|||
146972049|NCT04803214|530058527|FG001|Overall Study|Missed 12 month visit|3|||
146972050|NCT00644228|530058528|FG000|Randomization & Eligibility|Ineligible|31|||
146972051|NCT00644228|530058529|FG001|Randomization & Eligibility|Ineligible|21|||
146972052|NCT00644228|530058528|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
146972053|NCT00644228|530058529|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
146972054|NCT00644228|530058528|FG000|Randomization & Eligibility|Invalid Consent|0|||
146972055|NCT00644228|530058529|FG001|Randomization & Eligibility|Invalid Consent|1|||
146972056|NCT00644228|530058528|FG000|Induction Therapy|Adverse Event|22|||
146972057|NCT00644228|530058529|FG001|Induction Therapy|Adverse Event|55|||
146972058|NCT00644228|530058528|FG000|Induction Therapy|Withdrawal by Subject|10|||
146972059|NCT00644228|530058529|FG001|Induction Therapy|Withdrawal by Subject|3|||
146972060|NCT00644228|530058528|FG000|Induction Therapy|Progression/Relapse|24|||
146972061|NCT00644228|530058529|FG001|Induction Therapy|Progression/Relapse|12|||
146972062|NCT00644228|530058528|FG000|Induction Therapy|Death|3|||
146972063|NCT00644228|530058529|FG001|Induction Therapy|Death|7|||
146972064|NCT00644228|530058528|FG000|Induction Therapy|Not Protocol-Specified|24|||
146972065|NCT00644228|530058529|FG001|Induction Therapy|Not Protocol-Specified|28|||
146972066|NCT00644228|530058528|FG000|Maintenance|Adverse Event|27|||
146972067|NCT00644228|530058529|FG001|Maintenance|Adverse Event|31|||
146972068|NCT00644228|530058528|FG000|Maintenance|Withdrawal by Subject|6|||
146972069|NCT00644228|530058529|FG001|Maintenance|Withdrawal by Subject|4|||
146972070|NCT00644228|530058528|FG000|Maintenance|Progression/Relapse|67|||
146972071|NCT00644228|530058529|FG001|Maintenance|Progression/Relapse|42|||
146972072|NCT00644228|530058528|FG000|Maintenance|Death|3|||
146972073|NCT00644228|530058529|FG001|Maintenance|Death|3|||
146972074|NCT00644228|530058528|FG000|Maintenance|Not Protocol-Specified|14|||
146972075|NCT00644228|530058529|FG001|Maintenance|Not Protocol-Specified|15|||
146972076|NCT00644228|530058528|FG000|Maintenance|On Treatment|26|||
146972077|NCT00644228|530058529|FG001|Maintenance|On Treatment|40|||
146972078|NCT06078124|530058530|FG000|Overall Study|Lost to Follow-up|14|||
146972079|NCT06078124|530058531|FG001|Overall Study|Lost to Follow-up|14|||
146972080|NCT05824273|530058532|FG000|Overall Study|Lost to Follow-up|16|||
146972081|NCT05824273|530058533|FG001|Overall Study|Lost to Follow-up|13|||
146972082|NCT02736695|530058534|FG000|Overall Study|Ineligible|6|||
146972083|NCT02736695|530058535|FG001|Overall Study|Ineligible|0|||
146972084|NCT04223193|530058536|FG000|Overall Study|Adverse Event|6|||
146972085|NCT04223193|530058537|FG001|Overall Study|Adverse Event|36|||
146972086|NCT04223193|530058536|FG000|Overall Study|Lack of Efficacy|2|||
146972087|NCT04223193|530058537|FG001|Overall Study|Lack of Efficacy|2|||
146972088|NCT04223193|530058536|FG000|Overall Study|Lost to Follow-up|1|||
146972089|NCT04223193|530058537|FG001|Overall Study|Lost to Follow-up|1|||
146972090|NCT04223193|530058536|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
146972091|NCT04223193|530058537|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
146972092|NCT04223193|530058536|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
146972093|NCT04223193|530058537|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
146972094|NCT04223193|530058536|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146972095|NCT04223193|530058537|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146972096|NCT04223193|530058536|FG000|Overall Study|Physician Decision|0|||
146972097|NCT04223193|530058537|FG001|Overall Study|Physician Decision|1|||
146972098|NCT04223193|530058536|FG000|Overall Study|Protocol Violation|1|||
146972099|NCT04223193|530058537|FG001|Overall Study|Protocol Violation|1|||
146972100|NCT04223193|530058536|FG000|Overall Study|Site Terminated by Sponsor|1|||
146972101|NCT04223193|530058537|FG001|Overall Study|Site Terminated by Sponsor|3|||
146972102|NCT04223193|530058536|FG000|Overall Study|Withdrawal by Subject|5|||
146972103|NCT04223193|530058537|FG001|Overall Study|Withdrawal by Subject|6|||
146972104|NCT04223193|530058536|FG000|Overall Study|Other|3|||
146972105|NCT04223193|530058537|FG001|Overall Study|Other|6|||
146972106|NCT03193190|530058540|FG000|Stage 1|Arm Terminated by Sponsor|0|||
146972107|NCT03193190|530058541|FG001|Stage 1|Arm Terminated by Sponsor|0|||
146972108|NCT03193190|530058542|FG002|Stage 1|Arm Terminated by Sponsor|0|||
146972109|NCT03193190|530058543|FG003|Stage 1|Arm Terminated by Sponsor|1|||
146972110|NCT03193190|530058544|FG004|Stage 1|Arm Terminated by Sponsor|0|||
146972111|NCT03193190|530058545|FG005|Stage 1|Arm Terminated by Sponsor|2|||
146972112|NCT03193190|530058546|FG006|Stage 1|Arm Terminated by Sponsor|0|||
146972113|NCT03193190|530058547|FG007|Stage 1|Arm Terminated by Sponsor|0|||
146972114|NCT03193190|530058548|FG008|Stage 1|Arm Terminated by Sponsor|0|||
146972115|NCT03193190|530058549|FG009|Stage 1|Arm Terminated by Sponsor|0|||
146972116|NCT03193190|530058550|FG010|Stage 1|Arm Terminated by Sponsor|0|||
146972117|NCT03193190|530058551|FG011|Stage 1|Arm Terminated by Sponsor|0|||
146972118|NCT03193190|530058552|FG012|Stage 1|Arm Terminated by Sponsor|0|||
146972119|NCT03193190|530058553|FG013|Stage 1|Arm Terminated by Sponsor|0|||
146972120|NCT03193190|530058554|FG014|Stage 1|Arm Terminated by Sponsor|0|||
146972121|NCT03193190|530058555|FG015|Stage 1|Arm Terminated by Sponsor|0|||
146972122|NCT03193190|530058540|FG000|Stage 1|Death|22|||
146972123|NCT03193190|530058541|FG001|Stage 1|Death|8|||
146972124|NCT03193190|530058542|FG002|Stage 1|Death|23|||
146972125|NCT03193190|530058543|FG003|Stage 1|Death|14|||
146972126|NCT03193190|530058544|FG004|Stage 1|Death|34|||
146972127|NCT03193190|530058545|FG005|Stage 1|Death|28|||
146972128|NCT03193190|530058546|FG006|Stage 1|Death|19|||
146972129|NCT03193190|530058547|FG007|Stage 1|Death|21|||
146972130|NCT03193190|530058548|FG008|Stage 1|Death|14|||
146972131|NCT03193190|530058549|FG009|Stage 1|Death|10|||
146972132|NCT03193190|530058550|FG010|Stage 1|Death|59|||
146972133|NCT03193190|530058551|FG011|Stage 1|Death|14|||
146972134|NCT03193190|530058552|FG012|Stage 1|Death|14|||
146972135|NCT03193190|530058553|FG013|Stage 1|Death|0|||
146972136|NCT03193190|530058554|FG014|Stage 1|Death|0|||
146972137|NCT03193190|530058555|FG015|Stage 1|Death|0|||
146972138|NCT03193190|530058540|FG000|Stage 1|Lost to Follow-up|2|||
146972139|NCT03193190|530058541|FG001|Stage 1|Lost to Follow-up|1|||
146972140|NCT03193190|530058542|FG002|Stage 1|Lost to Follow-up|1|||
146972141|NCT03193190|530058543|FG003|Stage 1|Lost to Follow-up|0|||
146972142|NCT03193190|530058544|FG004|Stage 1|Lost to Follow-up|0|||
146972143|NCT03193190|530058545|FG005|Stage 1|Lost to Follow-up|0|||
146972144|NCT03193190|530058546|FG006|Stage 1|Lost to Follow-up|1|||
146972145|NCT03193190|530058547|FG007|Stage 1|Lost to Follow-up|0|||
146972146|NCT03193190|530058548|FG008|Stage 1|Lost to Follow-up|0|||
146972147|NCT03193190|530058549|FG009|Stage 1|Lost to Follow-up|0|||
146972148|NCT03193190|530058550|FG010|Stage 1|Lost to Follow-up|0|||
146972149|NCT03193190|530058551|FG011|Stage 1|Lost to Follow-up|0|||
146972150|NCT03193190|530058552|FG012|Stage 1|Lost to Follow-up|0|||
146972151|NCT03193190|530058553|FG013|Stage 1|Lost to Follow-up|0|||
146972152|NCT03193190|530058554|FG014|Stage 1|Lost to Follow-up|0|||
146972153|NCT03193190|530058555|FG015|Stage 1|Lost to Follow-up|0|||
146972154|NCT03193190|530058540|FG000|Stage 1|Reason not Specified|1|||
146972155|NCT03193190|530058541|FG001|Stage 1|Reason not Specified|0|||
146972156|NCT03193190|530058542|FG002|Stage 1|Reason not Specified|0|||
146972157|NCT03193190|530058543|FG003|Stage 1|Reason not Specified|1|||
146972158|NCT03193190|530058544|FG004|Stage 1|Reason not Specified|0|||
146972159|NCT03193190|530058545|FG005|Stage 1|Reason not Specified|1|||
146972160|NCT03193190|530058546|FG006|Stage 1|Reason not Specified|2|||
146972161|NCT03193190|530058547|FG007|Stage 1|Reason not Specified|2|||
146972162|NCT03193190|530058548|FG008|Stage 1|Reason not Specified|0|||
146972163|NCT03193190|530058549|FG009|Stage 1|Reason not Specified|1|||
146972164|NCT03193190|530058550|FG010|Stage 1|Reason not Specified|3|||
146972165|NCT03193190|530058551|FG011|Stage 1|Reason not Specified|0|||
146972166|NCT03193190|530058552|FG012|Stage 1|Reason not Specified|1|||
146972167|NCT03193190|530058553|FG013|Stage 1|Reason not Specified|0|||
146972168|NCT03193190|530058554|FG014|Stage 1|Reason not Specified|0|||
146972169|NCT03193190|530058555|FG015|Stage 1|Reason not Specified|0|||
146972170|NCT03193190|530058540|FG000|Stage 1|Physician Decision|0|||
146972171|NCT03193190|530058541|FG001|Stage 1|Physician Decision|0|||
146972172|NCT03193190|530058542|FG002|Stage 1|Physician Decision|0|||
146972173|NCT03193190|530058543|FG003|Stage 1|Physician Decision|0|||
146972174|NCT03193190|530058544|FG004|Stage 1|Physician Decision|0|||
146972175|NCT03193190|530058545|FG005|Stage 1|Physician Decision|0|||
146972176|NCT03193190|530058546|FG006|Stage 1|Physician Decision|0|||
146972177|NCT03193190|530058547|FG007|Stage 1|Physician Decision|0|||
146972178|NCT03193190|530058548|FG008|Stage 1|Physician Decision|0|||
146972179|NCT03193190|530058549|FG009|Stage 1|Physician Decision|0|||
146972180|NCT03193190|530058550|FG010|Stage 1|Physician Decision|0|||
146972181|NCT03193190|530058551|FG011|Stage 1|Physician Decision|1|||
146972182|NCT03193190|530058552|FG012|Stage 1|Physician Decision|0|||
146972183|NCT03193190|530058553|FG013|Stage 1|Physician Decision|0|||
146972184|NCT03193190|530058554|FG014|Stage 1|Physician Decision|0|||
146972185|NCT03193190|530058555|FG015|Stage 1|Physician Decision|0|||
146972186|NCT03193190|530058540|FG000|Stage 1|Progressive Disease|1|||
146972187|NCT03193190|530058541|FG001|Stage 1|Progressive Disease|0|||
146972188|NCT03193190|530058542|FG002|Stage 1|Progressive Disease|0|||
146972189|NCT03193190|530058543|FG003|Stage 1|Progressive Disease|0|||
146972190|NCT03193190|530058544|FG004|Stage 1|Progressive Disease|0|||
146972191|NCT03193190|530058545|FG005|Stage 1|Progressive Disease|0|||
146972192|NCT03193190|530058546|FG006|Stage 1|Progressive Disease|0|||
146972193|NCT03193190|530058547|FG007|Stage 1|Progressive Disease|0|||
146972194|NCT03193190|530058548|FG008|Stage 1|Progressive Disease|0|||
146972195|NCT03193190|530058549|FG009|Stage 1|Progressive Disease|0|||
146972196|NCT03193190|530058550|FG010|Stage 1|Progressive Disease|0|||
146972197|NCT03193190|530058551|FG011|Stage 1|Progressive Disease|0|||
146972198|NCT03193190|530058552|FG012|Stage 1|Progressive Disease|0|||
146972199|NCT03193190|530058553|FG013|Stage 1|Progressive Disease|0|||
146972200|NCT03193190|530058554|FG014|Stage 1|Progressive Disease|0|||
146972201|NCT03193190|530058555|FG015|Stage 1|Progressive Disease|0|||
146972202|NCT03193190|530058540|FG000|Stage 1|Study Terminated By Sponsor|3|||
146972203|NCT03193190|530058541|FG001|Stage 1|Study Terminated By Sponsor|0|||
146972204|NCT03193190|530058542|FG002|Stage 1|Study Terminated By Sponsor|0|||
146972205|NCT03193190|530058543|FG003|Stage 1|Study Terminated By Sponsor|0|||
146972206|NCT03193190|530058544|FG004|Stage 1|Study Terminated By Sponsor|6|||
146972207|NCT03193190|530058545|FG005|Stage 1|Study Terminated By Sponsor|0|||
146498906|NCT02244463|528329711|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
146498907|NCT02244463|528329706|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
146498908|NCT02244463|528329707|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
146498909|NCT02244463|528329708|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
146498910|NCT02244463|528329709|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
146498911|NCT02244463|528329710|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
146498912|NCT02244463|528329711|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
146498913|NCT02244463|528329706|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
146498914|NCT02244463|528329707|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
146498915|NCT02244463|528329708|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
146498916|NCT02244463|528329709|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
146498917|NCT02244463|528329710|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
146498918|NCT02244463|528329711|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
146498919|NCT02244463|528329706|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
146498920|NCT02244463|528329707|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
146498921|NCT02244463|528329708|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
146498922|NCT02244463|528329709|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
146498923|NCT02244463|528329710|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
146498924|NCT02244463|528329711|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
146498925|NCT02244463|528329706|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
146498926|NCT02244463|528329707|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
146498927|NCT02244463|528329708|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
146498928|NCT02244463|528329709|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
146498929|NCT02244463|528329710|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
146498930|NCT02244463|528329711|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
146912197|NCT01103349|529841439|FG002|Overall Study|Incorrectly included in the trial|0|||
146912198|NCT01103349|529841437|FG000|Overall Study|Withdrawal by Subject|1|||
146498931|NCT02244463|528329706|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
146565586|NCT02604511|528582586|FG000|Overall Study|Intercurrent illness|1|||
146565587|NCT03770286|528582587|FG000|Overall Study|Lost to Follow-up|6|||
146565588|NCT03770286|528582588|FG001|Overall Study|Lost to Follow-up|4|||
146565589|NCT03770286|528582589|FG002|Overall Study|Lost to Follow-up|3|||
146565590|NCT03770286|528582587|FG000|Overall Study|Protocol Violation|1|||
146565591|NCT03770286|528582588|FG001|Overall Study|Protocol Violation|0|||
146565592|NCT03770286|528582589|FG002|Overall Study|Protocol Violation|2|||
146565593|NCT01729039|528582592|FG000|Overall Study|disqualified|2|||
146565594|NCT01729039|528582593|FG001|Overall Study|disqualified|5|||
146565595|NCT01729039|528582592|FG000|Overall Study|Withdrawal by Subject|8|||
146565596|NCT01729039|528582593|FG001|Overall Study|Withdrawal by Subject|7|||
146565597|NCT05788991|528582595|FG000|Overall Study|Not treated with study medication|1|||
146565598|NCT05788991|528582596|FG001|Overall Study|Not treated with study medication|3|||
146565599|NCT05788991|528582595|FG000|Overall Study|Withdrawal by Subject|1|||
146565600|NCT05788991|528582596|FG001|Overall Study|Withdrawal by Subject|0|||
146565601|NCT05788991|528582595|FG000|Overall Study|Lack of Efficacy|0|||
146565602|NCT05788991|528582596|FG001|Overall Study|Lack of Efficacy|1|||
146565603|NCT05788991|528582595|FG000|Overall Study|Protocol Violation|1|||
146565604|NCT05788991|528582596|FG001|Overall Study|Protocol Violation|2|||
146565605|NCT04464473|528582597|FG000|Overall Study|New piercing could not be removed for scanning|0|||
146565606|NCT04464473|528582598|FG001|Overall Study|New piercing could not be removed for scanning|0|||
146565607|NCT04464473|528582599|FG002|Overall Study|New piercing could not be removed for scanning|0|||
146565608|NCT04464473|528582600|FG003|Overall Study|New piercing could not be removed for scanning|1|||
146565609|NCT04464473|528582601|FG004|Overall Study|New piercing could not be removed for scanning|0|||
146565610|NCT04464473|528582602|FG005|Overall Study|New piercing could not be removed for scanning|0|||
146565611|NCT04464473|528582597|FG000|Overall Study|Adverse Event|0|||
146565612|NCT04464473|528582598|FG001|Overall Study|Adverse Event|0|||
146565613|NCT04464473|528582599|FG002|Overall Study|Adverse Event|0|||
146565614|NCT04464473|528582600|FG003|Overall Study|Adverse Event|1|||
146565615|NCT04464473|528582601|FG004|Overall Study|Adverse Event|0|||
146565616|NCT04464473|528582602|FG005|Overall Study|Adverse Event|0|||
146565617|NCT04464473|528582597|FG000|Overall Study|Lost to Follow-up|0|||
146565618|NCT04464473|528582598|FG001|Overall Study|Lost to Follow-up|0|||
146565619|NCT04464473|528582599|FG002|Overall Study|Lost to Follow-up|0|||
146565620|NCT04464473|528582600|FG003|Overall Study|Lost to Follow-up|1|||
146565621|NCT04464473|528582601|FG004|Overall Study|Lost to Follow-up|0|||
146565622|NCT04464473|528582602|FG005|Overall Study|Lost to Follow-up|0|||
146565623|NCT03802396|528582603|FG000|Overall Study|Withdrawal by Subject|2|||
146565624|NCT03802396|528582604|FG001|Overall Study|Withdrawal by Subject|0|||
146912199|NCT01103349|529841438|FG001|Overall Study|Withdrawal by Subject|1|||
146498932|NCT02244463|528329707|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
146498933|NCT02244463|528329708|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
146498934|NCT02244463|528329709|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
146565625|NCT03802396|528582603|FG000|Overall Study|Surgery Cancelled|1|||
146498935|NCT02244463|528329710|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
146498936|NCT02244463|528329711|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
146498937|NCT02244463|528329706|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
146769012|NCT02020616|529321820|FG006|Overall Study|Randomized in Error|0|||
146769013|NCT02020616|529321814|FG000|Overall Study|Lack of Efficacy|0|||
146769014|NCT02020616|529321815|FG001|Overall Study|Lack of Efficacy|0|||
146769015|NCT02020616|529321816|FG002|Overall Study|Lack of Efficacy|0|||
146912200|NCT01103349|529841439|FG002|Overall Study|Withdrawal by Subject|0|||
146912201|NCT01103349|529841437|FG000|Overall Study|did not want to take trial medication|0|||
146912202|NCT01103349|529841438|FG001|Overall Study|did not want to take trial medication|1|||
146912203|NCT01103349|529841439|FG002|Overall Study|did not want to take trial medication|0|||
146912204|NCT01103349|529841437|FG000|Overall Study|forgot to take medication|0|||
146912205|NCT01103349|529841438|FG001|Overall Study|forgot to take medication|0|||
146912206|NCT01103349|529841439|FG002|Overall Study|forgot to take medication|1|||
146912207|NCT00958568|529841440|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
146912208|NCT00958568|529841441|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
146912209|NCT00958568|529841442|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
146912210|NCT00958568|529841443|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
146912211|NCT00958568|529841440|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
146912212|NCT00958568|529841441|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
146912213|NCT00958568|529841442|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
146912214|NCT00958568|529841443|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
146912215|NCT00958568|529841440|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
146912216|NCT00958568|529841441|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
146912217|NCT00958568|529841442|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
146912218|NCT00958568|529841443|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
146912219|NCT00958568|529841440|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
146912220|NCT00958568|529841441|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
146912221|NCT00958568|529841442|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
146912222|NCT00958568|529841443|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
146912223|NCT00958568|529841440|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
146912224|NCT00958568|529841441|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
146912225|NCT00958568|529841442|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
146912226|NCT00958568|529841443|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
146912227|NCT00958568|529841440|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
146912228|NCT00958568|529841441|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
146912229|NCT00958568|529841442|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
146912230|NCT00958568|529841443|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
146912231|NCT00958568|529841440|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
146912232|NCT00958568|529841441|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
146912233|NCT00958568|529841442|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
146912234|NCT00958568|529841443|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
146912235|NCT00958568|529841440|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
146565626|NCT03802396|528582604|FG001|Overall Study|Surgery Cancelled|0|||
146565627|NCT02661672|528582608|FG000|Overall Study|Lost to Follow-up|1|||
146565628|NCT02661672|528582608|FG000|Overall Study|Death|4|||
146565629|NCT02114177|528584214|FG000|Overall Study|Lost to Follow-up|1|||
146565630|NCT02114177|528584215|FG001|Overall Study|Lost to Follow-up|2|||
146565631|NCT02114177|528584214|FG000|Overall Study|Withdrawal by Subject|6|||
146565632|NCT02114177|528584215|FG001|Overall Study|Withdrawal by Subject|1|||
146565633|NCT02114177|528584214|FG000|Overall Study|Other|2|||
146565634|NCT02114177|528584215|FG001|Overall Study|Other|1|||
146565635|NCT01770743|528584216|FG000|Overall Study|Adverse Event|1|||
146565636|NCT01770743|528584217|FG001|Overall Study|Adverse Event|0|||
146565637|NCT01770743|528584218|FG002|Overall Study|Adverse Event|0|||
146565638|NCT01770743|528584219|FG003|Overall Study|Adverse Event|0|||
146565639|NCT01770743|528584220|FG004|Overall Study|Adverse Event|0|||
146565640|NCT01770743|528584216|FG000|Overall Study|Withdrawal by Subject|0|||
146565641|NCT01770743|528584217|FG001|Overall Study|Withdrawal by Subject|0|||
146565642|NCT01770743|528584218|FG002|Overall Study|Withdrawal by Subject|1|||
146565643|NCT01770743|528584219|FG003|Overall Study|Withdrawal by Subject|1|||
146565644|NCT01770743|528584220|FG004|Overall Study|Withdrawal by Subject|1|||
146565645|NCT01770743|528584216|FG000|Overall Study|Lost to Follow-up|0|||
146565646|NCT01770743|528584217|FG001|Overall Study|Lost to Follow-up|2|||
146565647|NCT01770743|528584218|FG002|Overall Study|Lost to Follow-up|0|||
146565648|NCT01770743|528584219|FG003|Overall Study|Lost to Follow-up|0|||
146565649|NCT01770743|528584220|FG004|Overall Study|Lost to Follow-up|1|||
146565650|NCT01770743|528584216|FG000|Overall Study|Sponsor Terminated Subject|1|||
146565651|NCT01770743|528584217|FG001|Overall Study|Sponsor Terminated Subject|0|||
146565652|NCT01770743|528584218|FG002|Overall Study|Sponsor Terminated Subject|0|||
146565653|NCT01770743|528584219|FG003|Overall Study|Sponsor Terminated Subject|1|||
146498938|NCT02244463|528329707|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
146498939|NCT02244463|528329708|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
146498940|NCT02244463|528329709|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
146498941|NCT02244463|528329710|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
146498942|NCT02244463|528329711|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
146498943|NCT02244463|528329706|FG000|Period 5: Phase II|Disease Progression|0|||
146498944|NCT02244463|528329707|FG001|Period 5: Phase II|Disease Progression|0|||
146498945|NCT02244463|528329708|FG002|Period 5: Phase II|Disease Progression|0|||
146498946|NCT02244463|528329709|FG003|Period 5: Phase II|Disease Progression|0|||
146498947|NCT02244463|528329710|FG004|Period 5: Phase II|Disease Progression|10|||
146498948|NCT02244463|528329711|FG005|Period 5: Phase II|Disease Progression|11|||
146498949|NCT02244463|528329706|FG000|Period 5: Phase II|Physician Decision|0|||
146498950|NCT02244463|528329707|FG001|Period 5: Phase II|Physician Decision|0|||
146498951|NCT02244463|528329708|FG002|Period 5: Phase II|Physician Decision|0|||
146498952|NCT02244463|528329709|FG003|Period 5: Phase II|Physician Decision|0|||
146498953|NCT02244463|528329710|FG004|Period 5: Phase II|Physician Decision|3|||
146498954|NCT02244463|528329711|FG005|Period 5: Phase II|Physician Decision|2|||
146498955|NCT02244463|528329706|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
146498956|NCT02244463|528329707|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
146498957|NCT02244463|528329708|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
146498958|NCT02244463|528329709|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
146498959|NCT02244463|528329710|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
146498960|NCT02244463|528329711|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
146498961|NCT02244463|528329706|FG000|Period 5: Phase II|Intercurrent Illness|0|||
146498962|NCT02244463|528329707|FG001|Period 5: Phase II|Intercurrent Illness|0|||
146498963|NCT02244463|528329708|FG002|Period 5: Phase II|Intercurrent Illness|0|||
146498964|NCT02244463|528329709|FG003|Period 5: Phase II|Intercurrent Illness|0|||
146498965|NCT02244463|528329710|FG004|Period 5: Phase II|Intercurrent Illness|2|||
146498966|NCT02244463|528329711|FG005|Period 5: Phase II|Intercurrent Illness|0|||
146972208|NCT03193190|530058546|FG006|Stage 1|Study Terminated By Sponsor|0|||
146972209|NCT03193190|530058547|FG007|Stage 1|Study Terminated By Sponsor|0|||
146498967|NCT02244463|528329706|FG000|Period 5: Phase II|Adverse Event|0|||
146498968|NCT02244463|528329707|FG001|Period 5: Phase II|Adverse Event|0|||
146498969|NCT02244463|528329708|FG002|Period 5: Phase II|Adverse Event|0|||
146498970|NCT02244463|528329709|FG003|Period 5: Phase II|Adverse Event|0|||
146498971|NCT02244463|528329710|FG004|Period 5: Phase II|Adverse Event|0|||
146498972|NCT02244463|528329711|FG005|Period 5: Phase II|Adverse Event|2|||
146498973|NCT02244463|528329706|FG000|Period 5: Phase II|Still On treatment|0|||
146498974|NCT02244463|528329707|FG001|Period 5: Phase II|Still On treatment|0|||
146498975|NCT02244463|528329708|FG002|Period 5: Phase II|Still On treatment|0|||
146498976|NCT02244463|528329709|FG003|Period 5: Phase II|Still On treatment|0|||
146498977|NCT02244463|528329710|FG004|Period 5: Phase II|Still On treatment|0|||
146498978|NCT02244463|528329711|FG005|Period 5: Phase II|Still On treatment|3|||
146498979|NCT05481125|528329712|FG000|Overall Study|Adverse Event|1|||
146498980|NCT05481125|528329713|FG001|Overall Study|Adverse Event|0|||
146498981|NCT05481125|528329712|FG000|Overall Study|Lost to Follow-up|0|||
146498982|NCT05481125|528329713|FG001|Overall Study|Lost to Follow-up|1|||
146498983|NCT05481125|528329712|FG000|Overall Study|Withdrawal by Subject|0|||
146498984|NCT05481125|528329713|FG001|Overall Study|Withdrawal by Subject|1|||
146498985|NCT01769508|528329714|FG000|Overall Study|Death|3|||
146498986|NCT01769508|528329714|FG000|Overall Study|Withdrawal by Subject|1|||
146498987|NCT01769508|528329714|FG000|Overall Study|Adverse Event|1|||
146498988|NCT01769508|528329714|FG000|Overall Study|Lost to Follow-up|1|||
146498989|NCT03615144|528329715|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
146498990|NCT03615144|528329716|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
146498991|NCT02587598|528329717|FG000|Overall Study|Death|4|||
146498992|NCT02587598|528329718|FG001|Overall Study|Death|8|||
146498993|NCT02587598|528329719|FG002|Overall Study|Death|4|||
146498994|NCT02587598|528329720|FG003|Overall Study|Death|16|||
146498995|NCT02587598|528329721|FG004|Overall Study|Death|9|||
146498996|NCT02587598|528329722|FG005|Overall Study|Death|4|||
146565654|NCT01770743|528584220|FG004|Overall Study|Sponsor Terminated Subject|0|||
146565655|NCT01770743|528584216|FG000|Overall Study|Moving Out of State|0|||
146565656|NCT01770743|528584217|FG001|Overall Study|Moving Out of State|1|||
146565657|NCT01770743|528584218|FG002|Overall Study|Moving Out of State|0|||
146972210|NCT03193190|530058548|FG008|Stage 1|Study Terminated By Sponsor|0|||
146498997|NCT02587598|528329723|FG006|Overall Study|Death|6|||
146498998|NCT02587598|528329724|FG007|Overall Study|Death|7|||
146498999|NCT02587598|528329725|FG008|Overall Study|Death|9|||
146499000|NCT02587598|528329726|FG009|Overall Study|Death|1|||
146499001|NCT02587598|528329727|FG010|Overall Study|Death|3|||
146499002|NCT02587598|528329717|FG000|Overall Study|Study Terminated by the Sponsor|0|||
146565658|NCT01770743|528584219|FG003|Overall Study|Moving Out of State|0|||
146499003|NCT02587598|528329718|FG001|Overall Study|Study Terminated by the Sponsor|1|||
146499004|NCT02587598|528329719|FG002|Overall Study|Study Terminated by the Sponsor|0|||
146499005|NCT02587598|528329720|FG003|Overall Study|Study Terminated by the Sponsor|3|||
146499006|NCT02587598|528329721|FG004|Overall Study|Study Terminated by the Sponsor|0|||
146499007|NCT02587598|528329722|FG005|Overall Study|Study Terminated by the Sponsor|1|||
146499008|NCT02587598|528329723|FG006|Overall Study|Study Terminated by the Sponsor|0|||
146499009|NCT02587598|528329724|FG007|Overall Study|Study Terminated by the Sponsor|0|||
146499010|NCT02587598|528329725|FG008|Overall Study|Study Terminated by the Sponsor|0|||
146499011|NCT02587598|528329726|FG009|Overall Study|Study Terminated by the Sponsor|1|||
146499012|NCT02587598|528329727|FG010|Overall Study|Study Terminated by the Sponsor|6|||
146499013|NCT02587598|528329717|FG000|Overall Study|Reason for study withdrawal not specified|0|||
146499014|NCT02587598|528329718|FG001|Overall Study|Reason for study withdrawal not specified|1|||
146499015|NCT02587598|528329719|FG002|Overall Study|Reason for study withdrawal not specified|0|||
146499016|NCT02587598|528329720|FG003|Overall Study|Reason for study withdrawal not specified|0|||
146499017|NCT02587598|528329721|FG004|Overall Study|Reason for study withdrawal not specified|0|||
146499018|NCT02587598|528329722|FG005|Overall Study|Reason for study withdrawal not specified|0|||
146499019|NCT02587598|528329723|FG006|Overall Study|Reason for study withdrawal not specified|0|||
146499020|NCT02587598|528329724|FG007|Overall Study|Reason for study withdrawal not specified|0|||
146499021|NCT02587598|528329725|FG008|Overall Study|Reason for study withdrawal not specified|0|||
146499022|NCT02587598|528329726|FG009|Overall Study|Reason for study withdrawal not specified|0|||
146565659|NCT01770743|528584220|FG004|Overall Study|Moving Out of State|0|||
146565660|NCT01585025|528584221|FG000|Overall Study|Withdrawal by Subject|0|||
146565661|NCT01585025|528584222|FG001|Overall Study|Withdrawal by Subject|3|||
146565662|NCT01585025|528584223|FG002|Overall Study|Withdrawal by Subject|4|||
146565663|NCT02986074|528584224|FG000|First Trial Period|Adverse Event|1|||
146565664|NCT02986074|528584225|FG001|First Trial Period|Adverse Event|0|||
146565665|NCT02986074|528584226|FG002|First Trial Period|Adverse Event|0|||
146565666|NCT02986074|528584227|FG003|First Trial Period|Adverse Event|0|||
146565667|NCT02986074|528584224|FG000|Follow up Period|system explant|0|||
146565668|NCT02986074|528584225|FG001|Follow up Period|system explant|0|||
146565669|NCT02986074|528584226|FG002|Follow up Period|system explant|1|||
146565670|NCT02986074|528584227|FG003|Follow up Period|system explant|2|||
146565671|NCT02986074|528584224|FG000|Follow up Period|Physician Decision|0|||
146565672|NCT02986074|528584225|FG001|Follow up Period|Physician Decision|0|||
146912236|NCT00958568|529841441|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
146912237|NCT00958568|529841442|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
146912238|NCT00958568|529841443|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
146912239|NCT00958568|529841440|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
146912240|NCT00958568|529841441|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
146912241|NCT00958568|529841442|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
146565673|NCT02986074|528584226|FG002|Follow up Period|Physician Decision|0|||
146565674|NCT02986074|528584227|FG003|Follow up Period|Physician Decision|1|||
146565675|NCT02415556|528584228|FG000|Overall Study|Adverse Event|3|||
146565676|NCT02415556|528584229|FG001|Overall Study|Adverse Event|4|||
146565677|NCT02415556|528584230|FG002|Overall Study|Adverse Event|2|||
146565678|NCT02415556|528584231|FG003|Overall Study|Adverse Event|4|||
146565679|NCT02415556|528584228|FG000|Overall Study|Lost to Follow-up|4|||
146565680|NCT02415556|528584229|FG001|Overall Study|Lost to Follow-up|5|||
146565681|NCT02415556|528584230|FG002|Overall Study|Lost to Follow-up|4|||
146565682|NCT02415556|528584231|FG003|Overall Study|Lost to Follow-up|1|||
146565683|NCT02415556|528584228|FG000|Overall Study|Withdrawal by Subject|13|||
146565684|NCT02415556|528584229|FG001|Overall Study|Withdrawal by Subject|4|||
146565685|NCT02415556|528584230|FG002|Overall Study|Withdrawal by Subject|14|||
146565686|NCT02415556|528584231|FG003|Overall Study|Withdrawal by Subject|12|||
146565687|NCT02415556|528584228|FG000|Overall Study|Physician Decision|1|||
146565688|NCT02415556|528584229|FG001|Overall Study|Physician Decision|3|||
146565689|NCT02415556|528584230|FG002|Overall Study|Physician Decision|1|||
146565690|NCT02415556|528584231|FG003|Overall Study|Physician Decision|2|||
146565691|NCT02415556|528584228|FG000|Overall Study|Censored - study completion|4|||
146565692|NCT02415556|528584229|FG001|Overall Study|Censored - study completion|5|||
146565693|NCT02415556|528584230|FG002|Overall Study|Censored - study completion|1|||
146565694|NCT02415556|528584231|FG003|Overall Study|Censored - study completion|0|||
146565695|NCT02415556|528584228|FG000|Overall Study|Family-related issues|0|||
146565696|NCT02415556|528584229|FG001|Overall Study|Family-related issues|0|||
146565697|NCT02415556|528584230|FG002|Overall Study|Family-related issues|0|||
146565698|NCT02415556|528584231|FG003|Overall Study|Family-related issues|1|||
146565699|NCT02115321|528584234|FG000|Overall Study|Death|1|||
146565700|NCT02115321|528584235|FG001|Overall Study|Death|0|||
146565701|NCT03218917|528584237|FG000|Overall Study|Adverse Event|3|||
146565702|NCT03218917|528584238|FG001|Overall Study|Adverse Event|3|||
146565703|NCT03218917|528584239|FG002|Overall Study|Adverse Event|2|||
146565704|NCT03218917|528584237|FG000|Overall Study|Subject withdrew consent|2|||
146565705|NCT03218917|528584238|FG001|Overall Study|Subject withdrew consent|4|||
146565706|NCT03218917|528584239|FG002|Overall Study|Subject withdrew consent|10|||
146565707|NCT03218917|528584237|FG000|Overall Study|Physician Decision|0|||
146912242|NCT00958568|529841443|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
146565708|NCT03218917|528584238|FG001|Overall Study|Physician Decision|1|||
146565709|NCT03218917|528584239|FG002|Overall Study|Physician Decision|1|||
146972211|NCT03193190|530058549|FG009|Stage 1|Study Terminated By Sponsor|0|||
146972212|NCT03193190|530058550|FG010|Stage 1|Study Terminated By Sponsor|0|||
146972213|NCT03193190|530058551|FG011|Stage 1|Study Terminated By Sponsor|0|||
146972214|NCT03193190|530058552|FG012|Stage 1|Study Terminated By Sponsor|0|||
146972215|NCT03193190|530058553|FG013|Stage 1|Study Terminated By Sponsor|0|||
146972216|NCT03193190|530058554|FG014|Stage 1|Study Terminated By Sponsor|0|||
146972217|NCT03193190|530058555|FG015|Stage 1|Study Terminated By Sponsor|0|||
146972218|NCT03193190|530058540|FG000|Stage 1|Withdrawal by Subject|6|||
146972219|NCT03193190|530058541|FG001|Stage 1|Withdrawal by Subject|0|||
146972220|NCT03193190|530058542|FG002|Stage 1|Withdrawal by Subject|1|||
146972221|NCT03193190|530058543|FG003|Stage 1|Withdrawal by Subject|0|||
146972222|NCT03193190|530058544|FG004|Stage 1|Withdrawal by Subject|2|||
146972223|NCT03193190|530058545|FG005|Stage 1|Withdrawal by Subject|0|||
146972224|NCT03193190|530058546|FG006|Stage 1|Withdrawal by Subject|3|||
146972225|NCT03193190|530058547|FG007|Stage 1|Withdrawal by Subject|2|||
146972226|NCT03193190|530058548|FG008|Stage 1|Withdrawal by Subject|2|||
146972227|NCT03193190|530058549|FG009|Stage 1|Withdrawal by Subject|4|||
146972228|NCT03193190|530058550|FG010|Stage 1|Withdrawal by Subject|9|||
146972229|NCT03193190|530058551|FG011|Stage 1|Withdrawal by Subject|1|||
146972230|NCT03193190|530058552|FG012|Stage 1|Withdrawal by Subject|0|||
146972231|NCT03193190|530058553|FG013|Stage 1|Withdrawal by Subject|0|||
146972232|NCT03193190|530058554|FG014|Stage 1|Withdrawal by Subject|0|||
146972233|NCT03193190|530058555|FG015|Stage 1|Withdrawal by Subject|0|||
146972234|NCT03193190|530058540|FG000|Stage 2|Death|0|||
146972235|NCT03193190|530058541|FG001|Stage 2|Death|0|||
146972236|NCT03193190|530058542|FG002|Stage 2|Death|0|||
146972237|NCT03193190|530058543|FG003|Stage 2|Death|0|||
146972238|NCT03193190|530058544|FG004|Stage 2|Death|0|||
146972239|NCT03193190|530058545|FG005|Stage 2|Death|0|||
146972240|NCT03193190|530058546|FG006|Stage 2|Death|0|||
146972241|NCT03193190|530058547|FG007|Stage 2|Death|0|||
146972242|NCT03193190|530058548|FG008|Stage 2|Death|0|||
146972243|NCT03193190|530058549|FG009|Stage 2|Death|0|||
146972244|NCT03193190|530058550|FG010|Stage 2|Death|0|||
146972245|NCT03193190|530058551|FG011|Stage 2|Death|0|||
146972246|NCT03193190|530058552|FG012|Stage 2|Death|0|||
146972247|NCT03193190|530058553|FG013|Stage 2|Death|14|||
146972248|NCT03193190|530058554|FG014|Stage 2|Death|4|||
146972249|NCT03193190|530058555|FG015|Stage 2|Death|1|||
146972250|NCT03193190|530058540|FG000|Stage 2|Lost to Follow-up|0|||
146972251|NCT03193190|530058541|FG001|Stage 2|Lost to Follow-up|0|||
146972252|NCT03193190|530058542|FG002|Stage 2|Lost to Follow-up|0|||
146972253|NCT03193190|530058543|FG003|Stage 2|Lost to Follow-up|0|||
146972254|NCT03193190|530058544|FG004|Stage 2|Lost to Follow-up|0|||
146972255|NCT03193190|530058545|FG005|Stage 2|Lost to Follow-up|0|||
146972256|NCT03193190|530058546|FG006|Stage 2|Lost to Follow-up|0|||
146972257|NCT03193190|530058547|FG007|Stage 2|Lost to Follow-up|0|||
146972258|NCT03193190|530058548|FG008|Stage 2|Lost to Follow-up|0|||
146972259|NCT03193190|530058549|FG009|Stage 2|Lost to Follow-up|0|||
146972260|NCT03193190|530058550|FG010|Stage 2|Lost to Follow-up|0|||
146972261|NCT03193190|530058551|FG011|Stage 2|Lost to Follow-up|0|||
146972262|NCT03193190|530058552|FG012|Stage 2|Lost to Follow-up|0|||
146972263|NCT03193190|530058553|FG013|Stage 2|Lost to Follow-up|0|||
146972264|NCT03193190|530058554|FG014|Stage 2|Lost to Follow-up|1|||
146972265|NCT03193190|530058555|FG015|Stage 2|Lost to Follow-up|0|||
146972266|NCT03193190|530058540|FG000|Stage 2|Withdrawal by Subject|0|||
146972267|NCT03193190|530058541|FG001|Stage 2|Withdrawal by Subject|0|||
146972268|NCT03193190|530058542|FG002|Stage 2|Withdrawal by Subject|0|||
146972269|NCT03193190|530058543|FG003|Stage 2|Withdrawal by Subject|0|||
146972270|NCT03193190|530058544|FG004|Stage 2|Withdrawal by Subject|0|||
146499023|NCT02587598|528329727|FG010|Overall Study|Reason for study withdrawal not specified|0|||
146499024|NCT02587598|528329717|FG000|Overall Study|Withdrawal by Subject|0|||
146499025|NCT02587598|528329718|FG001|Overall Study|Withdrawal by Subject|1|||
146499026|NCT02587598|528329719|FG002|Overall Study|Withdrawal by Subject|0|||
146499027|NCT02587598|528329720|FG003|Overall Study|Withdrawal by Subject|2|||
146499028|NCT02587598|528329721|FG004|Overall Study|Withdrawal by Subject|3|||
146499029|NCT02587598|528329722|FG005|Overall Study|Withdrawal by Subject|1|||
146499030|NCT02587598|528329723|FG006|Overall Study|Withdrawal by Subject|0|||
146499031|NCT02587598|528329724|FG007|Overall Study|Withdrawal by Subject|0|||
146972271|NCT03193190|530058545|FG005|Stage 2|Withdrawal by Subject|0|||
146972272|NCT03193190|530058546|FG006|Stage 2|Withdrawal by Subject|0|||
146972273|NCT03193190|530058547|FG007|Stage 2|Withdrawal by Subject|0|||
146972274|NCT03193190|530058548|FG008|Stage 2|Withdrawal by Subject|0|||
146972275|NCT03193190|530058549|FG009|Stage 2|Withdrawal by Subject|0|||
146972276|NCT03193190|530058550|FG010|Stage 2|Withdrawal by Subject|0|||
146972277|NCT03193190|530058551|FG011|Stage 2|Withdrawal by Subject|0|||
146972278|NCT03193190|530058552|FG012|Stage 2|Withdrawal by Subject|0|||
146972279|NCT03193190|530058553|FG013|Stage 2|Withdrawal by Subject|1|||
146972280|NCT03193190|530058554|FG014|Stage 2|Withdrawal by Subject|1|||
146972281|NCT03193190|530058555|FG015|Stage 2|Withdrawal by Subject|0|||
146972282|NCT03532295|530058556|FG000|Overall Study|Did not start treatment|0|||
146972283|NCT03532295|530058557|FG001|Overall Study|Did not start treatment|2|||
146972284|NCT03732677|530058561|FG000|Overall Study|Terminated the study|154|||
146645378|NCT00612105|528879321|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
146645379|NCT00612105|528879320|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
146645380|NCT00612105|528879321|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
146645381|NCT00612105|528879320|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
146645382|NCT00612105|528879321|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
146645383|NCT00612105|528879320|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
146645384|NCT00612105|528879321|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
146645385|NCT00612105|528879320|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
146645386|NCT00612105|528879321|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
146645387|NCT00612105|528879320|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
146645388|NCT00612105|528879321|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
146645389|NCT00612105|528879320|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
146645390|NCT00612105|528879321|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
146645391|NCT00612105|528879320|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
146645392|NCT00612105|528879321|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
146645393|NCT00612105|528879320|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
146645394|NCT00612105|528879321|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
146645395|NCT00612105|528879320|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
146645396|NCT00612105|528879321|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
146645397|NCT00612105|528879320|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
146645398|NCT00612105|528879321|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
146645399|NCT00612105|528879320|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
146645400|NCT00612105|528879321|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
146645401|NCT00717236|528879322|FG000|Double-Blind Period|Adverse Event|33|||
146645402|NCT00717236|528879323|FG001|Double-Blind Period|Adverse Event|6|||
146645403|NCT00717236|528879322|FG000|Double-Blind Period|Lack of Efficacy|6|||
146645404|NCT00717236|528879323|FG001|Double-Blind Period|Lack of Efficacy|6|||
146645405|NCT00717236|528879322|FG000|Double-Blind Period|Lost to Follow-up|3|||
146645406|NCT00717236|528879323|FG001|Double-Blind Period|Lost to Follow-up|5|||
146645407|NCT00717236|528879322|FG000|Double-Blind Period|Withdrawal by Subject|10|||
146645408|NCT00717236|528879323|FG001|Double-Blind Period|Withdrawal by Subject|2|||
146645409|NCT00717236|528879322|FG000|Double-Blind Period|Loss of efficacy|3|||
146645410|NCT00717236|528879323|FG001|Double-Blind Period|Loss of efficacy|0|||
146645411|NCT00717236|528879322|FG000|Double-Blind Period|Other: Death|1|||
146645412|NCT00717236|528879323|FG001|Double-Blind Period|Other: Death|0|||
146645413|NCT00717236|528879322|FG000|Double-Blind Period|Other: Pregnancy|1|||
146645414|NCT00717236|528879323|FG001|Double-Blind Period|Other: Pregnancy|0|||
146645415|NCT00717236|528879322|FG000|Double-Blind Period|Other: Protocol Violation|2|||
146645416|NCT00717236|528879323|FG001|Double-Blind Period|Other: Protocol Violation|0|||
146645417|NCT00717236|528879322|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
146645418|NCT00717236|528879323|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
146645419|NCT00717236|528879322|FG000|Double-Blind Period|Other: Site withdrew|2|||
146645420|NCT00717236|528879323|FG001|Double-Blind Period|Other: Site withdrew|0|||
146645421|NCT00717236|528879322|FG000|Double-Blind Period|Other: Screening failure|1|||
146645422|NCT00717236|528879323|FG001|Double-Blind Period|Other: Screening failure|0|||
146645423|NCT00717236|528879322|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
146645424|NCT00717236|528879323|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
146645425|NCT00717236|528879322|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
146645426|NCT00717236|528879323|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
146645427|NCT00717236|528879322|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
146645428|NCT00717236|528879323|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
146645429|NCT00717236|528879322|FG000|Double-Blind Period|Other: History of cancer|1|||
146645430|NCT00717236|528879323|FG001|Double-Blind Period|Other: History of cancer|0|||
146645431|NCT00717236|528879322|FG000|Double-Blind Period|Other: Sponsor request|1|||
146645432|NCT00717236|528879323|FG001|Double-Blind Period|Other: Sponsor request|0|||
146645433|NCT00717236|528879322|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
146645434|NCT00717236|528879323|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
146645435|NCT00717236|528879322|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
146645436|NCT00717236|528879323|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
146645437|NCT00717236|528879322|FG000|Double-Blind Period|Other: Subject moved|1|||
146645438|NCT00717236|528879323|FG001|Double-Blind Period|Other: Subject moved|1|||
146645439|NCT00717236|528879322|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
146645440|NCT00717236|528879323|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
146645441|NCT00717236|528879322|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
146769016|NCT02020616|529321817|FG003|Overall Study|Lack of Efficacy|0|||
146645442|NCT00717236|528879323|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
146645443|NCT00717236|528879322|FG000|Double-Blind Period|Other: Transportation problems|0|||
146645444|NCT00717236|528879323|FG001|Double-Blind Period|Other: Transportation problems|1|||
146499032|NCT02587598|528329725|FG008|Overall Study|Withdrawal by Subject|0|||
146499033|NCT02587598|528329726|FG009|Overall Study|Withdrawal by Subject|1|||
146499034|NCT02587598|528329727|FG010|Overall Study|Withdrawal by Subject|2|||
146499035|NCT02587598|528329717|FG000|Overall Study|Physician Decision|0|||
146499036|NCT02587598|528329718|FG001|Overall Study|Physician Decision|0|||
146499037|NCT02587598|528329719|FG002|Overall Study|Physician Decision|0|||
146499038|NCT02587598|528329720|FG003|Overall Study|Physician Decision|0|||
146499039|NCT02587598|528329721|FG004|Overall Study|Physician Decision|0|||
146565710|NCT03218917|528584237|FG000|Overall Study|Lost to Follow-up|1|||
146565711|NCT03218917|528584238|FG001|Overall Study|Lost to Follow-up|0|||
146565712|NCT03218917|528584239|FG002|Overall Study|Lost to Follow-up|0|||
146565713|NCT03218917|528584237|FG000|Overall Study|Reason Missing|0|||
146565714|NCT03218917|528584238|FG001|Overall Study|Reason Missing|2|||
146912243|NCT00958568|529841440|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
146912244|NCT00958568|529841441|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
146912245|NCT00958568|529841442|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
146912246|NCT00958568|529841443|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
146912247|NCT00958568|529841440|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
146912248|NCT00958568|529841441|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
146912249|NCT00958568|529841442|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
146912250|NCT00958568|529841443|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
146912251|NCT00958568|529841440|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
146912252|NCT00958568|529841441|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
146912253|NCT00958568|529841442|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
146912254|NCT00958568|529841443|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
146912255|NCT00958568|529841440|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
146912256|NCT00958568|529841441|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
146912257|NCT00958568|529841442|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
146912258|NCT00958568|529841443|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
146912259|NCT00958568|529841440|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
146912260|NCT00958568|529841441|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
146912261|NCT00958568|529841442|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
146912262|NCT00958568|529841443|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
146912263|NCT00958568|529841440|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
146912264|NCT00958568|529841441|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
146912265|NCT00958568|529841442|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
146912266|NCT00958568|529841443|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
146912267|NCT00958568|529841440|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
146912268|NCT00958568|529841441|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
146912269|NCT00958568|529841442|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
146912270|NCT00958568|529841443|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
146912271|NCT00958568|529841440|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
146912272|NCT00958568|529841441|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
146912273|NCT00958568|529841442|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
146912274|NCT00958568|529841443|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
146912275|NCT00958568|529841440|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
146912276|NCT00958568|529841441|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
146912277|NCT00958568|529841442|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
146912278|NCT00958568|529841443|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
146912279|NCT00958568|529841440|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
146912280|NCT00958568|529841441|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
146912281|NCT00958568|529841442|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
146912282|NCT00958568|529841443|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
146912283|NCT00958568|529841440|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
146912284|NCT00958568|529841441|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
146912285|NCT00958568|529841442|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
146912286|NCT00958568|529841443|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
146912287|NCT00958568|529841440|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
146912288|NCT00958568|529841441|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
146912289|NCT00958568|529841442|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
146912290|NCT00958568|529841443|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
146912291|NCT00958568|529841440|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
146912292|NCT00958568|529841441|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
146912293|NCT00958568|529841442|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
146645445|NCT00717236|528879322|FG000|Double-Blind Period|Other: Investigator Decision|0|||
146645446|NCT00717236|528879323|FG001|Double-Blind Period|Other: Investigator Decision|1|||
146645447|NCT00717236|528879322|FG000|Open-Label Period|Adverse Event|29|||
146645448|NCT00717236|528879323|FG001|Open-Label Period|Adverse Event|4|||
146645449|NCT00717236|528879322|FG000|Open-Label Period|Lack of Efficacy|30|||
146645450|NCT00717236|528879323|FG001|Open-Label Period|Lack of Efficacy|8|||
146645451|NCT00717236|528879322|FG000|Open-Label Period|Lost to Follow-up|28|||
146645452|NCT00717236|528879323|FG001|Open-Label Period|Lost to Follow-up|4|||
146645453|NCT00717236|528879322|FG000|Open-Label Period|Withdrawal by Subject|20|||
146645454|NCT00717236|528879323|FG001|Open-Label Period|Withdrawal by Subject|2|||
146645455|NCT00717236|528879322|FG000|Open-Label Period|Loss of Efficacy|6|||
146645456|NCT00717236|528879323|FG001|Open-Label Period|Loss of Efficacy|1|||
146645457|NCT00717236|528879322|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
146645458|NCT00717236|528879323|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
146645459|NCT00717236|528879322|FG000|Open-Label Period|Other: Lack of Compliance|1|||
146645460|NCT00717236|528879323|FG001|Open-Label Period|Other: Lack of Compliance|1|||
146645461|NCT00717236|528879322|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
146645462|NCT00717236|528879323|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
146645463|NCT00717236|528879322|FG000|Open-Label Period|Other: Moved|1|||
146645464|NCT00717236|528879323|FG001|Open-Label Period|Other: Moved|0|||
146645465|NCT00717236|528879322|FG000|Open-Label Period|Other: Investigator Decision|1|||
146645466|NCT00717236|528879323|FG001|Open-Label Period|Other: Investigator Decision|0|||
146645467|NCT00717236|528879322|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
146645468|NCT00717236|528879323|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
146645469|NCT00717236|528879322|FG000|Open-Label Period|Other: Sponsor Request|3|||
146645470|NCT00717236|528879323|FG001|Open-Label Period|Other: Sponsor Request|0|||
146645471|NCT00717236|528879322|FG000|Open-Label Period|Other: Cataract Surgery|1|||
146645472|NCT00717236|528879323|FG001|Open-Label Period|Other: Cataract Surgery|0|||
146645473|NCT00717236|528879322|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
146645474|NCT00717236|528879323|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
146645475|NCT00717236|528879322|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
146645476|NCT00717236|528879323|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
146645477|NCT00717236|528879322|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
146645478|NCT00717236|528879323|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
146645479|NCT00475982|528879324|FG000|Overall Study|surgery rescheduled|7|||
146645480|NCT00475982|528879325|FG001|Overall Study|surgery rescheduled|3|||
146645481|NCT01105767|528879326|FG000|Overall Study|Lost to Follow-up|1160|||
146645482|NCT01105767|528879327|FG001|Overall Study|Lost to Follow-up|1614|||
146645483|NCT01105767|528879328|FG002|Overall Study|Lost to Follow-up|1184|||
146645484|NCT00783198|528879334|FG000|Overall Study|Adverse Event|15|||
146645485|NCT00783198|528879335|FG001|Overall Study|Adverse Event|19|||
146645486|NCT00783198|528879336|FG002|Overall Study|Adverse Event|3|||
146645487|NCT00783198|528879334|FG000|Overall Study|Lost to Follow-up|11|||
146645488|NCT00783198|528879335|FG001|Overall Study|Lost to Follow-up|1|||
146645489|NCT00783198|528879336|FG002|Overall Study|Lost to Follow-up|7|||
146645490|NCT00783198|528879334|FG000|Overall Study|Withdrawal by Subject|22|||
146645491|NCT00783198|528879335|FG001|Overall Study|Withdrawal by Subject|14|||
146645492|NCT00783198|528879336|FG002|Overall Study|Withdrawal by Subject|20|||
146645493|NCT00783198|528879334|FG000|Overall Study|Noncompliance with protocol|7|||
146645494|NCT00783198|528879335|FG001|Overall Study|Noncompliance with protocol|7|||
146645495|NCT00783198|528879336|FG002|Overall Study|Noncompliance with protocol|10|||
146645496|NCT00783198|528879334|FG000|Overall Study|Did not meet protocol eligibility|0|||
146645497|NCT00783198|528879335|FG001|Overall Study|Did not meet protocol eligibility|1|||
146645498|NCT00783198|528879336|FG002|Overall Study|Did not meet protocol eligibility|0|||
146645499|NCT00783198|528879334|FG000|Overall Study|Administrative|2|||
146645500|NCT00783198|528879335|FG001|Overall Study|Administrative|1|||
146645501|NCT00783198|528879336|FG002|Overall Study|Administrative|2|||
146645502|NCT01510769|528879337|FG000|Overall Study|Adverse Event|7|||
146645503|NCT01510769|528879338|FG001|Overall Study|Adverse Event|6|||
146645504|NCT01510769|528879339|FG002|Overall Study|Adverse Event|4|||
146645505|NCT01510769|528879337|FG000|Overall Study|Gout Flare|0|||
146645506|NCT01510769|528879338|FG001|Overall Study|Gout Flare|3|||
146645507|NCT01510769|528879339|FG002|Overall Study|Gout Flare|1|||
146645508|NCT01510769|528879337|FG000|Overall Study|Protocol Violation|11|||
146645509|NCT01510769|528879338|FG001|Overall Study|Protocol Violation|10|||
146645510|NCT01510769|528879339|FG002|Overall Study|Protocol Violation|9|||
146645511|NCT01510769|528879337|FG000|Overall Study|Lost to Follow-up|5|||
146645512|NCT01510769|528879338|FG001|Overall Study|Lost to Follow-up|1|||
146645513|NCT01510769|528879339|FG002|Overall Study|Lost to Follow-up|5|||
146645514|NCT01510769|528879337|FG000|Overall Study|Withdrawal by Subject|3|||
146645515|NCT01510769|528879338|FG001|Overall Study|Withdrawal by Subject|4|||
146645516|NCT01510769|528879339|FG002|Overall Study|Withdrawal by Subject|3|||
146645517|NCT01510769|528879337|FG000|Overall Study|Death|1|||
146645518|NCT01510769|528879338|FG001|Overall Study|Death|1|||
146645519|NCT01510769|528879339|FG002|Overall Study|Death|0|||
146645520|NCT00929643|528879340|FG000|Overall Study|Protocol Violation|2|||
146972285|NCT03732677|530058562|FG001|Overall Study|Terminated the study|197|||
146972286|NCT03732677|530058561|FG000|Overall Study|Continuing study off treatment|379|||
146972287|NCT03732677|530058562|FG001|Overall Study|Continuing study off treatment|333|||
146972288|NCT04644237|530058563|FG000|Overall Study|Death|4|||
146972289|NCT04644237|530058564|FG001|Overall Study|Death|2|||
146972290|NCT04644237|530058563|FG000|Overall Study|Adverse Event|18|||
146499040|NCT02587598|528329722|FG005|Overall Study|Physician Decision|0|||
146499041|NCT02587598|528329723|FG006|Overall Study|Physician Decision|0|||
146499042|NCT02587598|528329724|FG007|Overall Study|Physician Decision|0|||
146499043|NCT02587598|528329725|FG008|Overall Study|Physician Decision|0|||
146499044|NCT02587598|528329726|FG009|Overall Study|Physician Decision|0|||
146972291|NCT04644237|530058564|FG001|Overall Study|Adverse Event|19|||
146972292|NCT04644237|530058563|FG000|Overall Study|Progressive Disease|61|||
146972293|NCT04644237|530058564|FG001|Overall Study|Progressive Disease|23|||
146972294|NCT04644237|530058563|FG000|Overall Study|Clinical Progression|4|||
146972295|NCT04644237|530058564|FG001|Overall Study|Clinical Progression|1|||
146972296|NCT04644237|530058563|FG000|Overall Study|Withdrawal by Subject|4|||
146499045|NCT02587598|528329727|FG010|Overall Study|Physician Decision|3|||
146645521|NCT02874144|528879341|FG000|Overall Study|Lost to Follow-up|3|||
146972297|NCT04644237|530058564|FG001|Overall Study|Withdrawal by Subject|2|||
146972298|NCT04644237|530058563|FG000|Overall Study|Physician Decision|4|||
146972299|NCT04644237|530058564|FG001|Overall Study|Physician Decision|0|||
146972300|NCT04644237|530058563|FG000|Overall Study|Other|6|||
146499046|NCT01704651|528329734|FG000|Overall Study|Pre-op withdrawal by subject|1|||
146645522|NCT02874144|528879342|FG001|Overall Study|Lost to Follow-up|5|||
146645523|NCT01578850|528879346|FG000|Period 1|Insufficient Clinical Response|1|||
146645524|NCT01578850|528879347|FG001|Period 1|Insufficient Clinical Response|0|||
146645525|NCT01578850|528879348|FG002|Period 1|Insufficient Clinical Response|0|||
146645526|NCT01578850|528879346|FG000|Period 1|Adverse Event|11|||
146645527|NCT01578850|528879347|FG001|Period 1|Adverse Event|0|||
146645528|NCT01578850|528879348|FG002|Period 1|Adverse Event|0|||
146645529|NCT01578850|528879346|FG000|Period 1|Death|1|||
146645530|NCT01578850|528879347|FG001|Period 1|Death|0|||
146645531|NCT01578850|528879348|FG002|Period 1|Death|0|||
146645532|NCT01578850|528879346|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
146645533|NCT01578850|528879347|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
146645534|NCT01578850|528879348|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
146645535|NCT01578850|528879346|FG000|Period 1|Withdrawal by Subject|9|||
146645536|NCT01578850|528879347|FG001|Period 1|Withdrawal by Subject|0|||
146645537|NCT01578850|528879348|FG002|Period 1|Withdrawal by Subject|0|||
146645538|NCT01578850|528879346|FG000|Period 1|Study Terminated by Sponsor|3|||
146645539|NCT01578850|528879347|FG001|Period 1|Study Terminated by Sponsor|0|||
146645540|NCT01578850|528879348|FG002|Period 1|Study Terminated by Sponsor|0|||
146645541|NCT01578850|528879346|FG000|Period 2|Insufficient Clinical Response|0|||
146645542|NCT01578850|528879347|FG001|Period 2|Insufficient Clinical Response|1|||
146645543|NCT01578850|528879348|FG002|Period 2|Insufficient Clinical Response|0|||
146645544|NCT01578850|528879346|FG000|Period 2|Adverse Event|0|||
146645545|NCT01578850|528879347|FG001|Period 2|Adverse Event|3|||
146645546|NCT01578850|528879348|FG002|Period 2|Adverse Event|6|||
146645547|NCT01578850|528879346|FG000|Period 2|Lost to Follow-up|0|||
146645548|NCT01578850|528879347|FG001|Period 2|Lost to Follow-up|1|||
146645549|NCT01578850|528879348|FG002|Period 2|Lost to Follow-up|2|||
146645550|NCT01578850|528879346|FG000|Period 2|Withdrawal by Subject|0|||
146645551|NCT01578850|528879347|FG001|Period 2|Withdrawal by Subject|2|||
146645552|NCT01578850|528879348|FG002|Period 2|Withdrawal by Subject|2|||
146645553|NCT01578850|528879346|FG000|Period 2|Study Terminated by Sponsor|0|||
146645554|NCT01578850|528879347|FG001|Period 2|Study Terminated by Sponsor|5|||
146645555|NCT01578850|528879348|FG002|Period 2|Study Terminated by Sponsor|4|||
146645556|NCT01578850|528879346|FG000|Period 2|Unspecified Reasons|0|||
146645557|NCT01578850|528879347|FG001|Period 2|Unspecified Reasons|1|||
146645558|NCT01578850|528879348|FG002|Period 2|Unspecified Reasons|0|||
146645559|NCT01711216|528879349|FG000|Overall Study|Adverse Event|4|||
146645560|NCT01711216|528879349|FG000|Overall Study|Pregnancy|56|||
146645561|NCT01711216|528879349|FG000|Overall Study|Withdrawal by Subject|6|||
146645562|NCT01711216|528879349|FG000|Overall Study|Lost to Follow-up|46|||
146645563|NCT01711216|528879349|FG000|Overall Study|variety of other minor reasons|83|||
146645564|NCT01711216|528879349|FG000|Overall Study|no reason specified|22|||
146645565|NCT02228980|528879350|FG000|Overall Study|Adverse Event|14|||
146645566|NCT02228980|528879351|FG001|Overall Study|Adverse Event|0|||
146645567|NCT02228980|528879352|FG002|Overall Study|Adverse Event|0|||
146645568|NCT02228980|528879353|FG003|Overall Study|Adverse Event|0|||
146645569|NCT02228980|528879350|FG000|Overall Study|Protocol Violation|7|||
146645570|NCT02228980|528879351|FG001|Overall Study|Protocol Violation|0|||
146645571|NCT02228980|528879352|FG002|Overall Study|Protocol Violation|0|||
146499047|NCT01704651|528329735|FG001|Overall Study|Pre-op withdrawal by subject|1|||
146645572|NCT02228980|528879353|FG003|Overall Study|Protocol Violation|0|||
146645573|NCT02228980|528879350|FG000|Overall Study|Withdrawal by Subject|3|||
146645574|NCT02228980|528879351|FG001|Overall Study|Withdrawal by Subject|3|||
146972301|NCT04644237|530058564|FG001|Overall Study|Other|3|||
146972302|NCT04644237|530058563|FG000|Overall Study|Randomized but not Treated|1|||
146972303|NCT04644237|530058564|FG001|Overall Study|Randomized but not Treated|0|||
146972304|NCT03131817|530058565|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
146972305|NCT05838755|530058566|FG000|Overall Study|Adverse Event|1|||
146972306|NCT05838755|530058567|FG001|Overall Study|Adverse Event|0|||
146972307|NCT05838755|530058568|FG002|Overall Study|Adverse Event|0|||
146499048|NCT01704651|528329734|FG000|Overall Study|Pre-op change in treatment plan|1|||
146499049|NCT01704651|528329735|FG001|Overall Study|Pre-op change in treatment plan|4|||
146499050|NCT01704651|528329734|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
146499051|NCT01704651|528329735|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
146499052|NCT01704651|528329734|FG000|Overall Study|Post-op did not have laparotomy|2|||
146499053|NCT01704651|528329735|FG001|Overall Study|Post-op did not have laparotomy|1|||
146499054|NCT00791661|528329736|FG000|7 Day Wash-out|Adverse Event|0|||
146499055|NCT00791661|528329737|FG001|7 Day Wash-out|Adverse Event|0|||
146499056|NCT00791661|528329738|FG002|7 Day Wash-out|Adverse Event|1|||
146499057|NCT00791661|528329736|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
146972308|NCT05838755|530058566|FG000|Overall Study|Lack of Efficacy|1|||
146972309|NCT05838755|530058567|FG001|Overall Study|Lack of Efficacy|0|||
146972310|NCT05838755|530058568|FG002|Overall Study|Lack of Efficacy|1|||
146972311|NCT05838755|530058566|FG000|Overall Study|Lost to Follow-up|0|||
146499058|NCT00791661|528329737|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
146499059|NCT00791661|528329738|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
146565715|NCT03218917|528584239|FG002|Overall Study|Reason Missing|0|||
146972312|NCT05838755|530058567|FG001|Overall Study|Lost to Follow-up|1|||
146972313|NCT05838755|530058568|FG002|Overall Study|Lost to Follow-up|4|||
146972314|NCT05838755|530058566|FG000|Overall Study|Withdrawal by Subject|0|||
146972315|NCT05838755|530058567|FG001|Overall Study|Withdrawal by Subject|2|||
146972316|NCT05838755|530058568|FG002|Overall Study|Withdrawal by Subject|0|||
146972317|NCT05838755|530058566|FG000|Overall Study|Study terminated by sponsor|26|||
146972318|NCT05838755|530058567|FG001|Overall Study|Study terminated by sponsor|27|||
146972319|NCT05838755|530058568|FG002|Overall Study|Study terminated by sponsor|26|||
146972320|NCT05838755|530058566|FG000|Overall Study|Randomized, not treated|2|||
146972321|NCT05838755|530058567|FG001|Overall Study|Randomized, not treated|0|||
146972322|NCT05838755|530058568|FG002|Overall Study|Randomized, not treated|1|||
146972323|NCT05838755|530058566|FG000|Overall Study|Pregnancy|0|||
146972324|NCT05838755|530058567|FG001|Overall Study|Pregnancy|1|||
146972325|NCT05838755|530058568|FG002|Overall Study|Pregnancy|0|||
146972326|NCT04439110|530058569|FG000|Overall Study|Ineligible|2|||
146972327|NCT04439110|530058569|FG000|Overall Study|Adverse Event|4|||
146972328|NCT04439110|530058569|FG000|Overall Study|Death|2|||
146565716|NCT03218917|528584237|FG000|Overall Study|Death|0|||
146565717|NCT03218917|528584238|FG001|Overall Study|Death|1|||
146565718|NCT03218917|528584239|FG002|Overall Study|Death|0|||
146565719|NCT03218917|528584237|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146565720|NCT03218917|528584238|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146565721|NCT03218917|528584239|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146565722|NCT02639390|528584240|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
146565723|NCT02639390|528584241|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
146565724|NCT01307449|528584242|FG000|Overall Study|Adverse Event|1|||
146565725|NCT01307449|528584243|FG001|Overall Study|Adverse Event|0|||
146565726|NCT01307449|528584244|FG002|Overall Study|Adverse Event|0|||
146565727|NCT01307449|528584245|FG003|Overall Study|Adverse Event|0|||
146565728|NCT01908140|528584246|FG000|Overall Study|Other or Progressive Disease|5|||
146565729|NCT01908140|528584247|FG001|Overall Study|Other or Progressive Disease|12|||
146565730|NCT01908140|528584246|FG000|Overall Study|Lack of Efficacy|7|||
146565731|NCT01908140|528584247|FG001|Overall Study|Lack of Efficacy|5|||
146565732|NCT01908140|528584246|FG000|Overall Study|Withdrawal by Subject|23|||
146565733|NCT01908140|528584247|FG001|Overall Study|Withdrawal by Subject|24|||
146565734|NCT01908140|528584246|FG000|Overall Study|Lost to Follow-up|1|||
146565735|NCT01908140|528584247|FG001|Overall Study|Lost to Follow-up|6|||
146565736|NCT01908140|528584246|FG000|Overall Study|Protocol Violation|8|||
146565737|NCT01908140|528584247|FG001|Overall Study|Protocol Violation|9|||
146565738|NCT01908140|528584246|FG000|Overall Study|Adverse Event|22|||
146565739|NCT01908140|528584247|FG001|Overall Study|Adverse Event|23|||
146565740|NCT00698828|528584250|FG000|Overall Study|Adverse Event|3|||
146565741|NCT00698828|528584251|FG001|Overall Study|Adverse Event|4|||
146565742|NCT00698828|528584252|FG002|Overall Study|Adverse Event|4|||
146565743|NCT00698828|528584250|FG000|Overall Study|Death|0|||
146972329|NCT04439110|530058569|FG000|Overall Study|Disease proression|25|||
146972330|NCT04439110|530058569|FG000|Overall Study|Withdrawal by Subject|1|||
146499060|NCT03605862|528329739|FG000|Overall Study|Withdrawal by Subject|12|||
146499061|NCT03605862|528329740|FG001|Overall Study|Withdrawal by Subject|9|||
146565744|NCT00698828|528584251|FG001|Overall Study|Death|0|||
146565745|NCT00698828|528584252|FG002|Overall Study|Death|1|||
146565746|NCT00698828|528584250|FG000|Overall Study|Exacerbation of COPD|1|||
146565747|NCT00698828|528584251|FG001|Overall Study|Exacerbation of COPD|3|||
146972331|NCT04439110|530058569|FG000|Overall Study|Alternative therapy|1|||
146972332|NCT04439110|530058569|FG000|Overall Study|Other complicating disease|1|||
146972333|NCT04439110|530058569|FG000|Overall Study|Personal reasons|1|||
146972334|NCT04439110|530058569|FG000|Overall Study|Still on treatment|1|||
146972335|NCT04647253|530058576|FG000|Overall Study|Death ≤ 365 Days|16|||
146972336|NCT04647253|530058577|FG001|Overall Study|Death ≤ 365 Days|7|||
146972337|NCT04647253|530058576|FG000|Overall Study|Physician Decision|0|||
146972338|NCT04647253|530058577|FG001|Overall Study|Physician Decision|1|||
146972339|NCT04647253|530058576|FG000|Overall Study|Withdrawal by Subject|7|||
146972340|NCT04647253|530058577|FG001|Overall Study|Withdrawal by Subject|2|||
146972341|NCT04647253|530058576|FG000|Overall Study|Missed 12-Month Visit|9|||
146972342|NCT04647253|530058577|FG001|Overall Study|Missed 12-Month Visit|7|||
146972343|NCT04647253|530058576|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
146972344|NCT04647253|530058577|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
146645575|NCT02228980|528879352|FG002|Overall Study|Withdrawal by Subject|2|||
146645576|NCT02228980|528879353|FG003|Overall Study|Withdrawal by Subject|3|||
146645577|NCT02929498|528879354|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
146645578|NCT02929498|528879355|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
146645579|NCT02929498|528879356|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
146645580|NCT02929498|528879354|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
146645581|NCT02929498|528879355|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
146645582|NCT02929498|528879356|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
146645583|NCT00750152|528879359|FG000|Overall Study|Adverse Event|2|||
146645584|NCT00750152|528879360|FG001|Overall Study|Adverse Event|1|||
146645585|NCT00750152|528879359|FG000|Overall Study|Lost to Follow-up|8|||
146645586|NCT00750152|528879360|FG001|Overall Study|Lost to Follow-up|13|||
146645587|NCT00750152|528879359|FG000|Overall Study|Withdrawal by Subject|3|||
146645588|NCT00750152|528879360|FG001|Overall Study|Withdrawal by Subject|3|||
146645589|NCT00750152|528879359|FG000|Overall Study|Physician Decision|1|||
146645590|NCT00750152|528879360|FG001|Overall Study|Physician Decision|1|||
146645591|NCT00750152|528879359|FG000|Overall Study|Non-compliance|0|||
146645592|NCT00750152|528879360|FG001|Overall Study|Non-compliance|1|||
146645593|NCT00750152|528879359|FG000|Overall Study|Termination by sponsor|1|||
146645594|NCT00750152|528879360|FG001|Overall Study|Termination by sponsor|0|||
146645595|NCT00750152|528879359|FG000|Overall Study|Other|7|||
146645596|NCT00750152|528879360|FG001|Overall Study|Other|8|||
146645597|NCT01028300|528879361|FG000|Overall Study|Study Terminated|4|||
146645598|NCT00715910|528879362|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
146645599|NCT00715910|528879363|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
146645600|NCT00715910|528879364|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
146645601|NCT00715910|528879365|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
146645602|NCT00715910|528879366|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
146645603|NCT00715910|528879367|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
146645604|NCT00715910|528879362|FG000|Booster and ESFU Phase|Other|0|||
146645605|NCT00715910|528879363|FG001|Booster and ESFU Phase|Other|0|||
146645606|NCT00715910|528879364|FG002|Booster and ESFU Phase|Other|0|||
146645607|NCT00715910|528879365|FG003|Booster and ESFU Phase|Other|5|||
146645608|NCT00715910|528879366|FG004|Booster and ESFU Phase|Other|1|||
146645609|NCT00715910|528879367|FG005|Booster and ESFU Phase|Other|0|||
146645610|NCT03698591|528879368|FG000|Overall Study|Withdrawal by Subject|2|||
146645611|NCT03698591|528879369|FG001|Overall Study|Withdrawal by Subject|2|||
146645612|NCT03698591|528879368|FG000|Overall Study|Failed drug screen|1|||
146645613|NCT03698591|528879369|FG001|Overall Study|Failed drug screen|1|||
146645614|NCT03698591|528879368|FG000|Overall Study|Failed health screen|0|||
146645615|NCT03698591|528879369|FG001|Overall Study|Failed health screen|1|||
146645616|NCT03698591|528879368|FG000|Overall Study|Ineligible for financial compensation|1|||
146645617|NCT03698591|528879369|FG001|Overall Study|Ineligible for financial compensation|0|||
146645618|NCT03698591|528879368|FG000|Overall Study|Equipment Error|1|||
146645619|NCT03698591|528879369|FG001|Overall Study|Equipment Error|0|||
146645620|NCT03698591|528879368|FG000|Overall Study|Could not establish TMS dosage|0|||
146972345|NCT02706353|530058578|FG000|Dose Level 1|Disease Progression|1|||
146972346|NCT02706353|530058579|FG001|Dose Level 1|Disease Progression|0|||
146972347|NCT02706353|530058580|FG002|Dose Level 1|Disease Progression|0|||
146645621|NCT03698591|528879369|FG001|Overall Study|Could not establish TMS dosage|1|||
146972348|NCT02706353|530058581|FG003|Dose Level 1|Disease Progression|0|||
146645622|NCT01165216|528879370|FG000|Overall Study|Adverse Event|6|||
146645623|NCT01165216|528879371|FG001|Overall Study|Adverse Event|3|||
146645624|NCT01165216|528879370|FG000|Overall Study|Withdrawal by Subject|1|||
146645625|NCT01165216|528879371|FG001|Overall Study|Withdrawal by Subject|1|||
146645626|NCT01165216|528879370|FG000|Overall Study|Disease progression|1|||
146972349|NCT02706353|530058582|FG004|Dose Level 1|Disease Progression|0|||
146972350|NCT02706353|530058583|FG005|Dose Level 1|Disease Progression|0|||
146645627|NCT01165216|528879371|FG001|Overall Study|Disease progression|3|||
146645628|NCT01379508|528879374|FG000|Treatment to Week 104|Adverse Event|2|||
146972351|NCT02706353|530058578|FG000|Dose Level 3|Disease Progression|0|||
146769017|NCT02020616|529321818|FG004|Overall Study|Lack of Efficacy|1|||
146972352|NCT02706353|530058579|FG001|Dose Level 3|Disease Progression|0|||
146972353|NCT02706353|530058580|FG002|Dose Level 3|Disease Progression|2|||
146972354|NCT02706353|530058581|FG003|Dose Level 3|Disease Progression|0|||
146972355|NCT02706353|530058582|FG004|Dose Level 3|Disease Progression|0|||
146972356|NCT02706353|530058583|FG005|Dose Level 3|Disease Progression|0|||
146972357|NCT02706353|530058578|FG000|Dose Level 4|Disease Progression|0|||
146972358|NCT02706353|530058579|FG001|Dose Level 4|Disease Progression|0|||
146972359|NCT02706353|530058580|FG002|Dose Level 4|Disease Progression|0|||
146972360|NCT02706353|530058581|FG003|Dose Level 4|Disease Progression|1|||
146972361|NCT02706353|530058582|FG004|Dose Level 4|Disease Progression|0|||
146972362|NCT02706353|530058583|FG005|Dose Level 4|Disease Progression|0|||
146972363|NCT02706353|530058578|FG000|Dose Level 4|Toxicity|0|||
146972364|NCT02706353|530058579|FG001|Dose Level 4|Toxicity|0|||
146972365|NCT02706353|530058580|FG002|Dose Level 4|Toxicity|0|||
146972366|NCT02706353|530058581|FG003|Dose Level 4|Toxicity|1|||
146645629|NCT01379508|528879375|FG001|Treatment to Week 104|Adverse Event|0|||
146645630|NCT01379508|528879376|FG002|Treatment to Week 104|Adverse Event|5|||
146645631|NCT01379508|528879377|FG003|Treatment to Week 104|Adverse Event|0|||
146645632|NCT01379508|528879374|FG000|Treatment to Week 104|Abnormal lab value|1|||
146645633|NCT01379508|528879375|FG001|Treatment to Week 104|Abnormal lab value|0|||
146645634|NCT01379508|528879376|FG002|Treatment to Week 104|Abnormal lab value|0|||
146645635|NCT01379508|528879377|FG003|Treatment to Week 104|Abnormal lab value|0|||
146645636|NCT01379508|528879374|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
146645637|NCT01379508|528879375|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
146645638|NCT01379508|528879376|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
146645639|NCT01379508|528879377|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
146645640|NCT01379508|528879374|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
146645641|NCT01379508|528879375|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
146645642|NCT01379508|528879376|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
146645643|NCT01379508|528879377|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
146645644|NCT01379508|528879374|FG000|Treatment to Week 104|Lost to Follow-up|5|||
146645645|NCT01379508|528879375|FG001|Treatment to Week 104|Lost to Follow-up|0|||
146645646|NCT01379508|528879376|FG002|Treatment to Week 104|Lost to Follow-up|3|||
146645647|NCT01379508|528879377|FG003|Treatment to Week 104|Lost to Follow-up|0|||
146645648|NCT01379508|528879374|FG000|Treatment to Week 104|Administrative problems|3|||
146645649|NCT01379508|528879375|FG001|Treatment to Week 104|Administrative problems|1|||
146645650|NCT01379508|528879376|FG002|Treatment to Week 104|Administrative problems|0|||
146645651|NCT01379508|528879377|FG003|Treatment to Week 104|Administrative problems|0|||
146645652|NCT01379508|528879374|FG000|Treatment to Week 104|Protocol Violation|1|||
146645653|NCT01379508|528879375|FG001|Treatment to Week 104|Protocol Violation|1|||
146645654|NCT01379508|528879376|FG002|Treatment to Week 104|Protocol Violation|1|||
146645655|NCT01379508|528879377|FG003|Treatment to Week 104|Protocol Violation|0|||
146645656|NCT01379508|528879374|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
146645657|NCT01379508|528879375|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
146645658|NCT01379508|528879376|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
146645659|NCT01379508|528879377|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
146645660|NCT01379508|528879374|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
146645661|NCT01379508|528879375|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
146645662|NCT01379508|528879376|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
146645663|NCT01379508|528879377|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
146645664|NCT01379508|528879374|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
146645665|NCT01379508|528879375|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
146645666|NCT01379508|528879376|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
146645667|NCT01379508|528879377|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
146645668|NCT01379508|528879374|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
146645669|NCT01379508|528879375|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
146645670|NCT01379508|528879376|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
146645671|NCT01379508|528879377|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
146972367|NCT02706353|530058582|FG004|Dose Level 4|Toxicity|0|||
146972368|NCT02706353|530058583|FG005|Dose Level 4|Toxicity|0|||
146499062|NCT03605862|528329739|FG000|Overall Study|Adverse Event|2|||
146499063|NCT03605862|528329740|FG001|Overall Study|Adverse Event|1|||
146499064|NCT03605862|528329739|FG000|Overall Study|Physician Decision|3|||
146499065|NCT03605862|528329740|FG001|Overall Study|Physician Decision|1|||
146499066|NCT03605862|528329739|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
146499067|NCT03605862|528329740|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
146499068|NCT00634803|528329743|FG000|Overall Study|Lost to Follow-up|6|||
146645672|NCT02626624|528879380|FG000|Overall Study|Adverse Event|1|||
146645673|NCT02626624|528879380|FG000|Overall Study|Lost to Follow-up|3|||
146645674|NCT02626624|528879380|FG000|Overall Study|Protocol Violation|4|||
146645675|NCT02626624|528879380|FG000|Overall Study|Death|2|||
146645676|NCT01948193|528881474|FG000|Overall Study|Serious event|2|||
146972369|NCT02706353|530058578|FG000|Dose Level 4|Death|0|||
146972370|NCT02706353|530058579|FG001|Dose Level 4|Death|0|||
146972371|NCT02706353|530058580|FG002|Dose Level 4|Death|0|||
146972372|NCT02706353|530058581|FG003|Dose Level 4|Death|1|||
146499069|NCT00634803|528329744|FG001|Overall Study|Lost to Follow-up|7|||
146499070|NCT00634803|528329745|FG002|Overall Study|Lost to Follow-up|7|||
146499071|NCT00364923|528329747|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
146499072|NCT00364923|528329747|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
146499073|NCT03474731|528329751|FG000|Overall Study|Withdrawal by Subject|36|||
146912294|NCT00958568|529841443|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
146912295|NCT00958568|529841440|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
146912296|NCT00958568|529841441|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
146912297|NCT00958568|529841442|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
146912298|NCT00958568|529841443|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
146912299|NCT00958568|529841440|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
146912300|NCT00958568|529841441|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
146912301|NCT00958568|529841442|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
146912302|NCT00958568|529841443|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
146912303|NCT00958568|529841440|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
146912304|NCT00958568|529841441|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
146912305|NCT00958568|529841442|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
146912306|NCT00958568|529841443|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
146912307|NCT00958568|529841440|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
146912308|NCT00958568|529841441|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
146912309|NCT00958568|529841442|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
146912310|NCT00958568|529841443|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
146912311|NCT00958568|529841440|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
146912312|NCT00958568|529841441|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
146912313|NCT00958568|529841442|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
146912314|NCT00958568|529841443|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
146912315|NCT00958568|529841440|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
146912316|NCT00958568|529841441|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
146912317|NCT00958568|529841442|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
146912318|NCT00958568|529841443|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
146912319|NCT00958568|529841440|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
146912320|NCT00958568|529841441|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
146912321|NCT00958568|529841442|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
146912322|NCT00958568|529841443|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
146912323|NCT00283712|529841448|FG000|Overall Study|Death|0|||
146912324|NCT00283712|529841449|FG001|Overall Study|Death|1|||
146912325|NCT04655586|529841455|FG000|Overall Study|Physician Decision|1|||
146912326|NCT04655586|529841456|FG001|Overall Study|Physician Decision|3|||
146912327|NCT04655586|529841457|FG002|Overall Study|Physician Decision|4|||
146912328|NCT04655586|529841455|FG000|Overall Study|Withdrawal by Subject|1|||
146912329|NCT04655586|529841456|FG001|Overall Study|Withdrawal by Subject|3|||
146912330|NCT04655586|529841457|FG002|Overall Study|Withdrawal by Subject|1|||
146912331|NCT04734873|529841462|FG000|Overall Study|Lost to Follow-up|1|||
146912332|NCT04734873|529841463|FG001|Overall Study|Lost to Follow-up|3|||
146912333|NCT04734873|529841464|FG002|Overall Study|Lost to Follow-up|2|||
146912334|NCT04734873|529841462|FG000|Overall Study|Randomized but not dosed|1|||
146912335|NCT04734873|529841463|FG001|Overall Study|Randomized but not dosed|0|||
146912336|NCT04734873|529841464|FG002|Overall Study|Randomized but not dosed|1|||
146912337|NCT02240628|529841465|FG000|Overall Study|Physician Decision|6|||
146912338|NCT02240628|529841466|FG001|Overall Study|Physician Decision|5|||
146912339|NCT04530825|529841469|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
146912340|NCT04530825|529841470|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
146912341|NCT04530825|529841471|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
146912342|NCT04530825|529841472|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
146972373|NCT02706353|530058582|FG004|Dose Level 4|Death|0|||
146972374|NCT02706353|530058583|FG005|Dose Level 4|Death|0|||
146972375|NCT02706353|530058578|FG000|Dose Level 5|Toxicity|0|||
146499074|NCT03474731|528329752|FG001|Overall Study|Withdrawal by Subject|29|||
146499075|NCT03474731|528329753|FG002|Overall Study|Withdrawal by Subject|11|||
146499076|NCT03474731|528329754|FG003|Overall Study|Withdrawal by Subject|27|||
146499077|NCT03474731|528329751|FG000|Overall Study|COVID|0|||
146499078|NCT03474731|528329752|FG001|Overall Study|COVID|23|||
146499079|NCT03474731|528329753|FG002|Overall Study|COVID|0|||
146499080|NCT03474731|528329754|FG003|Overall Study|COVID|0|||
146499081|NCT03474731|528329751|FG000|Overall Study|Participant moved from area|1|||
146499082|NCT03474731|528329752|FG001|Overall Study|Participant moved from area|0|||
146499083|NCT03474731|528329753|FG002|Overall Study|Participant moved from area|0|||
146499084|NCT03474731|528329754|FG003|Overall Study|Participant moved from area|0|||
146499085|NCT03474731|528329751|FG000|Overall Study|Lost to Follow-up|11|||
146499086|NCT03474731|528329752|FG001|Overall Study|Lost to Follow-up|3|||
146499087|NCT03474731|528329753|FG002|Overall Study|Lost to Follow-up|18|||
146972376|NCT02706353|530058579|FG001|Dose Level 5|Toxicity|0|||
146972377|NCT02706353|530058580|FG002|Dose Level 5|Toxicity|0|||
146972378|NCT02706353|530058581|FG003|Dose Level 5|Toxicity|0|||
146972379|NCT02706353|530058582|FG004|Dose Level 5|Toxicity|1|||
146972380|NCT02706353|530058583|FG005|Dose Level 5|Toxicity|0|||
146972381|NCT02706353|530058578|FG000|Dose Level 5|Disease Progression|0|||
146972382|NCT02706353|530058579|FG001|Dose Level 5|Disease Progression|0|||
146972383|NCT02706353|530058580|FG002|Dose Level 5|Disease Progression|0|||
146972384|NCT02706353|530058581|FG003|Dose Level 5|Disease Progression|0|||
146972385|NCT02706353|530058582|FG004|Dose Level 5|Disease Progression|3|||
146972386|NCT02706353|530058583|FG005|Dose Level 5|Disease Progression|2|||
146972387|NCT02706353|530058578|FG000|Dose Level 5|Death|0|||
146972388|NCT02706353|530058579|FG001|Dose Level 5|Death|0|||
146972389|NCT02706353|530058580|FG002|Dose Level 5|Death|0|||
146972390|NCT02706353|530058581|FG003|Dose Level 5|Death|0|||
146972391|NCT02706353|530058582|FG004|Dose Level 5|Death|1|||
146972392|NCT02706353|530058583|FG005|Dose Level 5|Death|6|||
146972393|NCT02706353|530058578|FG000|Dose Level 5|Withdrawal by Subject|0|||
146972394|NCT02706353|530058579|FG001|Dose Level 5|Withdrawal by Subject|0|||
146972395|NCT02706353|530058580|FG002|Dose Level 5|Withdrawal by Subject|0|||
146972396|NCT02706353|530058581|FG003|Dose Level 5|Withdrawal by Subject|0|||
146972397|NCT02706353|530058582|FG004|Dose Level 5|Withdrawal by Subject|0|||
146972398|NCT02706353|530058583|FG005|Dose Level 5|Withdrawal by Subject|2|||
146972399|NCT03560466|530058584|FG000|Overall Study|Adverse Event|1|||
146972400|NCT03560466|530058585|FG001|Overall Study|Adverse Event|2|||
146972401|NCT03560466|530058586|FG002|Overall Study|Adverse Event|0|||
146972402|NCT03560466|530058584|FG000|Overall Study|Poor Compliance to Protocol|0|||
146972403|NCT03560466|530058585|FG001|Overall Study|Poor Compliance to Protocol|2|||
146972404|NCT03560466|530058586|FG002|Overall Study|Poor Compliance to Protocol|0|||
146972405|NCT03560466|530058584|FG000|Overall Study|Other|6|||
146972406|NCT03560466|530058585|FG001|Overall Study|Other|8|||
146972407|NCT03560466|530058586|FG002|Overall Study|Other|1|||
146972408|NCT02038959|530059609|FG000|Overall Study|Withdrawal by Subject|6|||
146972409|NCT02038959|530059610|FG001|Overall Study|Withdrawal by Subject|8|||
146972410|NCT00819091|530059616|FG000|Overall Study|Adverse Event|3|||
146972411|NCT00819091|530059617|FG001|Overall Study|Adverse Event|5|||
146972412|NCT00819091|530059616|FG000|Overall Study|Protocol Violation|0|||
146972413|NCT00819091|530059617|FG001|Overall Study|Protocol Violation|1|||
146972414|NCT00819091|530059616|FG000|Overall Study|Lost to Follow-up|2|||
146972415|NCT00819091|530059617|FG001|Overall Study|Lost to Follow-up|0|||
146972416|NCT00819091|530059616|FG000|Overall Study|Withdrawal by Subject|1|||
146972417|NCT00819091|530059617|FG001|Overall Study|Withdrawal by Subject|2|||
146972418|NCT00819091|530059616|FG000|Overall Study|Other|1|||
146972419|NCT00819091|530059617|FG001|Overall Study|Other|2|||
146972420|NCT03911960|530059619|FG000|Overall Study|Lost to Follow-up|5|||
146972421|NCT03911960|530059620|FG001|Overall Study|Lost to Follow-up|3|||
146972422|NCT04318535|530059621|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
146972423|NCT04318535|530059622|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
146972424|NCT04318535|530059623|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
146972425|NCT02675426|530059626|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
146972426|NCT02675426|530059627|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
146972427|NCT02675426|530059628|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
146972428|NCT02675426|530059629|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
146972429|NCT02675426|530059626|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
146972430|NCT02675426|530059627|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
146972431|NCT02675426|530059628|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
146972432|NCT02675426|530059629|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
146972433|NCT02675426|530059626|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
146972434|NCT02675426|530059627|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
146972435|NCT02675426|530059628|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
146972436|NCT02675426|530059629|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
146565748|NCT00698828|528584252|FG002|Overall Study|Exacerbation of COPD|0|||
146565749|NCT00698828|528584250|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
146972437|NCT02675426|530059626|FG000|Period 1: Week 1 to Week 12|Other|2|||
146972438|NCT02675426|530059627|FG001|Period 1: Week 1 to Week 12|Other|1|||
146972439|NCT02675426|530059628|FG002|Period 1: Week 1 to Week 12|Other|0|||
146972440|NCT02675426|530059629|FG003|Period 1: Week 1 to Week 12|Other|2|||
146565750|NCT00698828|528584251|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
146972441|NCT02675426|530059626|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
146972442|NCT02675426|530059627|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
146972443|NCT02675426|530059628|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
146972444|NCT02675426|530059629|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
146972445|NCT02675426|530059626|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
146972446|NCT02675426|530059627|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
146972447|NCT02675426|530059628|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
146972448|NCT02675426|530059629|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
146972449|NCT02675426|530059626|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
146972450|NCT02675426|530059627|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
146972451|NCT02675426|530059628|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
146972452|NCT02675426|530059629|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
146972453|NCT02675426|530059626|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
146972454|NCT02675426|530059627|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
146972455|NCT02675426|530059628|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
146972456|NCT02675426|530059629|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
146972457|NCT02675426|530059626|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
146972458|NCT02675426|530059627|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
146972459|NCT02675426|530059628|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
146972460|NCT02675426|530059629|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
146972461|NCT02675426|530059626|FG000|Period 2: Week 12 to Week 260|Other|8|||
146972462|NCT02675426|530059627|FG001|Period 2: Week 12 to Week 260|Other|12|||
146972463|NCT02675426|530059628|FG002|Period 2: Week 12 to Week 260|Other|23|||
146972464|NCT02675426|530059629|FG003|Period 2: Week 12 to Week 260|Other|15|||
146972465|NCT02156466|530059632|FG000|Overall Study|Adverse Event|0|||
146972466|NCT02156466|530059633|FG001|Overall Study|Adverse Event|0|||
146972467|NCT02156466|530059634|FG002|Overall Study|Adverse Event|1|||
146972468|NCT02156466|530059635|FG003|Overall Study|Adverse Event|1|||
146972469|NCT02156466|530059636|FG004|Overall Study|Adverse Event|0|||
146972470|NCT02156466|530059632|FG000|Overall Study|Quantiferon Positivity|0|||
146972471|NCT02156466|530059633|FG001|Overall Study|Quantiferon Positivity|0|||
146972472|NCT02156466|530059634|FG002|Overall Study|Quantiferon Positivity|0|||
146972473|NCT02156466|530059635|FG003|Overall Study|Quantiferon Positivity|1|||
146972474|NCT02156466|530059636|FG004|Overall Study|Quantiferon Positivity|0|||
146972475|NCT02237118|530059637|FG000|Overall Study|Protocol Violation|0|||
146972476|NCT02237118|530059638|FG001|Overall Study|Protocol Violation|1|||
146972477|NCT02237118|530059637|FG000|Overall Study|consent withdrawn|1|||
146972478|NCT02237118|530059638|FG001|Overall Study|consent withdrawn|0|||
146972479|NCT00080288|530059639|FG000|Overall Study|Adverse Event|7|||
146972480|NCT00080288|530059640|FG001|Overall Study|Adverse Event|4|||
146972481|NCT00080288|530059639|FG000|Overall Study|Lost to Follow-up|3|||
146972482|NCT00080288|530059640|FG001|Overall Study|Lost to Follow-up|5|||
146972483|NCT00080288|530059639|FG000|Overall Study|Physician Decision|6|||
146972484|NCT00080288|530059640|FG001|Overall Study|Physician Decision|2|||
146972485|NCT00080288|530059639|FG000|Overall Study|Withdrawal by Subject|3|||
146972486|NCT00080288|530059640|FG001|Overall Study|Withdrawal by Subject|16|||
146972487|NCT00080288|530059639|FG000|Overall Study|Miscellaneous|11|||
146972488|NCT00080288|530059640|FG001|Overall Study|Miscellaneous|11|||
146972489|NCT02253654|530059641|FG000|Overall Study|Withdrawal by Subject|12|||
146972490|NCT02253654|530059642|FG001|Overall Study|Withdrawal by Subject|4|||
146972491|NCT02253654|530059641|FG000|Overall Study|Decision by Sponsor|1|||
146972492|NCT02253654|530059642|FG001|Overall Study|Decision by Sponsor|1|||
146972493|NCT02253654|530059641|FG000|Overall Study|Lost to Follow-up|2|||
146972494|NCT02253654|530059642|FG001|Overall Study|Lost to Follow-up|5|||
146972495|NCT02253654|530059641|FG000|Overall Study|Death|4|||
146972496|NCT02253654|530059642|FG001|Overall Study|Death|7|||
146972497|NCT02253654|530059641|FG000|Overall Study|Did Not Receive Study Treatment|4|||
146972498|NCT02253654|530059642|FG001|Overall Study|Did Not Receive Study Treatment|1|||
146972499|NCT03044431|530059645|FG000|Overall Study|Lost to Follow-up|59|||
146972500|NCT03456726|530059646|FG000|Overall Study|Disease Progression|6|||
146972501|NCT03456726|530059647|FG001|Overall Study|Disease Progression|1|||
146972502|NCT03456726|530059646|FG000|Overall Study|Adverse Event|4|||
146972503|NCT03456726|530059647|FG001|Overall Study|Adverse Event|2|||
146972504|NCT03456726|530059646|FG000|Overall Study|Withdrawal by Subject|1|||
146972505|NCT03456726|530059647|FG001|Overall Study|Withdrawal by Subject|0|||
146972506|NCT03456726|530059646|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
146972507|NCT03456726|530059647|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
146972508|NCT04470622|530059648|FG000|Overall Study|Withdrawal by Subject|0|||
146972509|NCT04470622|530059649|FG001|Overall Study|Withdrawal by Subject|1|||
146972510|NCT04470622|530059648|FG000|Overall Study|Screen Failure|0|||
146972511|NCT04470622|530059649|FG001|Overall Study|Screen Failure|1|||
146972512|NCT04470622|530059648|FG000|Overall Study|Death|0|||
146972513|NCT04470622|530059649|FG001|Overall Study|Death|1|||
146972514|NCT00399490|530059650|FG000|Overall Study|Adverse Event|19|||
146972515|NCT00399490|530059650|FG000|Overall Study|Lack of Efficacy|31|||
146972516|NCT00399490|530059650|FG000|Overall Study|Lost to Follow-up|5|||
146972517|NCT00399490|530059650|FG000|Overall Study|Withdrawal by Subject|18|||
146972518|NCT00399490|530059650|FG000|Overall Study|Other|25|||
146972519|NCT02328547|530059651|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
146972520|NCT02328547|530059652|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
146972521|NCT02328547|530059651|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
146972522|NCT02328547|530059652|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
146499088|NCT03474731|528329754|FG003|Overall Study|Lost to Follow-up|17|||
146972523|NCT02576054|530059653|FG000|Overall Study|Withdrawal by Subject|1|||
146972524|NCT01586624|530059658|FG000|Overall Study|Adverse Event|3|||
146972525|NCT01586624|530059659|FG001|Overall Study|Adverse Event|0|||
146972526|NCT01586624|530059660|FG002|Overall Study|Adverse Event|2|||
146972527|NCT01586624|530059661|FG003|Overall Study|Adverse Event|1|||
146972528|NCT01586624|530059662|FG004|Overall Study|Adverse Event|3|||
146972529|NCT01586624|530059663|FG005|Overall Study|Adverse Event|3|||
146972530|NCT01586624|530059664|FG006|Overall Study|Adverse Event|2|||
146972531|NCT01586624|530059665|FG007|Overall Study|Adverse Event|3|||
146972532|NCT01586624|530059658|FG000|Overall Study|Physician Decision|0|||
146972533|NCT01586624|530059659|FG001|Overall Study|Physician Decision|1|||
146972534|NCT01586624|530059660|FG002|Overall Study|Physician Decision|1|||
146972535|NCT01586624|530059661|FG003|Overall Study|Physician Decision|0|||
146972536|NCT01586624|530059662|FG004|Overall Study|Physician Decision|2|||
146972537|NCT01586624|530059663|FG005|Overall Study|Physician Decision|0|||
146972538|NCT01586624|530059664|FG006|Overall Study|Physician Decision|1|||
146972539|NCT01586624|530059665|FG007|Overall Study|Physician Decision|1|||
146972540|NCT01586624|530059658|FG000|Overall Study|Withdrawal by Subject|0|||
146972541|NCT01586624|530059659|FG001|Overall Study|Withdrawal by Subject|0|||
146972542|NCT01586624|530059660|FG002|Overall Study|Withdrawal by Subject|0|||
146972543|NCT01586624|530059661|FG003|Overall Study|Withdrawal by Subject|1|||
146972544|NCT01586624|530059662|FG004|Overall Study|Withdrawal by Subject|0|||
146972545|NCT01586624|530059663|FG005|Overall Study|Withdrawal by Subject|0|||
146972546|NCT01586624|530059664|FG006|Overall Study|Withdrawal by Subject|0|||
146972547|NCT01586624|530059665|FG007|Overall Study|Withdrawal by Subject|0|||
146972548|NCT01586624|530059658|FG000|Overall Study|Evidence of disease progression|1|||
146972549|NCT01586624|530059659|FG001|Overall Study|Evidence of disease progression|3|||
146972550|NCT01586624|530059660|FG002|Overall Study|Evidence of disease progression|2|||
146972551|NCT01586624|530059661|FG003|Overall Study|Evidence of disease progression|5|||
146972552|NCT01586624|530059662|FG004|Overall Study|Evidence of disease progression|3|||
146972553|NCT01586624|530059663|FG005|Overall Study|Evidence of disease progression|5|||
146972554|NCT01586624|530059664|FG006|Overall Study|Evidence of disease progression|4|||
146972555|NCT01586624|530059665|FG007|Overall Study|Evidence of disease progression|6|||
146972556|NCT01586624|530059658|FG000|Overall Study|Screen failure (no treatment received)|0|||
146972557|NCT01586624|530059659|FG001|Overall Study|Screen failure (no treatment received)|0|||
146972558|NCT01586624|530059660|FG002|Overall Study|Screen failure (no treatment received)|0|||
146972559|NCT01586624|530059661|FG003|Overall Study|Screen failure (no treatment received)|0|||
146972560|NCT01586624|530059662|FG004|Overall Study|Screen failure (no treatment received)|0|||
146972561|NCT01586624|530059663|FG005|Overall Study|Screen failure (no treatment received)|0|||
146972562|NCT01586624|530059664|FG006|Overall Study|Screen failure (no treatment received)|1|||
146972563|NCT01586624|530059665|FG007|Overall Study|Screen failure (no treatment received)|0|||
146972564|NCT00953927|530059666|FG000|Overall Study|Lost to Follow-up|61|||
146972565|NCT00953927|530059667|FG001|Overall Study|Lost to Follow-up|65|||
146972566|NCT00953927|530059666|FG000|Overall Study|Withdrawal by Subject|36|||
146972567|NCT00953927|530059667|FG001|Overall Study|Withdrawal by Subject|25|||
146972568|NCT00953927|530059666|FG000|Overall Study|Death|7|||
146972569|NCT00953927|530059667|FG001|Overall Study|Death|4|||
146972570|NCT00953927|530059666|FG000|Overall Study|Other study discontinuation|1|||
146972571|NCT00953927|530059667|FG001|Overall Study|Other study discontinuation|1|||
146972572|NCT01396161|530059668|FG000|Overall Study|Withdrawal by Subject|0|||
146972573|NCT01396161|530059669|FG001|Overall Study|Withdrawal by Subject|0|||
146972574|NCT01396161|530059670|FG002|Overall Study|Withdrawal by Subject|0|||
146972575|NCT01396161|530059671|FG003|Overall Study|Withdrawal by Subject|0|||
146972576|NCT01396161|530059672|FG004|Overall Study|Withdrawal by Subject|1|||
146972577|NCT01396161|530059673|FG005|Overall Study|Withdrawal by Subject|0|||
146972578|NCT01396161|530059674|FG006|Overall Study|Withdrawal by Subject|0|||
146972579|NCT01396161|530059668|FG000|Overall Study|Other|0|||
146972580|NCT01396161|530059669|FG001|Overall Study|Other|0|||
146972581|NCT01396161|530059670|FG002|Overall Study|Other|0|||
146972582|NCT01396161|530059671|FG003|Overall Study|Other|0|||
146565751|NCT00698828|528584252|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
146972583|NCT01396161|530059672|FG004|Overall Study|Other|0|||
146972584|NCT01396161|530059673|FG005|Overall Study|Other|0|||
146565752|NCT00698828|528584250|FG000|Overall Study|Investigator/Sponsor decision|1|||
146565753|NCT00698828|528584251|FG001|Overall Study|Investigator/Sponsor decision|0|||
146972585|NCT01396161|530059674|FG006|Overall Study|Other|1|||
146972586|NCT02962739|530059679|FG000|Overall Study|Withdrawal by Subject|0|||
146972587|NCT02962739|530059680|FG001|Overall Study|Withdrawal by Subject|1|||
146972588|NCT02962739|530059681|FG002|Overall Study|Withdrawal by Subject|0|||
146972589|NCT02962739|530059682|FG003|Overall Study|Withdrawal by Subject|0|||
146972590|NCT02962739|530059683|FG004|Overall Study|Withdrawal by Subject|0|||
146972591|NCT02962739|530059684|FG005|Overall Study|Withdrawal by Subject|0|||
146972592|NCT02962739|530059679|FG000|Overall Study|Protocol Violation|0|||
146972593|NCT02962739|530059680|FG001|Overall Study|Protocol Violation|0|||
146972594|NCT02962739|530059681|FG002|Overall Study|Protocol Violation|1|||
146972595|NCT02962739|530059682|FG003|Overall Study|Protocol Violation|0|||
146972596|NCT02962739|530059683|FG004|Overall Study|Protocol Violation|1|||
146972597|NCT02962739|530059684|FG005|Overall Study|Protocol Violation|0|||
146565754|NCT00698828|528584252|FG002|Overall Study|Investigator/Sponsor decision|2|||
146565755|NCT00698828|528584250|FG000|Overall Study|Lost to Follow-up|1|||
146565756|NCT00698828|528584251|FG001|Overall Study|Lost to Follow-up|1|||
146565757|NCT00698828|528584252|FG002|Overall Study|Lost to Follow-up|0|||
146565758|NCT00698828|528584250|FG000|Overall Study|Withdrew consent|0|||
146565759|NCT00698828|528584251|FG001|Overall Study|Withdrew consent|7|||
146565760|NCT00698828|528584252|FG002|Overall Study|Withdrew consent|4|||
146565761|NCT00698828|528584250|FG000|Overall Study|Withdrew consent (not treated)|2|||
146565762|NCT00698828|528584251|FG001|Overall Study|Withdrew consent (not treated)|0|||
146565763|NCT00698828|528584252|FG002|Overall Study|Withdrew consent (not treated)|0|||
146565764|NCT02013609|528584253|FG000|Overall Study|Withdrawal by Subject|9|||
146565765|NCT02013609|528584253|FG000|Overall Study|Lost to Follow-up|3|||
146565766|NCT02013609|528584253|FG000|Overall Study|Adverse Event|3|||
146565767|NCT02013609|528584253|FG000|Overall Study|Met Withdrawal Criteria|3|||
146565768|NCT01816295|528584254|FG000|Double Blind Phase|Adverse Event|11|||
146565769|NCT01816295|528584255|FG001|Double Blind Phase|Adverse Event|8|||
146565770|NCT01816295|528584254|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
146565771|NCT01816295|528584255|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
146565772|NCT01816295|528584254|FG000|Double Blind Phase|Lost to Follow-up|3|||
146565773|NCT01816295|528584255|FG001|Double Blind Phase|Lost to Follow-up|5|||
146565774|NCT01816295|528584254|FG000|Double Blind Phase|Physician Decision|2|||
146565775|NCT01816295|528584255|FG001|Double Blind Phase|Physician Decision|2|||
146565776|NCT01816295|528584254|FG000|Double Blind Phase|Protocol Violation|17|||
146565777|NCT01816295|528584255|FG001|Double Blind Phase|Protocol Violation|11|||
146565778|NCT01816295|528584254|FG000|Double Blind Phase|Sponsor Decision|8|||
146565779|NCT01816295|528584255|FG001|Double Blind Phase|Sponsor Decision|8|||
146565780|NCT01816295|528584254|FG000|Double Blind Phase|Withdrawal by Subject|22|||
146565781|NCT01816295|528584255|FG001|Double Blind Phase|Withdrawal by Subject|20|||
146565782|NCT01816295|528584254|FG000|OLE Phase|Adverse Event|17|||
146565783|NCT01816295|528584255|FG001|OLE Phase|Adverse Event|15|||
146565784|NCT01816295|528584254|FG000|OLE Phase|Death|1|||
146565785|NCT01816295|528584255|FG001|OLE Phase|Death|0|||
146565786|NCT01816295|528584254|FG000|OLE Phase|Entry Criteria Not Met|3|||
146565787|NCT01816295|528584255|FG001|OLE Phase|Entry Criteria Not Met|5|||
146565788|NCT01816295|528584254|FG000|OLE Phase|Lost to Follow-up|5|||
146565789|NCT01816295|528584255|FG001|OLE Phase|Lost to Follow-up|5|||
146565790|NCT01816295|528584254|FG000|OLE Phase|Physician Decision|3|||
146565791|NCT01816295|528584255|FG001|OLE Phase|Physician Decision|1|||
146565792|NCT01816295|528584254|FG000|OLE Phase|Protocol Violation|4|||
146565793|NCT01816295|528584255|FG001|OLE Phase|Protocol Violation|4|||
146565794|NCT01816295|528584254|FG000|OLE Phase|Sponsor Decision|7|||
146565795|NCT01816295|528584255|FG001|OLE Phase|Sponsor Decision|9|||
146565796|NCT01816295|528584254|FG000|OLE Phase|Withdrawal by Subject|10|||
146565797|NCT01816295|528584255|FG001|OLE Phase|Withdrawal by Subject|10|||
146565798|NCT01816295|528584254|FG000|OLE Phase|Lack of Efficacy|3|||
146565799|NCT01816295|528584255|FG001|OLE Phase|Lack of Efficacy|7|||
146565800|NCT01119287|528584256|FG000|Overall Study|Patient Decision, not related to AE|0|||
146565801|NCT01119287|528584257|FG001|Overall Study|Patient Decision, not related to AE|0|||
146565802|NCT01119287|528584258|FG002|Overall Study|Patient Decision, not related to AE|2|||
146565803|NCT01119287|528584259|FG003|Overall Study|Patient Decision, not related to AE|2|||
146565804|NCT01119287|528584260|FG004|Overall Study|Patient Decision, not related to AE|1|||
146565805|NCT01119287|528584261|FG005|Overall Study|Patient Decision, not related to AE|0|||
146565806|NCT01076010|528584264|FG000|Overall Study|Death|15|||
146565807|NCT01076010|528584265|FG001|Overall Study|Death|1|||
146565808|NCT01076010|528584266|FG002|Overall Study|Death|0|||
146565809|NCT01076010|528584264|FG000|Overall Study|Adverse Event|7|||
146565810|NCT01076010|528584265|FG001|Overall Study|Adverse Event|2|||
146565811|NCT01076010|528584266|FG002|Overall Study|Adverse Event|0|||
146565812|NCT01076010|528584264|FG000|Overall Study|Progressive disease|90|||
146565813|NCT01076010|528584265|FG001|Overall Study|Progressive disease|30|||
146565814|NCT01076010|528584266|FG002|Overall Study|Progressive disease|1|||
146565815|NCT01076010|528584264|FG000|Overall Study|Lack of Efficacy|4|||
146565816|NCT01076010|528584265|FG001|Overall Study|Lack of Efficacy|0|||
146565817|NCT01076010|528584266|FG002|Overall Study|Lack of Efficacy|0|||
146565818|NCT01076010|528584264|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
146565819|NCT01076010|528584265|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
146565820|NCT01076010|528584266|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
146565821|NCT01076010|528584264|FG000|Overall Study|Significant Surgical Procedure|0|||
146565822|NCT01076010|528584265|FG001|Overall Study|Significant Surgical Procedure|1|||
146565823|NCT01076010|528584266|FG002|Overall Study|Significant Surgical Procedure|0|||
146565824|NCT01076010|528584264|FG000|Overall Study|Protocol Violation|0|||
146565825|NCT01076010|528584265|FG001|Overall Study|Protocol Violation|1|||
146565826|NCT01076010|528584266|FG002|Overall Study|Protocol Violation|0|||
146565827|NCT01076010|528584264|FG000|Overall Study|Noncompliance|1|||
146565828|NCT01076010|528584265|FG001|Overall Study|Noncompliance|1|||
146565829|NCT01076010|528584266|FG002|Overall Study|Noncompliance|0|||
146645677|NCT01948193|528881474|FG000|Overall Study|Lost to Follow-up|7|||
146645678|NCT01964755|528881476|FG000|Overall Study|Death|2|||
146645679|NCT00361634|528881479|FG000|Overall Study|Lost to Follow-up|1|||
146645680|NCT00361634|528881479|FG000|Overall Study|Withdrawal by Subject|1|||
146645681|NCT05315908|528881480|FG000|Overall Study|Lost to Follow-up|4477|||
146645682|NCT05315908|528881481|FG001|Overall Study|Lost to Follow-up|4606|||
146645683|NCT00294762|528881482|FG000|Overall Study|Did not receive study treatment|3|||
146645684|NCT00294762|528881483|FG001|Overall Study|Did not receive study treatment|3|||
146645685|NCT02937584|528881484|FG000|Period 1|Adverse Event|1|||
146645686|NCT02937584|528881485|FG001|Period 1|Adverse Event|2|||
146645687|NCT02937584|528881484|FG000|Washout|Adverse Event|0|||
146645688|NCT02937584|528881485|FG001|Washout|Adverse Event|1|||
146645689|NCT02238080|528881486|FG000|Overall Study|Death|13|||
146645690|NCT02238080|528881486|FG000|Overall Study|Treatment interrupted|6|||
146645691|NCT02238080|528881486|FG000|Overall Study|Withdrawal by Subject|2|||
146645692|NCT02238080|528881486|FG000|Overall Study|Other|4|||
146645693|NCT01738646|528881495|FG000|Overall Study|Still Receiving Treatment|2|||
146645694|NCT01598129|528881496|FG000|Overall Study|Disease progression|6|||
146645695|NCT01598129|528881496|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
146645696|NCT01598129|528881496|FG000|Overall Study|Withdrawal by Subject|1|||
146645697|NCT00505076|528881497|FG000|Overall Study|Adverse Event|1|||
146645698|NCT00505076|528881498|FG001|Overall Study|Adverse Event|0|||
146645699|NCT00505076|528881499|FG002|Overall Study|Adverse Event|1|||
146645700|NCT00505076|528881497|FG000|Overall Study|Protocol Violation|2|||
146645701|NCT00505076|528881498|FG001|Overall Study|Protocol Violation|1|||
146645702|NCT00505076|528881499|FG002|Overall Study|Protocol Violation|2|||
146645703|NCT00505076|528881497|FG000|Overall Study|Withdrawal by Subject|0|||
146645704|NCT00505076|528881498|FG001|Overall Study|Withdrawal by Subject|1|||
146645705|NCT00505076|528881499|FG002|Overall Study|Withdrawal by Subject|2|||
146645706|NCT04093024|528881502|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
146645707|NCT04093024|528881503|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
146645708|NCT04093024|528881502|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
146645709|NCT04093024|528881503|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
146645710|NCT04093024|528881502|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
146645711|NCT04093024|528881503|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
146645712|NCT04093024|528881502|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
146645713|NCT04093024|528881503|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
146645714|NCT00647270|528881508|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
146645715|NCT00647270|528881509|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
146645716|NCT00647270|528881510|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
146645717|NCT00647270|528881508|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
146645718|NCT00647270|528881509|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
146645719|NCT00647270|528881510|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
146645720|NCT00647270|528881508|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
146645721|NCT00647270|528881509|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
146645722|NCT00647270|528881510|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
146645723|NCT00647270|528881508|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
146645724|NCT00647270|528881509|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
146645725|NCT00647270|528881510|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
146645726|NCT00647270|528881508|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
146645727|NCT00647270|528881509|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
146645728|NCT00647270|528881510|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
146645729|NCT00647270|528881508|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
146645730|NCT00647270|528881509|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
146645731|NCT00647270|528881510|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
146645732|NCT00647270|528881508|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
146645733|NCT00647270|528881509|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
146645734|NCT00647270|528881510|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
146645735|NCT03615040|528881513|FG000|Overall Study|Withdrawal by Subject|2|||
146645736|NCT03615040|528881514|FG001|Overall Study|Withdrawal by Subject|1|||
146645737|NCT03615040|528881513|FG000|Overall Study|Physician Decision|2|||
146645738|NCT03615040|528881514|FG001|Overall Study|Physician Decision|2|||
146645739|NCT03615040|528881513|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
146645740|NCT03615040|528881514|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
146645741|NCT03615040|528881513|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
146645742|NCT03615040|528881514|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
146645743|NCT03615040|528881513|FG000|Overall Study|Death|0|||
146645744|NCT03615040|528881514|FG001|Overall Study|Death|2|||
146645745|NCT01541397|528881517|FG000|Overall Study|Study ended prior to data collection|4|||
146645746|NCT01541397|528881518|FG001|Overall Study|Study ended prior to data collection|2|||
146972598|NCT00414011|530059685|FG000|Overall Study|Physician Decision|3|||
146972599|NCT00414011|530059685|FG000|Overall Study|Withdrawal by Subject|2|||
146972600|NCT02360397|530059692|FG000|Overall Study|Incomplete screening|3|||
146972601|NCT02360397|530059692|FG000|Overall Study|Adverse Event|1|||
146972602|NCT01537549|530059693|FG000|Overall Study|Lost to Follow-up|1|||
146972603|NCT01537549|530059693|FG000|Overall Study|Withdrawal by Subject|2|||
146972604|NCT05349188|530059700|FG000|Overall Study|Withdrawal by Subject|1|||
146972605|NCT05349188|530059701|FG001|Overall Study|Withdrawal by Subject|0|||
146972606|NCT01907516|530059702|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
146972607|NCT01907516|530059703|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
146972608|NCT01907516|530059702|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
146972609|NCT01907516|530059703|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
146972610|NCT01907516|530059702|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
146972611|NCT01907516|530059703|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
146972612|NCT01907516|530059702|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
146972613|NCT01907516|530059703|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
146972614|NCT00131937|530059704|FG000|Overall Study|Adverse Event|3|||
146972615|NCT00131937|530059704|FG000|Overall Study|Withdrawal by Subject|2|||
146972616|NCT00131937|530059704|FG000|Overall Study|Physician Decision|1|||
146972617|NCT00131937|530059704|FG000|Overall Study|Disease Progression|7|||
146972618|NCT00131937|530059704|FG000|Overall Study|Alternative therapy|1|||
146972619|NCT03703297|530059705|FG000|Overall Study|Death|115|||
146972620|NCT03703297|530059706|FG001|Overall Study|Death|0|||
146972621|NCT03703297|530059707|FG002|Overall Study|Death|144|||
146972622|NCT03703297|530059705|FG000|Overall Study|Withdrawal by Subject|9|||
146972623|NCT03703297|530059706|FG001|Overall Study|Withdrawal by Subject|0|||
146972624|NCT03703297|530059707|FG002|Overall Study|Withdrawal by Subject|11|||
146972625|NCT03703297|530059705|FG000|Overall Study|Ongoing at the time of DCO|140|||
146972626|NCT03703297|530059706|FG001|Overall Study|Ongoing at the time of DCO|200|||
146972627|NCT03703297|530059707|FG002|Overall Study|Ongoing at the time of DCO|111|||
146972628|NCT01211613|530061329|FG000|Overall Study|Lost to Follow-up|2|||
146972629|NCT01211613|530061330|FG001|Overall Study|Lost to Follow-up|2|||
146972630|NCT01211613|530061331|FG002|Overall Study|Lost to Follow-up|2|||
146972631|NCT01211613|530061329|FG000|Overall Study|Withdrawal by Subject|1|||
146972632|NCT01211613|530061330|FG001|Overall Study|Withdrawal by Subject|0|||
146972633|NCT01211613|530061331|FG002|Overall Study|Withdrawal by Subject|0|||
146972634|NCT01020773|530061332|FG000|Overall Study|Withdrawal by Subject|4|||
146972635|NCT01020773|530061333|FG001|Overall Study|Withdrawal by Subject|3|||
146972636|NCT03853213|530061334|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
146972637|NCT03853213|530061335|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
146972638|NCT03853213|530061334|FG000|Overall Study|Other (e.g., too busy)|0|||
146972639|NCT03853213|530061335|FG001|Overall Study|Other (e.g., too busy)|2|||
146972640|NCT03302299|530061336|FG000|Overall Study|Protocol Violation|1|||
146972641|NCT01458132|530061337|FG000|Overall Study|Other|15|||
146972642|NCT01458132|530061338|FG001|Overall Study|Other|3|||
146972643|NCT01788163|530061339|FG000|Overall Study|Other|53|||
146972644|NCT01788163|530061340|FG001|Overall Study|Other|0|||
146972645|NCT01788163|530061341|FG002|Overall Study|Other|0|||
146972646|NCT01788163|530061342|FG003|Overall Study|Other|0|||
146972647|NCT01788163|530061343|FG004|Overall Study|Other|0|||
146972648|NCT01788163|530061344|FG005|Overall Study|Other|7|||
146972649|NCT01788163|530061345|FG006|Overall Study|Other|1|||
146972650|NCT01788163|530061346|FG007|Overall Study|Other|48|||
146972651|NCT01788163|530061347|FG008|Overall Study|Other|15|||
146972652|NCT01788163|530061339|FG000|Overall Study|Withdrawal by Subject|2|||
146972653|NCT01788163|530061340|FG001|Overall Study|Withdrawal by Subject|0|||
146972654|NCT01788163|530061341|FG002|Overall Study|Withdrawal by Subject|0|||
146972655|NCT01788163|530061342|FG003|Overall Study|Withdrawal by Subject|0|||
146972656|NCT01788163|530061343|FG004|Overall Study|Withdrawal by Subject|0|||
146972657|NCT01788163|530061344|FG005|Overall Study|Withdrawal by Subject|0|||
146972658|NCT01788163|530061345|FG006|Overall Study|Withdrawal by Subject|0|||
146972659|NCT01788163|530061346|FG007|Overall Study|Withdrawal by Subject|0|||
146972660|NCT01788163|530061347|FG008|Overall Study|Withdrawal by Subject|1|||
146972661|NCT00545441|530061348|FG000|Overall Study|Fistula draining at 6 months|2|||
146972662|NCT00545441|530061349|FG001|Overall Study|Fistula draining at 6 months|4|||
146972663|NCT00545441|530061348|FG000|Overall Study|Lost to Follow-up|9|||
146972664|NCT00545441|530061349|FG001|Overall Study|Lost to Follow-up|5|||
146972665|NCT00545441|530061348|FG000|Overall Study|Technical failure|0|||
146972666|NCT00545441|530061349|FG001|Overall Study|Technical failure|1|||
146972667|NCT00545441|530061348|FG000|Overall Study|Withdrawal by Subject|1|||
146972668|NCT00545441|530061349|FG001|Overall Study|Withdrawal by Subject|1|||
146972669|NCT00545441|530061348|FG000|Overall Study|Persistence or recurrence of fistula|5|||
146972670|NCT00545441|530061349|FG001|Overall Study|Persistence or recurrence of fistula|2|||
146972671|NCT00545441|530061348|FG000|Overall Study|Patients were not treated|1|||
146972672|NCT00545441|530061349|FG001|Overall Study|Patients were not treated|3|||
146972673|NCT00265239|530061350|FG000|Overall Study|Adverse Event|2|||
146972674|NCT00265239|530061351|FG001|Overall Study|Adverse Event|1|||
146645747|NCT02267317|528881519|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
146645748|NCT02267317|528881520|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
146645749|NCT02267317|528881521|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
146645750|NCT02267317|528881522|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
146645751|NCT02267317|528881523|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
146645752|NCT02267317|528881524|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
146645753|NCT02267317|528881519|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
146645754|NCT02267317|528881520|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
146645755|NCT02267317|528881521|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
146645756|NCT02267317|528881522|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
146645757|NCT02267317|528881523|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
146645758|NCT02267317|528881524|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
146645759|NCT01128621|528881525|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
146645760|NCT01128621|528881526|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
146645761|NCT00233454|528881532|FG000|Overall Study|Death|6|||
146645762|NCT04224688|528881533|FG000|Overall Study|Withdrawal by Subject|1|||
146645763|NCT04224688|528881534|FG001|Overall Study|Withdrawal by Subject|3|||
146645764|NCT04224688|528881533|FG000|Overall Study|Lack of Efficacy|1|||
146645765|NCT04224688|528881534|FG001|Overall Study|Lack of Efficacy|1|||
146645766|NCT04224688|528881533|FG000|Overall Study|Adverse event, not fatal|0|||
146645767|NCT04224688|528881534|FG001|Overall Study|Adverse event, not fatal|2|||
146645768|NCT04224688|528881533|FG000|Overall Study|COVID-19|0|||
146645769|NCT04224688|528881534|FG001|Overall Study|COVID-19|1|||
146645770|NCT04074161|528881535|FG000|Overall Study|Withdrawal by Subject|2|||
146645771|NCT04074161|528881536|FG001|Overall Study|Withdrawal by Subject|4|||
146645772|NCT04074161|528881537|FG002|Overall Study|Withdrawal by Subject|1|||
146645773|NCT04074161|528881535|FG000|Overall Study|Lost to Follow-up|4|||
146645774|NCT04074161|528881536|FG001|Overall Study|Lost to Follow-up|5|||
146645775|NCT04074161|528881537|FG002|Overall Study|Lost to Follow-up|3|||
146645776|NCT00329849|528881540|FG000|Overall Study|Withdrawal by Subject|6|||
146645777|NCT00329849|528881541|FG001|Overall Study|Withdrawal by Subject|4|||
146645778|NCT00322621|528881542|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
146645779|NCT00322621|528881543|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
146645780|NCT00322621|528881544|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
146645781|NCT00322621|528881542|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
146645782|NCT00322621|528881543|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
146645783|NCT00322621|528881544|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
146645784|NCT00322621|528881542|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
146645785|NCT00322621|528881543|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
146645786|NCT00322621|528881544|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
146645787|NCT00322621|528881542|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
146645788|NCT00322621|528881543|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
146645789|NCT00322621|528881544|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
146645790|NCT00322621|528881542|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
146645791|NCT00322621|528881543|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
146645792|NCT00322621|528881544|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
146645793|NCT00322621|528881542|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
146645794|NCT00322621|528881543|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
146645795|NCT00322621|528881544|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
146645796|NCT00322621|528881542|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
146645797|NCT00322621|528881543|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
146645798|NCT00322621|528881544|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
146645799|NCT00322621|528881542|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
146645800|NCT00322621|528881543|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
146645801|NCT00322621|528881544|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
146645802|NCT00322621|528881542|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
146645803|NCT00322621|528881543|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
146645804|NCT00322621|528881544|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
146645805|NCT00322621|528881542|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
146645806|NCT00322621|528881543|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
146645807|NCT00322621|528881544|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
146645808|NCT00322621|528881542|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
146645809|NCT00322621|528881543|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
146645810|NCT00322621|528881544|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
146645811|NCT01038869|528881547|FG000|Overall Study|Withdrawal by Subject|1|||
146645812|NCT01038869|528881547|FG000|Overall Study|Lost to Follow-up|6|||
146645813|NCT02238067|528881548|FG000|Overall Study|Not completed survey at Month 6|45|||
146645814|NCT03726996|528881552|FG000|Overall Study|Parent's decision|2|||
146499089|NCT03474731|528329751|FG000|Overall Study|Death|0|||
146972675|NCT02803138|530061352|FG000|Overall Study|Failure to return|38|||
146972676|NCT02803138|530061352|FG000|Overall Study|Insufficient virological response|2|||
146972677|NCT02803138|530061352|FG000|Overall Study|Withdrawn consent|1|||
146972678|NCT02803138|530061352|FG000|Overall Study|Death|1|||
146972679|NCT02803138|530061352|FG000|Overall Study|Other, not specified|28|||
146972680|NCT00021229|530061353|FG000|Overall Study|Adverse Event|10|||
146972681|NCT00021229|530061354|FG001|Overall Study|Adverse Event|5|||
146972682|NCT00021229|530061355|FG002|Overall Study|Adverse Event|2|||
146972683|NCT00021229|530061353|FG000|Overall Study|Death|0|||
146972684|NCT00021229|530061354|FG001|Overall Study|Death|1|||
146972685|NCT00021229|530061355|FG002|Overall Study|Death|0|||
146972686|NCT00021229|530061353|FG000|Overall Study|Withdrawal by Subject|7|||
146972687|NCT00021229|530061354|FG001|Overall Study|Withdrawal by Subject|7|||
146972688|NCT00021229|530061355|FG002|Overall Study|Withdrawal by Subject|1|||
146972689|NCT00021229|530061353|FG000|Overall Study|Progressive Disease|15|||
146972690|NCT00021229|530061354|FG001|Overall Study|Progressive Disease|19|||
146972691|NCT00021229|530061355|FG002|Overall Study|Progressive Disease|12|||
146972692|NCT00021229|530061353|FG000|Overall Study|Protocol Violation|1|||
146972693|NCT00021229|530061354|FG001|Overall Study|Protocol Violation|1|||
146972694|NCT00021229|530061355|FG002|Overall Study|Protocol Violation|0|||
146972695|NCT00021229|530061353|FG000|Overall Study|Physician Decision|0|||
146972696|NCT00021229|530061354|FG001|Overall Study|Physician Decision|0|||
146972697|NCT00021229|530061355|FG002|Overall Study|Physician Decision|1|||
146972698|NCT00021229|530061353|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
146972699|NCT00021229|530061354|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
146972700|NCT00021229|530061355|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
146972701|NCT01858558|530061359|FG000|Overall Study|Death|1|||
146972702|NCT01858558|530061360|FG001|Overall Study|Death|1|||
146972703|NCT01858558|530061359|FG000|Overall Study|Lost to Follow-up|1|||
146645815|NCT03726996|528881552|FG000|Overall Study|Study early termination|2|||
146972704|NCT01858558|530061360|FG001|Overall Study|Lost to Follow-up|0|||
146972705|NCT01858558|530061359|FG000|Overall Study|Disease progression|3|||
146645816|NCT01328444|528881553|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
146645817|NCT01328444|528881554|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
146645818|NCT01328444|528881555|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
146645819|NCT01328444|528881556|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
146645820|NCT01328444|528881557|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
146645821|NCT01328444|528881558|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
146645822|NCT01328444|528881553|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
146645823|NCT01328444|528881554|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
146645824|NCT01328444|528881555|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
146645825|NCT01328444|528881556|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
146645826|NCT01328444|528881557|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
146645827|NCT01328444|528881558|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
146645828|NCT01328444|528881553|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
146645829|NCT01328444|528881554|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
146645830|NCT01328444|528881555|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
146645831|NCT01328444|528881556|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
146645832|NCT01328444|528881557|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
146645833|NCT01328444|528881558|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
146645834|NCT01328444|528881553|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
146645835|NCT01328444|528881554|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
146645836|NCT01328444|528881555|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
146645837|NCT01328444|528881556|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
146645838|NCT01328444|528881557|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
146645839|NCT01328444|528881558|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
146645840|NCT01328444|528881553|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
146645841|NCT01328444|528881554|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146645842|NCT01328444|528881555|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146645843|NCT01328444|528881556|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
146645844|NCT01328444|528881557|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146645845|NCT01328444|528881558|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
146645846|NCT01328444|528881553|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146645847|NCT01328444|528881554|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
146645848|NCT01328444|528881555|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
146769018|NCT02020616|529321819|FG005|Overall Study|Lack of Efficacy|0|||
146769019|NCT02020616|529321820|FG006|Overall Study|Lack of Efficacy|0|||
146769020|NCT00324038|529321829|FG000|Overall Study|Adverse Event|38|||
146972706|NCT01858558|530061360|FG001|Overall Study|Disease progression|1|||
146972707|NCT01858558|530061359|FG000|Overall Study|Product contamination|2|||
146972708|NCT01858558|530061360|FG001|Overall Study|Product contamination|0|||
146972709|NCT01858558|530061359|FG000|Overall Study|Failed expansion of cell product|2|||
146972710|NCT01858558|530061360|FG001|Overall Study|Failed expansion of cell product|0|||
146972711|NCT01784419|530061361|FG000|Overall Study|Adverse Event|3|||
146972712|NCT00306852|530061362|FG000|Overall Study|Death|14|||
146972713|NCT00306852|530061363|FG001|Overall Study|Death|14|||
146972714|NCT00306852|530061362|FG000|Overall Study|Lost to Follow-up|15|||
146972715|NCT00306852|530061363|FG001|Overall Study|Lost to Follow-up|24|||
146972716|NCT03578276|530061364|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
146972717|NCT03578276|530061365|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
146972718|NCT00883740|530061366|FG000|First Intervention|Lost to Follow-up|1|||
146972719|NCT00883740|530061367|FG001|First Intervention|Lost to Follow-up|0|||
146972720|NCT00883740|530061366|FG000|First Intervention|No longer willing to participate|2|||
146972721|NCT00883740|530061367|FG001|First Intervention|No longer willing to participate|0|||
146972722|NCT00883740|530061366|FG000|First Intervention|Protocol Violation|3|||
146972723|NCT00883740|530061367|FG001|First Intervention|Protocol Violation|6|||
146972724|NCT00883740|530061366|FG000|First Intervention|Adverse Event|1|||
146972725|NCT00883740|530061367|FG001|First Intervention|Adverse Event|2|||
146972726|NCT00883740|530061366|FG000|Second Intervention|Protocol Violation|1|||
146972727|NCT00883740|530061367|FG001|Second Intervention|Protocol Violation|0|||
146972728|NCT00883740|530061366|FG000|Second Intervention|No longer willing to participate|0|||
146972729|NCT00883740|530061367|FG001|Second Intervention|No longer willing to participate|1|||
146972730|NCT01286207|530061370|FG000|Overall Study|Adverse Event|27|||
146972731|NCT01286207|530061371|FG001|Overall Study|Adverse Event|41|||
146972732|NCT01286207|530061372|FG002|Overall Study|Adverse Event|8|||
146972733|NCT01286207|530061370|FG000|Overall Study|Lost to Follow-up|49|||
146972734|NCT01286207|530061371|FG001|Overall Study|Lost to Follow-up|43|||
146972735|NCT01286207|530061372|FG002|Overall Study|Lost to Follow-up|20|||
146972736|NCT01286207|530061370|FG000|Overall Study|Withdrawal by Subject|93|||
146972737|NCT01286207|530061371|FG001|Overall Study|Withdrawal by Subject|79|||
146972738|NCT01286207|530061372|FG002|Overall Study|Withdrawal by Subject|41|||
146972739|NCT01286207|530061370|FG000|Overall Study|Lack of Response|92|||
146972740|NCT01286207|530061371|FG001|Overall Study|Lack of Response|38|||
146972741|NCT01286207|530061372|FG002|Overall Study|Lack of Response|8|||
146972742|NCT01286207|530061370|FG000|Overall Study|Other|37|||
146972743|NCT01286207|530061371|FG001|Overall Study|Other|47|||
146972744|NCT01286207|530061372|FG002|Overall Study|Other|13|||
146972745|NCT00981409|530061373|FG000|Overall Study|Adverse Event|4|||
146972746|NCT00981409|530061374|FG001|Overall Study|Adverse Event|0|||
146972747|NCT00981409|530061373|FG000|Overall Study|Protocol Violation|0|||
146972748|NCT00981409|530061374|FG001|Overall Study|Protocol Violation|1|||
146972749|NCT00981409|530061373|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
146972750|NCT00981409|530061374|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
146972751|NCT00450177|530061375|FG000|Overall Study|Adverse Event|7|||
146972752|NCT00450177|530061376|FG001|Overall Study|Adverse Event|4|||
146972753|NCT00450177|530061375|FG000|Overall Study|Withdrawal by Subject|1|||
146972754|NCT00450177|530061376|FG001|Overall Study|Withdrawal by Subject|6|||
146972755|NCT00450177|530061375|FG000|Overall Study|Withdrawal by Primary Team|1|||
146972756|NCT00450177|530061376|FG001|Overall Study|Withdrawal by Primary Team|1|||
146972757|NCT02923115|530061377|FG000|Overall Study|Lost to Follow-up|0|||
146972758|NCT02923115|530061378|FG001|Overall Study|Lost to Follow-up|0|||
146972759|NCT02923115|530061379|FG002|Overall Study|Lost to Follow-up|0|||
146972760|NCT02923115|530061380|FG003|Overall Study|Lost to Follow-up|1|||
146972761|NCT02923115|530061381|FG004|Overall Study|Lost to Follow-up|0|||
146972762|NCT02923115|530061382|FG005|Overall Study|Lost to Follow-up|0|||
146972763|NCT02923115|530061377|FG000|Overall Study|Withdrawal by Subject|0|||
146972764|NCT02923115|530061378|FG001|Overall Study|Withdrawal by Subject|1|||
146972765|NCT02923115|530061379|FG002|Overall Study|Withdrawal by Subject|0|||
146972766|NCT02923115|530061380|FG003|Overall Study|Withdrawal by Subject|0|||
146972767|NCT02923115|530061381|FG004|Overall Study|Withdrawal by Subject|0|||
146972768|NCT02923115|530061382|FG005|Overall Study|Withdrawal by Subject|0|||
146972769|NCT02923115|530061377|FG000|Overall Study|Randomized, but not dosed|0|||
146972770|NCT02923115|530061378|FG001|Overall Study|Randomized, but not dosed|0|||
146972771|NCT02923115|530061379|FG002|Overall Study|Randomized, but not dosed|3|||
146972772|NCT02923115|530061380|FG003|Overall Study|Randomized, but not dosed|1|||
146972773|NCT02923115|530061381|FG004|Overall Study|Randomized, but not dosed|5|||
146972774|NCT02923115|530061382|FG005|Overall Study|Randomized, but not dosed|0|||
146972775|NCT03869684|530061385|FG000|Overall Study|Adverse Event|0|||
146972776|NCT03869684|530061386|FG001|Overall Study|Adverse Event|3|||
146972777|NCT03869684|530061387|FG002|Overall Study|Adverse Event|1|||
146972778|NCT03869684|530061385|FG000|Overall Study|Withdrawal by Subject|1|||
146972779|NCT03869684|530061386|FG001|Overall Study|Withdrawal by Subject|0|||
146972780|NCT03869684|530061387|FG002|Overall Study|Withdrawal by Subject|0|||
146972781|NCT03869684|530061385|FG000|Overall Study|Lost to Follow-up|1|||
146769021|NCT00324038|529321830|FG001|Overall Study|Adverse Event|23|||
146769022|NCT00324038|529321829|FG000|Overall Study|Lack of Efficacy|5|||
146972782|NCT03869684|530061386|FG001|Overall Study|Lost to Follow-up|0|||
146972783|NCT03869684|530061387|FG002|Overall Study|Lost to Follow-up|0|||
146972784|NCT03869684|530061385|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
146972785|NCT03869684|530061386|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
146972786|NCT03869684|530061387|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
146972787|NCT04056299|530061388|FG000|Overall Study|Sponsor discontinued study|3|||
146972788|NCT04056299|530061389|FG001|Overall Study|Sponsor discontinued study|3|||
146972789|NCT01296152|530061396|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
146972790|NCT04840901|530061397|FG000|Overall Study|Lost to Follow-up|3|||
146972791|NCT04840901|530061398|FG001|Overall Study|Lost to Follow-up|1|||
146972792|NCT04840901|530061397|FG000|Overall Study|Moved|1|||
146972793|NCT04840901|530061398|FG001|Overall Study|Moved|0|||
146972794|NCT04840901|530061397|FG000|Overall Study|Unable to comply with study schedule|0|||
146972795|NCT04840901|530061398|FG001|Overall Study|Unable to comply with study schedule|1|||
146972796|NCT04840901|530061397|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
146972797|NCT04840901|530061398|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
146972798|NCT01268683|530061399|FG000|Overall Study|Lost to Follow-up|1|||
146972799|NCT01268683|530061399|FG000|Overall Study|Death|1|||
146972800|NCT00103259|530061402|FG000|Overall Study|Death|3|||
146972801|NCT00103259|530061403|FG001|Overall Study|Death|2|||
146972802|NCT00103259|530061402|FG000|Overall Study|Withdrawal by Subject|2|||
146972803|NCT00103259|530061403|FG001|Overall Study|Withdrawal by Subject|3|||
146972804|NCT00103259|530061402|FG000|Overall Study|alternative therapy|1|||
146972805|NCT00103259|530061403|FG001|Overall Study|alternative therapy|0|||
146972806|NCT00103259|530061402|FG000|Overall Study|other (reasons were not specified)|2|||
146972807|NCT00103259|530061403|FG001|Overall Study|other (reasons were not specified)|1|||
146972808|NCT00103259|530061402|FG000|Overall Study|ineligible/no protocol therapy|4|||
146972809|NCT00103259|530061403|FG001|Overall Study|ineligible/no protocol therapy|6|||
146972810|NCT03224234|530061406|FG000|Main Study|Lost to Follow-up|5|||
146972811|NCT03224234|530061407|FG001|Main Study|Lost to Follow-up|5|||
146972812|NCT02610842|530061408|FG000|Overall Study|Lost to Follow-up|5|||
146972813|NCT01988493|530061409|FG000|Overall Study|Randomized but not treated|0|||
146972814|NCT01988493|530061410|FG001|Overall Study|Randomized but not treated|0|||
146972815|NCT01988493|530061411|FG002|Overall Study|Randomized but not treated|0|||
146972816|NCT01988493|530061412|FG003|Overall Study|Randomized but not treated|0|||
146972817|NCT01988493|530061413|FG004|Overall Study|Randomized but not treated|1|||
146972818|NCT02494583|530061414|FG000|Overall Study|Death|224|||
146972819|NCT02494583|530061415|FG001|Overall Study|Death|214|||
146972820|NCT02494583|530061416|FG002|Overall Study|Death|225|||
146972821|NCT02494583|530061414|FG000|Overall Study|Lost to Follow-up|1|||
146972822|NCT02494583|530061415|FG001|Overall Study|Lost to Follow-up|0|||
146972823|NCT02494583|530061416|FG002|Overall Study|Lost to Follow-up|0|||
146972824|NCT02494583|530061414|FG000|Overall Study|Protocol Violation|1|||
146972825|NCT02494583|530061415|FG001|Overall Study|Protocol Violation|2|||
146972826|NCT02494583|530061416|FG002|Overall Study|Protocol Violation|0|||
146972827|NCT02494583|530061414|FG000|Overall Study|Screen Failure|0|||
146972828|NCT02494583|530061415|FG001|Overall Study|Screen Failure|1|||
146972829|NCT02494583|530061416|FG002|Overall Study|Screen Failure|0|||
146972830|NCT02494583|530061414|FG000|Overall Study|Transferred to Extension Study|15|||
146972831|NCT02494583|530061415|FG001|Overall Study|Transferred to Extension Study|15|||
146972832|NCT02494583|530061416|FG002|Overall Study|Transferred to Extension Study|6|||
146972833|NCT02494583|530061414|FG000|Overall Study|Did Not Continue on Extension Study|8|||
146972834|NCT02494583|530061415|FG001|Overall Study|Did Not Continue on Extension Study|10|||
146972835|NCT02494583|530061416|FG002|Overall Study|Did Not Continue on Extension Study|4|||
146972836|NCT02494583|530061414|FG000|Overall Study|Withdrawal by Subject|7|||
146972837|NCT02494583|530061415|FG001|Overall Study|Withdrawal by Subject|15|||
146972838|NCT02494583|530061416|FG002|Overall Study|Withdrawal by Subject|15|||
146972839|NCT00627458|530061421|FG000|Overall Study|Migrated from study area|1|||
146972840|NCT00627458|530061422|FG001|Overall Study|Migrated from study area|0|||
146972841|NCT00627458|530061423|FG002|Overall Study|Migrated from study area|1|||
146972842|NCT00627458|530061421|FG000|Overall Study|Withdrawal by Subject|2|||
146972843|NCT00627458|530061422|FG001|Overall Study|Withdrawal by Subject|6|||
146972844|NCT00627458|530061423|FG002|Overall Study|Withdrawal by Subject|5|||
146645849|NCT01328444|528881556|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
146645850|NCT01328444|528881557|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
146972845|NCT00627458|530061421|FG000|Overall Study|Lost to Follow-up|1|||
146972846|NCT00627458|530061422|FG001|Overall Study|Lost to Follow-up|1|||
146972847|NCT00627458|530061423|FG002|Overall Study|Lost to Follow-up|0|||
146972848|NCT03891875|530061424|FG000|Overall Study|Withdrawal by Subject|20|||
146972849|NCT03891875|530061425|FG001|Overall Study|Withdrawal by Subject|3|||
146972850|NCT03891875|530061424|FG000|Overall Study|Adverse Event|10|||
146972851|NCT03891875|530061425|FG001|Overall Study|Adverse Event|4|||
146972852|NCT03891875|530061424|FG000|Overall Study|Physician Decision|1|||
146972853|NCT03891875|530061425|FG001|Overall Study|Physician Decision|1|||
146972854|NCT03891875|530061424|FG000|Overall Study|Protocol Violation|1|||
146972855|NCT03891875|530061425|FG001|Overall Study|Protocol Violation|0|||
146769023|NCT00324038|529321830|FG001|Overall Study|Lack of Efficacy|13|||
146972856|NCT03891875|530061424|FG000|Overall Study|Lost to Follow-up|1|||
146972857|NCT03891875|530061425|FG001|Overall Study|Lost to Follow-up|0|||
146972858|NCT03891875|530061424|FG000|Overall Study|COVID-19 infection|1|||
146972859|NCT03891875|530061425|FG001|Overall Study|COVID-19 infection|0|||
146972860|NCT02756078|530061428|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
146972861|NCT02756078|530061429|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
146972862|NCT02756078|530061428|FG000|Period 1|Lost to Follow-up|0|||
146972863|NCT02756078|530061429|FG001|Period 1|Lost to Follow-up|2|||
146972864|NCT02756078|530061428|FG000|Period 1|Protocol Violation|0|||
146972865|NCT02756078|530061429|FG001|Period 1|Protocol Violation|1|||
146972866|NCT02756078|530061428|FG000|Period 1|Adverse Event|1|||
146972867|NCT02756078|530061429|FG001|Period 1|Adverse Event|10|||
146972868|NCT02756078|530061428|FG000|Period 1|Withdrawal by Subject|6|||
146972869|NCT02756078|530061429|FG001|Period 1|Withdrawal by Subject|6|||
146972870|NCT02756078|530061428|FG000|Period 1|Lens Discomfort|2|||
146972871|NCT02756078|530061429|FG001|Period 1|Lens Discomfort|2|||
146972872|NCT02756078|530061428|FG000|Period 2|Adverse Event|3|||
146972873|NCT02756078|530061429|FG001|Period 2|Adverse Event|5|||
146972874|NCT02756078|530061428|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
146972875|NCT02756078|530061429|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
146972876|NCT02756078|530061428|FG000|Period 2|Withdrawal by Subject|3|||
146972877|NCT02756078|530061429|FG001|Period 2|Withdrawal by Subject|1|||
146972878|NCT02268045|530061430|FG000|Overall Study|Death|4|||
146972879|NCT02268045|530061431|FG001|Overall Study|Death|4|||
146972880|NCT02268045|530061430|FG000|Overall Study|Disease Progression|2|||
146972881|NCT02268045|530061431|FG001|Overall Study|Disease Progression|1|||
146972882|NCT02268045|530061430|FG000|Overall Study|Adverse Event|7|||
146972883|NCT02268045|530061431|FG001|Overall Study|Adverse Event|7|||
146972884|NCT02268045|530061430|FG000|Overall Study|Withdrawal by Subject|2|||
146972885|NCT02268045|530061431|FG001|Overall Study|Withdrawal by Subject|6|||
146972886|NCT02268045|530061430|FG000|Overall Study|Physician Decision|0|||
146972887|NCT02268045|530061431|FG001|Overall Study|Physician Decision|1|||
146972888|NCT02268045|530061430|FG000|Overall Study|Protocol Violation|1|||
146972889|NCT02268045|530061431|FG001|Overall Study|Protocol Violation|1|||
146972890|NCT03332212|530061434|FG000|Overall Study|Not treated|0|||
146972891|NCT03332212|530061435|FG001|Overall Study|Not treated|1|||
146972892|NCT03332212|530061436|FG002|Overall Study|Not treated|0|||
146972893|NCT03332212|530061437|FG003|Overall Study|Not treated|0|||
146972894|NCT03332212|530061434|FG000|Overall Study|Adverse Event|0|||
146972895|NCT03332212|530061435|FG001|Overall Study|Adverse Event|0|||
146972896|NCT03332212|530061436|FG002|Overall Study|Adverse Event|0|||
146972897|NCT03332212|530061437|FG003|Overall Study|Adverse Event|1|||
146972898|NCT03332212|530061434|FG000|Overall Study|worsening of disease under study|1|||
146972899|NCT03332212|530061435|FG001|Overall Study|worsening of disease under study|1|||
146972900|NCT03332212|530061436|FG002|Overall Study|worsening of disease under study|0|||
146972901|NCT03332212|530061437|FG003|Overall Study|worsening of disease under study|0|||
146972902|NCT02125734|530061441|FG000|Period 2|Adverse Event|0|||
146972903|NCT02125734|530061442|FG001|Period 2|Adverse Event|1|||
146972904|NCT01308762|530061443|FG000|Overall Study|Protocol Violation|0|||
146972905|NCT01308762|530061444|FG001|Overall Study|Protocol Violation|1|||
146972906|NCT01308762|530061445|FG002|Overall Study|Protocol Violation|0|||
146972907|NCT02617446|530061446|FG000|Overall Study|Withdrawal by Subject|0|||
146972908|NCT02617446|530061447|FG001|Overall Study|Withdrawal by Subject|2|||
146972909|NCT02617446|530061448|FG002|Overall Study|Withdrawal by Subject|0|||
146972910|NCT02617446|530061446|FG000|Overall Study|Adverse Event|1|||
146972911|NCT02617446|530061447|FG001|Overall Study|Adverse Event|0|||
146972912|NCT02617446|530061448|FG002|Overall Study|Adverse Event|5|||
146972913|NCT02617446|530061446|FG000|Overall Study|Lost to Follow-up|3|||
146972914|NCT02617446|530061447|FG001|Overall Study|Lost to Follow-up|0|||
146972915|NCT02617446|530061448|FG002|Overall Study|Lost to Follow-up|0|||
146972916|NCT02617446|530061446|FG000|Overall Study|Death|0|||
146972917|NCT02617446|530061447|FG001|Overall Study|Death|0|||
146972918|NCT02617446|530061448|FG002|Overall Study|Death|2|||
146972919|NCT01556490|530061457|FG000|Randomized Patients Summary|Protocol Violation|22|||
146972920|NCT01556490|530061458|FG001|Randomized Patients Summary|Protocol Violation|23|||
146972921|NCT01556490|530061457|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
146565830|NCT01076010|528584264|FG000|Overall Study|Withdrawal by Subject|3|||
146972922|NCT01556490|530061458|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
146972923|NCT02058368|530061459|FG000|Overall Study|Adverse Event|15|||
146972924|NCT02058368|530061460|FG001|Overall Study|Adverse Event|20|||
146972925|NCT02058368|530061459|FG000|Overall Study|Lack of Efficacy|0|||
146972926|NCT02058368|530061460|FG001|Overall Study|Lack of Efficacy|1|||
146972927|NCT02058368|530061459|FG000|Overall Study|Protocol Violation|0|||
146972928|NCT02058368|530061460|FG001|Overall Study|Protocol Violation|4|||
146972929|NCT02058368|530061459|FG000|Overall Study|Lost to Follow-up|2|||
146972930|NCT02058368|530061460|FG001|Overall Study|Lost to Follow-up|0|||
146972931|NCT02058368|530061459|FG000|Overall Study|Physician Decision|2|||
146972932|NCT02058368|530061460|FG001|Overall Study|Physician Decision|3|||
146972933|NCT02058368|530061459|FG000|Overall Study|Withdrawal by Subject|22|||
146972934|NCT02058368|530061460|FG001|Overall Study|Withdrawal by Subject|26|||
146972935|NCT01652872|530061461|FG000|Overall Study|Death|36|||
146972936|NCT01652872|530061462|FG001|Overall Study|Death|39|||
146972937|NCT01652872|530061461|FG000|Overall Study|Lost to Follow-up|28|||
146972938|NCT01652872|530061462|FG001|Overall Study|Lost to Follow-up|23|||
146972939|NCT01652872|530061461|FG000|Overall Study|Decision by sponsor|5|||
146972940|NCT01652872|530061462|FG001|Overall Study|Decision by sponsor|7|||
146972941|NCT01652872|530061461|FG000|Overall Study|Withdrawal by Subject|76|||
146972942|NCT01652872|530061462|FG001|Overall Study|Withdrawal by Subject|84|||
146972943|NCT03985293|530061465|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
146972944|NCT03985293|530061466|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
146972945|NCT03985293|530061467|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
146972946|NCT03985293|530061468|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
146972947|NCT03985293|530061469|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
146972948|NCT03985293|530061470|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
146972949|NCT03985293|530061465|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
146972950|NCT03985293|530061466|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
146972951|NCT03985293|530061467|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
146972952|NCT03985293|530061468|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
146972953|NCT03985293|530061469|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
146972954|NCT03985293|530061470|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
146972955|NCT03985293|530061465|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
146972956|NCT03985293|530061466|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
146972957|NCT03985293|530061467|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
146972958|NCT03985293|530061468|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
146972959|NCT03985293|530061469|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
146972960|NCT03985293|530061470|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
146972961|NCT03985293|530061465|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
146972962|NCT03985293|530061466|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
146972963|NCT03985293|530061467|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
146972964|NCT03985293|530061468|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
146972965|NCT03985293|530061469|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
146972966|NCT03985293|530061470|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
146972967|NCT03985293|530061465|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
146972968|NCT03985293|530061466|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
146972969|NCT03985293|530061467|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
146972970|NCT03985293|530061468|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
146972971|NCT03985293|530061469|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
146972972|NCT03985293|530061470|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
146972973|NCT03985293|530061465|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
146972974|NCT03985293|530061466|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
146972975|NCT03985293|530061467|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
146972976|NCT03985293|530061468|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
146972977|NCT03985293|530061469|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
146972978|NCT03985293|530061470|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
146972979|NCT03985293|530061465|FG000|FOLLOW-UP|Lost to Follow-up|0|||
146972980|NCT03985293|530061466|FG001|FOLLOW-UP|Lost to Follow-up|0|||
146972981|NCT03985293|530061467|FG002|FOLLOW-UP|Lost to Follow-up|1|||
146972982|NCT03985293|530061468|FG003|FOLLOW-UP|Lost to Follow-up|0|||
146972983|NCT03985293|530061469|FG004|FOLLOW-UP|Lost to Follow-up|0|||
146972984|NCT03985293|530061470|FG005|FOLLOW-UP|Lost to Follow-up|0|||
146972985|NCT03107715|530061471|FG000|Overall Study|did not deliver at the home hospital|4|||
146972986|NCT03107715|530061472|FG001|Overall Study|did not deliver at the home hospital|6|||
146972987|NCT03107715|530061471|FG000|Overall Study|infant stillborn|0|||
146972988|NCT03107715|530061472|FG001|Overall Study|infant stillborn|1|||
146972989|NCT01901146|530063818|FG000|Neoadjuvant Phase|Death|1|||
146972990|NCT01901146|530063819|FG001|Neoadjuvant Phase|Death|2|||
146972991|NCT01901146|530063820|FG002|Neoadjuvant Phase|Death|0|||
146972992|NCT01901146|530063821|FG003|Neoadjuvant Phase|Death|0|||
146972993|NCT01901146|530063822|FG004|Neoadjuvant Phase|Death|0|||
146972994|NCT01901146|530063818|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
146972995|NCT01901146|530063819|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
146972996|NCT01901146|530063820|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
146972997|NCT01901146|530063821|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
146972998|NCT01901146|530063822|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
146972999|NCT01901146|530063818|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
146973000|NCT01901146|530063819|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
146499090|NCT03474731|528329752|FG001|Overall Study|Death|1|||
146499091|NCT03474731|528329753|FG002|Overall Study|Death|0|||
146973001|NCT01901146|530063820|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
146973002|NCT01901146|530063821|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
146973003|NCT01901146|530063822|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
146973004|NCT01901146|530063818|FG000|Neoadjuvant Phase|Physician Decision|1|||
146973005|NCT01901146|530063819|FG001|Neoadjuvant Phase|Physician Decision|2|||
146973006|NCT01901146|530063820|FG002|Neoadjuvant Phase|Physician Decision|0|||
146973007|NCT01901146|530063821|FG003|Neoadjuvant Phase|Physician Decision|0|||
146973008|NCT01901146|530063822|FG004|Neoadjuvant Phase|Physician Decision|0|||
146973009|NCT01901146|530063818|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
146499092|NCT03474731|528329754|FG003|Overall Study|Death|0|||
146912343|NCT04530825|529841469|FG000|Overall Study|Did not complete follow-up|3|||
146912344|NCT04530825|529841470|FG001|Overall Study|Did not complete follow-up|0|||
146912345|NCT04530825|529841471|FG002|Overall Study|Did not complete follow-up|0|||
146912346|NCT04530825|529841472|FG003|Overall Study|Did not complete follow-up|0|||
146912347|NCT04101422|529841474|FG000|Overall Study|Ineligible|1|||
146912348|NCT04101422|529841475|FG001|Overall Study|Ineligible|0|||
146912349|NCT04101422|529841476|FG002|Overall Study|Ineligible|9|||
146912350|NCT04101422|529841477|FG003|Overall Study|Ineligible|0|||
146912351|NCT04101422|529841474|FG000|Overall Study|Withdrawal by Subject|0|||
146912352|NCT04101422|529841475|FG001|Overall Study|Withdrawal by Subject|0|||
146912353|NCT04101422|529841476|FG002|Overall Study|Withdrawal by Subject|1|||
146912354|NCT04101422|529841477|FG003|Overall Study|Withdrawal by Subject|0|||
146912355|NCT04101422|529841474|FG000|Overall Study|Not attending to the stimuli|0|||
146912356|NCT04101422|529841475|FG001|Overall Study|Not attending to the stimuli|0|||
146912357|NCT04101422|529841476|FG002|Overall Study|Not attending to the stimuli|4|||
146912358|NCT04101422|529841477|FG003|Overall Study|Not attending to the stimuli|0|||
146912359|NCT04101422|529841474|FG000|Overall Study|Did not download app|0|||
146912360|NCT04101422|529841475|FG001|Overall Study|Did not download app|0|||
146912361|NCT04101422|529841476|FG002|Overall Study|Did not download app|0|||
146912362|NCT04101422|529841477|FG003|Overall Study|Did not download app|17|||
146912363|NCT04101422|529841474|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
146912364|NCT04101422|529841475|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
146912365|NCT04101422|529841476|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
146912366|NCT04101422|529841477|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
146912367|NCT00552305|529841478|FG000|Overall Study|Adverse Event|43|||
146912368|NCT00552305|529841478|FG000|Overall Study|Lack of Efficacy|120|||
146912369|NCT00552305|529841478|FG000|Overall Study|Lost to Follow-up|4|||
146912370|NCT00552305|529841478|FG000|Overall Study|Protocol Violation|3|||
146912371|NCT00552305|529841478|FG000|Overall Study|Withdrawal by Subject|44|||
146912372|NCT00552305|529841478|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
146912373|NCT00552305|529841478|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
146912374|NCT00552305|529841478|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
146912375|NCT00552305|529841478|FG000|Overall Study|Unsatisfactory compliance|11|||
146912376|NCT00552305|529841478|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
146912377|NCT00552305|529841478|FG000|Overall Study|AE/Other: prohibited drug required|1|||
146912378|NCT00552305|529841478|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
146912379|NCT00552305|529841478|FG000|Overall Study|Other: Site closed|4|||
146912380|NCT00552305|529841478|FG000|Overall Study|Other: Personal problems|1|||
146912381|NCT00552305|529841478|FG000|Overall Study|Other: Unable to attend visits|1|||
146912382|NCT00552305|529841478|FG000|Overall Study|Other: Subject underwent surgery|4|||
146912383|NCT00552305|529841478|FG000|Overall Study|Other: Subject became pregnant|1|||
146912384|NCT00552305|529841478|FG000|Overall Study|Other: Health problems, not drug related|1|||
146912385|NCT00552305|529841478|FG000|Overall Study|Other: Subject moved from area|2|||
146912386|NCT00552305|529841478|FG000|Overall Study|Other: Subject incarcerated|1|||
146912387|NCT00552305|529841478|FG000|Overall Study|Other: Subject went to rehab|1|||
146912388|NCT04983901|529841481|FG000|Overall Study|Death|1|||
146912389|NCT04983901|529841482|FG001|Overall Study|Death|4|||
146912390|NCT04983901|529841481|FG000|Overall Study|Lost to Follow-up|3|||
146912391|NCT04983901|529841482|FG001|Overall Study|Lost to Follow-up|0|||
146912392|NCT04983901|529841481|FG000|Overall Study|Protocol Violation|1|||
146912393|NCT04983901|529841482|FG001|Overall Study|Protocol Violation|0|||
146912394|NCT04983901|529841481|FG000|Overall Study|Withdrawal by Subject|1|||
146912395|NCT04983901|529841482|FG001|Overall Study|Withdrawal by Subject|2|||
146912396|NCT01174784|529841483|FG000|Overall Study|Screen fails|4|||
146912397|NCT01671488|529841484|FG000|Overall Study|Withdrawal by Subject|1|||
146912398|NCT02285010|529841485|FG000|Overall Study|not abdominal hysterectomy|2|||
146912399|NCT02285010|529841486|FG001|Overall Study|not abdominal hysterectomy|0|||
146912400|NCT02285010|529841485|FG000|Overall Study|Not spinal anesthesia|3|||
146912401|NCT02285010|529841486|FG001|Overall Study|Not spinal anesthesia|1|||
146912402|NCT02902809|529841487|FG000|Overall Study|Discontinuation of asthma program|28|||
146912403|NCT00532259|529841488|FG000|Overall Study|Withdrawal by Subject|2|||
146912404|NCT00532259|529841488|FG000|Overall Study|Adverse Event|1|||
146912405|NCT00532259|529841488|FG000|Overall Study|Death|1|||
146912406|NCT00532259|529841488|FG000|Overall Study|Lack of Efficacy|21|||
146912407|NCT00532259|529841488|FG000|Overall Study|Lost to Follow-up|3|||
146912408|NCT00532259|529841488|FG000|Overall Study|Physician Decision|3|||
146912409|NCT00532259|529841488|FG000|Overall Study|Protocol Violation|1|||
146912410|NCT04983940|529841489|FG000|Overall Study|Lost to Follow-up|14|||
146912411|NCT04983940|529841489|FG000|Overall Study|Lack of Efficacy|2|||
146912412|NCT00465738|529841500|FG000|Overall Study|Lost to Follow-up|2|||
146912413|NCT00465738|529841501|FG001|Overall Study|Lost to Follow-up|0|||
146912414|NCT00465738|529841500|FG000|Overall Study|Adverse Event|0|||
146912415|NCT00465738|529841501|FG001|Overall Study|Adverse Event|1|||
146912416|NCT00465738|529841500|FG000|Overall Study|Withdrawal by Subject|2|||
146912417|NCT00465738|529841501|FG001|Overall Study|Withdrawal by Subject|0|||
146645851|NCT01328444|528881558|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146645852|NCT01328444|528881553|FG000|Washout Period (14 Days)|Adverse Event|1|||
146645853|NCT01328444|528881554|FG001|Washout Period (14 Days)|Adverse Event|1|||
146645854|NCT01328444|528881555|FG002|Washout Period (14 Days)|Adverse Event|0|||
146645855|NCT01328444|528881556|FG003|Washout Period (14 Days)|Adverse Event|1|||
146645856|NCT01328444|528881557|FG004|Washout Period (14 Days)|Adverse Event|1|||
146645857|NCT01328444|528881558|FG005|Washout Period (14 Days)|Adverse Event|2|||
146645858|NCT01328444|528881553|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
146645859|NCT01328444|528881554|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
146645860|NCT01328444|528881555|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
146645861|NCT01328444|528881556|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
146645862|NCT01328444|528881557|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
146645863|NCT01328444|528881558|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
146645864|NCT01328444|528881553|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
146645865|NCT01328444|528881554|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
146645866|NCT01328444|528881555|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
146645867|NCT01328444|528881556|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
146645868|NCT01328444|528881557|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
146645869|NCT01328444|528881558|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
146645870|NCT01328444|528881553|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
146645871|NCT01328444|528881554|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
146645872|NCT01328444|528881555|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
146645873|NCT01328444|528881556|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
146645874|NCT01328444|528881557|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
146645875|NCT01328444|528881558|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
146645876|NCT01328444|528881553|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
146645877|NCT01328444|528881554|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
146645878|NCT01328444|528881555|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
146645879|NCT01328444|528881556|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
146645880|NCT01328444|528881557|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
146645881|NCT01328444|528881558|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
146645882|NCT01328444|528881553|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
146645883|NCT01328444|528881554|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
146645884|NCT01328444|528881555|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
146645885|NCT01328444|528881556|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
146645886|NCT01328444|528881557|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
146645887|NCT01328444|528881558|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
146645888|NCT01328444|528881553|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
146645889|NCT01328444|528881554|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
146645890|NCT01328444|528881555|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
146645891|NCT01328444|528881556|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
146645892|NCT01328444|528881557|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
146912418|NCT00465738|529841500|FG000|Overall Study|Other|2|||
146912419|NCT00465738|529841501|FG001|Overall Study|Other|5|||
146912420|NCT02707757|529841502|FG000|Overall Study|Protocol Violation|3|||
146912421|NCT02707757|529841503|FG001|Overall Study|Protocol Violation|2|||
146912422|NCT02707757|529841502|FG000|Overall Study|Withdrawal by Subject|2|||
146912423|NCT02707757|529841503|FG001|Overall Study|Withdrawal by Subject|0|||
146912424|NCT02707757|529841502|FG000|Overall Study|Death|0|||
146912425|NCT02707757|529841503|FG001|Overall Study|Death|1|||
146912426|NCT02707757|529841502|FG000|Overall Study|Adverse Event|6|||
146912427|NCT02707757|529841503|FG001|Overall Study|Adverse Event|4|||
146912428|NCT02707757|529841502|FG000|Overall Study|Renal transplant/elective operation|1|||
146912429|NCT02707757|529841503|FG001|Overall Study|Renal transplant/elective operation|5|||
146912430|NCT01318902|529841508|FG000|Overall Study|Symptomatic Deterioration|0|||
146912431|NCT01318902|529841509|FG001|Overall Study|Symptomatic Deterioration|1|||
146912432|NCT01318902|529841510|FG002|Overall Study|Symptomatic Deterioration|1|||
146912433|NCT01318902|529841511|FG003|Overall Study|Symptomatic Deterioration|2|||
146912434|NCT01318902|529841508|FG000|Overall Study|Withdrawal by Patient|0|||
146912435|NCT01318902|529841509|FG001|Overall Study|Withdrawal by Patient|1|||
146912436|NCT01318902|529841510|FG002|Overall Study|Withdrawal by Patient|0|||
146912437|NCT01318902|529841511|FG003|Overall Study|Withdrawal by Patient|3|||
146912438|NCT01318902|529841508|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
146912439|NCT01318902|529841509|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
146912440|NCT01318902|529841510|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
146645893|NCT01328444|528881558|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
146645894|NCT01328444|528881553|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
146645895|NCT01328444|528881554|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
146645896|NCT01328444|528881555|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
146912441|NCT01318902|529841511|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
146912442|NCT01318902|529841508|FG000|Overall Study|Adverse Event|0|||
146912443|NCT01318902|529841509|FG001|Overall Study|Adverse Event|1|||
146973010|NCT01901146|530063819|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
146973011|NCT01901146|530063820|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
146973012|NCT01901146|530063821|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
146973013|NCT01901146|530063822|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
146973014|NCT01901146|530063818|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
146973015|NCT01901146|530063819|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
146973016|NCT01901146|530063820|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
146973017|NCT01901146|530063821|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
146973018|NCT01901146|530063822|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
146973019|NCT01901146|530063818|FG000|Adjuvant Phase|Other|0|||
146973020|NCT01901146|530063819|FG001|Adjuvant Phase|Other|0|||
146973021|NCT01901146|530063820|FG002|Adjuvant Phase|Other|1|||
146973022|NCT01901146|530063821|FG003|Adjuvant Phase|Other|0|||
146973023|NCT01901146|530063822|FG004|Adjuvant Phase|Other|0|||
146973024|NCT01901146|530063818|FG000|Adjuvant Phase|Death|0|||
146973025|NCT01901146|530063819|FG001|Adjuvant Phase|Death|0|||
146973026|NCT01901146|530063820|FG002|Adjuvant Phase|Death|0|||
146973027|NCT01901146|530063821|FG003|Adjuvant Phase|Death|0|||
146973028|NCT01901146|530063822|FG004|Adjuvant Phase|Death|3|||
146973029|NCT01901146|530063818|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
146973030|NCT01901146|530063819|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
146973031|NCT01901146|530063820|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
146973032|NCT01901146|530063821|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
146973033|NCT01901146|530063822|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
146973034|NCT01901146|530063818|FG000|Adjuvant Phase|Physician Decision|0|||
146973035|NCT01901146|530063819|FG001|Adjuvant Phase|Physician Decision|0|||
146973036|NCT01901146|530063820|FG002|Adjuvant Phase|Physician Decision|9|||
146973037|NCT01901146|530063821|FG003|Adjuvant Phase|Physician Decision|2|||
146973038|NCT01901146|530063822|FG004|Adjuvant Phase|Physician Decision|4|||
146973039|NCT01901146|530063818|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
146973040|NCT01901146|530063819|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
146973041|NCT01901146|530063820|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
146973042|NCT01901146|530063821|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
146973043|NCT01901146|530063822|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
146973044|NCT00297492|530063823|FG000|Set Quit Date|Lost to Follow-up|7|||
146973045|NCT00297492|530063824|FG001|Set Quit Date|Lost to Follow-up|13|||
146973046|NCT00297492|530063825|FG002|Set Quit Date|Lost to Follow-up|5|||
146973047|NCT00297492|530063823|FG000|6 Month Follow-up|Lost to Follow-up|63|||
146973048|NCT00297492|530063824|FG001|6 Month Follow-up|Lost to Follow-up|49|||
146973049|NCT00297492|530063825|FG002|6 Month Follow-up|Lost to Follow-up|27|||
146973050|NCT03724968|530063826|FG000|Overall Study|Insurance issues|0|||
146973051|NCT03724968|530063827|FG001|Overall Study|Insurance issues|1|||
146973052|NCT03724968|530063826|FG000|Overall Study|Study closed|0|||
146973053|NCT03724968|530063827|FG001|Overall Study|Study closed|1|||
146973054|NCT00569231|530063830|FG000|Overall Study|Study unrelated surgery|1|||
146973055|NCT00569231|530063830|FG000|Overall Study|Airfare expense|2|||
146973056|NCT00569231|530063830|FG000|Overall Study|Withdrawal by Subject|1|||
146973057|NCT00569231|530063830|FG000|Overall Study|Car accident injury|1|||
146973058|NCT00569231|530063830|FG000|Overall Study|Non-compliance|2|||
146973059|NCT01614925|530063831|FG000|Overall Study|Withdrawal by Subject|1|||
146973060|NCT01614925|530063832|FG001|Overall Study|Withdrawal by Subject|0|||
146973061|NCT01614925|530063831|FG000|Overall Study|Protocol Violation|3|||
146973062|NCT01614925|530063832|FG001|Overall Study|Protocol Violation|2|||
146973063|NCT02437890|530063837|FG000|Overall Study|Non-compliance to study drug|0|||
146973064|NCT02437890|530063838|FG001|Overall Study|Non-compliance to study drug|1|||
146973065|NCT02437890|530063839|FG002|Overall Study|Non-compliance to study drug|0|||
146973066|NCT02437890|530063840|FG003|Overall Study|Non-compliance to study drug|0|||
146973067|NCT02437890|530063841|FG004|Overall Study|Non-compliance to study drug|1|||
146973068|NCT02437890|530063837|FG000|Overall Study|Sponsor's decision|1|||
146973069|NCT02437890|530063838|FG001|Overall Study|Sponsor's decision|1|||
146645897|NCT01328444|528881556|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
146973070|NCT02437890|530063839|FG002|Overall Study|Sponsor's decision|4|||
146973071|NCT02437890|530063840|FG003|Overall Study|Sponsor's decision|0|||
146973072|NCT02437890|530063841|FG004|Overall Study|Sponsor's decision|2|||
146973073|NCT02437890|530063837|FG000|Overall Study|Physician Decision|0|||
146973074|NCT02437890|530063838|FG001|Overall Study|Physician Decision|0|||
146645898|NCT01328444|528881557|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
146973075|NCT02437890|530063839|FG002|Overall Study|Physician Decision|0|||
146973076|NCT02437890|530063840|FG003|Overall Study|Physician Decision|1|||
146973077|NCT02437890|530063841|FG004|Overall Study|Physician Decision|0|||
146973078|NCT02437890|530063837|FG000|Overall Study|Unable to attend visit(s)|1|||
146973079|NCT02437890|530063838|FG001|Overall Study|Unable to attend visit(s)|0|||
146973080|NCT02437890|530063839|FG002|Overall Study|Unable to attend visit(s)|0|||
146973081|NCT02437890|530063840|FG003|Overall Study|Unable to attend visit(s)|0|||
146973082|NCT02437890|530063841|FG004|Overall Study|Unable to attend visit(s)|0|||
146973083|NCT02437890|530063837|FG000|Overall Study|Lack of Efficacy|1|||
146973084|NCT02437890|530063838|FG001|Overall Study|Lack of Efficacy|3|||
146973085|NCT02437890|530063839|FG002|Overall Study|Lack of Efficacy|0|||
146973086|NCT02437890|530063840|FG003|Overall Study|Lack of Efficacy|3|||
146973087|NCT02437890|530063841|FG004|Overall Study|Lack of Efficacy|1|||
146973088|NCT02437890|530063837|FG000|Overall Study|Adverse Event|4|||
146973089|NCT02437890|530063838|FG001|Overall Study|Adverse Event|9|||
146973090|NCT02437890|530063839|FG002|Overall Study|Adverse Event|5|||
146973091|NCT02437890|530063840|FG003|Overall Study|Adverse Event|11|||
146645899|NCT01328444|528881558|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
146645900|NCT01328444|528881553|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146645901|NCT01328444|528881554|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146645902|NCT01328444|528881555|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146645903|NCT01328444|528881556|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146645904|NCT01328444|528881557|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146645905|NCT01328444|528881558|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146645906|NCT03531632|528881559|FG000|Overall Study|Adverse Event|0|||
146645907|NCT03531632|528881560|FG001|Overall Study|Adverse Event|0|||
146645908|NCT03531632|528881561|FG002|Overall Study|Adverse Event|1|||
146645909|NCT03531632|528881559|FG000|Overall Study|Death|4|||
146645910|NCT03531632|528881560|FG001|Overall Study|Death|0|||
146645911|NCT03531632|528881561|FG002|Overall Study|Death|14|||
146645912|NCT03531632|528881559|FG000|Overall Study|Study Terminated|1|||
146645913|NCT03531632|528881560|FG001|Overall Study|Study Terminated|3|||
146645914|NCT03531632|528881561|FG002|Overall Study|Study Terminated|11|||
146645915|NCT02743611|528881562|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
146645916|NCT02743611|528881563|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
146645917|NCT02743611|528881564|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
146645918|NCT02743611|528881565|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
146645919|NCT00600119|528881566|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
146645920|NCT00600119|528881567|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
146645921|NCT00600119|528881568|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
146645922|NCT00600119|528881569|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
146645923|NCT00600119|528881570|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
146645924|NCT00600119|528881571|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
146645925|NCT00600119|528881566|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
146645926|NCT00600119|528881567|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
146645927|NCT00600119|528881568|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
146645928|NCT00600119|528881569|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
146645929|NCT00600119|528881570|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
146645930|NCT00600119|528881571|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
146645931|NCT00600119|528881566|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
146645932|NCT00600119|528881567|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
146645933|NCT00600119|528881568|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
146645934|NCT00600119|528881569|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
146645935|NCT00600119|528881570|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
146645936|NCT00600119|528881571|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
146645937|NCT00600119|528881566|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
146645938|NCT00600119|528881567|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
146645939|NCT00600119|528881568|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
146645940|NCT00600119|528881569|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
146645941|NCT00600119|528881570|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
146645942|NCT00600119|528881571|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
146645943|NCT00600119|528881566|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
146645944|NCT00600119|528881567|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
146645945|NCT00600119|528881568|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
146645946|NCT00600119|528881569|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
146645947|NCT00600119|528881570|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
146645948|NCT00600119|528881571|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
146645949|NCT00600119|528881566|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
146973092|NCT02437890|530063841|FG004|Overall Study|Adverse Event|7|||
146973093|NCT02437890|530063837|FG000|Overall Study|Withdrawal by Subject|1|||
146499093|NCT03474731|528329751|FG000|Overall Study|Participant Removed|0|||
146499094|NCT03474731|528329752|FG001|Overall Study|Participant Removed|0|||
146499095|NCT03474731|528329753|FG002|Overall Study|Participant Removed|0|||
146499096|NCT03474731|528329754|FG003|Overall Study|Participant Removed|1|||
146499097|NCT02887248|528329760|FG000|Overall Study|Withdrawal by Subject|1|||
146499098|NCT02887248|528329760|FG000|Overall Study|Adverse Event|1|||
146499099|NCT02887248|528329760|FG000|Overall Study|Progressive Disease|1|||
146499100|NCT00765336|528329761|FG000|Overall Study|Protocol Violation|4|||
146499101|NCT00765336|528329762|FG001|Overall Study|Protocol Violation|2|||
146499102|NCT00765336|528329761|FG000|Overall Study|Withdrawal by Subject|6|||
146973094|NCT02437890|530063838|FG001|Overall Study|Withdrawal by Subject|2|||
146973095|NCT02437890|530063839|FG002|Overall Study|Withdrawal by Subject|6|||
146973096|NCT02437890|530063840|FG003|Overall Study|Withdrawal by Subject|5|||
146973097|NCT02437890|530063841|FG004|Overall Study|Withdrawal by Subject|5|||
146973098|NCT02437890|530063837|FG000|Overall Study|Death|0|||
146973099|NCT02437890|530063838|FG001|Overall Study|Death|0|||
146973100|NCT02437890|530063839|FG002|Overall Study|Death|0|||
146973101|NCT02437890|530063840|FG003|Overall Study|Death|2|||
146973102|NCT02437890|530063841|FG004|Overall Study|Death|0|||
146973103|NCT01190098|530063842|FG000|Overall Study|Adverse Event|2|||
146973104|NCT01190098|530063843|FG001|Overall Study|Adverse Event|0|||
146973105|NCT01190098|530063842|FG000|Overall Study|Patient coomorbidity|0|||
146973106|NCT01190098|530063843|FG001|Overall Study|Patient coomorbidity|1|||
146973107|NCT01190098|530063842|FG000|Overall Study|Lack of transportation|1|||
146973108|NCT01190098|530063843|FG001|Overall Study|Lack of transportation|0|||
146973109|NCT01190098|530063842|FG000|Overall Study|Other|0|||
146973110|NCT01190098|530063843|FG001|Overall Study|Other|1|||
146973111|NCT00344305|530063844|FG000|Overall Study|Lost to Follow-up|2|||
146973112|NCT00344305|530063845|FG001|Overall Study|Lost to Follow-up|0|||
146973113|NCT00344305|530063844|FG000|Overall Study|Participant was not contacted in window|0|||
146973114|NCT00344305|530063845|FG001|Overall Study|Participant was not contacted in window|1|||
146973115|NCT01227954|530063859|FG000|Overall Study|Protocol Violation|6|||
146973116|NCT01227954|530063859|FG000|Overall Study|No protocol treatment|7|||
146973117|NCT00078312|530063865|FG000|Overall Study|Adverse Event|43|||
146973118|NCT00078312|530063865|FG000|Overall Study|Lack of Efficacy|15|||
146973119|NCT00078312|530063865|FG000|Overall Study|Lost to Follow-up|41|||
146973120|NCT00078312|530063865|FG000|Overall Study|Physician Decision|9|||
146973121|NCT00078312|530063865|FG000|Overall Study|Protocol Violation|3|||
146973122|NCT00078312|530063865|FG000|Overall Study|Withdrawal by Subject|33|||
146973123|NCT00078312|530063865|FG000|Overall Study|Miscellaneous|33|||
146973124|NCT01875991|530063869|FG000|Overall Study|Withdrawal by Subject|6|||
146973125|NCT01875991|530063870|FG001|Overall Study|Withdrawal by Subject|6|||
146973126|NCT01875991|530063869|FG000|Overall Study|Sponsor Decision|1|||
146973127|NCT01875991|530063870|FG001|Overall Study|Sponsor Decision|0|||
146973128|NCT02216214|530063871|FG000|Overall Study|Randomized Never Received Study Drug|1|||
146973129|NCT02216214|530063872|FG001|Overall Study|Randomized Never Received Study Drug|0|||
146973130|NCT02216214|530063871|FG000|Overall Study|Adverse Event|10|||
146973131|NCT02216214|530063872|FG001|Overall Study|Adverse Event|8|||
146973132|NCT02216214|530063871|FG000|Overall Study|Lack of Efficacy|2|||
146973133|NCT02216214|530063872|FG001|Overall Study|Lack of Efficacy|2|||
146973134|NCT02216214|530063871|FG000|Overall Study|Lost to Follow-up|3|||
146973135|NCT02216214|530063872|FG001|Overall Study|Lost to Follow-up|2|||
146973136|NCT02216214|530063871|FG000|Overall Study|Protocol Violation|4|||
146973137|NCT02216214|530063872|FG001|Overall Study|Protocol Violation|2|||
146973138|NCT02216214|530063871|FG000|Overall Study|Withdrawal by Subject|22|||
146973139|NCT02216214|530063872|FG001|Overall Study|Withdrawal by Subject|20|||
146973140|NCT02216214|530063871|FG000|Overall Study|Study Terminated By Sponsor|0|||
146973141|NCT02216214|530063872|FG001|Overall Study|Study Terminated By Sponsor|1|||
146973142|NCT02216214|530063871|FG000|Overall Study|Miscellaneous|1|||
146973143|NCT02216214|530063872|FG001|Overall Study|Miscellaneous|1|||
146973144|NCT05354206|530063873|FG000|Overall Study|Withdrawal by Subject|1|||
146973145|NCT05354206|530063874|FG001|Overall Study|Withdrawal by Subject|0|||
146973146|NCT01414062|530063875|FG000|Overall Study|Lost to Follow-up|3|||
146973147|NCT01414062|530063876|FG001|Overall Study|Lost to Follow-up|2|||
146973148|NCT01414062|530063875|FG000|Overall Study|Left Country|1|||
146973149|NCT01414062|530063876|FG001|Overall Study|Left Country|1|||
146973150|NCT01414062|530063875|FG000|Overall Study|Family Disapproval|1|||
146565831|NCT01076010|528584265|FG001|Overall Study|Withdrawal by Subject|0|||
146565832|NCT01076010|528584266|FG002|Overall Study|Withdrawal by Subject|1|||
146565833|NCT01076010|528584264|FG000|Overall Study|Other|5|||
146565834|NCT01076010|528584265|FG001|Overall Study|Other|2|||
146565835|NCT01076010|528584266|FG002|Overall Study|Other|0|||
146565836|NCT01156844|528584267|FG000|Overall Study|Adverse Event|0|||
146565837|NCT01156844|528584268|FG001|Overall Study|Adverse Event|0|||
146565838|NCT01156844|528584269|FG002|Overall Study|Adverse Event|1|||
146565839|NCT01156844|528584270|FG003|Overall Study|Adverse Event|1|||
146565840|NCT01156844|528584267|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146565841|NCT01156844|528584268|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146565842|NCT01156844|528584269|FG002|Overall Study|Abnormal test procedure result(s)|2|||
146565843|NCT01156844|528584270|FG003|Overall Study|Abnormal test procedure result(s)|2|||
146565844|NCT01156844|528584267|FG000|Overall Study|Withdrawal by Subject|0|||
146565845|NCT01156844|528584268|FG001|Overall Study|Withdrawal by Subject|0|||
146973151|NCT01414062|530063876|FG001|Overall Study|Family Disapproval|0|||
146973152|NCT01414062|530063875|FG000|Overall Study|Withdrawal by Subject|0|||
146973153|NCT01414062|530063876|FG001|Overall Study|Withdrawal by Subject|1|||
146973154|NCT04285983|530063877|FG000|Overall Study|Protocol Violation|6|||
146973155|NCT04936334|530063878|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
146973156|NCT00902265|530063881|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
146565846|NCT01156844|528584269|FG002|Overall Study|Withdrawal by Subject|2|||
146565847|NCT01156844|528584270|FG003|Overall Study|Withdrawal by Subject|2|||
146565848|NCT01156844|528584267|FG000|Overall Study|Lost to Follow-up|0|||
146565849|NCT01156844|528584268|FG001|Overall Study|Lost to Follow-up|0|||
146565850|NCT01156844|528584269|FG002|Overall Study|Lost to Follow-up|1|||
146565851|NCT01156844|528584270|FG003|Overall Study|Lost to Follow-up|0|||
146565852|NCT01156844|528584267|FG000|Overall Study|Administrative problems|0|||
146565853|NCT01156844|528584268|FG001|Overall Study|Administrative problems|1|||
146565854|NCT01156844|528584269|FG002|Overall Study|Administrative problems|0|||
146565855|NCT01156844|528584270|FG003|Overall Study|Administrative problems|1|||
146565856|NCT01156844|528584267|FG000|Overall Study|Protocol deviation|2|||
146565857|NCT01156844|528584268|FG001|Overall Study|Protocol deviation|0|||
146565858|NCT01156844|528584269|FG002|Overall Study|Protocol deviation|0|||
146565859|NCT01156844|528584270|FG003|Overall Study|Protocol deviation|0|||
146565860|NCT00945659|528584272|FG000|Overall Study|Lost to Follow-up|7|||
146565861|NCT00945659|528584273|FG001|Overall Study|Lost to Follow-up|20|||
146565862|NCT00945659|528584274|FG002|Overall Study|Lost to Follow-up|17|||
146565863|NCT04067011|528584275|FG000|Overall Study|Not Treated|8|||
146565864|NCT04067011|528584276|FG001|Overall Study|Not Treated|7|||
146565865|NCT04067011|528584277|FG002|Overall Study|Not Treated|5|||
146565866|NCT04067011|528584275|FG000|Overall Study|Adverse Event|2|||
146565867|NCT04067011|528584276|FG001|Overall Study|Adverse Event|1|||
146565868|NCT04067011|528584277|FG002|Overall Study|Adverse Event|0|||
146565869|NCT04067011|528584275|FG000|Overall Study|Withdrawal by Subject|6|||
146565870|NCT04067011|528584276|FG001|Overall Study|Withdrawal by Subject|2|||
146565871|NCT04067011|528584277|FG002|Overall Study|Withdrawal by Subject|1|||
146565872|NCT04067011|528584275|FG000|Overall Study|Lost to Follow-up|0|||
146565873|NCT04067011|528584276|FG001|Overall Study|Lost to Follow-up|0|||
146565874|NCT04067011|528584277|FG002|Overall Study|Lost to Follow-up|1|||
146565875|NCT04067011|528584275|FG000|Overall Study|Physician Decision|1|||
146565876|NCT04067011|528584276|FG001|Overall Study|Physician Decision|1|||
146565877|NCT04067011|528584277|FG002|Overall Study|Physician Decision|0|||
146565878|NCT04067011|528584275|FG000|Overall Study|Other Reasons|2|||
146565879|NCT04067011|528584276|FG001|Overall Study|Other Reasons|0|||
146565880|NCT04067011|528584277|FG002|Overall Study|Other Reasons|1|||
146565881|NCT04067011|528584275|FG000|Overall Study|Missing|0|||
146565882|NCT04067011|528584276|FG001|Overall Study|Missing|2|||
146565883|NCT04067011|528584277|FG002|Overall Study|Missing|0|||
146565884|NCT05209386|528584278|FG000|Overall Study|Withdrawal by Subject|8|||
146565885|NCT05209386|528584278|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
146565886|NCT05200845|528584280|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
146565887|NCT05200845|528584281|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
146565888|NCT05200845|528584282|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
146565889|NCT05200845|528584283|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
146565890|NCT05200845|528584280|FG000|Overall Study|Withdrawal by Subject|0|||
146565891|NCT05200845|528584281|FG001|Overall Study|Withdrawal by Subject|1|||
146565892|NCT05200845|528584282|FG002|Overall Study|Withdrawal by Subject|1|||
146565893|NCT05200845|528584283|FG003|Overall Study|Withdrawal by Subject|0|||
146565894|NCT02412670|528584284|FG000|Overall Study|Adverse Event|4|||
146499103|NCT00765336|528329762|FG001|Overall Study|Withdrawal by Subject|4|||
146499104|NCT00765336|528329761|FG000|Overall Study|Lost to Follow-up|7|||
146499105|NCT00765336|528329762|FG001|Overall Study|Lost to Follow-up|9|||
146499106|NCT00765336|528329761|FG000|Overall Study|Adverse Event|2|||
146499107|NCT00765336|528329762|FG001|Overall Study|Adverse Event|1|||
146499108|NCT00478777|528329763|FG000|Overall Study|Adverse Event|29|||
146565895|NCT02412670|528584285|FG001|Overall Study|Adverse Event|1|||
146565896|NCT02412670|528584284|FG000|Overall Study|Physician Decision|1|||
146565897|NCT02412670|528584285|FG001|Overall Study|Physician Decision|0|||
146499109|NCT00478777|528329763|FG000|Overall Study|Lack of Efficacy|23|||
146499110|NCT00478777|528329763|FG000|Overall Study|Withdrawal by Subject|4|||
146499111|NCT00478777|528329763|FG000|Overall Study|Death|3|||
146499112|NCT00478777|528329763|FG000|Overall Study|Protocol Violation|3|||
146499113|NCT00478777|528329763|FG000|Overall Study|Lost to Follow-up|3|||
146499114|NCT00478777|528329763|FG000|Overall Study|Physician Decision|1|||
146499115|NCT00478777|528329763|FG000|Overall Study|Intolerance of therapy|1|||
146499116|NCT00478777|528329763|FG000|Overall Study|Lack of compliance|1|||
146499117|NCT00478777|528329763|FG000|Overall Study|Lymphocytes infusion|1|||
146499118|NCT00478777|528329763|FG000|Overall Study|End of therapy|2|||
146499119|NCT00478777|528329763|FG000|Overall Study|Not treated with lenalidomide|6|||
146645950|NCT00600119|528881567|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
146565898|NCT02412670|528584284|FG000|Overall Study|Withdrawal by Subject|1|||
146565899|NCT02412670|528584285|FG001|Overall Study|Withdrawal by Subject|0|||
146565900|NCT02412670|528584284|FG000|Overall Study|Ineligible|1|||
146565901|NCT02412670|528584285|FG001|Overall Study|Ineligible|0|||
146565902|NCT00565409|528584288|FG000|Period 1 Open Label|Adverse Event|17|||
146499120|NCT04105218|528329769|FG000|Overall Study|Withdrawal by Subject|3|||
146499121|NCT04105218|528329770|FG001|Overall Study|Withdrawal by Subject|2|||
146565903|NCT00565409|528584289|FG001|Period 1 Open Label|Adverse Event|0|||
146565904|NCT00565409|528584290|FG002|Period 1 Open Label|Adverse Event|0|||
146565905|NCT00565409|528584291|FG003|Period 1 Open Label|Adverse Event|0|||
146499122|NCT04105218|528329769|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
146499123|NCT04105218|528329770|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
146499124|NCT04105218|528329769|FG000|Overall Study|Failed screening tests|2|||
146499125|NCT04105218|528329770|FG001|Overall Study|Failed screening tests|1|||
146499126|NCT01323387|528329776|FG000|Overall Study|Withdrawal by Subject|41|||
146499127|NCT01323387|528329776|FG000|Overall Study|Radiographic Data Unavailable|1|||
146499128|NCT01323387|528329776|FG000|Overall Study|Revision|14|||
146499129|NCT01323387|528329776|FG000|Overall Study|Protocol Violation|12|||
146499130|NCT01323387|528329776|FG000|Overall Study|Randomized but Never Treated|16|||
146499131|NCT00570063|528329779|FG000|Overall Study|Adverse Event|4|||
146499132|NCT00570063|528329780|FG001|Overall Study|Adverse Event|1|||
146499133|NCT00570063|528329779|FG000|Overall Study|Lack of Efficacy|0|||
146499134|NCT00570063|528329780|FG001|Overall Study|Lack of Efficacy|1|||
146499135|NCT00570063|528329779|FG000|Overall Study|Withdrawal by Subject|4|||
146499136|NCT00570063|528329780|FG001|Overall Study|Withdrawal by Subject|3|||
146499137|NCT00570063|528329779|FG000|Overall Study|Sponsor's Decision|7|||
146565906|NCT00565409|528584288|FG000|Period 1 Open Label|Death|2|||
146565907|NCT00565409|528584289|FG001|Period 1 Open Label|Death|0|||
146565908|NCT00565409|528584290|FG002|Period 1 Open Label|Death|0|||
146565909|NCT00565409|528584291|FG003|Period 1 Open Label|Death|0|||
146565910|NCT00565409|528584288|FG000|Period 1 Open Label|Lost to Follow-up|1|||
146565911|NCT00565409|528584289|FG001|Period 1 Open Label|Lost to Follow-up|0|||
146565912|NCT00565409|528584290|FG002|Period 1 Open Label|Lost to Follow-up|0|||
146565913|NCT00565409|528584291|FG003|Period 1 Open Label|Lost to Follow-up|0|||
146565914|NCT00565409|528584288|FG000|Period 1 Open Label|Other|21|||
146565915|NCT00565409|528584289|FG001|Period 1 Open Label|Other|0|||
146565916|NCT00565409|528584290|FG002|Period 1 Open Label|Other|0|||
146565917|NCT00565409|528584291|FG003|Period 1 Open Label|Other|0|||
146565918|NCT00565409|528584288|FG000|Period 1 Open Label|Protocol Violation|14|||
146565919|NCT00565409|528584289|FG001|Period 1 Open Label|Protocol Violation|0|||
146499138|NCT00570063|528329780|FG001|Overall Study|Sponsor's Decision|3|||
146499139|NCT01554527|528329781|FG000|Overall Study|Withdrawal by Subject|1|||
146499140|NCT01554527|528329782|FG001|Overall Study|Withdrawal by Subject|0|||
146499141|NCT01554527|528329783|FG002|Overall Study|Withdrawal by Subject|3|||
146499142|NCT01554527|528329781|FG000|Overall Study|Lost to Follow-up|0|||
146499143|NCT01554527|528329782|FG001|Overall Study|Lost to Follow-up|0|||
146499144|NCT01554527|528329783|FG002|Overall Study|Lost to Follow-up|4|||
146499145|NCT01554527|528329781|FG000|Overall Study|Physician Decision|0|||
146499146|NCT01554527|528329782|FG001|Overall Study|Physician Decision|0|||
146499147|NCT01554527|528329783|FG002|Overall Study|Physician Decision|1|||
146499148|NCT00550043|528329784|FG000|Overall Study|Adverse Event|0|||
146499149|NCT00550043|528329785|FG001|Overall Study|Adverse Event|0|||
146499150|NCT00550043|528329786|FG002|Overall Study|Adverse Event|0|||
146499151|NCT00550043|528329787|FG003|Overall Study|Adverse Event|1|||
146499152|NCT00550043|528329788|FG004|Overall Study|Adverse Event|1|||
146499153|NCT00550043|528329784|FG000|Overall Study|Subject Withdrew Consent|0|||
146499154|NCT00550043|528329785|FG001|Overall Study|Subject Withdrew Consent|2|||
146499155|NCT00550043|528329786|FG002|Overall Study|Subject Withdrew Consent|1|||
146499156|NCT00550043|528329787|FG003|Overall Study|Subject Withdrew Consent|0|||
146499157|NCT00550043|528329788|FG004|Overall Study|Subject Withdrew Consent|0|||
146499158|NCT00550043|528329784|FG000|Overall Study|Other Reasons- Unspecified|0|||
146499159|NCT00550043|528329785|FG001|Overall Study|Other Reasons- Unspecified|1|||
146499160|NCT00550043|528329786|FG002|Overall Study|Other Reasons- Unspecified|0|||
146499161|NCT00550043|528329787|FG003|Overall Study|Other Reasons- Unspecified|1|||
146499162|NCT00550043|528329788|FG004|Overall Study|Other Reasons- Unspecified|0|||
146499163|NCT02073929|528329789|FG000|Overall Study|Lost to Follow-up|2|||
146499164|NCT02073929|528329790|FG001|Overall Study|Lost to Follow-up|1|||
146499165|NCT02073929|528329789|FG000|Overall Study|Adverse Event|2|||
146565920|NCT00565409|528584290|FG002|Period 1 Open Label|Protocol Violation|0|||
146565921|NCT00565409|528584291|FG003|Period 1 Open Label|Protocol Violation|0|||
146565922|NCT00565409|528584288|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
146565923|NCT00565409|528584289|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
146499166|NCT02073929|528329790|FG001|Overall Study|Adverse Event|1|||
146499167|NCT02073929|528329789|FG000|Overall Study|Withdrawal by Subject|0|||
146499168|NCT02073929|528329790|FG001|Overall Study|Withdrawal by Subject|1|||
146499169|NCT01483027|528329791|FG000|Overall Study|Administrative Reasons|2|||
146499170|NCT01483027|528329792|FG001|Overall Study|Administrative Reasons|1|||
146499171|NCT01483027|528329791|FG000|Overall Study|Withdrawal by Subject|21|||
146499172|NCT01483027|528329792|FG001|Overall Study|Withdrawal by Subject|32|||
146565924|NCT00565409|528584290|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
146565925|NCT00565409|528584291|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
146565926|NCT00565409|528584288|FG000|Period 1 Open Label|no conclusion of participation record|1|||
146565927|NCT00565409|528584289|FG001|Period 1 Open Label|no conclusion of participation record|0|||
146565928|NCT00565409|528584290|FG002|Period 1 Open Label|no conclusion of participation record|0|||
146769024|NCT00324038|529321829|FG000|Overall Study|Lost to Follow-up|0|||
146499173|NCT01483027|528329791|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
146499174|NCT01483027|528329792|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
146499175|NCT01483027|528329791|FG000|Overall Study|Lost to Follow-up|1|||
146499176|NCT01483027|528329792|FG001|Overall Study|Lost to Follow-up|1|||
146499177|NCT01483027|528329791|FG000|Overall Study|Adverse Event|0|||
146499178|NCT01483027|528329792|FG001|Overall Study|Adverse Event|1|||
146499179|NCT01483027|528329791|FG000|Overall Study|Withdrawal by Subject|0|||
146499180|NCT01483027|528329792|FG001|Overall Study|Withdrawal by Subject|1|||
146499181|NCT01314872|528329795|FG000|Treatment Period 1|Protocol Violation|2|||
146499182|NCT01314872|528329796|FG001|Treatment Period 1|Protocol Violation|1|||
146499183|NCT01314872|528329797|FG002|Treatment Period 1|Protocol Violation|1|||
146499184|NCT01314872|528329798|FG003|Treatment Period 1|Protocol Violation|0|||
146499185|NCT01314872|528329799|FG004|Treatment Period 1|Protocol Violation|1|||
146499186|NCT01314872|528329800|FG005|Treatment Period 1|Protocol Violation|0|||
146499187|NCT01314872|528329801|FG006|Treatment Period 1|Protocol Violation|0|||
146499188|NCT01314872|528329802|FG007|Treatment Period 1|Protocol Violation|0|||
146499189|NCT01314872|528329803|FG008|Treatment Period 1|Protocol Violation|0|||
146499190|NCT01314872|528329804|FG009|Treatment Period 1|Protocol Violation|1|||
146499191|NCT01314872|528329805|FG010|Treatment Period 1|Protocol Violation|1|||
146499192|NCT01314872|528329806|FG011|Treatment Period 1|Protocol Violation|0|||
146499193|NCT01314872|528329807|FG012|Treatment Period 1|Protocol Violation|0|||
146499194|NCT01314872|528329808|FG013|Treatment Period 1|Protocol Violation|0|||
146499195|NCT01314872|528329809|FG014|Treatment Period 1|Protocol Violation|0|||
146499196|NCT01314872|528329795|FG000|Treatment Period 1|Physician Decision|0|||
146499197|NCT01314872|528329796|FG001|Treatment Period 1|Physician Decision|1|||
146499198|NCT01314872|528329797|FG002|Treatment Period 1|Physician Decision|0|||
146499199|NCT01314872|528329798|FG003|Treatment Period 1|Physician Decision|1|||
146499200|NCT01314872|528329799|FG004|Treatment Period 1|Physician Decision|0|||
146499201|NCT01314872|528329800|FG005|Treatment Period 1|Physician Decision|0|||
146499202|NCT01314872|528329801|FG006|Treatment Period 1|Physician Decision|0|||
146499203|NCT01314872|528329802|FG007|Treatment Period 1|Physician Decision|0|||
146499204|NCT01314872|528329803|FG008|Treatment Period 1|Physician Decision|0|||
146499205|NCT01314872|528329804|FG009|Treatment Period 1|Physician Decision|1|||
146499206|NCT01314872|528329805|FG010|Treatment Period 1|Physician Decision|0|||
146499207|NCT01314872|528329806|FG011|Treatment Period 1|Physician Decision|0|||
146499208|NCT01314872|528329807|FG012|Treatment Period 1|Physician Decision|0|||
146499209|NCT01314872|528329808|FG013|Treatment Period 1|Physician Decision|0|||
146499210|NCT01314872|528329809|FG014|Treatment Period 1|Physician Decision|0|||
146499211|NCT01314872|528329795|FG000|Treatment Period 1|Lack of Efficacy|1|||
146499212|NCT01314872|528329796|FG001|Treatment Period 1|Lack of Efficacy|0|||
146499213|NCT01314872|528329797|FG002|Treatment Period 1|Lack of Efficacy|0|||
146499214|NCT01314872|528329798|FG003|Treatment Period 1|Lack of Efficacy|0|||
146499215|NCT01314872|528329799|FG004|Treatment Period 1|Lack of Efficacy|0|||
146499216|NCT01314872|528329800|FG005|Treatment Period 1|Lack of Efficacy|1|||
146499217|NCT01314872|528329801|FG006|Treatment Period 1|Lack of Efficacy|0|||
146499218|NCT01314872|528329802|FG007|Treatment Period 1|Lack of Efficacy|2|||
146499219|NCT01314872|528329803|FG008|Treatment Period 1|Lack of Efficacy|0|||
146499220|NCT01314872|528329804|FG009|Treatment Period 1|Lack of Efficacy|0|||
146499221|NCT01314872|528329805|FG010|Treatment Period 1|Lack of Efficacy|0|||
146499222|NCT01314872|528329806|FG011|Treatment Period 1|Lack of Efficacy|0|||
146499223|NCT01314872|528329807|FG012|Treatment Period 1|Lack of Efficacy|0|||
146499224|NCT01314872|528329808|FG013|Treatment Period 1|Lack of Efficacy|0|||
146499225|NCT01314872|528329809|FG014|Treatment Period 1|Lack of Efficacy|0|||
146499226|NCT01314872|528329795|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
146499227|NCT01314872|528329796|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
146499228|NCT01314872|528329797|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
146499229|NCT01314872|528329798|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
146499230|NCT01314872|528329799|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
146499231|NCT01314872|528329800|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
146499232|NCT01314872|528329801|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
146499233|NCT01314872|528329802|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
146499234|NCT01314872|528329803|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
146499235|NCT01314872|528329804|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
146499236|NCT01314872|528329805|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
146499237|NCT01314872|528329806|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
146499238|NCT01314872|528329807|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
146499239|NCT01314872|528329808|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
146499240|NCT01314872|528329809|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
146499241|NCT01314872|528329795|FG000|Treatment Period 1|Withdrawal by Subject|3|||
146499242|NCT01314872|528329796|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146499243|NCT01314872|528329797|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146565929|NCT00565409|528584291|FG003|Period 1 Open Label|no conclusion of participation record|0|||
146565930|NCT00565409|528584288|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
146565931|NCT00565409|528584289|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
146565932|NCT00565409|528584290|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
146565933|NCT00565409|528584291|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
146565934|NCT00565409|528584288|FG000|Period 2 Double-Blind|Adverse Event|0|||
146499244|NCT01314872|528329798|FG003|Treatment Period 1|Withdrawal by Subject|2|||
146499245|NCT01314872|528329799|FG004|Treatment Period 1|Withdrawal by Subject|3|||
146565935|NCT00565409|528584289|FG001|Period 2 Double-Blind|Adverse Event|7|||
146565936|NCT00565409|528584290|FG002|Period 2 Double-Blind|Adverse Event|4|||
146565937|NCT00565409|528584291|FG003|Period 2 Double-Blind|Adverse Event|5|||
146565938|NCT00565409|528584288|FG000|Period 2 Double-Blind|Death|0|||
146565939|NCT00565409|528584289|FG001|Period 2 Double-Blind|Death|2|||
146973157|NCT00902265|530063881|FG000|Overall Study|Adverse Event|2|||
146499246|NCT01314872|528329800|FG005|Treatment Period 1|Withdrawal by Subject|1|||
146499247|NCT01314872|528329801|FG006|Treatment Period 1|Withdrawal by Subject|3|||
146499248|NCT01314872|528329802|FG007|Treatment Period 1|Withdrawal by Subject|2|||
146499249|NCT01314872|528329803|FG008|Treatment Period 1|Withdrawal by Subject|2|||
146499250|NCT01314872|528329804|FG009|Treatment Period 1|Withdrawal by Subject|2|||
146499251|NCT01314872|528329805|FG010|Treatment Period 1|Withdrawal by Subject|1|||
146499252|NCT01314872|528329806|FG011|Treatment Period 1|Withdrawal by Subject|0|||
146499253|NCT01314872|528329807|FG012|Treatment Period 1|Withdrawal by Subject|0|||
146499254|NCT01314872|528329808|FG013|Treatment Period 1|Withdrawal by Subject|0|||
146499255|NCT01314872|528329809|FG014|Treatment Period 1|Withdrawal by Subject|0|||
146499256|NCT01314872|528329795|FG000|Treatment Period 1|Lost to Follow-up|0|||
146499257|NCT01314872|528329796|FG001|Treatment Period 1|Lost to Follow-up|1|||
146499258|NCT01314872|528329797|FG002|Treatment Period 1|Lost to Follow-up|2|||
146499259|NCT01314872|528329798|FG003|Treatment Period 1|Lost to Follow-up|2|||
146499260|NCT01314872|528329799|FG004|Treatment Period 1|Lost to Follow-up|1|||
146499261|NCT01314872|528329800|FG005|Treatment Period 1|Lost to Follow-up|1|||
146499262|NCT01314872|528329801|FG006|Treatment Period 1|Lost to Follow-up|1|||
146499263|NCT01314872|528329802|FG007|Treatment Period 1|Lost to Follow-up|1|||
146499264|NCT01314872|528329803|FG008|Treatment Period 1|Lost to Follow-up|1|||
146499265|NCT01314872|528329804|FG009|Treatment Period 1|Lost to Follow-up|0|||
146499266|NCT01314872|528329805|FG010|Treatment Period 1|Lost to Follow-up|0|||
146499267|NCT01314872|528329806|FG011|Treatment Period 1|Lost to Follow-up|0|||
146499268|NCT01314872|528329807|FG012|Treatment Period 1|Lost to Follow-up|0|||
146499269|NCT01314872|528329808|FG013|Treatment Period 1|Lost to Follow-up|0|||
146499270|NCT01314872|528329809|FG014|Treatment Period 1|Lost to Follow-up|0|||
146499271|NCT01314872|528329795|FG000|Period 2|Protocol Violation|0|||
146499272|NCT01314872|528329796|FG001|Period 2|Protocol Violation|0|||
146499273|NCT01314872|528329797|FG002|Period 2|Protocol Violation|0|||
146499274|NCT01314872|528329798|FG003|Period 2|Protocol Violation|0|||
146499275|NCT01314872|528329799|FG004|Period 2|Protocol Violation|0|||
146499276|NCT01314872|528329800|FG005|Period 2|Protocol Violation|0|||
146499277|NCT01314872|528329801|FG006|Period 2|Protocol Violation|0|||
146499278|NCT01314872|528329802|FG007|Period 2|Protocol Violation|0|||
146499279|NCT01314872|528329803|FG008|Period 2|Protocol Violation|0|||
146499280|NCT01314872|528329804|FG009|Period 2|Protocol Violation|0|||
146499281|NCT01314872|528329805|FG010|Period 2|Protocol Violation|0|||
146499282|NCT01314872|528329806|FG011|Period 2|Protocol Violation|3|||
146499283|NCT01314872|528329807|FG012|Period 2|Protocol Violation|3|||
146499284|NCT01314872|528329808|FG013|Period 2|Protocol Violation|2|||
146499285|NCT01314872|528329809|FG014|Period 2|Protocol Violation|0|||
146499286|NCT01314872|528329795|FG000|Period 2|Non-compliance with study drug|0|||
146499287|NCT01314872|528329796|FG001|Period 2|Non-compliance with study drug|0|||
146499288|NCT01314872|528329797|FG002|Period 2|Non-compliance with study drug|0|||
146499289|NCT01314872|528329798|FG003|Period 2|Non-compliance with study drug|0|||
146499290|NCT01314872|528329799|FG004|Period 2|Non-compliance with study drug|0|||
146499291|NCT01314872|528329800|FG005|Period 2|Non-compliance with study drug|0|||
146973158|NCT00902265|530063881|FG000|Overall Study|Lack of Efficacy|2|||
146973159|NCT00902265|530063881|FG000|Overall Study|Protocol Violation|1|||
146973160|NCT02866695|530063884|FG000|Overall Study|Adverse Event|1|||
146973161|NCT02866695|530063884|FG000|Overall Study|Lost to Follow-up|1|||
146499292|NCT01314872|528329801|FG006|Period 2|Non-compliance with study drug|0|||
146499293|NCT01314872|528329802|FG007|Period 2|Non-compliance with study drug|0|||
146499294|NCT01314872|528329803|FG008|Period 2|Non-compliance with study drug|0|||
146973162|NCT05016765|530063885|FG000|Overall Study|Lost to Follow-up|4|||
146973163|NCT03747939|530063886|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
146973164|NCT03747939|530063887|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
146973165|NCT03747939|530063888|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
146499295|NCT01314872|528329804|FG009|Period 2|Non-compliance with study drug|0|||
146499296|NCT01314872|528329805|FG010|Period 2|Non-compliance with study drug|0|||
146499297|NCT01314872|528329806|FG011|Period 2|Non-compliance with study drug|3|||
146499298|NCT01314872|528329807|FG012|Period 2|Non-compliance with study drug|3|||
146499299|NCT01314872|528329808|FG013|Period 2|Non-compliance with study drug|1|||
146973166|NCT03747939|530063889|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
146973167|NCT03747939|530063886|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
146499300|NCT01314872|528329809|FG014|Period 2|Non-compliance with study drug|2|||
146499301|NCT01314872|528329795|FG000|Period 2|Lack of Efficacy|0|||
146499302|NCT01314872|528329796|FG001|Period 2|Lack of Efficacy|0|||
146499303|NCT01314872|528329797|FG002|Period 2|Lack of Efficacy|0|||
146499304|NCT01314872|528329798|FG003|Period 2|Lack of Efficacy|0|||
146499305|NCT01314872|528329799|FG004|Period 2|Lack of Efficacy|0|||
146499306|NCT01314872|528329800|FG005|Period 2|Lack of Efficacy|0|||
146973168|NCT03747939|530063887|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
146973169|NCT03747939|530063888|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
146973170|NCT03747939|530063889|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
146973171|NCT03747939|530063886|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
146973172|NCT03747939|530063887|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
146973173|NCT03747939|530063888|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
146973174|NCT03747939|530063889|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
146973175|NCT03747939|530063886|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
146973176|NCT03747939|530063887|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
146973177|NCT03747939|530063888|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
146973178|NCT03747939|530063889|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
146973179|NCT03747939|530063886|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
146973180|NCT03747939|530063887|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
146973181|NCT03747939|530063888|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
146973182|NCT03747939|530063889|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
146973183|NCT03747939|530063886|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
146973184|NCT03747939|530063887|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
146973185|NCT03747939|530063888|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
146973186|NCT03747939|530063889|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
146499307|NCT01314872|528329801|FG006|Period 2|Lack of Efficacy|0|||
146499308|NCT01314872|528329802|FG007|Period 2|Lack of Efficacy|0|||
146499309|NCT01314872|528329803|FG008|Period 2|Lack of Efficacy|0|||
146499310|NCT01314872|528329804|FG009|Period 2|Lack of Efficacy|0|||
146499311|NCT01314872|528329805|FG010|Period 2|Lack of Efficacy|0|||
146499312|NCT01314872|528329806|FG011|Period 2|Lack of Efficacy|7|||
146499313|NCT01314872|528329807|FG012|Period 2|Lack of Efficacy|12|||
146565940|NCT00565409|528584290|FG002|Period 2 Double-Blind|Death|0|||
146565941|NCT00565409|528584291|FG003|Period 2 Double-Blind|Death|0|||
146565942|NCT00565409|528584288|FG000|Period 2 Double-Blind|Protocol Violation|0|||
146565943|NCT00565409|528584289|FG001|Period 2 Double-Blind|Protocol Violation|4|||
146565944|NCT00565409|528584290|FG002|Period 2 Double-Blind|Protocol Violation|6|||
146565945|NCT00565409|528584291|FG003|Period 2 Double-Blind|Protocol Violation|2|||
146565946|NCT00565409|528584288|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
146565947|NCT00565409|528584289|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
146565948|NCT00565409|528584290|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
146565949|NCT00565409|528584291|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
146565950|NCT00565409|528584288|FG000|Period 2 Double-Blind|Other|0|||
146565951|NCT00565409|528584289|FG001|Period 2 Double-Blind|Other|4|||
146565952|NCT00565409|528584290|FG002|Period 2 Double-Blind|Other|5|||
146565953|NCT00565409|528584291|FG003|Period 2 Double-Blind|Other|9|||
146565954|NCT00565409|528584288|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
146565955|NCT00565409|528584289|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
146565956|NCT00565409|528584290|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
146565957|NCT00565409|528584291|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
146565958|NCT02284191|528584295|FG000|Overall Study|Withdrawal by Subject|1|||
146565959|NCT02284191|528584296|FG001|Overall Study|Withdrawal by Subject|3|||
146565960|NCT02284191|528584295|FG000|Overall Study|Lost to Follow-up|1|||
146565961|NCT02284191|528584296|FG001|Overall Study|Lost to Follow-up|0|||
146565962|NCT02257684|528584299|FG000|Overall Study|Adverse Event|2|||
146565963|NCT02257684|528584299|FG000|Overall Study|Lack of Efficacy|1|||
146565964|NCT02257684|528584299|FG000|Overall Study|Sponsor's Decision|1|||
146565965|NCT01570387|528584300|FG000|Overall Study|Adverse Event|1|||
146565966|NCT01570387|528584301|FG001|Overall Study|Adverse Event|0|||
146565967|NCT01570387|528584302|FG002|Overall Study|Adverse Event|0|||
146565968|NCT01570387|528584303|FG003|Overall Study|Adverse Event|0|||
146565969|NCT01570387|528584300|FG000|Overall Study|Death|0|||
146565970|NCT01570387|528584301|FG001|Overall Study|Death|0|||
146565971|NCT01570387|528584302|FG002|Overall Study|Death|0|||
146565972|NCT01570387|528584303|FG003|Overall Study|Death|1|||
146565973|NCT01570387|528584300|FG000|Overall Study|Withdrawal by Subject|0|||
146565974|NCT01570387|528584301|FG001|Overall Study|Withdrawal by Subject|0|||
146565975|NCT01570387|528584302|FG002|Overall Study|Withdrawal by Subject|0|||
146645951|NCT00600119|528881568|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
146499314|NCT01314872|528329808|FG013|Period 2|Lack of Efficacy|9|||
146499315|NCT01314872|528329809|FG014|Period 2|Lack of Efficacy|2|||
146499316|NCT01314872|528329795|FG000|Period 2|Pregnancy|0|||
146769025|NCT00324038|529321830|FG001|Overall Study|Lost to Follow-up|2|||
146912444|NCT01318902|529841510|FG002|Overall Study|Adverse Event|0|||
146645952|NCT00600119|528881569|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
146645953|NCT00600119|528881570|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
146645954|NCT00600119|528881571|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
146645955|NCT00600119|528881566|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
146645956|NCT00600119|528881567|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
146645957|NCT00600119|528881568|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146645958|NCT00600119|528881569|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
146645959|NCT00600119|528881570|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
146645960|NCT00600119|528881571|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
146645961|NCT00600119|528881566|FG000|Double-blind Treatment Period|Other|0|||
146645962|NCT00600119|528881567|FG001|Double-blind Treatment Period|Other|0|||
146645963|NCT00600119|528881568|FG002|Double-blind Treatment Period|Other|0|||
146645964|NCT00600119|528881569|FG003|Double-blind Treatment Period|Other|0|||
146645965|NCT00600119|528881570|FG004|Double-blind Treatment Period|Other|2|||
146645966|NCT00600119|528881571|FG005|Double-blind Treatment Period|Other|1|||
146645967|NCT00600119|528881566|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
146645968|NCT00600119|528881567|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
146645969|NCT00600119|528881568|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
146645970|NCT00600119|528881569|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
146645971|NCT00600119|528881570|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
146645972|NCT00600119|528881571|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
146645973|NCT00600119|528881566|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
146645974|NCT00600119|528881567|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
146645975|NCT00600119|528881568|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
146645976|NCT00600119|528881569|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
146645977|NCT00600119|528881570|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
146645978|NCT00600119|528881571|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
146645979|NCT00600119|528881566|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
146645980|NCT00600119|528881567|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
146645981|NCT00600119|528881568|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
146645982|NCT00600119|528881569|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
146645983|NCT00600119|528881570|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
146645984|NCT00600119|528881571|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
146645985|NCT00600119|528881566|FG000|Double-blind Treatment Period|Physician Decision|2|||
146645986|NCT00600119|528881567|FG001|Double-blind Treatment Period|Physician Decision|0|||
146645987|NCT00600119|528881568|FG002|Double-blind Treatment Period|Physician Decision|0|||
146645988|NCT00600119|528881569|FG003|Double-blind Treatment Period|Physician Decision|0|||
146645989|NCT00600119|528881570|FG004|Double-blind Treatment Period|Physician Decision|0|||
146645990|NCT00600119|528881571|FG005|Double-blind Treatment Period|Physician Decision|0|||
146645991|NCT00600119|528881566|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
146645992|NCT00600119|528881567|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
146645993|NCT00600119|528881568|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
146645994|NCT00600119|528881569|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
146645995|NCT00600119|528881570|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
146645996|NCT00600119|528881571|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
146645997|NCT00600119|528881566|FG000|Double-blind Treatment Period|Adverse Event|1|||
146645998|NCT00600119|528881567|FG001|Double-blind Treatment Period|Adverse Event|1|||
146645999|NCT00600119|528881568|FG002|Double-blind Treatment Period|Adverse Event|0|||
146646000|NCT00600119|528881569|FG003|Double-blind Treatment Period|Adverse Event|1|||
146646001|NCT00600119|528881570|FG004|Double-blind Treatment Period|Adverse Event|2|||
146646002|NCT00600119|528881571|FG005|Double-blind Treatment Period|Adverse Event|10|||
146646003|NCT00600119|528881566|FG000|Follow-up Period|Adverse Event|0|||
146646004|NCT00600119|528881567|FG001|Follow-up Period|Adverse Event|0|||
146646005|NCT00600119|528881568|FG002|Follow-up Period|Adverse Event|0|||
146646006|NCT00600119|528881569|FG003|Follow-up Period|Adverse Event|0|||
146646007|NCT00600119|528881570|FG004|Follow-up Period|Adverse Event|0|||
146646008|NCT00600119|528881571|FG005|Follow-up Period|Adverse Event|1|||
146646009|NCT00600119|528881566|FG000|Follow-up Period|Other|1|||
146646010|NCT00600119|528881567|FG001|Follow-up Period|Other|0|||
146646011|NCT00600119|528881568|FG002|Follow-up Period|Other|0|||
146646012|NCT00600119|528881569|FG003|Follow-up Period|Other|0|||
146646013|NCT00600119|528881570|FG004|Follow-up Period|Other|0|||
146646014|NCT00600119|528881571|FG005|Follow-up Period|Other|0|||
146646015|NCT01616693|528881572|FG000|Evaluated for Safety|Physician Decision|1|||
146646016|NCT01616693|528881573|FG001|Evaluated for Safety|Physician Decision|0|||
146646017|NCT01616693|528881574|FG002|Evaluated for Safety|Physician Decision|1|||
146646018|NCT01616693|528881575|FG003|Evaluated for Safety|Physician Decision|0|||
146646019|NCT01616693|528881572|FG000|Received Both Vaccines|Adverse Event|2|||
146973187|NCT03747939|530063886|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
146973188|NCT03747939|530063887|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
146973189|NCT03747939|530063888|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
146973190|NCT03747939|530063889|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
146973191|NCT03747939|530063886|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
146973192|NCT03747939|530063887|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
146973193|NCT03747939|530063888|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
146973194|NCT03747939|530063889|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
146973195|NCT03747939|530063886|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
146973196|NCT03747939|530063887|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
146973197|NCT03747939|530063888|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
146973198|NCT03747939|530063889|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
146973199|NCT03747939|530063886|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
146973200|NCT03747939|530063887|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
146646020|NCT01616693|528881573|FG001|Received Both Vaccines|Adverse Event|0|||
146646021|NCT01616693|528881574|FG002|Received Both Vaccines|Adverse Event|0|||
146646022|NCT01616693|528881575|FG003|Received Both Vaccines|Adverse Event|0|||
146646023|NCT01616693|528881572|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
146646024|NCT01616693|528881573|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
146646025|NCT01616693|528881574|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
146646026|NCT01616693|528881575|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
146646027|NCT01616693|528881572|FG000|Received Both Vaccines|Lost to Follow-up|4|||
146646028|NCT01616693|528881573|FG001|Received Both Vaccines|Lost to Follow-up|3|||
146646029|NCT01616693|528881574|FG002|Received Both Vaccines|Lost to Follow-up|4|||
146646030|NCT01616693|528881575|FG003|Received Both Vaccines|Lost to Follow-up|4|||
146646031|NCT01616693|528881572|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
146646032|NCT01616693|528881573|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
146646033|NCT01616693|528881574|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
146646034|NCT01616693|528881575|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
146646035|NCT01950013|528881576|FG000|Overall Study|Withdrawal by Subject|0|||
146646036|NCT01950013|528881577|FG001|Overall Study|Withdrawal by Subject|2|||
146646037|NCT01950013|528881578|FG002|Overall Study|Withdrawal by Subject|0|||
146646038|NCT00271505|528881582|FG000|Overall Study|Screen Failure|3|||
146646039|NCT00271505|528881582|FG000|Overall Study|Adverse Event|1|||
146646040|NCT00271505|528881582|FG000|Overall Study|Death|1|||
146646041|NCT00539188|528881583|FG000|Overall Study|Withdrawal by Subject|1|||
146646042|NCT00539188|528881584|FG001|Overall Study|Withdrawal by Subject|0|||
146646043|NCT00539188|528881583|FG000|Overall Study|Lost to Follow-up|2|||
146646044|NCT00539188|528881584|FG001|Overall Study|Lost to Follow-up|1|||
146646045|NCT04784442|528881585|FG000|Overall Study|Adverse Event|1|||
146646046|NCT04784442|528881586|FG001|Overall Study|Adverse Event|0|||
146646047|NCT04784442|528881587|FG002|Overall Study|Adverse Event|2|||
146646048|NCT04784442|528881588|FG003|Overall Study|Adverse Event|1|||
146646049|NCT04784442|528881585|FG000|Overall Study|Protocol Violation|1|||
146646050|NCT04784442|528881586|FG001|Overall Study|Protocol Violation|0|||
146646051|NCT04784442|528881587|FG002|Overall Study|Protocol Violation|0|||
146646052|NCT04784442|528881588|FG003|Overall Study|Protocol Violation|0|||
146646053|NCT04784442|528881585|FG000|Overall Study|Non-compliance with study drug|1|||
146646054|NCT04784442|528881586|FG001|Overall Study|Non-compliance with study drug|0|||
146646055|NCT04784442|528881587|FG002|Overall Study|Non-compliance with study drug|0|||
146646056|NCT04784442|528881588|FG003|Overall Study|Non-compliance with study drug|0|||
146646057|NCT00486811|528881591|FG000|Overall Study|Adverse Event|28|||
146646058|NCT00486811|528881592|FG001|Overall Study|Adverse Event|60|||
146646059|NCT00486811|528881593|FG002|Overall Study|Adverse Event|135|||
146646060|NCT00486811|528881591|FG000|Overall Study|Lack of Efficacy|34|||
146646061|NCT00486811|528881592|FG001|Overall Study|Lack of Efficacy|14|||
146973201|NCT03747939|530063888|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
146973202|NCT03747939|530063889|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
146973203|NCT03747939|530063886|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
146499317|NCT01314872|528329796|FG001|Period 2|Pregnancy|0|||
146499318|NCT01314872|528329797|FG002|Period 2|Pregnancy|0|||
146499319|NCT01314872|528329798|FG003|Period 2|Pregnancy|0|||
146499320|NCT01314872|528329799|FG004|Period 2|Pregnancy|0|||
146646062|NCT00486811|528881593|FG002|Overall Study|Lack of Efficacy|7|||
146646063|NCT00486811|528881591|FG000|Overall Study|Lost to Follow-up|4|||
146646064|NCT00486811|528881592|FG001|Overall Study|Lost to Follow-up|6|||
146646065|NCT00486811|528881593|FG002|Overall Study|Lost to Follow-up|4|||
146646066|NCT00486811|528881591|FG000|Overall Study|Withdrawal by Subject|33|||
146646067|NCT00486811|528881592|FG001|Overall Study|Withdrawal by Subject|44|||
146646068|NCT00486811|528881593|FG002|Overall Study|Withdrawal by Subject|58|||
146646069|NCT00486811|528881591|FG000|Overall Study|Study drug non-compliant|5|||
146646070|NCT00486811|528881592|FG001|Overall Study|Study drug non-compliant|6|||
146646071|NCT00486811|528881593|FG002|Overall Study|Study drug non-compliant|3|||
146646072|NCT00486811|528881591|FG000|Overall Study|All other|18|||
146646073|NCT00486811|528881592|FG001|Overall Study|All other|11|||
146646074|NCT00486811|528881593|FG002|Overall Study|All other|7|||
146646075|NCT00852371|528881597|FG000|Overall Study|Lost to Follow-up|2|||
146646076|NCT00852371|528881598|FG001|Overall Study|Lost to Follow-up|3|||
146646077|NCT00852371|528881599|FG002|Overall Study|Lost to Follow-up|4|||
146646078|NCT00852371|528881600|FG003|Overall Study|Lost to Follow-up|2|||
146646079|NCT02756806|528881601|FG000|Overall Study|Study terminated early|5|||
146646080|NCT03158285|528881602|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
146646081|NCT03158285|528881603|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
146646082|NCT03158285|528881604|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
146646083|NCT03158285|528881602|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
146646084|NCT03158285|528881603|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
146646085|NCT03158285|528881604|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
146646086|NCT03158285|528881602|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
146646087|NCT03158285|528881603|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
146646088|NCT03158285|528881604|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
146646089|NCT03158285|528881602|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
146646090|NCT03158285|528881603|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
146646091|NCT03158285|528881604|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
146646092|NCT03158285|528881602|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
146646093|NCT03158285|528881603|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
146646094|NCT03158285|528881604|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
146646095|NCT03158285|528881602|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
146646096|NCT03158285|528881603|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
146646097|NCT03158285|528881604|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
146646098|NCT03158285|528881602|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
146646099|NCT03158285|528881603|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
146646100|NCT03158285|528881604|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
146646101|NCT03158285|528881602|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
146646102|NCT03158285|528881603|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
146646103|NCT03158285|528881604|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
146646104|NCT03158285|528881602|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
146646105|NCT03158285|528881603|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
146646106|NCT03158285|528881604|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
146646107|NCT03158285|528881602|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
146646108|NCT03158285|528881603|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
146646109|NCT03158285|528881604|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
146646110|NCT03158285|528881602|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
146646111|NCT03158285|528881603|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
146646112|NCT03158285|528881604|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
146646113|NCT03158285|528881602|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
146646114|NCT03158285|528881603|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
146646115|NCT03158285|528881604|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
146646116|NCT03158285|528881602|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
146646117|NCT03158285|528881603|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
146646118|NCT03158285|528881604|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
146646119|NCT03158285|528881602|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
146646120|NCT03158285|528881603|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
146646121|NCT03158285|528881604|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
146646122|NCT03158285|528881602|FG000|Active Treatment Period: Week 52-100|Death|1|||
146646123|NCT03158285|528881603|FG001|Active Treatment Period: Week 52-100|Death|0|||
146646124|NCT03158285|528881604|FG002|Active Treatment Period: Week 52-100|Death|0|||
146646125|NCT03158285|528881602|FG000|Active Treatment Period: Week 52-100|Other|4|||
146646126|NCT03158285|528881603|FG001|Active Treatment Period: Week 52-100|Other|1|||
146646127|NCT03158285|528881604|FG002|Active Treatment Period: Week 52-100|Other|0|||
146646128|NCT01008423|528881607|FG000|Overall Study|Adverse Event|13|||
146646129|NCT01008423|528881608|FG001|Overall Study|Adverse Event|6|||
146646130|NCT01008423|528881607|FG000|Overall Study|Withdrawal by Subject|4|||
146646131|NCT01008423|528881608|FG001|Overall Study|Withdrawal by Subject|7|||
146646132|NCT01008423|528881607|FG000|Overall Study|Lost to Follow-up|0|||
146646133|NCT01008423|528881608|FG001|Overall Study|Lost to Follow-up|2|||
146646134|NCT01008423|528881607|FG000|Overall Study|Low Cortisol|0|||
146646135|NCT01008423|528881608|FG001|Overall Study|Low Cortisol|1|||
146646136|NCT01008423|528881607|FG000|Overall Study|Lack of Efficacy|0|||
146646137|NCT01008423|528881608|FG001|Overall Study|Lack of Efficacy|5|||
146646138|NCT01008423|528881607|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
146646139|NCT01008423|528881608|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
146769026|NCT00324038|529321829|FG000|Overall Study|Other|6|||
146499321|NCT01314872|528329800|FG005|Period 2|Pregnancy|0|||
146499322|NCT01314872|528329801|FG006|Period 2|Pregnancy|0|||
146499323|NCT01314872|528329802|FG007|Period 2|Pregnancy|0|||
146499324|NCT01314872|528329803|FG008|Period 2|Pregnancy|0|||
146499325|NCT01314872|528329804|FG009|Period 2|Pregnancy|0|||
146499326|NCT01314872|528329805|FG010|Period 2|Pregnancy|0|||
146499327|NCT01314872|528329806|FG011|Period 2|Pregnancy|0|||
146499328|NCT01314872|528329807|FG012|Period 2|Pregnancy|0|||
146499329|NCT01314872|528329808|FG013|Period 2|Pregnancy|0|||
146499330|NCT01314872|528329809|FG014|Period 2|Pregnancy|1|||
146499331|NCT01314872|528329795|FG000|Period 2|Study terminated by Sponsor|0|||
146499332|NCT01314872|528329796|FG001|Period 2|Study terminated by Sponsor|0|||
146499333|NCT01314872|528329797|FG002|Period 2|Study terminated by Sponsor|0|||
146499334|NCT01314872|528329798|FG003|Period 2|Study terminated by Sponsor|0|||
146499335|NCT01314872|528329799|FG004|Period 2|Study terminated by Sponsor|0|||
146499336|NCT01314872|528329800|FG005|Period 2|Study terminated by Sponsor|0|||
146499337|NCT01314872|528329801|FG006|Period 2|Study terminated by Sponsor|0|||
146499338|NCT01314872|528329802|FG007|Period 2|Study terminated by Sponsor|0|||
146499339|NCT01314872|528329803|FG008|Period 2|Study terminated by Sponsor|0|||
146499340|NCT01314872|528329804|FG009|Period 2|Study terminated by Sponsor|0|||
146499341|NCT01314872|528329805|FG010|Period 2|Study terminated by Sponsor|0|||
146499342|NCT01314872|528329806|FG011|Period 2|Study terminated by Sponsor|2|||
146499343|NCT01314872|528329807|FG012|Period 2|Study terminated by Sponsor|2|||
146499344|NCT01314872|528329808|FG013|Period 2|Study terminated by Sponsor|3|||
146499345|NCT01314872|528329809|FG014|Period 2|Study terminated by Sponsor|0|||
146499346|NCT01314872|528329795|FG000|Period 2|Adverse event, non-fatal|0|||
146499347|NCT01314872|528329796|FG001|Period 2|Adverse event, non-fatal|0|||
146499348|NCT01314872|528329797|FG002|Period 2|Adverse event, non-fatal|0|||
146499349|NCT01314872|528329798|FG003|Period 2|Adverse event, non-fatal|0|||
146499350|NCT01314872|528329799|FG004|Period 2|Adverse event, non-fatal|0|||
146499351|NCT01314872|528329800|FG005|Period 2|Adverse event, non-fatal|0|||
146499352|NCT01314872|528329801|FG006|Period 2|Adverse event, non-fatal|0|||
146499353|NCT01314872|528329802|FG007|Period 2|Adverse event, non-fatal|0|||
146499354|NCT01314872|528329803|FG008|Period 2|Adverse event, non-fatal|0|||
146499355|NCT01314872|528329804|FG009|Period 2|Adverse event, non-fatal|0|||
146499356|NCT01314872|528329805|FG010|Period 2|Adverse event, non-fatal|0|||
146499357|NCT01314872|528329806|FG011|Period 2|Adverse event, non-fatal|13|||
146499358|NCT01314872|528329807|FG012|Period 2|Adverse event, non-fatal|16|||
146499359|NCT01314872|528329808|FG013|Period 2|Adverse event, non-fatal|24|||
146499360|NCT01314872|528329809|FG014|Period 2|Adverse event, non-fatal|9|||
146499361|NCT01314872|528329795|FG000|Period 2|Withdrawal by Subject|0|||
146499362|NCT01314872|528329796|FG001|Period 2|Withdrawal by Subject|0|||
146499363|NCT01314872|528329797|FG002|Period 2|Withdrawal by Subject|0|||
146499364|NCT01314872|528329798|FG003|Period 2|Withdrawal by Subject|0|||
146499365|NCT01314872|528329799|FG004|Period 2|Withdrawal by Subject|0|||
146499366|NCT01314872|528329800|FG005|Period 2|Withdrawal by Subject|0|||
146499367|NCT01314872|528329801|FG006|Period 2|Withdrawal by Subject|0|||
146499368|NCT01314872|528329802|FG007|Period 2|Withdrawal by Subject|0|||
146499369|NCT01314872|528329803|FG008|Period 2|Withdrawal by Subject|0|||
146499370|NCT01314872|528329804|FG009|Period 2|Withdrawal by Subject|0|||
146646140|NCT01008423|528881607|FG000|Overall Study|Personal Conflict|1|||
146769027|NCT00324038|529321830|FG001|Overall Study|Other|13|||
146646141|NCT01008423|528881608|FG001|Overall Study|Personal Conflict|0|||
146646142|NCT01008423|528881607|FG000|Overall Study|Other|0|||
146646143|NCT01008423|528881608|FG001|Overall Study|Other|1|||
146646144|NCT00946153|528881614|FG000|Phase 2|Adverse Event|0|||
146646145|NCT00946153|528881615|FG001|Phase 2|Adverse Event|0|||
146646146|NCT00946153|528881616|FG002|Phase 2|Adverse Event|0|||
146646147|NCT00946153|528881617|FG003|Phase 2|Adverse Event|0|||
146646148|NCT00946153|528881618|FG004|Phase 2|Adverse Event|6|||
146646149|NCT00946153|528881614|FG000|Phase 2|Need more reduction of dose|0|||
146646150|NCT00946153|528881615|FG001|Phase 2|Need more reduction of dose|0|||
146646151|NCT00946153|528881616|FG002|Phase 2|Need more reduction of dose|0|||
146499371|NCT01314872|528329805|FG010|Period 2|Withdrawal by Subject|0|||
146499372|NCT01314872|528329806|FG011|Period 2|Withdrawal by Subject|14|||
146499373|NCT01314872|528329807|FG012|Period 2|Withdrawal by Subject|17|||
146499374|NCT01314872|528329808|FG013|Period 2|Withdrawal by Subject|12|||
146499375|NCT01314872|528329809|FG014|Period 2|Withdrawal by Subject|4|||
146499376|NCT01314872|528329795|FG000|Period 2|Lost to Follow-up|0|||
146499377|NCT01314872|528329796|FG001|Period 2|Lost to Follow-up|0|||
146499378|NCT01314872|528329797|FG002|Period 2|Lost to Follow-up|0|||
146499379|NCT01314872|528329798|FG003|Period 2|Lost to Follow-up|0|||
146499380|NCT01314872|528329799|FG004|Period 2|Lost to Follow-up|0|||
146499381|NCT01314872|528329800|FG005|Period 2|Lost to Follow-up|0|||
146499382|NCT01314872|528329801|FG006|Period 2|Lost to Follow-up|0|||
146499383|NCT01314872|528329802|FG007|Period 2|Lost to Follow-up|0|||
146499384|NCT01314872|528329803|FG008|Period 2|Lost to Follow-up|0|||
146499385|NCT01314872|528329804|FG009|Period 2|Lost to Follow-up|0|||
146499386|NCT01314872|528329805|FG010|Period 2|Lost to Follow-up|0|||
146646152|NCT00946153|528881617|FG003|Phase 2|Need more reduction of dose|0|||
146499387|NCT01314872|528329806|FG011|Period 2|Lost to Follow-up|6|||
146499388|NCT01314872|528329807|FG012|Period 2|Lost to Follow-up|7|||
146565976|NCT01570387|528584303|FG003|Overall Study|Withdrawal by Subject|1|||
146565977|NCT03323164|528584307|FG000|Overall Study|Poor quality imaging/scans|2|||
146769028|NCT03070483|529321831|FG000|Overall Study|Lost to Follow-up|2|||
146769029|NCT02031471|529321832|FG000|24 Week Treatment Period|Adverse Event|6|||
146769030|NCT02031471|529321832|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
146499389|NCT01314872|528329808|FG013|Period 2|Lost to Follow-up|2|||
146499390|NCT01314872|528329809|FG014|Period 2|Lost to Follow-up|6|||
146499391|NCT00679029|528331199|FG000|Overall Study|Adverse Event|3|||
146499392|NCT00679029|528331199|FG000|Overall Study|Withdrawal by Subject|1|||
146499393|NCT00679029|528331199|FG000|Overall Study|Lost to Follow-up|1|||
146499394|NCT00769067|528331203|FG000|Overall Study|Death|89|||
146499395|NCT00769067|528331204|FG001|Overall Study|Death|86|||
146499396|NCT00769067|528331203|FG000|Overall Study|Lost to Follow-up|3|||
146499397|NCT00769067|528331204|FG001|Overall Study|Lost to Follow-up|1|||
146499398|NCT00769067|528331203|FG000|Overall Study|Study terminated by sponsor|1|||
146499399|NCT00769067|528331204|FG001|Overall Study|Study terminated by sponsor|3|||
146769031|NCT02031471|529321832|FG000|24 Week Treatment Period|Protocol Violation|1|||
146769032|NCT02031471|529321832|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
146769033|NCT02031471|529321832|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
146769034|NCT02031471|529321832|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
146769035|NCT02031471|529321832|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
146769036|NCT00361283|529321836|FG000|Overall Study|Lost to Follow-up|27|||
146769037|NCT00688519|529321837|FG000|Overall Study|Adverse Event|2|||
146769038|NCT00688519|529321838|FG001|Overall Study|Adverse Event|3|||
146769039|NCT00688519|529321837|FG000|Overall Study|Lost to Follow-up|3|||
146769040|NCT00688519|529321838|FG001|Overall Study|Lost to Follow-up|3|||
146769041|NCT00688519|529321837|FG000|Overall Study|Lack of Efficacy|3|||
146769042|NCT00688519|529321838|FG001|Overall Study|Lack of Efficacy|1|||
146769043|NCT00688519|529321837|FG000|Overall Study|Withdrawal by Subject|7|||
146769044|NCT00688519|529321838|FG001|Overall Study|Withdrawal by Subject|6|||
146769045|NCT00688519|529321837|FG000|Overall Study|Prohibited medication|1|||
146769046|NCT00688519|529321838|FG001|Overall Study|Prohibited medication|0|||
146769047|NCT00688519|529321837|FG000|Overall Study|Non-compliance|0|||
146769048|NCT00688519|529321838|FG001|Overall Study|Non-compliance|1|||
146769049|NCT00688519|529321837|FG000|Overall Study|Subject moved out of state|1|||
146769050|NCT00688519|529321838|FG001|Overall Study|Subject moved out of state|0|||
146769051|NCT00688519|529321837|FG000|Overall Study|Investigator decision|1|||
146769052|NCT00688519|529321838|FG001|Overall Study|Investigator decision|0|||
146769053|NCT00688519|529321837|FG000|Overall Study|Subject moved out of area|1|||
146769054|NCT00688519|529321838|FG001|Overall Study|Subject moved out of area|0|||
146769055|NCT00688519|529321837|FG000|Overall Study|Pregnancy|0|||
146769056|NCT00688519|529321838|FG001|Overall Study|Pregnancy|1|||
146769057|NCT01063517|529321839|FG000|Overall Study|Consent withdrawal|1|||
146769058|NCT01063517|529321840|FG001|Overall Study|Consent withdrawal|0|||
146769059|NCT01063517|529321839|FG000|Overall Study|Study reached data cut-off|19|||
146769060|NCT01063517|529321840|FG001|Overall Study|Study reached data cut-off|7|||
146769061|NCT01063517|529321839|FG000|Overall Study|Lost to Follow-up|4|||
146769062|NCT01063517|529321840|FG001|Overall Study|Lost to Follow-up|3|||
146769063|NCT01063517|529321839|FG000|Overall Study|Withdrawal by Subject|1|||
146769064|NCT01063517|529321840|FG001|Overall Study|Withdrawal by Subject|2|||
146769065|NCT01063517|529321839|FG000|Overall Study|Death|33|||
146646153|NCT00946153|528881618|FG004|Phase 2|Need more reduction of dose|2|||
146646154|NCT00946153|528881614|FG000|Phase 2|Physician Decision|0|||
146646155|NCT00946153|528881615|FG001|Phase 2|Physician Decision|0|||
146646156|NCT00946153|528881616|FG002|Phase 2|Physician Decision|0|||
146769066|NCT01063517|529321840|FG001|Overall Study|Death|48|||
146769067|NCT03284957|529323409|FG000|Overall Study|Adverse Event|0|||
146769068|NCT03284957|529323410|FG001|Overall Study|Adverse Event|0|||
146769069|NCT03284957|529323411|FG002|Overall Study|Adverse Event|0|||
146499400|NCT00769067|528331203|FG000|Overall Study|Other|1|||
146499401|NCT00769067|528331204|FG001|Overall Study|Other|3|||
146499402|NCT00769067|528331203|FG000|Overall Study|Withdrawal by Subject|0|||
146499403|NCT00769067|528331204|FG001|Overall Study|Withdrawal by Subject|1|||
146499404|NCT00809471|528331208|FG000|Overall Study|Protocol non-compliance|15|||
146499405|NCT00809471|528331209|FG001|Overall Study|Protocol non-compliance|15|||
146499406|NCT00809471|528331210|FG002|Overall Study|Protocol non-compliance|6|||
146565978|NCT03323164|528584308|FG001|Overall Study|Poor quality imaging/scans|2|||
146565979|NCT01823289|528584309|FG000|Overall Study|Lost to Follow-up|5|||
146565980|NCT01823289|528584309|FG000|Overall Study|Adverse Event|5|||
146565981|NCT01823289|528584309|FG000|Overall Study|Lack of Efficacy|1|||
146565982|NCT01823289|528584309|FG000|Overall Study|Physician Decision|9|||
146565983|NCT01823289|528584309|FG000|Overall Study|Administered contraindicated medicine|1|||
146565984|NCT01823289|528584309|FG000|Overall Study|Transaminase increased more than 3 times|1|||
146565985|NCT01823289|528584309|FG000|Overall Study|Drug affected efficacy and safety|1|||
146565986|NCT01823289|528584309|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
146565987|NCT00654732|528584314|FG000|Overall Study|Adverse Event|4|||
146565988|NCT00654732|528584315|FG001|Overall Study|Adverse Event|6|||
146499407|NCT00809471|528331208|FG000|Overall Study|Lost to Follow-up|4|||
146499408|NCT00809471|528331209|FG001|Overall Study|Lost to Follow-up|2|||
146499409|NCT00809471|528331210|FG002|Overall Study|Lost to Follow-up|9|||
146499410|NCT00809471|528331208|FG000|Overall Study|Adverse Event|0|||
146499411|NCT00809471|528331209|FG001|Overall Study|Adverse Event|2|||
146499412|NCT00809471|528331210|FG002|Overall Study|Adverse Event|2|||
146499413|NCT00809471|528331208|FG000|Overall Study|Requirement for restricted medication|1|||
146499414|NCT00809471|528331209|FG001|Overall Study|Requirement for restricted medication|1|||
146499415|NCT00809471|528331210|FG002|Overall Study|Requirement for restricted medication|0|||
146499416|NCT00831311|528331211|FG000|Overall Study|Definitive Contraindication|3|||
146499417|NCT00831311|528331212|FG001|Overall Study|Definitive Contraindication|3|||
146973204|NCT03747939|530063887|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
146973205|NCT03747939|530063888|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
146973206|NCT03747939|530063889|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
146973207|NCT03747939|530063886|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
146973208|NCT03747939|530063887|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
146973209|NCT03747939|530063888|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
146499418|NCT00831311|528331211|FG000|Overall Study|Lost to Follow-up|3|||
146499419|NCT00831311|528331212|FG001|Overall Study|Lost to Follow-up|0|||
146499420|NCT00831311|528331211|FG000|Overall Study|Physician Decision|0|||
146499421|NCT00831311|528331212|FG001|Overall Study|Physician Decision|1|||
146499422|NCT00831311|528331211|FG000|Overall Study|Withdrawal by Subject|6|||
146973210|NCT03747939|530063889|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
146973211|NCT03747939|530063886|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
146973212|NCT03747939|530063887|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
146973213|NCT03747939|530063888|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
146973214|NCT03747939|530063889|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
146973215|NCT03747939|530063886|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
146973216|NCT03747939|530063887|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
146973217|NCT03747939|530063888|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
146973218|NCT03747939|530063889|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
146973219|NCT01447628|530063892|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
146973220|NCT01447628|530063893|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
146973221|NCT01447628|530063894|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
146973222|NCT01447628|530063895|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
146973223|NCT00185731|530063896|FG000|Overall Study|Withdrawal by Subject|1|||
146973224|NCT00185731|530063896|FG000|Overall Study|Not Eligible|1|||
146973225|NCT03087773|530063897|FG000|Overall Study|Withdrawal by Subject|8|||
146973226|NCT03087773|530063898|FG001|Overall Study|Withdrawal by Subject|4|||
146973227|NCT03087773|530063897|FG000|Overall Study|Lost to Follow-up|12|||
146973228|NCT03087773|530063898|FG001|Overall Study|Lost to Follow-up|8|||
146973229|NCT05144477|530063901|FG000|Overall Study|Withdrawal by Subject|1|||
146973230|NCT05144477|530063902|FG001|Overall Study|Withdrawal by Subject|1|||
146973231|NCT02181842|530063903|FG000|Overall Study|Case Report Forms Uncollected|2|||
146973232|NCT04529096|530063904|FG000|Overall Study|Adverse Event|6|||
146973233|NCT04529096|530063905|FG001|Overall Study|Adverse Event|1|||
146973234|NCT04529096|530063904|FG000|Overall Study|Lack of Efficacy|1|||
146973235|NCT04529096|530063905|FG001|Overall Study|Lack of Efficacy|0|||
146973236|NCT04529096|530063904|FG000|Overall Study|Lost to Follow-up|1|||
146973237|NCT04529096|530063905|FG001|Overall Study|Lost to Follow-up|1|||
146973238|NCT04529096|530063904|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146973239|NCT04529096|530063905|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146973240|NCT04529096|530063904|FG000|Overall Study|Physician Decision|1|||
146973241|NCT04529096|530063905|FG001|Overall Study|Physician Decision|3|||
146973242|NCT04529096|530063904|FG000|Overall Study|Withdrawal by Subject|5|||
146973243|NCT04529096|530063905|FG001|Overall Study|Withdrawal by Subject|0|||
146973244|NCT00758706|530063906|FG000|Overall Study|Adverse Event|4|||
146973245|NCT00758706|530063907|FG001|Overall Study|Adverse Event|4|||
146973246|NCT03454672|530063917|FG000|Overall Study|Adverse Event|1|||
146973247|NCT03454672|530063918|FG001|Overall Study|Adverse Event|1|||
146973248|NCT03454672|530063917|FG000|Overall Study|Lost to Follow-up|1|||
146973249|NCT03454672|530063918|FG001|Overall Study|Lost to Follow-up|3|||
146973250|NCT03454672|530063917|FG000|Overall Study|painful|1|||
146973251|NCT03454672|530063918|FG001|Overall Study|painful|2|||
146499423|NCT00831311|528331212|FG001|Overall Study|Withdrawal by Subject|4|||
146499424|NCT00160706|528331218|FG000|Overall Study|Adverse Event|53|||
146499425|NCT00160706|528331218|FG000|Overall Study|Adverse Event and Other Reason|105|||
146499426|NCT00160706|528331218|FG000|Overall Study|Protocol Violation|3|||
146499427|NCT00160706|528331218|FG000|Overall Study|Withdrawal by Subject|41|||
146499428|NCT00160706|528331218|FG000|Overall Study|Withdrawal by Subject and Other|12|||
146646157|NCT00946153|528881617|FG003|Phase 2|Physician Decision|0|||
146973252|NCT03454672|530063917|FG000|Overall Study|Non-compliance|2|||
146973253|NCT03454672|530063918|FG001|Overall Study|Non-compliance|4|||
146973254|NCT03454672|530063917|FG000|Overall Study|personal reasons|3|||
146973255|NCT03454672|530063918|FG001|Overall Study|personal reasons|2|||
146499429|NCT00160706|528331218|FG000|Overall Study|Physician Decision|10|||
146499430|NCT00160706|528331218|FG000|Overall Study|Physician Decision and Other|3|||
146499431|NCT00160706|528331218|FG000|Overall Study|Lost to Follow-up|4|||
146499432|NCT00160706|528331218|FG000|Overall Study|Lost to Follow-up and Other|1|||
146499433|NCT00160706|528331218|FG000|Overall Study|Lack of Efficacy|42|||
146973256|NCT03454672|530063917|FG000|Overall Study|Withdrawal by Subject|1|||
146973257|NCT03454672|530063918|FG001|Overall Study|Withdrawal by Subject|0|||
146973258|NCT01488071|530063922|FG000|Overall Study|Adverse Event|15|||
146973259|NCT01488071|530063923|FG001|Overall Study|Adverse Event|23|||
146973260|NCT01488071|530063922|FG000|Overall Study|Lack of Efficacy|11|||
146973261|NCT01488071|530063923|FG001|Overall Study|Lack of Efficacy|17|||
146973262|NCT01488071|530063922|FG000|Overall Study|Non-compliance with study drug|2|||
146973263|NCT01488071|530063923|FG001|Overall Study|Non-compliance with study drug|0|||
146973264|NCT01488071|530063922|FG000|Overall Study|Protocol Violation|5|||
146973265|NCT01488071|530063923|FG001|Overall Study|Protocol Violation|7|||
146973266|NCT01488071|530063922|FG000|Overall Study|Withdrawal of Consent|14|||
146973267|NCT01488071|530063923|FG001|Overall Study|Withdrawal of Consent|12|||
146973268|NCT01488071|530063922|FG000|Overall Study|Lost to Follow-up|1|||
146973269|NCT01488071|530063923|FG001|Overall Study|Lost to Follow-up|0|||
146973270|NCT01488071|530063922|FG000|Overall Study|Administrative or Other Reason(s)|5|||
146973271|NCT01488071|530063923|FG001|Overall Study|Administrative or Other Reason(s)|4|||
146973272|NCT02139306|530063924|FG000|Overall Study|Withdrawal by Subject|4|||
146973273|NCT02139306|530063925|FG001|Overall Study|Withdrawal by Subject|6|||
146973274|NCT02139306|530063924|FG000|Overall Study|Adverse Event|3|||
146973275|NCT02139306|530063925|FG001|Overall Study|Adverse Event|4|||
146973276|NCT02139306|530063924|FG000|Overall Study|Physician Decision|0|||
146973277|NCT02139306|530063925|FG001|Overall Study|Physician Decision|1|||
146973278|NCT02139306|530063924|FG000|Overall Study|Other Unspecified|2|||
146973279|NCT02139306|530063925|FG001|Overall Study|Other Unspecified|3|||
146499434|NCT00160706|528331218|FG000|Overall Study|Lack of Efficacy and Other|1|||
146499435|NCT00160706|528331218|FG000|Overall Study|Other Reason|11|||
146499436|NCT03214380|528331219|FG000|Lead-in|Adverse Event|3|||
146499437|NCT03214380|528331220|FG001|Lead-in|Adverse Event|0|||
146499438|NCT03214380|528331221|FG002|Lead-in|Adverse Event|0|||
146499439|NCT03214380|528331222|FG003|Lead-in|Adverse Event|1|||
146499440|NCT03214380|528331223|FG004|Lead-in|Adverse Event|0|||
146499441|NCT03214380|528331224|FG005|Lead-in|Adverse Event|0|||
146646158|NCT00946153|528881618|FG004|Phase 2|Physician Decision|1|||
146646159|NCT00946153|528881614|FG000|Phase 2|14 days washout for recovery due to AE|0|||
146646160|NCT00946153|528881615|FG001|Phase 2|14 days washout for recovery due to AE|0|||
146646161|NCT00946153|528881616|FG002|Phase 2|14 days washout for recovery due to AE|0|||
146646162|NCT00946153|528881617|FG003|Phase 2|14 days washout for recovery due to AE|0|||
146646163|NCT00946153|528881618|FG004|Phase 2|14 days washout for recovery due to AE|4|||
146646164|NCT00530504|528881621|FG000|Overall Study|Death|54|||
146646165|NCT00530504|528881621|FG000|Overall Study|Lost to Follow-up|26|||
146646166|NCT00530504|528881621|FG000|Overall Study|Withdrawal by Subject|39|||
146646167|NCT00530504|528881621|FG000|Overall Study|Exited study due to other reasons|33|||
146646168|NCT00006289|528881622|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
146646169|NCT00006289|528881623|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
146646170|NCT00006289|528881622|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
146646171|NCT00006289|528881623|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
146646172|NCT05141448|528881633|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
146646173|NCT05141448|528881634|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
146646174|NCT05141448|528881635|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
146499442|NCT03214380|528331219|FG000|Lead-in|Lost to Follow-up|4|||
146499443|NCT03214380|528331220|FG001|Lead-in|Lost to Follow-up|0|||
146499444|NCT03214380|528331221|FG002|Lead-in|Lost to Follow-up|0|||
146646175|NCT05141448|528881636|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
146973280|NCT02139306|530063924|FG000|Overall Study|Protocol Violation|4|||
146973281|NCT02139306|530063925|FG001|Overall Study|Protocol Violation|0|||
146973282|NCT04449354|530063926|FG000|Overall Study|Withdrawal by Subject|1|||
146973283|NCT05899218|530063927|FG000|Overall Study|Lost to Follow-up|2|||
146973284|NCT05899218|530063928|FG001|Overall Study|Lost to Follow-up|2|||
146973285|NCT05899218|530063927|FG000|Overall Study|deemed ineligible out of country|1|||
146646176|NCT05141448|528881637|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
146973286|NCT05899218|530063928|FG001|Overall Study|deemed ineligible out of country|0|||
146973287|NCT02587325|530063929|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
146646177|NCT05141448|528881638|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
146973288|NCT02587325|530063930|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
146973289|NCT02587325|530063931|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
146973290|NCT02587325|530063932|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
146499445|NCT03214380|528331222|FG003|Lead-in|Lost to Follow-up|1|||
146499446|NCT03214380|528331223|FG004|Lead-in|Lost to Follow-up|0|||
146973291|NCT02587325|530063933|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
146499447|NCT03214380|528331224|FG005|Lead-in|Lost to Follow-up|0|||
146973292|NCT02587325|530063929|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
146973293|NCT02587325|530063930|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
146973294|NCT02587325|530063931|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
146973295|NCT02587325|530063932|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
146973296|NCT02587325|530063933|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
146973297|NCT02587325|530063929|FG000|32-Week Optional Extension Part|Adverse Event|0|||
146973298|NCT02587325|530063930|FG001|32-Week Optional Extension Part|Adverse Event|0|||
146973299|NCT02587325|530063931|FG002|32-Week Optional Extension Part|Adverse Event|1|||
146973300|NCT02587325|530063932|FG003|32-Week Optional Extension Part|Adverse Event|0|||
146973301|NCT02587325|530063933|FG004|32-Week Optional Extension Part|Adverse Event|0|||
146973302|NCT02587325|530063929|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
146973303|NCT02587325|530063930|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
146973304|NCT02587325|530063931|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
146973305|NCT02587325|530063932|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
146973306|NCT02587325|530063933|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
146973307|NCT00390572|530063934|FG000|Overall Study|Lost to Follow-up|8|||
146973308|NCT00390572|530063935|FG001|Overall Study|Lost to Follow-up|4|||
146973309|NCT00390572|530063934|FG000|Overall Study|health condition|0|||
146973310|NCT00390572|530063935|FG001|Overall Study|health condition|1|||
146973311|NCT02913261|530063942|FG000|Overall Study|Technical problems|0|||
146973312|NCT02913261|530063943|FG001|Overall Study|Technical problems|1|||
146973313|NCT02913261|530063942|FG000|Overall Study|Lack of Efficacy|32|||
146973314|NCT02913261|530063943|FG001|Overall Study|Lack of Efficacy|69|||
146973315|NCT02913261|530063942|FG000|Overall Study|Adverse Event|27|||
146973316|NCT02913261|530063943|FG001|Overall Study|Adverse Event|5|||
146973317|NCT02913261|530063942|FG000|Overall Study|Death|25|||
146973318|NCT02913261|530063943|FG001|Overall Study|Death|22|||
146973319|NCT02913261|530063942|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
146973320|NCT02913261|530063943|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
146973321|NCT02913261|530063942|FG000|Overall Study|Disease relapse|8|||
146769070|NCT03284957|529323412|FG003|Overall Study|Adverse Event|0|||
146769071|NCT03284957|529323413|FG004|Overall Study|Adverse Event|0|||
146973322|NCT02913261|530063943|FG001|Overall Study|Disease relapse|13|||
146973323|NCT02913261|530063942|FG000|Overall Study|Physician Decision|8|||
146973324|NCT02913261|530063943|FG001|Overall Study|Physician Decision|9|||
146973325|NCT02913261|530063942|FG000|Overall Study|Subject/guardian decision|4|||
146973326|NCT02913261|530063943|FG001|Overall Study|Subject/guardian decision|6|||
146973327|NCT02913261|530063942|FG000|Overall Study|Graft loss|2|||
146973328|NCT02913261|530063943|FG001|Overall Study|Graft loss|0|||
146973329|NCT02304302|530063944|FG000|Overall Study|Adverse Event|2|||
146973330|NCT02304302|530063945|FG001|Overall Study|Adverse Event|3|||
146973331|NCT02304302|530063944|FG000|Overall Study|Lost to Follow-up|1|||
146973332|NCT02304302|530063945|FG001|Overall Study|Lost to Follow-up|4|||
146973333|NCT02304302|530063944|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
146973334|NCT02304302|530063945|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
146973335|NCT00391118|530063946|FG000|Overall Study|Adverse Event|3|||
146973336|NCT00391118|530063947|FG001|Overall Study|Adverse Event|10|||
146973337|NCT00391118|530063948|FG002|Overall Study|Adverse Event|7|||
146973338|NCT00391118|530063946|FG000|Overall Study|Lost to Follow-up|0|||
146973339|NCT00391118|530063947|FG001|Overall Study|Lost to Follow-up|2|||
146973340|NCT00391118|530063948|FG002|Overall Study|Lost to Follow-up|3|||
146973341|NCT00391118|530063946|FG000|Overall Study|Withdrawal by Subject|0|||
146973342|NCT00391118|530063947|FG001|Overall Study|Withdrawal by Subject|9|||
146973343|NCT00391118|530063948|FG002|Overall Study|Withdrawal by Subject|1|||
146973344|NCT00391118|530063946|FG000|Overall Study|Death|0|||
146973345|NCT00391118|530063947|FG001|Overall Study|Death|1|||
146973346|NCT00391118|530063948|FG002|Overall Study|Death|0|||
146973347|NCT00391118|530063946|FG000|Overall Study|Physician Decision|0|||
146973348|NCT00391118|530063947|FG001|Overall Study|Physician Decision|3|||
146973349|NCT00391118|530063948|FG002|Overall Study|Physician Decision|0|||
146769072|NCT03284957|529323414|FG005|Overall Study|Adverse Event|1|||
146973350|NCT00391118|530063946|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
146973351|NCT00391118|530063947|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
146499448|NCT03214380|528331219|FG000|Lead-in|Eligibility Criteria|3|||
146499449|NCT03214380|528331220|FG001|Lead-in|Eligibility Criteria|0|||
146499450|NCT03214380|528331221|FG002|Lead-in|Eligibility Criteria|0|||
146499451|NCT03214380|528331222|FG003|Lead-in|Eligibility Criteria|0|||
146499452|NCT03214380|528331223|FG004|Lead-in|Eligibility Criteria|0|||
146769073|NCT03284957|529323415|FG006|Overall Study|Adverse Event|1|||
146769074|NCT03284957|529323416|FG007|Overall Study|Adverse Event|1|||
146973352|NCT00391118|530063948|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
146973353|NCT00391118|530063946|FG000|Overall Study|Progressive Disease|7|||
146973354|NCT00391118|530063947|FG001|Overall Study|Progressive Disease|26|||
146973355|NCT00391118|530063948|FG002|Overall Study|Progressive Disease|43|||
146973356|NCT00391118|530063946|FG000|Overall Study|Sponsor Decision|0|||
146973357|NCT00391118|530063947|FG001|Overall Study|Sponsor Decision|1|||
146973358|NCT00391118|530063948|FG002|Overall Study|Sponsor Decision|3|||
146973359|NCT00391118|530063946|FG000|Overall Study|Protocol Violation|1|||
146973360|NCT00391118|530063947|FG001|Overall Study|Protocol Violation|0|||
146973361|NCT00391118|530063948|FG002|Overall Study|Protocol Violation|0|||
146973362|NCT01892020|530063949|FG000|Period 1|Adverse Event|1|||
146973363|NCT01892020|530063950|FG001|Period 1|Adverse Event|1|||
146973364|NCT01892020|530063949|FG000|Period 1|Protocol Violation|2|||
146973365|NCT01892020|530063950|FG001|Period 1|Protocol Violation|4|||
146499453|NCT03214380|528331224|FG005|Lead-in|Eligibility Criteria|0|||
146499454|NCT03214380|528331219|FG000|Lead-in|Physician Decision|6|||
146499455|NCT03214380|528331220|FG001|Lead-in|Physician Decision|0|||
146499456|NCT03214380|528331221|FG002|Lead-in|Physician Decision|0|||
146973366|NCT01892020|530063949|FG000|Period 1|Unclassified|0|||
146973367|NCT01892020|530063950|FG001|Period 1|Unclassified|1|||
146973368|NCT01892020|530063949|FG000|Period 2|Protocol Violation|1|||
146973369|NCT01892020|530063950|FG001|Period 2|Protocol Violation|0|||
146973370|NCT03078192|530063955|FG000|Overall Study|Withdrawal by Subject|2|||
146973371|NCT03078192|530063956|FG001|Overall Study|Withdrawal by Subject|1|||
146499457|NCT03214380|528331222|FG003|Lead-in|Physician Decision|0|||
146499458|NCT03214380|528331223|FG004|Lead-in|Physician Decision|0|||
146499459|NCT03214380|528331224|FG005|Lead-in|Physician Decision|0|||
146499460|NCT03214380|528331219|FG000|Lead-in|Protocol Deviation|7|||
146499461|NCT03214380|528331220|FG001|Lead-in|Protocol Deviation|0|||
146499462|NCT03214380|528331221|FG002|Lead-in|Protocol Deviation|0|||
146499463|NCT03214380|528331222|FG003|Lead-in|Protocol Deviation|3|||
146499464|NCT03214380|528331223|FG004|Lead-in|Protocol Deviation|0|||
146499465|NCT03214380|528331224|FG005|Lead-in|Protocol Deviation|0|||
146499466|NCT03214380|528331219|FG000|Lead-in|Withdrawal by Subject|41|||
146499467|NCT03214380|528331220|FG001|Lead-in|Withdrawal by Subject|0|||
146499468|NCT03214380|528331221|FG002|Lead-in|Withdrawal by Subject|0|||
146499469|NCT03214380|528331222|FG003|Lead-in|Withdrawal by Subject|14|||
146499470|NCT03214380|528331223|FG004|Lead-in|Withdrawal by Subject|0|||
146499471|NCT03214380|528331224|FG005|Lead-in|Withdrawal by Subject|0|||
146499472|NCT03214380|528331219|FG000|Lead-in|Family Emergency|1|||
146499473|NCT03214380|528331220|FG001|Lead-in|Family Emergency|0|||
146973372|NCT03078192|530063955|FG000|Overall Study|screen failure|0|||
146973373|NCT03078192|530063956|FG001|Overall Study|screen failure|3|||
146973374|NCT03252756|530063959|FG000|Overall Study|Protocol Violation|2|||
146973375|NCT03252756|530063960|FG001|Overall Study|Protocol Violation|4|||
146973376|NCT03252756|530063959|FG000|Overall Study|COVID-19 Pandemic|1|||
146973377|NCT03252756|530063960|FG001|Overall Study|COVID-19 Pandemic|1|||
146973378|NCT03252756|530063959|FG000|Overall Study|Study Drug Expiration|0|||
146973379|NCT03252756|530063960|FG001|Overall Study|Study Drug Expiration|1|||
146973380|NCT03594175|530063961|FG000|Overall Study|Not treated|8|||
146973381|NCT03594175|530063962|FG001|Overall Study|Not treated|1|||
146973382|NCT03594175|530063963|FG002|Overall Study|Not treated|5|||
146973383|NCT03594175|530063961|FG000|Overall Study|Adverse Event|3|||
146499474|NCT03214380|528331221|FG002|Lead-in|Family Emergency|0|||
146499475|NCT03214380|528331222|FG003|Lead-in|Family Emergency|0|||
146499476|NCT03214380|528331223|FG004|Lead-in|Family Emergency|0|||
146499477|NCT03214380|528331224|FG005|Lead-in|Family Emergency|0|||
146499478|NCT03214380|528331219|FG000|Lead-in|Natural Disaster|9|||
146499479|NCT03214380|528331220|FG001|Lead-in|Natural Disaster|0|||
146499480|NCT03214380|528331221|FG002|Lead-in|Natural Disaster|0|||
146499481|NCT03214380|528331222|FG003|Lead-in|Natural Disaster|0|||
146646178|NCT05141448|528881633|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
146646179|NCT05141448|528881634|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
146646180|NCT05141448|528881635|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
146646181|NCT05141448|528881636|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
146646182|NCT05141448|528881637|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
146646183|NCT05141448|528881638|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
146646184|NCT05141448|528881633|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
146646185|NCT05141448|528881634|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
146499482|NCT03214380|528331223|FG004|Lead-in|Natural Disaster|0|||
146499483|NCT03214380|528331224|FG005|Lead-in|Natural Disaster|0|||
146499484|NCT03214380|528331219|FG000|Lead-in|Non Compliance|1|||
146646186|NCT05141448|528881635|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
146646187|NCT05141448|528881636|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
146646188|NCT05141448|528881637|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
146973384|NCT03594175|530063962|FG001|Overall Study|Adverse Event|0|||
146973385|NCT03594175|530063963|FG002|Overall Study|Adverse Event|0|||
146973386|NCT03594175|530063961|FG000|Overall Study|Withdrawal by Subject|3|||
146973387|NCT03594175|530063962|FG001|Overall Study|Withdrawal by Subject|0|||
146973388|NCT03594175|530063963|FG002|Overall Study|Withdrawal by Subject|0|||
146499485|NCT03214380|528331220|FG001|Lead-in|Non Compliance|0|||
146499486|NCT03214380|528331221|FG002|Lead-in|Non Compliance|0|||
146499487|NCT03214380|528331222|FG003|Lead-in|Non Compliance|0|||
146499488|NCT03214380|528331223|FG004|Lead-in|Non Compliance|0|||
146499489|NCT03214380|528331224|FG005|Lead-in|Non Compliance|0|||
146499490|NCT03214380|528331219|FG000|Lead-in|Participant Schedule|2|||
146499491|NCT03214380|528331220|FG001|Lead-in|Participant Schedule|0|||
146499492|NCT03214380|528331221|FG002|Lead-in|Participant Schedule|0|||
146499493|NCT03214380|528331222|FG003|Lead-in|Participant Schedule|0|||
146499494|NCT03214380|528331223|FG004|Lead-in|Participant Schedule|0|||
146499495|NCT03214380|528331224|FG005|Lead-in|Participant Schedule|0|||
146499496|NCT03214380|528331219|FG000|Treatment Period|Adverse Event|0|||
146646189|NCT05141448|528881638|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
146646190|NCT05141448|528881633|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
146646191|NCT05141448|528881634|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
146646192|NCT05141448|528881635|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
146646193|NCT05141448|528881636|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
146646194|NCT05141448|528881637|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
146646195|NCT05141448|528881638|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
146646196|NCT05141448|528881633|FG000|Period 2|COVID-19 Related|0|||
146646197|NCT05141448|528881634|FG001|Period 2|COVID-19 Related|0|||
146646198|NCT05141448|528881635|FG002|Period 2|COVID-19 Related|0|||
146646199|NCT05141448|528881636|FG003|Period 2|COVID-19 Related|1|||
146646200|NCT05141448|528881637|FG004|Period 2|COVID-19 Related|0|||
146646201|NCT05141448|528881638|FG005|Period 2|COVID-19 Related|1|||
146646202|NCT05141448|528881633|FG000|3|Covid-19 related|2|||
146646203|NCT05141448|528881634|FG001|3|Covid-19 related|0|||
146646204|NCT05141448|528881635|FG002|3|Covid-19 related|0|||
146646205|NCT05141448|528881636|FG003|3|Covid-19 related|0|||
146646206|NCT05141448|528881637|FG004|3|Covid-19 related|0|||
146646207|NCT05141448|528881638|FG005|3|Covid-19 related|1|||
146646208|NCT05141448|528881633|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
146646209|NCT05141448|528881634|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
146646210|NCT05141448|528881635|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
146646211|NCT05141448|528881636|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
146646212|NCT05141448|528881637|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
146646213|NCT05141448|528881638|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
146646214|NCT03865316|528883003|FG000|Overall Study|Procedure Cancelled|4|||
146646215|NCT03865316|528883003|FG000|Overall Study|Equipment failure|4|||
146646216|NCT03137069|528883009|FG000|Overall Study|Withdrawal by Subject|1|||
146646217|NCT03137069|528883010|FG001|Overall Study|Withdrawal by Subject|2|||
146646218|NCT03137069|528883011|FG002|Overall Study|Withdrawal by Subject|2|||
146646219|NCT03137069|528883012|FG003|Overall Study|Withdrawal by Subject|2|||
146646220|NCT03137069|528883013|FG004|Overall Study|Withdrawal by Subject|0|||
146646221|NCT03137069|528883014|FG005|Overall Study|Withdrawal by Subject|0|||
146646222|NCT03137069|528883009|FG000|Overall Study|Adverse Event|0|||
146646223|NCT03137069|528883010|FG001|Overall Study|Adverse Event|3|||
146646224|NCT03137069|528883011|FG002|Overall Study|Adverse Event|1|||
146646225|NCT03137069|528883012|FG003|Overall Study|Adverse Event|1|||
146646226|NCT03137069|528883013|FG004|Overall Study|Adverse Event|0|||
146646227|NCT03137069|528883014|FG005|Overall Study|Adverse Event|1|||
146646228|NCT03137069|528883009|FG000|Overall Study|Protocol Violation|0|||
146646229|NCT03137069|528883010|FG001|Overall Study|Protocol Violation|1|||
146646230|NCT03137069|528883011|FG002|Overall Study|Protocol Violation|0|||
146646231|NCT03137069|528883012|FG003|Overall Study|Protocol Violation|1|||
146646232|NCT03137069|528883013|FG004|Overall Study|Protocol Violation|1|||
146646233|NCT03137069|528883014|FG005|Overall Study|Protocol Violation|1|||
146646234|NCT03137069|528883009|FG000|Overall Study|Physician Decision|0|||
146646235|NCT03137069|528883010|FG001|Overall Study|Physician Decision|0|||
146646236|NCT03137069|528883011|FG002|Overall Study|Physician Decision|0|||
146646237|NCT03137069|528883012|FG003|Overall Study|Physician Decision|1|||
146646238|NCT03137069|528883013|FG004|Overall Study|Physician Decision|0|||
146646239|NCT03137069|528883014|FG005|Overall Study|Physician Decision|0|||
146646240|NCT03137069|528883009|FG000|Overall Study|Study Terminated by Sponsor|0|||
146646241|NCT03137069|528883010|FG001|Overall Study|Study Terminated by Sponsor|0|||
146646242|NCT03137069|528883011|FG002|Overall Study|Study Terminated by Sponsor|0|||
146646243|NCT03137069|528883012|FG003|Overall Study|Study Terminated by Sponsor|0|||
146646244|NCT03137069|528883013|FG004|Overall Study|Study Terminated by Sponsor|1|||
146499497|NCT03214380|528331220|FG001|Treatment Period|Adverse Event|1|||
146499498|NCT03214380|528331221|FG002|Treatment Period|Adverse Event|1|||
146646245|NCT03137069|528883014|FG005|Overall Study|Study Terminated by Sponsor|0|||
146646246|NCT03137069|528883009|FG000|Overall Study|Data Entry Error|0|||
146646247|NCT03137069|528883010|FG001|Overall Study|Data Entry Error|0|||
146646248|NCT03137069|528883011|FG002|Overall Study|Data Entry Error|0|||
146646249|NCT03137069|528883012|FG003|Overall Study|Data Entry Error|1|||
146646250|NCT03137069|528883013|FG004|Overall Study|Data Entry Error|0|||
146646251|NCT03137069|528883014|FG005|Overall Study|Data Entry Error|0|||
146646252|NCT00336856|528883015|FG000|Overall Study|Withdrawal by Subject|3|||
146646253|NCT00336856|528883015|FG000|Overall Study|Found ineligible at time of analysis|1|||
146646254|NCT02522624|528883017|FG000|Overall Study|Technical failure|1|||
146499499|NCT03214380|528331222|FG003|Treatment Period|Adverse Event|0|||
146646255|NCT02522624|528883018|FG001|Overall Study|Technical failure|0|||
146646256|NCT01325337|528883019|FG000|Overall Study|Adverse Event|0|||
146499500|NCT03214380|528331223|FG004|Treatment Period|Adverse Event|1|||
146499501|NCT03214380|528331224|FG005|Treatment Period|Adverse Event|0|||
146499502|NCT03214380|528331219|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
146499503|NCT03214380|528331220|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
146499504|NCT03214380|528331221|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
146499505|NCT03214380|528331222|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
146499506|NCT03214380|528331223|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
146499507|NCT03214380|528331224|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
146499508|NCT03214380|528331219|FG000|Treatment Period|Withdrawal by Subject|0|||
146499509|NCT03214380|528331220|FG001|Treatment Period|Withdrawal by Subject|10|||
146499510|NCT03214380|528331221|FG002|Treatment Period|Withdrawal by Subject|8|||
146973389|NCT03594175|530063961|FG000|Overall Study|Protocol Violation|2|||
146499511|NCT03214380|528331222|FG003|Treatment Period|Withdrawal by Subject|0|||
146499512|NCT03214380|528331223|FG004|Treatment Period|Withdrawal by Subject|7|||
146565989|NCT01734902|528584320|FG000|Overall Study|Other than listed|0|||
146565990|NCT01734902|528584321|FG001|Overall Study|Other than listed|2|||
146565991|NCT00060944|528584324|FG000|Overall Study|Adverse Event|12|||
146565992|NCT00060944|528584325|FG001|Overall Study|Adverse Event|10|||
146565993|NCT00060944|528584324|FG000|Overall Study|Death|2|||
146565994|NCT00060944|528584325|FG001|Overall Study|Death|3|||
146565995|NCT00060944|528584324|FG000|Overall Study|Withdrawal by Subject|18|||
146565996|NCT00060944|528584325|FG001|Overall Study|Withdrawal by Subject|5|||
146565997|NCT00060944|528584324|FG000|Overall Study|Disease Progression|93|||
146565998|NCT00060944|528584325|FG001|Overall Study|Disease Progression|94|||
146565999|NCT00060944|528584324|FG000|Overall Study|Lost to Follow-up|1|||
146566000|NCT00060944|528584325|FG001|Overall Study|Lost to Follow-up|0|||
146566001|NCT00060944|528584324|FG000|Overall Study|Subject Ineligible To Continue|2|||
146566002|NCT00060944|528584325|FG001|Overall Study|Subject Ineligible To Continue|1|||
146566003|NCT00060944|528584324|FG000|Overall Study|Treatment Switch|0|||
146566004|NCT00060944|528584325|FG001|Overall Study|Treatment Switch|13|||
146566005|NCT00060944|528584324|FG000|Overall Study|Other|2|||
146566006|NCT00060944|528584325|FG001|Overall Study|Other|4|||
146566007|NCT00060944|528584324|FG000|Overall Study|randomized but not treated|6|||
146566008|NCT00060944|528584325|FG001|Overall Study|randomized but not treated|4|||
146566009|NCT02536664|528584330|FG000|Overall Study|Inadequate completion of documentation|2|||
146566010|NCT02536664|528584331|FG001|Overall Study|Inadequate completion of documentation|4|||
146566011|NCT02536664|528584330|FG000|Overall Study|Progression|13|||
146566012|NCT02536664|528584331|FG001|Overall Study|Progression|18|||
146566013|NCT02536664|528584330|FG000|Overall Study|Death due to lymphoma|2|||
146566014|NCT02536664|528584331|FG001|Overall Study|Death due to lymphoma|1|||
146566015|NCT02536664|528584330|FG000|Overall Study|Death due to other reason|3|||
146566016|NCT02536664|528584331|FG001|Overall Study|Death due to other reason|2|||
146566017|NCT02536664|528584330|FG000|Overall Study|Intolerability|8|||
146566018|NCT02536664|528584331|FG001|Overall Study|Intolerability|6|||
146566019|NCT02536664|528584330|FG000|Overall Study|Withdrawal by Subject|8|||
146566020|NCT02536664|528584331|FG001|Overall Study|Withdrawal by Subject|5|||
146566021|NCT02536664|528584330|FG000|Overall Study|Other|18|||
146566022|NCT02536664|528584331|FG001|Overall Study|Other|24|||
146566023|NCT02536664|528584330|FG000|Overall Study|Missing|53|||
146566024|NCT02536664|528584331|FG001|Overall Study|Missing|20|||
146566025|NCT02359903|528584332|FG000|Overall Study|Adverse Event|0|||
146566026|NCT02359903|528584333|FG001|Overall Study|Adverse Event|2|||
146566027|NCT03383666|528584334|FG000|Overall Study|Withdrawal by Subject|2|||
146566028|NCT03383666|528584334|FG000|Overall Study|Lost to Follow-up|2|||
146566029|NCT03507127|528584342|FG000|Overall Study|Withdrawal by Subject|1|||
146566030|NCT03507127|528584343|FG001|Overall Study|Withdrawal by Subject|0|||
146566031|NCT03507127|528584342|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
146566032|NCT03507127|528584343|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
146566033|NCT00746811|528584348|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
146566034|NCT00746811|528584349|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
146566035|NCT02505425|528584353|FG000|Overall Study|Lost to Follow-up|41|||
146566036|NCT02505425|528584354|FG001|Overall Study|Lost to Follow-up|61|||
146566037|NCT02505425|528584355|FG002|Overall Study|Lost to Follow-up|31|||
146566038|NCT02505425|528584356|FG003|Overall Study|Lost to Follow-up|19|||
146566039|NCT02505425|528584353|FG000|Overall Study|Withdrawal by Subject|39|||
146566040|NCT02505425|528584354|FG001|Overall Study|Withdrawal by Subject|9|||
146566041|NCT02505425|528584355|FG002|Overall Study|Withdrawal by Subject|19|||
146566042|NCT02505425|528584356|FG003|Overall Study|Withdrawal by Subject|7|||
146566043|NCT02505425|528584353|FG000|Overall Study|Death|8|||
146566044|NCT02505425|528584354|FG001|Overall Study|Death|12|||
146566045|NCT02505425|528584355|FG002|Overall Study|Death|0|||
146566046|NCT02505425|528584356|FG003|Overall Study|Death|0|||
146566047|NCT02031302|528584357|FG000|Overall Study|Death|115|||
146566048|NCT02031302|528584358|FG001|Overall Study|Death|0|||
146566049|NCT02031302|528584357|FG000|Overall Study|Not treated with study valve system|18|||
146566050|NCT02031302|528584358|FG001|Overall Study|Not treated with study valve system|0|||
146566051|NCT02031302|528584357|FG000|Overall Study|Missed Follow Up|27|||
146566052|NCT02031302|528584358|FG001|Overall Study|Missed Follow Up|0|||
146769075|NCT03284957|529323417|FG008|Overall Study|Adverse Event|0|||
146769076|NCT03284957|529323418|FG009|Overall Study|Adverse Event|4|||
146769077|NCT03284957|529323419|FG010|Overall Study|Adverse Event|1|||
146769078|NCT03284957|529323420|FG011|Overall Study|Adverse Event|1|||
146769079|NCT03284957|529323421|FG012|Overall Study|Adverse Event|0|||
146769080|NCT03284957|529323422|FG013|Overall Study|Adverse Event|0|||
146769081|NCT03284957|529323423|FG014|Overall Study|Adverse Event|0|||
146499513|NCT03214380|528331224|FG005|Treatment Period|Withdrawal by Subject|11|||
146646257|NCT01325337|528883020|FG001|Overall Study|Adverse Event|2|||
146646258|NCT01325337|528883021|FG002|Overall Study|Adverse Event|2|||
146646259|NCT01325337|528883022|FG003|Overall Study|Adverse Event|1|||
146646260|NCT01325337|528883023|FG004|Overall Study|Adverse Event|2|||
146646261|NCT01325337|528883019|FG000|Overall Study|Lost to Follow-up|2|||
146646262|NCT01325337|528883020|FG001|Overall Study|Lost to Follow-up|2|||
146646263|NCT01325337|528883021|FG002|Overall Study|Lost to Follow-up|2|||
146646264|NCT01325337|528883022|FG003|Overall Study|Lost to Follow-up|1|||
146646265|NCT01325337|528883023|FG004|Overall Study|Lost to Follow-up|2|||
146646266|NCT01325337|528883019|FG000|Overall Study|Personal Reasons|2|||
146646267|NCT01325337|528883020|FG001|Overall Study|Personal Reasons|5|||
146646268|NCT01325337|528883021|FG002|Overall Study|Personal Reasons|4|||
146646269|NCT01325337|528883022|FG003|Overall Study|Personal Reasons|8|||
146646270|NCT01325337|528883023|FG004|Overall Study|Personal Reasons|3|||
146646271|NCT01325337|528883019|FG000|Overall Study|Withdrawal by Subject|1|||
146646272|NCT01325337|528883020|FG001|Overall Study|Withdrawal by Subject|0|||
146646273|NCT01325337|528883021|FG002|Overall Study|Withdrawal by Subject|1|||
146646274|NCT01325337|528883022|FG003|Overall Study|Withdrawal by Subject|0|||
146646275|NCT01325337|528883023|FG004|Overall Study|Withdrawal by Subject|1|||
146646276|NCT00843778|528883036|FG000|Overall Study|Adverse Event|15|||
146646277|NCT00843778|528883036|FG000|Overall Study|Lack of Efficacy|14|||
146646278|NCT00843778|528883036|FG000|Overall Study|Loss of efficacy|2|||
146646279|NCT00843778|528883036|FG000|Overall Study|Withdrawal by Subject|4|||
146646280|NCT00369629|528883037|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
146646281|NCT00369629|528883038|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
146646282|NCT00369629|528883039|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
146646283|NCT00369629|528883040|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
146646284|NCT00369629|528883037|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
146646285|NCT00369629|528883038|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
146646286|NCT00369629|528883039|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
146646287|NCT00369629|528883040|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
146646288|NCT00369629|528883037|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
146646289|NCT00369629|528883038|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
146646290|NCT00369629|528883039|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
146646291|NCT00369629|528883040|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
146646292|NCT00369629|528883037|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
146646293|NCT00369629|528883038|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
146646294|NCT00369629|528883039|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
146646295|NCT00369629|528883040|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
146646296|NCT00369629|528883037|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
146646297|NCT00369629|528883038|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
146646298|NCT00369629|528883039|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
146646299|NCT00369629|528883040|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
146646300|NCT00369629|528883037|FG000|Completed 4 More Cycles|Progressive disease|2|||
146646301|NCT00369629|528883038|FG001|Completed 4 More Cycles|Progressive disease|1|||
146646302|NCT00369629|528883039|FG002|Completed 4 More Cycles|Progressive disease|2|||
146646303|NCT00369629|528883040|FG003|Completed 4 More Cycles|Progressive disease|0|||
146646304|NCT00369629|528883037|FG000|Follow up for 1 Year|Death|2|||
146646305|NCT00369629|528883038|FG001|Follow up for 1 Year|Death|1|||
146646306|NCT00369629|528883039|FG002|Follow up for 1 Year|Death|1|||
146646307|NCT00369629|528883040|FG003|Follow up for 1 Year|Death|0|||
146646308|NCT00369629|528883037|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
146646309|NCT00369629|528883038|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
146646310|NCT00369629|528883039|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
146646311|NCT00369629|528883040|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
146646312|NCT00369629|528883037|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
146646313|NCT00369629|528883038|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
146646314|NCT00369629|528883039|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
146646315|NCT00369629|528883040|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
146646316|NCT02600871|528883041|FG000|Overall Study|Lost to Follow-up|13|||
146646317|NCT02600871|528883042|FG001|Overall Study|Lost to Follow-up|10|||
146646318|NCT03338959|528883043|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
146646319|NCT03338959|528883043|FG000|Overall Study|Physician Decision|1|||
146646320|NCT01604278|528883048|FG000|Overall Study|Lack of Efficacy|0|||
146769082|NCT03284957|529323424|FG015|Overall Study|Adverse Event|0|||
146973390|NCT03594175|530063962|FG001|Overall Study|Protocol Violation|2|||
146973391|NCT03594175|530063963|FG002|Overall Study|Protocol Violation|2|||
146499514|NCT03214380|528331219|FG000|Treatment Period|Death|0|||
146499515|NCT03214380|528331220|FG001|Treatment Period|Death|1|||
146499516|NCT03214380|528331221|FG002|Treatment Period|Death|2|||
146499517|NCT03214380|528331222|FG003|Treatment Period|Death|0|||
146499518|NCT03214380|528331223|FG004|Treatment Period|Death|0|||
146499519|NCT03214380|528331224|FG005|Treatment Period|Death|0|||
146499520|NCT03214380|528331219|FG000|Treatment Period|Lost to Follow-up|0|||
146499521|NCT03214380|528331220|FG001|Treatment Period|Lost to Follow-up|6|||
146499522|NCT03214380|528331221|FG002|Treatment Period|Lost to Follow-up|3|||
146499523|NCT03214380|528331222|FG003|Treatment Period|Lost to Follow-up|0|||
146499524|NCT03214380|528331223|FG004|Treatment Period|Lost to Follow-up|0|||
146499525|NCT03214380|528331224|FG005|Treatment Period|Lost to Follow-up|0|||
146499526|NCT03214380|528331219|FG000|Treatment Period|Participant schedule|0|||
146499527|NCT03214380|528331220|FG001|Treatment Period|Participant schedule|0|||
146499528|NCT03214380|528331221|FG002|Treatment Period|Participant schedule|1|||
146499529|NCT03214380|528331222|FG003|Treatment Period|Participant schedule|0|||
146499530|NCT03214380|528331223|FG004|Treatment Period|Participant schedule|0|||
146499531|NCT03214380|528331224|FG005|Treatment Period|Participant schedule|0|||
146499532|NCT03214380|528331219|FG000|Treatment Period|Treatment Interruption|0|||
146499533|NCT03214380|528331220|FG001|Treatment Period|Treatment Interruption|0|||
146499534|NCT03214380|528331221|FG002|Treatment Period|Treatment Interruption|1|||
146499535|NCT03214380|528331222|FG003|Treatment Period|Treatment Interruption|0|||
146499536|NCT03214380|528331223|FG004|Treatment Period|Treatment Interruption|0|||
146499537|NCT03214380|528331224|FG005|Treatment Period|Treatment Interruption|0|||
146499538|NCT03692325|528331228|FG000|Overall Study|Adverse Event|2|||
146499539|NCT03692325|528331228|FG000|Overall Study|Progression/Recurrence|2|||
146499540|NCT04481191|528331229|FG000|Overall Study|Withdrawn by parent/guardian|15|||
146499541|NCT04481191|528331230|FG001|Overall Study|Withdrawn by parent/guardian|10|||
146499542|NCT04292912|528331235|FG000|Overall Study|Physician Decision|1|||
146499543|NCT04292912|528331235|FG000|Overall Study|Protocol Violation|6|||
146499544|NCT00280397|528331236|FG000|Overall Study|Adverse Event|1|||
146499545|NCT01250873|528331246|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
146499546|NCT01250873|528331246|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
146566053|NCT02031302|528584357|FG000|Overall Study|Lost to Follow-up|4|||
146566054|NCT02031302|528584358|FG001|Overall Study|Lost to Follow-up|0|||
146566055|NCT02293551|528584365|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
146566056|NCT02293551|528584366|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
146973392|NCT01915498|530063964|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146973393|NCT01915498|530063965|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146973394|NCT01915498|530063966|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146973395|NCT01915498|530063967|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
146973396|NCT01915498|530063968|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
146973397|NCT01915498|530063969|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146973398|NCT01915498|530063970|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146973399|NCT01915498|530063971|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146973400|NCT01915498|530063972|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146973401|NCT01915498|530063973|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
146973402|NCT01915498|530063974|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146973403|NCT01915498|530063975|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146973404|NCT01915498|530063976|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
146973405|NCT01915498|530063977|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
146973406|NCT01915498|530063978|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
146973407|NCT01915498|530063979|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
146973408|NCT01915498|530063980|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
146973409|NCT01915498|530063981|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
146973410|NCT01915498|530063982|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146973411|NCT01915498|530063964|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146973412|NCT01915498|530063965|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146973413|NCT01915498|530063966|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146973414|NCT01915498|530063967|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146973415|NCT01915498|530063968|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146499547|NCT02278939|528331247|FG000|Overall Study|lack of time|1|||
146499548|NCT02278939|528331248|FG001|Overall Study|lack of time|0|||
146499549|NCT02278939|528331247|FG000|Overall Study|Lost to Follow-up|1|||
146499550|NCT02278939|528331248|FG001|Overall Study|Lost to Follow-up|1|||
146499551|NCT02278939|528331247|FG000|Overall Study|death in family|1|||
146499552|NCT02278939|528331248|FG001|Overall Study|death in family|0|||
146499553|NCT02278939|528331247|FG000|Overall Study|family emergency unable to commit|2|||
146646321|NCT01604278|528883049|FG001|Overall Study|Lack of Efficacy|1|||
146973416|NCT01915498|530063969|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
146973417|NCT01915498|530063970|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146973418|NCT01915498|530063971|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146973419|NCT01915498|530063972|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146973420|NCT01915498|530063973|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
146973421|NCT01915498|530063974|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146973422|NCT01915498|530063975|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146973423|NCT01915498|530063976|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146973424|NCT01915498|530063977|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
146973425|NCT01915498|530063978|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
146973426|NCT01915498|530063979|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
146973427|NCT01915498|530063980|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
146973428|NCT01915498|530063981|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
146973429|NCT01915498|530063982|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146973430|NCT01915498|530063964|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
146973431|NCT01915498|530063965|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146973432|NCT01915498|530063966|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146973433|NCT01915498|530063967|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146973434|NCT01915498|530063968|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146973435|NCT01915498|530063969|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
146973436|NCT01915498|530063970|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146973437|NCT01915498|530063971|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146973438|NCT01915498|530063972|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146973439|NCT01915498|530063973|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146973440|NCT01915498|530063974|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146973441|NCT01915498|530063975|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146973442|NCT01915498|530063976|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146973443|NCT01915498|530063977|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146973444|NCT01915498|530063978|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
146973445|NCT01915498|530063979|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146973446|NCT01915498|530063980|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146973447|NCT01915498|530063981|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
146973448|NCT01915498|530063982|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146973449|NCT01915498|530063964|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146973450|NCT01915498|530063965|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146973451|NCT01915498|530063966|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146973452|NCT01915498|530063967|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146973453|NCT01915498|530063968|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146973454|NCT01915498|530063969|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146973455|NCT01915498|530063970|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146973456|NCT01915498|530063971|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146973457|NCT01915498|530063972|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146973458|NCT01915498|530063973|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146973459|NCT01915498|530063974|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
146973460|NCT01915498|530063975|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146973461|NCT01915498|530063976|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146973462|NCT01915498|530063977|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
146973463|NCT01915498|530063978|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146973464|NCT01915498|530063979|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146973465|NCT01915498|530063980|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
146973466|NCT01915498|530063981|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
146973467|NCT01915498|530063982|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146973468|NCT01915498|530063964|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
146973469|NCT01915498|530063965|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
146973470|NCT01915498|530063966|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
146973471|NCT01915498|530063967|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
146973472|NCT01915498|530063968|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
146973473|NCT01915498|530063969|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
146566057|NCT02293551|528584367|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
146566058|NCT02293551|528584368|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
146566059|NCT02293551|528584369|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
146566060|NCT02293551|528584370|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
146566061|NCT02293551|528584365|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
146566062|NCT02293551|528584366|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
146566063|NCT02293551|528584367|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
146566064|NCT02293551|528584368|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
146566065|NCT02293551|528584369|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
146566066|NCT02293551|528584370|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
146566067|NCT02293551|528584365|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
146566068|NCT02293551|528584366|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
146566069|NCT02293551|528584367|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
146566070|NCT02293551|528584368|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
146566071|NCT02293551|528584369|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
146566072|NCT02293551|528584370|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
146566073|NCT02936323|528584371|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
146566074|NCT02936323|528584372|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
146566075|NCT02936323|528584373|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
146566076|NCT02936323|528584374|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
146566077|NCT02936323|528584375|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
146566078|NCT02936323|528584376|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
146566079|NCT02936323|528584377|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
146566080|NCT02936323|528584378|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
146566081|NCT02936323|528584379|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
146566082|NCT02936323|528584380|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
146566083|NCT02936323|528584371|FG000|Phase 1 Dose Escalation|Death|2|||
146566084|NCT02936323|528584372|FG001|Phase 1 Dose Escalation|Death|1|||
146566085|NCT02936323|528584373|FG002|Phase 1 Dose Escalation|Death|3|||
146566086|NCT02936323|528584374|FG003|Phase 1 Dose Escalation|Death|1|||
146566087|NCT02936323|528584375|FG004|Phase 1 Dose Escalation|Death|2|||
146566088|NCT02936323|528584376|FG005|Phase 1 Dose Escalation|Death|3|||
146566089|NCT02936323|528584377|FG006|Phase 1 Dose Escalation|Death|3|||
146566090|NCT02936323|528584378|FG007|Phase 1 Dose Escalation|Death|0|||
146566091|NCT02936323|528584379|FG008|Phase 1 Dose Escalation|Death|0|||
146566092|NCT02936323|528584380|FG009|Phase 1 Dose Escalation|Death|0|||
146566093|NCT02936323|528584371|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
146566094|NCT02936323|528584372|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
146566095|NCT02936323|528584373|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
146566096|NCT02936323|528584374|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
146566097|NCT02936323|528584375|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
146566098|NCT02936323|528584376|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
146566099|NCT02936323|528584377|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
146566100|NCT02936323|528584378|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
146566101|NCT02936323|528584379|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
146566102|NCT02936323|528584380|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
146566103|NCT02936323|528584371|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
146566104|NCT02936323|528584372|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
146566105|NCT02936323|528584373|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
146566106|NCT02936323|528584374|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
146566107|NCT02936323|528584375|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
146566108|NCT02936323|528584376|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
146566109|NCT02936323|528584377|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
146566110|NCT02936323|528584378|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
146566111|NCT02936323|528584379|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
146566112|NCT02936323|528584380|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
146566113|NCT02936323|528584371|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
146566114|NCT02936323|528584372|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
146566115|NCT02936323|528584373|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
146566116|NCT02936323|528584374|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
146566117|NCT02936323|528584375|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
146566118|NCT02936323|528584376|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
146566119|NCT02936323|528584377|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
146566120|NCT02936323|528584378|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
146566121|NCT02936323|528584379|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
146566122|NCT02936323|528584380|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
146566123|NCT02936323|528584371|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
146912445|NCT01318902|529841511|FG003|Overall Study|Adverse Event|0|||
146566124|NCT02936323|528584372|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
146566125|NCT02936323|528584373|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
146566126|NCT02936323|528584374|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
146566127|NCT02936323|528584375|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
146566128|NCT02936323|528584376|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
146912446|NCT01318902|529841508|FG000|Overall Study|Terminated by Sponsor|0|||
146912447|NCT01318902|529841509|FG001|Overall Study|Terminated by Sponsor|0|||
146912448|NCT01318902|529841510|FG002|Overall Study|Terminated by Sponsor|1|||
146912449|NCT01318902|529841511|FG003|Overall Study|Terminated by Sponsor|0|||
146912450|NCT03825042|529843072|FG000|Overall Study|Adverse Event|1|||
146912451|NCT03825042|529843073|FG001|Overall Study|Adverse Event|0|||
146912452|NCT03825042|529843072|FG000|Overall Study|Withdrawal by Subject|1|||
146912453|NCT03825042|529843073|FG001|Overall Study|Withdrawal by Subject|0|||
146912454|NCT01158534|529843074|FG000|Overall Study|Withdrawal by Subject|1|||
146912455|NCT01158534|529843074|FG000|Overall Study|Death|1|||
146912456|NCT01158534|529843074|FG000|Overall Study|Other|1|||
146912457|NCT04003155|529843075|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
146912458|NCT04003155|529843076|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
146912459|NCT04003155|529843077|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
146912460|NCT04003155|529843078|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
146912461|NCT04003155|529843079|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
146912462|NCT04003155|529843075|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
146912463|NCT04003155|529843076|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
146912464|NCT04003155|529843077|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
146912465|NCT04003155|529843078|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
146912466|NCT04003155|529843079|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
146912467|NCT04003155|529843075|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
146912468|NCT04003155|529843076|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
146912469|NCT04003155|529843077|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
146912470|NCT04003155|529843078|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
146912471|NCT04003155|529843079|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
146912472|NCT04003155|529843075|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
146912473|NCT04003155|529843076|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
146912474|NCT04003155|529843077|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
146912475|NCT04003155|529843078|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
146912476|NCT04003155|529843079|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
146912477|NCT04003155|529843075|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
146912478|NCT04003155|529843076|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
146912479|NCT04003155|529843077|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
146912480|NCT04003155|529843078|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
146912481|NCT04003155|529843079|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
146912482|NCT04003155|529843075|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
146912483|NCT04003155|529843076|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
146566129|NCT02936323|528584377|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
146566130|NCT02936323|528584378|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
146566131|NCT02936323|528584379|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
146566132|NCT02936323|528584380|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
146566133|NCT02936323|528584371|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
146566134|NCT02936323|528584372|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
146566135|NCT02936323|528584373|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
146566136|NCT02936323|528584374|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
146566137|NCT02936323|528584375|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
146566138|NCT02936323|528584376|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
146566139|NCT02936323|528584377|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
146566140|NCT02936323|528584378|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
146566141|NCT02936323|528584379|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
146566142|NCT02936323|528584380|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
146566143|NCT02936323|528584371|FG000|Phase 2a Dose Expansion|Death|0|||
146566144|NCT02936323|528584372|FG001|Phase 2a Dose Expansion|Death|0|||
146566145|NCT02936323|528584373|FG002|Phase 2a Dose Expansion|Death|0|||
146566146|NCT02936323|528584374|FG003|Phase 2a Dose Expansion|Death|0|||
146566147|NCT02936323|528584375|FG004|Phase 2a Dose Expansion|Death|0|||
146566148|NCT02936323|528584376|FG005|Phase 2a Dose Expansion|Death|0|||
146566149|NCT02936323|528584377|FG006|Phase 2a Dose Expansion|Death|0|||
146566150|NCT02936323|528584378|FG007|Phase 2a Dose Expansion|Death|4|||
146566151|NCT02936323|528584379|FG008|Phase 2a Dose Expansion|Death|8|||
146566152|NCT02936323|528584380|FG009|Phase 2a Dose Expansion|Death|10|||
146566153|NCT02781558|528584381|FG000|Overall Study|Lost to Follow-up|2|||
146566154|NCT02781558|528584382|FG001|Overall Study|Lost to Follow-up|2|||
146566155|NCT02781558|528584381|FG000|Overall Study|Adverse Event|1|||
146566156|NCT02781558|528584382|FG001|Overall Study|Adverse Event|0|||
146566157|NCT00545779|528584385|FG000|Overall Study|Violation of selection criteria at entry|8|||
146566158|NCT00545779|528584385|FG000|Overall Study|Other protocol violation|1|||
146566159|NCT00545779|528584385|FG000|Overall Study|Did not cooperate|7|||
146566160|NCT00545779|528584385|FG000|Overall Study|Withdrawal by Subject|20|||
146566161|NCT00545779|528584385|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
146566162|NCT00545779|528584385|FG000|Overall Study|Failure to return|3|||
146973474|NCT01915498|530063970|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
146973475|NCT01915498|530063971|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
146973476|NCT01915498|530063972|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
146973477|NCT01915498|530063973|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
146973478|NCT01915498|530063974|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
146973479|NCT01915498|530063975|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
146973480|NCT01915498|530063976|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
146973481|NCT01915498|530063977|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
146973482|NCT01915498|530063978|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
146973483|NCT01915498|530063979|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
146973484|NCT01915498|530063980|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
146973485|NCT01915498|530063981|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
146973486|NCT01915498|530063982|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
146973487|NCT01915498|530063964|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146973488|NCT01915498|530063965|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
146973489|NCT01915498|530063966|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
146973490|NCT01915498|530063967|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146973491|NCT01915498|530063968|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146973492|NCT01915498|530063969|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146973493|NCT01915498|530063970|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146973494|NCT01915498|530063971|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
146973495|NCT01915498|530063972|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
146973496|NCT01915498|530063973|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
146973497|NCT01915498|530063974|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146973498|NCT01915498|530063975|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
146973499|NCT01915498|530063976|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146973500|NCT01915498|530063977|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
146973501|NCT01915498|530063978|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146973502|NCT01915498|530063979|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
146973503|NCT01915498|530063980|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
146973504|NCT01915498|530063981|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
146973505|NCT01915498|530063982|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146973506|NCT01915498|530063964|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973507|NCT01915498|530063965|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973508|NCT01915498|530063966|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973509|NCT01915498|530063967|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973510|NCT01915498|530063968|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
146973511|NCT01915498|530063969|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973512|NCT01915498|530063970|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973513|NCT01915498|530063971|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973514|NCT01915498|530063972|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973515|NCT01915498|530063973|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
146973516|NCT01915498|530063974|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973517|NCT01915498|530063975|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973518|NCT01915498|530063976|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973519|NCT01915498|530063977|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973520|NCT01915498|530063978|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973521|NCT01915498|530063979|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973522|NCT01915498|530063980|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973523|NCT01915498|530063981|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973524|NCT01915498|530063982|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146973525|NCT01915498|530063964|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
146973526|NCT01915498|530063965|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
146973527|NCT01915498|530063966|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
146973528|NCT01915498|530063967|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
146973529|NCT01915498|530063968|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
146973530|NCT01915498|530063969|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
146973531|NCT01915498|530063970|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
146973532|NCT01915498|530063971|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
146973533|NCT01915498|530063972|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
146973534|NCT01915498|530063973|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
146973535|NCT01915498|530063974|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
146499554|NCT02278939|528331248|FG001|Overall Study|family emergency unable to commit|0|||
146646322|NCT01604278|528883048|FG000|Overall Study|Lost to Follow-up|1|||
146646323|NCT01604278|528883049|FG001|Overall Study|Lost to Follow-up|0|||
146973536|NCT01915498|530063975|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
146973537|NCT01915498|530063976|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
146973538|NCT01915498|530063977|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
146973539|NCT01915498|530063978|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
146973540|NCT01915498|530063979|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
146973541|NCT01915498|530063980|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
146973542|NCT01915498|530063981|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
146973543|NCT01915498|530063982|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
146973544|NCT01915498|530063964|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973545|NCT01915498|530063965|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973546|NCT01915498|530063966|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973547|NCT01915498|530063967|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973548|NCT01915498|530063968|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973549|NCT01915498|530063969|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973550|NCT01915498|530063970|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973551|NCT01915498|530063971|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973552|NCT01915498|530063972|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973553|NCT01915498|530063973|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973554|NCT01915498|530063974|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
146973555|NCT01915498|530063975|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973556|NCT01915498|530063976|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973557|NCT01915498|530063977|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973558|NCT01915498|530063978|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973559|NCT01915498|530063979|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973560|NCT01915498|530063980|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973561|NCT01915498|530063981|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973562|NCT01915498|530063982|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146973563|NCT01915498|530063964|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
146973564|NCT01915498|530063965|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
146973565|NCT01915498|530063966|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
146973566|NCT01915498|530063967|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
146973567|NCT01915498|530063968|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
146973568|NCT01915498|530063969|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
146973569|NCT01915498|530063970|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
146973570|NCT01915498|530063971|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
146973571|NCT01915498|530063972|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
146973572|NCT01915498|530063973|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
146973573|NCT01915498|530063974|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
146973574|NCT01915498|530063975|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
146973575|NCT01915498|530063976|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
146973576|NCT01915498|530063977|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
146973577|NCT01915498|530063978|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
146973578|NCT01915498|530063979|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
146973579|NCT01915498|530063980|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
146973580|NCT01915498|530063981|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
146973581|NCT01915498|530063982|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
146973582|NCT01915498|530063964|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
146973583|NCT01915498|530063965|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
146973584|NCT01915498|530063966|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
146973585|NCT01915498|530063967|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
146973586|NCT01915498|530063968|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
146973587|NCT01915498|530063969|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
146973588|NCT01915498|530063970|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
146973589|NCT01915498|530063971|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
146973590|NCT01915498|530063972|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
146973591|NCT01915498|530063973|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
146973592|NCT01915498|530063974|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
146973593|NCT01915498|530063975|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
146973594|NCT01915498|530063976|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
146973595|NCT01915498|530063977|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
146973596|NCT01915498|530063978|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
146973597|NCT01915498|530063979|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
146973598|NCT01915498|530063980|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
146973599|NCT01915498|530063981|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
146973600|NCT01915498|530063982|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
146973601|NCT01915498|530063964|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973602|NCT01915498|530063965|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973603|NCT01915498|530063966|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973604|NCT01915498|530063967|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973605|NCT01915498|530063968|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973606|NCT01915498|530063969|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973607|NCT01915498|530063970|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973608|NCT01915498|530063971|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973609|NCT01915498|530063972|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973610|NCT01915498|530063973|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973611|NCT01915498|530063974|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973612|NCT01915498|530063975|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973613|NCT01915498|530063976|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973614|NCT01915498|530063977|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973615|NCT01915498|530063978|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973616|NCT01915498|530063979|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973617|NCT01915498|530063980|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973618|NCT01915498|530063981|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146973619|NCT01915498|530063982|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
146973620|NCT01915498|530063964|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973621|NCT01915498|530063965|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973622|NCT01915498|530063966|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973623|NCT01915498|530063967|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973624|NCT01915498|530063968|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973625|NCT01915498|530063969|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973626|NCT01915498|530063970|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973627|NCT01915498|530063971|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973628|NCT01915498|530063972|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973629|NCT01915498|530063973|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973630|NCT01915498|530063974|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973631|NCT01915498|530063975|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973632|NCT01915498|530063976|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973633|NCT01915498|530063977|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973634|NCT01915498|530063978|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973635|NCT01915498|530063979|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973636|NCT01915498|530063980|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973637|NCT01915498|530063981|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146973638|NCT01915498|530063982|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
146973639|NCT01915498|530063964|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973640|NCT01915498|530063965|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973641|NCT01915498|530063966|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973642|NCT01915498|530063967|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973643|NCT01915498|530063968|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973644|NCT01915498|530063969|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973645|NCT01915498|530063970|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973646|NCT01915498|530063971|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973647|NCT01915498|530063972|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973648|NCT01915498|530063973|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973649|NCT01915498|530063974|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973650|NCT01915498|530063975|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973651|NCT01915498|530063976|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973652|NCT01915498|530063977|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973653|NCT01915498|530063978|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973654|NCT01915498|530063979|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973655|NCT01915498|530063980|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973656|NCT01915498|530063981|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146973657|NCT01915498|530063982|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
146973658|NCT01966107|530063983|FG000|Overall Study|excluded from FAS|21|||
146973659|NCT01966107|530063984|FG001|Overall Study|excluded from FAS|20|||
146973660|NCT01966107|530063983|FG000|Overall Study|discontinued treatment|345|||
146973661|NCT01966107|530063984|FG001|Overall Study|discontinued treatment|372|||
146973662|NCT01966107|530063983|FG000|Overall Study|due to study closure|164|||
146973663|NCT01966107|530063984|FG001|Overall Study|due to study closure|186|||
146973664|NCT01966107|530063983|FG000|Overall Study|withdrew from the study|272|||
146769083|NCT03284957|529323409|FG000|Overall Study|Progressive Disease|3|||
146646324|NCT01604278|528883048|FG000|Overall Study|Administrative problems|2|||
146646325|NCT01604278|528883049|FG001|Overall Study|Administrative problems|1|||
146646326|NCT01604278|528883048|FG000|Overall Study|Withdrawal by Subject|3|||
146646327|NCT01604278|528883049|FG001|Overall Study|Withdrawal by Subject|3|||
146646328|NCT01604278|528883048|FG000|Overall Study|Adverse Event|3|||
146646329|NCT01604278|528883049|FG001|Overall Study|Adverse Event|5|||
146646330|NCT01604278|528883048|FG000|Overall Study|Protocol Deviation|5|||
146646331|NCT01604278|528883049|FG001|Overall Study|Protocol Deviation|3|||
146646332|NCT00409331|528883050|FG000|Overall Study|Physician Decision|1|||
146646333|NCT02184455|528883051|FG000|Overall Study|Lost to Follow-up|1|||
146646334|NCT01347580|528883056|FG000|Overall Study|Withdrawal by Subject|13|||
146646335|NCT01347580|528883057|FG001|Overall Study|Withdrawal by Subject|23|||
146646336|NCT01347580|528883056|FG000|Overall Study|Death|30|||
146646337|NCT01347580|528883057|FG001|Overall Study|Death|19|||
146646338|NCT01347580|528883056|FG000|Overall Study|Protocol Violation|10|||
146646339|NCT01347580|528883057|FG001|Overall Study|Protocol Violation|7|||
146646340|NCT01347580|528883056|FG000|Overall Study|Lost to Follow-up|3|||
146646341|NCT01347580|528883057|FG001|Overall Study|Lost to Follow-up|1|||
146646342|NCT01347580|528883056|FG000|Overall Study|Had other reason|9|||
146646343|NCT01347580|528883057|FG001|Overall Study|Had other reason|6|||
146646344|NCT00730028|528883058|FG000|Overall Study|Adverse Event|23|||
146646345|NCT00730028|528883059|FG001|Overall Study|Adverse Event|26|||
146646346|NCT00730028|528883060|FG002|Overall Study|Adverse Event|16|||
146646347|NCT00730028|528883061|FG003|Overall Study|Adverse Event|20|||
146646348|NCT00730028|528883062|FG004|Overall Study|Adverse Event|43|||
146646349|NCT00730028|528883058|FG000|Overall Study|Lost to Follow-up|13|||
146646350|NCT00730028|528883059|FG001|Overall Study|Lost to Follow-up|26|||
146646351|NCT00730028|528883060|FG002|Overall Study|Lost to Follow-up|22|||
146646352|NCT00730028|528883061|FG003|Overall Study|Lost to Follow-up|26|||
146646353|NCT00730028|528883062|FG004|Overall Study|Lost to Follow-up|25|||
146646354|NCT00730028|528883058|FG000|Overall Study|Protocol Violation|6|||
146646355|NCT00730028|528883059|FG001|Overall Study|Protocol Violation|1|||
146646356|NCT00730028|528883060|FG002|Overall Study|Protocol Violation|1|||
146646357|NCT00730028|528883061|FG003|Overall Study|Protocol Violation|2|||
146646358|NCT00730028|528883062|FG004|Overall Study|Protocol Violation|0|||
146646359|NCT00730028|528883058|FG000|Overall Study|Withdrawal by Subject|9|||
146646360|NCT00730028|528883059|FG001|Overall Study|Withdrawal by Subject|5|||
146646361|NCT00730028|528883060|FG002|Overall Study|Withdrawal by Subject|4|||
146646362|NCT00730028|528883061|FG003|Overall Study|Withdrawal by Subject|5|||
146646363|NCT00730028|528883062|FG004|Overall Study|Withdrawal by Subject|9|||
146646364|NCT00730028|528883058|FG000|Overall Study|Physician Decision|3|||
146646365|NCT00730028|528883059|FG001|Overall Study|Physician Decision|3|||
146646366|NCT00730028|528883060|FG002|Overall Study|Physician Decision|2|||
146646367|NCT00730028|528883061|FG003|Overall Study|Physician Decision|3|||
146646368|NCT00730028|528883062|FG004|Overall Study|Physician Decision|2|||
146646369|NCT00730028|528883058|FG000|Overall Study|Treatment Failure|5|||
146646370|NCT00730028|528883059|FG001|Overall Study|Treatment Failure|5|||
146646371|NCT00730028|528883060|FG002|Overall Study|Treatment Failure|0|||
146646372|NCT00730028|528883061|FG003|Overall Study|Treatment Failure|0|||
146646373|NCT00730028|528883062|FG004|Overall Study|Treatment Failure|1|||
146646374|NCT00730028|528883058|FG000|Overall Study|Randomization Error|1|||
146646375|NCT00730028|528883059|FG001|Overall Study|Randomization Error|0|||
146646376|NCT00730028|528883060|FG002|Overall Study|Randomization Error|0|||
146646377|NCT00730028|528883061|FG003|Overall Study|Randomization Error|0|||
146646378|NCT00730028|528883062|FG004|Overall Study|Randomization Error|2|||
146646379|NCT00874939|528883063|FG000|Overall Study|Study terminated|4|||
146646380|NCT02870933|528883064|FG000|Overall Study|Death|2|||
146646381|NCT02870933|528883065|FG001|Overall Study|Death|1|||
146646382|NCT02870933|528883064|FG000|Overall Study|Withdrawal by Subject|0|||
146646383|NCT02870933|528883065|FG001|Overall Study|Withdrawal by Subject|1|||
146646384|NCT01250496|528883068|FG000|Overall Study|Study terminated|124|||
146646385|NCT01250496|528883069|FG001|Overall Study|Study terminated|124|||
146646386|NCT00003590|528883070|FG000|Overall Study|Ineligible Patient|1|||
146646387|NCT00003590|528883070|FG000|Overall Study|Adverse Event|7|||
146646388|NCT00003590|528883070|FG000|Overall Study|Withdrawal by Subject|1|||
146646389|NCT00003590|528883070|FG000|Overall Study|Lack of Efficacy|11|||
146646390|NCT00003590|528883070|FG000|Overall Study|Death|1|||
146646391|NCT00003590|528883070|FG000|Overall Study|Physician Decision|1|||
146646392|NCT01425463|528883076|FG000|Overall Study|Adverse Event|5|||
146646393|NCT01425463|528883077|FG001|Overall Study|Adverse Event|7|||
146646394|NCT01425463|528883076|FG000|Overall Study|Lack of Efficacy|1|||
146646395|NCT01425463|528883077|FG001|Overall Study|Lack of Efficacy|1|||
146646396|NCT01425463|528883076|FG000|Overall Study|Protocol Violation|2|||
146646397|NCT01425463|528883077|FG001|Overall Study|Protocol Violation|2|||
146646398|NCT01425463|528883076|FG000|Overall Study|Lost to Follow-up|5|||
146499555|NCT02423343|528331254|FG000|Overall Study|Withdrawal by Subject|0|||
146646399|NCT01425463|528883077|FG001|Overall Study|Lost to Follow-up|2|||
146646400|NCT01425463|528883076|FG000|Overall Study|Withdrawal by Subject|7|||
146646401|NCT01425463|528883077|FG001|Overall Study|Withdrawal by Subject|5|||
146646402|NCT01425463|528883076|FG000|Overall Study|Unknown Reason|4|||
146973665|NCT01966107|530063984|FG001|Overall Study|withdrew from the study|303|||
146973666|NCT00689273|530063985|FG000|Overall Study|Adverse Event|3|||
146973667|NCT00689273|530063986|FG001|Overall Study|Adverse Event|1|||
146973668|NCT00689273|530063985|FG000|Overall Study|Lack of Efficacy|3|||
146973669|NCT00689273|530063986|FG001|Overall Study|Lack of Efficacy|0|||
146973670|NCT00689273|530063985|FG000|Overall Study|Lost to Follow-up|0|||
146973671|NCT00689273|530063986|FG001|Overall Study|Lost to Follow-up|2|||
146973672|NCT00689273|530063985|FG000|Overall Study|Other|6|||
146973673|NCT00689273|530063986|FG001|Overall Study|Other|2|||
146973674|NCT00689273|530063985|FG000|Overall Study|Randomized but not Treated|1|||
146973675|NCT00689273|530063986|FG001|Overall Study|Randomized but not Treated|0|||
146973676|NCT01336608|530065718|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
146973677|NCT01336608|530065719|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146973678|NCT01336608|530065720|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146973679|NCT01336608|530065721|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146973680|NCT01336608|530065718|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
146973681|NCT01336608|530065719|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146973682|NCT01336608|530065720|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146973683|NCT01336608|530065721|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146973684|NCT01336608|530065718|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
146973685|NCT01336608|530065719|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
146973686|NCT01336608|530065720|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
146973687|NCT01336608|530065721|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
146973688|NCT01336608|530065718|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
146973689|NCT01336608|530065719|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
146973690|NCT01336608|530065720|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
146973691|NCT01336608|530065721|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
146973692|NCT01336608|530065718|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
146973693|NCT01336608|530065719|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146973694|NCT01336608|530065720|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146973695|NCT01336608|530065721|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146973696|NCT01336608|530065718|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
146973697|NCT01336608|530065719|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
146973698|NCT01336608|530065720|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
146973699|NCT01336608|530065721|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
146973700|NCT01336608|530065718|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146973701|NCT01336608|530065719|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
146973702|NCT01336608|530065720|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146973703|NCT01336608|530065721|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146973704|NCT01336608|530065718|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
146973705|NCT01336608|530065719|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
146973706|NCT01336608|530065720|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
146973707|NCT01336608|530065721|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
146973708|NCT01336608|530065718|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
146973709|NCT01336608|530065719|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
146973710|NCT01336608|530065720|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
146973711|NCT01336608|530065721|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
146973712|NCT01336608|530065718|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
146973713|NCT01336608|530065719|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
146973714|NCT01336608|530065720|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
146973715|NCT01336608|530065721|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
146973716|NCT01336608|530065718|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146973717|NCT01336608|530065719|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
146973718|NCT01336608|530065720|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146973719|NCT01336608|530065721|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146973720|NCT01336608|530065718|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
146973721|NCT01336608|530065719|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
146973722|NCT01336608|530065720|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
146973723|NCT01336608|530065721|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
146973724|NCT01336608|530065718|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
146973725|NCT01336608|530065719|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
146973726|NCT01336608|530065720|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
146973727|NCT01336608|530065721|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
146973728|NCT04723173|530065724|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
146973729|NCT02996448|530065725|FG000|Overall Study|Study terminated due to adverse effects|3|||
146973730|NCT00303316|530065728|FG000|Overall Study|Protocol Violation|1|||
146973731|NCT00303316|530065729|FG001|Overall Study|Protocol Violation|0|||
146973732|NCT00303316|530065728|FG000|Overall Study|Lost to Follow-up|0|||
146973733|NCT00303316|530065729|FG001|Overall Study|Lost to Follow-up|1|||
146973734|NCT00303316|530065728|FG000|Overall Study|Withdrawal by Subject|1|||
146973735|NCT00303316|530065729|FG001|Overall Study|Withdrawal by Subject|2|||
146973736|NCT01160198|530065733|FG000|Overall Study|Withdrawal by Subject|2|||
146973737|NCT01160198|530065734|FG001|Overall Study|Withdrawal by Subject|1|||
146973738|NCT01160198|530065735|FG002|Overall Study|Withdrawal by Subject|0|||
146973739|NCT01160198|530065733|FG000|Overall Study|Adverse Event|0|||
146973740|NCT01160198|530065734|FG001|Overall Study|Adverse Event|1|||
146973741|NCT01160198|530065735|FG002|Overall Study|Adverse Event|0|||
146973742|NCT01160198|530065733|FG000|Overall Study|Lost to Follow-up|0|||
146973743|NCT01160198|530065734|FG001|Overall Study|Lost to Follow-up|1|||
146973744|NCT01160198|530065735|FG002|Overall Study|Lost to Follow-up|0|||
146973745|NCT01160198|530065733|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
146973746|NCT01160198|530065734|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
146973747|NCT01160198|530065735|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
146973748|NCT01796860|530065737|FG000|Overall Study|Withdrawal by Subject|3|||
146973749|NCT02016755|530065738|FG000|Overall Study|Major amputation of index limb|2|||
146973750|NCT02016755|530065738|FG000|Overall Study|Adverse Event|2|||
146973751|NCT02016755|530065738|FG000|Overall Study|Physician Decision|1|||
146973752|NCT02016755|530065738|FG000|Overall Study|Death|2|||
146973753|NCT00563524|530065748|FG000|Overall Study|Adverse Event|0|||
146973754|NCT00563524|530065749|FG001|Overall Study|Adverse Event|1|||
146973755|NCT00563524|530065750|FG002|Overall Study|Adverse Event|0|||
146973756|NCT00563524|530065751|FG003|Overall Study|Adverse Event|0|||
146973757|NCT00563524|530065752|FG004|Overall Study|Adverse Event|2|||
146973758|NCT00563524|530065753|FG005|Overall Study|Adverse Event|0|||
146973759|NCT00563524|530065748|FG000|Overall Study|Lost to Follow-up|1|||
146973760|NCT00563524|530065749|FG001|Overall Study|Lost to Follow-up|0|||
146973761|NCT00563524|530065750|FG002|Overall Study|Lost to Follow-up|0|||
146973762|NCT00563524|530065751|FG003|Overall Study|Lost to Follow-up|0|||
146973763|NCT00563524|530065752|FG004|Overall Study|Lost to Follow-up|0|||
146973764|NCT00563524|530065753|FG005|Overall Study|Lost to Follow-up|0|||
146973765|NCT00563524|530065748|FG000|Overall Study|Protocol Violation|0|||
146973766|NCT00563524|530065749|FG001|Overall Study|Protocol Violation|1|||
146973767|NCT00563524|530065750|FG002|Overall Study|Protocol Violation|0|||
146973768|NCT00563524|530065751|FG003|Overall Study|Protocol Violation|0|||
146973769|NCT00563524|530065752|FG004|Overall Study|Protocol Violation|0|||
146973770|NCT00563524|530065753|FG005|Overall Study|Protocol Violation|0|||
146973771|NCT00563524|530065748|FG000|Overall Study|Withdrawal by Subject|1|||
146973772|NCT00563524|530065749|FG001|Overall Study|Withdrawal by Subject|1|||
146973773|NCT00563524|530065750|FG002|Overall Study|Withdrawal by Subject|3|||
146973774|NCT00563524|530065751|FG003|Overall Study|Withdrawal by Subject|0|||
146973775|NCT00563524|530065752|FG004|Overall Study|Withdrawal by Subject|0|||
146973776|NCT00563524|530065753|FG005|Overall Study|Withdrawal by Subject|1|||
146973777|NCT03543046|530065759|FG000|Overall Study|Adverse Event|1|||
146973778|NCT03543046|530065760|FG001|Overall Study|Adverse Event|1|||
146973779|NCT03543046|530065759|FG000|Overall Study|Physician Decision|1|||
146973780|NCT03543046|530065760|FG001|Overall Study|Physician Decision|1|||
146973781|NCT03543046|530065759|FG000|Overall Study|Protocol Violation|1|||
146973782|NCT03543046|530065760|FG001|Overall Study|Protocol Violation|0|||
146973783|NCT00520494|530065770|FG000|Overall Study|Withdrawal by Subject|1|||
146973784|NCT04247594|530065771|FG000|Overall Study|Withdrawal by Subject|4|||
146973785|NCT02748616|530065772|FG000|Overall Study|Lost to Follow-up|1|||
146973786|NCT02748616|530065772|FG000|Overall Study|Withdrawal by Subject|2|||
146973787|NCT02748616|530065772|FG000|Overall Study|Physician Decision|2|||
146973788|NCT02748616|530065772|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
146973789|NCT00713830|530065773|FG000|Overall Study|Adverse Event|23|||
146973790|NCT00713830|530065774|FG001|Overall Study|Adverse Event|71|||
146973791|NCT00713830|530065773|FG000|Overall Study|Lack of Efficacy|24|||
146973792|NCT00713830|530065774|FG001|Overall Study|Lack of Efficacy|16|||
146973793|NCT00713830|530065773|FG000|Overall Study|Lost to Follow-up|2|||
146566163|NCT01542788|528584386|FG000|Overall Study|Randomized but Not Treated|2|||
146973794|NCT00713830|530065774|FG001|Overall Study|Lost to Follow-up|9|||
146973795|NCT00713830|530065773|FG000|Overall Study|Withdrawal by Subject|13|||
146973796|NCT00713830|530065774|FG001|Overall Study|Withdrawal by Subject|23|||
146973797|NCT00713830|530065773|FG000|Overall Study|Poor Compliance to Protocol|7|||
146973798|NCT00713830|530065774|FG001|Overall Study|Poor Compliance to Protocol|14|||
146973799|NCT00713830|530065773|FG000|Overall Study|Familial and Personal Reasons|9|||
146973800|NCT00713830|530065774|FG001|Overall Study|Familial and Personal Reasons|34|||
146973801|NCT00713830|530065773|FG000|Overall Study|Sponsor Decision|4|||
146973802|NCT00713830|530065774|FG001|Overall Study|Sponsor Decision|10|||
146566164|NCT01542788|528584387|FG001|Overall Study|Randomized but Not Treated|0|||
146973803|NCT00422058|530065775|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
146973804|NCT00422058|530065776|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
146973805|NCT00422058|530065777|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
146973806|NCT00422058|530065778|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
146973807|NCT00422058|530065779|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
146973808|NCT00422058|530065780|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
146973809|NCT00422058|530065775|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
146973810|NCT00422058|530065776|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
146973811|NCT00422058|530065777|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
146973812|NCT00422058|530065778|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
146973813|NCT00422058|530065779|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
146973814|NCT00422058|530065780|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
146973815|NCT00422058|530065775|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
146973816|NCT00422058|530065776|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
146973817|NCT00422058|530065777|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
146973818|NCT00422058|530065778|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
146973819|NCT00422058|530065779|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
146973820|NCT00422058|530065780|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
146973821|NCT00422058|530065775|FG000|Double-Blind, Week 0-20|Other|11|||
146566165|NCT01542788|528584386|FG000|Overall Study|Lack of Efficacy|41|||
146566166|NCT01542788|528584387|FG001|Overall Study|Lack of Efficacy|71|||
146566167|NCT01542788|528584386|FG000|Overall Study|Lost to Follow-up|5|||
146566168|NCT01542788|528584387|FG001|Overall Study|Lost to Follow-up|0|||
146566169|NCT01542788|528584386|FG000|Overall Study|Death|3|||
146566170|NCT01542788|528584387|FG001|Overall Study|Death|0|||
146973822|NCT00422058|530065776|FG001|Double-Blind, Week 0-20|Other|3|||
146973823|NCT00422058|530065777|FG002|Double-Blind, Week 0-20|Other|8|||
146973824|NCT00422058|530065778|FG003|Double-Blind, Week 0-20|Other|8|||
146973825|NCT00422058|530065779|FG004|Double-Blind, Week 0-20|Other|4|||
146973826|NCT00422058|530065780|FG005|Double-Blind, Week 0-20|Other|10|||
146973827|NCT00422058|530065775|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
146973828|NCT00422058|530065776|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
146973829|NCT00422058|530065777|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
146973830|NCT00422058|530065778|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
146973831|NCT00422058|530065779|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
146973832|NCT00422058|530065780|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
146973833|NCT00422058|530065775|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
146973834|NCT00422058|530065776|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
146973835|NCT00422058|530065777|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
146973836|NCT00422058|530065778|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
146973837|NCT00422058|530065779|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
146973838|NCT00422058|530065780|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
146973839|NCT00422058|530065775|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
146975342|NCT00572156|530073541|FG002|Overall Study|Sponsor Decision|17|||
146566171|NCT01542788|528584386|FG000|Overall Study|Protocol Violation|2|||
146566172|NCT01542788|528584387|FG001|Overall Study|Protocol Violation|0|||
146566173|NCT01542788|528584386|FG000|Overall Study|Physician Decision|1|||
146566174|NCT01542788|528584387|FG001|Overall Study|Physician Decision|0|||
146566175|NCT01542788|528584386|FG000|Overall Study|Withdrawal by Subject|1|||
146566176|NCT01542788|528584387|FG001|Overall Study|Withdrawal by Subject|0|||
146566177|NCT03586973|528584388|FG000|Overall Study|Death|15|||
146566178|NCT03586973|528584389|FG001|Overall Study|Death|8|||
146566179|NCT03586973|528584388|FG000|Overall Study|Site Terminated by Sponsor|3|||
146566180|NCT03586973|528584389|FG001|Overall Study|Site Terminated by Sponsor|6|||
146566181|NCT03586973|528584388|FG000|Overall Study|Withdrawal by Subject|1|||
146566182|NCT03586973|528584389|FG001|Overall Study|Withdrawal by Subject|0|||
146566183|NCT03586973|528584388|FG000|Overall Study|Lost to Follow-up|1|||
146566184|NCT03586973|528584389|FG001|Overall Study|Lost to Follow-up|0|||
146566185|NCT01150357|528584390|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
146566186|NCT01150357|528584391|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
146566187|NCT01150357|528584392|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
146566188|NCT01150357|528584390|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
146566189|NCT01150357|528584391|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
146566190|NCT01150357|528584392|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
146566191|NCT01150357|528584390|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
146566192|NCT01150357|528584391|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
146566193|NCT01150357|528584392|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
146566194|NCT01150357|528584390|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
146566195|NCT01150357|528584391|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
146566196|NCT01150357|528584392|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
146566197|NCT01150357|528584390|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
146566198|NCT01150357|528584391|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
146566199|NCT01150357|528584392|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
146566200|NCT01150357|528584390|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
146566201|NCT01150357|528584391|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
146973840|NCT00422058|530065776|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
146973841|NCT00422058|530065777|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
146973842|NCT00422058|530065778|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
146973843|NCT00422058|530065779|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
146973844|NCT00422058|530065780|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
146973845|NCT00422058|530065775|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
146973846|NCT00422058|530065776|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
146973847|NCT00422058|530065777|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
146973848|NCT00422058|530065778|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
146973849|NCT00422058|530065779|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
146973850|NCT00422058|530065780|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
146973851|NCT00422058|530065775|FG000|Open-Label Extension, Week 20-104|Other|13|||
146646403|NCT01425463|528883077|FG001|Overall Study|Unknown Reason|7|||
146646404|NCT01332799|528883078|FG000|Overall Study|Insufficient funding|10|||
146646405|NCT01332799|528883079|FG001|Overall Study|Insufficient funding|10|||
146646406|NCT00668733|528883080|FG000|Overall Study|Lost to Follow-up|2|||
146646407|NCT00668733|528883081|FG001|Overall Study|Lost to Follow-up|3|||
146646408|NCT00668733|528883080|FG000|Overall Study|Withdrawal by Subject|0|||
146646409|NCT00668733|528883081|FG001|Overall Study|Withdrawal by Subject|4|||
146646410|NCT01909791|528883082|FG000|Overall Study|Death|9|||
146646411|NCT01909791|528883083|FG001|Overall Study|Death|8|||
146646412|NCT01909791|528883084|FG002|Overall Study|Death|4|||
146646413|NCT01909791|528883082|FG000|Overall Study|Withdrawal by Subject|5|||
146646414|NCT01909791|528883083|FG001|Overall Study|Withdrawal by Subject|9|||
146646415|NCT01909791|528883084|FG002|Overall Study|Withdrawal by Subject|13|||
146646416|NCT01909791|528883082|FG000|Overall Study|Lost to Follow-up|5|||
146646417|NCT01909791|528883083|FG001|Overall Study|Lost to Follow-up|11|||
146646418|NCT01909791|528883084|FG002|Overall Study|Lost to Follow-up|10|||
146646419|NCT01909791|528883082|FG000|Overall Study|Missed Visit|2|||
146646420|NCT01909791|528883083|FG001|Overall Study|Missed Visit|0|||
146646421|NCT01909791|528883084|FG002|Overall Study|Missed Visit|1|||
146646422|NCT01659554|528883087|FG000|Overall Study|Study Termination|4|||
146646423|NCT00538785|528883089|FG000|Overall Study|Death|9|||
146646424|NCT00538785|528883090|FG001|Overall Study|Death|10|||
146646425|NCT00538785|528883089|FG000|Overall Study|Withdrawal of consent|9|||
146646426|NCT00538785|528883090|FG001|Overall Study|Withdrawal of consent|7|||
146646427|NCT00538785|528883089|FG000|Overall Study|Lost to Follow-up|1|||
146646428|NCT00538785|528883090|FG001|Overall Study|Lost to Follow-up|0|||
146646429|NCT04022733|528883091|FG000|Overall Study|conversion to open surgery|3|||
146646430|NCT04022733|528883092|FG001|Overall Study|conversion to open surgery|2|||
146646431|NCT04022733|528883091|FG000|Overall Study|bradycardia|0|||
146646432|NCT04022733|528883092|FG001|Overall Study|bradycardia|1|||
146646433|NCT02208063|528883098|FG000|Overall Study|Death|3|||
146646434|NCT02208063|528883099|FG001|Overall Study|Death|5|||
146646435|NCT02208063|528883098|FG000|Overall Study|Not Specified in report|3|||
146646436|NCT02208063|528883099|FG001|Overall Study|Not Specified in report|4|||
146646437|NCT02208063|528883098|FG000|Overall Study|Withdrawal by Subject|5|||
146646438|NCT02208063|528883099|FG001|Overall Study|Withdrawal by Subject|2|||
146646439|NCT02208063|528883098|FG000|Overall Study|Lost to Follow-up|1|||
146646440|NCT02208063|528883099|FG001|Overall Study|Lost to Follow-up|0|||
146646441|NCT02122783|528883105|FG000|Overall Study|Adverse Event|0|||
146646442|NCT02122783|528883106|FG001|Overall Study|Adverse Event|1|||
146646443|NCT02213133|528883113|FG000|Overall Study|Participant discontinued study therapy|2|||
146646444|NCT02213133|528883114|FG001|Overall Study|Participant discontinued study therapy|0|||
146646445|NCT02213133|528883115|FG002|Overall Study|Participant discontinued study therapy|0|||
146646446|NCT02213133|528883113|FG000|Overall Study|Participant withdrew informed consent|2|||
146646447|NCT02213133|528883114|FG001|Overall Study|Participant withdrew informed consent|1|||
146646448|NCT02213133|528883115|FG002|Overall Study|Participant withdrew informed consent|2|||
146646449|NCT02213133|528883113|FG000|Overall Study|Disease progression|11|||
146646450|NCT02213133|528883114|FG001|Overall Study|Disease progression|2|||
146646451|NCT02213133|528883115|FG002|Overall Study|Disease progression|0|||
146646452|NCT02213133|528883113|FG000|Overall Study|Adverse Event (AE)|1|||
146646453|NCT02213133|528883114|FG001|Overall Study|Adverse Event (AE)|0|||
146973852|NCT00422058|530065776|FG001|Open-Label Extension, Week 20-104|Other|14|||
146973853|NCT00422058|530065777|FG002|Open-Label Extension, Week 20-104|Other|6|||
146973854|NCT00422058|530065778|FG003|Open-Label Extension, Week 20-104|Other|13|||
146646454|NCT02213133|528883115|FG002|Overall Study|Adverse Event (AE)|0|||
146646455|NCT02213133|528883113|FG000|Overall Study|Death|16|||
146646456|NCT02213133|528883114|FG001|Overall Study|Death|2|||
146646457|NCT02213133|528883115|FG002|Overall Study|Death|1|||
146646458|NCT02213133|528883113|FG000|Overall Study|Other|5|||
146646459|NCT02213133|528883114|FG001|Overall Study|Other|0|||
146646460|NCT02213133|528883115|FG002|Overall Study|Other|0|||
146646461|NCT02744040|528883118|FG000|Overall Study|Withdrawal by Subject|3|||
146646462|NCT02744040|528883119|FG001|Overall Study|Withdrawal by Subject|2|||
146646463|NCT02744040|528883120|FG002|Overall Study|Withdrawal by Subject|2|||
146975343|NCT00572156|530073542|FG003|Overall Study|Sponsor Decision|19|||
146646464|NCT02744040|528883118|FG000|Overall Study|Physician Decision|0|||
146646465|NCT02744040|528883119|FG001|Overall Study|Physician Decision|8|||
146646466|NCT02744040|528883120|FG002|Overall Study|Physician Decision|13|||
146646467|NCT02744040|528883118|FG000|Overall Study|Lost to Follow-up|3|||
146646468|NCT02744040|528883119|FG001|Overall Study|Lost to Follow-up|1|||
146646469|NCT02744040|528883120|FG002|Overall Study|Lost to Follow-up|7|||
146646470|NCT01642615|528883121|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
146646471|NCT01642615|528883122|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
146646472|NCT01642615|528883123|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
146646473|NCT01642615|528883121|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
146646474|NCT01642615|528883122|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
146646475|NCT01642615|528883123|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
146646476|NCT01642615|528883121|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
146646477|NCT01642615|528883122|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
146646478|NCT01642615|528883123|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
146646479|NCT01642615|528883121|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
146646480|NCT01642615|528883122|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
146646481|NCT01642615|528883123|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
146646482|NCT01642615|528883121|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
146646483|NCT01642615|528883122|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
146646484|NCT01642615|528883123|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
146646485|NCT01642615|528883121|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
146646486|NCT01642615|528883122|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
146646487|NCT01642615|528883123|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
146646488|NCT01642615|528883121|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
146912484|NCT04003155|529843077|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
146646489|NCT01642615|528883122|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
146646490|NCT01642615|528883123|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
146646491|NCT01642615|528883121|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
146646492|NCT01642615|528883122|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
146646493|NCT01642615|528883123|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
146646494|NCT01642615|528883121|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
146646495|NCT01642615|528883122|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
146646496|NCT01642615|528883123|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
146646497|NCT00096356|528883124|FG000|Overall Study|Adverse Event|11|||
146646498|NCT00096356|528883125|FG001|Overall Study|Adverse Event|9|||
146646499|NCT00096356|528883124|FG000|Overall Study|Physician Decision|5|||
146646500|NCT00096356|528883125|FG001|Overall Study|Physician Decision|3|||
146646501|NCT00096356|528883124|FG000|Overall Study|Withdrawal by Subject|17|||
146646502|NCT00096356|528883125|FG001|Overall Study|Withdrawal by Subject|23|||
146646503|NCT00096356|528883124|FG000|Overall Study|Lack of Efficacy|1|||
146912485|NCT04003155|529843078|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
146912486|NCT04003155|529843079|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
146912487|NCT04003155|529843075|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
146912488|NCT04003155|529843076|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
146912489|NCT04003155|529843077|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
146912490|NCT04003155|529843078|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
146912491|NCT04003155|529843079|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
146912492|NCT04003155|529843075|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
146912493|NCT04003155|529843076|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
146912494|NCT04003155|529843077|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
146912495|NCT04003155|529843078|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
146912496|NCT04003155|529843079|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
146912497|NCT04003155|529843075|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
146912498|NCT04003155|529843076|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
146912499|NCT04003155|529843077|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
146912500|NCT04003155|529843078|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
146912501|NCT04003155|529843079|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
146912502|NCT03042611|529843080|FG000|Core Phase|Withdrawal by Subject|13|||
146912503|NCT03042611|529843081|FG001|Core Phase|Withdrawal by Subject|4|||
146912504|NCT03042611|529843082|FG002|Core Phase|Withdrawal by Subject|0|||
146912505|NCT03042611|529843083|FG003|Core Phase|Withdrawal by Subject|0|||
146912506|NCT03042611|529843080|FG000|Core Phase|Death|232|||
146912507|NCT03042611|529843081|FG001|Core Phase|Death|110|||
146912508|NCT03042611|529843082|FG002|Core Phase|Death|0|||
146912509|NCT03042611|529843083|FG003|Core Phase|Death|0|||
146912510|NCT03042611|529843080|FG000|Core Phase|Lost to Follow-up|4|||
146912511|NCT03042611|529843081|FG001|Core Phase|Lost to Follow-up|7|||
146912512|NCT03042611|529843082|FG002|Core Phase|Lost to Follow-up|0|||
146912513|NCT03042611|529843083|FG003|Core Phase|Lost to Follow-up|0|||
146912514|NCT03042611|529843080|FG000|Core Phase|Physician Decision|7|||
146973855|NCT00422058|530065779|FG004|Open-Label Extension, Week 20-104|Other|16|||
146973856|NCT00422058|530065780|FG005|Open-Label Extension, Week 20-104|Other|18|||
146973857|NCT02787785|530065783|FG000|Overall Study|Death|3|||
146646504|NCT00096356|528883125|FG001|Overall Study|Lack of Efficacy|0|||
146646505|NCT00096356|528883124|FG000|Overall Study|multiple reasons|10|||
146646506|NCT00096356|528883125|FG001|Overall Study|multiple reasons|18|||
146646507|NCT00402740|528883129|FG000|Overall Study|Withdrawal by Subject|18|||
146646508|NCT00402740|528883129|FG000|Overall Study|Death|50|||
146646509|NCT00402740|528883129|FG000|Overall Study|Lost to Follow-up|6|||
146646510|NCT00402740|528883129|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
146646511|NCT00402740|528883129|FG000|Overall Study|Subject disposition unknown.|1|||
146646512|NCT01699867|528883132|FG000|Overall Study|Screening Failure|3|||
146646513|NCT01675167|528883145|FG000|Open-label Titration Phase|Adverse Event|81|||
146646514|NCT01675167|528883146|FG001|Open-label Titration Phase|Adverse Event|0|||
146646515|NCT01675167|528883147|FG002|Open-label Titration Phase|Adverse Event|0|||
146646516|NCT01675167|528883145|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
146646517|NCT01675167|528883146|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
146646518|NCT01675167|528883147|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
146646519|NCT01675167|528883145|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
146646520|NCT01675167|528883146|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
146646521|NCT01675167|528883147|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
146646522|NCT01675167|528883145|FG000|Open-label Titration Phase|Protocol Violation|43|||
146646523|NCT01675167|528883146|FG001|Open-label Titration Phase|Protocol Violation|0|||
146646524|NCT01675167|528883147|FG002|Open-label Titration Phase|Protocol Violation|0|||
146646525|NCT01675167|528883145|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
146646526|NCT01675167|528883146|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
146646527|NCT01675167|528883147|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
146769084|NCT03284957|529323410|FG001|Overall Study|Progressive Disease|3|||
146973858|NCT02787785|530065784|FG001|Overall Study|Death|4|||
146973859|NCT02787785|530065783|FG000|Overall Study|Lost to Follow-up|1|||
146973860|NCT02787785|530065784|FG001|Overall Study|Lost to Follow-up|1|||
146566202|NCT01150357|528584392|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
146566203|NCT01150357|528584390|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
146566204|NCT01150357|528584391|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
146566205|NCT01150357|528584392|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
146566206|NCT02336815|528585993|FG000|Overall Study|Disease Progression|45|||
146566207|NCT02336815|528585994|FG001|Overall Study|Disease Progression|70|||
146566208|NCT02336815|528585993|FG000|Overall Study|Adverse Event|18|||
146566209|NCT02336815|528585994|FG001|Overall Study|Adverse Event|39|||
146566210|NCT02336815|528585993|FG000|Overall Study|Physician Decision|11|||
146566211|NCT02336815|528585994|FG001|Overall Study|Physician Decision|4|||
146566212|NCT02336815|528585993|FG000|Overall Study|Withdrawal by Subject|3|||
146566213|NCT02336815|528585994|FG001|Overall Study|Withdrawal by Subject|2|||
146566214|NCT02336815|528585993|FG000|Overall Study|Lost to Follow-up|1|||
146566215|NCT02336815|528585994|FG001|Overall Study|Lost to Follow-up|3|||
146566216|NCT02336815|528585993|FG000|Overall Study|Other|1|||
146566217|NCT02336815|528585994|FG001|Overall Study|Other|5|||
146566218|NCT00952705|528585995|FG000|Overall Study|Lost to Follow-up|24|||
146566219|NCT00952705|528585996|FG001|Overall Study|Lost to Follow-up|8|||
146566220|NCT00952705|528585997|FG002|Overall Study|Lost to Follow-up|9|||
146566221|NCT00952705|528585995|FG000|Overall Study|Withdrawal by Subject|2|||
146566222|NCT00952705|528585996|FG001|Overall Study|Withdrawal by Subject|1|||
146566223|NCT00952705|528585997|FG002|Overall Study|Withdrawal by Subject|1|||
146566224|NCT00952705|528585995|FG000|Overall Study|Death|2|||
146566225|NCT00952705|528585996|FG001|Overall Study|Death|0|||
146566226|NCT00952705|528585997|FG002|Overall Study|Death|0|||
146566227|NCT00952705|528585995|FG000|Overall Study|Incarcerated post dose|5|||
146566228|NCT00952705|528585996|FG001|Overall Study|Incarcerated post dose|0|||
146566229|NCT00952705|528585997|FG002|Overall Study|Incarcerated post dose|0|||
146566230|NCT00952705|528585995|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
146566231|NCT00952705|528585996|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
146566232|NCT00952705|528585997|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
146566233|NCT00140140|528585998|FG000|Overall Study|Unacceptable toxicity|1|||
146566234|NCT00140140|528585999|FG001|Overall Study|Unacceptable toxicity|1|||
146566235|NCT00140140|528586000|FG002|Overall Study|Unacceptable toxicity|2|||
146566236|NCT00140140|528585998|FG000|Overall Study|Physician Decision|1|||
146566237|NCT00140140|528585999|FG001|Overall Study|Physician Decision|1|||
146566238|NCT00140140|528586000|FG002|Overall Study|Physician Decision|0|||
146566239|NCT03376516|528586001|FG000|Overall Study|Not treated|1|||
146566240|NCT03376516|528586001|FG000|Overall Study|Consent withdrawn|1|||
146566241|NCT01581684|528586002|FG000|Overall Study|Other reason not defined|0|||
146566242|NCT01581684|528586003|FG001|Overall Study|Other reason not defined|0|||
146566243|NCT01581684|528586004|FG002|Overall Study|Other reason not defined|0|||
146566244|NCT01581684|528586005|FG003|Overall Study|Other reason not defined|0|||
146973861|NCT02787785|530065783|FG000|Overall Study|Withdrawal by Subject|0|||
146566245|NCT01581684|528586006|FG004|Overall Study|Other reason not defined|0|||
146973862|NCT02787785|530065784|FG001|Overall Study|Withdrawal by Subject|5|||
146973863|NCT02030834|530065785|FG000|Overall Study|Death|4|||
146973864|NCT02030834|530065786|FG001|Overall Study|Death|0|||
146973865|NCT02030834|530065787|FG002|Overall Study|Death|0|||
146973866|NCT02030834|530065785|FG000|Overall Study|Manufacturing failure|2|||
146973867|NCT02030834|530065786|FG001|Overall Study|Manufacturing failure|0|||
146973868|NCT02030834|530065787|FG002|Overall Study|Manufacturing failure|1|||
146973869|NCT02030834|530065785|FG000|Overall Study|Disease progression|2|||
146973870|NCT02030834|530065786|FG001|Overall Study|Disease progression|0|||
146973871|NCT02030834|530065787|FG002|Overall Study|Disease progression|2|||
146973872|NCT02030834|530065785|FG000|Overall Study|Lost to Follow-up|1|||
146973873|NCT02030834|530065786|FG001|Overall Study|Lost to Follow-up|0|||
146973874|NCT02030834|530065787|FG002|Overall Study|Lost to Follow-up|0|||
146973875|NCT02030834|530065785|FG000|Overall Study|Withdrawal by Subject|1|||
146973876|NCT02030834|530065786|FG001|Overall Study|Withdrawal by Subject|0|||
146499556|NCT02423343|528331255|FG001|Overall Study|Withdrawal by Subject|1|||
146499557|NCT02423343|528331256|FG002|Overall Study|Withdrawal by Subject|0|||
146499558|NCT02423343|528331257|FG003|Overall Study|Withdrawal by Subject|0|||
146499559|NCT02423343|528331258|FG004|Overall Study|Withdrawal by Subject|0|||
146499560|NCT02423343|528331259|FG005|Overall Study|Withdrawal by Subject|0|||
146499561|NCT02423343|528331254|FG000|Overall Study|Progressive Disease|0|||
146499562|NCT02423343|528331255|FG001|Overall Study|Progressive Disease|0|||
146499563|NCT02423343|528331256|FG002|Overall Study|Progressive Disease|0|||
146499564|NCT02423343|528331257|FG003|Overall Study|Progressive Disease|0|||
146499565|NCT02423343|528331258|FG004|Overall Study|Progressive Disease|2|||
146499566|NCT02423343|528331259|FG005|Overall Study|Progressive Disease|0|||
146499567|NCT02423343|528331254|FG000|Overall Study|Adverse Event|0|||
146499568|NCT02423343|528331255|FG001|Overall Study|Adverse Event|0|||
146499569|NCT02423343|528331256|FG002|Overall Study|Adverse Event|0|||
146499570|NCT02423343|528331257|FG003|Overall Study|Adverse Event|0|||
146499571|NCT02423343|528331258|FG004|Overall Study|Adverse Event|2|||
146499572|NCT02423343|528331259|FG005|Overall Study|Adverse Event|0|||
146499573|NCT02423343|528331254|FG000|Overall Study|Death|0|||
146499574|NCT02423343|528331255|FG001|Overall Study|Death|0|||
146499575|NCT02423343|528331256|FG002|Overall Study|Death|0|||
146499576|NCT02423343|528331257|FG003|Overall Study|Death|0|||
146499577|NCT02423343|528331258|FG004|Overall Study|Death|1|||
146499578|NCT02423343|528331259|FG005|Overall Study|Death|0|||
146499579|NCT00930774|528331262|FG000|Overall Study|Withdrawal by Subject|1|||
146499580|NCT00930774|528331263|FG001|Overall Study|Withdrawal by Subject|9|||
146499581|NCT00930774|528331264|FG002|Overall Study|Withdrawal by Subject|2|||
146499582|NCT00930774|528331265|FG003|Overall Study|Withdrawal by Subject|0|||
146973877|NCT02030834|530065787|FG002|Overall Study|Withdrawal by Subject|0|||
146973878|NCT02030834|530065785|FG000|Overall Study|Lack of funding|1|||
146973879|NCT02030834|530065786|FG001|Overall Study|Lack of funding|0|||
146973880|NCT02030834|530065787|FG002|Overall Study|Lack of funding|0|||
146973881|NCT00854607|530065791|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
146973882|NCT00965263|530065799|FG000|Overall Study|Physician Decision|2|||
146973883|NCT00965263|530065800|FG001|Overall Study|Physician Decision|0|||
146973884|NCT00965263|530065799|FG000|Overall Study|Family emergency|0|||
146973885|NCT00965263|530065800|FG001|Overall Study|Family emergency|1|||
146973886|NCT00965263|530065799|FG000|Overall Study|Protocol Violation|0|||
146973887|NCT00965263|530065800|FG001|Overall Study|Protocol Violation|2|||
146973888|NCT01766310|530065801|FG000|Overall Study|Lost to Follow-up|1|||
146973889|NCT01766310|530065802|FG001|Overall Study|Lost to Follow-up|3|||
146973890|NCT03151707|530065803|FG000|Overall Study|Lost to Follow-up|6|||
146973891|NCT00646282|530065805|FG000|Overall Study|Protocol terminated|4|||
146973892|NCT00646282|530065806|FG001|Overall Study|Protocol terminated|4|||
146973893|NCT00530088|530065807|FG000|Overall Study|Disease Progression|4|||
146973894|NCT00530088|530065807|FG000|Overall Study|Physician Decision|4|||
146499583|NCT02042950|528331266|FG000|Overall Study|Progressive Disease|4|||
146499584|NCT01683266|528331269|FG000|Overall Study|Adverse Event|5|||
146499585|NCT01683266|528331270|FG001|Overall Study|Adverse Event|4|||
146499586|NCT01683266|528331269|FG000|Overall Study|Lack of Efficacy|5|||
146499587|NCT01683266|528331270|FG001|Overall Study|Lack of Efficacy|2|||
146646528|NCT01675167|528883145|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
146646529|NCT01675167|528883146|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
146646530|NCT01675167|528883147|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
146646531|NCT01675167|528883145|FG000|Open-label Titration Phase|Other|55|||
146499588|NCT01683266|528331269|FG000|Overall Study|Protocol Violation|13|||
146499589|NCT01683266|528331270|FG001|Overall Study|Protocol Violation|6|||
146499590|NCT01683266|528331269|FG000|Overall Study|Personal Reason|17|||
146499591|NCT01683266|528331270|FG001|Overall Study|Personal Reason|25|||
146646532|NCT01675167|528883146|FG001|Open-label Titration Phase|Other|0|||
146973895|NCT00530088|530065807|FG000|Overall Study|Other Not Specified|2|||
146973896|NCT00902278|530065808|FG000|Overall Study|Physician Decision|1|||
146973897|NCT00902278|530065809|FG001|Overall Study|Physician Decision|0|||
146973898|NCT00902278|530065810|FG002|Overall Study|Physician Decision|2|||
146973899|NCT00902278|530065811|FG003|Overall Study|Physician Decision|0|||
146499592|NCT01683266|528331269|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
146499593|NCT01683266|528331270|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
146499594|NCT01683266|528331269|FG000|Overall Study|Lost to Follow-up|5|||
146499595|NCT01683266|528331270|FG001|Overall Study|Lost to Follow-up|0|||
146499596|NCT01683266|528331269|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
146499597|NCT01683266|528331270|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
146646533|NCT01675167|528883147|FG002|Open-label Titration Phase|Other|0|||
146646534|NCT01675167|528883145|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
146646535|NCT01675167|528883146|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
146646536|NCT01675167|528883147|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
146646537|NCT01675167|528883145|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146646538|NCT01675167|528883146|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
146646539|NCT01675167|528883147|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
146646540|NCT01675167|528883145|FG000|Double-blind Treatment Phase|Adverse Event|0|||
146646541|NCT01675167|528883146|FG001|Double-blind Treatment Phase|Adverse Event|5|||
146646542|NCT01675167|528883147|FG002|Double-blind Treatment Phase|Adverse Event|13|||
146646543|NCT01675167|528883145|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
146646544|NCT01675167|528883146|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
146646545|NCT01675167|528883147|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
146646546|NCT01675167|528883145|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
146646547|NCT01675167|528883146|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
146646548|NCT01675167|528883147|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
146646549|NCT01675167|528883145|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
146646550|NCT01675167|528883146|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
146646551|NCT01675167|528883147|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
146646552|NCT01675167|528883145|FG000|Double-blind Treatment Phase|Other|0|||
146646553|NCT01675167|528883146|FG001|Double-blind Treatment Phase|Other|7|||
146646554|NCT01675167|528883147|FG002|Double-blind Treatment Phase|Other|5|||
146646555|NCT03255083|528883148|FG000|Overall Study|Clinical progression|1|||
146646556|NCT03255083|528883149|FG001|Overall Study|Clinical progression|0|||
146646557|NCT03255083|528883150|FG002|Overall Study|Clinical progression|0|||
146646558|NCT03255083|528883151|FG003|Overall Study|Clinical progression|0|||
146646559|NCT03255083|528883148|FG000|Overall Study|Adverse Event|0|||
146646560|NCT03255083|528883149|FG001|Overall Study|Adverse Event|1|||
146646561|NCT03255083|528883150|FG002|Overall Study|Adverse Event|0|||
146646562|NCT03255083|528883151|FG003|Overall Study|Adverse Event|0|||
146646563|NCT03255083|528883148|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
146646564|NCT03255083|528883149|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
146646565|NCT03255083|528883150|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
146646566|NCT03255083|528883151|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
146646567|NCT03255083|528883148|FG000|Overall Study|Withdrawal by Subject|1|||
146646568|NCT03255083|528883149|FG001|Overall Study|Withdrawal by Subject|1|||
146646569|NCT03255083|528883150|FG002|Overall Study|Withdrawal by Subject|1|||
146646570|NCT03255083|528883151|FG003|Overall Study|Withdrawal by Subject|0|||
146646571|NCT00363545|528883152|FG000|Overall Study|Serious Adverse Event|0|||
146646572|NCT00363545|528883153|FG001|Overall Study|Serious Adverse Event|1|||
146646573|NCT00363545|528883152|FG000|Overall Study|Withdrawal by Subject|12|||
146646574|NCT00363545|528883153|FG001|Overall Study|Withdrawal by Subject|15|||
146646575|NCT00363545|528883152|FG000|Overall Study|Migrated/moved from study area|3|||
146646576|NCT00363545|528883153|FG001|Overall Study|Migrated/moved from study area|6|||
146646577|NCT00363545|528883152|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
146646578|NCT00363545|528883153|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
146646579|NCT00363545|528883152|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
146646580|NCT00363545|528883153|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
146646581|NCT00363545|528883152|FG000|Overall Study|Others|1|||
146646582|NCT00363545|528883153|FG001|Overall Study|Others|0|||
146646583|NCT01457352|528883154|FG000|Period 1|Adverse Event|2|||
146646584|NCT01457352|528883155|FG001|Period 1|Adverse Event|0|||
146646585|NCT01457352|528883154|FG000|Period 1|Withdrawal by Subject|2|||
146646586|NCT01457352|528883155|FG001|Period 1|Withdrawal by Subject|0|||
146499598|NCT01683266|528331269|FG000|Overall Study|Nonserious Hypoglycemia|0|||
146646587|NCT01457352|528883154|FG000|Period 1|Physician Decision|2|||
146646588|NCT01457352|528883155|FG001|Period 1|Physician Decision|0|||
146646589|NCT01457352|528883154|FG000|Period 1|MS related disease progression|1|||
146646590|NCT01457352|528883155|FG001|Period 1|MS related disease progression|0|||
146646591|NCT01457352|528883154|FG000|Period 1|Withdrawn|1|||
146646592|NCT01457352|528883155|FG001|Period 1|Withdrawn|0|||
146646593|NCT01457352|528883154|FG000|Period 1|withdrew per sponsor|1|||
146646594|NCT01457352|528883155|FG001|Period 1|withdrew per sponsor|0|||
146646595|NCT01457352|528883154|FG000|Period 1|Protocol Violation|4|||
146646596|NCT01457352|528883155|FG001|Period 1|Protocol Violation|0|||
146646597|NCT01457352|528883154|FG000|Period 1|Did not meet eligibility criteria|3|||
146646598|NCT01457352|528883155|FG001|Period 1|Did not meet eligibility criteria|0|||
146973900|NCT00902278|530065812|FG004|Overall Study|Physician Decision|1|||
146973901|NCT00902278|530065808|FG000|Overall Study|Lost to Follow-up|3|||
146973902|NCT00902278|530065809|FG001|Overall Study|Lost to Follow-up|2|||
146973903|NCT00902278|530065810|FG002|Overall Study|Lost to Follow-up|3|||
146973904|NCT00902278|530065811|FG003|Overall Study|Lost to Follow-up|0|||
146973905|NCT00902278|530065812|FG004|Overall Study|Lost to Follow-up|1|||
146973906|NCT02873195|530065844|FG000|Overall Study|Ineligible|5|||
146973907|NCT02873195|530065845|FG001|Overall Study|Ineligible|0|||
146973908|NCT02508649|530065846|FG000|Overall Study|Withdrawal by Subject|4|||
146973909|NCT02508649|530065847|FG001|Overall Study|Withdrawal by Subject|6|||
146973910|NCT02508649|530065848|FG002|Overall Study|Withdrawal by Subject|5|||
146973911|NCT02508649|530065849|FG003|Overall Study|Withdrawal by Subject|6|||
146973912|NCT02508649|530065846|FG000|Overall Study|Investigator withdrew the subject|1|||
146973913|NCT02508649|530065847|FG001|Overall Study|Investigator withdrew the subject|2|||
146973914|NCT02508649|530065848|FG002|Overall Study|Investigator withdrew the subject|1|||
146973915|NCT02508649|530065849|FG003|Overall Study|Investigator withdrew the subject|0|||
146973916|NCT02508649|530065846|FG000|Overall Study|Post randomization screening failure|12|||
146973917|NCT02508649|530065847|FG001|Overall Study|Post randomization screening failure|4|||
146973918|NCT02508649|530065848|FG002|Overall Study|Post randomization screening failure|9|||
146973919|NCT02508649|530065849|FG003|Overall Study|Post randomization screening failure|3|||
146973920|NCT02508649|530065846|FG000|Overall Study|Lost to Follow-up|1|||
146973921|NCT02508649|530065847|FG001|Overall Study|Lost to Follow-up|1|||
146973922|NCT02508649|530065848|FG002|Overall Study|Lost to Follow-up|0|||
146973923|NCT02508649|530065849|FG003|Overall Study|Lost to Follow-up|1|||
146973924|NCT02149199|530065853|FG000|Overall Study|Study specific withdrawal criteria|4|||
146973925|NCT02149199|530065854|FG001|Overall Study|Study specific withdrawal criteria|21|||
146973926|NCT02149199|530065855|FG002|Overall Study|Study specific withdrawal criteria|6|||
146973927|NCT02149199|530065853|FG000|Overall Study|Other|20|||
146973928|NCT02149199|530065854|FG001|Overall Study|Other|25|||
146973929|NCT02149199|530065855|FG002|Overall Study|Other|20|||
146973930|NCT02149199|530065853|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
146973931|NCT02149199|530065854|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
146973932|NCT02149199|530065855|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
146973933|NCT02149199|530065853|FG000|Overall Study|Withdrawal by Subject|75|||
146499599|NCT01683266|528331270|FG001|Overall Study|Nonserious Hypoglycemia|3|||
146499600|NCT01683266|528331269|FG000|Overall Study|Perceived Lack of Efficacy|1|||
146499601|NCT01683266|528331270|FG001|Overall Study|Perceived Lack of Efficacy|1|||
146499602|NCT01683266|528331269|FG000|Overall Study|Possibly Hypoglycemia|1|||
146499603|NCT01683266|528331270|FG001|Overall Study|Possibly Hypoglycemia|0|||
146499604|NCT01683266|528331269|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
146499605|NCT01683266|528331270|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
146499606|NCT02217410|528331271|FG000|Overall Study|Graft Loss|0|||
146499607|NCT02217410|528331272|FG001|Overall Study|Graft Loss|0|||
146499608|NCT02217410|528331273|FG002|Overall Study|Graft Loss|2|||
146499609|NCT02217410|528331271|FG000|Overall Study|Withdrawal by Subject|0|||
146499610|NCT02217410|528331272|FG001|Overall Study|Withdrawal by Subject|0|||
146499611|NCT02217410|528331273|FG002|Overall Study|Withdrawal by Subject|2|||
146499612|NCT02217410|528331271|FG000|Overall Study|Lost to Follow-up|0|||
146499613|NCT02217410|528331272|FG001|Overall Study|Lost to Follow-up|0|||
146499614|NCT02217410|528331273|FG002|Overall Study|Lost to Follow-up|1|||
146499615|NCT02217410|528331271|FG000|Overall Study|Lack of Efficacy|0|||
146499616|NCT02217410|528331272|FG001|Overall Study|Lack of Efficacy|1|||
146499617|NCT02217410|528331273|FG002|Overall Study|Lack of Efficacy|0|||
146499618|NCT02217410|528331271|FG000|Overall Study|Physician Decision|1|||
146499619|NCT02217410|528331272|FG001|Overall Study|Physician Decision|3|||
146499620|NCT02217410|528331273|FG002|Overall Study|Physician Decision|0|||
146499621|NCT01940887|528331277|FG000|Year 1|Protocol Violation|0|||
146499622|NCT01940887|528331278|FG001|Year 1|Protocol Violation|1|||
146499623|NCT01940887|528331277|FG000|Year 1|Physician Decision|7|||
146499624|NCT01940887|528331278|FG001|Year 1|Physician Decision|3|||
146499625|NCT01940887|528331277|FG000|Year 1|Death|5|||
146499626|NCT01940887|528331278|FG001|Year 1|Death|3|||
146499627|NCT01940887|528331277|FG000|Year 1|Adverse Event|7|||
146499628|NCT01940887|528331278|FG001|Year 1|Adverse Event|6|||
146566246|NCT01581684|528586007|FG005|Overall Study|Other reason not defined|0|||
146566247|NCT01581684|528586008|FG006|Overall Study|Other reason not defined|0|||
146566248|NCT01581684|528586009|FG007|Overall Study|Other reason not defined|0|||
146566249|NCT01581684|528586010|FG008|Overall Study|Other reason not defined|1|||
146566250|NCT01581684|528586011|FG009|Overall Study|Other reason not defined|0|||
146973934|NCT02149199|530065854|FG001|Overall Study|Withdrawal by Subject|93|||
146973935|NCT02149199|530065855|FG002|Overall Study|Withdrawal by Subject|77|||
146973936|NCT02149199|530065853|FG000|Overall Study|Protocol Violation|16|||
146973937|NCT02149199|530065854|FG001|Overall Study|Protocol Violation|13|||
146973938|NCT02149199|530065855|FG002|Overall Study|Protocol Violation|15|||
146499629|NCT01940887|528331277|FG000|Year 1|Withdrawal by Subject|18|||
146499630|NCT01940887|528331278|FG001|Year 1|Withdrawal by Subject|9|||
146499631|NCT01940887|528331277|FG000|Year 1|Lost to Follow-up|2|||
146499632|NCT01940887|528331278|FG001|Year 1|Lost to Follow-up|1|||
146499633|NCT01940887|528331277|FG000|Year 2|Physician Decision|8|||
146499634|NCT01940887|528331278|FG001|Year 2|Physician Decision|1|||
146499635|NCT01940887|528331277|FG000|Year 2|Death|0|||
146499636|NCT01940887|528331278|FG001|Year 2|Death|2|||
146499637|NCT01940887|528331277|FG000|Year 2|Sponsor Decision, early termination|192|||
146499638|NCT01940887|528331278|FG001|Year 2|Sponsor Decision, early termination|203|||
146499639|NCT01940887|528331277|FG000|Year 2|Adverse Event|8|||
146499640|NCT01940887|528331278|FG001|Year 2|Adverse Event|2|||
146499641|NCT01940887|528331277|FG000|Year 2|Withdrawal by Subject|8|||
146499642|NCT01940887|528331278|FG001|Year 2|Withdrawal by Subject|8|||
146499643|NCT01940887|528331277|FG000|Year 2|Lost to Follow-up|1|||
146499644|NCT01940887|528331278|FG001|Year 2|Lost to Follow-up|6|||
146499645|NCT01062113|528331279|FG000|Overall Study|Adverse Event|1|||
146499646|NCT01062113|528331280|FG001|Overall Study|Adverse Event|0|||
146499647|NCT01062113|528331281|FG002|Overall Study|Adverse Event|0|||
146499648|NCT01062113|528331279|FG000|Overall Study|Lack of Efficacy|38|||
146499649|NCT01062113|528331280|FG001|Overall Study|Lack of Efficacy|22|||
146499650|NCT01062113|528331281|FG002|Overall Study|Lack of Efficacy|31|||
146499651|NCT01062113|528331279|FG000|Overall Study|Withdrawal by Subject|1|||
146499652|NCT01062113|528331280|FG001|Overall Study|Withdrawal by Subject|0|||
146973939|NCT02149199|530065853|FG000|Overall Study|Lost to Follow-up|3|||
146499653|NCT01062113|528331281|FG002|Overall Study|Withdrawal by Subject|0|||
146499654|NCT03521115|528331283|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
146499655|NCT03521115|528331284|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
146499656|NCT03521115|528331283|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
146499657|NCT03521115|528331284|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
146499658|NCT03655470|528331292|FG000|Overall Study|Lost to Follow-up|6|||
146499659|NCT03655470|528331293|FG001|Overall Study|Lost to Follow-up|7|||
146499660|NCT04590586|528331294|FG000|Overall Study|Death|7|||
146499661|NCT04590586|528331295|FG001|Overall Study|Death|1|||
146499662|NCT04590586|528331296|FG002|Overall Study|Death|37|||
146499663|NCT04590586|528331297|FG003|Overall Study|Death|34|||
146499664|NCT04590586|528331298|FG004|Overall Study|Death|19|||
146499665|NCT04590586|528331299|FG005|Overall Study|Death|3|||
146499666|NCT04590586|528331294|FG000|Overall Study|Lost to Follow-up|3|||
146499667|NCT04590586|528331295|FG001|Overall Study|Lost to Follow-up|0|||
146499668|NCT04590586|528331296|FG002|Overall Study|Lost to Follow-up|11|||
146499669|NCT04590586|528331297|FG003|Overall Study|Lost to Follow-up|11|||
146499670|NCT04590586|528331298|FG004|Overall Study|Lost to Follow-up|6|||
146499671|NCT04590586|528331299|FG005|Overall Study|Lost to Follow-up|0|||
146499672|NCT04590586|528331294|FG000|Overall Study|Withdrawal by Subject|0|||
146499673|NCT04590586|528331295|FG001|Overall Study|Withdrawal by Subject|0|||
146499674|NCT04590586|528331296|FG002|Overall Study|Withdrawal by Subject|6|||
146499675|NCT04590586|528331297|FG003|Overall Study|Withdrawal by Subject|0|||
146499676|NCT04590586|528331298|FG004|Overall Study|Withdrawal by Subject|3|||
146499677|NCT04590586|528331299|FG005|Overall Study|Withdrawal by Subject|0|||
146499678|NCT04590586|528331294|FG000|Overall Study|Other|3|||
146499679|NCT04590586|528331295|FG001|Overall Study|Other|0|||
146499680|NCT04590586|528331296|FG002|Overall Study|Other|1|||
146499681|NCT04590586|528331297|FG003|Overall Study|Other|1|||
146499682|NCT04590586|528331298|FG004|Overall Study|Other|2|||
146973940|NCT02149199|530065854|FG001|Overall Study|Lost to Follow-up|12|||
146973941|NCT02149199|530065855|FG002|Overall Study|Lost to Follow-up|11|||
146499683|NCT04590586|528331299|FG005|Overall Study|Other|1|||
146499684|NCT01893281|528331300|FG000|Overall Study|Adverse Event|1|||
146499685|NCT01893281|528331300|FG000|Overall Study|Protocol Violation|1|||
146499686|NCT01893281|528331300|FG000|Overall Study|Withdrawal by Subject|1|||
146499687|NCT00562302|528331306|FG000|Overall Study|Lost to Follow-up|3|||
146499688|NCT00562302|528331307|FG001|Overall Study|Lost to Follow-up|3|||
146499689|NCT00562302|528331306|FG000|Overall Study|Adverse Event|0|||
146499690|NCT00562302|528331307|FG001|Overall Study|Adverse Event|6|||
146499691|NCT00562302|528331306|FG000|Overall Study|Non-compliance|1|||
146499692|NCT00562302|528331307|FG001|Overall Study|Non-compliance|2|||
146499693|NCT00562302|528331306|FG000|Overall Study|Withdrawal by Subject|7|||
146499694|NCT00562302|528331307|FG001|Overall Study|Withdrawal by Subject|8|||
146499695|NCT00562302|528331306|FG000|Overall Study|Death|1|||
146499696|NCT00562302|528331307|FG001|Overall Study|Death|2|||
146499697|NCT00562302|528331306|FG000|Overall Study|Lung resection prior to study completion|7|||
146499698|NCT00562302|528331307|FG001|Overall Study|Lung resection prior to study completion|7|||
146499699|NCT00562302|528331306|FG000|Overall Study|Not stated|1|||
146499700|NCT00562302|528331307|FG001|Overall Study|Not stated|4|||
146499701|NCT01290679|528331308|FG000|Overall Study|Adverse Event|2|||
146499702|NCT01290679|528331309|FG001|Overall Study|Adverse Event|0|||
146973942|NCT02149199|530065853|FG000|Overall Study|Death|0|||
146499703|NCT01290679|528331308|FG000|Overall Study|Lost to Follow-up|8|||
146499704|NCT01290679|528331309|FG001|Overall Study|Lost to Follow-up|10|||
146499705|NCT01290679|528331308|FG000|Overall Study|Protocol Violation|0|||
146499706|NCT01290679|528331309|FG001|Overall Study|Protocol Violation|1|||
146499707|NCT01290679|528331308|FG000|Overall Study|Withdrawal by Subject|6|||
146499708|NCT01290679|528331309|FG001|Overall Study|Withdrawal by Subject|5|||
146973943|NCT02149199|530065854|FG001|Overall Study|Death|0|||
146499709|NCT01290679|528331308|FG000|Overall Study|Subject Entered Another Trial|0|||
146499710|NCT01290679|528331309|FG001|Overall Study|Subject Entered Another Trial|5|||
146499711|NCT04791319|528331310|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
146499712|NCT04791319|528331311|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
146499713|NCT04791319|528331312|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
146499714|NCT04791319|528331313|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
146499715|NCT04791319|528331314|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
146499716|NCT04791319|528331315|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
146499717|NCT04791319|528331316|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
146499718|NCT04791319|528331317|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
146499719|NCT04791319|528331318|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
146499720|NCT04791319|528331319|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
146499721|NCT04791319|528331320|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
146499722|NCT04791319|528331310|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
146499723|NCT04791319|528331311|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
146499724|NCT04791319|528331312|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
146499725|NCT04791319|528331313|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
146499726|NCT04791319|528331314|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
146499727|NCT04791319|528331315|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
146499728|NCT04791319|528331316|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
146499729|NCT04791319|528331317|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
146499730|NCT04791319|528331318|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
146499731|NCT04791319|528331319|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
146499732|NCT04791319|528331320|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
146499733|NCT04791319|528331310|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
146499734|NCT04791319|528331311|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
146499735|NCT04791319|528331312|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
146499736|NCT04791319|528331313|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
146499737|NCT04791319|528331314|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
146499738|NCT04791319|528331315|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
146499739|NCT04791319|528331316|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
146499740|NCT04791319|528331317|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
146912515|NCT03042611|529843081|FG001|Core Phase|Physician Decision|2|||
146912516|NCT03042611|529843082|FG002|Core Phase|Physician Decision|0|||
146912517|NCT03042611|529843083|FG003|Core Phase|Physician Decision|0|||
146912518|NCT03042611|529843080|FG000|Core Phase|Study Closed|0|||
146912519|NCT03042611|529843081|FG001|Core Phase|Study Closed|1|||
146912520|NCT03042611|529843082|FG002|Core Phase|Study Closed|0|||
146912521|NCT03042611|529843083|FG003|Core Phase|Study Closed|0|||
146912522|NCT03042611|529843080|FG000|Extension Phase|Death|0|||
146912523|NCT03042611|529843081|FG001|Extension Phase|Death|0|||
146912524|NCT03042611|529843082|FG002|Extension Phase|Death|34|||
146912525|NCT03042611|529843083|FG003|Extension Phase|Death|16|||
146912526|NCT03042611|529843080|FG000|Extension Phase|Lost to Follow-up|0|||
146912527|NCT03042611|529843081|FG001|Extension Phase|Lost to Follow-up|0|||
146912528|NCT03042611|529843082|FG002|Extension Phase|Lost to Follow-up|1|||
146912529|NCT03042611|529843083|FG003|Extension Phase|Lost to Follow-up|1|||
146912530|NCT03042611|529843080|FG000|Extension Phase|Study Closed|0|||
146912531|NCT03042611|529843081|FG001|Extension Phase|Study Closed|0|||
146912532|NCT03042611|529843082|FG002|Extension Phase|Study Closed|17|||
146912533|NCT03042611|529843083|FG003|Extension Phase|Study Closed|11|||
146912534|NCT01666444|529843087|FG000|Overall Study|Did not initiate treatment|2|||
146912535|NCT01666444|529843088|FG001|Overall Study|Did not initiate treatment|1|||
146912536|NCT00907478|529843090|FG000|Overall Study|Ineligibility determined|0|||
146912537|NCT00907478|529843091|FG001|Overall Study|Ineligibility determined|0|||
146912538|NCT00907478|529843092|FG002|Overall Study|Ineligibility determined|1|||
146912539|NCT00907478|529843090|FG000|Overall Study|Noncompliance|0|||
146912540|NCT00907478|529843091|FG001|Overall Study|Noncompliance|0|||
146912541|NCT00907478|529843092|FG002|Overall Study|Noncompliance|1|||
146912542|NCT00907478|529843090|FG000|Overall Study|Adverse Event|3|||
146912543|NCT00907478|529843091|FG001|Overall Study|Adverse Event|1|||
146912544|NCT00907478|529843092|FG002|Overall Study|Adverse Event|2|||
146912545|NCT00907478|529843090|FG000|Overall Study|Withdrawal by Subject|8|||
146912546|NCT00907478|529843091|FG001|Overall Study|Withdrawal by Subject|9|||
146912547|NCT00907478|529843092|FG002|Overall Study|Withdrawal by Subject|6|||
146912548|NCT00907478|529843090|FG000|Overall Study|Requirement for alternative therapy|1|||
146912549|NCT00907478|529843091|FG001|Overall Study|Requirement for alternative therapy|2|||
146912550|NCT00907478|529843092|FG002|Overall Study|Requirement for alternative therapy|3|||
146912551|NCT00907478|529843090|FG000|Overall Study|Physician Decision|2|||
146912552|NCT00907478|529843091|FG001|Overall Study|Physician Decision|0|||
146912553|NCT00907478|529843092|FG002|Overall Study|Physician Decision|3|||
146912554|NCT00907478|529843090|FG000|Overall Study|Death|4|||
146499741|NCT04791319|528331318|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
146499742|NCT04791319|528331319|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
146499743|NCT04791319|528331320|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
146499744|NCT04791319|528331310|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
146499745|NCT04791319|528331311|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
146499746|NCT04791319|528331312|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
146499747|NCT04791319|528331313|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
146499748|NCT04791319|528331314|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
146499749|NCT04791319|528331315|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
146499750|NCT04791319|528331316|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
146499751|NCT04791319|528331317|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
146499752|NCT04791319|528331318|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
146499753|NCT04791319|528331319|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
146499754|NCT04791319|528331320|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
146499755|NCT04791319|528331310|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
146499756|NCT04791319|528331311|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
146499757|NCT04791319|528331312|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
146499758|NCT04791319|528331313|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
146499759|NCT04791319|528331314|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
146499760|NCT04791319|528331315|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
146499761|NCT04791319|528331316|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
146499762|NCT04791319|528331317|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
146499763|NCT04791319|528331318|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
146499764|NCT04791319|528331319|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
146499765|NCT04791319|528331320|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
146499766|NCT04791319|528331310|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
146499767|NCT04791319|528331311|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
146499768|NCT04791319|528331312|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
146499769|NCT04791319|528331313|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
146499770|NCT04791319|528331314|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
146499771|NCT04791319|528331315|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
146499772|NCT04791319|528331316|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
146499773|NCT04791319|528331317|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
146499774|NCT04791319|528331318|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
146499775|NCT04791319|528331319|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
146499776|NCT04791319|528331320|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
146499777|NCT04791319|528331310|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
146499778|NCT04791319|528331311|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
146499779|NCT04791319|528331312|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
146499780|NCT04791319|528331313|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
146499781|NCT04791319|528331314|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
146499782|NCT04791319|528331315|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
146499783|NCT04791319|528331316|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
146499784|NCT04791319|528331317|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
146499785|NCT04791319|528331318|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
146499786|NCT04791319|528331319|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
146499787|NCT04791319|528331320|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
146499788|NCT04791319|528331310|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
146499789|NCT04791319|528331311|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
146499790|NCT04791319|528331312|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
146499791|NCT04791319|528331313|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
146499792|NCT04791319|528331314|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
146499793|NCT04791319|528331315|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
146499794|NCT04791319|528331316|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
146499795|NCT04791319|528331317|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
146499796|NCT04791319|528331318|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
146499797|NCT04791319|528331319|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
146499798|NCT04791319|528331320|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
146499799|NCT04791319|528331310|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
146499800|NCT04791319|528331311|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
146499801|NCT04791319|528331312|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
146499802|NCT04791319|528331313|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
146499803|NCT04791319|528331314|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
146499804|NCT04791319|528331315|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
146499805|NCT04791319|528331316|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
146499806|NCT04791319|528331317|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
146499807|NCT04791319|528331318|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
146499808|NCT04791319|528331319|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
146499809|NCT04791319|528331320|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
146499810|NCT00679289|528331321|FG000|Overall Study|Progressive disease|4|||
146499811|NCT00679289|528331322|FG001|Overall Study|Progressive disease|5|||
146499812|NCT00679289|528331323|FG002|Overall Study|Progressive disease|18|||
146499813|NCT00679289|528331321|FG000|Overall Study|Withdrawal by Subject|0|||
146499814|NCT00679289|528331322|FG001|Overall Study|Withdrawal by Subject|1|||
146499815|NCT00679289|528331323|FG002|Overall Study|Withdrawal by Subject|1|||
146499816|NCT00679289|528331321|FG000|Overall Study|Adverse Event|0|||
146499817|NCT00679289|528331322|FG001|Overall Study|Adverse Event|0|||
146499818|NCT00679289|528331323|FG002|Overall Study|Adverse Event|3|||
146499819|NCT00679289|528331321|FG000|Overall Study|Physician Decision|1|||
146499820|NCT00679289|528331322|FG001|Overall Study|Physician Decision|0|||
146499821|NCT00679289|528331323|FG002|Overall Study|Physician Decision|1|||
146499822|NCT00937040|528331324|FG000|Overall Study|Adverse Event|5|||
146499823|NCT00937040|528331325|FG001|Overall Study|Adverse Event|8|||
146499824|NCT00937040|528331324|FG000|Overall Study|Lost to Follow-up|12|||
146499825|NCT00937040|528331325|FG001|Overall Study|Lost to Follow-up|12|||
146499826|NCT00937040|528331324|FG000|Overall Study|Protocol Violation|3|||
146499827|NCT00937040|528331325|FG001|Overall Study|Protocol Violation|0|||
146499828|NCT00937040|528331324|FG000|Overall Study|Withdrawal by Subject|13|||
146499829|NCT00937040|528331325|FG001|Overall Study|Withdrawal by Subject|7|||
146499830|NCT00937040|528331324|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
146499831|NCT00937040|528331325|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
146499832|NCT00937040|528331324|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
146499833|NCT00937040|528331325|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
146499834|NCT01355575|528331329|FG000|Overall Study|Withdrawal by Subject|2|||
146499835|NCT02438826|528331334|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
146499836|NCT02438826|528331335|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
146499837|NCT02438826|528331336|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
146499838|NCT02438826|528331337|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
146499839|NCT02438826|528331334|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
146499840|NCT02438826|528331335|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
146499841|NCT02438826|528331336|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
146499842|NCT02438826|528331337|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
146973944|NCT02149199|530065855|FG002|Overall Study|Death|1|||
146973945|NCT02149199|530065853|FG000|Overall Study|Adverse Event|6|||
146973946|NCT02149199|530065854|FG001|Overall Study|Adverse Event|15|||
146973947|NCT02149199|530065855|FG002|Overall Study|Adverse Event|9|||
146973948|NCT01500434|530065858|FG000|Overall Study|Death|1|||
146973949|NCT01500434|530065858|FG000|Overall Study|Withdrawal by Subject|1|||
146973950|NCT01500434|530065858|FG000|Overall Study|Missed 12-month follow-up|5|||
146973951|NCT00633217|530065859|FG000|Overall Study|Adverse Event|5|||
146973952|NCT00633217|530065860|FG001|Overall Study|Adverse Event|9|||
146973953|NCT00633217|530065859|FG000|Overall Study|Lack of Efficacy|0|||
146973954|NCT00633217|530065860|FG001|Overall Study|Lack of Efficacy|2|||
146973955|NCT00633217|530065859|FG000|Overall Study|Protocol Violation|3|||
146499843|NCT02438826|528331334|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
146499844|NCT02438826|528331335|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
146499845|NCT02438826|528331336|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
146499846|NCT02438826|528331337|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
146499847|NCT02438826|528331334|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
146499848|NCT02438826|528331335|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
146499849|NCT02438826|528331336|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
146499850|NCT02438826|528331337|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
146499851|NCT02438826|528331334|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
146499852|NCT02438826|528331335|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
146499853|NCT02438826|528331336|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
146499854|NCT02438826|528331337|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
146499855|NCT02438826|528331334|FG000|Open-Label Treatment Phase|Adverse Event|11|||
146566251|NCT00598650|528586012|FG000|Overall Study|Withdrawal by Subject|3|||
146566252|NCT00598650|528586012|FG000|Overall Study|Adverse Event|18|||
146973956|NCT00633217|530065860|FG001|Overall Study|Protocol Violation|7|||
146973957|NCT00633217|530065859|FG000|Overall Study|Lost to Follow-up|2|||
146973958|NCT00633217|530065860|FG001|Overall Study|Lost to Follow-up|2|||
146973959|NCT00633217|530065859|FG000|Overall Study|Investigator Discretion|2|||
146973960|NCT00633217|530065860|FG001|Overall Study|Investigator Discretion|0|||
146973961|NCT00633217|530065859|FG000|Overall Study|Withdrew Consent|3|||
146973962|NCT00633217|530065860|FG001|Overall Study|Withdrew Consent|3|||
146973963|NCT04881448|530065861|FG000|Overall Study|Study cancelled by sponsor|220|||
146973964|NCT04881448|530065861|FG000|Overall Study|Withdrawal by Subject|2|||
146973965|NCT04881448|530065861|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
146973966|NCT00532779|530065862|FG000|Overall Study|Adverse Event|122|||
146973967|NCT00532779|530065863|FG001|Overall Study|Adverse Event|112|||
146973968|NCT00532779|530065864|FG002|Overall Study|Adverse Event|56|||
146499856|NCT02438826|528331335|FG001|Open-Label Treatment Phase|Adverse Event|6|||
146499857|NCT02438826|528331336|FG002|Open-Label Treatment Phase|Adverse Event|0|||
146499858|NCT02438826|528331337|FG003|Open-Label Treatment Phase|Adverse Event|0|||
146499859|NCT02438826|528331334|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
146499860|NCT02438826|528331335|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
146499861|NCT02438826|528331336|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
146499862|NCT02438826|528331337|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
146499863|NCT02438826|528331334|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
146499864|NCT02438826|528331335|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
146566253|NCT00598650|528586012|FG000|Overall Study|No treatment for 3 weeks|1|||
146973969|NCT00532779|530065862|FG000|Overall Study|Lost to Follow-up|76|||
146973970|NCT00532779|530065863|FG001|Overall Study|Lost to Follow-up|65|||
146973971|NCT00532779|530065864|FG002|Overall Study|Lost to Follow-up|66|||
146973972|NCT00532779|530065862|FG000|Overall Study|Withdrawal by Subject|63|||
146973973|NCT00532779|530065863|FG001|Overall Study|Withdrawal by Subject|60|||
146973974|NCT00532779|530065864|FG002|Overall Study|Withdrawal by Subject|90|||
146973975|NCT00532779|530065862|FG000|Overall Study|Lack of Efficacy|12|||
146973976|NCT00532779|530065863|FG001|Overall Study|Lack of Efficacy|12|||
146973977|NCT00532779|530065864|FG002|Overall Study|Lack of Efficacy|40|||
146973978|NCT00532779|530065862|FG000|Overall Study|Protocol Violation|5|||
146973979|NCT00532779|530065863|FG001|Overall Study|Protocol Violation|9|||
146973980|NCT00532779|530065864|FG002|Overall Study|Protocol Violation|7|||
146973981|NCT00532779|530065862|FG000|Overall Study|Pregnancy|2|||
146973982|NCT00532779|530065863|FG001|Overall Study|Pregnancy|5|||
146973983|NCT00532779|530065864|FG002|Overall Study|Pregnancy|3|||
146973984|NCT00532779|530065862|FG000|Overall Study|Death|0|||
146973985|NCT00532779|530065863|FG001|Overall Study|Death|1|||
146973986|NCT00532779|530065864|FG002|Overall Study|Death|0|||
146973987|NCT00532779|530065862|FG000|Overall Study|Drug noncompliance, moved, other|14|||
146973988|NCT00532779|530065863|FG001|Overall Study|Drug noncompliance, moved, other|23|||
146973989|NCT00532779|530065864|FG002|Overall Study|Drug noncompliance, moved, other|29|||
146973990|NCT02531698|530065870|FG000|Overall Study|Adverse Event|2|||
146973991|NCT02531698|530065871|FG001|Overall Study|Adverse Event|1|||
146973992|NCT02531698|530065870|FG000|Overall Study|Withdrawal by Subject|6|||
146973993|NCT02531698|530065871|FG001|Overall Study|Withdrawal by Subject|1|||
146973994|NCT02531698|530065870|FG000|Overall Study|Protocol Violation|2|||
146973995|NCT02531698|530065871|FG001|Overall Study|Protocol Violation|0|||
146973996|NCT02531698|530065870|FG000|Overall Study|Lost to Follow-up|1|||
146973997|NCT02531698|530065871|FG001|Overall Study|Lost to Follow-up|0|||
146973998|NCT02395536|530065872|FG000|Overall Study|Lost to Follow-up|4|||
146973999|NCT02395536|530065873|FG001|Overall Study|Lost to Follow-up|4|||
146974000|NCT02395536|530065872|FG000|Overall Study|Death|2|||
146974001|NCT02395536|530065873|FG001|Overall Study|Death|0|||
146974002|NCT02395536|530065872|FG000|Overall Study|Physician Decision|4|||
146974003|NCT02395536|530065873|FG001|Overall Study|Physician Decision|6|||
146974004|NCT02395536|530065872|FG000|Overall Study|Withdrawal by Subject|9|||
146974005|NCT02395536|530065873|FG001|Overall Study|Withdrawal by Subject|17|||
146974006|NCT02395536|530065872|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
146974007|NCT02395536|530065873|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
146499865|NCT02438826|528331336|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
146499866|NCT02438826|528331337|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
146499867|NCT02438826|528331334|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
146566254|NCT00598650|528586012|FG000|Overall Study|Not eligible|1|||
146566255|NCT00598650|528586012|FG000|Overall Study|Prohibited Concomitant Medication|2|||
146566256|NCT00598650|528586012|FG000|Overall Study|Physician Decision|2|||
146566257|NCT00399035|528586015|FG000|Overall Study|Death|289|||
146974008|NCT02395536|530065872|FG000|Overall Study|Insurance issue|0|||
146974009|NCT02395536|530065873|FG001|Overall Study|Insurance issue|1|||
146974010|NCT00701558|530065874|FG000|Overall Study|Death|7|||
146974011|NCT00701558|530065874|FG000|Overall Study|Lost to Follow-up|8|||
146974012|NCT00700310|530067403|FG000|Overall Study|Adverse Event|6|||
146974013|NCT00700310|530067404|FG001|Overall Study|Adverse Event|10|||
146974014|NCT00700310|530067405|FG002|Overall Study|Adverse Event|5|||
146974015|NCT00700310|530067406|FG003|Overall Study|Adverse Event|11|||
146974016|NCT00700310|530067403|FG000|Overall Study|Lost to Follow-up|4|||
146974017|NCT00700310|530067404|FG001|Overall Study|Lost to Follow-up|1|||
146974018|NCT00700310|530067405|FG002|Overall Study|Lost to Follow-up|0|||
146974019|NCT00700310|530067406|FG003|Overall Study|Lost to Follow-up|1|||
146499868|NCT02438826|528331335|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
146499869|NCT02438826|528331336|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
146499870|NCT02438826|528331337|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
146499871|NCT02438826|528331334|FG000|Post-Treatment Phase|Adverse Event|3|||
146499872|NCT02438826|528331335|FG001|Post-Treatment Phase|Adverse Event|0|||
146499873|NCT02438826|528331336|FG002|Post-Treatment Phase|Adverse Event|0|||
146499874|NCT02438826|528331337|FG003|Post-Treatment Phase|Adverse Event|0|||
146499875|NCT02438826|528331334|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
146499876|NCT02438826|528331335|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
146499877|NCT02438826|528331336|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
146499878|NCT02438826|528331337|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
146499879|NCT02438826|528331334|FG000|Post-Treatment Phase|Physician Decision|1|||
146499880|NCT02438826|528331335|FG001|Post-Treatment Phase|Physician Decision|0|||
146499881|NCT02438826|528331336|FG002|Post-Treatment Phase|Physician Decision|0|||
146499882|NCT02438826|528331337|FG003|Post-Treatment Phase|Physician Decision|0|||
146499883|NCT02438826|528331334|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
146499884|NCT02438826|528331335|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
146499885|NCT02438826|528331336|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
146974020|NCT00700310|530067403|FG000|Overall Study|Withdrawal by Subject|8|||
146499886|NCT02438826|528331337|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
146499887|NCT00972816|528332785|FG000|Overall Study|Adverse Event|0|||
146499888|NCT00972816|528332786|FG001|Overall Study|Adverse Event|0|||
146499889|NCT00972816|528332787|FG002|Overall Study|Adverse Event|1|||
146499890|NCT00972816|528332788|FG003|Overall Study|Adverse Event|0|||
146499891|NCT00972816|528332789|FG004|Overall Study|Adverse Event|0|||
146974021|NCT00700310|530067404|FG001|Overall Study|Withdrawal by Subject|9|||
146974022|NCT00700310|530067405|FG002|Overall Study|Withdrawal by Subject|8|||
146974023|NCT00700310|530067406|FG003|Overall Study|Withdrawal by Subject|8|||
146499892|NCT00972816|528332790|FG005|Overall Study|Adverse Event|0|||
146499893|NCT00972816|528332791|FG006|Overall Study|Adverse Event|0|||
146499894|NCT00972816|528332792|FG007|Overall Study|Adverse Event|0|||
146499895|NCT00972816|528332785|FG000|Overall Study|Withdrawal by Subject|4|||
146499896|NCT00972816|528332786|FG001|Overall Study|Withdrawal by Subject|2|||
146499897|NCT00972816|528332787|FG002|Overall Study|Withdrawal by Subject|1|||
146499898|NCT00972816|528332788|FG003|Overall Study|Withdrawal by Subject|3|||
146499899|NCT00972816|528332789|FG004|Overall Study|Withdrawal by Subject|0|||
146499900|NCT00972816|528332790|FG005|Overall Study|Withdrawal by Subject|1|||
146499901|NCT00972816|528332791|FG006|Overall Study|Withdrawal by Subject|1|||
146499902|NCT00972816|528332792|FG007|Overall Study|Withdrawal by Subject|2|||
146499903|NCT00972816|528332785|FG000|Overall Study|Lost to Follow-up|11|||
146499904|NCT00972816|528332786|FG001|Overall Study|Lost to Follow-up|9|||
146499905|NCT00972816|528332787|FG002|Overall Study|Lost to Follow-up|7|||
146499906|NCT00972816|528332788|FG003|Overall Study|Lost to Follow-up|5|||
146499907|NCT00972816|528332789|FG004|Overall Study|Lost to Follow-up|11|||
146499908|NCT00972816|528332790|FG005|Overall Study|Lost to Follow-up|10|||
146499909|NCT00972816|528332791|FG006|Overall Study|Lost to Follow-up|7|||
146499910|NCT00972816|528332792|FG007|Overall Study|Lost to Follow-up|7|||
146499911|NCT00972816|528332785|FG000|Overall Study|Inappropriate enrolment|0|||
146499912|NCT00972816|528332786|FG001|Overall Study|Inappropriate enrolment|0|||
146566258|NCT00399035|528586016|FG001|Overall Study|Death|141|||
146566259|NCT00399035|528586017|FG002|Overall Study|Death|234|||
146566260|NCT00399035|528586015|FG000|Overall Study|Lost to Follow-up|2|||
146566261|NCT00399035|528586016|FG001|Overall Study|Lost to Follow-up|1|||
146566262|NCT00399035|528586017|FG002|Overall Study|Lost to Follow-up|5|||
146566263|NCT00399035|528586015|FG000|Overall Study|Withdrawal by Subject|19|||
146974024|NCT00700310|530067403|FG000|Overall Study|Lack of Efficacy|0|||
146974025|NCT00700310|530067404|FG001|Overall Study|Lack of Efficacy|3|||
146499913|NCT00972816|528332787|FG002|Overall Study|Inappropriate enrolment|0|||
146499914|NCT00972816|528332788|FG003|Overall Study|Inappropriate enrolment|0|||
146499915|NCT00972816|528332789|FG004|Overall Study|Inappropriate enrolment|0|||
146499916|NCT00972816|528332790|FG005|Overall Study|Inappropriate enrolment|0|||
146499917|NCT00972816|528332791|FG006|Overall Study|Inappropriate enrolment|2|||
146499918|NCT00972816|528332792|FG007|Overall Study|Inappropriate enrolment|0|||
146499919|NCT00972816|528332785|FG000|Overall Study|Unable to classify|2|||
146566264|NCT00399035|528586016|FG001|Overall Study|Withdrawal by Subject|15|||
146566265|NCT00399035|528586017|FG002|Overall Study|Withdrawal by Subject|12|||
146974026|NCT00700310|530067405|FG002|Overall Study|Lack of Efficacy|0|||
146499920|NCT00972816|528332786|FG001|Overall Study|Unable to classify|0|||
146499921|NCT00972816|528332787|FG002|Overall Study|Unable to classify|0|||
146499922|NCT00972816|528332788|FG003|Overall Study|Unable to classify|0|||
146499923|NCT00972816|528332789|FG004|Overall Study|Unable to classify|1|||
146499924|NCT00972816|528332790|FG005|Overall Study|Unable to classify|0|||
146499925|NCT00972816|528332791|FG006|Overall Study|Unable to classify|0|||
146499926|NCT00972816|528332792|FG007|Overall Study|Unable to classify|0|||
146499927|NCT00593684|528332795|FG000|Overall Study|Death|2|||
146499928|NCT00593684|528332796|FG001|Overall Study|Death|1|||
146566266|NCT00399035|528586015|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
146499929|NCT03625466|528332797|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
146499930|NCT03625466|528332798|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
146499931|NCT03625466|528332799|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
146499932|NCT03625466|528332797|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
146499933|NCT03625466|528332798|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
146499934|NCT03625466|528332799|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
146499935|NCT03625466|528332797|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
146499936|NCT03625466|528332798|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
146499937|NCT03625466|528332799|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
146499938|NCT01905553|528332804|FG000|Period 2|Adverse Event|1|||
146499939|NCT01905553|528332805|FG001|Period 2|Adverse Event|0|||
146499940|NCT02817516|528332806|FG000|Overall Study|Other|0|||
146499941|NCT02817516|528332807|FG001|Overall Study|Other|0|||
146499942|NCT02817516|528332808|FG002|Overall Study|Other|1|||
146499943|NCT02817516|528332809|FG003|Overall Study|Other|0|||
146499944|NCT00664859|528332810|FG000|Overall Study|Adverse Event|2|||
146499945|NCT00664859|528332811|FG001|Overall Study|Adverse Event|1|||
146499946|NCT00664859|528332812|FG002|Overall Study|Adverse Event|3|||
146499947|NCT00664859|528332810|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
146499948|NCT00664859|528332811|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
146499949|NCT00664859|528332812|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
146499950|NCT00664859|528332810|FG000|Overall Study|Noncompliance with protocol|1|||
146499951|NCT00664859|528332811|FG001|Overall Study|Noncompliance with protocol|0|||
146499952|NCT00664859|528332812|FG002|Overall Study|Noncompliance with protocol|4|||
146499953|NCT00664859|528332810|FG000|Overall Study|Laboratory abnormality|2|||
146499954|NCT00664859|528332811|FG001|Overall Study|Laboratory abnormality|1|||
146499955|NCT00664859|528332812|FG002|Overall Study|Laboratory abnormality|4|||
146499956|NCT00664859|528332810|FG000|Overall Study|Withdrawal by Subject|4|||
146499957|NCT00664859|528332811|FG001|Overall Study|Withdrawal by Subject|1|||
146499958|NCT00664859|528332812|FG002|Overall Study|Withdrawal by Subject|3|||
146499959|NCT00664859|528332810|FG000|Overall Study|Lost to Follow-up|2|||
146499960|NCT00664859|528332811|FG001|Overall Study|Lost to Follow-up|2|||
146499961|NCT00664859|528332812|FG002|Overall Study|Lost to Follow-up|1|||
146499962|NCT00664859|528332810|FG000|Overall Study|Other|0|||
146499963|NCT00664859|528332811|FG001|Overall Study|Other|1|||
146499964|NCT00664859|528332812|FG002|Overall Study|Other|2|||
146499965|NCT00348595|528332813|FG000|Overall Study|Adverse Event|5|||
146499966|NCT00348595|528332814|FG001|Overall Study|Adverse Event|8|||
146499967|NCT00546117|528332815|FG000|Overall Study|Withdrawal by Subject|3|||
146499968|NCT00546117|528332816|FG001|Overall Study|Withdrawal by Subject|0|||
146499969|NCT00546117|528332815|FG000|Overall Study|Inability to schedule follow-up visit|1|||
146499970|NCT00546117|528332816|FG001|Overall Study|Inability to schedule follow-up visit|0|||
146499971|NCT01560234|528332819|FG000|Overall Study|Lost to Follow-up|3|||
146499972|NCT01560234|528332820|FG001|Overall Study|Lost to Follow-up|0|||
146499973|NCT01560234|528332821|FG002|Overall Study|Lost to Follow-up|1|||
146499974|NCT01560234|528332822|FG003|Overall Study|Lost to Follow-up|0|||
146499975|NCT01560234|528332823|FG004|Overall Study|Lost to Follow-up|0|||
146499976|NCT01560234|528332824|FG005|Overall Study|Lost to Follow-up|2|||
146499977|NCT01560234|528332825|FG006|Overall Study|Lost to Follow-up|0|||
146499978|NCT01560234|528332826|FG007|Overall Study|Lost to Follow-up|2|||
146499979|NCT03200704|528332828|FG000|Overall Study|Withdrawal by Subject|1|||
146499980|NCT01680861|528332829|FG000|Early Post-transplant Period|Protocol Violation|1|||
146499981|NCT01680861|528332830|FG001|Early Post-transplant Period|Protocol Violation|1|||
146499982|NCT00654875|528332831|FG000|Overall Study|Adverse Event|5|||
146499983|NCT00654875|528332832|FG001|Overall Study|Adverse Event|5|||
146499984|NCT00654875|528332831|FG000|Overall Study|Withdrawal by Subject|4|||
146499985|NCT00654875|528332832|FG001|Overall Study|Withdrawal by Subject|4|||
146499986|NCT00654875|528332831|FG000|Overall Study|Protocol Violation|3|||
146499987|NCT00654875|528332832|FG001|Overall Study|Protocol Violation|3|||
146499988|NCT00654875|528332831|FG000|Overall Study|Lack of Efficacy|2|||
146499989|NCT00654875|528332832|FG001|Overall Study|Lack of Efficacy|2|||
146499990|NCT00654875|528332831|FG000|Overall Study|Lost to Follow-up|1|||
146499991|NCT00654875|528332832|FG001|Overall Study|Lost to Follow-up|3|||
146499992|NCT00654875|528332831|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
146499993|NCT00654875|528332832|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
146499994|NCT00654875|528332831|FG000|Overall Study|Administrative Problems|1|||
146499995|NCT00654875|528332832|FG001|Overall Study|Administrative Problems|0|||
146499996|NCT01011465|528332833|FG000|Overall Study|Withdrawal by Subject|2|||
146499997|NCT01011465|528332834|FG001|Overall Study|Withdrawal by Subject|1|||
146499998|NCT01011465|528332835|FG002|Overall Study|Withdrawal by Subject|0|||
146499999|NCT01011465|528332836|FG003|Overall Study|Withdrawal by Subject|0|||
146500000|NCT01011465|528332837|FG004|Overall Study|Withdrawal by Subject|1|||
146500001|NCT01011465|528332838|FG005|Overall Study|Withdrawal by Subject|0|||
146500002|NCT01011465|528332839|FG006|Overall Study|Withdrawal by Subject|1|||
146500003|NCT01011465|528332840|FG007|Overall Study|Withdrawal by Subject|0|||
146500004|NCT00626821|528332847|FG000|Overall Study|Adverse Event|44|||
146500005|NCT00626821|528332847|FG000|Overall Study|Protocol Violation|33|||
146500006|NCT00626821|528332847|FG000|Overall Study|Withdrawal by Subject|10|||
146500007|NCT00626821|528332847|FG000|Overall Study|Physician Decision|9|||
146500008|NCT00626821|528332847|FG000|Overall Study|Product dysfunction|21|||
146500009|NCT00626821|528332847|FG000|Overall Study|other/unknown reason|104|||
146500010|NCT01609543|528332853|FG000|Overall Study|Disease Progression|28|||
146500011|NCT01609543|528332853|FG000|Overall Study|Adverse Event|5|||
146500012|NCT01609543|528332853|FG000|Overall Study|Withdrawal by Subject|1|||
146500013|NCT01609543|528332853|FG000|Overall Study|Protocol Violation|1|||
146500014|NCT01609543|528332853|FG000|Overall Study|Death|7|||
146500015|NCT02295020|528332854|FG000|Overall Study|Adverse Event|0|||
146500016|NCT02295020|528332855|FG001|Overall Study|Adverse Event|1|||
146500017|NCT02295020|528332854|FG000|Overall Study|Withdrawal by Subject|3|||
146500018|NCT02295020|528332855|FG001|Overall Study|Withdrawal by Subject|2|||
146500019|NCT00675428|528332860|FG000|Overall Study|Disease Progression|2|||
146500020|NCT00675428|528332861|FG001|Overall Study|Disease Progression|2|||
146500021|NCT00675428|528332860|FG000|Overall Study|No Disease Response After Cycle 6|0|||
146500022|NCT00675428|528332861|FG001|Overall Study|No Disease Response After Cycle 6|1|||
146500023|NCT00675428|528332860|FG000|Overall Study|Physician Decision|1|||
146500024|NCT00675428|528332861|FG001|Overall Study|Physician Decision|0|||
146500025|NCT00552396|528332864|FG000|Overall Study|protocol withdrawal criteria|3|||
146500026|NCT00552396|528332865|FG001|Overall Study|protocol withdrawal criteria|3|||
146500027|NCT00552396|528332866|FG002|Overall Study|protocol withdrawal criteria|3|||
146500028|NCT00552396|528332867|FG003|Overall Study|protocol withdrawal criteria|6|||
146500029|NCT00552396|528332868|FG004|Overall Study|protocol withdrawal criteria|3|||
146500030|NCT00552396|528332869|FG005|Overall Study|protocol withdrawal criteria|3|||
146500031|NCT00552396|528332870|FG006|Overall Study|protocol withdrawal criteria|9|||
146769085|NCT03284957|529323411|FG002|Overall Study|Progressive Disease|4|||
146500032|NCT02553499|528332877|FG000|Overall Study|Adverse Event|0|||
146500033|NCT02553499|528332878|FG001|Overall Study|Adverse Event|0|||
146500034|NCT02553499|528332879|FG002|Overall Study|Adverse Event|0|||
146500035|NCT02553499|528332880|FG003|Overall Study|Adverse Event|0|||
146500036|NCT02553499|528332881|FG004|Overall Study|Adverse Event|0|||
146500037|NCT02553499|528332882|FG005|Overall Study|Adverse Event|0|||
146500038|NCT02553499|528332883|FG006|Overall Study|Adverse Event|1|||
146500039|NCT02553499|528332884|FG007|Overall Study|Adverse Event|1|||
146500040|NCT02553499|528332885|FG008|Overall Study|Adverse Event|0|||
146500041|NCT02553499|528332886|FG009|Overall Study|Adverse Event|0|||
146500042|NCT02553499|528332887|FG010|Overall Study|Adverse Event|0|||
146500043|NCT02553499|528332888|FG011|Overall Study|Adverse Event|0|||
146566267|NCT00399035|528586016|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
146566268|NCT00399035|528586017|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
146566269|NCT00399035|528586015|FG000|Overall Study|Severe non-compliance with protocol|2|||
146566270|NCT00399035|528586016|FG001|Overall Study|Severe non-compliance with protocol|1|||
146566271|NCT00399035|528586017|FG002|Overall Study|Severe non-compliance with protocol|0|||
146566272|NCT02949011|528586020|FG000|Overall Study|Adverse Event|6|||
146566273|NCT02949011|528586021|FG001|Overall Study|Adverse Event|7|||
146566274|NCT02949011|528586022|FG002|Overall Study|Adverse Event|3|||
146566275|NCT02949011|528586020|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
146566276|NCT02949011|528586021|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
146566277|NCT02949011|528586022|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
146566278|NCT02949011|528586020|FG000|Overall Study|Protocol Deviation|5|||
146566279|NCT02949011|528586021|FG001|Overall Study|Protocol Deviation|3|||
146566280|NCT02949011|528586022|FG002|Overall Study|Protocol Deviation|3|||
146566281|NCT02949011|528586020|FG000|Overall Study|Lack of Efficacy|0|||
146566282|NCT02949011|528586021|FG001|Overall Study|Lack of Efficacy|2|||
146566283|NCT02949011|528586022|FG002|Overall Study|Lack of Efficacy|0|||
146566284|NCT02949011|528586020|FG000|Overall Study|Withdrawal by Subject|13|||
146566285|NCT02949011|528586021|FG001|Overall Study|Withdrawal by Subject|13|||
146566286|NCT02949011|528586022|FG002|Overall Study|Withdrawal by Subject|21|||
146566287|NCT02949011|528586020|FG000|Overall Study|Lost to Follow-up|7|||
146566288|NCT02949011|528586021|FG001|Overall Study|Lost to Follow-up|5|||
146566289|NCT02949011|528586022|FG002|Overall Study|Lost to Follow-up|5|||
146566290|NCT02949011|528586020|FG000|Overall Study|Death|0|||
146566291|NCT02949011|528586021|FG001|Overall Study|Death|0|||
146566292|NCT02949011|528586022|FG002|Overall Study|Death|1|||
146566293|NCT02949011|528586020|FG000|Overall Study|Miscellaneous|2|||
146566294|NCT02949011|528586021|FG001|Overall Study|Miscellaneous|4|||
146566295|NCT02949011|528586022|FG002|Overall Study|Miscellaneous|6|||
146566296|NCT01128569|528586023|FG000|Washout Period 1|Adverse Event|0|||
146566297|NCT01128569|528586024|FG001|Washout Period 1|Adverse Event|0|||
146566298|NCT01128569|528586025|FG002|Washout Period 1|Adverse Event|1|||
146566299|NCT01128569|528586026|FG003|Washout Period 1|Adverse Event|0|||
146566300|NCT01128569|528586027|FG004|Washout Period 1|Adverse Event|0|||
146566301|NCT01128569|528586028|FG005|Washout Period 1|Adverse Event|0|||
146566302|NCT01128569|528586023|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146566303|NCT01128569|528586024|FG001|Treatment Period 2|Withdrawal by Subject|1|||
146500044|NCT02553499|528332889|FG012|Overall Study|Adverse Event|0|||
146500045|NCT02553499|528332890|FG013|Overall Study|Adverse Event|1|||
146500046|NCT02553499|528332877|FG000|Overall Study|Death|0|||
146500047|NCT02553499|528332878|FG001|Overall Study|Death|1|||
146500048|NCT02553499|528332879|FG002|Overall Study|Death|1|||
146500049|NCT02553499|528332880|FG003|Overall Study|Death|0|||
146500050|NCT02553499|528332881|FG004|Overall Study|Death|1|||
146500051|NCT02553499|528332882|FG005|Overall Study|Death|2|||
146500052|NCT02553499|528332883|FG006|Overall Study|Death|0|||
146500053|NCT02553499|528332884|FG007|Overall Study|Death|0|||
146500054|NCT02553499|528332885|FG008|Overall Study|Death|0|||
146500055|NCT02553499|528332886|FG009|Overall Study|Death|0|||
146500056|NCT02553499|528332887|FG010|Overall Study|Death|1|||
146500057|NCT02553499|528332888|FG011|Overall Study|Death|0|||
146500058|NCT02553499|528332889|FG012|Overall Study|Death|0|||
146500059|NCT02553499|528332890|FG013|Overall Study|Death|0|||
146646599|NCT01457352|528883154|FG000|Period 2|Withdrawal by Subject|23|||
146646600|NCT01457352|528883155|FG001|Period 2|Withdrawal by Subject|0|||
146646601|NCT01457352|528883154|FG000|Period 2|Adverse Event|22|||
146646602|NCT01457352|528883155|FG001|Period 2|Adverse Event|0|||
146646603|NCT01457352|528883154|FG000|Period 2|no analysis|10|||
146646604|NCT01457352|528883155|FG001|Period 2|no analysis|0|||
146646605|NCT01457352|528883154|FG000|Period 2|Lack of Efficacy|8|||
146646606|NCT01457352|528883155|FG001|Period 2|Lack of Efficacy|0|||
146646607|NCT01457352|528883154|FG000|Period 2|Protocol Violation|4|||
146646608|NCT01457352|528883155|FG001|Period 2|Protocol Violation|0|||
146646609|NCT01457352|528883154|FG000|Period 2|Sponsor's withdrawal|7|||
146646610|NCT01457352|528883155|FG001|Period 2|Sponsor's withdrawal|0|||
146646611|NCT01457352|528883154|FG000|Period 2|Lost to Follow-up|1|||
146646612|NCT01457352|528883155|FG001|Period 2|Lost to Follow-up|0|||
146646613|NCT01457352|528883154|FG000|Period 2|dose change|1|||
146646614|NCT01457352|528883155|FG001|Period 2|dose change|0|||
146646615|NCT01457352|528883154|FG000|Period 2|Physician Decision|1|||
146646616|NCT01457352|528883155|FG001|Period 2|Physician Decision|0|||
146646617|NCT01457352|528883154|FG000|Period 2|Did not meet eligibility criteria|3|||
146646618|NCT01457352|528883155|FG001|Period 2|Did not meet eligibility criteria|0|||
146646619|NCT01457352|528883154|FG000|Period 3|Adverse Event|1|||
146646620|NCT01457352|528883155|FG001|Period 3|Adverse Event|1|||
146646621|NCT01457352|528883154|FG000|Period 3|Withdrawal by Subject|0|||
146646622|NCT01457352|528883155|FG001|Period 3|Withdrawal by Subject|2|||
146646623|NCT01457352|528883154|FG000|Period 3|incorrect treatment|0|||
146646624|NCT01457352|528883155|FG001|Period 3|incorrect treatment|1|||
146646625|NCT01457352|528883154|FG000|Period 3|Sponsor's withdrawal|0|||
146646626|NCT01457352|528883155|FG001|Period 3|Sponsor's withdrawal|1|||
146646627|NCT03952039|528883156|FG000|Overall Study|Adverse Event|22|||
146646628|NCT03952039|528883157|FG001|Overall Study|Adverse Event|8|||
146646629|NCT03952039|528883156|FG000|Overall Study|Withdrawal by Participant|17|||
146646630|NCT03952039|528883157|FG001|Overall Study|Withdrawal by Participant|12|||
146646631|NCT03952039|528883156|FG000|Overall Study|Death|13|||
146646632|NCT03952039|528883157|FG001|Overall Study|Death|6|||
146646633|NCT03952039|528883156|FG000|Overall Study|Lack of Efficacy|12|||
146646634|NCT03952039|528883157|FG001|Overall Study|Lack of Efficacy|2|||
146646635|NCT03952039|528883156|FG000|Overall Study|Physician Decision|9|||
146646636|NCT03952039|528883157|FG001|Overall Study|Physician Decision|3|||
146646637|NCT03952039|528883156|FG000|Overall Study|Progressive Disease|6|||
146646638|NCT03952039|528883157|FG001|Overall Study|Progressive Disease|4|||
146646639|NCT03952039|528883156|FG000|Overall Study|Other Reasons|12|||
146646640|NCT03952039|528883157|FG001|Overall Study|Other Reasons|4|||
146646641|NCT05009979|528883158|FG000|Overall Study|Withdrawal by Subject|1|||
146646642|NCT04174365|528883159|FG000|Overall Study|Lost to Follow-up|1|||
146646643|NCT04174365|528883160|FG001|Overall Study|Lost to Follow-up|2|||
146646644|NCT04174365|528883159|FG000|Overall Study|Adverse Event|2|||
146646645|NCT04174365|528883160|FG001|Overall Study|Adverse Event|1|||
146646646|NCT04174365|528883159|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
146646647|NCT04174365|528883160|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
146646648|NCT04174365|528883159|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
146646649|NCT04174365|528883160|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
146646650|NCT04174365|528883159|FG000|Overall Study|Protocol Deviation|1|||
146646651|NCT04174365|528883160|FG001|Overall Study|Protocol Deviation|0|||
146646652|NCT04174365|528883159|FG000|Overall Study|Lack of Efficacy|0|||
146646653|NCT04174365|528883160|FG001|Overall Study|Lack of Efficacy|2|||
146769086|NCT03284957|529323412|FG003|Overall Study|Progressive Disease|3|||
146912555|NCT00907478|529843091|FG001|Overall Study|Death|2|||
146500060|NCT02553499|528332877|FG000|Overall Study|Lost to Follow-up|0|||
146500061|NCT02553499|528332878|FG001|Overall Study|Lost to Follow-up|0|||
146500062|NCT02553499|528332879|FG002|Overall Study|Lost to Follow-up|0|||
146646654|NCT04174365|528883159|FG000|Overall Study|Disease Relapse|1|||
146500063|NCT02553499|528332880|FG003|Overall Study|Lost to Follow-up|0|||
146646655|NCT04174365|528883160|FG001|Overall Study|Disease Relapse|0|||
146646656|NCT04174365|528883159|FG000|Overall Study|Reason Not Specified|0|||
146769087|NCT03284957|529323413|FG004|Overall Study|Progressive Disease|3|||
146500064|NCT02553499|528332881|FG004|Overall Study|Lost to Follow-up|0|||
146500065|NCT02553499|528332882|FG005|Overall Study|Lost to Follow-up|0|||
146500066|NCT02553499|528332883|FG006|Overall Study|Lost to Follow-up|1|||
146500067|NCT02553499|528332884|FG007|Overall Study|Lost to Follow-up|0|||
146500068|NCT02553499|528332885|FG008|Overall Study|Lost to Follow-up|0|||
146500069|NCT02553499|528332886|FG009|Overall Study|Lost to Follow-up|0|||
146500070|NCT02553499|528332887|FG010|Overall Study|Lost to Follow-up|0|||
146500071|NCT02553499|528332888|FG011|Overall Study|Lost to Follow-up|0|||
146500072|NCT02553499|528332889|FG012|Overall Study|Lost to Follow-up|0|||
146500073|NCT02553499|528332890|FG013|Overall Study|Lost to Follow-up|0|||
146500074|NCT02553499|528332877|FG000|Overall Study|Physician Decision|0|||
146500075|NCT02553499|528332878|FG001|Overall Study|Physician Decision|1|||
146500076|NCT02553499|528332879|FG002|Overall Study|Physician Decision|1|||
146500077|NCT02553499|528332880|FG003|Overall Study|Physician Decision|0|||
146500078|NCT02553499|528332881|FG004|Overall Study|Physician Decision|1|||
146500079|NCT02553499|528332882|FG005|Overall Study|Physician Decision|0|||
146500080|NCT02553499|528332883|FG006|Overall Study|Physician Decision|0|||
146500081|NCT02553499|528332884|FG007|Overall Study|Physician Decision|1|||
146500082|NCT02553499|528332885|FG008|Overall Study|Physician Decision|1|||
146500083|NCT02553499|528332886|FG009|Overall Study|Physician Decision|2|||
146500084|NCT02553499|528332887|FG010|Overall Study|Physician Decision|1|||
146500085|NCT02553499|528332888|FG011|Overall Study|Physician Decision|3|||
146500086|NCT02553499|528332889|FG012|Overall Study|Physician Decision|1|||
146500087|NCT02553499|528332890|FG013|Overall Study|Physician Decision|0|||
146500088|NCT02553499|528332877|FG000|Overall Study|Progressive Disease|0|||
146500089|NCT02553499|528332878|FG001|Overall Study|Progressive Disease|0|||
146500090|NCT02553499|528332879|FG002|Overall Study|Progressive Disease|0|||
146974027|NCT00700310|530067406|FG003|Overall Study|Lack of Efficacy|1|||
146974028|NCT00700310|530067403|FG000|Overall Study|Administrative/Other|1|||
146974029|NCT00700310|530067404|FG001|Overall Study|Administrative/Other|3|||
146974030|NCT00700310|530067405|FG002|Overall Study|Administrative/Other|1|||
146974031|NCT00700310|530067406|FG003|Overall Study|Administrative/Other|3|||
146974032|NCT00700310|530067403|FG000|Overall Study|Randomized, Not Treated|2|||
146974033|NCT00700310|530067404|FG001|Overall Study|Randomized, Not Treated|0|||
146974034|NCT00700310|530067405|FG002|Overall Study|Randomized, Not Treated|2|||
146500091|NCT02553499|528332880|FG003|Overall Study|Progressive Disease|2|||
146500092|NCT02553499|528332881|FG004|Overall Study|Progressive Disease|1|||
146500093|NCT02553499|528332882|FG005|Overall Study|Progressive Disease|1|||
146500094|NCT02553499|528332883|FG006|Overall Study|Progressive Disease|1|||
146500095|NCT02553499|528332884|FG007|Overall Study|Progressive Disease|0|||
146500096|NCT02553499|528332885|FG008|Overall Study|Progressive Disease|0|||
146500097|NCT02553499|528332886|FG009|Overall Study|Progressive Disease|1|||
146500098|NCT02553499|528332887|FG010|Overall Study|Progressive Disease|0|||
146500099|NCT02553499|528332888|FG011|Overall Study|Progressive Disease|0|||
146500100|NCT02553499|528332889|FG012|Overall Study|Progressive Disease|2|||
146500101|NCT02553499|528332890|FG013|Overall Study|Progressive Disease|1|||
146500102|NCT02553499|528332877|FG000|Overall Study|Study Terminated by Sponsor|0|||
146500103|NCT02553499|528332878|FG001|Overall Study|Study Terminated by Sponsor|0|||
146500104|NCT02553499|528332879|FG002|Overall Study|Study Terminated by Sponsor|0|||
146500105|NCT02553499|528332880|FG003|Overall Study|Study Terminated by Sponsor|0|||
146500106|NCT02553499|528332881|FG004|Overall Study|Study Terminated by Sponsor|0|||
146500107|NCT02553499|528332882|FG005|Overall Study|Study Terminated by Sponsor|0|||
146500108|NCT02553499|528332883|FG006|Overall Study|Study Terminated by Sponsor|0|||
146500109|NCT02553499|528332884|FG007|Overall Study|Study Terminated by Sponsor|0|||
146500110|NCT02553499|528332885|FG008|Overall Study|Study Terminated by Sponsor|1|||
146500111|NCT02553499|528332886|FG009|Overall Study|Study Terminated by Sponsor|0|||
146500112|NCT02553499|528332887|FG010|Overall Study|Study Terminated by Sponsor|0|||
146500113|NCT02553499|528332888|FG011|Overall Study|Study Terminated by Sponsor|0|||
146500114|NCT02553499|528332889|FG012|Overall Study|Study Terminated by Sponsor|0|||
146500115|NCT02553499|528332890|FG013|Overall Study|Study Terminated by Sponsor|0|||
146500116|NCT02553499|528332877|FG000|Overall Study|Withdrawal by Subject|2|||
146500117|NCT02553499|528332878|FG001|Overall Study|Withdrawal by Subject|0|||
146566304|NCT01128569|528586025|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146566305|NCT01128569|528586026|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146566306|NCT01128569|528586027|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146566307|NCT01128569|528586028|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146566308|NCT03338400|528586029|FG000|Overall Study|Lost to Follow-up|1|||
146974035|NCT00700310|530067406|FG003|Overall Study|Randomized, Not Treated|2|||
146974036|NCT01422720|530067407|FG000|Overall Study|Adverse Event|16|||
146500118|NCT02553499|528332879|FG002|Overall Study|Withdrawal by Subject|0|||
146500119|NCT02553499|528332880|FG003|Overall Study|Withdrawal by Subject|0|||
146500120|NCT02553499|528332881|FG004|Overall Study|Withdrawal by Subject|0|||
146500121|NCT02553499|528332882|FG005|Overall Study|Withdrawal by Subject|0|||
146500122|NCT02553499|528332883|FG006|Overall Study|Withdrawal by Subject|0|||
146500123|NCT02553499|528332884|FG007|Overall Study|Withdrawal by Subject|1|||
146500124|NCT02553499|528332885|FG008|Overall Study|Withdrawal by Subject|1|||
146500125|NCT02553499|528332886|FG009|Overall Study|Withdrawal by Subject|0|||
146500126|NCT02553499|528332887|FG010|Overall Study|Withdrawal by Subject|1|||
146500127|NCT02553499|528332888|FG011|Overall Study|Withdrawal by Subject|0|||
146500128|NCT02553499|528332889|FG012|Overall Study|Withdrawal by Subject|0|||
146500129|NCT02553499|528332890|FG013|Overall Study|Withdrawal by Subject|0|||
146500130|NCT01582178|528332891|FG000|Overall Study|Physician Decision|6|||
146500131|NCT01582178|528332892|FG001|Overall Study|Physician Decision|5|||
146500132|NCT01726270|528332893|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
146500133|NCT01726270|528332893|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
146500134|NCT01726270|528332893|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
146500135|NCT01726270|528332893|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
146500136|NCT01726270|528332893|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
146500137|NCT01726270|528332893|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
146500138|NCT00582608|528332895|FG000|Overall Study|Not Treated|7|||
146500139|NCT00582608|528332895|FG000|Overall Study|Patient Ineligible|1|||
146500140|NCT00582608|528332895|FG000|Overall Study|Lack of accrual|4|||
146500141|NCT03478644|528332899|FG000|Phase 2|Withdrawal by Subject|2|||
146500142|NCT03478644|528332900|FG001|Phase 2|Withdrawal by Subject|1|||
146500143|NCT03478644|528332899|FG000|Phase 2|Lost to Follow-up|1|||
146500144|NCT03478644|528332900|FG001|Phase 2|Lost to Follow-up|0|||
146500145|NCT04152837|528332903|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
146500146|NCT04152837|528332903|FG000|Maintenance Period|Adverse Event|1|||
146500147|NCT04152837|528332903|FG000|Maintenance Period|Withdrawal by Subject|1|||
146500148|NCT04152837|528332903|FG000|Maintenance Period|Sponsor Termination of Study|2|||
146500149|NCT00586820|528332904|FG000|Overall Study|Unsuccessful PCI|1|||
146500150|NCT00586820|528332905|FG001|Overall Study|Unsuccessful PCI|0|||
146500151|NCT04463251|528332908|FG000|Overall Study|Death|1|||
146500152|NCT04463251|528332909|FG001|Overall Study|Death|0|||
146500153|NCT04463251|528332910|FG002|Overall Study|Death|1|||
146500154|NCT04463251|528332908|FG000|Overall Study|Adverse Event|0|||
146500155|NCT04463251|528332909|FG001|Overall Study|Adverse Event|1|||
146500156|NCT04463251|528332910|FG002|Overall Study|Adverse Event|0|||
146500157|NCT04463251|528332908|FG000|Overall Study|Lost to Follow-up|0|||
146500158|NCT04463251|528332909|FG001|Overall Study|Lost to Follow-up|1|||
146500159|NCT04463251|528332910|FG002|Overall Study|Lost to Follow-up|0|||
146500160|NCT04463251|528332908|FG000|Overall Study|Withdrawal by Subject|0|||
146500161|NCT04463251|528332909|FG001|Overall Study|Withdrawal by Subject|2|||
146500162|NCT04463251|528332910|FG002|Overall Study|Withdrawal by Subject|2|||
146500163|NCT00101166|528332913|FG000|Overall Study|progressive disease|10|||
146500164|NCT00686829|528332914|FG000|Overall Study|Adverse Event|5|||
146500165|NCT00686829|528332914|FG000|Overall Study|Lack of Efficacy|6|||
146500166|NCT00686829|528332914|FG000|Overall Study|Lost to Follow-up|4|||
146500167|NCT00686829|528332914|FG000|Overall Study|Withdrawal by Subject|14|||
146500168|NCT00686829|528332914|FG000|Overall Study|Protocol Violation|3|||
146500169|NCT00686829|528332914|FG000|Overall Study|Sponsor discontinued VCV|47|||
146500170|NCT01827267|528332915|FG000|Overall Study|Did not receive study drug|1|||
146500171|NCT01827267|528332916|FG001|Overall Study|Did not receive study drug|1|||
146500172|NCT01827267|528332915|FG000|Overall Study|Physician Decision|1|||
146500173|NCT01827267|528332916|FG001|Overall Study|Physician Decision|0|||
146500174|NCT01827267|528332915|FG000|Overall Study|Disease Progression|1|||
146500175|NCT01827267|528332916|FG001|Overall Study|Disease Progression|1|||
146500176|NCT01827267|528332915|FG000|Overall Study|Sponsor Discontinued Study|2|||
146500177|NCT01827267|528332916|FG001|Overall Study|Sponsor Discontinued Study|8|||
146500178|NCT01827267|528332915|FG000|Overall Study|Still on study|0|||
146500179|NCT01827267|528332916|FG001|Overall Study|Still on study|2|||
146500180|NCT01732640|528332917|FG000|Overall Study|Adverse Event|0|||
146500181|NCT01732640|528332918|FG001|Overall Study|Adverse Event|1|||
146500182|NCT01732640|528332917|FG000|Overall Study|Death|0|||
146500183|NCT01732640|528332918|FG001|Overall Study|Death|1|||
146500184|NCT03070002|528332921|FG000|Follow up for 2 Years|Death|1|||
146500185|NCT00712543|528332924|FG000|Day 8-14|Lost to Follow-up|0|||
146500186|NCT00712543|528332925|FG001|Day 8-14|Lost to Follow-up|2|||
146500187|NCT04520997|528332938|FG000|Overall Study|Lost to Follow-up|1|||
146500188|NCT04520997|528332939|FG001|Overall Study|Lost to Follow-up|1|||
146500189|NCT04520997|528332938|FG000|Overall Study|Withdrawal by Subject|1|||
146646657|NCT04174365|528883160|FG001|Overall Study|Reason Not Specified|1|||
146500190|NCT04520997|528332939|FG001|Overall Study|Withdrawal by Subject|0|||
146646658|NCT03472547|528883161|FG000|Overall Study|Withdrawal by Subject|30|||
146912556|NCT00907478|529843092|FG002|Overall Study|Death|1|||
146912557|NCT00907478|529843090|FG000|Overall Study|Protocol-specified criteria|5|||
146500191|NCT04520997|528332938|FG000|Overall Study|Not Treated|0|||
146500192|NCT04520997|528332939|FG001|Overall Study|Not Treated|1|||
146500193|NCT02981082|528332940|FG000|Overall Study|Withdrawal by Subject|2|||
146500194|NCT02981082|528332941|FG001|Overall Study|Withdrawal by Subject|0|||
146500195|NCT02981082|528332940|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
146912558|NCT00907478|529843091|FG001|Overall Study|Protocol-specified criteria|2|||
146500196|NCT02981082|528332941|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
146500197|NCT02981082|528332940|FG000|Overall Study|Adverse Event|0|||
146500198|NCT02981082|528332941|FG001|Overall Study|Adverse Event|1|||
146500199|NCT03689374|528332942|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
146500200|NCT03689374|528332943|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
146500201|NCT03689374|528332944|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
146500202|NCT03689374|528332942|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
146500203|NCT03689374|528332943|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
146500204|NCT03689374|528332944|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
146500205|NCT03689374|528332942|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
146500206|NCT03689374|528332943|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
146500207|NCT03689374|528332944|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
146500208|NCT03689374|528332942|FG000|Treatment Period (Week 0 to 52)|Death|0|||
146500209|NCT03689374|528332943|FG001|Treatment Period (Week 0 to 52)|Death|11|||
146500210|NCT03689374|528332944|FG002|Treatment Period (Week 0 to 52)|Death|1|||
146500211|NCT05367973|528332945|FG000|Overall Study|Adverse Event|0|||
146500212|NCT05367973|528332946|FG001|Overall Study|Adverse Event|2|||
146500213|NCT04984278|528335609|FG000|Period 1|Withdrawal by Subject|1|||
146500214|NCT04984278|528335610|FG001|Period 1|Withdrawal by Subject|0|||
146500215|NCT04984278|528335609|FG000|Period 1|Other|0|||
146500216|NCT04984278|528335610|FG001|Period 1|Other|1|||
146500217|NCT04984278|528335609|FG000|Period 2|Adverse Event|1|||
146500218|NCT04984278|528335610|FG001|Period 2|Adverse Event|0|||
146500219|NCT04984278|528335609|FG000|Period 2|Other|0|||
146500220|NCT04984278|528335610|FG001|Period 2|Other|1|||
146500221|NCT03535194|528335611|FG000|Induction Period|Adverse Event|2|||
146500222|NCT03535194|528335612|FG001|Induction Period|Adverse Event|2|||
146500223|NCT03535194|528335613|FG002|Induction Period|Adverse Event|1|||
146500224|NCT03535194|528335614|FG003|Induction Period|Adverse Event|3|||
146500225|NCT03535194|528335615|FG004|Induction Period|Adverse Event|0|||
146500226|NCT03535194|528335611|FG000|Induction Period|Death|0|||
146500227|NCT03535194|528335612|FG001|Induction Period|Death|1|||
146500228|NCT03535194|528335613|FG002|Induction Period|Death|0|||
146500229|NCT03535194|528335614|FG003|Induction Period|Death|0|||
146500230|NCT03535194|528335615|FG004|Induction Period|Death|0|||
146500231|NCT03535194|528335611|FG000|Induction Period|Lack of Efficacy|1|||
146500232|NCT03535194|528335612|FG001|Induction Period|Lack of Efficacy|3|||
146500233|NCT03535194|528335613|FG002|Induction Period|Lack of Efficacy|2|||
146500234|NCT03535194|528335614|FG003|Induction Period|Lack of Efficacy|2|||
146500235|NCT03535194|528335615|FG004|Induction Period|Lack of Efficacy|0|||
146500236|NCT03535194|528335611|FG000|Induction Period|Lost to Follow-up|3|||
146500237|NCT03535194|528335612|FG001|Induction Period|Lost to Follow-up|5|||
146500238|NCT03535194|528335613|FG002|Induction Period|Lost to Follow-up|2|||
146500239|NCT03535194|528335614|FG003|Induction Period|Lost to Follow-up|3|||
146500240|NCT03535194|528335615|FG004|Induction Period|Lost to Follow-up|0|||
146500241|NCT03535194|528335611|FG000|Induction Period|Physician Decision|1|||
146500242|NCT03535194|528335612|FG001|Induction Period|Physician Decision|1|||
146500243|NCT03535194|528335613|FG002|Induction Period|Physician Decision|0|||
146500244|NCT03535194|528335614|FG003|Induction Period|Physician Decision|0|||
146500245|NCT03535194|528335615|FG004|Induction Period|Physician Decision|0|||
146500246|NCT03535194|528335611|FG000|Induction Period|Protocol Violation|1|||
146500247|NCT03535194|528335612|FG001|Induction Period|Protocol Violation|0|||
146500248|NCT03535194|528335613|FG002|Induction Period|Protocol Violation|0|||
146500249|NCT03535194|528335614|FG003|Induction Period|Protocol Violation|1|||
146500250|NCT03535194|528335615|FG004|Induction Period|Protocol Violation|0|||
146500251|NCT03535194|528335611|FG000|Induction Period|Screen Failure|0|||
146500252|NCT03535194|528335612|FG001|Induction Period|Screen Failure|1|||
146646659|NCT02168387|528884716|FG000|Overall Study|Planned exubation|6|||
146646660|NCT02168387|528884717|FG001|Overall Study|Planned exubation|3|||
146646661|NCT02168387|528884716|FG000|Overall Study|Death|1|||
146646662|NCT02168387|528884717|FG001|Overall Study|Death|0|||
146646663|NCT01236547|528884720|FG000|Overall Study|Protocol Violation|0|||
146912559|NCT00907478|529843092|FG002|Overall Study|Protocol-specified criteria|3|||
146912560|NCT00907478|529843090|FG000|Overall Study|Pregnancy|0|||
146912561|NCT00907478|529843091|FG001|Overall Study|Pregnancy|1|||
146912562|NCT00907478|529843092|FG002|Overall Study|Pregnancy|1|||
146912563|NCT00907478|529843090|FG000|Overall Study|Lost to Follow-up|1|||
146912564|NCT00907478|529843091|FG001|Overall Study|Lost to Follow-up|0|||
146912565|NCT00907478|529843092|FG002|Overall Study|Lost to Follow-up|0|||
146912566|NCT00907478|529843090|FG000|Overall Study|Other|3|||
146912567|NCT00907478|529843091|FG001|Overall Study|Other|0|||
146912568|NCT00907478|529843092|FG002|Overall Study|Other|1|||
146912569|NCT01936649|529843097|FG000|Overall Study|Withdrawal by Subject|4|||
146912570|NCT01936649|529843097|FG000|Overall Study|Physician Decision|2|||
146912571|NCT01936649|529843097|FG000|Overall Study|Protocol Violation|2|||
146500253|NCT03535194|528335613|FG002|Induction Period|Screen Failure|0|||
146500254|NCT03535194|528335614|FG003|Induction Period|Screen Failure|0|||
146500255|NCT03535194|528335615|FG004|Induction Period|Screen Failure|0|||
146500256|NCT03535194|528335611|FG000|Induction Period|Withdrawal by Subject|3|||
146500257|NCT03535194|528335612|FG001|Induction Period|Withdrawal by Subject|4|||
146500258|NCT03535194|528335613|FG002|Induction Period|Withdrawal by Subject|3|||
146500259|NCT03535194|528335614|FG003|Induction Period|Withdrawal by Subject|2|||
146500260|NCT03535194|528335615|FG004|Induction Period|Withdrawal by Subject|0|||
146912572|NCT01936649|529843097|FG000|Overall Study|Other than specified above|5|||
146500261|NCT03535194|528335611|FG000|Maintenance Period|Adverse Event|6|||
146500262|NCT03535194|528335612|FG001|Maintenance Period|Adverse Event|5|||
146500263|NCT03535194|528335613|FG002|Maintenance Period|Adverse Event|1|||
146500264|NCT03535194|528335614|FG003|Maintenance Period|Adverse Event|11|||
146500265|NCT03535194|528335615|FG004|Maintenance Period|Adverse Event|4|||
146500266|NCT03535194|528335611|FG000|Maintenance Period|Lack of Efficacy|3|||
146646664|NCT01236547|528884721|FG001|Overall Study|Protocol Violation|1|||
146646665|NCT01236547|528884722|FG002|Overall Study|Protocol Violation|1|||
146500267|NCT03535194|528335612|FG001|Maintenance Period|Lack of Efficacy|2|||
146500268|NCT03535194|528335613|FG002|Maintenance Period|Lack of Efficacy|5|||
146500269|NCT03535194|528335614|FG003|Maintenance Period|Lack of Efficacy|9|||
146500270|NCT03535194|528335615|FG004|Maintenance Period|Lack of Efficacy|0|||
146500271|NCT03535194|528335611|FG000|Maintenance Period|Lost to Follow-up|4|||
146500272|NCT03535194|528335612|FG001|Maintenance Period|Lost to Follow-up|2|||
146500273|NCT03535194|528335613|FG002|Maintenance Period|Lost to Follow-up|1|||
146500274|NCT03535194|528335614|FG003|Maintenance Period|Lost to Follow-up|5|||
146500275|NCT03535194|528335615|FG004|Maintenance Period|Lost to Follow-up|2|||
146500276|NCT03535194|528335611|FG000|Maintenance Period|Other|1|||
146500277|NCT03535194|528335612|FG001|Maintenance Period|Other|2|||
146500278|NCT03535194|528335613|FG002|Maintenance Period|Other|0|||
146500279|NCT03535194|528335614|FG003|Maintenance Period|Other|0|||
146500280|NCT03535194|528335615|FG004|Maintenance Period|Other|0|||
146500281|NCT03535194|528335611|FG000|Maintenance Period|Physician Decision|1|||
146500282|NCT03535194|528335612|FG001|Maintenance Period|Physician Decision|2|||
146500283|NCT03535194|528335613|FG002|Maintenance Period|Physician Decision|0|||
146500284|NCT03535194|528335614|FG003|Maintenance Period|Physician Decision|2|||
146500285|NCT03535194|528335615|FG004|Maintenance Period|Physician Decision|0|||
146500286|NCT03535194|528335611|FG000|Maintenance Period|Pregnancy|0|||
146500287|NCT03535194|528335612|FG001|Maintenance Period|Pregnancy|0|||
146500288|NCT03535194|528335613|FG002|Maintenance Period|Pregnancy|0|||
146500289|NCT03535194|528335614|FG003|Maintenance Period|Pregnancy|2|||
146500290|NCT03535194|528335615|FG004|Maintenance Period|Pregnancy|0|||
146500291|NCT03535194|528335611|FG000|Maintenance Period|Protocol Violation|0|||
146500292|NCT03535194|528335612|FG001|Maintenance Period|Protocol Violation|1|||
146500293|NCT03535194|528335613|FG002|Maintenance Period|Protocol Violation|0|||
146500294|NCT03535194|528335614|FG003|Maintenance Period|Protocol Violation|0|||
146500295|NCT03535194|528335615|FG004|Maintenance Period|Protocol Violation|0|||
146500296|NCT03535194|528335611|FG000|Maintenance Period|Withdrawal by Subject|7|||
146500297|NCT03535194|528335612|FG001|Maintenance Period|Withdrawal by Subject|2|||
146500298|NCT03535194|528335613|FG002|Maintenance Period|Withdrawal by Subject|1|||
146500299|NCT03535194|528335614|FG003|Maintenance Period|Withdrawal by Subject|8|||
146500300|NCT03535194|528335615|FG004|Maintenance Period|Withdrawal by Subject|0|||
146500301|NCT03535194|528335611|FG000|Post-Treatment Followup Period|Adverse Event|4|||
146566309|NCT03338400|528586030|FG001|Overall Study|Lost to Follow-up|2|||
146566310|NCT01865487|528586034|FG000|Overall Study|Lost to Follow-up|0|||
146566311|NCT01865487|528586035|FG001|Overall Study|Lost to Follow-up|0|||
146566312|NCT01865487|528586036|FG002|Overall Study|Lost to Follow-up|0|||
146566313|NCT01865487|528586037|FG003|Overall Study|Lost to Follow-up|1|||
146566314|NCT01865487|528586038|FG004|Overall Study|Lost to Follow-up|0|||
146566315|NCT01865487|528586039|FG005|Overall Study|Lost to Follow-up|0|||
146566316|NCT01865487|528586040|FG006|Overall Study|Lost to Follow-up|1|||
146566317|NCT01865487|528586041|FG007|Overall Study|Lost to Follow-up|0|||
146566318|NCT01865487|528586042|FG008|Overall Study|Lost to Follow-up|0|||
146566319|NCT01865487|528586043|FG009|Overall Study|Lost to Follow-up|0|||
146566320|NCT01865487|528586034|FG000|Overall Study|Withdrawal by Subject|0|||
146566321|NCT01865487|528586035|FG001|Overall Study|Withdrawal by Subject|0|||
146566322|NCT01865487|528586036|FG002|Overall Study|Withdrawal by Subject|0|||
146566323|NCT01865487|528586037|FG003|Overall Study|Withdrawal by Subject|0|||
146566324|NCT01865487|528586038|FG004|Overall Study|Withdrawal by Subject|1|||
146566325|NCT01865487|528586039|FG005|Overall Study|Withdrawal by Subject|0|||
146566326|NCT01865487|528586040|FG006|Overall Study|Withdrawal by Subject|0|||
146500302|NCT03535194|528335612|FG001|Post-Treatment Followup Period|Adverse Event|5|||
146500303|NCT03535194|528335613|FG002|Post-Treatment Followup Period|Adverse Event|1|||
146500304|NCT03535194|528335614|FG003|Post-Treatment Followup Period|Adverse Event|8|||
146500305|NCT03535194|528335615|FG004|Post-Treatment Followup Period|Adverse Event|0|||
146500306|NCT03535194|528335611|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
146500307|NCT03535194|528335612|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
146566327|NCT01865487|528586041|FG007|Overall Study|Withdrawal by Subject|0|||
146566328|NCT01865487|528586042|FG008|Overall Study|Withdrawal by Subject|0|||
146566329|NCT01865487|528586043|FG009|Overall Study|Withdrawal by Subject|0|||
146566330|NCT01213082|528586047|FG000|Overall Study|Lost to Follow-up|6|||
146646666|NCT01236547|528884723|FG003|Overall Study|Protocol Violation|6|||
146500308|NCT03535194|528335613|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
146500309|NCT03535194|528335614|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
146500310|NCT03535194|528335615|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
146500311|NCT03535194|528335611|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
146566331|NCT01213082|528586048|FG001|Overall Study|Lost to Follow-up|7|||
146500312|NCT03535194|528335612|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
146500313|NCT03535194|528335613|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
146500314|NCT03535194|528335614|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
146500315|NCT03535194|528335615|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
146500316|NCT03535194|528335611|FG000|Post-Treatment Followup Period|Other|1|||
146500317|NCT03535194|528335612|FG001|Post-Treatment Followup Period|Other|0|||
146500318|NCT03535194|528335613|FG002|Post-Treatment Followup Period|Other|0|||
146500319|NCT03535194|528335614|FG003|Post-Treatment Followup Period|Other|5|||
146566332|NCT01213082|528586049|FG002|Overall Study|Lost to Follow-up|4|||
146566333|NCT01213082|528586047|FG000|Overall Study|Physician Decision|0|||
146566334|NCT01213082|528586048|FG001|Overall Study|Physician Decision|0|||
146566335|NCT01213082|528586049|FG002|Overall Study|Physician Decision|1|||
146566336|NCT01627691|528586050|FG000|Overall Study|Death|11|||
146566337|NCT01627691|528586050|FG000|Overall Study|Lost to Follow-up|3|||
146566338|NCT01627691|528586050|FG000|Overall Study|Withdrawal by Subject|1|||
146566339|NCT01627691|528586050|FG000|Overall Study|Missed the visit|3|||
146566340|NCT04661033|528586051|FG000|Overall Study|Adverse Event|0|||
146566341|NCT04661033|528586052|FG001|Overall Study|Adverse Event|0|||
146566342|NCT04661033|528586053|FG002|Overall Study|Adverse Event|1|||
146566343|NCT04661033|528586054|FG003|Overall Study|Adverse Event|0|||
146912573|NCT03554005|529843102|FG000|Overall Study|Not in participant's best interest|0|||
146912574|NCT03554005|529843103|FG001|Overall Study|Not in participant's best interest|0|||
146912575|NCT03554005|529843104|FG002|Overall Study|Not in participant's best interest|0|||
146912576|NCT03554005|529843105|FG003|Overall Study|Not in participant's best interest|0|||
146912577|NCT03554005|529843106|FG004|Overall Study|Not in participant's best interest|0|||
146912578|NCT03554005|529843107|FG005|Overall Study|Not in participant's best interest|1|||
146912579|NCT03554005|529843102|FG000|Overall Study|Disease Progression|1|||
146912580|NCT03554005|529843103|FG001|Overall Study|Disease Progression|1|||
146912581|NCT03554005|529843104|FG002|Overall Study|Disease Progression|1|||
146912582|NCT03554005|529843105|FG003|Overall Study|Disease Progression|1|||
146912583|NCT03554005|529843106|FG004|Overall Study|Disease Progression|5|||
146912584|NCT03554005|529843107|FG005|Overall Study|Disease Progression|6|||
146912585|NCT03554005|529843102|FG000|Overall Study|Adverse Event|0|||
146912586|NCT03554005|529843103|FG001|Overall Study|Adverse Event|0|||
146912587|NCT03554005|529843104|FG002|Overall Study|Adverse Event|0|||
146912588|NCT03554005|529843105|FG003|Overall Study|Adverse Event|0|||
146912589|NCT03554005|529843106|FG004|Overall Study|Adverse Event|0|||
146912590|NCT03554005|529843107|FG005|Overall Study|Adverse Event|3|||
146912591|NCT03554005|529843102|FG000|Overall Study|Physician Decision|0|||
146912592|NCT03554005|529843103|FG001|Overall Study|Physician Decision|0|||
146912593|NCT03554005|529843104|FG002|Overall Study|Physician Decision|0|||
146912594|NCT03554005|529843105|FG003|Overall Study|Physician Decision|0|||
146912595|NCT03554005|529843106|FG004|Overall Study|Physician Decision|1|||
146912596|NCT03554005|529843107|FG005|Overall Study|Physician Decision|0|||
146912597|NCT03554005|529843102|FG000|Overall Study|Other|0|||
146912598|NCT03554005|529843103|FG001|Overall Study|Other|0|||
146912599|NCT03554005|529843104|FG002|Overall Study|Other|0|||
146912600|NCT03554005|529843105|FG003|Overall Study|Other|0|||
146912601|NCT03554005|529843106|FG004|Overall Study|Other|0|||
146912602|NCT03554005|529843107|FG005|Overall Study|Other|1|||
146912603|NCT00631488|529843108|FG000|Overall Study|Adverse Event|1|||
146912604|NCT00631488|529843109|FG001|Overall Study|Adverse Event|0|||
146912605|NCT00631488|529843110|FG002|Overall Study|Adverse Event|0|||
146912606|NCT00631488|529843108|FG000|Overall Study|Lost to Follow-up|2|||
146912607|NCT00631488|529843109|FG001|Overall Study|Lost to Follow-up|2|||
146912608|NCT00631488|529843110|FG002|Overall Study|Lost to Follow-up|0|||
146912609|NCT00631488|529843108|FG000|Overall Study|Physician Decision|1|||
146912610|NCT00631488|529843109|FG001|Overall Study|Physician Decision|0|||
146912611|NCT00631488|529843110|FG002|Overall Study|Physician Decision|1|||
146912612|NCT00631488|529843108|FG000|Overall Study|Protocol Violation|0|||
146912613|NCT00631488|529843109|FG001|Overall Study|Protocol Violation|0|||
146912614|NCT00631488|529843110|FG002|Overall Study|Protocol Violation|1|||
146912615|NCT03648476|529843111|FG000|Overall Study|Withdrawal by Subject|2|||
146912616|NCT03648476|529843112|FG001|Overall Study|Withdrawal by Subject|1|||
146912617|NCT02639182|529843114|FG000|Overall Study|Disease Progression|50|||
146912618|NCT02639182|529843115|FG001|Overall Study|Disease Progression|49|||
146912619|NCT02639182|529843114|FG000|Overall Study|Adverse Event|7|||
146912620|NCT02639182|529843115|FG001|Overall Study|Adverse Event|5|||
146912621|NCT02639182|529843114|FG000|Overall Study|Physician Decision|3|||
146912622|NCT02639182|529843115|FG001|Overall Study|Physician Decision|3|||
146912623|NCT02639182|529843114|FG000|Overall Study|Withdrew Consent|5|||
146912624|NCT02639182|529843115|FG001|Overall Study|Withdrew Consent|4|||
146912625|NCT02639182|529843114|FG000|Overall Study|Lost to Follow-up|0|||
146500320|NCT03535194|528335615|FG004|Post-Treatment Followup Period|Other|0|||
146912626|NCT02639182|529843115|FG001|Overall Study|Lost to Follow-up|1|||
146912627|NCT02639182|529843114|FG000|Overall Study|Study Closure|1|||
146912628|NCT02639182|529843115|FG001|Overall Study|Study Closure|2|||
146912629|NCT02639182|529843114|FG000|Overall Study|Sponsor Ended Study|0|||
146566344|NCT04661033|528586051|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
146646667|NCT01236547|528884724|FG004|Overall Study|Protocol Violation|12|||
146646668|NCT00640224|528884729|FG000|Overall Study|Lost to Follow-up|5|||
146500321|NCT03535194|528335611|FG000|Post-Treatment Followup Period|Physician Decision|0|||
146500322|NCT03535194|528335612|FG001|Post-Treatment Followup Period|Physician Decision|2|||
146500323|NCT03535194|528335613|FG002|Post-Treatment Followup Period|Physician Decision|1|||
146500324|NCT03535194|528335614|FG003|Post-Treatment Followup Period|Physician Decision|1|||
146500325|NCT03535194|528335615|FG004|Post-Treatment Followup Period|Physician Decision|0|||
146500326|NCT03535194|528335611|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
146500327|NCT03535194|528335612|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
146500328|NCT03535194|528335613|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
146500329|NCT03535194|528335614|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
146500330|NCT03535194|528335615|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146500331|NCT01289639|528335616|FG000|Overall Study|Lost to Follow-up|1|||
146500332|NCT01289639|528335617|FG001|Overall Study|Lost to Follow-up|0|||
146500333|NCT01289639|528335618|FG002|Overall Study|Lost to Follow-up|0|||
146500334|NCT02780713|528335619|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
146500335|NCT02780713|528335620|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
146500336|NCT02780713|528335621|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
146500337|NCT02780713|528335622|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
146500338|NCT02780713|528335623|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
146500339|NCT01931475|528335626|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
146500340|NCT01931475|528335627|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
146500341|NCT01931475|528335626|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
146500342|NCT01931475|528335627|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
146500343|NCT01931475|528335626|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
146500344|NCT01931475|528335627|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
146500345|NCT01931475|528335626|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
146500346|NCT01931475|528335627|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
146500347|NCT01931475|528335626|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
146500348|NCT01931475|528335627|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
146500349|NCT01931475|528335626|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
146500350|NCT01931475|528335627|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
146500351|NCT01931475|528335626|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
146500352|NCT01931475|528335627|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
146500353|NCT01931475|528335626|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
146500354|NCT01931475|528335627|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
146500355|NCT01931475|528335626|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
146500356|NCT01931475|528335627|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
146500357|NCT01931475|528335626|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
146500358|NCT01931475|528335627|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
146500359|NCT01931475|528335626|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
146500360|NCT01931475|528335627|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
146500361|NCT03991299|528335628|FG000|Overall Study|Study closed, sponsor decision|3|||
146500362|NCT03991299|528335628|FG000|Overall Study|Withdrawal by Subject|1|||
146500363|NCT04429555|528335631|FG000|Overall Study|Death|0|||
146500364|NCT04429555|528335632|FG001|Overall Study|Death|2|||
146500365|NCT04429555|528335631|FG000|Overall Study|Other|2|||
146500366|NCT04429555|528335632|FG001|Overall Study|Other|0|||
146500367|NCT00425061|528335633|FG000|Overall Study|Adverse Event|1|||
146500368|NCT00425061|528335634|FG001|Overall Study|Adverse Event|0|||
146500369|NCT00425061|528335635|FG002|Overall Study|Adverse Event|0|||
146646669|NCT00640224|528884730|FG001|Overall Study|Lost to Follow-up|2|||
146500370|NCT00425061|528335636|FG003|Overall Study|Adverse Event|2|||
146500371|NCT00425061|528335637|FG004|Overall Study|Adverse Event|2|||
146500372|NCT00425061|528335638|FG005|Overall Study|Adverse Event|0|||
146500373|NCT00425061|528335639|FG006|Overall Study|Adverse Event|0|||
146500374|NCT00425061|528335633|FG000|Overall Study|Lost to Follow-up|0|||
146500375|NCT00425061|528335634|FG001|Overall Study|Lost to Follow-up|1|||
146500376|NCT00425061|528335635|FG002|Overall Study|Lost to Follow-up|0|||
146500377|NCT00425061|528335636|FG003|Overall Study|Lost to Follow-up|0|||
146500378|NCT00425061|528335637|FG004|Overall Study|Lost to Follow-up|0|||
146500379|NCT00425061|528335638|FG005|Overall Study|Lost to Follow-up|0|||
146500380|NCT00425061|528335639|FG006|Overall Study|Lost to Follow-up|0|||
146500381|NCT00425061|528335633|FG000|Overall Study|Protocol Violation|1|||
146500382|NCT00425061|528335634|FG001|Overall Study|Protocol Violation|0|||
146500383|NCT00425061|528335635|FG002|Overall Study|Protocol Violation|0|||
146500384|NCT00425061|528335636|FG003|Overall Study|Protocol Violation|0|||
146500385|NCT00425061|528335637|FG004|Overall Study|Protocol Violation|0|||
146500386|NCT00425061|528335638|FG005|Overall Study|Protocol Violation|0|||
146500387|NCT00425061|528335639|FG006|Overall Study|Protocol Violation|0|||
146500388|NCT00425061|528335633|FG000|Overall Study|Withdrawal by Subject|0|||
146912630|NCT02639182|529843115|FG001|Overall Study|Sponsor Ended Study|1|||
146646670|NCT00640224|528884731|FG002|Overall Study|Lost to Follow-up|0|||
146646671|NCT00640224|528884732|FG003|Overall Study|Lost to Follow-up|0|||
146646672|NCT00640224|528884729|FG000|Overall Study|Withdrawal by Subject|1|||
146646673|NCT00640224|528884730|FG001|Overall Study|Withdrawal by Subject|0|||
146646674|NCT00640224|528884731|FG002|Overall Study|Withdrawal by Subject|0|||
146646675|NCT00640224|528884732|FG003|Overall Study|Withdrawal by Subject|0|||
146646676|NCT00640224|528884729|FG000|Overall Study|Headaches|0|||
146646677|NCT00640224|528884730|FG001|Overall Study|Headaches|1|||
146646678|NCT00640224|528884731|FG002|Overall Study|Headaches|0|||
146646679|NCT00640224|528884732|FG003|Overall Study|Headaches|0|||
146646680|NCT00422513|528884733|FG000|Overall Study|Lack of Efficacy|4|||
146646681|NCT00422513|528884734|FG001|Overall Study|Lack of Efficacy|5|||
146646682|NCT00422513|528884733|FG000|Overall Study|Protocol Violation|23|||
146646683|NCT00422513|528884734|FG001|Overall Study|Protocol Violation|7|||
146646684|NCT00422513|528884733|FG000|Overall Study|Refused Treatment|4|||
146646685|NCT00422513|528884734|FG001|Overall Study|Refused Treatment|2|||
146646686|NCT00422513|528884733|FG000|Overall Study|Withdrawal by Subject|2|||
146646687|NCT00422513|528884734|FG001|Overall Study|Withdrawal by Subject|1|||
146646688|NCT00422513|528884733|FG000|Overall Study|early termination of the study|67|||
146646689|NCT00422513|528884734|FG001|Overall Study|early termination of the study|80|||
146646690|NCT00422513|528884733|FG000|Overall Study|Adverse Event|4|||
146646691|NCT00422513|528884734|FG001|Overall Study|Adverse Event|4|||
146646692|NCT00422513|528884733|FG000|Overall Study|Death|3|||
146646693|NCT00422513|528884734|FG001|Overall Study|Death|7|||
146646694|NCT03135119|528884735|FG000|Overall Study|Lost to Follow-up|2|||
146646695|NCT03135119|528884736|FG001|Overall Study|Lost to Follow-up|0|||
146646696|NCT03135119|528884735|FG000|Overall Study|Physician Decision|1|||
146646697|NCT03135119|528884736|FG001|Overall Study|Physician Decision|1|||
146646698|NCT03135119|528884735|FG000|Overall Study|COVID-19 Shutdown|2|||
146646699|NCT03135119|528884736|FG001|Overall Study|COVID-19 Shutdown|2|||
146646700|NCT01478048|528884737|FG000|Overall Study|Disease Progression|52|||
146646701|NCT01478048|528884738|FG001|Overall Study|Disease Progression|35|||
146646702|NCT01478048|528884737|FG000|Overall Study|study drug toxicity|11|||
146646703|NCT01478048|528884738|FG001|Overall Study|study drug toxicity|14|||
146646704|NCT01478048|528884737|FG000|Overall Study|Adverse Event|2|||
146500389|NCT00425061|528335634|FG001|Overall Study|Withdrawal by Subject|1|||
146500390|NCT00425061|528335635|FG002|Overall Study|Withdrawal by Subject|0|||
146500391|NCT00425061|528335636|FG003|Overall Study|Withdrawal by Subject|0|||
146500392|NCT00425061|528335637|FG004|Overall Study|Withdrawal by Subject|1|||
146500393|NCT00425061|528335638|FG005|Overall Study|Withdrawal by Subject|0|||
146500394|NCT00425061|528335639|FG006|Overall Study|Withdrawal by Subject|3|||
146500395|NCT00425061|528335633|FG000|Overall Study|Sponsor's request|0|||
146500396|NCT00425061|528335634|FG001|Overall Study|Sponsor's request|0|||
146500397|NCT00425061|528335635|FG002|Overall Study|Sponsor's request|0|||
146500398|NCT00425061|528335636|FG003|Overall Study|Sponsor's request|0|||
146500399|NCT00425061|528335637|FG004|Overall Study|Sponsor's request|19|||
146500400|NCT00425061|528335638|FG005|Overall Study|Sponsor's request|4|||
146500401|NCT00425061|528335639|FG006|Overall Study|Sponsor's request|15|||
146500402|NCT00425061|528335633|FG000|Overall Study|Physician Decision|0|||
146500403|NCT00425061|528335634|FG001|Overall Study|Physician Decision|0|||
146500404|NCT00425061|528335635|FG002|Overall Study|Physician Decision|0|||
146500405|NCT00425061|528335636|FG003|Overall Study|Physician Decision|0|||
146500406|NCT00425061|528335637|FG004|Overall Study|Physician Decision|1|||
146500407|NCT00425061|528335638|FG005|Overall Study|Physician Decision|0|||
146646705|NCT01478048|528884738|FG001|Overall Study|Adverse Event|11|||
146646706|NCT01478048|528884737|FG000|Overall Study|subject request to discontinue treatment|3|||
146646707|NCT01478048|528884738|FG001|Overall Study|subject request to discontinue treatment|5|||
146646708|NCT01478048|528884737|FG000|Overall Study|Withdrawal by Subject|2|||
146646709|NCT01478048|528884738|FG001|Overall Study|Withdrawal by Subject|5|||
146646710|NCT01478048|528884737|FG000|Overall Study|non-specified|6|||
146646711|NCT01478048|528884738|FG001|Overall Study|non-specified|4|||
146646712|NCT01478048|528884737|FG000|Overall Study|poor/non-compliance|0|||
146646713|NCT01478048|528884738|FG001|Overall Study|poor/non-compliance|1|||
146646714|NCT01478048|528884737|FG000|Overall Study|no longer meets study criteria|1|||
146646715|NCT01478048|528884738|FG001|Overall Study|no longer meets study criteria|0|||
146646716|NCT01252667|528884743|FG000|Overall Study|Transplant aborted post-conditioning|0|||
146912631|NCT02639182|529843114|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
146500408|NCT00425061|528335639|FG006|Overall Study|Physician Decision|0|||
146500409|NCT00425061|528335633|FG000|Overall Study|Other|0|||
146500410|NCT00425061|528335634|FG001|Overall Study|Other|0|||
146500411|NCT00425061|528335635|FG002|Overall Study|Other|0|||
146500412|NCT00425061|528335636|FG003|Overall Study|Other|0|||
146646717|NCT01252667|528884744|FG001|Overall Study|Transplant aborted post-conditioning|0|||
146646718|NCT01252667|528884745|FG002|Overall Study|Transplant aborted post-conditioning|0|||
146500413|NCT00425061|528335637|FG004|Overall Study|Other|3|||
146646719|NCT01252667|528884746|FG003|Overall Study|Transplant aborted post-conditioning|0|||
146646720|NCT01252667|528884747|FG004|Overall Study|Transplant aborted post-conditioning|0|||
146646721|NCT01252667|528884748|FG005|Overall Study|Transplant aborted post-conditioning|1|||
146646722|NCT03032380|528884749|FG000|Overall Study|Adverse Event|0|||
146500414|NCT00425061|528335638|FG005|Overall Study|Other|0|||
146500415|NCT00425061|528335639|FG006|Overall Study|Other|1|||
146500416|NCT03436693|528335640|FG000|Overall Study|Adverse Event|22|||
146500417|NCT03436693|528335641|FG001|Overall Study|Adverse Event|10|||
146500418|NCT03436693|528335640|FG000|Overall Study|Physician Decision|3|||
146500419|NCT03436693|528335641|FG001|Overall Study|Physician Decision|3|||
146500420|NCT03436693|528335640|FG000|Overall Study|Withdrawal by Subject|4|||
146500421|NCT03436693|528335641|FG001|Overall Study|Withdrawal by Subject|13|||
146500422|NCT03436693|528335640|FG000|Overall Study|Progressive Disease|1|||
146500423|NCT03436693|528335641|FG001|Overall Study|Progressive Disease|1|||
146500424|NCT04967885|528335644|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
146500425|NCT04967885|528335645|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
146500426|NCT04967885|528335644|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
146500427|NCT04967885|528335645|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
146500428|NCT04967885|528335644|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
146500429|NCT04967885|528335645|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
146500430|NCT04967885|528335644|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
146500431|NCT04967885|528335645|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
146500432|NCT04967885|528335644|FG000|EMI-II Intervention|Lost to Follow-up|14|||
146500433|NCT04967885|528335645|FG001|EMI-II Intervention|Lost to Follow-up|10|||
146500434|NCT00723008|528335646|FG000|Enrollment|Lost to Follow-up|1|||
146500435|NCT00723008|528335647|FG001|Enrollment|Lost to Follow-up|0|||
146500436|NCT00723008|528335646|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
146500437|NCT00723008|528335647|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
146500438|NCT00723008|528335646|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
146500439|NCT00723008|528335647|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
146500440|NCT00723008|528335646|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
146500441|NCT00723008|528335647|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
146500442|NCT00723008|528335646|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
146500443|NCT00723008|528335647|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
146500444|NCT00723008|528335646|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
146500445|NCT00723008|528335647|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
146500446|NCT05835011|528335648|FG000|Overall Study|Study Terminated by the Sponsor|1|||
146500447|NCT05835011|528335648|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
146500448|NCT01867710|528335653|FG000|Overall Study|Death|25|||
146500449|NCT01867710|528335654|FG001|Overall Study|Death|15|||
146500450|NCT01867710|528335655|FG002|Overall Study|Death|27|||
146500451|NCT01867710|528335656|FG003|Overall Study|Death|20|||
146500452|NCT01867710|528335653|FG000|Overall Study|Lost to Follow-up|3|||
146500453|NCT01867710|528335654|FG001|Overall Study|Lost to Follow-up|4|||
146500454|NCT01867710|528335655|FG002|Overall Study|Lost to Follow-up|3|||
146500455|NCT01867710|528335656|FG003|Overall Study|Lost to Follow-up|2|||
146500456|NCT01867710|528335653|FG000|Overall Study|Withdrawal of consent|2|||
146500457|NCT01867710|528335654|FG001|Overall Study|Withdrawal of consent|5|||
146500458|NCT01867710|528335655|FG002|Overall Study|Withdrawal of consent|1|||
146500459|NCT01867710|528335656|FG003|Overall Study|Withdrawal of consent|2|||
146500460|NCT01867710|528335653|FG000|Overall Study|Study Terminated by Sponsor|9|||
146500461|NCT01867710|528335654|FG001|Overall Study|Study Terminated by Sponsor|13|||
146500462|NCT01867710|528335655|FG002|Overall Study|Study Terminated by Sponsor|8|||
146500463|NCT01867710|528335656|FG003|Overall Study|Study Terminated by Sponsor|16|||
146500464|NCT01867710|528335653|FG000|Overall Study|Biochemical progression|0|||
146500465|NCT01867710|528335654|FG001|Overall Study|Biochemical progression|1|||
146500466|NCT01867710|528335655|FG002|Overall Study|Biochemical progression|0|||
146500467|NCT01867710|528335656|FG003|Overall Study|Biochemical progression|0|||
146500468|NCT01867710|528335653|FG000|Overall Study|Clinical progression|0|||
146500469|NCT01867710|528335654|FG001|Overall Study|Clinical progression|0|||
146500470|NCT01867710|528335655|FG002|Overall Study|Clinical progression|1|||
146646723|NCT03032380|528884750|FG001|Overall Study|Adverse Event|1|||
146646724|NCT03032380|528884749|FG000|Overall Study|Lack of Efficacy|1|||
146646725|NCT03032380|528884750|FG001|Overall Study|Lack of Efficacy|0|||
146500471|NCT01867710|528335656|FG003|Overall Study|Clinical progression|0|||
146500472|NCT01867710|528335653|FG000|Overall Study|Disease progression|1|||
146500473|NCT01867710|528335654|FG001|Overall Study|Disease progression|0|||
146500474|NCT01867710|528335655|FG002|Overall Study|Disease progression|0|||
146500475|NCT01867710|528335656|FG003|Overall Study|Disease progression|0|||
146500476|NCT01867710|528335653|FG000|Overall Study|Patient decision|0|||
146500477|NCT01867710|528335654|FG001|Overall Study|Patient decision|0|||
146646726|NCT03032380|528884749|FG000|Overall Study|Withdrawal by Subject|2|||
146500478|NCT01867710|528335655|FG002|Overall Study|Patient decision|0|||
146646727|NCT03032380|528884750|FG001|Overall Study|Withdrawal by Subject|3|||
146500479|NCT01867710|528335656|FG003|Overall Study|Patient decision|1|||
146500480|NCT01867710|528335653|FG000|Overall Study|Patient to follow subsequent treatment|0|||
146500481|NCT01867710|528335654|FG001|Overall Study|Patient to follow subsequent treatment|1|||
146500482|NCT01867710|528335655|FG002|Overall Study|Patient to follow subsequent treatment|0|||
146500483|NCT01867710|528335656|FG003|Overall Study|Patient to follow subsequent treatment|0|||
146500484|NCT01867710|528335653|FG000|Overall Study|Progressive disease|1|||
146646728|NCT03032380|528884749|FG000|Overall Study|Recovery|0|||
146769088|NCT03284957|529323414|FG005|Overall Study|Progressive Disease|5|||
146769089|NCT03284957|529323415|FG006|Overall Study|Progressive Disease|45|||
146769090|NCT03284957|529323416|FG007|Overall Study|Progressive Disease|8|||
146974037|NCT01422720|530067407|FG000|Overall Study|Lack of Efficacy|1|||
146974038|NCT01422720|530067407|FG000|Overall Study|Withdrawal by Subject|4|||
146500485|NCT01867710|528335654|FG001|Overall Study|Progressive disease|0|||
146500486|NCT01867710|528335655|FG002|Overall Study|Progressive disease|0|||
146500487|NCT01867710|528335656|FG003|Overall Study|Progressive disease|0|||
146500488|NCT01867710|528335653|FG000|Overall Study|Protocol Violation|0|||
146500489|NCT01867710|528335654|FG001|Overall Study|Protocol Violation|0|||
146500490|NCT01867710|528335655|FG002|Overall Study|Protocol Violation|0|||
146500491|NCT01867710|528335656|FG003|Overall Study|Protocol Violation|1|||
146500492|NCT01867710|528335653|FG000|Overall Study|PSA-progression|0|||
146500493|NCT01867710|528335654|FG001|Overall Study|PSA-progression|1|||
146500494|NCT01867710|528335655|FG002|Overall Study|PSA-progression|0|||
146500495|NCT01867710|528335656|FG003|Overall Study|PSA-progression|0|||
146500496|NCT01867710|528335653|FG000|Overall Study|Study medication no longer effective|0|||
146500497|NCT01867710|528335654|FG001|Overall Study|Study medication no longer effective|1|||
146500498|NCT01867710|528335655|FG002|Overall Study|Study medication no longer effective|0|||
146500499|NCT01867710|528335656|FG003|Overall Study|Study medication no longer effective|0|||
146500500|NCT01471340|528335660|FG000|Overall Study|Death|5|||
146500501|NCT01471340|528335661|FG001|Overall Study|Death|4|||
146500502|NCT01471340|528335660|FG000|Overall Study|Lost to Follow-up|0|||
146500503|NCT01471340|528335661|FG001|Overall Study|Lost to Follow-up|1|||
146500504|NCT01471340|528335660|FG000|Overall Study|Investigational site closure|0|||
146500505|NCT01471340|528335661|FG001|Overall Study|Investigational site closure|1|||
146500506|NCT01471340|528335660|FG000|Overall Study|Invalid informed consent|1|||
146500507|NCT01471340|528335661|FG001|Overall Study|Invalid informed consent|0|||
146500508|NCT00526669|528335662|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
146500509|NCT00526669|528335663|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
146500510|NCT00526669|528335662|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
146500511|NCT00526669|528335663|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
146500512|NCT00526669|528335662|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
146974039|NCT01422720|530067407|FG000|Overall Study|Ineligibility|1|||
146500513|NCT00526669|528335663|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
146500514|NCT00526669|528335662|FG000|Combined Treatment Phase|Death|0|||
146500515|NCT00526669|528335663|FG001|Combined Treatment Phase|Death|2|||
146500516|NCT03499899|528335664|FG000|Overall Study|Adverse Event|2|||
146500517|NCT03499899|528335665|FG001|Overall Study|Adverse Event|3|||
146500518|NCT03499899|528335666|FG002|Overall Study|Adverse Event|3|||
146500519|NCT03499899|528335664|FG000|Overall Study|Death|0|||
146500520|NCT03499899|528335665|FG001|Overall Study|Death|0|||
146500521|NCT03499899|528335666|FG002|Overall Study|Death|1|||
146500522|NCT03499899|528335664|FG000|Overall Study|Physician Decision|3|||
146500523|NCT03499899|528335665|FG001|Overall Study|Physician Decision|6|||
146500524|NCT03499899|528335666|FG002|Overall Study|Physician Decision|6|||
146500525|NCT03499899|528335664|FG000|Overall Study|Progressive disease|15|||
146500526|NCT03499899|528335665|FG001|Overall Study|Progressive disease|23|||
146500527|NCT03499899|528335666|FG002|Overall Study|Progressive disease|23|||
146500528|NCT03499899|528335664|FG000|Overall Study|Patient decision|0|||
146500529|NCT03499899|528335665|FG001|Overall Study|Patient decision|1|||
146500530|NCT03499899|528335666|FG002|Overall Study|Patient decision|1|||
146500531|NCT03499899|528335664|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
146500532|NCT03499899|528335665|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
146500533|NCT03499899|528335666|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
146500534|NCT01981954|528335671|FG000|Titration Period|Protocol Deviation|1|||
146500535|NCT01981954|528335671|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
146500536|NCT02218736|528335680|FG000|Overall Study|Withdrawal by Subject|10|||
146500537|NCT02218736|528335681|FG001|Overall Study|Withdrawal by Subject|9|||
146500538|NCT02218736|528335680|FG000|Overall Study|Protocol Violation|2|||
146500539|NCT02218736|528335681|FG001|Overall Study|Protocol Violation|0|||
146500540|NCT03702010|528335688|FG000|Follow-up (30days)|Lack of Efficacy|2|||
146500541|NCT03702010|528335689|FG001|Follow-up (30days)|Lack of Efficacy|2|||
146500542|NCT01254318|528335690|FG000|Overall Study|Lost to Follow-up|5|||
146500543|NCT01254318|528335690|FG000|Overall Study|Death|47|||
146500544|NCT01137110|528335703|FG000|Overall Study|Protocol Violation|1|||
146500545|NCT01137110|528335704|FG001|Overall Study|Protocol Violation|0|||
146500546|NCT00355147|528335707|FG000|Overall Study|Lost to Follow-up|10|||
146500547|NCT00355147|528335708|FG001|Overall Study|Lost to Follow-up|8|||
146500548|NCT00355147|528335707|FG000|Overall Study|Withdrawal by Subject|8|||
146500549|NCT00355147|528335708|FG001|Overall Study|Withdrawal by Subject|12|||
146500550|NCT03557931|528335715|FG000|Overall Study|Adverse Event|4|||
146500551|NCT03557931|528335716|FG001|Overall Study|Adverse Event|6|||
146500552|NCT03557931|528335717|FG002|Overall Study|Adverse Event|1|||
146500553|NCT03557931|528335715|FG000|Overall Study|Lost to Follow-up|4|||
146500554|NCT03557931|528335716|FG001|Overall Study|Lost to Follow-up|4|||
146500555|NCT03557931|528335717|FG002|Overall Study|Lost to Follow-up|1|||
146646729|NCT03032380|528884750|FG001|Overall Study|Recovery|1|||
146646730|NCT03032380|528884749|FG000|Overall Study|Death|39|||
146646731|NCT03032380|528884750|FG001|Overall Study|Death|34|||
146646732|NCT03032380|528884749|FG000|Overall Study|Other - Miscellaneous|0|||
146646733|NCT03032380|528884750|FG001|Overall Study|Other - Miscellaneous|1|||
146646734|NCT04644315|528884751|FG000|Overall Study|Subject withdrawal of consent|1|||
146500556|NCT03557931|528335715|FG000|Overall Study|Protocol Violation|1|||
146500557|NCT03557931|528335716|FG001|Overall Study|Protocol Violation|4|||
146500558|NCT03557931|528335717|FG002|Overall Study|Protocol Violation|1|||
146500559|NCT03557931|528335715|FG000|Overall Study|Withdrawal by Subject|14|||
146500560|NCT03557931|528335716|FG001|Overall Study|Withdrawal by Subject|0|||
146500561|NCT03557931|528335717|FG002|Overall Study|Withdrawal by Subject|7|||
146500562|NCT03557931|528335715|FG000|Overall Study|Miscellaneous|8|||
146500563|NCT03557931|528335716|FG001|Overall Study|Miscellaneous|5|||
146500564|NCT03557931|528335717|FG002|Overall Study|Miscellaneous|3|||
146500565|NCT02394340|528335718|FG000|Overall Study|Failed drug screen test|1|||
146500566|NCT02394340|528335718|FG000|Overall Study|Adverse Event|1|||
146500567|NCT03315286|528335721|FG000|Overall Study|Lost to Follow-up|0|||
146500568|NCT03315286|528335722|FG001|Overall Study|Lost to Follow-up|3|||
146500569|NCT03315286|528335721|FG000|Overall Study|Withdrawal by Subject|1|||
146500570|NCT03315286|528335722|FG001|Overall Study|Withdrawal by Subject|0|||
146500571|NCT03315286|528335721|FG000|Overall Study|Protocol Violation|0|||
146500572|NCT03315286|528335722|FG001|Overall Study|Protocol Violation|1|||
146500573|NCT02828124|528335723|FG000|Overall Study|Disease Progression|1|||
146500574|NCT02828124|528335724|FG001|Overall Study|Disease Progression|2|||
146500575|NCT02828124|528335725|FG002|Overall Study|Disease Progression|1|||
146500576|NCT02828124|528335726|FG003|Overall Study|Disease Progression|4|||
146500577|NCT02828124|528335723|FG000|Overall Study|AE Unrelated to Study Drug|0|||
146500578|NCT02828124|528335724|FG001|Overall Study|AE Unrelated to Study Drug|0|||
146500579|NCT02828124|528335725|FG002|Overall Study|AE Unrelated to Study Drug|0|||
146500580|NCT02828124|528335726|FG003|Overall Study|AE Unrelated to Study Drug|1|||
146500581|NCT02828124|528335723|FG000|Overall Study|Subject Withdrew Consent|0|||
146500582|NCT02828124|528335724|FG001|Overall Study|Subject Withdrew Consent|0|||
146500583|NCT02828124|528335725|FG002|Overall Study|Subject Withdrew Consent|0|||
146500584|NCT02828124|528335726|FG003|Overall Study|Subject Withdrew Consent|1|||
146500585|NCT02829723|528335728|FG000|Overall Study|Adverse Event|0|||
146500586|NCT02829723|528335729|FG001|Overall Study|Adverse Event|0|||
146500587|NCT02829723|528335730|FG002|Overall Study|Adverse Event|1|||
146500588|NCT02829723|528335731|FG003|Overall Study|Adverse Event|1|||
146500589|NCT02829723|528335732|FG004|Overall Study|Adverse Event|0|||
146500590|NCT02829723|528335733|FG005|Overall Study|Adverse Event|0|||
146500591|NCT02829723|528335734|FG006|Overall Study|Adverse Event|0|||
146500592|NCT02829723|528335735|FG007|Overall Study|Adverse Event|1|||
146500593|NCT02829723|528335736|FG008|Overall Study|Adverse Event|0|||
146500594|NCT02829723|528335737|FG009|Overall Study|Adverse Event|0|||
146500595|NCT02829723|528335738|FG010|Overall Study|Adverse Event|0|||
146500596|NCT02829723|528335739|FG011|Overall Study|Adverse Event|0|||
146500597|NCT02829723|528335740|FG012|Overall Study|Adverse Event|0|||
146500598|NCT02829723|528335741|FG013|Overall Study|Adverse Event|0|||
146500599|NCT02829723|528335742|FG014|Overall Study|Adverse Event|1|||
146500600|NCT02829723|528335743|FG015|Overall Study|Adverse Event|1|||
146500601|NCT02829723|528335744|FG016|Overall Study|Adverse Event|1|||
146500602|NCT02829723|528335745|FG017|Overall Study|Adverse Event|2|||
146500603|NCT02829723|528335746|FG018|Overall Study|Adverse Event|1|||
146500604|NCT02829723|528335747|FG019|Overall Study|Adverse Event|1|||
146500605|NCT02829723|528335748|FG020|Overall Study|Adverse Event|3|||
146500606|NCT02829723|528335749|FG021|Overall Study|Adverse Event|0|||
146500607|NCT02829723|528335750|FG022|Overall Study|Adverse Event|0|||
146500608|NCT02829723|528335751|FG023|Overall Study|Adverse Event|1|||
146500609|NCT02829723|528335752|FG024|Overall Study|Adverse Event|1|||
146500610|NCT02829723|528335753|FG025|Overall Study|Adverse Event|3|||
146500611|NCT02829723|528335754|FG026|Overall Study|Adverse Event|5|||
146500612|NCT02829723|528335728|FG000|Overall Study|Death|1|||
146646735|NCT01836276|528884752|FG000|Overall Study|Lost to Follow-up|28|||
146912632|NCT02639182|529843115|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
146769091|NCT03284957|529323417|FG008|Overall Study|Progressive Disease|5|||
146912633|NCT02546856|529843116|FG000|4 Months Evaluation|Death|2|||
146500613|NCT02829723|528335729|FG001|Overall Study|Death|0|||
146500614|NCT02829723|528335730|FG002|Overall Study|Death|1|||
146500615|NCT02829723|528335731|FG003|Overall Study|Death|1|||
146500616|NCT02829723|528335732|FG004|Overall Study|Death|0|||
146500617|NCT02829723|528335733|FG005|Overall Study|Death|0|||
146500618|NCT02829723|528335734|FG006|Overall Study|Death|2|||
146500619|NCT02829723|528335735|FG007|Overall Study|Death|0|||
146500620|NCT02829723|528335736|FG008|Overall Study|Death|1|||
146500621|NCT02829723|528335737|FG009|Overall Study|Death|0|||
146646736|NCT01836276|528884753|FG001|Overall Study|Lost to Follow-up|51|||
146646737|NCT01561898|528884754|FG000|Overall Study|Withdrawal by Subject|0|||
146500622|NCT02829723|528335738|FG010|Overall Study|Death|0|||
146500623|NCT02829723|528335739|FG011|Overall Study|Death|0|||
146646738|NCT01561898|528884755|FG001|Overall Study|Withdrawal by Subject|8|||
146974040|NCT00606801|530067408|FG000|Intervention|Protocol Violation|3|||
146974041|NCT00606801|530067409|FG001|Intervention|Protocol Violation|3|||
146974042|NCT02082262|530067410|FG000|Overall Study|Withdrawal by Subject|3|||
146974043|NCT02082262|530067410|FG000|Overall Study|Adverse Event|48|||
146974044|NCT01726335|530067413|FG000|Overall Study|Lost to Follow-up|2|||
146974045|NCT01726335|530067413|FG000|Overall Study|Withdrawal by Subject|15|||
146646739|NCT01561898|528884756|FG002|Overall Study|Withdrawal by Subject|12|||
146974046|NCT01726335|530067413|FG000|Overall Study|Adverse Event|4|||
146974047|NCT01726335|530067413|FG000|Overall Study|Lost to Follow-up|2|||
146974048|NCT01726335|530067413|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
146974049|NCT01074307|530067415|FG000|Overall Study|No primary endpoint evaluation|14|||
146974050|NCT01074307|530067416|FG001|Overall Study|No primary endpoint evaluation|6|||
146974051|NCT01074307|530067415|FG000|Overall Study|Exclusion criterion|0|||
146974052|NCT01074307|530067416|FG001|Overall Study|Exclusion criterion|1|||
146974053|NCT01074307|530067415|FG000|Overall Study|Protocol Violation|8|||
146974054|NCT01074307|530067416|FG001|Overall Study|Protocol Violation|5|||
146974055|NCT02162511|530067422|FG000|Overall Study|Lack of Efficacy|0|||
146974056|NCT02162511|530067423|FG001|Overall Study|Lack of Efficacy|0|||
146974057|NCT02162511|530067424|FG002|Overall Study|Lack of Efficacy|2|||
146974058|NCT02703454|530067429|FG000|Overall Study|Not treated|1|||
146974059|NCT02703454|530067430|FG001|Overall Study|Not treated|3|||
146974060|NCT02703454|530067429|FG000|Overall Study|Withdrawal by Subject|4|||
146974061|NCT02703454|530067430|FG001|Overall Study|Withdrawal by Subject|3|||
146974062|NCT02703454|530067429|FG000|Overall Study|Lost to Follow-up|1|||
146974063|NCT02703454|530067430|FG001|Overall Study|Lost to Follow-up|2|||
146974064|NCT02703454|530067429|FG000|Overall Study|Study discontinuation|5|||
146974065|NCT02703454|530067430|FG001|Overall Study|Study discontinuation|8|||
146974066|NCT02284373|530067431|FG000|Overall Study|Withdrawal by Subject|0|||
146974067|NCT02284373|530067432|FG001|Overall Study|Withdrawal by Subject|1|||
146974068|NCT02284373|530067433|FG002|Overall Study|Withdrawal by Subject|0|||
146974069|NCT02284373|530067431|FG000|Overall Study|Other|0|||
146974070|NCT02284373|530067432|FG001|Overall Study|Other|1|||
146974071|NCT02284373|530067433|FG002|Overall Study|Other|0|||
146974072|NCT02284373|530067431|FG000|Overall Study|Lost to Follow-up|0|||
146974073|NCT02284373|530067432|FG001|Overall Study|Lost to Follow-up|1|||
146974074|NCT02284373|530067433|FG002|Overall Study|Lost to Follow-up|0|||
146974075|NCT02499406|530067436|FG000|Overall Study|missed 3 treatment sessions|4|||
146646740|NCT01561898|528884757|FG003|Overall Study|Withdrawal by Subject|5|||
146646741|NCT01561898|528884754|FG000|Overall Study|Lack of Efficacy|0|||
146646742|NCT01561898|528884755|FG001|Overall Study|Lack of Efficacy|8|||
146646743|NCT01561898|528884756|FG002|Overall Study|Lack of Efficacy|10|||
146646744|NCT01561898|528884757|FG003|Overall Study|Lack of Efficacy|5|||
146646745|NCT01561898|528884754|FG000|Overall Study|Worsening of complications|0|||
146646746|NCT01561898|528884755|FG001|Overall Study|Worsening of complications|1|||
146646747|NCT01561898|528884756|FG002|Overall Study|Worsening of complications|0|||
146646748|NCT01561898|528884757|FG003|Overall Study|Worsening of complications|0|||
146646749|NCT01561898|528884754|FG000|Overall Study|Lost to Follow-up|0|||
146646750|NCT01561898|528884755|FG001|Overall Study|Lost to Follow-up|0|||
146646751|NCT01561898|528884756|FG002|Overall Study|Lost to Follow-up|1|||
146646752|NCT01561898|528884757|FG003|Overall Study|Lost to Follow-up|0|||
146646753|NCT01561898|528884754|FG000|Overall Study|Adverse Event|1|||
146646754|NCT01561898|528884755|FG001|Overall Study|Adverse Event|19|||
146646755|NCT01561898|528884756|FG002|Overall Study|Adverse Event|14|||
146646756|NCT01561898|528884757|FG003|Overall Study|Adverse Event|9|||
146646757|NCT01561898|528884754|FG000|Overall Study|Physician Decision|1|||
146646758|NCT01561898|528884755|FG001|Overall Study|Physician Decision|5|||
146646759|NCT01561898|528884756|FG002|Overall Study|Physician Decision|7|||
146646760|NCT01561898|528884757|FG003|Overall Study|Physician Decision|1|||
146646761|NCT00331552|528884760|FG000|Period 3: Phase II|Neurological Symptoms|1|||
146646762|NCT00331552|528884761|FG001|Period 3: Phase II|Neurological Symptoms|0|||
146974076|NCT00552617|530067440|FG000|Overall Study|Not Treated|0|||
146646763|NCT00331552|528884760|FG000|Period 3: Phase II|Severe Nausea|1|||
146646764|NCT00331552|528884761|FG001|Period 3: Phase II|Severe Nausea|0|||
146769092|NCT03284957|529323418|FG009|Overall Study|Progressive Disease|18|||
146974077|NCT00552617|530067441|FG001|Overall Study|Not Treated|0|||
146974078|NCT00552617|530067442|FG002|Overall Study|Not Treated|1|||
146646765|NCT01445548|528884762|FG000|Overall Study|Adverse Event|1|||
146646766|NCT01883453|528884764|FG000|Overall Study|No episode of common cold|25|||
146646767|NCT01883453|528884765|FG001|Overall Study|No episode of common cold|23|||
146646768|NCT03642132|528884767|FG000|Chemotherapy Period|Adverse Event|1|||
146646769|NCT03642132|528884768|FG001|Chemotherapy Period|Adverse Event|1|||
146974079|NCT00552617|530067443|FG003|Overall Study|Not Treated|0|||
146974080|NCT00552617|530067444|FG004|Overall Study|Not Treated|0|||
146974081|NCT00552617|530067445|FG005|Overall Study|Not Treated|0|||
146974082|NCT00552617|530067446|FG006|Overall Study|Not Treated|0|||
146974083|NCT00552617|530067447|FG007|Overall Study|Not Treated|0|||
146974084|NCT00552617|530067448|FG008|Overall Study|Not Treated|0|||
146974085|NCT00552617|530067449|FG009|Overall Study|Not Treated|1|||
146646770|NCT03642132|528884769|FG002|Chemotherapy Period|Adverse Event|0|||
146769093|NCT03284957|529323419|FG010|Overall Study|Progressive Disease|7|||
146646771|NCT03642132|528884767|FG000|Chemotherapy Period|Physician's decision|4|||
146646772|NCT03642132|528884768|FG001|Chemotherapy Period|Physician's decision|1|||
146646773|NCT03642132|528884769|FG002|Chemotherapy Period|Physician's decision|0|||
146646774|NCT03642132|528884767|FG000|Chemotherapy Period|Progressive disease|0|||
146646775|NCT03642132|528884768|FG001|Chemotherapy Period|Progressive disease|0|||
146646776|NCT03642132|528884769|FG002|Chemotherapy Period|Progressive disease|1|||
146646777|NCT03642132|528884767|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
146646778|NCT03642132|528884768|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
146646779|NCT03642132|528884769|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
146646780|NCT03642132|528884767|FG000|Chemotherapy Period|Other|1|||
146646781|NCT03642132|528884768|FG001|Chemotherapy Period|Other|0|||
146646782|NCT03642132|528884769|FG002|Chemotherapy Period|Other|2|||
146646783|NCT03642132|528884767|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
146646784|NCT03642132|528884768|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
146646785|NCT03642132|528884769|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
146646786|NCT03642132|528884767|FG000|Maintenance Period|Adverse Event|1|||
146646787|NCT03642132|528884768|FG001|Maintenance Period|Adverse Event|2|||
146646788|NCT03642132|528884769|FG002|Maintenance Period|Adverse Event|0|||
146646789|NCT03642132|528884767|FG000|Maintenance Period|Non-compliance with study drug|0|||
146646790|NCT03642132|528884768|FG001|Maintenance Period|Non-compliance with study drug|0|||
146646791|NCT03642132|528884769|FG002|Maintenance Period|Non-compliance with study drug|1|||
146646792|NCT03642132|528884767|FG000|Maintenance Period|Physician's decision|2|||
146646793|NCT03642132|528884768|FG001|Maintenance Period|Physician's decision|2|||
146646794|NCT03642132|528884769|FG002|Maintenance Period|Physician's decision|2|||
146646795|NCT03642132|528884767|FG000|Maintenance Period|Progressive disease|9|||
146646796|NCT03642132|528884768|FG001|Maintenance Period|Progressive disease|3|||
146646797|NCT03642132|528884769|FG002|Maintenance Period|Progressive disease|6|||
146646798|NCT03642132|528884767|FG000|Maintenance Period|Other|0|||
146646799|NCT03642132|528884768|FG001|Maintenance Period|Other|0|||
146646800|NCT03642132|528884769|FG002|Maintenance Period|Other|3|||
146646801|NCT03642132|528884767|FG000|Maintenance Period|Withdrawal by Subject|1|||
146646802|NCT03642132|528884768|FG001|Maintenance Period|Withdrawal by Subject|1|||
146646803|NCT03642132|528884769|FG002|Maintenance Period|Withdrawal by Subject|2|||
146646804|NCT03642132|528884767|FG000|Follow-up Period|Other|0|||
146646805|NCT03642132|528884768|FG001|Follow-up Period|Other|0|||
146646806|NCT03642132|528884769|FG002|Follow-up Period|Other|1|||
146646807|NCT03642132|528884767|FG000|Follow-up Period|Withdrawal by Subject|1|||
146646808|NCT03642132|528884768|FG001|Follow-up Period|Withdrawal by Subject|2|||
146646809|NCT03642132|528884769|FG002|Follow-up Period|Withdrawal by Subject|0|||
146646810|NCT03642132|528884767|FG000|Follow-up Period|Study terminated by sponsor|1|||
146646811|NCT03642132|528884768|FG001|Follow-up Period|Study terminated by sponsor|0|||
146646812|NCT03642132|528884769|FG002|Follow-up Period|Study terminated by sponsor|1|||
146646813|NCT03642132|528884767|FG000|Follow-up Period|Lack of Efficacy|1|||
146646814|NCT03642132|528884768|FG001|Follow-up Period|Lack of Efficacy|0|||
146646815|NCT03642132|528884769|FG002|Follow-up Period|Lack of Efficacy|0|||
146646816|NCT03642132|528884767|FG000|Follow-up Period|Death|1|||
146646817|NCT03642132|528884768|FG001|Follow-up Period|Death|0|||
146646818|NCT03642132|528884769|FG002|Follow-up Period|Death|2|||
146646819|NCT03642132|528884767|FG000|Follow-up Period|Adverse Event|1|||
146646820|NCT03642132|528884768|FG001|Follow-up Period|Adverse Event|0|||
146646821|NCT03642132|528884769|FG002|Follow-up Period|Adverse Event|0|||
146646822|NCT02577887|528884771|FG000|Overall Study|Death|93|||
146500624|NCT02829723|528335740|FG012|Overall Study|Death|2|||
146500625|NCT02829723|528335741|FG013|Overall Study|Death|1|||
146500626|NCT02829723|528335742|FG014|Overall Study|Death|0|||
146500627|NCT02829723|528335743|FG015|Overall Study|Death|0|||
146500628|NCT02829723|528335744|FG016|Overall Study|Death|0|||
146500629|NCT02829723|528335745|FG017|Overall Study|Death|0|||
146500630|NCT02829723|528335746|FG018|Overall Study|Death|0|||
146500631|NCT02829723|528335747|FG019|Overall Study|Death|0|||
146500632|NCT02829723|528335748|FG020|Overall Study|Death|0|||
146646823|NCT02577887|528884771|FG000|Overall Study|Protocol Violation|125|||
146646824|NCT02577887|528884771|FG000|Overall Study|Withdrawal by Subject|80|||
146646825|NCT00913458|528884772|FG000|Phase 1|Non-Responder|54|||
146646826|NCT00913458|528884773|FG001|Phase 1|Non-Responder|0|||
146646827|NCT00913458|528884774|FG002|Phase 1|Non-Responder|0|||
146646828|NCT00913458|528884775|FG003|Phase 1|Non-Responder|0|||
146646829|NCT00913458|528884776|FG004|Phase 1|Non-Responder|0|||
146646830|NCT00913458|528884777|FG005|Phase 1|Non-Responder|0|||
146646831|NCT00913458|528884778|FG006|Phase 1|Non-Responder|0|||
146646832|NCT00913458|528884772|FG000|Phase 1|Subject Request|17|||
146646833|NCT00913458|528884773|FG001|Phase 1|Subject Request|0|||
146974086|NCT00552617|530067440|FG000|Overall Study|Lost to Follow-up|0|||
146500633|NCT02829723|528335749|FG021|Overall Study|Death|2|||
146646834|NCT00913458|528884774|FG002|Phase 1|Subject Request|0|||
146646835|NCT00913458|528884775|FG003|Phase 1|Subject Request|0|||
146646836|NCT00913458|528884776|FG004|Phase 1|Subject Request|0|||
146646837|NCT00913458|528884777|FG005|Phase 1|Subject Request|0|||
146646838|NCT00913458|528884778|FG006|Phase 1|Subject Request|0|||
146646839|NCT00913458|528884772|FG000|Phase 1|Adverse Event|20|||
146646840|NCT00913458|528884773|FG001|Phase 1|Adverse Event|0|||
146500634|NCT02829723|528335750|FG022|Overall Study|Death|0|||
146500635|NCT02829723|528335751|FG023|Overall Study|Death|0|||
146500636|NCT02829723|528335752|FG024|Overall Study|Death|0|||
146769094|NCT03284957|529323420|FG011|Overall Study|Progressive Disease|2|||
146769095|NCT03284957|529323421|FG012|Overall Study|Progressive Disease|3|||
146500637|NCT02829723|528335753|FG025|Overall Study|Death|1|||
146646841|NCT00913458|528884774|FG002|Phase 1|Adverse Event|0|||
146646842|NCT00913458|528884775|FG003|Phase 1|Adverse Event|0|||
146646843|NCT00913458|528884776|FG004|Phase 1|Adverse Event|0|||
146646844|NCT00913458|528884777|FG005|Phase 1|Adverse Event|0|||
146646845|NCT00913458|528884778|FG006|Phase 1|Adverse Event|0|||
146646846|NCT00913458|528884772|FG000|Phase 1|Lost to Follow-up|2|||
146646847|NCT00913458|528884773|FG001|Phase 1|Lost to Follow-up|0|||
146646848|NCT00913458|528884774|FG002|Phase 1|Lost to Follow-up|0|||
146646849|NCT00913458|528884775|FG003|Phase 1|Lost to Follow-up|0|||
146646850|NCT00913458|528884776|FG004|Phase 1|Lost to Follow-up|0|||
146646851|NCT00913458|528884777|FG005|Phase 1|Lost to Follow-up|0|||
146646852|NCT00913458|528884778|FG006|Phase 1|Lost to Follow-up|0|||
146646853|NCT00913458|528884772|FG000|Phase 1|Protocol Violation|10|||
146646854|NCT00913458|528884773|FG001|Phase 1|Protocol Violation|0|||
146646855|NCT00913458|528884774|FG002|Phase 1|Protocol Violation|0|||
146646856|NCT00913458|528884775|FG003|Phase 1|Protocol Violation|0|||
146646857|NCT00913458|528884776|FG004|Phase 1|Protocol Violation|0|||
146646858|NCT00913458|528884777|FG005|Phase 1|Protocol Violation|0|||
146646859|NCT00913458|528884778|FG006|Phase 1|Protocol Violation|0|||
146646860|NCT00913458|528884772|FG000|Phase 1|Sponsor|2|||
146646861|NCT00913458|528884773|FG001|Phase 1|Sponsor|0|||
146646862|NCT00913458|528884774|FG002|Phase 1|Sponsor|0|||
146500638|NCT02829723|528335754|FG026|Overall Study|Death|2|||
146500639|NCT02829723|528335728|FG000|Overall Study|Physician Decision|0|||
146500640|NCT02829723|528335729|FG001|Overall Study|Physician Decision|0|||
146500641|NCT02829723|528335730|FG002|Overall Study|Physician Decision|0|||
146500642|NCT02829723|528335731|FG003|Overall Study|Physician Decision|0|||
146500643|NCT02829723|528335732|FG004|Overall Study|Physician Decision|0|||
146500644|NCT02829723|528335733|FG005|Overall Study|Physician Decision|0|||
146500645|NCT02829723|528335734|FG006|Overall Study|Physician Decision|0|||
146500646|NCT02829723|528335735|FG007|Overall Study|Physician Decision|0|||
146500647|NCT02829723|528335736|FG008|Overall Study|Physician Decision|0|||
146500648|NCT02829723|528335737|FG009|Overall Study|Physician Decision|1|||
146500649|NCT02829723|528335738|FG010|Overall Study|Physician Decision|1|||
146500650|NCT02829723|528335739|FG011|Overall Study|Physician Decision|0|||
146500651|NCT02829723|528335740|FG012|Overall Study|Physician Decision|0|||
146500652|NCT02829723|528335741|FG013|Overall Study|Physician Decision|1|||
146500653|NCT02829723|528335742|FG014|Overall Study|Physician Decision|0|||
146500654|NCT02829723|528335743|FG015|Overall Study|Physician Decision|0|||
146500655|NCT02829723|528335744|FG016|Overall Study|Physician Decision|2|||
146500656|NCT02829723|528335745|FG017|Overall Study|Physician Decision|0|||
146500657|NCT02829723|528335746|FG018|Overall Study|Physician Decision|0|||
146500658|NCT02829723|528335747|FG019|Overall Study|Physician Decision|0|||
146500659|NCT02829723|528335748|FG020|Overall Study|Physician Decision|0|||
146500660|NCT02829723|528335749|FG021|Overall Study|Physician Decision|0|||
146500661|NCT02829723|528335750|FG022|Overall Study|Physician Decision|1|||
146500662|NCT02829723|528335751|FG023|Overall Study|Physician Decision|1|||
146500663|NCT02829723|528335752|FG024|Overall Study|Physician Decision|1|||
146566345|NCT04661033|528586052|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
146566346|NCT04661033|528586053|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
146566347|NCT04661033|528586054|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
146566348|NCT04661033|528586051|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
146566349|NCT04661033|528586052|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
146566350|NCT04661033|528586053|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
146566351|NCT04661033|528586054|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
146566352|NCT04661033|528586051|FG000|Overall Study|Early discontinuation as per PI|1|||
146566353|NCT04661033|528586052|FG001|Overall Study|Early discontinuation as per PI|0|||
146566354|NCT04661033|528586053|FG002|Overall Study|Early discontinuation as per PI|0|||
146566355|NCT04661033|528586054|FG003|Overall Study|Early discontinuation as per PI|0|||
146566356|NCT03440008|528586057|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
146566357|NCT03440008|528586058|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
146646863|NCT00913458|528884775|FG003|Phase 1|Sponsor|0|||
146769096|NCT03284957|529323422|FG013|Overall Study|Progressive Disease|1|||
146500664|NCT02829723|528335753|FG025|Overall Study|Physician Decision|1|||
146646864|NCT00913458|528884776|FG004|Phase 1|Sponsor|0|||
146646865|NCT00913458|528884777|FG005|Phase 1|Sponsor|0|||
146646866|NCT00913458|528884778|FG006|Phase 1|Sponsor|0|||
146769097|NCT03284957|529323423|FG014|Overall Study|Progressive Disease|1|||
146500665|NCT02829723|528335754|FG026|Overall Study|Physician Decision|3|||
146500666|NCT02829723|528335728|FG000|Overall Study|Progressive disease|4|||
146646867|NCT00913458|528884772|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
146646868|NCT00913458|528884773|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
146646869|NCT00913458|528884774|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
146566358|NCT03440008|528586057|FG000|Overall Study|Withdrawal by Subject|1|||
146566359|NCT03440008|528586058|FG001|Overall Study|Withdrawal by Subject|0|||
146566360|NCT00760552|528586066|FG000|Overall Study|Death|2|||
146566361|NCT00760552|528586067|FG001|Overall Study|Death|0|||
146566362|NCT00760552|528586066|FG000|Overall Study|Lost to Follow-up|11|||
146566363|NCT00760552|528586067|FG001|Overall Study|Lost to Follow-up|10|||
146566364|NCT01736917|528586070|FG000|Overall Study|Adverse Event|1|||
146566365|NCT01736917|528586070|FG000|Overall Study|Protocol Violation|10|||
146566366|NCT01911260|528586071|FG000|Supplementation Period|transference or evasion of school|7|||
146566367|NCT01911260|528586072|FG001|Supplementation Period|transference or evasion of school|9|||
146566368|NCT01911260|528586073|FG002|Supplementation Period|transference or evasion of school|7|||
146566369|NCT01911260|528586074|FG003|Supplementation Period|transference or evasion of school|6|||
146566370|NCT01911260|528586071|FG000|Supplementation Period|Adverse Event|2|||
146566371|NCT01911260|528586072|FG001|Supplementation Period|Adverse Event|0|||
146566372|NCT01911260|528586073|FG002|Supplementation Period|Adverse Event|1|||
146646870|NCT00913458|528884775|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
146646871|NCT00913458|528884776|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
146646872|NCT00913458|528884777|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
146646873|NCT00913458|528884778|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
146646874|NCT00913458|528884772|FG000|Phase 2|Non-Responder|0|||
146646875|NCT00913458|528884773|FG001|Phase 2|Non-Responder|5|||
146646876|NCT00913458|528884774|FG002|Phase 2|Non-Responder|7|||
146646877|NCT00913458|528884775|FG003|Phase 2|Non-Responder|12|||
146646878|NCT00913458|528884776|FG004|Phase 2|Non-Responder|0|||
146646879|NCT00913458|528884777|FG005|Phase 2|Non-Responder|0|||
146646880|NCT00913458|528884778|FG006|Phase 2|Non-Responder|0|||
146646881|NCT00913458|528884772|FG000|Phase 2|Subject Request|0|||
146646882|NCT00913458|528884773|FG001|Phase 2|Subject Request|0|||
146646883|NCT00913458|528884774|FG002|Phase 2|Subject Request|1|||
146646884|NCT00913458|528884775|FG003|Phase 2|Subject Request|2|||
146646885|NCT00913458|528884776|FG004|Phase 2|Subject Request|0|||
146646886|NCT00913458|528884777|FG005|Phase 2|Subject Request|0|||
146646887|NCT00913458|528884778|FG006|Phase 2|Subject Request|0|||
146646888|NCT00913458|528884772|FG000|Phase 2|Adverse Event|0|||
146646889|NCT00913458|528884773|FG001|Phase 2|Adverse Event|3|||
146646890|NCT00913458|528884774|FG002|Phase 2|Adverse Event|0|||
146646891|NCT00913458|528884775|FG003|Phase 2|Adverse Event|1|||
146646892|NCT00913458|528884776|FG004|Phase 2|Adverse Event|0|||
146646893|NCT00913458|528884777|FG005|Phase 2|Adverse Event|0|||
146646894|NCT00913458|528884778|FG006|Phase 2|Adverse Event|0|||
146646895|NCT00913458|528884772|FG000|Phase 2|Lost to Follow-up|0|||
146646896|NCT00913458|528884773|FG001|Phase 2|Lost to Follow-up|0|||
146646897|NCT00913458|528884774|FG002|Phase 2|Lost to Follow-up|0|||
146646898|NCT00913458|528884775|FG003|Phase 2|Lost to Follow-up|1|||
146646899|NCT00913458|528884776|FG004|Phase 2|Lost to Follow-up|0|||
146646900|NCT00913458|528884777|FG005|Phase 2|Lost to Follow-up|0|||
146646901|NCT00913458|528884778|FG006|Phase 2|Lost to Follow-up|0|||
146646902|NCT00913458|528884772|FG000|Phase 2|Protocol Violation|0|||
146646903|NCT00913458|528884773|FG001|Phase 2|Protocol Violation|2|||
146566373|NCT01911260|528586074|FG003|Supplementation Period|Adverse Event|0|||
146566374|NCT01911260|528586071|FG000|Supplementation Period|refused to receive supplement|1|||
146566375|NCT01911260|528586072|FG001|Supplementation Period|refused to receive supplement|0|||
146566376|NCT01911260|528586073|FG002|Supplementation Period|refused to receive supplement|1|||
146566377|NCT01911260|528586074|FG003|Supplementation Period|refused to receive supplement|0|||
146566378|NCT01911260|528586071|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
146646904|NCT00913458|528884774|FG002|Phase 2|Protocol Violation|0|||
146646905|NCT00913458|528884775|FG003|Phase 2|Protocol Violation|0|||
146646906|NCT00913458|528884776|FG004|Phase 2|Protocol Violation|0|||
146646907|NCT00913458|528884777|FG005|Phase 2|Protocol Violation|0|||
146646908|NCT00913458|528884778|FG006|Phase 2|Protocol Violation|0|||
146646909|NCT00913458|528884772|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
146646910|NCT00913458|528884773|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
146646911|NCT00913458|528884774|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
146646912|NCT00913458|528884775|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
146646913|NCT00913458|528884776|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
146646914|NCT00913458|528884777|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
146646915|NCT00913458|528884778|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
146646916|NCT00913458|528884772|FG000|Phase 3|Adverse Event|0|||
146646917|NCT00913458|528884773|FG001|Phase 3|Adverse Event|0|||
146646918|NCT00913458|528884774|FG002|Phase 3|Adverse Event|0|||
146646919|NCT00913458|528884775|FG003|Phase 3|Adverse Event|0|||
146646920|NCT00913458|528884776|FG004|Phase 3|Adverse Event|5|||
146646921|NCT00913458|528884777|FG005|Phase 3|Adverse Event|4|||
146646922|NCT00913458|528884778|FG006|Phase 3|Adverse Event|1|||
146646923|NCT00913458|528884772|FG000|Phase 3|Lost to Follow-up|0|||
146646924|NCT00913458|528884773|FG001|Phase 3|Lost to Follow-up|0|||
146646925|NCT00913458|528884774|FG002|Phase 3|Lost to Follow-up|0|||
146646926|NCT00913458|528884775|FG003|Phase 3|Lost to Follow-up|0|||
146646927|NCT00913458|528884776|FG004|Phase 3|Lost to Follow-up|2|||
146646928|NCT00913458|528884777|FG005|Phase 3|Lost to Follow-up|0|||
146646929|NCT00913458|528884778|FG006|Phase 3|Lost to Follow-up|0|||
146646930|NCT00913458|528884772|FG000|Phase 3|Non-Responder|0|||
146646931|NCT00913458|528884773|FG001|Phase 3|Non-Responder|0|||
146646932|NCT00913458|528884774|FG002|Phase 3|Non-Responder|0|||
146646933|NCT00913458|528884775|FG003|Phase 3|Non-Responder|0|||
146646934|NCT00913458|528884776|FG004|Phase 3|Non-Responder|0|||
146566379|NCT01911260|528586072|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
146646935|NCT00913458|528884777|FG005|Phase 3|Non-Responder|1|||
146646936|NCT00913458|528884778|FG006|Phase 3|Non-Responder|3|||
146646937|NCT00913458|528884772|FG000|Phase 3|Withdrawal by Subject|0|||
146646938|NCT00913458|528884773|FG001|Phase 3|Withdrawal by Subject|0|||
146646939|NCT00913458|528884774|FG002|Phase 3|Withdrawal by Subject|0|||
146646940|NCT00913458|528884775|FG003|Phase 3|Withdrawal by Subject|0|||
146646941|NCT00913458|528884776|FG004|Phase 3|Withdrawal by Subject|1|||
146646942|NCT00913458|528884777|FG005|Phase 3|Withdrawal by Subject|2|||
146646943|NCT00913458|528884778|FG006|Phase 3|Withdrawal by Subject|0|||
146646944|NCT00913458|528884772|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
146646945|NCT00913458|528884773|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
146646946|NCT00913458|528884774|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
146646947|NCT00913458|528884775|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
146646948|NCT00913458|528884776|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
146646949|NCT00913458|528884777|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
146646950|NCT00913458|528884778|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
146646951|NCT02366091|528884779|FG000|Overall Study|Withdrawal by Subject|3|||
146646952|NCT02366091|528884780|FG001|Overall Study|Withdrawal by Subject|7|||
146646953|NCT02366091|528884781|FG002|Overall Study|Withdrawal by Subject|3|||
146646954|NCT02366091|528884782|FG003|Overall Study|Withdrawal by Subject|1|||
146566380|NCT01911260|528586073|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
146566381|NCT01911260|528586074|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
146566382|NCT01911260|528586071|FG000|Follow-up Period|transference or evasion of school|13|||
146566383|NCT01911260|528586072|FG001|Follow-up Period|transference or evasion of school|20|||
146566384|NCT01911260|528586073|FG002|Follow-up Period|transference or evasion of school|15|||
146566385|NCT01911260|528586074|FG003|Follow-up Period|transference or evasion of school|12|||
146566386|NCT00956293|528586077|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
146566387|NCT00956293|528586078|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
146566388|NCT00956293|528586079|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
146566389|NCT00956293|528586077|FG000|Main Period (Pre-randomization)|Death|0|||
146566390|NCT00956293|528586078|FG001|Main Period (Pre-randomization)|Death|0|||
146566391|NCT00956293|528586079|FG002|Main Period (Pre-randomization)|Death|1|||
146566392|NCT00956293|528586077|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
146566393|NCT00956293|528586078|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
146566394|NCT00956293|528586079|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
146566395|NCT00956293|528586077|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
146566396|NCT00956293|528586078|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
146566397|NCT00956293|528586079|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
146566398|NCT00956293|528586077|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
146566399|NCT00956293|528586078|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
146566400|NCT00956293|528586079|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
146566401|NCT00956293|528586077|FG000|Main Period (Pre-randomization)|Graft loss|0|||
146566402|NCT00956293|528586078|FG001|Main Period (Pre-randomization)|Graft loss|0|||
146566403|NCT00956293|528586079|FG002|Main Period (Pre-randomization)|Graft loss|7|||
146566404|NCT00956293|528586077|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
146566405|NCT00956293|528586078|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
146566406|NCT00956293|528586079|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
146566407|NCT00956293|528586077|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
146566408|NCT00956293|528586078|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
146566409|NCT00956293|528586079|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
146566410|NCT00956293|528586077|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
146566411|NCT00956293|528586078|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
146566412|NCT00956293|528586079|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
146566413|NCT00956293|528586077|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
146566414|NCT00956293|528586078|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
146566415|NCT00956293|528586079|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
146566416|NCT00956293|528586077|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
146566417|NCT00956293|528586078|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
146646955|NCT03595618|528884783|FG000|Overall Study|Adverse Event|16|||
146646956|NCT03595618|528884784|FG001|Overall Study|Adverse Event|17|||
146646957|NCT03595618|528884785|FG002|Overall Study|Adverse Event|20|||
146646958|NCT03595618|528884786|FG003|Overall Study|Adverse Event|8|||
146646959|NCT03595618|528884783|FG000|Overall Study|Withdrawal by Subject|12|||
146646960|NCT03595618|528884784|FG001|Overall Study|Withdrawal by Subject|14|||
146646961|NCT03595618|528884785|FG002|Overall Study|Withdrawal by Subject|14|||
146500667|NCT02829723|528335729|FG001|Overall Study|Progressive disease|6|||
146646962|NCT03595618|528884786|FG003|Overall Study|Withdrawal by Subject|10|||
146646963|NCT03595618|528884783|FG000|Overall Study|Lost to Follow-up|6|||
146646964|NCT03595618|528884784|FG001|Overall Study|Lost to Follow-up|4|||
146646965|NCT03595618|528884785|FG002|Overall Study|Lost to Follow-up|5|||
146646966|NCT03595618|528884786|FG003|Overall Study|Lost to Follow-up|6|||
146646967|NCT03595618|528884783|FG000|Overall Study|Protocol Violation|2|||
146646968|NCT03595618|528884784|FG001|Overall Study|Protocol Violation|0|||
146646969|NCT03595618|528884785|FG002|Overall Study|Protocol Violation|6|||
146646970|NCT03595618|528884786|FG003|Overall Study|Protocol Violation|2|||
146646971|NCT03595618|528884783|FG000|Overall Study|Physician Decision|0|||
146646972|NCT03595618|528884784|FG001|Overall Study|Physician Decision|0|||
146646973|NCT03595618|528884785|FG002|Overall Study|Physician Decision|1|||
146646974|NCT03595618|528884786|FG003|Overall Study|Physician Decision|2|||
146646975|NCT03595618|528884783|FG000|Overall Study|Miscellaneous|7|||
146646976|NCT03595618|528884784|FG001|Overall Study|Miscellaneous|5|||
146646977|NCT03595618|528884785|FG002|Overall Study|Miscellaneous|10|||
146646978|NCT03595618|528884786|FG003|Overall Study|Miscellaneous|6|||
146646979|NCT02338232|528884787|FG000|Overall Study|Screen Failure|3|||
146646980|NCT02338232|528884787|FG000|Overall Study|Withdrawal by Subject|6|||
146646981|NCT02338232|528884787|FG000|Overall Study|Adverse Event|2|||
146646982|NCT02279407|528884788|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
146646983|NCT02279407|528884789|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
146646984|NCT02279407|528884790|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
146646985|NCT02279407|528884791|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
146646986|NCT02279407|528884788|FG000|Overall Study|Withdrawal by Subject|1|||
146646987|NCT02279407|528884789|FG001|Overall Study|Withdrawal by Subject|0|||
146646988|NCT02279407|528884790|FG002|Overall Study|Withdrawal by Subject|1|||
146646989|NCT02279407|528884791|FG003|Overall Study|Withdrawal by Subject|1|||
146646990|NCT02279407|528884788|FG000|Overall Study|Adverse Event|1|||
146646991|NCT02279407|528884789|FG001|Overall Study|Adverse Event|1|||
146646992|NCT02279407|528884790|FG002|Overall Study|Adverse Event|2|||
146646993|NCT02279407|528884791|FG003|Overall Study|Adverse Event|0|||
146646994|NCT02500056|528884792|FG000|Overall Study|Lost to Follow-up|3|||
146646995|NCT02500056|528884793|FG001|Overall Study|Lost to Follow-up|7|||
146646996|NCT02500056|528884792|FG000|Overall Study|Recurrence|1|||
146646997|NCT02500056|528884793|FG001|Overall Study|Recurrence|0|||
146646998|NCT02500056|528884792|FG000|Overall Study|Death|3|||
146646999|NCT02500056|528884793|FG001|Overall Study|Death|1|||
146647000|NCT00864916|528884794|FG000|Overall Study|Lost to Follow-up|4|||
146647001|NCT00864916|528884795|FG001|Overall Study|Lost to Follow-up|4|||
146647002|NCT00864916|528884794|FG000|Overall Study|Protocol Violation|1|||
146647003|NCT00864916|528884795|FG001|Overall Study|Protocol Violation|0|||
146647004|NCT00864916|528884794|FG000|Overall Study|Withdrawal by Subject|1|||
146647005|NCT00864916|528884795|FG001|Overall Study|Withdrawal by Subject|0|||
146647006|NCT03890666|528884796|FG000|Overall Study|Withdrawal by Subject|0|||
146647007|NCT03890666|528884797|FG001|Overall Study|Withdrawal by Subject|1|||
146647008|NCT03890666|528884796|FG000|Overall Study|Protocol deviation|1|||
146647009|NCT03890666|528884797|FG001|Overall Study|Protocol deviation|4|||
146647010|NCT03890666|528884796|FG000|Overall Study|Lost to Follow-up|2|||
146647011|NCT03890666|528884797|FG001|Overall Study|Lost to Follow-up|5|||
146647012|NCT03890666|528884796|FG000|Overall Study|Other than specified|1|||
146647013|NCT03890666|528884797|FG001|Overall Study|Other than specified|8|||
146647014|NCT01105065|528884799|FG000|Overall Study|Adverse Event|5|||
146647015|NCT01105065|528884799|FG000|Overall Study|Technical Problems|1|||
146647016|NCT01155011|528884804|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
146647017|NCT01155011|528884805|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
146647018|NCT01155011|528884804|FG000|Baseline to 6 Months|investigator decision, moved|4|||
146647019|NCT01155011|528884805|FG001|Baseline to 6 Months|investigator decision, moved|5|||
146647020|NCT01155011|528884804|FG000|Baseline to 6 Months|Death|0|||
146647021|NCT01155011|528884805|FG001|Baseline to 6 Months|Death|1|||
146647022|NCT01155011|528884804|FG000|6 to 12 Months|Withdrawal by Subject|8|||
146647023|NCT01155011|528884805|FG001|6 to 12 Months|Withdrawal by Subject|5|||
146647024|NCT01155011|528884804|FG000|6 to 12 Months|Death|1|||
146647025|NCT01155011|528884805|FG001|6 to 12 Months|Death|5|||
146647026|NCT04620798|528884808|FG000|Overall Study|Lost to Follow-up|126|||
146500668|NCT02829723|528335730|FG002|Overall Study|Progressive disease|3|||
146500669|NCT02829723|528335731|FG003|Overall Study|Progressive disease|3|||
146647027|NCT04620798|528884809|FG001|Overall Study|Lost to Follow-up|138|||
146647028|NCT01960907|528884810|FG000|Overall Study|Death|4|||
146647029|NCT01960907|528884811|FG001|Overall Study|Death|3|||
146769098|NCT03284957|529323424|FG015|Overall Study|Progressive Disease|2|||
146647030|NCT01960907|528884810|FG000|Overall Study|Withdrawal by Subject|32|||
146647031|NCT01960907|528884811|FG001|Overall Study|Withdrawal by Subject|42|||
146647032|NCT03288142|528884819|FG000|Overall Study|Lost to Follow-up|22|||
146647033|NCT03288142|528884820|FG001|Overall Study|Lost to Follow-up|15|||
146647034|NCT01214395|528884823|FG000|Overall Study|All patients had infection|5|||
146647035|NCT02034409|528884824|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
146912634|NCT02546856|529843117|FG001|4 Months Evaluation|Death|3|||
146647036|NCT02034409|528884825|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
146647037|NCT02034409|528884824|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
146647038|NCT02034409|528884825|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
146647039|NCT02034409|528884824|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
146647040|NCT02034409|528884825|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
146647041|NCT02034409|528884824|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
146647042|NCT02034409|528884825|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
146647043|NCT02034409|528884824|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
146647044|NCT02034409|528884825|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
146647045|NCT02034409|528884824|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
146647046|NCT02034409|528884825|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
146974087|NCT00552617|530067441|FG001|Overall Study|Lost to Follow-up|0|||
146974088|NCT00552617|530067442|FG002|Overall Study|Lost to Follow-up|0|||
146974089|NCT00552617|530067443|FG003|Overall Study|Lost to Follow-up|1|||
146974090|NCT00552617|530067444|FG004|Overall Study|Lost to Follow-up|0|||
146974091|NCT00552617|530067445|FG005|Overall Study|Lost to Follow-up|2|||
146974092|NCT00552617|530067446|FG006|Overall Study|Lost to Follow-up|0|||
146647047|NCT00934843|528884826|FG000|Overall Study|Protocol Violation|0|||
146647048|NCT00934843|528884827|FG001|Overall Study|Protocol Violation|1|||
146647049|NCT00831493|528884830|FG000|Overall Study|Intractable nausea and vomiting|1|||
146647050|NCT00557856|528884833|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
146974093|NCT00552617|530067447|FG007|Overall Study|Lost to Follow-up|0|||
146500670|NCT02829723|528335732|FG004|Overall Study|Progressive disease|3|||
146647051|NCT00557856|528884834|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
146647052|NCT00557856|528884835|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
146647053|NCT00557856|528884836|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
146647054|NCT00557856|528884837|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
146647055|NCT00557856|528884838|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
146647056|NCT00557856|528884839|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
146647057|NCT00557856|528884840|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
146647058|NCT00557856|528884841|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
146647059|NCT00557856|528884833|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
146647060|NCT00557856|528884834|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
146647061|NCT00557856|528884835|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
146647062|NCT00557856|528884836|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
146647063|NCT00557856|528884837|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
146647064|NCT00557856|528884838|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
146647065|NCT00557856|528884839|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
146647066|NCT00557856|528884840|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
146974094|NCT00552617|530067448|FG008|Overall Study|Lost to Follow-up|2|||
146500671|NCT02829723|528335733|FG005|Overall Study|Progressive disease|5|||
146500672|NCT02829723|528335734|FG006|Overall Study|Progressive disease|4|||
146500673|NCT02829723|528335735|FG007|Overall Study|Progressive disease|6|||
146500674|NCT02829723|528335736|FG008|Overall Study|Progressive disease|8|||
146500675|NCT02829723|528335737|FG009|Overall Study|Progressive disease|4|||
146500676|NCT02829723|528335738|FG010|Overall Study|Progressive disease|9|||
146500677|NCT02829723|528335739|FG011|Overall Study|Progressive disease|0|||
146500678|NCT02829723|528335740|FG012|Overall Study|Progressive disease|3|||
146500679|NCT02829723|528335741|FG013|Overall Study|Progressive disease|4|||
146500680|NCT02829723|528335742|FG014|Overall Study|Progressive disease|2|||
146500681|NCT02829723|528335743|FG015|Overall Study|Progressive disease|4|||
146500682|NCT02829723|528335744|FG016|Overall Study|Progressive disease|5|||
146500683|NCT02829723|528335745|FG017|Overall Study|Progressive disease|3|||
146500684|NCT02829723|528335746|FG018|Overall Study|Progressive disease|4|||
146500685|NCT02829723|528335747|FG019|Overall Study|Progressive disease|4|||
146500686|NCT02829723|528335748|FG020|Overall Study|Progressive disease|7|||
146500687|NCT02829723|528335749|FG021|Overall Study|Progressive disease|6|||
146500688|NCT02829723|528335750|FG022|Overall Study|Progressive disease|3|||
146500689|NCT02829723|528335751|FG023|Overall Study|Progressive disease|3|||
146500690|NCT02829723|528335752|FG024|Overall Study|Progressive disease|3|||
146500691|NCT02829723|528335753|FG025|Overall Study|Progressive disease|16|||
146500692|NCT02829723|528335754|FG026|Overall Study|Progressive disease|10|||
146647067|NCT00557856|528884841|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
146647068|NCT00557856|528884833|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
146647069|NCT00557856|528884834|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
146974095|NCT00552617|530067449|FG009|Overall Study|Lost to Follow-up|0|||
146974096|NCT04651218|530067450|FG000|Overall Study|Withdrawal by Subject|0|||
146500693|NCT02829723|528335728|FG000|Overall Study|Subject/guardian decision|0|||
146500694|NCT02829723|528335729|FG001|Overall Study|Subject/guardian decision|1|||
146500695|NCT02829723|528335730|FG002|Overall Study|Subject/guardian decision|0|||
146500696|NCT02829723|528335731|FG003|Overall Study|Subject/guardian decision|1|||
146500697|NCT02829723|528335732|FG004|Overall Study|Subject/guardian decision|0|||
146647070|NCT00557856|528884835|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
146647071|NCT00557856|528884836|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
146647072|NCT00557856|528884837|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
146647073|NCT00557856|528884838|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
146647074|NCT00557856|528884839|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
146647075|NCT00557856|528884840|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
146647076|NCT00557856|528884841|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
146647077|NCT00557856|528884833|FG000|Part 1: Dose Escalation Phase|Other|0|||
146647078|NCT00557856|528884834|FG001|Part 1: Dose Escalation Phase|Other|0|||
146647079|NCT00557856|528884835|FG002|Part 1: Dose Escalation Phase|Other|1|||
146647080|NCT00557856|528884836|FG003|Part 1: Dose Escalation Phase|Other|1|||
146647081|NCT00557856|528884837|FG004|Part 1: Dose Escalation Phase|Other|0|||
146647082|NCT00557856|528884838|FG005|Part 1: Dose Escalation Phase|Other|0|||
146647083|NCT00557856|528884839|FG006|Part 1: Dose Escalation Phase|Other|0|||
146647084|NCT00557856|528884840|FG007|Part 1: Dose Escalation Phase|Other|1|||
146500698|NCT02829723|528335733|FG005|Overall Study|Subject/guardian decision|0|||
146500699|NCT02829723|528335734|FG006|Overall Study|Subject/guardian decision|0|||
146500700|NCT02829723|528335735|FG007|Overall Study|Subject/guardian decision|1|||
146500701|NCT02829723|528335736|FG008|Overall Study|Subject/guardian decision|0|||
146500702|NCT02829723|528335737|FG009|Overall Study|Subject/guardian decision|0|||
146500703|NCT02829723|528335738|FG010|Overall Study|Subject/guardian decision|0|||
146500704|NCT02829723|528335739|FG011|Overall Study|Subject/guardian decision|0|||
146500705|NCT02829723|528335740|FG012|Overall Study|Subject/guardian decision|0|||
146500706|NCT02829723|528335741|FG013|Overall Study|Subject/guardian decision|0|||
146500707|NCT02829723|528335742|FG014|Overall Study|Subject/guardian decision|1|||
146500708|NCT02829723|528335743|FG015|Overall Study|Subject/guardian decision|0|||
146500709|NCT02829723|528335744|FG016|Overall Study|Subject/guardian decision|1|||
146500710|NCT02829723|528335745|FG017|Overall Study|Subject/guardian decision|0|||
146500711|NCT02829723|528335746|FG018|Overall Study|Subject/guardian decision|1|||
146500712|NCT02829723|528335747|FG019|Overall Study|Subject/guardian decision|0|||
146500713|NCT02829723|528335748|FG020|Overall Study|Subject/guardian decision|1|||
146500714|NCT02829723|528335749|FG021|Overall Study|Subject/guardian decision|0|||
146500715|NCT02829723|528335750|FG022|Overall Study|Subject/guardian decision|0|||
146500716|NCT02829723|528335751|FG023|Overall Study|Subject/guardian decision|1|||
146500717|NCT02829723|528335752|FG024|Overall Study|Subject/guardian decision|0|||
146500718|NCT02829723|528335753|FG025|Overall Study|Subject/guardian decision|1|||
146500719|NCT02829723|528335754|FG026|Overall Study|Subject/guardian decision|1|||
146500720|NCT02829723|528335728|FG000|Overall Study|Study terminated by sponsor|0|||
146500721|NCT02829723|528335729|FG001|Overall Study|Study terminated by sponsor|0|||
146500722|NCT02829723|528335730|FG002|Overall Study|Study terminated by sponsor|0|||
146500723|NCT02829723|528335731|FG003|Overall Study|Study terminated by sponsor|0|||
146500724|NCT02829723|528335732|FG004|Overall Study|Study terminated by sponsor|0|||
146500725|NCT02829723|528335733|FG005|Overall Study|Study terminated by sponsor|0|||
146500726|NCT02829723|528335734|FG006|Overall Study|Study terminated by sponsor|0|||
146500727|NCT02829723|528335735|FG007|Overall Study|Study terminated by sponsor|0|||
146500728|NCT02829723|528335736|FG008|Overall Study|Study terminated by sponsor|0|||
146566418|NCT00956293|528586079|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
146566419|NCT00956293|528586077|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
146566420|NCT00956293|528586078|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
146566421|NCT00956293|528586079|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
146566422|NCT00956293|528586077|FG000|Main Period (Randomization)|Adverse Event|0|||
146566423|NCT00956293|528586078|FG001|Main Period (Randomization)|Adverse Event|15|||
146566424|NCT00956293|528586079|FG002|Main Period (Randomization)|Adverse Event|0|||
146566425|NCT00956293|528586077|FG000|Follow-up Period|Follow-up period was terminated.|20|||
146566426|NCT00956293|528586078|FG001|Follow-up Period|Follow-up period was terminated.|32|||
146566427|NCT00956293|528586079|FG002|Follow-up Period|Follow-up period was terminated.|0|||
146566428|NCT01240863|528586082|FG000|Open-label Titration Period|Adverse Event|47|||
146566429|NCT01240863|528586083|FG001|Open-label Titration Period|Adverse Event|0|||
146566430|NCT01240863|528586084|FG002|Open-label Titration Period|Adverse Event|0|||
146566431|NCT01240863|528586082|FG000|Open-label Titration Period|Lack of Efficacy|19|||
146566432|NCT01240863|528586083|FG001|Open-label Titration Period|Lack of Efficacy|0|||
146566433|NCT01240863|528586084|FG002|Open-label Titration Period|Lack of Efficacy|0|||
146566434|NCT01240863|528586082|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
146566435|NCT01240863|528586083|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
146566436|NCT01240863|528586084|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
146500729|NCT02829723|528335737|FG009|Overall Study|Study terminated by sponsor|0|||
146647085|NCT00557856|528884841|FG008|Part 1: Dose Escalation Phase|Other|0|||
146647086|NCT00557856|528884833|FG000|Part 1: Dose Escalation Phase|Death|0|||
146500730|NCT02829723|528335738|FG010|Overall Study|Study terminated by sponsor|0|||
146500731|NCT02829723|528335739|FG011|Overall Study|Study terminated by sponsor|0|||
146566437|NCT01240863|528586082|FG000|Open-label Titration Period|Protocol Violation|7|||
146647087|NCT00557856|528884834|FG001|Part 1: Dose Escalation Phase|Death|0|||
146647088|NCT00557856|528884835|FG002|Part 1: Dose Escalation Phase|Death|0|||
146500732|NCT02829723|528335740|FG012|Overall Study|Study terminated by sponsor|0|||
146500733|NCT02829723|528335741|FG013|Overall Study|Study terminated by sponsor|0|||
146500734|NCT02829723|528335742|FG014|Overall Study|Study terminated by sponsor|0|||
146500735|NCT02829723|528335743|FG015|Overall Study|Study terminated by sponsor|0|||
146500736|NCT02829723|528335744|FG016|Overall Study|Study terminated by sponsor|0|||
146500737|NCT02829723|528335745|FG017|Overall Study|Study terminated by sponsor|0|||
146500738|NCT02829723|528335746|FG018|Overall Study|Study terminated by sponsor|0|||
146500739|NCT02829723|528335747|FG019|Overall Study|Study terminated by sponsor|0|||
146500740|NCT02829723|528335748|FG020|Overall Study|Study terminated by sponsor|0|||
146500741|NCT02829723|528335749|FG021|Overall Study|Study terminated by sponsor|1|||
146500742|NCT02829723|528335750|FG022|Overall Study|Study terminated by sponsor|0|||
146500743|NCT02829723|528335751|FG023|Overall Study|Study terminated by sponsor|0|||
146500744|NCT02829723|528335752|FG024|Overall Study|Study terminated by sponsor|0|||
146500745|NCT02829723|528335753|FG025|Overall Study|Study terminated by sponsor|0|||
146500746|NCT02829723|528335754|FG026|Overall Study|Study terminated by sponsor|0|||
146500747|NCT00638443|528335755|FG000|First Intervention|Adverse Event|2|||
146500748|NCT00638443|528335756|FG001|First Intervention|Adverse Event|1|||
146500749|NCT04740827|528335765|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
146500750|NCT04740827|528335766|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
146500751|NCT04740827|528335765|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
146500752|NCT04740827|528335766|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
146500753|NCT04740827|528335765|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
146500754|NCT04740827|528335766|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
146500755|NCT04740827|528335765|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
146500756|NCT04740827|528335766|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
146500757|NCT04740827|528335765|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
146500758|NCT04740827|528335766|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
146500759|NCT04740827|528335765|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
146500760|NCT04740827|528335766|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
146500761|NCT02147158|528335767|FG000|Treatment Course 1|Adverse Event|1|||
146500762|NCT02147158|528335768|FG001|Treatment Course 1|Adverse Event|4|||
146500763|NCT02147158|528335769|FG002|Treatment Course 1|Adverse Event|3|||
146500764|NCT02147158|528335770|FG003|Treatment Course 1|Adverse Event|4|||
146500765|NCT02147158|528335771|FG004|Treatment Course 1|Adverse Event|1|||
146500766|NCT02147158|528335772|FG005|Treatment Course 1|Adverse Event|2|||
146500767|NCT02147158|528335767|FG000|Treatment Course 1|Lost to Follow-up|2|||
146500768|NCT02147158|528335768|FG001|Treatment Course 1|Lost to Follow-up|4|||
146500769|NCT02147158|528335769|FG002|Treatment Course 1|Lost to Follow-up|3|||
146500770|NCT02147158|528335770|FG003|Treatment Course 1|Lost to Follow-up|3|||
146500771|NCT02147158|528335771|FG004|Treatment Course 1|Lost to Follow-up|2|||
146500772|NCT02147158|528335772|FG005|Treatment Course 1|Lost to Follow-up|4|||
146500773|NCT02147158|528335767|FG000|Treatment Course 1|Protocol Violation|0|||
146500774|NCT02147158|528335768|FG001|Treatment Course 1|Protocol Violation|0|||
146500775|NCT02147158|528335769|FG002|Treatment Course 1|Protocol Violation|1|||
146500776|NCT02147158|528335770|FG003|Treatment Course 1|Protocol Violation|1|||
146500777|NCT02147158|528335771|FG004|Treatment Course 1|Protocol Violation|0|||
146500778|NCT02147158|528335772|FG005|Treatment Course 1|Protocol Violation|0|||
146500779|NCT02147158|528335767|FG000|Treatment Course 1|Withdrawal of Consent|1|||
146500780|NCT02147158|528335768|FG001|Treatment Course 1|Withdrawal of Consent|1|||
146500781|NCT02147158|528335769|FG002|Treatment Course 1|Withdrawal of Consent|1|||
146500782|NCT02147158|528335770|FG003|Treatment Course 1|Withdrawal of Consent|5|||
146500783|NCT02147158|528335771|FG004|Treatment Course 1|Withdrawal of Consent|3|||
146500784|NCT02147158|528335772|FG005|Treatment Course 1|Withdrawal of Consent|2|||
146500785|NCT02147158|528335767|FG000|Off-Treatment Interval 1|Adverse Event|1|||
146500786|NCT02147158|528335768|FG001|Off-Treatment Interval 1|Adverse Event|0|||
146500787|NCT02147158|528335769|FG002|Off-Treatment Interval 1|Adverse Event|0|||
146500788|NCT02147158|528335770|FG003|Off-Treatment Interval 1|Adverse Event|1|||
146500789|NCT02147158|528335771|FG004|Off-Treatment Interval 1|Adverse Event|0|||
146500790|NCT02147158|528335772|FG005|Off-Treatment Interval 1|Adverse Event|0|||
146500791|NCT02147158|528335767|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
146647089|NCT00557856|528884836|FG003|Part 1: Dose Escalation Phase|Death|0|||
146647090|NCT00557856|528884837|FG004|Part 1: Dose Escalation Phase|Death|0|||
146647091|NCT00557856|528884838|FG005|Part 1: Dose Escalation Phase|Death|1|||
146500792|NCT02147158|528335768|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
146500793|NCT02147158|528335769|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
146500794|NCT02147158|528335770|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
146500795|NCT02147158|528335771|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
146500796|NCT02147158|528335772|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
146500797|NCT02147158|528335767|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
146500798|NCT02147158|528335768|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
146500799|NCT02147158|528335769|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
146500800|NCT02147158|528335770|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
146647092|NCT00557856|528884839|FG006|Part 1: Dose Escalation Phase|Death|0|||
146647093|NCT00557856|528884840|FG007|Part 1: Dose Escalation Phase|Death|0|||
146500801|NCT02147158|528335771|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
146500802|NCT02147158|528335772|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
146500803|NCT02147158|528335767|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
146500804|NCT02147158|528335768|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
146500805|NCT02147158|528335769|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
146500806|NCT02147158|528335770|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
146500807|NCT02147158|528335771|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
146500808|NCT02147158|528335772|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
146500809|NCT02147158|528335767|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
146500810|NCT02147158|528335768|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
146500811|NCT02147158|528335769|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
146500812|NCT02147158|528335770|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
146500813|NCT02147158|528335771|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
146500814|NCT02147158|528335772|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
146500815|NCT02147158|528335767|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
146500816|NCT02147158|528335768|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
146500817|NCT02147158|528335769|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
146500818|NCT02147158|528335770|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
146500819|NCT02147158|528335771|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
146500820|NCT02147158|528335772|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
146500821|NCT02147158|528335767|FG000|Treatment Course 2|Adverse Event|0|||
146500822|NCT02147158|528335768|FG001|Treatment Course 2|Adverse Event|4|||
146500823|NCT02147158|528335769|FG002|Treatment Course 2|Adverse Event|2|||
146500824|NCT02147158|528335770|FG003|Treatment Course 2|Adverse Event|1|||
146500825|NCT02147158|528335771|FG004|Treatment Course 2|Adverse Event|0|||
146500826|NCT02147158|528335772|FG005|Treatment Course 2|Adverse Event|1|||
146500827|NCT02147158|528335767|FG000|Treatment Course 2|Withdrawal of Consent|0|||
146500828|NCT02147158|528335768|FG001|Treatment Course 2|Withdrawal of Consent|1|||
146500829|NCT02147158|528335769|FG002|Treatment Course 2|Withdrawal of Consent|2|||
146500830|NCT02147158|528335770|FG003|Treatment Course 2|Withdrawal of Consent|3|||
146500831|NCT02147158|528335771|FG004|Treatment Course 2|Withdrawal of Consent|0|||
146566438|NCT01240863|528586083|FG001|Open-label Titration Period|Protocol Violation|0|||
146566439|NCT01240863|528586084|FG002|Open-label Titration Period|Protocol Violation|0|||
146566440|NCT01240863|528586082|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
146566441|NCT01240863|528586083|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
146566442|NCT01240863|528586084|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
146566443|NCT01240863|528586082|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
146566444|NCT01240863|528586083|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
146566445|NCT01240863|528586084|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
146566446|NCT01240863|528586082|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
146566447|NCT01240863|528586083|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
146566448|NCT01240863|528586084|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
146566449|NCT01240863|528586082|FG000|Open-label Titration Period|Other|7|||
146566450|NCT01240863|528586083|FG001|Open-label Titration Period|Other|0|||
146566451|NCT01240863|528586084|FG002|Open-label Titration Period|Other|0|||
146566452|NCT01240863|528586082|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
146566453|NCT01240863|528586083|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
146566454|NCT01240863|528586084|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
146566455|NCT01240863|528586082|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
146566456|NCT01240863|528586083|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
146566457|NCT01240863|528586084|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
146566458|NCT01240863|528586082|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146566459|NCT01240863|528586083|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
146566460|NCT01240863|528586084|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
146566461|NCT01240863|528586082|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
146566462|NCT01240863|528586083|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
146566463|NCT01240863|528586084|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
146566464|NCT01240863|528586082|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
146566465|NCT01240863|528586083|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
146500832|NCT02147158|528335772|FG005|Treatment Course 2|Withdrawal of Consent|0|||
146500833|NCT02147158|528335767|FG000|Treatment Course 2|Lost to Follow-up|1|||
146566466|NCT01240863|528586084|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
146566467|NCT01240863|528586082|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
146566468|NCT01240863|528586083|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
146566469|NCT01240863|528586084|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
146566470|NCT01240863|528586082|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
146566471|NCT01240863|528586083|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
146500834|NCT02147158|528335768|FG001|Treatment Course 2|Lost to Follow-up|0|||
146500835|NCT02147158|528335769|FG002|Treatment Course 2|Lost to Follow-up|1|||
146500836|NCT02147158|528335770|FG003|Treatment Course 2|Lost to Follow-up|1|||
146500837|NCT02147158|528335771|FG004|Treatment Course 2|Lost to Follow-up|0|||
146500838|NCT02147158|528335772|FG005|Treatment Course 2|Lost to Follow-up|1|||
146500839|NCT02147158|528335767|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
146500840|NCT02147158|528335768|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
146500841|NCT02147158|528335769|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
146500842|NCT02147158|528335770|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
146500843|NCT02147158|528335771|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
146500844|NCT02147158|528335772|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
146500845|NCT02147158|528335767|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
146500846|NCT02147158|528335768|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
146500847|NCT02147158|528335769|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
146500848|NCT02147158|528335770|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
146500849|NCT02147158|528335771|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
146500850|NCT02147158|528335772|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
146500851|NCT02147158|528335767|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
146500852|NCT02147158|528335768|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
146500853|NCT02147158|528335769|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
146500854|NCT02147158|528335770|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
146500855|NCT02147158|528335771|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
146500856|NCT02147158|528335772|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
146500857|NCT02147158|528335767|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
146500858|NCT02147158|528335768|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
146500859|NCT02147158|528335769|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
146500860|NCT02147158|528335770|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
146500861|NCT02147158|528335771|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
146500862|NCT02147158|528335772|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
146500863|NCT02147158|528335767|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
146500864|NCT02147158|528335768|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
146500865|NCT02147158|528335769|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
146500866|NCT02147158|528335770|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
146500867|NCT02147158|528335771|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
146500868|NCT02147158|528335772|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
146500869|NCT03033602|528335773|FG000|Overall Study|Withdrawal by Subject|11|||
146500870|NCT03033602|528335774|FG001|Overall Study|Withdrawal by Subject|21|||
146500871|NCT03033602|528335773|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
146500872|NCT03033602|528335774|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
146500873|NCT03425396|528335775|FG000|Overall Study|Lost to Follow-up|2|||
146500874|NCT03425396|528335776|FG001|Overall Study|Lost to Follow-up|5|||
146500875|NCT03425396|528335777|FG002|Overall Study|Lost to Follow-up|2|||
146500876|NCT03425396|528335778|FG003|Overall Study|Lost to Follow-up|0|||
146500877|NCT03425396|528335779|FG004|Overall Study|Lost to Follow-up|0|||
146500878|NCT03425396|528335775|FG000|Overall Study|Withdrawal by Subject|0|||
146500879|NCT03425396|528335776|FG001|Overall Study|Withdrawal by Subject|1|||
146500880|NCT03425396|528335777|FG002|Overall Study|Withdrawal by Subject|0|||
146500881|NCT03425396|528335778|FG003|Overall Study|Withdrawal by Subject|1|||
146500882|NCT03425396|528335779|FG004|Overall Study|Withdrawal by Subject|0|||
146500883|NCT03425396|528335775|FG000|Overall Study|Other|0|||
146500884|NCT03425396|528335776|FG001|Overall Study|Other|1|||
146500885|NCT03425396|528335777|FG002|Overall Study|Other|1|||
146500886|NCT03425396|528335778|FG003|Overall Study|Other|0|||
146500887|NCT03425396|528335779|FG004|Overall Study|Other|1|||
146500888|NCT01441765|528335780|FG000|Overall Study|Death|1|||
146500889|NCT01441765|528335781|FG001|Overall Study|Death|0|||
146500890|NCT00940823|528335782|FG000|Overall Study|Death|8|||
146500891|NCT00940823|528335783|FG001|Overall Study|Death|12|||
146500892|NCT00940823|528335782|FG000|Overall Study|Lost to Follow-up|27|||
146500893|NCT00940823|528335783|FG001|Overall Study|Lost to Follow-up|20|||
146500894|NCT01082211|528335786|FG000|Overall Study|Protocol Violation|4|||
146500895|NCT01082211|528335786|FG000|Overall Study|No protocol treatment received|3|||
146500896|NCT04999163|528335787|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
146500897|NCT04999163|528335788|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
146500898|NCT04999163|528335787|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
146500899|NCT04999163|528335788|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
146500900|NCT04999163|528335787|FG000|Overall Study|Withdrawal by Subject|1|||
146500901|NCT04999163|528335788|FG001|Overall Study|Withdrawal by Subject|0|||
146500902|NCT00199797|528338098|FG000|Overall Study|Progressive Disease|1|||
146500903|NCT00199797|528338098|FG000|Overall Study|Adverse Event|1|||
146500904|NCT00199797|528338098|FG000|Overall Study|Physician Decision|1|||
146500905|NCT04250350|528338100|FG000|Overall Study|Withdrawal by Subject|13|||
146500906|NCT04250350|528338100|FG000|Overall Study|Lost to Follow-up|8|||
146500907|NCT04250350|528338100|FG000|Overall Study|Adverse Event|5|||
146500908|NCT04250350|528338100|FG000|Overall Study|Lack of Efficacy|4|||
146500909|NCT04250350|528338100|FG000|Overall Study|Physician Decision|1|||
146500910|NCT04250350|528338100|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
146500911|NCT00504725|528338105|FG000|Overall Study|Protocol Violation|1|||
146500912|NCT00504725|528338106|FG001|Overall Study|Protocol Violation|0|||
146500913|NCT00378508|528338107|FG000|Overall Study|Withdrawal by Subject|1|||
146500914|NCT00378508|528338108|FG001|Overall Study|Withdrawal by Subject|3|||
146500915|NCT00378508|528338107|FG000|Overall Study|Lost to Follow-up|1|||
146500916|NCT00378508|528338108|FG001|Overall Study|Lost to Follow-up|0|||
146500917|NCT01435018|528338109|FG000|Overall Study|Death|37|||
146500918|NCT01435018|528338110|FG001|Overall Study|Death|18|||
146500919|NCT01435018|528338111|FG002|Overall Study|Death|25|||
146500920|NCT01435018|528338109|FG000|Overall Study|Site is closing|4|||
146500921|NCT01435018|528338110|FG001|Overall Study|Site is closing|9|||
146500922|NCT01435018|528338111|FG002|Overall Study|Site is closing|7|||
146500923|NCT01435018|528338109|FG000|Overall Study|Withdrew consent|0|||
146500924|NCT01435018|528338110|FG001|Overall Study|Withdrew consent|3|||
146500925|NCT01435018|528338111|FG002|Overall Study|Withdrew consent|1|||
146500926|NCT01435018|528338109|FG000|Overall Study|Not willing to adhere to requirements|0|||
146500927|NCT01435018|528338110|FG001|Overall Study|Not willing to adhere to requirements|2|||
146500928|NCT01435018|528338111|FG002|Overall Study|Not willing to adhere to requirements|3|||
146500929|NCT01435018|528338109|FG000|Overall Study|Not able to get to clinic|2|||
146500930|NCT01435018|528338110|FG001|Overall Study|Not able to get to clinic|0|||
146500931|NCT01435018|528338111|FG002|Overall Study|Not able to get to clinic|2|||
146500932|NCT01435018|528338109|FG000|Overall Study|Severe debilitation, unable to continue|0|||
146500933|NCT01435018|528338110|FG001|Overall Study|Severe debilitation, unable to continue|0|||
146500934|NCT01435018|528338111|FG002|Overall Study|Severe debilitation, unable to continue|1|||
146500935|NCT01435018|528338109|FG000|Overall Study|Unable to contact participant/parent|1|||
146500936|NCT01435018|528338110|FG001|Overall Study|Unable to contact participant/parent|1|||
146500937|NCT01435018|528338111|FG002|Overall Study|Unable to contact participant/parent|1|||
146500938|NCT01435018|528338109|FG000|Overall Study|Enrollment Violation|0|||
146500939|NCT01435018|528338110|FG001|Overall Study|Enrollment Violation|1|||
146500940|NCT01435018|528338111|FG002|Overall Study|Enrollment Violation|0|||
146500941|NCT01435018|528338109|FG000|Overall Study|Never started chemotherapy|3|||
146500942|NCT01435018|528338110|FG001|Overall Study|Never started chemotherapy|0|||
146500943|NCT01435018|528338111|FG002|Overall Study|Never started chemotherapy|1|||
146500944|NCT03937908|528338112|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
146500945|NCT03937908|528338113|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
146500946|NCT03205761|528338114|FG000|Overall Study|Withdrawal by Subject|1|||
146500947|NCT03205761|528338114|FG000|Overall Study|Progressive Disease|10|||
146500948|NCT00636194|528338115|FG000|Overall Study|Study related symptoms and complaints|1|||
146500949|NCT00636194|528338116|FG001|Overall Study|Study related symptoms and complaints|0|||
146500950|NCT00636194|528338115|FG000|Overall Study|Protocol Violation|2|||
146500951|NCT00636194|528338116|FG001|Overall Study|Protocol Violation|0|||
146500952|NCT02163226|528338118|FG000|Overall Study|Death|2|||
146500953|NCT02163226|528338119|FG001|Overall Study|Death|1|||
146500954|NCT02163226|528338118|FG000|Overall Study|Withdrawal by Subject|5|||
146500955|NCT02163226|528338119|FG001|Overall Study|Withdrawal by Subject|2|||
146500956|NCT02163226|528338118|FG000|Overall Study|Returned home, local radiotherapy|3|||
146500957|NCT02163226|528338119|FG001|Overall Study|Returned home, local radiotherapy|0|||
146500958|NCT02163226|528338118|FG000|Overall Study|Repeat imaging showed no disease|2|||
146500959|NCT02163226|528338119|FG001|Overall Study|Repeat imaging showed no disease|0|||
146500960|NCT02163226|528338118|FG000|Overall Study|Incomplete radiotherapy|3|||
146500961|NCT02163226|528338119|FG001|Overall Study|Incomplete radiotherapy|0|||
146500962|NCT02163226|528338118|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
146500963|NCT02163226|528338119|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
146500964|NCT02163226|528338118|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
146500965|NCT02163226|528338119|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
146500966|NCT02163226|528338118|FG000|Overall Study|ineligible|0|||
146500967|NCT02163226|528338119|FG001|Overall Study|ineligible|3|||
146500968|NCT05318092|528338123|FG000|Overall Study|Lost to Follow-up|3|||
146500969|NCT05318092|528338123|FG000|Overall Study|Withdrawal by Subject|1|||
146500970|NCT02656290|528338136|FG000|Overall Study|Lost to Follow-up|1|||
146500971|NCT02656290|528338136|FG000|Overall Study|Reintervention|3|||
146500972|NCT01608087|528338137|FG000|Overall Study|Lost to Follow-up|0|||
146500973|NCT01608087|528338138|FG001|Overall Study|Lost to Follow-up|1|||
146500974|NCT01608087|528338139|FG002|Overall Study|Lost to Follow-up|0|||
146500975|NCT01608087|528338137|FG000|Overall Study|Other Reason|0|||
146500976|NCT01608087|528338138|FG001|Overall Study|Other Reason|1|||
146566472|NCT01240863|528586084|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
146566473|NCT01240863|528586082|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
146566474|NCT01240863|528586083|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
146566475|NCT01240863|528586084|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
146566476|NCT01816984|528586086|FG000|Overall Study|declining health status|1|||
146500977|NCT01608087|528338139|FG002|Overall Study|Other Reason|0|||
146500978|NCT02461524|528338141|FG000|Overall Study|Death|16|||
146500979|NCT02461524|528338141|FG000|Overall Study|Withdrawal by Subject|4|||
146500980|NCT02461524|528338141|FG000|Overall Study|Device Explanted|5|||
146500981|NCT02461524|528338141|FG000|Overall Study|Missed Visit|6|||
146500982|NCT01943851|528338143|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
146500983|NCT01943851|528338144|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
146500984|NCT01943851|528338145|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
146500985|NCT01943851|528338146|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
146500986|NCT01943851|528338147|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
146500987|NCT01943851|528338148|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
146500988|NCT01943851|528338149|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
146500989|NCT01943851|528338150|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
146500990|NCT01943851|528338151|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
146500991|NCT01943851|528338152|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
146500992|NCT01943851|528338153|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
146500993|NCT01943851|528338154|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
146500994|NCT01943851|528338155|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
146500995|NCT01943851|528338156|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
146500996|NCT01943851|528338157|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
146500997|NCT01943851|528338158|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
146500998|NCT01943851|528338159|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
146500999|NCT01943851|528338160|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
146501000|NCT01943851|528338143|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
146501001|NCT01943851|528338144|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
146501002|NCT01943851|528338145|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
146501003|NCT01943851|528338146|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
146501004|NCT01943851|528338147|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
146501005|NCT01943851|528338148|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
146501006|NCT01943851|528338149|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
146501007|NCT01943851|528338150|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
146501008|NCT01943851|528338151|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
146501009|NCT01943851|528338152|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
146501010|NCT01943851|528338153|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
146501011|NCT01943851|528338154|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
146501012|NCT01943851|528338155|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
146501013|NCT01943851|528338156|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
146501014|NCT01943851|528338157|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
146501015|NCT01943851|528338158|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
146501016|NCT01943851|528338159|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
146501017|NCT01943851|528338160|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
146501018|NCT01943851|528338143|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146501019|NCT01943851|528338144|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146501020|NCT01943851|528338145|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146501021|NCT01943851|528338146|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146501022|NCT01943851|528338147|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146501023|NCT01943851|528338148|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146501024|NCT01943851|528338149|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146501025|NCT01943851|528338150|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146501026|NCT01943851|528338151|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146501027|NCT01943851|528338152|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146501028|NCT01943851|528338153|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146501029|NCT01943851|528338154|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146501030|NCT01943851|528338155|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146501031|NCT01943851|528338156|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
146501032|NCT01943851|528338157|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146501033|NCT01943851|528338158|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146501034|NCT01943851|528338159|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146501035|NCT01943851|528338160|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
146566477|NCT05899829|528586087|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
146566478|NCT05899829|528586088|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
146566479|NCT05899829|528586087|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
146566480|NCT05899829|528586088|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
146566481|NCT00867035|528586089|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
146566482|NCT00867035|528586090|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
146566483|NCT00867035|528586089|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
146566484|NCT00867035|528586090|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
146566485|NCT02993263|528586091|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
146566486|NCT01405196|528586094|FG000|Overall Study|Study Terminated by Sponsor|0|||
146566487|NCT01405196|528586095|FG001|Overall Study|Study Terminated by Sponsor|0|||
146769099|NCT03284957|529323409|FG000|Overall Study|Withdrawal by Subject|0|||
146501036|NCT01943851|528338143|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501037|NCT01943851|528338144|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501038|NCT01943851|528338145|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501039|NCT01943851|528338146|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501040|NCT01943851|528338147|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501041|NCT01943851|528338148|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501042|NCT01943851|528338149|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501043|NCT01943851|528338150|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501044|NCT01943851|528338151|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501045|NCT01943851|528338152|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501046|NCT01943851|528338153|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501047|NCT01943851|528338154|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501048|NCT01943851|528338155|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501049|NCT01943851|528338156|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501050|NCT01943851|528338157|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501051|NCT01943851|528338158|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
146501052|NCT01943851|528338159|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501053|NCT01943851|528338160|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
146501054|NCT01943851|528338143|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
146501055|NCT01943851|528338144|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
146501056|NCT01943851|528338145|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
146501057|NCT01943851|528338146|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
146501058|NCT01943851|528338147|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
146501059|NCT01943851|528338148|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
146501060|NCT01943851|528338149|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
146501061|NCT01943851|528338150|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
146501062|NCT01943851|528338151|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
146501063|NCT01943851|528338152|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
146501064|NCT01943851|528338153|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
146501065|NCT01943851|528338154|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
146501066|NCT01943851|528338155|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
146501067|NCT01943851|528338156|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
146501068|NCT01943851|528338157|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
146501069|NCT01943851|528338158|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
146501070|NCT01943851|528338159|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
146501071|NCT01943851|528338160|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
146501072|NCT04304235|528338167|FG000|Overall Study|incomplete triage data|0|||
146501073|NCT04304235|528338168|FG001|Overall Study|incomplete triage data|69|||
146501074|NCT04304235|528338169|FG002|Overall Study|incomplete triage data|0|||
146501075|NCT04304235|528338170|FG003|Overall Study|incomplete triage data|0|||
146501076|NCT04304235|528338171|FG004|Overall Study|incomplete triage data|289|||
146501077|NCT04304235|528338172|FG005|Overall Study|incomplete triage data|123|||
146501078|NCT04304235|528338173|FG006|Overall Study|incomplete triage data|65|||
146501079|NCT02048826|528338181|FG000|Overall Study|Withdrawal by Subject|1|||
146501080|NCT02048826|528338182|FG001|Overall Study|Withdrawal by Subject|0|||
146501081|NCT04470544|528338183|FG000|Overall Study|Withdrawal by Subject|4|||
146501082|NCT04470544|528338184|FG001|Overall Study|Withdrawal by Subject|6|||
146501083|NCT00712881|528338188|FG000|Overall Study|Adverse Event|3|||
146501084|NCT00712881|528338189|FG001|Overall Study|Adverse Event|3|||
146501085|NCT00712881|528338188|FG000|Overall Study|Withdrawal by Subject|1|||
146501086|NCT00712881|528338189|FG001|Overall Study|Withdrawal by Subject|1|||
146501087|NCT00712881|528338188|FG000|Overall Study|Disease Progression|2|||
146501088|NCT00712881|528338189|FG001|Overall Study|Disease Progression|1|||
146501089|NCT00712881|528338188|FG000|Overall Study|Lost to Follow-up|1|||
146501090|NCT00712881|528338189|FG001|Overall Study|Lost to Follow-up|1|||
146501091|NCT00712881|528338188|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
146501092|NCT00712881|528338189|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
146501093|NCT00712881|528338188|FG000|Overall Study|Protocol Violation|1|||
146501094|NCT00712881|528338189|FG001|Overall Study|Protocol Violation|1|||
146501095|NCT00712881|528338188|FG000|Overall Study|Randomized but not treated|1|||
146501096|NCT00712881|528338189|FG001|Overall Study|Randomized but not treated|0|||
146501097|NCT04720911|528338193|FG000|Overall Study|Withdrawal by Subject|0|||
146501098|NCT04720911|528338194|FG001|Overall Study|Withdrawal by Subject|1|||
146501099|NCT04720911|528338195|FG002|Overall Study|Withdrawal by Subject|0|||
146501100|NCT00090220|528338196|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
146501101|NCT00090220|528338197|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
146501102|NCT00090220|528338198|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
146501103|NCT00090220|528338199|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
146501104|NCT00090220|528338200|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
146501105|NCT00090220|528338201|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
146501106|NCT00090220|528338196|FG000|Base Study Vaccination Period|Adverse Event|6|||
146501107|NCT00090220|528338197|FG001|Base Study Vaccination Period|Adverse Event|1|||
146501108|NCT00090220|528338198|FG002|Base Study Vaccination Period|Adverse Event|0|||
146501109|NCT00090220|528338199|FG003|Base Study Vaccination Period|Adverse Event|0|||
146501110|NCT00090220|528338200|FG004|Base Study Vaccination Period|Adverse Event|0|||
146501111|NCT00090220|528338201|FG005|Base Study Vaccination Period|Adverse Event|0|||
146501112|NCT00090220|528338196|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
146501113|NCT00090220|528338197|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
146501114|NCT00090220|528338198|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
146501115|NCT00090220|528338199|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
146501116|NCT00090220|528338200|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
146501117|NCT00090220|528338201|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
146501118|NCT00090220|528338196|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
146501119|NCT00090220|528338197|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
146501120|NCT00090220|528338198|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
146501121|NCT00090220|528338199|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
146501122|NCT00090220|528338200|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
146501123|NCT00090220|528338201|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
146501124|NCT00090220|528338196|FG000|Base Study Vaccination Period|Patient Moved|6|||
146501125|NCT00090220|528338197|FG001|Base Study Vaccination Period|Patient Moved|2|||
146501126|NCT00090220|528338198|FG002|Base Study Vaccination Period|Patient Moved|0|||
146501127|NCT00090220|528338199|FG003|Base Study Vaccination Period|Patient Moved|0|||
146501128|NCT00090220|528338200|FG004|Base Study Vaccination Period|Patient Moved|0|||
146501129|NCT00090220|528338201|FG005|Base Study Vaccination Period|Patient Moved|0|||
146501130|NCT00090220|528338196|FG000|Base Study Vaccination Period|Other|4|||
146501131|NCT00090220|528338197|FG001|Base Study Vaccination Period|Other|4|||
146501132|NCT00090220|528338198|FG002|Base Study Vaccination Period|Other|0|||
146501133|NCT00090220|528338199|FG003|Base Study Vaccination Period|Other|0|||
146501134|NCT00090220|528338200|FG004|Base Study Vaccination Period|Other|0|||
146501135|NCT00090220|528338201|FG005|Base Study Vaccination Period|Other|0|||
146501136|NCT00090220|528338196|FG000|Base Study Follow-up Period|Adverse Event|6|||
146501137|NCT00090220|528338197|FG001|Base Study Follow-up Period|Adverse Event|1|||
146501138|NCT00090220|528338198|FG002|Base Study Follow-up Period|Adverse Event|0|||
146501139|NCT00090220|528338199|FG003|Base Study Follow-up Period|Adverse Event|0|||
146501140|NCT00090220|528338200|FG004|Base Study Follow-up Period|Adverse Event|0|||
146501141|NCT00090220|528338201|FG005|Base Study Follow-up Period|Adverse Event|0|||
146501142|NCT00090220|528338196|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
146501143|NCT00090220|528338197|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
146501144|NCT00090220|528338198|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
146501145|NCT00090220|528338199|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
146501146|NCT00090220|528338200|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
146501147|NCT00090220|528338201|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
146501148|NCT00090220|528338196|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
146501149|NCT00090220|528338197|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
146501150|NCT00090220|528338198|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
146501151|NCT00090220|528338199|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
146501152|NCT00090220|528338200|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
146501153|NCT00090220|528338201|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
146501154|NCT00090220|528338196|FG000|Base Study Follow-up Period|Patient Moved|20|||
146501155|NCT00090220|528338197|FG001|Base Study Follow-up Period|Patient Moved|28|||
146501156|NCT00090220|528338198|FG002|Base Study Follow-up Period|Patient Moved|0|||
146501157|NCT00090220|528338199|FG003|Base Study Follow-up Period|Patient Moved|0|||
146501158|NCT00090220|528338200|FG004|Base Study Follow-up Period|Patient Moved|0|||
146501159|NCT00090220|528338201|FG005|Base Study Follow-up Period|Patient Moved|0|||
146501160|NCT00090220|528338196|FG000|Base Study Follow-up Period|Other|19|||
146501161|NCT00090220|528338197|FG001|Base Study Follow-up Period|Other|21|||
146501162|NCT00090220|528338198|FG002|Base Study Follow-up Period|Other|0|||
146501163|NCT00090220|528338199|FG003|Base Study Follow-up Period|Other|0|||
146501164|NCT00090220|528338200|FG004|Base Study Follow-up Period|Other|0|||
146647094|NCT00557856|528884841|FG008|Part 1: Dose Escalation Phase|Death|0|||
146647095|NCT00557856|528884833|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
146647096|NCT00557856|528884834|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
146501165|NCT00090220|528338201|FG005|Base Study Follow-up Period|Other|0|||
146501166|NCT00090220|528338196|FG000|Extension 1 (EXT1)|Adverse Event|0|||
146501167|NCT00090220|528338197|FG001|Extension 1 (EXT1)|Adverse Event|0|||
146912635|NCT02546856|529843116|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
146501168|NCT00090220|528338198|FG002|Extension 1 (EXT1)|Adverse Event|4|||
146501169|NCT00090220|528338199|FG003|Extension 1 (EXT1)|Adverse Event|0|||
146501170|NCT00090220|528338200|FG004|Extension 1 (EXT1)|Adverse Event|0|||
146501171|NCT00090220|528338201|FG005|Extension 1 (EXT1)|Adverse Event|0|||
146501172|NCT00090220|528338196|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
146501173|NCT00090220|528338197|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
146501174|NCT00090220|528338198|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
146501175|NCT00090220|528338199|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
146501176|NCT00090220|528338200|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
146501177|NCT00090220|528338201|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
146501178|NCT00090220|528338196|FG000|Extension 1 (EXT1)|Moved|0|||
146501179|NCT00090220|528338197|FG001|Extension 1 (EXT1)|Moved|0|||
146501180|NCT00090220|528338198|FG002|Extension 1 (EXT1)|Moved|2|||
146501181|NCT00090220|528338199|FG003|Extension 1 (EXT1)|Moved|1|||
146501182|NCT00090220|528338200|FG004|Extension 1 (EXT1)|Moved|0|||
146501183|NCT00090220|528338201|FG005|Extension 1 (EXT1)|Moved|0|||
146501184|NCT00090220|528338196|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
146501185|NCT00090220|528338197|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
146501186|NCT00090220|528338198|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
146501187|NCT00090220|528338199|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
146501188|NCT00090220|528338200|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
146501189|NCT00090220|528338201|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
146501190|NCT00090220|528338196|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
146501191|NCT00090220|528338197|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
146501192|NCT00090220|528338198|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
146501193|NCT00090220|528338199|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
146501194|NCT00090220|528338200|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
146501195|NCT00090220|528338201|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
146501196|NCT00090220|528338196|FG000|Extension 1 (EXT1)|Other reason|0|||
146501197|NCT00090220|528338197|FG001|Extension 1 (EXT1)|Other reason|0|||
146501198|NCT00090220|528338198|FG002|Extension 1 (EXT1)|Other reason|2|||
146501199|NCT00090220|528338199|FG003|Extension 1 (EXT1)|Other reason|0|||
146501200|NCT00090220|528338200|FG004|Extension 1 (EXT1)|Other reason|0|||
146501201|NCT00090220|528338201|FG005|Extension 1 (EXT1)|Other reason|0|||
146501202|NCT00090220|528338196|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
146501203|NCT00090220|528338197|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
146501204|NCT00090220|528338198|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
146501205|NCT00090220|528338199|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
146501206|NCT00090220|528338200|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
146501207|NCT00090220|528338201|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
146501208|NCT00090220|528338196|FG000|Long-term Follow-up (EXT2)|Death|0|||
146501209|NCT00090220|528338197|FG001|Long-term Follow-up (EXT2)|Death|0|||
146501210|NCT00090220|528338198|FG002|Long-term Follow-up (EXT2)|Death|0|||
146501211|NCT00090220|528338199|FG003|Long-term Follow-up (EXT2)|Death|0|||
146501212|NCT00090220|528338200|FG004|Long-term Follow-up (EXT2)|Death|1|||
146501213|NCT00090220|528338201|FG005|Long-term Follow-up (EXT2)|Death|1|||
146501214|NCT00090220|528338196|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
146501215|NCT00090220|528338197|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
146501216|NCT00090220|528338198|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
146501217|NCT00090220|528338199|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
146501218|NCT00090220|528338200|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
146501219|NCT00090220|528338201|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
146501220|NCT00090220|528338196|FG000|Long-term Follow-up (EXT2)|Other|0|||
146501221|NCT00090220|528338197|FG001|Long-term Follow-up (EXT2)|Other|0|||
146501222|NCT00090220|528338198|FG002|Long-term Follow-up (EXT2)|Other|0|||
146566488|NCT01405196|528586096|FG002|Overall Study|Study Terminated by Sponsor|9|||
146566489|NCT01405196|528586097|FG003|Overall Study|Study Terminated by Sponsor|0|||
146566490|NCT01405196|528586094|FG000|Overall Study|Other|2|||
146566491|NCT01405196|528586095|FG001|Overall Study|Other|2|||
146566492|NCT01405196|528586096|FG002|Overall Study|Other|5|||
146566493|NCT01405196|528586097|FG003|Overall Study|Other|0|||
146566494|NCT01405196|528586094|FG000|Overall Study|Withdrawal by Subject|4|||
146501223|NCT00090220|528338199|FG003|Long-term Follow-up (EXT2)|Other|0|||
146501224|NCT00090220|528338200|FG004|Long-term Follow-up (EXT2)|Other|1|||
146501225|NCT00090220|528338201|FG005|Long-term Follow-up (EXT2)|Other|0|||
146501226|NCT00941863|528338202|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
146501227|NCT00941863|528338203|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
146501228|NCT00941863|528338204|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
146501229|NCT00941863|528338205|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
146501230|NCT00941863|528338206|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
146501231|NCT00941863|528338202|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
146501232|NCT00941863|528338203|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
146501233|NCT00941863|528338204|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
146501234|NCT00941863|528338205|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
146501235|NCT00941863|528338206|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
146566495|NCT01405196|528586095|FG001|Overall Study|Withdrawal by Subject|6|||
146501236|NCT00941863|528338202|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
146501237|NCT00941863|528338203|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
146501238|NCT00941863|528338204|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
146501239|NCT00941863|528338205|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
146501240|NCT00941863|528338206|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
146566496|NCT01405196|528586096|FG002|Overall Study|Withdrawal by Subject|3|||
146501241|NCT00941863|528338202|FG000|Until Primary Completion Date (PCD)|Death|0|||
146501242|NCT00941863|528338203|FG001|Until Primary Completion Date (PCD)|Death|0|||
146501243|NCT00941863|528338204|FG002|Until Primary Completion Date (PCD)|Death|1|||
146501244|NCT00941863|528338205|FG003|Until Primary Completion Date (PCD)|Death|2|||
146501245|NCT00941863|528338206|FG004|Until Primary Completion Date (PCD)|Death|7|||
146501246|NCT00941863|528338202|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
146501247|NCT00941863|528338203|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
146501248|NCT00941863|528338204|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
146501249|NCT00941863|528338205|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
146501250|NCT00941863|528338206|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
146501251|NCT00941863|528338202|FG000|Continued After PCD|Withdrawal by Subject|0|||
146501252|NCT00941863|528338203|FG001|Continued After PCD|Withdrawal by Subject|0|||
146501253|NCT00941863|528338204|FG002|Continued After PCD|Withdrawal by Subject|0|||
146501254|NCT00941863|528338205|FG003|Continued After PCD|Withdrawal by Subject|0|||
146501255|NCT00941863|528338206|FG004|Continued After PCD|Withdrawal by Subject|1|||
146501256|NCT00941863|528338202|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
146501257|NCT00941863|528338203|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
146501258|NCT00941863|528338204|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
146501259|NCT00941863|528338205|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
146501260|NCT00941863|528338206|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
146501261|NCT00747474|528338207|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
146501262|NCT00747474|528338208|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
146501263|NCT00747474|528338209|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
146501264|NCT00747474|528338210|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
146501265|NCT00747474|528338211|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
146501266|NCT00747474|528338212|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
146501267|NCT00747474|528338213|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
146501268|NCT00747474|528338214|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
146501269|NCT00747474|528338215|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
146501270|NCT00747474|528338216|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
146501271|NCT00747474|528338217|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
146501272|NCT00747474|528338218|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
146501273|NCT02989649|528338219|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
146501274|NCT02989649|528338219|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
146501275|NCT02989649|528338219|FG000|Overall Study|Lost For Observation During Study|3|||
146501276|NCT02989649|528338219|FG000|Overall Study|Reason Not Specified|13|||
146501277|NCT00256854|528338220|FG000|Overall Study|Withdrawal by Subject|2|||
146501278|NCT00256854|528338221|FG001|Overall Study|Withdrawal by Subject|3|||
146501279|NCT00256854|528338222|FG002|Overall Study|Withdrawal by Subject|0|||
146501280|NCT00256854|528338223|FG003|Overall Study|Withdrawal by Subject|0|||
146501281|NCT00256854|528338224|FG004|Overall Study|Withdrawal by Subject|0|||
146501282|NCT00256854|528338225|FG005|Overall Study|Withdrawal by Subject|0|||
146501283|NCT00256854|528338220|FG000|Overall Study|Lack of Efficacy|1|||
146501284|NCT00256854|528338221|FG001|Overall Study|Lack of Efficacy|0|||
146501285|NCT00256854|528338222|FG002|Overall Study|Lack of Efficacy|0|||
146501286|NCT00256854|528338223|FG003|Overall Study|Lack of Efficacy|0|||
146501287|NCT00256854|528338224|FG004|Overall Study|Lack of Efficacy|0|||
146501288|NCT00256854|528338225|FG005|Overall Study|Lack of Efficacy|0|||
146501289|NCT00256854|528338220|FG000|Overall Study|Protocol Violation|0|||
146501290|NCT00256854|528338221|FG001|Overall Study|Protocol Violation|1|||
146501291|NCT00256854|528338222|FG002|Overall Study|Protocol Violation|1|||
146501292|NCT00256854|528338223|FG003|Overall Study|Protocol Violation|1|||
146501293|NCT00256854|528338224|FG004|Overall Study|Protocol Violation|0|||
146501294|NCT00256854|528338225|FG005|Overall Study|Protocol Violation|0|||
146501295|NCT00256854|528338220|FG000|Overall Study|Adverse Event|0|||
146501296|NCT00256854|528338221|FG001|Overall Study|Adverse Event|0|||
146566497|NCT01405196|528586097|FG003|Overall Study|Withdrawal by Subject|6|||
146566498|NCT01405196|528586094|FG000|Overall Study|Adverse Event|2|||
146566499|NCT01405196|528586095|FG001|Overall Study|Adverse Event|2|||
146566500|NCT01405196|528586096|FG002|Overall Study|Adverse Event|0|||
146566501|NCT01405196|528586097|FG003|Overall Study|Adverse Event|2|||
146566502|NCT01405196|528586094|FG000|Overall Study|Death|1|||
146566503|NCT01405196|528586095|FG001|Overall Study|Death|0|||
146566504|NCT01405196|528586096|FG002|Overall Study|Death|3|||
146501297|NCT00256854|528338222|FG002|Overall Study|Adverse Event|2|||
146501298|NCT00256854|528338223|FG003|Overall Study|Adverse Event|2|||
146501299|NCT00256854|528338224|FG004|Overall Study|Adverse Event|0|||
146566505|NCT01405196|528586097|FG003|Overall Study|Death|0|||
146501300|NCT00256854|528338225|FG005|Overall Study|Adverse Event|1|||
146501301|NCT00256854|528338220|FG000|Overall Study|Not compliant with the study drug|0|||
146501302|NCT00256854|528338221|FG001|Overall Study|Not compliant with the study drug|0|||
146566506|NCT01405196|528586094|FG000|Overall Study|Lost to Follow-up|2|||
146566507|NCT01405196|528586095|FG001|Overall Study|Lost to Follow-up|2|||
146501303|NCT00256854|528338222|FG002|Overall Study|Not compliant with the study drug|0|||
146501304|NCT00256854|528338223|FG003|Overall Study|Not compliant with the study drug|0|||
146501305|NCT00256854|528338224|FG004|Overall Study|Not compliant with the study drug|1|||
146501306|NCT00256854|528338225|FG005|Overall Study|Not compliant with the study drug|0|||
146501307|NCT02353442|528338226|FG000|Overall Study|Withdrawal by Subject|3|||
146501308|NCT02353442|528338227|FG001|Overall Study|Withdrawal by Subject|4|||
146501309|NCT03990571|528338229|FG000|Overall Study|Withdrawal by Subject|1|||
146501310|NCT03990571|528338229|FG000|Overall Study|Insurance Issues|3|||
146501311|NCT03990571|528338229|FG000|Overall Study|Covid Restrictions|2|||
146501312|NCT03514485|528338230|FG000|Overall Study|Lost to Follow-up|5|||
146501313|NCT03514485|528338231|FG001|Overall Study|Lost to Follow-up|3|||
146501314|NCT03514485|528338232|FG002|Overall Study|Lost to Follow-up|2|||
146501315|NCT03514485|528338233|FG003|Overall Study|Lost to Follow-up|0|||
146501316|NCT03514485|528338234|FG004|Overall Study|Lost to Follow-up|1|||
146501317|NCT03514485|528338235|FG005|Overall Study|Lost to Follow-up|4|||
146501318|NCT03514485|528338230|FG000|Overall Study|Withdrawal by Subject|0|||
146501319|NCT03514485|528338231|FG001|Overall Study|Withdrawal by Subject|1|||
146501320|NCT03514485|528338232|FG002|Overall Study|Withdrawal by Subject|3|||
146501321|NCT03514485|528338233|FG003|Overall Study|Withdrawal by Subject|1|||
146501322|NCT03514485|528338234|FG004|Overall Study|Withdrawal by Subject|2|||
146501323|NCT03514485|528338235|FG005|Overall Study|Withdrawal by Subject|1|||
146501324|NCT03075891|528338237|FG000|Overall Study|Withdrawal by Subject|3|||
146501325|NCT03075891|528338238|FG001|Overall Study|Withdrawal by Subject|6|||
146501326|NCT03075891|528338237|FG000|Overall Study|Lost to Follow-up|1|||
146501327|NCT03075891|528338238|FG001|Overall Study|Lost to Follow-up|0|||
146501328|NCT03075891|528338237|FG000|Overall Study|Pregnancy|3|||
146501329|NCT03075891|528338238|FG001|Overall Study|Pregnancy|1|||
146501330|NCT03075891|528338237|FG000|Overall Study|visits not performed (no time)|1|||
146501331|NCT03075891|528338238|FG001|Overall Study|visits not performed (no time)|0|||
146501332|NCT03075891|528338237|FG000|Overall Study|Drug abuse relapse issue|0|||
146501333|NCT03075891|528338238|FG001|Overall Study|Drug abuse relapse issue|1|||
146501334|NCT03075891|528338237|FG000|Overall Study|Participant requiring study withdrawal|0|||
146501335|NCT03075891|528338238|FG001|Overall Study|Participant requiring study withdrawal|1|||
146501336|NCT03075891|528338237|FG000|Overall Study|Adverse event, non-fatal|1|||
146501337|NCT03075891|528338238|FG001|Overall Study|Adverse event, non-fatal|4|||
146501338|NCT02004886|528338239|FG000|Overall Study|Adverse Event|0|||
146501339|NCT02004886|528338240|FG001|Overall Study|Adverse Event|1|||
146501340|NCT02004886|528338241|FG002|Overall Study|Adverse Event|0|||
146501341|NCT02004886|528338242|FG003|Overall Study|Adverse Event|0|||
146501342|NCT02004886|528338239|FG000|Overall Study|Unable to attend future visits|1|||
146501343|NCT02004886|528338240|FG001|Overall Study|Unable to attend future visits|0|||
146501344|NCT02004886|528338241|FG002|Overall Study|Unable to attend future visits|0|||
146501345|NCT02004886|528338242|FG003|Overall Study|Unable to attend future visits|0|||
146501346|NCT01878084|528338243|FG000|Overall Study|Physician Decision|2|||
146501347|NCT01876784|528338244|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
146501348|NCT01876784|528338245|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
146501349|NCT01876784|528338244|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
146501350|NCT01876784|528338245|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
146501351|NCT01876784|528338244|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
146501352|NCT01876784|528338245|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
146501353|NCT01876784|528338244|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
146501354|NCT01876784|528338245|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
146501355|NCT01876784|528338244|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
146501356|NCT01876784|528338245|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
146501357|NCT01876784|528338244|FG000|Randomized Treatment Period (40 Months)|Death|1|||
146501358|NCT01876784|528338245|FG001|Randomized Treatment Period (40 Months)|Death|0|||
146501359|NCT01876784|528338244|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
146501360|NCT01876784|528338245|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
146501361|NCT01876784|528338244|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
146501362|NCT01876784|528338245|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
146501363|NCT01876784|528338244|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
146501364|NCT01876784|528338245|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
146501365|NCT01876784|528338244|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
146566508|NCT01405196|528586096|FG002|Overall Study|Lost to Follow-up|3|||
146566509|NCT01405196|528586097|FG003|Overall Study|Lost to Follow-up|1|||
146566510|NCT04704193|528586100|FG000|Overall Study|Withdrawal by Subject|1|||
146566511|NCT00542178|528586101|FG000|Overall Study|did not complete year 4 follow-up|75|||
146566512|NCT00542178|528586102|FG001|Overall Study|did not complete year 4 follow-up|80|||
146566513|NCT00542178|528586103|FG002|Overall Study|did not complete year 4 follow-up|74|||
146566514|NCT00542178|528586104|FG003|Overall Study|did not complete year 4 follow-up|62|||
146566515|NCT00542178|528586105|FG004|Overall Study|did not complete year 4 follow-up|64|||
146566516|NCT00542178|528586106|FG005|Overall Study|did not complete year 4 follow-up|89|||
146566517|NCT00542178|528586107|FG006|Overall Study|did not complete year 4 follow-up|87|||
146566518|NCT00542178|528586108|FG007|Overall Study|did not complete year 4 follow-up|85|||
146566519|NCT02611037|528586111|FG000|Overall Study|Withdrawal prior to treatment|2|||
146566520|NCT02611037|528586112|FG001|Overall Study|Withdrawal prior to treatment|0|||
146566521|NCT00829998|528586113|FG000|Washout|Adverse Event|0|||
146566522|NCT00829998|528586114|FG001|Washout|Adverse Event|1|||
146566523|NCT05270863|528586117|FG000|Visit 2 First Intervention|Randomization error|0|||
146566524|NCT05270863|528586118|FG001|Visit 2 First Intervention|Randomization error|0|||
146566525|NCT05270863|528586119|FG002|Visit 2 First Intervention|Randomization error|0|||
146566526|NCT05270863|528586120|FG003|Visit 2 First Intervention|Randomization error|1|||
146566527|NCT05270863|528586121|FG004|Visit 2 First Intervention|Randomization error|0|||
146566528|NCT05270863|528586122|FG005|Visit 2 First Intervention|Randomization error|0|||
146566529|NCT05270863|528586117|FG000|First Washout|Withdrawal by Subject|0|||
146566530|NCT05270863|528586118|FG001|First Washout|Withdrawal by Subject|0|||
146566531|NCT05270863|528586119|FG002|First Washout|Withdrawal by Subject|0|||
146566532|NCT05270863|528586120|FG003|First Washout|Withdrawal by Subject|0|||
146566533|NCT05270863|528586121|FG004|First Washout|Withdrawal by Subject|1|||
146566534|NCT05270863|528586122|FG005|First Washout|Withdrawal by Subject|1|||
146566535|NCT05270863|528586117|FG000|First Washout|Lost to Follow-up|0|||
146566536|NCT05270863|528586118|FG001|First Washout|Lost to Follow-up|0|||
146566537|NCT05270863|528586119|FG002|First Washout|Lost to Follow-up|0|||
146566538|NCT05270863|528586120|FG003|First Washout|Lost to Follow-up|0|||
146566539|NCT05270863|528586121|FG004|First Washout|Lost to Follow-up|0|||
146566540|NCT05270863|528586122|FG005|First Washout|Lost to Follow-up|1|||
146566541|NCT05270863|528586117|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
146566542|NCT05270863|528586118|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
146566543|NCT05270863|528586119|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
146566544|NCT05270863|528586120|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
146566545|NCT05270863|528586121|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
146566546|NCT05270863|528586122|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
146566547|NCT05270863|528586117|FG000|Second Washout|Withdrawal by Subject|1|||
146566548|NCT05270863|528586118|FG001|Second Washout|Withdrawal by Subject|1|||
146566549|NCT05270863|528586119|FG002|Second Washout|Withdrawal by Subject|0|||
146566550|NCT05270863|528586120|FG003|Second Washout|Withdrawal by Subject|0|||
146566551|NCT05270863|528586121|FG004|Second Washout|Withdrawal by Subject|0|||
146566552|NCT05270863|528586122|FG005|Second Washout|Withdrawal by Subject|0|||
146566553|NCT05270863|528586117|FG000|Second Washout|Lost to Follow-up|0|||
146566554|NCT05270863|528586118|FG001|Second Washout|Lost to Follow-up|0|||
146566555|NCT05270863|528586119|FG002|Second Washout|Lost to Follow-up|0|||
146566556|NCT05270863|528586120|FG003|Second Washout|Lost to Follow-up|1|||
146566557|NCT05270863|528586121|FG004|Second Washout|Lost to Follow-up|0|||
146566558|NCT05270863|528586122|FG005|Second Washout|Lost to Follow-up|0|||
146566559|NCT04712669|528586123|FG000|Double Blind Phase|Adverse Event|4|||
146566560|NCT04712669|528586124|FG001|Double Blind Phase|Adverse Event|4|||
146566561|NCT04712669|528586125|FG002|Double Blind Phase|Adverse Event|3|||
146566562|NCT04712669|528586126|FG003|Double Blind Phase|Adverse Event|0|||
146566563|NCT04712669|528586127|FG004|Double Blind Phase|Adverse Event|0|||
146566564|NCT04712669|528586128|FG005|Double Blind Phase|Adverse Event|0|||
146566565|NCT04712669|528586129|FG006|Double Blind Phase|Adverse Event|0|||
146566566|NCT04712669|528586130|FG007|Double Blind Phase|Adverse Event|0|||
146566567|NCT04712669|528586123|FG000|Double Blind Phase|Physician Decision|1|||
146566568|NCT04712669|528586124|FG001|Double Blind Phase|Physician Decision|0|||
146566569|NCT04712669|528586125|FG002|Double Blind Phase|Physician Decision|0|||
146566570|NCT04712669|528586126|FG003|Double Blind Phase|Physician Decision|0|||
146566571|NCT04712669|528586127|FG004|Double Blind Phase|Physician Decision|0|||
146566572|NCT04712669|528586128|FG005|Double Blind Phase|Physician Decision|0|||
146566573|NCT04712669|528586129|FG006|Double Blind Phase|Physician Decision|0|||
146566574|NCT04712669|528586130|FG007|Double Blind Phase|Physician Decision|0|||
146566575|NCT04712669|528586123|FG000|Double Blind Phase|Withdrawal by Subject|3|||
146566576|NCT04712669|528586124|FG001|Double Blind Phase|Withdrawal by Subject|6|||
146566577|NCT04712669|528586125|FG002|Double Blind Phase|Withdrawal by Subject|0|||
146566578|NCT04712669|528586126|FG003|Double Blind Phase|Withdrawal by Subject|0|||
146647097|NCT00557856|528884835|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
146566579|NCT04712669|528586127|FG004|Double Blind Phase|Withdrawal by Subject|0|||
146647098|NCT00557856|528884836|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
146647099|NCT00557856|528884837|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
146647100|NCT00557856|528884838|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
146647101|NCT00557856|528884839|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
146566580|NCT04712669|528586128|FG005|Double Blind Phase|Withdrawal by Subject|0|||
146566581|NCT04712669|528586129|FG006|Double Blind Phase|Withdrawal by Subject|0|||
146566582|NCT04712669|528586130|FG007|Double Blind Phase|Withdrawal by Subject|0|||
146566583|NCT04712669|528586123|FG000|Double Blind Phase|Termination by Sponsor|0|||
146566584|NCT04712669|528586124|FG001|Double Blind Phase|Termination by Sponsor|0|||
146647102|NCT00557856|528884840|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
146501366|NCT01876784|528338245|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
146501367|NCT01876784|528338244|FG000|Open-label Period (31 Months)|Adverse Event|2|||
146501368|NCT01876784|528338245|FG001|Open-label Period (31 Months)|Adverse Event|6|||
146501369|NCT01876784|528338244|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
146501370|NCT01876784|528338245|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
146501371|NCT01876784|528338244|FG000|Open-label Period (31 Months)|Progressive disease|4|||
146501372|NCT01876784|528338245|FG001|Open-label Period (31 Months)|Progressive disease|35|||
146501373|NCT01876784|528338244|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
146501374|NCT01876784|528338245|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
146501375|NCT01876784|528338244|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
146501376|NCT01876784|528338245|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
146501377|NCT01876784|528338244|FG000|Open-label Period (31 Months)|Death|0|||
146501378|NCT01876784|528338245|FG001|Open-label Period (31 Months)|Death|1|||
146501379|NCT01876784|528338244|FG000|Open-label Period (31 Months)|Other than specified above|9|||
146501380|NCT01876784|528338245|FG001|Open-label Period (31 Months)|Other than specified above|18|||
146501381|NCT03891862|528338247|FG000|Open-label Period|Adverse Event|2|||
146501382|NCT03891862|528338248|FG001|Open-label Period|Adverse Event|0|||
146501383|NCT03891862|528338249|FG002|Open-label Period|Adverse Event|0|||
146501384|NCT03891862|528338247|FG000|Open-label Period|Protocol Violation|5|||
146501385|NCT03891862|528338248|FG001|Open-label Period|Protocol Violation|0|||
146501386|NCT03891862|528338249|FG002|Open-label Period|Protocol Violation|0|||
146501387|NCT03891862|528338247|FG000|Open-label Period|Withdrawal by Subject|6|||
146501388|NCT03891862|528338248|FG001|Open-label Period|Withdrawal by Subject|0|||
146501389|NCT03891862|528338249|FG002|Open-label Period|Withdrawal by Subject|0|||
146501390|NCT03891862|528338247|FG000|Open-label Period|Death|1|||
146501391|NCT03891862|528338248|FG001|Open-label Period|Death|0|||
146501392|NCT03891862|528338249|FG002|Open-label Period|Death|0|||
146501393|NCT03891862|528338247|FG000|Open-label Period|Lost to Follow-up|2|||
146501394|NCT03891862|528338248|FG001|Open-label Period|Lost to Follow-up|0|||
146501395|NCT03891862|528338249|FG002|Open-label Period|Lost to Follow-up|0|||
146501396|NCT03891862|528338247|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
146501397|NCT03891862|528338248|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
146501398|NCT03891862|528338249|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
146501399|NCT03891862|528338247|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
146501400|NCT03891862|528338248|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
146501401|NCT03891862|528338249|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
146501402|NCT03891862|528338247|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
146501403|NCT03891862|528338248|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
146501404|NCT03891862|528338249|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
146501405|NCT03891862|528338247|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
146501406|NCT03891862|528338248|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
146501407|NCT03891862|528338249|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
146501408|NCT01194531|528338250|FG000|Overall Study|Withdrawal by Subject|1|||
146501409|NCT01194531|528338251|FG001|Overall Study|Withdrawal by Subject|0|||
146501410|NCT01194531|528338250|FG000|Overall Study|Protocol Violation|4|||
146501411|NCT01194531|528338251|FG001|Overall Study|Protocol Violation|1|||
146501412|NCT01194531|528338250|FG000|Overall Study|Physician Decision|0|||
146501413|NCT01194531|528338251|FG001|Overall Study|Physician Decision|2|||
146501414|NCT01500187|528338253|FG000|Overall Study|Lost to Follow-up|6|||
146501415|NCT01500187|528338254|FG001|Overall Study|Lost to Follow-up|0|||
146501416|NCT01435460|528338262|FG000|Overall Study|Adverse Event|2|||
146501417|NCT01435460|528338263|FG001|Overall Study|Adverse Event|1|||
146501418|NCT01435460|528338262|FG000|Overall Study|Lost to Follow-up|6|||
146501419|NCT01435460|528338263|FG001|Overall Study|Lost to Follow-up|1|||
146501420|NCT01435460|528338262|FG000|Overall Study|Withdrawal by Subject|1|||
146501421|NCT01435460|528338263|FG001|Overall Study|Withdrawal by Subject|3|||
146501422|NCT01435460|528338262|FG000|Overall Study|Protocol Violation|0|||
146501423|NCT01435460|528338263|FG001|Overall Study|Protocol Violation|1|||
146501424|NCT01435460|528338262|FG000|Overall Study|Did not meet eligibility criteria|2|||
146501425|NCT01435460|528338263|FG001|Overall Study|Did not meet eligibility criteria|0|||
146647103|NCT00557856|528884841|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
146647104|NCT00557856|528884833|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
146501426|NCT01706939|528338264|FG000|Pre Randomization|Screen Failure|1|||
146501427|NCT01706939|528338265|FG001|Pre Randomization|Screen Failure|0|||
146501428|NCT01706939|528338266|FG002|Pre Randomization|Screen Failure|0|||
146501429|NCT01706939|528338264|FG000|Pre Randomization|Ineligible for Randomization|1|||
146647105|NCT00557856|528884834|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
146501430|NCT01706939|528338265|FG001|Pre Randomization|Ineligible for Randomization|0|||
146501431|NCT01706939|528338266|FG002|Pre Randomization|Ineligible for Randomization|0|||
146501432|NCT01706939|528338264|FG000|Pre Randomization|Withdrawal by Subject|1|||
146647106|NCT00557856|528884835|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
146647107|NCT00557856|528884836|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
146647108|NCT00557856|528884837|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
146769100|NCT03284957|529323410|FG001|Overall Study|Withdrawal by Subject|0|||
146501433|NCT01706939|528338265|FG001|Pre Randomization|Withdrawal by Subject|0|||
146501434|NCT01706939|528338266|FG002|Pre Randomization|Withdrawal by Subject|0|||
146501435|NCT01706939|528338264|FG000|Randomization|Insufficient QoL survey compliance|0|||
146501436|NCT01706939|528338265|FG001|Randomization|Insufficient QoL survey compliance|1|||
146501437|NCT01706939|528338266|FG002|Randomization|Insufficient QoL survey compliance|1|||
146501438|NCT01706939|528338264|FG000|Randomization|Progression of disease|0|||
146501439|NCT01706939|528338265|FG001|Randomization|Progression of disease|2|||
146501440|NCT01706939|528338266|FG002|Randomization|Progression of disease|1|||
146501441|NCT01046903|528338267|FG000|Overall Study|Lost to Follow-up|16|||
146501442|NCT01046903|528338267|FG000|Overall Study|Adverse Event|4|||
146501443|NCT01046903|528338267|FG000|Overall Study|Withdrawal by Subject|3|||
146501444|NCT01046903|528338267|FG000|Overall Study|Other|5|||
146501445|NCT01343277|528338268|FG000|Overall Study|Other|3|||
146501446|NCT01343277|528338269|FG001|Overall Study|Other|3|||
146501447|NCT01343277|528338268|FG000|Overall Study|Withdrawal by Subject|18|||
146501448|NCT01343277|528338269|FG001|Overall Study|Withdrawal by Subject|13|||
146501449|NCT01343277|528338268|FG000|Overall Study|Physician Decision|1|||
146501450|NCT01343277|528338269|FG001|Overall Study|Physician Decision|2|||
146501451|NCT01343277|528338268|FG000|Overall Study|Death|10|||
146501452|NCT01343277|528338269|FG001|Overall Study|Death|1|||
146501453|NCT01343277|528338268|FG000|Overall Study|Adverse Event|67|||
146501454|NCT01343277|528338269|FG001|Overall Study|Adverse Event|13|||
146501455|NCT01343277|528338268|FG000|Overall Study|Disease progression|270|||
146501456|NCT01343277|528338269|FG001|Overall Study|Disease progression|138|||
146501457|NCT01343277|528338268|FG000|Overall Study|Randomized not treated|6|||
146501458|NCT01343277|528338269|FG001|Overall Study|Randomized not treated|21|||
146501459|NCT01343277|528338268|FG000|Overall Study|Treatment ongoing|8|||
146501460|NCT01343277|528338269|FG001|Overall Study|Treatment ongoing|2|||
146501461|NCT01343277|528338268|FG000|Overall Study|Subsequent anticancer therapy|1|||
146501462|NCT01343277|528338269|FG001|Overall Study|Subsequent anticancer therapy|0|||
146501463|NCT01894100|528338270|FG000|Overall Study|Lost to Follow-up|0|||
146501464|NCT01894100|528338271|FG001|Overall Study|Lost to Follow-up|1|||
146501465|NCT01894100|528338270|FG000|Overall Study|Withdrawal by Subject|3|||
146501466|NCT01894100|528338271|FG001|Overall Study|Withdrawal by Subject|0|||
146501467|NCT00135512|528338272|FG000|Overall Study|Adverse Event|56|||
146501468|NCT00135512|528338272|FG000|Overall Study|Lack of Efficacy|25|||
146501469|NCT00135512|528338272|FG000|Overall Study|Other|42|||
146501470|NCT01094301|528338273|FG000|Trial Stage|Withdrawal by Subject|1|||
146501471|NCT01094301|528338273|FG000|Implant Stage|Adverse Event|1|||
146501472|NCT01094301|528338273|FG000|Implant Stage|Protocol Violation|1|||
146501473|NCT01094301|528338273|FG000|Implant Stage|Withdrawal by Subject|2|||
146501474|NCT01094301|528338273|FG000|Implant Stage|No return of pain|4|||
146501475|NCT04013672|528338275|FG000|Overall Study|Withdrawal by Subject|3|||
146501476|NCT04013672|528338276|FG001|Overall Study|Withdrawal by Subject|0|||
146501477|NCT04013672|528338275|FG000|Overall Study|Death|1|||
146501478|NCT04013672|528338276|FG001|Overall Study|Death|0|||
146501479|NCT04013672|528338275|FG000|Overall Study|Physician Decision|5|||
146566585|NCT04712669|528586125|FG002|Double Blind Phase|Termination by Sponsor|1|||
146566586|NCT04712669|528586126|FG003|Double Blind Phase|Termination by Sponsor|0|||
146566587|NCT04712669|528586127|FG004|Double Blind Phase|Termination by Sponsor|0|||
146566588|NCT04712669|528586128|FG005|Double Blind Phase|Termination by Sponsor|0|||
146566589|NCT04712669|528586129|FG006|Double Blind Phase|Termination by Sponsor|0|||
146566590|NCT04712669|528586130|FG007|Double Blind Phase|Termination by Sponsor|0|||
146566591|NCT04712669|528586123|FG000|Open Label Phase|Adverse Event|0|||
146566592|NCT04712669|528586124|FG001|Open Label Phase|Adverse Event|0|||
146566593|NCT04712669|528586125|FG002|Open Label Phase|Adverse Event|0|||
146566594|NCT04712669|528586126|FG003|Open Label Phase|Adverse Event|1|||
146566595|NCT04712669|528586127|FG004|Open Label Phase|Adverse Event|1|||
146566596|NCT04712669|528586128|FG005|Open Label Phase|Adverse Event|3|||
146566597|NCT04712669|528586129|FG006|Open Label Phase|Adverse Event|1|||
146566598|NCT04712669|528586130|FG007|Open Label Phase|Adverse Event|2|||
146566599|NCT04712669|528586123|FG000|Open Label Phase|Death|0|||
146769101|NCT03284957|529323411|FG002|Overall Study|Withdrawal by Subject|0|||
146501480|NCT04013672|528338276|FG001|Overall Study|Physician Decision|0|||
146501481|NCT00430573|528338277|FG000|Overall Study|Withdrawal by Subject|5|||
146501482|NCT05020665|528338280|FG000|Overall Study|Study terminated by Sponsor|5|||
146501483|NCT05020665|528338281|FG001|Overall Study|Study terminated by Sponsor|4|||
146501484|NCT05020665|528338280|FG000|Overall Study|Death|2|||
146501485|NCT05020665|528338281|FG001|Overall Study|Death|1|||
146501486|NCT05020665|528338280|FG000|Overall Study|Physician Decision|0|||
146501487|NCT05020665|528338281|FG001|Overall Study|Physician Decision|1|||
146501488|NCT05020665|528338280|FG000|Overall Study|Withdrawal by Subject|0|||
146566600|NCT04712669|528586124|FG001|Open Label Phase|Death|0|||
146566601|NCT04712669|528586125|FG002|Open Label Phase|Death|0|||
146566602|NCT04712669|528586126|FG003|Open Label Phase|Death|1|||
146566603|NCT04712669|528586127|FG004|Open Label Phase|Death|0|||
146566604|NCT04712669|528586128|FG005|Open Label Phase|Death|0|||
146566605|NCT04712669|528586129|FG006|Open Label Phase|Death|0|||
146566606|NCT04712669|528586130|FG007|Open Label Phase|Death|0|||
146566607|NCT04712669|528586123|FG000|Open Label Phase|Lack of Efficacy|0|||
146566608|NCT04712669|528586124|FG001|Open Label Phase|Lack of Efficacy|0|||
146566609|NCT04712669|528586125|FG002|Open Label Phase|Lack of Efficacy|0|||
146566610|NCT04712669|528586126|FG003|Open Label Phase|Lack of Efficacy|0|||
146566611|NCT04712669|528586127|FG004|Open Label Phase|Lack of Efficacy|1|||
146566612|NCT04712669|528586128|FG005|Open Label Phase|Lack of Efficacy|0|||
146566613|NCT04712669|528586129|FG006|Open Label Phase|Lack of Efficacy|0|||
146566614|NCT04712669|528586130|FG007|Open Label Phase|Lack of Efficacy|0|||
146566615|NCT04712669|528586123|FG000|Open Label Phase|Lost to Follow-up|0|||
146566616|NCT04712669|528586124|FG001|Open Label Phase|Lost to Follow-up|0|||
146566617|NCT04712669|528586125|FG002|Open Label Phase|Lost to Follow-up|0|||
146566618|NCT04712669|528586126|FG003|Open Label Phase|Lost to Follow-up|0|||
146566619|NCT04712669|528586127|FG004|Open Label Phase|Lost to Follow-up|0|||
146566620|NCT04712669|528586128|FG005|Open Label Phase|Lost to Follow-up|0|||
146566621|NCT04712669|528586129|FG006|Open Label Phase|Lost to Follow-up|1|||
146566622|NCT04712669|528586130|FG007|Open Label Phase|Lost to Follow-up|1|||
146566623|NCT04712669|528586123|FG000|Open Label Phase|Physician Decision|0|||
146566624|NCT04712669|528586124|FG001|Open Label Phase|Physician Decision|0|||
146566625|NCT04712669|528586125|FG002|Open Label Phase|Physician Decision|0|||
146566626|NCT04712669|528586126|FG003|Open Label Phase|Physician Decision|1|||
146566627|NCT04712669|528586127|FG004|Open Label Phase|Physician Decision|0|||
146566628|NCT04712669|528586128|FG005|Open Label Phase|Physician Decision|0|||
146566629|NCT04712669|528586129|FG006|Open Label Phase|Physician Decision|0|||
146566630|NCT04712669|528586130|FG007|Open Label Phase|Physician Decision|0|||
146647109|NCT00557856|528884838|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
146647110|NCT00557856|528884839|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
146647111|NCT00557856|528884840|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
146647112|NCT00557856|528884841|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
146647113|NCT00557856|528884833|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
146647114|NCT00557856|528884834|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
146647115|NCT00557856|528884835|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
146647116|NCT00557856|528884836|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
146647117|NCT00557856|528884837|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
146647118|NCT00557856|528884838|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
146647119|NCT00557856|528884839|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
146647120|NCT00557856|528884840|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
146647121|NCT00557856|528884841|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
146647122|NCT00557856|528884833|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
146647123|NCT00557856|528884834|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
146647124|NCT00557856|528884835|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
146647125|NCT00557856|528884836|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
146647126|NCT00557856|528884837|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
146647127|NCT00557856|528884838|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
146647128|NCT00557856|528884839|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
146647129|NCT00557856|528884840|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
146647130|NCT00557856|528884841|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
146647131|NCT00557856|528884833|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
146647132|NCT00557856|528884834|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
146647133|NCT00557856|528884835|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
146647134|NCT00557856|528884836|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
146647135|NCT00557856|528884837|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
146647136|NCT00557856|528884838|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
146647137|NCT00557856|528884839|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
146647138|NCT00557856|528884840|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
146647139|NCT00557856|528884841|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
146647140|NCT00557856|528884833|FG000|Part 2: Exploratory Phase|Other|0|||
146647141|NCT00557856|528884834|FG001|Part 2: Exploratory Phase|Other|0|||
146647142|NCT00557856|528884835|FG002|Part 2: Exploratory Phase|Other|0|||
146647143|NCT00557856|528884836|FG003|Part 2: Exploratory Phase|Other|0|||
146647144|NCT00557856|528884837|FG004|Part 2: Exploratory Phase|Other|0|||
146566631|NCT04712669|528586123|FG000|Open Label Phase|Withdrawal by Subject|0|||
146566632|NCT04712669|528586124|FG001|Open Label Phase|Withdrawal by Subject|0|||
146566633|NCT04712669|528586125|FG002|Open Label Phase|Withdrawal by Subject|0|||
146566634|NCT04712669|528586126|FG003|Open Label Phase|Withdrawal by Subject|1|||
146566635|NCT04712669|528586127|FG004|Open Label Phase|Withdrawal by Subject|5|||
146647145|NCT00557856|528884838|FG005|Part 2: Exploratory Phase|Other|0|||
146647146|NCT00557856|528884839|FG006|Part 2: Exploratory Phase|Other|0|||
146647147|NCT00557856|528884840|FG007|Part 2: Exploratory Phase|Other|0|||
146647148|NCT00557856|528884841|FG008|Part 2: Exploratory Phase|Other|1|||
146647149|NCT00557856|528884833|FG000|Part 2: Exploratory Phase|Death|0|||
146501489|NCT05020665|528338281|FG001|Overall Study|Withdrawal by Subject|1|||
146501490|NCT05020665|528338280|FG000|Overall Study|Reason not specified|1|||
146501491|NCT05020665|528338281|FG001|Overall Study|Reason not specified|0|||
146769102|NCT03284957|529323412|FG003|Overall Study|Withdrawal by Subject|0|||
146769103|NCT03284957|529323413|FG004|Overall Study|Withdrawal by Subject|0|||
146769104|NCT03284957|529323414|FG005|Overall Study|Withdrawal by Subject|0|||
146769105|NCT03284957|529323415|FG006|Overall Study|Withdrawal by Subject|0|||
146769106|NCT03284957|529323416|FG007|Overall Study|Withdrawal by Subject|0|||
146769107|NCT03284957|529323417|FG008|Overall Study|Withdrawal by Subject|0|||
146647150|NCT00557856|528884834|FG001|Part 2: Exploratory Phase|Death|0|||
146647151|NCT00557856|528884835|FG002|Part 2: Exploratory Phase|Death|0|||
146647152|NCT00557856|528884836|FG003|Part 2: Exploratory Phase|Death|0|||
146647153|NCT00557856|528884837|FG004|Part 2: Exploratory Phase|Death|0|||
146501492|NCT01868022|528338282|FG000|Overall Study|Withdrawal by Subject|0|||
146501493|NCT01868022|528338283|FG001|Overall Study|Withdrawal by Subject|0|||
146501494|NCT01868022|528338284|FG002|Overall Study|Withdrawal by Subject|1|||
146501495|NCT01868022|528338285|FG003|Overall Study|Withdrawal by Subject|1|||
146501496|NCT01868022|528338286|FG004|Overall Study|Withdrawal by Subject|0|||
146501497|NCT01868022|528338287|FG005|Overall Study|Withdrawal by Subject|0|||
146501498|NCT01868022|528338288|FG006|Overall Study|Withdrawal by Subject|0|||
146501499|NCT01868022|528338289|FG007|Overall Study|Withdrawal by Subject|1|||
146501500|NCT01868022|528338290|FG008|Overall Study|Withdrawal by Subject|0|||
146501501|NCT01868022|528338282|FG000|Overall Study|Adverse Event|0|||
146501502|NCT01868022|528338283|FG001|Overall Study|Adverse Event|0|||
146501503|NCT01868022|528338284|FG002|Overall Study|Adverse Event|0|||
146501504|NCT01868022|528338285|FG003|Overall Study|Adverse Event|0|||
146501505|NCT01868022|528338286|FG004|Overall Study|Adverse Event|2|||
146501506|NCT01868022|528338287|FG005|Overall Study|Adverse Event|0|||
146501507|NCT01868022|528338288|FG006|Overall Study|Adverse Event|0|||
146647154|NCT00557856|528884838|FG005|Part 2: Exploratory Phase|Death|0|||
146647155|NCT00557856|528884839|FG006|Part 2: Exploratory Phase|Death|0|||
146647156|NCT00557856|528884840|FG007|Part 2: Exploratory Phase|Death|0|||
146647157|NCT00557856|528884841|FG008|Part 2: Exploratory Phase|Death|2|||
146647158|NCT00557856|528884833|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
146647159|NCT00557856|528884834|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
146647160|NCT00557856|528884835|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
146647161|NCT00557856|528884836|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
146647162|NCT00557856|528884837|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
146647163|NCT00557856|528884838|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
146647164|NCT00557856|528884839|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
146647165|NCT00557856|528884840|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
146647166|NCT00557856|528884841|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
146647167|NCT05092360|528884842|FG000|Overall Study|Withdrawal by Subject|21|||
146647168|NCT05092360|528884843|FG001|Overall Study|Withdrawal by Subject|4|||
146647169|NCT05092360|528884844|FG002|Overall Study|Withdrawal by Subject|9|||
146647170|NCT05092360|528884845|FG003|Overall Study|Withdrawal by Subject|26|||
146647171|NCT05092360|528884842|FG000|Overall Study|Death|97|||
146647172|NCT05092360|528884843|FG001|Overall Study|Death|14|||
146501508|NCT01868022|528338289|FG007|Overall Study|Adverse Event|2|||
146501509|NCT01868022|528338290|FG008|Overall Study|Adverse Event|2|||
146647173|NCT05092360|528884844|FG002|Overall Study|Death|31|||
146647174|NCT05092360|528884845|FG003|Overall Study|Death|101|||
146647175|NCT05092360|528884842|FG000|Overall Study|Lost to Follow-up|1|||
146647176|NCT05092360|528884843|FG001|Overall Study|Lost to Follow-up|2|||
146769108|NCT03284957|529323418|FG009|Overall Study|Withdrawal by Subject|2|||
146769109|NCT03284957|529323419|FG010|Overall Study|Withdrawal by Subject|0|||
146769110|NCT03284957|529323420|FG011|Overall Study|Withdrawal by Subject|0|||
146501510|NCT01868022|528338282|FG000|Overall Study|Physician Decision|0|||
146501511|NCT01868022|528338283|FG001|Overall Study|Physician Decision|0|||
146501512|NCT01868022|528338284|FG002|Overall Study|Physician Decision|0|||
146501513|NCT01868022|528338285|FG003|Overall Study|Physician Decision|0|||
146501514|NCT01868022|528338286|FG004|Overall Study|Physician Decision|0|||
146501515|NCT01868022|528338287|FG005|Overall Study|Physician Decision|1|||
146501516|NCT01868022|528338288|FG006|Overall Study|Physician Decision|0|||
146501517|NCT01868022|528338289|FG007|Overall Study|Physician Decision|2|||
146501518|NCT01868022|528338290|FG008|Overall Study|Physician Decision|0|||
146501519|NCT01868022|528338282|FG000|Overall Study|Study closed/terminated|0|||
146501520|NCT01868022|528338283|FG001|Overall Study|Study closed/terminated|0|||
146501521|NCT01868022|528338284|FG002|Overall Study|Study closed/terminated|0|||
146501522|NCT01868022|528338285|FG003|Overall Study|Study closed/terminated|0|||
146501523|NCT01868022|528338286|FG004|Overall Study|Study closed/terminated|0|||
146501524|NCT01868022|528338287|FG005|Overall Study|Study closed/terminated|0|||
146501525|NCT01868022|528338288|FG006|Overall Study|Study closed/terminated|0|||
146501526|NCT01868022|528338289|FG007|Overall Study|Study closed/terminated|1|||
146501527|NCT01868022|528338290|FG008|Overall Study|Study closed/terminated|0|||
146501528|NCT01868022|528338282|FG000|Overall Study|Ongoing|0|||
146974097|NCT04651218|530067451|FG001|Overall Study|Withdrawal by Subject|2|||
146974098|NCT01399125|530067454|FG000|Overall Study|Adverse Event|32|||
146974099|NCT01399125|530067455|FG001|Overall Study|Adverse Event|30|||
146974100|NCT01399125|530067454|FG000|Overall Study|Abnormal Lab values|0|||
146974101|NCT01399125|530067455|FG001|Overall Study|Abnormal Lab values|1|||
146974102|NCT01399125|530067454|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146974103|NCT01399125|530067455|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
146974104|NCT01399125|530067454|FG000|Overall Study|Withdrawal by Subject|5|||
146974105|NCT01399125|530067455|FG001|Overall Study|Withdrawal by Subject|8|||
146974106|NCT01399125|530067454|FG000|Overall Study|Lost to Follow-up|2|||
146974107|NCT01399125|530067455|FG001|Overall Study|Lost to Follow-up|3|||
146974108|NCT01399125|530067454|FG000|Overall Study|Administrative Problems|7|||
146974109|NCT01399125|530067455|FG001|Overall Study|Administrative Problems|11|||
146974110|NCT01399125|530067454|FG000|Overall Study|Death|0|||
146974111|NCT01399125|530067455|FG001|Overall Study|Death|1|||
146974112|NCT01399125|530067454|FG000|Overall Study|Protocol Deviation|5|||
146974113|NCT01399125|530067455|FG001|Overall Study|Protocol Deviation|2|||
146974114|NCT00948025|530067464|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
146974115|NCT00948025|530067465|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
146974116|NCT00948025|530067464|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
146974117|NCT00948025|530067465|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
146974118|NCT00948025|530067464|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
146974119|NCT00948025|530067465|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
146974120|NCT03959137|530067469|FG000|Overall Study|Protocol Violation|6|||
146647177|NCT05092360|528884844|FG002|Overall Study|Lost to Follow-up|2|||
146647178|NCT05092360|528884845|FG003|Overall Study|Lost to Follow-up|2|||
146974121|NCT01591499|530067471|FG000|Baseline Visit|Withdrawal by Subject|0|||
146974122|NCT01591499|530067472|FG001|Baseline Visit|Withdrawal by Subject|2|||
146501529|NCT01868022|528338283|FG001|Overall Study|Ongoing|0|||
146647179|NCT05092360|528884842|FG000|Overall Study|Study terminated by sponsor|65|||
146647180|NCT05092360|528884843|FG001|Overall Study|Study terminated by sponsor|7|||
146647181|NCT05092360|528884844|FG002|Overall Study|Study terminated by sponsor|13|||
146647182|NCT05092360|528884845|FG003|Overall Study|Study terminated by sponsor|61|||
146647183|NCT01525225|528884846|FG000|Enrollment|No longer met study criteria|1|||
146647184|NCT01525225|528884846|FG000|Enrollment|Other|1|||
146647185|NCT00910624|528886798|FG000|Treatment Phase|Adverse Event|2|||
146974123|NCT01591499|530067473|FG002|Baseline Visit|Withdrawal by Subject|0|||
146974124|NCT01591499|530067474|FG003|Baseline Visit|Withdrawal by Subject|2|||
146974125|NCT01591499|530067471|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
146974126|NCT01591499|530067472|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
146501530|NCT01868022|528338284|FG002|Overall Study|Ongoing|0|||
146501531|NCT01868022|528338285|FG003|Overall Study|Ongoing|0|||
146501532|NCT01868022|528338286|FG004|Overall Study|Ongoing|0|||
146501533|NCT01868022|528338287|FG005|Overall Study|Ongoing|0|||
146501534|NCT01868022|528338288|FG006|Overall Study|Ongoing|0|||
146501535|NCT01868022|528338289|FG007|Overall Study|Ongoing|3|||
146501536|NCT01868022|528338290|FG008|Overall Study|Ongoing|0|||
146501537|NCT01106677|528340133|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
146501538|NCT01106677|528340134|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
146501539|NCT01106677|528340135|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
146501540|NCT01106677|528340136|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
146501541|NCT01106677|528340133|FG000|Core Period: Baseline to Week 26|Death|0|||
146501542|NCT01106677|528340134|FG001|Core Period: Baseline to Week 26|Death|0|||
146501543|NCT01106677|528340135|FG002|Core Period: Baseline to Week 26|Death|1|||
146501544|NCT01106677|528340136|FG003|Core Period: Baseline to Week 26|Death|0|||
146501545|NCT01106677|528340133|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
146501546|NCT01106677|528340134|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
146501547|NCT01106677|528340135|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
146501548|NCT01106677|528340136|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
146501549|NCT01106677|528340133|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
146501550|NCT01106677|528340134|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
146501551|NCT01106677|528340135|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
146501552|NCT01106677|528340136|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
146501553|NCT01106677|528340133|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
146501554|NCT01106677|528340134|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
146501555|NCT01106677|528340135|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
146501556|NCT01106677|528340136|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
146501557|NCT01106677|528340133|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
146501558|NCT01106677|528340134|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
146501559|NCT01106677|528340135|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
146501560|NCT01106677|528340136|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
146501561|NCT01106677|528340133|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
146501562|NCT01106677|528340134|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
146647186|NCT00910624|528886799|FG001|Treatment Phase|Adverse Event|6|||
146647187|NCT00910624|528886800|FG002|Treatment Phase|Adverse Event|6|||
146647188|NCT00910624|528886801|FG003|Treatment Phase|Adverse Event|0|||
146501563|NCT01106677|528340135|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
146501564|NCT01106677|528340136|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
146501565|NCT01106677|528340133|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
146501566|NCT01106677|528340134|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
146501567|NCT01106677|528340135|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
146501568|NCT01106677|528340136|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
146501569|NCT01106677|528340133|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
146501570|NCT01106677|528340134|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
146501571|NCT01106677|528340135|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
146501572|NCT01106677|528340136|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
146501573|NCT01106677|528340133|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
146501574|NCT01106677|528340134|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
146501575|NCT01106677|528340135|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
146501576|NCT01106677|528340136|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
146501577|NCT01106677|528340133|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
146501578|NCT01106677|528340134|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
146501579|NCT01106677|528340135|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
146566636|NCT04712669|528586128|FG005|Open Label Phase|Withdrawal by Subject|5|||
146566637|NCT04712669|528586129|FG006|Open Label Phase|Withdrawal by Subject|0|||
146566638|NCT04712669|528586130|FG007|Open Label Phase|Withdrawal by Subject|4|||
146566639|NCT04712669|528586123|FG000|Open Label Phase|Termination by Sponsor|0|||
146566640|NCT04712669|528586124|FG001|Open Label Phase|Termination by Sponsor|0|||
146566641|NCT04712669|528586125|FG002|Open Label Phase|Termination by Sponsor|0|||
146566642|NCT04712669|528586126|FG003|Open Label Phase|Termination by Sponsor|11|||
146566643|NCT04712669|528586127|FG004|Open Label Phase|Termination by Sponsor|9|||
146566644|NCT04712669|528586128|FG005|Open Label Phase|Termination by Sponsor|14|||
146566645|NCT04712669|528586129|FG006|Open Label Phase|Termination by Sponsor|0|||
146566646|NCT04712669|528586130|FG007|Open Label Phase|Termination by Sponsor|14|||
146566647|NCT04577404|528586131|FG000|Overall Study|Adverse Event|31|||
146566648|NCT04577404|528586131|FG000|Overall Study|Death|1|||
146566649|NCT04577404|528586131|FG000|Overall Study|Lack of Efficacy|3|||
146566650|NCT04577404|528586131|FG000|Overall Study|Physician Decision|7|||
146566651|NCT04577404|528586131|FG000|Overall Study|Withdrawal by Subject|21|||
146566652|NCT04577404|528586131|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
146566653|NCT02561962|528586141|FG000|Overall Study|Withdrawal by Subject|1|||
146566654|NCT02561962|528586142|FG001|Overall Study|Withdrawal by Subject|0|||
146566655|NCT02561962|528586143|FG002|Overall Study|Withdrawal by Subject|0|||
146566656|NCT02561962|528586144|FG003|Overall Study|Withdrawal by Subject|0|||
146566657|NCT02561962|528586145|FG004|Overall Study|Withdrawal by Subject|1|||
146566658|NCT02561962|528586146|FG005|Overall Study|Withdrawal by Subject|1|||
146566659|NCT02561962|528586147|FG006|Overall Study|Withdrawal by Subject|2|||
146566660|NCT02561962|528586148|FG007|Overall Study|Withdrawal by Subject|1|||
146566661|NCT02561962|528586149|FG008|Overall Study|Withdrawal by Subject|0|||
146566662|NCT02561962|528586141|FG000|Overall Study|Decision by sponsor|0|||
146566663|NCT02561962|528586142|FG001|Overall Study|Decision by sponsor|0|||
146566664|NCT02561962|528586143|FG002|Overall Study|Decision by sponsor|0|||
146566665|NCT02561962|528586144|FG003|Overall Study|Decision by sponsor|0|||
146566666|NCT02561962|528586145|FG004|Overall Study|Decision by sponsor|1|||
146566667|NCT02561962|528586146|FG005|Overall Study|Decision by sponsor|1|||
146566668|NCT02561962|528586147|FG006|Overall Study|Decision by sponsor|0|||
146566669|NCT02561962|528586148|FG007|Overall Study|Decision by sponsor|3|||
146566670|NCT02561962|528586149|FG008|Overall Study|Decision by sponsor|0|||
146566671|NCT02561962|528586141|FG000|Overall Study|Lost to Follow-up|0|||
146566672|NCT02561962|528586142|FG001|Overall Study|Lost to Follow-up|0|||
146566673|NCT02561962|528586143|FG002|Overall Study|Lost to Follow-up|0|||
146566674|NCT02561962|528586144|FG003|Overall Study|Lost to Follow-up|0|||
146566675|NCT02561962|528586145|FG004|Overall Study|Lost to Follow-up|0|||
146566676|NCT02561962|528586146|FG005|Overall Study|Lost to Follow-up|1|||
146566677|NCT02561962|528586147|FG006|Overall Study|Lost to Follow-up|0|||
146566678|NCT02561962|528586148|FG007|Overall Study|Lost to Follow-up|0|||
146566679|NCT02561962|528586149|FG008|Overall Study|Lost to Follow-up|0|||
146568921|NCT00940602|528595501|FG000|Overall Study|Patient/guardian decision|13|||
146568922|NCT00940602|528595502|FG001|Overall Study|Patient/guardian decision|28|||
146568923|NCT00940602|528595501|FG000|Overall Study|Physician Decision|8|||
146568924|NCT00940602|528595502|FG001|Overall Study|Physician Decision|5|||
146568925|NCT00940602|528595501|FG000|Overall Study|Pregnancy|1|||
146568926|NCT00940602|528595502|FG001|Overall Study|Pregnancy|0|||
146568927|NCT00940602|528595501|FG000|Overall Study|Protocol Deviation (untreated)|1|||
146647189|NCT00910624|528886798|FG000|Treatment Phase|Treatment Failure|23|||
146568928|NCT00940602|528595502|FG001|Overall Study|Protocol Deviation (untreated)|0|||
146501580|NCT01106677|528340136|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
146501581|NCT01106677|528340133|FG000|Core Period: Baseline to Week 26|Other|8|||
146501582|NCT01106677|528340134|FG001|Core Period: Baseline to Week 26|Other|14|||
146501583|NCT01106677|528340135|FG002|Core Period: Baseline to Week 26|Other|8|||
146501584|NCT01106677|528340136|FG003|Core Period: Baseline to Week 26|Other|23|||
146501585|NCT01106677|528340133|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
146501586|NCT01106677|528340134|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
146501587|NCT01106677|528340135|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
146501588|NCT01106677|528340136|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
146501589|NCT01106677|528340133|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
146501590|NCT01106677|528340134|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
146501591|NCT01106677|528340135|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
146501592|NCT01106677|528340136|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
146501593|NCT01106677|528340133|FG000|Extension Period: Week 26 to Week 52|Death|0|||
146501594|NCT01106677|528340134|FG001|Extension Period: Week 26 to Week 52|Death|0|||
146501595|NCT01106677|528340135|FG002|Extension Period: Week 26 to Week 52|Death|0|||
146501596|NCT01106677|528340136|FG003|Extension Period: Week 26 to Week 52|Death|1|||
146501597|NCT01106677|528340133|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
146501598|NCT01106677|528340134|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
146501599|NCT01106677|528340135|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
146501600|NCT01106677|528340136|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
146501601|NCT01106677|528340133|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
146501602|NCT01106677|528340134|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
146501603|NCT01106677|528340135|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
146501604|NCT01106677|528340136|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
146501605|NCT01106677|528340133|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
146501606|NCT01106677|528340134|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
146501607|NCT01106677|528340135|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
146501608|NCT01106677|528340136|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
146501609|NCT01106677|528340133|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
146501610|NCT01106677|528340134|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
146501611|NCT01106677|528340135|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
146501612|NCT01106677|528340136|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
146501613|NCT01106677|528340133|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
146501614|NCT01106677|528340134|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
146501615|NCT01106677|528340135|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
146501616|NCT01106677|528340136|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
146501617|NCT01106677|528340133|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
146501618|NCT01106677|528340134|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
146501619|NCT01106677|528340135|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
146501620|NCT01106677|528340136|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
146501621|NCT01106677|528340133|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
146501622|NCT01106677|528340134|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
146501623|NCT01106677|528340135|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
146501624|NCT01106677|528340136|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
146501625|NCT01106677|528340133|FG000|Extension Period: Week 26 to Week 52|Other|6|||
146501626|NCT01106677|528340134|FG001|Extension Period: Week 26 to Week 52|Other|5|||
146501627|NCT01106677|528340135|FG002|Extension Period: Week 26 to Week 52|Other|8|||
146501628|NCT01106677|528340136|FG003|Extension Period: Week 26 to Week 52|Other|5|||
146501629|NCT03875092|528340137|FG000|Overall Study|Adverse Event|2|||
146501630|NCT03875092|528340138|FG001|Overall Study|Adverse Event|5|||
146501631|NCT03875092|528340137|FG000|Overall Study|Death|44|||
146501632|NCT03875092|528340138|FG001|Overall Study|Death|51|||
146501633|NCT03875092|528340137|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
146501634|NCT03875092|528340138|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
146501635|NCT04114357|528340139|FG000|Baseline-Randomization|Adverse Event|2|||
146501636|NCT04114357|528340140|FG001|Baseline-Randomization|Adverse Event|1|||
146501637|NCT04114357|528340139|FG000|Baseline-Randomization|Lost to Follow-up|1|||
146501638|NCT04114357|528340140|FG001|Baseline-Randomization|Lost to Follow-up|1|||
146501639|NCT04114357|528340139|FG000|Cross-over|Adverse Event|0|||
146501640|NCT04114357|528340140|FG001|Cross-over|Adverse Event|1|||
146501641|NCT03693612|528340141|FG000|Overall Study|Lost to Follow-up|0|||
146501642|NCT03693612|528340142|FG001|Overall Study|Lost to Follow-up|0|||
146501643|NCT03693612|528340143|FG002|Overall Study|Lost to Follow-up|0|||
146501644|NCT03693612|528340144|FG003|Overall Study|Lost to Follow-up|0|||
146566680|NCT02735421|528587897|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
146566681|NCT02735421|528587897|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
146566682|NCT02735421|528587897|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
146501645|NCT03693612|528340145|FG004|Overall Study|Lost to Follow-up|1|||
146501646|NCT03693612|528340146|FG005|Overall Study|Lost to Follow-up|0|||
146501647|NCT03693612|528340147|FG006|Overall Study|Lost to Follow-up|0|||
146501648|NCT03693612|528340141|FG000|Overall Study|Withdrawal by Subject|0|||
146501649|NCT03693612|528340142|FG001|Overall Study|Withdrawal by Subject|0|||
146501650|NCT03693612|528340143|FG002|Overall Study|Withdrawal by Subject|1|||
146501651|NCT03693612|528340144|FG003|Overall Study|Withdrawal by Subject|0|||
146501652|NCT03693612|528340145|FG004|Overall Study|Withdrawal by Subject|2|||
146501653|NCT03693612|528340146|FG005|Overall Study|Withdrawal by Subject|0|||
146501654|NCT03693612|528340147|FG006|Overall Study|Withdrawal by Subject|0|||
146501655|NCT03693612|528340141|FG000|Overall Study|Study Terminated by Sponsor|0|||
146501656|NCT03693612|528340142|FG001|Overall Study|Study Terminated by Sponsor|1|||
146501657|NCT03693612|528340143|FG002|Overall Study|Study Terminated by Sponsor|0|||
146501658|NCT03693612|528340144|FG003|Overall Study|Study Terminated by Sponsor|0|||
146501659|NCT03693612|528340145|FG004|Overall Study|Study Terminated by Sponsor|3|||
146501660|NCT03693612|528340146|FG005|Overall Study|Study Terminated by Sponsor|0|||
146501661|NCT03693612|528340147|FG006|Overall Study|Study Terminated by Sponsor|0|||
146501662|NCT03854370|528340152|FG000|Overall Study|samples not collected|1|||
146501663|NCT03854370|528340153|FG001|Overall Study|samples not collected|1|||
146501664|NCT03854370|528340154|FG002|Overall Study|samples not collected|1|||
146501665|NCT03854370|528340155|FG003|Overall Study|samples not collected|1|||
146501666|NCT00452673|528340156|FG000|Dose Escalation Period|Disease Progression|6|||
146501667|NCT00452673|528340157|FG001|Dose Escalation Period|Disease Progression|6|||
146501668|NCT00452673|528340158|FG002|Dose Escalation Period|Disease Progression|2|||
146501669|NCT00452673|528340159|FG003|Dose Escalation Period|Disease Progression|6|||
146501670|NCT00452673|528340160|FG004|Dose Escalation Period|Disease Progression|0|||
146501671|NCT00452673|528340156|FG000|Dose Escalation Period|study drug toxicity|1|||
146501672|NCT00452673|528340157|FG001|Dose Escalation Period|study drug toxicity|3|||
146501673|NCT00452673|528340158|FG002|Dose Escalation Period|study drug toxicity|3|||
146501674|NCT00452673|528340159|FG003|Dose Escalation Period|study drug toxicity|1|||
146501675|NCT00452673|528340160|FG004|Dose Escalation Period|study drug toxicity|0|||
146501676|NCT00452673|528340156|FG000|Dose Escalation Period|Other|0|||
146501677|NCT00452673|528340157|FG001|Dose Escalation Period|Other|0|||
146501678|NCT00452673|528340158|FG002|Dose Escalation Period|Other|1|||
146501679|NCT00452673|528340159|FG003|Dose Escalation Period|Other|0|||
146501680|NCT00452673|528340160|FG004|Dose Escalation Period|Other|0|||
146501681|NCT00452673|528340156|FG000|Dose Escalation Period|Adverse Event|0|||
146501682|NCT00452673|528340157|FG001|Dose Escalation Period|Adverse Event|0|||
146501683|NCT00452673|528340158|FG002|Dose Escalation Period|Adverse Event|0|||
146501684|NCT00452673|528340159|FG003|Dose Escalation Period|Adverse Event|1|||
146501685|NCT00452673|528340160|FG004|Dose Escalation Period|Adverse Event|0|||
146501686|NCT00452673|528340156|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
146501687|NCT00452673|528340157|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
146501688|NCT00452673|528340158|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
146501689|NCT00452673|528340159|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
146501690|NCT00452673|528340160|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
146501691|NCT00452673|528340156|FG000|Dose Expansion Period|Disease Progression|0|||
146501692|NCT00452673|528340157|FG001|Dose Expansion Period|Disease Progression|0|||
146501693|NCT00452673|528340158|FG002|Dose Expansion Period|Disease Progression|0|||
146501694|NCT00452673|528340159|FG003|Dose Expansion Period|Disease Progression|0|||
146501695|NCT00452673|528340160|FG004|Dose Expansion Period|Disease Progression|19|||
146501696|NCT00452673|528340156|FG000|Dose Expansion Period|Other|0|||
146501697|NCT00452673|528340157|FG001|Dose Expansion Period|Other|0|||
146501698|NCT00452673|528340158|FG002|Dose Expansion Period|Other|0|||
146501699|NCT00452673|528340159|FG003|Dose Expansion Period|Other|0|||
146501700|NCT00452673|528340160|FG004|Dose Expansion Period|Other|2|||
146501701|NCT01300338|528340169|FG000|Overall Study|Lost to Follow-up|5|||
146501702|NCT01300338|528340170|FG001|Overall Study|Lost to Follow-up|0|||
146501703|NCT00381238|528340175|FG000|Overall Study|Adverse Event|3|||
146566683|NCT02735421|528587897|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
146566684|NCT02735421|528587897|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
146501704|NCT00381238|528340175|FG000|Overall Study|Protocol Violation|1|||
146912636|NCT02546856|529843117|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
146501705|NCT00381238|528340175|FG000|Overall Study|Withdrawal by Subject|4|||
146501706|NCT00381238|528340175|FG000|Overall Study|Lack of Efficacy|2|||
146501707|NCT00381238|528340175|FG000|Overall Study|Withdrew by physician|1|||
146501708|NCT00381238|528340175|FG000|Overall Study|Disease progression|1|||
146501709|NCT00843037|528340179|FG000|Overall Study|Lost to Follow-up|1|||
146501710|NCT00401544|528340182|FG000|Overall Study|Adverse Event|5|||
146501711|NCT00401544|528340183|FG001|Overall Study|Adverse Event|1|||
146501712|NCT00401544|528340184|FG002|Overall Study|Adverse Event|1|||
146501713|NCT00401544|528340185|FG003|Overall Study|Adverse Event|1|||
146501714|NCT00401544|528340182|FG000|Overall Study|Death|3|||
146501715|NCT00401544|528340183|FG001|Overall Study|Death|6|||
146501716|NCT00401544|528340184|FG002|Overall Study|Death|2|||
146501717|NCT00401544|528340185|FG003|Overall Study|Death|5|||
146647190|NCT00910624|528886799|FG001|Treatment Phase|Treatment Failure|10|||
146647191|NCT00910624|528886800|FG002|Treatment Phase|Treatment Failure|0|||
146647192|NCT00910624|528886801|FG003|Treatment Phase|Treatment Failure|0|||
146974127|NCT01591499|530067473|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
146974128|NCT01591499|530067474|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
146974129|NCT01591499|530067471|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
146501718|NCT00401544|528340182|FG000|Overall Study|Lost to Follow-up|2|||
146501719|NCT00401544|528340183|FG001|Overall Study|Lost to Follow-up|0|||
146647193|NCT00910624|528886798|FG000|Treatment Phase|Lost to Follow-up|0|||
146647194|NCT00910624|528886799|FG001|Treatment Phase|Lost to Follow-up|0|||
146501720|NCT00401544|528340184|FG002|Overall Study|Lost to Follow-up|1|||
146501721|NCT00401544|528340185|FG003|Overall Study|Lost to Follow-up|1|||
146501722|NCT00401544|528340182|FG000|Overall Study|Withdrawal by Subject|7|||
146501723|NCT00401544|528340183|FG001|Overall Study|Withdrawal by Subject|6|||
146974130|NCT01591499|530067472|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
146974131|NCT01591499|530067473|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
146974132|NCT01591499|530067474|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
146974133|NCT00995488|530067475|FG000|Overall Study|Withdrawal by Subject|1|||
146974134|NCT01289990|530067476|FG000|Overall Study|Death|0|||
146974135|NCT01289990|530067477|FG001|Overall Study|Death|0|||
146974136|NCT01289990|530067478|FG002|Overall Study|Death|0|||
146974137|NCT01289990|530067479|FG003|Overall Study|Death|1|||
146974138|NCT01289990|530067480|FG004|Overall Study|Death|2|||
146974139|NCT01289990|530067481|FG005|Overall Study|Death|1|||
146974140|NCT01289990|530067482|FG006|Overall Study|Death|0|||
146974141|NCT01289990|530067483|FG007|Overall Study|Death|0|||
146974142|NCT01289990|530067484|FG008|Overall Study|Death|0|||
146974143|NCT01289990|530067485|FG009|Overall Study|Death|0|||
146974144|NCT01289990|530067486|FG010|Overall Study|Death|0|||
146974145|NCT01289990|530067487|FG011|Overall Study|Death|1|||
146974146|NCT01289990|530067488|FG012|Overall Study|Death|0|||
146974147|NCT01289990|530067476|FG000|Overall Study|Lost to Follow-up|3|||
146974148|NCT01289990|530067477|FG001|Overall Study|Lost to Follow-up|2|||
146974149|NCT01289990|530067478|FG002|Overall Study|Lost to Follow-up|5|||
146974150|NCT01289990|530067479|FG003|Overall Study|Lost to Follow-up|5|||
146974151|NCT01289990|530067480|FG004|Overall Study|Lost to Follow-up|3|||
146974152|NCT01289990|530067481|FG005|Overall Study|Lost to Follow-up|4|||
146974153|NCT01289990|530067482|FG006|Overall Study|Lost to Follow-up|2|||
146974154|NCT01289990|530067483|FG007|Overall Study|Lost to Follow-up|2|||
146974155|NCT01289990|530067484|FG008|Overall Study|Lost to Follow-up|1|||
146974156|NCT01289990|530067485|FG009|Overall Study|Lost to Follow-up|4|||
146974157|NCT01289990|530067486|FG010|Overall Study|Lost to Follow-up|2|||
146974158|NCT01289990|530067487|FG011|Overall Study|Lost to Follow-up|1|||
146974159|NCT01289990|530067488|FG012|Overall Study|Lost to Follow-up|2|||
146974160|NCT01289990|530067476|FG000|Overall Study|Withdrawal by Subject|15|||
146974161|NCT01289990|530067477|FG001|Overall Study|Withdrawal by Subject|14|||
146501724|NCT00401544|528340184|FG002|Overall Study|Withdrawal by Subject|6|||
146501725|NCT00401544|528340185|FG003|Overall Study|Withdrawal by Subject|5|||
146501726|NCT00401544|528340182|FG000|Overall Study|Physician Decision|1|||
146501727|NCT00401544|528340183|FG001|Overall Study|Physician Decision|3|||
146501728|NCT00401544|528340184|FG002|Overall Study|Physician Decision|0|||
146501729|NCT00401544|528340185|FG003|Overall Study|Physician Decision|0|||
146501730|NCT00401544|528340182|FG000|Overall Study|Ineligibility determined|0|||
146501731|NCT00401544|528340183|FG001|Overall Study|Ineligibility determined|1|||
146501732|NCT00401544|528340184|FG002|Overall Study|Ineligibility determined|0|||
146501733|NCT00401544|528340185|FG003|Overall Study|Ineligibility determined|2|||
146501734|NCT00401544|528340182|FG000|Overall Study|Disease progression|0|||
146501735|NCT00401544|528340183|FG001|Overall Study|Disease progression|1|||
146501736|NCT00401544|528340184|FG002|Overall Study|Disease progression|0|||
146501737|NCT00401544|528340185|FG003|Overall Study|Disease progression|0|||
146501738|NCT00401544|528340182|FG000|Overall Study|Other|0|||
146647195|NCT00910624|528886800|FG002|Treatment Phase|Lost to Follow-up|1|||
146647196|NCT00910624|528886801|FG003|Treatment Phase|Lost to Follow-up|0|||
146501739|NCT00401544|528340183|FG001|Overall Study|Other|0|||
146647197|NCT00910624|528886798|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
146501740|NCT00401544|528340184|FG002|Overall Study|Other|2|||
146647198|NCT00910624|528886799|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
146647199|NCT00910624|528886800|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
146501741|NCT00401544|528340185|FG003|Overall Study|Other|2|||
146501742|NCT02222545|528340189|FG000|Overall Study|Adverse Event|1|||
146501743|NCT02222545|528340190|FG001|Overall Study|Adverse Event|0|||
146501744|NCT02222545|528340191|FG002|Overall Study|Adverse Event|2|||
146501745|NCT02222545|528340189|FG000|Overall Study|Death|0|||
146501746|NCT02222545|528340190|FG001|Overall Study|Death|0|||
146974162|NCT01289990|530067478|FG002|Overall Study|Withdrawal by Subject|12|||
146974163|NCT01289990|530067479|FG003|Overall Study|Withdrawal by Subject|13|||
146974164|NCT01289990|530067480|FG004|Overall Study|Withdrawal by Subject|8|||
146974165|NCT01289990|530067481|FG005|Overall Study|Withdrawal by Subject|7|||
146974166|NCT01289990|530067482|FG006|Overall Study|Withdrawal by Subject|13|||
146647200|NCT00910624|528886801|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
146647201|NCT00910624|528886798|FG000|Treatment Phase|Withdrawal by Subject|2|||
146647202|NCT00910624|528886799|FG001|Treatment Phase|Withdrawal by Subject|1|||
146647203|NCT00910624|528886800|FG002|Treatment Phase|Withdrawal by Subject|0|||
146647204|NCT00910624|528886801|FG003|Treatment Phase|Withdrawal by Subject|0|||
146501747|NCT02222545|528340191|FG002|Overall Study|Death|9|||
146501748|NCT02222545|528340189|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
146501749|NCT02222545|528340190|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
146501750|NCT02222545|528340191|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
146501751|NCT02222545|528340189|FG000|Overall Study|Withdrawal by Subject|0|||
146647205|NCT00910624|528886798|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
146647206|NCT00910624|528886799|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
146647207|NCT00910624|528886800|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
146647208|NCT00910624|528886801|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
146647209|NCT00910624|528886798|FG000|Follow-Up Phase|Adverse Event|0|||
146647210|NCT00910624|528886799|FG001|Follow-Up Phase|Adverse Event|0|||
146647211|NCT00910624|528886800|FG002|Follow-Up Phase|Adverse Event|1|||
146647212|NCT00910624|528886801|FG003|Follow-Up Phase|Adverse Event|0|||
146647213|NCT00910624|528886798|FG000|Follow-Up Phase|Lost to Follow-up|3|||
146647214|NCT00910624|528886799|FG001|Follow-Up Phase|Lost to Follow-up|1|||
146647215|NCT00910624|528886800|FG002|Follow-Up Phase|Lost to Follow-up|2|||
146647216|NCT00910624|528886801|FG003|Follow-Up Phase|Lost to Follow-up|0|||
146647217|NCT00910624|528886798|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
146647218|NCT00910624|528886799|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
146647219|NCT00910624|528886800|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
146647220|NCT00910624|528886801|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
146647221|NCT00910624|528886798|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
146647222|NCT00910624|528886799|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
146647223|NCT00910624|528886800|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
146647224|NCT00910624|528886801|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
146647225|NCT00910624|528886798|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
146647226|NCT00910624|528886799|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
146647227|NCT00910624|528886800|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
146647228|NCT00910624|528886801|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
146647229|NCT00910624|528886798|FG000|Follow-Up Phase|Administrative|0|||
146647230|NCT00910624|528886799|FG001|Follow-Up Phase|Administrative|1|||
146647231|NCT00910624|528886800|FG002|Follow-Up Phase|Administrative|1|||
146647232|NCT00910624|528886801|FG003|Follow-Up Phase|Administrative|0|||
146647233|NCT01122264|528886802|FG000|Overall Study|Adverse Event|6|||
146647234|NCT01122264|528886803|FG001|Overall Study|Adverse Event|5|||
146647235|NCT01122264|528886804|FG002|Overall Study|Adverse Event|7|||
146647236|NCT01122264|528886802|FG000|Overall Study|Death|1|||
146647237|NCT01122264|528886803|FG001|Overall Study|Death|0|||
146647238|NCT01122264|528886804|FG002|Overall Study|Death|0|||
146647239|NCT01122264|528886802|FG000|Overall Study|Lost to Follow-up|5|||
146647240|NCT01122264|528886803|FG001|Overall Study|Lost to Follow-up|9|||
146647241|NCT01122264|528886804|FG002|Overall Study|Lost to Follow-up|13|||
146647242|NCT01122264|528886802|FG000|Overall Study|Entry Criteria Not Met|1|||
146647243|NCT01122264|528886803|FG001|Overall Study|Entry Criteria Not Met|0|||
146647244|NCT01122264|528886804|FG002|Overall Study|Entry Criteria Not Met|0|||
146647245|NCT01122264|528886802|FG000|Overall Study|Protocol Violation|7|||
146647246|NCT01122264|528886803|FG001|Overall Study|Protocol Violation|7|||
146501752|NCT02222545|528340190|FG001|Overall Study|Withdrawal by Subject|0|||
146501753|NCT02222545|528340191|FG002|Overall Study|Withdrawal by Subject|3|||
146501754|NCT02222545|528340189|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
146501755|NCT02222545|528340190|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
146501756|NCT02222545|528340191|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
146647247|NCT01122264|528886804|FG002|Overall Study|Protocol Violation|9|||
146647248|NCT01122264|528886802|FG000|Overall Study|Withdrawal by Subject|6|||
146647249|NCT01122264|528886803|FG001|Overall Study|Withdrawal by Subject|6|||
146647250|NCT01122264|528886804|FG002|Overall Study|Withdrawal by Subject|16|||
146647251|NCT01122264|528886802|FG000|Overall Study|Physician Decision|3|||
146647252|NCT01122264|528886803|FG001|Overall Study|Physician Decision|1|||
146647253|NCT01122264|528886804|FG002|Overall Study|Physician Decision|1|||
146647254|NCT01122264|528886802|FG000|Overall Study|Lack of Efficacy|3|||
146647255|NCT01122264|528886803|FG001|Overall Study|Lack of Efficacy|1|||
146501757|NCT02651155|528340193|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
146501758|NCT02651155|528340194|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
146647256|NCT01122264|528886804|FG002|Overall Study|Lack of Efficacy|1|||
146647257|NCT00097981|528886813|FG000|Overall Study|Adverse Event|31|||
146647258|NCT00097981|528886814|FG001|Overall Study|Adverse Event|44|||
146647259|NCT00097981|528886813|FG000|Overall Study|Withdrawal by Subject|10|||
146647260|NCT00097981|528886814|FG001|Overall Study|Withdrawal by Subject|8|||
146647261|NCT00097981|528886813|FG000|Overall Study|Protocol Violation|1|||
146647262|NCT00097981|528886814|FG001|Overall Study|Protocol Violation|1|||
146501759|NCT02651155|528340193|FG000|Overall Study|Voluntary Withdrawal|5|||
146501760|NCT02651155|528340194|FG001|Overall Study|Voluntary Withdrawal|0|||
146501761|NCT00537316|528340195|FG000|Part 1|Adverse Event|7|||
146501762|NCT00537316|528340196|FG001|Part 1|Adverse Event|11|||
146501763|NCT00537316|528340197|FG002|Part 1|Adverse Event|8|||
146501764|NCT00537316|528340198|FG003|Part 1|Adverse Event|0|||
146501765|NCT00537316|528340199|FG004|Part 1|Adverse Event|0|||
146501766|NCT00537316|528340200|FG005|Part 1|Adverse Event|0|||
146501767|NCT00537316|528340201|FG006|Part 1|Adverse Event|0|||
146501768|NCT00537316|528340195|FG000|Part 1|Protocol defined clinical event|1|||
146501769|NCT00537316|528340196|FG001|Part 1|Protocol defined clinical event|0|||
146501770|NCT00537316|528340197|FG002|Part 1|Protocol defined clinical event|0|||
146501771|NCT00537316|528340198|FG003|Part 1|Protocol defined clinical event|0|||
146501772|NCT00537316|528340199|FG004|Part 1|Protocol defined clinical event|0|||
146501773|NCT00537316|528340200|FG005|Part 1|Protocol defined clinical event|0|||
146501774|NCT00537316|528340201|FG006|Part 1|Protocol defined clinical event|0|||
146501775|NCT00537316|528340195|FG000|Part 1|Lost to Follow-up|1|||
146501776|NCT00537316|528340196|FG001|Part 1|Lost to Follow-up|0|||
146501777|NCT00537316|528340197|FG002|Part 1|Lost to Follow-up|0|||
146501778|NCT00537316|528340198|FG003|Part 1|Lost to Follow-up|0|||
146501779|NCT00537316|528340199|FG004|Part 1|Lost to Follow-up|0|||
146501780|NCT00537316|528340200|FG005|Part 1|Lost to Follow-up|0|||
146501781|NCT00537316|528340201|FG006|Part 1|Lost to Follow-up|0|||
146501782|NCT00537316|528340195|FG000|Part 1|Withdrawal by Subject|3|||
146501783|NCT00537316|528340196|FG001|Part 1|Withdrawal by Subject|8|||
146501784|NCT00537316|528340197|FG002|Part 1|Withdrawal by Subject|4|||
146501785|NCT00537316|528340198|FG003|Part 1|Withdrawal by Subject|0|||
146501786|NCT00537316|528340199|FG004|Part 1|Withdrawal by Subject|0|||
146501787|NCT00537316|528340200|FG005|Part 1|Withdrawal by Subject|0|||
146501788|NCT00537316|528340201|FG006|Part 1|Withdrawal by Subject|0|||
146501789|NCT00537316|528340195|FG000|Part 1|Protocol Violation|1|||
146501790|NCT00537316|528340196|FG001|Part 1|Protocol Violation|5|||
146501791|NCT00537316|528340197|FG002|Part 1|Protocol Violation|1|||
146501792|NCT00537316|528340198|FG003|Part 1|Protocol Violation|0|||
146501793|NCT00537316|528340199|FG004|Part 1|Protocol Violation|0|||
146501794|NCT00537316|528340200|FG005|Part 1|Protocol Violation|0|||
146501795|NCT00537316|528340201|FG006|Part 1|Protocol Violation|0|||
146501796|NCT00537316|528340195|FG000|Part 1|Did not meet protocol eligibility|1|||
146501797|NCT00537316|528340196|FG001|Part 1|Did not meet protocol eligibility|3|||
146501798|NCT00537316|528340197|FG002|Part 1|Did not meet protocol eligibility|2|||
146501799|NCT00537316|528340198|FG003|Part 1|Did not meet protocol eligibility|0|||
146501800|NCT00537316|528340199|FG004|Part 1|Did not meet protocol eligibility|0|||
146501801|NCT00537316|528340200|FG005|Part 1|Did not meet protocol eligibility|0|||
146501802|NCT00537316|528340201|FG006|Part 1|Did not meet protocol eligibility|0|||
146501803|NCT00537316|528340195|FG000|Part 1|Administrative|0|||
146501804|NCT00537316|528340196|FG001|Part 1|Administrative|0|||
146501805|NCT00537316|528340197|FG002|Part 1|Administrative|2|||
146501806|NCT00537316|528340198|FG003|Part 1|Administrative|0|||
146501807|NCT00537316|528340199|FG004|Part 1|Administrative|0|||
146501808|NCT00537316|528340200|FG005|Part 1|Administrative|0|||
146501809|NCT00537316|528340201|FG006|Part 1|Administrative|0|||
146501810|NCT00537316|528340195|FG000|Part 2|Never entered follow-up|0|||
146501811|NCT00537316|528340196|FG001|Part 2|Never entered follow-up|0|||
146501812|NCT00537316|528340197|FG002|Part 2|Never entered follow-up|0|||
146566685|NCT02735421|528587897|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
146566686|NCT02735421|528587897|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
146566687|NCT00269113|528587898|FG000|Overall Study|Adverse Event|14|||
146566688|NCT00269113|528587899|FG001|Overall Study|Adverse Event|7|||
146566689|NCT00269113|528587898|FG000|Overall Study|Lack of Efficacy|35|||
146566690|NCT00269113|528587899|FG001|Overall Study|Lack of Efficacy|18|||
146566691|NCT00269113|528587898|FG000|Overall Study|Early Improvement|2|||
146566692|NCT00269113|528587899|FG001|Overall Study|Early Improvement|0|||
146566693|NCT00269113|528587898|FG000|Overall Study|Withdrawal by Subject|0|||
146566694|NCT00269113|528587899|FG001|Overall Study|Withdrawal by Subject|2|||
146501813|NCT00537316|528340198|FG003|Part 2|Never entered follow-up|0|||
146501814|NCT00537316|528340199|FG004|Part 2|Never entered follow-up|0|||
146501815|NCT00537316|528340200|FG005|Part 2|Never entered follow-up|0|||
146501816|NCT00537316|528340201|FG006|Part 2|Never entered follow-up|1|||
146501817|NCT00537316|528340195|FG000|Part 2|Adverse Event|4|||
146566695|NCT00269113|528587898|FG000|Overall Study|Death|6|||
146501818|NCT00537316|528340196|FG001|Part 2|Adverse Event|0|||
146501819|NCT00537316|528340197|FG002|Part 2|Adverse Event|2|||
146501820|NCT00537316|528340198|FG003|Part 2|Adverse Event|0|||
146501821|NCT00537316|528340199|FG004|Part 2|Adverse Event|0|||
146501822|NCT00537316|528340200|FG005|Part 2|Adverse Event|0|||
146566696|NCT00269113|528587899|FG001|Overall Study|Death|2|||
146566697|NCT00269113|528587898|FG000|Overall Study|Lost to Follow-up|2|||
146501823|NCT00537316|528340201|FG006|Part 2|Adverse Event|0|||
146501824|NCT00537316|528340195|FG000|Part 2|Lost to Follow-up|1|||
146501825|NCT00537316|528340196|FG001|Part 2|Lost to Follow-up|0|||
146501826|NCT00537316|528340197|FG002|Part 2|Lost to Follow-up|2|||
146501827|NCT00537316|528340198|FG003|Part 2|Lost to Follow-up|0|||
146501828|NCT00537316|528340199|FG004|Part 2|Lost to Follow-up|0|||
146501829|NCT00537316|528340200|FG005|Part 2|Lost to Follow-up|0|||
146501830|NCT00537316|528340201|FG006|Part 2|Lost to Follow-up|0|||
146501831|NCT00537316|528340195|FG000|Part 2|Withdrawal by Subject|5|||
146501832|NCT00537316|528340196|FG001|Part 2|Withdrawal by Subject|1|||
146501833|NCT00537316|528340197|FG002|Part 2|Withdrawal by Subject|4|||
146501834|NCT00537316|528340198|FG003|Part 2|Withdrawal by Subject|0|||
146501835|NCT00537316|528340199|FG004|Part 2|Withdrawal by Subject|0|||
146501836|NCT00537316|528340200|FG005|Part 2|Withdrawal by Subject|0|||
146501837|NCT00537316|528340201|FG006|Part 2|Withdrawal by Subject|0|||
146501838|NCT00537316|528340195|FG000|Part 2|Administrative|16|||
146501839|NCT00537316|528340196|FG001|Part 2|Administrative|8|||
146501840|NCT00537316|528340197|FG002|Part 2|Administrative|24|||
146501841|NCT00537316|528340198|FG003|Part 2|Administrative|3|||
146501842|NCT00537316|528340199|FG004|Part 2|Administrative|1|||
146501843|NCT00537316|528340200|FG005|Part 2|Administrative|4|||
146501844|NCT00537316|528340201|FG006|Part 2|Administrative|1|||
146501845|NCT04533412|528340202|FG000|Overall Study|Withdrawal by Subject|1|||
146501846|NCT04533412|528340203|FG001|Overall Study|Withdrawal by Subject|1|||
146501847|NCT04533412|528340202|FG000|Overall Study|Lost to Follow-up|1|||
146501848|NCT04533412|528340203|FG001|Overall Study|Lost to Follow-up|4|||
146501849|NCT05113979|528340204|FG000|Overall Study|Death|2|||
146501850|NCT05113979|528340204|FG000|Overall Study|Lost to Follow-up|1|||
146501851|NCT00968981|528340207|FG000|Overall Study|Adverse Event|2|||
146501852|NCT00968981|528340208|FG001|Overall Study|Adverse Event|0|||
146501853|NCT00968981|528340209|FG002|Overall Study|Adverse Event|0|||
146501854|NCT00968981|528340207|FG000|Overall Study|Disease Progression|14|||
146501855|NCT00968981|528340208|FG001|Overall Study|Disease Progression|16|||
146501856|NCT00968981|528340209|FG002|Overall Study|Disease Progression|13|||
146501857|NCT00968981|528340207|FG000|Overall Study|Lost to Follow-up|0|||
146501858|NCT00968981|528340208|FG001|Overall Study|Lost to Follow-up|0|||
146501859|NCT00968981|528340209|FG002|Overall Study|Lost to Follow-up|1|||
146501860|NCT00968981|528340207|FG000|Overall Study|Physician Decision|5|||
146501861|NCT00968981|528340208|FG001|Overall Study|Physician Decision|3|||
146501862|NCT00968981|528340209|FG002|Overall Study|Physician Decision|5|||
146501863|NCT00968981|528340207|FG000|Overall Study|Withdrawal by Subject|1|||
146501864|NCT00968981|528340208|FG001|Overall Study|Withdrawal by Subject|3|||
146501865|NCT00968981|528340209|FG002|Overall Study|Withdrawal by Subject|3|||
146501866|NCT04016779|528340215|FG000|Overall Study|Adverse Event|9|||
146501867|NCT04016779|528340216|FG001|Overall Study|Adverse Event|17|||
146501868|NCT04016779|528340215|FG000|Overall Study|Lack of Efficacy|4|||
146501869|NCT04016779|528340216|FG001|Overall Study|Lack of Efficacy|1|||
146501870|NCT04016779|528340215|FG000|Overall Study|Lost to Follow-up|5|||
146501871|NCT04016779|528340216|FG001|Overall Study|Lost to Follow-up|14|||
146501872|NCT04016779|528340215|FG000|Overall Study|Physician Decision|1|||
146501873|NCT04016779|528340216|FG001|Overall Study|Physician Decision|3|||
146501874|NCT04016779|528340215|FG000|Overall Study|Withdrawal by Subject|6|||
146501875|NCT04016779|528340216|FG001|Overall Study|Withdrawal by Subject|8|||
146501876|NCT04016779|528340215|FG000|Overall Study|Non-compliance with Study Drug|2|||
146501877|NCT04016779|528340216|FG001|Overall Study|Non-compliance with Study Drug|3|||
146501878|NCT04016779|528340215|FG000|Overall Study|Other, Multiple categories|17|||
146501879|NCT04016779|528340216|FG001|Overall Study|Other, Multiple categories|17|||
146501880|NCT00330343|528340217|FG000|Overall Study|Lost to Follow-up|5|||
146501881|NCT00281632|528340218|FG000|Overall Study|Adverse Event|7|||
146501882|NCT00281632|528340218|FG000|Overall Study|Withdrawal by Subject|2|||
146501883|NCT00281632|528340218|FG000|Overall Study|Disease Progression|22|||
146501884|NCT00281632|528340218|FG000|Overall Study|Death|1|||
146501885|NCT00281632|528340218|FG000|Overall Study|Physician Decision|1|||
146501886|NCT00281632|528340218|FG000|Overall Study|Ongoing|3|||
146501887|NCT06586788|528340219|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
146501888|NCT02691936|528340223|FG000|Overall Study|Withdrawal by Subject|2|||
146501889|NCT02691936|528340224|FG001|Overall Study|Withdrawal by Subject|5|||
146566698|NCT00269113|528587899|FG001|Overall Study|Lost to Follow-up|1|||
146566699|NCT00269113|528587898|FG000|Overall Study|Protocol Violation|15|||
146566700|NCT00269113|528587899|FG001|Overall Study|Protocol Violation|5|||
146566701|NCT00269113|528587898|FG000|Overall Study|Other|0|||
146501890|NCT03696108|528340225|FG000|Overall Study|Physician Decision|1|||
146501891|NCT03696108|528340226|FG001|Overall Study|Physician Decision|0|||
146501892|NCT03696108|528340225|FG000|Overall Study|Withdrawal by Subject|3|||
146501893|NCT03696108|528340226|FG001|Overall Study|Withdrawal by Subject|6|||
146501894|NCT05239494|528340227|FG000|Overall Study|Lost to Follow-up|1|||
146501895|NCT01053962|528340230|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
146501896|NCT01053962|528340231|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
146501897|NCT01053962|528340232|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
146501898|NCT01053962|528340233|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
146501899|NCT01053962|528340234|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
146501900|NCT01053962|528340230|FG000|Pretreatment Period|Venipuncture Failure|0|||
146501901|NCT01053962|528340231|FG001|Pretreatment Period|Venipuncture Failure|0|||
146501902|NCT01053962|528340232|FG002|Pretreatment Period|Venipuncture Failure|1|||
146566702|NCT00269113|528587899|FG001|Overall Study|Other|2|||
146647263|NCT00097981|528886813|FG000|Overall Study|Death|2|||
146647264|NCT00097981|528886814|FG001|Overall Study|Death|4|||
146974167|NCT01289990|530067483|FG007|Overall Study|Withdrawal by Subject|9|||
146974168|NCT01289990|530067484|FG008|Overall Study|Withdrawal by Subject|12|||
146974169|NCT01289990|530067485|FG009|Overall Study|Withdrawal by Subject|13|||
146974170|NCT01289990|530067486|FG010|Overall Study|Withdrawal by Subject|11|||
146501903|NCT01053962|528340233|FG003|Pretreatment Period|Venipuncture Failure|0|||
146501904|NCT01053962|528340234|FG004|Pretreatment Period|Venipuncture Failure|0|||
146501905|NCT01053962|528340230|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
146501906|NCT01053962|528340231|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
146501907|NCT01053962|528340232|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
146501908|NCT01053962|528340233|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
146501909|NCT01053962|528340234|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
146501910|NCT01053962|528340230|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
146501911|NCT01053962|528340231|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
146501912|NCT01053962|528340232|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
146501913|NCT01053962|528340233|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
146501914|NCT01053962|528340234|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
146501915|NCT01053962|528340230|FG000|Treatment Period|Lack of Efficacy|0|||
146501916|NCT01053962|528340231|FG001|Treatment Period|Lack of Efficacy|0|||
146501917|NCT01053962|528340232|FG002|Treatment Period|Lack of Efficacy|0|||
146501918|NCT01053962|528340233|FG003|Treatment Period|Lack of Efficacy|0|||
146501919|NCT01053962|528340234|FG004|Treatment Period|Lack of Efficacy|1|||
146501920|NCT01053962|528340230|FG000|Treatment Period|Adverse Event|0|||
146501921|NCT01053962|528340231|FG001|Treatment Period|Adverse Event|0|||
146501922|NCT01053962|528340232|FG002|Treatment Period|Adverse Event|0|||
146501923|NCT01053962|528340233|FG003|Treatment Period|Adverse Event|0|||
146501924|NCT01053962|528340234|FG004|Treatment Period|Adverse Event|1|||
146501925|NCT01053962|528340230|FG000|Treatment Period|Withdrawal by Subject|0|||
146501926|NCT01053962|528340231|FG001|Treatment Period|Withdrawal by Subject|0|||
146501927|NCT01053962|528340232|FG002|Treatment Period|Withdrawal by Subject|0|||
146501928|NCT01053962|528340233|FG003|Treatment Period|Withdrawal by Subject|0|||
146501929|NCT01053962|528340234|FG004|Treatment Period|Withdrawal by Subject|1|||
146501930|NCT01053962|528340230|FG000|Treatment Period|Noncompliance with protocol|1|||
146501931|NCT01053962|528340231|FG001|Treatment Period|Noncompliance with protocol|0|||
146501932|NCT01053962|528340232|FG002|Treatment Period|Noncompliance with protocol|0|||
146501933|NCT01053962|528340233|FG003|Treatment Period|Noncompliance with protocol|0|||
146501934|NCT01053962|528340234|FG004|Treatment Period|Noncompliance with protocol|0|||
146501935|NCT02892422|528340235|FG000|Overall Study|Enrolled not treated|4|||
146501936|NCT02892422|528340235|FG000|Overall Study|Adverse Event|38|||
146501937|NCT02892422|528340235|FG000|Overall Study|Lack of Efficacy|32|||
146501938|NCT02892422|528340235|FG000|Overall Study|Non-compliance with study drug|11|||
146501939|NCT02892422|528340235|FG000|Overall Study|Protocol Violation|4|||
146501940|NCT02892422|528340235|FG000|Overall Study|Withdrawal by Subject|56|||
146501941|NCT02892422|528340235|FG000|Overall Study|Lost to Follow-up|5|||
146501942|NCT02892422|528340235|FG000|Overall Study|sponsor information 16159A results|21|||
146501943|NCT02892422|528340235|FG000|Overall Study|withdrawal of consent|13|||
146501944|NCT02892422|528340235|FG000|Overall Study|exclusion criteria met|3|||
146501945|NCT02892422|528340235|FG000|Overall Study|moving elsewhere|4|||
146647265|NCT00097981|528886813|FG000|Overall Study|Physician Decision|7|||
146647266|NCT00097981|528886814|FG001|Overall Study|Physician Decision|1|||
146647267|NCT00097981|528886813|FG000|Overall Study|Disease Progression|8|||
146647268|NCT00097981|528886814|FG001|Overall Study|Disease Progression|2|||
146647269|NCT00097981|528886813|FG000|Overall Study|Transplant planned|28|||
146647270|NCT00097981|528886814|FG001|Overall Study|Transplant planned|27|||
146647271|NCT00097981|528886813|FG000|Overall Study|Other|19|||
146647272|NCT00097981|528886814|FG001|Overall Study|Other|13|||
146647273|NCT00412373|528886815|FG000|Overall Study|Adverse Event|8|||
146647274|NCT00412373|528886816|FG001|Overall Study|Adverse Event|13|||
146647275|NCT00412373|528886815|FG000|Overall Study|Lack of Efficacy|16|||
146647276|NCT00412373|528886816|FG001|Overall Study|Lack of Efficacy|22|||
146501946|NCT02892422|528340235|FG000|Overall Study|non-compliance|10|||
146501947|NCT02892422|528340235|FG000|Overall Study|patient legally incapable|1|||
146501948|NCT02892422|528340235|FG000|Overall Study|patient decision|7|||
146501949|NCT02892422|528340235|FG000|Overall Study|Investigator decision|1|||
146501950|NCT03089697|528340236|FG000|Overall Study|Adverse Event|1|||
146769111|NCT03284957|529323421|FG012|Overall Study|Withdrawal by Subject|0|||
146501951|NCT03089697|528340237|FG001|Overall Study|Adverse Event|2|||
146501952|NCT03089697|528340236|FG000|Overall Study|Withdrawal by Subject|1|||
146501953|NCT03089697|528340237|FG001|Overall Study|Withdrawal by Subject|0|||
146501954|NCT02693171|528340249|FG000|Overall Study|Adverse Event|1|||
146501955|NCT02693171|528340249|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
146501956|NCT00595517|528340250|FG000|Overall Study|Adverse Event|6|||
146501957|NCT00595517|528340250|FG000|Overall Study|Withdrawal by Subject|4|||
146501958|NCT00595517|528340250|FG000|Overall Study|Protocol Violation|2|||
146647277|NCT00412373|528886815|FG000|Overall Study|Lost to Follow-up|7|||
146647278|NCT00412373|528886816|FG001|Overall Study|Lost to Follow-up|13|||
146647279|NCT00412373|528886815|FG000|Overall Study|Withdrawal by Subject|8|||
146501959|NCT00595517|528340250|FG000|Overall Study|Recurrence of ulcer|5|||
146501960|NCT00595517|528340250|FG000|Overall Study|usage of prohibited treatment|1|||
146501961|NCT00595517|528340250|FG000|Overall Study|No intention to attend regularly|1|||
146501962|NCT01167881|528340251|FG000|Overall Study|Adverse Event|47|||
146501963|NCT01167881|528340252|FG001|Overall Study|Adverse Event|51|||
146501964|NCT01167881|528340251|FG000|Overall Study|Lack of Efficacy|4|||
146501965|NCT01167881|528340252|FG001|Overall Study|Lack of Efficacy|7|||
146501966|NCT01167881|528340251|FG000|Overall Study|Non compliant with protocol|9|||
146501967|NCT01167881|528340252|FG001|Overall Study|Non compliant with protocol|18|||
146501968|NCT01167881|528340251|FG000|Overall Study|Lost to Follow-up|19|||
146501969|NCT01167881|528340252|FG001|Overall Study|Lost to Follow-up|20|||
146501970|NCT01167881|528340251|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
146501971|NCT01167881|528340252|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
146501972|NCT01167881|528340251|FG000|Overall Study|Not treated|4|||
146501973|NCT01167881|528340252|FG001|Overall Study|Not treated|0|||
146501974|NCT01167881|528340251|FG000|Overall Study|Other not defined above|31|||
146501975|NCT01167881|528340252|FG001|Overall Study|Other not defined above|55|||
146501976|NCT01992653|528340253|FG000|Overall Study|Death|0|||
146501977|NCT01992653|528340254|FG001|Overall Study|Death|0|||
146501978|NCT01992653|528340255|FG002|Overall Study|Death|1|||
146501979|NCT01992653|528340256|FG003|Overall Study|Death|0|||
146501980|NCT01992653|528340257|FG004|Overall Study|Death|1|||
146501981|NCT01992653|528340258|FG005|Overall Study|Death|0|||
146501982|NCT01992653|528340259|FG006|Overall Study|Death|4|||
146501983|NCT01992653|528340260|FG007|Overall Study|Death|2|||
146501984|NCT01992653|528340253|FG000|Overall Study|Lost to Follow-up|0|||
146501985|NCT01992653|528340254|FG001|Overall Study|Lost to Follow-up|0|||
146501986|NCT01992653|528340255|FG002|Overall Study|Lost to Follow-up|0|||
146501987|NCT01992653|528340256|FG003|Overall Study|Lost to Follow-up|0|||
146501988|NCT01992653|528340257|FG004|Overall Study|Lost to Follow-up|0|||
146501989|NCT01992653|528340258|FG005|Overall Study|Lost to Follow-up|0|||
146501990|NCT01992653|528340259|FG006|Overall Study|Lost to Follow-up|0|||
146501991|NCT01992653|528340260|FG007|Overall Study|Lost to Follow-up|1|||
146501992|NCT01992653|528340253|FG000|Overall Study|Study Completed|0|||
146501993|NCT01992653|528340254|FG001|Overall Study|Study Completed|0|||
146501994|NCT01992653|528340255|FG002|Overall Study|Study Completed|0|||
146501995|NCT01992653|528340256|FG003|Overall Study|Study Completed|0|||
146501996|NCT01992653|528340257|FG004|Overall Study|Study Completed|0|||
146501997|NCT01992653|528340258|FG005|Overall Study|Study Completed|0|||
146501998|NCT01992653|528340259|FG006|Overall Study|Study Completed|0|||
146501999|NCT01992653|528340260|FG007|Overall Study|Study Completed|1|||
146502000|NCT01992653|528340253|FG000|Overall Study|Disease Progression|0|||
146502001|NCT01992653|528340254|FG001|Overall Study|Disease Progression|0|||
146502002|NCT01992653|528340255|FG002|Overall Study|Disease Progression|0|||
146647280|NCT00412373|528886816|FG001|Overall Study|Withdrawal by Subject|27|||
146647281|NCT00412373|528886815|FG000|Overall Study|Other|2|||
146647282|NCT00412373|528886816|FG001|Overall Study|Other|2|||
146647283|NCT01009840|528886817|FG000|Overall Study|Lost to Follow-up|1|||
146647284|NCT01009840|528886817|FG000|Overall Study|Adverse Event|4|||
146647285|NCT01009840|528886817|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
146647286|NCT01009840|528886817|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
146647287|NCT01009840|528886817|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
146502003|NCT01992653|528340256|FG003|Overall Study|Disease Progression|0|||
146502004|NCT01992653|528340257|FG004|Overall Study|Disease Progression|0|||
146502005|NCT01992653|528340258|FG005|Overall Study|Disease Progression|0|||
146502006|NCT01992653|528340259|FG006|Overall Study|Disease Progression|4|||
146502007|NCT01992653|528340260|FG007|Overall Study|Disease Progression|0|||
146502008|NCT00556933|528340268|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
146502009|NCT00556933|528340269|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
146502010|NCT00556933|528340270|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
146502011|NCT00556933|528340271|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
146502012|NCT00556933|528340268|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
146502013|NCT00556933|528340269|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
146502014|NCT00556933|528340270|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
146502015|NCT00556933|528340271|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
146502016|NCT00556933|528340268|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
146502017|NCT00556933|528340269|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
146502018|NCT00556933|528340270|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
146502019|NCT00556933|528340271|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
146502020|NCT00556933|528340268|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
146502021|NCT00556933|528340269|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
146502022|NCT00556933|528340270|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
146502023|NCT00556933|528340271|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
146502024|NCT00556933|528340268|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
146769112|NCT03284957|529323422|FG013|Overall Study|Withdrawal by Subject|0|||
146769113|NCT03284957|529323423|FG014|Overall Study|Withdrawal by Subject|0|||
146502025|NCT00556933|528340269|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
146502026|NCT00556933|528340270|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
146502027|NCT00556933|528340271|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
146502028|NCT00556933|528340268|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
146502029|NCT00556933|528340269|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
146502030|NCT00556933|528340270|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
146502031|NCT00556933|528340271|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
146502032|NCT00556933|528340268|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
146502033|NCT00556933|528340269|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
146502034|NCT00556933|528340270|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
146502035|NCT00556933|528340271|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
146502036|NCT00556933|528340268|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
146502037|NCT00556933|528340269|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
146502038|NCT00556933|528340270|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
146502039|NCT00556933|528340271|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
146502040|NCT00556933|528340268|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
146502041|NCT00556933|528340269|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
146502042|NCT00556933|528340270|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
146502043|NCT00556933|528340271|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
146502044|NCT00556933|528340268|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
146502045|NCT00556933|528340269|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
146502046|NCT00556933|528340270|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
146502047|NCT00556933|528340271|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
146502048|NCT00556933|528340268|FG000|CNI Withdrawal vs. Minimization|Death|0|||
146502049|NCT00556933|528340269|FG001|CNI Withdrawal vs. Minimization|Death|0|||
146502050|NCT00556933|528340270|FG002|CNI Withdrawal vs. Minimization|Death|0|||
146502051|NCT00556933|528340271|FG003|CNI Withdrawal vs. Minimization|Death|1|||
146502052|NCT03887442|528340272|FG000|Overall Study|Adverse Event|1|||
146502053|NCT03887442|528340273|FG001|Overall Study|Adverse Event|0|||
146502054|NCT01628198|528340276|FG000|Overall Study|Lost to Follow-up|7|||
146502055|NCT01628198|528340276|FG000|Overall Study|Withdrawal by Subject|10|||
146502056|NCT01628198|528340276|FG000|Overall Study|Screen failure|1|||
146502057|NCT00022698|528340278|FG000|Overall Study|Adverse Event|5|||
146502058|NCT00022698|528340279|FG001|Overall Study|Adverse Event|9|||
146502059|NCT00022698|528340278|FG000|Overall Study|Death|0|||
146502060|NCT00022698|528340279|FG001|Overall Study|Death|2|||
146502061|NCT00022698|528340278|FG000|Overall Study|Failure to return|0|||
146502062|NCT00022698|528340279|FG001|Overall Study|Failure to return|1|||
146502063|NCT00022698|528340278|FG000|Overall Study|Refused treatment|0|||
146502064|NCT00022698|528340279|FG001|Overall Study|Refused treatment|2|||
146502065|NCT00022698|528340278|FG000|Overall Study|Insufficient therapeutic response|2|||
146502066|NCT00022698|528340279|FG001|Overall Study|Insufficient therapeutic response|14|||
146502067|NCT00022698|528340278|FG000|Overall Study|Administrative /other|1|||
146502068|NCT00022698|528340279|FG001|Overall Study|Administrative /other|7|||
146502069|NCT02504827|528340280|FG000|Overall Study|Could not produce sputum|1|||
146502070|NCT03386994|528340281|FG000|Overall Study|Lung transplant|1|||
146502071|NCT03386994|528340281|FG000|Overall Study|Adverse Event|14|||
146502072|NCT03386994|528340281|FG000|Overall Study|Lost to Follow-up|4|||
146502073|NCT03386994|528340281|FG000|Overall Study|Withdrawal by Subject|3|||
146502074|NCT03386994|528340281|FG000|Overall Study|Death|16|||
146502075|NCT01743560|528340282|FG000|Overall Study|Disease progression|26|||
146502076|NCT01743560|528340282|FG000|Overall Study|Adverse Event|8|||
146502077|NCT01743560|528340282|FG000|Overall Study|Death|3|||
146502078|NCT01743560|528340282|FG000|Overall Study|Withdrawal by Subject|2|||
146502079|NCT01743560|528340282|FG000|Overall Study|Protocol Violation|1|||
146502080|NCT01743560|528340282|FG000|Overall Study|>1 dose of study drug|3|||
146502081|NCT03634033|528341813|FG000|Overall Study|Did not have a post-assessment|384|||
146502082|NCT03634033|528341814|FG001|Overall Study|Did not have a post-assessment|291|||
146502083|NCT03634033|528341815|FG002|Overall Study|Did not have a post-assessment|114|||
146502084|NCT03634033|528341816|FG003|Overall Study|Did not have a post-assessment|161|||
146502085|NCT03634033|528341817|FG004|Overall Study|Did not have a post-assessment|5|||
146502086|NCT03634033|528341818|FG005|Overall Study|Did not have a post-assessment|0|||
146502087|NCT03634033|528341819|FG006|Overall Study|Did not have a post-assessment|0|||
146502088|NCT03634033|528341813|FG000|Overall Study|Death|0|||
146502089|NCT03634033|528341814|FG001|Overall Study|Death|0|||
146502090|NCT03634033|528341815|FG002|Overall Study|Death|0|||
146502091|NCT03634033|528341816|FG003|Overall Study|Death|0|||
146502092|NCT03634033|528341817|FG004|Overall Study|Death|0|||
146502093|NCT03634033|528341818|FG005|Overall Study|Death|7|||
146502094|NCT03634033|528341819|FG006|Overall Study|Death|7|||
146502095|NCT03634033|528341813|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
146769114|NCT03284957|529323424|FG015|Overall Study|Withdrawal by Subject|0|||
146647288|NCT01002820|528886825|FG000|Overall Study|Adverse Event|1|||
146647289|NCT01002820|528886825|FG000|Overall Study|Withdrawal by Subject|2|||
146647290|NCT01002820|528886825|FG000|Overall Study|Lack of Efficacy|1|||
146647291|NCT01673347|528886826|FG000|Overall Study|failure of allograft|7|||
146647292|NCT00895011|528886832|FG000|Overall Study|Withdrawal by Subject|14|||
146647293|NCT00895011|528886833|FG001|Overall Study|Withdrawal by Subject|7|||
146647294|NCT00895011|528886834|FG002|Overall Study|Withdrawal by Subject|2|||
146647295|NCT00895011|528886832|FG000|Overall Study|Lost to Follow-up|5|||
146647296|NCT00895011|528886833|FG001|Overall Study|Lost to Follow-up|4|||
146647297|NCT00895011|528886834|FG002|Overall Study|Lost to Follow-up|1|||
146647298|NCT00895011|528886832|FG000|Overall Study|Protocol Violation|3|||
146647299|NCT00895011|528886833|FG001|Overall Study|Protocol Violation|1|||
146647300|NCT00895011|528886834|FG002|Overall Study|Protocol Violation|3|||
146647301|NCT00895011|528886832|FG000|Overall Study|Adverse Event|1|||
146647302|NCT00895011|528886833|FG001|Overall Study|Adverse Event|2|||
146647303|NCT00895011|528886834|FG002|Overall Study|Adverse Event|2|||
146647304|NCT00895011|528886832|FG000|Overall Study|schedule conflict|1|||
146647305|NCT00895011|528886833|FG001|Overall Study|schedule conflict|0|||
146647306|NCT00895011|528886834|FG002|Overall Study|schedule conflict|0|||
146647307|NCT02661178|528886842|FG000|Part 1|Protocol Violation|1|||
146647308|NCT02661178|528886843|FG001|Part 1|Protocol Violation|0|||
146647309|NCT02661178|528886844|FG002|Part 1|Protocol Violation|0|||
146647310|NCT02661178|528886845|FG003|Part 1|Protocol Violation|0|||
146647311|NCT02661178|528886846|FG004|Part 1|Protocol Violation|0|||
146647312|NCT02661178|528886847|FG005|Part 1|Protocol Violation|0|||
146647313|NCT02661178|528886848|FG006|Part 1|Protocol Violation|0|||
146647314|NCT02661178|528886849|FG007|Part 1|Protocol Violation|0|||
146647315|NCT02661178|528886850|FG008|Part 1|Protocol Violation|0|||
146647316|NCT02661178|528886851|FG009|Part 1|Protocol Violation|0|||
146647317|NCT02661178|528886852|FG010|Part 1|Protocol Violation|0|||
146647318|NCT02661178|528886853|FG011|Part 1|Protocol Violation|0|||
146647319|NCT02661178|528886854|FG012|Part 1|Protocol Violation|0|||
146647320|NCT02661178|528886855|FG013|Part 1|Protocol Violation|0|||
146647321|NCT02661178|528886856|FG014|Part 1|Protocol Violation|0|||
146647322|NCT03859973|528886857|FG000|Overall Study|Other reason than listed|3|||
146647323|NCT03859973|528886858|FG001|Overall Study|Other reason than listed|2|||
146647324|NCT03859973|528886857|FG000|Overall Study|COVID-19 related, not due to AE|3|||
146647325|NCT03859973|528886858|FG001|Overall Study|COVID-19 related, not due to AE|4|||
146647326|NCT03859973|528886857|FG000|Overall Study|Withdrawal by Subject|8|||
146647327|NCT03859973|528886858|FG001|Overall Study|Withdrawal by Subject|9|||
146647328|NCT03859973|528886857|FG000|Overall Study|Lost to Follow-up|2|||
146647329|NCT03859973|528886858|FG001|Overall Study|Lost to Follow-up|3|||
146647330|NCT03859973|528886857|FG000|Overall Study|Protocol Violation|1|||
146647331|NCT03859973|528886858|FG001|Overall Study|Protocol Violation|3|||
146647332|NCT03859973|528886857|FG000|Overall Study|Adverse Event|3|||
146647333|NCT03859973|528886858|FG001|Overall Study|Adverse Event|5|||
146647334|NCT02855541|528886859|FG000|Overall Study|Change in health status|2|||
146502096|NCT03634033|528341814|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
146502097|NCT03634033|528341815|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
146502098|NCT03634033|528341816|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
146502099|NCT03634033|528341817|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
146502100|NCT03634033|528341818|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
146502101|NCT03634033|528341819|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
146502102|NCT03634033|528341813|FG000|Overall Study|Lost to Follow-up|0|||
146502103|NCT03634033|528341814|FG001|Overall Study|Lost to Follow-up|0|||
146502104|NCT03634033|528341815|FG002|Overall Study|Lost to Follow-up|0|||
146502105|NCT03634033|528341816|FG003|Overall Study|Lost to Follow-up|0|||
146502106|NCT03634033|528341817|FG004|Overall Study|Lost to Follow-up|0|||
146502107|NCT03634033|528341818|FG005|Overall Study|Lost to Follow-up|1|||
146502108|NCT03634033|528341819|FG006|Overall Study|Lost to Follow-up|2|||
146502109|NCT03634033|528341813|FG000|Overall Study|Withdrawal by Subject|0|||
146502110|NCT03634033|528341814|FG001|Overall Study|Withdrawal by Subject|0|||
146502111|NCT03634033|528341815|FG002|Overall Study|Withdrawal by Subject|0|||
146502112|NCT03634033|528341816|FG003|Overall Study|Withdrawal by Subject|0|||
146647335|NCT02855541|528886859|FG000|Overall Study|Withdrawal by Subject|2|||
146647336|NCT04493892|528886865|FG000|Overall Study|Withdrawal by Subject|15|||
146647337|NCT01689532|528886866|FG000|Overall Study|Adverse Event|9|||
146769115|NCT03284957|529323409|FG000|Overall Study|Other|0|||
146502113|NCT03634033|528341817|FG004|Overall Study|Withdrawal by Subject|0|||
146647338|NCT01689532|528886867|FG001|Overall Study|Adverse Event|5|||
146647339|NCT01689532|528886866|FG000|Overall Study|Lack of Efficacy|2|||
146647340|NCT01689532|528886867|FG001|Overall Study|Lack of Efficacy|2|||
146647341|NCT01689532|528886866|FG000|Overall Study|Withdrawal by Subject|1|||
146647342|NCT01689532|528886867|FG001|Overall Study|Withdrawal by Subject|2|||
146647343|NCT01689532|528886866|FG000|Overall Study|Physician Decision|2|||
146647344|NCT01689532|528886867|FG001|Overall Study|Physician Decision|0|||
146647345|NCT01363349|528886868|FG000|Overall Study|Adverse Event|6|||
146647346|NCT01363349|528886869|FG001|Overall Study|Adverse Event|7|||
146769116|NCT03284957|529323410|FG001|Overall Study|Other|0|||
146974171|NCT01289990|530067487|FG011|Overall Study|Withdrawal by Subject|13|||
146974172|NCT01289990|530067488|FG012|Overall Study|Withdrawal by Subject|16|||
146974173|NCT01289990|530067476|FG000|Overall Study|discontinued in preceding trial|18|||
146974174|NCT01289990|530067477|FG001|Overall Study|discontinued in preceding trial|20|||
146974175|NCT01289990|530067478|FG002|Overall Study|discontinued in preceding trial|41|||
146974176|NCT01289990|530067479|FG003|Overall Study|discontinued in preceding trial|17|||
146974177|NCT01289990|530067480|FG004|Overall Study|discontinued in preceding trial|11|||
146974178|NCT01289990|530067481|FG005|Overall Study|discontinued in preceding trial|12|||
146974179|NCT01289990|530067482|FG006|Overall Study|discontinued in preceding trial|18|||
146974180|NCT01289990|530067483|FG007|Overall Study|discontinued in preceding trial|8|||
146974181|NCT01289990|530067484|FG008|Overall Study|discontinued in preceding trial|17|||
146974182|NCT01289990|530067485|FG009|Overall Study|discontinued in preceding trial|21|||
146974183|NCT01289990|530067486|FG010|Overall Study|discontinued in preceding trial|17|||
146974184|NCT01289990|530067487|FG011|Overall Study|discontinued in preceding trial|17|||
146974185|NCT01289990|530067488|FG012|Overall Study|discontinued in preceding trial|24|||
146974186|NCT01289990|530067476|FG000|Overall Study|did not continue in extension|41|||
146974187|NCT01289990|530067477|FG001|Overall Study|did not continue in extension|45|||
146974188|NCT01289990|530067478|FG002|Overall Study|did not continue in extension|51|||
146974189|NCT01289990|530067479|FG003|Overall Study|did not continue in extension|51|||
146974190|NCT01289990|530067480|FG004|Overall Study|did not continue in extension|48|||
146974191|NCT01289990|530067481|FG005|Overall Study|did not continue in extension|50|||
146974192|NCT01289990|530067482|FG006|Overall Study|did not continue in extension|54|||
146974193|NCT01289990|530067483|FG007|Overall Study|did not continue in extension|36|||
146974194|NCT01289990|530067484|FG008|Overall Study|did not continue in extension|44|||
146974195|NCT01289990|530067485|FG009|Overall Study|did not continue in extension|48|||
146974196|NCT01289990|530067486|FG010|Overall Study|did not continue in extension|45|||
146974197|NCT01289990|530067487|FG011|Overall Study|did not continue in extension|34|||
146974198|NCT01289990|530067488|FG012|Overall Study|did not continue in extension|56|||
146974199|NCT01289990|530067476|FG000|Overall Study|Not treated|0|||
146974200|NCT01289990|530067477|FG001|Overall Study|Not treated|0|||
146974201|NCT01289990|530067478|FG002|Overall Study|Not treated|0|||
146974202|NCT01289990|530067479|FG003|Overall Study|Not treated|0|||
146974203|NCT01289990|530067480|FG004|Overall Study|Not treated|0|||
146974204|NCT01289990|530067481|FG005|Overall Study|Not treated|0|||
146974205|NCT01289990|530067482|FG006|Overall Study|Not treated|1|||
146974206|NCT01289990|530067483|FG007|Overall Study|Not treated|0|||
146974207|NCT01289990|530067484|FG008|Overall Study|Not treated|1|||
146974208|NCT01289990|530067485|FG009|Overall Study|Not treated|0|||
146974209|NCT01289990|530067486|FG010|Overall Study|Not treated|1|||
146974210|NCT01289990|530067487|FG011|Overall Study|Not treated|2|||
146974211|NCT01289990|530067488|FG012|Overall Study|Not treated|0|||
146974212|NCT00683904|530067489|FG000|Dose Level 1|Disease progression|2|||
146974213|NCT00683904|530067490|FG001|Dose Level 1|Disease progression|0|||
146974214|NCT00683904|530067489|FG000|Dose Level 1|Adverse Event|1|||
146974215|NCT00683904|530067490|FG001|Dose Level 1|Adverse Event|0|||
146974216|NCT00683904|530067489|FG000|Dose Level 2|Adverse Event|0|||
146974217|NCT00683904|530067490|FG001|Dose Level 2|Adverse Event|2|||
146974218|NCT01220128|530067491|FG000|Overall Study|Progressive disease|0|||
146974219|NCT01220128|530067492|FG001|Overall Study|Progressive disease|0|||
146974220|NCT01220128|530067493|FG002|Overall Study|Progressive disease|2|||
146502114|NCT03634033|528341818|FG005|Overall Study|Withdrawal by Subject|0|||
146502115|NCT03634033|528341819|FG006|Overall Study|Withdrawal by Subject|1|||
146502116|NCT06366087|528341820|FG000|Overall Study|Withdrawal by Subject|0|||
146502117|NCT06366087|528341821|FG001|Overall Study|Withdrawal by Subject|1|||
146502118|NCT02836236|528341822|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
146502119|NCT02836236|528341823|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
146502120|NCT02836236|528341824|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
146974221|NCT01220128|530067494|FG003|Overall Study|Progressive disease|0|||
146974222|NCT01220128|530067495|FG004|Overall Study|Progressive disease|0|||
146974223|NCT01220128|530067496|FG005|Overall Study|Progressive disease|0|||
146974224|NCT01220128|530067497|FG006|Overall Study|Progressive disease|0|||
146974225|NCT01220128|530067491|FG000|Overall Study|Sponsor study termination|0|||
146974226|NCT01220128|530067492|FG001|Overall Study|Sponsor study termination|1|||
146974227|NCT01220128|530067493|FG002|Overall Study|Sponsor study termination|0|||
146974228|NCT01220128|530067494|FG003|Overall Study|Sponsor study termination|0|||
146974229|NCT01220128|530067495|FG004|Overall Study|Sponsor study termination|0|||
146974230|NCT01220128|530067496|FG005|Overall Study|Sponsor study termination|0|||
146974231|NCT01220128|530067497|FG006|Overall Study|Sponsor study termination|1|||
146974232|NCT01220128|530067491|FG000|Overall Study|Adverse event, serious fatal|2|||
146502121|NCT02836236|528341825|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
146502122|NCT02836236|528341822|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
146974233|NCT01220128|530067492|FG001|Overall Study|Adverse event, serious fatal|0|||
146974234|NCT01220128|530067493|FG002|Overall Study|Adverse event, serious fatal|0|||
146974235|NCT01220128|530067494|FG003|Overall Study|Adverse event, serious fatal|0|||
146974236|NCT01220128|530067495|FG004|Overall Study|Adverse event, serious fatal|0|||
146502123|NCT02836236|528341823|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
146502124|NCT02836236|528341824|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
146502125|NCT02836236|528341825|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
146502126|NCT02836236|528341822|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
146502127|NCT02836236|528341823|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
146502128|NCT02836236|528341824|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
146502129|NCT02836236|528341825|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
146502130|NCT02836236|528341822|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
146502131|NCT02836236|528341823|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
146502132|NCT02836236|528341824|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
146502133|NCT02836236|528341825|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
146502134|NCT02836236|528341822|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
146502135|NCT02836236|528341823|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
146502136|NCT02836236|528341824|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
146502137|NCT02836236|528341825|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
146502138|NCT02836236|528341822|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
146502139|NCT02836236|528341823|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
146502140|NCT02836236|528341824|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
146502141|NCT02836236|528341825|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
146502142|NCT02836236|528341822|FG000|Open-Label TAF Treatment Phase|Death|0|||
146502143|NCT02836236|528341823|FG001|Open-Label TAF Treatment Phase|Death|0|||
146502144|NCT02836236|528341824|FG002|Open-Label TAF Treatment Phase|Death|1|||
146502145|NCT02836236|528341825|FG003|Open-Label TAF Treatment Phase|Death|1|||
146502146|NCT02836236|528341822|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
146502147|NCT02836236|528341823|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
146502148|NCT02836236|528341824|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
146502149|NCT02836236|528341825|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
146502150|NCT01669174|528341833|FG000|Overall Study|Subject withdrew consent|2|||
146502151|NCT01669174|528341834|FG001|Overall Study|Subject withdrew consent|2|||
146502152|NCT01669174|528341833|FG000|Overall Study|Lost to Follow-up|1|||
146502153|NCT01669174|528341834|FG001|Overall Study|Lost to Follow-up|0|||
146502154|NCT01669174|528341833|FG000|Overall Study|Adverse Event|2|||
146502155|NCT01669174|528341834|FG001|Overall Study|Adverse Event|2|||
146502156|NCT01669174|528341833|FG000|Overall Study|Administrative problems|1|||
146502157|NCT01669174|528341834|FG001|Overall Study|Administrative problems|2|||
146502158|NCT01953601|528341835|FG000|Part 1 (Base Study)|Adverse Event|24|||
146502159|NCT01953601|528341836|FG001|Part 1 (Base Study)|Adverse Event|37|||
146502160|NCT01953601|528341837|FG002|Part 1 (Base Study)|Adverse Event|15|||
146502161|NCT01953601|528341835|FG000|Part 1 (Base Study)|Death|2|||
146502162|NCT01953601|528341836|FG001|Part 1 (Base Study)|Death|0|||
146974237|NCT01220128|530067496|FG005|Overall Study|Adverse event, serious fatal|0|||
146974238|NCT01220128|530067497|FG006|Overall Study|Adverse event, serious fatal|1|||
146974239|NCT01220128|530067491|FG000|Overall Study|Adverse event, non-fatal|1|||
146974240|NCT01220128|530067492|FG001|Overall Study|Adverse event, non-fatal|0|||
146974241|NCT01220128|530067493|FG002|Overall Study|Adverse event, non-fatal|0|||
146974242|NCT01220128|530067494|FG003|Overall Study|Adverse event, non-fatal|0|||
146974243|NCT01220128|530067495|FG004|Overall Study|Adverse event, non-fatal|0|||
146974244|NCT01220128|530067496|FG005|Overall Study|Adverse event, non-fatal|0|||
146974245|NCT01220128|530067497|FG006|Overall Study|Adverse event, non-fatal|3|||
146974246|NCT01220128|530067491|FG000|Overall Study|Other|0|||
146974247|NCT01220128|530067492|FG001|Overall Study|Other|0|||
146974248|NCT01220128|530067493|FG002|Overall Study|Other|1|||
146974249|NCT01220128|530067494|FG003|Overall Study|Other|0|||
146974250|NCT01220128|530067495|FG004|Overall Study|Other|0|||
146974251|NCT01220128|530067496|FG005|Overall Study|Other|0|||
146974252|NCT01220128|530067497|FG006|Overall Study|Other|0|||
146974253|NCT01220128|530067491|FG000|Overall Study|Consent withdrawn by subject|1|||
146974254|NCT01220128|530067492|FG001|Overall Study|Consent withdrawn by subject|0|||
146974255|NCT01220128|530067493|FG002|Overall Study|Consent withdrawn by subject|0|||
146502163|NCT01953601|528341837|FG002|Part 1 (Base Study)|Death|3|||
146502164|NCT01953601|528341835|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
146647347|NCT01363349|528886868|FG000|Overall Study|Lack of Efficacy|3|||
146647348|NCT01363349|528886869|FG001|Overall Study|Lack of Efficacy|10|||
146502165|NCT01953601|528341836|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
146502166|NCT01953601|528341837|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
146502167|NCT01953601|528341835|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
146502168|NCT01953601|528341836|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
146502169|NCT01953601|528341837|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
146502170|NCT01953601|528341835|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
146502171|NCT01953601|528341836|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
146974256|NCT01220128|530067494|FG003|Overall Study|Consent withdrawn by subject|0|||
146974257|NCT01220128|530067495|FG004|Overall Study|Consent withdrawn by subject|0|||
146974258|NCT01220128|530067496|FG005|Overall Study|Consent withdrawn by subject|0|||
146974259|NCT01220128|530067497|FG006|Overall Study|Consent withdrawn by subject|0|||
146647349|NCT01363349|528886868|FG000|Overall Study|Non compliance/Protocol deviations|2|||
146647350|NCT01363349|528886869|FG001|Overall Study|Non compliance/Protocol deviations|2|||
146647351|NCT01363349|528886868|FG000|Overall Study|Withdrawal by Subject|14|||
146647352|NCT01363349|528886869|FG001|Overall Study|Withdrawal by Subject|6|||
146647353|NCT01363349|528886868|FG000|Overall Study|Lost to Follow-up|5|||
146647354|NCT01363349|528886869|FG001|Overall Study|Lost to Follow-up|6|||
146647355|NCT01363349|528886868|FG000|Overall Study|Not reported|36|||
146647356|NCT01363349|528886869|FG001|Overall Study|Not reported|37|||
146647357|NCT01363349|528886868|FG000|Overall Study|missing|1|||
146647358|NCT01363349|528886869|FG001|Overall Study|missing|2|||
146647359|NCT01958489|528886870|FG000|Period 2|Adverse Event|0|||
146647360|NCT01958489|528886871|FG001|Period 2|Adverse Event|1|||
146647361|NCT00422084|528886874|FG000|Overall Study|Adverse Event|21|||
146647362|NCT00422084|528886875|FG001|Overall Study|Adverse Event|7|||
146647363|NCT00422084|528886874|FG000|Overall Study|Withdrawal by Subject|12|||
146647364|NCT00422084|528886875|FG001|Overall Study|Withdrawal by Subject|9|||
146647365|NCT00422084|528886874|FG000|Overall Study|Lost to Follow-up|14|||
146647366|NCT00422084|528886875|FG001|Overall Study|Lost to Follow-up|9|||
146647367|NCT00422084|528886874|FG000|Overall Study|Protocol Violation|4|||
146647368|NCT00422084|528886875|FG001|Overall Study|Protocol Violation|1|||
146647369|NCT00422084|528886874|FG000|Overall Study|Lack of Efficacy|40|||
146647370|NCT00422084|528886875|FG001|Overall Study|Lack of Efficacy|42|||
146647371|NCT00422084|528886874|FG000|Overall Study|P. vivax infection|3|||
146647372|NCT00422084|528886875|FG001|Overall Study|P. vivax infection|6|||
146647373|NCT00422084|528886874|FG000|Overall Study|Cyesis|1|||
146647374|NCT00422084|528886875|FG001|Overall Study|Cyesis|0|||
146647375|NCT00422084|528886874|FG000|Overall Study|Withdrawn from study accidentally|1|||
146647376|NCT00422084|528886875|FG001|Overall Study|Withdrawn from study accidentally|0|||
146647377|NCT00422084|528886874|FG000|Overall Study|Non-compliance|1|||
146647378|NCT00422084|528886875|FG001|Overall Study|Non-compliance|0|||
146647379|NCT00422084|528886874|FG000|Overall Study|Re-location|0|||
146647380|NCT00422084|528886875|FG001|Overall Study|Re-location|1|||
146647381|NCT00422084|528886874|FG000|Overall Study|Not defined|1|||
146647382|NCT00422084|528886875|FG001|Overall Study|Not defined|1|||
146647383|NCT03774823|528886876|FG000|Overall Study|Withdrawal by Subject|1|||
146647384|NCT03774823|528886877|FG001|Overall Study|Withdrawal by Subject|1|||
146647385|NCT03996369|528886882|FG000|Overall Study|Protocol deviation|1|||
146647386|NCT03996369|528886883|FG001|Overall Study|Protocol deviation|1|||
146647387|NCT03996369|528886882|FG000|Overall Study|Physician Decision|4|||
146647388|NCT03996369|528886883|FG001|Overall Study|Physician Decision|2|||
146647389|NCT03996369|528886882|FG000|Overall Study|Participant decision|0|||
146647390|NCT03996369|528886883|FG001|Overall Study|Participant decision|1|||
146647391|NCT03996369|528886882|FG000|Overall Study|Lack of Efficacy|4|||
146647392|NCT03996369|528886883|FG001|Overall Study|Lack of Efficacy|0|||
146647393|NCT03996369|528886882|FG000|Overall Study|Adverse Event|9|||
146647394|NCT03996369|528886883|FG001|Overall Study|Adverse Event|0|||
146647395|NCT03996369|528886882|FG000|Overall Study|Withdrawal by Subject|6|||
146647396|NCT03996369|528886883|FG001|Overall Study|Withdrawal by Subject|8|||
146647397|NCT03996369|528886882|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
146647398|NCT03996369|528886883|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
146647399|NCT03996369|528886882|FG000|Overall Study|Lost to Follow-up|0|||
146647400|NCT03996369|528886883|FG001|Overall Study|Lost to Follow-up|1|||
146647401|NCT00653432|528886885|FG000|Overall Study|Adverse Event|4|||
146647402|NCT00653432|528886886|FG001|Overall Study|Adverse Event|1|||
146647403|NCT00653432|528886885|FG000|Overall Study|Withdrawal by Subject|4|||
146647404|NCT00653432|528886886|FG001|Overall Study|Withdrawal by Subject|5|||
146647405|NCT00653432|528886885|FG000|Overall Study|Lost to Follow-up|7|||
146647406|NCT00653432|528886886|FG001|Overall Study|Lost to Follow-up|6|||
146647407|NCT00653432|528886885|FG000|Overall Study|Use/Need of Con Therapy|2|||
146647408|NCT00653432|528886886|FG001|Overall Study|Use/Need of Con Therapy|1|||
146647409|NCT00653432|528886885|FG000|Overall Study|Other - Reason Not Provided|5|||
146769117|NCT03284957|529323411|FG002|Overall Study|Other|0|||
146647410|NCT00653432|528886886|FG001|Overall Study|Other - Reason Not Provided|3|||
146647411|NCT05277337|528886887|FG000|Overall Study|Lost to Follow-up|2|||
146647412|NCT05277337|528886888|FG001|Overall Study|Lost to Follow-up|0|||
146647413|NCT05277337|528886887|FG000|Overall Study|Withdrawal by Subject|1|||
146647414|NCT05277337|528886888|FG001|Overall Study|Withdrawal by Subject|0|||
146647415|NCT01782469|528886889|FG000|Overall Study|Lost to Follow-up|1|||
146647416|NCT00357760|528886892|FG000|Overall Study|Disease progression|44|||
146647417|NCT00357760|528886893|FG001|Overall Study|Disease progression|17|||
146647418|NCT00357760|528886892|FG000|Overall Study|Adverse Event|10|||
146647419|NCT00357760|528886893|FG001|Overall Study|Adverse Event|7|||
146647420|NCT00357760|528886892|FG000|Overall Study|Death|0|||
146647421|NCT00357760|528886893|FG001|Overall Study|Death|3|||
146647422|NCT00357760|528886892|FG000|Overall Study|Alternative therapy|1|||
146647423|NCT00357760|528886893|FG001|Overall Study|Alternative therapy|0|||
146647424|NCT00357760|528886892|FG000|Overall Study|Withdrawal by Subject|0|||
146647425|NCT00357760|528886893|FG001|Overall Study|Withdrawal by Subject|2|||
146647426|NCT00357760|528886892|FG000|Overall Study|Never started treatment|2|||
146769118|NCT03284957|529323412|FG003|Overall Study|Other|0|||
146647427|NCT00357760|528886893|FG001|Overall Study|Never started treatment|1|||
146647428|NCT00357760|528886892|FG000|Overall Study|Ineligible|0|||
146647429|NCT00357760|528886893|FG001|Overall Study|Ineligible|2|||
146647430|NCT00357760|528886892|FG000|Overall Study|Physician Decision|2|||
146647431|NCT00357760|528886893|FG001|Overall Study|Physician Decision|1|||
146647432|NCT00357760|528886892|FG000|Overall Study|Protocol Violation|0|||
146647433|NCT00357760|528886893|FG001|Overall Study|Protocol Violation|1|||
146647434|NCT00357760|528886892|FG000|Overall Study|To receive hospice care|0|||
146647435|NCT00357760|528886893|FG001|Overall Study|To receive hospice care|1|||
146647436|NCT02350764|528886894|FG000|Overall Study|Adverse Event|4|||
146647437|NCT02350764|528886894|FG000|Overall Study|Death|3|||
146647438|NCT02350764|528886894|FG000|Overall Study|Physician Decision|2|||
146647439|NCT02350764|528886894|FG000|Overall Study|Withdrawal by Subject|2|||
146647440|NCT01224782|528886898|FG000|Overall Study|Lost to Follow-up|177|||
146647441|NCT01224782|528886898|FG000|Overall Study|Withdrawal by Subject|16|||
146647442|NCT01224782|528886898|FG000|Overall Study|Death|14|||
146647443|NCT01224782|528886898|FG000|Overall Study|Improvement|13|||
146647444|NCT01224782|528886898|FG000|Overall Study|Adverse Event|12|||
146647445|NCT01224782|528886898|FG000|Overall Study|Adverse Reaction|11|||
146647446|NCT01224782|528886898|FG000|Overall Study|Noncompliance|10|||
146647447|NCT01224782|528886898|FG000|Overall Study|Other|4|||
146647448|NCT01224782|528886898|FG000|Overall Study|Start of Dialysis|3|||
146647449|NCT01224782|528886898|FG000|Overall Study|Change of Treatment|1|||
146647450|NCT01224782|528886898|FG000|Overall Study|Financial Reasons|1|||
146647451|NCT01224782|528886898|FG000|Overall Study|Deterioration|1|||
146647452|NCT01224782|528886898|FG000|Overall Study|Transplantation|1|||
146647453|NCT00441116|528886899|FG000|Overall Study|Adverse Event|1|||
146647454|NCT00441116|528886900|FG001|Overall Study|Adverse Event|1|||
146647455|NCT00441116|528886899|FG000|Overall Study|Withdrawal by Subject|1|||
146647456|NCT00441116|528886900|FG001|Overall Study|Withdrawal by Subject|0|||
146647457|NCT00441116|528886899|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
146647458|NCT00441116|528886900|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
146647459|NCT02925338|528886901|FG000|Overall Study|Death|0|||
146647460|NCT02925338|528886902|FG001|Overall Study|Death|2|||
146647461|NCT02925338|528886903|FG002|Overall Study|Death|1|||
146647462|NCT02925338|528886904|FG003|Overall Study|Death|0|||
146647463|NCT02925338|528886905|FG004|Overall Study|Death|0|||
146647464|NCT02925338|528886901|FG000|Overall Study|Lost to Follow-up|30|||
146647465|NCT02925338|528886902|FG001|Overall Study|Lost to Follow-up|10|||
146647466|NCT02925338|528886903|FG002|Overall Study|Lost to Follow-up|1|||
146647467|NCT02925338|528886904|FG003|Overall Study|Lost to Follow-up|16|||
146647468|NCT02925338|528886905|FG004|Overall Study|Lost to Follow-up|3|||
146647469|NCT02925338|528886901|FG000|Overall Study|Withdrawal by Subject|3|||
146647470|NCT02925338|528886902|FG001|Overall Study|Withdrawal by Subject|0|||
146647471|NCT02925338|528886903|FG002|Overall Study|Withdrawal by Subject|3|||
146647472|NCT02925338|528886904|FG003|Overall Study|Withdrawal by Subject|2|||
146647473|NCT02925338|528886905|FG004|Overall Study|Withdrawal by Subject|2|||
146647474|NCT02925338|528886901|FG000|Overall Study|Missing|38|||
146647475|NCT02925338|528886902|FG001|Overall Study|Missing|27|||
146647476|NCT02925338|528886903|FG002|Overall Study|Missing|0|||
146647477|NCT02925338|528886904|FG003|Overall Study|Missing|3|||
146647478|NCT02925338|528886905|FG004|Overall Study|Missing|2|||
146647479|NCT02925338|528886901|FG000|Overall Study|Participant's Decision|11|||
146647480|NCT02925338|528886902|FG001|Overall Study|Participant's Decision|7|||
146647481|NCT02925338|528886903|FG002|Overall Study|Participant's Decision|3|||
146647482|NCT02925338|528886904|FG003|Overall Study|Participant's Decision|8|||
146647483|NCT02925338|528886905|FG004|Overall Study|Participant's Decision|1|||
146647484|NCT02925338|528886901|FG000|Overall Study|Treatment Discontinuation|144|||
146647485|NCT02925338|528886902|FG001|Overall Study|Treatment Discontinuation|65|||
146647486|NCT02925338|528886903|FG002|Overall Study|Treatment Discontinuation|56|||
146647487|NCT02925338|528886904|FG003|Overall Study|Treatment Discontinuation|131|||
146647488|NCT02925338|528886905|FG004|Overall Study|Treatment Discontinuation|22|||
146647489|NCT00548184|528886906|FG000|Overall Study|Adverse Event|3|||
146647490|NCT00548184|528886906|FG000|Overall Study|took other drug|1|||
146647491|NCT00548184|528886906|FG000|Overall Study|Found Her2 negative|1|||
146647492|NCT02395172|528886907|FG000|Overall Study|Participants randomized but not treated|3|||
146647493|NCT02395172|528886908|FG001|Overall Study|Participants randomized but not treated|31|||
146647494|NCT00029146|528886911|FG000|Overall Study|Lost to Follow-up|2|||
146647495|NCT00029146|528886912|FG001|Overall Study|Lost to Follow-up|1|||
146647496|NCT00946985|528886913|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
146647497|NCT00946985|528886913|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
146647498|NCT00946985|528886913|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
146647499|NCT00946985|528886913|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
146647500|NCT00946985|528886913|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
146647501|NCT00946985|528886913|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
146647502|NCT00946985|528886913|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
146647503|NCT00946985|528886913|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
146647504|NCT00946985|528886913|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
146647505|NCT01546623|528886914|FG000|Overall Study|Adverse Event|2|||
146647506|NCT01546623|528886915|FG001|Overall Study|Adverse Event|3|||
146647507|NCT01546623|528886914|FG000|Overall Study|Major Protocol Deviation|1|||
146647508|NCT01546623|528886915|FG001|Overall Study|Major Protocol Deviation|1|||
146647509|NCT01546623|528886914|FG000|Overall Study|High Prostate specific antigen|2|||
146647510|NCT01546623|528886915|FG001|Overall Study|High Prostate specific antigen|1|||
146647511|NCT01546623|528886914|FG000|Overall Study|Did Not Receive Study Drug|1|||
146647512|NCT01546623|528886915|FG001|Overall Study|Did Not Receive Study Drug|1|||
146647513|NCT01590758|528886916|FG000|Overall Study|Withdrawal by Subject|0|||
146647514|NCT01590758|528886917|FG001|Overall Study|Withdrawal by Subject|3|||
146647515|NCT01590758|528886916|FG000|Overall Study|Physician Decision|1|||
146647516|NCT01590758|528886917|FG001|Overall Study|Physician Decision|2|||
146647517|NCT01590758|528886916|FG000|Overall Study|Lost to Follow-up|4|||
146647518|NCT01590758|528886917|FG001|Overall Study|Lost to Follow-up|2|||
146647519|NCT04525885|528886918|FG000|Overall Study|Screen Failure|1|||
146647520|NCT04525885|528886919|FG001|Overall Study|Screen Failure|0|||
146502172|NCT01953601|528341837|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
146502173|NCT01953601|528341835|FG000|Part 1 (Base Study)|Physician Decision|3|||
146502174|NCT01953601|528341836|FG001|Part 1 (Base Study)|Physician Decision|7|||
146502175|NCT01953601|528341837|FG002|Part 1 (Base Study)|Physician Decision|4|||
146647521|NCT04525885|528886920|FG002|Overall Study|Screen Failure|0|||
146647522|NCT04525885|528886918|FG000|Overall Study|Withdrawal by Subject|14|||
146502176|NCT01953601|528341835|FG000|Part 1 (Base Study)|Screen failure|1|||
146502177|NCT01953601|528341836|FG001|Part 1 (Base Study)|Screen failure|0|||
146502178|NCT01953601|528341837|FG002|Part 1 (Base Study)|Screen failure|1|||
146502179|NCT01953601|528341835|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
146502180|NCT01953601|528341836|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
146647523|NCT04525885|528886919|FG001|Overall Study|Withdrawal by Subject|6|||
146647524|NCT04525885|528886920|FG002|Overall Study|Withdrawal by Subject|20|||
146647525|NCT04525885|528886918|FG000|Overall Study|Physician Decision|1|||
146647526|NCT04525885|528886919|FG001|Overall Study|Physician Decision|0|||
146647527|NCT04525885|528886920|FG002|Overall Study|Physician Decision|1|||
146647528|NCT02717832|528886921|FG000|Overall Study|Inability to place IV|3|||
146647529|NCT00978757|528886924|FG000|Overall Study|Physician Decision|1|||
146647530|NCT00978757|528886925|FG001|Overall Study|Physician Decision|3|||
146647531|NCT01185353|528886926|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
146647532|NCT01185353|528886927|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
146647533|NCT01185353|528886928|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
146647534|NCT01185353|528886929|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
146647535|NCT01185353|528886930|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
146647536|NCT01185353|528886931|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
146647537|NCT01185353|528886932|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
146647538|NCT01185353|528886933|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
146647539|NCT01185353|528886934|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
146647540|NCT01185353|528886935|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
146647541|NCT01185353|528886926|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146647542|NCT01185353|528886927|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146647543|NCT01185353|528886928|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146647544|NCT01185353|528886929|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146647545|NCT01185353|528886930|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
146647546|NCT01185353|528886931|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146647547|NCT01185353|528886932|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146647548|NCT01185353|528886933|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146647549|NCT01185353|528886934|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146647550|NCT01185353|528886935|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146647551|NCT01185353|528886926|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
146647552|NCT01185353|528886927|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
146647553|NCT01185353|528886928|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
146647554|NCT01185353|528886929|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
146647555|NCT01185353|528886930|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
146647556|NCT01185353|528886931|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
146647557|NCT01185353|528886932|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
146647558|NCT01185353|528886933|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
146647559|NCT01185353|528886934|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
146647560|NCT01185353|528886935|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
146647561|NCT01185353|528886926|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
146647562|NCT01185353|528886927|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
146647563|NCT01185353|528886928|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
146647564|NCT01185353|528886929|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
146647565|NCT01185353|528886930|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
146647566|NCT01185353|528886931|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
146647567|NCT01185353|528886932|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
146502181|NCT01953601|528341837|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
146974260|NCT02392559|530067498|FG000|Overall Study|Withdrawal by Subject|0|||
146502182|NCT01953601|528341835|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
146974261|NCT02392559|530067499|FG001|Overall Study|Withdrawal by Subject|1|||
146502183|NCT01953601|528341836|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
146502184|NCT01953601|528341837|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
146502185|NCT01953601|528341835|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
146502186|NCT01953601|528341836|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
146502187|NCT01953601|528341837|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
146502188|NCT01953601|528341835|FG000|Part 1 (Base Study)|Subject moved|2|||
146502189|NCT01953601|528341836|FG001|Part 1 (Base Study)|Subject moved|2|||
146502190|NCT01953601|528341837|FG002|Part 1 (Base Study)|Subject moved|1|||
146502191|NCT01953601|528341835|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
146502192|NCT01953601|528341836|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
146502193|NCT01953601|528341837|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
146502194|NCT01953601|528341835|FG000|Part 2 (Extension Study)|Adverse Event|1|||
146502195|NCT01953601|528341836|FG001|Part 2 (Extension Study)|Adverse Event|1|||
146502196|NCT01953601|528341837|FG002|Part 2 (Extension Study)|Adverse Event|10|||
146502197|NCT01953601|528341835|FG000|Part 2 (Extension Study)|Death|0|||
146502198|NCT01953601|528341836|FG001|Part 2 (Extension Study)|Death|3|||
146502199|NCT01953601|528341837|FG002|Part 2 (Extension Study)|Death|0|||
146502200|NCT01953601|528341835|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
146502201|NCT01953601|528341836|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
146502202|NCT01953601|528341837|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
146502203|NCT01953601|528341835|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
146502204|NCT01953601|528341836|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
146502205|NCT01953601|528341837|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
146502206|NCT01953601|528341835|FG000|Part 2 (Extension Study)|Physician Decision|2|||
146502207|NCT01953601|528341836|FG001|Part 2 (Extension Study)|Physician Decision|0|||
146502208|NCT01953601|528341837|FG002|Part 2 (Extension Study)|Physician Decision|2|||
146502209|NCT01953601|528341835|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
146502210|NCT01953601|528341836|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
146502211|NCT01953601|528341837|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
146502212|NCT01953601|528341835|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
146502213|NCT01953601|528341836|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
146502214|NCT01953601|528341837|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
146502215|NCT01953601|528341835|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
146502216|NCT01953601|528341836|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
146502217|NCT01953601|528341837|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
146502218|NCT01953601|528341835|FG000|Part 2 (Extension Study)|Subject moved|0|||
146502219|NCT01953601|528341836|FG001|Part 2 (Extension Study)|Subject moved|0|||
146502220|NCT01953601|528341837|FG002|Part 2 (Extension Study)|Subject moved|1|||
146502221|NCT01953601|528341835|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
146502222|NCT01953601|528341836|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
146502223|NCT01953601|528341837|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
146502224|NCT04310397|528341844|FG000|Overall Study|Lack of Efficacy|3|||
146502225|NCT04310397|528341844|FG000|Overall Study|Withdrawal by Subject|1|||
146502226|NCT00614523|528341845|FG000|Overall Study|Adverse Event|4|||
146502227|NCT00614523|528341846|FG001|Overall Study|Adverse Event|20|||
146502228|NCT00614523|528341845|FG000|Overall Study|Death|5|||
146502229|NCT00614523|528341846|FG001|Overall Study|Death|8|||
146502230|NCT00614523|528341845|FG000|Overall Study|Lack of Efficacy|9|||
146502231|NCT00614523|528341846|FG001|Overall Study|Lack of Efficacy|11|||
146502232|NCT00614523|528341845|FG000|Overall Study|Lost to Follow-up|0|||
146502233|NCT00614523|528341846|FG001|Overall Study|Lost to Follow-up|1|||
146502234|NCT00614523|528341845|FG000|Overall Study|Protocol Violation|3|||
146502235|NCT00614523|528341846|FG001|Overall Study|Protocol Violation|2|||
146502236|NCT00614523|528341845|FG000|Overall Study|Withdrawal by Subject|12|||
146502237|NCT00614523|528341846|FG001|Overall Study|Withdrawal by Subject|22|||
146502238|NCT00614523|528341845|FG000|Overall Study|Other|6|||
146502239|NCT00614523|528341846|FG001|Overall Study|Other|11|||
146974262|NCT00752895|530067504|FG000|Overall Study|Withdrawal by Subject|8|||
146502240|NCT00614523|528341845|FG000|Overall Study|Ineligibility Determined|1|||
146502241|NCT00614523|528341846|FG001|Overall Study|Ineligibility Determined|2|||
146502242|NCT00614523|528341845|FG000|Overall Study|Disease Progression|0|||
146502243|NCT00614523|528341846|FG001|Overall Study|Disease Progression|8|||
146502244|NCT00614523|528341845|FG000|Overall Study|Administrative Decision|23|||
146502245|NCT00614523|528341846|FG001|Overall Study|Administrative Decision|46|||
146502246|NCT00723255|528341847|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
146502247|NCT00723255|528341847|FG000|Overall Study|Ineligible: Second primary|1|||
146502248|NCT00723255|528341847|FG000|Overall Study|Ineligible: Wrong Primary|2|||
146502249|NCT03962790|528341848|FG000|Period 1|Adverse Event|0|||
146502250|NCT03962790|528341849|FG001|Period 1|Adverse Event|1|||
146502251|NCT03962790|528341848|FG000|Period 1|Failed to meet all eligibility criteria|1|||
146974263|NCT00752895|530067505|FG001|Overall Study|Withdrawal by Subject|3|||
146502252|NCT03962790|528341849|FG001|Period 1|Failed to meet all eligibility criteria|1|||
146502253|NCT03962790|528341848|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
146502254|NCT03962790|528341849|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
146502255|NCT03962790|528341848|FG000|Period 1|Withdrawal by Subject|1|||
146502256|NCT03962790|528341849|FG001|Period 1|Withdrawal by Subject|0|||
146502257|NCT03452488|528341856|FG000|Overall Study|Adverse Event|4|||
146502258|NCT03452488|528341857|FG001|Overall Study|Adverse Event|6|||
146502259|NCT03452488|528341858|FG002|Overall Study|Adverse Event|1|||
146502260|NCT03452488|528341856|FG000|Overall Study|Death|0|||
146502261|NCT03452488|528341857|FG001|Overall Study|Death|0|||
146502262|NCT03452488|528341858|FG002|Overall Study|Death|1|||
146502263|NCT03452488|528341856|FG000|Overall Study|Lost to Follow-up|1|||
146502264|NCT03452488|528341857|FG001|Overall Study|Lost to Follow-up|2|||
146502265|NCT03452488|528341858|FG002|Overall Study|Lost to Follow-up|0|||
146502266|NCT03452488|528341856|FG000|Overall Study|PI Decision|1|||
146502267|NCT03452488|528341857|FG001|Overall Study|PI Decision|0|||
146502268|NCT03452488|528341858|FG002|Overall Study|PI Decision|0|||
146502269|NCT03452488|528341856|FG000|Overall Study|Withdrew consent|4|||
146502270|NCT03452488|528341857|FG001|Overall Study|Withdrew consent|2|||
146502271|NCT03452488|528341858|FG002|Overall Study|Withdrew consent|2|||
146502272|NCT03452488|528341856|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
146502273|NCT03452488|528341857|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
146502274|NCT03452488|528341858|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
146502275|NCT03452488|528341856|FG000|Overall Study|Other|0|||
146502276|NCT03452488|528341857|FG001|Overall Study|Other|2|||
146502277|NCT03452488|528341858|FG002|Overall Study|Other|2|||
146502278|NCT02980341|528341861|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
146502279|NCT02980341|528341862|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
146502280|NCT02980341|528341863|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
146502281|NCT02980341|528341864|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
146502282|NCT02980341|528341865|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
146502283|NCT02980341|528341866|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
146502284|NCT02980341|528341867|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
146502285|NCT02980341|528341868|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
146502286|NCT02980341|528341869|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
146502287|NCT02980341|528341870|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
146502288|NCT02980341|528341871|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
146502289|NCT02980341|528341861|FG000|Dose Escalation|Clinical progression|0|||
146502290|NCT02980341|528341862|FG001|Dose Escalation|Clinical progression|0|||
146502291|NCT02980341|528341863|FG002|Dose Escalation|Clinical progression|2|||
146502292|NCT02980341|528341864|FG003|Dose Escalation|Clinical progression|1|||
146502293|NCT02980341|528341865|FG004|Dose Escalation|Clinical progression|0|||
146502294|NCT02980341|528341866|FG005|Dose Escalation|Clinical progression|0|||
146502295|NCT02980341|528341867|FG006|Dose Escalation|Clinical progression|0|||
146502296|NCT02980341|528341868|FG007|Dose Escalation|Clinical progression|0|||
146502297|NCT02980341|528341869|FG008|Dose Escalation|Clinical progression|0|||
146502298|NCT02980341|528341870|FG009|Dose Escalation|Clinical progression|0|||
146502299|NCT02980341|528341871|FG010|Dose Escalation|Clinical progression|0|||
146502300|NCT02980341|528341861|FG000|Dose Escalation|Adverse Event|0|||
146502301|NCT02980341|528341862|FG001|Dose Escalation|Adverse Event|0|||
146502302|NCT02980341|528341863|FG002|Dose Escalation|Adverse Event|1|||
146502303|NCT02980341|528341864|FG003|Dose Escalation|Adverse Event|2|||
146502304|NCT02980341|528341865|FG004|Dose Escalation|Adverse Event|2|||
146502305|NCT02980341|528341866|FG005|Dose Escalation|Adverse Event|0|||
146502306|NCT02980341|528341867|FG006|Dose Escalation|Adverse Event|0|||
146502307|NCT02980341|528341868|FG007|Dose Escalation|Adverse Event|0|||
146502308|NCT02980341|528341869|FG008|Dose Escalation|Adverse Event|0|||
146502309|NCT02980341|528341870|FG009|Dose Escalation|Adverse Event|0|||
146502310|NCT02980341|528341871|FG010|Dose Escalation|Adverse Event|0|||
146502311|NCT02980341|528341861|FG000|Dose Escalation|Withdrawal by Subject|0|||
146502312|NCT02980341|528341862|FG001|Dose Escalation|Withdrawal by Subject|0|||
146502313|NCT02980341|528341863|FG002|Dose Escalation|Withdrawal by Subject|1|||
146502314|NCT02980341|528341864|FG003|Dose Escalation|Withdrawal by Subject|0|||
146502315|NCT02980341|528341865|FG004|Dose Escalation|Withdrawal by Subject|0|||
146502316|NCT02980341|528341866|FG005|Dose Escalation|Withdrawal by Subject|0|||
146502317|NCT02980341|528341867|FG006|Dose Escalation|Withdrawal by Subject|0|||
146502318|NCT02980341|528341868|FG007|Dose Escalation|Withdrawal by Subject|0|||
146502319|NCT02980341|528341869|FG008|Dose Escalation|Withdrawal by Subject|0|||
146502320|NCT02980341|528341870|FG009|Dose Escalation|Withdrawal by Subject|0|||
146502321|NCT02980341|528341871|FG010|Dose Escalation|Withdrawal by Subject|0|||
146502322|NCT02980341|528341861|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
146502323|NCT02980341|528341862|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
146502324|NCT02980341|528341863|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
146502325|NCT02980341|528341864|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
146502326|NCT02980341|528341865|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
146502327|NCT02980341|528341866|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
146502328|NCT02980341|528341867|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
146502329|NCT02980341|528341868|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
146502330|NCT02980341|528341869|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
146502331|NCT02980341|528341870|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
146502332|NCT02980341|528341871|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
146502333|NCT02980341|528341861|FG000|Dose Escalation|Due to investigator's decision|0|||
146502334|NCT02980341|528341862|FG001|Dose Escalation|Due to investigator's decision|0|||
146502335|NCT02980341|528341863|FG002|Dose Escalation|Due to investigator's decision|0|||
146502336|NCT02980341|528341864|FG003|Dose Escalation|Due to investigator's decision|0|||
146502337|NCT02980341|528341865|FG004|Dose Escalation|Due to investigator's decision|1|||
146502338|NCT02980341|528341866|FG005|Dose Escalation|Due to investigator's decision|0|||
146502339|NCT02980341|528341867|FG006|Dose Escalation|Due to investigator's decision|0|||
146502340|NCT02980341|528341868|FG007|Dose Escalation|Due to investigator's decision|0|||
146502341|NCT02980341|528341869|FG008|Dose Escalation|Due to investigator's decision|0|||
146502342|NCT02980341|528341870|FG009|Dose Escalation|Due to investigator's decision|0|||
146502343|NCT02980341|528341871|FG010|Dose Escalation|Due to investigator's decision|0|||
146502344|NCT02980341|528341861|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
146502345|NCT02980341|528341862|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
146502346|NCT02980341|528341863|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
146647568|NCT01185353|528886933|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
146647569|NCT01185353|528886934|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
146647570|NCT01185353|528886935|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
146647571|NCT01185353|528886926|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146647572|NCT01185353|528886927|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146502347|NCT02980341|528341864|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
146502348|NCT02980341|528341865|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
146502349|NCT02980341|528341866|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
146502350|NCT02980341|528341867|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
146502351|NCT02980341|528341868|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
146566703|NCT00652743|528587902|FG000|Months 12-18|Lost to Follow-up|1|||
146647573|NCT01185353|528886928|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146566704|NCT00652743|528587903|FG001|Months 12-18|Lost to Follow-up|2|||
146647574|NCT01185353|528886929|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146647575|NCT01185353|528886930|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
146647576|NCT01185353|528886931|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146647577|NCT01185353|528886932|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146647578|NCT01185353|528886933|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146647579|NCT01185353|528886934|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146647580|NCT01185353|528886935|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146647581|NCT01185353|528886926|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
146647582|NCT01185353|528886927|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
146647583|NCT01185353|528886928|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
146647584|NCT01185353|528886929|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
146647585|NCT01185353|528886930|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
146647586|NCT01185353|528886931|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
146647587|NCT01185353|528886932|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
146647588|NCT01185353|528886933|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
146647589|NCT01185353|528886934|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
146647590|NCT01185353|528886935|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
146647591|NCT01185353|528886926|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
146647592|NCT01185353|528886927|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
146647593|NCT01185353|528886928|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
146647594|NCT01185353|528886929|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
146502352|NCT02980341|528341869|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
146502353|NCT02980341|528341870|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
146502354|NCT02980341|528341871|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
146566705|NCT00652743|528587904|FG002|Months 12-18|Lost to Follow-up|7|||
146566706|NCT00652743|528587902|FG000|Months 24-30|Other|5|||
146566707|NCT00652743|528587903|FG001|Months 24-30|Other|1|||
146566708|NCT00652743|528587904|FG002|Months 24-30|Other|11|||
146566709|NCT00652743|528587902|FG000|Months 36-42|Serious Adverse Events|0|||
146566710|NCT00652743|528587903|FG001|Months 36-42|Serious Adverse Events|1|||
146566711|NCT00652743|528587904|FG002|Months 36-42|Serious Adverse Events|1|||
146566712|NCT00652743|528587902|FG000|Months 36-42|Withdrawal by Subject|1|||
146502355|NCT02980341|528341861|FG000|Dose Finding|Adverse Event|0|||
146566713|NCT00652743|528587903|FG001|Months 36-42|Withdrawal by Subject|1|||
146566714|NCT00652743|528587904|FG002|Months 36-42|Withdrawal by Subject|0|||
146647595|NCT01185353|528886930|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
146912637|NCT02546856|529843116|FG000|4 Months Evaluation|Lost to Follow-up|3|||
146566715|NCT00652743|528587902|FG000|Months 36-42|Lost to Follow-up|0|||
146647596|NCT01185353|528886931|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
146647597|NCT01185353|528886932|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
146502356|NCT02980341|528341862|FG001|Dose Finding|Adverse Event|0|||
146502357|NCT02980341|528341863|FG002|Dose Finding|Adverse Event|0|||
146502358|NCT02980341|528341864|FG003|Dose Finding|Adverse Event|0|||
146502359|NCT02980341|528341865|FG004|Dose Finding|Adverse Event|0|||
146502360|NCT02980341|528341866|FG005|Dose Finding|Adverse Event|3|||
146502361|NCT02980341|528341867|FG006|Dose Finding|Adverse Event|0|||
146502362|NCT02980341|528341868|FG007|Dose Finding|Adverse Event|0|||
146502363|NCT02980341|528341869|FG008|Dose Finding|Adverse Event|0|||
146502364|NCT02980341|528341870|FG009|Dose Finding|Adverse Event|0|||
146502365|NCT02980341|528341871|FG010|Dose Finding|Adverse Event|0|||
146502366|NCT02980341|528341861|FG000|Dose Finding|Withdrawal by Subject|0|||
146502367|NCT02980341|528341862|FG001|Dose Finding|Withdrawal by Subject|0|||
146502368|NCT02980341|528341863|FG002|Dose Finding|Withdrawal by Subject|0|||
146502369|NCT02980341|528341864|FG003|Dose Finding|Withdrawal by Subject|0|||
146502370|NCT02980341|528341865|FG004|Dose Finding|Withdrawal by Subject|0|||
146502371|NCT02980341|528341866|FG005|Dose Finding|Withdrawal by Subject|1|||
146502372|NCT02980341|528341867|FG006|Dose Finding|Withdrawal by Subject|1|||
146502373|NCT02980341|528341868|FG007|Dose Finding|Withdrawal by Subject|0|||
146502374|NCT02980341|528341869|FG008|Dose Finding|Withdrawal by Subject|0|||
146502375|NCT02980341|528341870|FG009|Dose Finding|Withdrawal by Subject|0|||
146502376|NCT02980341|528341871|FG010|Dose Finding|Withdrawal by Subject|0|||
146502377|NCT02980341|528341861|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
146502378|NCT02980341|528341862|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
146502379|NCT02980341|528341863|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
146502380|NCT02980341|528341864|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
146502381|NCT02980341|528341865|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
146502382|NCT02980341|528341866|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
146647598|NCT01185353|528886933|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
146647599|NCT01185353|528886934|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
146502383|NCT02980341|528341867|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
146502384|NCT02980341|528341868|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
146502385|NCT02980341|528341869|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
146502386|NCT02980341|528341870|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
146502387|NCT02980341|528341871|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
146502388|NCT02980341|528341861|FG000|Dose Expansion|Clinical progression|0|||
146502389|NCT02980341|528341862|FG001|Dose Expansion|Clinical progression|0|||
146502390|NCT02980341|528341863|FG002|Dose Expansion|Clinical progression|0|||
146502391|NCT02980341|528341864|FG003|Dose Expansion|Clinical progression|0|||
146502392|NCT02980341|528341865|FG004|Dose Expansion|Clinical progression|0|||
146502393|NCT02980341|528341866|FG005|Dose Expansion|Clinical progression|0|||
146502394|NCT02980341|528341867|FG006|Dose Expansion|Clinical progression|0|||
146502395|NCT02980341|528341868|FG007|Dose Expansion|Clinical progression|4|||
146502396|NCT02980341|528341869|FG008|Dose Expansion|Clinical progression|3|||
146502397|NCT02980341|528341870|FG009|Dose Expansion|Clinical progression|1|||
146502398|NCT02980341|528341871|FG010|Dose Expansion|Clinical progression|4|||
146502399|NCT02980341|528341861|FG000|Dose Expansion|Adverse Event|0|||
146502400|NCT02980341|528341862|FG001|Dose Expansion|Adverse Event|0|||
146502401|NCT02980341|528341863|FG002|Dose Expansion|Adverse Event|0|||
146502402|NCT02980341|528341864|FG003|Dose Expansion|Adverse Event|0|||
146502403|NCT02980341|528341865|FG004|Dose Expansion|Adverse Event|0|||
146502404|NCT02980341|528341866|FG005|Dose Expansion|Adverse Event|0|||
146502405|NCT02980341|528341867|FG006|Dose Expansion|Adverse Event|0|||
146502406|NCT02980341|528341868|FG007|Dose Expansion|Adverse Event|3|||
146502407|NCT02980341|528341869|FG008|Dose Expansion|Adverse Event|0|||
146502408|NCT02980341|528341870|FG009|Dose Expansion|Adverse Event|1|||
146502409|NCT02980341|528341871|FG010|Dose Expansion|Adverse Event|3|||
146502410|NCT02980341|528341861|FG000|Dose Expansion|Death|0|||
146502411|NCT02980341|528341862|FG001|Dose Expansion|Death|0|||
146502412|NCT02980341|528341863|FG002|Dose Expansion|Death|0|||
146502413|NCT02980341|528341864|FG003|Dose Expansion|Death|0|||
146502414|NCT02980341|528341865|FG004|Dose Expansion|Death|0|||
146502415|NCT02980341|528341866|FG005|Dose Expansion|Death|0|||
146502416|NCT02980341|528341867|FG006|Dose Expansion|Death|0|||
146502417|NCT02980341|528341868|FG007|Dose Expansion|Death|0|||
146502418|NCT02980341|528341869|FG008|Dose Expansion|Death|2|||
146502419|NCT02980341|528341870|FG009|Dose Expansion|Death|1|||
146502420|NCT02980341|528341871|FG010|Dose Expansion|Death|0|||
146502421|NCT02980341|528341861|FG000|Dose Expansion|Withdrawal by Subject|0|||
146647600|NCT01185353|528886935|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
146502422|NCT02980341|528341862|FG001|Dose Expansion|Withdrawal by Subject|0|||
146502423|NCT02980341|528341863|FG002|Dose Expansion|Withdrawal by Subject|0|||
146502424|NCT02980341|528341864|FG003|Dose Expansion|Withdrawal by Subject|0|||
146502425|NCT02980341|528341865|FG004|Dose Expansion|Withdrawal by Subject|0|||
146502426|NCT02980341|528341866|FG005|Dose Expansion|Withdrawal by Subject|0|||
146647601|NCT01185353|528886926|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
146647602|NCT01185353|528886927|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
146647603|NCT01185353|528886928|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
146647604|NCT01185353|528886929|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
146647605|NCT01185353|528886930|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
146647606|NCT01185353|528886931|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
146647607|NCT01185353|528886932|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
146647608|NCT01185353|528886933|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
146647609|NCT01185353|528886934|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
146647610|NCT01185353|528886935|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
146647611|NCT01185353|528886926|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
146647612|NCT01185353|528886927|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
146647613|NCT01185353|528886928|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
146647614|NCT01185353|528886929|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
146647615|NCT01185353|528886930|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
146647616|NCT01185353|528886931|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
146647617|NCT01185353|528886932|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
146647618|NCT01185353|528886933|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
146647619|NCT01185353|528886934|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
146647620|NCT01185353|528886935|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
146647621|NCT01185353|528886926|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
146647622|NCT01185353|528886927|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
146647623|NCT01185353|528886928|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
146647624|NCT01185353|528886929|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
146647625|NCT01185353|528886930|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
146647626|NCT01185353|528886931|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
146647627|NCT01185353|528886932|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
146647628|NCT01185353|528886933|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
146647629|NCT01185353|528886934|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
146647630|NCT01185353|528886935|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
146647631|NCT01185353|528886926|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146647632|NCT01185353|528886927|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146647633|NCT01185353|528886928|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146647634|NCT01185353|528886929|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146647635|NCT01185353|528886930|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146647636|NCT01185353|528886931|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146647637|NCT01185353|528886932|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
146647638|NCT01185353|528886933|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146647639|NCT01185353|528886934|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146647640|NCT01185353|528886935|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146647641|NCT01185353|528886926|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
146647642|NCT01185353|528886927|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
146647643|NCT01185353|528886928|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
146647644|NCT01185353|528886929|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
146647645|NCT01185353|528886930|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
146647646|NCT01185353|528886931|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
146647647|NCT01185353|528886932|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
146647648|NCT01185353|528886933|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
146647649|NCT01185353|528886934|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
146647650|NCT01185353|528886935|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
146647651|NCT01185353|528886926|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
146647652|NCT01185353|528886927|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
146647653|NCT01185353|528886928|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
146647654|NCT01185353|528886929|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
146647655|NCT01185353|528886930|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
146647656|NCT01185353|528886931|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
146647657|NCT01185353|528886932|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
146647658|NCT01185353|528886933|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
146647659|NCT01185353|528886934|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
146647660|NCT01185353|528886935|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
146647661|NCT01185353|528886926|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
146647662|NCT01185353|528886927|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
146647663|NCT01185353|528886928|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
146647664|NCT01185353|528886929|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
146647665|NCT01185353|528886930|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
146647666|NCT01185353|528886931|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
146647667|NCT01185353|528886932|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
146647668|NCT01185353|528886933|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
146647669|NCT01185353|528886934|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
146647670|NCT01185353|528886935|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
146647671|NCT01185353|528886926|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146647672|NCT01185353|528886927|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146647673|NCT01185353|528886928|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146647674|NCT01185353|528886929|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146647675|NCT01185353|528886930|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146647676|NCT01185353|528886931|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146647677|NCT01185353|528886932|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146647678|NCT01185353|528886933|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146647679|NCT01185353|528886934|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
146647680|NCT01185353|528886935|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146647681|NCT01185353|528886926|FG000|Part C (Weeks 24 Through 76)|Death|0|||
146647682|NCT01185353|528886927|FG001|Part C (Weeks 24 Through 76)|Death|0|||
146647683|NCT01185353|528886928|FG002|Part C (Weeks 24 Through 76)|Death|0|||
146647684|NCT01185353|528886929|FG003|Part C (Weeks 24 Through 76)|Death|0|||
146647685|NCT01185353|528886930|FG004|Part C (Weeks 24 Through 76)|Death|0|||
146647686|NCT01185353|528886931|FG005|Part C (Weeks 24 Through 76)|Death|0|||
146647687|NCT01185353|528886932|FG006|Part C (Weeks 24 Through 76)|Death|0|||
146647688|NCT01185353|528886933|FG007|Part C (Weeks 24 Through 76)|Death|0|||
146647689|NCT01185353|528886934|FG008|Part C (Weeks 24 Through 76)|Death|0|||
146647690|NCT01185353|528886935|FG009|Part C (Weeks 24 Through 76)|Death|1|||
146647691|NCT01185353|528886926|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146647692|NCT01185353|528886927|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146647693|NCT01185353|528886928|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146647694|NCT01185353|528886929|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146647695|NCT01185353|528886930|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146647696|NCT01185353|528886931|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146647697|NCT01185353|528886932|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146647698|NCT01185353|528886933|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146647699|NCT01185353|528886934|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146647700|NCT01185353|528886935|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
146647701|NCT01185353|528886926|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146647702|NCT01185353|528886927|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146647703|NCT01185353|528886928|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146647704|NCT01185353|528886929|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146647705|NCT01185353|528886930|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146647706|NCT01185353|528886931|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146647707|NCT01185353|528886932|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146647708|NCT01185353|528886933|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146647709|NCT01185353|528886934|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146647710|NCT01185353|528886935|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
146647711|NCT01185353|528886926|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
146647712|NCT01185353|528886927|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
146647713|NCT01185353|528886928|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
146647714|NCT01185353|528886929|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
146647715|NCT01185353|528886930|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
146647716|NCT01185353|528886931|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
146647717|NCT01185353|528886932|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
146647718|NCT01185353|528886933|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
146647719|NCT01185353|528886934|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
146647720|NCT01185353|528886935|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
146647721|NCT01185353|528886926|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
146647722|NCT01185353|528886927|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
146647723|NCT01185353|528886928|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
146647724|NCT01185353|528886929|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
146647725|NCT01185353|528886930|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
146647726|NCT01185353|528886931|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
146647727|NCT01185353|528886932|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
146647728|NCT01185353|528886933|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
146647729|NCT01185353|528886934|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
146974264|NCT00314262|530067506|FG000|Overall Study|Adverse Event|2|||
146647730|NCT01185353|528886935|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
146647731|NCT01185353|528886926|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
146647732|NCT01185353|528886927|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
146647733|NCT01185353|528886928|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
146647734|NCT01185353|528886929|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
146647735|NCT01185353|528886930|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
146647736|NCT01185353|528886931|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
146647737|NCT01185353|528886932|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
146647738|NCT01185353|528886933|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
146647739|NCT01185353|528886934|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
146647740|NCT01185353|528886935|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
146647741|NCT01185353|528886926|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
146647742|NCT01185353|528886927|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
146647743|NCT01185353|528886928|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
146647744|NCT01185353|528886929|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
146647745|NCT01185353|528886930|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
146647746|NCT01185353|528886931|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
146647747|NCT01185353|528886932|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
146647748|NCT01185353|528886933|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
146647749|NCT01185353|528886934|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
146647750|NCT01185353|528886935|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
146647751|NCT02270944|528886939|FG000|Overall Study|Lost to Follow-up|9|||
146647752|NCT02270944|528886940|FG001|Overall Study|Lost to Follow-up|4|||
146647753|NCT02270944|528886939|FG000|Overall Study|Withdrawal by Subject|2|||
146647754|NCT02270944|528886940|FG001|Overall Study|Withdrawal by Subject|1|||
146647755|NCT01144299|528886941|FG000|Overall Study|Lost to Follow-up|1|||
146647756|NCT01144299|528886942|FG001|Overall Study|Lost to Follow-up|0|||
146647757|NCT01144299|528886941|FG000|Overall Study|Withdrawal by Subject|1|||
146769119|NCT03284957|529323413|FG004|Overall Study|Other|0|||
146769120|NCT03284957|529323414|FG005|Overall Study|Other|0|||
146769121|NCT03284957|529323415|FG006|Overall Study|Other|3|||
146769122|NCT03284957|529323416|FG007|Overall Study|Other|0|||
146502427|NCT02980341|528341867|FG006|Dose Expansion|Withdrawal by Subject|0|||
146502428|NCT02980341|528341868|FG007|Dose Expansion|Withdrawal by Subject|2|||
146502429|NCT02980341|528341869|FG008|Dose Expansion|Withdrawal by Subject|0|||
146502430|NCT02980341|528341870|FG009|Dose Expansion|Withdrawal by Subject|1|||
146502431|NCT02980341|528341871|FG010|Dose Expansion|Withdrawal by Subject|0|||
146502432|NCT02980341|528341861|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
146502433|NCT02980341|528341862|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
146502434|NCT02980341|528341863|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
146502435|NCT02980341|528341864|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
146502436|NCT02980341|528341865|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
146502437|NCT02980341|528341866|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
146502438|NCT02980341|528341867|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
146502439|NCT02980341|528341868|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
146502440|NCT02980341|528341869|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
146502441|NCT02980341|528341870|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
146502442|NCT02980341|528341871|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
146502443|NCT02980341|528341861|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
146502444|NCT02980341|528341862|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
146502445|NCT02980341|528341863|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
146502446|NCT02980341|528341864|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
146502447|NCT02980341|528341865|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
146502448|NCT02980341|528341866|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
146502449|NCT02980341|528341867|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
146502450|NCT02980341|528341868|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
146502451|NCT02980341|528341869|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
146502452|NCT02980341|528341870|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
146502453|NCT02980341|528341871|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
146502454|NCT02980341|528341861|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
146502455|NCT02980341|528341862|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
146502456|NCT02980341|528341863|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
146502457|NCT02980341|528341864|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
146502458|NCT02980341|528341865|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
146647758|NCT01144299|528886942|FG001|Overall Study|Withdrawal by Subject|0|||
146647759|NCT02342418|528886945|FG000|Overall Study|Adverse Event|0|||
146912638|NCT02546856|529843117|FG001|4 Months Evaluation|Lost to Follow-up|3|||
146647760|NCT02342418|528886946|FG001|Overall Study|Adverse Event|1|||
146647761|NCT04255394|528886947|FG000|Overall Study|Death|35|||
146647762|NCT04255394|528886948|FG001|Overall Study|Death|25|||
146769123|NCT03284957|529323417|FG008|Overall Study|Other|1|||
146769124|NCT03284957|529323418|FG009|Overall Study|Other|6|||
146647763|NCT04255394|528886947|FG000|Overall Study|Device removed|2|||
146647764|NCT04255394|528886948|FG001|Overall Study|Device removed|10|||
146647765|NCT04255394|528886947|FG000|Overall Study|Withdrawal by Subject|9|||
146647766|NCT04255394|528886948|FG001|Overall Study|Withdrawal by Subject|8|||
146647767|NCT04255394|528886947|FG000|Overall Study|Screen Failure/Not treated|12|||
146647768|NCT04255394|528886948|FG001|Overall Study|Screen Failure/Not treated|8|||
146647769|NCT04255394|528886947|FG000|Overall Study|Lost to Follow-up|123|||
146647770|NCT04255394|528886948|FG001|Overall Study|Lost to Follow-up|265|||
146647771|NCT04255394|528886947|FG000|Overall Study|Adverse Event|1|||
146647772|NCT04255394|528886948|FG001|Overall Study|Adverse Event|3|||
146647773|NCT03612856|528886958|FG000|Pre-dose Period|Physician Decision|0|||
146647774|NCT03612856|528886959|FG001|Pre-dose Period|Physician Decision|1|||
146647775|NCT03612856|528886960|FG002|Pre-dose Period|Physician Decision|1|||
146647776|NCT03612856|528886958|FG000|Pre-dose Period|Withdrawal by Subject|0|||
146647777|NCT03612856|528886959|FG001|Pre-dose Period|Withdrawal by Subject|1|||
146647778|NCT03612856|528886960|FG002|Pre-dose Period|Withdrawal by Subject|0|||
146502459|NCT02980341|528341866|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
146502460|NCT02980341|528341867|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
146502461|NCT02980341|528341868|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
146502462|NCT02980341|528341869|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
146502463|NCT02980341|528341870|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
146502464|NCT02980341|528341871|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
146502465|NCT02980341|528341861|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
146502466|NCT02980341|528341862|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
146502467|NCT02980341|528341863|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
146502468|NCT02980341|528341864|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
146502469|NCT02980341|528341865|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
146502470|NCT02980341|528341866|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
146502471|NCT02980341|528341867|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
146502472|NCT02980341|528341868|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
146502473|NCT02980341|528341869|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
146502474|NCT02980341|528341870|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
146502475|NCT02980341|528341871|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
146502476|NCT00749684|528341874|FG000|Overall Study|Death|1|||
146502477|NCT00749684|528341874|FG000|Overall Study|Adverse Event|27|||
146502478|NCT00749684|528341874|FG000|Overall Study|Participant's Wish|10|||
146502479|NCT00749684|528341874|FG000|Overall Study|Not Documented|1|||
146502480|NCT00749684|528341874|FG000|Overall Study|Progressive Desease|31|||
146502481|NCT00749684|528341874|FG000|Overall Study|Therapy according to protocol + AE|2|||
146502482|NCT00749684|528341874|FG000|Overall Study|AE+discontinuation on participants wish|1|||
146502483|NCT00749684|528341874|FG000|Overall Study|Missing|9|||
146502484|NCT04603482|528341875|FG000|Overall Study|Lost to Follow-up|15|||
146502485|NCT04603482|528341876|FG001|Overall Study|Lost to Follow-up|15|||
146502486|NCT04603482|528341877|FG002|Overall Study|Lost to Follow-up|15|||
146502487|NCT00373958|528341878|FG000|Infant Series|Withdrawal by Subject|13|||
146502488|NCT00373958|528341879|FG001|Infant Series|Withdrawal by Subject|15|||
146502489|NCT00373958|528341878|FG000|Infant Series|Failed to return|8|||
146502490|NCT00373958|528341879|FG001|Infant Series|Failed to return|13|||
146502491|NCT00373958|528341878|FG000|Infant Series|Lost to Follow-up|6|||
146502492|NCT00373958|528341879|FG001|Infant Series|Lost to Follow-up|5|||
146502493|NCT00373958|528341878|FG000|Infant Series|Protocol Violation|3|||
146502494|NCT00373958|528341879|FG001|Infant Series|Protocol Violation|7|||
146502495|NCT00373958|528341878|FG000|Infant Series|Lost Kaiser coverage|4|||
146502496|NCT00373958|528341879|FG001|Infant Series|Lost Kaiser coverage|0|||
146502497|NCT00373958|528341878|FG000|Infant Series|Child relocated|1|||
146502498|NCT00373958|528341879|FG001|Infant Series|Child relocated|0|||
146502499|NCT00373958|528341878|FG000|Infant Series|Consent was not received|1|||
146502500|NCT00373958|528341879|FG001|Infant Series|Consent was not received|0|||
146502501|NCT00373958|528341878|FG000|Infant Series|Adverse Event|3|||
146502502|NCT00373958|528341879|FG001|Infant Series|Adverse Event|1|||
146502503|NCT00373958|528341878|FG000|Infant Series|Physician Decision|1|||
146502504|NCT00373958|528341879|FG001|Infant Series|Physician Decision|1|||
146502505|NCT00373958|528341878|FG000|Toddler Dose|Lost to Follow-up|5|||
146502506|NCT00373958|528341879|FG001|Toddler Dose|Lost to Follow-up|8|||
146502507|NCT00373958|528341878|FG000|Toddler Dose|Withdrawal by Subject|2|||
146502508|NCT00373958|528341879|FG001|Toddler Dose|Withdrawal by Subject|2|||
146502509|NCT00373958|528341878|FG000|Toddler Dose|Failed to return|1|||
146647779|NCT01576159|528886961|FG000|Overall Study|Withdrawal by Subject|0|||
146647780|NCT01576159|528886962|FG001|Overall Study|Withdrawal by Subject|1|||
146647781|NCT01576159|528886963|FG002|Overall Study|Withdrawal by Subject|0|||
146769125|NCT03284957|529323419|FG010|Overall Study|Other|0|||
146912639|NCT02546856|529843116|FG000|4 Months Evaluation|Physician Decision|3|||
146912640|NCT02546856|529843117|FG001|4 Months Evaluation|Physician Decision|0|||
146502510|NCT00373958|528341879|FG001|Toddler Dose|Failed to return|2|||
146502511|NCT00373958|528341878|FG000|Toddler Dose|Protocol Violation|0|||
146502512|NCT00373958|528341879|FG001|Toddler Dose|Protocol Violation|1|||
146502513|NCT00373958|528341878|FG000|Toddler Dose|Withdrawn after infant series|22|||
146502514|NCT00373958|528341879|FG001|Toddler Dose|Withdrawn after infant series|25|||
146502515|NCT01054196|528341883|FG000|Overall Study|Physician Decision|0|||
146502516|NCT01054196|528341884|FG001|Overall Study|Physician Decision|0|||
146502517|NCT01054196|528341885|FG002|Overall Study|Physician Decision|0|||
146502518|NCT01054196|528341886|FG003|Overall Study|Physician Decision|1|||
146502519|NCT01054196|528341887|FG004|Overall Study|Physician Decision|0|||
146502520|NCT01054196|528341888|FG005|Overall Study|Physician Decision|0|||
146502521|NCT01054196|528341889|FG006|Overall Study|Physician Decision|1|||
146502522|NCT00179673|528341891|FG000|Overall Study|Adverse Event|7|||
146502523|NCT00179673|528341891|FG000|Overall Study|Lack of Efficacy|15|||
146502524|NCT00179673|528341891|FG000|Overall Study|Withdrawal by Subject|3|||
146502525|NCT00179673|528341891|FG000|Overall Study|Death|4|||
146502526|NCT00179673|528341891|FG000|Overall Study|Other Observations and options|14|||
146502527|NCT00492648|528341892|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
146502528|NCT00492648|528341893|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
146502529|NCT00282113|528341894|FG000|Overall Study|Removed at parents request|1|||
146502530|NCT00282113|528341895|FG001|Overall Study|Removed at parents request|0|||
146502531|NCT00282113|528341896|FG002|Overall Study|Removed at parents request|0|||
146502532|NCT03382834|528341897|FG000|Step 1|Lost to Follow-up|0|||
146502533|NCT03382834|528341898|FG001|Step 1|Lost to Follow-up|1|||
146502534|NCT03382834|528341897|FG000|Step 2|Death|1|||
146502535|NCT03382834|528341898|FG001|Step 2|Death|0|||
146502536|NCT03382834|528341897|FG000|Step 2|Lost to Follow-up|2|||
146502537|NCT03382834|528341898|FG001|Step 2|Lost to Follow-up|2|||
146502538|NCT03382834|528341897|FG000|Step 2|Site Terminated by Sponsor|1|||
146502539|NCT03382834|528341898|FG001|Step 2|Site Terminated by Sponsor|0|||
146502540|NCT02387957|528341899|FG000|Overall Study|The study was discontinued|21|||
146502541|NCT02387957|528341900|FG001|Overall Study|The study was discontinued|21|||
146502542|NCT02387957|528341901|FG002|Overall Study|The study was discontinued|20|||
146502543|NCT02294396|528341902|FG000|Overall Study|Adverse Event|26|||
146502544|NCT02294396|528341903|FG001|Overall Study|Adverse Event|25|||
146502545|NCT02294396|528341904|FG002|Overall Study|Adverse Event|21|||
146502546|NCT02294396|528341905|FG003|Overall Study|Adverse Event|24|||
146502547|NCT02294396|528341902|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
146502548|NCT02294396|528341903|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
146566716|NCT00652743|528587903|FG001|Months 36-42|Lost to Follow-up|1|||
146566717|NCT00652743|528587904|FG002|Months 36-42|Lost to Follow-up|0|||
146566718|NCT00652743|528587902|FG000|Months 36-42|Migrated/moved from study area|1|||
146566719|NCT00652743|528587903|FG001|Months 36-42|Migrated/moved from study area|0|||
146566720|NCT00652743|528587904|FG002|Months 36-42|Migrated/moved from study area|0|||
146566721|NCT00652743|528587902|FG000|Months 36-42|Other|4|||
146566722|NCT00652743|528587903|FG001|Months 36-42|Other|2|||
146566723|NCT00652743|528587904|FG002|Months 36-42|Other|8|||
146566724|NCT00503984|528587909|FG000|Overall Study|Protocol Violation|0|||
146566725|NCT00503984|528587910|FG001|Overall Study|Protocol Violation|1|||
146566726|NCT00503984|528587911|FG002|Overall Study|Protocol Violation|0|||
146566727|NCT00503984|528587912|FG003|Overall Study|Protocol Violation|0|||
146566728|NCT00503984|528587913|FG004|Overall Study|Protocol Violation|0|||
146566729|NCT00503984|528587914|FG005|Overall Study|Protocol Violation|0|||
146566730|NCT00503984|528587909|FG000|Overall Study|Adverse Event|0|||
146566731|NCT00503984|528587910|FG001|Overall Study|Adverse Event|1|||
146566732|NCT00503984|528587911|FG002|Overall Study|Adverse Event|0|||
146566733|NCT00503984|528587912|FG003|Overall Study|Adverse Event|0|||
146566734|NCT00503984|528587913|FG004|Overall Study|Adverse Event|0|||
146566735|NCT00503984|528587914|FG005|Overall Study|Adverse Event|0|||
146566736|NCT00503984|528587909|FG000|Overall Study|Death|0|||
146566737|NCT00503984|528587910|FG001|Overall Study|Death|0|||
146566738|NCT00503984|528587911|FG002|Overall Study|Death|0|||
146566739|NCT00503984|528587912|FG003|Overall Study|Death|0|||
146566740|NCT00503984|528587913|FG004|Overall Study|Death|1|||
146566741|NCT00503984|528587914|FG005|Overall Study|Death|0|||
146566742|NCT01246960|528587915|FG000|Overall Study|Lost to Follow-up|3|||
146566743|NCT01246960|528587916|FG001|Overall Study|Lost to Follow-up|1|||
146566744|NCT01246960|528587915|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
146566745|NCT01246960|528587916|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
146566746|NCT02122380|528587919|FG000|First Intervention (30 Days)|Adverse Event|1|||
146566747|NCT02122380|528587920|FG001|First Intervention (30 Days)|Adverse Event|0|||
146566748|NCT02122380|528587919|FG000|First Intervention (30 Days)|Physician Decision|0|||
146566749|NCT02122380|528587920|FG001|First Intervention (30 Days)|Physician Decision|1|||
146566750|NCT02122380|528587919|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
146566751|NCT02122380|528587920|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
146974265|NCT00314262|530067506|FG000|Overall Study|Withdrawal by Subject|2|||
146974266|NCT00314262|530067506|FG000|Overall Study|Physician Decision|1|||
146974267|NCT02662556|530067507|FG000|Overall Study|Adverse Event|4|||
146974268|NCT02662556|530067507|FG000|Overall Study|Lack of Efficacy|4|||
146974269|NCT00828516|530067516|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
146974270|NCT01556165|530067517|FG000|Overall Study|Adverse Event|5|||
146974271|NCT01556165|530067518|FG001|Overall Study|Adverse Event|3|||
146974272|NCT01556165|530067517|FG000|Overall Study|Protocol Violation|0|||
146974273|NCT01556165|530067518|FG001|Overall Study|Protocol Violation|3|||
146974274|NCT01556165|530067517|FG000|Overall Study|Withdrawal of Consent|7|||
146974275|NCT01556165|530067518|FG001|Overall Study|Withdrawal of Consent|1|||
146974276|NCT01640964|530067524|FG000|Overall Study|Lost to Follow-up|0|||
146974277|NCT01640964|530067525|FG001|Overall Study|Lost to Follow-up|0|||
146974278|NCT01640964|530067526|FG002|Overall Study|Lost to Follow-up|1|||
146974279|NCT01640964|530067524|FG000|Overall Study|Protocol Deviation|1|||
146974280|NCT01640964|530067525|FG001|Overall Study|Protocol Deviation|1|||
146974281|NCT01640964|530067526|FG002|Overall Study|Protocol Deviation|2|||
146974282|NCT02787746|530067527|FG000|Overall Study|Adverse Event|42|||
146974283|NCT02787746|530067527|FG000|Overall Study|Withdrawal by Subject|65|||
146974284|NCT02787746|530067527|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
146974285|NCT04822701|530067533|FG000|Overall Study|Not treated|2|||
146974286|NCT04822701|530067534|FG001|Overall Study|Not treated|0|||
146974287|NCT04822701|530067533|FG000|Overall Study|Lost to Follow-up|1|||
146974288|NCT04822701|530067534|FG001|Overall Study|Lost to Follow-up|0|||
146974289|NCT04822701|530067533|FG000|Overall Study|Withdrawal by Subject|1|||
146974290|NCT04822701|530067534|FG001|Overall Study|Withdrawal by Subject|0|||
146974291|NCT01408576|530069478|FG000|Overall Study|Lack of Efficacy|17|||
146974292|NCT01408576|530069479|FG001|Overall Study|Lack of Efficacy|30|||
146974293|NCT01408576|530069480|FG002|Overall Study|Lack of Efficacy|48|||
146974294|NCT01408576|530069478|FG000|Overall Study|Protocol Violation|1|||
146974295|NCT01408576|530069479|FG001|Overall Study|Protocol Violation|2|||
146974296|NCT01408576|530069480|FG002|Overall Study|Protocol Violation|2|||
146974297|NCT01408576|530069478|FG000|Overall Study|Lost to Follow-up|10|||
146974298|NCT01408576|530069479|FG001|Overall Study|Lost to Follow-up|9|||
146974299|NCT01408576|530069480|FG002|Overall Study|Lost to Follow-up|17|||
146974300|NCT01408576|530069478|FG000|Overall Study|Withdrawal by Subject|34|||
146974301|NCT01408576|530069479|FG001|Overall Study|Withdrawal by Subject|60|||
146974302|NCT01408576|530069480|FG002|Overall Study|Withdrawal by Subject|66|||
146974303|NCT01408576|530069478|FG000|Overall Study|Sponsor terminated study|89|||
146974304|NCT01408576|530069479|FG001|Overall Study|Sponsor terminated study|333|||
146974305|NCT01408576|530069480|FG002|Overall Study|Sponsor terminated study|330|||
146974306|NCT01408576|530069478|FG000|Overall Study|AE, serious fatal|4|||
146974307|NCT01408576|530069479|FG001|Overall Study|AE, serious fatal|4|||
146974308|NCT01408576|530069480|FG002|Overall Study|AE, serious fatal|1|||
146974309|NCT01408576|530069478|FG000|Overall Study|SAE, non-fatal|11|||
146974310|NCT01408576|530069479|FG001|Overall Study|SAE, non-fatal|23|||
146974311|NCT01408576|530069480|FG002|Overall Study|SAE, non-fatal|14|||
146974312|NCT01408576|530069478|FG000|Overall Study|AE, non-serious non-fatal|12|||
146974313|NCT01408576|530069479|FG001|Overall Study|AE, non-serious non-fatal|19|||
146974314|NCT01408576|530069480|FG002|Overall Study|AE, non-serious non-fatal|11|||
146974315|NCT01408576|530069478|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
146974316|NCT01408576|530069479|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
146974317|NCT01408576|530069480|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
146974318|NCT01408576|530069478|FG000|Overall Study|AE, unknown type|0|||
146974319|NCT01408576|530069479|FG001|Overall Study|AE, unknown type|1|||
146974320|NCT01408576|530069480|FG002|Overall Study|AE, unknown type|0|||
146974321|NCT01408576|530069478|FG000|Overall Study|Other|10|||
146974322|NCT01408576|530069479|FG001|Overall Study|Other|16|||
146974323|NCT01408576|530069480|FG002|Overall Study|Other|18|||
146974324|NCT00802529|530069481|FG000|Overall Study|Lost to Follow-up|0|||
146974325|NCT00802529|530069482|FG001|Overall Study|Lost to Follow-up|1|||
146974326|NCT02476851|530069483|FG000|Overall Study|Protocol Violation|1|||
146974327|NCT02476851|530069484|FG001|Overall Study|Protocol Violation|1|||
146502549|NCT02294396|528341904|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
146502550|NCT02294396|528341905|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
146502551|NCT02294396|528341902|FG000|Overall Study|Withdrawal by Subject|8|||
146502552|NCT02294396|528341903|FG001|Overall Study|Withdrawal by Subject|6|||
146502553|NCT02294396|528341904|FG002|Overall Study|Withdrawal by Subject|6|||
146502554|NCT02294396|528341905|FG003|Overall Study|Withdrawal by Subject|8|||
146502555|NCT02294396|528341902|FG000|Overall Study|Lost to Follow-up|0|||
146502556|NCT02294396|528341903|FG001|Overall Study|Lost to Follow-up|0|||
146502557|NCT02294396|528341904|FG002|Overall Study|Lost to Follow-up|1|||
146502558|NCT02294396|528341905|FG003|Overall Study|Lost to Follow-up|1|||
146502559|NCT02294396|528341902|FG000|Overall Study|Protocol Deviation|3|||
146502560|NCT02294396|528341903|FG001|Overall Study|Protocol Deviation|2|||
146974328|NCT00337129|530069485|FG000|Overall Study|Adverse Event|4|||
146974329|NCT00337129|530069485|FG000|Overall Study|Withdrawal by Subject|1|||
146974330|NCT00337129|530069485|FG000|Overall Study|Lack of Efficacy|32|||
146502561|NCT02294396|528341904|FG002|Overall Study|Protocol Deviation|2|||
146502562|NCT02294396|528341905|FG003|Overall Study|Protocol Deviation|1|||
146502563|NCT02294396|528341902|FG000|Overall Study|Miscellaneous|2|||
146502564|NCT02294396|528341903|FG001|Overall Study|Miscellaneous|0|||
146502565|NCT02294396|528341904|FG002|Overall Study|Miscellaneous|5|||
146502566|NCT02294396|528341905|FG003|Overall Study|Miscellaneous|2|||
146647782|NCT01576159|528886964|FG003|Overall Study|Withdrawal by Subject|0|||
146647783|NCT01576159|528886961|FG000|Overall Study|Physician Decision|0|||
146647784|NCT01576159|528886962|FG001|Overall Study|Physician Decision|0|||
146647785|NCT01576159|528886963|FG002|Overall Study|Physician Decision|1|||
146647786|NCT01576159|528886964|FG003|Overall Study|Physician Decision|0|||
146647787|NCT01576159|528886961|FG000|Overall Study|Lost to Follow-up|0|||
146647788|NCT01576159|528886962|FG001|Overall Study|Lost to Follow-up|0|||
146647789|NCT01576159|528886963|FG002|Overall Study|Lost to Follow-up|0|||
146647790|NCT01576159|528886964|FG003|Overall Study|Lost to Follow-up|1|||
146647791|NCT01576159|528886961|FG000|Overall Study|Protocol Violation|1|||
146647792|NCT01576159|528886962|FG001|Overall Study|Protocol Violation|0|||
146647793|NCT01576159|528886963|FG002|Overall Study|Protocol Violation|0|||
146647794|NCT01576159|528886964|FG003|Overall Study|Protocol Violation|0|||
146647795|NCT01181986|528886965|FG000|Phase 1|Lost to Follow-up|0|||
146502567|NCT02949843|528341906|FG000|Overall Study|Withdrawal by Subject|0|||
146502568|NCT02949843|528341907|FG001|Overall Study|Withdrawal by Subject|1|||
146502569|NCT02949843|528341908|FG002|Overall Study|Withdrawal by Subject|1|||
146502570|NCT02120833|528341909|FG000|Overall Study|Adverse Event|1|||
146502571|NCT02120833|528341910|FG001|Overall Study|Adverse Event|0|||
146502572|NCT02120833|528341909|FG000|Overall Study|Withdrawal by Subject|2|||
146502573|NCT02120833|528341910|FG001|Overall Study|Withdrawal by Subject|0|||
146502574|NCT02120833|528341909|FG000|Overall Study|Lost to Follow-up|1|||
146502575|NCT02120833|528341910|FG001|Overall Study|Lost to Follow-up|1|||
146502576|NCT03613649|528341911|FG000|Second Treatment|Lost to Follow-up|0|||
146502577|NCT03613649|528341912|FG001|Second Treatment|Lost to Follow-up|0|||
146502578|NCT03613649|528341913|FG002|Second Treatment|Lost to Follow-up|1|||
146502579|NCT03613649|528341914|FG003|Second Treatment|Lost to Follow-up|0|||
146502580|NCT03613649|528341915|FG004|Second Treatment|Lost to Follow-up|0|||
146502581|NCT03613649|528341916|FG005|Second Treatment|Lost to Follow-up|0|||
146502582|NCT03613649|528341917|FG006|Second Treatment|Lost to Follow-up|0|||
146502583|NCT03613649|528341918|FG007|Second Treatment|Lost to Follow-up|0|||
146502584|NCT03613649|528341919|FG008|Second Treatment|Lost to Follow-up|0|||
146502585|NCT03613649|528341920|FG009|Second Treatment|Lost to Follow-up|0|||
146502586|NCT03613649|528341921|FG010|Second Treatment|Lost to Follow-up|0|||
146502587|NCT03613649|528341922|FG011|Second Treatment|Lost to Follow-up|0|||
146566752|NCT02122380|528587919|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
146566753|NCT02122380|528587920|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
146566754|NCT02122380|528587919|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
146566755|NCT02122380|528587920|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
146566756|NCT04102007|528587925|FG000|Overall Study|Adverse Event|4|||
146566757|NCT04102007|528587925|FG000|Overall Study|Lost to Follow-up|3|||
146566758|NCT04102007|528587925|FG000|Overall Study|Withdrawal by Subject|12|||
146566759|NCT04102007|528587925|FG000|Overall Study|Eligibility Violation|5|||
146566760|NCT04102007|528587925|FG000|Overall Study|Lack of Efficacy|6|||
146566761|NCT04102007|528587925|FG000|Overall Study|Protocol Deviation|5|||
146566762|NCT04102007|528587925|FG000|Overall Study|Protocol Compliance|1|||
146566763|NCT04102007|528587925|FG000|Overall Study|Withdrew Treatment|2|||
146566764|NCT04102007|528587925|FG000|Overall Study|Pregnancy|1|||
146566765|NCT05173974|528587926|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
146566766|NCT05173974|528587927|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
146566767|NCT05173974|528587928|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
146566768|NCT05173974|528587929|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
146566769|NCT05173974|528587926|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
146566770|NCT05173974|528587927|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
146566771|NCT05173974|528587928|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
146566772|NCT05173974|528587929|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
146566773|NCT03289143|528587930|FG000|Overall Study|Caregiver Unavailability|1|||
146566774|NCT03289143|528587931|FG001|Overall Study|Caregiver Unavailability|1|||
146566775|NCT03289143|528587932|FG002|Overall Study|Caregiver Unavailability|0|||
146566776|NCT03289143|528587933|FG003|Overall Study|Caregiver Unavailability|0|||
146566777|NCT03289143|528587930|FG000|Overall Study|Research Department Closure|0|||
146566778|NCT03289143|528587931|FG001|Overall Study|Research Department Closure|0|||
146566779|NCT03289143|528587932|FG002|Overall Study|Research Department Closure|1|||
146566780|NCT03289143|528587933|FG003|Overall Study|Research Department Closure|0|||
146566781|NCT03289143|528587930|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
146566782|NCT03289143|528587931|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
146647796|NCT01181986|528886966|FG001|Phase 1|Lost to Follow-up|1|||
146647797|NCT01181986|528886967|FG002|Phase 1|Lost to Follow-up|1|||
146647798|NCT01181986|528886965|FG000|Phase 1|Adverse Event|0|||
146647799|NCT01181986|528886966|FG001|Phase 1|Adverse Event|0|||
146647800|NCT01181986|528886967|FG002|Phase 1|Adverse Event|1|||
146647801|NCT01181986|528886965|FG000|Phase 1|Protocol Violation|1|||
146647802|NCT01181986|528886966|FG001|Phase 1|Protocol Violation|0|||
146647803|NCT01181986|528886967|FG002|Phase 1|Protocol Violation|0|||
146647804|NCT01181986|528886965|FG000|Phase 2|Adverse Event|0|||
146647805|NCT01181986|528886966|FG001|Phase 2|Adverse Event|3|||
146502588|NCT03613649|528341911|FG000|Second Treatment|Withdrawal by Subject|0|||
146502589|NCT03613649|528341912|FG001|Second Treatment|Withdrawal by Subject|0|||
146502590|NCT03613649|528341913|FG002|Second Treatment|Withdrawal by Subject|0|||
146502591|NCT03613649|528341914|FG003|Second Treatment|Withdrawal by Subject|0|||
146502592|NCT03613649|528341915|FG004|Second Treatment|Withdrawal by Subject|1|||
146502593|NCT03613649|528341916|FG005|Second Treatment|Withdrawal by Subject|0|||
146502594|NCT03613649|528341917|FG006|Second Treatment|Withdrawal by Subject|0|||
146502595|NCT03613649|528341918|FG007|Second Treatment|Withdrawal by Subject|0|||
146502596|NCT03613649|528341919|FG008|Second Treatment|Withdrawal by Subject|0|||
146502597|NCT03613649|528341920|FG009|Second Treatment|Withdrawal by Subject|0|||
146502598|NCT03613649|528341921|FG010|Second Treatment|Withdrawal by Subject|0|||
146502599|NCT03613649|528341922|FG011|Second Treatment|Withdrawal by Subject|0|||
146502600|NCT03613649|528341911|FG000|Third Treatment|Lost to Follow-up|0|||
146502601|NCT03613649|528341912|FG001|Third Treatment|Lost to Follow-up|0|||
146502602|NCT03613649|528341913|FG002|Third Treatment|Lost to Follow-up|0|||
146502603|NCT03613649|528341914|FG003|Third Treatment|Lost to Follow-up|0|||
146502604|NCT03613649|528341915|FG004|Third Treatment|Lost to Follow-up|1|||
146502605|NCT03613649|528341916|FG005|Third Treatment|Lost to Follow-up|0|||
146502606|NCT03613649|528341917|FG006|Third Treatment|Lost to Follow-up|0|||
146502607|NCT03613649|528341918|FG007|Third Treatment|Lost to Follow-up|0|||
146502608|NCT03613649|528341919|FG008|Third Treatment|Lost to Follow-up|0|||
146502609|NCT03613649|528341920|FG009|Third Treatment|Lost to Follow-up|0|||
146502610|NCT03613649|528341921|FG010|Third Treatment|Lost to Follow-up|0|||
146502611|NCT03613649|528341922|FG011|Third Treatment|Lost to Follow-up|1|||
146502612|NCT03613649|528341911|FG000|Third Treatment|Protocol Violation|0|||
146502613|NCT03613649|528341912|FG001|Third Treatment|Protocol Violation|0|||
146566783|NCT03289143|528587932|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
146566784|NCT03289143|528587933|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
146566785|NCT03289143|528587930|FG000|Overall Study|Medical Monitor Decision|1|||
146566786|NCT03289143|528587931|FG001|Overall Study|Medical Monitor Decision|0|||
146566787|NCT03289143|528587932|FG002|Overall Study|Medical Monitor Decision|0|||
146566788|NCT03289143|528587933|FG003|Overall Study|Medical Monitor Decision|0|||
146566789|NCT03289143|528587930|FG000|Overall Study|Participant Non-Compliance|0|||
146566790|NCT03289143|528587931|FG001|Overall Study|Participant Non-Compliance|0|||
146566791|NCT03289143|528587932|FG002|Overall Study|Participant Non-Compliance|1|||
146566792|NCT03289143|528587933|FG003|Overall Study|Participant Non-Compliance|0|||
146566793|NCT03289143|528587930|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
146566794|NCT03289143|528587931|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
146566795|NCT03289143|528587932|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
146566796|NCT03289143|528587933|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
146566797|NCT03289143|528587930|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
146566798|NCT03289143|528587931|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
146566799|NCT03289143|528587932|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
146566800|NCT03289143|528587933|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
146566801|NCT03289143|528587930|FG000|Overall Study|Caregiver Passed Away|1|||
146566802|NCT03289143|528587931|FG001|Overall Study|Caregiver Passed Away|0|||
146566803|NCT03289143|528587932|FG002|Overall Study|Caregiver Passed Away|0|||
146647806|NCT01181986|528886967|FG002|Phase 2|Adverse Event|0|||
146647807|NCT01181986|528886965|FG000|Phase 2|Medical condition|0|||
146647808|NCT01181986|528886966|FG001|Phase 2|Medical condition|1|||
146647809|NCT01181986|528886967|FG002|Phase 2|Medical condition|0|||
146647810|NCT01011309|528886968|FG000|Overall Study|Adverse Event|2|||
146647811|NCT01011309|528886969|FG001|Overall Study|Adverse Event|1|||
146647812|NCT01011309|528886970|FG002|Overall Study|Adverse Event|2|||
146647813|NCT01011309|528886968|FG000|Overall Study|Lack of Efficacy|0|||
146647814|NCT01011309|528886969|FG001|Overall Study|Lack of Efficacy|1|||
146647815|NCT01011309|528886970|FG002|Overall Study|Lack of Efficacy|0|||
146647816|NCT01011309|528886968|FG000|Overall Study|Protocol Violation|0|||
146647817|NCT01011309|528886969|FG001|Overall Study|Protocol Violation|1|||
146647818|NCT01011309|528886970|FG002|Overall Study|Protocol Violation|3|||
146647819|NCT01182844|528886980|FG000|Overall Study|Withdrawal by Subject|0|||
146502614|NCT03613649|528341913|FG002|Third Treatment|Protocol Violation|0|||
146502615|NCT03613649|528341914|FG003|Third Treatment|Protocol Violation|0|||
146502616|NCT03613649|528341915|FG004|Third Treatment|Protocol Violation|0|||
146647820|NCT01182844|528886981|FG001|Overall Study|Withdrawal by Subject|2|||
146647821|NCT01330017|528888432|FG000|Overall Study|Adverse Event|0|||
146647822|NCT01330017|528888433|FG001|Overall Study|Adverse Event|1|||
146647823|NCT01330017|528888434|FG002|Overall Study|Adverse Event|1|||
146647824|NCT01330017|528888435|FG003|Overall Study|Adverse Event|4|||
146647825|NCT01330017|528888436|FG004|Overall Study|Adverse Event|0|||
146769126|NCT03284957|529323420|FG011|Overall Study|Other|0|||
146769127|NCT03284957|529323421|FG012|Overall Study|Other|0|||
146769128|NCT03284957|529323422|FG013|Overall Study|Other|0|||
146647826|NCT01330017|528888432|FG000|Overall Study|Withdrawal by Subject|0|||
146647827|NCT01330017|528888433|FG001|Overall Study|Withdrawal by Subject|0|||
146647828|NCT01330017|528888434|FG002|Overall Study|Withdrawal by Subject|1|||
146502617|NCT03613649|528341916|FG005|Third Treatment|Protocol Violation|0|||
146502618|NCT03613649|528341917|FG006|Third Treatment|Protocol Violation|1|||
146502619|NCT03613649|528341918|FG007|Third Treatment|Protocol Violation|0|||
146502620|NCT03613649|528341919|FG008|Third Treatment|Protocol Violation|0|||
146502621|NCT03613649|528341920|FG009|Third Treatment|Protocol Violation|0|||
146502622|NCT03613649|528341921|FG010|Third Treatment|Protocol Violation|0|||
146502623|NCT03613649|528341922|FG011|Third Treatment|Protocol Violation|1|||
146502624|NCT03613649|528341911|FG000|Fourth Treatment|Protocol Violation|1|||
146502625|NCT03613649|528341912|FG001|Fourth Treatment|Protocol Violation|0|||
146502626|NCT03613649|528341913|FG002|Fourth Treatment|Protocol Violation|0|||
146502627|NCT03613649|528341914|FG003|Fourth Treatment|Protocol Violation|0|||
146502628|NCT03613649|528341915|FG004|Fourth Treatment|Protocol Violation|1|||
146502629|NCT03613649|528341916|FG005|Fourth Treatment|Protocol Violation|0|||
146502630|NCT03613649|528341917|FG006|Fourth Treatment|Protocol Violation|0|||
146502631|NCT03613649|528341918|FG007|Fourth Treatment|Protocol Violation|0|||
146502632|NCT03613649|528341919|FG008|Fourth Treatment|Protocol Violation|0|||
146502633|NCT03613649|528341920|FG009|Fourth Treatment|Protocol Violation|0|||
146502634|NCT03613649|528341921|FG010|Fourth Treatment|Protocol Violation|0|||
146502635|NCT03613649|528341922|FG011|Fourth Treatment|Protocol Violation|0|||
146502636|NCT03613649|528341911|FG000|Fourth Treatment|Physician Decision|0|||
146502637|NCT03613649|528341912|FG001|Fourth Treatment|Physician Decision|0|||
146502638|NCT03613649|528341913|FG002|Fourth Treatment|Physician Decision|0|||
146502639|NCT03613649|528341914|FG003|Fourth Treatment|Physician Decision|0|||
146502640|NCT03613649|528341915|FG004|Fourth Treatment|Physician Decision|0|||
146502641|NCT03613649|528341916|FG005|Fourth Treatment|Physician Decision|0|||
146502642|NCT03613649|528341917|FG006|Fourth Treatment|Physician Decision|1|||
146502643|NCT03613649|528341918|FG007|Fourth Treatment|Physician Decision|0|||
146502644|NCT03613649|528341919|FG008|Fourth Treatment|Physician Decision|0|||
146502645|NCT03613649|528341920|FG009|Fourth Treatment|Physician Decision|0|||
146502646|NCT03613649|528341921|FG010|Fourth Treatment|Physician Decision|0|||
146502647|NCT03613649|528341922|FG011|Fourth Treatment|Physician Decision|0|||
146502648|NCT03429244|528341923|FG000|Overall Study|Withdrawal by Subject|2|||
146502649|NCT03429244|528341924|FG001|Overall Study|Withdrawal by Subject|1|||
146502650|NCT03429244|528341925|FG002|Overall Study|Withdrawal by Subject|1|||
146502651|NCT00750139|528341926|FG000|Overall Study|Adverse Event|1|||
146502652|NCT00750139|528341927|FG001|Overall Study|Adverse Event|2|||
146502653|NCT00750139|528341928|FG002|Overall Study|Adverse Event|0|||
146502654|NCT00750139|528341929|FG003|Overall Study|Adverse Event|1|||
146502655|NCT00750139|528341926|FG000|Overall Study|Lost to Follow-up|17|||
146502656|NCT00750139|528341927|FG001|Overall Study|Lost to Follow-up|12|||
146502657|NCT00750139|528341928|FG002|Overall Study|Lost to Follow-up|15|||
146502658|NCT00750139|528341929|FG003|Overall Study|Lost to Follow-up|6|||
146502659|NCT00750139|528341926|FG000|Overall Study|Withdrawal by Subject|3|||
146502660|NCT00750139|528341927|FG001|Overall Study|Withdrawal by Subject|2|||
146502661|NCT00750139|528341928|FG002|Overall Study|Withdrawal by Subject|6|||
146502662|NCT00750139|528341929|FG003|Overall Study|Withdrawal by Subject|2|||
146502663|NCT00750139|528341926|FG000|Overall Study|Physician Decision|1|||
146502664|NCT00750139|528341927|FG001|Overall Study|Physician Decision|1|||
146647829|NCT01330017|528888435|FG003|Overall Study|Withdrawal by Subject|0|||
146647830|NCT01330017|528888436|FG004|Overall Study|Withdrawal by Subject|1|||
146647831|NCT01330017|528888432|FG000|Overall Study|Lost to Follow-up|0|||
146769129|NCT03284957|529323423|FG014|Overall Study|Other|2|||
146769130|NCT03284957|529323424|FG015|Overall Study|Other|0|||
146647832|NCT01330017|528888433|FG001|Overall Study|Lost to Follow-up|0|||
146647833|NCT01330017|528888434|FG002|Overall Study|Lost to Follow-up|1|||
146647834|NCT01330017|528888435|FG003|Overall Study|Lost to Follow-up|0|||
146647835|NCT01330017|528888436|FG004|Overall Study|Lost to Follow-up|0|||
146647836|NCT01330017|528888432|FG000|Overall Study|Protocol Violation|0|||
146647837|NCT01330017|528888433|FG001|Overall Study|Protocol Violation|0|||
146502665|NCT00750139|528341928|FG002|Overall Study|Physician Decision|0|||
146502666|NCT00750139|528341929|FG003|Overall Study|Physician Decision|0|||
146502667|NCT00750139|528341926|FG000|Overall Study|Non-compliance|1|||
146502668|NCT00750139|528341927|FG001|Overall Study|Non-compliance|0|||
146502669|NCT00750139|528341928|FG002|Overall Study|Non-compliance|1|||
146502670|NCT00750139|528341929|FG003|Overall Study|Non-compliance|3|||
146502671|NCT00750139|528341926|FG000|Overall Study|Termination by sponsor|4|||
146502672|NCT00750139|528341927|FG001|Overall Study|Termination by sponsor|0|||
146502673|NCT00750139|528341928|FG002|Overall Study|Termination by sponsor|0|||
146502674|NCT00750139|528341929|FG003|Overall Study|Termination by sponsor|1|||
146647838|NCT01330017|528888434|FG002|Overall Study|Protocol Violation|0|||
146647839|NCT01330017|528888435|FG003|Overall Study|Protocol Violation|1|||
146770139|NCT00818454|529327379|FG002|Washout Period of 1 Week|Protocol Violation|0|||
146502675|NCT00750139|528341926|FG000|Overall Study|Non-specific|62|||
146502676|NCT00750139|528341927|FG001|Overall Study|Non-specific|42|||
146502677|NCT00750139|528341928|FG002|Overall Study|Non-specific|79|||
146502678|NCT00750139|528341929|FG003|Overall Study|Non-specific|33|||
146502679|NCT00658775|528341930|FG000|Overall Study|Adverse Event|4|||
146502680|NCT00658775|528341931|FG001|Overall Study|Adverse Event|6|||
146502681|NCT00658775|528341930|FG000|Overall Study|Lost to Follow-up|17|||
146502682|NCT00658775|528341931|FG001|Overall Study|Lost to Follow-up|18|||
146502683|NCT00658775|528341930|FG000|Overall Study|Withdrawal by Subject|6|||
146502684|NCT00658775|528341931|FG001|Overall Study|Withdrawal by Subject|4|||
146502685|NCT00658775|528341930|FG000|Overall Study|Withdrawal of consent|8|||
146502686|NCT00658775|528341931|FG001|Overall Study|Withdrawal of consent|7|||
146502687|NCT00658775|528341930|FG000|Overall Study|Other|7|||
146502688|NCT00658775|528341931|FG001|Overall Study|Other|8|||
146502689|NCT00977314|528341934|FG000|Overall Study|Withdrawal by Subject|1|||
146502690|NCT00977314|528341935|FG001|Overall Study|Withdrawal by Subject|0|||
146502691|NCT00977314|528341934|FG000|Overall Study|Physician Decision|1|||
146566804|NCT03289143|528587933|FG003|Overall Study|Caregiver Passed Away|0|||
146566805|NCT03289143|528587930|FG000|Overall Study|Physician Decision|0|||
146566806|NCT03289143|528587931|FG001|Overall Study|Physician Decision|2|||
146566807|NCT03289143|528587932|FG002|Overall Study|Physician Decision|2|||
146566808|NCT03289143|528587933|FG003|Overall Study|Physician Decision|2|||
146566809|NCT03289143|528587930|FG000|Overall Study|Protocol Deviation|2|||
146566810|NCT03289143|528587931|FG001|Overall Study|Protocol Deviation|1|||
146566811|NCT03289143|528587932|FG002|Overall Study|Protocol Deviation|3|||
146566812|NCT03289143|528587933|FG003|Overall Study|Protocol Deviation|1|||
146566813|NCT03289143|528587930|FG000|Overall Study|Study Terminated By Sponsor|101|||
146566814|NCT03289143|528587931|FG001|Overall Study|Study Terminated By Sponsor|75|||
146566815|NCT03289143|528587932|FG002|Overall Study|Study Terminated By Sponsor|100|||
146566816|NCT03289143|528587933|FG003|Overall Study|Study Terminated By Sponsor|69|||
146566817|NCT03289143|528587930|FG000|Overall Study|Withdrawal by Subject|14|||
146769131|NCT03544515|529323427|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
146974331|NCT00337129|530069485|FG000|Overall Study|Death|2|||
146974332|NCT00337129|530069485|FG000|Overall Study|not protocol specified|1|||
146974333|NCT00647426|530069486|FG000|Overall Study|Withdrawal by Subject|2|||
146769132|NCT03544515|529323428|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
146769133|NCT03544515|529323427|FG000|Overall Study|Lost to Follow-up|2|||
146769134|NCT03544515|529323428|FG001|Overall Study|Lost to Follow-up|0|||
146769135|NCT03622593|529323429|FG000|Overall Study|Withdrawal by Subject|11|||
146769136|NCT03622593|529323430|FG001|Overall Study|Withdrawal by Subject|9|||
146769137|NCT03622593|529323431|FG002|Overall Study|Withdrawal by Subject|13|||
146769138|NCT03622593|529323429|FG000|Overall Study|Death|12|||
146769139|NCT03622593|529323430|FG001|Overall Study|Death|9|||
146769140|NCT03622593|529323431|FG002|Overall Study|Death|10|||
146769141|NCT03622593|529323429|FG000|Overall Study|Lost to Follow-up|11|||
146769142|NCT03622593|529323430|FG001|Overall Study|Lost to Follow-up|5|||
146769143|NCT03622593|529323431|FG002|Overall Study|Lost to Follow-up|8|||
146769144|NCT03622593|529323429|FG000|Overall Study|Adverse Event|4|||
146769145|NCT03622593|529323430|FG001|Overall Study|Adverse Event|5|||
146769146|NCT03622593|529323431|FG002|Overall Study|Adverse Event|6|||
146769147|NCT03622593|529323429|FG000|Overall Study|Physician Decision|2|||
146769148|NCT03622593|529323430|FG001|Overall Study|Physician Decision|1|||
146769149|NCT03622593|529323431|FG002|Overall Study|Physician Decision|6|||
146769150|NCT03622593|529323429|FG000|Overall Study|Other|2|||
146769151|NCT03622593|529323430|FG001|Overall Study|Other|2|||
146769152|NCT03622593|529323431|FG002|Overall Study|Other|3|||
146769153|NCT03622593|529323429|FG000|Overall Study|Protocol Violation|0|||
146974334|NCT01467570|530069490|FG000|Overall Study|Lost to Follow-up|8|||
146974335|NCT01467570|530069491|FG001|Overall Study|Lost to Follow-up|9|||
146502692|NCT00977314|528341935|FG001|Overall Study|Physician Decision|0|||
146502693|NCT02107859|528341936|FG000|Overall Study|Withdrawal by Subject|14|||
146566818|NCT03289143|528587931|FG001|Overall Study|Withdrawal by Subject|6|||
146566819|NCT03289143|528587932|FG002|Overall Study|Withdrawal by Subject|14|||
146769154|NCT03622593|529323430|FG001|Overall Study|Protocol Violation|0|||
146769155|NCT03622593|529323431|FG002|Overall Study|Protocol Violation|1|||
146769156|NCT03622593|529323429|FG000|Overall Study|Pregnancy|0|||
146769157|NCT03622593|529323430|FG001|Overall Study|Pregnancy|0|||
146566820|NCT03289143|528587933|FG003|Overall Study|Withdrawal by Subject|12|||
146769158|NCT03622593|529323431|FG002|Overall Study|Pregnancy|1|||
146769159|NCT01393119|529323432|FG000|Overall Study|Adverse Event|1|||
146502694|NCT02107859|528341936|FG000|Overall Study|Adverse Event|3|||
146502695|NCT02107859|528341936|FG000|Overall Study|Study closure|41|||
146502696|NCT02107859|528341936|FG000|Overall Study|Other than specified|3|||
146502697|NCT00877487|528341939|FG000|Open-label Treatment Phase|Adverse Event|1|||
146502698|NCT00877487|528341940|FG001|Open-label Treatment Phase|Adverse Event|0|||
146647840|NCT01330017|528888436|FG004|Overall Study|Protocol Violation|0|||
146647841|NCT01330017|528888432|FG000|Overall Study|Unknown Reason|5|||
146502699|NCT00877487|528341939|FG000|Open-label Treatment Phase|Protocol Violation|3|||
146502700|NCT00877487|528341940|FG001|Open-label Treatment Phase|Protocol Violation|0|||
146502701|NCT00877487|528341939|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
146502702|NCT00877487|528341940|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
146502703|NCT00877487|528341939|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
146502704|NCT00877487|528341940|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
146502705|NCT00877487|528341939|FG000|Open-label Treatment Phase|Out of country for business|1|||
146502706|NCT00877487|528341940|FG001|Open-label Treatment Phase|Out of country for business|0|||
146502707|NCT00877487|528341939|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
146502708|NCT00877487|528341940|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
146502709|NCT00877487|528341939|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
146502710|NCT00877487|528341940|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
146502711|NCT00877487|528341939|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
146502712|NCT00877487|528341940|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
146502713|NCT00877487|528341939|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
146502714|NCT00877487|528341940|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
146502715|NCT01516008|528341941|FG000|Overall Study|Adverse Event|0|||
146502716|NCT01516008|528341942|FG001|Overall Study|Adverse Event|2|||
146647842|NCT01330017|528888433|FG001|Overall Study|Unknown Reason|3|||
146647843|NCT01330017|528888434|FG002|Overall Study|Unknown Reason|5|||
146647844|NCT01330017|528888435|FG003|Overall Study|Unknown Reason|7|||
146647845|NCT01330017|528888436|FG004|Overall Study|Unknown Reason|2|||
146647846|NCT01221272|528888438|FG000|Period 1|Adverse Event|2|||
146647847|NCT01221272|528888439|FG001|Period 1|Adverse Event|0|||
146647848|NCT01221272|528888438|FG000|Period 1|Consent Withdrawal|0|||
146647849|NCT01221272|528888439|FG001|Period 1|Consent Withdrawal|1|||
146647850|NCT01221272|528888438|FG000|Period 1|Significant Dosing Noncompliance|0|||
146647851|NCT01221272|528888439|FG001|Period 1|Significant Dosing Noncompliance|1|||
146647852|NCT01221272|528888438|FG000|Period 2|Adverse Event|0|||
146647853|NCT01221272|528888439|FG001|Period 2|Adverse Event|2|||
146647854|NCT02043899|528888443|FG000|Overall Study|Adverse Event|3|||
146647855|NCT02043899|528888443|FG000|Overall Study|Physician Decision|1|||
146647856|NCT02043899|528888443|FG000|Overall Study|Withdrawal by Subject|2|||
146647857|NCT02043899|528888443|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
146647858|NCT02043899|528888443|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
146647859|NCT02043899|528888443|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
146647860|NCT02043899|528888443|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
146647861|NCT02043899|528888443|FG000|Overall Study|Treatment delayed|1|||
146647862|NCT03254108|528888444|FG000|Overall Study|Adverse Event|0|||
146647863|NCT03254108|528888445|FG001|Overall Study|Adverse Event|2|||
146502717|NCT01516008|528341943|FG002|Overall Study|Adverse Event|7|||
146647864|NCT03254108|528888446|FG002|Overall Study|Adverse Event|0|||
146647865|NCT03254108|528888447|FG003|Overall Study|Adverse Event|1|||
146647866|NCT03254108|528888448|FG004|Overall Study|Adverse Event|1|||
146647867|NCT03254108|528888444|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
146647868|NCT03254108|528888445|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
146647869|NCT03254108|528888446|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
146502718|NCT01516008|528341941|FG000|Overall Study|Lack of Efficacy|44|||
146502719|NCT01516008|528341942|FG001|Overall Study|Lack of Efficacy|14|||
146647870|NCT03254108|528888447|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
146647871|NCT03254108|528888448|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
146647872|NCT01771809|528888449|FG000|Overall Study|Adverse Event|4|||
146647873|NCT01771809|528888450|FG001|Overall Study|Adverse Event|12|||
146647874|NCT01771809|528888449|FG000|Overall Study|Protocol Violation|0|||
146647875|NCT01771809|528888450|FG001|Overall Study|Protocol Violation|1|||
146647876|NCT01771809|528888449|FG000|Overall Study|Withdrawal by Subject|34|||
146647877|NCT01771809|528888450|FG001|Overall Study|Withdrawal by Subject|42|||
146647878|NCT01771809|528888449|FG000|Overall Study|Lost to Follow-up|1|||
146647879|NCT01771809|528888450|FG001|Overall Study|Lost to Follow-up|3|||
146647880|NCT01771809|528888449|FG000|Overall Study|Other (Insufficient clinical response)|22|||
146647881|NCT01771809|528888450|FG001|Overall Study|Other (Insufficient clinical response)|20|||
146502720|NCT01516008|528341943|FG002|Overall Study|Lack of Efficacy|10|||
146647882|NCT01771809|528888449|FG000|Overall Study|Death|1|||
146647883|NCT01771809|528888450|FG001|Overall Study|Death|0|||
146647884|NCT01771809|528888449|FG000|Overall Study|Other (other)|9|||
146647885|NCT01771809|528888450|FG001|Overall Study|Other (other)|5|||
146647886|NCT00362180|528888451|FG000|Treated Period|Withdrawal by Subject|1|||
146647887|NCT00362180|528888452|FG001|Treated Period|Withdrawal by Subject|0|||
146647888|NCT00362180|528888453|FG002|Treated Period|Withdrawal by Subject|0|||
146647889|NCT00362180|528888454|FG003|Treated Period|Withdrawal by Subject|0|||
146502721|NCT01516008|528341941|FG000|Overall Study|Protocol Violation|1|||
146502722|NCT01516008|528341942|FG001|Overall Study|Protocol Violation|0|||
146502723|NCT01516008|528341943|FG002|Overall Study|Protocol Violation|0|||
146502724|NCT01516008|528341941|FG000|Overall Study|Reason not specified|0|||
146502725|NCT01516008|528341942|FG001|Overall Study|Reason not specified|0|||
146502726|NCT01516008|528341943|FG002|Overall Study|Reason not specified|1|||
146502727|NCT01217476|528341944|FG000|Overall Study|Adverse Event|6|||
146502728|NCT01217476|528341945|FG001|Overall Study|Adverse Event|1|||
146502729|NCT01217476|528341944|FG000|Overall Study|Physician Decision|0|||
146502730|NCT01217476|528341945|FG001|Overall Study|Physician Decision|1|||
146502731|NCT01217476|528341944|FG000|Overall Study|Withdrawal by Subject|3|||
146502732|NCT01217476|528341945|FG001|Overall Study|Withdrawal by Subject|3|||
146502733|NCT01217476|528341944|FG000|Overall Study|Surgery on the Target Limb|0|||
146502734|NCT01217476|528341945|FG001|Overall Study|Surgery on the Target Limb|2|||
146502735|NCT01217476|528341944|FG000|Overall Study|Protocol Deviation|1|||
146502736|NCT01217476|528341945|FG001|Overall Study|Protocol Deviation|0|||
146502737|NCT01217476|528341944|FG000|Overall Study|Other|2|||
146502738|NCT01217476|528341945|FG001|Overall Study|Other|0|||
146502739|NCT00986921|528341950|FG000|Overall Study|Physician Decision|1|||
146502740|NCT00986921|528341951|FG001|Overall Study|Physician Decision|0|||
146502741|NCT00813813|528341952|FG000|Overall Study|Withdrawal by Subject|1|||
146502742|NCT00813813|528341953|FG001|Overall Study|Withdrawal by Subject|1|||
146502743|NCT00813813|528341952|FG000|Overall Study|Lost to Follow-up|2|||
146502744|NCT00813813|528341953|FG001|Overall Study|Lost to Follow-up|7|||
146502745|NCT00813813|528341952|FG000|Overall Study|Other|0|||
146502746|NCT00813813|528341953|FG001|Overall Study|Other|1|||
146502747|NCT04445714|528341954|FG000|Overall Study|Discontinuation of the study|14|||
146502748|NCT04445714|528341954|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
146502749|NCT04445714|528341954|FG000|Overall Study|Withdrawal of Informed Consent|8|||
146502750|NCT02805660|528341955|FG000|Overall Study|Death|5|||
146502751|NCT02805660|528341956|FG001|Overall Study|Death|2|||
146502752|NCT02805660|528341957|FG002|Overall Study|Death|9|||
146502753|NCT02805660|528341958|FG003|Overall Study|Death|5|||
146502754|NCT02805660|528341959|FG004|Overall Study|Death|0|||
146502755|NCT02805660|528341960|FG005|Overall Study|Death|14|||
146502756|NCT02805660|528341961|FG006|Overall Study|Death|12|||
146502757|NCT02805660|528341955|FG000|Overall Study|Lost to Follow-up|0|||
146502758|NCT02805660|528341956|FG001|Overall Study|Lost to Follow-up|1|||
146502759|NCT02805660|528341957|FG002|Overall Study|Lost to Follow-up|1|||
146502760|NCT02805660|528341958|FG003|Overall Study|Lost to Follow-up|2|||
146502761|NCT02805660|528341959|FG004|Overall Study|Lost to Follow-up|0|||
146502762|NCT02805660|528341960|FG005|Overall Study|Lost to Follow-up|0|||
146502763|NCT02805660|528341961|FG006|Overall Study|Lost to Follow-up|0|||
146502764|NCT02805660|528341955|FG000|Overall Study|Withdrawal by Subject|0|||
146502765|NCT02805660|528341956|FG001|Overall Study|Withdrawal by Subject|0|||
146502766|NCT02805660|528341957|FG002|Overall Study|Withdrawal by Subject|0|||
146502767|NCT02805660|528341958|FG003|Overall Study|Withdrawal by Subject|3|||
146647890|NCT00362180|528888455|FG004|Treated Period|Withdrawal by Subject|0|||
146647891|NCT00362180|528888456|FG005|Treated Period|Withdrawal by Subject|0|||
146647892|NCT00362180|528888457|FG006|Treated Period|Withdrawal by Subject|0|||
146647893|NCT00362180|528888458|FG007|Treated Period|Withdrawal by Subject|0|||
146647894|NCT00362180|528888459|FG008|Treated Period|Withdrawal by Subject|0|||
146647895|NCT00362180|528888451|FG000|Treated Period|Adverse Event|0|||
146647896|NCT00362180|528888452|FG001|Treated Period|Adverse Event|0|||
146647897|NCT00362180|528888453|FG002|Treated Period|Adverse Event|0|||
146647898|NCT00362180|528888454|FG003|Treated Period|Adverse Event|0|||
146647899|NCT00362180|528888455|FG004|Treated Period|Adverse Event|0|||
146647900|NCT00362180|528888456|FG005|Treated Period|Adverse Event|1|||
146647901|NCT00362180|528888457|FG006|Treated Period|Adverse Event|0|||
146647902|NCT00362180|528888458|FG007|Treated Period|Adverse Event|1|||
146647903|NCT00362180|528888459|FG008|Treated Period|Adverse Event|0|||
146647904|NCT01106092|528888460|FG000|Overall Study|Withdrawal by Subject|0|||
146647905|NCT01106092|528888461|FG001|Overall Study|Withdrawal by Subject|0|||
146647906|NCT01106092|528888462|FG002|Overall Study|Withdrawal by Subject|0|||
146647907|NCT01106092|528888463|FG003|Overall Study|Withdrawal by Subject|1|||
146647908|NCT02434471|528888468|FG000|Overall Study|Physician Decision|9|||
146647909|NCT04839562|528888473|FG000|Overall Study|Withdrawal by Subject|0|||
146647910|NCT04839562|528888474|FG001|Overall Study|Withdrawal by Subject|1|||
146647911|NCT04839562|528888473|FG000|Overall Study|Physician Decision|0|||
146502768|NCT02805660|528341959|FG004|Overall Study|Withdrawal by Subject|1|||
146502769|NCT02805660|528341960|FG005|Overall Study|Withdrawal by Subject|0|||
146502770|NCT02805660|528341961|FG006|Overall Study|Withdrawal by Subject|2|||
146502771|NCT02805660|528341955|FG000|Overall Study|Study terminated by Sponsor|0|||
146502772|NCT02805660|528341956|FG001|Overall Study|Study terminated by Sponsor|0|||
146502773|NCT02805660|528341957|FG002|Overall Study|Study terminated by Sponsor|1|||
146647912|NCT04839562|528888474|FG001|Overall Study|Physician Decision|1|||
146502774|NCT02805660|528341958|FG003|Overall Study|Study terminated by Sponsor|4|||
146502775|NCT02805660|528341959|FG004|Overall Study|Study terminated by Sponsor|2|||
146502776|NCT02805660|528341960|FG005|Overall Study|Study terminated by Sponsor|3|||
146647913|NCT00003472|528888480|FG000|Overall Study|Not evaluable|3|||
146647914|NCT01012219|528888481|FG000|Period 1|Withdrawal by Subject|1|||
146502777|NCT02805660|528341961|FG006|Overall Study|Study terminated by Sponsor|1|||
146502778|NCT02805660|528341955|FG000|Overall Study|Miscellaneous|0|||
146502779|NCT02805660|528341956|FG001|Overall Study|Miscellaneous|1|||
146502780|NCT02805660|528341957|FG002|Overall Study|Miscellaneous|0|||
146502781|NCT02805660|528341958|FG003|Overall Study|Miscellaneous|4|||
146502782|NCT02805660|528341959|FG004|Overall Study|Miscellaneous|0|||
146502783|NCT02805660|528341960|FG005|Overall Study|Miscellaneous|6|||
146502784|NCT02805660|528341961|FG006|Overall Study|Miscellaneous|4|||
146502785|NCT02778074|528341962|FG000|Overall Study|Lost to Follow-up|7|||
146502786|NCT02778074|528341963|FG001|Overall Study|Lost to Follow-up|10|||
146502787|NCT01684943|528341964|FG000|Overall Study|Inadequate Venous Access|3|||
146502788|NCT01684943|528341965|FG001|Overall Study|Inadequate Venous Access|0|||
146502789|NCT01684943|528341966|FG002|Overall Study|Inadequate Venous Access|0|||
146502790|NCT01684943|528341964|FG000|Overall Study|Principal Investigator Determination|1|||
146502791|NCT01684943|528341965|FG001|Overall Study|Principal Investigator Determination|0|||
146502792|NCT01684943|528341966|FG002|Overall Study|Principal Investigator Determination|0|||
146647915|NCT01012219|528888481|FG000|Period 2|Withdrawal by Subject|1|||
146647916|NCT01444092|528888486|FG000|Overall Study|Adverse Event|8|||
146647917|NCT01444092|528888486|FG000|Overall Study|Protocol Violation|1|||
146647918|NCT01444092|528888486|FG000|Overall Study|Withdrawal by Subject|1|||
146647919|NCT01444092|528888486|FG000|Overall Study|Other Eligibility criteria|7|||
146647920|NCT01328366|528888489|FG000|Overall Study|Death|1|||
146647921|NCT01328366|528888489|FG000|Overall Study|Withdrawal by Subject|2|||
146647922|NCT01328366|528888489|FG000|Overall Study|Lost to Follow-up|7|||
146647923|NCT03005873|528888490|FG000|Overall Study|Prohibited medication use post radnomization|1|||
146647924|NCT03005873|528888491|FG001|Overall Study|Prohibited medication use post radnomization|1|||
146647925|NCT03005873|528888492|FG002|Overall Study|Prohibited medication use post radnomization|1|||
146502793|NCT01684943|528341964|FG000|Overall Study|Excluded from Analysis|1|||
146502794|NCT01684943|528341965|FG001|Overall Study|Excluded from Analysis|1|||
146502795|NCT01684943|528341966|FG002|Overall Study|Excluded from Analysis|1|||
146502796|NCT01684943|528341964|FG000|Overall Study|Lost to Follow-up|3|||
146502797|NCT01684943|528341965|FG001|Overall Study|Lost to Follow-up|0|||
146502798|NCT01684943|528341966|FG002|Overall Study|Lost to Follow-up|0|||
146502799|NCT01684943|528341964|FG000|Overall Study|Planning Pregnancy|1|||
146502800|NCT01684943|528341965|FG001|Overall Study|Planning Pregnancy|0|||
146502801|NCT01684943|528341966|FG002|Overall Study|Planning Pregnancy|0|||
146502802|NCT03963232|528341970|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
146502803|NCT03963232|528341971|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
146566821|NCT03289143|528587930|FG000|Overall Study|Adverse Event|10|||
146566822|NCT03289143|528587931|FG001|Overall Study|Adverse Event|7|||
146566823|NCT03289143|528587932|FG002|Overall Study|Adverse Event|6|||
146566824|NCT03289143|528587933|FG003|Overall Study|Adverse Event|5|||
146566825|NCT03289143|528587930|FG000|Overall Study|Death|2|||
146566826|NCT03289143|528587931|FG001|Overall Study|Death|0|||
146566827|NCT03289143|528587932|FG002|Overall Study|Death|2|||
146566828|NCT03289143|528587933|FG003|Overall Study|Death|1|||
146566829|NCT03289143|528587930|FG000|Overall Study|Lost to Follow-up|2|||
146566830|NCT03289143|528587931|FG001|Overall Study|Lost to Follow-up|1|||
146566831|NCT03289143|528587932|FG002|Overall Study|Lost to Follow-up|1|||
146566832|NCT03289143|528587933|FG003|Overall Study|Lost to Follow-up|0|||
146566833|NCT03289143|528587930|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
146566834|NCT03289143|528587931|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
146566835|NCT03289143|528587932|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
146566836|NCT03289143|528587933|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
146566837|NCT03289143|528587930|FG000|Overall Study|Withdrawal by Caregiver|0|||
146566838|NCT03289143|528587931|FG001|Overall Study|Withdrawal by Caregiver|1|||
146566839|NCT03289143|528587932|FG002|Overall Study|Withdrawal by Caregiver|0|||
146566840|NCT03289143|528587933|FG003|Overall Study|Withdrawal by Caregiver|0|||
146566841|NCT03289143|528587930|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
146566842|NCT03289143|528587931|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
146566843|NCT03289143|528587932|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
146566844|NCT03289143|528587933|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
146566845|NCT03289143|528587930|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
146566846|NCT03289143|528587931|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
146566847|NCT03289143|528587932|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
146566848|NCT03289143|528587933|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
146566849|NCT00948688|528587934|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
146566850|NCT00948688|528587935|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
146974346|NCT02626182|530069496|FG000|Overall Study|Adverse Event|2|||
146974347|NCT02626182|530069497|FG001|Overall Study|Adverse Event|0|||
146974348|NCT01084603|530069500|FG000|Baseline|Withdrawal by Subject|2|||
146974349|NCT01084603|530069500|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
146974350|NCT01084603|530069500|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
146974351|NCT01084603|530069500|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
146974352|NCT01084603|530069500|FG000|Washout Period 4|Adverse Event|1|||
146974353|NCT03836729|530069503|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
146974354|NCT03372369|530069509|FG000|Qualification Period|Withdrawal by Subject|16|||
146974355|NCT03372369|530069510|FG001|Qualification Period|Withdrawal by Subject|13|||
146974356|NCT03372369|530069509|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
146974357|NCT03372369|530069510|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
146974358|NCT03372369|530069509|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
146974359|NCT03372369|530069510|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
146974360|NCT02239601|530069511|FG000|Overall Study|Withdrawal by Subject|3|||
146974361|NCT02239601|530069512|FG001|Overall Study|Withdrawal by Subject|4|||
146974362|NCT02239601|530069511|FG000|Overall Study|Protocol Violation|4|||
146974363|NCT02239601|530069512|FG001|Overall Study|Protocol Violation|2|||
146974364|NCT01508325|530069513|FG000|Overall Study|Withdrawal by Subject|8|||
146974365|NCT01508325|530069514|FG001|Overall Study|Withdrawal by Subject|9|||
146974366|NCT01508325|530069513|FG000|Overall Study|Protocol Violation|0|||
146974367|NCT01508325|530069514|FG001|Overall Study|Protocol Violation|3|||
146974368|NCT01508325|530069513|FG000|Overall Study|Physician Decision|2|||
146974369|NCT01508325|530069514|FG001|Overall Study|Physician Decision|1|||
146974370|NCT01508325|530069513|FG000|Overall Study|Adverse Event|1|||
146974371|NCT01508325|530069514|FG001|Overall Study|Adverse Event|0|||
146974372|NCT01508325|530069513|FG000|Overall Study|Lost to Follow-up|5|||
146974373|NCT01508325|530069514|FG001|Overall Study|Lost to Follow-up|6|||
146974374|NCT01508325|530069513|FG000|Overall Study|Other|2|||
146974375|NCT01508325|530069514|FG001|Overall Study|Other|2|||
146974376|NCT01392170|530069515|FG000|Overall Study|Withdrawal by Subject|1|||
146974377|NCT01392170|530069515|FG000|Overall Study|Ineligible|1|||
146974378|NCT00763269|530069523|FG000|Overall Study|Lost to Follow-up|12|||
146974379|NCT00763269|530069524|FG001|Overall Study|Lost to Follow-up|13|||
146974380|NCT03174925|530069527|FG000|Overall Study|Elastographic images not retrievable|2|||
146974381|NCT03174925|530069527|FG000|Overall Study|Elastography image not interpretable|1|||
146974382|NCT01791127|530069528|FG000|Overall Study|Death|356|||
146974383|NCT01791127|530069528|FG000|Overall Study|Patient has withdrawn from study|293|||
146974384|NCT01791127|530069528|FG000|Overall Study|Lost to Follow-up|42|||
146974385|NCT01791127|530069528|FG000|Overall Study|All Siello leads are explanted|31|||
146974386|NCT01791127|530069528|FG000|Overall Study|Completion of 30 day safety registry|1|||
146974387|NCT01791127|530069528|FG000|Overall Study|Study terminated for EP Passion|749|||
146974388|NCT00589693|530069534|FG000|Overall Study|randomized in error|12|||
146974389|NCT00589693|530069535|FG001|Overall Study|randomized in error|6|||
146974390|NCT00589693|530069534|FG000|Overall Study|Adverse Event|4|||
146974391|NCT00589693|530069535|FG001|Overall Study|Adverse Event|4|||
146974392|NCT00589693|530069534|FG000|Overall Study|Death|26|||
146974393|NCT00589693|530069535|FG001|Overall Study|Death|16|||
146974394|NCT00589693|530069534|FG000|Overall Study|Lack of Efficacy|0|||
146974395|NCT00589693|530069535|FG001|Overall Study|Lack of Efficacy|1|||
146566851|NCT00948688|528587934|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
146566852|NCT00948688|528587935|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
146566853|NCT00948688|528587934|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
146566854|NCT00948688|528587935|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
146566855|NCT00730756|528587936|FG000|Overall Study|Adverse Event|2|||
146566856|NCT00730756|528587937|FG001|Overall Study|Adverse Event|0|||
146566857|NCT00730756|528587936|FG000|Overall Study|Lack of Efficacy|1|||
146566858|NCT00730756|528587937|FG001|Overall Study|Lack of Efficacy|1|||
146566859|NCT00730756|528587936|FG000|Overall Study|Protocol Deviation|1|||
146566860|NCT00730756|528587937|FG001|Overall Study|Protocol Deviation|2|||
146566861|NCT00730756|528587936|FG000|Overall Study|Lost to Follow-up|0|||
146566862|NCT00730756|528587937|FG001|Overall Study|Lost to Follow-up|1|||
146566863|NCT00730756|528587936|FG000|Overall Study|Withdrew Consent|0|||
146566864|NCT00730756|528587937|FG001|Overall Study|Withdrew Consent|1|||
146566865|NCT00524121|528587940|FG000|Overall Study|Disease progression|6|||
146566866|NCT00524121|528587940|FG000|Overall Study|Adverse Event|4|||
146566867|NCT00524121|528587940|FG000|Overall Study|Patient refused|2|||
146566868|NCT00524121|528587940|FG000|Overall Study|Other|1|||
146566869|NCT00524121|528587940|FG000|Overall Study|Death|1|||
146566870|NCT00524121|528587940|FG000|Overall Study|Not treated (became ineligible)|4|||
146974396|NCT00589693|530069534|FG000|Overall Study|Lost to Follow-up|1|||
146566871|NCT00524121|528587940|FG000|Overall Study|Not treated (changed mind)|1|||
146566872|NCT01840943|528587941|FG000|Overall Study|Withdrawal by Subject|5|||
146566873|NCT01840943|528587942|FG001|Overall Study|Withdrawal by Subject|6|||
146502804|NCT03963232|528341970|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
146647926|NCT03005873|528888490|FG000|Overall Study|Withdrew consent|0|||
146647927|NCT03005873|528888491|FG001|Overall Study|Withdrew consent|1|||
146769160|NCT01393119|529323433|FG001|Overall Study|Adverse Event|1|||
146769161|NCT01393119|529323434|FG002|Overall Study|Adverse Event|0|||
146769162|NCT01393119|529323435|FG003|Overall Study|Adverse Event|1|||
146769163|NCT01393119|529323432|FG000|Overall Study|Withdrawal by Subject|0|||
146769164|NCT01393119|529323433|FG001|Overall Study|Withdrawal by Subject|1|||
146769165|NCT01393119|529323434|FG002|Overall Study|Withdrawal by Subject|1|||
146769166|NCT01393119|529323435|FG003|Overall Study|Withdrawal by Subject|0|||
146769167|NCT01393119|529323432|FG000|Overall Study|Lack of Efficacy|1|||
146769168|NCT01393119|529323433|FG001|Overall Study|Lack of Efficacy|0|||
146769169|NCT01393119|529323434|FG002|Overall Study|Lack of Efficacy|2|||
146769170|NCT01393119|529323435|FG003|Overall Study|Lack of Efficacy|1|||
146769171|NCT01393119|529323432|FG000|Overall Study|Protocol Violation|0|||
146769172|NCT01393119|529323433|FG001|Overall Study|Protocol Violation|0|||
146769173|NCT01393119|529323434|FG002|Overall Study|Protocol Violation|1|||
146769174|NCT01393119|529323435|FG003|Overall Study|Protocol Violation|0|||
146769175|NCT01393119|529323432|FG000|Overall Study|Death|0|||
146769176|NCT01393119|529323433|FG001|Overall Study|Death|0|||
146769177|NCT01393119|529323434|FG002|Overall Study|Death|0|||
146769178|NCT01393119|529323435|FG003|Overall Study|Death|1|||
146769179|NCT01393119|529323432|FG000|Overall Study|Randomized but Not treated|1|||
146769180|NCT01393119|529323433|FG001|Overall Study|Randomized but Not treated|0|||
146769181|NCT01393119|529323434|FG002|Overall Study|Randomized but Not treated|1|||
146769182|NCT01393119|529323435|FG003|Overall Study|Randomized but Not treated|1|||
146769183|NCT01393119|529323432|FG000|Overall Study|Sponsor Termination of Study|11|||
146769184|NCT01393119|529323433|FG001|Overall Study|Sponsor Termination of Study|12|||
146769185|NCT01393119|529323434|FG002|Overall Study|Sponsor Termination of Study|9|||
146647928|NCT03005873|528888492|FG002|Overall Study|Withdrew consent|2|||
146647929|NCT03005873|528888490|FG000|Overall Study|Lost to Follow-up|0|||
146647930|NCT03005873|528888491|FG001|Overall Study|Lost to Follow-up|1|||
146647931|NCT03005873|528888492|FG002|Overall Study|Lost to Follow-up|0|||
146647932|NCT03005873|528888490|FG000|Overall Study|Ineligible post randomization|0|||
146647933|NCT03005873|528888491|FG001|Overall Study|Ineligible post randomization|0|||
146647934|NCT03005873|528888492|FG002|Overall Study|Ineligible post randomization|1|||
146647935|NCT04585009|528888493|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
146647936|NCT04585009|528888494|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146647937|NCT04585009|528888495|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146647938|NCT04585009|528888496|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146647939|NCT04585009|528888497|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146647940|NCT04585009|528888498|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146647941|NCT04585009|528888499|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146647942|NCT04585009|528888500|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146647943|NCT04585009|528888501|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146647944|NCT04585009|528888502|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146647945|NCT04585009|528888503|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146647946|NCT04585009|528888504|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146647947|NCT04585009|528888493|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
146647948|NCT04585009|528888494|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146647949|NCT04585009|528888495|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146647950|NCT04585009|528888496|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146647951|NCT04585009|528888497|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146647952|NCT04585009|528888498|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146647953|NCT04585009|528888499|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146647954|NCT04585009|528888500|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146647955|NCT04585009|528888501|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146647956|NCT04585009|528888502|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146647957|NCT04585009|528888503|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146647958|NCT04585009|528888504|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146647959|NCT04585009|528888493|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146647960|NCT04585009|528888494|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146647961|NCT04585009|528888495|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146647962|NCT04585009|528888496|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146769186|NCT01393119|529323435|FG003|Overall Study|Sponsor Termination of Study|12|||
146769187|NCT01266265|529323436|FG000|Overall Study|Death|95|||
146769188|NCT01266265|529323437|FG001|Overall Study|Death|73|||
146769189|NCT01266265|529323436|FG000|Overall Study|Lost to Follow-up|23|||
146912641|NCT02546856|529843116|FG000|4 Months Evaluation|Working or living abroad|5|||
146912642|NCT02546856|529843117|FG001|4 Months Evaluation|Working or living abroad|1|||
146769190|NCT01266265|529323437|FG001|Overall Study|Lost to Follow-up|28|||
146647963|NCT04585009|528888497|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146502805|NCT03963232|528341971|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
146502806|NCT03963232|528341970|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
146502807|NCT03963232|528341971|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
146502808|NCT03963232|528341970|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
146502809|NCT03963232|528341971|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
146502810|NCT03963232|528341970|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
146502811|NCT03963232|528341971|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
146502812|NCT03963232|528341970|FG000|Open-Label Treatment Phase|Adverse Event|1|||
146502813|NCT03963232|528341971|FG001|Open-Label Treatment Phase|Adverse Event|2|||
146502814|NCT03963232|528341970|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
146502815|NCT03963232|528341971|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
146502816|NCT03963232|528341970|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
146502817|NCT03963232|528341971|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
146502818|NCT03963232|528341970|FG000|Open-Label Treatment Phase|Pregnancy|1|||
146502819|NCT03963232|528341971|FG001|Open-Label Treatment Phase|Pregnancy|0|||
146502820|NCT03963232|528341970|FG000|Follow-up Phase|Withdrawal by Subject|7|||
146502821|NCT03963232|528341971|FG001|Follow-up Phase|Withdrawal by Subject|5|||
146502822|NCT03963232|528341970|FG000|Follow-up Phase|Protocol Violation|0|||
146502823|NCT03963232|528341971|FG001|Follow-up Phase|Protocol Violation|2|||
146502824|NCT03963232|528341970|FG000|Follow-up Phase|Adverse Event|0|||
146502825|NCT03963232|528341971|FG001|Follow-up Phase|Adverse Event|1|||
146647964|NCT04585009|528888498|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146769191|NCT01266265|529323436|FG000|Overall Study|Withdrawal by Subject|13|||
146502826|NCT03963232|528341970|FG000|Follow-up Phase|Lost to Follow-up|0|||
146647965|NCT04585009|528888499|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146647966|NCT04585009|528888500|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
146647967|NCT04585009|528888501|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146647968|NCT04585009|528888502|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146647969|NCT04585009|528888503|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146647970|NCT04585009|528888504|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146647971|NCT04585009|528888493|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146647972|NCT04585009|528888494|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146647973|NCT04585009|528888495|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146647974|NCT04585009|528888496|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146647975|NCT04585009|528888497|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
146647976|NCT04585009|528888498|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146647977|NCT04585009|528888499|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146647978|NCT04585009|528888500|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146647979|NCT04585009|528888501|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146647980|NCT04585009|528888502|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146647981|NCT04585009|528888503|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146647982|NCT04585009|528888504|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146647983|NCT04585009|528888493|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146647984|NCT04585009|528888494|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146647985|NCT04585009|528888495|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146647986|NCT04585009|528888496|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146647987|NCT04585009|528888497|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146647988|NCT04585009|528888498|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146647989|NCT04585009|528888499|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146647990|NCT04585009|528888500|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146647991|NCT04585009|528888501|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146647992|NCT04585009|528888502|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
146647993|NCT04585009|528888503|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146647994|NCT04585009|528888504|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146647995|NCT04585009|528888493|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146647996|NCT04585009|528888494|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146647997|NCT04585009|528888495|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146647998|NCT04585009|528888496|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146647999|NCT04585009|528888497|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146648000|NCT04585009|528888498|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146648001|NCT04585009|528888499|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146648002|NCT04585009|528888500|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146912643|NCT02546856|529843116|FG000|4 Months Evaluation|reasons not due to titration|4|||
146502827|NCT03963232|528341971|FG001|Follow-up Phase|Lost to Follow-up|1|||
146502828|NCT03512210|528341973|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
146502829|NCT03512210|528341973|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
146502830|NCT03512210|528341973|FG000|Step 2:Post-MINMON|Death|2|||
146974397|NCT00589693|530069535|FG001|Overall Study|Lost to Follow-up|0|||
146974398|NCT00589693|530069534|FG000|Overall Study|Physician Decision|0|||
146974399|NCT00589693|530069535|FG001|Overall Study|Physician Decision|1|||
146502831|NCT03512210|528341973|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
146502832|NCT03512210|528341973|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
146502833|NCT01672710|528341976|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
146502834|NCT01672710|528341977|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
146502835|NCT01672710|528341976|FG000|3 Month Follow up|Lost to Follow-up|2|||
146502836|NCT01672710|528341977|FG001|3 Month Follow up|Lost to Follow-up|3|||
146502837|NCT01672710|528341976|FG000|3 Month Follow up|follow up due after termination date|4|||
146502838|NCT01672710|528341977|FG001|3 Month Follow up|follow up due after termination date|1|||
146502839|NCT02122887|528341978|FG000|Overall Study|Withdrawal by Subject|20|||
146502840|NCT02122887|528341979|FG001|Overall Study|Withdrawal by Subject|2|||
146502841|NCT03725761|528341980|FG000|Overall Study|still on study|1|||
146502842|NCT01397786|528344211|FG000|Phase A|Lost to Follow-up|0|||
146502843|NCT01397786|528344212|FG001|Phase A|Lost to Follow-up|0|||
146502844|NCT01397786|528344213|FG002|Phase A|Lost to Follow-up|6|||
146502845|NCT01397786|528344211|FG000|Phase A|Adverse Event|0|||
146502846|NCT01397786|528344212|FG001|Phase A|Adverse Event|0|||
146502847|NCT01397786|528344213|FG002|Phase A|Adverse Event|8|||
146502848|NCT01397786|528344211|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
146502849|NCT01397786|528344212|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
146502850|NCT01397786|528344213|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
146502851|NCT01397786|528344211|FG000|Phase A|Physician Decision|0|||
146502852|NCT01397786|528344212|FG001|Phase A|Physician Decision|0|||
146502853|NCT01397786|528344213|FG002|Phase A|Physician Decision|1|||
146502854|NCT01397786|528344211|FG000|Phase A|Withdrawal by Subject|0|||
146502855|NCT01397786|528344212|FG001|Phase A|Withdrawal by Subject|0|||
146502856|NCT01397786|528344213|FG002|Phase A|Withdrawal by Subject|5|||
146502857|NCT01397786|528344211|FG000|Phase A|Lack of Efficacy|0|||
146502858|NCT01397786|528344212|FG001|Phase A|Lack of Efficacy|0|||
146502859|NCT01397786|528344213|FG002|Phase A|Lack of Efficacy|1|||
146502860|NCT01397786|528344211|FG000|Phase B|Lost to Follow-up|22|||
146502861|NCT01397786|528344212|FG001|Phase B|Lost to Follow-up|12|||
146502862|NCT01397786|528344213|FG002|Phase B|Lost to Follow-up|22|||
146502863|NCT01397786|528344211|FG000|Phase B|Adverse Event|109|||
146502864|NCT01397786|528344212|FG001|Phase B|Adverse Event|23|||
146502865|NCT01397786|528344213|FG002|Phase B|Adverse Event|27|||
146502866|NCT01397786|528344211|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
146502867|NCT01397786|528344212|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
146502868|NCT01397786|528344213|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
146502869|NCT01397786|528344211|FG000|Phase B|Physician Decision|9|||
146502870|NCT01397786|528344212|FG001|Phase B|Physician Decision|1|||
146502871|NCT01397786|528344213|FG002|Phase B|Physician Decision|3|||
146502872|NCT01397786|528344211|FG000|Phase B|Withdrawal by Subject|102|||
146502873|NCT01397786|528344212|FG001|Phase B|Withdrawal by Subject|45|||
146502874|NCT01397786|528344213|FG002|Phase B|Withdrawal by Subject|30|||
146502875|NCT01397786|528344211|FG000|Phase B|Protocol Deviation|1|||
146502876|NCT01397786|528344212|FG001|Phase B|Protocol Deviation|2|||
146502877|NCT01397786|528344213|FG002|Phase B|Protocol Deviation|4|||
146502878|NCT01397786|528344211|FG000|Phase B|Lack of Efficacy|22|||
146502879|NCT01397786|528344212|FG001|Phase B|Lack of Efficacy|7|||
146502880|NCT01397786|528344213|FG002|Phase B|Lack of Efficacy|14|||
146502881|NCT00860249|528344217|FG000|Overall Study|trial was terminated prior to completion|21|||
146502882|NCT00860249|528344218|FG001|Overall Study|trial was terminated prior to completion|18|||
146502883|NCT00860249|528344219|FG002|Overall Study|trial was terminated prior to completion|21|||
146502884|NCT00784550|528344220|FG000|Overall Study|Adverse Event|12|||
146974400|NCT00589693|530069534|FG000|Overall Study|Protocol Violation|1|||
146974401|NCT00589693|530069535|FG001|Overall Study|Protocol Violation|1|||
146974402|NCT03231709|530069536|FG000|Treatment Period 1|Reason not Specified|0|||
146974403|NCT03231709|530069537|FG001|Treatment Period 1|Reason not Specified|1|||
146502885|NCT00784550|528344221|FG001|Overall Study|Adverse Event|10|||
146502886|NCT00784550|528344220|FG000|Overall Study|Lack of Efficacy|0|||
146502887|NCT00784550|528344221|FG001|Overall Study|Lack of Efficacy|1|||
146502888|NCT00784550|528344220|FG000|Overall Study|Protocol Violation|10|||
146502889|NCT00784550|528344221|FG001|Overall Study|Protocol Violation|10|||
146502890|NCT00784550|528344220|FG000|Overall Study|Lost to Follow-up|8|||
146502891|NCT00784550|528344221|FG001|Overall Study|Lost to Follow-up|5|||
146502892|NCT00784550|528344220|FG000|Overall Study|Physician Decision|2|||
146502893|NCT00784550|528344221|FG001|Overall Study|Physician Decision|3|||
146502894|NCT00784550|528344220|FG000|Overall Study|Withdrawal by Subject|4|||
146769192|NCT01266265|529323437|FG001|Overall Study|Withdrawal by Subject|11|||
146974404|NCT03231709|530069536|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
146974405|NCT03231709|530069537|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
146502895|NCT00784550|528344221|FG001|Overall Study|Withdrawal by Subject|13|||
146502896|NCT05903924|528344222|FG000|Overall Study|Lost to Follow-up|1|||
146502897|NCT05903924|528344223|FG001|Overall Study|Lost to Follow-up|0|||
146502898|NCT05903924|528344224|FG002|Overall Study|Lost to Follow-up|0|||
146502899|NCT01275755|528344236|FG000|Double-blind Treatment Period|Adverse Event|0|||
146648003|NCT04585009|528888501|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146648004|NCT04585009|528888502|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146648005|NCT04585009|528888503|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146648006|NCT04585009|528888504|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
146648007|NCT01713933|528888507|FG000|Overall Study|Lost to Follow-up|2|||
146648008|NCT01713933|528888507|FG000|Overall Study|Withdrawal by Subject|3|||
146648009|NCT01713933|528888507|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
146648010|NCT01104376|528888512|FG000|Overall Study|Withdrawal by Subject|15|||
146648011|NCT01104376|528888512|FG000|Overall Study|Consented but excluded after labs|13|||
146648012|NCT00797966|528888513|FG000|Phase A|Lost to Follow-up|0|||
146769193|NCT01266265|529323436|FG000|Overall Study|Respiratory-related adverse event|2|||
146648013|NCT00797966|528888514|FG001|Phase A|Lost to Follow-up|0|||
146648014|NCT00797966|528888515|FG002|Phase A|Lost to Follow-up|0|||
146648015|NCT00797966|528888516|FG003|Phase A|Lost to Follow-up|0|||
146648016|NCT00797966|528888517|FG004|Phase A|Lost to Follow-up|33|||
146648017|NCT00797966|528888518|FG005|Phase A|Lost to Follow-up|0|||
146648018|NCT00797966|528888513|FG000|Phase A|Adverse Event|0|||
146648019|NCT00797966|528888514|FG001|Phase A|Adverse Event|0|||
146648020|NCT00797966|528888515|FG002|Phase A|Adverse Event|0|||
146769194|NCT01266265|529323437|FG001|Overall Study|Respiratory-related adverse event|1|||
146769195|NCT01266265|529323436|FG000|Overall Study|Transferred care to another provider|22|||
146769196|NCT01266265|529323437|FG001|Overall Study|Transferred care to another provider|28|||
146769197|NCT01266265|529323436|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
146769198|NCT01266265|529323437|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
146648021|NCT00797966|528888516|FG003|Phase A|Adverse Event|0|||
146648022|NCT00797966|528888517|FG004|Phase A|Adverse Event|46|||
146648023|NCT00797966|528888518|FG005|Phase A|Adverse Event|0|||
146648024|NCT00797966|528888513|FG000|Phase A|Met withdrawal criteria|0|||
146648025|NCT00797966|528888514|FG001|Phase A|Met withdrawal criteria|0|||
146648026|NCT00797966|528888515|FG002|Phase A|Met withdrawal criteria|0|||
146648027|NCT00797966|528888516|FG003|Phase A|Met withdrawal criteria|0|||
146648028|NCT00797966|528888517|FG004|Phase A|Met withdrawal criteria|4|||
146648029|NCT00797966|528888518|FG005|Phase A|Met withdrawal criteria|0|||
146648030|NCT00797966|528888513|FG000|Phase A|Physician Decision|0|||
146648031|NCT00797966|528888514|FG001|Phase A|Physician Decision|0|||
146648032|NCT00797966|528888515|FG002|Phase A|Physician Decision|0|||
146648033|NCT00797966|528888516|FG003|Phase A|Physician Decision|0|||
146648034|NCT00797966|528888517|FG004|Phase A|Physician Decision|13|||
146648035|NCT00797966|528888518|FG005|Phase A|Physician Decision|0|||
146648036|NCT00797966|528888513|FG000|Phase A|Withdrawal by Subject|0|||
146648037|NCT00797966|528888514|FG001|Phase A|Withdrawal by Subject|0|||
146769199|NCT01266265|529323436|FG000|Overall Study|Enrolled in another clinical study|15|||
146769200|NCT01266265|529323437|FG001|Overall Study|Enrolled in another clinical study|26|||
146648038|NCT00797966|528888515|FG002|Phase A|Withdrawal by Subject|0|||
146648039|NCT00797966|528888516|FG003|Phase A|Withdrawal by Subject|0|||
146648040|NCT00797966|528888517|FG004|Phase A|Withdrawal by Subject|33|||
146648041|NCT00797966|528888518|FG005|Phase A|Withdrawal by Subject|0|||
146648042|NCT00797966|528888513|FG000|Phase A|Protocol deviation|0|||
146648043|NCT00797966|528888514|FG001|Phase A|Protocol deviation|0|||
146769201|NCT01266265|529323436|FG000|Overall Study|Non-compliance|8|||
146912644|NCT02546856|529843117|FG001|4 Months Evaluation|reasons not due to titration|1|||
146912645|NCT02546856|529843116|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
146912646|NCT02546856|529843117|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
146912647|NCT02546856|529843116|FG000|6 Months Evaluation|Death|1|||
146912648|NCT02546856|529843117|FG001|6 Months Evaluation|Death|1|||
146912649|NCT02546856|529843116|FG000|6 Months Evaluation|Lost to Follow-up|1|||
146912650|NCT02546856|529843117|FG001|6 Months Evaluation|Lost to Follow-up|1|||
146912651|NCT02546856|529843116|FG000|6 Months Evaluation|Working or living abroad|6|||
146912652|NCT02546856|529843117|FG001|6 Months Evaluation|Working or living abroad|4|||
146912653|NCT02546856|529843116|FG000|6 Months Evaluation|reasons not due to titration|0|||
146912654|NCT02546856|529843117|FG001|6 Months Evaluation|reasons not due to titration|1|||
146912655|NCT00130208|529843118|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
146912656|NCT00130208|529843119|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
146912657|NCT00130208|529843118|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
146912658|NCT00130208|529843119|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
146912659|NCT00130208|529843118|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
146912660|NCT00130208|529843119|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
146912661|NCT00130208|529843118|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
146912662|NCT00130208|529843119|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
146912663|NCT00130208|529843118|FG000|Maintenance Period (26 Weeks)|Other|1|||
146912664|NCT00130208|529843119|FG001|Maintenance Period (26 Weeks)|Other|1|||
146912665|NCT00130208|529843118|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
146912666|NCT00130208|529843119|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
146974406|NCT02609178|530069538|FG000|First Crown|Withdrawal by Subject|0|||
146648044|NCT00797966|528888515|FG002|Phase A|Protocol deviation|0|||
146648045|NCT00797966|528888516|FG003|Phase A|Protocol deviation|0|||
146769202|NCT01266265|529323437|FG001|Overall Study|Non-compliance|5|||
146974407|NCT02609178|530069539|FG001|First Crown|Withdrawal by Subject|0|||
146974408|NCT02609178|530069540|FG002|First Crown|Withdrawal by Subject|1|||
146974409|NCT02609178|530069541|FG003|First Crown|Withdrawal by Subject|1|||
146974410|NCT02609178|530069542|FG004|First Crown|Withdrawal by Subject|0|||
146974411|NCT02609178|530069543|FG005|First Crown|Withdrawal by Subject|0|||
146974412|NCT01128153|530069544|FG000|Overall Study|Adverse Event|1|||
146974413|NCT01128153|530069545|FG001|Overall Study|Adverse Event|3|||
146974414|NCT01128153|530069544|FG000|Overall Study|Condition under investigation worsened|8|||
146974415|NCT01128153|530069545|FG001|Overall Study|Condition under investigation worsened|7|||
146974416|NCT01128153|530069544|FG000|Overall Study|Withdrawal by Subject|2|||
146974417|NCT01128153|530069545|FG001|Overall Study|Withdrawal by Subject|3|||
146974418|NCT01128153|530069544|FG000|Overall Study|Incorrect enrolment to study|2|||
146974419|NCT01128153|530069545|FG001|Overall Study|Incorrect enrolment to study|1|||
146974420|NCT01128153|530069544|FG000|Overall Study|Protocol Violation|2|||
146974421|NCT01128153|530069545|FG001|Overall Study|Protocol Violation|0|||
146974422|NCT01128153|530069544|FG000|Overall Study|Developed discontinuation criteria|1|||
146974423|NCT01128153|530069545|FG001|Overall Study|Developed discontinuation criteria|1|||
146974424|NCT01954082|530069546|FG000|Overall Study|Study Suspension|42|||
146974425|NCT01954082|530069547|FG001|Overall Study|Study Suspension|36|||
146974426|NCT01954082|530069546|FG000|Overall Study|Adverse Event|10|||
146974427|NCT01954082|530069547|FG001|Overall Study|Adverse Event|4|||
146974428|NCT01954082|530069546|FG000|Overall Study|Intolerance|0|||
146974429|NCT01954082|530069547|FG001|Overall Study|Intolerance|1|||
146974430|NCT01954082|530069546|FG000|Overall Study|Non-compliance|6|||
146974431|NCT01954082|530069547|FG001|Overall Study|Non-compliance|4|||
146974432|NCT01954082|530069546|FG000|Overall Study|Physician Decision|2|||
146974433|NCT01954082|530069547|FG001|Overall Study|Physician Decision|0|||
146974434|NCT01954082|530069546|FG000|Overall Study|Parent Decision|1|||
146974435|NCT01954082|530069547|FG001|Overall Study|Parent Decision|0|||
146974436|NCT01954082|530069546|FG000|Overall Study|Withdrawal by Subject|0|||
146974437|NCT01954082|530069547|FG001|Overall Study|Withdrawal by Subject|1|||
146974438|NCT01954082|530069546|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
146974439|NCT01954082|530069547|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
146648046|NCT00797966|528888517|FG004|Phase A|Protocol deviation|56|||
146648047|NCT00797966|528888518|FG005|Phase A|Protocol deviation|0|||
146648048|NCT00797966|528888513|FG000|Phase B|Lost to Follow-up|0|||
146648049|NCT00797966|528888514|FG001|Phase B|Lost to Follow-up|1|||
146648050|NCT00797966|528888515|FG002|Phase B|Lost to Follow-up|3|||
146648051|NCT00797966|528888516|FG003|Phase B|Lost to Follow-up|0|||
146648052|NCT00797966|528888517|FG004|Phase B|Lost to Follow-up|0|||
146648053|NCT00797966|528888518|FG005|Phase B|Lost to Follow-up|0|||
146648054|NCT00797966|528888513|FG000|Phase B|Adverse Event|2|||
146648055|NCT00797966|528888514|FG001|Phase B|Adverse Event|1|||
146912667|NCT00130208|529843118|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
146912668|NCT00130208|529843119|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
146912669|NCT00130208|529843118|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
146912670|NCT00130208|529843119|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
146912671|NCT00130208|529843118|FG000|Washout Period (8 Weeks)|Other|1|||
146912672|NCT00130208|529843119|FG001|Washout Period (8 Weeks)|Other|1|||
146912673|NCT03268746|529843124|FG000|Overall Study|Withdrawal by Subject|1|||
146912674|NCT02927171|529843126|FG000|Overall Study|Lost to Follow-up|0|||
146912675|NCT02927171|529843127|FG001|Overall Study|Lost to Follow-up|1|||
146912676|NCT00718861|529843130|FG000|Overall Study|Withdrawal by Subject|15|||
146912677|NCT00718861|529843131|FG001|Overall Study|Withdrawal by Subject|10|||
146912678|NCT00718861|529843130|FG000|Overall Study|Adverse Event|2|||
146912679|NCT00718861|529843131|FG001|Overall Study|Adverse Event|1|||
146912680|NCT00718861|529843130|FG000|Overall Study|Lost to Follow-up|2|||
146912681|NCT00718861|529843131|FG001|Overall Study|Lost to Follow-up|1|||
146912682|NCT00718861|529843130|FG000|Overall Study|Administrative Problems|1|||
146912683|NCT00718861|529843131|FG001|Overall Study|Administrative Problems|1|||
146912684|NCT00718861|529843130|FG000|Overall Study|Death|1|||
146912685|NCT00718861|529843131|FG001|Overall Study|Death|5|||
146974440|NCT01954082|530069546|FG000|Overall Study|Redirection of Care|0|||
146974441|NCT01954082|530069547|FG001|Overall Study|Redirection of Care|2|||
146974442|NCT01954082|530069546|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
146648056|NCT00797966|528888515|FG002|Phase B|Adverse Event|3|||
146648057|NCT00797966|528888516|FG003|Phase B|Adverse Event|1|||
146648058|NCT00797966|528888517|FG004|Phase B|Adverse Event|0|||
146648059|NCT00797966|528888518|FG005|Phase B|Adverse Event|0|||
146912686|NCT02433288|529843132|FG000|Overall Study|Severe non-compliance to protocol|13|||
146974443|NCT01954082|530069547|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
146974444|NCT01954082|530069546|FG000|Overall Study|Comfort Care|0|||
146974445|NCT01954082|530069547|FG001|Overall Study|Comfort Care|1|||
146648060|NCT00797966|528888513|FG000|Phase B|Met Withdrawal Criteria|3|||
146974446|NCT01954082|530069546|FG000|Overall Study|Infant Moved|0|||
146974447|NCT01954082|530069547|FG001|Overall Study|Infant Moved|1|||
146974448|NCT01954082|530069546|FG000|Overall Study|Randomized not Treated|4|||
146648061|NCT00797966|528888514|FG001|Phase B|Met Withdrawal Criteria|3|||
146912687|NCT02433288|529843133|FG001|Overall Study|Severe non-compliance to protocol|7|||
146648062|NCT00797966|528888515|FG002|Phase B|Met Withdrawal Criteria|6|||
146648063|NCT00797966|528888516|FG003|Phase B|Met Withdrawal Criteria|1|||
146648064|NCT00797966|528888517|FG004|Phase B|Met Withdrawal Criteria|0|||
146648065|NCT00797966|528888518|FG005|Phase B|Met Withdrawal Criteria|0|||
146648066|NCT00797966|528888513|FG000|Phase B|Physician Decision|1|||
146648067|NCT00797966|528888514|FG001|Phase B|Physician Decision|0|||
146648068|NCT00797966|528888515|FG002|Phase B|Physician Decision|3|||
146648069|NCT00797966|528888516|FG003|Phase B|Physician Decision|1|||
146648070|NCT00797966|528888517|FG004|Phase B|Physician Decision|0|||
146648071|NCT00797966|528888518|FG005|Phase B|Physician Decision|0|||
146648072|NCT00797966|528888513|FG000|Phase B|Withdrawal by Subject|1|||
146648073|NCT00797966|528888514|FG001|Phase B|Withdrawal by Subject|4|||
146648074|NCT00797966|528888515|FG002|Phase B|Withdrawal by Subject|3|||
146648075|NCT00797966|528888516|FG003|Phase B|Withdrawal by Subject|3|||
146648076|NCT00797966|528888517|FG004|Phase B|Withdrawal by Subject|0|||
146648077|NCT00797966|528888518|FG005|Phase B|Withdrawal by Subject|0|||
146648078|NCT00797966|528888513|FG000|Phase B|Protocol Deviation|4|||
146648079|NCT00797966|528888514|FG001|Phase B|Protocol Deviation|8|||
146648080|NCT00797966|528888515|FG002|Phase B|Protocol Deviation|2|||
146648081|NCT00797966|528888516|FG003|Phase B|Protocol Deviation|6|||
146648082|NCT00797966|528888517|FG004|Phase B|Protocol Deviation|0|||
146648083|NCT00797966|528888518|FG005|Phase B|Protocol Deviation|0|||
146648084|NCT00797966|528888513|FG000|Phase B|Lack of Efficacy|0|||
146648085|NCT00797966|528888514|FG001|Phase B|Lack of Efficacy|1|||
146648086|NCT00797966|528888515|FG002|Phase B|Lack of Efficacy|1|||
146912688|NCT02433288|529843132|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
146912689|NCT02433288|529843133|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
146912690|NCT02433288|529843132|FG000|Overall Study|Withdrawal by Subject|101|||
146912691|NCT02433288|529843133|FG001|Overall Study|Withdrawal by Subject|99|||
146648087|NCT00797966|528888516|FG003|Phase B|Lack of Efficacy|4|||
146648088|NCT00797966|528888517|FG004|Phase B|Lack of Efficacy|0|||
146912692|NCT02433288|529843132|FG000|Overall Study|Lost to Follow-up|2|||
146912693|NCT02433288|529843133|FG001|Overall Study|Lost to Follow-up|14|||
146912694|NCT02433288|529843132|FG000|Overall Study|Death|0|||
146912695|NCT02433288|529843133|FG001|Overall Study|Death|3|||
146912696|NCT03350750|529843134|FG000|Overall Study|Death|1|||
146912697|NCT03350750|529843135|FG001|Overall Study|Death|1|||
146912698|NCT00858702|529843136|FG000|Overall Study|Lack of Efficacy|1|||
146912699|NCT00858702|529843137|FG001|Overall Study|Lack of Efficacy|0|||
146912700|NCT00858702|529843136|FG000|Overall Study|Protocol Violation|1|||
146912701|NCT00858702|529843137|FG001|Overall Study|Protocol Violation|1|||
146912702|NCT00858702|529843136|FG000|Overall Study|Other|2|||
146912703|NCT00858702|529843137|FG001|Overall Study|Other|1|||
146912704|NCT00858702|529843136|FG000|Overall Study|Withdrawal by Subject|1|||
146912705|NCT00858702|529843137|FG001|Overall Study|Withdrawal by Subject|0|||
146912706|NCT01849250|529843142|FG000|Overall Study|Withdrawal by Subject|1|||
146912707|NCT01849250|529843143|FG001|Overall Study|Withdrawal by Subject|0|||
146912708|NCT01849250|529843142|FG000|Overall Study|Not Evaluable|5|||
146912709|NCT01849250|529843143|FG001|Overall Study|Not Evaluable|3|||
146912710|NCT01849250|529843142|FG000|Overall Study|Screen Failure|1|||
146912711|NCT01849250|529843143|FG001|Overall Study|Screen Failure|0|||
146912712|NCT00367640|529843144|FG000|Overall Study|Adverse Event|3|||
146912713|NCT00367640|529843145|FG001|Overall Study|Adverse Event|6|||
146912714|NCT00367640|529843146|FG002|Overall Study|Adverse Event|8|||
146912715|NCT00367640|529843147|FG003|Overall Study|Adverse Event|0|||
146912716|NCT00367640|529843144|FG000|Overall Study|Withdrawal by Subject|8|||
146912717|NCT00367640|529843145|FG001|Overall Study|Withdrawal by Subject|11|||
146912718|NCT00367640|529843146|FG002|Overall Study|Withdrawal by Subject|8|||
146912719|NCT00367640|529843147|FG003|Overall Study|Withdrawal by Subject|6|||
146912720|NCT00367640|529843144|FG000|Overall Study|Any other reason not above-mentioned|7|||
146912721|NCT00367640|529843145|FG001|Overall Study|Any other reason not above-mentioned|5|||
146912722|NCT00367640|529843146|FG002|Overall Study|Any other reason not above-mentioned|3|||
146912723|NCT00367640|529843147|FG003|Overall Study|Any other reason not above-mentioned|4|||
146648089|NCT00797966|528888518|FG005|Phase B|Lack of Efficacy|0|||
146912724|NCT04504032|529843152|FG000|Overall Study|Adverse Event|1|||
146912725|NCT04504032|529843153|FG001|Overall Study|Adverse Event|2|||
146912726|NCT04504032|529843152|FG000|Overall Study|Lost to Follow-up|6|||
146912727|NCT04504032|529843153|FG001|Overall Study|Lost to Follow-up|9|||
146912728|NCT04504032|529843152|FG000|Overall Study|Protocol Violation|2|||
146912729|NCT04504032|529843153|FG001|Overall Study|Protocol Violation|0|||
146912730|NCT04504032|529843152|FG000|Overall Study|Study terminated by sponsor|1|||
146648090|NCT00797966|528888513|FG000|Phase A+|Lost to Follow-up|0|||
146648091|NCT00797966|528888514|FG001|Phase A+|Lost to Follow-up|0|||
146912731|NCT04504032|529843153|FG001|Overall Study|Study terminated by sponsor|2|||
146912732|NCT04504032|529843152|FG000|Overall Study|Withdrawal by Subject|9|||
146648092|NCT00797966|528888515|FG002|Phase A+|Lost to Follow-up|0|||
146648093|NCT00797966|528888516|FG003|Phase A+|Lost to Follow-up|0|||
146648094|NCT00797966|528888517|FG004|Phase A+|Lost to Follow-up|0|||
146912733|NCT04504032|529843153|FG001|Overall Study|Withdrawal by Subject|11|||
146502900|NCT01275755|528344237|FG001|Double-blind Treatment Period|Adverse Event|2|||
146502901|NCT01275755|528344236|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
146502902|NCT01275755|528344237|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
146502903|NCT01275755|528344236|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
146502904|NCT01275755|528344237|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
146502905|NCT01275755|528344236|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
146502906|NCT01275755|528344237|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
146502907|NCT00174967|528344240|FG000|Overall Study|Adverse Event|1|||
146502908|NCT00174967|528344241|FG001|Overall Study|Adverse Event|2|||
146502909|NCT00174967|528344242|FG002|Overall Study|Adverse Event|2|||
146502910|NCT00174967|528344243|FG003|Overall Study|Adverse Event|1|||
146502911|NCT00174967|528344240|FG000|Overall Study|Gout Flare|0|||
146502912|NCT00174967|528344241|FG001|Overall Study|Gout Flare|0|||
146502913|NCT00174967|528344242|FG002|Overall Study|Gout Flare|0|||
146502914|NCT00174967|528344243|FG003|Overall Study|Gout Flare|1|||
146502915|NCT00174967|528344240|FG000|Overall Study|Other|0|||
146502916|NCT00174967|528344241|FG001|Overall Study|Other|1|||
146502917|NCT00174967|528344242|FG002|Overall Study|Other|0|||
146502918|NCT00174967|528344243|FG003|Overall Study|Other|0|||
146502919|NCT04420585|528344244|FG000|Overall Study|Adverse Event|1|||
146502920|NCT04420585|528344244|FG000|Overall Study|Never initiated medication|2|||
146502921|NCT00477750|528344245|FG000|Overall Study|Currently Receiving Treatment|11|||
146502922|NCT03558152|528344246|FG000|Overall Study|Adverse Event|0|||
146502923|NCT03558152|528344247|FG001|Overall Study|Adverse Event|0|||
146502924|NCT03558152|528344248|FG002|Overall Study|Adverse Event|1|||
146502925|NCT03558152|528344249|FG003|Overall Study|Adverse Event|1|||
146502926|NCT03558152|528344250|FG004|Overall Study|Adverse Event|2|||
146502927|NCT03558152|528344251|FG005|Overall Study|Adverse Event|1|||
146502928|NCT03558152|528344252|FG006|Overall Study|Adverse Event|1|||
146502929|NCT03558152|528344253|FG007|Overall Study|Adverse Event|0|||
146502930|NCT03558152|528344246|FG000|Overall Study|Death|0|||
146502931|NCT03558152|528344247|FG001|Overall Study|Death|0|||
146502932|NCT03558152|528344248|FG002|Overall Study|Death|0|||
146502933|NCT03558152|528344249|FG003|Overall Study|Death|0|||
146502934|NCT03558152|528344250|FG004|Overall Study|Death|1|||
146502935|NCT03558152|528344251|FG005|Overall Study|Death|0|||
146502936|NCT03558152|528344252|FG006|Overall Study|Death|0|||
146502937|NCT03558152|528344253|FG007|Overall Study|Death|0|||
146502938|NCT03558152|528344246|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
146502939|NCT03558152|528344247|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
146502940|NCT03558152|528344248|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
146648095|NCT00797966|528888518|FG005|Phase A+|Lost to Follow-up|9|||
146648096|NCT00797966|528888513|FG000|Phase A+|Met withdrawal criteria|0|||
146648097|NCT00797966|528888514|FG001|Phase A+|Met withdrawal criteria|0|||
146648098|NCT00797966|528888515|FG002|Phase A+|Met withdrawal criteria|0|||
146648099|NCT00797966|528888516|FG003|Phase A+|Met withdrawal criteria|0|||
146648100|NCT00797966|528888517|FG004|Phase A+|Met withdrawal criteria|0|||
146648101|NCT00797966|528888518|FG005|Phase A+|Met withdrawal criteria|5|||
146648102|NCT00797966|528888513|FG000|Phase A+|Withdrawal by Subject|0|||
146648103|NCT00797966|528888514|FG001|Phase A+|Withdrawal by Subject|0|||
146648104|NCT00797966|528888515|FG002|Phase A+|Withdrawal by Subject|0|||
146648105|NCT00797966|528888516|FG003|Phase A+|Withdrawal by Subject|0|||
146648106|NCT00797966|528888517|FG004|Phase A+|Withdrawal by Subject|0|||
146648107|NCT00797966|528888518|FG005|Phase A+|Withdrawal by Subject|6|||
146648108|NCT00797966|528888513|FG000|Phase A+|Adverse Event|0|||
146648109|NCT00797966|528888514|FG001|Phase A+|Adverse Event|0|||
146648110|NCT00797966|528888515|FG002|Phase A+|Adverse Event|0|||
146648111|NCT00797966|528888516|FG003|Phase A+|Adverse Event|0|||
146648112|NCT00797966|528888517|FG004|Phase A+|Adverse Event|0|||
146648113|NCT00797966|528888518|FG005|Phase A+|Adverse Event|4|||
146502941|NCT03558152|528344249|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
146502942|NCT03558152|528344250|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
146502943|NCT03558152|528344251|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
146502944|NCT03558152|528344252|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
146648114|NCT00797966|528888513|FG000|Phase A+|Protocol deviation|0|||
146648115|NCT00797966|528888514|FG001|Phase A+|Protocol deviation|0|||
146648116|NCT00797966|528888515|FG002|Phase A+|Protocol deviation|0|||
146648117|NCT00797966|528888516|FG003|Phase A+|Protocol deviation|0|||
146502945|NCT03558152|528344253|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
146502946|NCT03558152|528344246|FG000|Overall Study|Miscalculation in mmcs|0|||
146502947|NCT03558152|528344247|FG001|Overall Study|Miscalculation in mmcs|0|||
146502948|NCT03558152|528344248|FG002|Overall Study|Miscalculation in mmcs|0|||
146502949|NCT03558152|528344249|FG003|Overall Study|Miscalculation in mmcs|0|||
146502950|NCT03558152|528344250|FG004|Overall Study|Miscalculation in mmcs|0|||
146502951|NCT03558152|528344251|FG005|Overall Study|Miscalculation in mmcs|0|||
146502952|NCT03558152|528344252|FG006|Overall Study|Miscalculation in mmcs|1|||
146502953|NCT03558152|528344253|FG007|Overall Study|Miscalculation in mmcs|0|||
146648118|NCT00797966|528888517|FG004|Phase A+|Protocol deviation|0|||
146502954|NCT03558152|528344246|FG000|Overall Study|Mistake in calculation|0|||
146502955|NCT03558152|528344247|FG001|Overall Study|Mistake in calculation|0|||
146502956|NCT03558152|528344248|FG002|Overall Study|Mistake in calculation|0|||
146502957|NCT03558152|528344249|FG003|Overall Study|Mistake in calculation|1|||
146502958|NCT03558152|528344250|FG004|Overall Study|Mistake in calculation|0|||
146502959|NCT03558152|528344251|FG005|Overall Study|Mistake in calculation|0|||
146502960|NCT03558152|528344252|FG006|Overall Study|Mistake in calculation|0|||
146502961|NCT03558152|528344253|FG007|Overall Study|Mistake in calculation|0|||
146502962|NCT03558152|528344246|FG000|Overall Study|Mistake in evaluation of disease status|0|||
146502963|NCT03558152|528344247|FG001|Overall Study|Mistake in evaluation of disease status|0|||
146502964|NCT03558152|528344248|FG002|Overall Study|Mistake in evaluation of disease status|0|||
146502965|NCT03558152|528344249|FG003|Overall Study|Mistake in evaluation of disease status|0|||
146502966|NCT03558152|528344250|FG004|Overall Study|Mistake in evaluation of disease status|0|||
146502967|NCT03558152|528344251|FG005|Overall Study|Mistake in evaluation of disease status|0|||
146502968|NCT03558152|528344252|FG006|Overall Study|Mistake in evaluation of disease status|0|||
146502969|NCT03558152|528344253|FG007|Overall Study|Mistake in evaluation of disease status|1|||
146502970|NCT03558152|528344246|FG000|Overall Study|Physician Decision|0|||
146502971|NCT03558152|528344247|FG001|Overall Study|Physician Decision|0|||
146502972|NCT03558152|528344248|FG002|Overall Study|Physician Decision|0|||
146502973|NCT03558152|528344249|FG003|Overall Study|Physician Decision|0|||
146502974|NCT03558152|528344250|FG004|Overall Study|Physician Decision|0|||
146502975|NCT03558152|528344251|FG005|Overall Study|Physician Decision|0|||
146502976|NCT03558152|528344252|FG006|Overall Study|Physician Decision|1|||
146502977|NCT03558152|528344253|FG007|Overall Study|Physician Decision|0|||
146502978|NCT03558152|528344246|FG000|Overall Study|Withdrawal by Subject|2|||
146502979|NCT03558152|528344247|FG001|Overall Study|Withdrawal by Subject|3|||
146502980|NCT03558152|528344248|FG002|Overall Study|Withdrawal by Subject|2|||
146502981|NCT03558152|528344249|FG003|Overall Study|Withdrawal by Subject|1|||
146502982|NCT03558152|528344250|FG004|Overall Study|Withdrawal by Subject|1|||
146502983|NCT03558152|528344251|FG005|Overall Study|Withdrawal by Subject|1|||
146502984|NCT03558152|528344252|FG006|Overall Study|Withdrawal by Subject|3|||
146502985|NCT03558152|528344253|FG007|Overall Study|Withdrawal by Subject|2|||
146502986|NCT03558152|528344246|FG000|Overall Study|Lack of Efficacy|11|||
146502987|NCT03558152|528344247|FG001|Overall Study|Lack of Efficacy|11|||
146502988|NCT03558152|528344248|FG002|Overall Study|Lack of Efficacy|10|||
146502989|NCT03558152|528344249|FG003|Overall Study|Lack of Efficacy|11|||
146502990|NCT03558152|528344250|FG004|Overall Study|Lack of Efficacy|14|||
146502991|NCT03558152|528344251|FG005|Overall Study|Lack of Efficacy|12|||
146502992|NCT03558152|528344252|FG006|Overall Study|Lack of Efficacy|14|||
146502993|NCT03558152|528344253|FG007|Overall Study|Lack of Efficacy|13|||
146502994|NCT03558152|528344246|FG000|Overall Study|Protocol Violation|1|||
146502995|NCT03558152|528344247|FG001|Overall Study|Protocol Violation|1|||
146502996|NCT03558152|528344248|FG002|Overall Study|Protocol Violation|0|||
146502997|NCT03558152|528344249|FG003|Overall Study|Protocol Violation|1|||
146502998|NCT03558152|528344250|FG004|Overall Study|Protocol Violation|1|||
146502999|NCT03558152|528344251|FG005|Overall Study|Protocol Violation|0|||
146503000|NCT03558152|528344252|FG006|Overall Study|Protocol Violation|2|||
146503001|NCT03558152|528344253|FG007|Overall Study|Protocol Violation|0|||
146503002|NCT00601172|528344254|FG000|Overall Study|Adverse Event|43|||
146503003|NCT00601172|528344255|FG001|Overall Study|Adverse Event|32|||
146503004|NCT00601172|528344254|FG000|Overall Study|Lack of Efficacy|11|||
146503005|NCT00601172|528344255|FG001|Overall Study|Lack of Efficacy|12|||
146503006|NCT00601172|528344254|FG000|Overall Study|Protocol Violation|2|||
146503007|NCT00601172|528344255|FG001|Overall Study|Protocol Violation|5|||
146503008|NCT00601172|528344254|FG000|Overall Study|Lost to Follow-up|4|||
146503009|NCT00601172|528344255|FG001|Overall Study|Lost to Follow-up|3|||
146503010|NCT00601172|528344254|FG000|Overall Study|Physician Decision|27|||
146503011|NCT00601172|528344255|FG001|Overall Study|Physician Decision|28|||
146566874|NCT01840943|528587941|FG000|Overall Study|Physician Decision|4|||
146566875|NCT01840943|528587942|FG001|Overall Study|Physician Decision|2|||
146566876|NCT01840943|528587941|FG000|Overall Study|Lost to Follow-up|4|||
146566877|NCT01840943|528587942|FG001|Overall Study|Lost to Follow-up|4|||
146566878|NCT01446874|528587943|FG000|Overall Study|Not eligible|1|||
146566879|NCT01446874|528587944|FG001|Overall Study|Not eligible|0|||
146566880|NCT01446874|528587945|FG002|Overall Study|Not eligible|0|||
146503012|NCT00601172|528344254|FG000|Overall Study|Withdrawal by Subject|35|||
146503013|NCT00601172|528344255|FG001|Overall Study|Withdrawal by Subject|27|||
146503014|NCT00601172|528344254|FG000|Overall Study|Did not meet continuation criteria|19|||
146503015|NCT00601172|528344255|FG001|Overall Study|Did not meet continuation criteria|20|||
146503016|NCT00900757|528344256|FG000|Overall Study|screen failure|19|||
146503017|NCT02703272|528344257|FG000|Overall Study|Death|4|||
146503018|NCT02703272|528344258|FG001|Overall Study|Death|9|||
146503019|NCT02703272|528344259|FG002|Overall Study|Death|19|||
146566881|NCT01446874|528587943|FG000|Overall Study|No surgery/No qualifying surgery|1|||
146566882|NCT01446874|528587944|FG001|Overall Study|No surgery/No qualifying surgery|0|||
146503020|NCT02703272|528344260|FG003|Overall Study|Death|10|||
146566883|NCT01446874|528587945|FG002|Overall Study|No surgery/No qualifying surgery|12|||
146503021|NCT02703272|528344257|FG000|Overall Study|Withdrawal by Subject|0|||
146503022|NCT02703272|528344258|FG001|Overall Study|Withdrawal by Subject|0|||
146503023|NCT02703272|528344259|FG002|Overall Study|Withdrawal by Subject|4|||
146503024|NCT02703272|528344260|FG003|Overall Study|Withdrawal by Subject|2|||
146503025|NCT02703272|528344257|FG000|Overall Study|Study Terminated by Sponsor|6|||
146503026|NCT02703272|528344258|FG001|Overall Study|Study Terminated by Sponsor|1|||
146503027|NCT02703272|528344259|FG002|Overall Study|Study Terminated by Sponsor|12|||
146503028|NCT02703272|528344260|FG003|Overall Study|Study Terminated by Sponsor|4|||
146503029|NCT02703272|528344257|FG000|Overall Study|Other|1|||
146503030|NCT02703272|528344258|FG001|Overall Study|Other|0|||
146503031|NCT02703272|528344259|FG002|Overall Study|Other|0|||
146503032|NCT02703272|528344260|FG003|Overall Study|Other|0|||
146503033|NCT00976820|528344261|FG000|Overall Study|Lost to Follow-up|5|||
146503034|NCT00976820|528344262|FG001|Overall Study|Lost to Follow-up|16|||
146503035|NCT00976820|528344263|FG002|Overall Study|Lost to Follow-up|2|||
146503036|NCT00976820|528344264|FG003|Overall Study|Lost to Follow-up|3|||
146503037|NCT00976820|528344261|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
146503038|NCT00976820|528344262|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
146503039|NCT00976820|528344263|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
146503040|NCT00976820|528344264|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
146503041|NCT00976820|528344261|FG000|Overall Study|Withdrawal by Subject|2|||
146503042|NCT00976820|528344262|FG001|Overall Study|Withdrawal by Subject|4|||
146503043|NCT00976820|528344263|FG002|Overall Study|Withdrawal by Subject|1|||
146503044|NCT00976820|528344264|FG003|Overall Study|Withdrawal by Subject|4|||
146503045|NCT01489254|528344265|FG000|Double-blind Part|Adverse Event|7|||
146503046|NCT01489254|528344266|FG001|Double-blind Part|Adverse Event|2|||
146503047|NCT01489254|528344267|FG002|Double-blind Part|Adverse Event|2|||
146503048|NCT01489254|528344268|FG003|Double-blind Part|Adverse Event|0|||
146503049|NCT01489254|528344265|FG000|Double-blind Part|Pregnancy|1|||
146503050|NCT01489254|528344266|FG001|Double-blind Part|Pregnancy|3|||
146503051|NCT01489254|528344267|FG002|Double-blind Part|Pregnancy|0|||
146503052|NCT01489254|528344268|FG003|Double-blind Part|Pregnancy|0|||
146503053|NCT01489254|528344265|FG000|Double-blind Part|Withdrawal by Subject|12|||
146503054|NCT01489254|528344266|FG001|Double-blind Part|Withdrawal by Subject|20|||
146503055|NCT01489254|528344267|FG002|Double-blind Part|Withdrawal by Subject|1|||
146503056|NCT01489254|528344268|FG003|Double-blind Part|Withdrawal by Subject|0|||
146503057|NCT01489254|528344265|FG000|Double-blind Part|Lost to Follow-up|1|||
146503058|NCT01489254|528344266|FG001|Double-blind Part|Lost to Follow-up|2|||
146503059|NCT01489254|528344267|FG002|Double-blind Part|Lost to Follow-up|0|||
146503060|NCT01489254|528344268|FG003|Double-blind Part|Lost to Follow-up|0|||
146503061|NCT01489254|528344265|FG000|Double-blind Part|Other reasons for not completing study|4|||
146503062|NCT01489254|528344266|FG001|Double-blind Part|Other reasons for not completing study|6|||
146503063|NCT01489254|528344267|FG002|Double-blind Part|Other reasons for not completing study|0|||
146503064|NCT01489254|528344268|FG003|Double-blind Part|Other reasons for not completing study|0|||
146503065|NCT01489254|528344265|FG000|Open-label Extension Part|Adverse Event|0|||
146503066|NCT01489254|528344266|FG001|Open-label Extension Part|Adverse Event|0|||
146503067|NCT01489254|528344267|FG002|Open-label Extension Part|Adverse Event|0|||
146503068|NCT01489254|528344268|FG003|Open-label Extension Part|Adverse Event|10|||
146503069|NCT01489254|528344265|FG000|Open-label Extension Part|Pregnancy|0|||
146503070|NCT01489254|528344266|FG001|Open-label Extension Part|Pregnancy|0|||
146503071|NCT01489254|528344267|FG002|Open-label Extension Part|Pregnancy|0|||
146503072|NCT01489254|528344268|FG003|Open-label Extension Part|Pregnancy|3|||
146503073|NCT01489254|528344265|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
146503074|NCT01489254|528344266|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
146503075|NCT01489254|528344267|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
146503076|NCT01489254|528344268|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
146503077|NCT01489254|528344265|FG000|Open-label Extension Part|Protocol Violation|0|||
146503078|NCT01489254|528344266|FG001|Open-label Extension Part|Protocol Violation|0|||
146503079|NCT01489254|528344267|FG002|Open-label Extension Part|Protocol Violation|0|||
146503080|NCT01489254|528344268|FG003|Open-label Extension Part|Protocol Violation|1|||
146503081|NCT01489254|528344265|FG000|Open-label Extension Part|Lost to Follow-up|0|||
146503082|NCT01489254|528344266|FG001|Open-label Extension Part|Lost to Follow-up|0|||
146503083|NCT01489254|528344267|FG002|Open-label Extension Part|Lost to Follow-up|0|||
146503084|NCT01489254|528344268|FG003|Open-label Extension Part|Lost to Follow-up|9|||
146503085|NCT01489254|528344265|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
146503086|NCT01489254|528344266|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
146503087|NCT01489254|528344267|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
146648119|NCT00797966|528888518|FG005|Phase A+|Protocol deviation|4|||
146503088|NCT01489254|528344268|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
146503089|NCT04240457|528344270|FG000|Overall Study|Lost to Follow-up|5|||
146503090|NCT04240457|528344271|FG001|Overall Study|Lost to Follow-up|1|||
146503091|NCT00844480|528344272|FG000|Overall Study|Withdrawal by Subject|2|||
146503092|NCT00844480|528344273|FG001|Overall Study|Withdrawal by Subject|3|||
146503093|NCT00319592|528344276|FG000|Overall Study|Protocol Violation|1|||
146912734|NCT04504032|529843152|FG000|Overall Study|Disease progression prior to dosing|15|||
146912735|NCT04504032|529843153|FG001|Overall Study|Disease progression prior to dosing|3|||
146912736|NCT04504032|529843152|FG000|Overall Study|Drug supply issues|1|||
146912737|NCT04504032|529843153|FG001|Overall Study|Drug supply issues|1|||
146912738|NCT04504032|529843152|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
146912739|NCT04504032|529843153|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
146912740|NCT00771030|529843154|FG000|Overall Study|Adverse Event|0|||
146912741|NCT00771030|529843155|FG001|Overall Study|Adverse Event|1|||
146912742|NCT00771030|529843156|FG002|Overall Study|Adverse Event|0|||
146648120|NCT01242813|528888519|FG000|Overall Study|Lost to Follow-up|2|||
146648121|NCT03337490|528888521|FG000|Overall Study|Withdrawal by Subject|1|||
146648122|NCT03337490|528888522|FG001|Overall Study|Withdrawal by Subject|0|||
146648123|NCT03337490|528888523|FG002|Overall Study|Withdrawal by Subject|0|||
146648124|NCT03337490|528888521|FG000|Overall Study|Lack of Efficacy|10|||
146648125|NCT03337490|528888522|FG001|Overall Study|Lack of Efficacy|12|||
146648126|NCT03337490|528888523|FG002|Overall Study|Lack of Efficacy|35|||
146648127|NCT03337490|528888521|FG000|Overall Study|Physician Decision|0|||
146648128|NCT03337490|528888522|FG001|Overall Study|Physician Decision|1|||
146648129|NCT03337490|528888523|FG002|Overall Study|Physician Decision|0|||
146648130|NCT03337490|528888521|FG000|Overall Study|Lost to Follow-up|0|||
146648131|NCT03337490|528888522|FG001|Overall Study|Lost to Follow-up|1|||
146648132|NCT03337490|528888523|FG002|Overall Study|Lost to Follow-up|0|||
146648133|NCT03560518|528888524|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
146648134|NCT03560518|528888525|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
146648135|NCT03560518|528888526|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
146648136|NCT03560518|528888524|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
146648137|NCT03560518|528888525|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
146648138|NCT03560518|528888526|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
146648139|NCT03560518|528888524|FG000|Double Blind Treatment Period|Protocol Violation|1|||
146648140|NCT03560518|528888525|FG001|Double Blind Treatment Period|Protocol Violation|2|||
146648141|NCT03560518|528888526|FG002|Double Blind Treatment Period|Protocol Violation|0|||
146648142|NCT03560518|528888524|FG000|Double Blind Treatment Period|Pregnancy|0|||
146648143|NCT03560518|528888525|FG001|Double Blind Treatment Period|Pregnancy|2|||
146648144|NCT03560518|528888526|FG002|Double Blind Treatment Period|Pregnancy|0|||
146648145|NCT03560518|528888524|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
146648146|NCT03560518|528888525|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
146648147|NCT03560518|528888526|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
146648148|NCT03560518|528888524|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
146648149|NCT03560518|528888525|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
146648150|NCT03560518|528888526|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
146648151|NCT03560518|528888524|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
146648152|NCT03560518|528888525|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
146648153|NCT03560518|528888526|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
146648154|NCT03560518|528888524|FG000|Double Blind Treatment Period|Adverse Event|0|||
146648155|NCT03560518|528888525|FG001|Double Blind Treatment Period|Adverse Event|3|||
146648156|NCT03560518|528888526|FG002|Double Blind Treatment Period|Adverse Event|1|||
146648157|NCT00917644|528888527|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
146648158|NCT00917644|528888528|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
146648159|NCT00917644|528888527|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
146648160|NCT00917644|528888528|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
146648161|NCT00917644|528888527|FG000|Period 2: Second Intervention|family emergency|1|||
146648162|NCT00917644|528888528|FG001|Period 2: Second Intervention|family emergency|0|||
146648163|NCT00958438|528888531|FG000|Overall Study|Protocol Violation|3|||
146648164|NCT00958438|528888532|FG001|Overall Study|Protocol Violation|2|||
146648165|NCT00958438|528888533|FG002|Overall Study|Protocol Violation|2|||
146648166|NCT00958438|528888531|FG000|Overall Study|Withdrawal by Subject|4|||
146648167|NCT00958438|528888532|FG001|Overall Study|Withdrawal by Subject|2|||
146648168|NCT00958438|528888533|FG002|Overall Study|Withdrawal by Subject|1|||
146648169|NCT00958438|528888531|FG000|Overall Study|Adverse Event|0|||
146648170|NCT00958438|528888532|FG001|Overall Study|Adverse Event|3|||
146648171|NCT00958438|528888533|FG002|Overall Study|Adverse Event|0|||
146648172|NCT00958438|528888531|FG000|Overall Study|Physician Decision|1|||
146648173|NCT00958438|528888532|FG001|Overall Study|Physician Decision|0|||
146648174|NCT00958438|528888533|FG002|Overall Study|Physician Decision|1|||
146648175|NCT00958438|528888531|FG000|Overall Study|Other than specified above|2|||
146648176|NCT00958438|528888532|FG001|Overall Study|Other than specified above|3|||
146769203|NCT01266265|529323436|FG000|Overall Study|Lung transplant|6|||
146648177|NCT00958438|528888533|FG002|Overall Study|Other than specified above|2|||
146648178|NCT02788279|528888534|FG000|Overall Study|Death|62|||
146769204|NCT01266265|529323437|FG001|Overall Study|Lung transplant|5|||
146912743|NCT00771030|529843157|FG003|Overall Study|Adverse Event|0|||
146912744|NCT00771030|529843158|FG004|Overall Study|Adverse Event|0|||
146648179|NCT02788279|528888535|FG001|Overall Study|Death|136|||
146648180|NCT02788279|528888536|FG002|Overall Study|Death|72|||
146769205|NCT01266265|529323436|FG000|Overall Study|Site closed early|4|||
146769206|NCT01266265|529323437|FG001|Overall Study|Site closed early|3|||
146769207|NCT01266265|529323436|FG000|Overall Study|Clinical worsening|1|||
146769208|NCT01266265|529323437|FG001|Overall Study|Clinical worsening|1|||
146912745|NCT00771030|529843159|FG005|Overall Study|Adverse Event|0|||
146769209|NCT01580293|529323438|FG000|Part A_Main Trial|Adverse Event|0|||
146769210|NCT01580293|529323439|FG001|Part A_Main Trial|Adverse Event|2|||
146769211|NCT01580293|529323440|FG002|Part A_Main Trial|Adverse Event|0|||
146769212|NCT01580293|529323438|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
146769213|NCT01580293|529323439|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
146769214|NCT01580293|529323440|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
146769215|NCT01580293|529323438|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
146769216|NCT01580293|529323439|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
146769217|NCT01580293|529323440|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
146769218|NCT01580293|529323438|FG000|Part A_Extension|Adverse Event|0|||
146769219|NCT01580293|529323439|FG001|Part A_Extension|Adverse Event|2|||
146769220|NCT01580293|529323440|FG002|Part A_Extension|Adverse Event|0|||
146769221|NCT01580293|529323438|FG000|Part A_Extension|Withdrawal by Subject|0|||
146769222|NCT01580293|529323439|FG001|Part A_Extension|Withdrawal by Subject|3|||
146648181|NCT02788279|528888534|FG000|Overall Study|Withdrawal by Subject|10|||
146648182|NCT02788279|528888535|FG001|Overall Study|Withdrawal by Subject|15|||
146648183|NCT02788279|528888536|FG002|Overall Study|Withdrawal by Subject|5|||
146648184|NCT02788279|528888534|FG000|Overall Study|Lost to Follow-up|0|||
146648185|NCT02788279|528888535|FG001|Overall Study|Lost to Follow-up|3|||
146648186|NCT02788279|528888536|FG002|Overall Study|Lost to Follow-up|2|||
146648187|NCT02788279|528888534|FG000|Overall Study|Sponsor decision|18|||
146648188|NCT02788279|528888535|FG001|Overall Study|Sponsor decision|29|||
146769223|NCT01580293|529323440|FG002|Part A_Extension|Withdrawal by Subject|0|||
146769224|NCT01580293|529323438|FG000|Part A_Extension|Lost to Follow-up|0|||
146769225|NCT01580293|529323439|FG001|Part A_Extension|Lost to Follow-up|1|||
146769226|NCT01580293|529323440|FG002|Part A_Extension|Lost to Follow-up|0|||
146769227|NCT01580293|529323438|FG000|Part A_Extension|Other Reason|0|||
146912746|NCT00771030|529843160|FG006|Overall Study|Adverse Event|0|||
146912747|NCT02805907|529843161|FG000|Overall Study|Lost to Follow-up|3|||
146912748|NCT02805907|529843162|FG001|Overall Study|Lost to Follow-up|3|||
146912749|NCT02416908|529843173|FG000|Dose Escalation Phase|Adverse Event|0|||
146912750|NCT02416908|529843174|FG001|Dose Escalation Phase|Adverse Event|0|||
146912751|NCT02416908|529843175|FG002|Dose Escalation Phase|Adverse Event|3|||
146912752|NCT02416908|529843176|FG003|Dose Escalation Phase|Adverse Event|0|||
146912753|NCT02416908|529843173|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
146912754|NCT02416908|529843174|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
146912755|NCT02416908|529843175|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
146912756|NCT02416908|529843176|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
146912757|NCT01214434|529843179|FG000|Overall Study|Withdrawal by Subject|1|||
146912758|NCT01214434|529843180|FG001|Overall Study|Withdrawal by Subject|0|||
146912759|NCT01214434|529843179|FG000|Overall Study|Lost to Follow-up|2|||
146912760|NCT01214434|529843180|FG001|Overall Study|Lost to Follow-up|2|||
146912761|NCT01214434|529843179|FG000|Overall Study|Site error|1|||
146912762|NCT01214434|529843180|FG001|Overall Study|Site error|0|||
146912763|NCT01651052|529843182|FG000|Overall Study|Death|21|||
146912764|NCT01651052|529843182|FG000|Overall Study|Explant|1|||
146912765|NCT01651052|529843182|FG000|Overall Study|Withdrawal by Subject|1|||
146912766|NCT01651052|529843182|FG000|Overall Study|Lost to Follow-up|3|||
146912767|NCT03503773|529843183|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
146912768|NCT03503773|529843184|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
146912769|NCT03503773|529843183|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
146912770|NCT03503773|529843184|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
146912771|NCT03503773|529843183|FG000|Overall Study|Not completing the primary ABPM|3|||
146912772|NCT03503773|529843184|FG001|Overall Study|Not completing the primary ABPM|1|||
146503094|NCT00319592|528344277|FG001|Overall Study|Protocol Violation|0|||
146503095|NCT00319592|528344276|FG000|Overall Study|Physician Decision|0|||
146503096|NCT00319592|528344277|FG001|Overall Study|Physician Decision|1|||
146912773|NCT03503773|529843183|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
146912774|NCT03503773|529843184|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
146503097|NCT01820572|528344284|FG000|Randomization|Not Treated|2|||
146503098|NCT01820572|528344285|FG001|Randomization|Not Treated|1|||
146503099|NCT01820572|528344284|FG000|Treatment Period|Adverse Event|12|||
146503100|NCT01820572|528344285|FG001|Treatment Period|Adverse Event|7|||
146769228|NCT01580293|529323439|FG001|Part A_Extension|Other Reason|1|||
146769229|NCT01580293|529323440|FG002|Part A_Extension|Other Reason|0|||
146769230|NCT01580293|529323438|FG000|Part A_Extension|Completed Japan only|0|||
146769231|NCT01580293|529323439|FG001|Part A_Extension|Completed Japan only|5|||
146503101|NCT01820572|528344284|FG000|Treatment Period|Death|3|||
146503102|NCT01820572|528344285|FG001|Treatment Period|Death|3|||
146503103|NCT01820572|528344284|FG000|Treatment Period|Lack of Efficacy|1|||
146648189|NCT02788279|528888536|FG002|Overall Study|Sponsor decision|11|||
146769232|NCT01580293|529323440|FG002|Part A_Extension|Completed Japan only|0|||
146769233|NCT01580293|529323438|FG000|Part B|Withdrawal by Subject|0|||
146769234|NCT01580293|529323439|FG001|Part B|Withdrawal by Subject|0|||
146769235|NCT01580293|529323440|FG002|Part B|Withdrawal by Subject|1|||
146769236|NCT01580293|529323438|FG000|Part B|Other reason|0|||
146769237|NCT01580293|529323439|FG001|Part B|Other reason|0|||
146769238|NCT01580293|529323440|FG002|Part B|Other reason|1|||
146769239|NCT02544152|529323441|FG000|Overall Study|Adverse Event|0|||
146769240|NCT02544152|529323442|FG001|Overall Study|Adverse Event|4|||
146769241|NCT02544152|529323441|FG000|Overall Study|Withdrawal by Subject|0|||
146769242|NCT02544152|529323442|FG001|Overall Study|Withdrawal by Subject|3|||
146912775|NCT00425438|529843188|FG000|Overall Study|Termination by Sponsor|25|||
146912776|NCT00425438|529843189|FG001|Overall Study|Termination by Sponsor|27|||
146566884|NCT01446874|528587943|FG000|Overall Study|Non-compliance|0|||
146912777|NCT04156646|529843194|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
146912778|NCT04156646|529843195|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
146566885|NCT01446874|528587944|FG001|Overall Study|Non-compliance|4|||
146566886|NCT01446874|528587945|FG002|Overall Study|Non-compliance|0|||
146566887|NCT01446874|528587943|FG000|Overall Study|Antibiotics for pre-op infection|0|||
146566888|NCT01446874|528587944|FG001|Overall Study|Antibiotics for pre-op infection|0|||
146566889|NCT01446874|528587945|FG002|Overall Study|Antibiotics for pre-op infection|2|||
146566890|NCT01446874|528587943|FG000|Overall Study|Withdrawal by Subject|0|||
146566891|NCT01446874|528587944|FG001|Overall Study|Withdrawal by Subject|0|||
146566892|NCT01446874|528587945|FG002|Overall Study|Withdrawal by Subject|4|||
146566893|NCT01135992|528587946|FG000|Overall Study|Adverse Event|1|||
146566894|NCT01135992|528587946|FG000|Overall Study|Lack of Efficacy|1|||
146566895|NCT01135992|528587946|FG000|Overall Study|Protocol Violation|2|||
146566896|NCT01135992|528587946|FG000|Overall Study|Withdrawal criteria|10|||
146566897|NCT01135992|528587946|FG000|Overall Study|Unclassified|7|||
146566898|NCT01977898|528587947|FG000|Overall Study|Non functioning catheter|1|||
146566899|NCT01977898|528587948|FG001|Overall Study|Non functioning catheter|1|||
146566900|NCT01049373|528587954|FG000|Overall Study|Protocol Violation|9|||
146566901|NCT01049373|528587955|FG001|Overall Study|Protocol Violation|9|||
146566902|NCT01049373|528587954|FG000|Overall Study|Withdrawal by Subject|8|||
146566903|NCT01049373|528587955|FG001|Overall Study|Withdrawal by Subject|5|||
146566904|NCT01049373|528587954|FG000|Overall Study|Adverse Event|3|||
146566905|NCT01049373|528587955|FG001|Overall Study|Adverse Event|3|||
146566906|NCT01049373|528587954|FG000|Overall Study|Lost to Follow-up|9|||
146566907|NCT01049373|528587955|FG001|Overall Study|Lost to Follow-up|4|||
146566908|NCT01049373|528587954|FG000|Overall Study|no evaluable study values|9|||
146566909|NCT01049373|528587955|FG001|Overall Study|no evaluable study values|21|||
146566910|NCT01049373|528587954|FG000|Overall Study|Other|1|||
146566911|NCT01049373|528587955|FG001|Overall Study|Other|1|||
146566912|NCT01049373|528587954|FG000|Overall Study|Non-cooperation|0|||
146566913|NCT01049373|528587955|FG001|Overall Study|Non-cooperation|1|||
146566914|NCT01693367|528587956|FG000|Overall Study|Withdrawal by Subject|1|||
146566915|NCT01693367|528587957|FG001|Overall Study|Withdrawal by Subject|1|||
146566916|NCT01693367|528587956|FG000|Overall Study|Physician Decision|0|||
146566917|NCT01693367|528587957|FG001|Overall Study|Physician Decision|1|||
146566918|NCT03610048|528587958|FG000|Overall Study|Study terminated by sponsor|84|||
146566919|NCT03610048|528587958|FG000|Overall Study|Adverse Event|32|||
146566920|NCT03610048|528587958|FG000|Overall Study|Withdrawal by Subject|31|||
146566921|NCT03610048|528587958|FG000|Overall Study|Lost to Follow-up|8|||
146566922|NCT03610048|528587958|FG000|Overall Study|Other|4|||
146566923|NCT03610048|528587958|FG000|Overall Study|Physician Decision|1|||
146566924|NCT03610048|528587958|FG000|Overall Study|Pregnancy|1|||
146566925|NCT01155050|528587959|FG000|Overall Study|Lost to Follow-up|15|||
146566926|NCT01155050|528587960|FG001|Overall Study|Lost to Follow-up|20|||
146566927|NCT01155050|528587961|FG002|Overall Study|Lost to Follow-up|19|||
146566928|NCT01155050|528587962|FG003|Overall Study|Lost to Follow-up|22|||
146566929|NCT02136914|528587963|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
146566930|NCT02136914|528587964|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
146566931|NCT02136914|528587963|FG000|Overall Study|Withdrawal by Subject|3|||
146566932|NCT02136914|528587964|FG001|Overall Study|Withdrawal by Subject|10|||
146566933|NCT02136914|528587963|FG000|Overall Study|Subject Unwilling to Proceed|7|||
146566934|NCT02136914|528587964|FG001|Overall Study|Subject Unwilling to Proceed|2|||
146566935|NCT02136914|528587963|FG000|Overall Study|Lost to Follow-up|1|||
146566936|NCT02136914|528587964|FG001|Overall Study|Lost to Follow-up|1|||
146566937|NCT02136914|528587963|FG000|Overall Study|Did Not Receive Study Drug|2|||
146566938|NCT02136914|528587964|FG001|Overall Study|Did Not Receive Study Drug|0|||
146566939|NCT02136914|528587963|FG000|Overall Study|Lack of Efficacy|1|||
146566940|NCT02136914|528587964|FG001|Overall Study|Lack of Efficacy|0|||
146566941|NCT02136914|528587963|FG000|Overall Study|Death|0|||
146566942|NCT02136914|528587964|FG001|Overall Study|Death|1|||
146566943|NCT00329030|528587967|FG000|Overall Study|Withdrawal by Subject|1|||
146566944|NCT00329030|528587968|FG001|Overall Study|Withdrawal by Subject|3|||
146769243|NCT02544152|529323441|FG000|Overall Study|Other|1|||
146769244|NCT02544152|529323442|FG001|Overall Study|Other|0|||
146769245|NCT00423098|529323443|FG000|Overall Study|Adverse Event|1|||
146503104|NCT01820572|528344285|FG001|Treatment Period|Lack of Efficacy|0|||
146503105|NCT01820572|528344284|FG000|Treatment Period|poor/non compliance|0|||
146503106|NCT01820572|528344285|FG001|Treatment Period|poor/non compliance|3|||
146503107|NCT01820572|528344284|FG000|Treatment Period|request to discontinue|6|||
146503108|NCT01820572|528344285|FG001|Treatment Period|request to discontinue|11|||
146503109|NCT01820572|528344284|FG000|Treatment Period|No longer meets study criteria|3|||
146503110|NCT01820572|528344285|FG001|Treatment Period|No longer meets study criteria|10|||
146503111|NCT01820572|528344284|FG000|Treatment Period|withdrew consent|1|||
146503112|NCT01820572|528344285|FG001|Treatment Period|withdrew consent|2|||
146503113|NCT04439214|528344291|FG000|Overall Study|Adverse Event|13|||
146503114|NCT04439214|528344291|FG000|Overall Study|Disease progression|16|||
146503115|NCT04439214|528344291|FG000|Overall Study|Death|1|||
146503116|NCT04439214|528344291|FG000|Overall Study|Withdrawal by Subject|2|||
146503117|NCT04439214|528344291|FG000|Overall Study|Declining health|1|||
146503118|NCT04439214|528344291|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
146503119|NCT04439214|528344291|FG000|Overall Study|Ineligible|5|||
146503120|NCT02235077|528344292|FG000|Overall Study|Death|5|||
146503121|NCT02235077|528344293|FG001|Overall Study|Death|7|||
146503122|NCT02235077|528344292|FG000|Overall Study|Lost to Follow-up|5|||
146503123|NCT02235077|528344293|FG001|Overall Study|Lost to Follow-up|6|||
146503124|NCT02235077|528344292|FG000|Overall Study|Withdrawal by Subject|8|||
146503125|NCT02235077|528344293|FG001|Overall Study|Withdrawal by Subject|5|||
146503126|NCT02235077|528344292|FG000|Overall Study|Physician Decision|0|||
146503127|NCT02235077|528344293|FG001|Overall Study|Physician Decision|1|||
146503128|NCT03852628|528344294|FG000|Overall Study|Lost to Follow-up|7|||
146503129|NCT03852628|528344295|FG001|Overall Study|Lost to Follow-up|6|||
146503130|NCT03852628|528344294|FG000|Overall Study|Lack of Efficacy|6|||
146503131|NCT03852628|528344295|FG001|Overall Study|Lack of Efficacy|6|||
146503132|NCT02964208|528344296|FG000|Overall Study|Death|103|||
146503133|NCT02964208|528344296|FG000|Overall Study|Withdrawal by Subject|6|||
146503134|NCT02964208|528344296|FG000|Overall Study|Lost to Follow-up|6|||
146503135|NCT02964208|528344296|FG000|Overall Study|Unsuccessful Procedure|5|||
146503136|NCT02964208|528344296|FG000|Overall Study|Device Explant|1|||
146503137|NCT02964208|528344296|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
146503138|NCT01668173|528344305|FG000|Overall Study|Adverse Event|3|||
146503139|NCT01668173|528344305|FG000|Overall Study|Trial suspension|4|||
146503140|NCT01295827|528344308|FG000|Overall Study|Adverse Event|1|||
146503141|NCT01295827|528344309|FG001|Overall Study|Adverse Event|2|||
146503142|NCT01295827|528344310|FG002|Overall Study|Adverse Event|2|||
146503143|NCT01295827|528344311|FG003|Overall Study|Adverse Event|1|||
146503144|NCT01295827|528344312|FG004|Overall Study|Adverse Event|1|||
146503145|NCT01295827|528344313|FG005|Overall Study|Adverse Event|4|||
146503146|NCT01295827|528344314|FG006|Overall Study|Adverse Event|15|||
146503147|NCT01295827|528344315|FG007|Overall Study|Adverse Event|49|||
146503148|NCT01295827|528344316|FG008|Overall Study|Adverse Event|22|||
146503149|NCT01295827|528344317|FG009|Overall Study|Adverse Event|7|||
146503150|NCT01295827|528344318|FG010|Overall Study|Adverse Event|50|||
146503151|NCT01295827|528344319|FG011|Overall Study|Adverse Event|21|||
146503152|NCT01295827|528344320|FG012|Overall Study|Adverse Event|0|||
146503153|NCT01295827|528344321|FG013|Overall Study|Adverse Event|0|||
146503154|NCT01295827|528344322|FG014|Overall Study|Adverse Event|0|||
146503155|NCT01295827|528344308|FG000|Overall Study|Lost to Follow-up|0|||
146503156|NCT01295827|528344309|FG001|Overall Study|Lost to Follow-up|0|||
146503157|NCT01295827|528344310|FG002|Overall Study|Lost to Follow-up|3|||
146503158|NCT01295827|528344311|FG003|Overall Study|Lost to Follow-up|0|||
146503159|NCT01295827|528344312|FG004|Overall Study|Lost to Follow-up|1|||
146769246|NCT00423098|529323444|FG001|Overall Study|Adverse Event|2|||
146769247|NCT00423098|529323443|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146769248|NCT00423098|529323444|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146769249|NCT00423098|529323443|FG000|Overall Study|Administrative problems|0|||
146769250|NCT00423098|529323444|FG001|Overall Study|Administrative problems|1|||
146503160|NCT01295827|528344313|FG005|Overall Study|Lost to Follow-up|0|||
146503161|NCT01295827|528344314|FG006|Overall Study|Lost to Follow-up|4|||
146769251|NCT00423098|529323443|FG000|Overall Study|Death|2|||
146769252|NCT00423098|529323444|FG001|Overall Study|Death|0|||
146769253|NCT00516386|529323446|FG000|Overall Study|not interested in the study|4|||
146912779|NCT01208181|529843196|FG000|Part 1|Withdrawal by Subject|11|||
146503162|NCT01295827|528344315|FG007|Overall Study|Lost to Follow-up|8|||
146503163|NCT01295827|528344316|FG008|Overall Study|Lost to Follow-up|7|||
146503164|NCT01295827|528344317|FG009|Overall Study|Lost to Follow-up|4|||
146503165|NCT01295827|528344318|FG010|Overall Study|Lost to Follow-up|7|||
146503166|NCT01295827|528344319|FG011|Overall Study|Lost to Follow-up|3|||
146503167|NCT01295827|528344320|FG012|Overall Study|Lost to Follow-up|0|||
146503168|NCT01295827|528344321|FG013|Overall Study|Lost to Follow-up|0|||
146503169|NCT01295827|528344322|FG014|Overall Study|Lost to Follow-up|0|||
146503170|NCT01295827|528344308|FG000|Overall Study|Not Reported|0|||
146503171|NCT01295827|528344309|FG001|Overall Study|Not Reported|0|||
146769254|NCT00516386|529323446|FG000|Overall Study|Lost to Follow-up|2|||
146769255|NCT02698891|529323447|FG000|Overall Study|Withdrawal by Subject|2|||
146912780|NCT01208181|529843197|FG001|Part 1|Withdrawal by Subject|10|||
146912781|NCT01208181|529843198|FG002|Part 1|Withdrawal by Subject|0|||
146912782|NCT01208181|529843199|FG003|Part 1|Withdrawal by Subject|0|||
146912783|NCT01208181|529843200|FG004|Part 1|Withdrawal by Subject|0|||
146912784|NCT01208181|529843196|FG000|Part 1|Technical problem|5|||
146912785|NCT01208181|529843197|FG001|Part 1|Technical problem|0|||
146912786|NCT01208181|529843198|FG002|Part 1|Technical problem|0|||
146912787|NCT01208181|529843199|FG003|Part 1|Technical problem|0|||
146912788|NCT01208181|529843200|FG004|Part 1|Technical problem|0|||
146912789|NCT01208181|529843196|FG000|Part 1|Protocol Violation|10|||
146912790|NCT01208181|529843197|FG001|Part 1|Protocol Violation|5|||
146912791|NCT01208181|529843198|FG002|Part 1|Protocol Violation|0|||
146912792|NCT01208181|529843199|FG003|Part 1|Protocol Violation|0|||
146912793|NCT01208181|529843200|FG004|Part 1|Protocol Violation|0|||
146912794|NCT01208181|529843196|FG000|Part 1|Physician Decision|4|||
146912795|NCT01208181|529843197|FG001|Part 1|Physician Decision|0|||
146912796|NCT01208181|529843198|FG002|Part 1|Physician Decision|0|||
146912797|NCT01208181|529843199|FG003|Part 1|Physician Decision|0|||
146912798|NCT01208181|529843200|FG004|Part 1|Physician Decision|0|||
146912799|NCT01208181|529843196|FG000|Part 1|Non-compliance with study drug|1|||
146912800|NCT01208181|529843197|FG001|Part 1|Non-compliance with study drug|1|||
146912801|NCT01208181|529843198|FG002|Part 1|Non-compliance with study drug|0|||
146912802|NCT01208181|529843199|FG003|Part 1|Non-compliance with study drug|0|||
146912803|NCT01208181|529843200|FG004|Part 1|Non-compliance with study drug|0|||
146912804|NCT01208181|529843196|FG000|Part 1|Lost to Follow-up|5|||
146912805|NCT01208181|529843197|FG001|Part 1|Lost to Follow-up|3|||
146912806|NCT01208181|529843198|FG002|Part 1|Lost to Follow-up|0|||
146503172|NCT01295827|528344310|FG002|Overall Study|Not Reported|0|||
146503173|NCT01295827|528344311|FG003|Overall Study|Not Reported|1|||
146503174|NCT01295827|528344312|FG004|Overall Study|Not Reported|0|||
146503175|NCT01295827|528344313|FG005|Overall Study|Not Reported|0|||
146503176|NCT01295827|528344314|FG006|Overall Study|Not Reported|24|||
146503177|NCT01295827|528344315|FG007|Overall Study|Not Reported|58|||
146503178|NCT01295827|528344316|FG008|Overall Study|Not Reported|41|||
146503179|NCT01295827|528344317|FG009|Overall Study|Not Reported|2|||
146503180|NCT01295827|528344318|FG010|Overall Study|Not Reported|23|||
146503181|NCT01295827|528344319|FG011|Overall Study|Not Reported|13|||
146503182|NCT01295827|528344320|FG012|Overall Study|Not Reported|0|||
146503183|NCT01295827|528344321|FG013|Overall Study|Not Reported|0|||
146503184|NCT01295827|528344322|FG014|Overall Study|Not Reported|0|||
146503185|NCT01295827|528344308|FG000|Overall Study|Progressive Disease|2|||
146503186|NCT01295827|528344309|FG001|Overall Study|Progressive Disease|1|||
146503187|NCT01295827|528344310|FG002|Overall Study|Progressive Disease|5|||
146503188|NCT01295827|528344311|FG003|Overall Study|Progressive Disease|2|||
146503189|NCT01295827|528344312|FG004|Overall Study|Progressive Disease|0|||
146503190|NCT01295827|528344313|FG005|Overall Study|Progressive Disease|1|||
146503191|NCT01295827|528344314|FG006|Overall Study|Progressive Disease|87|||
146503192|NCT01295827|528344315|FG007|Overall Study|Progressive Disease|144|||
146503193|NCT01295827|528344316|FG008|Overall Study|Progressive Disease|85|||
146503194|NCT01295827|528344317|FG009|Overall Study|Progressive Disease|40|||
146503195|NCT01295827|528344318|FG010|Overall Study|Progressive Disease|175|||
146503196|NCT01295827|528344319|FG011|Overall Study|Progressive Disease|136|||
146503197|NCT01295827|528344320|FG012|Overall Study|Progressive Disease|0|||
146503198|NCT01295827|528344321|FG013|Overall Study|Progressive Disease|0|||
146503199|NCT01295827|528344322|FG014|Overall Study|Progressive Disease|0|||
146503200|NCT01295827|528344308|FG000|Overall Study|Screen Failure|0|||
146503201|NCT01295827|528344309|FG001|Overall Study|Screen Failure|0|||
146503202|NCT01295827|528344310|FG002|Overall Study|Screen Failure|0|||
146503203|NCT01295827|528344311|FG003|Overall Study|Screen Failure|0|||
146503204|NCT01295827|528344312|FG004|Overall Study|Screen Failure|0|||
146503205|NCT01295827|528344313|FG005|Overall Study|Screen Failure|0|||
146503206|NCT01295827|528344314|FG006|Overall Study|Screen Failure|2|||
146503207|NCT01295827|528344315|FG007|Overall Study|Screen Failure|2|||
146503208|NCT01295827|528344316|FG008|Overall Study|Screen Failure|2|||
146503209|NCT01295827|528344317|FG009|Overall Study|Screen Failure|0|||
146503210|NCT01295827|528344318|FG010|Overall Study|Screen Failure|1|||
146912807|NCT01208181|529843199|FG003|Part 1|Lost to Follow-up|0|||
146912808|NCT01208181|529843200|FG004|Part 1|Lost to Follow-up|1|||
146912809|NCT01208181|529843196|FG000|Part 1|Lack of Efficacy|37|||
146912810|NCT01208181|529843197|FG001|Part 1|Lack of Efficacy|12|||
146912811|NCT01208181|529843198|FG002|Part 1|Lack of Efficacy|0|||
146912812|NCT01208181|529843199|FG003|Part 1|Lack of Efficacy|0|||
146912813|NCT01208181|529843200|FG004|Part 1|Lack of Efficacy|17|||
146912814|NCT01208181|529843196|FG000|Part 1|Adverse Event|26|||
146503211|NCT01295827|528344319|FG011|Overall Study|Screen Failure|0|||
146503212|NCT01295827|528344320|FG012|Overall Study|Screen Failure|0|||
146503213|NCT01295827|528344321|FG013|Overall Study|Screen Failure|0|||
146503214|NCT01295827|528344322|FG014|Overall Study|Screen Failure|0|||
146503215|NCT01295827|528344308|FG000|Overall Study|Withdrawal by Subject|1|||
146912815|NCT01208181|529843197|FG001|Part 1|Adverse Event|24|||
146912816|NCT01208181|529843198|FG002|Part 1|Adverse Event|0|||
146912817|NCT01208181|529843199|FG003|Part 1|Adverse Event|0|||
146912818|NCT01208181|529843200|FG004|Part 1|Adverse Event|4|||
146769256|NCT02698891|529323447|FG000|Overall Study|deemed ineligible|1|||
146503216|NCT01295827|528344309|FG001|Overall Study|Withdrawal by Subject|0|||
146503217|NCT01295827|528344310|FG002|Overall Study|Withdrawal by Subject|2|||
146503218|NCT01295827|528344311|FG003|Overall Study|Withdrawal by Subject|0|||
146503219|NCT01295827|528344312|FG004|Overall Study|Withdrawal by Subject|0|||
146503220|NCT01295827|528344313|FG005|Overall Study|Withdrawal by Subject|1|||
146503221|NCT01295827|528344314|FG006|Overall Study|Withdrawal by Subject|13|||
146503222|NCT01295827|528344315|FG007|Overall Study|Withdrawal by Subject|35|||
146503223|NCT01295827|528344316|FG008|Overall Study|Withdrawal by Subject|11|||
146503224|NCT01295827|528344317|FG009|Overall Study|Withdrawal by Subject|2|||
146503225|NCT01295827|528344318|FG010|Overall Study|Withdrawal by Subject|18|||
146503226|NCT01295827|528344319|FG011|Overall Study|Withdrawal by Subject|13|||
146503227|NCT01295827|528344320|FG012|Overall Study|Withdrawal by Subject|0|||
146503228|NCT01295827|528344321|FG013|Overall Study|Withdrawal by Subject|0|||
146503229|NCT01295827|528344322|FG014|Overall Study|Withdrawal by Subject|0|||
146503230|NCT01295827|528344308|FG000|Overall Study|Other|0|||
146503231|NCT01295827|528344309|FG001|Overall Study|Other|0|||
146503232|NCT01295827|528344310|FG002|Overall Study|Other|0|||
146503233|NCT01295827|528344311|FG003|Overall Study|Other|0|||
146503234|NCT01295827|528344312|FG004|Overall Study|Other|0|||
146503235|NCT01295827|528344313|FG005|Overall Study|Other|0|||
146503236|NCT01295827|528344314|FG006|Overall Study|Other|1|||
146503237|NCT01295827|528344315|FG007|Overall Study|Other|1|||
146503238|NCT01295827|528344316|FG008|Overall Study|Other|1|||
146503239|NCT01295827|528344317|FG009|Overall Study|Other|0|||
146503240|NCT01295827|528344318|FG010|Overall Study|Other|2|||
146503241|NCT01295827|528344319|FG011|Overall Study|Other|0|||
146503242|NCT01295827|528344320|FG012|Overall Study|Other|0|||
146503243|NCT01295827|528344321|FG013|Overall Study|Other|0|||
146503244|NCT01295827|528344322|FG014|Overall Study|Other|0|||
146503245|NCT00072280|528344323|FG000|Treatment|Found ineligible|1|||
146503246|NCT00072280|528344324|FG001|Treatment|Found ineligible|2|||
146503247|NCT00072280|528344323|FG000|Follow-up|Early termination of study|2|||
146503248|NCT00072280|528344324|FG001|Follow-up|Early termination of study|2|||
146503249|NCT00746564|528344325|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
146503250|NCT03226769|528344328|FG000|Overall Study|Withdrawal by Subject|0|||
146503251|NCT03226769|528344329|FG001|Overall Study|Withdrawal by Subject|1|||
146503252|NCT02640677|528344332|FG000|Overall Study|Lost to Follow-up|1|||
146503253|NCT02640677|528344332|FG000|Overall Study|Withdrawal by Subject|1|||
146503254|NCT00957268|528344342|FG000|Overall Study|Voluntary Withdrawal|0|||
146503255|NCT00957268|528344343|FG001|Overall Study|Voluntary Withdrawal|0|||
146503256|NCT00957268|528344344|FG002|Overall Study|Voluntary Withdrawal|1|||
146503257|NCT00957268|528344345|FG003|Overall Study|Voluntary Withdrawal|0|||
146503258|NCT00957268|528344346|FG004|Overall Study|Voluntary Withdrawal|0|||
146503259|NCT01758731|528344347|FG000|Overall Study|Physician Decision|1|||
146503260|NCT02396420|528344353|FG000|Overall Study|Death|1|||
146503261|NCT01273623|528344355|FG000|Overall Study|did not meet IVUS criteria|29|||
146648190|NCT01579812|528888537|FG000|Overall Study|Ineligible after treatment start|40|||
146648191|NCT01579812|528888537|FG000|Overall Study|Patient choice|3|||
146648192|NCT01579812|528888537|FG000|Overall Study|Noncompliance|3|||
146648193|NCT01579812|528888537|FG000|Overall Study|Withdrawal by Subject|6|||
146648194|NCT04987944|528888539|FG000|Overall Study|Adverse Event|0|||
146648195|NCT04987944|528888540|FG001|Overall Study|Adverse Event|1|||
146648196|NCT04987944|528888539|FG000|Overall Study|Withdrawal by Subject|0|||
146648197|NCT04987944|528888540|FG001|Overall Study|Withdrawal by Subject|1|||
146648198|NCT04136444|528888546|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
146648199|NCT04136444|528888547|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
146648200|NCT02095132|528888553|FG000|Overall Study|Adverse Event|0|||
146648201|NCT02095132|528888554|FG001|Overall Study|Adverse Event|0|||
146648202|NCT02095132|528888555|FG002|Overall Study|Adverse Event|0|||
146648203|NCT02095132|528888556|FG003|Overall Study|Adverse Event|0|||
146648204|NCT02095132|528888557|FG004|Overall Study|Adverse Event|1|||
146648205|NCT02095132|528888558|FG005|Overall Study|Adverse Event|0|||
146648206|NCT02095132|528888559|FG006|Overall Study|Adverse Event|1|||
146769257|NCT02698891|529323447|FG000|Overall Study|Adverse Event|9|||
146769258|NCT02383472|529323448|FG000|Overall Study|Withdrawal by Subject|1|||
146769259|NCT02383472|529323449|FG001|Overall Study|Withdrawal by Subject|1|||
146503262|NCT01493284|528344356|FG000|Overall Study|Death|29|||
146503263|NCT01493284|528344356|FG000|Overall Study|Withdrawal by Subject|32|||
146503264|NCT03489707|528344357|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
146503265|NCT03489707|528344358|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
146503266|NCT03489707|528344357|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
146503267|NCT03489707|528344358|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
146503268|NCT00519428|528344359|FG000|Overall Study|Adverse Event|5|||
146503269|NCT00519428|528344360|FG001|Overall Study|Adverse Event|2|||
146503270|NCT00519428|528344361|FG002|Overall Study|Adverse Event|10|||
146503271|NCT00519428|528344359|FG000|Overall Study|Lost to Follow-up|7|||
146503272|NCT00519428|528344360|FG001|Overall Study|Lost to Follow-up|7|||
146503273|NCT00519428|528344361|FG002|Overall Study|Lost to Follow-up|6|||
146503274|NCT00519428|528344359|FG000|Overall Study|Withdrawal by Subject|8|||
146503275|NCT00519428|528344360|FG001|Overall Study|Withdrawal by Subject|3|||
146503276|NCT00519428|528344361|FG002|Overall Study|Withdrawal by Subject|7|||
146503277|NCT00519428|528344359|FG000|Overall Study|unstated|1|||
146503278|NCT00519428|528344360|FG001|Overall Study|unstated|3|||
146503279|NCT00519428|528344361|FG002|Overall Study|unstated|2|||
146503280|NCT00325156|528344362|FG000|Overall Study|Protocol Violation|8|||
146503281|NCT00325156|528344362|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
146503282|NCT00325156|528344362|FG000|Overall Study|Migrated/moved from study area|12|||
146503283|NCT00325156|528344362|FG000|Overall Study|Adverse event, non-fatal|3|||
146503284|NCT00325156|528344362|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
146503285|NCT00325156|528344362|FG000|Overall Study|Other|1|||
146503286|NCT00325156|528344362|FG000|Overall Study|Withdrawal by Subject|31|||
146503287|NCT03395184|528344363|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
146503288|NCT03395184|528344364|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
146503289|NCT03395184|528344365|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
146503290|NCT03395184|528344366|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
146503291|NCT03395184|528344367|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
146503292|NCT03395184|528344368|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
146503293|NCT03395184|528344369|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
146503294|NCT03395184|528344363|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
146503295|NCT03395184|528344364|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
146503296|NCT03395184|528344365|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
146503297|NCT03395184|528344366|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
146503298|NCT03395184|528344367|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
146503299|NCT03395184|528344368|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
146503300|NCT03395184|528344369|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
146503301|NCT03395184|528344363|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
146503302|NCT03395184|528344364|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
146503303|NCT03395184|528344365|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
146503304|NCT03395184|528344366|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
146503305|NCT03395184|528344367|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
146503306|NCT03395184|528344368|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
146503307|NCT03395184|528344369|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
146503308|NCT03395184|528344363|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
146503309|NCT03395184|528344364|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
146503310|NCT03395184|528344365|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
146503311|NCT03395184|528344366|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
146503312|NCT03395184|528344367|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
146503313|NCT03395184|528344368|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
146503314|NCT03395184|528344369|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
146503315|NCT03395184|528344363|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
146503316|NCT03395184|528344364|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
146503317|NCT03395184|528344365|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
146503318|NCT03395184|528344366|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
146503319|NCT03395184|528344367|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
146503320|NCT03395184|528344368|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
146503321|NCT03395184|528344369|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
146503322|NCT03395184|528344363|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
146503323|NCT03395184|528344364|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
146503324|NCT03395184|528344365|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
146503325|NCT03395184|528344366|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
146503326|NCT03395184|528344367|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
146503327|NCT03395184|528344368|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
146503328|NCT03395184|528344369|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
146503329|NCT03395184|528344363|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
146503330|NCT03395184|528344364|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
146503331|NCT03395184|528344365|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
146503332|NCT03395184|528344366|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
146503333|NCT03395184|528344367|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
146503334|NCT03395184|528344368|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
146503335|NCT03395184|528344369|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
146503336|NCT03395184|528344363|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
146503337|NCT03395184|528344364|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
146503338|NCT03395184|528344365|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
146503339|NCT03395184|528344366|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
146503340|NCT03395184|528344367|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
146503341|NCT03395184|528344368|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
146503342|NCT03395184|528344369|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
146503343|NCT03395184|528344363|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
146503344|NCT03395184|528344364|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
146503345|NCT03395184|528344365|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
146503346|NCT03395184|528344366|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
146503347|NCT03395184|528344367|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
146503348|NCT03395184|528344368|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
146503349|NCT03395184|528344369|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
146503350|NCT03395184|528344363|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
146503351|NCT03395184|528344364|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
146503352|NCT03395184|528344365|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
146503353|NCT03395184|528344366|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
146503354|NCT03395184|528344367|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
146503355|NCT03395184|528344368|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
146503356|NCT03395184|528344369|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
146503357|NCT03395184|528344363|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
146503358|NCT03395184|528344364|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
146503359|NCT03395184|528344365|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
146503360|NCT03395184|528344366|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
146503361|NCT03395184|528344367|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
146503362|NCT03395184|528344368|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
146503363|NCT03395184|528344369|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
146503364|NCT03395184|528344363|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
146503365|NCT03395184|528344364|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
146503366|NCT03395184|528344365|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
146503367|NCT03395184|528344366|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
146503368|NCT03395184|528344367|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
146503369|NCT03395184|528344368|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
146503370|NCT03395184|528344369|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
146503371|NCT01817582|528344370|FG000|Overall Study|Withdrawal by Subject|0|||
146503372|NCT01817582|528344371|FG001|Overall Study|Withdrawal by Subject|1|||
146503373|NCT01817582|528344372|FG002|Overall Study|Withdrawal by Subject|0|||
146503374|NCT01817582|528344370|FG000|Overall Study|Participant revealed masked treatment|1|||
146503375|NCT01817582|528344371|FG001|Overall Study|Participant revealed masked treatment|0|||
146503376|NCT01817582|528344372|FG002|Overall Study|Participant revealed masked treatment|0|||
146503377|NCT01817582|528344370|FG000|Overall Study|Randomized but exclusion criteria met|1|||
146503378|NCT01817582|528344371|FG001|Overall Study|Randomized but exclusion criteria met|0|||
146503379|NCT01817582|528344372|FG002|Overall Study|Randomized but exclusion criteria met|0|||
146503380|NCT03053063|528344373|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
146503381|NCT03053063|528344374|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
146503382|NCT03053063|528344375|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
146503383|NCT03053063|528344376|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
146503384|NCT03053063|528344373|FG000|Randomized Phase|Withdrew consent|8|||
146503385|NCT03053063|528344374|FG001|Randomized Phase|Withdrew consent|11|||
146503386|NCT03053063|528344375|FG002|Randomized Phase|Withdrew consent|5|||
146503387|NCT03053063|528344376|FG003|Randomized Phase|Withdrew consent|0|||
146503388|NCT03053063|528344373|FG000|Randomized Phase|Investigator's Discretion|8|||
146503389|NCT03053063|528344374|FG001|Randomized Phase|Investigator's Discretion|6|||
146503390|NCT03053063|528344375|FG002|Randomized Phase|Investigator's Discretion|2|||
146503391|NCT03053063|528344376|FG003|Randomized Phase|Investigator's Discretion|0|||
146503392|NCT03053063|528344373|FG000|Randomized Phase|Lost to Follow-up|3|||
146503393|NCT03053063|528344374|FG001|Randomized Phase|Lost to Follow-up|5|||
146648207|NCT02095132|528888560|FG007|Overall Study|Adverse Event|0|||
146648208|NCT02095132|528888561|FG008|Overall Study|Adverse Event|0|||
146648209|NCT02095132|528888553|FG000|Overall Study|Death|0|||
146648210|NCT02095132|528888554|FG001|Overall Study|Death|0|||
146648211|NCT02095132|528888555|FG002|Overall Study|Death|0|||
146648212|NCT02095132|528888556|FG003|Overall Study|Death|0|||
146648213|NCT02095132|528888557|FG004|Overall Study|Death|0|||
146648214|NCT02095132|528888558|FG005|Overall Study|Death|0|||
146648215|NCT02095132|528888559|FG006|Overall Study|Death|1|||
146648216|NCT02095132|528888560|FG007|Overall Study|Death|0|||
146912819|NCT01208181|529843196|FG000|Part 2|Adverse Event|0|||
146912820|NCT01208181|529843197|FG001|Part 2|Adverse Event|0|||
146503394|NCT03053063|528344375|FG002|Randomized Phase|Lost to Follow-up|1|||
146503395|NCT03053063|528344376|FG003|Randomized Phase|Lost to Follow-up|0|||
146503396|NCT03053063|528344373|FG000|Randomized Phase|Adverse Event|0|||
146503397|NCT03053063|528344374|FG001|Randomized Phase|Adverse Event|1|||
146648217|NCT02095132|528888561|FG008|Overall Study|Death|0|||
146648218|NCT02095132|528888553|FG000|Overall Study|Lack of Efficacy|3|||
146648219|NCT02095132|528888554|FG001|Overall Study|Lack of Efficacy|5|||
146912821|NCT01208181|529843198|FG002|Part 2|Adverse Event|6|||
146912822|NCT01208181|529843199|FG003|Part 2|Adverse Event|7|||
146503398|NCT03053063|528344375|FG002|Randomized Phase|Adverse Event|0|||
146503399|NCT03053063|528344376|FG003|Randomized Phase|Adverse Event|0|||
146503400|NCT03053063|528344373|FG000|Randomized Phase|Randomized but Never Treated|1|||
146503401|NCT03053063|528344374|FG001|Randomized Phase|Randomized but Never Treated|3|||
146503402|NCT03053063|528344375|FG002|Randomized Phase|Randomized but Never Treated|2|||
146503403|NCT03053063|528344376|FG003|Randomized Phase|Randomized but Never Treated|0|||
146503404|NCT03053063|528344373|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
146503405|NCT03053063|528344374|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
146503406|NCT03053063|528344375|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
146503407|NCT03053063|528344376|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
146503408|NCT03053063|528344373|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
146503409|NCT03053063|528344374|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
146503410|NCT03053063|528344375|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
146503411|NCT03053063|528344376|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
146503412|NCT03053063|528344373|FG000|Open-Label Phase|Death|0|||
146503413|NCT03053063|528344374|FG001|Open-Label Phase|Death|0|||
146503414|NCT03053063|528344375|FG002|Open-Label Phase|Death|0|||
146503415|NCT03053063|528344376|FG003|Open-Label Phase|Death|2|||
146503416|NCT03053063|528344373|FG000|Open-Label Phase|Investigator's discretion|0|||
146503417|NCT03053063|528344374|FG001|Open-Label Phase|Investigator's discretion|0|||
146503418|NCT03053063|528344375|FG002|Open-Label Phase|Investigator's discretion|0|||
146503419|NCT03053063|528344376|FG003|Open-Label Phase|Investigator's discretion|2|||
146503420|NCT00356135|528344380|FG000|Overall Study|Protocol Violation|1|||
146503421|NCT00356135|528344381|FG001|Overall Study|Protocol Violation|0|||
146503422|NCT00356135|528344382|FG002|Overall Study|Protocol Violation|0|||
146503423|NCT00356135|528344380|FG000|Overall Study|Adverse Event|1|||
146503424|NCT00356135|528344381|FG001|Overall Study|Adverse Event|0|||
146503425|NCT00356135|528344382|FG002|Overall Study|Adverse Event|0|||
146503426|NCT00356135|528344380|FG000|Overall Study|Lost to Follow-up|0|||
146503427|NCT00356135|528344381|FG001|Overall Study|Lost to Follow-up|0|||
146503428|NCT00356135|528344382|FG002|Overall Study|Lost to Follow-up|1|||
146503429|NCT00356135|528344380|FG000|Overall Study|Physician Decision|1|||
146503430|NCT00356135|528344381|FG001|Overall Study|Physician Decision|1|||
146503431|NCT00356135|528344382|FG002|Overall Study|Physician Decision|1|||
146503432|NCT00356135|528344380|FG000|Overall Study|Subject non-compliance|1|||
146503433|NCT00356135|528344381|FG001|Overall Study|Subject non-compliance|1|||
146503434|NCT00356135|528344382|FG002|Overall Study|Subject non-compliance|3|||
146503435|NCT03617770|528344383|FG000|Overall Study|Lost to Follow-up|1|||
146503436|NCT03617770|528344384|FG001|Overall Study|Lost to Follow-up|0|||
146503437|NCT05033262|528344385|FG000|Overall Study|Lost to Follow-up|1|||
146503438|NCT05033262|528344386|FG001|Overall Study|Lost to Follow-up|0|||
146503439|NCT05033262|528344387|FG002|Overall Study|Lost to Follow-up|0|||
146503440|NCT05033262|528344388|FG003|Overall Study|Lost to Follow-up|1|||
146503441|NCT05270395|528344389|FG000|Overall Study|Lost to Follow-up|2|||
146503442|NCT05270395|528344390|FG001|Overall Study|Lost to Follow-up|2|||
146503443|NCT05270395|528344389|FG000|Overall Study|Death|1|||
146503444|NCT05270395|528344390|FG001|Overall Study|Death|2|||
146503445|NCT05270395|528344389|FG000|Overall Study|Study Team Withdrew|1|||
146503446|NCT05270395|528344390|FG001|Overall Study|Study Team Withdrew|0|||
146503447|NCT04434469|528346715|FG000|Overall Study|Death|2|||
146503448|NCT04434469|528346716|FG001|Overall Study|Death|3|||
146912823|NCT01208181|529843200|FG004|Part 2|Adverse Event|0|||
146912824|NCT01208181|529843196|FG000|Part 2|Withdrawal by Subject|0|||
146503449|NCT04434469|528346717|FG002|Overall Study|Death|2|||
146503450|NCT04434469|528346718|FG003|Overall Study|Death|2|||
146503451|NCT04434469|528346719|FG004|Overall Study|Death|2|||
146503452|NCT04434469|528346720|FG005|Overall Study|Death|0|||
146503453|NCT04434469|528346715|FG000|Overall Study|Lost to Follow-up|0|||
146503454|NCT04434469|528346716|FG001|Overall Study|Lost to Follow-up|0|||
146503455|NCT04434469|528346717|FG002|Overall Study|Lost to Follow-up|0|||
146503456|NCT04434469|528346718|FG003|Overall Study|Lost to Follow-up|1|||
146503457|NCT04434469|528346719|FG004|Overall Study|Lost to Follow-up|1|||
146503458|NCT04434469|528346720|FG005|Overall Study|Lost to Follow-up|0|||
146503459|NCT04434469|528346715|FG000|Overall Study|Study terminated by sponsor|1|||
146503460|NCT04434469|528346716|FG001|Overall Study|Study terminated by sponsor|1|||
146503461|NCT04434469|528346717|FG002|Overall Study|Study terminated by sponsor|1|||
146566945|NCT00329030|528587967|FG000|Overall Study|Progressive Disease|6|||
146566946|NCT00329030|528587968|FG001|Overall Study|Progressive Disease|2|||
146566947|NCT00329030|528587967|FG000|Overall Study|Ineligible Pathology|1|||
146566948|NCT00329030|528587968|FG001|Overall Study|Ineligible Pathology|1|||
146566949|NCT00325143|528587969|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
146566950|NCT00325143|528587969|FG000|Overall Study|Migrated/moved from study area|1|||
146566951|NCT00325143|528587969|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
146566952|NCT00325143|528587969|FG000|Overall Study|Withdrawal by Subject|8|||
146566953|NCT02286895|528587970|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
146566954|NCT02286895|528587971|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
146566955|NCT02286895|528587970|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
146648220|NCT02095132|528888555|FG002|Overall Study|Lack of Efficacy|2|||
146648221|NCT02095132|528888556|FG003|Overall Study|Lack of Efficacy|8|||
146648222|NCT02095132|528888557|FG004|Overall Study|Lack of Efficacy|3|||
146648223|NCT02095132|528888558|FG005|Overall Study|Lack of Efficacy|6|||
146648224|NCT02095132|528888559|FG006|Overall Study|Lack of Efficacy|10|||
146648225|NCT02095132|528888560|FG007|Overall Study|Lack of Efficacy|9|||
146648226|NCT02095132|528888561|FG008|Overall Study|Lack of Efficacy|8|||
146648227|NCT02095132|528888553|FG000|Overall Study|Physician Decision|1|||
146503462|NCT04434469|528346718|FG003|Overall Study|Study terminated by sponsor|2|||
146503463|NCT04434469|528346719|FG004|Overall Study|Study terminated by sponsor|3|||
146503464|NCT04434469|528346720|FG005|Overall Study|Study terminated by sponsor|3|||
146503465|NCT04434469|528346715|FG000|Overall Study|Withdrawal by Subject|0|||
146503466|NCT04434469|528346716|FG001|Overall Study|Withdrawal by Subject|0|||
146503467|NCT04434469|528346717|FG002|Overall Study|Withdrawal by Subject|1|||
146503468|NCT04434469|528346718|FG003|Overall Study|Withdrawal by Subject|0|||
146503469|NCT04434469|528346719|FG004|Overall Study|Withdrawal by Subject|0|||
146503470|NCT04434469|528346720|FG005|Overall Study|Withdrawal by Subject|0|||
146503471|NCT01154296|528346721|FG000|Randomization and Intervention|Decided to decline|1|||
146503472|NCT01154296|528346722|FG001|Randomization and Intervention|Decided to decline|1|||
146648228|NCT02095132|528888554|FG001|Overall Study|Physician Decision|0|||
146648229|NCT02095132|528888555|FG002|Overall Study|Physician Decision|0|||
146648230|NCT02095132|528888556|FG003|Overall Study|Physician Decision|0|||
146648231|NCT02095132|528888557|FG004|Overall Study|Physician Decision|0|||
146648232|NCT02095132|528888558|FG005|Overall Study|Physician Decision|0|||
146503473|NCT01154296|528346721|FG000|Randomization and Intervention|Declined by staff|1|||
146503474|NCT01154296|528346722|FG001|Randomization and Intervention|Declined by staff|0|||
146503475|NCT01154296|528346721|FG000|Randomization and Intervention|Did not return|1|||
146503476|NCT01154296|528346722|FG001|Randomization and Intervention|Did not return|0|||
146503477|NCT01154296|528346721|FG000|Randomization and Intervention|Left before test|0|||
146503478|NCT01154296|528346722|FG001|Randomization and Intervention|Left before test|1|||
146503479|NCT01154296|528346721|FG000|Randomization and Intervention|Left clinic early|2|||
146503480|NCT01154296|528346722|FG001|Randomization and Intervention|Left clinic early|0|||
146503481|NCT01154296|528346721|FG000|6-month Follow-up|Lost contact|269|||
146503482|NCT01154296|528346722|FG001|6-month Follow-up|Lost contact|275|||
146503483|NCT01154296|528346721|FG000|6-month Follow-up|Incarcerated|37|||
146503484|NCT01154296|528346722|FG001|6-month Follow-up|Incarcerated|32|||
146503485|NCT01154296|528346721|FG000|6-month Follow-up|Withdrew consent|14|||
146503486|NCT01154296|528346722|FG001|6-month Follow-up|Withdrew consent|15|||
146503487|NCT01154296|528346721|FG000|6-month Follow-up|Death|3|||
146503488|NCT01154296|528346722|FG001|6-month Follow-up|Death|2|||
146503489|NCT01154296|528346721|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
146503490|NCT01154296|528346722|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
146503491|NCT01936181|528346727|FG000|Randomised, Double-blind|Adverse Event|27|||
146503492|NCT01936181|528346728|FG001|Randomised, Double-blind|Adverse Event|21|||
146503493|NCT01936181|528346729|FG002|Randomised, Double-blind|Adverse Event|0|||
146503494|NCT01936181|528346730|FG003|Randomised, Double-blind|Adverse Event|0|||
146503495|NCT01936181|528346727|FG000|Randomised, Double-blind|Protocol Violation|1|||
146648233|NCT02095132|528888559|FG006|Overall Study|Physician Decision|1|||
146648234|NCT02095132|528888560|FG007|Overall Study|Physician Decision|0|||
146648235|NCT02095132|528888561|FG008|Overall Study|Physician Decision|2|||
146648236|NCT02095132|528888553|FG000|Overall Study|Withdrawal by Subject|0|||
146648237|NCT02095132|528888554|FG001|Overall Study|Withdrawal by Subject|0|||
146648238|NCT02095132|528888555|FG002|Overall Study|Withdrawal by Subject|2|||
146648239|NCT02095132|528888556|FG003|Overall Study|Withdrawal by Subject|2|||
146648240|NCT02095132|528888557|FG004|Overall Study|Withdrawal by Subject|3|||
146648241|NCT02095132|528888558|FG005|Overall Study|Withdrawal by Subject|0|||
146912825|NCT01208181|529843197|FG001|Part 2|Withdrawal by Subject|0|||
146648242|NCT02095132|528888559|FG006|Overall Study|Withdrawal by Subject|5|||
146648243|NCT02095132|528888560|FG007|Overall Study|Withdrawal by Subject|0|||
146648244|NCT02095132|528888561|FG008|Overall Study|Withdrawal by Subject|0|||
146648245|NCT04905498|528888562|FG000|Overall Study|Lost to Follow-up|0|||
146912826|NCT01208181|529843198|FG002|Part 2|Withdrawal by Subject|1|||
146912827|NCT01208181|529843199|FG003|Part 2|Withdrawal by Subject|1|||
146503496|NCT01936181|528346728|FG001|Randomised, Double-blind|Protocol Violation|5|||
146503497|NCT01936181|528346729|FG002|Randomised, Double-blind|Protocol Violation|0|||
146503498|NCT01936181|528346730|FG003|Randomised, Double-blind|Protocol Violation|0|||
146503499|NCT01936181|528346727|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
146503500|NCT01936181|528346728|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
146503501|NCT01936181|528346729|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
146503502|NCT01936181|528346730|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
146648246|NCT04905498|528888563|FG001|Overall Study|Lost to Follow-up|2|||
146648247|NCT04905498|528888562|FG000|Overall Study|COVID lockdown|1|||
146648248|NCT04905498|528888563|FG001|Overall Study|COVID lockdown|0|||
146648249|NCT00409175|528888564|FG000|Overall Study|Adverse Event|4|||
146648250|NCT00409175|528888565|FG001|Overall Study|Adverse Event|3|||
146648251|NCT00409175|528888564|FG000|Overall Study|Withdrawal by Subject|1|||
146503503|NCT01936181|528346727|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
146503504|NCT01936181|528346728|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
146503505|NCT01936181|528346729|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
146503506|NCT01936181|528346730|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
146503507|NCT01936181|528346727|FG000|Randomised, Double-blind|Pregnancy|0|||
146503508|NCT01936181|528346728|FG001|Randomised, Double-blind|Pregnancy|1|||
146503509|NCT01936181|528346729|FG002|Randomised, Double-blind|Pregnancy|0|||
146503510|NCT01936181|528346730|FG003|Randomised, Double-blind|Pregnancy|0|||
146503511|NCT01936181|528346727|FG000|Randomised, Double-blind|Physician Decision|4|||
146503512|NCT01936181|528346728|FG001|Randomised, Double-blind|Physician Decision|4|||
146503513|NCT01936181|528346729|FG002|Randomised, Double-blind|Physician Decision|0|||
146503514|NCT01936181|528346730|FG003|Randomised, Double-blind|Physician Decision|0|||
146503515|NCT01936181|528346727|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
146503516|NCT01936181|528346728|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
146503517|NCT01936181|528346729|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
146503518|NCT01936181|528346730|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
146503519|NCT01936181|528346727|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
146503520|NCT01936181|528346728|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
146503521|NCT01936181|528346729|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
146503522|NCT01936181|528346730|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
146503523|NCT01936181|528346727|FG000|Transition-extension|Adverse Event|3|||
146503524|NCT01936181|528346728|FG001|Transition-extension|Adverse Event|0|||
146503525|NCT01936181|528346729|FG002|Transition-extension|Adverse Event|3|||
146503526|NCT01936181|528346730|FG003|Transition-extension|Adverse Event|1|||
146503527|NCT01936181|528346727|FG000|Transition-extension|Lost to Follow-up|3|||
146503528|NCT01936181|528346728|FG001|Transition-extension|Lost to Follow-up|0|||
146503529|NCT01936181|528346729|FG002|Transition-extension|Lost to Follow-up|1|||
146503530|NCT01936181|528346730|FG003|Transition-extension|Lost to Follow-up|2|||
146503531|NCT01936181|528346727|FG000|Transition-extension|Physician Decision|2|||
146503532|NCT01936181|528346728|FG001|Transition-extension|Physician Decision|0|||
146503533|NCT01936181|528346729|FG002|Transition-extension|Physician Decision|0|||
146503534|NCT01936181|528346730|FG003|Transition-extension|Physician Decision|1|||
146503535|NCT01936181|528346727|FG000|Transition-extension|Withdrawal by Subject|7|||
146503536|NCT01936181|528346728|FG001|Transition-extension|Withdrawal by Subject|0|||
146503537|NCT01936181|528346729|FG002|Transition-extension|Withdrawal by Subject|2|||
146503538|NCT01936181|528346730|FG003|Transition-extension|Withdrawal by Subject|1|||
146503539|NCT00970632|528346735|FG000|Overall Study|Adverse Event|2|||
146503540|NCT00970632|528346736|FG001|Overall Study|Adverse Event|2|||
146503541|NCT00970632|528346737|FG002|Overall Study|Adverse Event|1|||
146503542|NCT00970632|528346735|FG000|Overall Study|Lack of Efficacy|3|||
146503543|NCT00970632|528346736|FG001|Overall Study|Lack of Efficacy|0|||
146503544|NCT00970632|528346737|FG002|Overall Study|Lack of Efficacy|0|||
146503545|NCT00970632|528346735|FG000|Overall Study|Lost to Follow-up|3|||
146503546|NCT00970632|528346736|FG001|Overall Study|Lost to Follow-up|0|||
146503547|NCT00970632|528346737|FG002|Overall Study|Lost to Follow-up|2|||
146503548|NCT00970632|528346735|FG000|Overall Study|Protocol Violation|8|||
146503549|NCT00970632|528346736|FG001|Overall Study|Protocol Violation|5|||
146503550|NCT00970632|528346737|FG002|Overall Study|Protocol Violation|8|||
146503551|NCT00970632|528346735|FG000|Overall Study|Withdrawal by Subject|7|||
146503552|NCT00970632|528346736|FG001|Overall Study|Withdrawal by Subject|6|||
146503553|NCT00970632|528346737|FG002|Overall Study|Withdrawal by Subject|4|||
146503554|NCT00970632|528346735|FG000|Overall Study|Entry criteria not met|0|||
146503555|NCT00970632|528346736|FG001|Overall Study|Entry criteria not met|2|||
146503556|NCT00970632|528346737|FG002|Overall Study|Entry criteria not met|2|||
146503557|NCT00970632|528346735|FG000|Overall Study|Sponsor decision|1|||
146503558|NCT00970632|528346736|FG001|Overall Study|Sponsor decision|0|||
146503559|NCT00970632|528346737|FG002|Overall Study|Sponsor decision|1|||
146503560|NCT03320850|528346740|FG000|Overall Study|Lost to Follow-up|0|||
146648252|NCT00409175|528888565|FG001|Overall Study|Withdrawal by Subject|2|||
146648253|NCT00409175|528888564|FG000|Overall Study|Negative genotype|0|||
146648254|NCT00409175|528888565|FG001|Overall Study|Negative genotype|1|||
146503561|NCT03320850|528346741|FG001|Overall Study|Lost to Follow-up|0|||
146503562|NCT03320850|528346742|FG002|Overall Study|Lost to Follow-up|0|||
146503563|NCT03320850|528346743|FG003|Overall Study|Lost to Follow-up|0|||
146503564|NCT03320850|528346744|FG004|Overall Study|Lost to Follow-up|1|||
146503565|NCT03320850|528346745|FG005|Overall Study|Lost to Follow-up|2|||
146503566|NCT03320850|528346746|FG006|Overall Study|Lost to Follow-up|2|||
146503567|NCT03320850|528346747|FG007|Overall Study|Lost to Follow-up|0|||
146503568|NCT03320850|528346748|FG008|Overall Study|Lost to Follow-up|6|||
146503569|NCT03320850|528346749|FG009|Overall Study|Lost to Follow-up|4|||
146503570|NCT03320850|528346740|FG000|Overall Study|Withdrawal by Subject|0|||
146503571|NCT03320850|528346741|FG001|Overall Study|Withdrawal by Subject|0|||
146503572|NCT03320850|528346742|FG002|Overall Study|Withdrawal by Subject|0|||
146503573|NCT03320850|528346743|FG003|Overall Study|Withdrawal by Subject|0|||
146503574|NCT03320850|528346744|FG004|Overall Study|Withdrawal by Subject|1|||
146503575|NCT03320850|528346745|FG005|Overall Study|Withdrawal by Subject|2|||
146503576|NCT03320850|528346746|FG006|Overall Study|Withdrawal by Subject|4|||
146503577|NCT03320850|528346747|FG007|Overall Study|Withdrawal by Subject|5|||
146503578|NCT03320850|528346748|FG008|Overall Study|Withdrawal by Subject|2|||
146503579|NCT03320850|528346749|FG009|Overall Study|Withdrawal by Subject|1|||
146503580|NCT03320850|528346740|FG000|Overall Study|Lack of Efficacy|0|||
146503581|NCT03320850|528346741|FG001|Overall Study|Lack of Efficacy|0|||
146503582|NCT03320850|528346742|FG002|Overall Study|Lack of Efficacy|0|||
146503583|NCT03320850|528346743|FG003|Overall Study|Lack of Efficacy|1|||
146503584|NCT03320850|528346744|FG004|Overall Study|Lack of Efficacy|0|||
146503585|NCT03320850|528346745|FG005|Overall Study|Lack of Efficacy|1|||
146503586|NCT03320850|528346746|FG006|Overall Study|Lack of Efficacy|0|||
146503587|NCT03320850|528346747|FG007|Overall Study|Lack of Efficacy|2|||
146503588|NCT03320850|528346748|FG008|Overall Study|Lack of Efficacy|0|||
146503589|NCT03320850|528346749|FG009|Overall Study|Lack of Efficacy|3|||
146503590|NCT03320850|528346740|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
146503591|NCT03320850|528346741|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
146648255|NCT00409175|528888564|FG000|Overall Study|Liver transplantation|13|||
146648256|NCT00409175|528888565|FG001|Overall Study|Liver transplantation|13|||
146648257|NCT02946931|528888570|FG000|Overall Study|Did not require collection of CRFs|588|||
146648258|NCT02946931|528888570|FG000|Overall Study|Other than listed|37|||
146648259|NCT02946931|528888570|FG000|Overall Study|Discharge from hospital|118|||
146648260|NCT02946931|528888570|FG000|Overall Study|Adverse Event|81|||
146648261|NCT02946931|528888570|FG000|Overall Study|CRFs not valid|1|||
146648262|NCT02946931|528888570|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
146648263|NCT03339297|528888571|FG000|Overall Study|Relapse of Hematologic Disease|1|||
146648264|NCT03339297|528888572|FG001|Overall Study|Relapse of Hematologic Disease|0|||
146648265|NCT03339297|528888571|FG000|Overall Study|Death|10|||
146648266|NCT03339297|528888572|FG001|Overall Study|Death|7|||
146648267|NCT03339297|528888571|FG000|Overall Study|Hepatic Candidosis|1|||
146648268|NCT03339297|528888572|FG001|Overall Study|Hepatic Candidosis|0|||
146648269|NCT03339297|528888571|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
146648270|NCT03339297|528888572|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
146648271|NCT03339297|528888571|FG000|Overall Study|Consent Withdrawn by Participant|3|||
146648272|NCT03339297|528888572|FG001|Overall Study|Consent Withdrawn by Participant|3|||
146648273|NCT03339297|528888571|FG000|Overall Study|Disease Relapse|2|||
146648274|NCT03339297|528888572|FG001|Overall Study|Disease Relapse|0|||
146648275|NCT03339297|528888571|FG000|Overall Study|Physician Decision|1|||
146648276|NCT03339297|528888572|FG001|Overall Study|Physician Decision|1|||
146648277|NCT03339297|528888571|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
146648278|NCT03339297|528888572|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
146648279|NCT03339297|528888571|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
146648280|NCT03339297|528888572|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
146648281|NCT03339297|528888571|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
146648282|NCT03339297|528888572|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
146648283|NCT03339297|528888571|FG000|Overall Study|Adverse Event, Non-fatal|1|||
146648284|NCT03339297|528888572|FG001|Overall Study|Adverse Event, Non-fatal|0|||
146648285|NCT03339297|528888571|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
146648286|NCT03339297|528888572|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
146648287|NCT03339297|528888571|FG000|Overall Study|Patient Was Not Eligible|1|||
146648288|NCT03339297|528888572|FG001|Overall Study|Patient Was Not Eligible|0|||
146648289|NCT03241368|528888583|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
146648290|NCT03241368|528888583|FG000|Overall Study|Lost to Follow-up|1|||
146648291|NCT03241368|528888583|FG000|Overall Study|Physician Decision|6|||
146648292|NCT03241368|528888583|FG000|Overall Study|Withdrawal by Subject|6|||
146648293|NCT03241368|528888583|FG000|Overall Study|Protocol Violation|1|||
146648294|NCT00065429|528888586|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
146648295|NCT00065429|528888587|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
146648296|NCT00065429|528888588|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
146503592|NCT03320850|528346742|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
146503593|NCT03320850|528346743|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
146503594|NCT03320850|528346744|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
146503595|NCT03320850|528346745|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
146503596|NCT03320850|528346746|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
146503597|NCT03320850|528346747|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
146503598|NCT03320850|528346748|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
146503599|NCT03320850|528346749|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
146503600|NCT03320850|528346740|FG000|Overall Study|Adverse Event|0|||
146503601|NCT03320850|528346741|FG001|Overall Study|Adverse Event|0|||
146648297|NCT00065429|528888589|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
146648298|NCT00065429|528888590|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
146769260|NCT01111526|529323450|FG000|Overall Study|GVHD Disease Progression|0|||
146769261|NCT01111526|529323451|FG001|Overall Study|GVHD Disease Progression|1|||
146648299|NCT00065429|528888591|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
146648300|NCT00065429|528888592|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
146648301|NCT00065429|528888586|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
146648302|NCT00065429|528888587|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
146503602|NCT03320850|528346742|FG002|Overall Study|Adverse Event|0|||
146503603|NCT03320850|528346743|FG003|Overall Study|Adverse Event|0|||
146503604|NCT03320850|528346744|FG004|Overall Study|Adverse Event|0|||
146503605|NCT03320850|528346745|FG005|Overall Study|Adverse Event|2|||
146503606|NCT03320850|528346746|FG006|Overall Study|Adverse Event|1|||
146503607|NCT03320850|528346747|FG007|Overall Study|Adverse Event|0|||
146503608|NCT03320850|528346748|FG008|Overall Study|Adverse Event|2|||
146503609|NCT03320850|528346749|FG009|Overall Study|Adverse Event|0|||
146503610|NCT03320850|528346740|FG000|Overall Study|Reason Not Specified|0|||
146503611|NCT03320850|528346741|FG001|Overall Study|Reason Not Specified|0|||
146503612|NCT03320850|528346742|FG002|Overall Study|Reason Not Specified|0|||
146503613|NCT03320850|528346743|FG003|Overall Study|Reason Not Specified|0|||
146503614|NCT03320850|528346744|FG004|Overall Study|Reason Not Specified|0|||
146503615|NCT03320850|528346745|FG005|Overall Study|Reason Not Specified|1|||
146503616|NCT03320850|528346746|FG006|Overall Study|Reason Not Specified|0|||
146503617|NCT03320850|528346747|FG007|Overall Study|Reason Not Specified|0|||
146503618|NCT03320850|528346748|FG008|Overall Study|Reason Not Specified|0|||
146503619|NCT03320850|528346749|FG009|Overall Study|Reason Not Specified|1|||
146503620|NCT01424514|528346756|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
146503621|NCT01424514|528346757|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
146503622|NCT01424514|528346756|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
146503623|NCT01424514|528346757|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
146503624|NCT01286168|528346758|FG000|Overall Study|Withdrawal by Subject|1|||
146503625|NCT01286168|528346758|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
146503626|NCT02653170|528346761|FG000|Overall Study|Withdrawal by Subject|3|||
146503627|NCT02653170|528346762|FG001|Overall Study|Withdrawal by Subject|8|||
146503628|NCT02653170|528346763|FG002|Overall Study|Withdrawal by Subject|3|||
146503629|NCT02653170|528346761|FG000|Overall Study|withdrawn by study team|2|||
146503630|NCT02653170|528346762|FG001|Overall Study|withdrawn by study team|4|||
146503631|NCT02653170|528346763|FG002|Overall Study|withdrawn by study team|5|||
146503632|NCT02653170|528346761|FG000|Overall Study|Lost to Follow-up|12|||
146503633|NCT02653170|528346762|FG001|Overall Study|Lost to Follow-up|4|||
146503634|NCT02653170|528346763|FG002|Overall Study|Lost to Follow-up|10|||
146503635|NCT04598451|528346764|FG000|Overall Study|Adverse Event|3|||
146503636|NCT04598451|528346765|FG001|Overall Study|Adverse Event|2|||
146503637|NCT04598451|528346764|FG000|Overall Study|Withdrawal by Subject|3|||
146503638|NCT04598451|528346765|FG001|Overall Study|Withdrawal by Subject|7|||
146503639|NCT04598451|528346764|FG000|Overall Study|Lost to Follow-up|2|||
146503640|NCT04598451|528346765|FG001|Overall Study|Lost to Follow-up|0|||
146503641|NCT04598451|528346764|FG000|Overall Study|Physician Decision|4|||
146503642|NCT04598451|528346765|FG001|Overall Study|Physician Decision|1|||
146503643|NCT04598451|528346764|FG000|Overall Study|Requires Prohibited Medication|1|||
146503644|NCT04598451|528346765|FG001|Overall Study|Requires Prohibited Medication|0|||
146503645|NCT04598451|528346764|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
146503646|NCT04598451|528346765|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
146503647|NCT02002533|528346766|FG000|Overall Study|Withdrawal by Subject|6|||
146503648|NCT02002533|528346767|FG001|Overall Study|Withdrawal by Subject|13|||
146503649|NCT02002533|528346766|FG000|Overall Study|Protocol Violation|0|||
146503650|NCT02002533|528346767|FG001|Overall Study|Protocol Violation|1|||
146503651|NCT02002533|528346766|FG000|Overall Study|Adverse Event|0|||
146503652|NCT02002533|528346767|FG001|Overall Study|Adverse Event|3|||
146503653|NCT02002533|528346766|FG000|Overall Study|Lost to Follow-up|0|||
146503654|NCT02002533|528346767|FG001|Overall Study|Lost to Follow-up|1|||
146503655|NCT02086448|528346773|FG000|Overall Study|Withdrawal by Subject|1|||
146648303|NCT00065429|528888588|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
146648304|NCT00065429|528888589|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
146503656|NCT02086448|528346774|FG001|Overall Study|Withdrawal by Subject|0|||
146503657|NCT02086448|528346775|FG002|Overall Study|Withdrawal by Subject|0|||
146503658|NCT02086448|528346776|FG003|Overall Study|Withdrawal by Subject|2|||
146503659|NCT01482065|528346799|FG000|Overall Study|Withdrawal by Subject|0|||
146503660|NCT01482065|528346800|FG001|Overall Study|Withdrawal by Subject|1|||
146503661|NCT01942486|528346801|FG000|Overall Study|Lost to Follow-up|27|||
146503662|NCT03728426|528346802|FG000|Overall Study|Death|3|||
146769262|NCT01111526|529323452|FG002|Overall Study|GVHD Disease Progression|2|||
146912828|NCT01208181|529843200|FG004|Part 2|Withdrawal by Subject|0|||
146503663|NCT00231114|528346803|FG000|Randomized|Withdrawal by Subject|6|||
146503664|NCT00231114|528346804|FG001|Randomized|Withdrawal by Subject|3|||
146503665|NCT00231114|528346803|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
146503666|NCT00231114|528346804|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
146503667|NCT00231114|528346803|FG000|Post-Treatment Period|Lost to Follow-up|6|||
146769263|NCT02013830|529323453|FG000|Overall Study|Adverse Event|3|||
146769264|NCT02013830|529323453|FG000|Overall Study|Death|1|||
146769265|NCT02013830|529323453|FG000|Overall Study|Insufficient therapeutic response|25|||
146769266|NCT02013830|529323453|FG000|Overall Study|Refused treatment|1|||
146769267|NCT04424641|529323456|FG000|Overall Study|Death|1|||
146769268|NCT04424641|529323457|FG001|Overall Study|Death|2|||
146769269|NCT04424641|529323458|FG002|Overall Study|Death|3|||
146769270|NCT04424641|529323459|FG003|Overall Study|Death|0|||
146769271|NCT04424641|529323460|FG004|Overall Study|Death|3|||
146769272|NCT04424641|529323461|FG005|Overall Study|Death|0|||
146769273|NCT04424641|529323462|FG006|Overall Study|Death|1|||
146769274|NCT04424641|529323463|FG007|Overall Study|Death|2|||
146769275|NCT04424641|529323456|FG000|Overall Study|Sponsor decision|0|||
146769276|NCT04424641|529323457|FG001|Overall Study|Sponsor decision|2|||
146769277|NCT04424641|529323458|FG002|Overall Study|Sponsor decision|3|||
146769278|NCT04424641|529323459|FG003|Overall Study|Sponsor decision|7|||
146769279|NCT04424641|529323460|FG004|Overall Study|Sponsor decision|2|||
146769280|NCT04424641|529323461|FG005|Overall Study|Sponsor decision|2|||
146769281|NCT04424641|529323462|FG006|Overall Study|Sponsor decision|3|||
146769282|NCT04424641|529323463|FG007|Overall Study|Sponsor decision|4|||
146769283|NCT04424641|529323456|FG000|Overall Study|Withdrawal by Subject|0|||
146769284|NCT04424641|529323457|FG001|Overall Study|Withdrawal by Subject|0|||
146769285|NCT04424641|529323458|FG002|Overall Study|Withdrawal by Subject|0|||
146769286|NCT04424641|529323459|FG003|Overall Study|Withdrawal by Subject|0|||
146769287|NCT04424641|529323460|FG004|Overall Study|Withdrawal by Subject|1|||
146769288|NCT04424641|529323461|FG005|Overall Study|Withdrawal by Subject|0|||
146769289|NCT04424641|529323462|FG006|Overall Study|Withdrawal by Subject|0|||
146648305|NCT00065429|528888590|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
146648306|NCT00065429|528888591|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
146648307|NCT00065429|528888592|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
146648308|NCT00065429|528888586|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
146648309|NCT00065429|528888587|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
146648310|NCT00065429|528888588|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
146648311|NCT00065429|528888589|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
146648312|NCT00065429|528888590|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
146648313|NCT00065429|528888591|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
146648314|NCT00065429|528888592|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
146769290|NCT04424641|529323463|FG007|Overall Study|Withdrawal by Subject|0|||
146769291|NCT04424641|529323456|FG000|Overall Study|Other|0|||
146769292|NCT04424641|529323457|FG001|Overall Study|Other|0|||
146769293|NCT04424641|529323458|FG002|Overall Study|Other|1|||
146769294|NCT04424641|529323459|FG003|Overall Study|Other|0|||
146769295|NCT04424641|529323460|FG004|Overall Study|Other|0|||
146769296|NCT04424641|529323461|FG005|Overall Study|Other|0|||
146769297|NCT04424641|529323462|FG006|Overall Study|Other|0|||
146769298|NCT04424641|529323463|FG007|Overall Study|Other|0|||
146769299|NCT01171625|529323470|FG000|Overall Study|On-Protocol|67|||
146769300|NCT01171625|529323470|FG000|Overall Study|Death|38|||
146769301|NCT01171625|529323470|FG000|Overall Study|Withdrawal by Subject|31|||
146769302|NCT01171625|529323470|FG000|Overall Study|Explanted|10|||
146769303|NCT01171625|529323470|FG000|Overall Study|Lost to Follow-up|5|||
146769304|NCT01171625|529323470|FG000|Overall Study|Patient received valve-in-valve|3|||
146769305|NCT01171625|529323470|FG000|Overall Study|Other|1|||
146769306|NCT01171625|529323470|FG000|Overall Study|Consented but did not receive device|25|||
146503668|NCT00231114|528346804|FG001|Post-Treatment Period|Lost to Follow-up|1|||
146503669|NCT00231114|528346803|FG000|Post-Treatment Period|Physician Decision|1|||
146503670|NCT00231114|528346804|FG001|Post-Treatment Period|Physician Decision|0|||
146503671|NCT00231114|528346803|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
146503672|NCT00231114|528346804|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
146648315|NCT00065429|528888586|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
146503673|NCT02005692|528346805|FG000|Overall Study|Protocol Violation|1|||
146503674|NCT02005692|528346805|FG000|Overall Study|Withdrawal by Subject|1|||
146648316|NCT00065429|528888587|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
146648317|NCT00065429|528888588|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
146648318|NCT00065429|528888589|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
146648319|NCT00065429|528888590|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
146769307|NCT03557008|529323471|FG000|Overall Study|Withdrawal by Subject|2|||
146769308|NCT03557008|529323472|FG001|Overall Study|Withdrawal by Subject|2|||
146769309|NCT03557008|529323471|FG000|Overall Study|Early termination from study|3|||
146769310|NCT03557008|529323472|FG001|Overall Study|Early termination from study|1|||
146769311|NCT00186186|529323473|FG000|Overall Study|Lack of Efficacy|3|||
146769312|NCT00186186|529323473|FG000|Overall Study|Withdrawal by Subject|3|||
146769313|NCT00186186|529323473|FG000|Overall Study|Not reported as to reason|2|||
146769314|NCT00807144|529323474|FG000|Overall Study|Lost to Follow-up|0|||
146769315|NCT00807144|529323475|FG001|Overall Study|Lost to Follow-up|1|||
146769316|NCT03959241|529323479|FG000|Overall Study|Withdrawal by Subject|7|||
146503675|NCT02005692|528346805|FG000|Overall Study|Discharged earlier than anticipated|5|||
146769317|NCT03959241|529323480|FG001|Overall Study|Withdrawal by Subject|8|||
146503676|NCT01194999|528346806|FG000|Overall Study|Lost to Follow-up|17|||
146503677|NCT02091375|528346807|FG000|Overall Study|Adverse Event|8|||
146503678|NCT02091375|528346808|FG001|Overall Study|Adverse Event|1|||
146503679|NCT02091375|528346807|FG000|Overall Study|Lost to Follow-up|0|||
146503680|NCT02091375|528346808|FG001|Overall Study|Lost to Follow-up|1|||
146503681|NCT02091375|528346807|FG000|Overall Study|Withdrawal by Subject|0|||
146503682|NCT02091375|528346808|FG001|Overall Study|Withdrawal by Subject|1|||
146503683|NCT02091375|528346807|FG000|Overall Study|Withdrawn by the investigator|1|||
146503684|NCT02091375|528346808|FG001|Overall Study|Withdrawn by the investigator|0|||
146503685|NCT02682823|528346809|FG000|Overall Study|Withdrawal by Subject|0|||
146503686|NCT02682823|528346810|FG001|Overall Study|Withdrawal by Subject|0|||
146503687|NCT02682823|528346811|FG002|Overall Study|Withdrawal by Subject|1|||
146503688|NCT02682823|528346812|FG003|Overall Study|Withdrawal by Subject|0|||
146503689|NCT02682823|528346813|FG004|Overall Study|Withdrawal by Subject|1|||
146503690|NCT02682823|528346809|FG000|Overall Study|Protocol Deviation|0|||
146503691|NCT02682823|528346810|FG001|Overall Study|Protocol Deviation|1|||
146503692|NCT02682823|528346811|FG002|Overall Study|Protocol Deviation|0|||
146503693|NCT02682823|528346812|FG003|Overall Study|Protocol Deviation|0|||
146503694|NCT02682823|528346813|FG004|Overall Study|Protocol Deviation|0|||
146503695|NCT02682823|528346809|FG000|Overall Study|Adverse Event|0|||
146503696|NCT02682823|528346810|FG001|Overall Study|Adverse Event|0|||
146503697|NCT02682823|528346811|FG002|Overall Study|Adverse Event|0|||
146503698|NCT02682823|528346812|FG003|Overall Study|Adverse Event|1|||
146503699|NCT02682823|528346813|FG004|Overall Study|Adverse Event|0|||
146503700|NCT03781583|528346814|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
146503701|NCT03781583|528346815|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
146503702|NCT03781583|528346816|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
146503703|NCT03781583|528346817|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
146503704|NCT03781583|528346814|FG000|Overall Study|Technology did not work for that person in that environment|1|||
146503705|NCT03781583|528346815|FG001|Overall Study|Technology did not work for that person in that environment|0|||
146503706|NCT03781583|528346816|FG002|Overall Study|Technology did not work for that person in that environment|0|||
146503707|NCT03781583|528346817|FG003|Overall Study|Technology did not work for that person in that environment|0|||
146503708|NCT03781583|528346814|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
146503709|NCT03781583|528346815|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
146503710|NCT03781583|528346816|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
146503711|NCT03781583|528346817|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
146503712|NCT03781583|528346814|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
146503713|NCT03781583|528346815|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
146503714|NCT03781583|528346816|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
146503715|NCT03781583|528346817|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
146503716|NCT05139303|528346818|FG000|Overall Study|Lost to Follow-up|3|||
146503717|NCT05139303|528346819|FG001|Overall Study|Lost to Follow-up|0|||
146503718|NCT05139303|528346818|FG000|Overall Study|Adverse Event|1|||
146503719|NCT05139303|528346819|FG001|Overall Study|Adverse Event|0|||
146503720|NCT01938430|528346820|FG000|Overall Study|Randomized but Not Treated|0|||
146503721|NCT01938430|528346821|FG001|Overall Study|Randomized but Not Treated|0|||
146503722|NCT01938430|528346822|FG002|Overall Study|Randomized but Not Treated|0|||
146503723|NCT01938430|528346823|FG003|Overall Study|Randomized but Not Treated|0|||
146503724|NCT01938430|528346824|FG004|Overall Study|Randomized but Not Treated|0|||
146503725|NCT01938430|528346825|FG005|Overall Study|Randomized but Not Treated|0|||
146503726|NCT01938430|528346826|FG006|Overall Study|Randomized but Not Treated|0|||
146503727|NCT01938430|528346827|FG007|Overall Study|Randomized but Not Treated|0|||
146503728|NCT01938430|528346828|FG008|Overall Study|Randomized but Not Treated|0|||
146503729|NCT01938430|528346829|FG009|Overall Study|Randomized but Not Treated|0|||
146503730|NCT01938430|528346830|FG010|Overall Study|Randomized but Not Treated|1|||
146503731|NCT01938430|528346831|FG011|Overall Study|Randomized but Not Treated|0|||
146503732|NCT01938430|528346832|FG012|Overall Study|Randomized but Not Treated|0|||
146503733|NCT01938430|528346833|FG013|Overall Study|Randomized but Not Treated|1|||
146503734|NCT01938430|528346820|FG000|Overall Study|Adverse Event|0|||
146503735|NCT01938430|528346821|FG001|Overall Study|Adverse Event|0|||
146503736|NCT01938430|528346822|FG002|Overall Study|Adverse Event|0|||
146503737|NCT01938430|528346823|FG003|Overall Study|Adverse Event|0|||
146503738|NCT01938430|528346824|FG004|Overall Study|Adverse Event|0|||
146503739|NCT01938430|528346825|FG005|Overall Study|Adverse Event|0|||
146503740|NCT01938430|528346826|FG006|Overall Study|Adverse Event|1|||
146503741|NCT01938430|528346827|FG007|Overall Study|Adverse Event|0|||
146503742|NCT01938430|528346828|FG008|Overall Study|Adverse Event|0|||
146503743|NCT01938430|528346829|FG009|Overall Study|Adverse Event|0|||
146503744|NCT01938430|528346830|FG010|Overall Study|Adverse Event|0|||
146648320|NCT00065429|528888591|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
146648321|NCT00065429|528888592|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
146503745|NCT01938430|528346831|FG011|Overall Study|Adverse Event|0|||
146503746|NCT01938430|528346832|FG012|Overall Study|Adverse Event|0|||
146503747|NCT01938430|528346833|FG013|Overall Study|Adverse Event|0|||
146503748|NCT01938430|528346820|FG000|Overall Study|Death|1|||
146503749|NCT01938430|528346821|FG001|Overall Study|Death|2|||
146503750|NCT01938430|528346822|FG002|Overall Study|Death|2|||
146503751|NCT01938430|528346823|FG003|Overall Study|Death|1|||
146503752|NCT01938430|528346824|FG004|Overall Study|Death|0|||
146503753|NCT01938430|528346825|FG005|Overall Study|Death|0|||
146503754|NCT01938430|528346826|FG006|Overall Study|Death|1|||
146503755|NCT01938430|528346827|FG007|Overall Study|Death|1|||
146503756|NCT01938430|528346828|FG008|Overall Study|Death|2|||
146503757|NCT01938430|528346829|FG009|Overall Study|Death|3|||
146503758|NCT01938430|528346830|FG010|Overall Study|Death|0|||
146503759|NCT01938430|528346831|FG011|Overall Study|Death|0|||
146503760|NCT01938430|528346832|FG012|Overall Study|Death|0|||
146503761|NCT01938430|528346833|FG013|Overall Study|Death|0|||
146503762|NCT01938430|528346820|FG000|Overall Study|Investigator's Discretion|0|||
146503763|NCT01938430|528346821|FG001|Overall Study|Investigator's Discretion|0|||
146503764|NCT01938430|528346822|FG002|Overall Study|Investigator's Discretion|1|||
146503765|NCT01938430|528346823|FG003|Overall Study|Investigator's Discretion|0|||
146503766|NCT01938430|528346824|FG004|Overall Study|Investigator's Discretion|0|||
146503767|NCT01938430|528346825|FG005|Overall Study|Investigator's Discretion|0|||
146503768|NCT01938430|528346826|FG006|Overall Study|Investigator's Discretion|0|||
146503769|NCT01938430|528346827|FG007|Overall Study|Investigator's Discretion|0|||
146503770|NCT01938430|528346828|FG008|Overall Study|Investigator's Discretion|0|||
146503771|NCT01938430|528346829|FG009|Overall Study|Investigator's Discretion|0|||
146503772|NCT01938430|528346830|FG010|Overall Study|Investigator's Discretion|0|||
146503773|NCT01938430|528346831|FG011|Overall Study|Investigator's Discretion|0|||
146503774|NCT01938430|528346832|FG012|Overall Study|Investigator's Discretion|0|||
146503775|NCT01938430|528346833|FG013|Overall Study|Investigator's Discretion|0|||
146503776|NCT01938430|528346820|FG000|Overall Study|Lack of Efficacy|3|||
146503777|NCT01938430|528346821|FG001|Overall Study|Lack of Efficacy|1|||
146503778|NCT01938430|528346822|FG002|Overall Study|Lack of Efficacy|1|||
146503779|NCT01938430|528346823|FG003|Overall Study|Lack of Efficacy|1|||
146503780|NCT01938430|528346824|FG004|Overall Study|Lack of Efficacy|0|||
146503781|NCT01938430|528346825|FG005|Overall Study|Lack of Efficacy|0|||
146503782|NCT01938430|528346826|FG006|Overall Study|Lack of Efficacy|0|||
146503783|NCT01938430|528346827|FG007|Overall Study|Lack of Efficacy|0|||
146503784|NCT01938430|528346828|FG008|Overall Study|Lack of Efficacy|1|||
146503785|NCT01938430|528346829|FG009|Overall Study|Lack of Efficacy|0|||
146503786|NCT01938430|528346830|FG010|Overall Study|Lack of Efficacy|2|||
146769318|NCT03959241|529323479|FG000|Overall Study|Lost to Follow-up|1|||
146503787|NCT01938430|528346831|FG011|Overall Study|Lack of Efficacy|1|||
146503788|NCT01938430|528346832|FG012|Overall Study|Lack of Efficacy|0|||
146503789|NCT01938430|528346833|FG013|Overall Study|Lack of Efficacy|0|||
146503790|NCT01938430|528346820|FG000|Overall Study|Lost to Follow-up|0|||
146503791|NCT01938430|528346821|FG001|Overall Study|Lost to Follow-up|0|||
146503792|NCT01938430|528346822|FG002|Overall Study|Lost to Follow-up|1|||
146503793|NCT01938430|528346823|FG003|Overall Study|Lost to Follow-up|0|||
146503794|NCT01938430|528346824|FG004|Overall Study|Lost to Follow-up|0|||
146503795|NCT01938430|528346825|FG005|Overall Study|Lost to Follow-up|1|||
146503796|NCT01938430|528346826|FG006|Overall Study|Lost to Follow-up|0|||
146503797|NCT01938430|528346827|FG007|Overall Study|Lost to Follow-up|0|||
146503798|NCT01938430|528346828|FG008|Overall Study|Lost to Follow-up|0|||
146503799|NCT01938430|528346829|FG009|Overall Study|Lost to Follow-up|0|||
146503800|NCT01938430|528346830|FG010|Overall Study|Lost to Follow-up|0|||
146503801|NCT01938430|528346831|FG011|Overall Study|Lost to Follow-up|0|||
146503802|NCT01938430|528346832|FG012|Overall Study|Lost to Follow-up|0|||
146503803|NCT01938430|528346833|FG013|Overall Study|Lost to Follow-up|0|||
146503804|NCT01938430|528346820|FG000|Overall Study|Withdrew Consent|0|||
146503805|NCT01938430|528346821|FG001|Overall Study|Withdrew Consent|0|||
146503806|NCT01938430|528346822|FG002|Overall Study|Withdrew Consent|0|||
146503807|NCT01938430|528346823|FG003|Overall Study|Withdrew Consent|0|||
146503808|NCT01938430|528346824|FG004|Overall Study|Withdrew Consent|0|||
146503809|NCT01938430|528346825|FG005|Overall Study|Withdrew Consent|0|||
146503810|NCT01938430|528346826|FG006|Overall Study|Withdrew Consent|0|||
146503811|NCT01938430|528346827|FG007|Overall Study|Withdrew Consent|0|||
146503812|NCT01938430|528346828|FG008|Overall Study|Withdrew Consent|1|||
146503813|NCT01938430|528346829|FG009|Overall Study|Withdrew Consent|0|||
146503814|NCT01938430|528346830|FG010|Overall Study|Withdrew Consent|0|||
146503815|NCT01938430|528346831|FG011|Overall Study|Withdrew Consent|0|||
146503816|NCT01938430|528346832|FG012|Overall Study|Withdrew Consent|0|||
146503817|NCT01938430|528346833|FG013|Overall Study|Withdrew Consent|0|||
146769319|NCT03959241|529323480|FG001|Overall Study|Lost to Follow-up|0|||
146769320|NCT03959241|529323479|FG000|Overall Study|Move to Hospice Care|1|||
146503818|NCT03875482|528346834|FG000|Overall Study|Adverse Event|0|||
146503819|NCT03875482|528346835|FG001|Overall Study|Adverse Event|1|||
146503820|NCT03875482|528346834|FG000|Overall Study|Withdrew consent|5|||
146503821|NCT03875482|528346835|FG001|Overall Study|Withdrew consent|6|||
146503822|NCT03875482|528346834|FG000|Overall Study|Lost to Follow-up|8|||
146769321|NCT03959241|529323480|FG001|Overall Study|Move to Hospice Care|0|||
146769322|NCT03959241|529323479|FG000|Overall Study|Screen Failure|1|||
146769323|NCT03959241|529323480|FG001|Overall Study|Screen Failure|0|||
146769324|NCT03959241|529323479|FG000|Overall Study|Disease Relapse|0|||
146769325|NCT03959241|529323480|FG001|Overall Study|Disease Relapse|1|||
146769326|NCT03959241|529323479|FG000|Overall Study|Off Study|1|||
146769327|NCT03959241|529323480|FG001|Overall Study|Off Study|0|||
146769328|NCT03192046|529323482|FG000|Overall Study|Withdrawal by Subject|1|||
146769329|NCT03192046|529323483|FG001|Overall Study|Withdrawal by Subject|1|||
146769330|NCT00842257|529323484|FG000|Overall Study|Adverse Event|1|||
146769331|NCT01147341|529323485|FG000|Double Blind Period|Lack of Efficacy|1|||
146769332|NCT01147341|529323486|FG001|Double Blind Period|Lack of Efficacy|1|||
146769333|NCT01147341|529323485|FG000|Double Blind Period|Withdrawal by Subject|0|||
146769334|NCT01147341|529323486|FG001|Double Blind Period|Withdrawal by Subject|1|||
146769335|NCT01147341|529323485|FG000|Open Label Period|Lack of Efficacy|3|||
146769336|NCT01147341|529323486|FG001|Open Label Period|Lack of Efficacy|0|||
146769337|NCT01147341|529323485|FG000|Open Label Period|Subject moved|1|||
146769338|NCT01147341|529323486|FG001|Open Label Period|Subject moved|0|||
146769339|NCT05641311|529323488|FG000|Dosing Period 1|Adverse Event|1|||
146769340|NCT05641311|529323489|FG001|Dosing Period 1|Adverse Event|0|||
146769341|NCT00922207|529323490|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
146769342|NCT00922207|529323491|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
146769343|NCT00922207|529323492|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
146769344|NCT00922207|529323490|FG000|Overall Study|Insufficient Therapeutic Response|0|||
146769345|NCT00922207|529323491|FG001|Overall Study|Insufficient Therapeutic Response|0|||
146769346|NCT00922207|529323492|FG002|Overall Study|Insufficient Therapeutic Response|1|||
146769347|NCT00922207|529323490|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
146769348|NCT00922207|529323491|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
146769349|NCT00922207|529323492|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
146769350|NCT00922207|529323490|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
146769351|NCT00922207|529323491|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
146769352|NCT00922207|529323492|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
146769353|NCT00922207|529323490|FG000|Overall Study|Withdrew Consent|2|||
146769354|NCT00922207|529323491|FG001|Overall Study|Withdrew Consent|5|||
146769355|NCT00922207|529323492|FG002|Overall Study|Withdrew Consent|2|||
146769356|NCT00922207|529323490|FG000|Overall Study|Abnormality of Laboratory Test|0|||
146769357|NCT00922207|529323491|FG001|Overall Study|Abnormality of Laboratory Test|1|||
146769358|NCT00922207|529323492|FG002|Overall Study|Abnormality of Laboratory Test|1|||
146769359|NCT02969863|529323497|FG000|Overall Study|Physician Decision|1|||
146769360|NCT02969863|529323498|FG001|Overall Study|Physician Decision|0|||
146769361|NCT02969863|529323499|FG002|Overall Study|Physician Decision|0|||
146769362|NCT02969863|529323500|FG003|Overall Study|Physician Decision|0|||
146769363|NCT02969863|529323501|FG004|Overall Study|Physician Decision|0|||
146769364|NCT02969863|529323502|FG005|Overall Study|Physician Decision|0|||
146769365|NCT02705586|529323509|FG000|Overall Study|Health Issues|2|||
146769366|NCT02705586|529323509|FG000|Overall Study|Transportation Difficulties|5|||
146769367|NCT02705586|529323509|FG000|Overall Study|Vacation/Planned Absence|1|||
146769368|NCT02045836|529323513|FG000|Overall Study|Adverse Event|4|||
146769369|NCT02045836|529323514|FG001|Overall Study|Adverse Event|4|||
146769370|NCT02045836|529323513|FG000|Overall Study|Withdrawal by Subject|1|||
146769371|NCT02045836|529323514|FG001|Overall Study|Withdrawal by Subject|1|||
146769372|NCT02045836|529323513|FG000|Overall Study|Lost to Follow-up|4|||
146769373|NCT02045836|529323514|FG001|Overall Study|Lost to Follow-up|7|||
146769374|NCT02045836|529323513|FG000|Overall Study|Migrated from study area|0|||
146769375|NCT02045836|529323514|FG001|Overall Study|Migrated from study area|2|||
146769376|NCT03920215|529323516|FG000|Overall Study|Lost to Follow-up|1|||
146769377|NCT03920215|529323517|FG001|Overall Study|Lost to Follow-up|2|||
146769378|NCT03920215|529323518|FG002|Overall Study|Lost to Follow-up|0|||
146648322|NCT00065429|528888586|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
146648323|NCT00065429|528888587|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
146648324|NCT00065429|528888588|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
146648325|NCT00065429|528888589|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
146648326|NCT00065429|528888590|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
146648327|NCT00065429|528888591|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
146648328|NCT00065429|528888592|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
146648329|NCT00065429|528888586|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
146769379|NCT03920215|529323519|FG003|Overall Study|Lost to Follow-up|0|||
146769380|NCT03920215|529323516|FG000|Overall Study|Death|0|||
146769381|NCT03920215|529323517|FG001|Overall Study|Death|0|||
146769382|NCT03920215|529323518|FG002|Overall Study|Death|0|||
146769383|NCT03920215|529323519|FG003|Overall Study|Death|1|||
146769384|NCT02798835|529323520|FG000|Overall Study|Protocol Violation|0|||
146769385|NCT02798835|529323521|FG001|Overall Study|Protocol Violation|0|||
146769386|NCT02798835|529323522|FG002|Overall Study|Protocol Violation|3|||
146769387|NCT03024606|529323527|FG000|Overall Study|Withdrawal by Subject|9|||
146769388|NCT03024606|529323528|FG001|Overall Study|Withdrawal by Subject|10|||
146566956|NCT02286895|528587971|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
146566957|NCT02286895|528587970|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
146566958|NCT02286895|528587971|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
146566959|NCT03036852|528587972|FG000|Overall Study|Death|2|||
146566960|NCT03036852|528587972|FG000|Overall Study|Lack of Efficacy|2|||
146566961|NCT03036852|528587972|FG000|Overall Study|Adverse Event|1|||
146566962|NCT03036852|528587972|FG000|Overall Study|Lost to Follow-up|1|||
146566963|NCT02441218|528587979|FG000|Overall Study|Death|503|||
146566964|NCT02441218|528587980|FG001|Overall Study|Death|553|||
146566965|NCT02441218|528587979|FG000|Overall Study|Withdrawal by Subject|73|||
146566966|NCT02441218|528587980|FG001|Overall Study|Withdrawal by Subject|58|||
146566967|NCT02441218|528587979|FG000|Overall Study|Lost to Follow-up|2|||
146566968|NCT02441218|528587980|FG001|Overall Study|Lost to Follow-up|1|||
146566969|NCT01541371|528587981|FG000|Overall Study|Withdrawal by Subject|14|||
146566970|NCT01541371|528587981|FG000|Overall Study|Lost to Follow-up|21|||
146566971|NCT01541371|528587981|FG000|Overall Study|Adverse Event|15|||
146566972|NCT01541371|528587981|FG000|Overall Study|Lack of Efficacy|12|||
146566973|NCT01541371|528587981|FG000|Overall Study|Protocol Violation|6|||
146566974|NCT01541371|528587981|FG000|Overall Study|Study medication non-compliance|3|||
146566975|NCT01541371|528587981|FG000|Overall Study|Other|6|||
146566976|NCT00163189|528587984|FG000|Overall Study|Other|6|||
146566977|NCT00163189|528587984|FG000|Overall Study|Lost to Follow-up|1|||
146566978|NCT00163189|528587984|FG000|Overall Study|Protocol Violation|2|||
146566979|NCT00163189|528587984|FG000|Overall Study|Death|3|||
146566980|NCT00163189|528587984|FG000|Overall Study|Adverse Event|6|||
146566981|NCT00163189|528587984|FG000|Overall Study|Lack of Efficacy|7|||
146566982|NCT00163189|528587984|FG000|Overall Study|Study terminated by sponsor|11|||
146566983|NCT00163189|528587984|FG000|Overall Study|Withdrawal by Subject|11|||
146566984|NCT00163189|528587984|FG000|Overall Study|Did not meet continuation criterion|16|||
146566985|NCT03435380|528587985|FG000|Overall Study|Death|1|||
146566986|NCT03435380|528587986|FG001|Overall Study|Death|2|||
146566987|NCT03435380|528587987|FG002|Overall Study|Death|1|||
146566988|NCT03435380|528587985|FG000|Overall Study|Lost to Follow-up|12|||
146566989|NCT03435380|528587986|FG001|Overall Study|Lost to Follow-up|8|||
146566990|NCT03435380|528587987|FG002|Overall Study|Lost to Follow-up|6|||
146566991|NCT03435380|528587985|FG000|Overall Study|Physician Decision|1|||
146566992|NCT03435380|528587986|FG001|Overall Study|Physician Decision|0|||
146566993|NCT03435380|528587987|FG002|Overall Study|Physician Decision|0|||
146566994|NCT03435380|528587985|FG000|Overall Study|Withdrawal by Subject|0|||
146566995|NCT03435380|528587986|FG001|Overall Study|Withdrawal by Subject|1|||
146566996|NCT03435380|528587987|FG002|Overall Study|Withdrawal by Subject|1|||
146566997|NCT03435380|528587985|FG000|Overall Study|Ineligible|0|||
146566998|NCT03435380|528587986|FG001|Overall Study|Ineligible|1|||
146566999|NCT03435380|528587987|FG002|Overall Study|Ineligible|1|||
146567000|NCT01531998|528587992|FG000|Overall Study|Withdrawal by Subject|3|||
146567001|NCT01130337|528587998|FG000|Overall Study|Withdrawal by Subject|3|||
146567002|NCT01130337|528587998|FG000|Overall Study|Principal investigator decision|1|||
146567003|NCT01130337|528587998|FG000|Overall Study|Death|1|||
146567004|NCT01130337|528587998|FG000|Overall Study|Disease progression|1|||
146567005|NCT01130337|528587998|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
146567006|NCT01130337|528587998|FG000|Overall Study|Surgical resection (R2)|1|||
146567007|NCT03886493|528587999|FG000|Overall Study|Adverse Event|1|||
146567008|NCT00181844|528588000|FG000|Signed Consent|Withdrawal by Subject|5|||
146567009|NCT00181844|528588000|FG000|Signed Consent|Did not meet entrance criteria|7|||
146567010|NCT00181844|528588000|FG000|Exposed to Study Medication|Adverse Event|10|||
146567011|NCT00181844|528588000|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
146567012|NCT00181844|528588000|FG000|Exposed to Study Medication|Non-compliance|2|||
146567013|NCT00181844|528588000|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
146567014|NCT00181844|528588000|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
146567015|NCT00107276|528588001|FG000|Overall Study|Progression|46|||
146567016|NCT00107276|528588001|FG000|Overall Study|Adverse Event|6|||
146567017|NCT00107276|528588001|FG000|Overall Study|M.D. decision|2|||
146567018|NCT00107276|528588001|FG000|Overall Study|Patient refusal|1|||
146567019|NCT00107276|528588001|FG000|Overall Study|Death|1|||
146567020|NCT00107276|528588001|FG000|Overall Study|Ineligible|16|||
146567021|NCT03179761|528588002|FG000|Overall Study|Death|2|||
146567022|NCT03179761|528588003|FG001|Overall Study|Death|5|||
146567023|NCT03179761|528588002|FG000|Overall Study|Lost to Follow-up|2|||
146567024|NCT03179761|528588003|FG001|Overall Study|Lost to Follow-up|2|||
146567025|NCT03179761|528588002|FG000|Overall Study|Protocol Violation|1|||
146567026|NCT03179761|528588003|FG001|Overall Study|Protocol Violation|0|||
146567027|NCT03179761|528588002|FG000|Overall Study|Withdrawal by Subject|1|||
146567028|NCT03179761|528588003|FG001|Overall Study|Withdrawal by Subject|4|||
146567029|NCT03179761|528588002|FG000|Overall Study|Investigator Request|0|||
146567030|NCT03179761|528588003|FG001|Overall Study|Investigator Request|2|||
146567031|NCT03498716|528588012|FG000|Overall Study|Withdrawal by Subject|88|||
146567032|NCT03498716|528588013|FG001|Overall Study|Withdrawal by Subject|73|||
146567033|NCT03498716|528588012|FG000|Overall Study|Study Terminated By Sponsor|933|||
146568929|NCT00940602|528595501|FG000|Overall Study|Disease progression|8|||
146503823|NCT03875482|528346835|FG001|Overall Study|Lost to Follow-up|2|||
146503824|NCT03875482|528346834|FG000|Overall Study|Lack of Efficacy|0|||
146503825|NCT03875482|528346835|FG001|Overall Study|Lack of Efficacy|11|||
146503826|NCT00507819|528346838|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
146503827|NCT00507819|528346839|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
146503828|NCT03261674|528346842|FG000|Overall Study|Lost to Follow-up|6|||
146503829|NCT03261674|528346843|FG001|Overall Study|Lost to Follow-up|7|||
146503830|NCT03261674|528346842|FG000|Overall Study|Protocol Violation|1|||
146503831|NCT03261674|528346843|FG001|Overall Study|Protocol Violation|4|||
146503832|NCT03261674|528346842|FG000|Overall Study|Withdrawal by Subject|1|||
146503833|NCT03261674|528346843|FG001|Overall Study|Withdrawal by Subject|4|||
146503834|NCT03261674|528346842|FG000|Overall Study|Physician Decision|1|||
146503835|NCT03261674|528346843|FG001|Overall Study|Physician Decision|0|||
146503836|NCT02045862|528346846|FG000|Overall Study|Death|0|||
146503837|NCT02045862|528346847|FG001|Overall Study|Death|0|||
146503838|NCT02045862|528346848|FG002|Overall Study|Death|1|||
146503839|NCT02045862|528346846|FG000|Overall Study|Miscellaneous|5|||
146503840|NCT02045862|528346847|FG001|Overall Study|Miscellaneous|0|||
146503841|NCT02045862|528346848|FG002|Overall Study|Miscellaneous|8|||
146503842|NCT02045862|528346846|FG000|Overall Study|Withdrawal by Patient|18|||
146503843|NCT02045862|528346847|FG001|Overall Study|Withdrawal by Patient|27|||
146503844|NCT02045862|528346848|FG002|Overall Study|Withdrawal by Patient|57|||
146503845|NCT02045862|528346846|FG000|Overall Study|Protocol Violation|0|||
146503846|NCT02045862|528346847|FG001|Overall Study|Protocol Violation|0|||
146503847|NCT02045862|528346848|FG002|Overall Study|Protocol Violation|6|||
146503848|NCT02045862|528346846|FG000|Overall Study|Lack of Efficacy|8|||
146503849|NCT02045862|528346847|FG001|Overall Study|Lack of Efficacy|4|||
146503850|NCT02045862|528346848|FG002|Overall Study|Lack of Efficacy|13|||
146503851|NCT02045862|528346846|FG000|Overall Study|Randomized but not Received Study Drug|0|||
146503852|NCT02045862|528346847|FG001|Overall Study|Randomized but not Received Study Drug|2|||
146503853|NCT02045862|528346848|FG002|Overall Study|Randomized but not Received Study Drug|8|||
146503854|NCT02045862|528346846|FG000|Overall Study|Adverse Event|7|||
146503855|NCT02045862|528346847|FG001|Overall Study|Adverse Event|5|||
146503856|NCT02045862|528346848|FG002|Overall Study|Adverse Event|27|||
146503857|NCT02045862|528346846|FG000|Overall Study|Lost to Follow-up|1|||
146503858|NCT02045862|528346847|FG001|Overall Study|Lost to Follow-up|2|||
146503859|NCT02045862|528346848|FG002|Overall Study|Lost to Follow-up|6|||
146503860|NCT00623935|528346849|FG000|Overall Study|Death|1|||
146503861|NCT00623935|528346849|FG000|Overall Study|Patient Declined Transplant|1|||
146503862|NCT01075646|528346852|FG000|Overall Study|Lost to Follow-up|4|||
146503863|NCT01075646|528346853|FG001|Overall Study|Lost to Follow-up|3|||
146503864|NCT01075646|528346854|FG002|Overall Study|Lost to Follow-up|1|||
146503865|NCT01075646|528346855|FG003|Overall Study|Lost to Follow-up|2|||
146503866|NCT01647516|528346856|FG000|Induction Period (IP)|Physician Decision|2|||
146503867|NCT01647516|528346857|FG001|Induction Period (IP)|Physician Decision|0|||
146503868|NCT01647516|528346858|FG002|Induction Period (IP)|Physician Decision|0|||
146503869|NCT01647516|528346859|FG003|Induction Period (IP)|Physician Decision|0|||
146503870|NCT01647516|528346860|FG004|Induction Period (IP)|Physician Decision|0|||
146503871|NCT01647516|528346861|FG005|Induction Period (IP)|Physician Decision|0|||
146503872|NCT01647516|528346856|FG000|Induction Period (IP)|Adverse Event|1|||
146503873|NCT01647516|528346857|FG001|Induction Period (IP)|Adverse Event|2|||
146503874|NCT01647516|528346858|FG002|Induction Period (IP)|Adverse Event|0|||
146503875|NCT01647516|528346859|FG003|Induction Period (IP)|Adverse Event|0|||
146503876|NCT01647516|528346860|FG004|Induction Period (IP)|Adverse Event|0|||
146503877|NCT01647516|528346861|FG005|Induction Period (IP)|Adverse Event|0|||
146503878|NCT01647516|528346856|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
146503879|NCT01647516|528346857|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
146503880|NCT01647516|528346858|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
146503881|NCT01647516|528346859|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
146503882|NCT01647516|528346860|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
146503883|NCT01647516|528346861|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
146503884|NCT01647516|528346856|FG000|Induction Period (IP)|Participant Choice|0|||
146503885|NCT01647516|528346857|FG001|Induction Period (IP)|Participant Choice|0|||
146503886|NCT01647516|528346858|FG002|Induction Period (IP)|Participant Choice|1|||
146503887|NCT01647516|528346859|FG003|Induction Period (IP)|Participant Choice|0|||
146503888|NCT01647516|528346860|FG004|Induction Period (IP)|Participant Choice|0|||
146503889|NCT01647516|528346861|FG005|Induction Period (IP)|Participant Choice|0|||
146503890|NCT01647516|528346856|FG000|Induction Period (IP)|Lack of Efficacy|1|||
146503891|NCT01647516|528346857|FG001|Induction Period (IP)|Lack of Efficacy|0|||
146503892|NCT01647516|528346858|FG002|Induction Period (IP)|Lack of Efficacy|0|||
146567034|NCT03498716|528588013|FG001|Overall Study|Study Terminated By Sponsor|927|||
146567035|NCT03498716|528588012|FG000|Overall Study|Lost to Follow-up|15|||
146567036|NCT03498716|528588013|FG001|Overall Study|Lost to Follow-up|26|||
146567037|NCT03498716|528588012|FG000|Overall Study|Disease Relapse|0|||
146567038|NCT03498716|528588013|FG001|Overall Study|Disease Relapse|1|||
146567039|NCT03498716|528588012|FG000|Overall Study|Death|58|||
146567040|NCT03498716|528588013|FG001|Overall Study|Death|72|||
146567041|NCT03498716|528588012|FG000|Overall Study|Physician Decision|4|||
146503893|NCT01647516|528346859|FG003|Induction Period (IP)|Lack of Efficacy|0|||
146503894|NCT01647516|528346860|FG004|Induction Period (IP)|Lack of Efficacy|0|||
146503895|NCT01647516|528346861|FG005|Induction Period (IP)|Lack of Efficacy|0|||
146503896|NCT01647516|528346856|FG000|Induction Period (IP)|No study drug received|1|||
146503897|NCT01647516|528346857|FG001|Induction Period (IP)|No study drug received|1|||
146503898|NCT01647516|528346858|FG002|Induction Period (IP)|No study drug received|0|||
146503899|NCT01647516|528346859|FG003|Induction Period (IP)|No study drug received|0|||
146503900|NCT01647516|528346860|FG004|Induction Period (IP)|No study drug received|0|||
146503901|NCT01647516|528346861|FG005|Induction Period (IP)|No study drug received|0|||
146503902|NCT01647516|528346856|FG000|Maintenance Period (MP)|Adverse Event|2|||
146503903|NCT01647516|528346857|FG001|Maintenance Period (MP)|Adverse Event|1|||
146503904|NCT01647516|528346858|FG002|Maintenance Period (MP)|Adverse Event|0|||
146503905|NCT01647516|528346859|FG003|Maintenance Period (MP)|Adverse Event|0|||
146503906|NCT01647516|528346860|FG004|Maintenance Period (MP)|Adverse Event|0|||
146503907|NCT01647516|528346861|FG005|Maintenance Period (MP)|Adverse Event|0|||
146503908|NCT01647516|528346856|FG000|Maintenance Period (MP)|Non-compliance|1|||
146503909|NCT01647516|528346857|FG001|Maintenance Period (MP)|Non-compliance|0|||
146503910|NCT01647516|528346858|FG002|Maintenance Period (MP)|Non-compliance|0|||
146503911|NCT01647516|528346859|FG003|Maintenance Period (MP)|Non-compliance|0|||
146503912|NCT01647516|528346860|FG004|Maintenance Period (MP)|Non-compliance|0|||
146503913|NCT01647516|528346861|FG005|Maintenance Period (MP)|Non-compliance|0|||
146503914|NCT01647516|528346856|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
146503915|NCT01647516|528346857|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
146503916|NCT01647516|528346858|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
146503917|NCT01647516|528346859|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
146503918|NCT01647516|528346860|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
146503919|NCT01647516|528346861|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
146503920|NCT01647516|528346856|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
146503921|NCT01647516|528346857|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
146503922|NCT01647516|528346858|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
146503923|NCT01647516|528346859|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
146503924|NCT01647516|528346860|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
146503925|NCT01647516|528346861|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
146503926|NCT01647516|528346856|FG000|Open-Label Period|Adverse Event|0|||
146503927|NCT01647516|528346857|FG001|Open-Label Period|Adverse Event|0|||
146503928|NCT01647516|528346858|FG002|Open-Label Period|Adverse Event|0|||
146503929|NCT01647516|528346859|FG003|Open-Label Period|Adverse Event|5|||
146503930|NCT01647516|528346860|FG004|Open-Label Period|Adverse Event|6|||
146503931|NCT01647516|528346861|FG005|Open-Label Period|Adverse Event|3|||
146503932|NCT01647516|528346856|FG000|Open-Label Period|Pregnancy|0|||
146503933|NCT01647516|528346857|FG001|Open-Label Period|Pregnancy|0|||
146503934|NCT01647516|528346858|FG002|Open-Label Period|Pregnancy|0|||
146503935|NCT01647516|528346859|FG003|Open-Label Period|Pregnancy|0|||
146503936|NCT01647516|528346860|FG004|Open-Label Period|Pregnancy|0|||
146503937|NCT01647516|528346861|FG005|Open-Label Period|Pregnancy|1|||
146503938|NCT01647516|528346856|FG000|Open-Label Period|Non-compliance|0|||
146503939|NCT01647516|528346857|FG001|Open-Label Period|Non-compliance|0|||
146503940|NCT01647516|528346858|FG002|Open-Label Period|Non-compliance|0|||
146503941|NCT01647516|528346859|FG003|Open-Label Period|Non-compliance|1|||
146503942|NCT01647516|528346860|FG004|Open-Label Period|Non-compliance|0|||
146503943|NCT01647516|528346861|FG005|Open-Label Period|Non-compliance|1|||
146503944|NCT01647516|528346856|FG000|Open-Label Period|Physician Decision|0|||
146503945|NCT01647516|528346857|FG001|Open-Label Period|Physician Decision|0|||
146503946|NCT01647516|528346858|FG002|Open-Label Period|Physician Decision|0|||
146503947|NCT01647516|528346859|FG003|Open-Label Period|Physician Decision|1|||
146503948|NCT01647516|528346860|FG004|Open-Label Period|Physician Decision|1|||
146503949|NCT01647516|528346861|FG005|Open-Label Period|Physician Decision|0|||
146503950|NCT01647516|528346856|FG000|Open-Label Period|Withdrawal by Subject|0|||
146503951|NCT01647516|528346857|FG001|Open-Label Period|Withdrawal by Subject|0|||
146503952|NCT01647516|528346858|FG002|Open-Label Period|Withdrawal by Subject|0|||
146503953|NCT01647516|528346859|FG003|Open-Label Period|Withdrawal by Subject|9|||
146503954|NCT01647516|528346860|FG004|Open-Label Period|Withdrawal by Subject|11|||
146503955|NCT01647516|528346861|FG005|Open-Label Period|Withdrawal by Subject|6|||
146503956|NCT01647516|528346856|FG000|Open-Label Period|Lost to Follow-up|0|||
146503957|NCT01647516|528346857|FG001|Open-Label Period|Lost to Follow-up|0|||
146648330|NCT00065429|528888587|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
146648331|NCT00065429|528888588|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
146648332|NCT00065429|528888589|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
146648333|NCT00065429|528888590|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
146648334|NCT00065429|528888591|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
146648335|NCT00065429|528888592|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
146503958|NCT01647516|528346858|FG002|Open-Label Period|Lost to Follow-up|0|||
146503959|NCT01647516|528346859|FG003|Open-Label Period|Lost to Follow-up|1|||
146503960|NCT01647516|528346860|FG004|Open-Label Period|Lost to Follow-up|0|||
146503961|NCT01647516|528346861|FG005|Open-Label Period|Lost to Follow-up|1|||
146769389|NCT02547922|529323535|FG000|Overall Study|Withdrawal by Subject|9|||
146769390|NCT02547922|529323536|FG001|Overall Study|Withdrawal by Subject|6|||
146769391|NCT02547922|529323537|FG002|Overall Study|Withdrawal by Subject|10|||
146769392|NCT02547922|529323535|FG000|Overall Study|Adverse Event|3|||
146769393|NCT02547922|529323536|FG001|Overall Study|Adverse Event|1|||
146769394|NCT02547922|529323537|FG002|Overall Study|Adverse Event|2|||
146769395|NCT02547922|529323535|FG000|Overall Study|Lost to Follow-up|1|||
146769396|NCT02547922|529323536|FG001|Overall Study|Lost to Follow-up|0|||
146769397|NCT02547922|529323537|FG002|Overall Study|Lost to Follow-up|0|||
146769398|NCT02547922|529323535|FG000|Overall Study|Lack of Efficacy|5|||
146769399|NCT02547922|529323536|FG001|Overall Study|Lack of Efficacy|7|||
146769400|NCT02547922|529323537|FG002|Overall Study|Lack of Efficacy|4|||
146769401|NCT02547922|529323535|FG000|Overall Study|Death|1|||
146503962|NCT01647516|528346856|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
146503963|NCT01647516|528346857|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
146503964|NCT01647516|528346858|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
146503965|NCT01647516|528346859|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
146503966|NCT01647516|528346860|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
146503967|NCT01647516|528346861|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
146503968|NCT01647516|528346856|FG000|Open-Label Period|Lack of Efficacy|0|||
146503969|NCT01647516|528346857|FG001|Open-Label Period|Lack of Efficacy|0|||
146503970|NCT01647516|528346858|FG002|Open-Label Period|Lack of Efficacy|0|||
146503971|NCT01647516|528346859|FG003|Open-Label Period|Lack of Efficacy|7|||
146503972|NCT01647516|528346860|FG004|Open-Label Period|Lack of Efficacy|9|||
146503973|NCT01647516|528346861|FG005|Open-Label Period|Lack of Efficacy|10|||
146503974|NCT01647516|528346856|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
146503975|NCT01647516|528346857|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
146503976|NCT01647516|528346858|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
146503977|NCT01647516|528346859|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
146503978|NCT01647516|528346860|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
146503979|NCT01647516|528346861|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
146503980|NCT01647516|528346856|FG000|Open-Label Period|No completion / discontinuation visit|0|||
146503981|NCT01647516|528346857|FG001|Open-Label Period|No completion / discontinuation visit|0|||
146503982|NCT01647516|528346858|FG002|Open-Label Period|No completion / discontinuation visit|0|||
146503983|NCT01647516|528346859|FG003|Open-Label Period|No completion / discontinuation visit|0|||
146503984|NCT01647516|528346860|FG004|Open-Label Period|No completion / discontinuation visit|2|||
146503985|NCT01647516|528346861|FG005|Open-Label Period|No completion / discontinuation visit|1|||
146503986|NCT02822573|528346862|FG000|Overall Study|Lost to Follow-up|5|||
146503987|NCT02822573|528346863|FG001|Overall Study|Lost to Follow-up|3|||
146503988|NCT02822573|528346862|FG000|Overall Study|Physician Decision|1|||
146503989|NCT02822573|528346863|FG001|Overall Study|Physician Decision|1|||
146503990|NCT02822573|528346862|FG000|Overall Study|Withdrawal by Subject|9|||
146503991|NCT02822573|528346863|FG001|Overall Study|Withdrawal by Subject|5|||
146503992|NCT02822573|528346862|FG000|Overall Study|Protocol Violation|6|||
146503993|NCT02822573|528346863|FG001|Overall Study|Protocol Violation|4|||
146503994|NCT02822573|528346862|FG000|Overall Study|Too sick or ill|2|||
146503995|NCT02822573|528346863|FG001|Overall Study|Too sick or ill|1|||
146503996|NCT02822573|528346862|FG000|Overall Study|Disease Progression|1|||
146503997|NCT02822573|528346863|FG001|Overall Study|Disease Progression|1|||
146503998|NCT02822573|528346862|FG000|Overall Study|No reason given|6|||
146503999|NCT02822573|528346863|FG001|Overall Study|No reason given|4|||
146504000|NCT04143594|528346864|FG000|Overall Study|Withdrew consent|3|||
146504001|NCT04143594|528346865|FG001|Overall Study|Withdrew consent|10|||
146504002|NCT04143594|528346866|FG002|Overall Study|Withdrew consent|3|||
146504003|NCT04143594|528346867|FG003|Overall Study|Withdrew consent|1|||
146504004|NCT04143594|528346864|FG000|Overall Study|Lost to Follow-up|3|||
146504005|NCT04143594|528346865|FG001|Overall Study|Lost to Follow-up|5|||
146504006|NCT04143594|528346866|FG002|Overall Study|Lost to Follow-up|11|||
146504007|NCT04143594|528346867|FG003|Overall Study|Lost to Follow-up|0|||
146504008|NCT04143594|528346864|FG000|Overall Study|Investigator's discretion|2|||
146504009|NCT04143594|528346865|FG001|Overall Study|Investigator's discretion|2|||
146769402|NCT02547922|529323536|FG001|Overall Study|Death|0|||
146504010|NCT04143594|528346866|FG002|Overall Study|Investigator's discretion|0|||
146504011|NCT04143594|528346867|FG003|Overall Study|Investigator's discretion|0|||
146769403|NCT02547922|529323537|FG002|Overall Study|Death|0|||
146769404|NCT02547922|529323535|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
146769405|NCT02547922|529323536|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
146504012|NCT04143594|528346864|FG000|Overall Study|Randomized but never treated|0|||
146504013|NCT04143594|528346865|FG001|Overall Study|Randomized but never treated|0|||
146504014|NCT04143594|528346866|FG002|Overall Study|Randomized but never treated|0|||
146504015|NCT04143594|528346867|FG003|Overall Study|Randomized but never treated|1|||
146504016|NCT04143594|528346864|FG000|Overall Study|Death|1|||
146504017|NCT04143594|528346865|FG001|Overall Study|Death|0|||
146504018|NCT04143594|528346866|FG002|Overall Study|Death|1|||
146504019|NCT04143594|528346867|FG003|Overall Study|Death|0|||
146504020|NCT04143594|528346864|FG000|Overall Study|Adverse Event|1|||
146504021|NCT04143594|528346865|FG001|Overall Study|Adverse Event|0|||
146504022|NCT04143594|528346866|FG002|Overall Study|Adverse Event|0|||
146504023|NCT04143594|528346867|FG003|Overall Study|Adverse Event|0|||
146504024|NCT04143594|528346864|FG000|Overall Study|Pregnancy|0|||
146504025|NCT04143594|528346865|FG001|Overall Study|Pregnancy|0|||
146504026|NCT04143594|528346866|FG002|Overall Study|Pregnancy|1|||
146504027|NCT04143594|528346867|FG003|Overall Study|Pregnancy|0|||
146504028|NCT04143594|528346864|FG000|Overall Study|Lack of Efficacy|1|||
146504029|NCT04143594|528346865|FG001|Overall Study|Lack of Efficacy|1|||
146504030|NCT04143594|528346866|FG002|Overall Study|Lack of Efficacy|0|||
146504031|NCT04143594|528346867|FG003|Overall Study|Lack of Efficacy|0|||
146504032|NCT03155178|528346868|FG000|Overall Study|Did not meet treatment day baseline|7|||
146504033|NCT03155178|528346869|FG001|Overall Study|Did not meet treatment day baseline|7|||
146504034|NCT03155178|528346870|FG002|Overall Study|Did not meet treatment day baseline|7|||
146504035|NCT03155178|528346871|FG003|Overall Study|Did not meet treatment day baseline|7|||
146504036|NCT01023256|528346872|FG000|Overall Study|Protocol Violation|2|||
146504037|NCT01023256|528346873|FG001|Overall Study|Protocol Violation|3|||
146504038|NCT01023256|528346874|FG002|Overall Study|Protocol Violation|0|||
146504039|NCT01023256|528346875|FG003|Overall Study|Protocol Violation|0|||
146504040|NCT01023256|528346872|FG000|Overall Study|Randomized but not treated|1|||
146504041|NCT01023256|528346873|FG001|Overall Study|Randomized but not treated|0|||
146504042|NCT01023256|528346874|FG002|Overall Study|Randomized but not treated|1|||
146504043|NCT01023256|528346875|FG003|Overall Study|Randomized but not treated|0|||
146504044|NCT01023256|528346872|FG000|Overall Study|Other|1|||
146504045|NCT01023256|528346873|FG001|Overall Study|Other|0|||
146504046|NCT01023256|528346874|FG002|Overall Study|Other|0|||
146504047|NCT01023256|528346875|FG003|Overall Study|Other|2|||
146504048|NCT01023256|528346872|FG000|Overall Study|Adverse Event|0|||
146504049|NCT01023256|528346873|FG001|Overall Study|Adverse Event|0|||
146504050|NCT01023256|528346874|FG002|Overall Study|Adverse Event|0|||
146504051|NCT01023256|528346875|FG003|Overall Study|Adverse Event|1|||
146504052|NCT01023256|528346872|FG000|Overall Study|Withdrawal by Subject|0|||
146504053|NCT01023256|528346873|FG001|Overall Study|Withdrawal by Subject|0|||
146504054|NCT01023256|528346874|FG002|Overall Study|Withdrawal by Subject|0|||
146504055|NCT01023256|528346875|FG003|Overall Study|Withdrawal by Subject|2|||
146504056|NCT00308087|528346876|FG000|Overall Study|Progressive Disease|19|||
146504057|NCT00308087|528346877|FG001|Overall Study|Progressive Disease|21|||
146504058|NCT00308087|528346876|FG000|Overall Study|Study Closure|11|||
146504059|NCT00308087|528346877|FG001|Overall Study|Study Closure|12|||
146504060|NCT00308087|528346876|FG000|Overall Study|Withdrawal by Subject|2|||
146504061|NCT00308087|528346877|FG001|Overall Study|Withdrawal by Subject|1|||
146504062|NCT00308087|528346876|FG000|Overall Study|Other|4|||
146504063|NCT00308087|528346877|FG001|Overall Study|Other|3|||
146504064|NCT01044290|528346878|FG000|Follow-up 1|Death|3|||
146504065|NCT01044290|528346879|FG001|Follow-up 1|Death|3|||
146504066|NCT01044290|528346880|FG002|Follow-up 1|Death|1|||
146504067|NCT01044290|528346878|FG000|Follow-up 1|Withdrawal by Subject|2|||
146504068|NCT01044290|528346879|FG001|Follow-up 1|Withdrawal by Subject|2|||
146504069|NCT01044290|528346880|FG002|Follow-up 1|Withdrawal by Subject|0|||
146504070|NCT01044290|528346878|FG000|Follow-Up 2|Death|0|||
146504071|NCT01044290|528346879|FG001|Follow-Up 2|Death|1|||
146504072|NCT01044290|528346880|FG002|Follow-Up 2|Death|1|||
146504073|NCT01044290|528346878|FG000|Follow-Up 2|Withdrawal by Subject|0|||
146504074|NCT01044290|528346879|FG001|Follow-Up 2|Withdrawal by Subject|1|||
146648336|NCT00065429|528888586|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
146648337|NCT00065429|528888587|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
146648338|NCT00065429|528888588|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
146648339|NCT00065429|528888589|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
146648340|NCT00065429|528888590|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
146912829|NCT01208181|529843196|FG000|Part 2|Protocol Violation|0|||
146504075|NCT01044290|528346880|FG002|Follow-Up 2|Withdrawal by Subject|1|||
146504076|NCT04323306|528346881|FG000|Overall Study|Physician Decision|1|||
146504077|NCT04323306|528346882|FG001|Overall Study|Physician Decision|0|||
146504078|NCT04323306|528346883|FG002|Overall Study|Physician Decision|0|||
146504079|NCT04323306|528346884|FG003|Overall Study|Physician Decision|0|||
146504080|NCT04323306|528346885|FG004|Overall Study|Physician Decision|0|||
146504081|NCT04323306|528346886|FG005|Overall Study|Physician Decision|0|||
146504082|NCT04323306|528346887|FG006|Overall Study|Physician Decision|0|||
146504083|NCT04323306|528346888|FG007|Overall Study|Physician Decision|0|||
146504084|NCT04323306|528346889|FG008|Overall Study|Physician Decision|0|||
146504085|NCT04323306|528346881|FG000|Overall Study|Withdrawal by Subject|0|||
146504086|NCT04323306|528346882|FG001|Overall Study|Withdrawal by Subject|0|||
146504087|NCT04323306|528346883|FG002|Overall Study|Withdrawal by Subject|0|||
146504088|NCT04323306|528346884|FG003|Overall Study|Withdrawal by Subject|0|||
146504089|NCT04323306|528346885|FG004|Overall Study|Withdrawal by Subject|0|||
146504090|NCT04323306|528346886|FG005|Overall Study|Withdrawal by Subject|1|||
146504091|NCT04323306|528346887|FG006|Overall Study|Withdrawal by Subject|3|||
146504092|NCT04323306|528346888|FG007|Overall Study|Withdrawal by Subject|0|||
146504093|NCT04323306|528346889|FG008|Overall Study|Withdrawal by Subject|1|||
146504094|NCT01646021|528346892|FG000|Overall Study|Death|77|||
146504095|NCT01646021|528346893|FG001|Overall Study|Death|83|||
146504096|NCT01646021|528346892|FG000|Overall Study|Study Terminated by Sponsor|50|||
146504097|NCT01646021|528346893|FG001|Overall Study|Study Terminated by Sponsor|41|||
146504098|NCT01646021|528346892|FG000|Overall Study|Lost to Follow-up|2|||
146504099|NCT01646021|528346893|FG001|Overall Study|Lost to Follow-up|2|||
146504100|NCT01646021|528346892|FG000|Overall Study|Withdrawal by Subject|10|||
146504101|NCT01646021|528346893|FG001|Overall Study|Withdrawal by Subject|15|||
146504102|NCT04712019|528346894|FG000|Overall Study|Withdrawal by Subject|2|||
146504103|NCT04712019|528346895|FG001|Overall Study|Withdrawal by Subject|2|||
146648341|NCT00065429|528888591|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
146648342|NCT00065429|528888592|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
146648343|NCT00832624|528888596|FG000|Overall Study|Study Terminated|10|||
146648344|NCT00636363|528888599|FG000|Overall Study|Conjunctivitis|0|||
146648345|NCT00636363|528888600|FG001|Overall Study|Conjunctivitis|0|||
146648346|NCT00636363|528888601|FG002|Overall Study|Conjunctivitis|1|||
146648347|NCT00636363|528888599|FG000|Overall Study|Adverse Event|0|||
146648348|NCT00636363|528888600|FG001|Overall Study|Adverse Event|0|||
146648349|NCT00636363|528888601|FG002|Overall Study|Adverse Event|1|||
146648350|NCT00636363|528888599|FG000|Overall Study|Positive slit lamp finding|0|||
146648351|NCT00636363|528888600|FG001|Overall Study|Positive slit lamp finding|2|||
146648352|NCT00636363|528888601|FG002|Overall Study|Positive slit lamp finding|1|||
146648353|NCT00636363|528888599|FG000|Overall Study|Study related symptoms/complaints|8|||
146648354|NCT00636363|528888600|FG001|Overall Study|Study related symptoms/complaints|7|||
146648355|NCT00636363|528888601|FG002|Overall Study|Study related symptoms/complaints|4|||
146648356|NCT00636363|528888599|FG000|Overall Study|Met ineligibility criteria|0|||
146648357|NCT00636363|528888600|FG001|Overall Study|Met ineligibility criteria|0|||
146648358|NCT00636363|528888601|FG002|Overall Study|Met ineligibility criteria|3|||
146648359|NCT00636363|528888599|FG000|Overall Study|Missed > 1 visit|0|||
146648360|NCT00636363|528888600|FG001|Overall Study|Missed > 1 visit|1|||
146648361|NCT00636363|528888601|FG002|Overall Study|Missed > 1 visit|3|||
146648362|NCT00636363|528888599|FG000|Overall Study|Lack of motivation|1|||
146648363|NCT00636363|528888600|FG001|Overall Study|Lack of motivation|0|||
146648364|NCT00636363|528888601|FG002|Overall Study|Lack of motivation|1|||
146648365|NCT00636363|528888599|FG000|Overall Study|Protocol Violation|0|||
146648366|NCT00636363|528888600|FG001|Overall Study|Protocol Violation|3|||
146648367|NCT00636363|528888601|FG002|Overall Study|Protocol Violation|0|||
146648368|NCT00636363|528888599|FG000|Overall Study|Lost to Follow-up|3|||
146648369|NCT00636363|528888600|FG001|Overall Study|Lost to Follow-up|4|||
146648370|NCT00636363|528888601|FG002|Overall Study|Lost to Follow-up|2|||
146648371|NCT00636363|528888599|FG000|Overall Study|Withdrawal by Subject|1|||
146648372|NCT00636363|528888600|FG001|Overall Study|Withdrawal by Subject|3|||
146648373|NCT00636363|528888601|FG002|Overall Study|Withdrawal by Subject|2|||
146504104|NCT04712019|528346894|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
146504105|NCT04712019|528346895|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
146504106|NCT01967706|528346903|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
146504107|NCT01967706|528346904|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
146648374|NCT00280748|528888605|FG000|Overall Study|Decline in performance|3|||
146648375|NCT00280748|528888605|FG000|Overall Study|Extra-cranial disease progression|1|||
146648376|NCT01765218|528888606|FG000|Overall Study|Protocol Violation|1|||
146648377|NCT01765218|528888607|FG001|Overall Study|Protocol Violation|2|||
146648378|NCT00313781|528888608|FG000|Before Crossover|Death|22|||
146648379|NCT00313781|528888609|FG001|Before Crossover|Death|8|||
146648380|NCT00313781|528888610|FG002|Before Crossover|Death|0|||
146648381|NCT00313781|528888608|FG000|Before Crossover|Lost to Follow-up|0|||
146648382|NCT00313781|528888609|FG001|Before Crossover|Lost to Follow-up|3|||
146648383|NCT00313781|528888610|FG002|Before Crossover|Lost to Follow-up|0|||
146648384|NCT00313781|528888608|FG000|Before Crossover|Withdrawal by Subject|3|||
146648385|NCT00313781|528888609|FG001|Before Crossover|Withdrawal by Subject|1|||
146648386|NCT00313781|528888610|FG002|Before Crossover|Withdrawal by Subject|0|||
146648387|NCT00313781|528888608|FG000|Before Crossover|Other|45|||
146648388|NCT00313781|528888609|FG001|Before Crossover|Other|30|||
146648389|NCT00313781|528888610|FG002|Before Crossover|Other|0|||
146648390|NCT00313781|528888608|FG000|Before Crossover|Crossover|0|||
146648391|NCT00313781|528888609|FG001|Before Crossover|Crossover|37|||
146769406|NCT02547922|529323537|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
146648392|NCT00313781|528888610|FG002|Before Crossover|Crossover|0|||
146648393|NCT00313781|528888608|FG000|Before Crossover|Randomized, not treated|5|||
146504108|NCT01967706|528346905|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
146504109|NCT01967706|528346906|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
146648394|NCT00313781|528888609|FG001|Before Crossover|Randomized, not treated|0|||
146648395|NCT00313781|528888610|FG002|Before Crossover|Randomized, not treated|0|||
146648396|NCT00313781|528888608|FG000|After Crossover|Death|0|||
146648397|NCT00313781|528888609|FG001|After Crossover|Death|0|||
146648398|NCT00313781|528888610|FG002|After Crossover|Death|6|||
146504110|NCT02347891|528346909|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
146504111|NCT02347891|528346910|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
146504112|NCT02347891|528346909|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
146504113|NCT02347891|528346910|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
146504114|NCT02541669|528346913|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
146504115|NCT02541669|528346914|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
146504116|NCT02541669|528346915|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
146504117|NCT02541669|528346916|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
146504118|NCT02541669|528346917|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
146504119|NCT00834639|528346918|FG000|Second Intervention|Physician Decision|0|||
146504120|NCT00834639|528346919|FG001|Second Intervention|Physician Decision|2|||
146504121|NCT04739722|528346920|FG000|Overall Study|Lost to Follow-up|5301|||
146504122|NCT04739722|528346920|FG000|Overall Study|Withdrawal by Subject|42|||
146504123|NCT04739722|528346920|FG000|Overall Study|Non Average-risk|1157|||
146504124|NCT00725608|528346921|FG000|Overall Study|Lost to Follow-up|60|||
146504125|NCT00725608|528346921|FG000|Overall Study|Adverse Event|14|||
146504126|NCT00725608|528346921|FG000|Overall Study|Individual reasons|86|||
146504127|NCT00725608|528346921|FG000|Overall Study|Other|7|||
146504128|NCT03047720|528346925|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
146504129|NCT03047720|528346926|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
146504130|NCT00614120|528346927|FG000|Overall Study|Adverse Event|9|||
146504131|NCT00614120|528346928|FG001|Overall Study|Adverse Event|22|||
146504132|NCT00614120|528346929|FG002|Overall Study|Adverse Event|30|||
146504133|NCT00614120|528346930|FG003|Overall Study|Adverse Event|3|||
146504134|NCT00614120|528346927|FG000|Overall Study|Lack of Efficacy|3|||
146504135|NCT00614120|528346928|FG001|Overall Study|Lack of Efficacy|3|||
146504136|NCT00614120|528346929|FG002|Overall Study|Lack of Efficacy|2|||
146504137|NCT00614120|528346930|FG003|Overall Study|Lack of Efficacy|2|||
146504138|NCT00614120|528346927|FG000|Overall Study|Protocol Violation|2|||
146504139|NCT00614120|528346928|FG001|Overall Study|Protocol Violation|5|||
146504140|NCT00614120|528346929|FG002|Overall Study|Protocol Violation|3|||
146504141|NCT00614120|528346930|FG003|Overall Study|Protocol Violation|1|||
146504142|NCT00614120|528346927|FG000|Overall Study|Withdrawal criteria|1|||
146504143|NCT00614120|528346928|FG001|Overall Study|Withdrawal criteria|0|||
146504144|NCT00614120|528346929|FG002|Overall Study|Withdrawal criteria|0|||
146504145|NCT00614120|528346930|FG003|Overall Study|Withdrawal criteria|0|||
146504146|NCT00614120|528346927|FG000|Overall Study|Withdrawal by Subject|9|||
146504147|NCT00614120|528346928|FG001|Overall Study|Withdrawal by Subject|10|||
146504148|NCT00614120|528346929|FG002|Overall Study|Withdrawal by Subject|16|||
146504149|NCT00614120|528346930|FG003|Overall Study|Withdrawal by Subject|3|||
146504150|NCT00614120|528346927|FG000|Overall Study|Did not meet trial criteria|0|||
146504151|NCT00614120|528346928|FG001|Overall Study|Did not meet trial criteria|1|||
146504152|NCT00614120|528346929|FG002|Overall Study|Did not meet trial criteria|1|||
146504153|NCT00614120|528346930|FG003|Overall Study|Did not meet trial criteria|1|||
146504154|NCT00614120|528346927|FG000|Overall Study|hCG positive (not pregnant)|0|||
146504155|NCT00614120|528346928|FG001|Overall Study|hCG positive (not pregnant)|0|||
146504156|NCT00614120|528346929|FG002|Overall Study|hCG positive (not pregnant)|1|||
146504157|NCT00614120|528346930|FG003|Overall Study|hCG positive (not pregnant)|0|||
146504158|NCT00614120|528346927|FG000|Overall Study|Hypoglycaemia|0|||
146504159|NCT00614120|528346928|FG001|Overall Study|Hypoglycaemia|0|||
146504160|NCT00614120|528346929|FG002|Overall Study|Hypoglycaemia|0|||
146504161|NCT00614120|528346930|FG003|Overall Study|Hypoglycaemia|1|||
146769407|NCT02547922|529323535|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
146769408|NCT02547922|529323536|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
146504162|NCT00614120|528346927|FG000|Overall Study|Lack of trial product|3|||
146504163|NCT00614120|528346928|FG001|Overall Study|Lack of trial product|3|||
146504164|NCT00614120|528346929|FG002|Overall Study|Lack of trial product|2|||
146504165|NCT00614120|528346930|FG003|Overall Study|Lack of trial product|0|||
146504166|NCT00614120|528346927|FG000|Overall Study|Late syphilis, latent|1|||
146504167|NCT00614120|528346928|FG001|Overall Study|Late syphilis, latent|0|||
146504168|NCT00614120|528346929|FG002|Overall Study|Late syphilis, latent|0|||
146504169|NCT00614120|528346930|FG003|Overall Study|Late syphilis, latent|0|||
146504170|NCT00614120|528346927|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
146504171|NCT00614120|528346928|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
146504172|NCT00614120|528346929|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
146504173|NCT00614120|528346930|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
146504174|NCT00614120|528346927|FG000|Overall Study|Lost to Follow-up|1|||
146504175|NCT00614120|528346928|FG001|Overall Study|Lost to Follow-up|2|||
146504176|NCT00614120|528346929|FG002|Overall Study|Lost to Follow-up|3|||
146504177|NCT00614120|528346930|FG003|Overall Study|Lost to Follow-up|4|||
146504178|NCT00732758|528346931|FG000|Overall Study|Lost to Follow-up|8|||
146504179|NCT00732758|528346932|FG001|Overall Study|Lost to Follow-up|16|||
146504180|NCT01552915|528346933|FG000|Overall Study|Adverse Event|3|||
146504181|NCT01552915|528346934|FG001|Overall Study|Adverse Event|14|||
146769409|NCT02547922|529323537|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
146769410|NCT02547922|529323535|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
146504182|NCT01552915|528346935|FG002|Overall Study|Adverse Event|3|||
146504183|NCT01552915|528346933|FG000|Overall Study|Lost to Follow-up|4|||
146504184|NCT01552915|528346934|FG001|Overall Study|Lost to Follow-up|6|||
146504185|NCT01552915|528346935|FG002|Overall Study|Lost to Follow-up|5|||
146504186|NCT01552915|528346933|FG000|Overall Study|Withdrawal by Subject|6|||
146504187|NCT01552915|528346934|FG001|Overall Study|Withdrawal by Subject|4|||
146504188|NCT01552915|528346935|FG002|Overall Study|Withdrawal by Subject|5|||
146504189|NCT01552915|528346933|FG000|Overall Study|Protocol Violation|0|||
146504190|NCT01552915|528346934|FG001|Overall Study|Protocol Violation|4|||
146504191|NCT01552915|528346935|FG002|Overall Study|Protocol Violation|4|||
146504192|NCT01552915|528346933|FG000|Overall Study|Lack of Efficacy|8|||
146648399|NCT00313781|528888608|FG000|After Crossover|Withdrawal by Subject|0|||
146648400|NCT00313781|528888609|FG001|After Crossover|Withdrawal by Subject|0|||
146648401|NCT00313781|528888610|FG002|After Crossover|Withdrawal by Subject|3|||
146648402|NCT00313781|528888608|FG000|After Crossover|Other|0|||
146648403|NCT00313781|528888609|FG001|After Crossover|Other|0|||
146648404|NCT00313781|528888610|FG002|After Crossover|Other|18|||
146648405|NCT03567343|528888612|FG000|Overall Study|Lost to Follow-up|2|||
146648406|NCT03567343|528888613|FG001|Overall Study|Lost to Follow-up|1|||
146648407|NCT03567343|528888612|FG000|Overall Study|No longer eligible|2|||
146648408|NCT03567343|528888613|FG001|Overall Study|No longer eligible|1|||
146648409|NCT03567343|528888612|FG000|Overall Study|Adverse Event|1|||
146648410|NCT03567343|528888613|FG001|Overall Study|Adverse Event|0|||
146648411|NCT03567343|528888612|FG000|Overall Study|Protocol Violation|1|||
146648412|NCT03567343|528888613|FG001|Overall Study|Protocol Violation|1|||
146648413|NCT01433250|528888614|FG000|Overall Study|Protocol Violation|0|||
146648414|NCT01433250|528888615|FG001|Overall Study|Protocol Violation|1|||
146648415|NCT01433250|528888614|FG000|Overall Study|Withdrawal by Subject|3|||
146648416|NCT01433250|528888615|FG001|Overall Study|Withdrawal by Subject|2|||
146648417|NCT03148691|528888616|FG000|Overall Study|Protocol Violation|1|||
146648418|NCT03148691|528888617|FG001|Overall Study|Protocol Violation|2|||
146648419|NCT03148691|528888618|FG002|Overall Study|Protocol Violation|7|||
146648420|NCT03148691|528888616|FG000|Overall Study|Lost to Follow-up|0|||
146648421|NCT03148691|528888617|FG001|Overall Study|Lost to Follow-up|0|||
146648422|NCT03148691|528888618|FG002|Overall Study|Lost to Follow-up|1|||
146648423|NCT03148691|528888616|FG000|Overall Study|Other|1|||
146648424|NCT03148691|528888617|FG001|Overall Study|Other|0|||
146648425|NCT03148691|528888618|FG002|Overall Study|Other|0|||
146648426|NCT03148691|528888616|FG000|Overall Study|Withdrawal by Subject|1|||
146648427|NCT03148691|528888617|FG001|Overall Study|Withdrawal by Subject|0|||
146648428|NCT03148691|528888618|FG002|Overall Study|Withdrawal by Subject|0|||
146648429|NCT00576420|528890737|FG000|Overall Study|Death|0|||
146648430|NCT00576420|528890738|FG001|Overall Study|Death|0|||
146648431|NCT00576420|528890739|FG002|Overall Study|Death|1|||
146648432|NCT01340872|528890741|FG000|Double-blind Phase|Adverse Event|6|||
146648433|NCT01340872|528890742|FG001|Double-blind Phase|Adverse Event|4|||
146648434|NCT01340872|528890743|FG002|Double-blind Phase|Adverse Event|0|||
146648435|NCT01340872|528890744|FG003|Double-blind Phase|Adverse Event|0|||
146648436|NCT01340872|528890741|FG000|Double-blind Phase|Withdrawal by Subject|3|||
146648437|NCT01340872|528890742|FG001|Double-blind Phase|Withdrawal by Subject|5|||
146648438|NCT01340872|528890743|FG002|Double-blind Phase|Withdrawal by Subject|0|||
146648439|NCT01340872|528890744|FG003|Double-blind Phase|Withdrawal by Subject|0|||
146648440|NCT01340872|528890741|FG000|Double-blind Phase|Lost to Follow-up|0|||
146648441|NCT01340872|528890742|FG001|Double-blind Phase|Lost to Follow-up|1|||
146648442|NCT01340872|528890743|FG002|Double-blind Phase|Lost to Follow-up|0|||
146648443|NCT01340872|528890744|FG003|Double-blind Phase|Lost to Follow-up|0|||
146648444|NCT01340872|528890741|FG000|Double-blind Phase|Protocol Violation|0|||
146648445|NCT01340872|528890742|FG001|Double-blind Phase|Protocol Violation|1|||
146648446|NCT01340872|528890743|FG002|Double-blind Phase|Protocol Violation|0|||
146648447|NCT01340872|528890744|FG003|Double-blind Phase|Protocol Violation|0|||
146648448|NCT01340872|528890741|FG000|Open-label Phase|Physician Decision|0|||
146648449|NCT01340872|528890742|FG001|Open-label Phase|Physician Decision|0|||
146504193|NCT01552915|528346934|FG001|Overall Study|Lack of Efficacy|1|||
146504194|NCT01552915|528346935|FG002|Overall Study|Lack of Efficacy|4|||
146504195|NCT01552915|528346933|FG000|Overall Study|Other|2|||
146504196|NCT01552915|528346934|FG001|Overall Study|Other|0|||
146504197|NCT01552915|528346935|FG002|Overall Study|Other|6|||
146504198|NCT02858180|528346939|FG000|Overall Study|Lost to Follow-up|0|||
146648450|NCT01340872|528890743|FG002|Open-label Phase|Physician Decision|2|||
146648451|NCT01340872|528890744|FG003|Open-label Phase|Physician Decision|1|||
146648452|NCT01340872|528890741|FG000|Open-label Phase|Pregnancy|0|||
146504199|NCT02858180|528346940|FG001|Overall Study|Lost to Follow-up|2|||
146504200|NCT00979420|528346941|FG000|Overall Study|Adverse Event|1|||
146504201|NCT00979420|528346942|FG001|Overall Study|Adverse Event|0|||
146504202|NCT00979420|528346943|FG002|Overall Study|Adverse Event|0|||
146648453|NCT01340872|528890742|FG001|Open-label Phase|Pregnancy|0|||
146648454|NCT01340872|528890743|FG002|Open-label Phase|Pregnancy|1|||
146648455|NCT01340872|528890744|FG003|Open-label Phase|Pregnancy|0|||
146648456|NCT01340872|528890741|FG000|Open-label Phase|Adverse Event|0|||
146648457|NCT01340872|528890742|FG001|Open-label Phase|Adverse Event|0|||
146912830|NCT01208181|529843197|FG001|Part 2|Protocol Violation|0|||
146912831|NCT01208181|529843198|FG002|Part 2|Protocol Violation|1|||
146912832|NCT01208181|529843199|FG003|Part 2|Protocol Violation|0|||
146912833|NCT01208181|529843200|FG004|Part 2|Protocol Violation|0|||
146912834|NCT01208181|529843196|FG000|Part 2|Physician Decision|0|||
146912835|NCT01208181|529843197|FG001|Part 2|Physician Decision|0|||
146912836|NCT01208181|529843198|FG002|Part 2|Physician Decision|1|||
146912837|NCT01208181|529843199|FG003|Part 2|Physician Decision|2|||
146912838|NCT01208181|529843200|FG004|Part 2|Physician Decision|0|||
146912839|NCT01208181|529843196|FG000|Part 2|Non-compliance with study drug|0|||
146912840|NCT01208181|529843197|FG001|Part 2|Non-compliance with study drug|0|||
146912841|NCT01208181|529843198|FG002|Part 2|Non-compliance with study drug|1|||
146504203|NCT00979420|528346944|FG003|Overall Study|Adverse Event|0|||
146648458|NCT01340872|528890743|FG002|Open-label Phase|Adverse Event|8|||
146648459|NCT01340872|528890744|FG003|Open-label Phase|Adverse Event|4|||
146648460|NCT01340872|528890741|FG000|Open-label Phase|Withdrawal by Subject|0|||
146648461|NCT01340872|528890742|FG001|Open-label Phase|Withdrawal by Subject|0|||
146648462|NCT01340872|528890743|FG002|Open-label Phase|Withdrawal by Subject|1|||
146648463|NCT01340872|528890744|FG003|Open-label Phase|Withdrawal by Subject|6|||
146648464|NCT01340872|528890741|FG000|Open-label Phase|Worsening of IBD|0|||
146648465|NCT01340872|528890742|FG001|Open-label Phase|Worsening of IBD|0|||
146648466|NCT01340872|528890743|FG002|Open-label Phase|Worsening of IBD|1|||
146648467|NCT01340872|528890744|FG003|Open-label Phase|Worsening of IBD|0|||
146648468|NCT02656680|528890747|FG000|Overall Study|Lost to Follow-up|0|||
146648469|NCT02656680|528890748|FG001|Overall Study|Lost to Follow-up|1|||
146648470|NCT02656680|528890749|FG002|Overall Study|Lost to Follow-up|7|||
146648471|NCT01246466|528890752|FG000|Overall Study|Death|1|||
146648472|NCT01246466|528890752|FG000|Overall Study|Withdrawal by Subject|1|||
146648473|NCT00877773|528890753|FG000|Overall Study|Disease Progression|44|||
146648474|NCT01350544|528890756|FG000|Overall Study|Administrative Withdrawal|0|||
146648475|NCT01350544|528890757|FG001|Overall Study|Administrative Withdrawal|1|||
146648476|NCT01350544|528890756|FG000|Overall Study|Death|1|||
146648477|NCT01350544|528890757|FG001|Overall Study|Death|2|||
146648478|NCT01350544|528890756|FG000|Overall Study|Moved out of LA County|2|||
146648479|NCT01350544|528890757|FG001|Overall Study|Moved out of LA County|2|||
146648480|NCT01350544|528890756|FG000|Overall Study|Medical Issues|1|||
146648481|NCT01350544|528890757|FG001|Overall Study|Medical Issues|1|||
146648482|NCT01350544|528890756|FG000|Overall Study|Withdrawal by Subject|0|||
146648483|NCT01350544|528890757|FG001|Overall Study|Withdrawal by Subject|1|||
146648484|NCT01350544|528890756|FG000|Overall Study|Incarceration|1|||
146648485|NCT01350544|528890757|FG001|Overall Study|Incarceration|0|||
146648486|NCT01350544|528890756|FG000|Overall Study|Lost to Follow-up|18|||
146648487|NCT01350544|528890757|FG001|Overall Study|Lost to Follow-up|15|||
146648488|NCT02882152|528890758|FG000|Overall Study|Lost to Follow-up|1|||
146648489|NCT02882152|528890759|FG001|Overall Study|Lost to Follow-up|0|||
146648490|NCT01430754|528890762|FG000|Run-In Phase|Circadian Period Ineligible|24|||
146648491|NCT01430754|528890763|FG001|Run-In Phase|Circadian Period Ineligible|0|||
146648492|NCT01430754|528890762|FG000|Run-In Phase|Protocol Violation|6|||
146648493|NCT01430754|528890763|FG001|Run-In Phase|Protocol Violation|0|||
146648494|NCT01430754|528890762|FG000|Run-In Phase|Adverse Event|2|||
146648495|NCT01430754|528890763|FG001|Run-In Phase|Adverse Event|0|||
146648496|NCT01430754|528890762|FG000|Run-In Phase|Other|2|||
146648497|NCT01430754|528890763|FG001|Run-In Phase|Other|0|||
146648498|NCT01430754|528890762|FG000|Run-In Phase|Withdrawal by Subject|2|||
146648499|NCT01430754|528890763|FG001|Run-In Phase|Withdrawal by Subject|0|||
146648500|NCT01430754|528890762|FG000|Run-In Phase|Lost to Follow-up|1|||
146648501|NCT01430754|528890763|FG001|Run-In Phase|Lost to Follow-up|0|||
146648502|NCT01369329|528890767|FG000|Overall Study|Withdrawal by Subject|8|||
146648503|NCT01369329|528890768|FG001|Overall Study|Withdrawal by Subject|6|||
146648504|NCT01369329|528890769|FG002|Overall Study|Withdrawal by Subject|10|||
146648505|NCT01369329|528890767|FG000|Overall Study|Lost to Follow-up|2|||
146648506|NCT01369329|528890768|FG001|Overall Study|Lost to Follow-up|2|||
146648507|NCT01369329|528890769|FG002|Overall Study|Lost to Follow-up|2|||
146648508|NCT01369329|528890767|FG000|Overall Study|Other|2|||
146648509|NCT01369329|528890768|FG001|Overall Study|Other|3|||
146648510|NCT01369329|528890769|FG002|Overall Study|Other|2|||
146648511|NCT00701662|528890770|FG000|Overall Study|Lack of Efficacy|1|||
146648512|NCT00159822|528890771|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
146648513|NCT00159822|528890771|FG000|Voriconazole Treatment Period|Adverse Event|9|||
146648514|NCT00159822|528890771|FG000|Voriconazole Treatment Period|Death|4|||
146648515|NCT00159822|528890771|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
146648516|NCT00159822|528890771|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
146648517|NCT00159822|528890771|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
146648518|NCT00159822|528890771|FG000|Post-treatment Follow-up Period|Death|1|||
146648519|NCT00159822|528890771|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
146648520|NCT00159822|528890771|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
146912842|NCT01208181|529843199|FG003|Part 2|Non-compliance with study drug|1|||
146912843|NCT01208181|529843200|FG004|Part 2|Non-compliance with study drug|0|||
146912844|NCT01208181|529843196|FG000|Part 2|Lost to Follow-up|0|||
146648521|NCT00275821|528890773|FG000|Overall Study|Adverse Event|4|||
146648522|NCT00275821|528890774|FG001|Overall Study|Adverse Event|12|||
146648523|NCT00275821|528890775|FG002|Overall Study|Adverse Event|5|||
146648524|NCT00275821|528890773|FG000|Overall Study|Administrative problems|3|||
146648525|NCT00275821|528890774|FG001|Overall Study|Administrative problems|4|||
146648526|NCT00275821|528890775|FG002|Overall Study|Administrative problems|4|||
146912845|NCT01208181|529843197|FG001|Part 2|Lost to Follow-up|0|||
146912846|NCT01208181|529843198|FG002|Part 2|Lost to Follow-up|1|||
146912847|NCT01208181|529843199|FG003|Part 2|Lost to Follow-up|2|||
146648527|NCT00275821|528890773|FG000|Overall Study|Withdrawal by Subject|0|||
146648528|NCT00275821|528890774|FG001|Overall Study|Withdrawal by Subject|2|||
146648529|NCT00275821|528890775|FG002|Overall Study|Withdrawal by Subject|1|||
146648530|NCT00275821|528890773|FG000|Overall Study|Lost to Follow-up|0|||
146912848|NCT01208181|529843200|FG004|Part 2|Lost to Follow-up|0|||
146912849|NCT01208181|529843196|FG000|Part 2|Lack of Efficacy|0|||
146912850|NCT01208181|529843197|FG001|Part 2|Lack of Efficacy|0|||
146912851|NCT01208181|529843198|FG002|Part 2|Lack of Efficacy|5|||
146912852|NCT01208181|529843199|FG003|Part 2|Lack of Efficacy|7|||
146912853|NCT01208181|529843200|FG004|Part 2|Lack of Efficacy|0|||
146912854|NCT01478347|529843202|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
146912855|NCT01478347|529843202|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
146648531|NCT00275821|528890774|FG001|Overall Study|Lost to Follow-up|1|||
146648532|NCT00275821|528890775|FG002|Overall Study|Lost to Follow-up|1|||
146648533|NCT00275821|528890773|FG000|Overall Study|Death|0|||
146648534|NCT00275821|528890774|FG001|Overall Study|Death|2|||
146648535|NCT00275821|528890775|FG002|Overall Study|Death|1|||
146648536|NCT00275821|528890773|FG000|Overall Study|Lack of Efficacy|2|||
146648537|NCT00275821|528890774|FG001|Overall Study|Lack of Efficacy|1|||
146648538|NCT00275821|528890775|FG002|Overall Study|Lack of Efficacy|0|||
146648539|NCT00275821|528890773|FG000|Overall Study|Protocol Violation|5|||
146648540|NCT00275821|528890774|FG001|Overall Study|Protocol Violation|1|||
146648541|NCT00275821|528890775|FG002|Overall Study|Protocol Violation|0|||
146648542|NCT01133990|528890778|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
146648543|NCT01133990|528890779|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146648544|NCT01133990|528890780|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146648545|NCT01133990|528890781|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146912856|NCT01478347|529843202|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
146912857|NCT01645930|529843203|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
146912858|NCT01645930|529843203|FG000|Overall Study|Progressive Disease|12|||
146912859|NCT01645930|529843203|FG000|Overall Study|Adverse Event|4|||
146912860|NCT01645930|529843203|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
146912861|NCT01645930|529843203|FG000|Overall Study|Withdrawal by Participant|2|||
146912862|NCT01645930|529843203|FG000|Overall Study|Reason not Defined|1|||
146912863|NCT01845077|529843206|FG000|Washout Period|Lost to Follow-up|0|||
146504204|NCT00979420|528346941|FG000|Overall Study|Lack of Efficacy|3|||
146504205|NCT00979420|528346942|FG001|Overall Study|Lack of Efficacy|0|||
146504206|NCT00979420|528346943|FG002|Overall Study|Lack of Efficacy|1|||
146504207|NCT00979420|528346944|FG003|Overall Study|Lack of Efficacy|1|||
146504208|NCT00979420|528346941|FG000|Overall Study|Other reasons not related to Viramune|3|||
146504209|NCT00979420|528346942|FG001|Overall Study|Other reasons not related to Viramune|0|||
146504210|NCT00979420|528346943|FG002|Overall Study|Other reasons not related to Viramune|0|||
146504211|NCT00979420|528346944|FG003|Overall Study|Other reasons not related to Viramune|1|||
146504212|NCT02572076|528346946|FG000|Overall Study|Protocol Violation|1|||
146504213|NCT04064411|528346954|FG000|Overall Study|Adverse Event|29|||
146504214|NCT04064411|528346955|FG001|Overall Study|Adverse Event|19|||
146504215|NCT04064411|528346954|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
146504216|NCT04064411|528346955|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
146504217|NCT04064411|528346954|FG000|Overall Study|Protocol Deviation|0|||
146504218|NCT04064411|528346955|FG001|Overall Study|Protocol Deviation|2|||
146504219|NCT04064411|528346954|FG000|Overall Study|Withdrawal by Subject|25|||
146504220|NCT04064411|528346955|FG001|Overall Study|Withdrawal by Subject|29|||
146504221|NCT04064411|528346954|FG000|Overall Study|Lost to Follow-up|5|||
146504222|NCT04064411|528346955|FG001|Overall Study|Lost to Follow-up|2|||
146648546|NCT01133990|528890782|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146648547|NCT01133990|528890783|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146648548|NCT01133990|528890778|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
146648549|NCT01133990|528890779|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
146648550|NCT01133990|528890780|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
146648551|NCT01133990|528890781|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
146648552|NCT01133990|528890782|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
146648553|NCT01133990|528890783|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
146648554|NCT01133990|528890778|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
146912864|NCT01845077|529843207|FG001|Washout Period|Lost to Follow-up|1|||
146912865|NCT01845077|529843208|FG002|Washout Period|Lost to Follow-up|0|||
146912866|NCT01845077|529843209|FG003|Washout Period|Lost to Follow-up|1|||
146504223|NCT04064411|528346954|FG000|Overall Study|Other than Specified|4|||
146504224|NCT04064411|528346955|FG001|Overall Study|Other than Specified|1|||
146504225|NCT04064411|528346954|FG000|Overall Study|Death|1|||
146504226|NCT04064411|528346955|FG001|Overall Study|Death|0|||
146504227|NCT00743288|528348916|FG000|Overall Study|Adverse Event|1|||
146504228|NCT00743288|528348917|FG001|Overall Study|Adverse Event|1|||
146504229|NCT00743288|528348918|FG002|Overall Study|Adverse Event|2|||
146504230|NCT00743288|528348919|FG003|Overall Study|Adverse Event|2|||
146504231|NCT00743288|528348920|FG004|Overall Study|Adverse Event|1|||
146504232|NCT00743288|528348921|FG005|Overall Study|Adverse Event|1|||
146504233|NCT00743288|528348922|FG006|Overall Study|Adverse Event|2|||
146504234|NCT00743288|528348916|FG000|Overall Study|Withdrawal by Subject|0|||
146504235|NCT00743288|528348917|FG001|Overall Study|Withdrawal by Subject|0|||
146504236|NCT00743288|528348918|FG002|Overall Study|Withdrawal by Subject|1|||
146504237|NCT00743288|528348919|FG003|Overall Study|Withdrawal by Subject|0|||
146504238|NCT00743288|528348920|FG004|Overall Study|Withdrawal by Subject|0|||
146504239|NCT00743288|528348921|FG005|Overall Study|Withdrawal by Subject|1|||
146504240|NCT00743288|528348922|FG006|Overall Study|Withdrawal by Subject|1|||
146504241|NCT00743288|528348916|FG000|Overall Study|Progressive disease (PD)|2|||
146504242|NCT00743288|528348917|FG001|Overall Study|Progressive disease (PD)|0|||
146504243|NCT00743288|528348918|FG002|Overall Study|Progressive disease (PD)|1|||
146504244|NCT00743288|528348919|FG003|Overall Study|Progressive disease (PD)|4|||
146504245|NCT00743288|528348920|FG004|Overall Study|Progressive disease (PD)|5|||
146504246|NCT00743288|528348921|FG005|Overall Study|Progressive disease (PD)|3|||
146504247|NCT00743288|528348922|FG006|Overall Study|Progressive disease (PD)|6|||
146504248|NCT00743288|528348916|FG000|Overall Study|Worsening of condition (Not PD)|0|||
146504249|NCT00743288|528348917|FG001|Overall Study|Worsening of condition (Not PD)|2|||
146504250|NCT00743288|528348918|FG002|Overall Study|Worsening of condition (Not PD)|1|||
146504251|NCT00743288|528348919|FG003|Overall Study|Worsening of condition (Not PD)|1|||
146504252|NCT00743288|528348920|FG004|Overall Study|Worsening of condition (Not PD)|0|||
146504253|NCT00743288|528348921|FG005|Overall Study|Worsening of condition (Not PD)|0|||
146504254|NCT00743288|528348922|FG006|Overall Study|Worsening of condition (Not PD)|0|||
146504255|NCT00688701|528348923|FG000|Overall Study|Adverse Event|1|||
146504256|NCT00688701|528348924|FG001|Overall Study|Adverse Event|0|||
146504257|NCT00688701|528348925|FG002|Overall Study|Adverse Event|5|||
146504258|NCT00688701|528348926|FG003|Overall Study|Adverse Event|3|||
146504259|NCT00688701|528348923|FG000|Overall Study|Lack of Efficacy|0|||
146504260|NCT00688701|528348924|FG001|Overall Study|Lack of Efficacy|1|||
146504261|NCT00688701|528348925|FG002|Overall Study|Lack of Efficacy|0|||
146504262|NCT00688701|528348926|FG003|Overall Study|Lack of Efficacy|0|||
146504263|NCT00688701|528348923|FG000|Overall Study|Withdrawal by Subject|3|||
146504264|NCT00688701|528348924|FG001|Overall Study|Withdrawal by Subject|3|||
146504265|NCT00688701|528348925|FG002|Overall Study|Withdrawal by Subject|4|||
146504266|NCT00688701|528348926|FG003|Overall Study|Withdrawal by Subject|8|||
146504267|NCT00688701|528348923|FG000|Overall Study|Poor compliance to protocol|0|||
146504268|NCT00688701|528348924|FG001|Overall Study|Poor compliance to protocol|1|||
146504269|NCT00688701|528348925|FG002|Overall Study|Poor compliance to protocol|1|||
146504270|NCT00688701|528348926|FG003|Overall Study|Poor compliance to protocol|0|||
146504271|NCT04166591|528348928|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
146504272|NCT04166591|528348929|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
146504273|NCT04166591|528348930|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
146504274|NCT04166591|528348931|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
146504275|NCT04166591|528348928|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
146504276|NCT04166591|528348929|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
146504277|NCT04166591|528348930|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
146504278|NCT04166591|528348931|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
146504279|NCT03030989|528348932|FG000|Overall Study|Fever|2|||
146504280|NCT03030989|528348933|FG001|Overall Study|Fever|2|||
146504281|NCT03030989|528348932|FG000|Overall Study|Rash|2|||
146504282|NCT03030989|528348933|FG001|Overall Study|Rash|1|||
146504283|NCT03030989|528348932|FG000|Overall Study|Fatigue/Overwhelmed|1|||
146504284|NCT03030989|528348933|FG001|Overall Study|Fatigue/Overwhelmed|5|||
146504285|NCT03030989|528348932|FG000|Overall Study|Positive Blood Cultures|2|||
146504286|NCT03030989|528348933|FG001|Overall Study|Positive Blood Cultures|1|||
146504287|NCT03030989|528348932|FG000|Overall Study|Line Removed|0|||
146974449|NCT01954082|530069547|FG001|Overall Study|Randomized not Treated|2|||
146504288|NCT03030989|528348933|FG001|Overall Study|Line Removed|2|||
146504289|NCT03030989|528348932|FG000|Overall Study|No longer interested|5|||
146504290|NCT03030989|528348933|FG001|Overall Study|No longer interested|3|||
146504291|NCT02730377|528348934|FG000|Overall Study|Other|5|||
146504292|NCT02730377|528348935|FG001|Overall Study|Other|4|||
146504293|NCT02730377|528348934|FG000|Overall Study|Death|1|||
146504294|NCT02730377|528348935|FG001|Overall Study|Death|8|||
146504295|NCT02730377|528348934|FG000|Overall Study|Inadequate glycaemic control|368|||
146504296|NCT02730377|528348935|FG001|Overall Study|Inadequate glycaemic control|473|||
146504297|NCT02730377|528348934|FG000|Overall Study|Adverse Event|79|||
146769411|NCT02547922|529323536|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
146769412|NCT02547922|529323537|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
146769413|NCT02547922|529323535|FG000|Overall Study|Physician Decision|2|||
146769414|NCT02547922|529323536|FG001|Overall Study|Physician Decision|1|||
146769415|NCT02547922|529323537|FG002|Overall Study|Physician Decision|2|||
146769416|NCT02547922|529323535|FG000|Overall Study|Patients did not receive IP|1|||
146769417|NCT02547922|529323536|FG001|Overall Study|Patients did not receive IP|1|||
146769418|NCT02547922|529323537|FG002|Overall Study|Patients did not receive IP|0|||
146769419|NCT00102063|529323542|FG000|Overall Study|Lack of Efficacy|5|||
146769420|NCT00102063|529323543|FG001|Overall Study|Lack of Efficacy|1|||
146769421|NCT00102063|529323544|FG002|Overall Study|Lack of Efficacy|1|||
146769422|NCT00102063|529323542|FG000|Overall Study|Adverse Event|7|||
146769423|NCT00102063|529323543|FG001|Overall Study|Adverse Event|4|||
146769424|NCT00102063|529323544|FG002|Overall Study|Adverse Event|2|||
146769425|NCT00102063|529323542|FG000|Overall Study|Withdrawal by Subject|4|||
146769426|NCT00102063|529323543|FG001|Overall Study|Withdrawal by Subject|12|||
146769427|NCT00102063|529323544|FG002|Overall Study|Withdrawal by Subject|5|||
146769428|NCT00102063|529323542|FG000|Overall Study|Lost to Follow-up|0|||
146769429|NCT00102063|529323543|FG001|Overall Study|Lost to Follow-up|0|||
146769430|NCT00102063|529323544|FG002|Overall Study|Lost to Follow-up|1|||
146769431|NCT00102063|529323542|FG000|Overall Study|Protocol Violation|0|||
146769432|NCT00102063|529323543|FG001|Overall Study|Protocol Violation|1|||
146769433|NCT00102063|529323544|FG002|Overall Study|Protocol Violation|1|||
146769434|NCT02739035|529323547|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
146769435|NCT02739035|529323548|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
146504298|NCT02730377|528348935|FG001|Overall Study|Adverse Event|41|||
146504299|NCT02730377|528348934|FG000|Overall Study|Protocol Violation|23|||
146504300|NCT02730377|528348935|FG001|Overall Study|Protocol Violation|30|||
146504301|NCT02730377|528348934|FG000|Overall Study|Lack of Efficacy|4|||
146504302|NCT02730377|528348935|FG001|Overall Study|Lack of Efficacy|13|||
146504303|NCT02730377|528348934|FG000|Overall Study|Pregnancy|0|||
146504304|NCT02730377|528348935|FG001|Overall Study|Pregnancy|1|||
146504305|NCT02730377|528348934|FG000|Overall Study|Withdrawal by Subject|45|||
146504306|NCT02730377|528348935|FG001|Overall Study|Withdrawal by Subject|42|||
146504307|NCT02730377|528348934|FG000|Overall Study|Lost to Follow-up|25|||
146504308|NCT02730377|528348935|FG001|Overall Study|Lost to Follow-up|21|||
146504309|NCT02706886|528348936|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
146504310|NCT02706886|528348937|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
146504311|NCT02706886|528348938|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
146504312|NCT02706886|528348939|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
146504313|NCT02706886|528348940|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
146504314|NCT02706886|528348941|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
146504315|NCT02706886|528348942|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
146504316|NCT02706886|528348943|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
146504317|NCT02706886|528348944|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
146504318|NCT03917472|528348945|FG000|Overall Study|Physician Decision|4|||
146504319|NCT03917472|528348946|FG001|Overall Study|Physician Decision|0|||
146504320|NCT03917472|528348945|FG000|Overall Study|Adverse Event|3|||
146504321|NCT03917472|528348946|FG001|Overall Study|Adverse Event|1|||
146504322|NCT03917472|528348945|FG000|Overall Study|Death|7|||
146504323|NCT03917472|528348946|FG001|Overall Study|Death|5|||
146504324|NCT03917472|528348945|FG000|Overall Study|Withdrawal by Subject|11|||
146504325|NCT03917472|528348946|FG001|Overall Study|Withdrawal by Subject|4|||
146504326|NCT03917472|528348945|FG000|Overall Study|Lost to Follow-up|10|||
146504327|NCT03917472|528348946|FG001|Overall Study|Lost to Follow-up|5|||
146504328|NCT02759055|528348947|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
146504329|NCT02759055|528348948|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
146504330|NCT04934189|528348949|FG000|Overall Study|Lost to Follow-up|4|||
146504331|NCT04934189|528348949|FG000|Overall Study|Withdrawal by Subject|17|||
146504332|NCT02487771|528348951|FG000|Overall Study|Lost to Follow-up|2|||
146504333|NCT02487771|528348952|FG001|Overall Study|Lost to Follow-up|3|||
146504334|NCT02487771|528348951|FG000|Overall Study|Moved out of area|5|||
146769436|NCT02739035|529323547|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
146504335|NCT02487771|528348952|FG001|Overall Study|Moved out of area|6|||
146504336|NCT02487771|528348951|FG000|Overall Study|Withdrawal by Subject|3|||
146504337|NCT02487771|528348952|FG001|Overall Study|Withdrawal by Subject|5|||
146504338|NCT01871402|528348953|FG000|Overall Study|Lost to Follow-up|1|||
146567042|NCT03498716|528588013|FG001|Overall Study|Physician Decision|2|||
146769437|NCT02739035|529323548|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
146769438|NCT02739035|529323547|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
146769439|NCT02739035|529323548|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
146504339|NCT01871402|528348954|FG001|Overall Study|Lost to Follow-up|0|||
146504340|NCT01871402|528348953|FG000|Overall Study|Withdrawal by Subject|0|||
146504341|NCT01871402|528348954|FG001|Overall Study|Withdrawal by Subject|2|||
146504342|NCT01871402|528348953|FG000|Overall Study|Non-compliance|0|||
146504343|NCT01871402|528348954|FG001|Overall Study|Non-compliance|1|||
146504344|NCT04594941|528348955|FG000|Overall Study|Other|0|||
146504345|NCT04594941|528348956|FG001|Overall Study|Other|3|||
146648555|NCT01133990|528890779|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
146648556|NCT01133990|528890780|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
146504346|NCT04594941|528348957|FG002|Overall Study|Other|1|||
146504347|NCT04594941|528348958|FG003|Overall Study|Other|0|||
146504348|NCT02424630|528348959|FG000|Overall Study|No rotator cuff tear|1|||
146504349|NCT02424630|528348960|FG001|Overall Study|No rotator cuff tear|2|||
146504350|NCT02424630|528348959|FG000|Overall Study|Open procedure|0|||
146504351|NCT02424630|528348960|FG001|Overall Study|Open procedure|1|||
146504352|NCT02637895|528348961|FG000|Overall Study|Lost to Follow-up|4|||
146504353|NCT02637895|528348962|FG001|Overall Study|Lost to Follow-up|0|||
146504354|NCT02637895|528348961|FG000|Overall Study|Protocol Violation|0|||
146504355|NCT02637895|528348962|FG001|Overall Study|Protocol Violation|1|||
146504356|NCT02637895|528348961|FG000|Overall Study|Lack of Efficacy|1|||
146504357|NCT02637895|528348962|FG001|Overall Study|Lack of Efficacy|0|||
146504358|NCT02637895|528348961|FG000|Overall Study|Withdrawal by Subject|1|||
146504359|NCT02637895|528348962|FG001|Overall Study|Withdrawal by Subject|1|||
146504360|NCT02637895|528348961|FG000|Overall Study|Abnormal baseline lab|0|||
146504361|NCT02637895|528348962|FG001|Overall Study|Abnormal baseline lab|1|||
146504362|NCT01895270|528348965|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
146504363|NCT01895270|528348966|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
146504364|NCT01895270|528348965|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
146504365|NCT01895270|528348966|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
146504366|NCT01895270|528348965|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
146504367|NCT01895270|528348966|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
146504368|NCT01895270|528348965|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
146504369|NCT01895270|528348966|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
146504370|NCT01895270|528348965|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
146504371|NCT01895270|528348966|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
146504372|NCT01895270|528348965|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
146504373|NCT01895270|528348966|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
146504374|NCT01895270|528348965|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
146504375|NCT01895270|528348966|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
146504376|NCT05896527|528348968|FG000|Overall Study|Withdrawal by Subject|11|||
146504377|NCT05896527|528348969|FG001|Overall Study|Withdrawal by Subject|10|||
146504378|NCT05896527|528348970|FG002|Overall Study|Withdrawal by Subject|4|||
146504379|NCT05896527|528348971|FG003|Overall Study|Withdrawal by Subject|3|||
146504380|NCT05896527|528348972|FG004|Overall Study|Withdrawal by Subject|2|||
146504381|NCT05896527|528348968|FG000|Overall Study|Lost to Follow-up|0|||
146504382|NCT05896527|528348969|FG001|Overall Study|Lost to Follow-up|2|||
146504383|NCT05896527|528348970|FG002|Overall Study|Lost to Follow-up|2|||
146504384|NCT05896527|528348971|FG003|Overall Study|Lost to Follow-up|2|||
146504385|NCT05896527|528348972|FG004|Overall Study|Lost to Follow-up|1|||
146504386|NCT05896527|528348968|FG000|Overall Study|Significant protocol noncompliance|0|||
146504387|NCT05896527|528348969|FG001|Overall Study|Significant protocol noncompliance|1|||
146504388|NCT05896527|528348970|FG002|Overall Study|Significant protocol noncompliance|0|||
146504389|NCT05896527|528348971|FG003|Overall Study|Significant protocol noncompliance|0|||
146504390|NCT05896527|528348972|FG004|Overall Study|Significant protocol noncompliance|0|||
146504391|NCT05896527|528348968|FG000|Overall Study|Eligibility criteria not met|1|||
146504392|NCT05896527|528348969|FG001|Overall Study|Eligibility criteria not met|0|||
146504393|NCT05896527|528348970|FG002|Overall Study|Eligibility criteria not met|0|||
146504394|NCT05896527|528348971|FG003|Overall Study|Eligibility criteria not met|0|||
146504395|NCT05896527|528348972|FG004|Overall Study|Eligibility criteria not met|0|||
146504396|NCT05896527|528348968|FG000|Overall Study|Sponsor's decision|0|||
146504397|NCT05896527|528348969|FG001|Overall Study|Sponsor's decision|0|||
146504398|NCT05896527|528348970|FG002|Overall Study|Sponsor's decision|0|||
146504399|NCT05896527|528348971|FG003|Overall Study|Sponsor's decision|1|||
146504400|NCT05896527|528348972|FG004|Overall Study|Sponsor's decision|0|||
146504401|NCT05896527|528348968|FG000|Overall Study|Investigator's decision|0|||
146504402|NCT05896527|528348969|FG001|Overall Study|Investigator's decision|1|||
146504403|NCT05896527|528348970|FG002|Overall Study|Investigator's decision|0|||
146567043|NCT03139448|528588017|FG000|Overall Study|Lack of Efficacy|6|||
146567044|NCT03139448|528588018|FG001|Overall Study|Lack of Efficacy|7|||
146567045|NCT03139448|528588017|FG000|Overall Study|Location of procedure changed|2|||
146567046|NCT03139448|528588018|FG001|Overall Study|Location of procedure changed|8|||
146567047|NCT03139448|528588017|FG000|Overall Study|Withdrawal by Subject|3|||
146567048|NCT03139448|528588018|FG001|Overall Study|Withdrawal by Subject|6|||
146567049|NCT03139448|528588017|FG000|Overall Study|Screen fail|1|||
146567050|NCT03139448|528588018|FG001|Overall Study|Screen fail|3|||
146648557|NCT01133990|528890781|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
146567051|NCT03139448|528588017|FG000|Overall Study|Physician Decision|0|||
146648558|NCT01133990|528890782|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
146648559|NCT01133990|528890783|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
146648560|NCT01133990|528890778|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
146504404|NCT05896527|528348971|FG003|Overall Study|Investigator's decision|0|||
146504405|NCT05896527|528348972|FG004|Overall Study|Investigator's decision|0|||
146504406|NCT05896527|528348968|FG000|Overall Study|Pregnancy of his partner|0|||
146504407|NCT05896527|528348969|FG001|Overall Study|Pregnancy of his partner|0|||
146504408|NCT05896527|528348970|FG002|Overall Study|Pregnancy of his partner|0|||
146504409|NCT05896527|528348971|FG003|Overall Study|Pregnancy of his partner|1|||
146504410|NCT05896527|528348972|FG004|Overall Study|Pregnancy of his partner|0|||
146504411|NCT03085238|528348973|FG000|Overall Study|Adverse Event|2|||
146504412|NCT03085238|528348973|FG000|Overall Study|Death|2|||
146504413|NCT01279070|528348974|FG000|Overall Study|Withdrawal by Subject|2|||
146504414|NCT01279070|528348975|FG001|Overall Study|Withdrawal by Subject|3|||
146504415|NCT01279070|528348974|FG000|Overall Study|Acute exacerbation|3|||
146504416|NCT01279070|528348975|FG001|Overall Study|Acute exacerbation|1|||
146504417|NCT01741792|528348976|FG000|Overall Study|Death|6|||
146504418|NCT01741792|528348977|FG001|Overall Study|Death|1|||
146504419|NCT01741792|528348978|FG002|Overall Study|Death|12|||
146504420|NCT00761280|528348979|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
146504421|NCT00761280|528348980|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
146504422|NCT00761280|528348979|FG000|Randomization to First Dose|Sponsor decision|1|||
146504423|NCT00761280|528348980|FG001|Randomization to First Dose|Sponsor decision|0|||
146504424|NCT00761280|528348979|FG000|Randomization to First Dose|Other|1|||
146504425|NCT00761280|528348980|FG001|Randomization to First Dose|Other|0|||
146504426|NCT00761280|528348979|FG000|First Dose to End of Study|End of trial|5|||
146504427|NCT00761280|528348980|FG001|First Dose to End of Study|End of trial|5|||
146504428|NCT00761280|528348979|FG000|First Dose to End of Study|Progressive disease|5|||
146504429|NCT00761280|528348980|FG001|First Dose to End of Study|Progressive disease|3|||
146504430|NCT00761280|528348979|FG000|First Dose to End of Study|Sponsor decision|1|||
146504431|NCT00761280|528348980|FG001|First Dose to End of Study|Sponsor decision|2|||
146504432|NCT00761280|528348979|FG000|First Dose to End of Study|Death|1|||
146504433|NCT00761280|528348980|FG001|First Dose to End of Study|Death|0|||
146504434|NCT00761280|528348979|FG000|First Dose to End of Study|Lost to Follow-up|0|||
146504435|NCT00761280|528348980|FG001|First Dose to End of Study|Lost to Follow-up|1|||
146504436|NCT04507256|528348984|FG000|Overall Study|Withdrawal by Subject|1|||
146504437|NCT04507256|528348985|FG001|Overall Study|Withdrawal by Subject|0|||
146504438|NCT04507256|528348986|FG002|Overall Study|Withdrawal by Subject|0|||
146504439|NCT04507256|528348987|FG003|Overall Study|Withdrawal by Subject|1|||
146504440|NCT04507256|528348988|FG004|Overall Study|Withdrawal by Subject|0|||
146567052|NCT03139448|528588018|FG001|Overall Study|Physician Decision|2|||
146567053|NCT01987557|528588019|FG000|Overall Study|Protocol Violation|1|||
146567054|NCT01987557|528588020|FG001|Overall Study|Protocol Violation|0|||
146567055|NCT01987557|528588021|FG002|Overall Study|Protocol Violation|1|||
146567056|NCT01987557|528588019|FG000|Overall Study|Withdrawal by Subject|2|||
146567057|NCT01987557|528588020|FG001|Overall Study|Withdrawal by Subject|1|||
146567058|NCT01987557|528588021|FG002|Overall Study|Withdrawal by Subject|2|||
146567059|NCT01987557|528588019|FG000|Overall Study|Adverse Event|0|||
146567060|NCT01987557|528588020|FG001|Overall Study|Adverse Event|2|||
146567061|NCT01987557|528588021|FG002|Overall Study|Adverse Event|0|||
146567062|NCT01854528|528588027|FG000|Overall Study|Adverse Event|0|||
146567063|NCT01854528|528588028|FG001|Overall Study|Adverse Event|4|||
146567064|NCT01854528|528588027|FG000|Overall Study|Withdrawal by Subject|0|||
146567065|NCT01854528|528588028|FG001|Overall Study|Withdrawal by Subject|2|||
146567066|NCT01854528|528588027|FG000|Overall Study|Virologic Failure|0|||
146567067|NCT01854528|528588028|FG001|Overall Study|Virologic Failure|9|||
146567068|NCT00518180|528588029|FG000|Overall Study|Withdrawal by Subject|29|||
146567069|NCT00518180|528588030|FG001|Overall Study|Withdrawal by Subject|30|||
146567070|NCT00518180|528588031|FG002|Overall Study|Withdrawal by Subject|42|||
146567071|NCT00518180|528588029|FG000|Overall Study|Lost to Follow-up|30|||
146567072|NCT00518180|528588030|FG001|Overall Study|Lost to Follow-up|28|||
146567073|NCT00518180|528588031|FG002|Overall Study|Lost to Follow-up|34|||
146567074|NCT00518180|528588029|FG000|Overall Study|Administrative reason|0|||
146504441|NCT04507256|528348989|FG005|Overall Study|Withdrawal by Subject|0|||
146504442|NCT00631410|528348990|FG000|Overall Study|Adverse Event|1|||
146504443|NCT00631410|528348991|FG001|Overall Study|Adverse Event|3|||
146504444|NCT00631410|528348990|FG000|Overall Study|Objective Progression or Relapse|4|||
146504445|NCT00631410|528348991|FG001|Overall Study|Objective Progression or Relapse|3|||
146504446|NCT00631410|528348990|FG000|Overall Study|Surgery|1|||
146504447|NCT00631410|528348991|FG001|Overall Study|Surgery|0|||
146504448|NCT00782184|528349004|FG000|Overall Study|Adverse Event|1|||
146567075|NCT00518180|528588030|FG001|Overall Study|Administrative reason|2|||
146567076|NCT00518180|528588031|FG002|Overall Study|Administrative reason|2|||
146567077|NCT00518180|528588029|FG000|Overall Study|Protocol Violation|5|||
146567078|NCT00518180|528588030|FG001|Overall Study|Protocol Violation|7|||
146567079|NCT00518180|528588031|FG002|Overall Study|Protocol Violation|4|||
146567080|NCT00518180|528588029|FG000|Overall Study|Unable to classify|0|||
146567081|NCT00518180|528588030|FG001|Overall Study|Unable to classify|2|||
146567082|NCT00518180|528588031|FG002|Overall Study|Unable to classify|0|||
146504449|NCT00782184|528349005|FG001|Overall Study|Adverse Event|2|||
146567083|NCT00518180|528588029|FG000|Overall Study|Adverse Event|1|||
146504450|NCT00782184|528349004|FG000|Overall Study|Protocol Violation|0|||
146504451|NCT00782184|528349005|FG001|Overall Study|Protocol Violation|1|||
146504452|NCT00782184|528349004|FG000|Overall Study|Withdrawal by Subject|3|||
146504453|NCT00782184|528349005|FG001|Overall Study|Withdrawal by Subject|2|||
146504454|NCT01676896|528349012|FG000|Overall Study|Withdrawal by Subject|12|||
146504455|NCT01676896|528349013|FG001|Overall Study|Withdrawal by Subject|7|||
146504456|NCT01676896|528349014|FG002|Overall Study|Withdrawal by Subject|19|||
146504457|NCT01613222|528349017|FG000|Overall Study|Physician Decision|1|||
146648561|NCT01133990|528890779|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
146504458|NCT01613222|528349017|FG000|Overall Study|Unable to place arterial line|1|||
146504459|NCT01613222|528349017|FG000|Overall Study|Reused disposable sensors|10|||
146504460|NCT01895608|528349018|FG000|Overall Study|change in health status|0|||
146504461|NCT01895608|528349019|FG001|Overall Study|change in health status|1|||
146504462|NCT01895608|528349020|FG002|Overall Study|change in health status|1|||
146504463|NCT01895608|528349021|FG003|Overall Study|change in health status|0|||
146504464|NCT01895608|528349018|FG000|Overall Study|Withdrawal by Subject|0|||
146504465|NCT01895608|528349019|FG001|Overall Study|Withdrawal by Subject|0|||
146504466|NCT01895608|528349020|FG002|Overall Study|Withdrawal by Subject|2|||
146504467|NCT01895608|528349021|FG003|Overall Study|Withdrawal by Subject|0|||
146504468|NCT03505593|528349022|FG000|Overall Study|Withdrawal by Subject|1|||
146504469|NCT03505593|528349022|FG000|Overall Study|Died before procedure|1|||
146504470|NCT03505593|528349022|FG000|Overall Study|Anatomical abnormality|1|||
146504471|NCT03505593|528349022|FG000|Overall Study|Unable to pass through esophagus|1|||
146504472|NCT03505593|528349022|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
146504473|NCT02855359|528349026|FG000|Overall Study|Death|2|||
146504474|NCT02855359|528349027|FG001|Overall Study|Death|2|||
146504475|NCT02855359|528349028|FG002|Overall Study|Death|0|||
146504476|NCT02855359|528349029|FG003|Overall Study|Death|0|||
146504477|NCT02855359|528349026|FG000|Overall Study|Study Termination by Sponsor|9|||
146504478|NCT02855359|528349027|FG001|Overall Study|Study Termination by Sponsor|11|||
146504479|NCT02855359|528349028|FG002|Overall Study|Study Termination by Sponsor|0|||
146504480|NCT02855359|528349029|FG003|Overall Study|Study Termination by Sponsor|0|||
146504481|NCT01154088|528349030|FG000|Overall Study|Lost to Follow-up|4|||
146504482|NCT01154088|528349031|FG001|Overall Study|Lost to Follow-up|6|||
146504483|NCT01154088|528349032|FG002|Overall Study|Lost to Follow-up|7|||
146504484|NCT05129137|528349035|FG000|Second Period|Adverse Event|1|||
146504485|NCT05129137|528349036|FG001|Second Period|Adverse Event|0|||
146504486|NCT05129137|528349037|FG002|Second Period|Adverse Event|0|||
146504487|NCT05129137|528349038|FG003|Second Period|Adverse Event|0|||
146504488|NCT05129137|528349035|FG000|Second Period|Protocol Violation|0|||
146504489|NCT05129137|528349036|FG001|Second Period|Protocol Violation|0|||
146504490|NCT05129137|528349037|FG002|Second Period|Protocol Violation|0|||
146504491|NCT05129137|528349038|FG003|Second Period|Protocol Violation|1|||
146504492|NCT05129137|528349035|FG000|Third Period|Protocol Violation|0|||
146504493|NCT05129137|528349036|FG001|Third Period|Protocol Violation|0|||
146504494|NCT05129137|528349037|FG002|Third Period|Protocol Violation|0|||
146504495|NCT05129137|528349038|FG003|Third Period|Protocol Violation|1|||
146504496|NCT05129137|528349035|FG000|Forth Period|Protocol Violation|0|||
146504497|NCT05129137|528349036|FG001|Forth Period|Protocol Violation|1|||
146504498|NCT05129137|528349037|FG002|Forth Period|Protocol Violation|0|||
146504499|NCT05129137|528349038|FG003|Forth Period|Protocol Violation|0|||
146504500|NCT05129137|528349035|FG000|Forth Period|Withdrawal by Subject|0|||
146504501|NCT05129137|528349036|FG001|Forth Period|Withdrawal by Subject|0|||
146504502|NCT05129137|528349037|FG002|Forth Period|Withdrawal by Subject|1|||
146504503|NCT05129137|528349038|FG003|Forth Period|Withdrawal by Subject|0|||
146504504|NCT01084668|528349039|FG000|Overall Study|Lack of Efficacy|5|||
146504505|NCT01084668|528349039|FG000|Overall Study|Withdrawal by Subject|2|||
146504506|NCT01084668|528349039|FG000|Overall Study|Pregnancy|1|||
146504507|NCT01084668|528349039|FG000|Overall Study|Non-compliance|1|||
146504508|NCT01869699|528349041|FG000|Overall Study|Withdrawal by Subject|1|||
146504509|NCT01869699|528349042|FG001|Overall Study|Withdrawal by Subject|0|||
146504510|NCT01475851|528349045|FG000|Overall Study|Protocol defined stopping criteria|1|||
146648562|NCT01133990|528890780|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
146648563|NCT01133990|528890781|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
146648564|NCT01133990|528890782|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
146648565|NCT01133990|528890783|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
146648566|NCT02282345|528890785|FG000|Overall Study|Progression|0|||
146648567|NCT02282345|528890786|FG001|Overall Study|Progression|1|||
146648568|NCT01185301|528890787|FG000|Overall Study|Adverse Event|3|||
146648569|NCT01185301|528890788|FG001|Overall Study|Adverse Event|0|||
146648570|NCT01185301|528890789|FG002|Overall Study|Adverse Event|2|||
146504511|NCT01475851|528349046|FG001|Overall Study|Protocol defined stopping criteria|0|||
146648571|NCT01185301|528890790|FG003|Overall Study|Adverse Event|3|||
146504512|NCT02447497|528349049|FG000|Overall Study|Did not meet treatment day baseline.|6|||
146504513|NCT02447497|528349050|FG001|Overall Study|Did not meet treatment day baseline.|5|||
146504514|NCT02447497|528349051|FG002|Overall Study|Did not meet treatment day baseline.|2|||
146504515|NCT02447497|528349052|FG003|Overall Study|Did not meet treatment day baseline.|2|||
146504516|NCT02447497|528349049|FG000|Overall Study|Dressing was compromised|0|||
146504517|NCT02447497|528349050|FG001|Overall Study|Dressing was compromised|1|||
146504518|NCT02447497|528349051|FG002|Overall Study|Dressing was compromised|0|||
146504519|NCT02447497|528349052|FG003|Overall Study|Dressing was compromised|0|||
146504520|NCT01322035|528349053|FG000|Overall Study|Lost to Follow-up|8|||
146504521|NCT01322035|528349054|FG001|Overall Study|Lost to Follow-up|3|||
146504522|NCT00727844|528349055|FG000|Initial Randomization|Physician Decision|2|||
146504523|NCT00727844|528349056|FG001|Initial Randomization|Physician Decision|0|||
146504524|NCT00727844|528349057|FG002|Initial Randomization|Physician Decision|0|||
146504525|NCT00727844|528349058|FG003|Initial Randomization|Physician Decision|0|||
146504526|NCT04569968|528349059|FG000|Overall Study|Lost to Follow-up|2|||
146504527|NCT04569968|528349060|FG001|Overall Study|Lost to Follow-up|5|||
146504528|NCT04569968|528349059|FG000|Overall Study|Story of head and/or neck surgery|2|||
146504529|NCT04569968|528349060|FG001|Overall Study|Story of head and/or neck surgery|2|||
146504530|NCT04569968|528349059|FG000|Overall Study|Time of stroke onset|8|||
146504531|NCT04569968|528349060|FG001|Overall Study|Time of stroke onset|7|||
146504532|NCT04569968|528349059|FG000|Overall Study|Type of strokr|12|||
146504533|NCT04569968|528349060|FG001|Overall Study|Type of strokr|8|||
146504534|NCT04569968|528349059|FG000|Overall Study|Cooperation|8|||
146504535|NCT04569968|528349060|FG001|Overall Study|Cooperation|8|||
146504536|NCT04569968|528349059|FG000|Overall Study|Age interval|17|||
146648572|NCT01185301|528890787|FG000|Overall Study|Withdrawal by Subject|7|||
146504537|NCT04569968|528349060|FG001|Overall Study|Age interval|6|||
146504538|NCT04569968|528349059|FG000|Overall Study|Denial of participation to the study|0|||
146504539|NCT04569968|528349060|FG001|Overall Study|Denial of participation to the study|3|||
146504540|NCT04569968|528349059|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
146504541|NCT04569968|528349060|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
146504542|NCT04569968|528349059|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
146504543|NCT04569968|528349060|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
146504544|NCT04569968|528349059|FG000|Overall Study|Quarantine|1|||
146504545|NCT04569968|528349060|FG001|Overall Study|Quarantine|0|||
146504546|NCT04569968|528349059|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
146504547|NCT04569968|528349060|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
146504548|NCT04569968|528349059|FG000|Overall Study|Repetitive stroke|8|||
146504549|NCT04569968|528349060|FG001|Overall Study|Repetitive stroke|0|||
146504550|NCT04569968|528349059|FG000|Overall Study|Insufficient mastication|1|||
146504551|NCT04569968|528349060|FG001|Overall Study|Insufficient mastication|0|||
146504552|NCT04569968|528349059|FG000|Overall Study|Infection|1|||
146504553|NCT04569968|528349060|FG001|Overall Study|Infection|0|||
146504554|NCT00574249|528349068|FG000|Overall Study|Adverse Event|6|||
146504555|NCT00574249|528349069|FG001|Overall Study|Adverse Event|18|||
146504556|NCT00574249|528349068|FG000|Overall Study|Lack of Efficacy|5|||
146504557|NCT00574249|528349069|FG001|Overall Study|Lack of Efficacy|3|||
146504558|NCT00574249|528349068|FG000|Overall Study|Lost to Follow-up|4|||
146504559|NCT00574249|528349069|FG001|Overall Study|Lost to Follow-up|3|||
146504560|NCT00574249|528349068|FG000|Overall Study|Protocol Violation|5|||
146504561|NCT00574249|528349069|FG001|Overall Study|Protocol Violation|2|||
146504562|NCT00574249|528349068|FG000|Overall Study|History of carcinoma|1|||
146504563|NCT00574249|528349069|FG001|Overall Study|History of carcinoma|0|||
146504564|NCT00574249|528349068|FG000|Overall Study|Withdrawal by Subject|3|||
146504565|NCT00574249|528349069|FG001|Overall Study|Withdrawal by Subject|0|||
146504566|NCT00574249|528349068|FG000|Overall Study|Physician Decision|1|||
146504567|NCT00574249|528349069|FG001|Overall Study|Physician Decision|0|||
146504568|NCT00574249|528349068|FG000|Overall Study|Pregnancy|1|||
146504569|NCT00574249|528349069|FG001|Overall Study|Pregnancy|0|||
146504570|NCT00574249|528349068|FG000|Overall Study|Excluded by company|0|||
146504571|NCT00574249|528349069|FG001|Overall Study|Excluded by company|1|||
146504572|NCT00574249|528349068|FG000|Overall Study|PPD test taken twice|0|||
146504573|NCT00574249|528349069|FG001|Overall Study|PPD test taken twice|1|||
146974450|NCT02419469|530069548|FG000|Overall Study|Withdrawal by Subject|1|||
146504574|NCT01680159|528349071|FG000|Screening Period|Not meet criteria for dose-up period|7|||
146504575|NCT01680159|528349071|FG000|Increased Dose Period|Adverse Event|6|||
146504576|NCT01680159|528349071|FG000|Increased Dose Period|Withdrawal by Subject|2|||
146504577|NCT02783729|528349075|FG000|Overall Study|Lack of Efficacy|1|||
146504578|NCT02783729|528349076|FG001|Overall Study|Lack of Efficacy|0|||
146504579|NCT02783729|528349077|FG002|Overall Study|Lack of Efficacy|0|||
146504580|NCT02783729|528349078|FG003|Overall Study|Lack of Efficacy|0|||
146504581|NCT02783729|528349075|FG000|Overall Study|Adverse Event|2|||
146504582|NCT02783729|528349076|FG001|Overall Study|Adverse Event|6|||
146504583|NCT02783729|528349077|FG002|Overall Study|Adverse Event|2|||
146504584|NCT02783729|528349078|FG003|Overall Study|Adverse Event|3|||
146504585|NCT02783729|528349075|FG000|Overall Study|Other|1|||
146504586|NCT02783729|528349076|FG001|Overall Study|Other|6|||
146504587|NCT02783729|528349077|FG002|Overall Study|Other|2|||
146504588|NCT02783729|528349078|FG003|Overall Study|Other|3|||
146504589|NCT02783729|528349075|FG000|Overall Study|Withdrawal by Subject|2|||
146648573|NCT01185301|528890788|FG001|Overall Study|Withdrawal by Subject|5|||
146648574|NCT01185301|528890789|FG002|Overall Study|Withdrawal by Subject|2|||
146567084|NCT00518180|528588030|FG001|Overall Study|Adverse Event|0|||
146567085|NCT00518180|528588031|FG002|Overall Study|Adverse Event|0|||
146567086|NCT03508050|528588032|FG000|Overall Study|Pleural adhesions|1|||
146567087|NCT03508050|528588033|FG001|Overall Study|Pleural adhesions|0|||
146567088|NCT03508050|528588032|FG000|Overall Study|Mucus plug|1|||
146567089|NCT03508050|528588033|FG001|Overall Study|Mucus plug|0|||
146648575|NCT01185301|528890790|FG003|Overall Study|Withdrawal by Subject|3|||
146567090|NCT03508050|528588032|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
146567091|NCT03508050|528588033|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
146567092|NCT03508050|528588032|FG000|Overall Study|Sustained desaturation|0|||
146567093|NCT03508050|528588033|FG001|Overall Study|Sustained desaturation|1|||
146567094|NCT03710889|528588038|FG000|Overall Study|Adverse Event|2|||
146567095|NCT03710889|528588038|FG000|Overall Study|Protocol Deviation|1|||
146567096|NCT04881760|528588039|FG000|Overall Study|Adverse Event|0|||
146648576|NCT01185301|528890787|FG000|Overall Study|Lost to Follow-up|2|||
146648577|NCT01185301|528890788|FG001|Overall Study|Lost to Follow-up|0|||
146648578|NCT01185301|528890789|FG002|Overall Study|Lost to Follow-up|0|||
146648579|NCT01185301|528890790|FG003|Overall Study|Lost to Follow-up|1|||
146648580|NCT01185301|528890787|FG000|Overall Study|Other Reason|3|||
146648581|NCT01185301|528890788|FG001|Overall Study|Other Reason|2|||
146648582|NCT01185301|528890789|FG002|Overall Study|Other Reason|2|||
146648583|NCT01185301|528890790|FG003|Overall Study|Other Reason|2|||
146648584|NCT02683746|528890791|FG000|Overall Study|Adverse Event|3|||
146648585|NCT02683746|528890792|FG001|Overall Study|Adverse Event|2|||
146648586|NCT02683746|528890791|FG000|Overall Study|Lost to Follow-up|5|||
146648587|NCT02683746|528890792|FG001|Overall Study|Lost to Follow-up|6|||
146648588|NCT02683746|528890791|FG000|Overall Study|Withdrawal by Subject|6|||
146648589|NCT02683746|528890792|FG001|Overall Study|Withdrawal by Subject|5|||
146648590|NCT02683746|528890791|FG000|Overall Study|Physician Decision|2|||
146648591|NCT02683746|528890792|FG001|Overall Study|Physician Decision|1|||
146648592|NCT02108262|528890800|FG000|Overall Study|Non-compliance|0|||
146648593|NCT02108262|528890801|FG001|Overall Study|Non-compliance|2|||
146648594|NCT02108262|528890802|FG002|Overall Study|Non-compliance|1|||
146648595|NCT02108262|528890803|FG003|Overall Study|Non-compliance|1|||
146648596|NCT02108262|528890800|FG000|Overall Study|Randomized by error/screen failure|0|||
146648597|NCT02108262|528890801|FG001|Overall Study|Randomized by error/screen failure|0|||
146648598|NCT02108262|528890802|FG002|Overall Study|Randomized by error/screen failure|1|||
146648599|NCT02108262|528890803|FG003|Overall Study|Randomized by error/screen failure|0|||
146648600|NCT02108262|528890800|FG000|Overall Study|Distance to center|0|||
146648601|NCT02108262|528890801|FG001|Overall Study|Distance to center|1|||
146648602|NCT02108262|528890802|FG002|Overall Study|Distance to center|1|||
146648603|NCT02108262|528890803|FG003|Overall Study|Distance to center|0|||
146648604|NCT02108262|528890800|FG000|Overall Study|Adverse Event|0|||
146648605|NCT02108262|528890801|FG001|Overall Study|Adverse Event|11|||
146648606|NCT02108262|528890802|FG002|Overall Study|Adverse Event|6|||
146648607|NCT02108262|528890803|FG003|Overall Study|Adverse Event|12|||
146648608|NCT02108262|528890800|FG000|Overall Study|Death|0|||
146648609|NCT02108262|528890801|FG001|Overall Study|Death|2|||
146648610|NCT02108262|528890802|FG002|Overall Study|Death|2|||
146648611|NCT02108262|528890803|FG003|Overall Study|Death|1|||
146648612|NCT02108262|528890800|FG000|Overall Study|Lost to Follow-up|0|||
146648613|NCT02108262|528890801|FG001|Overall Study|Lost to Follow-up|0|||
146648614|NCT02108262|528890802|FG002|Overall Study|Lost to Follow-up|1|||
146648615|NCT02108262|528890803|FG003|Overall Study|Lost to Follow-up|0|||
146648616|NCT02108262|528890800|FG000|Overall Study|Physician Decision|0|||
146648617|NCT02108262|528890801|FG001|Overall Study|Physician Decision|0|||
146648618|NCT02108262|528890802|FG002|Overall Study|Physician Decision|2|||
146648619|NCT02108262|528890803|FG003|Overall Study|Physician Decision|0|||
146648620|NCT02108262|528890800|FG000|Overall Study|Withdrawal by Subject|0|||
146648621|NCT02108262|528890801|FG001|Overall Study|Withdrawal by Subject|7|||
146648622|NCT02108262|528890802|FG002|Overall Study|Withdrawal by Subject|3|||
146648623|NCT02108262|528890803|FG003|Overall Study|Withdrawal by Subject|4|||
146648624|NCT02108262|528890800|FG000|Overall Study|Due to key hepatic values|0|||
146567097|NCT04881760|528588040|FG001|Overall Study|Adverse Event|1|||
146567098|NCT04881760|528588041|FG002|Overall Study|Adverse Event|1|||
146567099|NCT04881760|528588042|FG003|Overall Study|Adverse Event|0|||
146567100|NCT04881760|528588043|FG004|Overall Study|Adverse Event|1|||
146567101|NCT04881760|528588044|FG005|Overall Study|Adverse Event|1|||
146912867|NCT01845077|529843210|FG004|Washout Period|Lost to Follow-up|0|||
146648625|NCT02108262|528890801|FG001|Overall Study|Due to key hepatic values|1|||
146648626|NCT02108262|528890802|FG002|Overall Study|Due to key hepatic values|0|||
146648627|NCT02108262|528890803|FG003|Overall Study|Due to key hepatic values|0|||
146648628|NCT02108262|528890800|FG000|Overall Study|Unable to contact patient|0|||
146567102|NCT04881760|528588045|FG006|Overall Study|Adverse Event|2|||
146567103|NCT04881760|528588039|FG000|Overall Study|Death|0|||
146648629|NCT02108262|528890801|FG001|Overall Study|Unable to contact patient|3|||
146648630|NCT02108262|528890802|FG002|Overall Study|Unable to contact patient|1|||
146648631|NCT02108262|528890803|FG003|Overall Study|Unable to contact patient|2|||
146648632|NCT02108262|528890800|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
146648633|NCT02108262|528890801|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
146648634|NCT02108262|528890802|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
146648635|NCT02108262|528890803|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
146648636|NCT02108262|528890800|FG000|Overall Study|Patient did not want another infusion|0|||
146648637|NCT02108262|528890801|FG001|Overall Study|Patient did not want another infusion|3|||
146648638|NCT02108262|528890802|FG002|Overall Study|Patient did not want another infusion|3|||
146648639|NCT02108262|528890803|FG003|Overall Study|Patient did not want another infusion|2|||
146648640|NCT02108262|528890800|FG000|Overall Study|Vacation|0|||
146648641|NCT02108262|528890801|FG001|Overall Study|Vacation|1|||
146648642|NCT02108262|528890802|FG002|Overall Study|Vacation|0|||
146648643|NCT02108262|528890803|FG003|Overall Study|Vacation|0|||
146648644|NCT02108262|528890800|FG000|Overall Study|Patient decision|0|||
146648645|NCT02108262|528890801|FG001|Overall Study|Patient decision|7|||
146648646|NCT02108262|528890802|FG002|Overall Study|Patient decision|9|||
146648647|NCT02108262|528890803|FG003|Overall Study|Patient decision|14|||
146648648|NCT02108262|528890800|FG000|Overall Study|Missed IV due to pharmacy error|0|||
146648649|NCT02108262|528890801|FG001|Overall Study|Missed IV due to pharmacy error|0|||
146648650|NCT02108262|528890802|FG002|Overall Study|Missed IV due to pharmacy error|1|||
146648651|NCT02108262|528890803|FG003|Overall Study|Missed IV due to pharmacy error|0|||
146648652|NCT00869778|528890807|FG000|Overall Study|Adverse Event|2|||
146648653|NCT00869778|528890808|FG001|Overall Study|Adverse Event|0|||
146648654|NCT00869778|528890809|FG002|Overall Study|Adverse Event|0|||
146648655|NCT00869778|528890807|FG000|Overall Study|Withdrawal by Subject|3|||
146648656|NCT00869778|528890808|FG001|Overall Study|Withdrawal by Subject|4|||
146648657|NCT00869778|528890809|FG002|Overall Study|Withdrawal by Subject|5|||
146648658|NCT00869778|528890807|FG000|Overall Study|Pregnancy|1|||
146648659|NCT00869778|528890808|FG001|Overall Study|Pregnancy|0|||
146648660|NCT00869778|528890809|FG002|Overall Study|Pregnancy|0|||
146648661|NCT00869778|528890807|FG000|Overall Study|Protocol Violation|5|||
146648662|NCT00869778|528890808|FG001|Overall Study|Protocol Violation|3|||
146648663|NCT00869778|528890809|FG002|Overall Study|Protocol Violation|5|||
146648664|NCT00869778|528890807|FG000|Overall Study|Unblinding|1|||
146648665|NCT00869778|528890808|FG001|Overall Study|Unblinding|0|||
146648666|NCT00869778|528890809|FG002|Overall Study|Unblinding|0|||
146648667|NCT03316911|528890815|FG000|Overall Study|Lost to Follow-up|33|||
146648668|NCT03316911|528890816|FG001|Overall Study|Lost to Follow-up|29|||
146648669|NCT01119937|528890817|FG000|Overall Study|Adverse Event|11|||
146648670|NCT01119937|528890818|FG001|Overall Study|Adverse Event|5|||
146648671|NCT01119937|528890817|FG000|Overall Study|Protocol deviation|3|||
146648672|NCT01119937|528890818|FG001|Overall Study|Protocol deviation|1|||
146648673|NCT01119937|528890817|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
146648674|NCT01119937|528890818|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146648675|NCT01119937|528890817|FG000|Overall Study|Withdrawal by Subject|2|||
146648676|NCT01119937|528890818|FG001|Overall Study|Withdrawal by Subject|1|||
146648677|NCT01270802|528890819|FG000|Overall Study|Withdrawal by Subject|1|||
146648678|NCT01270802|528890820|FG001|Overall Study|Withdrawal by Subject|0|||
146648679|NCT01270802|528890819|FG000|Overall Study|Adverse Event|1|||
146648680|NCT01270802|528890820|FG001|Overall Study|Adverse Event|0|||
146648681|NCT01270802|528890819|FG000|Overall Study|Lost to Follow-up|0|||
146648682|NCT01270802|528890820|FG001|Overall Study|Lost to Follow-up|1|||
146648683|NCT04740905|528890821|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
146648684|NCT04740905|528890822|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
146648685|NCT04740905|528890821|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
146648686|NCT04740905|528890822|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
146648687|NCT04740905|528890821|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
146648688|NCT04740905|528890822|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
146648689|NCT04740905|528890821|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
146648690|NCT04740905|528890822|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
146648691|NCT04740905|528890821|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
146648692|NCT04740905|528890822|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
146648693|NCT04740905|528890821|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
146648694|NCT04740905|528890822|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
146648695|NCT04740905|528890821|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
146648696|NCT04740905|528890822|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
146648697|NCT04740905|528890821|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
146648698|NCT04740905|528890822|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
146648699|NCT04740905|528890821|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
146648700|NCT04740905|528890822|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
146648701|NCT04740905|528890821|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
146648702|NCT04740905|528890822|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
146648703|NCT04740905|528890821|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
146648704|NCT04740905|528890822|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
146769440|NCT02739035|529323547|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
146504590|NCT02783729|528349076|FG001|Overall Study|Withdrawal by Subject|3|||
146504591|NCT02783729|528349077|FG002|Overall Study|Withdrawal by Subject|1|||
146504592|NCT02783729|528349078|FG003|Overall Study|Withdrawal by Subject|2|||
146504593|NCT02783729|528349075|FG000|Overall Study|Participant's choice|2|||
146504594|NCT02783729|528349076|FG001|Overall Study|Participant's choice|1|||
146504595|NCT02783729|528349077|FG002|Overall Study|Participant's choice|2|||
146504596|NCT02783729|528349078|FG003|Overall Study|Participant's choice|1|||
146504597|NCT02783729|528349075|FG000|Overall Study|Lost to Follow-up|2|||
146504598|NCT02783729|528349076|FG001|Overall Study|Lost to Follow-up|1|||
146504599|NCT02783729|528349077|FG002|Overall Study|Lost to Follow-up|1|||
146504600|NCT02783729|528349078|FG003|Overall Study|Lost to Follow-up|0|||
146504601|NCT04021121|528349083|FG000|Overall Study|Death|3|||
146504602|NCT04021121|528349084|FG001|Overall Study|Death|3|||
146504603|NCT04021121|528349085|FG002|Overall Study|Death|5|||
146504604|NCT04021121|528349086|FG003|Overall Study|Death|4|||
146504605|NCT02288091|528349087|FG000|Overall Study|Lost to Follow-up|1|||
146504606|NCT02288091|528349087|FG000|Overall Study|Screen fail|7|||
146504607|NCT03843632|528349093|FG000|Overall Study|Withdrawal by Subject|1|||
146504608|NCT03843632|528349094|FG001|Overall Study|Withdrawal by Subject|0|||
146504609|NCT03843632|528349095|FG002|Overall Study|Withdrawal by Subject|0|||
146504610|NCT03843632|528349096|FG003|Overall Study|Withdrawal by Subject|0|||
146504611|NCT03403751|528349097|FG000|Overall Study|Death|5|||
146504612|NCT03403751|528349098|FG001|Overall Study|Death|6|||
146504613|NCT03403751|528349097|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
146504614|NCT03403751|528349098|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
146504615|NCT02272842|528349101|FG000|Overall Study|Lost to Follow-up|8|||
146504616|NCT02272842|528349102|FG001|Overall Study|Lost to Follow-up|8|||
146504617|NCT02272842|528349101|FG000|Overall Study|Withdrawal by Subject|8|||
146504618|NCT02272842|528349102|FG001|Overall Study|Withdrawal by Subject|2|||
146504619|NCT02031640|528351115|FG000|Screening Period|Adverse Event|1|||
146504620|NCT02031640|528351116|FG001|Screening Period|Adverse Event|0|||
146504621|NCT02031640|528351117|FG002|Screening Period|Adverse Event|0|||
146504622|NCT02031640|528351118|FG003|Screening Period|Adverse Event|0|||
146504623|NCT02031640|528351119|FG004|Screening Period|Adverse Event|0|||
146504624|NCT02031640|528351120|FG005|Screening Period|Adverse Event|0|||
146504625|NCT02031640|528351115|FG000|Screening Period|Withdrawal by Subject|29|||
146504626|NCT02031640|528351116|FG001|Screening Period|Withdrawal by Subject|0|||
146504627|NCT02031640|528351117|FG002|Screening Period|Withdrawal by Subject|0|||
146504628|NCT02031640|528351118|FG003|Screening Period|Withdrawal by Subject|0|||
146504629|NCT02031640|528351119|FG004|Screening Period|Withdrawal by Subject|0|||
146504630|NCT02031640|528351120|FG005|Screening Period|Withdrawal by Subject|0|||
146504631|NCT02031640|528351115|FG000|Screening Period|Inclusion criteria not met|312|||
146504632|NCT02031640|528351116|FG001|Screening Period|Inclusion criteria not met|0|||
146504633|NCT02031640|528351117|FG002|Screening Period|Inclusion criteria not met|0|||
146504634|NCT02031640|528351118|FG003|Screening Period|Inclusion criteria not met|0|||
146504635|NCT02031640|528351119|FG004|Screening Period|Inclusion criteria not met|0|||
146504636|NCT02031640|528351120|FG005|Screening Period|Inclusion criteria not met|0|||
146504637|NCT02031640|528351115|FG000|Screening Period|Exclusion criteria met|30|||
146504638|NCT02031640|528351116|FG001|Screening Period|Exclusion criteria met|0|||
146504639|NCT02031640|528351117|FG002|Screening Period|Exclusion criteria met|0|||
146504640|NCT02031640|528351118|FG003|Screening Period|Exclusion criteria met|0|||
146504641|NCT02031640|528351119|FG004|Screening Period|Exclusion criteria met|0|||
146504642|NCT02031640|528351120|FG005|Screening Period|Exclusion criteria met|0|||
146504643|NCT02031640|528351115|FG000|Screening Period|Lost to Follow-up|14|||
146504644|NCT02031640|528351116|FG001|Screening Period|Lost to Follow-up|0|||
146504645|NCT02031640|528351117|FG002|Screening Period|Lost to Follow-up|0|||
146504646|NCT02031640|528351118|FG003|Screening Period|Lost to Follow-up|0|||
146504647|NCT02031640|528351119|FG004|Screening Period|Lost to Follow-up|0|||
146504648|NCT02031640|528351120|FG005|Screening Period|Lost to Follow-up|0|||
146504649|NCT02031640|528351115|FG000|Screening Period|Enrollment closed|26|||
146504650|NCT02031640|528351116|FG001|Screening Period|Enrollment closed|0|||
146504651|NCT02031640|528351117|FG002|Screening Period|Enrollment closed|0|||
146504652|NCT02031640|528351118|FG003|Screening Period|Enrollment closed|0|||
146504653|NCT02031640|528351119|FG004|Screening Period|Enrollment closed|0|||
146504654|NCT02031640|528351120|FG005|Screening Period|Enrollment closed|0|||
146504655|NCT02031640|528351115|FG000|Run-In Period|Adverse Event|4|||
146504656|NCT02031640|528351116|FG001|Run-In Period|Adverse Event|0|||
146504657|NCT02031640|528351117|FG002|Run-In Period|Adverse Event|0|||
146504658|NCT02031640|528351118|FG003|Run-In Period|Adverse Event|0|||
146504659|NCT02031640|528351119|FG004|Run-In Period|Adverse Event|0|||
146504660|NCT02031640|528351120|FG005|Run-In Period|Adverse Event|0|||
146504661|NCT02031640|528351115|FG000|Run-In Period|Withdrawal by Subject|17|||
146504662|NCT02031640|528351116|FG001|Run-In Period|Withdrawal by Subject|0|||
146504663|NCT02031640|528351117|FG002|Run-In Period|Withdrawal by Subject|0|||
146769441|NCT02739035|529323548|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
146504664|NCT02031640|528351118|FG003|Run-In Period|Withdrawal by Subject|0|||
146504665|NCT02031640|528351119|FG004|Run-In Period|Withdrawal by Subject|0|||
146504666|NCT02031640|528351120|FG005|Run-In Period|Withdrawal by Subject|0|||
146504667|NCT02031640|528351115|FG000|Run-In Period|Inclusion criteria not met|38|||
146504668|NCT02031640|528351116|FG001|Run-In Period|Inclusion criteria not met|0|||
146504669|NCT02031640|528351117|FG002|Run-In Period|Inclusion criteria not met|0|||
146504670|NCT02031640|528351118|FG003|Run-In Period|Inclusion criteria not met|0|||
146504671|NCT02031640|528351119|FG004|Run-In Period|Inclusion criteria not met|0|||
146504672|NCT02031640|528351120|FG005|Run-In Period|Inclusion criteria not met|0|||
146504673|NCT02031640|528351115|FG000|Run-In Period|Exclusion criteria met|8|||
146504674|NCT02031640|528351116|FG001|Run-In Period|Exclusion criteria met|0|||
146504675|NCT02031640|528351117|FG002|Run-In Period|Exclusion criteria met|0|||
146504676|NCT02031640|528351118|FG003|Run-In Period|Exclusion criteria met|0|||
146504677|NCT02031640|528351119|FG004|Run-In Period|Exclusion criteria met|0|||
146504678|NCT02031640|528351120|FG005|Run-In Period|Exclusion criteria met|0|||
146504679|NCT02031640|528351115|FG000|Run-In Period|Randomization criteria not met|85|||
146504680|NCT02031640|528351116|FG001|Run-In Period|Randomization criteria not met|0|||
146504681|NCT02031640|528351117|FG002|Run-In Period|Randomization criteria not met|0|||
146504682|NCT02031640|528351118|FG003|Run-In Period|Randomization criteria not met|0|||
146504683|NCT02031640|528351119|FG004|Run-In Period|Randomization criteria not met|0|||
146504684|NCT02031640|528351120|FG005|Run-In Period|Randomization criteria not met|0|||
146504685|NCT02031640|528351115|FG000|Run-In Period|Various administrative reasons|17|||
146504686|NCT02031640|528351116|FG001|Run-In Period|Various administrative reasons|0|||
146504687|NCT02031640|528351117|FG002|Run-In Period|Various administrative reasons|0|||
146504688|NCT02031640|528351118|FG003|Run-In Period|Various administrative reasons|0|||
146504689|NCT02031640|528351119|FG004|Run-In Period|Various administrative reasons|0|||
146504690|NCT02031640|528351120|FG005|Run-In Period|Various administrative reasons|0|||
146504691|NCT02031640|528351115|FG000|Double-blind Treatment Period|Protocol deviation|0|||
146504692|NCT02031640|528351116|FG001|Double-blind Treatment Period|Protocol deviation|2|||
146504693|NCT02031640|528351117|FG002|Double-blind Treatment Period|Protocol deviation|0|||
146504694|NCT02031640|528351118|FG003|Double-blind Treatment Period|Protocol deviation|1|||
146504695|NCT02031640|528351119|FG004|Double-blind Treatment Period|Protocol deviation|3|||
146504696|NCT02031640|528351120|FG005|Double-blind Treatment Period|Protocol deviation|1|||
146504697|NCT02031640|528351115|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
146504698|NCT02031640|528351116|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
146504699|NCT02031640|528351117|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
146504700|NCT02031640|528351118|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
146504701|NCT02031640|528351119|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
146504702|NCT02031640|528351120|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
146504703|NCT02031640|528351115|FG000|Double-blind Treatment Period|Non-compliance|0|||
146504704|NCT02031640|528351116|FG001|Double-blind Treatment Period|Non-compliance|1|||
146504705|NCT02031640|528351117|FG002|Double-blind Treatment Period|Non-compliance|0|||
146504706|NCT02031640|528351118|FG003|Double-blind Treatment Period|Non-compliance|1|||
146504707|NCT02031640|528351119|FG004|Double-blind Treatment Period|Non-compliance|1|||
146504708|NCT02031640|528351120|FG005|Double-blind Treatment Period|Non-compliance|0|||
146504709|NCT02031640|528351115|FG000|Double-blind Treatment Period|Adverse Event|0|||
146504710|NCT02031640|528351116|FG001|Double-blind Treatment Period|Adverse Event|0|||
146504711|NCT02031640|528351117|FG002|Double-blind Treatment Period|Adverse Event|0|||
146504712|NCT02031640|528351118|FG003|Double-blind Treatment Period|Adverse Event|2|||
146504713|NCT02031640|528351119|FG004|Double-blind Treatment Period|Adverse Event|0|||
146504714|NCT02031640|528351120|FG005|Double-blind Treatment Period|Adverse Event|0|||
146504715|NCT02031640|528351115|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
146504716|NCT02031640|528351116|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
146504717|NCT02031640|528351117|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
146504718|NCT02031640|528351118|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
146504719|NCT02031640|528351119|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
146504720|NCT02031640|528351120|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
146504721|NCT02031640|528351115|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
146504722|NCT02031640|528351116|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
146567104|NCT04881760|528588040|FG001|Overall Study|Death|0|||
146567105|NCT04881760|528588041|FG002|Overall Study|Death|0|||
146567106|NCT04881760|528588042|FG003|Overall Study|Death|1|||
146567107|NCT04881760|528588043|FG004|Overall Study|Death|0|||
146567108|NCT04881760|528588044|FG005|Overall Study|Death|0|||
146567109|NCT04881760|528588045|FG006|Overall Study|Death|0|||
146567110|NCT04881760|528588039|FG000|Overall Study|Lost to Follow-up|5|||
146567111|NCT04881760|528588040|FG001|Overall Study|Lost to Follow-up|7|||
146504723|NCT02031640|528351117|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
146567112|NCT04881760|528588041|FG002|Overall Study|Lost to Follow-up|5|||
146567113|NCT04881760|528588042|FG003|Overall Study|Lost to Follow-up|1|||
146567114|NCT04881760|528588043|FG004|Overall Study|Lost to Follow-up|2|||
146567115|NCT04881760|528588044|FG005|Overall Study|Lost to Follow-up|4|||
146567116|NCT04881760|528588045|FG006|Overall Study|Lost to Follow-up|4|||
146567117|NCT04881760|528588039|FG000|Overall Study|Withdrawal by Subject|13|||
146567118|NCT04881760|528588040|FG001|Overall Study|Withdrawal by Subject|1|||
146504724|NCT02031640|528351118|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
146504725|NCT02031640|528351119|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
146504726|NCT02031640|528351120|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
146504727|NCT00890084|528351125|FG000|Overall Study|Adverse Event|16|||
146504728|NCT00890084|528351125|FG000|Overall Study|Lost to Follow-up|126|||
146504729|NCT02738879|528351126|FG000|Overall Study|Adverse Event|1|||
146504730|NCT02738879|528351127|FG001|Overall Study|Adverse Event|1|||
146504731|NCT02738879|528351126|FG000|Overall Study|Death|0|||
146504732|NCT02738879|528351127|FG001|Overall Study|Death|2|||
146504733|NCT02738879|528351126|FG000|Overall Study|Lost to Follow-up|1|||
146504734|NCT02738879|528351127|FG001|Overall Study|Lost to Follow-up|5|||
146504735|NCT02738879|528351126|FG000|Overall Study|Protocol Violation|1|||
146504736|NCT02738879|528351127|FG001|Overall Study|Protocol Violation|3|||
146504737|NCT02738879|528351126|FG000|Overall Study|Physician Decision|3|||
146504738|NCT02738879|528351127|FG001|Overall Study|Physician Decision|4|||
146504739|NCT02738879|528351126|FG000|Overall Study|Pregnancy|0|||
146504740|NCT02738879|528351127|FG001|Overall Study|Pregnancy|1|||
146504741|NCT02738879|528351126|FG000|Overall Study|Screen Failure|1|||
146504742|NCT02738879|528351127|FG001|Overall Study|Screen Failure|2|||
146504743|NCT02738879|528351126|FG000|Overall Study|Site Discontinued Study Participation|1|||
146504744|NCT02738879|528351127|FG001|Overall Study|Site Discontinued Study Participation|0|||
146504745|NCT02738879|528351126|FG000|Overall Study|Withdrawal by Subject|5|||
146504746|NCT02738879|528351127|FG001|Overall Study|Withdrawal by Subject|7|||
146504747|NCT01438294|528351128|FG000|Overall Study|Lost to Follow-up|3|||
146504748|NCT01438294|528351129|FG001|Overall Study|Lost to Follow-up|7|||
146504749|NCT01346189|528351130|FG000|Overall Study|Withdrawal by Subject|7|||
146504750|NCT01346189|528351131|FG001|Overall Study|Withdrawal by Subject|5|||
146504751|NCT01346189|528351132|FG002|Overall Study|Withdrawal by Subject|3|||
146504752|NCT01346189|528351133|FG003|Overall Study|Withdrawal by Subject|5|||
146504753|NCT01346189|528351130|FG000|Overall Study|Physician Decision|4|||
146504754|NCT01346189|528351131|FG001|Overall Study|Physician Decision|0|||
146504755|NCT01346189|528351132|FG002|Overall Study|Physician Decision|0|||
146504756|NCT01346189|528351133|FG003|Overall Study|Physician Decision|0|||
146504757|NCT01346189|528351130|FG000|Overall Study|Moved|3|||
146504758|NCT01346189|528351131|FG001|Overall Study|Moved|0|||
146504759|NCT01346189|528351132|FG002|Overall Study|Moved|4|||
146504760|NCT01346189|528351133|FG003|Overall Study|Moved|0|||
146504761|NCT01346189|528351130|FG000|Overall Study|Other|2|||
146504762|NCT01346189|528351131|FG001|Overall Study|Other|4|||
146504763|NCT01346189|528351132|FG002|Overall Study|Other|7|||
146504764|NCT01346189|528351133|FG003|Overall Study|Other|3|||
146504765|NCT01346189|528351130|FG000|Overall Study|Death|0|||
146504766|NCT01346189|528351131|FG001|Overall Study|Death|3|||
146504767|NCT01346189|528351132|FG002|Overall Study|Death|0|||
146504768|NCT01346189|528351133|FG003|Overall Study|Death|0|||
146504769|NCT01346189|528351130|FG000|Overall Study|Non-health system primary care physician|0|||
146504770|NCT01346189|528351131|FG001|Overall Study|Non-health system primary care physician|5|||
146504771|NCT01346189|528351132|FG002|Overall Study|Non-health system primary care physician|0|||
146504772|NCT01346189|528351133|FG003|Overall Study|Non-health system primary care physician|0|||
146504773|NCT01346189|528351130|FG000|Overall Study|Travel|0|||
146504774|NCT01346189|528351131|FG001|Overall Study|Travel|0|||
146504775|NCT01346189|528351132|FG002|Overall Study|Travel|0|||
146504776|NCT01346189|528351133|FG003|Overall Study|Travel|3|||
146504777|NCT01730534|528351134|FG000|Overall Study|Withdrawal by Subject|97|||
146504778|NCT01730534|528351135|FG001|Overall Study|Withdrawal by Subject|127|||
146504779|NCT01730534|528351134|FG000|Overall Study|Lost to Follow-up|12|||
146504780|NCT01730534|528351135|FG001|Overall Study|Lost to Follow-up|18|||
146504781|NCT02256982|528351136|FG000|Overall Study|Disease Progression|0|||
146504782|NCT02256982|528351137|FG001|Overall Study|Disease Progression|1|||
146504783|NCT03614078|528351138|FG000|Overall Study|Withdrawal by Subject|2|||
146504784|NCT03614078|528351139|FG001|Overall Study|Withdrawal by Subject|2|||
146504785|NCT03614078|528351140|FG002|Overall Study|Withdrawal by Subject|3|||
146504786|NCT03614078|528351138|FG000|Overall Study|Participant Did Not Return for Visit|0|||
146504787|NCT03614078|528351139|FG001|Overall Study|Participant Did Not Return for Visit|1|||
146504788|NCT03614078|528351140|FG002|Overall Study|Participant Did Not Return for Visit|0|||
146504789|NCT03614078|528351138|FG000|Overall Study|High Neutrophils|0|||
146504790|NCT03614078|528351139|FG001|Overall Study|High Neutrophils|0|||
146504791|NCT03614078|528351140|FG002|Overall Study|High Neutrophils|2|||
146504792|NCT03614078|528351138|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
146504793|NCT03614078|528351139|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
146504794|NCT03614078|528351140|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
146504795|NCT03614078|528351138|FG000|Overall Study|Exacerbation of Psoriasis|0|||
146648705|NCT04740905|528890821|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
146504796|NCT03614078|528351139|FG001|Overall Study|Exacerbation of Psoriasis|1|||
146504797|NCT03614078|528351140|FG002|Overall Study|Exacerbation of Psoriasis|0|||
146504798|NCT03614078|528351138|FG000|Overall Study|Adverse Event|0|||
146504799|NCT03614078|528351139|FG001|Overall Study|Adverse Event|2|||
146504800|NCT03614078|528351140|FG002|Overall Study|Adverse Event|0|||
146504801|NCT03614078|528351138|FG000|Overall Study|Dizziness and Rash|0|||
146504802|NCT03614078|528351139|FG001|Overall Study|Dizziness and Rash|1|||
146504803|NCT03614078|528351140|FG002|Overall Study|Dizziness and Rash|0|||
146504804|NCT04964544|528351143|FG000|Overall Study|Screen failure or other uncategorised|10|||
146504805|NCT04964544|528351143|FG000|Overall Study|Physician Decision|4|||
146504806|NCT04964544|528351143|FG000|Overall Study|Lost to Follow-up|9|||
146504807|NCT04964544|528351143|FG000|Overall Study|Withdrawal by Subject|18|||
146504808|NCT04964544|528351143|FG000|Overall Study|Death|1|||
146504809|NCT02833844|528351149|FG000|Double-Blind Period|Withdrawal by Subject|2|||
146504810|NCT02833844|528351150|FG001|Double-Blind Period|Withdrawal by Subject|3|||
146504811|NCT02833844|528351149|FG000|Double-Blind Period|Protocol Violation|0|||
146504812|NCT02833844|528351150|FG001|Double-Blind Period|Protocol Violation|4|||
146504813|NCT02833844|528351149|FG000|Open-Label Period|Death|0|||
146504814|NCT02833844|528351150|FG001|Open-Label Period|Death|2|||
146504815|NCT02833844|528351149|FG000|Open-Label Period|Lost to Follow-up|1|||
146504816|NCT02833844|528351150|FG001|Open-Label Period|Lost to Follow-up|0|||
146504817|NCT02833844|528351149|FG000|Open-Label Period|Withdrawal by Subject|1|||
146504818|NCT02833844|528351150|FG001|Open-Label Period|Withdrawal by Subject|0|||
146504819|NCT01899742|528351153|FG000|Overall Study|Adverse Event|5|||
146504820|NCT01899742|528351154|FG001|Overall Study|Adverse Event|4|||
146504821|NCT01899742|528351153|FG000|Overall Study|Lack of Efficacy|1|||
146504822|NCT01899742|528351154|FG001|Overall Study|Lack of Efficacy|5|||
146504823|NCT01899742|528351153|FG000|Overall Study|Protocol Violation|2|||
146504824|NCT01899742|528351154|FG001|Overall Study|Protocol Violation|2|||
146504825|NCT01899742|528351153|FG000|Overall Study|Withdrawal by Subject|9|||
146504826|NCT01899742|528351154|FG001|Overall Study|Withdrawal by Subject|5|||
146504827|NCT02662764|528351155|FG000|Overall Study|Adverse Event|6|||
146504828|NCT02662764|528351155|FG000|Overall Study|Lack of Efficacy|8|||
146504829|NCT02662764|528351155|FG000|Overall Study|Protocol Violation|1|||
146504830|NCT02662764|528351155|FG000|Overall Study|Withdrawal by Subject|5|||
146504831|NCT02662764|528351155|FG000|Overall Study|Device failure|4|||
146504832|NCT02662764|528351155|FG000|Overall Study|Patient changed treatment|1|||
146504833|NCT02662764|528351155|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
146504834|NCT00089778|528351162|FG000|Overall Study|Protocol Violation|0|||
146504835|NCT00089778|528351163|FG001|Overall Study|Protocol Violation|0|||
146504836|NCT00089778|528351164|FG002|Overall Study|Protocol Violation|1|||
146504837|NCT00177307|528351165|FG000|Overall Study|Withdrawal by Subject|1|||
146504838|NCT02677038|528351166|FG000|Overall Study|Physician Decision|1|||
146504839|NCT02677038|528351166|FG000|Overall Study|Withdrawal by Subject|1|||
146504840|NCT02777970|528351172|FG000|Overall Study|Lost to Follow-up|0|||
146504841|NCT02777970|528351173|FG001|Overall Study|Lost to Follow-up|1|||
146504842|NCT02777970|528351174|FG002|Overall Study|Lost to Follow-up|0|||
146504843|NCT02777970|528351172|FG000|Overall Study|Protocol Violation|1|||
146504844|NCT02777970|528351173|FG001|Overall Study|Protocol Violation|0|||
146504845|NCT02777970|528351174|FG002|Overall Study|Protocol Violation|0|||
146504846|NCT05845567|528351178|FG000|Overall Study|Withdrawal by Subject|1|||
146504847|NCT01104246|528351179|FG000|Overall Study|Withdrawal by Subject|1|||
146504848|NCT01104246|528351179|FG000|Overall Study|did not meet inclusion criteria|4|||
146504849|NCT05178641|528351180|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
146504850|NCT05178641|528351181|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
146504851|NCT05178641|528351180|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
146504852|NCT05178641|528351181|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
146504853|NCT01083186|528351182|FG000|Overall Study|Lost to Follow-up|48|||
146504854|NCT01083186|528351182|FG000|Overall Study|Consent Withdrawal|7|||
146504855|NCT01083186|528351182|FG000|Overall Study|Death|3|||
146504856|NCT01083186|528351182|FG000|Overall Study|Adverse Event|3|||
146504857|NCT01083186|528351182|FG000|Overall Study|Lack of Efficacy|2|||
146504858|NCT01083186|528351182|FG000|Overall Study|Hemodialysis Initiation|28|||
146504859|NCT01083186|528351182|FG000|Overall Study|Administrative Reasons|2|||
146504860|NCT01083186|528351182|FG000|Overall Study|Non-compliance to Study Treatment|1|||
146504861|NCT03729570|528351188|FG000|Overall Study|Lost to Follow-up|16|||
146504862|NCT03729570|528351189|FG001|Overall Study|Lost to Follow-up|20|||
146504863|NCT03729570|528351188|FG000|Overall Study|Seroconversion|5|||
146504864|NCT03729570|528351189|FG001|Overall Study|Seroconversion|0|||
146504865|NCT03729570|528351188|FG000|Overall Study|Moved out of the city|1|||
146504866|NCT03729570|528351189|FG001|Overall Study|Moved out of the city|0|||
146504867|NCT03729570|528351188|FG000|Overall Study|Time Conflict|1|||
146504868|NCT03729570|528351189|FG001|Overall Study|Time Conflict|0|||
146504869|NCT03729570|528351188|FG000|Overall Study|Time Commitment|2|||
146504870|NCT03729570|528351189|FG001|Overall Study|Time Commitment|0|||
146504871|NCT03729570|528351188|FG000|Overall Study|Bad Experience|0|||
146504872|NCT03729570|528351189|FG001|Overall Study|Bad Experience|1|||
146504873|NCT03729570|528351188|FG000|Overall Study|No reason provided|2|||
146504874|NCT03729570|528351189|FG001|Overall Study|No reason provided|1|||
146504875|NCT03729570|528351188|FG000|Overall Study|Family Conflict|0|||
146504876|NCT03729570|528351189|FG001|Overall Study|Family Conflict|1|||
146504877|NCT03729570|528351188|FG000|Overall Study|Did not want to continue taking medications|0|||
146504878|NCT03729570|528351189|FG001|Overall Study|Did not want to continue taking medications|1|||
146769442|NCT00940992|529323551|FG000|Overall Study|Adverse Event|2|||
146769443|NCT00940992|529323552|FG001|Overall Study|Adverse Event|0|||
146769444|NCT00940992|529323553|FG002|Overall Study|Adverse Event|1|||
146769445|NCT00940992|529323551|FG000|Overall Study|subject request|2|||
146769446|NCT00940992|529323552|FG001|Overall Study|subject request|1|||
146769447|NCT00940992|529323553|FG002|Overall Study|subject request|0|||
146769448|NCT00940992|529323551|FG000|Overall Study|Lost to Follow-up|0|||
146769449|NCT00940992|529323552|FG001|Overall Study|Lost to Follow-up|1|||
146769450|NCT00940992|529323553|FG002|Overall Study|Lost to Follow-up|1|||
146648706|NCT04740905|528890822|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
146648707|NCT04740905|528890821|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
146648708|NCT04740905|528890822|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
146648709|NCT04740905|528890821|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
146648710|NCT04740905|528890822|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
146648711|NCT01566214|528890823|FG000|Overall Study|Lost to Follow-up|3|||
146648712|NCT01566214|528890824|FG001|Overall Study|Lost to Follow-up|0|||
146648713|NCT03051620|528890825|FG000|Overall Study|Lost to Follow-up|6|||
146648714|NCT03051620|528890825|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
146648715|NCT01073462|528890829|FG000|Overall Study|Death|14|||
146648716|NCT01073462|528890829|FG000|Overall Study|Kidney transplant|10|||
146648717|NCT01073462|528890829|FG000|Overall Study|Low parathyroid hormone levels|8|||
146504879|NCT03729570|528351188|FG000|Overall Study|Found another PrEP provider|1|||
146504880|NCT03729570|528351189|FG001|Overall Study|Found another PrEP provider|0|||
146504881|NCT03729570|528351188|FG000|Overall Study|Did not enjoy being in the control group|0|||
146504882|NCT03729570|528351189|FG001|Overall Study|Did not enjoy being in the control group|1|||
146504883|NCT01867294|528351192|FG000|Overall Study|Withdrawal by Subject|1|||
146504884|NCT01867294|528351193|FG001|Overall Study|Withdrawal by Subject|1|||
146504885|NCT01867294|528351194|FG002|Overall Study|Withdrawal by Subject|0|||
146504886|NCT01867294|528351195|FG003|Overall Study|Withdrawal by Subject|0|||
146504887|NCT00278148|528351196|FG000|Phase II - Expansion Phase|Disease progression|0|||
146504888|NCT00278148|528351197|FG001|Phase II - Expansion Phase|Disease progression|0|||
146504889|NCT00278148|528351198|FG002|Phase II - Expansion Phase|Disease progression|4|||
146504890|NCT00278148|528351196|FG000|Phase II - Expansion Phase|Adverse Event|0|||
146504891|NCT00278148|528351197|FG001|Phase II - Expansion Phase|Adverse Event|0|||
146504892|NCT00278148|528351198|FG002|Phase II - Expansion Phase|Adverse Event|2|||
146504893|NCT02083185|528351200|FG000|Overall Study|Lost to Follow-up|0|||
146504894|NCT02083185|528351201|FG001|Overall Study|Lost to Follow-up|3|||
146504895|NCT02083185|528351202|FG002|Overall Study|Lost to Follow-up|0|||
146504896|NCT02083185|528351200|FG000|Overall Study|Withdrawal by Subject|9|||
146504897|NCT02083185|528351201|FG001|Overall Study|Withdrawal by Subject|15|||
146504898|NCT02083185|528351202|FG002|Overall Study|Withdrawal by Subject|1|||
146504899|NCT02083185|528351200|FG000|Overall Study|Death|2|||
146504900|NCT02083185|528351201|FG001|Overall Study|Death|2|||
146648718|NCT01073462|528890829|FG000|Overall Study|Serious adverse event|2|||
146648719|NCT01073462|528890829|FG000|Overall Study|Lost to Follow-up|7|||
146648720|NCT03554486|528890830|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
146648721|NCT03554486|528890831|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
146648722|NCT03554486|528890832|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
146648723|NCT03554486|528890830|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
146648724|NCT03554486|528890831|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
146648725|NCT03554486|528890832|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
146769451|NCT00630786|529323557|FG000|Overall Study|Physician Decision|0|||
146769452|NCT00630786|529323558|FG001|Overall Study|Physician Decision|0|||
146769453|NCT00630786|529323559|FG002|Overall Study|Physician Decision|1|||
146504901|NCT02083185|528351202|FG002|Overall Study|Death|1|||
146504902|NCT02083185|528351200|FG000|Overall Study|Reason not Specified|9|||
146504903|NCT02083185|528351201|FG001|Overall Study|Reason not Specified|6|||
146504904|NCT02083185|528351202|FG002|Overall Study|Reason not Specified|5|||
146504905|NCT02083185|528351200|FG000|Overall Study|Study Terminated by Sponsor|0|||
146504906|NCT02083185|528351201|FG001|Overall Study|Study Terminated by Sponsor|1|||
146504907|NCT02083185|528351202|FG002|Overall Study|Study Terminated by Sponsor|0|||
146504908|NCT02083185|528351200|FG000|Overall Study|Did not Receive Study Drug|0|||
146504909|NCT02083185|528351201|FG001|Overall Study|Did not Receive Study Drug|2|||
146504910|NCT02083185|528351202|FG002|Overall Study|Did not Receive Study Drug|0|||
146504911|NCT03419598|528351203|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
146504912|NCT00070018|528351204|FG000|Overall Study|Adverse Event|2|||
146504913|NCT00070018|528351204|FG000|Overall Study|Lack of Efficacy|1|||
146504914|NCT00070018|528351204|FG000|Overall Study|Withdrawal by Subject|1|||
146504915|NCT00985959|528351205|FG000|Overall Study|Adverse Event|0|||
146504916|NCT00985959|528351206|FG001|Overall Study|Adverse Event|0|||
146504917|NCT00985959|528351207|FG002|Overall Study|Adverse Event|19|||
146648726|NCT03554486|528890830|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
146648727|NCT03554486|528890831|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
146769454|NCT00630786|529323557|FG000|Overall Study|Withdrawal by Subject|0|||
146648728|NCT03554486|528890832|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
146648729|NCT02509117|528890836|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146648730|NCT02509117|528890837|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
146648731|NCT02509117|528890838|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146648732|NCT02509117|528890839|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146648733|NCT02509117|528890840|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146648734|NCT02509117|528890841|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146504918|NCT00985959|528351205|FG000|Overall Study|Withdrawal by Subject|0|||
146504919|NCT00985959|528351206|FG001|Overall Study|Withdrawal by Subject|0|||
146504920|NCT00985959|528351207|FG002|Overall Study|Withdrawal by Subject|8|||
146504921|NCT00985959|528351205|FG000|Overall Study|Progressive disease|1|||
146504922|NCT00985959|528351206|FG001|Overall Study|Progressive disease|2|||
146504923|NCT00985959|528351207|FG002|Overall Study|Progressive disease|8|||
146504924|NCT00985959|528351205|FG000|Overall Study|Unrecovered toxicity|0|||
146504925|NCT00985959|528351206|FG001|Overall Study|Unrecovered toxicity|0|||
146504926|NCT00985959|528351207|FG002|Overall Study|Unrecovered toxicity|7|||
146504927|NCT00985959|528351205|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
146504928|NCT00985959|528351206|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
146504929|NCT00985959|528351207|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
146504930|NCT00985959|528351205|FG000|Overall Study|Complete response observed over 2 cycles|0|||
146504931|NCT00985959|528351206|FG001|Overall Study|Complete response observed over 2 cycles|1|||
146504932|NCT00985959|528351207|FG002|Overall Study|Complete response observed over 2 cycles|4|||
146504933|NCT00985959|528351205|FG000|Overall Study|Other|0|||
146504934|NCT00985959|528351206|FG001|Overall Study|Other|0|||
146504935|NCT00985959|528351207|FG002|Overall Study|Other|11|||
146504936|NCT03197870|528351212|FG000|Overall Study|Adverse Event|9|||
146504937|NCT03197870|528351213|FG001|Overall Study|Adverse Event|4|||
146504938|NCT03197870|528351214|FG002|Overall Study|Adverse Event|6|||
146504939|NCT03197870|528351212|FG000|Overall Study|Withdrawal by Subject|2|||
146504940|NCT03197870|528351213|FG001|Overall Study|Withdrawal by Subject|3|||
146504941|NCT03197870|528351214|FG002|Overall Study|Withdrawal by Subject|0|||
146504942|NCT03197870|528351212|FG000|Overall Study|Lost to Follow-up|2|||
146504943|NCT03197870|528351213|FG001|Overall Study|Lost to Follow-up|2|||
146504944|NCT03197870|528351214|FG002|Overall Study|Lost to Follow-up|0|||
146504945|NCT03197870|528351212|FG000|Overall Study|data not available|1|||
146504946|NCT03197870|528351213|FG001|Overall Study|data not available|1|||
146504947|NCT03197870|528351214|FG002|Overall Study|data not available|0|||
146504948|NCT01508130|528351215|FG000|Overall Study|Adverse Event|81|||
146504949|NCT01508130|528351216|FG001|Overall Study|Adverse Event|28|||
146504950|NCT01508130|528351215|FG000|Overall Study|Death|3|||
146504951|NCT01508130|528351216|FG001|Overall Study|Death|1|||
146504952|NCT01508130|528351215|FG000|Overall Study|Protocol Violation|2|||
146504953|NCT01508130|528351216|FG001|Overall Study|Protocol Violation|0|||
146504954|NCT01508130|528351215|FG000|Overall Study|Lost to Follow-up|25|||
146504955|NCT01508130|528351216|FG001|Overall Study|Lost to Follow-up|2|||
146504956|NCT01508130|528351215|FG000|Overall Study|Withdrawal by Subject|3|||
146504957|NCT01508130|528351216|FG001|Overall Study|Withdrawal by Subject|3|||
146504958|NCT01508130|528351215|FG000|Overall Study|Subject's substantial non-compliance|25|||
146504959|NCT01508130|528351216|FG001|Overall Study|Subject's substantial non-compliance|9|||
146504960|NCT01508130|528351215|FG000|Overall Study|Insufficient therapeutic response|74|||
146504961|NCT01508130|528351216|FG001|Overall Study|Insufficient therapeutic response|23|||
146648735|NCT02509117|528890842|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146648736|NCT02509117|528890843|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146648737|NCT02509117|528890844|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146648738|NCT02509117|528890845|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146504962|NCT01508130|528351215|FG000|Overall Study|Administrative|14|||
146504963|NCT01508130|528351216|FG001|Overall Study|Administrative|3|||
146504964|NCT05036668|528351217|FG000|Overall Study|lost to follow Up|0|||
146504965|NCT05036668|528351218|FG001|Overall Study|lost to follow Up|0|||
146504966|NCT05036668|528351219|FG002|Overall Study|lost to follow Up|1|||
146504967|NCT00471718|528351223|FG000|Overall Study|Adverse Event|3|||
146504968|NCT00471718|528351223|FG000|Overall Study|other complicating disease|1|||
146648739|NCT02509117|528890836|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
146648740|NCT02509117|528890837|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
146648741|NCT02509117|528890838|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
146648742|NCT02509117|528890839|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
146504969|NCT00471718|528351223|FG000|Overall Study|disease progression|22|||
146504970|NCT00471718|528351223|FG000|Overall Study|Withdrawal by Subject|1|||
146504971|NCT01446237|528351224|FG000|Overall Study|Adverse Event|1|||
146504972|NCT01446237|528351224|FG000|Overall Study|Lost to Follow-up|2|||
146504973|NCT01446237|528351224|FG000|Overall Study|Withdrawal by Subject|7|||
146504974|NCT01931956|528351225|FG000|Overall Study|Death|42|||
146504975|NCT01931956|528351226|FG001|Overall Study|Death|7|||
146504976|NCT01931956|528351227|FG002|Overall Study|Death|379|||
146504977|NCT01931956|528351228|FG003|Overall Study|Death|96|||
146504978|NCT01931956|528351225|FG000|Overall Study|Withdrawal by Subject|5|||
146504979|NCT01931956|528351226|FG001|Overall Study|Withdrawal by Subject|0|||
146504980|NCT01931956|528351227|FG002|Overall Study|Withdrawal by Subject|70|||
146504981|NCT01931956|528351228|FG003|Overall Study|Withdrawal by Subject|30|||
146504982|NCT01931956|528351225|FG000|Overall Study|Lost to Follow-up|2|||
146504983|NCT01931956|528351226|FG001|Overall Study|Lost to Follow-up|0|||
146504984|NCT01931956|528351227|FG002|Overall Study|Lost to Follow-up|11|||
146504985|NCT01931956|528351228|FG003|Overall Study|Lost to Follow-up|7|||
146504986|NCT01931956|528351225|FG000|Overall Study|Expected|2|||
146504987|NCT01931956|528351226|FG001|Overall Study|Expected|0|||
146504988|NCT01931956|528351227|FG002|Overall Study|Expected|6|||
146504989|NCT01931956|528351228|FG003|Overall Study|Expected|0|||
146504990|NCT01931956|528351225|FG000|Overall Study|Not due|0|||
146504991|NCT01931956|528351226|FG001|Overall Study|Not due|0|||
146504992|NCT01931956|528351227|FG002|Overall Study|Not due|21|||
146504993|NCT01931956|528351228|FG003|Overall Study|Not due|0|||
146504994|NCT02847494|528351229|FG000|Overall Study|Lost to Follow-up|8|||
146504995|NCT02847494|528351230|FG001|Overall Study|Lost to Follow-up|5|||
146504996|NCT02841280|528351233|FG000|Overall Study|Adverse Event|2|||
146504997|NCT02841280|528351234|FG001|Overall Study|Adverse Event|1|||
146504998|NCT02841280|528351233|FG000|Overall Study|Death|1|||
146504999|NCT02841280|528351234|FG001|Overall Study|Death|0|||
146505000|NCT02841280|528351233|FG000|Overall Study|Lost to Follow-up|2|||
146505001|NCT02841280|528351234|FG001|Overall Study|Lost to Follow-up|2|||
146505002|NCT02841280|528351233|FG000|Overall Study|Withdrawal by Subject|7|||
146505003|NCT02841280|528351234|FG001|Overall Study|Withdrawal by Subject|3|||
146505004|NCT02841280|528351233|FG000|Overall Study|Stop Point: BP above threshold|2|||
146505005|NCT02841280|528351234|FG001|Overall Study|Stop Point: BP above threshold|0|||
146505006|NCT01340027|528351236|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
146505007|NCT01340027|528351237|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
146505008|NCT01340027|528351238|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
146505009|NCT01340027|528351239|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
146505010|NCT01340027|528351240|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
146505011|NCT01340027|528351241|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
146505012|NCT01340027|528351242|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
146505013|NCT01340027|528351243|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
146505014|NCT01340027|528351244|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
146505015|NCT01340027|528351245|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
146505016|NCT01340027|528351246|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
146505017|NCT01340027|528351247|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
146505018|NCT01340027|528351236|FG000|Overall Study|Adverse Event|0|||
146505019|NCT01340027|528351237|FG001|Overall Study|Adverse Event|1|||
146505020|NCT01340027|528351238|FG002|Overall Study|Adverse Event|2|||
146505021|NCT01340027|528351239|FG003|Overall Study|Adverse Event|0|||
146505022|NCT01340027|528351240|FG004|Overall Study|Adverse Event|1|||
146505023|NCT01340027|528351241|FG005|Overall Study|Adverse Event|2|||
146505024|NCT01340027|528351242|FG006|Overall Study|Adverse Event|2|||
146505025|NCT01340027|528351243|FG007|Overall Study|Adverse Event|1|||
146505026|NCT01340027|528351244|FG008|Overall Study|Adverse Event|4|||
146505027|NCT01340027|528351245|FG009|Overall Study|Adverse Event|1|||
146505028|NCT01340027|528351246|FG010|Overall Study|Adverse Event|1|||
146505029|NCT01340027|528351247|FG011|Overall Study|Adverse Event|3|||
146505030|NCT01340027|528351236|FG000|Overall Study|Lack of Efficacy|0|||
146505031|NCT01340027|528351237|FG001|Overall Study|Lack of Efficacy|0|||
146505032|NCT01340027|528351238|FG002|Overall Study|Lack of Efficacy|0|||
146505033|NCT01340027|528351239|FG003|Overall Study|Lack of Efficacy|0|||
146505034|NCT01340027|528351240|FG004|Overall Study|Lack of Efficacy|0|||
146505035|NCT01340027|528351241|FG005|Overall Study|Lack of Efficacy|0|||
146505036|NCT01340027|528351242|FG006|Overall Study|Lack of Efficacy|1|||
146505037|NCT01340027|528351243|FG007|Overall Study|Lack of Efficacy|1|||
146648743|NCT02509117|528890840|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
146648744|NCT02509117|528890841|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
146648745|NCT02509117|528890842|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
146648746|NCT02509117|528890843|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
146505038|NCT01340027|528351244|FG008|Overall Study|Lack of Efficacy|1|||
146505039|NCT01340027|528351245|FG009|Overall Study|Lack of Efficacy|0|||
146505040|NCT01340027|528351246|FG010|Overall Study|Lack of Efficacy|0|||
146505041|NCT01340027|528351247|FG011|Overall Study|Lack of Efficacy|0|||
146505042|NCT01340027|528351236|FG000|Overall Study|Lost to Follow-up|0|||
146505043|NCT01340027|528351237|FG001|Overall Study|Lost to Follow-up|1|||
146505044|NCT01340027|528351238|FG002|Overall Study|Lost to Follow-up|0|||
146505045|NCT01340027|528351239|FG003|Overall Study|Lost to Follow-up|0|||
146505046|NCT01340027|528351240|FG004|Overall Study|Lost to Follow-up|0|||
146505047|NCT01340027|528351241|FG005|Overall Study|Lost to Follow-up|0|||
146505048|NCT01340027|528351242|FG006|Overall Study|Lost to Follow-up|1|||
146505049|NCT01340027|528351243|FG007|Overall Study|Lost to Follow-up|0|||
146505050|NCT01340027|528351244|FG008|Overall Study|Lost to Follow-up|0|||
146505051|NCT01340027|528351245|FG009|Overall Study|Lost to Follow-up|1|||
146505052|NCT01340027|528351246|FG010|Overall Study|Lost to Follow-up|0|||
146505053|NCT01340027|528351247|FG011|Overall Study|Lost to Follow-up|0|||
146505054|NCT01340027|528351236|FG000|Overall Study|Protocol Violation|1|||
146505055|NCT01340027|528351237|FG001|Overall Study|Protocol Violation|2|||
146505056|NCT01340027|528351238|FG002|Overall Study|Protocol Violation|0|||
146505057|NCT01340027|528351239|FG003|Overall Study|Protocol Violation|0|||
146505058|NCT01340027|528351240|FG004|Overall Study|Protocol Violation|6|||
146505059|NCT01340027|528351241|FG005|Overall Study|Protocol Violation|0|||
146505060|NCT01340027|528351242|FG006|Overall Study|Protocol Violation|0|||
146505061|NCT01340027|528351243|FG007|Overall Study|Protocol Violation|1|||
146505062|NCT01340027|528351244|FG008|Overall Study|Protocol Violation|2|||
146505063|NCT01340027|528351245|FG009|Overall Study|Protocol Violation|2|||
146505064|NCT01340027|528351246|FG010|Overall Study|Protocol Violation|0|||
146505065|NCT01340027|528351247|FG011|Overall Study|Protocol Violation|0|||
146505066|NCT01340027|528351236|FG000|Overall Study|Withdrawal by Subject|4|||
146505067|NCT01340027|528351237|FG001|Overall Study|Withdrawal by Subject|3|||
146505068|NCT01340027|528351238|FG002|Overall Study|Withdrawal by Subject|1|||
146505069|NCT01340027|528351239|FG003|Overall Study|Withdrawal by Subject|3|||
146505070|NCT01340027|528351240|FG004|Overall Study|Withdrawal by Subject|3|||
146505071|NCT01340027|528351241|FG005|Overall Study|Withdrawal by Subject|2|||
146505072|NCT01340027|528351242|FG006|Overall Study|Withdrawal by Subject|3|||
146505073|NCT01340027|528351243|FG007|Overall Study|Withdrawal by Subject|4|||
146505074|NCT01340027|528351244|FG008|Overall Study|Withdrawal by Subject|1|||
146505075|NCT01340027|528351245|FG009|Overall Study|Withdrawal by Subject|2|||
146505076|NCT01340027|528351246|FG010|Overall Study|Withdrawal by Subject|0|||
146505077|NCT01340027|528351247|FG011|Overall Study|Withdrawal by Subject|1|||
146505078|NCT01340027|528351236|FG000|Overall Study|Miscellaneous|0|||
146505079|NCT01340027|528351237|FG001|Overall Study|Miscellaneous|0|||
146505080|NCT01340027|528351238|FG002|Overall Study|Miscellaneous|0|||
146505081|NCT01340027|528351239|FG003|Overall Study|Miscellaneous|1|||
146505082|NCT01340027|528351240|FG004|Overall Study|Miscellaneous|0|||
146505083|NCT01340027|528351241|FG005|Overall Study|Miscellaneous|0|||
146505084|NCT01340027|528351242|FG006|Overall Study|Miscellaneous|0|||
146505085|NCT01340027|528351243|FG007|Overall Study|Miscellaneous|0|||
146505086|NCT01340027|528351244|FG008|Overall Study|Miscellaneous|0|||
146505087|NCT01340027|528351245|FG009|Overall Study|Miscellaneous|0|||
146505088|NCT01340027|528351246|FG010|Overall Study|Miscellaneous|1|||
146505089|NCT01340027|528351247|FG011|Overall Study|Miscellaneous|0|||
146505090|NCT02496091|528351248|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
146505091|NCT03055494|528352817|FG000|Overall Study|Lost to Follow-up|6|||
146505092|NCT03055494|528352818|FG001|Overall Study|Lost to Follow-up|0|||
146505093|NCT03055494|528352817|FG000|Overall Study|Physician Decision|2|||
146505094|NCT03055494|528352818|FG001|Overall Study|Physician Decision|0|||
146505095|NCT03055494|528352817|FG000|Overall Study|Withdrawal by Subject|1|||
146505096|NCT03055494|528352818|FG001|Overall Study|Withdrawal by Subject|0|||
146505097|NCT03055494|528352817|FG000|Overall Study|Adverse Event|0|||
146505098|NCT03055494|528352818|FG001|Overall Study|Adverse Event|1|||
146505099|NCT03055494|528352817|FG000|Overall Study|Non-compliance with study treatment|1|||
146505100|NCT03055494|528352818|FG001|Overall Study|Non-compliance with study treatment|0|||
146505101|NCT03197467|528352821|FG000|Overall Study|Withdrawal by Subject|1|||
146505102|NCT04338269|528352825|FG000|Overall Study|Death|86|||
146567119|NCT04881760|528588041|FG002|Overall Study|Withdrawal by Subject|1|||
146567120|NCT04881760|528588042|FG003|Overall Study|Withdrawal by Subject|4|||
146567121|NCT04881760|528588043|FG004|Overall Study|Withdrawal by Subject|2|||
146567122|NCT04881760|528588044|FG005|Overall Study|Withdrawal by Subject|1|||
146567123|NCT04881760|528588045|FG006|Overall Study|Withdrawal by Subject|2|||
146567124|NCT04881760|528588039|FG000|Overall Study|Randomized but Never Treated|0|||
146567125|NCT04881760|528588040|FG001|Overall Study|Randomized but Never Treated|0|||
146567126|NCT04881760|528588041|FG002|Overall Study|Randomized but Never Treated|0|||
146648747|NCT02509117|528890844|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
146648748|NCT02509117|528890845|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
146505103|NCT04338269|528352826|FG001|Overall Study|Death|89|||
146567127|NCT04881760|528588042|FG003|Overall Study|Randomized but Never Treated|1|||
146567128|NCT04881760|528588043|FG004|Overall Study|Randomized but Never Treated|0|||
146567129|NCT04881760|528588044|FG005|Overall Study|Randomized but Never Treated|0|||
146648749|NCT02509117|528890836|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146505104|NCT04338269|528352825|FG000|Overall Study|Lost to Follow-up|1|||
146505105|NCT04338269|528352826|FG001|Overall Study|Lost to Follow-up|2|||
146505106|NCT04338269|528352825|FG000|Overall Study|Physician Decision|1|||
146769455|NCT00630786|529323558|FG001|Overall Study|Withdrawal by Subject|1|||
146505107|NCT04338269|528352826|FG001|Overall Study|Physician Decision|0|||
146505108|NCT04338269|528352825|FG000|Overall Study|Withdrawal by Subject|14|||
146505109|NCT04338269|528352826|FG001|Overall Study|Withdrawal by Subject|11|||
146505110|NCT03339726|528352827|FG000|Overall Study|Withdrawal by Subject|1|||
146505111|NCT03339726|528352828|FG001|Overall Study|Withdrawal by Subject|0|||
146505112|NCT03339726|528352829|FG002|Overall Study|Withdrawal by Subject|0|||
146505113|NCT03339726|528352827|FG000|Overall Study|Lost to Follow-up|0|||
146505114|NCT03339726|528352828|FG001|Overall Study|Lost to Follow-up|1|||
146505115|NCT03339726|528352829|FG002|Overall Study|Lost to Follow-up|0|||
146505116|NCT03960021|528352835|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
146505117|NCT02203851|528352836|FG000|Overall Study|Lost to Follow-up|4|||
146505118|NCT02203851|528352836|FG000|Overall Study|Withdrawal by Subject|6|||
146505119|NCT02203851|528352836|FG000|Overall Study|Other|1|||
146505120|NCT04161079|528352837|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
146505121|NCT02515994|528352838|FG000|Overall Study|Protocol Violation|3|||
146505122|NCT02515994|528352839|FG001|Overall Study|Protocol Violation|5|||
146505123|NCT02515994|528352838|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
146505124|NCT02515994|528352839|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
146505125|NCT02515994|528352838|FG000|Overall Study|Adverse Event|3|||
146505126|NCT02515994|528352839|FG001|Overall Study|Adverse Event|1|||
146505127|NCT02515994|528352838|FG000|Overall Study|Withdrawal by Subject|2|||
146505128|NCT02515994|528352839|FG001|Overall Study|Withdrawal by Subject|0|||
146505129|NCT04045132|528352840|FG000|Overall Study|Lost to Follow-up|3|||
146505130|NCT04045132|528352841|FG001|Overall Study|Lost to Follow-up|6|||
146505131|NCT02111785|528352844|FG000|Overall Study|Death|0|||
146505132|NCT02111785|528352845|FG001|Overall Study|Death|1|||
146505133|NCT02111785|528352846|FG002|Overall Study|Death|0|||
146505134|NCT02111785|528352847|FG003|Overall Study|Death|0|||
146505135|NCT00759785|528352854|FG000|Overall Study|Participant sample not evaluable|11|||
146505136|NCT00759785|528352855|FG001|Overall Study|Participant sample not evaluable|2|||
146505137|NCT00759785|528352854|FG000|Overall Study|Participant sample lost|0|||
146505138|NCT00759785|528352855|FG001|Overall Study|Participant sample lost|1|||
146505139|NCT00759785|528352854|FG000|Overall Study|Protocol Violation|1|||
146505140|NCT00759785|528352855|FG001|Overall Study|Protocol Violation|0|||
146505141|NCT00759785|528352854|FG000|Overall Study|Physician Decision|0|||
146505142|NCT00759785|528352855|FG001|Overall Study|Physician Decision|1|||
146505143|NCT00759785|528352854|FG000|Overall Study|Withdrawal by Subject|0|||
146505144|NCT00759785|528352855|FG001|Overall Study|Withdrawal by Subject|1|||
146505145|NCT04521621|528352859|FG000|Overall Study|Death|17|||
146505146|NCT04521621|528352860|FG001|Overall Study|Death|8|||
146505147|NCT04521621|528352861|FG002|Overall Study|Death|8|||
146505148|NCT04521621|528352862|FG003|Overall Study|Death|5|||
146505149|NCT04521621|528352863|FG004|Overall Study|Death|2|||
146505150|NCT04521621|528352864|FG005|Overall Study|Death|7|||
146505151|NCT04521621|528352865|FG006|Overall Study|Death|0|||
146505152|NCT04521621|528352866|FG007|Overall Study|Death|0|||
146505153|NCT04521621|528352859|FG000|Overall Study|Study Terminated by Sponsor|4|||
146505154|NCT04521621|528352860|FG001|Overall Study|Study Terminated by Sponsor|6|||
146505155|NCT04521621|528352861|FG002|Overall Study|Study Terminated by Sponsor|8|||
146505156|NCT04521621|528352862|FG003|Overall Study|Study Terminated by Sponsor|0|||
146505157|NCT04521621|528352863|FG004|Overall Study|Study Terminated by Sponsor|1|||
146505158|NCT04521621|528352864|FG005|Overall Study|Study Terminated by Sponsor|7|||
146505159|NCT04521621|528352865|FG006|Overall Study|Study Terminated by Sponsor|0|||
146505160|NCT04521621|528352866|FG007|Overall Study|Study Terminated by Sponsor|0|||
146505161|NCT04521621|528352859|FG000|Overall Study|Withdrawal by Subject|0|||
146505162|NCT04521621|528352860|FG001|Overall Study|Withdrawal by Subject|0|||
146505163|NCT04521621|528352861|FG002|Overall Study|Withdrawal by Subject|1|||
146505164|NCT04521621|528352862|FG003|Overall Study|Withdrawal by Subject|1|||
146505165|NCT04521621|528352863|FG004|Overall Study|Withdrawal by Subject|0|||
146505166|NCT04521621|528352864|FG005|Overall Study|Withdrawal by Subject|0|||
146505167|NCT04521621|528352865|FG006|Overall Study|Withdrawal by Subject|0|||
146505168|NCT04521621|528352866|FG007|Overall Study|Withdrawal by Subject|0|||
146505169|NCT04521621|528352859|FG000|Overall Study|Allocated in error without study intervention|1|||
146505170|NCT04521621|528352860|FG001|Overall Study|Allocated in error without study intervention|0|||
146505171|NCT04521621|528352861|FG002|Overall Study|Allocated in error without study intervention|0|||
146505172|NCT04521621|528352862|FG003|Overall Study|Allocated in error without study intervention|0|||
146505173|NCT04521621|528352863|FG004|Overall Study|Allocated in error without study intervention|0|||
146505174|NCT04521621|528352864|FG005|Overall Study|Allocated in error without study intervention|0|||
146505175|NCT04521621|528352865|FG006|Overall Study|Allocated in error without study intervention|0|||
146505176|NCT04521621|528352866|FG007|Overall Study|Allocated in error without study intervention|0|||
146505177|NCT03671564|528352867|FG000|Overall Study|Progressive Disease|3|||
146505178|NCT03671564|528352868|FG001|Overall Study|Progressive Disease|5|||
146505179|NCT03671564|528352869|FG002|Overall Study|Progressive Disease|3|||
146567130|NCT04881760|528588045|FG006|Overall Study|Randomized but Never Treated|0|||
146567131|NCT04881760|528588039|FG000|Overall Study|Inadvertent Enrollment|2|||
146567132|NCT04881760|528588040|FG001|Overall Study|Inadvertent Enrollment|0|||
146505180|NCT03671564|528352867|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
146505181|NCT03671564|528352868|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
146567133|NCT04881760|528588041|FG002|Overall Study|Inadvertent Enrollment|0|||
146567134|NCT04881760|528588042|FG003|Overall Study|Inadvertent Enrollment|0|||
146505182|NCT03671564|528352869|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
146505183|NCT03671564|528352867|FG000|Overall Study|Withdrawal by Subject|1|||
146505184|NCT03671564|528352868|FG001|Overall Study|Withdrawal by Subject|1|||
146505185|NCT03671564|528352869|FG002|Overall Study|Withdrawal by Subject|0|||
146505186|NCT01968707|528352875|FG000|Overall Study|Did not meet treatment day baseline|49|||
146505187|NCT01968707|528352876|FG001|Overall Study|Did not meet treatment day baseline|12|||
146505188|NCT01968707|528352877|FG002|Overall Study|Did not meet treatment day baseline|41|||
146505189|NCT01968707|528352878|FG003|Overall Study|Did not meet treatment day baseline|44|||
146505190|NCT01968707|528352879|FG004|Overall Study|Did not meet treatment day baseline|36|||
146505191|NCT01968707|528352880|FG005|Overall Study|Did not meet treatment day baseline|11|||
146505192|NCT01968707|528352881|FG006|Overall Study|Did not meet treatment day baseline|34|||
146505193|NCT01968707|528352882|FG007|Overall Study|Did not meet treatment day baseline|35|||
146505194|NCT01740128|528352887|FG000|Overall Study|Pregnancy|0|||
146505195|NCT01740128|528352888|FG001|Overall Study|Pregnancy|1|||
146505196|NCT01740128|528352887|FG000|Overall Study|Protocol Violation|1|||
146505197|NCT01740128|528352888|FG001|Overall Study|Protocol Violation|2|||
146505198|NCT01740128|528352887|FG000|Overall Study|Lost to Follow-up|2|||
146505199|NCT01740128|528352888|FG001|Overall Study|Lost to Follow-up|2|||
146505200|NCT01740128|528352887|FG000|Overall Study|Withdrawal by Subject|1|||
146505201|NCT01740128|528352888|FG001|Overall Study|Withdrawal by Subject|0|||
146505202|NCT01740128|528352887|FG000|Overall Study|Insufficient protocol compliance|2|||
146505203|NCT01740128|528352888|FG001|Overall Study|Insufficient protocol compliance|2|||
146505204|NCT02474589|528352889|FG000|Overall Study|Adverse Event|6|||
146505205|NCT02474589|528352890|FG001|Overall Study|Adverse Event|2|||
146505206|NCT02474589|528352889|FG000|Overall Study|Lost to Follow-up|6|||
146505207|NCT02474589|528352890|FG001|Overall Study|Lost to Follow-up|1|||
146505208|NCT02474589|528352889|FG000|Overall Study|Protocol Violation|4|||
146505209|NCT02474589|528352890|FG001|Overall Study|Protocol Violation|1|||
146505210|NCT02474589|528352889|FG000|Overall Study|Withdrawal by Subject|4|||
146505211|NCT02474589|528352890|FG001|Overall Study|Withdrawal by Subject|0|||
146505212|NCT02474589|528352889|FG000|Overall Study|Inability to complete study procedures|5|||
146505213|NCT02474589|528352890|FG001|Overall Study|Inability to complete study procedures|1|||
146505214|NCT00380081|528352893|FG000|Overall Study|Withdrawal by Subject|0|||
146505215|NCT00380081|528352894|FG001|Overall Study|Withdrawal by Subject|0|||
146505216|NCT00380081|528352895|FG002|Overall Study|Withdrawal by Subject|0|||
146505217|NCT00380081|528352896|FG003|Overall Study|Withdrawal by Subject|0|||
146505218|NCT00380081|528352897|FG004|Overall Study|Withdrawal by Subject|1|||
146505219|NCT00380081|528352898|FG005|Overall Study|Withdrawal by Subject|0|||
146505220|NCT00380081|528352893|FG000|Overall Study|Family Emergency|0|||
146505221|NCT00380081|528352894|FG001|Overall Study|Family Emergency|0|||
146505222|NCT00380081|528352895|FG002|Overall Study|Family Emergency|0|||
146505223|NCT00380081|528352896|FG003|Overall Study|Family Emergency|0|||
146505224|NCT00380081|528352897|FG004|Overall Study|Family Emergency|0|||
146505225|NCT00380081|528352898|FG005|Overall Study|Family Emergency|1|||
146505226|NCT02658734|528352899|FG000|Overall Study|Adverse Event|2|||
146505227|NCT02658734|528352899|FG000|Overall Study|Death|4|||
146505228|NCT02658734|528352899|FG000|Overall Study|Lost to Follow-up|7|||
146505229|NCT02658734|528352899|FG000|Overall Study|Withdrawal of Consent|16|||
146505230|NCT02658734|528352899|FG000|Overall Study|Disease Progression|28|||
146505231|NCT02231879|528352900|FG000|Overall Study|Adverse Event|2|||
146505232|NCT02231879|528352901|FG001|Overall Study|Adverse Event|1|||
146505233|NCT02231879|528352900|FG000|Overall Study|Lack of Efficacy|0|||
146505234|NCT02231879|528352901|FG001|Overall Study|Lack of Efficacy|1|||
146505235|NCT00189306|528352902|FG000|Treatment Period|Withdrawal by Subject|2|||
146505236|NCT00189306|528352902|FG000|Treatment Period|Adverse Event|2|||
146505237|NCT00189306|528352902|FG000|Treatment Period|Protocol Violation|1|||
146567135|NCT04881760|528588043|FG004|Overall Study|Inadvertent Enrollment|0|||
146567136|NCT04881760|528588044|FG005|Overall Study|Inadvertent Enrollment|0|||
146567137|NCT04881760|528588045|FG006|Overall Study|Inadvertent Enrollment|0|||
146567138|NCT04881760|528588039|FG000|Overall Study|Site Closure|0|||
146567139|NCT04881760|528588040|FG001|Overall Study|Site Closure|0|||
146567140|NCT04881760|528588041|FG002|Overall Study|Site Closure|0|||
146567141|NCT04881760|528588042|FG003|Overall Study|Site Closure|1|||
146567142|NCT04881760|528588043|FG004|Overall Study|Site Closure|0|||
146567143|NCT04881760|528588044|FG005|Overall Study|Site Closure|0|||
146912868|NCT01845077|529843211|FG005|Washout Period|Lost to Follow-up|1|||
146505238|NCT00189306|528352902|FG000|Posttreatment Period|Death|1|||
146505239|NCT00189306|528352902|FG000|Posttreatment Period|Withdrawal by Subject|2|||
146505240|NCT00189306|528352902|FG000|Posttreatment Period|Noncompliance|1|||
146505241|NCT00189306|528352902|FG000|Posttreatment Period|Target lesion excised|1|||
146505242|NCT00189306|528352902|FG000|Posttreatment Period|Protocol Violation|1|||
146505243|NCT00189306|528352902|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
146505244|NCT00189306|528352902|FG000|Posttreatment Period|Local skin reaction/sign|1|||
146505245|NCT00189306|528352902|FG000|Long-Term Follow-up|Adverse Event|2|||
146567144|NCT04881760|528588045|FG006|Overall Study|Site Closure|0|||
146505246|NCT00189306|528352902|FG000|Long-Term Follow-up|Death|4|||
146505247|NCT00189306|528352902|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
146505248|NCT00189306|528352902|FG000|Long-Term Follow-up|Intercurrent disease|2|||
146505249|NCT00189306|528352902|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
146505250|NCT00189306|528352902|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
146505251|NCT00459706|528352903|FG000|Overall Study|Adverse Event|19|||
146505252|NCT00459706|528352904|FG001|Overall Study|Adverse Event|13|||
146505253|NCT00459706|528352903|FG000|Overall Study|Withdrawal by Subject|1|||
146505254|NCT00459706|528352904|FG001|Overall Study|Withdrawal by Subject|6|||
146505255|NCT00459706|528352903|FG000|Overall Study|Physician Decision|2|||
146505256|NCT00459706|528352904|FG001|Overall Study|Physician Decision|0|||
146505257|NCT00459706|528352903|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
146505258|NCT00459706|528352904|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
146505259|NCT00459706|528352903|FG000|Overall Study|Protocol Violation|2|||
146505260|NCT00459706|528352904|FG001|Overall Study|Protocol Violation|1|||
146505261|NCT00459706|528352903|FG000|Overall Study|Failed to Return|1|||
146505262|NCT00459706|528352904|FG001|Overall Study|Failed to Return|0|||
146505263|NCT00459706|528352903|FG000|Overall Study|Other|0|||
146505264|NCT00459706|528352904|FG001|Overall Study|Other|1|||
146505265|NCT03640481|528352905|FG000|Overall Study|Death|14|||
146505266|NCT03640481|528352906|FG001|Overall Study|Death|14|||
146505267|NCT03640481|528352907|FG002|Overall Study|Death|0|||
146505268|NCT03640481|528352908|FG003|Overall Study|Death|0|||
146505269|NCT03640481|528352905|FG000|Overall Study|Lost to Follow-up|2|||
146505270|NCT03640481|528352906|FG001|Overall Study|Lost to Follow-up|0|||
146505271|NCT03640481|528352907|FG002|Overall Study|Lost to Follow-up|0|||
146505272|NCT03640481|528352908|FG003|Overall Study|Lost to Follow-up|0|||
146505273|NCT03640481|528352905|FG000|Overall Study|Site terminated by sponsor|1|||
146505274|NCT03640481|528352906|FG001|Overall Study|Site terminated by sponsor|3|||
146505275|NCT03640481|528352907|FG002|Overall Study|Site terminated by sponsor|0|||
146505276|NCT03640481|528352908|FG003|Overall Study|Site terminated by sponsor|0|||
146505277|NCT03640481|528352905|FG000|Overall Study|Study terminated by sponsor|29|||
146505278|NCT03640481|528352906|FG001|Overall Study|Study terminated by sponsor|42|||
146505279|NCT03640481|528352907|FG002|Overall Study|Study terminated by sponsor|1|||
146505280|NCT03640481|528352908|FG003|Overall Study|Study terminated by sponsor|0|||
146505281|NCT03640481|528352905|FG000|Overall Study|Withdrawal by Subject|5|||
146505282|NCT03640481|528352906|FG001|Overall Study|Withdrawal by Subject|4|||
146505283|NCT03640481|528352907|FG002|Overall Study|Withdrawal by Subject|0|||
146505284|NCT03640481|528352908|FG003|Overall Study|Withdrawal by Subject|1|||
146505285|NCT03640481|528352905|FG000|Overall Study|Other|26|||
146505286|NCT03640481|528352906|FG001|Overall Study|Other|12|||
146505287|NCT03640481|528352907|FG002|Overall Study|Other|1|||
146505288|NCT03640481|528352908|FG003|Overall Study|Other|0|||
146505289|NCT03640481|528352905|FG000|Overall Study|Randomized, but not treated|1|||
146505290|NCT03640481|528352906|FG001|Overall Study|Randomized, but not treated|3|||
146505291|NCT03640481|528352907|FG002|Overall Study|Randomized, but not treated|0|||
146505292|NCT03640481|528352908|FG003|Overall Study|Randomized, but not treated|0|||
146505293|NCT01546168|528352911|FG000|Overall Study|Lost to Follow-up|1|||
146505294|NCT01546168|528352912|FG001|Overall Study|Lost to Follow-up|0|||
146505295|NCT01546168|528352911|FG000|Overall Study|Withdrawal by Subject|1|||
146505296|NCT01546168|528352912|FG001|Overall Study|Withdrawal by Subject|0|||
146505297|NCT01546168|528352911|FG000|Overall Study|ineligible after signing consent|2|||
146505298|NCT01546168|528352912|FG001|Overall Study|ineligible after signing consent|0|||
146505299|NCT00423189|528352915|FG000|Overall Study|Death|0|||
146505300|NCT00423189|528352916|FG001|Overall Study|Death|1|||
146505301|NCT00423189|528352917|FG002|Overall Study|Death|0|||
146505302|NCT01258075|528352924|FG000|Overall Study|Adverse Event|8|||
146505303|NCT01258075|528352925|FG001|Overall Study|Adverse Event|3|||
146505304|NCT01258075|528352924|FG000|Overall Study|Lost to Follow-up|11|||
146505305|NCT01258075|528352925|FG001|Overall Study|Lost to Follow-up|6|||
146505306|NCT01258075|528352924|FG000|Overall Study|Withdrawal by Subject|10|||
146505307|NCT01258075|528352925|FG001|Overall Study|Withdrawal by Subject|7|||
146505308|NCT01258075|528352924|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
146505309|NCT01258075|528352925|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
146505310|NCT01258075|528352924|FG000|Overall Study|Other|12|||
146505311|NCT01258075|528352925|FG001|Overall Study|Other|5|||
146505312|NCT02939716|528352926|FG000|Overall Study|scanner failure|0|||
146505313|NCT02939716|528352927|FG001|Overall Study|scanner failure|0|||
146505314|NCT02939716|528352928|FG002|Overall Study|scanner failure|0|||
146505315|NCT02939716|528352929|FG003|Overall Study|scanner failure|1|||
146648750|NCT02509117|528890837|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146505316|NCT02939716|528352930|FG004|Overall Study|scanner failure|1|||
146505317|NCT02939716|528352931|FG005|Overall Study|scanner failure|1|||
146505318|NCT01618019|528352937|FG000|Overall Study|Withdrawal by Subject|14|||
146505319|NCT01618019|528352938|FG001|Overall Study|Withdrawal by Subject|14|||
146505320|NCT01542034|528352939|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
146505321|NCT01542034|528352940|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
146505322|NCT01542034|528352939|FG000|Overall Study|Administrative decision|0|||
146505323|NCT01542034|528352940|FG001|Overall Study|Administrative decision|3|||
146505324|NCT01542034|528352939|FG000|Overall Study|Subject Noncompliance|1|||
146505325|NCT01542034|528352940|FG001|Overall Study|Subject Noncompliance|0|||
146505326|NCT01542034|528352939|FG000|Overall Study|Adverse Event|2|||
146505327|NCT01542034|528352940|FG001|Overall Study|Adverse Event|2|||
146505328|NCT01542034|528352939|FG000|Overall Study|Lost to Follow-up|7|||
146505329|NCT01542034|528352940|FG001|Overall Study|Lost to Follow-up|6|||
146505330|NCT00978250|528352945|FG000|Overall Study|Late determination of ineligibility|0|||
146505331|NCT00978250|528352946|FG001|Overall Study|Late determination of ineligibility|1|||
146505332|NCT00978250|528352947|FG002|Overall Study|Late determination of ineligibility|0|||
146505333|NCT00978250|528352948|FG003|Overall Study|Late determination of ineligibility|1|||
146505334|NCT00387010|528352949|FG000|Dose Titration Period|Adverse Event|12|||
146505335|NCT00387010|528352949|FG000|Dose Titration Period|Lack of Efficacy|5|||
146505336|NCT00387010|528352949|FG000|Dose Titration Period|Withdrawal by Subject|3|||
146505337|NCT00387010|528352949|FG000|Dose Titration Period|Protocol Violation|1|||
146505338|NCT00387010|528352949|FG000|Dose Titration Period|Lost to Follow-up|2|||
146505339|NCT00387010|528352949|FG000|Dose Titration Period|Noncompliance with study medication|8|||
146505340|NCT00387010|528352949|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
146505341|NCT00387010|528352949|FG000|Treatment Period|Adverse Event|4|||
146505342|NCT00387010|528352949|FG000|Treatment Period|Withdrawal by Subject|1|||
146505343|NCT00387010|528352949|FG000|Treatment Period|Noncompliance with study medication|2|||
146505344|NCT00387010|528352949|FG000|Treatment Period|Noncompliance with study procedures|3|||
146505345|NCT00387010|528352949|FG000|Treatment Period|Participant reported study drug stolen|1|||
146505346|NCT00520481|528352950|FG000|Overall Study|Adverse Event|4|||
146505347|NCT00520481|528352951|FG001|Overall Study|Adverse Event|1|||
146505348|NCT00520481|528352950|FG000|Overall Study|Withdrawal by Subject|3|||
146505349|NCT00520481|528352951|FG001|Overall Study|Withdrawal by Subject|0|||
146505350|NCT00381043|528352959|FG000|Overall Study|Lost to Follow-up|8|||
146505351|NCT00381043|528352960|FG001|Overall Study|Lost to Follow-up|6|||
146505352|NCT00381043|528352959|FG000|Overall Study|Withdrawal by Subject|3|||
146505353|NCT00381043|528352960|FG001|Overall Study|Withdrawal by Subject|1|||
146505354|NCT00381043|528352959|FG000|Overall Study|wanted more care|0|||
146505355|NCT00381043|528352960|FG001|Overall Study|wanted more care|1|||
146505356|NCT00381043|528352959|FG000|Overall Study|incarcerated|1|||
146505357|NCT00381043|528352960|FG001|Overall Study|incarcerated|0|||
146505358|NCT02294175|528352961|FG000|Overall Study|Withdrawal by Subject|1|||
146505359|NCT02294175|528352962|FG001|Overall Study|Withdrawal by Subject|2|||
146505360|NCT02294175|528352961|FG000|Overall Study|pt taking excluded medication|3|||
146505361|NCT02294175|528352962|FG001|Overall Study|pt taking excluded medication|1|||
146505362|NCT02294175|528352961|FG000|Overall Study|Protocol Violation|1|||
146505363|NCT02294175|528352962|FG001|Overall Study|Protocol Violation|0|||
146505364|NCT02294175|528352961|FG000|Overall Study|Lost to Follow-up|0|||
146505365|NCT02294175|528352962|FG001|Overall Study|Lost to Follow-up|1|||
146505366|NCT02294175|528352961|FG000|Overall Study|wound healed|0|||
146505367|NCT02294175|528352962|FG001|Overall Study|wound healed|2|||
146505368|NCT01901653|528352963|FG000|Overall Study|Death|2|||
146505369|NCT01901653|528352964|FG001|Overall Study|Death|1|||
146505370|NCT01901653|528352965|FG002|Overall Study|Death|8|||
146505371|NCT01901653|528352966|FG003|Overall Study|Death|3|||
146505372|NCT01901653|528352967|FG004|Overall Study|Death|2|||
146505373|NCT01901653|528352968|FG005|Overall Study|Death|2|||
146505374|NCT01901653|528352969|FG006|Overall Study|Death|6|||
146505375|NCT01901653|528352970|FG007|Overall Study|Death|9|||
146505376|NCT01901653|528352971|FG008|Overall Study|Death|1|||
146505377|NCT01901653|528352972|FG009|Overall Study|Death|16|||
146505378|NCT01901653|528352973|FG010|Overall Study|Death|2|||
146505379|NCT01901653|528352974|FG011|Overall Study|Death|15|||
146505380|NCT01901653|528352975|FG012|Overall Study|Death|4|||
146505381|NCT01901653|528352963|FG000|Overall Study|Lost to Follow-up|1|||
146505382|NCT01901653|528352964|FG001|Overall Study|Lost to Follow-up|0|||
146505383|NCT01901653|528352965|FG002|Overall Study|Lost to Follow-up|2|||
146505384|NCT01901653|528352966|FG003|Overall Study|Lost to Follow-up|0|||
146505385|NCT01901653|528352967|FG004|Overall Study|Lost to Follow-up|0|||
146505386|NCT01901653|528352968|FG005|Overall Study|Lost to Follow-up|1|||
146505387|NCT01901653|528352969|FG006|Overall Study|Lost to Follow-up|0|||
146505388|NCT01901653|528352970|FG007|Overall Study|Lost to Follow-up|1|||
146505389|NCT01901653|528352971|FG008|Overall Study|Lost to Follow-up|0|||
146505390|NCT01901653|528352972|FG009|Overall Study|Lost to Follow-up|0|||
146505391|NCT01901653|528352973|FG010|Overall Study|Lost to Follow-up|0|||
146505392|NCT01901653|528352974|FG011|Overall Study|Lost to Follow-up|0|||
146505393|NCT01901653|528352975|FG012|Overall Study|Lost to Follow-up|0|||
146505394|NCT01901653|528352963|FG000|Overall Study|Withdrawal by Subject|0|||
146568930|NCT00940602|528595502|FG001|Overall Study|Disease progression|2|||
146568931|NCT00940602|528595501|FG000|Overall Study|Death|38|||
146568932|NCT00940602|528595502|FG001|Overall Study|Death|19|||
146568933|NCT00940602|528595501|FG000|Overall Study|Lost to Follow-up|3|||
146568934|NCT00940602|528595502|FG001|Overall Study|Lost to Follow-up|1|||
146568935|NCT00940602|528595501|FG000|Overall Study|Patient withdrew consent|26|||
146568936|NCT00940602|528595502|FG001|Overall Study|Patient withdrew consent|13|||
146568937|NCT00940602|528595501|FG000|Overall Study|Adverse Event|7|||
146505395|NCT01901653|528352964|FG001|Overall Study|Withdrawal by Subject|0|||
146505396|NCT01901653|528352965|FG002|Overall Study|Withdrawal by Subject|0|||
146505397|NCT01901653|528352966|FG003|Overall Study|Withdrawal by Subject|0|||
146505398|NCT01901653|528352967|FG004|Overall Study|Withdrawal by Subject|0|||
146505399|NCT01901653|528352968|FG005|Overall Study|Withdrawal by Subject|0|||
146505400|NCT01901653|528352969|FG006|Overall Study|Withdrawal by Subject|1|||
146505401|NCT01901653|528352970|FG007|Overall Study|Withdrawal by Subject|0|||
146505402|NCT01901653|528352971|FG008|Overall Study|Withdrawal by Subject|0|||
146505403|NCT01901653|528352972|FG009|Overall Study|Withdrawal by Subject|0|||
146505404|NCT01901653|528352973|FG010|Overall Study|Withdrawal by Subject|0|||
146505405|NCT01901653|528352974|FG011|Overall Study|Withdrawal by Subject|0|||
146505406|NCT01901653|528352975|FG012|Overall Study|Withdrawal by Subject|0|||
146505407|NCT01901653|528352963|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
146505408|NCT01901653|528352964|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
146505409|NCT01901653|528352965|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
146505410|NCT01901653|528352966|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
146505411|NCT01901653|528352967|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
146505412|NCT01901653|528352968|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
146505413|NCT01901653|528352969|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
146505414|NCT01901653|528352970|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
146505415|NCT01901653|528352971|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
146505416|NCT01901653|528352972|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
146505417|NCT01901653|528352973|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
146505418|NCT01901653|528352974|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
146505419|NCT01901653|528352975|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
146505420|NCT04553471|528352976|FG000|Overall Study|Did not start treatment on protocol|3|||
146505421|NCT04553471|528352976|FG000|Overall Study|Death|1|||
146505422|NCT00833482|528352977|FG000|Days 11-20|Adverse Event|0|||
146505423|NCT00833482|528352978|FG001|Days 11-20|Adverse Event|2|||
146505424|NCT00833482|528352979|FG002|Days 11-20|Adverse Event|0|||
146505425|NCT00833482|528352980|FG003|Days 11-20|Adverse Event|0|||
146505426|NCT00833482|528352981|FG004|Days 11-20|Adverse Event|0|||
146505427|NCT00833482|528352982|FG005|Days 11-20|Adverse Event|0|||
146505428|NCT00833482|528352977|FG000|Days 11-20|Withdrawal by Subject|0|||
146505429|NCT00833482|528352978|FG001|Days 11-20|Withdrawal by Subject|1|||
146505430|NCT00833482|528352979|FG002|Days 11-20|Withdrawal by Subject|0|||
146505431|NCT00833482|528352980|FG003|Days 11-20|Withdrawal by Subject|0|||
146505432|NCT00833482|528352981|FG004|Days 11-20|Withdrawal by Subject|0|||
146505433|NCT00833482|528352982|FG005|Days 11-20|Withdrawal by Subject|0|||
146505434|NCT00833482|528352977|FG000|Days 21-30|Adverse Event|0|||
146505435|NCT00833482|528352978|FG001|Days 21-30|Adverse Event|0|||
146505436|NCT00833482|528352979|FG002|Days 21-30|Adverse Event|1|||
146505437|NCT00833482|528352980|FG003|Days 21-30|Adverse Event|0|||
146505438|NCT00833482|528352981|FG004|Days 21-30|Adverse Event|0|||
146505439|NCT00833482|528352982|FG005|Days 21-30|Adverse Event|0|||
146505440|NCT00833482|528352977|FG000|Days 21-30|Withdrawal by Subject|0|||
146505441|NCT00833482|528352978|FG001|Days 21-30|Withdrawal by Subject|0|||
146505442|NCT00833482|528352979|FG002|Days 21-30|Withdrawal by Subject|0|||
146505443|NCT00833482|528352980|FG003|Days 21-30|Withdrawal by Subject|0|||
146505444|NCT00833482|528352981|FG004|Days 21-30|Withdrawal by Subject|1|||
146505445|NCT00833482|528352982|FG005|Days 21-30|Withdrawal by Subject|0|||
146505446|NCT01970475|528352984|FG000|Overall Study|Withdrawal by Subject|11|||
146505447|NCT01970475|528352985|FG001|Overall Study|Withdrawal by Subject|6|||
146505448|NCT01970475|528352984|FG000|Overall Study|Adverse Event|7|||
146505449|NCT01970475|528352985|FG001|Overall Study|Adverse Event|3|||
146648751|NCT02509117|528890838|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146505450|NCT01970475|528352984|FG000|Overall Study|Lost to Follow-up|2|||
146505451|NCT01970475|528352985|FG001|Overall Study|Lost to Follow-up|2|||
146505452|NCT01970475|528352984|FG000|Overall Study|Protocol Violation|1|||
146505453|NCT01970475|528352985|FG001|Overall Study|Protocol Violation|0|||
146505454|NCT03666533|528354443|FG000|Overall Study|Lost to Follow-up|2|||
146505455|NCT03666533|528354444|FG001|Overall Study|Lost to Follow-up|2|||
146505456|NCT02017717|528354445|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
146505457|NCT02017717|528354446|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
146505458|NCT02017717|528354447|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
146505459|NCT02017717|528354448|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
146505460|NCT02017717|528354449|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
146505461|NCT02017717|528354450|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
146505462|NCT02017717|528354451|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
146505463|NCT02017717|528354452|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
146505464|NCT02017717|528354453|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
146505465|NCT02017717|528354445|FG000|Before Treatment Period|Participant request to stop therapy|0|||
146505466|NCT02017717|528354446|FG001|Before Treatment Period|Participant request to stop therapy|0|||
146505467|NCT02017717|528354447|FG002|Before Treatment Period|Participant request to stop therapy|0|||
146505468|NCT02017717|528354448|FG003|Before Treatment Period|Participant request to stop therapy|0|||
146505469|NCT02017717|528354449|FG004|Before Treatment Period|Participant request to stop therapy|0|||
146505470|NCT02017717|528354450|FG005|Before Treatment Period|Participant request to stop therapy|0|||
146505471|NCT02017717|528354451|FG006|Before Treatment Period|Participant request to stop therapy|0|||
146505472|NCT02017717|528354452|FG007|Before Treatment Period|Participant request to stop therapy|0|||
146505473|NCT02017717|528354453|FG008|Before Treatment Period|Participant request to stop therapy|5|||
146505474|NCT02017717|528354445|FG000|Before Treatment Period|Participant withdrew consent|0|||
146505475|NCT02017717|528354446|FG001|Before Treatment Period|Participant withdrew consent|0|||
146505476|NCT02017717|528354447|FG002|Before Treatment Period|Participant withdrew consent|0|||
146505477|NCT02017717|528354448|FG003|Before Treatment Period|Participant withdrew consent|0|||
146505478|NCT02017717|528354449|FG004|Before Treatment Period|Participant withdrew consent|0|||
146505479|NCT02017717|528354450|FG005|Before Treatment Period|Participant withdrew consent|0|||
146505480|NCT02017717|528354451|FG006|Before Treatment Period|Participant withdrew consent|2|||
146505481|NCT02017717|528354452|FG007|Before Treatment Period|Participant withdrew consent|0|||
146505482|NCT02017717|528354453|FG008|Before Treatment Period|Participant withdrew consent|11|||
146505483|NCT02017717|528354445|FG000|Before Treatment Period|Lost to Follow-up|0|||
146505484|NCT02017717|528354446|FG001|Before Treatment Period|Lost to Follow-up|0|||
146505485|NCT02017717|528354447|FG002|Before Treatment Period|Lost to Follow-up|0|||
146505486|NCT02017717|528354448|FG003|Before Treatment Period|Lost to Follow-up|0|||
146505487|NCT02017717|528354449|FG004|Before Treatment Period|Lost to Follow-up|0|||
146505488|NCT02017717|528354450|FG005|Before Treatment Period|Lost to Follow-up|0|||
146505489|NCT02017717|528354451|FG006|Before Treatment Period|Lost to Follow-up|0|||
146505490|NCT02017717|528354452|FG007|Before Treatment Period|Lost to Follow-up|0|||
146505491|NCT02017717|528354453|FG008|Before Treatment Period|Lost to Follow-up|1|||
146505492|NCT02017717|528354445|FG000|Before Treatment Period|Participant no longer met criteria|0|||
146505493|NCT02017717|528354446|FG001|Before Treatment Period|Participant no longer met criteria|0|||
146505494|NCT02017717|528354447|FG002|Before Treatment Period|Participant no longer met criteria|0|||
146505495|NCT02017717|528354448|FG003|Before Treatment Period|Participant no longer met criteria|0|||
146505496|NCT02017717|528354449|FG004|Before Treatment Period|Participant no longer met criteria|0|||
146505497|NCT02017717|528354450|FG005|Before Treatment Period|Participant no longer met criteria|1|||
146505498|NCT02017717|528354451|FG006|Before Treatment Period|Participant no longer met criteria|0|||
146505499|NCT02017717|528354452|FG007|Before Treatment Period|Participant no longer met criteria|1|||
146505500|NCT02017717|528354453|FG008|Before Treatment Period|Participant no longer met criteria|2|||
146505501|NCT02017717|528354445|FG000|Before Treatment Period|other reason|0|||
146505502|NCT02017717|528354446|FG001|Before Treatment Period|other reason|0|||
146505503|NCT02017717|528354447|FG002|Before Treatment Period|other reason|0|||
146505504|NCT02017717|528354448|FG003|Before Treatment Period|other reason|0|||
146505505|NCT02017717|528354449|FG004|Before Treatment Period|other reason|0|||
146505506|NCT02017717|528354450|FG005|Before Treatment Period|other reason|0|||
146505507|NCT02017717|528354451|FG006|Before Treatment Period|other reason|0|||
146505508|NCT02017717|528354452|FG007|Before Treatment Period|other reason|0|||
146505509|NCT02017717|528354453|FG008|Before Treatment Period|other reason|1|||
146505510|NCT02017717|528354445|FG000|Treatment Period|Disease progression|7|||
146505511|NCT02017717|528354446|FG001|Treatment Period|Disease progression|9|||
146505512|NCT02017717|528354447|FG002|Treatment Period|Disease progression|12|||
146505513|NCT02017717|528354448|FG003|Treatment Period|Disease progression|20|||
146505514|NCT02017717|528354449|FG004|Treatment Period|Disease progression|26|||
146505515|NCT02017717|528354450|FG005|Treatment Period|Disease progression|16|||
146505516|NCT02017717|528354451|FG006|Treatment Period|Disease progression|22|||
146505517|NCT02017717|528354452|FG007|Treatment Period|Disease progression|165|||
146505518|NCT02017717|528354453|FG008|Treatment Period|Disease progression|135|||
146505519|NCT02017717|528354445|FG000|Treatment Period|Study drug toxicity|3|||
146505520|NCT02017717|528354446|FG001|Treatment Period|Study drug toxicity|0|||
146505521|NCT02017717|528354447|FG002|Treatment Period|Study drug toxicity|1|||
146505522|NCT02017717|528354448|FG003|Treatment Period|Study drug toxicity|4|||
146505523|NCT02017717|528354449|FG004|Treatment Period|Study drug toxicity|4|||
146505524|NCT02017717|528354450|FG005|Treatment Period|Study drug toxicity|5|||
146505525|NCT02017717|528354451|FG006|Treatment Period|Study drug toxicity|3|||
146505526|NCT02017717|528354452|FG007|Treatment Period|Study drug toxicity|7|||
146505527|NCT02017717|528354453|FG008|Treatment Period|Study drug toxicity|11|||
146505528|NCT02017717|528354445|FG000|Treatment Period|Death|0|||
146505529|NCT02017717|528354446|FG001|Treatment Period|Death|0|||
146505530|NCT02017717|528354447|FG002|Treatment Period|Death|1|||
146567145|NCT00636181|528588050|FG000|Overall Study|Withdrawal by Subject|8|||
146505531|NCT02017717|528354448|FG003|Treatment Period|Death|0|||
146505532|NCT02017717|528354449|FG004|Treatment Period|Death|0|||
146505533|NCT02017717|528354450|FG005|Treatment Period|Death|2|||
146505534|NCT02017717|528354451|FG006|Treatment Period|Death|0|||
146567146|NCT00636181|528588051|FG001|Overall Study|Withdrawal by Subject|6|||
146505535|NCT02017717|528354452|FG007|Treatment Period|Death|0|||
146505536|NCT02017717|528354453|FG008|Treatment Period|Death|0|||
146505537|NCT02017717|528354445|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
146505538|NCT02017717|528354446|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
146505539|NCT02017717|528354447|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
146505540|NCT02017717|528354448|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
146505541|NCT02017717|528354449|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
146505542|NCT02017717|528354450|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
146505543|NCT02017717|528354451|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
146505544|NCT02017717|528354452|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
146505545|NCT02017717|528354453|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
146505546|NCT02017717|528354445|FG000|Treatment Period|Participant request to stop therapy|0|||
146505547|NCT02017717|528354446|FG001|Treatment Period|Participant request to stop therapy|0|||
146505548|NCT02017717|528354447|FG002|Treatment Period|Participant request to stop therapy|3|||
146505549|NCT02017717|528354448|FG003|Treatment Period|Participant request to stop therapy|6|||
146505550|NCT02017717|528354449|FG004|Treatment Period|Participant request to stop therapy|0|||
146505551|NCT02017717|528354450|FG005|Treatment Period|Participant request to stop therapy|2|||
146505552|NCT02017717|528354451|FG006|Treatment Period|Participant request to stop therapy|1|||
146505553|NCT02017717|528354452|FG007|Treatment Period|Participant request to stop therapy|4|||
146505554|NCT02017717|528354453|FG008|Treatment Period|Participant request to stop therapy|7|||
146505555|NCT02017717|528354445|FG000|Treatment Period|Participant withdrew consent|0|||
146505556|NCT02017717|528354446|FG001|Treatment Period|Participant withdrew consent|0|||
146505557|NCT02017717|528354447|FG002|Treatment Period|Participant withdrew consent|1|||
146505558|NCT02017717|528354448|FG003|Treatment Period|Participant withdrew consent|0|||
146505559|NCT02017717|528354449|FG004|Treatment Period|Participant withdrew consent|0|||
146505560|NCT02017717|528354450|FG005|Treatment Period|Participant withdrew consent|2|||
146505561|NCT02017717|528354451|FG006|Treatment Period|Participant withdrew consent|0|||
146505562|NCT02017717|528354452|FG007|Treatment Period|Participant withdrew consent|1|||
146505563|NCT02017717|528354453|FG008|Treatment Period|Participant withdrew consent|4|||
146505564|NCT02017717|528354445|FG000|Treatment Period|Participant no longer met criteria|0|||
146505565|NCT02017717|528354446|FG001|Treatment Period|Participant no longer met criteria|0|||
146505566|NCT02017717|528354447|FG002|Treatment Period|Participant no longer met criteria|0|||
146505567|NCT02017717|528354448|FG003|Treatment Period|Participant no longer met criteria|0|||
146505568|NCT02017717|528354449|FG004|Treatment Period|Participant no longer met criteria|0|||
146505569|NCT02017717|528354450|FG005|Treatment Period|Participant no longer met criteria|0|||
146505570|NCT02017717|528354451|FG006|Treatment Period|Participant no longer met criteria|0|||
146505571|NCT02017717|528354452|FG007|Treatment Period|Participant no longer met criteria|0|||
146505572|NCT02017717|528354453|FG008|Treatment Period|Participant no longer met criteria|1|||
146505573|NCT02017717|528354445|FG000|Treatment Period|Other reasons|0|||
146505574|NCT02017717|528354446|FG001|Treatment Period|Other reasons|0|||
146505575|NCT02017717|528354447|FG002|Treatment Period|Other reasons|0|||
146505576|NCT02017717|528354448|FG003|Treatment Period|Other reasons|1|||
146505577|NCT02017717|528354449|FG004|Treatment Period|Other reasons|0|||
146505578|NCT02017717|528354450|FG005|Treatment Period|Other reasons|1|||
146505579|NCT02017717|528354451|FG006|Treatment Period|Other reasons|1|||
146505580|NCT02017717|528354452|FG007|Treatment Period|Other reasons|1|||
146505581|NCT02017717|528354453|FG008|Treatment Period|Other reasons|1|||
146505582|NCT02017717|528354445|FG000|Treatment Period|Maximum clinical benefit|0|||
146567147|NCT00636181|528588052|FG002|Overall Study|Withdrawal by Subject|10|||
146567148|NCT04549454|528588055|FG000|T1 to T2|Lost to Follow-up|22|||
146567149|NCT04549454|528588056|FG001|T1 to T2|Lost to Follow-up|26|||
146567150|NCT04549454|528588055|FG000|T1 to T3|Lost to Follow-up|31|||
146567151|NCT04549454|528588056|FG001|T1 to T3|Lost to Follow-up|36|||
146567152|NCT05076045|528588063|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
146567153|NCT05076045|528588064|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
146567154|NCT01492426|528589719|FG000|Treatment|Death|0|||
146567155|NCT01492426|528589720|FG001|Treatment|Death|1|||
146567156|NCT01492426|528589719|FG000|Treatment|Other|1|||
146567157|NCT01492426|528589720|FG001|Treatment|Other|0|||
146567158|NCT01492426|528589719|FG000|Treatment|Adverse Event|25|||
146567159|NCT01492426|528589720|FG001|Treatment|Adverse Event|25|||
146567160|NCT01492426|528589719|FG000|Treatment|Lack of Efficacy|38|||
146567161|NCT01492426|528589720|FG001|Treatment|Lack of Efficacy|5|||
146567162|NCT01492426|528589719|FG000|Treatment|Participant withdrew consent|1|||
146567163|NCT01492426|528589720|FG001|Treatment|Participant withdrew consent|2|||
146567164|NCT01492426|528589719|FG000|Treatment|Poor compliance/noncompliance|1|||
146567165|NCT01492426|528589720|FG001|Treatment|Poor compliance/noncompliance|0|||
146505583|NCT02017717|528354446|FG001|Treatment Period|Maximum clinical benefit|0|||
146505584|NCT02017717|528354447|FG002|Treatment Period|Maximum clinical benefit|0|||
146505585|NCT02017717|528354448|FG003|Treatment Period|Maximum clinical benefit|0|||
146505586|NCT02017717|528354449|FG004|Treatment Period|Maximum clinical benefit|0|||
146567166|NCT01492426|528589719|FG000|Treatment|Subject requested discontinue study drug|7|||
146567167|NCT01492426|528589720|FG001|Treatment|Subject requested discontinue study drug|3|||
146567168|NCT01492426|528589719|FG000|Treatment|Lost to Follow-up|9|||
146505587|NCT02017717|528354450|FG005|Treatment Period|Maximum clinical benefit|0|||
146505588|NCT02017717|528354451|FG006|Treatment Period|Maximum clinical benefit|0|||
146505589|NCT02017717|528354452|FG007|Treatment Period|Maximum clinical benefit|0|||
146505590|NCT02017717|528354453|FG008|Treatment Period|Maximum clinical benefit|1|||
146505591|NCT02017717|528354445|FG000|Treatment Period|Not reported|0|||
146505592|NCT02017717|528354446|FG001|Treatment Period|Not reported|1|||
146505593|NCT02017717|528354447|FG002|Treatment Period|Not reported|0|||
146505594|NCT02017717|528354448|FG003|Treatment Period|Not reported|0|||
146505595|NCT02017717|528354449|FG004|Treatment Period|Not reported|0|||
146505596|NCT02017717|528354450|FG005|Treatment Period|Not reported|0|||
146505597|NCT02017717|528354451|FG006|Treatment Period|Not reported|0|||
146505598|NCT02017717|528354452|FG007|Treatment Period|Not reported|0|||
146505599|NCT02017717|528354453|FG008|Treatment Period|Not reported|0|||
146505600|NCT04488419|528354454|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
146505601|NCT04488419|528354455|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
146505602|NCT04488419|528354456|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
146505603|NCT04488419|528354454|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
146505604|NCT04488419|528354455|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
146505605|NCT04488419|528354456|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
146505606|NCT04488419|528354454|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
146648752|NCT02509117|528890839|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146648753|NCT02509117|528890840|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146648754|NCT02509117|528890841|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146648755|NCT02509117|528890842|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146648756|NCT02509117|528890843|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146648757|NCT02509117|528890844|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146648758|NCT02509117|528890845|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
146648759|NCT04345367|528890846|FG000|Overall Study|Other|3|||
146648760|NCT04345367|528890847|FG001|Overall Study|Other|4|||
146648761|NCT04345367|528890846|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
146648762|NCT04345367|528890847|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
146648763|NCT04345367|528890846|FG000|Overall Study|Withdrawal by Subject|11|||
146769456|NCT00630786|529323559|FG002|Overall Study|Withdrawal by Subject|1|||
146769457|NCT00630786|529323557|FG000|Overall Study|Lost to Follow-up|0|||
146505607|NCT04488419|528354455|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
146505608|NCT04488419|528354456|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
146505609|NCT04488419|528354454|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
146505610|NCT04488419|528354455|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
146505611|NCT04488419|528354456|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
146505612|NCT04488419|528354454|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
146505613|NCT04488419|528354455|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
146505614|NCT04488419|528354456|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
146505615|NCT04488419|528354454|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
146505616|NCT04488419|528354455|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
146505617|NCT04488419|528354456|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
146505618|NCT04488419|528354454|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
146505619|NCT04488419|528354455|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
146505620|NCT04488419|528354456|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
146505621|NCT04488419|528354454|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
146505622|NCT04488419|528354455|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
146505623|NCT04488419|528354456|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
146505624|NCT04488419|528354454|FG000|Primary Analysis Population|Adverse Event|6|||
146505625|NCT04488419|528354455|FG001|Primary Analysis Population|Adverse Event|9|||
146505626|NCT04488419|528354456|FG002|Primary Analysis Population|Adverse Event|0|||
146505627|NCT04488419|528354454|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
146505628|NCT04488419|528354455|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
146505629|NCT04488419|528354456|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
146505630|NCT04488419|528354454|FG000|Primary Analysis Population|Protocol Violation|1|||
146505631|NCT04488419|528354455|FG001|Primary Analysis Population|Protocol Violation|1|||
146505632|NCT04488419|528354456|FG002|Primary Analysis Population|Protocol Violation|0|||
146505633|NCT04488419|528354454|FG000|Primary Analysis Population|Undetermined|7|||
146505634|NCT04488419|528354455|FG001|Primary Analysis Population|Undetermined|3|||
146505635|NCT04488419|528354456|FG002|Primary Analysis Population|Undetermined|0|||
146505636|NCT04488419|528354454|FG000|Primary Analysis Population|>1 Reason|2|||
146505637|NCT04488419|528354455|FG001|Primary Analysis Population|>1 Reason|4|||
146505638|NCT04488419|528354456|FG002|Primary Analysis Population|>1 Reason|0|||
146505639|NCT01632150|528354459|FG000|Overall Study|Disease progression|27|||
146505640|NCT01632150|528354459|FG000|Overall Study|Study drug toxicity|1|||
146505641|NCT01632150|528354459|FG000|Overall Study|Unrelated adverse event|7|||
146505642|NCT01632150|528354459|FG000|Overall Study|Withdrawal by Subject|2|||
146505643|NCT01632150|528354459|FG000|Overall Study|Patient underwent autologous transplant|1|||
146505644|NCT01632150|528354459|FG000|Overall Study|Moved to compassionate program|2|||
146505645|NCT02879994|528354462|FG000|Overall Study|off treatment early|7|||
146505646|NCT02879994|528354462|FG000|Overall Study|Adverse Event|2|||
146505647|NCT02879994|528354462|FG000|Overall Study|Death|2|||
146505648|NCT02143791|528354463|FG000|Enrolled|Withdrawal by Subject|4|||
146505649|NCT02143791|528354463|FG000|Trial Stimulation|Lack of Efficacy|21|||
146505650|NCT02143791|528354463|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
146505651|NCT02143791|528354463|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
146505652|NCT02143791|528354463|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
146505653|NCT02143791|528354463|FG000|Any Programming (3-6 Months)|Missing Data|1|||
146505654|NCT02143791|528354463|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
146505655|NCT04327661|528354470|FG000|Overall Study|Withdrawal by Subject|1|||
146505656|NCT04327661|528354471|FG001|Overall Study|Withdrawal by Subject|0|||
146505657|NCT04327661|528354472|FG002|Overall Study|Withdrawal by Subject|0|||
146505658|NCT03391232|528354473|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
146505659|NCT03391232|528354474|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
146505660|NCT03391232|528354473|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
146505661|NCT03391232|528354474|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
146505662|NCT02091960|528354475|FG000|Overall Study|Death|7|||
146505663|NCT02091960|528354475|FG000|Overall Study|Withdrawal by Subject|1|||
146505664|NCT02091960|528354475|FG000|Overall Study|Miscellaneous Reasons|37|||
146505665|NCT01995175|528354481|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
146505666|NCT01995175|528354481|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
146505667|NCT01995175|528354481|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
146505668|NCT01995175|528354481|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
146505669|NCT01995175|528354481|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
146505670|NCT01995175|528354481|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
146505671|NCT01995175|528354481|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
146505672|NCT01995175|528354481|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
146505673|NCT01995175|528354481|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
146505674|NCT01877551|528354482|FG000|Overall Study|Physician Decision|0|||
146505675|NCT01877551|528354483|FG001|Overall Study|Physician Decision|1|||
146505676|NCT00984061|528354484|FG000|Clarithromycin Alone|Protocol Violation|1|||
146505677|NCT02691013|528354487|FG000|Overall Study|Withdrawal by Subject|3|||
146505678|NCT02691013|528354488|FG001|Overall Study|Withdrawal by Subject|0|||
146505679|NCT01282164|528354494|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
146505680|NCT01282164|528354495|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
146505681|NCT01185509|528354498|FG000|Overall Study|Progression/Relapse|9|||
146505682|NCT01185509|528354499|FG001|Overall Study|Progression/Relapse|15|||
146505683|NCT01185509|528354498|FG000|Overall Study|Physician Decision|2|||
146505684|NCT01185509|528354499|FG001|Overall Study|Physician Decision|2|||
146505685|NCT01185509|528354498|FG000|Overall Study|Withdrawal by Subject|0|||
146505686|NCT01185509|528354499|FG001|Overall Study|Withdrawal by Subject|1|||
146505687|NCT01185509|528354498|FG000|Overall Study|Death|0|||
146505688|NCT01185509|528354499|FG001|Overall Study|Death|1|||
146505689|NCT01185509|528354498|FG000|Overall Study|Intercurrent Illness|0|||
146505690|NCT01185509|528354499|FG001|Overall Study|Intercurrent Illness|1|||
146505691|NCT00108485|528354507|FG000|Overall Study|Withdrawal by Subject|3|||
146505692|NCT00108485|528354508|FG001|Overall Study|Withdrawal by Subject|0|||
146505693|NCT00108485|528354507|FG000|Overall Study|Lost to Follow-up|0|||
146505694|NCT00108485|528354508|FG001|Overall Study|Lost to Follow-up|2|||
146505695|NCT02062944|528354518|FG000|Overall Study|Lost to Follow-up|1|||
146505696|NCT02062944|528354518|FG000|Overall Study|New hemotological disorder identified|1|||
146505697|NCT02062944|528354518|FG000|Overall Study|Uncontrolled Hypertension|1|||
146505698|NCT02062944|528354518|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
146505699|NCT02122770|528354519|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
146505700|NCT02122770|528354520|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
146505701|NCT02122770|528354521|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
146505702|NCT02122770|528354522|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
146648764|NCT04345367|528890847|FG001|Overall Study|Withdrawal by Subject|11|||
146648765|NCT04345367|528890846|FG000|Overall Study|Protocol Violation|4|||
146648766|NCT04345367|528890847|FG001|Overall Study|Protocol Violation|3|||
146648767|NCT04345367|528890846|FG000|Overall Study|Lost to Follow-up|2|||
146648768|NCT04345367|528890847|FG001|Overall Study|Lost to Follow-up|4|||
146648769|NCT04345367|528890846|FG000|Overall Study|Lack of Efficacy|2|||
146648770|NCT04345367|528890847|FG001|Overall Study|Lack of Efficacy|0|||
146648771|NCT04345367|528890846|FG000|Overall Study|Death|2|||
146648772|NCT04345367|528890847|FG001|Overall Study|Death|0|||
146648773|NCT04345367|528890846|FG000|Overall Study|Adverse Event|10|||
146648774|NCT04345367|528890847|FG001|Overall Study|Adverse Event|9|||
146648775|NCT00781885|528890853|FG000|Overall Study|Physician Decision|1|||
146505703|NCT02122770|528354523|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
146505704|NCT02122770|528354524|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
146505705|NCT02122770|528354519|FG000|Part A: Drug-drug Interaction 2|Other|0|||
146505706|NCT02122770|528354520|FG001|Part A: Drug-drug Interaction 2|Other|0|||
146505707|NCT02122770|528354521|FG002|Part A: Drug-drug Interaction 2|Other|1|||
146505708|NCT02122770|528354522|FG003|Part A: Drug-drug Interaction 2|Other|0|||
146505709|NCT02122770|528354523|FG004|Part A: Drug-drug Interaction 2|Other|0|||
146505710|NCT02122770|528354524|FG005|Part A: Drug-drug Interaction 2|Other|0|||
146505711|NCT02122770|528354519|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
146505712|NCT02122770|528354520|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
146505713|NCT02122770|528354521|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
146505714|NCT02122770|528354522|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
146505715|NCT02122770|528354523|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
146505716|NCT02122770|528354524|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
146505717|NCT02122770|528354519|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
146505718|NCT02122770|528354520|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
146505719|NCT02122770|528354521|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
146505720|NCT02122770|528354522|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
146505721|NCT02122770|528354523|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
146505722|NCT02122770|528354524|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
146505723|NCT02122770|528354519|FG000|Part B: Standard of Care|Adverse Event|0|||
146505724|NCT02122770|528354520|FG001|Part B: Standard of Care|Adverse Event|0|||
146505725|NCT02122770|528354521|FG002|Part B: Standard of Care|Adverse Event|0|||
146505726|NCT02122770|528354522|FG003|Part B: Standard of Care|Adverse Event|0|||
146505727|NCT02122770|528354523|FG004|Part B: Standard of Care|Adverse Event|4|||
146505728|NCT02122770|528354524|FG005|Part B: Standard of Care|Adverse Event|1|||
146505729|NCT02122770|528354519|FG000|Part B: Standard of Care|Other|0|||
146505730|NCT02122770|528354520|FG001|Part B: Standard of Care|Other|0|||
146505731|NCT02122770|528354521|FG002|Part B: Standard of Care|Other|0|||
146505732|NCT02122770|528354522|FG003|Part B: Standard of Care|Other|0|||
146505733|NCT02122770|528354523|FG004|Part B: Standard of Care|Other|0|||
146505734|NCT02122770|528354524|FG005|Part B: Standard of Care|Other|2|||
146505735|NCT02122770|528354519|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
146505736|NCT02122770|528354520|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
146505737|NCT02122770|528354521|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
146505738|NCT02122770|528354522|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
146505739|NCT02122770|528354523|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
146505740|NCT02122770|528354524|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
146505741|NCT02122770|528354519|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
146505742|NCT02122770|528354520|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
146505743|NCT02122770|528354521|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
146505744|NCT02122770|528354522|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
146505745|NCT02122770|528354523|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
146505746|NCT02122770|528354524|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
146505747|NCT02122770|528354519|FG000|Part B: Standard of Care|Progressive Disease|0|||
146505748|NCT02122770|528354520|FG001|Part B: Standard of Care|Progressive Disease|0|||
146505749|NCT02122770|528354521|FG002|Part B: Standard of Care|Progressive Disease|0|||
146505750|NCT02122770|528354522|FG003|Part B: Standard of Care|Progressive Disease|0|||
146505751|NCT02122770|528354523|FG004|Part B: Standard of Care|Progressive Disease|10|||
146505752|NCT02122770|528354524|FG005|Part B: Standard of Care|Progressive Disease|8|||
146505753|NCT02017912|528354525|FG000|Overall Study|Withdrawal by Subject|2|||
146505754|NCT02017912|528354526|FG001|Overall Study|Withdrawal by Subject|1|||
146505755|NCT02017912|528354525|FG000|Overall Study|miscellaneous|1|||
146505756|NCT02017912|528354526|FG001|Overall Study|miscellaneous|1|||
146505757|NCT00535847|528354527|FG000|Overall Study|Adverse Event|5|||
146505758|NCT00535847|528354528|FG001|Overall Study|Adverse Event|3|||
146505759|NCT00535847|528354529|FG002|Overall Study|Adverse Event|2|||
146505760|NCT00535847|528354527|FG000|Overall Study|Non compliance|1|||
146505761|NCT00535847|528354528|FG001|Overall Study|Non compliance|1|||
146505762|NCT00535847|528354529|FG002|Overall Study|Non compliance|0|||
146505763|NCT00535847|528354527|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
146505764|NCT00535847|528354528|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
146505765|NCT00535847|528354529|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
146505766|NCT05007041|528354530|FG000|Overall Study|Missing Diary Entries|0|||
146505767|NCT05007041|528354531|FG001|Overall Study|Missing Diary Entries|1|||
146505768|NCT02850016|528354532|FG000|Overall Study|Withdrawal by Subject|1|||
146505769|NCT02850016|528354533|FG001|Overall Study|Withdrawal by Subject|2|||
146505770|NCT00976209|528354535|FG000|Treatment Period 1|Protocol Violation|1|||
146505771|NCT00976209|528354536|FG001|Treatment Period 1|Protocol Violation|0|||
146505772|NCT00976209|528354535|FG000|Treatment Period 1|Lost to Follow-up|2|||
146505773|NCT00976209|528354536|FG001|Treatment Period 1|Lost to Follow-up|0|||
146505774|NCT00976209|528354535|FG000|Treatment Period 1|Other|0|||
146567169|NCT01492426|528589720|FG001|Treatment|Lost to Follow-up|4|||
146567170|NCT01492426|528589719|FG000|Treatment|Participant does not meet study criteria|1|||
146567171|NCT01492426|528589720|FG001|Treatment|Participant does not meet study criteria|0|||
146769458|NCT00630786|529323558|FG001|Overall Study|Lost to Follow-up|1|||
146769459|NCT00630786|529323559|FG002|Overall Study|Lost to Follow-up|0|||
146769460|NCT00630786|529323557|FG000|Overall Study|Other|1|||
146505775|NCT00976209|528354536|FG001|Treatment Period 1|Other|1|||
146505776|NCT00976209|528354535|FG000|Wash-out Period|Adverse Event|1|||
146567172|NCT01492426|528589719|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
146567173|NCT01492426|528589720|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
146567174|NCT01492426|528589719|FG000|Follow-Up|Death|1|||
146567175|NCT01492426|528589720|FG001|Follow-Up|Death|0|||
146567176|NCT01492426|528589719|FG000|Follow-Up|Other|4|||
146567177|NCT01492426|528589720|FG001|Follow-Up|Other|2|||
146567178|NCT01492426|528589719|FG000|Follow-Up|Participant Withdrew Consent|6|||
146567179|NCT01492426|528589720|FG001|Follow-Up|Participant Withdrew Consent|1|||
146505777|NCT00976209|528354536|FG001|Wash-out Period|Adverse Event|2|||
146505778|NCT00976209|528354535|FG000|Wash-out Period|Lost to Follow-up|1|||
146505779|NCT00976209|528354536|FG001|Wash-out Period|Lost to Follow-up|0|||
146505780|NCT00976209|528354535|FG000|Wash-out Period|Protocol Violation|1|||
146505781|NCT00976209|528354536|FG001|Wash-out Period|Protocol Violation|0|||
146505782|NCT00976209|528354535|FG000|Wash-out Period|Other|1|||
146505783|NCT00976209|528354536|FG001|Wash-out Period|Other|0|||
146505784|NCT00976209|528354535|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146505785|NCT00976209|528354536|FG001|Treatment Period 2|Withdrawal by Subject|1|||
146505786|NCT00976209|528354535|FG000|Treatment Period 2|Lost to Follow-up|0|||
146505787|NCT00976209|528354536|FG001|Treatment Period 2|Lost to Follow-up|1|||
146567180|NCT01492426|528589719|FG000|Follow-Up|Lost to Follow-up|12|||
146567181|NCT01492426|528589720|FG001|Follow-Up|Lost to Follow-up|6|||
146567182|NCT03549338|528589721|FG000|Overall Study|Progressive Disease|1|||
146567183|NCT03549338|528589722|FG001|Overall Study|Progressive Disease|0|||
146567184|NCT03549338|528589723|FG002|Overall Study|Progressive Disease|0|||
146567185|NCT03549338|528589721|FG000|Overall Study|Clinical Progression|0|||
146567186|NCT03549338|528589722|FG001|Overall Study|Clinical Progression|1|||
146567187|NCT03549338|528589723|FG002|Overall Study|Clinical Progression|0|||
146567188|NCT01173679|528589724|FG000|Overall Study|Death|1|||
146567189|NCT02026011|528589725|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
146567190|NCT02026011|528589726|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
146567191|NCT02026011|528589725|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
146567192|NCT02026011|528589726|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
146567193|NCT02026011|528589725|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
146567194|NCT02026011|528589726|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
146567195|NCT02026011|528589725|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
146567196|NCT02026011|528589726|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
146567197|NCT00939107|528589727|FG000|Overall Study|Lost to Follow-up|14|||
146567198|NCT00939107|528589728|FG001|Overall Study|Lost to Follow-up|12|||
146567199|NCT05010070|528589729|FG000|Overall Study|Lost to Follow-up|1|||
146567200|NCT05010070|528589729|FG000|Overall Study|Withdrawal by Subject|1|||
146567201|NCT00529243|528589730|FG000|Overall Study|Adverse Event|1|||
146567202|NCT00529243|528589730|FG000|Overall Study|Death|1|||
146567203|NCT00529243|528589730|FG000|Overall Study|Relocated|1|||
146567204|NCT00639457|528589731|FG000|Overall Study|Withdrawal by Subject|2|||
146567205|NCT00639457|528589732|FG001|Overall Study|Withdrawal by Subject|3|||
146567206|NCT03235050|528589733|FG000|Overall Study|Adverse Event|0|||
146567207|NCT03235050|528589734|FG001|Overall Study|Adverse Event|0|||
146567208|NCT03235050|528589735|FG002|Overall Study|Adverse Event|1|||
146567209|NCT03235050|528589736|FG003|Overall Study|Adverse Event|4|||
146567210|NCT03235050|528589737|FG004|Overall Study|Adverse Event|1|||
146567211|NCT03235050|528589733|FG000|Overall Study|Death|0|||
146567212|NCT03235050|528589734|FG001|Overall Study|Death|0|||
146567213|NCT03235050|528589735|FG002|Overall Study|Death|0|||
146567214|NCT03235050|528589736|FG003|Overall Study|Death|2|||
146567215|NCT03235050|528589737|FG004|Overall Study|Death|1|||
146567216|NCT03235050|528589733|FG000|Overall Study|Lost to Follow-up|1|||
146567217|NCT03235050|528589734|FG001|Overall Study|Lost to Follow-up|2|||
146567218|NCT03235050|528589735|FG002|Overall Study|Lost to Follow-up|1|||
146567219|NCT03235050|528589736|FG003|Overall Study|Lost to Follow-up|2|||
146567220|NCT03235050|528589737|FG004|Overall Study|Lost to Follow-up|0|||
146567221|NCT03235050|528589733|FG000|Overall Study|Withdrawal by Subject|3|||
146567222|NCT03235050|528589734|FG001|Overall Study|Withdrawal by Subject|2|||
146567223|NCT03235050|528589735|FG002|Overall Study|Withdrawal by Subject|2|||
146567224|NCT03235050|528589736|FG003|Overall Study|Withdrawal by Subject|5|||
146567225|NCT03235050|528589737|FG004|Overall Study|Withdrawal by Subject|7|||
146567226|NCT03235050|528589733|FG000|Overall Study|Other reasons|0|||
146567227|NCT03235050|528589734|FG001|Overall Study|Other reasons|1|||
146505788|NCT01252563|528354537|FG000|Overall Study|Contract Deviation|41|||
146505789|NCT01252563|528354537|FG000|Overall Study|Centralized Registration Deviation|30|||
146505790|NCT01252563|528354537|FG000|Overall Study|Lost to Follow-up|161|||
146567228|NCT03235050|528589735|FG002|Overall Study|Other reasons|0|||
146567229|NCT03235050|528589736|FG003|Overall Study|Other reasons|1|||
146769461|NCT00630786|529323558|FG001|Overall Study|Other|0|||
146769462|NCT00630786|529323559|FG002|Overall Study|Other|0|||
146769463|NCT01286272|529324830|FG000|Overall Study|Ineligible after beginning treatment|1|||
146769464|NCT01286272|529324831|FG001|Overall Study|Ineligible after beginning treatment|3|||
146769465|NCT04001829|529324832|FG000|Overall Study|Never start protocol therapy|5|||
146769466|NCT04001829|529324833|FG001|Overall Study|Never start protocol therapy|5|||
146769467|NCT04001829|529324832|FG000|Overall Study|Adverse Event|11|||
146769468|NCT04001829|529324833|FG001|Overall Study|Adverse Event|7|||
146769469|NCT04001829|529324832|FG000|Overall Study|Alternative therapy|1|||
146769470|NCT04001829|529324833|FG001|Overall Study|Alternative therapy|2|||
146769471|NCT04001829|529324832|FG000|Overall Study|Disease progression/relapse|2|||
146769472|NCT04001829|529324833|FG001|Overall Study|Disease progression/relapse|1|||
146769473|NCT04001829|529324832|FG000|Overall Study|Other complicating disease|1|||
146769474|NCT04001829|529324833|FG001|Overall Study|Other complicating disease|0|||
146769475|NCT04001829|529324832|FG000|Overall Study|Withdrawal by Subject|1|||
146769476|NCT04001829|529324833|FG001|Overall Study|Withdrawal by Subject|4|||
146769477|NCT04001829|529324832|FG000|Overall Study|Ineligible|2|||
146769478|NCT04001829|529324833|FG001|Overall Study|Ineligible|2|||
146769479|NCT04001829|529324832|FG000|Overall Study|Reason missing due to delinquent data|1|||
146769480|NCT04001829|529324833|FG001|Overall Study|Reason missing due to delinquent data|0|||
146769481|NCT05011396|529324834|FG000|Overall Study|Lost to Follow-up|3|||
146769482|NCT05011396|529324835|FG001|Overall Study|Lost to Follow-up|1|||
146769483|NCT05011396|529324834|FG000|Overall Study|Withdrawal by Subject|0|||
146769484|NCT05011396|529324835|FG001|Overall Study|Withdrawal by Subject|1|||
146769485|NCT05011396|529324834|FG000|Overall Study|Positive Drug Screen|0|||
146769486|NCT05011396|529324835|FG001|Overall Study|Positive Drug Screen|1|||
146769487|NCT03253848|529324836|FG000|Overall Study|Adverse Event|7|||
146769488|NCT03253848|529324836|FG000|Overall Study|Death|5|||
146769489|NCT03253848|529324836|FG000|Overall Study|initiation of other treatments|3|||
146769490|NCT03253848|529324836|FG000|Overall Study|Other complicating disease|1|||
146769491|NCT03253848|529324836|FG000|Overall Study|Withdrawal by Subject|1|||
146769492|NCT03253848|529324836|FG000|Overall Study|Declining health|1|||
146769493|NCT02983617|529324839|FG000|Overall Study|Adverse Event|0|||
146769494|NCT02983617|529324840|FG001|Overall Study|Adverse Event|7|||
146769495|NCT02983617|529324839|FG000|Overall Study|Death|0|||
146769496|NCT02983617|529324840|FG001|Overall Study|Death|1|||
146769497|NCT02983617|529324839|FG000|Overall Study|Investigator's Discretion|0|||
146769498|NCT02983617|529324840|FG001|Overall Study|Investigator's Discretion|1|||
146769499|NCT00711958|529324843|FG000|Overall Study|Withdrawal by Subject|6|||
146769500|NCT00711958|529324844|FG001|Overall Study|Withdrawal by Subject|8|||
146769501|NCT00711958|529324843|FG000|Overall Study|Lack of Efficacy|3|||
146769502|NCT00711958|529324844|FG001|Overall Study|Lack of Efficacy|1|||
146769503|NCT00711958|529324843|FG000|Overall Study|Clinical deterioration|1|||
146769504|NCT00711958|529324844|FG001|Overall Study|Clinical deterioration|0|||
146769505|NCT00711958|529324843|FG000|Overall Study|Adverse Event|9|||
146769506|NCT00711958|529324844|FG001|Overall Study|Adverse Event|7|||
146769507|NCT00711958|529324843|FG000|Overall Study|Protocol Violation|1|||
146769508|NCT00711958|529324844|FG001|Overall Study|Protocol Violation|0|||
146769509|NCT00711958|529324843|FG000|Overall Study|Lost to Follow-up|2|||
146769510|NCT00711958|529324844|FG001|Overall Study|Lost to Follow-up|2|||
146769511|NCT00711958|529324843|FG000|Overall Study|Death|10|||
146567230|NCT03235050|528589737|FG004|Overall Study|Other reasons|2|||
146567231|NCT01621178|528589741|FG000|Overall Study|Adverse Event|5|||
146567232|NCT01621178|528589742|FG001|Overall Study|Adverse Event|2|||
146567233|NCT01621178|528589743|FG002|Overall Study|Adverse Event|8|||
146567234|NCT01621178|528589741|FG000|Overall Study|Death|6|||
146567235|NCT01621178|528589742|FG001|Overall Study|Death|7|||
146567236|NCT01621178|528589743|FG002|Overall Study|Death|2|||
146769512|NCT00711958|529324844|FG001|Overall Study|Death|5|||
146769513|NCT00711958|529324843|FG000|Overall Study|Progression of disease|1|||
146769514|NCT00711958|529324844|FG001|Overall Study|Progression of disease|0|||
146769515|NCT02296424|529324848|FG000|Part 1|New therapy for study indication|0|||
146769516|NCT02296424|529324849|FG001|Part 1|New therapy for study indication|1|||
146769517|NCT02296424|529324850|FG002|Part 1|New therapy for study indication|0|||
146567237|NCT01621178|528589741|FG000|Overall Study|Lost to Follow-up|1|||
146567238|NCT01621178|528589742|FG001|Overall Study|Lost to Follow-up|2|||
146769518|NCT02296424|529324851|FG003|Part 1|New therapy for study indication|0|||
146769519|NCT02296424|529324848|FG000|Part 1|Protocol Violation|0|||
146769520|NCT02296424|529324849|FG001|Part 1|Protocol Violation|1|||
146769521|NCT02296424|529324850|FG002|Part 1|Protocol Violation|0|||
146769522|NCT02296424|529324851|FG003|Part 1|Protocol Violation|0|||
146769523|NCT02296424|529324848|FG000|Part 1|Withdrawal by Subject|0|||
146567239|NCT01621178|528589743|FG002|Overall Study|Lost to Follow-up|1|||
146769524|NCT02296424|529324849|FG001|Part 1|Withdrawal by Subject|2|||
146567240|NCT01621178|528589741|FG000|Overall Study|Withdrawal by Subject|14|||
146769525|NCT02296424|529324850|FG002|Part 1|Withdrawal by Subject|0|||
146769526|NCT02296424|529324851|FG003|Part 1|Withdrawal by Subject|0|||
146505791|NCT01252563|528354537|FG000|Overall Study|No visit after first day of treatment|194|||
146505792|NCT01252563|528354537|FG000|Overall Study|No drug administration|6|||
146505793|NCT02951533|528354541|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
146505794|NCT02951533|528354542|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
146505795|NCT02951533|528354543|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
146505796|NCT02951533|528354541|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
146505797|NCT02951533|528354542|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
146505798|NCT02951533|528354543|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
146505799|NCT02951533|528354541|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
146505800|NCT02951533|528354542|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
146505801|NCT02951533|528354543|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
146505802|NCT02951533|528354541|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
146505803|NCT02951533|528354542|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
146505804|NCT02951533|528354543|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
146505805|NCT02951533|528354541|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
146505806|NCT02951533|528354542|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
146505807|NCT02951533|528354543|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
146505808|NCT02951533|528354541|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
146505809|NCT02951533|528354542|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
146505810|NCT02951533|528354543|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
146505811|NCT02951533|528354541|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
146505812|NCT02951533|528354542|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
146505813|NCT02951533|528354543|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
146505814|NCT02951533|528354541|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
146505815|NCT02951533|528354542|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
146505816|NCT02951533|528354543|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
146505817|NCT02951533|528354541|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
146505818|NCT02951533|528354542|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
146505819|NCT02951533|528354543|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
146505820|NCT02951533|528354541|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
146505821|NCT02951533|528354542|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
146505822|NCT02951533|528354543|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
146505823|NCT02951533|528354541|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
146505824|NCT02951533|528354542|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
146505825|NCT02951533|528354543|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
146505826|NCT02029989|528354544|FG000|Overall Study|Withdrawal by Subject|1|||
146505827|NCT02029989|528354545|FG001|Overall Study|Withdrawal by Subject|0|||
146505828|NCT02029989|528354544|FG000|Overall Study|Withdrawal: Fear of needles|1|||
146505829|NCT02029989|528354545|FG001|Overall Study|Withdrawal: Fear of needles|0|||
146505830|NCT02029989|528354544|FG000|Overall Study|Change of location|2|||
146505831|NCT02029989|528354545|FG001|Overall Study|Change of location|3|||
146505832|NCT02029989|528354544|FG000|Overall Study|Physician Decision|2|||
146505833|NCT02029989|528354545|FG001|Overall Study|Physician Decision|0|||
146505834|NCT02029989|528354544|FG000|Overall Study|Lost to Follow-up|9|||
146505835|NCT02029989|528354545|FG001|Overall Study|Lost to Follow-up|7|||
146505836|NCT02029989|528354544|FG000|Overall Study|Death|0|||
146505837|NCT02029989|528354545|FG001|Overall Study|Death|1|||
146505838|NCT02029989|528354544|FG000|Overall Study|Protocol Violation|1|||
146505839|NCT02029989|528354545|FG001|Overall Study|Protocol Violation|0|||
146505840|NCT02727777|528354552|FG000|Overall Study|Screen Failure|2|||
146505841|NCT02727777|528354553|FG001|Overall Study|Screen Failure|0|||
146567241|NCT01621178|528589742|FG001|Overall Study|Withdrawal by Subject|17|||
146567242|NCT01621178|528589743|FG002|Overall Study|Withdrawal by Subject|18|||
146567243|NCT01621178|528589741|FG000|Overall Study|Physician Decision|5|||
146567244|NCT01621178|528589742|FG001|Overall Study|Physician Decision|2|||
146567245|NCT01621178|528589743|FG002|Overall Study|Physician Decision|7|||
146567246|NCT00105534|528589744|FG000|Overall Study|Adverse Event|2|||
146567247|NCT00105534|528589745|FG001|Overall Study|Adverse Event|5|||
146567248|NCT00105534|528589744|FG000|Overall Study|Protocol Violation|1|||
146567249|NCT00105534|528589745|FG001|Overall Study|Protocol Violation|4|||
146648776|NCT02576145|528890854|FG000|Overall Study|Adverse Event|1|||
146505842|NCT02727777|528354554|FG002|Overall Study|Screen Failure|0|||
146505843|NCT02727777|528354552|FG000|Overall Study|Progressive disease|2|||
146505844|NCT02727777|528354553|FG001|Overall Study|Progressive disease|0|||
146505845|NCT02727777|528354554|FG002|Overall Study|Progressive disease|0|||
146505846|NCT01738503|528354555|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
146505847|NCT01738503|528354556|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
146505848|NCT01738503|528354557|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
146505849|NCT01738503|528354558|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
146505850|NCT01738503|528354559|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
146505851|NCT01738503|528354560|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
146567250|NCT00105534|528589744|FG000|Overall Study|Withdrawal by Subject|6|||
146648777|NCT02576145|528890855|FG001|Overall Study|Adverse Event|0|||
146648778|NCT02576145|528890854|FG000|Overall Study|Withdrawal by Subject|1|||
146648779|NCT02576145|528890855|FG001|Overall Study|Withdrawal by Subject|0|||
146648780|NCT02576145|528890854|FG000|Overall Study|Acute rejection|1|||
146648781|NCT02576145|528890855|FG001|Overall Study|Acute rejection|0|||
146648782|NCT02576145|528890854|FG000|Overall Study|Tetanus Titers Decreased|0|||
146648783|NCT02576145|528890855|FG001|Overall Study|Tetanus Titers Decreased|1|||
146505852|NCT01738503|528354561|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
146505853|NCT01738503|528354555|FG000|Treatment Period|Adverse Event|0|||
146505854|NCT01738503|528354556|FG001|Treatment Period|Adverse Event|1|||
146505855|NCT01738503|528354557|FG002|Treatment Period|Adverse Event|0|||
146505856|NCT01738503|528354558|FG003|Treatment Period|Adverse Event|1|||
146505857|NCT01738503|528354559|FG004|Treatment Period|Adverse Event|2|||
146505858|NCT01738503|528354560|FG005|Treatment Period|Adverse Event|2|||
146505859|NCT01738503|528354561|FG006|Treatment Period|Adverse Event|2|||
146505860|NCT01738503|528354555|FG000|Treatment Period|Lost to Follow-up|0|||
146505861|NCT01738503|528354556|FG001|Treatment Period|Lost to Follow-up|0|||
146505862|NCT01738503|528354557|FG002|Treatment Period|Lost to Follow-up|3|||
146648784|NCT01227824|528890856|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
146648785|NCT01227824|528890857|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
146648786|NCT01227824|528890858|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
146648787|NCT01227824|528890856|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
146505863|NCT01738503|528354558|FG003|Treatment Period|Lost to Follow-up|4|||
146505864|NCT01738503|528354559|FG004|Treatment Period|Lost to Follow-up|1|||
146505865|NCT01738503|528354560|FG005|Treatment Period|Lost to Follow-up|1|||
146505866|NCT01738503|528354561|FG006|Treatment Period|Lost to Follow-up|5|||
146505867|NCT01738503|528354555|FG000|Treatment Period|Withdrawal by Subject|0|||
146505868|NCT01738503|528354556|FG001|Treatment Period|Withdrawal by Subject|1|||
146505869|NCT01738503|528354557|FG002|Treatment Period|Withdrawal by Subject|0|||
146505870|NCT01738503|528354558|FG003|Treatment Period|Withdrawal by Subject|1|||
146505871|NCT01738503|528354559|FG004|Treatment Period|Withdrawal by Subject|1|||
146505872|NCT01738503|528354560|FG005|Treatment Period|Withdrawal by Subject|1|||
146505873|NCT01738503|528354561|FG006|Treatment Period|Withdrawal by Subject|1|||
146505874|NCT01738503|528354555|FG000|Treatment Period|Protocol Violation|0|||
146505875|NCT01738503|528354556|FG001|Treatment Period|Protocol Violation|3|||
146505876|NCT01738503|528354557|FG002|Treatment Period|Protocol Violation|1|||
146505877|NCT01738503|528354558|FG003|Treatment Period|Protocol Violation|0|||
146505878|NCT01738503|528354559|FG004|Treatment Period|Protocol Violation|4|||
146648788|NCT01227824|528890857|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
146648789|NCT01227824|528890858|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
146648790|NCT01227824|528890856|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
146648791|NCT01227824|528890857|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
146648792|NCT01227824|528890858|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
146648793|NCT01227824|528890856|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
146648794|NCT01227824|528890857|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
146648795|NCT01227824|528890858|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
146648796|NCT01227824|528890856|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
146648797|NCT01227824|528890857|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
146648798|NCT01227824|528890858|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
146648799|NCT01227824|528890856|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
146648800|NCT01227824|528890857|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
146648801|NCT01227824|528890858|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
146648802|NCT01227824|528890856|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
146648803|NCT01227824|528890857|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
146648804|NCT01227824|528890858|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
146648805|NCT01227824|528890856|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
146648806|NCT01227824|528890857|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
146648807|NCT01227824|528890858|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
146648808|NCT01227824|528890856|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
146648809|NCT01227824|528890857|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
146912869|NCT01845077|529843206|FG000|Washout Period|Adverse Event|1|||
146912870|NCT01845077|529843207|FG001|Washout Period|Adverse Event|0|||
146912871|NCT01845077|529843208|FG002|Washout Period|Adverse Event|0|||
146912872|NCT01845077|529843209|FG003|Washout Period|Adverse Event|0|||
146912873|NCT01845077|529843210|FG004|Washout Period|Adverse Event|0|||
146505879|NCT01738503|528354560|FG005|Treatment Period|Protocol Violation|2|||
146505880|NCT01738503|528354561|FG006|Treatment Period|Protocol Violation|0|||
146505881|NCT01738503|528354555|FG000|Treatment Period|Other|0|||
146505882|NCT01738503|528354556|FG001|Treatment Period|Other|0|||
146505883|NCT01738503|528354557|FG002|Treatment Period|Other|1|||
146505884|NCT01738503|528354558|FG003|Treatment Period|Other|0|||
146505885|NCT01738503|528354559|FG004|Treatment Period|Other|0|||
146505886|NCT01738503|528354560|FG005|Treatment Period|Other|0|||
146505887|NCT01738503|528354561|FG006|Treatment Period|Other|0|||
146505888|NCT01738503|528354555|FG000|PET Imaging Sub-study|Adverse Event|0|||
146505889|NCT01738503|528354556|FG001|PET Imaging Sub-study|Adverse Event|0|||
146505890|NCT01738503|528354557|FG002|PET Imaging Sub-study|Adverse Event|0|||
146505891|NCT01738503|528354558|FG003|PET Imaging Sub-study|Adverse Event|0|||
146505892|NCT01738503|528354559|FG004|PET Imaging Sub-study|Adverse Event|0|||
146505893|NCT01738503|528354560|FG005|PET Imaging Sub-study|Adverse Event|1|||
146505894|NCT01738503|528354561|FG006|PET Imaging Sub-study|Adverse Event|0|||
146505895|NCT01738503|528354555|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
146505896|NCT01738503|528354556|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
146505897|NCT01738503|528354557|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
146505898|NCT01738503|528354558|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
146505899|NCT01738503|528354559|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
146505900|NCT01738503|528354560|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
146505901|NCT01738503|528354561|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
146505902|NCT04696354|528354562|FG000|Overall Study|Study termination|6|||
146505903|NCT04696354|528354563|FG001|Overall Study|Study termination|6|||
146505904|NCT03005327|528354564|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
146505905|NCT03005327|528354565|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
146505906|NCT03005327|528354566|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
146648810|NCT01227824|528890858|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
146648811|NCT01227824|528890856|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
146648812|NCT01227824|528890857|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
146505907|NCT03005327|528354567|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
146505908|NCT03005327|528354564|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146505909|NCT03005327|528354565|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
146505910|NCT03005327|528354566|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146505911|NCT03005327|528354567|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146505912|NCT04687072|528354568|FG000|Overall Study|Adverse Event|2|||
146505913|NCT04687072|528354569|FG001|Overall Study|Adverse Event|0|||
146505914|NCT04687072|528354568|FG000|Overall Study|Death|1|||
146505915|NCT04687072|528354569|FG001|Overall Study|Death|0|||
146505916|NCT04687072|528354568|FG000|Overall Study|Lack of Efficacy|2|||
146505917|NCT04687072|528354569|FG001|Overall Study|Lack of Efficacy|1|||
146505918|NCT04687072|528354568|FG000|Overall Study|Physician Decision|1|||
146505919|NCT04687072|528354569|FG001|Overall Study|Physician Decision|0|||
146505920|NCT04687072|528354568|FG000|Overall Study|Pregnancy|1|||
146505921|NCT04687072|528354569|FG001|Overall Study|Pregnancy|0|||
146505922|NCT04687072|528354568|FG000|Overall Study|Requires Prohibited Medication|2|||
146505923|NCT04687072|528354569|FG001|Overall Study|Requires Prohibited Medication|0|||
146505924|NCT04687072|528354568|FG000|Overall Study|Withdrawal of Consent|11|||
146505925|NCT04687072|528354569|FG001|Overall Study|Withdrawal of Consent|6|||
146505926|NCT04687072|528354568|FG000|Overall Study|Miscellaneous|4|||
146505927|NCT04687072|528354569|FG001|Overall Study|Miscellaneous|1|||
146505928|NCT02600845|528354574|FG000|Overall Study|Reason Not Specified|3|||
146505929|NCT02600845|528354574|FG000|Overall Study|Non-compliance with Study Procedures|10|||
146505930|NCT02600845|528354574|FG000|Overall Study|Consent Withdrawal|5|||
146505931|NCT00965341|528354575|FG000|Overall Study|Withdrew consent|1|||
146505932|NCT00965341|528354576|FG001|Overall Study|Withdrew consent|5|||
146505933|NCT00965341|528354575|FG000|Overall Study|Lost to Follow-up|1|||
146505934|NCT00965341|528354576|FG001|Overall Study|Lost to Follow-up|0|||
146505935|NCT00965341|528354575|FG000|Overall Study|Transportation issues|4|||
146505936|NCT00965341|528354576|FG001|Overall Study|Transportation issues|3|||
146505937|NCT02234596|528354577|FG000|Overall Study|Participant not treated|2|||
146505938|NCT05072106|528356822|FG000|Overall Study|Progressive disease|3|||
146505939|NCT05072106|528356823|FG001|Overall Study|Progressive disease|3|||
146505940|NCT05072106|528356822|FG000|Overall Study|Compassionate use|3|||
146505941|NCT05072106|528356823|FG001|Overall Study|Compassionate use|1|||
146505942|NCT05072106|528356822|FG000|Overall Study|Withdrawal by Subject|1|||
146505943|NCT05072106|528356823|FG001|Overall Study|Withdrawal by Subject|0|||
146505944|NCT04240886|528356828|FG000|Treatment Phase|Death|4|||
146648813|NCT01227824|528890858|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
146505945|NCT04240886|528356828|FG000|Treatment Phase|Discontinuation by Subject|1|||
146505946|NCT04240886|528356828|FG000|Treatment Phase|Adverse Event|5|||
146505947|NCT04240886|528356828|FG000|Follow-up Phase|Withdrawal by Subject|1|||
146505948|NCT04240886|528356828|FG000|Follow-up Phase|Discontinuation by Subject|1|||
146912874|NCT01845077|529843211|FG005|Washout Period|Adverse Event|0|||
146505949|NCT04240886|528356828|FG000|Follow-up Phase|Death|2|||
146505950|NCT04743804|528356829|FG000|Overall Study|Other|1|||
146505951|NCT04743804|528356830|FG001|Overall Study|Other|0|||
146505952|NCT04743804|528356829|FG000|Overall Study|Withdrawal by Subject|0|||
146505953|NCT04743804|528356830|FG001|Overall Study|Withdrawal by Subject|1|||
146505954|NCT04743804|528356829|FG000|Overall Study|Study Terminated by Sponsor|1|||
146505955|NCT04743804|528356830|FG001|Overall Study|Study Terminated by Sponsor|4|||
146974451|NCT01682512|530069549|FG000|Overall Study|Adverse Event|6|||
146974452|NCT01682512|530069550|FG001|Overall Study|Adverse Event|5|||
146974453|NCT01682512|530069551|FG002|Overall Study|Adverse Event|2|||
146974454|NCT01682512|530069549|FG000|Overall Study|Withdrawal by Subject|2|||
146974455|NCT01682512|530069550|FG001|Overall Study|Withdrawal by Subject|6|||
146974456|NCT01682512|530069551|FG002|Overall Study|Withdrawal by Subject|3|||
146974457|NCT01682512|530069549|FG000|Overall Study|Physician Decision|0|||
146974458|NCT01682512|530069550|FG001|Overall Study|Physician Decision|2|||
146567251|NCT00105534|528589745|FG001|Overall Study|Withdrawal by Subject|6|||
146567252|NCT00105534|528589744|FG000|Overall Study|Lost to Follow-up|5|||
146567253|NCT00105534|528589745|FG001|Overall Study|Lost to Follow-up|1|||
146567254|NCT00105534|528589744|FG000|Overall Study|Lack of Efficacy|7|||
146567255|NCT00105534|528589745|FG001|Overall Study|Lack of Efficacy|15|||
146567256|NCT00105534|528589744|FG000|Overall Study|Treatment unmasked|1|||
146567257|NCT00105534|528589745|FG001|Overall Study|Treatment unmasked|0|||
146567258|NCT00105534|528589744|FG000|Overall Study|Other Reason|0|||
146567259|NCT00105534|528589745|FG001|Overall Study|Other Reason|2|||
146567260|NCT02935192|528589746|FG000|Overall Study|Withdrawal by Subject|8|||
146567261|NCT02935192|528589747|FG001|Overall Study|Withdrawal by Subject|4|||
146567262|NCT02465931|528589748|FG000|Overall Study|Lost to Follow-up|9|||
146567263|NCT02465931|528589749|FG001|Overall Study|Lost to Follow-up|11|||
146567264|NCT02465931|528589748|FG000|Overall Study|Protocol Violation|1|||
146567265|NCT02465931|528589749|FG001|Overall Study|Protocol Violation|0|||
146567266|NCT02465931|528589748|FG000|Overall Study|Withdrawal by Subject|1|||
146567267|NCT02465931|528589749|FG001|Overall Study|Withdrawal by Subject|0|||
146567268|NCT02896257|528589751|FG000|Providers|Without eligible patients|21|||
146567269|NCT02896257|528589752|FG001|Providers|Without eligible patients|28|||
146567270|NCT02896257|528589751|FG000|Patients|PFT entry criteria not met|43|||
146648814|NCT01227824|528890856|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
146648815|NCT01227824|528890857|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
146648816|NCT01227824|528890858|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
146648817|NCT01227824|528890856|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
146648818|NCT01227824|528890857|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
146648819|NCT01227824|528890858|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
146648820|NCT01227824|528890856|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
146648821|NCT01227824|528890857|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
146648822|NCT01227824|528890858|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
146648823|NCT01227824|528890856|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
146648824|NCT01227824|528890857|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
146648825|NCT01227824|528890858|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
146648826|NCT01227824|528890856|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
146648827|NCT01227824|528890857|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
146648828|NCT01227824|528890858|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
146648829|NCT01755026|528890859|FG000|Overall Study|Adverse Event|1|||
146648830|NCT01755026|528890860|FG001|Overall Study|Adverse Event|0|||
146648831|NCT01755026|528890859|FG000|Overall Study|Withdrawal by Subject|1|||
146648832|NCT01755026|528890860|FG001|Overall Study|Withdrawal by Subject|1|||
146648833|NCT01700387|528890868|FG000|Overall Study|Withdrawal by Subject|1|||
146648834|NCT01700387|528890869|FG001|Overall Study|Withdrawal by Subject|2|||
146648835|NCT01700387|528890868|FG000|Overall Study|Adverse Event|1|||
146648836|NCT01700387|528890869|FG001|Overall Study|Adverse Event|1|||
146648837|NCT01700387|528890868|FG000|Overall Study|Lost to Follow-up|2|||
146648838|NCT01700387|528890869|FG001|Overall Study|Lost to Follow-up|1|||
146648839|NCT02730793|528890872|FG000|Overall Study|Physician Decision|0|||
146648840|NCT02730793|528890873|FG001|Overall Study|Physician Decision|1|||
146648841|NCT02730793|528890872|FG000|Overall Study|Withdrawal by Subject|0|||
146648842|NCT02730793|528890873|FG001|Overall Study|Withdrawal by Subject|1|||
146648843|NCT02365233|528890874|FG000|Overall Study|IRB withheld the data|1|||
146648844|NCT02365233|528890875|FG001|Overall Study|IRB withheld the data|2|||
146648845|NCT02365233|528890876|FG002|Overall Study|IRB withheld the data|2|||
146648846|NCT00995566|528890877|FG000|Overall Study|Adverse Event|2|||
146648847|NCT00995566|528890877|FG000|Overall Study|Early study termination|52|||
146648848|NCT00545129|528890878|FG000|Overall Study|Lack of Efficacy|2|||
146648849|NCT00545129|528890879|FG001|Overall Study|Lack of Efficacy|5|||
146648850|NCT00545129|528890878|FG000|Overall Study|Death|2|||
146974459|NCT01682512|530069551|FG002|Overall Study|Physician Decision|0|||
146567271|NCT02896257|528589752|FG001|Patients|PFT entry criteria not met|50|||
146567272|NCT02896257|528589751|FG000|Patients|No capacity to review|8|||
146648851|NCT00545129|528890879|FG001|Overall Study|Death|1|||
146648852|NCT00545129|528890878|FG000|Overall Study|Adverse Event|1|||
146567273|NCT02896257|528589752|FG001|Patients|No capacity to review|11|||
146567274|NCT02896257|528589751|FG000|Patients|Appointment rescheduled/cancelled|5|||
146567275|NCT02896257|528589752|FG001|Patients|Appointment rescheduled/cancelled|7|||
146974460|NCT01682512|530069549|FG000|Overall Study|Study terminated by sponsor|46|||
146974461|NCT01682512|530069550|FG001|Overall Study|Study terminated by sponsor|43|||
146769527|NCT02296424|529324848|FG000|Part 1|Study terminated by sponsor|0|||
146769528|NCT02296424|529324849|FG001|Part 1|Study terminated by sponsor|1|||
146769529|NCT02296424|529324850|FG002|Part 1|Study terminated by sponsor|0|||
146769530|NCT02296424|529324851|FG003|Part 1|Study terminated by sponsor|0|||
146769531|NCT02296424|529324848|FG000|Part 1|Adverse Event|2|||
146769532|NCT02296424|529324849|FG001|Part 1|Adverse Event|11|||
146769533|NCT02296424|529324850|FG002|Part 1|Adverse Event|0|||
146769534|NCT02296424|529324851|FG003|Part 1|Adverse Event|0|||
146769535|NCT02296424|529324848|FG000|Part 1|Lack of Efficacy|5|||
146769536|NCT02296424|529324849|FG001|Part 1|Lack of Efficacy|17|||
146769537|NCT02296424|529324850|FG002|Part 1|Lack of Efficacy|0|||
146769538|NCT02296424|529324851|FG003|Part 1|Lack of Efficacy|0|||
146769539|NCT02296424|529324848|FG000|Part 1|16 directly started part II|16|||
146769540|NCT02296424|529324849|FG001|Part 1|16 directly started part II|0|||
146769541|NCT02296424|529324850|FG002|Part 1|16 directly started part II|0|||
146769542|NCT02296424|529324851|FG003|Part 1|16 directly started part II|0|||
146769543|NCT02296424|529324848|FG000|Part 2|Lack of Efficacy|0|||
146769544|NCT02296424|529324849|FG001|Part 2|Lack of Efficacy|0|||
146769545|NCT02296424|529324850|FG002|Part 2|Lack of Efficacy|1|||
146769546|NCT02296424|529324851|FG003|Part 2|Lack of Efficacy|0|||
146769547|NCT02296424|529324848|FG000|Part 2|Adverse Event|0|||
146769548|NCT02296424|529324849|FG001|Part 2|Adverse Event|0|||
146769549|NCT02296424|529324850|FG002|Part 2|Adverse Event|1|||
146769550|NCT02296424|529324851|FG003|Part 2|Adverse Event|0|||
146769551|NCT02296424|529324848|FG000|Part 2|Lost to Follow-up|0|||
146769552|NCT02296424|529324849|FG001|Part 2|Lost to Follow-up|0|||
146769553|NCT02296424|529324850|FG002|Part 2|Lost to Follow-up|1|||
146648853|NCT00545129|528890879|FG001|Overall Study|Adverse Event|1|||
146648854|NCT00545129|528890878|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
146648855|NCT00545129|528890879|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
146648856|NCT00545129|528890878|FG000|Overall Study|Other|3|||
146648857|NCT00545129|528890879|FG001|Overall Study|Other|3|||
146505956|NCT04743804|528356829|FG000|Overall Study|Physician Decision|0|||
146505957|NCT04743804|528356830|FG001|Overall Study|Physician Decision|1|||
146505958|NCT04743804|528356829|FG000|Overall Study|Death|3|||
146505959|NCT04743804|528356830|FG001|Overall Study|Death|0|||
146505960|NCT04488497|528356836|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
146648858|NCT03678870|528890880|FG000|Overall Study|prescribed non- protocol medications|10|||
146648859|NCT03678870|528890881|FG001|Overall Study|prescribed non- protocol medications|6|||
146648860|NCT03678870|528890880|FG000|Overall Study|Lost to Follow-up|3|||
146648861|NCT03678870|528890881|FG001|Overall Study|Lost to Follow-up|2|||
146648862|NCT01454778|528890882|FG000|Overall Study|Lost to Follow-up|2|||
146648863|NCT01454778|528890882|FG000|Overall Study|Death|1|||
146648864|NCT00348881|528890883|FG000|Overall Study|Lost to Follow-up|12|||
146648865|NCT00348881|528890884|FG001|Overall Study|Lost to Follow-up|6|||
146648866|NCT00348881|528890883|FG000|Overall Study|Withdrawal by Subject|3|||
146648867|NCT00348881|528890884|FG001|Overall Study|Withdrawal by Subject|4|||
146648868|NCT00348881|528890883|FG000|Overall Study|Adverse Event|2|||
146648869|NCT00348881|528890884|FG001|Overall Study|Adverse Event|0|||
146648870|NCT00348881|528890883|FG000|Overall Study|Serious Adverse Event|0|||
146648871|NCT00348881|528890884|FG001|Overall Study|Serious Adverse Event|2|||
146648872|NCT01981551|528890891|FG000|Overall Study|Refused further treatment|8|||
146648873|NCT01981551|528890891|FG000|Overall Study|Adverse Event|1|||
146648874|NCT02880956|528890892|FG000|Overall Study|Adverse Event|3|||
146648875|NCT02880956|528890893|FG001|Overall Study|Adverse Event|6|||
146648876|NCT02880956|528890894|FG002|Overall Study|Adverse Event|5|||
146648877|NCT02880956|528890895|FG003|Overall Study|Adverse Event|4|||
146648878|NCT02880956|528890892|FG000|Overall Study|Withdrawal by Subject|9|||
146648879|NCT02880956|528890893|FG001|Overall Study|Withdrawal by Subject|4|||
146648880|NCT02880956|528890894|FG002|Overall Study|Withdrawal by Subject|6|||
146648881|NCT02880956|528890895|FG003|Overall Study|Withdrawal by Subject|11|||
146648882|NCT02880956|528890892|FG000|Overall Study|Lost to Follow-up|0|||
146648883|NCT02880956|528890893|FG001|Overall Study|Lost to Follow-up|1|||
146648884|NCT02880956|528890894|FG002|Overall Study|Lost to Follow-up|0|||
146648885|NCT02880956|528890895|FG003|Overall Study|Lost to Follow-up|0|||
146648886|NCT02880956|528890892|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
146648887|NCT02880956|528890893|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
146769554|NCT02296424|529324851|FG003|Part 2|Lost to Follow-up|0|||
146769555|NCT00071799|529324852|FG000|Overall Study|Adverse Event|19|||
146769556|NCT00071799|529324853|FG001|Overall Study|Adverse Event|10|||
146505961|NCT04488497|528356837|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
146769557|NCT00071799|529324852|FG000|Overall Study|Protocol Violation|1|||
146505962|NCT04488497|528356836|FG000|Intervention|Physician Decision|2|||
146648888|NCT02880956|528890894|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
146648889|NCT02880956|528890895|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
146648890|NCT02880956|528890892|FG000|Overall Study|Other, Not Specified|4|||
146769558|NCT00071799|529324853|FG001|Overall Study|Protocol Violation|7|||
146769559|NCT00071799|529324852|FG000|Overall Study|Lost to Follow-up|1|||
146769560|NCT00071799|529324853|FG001|Overall Study|Lost to Follow-up|1|||
146648891|NCT02880956|528890893|FG001|Overall Study|Other, Not Specified|2|||
146648892|NCT02880956|528890894|FG002|Overall Study|Other, Not Specified|0|||
146648893|NCT02880956|528890895|FG003|Overall Study|Other, Not Specified|3|||
146648894|NCT00603590|528892931|FG000|Overall Study|Did not attend study clinic|39|||
146648895|NCT00603590|528892932|FG001|Overall Study|Did not attend study clinic|30|||
146648896|NCT00603590|528892931|FG000|Overall Study|Refused blood test|5|||
146648897|NCT00603590|528892932|FG001|Overall Study|Refused blood test|1|||
146648898|NCT00603590|528892931|FG000|Overall Study|Patient discontinued study drug|22|||
146648899|NCT00603590|528892932|FG001|Overall Study|Patient discontinued study drug|15|||
146648900|NCT00603590|528892931|FG000|Overall Study|Adverse Event|2|||
146648901|NCT00603590|528892932|FG001|Overall Study|Adverse Event|0|||
146648902|NCT00603590|528892931|FG000|Overall Study|Lost to Follow-up|8|||
146648903|NCT00603590|528892932|FG001|Overall Study|Lost to Follow-up|4|||
146648904|NCT00603590|528892931|FG000|Overall Study|Cardiovascular event|0|||
146648905|NCT00603590|528892932|FG001|Overall Study|Cardiovascular event|1|||
146648906|NCT00393510|528892938|FG000|Overall Study|Physician Decision|3|||
146648907|NCT00393510|528892939|FG001|Overall Study|Physician Decision|9|||
146648908|NCT03077087|528892942|FG000|Overall Study|Physician Decision|2|||
146648909|NCT00770146|528892943|FG000|Treatment Period|Withdrawal by Subject|6|||
146648910|NCT00770146|528892944|FG001|Treatment Period|Withdrawal by Subject|13|||
146648911|NCT00770146|528892943|FG000|Treatment Period|Adverse Event|2|||
146648912|NCT00770146|528892944|FG001|Treatment Period|Adverse Event|26|||
146648913|NCT00770146|528892943|FG000|Treatment Period|Other|1|||
146648914|NCT00770146|528892944|FG001|Treatment Period|Other|5|||
146648915|NCT00770146|528892943|FG000|Treatment Period|Protocol non-compliance|0|||
146648916|NCT00770146|528892944|FG001|Treatment Period|Protocol non-compliance|1|||
146648917|NCT00770146|528892943|FG000|Follow-up Period|Withdrawal by Subject|7|||
146648918|NCT00770146|528892944|FG001|Follow-up Period|Withdrawal by Subject|13|||
146648919|NCT00770146|528892943|FG000|Follow-up Period|Adverse Event|0|||
146648920|NCT00770146|528892944|FG001|Follow-up Period|Adverse Event|2|||
146648921|NCT00770146|528892943|FG000|Follow-up Period|Other|4|||
146648922|NCT00770146|528892944|FG001|Follow-up Period|Other|5|||
146648923|NCT02412488|528892947|FG000|Overall Study|Lost to Follow-up|10|||
146648924|NCT02412488|528892947|FG000|Overall Study|Withdrawal by Subject|5|||
146648925|NCT02412488|528892947|FG000|Overall Study|Physician Decision|1|||
146648926|NCT02412488|528892947|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
146648927|NCT02412488|528892947|FG000|Overall Study|Reveal LINQ explant|1|||
146648928|NCT01989468|528892948|FG000|Overall Study|Adverse Event|10|||
146648929|NCT01989468|528892949|FG001|Overall Study|Adverse Event|15|||
146505963|NCT04488497|528356837|FG001|Intervention|Physician Decision|1|||
146505964|NCT04488497|528356836|FG000|Intervention|Withdrawal by Subject|5|||
146505965|NCT04488497|528356837|FG001|Intervention|Withdrawal by Subject|6|||
146505966|NCT04488497|528356836|FG000|Intervention|Lost to Follow-up|2|||
146505967|NCT04488497|528356837|FG001|Intervention|Lost to Follow-up|0|||
146505968|NCT04488497|528356836|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
146505969|NCT04488497|528356837|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
146505970|NCT04488497|528356836|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
146505971|NCT04488497|528356837|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
146505972|NCT04063657|528356840|FG000|Overall Study|Lost to Follow-up|1|||
146505973|NCT04063657|528356841|FG001|Overall Study|Lost to Follow-up|0|||
146505974|NCT03408444|528356842|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
146505975|NCT03408444|528356843|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
146505976|NCT03408444|528356844|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
146505977|NCT03408444|528356845|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
146505978|NCT03408444|528356842|FG000|Overall Study|Lens Discomfort|0|||
146505979|NCT03408444|528356843|FG001|Overall Study|Lens Discomfort|1|||
146505980|NCT03408444|528356844|FG002|Overall Study|Lens Discomfort|0|||
146505981|NCT03408444|528356845|FG003|Overall Study|Lens Discomfort|0|||
146505982|NCT03408444|528356842|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
146505983|NCT03408444|528356843|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
146505984|NCT03408444|528356844|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
146505985|NCT03408444|528356845|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
146505986|NCT03408444|528356842|FG000|Overall Study|Withdrawal by Subject|0|||
146648930|NCT01989468|528892950|FG002|Overall Study|Adverse Event|4|||
146648931|NCT01989468|528892951|FG003|Overall Study|Adverse Event|5|||
146648932|NCT01989468|528892952|FG004|Overall Study|Adverse Event|4|||
146648933|NCT01989468|528892948|FG000|Overall Study|Lack of Efficacy|11|||
146648934|NCT01989468|528892949|FG001|Overall Study|Lack of Efficacy|11|||
146648935|NCT01989468|528892950|FG002|Overall Study|Lack of Efficacy|7|||
146648936|NCT01989468|528892951|FG003|Overall Study|Lack of Efficacy|4|||
146648937|NCT01989468|528892952|FG004|Overall Study|Lack of Efficacy|2|||
146648938|NCT01989468|528892948|FG000|Overall Study|Lost to Follow-up|5|||
146648939|NCT01989468|528892949|FG001|Overall Study|Lost to Follow-up|2|||
146974462|NCT01682512|530069551|FG002|Overall Study|Study terminated by sponsor|0|||
146648940|NCT01989468|528892950|FG002|Overall Study|Lost to Follow-up|0|||
146648941|NCT01989468|528892951|FG003|Overall Study|Lost to Follow-up|1|||
146648942|NCT01989468|528892952|FG004|Overall Study|Lost to Follow-up|1|||
146648943|NCT01989468|528892948|FG000|Overall Study|Physician Decision|4|||
146648944|NCT01989468|528892949|FG001|Overall Study|Physician Decision|1|||
146505987|NCT03408444|528356843|FG001|Overall Study|Withdrawal by Subject|2|||
146505988|NCT03408444|528356844|FG002|Overall Study|Withdrawal by Subject|3|||
146505989|NCT03408444|528356845|FG003|Overall Study|Withdrawal by Subject|0|||
146505990|NCT03408444|528356842|FG000|Overall Study|Lost to Follow-up|0|||
146505991|NCT03408444|528356843|FG001|Overall Study|Lost to Follow-up|0|||
146505992|NCT03408444|528356844|FG002|Overall Study|Lost to Follow-up|1|||
146505993|NCT03408444|528356845|FG003|Overall Study|Lost to Follow-up|0|||
146505994|NCT03408444|528356842|FG000|Overall Study|Adverse Event|0|||
146505995|NCT03408444|528356843|FG001|Overall Study|Adverse Event|0|||
146505996|NCT03408444|528356844|FG002|Overall Study|Adverse Event|0|||
146505997|NCT03408444|528356845|FG003|Overall Study|Adverse Event|1|||
146505998|NCT03408444|528356842|FG000|Overall Study|Lens Handling Difficulties|0|||
146505999|NCT03408444|528356843|FG001|Overall Study|Lens Handling Difficulties|0|||
146506000|NCT03408444|528356844|FG002|Overall Study|Lens Handling Difficulties|1|||
146506001|NCT03408444|528356845|FG003|Overall Study|Lens Handling Difficulties|0|||
146506002|NCT03408444|528356842|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
146506003|NCT03408444|528356843|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
146506004|NCT03408444|528356844|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
146506005|NCT03408444|528356845|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
146506006|NCT04984681|528356846|FG000|Overall Study|Lost to Follow-up|3|||
146506007|NCT04984681|528356847|FG001|Overall Study|Lost to Follow-up|1|||
146506008|NCT01473394|528356848|FG000|Overall Study|Adverse Event|13|||
146506009|NCT01473394|528356849|FG001|Overall Study|Adverse Event|16|||
146506010|NCT01473394|528356848|FG000|Overall Study|Insufficient Therapeutic Response|4|||
146506011|NCT01473394|528356849|FG001|Overall Study|Insufficient Therapeutic Response|1|||
146506012|NCT01473394|528356848|FG000|Overall Study|Protocol Violation|7|||
146506013|NCT01473394|528356849|FG001|Overall Study|Protocol Violation|5|||
146506014|NCT01473394|528356848|FG000|Overall Study|Withdrew Consent|12|||
146506015|NCT01473394|528356849|FG001|Overall Study|Withdrew Consent|10|||
146506016|NCT01473394|528356848|FG000|Overall Study|Lost to Follow-up|9|||
146506017|NCT01473394|528356849|FG001|Overall Study|Lost to Follow-up|11|||
146506018|NCT04777201|528356853|FG000|Main Study|Withdrawal by Subject|19|||
146506019|NCT04777201|528356854|FG001|Main Study|Withdrawal by Subject|27|||
146506020|NCT04777201|528356855|FG002|Main Study|Withdrawal by Subject|0|||
146506021|NCT04777201|528356853|FG000|Main Study|Death|13|||
146506022|NCT04777201|528356854|FG001|Main Study|Death|27|||
146506023|NCT04777201|528356855|FG002|Main Study|Death|0|||
146506024|NCT04777201|528356853|FG000|Main Study|Subject missed the safety follow-up visit|9|||
146506025|NCT04777201|528356854|FG001|Main Study|Subject missed the safety follow-up visit|10|||
146506026|NCT04777201|528356855|FG002|Main Study|Subject missed the safety follow-up visit|0|||
146506027|NCT04777201|528356853|FG000|Main Study|Physician Decision|8|||
146506028|NCT04777201|528356854|FG001|Main Study|Physician Decision|10|||
146567276|NCT02896257|528589751|FG000|Patients|PCP not assigned a clinic|4|||
146567277|NCT02896257|528589752|FG001|Patients|PCP not assigned a clinic|0|||
146567278|NCT02896257|528589751|FG000|Patients|No history of COPD|0|||
146567279|NCT02896257|528589752|FG001|Patients|No history of COPD|1|||
146567280|NCT02896257|528589751|FG000|Patients|Deceased between review and index date|0|||
146567281|NCT02896257|528589752|FG001|Patients|Deceased between review and index date|1|||
146567282|NCT02896257|528589751|FG000|Patients|No ICS Rx upon review|1|||
146567283|NCT02896257|528589752|FG001|Patients|No ICS Rx upon review|1|||
146567284|NCT02896257|528589751|FG000|Patients|Protocol Violation|2|||
146567285|NCT02896257|528589752|FG001|Patients|Protocol Violation|1|||
146567286|NCT02896257|528589751|FG000|Patients|Hospice care|0|||
146567287|NCT02896257|528589752|FG001|Patients|Hospice care|1|||
146567288|NCT00492557|528589753|FG000|Overall Study|Subject request|12|||
146567289|NCT00492557|528589754|FG001|Overall Study|Subject request|11|||
146567290|NCT00492557|528589753|FG000|Overall Study|Protocol Violation|7|||
146567291|NCT00492557|528589754|FG001|Overall Study|Protocol Violation|8|||
146567292|NCT00492557|528589753|FG000|Overall Study|Other|2|||
146567293|NCT00492557|528589754|FG001|Overall Study|Other|2|||
146506029|NCT04777201|528356855|FG002|Main Study|Physician Decision|0|||
146506030|NCT04777201|528356853|FG000|Main Study|Adverse Event|8|||
146506031|NCT04777201|528356854|FG001|Main Study|Adverse Event|8|||
146506032|NCT04777201|528356855|FG002|Main Study|Adverse Event|0|||
146506033|NCT04777201|528356853|FG000|Main Study|Lost to Follow-up|9|||
146506034|NCT04777201|528356854|FG001|Main Study|Lost to Follow-up|4|||
146506035|NCT04777201|528356855|FG002|Main Study|Lost to Follow-up|0|||
146506036|NCT04777201|528356853|FG000|Main Study|Reason not specified|3|||
146567294|NCT00492557|528589753|FG000|Overall Study|Death|1|||
146506037|NCT04777201|528356854|FG001|Main Study|Reason not specified|3|||
146506038|NCT04777201|528356855|FG002|Main Study|Reason not specified|0|||
146506039|NCT04777201|528356853|FG000|Main Study|Lack of Efficacy|1|||
146567295|NCT00492557|528589754|FG001|Overall Study|Death|1|||
146567296|NCT00492557|528589753|FG000|Overall Study|Adverse Event|1|||
146567297|NCT00492557|528589754|FG001|Overall Study|Adverse Event|0|||
146567298|NCT00492557|528589753|FG000|Overall Study|Failed to return|1|||
146567299|NCT00492557|528589754|FG001|Overall Study|Failed to return|0|||
146567300|NCT00492557|528589753|FG000|Overall Study|Lost to Follow-up|0|||
146567301|NCT00492557|528589754|FG001|Overall Study|Lost to Follow-up|1|||
146567302|NCT04778592|528589756|FG000|Overall Study|Adverse Event|1|||
146567303|NCT04778592|528589757|FG001|Overall Study|Adverse Event|2|||
146567304|NCT04778592|528589756|FG000|Overall Study|Withdrawal by Subject|1|||
146567305|NCT04778592|528589757|FG001|Overall Study|Withdrawal by Subject|2|||
146567306|NCT03423602|528589758|FG000|Overall Study|Death|1|||
146567307|NCT03423602|528589758|FG000|Overall Study|Lost to Follow-up|6|||
146567308|NCT03423602|528589758|FG000|Overall Study|Protocol Violation|1|||
146567309|NCT03423602|528589758|FG000|Overall Study|Withdrawal by Subject|4|||
146567310|NCT03423121|528589759|FG000|Overall Study|Lost to Follow-up|2|||
146567311|NCT03423121|528589760|FG001|Overall Study|Lost to Follow-up|6|||
146567312|NCT03423121|528589759|FG000|Overall Study|Adverse Event|1|||
146567313|NCT03423121|528589760|FG001|Overall Study|Adverse Event|0|||
146567314|NCT01354223|528589761|FG000|Overall Study|Withdrawal by Subject|3|||
146567315|NCT01354223|528589762|FG001|Overall Study|Withdrawal by Subject|1|||
146567316|NCT01192126|528589763|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
146567317|NCT01192126|528589764|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
146567318|NCT01192126|528589763|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
146567319|NCT01192126|528589764|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
146567320|NCT01126190|528589768|FG000|Double-Blind Phase|Death|0|||
146567321|NCT01126190|528589769|FG001|Double-Blind Phase|Death|1|||
146567322|NCT01126190|528589770|FG002|Double-Blind Phase|Death|0|||
146567323|NCT01126190|528589768|FG000|Double-Blind Phase|Adverse Event|1|||
146567324|NCT01126190|528589769|FG001|Double-Blind Phase|Adverse Event|2|||
146567325|NCT01126190|528589770|FG002|Double-Blind Phase|Adverse Event|0|||
146567326|NCT01126190|528589768|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
146567327|NCT01126190|528589769|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
146567328|NCT01126190|528589770|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
146567329|NCT01126190|528589768|FG000|Double-Blind Phase|Request of Investigator|1|||
146769561|NCT00071799|529324852|FG000|Overall Study|Withdrawal by Subject|15|||
146769562|NCT00071799|529324853|FG001|Overall Study|Withdrawal by Subject|37|||
146769563|NCT00071799|529324852|FG000|Overall Study|Physician Decision|0|||
146567330|NCT01126190|528589769|FG001|Double-Blind Phase|Request of Investigator|0|||
146567331|NCT01126190|528589770|FG002|Double-Blind Phase|Request of Investigator|0|||
146567332|NCT01126190|528589768|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
146567333|NCT01126190|528589769|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
146567334|NCT01126190|528589770|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
146567335|NCT01126190|528589768|FG000|Double-Blind Phase|Non-compliance|1|||
146567336|NCT01126190|528589769|FG001|Double-Blind Phase|Non-compliance|0|||
146567337|NCT01126190|528589770|FG002|Double-Blind Phase|Non-compliance|0|||
146567338|NCT01126190|528589768|FG000|Double-Blind Phase|Lost to Follow-up|1|||
146567339|NCT01126190|528589769|FG001|Double-Blind Phase|Lost to Follow-up|3|||
146567340|NCT01126190|528589770|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146567341|NCT01126190|528589768|FG000|Open-Label Phase|Death|0|||
146567342|NCT01126190|528589769|FG001|Open-Label Phase|Death|0|||
146567343|NCT01126190|528589770|FG002|Open-Label Phase|Death|1|||
146567344|NCT01126190|528589768|FG000|Open-Label Phase|Adverse Event|0|||
146567345|NCT01126190|528589769|FG001|Open-Label Phase|Adverse Event|0|||
146567346|NCT01126190|528589770|FG002|Open-Label Phase|Adverse Event|4|||
146567347|NCT01126190|528589768|FG000|Open-Label Phase|Withdrawal by Subject|0|||
146567348|NCT01126190|528589769|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146567349|NCT01126190|528589770|FG002|Open-Label Phase|Withdrawal by Subject|6|||
146567350|NCT01114737|528589771|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
146567351|NCT01114737|528589772|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
146567352|NCT01114737|528589771|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
146567353|NCT01114737|528589772|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
146567354|NCT01114737|528589771|FG000|Randomized Treatment Period|Pregnancy|1|||
146567355|NCT01114737|528589772|FG001|Randomized Treatment Period|Pregnancy|0|||
146769564|NCT00071799|529324853|FG001|Overall Study|Physician Decision|2|||
146769565|NCT00071799|529324852|FG000|Overall Study|Lack of Efficacy|11|||
146912875|NCT01845077|529843206|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
146567356|NCT01114737|528589771|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
146567357|NCT01114737|528589772|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
146567358|NCT01114737|528589771|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
146567359|NCT01114737|528589772|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
146912876|NCT01845077|529843207|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
146567360|NCT01114737|528589771|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
146567361|NCT01114737|528589772|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
146567362|NCT02660229|528589776|FG000|Overall Study|Adverse Event|2|||
146567363|NCT02660229|528589777|FG001|Overall Study|Adverse Event|0|||
146567364|NCT02660229|528589776|FG000|Overall Study|Withdrawal by Subject|0|||
146567365|NCT02660229|528589777|FG001|Overall Study|Withdrawal by Subject|1|||
146567366|NCT01466491|528589778|FG000|Overall Study|Protocol Violation|0|||
146769566|NCT00071799|529324853|FG001|Overall Study|Lack of Efficacy|18|||
146506040|NCT04777201|528356854|FG001|Main Study|Lack of Efficacy|1|||
146506041|NCT04777201|528356855|FG002|Main Study|Lack of Efficacy|0|||
146506042|NCT04777201|528356853|FG000|Main Study|Protocol Violation|1|||
146506043|NCT04777201|528356854|FG001|Main Study|Protocol Violation|0|||
146506044|NCT04777201|528356855|FG002|Main Study|Protocol Violation|0|||
146506045|NCT04777201|528356853|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
146506046|NCT04777201|528356854|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
146506047|NCT04777201|528356855|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
146506048|NCT04777201|528356853|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
146506049|NCT04777201|528356854|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
146506050|NCT04777201|528356855|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
146506051|NCT04777201|528356853|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
146506052|NCT04777201|528356854|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
146506053|NCT04777201|528356855|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
146506054|NCT04777201|528356853|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
146506055|NCT04777201|528356854|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
146506056|NCT04777201|528356855|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
146506057|NCT04777201|528356853|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
146506058|NCT04777201|528356854|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
146506059|NCT04777201|528356855|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
146506060|NCT04777201|528356853|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
146506061|NCT04777201|528356854|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
146506062|NCT04777201|528356855|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
146506063|NCT02275780|528356856|FG000|Base Study: 96 Weeks|Adverse Event|6|||
146506064|NCT02275780|528356857|FG001|Base Study: 96 Weeks|Adverse Event|14|||
146506065|NCT02275780|528356856|FG000|Base Study: 96 Weeks|Death|3|||
146506066|NCT02275780|528356857|FG001|Base Study: 96 Weeks|Death|1|||
146506067|NCT02275780|528356856|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
146506068|NCT02275780|528356857|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
146567367|NCT01466491|528589779|FG001|Overall Study|Protocol Violation|3|||
146567368|NCT01466491|528589780|FG002|Overall Study|Protocol Violation|2|||
146567369|NCT01466491|528589781|FG003|Overall Study|Protocol Violation|0|||
146567370|NCT01466491|528589778|FG000|Overall Study|Missing Data|0|||
146567371|NCT01466491|528589779|FG001|Overall Study|Missing Data|0|||
146567372|NCT01466491|528589780|FG002|Overall Study|Missing Data|1|||
146567373|NCT01466491|528589781|FG003|Overall Study|Missing Data|0|||
146567374|NCT02727322|528589782|FG000|Overall Study|Withdrawal by Subject|1|||
146567375|NCT02727322|528589783|FG001|Overall Study|Withdrawal by Subject|1|||
146567376|NCT02727322|528589782|FG000|Overall Study|Protocol Violation|1|||
146567377|NCT02727322|528589783|FG001|Overall Study|Protocol Violation|0|||
146567378|NCT02852967|528589784|FG000|Overall Study|Adverse Event|3|||
146567379|NCT02852967|528589785|FG001|Overall Study|Adverse Event|1|||
146567380|NCT02852967|528589786|FG002|Overall Study|Adverse Event|0|||
146567381|NCT02852967|528589787|FG003|Overall Study|Adverse Event|1|||
146567382|NCT02852967|528589788|FG004|Overall Study|Adverse Event|0|||
146567383|NCT02852967|528589784|FG000|Overall Study|Death|1|||
146567384|NCT02852967|528589785|FG001|Overall Study|Death|0|||
146567385|NCT02852967|528589786|FG002|Overall Study|Death|0|||
146567386|NCT02852967|528589787|FG003|Overall Study|Death|0|||
146567387|NCT02852967|528589788|FG004|Overall Study|Death|0|||
146567388|NCT02852967|528589784|FG000|Overall Study|Lost to Follow-up|1|||
146567389|NCT02852967|528589785|FG001|Overall Study|Lost to Follow-up|2|||
146567390|NCT02852967|528589786|FG002|Overall Study|Lost to Follow-up|3|||
146567391|NCT02852967|528589787|FG003|Overall Study|Lost to Follow-up|4|||
146567392|NCT02852967|528589788|FG004|Overall Study|Lost to Follow-up|4|||
146567393|NCT02852967|528589784|FG000|Overall Study|Withdrawal by Subject|6|||
146567394|NCT02852967|528589785|FG001|Overall Study|Withdrawal by Subject|12|||
146567395|NCT02852967|528589786|FG002|Overall Study|Withdrawal by Subject|7|||
146567396|NCT02852967|528589787|FG003|Overall Study|Withdrawal by Subject|10|||
146567397|NCT02852967|528589788|FG004|Overall Study|Withdrawal by Subject|10|||
146567398|NCT02852967|528589784|FG000|Overall Study|SAE|0|||
146567399|NCT02852967|528589785|FG001|Overall Study|SAE|0|||
146567400|NCT02852967|528589786|FG002|Overall Study|SAE|0|||
146567401|NCT02852967|528589787|FG003|Overall Study|SAE|3|||
146567402|NCT02852967|528589788|FG004|Overall Study|SAE|0|||
146567403|NCT02852967|528589784|FG000|Overall Study|Elevated Liver Enzymes|2|||
146567404|NCT02852967|528589785|FG001|Overall Study|Elevated Liver Enzymes|0|||
146567405|NCT02852967|528589786|FG002|Overall Study|Elevated Liver Enzymes|0|||
146506069|NCT02275780|528356856|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
146506070|NCT02275780|528356857|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
146506071|NCT02275780|528356856|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
146567406|NCT02852967|528589787|FG003|Overall Study|Elevated Liver Enzymes|2|||
146567407|NCT02852967|528589788|FG004|Overall Study|Elevated Liver Enzymes|2|||
146567408|NCT02852967|528589784|FG000|Overall Study|Physician Decision|0|||
146567409|NCT02852967|528589785|FG001|Overall Study|Physician Decision|0|||
146567410|NCT02852967|528589786|FG002|Overall Study|Physician Decision|0|||
146648945|NCT01989468|528892950|FG002|Overall Study|Physician Decision|0|||
146648946|NCT01989468|528892951|FG003|Overall Study|Physician Decision|1|||
146506072|NCT02275780|528356857|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
146506073|NCT02275780|528356856|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
146506074|NCT02275780|528356857|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
146648947|NCT01989468|528892952|FG004|Overall Study|Physician Decision|0|||
146648948|NCT01989468|528892948|FG000|Overall Study|Pregnancy|0|||
146648949|NCT01989468|528892949|FG001|Overall Study|Pregnancy|1|||
146648950|NCT01989468|528892950|FG002|Overall Study|Pregnancy|0|||
146648951|NCT01989468|528892951|FG003|Overall Study|Pregnancy|0|||
146648952|NCT01989468|528892952|FG004|Overall Study|Pregnancy|0|||
146648953|NCT01989468|528892948|FG000|Overall Study|Technical Problems|3|||
146648954|NCT01989468|528892949|FG001|Overall Study|Technical Problems|1|||
146648955|NCT01989468|528892950|FG002|Overall Study|Technical Problems|3|||
146648956|NCT01989468|528892951|FG003|Overall Study|Technical Problems|1|||
146648957|NCT01989468|528892952|FG004|Overall Study|Technical Problems|0|||
146648958|NCT01989468|528892948|FG000|Overall Study|Subject Guardian Decision|11|||
146648959|NCT01989468|528892949|FG001|Overall Study|Subject Guardian Decision|6|||
146648960|NCT01989468|528892950|FG002|Overall Study|Subject Guardian Decision|4|||
146648961|NCT01989468|528892951|FG003|Overall Study|Subject Guardian Decision|4|||
146648962|NCT01989468|528892952|FG004|Overall Study|Subject Guardian Decision|1|||
146648963|NCT01989468|528892948|FG000|Overall Study|Death|3|||
146648964|NCT01989468|528892949|FG001|Overall Study|Death|0|||
146648965|NCT01989468|528892950|FG002|Overall Study|Death|1|||
146648966|NCT01989468|528892951|FG003|Overall Study|Death|0|||
146648967|NCT01989468|528892952|FG004|Overall Study|Death|0|||
146648968|NCT03222492|528892954|FG000|Overall Study|Withdrawal by Subject|0|||
146648969|NCT03222492|528892955|FG001|Overall Study|Withdrawal by Subject|0|||
146648970|NCT03222492|528892956|FG002|Overall Study|Withdrawal by Subject|1|||
146648971|NCT03222492|528892957|FG003|Overall Study|Withdrawal by Subject|0|||
146648972|NCT03222492|528892954|FG000|Overall Study|COVID-19 related|0|||
146506075|NCT02275780|528356856|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
146506076|NCT02275780|528356857|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
146506077|NCT02275780|528356856|FG000|Base Study: 96 Weeks|Physician Decision|2|||
146506078|NCT02275780|528356857|FG001|Base Study: 96 Weeks|Physician Decision|4|||
146506079|NCT02275780|528356856|FG000|Base Study: 96 Weeks|Pregnancy|2|||
146506080|NCT02275780|528356857|FG001|Base Study: 96 Weeks|Pregnancy|1|||
146567411|NCT02852967|528589787|FG003|Overall Study|Physician Decision|1|||
146567412|NCT02852967|528589788|FG004|Overall Study|Physician Decision|0|||
146567413|NCT02852967|528589784|FG000|Overall Study|Lack of Efficacy|0|||
146567414|NCT02852967|528589785|FG001|Overall Study|Lack of Efficacy|1|||
146567415|NCT02852967|528589786|FG002|Overall Study|Lack of Efficacy|0|||
146648973|NCT03222492|528892955|FG001|Overall Study|COVID-19 related|0|||
146648974|NCT03222492|528892956|FG002|Overall Study|COVID-19 related|1|||
146648975|NCT03222492|528892957|FG003|Overall Study|COVID-19 related|0|||
146648976|NCT00674154|528892958|FG000|Overall Study|Withdrawal by Subject|3|||
146648977|NCT00674154|528892959|FG001|Overall Study|Withdrawal by Subject|1|||
146648978|NCT00674154|528892958|FG000|Overall Study|Did not want parathyroidectomy|0|||
146648979|NCT00674154|528892959|FG001|Overall Study|Did not want parathyroidectomy|2|||
146648980|NCT00816023|528892960|FG000|Overall Study|Lost to Follow-up|1|||
146648981|NCT00816023|528892961|FG001|Overall Study|Lost to Follow-up|1|||
146648982|NCT00816023|528892962|FG002|Overall Study|Lost to Follow-up|0|||
146648983|NCT00816023|528892963|FG003|Overall Study|Lost to Follow-up|0|||
146648984|NCT00816023|528892960|FG000|Overall Study|Withdrawal by Subject|1|||
146648985|NCT00816023|528892961|FG001|Overall Study|Withdrawal by Subject|0|||
146648986|NCT00816023|528892962|FG002|Overall Study|Withdrawal by Subject|0|||
146648987|NCT00816023|528892963|FG003|Overall Study|Withdrawal by Subject|0|||
146769567|NCT00071799|529324852|FG000|Overall Study|Disease Progression|23|||
146506081|NCT02275780|528356856|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
146567416|NCT02852967|528589787|FG003|Overall Study|Lack of Efficacy|0|||
146506082|NCT02275780|528356857|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
146506083|NCT02275780|528356856|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
146567417|NCT02852967|528589788|FG004|Overall Study|Lack of Efficacy|0|||
146567418|NCT02852967|528589784|FG000|Overall Study|Non-compliance|0|||
146567419|NCT02852967|528589785|FG001|Overall Study|Non-compliance|0|||
146567420|NCT02852967|528589786|FG002|Overall Study|Non-compliance|1|||
146567421|NCT02852967|528589787|FG003|Overall Study|Non-compliance|1|||
146648988|NCT00816023|528892960|FG000|Overall Study|Physician Decision|0|||
146648989|NCT00816023|528892961|FG001|Overall Study|Physician Decision|0|||
146648990|NCT00816023|528892962|FG002|Overall Study|Physician Decision|1|||
146648991|NCT00816023|528892963|FG003|Overall Study|Physician Decision|0|||
146648992|NCT00816023|528892960|FG000|Overall Study|assessments complete prior to window|1|||
146648993|NCT00816023|528892961|FG001|Overall Study|assessments complete prior to window|1|||
146648994|NCT00816023|528892962|FG002|Overall Study|assessments complete prior to window|2|||
146648995|NCT00816023|528892963|FG003|Overall Study|assessments complete prior to window|1|||
146648996|NCT00816023|528892960|FG000|Overall Study|Randomized Not Treated|6|||
146648997|NCT00816023|528892961|FG001|Overall Study|Randomized Not Treated|4|||
146648998|NCT00816023|528892962|FG002|Overall Study|Randomized Not Treated|6|||
146506084|NCT02275780|528356857|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
146506085|NCT02275780|528356856|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
146506086|NCT02275780|528356857|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
146506087|NCT02275780|528356856|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
146506088|NCT02275780|528356857|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
146506089|NCT02275780|528356856|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
146506090|NCT02275780|528356857|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
146506091|NCT02275780|528356856|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
146506092|NCT02275780|528356857|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
146506093|NCT02275780|528356856|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
146506094|NCT02275780|528356857|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
146506095|NCT02275780|528356856|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
146506096|NCT02275780|528356857|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
146506097|NCT02275780|528356856|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
146506098|NCT02275780|528356857|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
146506099|NCT02275780|528356856|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
146506100|NCT02275780|528356857|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
146506101|NCT02275780|528356856|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
146506102|NCT02275780|528356857|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
146506103|NCT02275780|528356856|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
146506104|NCT02275780|528356857|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
146506105|NCT02275780|528356856|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
146506106|NCT02275780|528356857|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
146506107|NCT02275780|528356856|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
146506108|NCT02275780|528356857|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
146506109|NCT02275780|528356856|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
146506110|NCT02275780|528356857|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
146506111|NCT02275780|528356856|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
146506112|NCT02275780|528356857|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
146506113|NCT02275780|528356856|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
146506114|NCT02275780|528356857|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
146506115|NCT02275780|528356856|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
146506116|NCT02275780|528356857|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
146567422|NCT02852967|528589788|FG004|Overall Study|Non-compliance|0|||
146567423|NCT02852967|528589784|FG000|Overall Study|Dispensing Drug Violation|0|||
146567424|NCT02852967|528589785|FG001|Overall Study|Dispensing Drug Violation|0|||
146567425|NCT02852967|528589786|FG002|Overall Study|Dispensing Drug Violation|1|||
146567426|NCT02852967|528589787|FG003|Overall Study|Dispensing Drug Violation|0|||
146567427|NCT02852967|528589788|FG004|Overall Study|Dispensing Drug Violation|0|||
146567428|NCT02852967|528589784|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
146567429|NCT02852967|528589785|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
146567430|NCT02852967|528589786|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
146567431|NCT02852967|528589787|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
146567432|NCT02852967|528589788|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
146567433|NCT01123148|528589789|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
146567434|NCT01123148|528589789|FG000|Overall Study|Didn't meet milestone criteria|1|||
146567435|NCT03046446|528589790|FG000|Overall Study|Lack of Efficacy|7|||
146567436|NCT03046446|528589790|FG000|Overall Study|Adverse Event|6|||
146567437|NCT03046446|528589790|FG000|Overall Study|Lost to Follow-up|3|||
146567438|NCT03046446|528589790|FG000|Overall Study|Withdrawal by Subject|14|||
146567439|NCT03046446|528589790|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
146567440|NCT03046446|528589790|FG000|Overall Study|Disease Progression (see caveats)|25|||
146567441|NCT03046446|528589790|FG000|Overall Study|Non OA related knee surgery|1|||
146567442|NCT02808897|528589791|FG000|Overall Study|Lost to Follow-up|9|||
146567443|NCT02808897|528589792|FG001|Overall Study|Lost to Follow-up|11|||
146567444|NCT01496287|528589793|FG000|Overall Study|Lost to Follow-up|1|||
146567445|NCT01496287|528589793|FG000|Overall Study|Incomplete anesthesia|5|||
146567446|NCT03012334|528589794|FG000|Period 1|Withdrawal by Subject|0|||
146567447|NCT03012334|528589795|FG001|Period 1|Withdrawal by Subject|0|||
146567448|NCT03012334|528589796|FG002|Period 1|Withdrawal by Subject|0|||
146567449|NCT03012334|528589797|FG003|Period 1|Withdrawal by Subject|0|||
146567450|NCT03012334|528589798|FG004|Period 1|Withdrawal by Subject|0|||
146567451|NCT03012334|528589799|FG005|Period 1|Withdrawal by Subject|0|||
146567452|NCT03012334|528589800|FG006|Period 1|Withdrawal by Subject|0|||
146567453|NCT03012334|528589801|FG007|Period 1|Withdrawal by Subject|0|||
146567454|NCT03012334|528589802|FG008|Period 1|Withdrawal by Subject|0|||
146567455|NCT03012334|528589803|FG009|Period 1|Withdrawal by Subject|1|||
146567456|NCT03012334|528589794|FG000|Period 2|Withdrawal by Subject|0|||
146648999|NCT00816023|528892963|FG003|Overall Study|Randomized Not Treated|11|||
146649000|NCT04449029|528892964|FG000|Overall Study|Adverse Event|0|||
146649001|NCT04449029|528892965|FG001|Overall Study|Adverse Event|1|||
146649002|NCT04449029|528892966|FG002|Overall Study|Adverse Event|1|||
146649003|NCT04449029|528892967|FG003|Overall Study|Adverse Event|0|||
146649004|NCT04449029|528892968|FG004|Overall Study|Adverse Event|1|||
146506117|NCT02275780|528356856|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
146506118|NCT02275780|528356857|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
146506119|NCT02275780|528356856|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
146506120|NCT02275780|528356857|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
146506121|NCT02275780|528356856|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
146506122|NCT02275780|528356857|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
146506123|NCT02275780|528356856|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
146506124|NCT02275780|528356857|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
146506125|NCT01054300|528356860|FG000|Period 1|Adverse Event|1|||
146506126|NCT01054300|528356861|FG001|Period 1|Adverse Event|0|||
146506127|NCT01054300|528356862|FG002|Period 1|Adverse Event|0|||
146506128|NCT01054300|528356863|FG003|Period 1|Adverse Event|0|||
146506129|NCT01054300|528356860|FG000|Period 2|Withdrawal by Subject|0|||
146506130|NCT01054300|528356861|FG001|Period 2|Withdrawal by Subject|0|||
146506131|NCT01054300|528356862|FG002|Period 2|Withdrawal by Subject|1|||
146506132|NCT01054300|528356863|FG003|Period 2|Withdrawal by Subject|0|||
146506133|NCT00738881|528356867|FG000|Overall Study|Withdrawal by Subject|0|||
146506134|NCT00738881|528356868|FG001|Overall Study|Withdrawal by Subject|2|||
146506135|NCT01041976|528356869|FG000|Overall Study|Withdrawal by Subject|3|||
146506136|NCT01041976|528356870|FG001|Overall Study|Withdrawal by Subject|0|||
146506137|NCT01041976|528356869|FG000|Overall Study|Incarceration|2|||
146506138|NCT01041976|528356870|FG001|Overall Study|Incarceration|0|||
146506139|NCT01041976|528356869|FG000|Overall Study|Death|0|||
146506140|NCT01041976|528356870|FG001|Overall Study|Death|4|||
146506141|NCT02370667|528356871|FG000|Overall Study|Lost to Follow-up|0|||
146506142|NCT02370667|528356872|FG001|Overall Study|Lost to Follow-up|1|||
146506143|NCT02370667|528356873|FG002|Overall Study|Lost to Follow-up|0|||
146506144|NCT02612610|528356874|FG000|Overall Study|Withdrawal by Subject|1|||
146506145|NCT02612610|528356875|FG001|Overall Study|Withdrawal by Subject|1|||
146506146|NCT02612610|528356876|FG002|Overall Study|Withdrawal by Subject|0|||
146506147|NCT02612610|528356877|FG003|Overall Study|Withdrawal by Subject|2|||
146506148|NCT02612610|528356874|FG000|Overall Study|Adverse Event|2|||
146506149|NCT02612610|528356875|FG001|Overall Study|Adverse Event|2|||
146506150|NCT02612610|528356876|FG002|Overall Study|Adverse Event|3|||
146506151|NCT02612610|528356877|FG003|Overall Study|Adverse Event|10|||
146506152|NCT02612610|528356874|FG000|Overall Study|Lost to Follow-up|0|||
146506153|NCT02612610|528356875|FG001|Overall Study|Lost to Follow-up|1|||
146506154|NCT02612610|528356876|FG002|Overall Study|Lost to Follow-up|0|||
146506155|NCT02612610|528356877|FG003|Overall Study|Lost to Follow-up|0|||
146506156|NCT02612610|528356874|FG000|Overall Study|Protocol Violation|0|||
146506157|NCT02612610|528356875|FG001|Overall Study|Protocol Violation|1|||
146506158|NCT02612610|528356876|FG002|Overall Study|Protocol Violation|1|||
146506159|NCT02612610|528356877|FG003|Overall Study|Protocol Violation|0|||
146506160|NCT02612610|528356874|FG000|Overall Study|Lack of Efficacy|1|||
146506161|NCT02612610|528356875|FG001|Overall Study|Lack of Efficacy|2|||
146506162|NCT02612610|528356876|FG002|Overall Study|Lack of Efficacy|0|||
146506163|NCT02612610|528356877|FG003|Overall Study|Lack of Efficacy|1|||
146506164|NCT02612610|528356874|FG000|Overall Study|Physician Decision|0|||
146506165|NCT02612610|528356875|FG001|Overall Study|Physician Decision|1|||
146506166|NCT02612610|528356876|FG002|Overall Study|Physician Decision|0|||
146506167|NCT02612610|528356877|FG003|Overall Study|Physician Decision|0|||
146506168|NCT02612610|528356874|FG000|Overall Study|Noncompliance|1|||
146506169|NCT02612610|528356875|FG001|Overall Study|Noncompliance|0|||
146506170|NCT02612610|528356876|FG002|Overall Study|Noncompliance|0|||
146506171|NCT02612610|528356877|FG003|Overall Study|Noncompliance|0|||
146506172|NCT02612610|528356874|FG000|Overall Study|Cough Improvement|0|||
146506173|NCT02612610|528356875|FG001|Overall Study|Cough Improvement|0|||
146506174|NCT02612610|528356876|FG002|Overall Study|Cough Improvement|1|||
146506175|NCT02612610|528356877|FG003|Overall Study|Cough Improvement|0|||
146506176|NCT00176644|528356878|FG000|Overall Study|Withdrawal by Subject|1|||
146506177|NCT01801280|528356879|FG000|Period 1|Withdrawal by Subject|0|||
146506178|NCT01801280|528356880|FG001|Period 1|Withdrawal by Subject|1|||
146506179|NCT01801280|528356881|FG002|Period 1|Withdrawal by Subject|0|||
146506180|NCT01801280|528356882|FG003|Period 1|Withdrawal by Subject|0|||
146506181|NCT01801280|528356879|FG000|Period 2|Withdrawal by Subject|1|||
146506182|NCT01801280|528356880|FG001|Period 2|Withdrawal by Subject|0|||
146506183|NCT01801280|528356881|FG002|Period 2|Withdrawal by Subject|0|||
146506184|NCT01801280|528356882|FG003|Period 2|Withdrawal by Subject|0|||
146506185|NCT01801280|528356879|FG000|Period 4|Protocol Violation|0|||
146506186|NCT01801280|528356880|FG001|Period 4|Protocol Violation|0|||
146506187|NCT01801280|528356881|FG002|Period 4|Protocol Violation|1|||
146649005|NCT04449029|528892969|FG005|Overall Study|Adverse Event|0|||
146506188|NCT01801280|528356882|FG003|Period 4|Protocol Violation|0|||
146506189|NCT01866657|528356888|FG000|Overall Study|Surgery canceled|2|||
146506190|NCT01866657|528356889|FG001|Overall Study|Surgery canceled|0|||
146506191|NCT03973918|528356892|FG000|Overall Study|Adverse Event|0|||
146506192|NCT03973918|528356893|FG001|Overall Study|Adverse Event|0|||
146506193|NCT03973918|528356894|FG002|Overall Study|Adverse Event|0|||
146506194|NCT03973918|528356895|FG003|Overall Study|Adverse Event|1|||
146506195|NCT03973918|528356892|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
146506196|NCT03973918|528356893|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
146506197|NCT03973918|528356894|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
146506198|NCT03973918|528356895|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
146506199|NCT04351373|528356896|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
146506200|NCT02880865|528356904|FG000|Overall Study|Adverse Event|1|||
146506201|NCT02880865|528356905|FG001|Overall Study|Adverse Event|0|||
146506202|NCT02880865|528356904|FG000|Overall Study|Withdrawal by Subject|0|||
146506203|NCT02880865|528356905|FG001|Overall Study|Withdrawal by Subject|2|||
146506204|NCT02880865|528356904|FG000|Overall Study|Physician Decision|0|||
146506205|NCT02880865|528356905|FG001|Overall Study|Physician Decision|1|||
146506206|NCT03045276|528356907|FG000|Intervention Phase|Withdrawal by Subject|7|||
146506207|NCT03045276|528356908|FG001|Intervention Phase|Withdrawal by Subject|2|||
146506208|NCT03045276|528356909|FG002|Intervention Phase|Withdrawal by Subject|3|||
146506209|NCT03045276|528356910|FG003|Intervention Phase|Withdrawal by Subject|7|||
146506210|NCT03045276|528356907|FG000|Intervention Phase|Developed exclusionary criteria|3|||
146506211|NCT03045276|528356908|FG001|Intervention Phase|Developed exclusionary criteria|3|||
146506212|NCT03045276|528356909|FG002|Intervention Phase|Developed exclusionary criteria|0|||
146506213|NCT03045276|528356910|FG003|Intervention Phase|Developed exclusionary criteria|0|||
146506214|NCT03045276|528356907|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
146506215|NCT03045276|528356908|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
146506216|NCT03045276|528356909|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
146506217|NCT03045276|528356910|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
146506218|NCT03045276|528356907|FG000|Follow-Up Phase|Lost to Follow-up|0|||
146506219|NCT03045276|528356908|FG001|Follow-Up Phase|Lost to Follow-up|1|||
146506220|NCT03045276|528356909|FG002|Follow-Up Phase|Lost to Follow-up|0|||
146506221|NCT03045276|528356910|FG003|Follow-Up Phase|Lost to Follow-up|1|||
146506222|NCT03045276|528356907|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
146506223|NCT03045276|528356908|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
146506224|NCT03045276|528356909|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
146506225|NCT03045276|528356910|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
146506226|NCT02375555|528356931|FG000|Induction Period|Adverse Event|7|||
146506227|NCT02375555|528356931|FG000|Induction Period|Withdrawal by Subject|2|||
146506228|NCT02375555|528356931|FG000|Induction Period|Other|1|||
146506229|NCT02375555|528356931|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
146506230|NCT02375555|528356931|FG000|Maintenance Period|Adverse Event|2|||
146506231|NCT02375555|528356931|FG000|Maintenance Period|Withdrawal by Subject|4|||
146506232|NCT02375555|528356931|FG000|Maintenance Period|Death|1|||
146506233|NCT02375555|528356931|FG000|Maintenance Period|Disease Progression|5|||
146506234|NCT02375555|528356931|FG000|Maintenance Period|Patient Non-compliance|1|||
146506235|NCT02375555|528356931|FG000|Maintenance Period|Still on maintenance|16|||
146506236|NCT02548351|528356936|FG000|Overall Study|Withdrawal by Subject|149|||
146506237|NCT02548351|528356937|FG001|Overall Study|Withdrawal by Subject|154|||
146506238|NCT02548351|528356938|FG002|Overall Study|Withdrawal by Subject|152|||
146506239|NCT02548351|528356936|FG000|Overall Study|Death|11|||
146506240|NCT02548351|528356937|FG001|Overall Study|Death|15|||
146506241|NCT02548351|528356938|FG002|Overall Study|Death|12|||
146506242|NCT02548351|528356936|FG000|Overall Study|Adverse Event|22|||
146506243|NCT02548351|528356937|FG001|Overall Study|Adverse Event|56|||
146506244|NCT02548351|528356938|FG002|Overall Study|Adverse Event|36|||
146506245|NCT02548351|528356936|FG000|Overall Study|Study Terminated by Sponsor|549|||
146506246|NCT02548351|528356937|FG001|Overall Study|Study Terminated by Sponsor|509|||
146506247|NCT02548351|528356938|FG002|Overall Study|Study Terminated by Sponsor|528|||
146506248|NCT02548351|528356936|FG000|Overall Study|Site Closure|14|||
146506249|NCT02548351|528356937|FG001|Overall Study|Site Closure|5|||
146506250|NCT02548351|528356938|FG002|Overall Study|Site Closure|7|||
146506251|NCT02548351|528356936|FG000|Overall Study|Non-compliance with Study Drug|4|||
146506252|NCT02548351|528356937|FG001|Overall Study|Non-compliance with Study Drug|2|||
146506253|NCT02548351|528356938|FG002|Overall Study|Non-compliance with Study Drug|0|||
146506254|NCT02548351|528356936|FG000|Overall Study|Protocol Violation|2|||
146506255|NCT02548351|528356937|FG001|Overall Study|Protocol Violation|1|||
146506256|NCT02548351|528356938|FG002|Overall Study|Protocol Violation|2|||
146506257|NCT02548351|528356936|FG000|Overall Study|Physician Decision|11|||
146506258|NCT02548351|528356937|FG001|Overall Study|Physician Decision|18|||
146506259|NCT02548351|528356938|FG002|Overall Study|Physician Decision|11|||
146506260|NCT02548351|528356936|FG000|Overall Study|Lost to Follow-up|43|||
146506261|NCT02548351|528356937|FG001|Overall Study|Lost to Follow-up|50|||
146506262|NCT02548351|528356938|FG002|Overall Study|Lost to Follow-up|57|||
146506263|NCT02548351|528356936|FG000|Overall Study|Other|19|||
146506264|NCT02548351|528356937|FG001|Overall Study|Other|16|||
146506265|NCT02548351|528356938|FG002|Overall Study|Other|20|||
146506266|NCT02548351|528356936|FG000|Overall Study|Missing|1|||
146506267|NCT02548351|528356937|FG001|Overall Study|Missing|1|||
146506268|NCT02548351|528356938|FG002|Overall Study|Missing|0|||
146506269|NCT01744184|528356939|FG000|Overall Study|Adverse Event|1|||
146506270|NCT01744184|528356940|FG001|Overall Study|Adverse Event|0|||
146506271|NCT01744184|528356939|FG000|Overall Study|Withdrawal by Subject|0|||
146506272|NCT01744184|528356940|FG001|Overall Study|Withdrawal by Subject|1|||
146506273|NCT02091986|528356944|FG000|Overall Study|7 rand in error 1 patient decision|2|||
146506274|NCT02091986|528356945|FG001|Overall Study|7 rand in error 1 patient decision|3|||
146506275|NCT02091986|528356946|FG002|Overall Study|7 rand in error 1 patient decision|3|||
146506276|NCT02091986|528356944|FG000|Overall Study|Lost to Follow-up|1|||
146506277|NCT02091986|528356945|FG001|Overall Study|Lost to Follow-up|0|||
146506278|NCT02091986|528356946|FG002|Overall Study|Lost to Follow-up|0|||
146506279|NCT02091986|528356944|FG000|Overall Study|Withdrawal by Subject|4|||
146506280|NCT02091986|528356945|FG001|Overall Study|Withdrawal by Subject|8|||
146506281|NCT02091986|528356946|FG002|Overall Study|Withdrawal by Subject|3|||
146506282|NCT02091986|528356944|FG000|Overall Study|Adverse Event|0|||
146506283|NCT02091986|528356945|FG001|Overall Study|Adverse Event|0|||
146506284|NCT02091986|528356946|FG002|Overall Study|Adverse Event|2|||
146506285|NCT00125242|528356947|FG000|Overall Study|did not qualify|7|||
146506286|NCT00125242|528356948|FG001|Overall Study|did not qualify|2|||
146506287|NCT01664949|528356951|FG000|Overall Study|Adverse Event|11|||
146506288|NCT01664949|528356952|FG001|Overall Study|Adverse Event|12|||
146506289|NCT01664949|528356951|FG000|Overall Study|Lack of Efficacy|1|||
146506290|NCT01664949|528356952|FG001|Overall Study|Lack of Efficacy|1|||
146506291|NCT01664949|528356951|FG000|Overall Study|Lost to Follow-up|1|||
146506292|NCT01664949|528356952|FG001|Overall Study|Lost to Follow-up|2|||
146506293|NCT01664949|528356951|FG000|Overall Study|Personal Reasons|3|||
146506294|NCT01664949|528356952|FG001|Overall Study|Personal Reasons|4|||
146506295|NCT01664949|528356951|FG000|Overall Study|Protocol Violation|5|||
146506296|NCT01664949|528356952|FG001|Overall Study|Protocol Violation|5|||
146506297|NCT01664949|528356951|FG000|Overall Study|Other Miscellaneous Reasons|3|||
146506298|NCT01664949|528356952|FG001|Overall Study|Other Miscellaneous Reasons|1|||
146506299|NCT02537431|528356957|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
146506300|NCT00794040|528356958|FG000|Overall Study|Withdrawal by Subject|3|||
146506301|NCT00794040|528356959|FG001|Overall Study|Withdrawal by Subject|4|||
146506302|NCT00794040|528356958|FG000|Overall Study|Physician Decision|0|||
146506303|NCT00794040|528356959|FG001|Overall Study|Physician Decision|1|||
146506304|NCT01263782|528356960|FG000|Overall Study|Death|0|||
146506305|NCT01263782|528356961|FG001|Overall Study|Death|0|||
146506306|NCT01263782|528356962|FG002|Overall Study|Death|1|||
146506307|NCT01263782|528356963|FG003|Overall Study|Death|0|||
146506308|NCT01263782|528356960|FG000|Overall Study|Progressive disease|0|||
146506309|NCT01263782|528356961|FG001|Overall Study|Progressive disease|0|||
146506310|NCT01263782|528356962|FG002|Overall Study|Progressive disease|0|||
146506311|NCT01263782|528356963|FG003|Overall Study|Progressive disease|1|||
146506312|NCT01263782|528356960|FG000|Overall Study|Too early|0|||
146506313|NCT01263782|528356961|FG001|Overall Study|Too early|0|||
146506314|NCT01263782|528356962|FG002|Overall Study|Too early|1|||
146506315|NCT01263782|528356963|FG003|Overall Study|Too early|0|||
146506316|NCT01263782|528356960|FG000|Overall Study|Inevaluable|0|||
146506317|NCT01263782|528356961|FG001|Overall Study|Inevaluable|0|||
146506318|NCT01263782|528356962|FG002|Overall Study|Inevaluable|1|||
146506319|NCT01263782|528356963|FG003|Overall Study|Inevaluable|0|||
146506320|NCT00915876|528356964|FG000|Overall Study|Adverse Event|0|||
146567457|NCT03012334|528589795|FG001|Period 2|Withdrawal by Subject|1|||
146567458|NCT03012334|528589796|FG002|Period 2|Withdrawal by Subject|0|||
146506321|NCT00915876|528356965|FG001|Overall Study|Adverse Event|1|||
146506322|NCT04545567|528356967|FG000|Overall Study|tested positive for SARS-co-V2|1|||
146506323|NCT04545567|528356968|FG001|Overall Study|tested positive for SARS-co-V2|1|||
146506324|NCT04545567|528356967|FG000|Overall Study|Withdrawal by Subject|0|||
146506325|NCT04545567|528356968|FG001|Overall Study|Withdrawal by Subject|1|||
146506326|NCT02419612|528356972|FG000|Short-term Treatment Period|Adverse Event|1|||
146506327|NCT02419612|528356973|FG001|Short-term Treatment Period|Adverse Event|1|||
146506328|NCT02419612|528356972|FG000|Short-term Treatment Period|Death|0|||
146567459|NCT03012334|528589797|FG003|Period 2|Withdrawal by Subject|0|||
146506329|NCT02419612|528356973|FG001|Short-term Treatment Period|Death|2|||
146506330|NCT02419612|528356972|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
146506331|NCT02419612|528356973|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
146506332|NCT02419612|528356972|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
146506333|NCT02419612|528356973|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
146506334|NCT02419612|528356972|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
146506335|NCT02419612|528356973|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
146506336|NCT02419612|528356972|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
146506337|NCT02419612|528356973|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
146567460|NCT03012334|528589798|FG004|Period 2|Withdrawal by Subject|0|||
146567461|NCT03012334|528589799|FG005|Period 2|Withdrawal by Subject|0|||
146567462|NCT03012334|528589800|FG006|Period 2|Withdrawal by Subject|0|||
146567463|NCT03012334|528589801|FG007|Period 2|Withdrawal by Subject|0|||
146567464|NCT03012334|528589802|FG008|Period 2|Withdrawal by Subject|0|||
146567465|NCT03012334|528589803|FG009|Period 2|Withdrawal by Subject|0|||
146567466|NCT03012334|528589794|FG000|Period 2|Protocol Violation|0|||
146567467|NCT03012334|528589795|FG001|Period 2|Protocol Violation|0|||
146567468|NCT03012334|528589796|FG002|Period 2|Protocol Violation|1|||
146567469|NCT03012334|528589797|FG003|Period 2|Protocol Violation|0|||
146567470|NCT03012334|528589798|FG004|Period 2|Protocol Violation|0|||
146567471|NCT03012334|528589799|FG005|Period 2|Protocol Violation|0|||
146567472|NCT03012334|528589800|FG006|Period 2|Protocol Violation|0|||
146567473|NCT03012334|528589801|FG007|Period 2|Protocol Violation|1|||
146567474|NCT03012334|528589802|FG008|Period 2|Protocol Violation|0|||
146567475|NCT03012334|528589803|FG009|Period 2|Protocol Violation|0|||
146567476|NCT03012334|528589794|FG000|Period 4|Non-Compliance|0|||
146567477|NCT03012334|528589795|FG001|Period 4|Non-Compliance|0|||
146567478|NCT03012334|528589796|FG002|Period 4|Non-Compliance|0|||
146567479|NCT03012334|528589797|FG003|Period 4|Non-Compliance|0|||
146567480|NCT03012334|528589798|FG004|Period 4|Non-Compliance|0|||
146567481|NCT03012334|528589799|FG005|Period 4|Non-Compliance|0|||
146567482|NCT03012334|528589800|FG006|Period 4|Non-Compliance|1|||
146567483|NCT03012334|528589801|FG007|Period 4|Non-Compliance|0|||
146567484|NCT03012334|528589802|FG008|Period 4|Non-Compliance|0|||
146567485|NCT03012334|528589803|FG009|Period 4|Non-Compliance|0|||
146567486|NCT03012334|528589794|FG000|Period 4|Adverse Event|0|||
146567487|NCT03012334|528589795|FG001|Period 4|Adverse Event|0|||
146567488|NCT03012334|528589796|FG002|Period 4|Adverse Event|0|||
146567489|NCT03012334|528589797|FG003|Period 4|Adverse Event|0|||
146567490|NCT03012334|528589798|FG004|Period 4|Adverse Event|0|||
146567491|NCT03012334|528589799|FG005|Period 4|Adverse Event|0|||
146567492|NCT03012334|528589800|FG006|Period 4|Adverse Event|0|||
146567493|NCT03012334|528589801|FG007|Period 4|Adverse Event|0|||
146567494|NCT03012334|528589802|FG008|Period 4|Adverse Event|1|||
146567495|NCT03012334|528589803|FG009|Period 4|Adverse Event|0|||
146567496|NCT01823107|528589804|FG000|Overall Study|Withdrawal by Subject|1|||
146567497|NCT00256126|528589805|FG000|Overall Study|Adverse Event|1|||
146567498|NCT00256126|528589806|FG001|Overall Study|Adverse Event|0|||
146567499|NCT00256126|528589805|FG000|Overall Study|Other|1|||
146567500|NCT00256126|528589806|FG001|Overall Study|Other|2|||
146567501|NCT00800735|528589807|FG000|Overall Study|Administrative/Other|2|||
146567502|NCT00800735|528589807|FG000|Overall Study|Insufficient Therapeutic Response|2|||
146567503|NCT00800735|528589807|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
146567504|NCT00800735|528589807|FG000|Overall Study|Withdrew Consent|3|||
146567505|NCT02154061|528589808|FG000|Overall Study|Pregnancy|1|||
146567506|NCT02154061|528589809|FG001|Overall Study|Pregnancy|0|||
146567507|NCT02154061|528589808|FG000|Overall Study|enrolled but not vaccinated|1|||
146567508|NCT02154061|528589809|FG001|Overall Study|enrolled but not vaccinated|0|||
146567509|NCT01936831|528589815|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
146567510|NCT01936831|528589816|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
146567511|NCT01936831|528589817|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
146567512|NCT01936831|528589818|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
146567513|NCT01936831|528589819|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
146567514|NCT01936831|528589820|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
146567515|NCT01936831|528589821|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
146567516|NCT01936831|528589822|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
146567517|NCT01936831|528589823|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
146567518|NCT02133573|528589824|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
146567519|NCT02133573|528589825|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
146567520|NCT02133573|528589824|FG000|Overall Study|Child Deaths|3|||
146567521|NCT02133573|528589825|FG001|Overall Study|Child Deaths|5|||
146567522|NCT02133573|528589824|FG000|Overall Study|Child Declined Follow Ups|2|||
146567523|NCT02133573|528589825|FG001|Overall Study|Child Declined Follow Ups|1|||
146567524|NCT02133573|528589824|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
146567525|NCT02133573|528589825|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
146567526|NCT00454116|528589827|FG000|Overall Study|Adverse Event|5|||
146567527|NCT00454116|528589828|FG001|Overall Study|Adverse Event|11|||
146567528|NCT00454116|528589829|FG002|Overall Study|Adverse Event|9|||
146567529|NCT00454116|528589827|FG000|Overall Study|Condition under investigation worsened|17|||
146567530|NCT00454116|528589828|FG001|Overall Study|Condition under investigation worsened|13|||
146567531|NCT00454116|528589829|FG002|Overall Study|Condition under investigation worsened|18|||
146567532|NCT00454116|528589827|FG000|Overall Study|Withdrawal by Subject|3|||
146567533|NCT00454116|528589828|FG001|Overall Study|Withdrawal by Subject|3|||
146567534|NCT00454116|528589829|FG002|Overall Study|Withdrawal by Subject|1|||
146567535|NCT00454116|528589827|FG000|Overall Study|Other|2|||
146567536|NCT00454116|528589828|FG001|Overall Study|Other|2|||
146567537|NCT00454116|528589829|FG002|Overall Study|Other|0|||
146567538|NCT02431325|528589832|FG000|Overall Study|Adverse Event|3|||
146506338|NCT02419612|528356972|FG000|Short-term Treatment Period|Worsening of liver function|0|||
146506339|NCT02419612|528356973|FG001|Short-term Treatment Period|Worsening of liver function|1|||
146506340|NCT02419612|528356972|FG000|Short-term Treatment Period|Subject moved out of state|0|||
146506341|NCT02419612|528356973|FG001|Short-term Treatment Period|Subject moved out of state|1|||
146506342|NCT02419612|528356972|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
146506343|NCT02419612|528356973|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
146506344|NCT02419612|528356972|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
146506345|NCT02419612|528356973|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
146506346|NCT02419612|528356972|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
146506347|NCT02419612|528356973|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
146506348|NCT02419612|528356972|FG000|Long-term Treatment Period|Death|0|||
146506349|NCT02419612|528356973|FG001|Long-term Treatment Period|Death|1|||
146506350|NCT02419612|528356972|FG000|Long-term Treatment Period|Adverse Event|0|||
146506351|NCT02419612|528356973|FG001|Long-term Treatment Period|Adverse Event|5|||
146506352|NCT02419612|528356972|FG000|Long-term Treatment Period|Other|4|||
146506353|NCT02419612|528356973|FG001|Long-term Treatment Period|Other|4|||
146506354|NCT02419612|528356972|FG000|Long-term Treatment Period|Subject Decision|2|||
146506355|NCT02419612|528356973|FG001|Long-term Treatment Period|Subject Decision|4|||
146506356|NCT02419612|528356972|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
146506357|NCT02419612|528356973|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
146506358|NCT03626363|528356974|FG000|Overall Study|Protocol Violation|4|||
146506359|NCT03626363|528356975|FG001|Overall Study|Protocol Violation|0|||
146506360|NCT03626363|528356974|FG000|Overall Study|Lost to Follow-up|5|||
146506361|NCT03626363|528356975|FG001|Overall Study|Lost to Follow-up|7|||
146506362|NCT00533702|528356976|FG000|Overall Study|Withdrawal by Subject|3|||
146506363|NCT00533702|528356977|FG001|Overall Study|Withdrawal by Subject|1|||
146506364|NCT00533702|528356976|FG000|Overall Study|Found ineligible after randomization|2|||
146506365|NCT00533702|528356977|FG001|Overall Study|Found ineligible after randomization|1|||
146506366|NCT01095978|528356978|FG000|Overall Study|Did not take Klacid SR|2|||
146506367|NCT01095978|528356978|FG000|Overall Study|Adverse Event|1|||
146506368|NCT00960986|528356986|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
146506369|NCT00960986|528356987|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
146506370|NCT00960986|528356988|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
146506371|NCT00960986|528356989|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
146506372|NCT00960986|528356986|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
146506373|NCT00960986|528356987|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
146506374|NCT00960986|528356988|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
146506375|NCT00960986|528356989|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
146506376|NCT00960986|528356986|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
146506377|NCT00960986|528356987|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
146506378|NCT00960986|528356988|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
146506379|NCT00960986|528356989|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
146506380|NCT00960986|528356986|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
146506381|NCT00960986|528356987|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
146506382|NCT00960986|528356988|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
146506383|NCT00960986|528356989|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
146506384|NCT00960986|528356986|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
146506385|NCT00960986|528356987|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
146506386|NCT00960986|528356988|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
146506387|NCT00960986|528356989|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
146506388|NCT00960986|528356986|FG000|Period 3 (7-week Therapy Period)|Death|0|||
146506389|NCT00960986|528356987|FG001|Period 3 (7-week Therapy Period)|Death|0|||
146506390|NCT00960986|528356988|FG002|Period 3 (7-week Therapy Period)|Death|1|||
146506391|NCT00960986|528356989|FG003|Period 3 (7-week Therapy Period)|Death|0|||
146506392|NCT00960986|528356986|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
146506393|NCT00960986|528356987|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
146506394|NCT00960986|528356988|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
146506395|NCT00960986|528356989|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
146506396|NCT00960986|528356986|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
146506397|NCT00960986|528356987|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
146506398|NCT00960986|528356988|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
146974463|NCT01682512|530069549|FG000|Overall Study|Lost to Follow-up|3|||
146974464|NCT01682512|530069550|FG001|Overall Study|Lost to Follow-up|0|||
146506399|NCT00960986|528356989|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
146506400|NCT00960986|528356986|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
146506401|NCT00960986|528356987|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
146506402|NCT00960986|528356988|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
146506403|NCT00960986|528356989|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
146506404|NCT00960986|528356986|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
146506405|NCT00960986|528356987|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
146506406|NCT00960986|528356988|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
146506407|NCT00960986|528356989|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
146506408|NCT01984892|528356990|FG000|Overall Study|Progressive disease|7|||
146506409|NCT04464720|528356991|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
146506410|NCT04413552|528356997|FG000|Overall Study|Adverse Event|0|||
146506411|NCT04413552|528356998|FG001|Overall Study|Adverse Event|0|||
146506412|NCT04413552|528356999|FG002|Overall Study|Adverse Event|0|||
146506413|NCT04413552|528357000|FG003|Overall Study|Adverse Event|0|||
146506414|NCT04413552|528357001|FG004|Overall Study|Adverse Event|0|||
146506415|NCT04413552|528357002|FG005|Overall Study|Adverse Event|0|||
146506416|NCT04413552|528357003|FG006|Overall Study|Adverse Event|1|||
146506417|NCT04413552|528357004|FG007|Overall Study|Adverse Event|0|||
146506418|NCT04413552|528357005|FG008|Overall Study|Adverse Event|0|||
146506419|NCT04413552|528357006|FG009|Overall Study|Adverse Event|0|||
146506420|NCT01794793|528357009|FG000|Treatment Period|Withdrawal by Subject|24|||
146506421|NCT01794793|528357009|FG000|Treatment Period|Lack of Efficacy|22|||
146506422|NCT01794793|528357009|FG000|Treatment Period|Adverse Event|17|||
146506423|NCT01794793|528357009|FG000|Treatment Period|Physician Decision|14|||
146506424|NCT01794793|528357009|FG000|Treatment Period|Lost to Follow-up|7|||
146506425|NCT01794793|528357009|FG000|Treatment Period|Death|6|||
146506426|NCT01794793|528357009|FG000|Treatment Period|Protocol Violation|5|||
146506427|NCT01794793|528357009|FG000|Treatment Period|administrative problem|3|||
146506428|NCT01794793|528357009|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
146506429|NCT01794793|528357009|FG000|Post-treatment Follow-up|Adverse Event|8|||
146506430|NCT01794793|528357009|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
146506431|NCT01794793|528357009|FG000|Post-treatment Follow-up|administrative problem|5|||
146506432|NCT01794793|528357009|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
146506433|NCT01794793|528357009|FG000|Post-treatment Follow-up|Protocol Violation|3|||
146506434|NCT04852679|528357012|FG000|Main Intervention Period|Withdrawal by Subject|3|||
146506435|NCT04852679|528357012|FG000|Main Intervention Period|Adverse Event|1|||
146506436|NCT04852679|528357012|FG000|Main Intervention Period|Progressive Disease|16|||
146506437|NCT04852679|528357012|FG000|Main Intervention Period|Refused study visit|1|||
146506438|NCT04852679|528357012|FG000|Independent Injection Period|Missed study visit|1|||
146506439|NCT01294696|528357014|FG000|Overall Study|Screening failures|7|||
146506440|NCT01294696|528357014|FG000|Overall Study|Protocol Violation|8|||
146506441|NCT01294696|528357014|FG000|Overall Study|Missing BPI Response|7|||
146506442|NCT01294696|528357014|FG000|Overall Study|Site closure|52|||
146506443|NCT01944670|528358702|FG000|Overall Study|Lost to Follow-up|2|||
146506444|NCT04542499|528358703|FG000|Overall Study|Adverse Event|23|||
146506445|NCT04542499|528358704|FG001|Overall Study|Adverse Event|43|||
146506446|NCT04542499|528358703|FG000|Overall Study|Lack of Efficacy|5|||
146506447|NCT04542499|528358704|FG001|Overall Study|Lack of Efficacy|2|||
146506448|NCT04542499|528358703|FG000|Overall Study|Lost to Follow-up|3|||
146506449|NCT04542499|528358704|FG001|Overall Study|Lost to Follow-up|4|||
146506450|NCT04542499|528358703|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
146506451|NCT04542499|528358704|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
146506452|NCT04542499|528358703|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
146506453|NCT04542499|528358704|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
146506454|NCT04542499|528358703|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146506455|NCT04542499|528358704|FG001|Overall Study|Non-Compliance with Study Drug|2|||
146506456|NCT04542499|528358703|FG000|Overall Study|Physician Decision|0|||
146506457|NCT04542499|528358704|FG001|Overall Study|Physician Decision|1|||
146506458|NCT04542499|528358703|FG000|Overall Study|Site Terminated by Sponsor|3|||
146506459|NCT04542499|528358704|FG001|Overall Study|Site Terminated by Sponsor|5|||
146649006|NCT04449029|528892970|FG006|Overall Study|Adverse Event|1|||
146649007|NCT04449029|528892971|FG007|Overall Study|Adverse Event|0|||
146649008|NCT04449029|528892964|FG000|Overall Study|Lost to Follow-up|0|||
146506460|NCT04542499|528358703|FG000|Overall Study|Withdrawal by Subject|12|||
146506461|NCT04542499|528358704|FG001|Overall Study|Withdrawal by Subject|33|||
146506462|NCT04542499|528358703|FG000|Overall Study|Other|2|||
146506463|NCT04542499|528358704|FG001|Overall Study|Other|2|||
146506464|NCT04035434|528358705|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506465|NCT04035434|528358706|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
146506466|NCT04035434|528358707|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506467|NCT04035434|528358708|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
146506468|NCT04035434|528358709|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
146506469|NCT04035434|528358710|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506470|NCT04035434|528358711|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506471|NCT04035434|528358712|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506472|NCT04035434|528358713|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506473|NCT04035434|528358714|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506474|NCT04035434|528358715|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
146649009|NCT04449029|528892965|FG001|Overall Study|Lost to Follow-up|1|||
146506475|NCT04035434|528358716|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
146506476|NCT04035434|528358717|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506477|NCT04035434|528358705|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
146506478|NCT04035434|528358706|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
146506479|NCT04035434|528358707|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
146506480|NCT04035434|528358708|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
146506481|NCT04035434|528358709|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
146506482|NCT04035434|528358710|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
146506483|NCT04035434|528358711|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
146506484|NCT04035434|528358712|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
146506485|NCT04035434|528358713|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
146506486|NCT04035434|528358714|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
146506487|NCT04035434|528358715|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
146506488|NCT04035434|528358716|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
146506489|NCT04035434|528358717|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
146506490|NCT04035434|528358705|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
146506491|NCT04035434|528358706|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
146506492|NCT04035434|528358707|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
146506493|NCT04035434|528358708|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
146506494|NCT04035434|528358709|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
146506495|NCT04035434|528358710|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
146506496|NCT04035434|528358711|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
146506497|NCT04035434|528358712|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
146506498|NCT04035434|528358713|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
146506499|NCT04035434|528358714|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
146506500|NCT04035434|528358715|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
146506501|NCT04035434|528358716|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
146506502|NCT04035434|528358717|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
146506503|NCT04035434|528358705|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
146506504|NCT04035434|528358706|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
146506505|NCT04035434|528358707|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
146506506|NCT04035434|528358708|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
146506507|NCT04035434|528358709|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
146506508|NCT04035434|528358710|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
146506509|NCT04035434|528358711|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
146506510|NCT04035434|528358712|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
146506511|NCT04035434|528358713|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
146506512|NCT04035434|528358714|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
146506513|NCT04035434|528358715|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
146506514|NCT04035434|528358716|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
146506515|NCT04035434|528358717|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
146506516|NCT04035434|528358705|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
146506517|NCT04035434|528358706|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
146506518|NCT04035434|528358707|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
146506519|NCT04035434|528358708|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
146506520|NCT04035434|528358709|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
146506521|NCT04035434|528358710|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
146506522|NCT04035434|528358711|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
146506523|NCT04035434|528358712|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
146506524|NCT04035434|528358713|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
146506525|NCT04035434|528358714|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
146506526|NCT04035434|528358715|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
146506527|NCT04035434|528358716|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
146506528|NCT04035434|528358717|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
146506529|NCT04035434|528358705|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506530|NCT04035434|528358706|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506531|NCT04035434|528358707|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506532|NCT04035434|528358708|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506533|NCT04035434|528358709|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506534|NCT04035434|528358710|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
146506535|NCT04035434|528358711|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
146567539|NCT02431325|528589833|FG001|Overall Study|Adverse Event|0|||
146567540|NCT02431325|528589832|FG000|Overall Study|Lost to Follow-up|0|||
146567541|NCT02431325|528589833|FG001|Overall Study|Lost to Follow-up|1|||
146567542|NCT02431325|528589832|FG000|Overall Study|Withdrawal by Subject|1|||
146567543|NCT02431325|528589833|FG001|Overall Study|Withdrawal by Subject|2|||
146506536|NCT04035434|528358712|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506537|NCT04035434|528358713|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506538|NCT04035434|528358714|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506539|NCT04035434|528358715|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506540|NCT04035434|528358716|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506541|NCT04035434|528358717|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
146506542|NCT04035434|528358705|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
146506543|NCT04035434|528358706|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
146506544|NCT04035434|528358707|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
146506545|NCT04035434|528358708|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
146506546|NCT04035434|528358709|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
146506547|NCT04035434|528358710|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
146506548|NCT04035434|528358711|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
146506549|NCT04035434|528358712|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
146506550|NCT04035434|528358713|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
146506551|NCT04035434|528358714|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
146506552|NCT04035434|528358715|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
146506553|NCT04035434|528358716|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
146506554|NCT04035434|528358717|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
146506555|NCT01214252|528358720|FG000|Overall Study|Not eligible per protocol|82|||
146506556|NCT00552032|528358721|FG000|Overall Study|Withdrawal by Subject|2|||
146506557|NCT00552032|528358722|FG001|Overall Study|Withdrawal by Subject|2|||
146506558|NCT00552032|528358721|FG000|Overall Study|Protocol Violation|7|||
146506559|NCT00552032|528358722|FG001|Overall Study|Protocol Violation|12|||
146506560|NCT00552032|528358721|FG000|Overall Study|Lost to Follow-up|8|||
146506561|NCT00552032|528358722|FG001|Overall Study|Lost to Follow-up|5|||
146506562|NCT04430738|528358723|FG000|Phase 1: Dose Escalation|Death|1|||
146506563|NCT04430738|528358724|FG001|Phase 1: Dose Escalation|Death|4|||
146506564|NCT04430738|528358725|FG002|Phase 1: Dose Escalation|Death|4|||
146506565|NCT04430738|528358726|FG003|Phase 1: Dose Escalation|Death|1|||
146506566|NCT04430738|528358727|FG004|Phase 1: Dose Escalation|Death|6|||
146506567|NCT04430738|528358728|FG005|Phase 1: Dose Escalation|Death|0|||
146506568|NCT04430738|528358723|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
146506569|NCT04430738|528358724|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
146506570|NCT04430738|528358725|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
146506571|NCT04430738|528358726|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
146506572|NCT04430738|528358727|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
146506573|NCT04430738|528358728|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
146506574|NCT04430738|528358723|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
146506575|NCT04430738|528358724|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
146506576|NCT04430738|528358725|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
146506577|NCT04430738|528358726|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
146506578|NCT04430738|528358727|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
146506579|NCT04430738|528358728|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
146506580|NCT04430738|528358723|FG000|Phase 1: Dose Escalation|Other|1|||
146506581|NCT04430738|528358724|FG001|Phase 1: Dose Escalation|Other|0|||
146506582|NCT04430738|528358725|FG002|Phase 1: Dose Escalation|Other|0|||
146506583|NCT04430738|528358726|FG003|Phase 1: Dose Escalation|Other|0|||
146506584|NCT04430738|528358727|FG004|Phase 1: Dose Escalation|Other|0|||
146506585|NCT04430738|528358728|FG005|Phase 1: Dose Escalation|Other|0|||
146506586|NCT04430738|528358723|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
146506587|NCT04430738|528358724|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
146506588|NCT04430738|528358725|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
146506589|NCT04430738|528358726|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
146506590|NCT04430738|528358727|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
146506591|NCT04430738|528358728|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
146506592|NCT04430738|528358723|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
146568938|NCT00940602|528595502|FG001|Overall Study|Adverse Event|2|||
146769568|NCT00071799|529324853|FG001|Overall Study|Disease Progression|20|||
146769569|NCT00071799|529324852|FG000|Overall Study|Different Central+Local Pathology Review|0|||
146769570|NCT00071799|529324853|FG001|Overall Study|Different Central+Local Pathology Review|1|||
146769571|NCT00071799|529324852|FG000|Overall Study|Not Documented|0|||
146769572|NCT00071799|529324853|FG001|Overall Study|Not Documented|2|||
146769573|NCT00814346|529324854|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
146769574|NCT00814346|529324855|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
146769575|NCT00814346|529324854|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
146506593|NCT04430738|528358724|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
146506594|NCT04430738|528358725|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
146506595|NCT04430738|528358726|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
146506596|NCT04430738|528358727|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
146506597|NCT04430738|528358728|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
146506598|NCT00348790|528358729|FG000|Completed Treatment|Withdrawal by Subject|4|||
146506599|NCT00348790|528358729|FG000|Completed Treatment|Disease progression|14|||
146506600|NCT00348790|528358729|FG000|Completed Treatment|Adverse Event|4|||
146506601|NCT00348790|528358729|FG000|Completed Treatment|Required surgery|2|||
146506602|NCT00348790|528358729|FG000|Completed Treatment|Unable to travel to study site|1|||
146506603|NCT04186806|528358730|FG000|Period 1: 7 Days|Adverse Event|1|||
146506604|NCT04186806|528358731|FG001|Period 1: 7 Days|Adverse Event|0|||
146506605|NCT03409107|528358732|FG000|Overall Study|Withdrawal by Subject|4|||
146506606|NCT03409107|528358733|FG001|Overall Study|Withdrawal by Subject|2|||
146506607|NCT03409107|528358732|FG000|Overall Study|Physician Decision|1|||
146506608|NCT03409107|528358733|FG001|Overall Study|Physician Decision|0|||
146506609|NCT03409107|528358732|FG000|Overall Study|Lost to Follow-up|7|||
146506610|NCT03409107|528358733|FG001|Overall Study|Lost to Follow-up|2|||
146506611|NCT03409107|528358732|FG000|Overall Study|Adverse Event|5|||
146506612|NCT03409107|528358733|FG001|Overall Study|Adverse Event|3|||
146506613|NCT00916344|528358734|FG000|Overall Study|Death|2|||
146506614|NCT00916344|528358734|FG000|Overall Study|ICD upgrade|1|||
146506615|NCT00916344|528358734|FG000|Overall Study|Drop-out|5|||
146506616|NCT03687372|528358739|FG000|Overall Study|Lost to Follow-up|12|||
146506617|NCT03687372|528358740|FG001|Overall Study|Lost to Follow-up|21|||
146506618|NCT03687372|528358739|FG000|Overall Study|Withdrawal by Subject|4|||
146506619|NCT03687372|528358740|FG001|Overall Study|Withdrawal by Subject|17|||
146506620|NCT03687372|528358739|FG000|Overall Study|Investigator Decision|1|||
146506621|NCT03687372|528358740|FG001|Overall Study|Investigator Decision|1|||
146506622|NCT03602391|528358743|FG000|Overall Study|COVID-19|7|||
146506623|NCT03602391|528358744|FG001|Overall Study|COVID-19|6|||
146506624|NCT00705718|528358755|FG000|Overall Study|Death|6|||
146649010|NCT04449029|528892966|FG002|Overall Study|Lost to Follow-up|0|||
146649011|NCT04449029|528892967|FG003|Overall Study|Lost to Follow-up|0|||
146649012|NCT04449029|528892968|FG004|Overall Study|Lost to Follow-up|0|||
146649013|NCT04449029|528892969|FG005|Overall Study|Lost to Follow-up|0|||
146649014|NCT04449029|528892970|FG006|Overall Study|Lost to Follow-up|0|||
146649015|NCT04449029|528892971|FG007|Overall Study|Lost to Follow-up|0|||
146649016|NCT04449029|528892964|FG000|Overall Study|Protocol Violation|0|||
146649017|NCT04449029|528892965|FG001|Overall Study|Protocol Violation|1|||
146649018|NCT04449029|528892966|FG002|Overall Study|Protocol Violation|0|||
146649019|NCT04449029|528892967|FG003|Overall Study|Protocol Violation|0|||
146649020|NCT04449029|528892968|FG004|Overall Study|Protocol Violation|0|||
146649021|NCT04449029|528892969|FG005|Overall Study|Protocol Violation|0|||
146649022|NCT04449029|528892970|FG006|Overall Study|Protocol Violation|0|||
146649023|NCT04449029|528892971|FG007|Overall Study|Protocol Violation|0|||
146649024|NCT04449029|528892964|FG000|Overall Study|Physician Decision|0|||
146649025|NCT04449029|528892965|FG001|Overall Study|Physician Decision|0|||
146649026|NCT04449029|528892966|FG002|Overall Study|Physician Decision|0|||
146649027|NCT04449029|528892967|FG003|Overall Study|Physician Decision|0|||
146649028|NCT04449029|528892968|FG004|Overall Study|Physician Decision|0|||
146649029|NCT04449029|528892969|FG005|Overall Study|Physician Decision|1|||
146649030|NCT04449029|528892970|FG006|Overall Study|Physician Decision|0|||
146649031|NCT04449029|528892971|FG007|Overall Study|Physician Decision|0|||
146649032|NCT04449029|528892964|FG000|Overall Study|Withdrawal by Subject|3|||
146649033|NCT04449029|528892965|FG001|Overall Study|Withdrawal by Subject|0|||
146649034|NCT04449029|528892966|FG002|Overall Study|Withdrawal by Subject|1|||
146649035|NCT04449029|528892967|FG003|Overall Study|Withdrawal by Subject|1|||
146649036|NCT04449029|528892968|FG004|Overall Study|Withdrawal by Subject|5|||
146649037|NCT04449029|528892969|FG005|Overall Study|Withdrawal by Subject|1|||
146649038|NCT04449029|528892970|FG006|Overall Study|Withdrawal by Subject|4|||
146649039|NCT04449029|528892971|FG007|Overall Study|Withdrawal by Subject|0|||
146974465|NCT01682512|530069551|FG002|Overall Study|Lost to Follow-up|2|||
146506625|NCT00705718|528358756|FG001|Overall Study|Death|6|||
146506626|NCT00705718|528358755|FG000|Overall Study|Not due for Visit|0|||
146649040|NCT02025556|528892977|FG000|Overall Study|Adverse Event|0|||
146974466|NCT01682512|530069549|FG000|Overall Study|Protocol Violation|2|||
146649041|NCT02025556|528892978|FG001|Overall Study|Adverse Event|4|||
146506627|NCT00705718|528358756|FG001|Overall Study|Not due for Visit|12|||
146506628|NCT00705718|528358755|FG000|Overall Study|Follow up not done|1|||
146506629|NCT00705718|528358756|FG001|Overall Study|Follow up not done|4|||
146506630|NCT02954653|528358757|FG000|Overall Study|Death|3|||
146506631|NCT02954653|528358758|FG001|Overall Study|Death|1|||
146506632|NCT02954653|528358759|FG002|Overall Study|Death|0|||
146506633|NCT02954653|528358760|FG003|Overall Study|Death|0|||
146649042|NCT02025556|528892979|FG002|Overall Study|Adverse Event|2|||
146649043|NCT02025556|528892977|FG000|Overall Study|Lack of Efficacy|2|||
146649044|NCT02025556|528892978|FG001|Overall Study|Lack of Efficacy|1|||
146649045|NCT02025556|528892979|FG002|Overall Study|Lack of Efficacy|0|||
146649046|NCT02025556|528892977|FG000|Overall Study|Protocol Violation|2|||
146567544|NCT02431325|528589832|FG000|Overall Study|Declined to take study medication|1|||
146567545|NCT02431325|528589833|FG001|Overall Study|Declined to take study medication|0|||
146567546|NCT02431325|528589832|FG000|Overall Study|Withdrew before starting study medication|1|||
146567547|NCT02431325|528589833|FG001|Overall Study|Withdrew before starting study medication|0|||
146567548|NCT02431325|528589832|FG000|Overall Study|Placebo shortage|2|||
146567549|NCT02431325|528589833|FG001|Overall Study|Placebo shortage|0|||
146567550|NCT01917318|528589834|FG000|First Treatment|Withdrawal by Subject|0|||
146567551|NCT01917318|528589835|FG001|First Treatment|Withdrawal by Subject|1|||
146506634|NCT02954653|528358761|FG004|Overall Study|Death|0|||
146506635|NCT02954653|528358762|FG005|Overall Study|Death|0|||
146506636|NCT02954653|528358763|FG006|Overall Study|Death|0|||
146506637|NCT02954653|528358764|FG007|Overall Study|Death|0|||
146506638|NCT02954653|528358765|FG008|Overall Study|Death|0|||
146506639|NCT02954653|528358757|FG000|Overall Study|Randomized but did not receive treatment|1|||
146506640|NCT02954653|528358758|FG001|Overall Study|Randomized but did not receive treatment|0|||
146506641|NCT02954653|528358759|FG002|Overall Study|Randomized but did not receive treatment|0|||
146506642|NCT02954653|528358760|FG003|Overall Study|Randomized but did not receive treatment|0|||
146506643|NCT02954653|528358761|FG004|Overall Study|Randomized but did not receive treatment|0|||
146506644|NCT02954653|528358762|FG005|Overall Study|Randomized but did not receive treatment|0|||
146506645|NCT02954653|528358763|FG006|Overall Study|Randomized but did not receive treatment|0|||
146506646|NCT02954653|528358764|FG007|Overall Study|Randomized but did not receive treatment|0|||
146506647|NCT02954653|528358765|FG008|Overall Study|Randomized but did not receive treatment|0|||
146506648|NCT02954653|528358757|FG000|Overall Study|Started another anti-cancer therapy|0|||
146506649|NCT02954653|528358758|FG001|Overall Study|Started another anti-cancer therapy|1|||
146506650|NCT02954653|528358759|FG002|Overall Study|Started another anti-cancer therapy|0|||
146506651|NCT02954653|528358760|FG003|Overall Study|Started another anti-cancer therapy|0|||
146506652|NCT02954653|528358761|FG004|Overall Study|Started another anti-cancer therapy|0|||
146506653|NCT02954653|528358762|FG005|Overall Study|Started another anti-cancer therapy|0|||
146506654|NCT02954653|528358763|FG006|Overall Study|Started another anti-cancer therapy|0|||
146506655|NCT02954653|528358764|FG007|Overall Study|Started another anti-cancer therapy|0|||
146506656|NCT02954653|528358765|FG008|Overall Study|Started another anti-cancer therapy|0|||
146506657|NCT02954653|528358757|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
146506658|NCT02954653|528358758|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
146506659|NCT02954653|528358759|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
146506660|NCT02954653|528358760|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
146506661|NCT02954653|528358761|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
146506662|NCT02954653|528358762|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
146506663|NCT02954653|528358763|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
146506664|NCT02954653|528358764|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
146506665|NCT02954653|528358765|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
146506666|NCT03054064|528358766|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
146506667|NCT03054064|528358766|FG000|Overall Study|Investigator Decision|2|||
146506668|NCT03054064|528358766|FG000|Overall Study|Bladder Issue|1|||
146506669|NCT03054064|528358766|FG000|Overall Study|High Blood Pressure|1|||
146506670|NCT03054064|528358766|FG000|Overall Study|Change in Status|1|||
146506671|NCT01459718|528358769|FG000|Overall Study|Physician Decision|1|||
146506672|NCT01459718|528358769|FG000|Overall Study|Lost to Follow-up|1|||
146506673|NCT01459718|528358769|FG000|Overall Study|Adverse Event|1|||
146506674|NCT00581542|528358770|FG000|Overall Study|they met an exclusion criteria|2|||
146506675|NCT00581542|528358771|FG001|Overall Study|they met an exclusion criteria|2|||
146506676|NCT00581542|528358770|FG000|Overall Study|Lost to Follow-up|9|||
146567552|NCT01008618|528589836|FG000|Period 1 (Titration Period)|Physician Decision|2|||
146567553|NCT01008618|528589837|FG001|Period 1 (Titration Period)|Physician Decision|0|||
146567554|NCT01008618|528589838|FG002|Period 1 (Titration Period)|Physician Decision|0|||
146567555|NCT01008618|528589836|FG000|Period 1 (Titration Period)|Adverse Event|33|||
146567556|NCT01008618|528589837|FG001|Period 1 (Titration Period)|Adverse Event|0|||
146567557|NCT01008618|528589838|FG002|Period 1 (Titration Period)|Adverse Event|0|||
146567558|NCT01008618|528589836|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
146567559|NCT01008618|528589837|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
146567560|NCT01008618|528589838|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
146567561|NCT01008618|528589836|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
146567562|NCT01008618|528589837|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
146567563|NCT01008618|528589838|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
146649047|NCT02025556|528892978|FG001|Overall Study|Protocol Violation|1|||
146506677|NCT00581542|528358771|FG001|Overall Study|Lost to Follow-up|21|||
146506678|NCT01546571|528358772|FG000|Overall Study|Adverse Event|1|||
146506679|NCT01546571|528358773|FG001|Overall Study|Adverse Event|0|||
146506680|NCT01546571|528358774|FG002|Overall Study|Adverse Event|0|||
146506681|NCT01546571|528358775|FG003|Overall Study|Adverse Event|1|||
146506682|NCT01546571|528358776|FG004|Overall Study|Adverse Event|0|||
146567564|NCT01008618|528589836|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
146649048|NCT02025556|528892979|FG002|Overall Study|Protocol Violation|0|||
146506683|NCT01546571|528358772|FG000|Overall Study|assigned placebo in Part A|0|||
146506684|NCT01546571|528358773|FG001|Overall Study|assigned placebo in Part A|0|||
146506685|NCT01546571|528358774|FG002|Overall Study|assigned placebo in Part A|22|||
146506686|NCT01546571|528358775|FG003|Overall Study|assigned placebo in Part A|0|||
146506687|NCT01546571|528358776|FG004|Overall Study|assigned placebo in Part A|0|||
146506688|NCT01546571|528358772|FG000|Overall Study|Death|0|||
146506689|NCT01546571|528358773|FG001|Overall Study|Death|1|||
146506690|NCT01546571|528358774|FG002|Overall Study|Death|0|||
146506691|NCT01546571|528358775|FG003|Overall Study|Death|0|||
146506692|NCT01546571|528358776|FG004|Overall Study|Death|0|||
146506693|NCT01546571|528358772|FG000|Overall Study|Lost to Follow-up|0|||
146506694|NCT01546571|528358773|FG001|Overall Study|Lost to Follow-up|0|||
146506695|NCT01546571|528358774|FG002|Overall Study|Lost to Follow-up|2|||
146506696|NCT01546571|528358775|FG003|Overall Study|Lost to Follow-up|2|||
146506697|NCT01546571|528358776|FG004|Overall Study|Lost to Follow-up|3|||
146506698|NCT01546571|528358772|FG000|Overall Study|Pregnancy|0|||
146506699|NCT01546571|528358773|FG001|Overall Study|Pregnancy|0|||
146506700|NCT01546571|528358774|FG002|Overall Study|Pregnancy|0|||
146506701|NCT01546571|528358775|FG003|Overall Study|Pregnancy|1|||
146506702|NCT01546571|528358776|FG004|Overall Study|Pregnancy|0|||
146506703|NCT01546571|528358772|FG000|Overall Study|Disease Progression|20|||
146506704|NCT01546571|528358773|FG001|Overall Study|Disease Progression|18|||
146506705|NCT01546571|528358774|FG002|Overall Study|Disease Progression|15|||
146506706|NCT01546571|528358775|FG003|Overall Study|Disease Progression|73|||
146506707|NCT01546571|528358776|FG004|Overall Study|Disease Progression|37|||
146506708|NCT01546571|528358772|FG000|Overall Study|Withdrawal by Subject|1|||
146506709|NCT01546571|528358773|FG001|Overall Study|Withdrawal by Subject|2|||
146506710|NCT01546571|528358774|FG002|Overall Study|Withdrawal by Subject|4|||
146506711|NCT01546571|528358775|FG003|Overall Study|Withdrawal by Subject|9|||
146506712|NCT01546571|528358776|FG004|Overall Study|Withdrawal by Subject|2|||
146506713|NCT01546571|528358772|FG000|Overall Study|Intercurrent Illness|1|||
146506714|NCT01546571|528358773|FG001|Overall Study|Intercurrent Illness|2|||
146506715|NCT01546571|528358774|FG002|Overall Study|Intercurrent Illness|0|||
146506716|NCT01546571|528358775|FG003|Overall Study|Intercurrent Illness|0|||
146506717|NCT01546571|528358776|FG004|Overall Study|Intercurrent Illness|0|||
146506718|NCT01546571|528358772|FG000|Overall Study|Other Cancers|0|||
146506719|NCT01546571|528358773|FG001|Overall Study|Other Cancers|0|||
146506720|NCT01546571|528358774|FG002|Overall Study|Other Cancers|0|||
146506721|NCT01546571|528358775|FG003|Overall Study|Other Cancers|3|||
146506722|NCT01546571|528358776|FG004|Overall Study|Other Cancers|1|||
146506723|NCT01546571|528358772|FG000|Overall Study|Other|0|||
146506724|NCT01546571|528358773|FG001|Overall Study|Other|0|||
146506725|NCT01546571|528358774|FG002|Overall Study|Other|3|||
146506726|NCT01546571|528358775|FG003|Overall Study|Other|0|||
146506727|NCT01546571|528358776|FG004|Overall Study|Other|0|||
146506728|NCT01880086|528358779|FG000|Overall Study|Lost to Follow-up|1|||
146506729|NCT01880086|528358780|FG001|Overall Study|Lost to Follow-up|1|||
146506730|NCT05174949|528358786|FG000|Overall Study|Physician Decision|1|||
146506731|NCT05174949|528358787|FG001|Overall Study|Physician Decision|2|||
146506732|NCT05174949|528358788|FG002|Overall Study|Physician Decision|0|||
146506733|NCT05174949|528358789|FG003|Overall Study|Physician Decision|1|||
146506734|NCT05174949|528358790|FG004|Overall Study|Physician Decision|0|||
146506735|NCT05174949|528358791|FG005|Overall Study|Physician Decision|0|||
146506736|NCT05174949|528358786|FG000|Overall Study|Withdrawal by Subject|0|||
146506737|NCT05174949|528358787|FG001|Overall Study|Withdrawal by Subject|1|||
146506738|NCT05174949|528358788|FG002|Overall Study|Withdrawal by Subject|0|||
146506739|NCT05174949|528358789|FG003|Overall Study|Withdrawal by Subject|0|||
146506740|NCT05174949|528358790|FG004|Overall Study|Withdrawal by Subject|0|||
146506741|NCT05174949|528358791|FG005|Overall Study|Withdrawal by Subject|0|||
146506742|NCT05174949|528358786|FG000|Overall Study|Lost to Follow-up|0|||
146506743|NCT05174949|528358787|FG001|Overall Study|Lost to Follow-up|0|||
146506744|NCT05174949|528358788|FG002|Overall Study|Lost to Follow-up|0|||
146506745|NCT05174949|528358789|FG003|Overall Study|Lost to Follow-up|1|||
146649049|NCT02025556|528892977|FG000|Overall Study|Withdrawal by Subject|0|||
146506746|NCT05174949|528358790|FG004|Overall Study|Lost to Follow-up|0|||
146649050|NCT02025556|528892978|FG001|Overall Study|Withdrawal by Subject|3|||
146506747|NCT05174949|528358791|FG005|Overall Study|Lost to Follow-up|0|||
146506748|NCT01123941|528358792|FG000|Overall Study|Lost to Follow-up|2|||
146506749|NCT01123941|528358793|FG001|Overall Study|Lost to Follow-up|1|||
146506750|NCT05083923|528358803|FG000|Overall Study|Adverse Event|2|||
146506751|NCT05083923|528358804|FG001|Overall Study|Adverse Event|0|||
146506752|NCT05083923|528358803|FG000|Overall Study|Lack of Efficacy|1|||
146506753|NCT05083923|528358804|FG001|Overall Study|Lack of Efficacy|3|||
146506754|NCT05083923|528358803|FG000|Overall Study|Withdrawal by Subject|2|||
146506755|NCT05083923|528358804|FG001|Overall Study|Withdrawal by Subject|6|||
146506756|NCT05083923|528358803|FG000|Overall Study|Reason Not Specified|0|||
146506757|NCT05083923|528358804|FG001|Overall Study|Reason Not Specified|1|||
146506758|NCT01537068|528358809|FG000|Overall Study|Lost to Follow-up|2|||
146506759|NCT01537068|528358810|FG001|Overall Study|Lost to Follow-up|1|||
146506760|NCT01537068|528358809|FG000|Overall Study|Adverse Event|0|||
146649051|NCT02025556|528892979|FG002|Overall Study|Withdrawal by Subject|6|||
146649052|NCT02025556|528892977|FG000|Overall Study|Lost to Follow-up|2|||
146506761|NCT01537068|528358810|FG001|Overall Study|Adverse Event|1|||
146506762|NCT01537068|528358809|FG000|Overall Study|Withdrawal by Subject|1|||
146506763|NCT01537068|528358810|FG001|Overall Study|Withdrawal by Subject|1|||
146506764|NCT01537068|528358809|FG000|Overall Study|Lack of Efficacy|1|||
146506765|NCT01537068|528358810|FG001|Overall Study|Lack of Efficacy|0|||
146506766|NCT03802565|528358811|FG000|Overall Study|Adverse Event|0|||
146506767|NCT03802565|528358812|FG001|Overall Study|Adverse Event|1|||
146506768|NCT03802565|528358813|FG002|Overall Study|Adverse Event|2|||
146506769|NCT03802565|528358814|FG003|Overall Study|Adverse Event|1|||
146506770|NCT03802565|528358815|FG004|Overall Study|Adverse Event|1|||
146506771|NCT03802565|528358811|FG000|Overall Study|Withdrawal by Subject|2|||
146506772|NCT03802565|528358812|FG001|Overall Study|Withdrawal by Subject|2|||
146506773|NCT03802565|528358813|FG002|Overall Study|Withdrawal by Subject|2|||
146506774|NCT03802565|528358814|FG003|Overall Study|Withdrawal by Subject|0|||
146506775|NCT03802565|528358815|FG004|Overall Study|Withdrawal by Subject|1|||
146506776|NCT03802565|528358811|FG000|Overall Study|Protocol Violation|2|||
146506777|NCT03802565|528358812|FG001|Overall Study|Protocol Violation|1|||
146506778|NCT03802565|528358813|FG002|Overall Study|Protocol Violation|4|||
146506779|NCT03802565|528358814|FG003|Overall Study|Protocol Violation|5|||
146506780|NCT03802565|528358815|FG004|Overall Study|Protocol Violation|1|||
146506781|NCT03802565|528358811|FG000|Overall Study|Lost to Follow-up|0|||
146506782|NCT03802565|528358812|FG001|Overall Study|Lost to Follow-up|0|||
146506783|NCT03802565|528358813|FG002|Overall Study|Lost to Follow-up|1|||
146506784|NCT03802565|528358814|FG003|Overall Study|Lost to Follow-up|0|||
146506785|NCT03802565|528358815|FG004|Overall Study|Lost to Follow-up|0|||
146506786|NCT03802565|528358811|FG000|Overall Study|Subjects Related to Each Other|1|||
146506787|NCT03802565|528358812|FG001|Overall Study|Subjects Related to Each Other|0|||
146506788|NCT03802565|528358813|FG002|Overall Study|Subjects Related to Each Other|0|||
146506789|NCT03802565|528358814|FG003|Overall Study|Subjects Related to Each Other|2|||
146506790|NCT03802565|528358815|FG004|Overall Study|Subjects Related to Each Other|1|||
146506791|NCT03802565|528358811|FG000|Overall Study|Elevated Enzymes|0|||
146506792|NCT03802565|528358812|FG001|Overall Study|Elevated Enzymes|0|||
146506793|NCT03802565|528358813|FG002|Overall Study|Elevated Enzymes|0|||
146506794|NCT03802565|528358814|FG003|Overall Study|Elevated Enzymes|0|||
146506795|NCT03802565|528358815|FG004|Overall Study|Elevated Enzymes|2|||
146506796|NCT03099694|528358816|FG000|Overall Study|Withdrawal by Subject|11|||
146506797|NCT03099694|528358817|FG001|Overall Study|Withdrawal by Subject|13|||
146506798|NCT03099694|528358816|FG000|Overall Study|Lost to Follow-up|9|||
146506799|NCT03099694|528358817|FG001|Overall Study|Lost to Follow-up|5|||
146506800|NCT02291601|528358818|FG000|Abdomen|Did not qualify|333|||
146506801|NCT02291601|528358819|FG001|Abdomen|Did not qualify|54|||
146506802|NCT02291601|528358820|FG002|Abdomen|Did not qualify|339|||
146506803|NCT02291601|528358818|FG000|Groin|Did not qualify|183|||
146506804|NCT02291601|528358819|FG001|Groin|Did not qualify|30|||
146506805|NCT02291601|528358820|FG002|Groin|Did not qualify|177|||
146506806|NCT03379753|528358826|FG000|Overall Study|Withdrawal by Subject|2|||
146506807|NCT03379753|528358827|FG001|Overall Study|Withdrawal by Subject|1|||
146506808|NCT03379753|528358826|FG000|Overall Study|not having correct procedure|1|||
146506809|NCT03379753|528358827|FG001|Overall Study|not having correct procedure|2|||
146506810|NCT03379753|528358826|FG000|Overall Study|No primary outcome|12|||
146506811|NCT03379753|528358827|FG001|Overall Study|No primary outcome|22|||
146506812|NCT00347919|528358828|FG000|Overall Study|Lost to Follow-up|11|||
146506813|NCT00347919|528358829|FG001|Overall Study|Lost to Follow-up|13|||
146506814|NCT00347919|528358830|FG002|Overall Study|Lost to Follow-up|0|||
146506815|NCT00347919|528358828|FG000|Overall Study|Withdrawal by Subject|6|||
146506816|NCT00347919|528358829|FG001|Overall Study|Withdrawal by Subject|8|||
146506817|NCT00347919|528358830|FG002|Overall Study|Withdrawal by Subject|0|||
146506818|NCT00347919|528358828|FG000|Overall Study|Physician Decision|1|||
146506819|NCT00347919|528358829|FG001|Overall Study|Physician Decision|1|||
146506820|NCT00347919|528358830|FG002|Overall Study|Physician Decision|0|||
146506821|NCT00347919|528358828|FG000|Overall Study|Sponsor terminated study|15|||
146506822|NCT00347919|528358829|FG001|Overall Study|Sponsor terminated study|10|||
146506823|NCT00347919|528358830|FG002|Overall Study|Sponsor terminated study|16|||
146506824|NCT00347919|528358828|FG000|Overall Study|Death|35|||
146506825|NCT00347919|528358829|FG001|Overall Study|Death|42|||
146506826|NCT00347919|528358830|FG002|Overall Study|Death|19|||
146506827|NCT00347919|528358828|FG000|Overall Study|Par. Started Other Treatment|1|||
146506828|NCT00347919|528358829|FG001|Overall Study|Par. Started Other Treatment|1|||
146506829|NCT00347919|528358830|FG002|Overall Study|Par. Started Other Treatment|1|||
146506830|NCT00347919|528358828|FG000|Overall Study|Missing|2|||
146506831|NCT00347919|528358829|FG001|Overall Study|Missing|1|||
146506832|NCT00347919|528358830|FG002|Overall Study|Missing|2|||
146506833|NCT04713592|528358839|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
146506834|NCT04713592|528358840|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
146506835|NCT04713592|528358841|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
146506836|NCT04713592|528358842|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
146649053|NCT02025556|528892978|FG001|Overall Study|Lost to Follow-up|4|||
146649054|NCT02025556|528892979|FG002|Overall Study|Lost to Follow-up|0|||
146649055|NCT02025556|528892977|FG000|Overall Study|Reason not reported|0|||
146649056|NCT02025556|528892978|FG001|Overall Study|Reason not reported|0|||
146506837|NCT04713592|528358839|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
146506838|NCT04713592|528358840|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
146506839|NCT04713592|528358841|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
146506840|NCT04713592|528358842|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
146506841|NCT04713592|528358839|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
146506842|NCT04713592|528358840|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
146506843|NCT04713592|528358841|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
146506844|NCT04713592|528358842|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
146506845|NCT04713592|528358839|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
146506846|NCT04713592|528358840|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
146506847|NCT04713592|528358841|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
146506848|NCT04713592|528358842|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
146506849|NCT04713592|528358839|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
146506850|NCT04713592|528358840|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
146506851|NCT04713592|528358841|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
146506852|NCT04713592|528358842|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
146506853|NCT04713592|528358839|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146506854|NCT04713592|528358840|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
146506855|NCT04713592|528358841|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
146506856|NCT04713592|528358842|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
146506857|NCT04713592|528358839|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
146506858|NCT04713592|528358840|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
146506859|NCT04713592|528358841|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
146506860|NCT04713592|528358842|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
146506861|NCT02225366|528358843|FG000|Overall Study|Lack of Efficacy|1|||
146506862|NCT02225366|528358844|FG001|Overall Study|Lack of Efficacy|0|||
146506863|NCT01190267|528358847|FG000|Overall Study|Adverse Event|10|||
146506864|NCT01190267|528358848|FG001|Overall Study|Adverse Event|0|||
146506865|NCT01190267|528358847|FG000|Overall Study|Treatment Failure|8|||
146506866|NCT01190267|528358848|FG001|Overall Study|Treatment Failure|2|||
146506867|NCT01190267|528358847|FG000|Overall Study|Lost to Follow-up|2|||
146506868|NCT01190267|528358848|FG001|Overall Study|Lost to Follow-up|0|||
146506869|NCT01190267|528358847|FG000|Overall Study|Withdrawal by Subject|13|||
146506870|NCT01190267|528358848|FG001|Overall Study|Withdrawal by Subject|1|||
146506871|NCT01190267|528358847|FG000|Overall Study|Protocol Violation|8|||
146506872|NCT01190267|528358848|FG001|Overall Study|Protocol Violation|1|||
146506873|NCT04017832|528358849|FG000|Overall Study|Withdrawal by Subject|13|||
146506874|NCT04017832|528358850|FG001|Overall Study|Withdrawal by Subject|12|||
146506875|NCT04017832|528358851|FG002|Overall Study|Withdrawal by Subject|21|||
146506876|NCT04017832|528358852|FG003|Overall Study|Withdrawal by Subject|7|||
146506877|NCT04017832|528358849|FG000|Overall Study|Lost to Follow-up|0|||
146506878|NCT04017832|528358850|FG001|Overall Study|Lost to Follow-up|3|||
146506879|NCT04017832|528358851|FG002|Overall Study|Lost to Follow-up|3|||
146649057|NCT02025556|528892979|FG002|Overall Study|Reason not reported|1|||
146649058|NCT02486627|528892981|FG000|Overall Study|Death|1|||
146649059|NCT02486627|528892982|FG001|Overall Study|Death|0|||
146649060|NCT02486627|528892981|FG000|Overall Study|Other Unspecified|0|||
146649061|NCT02486627|528892982|FG001|Overall Study|Other Unspecified|2|||
146649062|NCT02486627|528892981|FG000|Overall Study|Consent Withdrawn by Participant|4|||
146649063|NCT02486627|528892982|FG001|Overall Study|Consent Withdrawn by Participant|3|||
146506880|NCT04017832|528358852|FG003|Overall Study|Lost to Follow-up|1|||
146506881|NCT04017832|528358849|FG000|Overall Study|Physician Decision|1|||
146506882|NCT04017832|528358850|FG001|Overall Study|Physician Decision|1|||
146506883|NCT04017832|528358851|FG002|Overall Study|Physician Decision|1|||
146506884|NCT04017832|528358852|FG003|Overall Study|Physician Decision|1|||
146506885|NCT04017832|528358849|FG000|Overall Study|Death|2|||
146506886|NCT04017832|528358850|FG001|Overall Study|Death|2|||
146506887|NCT04017832|528358851|FG002|Overall Study|Death|1|||
146506888|NCT04017832|528358852|FG003|Overall Study|Death|0|||
146506889|NCT01382225|528358853|FG000|Overall Study|Adverse Event|3|||
146506890|NCT01382225|528358854|FG001|Overall Study|Adverse Event|2|||
146506891|NCT01382225|528358853|FG000|Overall Study|Protocol Violation|2|||
146649064|NCT02486627|528892981|FG000|Overall Study|Significant Participant Noncompliance|1|||
146506892|NCT01382225|528358854|FG001|Overall Study|Protocol Violation|1|||
146506893|NCT01382225|528358853|FG000|Overall Study|Subject Withdrew Consent|5|||
146506894|NCT01382225|528358854|FG001|Overall Study|Subject Withdrew Consent|2|||
146506895|NCT01382225|528358853|FG000|Overall Study|Other|4|||
146649065|NCT02486627|528892982|FG001|Overall Study|Significant Participant Noncompliance|1|||
146649066|NCT02486627|528892981|FG000|Overall Study|Lost to Follow-up|1|||
146649067|NCT02486627|528892982|FG001|Overall Study|Lost to Follow-up|3|||
146506896|NCT01382225|528358854|FG001|Overall Study|Other|2|||
146506897|NCT02484651|528358860|FG000|Overall Study|Patients' data files were corrupted.|1|||
146506898|NCT02484651|528358861|FG001|Overall Study|Patients' data files were corrupted.|1|||
146506899|NCT02484651|528358860|FG000|Overall Study|BIS monitoring failed.|1|||
146506900|NCT02484651|528358861|FG001|Overall Study|BIS monitoring failed.|1|||
146506901|NCT02484651|528358860|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
146506902|NCT02484651|528358861|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
146506903|NCT01419080|528358862|FG000|Overall Study|Withdrawal by Subject|75|||
146506904|NCT01419080|528358862|FG000|Overall Study|Death|30|||
146506905|NCT01419080|528358862|FG000|Overall Study|Lost to Follow-up|23|||
146506906|NCT01419080|528358862|FG000|Overall Study|Too Ill|3|||
146506907|NCT02417961|528360819|FG000|Overall Study|Adverse Event|1|||
146506908|NCT02417961|528360819|FG000|Overall Study|Lost to Follow-up|1|||
146506909|NCT02417961|528360819|FG000|Overall Study|Withdrawal by Subject|2|||
146506910|NCT05079750|528360820|FG000|Overall Study|Lost to Follow-up|0|||
146506911|NCT05079750|528360821|FG001|Overall Study|Lost to Follow-up|0|||
146506912|NCT05079750|528360822|FG002|Overall Study|Lost to Follow-up|1|||
146506913|NCT05091346|528360823|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
146506914|NCT05091346|528360824|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
146506915|NCT05091346|528360825|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
146506916|NCT05091346|528360826|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
146506917|NCT05091346|528360827|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
146506918|NCT05091346|528360823|FG000|Overall Study|Death|6|||
146506919|NCT05091346|528360824|FG001|Overall Study|Death|5|||
146506920|NCT05091346|528360825|FG002|Overall Study|Death|8|||
146506921|NCT05091346|528360826|FG003|Overall Study|Death|16|||
146506922|NCT05091346|528360827|FG004|Overall Study|Death|26|||
146506923|NCT05091346|528360823|FG000|Overall Study|Lost to Follow-up|0|||
146506924|NCT05091346|528360824|FG001|Overall Study|Lost to Follow-up|0|||
146506925|NCT05091346|528360825|FG002|Overall Study|Lost to Follow-up|0|||
146506926|NCT05091346|528360826|FG003|Overall Study|Lost to Follow-up|1|||
146649068|NCT00247611|528892986|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
146649069|NCT00247611|528892987|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
146649070|NCT00247611|528892986|FG000|Baselined|Completed baseline only|9|||
146649071|NCT00247611|528892987|FG001|Baselined|Completed baseline only|8|||
146649072|NCT00796991|528892994|FG000|Overall Study|Adverse Event|0|||
146649073|NCT00796991|528892995|FG001|Overall Study|Adverse Event|0|||
146649074|NCT00796991|528892996|FG002|Overall Study|Adverse Event|1|||
146649075|NCT00796991|528892994|FG000|Overall Study|Death|2|||
146649076|NCT00796991|528892995|FG001|Overall Study|Death|0|||
146649077|NCT00796991|528892996|FG002|Overall Study|Death|0|||
146649078|NCT00796991|528892994|FG000|Overall Study|Disease Progression|10|||
146649079|NCT00796991|528892995|FG001|Overall Study|Disease Progression|9|||
146649080|NCT00796991|528892996|FG002|Overall Study|Disease Progression|7|||
146649081|NCT00796991|528892994|FG000|Overall Study|Study Drug Toxicity|3|||
146649082|NCT00796991|528892995|FG001|Overall Study|Study Drug Toxicity|3|||
146649083|NCT00796991|528892996|FG002|Overall Study|Study Drug Toxicity|5|||
146649084|NCT00796991|528892994|FG000|Overall Study|Withdrawal by Subject|0|||
146649085|NCT00796991|528892995|FG001|Overall Study|Withdrawal by Subject|0|||
146649086|NCT00796991|528892996|FG002|Overall Study|Withdrawal by Subject|1|||
146506927|NCT05091346|528360827|FG004|Overall Study|Lost to Follow-up|0|||
146506928|NCT05091346|528360823|FG000|Overall Study|Withdrawal by Subject|0|||
146506929|NCT05091346|528360824|FG001|Overall Study|Withdrawal by Subject|1|||
146506930|NCT05091346|528360825|FG002|Overall Study|Withdrawal by Subject|2|||
146506931|NCT05091346|528360826|FG003|Overall Study|Withdrawal by Subject|2|||
146506932|NCT05091346|528360827|FG004|Overall Study|Withdrawal by Subject|1|||
146506933|NCT00197002|528360828|FG000|Overall Study|Adverse Event|0|||
146506934|NCT00197002|528360829|FG001|Overall Study|Adverse Event|1|||
146649087|NCT00171834|528892997|FG000|Overall Study|Adverse Event|2|||
146649088|NCT00171834|528892998|FG001|Overall Study|Adverse Event|1|||
146649089|NCT00171834|528892999|FG002|Overall Study|Adverse Event|3|||
146649090|NCT00171834|528893000|FG003|Overall Study|Adverse Event|2|||
146649091|NCT00171834|528893001|FG004|Overall Study|Adverse Event|2|||
146649092|NCT00171834|528893002|FG005|Overall Study|Adverse Event|15|||
146912877|NCT01845077|529843208|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
146506935|NCT00197002|528360830|FG002|Overall Study|Adverse Event|0|||
146506936|NCT00197002|528360828|FG000|Overall Study|Protocol Violation|1|||
146506937|NCT00197002|528360829|FG001|Overall Study|Protocol Violation|0|||
146506938|NCT00197002|528360830|FG002|Overall Study|Protocol Violation|2|||
146506939|NCT00197002|528360828|FG000|Overall Study|Withdrawal by Subject|9|||
146506940|NCT00197002|528360829|FG001|Overall Study|Withdrawal by Subject|5|||
146506941|NCT00197002|528360830|FG002|Overall Study|Withdrawal by Subject|7|||
146649093|NCT00171834|528893003|FG006|Overall Study|Adverse Event|1|||
146649094|NCT00171834|528892997|FG000|Overall Study|Withdrawal by Subject|0|||
146649095|NCT00171834|528892998|FG001|Overall Study|Withdrawal by Subject|2|||
146649096|NCT00171834|528892999|FG002|Overall Study|Withdrawal by Subject|0|||
146649097|NCT00171834|528893000|FG003|Overall Study|Withdrawal by Subject|1|||
146567565|NCT01008618|528589837|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
146567566|NCT01008618|528589838|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
146567567|NCT01008618|528589836|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
146567568|NCT01008618|528589837|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
146567569|NCT01008618|528589838|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
146567570|NCT01008618|528589836|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
146567571|NCT01008618|528589837|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
146567572|NCT01008618|528589838|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
146567573|NCT01008618|528589836|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
146567574|NCT01008618|528589837|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
146567575|NCT01008618|528589838|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
146567576|NCT01008618|528589836|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
146567577|NCT01008618|528589837|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
146567578|NCT01008618|528589838|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
146567579|NCT01008618|528589836|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
146567580|NCT01008618|528589837|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
146567581|NCT01008618|528589838|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
146567582|NCT01008618|528589836|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
146567583|NCT01008618|528589837|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
146567584|NCT01008618|528589838|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
146567585|NCT01008618|528589836|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
146567586|NCT01008618|528589837|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
146567587|NCT01008618|528589838|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
146567588|NCT02927795|528589841|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
146567589|NCT02927795|528589841|FG000|Overall Study|Not Treated|4|||
146567590|NCT02581891|528589842|FG000|Overall Study|Adverse Event|4|||
146567591|NCT02581891|528589843|FG001|Overall Study|Adverse Event|6|||
146567592|NCT02581891|528589842|FG000|Overall Study|Death|3|||
146567593|NCT02581891|528589843|FG001|Overall Study|Death|4|||
146567594|NCT02581891|528589842|FG000|Overall Study|Lost to Follow-up|1|||
146567595|NCT02581891|528589843|FG001|Overall Study|Lost to Follow-up|2|||
146567596|NCT02581891|528589842|FG000|Overall Study|Physician Decision|0|||
146567597|NCT02581891|528589843|FG001|Overall Study|Physician Decision|1|||
146567598|NCT02581891|528589842|FG000|Overall Study|Withdrawal by Subject|4|||
146567599|NCT02581891|528589843|FG001|Overall Study|Withdrawal by Subject|5|||
146567600|NCT02581891|528589842|FG000|Overall Study|Other Reasons|3|||
146567601|NCT02581891|528589843|FG001|Overall Study|Other Reasons|1|||
146567602|NCT02581891|528589842|FG000|Overall Study|Discontinued during followup|1|||
146567603|NCT02581891|528589843|FG001|Overall Study|Discontinued during followup|0|||
146567604|NCT01534481|528589849|FG000|Overall Study|Lost to Follow-up|29|||
146567605|NCT01534481|528589850|FG001|Overall Study|Lost to Follow-up|24|||
146567606|NCT01534481|528589849|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
146567607|NCT01534481|528589850|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
146567608|NCT05525910|528589851|FG000|Period 4|Per sponsor due to study timelines|0|||
146567609|NCT05525910|528589852|FG001|Period 4|Per sponsor due to study timelines|0|||
146567610|NCT05525910|528589853|FG002|Period 4|Per sponsor due to study timelines|1|||
146567611|NCT05525910|528589854|FG003|Period 4|Per sponsor due to study timelines|1|||
146567612|NCT05525910|528589855|FG004|Period 4|Per sponsor due to study timelines|1|||
146567613|NCT01812057|528589862|FG000|Overall Study|Protocol Violation|1|||
146567614|NCT01812057|528589863|FG001|Overall Study|Protocol Violation|0|||
146567615|NCT01812057|528589862|FG000|Overall Study|Physician Decision|1|||
146567616|NCT01812057|528589863|FG001|Overall Study|Physician Decision|0|||
146567617|NCT01880957|528589868|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
146567618|NCT01880957|528589869|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
146567619|NCT01880957|528589868|FG000|Overall Study|Lost to Follow-up|11|||
146567620|NCT01880957|528589869|FG001|Overall Study|Lost to Follow-up|0|||
146567621|NCT01880957|528589868|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
146567622|NCT01880957|528589869|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
146567623|NCT02951780|528589872|FG000|Period 1|Adverse Event|0|||
146567624|NCT02951780|528589873|FG001|Period 1|Adverse Event|0|||
146567625|NCT02951780|528589874|FG002|Period 1|Adverse Event|0|||
146567626|NCT02951780|528589875|FG003|Period 1|Adverse Event|1|||
146567627|NCT02951780|528589876|FG004|Period 1|Adverse Event|0|||
146567628|NCT02951780|528589877|FG005|Period 1|Adverse Event|0|||
146567629|NCT02951780|528589878|FG006|Period 1|Adverse Event|0|||
146567630|NCT02951780|528589879|FG007|Period 1|Adverse Event|0|||
146567631|NCT02951780|528589880|FG008|Period 1|Adverse Event|0|||
146567632|NCT02951780|528589872|FG000|Period 1|Scheduling Conflicts|0|||
146567633|NCT02951780|528589873|FG001|Period 1|Scheduling Conflicts|0|||
146567634|NCT02951780|528589874|FG002|Period 1|Scheduling Conflicts|0|||
146567635|NCT02951780|528589875|FG003|Period 1|Scheduling Conflicts|0|||
146567636|NCT02951780|528589876|FG004|Period 1|Scheduling Conflicts|0|||
146567637|NCT02951780|528589877|FG005|Period 1|Scheduling Conflicts|0|||
146649098|NCT00171834|528893001|FG004|Overall Study|Withdrawal by Subject|1|||
146649099|NCT00171834|528893002|FG005|Overall Study|Withdrawal by Subject|1|||
146649100|NCT00171834|528893003|FG006|Overall Study|Withdrawal by Subject|0|||
146649101|NCT00171834|528892997|FG000|Overall Study|Death from study indication|0|||
146649102|NCT00171834|528892998|FG001|Overall Study|Death from study indication|1|||
146649103|NCT00171834|528892999|FG002|Overall Study|Death from study indication|0|||
146649104|NCT00171834|528893000|FG003|Overall Study|Death from study indication|0|||
146649105|NCT00171834|528893001|FG004|Overall Study|Death from study indication|1|||
146649106|NCT00171834|528893002|FG005|Overall Study|Death from study indication|0|||
146649107|NCT00171834|528893003|FG006|Overall Study|Death from study indication|0|||
146649108|NCT00171834|528892997|FG000|Overall Study|Disease Progression|4|||
146649109|NCT00171834|528892998|FG001|Overall Study|Disease Progression|8|||
146649110|NCT00171834|528892999|FG002|Overall Study|Disease Progression|8|||
146649111|NCT00171834|528893000|FG003|Overall Study|Disease Progression|9|||
146649112|NCT00171834|528893001|FG004|Overall Study|Disease Progression|2|||
146649113|NCT00171834|528893002|FG005|Overall Study|Disease Progression|18|||
146649114|NCT00171834|528893003|FG006|Overall Study|Disease Progression|3|||
146649115|NCT00171834|528892997|FG000|Overall Study|Treatment Duration Completed|0|||
146649116|NCT00171834|528892998|FG001|Overall Study|Treatment Duration Completed|0|||
146649117|NCT00171834|528892999|FG002|Overall Study|Treatment Duration Completed|1|||
146649118|NCT00171834|528893000|FG003|Overall Study|Treatment Duration Completed|0|||
146649119|NCT00171834|528893001|FG004|Overall Study|Treatment Duration Completed|2|||
146649120|NCT00171834|528893002|FG005|Overall Study|Treatment Duration Completed|1|||
146649121|NCT00171834|528893003|FG006|Overall Study|Treatment Duration Completed|0|||
146649122|NCT02431260|528893004|FG000|Overall Study|Subject Decision|0|||
146649123|NCT02431260|528893005|FG001|Overall Study|Subject Decision|1|||
146649124|NCT02431260|528893006|FG002|Overall Study|Subject Decision|1|||
146649125|NCT02431260|528893007|FG003|Overall Study|Subject Decision|0|||
146649126|NCT02431260|528893008|FG004|Overall Study|Subject Decision|0|||
146649127|NCT02431260|528893009|FG005|Overall Study|Subject Decision|0|||
146649128|NCT02431260|528893010|FG006|Overall Study|Subject Decision|0|||
146649129|NCT02431260|528893011|FG007|Overall Study|Subject Decision|0|||
146649130|NCT02431260|528893012|FG008|Overall Study|Subject Decision|1|||
146649131|NCT02431260|528893013|FG009|Overall Study|Subject Decision|1|||
146649132|NCT02431260|528893014|FG010|Overall Study|Subject Decision|0|||
146649133|NCT02431260|528893015|FG011|Overall Study|Subject Decision|1|||
146649134|NCT02431260|528893016|FG012|Overall Study|Subject Decision|0|||
146649135|NCT02431260|528893017|FG013|Overall Study|Subject Decision|0|||
146649136|NCT02431260|528893004|FG000|Overall Study|Death|4|||
146649137|NCT02431260|528893005|FG001|Overall Study|Death|4|||
146649138|NCT02431260|528893006|FG002|Overall Study|Death|3|||
146649139|NCT02431260|528893007|FG003|Overall Study|Death|4|||
146649140|NCT02431260|528893008|FG004|Overall Study|Death|2|||
146649141|NCT02431260|528893009|FG005|Overall Study|Death|2|||
146649142|NCT02431260|528893010|FG006|Overall Study|Death|3|||
146649143|NCT02431260|528893011|FG007|Overall Study|Death|1|||
146649144|NCT02431260|528893012|FG008|Overall Study|Death|6|||
146649145|NCT02431260|528893013|FG009|Overall Study|Death|6|||
146649146|NCT02431260|528893014|FG010|Overall Study|Death|3|||
146649147|NCT02431260|528893015|FG011|Overall Study|Death|2|||
146649148|NCT02431260|528893016|FG012|Overall Study|Death|5|||
146649149|NCT02431260|528893017|FG013|Overall Study|Death|1|||
146649150|NCT02431260|528893004|FG000|Overall Study|Lost to Follow-up|0|||
146649151|NCT02431260|528893005|FG001|Overall Study|Lost to Follow-up|0|||
146649152|NCT02431260|528893006|FG002|Overall Study|Lost to Follow-up|0|||
146649153|NCT02431260|528893007|FG003|Overall Study|Lost to Follow-up|0|||
146649154|NCT02431260|528893008|FG004|Overall Study|Lost to Follow-up|0|||
146649155|NCT02431260|528893009|FG005|Overall Study|Lost to Follow-up|1|||
146649156|NCT02431260|528893010|FG006|Overall Study|Lost to Follow-up|0|||
146649157|NCT02431260|528893011|FG007|Overall Study|Lost to Follow-up|0|||
146649158|NCT02431260|528893012|FG008|Overall Study|Lost to Follow-up|0|||
146649159|NCT02431260|528893013|FG009|Overall Study|Lost to Follow-up|0|||
146649160|NCT02431260|528893014|FG010|Overall Study|Lost to Follow-up|0|||
146912878|NCT01845077|529843209|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
146912879|NCT01845077|529843210|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
146649161|NCT02431260|528893015|FG011|Overall Study|Lost to Follow-up|0|||
146649162|NCT02431260|528893016|FG012|Overall Study|Lost to Follow-up|0|||
146649163|NCT02431260|528893017|FG013|Overall Study|Lost to Follow-up|0|||
146649164|NCT02431260|528893004|FG000|Overall Study|Study Terminated by the Sponsor|0|||
146649165|NCT02431260|528893005|FG001|Overall Study|Study Terminated by the Sponsor|0|||
146649166|NCT02431260|528893006|FG002|Overall Study|Study Terminated by the Sponsor|2|||
146649167|NCT02431260|528893007|FG003|Overall Study|Study Terminated by the Sponsor|1|||
146649168|NCT02431260|528893008|FG004|Overall Study|Study Terminated by the Sponsor|1|||
146649169|NCT02431260|528893009|FG005|Overall Study|Study Terminated by the Sponsor|0|||
146649170|NCT02431260|528893010|FG006|Overall Study|Study Terminated by the Sponsor|1|||
146649171|NCT02431260|528893011|FG007|Overall Study|Study Terminated by the Sponsor|2|||
146649172|NCT02431260|528893012|FG008|Overall Study|Study Terminated by the Sponsor|1|||
146649173|NCT02431260|528893013|FG009|Overall Study|Study Terminated by the Sponsor|1|||
146506942|NCT00197002|528360828|FG000|Overall Study|Migrated/moved from study area|3|||
146506943|NCT00197002|528360829|FG001|Overall Study|Migrated/moved from study area|5|||
146506944|NCT00197002|528360830|FG002|Overall Study|Migrated/moved from study area|1|||
146506945|NCT00197002|528360828|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
146506946|NCT00197002|528360829|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
146506947|NCT00197002|528360830|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
146506948|NCT00197002|528360828|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
146506949|NCT00197002|528360829|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
146506950|NCT00197002|528360830|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
146506951|NCT00197002|528360828|FG000|Overall Study|Others|3|||
146506952|NCT00197002|528360829|FG001|Overall Study|Others|1|||
146506953|NCT00197002|528360830|FG002|Overall Study|Others|1|||
146506954|NCT03569293|528360833|FG000|Overall Study|Adverse Event|4|||
146506955|NCT03569293|528360834|FG001|Overall Study|Adverse Event|1|||
146506956|NCT03569293|528360835|FG002|Overall Study|Adverse Event|5|||
146506957|NCT03569293|528360836|FG003|Overall Study|Adverse Event|1|||
146506958|NCT03569293|528360837|FG004|Overall Study|Adverse Event|0|||
146506959|NCT03569293|528360838|FG005|Overall Study|Adverse Event|0|||
146506960|NCT03569293|528360833|FG000|Overall Study|Withdrawal by Subject|16|||
146506961|NCT03569293|528360834|FG001|Overall Study|Withdrawal by Subject|2|||
146506962|NCT03569293|528360835|FG002|Overall Study|Withdrawal by Subject|4|||
146506963|NCT03569293|528360836|FG003|Overall Study|Withdrawal by Subject|1|||
146506964|NCT03569293|528360837|FG004|Overall Study|Withdrawal by Subject|0|||
146506965|NCT03569293|528360838|FG005|Overall Study|Withdrawal by Subject|0|||
146506966|NCT03569293|528360833|FG000|Overall Study|Lost to Follow-up|1|||
146506967|NCT03569293|528360834|FG001|Overall Study|Lost to Follow-up|3|||
146506968|NCT03569293|528360835|FG002|Overall Study|Lost to Follow-up|1|||
146506969|NCT03569293|528360836|FG003|Overall Study|Lost to Follow-up|1|||
146506970|NCT03569293|528360837|FG004|Overall Study|Lost to Follow-up|0|||
146506971|NCT03569293|528360838|FG005|Overall Study|Lost to Follow-up|0|||
146506972|NCT03569293|528360833|FG000|Overall Study|Other|8|||
146506973|NCT03569293|528360834|FG001|Overall Study|Other|2|||
146506974|NCT03569293|528360835|FG002|Overall Study|Other|1|||
146506975|NCT03569293|528360836|FG003|Overall Study|Other|1|||
146506976|NCT03569293|528360837|FG004|Overall Study|Other|0|||
146506977|NCT03569293|528360838|FG005|Overall Study|Other|0|||
146506978|NCT03569293|528360833|FG000|Overall Study|Ongoing at Time of Analysis|8|||
146506979|NCT03569293|528360834|FG001|Overall Study|Ongoing at Time of Analysis|1|||
146506980|NCT03569293|528360835|FG002|Overall Study|Ongoing at Time of Analysis|3|||
146506981|NCT03569293|528360836|FG003|Overall Study|Ongoing at Time of Analysis|0|||
146506982|NCT03569293|528360837|FG004|Overall Study|Ongoing at Time of Analysis|0|||
146506983|NCT03569293|528360838|FG005|Overall Study|Ongoing at Time of Analysis|0|||
146506984|NCT03839459|528360849|FG000|Overall Study|Withdrawal by Subject|2|||
146506985|NCT03839459|528360849|FG000|Overall Study|progression of disease|3|||
146506986|NCT05376241|528360854|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
146506987|NCT05376241|528360854|FG000|Overall Study|103 did not complete the survey|103|||
146506988|NCT05376241|528360854|FG000|Overall Study|17 failed 2 attention check questions|17|||
146567638|NCT02951780|528589878|FG006|Period 1|Scheduling Conflicts|0|||
146567639|NCT02951780|528589879|FG007|Period 1|Scheduling Conflicts|1|||
146567640|NCT02951780|528589880|FG008|Period 1|Scheduling Conflicts|0|||
146567641|NCT02951780|528589872|FG000|Period 2|Scheduling Conflicts|0|||
146567642|NCT02951780|528589873|FG001|Period 2|Scheduling Conflicts|0|||
146567643|NCT02951780|528589874|FG002|Period 2|Scheduling Conflicts|0|||
146567644|NCT02951780|528589875|FG003|Period 2|Scheduling Conflicts|0|||
146567645|NCT02951780|528589876|FG004|Period 2|Scheduling Conflicts|0|||
146567646|NCT02951780|528589877|FG005|Period 2|Scheduling Conflicts|0|||
146567647|NCT02951780|528589878|FG006|Period 2|Scheduling Conflicts|0|||
146567648|NCT02951780|528589879|FG007|Period 2|Scheduling Conflicts|1|||
146567649|NCT02951780|528589880|FG008|Period 2|Scheduling Conflicts|0|||
146567650|NCT02289469|528589883|FG000|Overall Study|Unable to match a control|6|||
146567651|NCT02289469|528589884|FG001|Overall Study|Unable to match a control|0|||
146567652|NCT01082614|528589885|FG000|Overall Study|Adverse Event|1|||
146567653|NCT01082614|528589886|FG001|Overall Study|Adverse Event|4|||
146567654|NCT01082614|528589885|FG000|Overall Study|Equipment Malfunction|0|||
146567655|NCT01082614|528589886|FG001|Overall Study|Equipment Malfunction|1|||
146567656|NCT01082614|528589885|FG000|Overall Study|Physician Decision|2|||
146567657|NCT01082614|528589886|FG001|Overall Study|Physician Decision|0|||
146567658|NCT00421148|528589887|FG000|Overall Study|Lost to Follow-up|0|||
146567659|NCT00421148|528589888|FG001|Overall Study|Lost to Follow-up|0|||
146567660|NCT00421148|528589889|FG002|Overall Study|Lost to Follow-up|0|||
146567661|NCT00421148|528589890|FG003|Overall Study|Lost to Follow-up|0|||
146567662|NCT00421148|528589891|FG004|Overall Study|Lost to Follow-up|0|||
146567663|NCT00421148|528589892|FG005|Overall Study|Lost to Follow-up|0|||
146567664|NCT00421148|528589893|FG006|Overall Study|Lost to Follow-up|0|||
146567665|NCT00421148|528589894|FG007|Overall Study|Lost to Follow-up|0|||
146567666|NCT00421148|528589895|FG008|Overall Study|Lost to Follow-up|0|||
146567667|NCT00421148|528589896|FG009|Overall Study|Lost to Follow-up|0|||
146567668|NCT00421148|528589897|FG010|Overall Study|Lost to Follow-up|0|||
146974467|NCT01682512|530069550|FG001|Overall Study|Protocol Violation|3|||
146506989|NCT03036098|528360855|FG000|Pre-Treatment|Other Reasons|1|||
146506990|NCT03036098|528360856|FG001|Pre-Treatment|Other Reasons|2|||
146506991|NCT03036098|528360857|FG002|Pre-Treatment|Other Reasons|0|||
146506992|NCT03036098|528360858|FG003|Pre-Treatment|Other Reasons|5|||
146506993|NCT03036098|528360855|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
146506994|NCT03036098|528360856|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
146506995|NCT03036098|528360857|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
146506996|NCT03036098|528360858|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
146506997|NCT03036098|528360855|FG000|Pre-Treatment|Withdrawal by Subject|1|||
146506998|NCT03036098|528360856|FG001|Pre-Treatment|Withdrawal by Subject|14|||
146506999|NCT03036098|528360857|FG002|Pre-Treatment|Withdrawal by Subject|0|||
146507000|NCT03036098|528360858|FG003|Pre-Treatment|Withdrawal by Subject|5|||
146507001|NCT03036098|528360855|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
146507002|NCT03036098|528360856|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
146507003|NCT03036098|528360857|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
146507004|NCT03036098|528360858|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
146507005|NCT03036098|528360855|FG000|Treatment|Disease Progression|130|||
146507006|NCT03036098|528360856|FG001|Treatment|Disease Progression|77|||
146507007|NCT03036098|528360857|FG002|Treatment|Disease Progression|168|||
146507008|NCT03036098|528360858|FG003|Treatment|Disease Progression|50|||
146507009|NCT03036098|528360855|FG000|Treatment|Study Drug Toxicity|95|||
146507010|NCT03036098|528360856|FG001|Treatment|Study Drug Toxicity|45|||
146507011|NCT03036098|528360857|FG002|Treatment|Study Drug Toxicity|26|||
146507012|NCT03036098|528360858|FG003|Treatment|Study Drug Toxicity|22|||
146507013|NCT03036098|528360855|FG000|Treatment|Death|9|||
146507014|NCT03036098|528360856|FG001|Treatment|Death|3|||
146507015|NCT03036098|528360857|FG002|Treatment|Death|1|||
146507016|NCT03036098|528360858|FG003|Treatment|Death|2|||
146507017|NCT03036098|528360855|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
146507018|NCT03036098|528360856|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
146507019|NCT03036098|528360857|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
146507020|NCT03036098|528360858|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
146507021|NCT03036098|528360855|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
146507022|NCT03036098|528360856|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
146507023|NCT03036098|528360857|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
146507024|NCT03036098|528360858|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
146507025|NCT03036098|528360855|FG000|Treatment|Withdrawal by Subject|2|||
146507026|NCT03036098|528360856|FG001|Treatment|Withdrawal by Subject|9|||
146507027|NCT03036098|528360857|FG002|Treatment|Withdrawal by Subject|2|||
146507028|NCT03036098|528360858|FG003|Treatment|Withdrawal by Subject|4|||
146507029|NCT03036098|528360855|FG000|Treatment|Maximum Clinical Benefit|6|||
146507030|NCT03036098|528360856|FG001|Treatment|Maximum Clinical Benefit|1|||
146507031|NCT03036098|528360857|FG002|Treatment|Maximum Clinical Benefit|6|||
146567669|NCT00421148|528589898|FG011|Overall Study|Lost to Follow-up|0|||
146567670|NCT00421148|528589899|FG012|Overall Study|Lost to Follow-up|0|||
146567671|NCT00421148|528589900|FG013|Overall Study|Lost to Follow-up|0|||
146567672|NCT00421148|528589901|FG014|Overall Study|Lost to Follow-up|0|||
146567673|NCT00421148|528589902|FG015|Overall Study|Lost to Follow-up|0|||
146567674|NCT00421148|528589903|FG016|Overall Study|Lost to Follow-up|0|||
146567675|NCT00421148|528589904|FG017|Overall Study|Lost to Follow-up|1|||
146567676|NCT00421148|528589905|FG018|Overall Study|Lost to Follow-up|0|||
146567677|NCT00421148|528589906|FG019|Overall Study|Lost to Follow-up|0|||
146567678|NCT00421148|528589887|FG000|Overall Study|Withdrawal by Subject|0|||
146567679|NCT00421148|528589888|FG001|Overall Study|Withdrawal by Subject|0|||
146567680|NCT00421148|528589889|FG002|Overall Study|Withdrawal by Subject|0|||
146567681|NCT00421148|528589890|FG003|Overall Study|Withdrawal by Subject|0|||
146567682|NCT00421148|528589891|FG004|Overall Study|Withdrawal by Subject|0|||
146567683|NCT00421148|528589892|FG005|Overall Study|Withdrawal by Subject|0|||
146567684|NCT00421148|528589893|FG006|Overall Study|Withdrawal by Subject|0|||
146567685|NCT00421148|528589894|FG007|Overall Study|Withdrawal by Subject|0|||
146567686|NCT00421148|528589895|FG008|Overall Study|Withdrawal by Subject|0|||
146567687|NCT00421148|528589896|FG009|Overall Study|Withdrawal by Subject|0|||
146567688|NCT00421148|528589897|FG010|Overall Study|Withdrawal by Subject|0|||
146567689|NCT00421148|528589898|FG011|Overall Study|Withdrawal by Subject|0|||
146567690|NCT00421148|528589899|FG012|Overall Study|Withdrawal by Subject|0|||
146567691|NCT00421148|528589900|FG013|Overall Study|Withdrawal by Subject|0|||
146567692|NCT00421148|528589901|FG014|Overall Study|Withdrawal by Subject|0|||
146567693|NCT00421148|528589902|FG015|Overall Study|Withdrawal by Subject|0|||
146507032|NCT03036098|528360858|FG003|Treatment|Maximum Clinical Benefit|10|||
146507033|NCT03036098|528360855|FG000|Treatment|Poor/Non Compliance|1|||
146507034|NCT03036098|528360856|FG001|Treatment|Poor/Non Compliance|2|||
146507035|NCT03036098|528360857|FG002|Treatment|Poor/Non Compliance|0|||
146567694|NCT00421148|528589903|FG016|Overall Study|Withdrawal by Subject|0|||
146567695|NCT00421148|528589904|FG017|Overall Study|Withdrawal by Subject|1|||
146974468|NCT01682512|530069551|FG002|Overall Study|Protocol Violation|2|||
146649174|NCT02431260|528893014|FG010|Overall Study|Study Terminated by the Sponsor|1|||
146649175|NCT02431260|528893015|FG011|Overall Study|Study Terminated by the Sponsor|0|||
146649176|NCT02431260|528893016|FG012|Overall Study|Study Terminated by the Sponsor|4|||
146649177|NCT02431260|528893017|FG013|Overall Study|Study Terminated by the Sponsor|0|||
146649178|NCT02431260|528893004|FG000|Overall Study|Physician Decision|0|||
146649179|NCT02431260|528893005|FG001|Overall Study|Physician Decision|0|||
146649180|NCT02431260|528893006|FG002|Overall Study|Physician Decision|0|||
146649181|NCT02431260|528893007|FG003|Overall Study|Physician Decision|0|||
146649182|NCT02431260|528893008|FG004|Overall Study|Physician Decision|0|||
146649183|NCT02431260|528893009|FG005|Overall Study|Physician Decision|1|||
146649184|NCT02431260|528893010|FG006|Overall Study|Physician Decision|0|||
146649185|NCT02431260|528893011|FG007|Overall Study|Physician Decision|0|||
146649186|NCT02431260|528893012|FG008|Overall Study|Physician Decision|0|||
146649187|NCT02431260|528893013|FG009|Overall Study|Physician Decision|0|||
146649188|NCT02431260|528893014|FG010|Overall Study|Physician Decision|0|||
146649189|NCT02431260|528893015|FG011|Overall Study|Physician Decision|0|||
146649190|NCT02431260|528893016|FG012|Overall Study|Physician Decision|0|||
146649191|NCT02431260|528893017|FG013|Overall Study|Physician Decision|0|||
146649192|NCT02431260|528893004|FG000|Overall Study|Other Unspecified|0|||
146649193|NCT02431260|528893005|FG001|Overall Study|Other Unspecified|0|||
146649194|NCT02431260|528893006|FG002|Overall Study|Other Unspecified|0|||
146649195|NCT02431260|528893007|FG003|Overall Study|Other Unspecified|0|||
146649196|NCT02431260|528893008|FG004|Overall Study|Other Unspecified|0|||
146649197|NCT02431260|528893009|FG005|Overall Study|Other Unspecified|0|||
146649198|NCT02431260|528893010|FG006|Overall Study|Other Unspecified|0|||
146649199|NCT02431260|528893011|FG007|Overall Study|Other Unspecified|0|||
146649200|NCT02431260|528893012|FG008|Overall Study|Other Unspecified|0|||
146649201|NCT02431260|528893013|FG009|Overall Study|Other Unspecified|0|||
146649202|NCT02431260|528893014|FG010|Overall Study|Other Unspecified|0|||
146649203|NCT02431260|528893015|FG011|Overall Study|Other Unspecified|1|||
146649204|NCT02431260|528893016|FG012|Overall Study|Other Unspecified|1|||
146649205|NCT02431260|528893017|FG013|Overall Study|Other Unspecified|0|||
146649206|NCT00439738|528893019|FG000|Overall Study|Withdrawal by Subject|16|||
146649207|NCT00439738|528893020|FG001|Overall Study|Withdrawal by Subject|13|||
146649208|NCT00439738|528893019|FG000|Overall Study|Adverse Event|6|||
146649209|NCT00439738|528893020|FG001|Overall Study|Adverse Event|4|||
146649210|NCT00439738|528893019|FG000|Overall Study|Lost to Follow-up|5|||
146649211|NCT00439738|528893020|FG001|Overall Study|Lost to Follow-up|6|||
146649212|NCT00439738|528893019|FG000|Overall Study|Protocol Violation|6|||
146649213|NCT00439738|528893020|FG001|Overall Study|Protocol Violation|3|||
146649214|NCT00439738|528893019|FG000|Overall Study|Lack of Efficacy|2|||
146649215|NCT00439738|528893020|FG001|Overall Study|Lack of Efficacy|2|||
146649216|NCT00439738|528893019|FG000|Overall Study|Abnormal Lab Values|1|||
146649217|NCT00439738|528893020|FG001|Overall Study|Abnormal Lab Values|0|||
146649218|NCT00392379|528893021|FG000|Overall Study|Withdrawal by Subject|17|||
146649219|NCT00392379|528893022|FG001|Overall Study|Withdrawal by Subject|28|||
146649220|NCT00392379|528893021|FG000|Overall Study|Lost to Follow-up|4|||
146649221|NCT00392379|528893022|FG001|Overall Study|Lost to Follow-up|9|||
146649222|NCT00392379|528893021|FG000|Overall Study|Adverse Event|1|||
146649223|NCT00392379|528893022|FG001|Overall Study|Adverse Event|1|||
146649224|NCT01978938|528893023|FG000|Overall Study|Lost to Follow-up|12|||
146649225|NCT01978938|528893024|FG001|Overall Study|Lost to Follow-up|6|||
146649226|NCT01978938|528893023|FG000|Overall Study|Withdrawal by Subject|8|||
146649227|NCT01978938|528893024|FG001|Overall Study|Withdrawal by Subject|4|||
146649228|NCT01978938|528893023|FG000|Overall Study|Adverse Event, non-fatal|2|||
146649229|NCT01978938|528893024|FG001|Overall Study|Adverse Event, non-fatal|1|||
146649230|NCT01978938|528893023|FG000|Overall Study|Participant noncompliance|1|||
146649231|NCT01978938|528893024|FG001|Overall Study|Participant noncompliance|1|||
146649232|NCT01978938|528893023|FG000|Overall Study|Did not meet inclusion criteria|0|||
146649233|NCT01978938|528893024|FG001|Overall Study|Did not meet inclusion criteria|1|||
146649234|NCT01978938|528893023|FG000|Overall Study|Previously scheduled procedure|0|||
146649235|NCT01978938|528893024|FG001|Overall Study|Previously scheduled procedure|1|||
146649236|NCT01806662|528893028|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
146649237|NCT01806662|528893029|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
146649238|NCT01806662|528893028|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
146649239|NCT01806662|528893029|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
146649240|NCT01806662|528893028|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
146649241|NCT01806662|528893029|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
146649242|NCT01806662|528893028|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
146649243|NCT01806662|528893029|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
146649244|NCT00043550|528893032|FG000|Overall Study|Withdrawal by Subject|22|||
146649245|NCT00043550|528893033|FG001|Overall Study|Withdrawal by Subject|12|||
146649246|NCT00043550|528893034|FG002|Overall Study|Withdrawal by Subject|20|||
146649247|NCT00710762|528893039|FG000|Overall Study|Progressive disease|27|||
146649248|NCT00710762|528893040|FG001|Overall Study|Progressive disease|30|||
146649249|NCT00710762|528893039|FG000|Overall Study|Adverse Event other disease worsening|2|||
146649250|NCT00710762|528893040|FG001|Overall Study|Adverse Event other disease worsening|1|||
146567696|NCT00421148|528589905|FG018|Overall Study|Withdrawal by Subject|0|||
146567697|NCT00421148|528589906|FG019|Overall Study|Withdrawal by Subject|0|||
146567698|NCT00421148|528589887|FG000|Overall Study|Protocol Violation|0|||
146567699|NCT00421148|528589888|FG001|Overall Study|Protocol Violation|0|||
146567700|NCT00421148|528589889|FG002|Overall Study|Protocol Violation|0|||
146567701|NCT00421148|528589890|FG003|Overall Study|Protocol Violation|0|||
146567702|NCT00421148|528589891|FG004|Overall Study|Protocol Violation|0|||
146567703|NCT00421148|528589892|FG005|Overall Study|Protocol Violation|1|||
146567704|NCT00421148|528589893|FG006|Overall Study|Protocol Violation|0|||
146567705|NCT00421148|528589894|FG007|Overall Study|Protocol Violation|0|||
146567706|NCT00421148|528589895|FG008|Overall Study|Protocol Violation|0|||
146567707|NCT00421148|528589896|FG009|Overall Study|Protocol Violation|0|||
146567708|NCT00421148|528589897|FG010|Overall Study|Protocol Violation|0|||
146567709|NCT00421148|528589898|FG011|Overall Study|Protocol Violation|0|||
146567710|NCT00421148|528589899|FG012|Overall Study|Protocol Violation|0|||
146567711|NCT00421148|528589900|FG013|Overall Study|Protocol Violation|0|||
146567712|NCT00421148|528589901|FG014|Overall Study|Protocol Violation|0|||
146567713|NCT00421148|528589902|FG015|Overall Study|Protocol Violation|0|||
146567714|NCT00421148|528589903|FG016|Overall Study|Protocol Violation|0|||
146567715|NCT00421148|528589904|FG017|Overall Study|Protocol Violation|0|||
146567716|NCT00421148|528589905|FG018|Overall Study|Protocol Violation|1|||
146567717|NCT00421148|528589906|FG019|Overall Study|Protocol Violation|0|||
146567718|NCT01538199|528589907|FG000|Overall Study|Lost to Follow-up|1|||
146567719|NCT01538199|528589908|FG001|Overall Study|Lost to Follow-up|2|||
146567720|NCT01538199|528589909|FG002|Overall Study|Lost to Follow-up|1|||
146567721|NCT01538199|528589910|FG003|Overall Study|Lost to Follow-up|0|||
146567722|NCT01538199|528589907|FG000|Overall Study|participant did not have time|1|||
146567723|NCT01538199|528589908|FG001|Overall Study|participant did not have time|0|||
146567724|NCT01538199|528589909|FG002|Overall Study|participant did not have time|0|||
146567725|NCT01538199|528589910|FG003|Overall Study|participant did not have time|2|||
146567726|NCT01538199|528589907|FG000|Overall Study|Lack of Efficacy|0|||
146567727|NCT01538199|528589908|FG001|Overall Study|Lack of Efficacy|1|||
146567728|NCT01538199|528589909|FG002|Overall Study|Lack of Efficacy|0|||
146567729|NCT01538199|528589910|FG003|Overall Study|Lack of Efficacy|0|||
146567730|NCT02081586|528589911|FG000|Overall Study|Lost to Follow-up|0|||
146567731|NCT02081586|528589912|FG001|Overall Study|Lost to Follow-up|1|||
146567732|NCT02081586|528589913|FG002|Overall Study|Lost to Follow-up|0|||
146567733|NCT02081586|528589914|FG003|Overall Study|Lost to Follow-up|1|||
146567734|NCT02081586|528589911|FG000|Overall Study|Head injury not related to study|0|||
146567735|NCT02081586|528589912|FG001|Overall Study|Head injury not related to study|0|||
146567736|NCT02081586|528589913|FG002|Overall Study|Head injury not related to study|1|||
146567737|NCT02081586|528589914|FG003|Overall Study|Head injury not related to study|0|||
146567738|NCT02121509|528589918|FG000|Washout Period (35 Days)|Adverse Event|1|||
146567739|NCT02121509|528589919|FG001|Washout Period (35 Days)|Adverse Event|1|||
146567740|NCT02121509|528589920|FG002|Washout Period (35 Days)|Adverse Event|0|||
146567741|NCT02121509|528589921|FG003|Washout Period (35 Days)|Adverse Event|0|||
146567742|NCT02121509|528589918|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
146567743|NCT02121509|528589919|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
146567744|NCT02121509|528589920|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
146567745|NCT02121509|528589921|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
146567746|NCT02121509|528589918|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
146567747|NCT02121509|528589919|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
146567748|NCT02121509|528589920|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
146567749|NCT02121509|528589921|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
146567750|NCT00322049|528591646|FG000|Overall Study|Moved out of area|0|||
146567751|NCT00322049|528591647|FG001|Overall Study|Moved out of area|0|||
146567752|NCT00322049|528591648|FG002|Overall Study|Moved out of area|0|||
146567753|NCT00322049|528591649|FG003|Overall Study|Moved out of area|1|||
146567754|NCT00322049|528591646|FG000|Overall Study|Infected with Dengue during study|0|||
146567755|NCT00322049|528591647|FG001|Overall Study|Infected with Dengue during study|1|||
146567756|NCT00322049|528591648|FG002|Overall Study|Infected with Dengue during study|0|||
146567757|NCT00322049|528591649|FG003|Overall Study|Infected with Dengue during study|0|||
146567758|NCT01978145|528591650|FG000|Treatment Period 1|Adverse Event|1|||
146567759|NCT01978145|528591651|FG001|Treatment Period 1|Adverse Event|9|||
146567760|NCT01978145|528591650|FG000|Treatment Period 1|Physician Decision|1|||
146567761|NCT01978145|528591651|FG001|Treatment Period 1|Physician Decision|0|||
146567762|NCT01978145|528591650|FG000|Treatment Period 1|Withdrawal by Subject|5|||
146567763|NCT01978145|528591651|FG001|Treatment Period 1|Withdrawal by Subject|4|||
146567764|NCT01978145|528591650|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
146567765|NCT01978145|528591651|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
146567766|NCT01978145|528591650|FG000|Washout Period 1|Adverse Event|0|||
146567767|NCT01978145|528591651|FG001|Washout Period 1|Adverse Event|1|||
146567768|NCT01978145|528591650|FG000|Washout Period 1|Withdrawal by Subject|1|||
146567769|NCT01978145|528591651|FG001|Washout Period 1|Withdrawal by Subject|1|||
146567770|NCT01978145|528591650|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
146567771|NCT01978145|528591651|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
146507036|NCT03036098|528360858|FG003|Treatment|Poor/Non Compliance|1|||
146507037|NCT03036098|528360855|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
146507038|NCT03036098|528360856|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
146507039|NCT03036098|528360857|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
146507040|NCT03036098|528360858|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
146507041|NCT03036098|528360855|FG000|Treatment|Administrative Reason by Sponsor|1|||
146507042|NCT03036098|528360856|FG001|Treatment|Administrative Reason by Sponsor|0|||
146507043|NCT03036098|528360857|FG002|Treatment|Administrative Reason by Sponsor|2|||
146507044|NCT03036098|528360858|FG003|Treatment|Administrative Reason by Sponsor|1|||
146507045|NCT03036098|528360855|FG000|Treatment|Other Reasons|31|||
146507046|NCT03036098|528360856|FG001|Treatment|Other Reasons|5|||
146507047|NCT03036098|528360857|FG002|Treatment|Other Reasons|21|||
146507048|NCT03036098|528360858|FG003|Treatment|Other Reasons|8|||
146507049|NCT03036098|528360855|FG000|Treatment|Ongoing Treatment|0|||
146507050|NCT03036098|528360856|FG001|Treatment|Ongoing Treatment|0|||
146507051|NCT03036098|528360857|FG002|Treatment|Ongoing Treatment|23|||
146507052|NCT03036098|528360858|FG003|Treatment|Ongoing Treatment|0|||
146507053|NCT02276053|528360861|FG000|Overall Study|Death|2|||
146507054|NCT02276053|528360861|FG000|Overall Study|Adverse Event|5|||
146507055|NCT02276053|528360861|FG000|Overall Study|Lack of Efficacy|2|||
146507056|NCT02276053|528360861|FG000|Overall Study|Withdrawal by Subject|1|||
146507057|NCT02276053|528360861|FG000|Overall Study|Patient does not meet selection criteria|3|||
146507058|NCT02276053|528360861|FG000|Overall Study|Patient needs to increase baseline AED|1|||
146507059|NCT01632904|528360862|FG000|Overall Study|Adverse Event|4|||
146507060|NCT01632904|528360863|FG001|Overall Study|Adverse Event|1|||
146507061|NCT01632904|528360862|FG000|Overall Study|Physician Decision|0|||
146507062|NCT01632904|528360863|FG001|Overall Study|Physician Decision|1|||
146507063|NCT01632904|528360862|FG000|Overall Study|Subject decision|3|||
146507064|NCT01632904|528360863|FG001|Overall Study|Subject decision|2|||
146507065|NCT01632904|528360862|FG000|Overall Study|Disease Progression|0|||
146507066|NCT01632904|528360863|FG001|Overall Study|Disease Progression|1|||
146507067|NCT01632904|528360862|FG000|Overall Study|Reason for discontinuation not available|0|||
146507068|NCT01632904|528360863|FG001|Overall Study|Reason for discontinuation not available|1|||
146507069|NCT02059434|528360867|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
146507070|NCT02059434|528360868|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
146507071|NCT02059434|528360869|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
146507072|NCT02059434|528360870|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
146507073|NCT02059434|528360871|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
146507074|NCT02059434|528360872|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
146507075|NCT02059434|528360873|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
146507076|NCT02059434|528360874|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
146507077|NCT02059434|528360875|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
146507078|NCT02059434|528360867|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
146507079|NCT02059434|528360868|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
146507080|NCT02059434|528360869|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
146507081|NCT02059434|528360870|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
146507082|NCT02059434|528360871|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
146507083|NCT02059434|528360872|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
146507084|NCT02059434|528360873|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
146507085|NCT02059434|528360874|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
146507086|NCT02059434|528360875|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
146507087|NCT02059434|528360867|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
146507088|NCT02059434|528360868|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
146507089|NCT02059434|528360869|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
146507090|NCT02059434|528360870|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
146507091|NCT02059434|528360871|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
146507092|NCT02059434|528360872|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
146507093|NCT02059434|528360873|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
146507094|NCT02059434|528360874|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
146507095|NCT02059434|528360875|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
146507096|NCT02059434|528360867|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
146507097|NCT02059434|528360868|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
146507098|NCT02059434|528360869|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
146507099|NCT02059434|528360870|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
146507100|NCT02059434|528360871|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
146507101|NCT02059434|528360872|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
146507102|NCT02059434|528360873|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
146507103|NCT02059434|528360874|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
146507104|NCT02059434|528360875|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
146507105|NCT02059434|528360867|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
146567772|NCT01978145|528591650|FG000|Treatment Period 2|Adverse Event|3|||
146649251|NCT00710762|528893039|FG000|Overall Study|Other Adverse Event|7|||
146649252|NCT00710762|528893040|FG001|Overall Study|Other Adverse Event|7|||
146649253|NCT00710762|528893039|FG000|Overall Study|Lost to Follow-up|1|||
146649254|NCT00710762|528893040|FG001|Overall Study|Lost to Follow-up|0|||
146649255|NCT00710762|528893039|FG000|Overall Study|Reason other than listed above|2|||
146649256|NCT00710762|528893040|FG001|Overall Study|Reason other than listed above|2|||
146649257|NCT01375075|528893041|FG000|Overall Study|Adverse Event|0|||
146649258|NCT01375075|528893042|FG001|Overall Study|Adverse Event|0|||
146649259|NCT01375075|528893043|FG002|Overall Study|Adverse Event|3|||
146649260|NCT01375075|528893044|FG003|Overall Study|Adverse Event|1|||
146649261|NCT01375075|528893045|FG004|Overall Study|Adverse Event|0|||
146649262|NCT01375075|528893046|FG005|Overall Study|Adverse Event|1|||
146649263|NCT01375075|528893041|FG000|Overall Study|Entry Criterion Not Met|1|||
146649264|NCT01375075|528893042|FG001|Overall Study|Entry Criterion Not Met|0|||
146649265|NCT01375075|528893043|FG002|Overall Study|Entry Criterion Not Met|0|||
146649266|NCT01375075|528893044|FG003|Overall Study|Entry Criterion Not Met|0|||
146649267|NCT01375075|528893045|FG004|Overall Study|Entry Criterion Not Met|0|||
146649268|NCT01375075|528893046|FG005|Overall Study|Entry Criterion Not Met|1|||
146649269|NCT01375075|528893041|FG000|Overall Study|Withdrawal by Subject|0|||
146649270|NCT01375075|528893042|FG001|Overall Study|Withdrawal by Subject|1|||
146649271|NCT01375075|528893043|FG002|Overall Study|Withdrawal by Subject|0|||
146649272|NCT01375075|528893044|FG003|Overall Study|Withdrawal by Subject|0|||
146649273|NCT01375075|528893045|FG004|Overall Study|Withdrawal by Subject|0|||
146649274|NCT01375075|528893046|FG005|Overall Study|Withdrawal by Subject|1|||
146649275|NCT00821509|528893047|FG000|Overall Study|Withdrawal by Subject|12|||
146649276|NCT00821509|528893048|FG001|Overall Study|Withdrawal by Subject|11|||
146649277|NCT00821509|528893049|FG002|Overall Study|Withdrawal by Subject|34|||
146649278|NCT03104816|528893051|FG000|Overall Study|Lack of Efficacy|0|||
146649279|NCT03104816|528893052|FG001|Overall Study|Lack of Efficacy|2|||
146649280|NCT03104816|528893053|FG002|Overall Study|Lack of Efficacy|0|||
146649281|NCT03104816|528893051|FG000|Overall Study|Protocol Violation|2|||
146649282|NCT03104816|528893052|FG001|Overall Study|Protocol Violation|0|||
146649283|NCT03104816|528893053|FG002|Overall Study|Protocol Violation|2|||
146649284|NCT01894568|528893054|FG000|Overall Study|Adverse Event|2|||
146649285|NCT01894568|528893055|FG001|Overall Study|Adverse Event|3|||
146649286|NCT01894568|528893054|FG000|Overall Study|Protocol required discontinuation|2|||
146649287|NCT01894568|528893055|FG001|Overall Study|Protocol required discontinuation|1|||
146649288|NCT01894568|528893054|FG000|Overall Study|Withdrawal by Subject|5|||
146649289|NCT01894568|528893055|FG001|Overall Study|Withdrawal by Subject|5|||
146649290|NCT01894568|528893054|FG000|Overall Study|Physician Decision|1|||
146649291|NCT01894568|528893055|FG001|Overall Study|Physician Decision|0|||
146649292|NCT01894568|528893054|FG000|Overall Study|Lost to Follow-up|0|||
146649293|NCT01894568|528893055|FG001|Overall Study|Lost to Follow-up|1|||
146649294|NCT00807573|528893056|FG000|Overall Study|Withdrawal by Subject|1|||
146649295|NCT00807573|528893056|FG000|Overall Study|Adverse Event|1|||
146649296|NCT01426789|528893057|FG000|Part 1|Protocol deviation|0|||
146649297|NCT01426789|528893058|FG001|Part 1|Protocol deviation|1|||
146649298|NCT01426789|528893059|FG002|Part 1|Protocol deviation|0|||
146649299|NCT01426789|528893060|FG003|Part 1|Protocol deviation|0|||
146649300|NCT01426789|528893061|FG004|Part 1|Protocol deviation|0|||
146649301|NCT01426789|528893062|FG005|Part 1|Protocol deviation|0|||
146649302|NCT01426789|528893057|FG000|Part 1|Lost to Follow-up|1|||
146649303|NCT01426789|528893058|FG001|Part 1|Lost to Follow-up|2|||
146649304|NCT01426789|528893059|FG002|Part 1|Lost to Follow-up|0|||
146649305|NCT01426789|528893060|FG003|Part 1|Lost to Follow-up|0|||
146649306|NCT01426789|528893061|FG004|Part 1|Lost to Follow-up|0|||
146649307|NCT01426789|528893062|FG005|Part 1|Lost to Follow-up|0|||
146649308|NCT01426789|528893057|FG000|Part 1|Lack of Efficacy|2|||
146649309|NCT01426789|528893058|FG001|Part 1|Lack of Efficacy|1|||
146649310|NCT01426789|528893059|FG002|Part 1|Lack of Efficacy|0|||
146649311|NCT01426789|528893060|FG003|Part 1|Lack of Efficacy|0|||
146649312|NCT01426789|528893061|FG004|Part 1|Lack of Efficacy|0|||
146649313|NCT01426789|528893062|FG005|Part 1|Lack of Efficacy|0|||
146649314|NCT01426789|528893057|FG000|Part 1|Adverse Event|3|||
146649315|NCT01426789|528893058|FG001|Part 1|Adverse Event|0|||
146649316|NCT01426789|528893059|FG002|Part 1|Adverse Event|0|||
146649317|NCT01426789|528893060|FG003|Part 1|Adverse Event|0|||
146649318|NCT01426789|528893061|FG004|Part 1|Adverse Event|0|||
146649319|NCT01426789|528893062|FG005|Part 1|Adverse Event|0|||
146649320|NCT01426789|528893057|FG000|Part 2|Protocol deviation|0|||
146649321|NCT01426789|528893058|FG001|Part 2|Protocol deviation|0|||
146649322|NCT01426789|528893059|FG002|Part 2|Protocol deviation|1|||
146649323|NCT01426789|528893060|FG003|Part 2|Protocol deviation|0|||
146649324|NCT01426789|528893061|FG004|Part 2|Protocol deviation|0|||
146649325|NCT01426789|528893062|FG005|Part 2|Protocol deviation|0|||
146649326|NCT01426789|528893057|FG000|Part 2|Death|0|||
146649327|NCT01426789|528893058|FG001|Part 2|Death|0|||
146649328|NCT01426789|528893059|FG002|Part 2|Death|1|||
146649329|NCT01426789|528893060|FG003|Part 2|Death|0|||
146649330|NCT01426789|528893061|FG004|Part 2|Death|1|||
146649331|NCT01426789|528893062|FG005|Part 2|Death|0|||
146649332|NCT01426789|528893057|FG000|Part 2|Administrative problems|0|||
146649333|NCT01426789|528893058|FG001|Part 2|Administrative problems|0|||
146649334|NCT01426789|528893059|FG002|Part 2|Administrative problems|2|||
146649335|NCT01426789|528893060|FG003|Part 2|Administrative problems|0|||
146649336|NCT01426789|528893061|FG004|Part 2|Administrative problems|1|||
146649337|NCT01426789|528893062|FG005|Part 2|Administrative problems|0|||
146649338|NCT01426789|528893057|FG000|Part 2|Lost to Follow-up|0|||
146507106|NCT02059434|528360868|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
146507107|NCT02059434|528360869|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
146507108|NCT02059434|528360870|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
146507109|NCT02059434|528360871|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
146507110|NCT02059434|528360872|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
146507111|NCT02059434|528360873|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
146507112|NCT02059434|528360874|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
146507113|NCT02059434|528360875|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
146507114|NCT03201874|528360880|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
146507115|NCT03201874|528360881|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
146507116|NCT03201874|528360880|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
146507117|NCT03201874|528360881|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
146507118|NCT02907593|528360882|FG000|Overall Study|Withdrawal by Subject|0|||
146507119|NCT02907593|528360883|FG001|Overall Study|Withdrawal by Subject|0|||
146507120|NCT02907593|528360884|FG002|Overall Study|Withdrawal by Subject|1|||
146507121|NCT02907593|528360885|FG003|Overall Study|Withdrawal by Subject|0|||
146507122|NCT01668966|528360906|FG000|Overall Study|Withdrawal by Subject|1|||
146649339|NCT01426789|528893058|FG001|Part 2|Lost to Follow-up|0|||
146649340|NCT01426789|528893059|FG002|Part 2|Lost to Follow-up|4|||
146649341|NCT01426789|528893060|FG003|Part 2|Lost to Follow-up|0|||
146649342|NCT01426789|528893061|FG004|Part 2|Lost to Follow-up|1|||
146649343|NCT01426789|528893062|FG005|Part 2|Lost to Follow-up|0|||
146649344|NCT01426789|528893057|FG000|Part 2|Withdrawal by Subject|0|||
146649345|NCT01426789|528893058|FG001|Part 2|Withdrawal by Subject|0|||
146649346|NCT01426789|528893059|FG002|Part 2|Withdrawal by Subject|0|||
146649347|NCT01426789|528893060|FG003|Part 2|Withdrawal by Subject|1|||
146649348|NCT01426789|528893061|FG004|Part 2|Withdrawal by Subject|2|||
146649349|NCT01426789|528893062|FG005|Part 2|Withdrawal by Subject|0|||
146649350|NCT01426789|528893057|FG000|Part 2|Lack of Efficacy|0|||
146649351|NCT01426789|528893058|FG001|Part 2|Lack of Efficacy|0|||
146649352|NCT01426789|528893059|FG002|Part 2|Lack of Efficacy|5|||
146649353|NCT01426789|528893060|FG003|Part 2|Lack of Efficacy|0|||
146649354|NCT01426789|528893061|FG004|Part 2|Lack of Efficacy|2|||
146649355|NCT01426789|528893062|FG005|Part 2|Lack of Efficacy|0|||
146649356|NCT01426789|528893057|FG000|Part 2|Adverse Event|0|||
146649357|NCT01426789|528893058|FG001|Part 2|Adverse Event|0|||
146649358|NCT01426789|528893059|FG002|Part 2|Adverse Event|2|||
146649359|NCT01426789|528893060|FG003|Part 2|Adverse Event|0|||
146649360|NCT01426789|528893061|FG004|Part 2|Adverse Event|1|||
146649361|NCT01426789|528893062|FG005|Part 2|Adverse Event|0|||
146649362|NCT04054947|528893063|FG000|Overall Study|Withdrawal by Subject|1|||
146649363|NCT04054947|528893064|FG001|Overall Study|Withdrawal by Subject|0|||
146649364|NCT04054947|528893063|FG000|Overall Study|Lost to Follow-up|2|||
146649365|NCT04054947|528893064|FG001|Overall Study|Lost to Follow-up|5|||
146649366|NCT00311584|528893065|FG000|Overall Study|Death|1|||
146649367|NCT00311584|528893066|FG001|Overall Study|Death|0|||
146507123|NCT01668966|528360906|FG000|Overall Study|Death|1|||
146507124|NCT01668966|528360906|FG000|Overall Study|Not treated|2|||
146649368|NCT00311584|528893065|FG000|Overall Study|Lack of Efficacy|12|||
146649369|NCT00311584|528893066|FG001|Overall Study|Lack of Efficacy|15|||
146649370|NCT00311584|528893065|FG000|Overall Study|Physician Decision|4|||
146649371|NCT00311584|528893066|FG001|Overall Study|Physician Decision|5|||
146649372|NCT00311584|528893065|FG000|Overall Study|Withdrawal by Subject|1|||
146649373|NCT00311584|528893066|FG001|Overall Study|Withdrawal by Subject|1|||
146649374|NCT00311584|528893065|FG000|Overall Study|ineligible|2|||
146649375|NCT00311584|528893066|FG001|Overall Study|ineligible|2|||
146649376|NCT03720652|528893067|FG000|Overall Study|Withdrawal by Subject|2|||
146649377|NCT03720652|528893068|FG001|Overall Study|Withdrawal by Subject|7|||
146649378|NCT03720652|528893067|FG000|Overall Study|Lost to Follow-up|0|||
146649379|NCT03720652|528893068|FG001|Overall Study|Lost to Follow-up|4|||
146649380|NCT03073733|528893075|FG000|Overall Study|Lost to Follow-up|1|||
146649381|NCT03073733|528893076|FG001|Overall Study|Lost to Follow-up|0|||
146649382|NCT03073733|528893077|FG002|Overall Study|Lost to Follow-up|0|||
146649383|NCT03073733|528893075|FG000|Overall Study|Physician Decision|0|||
146649384|NCT03073733|528893076|FG001|Overall Study|Physician Decision|1|||
146649385|NCT03073733|528893077|FG002|Overall Study|Physician Decision|0|||
146649386|NCT03073733|528893075|FG000|Overall Study|Withdrawal by Subject|0|||
146649387|NCT03073733|528893076|FG001|Overall Study|Withdrawal by Subject|0|||
146649388|NCT03073733|528893077|FG002|Overall Study|Withdrawal by Subject|1|||
146649389|NCT00835731|528893078|FG000|Overall Study|Withdrawal by Subject|1|||
146649390|NCT00835731|528893079|FG001|Overall Study|Withdrawal by Subject|0|||
146649391|NCT00835731|528893078|FG000|Overall Study|Physician Decision|1|||
146649392|NCT00835731|528893079|FG001|Overall Study|Physician Decision|1|||
146507125|NCT02659514|528360919|FG000|Overall Study|Adverse Event|3|||
146507126|NCT02659514|528360920|FG001|Overall Study|Adverse Event|12|||
146507127|NCT02659514|528360919|FG000|Overall Study|Disease Progression|23|||
146507128|NCT02659514|528360920|FG001|Overall Study|Disease Progression|13|||
146649393|NCT01227629|528893080|FG000|Overall Study|Adverse Event|2|||
146649394|NCT01227629|528893081|FG001|Overall Study|Adverse Event|2|||
146649395|NCT01227629|528893082|FG002|Overall Study|Adverse Event|1|||
146649396|NCT01227629|528893083|FG003|Overall Study|Adverse Event|6|||
146649397|NCT01227629|528893084|FG004|Overall Study|Adverse Event|1|||
146649398|NCT01227629|528893085|FG005|Overall Study|Adverse Event|1|||
146649399|NCT01227629|528893086|FG006|Overall Study|Adverse Event|6|||
146649400|NCT01227629|528893087|FG007|Overall Study|Adverse Event|6|||
146649401|NCT01227629|528893088|FG008|Overall Study|Adverse Event|4|||
146649402|NCT01227629|528893089|FG009|Overall Study|Adverse Event|0|||
146649403|NCT01227629|528893080|FG000|Overall Study|Protocol Violation|0|||
146649404|NCT01227629|528893081|FG001|Overall Study|Protocol Violation|0|||
146649405|NCT01227629|528893082|FG002|Overall Study|Protocol Violation|0|||
146649406|NCT01227629|528893083|FG003|Overall Study|Protocol Violation|1|||
146649407|NCT01227629|528893084|FG004|Overall Study|Protocol Violation|0|||
146649408|NCT01227629|528893085|FG005|Overall Study|Protocol Violation|0|||
146649409|NCT01227629|528893086|FG006|Overall Study|Protocol Violation|0|||
146649410|NCT01227629|528893087|FG007|Overall Study|Protocol Violation|0|||
146649411|NCT01227629|528893088|FG008|Overall Study|Protocol Violation|0|||
146649412|NCT01227629|528893089|FG009|Overall Study|Protocol Violation|0|||
146649413|NCT01227629|528893080|FG000|Overall Study|Lost to Follow-up|0|||
146649414|NCT01227629|528893081|FG001|Overall Study|Lost to Follow-up|0|||
146649415|NCT01227629|528893082|FG002|Overall Study|Lost to Follow-up|0|||
146507129|NCT02659514|528360919|FG000|Overall Study|Withdrawal by Subject|0|||
146507130|NCT02659514|528360920|FG001|Overall Study|Withdrawal by Subject|4|||
146507131|NCT02659514|528360919|FG000|Overall Study|Lost to Follow-up|0|||
146507132|NCT02659514|528360920|FG001|Overall Study|Lost to Follow-up|1|||
146507133|NCT02659514|528360919|FG000|Overall Study|Death|6|||
146507134|NCT02659514|528360920|FG001|Overall Study|Death|1|||
146507135|NCT02659514|528360919|FG000|Overall Study|Reason Unspecified|0|||
146507136|NCT02659514|528360920|FG001|Overall Study|Reason Unspecified|3|||
146507137|NCT00878969|528360924|FG000|Overall Study|Physician Decision|5|||
146507138|NCT00878969|528360925|FG001|Overall Study|Physician Decision|3|||
146507139|NCT00878969|528360926|FG002|Overall Study|Physician Decision|2|||
146507140|NCT00878969|528360924|FG000|Overall Study|Withdrawal by Subject|1|||
146507141|NCT00878969|528360925|FG001|Overall Study|Withdrawal by Subject|6|||
146507142|NCT00878969|528360926|FG002|Overall Study|Withdrawal by Subject|3|||
146507143|NCT00878969|528360924|FG000|Overall Study|kidney transplant|2|||
146507144|NCT00878969|528360925|FG001|Overall Study|kidney transplant|3|||
146507145|NCT00878969|528360926|FG002|Overall Study|kidney transplant|2|||
146507146|NCT00878969|528360924|FG000|Overall Study|Adverse Event|3|||
146507147|NCT00878969|528360925|FG001|Overall Study|Adverse Event|1|||
146507148|NCT00878969|528360926|FG002|Overall Study|Adverse Event|2|||
146507149|NCT00878969|528360924|FG000|Overall Study|Lost to Follow-up|2|||
146507150|NCT00878969|528360925|FG001|Overall Study|Lost to Follow-up|1|||
146507151|NCT00878969|528360926|FG002|Overall Study|Lost to Follow-up|0|||
146507152|NCT00878969|528360924|FG000|Overall Study|Protocol Violation|2|||
146507153|NCT00878969|528360925|FG001|Overall Study|Protocol Violation|0|||
146507154|NCT00878969|528360926|FG002|Overall Study|Protocol Violation|0|||
146649416|NCT01227629|528893083|FG003|Overall Study|Lost to Follow-up|0|||
146507155|NCT00878969|528360924|FG000|Overall Study|Death|0|||
146507156|NCT00878969|528360925|FG001|Overall Study|Death|0|||
146507157|NCT00878969|528360926|FG002|Overall Study|Death|2|||
146507158|NCT00878969|528360924|FG000|Overall Study|Pregnancy|0|||
146507159|NCT00878969|528360925|FG001|Overall Study|Pregnancy|1|||
146649417|NCT01227629|528893084|FG004|Overall Study|Lost to Follow-up|1|||
146649418|NCT01227629|528893085|FG005|Overall Study|Lost to Follow-up|0|||
146649419|NCT01227629|528893086|FG006|Overall Study|Lost to Follow-up|0|||
146507160|NCT00878969|528360926|FG002|Overall Study|Pregnancy|0|||
146507161|NCT00655733|528360927|FG000|Overall Study|Lost to Follow-up|2|||
146649420|NCT01227629|528893087|FG007|Overall Study|Lost to Follow-up|0|||
146649421|NCT01227629|528893088|FG008|Overall Study|Lost to Follow-up|0|||
146649422|NCT01227629|528893089|FG009|Overall Study|Lost to Follow-up|0|||
146507162|NCT00655733|528360928|FG001|Overall Study|Lost to Follow-up|2|||
146507163|NCT00655733|528360927|FG000|Overall Study|Adverse Event|2|||
146649423|NCT01227629|528893080|FG000|Overall Study|Withdrawal by Subject|0|||
146649424|NCT01227629|528893081|FG001|Overall Study|Withdrawal by Subject|0|||
146507164|NCT00655733|528360928|FG001|Overall Study|Adverse Event|2|||
146507165|NCT00655733|528360927|FG000|Overall Study|Withdrawal by Subject|3|||
146507166|NCT00655733|528360928|FG001|Overall Study|Withdrawal by Subject|3|||
146649425|NCT01227629|528893082|FG002|Overall Study|Withdrawal by Subject|0|||
146507167|NCT00655733|528360927|FG000|Overall Study|Physician Decision|0|||
146507168|NCT00655733|528360928|FG001|Overall Study|Physician Decision|1|||
146649426|NCT01227629|528893083|FG003|Overall Study|Withdrawal by Subject|0|||
146649427|NCT01227629|528893084|FG004|Overall Study|Withdrawal by Subject|0|||
146507169|NCT02035748|528360929|FG000|Overall Study|Adverse Event|5|||
146507170|NCT02035748|528360929|FG000|Overall Study|Death|3|||
146507171|NCT02035748|528360929|FG000|Overall Study|Lost to Follow-up|2|||
146507172|NCT02035748|528360929|FG000|Overall Study|Physician Decision|3|||
146507173|NCT02035748|528360929|FG000|Overall Study|Withdrawal by Subject|6|||
146507174|NCT02035748|528360929|FG000|Overall Study|Progressive Disease|1|||
146507175|NCT01088243|528360931|FG000|Overall Study|Adverse Event|1|||
146507176|NCT01088243|528360932|FG001|Overall Study|Adverse Event|0|||
146507177|NCT04495816|528360933|FG000|Overall Study|Lost to Follow-up|10|||
146507178|NCT04495816|528360934|FG001|Overall Study|Lost to Follow-up|4|||
146507179|NCT04495816|528360933|FG000|Overall Study|Withdrawal by Subject|3|||
146507180|NCT04495816|528360934|FG001|Overall Study|Withdrawal by Subject|5|||
146507181|NCT03536949|528360935|FG000|Overall Study|Adverse Event|4|||
146507182|NCT03536949|528360936|FG001|Overall Study|Adverse Event|0|||
146507183|NCT03536949|528360935|FG000|Overall Study|Lost to Follow-up|2|||
146507184|NCT03536949|528360936|FG001|Overall Study|Lost to Follow-up|1|||
146507185|NCT03536949|528360935|FG000|Overall Study|Withdrawal by Subject|6|||
146507186|NCT03536949|528360936|FG001|Overall Study|Withdrawal by Subject|0|||
146507187|NCT03536949|528360935|FG000|Overall Study|Non-compliance|2|||
146507188|NCT03536949|528360936|FG001|Overall Study|Non-compliance|1|||
146507189|NCT06137703|528360938|FG000|Overall Study|Other|0|||
146507190|NCT06137703|528360939|FG001|Overall Study|Other|1|||
146507191|NCT06137703|528360940|FG002|Overall Study|Other|0|||
146507192|NCT06137703|528360941|FG003|Overall Study|Other|0|||
146507193|NCT06137703|528360938|FG000|Overall Study|Adverse Event|0|||
146507194|NCT06137703|528360939|FG001|Overall Study|Adverse Event|0|||
146507195|NCT06137703|528360940|FG002|Overall Study|Adverse Event|1|||
146507196|NCT06137703|528360941|FG003|Overall Study|Adverse Event|0|||
146507197|NCT00597506|528360942|FG000|Overall Study|Subject is being followed for survival|1|||
146507198|NCT03199612|528360945|FG000|Overall Study|Adverse Event|1|||
146507199|NCT03199612|528360946|FG001|Overall Study|Adverse Event|0|||
146507200|NCT02543892|528360951|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
146507201|NCT02543892|528360952|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
146507202|NCT02543892|528360953|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
146507203|NCT02543892|528360954|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
146507204|NCT02543892|528360955|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
146507205|NCT02543892|528360956|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
146507206|NCT02543892|528360957|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
146507207|NCT02543892|528360958|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
146507208|NCT02543892|528360951|FG000|Received Vaccination 2|Physician Decision|0|||
146507209|NCT02543892|528360952|FG001|Received Vaccination 2|Physician Decision|0|||
146507210|NCT02543892|528360953|FG002|Received Vaccination 2|Physician Decision|0|||
146507211|NCT02543892|528360954|FG003|Received Vaccination 2|Physician Decision|0|||
146507212|NCT02543892|528360955|FG004|Received Vaccination 2|Physician Decision|0|||
146507213|NCT02543892|528360956|FG005|Received Vaccination 2|Physician Decision|1|||
146507214|NCT02543892|528360957|FG006|Received Vaccination 2|Physician Decision|0|||
146507215|NCT02543892|528360958|FG007|Received Vaccination 2|Physician Decision|0|||
146507216|NCT02543892|528360951|FG000|Received Vaccination 2|Adverse Event|0|||
146507217|NCT02543892|528360952|FG001|Received Vaccination 2|Adverse Event|1|||
146507218|NCT02543892|528360953|FG002|Received Vaccination 2|Adverse Event|0|||
146507219|NCT02543892|528360954|FG003|Received Vaccination 2|Adverse Event|0|||
146507220|NCT02543892|528360955|FG004|Received Vaccination 2|Adverse Event|0|||
146507221|NCT02543892|528360956|FG005|Received Vaccination 2|Adverse Event|0|||
146507222|NCT02543892|528360957|FG006|Received Vaccination 2|Adverse Event|0|||
146507223|NCT02543892|528360958|FG007|Received Vaccination 2|Adverse Event|0|||
146507224|NCT02543892|528360951|FG000|Had Immunology Data|Withdrawal by Subject|0|||
146507225|NCT02543892|528360952|FG001|Had Immunology Data|Withdrawal by Subject|0|||
146507226|NCT02543892|528360953|FG002|Had Immunology Data|Withdrawal by Subject|0|||
146507227|NCT02543892|528360954|FG003|Had Immunology Data|Withdrawal by Subject|0|||
146507228|NCT02543892|528360955|FG004|Had Immunology Data|Withdrawal by Subject|0|||
146507229|NCT02543892|528360956|FG005|Had Immunology Data|Withdrawal by Subject|0|||
146507230|NCT02543892|528360957|FG006|Had Immunology Data|Withdrawal by Subject|1|||
146507231|NCT02543892|528360958|FG007|Had Immunology Data|Withdrawal by Subject|0|||
146507232|NCT00081731|528360959|FG000|Overall Study|scientific integrity issue|8|||
146507233|NCT00081731|528360960|FG001|Overall Study|scientific integrity issue|8|||
146507234|NCT00785213|528360961|FG000|Quinine Sulfate Alone|Adverse Event|4|||
146507235|NCT00785213|528360961|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
146507236|NCT01500213|528360962|FG000|Overall Study|Adverse Event|35|||
146507237|NCT01500213|528360963|FG001|Overall Study|Adverse Event|35|||
146507238|NCT01500213|528360962|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
146507239|NCT01500213|528360963|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
146507240|NCT01500213|528360962|FG000|Overall Study|Withdrawal by Subject|28|||
146507241|NCT01500213|528360963|FG001|Overall Study|Withdrawal by Subject|37|||
146507242|NCT01500213|528360962|FG000|Overall Study|Death|7|||
146507243|NCT01500213|528360963|FG001|Overall Study|Death|3|||
146507244|NCT01500213|528360962|FG000|Overall Study|Disease Progression|13|||
146507245|NCT01500213|528360963|FG001|Overall Study|Disease Progression|21|||
146507246|NCT01500213|528360962|FG000|Overall Study|Protocol Violation|19|||
146507247|NCT01500213|528360963|FG001|Overall Study|Protocol Violation|19|||
146507248|NCT01500213|528360962|FG000|Overall Study|Physician Decision|12|||
146507249|NCT01500213|528360963|FG001|Overall Study|Physician Decision|10|||
146507250|NCT01500213|528360962|FG000|Overall Study|Lack of Efficacy|9|||
146507251|NCT01500213|528360963|FG001|Overall Study|Lack of Efficacy|7|||
146507252|NCT01500213|528360962|FG000|Overall Study|Lost to Follow-up|3|||
146507253|NCT01500213|528360963|FG001|Overall Study|Lost to Follow-up|6|||
146507254|NCT01500213|528360962|FG000|Overall Study|Other Reasons|7|||
146507255|NCT01500213|528360963|FG001|Overall Study|Other Reasons|5|||
146507256|NCT02386345|528360964|FG000|Overall Study|Not treated|14|||
146507257|NCT02386345|528360964|FG000|Overall Study|Lost to Follow-up|1|||
146507258|NCT02386345|528360964|FG000|Overall Study|Adverse Event|5|||
146507259|NCT02386345|528360964|FG000|Overall Study|Repeat Procedure|10|||
146507260|NCT02386345|528360964|FG000|Overall Study|Did not complete 12-month follow-up|72|||
146507261|NCT02003963|528360966|FG000|Overall Study|Lost to Follow-up|2|||
146507262|NCT02003963|528360967|FG001|Overall Study|Lost to Follow-up|1|||
146507263|NCT04050124|528360969|FG000|Overall Study|Death|1|||
146507264|NCT04050124|528360970|FG001|Overall Study|Death|0|||
146507265|NCT06011161|528360971|FG000|Overall Study|Withdrawal by Subject|2|||
146507266|NCT06011161|528360971|FG000|Overall Study|Lost to Follow-up|5|||
146507267|NCT00430352|528360975|FG000|Overall Study|Disease progression|58|||
146507268|NCT00430352|528360975|FG000|Overall Study|Withdrawal by Subject|11|||
146507269|NCT00430352|528360975|FG000|Overall Study|Adverse Event|16|||
146507270|NCT00430352|528360975|FG000|Overall Study|Death|5|||
146507271|NCT00430352|528360975|FG000|Overall Study|Other|48|||
146507272|NCT01597375|528360976|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
146507273|NCT01597375|528360977|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
146567773|NCT01978145|528591651|FG001|Treatment Period 2|Adverse Event|3|||
146567774|NCT01978145|528591650|FG000|Treatment Period 2|Protocol Violation|0|||
146567775|NCT01978145|528591651|FG001|Treatment Period 2|Protocol Violation|1|||
146567776|NCT01978145|528591650|FG000|Treatment Period 2|Lost to Follow-up|1|||
146567777|NCT01978145|528591651|FG001|Treatment Period 2|Lost to Follow-up|1|||
146567778|NCT01978145|528591650|FG000|Treatment Period 2|Withdrawal by Subject|7|||
146567779|NCT01978145|528591651|FG001|Treatment Period 2|Withdrawal by Subject|4|||
146567780|NCT01978145|528591650|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
146567781|NCT01978145|528591651|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
146567782|NCT01250054|528591652|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
146567783|NCT01250054|528591653|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
146567784|NCT00755807|528591658|FG000|Acute Phase|Adverse Event|16|||
146567785|NCT00755807|528591659|FG001|Acute Phase|Adverse Event|5|||
146567786|NCT00755807|528591658|FG000|Acute Phase|Protocol Violation|1|||
146567787|NCT00755807|528591659|FG001|Acute Phase|Protocol Violation|3|||
146567788|NCT00755807|528591658|FG000|Acute Phase|Withdrawal by Subject|1|||
146567789|NCT00755807|528591659|FG001|Acute Phase|Withdrawal by Subject|2|||
146567790|NCT00755807|528591658|FG000|Acute Phase|Lack of Efficacy|0|||
146567791|NCT00755807|528591659|FG001|Acute Phase|Lack of Efficacy|1|||
146567792|NCT00755807|528591658|FG000|Acute Phase|Physician Decision|0|||
146567793|NCT00755807|528591659|FG001|Acute Phase|Physician Decision|1|||
146567794|NCT00755807|528591658|FG000|Open-label Extension Phase|Adverse Event|7|||
146567795|NCT00755807|528591659|FG001|Open-label Extension Phase|Adverse Event|7|||
146567796|NCT00755807|528591658|FG000|Open-label Extension Phase|Protocol Violation|5|||
146567797|NCT00755807|528591659|FG001|Open-label Extension Phase|Protocol Violation|2|||
146567798|NCT00755807|528591658|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
146567799|NCT00755807|528591659|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
146567800|NCT00755807|528591658|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
146567801|NCT00755807|528591659|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
146567802|NCT00755807|528591658|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
146567803|NCT00755807|528591659|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
146567804|NCT00755807|528591658|FG000|Open-label Extension Phase|Sponsor Decision|0|||
146567805|NCT00755807|528591659|FG001|Open-label Extension Phase|Sponsor Decision|1|||
146567806|NCT02921789|528591662|FG000|Overall Study|Adverse Event|0|||
146567807|NCT02921789|528591663|FG001|Overall Study|Adverse Event|1|||
146567808|NCT02921789|528591662|FG000|Overall Study|Lost to Follow-up|1|||
146567809|NCT02921789|528591663|FG001|Overall Study|Lost to Follow-up|0|||
146567810|NCT02921789|528591662|FG000|Overall Study|Protocol Deviation|2|||
146567811|NCT02921789|528591663|FG001|Overall Study|Protocol Deviation|0|||
146507274|NCT01597375|528360976|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
146507275|NCT01597375|528360977|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
146567812|NCT02921789|528591662|FG000|Overall Study|Withdrawal by Subject|2|||
146567813|NCT02921789|528591663|FG001|Overall Study|Withdrawal by Subject|1|||
146567814|NCT02921789|528591662|FG000|Overall Study|Miscellaneous|3|||
146507276|NCT01597375|528360976|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
146507277|NCT01597375|528360977|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
146567815|NCT02921789|528591663|FG001|Overall Study|Miscellaneous|2|||
146567816|NCT02580877|528591664|FG000|Overall Study|Withdrawal by Subject|1|||
146567817|NCT02580877|528591665|FG001|Overall Study|Withdrawal by Subject|3|||
146507278|NCT01597375|528360976|FG000|Washout (2 Weeks)|Adverse Event|1|||
146507279|NCT01597375|528360977|FG001|Washout (2 Weeks)|Adverse Event|0|||
146507280|NCT01597375|528360976|FG000|Second Intervention|Failed to react at both Aspirin|1|||
146507281|NCT01597375|528360977|FG001|Second Intervention|Failed to react at both Aspirin|1|||
146507282|NCT01077739|528360980|FG000|Overall Study|Premature withdrawal|1|||
146507283|NCT01077739|528360981|FG001|Overall Study|Premature withdrawal|3|||
146507284|NCT01077739|528360980|FG000|Overall Study|Withdrawal by Subject|1|||
146507285|NCT01077739|528360981|FG001|Overall Study|Withdrawal by Subject|0|||
146507286|NCT01077739|528360980|FG000|Overall Study|Death|0|||
146507287|NCT01077739|528360981|FG001|Overall Study|Death|3|||
146507288|NCT01077739|528360980|FG000|Overall Study|Unacceptable toxicity|1|||
146507289|NCT01077739|528360981|FG001|Overall Study|Unacceptable toxicity|2|||
146507290|NCT01077739|528360980|FG000|Overall Study|Other|2|||
146507291|NCT01077739|528360981|FG001|Overall Study|Other|2|||
146507292|NCT00877071|528360982|FG000|Overall Study|disease progression|2|||
146507293|NCT05723328|528360983|FG000|Overall Study|Investigator's Decision|5|||
146507294|NCT05723328|528360984|FG001|Overall Study|Investigator's Decision|2|||
146507295|NCT03495154|528360986|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
146507296|NCT03495154|528360986|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
146507297|NCT03495154|528360986|FG000|Overall Study|Screen Failures During Surgery|6|||
146507298|NCT03495154|528360986|FG000|Overall Study|Death|2|||
146507299|NCT03495154|528360986|FG000|Overall Study|Lost to Follow-up|16|||
146507300|NCT03495154|528360986|FG000|Overall Study|Withdrawal by Subject|2|||
146507301|NCT03495154|528360986|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
146507302|NCT05685732|528360987|FG000|Overall Study|Withdrawal by Subject|2|||
146507303|NCT05685732|528360988|FG001|Overall Study|Withdrawal by Subject|0|||
146507304|NCT05685732|528360989|FG002|Overall Study|Withdrawal by Subject|2|||
146507305|NCT05685732|528360990|FG003|Overall Study|Withdrawal by Subject|3|||
146507306|NCT05685732|528360987|FG000|Overall Study|Protocol Violation|1|||
146507307|NCT05685732|528360988|FG001|Overall Study|Protocol Violation|2|||
146507308|NCT05685732|528360989|FG002|Overall Study|Protocol Violation|4|||
146507309|NCT05685732|528360990|FG003|Overall Study|Protocol Violation|1|||
146567818|NCT02580877|528591664|FG000|Overall Study|Adverse Event|0|||
146567819|NCT02580877|528591665|FG001|Overall Study|Adverse Event|1|||
146567820|NCT02903823|528591666|FG000|Overall Study|Physician Decision|5|||
146567821|NCT02903823|528591666|FG000|Overall Study|Could not advance catheter|1|||
146567822|NCT02903823|528591666|FG000|Overall Study|Catheter dislodgement|1|||
146567823|NCT01832727|528591670|FG000|Overall Study|Adverse Event|4|||
146567824|NCT01832727|528591671|FG001|Overall Study|Adverse Event|6|||
146567825|NCT01832727|528591672|FG002|Overall Study|Adverse Event|1|||
146567826|NCT01832727|528591673|FG003|Overall Study|Adverse Event|0|||
146567827|NCT01832727|528591674|FG004|Overall Study|Adverse Event|1|||
146567828|NCT01832727|528591675|FG005|Overall Study|Adverse Event|1|||
146567829|NCT01832727|528591676|FG006|Overall Study|Adverse Event|2|||
146567830|NCT01832727|528591677|FG007|Overall Study|Adverse Event|1|||
146567831|NCT01832727|528591678|FG008|Overall Study|Adverse Event|9|||
146567832|NCT01832727|528591670|FG000|Overall Study|Disease progression|3|||
146567833|NCT01832727|528591671|FG001|Overall Study|Disease progression|0|||
146567834|NCT01832727|528591672|FG002|Overall Study|Disease progression|2|||
146567835|NCT01832727|528591673|FG003|Overall Study|Disease progression|1|||
146567836|NCT01832727|528591674|FG004|Overall Study|Disease progression|3|||
146567837|NCT01832727|528591675|FG005|Overall Study|Disease progression|3|||
146567838|NCT01832727|528591676|FG006|Overall Study|Disease progression|6|||
146567839|NCT01832727|528591677|FG007|Overall Study|Disease progression|2|||
146567840|NCT01832727|528591678|FG008|Overall Study|Disease progression|7|||
146567841|NCT01832727|528591670|FG000|Overall Study|Lost to Follow-up|0|||
146567842|NCT01832727|528591671|FG001|Overall Study|Lost to Follow-up|0|||
146567843|NCT01832727|528591672|FG002|Overall Study|Lost to Follow-up|0|||
146567844|NCT01832727|528591673|FG003|Overall Study|Lost to Follow-up|1|||
146567845|NCT01832727|528591674|FG004|Overall Study|Lost to Follow-up|0|||
146567846|NCT01832727|528591675|FG005|Overall Study|Lost to Follow-up|0|||
146567847|NCT01832727|528591676|FG006|Overall Study|Lost to Follow-up|0|||
146567848|NCT01832727|528591677|FG007|Overall Study|Lost to Follow-up|0|||
146567849|NCT01832727|528591678|FG008|Overall Study|Lost to Follow-up|0|||
146567850|NCT01832727|528591670|FG000|Overall Study|Physician Decision|1|||
146649428|NCT01227629|528893085|FG005|Overall Study|Withdrawal by Subject|0|||
146649429|NCT01227629|528893086|FG006|Overall Study|Withdrawal by Subject|2|||
146507310|NCT05685732|528360987|FG000|Overall Study|Lost to Follow-up|5|||
146507311|NCT05685732|528360988|FG001|Overall Study|Lost to Follow-up|1|||
146507312|NCT05685732|528360989|FG002|Overall Study|Lost to Follow-up|3|||
146507313|NCT05685732|528360990|FG003|Overall Study|Lost to Follow-up|1|||
146567851|NCT01832727|528591671|FG001|Overall Study|Physician Decision|0|||
146567852|NCT01832727|528591672|FG002|Overall Study|Physician Decision|0|||
146507314|NCT05685732|528360987|FG000|Overall Study|Adverse Event|2|||
146567853|NCT01832727|528591673|FG003|Overall Study|Physician Decision|1|||
146567854|NCT01832727|528591674|FG004|Overall Study|Physician Decision|0|||
146567855|NCT01832727|528591675|FG005|Overall Study|Physician Decision|1|||
146567856|NCT01832727|528591676|FG006|Overall Study|Physician Decision|0|||
146567857|NCT01832727|528591677|FG007|Overall Study|Physician Decision|0|||
146507315|NCT05685732|528360988|FG001|Overall Study|Adverse Event|1|||
146507316|NCT05685732|528360989|FG002|Overall Study|Adverse Event|0|||
146507317|NCT05685732|528360990|FG003|Overall Study|Adverse Event|0|||
146507318|NCT05685732|528360987|FG000|Overall Study|Physician Decision|1|||
146507319|NCT05685732|528360988|FG001|Overall Study|Physician Decision|0|||
146507320|NCT05685732|528360989|FG002|Overall Study|Physician Decision|0|||
146507321|NCT05685732|528360990|FG003|Overall Study|Physician Decision|0|||
146507322|NCT02640404|528360991|FG000|Overall Study|Protocol Violation|1|||
146507323|NCT02640404|528360992|FG001|Overall Study|Protocol Violation|0|||
146507324|NCT02640404|528360991|FG000|Overall Study|Withdrawal by Subject|1|||
146507325|NCT02640404|528360992|FG001|Overall Study|Withdrawal by Subject|0|||
146507326|NCT04908202|528360994|FG000|Pre-Treatment Period|OTHER REASONS|3|||
146507327|NCT04908202|528360995|FG001|Pre-Treatment Period|OTHER REASONS|1|||
146507328|NCT04908202|528360996|FG002|Pre-Treatment Period|OTHER REASONS|0|||
146507329|NCT04908202|528360997|FG003|Pre-Treatment Period|OTHER REASONS|0|||
146507330|NCT04908202|528360994|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
146507331|NCT04908202|528360995|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
146507332|NCT04908202|528360996|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
146507333|NCT04908202|528360997|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
146507334|NCT04908202|528360994|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
146507335|NCT04908202|528360995|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
146507336|NCT04908202|528360996|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
146507337|NCT04908202|528360997|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
146507338|NCT04908202|528360994|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
146507339|NCT04908202|528360995|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
146507340|NCT04908202|528360996|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
146507341|NCT04908202|528360997|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
146507342|NCT04908202|528360994|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
146507343|NCT04908202|528360995|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
146507344|NCT04908202|528360996|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
146507345|NCT04908202|528360997|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
146507346|NCT04908202|528360994|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
146507347|NCT04908202|528360995|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
146507348|NCT04908202|528360996|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
146567858|NCT01832727|528591678|FG008|Overall Study|Physician Decision|0|||
146567859|NCT01832727|528591670|FG000|Overall Study|Withdrawal by Subject|1|||
146567860|NCT01832727|528591671|FG001|Overall Study|Withdrawal by Subject|1|||
146567861|NCT01832727|528591672|FG002|Overall Study|Withdrawal by Subject|0|||
146567862|NCT01832727|528591673|FG003|Overall Study|Withdrawal by Subject|1|||
146567863|NCT01832727|528591674|FG004|Overall Study|Withdrawal by Subject|0|||
146567864|NCT01832727|528591675|FG005|Overall Study|Withdrawal by Subject|1|||
146567865|NCT01832727|528591676|FG006|Overall Study|Withdrawal by Subject|0|||
146567866|NCT01832727|528591677|FG007|Overall Study|Withdrawal by Subject|2|||
146567867|NCT01832727|528591678|FG008|Overall Study|Withdrawal by Subject|1|||
146567868|NCT01832727|528591670|FG000|Overall Study|Study terminated by sponsor|0|||
146567869|NCT01832727|528591671|FG001|Overall Study|Study terminated by sponsor|0|||
146567870|NCT01832727|528591672|FG002|Overall Study|Study terminated by sponsor|0|||
146649430|NCT01227629|528893087|FG007|Overall Study|Withdrawal by Subject|0|||
146649431|NCT01227629|528893088|FG008|Overall Study|Withdrawal by Subject|0|||
146567871|NCT01832727|528591673|FG003|Overall Study|Study terminated by sponsor|0|||
146649432|NCT01227629|528893089|FG009|Overall Study|Withdrawal by Subject|1|||
146649433|NCT01227629|528893080|FG000|Overall Study|Other|0|||
146649434|NCT01227629|528893081|FG001|Overall Study|Other|0|||
146649435|NCT01227629|528893082|FG002|Overall Study|Other|0|||
146649436|NCT01227629|528893083|FG003|Overall Study|Other|1|||
146649437|NCT01227629|528893084|FG004|Overall Study|Other|0|||
146649438|NCT01227629|528893085|FG005|Overall Study|Other|0|||
146649439|NCT01227629|528893086|FG006|Overall Study|Other|0|||
146649440|NCT01227629|528893087|FG007|Overall Study|Other|0|||
146649441|NCT01227629|528893088|FG008|Overall Study|Other|2|||
146649442|NCT01227629|528893089|FG009|Overall Study|Other|1|||
146649443|NCT03976648|528893091|FG000|Overall Study|Adverse Event|0|||
146649444|NCT03976648|528893092|FG001|Overall Study|Adverse Event|2|||
146649445|NCT03976648|528893091|FG000|Overall Study|Study terminated by sponsor|21|||
146649446|NCT03976648|528893092|FG001|Overall Study|Study terminated by sponsor|8|||
146649447|NCT01155167|528893093|FG000|Overall Study|Insufficient ultrasound data|2|||
146649448|NCT01155167|528893094|FG001|Overall Study|Insufficient ultrasound data|0|||
146649449|NCT01155167|528893093|FG000|Overall Study|Access site changed to femoral artery|1|||
146649450|NCT01155167|528893094|FG001|Overall Study|Access site changed to femoral artery|0|||
146649451|NCT00881868|528893095|FG000|Overall Study|Adverse Event|0|||
146507349|NCT04908202|528360997|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
146567872|NCT01832727|528591674|FG004|Overall Study|Study terminated by sponsor|0|||
146649452|NCT00881868|528893096|FG001|Overall Study|Adverse Event|1|||
146507350|NCT04908202|528360994|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
146507351|NCT04908202|528360995|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
146507352|NCT04908202|528360996|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
146507353|NCT04908202|528360997|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
146507354|NCT04908202|528360994|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
146507355|NCT04908202|528360995|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
146507356|NCT04908202|528360996|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
146507357|NCT04908202|528360997|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
146507358|NCT04908202|528360994|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
146507359|NCT04908202|528360995|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
146507360|NCT04908202|528360996|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
146507361|NCT04908202|528360997|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
146507362|NCT04908202|528360994|FG000|Active Treatment Period|OTHER REASONS|0|||
146507363|NCT04908202|528360995|FG001|Active Treatment Period|OTHER REASONS|0|||
146507364|NCT04908202|528360996|FG002|Active Treatment Period|OTHER REASONS|1|||
146507365|NCT04908202|528360997|FG003|Active Treatment Period|OTHER REASONS|3|||
146507366|NCT04908202|528360994|FG000|Active Treatment Period|Lack of Efficacy|0|||
146507367|NCT04908202|528360995|FG001|Active Treatment Period|Lack of Efficacy|0|||
146507368|NCT04908202|528360996|FG002|Active Treatment Period|Lack of Efficacy|4|||
146507369|NCT04908202|528360997|FG003|Active Treatment Period|Lack of Efficacy|5|||
146507370|NCT04908202|528360994|FG000|Active Treatment Period|Adverse Event|0|||
146507371|NCT04908202|528360995|FG001|Active Treatment Period|Adverse Event|0|||
146507372|NCT04908202|528360996|FG002|Active Treatment Period|Adverse Event|5|||
146507373|NCT04908202|528360997|FG003|Active Treatment Period|Adverse Event|8|||
146507374|NCT04908202|528360994|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
146507375|NCT04908202|528360995|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
146507376|NCT04908202|528360996|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
146507377|NCT04908202|528360997|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
146507378|NCT04908202|528360994|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
146507379|NCT04908202|528360995|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
146507380|NCT04908202|528360996|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
146507381|NCT04908202|528360997|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
146507382|NCT04908202|528360994|FG000|Active Treatment Period|Lost to Follow-up|0|||
146507383|NCT04908202|528360995|FG001|Active Treatment Period|Lost to Follow-up|0|||
146507384|NCT04908202|528360996|FG002|Active Treatment Period|Lost to Follow-up|2|||
146507385|NCT04908202|528360997|FG003|Active Treatment Period|Lost to Follow-up|2|||
146507386|NCT04908202|528360994|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
146507387|NCT04908202|528360995|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
146507388|NCT04908202|528360996|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
146507389|NCT04908202|528360997|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
146507390|NCT04908202|528360994|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
146507391|NCT04908202|528360995|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
146507392|NCT04908202|528360996|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
146507393|NCT04908202|528360997|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
146507394|NCT04908202|528360994|FG000|Active Treatment Period|ONGOING Treatment|0|||
146507395|NCT04908202|528360995|FG001|Active Treatment Period|ONGOING Treatment|0|||
146507396|NCT04908202|528360996|FG002|Active Treatment Period|ONGOING Treatment|117|||
146507397|NCT04908202|528360997|FG003|Active Treatment Period|ONGOING Treatment|114|||
146507398|NCT02100670|528360998|FG000|Overall Study|Adverse Event|10|||
146507399|NCT02100670|528360999|FG001|Overall Study|Adverse Event|3|||
146507400|NCT02100670|528361000|FG002|Overall Study|Adverse Event|3|||
146507401|NCT02100670|528361001|FG003|Overall Study|Adverse Event|0|||
146507402|NCT02100670|528360998|FG000|Overall Study|Lost to Follow-up|1|||
146507403|NCT02100670|528360999|FG001|Overall Study|Lost to Follow-up|0|||
146507404|NCT02100670|528361000|FG002|Overall Study|Lost to Follow-up|0|||
146567873|NCT01832727|528591675|FG005|Overall Study|Study terminated by sponsor|0|||
146567874|NCT01832727|528591676|FG006|Overall Study|Study terminated by sponsor|0|||
146567875|NCT01832727|528591677|FG007|Overall Study|Study terminated by sponsor|1|||
146567876|NCT01832727|528591678|FG008|Overall Study|Study terminated by sponsor|1|||
146567877|NCT03434834|528591679|FG000|Overall Study|unable to swallow OCT probe|16|||
146567878|NCT01657305|528591685|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
146567879|NCT01657305|528591685|FG000|Overall Study|Withdrawal by Subject|4|||
146567880|NCT01657305|528591685|FG000|Overall Study|Adverse Event|1|||
146649453|NCT00881868|528893095|FG000|Overall Study|Lost to Follow-up|2|||
146649454|NCT00881868|528893096|FG001|Overall Study|Lost to Follow-up|1|||
146649455|NCT00881868|528893095|FG000|Overall Study|Physician Decision|4|||
146507405|NCT02100670|528361001|FG003|Overall Study|Lost to Follow-up|0|||
146507406|NCT02100670|528360998|FG000|Overall Study|Protocol Violation|0|||
146567881|NCT01657305|528591685|FG000|Overall Study|Lost to Follow-up|1|||
146567882|NCT01657305|528591685|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
146649456|NCT00881868|528893096|FG001|Overall Study|Physician Decision|0|||
146507407|NCT02100670|528360999|FG001|Overall Study|Protocol Violation|1|||
146507408|NCT02100670|528361000|FG002|Overall Study|Protocol Violation|0|||
146507409|NCT02100670|528361001|FG003|Overall Study|Protocol Violation|1|||
146507410|NCT02100670|528360998|FG000|Overall Study|Withdrawal of Consent|0|||
146507411|NCT02100670|528360999|FG001|Overall Study|Withdrawal of Consent|1|||
146507412|NCT02100670|528361000|FG002|Overall Study|Withdrawal of Consent|1|||
146507413|NCT02100670|528361001|FG003|Overall Study|Withdrawal of Consent|0|||
146507414|NCT02100670|528360998|FG000|Overall Study|No swelling no pain|1|||
146507415|NCT02100670|528360999|FG001|Overall Study|No swelling no pain|0|||
146507416|NCT02100670|528361000|FG002|Overall Study|No swelling no pain|0|||
146507417|NCT02100670|528361001|FG003|Overall Study|No swelling no pain|0|||
146507418|NCT02100670|528360998|FG000|Overall Study|Poor Efficacy|0|||
146507419|NCT02100670|528360999|FG001|Overall Study|Poor Efficacy|1|||
146507420|NCT02100670|528361000|FG002|Overall Study|Poor Efficacy|0|||
146507421|NCT02100670|528361001|FG003|Overall Study|Poor Efficacy|0|||
146507422|NCT02100670|528360998|FG000|Overall Study|Physician Decision|0|||
146507423|NCT02100670|528360999|FG001|Overall Study|Physician Decision|1|||
146507424|NCT02100670|528361000|FG002|Overall Study|Physician Decision|0|||
146507425|NCT02100670|528361001|FG003|Overall Study|Physician Decision|0|||
146507426|NCT02100670|528360998|FG000|Overall Study|Withdrawal by Subject|1|||
146507427|NCT02100670|528360999|FG001|Overall Study|Withdrawal by Subject|0|||
146507428|NCT02100670|528361000|FG002|Overall Study|Withdrawal by Subject|0|||
146507429|NCT02100670|528361001|FG003|Overall Study|Withdrawal by Subject|0|||
146507430|NCT05897827|528362701|FG000|Overall Study|Lost to Follow-up|33|||
146507431|NCT05897827|528362702|FG001|Overall Study|Lost to Follow-up|14|||
146507432|NCT05897827|528362701|FG000|Overall Study|Withdrawal by Subject|1|||
146507433|NCT05897827|528362702|FG001|Overall Study|Withdrawal by Subject|1|||
146507434|NCT01004406|528362703|FG000|Overall Study|Withdrawal by Subject|2|||
146507435|NCT01004406|528362704|FG001|Overall Study|Withdrawal by Subject|0|||
146507436|NCT01004406|528362703|FG000|Overall Study|Lost to Follow-up|1|||
146507437|NCT01004406|528362704|FG001|Overall Study|Lost to Follow-up|0|||
146507438|NCT01752634|528362705|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
146507439|NCT01752634|528362706|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
146507440|NCT01752634|528362707|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
146507441|NCT01752634|528362708|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
146507442|NCT01752634|528362709|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
146507443|NCT01752634|528362710|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
146507444|NCT01752634|528362705|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
146507445|NCT01752634|528362706|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
146507446|NCT01752634|528362707|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
146507447|NCT01752634|528362708|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
146507448|NCT01752634|528362709|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
146507449|NCT01752634|528362710|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
146507450|NCT01752634|528362705|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
146507451|NCT01752634|528362706|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
146507452|NCT01752634|528362707|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
146507453|NCT01752634|528362708|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
146507454|NCT01752634|528362709|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
146507455|NCT01752634|528362710|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
146507456|NCT01752634|528362705|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
146507457|NCT01752634|528362706|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
146649457|NCT00881868|528893095|FG000|Overall Study|Protocol Violation|2|||
146507458|NCT01752634|528362707|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
146507459|NCT01752634|528362708|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
146507460|NCT01752634|528362709|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
146507461|NCT01752634|528362710|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
146507462|NCT01752634|528362705|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
146507463|NCT01752634|528362706|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
146567883|NCT04436744|528591689|FG000|Overall Study|Adverse Event|1|||
146567884|NCT04436744|528591690|FG001|Overall Study|Adverse Event|1|||
146567885|NCT04436744|528591689|FG000|Overall Study|Death|1|||
146567886|NCT04436744|528591690|FG001|Overall Study|Death|0|||
146567887|NCT04436744|528591689|FG000|Overall Study|Lost to Follow-up|0|||
146567888|NCT04436744|528591690|FG001|Overall Study|Lost to Follow-up|2|||
146567889|NCT04436744|528591689|FG000|Overall Study|Physician Decision|0|||
146567890|NCT04436744|528591690|FG001|Overall Study|Physician Decision|1|||
146567891|NCT04436744|528591689|FG000|Overall Study|Progressive Disease|0|||
146567892|NCT04436744|528591690|FG001|Overall Study|Progressive Disease|4|||
146567893|NCT04436744|528591689|FG000|Overall Study|Protocol Deviation|1|||
146567894|NCT04436744|528591690|FG001|Overall Study|Protocol Deviation|1|||
146567895|NCT04436744|528591689|FG000|Overall Study|Withdrawal by Subject|1|||
146567896|NCT04436744|528591690|FG001|Overall Study|Withdrawal by Subject|2|||
146567897|NCT01133847|528591691|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
146567898|NCT01133847|528591692|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
146507464|NCT01752634|528362707|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
146507465|NCT01752634|528362708|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
146507466|NCT01752634|528362709|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
146507467|NCT01752634|528362710|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
146507468|NCT01752634|528362705|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
146507469|NCT01752634|528362706|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
146507470|NCT01752634|528362707|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
146507471|NCT01752634|528362708|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
146507472|NCT01752634|528362709|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
146507473|NCT01752634|528362710|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
146507474|NCT01752634|528362705|FG000|Week 24 to Week 260|Physician Decision|1|||
146507475|NCT01752634|528362706|FG001|Week 24 to Week 260|Physician Decision|2|||
146507476|NCT01752634|528362707|FG002|Week 24 to Week 260|Physician Decision|4|||
146507477|NCT01752634|528362708|FG003|Week 24 to Week 260|Physician Decision|2|||
146507478|NCT01752634|528362709|FG004|Week 24 to Week 260|Physician Decision|1|||
146507479|NCT01752634|528362710|FG005|Week 24 to Week 260|Physician Decision|0|||
146507480|NCT01752634|528362705|FG000|Week 24 to Week 260|Death|0|||
146507481|NCT01752634|528362706|FG001|Week 24 to Week 260|Death|1|||
146507482|NCT01752634|528362707|FG002|Week 24 to Week 260|Death|0|||
146507483|NCT01752634|528362708|FG003|Week 24 to Week 260|Death|0|||
146507484|NCT01752634|528362709|FG004|Week 24 to Week 260|Death|0|||
146507485|NCT01752634|528362710|FG005|Week 24 to Week 260|Death|0|||
146507486|NCT01752634|528362705|FG000|Week 24 to Week 260|Pregnancy|0|||
146507487|NCT01752634|528362706|FG001|Week 24 to Week 260|Pregnancy|0|||
146507488|NCT01752634|528362707|FG002|Week 24 to Week 260|Pregnancy|1|||
146507489|NCT01752634|528362708|FG003|Week 24 to Week 260|Pregnancy|0|||
146507490|NCT01752634|528362709|FG004|Week 24 to Week 260|Pregnancy|0|||
146507491|NCT01752634|528362710|FG005|Week 24 to Week 260|Pregnancy|0|||
146507492|NCT01752634|528362705|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
146507493|NCT01752634|528362706|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
146507494|NCT01752634|528362707|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
146507495|NCT01752634|528362708|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
146507496|NCT01752634|528362709|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
146507497|NCT01752634|528362710|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
146507498|NCT01752634|528362705|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
146507499|NCT01752634|528362706|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
146507500|NCT01752634|528362707|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
146507501|NCT01752634|528362708|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
146507502|NCT01752634|528362709|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
146507503|NCT01752634|528362710|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
146507504|NCT01752634|528362705|FG000|Week 24 to Week 260|Adverse Event|4|||
146507505|NCT01752634|528362706|FG001|Week 24 to Week 260|Adverse Event|8|||
146507506|NCT01752634|528362707|FG002|Week 24 to Week 260|Adverse Event|8|||
146507507|NCT01752634|528362708|FG003|Week 24 to Week 260|Adverse Event|4|||
146507508|NCT01752634|528362709|FG004|Week 24 to Week 260|Adverse Event|2|||
146507509|NCT01752634|528362710|FG005|Week 24 to Week 260|Adverse Event|0|||
146507510|NCT05562934|528362714|FG000|Overall Study|Adverse Event|0|||
146507511|NCT05562934|528362715|FG001|Overall Study|Adverse Event|2|||
146507512|NCT05562934|528362716|FG002|Overall Study|Adverse Event|0|||
146507513|NCT05562934|528362717|FG003|Overall Study|Adverse Event|0|||
146507514|NCT05562934|528362718|FG004|Overall Study|Adverse Event|2|||
146507515|NCT05562934|528362714|FG000|Overall Study|Lost to Follow-up|0|||
146507516|NCT05562934|528362715|FG001|Overall Study|Lost to Follow-up|0|||
146507517|NCT05562934|528362716|FG002|Overall Study|Lost to Follow-up|0|||
146507518|NCT05562934|528362717|FG003|Overall Study|Lost to Follow-up|0|||
146507519|NCT05562934|528362718|FG004|Overall Study|Lost to Follow-up|1|||
146507520|NCT05562934|528362714|FG000|Overall Study|Protocol Violation|0|||
146507521|NCT05562934|528362715|FG001|Overall Study|Protocol Violation|0|||
146507522|NCT05562934|528362716|FG002|Overall Study|Protocol Violation|0|||
146507523|NCT05562934|528362717|FG003|Overall Study|Protocol Violation|1|||
146507524|NCT05562934|528362718|FG004|Overall Study|Protocol Violation|1|||
146507525|NCT05562934|528362714|FG000|Overall Study|Withdrawal by Subject|0|||
146507526|NCT05562934|528362715|FG001|Overall Study|Withdrawal by Subject|0|||
146507527|NCT05562934|528362716|FG002|Overall Study|Withdrawal by Subject|1|||
146507528|NCT05562934|528362717|FG003|Overall Study|Withdrawal by Subject|1|||
146507529|NCT05562934|528362718|FG004|Overall Study|Withdrawal by Subject|0|||
146507530|NCT05128773|528362721|FG000|Overall Study|Sponsor decision to terminate study|3|||
146507531|NCT04697056|528362722|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
146507532|NCT04697056|528362723|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
146507533|NCT05741346|528362724|FG000|Overall Study|Withdrawn due to termination of study|28|||
146507534|NCT04982575|528362732|FG000|Overall Study|Withdrawal by Subject|2|||
146507535|NCT04982575|528362733|FG001|Overall Study|Withdrawal by Subject|0|||
146507536|NCT04982575|528362734|FG002|Overall Study|Withdrawal by Subject|2|||
146507537|NCT01702532|528362739|FG000|Overall Study|Adverse Event|0|||
146507538|NCT01702532|528362740|FG001|Overall Study|Adverse Event|1|||
146507539|NCT01451164|528362741|FG000|Overall Study|Adverse Event|19|||
146769576|NCT00814346|529324855|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
146769577|NCT00814346|529324854|FG000|Open Phase (17 Months)|Adverse Event|5|||
146769578|NCT00814346|529324855|FG001|Open Phase (17 Months)|Adverse Event|0|||
146769579|NCT00814346|529324854|FG000|Open Phase (17 Months)|Consent|2|||
146769580|NCT00814346|529324855|FG001|Open Phase (17 Months)|Consent|0|||
146769581|NCT00814346|529324854|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
146769582|NCT00814346|529324855|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
146769583|NCT00814346|529324854|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
146769584|NCT00814346|529324855|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
146769585|NCT05136443|529324857|FG000|Overall Study|Lost to Follow-up|2|||
146769586|NCT05136443|529324857|FG000|Overall Study|Adverse Event|2|||
146769587|NCT00762606|529324869|FG000|Overall Study|Lost to Follow-up|18|||
146769588|NCT00762606|529324870|FG001|Overall Study|Lost to Follow-up|13|||
146769589|NCT03299816|529324883|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
146769590|NCT03299816|529324884|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
146769591|NCT03299816|529324883|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
146769592|NCT03299816|529324884|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
146769593|NCT03299816|529324883|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
146769594|NCT03299816|529324884|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
146769595|NCT00367991|529324886|FG000|Overall Study|Withdrawal by Subject|1|||
146769596|NCT00367991|529324887|FG001|Overall Study|Withdrawal by Subject|1|||
146769597|NCT00367991|529324886|FG000|Overall Study|Adverse Event|1|||
146769598|NCT00367991|529324887|FG001|Overall Study|Adverse Event|1|||
146769599|NCT03515304|529324888|FG000|Overall Study|Lost to Follow-up|0|||
146769600|NCT03515304|529324889|FG001|Overall Study|Lost to Follow-up|3|||
146769601|NCT04221438|529324904|FG000|Overall Study|Adverse Event|1|||
146769602|NCT04221438|529324904|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
146769603|NCT00588770|529324907|FG000|Overall Study|Disease progression|85|||
146769604|NCT00588770|529324908|FG001|Overall Study|Disease progression|68|||
146769605|NCT00588770|529324907|FG000|Overall Study|Adverse Event|29|||
146769606|NCT00588770|529324908|FG001|Overall Study|Adverse Event|58|||
146769607|NCT00588770|529324907|FG000|Overall Study|Death|13|||
146769608|NCT00588770|529324908|FG001|Overall Study|Death|22|||
146769609|NCT00588770|529324907|FG000|Overall Study|Withdrawal by Subject|15|||
146769610|NCT00588770|529324908|FG001|Overall Study|Withdrawal by Subject|25|||
146769611|NCT00588770|529324907|FG000|Overall Study|Alternative therapy|2|||
146769612|NCT00588770|529324908|FG001|Overall Study|Alternative therapy|4|||
146769613|NCT00588770|529324907|FG000|Overall Study|Other complicating disease|3|||
146769614|NCT00588770|529324908|FG001|Overall Study|Other complicating disease|2|||
146769615|NCT00588770|529324907|FG000|Overall Study|Not start protocol therapy|0|||
146769616|NCT00588770|529324908|FG001|Overall Study|Not start protocol therapy|9|||
146769617|NCT00588770|529324907|FG000|Overall Study|Lack of Efficacy|8|||
146507540|NCT01451164|528362742|FG001|Overall Study|Adverse Event|12|||
146507541|NCT01451164|528362743|FG002|Overall Study|Adverse Event|18|||
146507542|NCT01451164|528362744|FG003|Overall Study|Adverse Event|21|||
146507543|NCT01451164|528362741|FG000|Overall Study|Withdrawal Criteria|1|||
146507544|NCT01451164|528362742|FG001|Overall Study|Withdrawal Criteria|1|||
146507545|NCT01451164|528362743|FG002|Overall Study|Withdrawal Criteria|1|||
146507546|NCT01451164|528362744|FG003|Overall Study|Withdrawal Criteria|1|||
146507547|NCT01451164|528362741|FG000|Overall Study|Physician Decision|2|||
146507548|NCT01451164|528362742|FG001|Overall Study|Physician Decision|0|||
146507549|NCT01451164|528362743|FG002|Overall Study|Physician Decision|1|||
146507550|NCT01451164|528362744|FG003|Overall Study|Physician Decision|0|||
146507551|NCT01451164|528362741|FG000|Overall Study|Withdrawal by Subject|14|||
146769618|NCT00588770|529324908|FG001|Overall Study|Lack of Efficacy|10|||
146507552|NCT01451164|528362742|FG001|Overall Study|Withdrawal by Subject|11|||
146769619|NCT00588770|529324907|FG000|Overall Study|Physician discretion|2|||
146769620|NCT00588770|529324908|FG001|Overall Study|Physician discretion|0|||
146769621|NCT00588770|529324907|FG000|Overall Study|Patient non-compliance|2|||
146769622|NCT00588770|529324908|FG001|Overall Study|Patient non-compliance|2|||
146769623|NCT01585558|529324909|FG000|Overall Study|Withdrawal by Subject|4|||
146769624|NCT01585558|529324910|FG001|Overall Study|Withdrawal by Subject|5|||
146769625|NCT01585558|529324911|FG002|Overall Study|Withdrawal by Subject|8|||
146769626|NCT01585558|529324909|FG000|Overall Study|Lost to Follow-up|2|||
146769627|NCT01585558|529324910|FG001|Overall Study|Lost to Follow-up|0|||
146769628|NCT01585558|529324911|FG002|Overall Study|Lost to Follow-up|3|||
146769629|NCT01585558|529324909|FG000|Overall Study|Adverse Event|3|||
146769630|NCT01585558|529324910|FG001|Overall Study|Adverse Event|4|||
146769631|NCT01585558|529324911|FG002|Overall Study|Adverse Event|1|||
146507553|NCT01451164|528362743|FG002|Overall Study|Withdrawal by Subject|16|||
146507554|NCT01451164|528362744|FG003|Overall Study|Withdrawal by Subject|17|||
146769632|NCT01585558|529324909|FG000|Overall Study|Protocol Violation|4|||
146769633|NCT01585558|529324910|FG001|Overall Study|Protocol Violation|3|||
146769634|NCT01585558|529324911|FG002|Overall Study|Protocol Violation|2|||
146769635|NCT01585558|529324909|FG000|Overall Study|Lack of Efficacy|0|||
146769636|NCT01585558|529324910|FG001|Overall Study|Lack of Efficacy|0|||
146769637|NCT01585558|529324911|FG002|Overall Study|Lack of Efficacy|1|||
146507555|NCT01451164|528362741|FG000|Overall Study|Protocol Violation|0|||
146507556|NCT01451164|528362742|FG001|Overall Study|Protocol Violation|1|||
146507557|NCT01451164|528362743|FG002|Overall Study|Protocol Violation|0|||
146507558|NCT01451164|528362744|FG003|Overall Study|Protocol Violation|0|||
146507559|NCT01451164|528362741|FG000|Overall Study|Lack of Efficacy|7|||
146507560|NCT01451164|528362742|FG001|Overall Study|Lack of Efficacy|9|||
146507561|NCT01451164|528362743|FG002|Overall Study|Lack of Efficacy|9|||
146507562|NCT01451164|528362744|FG003|Overall Study|Lack of Efficacy|7|||
146507563|NCT01846221|528362745|FG000|Overall Study|Catheter Failure|2|||
146507564|NCT01846221|528362746|FG001|Overall Study|Catheter Failure|0|||
146507565|NCT01846221|528362745|FG000|Overall Study|Age Exclusion|1|||
146507566|NCT01846221|528362746|FG001|Overall Study|Age Exclusion|0|||
146507567|NCT04599933|528362747|FG000|Overall Study|Adverse Event|4|||
146507568|NCT04599933|528362748|FG001|Overall Study|Adverse Event|1|||
146507569|NCT04599933|528362747|FG000|Overall Study|Withdrawal by Subject|4|||
146507570|NCT04599933|528362748|FG001|Overall Study|Withdrawal by Subject|2|||
146507571|NCT04599933|528362747|FG000|Overall Study|Lost to Follow-up|0|||
146567899|NCT01133847|528591693|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
146567900|NCT01133847|528591691|FG000|Follow-Up Phase|Lost to Follow-up|1|||
146567901|NCT01133847|528591692|FG001|Follow-Up Phase|Lost to Follow-up|3|||
146567902|NCT01133847|528591693|FG002|Follow-Up Phase|Lost to Follow-up|7|||
146567903|NCT02961244|528591695|FG000|Overall Study|Protocol Violation|0|||
146649458|NCT00881868|528893096|FG001|Overall Study|Protocol Violation|0|||
146649459|NCT00960570|528893097|FG000|21 Day Washout Period|Adverse Event|1|||
146649460|NCT00960570|528893097|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
146649461|NCT00960570|528893097|FG000|1 Day Period Between Dosing|Adverse Event|2|||
146649462|NCT00960570|528893097|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
146649463|NCT01451437|528893098|FG000|Overall Study|Adverse Event|0|||
146649464|NCT01451437|528893099|FG001|Overall Study|Adverse Event|0|||
146649465|NCT01451437|528893100|FG002|Overall Study|Adverse Event|0|||
146649466|NCT01451437|528893101|FG003|Overall Study|Adverse Event|0|||
146649467|NCT01451437|528893102|FG004|Overall Study|Adverse Event|0|||
146649468|NCT01451437|528893103|FG005|Overall Study|Adverse Event|1|||
146649469|NCT01451437|528893104|FG006|Overall Study|Adverse Event|1|||
146649470|NCT01451437|528893105|FG007|Overall Study|Adverse Event|2|||
146649471|NCT01451437|528893106|FG008|Overall Study|Adverse Event|1|||
146649472|NCT01451437|528893098|FG000|Overall Study|Physician Decision|1|||
146649473|NCT01451437|528893099|FG001|Overall Study|Physician Decision|1|||
146649474|NCT01451437|528893100|FG002|Overall Study|Physician Decision|2|||
146649475|NCT01451437|528893101|FG003|Overall Study|Physician Decision|0|||
146649476|NCT01451437|528893102|FG004|Overall Study|Physician Decision|0|||
146649477|NCT01451437|528893103|FG005|Overall Study|Physician Decision|0|||
146507572|NCT04599933|528362748|FG001|Overall Study|Lost to Follow-up|1|||
146507573|NCT04599933|528362747|FG000|Overall Study|Physician Decision|0|||
146567904|NCT02961244|528591696|FG001|Overall Study|Protocol Violation|1|||
146567905|NCT02961244|528591695|FG000|Overall Study|Withdrawal by Subject|1|||
146567906|NCT02961244|528591696|FG001|Overall Study|Withdrawal by Subject|2|||
146567907|NCT02961244|528591695|FG000|Overall Study|Surgery plan change after study approval|0|||
146567908|NCT02961244|528591696|FG001|Overall Study|Surgery plan change after study approval|2|||
146567909|NCT02961244|528591695|FG000|Overall Study|Lost to Follow-up|0|||
146567910|NCT02961244|528591696|FG001|Overall Study|Lost to Follow-up|2|||
146567911|NCT02961244|528591695|FG000|Overall Study|İnadequate data|0|||
146567912|NCT02961244|528591696|FG001|Overall Study|İnadequate data|2|||
146567913|NCT03789292|528591697|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
146567914|NCT03789292|528591698|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
146567915|NCT03789292|528591699|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
146567916|NCT03789292|528591697|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
146567917|NCT03789292|528591698|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
146567918|NCT03789292|528591699|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
146567919|NCT03789292|528591697|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
146567920|NCT03789292|528591698|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
146567921|NCT03789292|528591699|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
146649478|NCT01451437|528893104|FG006|Overall Study|Physician Decision|0|||
146507574|NCT04599933|528362748|FG001|Overall Study|Physician Decision|1|||
146567922|NCT03789292|528591697|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
146567923|NCT03789292|528591698|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
146567924|NCT03789292|528591699|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
146649479|NCT01451437|528893105|FG007|Overall Study|Physician Decision|0|||
146507575|NCT04599933|528362747|FG000|Overall Study|Screen Failure|1|||
146507576|NCT04599933|528362748|FG001|Overall Study|Screen Failure|2|||
146649480|NCT01451437|528893106|FG008|Overall Study|Physician Decision|0|||
146649481|NCT01451437|528893098|FG000|Overall Study|Disease Progression|0|||
146649482|NCT01451437|528893099|FG001|Overall Study|Disease Progression|0|||
146649483|NCT01451437|528893100|FG002|Overall Study|Disease Progression|1|||
146507577|NCT04329091|528362749|FG000|Overall Study|Physician Decision|5|||
146507578|NCT00741091|528362752|FG000|Overall Study|Death|13|||
146567925|NCT03789292|528591697|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
146507579|NCT00741091|528362752|FG000|Overall Study|Lost to Follow-up|16|||
146507580|NCT00741091|528362752|FG000|Overall Study|Withdrawal by Subject|6|||
146649484|NCT01451437|528893101|FG003|Overall Study|Disease Progression|1|||
146649485|NCT01451437|528893102|FG004|Overall Study|Disease Progression|3|||
146507581|NCT00741091|528362752|FG000|Overall Study|Missed Visit|22|||
146507582|NCT01801358|528362753|FG000|Overall Study|Adverse Event|0|||
146507583|NCT01801358|528362754|FG001|Overall Study|Adverse Event|2|||
146507584|NCT01801358|528362755|FG002|Overall Study|Adverse Event|1|||
146507585|NCT01801358|528362756|FG003|Overall Study|Adverse Event|0|||
146507586|NCT01801358|528362757|FG004|Overall Study|Adverse Event|0|||
146507587|NCT01801358|528362758|FG005|Overall Study|Adverse Event|1|||
146507588|NCT01801358|528362753|FG000|Overall Study|Physician Decision|0|||
146507589|NCT01801358|528362754|FG001|Overall Study|Physician Decision|0|||
146507590|NCT01801358|528362755|FG002|Overall Study|Physician Decision|1|||
146507591|NCT01801358|528362756|FG003|Overall Study|Physician Decision|0|||
146507592|NCT01801358|528362757|FG004|Overall Study|Physician Decision|0|||
146507593|NCT01801358|528362758|FG005|Overall Study|Physician Decision|0|||
146507594|NCT01801358|528362753|FG000|Overall Study|Progressive Disease|6|||
146507595|NCT01801358|528362754|FG001|Overall Study|Progressive Disease|4|||
146507596|NCT01801358|528362755|FG002|Overall Study|Progressive Disease|4|||
146507597|NCT01801358|528362756|FG003|Overall Study|Progressive Disease|5|||
146507598|NCT01801358|528362757|FG004|Overall Study|Progressive Disease|6|||
146507599|NCT01801358|528362758|FG005|Overall Study|Progressive Disease|5|||
146507600|NCT01801358|528362753|FG000|Overall Study|Withdrawal by Subject|0|||
146649486|NCT01451437|528893103|FG005|Overall Study|Disease Progression|2|||
146649487|NCT01451437|528893104|FG006|Overall Study|Disease Progression|3|||
146649488|NCT01451437|528893105|FG007|Overall Study|Disease Progression|1|||
146649489|NCT01451437|528893106|FG008|Overall Study|Disease Progression|3|||
146649490|NCT01451437|528893098|FG000|Overall Study|Protocol Violation|0|||
146649491|NCT01451437|528893099|FG001|Overall Study|Protocol Violation|0|||
146649492|NCT01451437|528893100|FG002|Overall Study|Protocol Violation|0|||
146649493|NCT01451437|528893101|FG003|Overall Study|Protocol Violation|0|||
146649494|NCT01451437|528893102|FG004|Overall Study|Protocol Violation|0|||
146649495|NCT01451437|528893103|FG005|Overall Study|Protocol Violation|0|||
146507601|NCT01801358|528362754|FG001|Overall Study|Withdrawal by Subject|0|||
146507602|NCT01801358|528362755|FG002|Overall Study|Withdrawal by Subject|0|||
146507603|NCT01801358|528362756|FG003|Overall Study|Withdrawal by Subject|1|||
146507604|NCT01801358|528362757|FG004|Overall Study|Withdrawal by Subject|0|||
146507605|NCT01801358|528362758|FG005|Overall Study|Withdrawal by Subject|2|||
146507606|NCT03787303|528362759|FG000|Overall Study|Death|1|||
146507607|NCT03787303|528362759|FG000|Overall Study|Premature Termination of Study|1|||
146507608|NCT01527487|528362762|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
146567926|NCT03789292|528591698|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
146649496|NCT01451437|528893104|FG006|Overall Study|Protocol Violation|1|||
146649497|NCT01451437|528893105|FG007|Overall Study|Protocol Violation|0|||
146649498|NCT01451437|528893106|FG008|Overall Study|Protocol Violation|0|||
146649499|NCT01451437|528893098|FG000|Overall Study|Withdrawal by Subject|0|||
146649500|NCT01451437|528893099|FG001|Overall Study|Withdrawal by Subject|0|||
146649501|NCT01451437|528893100|FG002|Overall Study|Withdrawal by Subject|0|||
146649502|NCT01451437|528893101|FG003|Overall Study|Withdrawal by Subject|0|||
146649503|NCT01451437|528893102|FG004|Overall Study|Withdrawal by Subject|1|||
146567927|NCT03789292|528591699|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
146567928|NCT03789292|528591697|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
146567929|NCT03789292|528591698|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
146567930|NCT03789292|528591699|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
146567931|NCT03789292|528591697|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
146567932|NCT03789292|528591698|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
146567933|NCT03789292|528591699|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
146567934|NCT03789292|528591697|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
146567935|NCT03789292|528591698|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
146649504|NCT01451437|528893103|FG005|Overall Study|Withdrawal by Subject|0|||
146649505|NCT01451437|528893104|FG006|Overall Study|Withdrawal by Subject|1|||
146649506|NCT01451437|528893105|FG007|Overall Study|Withdrawal by Subject|0|||
146507609|NCT01527487|528362763|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
146507610|NCT01527487|528362762|FG000|Overall Study|Disease Progression|4|||
146507611|NCT01527487|528362763|FG001|Overall Study|Disease Progression|1|||
146567936|NCT03789292|528591699|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
146567937|NCT03789292|528591697|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
146649507|NCT01451437|528893106|FG008|Overall Study|Withdrawal by Subject|0|||
146649508|NCT02081859|528893109|FG000|Overall Study|No fertilization|2|||
146649509|NCT02081859|528893110|FG001|Overall Study|No fertilization|2|||
146649510|NCT02081859|528893109|FG000|Overall Study|No sperm|1|||
146649511|NCT02081859|528893110|FG001|Overall Study|No sperm|0|||
146507612|NCT01527487|528362762|FG000|Overall Study|Adverse Event|1|||
146507613|NCT01527487|528362763|FG001|Overall Study|Adverse Event|1|||
146507614|NCT01527487|528362762|FG000|Overall Study|Death|0|||
146769638|NCT00997386|529324912|FG000|Overall Study|Death|7|||
146769639|NCT00617201|529324915|FG000|Overall Study|Lost to Follow-up|9|||
146769640|NCT00617201|529324916|FG001|Overall Study|Lost to Follow-up|13|||
146769641|NCT01350804|529324917|FG000|Core Study|Withdrawal by Subject|11|||
146769642|NCT01350804|529324918|FG001|Core Study|Withdrawal by Subject|17|||
146507615|NCT01527487|528362763|FG001|Overall Study|Death|1|||
146507616|NCT01210495|528362764|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
146507617|NCT01210495|528362765|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
146507618|NCT01210495|528362766|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
146507619|NCT01210495|528362767|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
146507620|NCT01210495|528362764|FG000|Overall Study|Death|14|||
146507621|NCT01210495|528362765|FG001|Overall Study|Death|7|||
146507622|NCT01210495|528362766|FG002|Overall Study|Death|112|||
146769643|NCT01350804|529324919|FG002|Core Study|Withdrawal by Subject|16|||
146769644|NCT01350804|529324920|FG003|Core Study|Withdrawal by Subject|7|||
146769645|NCT01350804|529324917|FG000|Core Study|Study terminated by Sponsor|0|||
146769646|NCT01350804|529324918|FG001|Core Study|Study terminated by Sponsor|0|||
146769647|NCT01350804|529324919|FG002|Core Study|Study terminated by Sponsor|0|||
146769648|NCT01350804|529324920|FG003|Core Study|Study terminated by Sponsor|2|||
146769649|NCT01350804|529324917|FG000|Core Study|Protocol deviation|1|||
146769650|NCT01350804|529324918|FG001|Core Study|Protocol deviation|0|||
146769651|NCT01350804|529324919|FG002|Core Study|Protocol deviation|1|||
146769652|NCT01350804|529324920|FG003|Core Study|Protocol deviation|0|||
146769653|NCT01350804|529324917|FG000|Core Study|Physician Decision|1|||
146769654|NCT01350804|529324918|FG001|Core Study|Physician Decision|0|||
146769655|NCT01350804|529324919|FG002|Core Study|Physician Decision|1|||
146769656|NCT01350804|529324920|FG003|Core Study|Physician Decision|3|||
146769657|NCT01350804|529324917|FG000|Core Study|Lost to Follow-up|3|||
146769658|NCT01350804|529324918|FG001|Core Study|Lost to Follow-up|0|||
146769659|NCT01350804|529324919|FG002|Core Study|Lost to Follow-up|2|||
146769660|NCT01350804|529324920|FG003|Core Study|Lost to Follow-up|1|||
146769661|NCT01350804|529324917|FG000|Core Study|Lack of Efficacy|16|||
146769662|NCT01350804|529324918|FG001|Core Study|Lack of Efficacy|19|||
146507623|NCT01210495|528362767|FG003|Overall Study|Death|54|||
146507624|NCT01210495|528362764|FG000|Overall Study|Study Terminated by Sponsor|0|||
146769663|NCT01350804|529324919|FG002|Core Study|Lack of Efficacy|18|||
146769664|NCT01350804|529324920|FG003|Core Study|Lack of Efficacy|5|||
146769665|NCT01350804|529324917|FG000|Core Study|Death|1|||
146769666|NCT01350804|529324918|FG001|Core Study|Death|1|||
146769667|NCT01350804|529324919|FG002|Core Study|Death|1|||
146769668|NCT01350804|529324920|FG003|Core Study|Death|0|||
146769669|NCT01350804|529324917|FG000|Core Study|Adverse Event|8|||
146769670|NCT01350804|529324918|FG001|Core Study|Adverse Event|10|||
146769671|NCT01350804|529324919|FG002|Core Study|Adverse Event|8|||
146507625|NCT01210495|528362765|FG001|Overall Study|Study Terminated by Sponsor|0|||
146507626|NCT01210495|528362766|FG002|Overall Study|Study Terminated by Sponsor|4|||
146507627|NCT01210495|528362767|FG003|Overall Study|Study Terminated by Sponsor|11|||
146507628|NCT01210495|528362764|FG000|Overall Study|Lost to Follow-up|0|||
146507629|NCT01210495|528362765|FG001|Overall Study|Lost to Follow-up|0|||
146507630|NCT01210495|528362766|FG002|Overall Study|Lost to Follow-up|1|||
146507631|NCT01210495|528362767|FG003|Overall Study|Lost to Follow-up|1|||
146507632|NCT01210495|528362764|FG000|Overall Study|Other unspecified|0|||
146507633|NCT01210495|528362765|FG001|Overall Study|Other unspecified|0|||
146507634|NCT01210495|528362766|FG002|Overall Study|Other unspecified|6|||
146507635|NCT01210495|528362767|FG003|Overall Study|Other unspecified|0|||
146507636|NCT01384019|528362768|FG000|Overall Study|Withdrawal by Subject|3|||
146649512|NCT02081859|528893109|FG000|Overall Study|Unanticipated freeze all cycle|2|||
146649513|NCT02081859|528893110|FG001|Overall Study|Unanticipated freeze all cycle|6|||
146649514|NCT02081859|528893109|FG000|Overall Study|< 4 embryos|27|||
146649515|NCT02081859|528893110|FG001|Overall Study|< 4 embryos|23|||
146649516|NCT02081859|528893109|FG000|Overall Study|Other reasons|2|||
146649517|NCT02081859|528893110|FG001|Overall Study|Other reasons|0|||
146649518|NCT03658876|528894870|FG000|Overall Study|Protocol Violation|3|||
146649519|NCT03658876|528894871|FG001|Overall Study|Protocol Violation|2|||
146649520|NCT03658876|528894870|FG000|Overall Study|Withdrawal by Subject|2|||
146649521|NCT03658876|528894871|FG001|Overall Study|Withdrawal by Subject|0|||
146649522|NCT03658876|528894870|FG000|Overall Study|Death|0|||
146649523|NCT03658876|528894871|FG001|Overall Study|Death|1|||
146649524|NCT03658876|528894870|FG000|Overall Study|Intercurrent illness|6|||
146649525|NCT03658876|528894871|FG001|Overall Study|Intercurrent illness|4|||
146649526|NCT03658876|528894870|FG000|Overall Study|Transplantation/other operation|1|||
146649527|NCT03658876|528894871|FG001|Overall Study|Transplantation/other operation|5|||
146507637|NCT01384019|528362769|FG001|Overall Study|Withdrawal by Subject|0|||
146507638|NCT01384019|528362768|FG000|Overall Study|Death|1|||
146649528|NCT02616146|528894872|FG000|Overall Study|Adverse Event|64|||
146649529|NCT02616146|528894873|FG001|Overall Study|Adverse Event|24|||
146769672|NCT01350804|529324920|FG003|Core Study|Adverse Event|8|||
146769673|NCT01350804|529324917|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
146769674|NCT01350804|529324918|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
146769675|NCT01350804|529324919|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
146769676|NCT01350804|529324920|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
146769677|NCT01350804|529324917|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
146769678|NCT01350804|529324918|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
146769679|NCT01350804|529324919|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
146769680|NCT01350804|529324920|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
146769681|NCT01350804|529324917|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
146769682|NCT01350804|529324918|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
146769683|NCT01350804|529324919|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
146769684|NCT01350804|529324920|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
146769685|NCT01350804|529324917|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
146769686|NCT01350804|529324918|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
146769687|NCT01350804|529324919|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
146769688|NCT01350804|529324920|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
146769689|NCT01350804|529324917|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
146649530|NCT02616146|528894872|FG000|Overall Study|Lost to Follow-up|23|||
146649531|NCT02616146|528894873|FG001|Overall Study|Lost to Follow-up|13|||
146649532|NCT02616146|528894872|FG000|Overall Study|Non-compliance with study protocol|2|||
146649533|NCT02616146|528894873|FG001|Overall Study|Non-compliance with study protocol|0|||
146649534|NCT02616146|528894872|FG000|Overall Study|Non-compliance with study drug|4|||
146649535|NCT02616146|528894873|FG001|Overall Study|Non-compliance with study drug|2|||
146649536|NCT02616146|528894872|FG000|Overall Study|Pregnancy|2|||
146649537|NCT02616146|528894873|FG001|Overall Study|Pregnancy|2|||
146649538|NCT02616146|528894872|FG000|Overall Study|Pregnancy wish|3|||
146649539|NCT02616146|528894873|FG001|Overall Study|Pregnancy wish|0|||
146649540|NCT02616146|528894872|FG000|Overall Study|Protocol Violation|6|||
146649541|NCT02616146|528894873|FG001|Overall Study|Protocol Violation|3|||
146649542|NCT02616146|528894872|FG000|Overall Study|Study terminated by sponsor|1372|||
146649543|NCT02616146|528894873|FG001|Overall Study|Study terminated by sponsor|432|||
146649544|NCT02616146|528894872|FG000|Overall Study|Participant moved|4|||
146649545|NCT02616146|528894873|FG001|Overall Study|Participant moved|3|||
146649546|NCT02616146|528894872|FG000|Overall Study|Withdrawal by Subject|30|||
146649547|NCT02616146|528894873|FG001|Overall Study|Withdrawal by Subject|24|||
146649548|NCT02616146|528894872|FG000|Overall Study|Physician Decision|2|||
146649549|NCT02616146|528894873|FG001|Overall Study|Physician Decision|1|||
146649550|NCT03039621|528894874|FG000|Overall Study|Violation of inclusion criteria|3|||
146649551|NCT03039621|528894875|FG001|Overall Study|Violation of inclusion criteria|2|||
146649552|NCT03039621|528894874|FG000|Overall Study|Non-compliance with protocol requirement|4|||
146649553|NCT03039621|528894875|FG001|Overall Study|Non-compliance with protocol requirement|5|||
146649554|NCT03039621|528894874|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
146649555|NCT03039621|528894875|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
146649556|NCT03039621|528894874|FG000|Overall Study|Violation of non-inclusion criteria|1|||
146649557|NCT03039621|528894875|FG001|Overall Study|Violation of non-inclusion criteria|2|||
146649558|NCT05338671|528894879|FG000|Overall Study|Lost to Follow-up|2|||
146649559|NCT05338671|528894880|FG001|Overall Study|Lost to Follow-up|2|||
146649560|NCT05338671|528894879|FG000|Overall Study|Root canal completed in a single visit|1|||
146649561|NCT05338671|528894880|FG001|Overall Study|Root canal completed in a single visit|0|||
146649562|NCT03085914|528894883|FG000|Overall Study|Death|6|||
146649563|NCT03085914|528894884|FG001|Overall Study|Death|6|||
146649564|NCT03085914|528894885|FG002|Overall Study|Death|4|||
146649565|NCT03085914|528894886|FG003|Overall Study|Death|1|||
146649566|NCT03085914|528894887|FG004|Overall Study|Death|5|||
146649567|NCT03085914|528894888|FG005|Overall Study|Death|2|||
146649568|NCT03085914|528894889|FG006|Overall Study|Death|2|||
146649569|NCT03085914|528894883|FG000|Overall Study|Withdrawal by Subject|1|||
146649570|NCT03085914|528894884|FG001|Overall Study|Withdrawal by Subject|1|||
146649571|NCT03085914|528894885|FG002|Overall Study|Withdrawal by Subject|2|||
146649572|NCT03085914|528894886|FG003|Overall Study|Withdrawal by Subject|2|||
146649573|NCT03085914|528894887|FG004|Overall Study|Withdrawal by Subject|2|||
146649574|NCT03085914|528894888|FG005|Overall Study|Withdrawal by Subject|0|||
146649575|NCT03085914|528894889|FG006|Overall Study|Withdrawal by Subject|1|||
146769690|NCT01350804|529324918|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
146769691|NCT01350804|529324919|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
146649576|NCT03085914|528894883|FG000|Overall Study|Lost to Follow-up|0|||
146649577|NCT03085914|528894884|FG001|Overall Study|Lost to Follow-up|0|||
146649578|NCT03085914|528894885|FG002|Overall Study|Lost to Follow-up|1|||
146769692|NCT01350804|529324920|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
146649579|NCT03085914|528894886|FG003|Overall Study|Lost to Follow-up|0|||
146649580|NCT03085914|528894887|FG004|Overall Study|Lost to Follow-up|0|||
146649581|NCT03085914|528894888|FG005|Overall Study|Lost to Follow-up|1|||
146649582|NCT03085914|528894889|FG006|Overall Study|Lost to Follow-up|1|||
146649583|NCT03085914|528894883|FG000|Overall Study|Reason was not specified,|2|||
146649584|NCT03085914|528894884|FG001|Overall Study|Reason was not specified,|2|||
146649585|NCT03085914|528894885|FG002|Overall Study|Reason was not specified,|2|||
146649586|NCT03085914|528894886|FG003|Overall Study|Reason was not specified,|3|||
146507639|NCT01384019|528362769|FG001|Overall Study|Death|0|||
146507640|NCT01384019|528362768|FG000|Overall Study|MRI refusal|6|||
146507641|NCT01384019|528362769|FG001|Overall Study|MRI refusal|6|||
146507642|NCT00767039|528362772|FG000|Overall Study|Death|5|||
146507643|NCT00767039|528362773|FG001|Overall Study|Death|2|||
146507644|NCT01826370|528362774|FG000|Overall Study|Protocol Violation|6|||
146974469|NCT01682512|530069549|FG000|Overall Study|Primary lack of efficacy|10|||
146507645|NCT01826370|528362774|FG000|Overall Study|Lost to Follow-up|12|||
146507646|NCT01826370|528362774|FG000|Overall Study|Other reason not defined above|2|||
146507647|NCT04416737|528362776|FG000|Week 1 (First Injection)|Physician Decision|0|||
146507648|NCT04416737|528362777|FG001|Week 1 (First Injection)|Physician Decision|1|||
146567938|NCT03789292|528591698|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
146567939|NCT03789292|528591699|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
146567940|NCT03789292|528591697|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
146567941|NCT03789292|528591698|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
146567942|NCT03789292|528591699|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
146567943|NCT03789292|528591697|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
146567944|NCT03789292|528591698|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
146567945|NCT03789292|528591699|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
146567946|NCT03789292|528591697|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
146567947|NCT03789292|528591698|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
146567948|NCT03789292|528591699|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
146567949|NCT03789292|528591697|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
146567950|NCT03789292|528591698|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
146567951|NCT03789292|528591699|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
146567952|NCT00967616|528591700|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
146567953|NCT00967616|528591701|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
146567954|NCT00967616|528591700|FG000|Overall Study|Death|0|||
146567955|NCT00967616|528591701|FG001|Overall Study|Death|3|||
146567956|NCT00967616|528591700|FG000|Overall Study|Withdrawal by Subject|8|||
146567957|NCT00967616|528591701|FG001|Overall Study|Withdrawal by Subject|4|||
146567958|NCT00967616|528591700|FG000|Overall Study|Progressive Disease|31|||
146567959|NCT00967616|528591701|FG001|Overall Study|Progressive Disease|18|||
146567960|NCT00967616|528591700|FG000|Overall Study|Other|8|||
146567961|NCT00967616|528591701|FG001|Overall Study|Other|8|||
146567962|NCT00967616|528591700|FG000|Overall Study|Protocol Violation|1|||
146567963|NCT00967616|528591701|FG001|Overall Study|Protocol Violation|0|||
146567964|NCT01696643|528591702|FG000|Overall Study|Adverse Event|15|||
146567965|NCT01696643|528591703|FG001|Overall Study|Adverse Event|7|||
146567966|NCT01696643|528591702|FG000|Overall Study|Death|1|||
146567967|NCT01696643|528591703|FG001|Overall Study|Death|2|||
146567968|NCT01696643|528591702|FG000|Overall Study|Lack of Efficacy|3|||
146567969|NCT01696643|528591703|FG001|Overall Study|Lack of Efficacy|0|||
146567970|NCT01696643|528591702|FG000|Overall Study|Lost to Follow-up|67|||
146567971|NCT01696643|528591703|FG001|Overall Study|Lost to Follow-up|67|||
146567972|NCT01696643|528591702|FG000|Overall Study|Physician Decision|3|||
146567973|NCT01696643|528591703|FG001|Overall Study|Physician Decision|2|||
146567974|NCT01696643|528591702|FG000|Overall Study|Pregnancy|0|||
146567975|NCT01696643|528591703|FG001|Overall Study|Pregnancy|1|||
146567976|NCT01696643|528591702|FG000|Overall Study|Protocol Violation|7|||
146567977|NCT01696643|528591703|FG001|Overall Study|Protocol Violation|7|||
146567978|NCT01696643|528591702|FG000|Overall Study|Study Terminated by Sponsor|286|||
146567979|NCT01696643|528591703|FG001|Overall Study|Study Terminated by Sponsor|294|||
146567980|NCT01696643|528591702|FG000|Overall Study|Withdrawal by Subject|142|||
146567981|NCT01696643|528591703|FG001|Overall Study|Withdrawal by Subject|149|||
146567982|NCT01696643|528591702|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
146567983|NCT01696643|528591703|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
146567984|NCT01696643|528591702|FG000|Overall Study|Site Error|2|||
146567985|NCT01696643|528591703|FG001|Overall Study|Site Error|1|||
146567986|NCT01696643|528591702|FG000|Overall Study|Participant Incarcerated|0|||
146567987|NCT01696643|528591703|FG001|Overall Study|Participant Incarcerated|1|||
146567988|NCT01696643|528591702|FG000|Overall Study|Medical Monitor Decision|0|||
146567989|NCT01696643|528591703|FG001|Overall Study|Medical Monitor Decision|2|||
146567990|NCT01696643|528591702|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
146567991|NCT01696643|528591703|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
146567992|NCT00575666|528591704|FG000|Overall Study|Withdrawal by Subject|3|||
146567993|NCT00575666|528591705|FG001|Overall Study|Withdrawal by Subject|2|||
146567994|NCT00575666|528591704|FG000|Overall Study|Physician Decision|1|||
146567995|NCT00575666|528591705|FG001|Overall Study|Physician Decision|1|||
146974470|NCT01682512|530069550|FG001|Overall Study|Primary lack of efficacy|7|||
146974471|NCT01682512|530069551|FG002|Overall Study|Primary lack of efficacy|7|||
146567996|NCT00508482|528591706|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
146507649|NCT01472757|528362783|FG000|Overall Study|Withdrawal by Subject|1|||
146769693|NCT01350804|529324917|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
146769694|NCT01350804|529324918|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
146769695|NCT01350804|529324919|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
146769696|NCT01350804|529324920|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
146769697|NCT04480827|529326551|FG000|Overall Study|Adverse Event|0|||
146769698|NCT04480827|529326552|FG001|Overall Study|Adverse Event|0|||
146769699|NCT04480827|529326553|FG002|Overall Study|Adverse Event|0|||
146769700|NCT04480827|529326554|FG003|Overall Study|Adverse Event|0|||
146769701|NCT04480827|529326555|FG004|Overall Study|Adverse Event|0|||
146769702|NCT04480827|529326556|FG005|Overall Study|Adverse Event|1|||
146769703|NCT04480827|529326557|FG006|Overall Study|Adverse Event|0|||
146769704|NCT04218110|529326558|FG000|Overall Study|Withdrawal by Subject|0|||
146769705|NCT04218110|529326559|FG001|Overall Study|Withdrawal by Subject|0|||
146769706|NCT04218110|529326560|FG002|Overall Study|Withdrawal by Subject|0|||
146507650|NCT01472757|528362784|FG001|Overall Study|Withdrawal by Subject|2|||
146507651|NCT01472757|528362785|FG002|Overall Study|Withdrawal by Subject|2|||
146507652|NCT01472757|528362786|FG003|Overall Study|Withdrawal by Subject|0|||
146507653|NCT01472757|528362783|FG000|Overall Study|Asthma exacerbation|4|||
146769707|NCT04218110|529326561|FG003|Overall Study|Withdrawal by Subject|1|||
146769708|NCT00002842|529326562|FG000|Overall Study|ineligible for surgical resection|27|||
146769709|NCT02015546|529326563|FG000|Overall Study|Withdrawal by Subject|1|||
146507654|NCT01472757|528362784|FG001|Overall Study|Asthma exacerbation|1|||
146507655|NCT01472757|528362785|FG002|Overall Study|Asthma exacerbation|2|||
146507656|NCT01472757|528362786|FG003|Overall Study|Asthma exacerbation|1|||
146507657|NCT01472757|528362783|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
146507658|NCT01472757|528362784|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
146507659|NCT01472757|528362785|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
146507660|NCT01472757|528362786|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
146507661|NCT01472757|528362783|FG000|Overall Study|Protocol Violation|3|||
146769710|NCT02015546|529326564|FG001|Overall Study|Withdrawal by Subject|1|||
146769711|NCT02015546|529326565|FG002|Overall Study|Withdrawal by Subject|1|||
146769712|NCT02015546|529326563|FG000|Overall Study|Screem Failure|2|||
146507662|NCT01472757|528362784|FG001|Overall Study|Protocol Violation|2|||
146507663|NCT01472757|528362785|FG002|Overall Study|Protocol Violation|4|||
146507664|NCT01472757|528362786|FG003|Overall Study|Protocol Violation|4|||
146507665|NCT01472757|528362783|FG000|Overall Study|Other reasons|1|||
146507666|NCT01472757|528362784|FG001|Overall Study|Other reasons|0|||
146507667|NCT01472757|528362785|FG002|Overall Study|Other reasons|2|||
146507668|NCT01472757|528362786|FG003|Overall Study|Other reasons|2|||
146507669|NCT04489381|528362791|FG000|Overall Study|Lost to Follow-up|2|||
146507670|NCT04489381|528362792|FG001|Overall Study|Lost to Follow-up|3|||
146507671|NCT04489381|528362791|FG000|Overall Study|Withdrawal by Subject|1|||
146507672|NCT04489381|528362792|FG001|Overall Study|Withdrawal by Subject|0|||
146507673|NCT00526331|528362795|FG000|Overall Study|Sponsor Termination|55|||
146507674|NCT01259375|528362796|FG000|Overall Study|Adverse Event|1|||
146507675|NCT00628095|528362797|FG000|Overall Study|Adverse Event|5|||
146507676|NCT00628095|528362798|FG001|Overall Study|Adverse Event|3|||
146507677|NCT00628095|528362797|FG000|Overall Study|Lack of Efficacy|0|||
146507678|NCT00628095|528362798|FG001|Overall Study|Lack of Efficacy|3|||
146507679|NCT00628095|528362797|FG000|Overall Study|Withdrawal by Subject|2|||
146507680|NCT00628095|528362798|FG001|Overall Study|Withdrawal by Subject|0|||
146507681|NCT00628095|528362797|FG000|Overall Study|Other|0|||
146507682|NCT00628095|528362798|FG001|Overall Study|Other|1|||
146507683|NCT00478699|528362803|FG000|Overall Study|Inclusion Error|1|||
146507684|NCT00478699|528362804|FG001|Overall Study|Inclusion Error|7|||
146507685|NCT00478699|528362803|FG000|Overall Study|Not receive study treatment|6|||
146507686|NCT00478699|528362804|FG001|Overall Study|Not receive study treatment|30|||
146507687|NCT01043705|528362807|FG000|Overall Study|Death|28|||
146507688|NCT01043705|528362808|FG001|Overall Study|Death|60|||
146507689|NCT01043705|528362809|FG002|Overall Study|Death|26|||
146507690|NCT01043705|528362807|FG000|Overall Study|Lost to Follow-up|27|||
146507691|NCT01043705|528362808|FG001|Overall Study|Lost to Follow-up|12|||
146507692|NCT01043705|528362809|FG002|Overall Study|Lost to Follow-up|0|||
146507693|NCT01043705|528362807|FG000|Overall Study|Multiple Reasons|4|||
146507694|NCT01043705|528362808|FG001|Overall Study|Multiple Reasons|7|||
146769713|NCT02015546|529326564|FG001|Overall Study|Screem Failure|1|||
146769714|NCT02015546|529326565|FG002|Overall Study|Screem Failure|3|||
146769715|NCT05855655|529326566|FG000|Overall Study|Withdrawal by Subject|0|||
146507695|NCT01043705|528362809|FG002|Overall Study|Multiple Reasons|0|||
146507696|NCT01043705|528362807|FG000|Overall Study|Protocol Violation|2|||
146507697|NCT01043705|528362808|FG001|Overall Study|Protocol Violation|1|||
146507698|NCT01043705|528362809|FG002|Overall Study|Protocol Violation|0|||
146507699|NCT01043705|528362807|FG000|Overall Study|Withdrawal by Subject|8|||
146507700|NCT01043705|528362808|FG001|Overall Study|Withdrawal by Subject|6|||
146507701|NCT01043705|528362809|FG002|Overall Study|Withdrawal by Subject|0|||
146507702|NCT01043705|528362807|FG000|Overall Study|Site Closure|8|||
146507703|NCT01043705|528362808|FG001|Overall Study|Site Closure|0|||
146507704|NCT01043705|528362809|FG002|Overall Study|Site Closure|0|||
146649587|NCT03085914|528894887|FG004|Overall Study|Reason was not specified,|3|||
146649588|NCT03085914|528894888|FG005|Overall Study|Reason was not specified,|3|||
146649589|NCT03085914|528894889|FG006|Overall Study|Reason was not specified,|6|||
146649590|NCT03085914|528894883|FG000|Overall Study|Progressive Disease|0|||
146649591|NCT03085914|528894884|FG001|Overall Study|Progressive Disease|0|||
146649592|NCT03085914|528894885|FG002|Overall Study|Progressive Disease|2|||
146649593|NCT03085914|528894886|FG003|Overall Study|Progressive Disease|2|||
146649594|NCT03085914|528894887|FG004|Overall Study|Progressive Disease|1|||
146649595|NCT03085914|528894888|FG005|Overall Study|Progressive Disease|1|||
146649596|NCT03085914|528894889|FG006|Overall Study|Progressive Disease|1|||
146649597|NCT03085914|528894883|FG000|Overall Study|Study Terminated by the Sponsor|0|||
146649598|NCT03085914|528894884|FG001|Overall Study|Study Terminated by the Sponsor|0|||
146649599|NCT03085914|528894885|FG002|Overall Study|Study Terminated by the Sponsor|0|||
146649600|NCT03085914|528894886|FG003|Overall Study|Study Terminated by the Sponsor|1|||
146649601|NCT03085914|528894887|FG004|Overall Study|Study Terminated by the Sponsor|2|||
146649602|NCT03085914|528894888|FG005|Overall Study|Study Terminated by the Sponsor|1|||
146649603|NCT03085914|528894889|FG006|Overall Study|Study Terminated by the Sponsor|0|||
146649604|NCT01215916|528894890|FG000|Overall Study|Progressive Disease|0|||
146649605|NCT01215916|528894891|FG001|Overall Study|Progressive Disease|2|||
146649606|NCT01215916|528894892|FG002|Overall Study|Progressive Disease|1|||
146649607|NCT01215916|528894893|FG003|Overall Study|Progressive Disease|2|||
146649608|NCT01215916|528894894|FG004|Overall Study|Progressive Disease|5|||
146649609|NCT01215916|528894895|FG005|Overall Study|Progressive Disease|4|||
146649610|NCT01215916|528894896|FG006|Overall Study|Progressive Disease|5|||
146649611|NCT01215916|528894897|FG007|Overall Study|Progressive Disease|3|||
146649612|NCT01215916|528894898|FG008|Overall Study|Progressive Disease|1|||
146649613|NCT01215916|528894890|FG000|Overall Study|Adverse Event|1|||
146649614|NCT01215916|528894891|FG001|Overall Study|Adverse Event|1|||
146649615|NCT01215916|528894892|FG002|Overall Study|Adverse Event|0|||
146649616|NCT01215916|528894893|FG003|Overall Study|Adverse Event|1|||
146649617|NCT01215916|528894894|FG004|Overall Study|Adverse Event|0|||
146649618|NCT01215916|528894895|FG005|Overall Study|Adverse Event|0|||
146649619|NCT01215916|528894896|FG006|Overall Study|Adverse Event|3|||
146649620|NCT01215916|528894897|FG007|Overall Study|Adverse Event|0|||
146649621|NCT01215916|528894898|FG008|Overall Study|Adverse Event|0|||
146649622|NCT01215916|528894890|FG000|Overall Study|Withdrawal by Subject|0|||
146649623|NCT01215916|528894891|FG001|Overall Study|Withdrawal by Subject|1|||
146649624|NCT01215916|528894892|FG002|Overall Study|Withdrawal by Subject|1|||
146649625|NCT01215916|528894893|FG003|Overall Study|Withdrawal by Subject|2|||
146649626|NCT01215916|528894894|FG004|Overall Study|Withdrawal by Subject|0|||
146649627|NCT01215916|528894895|FG005|Overall Study|Withdrawal by Subject|0|||
146649628|NCT01215916|528894896|FG006|Overall Study|Withdrawal by Subject|1|||
146649629|NCT01215916|528894897|FG007|Overall Study|Withdrawal by Subject|0|||
146649630|NCT01215916|528894898|FG008|Overall Study|Withdrawal by Subject|0|||
146649631|NCT01215916|528894890|FG000|Overall Study|Death|0|||
146649632|NCT01215916|528894891|FG001|Overall Study|Death|1|||
146649633|NCT01215916|528894892|FG002|Overall Study|Death|0|||
146649634|NCT01215916|528894893|FG003|Overall Study|Death|0|||
146649635|NCT01215916|528894894|FG004|Overall Study|Death|1|||
146649636|NCT01215916|528894895|FG005|Overall Study|Death|0|||
146649637|NCT01215916|528894896|FG006|Overall Study|Death|0|||
146649638|NCT01215916|528894897|FG007|Overall Study|Death|0|||
146649639|NCT01215916|528894898|FG008|Overall Study|Death|1|||
146649640|NCT01215916|528894890|FG000|Overall Study|Physician Decision|0|||
146507705|NCT01043705|528362807|FG000|Overall Study|Subsequent Procedure|9|||
146507706|NCT01043705|528362808|FG001|Overall Study|Subsequent Procedure|24|||
146507707|NCT01043705|528362809|FG002|Overall Study|Subsequent Procedure|29|||
146507708|NCT01043705|528362807|FG000|Overall Study|Adverse Event|0|||
146507709|NCT01043705|528362808|FG001|Overall Study|Adverse Event|2|||
146507710|NCT01043705|528362809|FG002|Overall Study|Adverse Event|0|||
146507711|NCT01043705|528362807|FG000|Overall Study|Screen Fail|21|||
146507712|NCT01043705|528362808|FG001|Overall Study|Screen Fail|0|||
146507713|NCT01043705|528362809|FG002|Overall Study|Screen Fail|0|||
146507714|NCT01043705|528362807|FG000|Overall Study|Other|0|||
146507715|NCT01043705|528362808|FG001|Overall Study|Other|19|||
146649641|NCT01215916|528894891|FG001|Overall Study|Physician Decision|0|||
146649642|NCT01215916|528894892|FG002|Overall Study|Physician Decision|1|||
146649643|NCT01215916|528894893|FG003|Overall Study|Physician Decision|1|||
146649644|NCT01215916|528894894|FG004|Overall Study|Physician Decision|0|||
146649645|NCT01215916|528894895|FG005|Overall Study|Physician Decision|0|||
146649646|NCT01215916|528894896|FG006|Overall Study|Physician Decision|0|||
146649647|NCT01215916|528894897|FG007|Overall Study|Physician Decision|0|||
146649648|NCT01215916|528894898|FG008|Overall Study|Physician Decision|0|||
146649649|NCT02353143|528894899|FG000|Overall Study|Withdrawal by Subject|1|||
146649650|NCT02353143|528894900|FG001|Overall Study|Withdrawal by Subject|0|||
146649651|NCT02353143|528894901|FG002|Overall Study|Withdrawal by Subject|0|||
146649652|NCT02353143|528894902|FG003|Overall Study|Withdrawal by Subject|0|||
146507716|NCT01043705|528362809|FG002|Overall Study|Other|25|||
146507717|NCT05020366|528362812|FG000|Overall Study|Lost to Follow-up|2|||
146507718|NCT05020366|528362813|FG001|Overall Study|Lost to Follow-up|0|||
146507719|NCT05020366|528362812|FG000|Overall Study|Withdrawal by Subject|2|||
146507720|NCT05020366|528362813|FG001|Overall Study|Withdrawal by Subject|0|||
146507721|NCT00656851|528362819|FG000|Overall Study|Withdrawal by Subject|0|||
146507722|NCT00656851|528362820|FG001|Overall Study|Withdrawal by Subject|4|||
146507723|NCT04601103|528362822|FG000|Overall Study|Needed crown & cleaning|0|||
146507724|NCT04601103|528362823|FG001|Overall Study|Needed crown & cleaning|0|||
146507725|NCT04601103|528362824|FG002|Overall Study|Needed crown & cleaning|1|||
146507726|NCT04601103|528362822|FG000|Overall Study|study was terminated|18|||
146507727|NCT04601103|528362823|FG001|Overall Study|study was terminated|18|||
146507728|NCT04601103|528362824|FG002|Overall Study|study was terminated|16|||
146507729|NCT04442269|528362827|FG000|Overall Study|Adverse Event|1|||
146507730|NCT04442269|528362828|FG001|Overall Study|Adverse Event|0|||
146507731|NCT04442269|528362827|FG000|Overall Study|Death|0|||
146507732|NCT04442269|528362828|FG001|Overall Study|Death|1|||
146507733|NCT04442269|528362827|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
146507734|NCT04442269|528362828|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
146507735|NCT04442269|528362827|FG000|Overall Study|Lost to Follow-up|1|||
146507736|NCT04442269|528362828|FG001|Overall Study|Lost to Follow-up|0|||
146507737|NCT04442269|528362827|FG000|Overall Study|Withdrawal by Subject|3|||
146507738|NCT04442269|528362828|FG001|Overall Study|Withdrawal by Subject|2|||
146507739|NCT04442269|528362827|FG000|Overall Study|Protocol Deviation|0|||
146507740|NCT04442269|528362828|FG001|Overall Study|Protocol Deviation|1|||
146507741|NCT04442269|528362827|FG000|Overall Study|Travel Limitations|1|||
146507742|NCT04442269|528362828|FG001|Overall Study|Travel Limitations|1|||
146507743|NCT04326439|528362829|FG000|Overall Study|Withdrawal by Subject|1|||
146507744|NCT04326439|528362830|FG001|Overall Study|Withdrawal by Subject|0|||
146507745|NCT04326439|528362829|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
146507746|NCT04326439|528362830|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
146507747|NCT04326439|528362829|FG000|Overall Study|Relapse after Induction 2|0|||
146507748|NCT04326439|528362830|FG001|Overall Study|Relapse after Induction 2|1|||
146507749|NCT04326439|528362829|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
146507750|NCT04326439|528362830|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
146507751|NCT03932331|528362834|FG000|Overall Study|Death|0|||
146507752|NCT03932331|528362835|FG001|Overall Study|Death|7|||
146507753|NCT03932331|528362836|FG002|Overall Study|Death|2|||
146507754|NCT03932331|528362834|FG000|Overall Study|Withdrawal by Subject|0|||
146507755|NCT03932331|528362835|FG001|Overall Study|Withdrawal by Subject|3|||
146507756|NCT03932331|528362836|FG002|Overall Study|Withdrawal by Subject|0|||
146507757|NCT03932331|528362834|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
146507758|NCT03932331|528362835|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
146649653|NCT02353143|528894903|FG004|Overall Study|Withdrawal by Subject|1|||
146649654|NCT02353143|528894904|FG005|Overall Study|Withdrawal by Subject|0|||
146649655|NCT02353143|528894905|FG006|Overall Study|Withdrawal by Subject|0|||
146649656|NCT02353143|528894906|FG007|Overall Study|Withdrawal by Subject|1|||
146649657|NCT02353143|528894907|FG008|Overall Study|Withdrawal by Subject|1|||
146649658|NCT02353143|528894899|FG000|Overall Study|Lack of Efficacy|2|||
146649659|NCT02353143|528894900|FG001|Overall Study|Lack of Efficacy|1|||
146649660|NCT02353143|528894901|FG002|Overall Study|Lack of Efficacy|2|||
146649661|NCT02353143|528894902|FG003|Overall Study|Lack of Efficacy|4|||
146649662|NCT02353143|528894903|FG004|Overall Study|Lack of Efficacy|13|||
146649663|NCT02353143|528894904|FG005|Overall Study|Lack of Efficacy|2|||
146649664|NCT02353143|528894905|FG006|Overall Study|Lack of Efficacy|2|||
146649665|NCT02353143|528894906|FG007|Overall Study|Lack of Efficacy|2|||
146649666|NCT02353143|528894907|FG008|Overall Study|Lack of Efficacy|1|||
146649667|NCT02353143|528894899|FG000|Overall Study|reason not specified|1|||
146649668|NCT02353143|528894900|FG001|Overall Study|reason not specified|2|||
146649669|NCT02353143|528894901|FG002|Overall Study|reason not specified|0|||
146649670|NCT02353143|528894902|FG003|Overall Study|reason not specified|0|||
146649671|NCT02353143|528894903|FG004|Overall Study|reason not specified|6|||
146649672|NCT02353143|528894904|FG005|Overall Study|reason not specified|1|||
146649673|NCT02353143|528894905|FG006|Overall Study|reason not specified|0|||
146649674|NCT02353143|528894906|FG007|Overall Study|reason not specified|3|||
146649675|NCT02353143|528894907|FG008|Overall Study|reason not specified|1|||
146649676|NCT02353143|528894899|FG000|Overall Study|Physician Decision|0|||
146649677|NCT02353143|528894900|FG001|Overall Study|Physician Decision|4|||
146649678|NCT02353143|528894901|FG002|Overall Study|Physician Decision|2|||
146649679|NCT02353143|528894902|FG003|Overall Study|Physician Decision|3|||
146649680|NCT02353143|528894903|FG004|Overall Study|Physician Decision|4|||
146649681|NCT02353143|528894904|FG005|Overall Study|Physician Decision|0|||
146649682|NCT02353143|528894905|FG006|Overall Study|Physician Decision|1|||
146649683|NCT02353143|528894906|FG007|Overall Study|Physician Decision|2|||
146649684|NCT02353143|528894907|FG008|Overall Study|Physician Decision|0|||
146649685|NCT02353143|528894899|FG000|Overall Study|Adverse Event|0|||
146649686|NCT02353143|528894900|FG001|Overall Study|Adverse Event|0|||
146649687|NCT02353143|528894901|FG002|Overall Study|Adverse Event|1|||
146507759|NCT03932331|528362836|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
146649688|NCT02353143|528894902|FG003|Overall Study|Adverse Event|0|||
146507760|NCT03932331|528362834|FG000|Overall Study|Progressive disease|3|||
146507761|NCT03932331|528362835|FG001|Overall Study|Progressive disease|0|||
146507762|NCT03932331|528362836|FG002|Overall Study|Progressive disease|0|||
146507763|NCT03932331|528362834|FG000|Overall Study|Lung infection|1|||
146507764|NCT03932331|528362835|FG001|Overall Study|Lung infection|0|||
146507765|NCT03932331|528362836|FG002|Overall Study|Lung infection|0|||
146507766|NCT03932331|528362834|FG000|Overall Study|Other|0|||
146507767|NCT03932331|528362835|FG001|Overall Study|Other|0|||
146649689|NCT02353143|528894903|FG004|Overall Study|Adverse Event|1|||
146649690|NCT02353143|528894904|FG005|Overall Study|Adverse Event|1|||
146649691|NCT02353143|528894905|FG006|Overall Study|Adverse Event|0|||
146649692|NCT02353143|528894906|FG007|Overall Study|Adverse Event|0|||
146649693|NCT02353143|528894907|FG008|Overall Study|Adverse Event|0|||
146649694|NCT02353143|528894899|FG000|Overall Study|patient receiving other treatment for AML|0|||
146649695|NCT02353143|528894900|FG001|Overall Study|patient receiving other treatment for AML|0|||
146649696|NCT02353143|528894901|FG002|Overall Study|patient receiving other treatment for AML|1|||
146649697|NCT02353143|528894902|FG003|Overall Study|patient receiving other treatment for AML|0|||
146649698|NCT02353143|528894903|FG004|Overall Study|patient receiving other treatment for AML|0|||
146649699|NCT02353143|528894904|FG005|Overall Study|patient receiving other treatment for AML|0|||
146649700|NCT02353143|528894905|FG006|Overall Study|patient receiving other treatment for AML|0|||
146649701|NCT02353143|528894906|FG007|Overall Study|patient receiving other treatment for AML|0|||
146507768|NCT03932331|528362836|FG002|Overall Study|Other|58|||
146507769|NCT01032239|528362837|FG000|Overall Study|Lost to Follow-up|3|||
146507770|NCT01032239|528362838|FG001|Overall Study|Lost to Follow-up|2|||
146507771|NCT01032239|528362837|FG000|Overall Study|Withdrawal by Subject|2|||
146649702|NCT02353143|528894907|FG008|Overall Study|patient receiving other treatment for AML|0|||
146974472|NCT01682512|530069549|FG000|Overall Study|Secondary lack of efficacy|1|||
146507772|NCT01032239|528362838|FG001|Overall Study|Withdrawal by Subject|3|||
146507773|NCT01032239|528362837|FG000|Overall Study|Death|1|||
146507774|NCT01032239|528362838|FG001|Overall Study|Death|0|||
146507775|NCT01032239|528362837|FG000|Overall Study|Protocol Violation|1|||
146507776|NCT01032239|528362838|FG001|Overall Study|Protocol Violation|0|||
146507777|NCT03782298|528362839|FG000|Overall Study|Protocol Deviation|4|||
146507778|NCT01797081|528362840|FG000|Overall Study|Adverse Event|1|||
146507779|NCT01797081|528362841|FG001|Overall Study|Adverse Event|0|||
146507780|NCT01797081|528362842|FG002|Overall Study|Adverse Event|1|||
146507781|NCT01797081|528362843|FG003|Overall Study|Adverse Event|0|||
146507782|NCT01797081|528362840|FG000|Overall Study|Pregnancy|1|||
146507783|NCT01797081|528362841|FG001|Overall Study|Pregnancy|0|||
146507784|NCT01797081|528362842|FG002|Overall Study|Pregnancy|0|||
146507785|NCT01797081|528362843|FG003|Overall Study|Pregnancy|0|||
146507786|NCT01797081|528362840|FG000|Overall Study|Personal Reasons|12|||
146507787|NCT01797081|528362841|FG001|Overall Study|Personal Reasons|4|||
146507788|NCT01797081|528362842|FG002|Overall Study|Personal Reasons|4|||
146507789|NCT01797081|528362843|FG003|Overall Study|Personal Reasons|8|||
146507790|NCT01797081|528362840|FG000|Overall Study|Protocol Violation|0|||
146507791|NCT01797081|528362841|FG001|Overall Study|Protocol Violation|0|||
146507792|NCT01797081|528362842|FG002|Overall Study|Protocol Violation|0|||
146507793|NCT01797081|528362843|FG003|Overall Study|Protocol Violation|1|||
146507794|NCT05513703|528362847|FG000|Overall Study|Death|4|||
146507795|NCT05513703|528362847|FG000|Overall Study|Study terminated by sponsor|5|||
146507796|NCT01793688|528362850|FG000|Overall Study|Protocol Violation|2|||
146507797|NCT03649178|528362851|FG000|Overall Study|Adverse Event|1|||
146507798|NCT03649178|528362852|FG001|Overall Study|Adverse Event|2|||
146507799|NCT03649178|528362851|FG000|Overall Study|Withdrawal by Subject|0|||
146507800|NCT03649178|528362852|FG001|Overall Study|Withdrawal by Subject|2|||
146507801|NCT03649178|528362851|FG000|Overall Study|COVID regulation required halt in protocol|1|||
146507802|NCT03649178|528362852|FG001|Overall Study|COVID regulation required halt in protocol|0|||
146507803|NCT03003494|528362853|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
146507804|NCT05238025|528362854|FG000|Overall Study|Adverse Event|2|||
146507805|NCT05238025|528362855|FG001|Overall Study|Adverse Event|2|||
146507806|NCT05238025|528362854|FG000|Overall Study|Lost to Follow-up|334|||
146507807|NCT05238025|528362855|FG001|Overall Study|Lost to Follow-up|339|||
146507808|NCT05238025|528362854|FG000|Overall Study|Withdrawal by Subject|203|||
146507809|NCT05238025|528362855|FG001|Overall Study|Withdrawal by Subject|222|||
146507810|NCT05238025|528362854|FG000|Overall Study|Physician Decision|20|||
146507811|NCT05238025|528362855|FG001|Overall Study|Physician Decision|8|||
146507812|NCT05238025|528362854|FG000|Overall Study|Protocol Violation|6|||
146507813|NCT05238025|528362855|FG001|Overall Study|Protocol Violation|2|||
146507814|NCT05238025|528362854|FG000|Overall Study|Death|38|||
146507815|NCT05238025|528362855|FG001|Overall Study|Death|32|||
146507816|NCT05238025|528362854|FG000|Overall Study|Study terminated by Sponsor|6358|||
146507817|NCT05238025|528362855|FG001|Overall Study|Study terminated by Sponsor|6358|||
146649703|NCT02353143|528894899|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
146769716|NCT05855655|529326567|FG001|Overall Study|Withdrawal by Subject|1|||
146507818|NCT05238025|528362854|FG000|Overall Study|Other Reason|669|||
146507819|NCT05238025|528362855|FG001|Overall Study|Other Reason|690|||
146507820|NCT03814720|528362860|FG000|Overall Study|Lost to Follow-up|0|||
146507821|NCT03814720|528362861|FG001|Overall Study|Lost to Follow-up|1|||
146769717|NCT05855655|529326566|FG000|Overall Study|Lost to Follow-up|4|||
146769718|NCT05855655|529326567|FG001|Overall Study|Lost to Follow-up|0|||
146769719|NCT01337635|529326568|FG000|Overall Study|Lost to Follow-up|0|||
146769720|NCT01337635|529326569|FG001|Overall Study|Lost to Follow-up|1|||
146769721|NCT01113931|529326572|FG000|Overall Study|Adverse Event|2|||
146769722|NCT01113931|529326573|FG001|Overall Study|Adverse Event|2|||
146769723|NCT01113931|529326572|FG000|Overall Study|Physician Decision|0|||
146769724|NCT01113931|529326573|FG001|Overall Study|Physician Decision|2|||
146769725|NCT01113931|529326572|FG000|Overall Study|Lost to Follow-up|12|||
146769726|NCT01113931|529326573|FG001|Overall Study|Lost to Follow-up|9|||
146769727|NCT01113931|529326572|FG000|Overall Study|Various|2|||
146769728|NCT01113931|529326573|FG001|Overall Study|Various|4|||
146769729|NCT01113931|529326572|FG000|Overall Study|Withdrawal by Subject|3|||
146769730|NCT01113931|529326573|FG001|Overall Study|Withdrawal by Subject|0|||
146769731|NCT01307267|529326574|FG000|Overall Study|Death|4|||
146769732|NCT01307267|529326575|FG001|Overall Study|Death|3|||
146769733|NCT01307267|529326576|FG002|Overall Study|Death|5|||
146769734|NCT01307267|529326577|FG003|Overall Study|Death|3|||
146769735|NCT01307267|529326578|FG004|Overall Study|Death|1|||
146769736|NCT01307267|529326579|FG005|Overall Study|Death|26|||
146769737|NCT01307267|529326580|FG006|Overall Study|Death|2|||
146769738|NCT01307267|529326581|FG007|Overall Study|Death|2|||
146769739|NCT01307267|529326582|FG008|Overall Study|Death|21|||
146769740|NCT01307267|529326583|FG009|Overall Study|Death|2|||
146769741|NCT01307267|529326584|FG010|Overall Study|Death|3|||
146769742|NCT01307267|529326585|FG011|Overall Study|Death|9|||
146769743|NCT01307267|529326586|FG012|Overall Study|Death|0|||
146769744|NCT01307267|529326587|FG013|Overall Study|Death|0|||
146769745|NCT01307267|529326588|FG014|Overall Study|Death|0|||
146769746|NCT01307267|529326589|FG015|Overall Study|Death|0|||
146769747|NCT01307267|529326590|FG016|Overall Study|Death|1|||
146769748|NCT01307267|529326591|FG017|Overall Study|Death|1|||
146769749|NCT01307267|529326592|FG018|Overall Study|Death|2|||
146769750|NCT01307267|529326593|FG019|Overall Study|Death|8|||
146769751|NCT01307267|529326594|FG020|Overall Study|Death|1|||
146769752|NCT01307267|529326595|FG021|Overall Study|Death|2|||
146769753|NCT01307267|529326596|FG022|Overall Study|Death|2|||
146769754|NCT01307267|529326574|FG000|Overall Study|Lost to Follow-up|0|||
146769755|NCT01307267|529326575|FG001|Overall Study|Lost to Follow-up|0|||
146769756|NCT01307267|529326576|FG002|Overall Study|Lost to Follow-up|0|||
146769757|NCT01307267|529326577|FG003|Overall Study|Lost to Follow-up|0|||
146769758|NCT01307267|529326578|FG004|Overall Study|Lost to Follow-up|0|||
146769759|NCT01307267|529326579|FG005|Overall Study|Lost to Follow-up|7|||
146769760|NCT01307267|529326580|FG006|Overall Study|Lost to Follow-up|0|||
146507822|NCT03814720|528362862|FG002|Overall Study|Lost to Follow-up|0|||
146507823|NCT03814720|528362863|FG003|Overall Study|Lost to Follow-up|0|||
146769761|NCT01307267|529326581|FG007|Overall Study|Lost to Follow-up|0|||
146769762|NCT01307267|529326582|FG008|Overall Study|Lost to Follow-up|1|||
146769763|NCT01307267|529326583|FG009|Overall Study|Lost to Follow-up|2|||
146507824|NCT03814720|528362864|FG004|Overall Study|Lost to Follow-up|0|||
146507825|NCT02135107|528362871|FG000|Treatment Period|Withdrawal by Subject|11|||
146507826|NCT02135107|528362872|FG001|Treatment Period|Withdrawal by Subject|0|||
146507827|NCT02135107|528362873|FG002|Treatment Period|Withdrawal by Subject|0|||
146507828|NCT02135107|528362874|FG003|Treatment Period|Withdrawal by Subject|0|||
146507829|NCT02135107|528362871|FG000|Treatment Period|Adverse Event|5|||
146507830|NCT02135107|528362872|FG001|Treatment Period|Adverse Event|2|||
146507831|NCT02135107|528362873|FG002|Treatment Period|Adverse Event|0|||
146507832|NCT02135107|528362874|FG003|Treatment Period|Adverse Event|0|||
146507833|NCT02135107|528362871|FG000|Treatment Period|Pregnancy|1|||
146507834|NCT02135107|528362872|FG001|Treatment Period|Pregnancy|0|||
146507835|NCT02135107|528362873|FG002|Treatment Period|Pregnancy|0|||
146507836|NCT02135107|528362874|FG003|Treatment Period|Pregnancy|0|||
146507837|NCT02135107|528362871|FG000|Treatment Period|Other|115|||
146507838|NCT02135107|528362872|FG001|Treatment Period|Other|24|||
146507839|NCT02135107|528362873|FG002|Treatment Period|Other|0|||
146507840|NCT02135107|528362874|FG003|Treatment Period|Other|0|||
146507841|NCT02135107|528362871|FG000|Maintenance Therapy Period|Adverse Event|0|||
146507842|NCT02135107|528362872|FG001|Maintenance Therapy Period|Adverse Event|0|||
146507843|NCT02135107|528362873|FG002|Maintenance Therapy Period|Adverse Event|3|||
146974473|NCT01682512|530069550|FG001|Overall Study|Secondary lack of efficacy|1|||
146507844|NCT02135107|528362874|FG003|Maintenance Therapy Period|Adverse Event|7|||
146507845|NCT02135107|528362871|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
146769764|NCT01307267|529326584|FG010|Overall Study|Lost to Follow-up|1|||
146769765|NCT01307267|529326585|FG011|Overall Study|Lost to Follow-up|0|||
146507846|NCT02135107|528362872|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
146507847|NCT02135107|528362873|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
146769766|NCT01307267|529326586|FG012|Overall Study|Lost to Follow-up|0|||
146769767|NCT01307267|529326587|FG013|Overall Study|Lost to Follow-up|0|||
146769768|NCT01307267|529326588|FG014|Overall Study|Lost to Follow-up|0|||
146769769|NCT01307267|529326589|FG015|Overall Study|Lost to Follow-up|0|||
146769770|NCT01307267|529326590|FG016|Overall Study|Lost to Follow-up|0|||
146769771|NCT01307267|529326591|FG017|Overall Study|Lost to Follow-up|0|||
146769772|NCT01307267|529326592|FG018|Overall Study|Lost to Follow-up|0|||
146769773|NCT01307267|529326593|FG019|Overall Study|Lost to Follow-up|2|||
146769774|NCT01307267|529326594|FG020|Overall Study|Lost to Follow-up|0|||
146769775|NCT01307267|529326595|FG021|Overall Study|Lost to Follow-up|0|||
146769776|NCT01307267|529326596|FG022|Overall Study|Lost to Follow-up|0|||
146769777|NCT01307267|529326574|FG000|Overall Study|Withdrawal by Subject|0|||
146769778|NCT01307267|529326575|FG001|Overall Study|Withdrawal by Subject|0|||
146769779|NCT01307267|529326576|FG002|Overall Study|Withdrawal by Subject|0|||
146769780|NCT01307267|529326577|FG003|Overall Study|Withdrawal by Subject|0|||
146769781|NCT01307267|529326578|FG004|Overall Study|Withdrawal by Subject|0|||
146769782|NCT01307267|529326579|FG005|Overall Study|Withdrawal by Subject|1|||
146769783|NCT01307267|529326580|FG006|Overall Study|Withdrawal by Subject|0|||
146769784|NCT01307267|529326581|FG007|Overall Study|Withdrawal by Subject|1|||
146769785|NCT01307267|529326582|FG008|Overall Study|Withdrawal by Subject|5|||
146769786|NCT01307267|529326583|FG009|Overall Study|Withdrawal by Subject|1|||
146769787|NCT01307267|529326584|FG010|Overall Study|Withdrawal by Subject|1|||
146769788|NCT01307267|529326585|FG011|Overall Study|Withdrawal by Subject|1|||
146769789|NCT01307267|529326586|FG012|Overall Study|Withdrawal by Subject|0|||
146769790|NCT01307267|529326587|FG013|Overall Study|Withdrawal by Subject|0|||
146769791|NCT01307267|529326588|FG014|Overall Study|Withdrawal by Subject|0|||
146769792|NCT01307267|529326589|FG015|Overall Study|Withdrawal by Subject|0|||
146769793|NCT01307267|529326590|FG016|Overall Study|Withdrawal by Subject|0|||
146769794|NCT01307267|529326591|FG017|Overall Study|Withdrawal by Subject|0|||
146769795|NCT01307267|529326592|FG018|Overall Study|Withdrawal by Subject|0|||
146769796|NCT01307267|529326593|FG019|Overall Study|Withdrawal by Subject|3|||
146769797|NCT01307267|529326594|FG020|Overall Study|Withdrawal by Subject|0|||
146769798|NCT01307267|529326595|FG021|Overall Study|Withdrawal by Subject|0|||
146769799|NCT01307267|529326596|FG022|Overall Study|Withdrawal by Subject|0|||
146769800|NCT01307267|529326574|FG000|Overall Study|Other|0|||
146769801|NCT01307267|529326575|FG001|Overall Study|Other|0|||
146769802|NCT01307267|529326576|FG002|Overall Study|Other|0|||
146769803|NCT01307267|529326577|FG003|Overall Study|Other|0|||
146769804|NCT01307267|529326578|FG004|Overall Study|Other|0|||
146769805|NCT01307267|529326579|FG005|Overall Study|Other|7|||
146769806|NCT01307267|529326580|FG006|Overall Study|Other|0|||
146769807|NCT01307267|529326581|FG007|Overall Study|Other|1|||
146769808|NCT01307267|529326582|FG008|Overall Study|Other|3|||
146769809|NCT01307267|529326583|FG009|Overall Study|Other|0|||
146769810|NCT01307267|529326584|FG010|Overall Study|Other|1|||
146769811|NCT01307267|529326585|FG011|Overall Study|Other|1|||
146769812|NCT01307267|529326586|FG012|Overall Study|Other|1|||
146769813|NCT01307267|529326587|FG013|Overall Study|Other|0|||
146769814|NCT01307267|529326588|FG014|Overall Study|Other|2|||
146769815|NCT01307267|529326589|FG015|Overall Study|Other|1|||
146769816|NCT01307267|529326590|FG016|Overall Study|Other|0|||
146769817|NCT01307267|529326591|FG017|Overall Study|Other|0|||
146769818|NCT01307267|529326592|FG018|Overall Study|Other|0|||
146769819|NCT01307267|529326593|FG019|Overall Study|Other|19|||
146769820|NCT01307267|529326594|FG020|Overall Study|Other|2|||
146769821|NCT01307267|529326595|FG021|Overall Study|Other|3|||
146769822|NCT01307267|529326596|FG022|Overall Study|Other|2|||
146769823|NCT04956575|529326600|FG000|Overall Study|Death|1|||
146769824|NCT04956575|529326601|FG001|Overall Study|Death|0|||
146769825|NCT04956575|529326602|FG002|Overall Study|Death|0|||
146769826|NCT04956575|529326603|FG003|Overall Study|Death|0|||
146769827|NCT04956575|529326604|FG004|Overall Study|Death|0|||
146769828|NCT04956575|529326605|FG005|Overall Study|Death|0|||
146769829|NCT04956575|529326606|FG006|Overall Study|Death|0|||
146769830|NCT04956575|529326607|FG007|Overall Study|Death|1|||
146769831|NCT04956575|529326608|FG008|Overall Study|Death|0|||
146769832|NCT04956575|529326609|FG009|Overall Study|Death|1|||
146769833|NCT04956575|529326610|FG010|Overall Study|Death|0|||
146769834|NCT04956575|529326611|FG011|Overall Study|Death|0|||
146769835|NCT04956575|529326600|FG000|Overall Study|Lost to Follow-up|3|||
146769836|NCT04956575|529326601|FG001|Overall Study|Lost to Follow-up|4|||
146769837|NCT04956575|529326602|FG002|Overall Study|Lost to Follow-up|2|||
146769838|NCT04956575|529326603|FG003|Overall Study|Lost to Follow-up|3|||
146769839|NCT04956575|529326604|FG004|Overall Study|Lost to Follow-up|1|||
146769840|NCT04956575|529326605|FG005|Overall Study|Lost to Follow-up|10|||
146912880|NCT01845077|529843211|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
146769841|NCT04956575|529326606|FG006|Overall Study|Lost to Follow-up|11|||
146769842|NCT04956575|529326607|FG007|Overall Study|Lost to Follow-up|7|||
146912881|NCT01845077|529843206|FG000|Washout Period|Protocol Violation|0|||
146769843|NCT04956575|529326608|FG008|Overall Study|Lost to Follow-up|4|||
146769844|NCT04956575|529326609|FG009|Overall Study|Lost to Follow-up|2|||
146769845|NCT04956575|529326610|FG010|Overall Study|Lost to Follow-up|3|||
146769846|NCT04956575|529326611|FG011|Overall Study|Lost to Follow-up|8|||
146769847|NCT04956575|529326600|FG000|Overall Study|Withdrawal by Subject|1|||
146769848|NCT04956575|529326601|FG001|Overall Study|Withdrawal by Subject|2|||
146769849|NCT04956575|529326602|FG002|Overall Study|Withdrawal by Subject|1|||
146769850|NCT04956575|529326603|FG003|Overall Study|Withdrawal by Subject|4|||
146649704|NCT02353143|528894900|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
146649705|NCT02353143|528894901|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
146649706|NCT02353143|528894902|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
146649707|NCT02353143|528894903|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
146649708|NCT02353143|528894904|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
146649709|NCT02353143|528894905|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
146649710|NCT02353143|528894906|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
146649711|NCT02353143|528894907|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
146649712|NCT01029405|528894908|FG000|Overall Study|Withdrawal by Subject|0|||
146649713|NCT01029405|528894909|FG001|Overall Study|Withdrawal by Subject|1|||
146649714|NCT01029405|528894910|FG002|Overall Study|Withdrawal by Subject|2|||
146649715|NCT01029405|528894911|FG003|Overall Study|Withdrawal by Subject|0|||
146649716|NCT01029405|528894908|FG000|Overall Study|Protocol Violation|0|||
146649717|NCT01029405|528894909|FG001|Overall Study|Protocol Violation|0|||
146649718|NCT01029405|528894910|FG002|Overall Study|Protocol Violation|0|||
146649719|NCT01029405|528894911|FG003|Overall Study|Protocol Violation|1|||
146649720|NCT01029405|528894908|FG000|Overall Study|Adverse Event|0|||
146649721|NCT01029405|528894909|FG001|Overall Study|Adverse Event|0|||
146649722|NCT01029405|528894910|FG002|Overall Study|Adverse Event|1|||
146649723|NCT01029405|528894911|FG003|Overall Study|Adverse Event|1|||
146649724|NCT01029405|528894908|FG000|Overall Study|Lost to Follow-up|2|||
146649725|NCT01029405|528894909|FG001|Overall Study|Lost to Follow-up|1|||
146649726|NCT01029405|528894910|FG002|Overall Study|Lost to Follow-up|1|||
146649727|NCT01029405|528894911|FG003|Overall Study|Lost to Follow-up|2|||
146649728|NCT01029405|528894908|FG000|Overall Study|Other|0|||
146649729|NCT01029405|528894909|FG001|Overall Study|Other|1|||
146649730|NCT01029405|528894910|FG002|Overall Study|Other|0|||
146649731|NCT01029405|528894911|FG003|Overall Study|Other|1|||
146649732|NCT01534182|528894912|FG000|Overall Study|Administrative problems|1|||
146649733|NCT01534182|528894913|FG001|Overall Study|Administrative problems|0|||
146649734|NCT01534182|528894912|FG000|Overall Study|Withdrawal by Subject|4|||
146649735|NCT01534182|528894913|FG001|Overall Study|Withdrawal by Subject|7|||
146649736|NCT01534182|528894912|FG000|Overall Study|Adverse Event|7|||
146649737|NCT01534182|528894913|FG001|Overall Study|Adverse Event|3|||
146649738|NCT01525901|528894916|FG000|Period 2: 12 Weeks|Adverse Event|0|||
146649739|NCT01525901|528894917|FG001|Period 2: 12 Weeks|Adverse Event|1|||
146649740|NCT01525901|528894918|FG002|Period 2: 12 Weeks|Adverse Event|0|||
146649741|NCT01525901|528894919|FG003|Period 2: 12 Weeks|Adverse Event|0|||
146649742|NCT05027971|528894922|FG000|Overall Study|Physician Decision|7|||
146649743|NCT05027971|528894923|FG001|Overall Study|Physician Decision|3|||
146649744|NCT05027971|528894922|FG000|Overall Study|Lost to Follow-up|1|||
146649745|NCT05027971|528894923|FG001|Overall Study|Lost to Follow-up|1|||
146649746|NCT05027971|528894922|FG000|Overall Study|Withdrawal by Subject|0|||
146649747|NCT05027971|528894923|FG001|Overall Study|Withdrawal by Subject|2|||
146649748|NCT05027971|528894922|FG000|Overall Study|Non-study fiber used.|0|||
146649749|NCT05027971|528894923|FG001|Overall Study|Non-study fiber used.|1|||
146649750|NCT05027971|528894922|FG000|Overall Study|Protocol Violation|0|||
146649751|NCT05027971|528894923|FG001|Overall Study|Protocol Violation|2|||
146649752|NCT02112045|528894924|FG000|Overall Study|Withdrawal by Subject|1|||
146649753|NCT02112045|528894925|FG001|Overall Study|Withdrawal by Subject|0|||
146649754|NCT00627445|528894926|FG000|Overall Study|Adverse Event|3|||
146649755|NCT00627445|528894927|FG001|Overall Study|Adverse Event|3|||
146649756|NCT00627445|528894926|FG000|Overall Study|Lack of Efficacy|0|||
146649757|NCT00627445|528894927|FG001|Overall Study|Lack of Efficacy|1|||
146649758|NCT00627445|528894926|FG000|Overall Study|Other|6|||
146649759|NCT00627445|528894927|FG001|Overall Study|Other|8|||
146649760|NCT01238588|528894932|FG000|Overall Study|Withdrawal by Subject|1|||
146649761|NCT01238588|528894932|FG000|Overall Study|Physician Decision|2|||
146649762|NCT05395091|528894934|FG000|Baseline to Month 12|Adverse Event|7|||
146649763|NCT05395091|528894935|FG001|Baseline to Month 12|Adverse Event|2|||
146649764|NCT05395091|528894936|FG002|Baseline to Month 12|Adverse Event|0|||
146649765|NCT05395091|528894934|FG000|Baseline to Month 12|Death|3|||
146649766|NCT05395091|528894935|FG001|Baseline to Month 12|Death|1|||
146649767|NCT05395091|528894936|FG002|Baseline to Month 12|Death|0|||
146649768|NCT05395091|528894934|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
146649769|NCT05395091|528894935|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
146649770|NCT05395091|528894936|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
146649771|NCT05395091|528894934|FG000|Baseline to Month 12|Protocol Violation|2|||
146649772|NCT05395091|528894935|FG001|Baseline to Month 12|Protocol Violation|3|||
146649773|NCT05395091|528894936|FG002|Baseline to Month 12|Protocol Violation|0|||
146649774|NCT05395091|528894934|FG000|Baseline to Month 12|Physician Decision|1|||
146649775|NCT05395091|528894935|FG001|Baseline to Month 12|Physician Decision|0|||
146649776|NCT05395091|528894936|FG002|Baseline to Month 12|Physician Decision|0|||
146649777|NCT05395091|528894934|FG000|Month 12 to Month 18|Death|1|||
146649778|NCT05395091|528894935|FG001|Month 12 to Month 18|Death|0|||
146649779|NCT05395091|528894936|FG002|Month 12 to Month 18|Death|0|||
146649780|NCT05395091|528894934|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
146649781|NCT05395091|528894935|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
146507848|NCT02135107|528362874|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
146507849|NCT02135107|528362871|FG000|Maintenance Therapy Period|Pregnancy|0|||
146507850|NCT02135107|528362872|FG001|Maintenance Therapy Period|Pregnancy|0|||
146507851|NCT02135107|528362873|FG002|Maintenance Therapy Period|Pregnancy|0|||
146507852|NCT02135107|528362874|FG003|Maintenance Therapy Period|Pregnancy|1|||
146507853|NCT02135107|528362871|FG000|Maintenance Therapy Period|Other|0|||
146507854|NCT02135107|528362872|FG001|Maintenance Therapy Period|Other|0|||
146507855|NCT02135107|528362873|FG002|Maintenance Therapy Period|Other|7|||
146507856|NCT02135107|528362874|FG003|Maintenance Therapy Period|Other|8|||
146507857|NCT02278120|528362876|FG000|Treatment Period|Progressive disease|234|||
146507858|NCT02278120|528362877|FG001|Treatment Period|Progressive disease|260|||
146507859|NCT02278120|528362876|FG000|Treatment Period|Subject/guardian decision|23|||
146507860|NCT02278120|528362877|FG001|Treatment Period|Subject/guardian decision|20|||
146507861|NCT02278120|528362876|FG000|Treatment Period|Adverse Event|16|||
146507862|NCT02278120|528362877|FG001|Treatment Period|Adverse Event|14|||
146507863|NCT02278120|528362876|FG000|Treatment Period|Physician Decision|14|||
146507864|NCT02278120|528362877|FG001|Treatment Period|Physician Decision|27|||
146507865|NCT02278120|528362876|FG000|Treatment Period|Death|3|||
146507866|NCT02278120|528362877|FG001|Treatment Period|Death|3|||
146507867|NCT02278120|528362876|FG000|Treatment Period|Lost to Follow-up|2|||
146507868|NCT02278120|528362877|FG001|Treatment Period|Lost to Follow-up|0|||
146507869|NCT02278120|528362876|FG000|Treatment Period|Protocol deviation|0|||
146507870|NCT02278120|528362877|FG001|Treatment Period|Protocol deviation|2|||
146507871|NCT02278120|528362876|FG000|Treatment Period|Study terminated as per protocol|43|||
146507872|NCT02278120|528362877|FG001|Treatment Period|Study terminated as per protocol|11|||
146507873|NCT02278120|528362876|FG000|Post-treatment Efficacy Follow-up|Death|0|||
146507874|NCT02278120|528362877|FG001|Post-treatment Efficacy Follow-up|Death|1|||
146507875|NCT02278120|528362876|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
146507876|NCT02278120|528362877|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
146507877|NCT02278120|528362876|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
146507878|NCT02278120|528362877|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
146507879|NCT02278120|528362876|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
146507880|NCT02278120|528362877|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
146507881|NCT02278120|528362876|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
146507882|NCT02278120|528362877|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
146507883|NCT03197324|528362878|FG000|Overall Study|Adverse Event|0|||
146507884|NCT03197324|528362879|FG001|Overall Study|Adverse Event|1|||
146507885|NCT00102531|528362880|FG000|Overall Study|Adverse Event|0|||
146507886|NCT00102531|528362881|FG001|Overall Study|Adverse Event|1|||
146507887|NCT00102531|528362880|FG000|Overall Study|Disease Progression|5|||
146507888|NCT00102531|528362881|FG001|Overall Study|Disease Progression|9|||
146507889|NCT00102531|528362880|FG000|Overall Study|Physician Decision|0|||
146507890|NCT00102531|528362881|FG001|Overall Study|Physician Decision|1|||
146507891|NCT00954512|528362883|FG000|Overall Study|Withdrawal by Subject|0|||
146507892|NCT00954512|528362884|FG001|Overall Study|Withdrawal by Subject|0|||
146507893|NCT00954512|528362885|FG002|Overall Study|Withdrawal by Subject|0|||
146507894|NCT00954512|528362886|FG003|Overall Study|Withdrawal by Subject|0|||
146507895|NCT00954512|528362887|FG004|Overall Study|Withdrawal by Subject|0|||
146507896|NCT00954512|528362888|FG005|Overall Study|Withdrawal by Subject|1|||
146507897|NCT00954512|528362883|FG000|Overall Study|Adverse Event|0|||
146507898|NCT00954512|528362884|FG001|Overall Study|Adverse Event|0|||
146507899|NCT00954512|528362885|FG002|Overall Study|Adverse Event|0|||
146507900|NCT00954512|528362886|FG003|Overall Study|Adverse Event|0|||
146507901|NCT00954512|528362887|FG004|Overall Study|Adverse Event|1|||
146507902|NCT00954512|528362888|FG005|Overall Study|Adverse Event|2|||
146507903|NCT00954512|528362883|FG000|Overall Study|Physician Decision|0|||
146507904|NCT00954512|528362884|FG001|Overall Study|Physician Decision|1|||
146912882|NCT01845077|529843207|FG001|Washout Period|Protocol Violation|0|||
146507905|NCT00954512|528362885|FG002|Overall Study|Physician Decision|0|||
146507906|NCT00954512|528362886|FG003|Overall Study|Physician Decision|1|||
146507907|NCT00954512|528362887|FG004|Overall Study|Physician Decision|0|||
146912883|NCT01845077|529843208|FG002|Washout Period|Protocol Violation|0|||
146507908|NCT00954512|528362888|FG005|Overall Study|Physician Decision|0|||
146507909|NCT00954512|528362883|FG000|Overall Study|Symptomatic Deterioration|0|||
146507910|NCT00954512|528362884|FG001|Overall Study|Symptomatic Deterioration|1|||
146507911|NCT00954512|528362885|FG002|Overall Study|Symptomatic Deterioration|0|||
146507912|NCT00954512|528362886|FG003|Overall Study|Symptomatic Deterioration|0|||
146507913|NCT00954512|528362887|FG004|Overall Study|Symptomatic Deterioration|2|||
146507914|NCT00954512|528362888|FG005|Overall Study|Symptomatic Deterioration|0|||
146507915|NCT00954512|528362883|FG000|Overall Study|Progression of Disease|2|||
146507916|NCT00954512|528362884|FG001|Overall Study|Progression of Disease|1|||
146507917|NCT00954512|528362885|FG002|Overall Study|Progression of Disease|0|||
146507918|NCT00954512|528362886|FG003|Overall Study|Progression of Disease|1|||
146507919|NCT00954512|528362887|FG004|Overall Study|Progression of Disease|1|||
146912884|NCT01845077|529843209|FG003|Washout Period|Protocol Violation|1|||
146912885|NCT01845077|529843210|FG004|Washout Period|Protocol Violation|1|||
146649782|NCT05395091|528894936|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
146649783|NCT05395091|528894934|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
146649784|NCT05395091|528894935|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
146649785|NCT05395091|528894936|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
146649786|NCT05395091|528894934|FG000|Month 12 to Month 18|Other reasons|0|||
146649787|NCT05395091|528894935|FG001|Month 12 to Month 18|Other reasons|0|||
146649788|NCT05395091|528894936|FG002|Month 12 to Month 18|Other reasons|1|||
146649789|NCT01509053|528894938|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
146649790|NCT01509053|528894938|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
146649791|NCT01509053|528894938|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
146649792|NCT01509053|528894938|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
146649793|NCT01509053|528894938|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
146649794|NCT01509053|528894938|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
146649795|NCT01915303|528894941|FG000|Core Phase|Adverse Event|7|||
146649796|NCT01915303|528894941|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
146649797|NCT01915303|528894941|FG000|Core Phase|Death|2|||
146649798|NCT01915303|528894941|FG000|Core Phase|Protocol Violation|2|||
146507920|NCT00954512|528362888|FG005|Overall Study|Progression of Disease|1|||
146507921|NCT05397171|528362889|FG000|Overall Study|Death|2|||
146507922|NCT05397171|528362890|FG001|Overall Study|Death|3|||
146507923|NCT05397171|528362891|FG002|Overall Study|Death|3|||
146649799|NCT01915303|528894941|FG000|Core Phase|Abnormal lab value|1|||
146507924|NCT05397171|528362889|FG000|Overall Study|Study Terminated By Sponsor|1|||
146507925|NCT05397171|528362890|FG001|Overall Study|Study Terminated By Sponsor|2|||
146507926|NCT05397171|528362891|FG002|Overall Study|Study Terminated By Sponsor|3|||
146507927|NCT05397171|528362889|FG000|Overall Study|Withdrawal by Subject|0|||
146507928|NCT05397171|528362890|FG001|Overall Study|Withdrawal by Subject|1|||
146507929|NCT05397171|528362891|FG002|Overall Study|Withdrawal by Subject|1|||
146507930|NCT01390428|528364499|FG000|Overall Study|Elective Surgery|0|||
146507931|NCT01390428|528364500|FG001|Overall Study|Elective Surgery|0|||
146507932|NCT01390428|528364501|FG002|Overall Study|Elective Surgery|0|||
146507933|NCT01390428|528364502|FG003|Overall Study|Elective Surgery|0|||
146507934|NCT01390428|528364503|FG004|Overall Study|Elective Surgery|1|||
146649800|NCT01915303|528894941|FG000|Core Phase|Withdrawal by Subject|1|||
146649801|NCT01915303|528894941|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
146649802|NCT01915303|528894941|FG000|Extension Phase|Withdrawal by Subject|4|||
146649803|NCT01915303|528894941|FG000|Extension Phase|Adverse Event|3|||
146649804|NCT01915303|528894941|FG000|Extension Phase|Death|1|||
146649805|NCT01915303|528894941|FG000|Extension Phase|Protocol Violation|1|||
146649806|NCT00834080|528894943|FG000|Overall Study|Adverse Event|7|||
146649807|NCT00834080|528894943|FG000|Overall Study|Lost to Follow-up|7|||
146649808|NCT00834080|528894943|FG000|Overall Study|Withdrawal by Subject|5|||
146649809|NCT00834080|528894943|FG000|Overall Study|Other - Pregnancy|1|||
146649810|NCT00834080|528894943|FG000|Overall Study|Other - False positive tests of the UDS|1|||
146649811|NCT00834080|528894943|FG000|Overall Study|Physician Decision|1|||
146649812|NCT00834080|528894943|FG000|Overall Study|Subject Relocated|1|||
146649813|NCT00796523|528894947|FG000|Overall Study|Lost to Follow-up|9|||
146649814|NCT00796523|528894948|FG001|Overall Study|Lost to Follow-up|7|||
146649815|NCT00321646|528894950|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
146649816|NCT00321646|528894950|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
146649817|NCT00321646|528894950|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
146649818|NCT01284491|528894952|FG000|Overall Study|Study termination|13|||
146649819|NCT02694757|528894953|FG000|Overall Study|Lack of Efficacy|3|||
146649820|NCT00095147|528894954|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
146649821|NCT00095147|528894955|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
146649822|NCT00095147|528894956|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
146649823|NCT00095147|528894957|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
146649824|NCT00095147|528894958|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
146649825|NCT00095147|528894954|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
146649826|NCT00095147|528894955|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
146649827|NCT00095147|528894956|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
146649828|NCT00095147|528894957|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
146649829|NCT00095147|528894958|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
146649830|NCT00095147|528894954|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
146649831|NCT00095147|528894955|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
146649832|NCT00095147|528894956|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
146649833|NCT00095147|528894957|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
146649834|NCT00095147|528894958|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
146649835|NCT00095147|528894954|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
146649836|NCT00095147|528894955|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
146912886|NCT01845077|529843211|FG005|Washout Period|Protocol Violation|0|||
146507935|NCT01390428|528364504|FG005|Overall Study|Elective Surgery|0|||
146507936|NCT01390428|528364499|FG000|Overall Study|Withdrawal by Subject|0|||
146507937|NCT01390428|528364500|FG001|Overall Study|Withdrawal by Subject|0|||
146507938|NCT01390428|528364501|FG002|Overall Study|Withdrawal by Subject|1|||
146507939|NCT01390428|528364502|FG003|Overall Study|Withdrawal by Subject|0|||
146507940|NCT01390428|528364503|FG004|Overall Study|Withdrawal by Subject|0|||
146507941|NCT01390428|528364504|FG005|Overall Study|Withdrawal by Subject|0|||
146507942|NCT02928770|528364505|FG000|Overall Study|Withdrawal by Subject|2|||
146507943|NCT05906836|528364509|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
146507944|NCT05906836|528364509|FG000|Overall Study|Lost to Follow-up|1|||
146649837|NCT00095147|528894956|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
146649838|NCT00095147|528894957|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
146649839|NCT00095147|528894958|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
146649840|NCT00095147|528894954|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
146649841|NCT00095147|528894955|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
146649842|NCT00095147|528894956|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
146649843|NCT00095147|528894957|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
146649844|NCT00095147|528894958|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
146649845|NCT00095147|528894954|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
146649846|NCT00095147|528894955|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
146649847|NCT00095147|528894956|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
146649848|NCT00095147|528894957|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
146649849|NCT00095147|528894958|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
146649850|NCT00095147|528894954|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
146649851|NCT00095147|528894955|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
146649852|NCT00095147|528894956|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
146649853|NCT00095147|528894957|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
146649854|NCT00095147|528894958|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
146649855|NCT00095147|528894954|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
146649856|NCT00095147|528894955|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
146649857|NCT00095147|528894956|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
146649858|NCT00095147|528894957|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
146649859|NCT00095147|528894958|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
146649860|NCT00095147|528894954|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
146649861|NCT00095147|528894955|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
146649862|NCT00095147|528894956|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
146649863|NCT00095147|528894957|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
146649864|NCT00095147|528894958|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
146649865|NCT00095147|528894954|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
146649866|NCT00095147|528894955|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
146649867|NCT00095147|528894956|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
146649868|NCT00095147|528894957|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
146649869|NCT00095147|528894958|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
146649870|NCT00095147|528894954|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
146649871|NCT00095147|528894955|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
146649872|NCT00095147|528894956|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
146649873|NCT00095147|528894957|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
146649874|NCT00095147|528894958|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
146649875|NCT00095147|528894954|FG000|Long-term Extension Period|Death|0|||
146649876|NCT00095147|528894955|FG001|Long-term Extension Period|Death|0|||
146649877|NCT00095147|528894956|FG002|Long-term Extension Period|Death|0|||
146649878|NCT00095147|528894957|FG003|Long-term Extension Period|Death|0|||
146649879|NCT00095147|528894958|FG004|Long-term Extension Period|Death|3|||
146649880|NCT00095147|528894954|FG000|Long-term Extension Period|Adverse Event|0|||
146649881|NCT00095147|528894955|FG001|Long-term Extension Period|Adverse Event|0|||
146649882|NCT00095147|528894956|FG002|Long-term Extension Period|Adverse Event|0|||
146649883|NCT00095147|528894957|FG003|Long-term Extension Period|Adverse Event|0|||
146649884|NCT00095147|528894958|FG004|Long-term Extension Period|Adverse Event|11|||
146649885|NCT00095147|528894954|FG000|Long-term Extension Period|Lack of Efficacy|0|||
146649886|NCT00095147|528894955|FG001|Long-term Extension Period|Lack of Efficacy|0|||
146649887|NCT00095147|528894956|FG002|Long-term Extension Period|Lack of Efficacy|0|||
146649888|NCT00095147|528894957|FG003|Long-term Extension Period|Lack of Efficacy|0|||
146507945|NCT04322539|528364510|FG000|Overall Study|Adverse Event|2|||
146507946|NCT04322539|528364511|FG001|Overall Study|Adverse Event|0|||
146912887|NCT00394914|529843214|FG000|Treatment Period|Adverse Event|0|||
146912888|NCT00394914|529843215|FG001|Treatment Period|Adverse Event|3|||
146507947|NCT04322539|528364510|FG000|Overall Study|Death|411|||
146507948|NCT04322539|528364511|FG001|Overall Study|Death|203|||
146912889|NCT00394914|529843216|FG002|Treatment Period|Adverse Event|1|||
146507949|NCT04322539|528364510|FG000|Overall Study|Lost to Follow-up|3|||
146769851|NCT04956575|529326604|FG004|Overall Study|Withdrawal by Subject|2|||
146912890|NCT00394914|529843214|FG000|Treatment Period|Lost to Follow-up|0|||
146507950|NCT04322539|528364511|FG001|Overall Study|Lost to Follow-up|1|||
146649889|NCT00095147|528894958|FG004|Long-term Extension Period|Lack of Efficacy|9|||
146649890|NCT00095147|528894954|FG000|Long-term Extension Period|Lost to Follow-up|0|||
146649891|NCT00095147|528894955|FG001|Long-term Extension Period|Lost to Follow-up|0|||
146649892|NCT00095147|528894956|FG002|Long-term Extension Period|Lost to Follow-up|0|||
146649893|NCT00095147|528894957|FG003|Long-term Extension Period|Lost to Follow-up|0|||
146649894|NCT00095147|528894958|FG004|Long-term Extension Period|Lost to Follow-up|6|||
146649895|NCT00095147|528894954|FG000|Long-term Extension Period|Withdrawal of consent|0|||
146649896|NCT00095147|528894955|FG001|Long-term Extension Period|Withdrawal of consent|0|||
146649897|NCT00095147|528894956|FG002|Long-term Extension Period|Withdrawal of consent|0|||
146649898|NCT00095147|528894957|FG003|Long-term Extension Period|Withdrawal of consent|0|||
146649899|NCT00095147|528894958|FG004|Long-term Extension Period|Withdrawal of consent|12|||
146649900|NCT00095147|528894954|FG000|Long-term Extension Period|Pregnancy|0|||
146649901|NCT00095147|528894955|FG001|Long-term Extension Period|Pregnancy|0|||
146649902|NCT00095147|528894956|FG002|Long-term Extension Period|Pregnancy|0|||
146649903|NCT00095147|528894957|FG003|Long-term Extension Period|Pregnancy|0|||
146649904|NCT00095147|528894958|FG004|Long-term Extension Period|Pregnancy|1|||
146649905|NCT00095147|528894954|FG000|Long-term Extension Period|No longer meets study criteria|0|||
146649906|NCT00095147|528894955|FG001|Long-term Extension Period|No longer meets study criteria|0|||
146649907|NCT00095147|528894956|FG002|Long-term Extension Period|No longer meets study criteria|0|||
146649908|NCT00095147|528894957|FG003|Long-term Extension Period|No longer meets study criteria|0|||
146649909|NCT00095147|528894958|FG004|Long-term Extension Period|No longer meets study criteria|1|||
146649910|NCT00095147|528894954|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
146649911|NCT00095147|528894955|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
146649912|NCT00095147|528894956|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
146649913|NCT00095147|528894957|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
146649914|NCT00095147|528894958|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
146649915|NCT00095147|528894954|FG000|Long-term Extension Period|Leaving country|0|||
146649916|NCT00095147|528894955|FG001|Long-term Extension Period|Leaving country|0|||
146649917|NCT00095147|528894956|FG002|Long-term Extension Period|Leaving country|0|||
146649918|NCT00095147|528894957|FG003|Long-term Extension Period|Leaving country|0|||
146649919|NCT00095147|528894958|FG004|Long-term Extension Period|Leaving country|1|||
146649920|NCT02395302|528894959|FG000|Overall Study|Screen Failure|3|||
146649921|NCT02395302|528894959|FG000|Overall Study|Run In Failure|7|||
146649922|NCT02395302|528894959|FG000|Overall Study|Withdrawal by Subject|2|||
146649923|NCT02395302|528894959|FG000|Overall Study|Physician Decision|2|||
146649924|NCT02650921|528894960|FG000|Overall Study|Withdrawal by Subject|4|||
146649925|NCT02650921|528894960|FG000|Overall Study|Lost to Follow-up|2|||
146769852|NCT04956575|529326605|FG005|Overall Study|Withdrawal by Subject|8|||
146769853|NCT04956575|529326606|FG006|Overall Study|Withdrawal by Subject|5|||
146769854|NCT04956575|529326607|FG007|Overall Study|Withdrawal by Subject|1|||
146649926|NCT02650921|528894960|FG000|Overall Study|Adverse Event|1|||
146649927|NCT02650921|528894960|FG000|Overall Study|Due to Medical Condition|1|||
146769855|NCT04956575|529326608|FG008|Overall Study|Withdrawal by Subject|1|||
146769856|NCT04956575|529326609|FG009|Overall Study|Withdrawal by Subject|0|||
146769857|NCT04956575|529326610|FG010|Overall Study|Withdrawal by Subject|3|||
146649928|NCT00783302|528894961|FG000|Overall Study|Lost to Follow-up|17|||
146649929|NCT00783302|528894961|FG000|Overall Study|Technical Problems|11|||
146649930|NCT00783302|528894961|FG000|Overall Study|Protocol Violation|3|||
146649931|NCT00783302|528894961|FG000|Overall Study|Physician Decision|1|||
146649932|NCT00783302|528894961|FG000|Overall Study|Withdrawal by Subject|3|||
146649933|NCT00160667|528894962|FG000|Overall Study|Adverse Event|3|||
146649934|NCT00160667|528894963|FG001|Overall Study|Adverse Event|1|||
146649935|NCT00160667|528894964|FG002|Overall Study|Adverse Event|4|||
146649936|NCT00160667|528894962|FG000|Overall Study|Withdrawal by Subject|2|||
146649937|NCT00160667|528894963|FG001|Overall Study|Withdrawal by Subject|0|||
146649938|NCT00160667|528894964|FG002|Overall Study|Withdrawal by Subject|1|||
146649939|NCT00160667|528894962|FG000|Overall Study|Lack of Efficacy|0|||
146649940|NCT00160667|528894963|FG001|Overall Study|Lack of Efficacy|1|||
146649941|NCT00160667|528894964|FG002|Overall Study|Lack of Efficacy|0|||
146649942|NCT00160667|528894962|FG000|Overall Study|Protocol Violation|0|||
146649943|NCT00160667|528894963|FG001|Overall Study|Protocol Violation|1|||
146649944|NCT00160667|528894964|FG002|Overall Study|Protocol Violation|0|||
146649945|NCT00160667|528894962|FG000|Overall Study|Patient decision|0|||
146649946|NCT00160667|528894963|FG001|Overall Study|Patient decision|0|||
146649947|NCT00160667|528894964|FG002|Overall Study|Patient decision|1|||
146769858|NCT04956575|529326611|FG011|Overall Study|Withdrawal by Subject|1|||
146649948|NCT01917656|528894968|FG000|Overall Study|Adverse Event|11|||
146649949|NCT01917656|528894969|FG001|Overall Study|Adverse Event|0|||
146649950|NCT01917656|528894968|FG000|Overall Study|Withdrawal criteria|8|||
146649951|NCT01917656|528894969|FG001|Overall Study|Withdrawal criteria|14|||
146649952|NCT01917656|528894968|FG000|Overall Study|Unclassified|0|||
146649953|NCT01917656|528894969|FG001|Overall Study|Unclassified|3|||
146649954|NCT01917656|528894968|FG000|Overall Study|Withdrawal by Subject|4|||
146769859|NCT03593876|529326612|FG000|Overall Study|Withdrawal by Subject|1|||
146912891|NCT00394914|529843215|FG001|Treatment Period|Lost to Follow-up|1|||
146912892|NCT00394914|529843216|FG002|Treatment Period|Lost to Follow-up|0|||
146912893|NCT00394914|529843214|FG000|Treatment Period|Withdrawal by Subject|0|||
146912894|NCT00394914|529843215|FG001|Treatment Period|Withdrawal by Subject|2|||
146912895|NCT00394914|529843216|FG002|Treatment Period|Withdrawal by Subject|2|||
146912896|NCT00394914|529843214|FG000|Treatment Period|Noncompliance with protocol|0|||
146912897|NCT00394914|529843215|FG001|Treatment Period|Noncompliance with protocol|3|||
146912898|NCT00394914|529843216|FG002|Treatment Period|Noncompliance with protocol|2|||
146912899|NCT00394914|529843214|FG000|Treatment Period|Did not meet protocol eligibility|0|||
146912900|NCT00394914|529843215|FG001|Treatment Period|Did not meet protocol eligibility|1|||
146912901|NCT00394914|529843216|FG002|Treatment Period|Did not meet protocol eligibility|1|||
146912902|NCT00312377|529843220|FG000|Overall Study|Death|403|||
146912903|NCT00312377|529843221|FG001|Overall Study|Death|418|||
146912904|NCT00312377|529843220|FG000|Overall Study|Withdrawal by Subject|23|||
146912905|NCT00312377|529843221|FG001|Overall Study|Withdrawal by Subject|30|||
146912906|NCT00312377|529843220|FG000|Overall Study|Lost to Follow-up|9|||
146912907|NCT00312377|529843221|FG001|Overall Study|Lost to Follow-up|12|||
146912908|NCT00312377|529843220|FG000|Overall Study|Non-compliance|0|||
146912909|NCT00312377|529843221|FG001|Overall Study|Non-compliance|2|||
146912910|NCT00312377|529843220|FG000|Overall Study|Randomised but never received treatment|6|||
146912911|NCT00312377|529843221|FG001|Overall Study|Randomised but never received treatment|6|||
146912912|NCT00312377|529843220|FG000|Overall Study|Discontinue treatment survival follow up|202|||
146912913|NCT00312377|529843221|FG001|Overall Study|Discontinue treatment survival follow up|200|||
146507951|NCT04322539|528364510|FG000|Overall Study|Withdrawal of consent|14|||
146507952|NCT04322539|528364511|FG001|Overall Study|Withdrawal of consent|8|||
146649955|NCT01917656|528894969|FG001|Overall Study|Withdrawal by Subject|3|||
146649956|NCT01917656|528894968|FG000|Overall Study|Lost to Follow-up|3|||
146649957|NCT01917656|528894969|FG001|Overall Study|Lost to Follow-up|4|||
146507953|NCT04322539|528364510|FG000|Overall Study|Radiological Disease Progression|6|||
146507954|NCT04322539|528364511|FG001|Overall Study|Radiological Disease Progression|0|||
146507955|NCT04322539|528364510|FG000|Overall Study|Sponsor Decision|19|||
146507956|NCT04322539|528364511|FG001|Overall Study|Sponsor Decision|14|||
146507957|NCT04322539|528364510|FG000|Overall Study|Other|6|||
146507958|NCT04322539|528364511|FG001|Overall Study|Other|4|||
146507959|NCT03617861|528364512|FG000|Second Intervention (1 Day)|Adverse Event|0|||
146507960|NCT03617861|528364513|FG001|Second Intervention (1 Day)|Adverse Event|0|||
146507961|NCT03617861|528364514|FG002|Second Intervention (1 Day)|Adverse Event|1|||
146507962|NCT03617861|528364515|FG003|Second Intervention (1 Day)|Adverse Event|0|||
146507963|NCT00623597|528364516|FG000|Overall Study|Failed to return|1|||
146507964|NCT00623597|528364517|FG001|Overall Study|Failed to return|0|||
146507965|NCT02963558|528364520|FG000|Overall Study|Withdrawn by investigator|1|||
146507966|NCT02963558|528364521|FG001|Overall Study|Withdrawn by investigator|0|||
146507967|NCT02963558|528364520|FG000|Overall Study|Withdrawal by Subject|0|||
146507968|NCT02963558|528364521|FG001|Overall Study|Withdrawal by Subject|1|||
146507969|NCT02339155|528364522|FG000|Overall Study|Adverse Event|0|||
146507970|NCT02339155|528364523|FG001|Overall Study|Adverse Event|6|||
146507971|NCT02339155|528364522|FG000|Overall Study|Death|1|||
146507972|NCT02339155|528364523|FG001|Overall Study|Death|1|||
146507973|NCT02339155|528364522|FG000|Overall Study|Lost to Follow-up|8|||
146507974|NCT02339155|528364523|FG001|Overall Study|Lost to Follow-up|9|||
146507975|NCT02339155|528364522|FG000|Overall Study|Physician Decision|2|||
146507976|NCT02339155|528364523|FG001|Overall Study|Physician Decision|1|||
146507977|NCT02339155|528364522|FG000|Overall Study|Withdrawal by Subject|4|||
146507978|NCT02339155|528364523|FG001|Overall Study|Withdrawal by Subject|4|||
146507979|NCT03226678|528364524|FG000|Part A (Core Study Phase)|Adverse Event|0|||
146507980|NCT03226678|528364525|FG001|Part A (Core Study Phase)|Adverse Event|1|||
146507981|NCT03226678|528364526|FG002|Part A (Core Study Phase)|Adverse Event|0|||
146507982|NCT03226678|528364527|FG003|Part A (Core Study Phase)|Adverse Event|0|||
146507983|NCT03226678|528364528|FG004|Part A (Core Study Phase)|Adverse Event|0|||
146507984|NCT03226678|528364529|FG005|Part A (Core Study Phase)|Adverse Event|0|||
146507985|NCT03226678|528364524|FG000|Part A (Core Study Phase)|Death|0|||
146649958|NCT02285062|528894970|FG000|Pre-Treatment Period|Protocol Violation|0|||
146649959|NCT02285062|528894971|FG001|Pre-Treatment Period|Protocol Violation|2|||
146649960|NCT02285062|528894970|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
146649961|NCT02285062|528894971|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
146649962|NCT02015221|528894972|FG000|Overall Study|Withdrawal by Subject|8|||
146649963|NCT02015221|528894973|FG001|Overall Study|Withdrawal by Subject|6|||
146649964|NCT02015221|528894972|FG000|Overall Study|Lost to Follow-up|1|||
146912914|NCT00312377|529843220|FG000|Overall Study|Site ended participation in study|1|||
146507986|NCT03226678|528364525|FG001|Part A (Core Study Phase)|Death|0|||
146507987|NCT03226678|528364526|FG002|Part A (Core Study Phase)|Death|1|||
146507988|NCT03226678|528364527|FG003|Part A (Core Study Phase)|Death|0|||
146507989|NCT03226678|528364528|FG004|Part A (Core Study Phase)|Death|0|||
146507990|NCT03226678|528364529|FG005|Part A (Core Study Phase)|Death|0|||
146912915|NCT00312377|529843221|FG001|Overall Study|Site ended participation in study|0|||
146649965|NCT02015221|528894973|FG001|Overall Study|Lost to Follow-up|0|||
146507991|NCT03226678|528364524|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
146507992|NCT03226678|528364525|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
146507993|NCT03226678|528364526|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
146974474|NCT01682512|530069551|FG002|Overall Study|Secondary lack of efficacy|0|||
146974475|NCT01682512|530069549|FG000|Overall Study|Other than stated above|2|||
146974476|NCT01682512|530069550|FG001|Overall Study|Other than stated above|4|||
146974477|NCT01682512|530069551|FG002|Overall Study|Other than stated above|2|||
146974478|NCT01377233|530069552|FG000|Open-label|Adverse Event|1|||
146974479|NCT01377233|530069553|FG001|Open-label|Adverse Event|0|||
146974480|NCT01377233|530069554|FG002|Open-label|Adverse Event|0|||
146974481|NCT01377233|530069555|FG003|Open-label|Adverse Event|0|||
146974482|NCT01377233|530069556|FG004|Open-label|Adverse Event|0|||
146974483|NCT01377233|530069552|FG000|Open-label|Withdrawal by Subject|3|||
146974484|NCT01377233|530069553|FG001|Open-label|Withdrawal by Subject|0|||
146974485|NCT01377233|530069554|FG002|Open-label|Withdrawal by Subject|0|||
146974486|NCT01377233|530069555|FG003|Open-label|Withdrawal by Subject|0|||
146507994|NCT03226678|528364527|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
146507995|NCT03226678|528364528|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
146507996|NCT03226678|528364529|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
146507997|NCT03226678|528364524|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
146507998|NCT03226678|528364525|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
146507999|NCT03226678|528364526|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
146508000|NCT03226678|528364527|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
146508001|NCT03226678|528364528|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
146508002|NCT03226678|528364529|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
146508003|NCT03226678|528364524|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
146508004|NCT03226678|528364525|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
146508005|NCT03226678|528364526|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
146508006|NCT03226678|528364527|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
146508007|NCT03226678|528364528|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
146508008|NCT03226678|528364529|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
146508009|NCT03226678|528364524|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
146508010|NCT03226678|528364525|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
146508011|NCT03226678|528364526|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
146508012|NCT03226678|528364527|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
146508013|NCT03226678|528364528|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
146508014|NCT03226678|528364529|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
146508015|NCT03226678|528364524|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
146508016|NCT03226678|528364525|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
146508017|NCT03226678|528364526|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
146508018|NCT03226678|528364527|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
146508019|NCT03226678|528364528|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
146508020|NCT03226678|528364529|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
146508021|NCT03226678|528364524|FG000|Part B (Long-Term Extension Phase)|Death|0|||
146567997|NCT00508482|528591707|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
146567998|NCT00508482|528591708|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
146567999|NCT00508482|528591706|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
146568000|NCT00508482|528591707|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
146568001|NCT00508482|528591708|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
146568002|NCT00508482|528591706|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
146568003|NCT00508482|528591707|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
146568004|NCT00508482|528591708|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
146568005|NCT02850978|528591715|FG000|Overall Study|Uncollectable CRF|27|||
146568006|NCT02850978|528591715|FG000|Overall Study|No visit since the first visit|35|||
146568007|NCT02850978|528591715|FG000|Overall Study|Adverse Event|81|||
146568008|NCT02850978|528591715|FG000|Overall Study|Lack of Efficacy|40|||
146568009|NCT02850978|528591715|FG000|Overall Study|Improvement in condition|34|||
146568010|NCT02850978|528591715|FG000|Overall Study|Lost to Follow-up|121|||
146568011|NCT02850978|528591715|FG000|Overall Study|Reason not listed|88|||
146568012|NCT00570713|528591716|FG000|Overall Study|Adverse Event|16|||
146568013|NCT00570713|528591717|FG001|Overall Study|Adverse Event|9|||
146568014|NCT00570713|528591716|FG000|Overall Study|Death|7|||
146568015|NCT00570713|528591717|FG001|Overall Study|Death|7|||
146568016|NCT00570713|528591716|FG000|Overall Study|Lack of Efficacy|40|||
146568017|NCT00570713|528591717|FG001|Overall Study|Lack of Efficacy|49|||
146568018|NCT00570713|528591716|FG000|Overall Study|Physician Decision|2|||
146568019|NCT00570713|528591717|FG001|Overall Study|Physician Decision|2|||
146568020|NCT00570713|528591716|FG000|Overall Study|Withdrawal by Subject|3|||
146568021|NCT00570713|528591717|FG001|Overall Study|Withdrawal by Subject|3|||
146568022|NCT00570713|528591716|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
146974487|NCT01377233|530069556|FG004|Open-label|Withdrawal by Subject|0|||
146974488|NCT01377233|530069552|FG000|Double-blind|Adverse Event|0|||
146974489|NCT01377233|530069553|FG001|Double-blind|Adverse Event|1|||
146649966|NCT01306929|528894974|FG000|Overall Study|Withdrawal by Subject|23|||
146649967|NCT01306929|528894974|FG000|Overall Study|Adverse Event|21|||
146649968|NCT01306929|528894974|FG000|Overall Study|Physician Decision|13|||
146649969|NCT01306929|528894974|FG000|Overall Study|Death|8|||
146649970|NCT01306929|528894974|FG000|Overall Study|Withdrawal by parent/guardian|5|||
146649971|NCT01306929|528894974|FG000|Overall Study|Protocol Violation|3|||
146649972|NCT01306929|528894974|FG000|Overall Study|Non-compliance with study drug|2|||
146649973|NCT01306929|528894974|FG000|Overall Study|Lost to Follow-up|2|||
146649974|NCT01306929|528894974|FG000|Overall Study|Various|17|||
146649975|NCT03709576|528894980|FG000|Overall Study|progression prior to enrollment|1|||
146649976|NCT03041129|528894984|FG000|Overall Study|Withdrawal by Subject|2|||
146649977|NCT03041129|528894985|FG001|Overall Study|Withdrawal by Subject|0|||
146649978|NCT03041129|528894986|FG002|Overall Study|Withdrawal by Subject|0|||
146649979|NCT03041129|528894987|FG003|Overall Study|Withdrawal by Subject|0|||
146649980|NCT00890045|528894990|FG000|Overall Study|Death|0|||
146649981|NCT00890045|528894991|FG001|Overall Study|Death|1|||
146649982|NCT00890045|528894990|FG000|Overall Study|Did not receive HeRO Graft|0|||
146649983|NCT00890045|528894991|FG001|Overall Study|Did not receive HeRO Graft|2|||
146649984|NCT00890045|528894990|FG000|Overall Study|Lost to Follow-up|5|||
146649985|NCT00890045|528894991|FG001|Overall Study|Lost to Follow-up|7|||
146649986|NCT00510653|528894992|FG000|Overall Study|Withdrawal by Subject|8|||
146912916|NCT05258058|529843224|FG000|Overall Study|Withdrawal by Subject|2|||
146912917|NCT02179398|529843227|FG000|Overall Study|Lack of obligatory data|3|||
146912918|NCT02179398|529843228|FG001|Overall Study|Lack of obligatory data|3|||
146912919|NCT02179398|529843227|FG000|Overall Study|Lost to Follow-up|0|||
146912920|NCT02179398|529843228|FG001|Overall Study|Lost to Follow-up|1|||
146912921|NCT02519231|529843234|FG000|Overall Study|Lost to Follow-up|2|||
146912922|NCT02519231|529843235|FG001|Overall Study|Lost to Follow-up|5|||
146912923|NCT02519231|529843234|FG000|Overall Study|Withdrawal by Subject|0|||
146912924|NCT02519231|529843235|FG001|Overall Study|Withdrawal by Subject|1|||
146649987|NCT00510653|528894992|FG000|Overall Study|Monetary|3|||
146649988|NCT00483756|528894995|FG000|Overall Study|Death|2|||
146649989|NCT00483756|528894996|FG001|Overall Study|Death|0|||
146649990|NCT00483756|528894997|FG002|Overall Study|Death|1|||
146649991|NCT00483756|528894995|FG000|Overall Study|Adverse Event|19|||
146649992|NCT00483756|528894996|FG001|Overall Study|Adverse Event|38|||
146649993|NCT00483756|528894997|FG002|Overall Study|Adverse Event|40|||
146649994|NCT00483756|528894995|FG000|Overall Study|Lack of Efficacy|1|||
146649995|NCT00483756|528894996|FG001|Overall Study|Lack of Efficacy|0|||
146649996|NCT00483756|528894997|FG002|Overall Study|Lack of Efficacy|0|||
146649997|NCT00483756|528894995|FG000|Overall Study|Lost to Follow-up|3|||
146649998|NCT00483756|528894996|FG001|Overall Study|Lost to Follow-up|1|||
146649999|NCT00483756|528894997|FG002|Overall Study|Lost to Follow-up|0|||
146650000|NCT00483756|528894995|FG000|Overall Study|Withdrawal by Subject|5|||
146650001|NCT00483756|528894996|FG001|Overall Study|Withdrawal by Subject|3|||
146912925|NCT00815308|529843236|FG000|Overall Study|Adverse Event|4|||
146912926|NCT00815308|529843236|FG000|Overall Study|Withdrawal by Subject|0|||
146912927|NCT00815308|529843236|FG000|Overall Study|Protocol Violation|6|||
146912928|NCT00734929|529843237|FG000|Overall Study|Lost to Follow-up|1|||
146912929|NCT00734929|529843238|FG001|Overall Study|Lost to Follow-up|2|||
146912930|NCT00734929|529843237|FG000|Overall Study|No intervention/ screen fail|5|||
146912931|NCT00734929|529843238|FG001|Overall Study|No intervention/ screen fail|3|||
146912932|NCT03314519|529845161|FG000|Overall Study|Protocol Violation|3|||
146912933|NCT03314519|529845162|FG001|Overall Study|Protocol Violation|2|||
146912934|NCT01912872|529845163|FG000|Overall Study|Lost to Follow-up|2|||
146912935|NCT01912872|529845164|FG001|Overall Study|Lost to Follow-up|3|||
146912936|NCT01912872|529845165|FG002|Overall Study|Lost to Follow-up|5|||
146912937|NCT01912872|529845166|FG003|Overall Study|Lost to Follow-up|5|||
146912938|NCT01912872|529845163|FG000|Overall Study|Other unspecified|3|||
146650002|NCT00483756|528894997|FG002|Overall Study|Withdrawal by Subject|4|||
146650003|NCT00483756|528894995|FG000|Overall Study|Other|2|||
146650004|NCT00483756|528894996|FG001|Overall Study|Other|4|||
146650005|NCT00483756|528894997|FG002|Overall Study|Other|3|||
146650006|NCT00483756|528894995|FG000|Overall Study|Randomized, Not Treated|1|||
146650007|NCT00483756|528894996|FG001|Overall Study|Randomized, Not Treated|4|||
146650008|NCT00483756|528894997|FG002|Overall Study|Randomized, Not Treated|4|||
146650009|NCT01947855|528894998|FG000|Overall Study|Withdrawal by Subject|1|||
146912939|NCT01912872|529845164|FG001|Overall Study|Other unspecified|1|||
146912940|NCT01912872|529845165|FG002|Overall Study|Other unspecified|3|||
146912941|NCT01912872|529845166|FG003|Overall Study|Other unspecified|0|||
146912942|NCT01912872|529845163|FG000|Overall Study|Informed consent withdrawn|0|||
146912943|NCT01912872|529845164|FG001|Overall Study|Informed consent withdrawn|0|||
146912944|NCT01912872|529845165|FG002|Overall Study|Informed consent withdrawn|1|||
146912945|NCT01912872|529845166|FG003|Overall Study|Informed consent withdrawn|1|||
146912946|NCT01912872|529845163|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
146912947|NCT01912872|529845164|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
146912948|NCT01912872|529845165|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
146912949|NCT01912872|529845166|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
146650010|NCT01947855|528894999|FG001|Overall Study|Withdrawal by Subject|0|||
146650011|NCT01947855|528895000|FG002|Overall Study|Withdrawal by Subject|0|||
146650012|NCT00436501|528895001|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
146650013|NCT00436501|528895002|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
146650014|NCT00436501|528895001|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
146650015|NCT00436501|528895002|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
146650016|NCT00495040|528895003|FG000|Overall Study|Withdrawal by Subject|3|||
146650017|NCT00621621|528895008|FG000|Overall Study|Subjects were exited at EP study|30|||
146650018|NCT00621621|528895009|FG001|Overall Study|Subjects were exited at EP study|0|||
146650019|NCT02282293|528895012|FG000|Overall Study|Lost to Follow-up|2|||
146912950|NCT01912872|529845163|FG000|Overall Study|Protocol Violation|0|||
146912951|NCT01912872|529845164|FG001|Overall Study|Protocol Violation|0|||
146912952|NCT01912872|529845165|FG002|Overall Study|Protocol Violation|1|||
146912953|NCT01912872|529845166|FG003|Overall Study|Protocol Violation|0|||
146912954|NCT01912872|529845163|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146650020|NCT02282293|528895013|FG001|Overall Study|Lost to Follow-up|2|||
146650021|NCT02282293|528895012|FG000|Overall Study|Unable to comply with study procedures|1|||
146650022|NCT02282293|528895013|FG001|Overall Study|Unable to comply with study procedures|0|||
146650023|NCT02282293|528895012|FG000|Overall Study|Moved out of study area|0|||
146650024|NCT02282293|528895013|FG001|Overall Study|Moved out of study area|1|||
146650025|NCT03011892|528895014|FG000|Double Blind (DB) Period|Adverse Event|0|||
146650026|NCT03011892|528895015|FG001|Double Blind (DB) Period|Adverse Event|1|||
146912955|NCT01912872|529845164|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146912956|NCT01912872|529845165|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146912957|NCT01912872|529845166|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
146912958|NCT01912872|529845163|FG000|Overall Study|Withdrawal of study medication|0|||
146912959|NCT01912872|529845164|FG001|Overall Study|Withdrawal of study medication|0|||
146912960|NCT01912872|529845165|FG002|Overall Study|Withdrawal of study medication|0|||
146912961|NCT01912872|529845166|FG003|Overall Study|Withdrawal of study medication|2|||
146912962|NCT01912872|529845163|FG000|Overall Study|Missing|0|||
146912963|NCT01912872|529845164|FG001|Overall Study|Missing|0|||
146912964|NCT01912872|529845165|FG002|Overall Study|Missing|0|||
146912965|NCT01912872|529845166|FG003|Overall Study|Missing|1|||
146912966|NCT01713036|529845169|FG000|Overall Study|Death|1|||
146912967|NCT00592358|529845170|FG000|Overall Study|Withdrawal by Subject|2|||
146912968|NCT00592358|529845170|FG000|Overall Study|Adverse Event|1|||
146912969|NCT00592358|529845170|FG000|Overall Study|Lack of Efficacy|2|||
146912970|NCT00592358|529845170|FG000|Overall Study|Inability to swallow pills|1|||
146912971|NCT01166659|529845171|FG000|Overall Study|Subject Decision|8|||
146912972|NCT01166659|529845171|FG000|Overall Study|Investigator Decision|2|||
146912973|NCT01166659|529845171|FG000|Overall Study|Death|1|||
146912974|NCT01166659|529845171|FG000|Overall Study|Lost to Follow-up|1|||
146912975|NCT01166659|529845171|FG000|Overall Study|Study Closed at Site|1|||
146912976|NCT04760314|529845174|FG000|Induction Period|Withdrawal by Subject|0|||
146912977|NCT04760314|529845175|FG001|Induction Period|Withdrawal by Subject|1|||
146912978|NCT04760314|529845176|FG002|Induction Period|Withdrawal by Subject|1|||
146912979|NCT04760314|529845177|FG003|Induction Period|Withdrawal by Subject|0|||
146912980|NCT04760314|529845178|FG004|Induction Period|Withdrawal by Subject|0|||
146912981|NCT04760314|529845179|FG005|Induction Period|Withdrawal by Subject|0|||
146912982|NCT04760314|529845180|FG006|Induction Period|Withdrawal by Subject|0|||
146912983|NCT04760314|529845181|FG007|Induction Period|Withdrawal by Subject|0|||
146912984|NCT04760314|529845182|FG008|Induction Period|Withdrawal by Subject|0|||
146912985|NCT04760314|529845183|FG009|Induction Period|Withdrawal by Subject|0|||
146912986|NCT04760314|529845184|FG010|Induction Period|Withdrawal by Subject|0|||
146912987|NCT04760314|529845174|FG000|Induction Period|Adverse Event|0|||
146912988|NCT04760314|529845175|FG001|Induction Period|Adverse Event|0|||
146912989|NCT04760314|529845176|FG002|Induction Period|Adverse Event|2|||
146912990|NCT04760314|529845177|FG003|Induction Period|Adverse Event|0|||
146912991|NCT04760314|529845178|FG004|Induction Period|Adverse Event|0|||
146912992|NCT04760314|529845179|FG005|Induction Period|Adverse Event|0|||
146912993|NCT04760314|529845180|FG006|Induction Period|Adverse Event|0|||
146912994|NCT04760314|529845181|FG007|Induction Period|Adverse Event|0|||
146912995|NCT04760314|529845182|FG008|Induction Period|Adverse Event|0|||
146912996|NCT04760314|529845183|FG009|Induction Period|Adverse Event|0|||
146912997|NCT04760314|529845184|FG010|Induction Period|Adverse Event|0|||
146912998|NCT04760314|529845174|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
146912999|NCT04760314|529845175|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
146913000|NCT04760314|529845176|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
146913001|NCT04760314|529845177|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
146913002|NCT04760314|529845178|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
146913003|NCT04760314|529845179|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
146913004|NCT04760314|529845180|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
146913005|NCT04760314|529845181|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
146650027|NCT03011892|528895016|FG002|Double Blind (DB) Period|Adverse Event|1|||
146650028|NCT03011892|528895017|FG003|Double Blind (DB) Period|Adverse Event|0|||
146913006|NCT04760314|529845182|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
146913007|NCT04760314|529845183|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
146913008|NCT04760314|529845184|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
146913009|NCT04760314|529845174|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
146913010|NCT04760314|529845175|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
146913011|NCT04760314|529845176|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
146913012|NCT04760314|529845177|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
146913013|NCT04760314|529845178|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
146913014|NCT04760314|529845179|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
146913015|NCT04760314|529845180|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
146913016|NCT04760314|529845181|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
146913017|NCT04760314|529845182|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
146913018|NCT04760314|529845183|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
146913019|NCT04760314|529845184|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
146913020|NCT04760314|529845174|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146913021|NCT04760314|529845175|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146913022|NCT04760314|529845176|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146913023|NCT04760314|529845177|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146913024|NCT04760314|529845178|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
146913025|NCT04760314|529845179|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146913026|NCT04760314|529845180|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146974490|NCT01377233|530069554|FG002|Double-blind|Adverse Event|2|||
146974491|NCT01377233|530069555|FG003|Double-blind|Adverse Event|2|||
146974492|NCT01377233|530069556|FG004|Double-blind|Adverse Event|0|||
146974493|NCT01377233|530069552|FG000|Double-blind|Protocol Violation|0|||
146974494|NCT01377233|530069553|FG001|Double-blind|Protocol Violation|0|||
146974495|NCT01377233|530069554|FG002|Double-blind|Protocol Violation|0|||
146974496|NCT01377233|530069555|FG003|Double-blind|Protocol Violation|0|||
146974497|NCT01377233|530069556|FG004|Double-blind|Protocol Violation|1|||
146974498|NCT01377233|530069552|FG000|Double-blind|Withdrawal by Subject|0|||
146974499|NCT01377233|530069553|FG001|Double-blind|Withdrawal by Subject|0|||
146974500|NCT01377233|530069554|FG002|Double-blind|Withdrawal by Subject|0|||
146974501|NCT01377233|530069555|FG003|Double-blind|Withdrawal by Subject|1|||
146974502|NCT01377233|530069556|FG004|Double-blind|Withdrawal by Subject|0|||
146974503|NCT01377233|530069552|FG000|Double-blind|Administrative or other|0|||
146974504|NCT01377233|530069553|FG001|Double-blind|Administrative or other|0|||
146974505|NCT01377233|530069554|FG002|Double-blind|Administrative or other|0|||
146974506|NCT01377233|530069555|FG003|Double-blind|Administrative or other|1|||
146974507|NCT01377233|530069556|FG004|Double-blind|Administrative or other|1|||
146974508|NCT01785875|530069557|FG000|Overall Study|Withdrawal by Subject|41|||
146974509|NCT01785875|530069558|FG001|Overall Study|Withdrawal by Subject|34|||
146974510|NCT01785875|530069559|FG002|Overall Study|Withdrawal by Subject|36|||
146974511|NCT01785875|530069557|FG000|Overall Study|Lost to Follow-up|19|||
146974512|NCT01785875|530069558|FG001|Overall Study|Lost to Follow-up|22|||
146974513|NCT01785875|530069559|FG002|Overall Study|Lost to Follow-up|6|||
146974514|NCT01785875|530069557|FG000|Overall Study|Death|27|||
146974515|NCT01785875|530069558|FG001|Overall Study|Death|16|||
146974516|NCT01785875|530069559|FG002|Overall Study|Death|7|||
146974517|NCT01785875|530069557|FG000|Overall Study|Sponsor Decision|0|||
146974518|NCT01785875|530069558|FG001|Overall Study|Sponsor Decision|2|||
146974519|NCT01785875|530069559|FG002|Overall Study|Sponsor Decision|0|||
146974520|NCT01785875|530069557|FG000|Overall Study|Protocol Specified Criteria|207|||
146913027|NCT04760314|529845181|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146913028|NCT04760314|529845182|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146913029|NCT04760314|529845183|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146974521|NCT01785875|530069558|FG001|Overall Study|Protocol Specified Criteria|214|||
146974522|NCT01785875|530069559|FG002|Overall Study|Protocol Specified Criteria|55|||
146974523|NCT01785875|530069557|FG000|Overall Study|Missing|0|||
146974524|NCT01785875|530069558|FG001|Overall Study|Missing|1|||
146974525|NCT01785875|530069559|FG002|Overall Study|Missing|3|||
146974526|NCT00417027|530069562|FG000|Overall Study|Protocol Violation|0|||
146974527|NCT00417027|530069563|FG001|Overall Study|Protocol Violation|5|||
146974528|NCT00417027|530069564|FG002|Overall Study|Protocol Violation|5|||
146974529|NCT03137082|530069565|FG000|Overall Study|Withdrawal by Subject|1|||
146974530|NCT03137082|530069566|FG001|Overall Study|Withdrawal by Subject|1|||
146974531|NCT03137082|530069565|FG000|Overall Study|Lost to Follow-up|1|||
146974532|NCT03137082|530069566|FG001|Overall Study|Lost to Follow-up|0|||
146974533|NCT00707174|530069567|FG000|Overall Study|Adverse Event|1|||
146508022|NCT03226678|528364525|FG001|Part B (Long-Term Extension Phase)|Death|0|||
146508023|NCT03226678|528364526|FG002|Part B (Long-Term Extension Phase)|Death|0|||
146508024|NCT03226678|528364527|FG003|Part B (Long-Term Extension Phase)|Death|0|||
146508025|NCT03226678|528364528|FG004|Part B (Long-Term Extension Phase)|Death|0|||
146974534|NCT00707174|530069568|FG001|Overall Study|Adverse Event|6|||
146974535|NCT00707174|530069567|FG000|Overall Study|Withdrawal by Subject|4|||
146974536|NCT00707174|530069568|FG001|Overall Study|Withdrawal by Subject|1|||
146974537|NCT00544557|530069569|FG000|Overall Study|Adverse Event|140|||
146974538|NCT00544557|530069569|FG000|Overall Study|Lack of Efficacy|196|||
146974539|NCT00544557|530069569|FG000|Overall Study|Other|98|||
146974540|NCT04057118|530069570|FG000|Overall Study|Adverse Event|1|||
146974541|NCT04057118|530069571|FG001|Overall Study|Adverse Event|0|||
146974542|NCT04057118|530069572|FG002|Overall Study|Adverse Event|1|||
146974543|NCT04057118|530069573|FG003|Overall Study|Adverse Event|1|||
146974544|NCT04057118|530069570|FG000|Overall Study|Physician Decision|0|||
146974545|NCT04057118|530069571|FG001|Overall Study|Physician Decision|0|||
146974546|NCT04057118|530069572|FG002|Overall Study|Physician Decision|1|||
146974547|NCT04057118|530069573|FG003|Overall Study|Physician Decision|1|||
146974548|NCT04057118|530069570|FG000|Overall Study|Withdrawal by Subject|2|||
146974549|NCT04057118|530069571|FG001|Overall Study|Withdrawal by Subject|2|||
146974550|NCT04057118|530069572|FG002|Overall Study|Withdrawal by Subject|0|||
146974551|NCT04057118|530069573|FG003|Overall Study|Withdrawal by Subject|2|||
146974552|NCT04057118|530069570|FG000|Overall Study|Not Specific|0|||
146974553|NCT04057118|530069571|FG001|Overall Study|Not Specific|0|||
146974554|NCT04057118|530069572|FG002|Overall Study|Not Specific|1|||
146974555|NCT04057118|530069573|FG003|Overall Study|Not Specific|1|||
146974556|NCT04333199|530069581|FG000|Evaluated Patients|Lost to Follow-up|0|||
146974557|NCT04333199|530069582|FG001|Evaluated Patients|Lost to Follow-up|1|||
146974558|NCT04333199|530069583|FG002|Evaluated Patients|Lost to Follow-up|2|||
146974559|NCT00810615|530069589|FG000|Overall Study|Withdrawal by Subject|1|||
146974560|NCT00810615|530069590|FG001|Overall Study|Withdrawal by Subject|1|||
146974561|NCT02567266|530069591|FG000|Overall Study|Withdrawal by Subject|10|||
146974562|NCT02567266|530069592|FG001|Overall Study|Withdrawal by Subject|7|||
146974563|NCT02567266|530069593|FG002|Overall Study|Withdrawal by Subject|6|||
146508026|NCT03226678|528364529|FG005|Part B (Long-Term Extension Phase)|Death|1|||
146508027|NCT03226678|528364524|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
146568023|NCT00570713|528591717|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
146974564|NCT02567266|530069591|FG000|Overall Study|Lost to Follow-up|13|||
146974565|NCT02567266|530069592|FG001|Overall Study|Lost to Follow-up|8|||
146974566|NCT02567266|530069593|FG002|Overall Study|Lost to Follow-up|10|||
146974567|NCT02702271|530069597|FG000|Overall Study|Death|36|||
146974568|NCT02702271|530069598|FG001|Overall Study|Death|7|||
146974569|NCT02702271|530069597|FG000|Overall Study|Lost to Follow-up|12|||
146508028|NCT03226678|528364525|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
146508029|NCT03226678|528364526|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
146508030|NCT03226678|528364527|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
146508031|NCT03226678|528364528|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
146508032|NCT03226678|528364529|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
146508033|NCT03226678|528364524|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
146508034|NCT03226678|528364525|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
146508035|NCT03226678|528364526|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
146508036|NCT03226678|528364527|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
146508037|NCT03226678|528364528|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
146508038|NCT03226678|528364529|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
146508039|NCT03226678|528364524|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
146508040|NCT03226678|528364525|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
146508041|NCT03226678|528364526|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
146508042|NCT03226678|528364527|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
146508043|NCT03226678|528364528|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
146508044|NCT03226678|528364529|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
146508045|NCT03427268|528364534|FG000|Overall Study|Progressive disease|25|||
146508046|NCT03427268|528364534|FG000|Overall Study|Never treated|2|||
146508047|NCT03427268|528364534|FG000|Overall Study|Compassionate use|1|||
146508048|NCT03427268|528364534|FG000|Overall Study|Withdrawal by Subject|1|||
146508049|NCT03427268|528364534|FG000|Overall Study|Adverse Event|3|||
146508050|NCT00345878|528364538|FG000|Overall Study|Adverse Event|1|||
146508051|NCT00345878|528364539|FG001|Overall Study|Adverse Event|0|||
146508052|NCT00345878|528364538|FG000|Overall Study|Lost to Follow-up|2|||
146508053|NCT00345878|528364539|FG001|Overall Study|Lost to Follow-up|1|||
146508054|NCT00345878|528364538|FG000|Overall Study|Other|1|||
146508055|NCT00345878|528364539|FG001|Overall Study|Other|0|||
146508056|NCT01643798|528364540|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
146508057|NCT01643798|528364541|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
146508058|NCT02045732|528364547|FG000|Overall Study|At the discretion of the investigator|1|||
146508059|NCT02045732|528364548|FG001|Overall Study|At the discretion of the investigator|1|||
146508060|NCT01349322|528364549|FG000|Overall Study|Protocol Violation|45|||
146508061|NCT01349322|528364550|FG001|Overall Study|Protocol Violation|47|||
146974570|NCT02702271|530069598|FG001|Overall Study|Lost to Follow-up|0|||
146974571|NCT02702271|530069597|FG000|Overall Study|Withdrawal by Subject|8|||
146974572|NCT02702271|530069598|FG001|Overall Study|Withdrawal by Subject|1|||
146974573|NCT02702271|530069597|FG000|Overall Study|Physician Decision|2|||
146913030|NCT04760314|529845184|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146913031|NCT04760314|529845174|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
146913032|NCT04760314|529845175|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
146913033|NCT04760314|529845176|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
146913034|NCT04760314|529845177|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
146913035|NCT04760314|529845178|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
146913036|NCT04760314|529845179|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
146974574|NCT02702271|530069598|FG001|Overall Study|Physician Decision|0|||
146974575|NCT02702271|530069597|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
146974576|NCT02702271|530069598|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
146974577|NCT03091400|530069599|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
146974578|NCT03091400|530069600|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
146974579|NCT05789420|530069601|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
146974580|NCT05789420|530069601|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
146974581|NCT05473247|530069602|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
146974582|NCT02340078|530069608|FG000|Overall Study|Protocol Violation|1|||
146974583|NCT01831596|530069609|FG000|Overall Study|Other|8|||
146974584|NCT01311505|530069610|FG000|First Intervention Period|Protocol Violation|0|||
146974585|NCT01311505|530069611|FG001|First Intervention Period|Protocol Violation|1|||
146974586|NCT00446134|530069612|FG000|Overall Study|Adverse Event|7|||
146974587|NCT00446134|530069613|FG001|Overall Study|Adverse Event|17|||
146974588|NCT00446134|530069614|FG002|Overall Study|Adverse Event|13|||
146974589|NCT00446134|530069615|FG003|Overall Study|Adverse Event|18|||
146974590|NCT00446134|530069612|FG000|Overall Study|Lack of Efficacy|19|||
146974591|NCT00446134|530069613|FG001|Overall Study|Lack of Efficacy|19|||
146508062|NCT05014815|528364551|FG000|Overall Study|Death|63|||
146508063|NCT05014815|528364552|FG001|Overall Study|Death|70|||
146508064|NCT05014815|528364551|FG000|Overall Study|Withdrawal by Subject|10|||
146508065|NCT05014815|528364552|FG001|Overall Study|Withdrawal by Subject|10|||
146508066|NCT05014815|528364551|FG000|Overall Study|Lost to Follow-up|4|||
146508067|NCT05014815|528364552|FG001|Overall Study|Lost to Follow-up|2|||
146508068|NCT05014815|528364551|FG000|Overall Study|Physician Decision|2|||
146508069|NCT05014815|528364552|FG001|Overall Study|Physician Decision|4|||
146508070|NCT04247880|528364553|FG000|Overall Study|Lost to Follow-up|24|||
146508071|NCT04247880|528364554|FG001|Overall Study|Lost to Follow-up|17|||
146508072|NCT04247880|528364553|FG000|Overall Study|Withdrawal by Subject|3|||
146508073|NCT04247880|528364554|FG001|Overall Study|Withdrawal by Subject|0|||
146508074|NCT06303167|528364559|FG000|Overall Study|Ineligible|1|||
146508075|NCT06303167|528364559|FG000|Overall Study|Never start protocol therapy|2|||
146508076|NCT06303167|528364559|FG000|Overall Study|Disease progression|16|||
146508077|NCT04076059|528364562|FG000|Double Blind Phase|Progressive disease|22|||
146508078|NCT04076059|528364563|FG001|Double Blind Phase|Progressive disease|26|||
146508079|NCT04076059|528364564|FG002|Double Blind Phase|Progressive disease|0|||
146508080|NCT04076059|528364562|FG000|Double Blind Phase|Withdrawal by Subject|4|||
146508081|NCT04076059|528364563|FG001|Double Blind Phase|Withdrawal by Subject|11|||
146508082|NCT04076059|528364564|FG002|Double Blind Phase|Withdrawal by Subject|0|||
146508083|NCT04076059|528364562|FG000|Double Blind Phase|Death|1|||
146508084|NCT04076059|528364563|FG001|Double Blind Phase|Death|1|||
146508085|NCT04076059|528364564|FG002|Double Blind Phase|Death|0|||
146508086|NCT04076059|528364562|FG000|Double Blind Phase|Lost to Follow-up|1|||
146508087|NCT04076059|528364563|FG001|Double Blind Phase|Lost to Follow-up|0|||
146508088|NCT04076059|528364564|FG002|Double Blind Phase|Lost to Follow-up|0|||
146508089|NCT04076059|528364562|FG000|Double Blind Phase|Adverse Event|5|||
146508090|NCT04076059|528364563|FG001|Double Blind Phase|Adverse Event|1|||
146508091|NCT04076059|528364564|FG002|Double Blind Phase|Adverse Event|0|||
146508092|NCT04076059|528364562|FG000|Double Blind Phase|Ongoing Participants|82|||
146508093|NCT04076059|528364563|FG001|Double Blind Phase|Ongoing Participants|18|||
146568024|NCT02765399|528591720|FG000|Overall Study|Nausea|1|||
146568025|NCT02765399|528591721|FG001|Overall Study|Nausea|0|||
146568026|NCT00120627|528591726|FG000|Overall Study|Withdrawal by Subject|5|||
146568027|NCT00120627|528591727|FG001|Overall Study|Withdrawal by Subject|5|||
146568028|NCT04016714|528591728|FG000|Overall Study|Death|1|||
146568029|NCT04016714|528591729|FG001|Overall Study|Death|0|||
146568030|NCT04016714|528591728|FG000|Overall Study|Lost to Follow-up|3|||
146568031|NCT04016714|528591729|FG001|Overall Study|Lost to Follow-up|1|||
146568032|NCT04016714|528591728|FG000|Overall Study|Physician Decision|3|||
146568033|NCT04016714|528591729|FG001|Overall Study|Physician Decision|3|||
146568034|NCT04016714|528591728|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
146568035|NCT04016714|528591729|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
146568036|NCT01677988|528591734|FG000|Overall Study|Lack of Efficacy|2|||
146508094|NCT04076059|528364564|FG002|Double Blind Phase|Ongoing Participants|0|||
146508095|NCT04076059|528364562|FG000|Double Blind Phase|Miscellaneous|3|||
146568037|NCT01822665|528591738|FG000|Overall Study|Adverse Event|3|||
146568038|NCT01822665|528591738|FG000|Overall Study|Other Reason|5|||
146568039|NCT00271544|528591739|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
146568040|NCT00271544|528591739|FG000|Overall Study|Model 4196 lead not attempted|9|||
146974592|NCT00446134|530069614|FG002|Overall Study|Lack of Efficacy|24|||
146974593|NCT00446134|530069615|FG003|Overall Study|Lack of Efficacy|19|||
146974594|NCT00446134|530069612|FG000|Overall Study|Protocol Violation|0|||
146913037|NCT04760314|529845180|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
146913038|NCT04760314|529845181|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
146913039|NCT04760314|529845182|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
146913040|NCT04760314|529845183|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
146913041|NCT04760314|529845184|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
146913042|NCT04760314|529845174|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146913043|NCT04760314|529845175|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146913044|NCT04760314|529845176|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146913045|NCT04760314|529845177|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146913046|NCT04760314|529845178|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146913047|NCT04760314|529845179|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146913048|NCT04760314|529845180|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146913049|NCT04760314|529845181|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
146913050|NCT04760314|529845182|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146913051|NCT04760314|529845183|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
146913052|NCT04760314|529845184|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
146913053|NCT04760314|529845174|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146913054|NCT04760314|529845175|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146913055|NCT04760314|529845176|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146913056|NCT04760314|529845177|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146913057|NCT04760314|529845178|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146913058|NCT04760314|529845179|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146913059|NCT04760314|529845180|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146913060|NCT04760314|529845181|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
146913061|NCT04760314|529845182|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
146913062|NCT04760314|529845183|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
146913063|NCT04760314|529845184|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146913064|NCT04760314|529845174|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146913065|NCT04760314|529845175|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146913066|NCT04760314|529845176|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146913067|NCT04760314|529845177|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146913068|NCT04760314|529845178|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146913069|NCT04760314|529845179|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146913070|NCT04760314|529845180|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146913071|NCT04760314|529845181|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
146913072|NCT04760314|529845182|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146913073|NCT04760314|529845183|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146913074|NCT04760314|529845184|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146913075|NCT04760314|529845174|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
146913076|NCT04760314|529845175|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
146913077|NCT04760314|529845176|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
146913078|NCT04760314|529845177|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
146913079|NCT04760314|529845178|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
146913080|NCT04760314|529845179|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
146913081|NCT04760314|529845180|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
146913082|NCT04760314|529845181|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
146913083|NCT04760314|529845182|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
146913084|NCT04760314|529845183|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
146913085|NCT04760314|529845184|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
146913086|NCT04275310|529845185|FG000|Overall Study|Non-randomized due to running out of funding|4|||
146913087|NCT04275310|529845186|FG001|Overall Study|Non-randomized due to running out of funding|0|||
146913088|NCT01097616|529845187|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
146913089|NCT01097616|529845188|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
146913090|NCT01097616|529845189|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
146974595|NCT00446134|530069613|FG001|Overall Study|Protocol Violation|2|||
146974596|NCT00446134|530069614|FG002|Overall Study|Protocol Violation|1|||
146974597|NCT00446134|530069615|FG003|Overall Study|Protocol Violation|0|||
146974598|NCT00446134|530069612|FG000|Overall Study|Lost to Follow-up|1|||
146974599|NCT00446134|530069613|FG001|Overall Study|Lost to Follow-up|3|||
146974600|NCT00446134|530069614|FG002|Overall Study|Lost to Follow-up|1|||
146974601|NCT00446134|530069615|FG003|Overall Study|Lost to Follow-up|1|||
146974602|NCT00446134|530069612|FG000|Overall Study|Withdrawal by Subject|3|||
146974603|NCT00446134|530069613|FG001|Overall Study|Withdrawal by Subject|3|||
146974604|NCT00446134|530069614|FG002|Overall Study|Withdrawal by Subject|1|||
146974605|NCT00446134|530069615|FG003|Overall Study|Withdrawal by Subject|3|||
146974606|NCT00446134|530069612|FG000|Overall Study|Physician Decision|0|||
146913091|NCT01097616|529845190|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146913092|NCT01097616|529845191|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146913093|NCT01097616|529845192|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146913094|NCT01097616|529845193|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146913095|NCT01097616|529845194|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146913096|NCT01097616|529845187|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
146913097|NCT01097616|529845188|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
146913098|NCT01097616|529845189|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
146913099|NCT01097616|529845190|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146913100|NCT01097616|529845191|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146913101|NCT01097616|529845192|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146913102|NCT01097616|529845193|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146913103|NCT01097616|529845194|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146913104|NCT01097616|529845187|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
146913105|NCT01097616|529845188|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
146974607|NCT00446134|530069613|FG001|Overall Study|Physician Decision|0|||
146974608|NCT00446134|530069614|FG002|Overall Study|Physician Decision|0|||
146974609|NCT00446134|530069615|FG003|Overall Study|Physician Decision|2|||
146974610|NCT00446134|530069612|FG000|Overall Study|Adverse Event-Diarrhea|1|||
146974611|NCT00446134|530069613|FG001|Overall Study|Adverse Event-Diarrhea|1|||
146974612|NCT00446134|530069614|FG002|Overall Study|Adverse Event-Diarrhea|2|||
146974613|NCT00446134|530069615|FG003|Overall Study|Adverse Event-Diarrhea|0|||
146974614|NCT00446134|530069612|FG000|Overall Study|Reason Not Completed|3|||
146974615|NCT00446134|530069613|FG001|Overall Study|Reason Not Completed|0|||
146974616|NCT00446134|530069614|FG002|Overall Study|Reason Not Completed|1|||
146974617|NCT00446134|530069615|FG003|Overall Study|Reason Not Completed|2|||
146974618|NCT00567996|530069619|FG000|Overall Study|Adverse Event|18|||
146974619|NCT00567996|530069620|FG001|Overall Study|Adverse Event|16|||
146974620|NCT00567996|530069621|FG002|Overall Study|Adverse Event|13|||
146974621|NCT00567996|530069619|FG000|Overall Study|Protocol Deviation|9|||
146974622|NCT00567996|530069620|FG001|Overall Study|Protocol Deviation|11|||
146508096|NCT04076059|528364563|FG001|Double Blind Phase|Miscellaneous|1|||
146650029|NCT03011892|528895018|FG004|Double Blind (DB) Period|Adverse Event|0|||
146913106|NCT01097616|529845189|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
146913107|NCT01097616|529845190|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146974623|NCT00567996|530069621|FG002|Overall Study|Protocol Deviation|13|||
146974624|NCT00567996|530069619|FG000|Overall Study|Withdrawal by Subject|8|||
146974625|NCT00567996|530069620|FG001|Overall Study|Withdrawal by Subject|12|||
146974626|NCT00567996|530069621|FG002|Overall Study|Withdrawal by Subject|22|||
146508097|NCT04076059|528364564|FG002|Double Blind Phase|Miscellaneous|0|||
146508098|NCT04076059|528364562|FG000|Double Blind Phase|Protocol Deviation|1|||
146508099|NCT04076059|528364563|FG001|Double Blind Phase|Protocol Deviation|1|||
146508100|NCT04076059|528364564|FG002|Double Blind Phase|Protocol Deviation|0|||
146508101|NCT04076059|528364562|FG000|Double Blind Phase|Did not take study drug|1|||
146508102|NCT04076059|528364563|FG001|Double Blind Phase|Did not take study drug|1|||
146508103|NCT04076059|528364564|FG002|Double Blind Phase|Did not take study drug|0|||
146508104|NCT04076059|528364562|FG000|Open Label Phase|Progressive disease|0|||
146508105|NCT04076059|528364563|FG001|Open Label Phase|Progressive disease|0|||
146508106|NCT04076059|528364564|FG002|Open Label Phase|Progressive disease|7|||
146508107|NCT04076059|528364562|FG000|Open Label Phase|Withdrawal by Subject|0|||
146508108|NCT04076059|528364563|FG001|Open Label Phase|Withdrawal by Subject|0|||
146508109|NCT04076059|528364564|FG002|Open Label Phase|Withdrawal by Subject|3|||
146508110|NCT04076059|528364562|FG000|Open Label Phase|Death|0|||
146508111|NCT04076059|528364563|FG001|Open Label Phase|Death|0|||
146508112|NCT04076059|528364564|FG002|Open Label Phase|Death|2|||
146508113|NCT04076059|528364562|FG000|Open Label Phase|Ongoing Participants|0|||
146508114|NCT04076059|528364563|FG001|Open Label Phase|Ongoing Participants|0|||
146508115|NCT04076059|528364564|FG002|Open Label Phase|Ongoing Participants|11|||
146508116|NCT02677896|528364565|FG000|Double Blind Period (up to 35 Months)|Death|117|||
146508117|NCT02677896|528364566|FG001|Double Blind Period (up to 35 Months)|Death|197|||
146508118|NCT02677896|528364565|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
146508119|NCT02677896|528364566|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
146508120|NCT02677896|528364565|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
146508121|NCT02677896|528364566|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
146508122|NCT02677896|528364565|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
146508123|NCT02677896|528364566|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
146508124|NCT02677896|528364565|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
146508125|NCT02677896|528364566|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
146508126|NCT02677896|528364565|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
146508127|NCT02677896|528364566|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
146769860|NCT03593876|529326612|FG000|Overall Study|Discharged home before intervention completion|2|||
146769861|NCT00854906|529326615|FG000|Overall Study|One person had no ocular history|1|||
146769862|NCT04527549|529326619|FG000|Overall Study|Withdrawal by Subject|1|||
146769863|NCT04527549|529326620|FG001|Overall Study|Withdrawal by Subject|1|||
146769864|NCT05764161|529326623|FG000|12-week DBVC Period|Lack of Efficacy|2|||
146769865|NCT05764161|529326624|FG001|12-week DBVC Period|Lack of Efficacy|1|||
146769866|NCT05764161|529326623|FG000|12-week DBVC Period|Lost to Follow-up|0|||
146769867|NCT05764161|529326624|FG001|12-week DBVC Period|Lost to Follow-up|2|||
146769868|NCT05764161|529326623|FG000|12-week DBVC Period|Protocol Violation|2|||
146769869|NCT05764161|529326624|FG001|12-week DBVC Period|Protocol Violation|4|||
146769870|NCT05764161|529326623|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
146769871|NCT05764161|529326624|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
146769872|NCT05764161|529326623|FG000|40-week OLE Period|Lack of Efficacy|0|||
146769873|NCT05764161|529326624|FG001|40-week OLE Period|Lack of Efficacy|1|||
146769874|NCT05764161|529326623|FG000|40-week OLE Period|Lost to Follow-up|1|||
146769875|NCT05764161|529326624|FG001|40-week OLE Period|Lost to Follow-up|4|||
146769876|NCT05764161|529326623|FG000|40-week OLE Period|Withdrawal by Subject|2|||
146769877|NCT05764161|529326624|FG001|40-week OLE Period|Withdrawal by Subject|7|||
146769878|NCT05764161|529326623|FG000|40-week OLE Period|Extended Travel|0|||
146769879|NCT05764161|529326624|FG001|40-week OLE Period|Extended Travel|1|||
146769880|NCT05764161|529326623|FG000|40-week OLE Period|Ongoing|66|||
146769881|NCT05764161|529326624|FG001|40-week OLE Period|Ongoing|59|||
146769882|NCT03718767|529326625|FG000|Overall Study|Declined to participate (before treatment started)|0|||
146769883|NCT03718767|529326626|FG001|Overall Study|Declined to participate (before treatment started)|0|||
146769884|NCT03718767|529326627|FG002|Overall Study|Declined to participate (before treatment started)|7|||
146769885|NCT03718767|529326625|FG000|Overall Study|Ineligible|0|||
146769886|NCT03718767|529326626|FG001|Overall Study|Ineligible|0|||
146769887|NCT03718767|529326627|FG002|Overall Study|Ineligible|17|||
146769888|NCT00831415|529326628|FG000|Overall Study|Adverse Event|14|||
146769889|NCT00831415|529326628|FG000|Overall Study|Failed to return|3|||
146769890|NCT00831415|529326628|FG000|Overall Study|Physician Decision|6|||
146769891|NCT00831415|529326628|FG000|Overall Study|Lost to Follow-up|9|||
146769892|NCT00831415|529326628|FG000|Overall Study|Protocol Violation|3|||
146769893|NCT00831415|529326628|FG000|Overall Study|Withdrawal by Subject|35|||
146769894|NCT00831415|529326628|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
146769895|NCT00831415|529326628|FG000|Overall Study|Death|1|||
146769896|NCT01290224|529326629|FG000|Overall Study|Adverse Event|1|||
146769897|NCT01290224|529326629|FG000|Overall Study|Refused Further Treatment|4|||
146769898|NCT05694065|529326630|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
146769899|NCT05694065|529326630|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
146769900|NCT05694065|529326630|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
146769901|NCT03861767|529326631|FG000|Overall Study|Withdrawal by Subject|2|||
146769902|NCT03861767|529326632|FG001|Overall Study|Withdrawal by Subject|1|||
146769903|NCT03861767|529326633|FG002|Overall Study|Withdrawal by Subject|0|||
146913108|NCT01097616|529845191|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146913109|NCT01097616|529845192|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146913110|NCT01097616|529845193|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146913111|NCT01097616|529845194|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146913112|NCT01097616|529845187|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
146913113|NCT01097616|529845188|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
146913114|NCT01097616|529845189|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146913115|NCT01097616|529845190|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146913116|NCT01097616|529845191|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146913117|NCT01097616|529845192|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146913118|NCT01097616|529845193|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146913119|NCT01097616|529845194|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146913120|NCT01097616|529845187|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
146913121|NCT01097616|529845188|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
146913122|NCT01097616|529845189|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
146913123|NCT01097616|529845190|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146913124|NCT01097616|529845191|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146913125|NCT01097616|529845192|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146913126|NCT01097616|529845193|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146913127|NCT01097616|529845194|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146913128|NCT01097616|529845187|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
146913129|NCT01097616|529845188|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
146913130|NCT01097616|529845189|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
146913131|NCT01097616|529845190|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
146769904|NCT03861767|529326634|FG003|Overall Study|Withdrawal by Subject|5|||
146769905|NCT03861767|529326635|FG004|Overall Study|Withdrawal by Subject|2|||
146913132|NCT01097616|529845191|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
146913133|NCT01097616|529845192|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
146913134|NCT01097616|529845193|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
146913135|NCT01097616|529845194|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
146913136|NCT01097616|529845187|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
146913137|NCT01097616|529845188|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
146913138|NCT01097616|529845189|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146913139|NCT01097616|529845190|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146508128|NCT02677896|528364565|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
146508129|NCT02677896|528364566|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
146508130|NCT02677896|528364565|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
146508131|NCT02677896|528364566|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
146508132|NCT02677896|528364565|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
146508133|NCT02677896|528364566|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
146508134|NCT02677896|528364565|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
146508135|NCT02677896|528364566|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
146508136|NCT02677896|528364565|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
146508137|NCT02677896|528364566|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
146508138|NCT02677896|528364565|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
146508139|NCT02677896|528364566|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
146508140|NCT02677896|528364565|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
146508141|NCT02677896|528364566|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
146508142|NCT02677896|528364565|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
146508143|NCT02677896|528364566|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
146508144|NCT03385304|528364572|FG000|Overall Study|Death|19|||
146508145|NCT03385304|528364573|FG001|Overall Study|Death|7|||
146508146|NCT03385304|528364572|FG000|Overall Study|Lost to Follow-up|17|||
146508147|NCT03385304|528364573|FG001|Overall Study|Lost to Follow-up|14|||
146508148|NCT03385304|528364572|FG000|Overall Study|Withdrawal by Subject|3|||
146508149|NCT03385304|528364573|FG001|Overall Study|Withdrawal by Subject|2|||
146508150|NCT03385304|528364572|FG000|Overall Study|Incarceration|2|||
146508151|NCT03385304|528364573|FG001|Overall Study|Incarceration|3|||
146508152|NCT01097421|528364574|FG000|Overall Study|Adverse Event|8|||
146508153|NCT01097421|528364574|FG000|Overall Study|Protocol Violation|2|||
146508154|NCT01097421|528364574|FG000|Overall Study|Lost to Follow-up|1|||
146508155|NCT01097421|528364574|FG000|Overall Study|Withdrawal by Subject|3|||
146508156|NCT01120249|528364577|FG000|Overall Study|No protocol treatment received|21|||
146508157|NCT01120249|528364578|FG001|Overall Study|No protocol treatment received|15|||
146508158|NCT01120249|528364577|FG000|Overall Study|Disease recurrence|107|||
146508159|NCT01120249|528364578|FG001|Overall Study|Disease recurrence|57|||
146508160|NCT01120249|528364577|FG000|Overall Study|Death|1|||
146508161|NCT01120249|528364578|FG001|Overall Study|Death|0|||
146508162|NCT01120249|528364577|FG000|Overall Study|Adverse Event|40|||
146508163|NCT01120249|528364578|FG001|Overall Study|Adverse Event|276|||
146508164|NCT01120249|528364577|FG000|Overall Study|Participant refusal|34|||
146508165|NCT01120249|528364578|FG001|Overall Study|Participant refusal|42|||
146508166|NCT01120249|528364577|FG000|Overall Study|Other reasons, not protocol specified|29|||
146508167|NCT01120249|528364578|FG001|Overall Study|Other reasons, not protocol specified|22|||
146508168|NCT01701193|528364579|FG000|Overall Study|Withdrawal by Subject|2|||
146508169|NCT01701193|528364580|FG001|Overall Study|Withdrawal by Subject|2|||
146508170|NCT01701193|528364581|FG002|Overall Study|Withdrawal by Subject|1|||
146508171|NCT01701193|528364582|FG003|Overall Study|Withdrawal by Subject|2|||
146508172|NCT01701193|528364579|FG000|Overall Study|Adverse Event|1|||
146508173|NCT01701193|528364580|FG001|Overall Study|Adverse Event|0|||
146508174|NCT01701193|528364581|FG002|Overall Study|Adverse Event|0|||
146508175|NCT01701193|528364582|FG003|Overall Study|Adverse Event|0|||
146508176|NCT02720744|528364583|FG000|Overall Study|Protocol Violation|0|||
146508177|NCT02720744|528364584|FG001|Overall Study|Protocol Violation|2|||
146508178|NCT02720744|528364583|FG000|Overall Study|Pregnancy|2|||
146508179|NCT02720744|528364584|FG001|Overall Study|Pregnancy|0|||
146568041|NCT00271544|528591739|FG000|Overall Study|Implant not attempted|4|||
146769906|NCT03861767|529326636|FG005|Overall Study|Withdrawal by Subject|1|||
146913140|NCT01097616|529845191|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146913141|NCT01097616|529845192|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146913142|NCT01097616|529845193|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146913143|NCT01097616|529845194|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146913144|NCT01097616|529845187|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146913145|NCT01097616|529845188|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146913146|NCT01097616|529845189|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
146913147|NCT01097616|529845190|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146913148|NCT01097616|529845191|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146769907|NCT03861767|529326637|FG006|Overall Study|Withdrawal by Subject|3|||
146769908|NCT03861767|529326638|FG007|Overall Study|Withdrawal by Subject|1|||
146769909|NCT03861767|529326639|FG008|Overall Study|Withdrawal by Subject|0|||
146769910|NCT03861767|529326640|FG009|Overall Study|Withdrawal by Subject|5|||
146769911|NCT00346333|529326641|FG000|Overall Study|Death|1|||
146769912|NCT00346333|529326642|FG001|Overall Study|Death|0|||
146769913|NCT00346333|529326641|FG000|Overall Study|unwilling or unable to continue|4|||
146769914|NCT00346333|529326642|FG001|Overall Study|unwilling or unable to continue|8|||
146769915|NCT03184558|529326643|FG000|Overall Study|Withdrawal by Subject|2|||
146769916|NCT03184558|529326643|FG000|Overall Study|Death|16|||
146769917|NCT03184558|529326643|FG000|Overall Study|Lost to Follow-up|2|||
146769918|NCT03184558|529326643|FG000|Overall Study|Other|9|||
146769919|NCT05299606|529326644|FG000|Overall Study|Death|1|||
146769920|NCT03460756|529326645|FG000|Overall Study|Adverse Event|0|||
146769921|NCT03460756|529326646|FG001|Overall Study|Adverse Event|0|||
146769922|NCT03460756|529326647|FG002|Overall Study|Adverse Event|0|||
146769923|NCT03460756|529326648|FG003|Overall Study|Adverse Event|1|||
146769924|NCT03460756|529326645|FG000|Overall Study|Lack of Efficacy|0|||
146769925|NCT03460756|529326646|FG001|Overall Study|Lack of Efficacy|0|||
146769926|NCT03460756|529326647|FG002|Overall Study|Lack of Efficacy|0|||
146769927|NCT03460756|529326648|FG003|Overall Study|Lack of Efficacy|2|||
146769928|NCT03460756|529326645|FG000|Overall Study|Lost to Follow-up|0|||
146769929|NCT03460756|529326646|FG001|Overall Study|Lost to Follow-up|1|||
146769930|NCT03460756|529326647|FG002|Overall Study|Lost to Follow-up|2|||
146769931|NCT03460756|529326648|FG003|Overall Study|Lost to Follow-up|1|||
146769932|NCT03460756|529326645|FG000|Overall Study|Pregnancy|0|||
146769933|NCT03460756|529326646|FG001|Overall Study|Pregnancy|0|||
146769934|NCT03460756|529326647|FG002|Overall Study|Pregnancy|0|||
146769935|NCT03460756|529326648|FG003|Overall Study|Pregnancy|1|||
146769936|NCT03460756|529326645|FG000|Overall Study|Protocol Violation|0|||
146769937|NCT03460756|529326646|FG001|Overall Study|Protocol Violation|0|||
146769938|NCT03460756|529326647|FG002|Overall Study|Protocol Violation|0|||
146769939|NCT03460756|529326648|FG003|Overall Study|Protocol Violation|1|||
146769940|NCT03460756|529326645|FG000|Overall Study|Withdrawal by Subject|0|||
146769941|NCT03460756|529326646|FG001|Overall Study|Withdrawal by Subject|4|||
146769942|NCT03460756|529326647|FG002|Overall Study|Withdrawal by Subject|7|||
146769943|NCT03460756|529326648|FG003|Overall Study|Withdrawal by Subject|3|||
146769944|NCT03946670|529326652|FG000|Overall Study|Progressive Disease|34|||
146769945|NCT03946670|529326653|FG001|Overall Study|Progressive Disease|27|||
146769946|NCT03946670|529326652|FG000|Overall Study|Adverse Event|7|||
146769947|NCT03946670|529326653|FG001|Overall Study|Adverse Event|10|||
146769948|NCT03946670|529326652|FG000|Overall Study|Physician Decision|6|||
146769949|NCT03946670|529326653|FG001|Overall Study|Physician Decision|5|||
146769950|NCT03946670|529326652|FG000|Overall Study|Death|5|||
146769951|NCT03946670|529326653|FG001|Overall Study|Death|8|||
146769952|NCT03946670|529326652|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
146769953|NCT03946670|529326653|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
146769954|NCT03946670|529326652|FG000|Overall Study|Subject Decision|4|||
146769955|NCT03946670|529326653|FG001|Overall Study|Subject Decision|5|||
146769956|NCT03946670|529326652|FG000|Overall Study|Study Terminated By Sponsor|2|||
146913149|NCT01097616|529845192|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146913150|NCT01097616|529845193|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146913151|NCT01097616|529845194|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146913152|NCT01097616|529845187|FG000|Optional DB EXT Phase|Adverse Event|0|||
146913153|NCT01097616|529845188|FG001|Optional DB EXT Phase|Adverse Event|7|||
146913154|NCT01097616|529845189|FG002|Optional DB EXT Phase|Adverse Event|2|||
146913155|NCT01097616|529845190|FG003|Optional DB EXT Phase|Adverse Event|0|||
146913156|NCT01097616|529845191|FG004|Optional DB EXT Phase|Adverse Event|0|||
146913157|NCT01097616|529845192|FG005|Optional DB EXT Phase|Adverse Event|0|||
146913158|NCT01097616|529845193|FG006|Optional DB EXT Phase|Adverse Event|0|||
146913159|NCT01097616|529845194|FG007|Optional DB EXT Phase|Adverse Event|0|||
146508180|NCT02720744|528364583|FG000|Overall Study|Lack of Efficacy|2|||
146508181|NCT02720744|528364584|FG001|Overall Study|Lack of Efficacy|8|||
146508182|NCT02720744|528364583|FG000|Overall Study|Adverse Event|21|||
146508183|NCT02720744|528364584|FG001|Overall Study|Adverse Event|3|||
146508184|NCT02720744|528364583|FG000|Overall Study|Withdrawal by Subject|11|||
146508185|NCT02720744|528364584|FG001|Overall Study|Withdrawal by Subject|11|||
146508186|NCT02720744|528364583|FG000|Overall Study|Lost to follow up|2|||
146508187|NCT02720744|528364584|FG001|Overall Study|Lost to follow up|0|||
146508188|NCT02720744|528364583|FG000|Overall Study|Non Compliance with Investigational Product|0|||
146769957|NCT03946670|529326653|FG001|Overall Study|Study Terminated By Sponsor|0|||
146769958|NCT03946670|529326652|FG000|Overall Study|New Therapy For Study Indication|1|||
146769959|NCT03946670|529326653|FG001|Overall Study|New Therapy For Study Indication|0|||
146769960|NCT03946670|529326652|FG000|Overall Study|Not Treated|1|||
146769961|NCT03946670|529326653|FG001|Overall Study|Not Treated|1|||
146769962|NCT02425111|529326654|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
146769963|NCT02425111|529326654|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
146769964|NCT02425111|529326654|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
146913160|NCT01097616|529845187|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
146913161|NCT01097616|529845188|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
146913162|NCT01097616|529845189|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
146913163|NCT01097616|529845190|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
146913164|NCT01097616|529845191|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
146913165|NCT01097616|529845192|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
146913166|NCT01097616|529845193|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
146913167|NCT01097616|529845194|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
146913168|NCT01097616|529845187|FG000|Optional DB EXT Phase|Protocol Violation|0|||
146913169|NCT01097616|529845188|FG001|Optional DB EXT Phase|Protocol Violation|2|||
146913170|NCT01097616|529845189|FG002|Optional DB EXT Phase|Protocol Violation|3|||
146913171|NCT01097616|529845190|FG003|Optional DB EXT Phase|Protocol Violation|0|||
146913172|NCT01097616|529845191|FG004|Optional DB EXT Phase|Protocol Violation|0|||
146913173|NCT01097616|529845192|FG005|Optional DB EXT Phase|Protocol Violation|0|||
146913174|NCT01097616|529845193|FG006|Optional DB EXT Phase|Protocol Violation|0|||
146913175|NCT01097616|529845194|FG007|Optional DB EXT Phase|Protocol Violation|0|||
146913176|NCT01097616|529845187|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
146913177|NCT01097616|529845188|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
146913178|NCT01097616|529845189|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
146913179|NCT01097616|529845190|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
146913180|NCT01097616|529845191|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
146913181|NCT01097616|529845192|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
146913182|NCT01097616|529845193|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
146913183|NCT01097616|529845194|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
146913184|NCT01097616|529845187|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
146913185|NCT01097616|529845188|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
146913186|NCT01097616|529845189|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
146913187|NCT01097616|529845190|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
146913188|NCT01097616|529845191|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
146913189|NCT01097616|529845192|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
146913190|NCT01097616|529845193|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
146913191|NCT01097616|529845194|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
146913192|NCT01097616|529845187|FG000|Optional DB EXT Phase|Physician Decision|1|||
146913193|NCT01097616|529845188|FG001|Optional DB EXT Phase|Physician Decision|0|||
146913194|NCT01097616|529845189|FG002|Optional DB EXT Phase|Physician Decision|0|||
146913195|NCT01097616|529845190|FG003|Optional DB EXT Phase|Physician Decision|0|||
146913196|NCT01097616|529845191|FG004|Optional DB EXT Phase|Physician Decision|0|||
146913197|NCT01097616|529845192|FG005|Optional DB EXT Phase|Physician Decision|0|||
146913198|NCT01097616|529845193|FG006|Optional DB EXT Phase|Physician Decision|0|||
146913199|NCT01097616|529845194|FG007|Optional DB EXT Phase|Physician Decision|0|||
146913200|NCT01097616|529845187|FG000|DB RO Phase|Adverse Event|0|||
146913201|NCT01097616|529845188|FG001|DB RO Phase|Adverse Event|0|||
146913202|NCT01097616|529845189|FG002|DB RO Phase|Adverse Event|0|||
146913203|NCT01097616|529845190|FG003|DB RO Phase|Adverse Event|0|||
146913204|NCT01097616|529845191|FG004|DB RO Phase|Adverse Event|0|||
146913205|NCT01097616|529845192|FG005|DB RO Phase|Adverse Event|0|||
146913206|NCT01097616|529845193|FG006|DB RO Phase|Adverse Event|1|||
146913207|NCT01097616|529845194|FG007|DB RO Phase|Adverse Event|0|||
146913208|NCT01097616|529845187|FG000|DB RO Phase|Withdrawal by Subject|0|||
146913209|NCT01097616|529845188|FG001|DB RO Phase|Withdrawal by Subject|0|||
146913210|NCT01097616|529845189|FG002|DB RO Phase|Withdrawal by Subject|0|||
146913211|NCT01097616|529845190|FG003|DB RO Phase|Withdrawal by Subject|0|||
146913212|NCT01097616|529845191|FG004|DB RO Phase|Withdrawal by Subject|0|||
146913213|NCT01097616|529845192|FG005|DB RO Phase|Withdrawal by Subject|1|||
146913214|NCT01097616|529845193|FG006|DB RO Phase|Withdrawal by Subject|0|||
146913215|NCT01097616|529845194|FG007|DB RO Phase|Withdrawal by Subject|0|||
146913216|NCT01097616|529845187|FG000|DB RO Phase|Lost to Follow-up|0|||
146913217|NCT01097616|529845188|FG001|DB RO Phase|Lost to Follow-up|0|||
146568042|NCT04540367|528591740|FG000|Overall Study|Withdrawal by Subject|0|||
146568043|NCT04540367|528591741|FG001|Overall Study|Withdrawal by Subject|0|||
146568044|NCT04540367|528591742|FG002|Overall Study|Withdrawal by Subject|0|||
146568045|NCT04540367|528591743|FG003|Overall Study|Withdrawal by Subject|2|||
146568046|NCT04540367|528591740|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
146913218|NCT01097616|529845189|FG002|DB RO Phase|Lost to Follow-up|0|||
146913219|NCT01097616|529845190|FG003|DB RO Phase|Lost to Follow-up|1|||
146913220|NCT01097616|529845191|FG004|DB RO Phase|Lost to Follow-up|1|||
146913221|NCT01097616|529845192|FG005|DB RO Phase|Lost to Follow-up|0|||
146913222|NCT01097616|529845193|FG006|DB RO Phase|Lost to Follow-up|0|||
146913223|NCT01097616|529845194|FG007|DB RO Phase|Lost to Follow-up|1|||
146913224|NCT01097616|529845187|FG000|DB RO Phase|Not Treated in RO|0|||
146913225|NCT01097616|529845188|FG001|DB RO Phase|Not Treated in RO|0|||
146913226|NCT01097616|529845189|FG002|DB RO Phase|Not Treated in RO|0|||
146913227|NCT01097616|529845190|FG003|DB RO Phase|Not Treated in RO|0|||
146913228|NCT01097616|529845191|FG004|DB RO Phase|Not Treated in RO|0|||
146913229|NCT01097616|529845192|FG005|DB RO Phase|Not Treated in RO|1|||
146913230|NCT01097616|529845193|FG006|DB RO Phase|Not Treated in RO|0|||
146913231|NCT01097616|529845194|FG007|DB RO Phase|Not Treated in RO|0|||
146769965|NCT02425111|529326654|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
146769966|NCT02425111|529326654|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
146769967|NCT02425111|529326654|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
146769968|NCT00843882|529326655|FG000|Step 1|Lack of Efficacy|14|||
146769969|NCT00843882|529326656|FG001|Step 1|Lack of Efficacy|10|||
146769970|NCT00843882|529326657|FG002|Step 1|Lack of Efficacy|21|||
146769971|NCT00843882|529326655|FG000|Step 1|Adverse Event|8|||
146913232|NCT00589472|529845196|FG000|Overall Study|Adverse Event|1|||
146913233|NCT01372878|529845197|FG000|Overall Study|Withdrawal by Subject|63|||
146974627|NCT00567996|530069619|FG000|Overall Study|Abnormal Lab value(s)|2|||
146974628|NCT00567996|530069620|FG001|Overall Study|Abnormal Lab value(s)|1|||
146974629|NCT00567996|530069621|FG002|Overall Study|Abnormal Lab value(s)|2|||
146974630|NCT00567996|530069619|FG000|Overall Study|Abnormal test procedure result(s)|2|||
146974631|NCT00567996|530069620|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146913234|NCT01372878|529845197|FG000|Overall Study|Protocol Violation|17|||
146913235|NCT01372878|529845197|FG000|Overall Study|incomplete study procedure|104|||
146913236|NCT00117338|529845198|FG000|Overall Study|Adverse Event|0|||
146913237|NCT00117338|529845199|FG001|Overall Study|Adverse Event|1|||
146913238|NCT00117338|529845198|FG000|Overall Study|Protocol Violation|3|||
146913239|NCT00117338|529845199|FG001|Overall Study|Protocol Violation|2|||
146913240|NCT00117338|529845198|FG000|Overall Study|Withdrawal by Subject|1|||
146913241|NCT00117338|529845199|FG001|Overall Study|Withdrawal by Subject|0|||
146913242|NCT00117338|529845198|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
146913243|NCT00117338|529845199|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
146913244|NCT00117338|529845198|FG000|Overall Study|Lack of Efficacy|0|||
146913245|NCT00117338|529845199|FG001|Overall Study|Lack of Efficacy|1|||
146913246|NCT00546351|529845200|FG000|Overall Study|Adverse Event|76|||
146913247|NCT00546351|529845200|FG000|Overall Study|Lack of Efficacy|15|||
146913248|NCT00546351|529845200|FG000|Overall Study|Withdrawal by Subject|109|||
146913249|NCT00546351|529845200|FG000|Overall Study|Lost to Follow-up|9|||
146913250|NCT00546351|529845200|FG000|Overall Study|Protocol Deviation|1|||
146913251|NCT00546351|529845200|FG000|Overall Study|Unsatisfactory compliance|9|||
146913252|NCT00546351|529845200|FG000|Overall Study|Other reasons for premature termination|17|||
146913253|NCT01342640|529845201|FG000|Overall Study|Adverse Event|3|||
146913254|NCT01342640|529845201|FG000|Overall Study|Protocol Violation|16|||
146913255|NCT01342640|529845201|FG000|Overall Study|Lost to Follow-up|21|||
146913256|NCT01342640|529845201|FG000|Overall Study|Other|1|||
146913257|NCT02616029|529845202|FG000|Overall Study|Adverse Event|1|||
146913258|NCT02616029|529845203|FG001|Overall Study|Adverse Event|0|||
146913259|NCT02616029|529845202|FG000|Overall Study|Death|0|||
146913260|NCT02616029|529845203|FG001|Overall Study|Death|1|||
146913261|NCT02616029|529845202|FG000|Overall Study|Protocol Violation|1|||
146913262|NCT02616029|529845203|FG001|Overall Study|Protocol Violation|0|||
146974632|NCT00567996|530069621|FG002|Overall Study|Abnormal test procedure result(s)|1|||
146974633|NCT00567996|530069619|FG000|Overall Study|Lost to Follow-up|2|||
146974634|NCT00567996|530069620|FG001|Overall Study|Lost to Follow-up|5|||
146974635|NCT00567996|530069621|FG002|Overall Study|Lost to Follow-up|2|||
146974636|NCT00567996|530069619|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146974637|NCT00567996|530069620|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146974638|NCT00567996|530069621|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
146974639|NCT00567996|530069619|FG000|Overall Study|Administrative problems|1|||
146974640|NCT00567996|530069620|FG001|Overall Study|Administrative problems|1|||
146974641|NCT00567996|530069621|FG002|Overall Study|Administrative problems|0|||
146974642|NCT00567996|530069619|FG000|Overall Study|Death|1|||
146974643|NCT00567996|530069620|FG001|Overall Study|Death|0|||
146974644|NCT00567996|530069621|FG002|Overall Study|Death|2|||
146974645|NCT00567996|530069619|FG000|Overall Study|Patient's inability to use the device|0|||
146974646|NCT00567996|530069620|FG001|Overall Study|Patient's inability to use the device|1|||
146974647|NCT00567996|530069621|FG002|Overall Study|Patient's inability to use the device|0|||
146974648|NCT02956005|530069622|FG000|Overall Study|Not eligible|1|||
146974649|NCT02956005|530069622|FG000|Overall Study|Withdrawal by Subject|3|||
146769972|NCT00843882|529326656|FG001|Step 1|Adverse Event|17|||
146769973|NCT00843882|529326657|FG002|Step 1|Adverse Event|20|||
146769974|NCT00843882|529326655|FG000|Step 1|Death|1|||
146769975|NCT00843882|529326656|FG001|Step 1|Death|2|||
146913263|NCT02616029|529845202|FG000|Overall Study|Withdrew Consent|1|||
146913264|NCT02616029|529845203|FG001|Overall Study|Withdrew Consent|0|||
146913265|NCT02616029|529845202|FG000|Overall Study|Enrolled and Never Treated|1|||
146913266|NCT02616029|529845203|FG001|Overall Study|Enrolled and Never Treated|1|||
146913267|NCT00479466|529845205|FG000|Overall Study|Adverse Event|5|||
146913268|NCT00479466|529845206|FG001|Overall Study|Adverse Event|1|||
146913269|NCT00479466|529845207|FG002|Overall Study|Adverse Event|0|||
146769976|NCT00843882|529326657|FG002|Step 1|Death|4|||
146913270|NCT00479466|529845208|FG003|Overall Study|Adverse Event|1|||
146913271|NCT00479466|529845209|FG004|Overall Study|Adverse Event|2|||
146913272|NCT00479466|529845210|FG005|Overall Study|Adverse Event|0|||
146974650|NCT02956005|530069622|FG000|Overall Study|Physician Decision|12|||
146974651|NCT02524665|530069625|FG000|Overall Study|Lost to Follow-up|1|||
146769977|NCT00843882|529326655|FG000|Step 1|Withdrawal by Subject|6|||
146769978|NCT00843882|529326656|FG001|Step 1|Withdrawal by Subject|12|||
146769979|NCT00843882|529326657|FG002|Step 1|Withdrawal by Subject|9|||
146769980|NCT00843882|529326655|FG000|Step 1|Physician Decision|0|||
146769981|NCT00843882|529326656|FG001|Step 1|Physician Decision|5|||
146913273|NCT00479466|529845205|FG000|Overall Study|Hyperglycemia|0|||
146913274|NCT00479466|529845206|FG001|Overall Study|Hyperglycemia|0|||
146913275|NCT00479466|529845207|FG002|Overall Study|Hyperglycemia|0|||
146913276|NCT00479466|529845208|FG003|Overall Study|Hyperglycemia|0|||
146913277|NCT00479466|529845209|FG004|Overall Study|Hyperglycemia|0|||
146913278|NCT00479466|529845210|FG005|Overall Study|Hyperglycemia|1|||
146913279|NCT00479466|529845205|FG000|Overall Study|Lack of Efficacy|2|||
146913280|NCT00479466|529845206|FG001|Overall Study|Lack of Efficacy|0|||
146913281|NCT00479466|529845207|FG002|Overall Study|Lack of Efficacy|1|||
146913282|NCT00479466|529845208|FG003|Overall Study|Lack of Efficacy|0|||
146913283|NCT00479466|529845209|FG004|Overall Study|Lack of Efficacy|0|||
146913284|NCT00479466|529845210|FG005|Overall Study|Lack of Efficacy|0|||
146913285|NCT00479466|529845205|FG000|Overall Study|Lost to Follow-up|0|||
146913286|NCT00479466|529845206|FG001|Overall Study|Lost to Follow-up|1|||
146913287|NCT00479466|529845207|FG002|Overall Study|Lost to Follow-up|1|||
146913288|NCT00479466|529845208|FG003|Overall Study|Lost to Follow-up|0|||
146913289|NCT00479466|529845209|FG004|Overall Study|Lost to Follow-up|2|||
146913290|NCT00479466|529845210|FG005|Overall Study|Lost to Follow-up|2|||
146913291|NCT00479466|529845205|FG000|Overall Study|Physician Decision|2|||
146913292|NCT00479466|529845206|FG001|Overall Study|Physician Decision|1|||
146913293|NCT00479466|529845207|FG002|Overall Study|Physician Decision|1|||
146913294|NCT00479466|529845208|FG003|Overall Study|Physician Decision|0|||
146913295|NCT00479466|529845209|FG004|Overall Study|Physician Decision|0|||
146913296|NCT00479466|529845210|FG005|Overall Study|Physician Decision|0|||
146913297|NCT00479466|529845205|FG000|Overall Study|Pregnancy|0|||
146913298|NCT00479466|529845206|FG001|Overall Study|Pregnancy|0|||
146913299|NCT00479466|529845207|FG002|Overall Study|Pregnancy|0|||
146913300|NCT00479466|529845208|FG003|Overall Study|Pregnancy|0|||
146913301|NCT00479466|529845209|FG004|Overall Study|Pregnancy|1|||
146913302|NCT00479466|529845210|FG005|Overall Study|Pregnancy|0|||
146913303|NCT00479466|529845205|FG000|Overall Study|Protocol Violation|1|||
146913304|NCT00479466|529845206|FG001|Overall Study|Protocol Violation|0|||
146913305|NCT00479466|529845207|FG002|Overall Study|Protocol Violation|0|||
146913306|NCT00479466|529845208|FG003|Overall Study|Protocol Violation|0|||
146913307|NCT00479466|529845209|FG004|Overall Study|Protocol Violation|0|||
146913308|NCT00479466|529845210|FG005|Overall Study|Protocol Violation|0|||
146650030|NCT03011892|528895019|FG005|Double Blind (DB) Period|Adverse Event|0|||
146650031|NCT03011892|528895020|FG006|Double Blind (DB) Period|Adverse Event|0|||
146650032|NCT03011892|528895021|FG007|Double Blind (DB) Period|Adverse Event|0|||
146650033|NCT03011892|528895022|FG008|Double Blind (DB) Period|Adverse Event|0|||
146650034|NCT03011892|528895023|FG009|Double Blind (DB) Period|Adverse Event|0|||
146650035|NCT03011892|528895024|FG010|Double Blind (DB) Period|Adverse Event|0|||
146650036|NCT03011892|528895025|FG011|Double Blind (DB) Period|Adverse Event|0|||
146650037|NCT03011892|528895014|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
146650038|NCT03011892|528895015|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
146650039|NCT03011892|528895016|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
146650040|NCT03011892|528895017|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
146650041|NCT03011892|528895018|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
146650042|NCT03011892|528895019|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
146650043|NCT03011892|528895020|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
146650044|NCT03011892|528895021|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
146650045|NCT03011892|528895022|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
146650046|NCT03011892|528895023|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
146650047|NCT03011892|528895024|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
146650048|NCT03011892|528895025|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
146650049|NCT03011892|528895014|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
146650050|NCT03011892|528895015|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
146650051|NCT03011892|528895016|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
146650052|NCT03011892|528895017|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
146650053|NCT03011892|528895018|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
146650054|NCT03011892|528895019|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
146650055|NCT03011892|528895020|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
146650056|NCT03011892|528895021|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
146650057|NCT03011892|528895022|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
146769982|NCT00843882|529326657|FG002|Step 1|Physician Decision|1|||
146913309|NCT00479466|529845205|FG000|Overall Study|Withdrawal by Subject|3|||
146913310|NCT00479466|529845206|FG001|Overall Study|Withdrawal by Subject|5|||
146913311|NCT00479466|529845207|FG002|Overall Study|Withdrawal by Subject|0|||
146913312|NCT00479466|529845208|FG003|Overall Study|Withdrawal by Subject|2|||
146913313|NCT00479466|529845209|FG004|Overall Study|Withdrawal by Subject|3|||
146913314|NCT00479466|529845210|FG005|Overall Study|Withdrawal by Subject|1|||
146913315|NCT00850499|529845216|FG000|Overall Study|Adverse Event|3|||
146769983|NCT00843882|529326655|FG000|Step 1|Patient and physician's decision|0|||
146974652|NCT02602080|530069628|FG000|Overall Study|Protocol Violation|6|||
146974653|NCT02602080|530069629|FG001|Overall Study|Protocol Violation|1|||
146974654|NCT02602080|530069630|FG002|Overall Study|Protocol Violation|3|||
146650058|NCT03011892|528895023|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
146650059|NCT03011892|528895024|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
146650060|NCT03011892|528895025|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
146650061|NCT03011892|528895014|FG000|Double Blind (DB) Period|Other|1|||
146650062|NCT03011892|528895015|FG001|Double Blind (DB) Period|Other|1|||
146650063|NCT03011892|528895016|FG002|Double Blind (DB) Period|Other|1|||
146650064|NCT03011892|528895017|FG003|Double Blind (DB) Period|Other|0|||
146650065|NCT03011892|528895018|FG004|Double Blind (DB) Period|Other|1|||
146650066|NCT03011892|528895019|FG005|Double Blind (DB) Period|Other|0|||
146650067|NCT03011892|528895020|FG006|Double Blind (DB) Period|Other|0|||
146650068|NCT03011892|528895021|FG007|Double Blind (DB) Period|Other|0|||
146650069|NCT03011892|528895022|FG008|Double Blind (DB) Period|Other|0|||
146650070|NCT03011892|528895023|FG009|Double Blind (DB) Period|Other|0|||
146650071|NCT03011892|528895024|FG010|Double Blind (DB) Period|Other|0|||
146650072|NCT03011892|528895025|FG011|Double Blind (DB) Period|Other|0|||
146650073|NCT03011892|528895014|FG000|Double Blind (DB) Period|Physician Decision|1|||
146650074|NCT03011892|528895015|FG001|Double Blind (DB) Period|Physician Decision|0|||
146650075|NCT03011892|528895016|FG002|Double Blind (DB) Period|Physician Decision|1|||
146650076|NCT03011892|528895017|FG003|Double Blind (DB) Period|Physician Decision|0|||
146650077|NCT03011892|528895018|FG004|Double Blind (DB) Period|Physician Decision|0|||
146650078|NCT03011892|528895019|FG005|Double Blind (DB) Period|Physician Decision|0|||
146650079|NCT03011892|528895020|FG006|Double Blind (DB) Period|Physician Decision|0|||
146650080|NCT03011892|528895021|FG007|Double Blind (DB) Period|Physician Decision|0|||
146650081|NCT03011892|528895022|FG008|Double Blind (DB) Period|Physician Decision|0|||
146650082|NCT03011892|528895023|FG009|Double Blind (DB) Period|Physician Decision|0|||
146650083|NCT03011892|528895024|FG010|Double Blind (DB) Period|Physician Decision|0|||
146650084|NCT03011892|528895025|FG011|Double Blind (DB) Period|Physician Decision|0|||
146650085|NCT03011892|528895014|FG000|Double Blind (DB) Period|Pregnancy|0|||
146650086|NCT03011892|528895015|FG001|Double Blind (DB) Period|Pregnancy|0|||
146650087|NCT03011892|528895016|FG002|Double Blind (DB) Period|Pregnancy|0|||
146650088|NCT03011892|528895017|FG003|Double Blind (DB) Period|Pregnancy|0|||
146650089|NCT03011892|528895018|FG004|Double Blind (DB) Period|Pregnancy|1|||
146650090|NCT03011892|528895019|FG005|Double Blind (DB) Period|Pregnancy|0|||
146650091|NCT03011892|528895020|FG006|Double Blind (DB) Period|Pregnancy|0|||
146650092|NCT03011892|528895021|FG007|Double Blind (DB) Period|Pregnancy|0|||
146650093|NCT03011892|528895022|FG008|Double Blind (DB) Period|Pregnancy|0|||
146650094|NCT03011892|528895023|FG009|Double Blind (DB) Period|Pregnancy|0|||
146650095|NCT03011892|528895024|FG010|Double Blind (DB) Period|Pregnancy|0|||
146650096|NCT03011892|528895025|FG011|Double Blind (DB) Period|Pregnancy|0|||
146650097|NCT03011892|528895014|FG000|Double Blind (DB) Period|Protocol Violation|1|||
146650098|NCT03011892|528895015|FG001|Double Blind (DB) Period|Protocol Violation|0|||
146650099|NCT03011892|528895016|FG002|Double Blind (DB) Period|Protocol Violation|0|||
146650100|NCT03011892|528895017|FG003|Double Blind (DB) Period|Protocol Violation|0|||
146650101|NCT03011892|528895018|FG004|Double Blind (DB) Period|Protocol Violation|0|||
146650102|NCT03011892|528895019|FG005|Double Blind (DB) Period|Protocol Violation|0|||
146650103|NCT03011892|528895020|FG006|Double Blind (DB) Period|Protocol Violation|0|||
146650104|NCT03011892|528895021|FG007|Double Blind (DB) Period|Protocol Violation|0|||
146650105|NCT03011892|528895022|FG008|Double Blind (DB) Period|Protocol Violation|0|||
146650106|NCT03011892|528895023|FG009|Double Blind (DB) Period|Protocol Violation|0|||
146650107|NCT03011892|528895024|FG010|Double Blind (DB) Period|Protocol Violation|0|||
146650108|NCT03011892|528895025|FG011|Double Blind (DB) Period|Protocol Violation|0|||
146650109|NCT03011892|528895014|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
146650110|NCT03011892|528895015|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
146650111|NCT03011892|528895016|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
146650112|NCT03011892|528895017|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
146650113|NCT03011892|528895018|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
146650114|NCT03011892|528895019|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
146650115|NCT03011892|528895020|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
146650116|NCT03011892|528895021|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
146650117|NCT03011892|528895022|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
146650118|NCT03011892|528895023|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
146650119|NCT03011892|528895024|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
146650120|NCT03011892|528895025|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
146650121|NCT03011892|528895014|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
146650122|NCT03011892|528895015|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
146650123|NCT03011892|528895016|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
146650124|NCT03011892|528895017|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
146974655|NCT01066039|530069633|FG000|Overall Study|Adverse Event|6|||
146650125|NCT03011892|528895018|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
146974656|NCT01066039|530069633|FG000|Overall Study|Withdrawal by Subject|17|||
146913316|NCT00850499|529845217|FG001|Overall Study|Adverse Event|1|||
146913317|NCT00850499|529845216|FG000|Overall Study|Lack of Efficacy|0|||
146913318|NCT00850499|529845217|FG001|Overall Study|Lack of Efficacy|1|||
146913319|NCT02385123|529845218|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
146913320|NCT04498910|529845222|FG000|Overall Study|Lost to Follow-up|0|||
146913321|NCT04498910|529845223|FG001|Overall Study|Lost to Follow-up|1|||
146913322|NCT04498910|529845222|FG000|Overall Study|Withdrawal by Subject|2|||
146913323|NCT04498910|529845223|FG001|Overall Study|Withdrawal by Subject|1|||
146913324|NCT04498910|529845222|FG000|Overall Study|Adverse Event|1|||
146913325|NCT04498910|529845223|FG001|Overall Study|Adverse Event|0|||
146913326|NCT02345434|529845226|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
146913327|NCT02345434|529845227|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
146913328|NCT01703819|529845228|FG000|Overall Study|Adverse Event|0|||
146913329|NCT01703819|529845229|FG001|Overall Study|Adverse Event|1|||
146913330|NCT01703819|529845228|FG000|Overall Study|Withdrawal by Subject|0|||
146913331|NCT01703819|529845229|FG001|Overall Study|Withdrawal by Subject|1|||
146913332|NCT01302041|529845236|FG000|Overall Study|Death|5|||
146913333|NCT01302041|529845236|FG000|Overall Study|Withdrawal by Subject|4|||
146913334|NCT01302041|529845236|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
146913335|NCT01302041|529845236|FG000|Overall Study|Other-Miscellaneous Reason|2|||
146913336|NCT02064439|529845237|FG000|Overall Study|Adverse Event|51|||
146913337|NCT02064439|529845238|FG001|Overall Study|Adverse Event|47|||
146913338|NCT02064439|529845239|FG002|Overall Study|Adverse Event|46|||
146913339|NCT02064439|529845237|FG000|Overall Study|Death|0|||
146913340|NCT02064439|529845238|FG001|Overall Study|Death|2|||
146913341|NCT02064439|529845239|FG002|Overall Study|Death|3|||
146913342|NCT02064439|529845237|FG000|Overall Study|Withdrawal by Subject|29|||
146913343|NCT02064439|529845238|FG001|Overall Study|Withdrawal by Subject|18|||
146913344|NCT02064439|529845239|FG002|Overall Study|Withdrawal by Subject|26|||
146913345|NCT02064439|529845237|FG000|Overall Study|Protocol Violation|3|||
146913346|NCT02064439|529845238|FG001|Overall Study|Protocol Violation|5|||
146913347|NCT02064439|529845239|FG002|Overall Study|Protocol Violation|3|||
146913348|NCT02064439|529845237|FG000|Overall Study|Lost to Follow-up|1|||
146913349|NCT02064439|529845238|FG001|Overall Study|Lost to Follow-up|3|||
146913350|NCT02064439|529845239|FG002|Overall Study|Lost to Follow-up|4|||
146913351|NCT02064439|529845237|FG000|Overall Study|Non-compliance with study medication|21|||
146913352|NCT02064439|529845238|FG001|Overall Study|Non-compliance with study medication|19|||
146913353|NCT02064439|529845239|FG002|Overall Study|Non-compliance with study medication|23|||
146913354|NCT02064439|529845237|FG000|Overall Study|Physician Decision|0|||
146913355|NCT02064439|529845238|FG001|Overall Study|Physician Decision|1|||
146913356|NCT02064439|529845239|FG002|Overall Study|Physician Decision|1|||
146913357|NCT02064439|529845237|FG000|Overall Study|Logistical difficulties|6|||
146913358|NCT02064439|529845238|FG001|Overall Study|Logistical difficulties|5|||
146913359|NCT02064439|529845239|FG002|Overall Study|Logistical difficulties|2|||
146913360|NCT02064439|529845237|FG000|Overall Study|Efficacy outcome reached|18|||
146913361|NCT02064439|529845238|FG001|Overall Study|Efficacy outcome reached|16|||
146913362|NCT02064439|529845239|FG002|Overall Study|Efficacy outcome reached|57|||
146913363|NCT02064439|529845237|FG000|Overall Study|Safety outcome reached|12|||
146913364|NCT02064439|529845238|FG001|Overall Study|Safety outcome reached|20|||
146913365|NCT02064439|529845239|FG002|Overall Study|Safety outcome reached|10|||
146913366|NCT02064439|529845237|FG000|Overall Study|Other|2|||
146913367|NCT02064439|529845238|FG001|Overall Study|Other|2|||
146913368|NCT02064439|529845239|FG002|Overall Study|Other|7|||
146913369|NCT02234583|529845240|FG000|Overall Study|Adverse Event|172|||
146913370|NCT02234583|529845241|FG001|Overall Study|Adverse Event|156|||
146913371|NCT02234583|529845240|FG000|Overall Study|Withdrawal by Subject|109|||
146913372|NCT02234583|529845241|FG001|Overall Study|Withdrawal by Subject|157|||
146913373|NCT02234583|529845240|FG000|Overall Study|Lost to Follow-up|0|||
146913374|NCT02234583|529845241|FG001|Overall Study|Lost to Follow-up|1|||
146913375|NCT02234583|529845240|FG000|Overall Study|Lack of Efficacy|58|||
146913376|NCT02234583|529845241|FG001|Overall Study|Lack of Efficacy|103|||
146913377|NCT02234583|529845240|FG000|Overall Study|Protocol Violation|35|||
146913378|NCT02234583|529845241|FG001|Overall Study|Protocol Violation|42|||
146913379|NCT02234583|529845240|FG000|Overall Study|Other|39|||
146508189|NCT02720744|528364584|FG001|Overall Study|Non Compliance with Investigational Product|1|||
146913380|NCT02234583|529845241|FG001|Overall Study|Other|97|||
146913381|NCT01839188|529845243|FG000|Overall Study|Withdrawal by Subject|1|||
146913382|NCT01022853|529845251|FG000|Overall Study|Progressive disease|2|||
146913383|NCT01022853|529845252|FG001|Overall Study|Progressive disease|3|||
146913384|NCT01022853|529845253|FG002|Overall Study|Progressive disease|11|||
146913385|NCT01022853|529845254|FG003|Overall Study|Progressive disease|7|||
146913386|NCT01022853|529845255|FG004|Overall Study|Progressive disease|1|||
146913387|NCT01022853|529845251|FG000|Overall Study|Dose-limiting toxicity|0|||
146913388|NCT01022853|529845252|FG001|Overall Study|Dose-limiting toxicity|0|||
146913389|NCT01022853|529845253|FG002|Overall Study|Dose-limiting toxicity|0|||
146913390|NCT01022853|529845254|FG003|Overall Study|Dose-limiting toxicity|0|||
146913391|NCT01022853|529845255|FG004|Overall Study|Dose-limiting toxicity|1|||
146913392|NCT01022853|529845251|FG000|Overall Study|Withdrawal by Subject|0|||
146913393|NCT01022853|529845252|FG001|Overall Study|Withdrawal by Subject|1|||
146913394|NCT01022853|529845253|FG002|Overall Study|Withdrawal by Subject|1|||
146913395|NCT01022853|529845254|FG003|Overall Study|Withdrawal by Subject|1|||
146913396|NCT01022853|529845255|FG004|Overall Study|Withdrawal by Subject|0|||
146913397|NCT01022853|529845251|FG000|Overall Study|Other not stated above|1|||
146913398|NCT01022853|529845252|FG001|Overall Study|Other not stated above|0|||
146913399|NCT01022853|529845253|FG002|Overall Study|Other not stated above|1|||
146913400|NCT01022853|529845254|FG003|Overall Study|Other not stated above|0|||
146913401|NCT01022853|529845255|FG004|Overall Study|Other not stated above|0|||
146913402|NCT02075255|529845256|FG000|Overall Study|Study specific withdrawal criteria|0|||
146913403|NCT02075255|529845257|FG001|Overall Study|Study specific withdrawal criteria|1|||
146913404|NCT02075255|529845258|FG002|Overall Study|Study specific withdrawal criteria|1|||
146913405|NCT02075255|529845256|FG000|Overall Study|Withdrawal by Subject|4|||
146913406|NCT02075255|529845257|FG001|Overall Study|Withdrawal by Subject|1|||
146913407|NCT02075255|529845258|FG002|Overall Study|Withdrawal by Subject|0|||
146913408|NCT02075255|529845256|FG000|Overall Study|Lost to Follow-up|0|||
146913409|NCT02075255|529845257|FG001|Overall Study|Lost to Follow-up|0|||
146913410|NCT02075255|529845258|FG002|Overall Study|Lost to Follow-up|1|||
146913411|NCT02075255|529845256|FG000|Overall Study|Adverse Event|0|||
146913412|NCT02075255|529845257|FG001|Overall Study|Adverse Event|0|||
146913413|NCT02075255|529845258|FG002|Overall Study|Adverse Event|1|||
146913414|NCT02075255|529845256|FG000|Overall Study|Death|0|||
146913415|NCT02075255|529845257|FG001|Overall Study|Death|2|||
146913416|NCT02075255|529845258|FG002|Overall Study|Death|0|||
146913417|NCT03792750|529845259|FG000|Overall Study|Death|3|||
146913418|NCT01748760|529845260|FG000|Overall Study|Withdrawal by Subject|1|||
146913419|NCT01748760|529845261|FG001|Overall Study|Withdrawal by Subject|1|||
146913420|NCT01748760|529845260|FG000|Overall Study|Lost to Follow-up|5|||
146913421|NCT01748760|529845261|FG001|Overall Study|Lost to Follow-up|1|||
146913422|NCT03245814|529845262|FG000|Overall Study|Lost to Follow-up|5|||
146913423|NCT03245814|529845263|FG001|Overall Study|Lost to Follow-up|8|||
146913424|NCT03245814|529845262|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
146913425|NCT03245814|529845263|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
146913426|NCT02263365|529845267|FG000|Overall Study|Physician Decision|22|||
146913427|NCT02263365|529845268|FG001|Overall Study|Physician Decision|18|||
146913428|NCT00510692|529845269|FG000|Overall Study|Adverse Event|1|||
146913429|NCT00510692|529845270|FG001|Overall Study|Adverse Event|3|||
146913430|NCT00510692|529845269|FG000|Overall Study|Withdrawal by Subject|1|||
146913431|NCT00510692|529845270|FG001|Overall Study|Withdrawal by Subject|0|||
146913432|NCT00945191|529845271|FG000|Overall Study|Did not achieve a complete response|18|||
146913433|NCT00945191|529845271|FG000|Overall Study|Participant relocated to another state|1|||
146913434|NCT00945191|529845271|FG000|Overall Study|Disease progression|3|||
146913435|NCT00945191|529845271|FG000|Overall Study|Serious adverse event or adverse event|1|||
146913436|NCT00945191|529845271|FG000|Overall Study|Investigator's discretion|1|||
146913437|NCT00784784|529845272|FG000|Overall Study|Withdrawal by Subject|2|||
146913438|NCT00784784|529845273|FG001|Overall Study|Withdrawal by Subject|2|||
146913439|NCT00872898|529845274|FG000|Part Two - Double Blind|Adverse Event|4|||
146913440|NCT00872898|529845275|FG001|Part Two - Double Blind|Adverse Event|3|||
146913441|NCT00872898|529845274|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
146913442|NCT00872898|529845275|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
146913443|NCT00872898|529845274|FG000|Part Two - Double Blind|Protocol Violation|1|||
146913444|NCT00872898|529845275|FG001|Part Two - Double Blind|Protocol Violation|0|||
146913445|NCT00872898|529845274|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
146913446|NCT00872898|529845275|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
146650126|NCT03011892|528895019|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
146650127|NCT03011892|528895020|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
146650128|NCT03011892|528895021|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
146650129|NCT03011892|528895022|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
146650130|NCT03011892|528895023|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
146650131|NCT03011892|528895024|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
146650132|NCT03011892|528895025|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
146650133|NCT03011892|528895014|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
146913447|NCT00872898|529845274|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
146913448|NCT00872898|529845275|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
146913449|NCT00872898|529845274|FG000|Part Two - Double Blind|Other reasons|2|||
146913450|NCT00872898|529845275|FG001|Part Two - Double Blind|Other reasons|0|||
146913451|NCT01004146|529845276|FG000|Overall Study|Withdrawal by Subject|4|||
146913452|NCT01004146|529845277|FG001|Overall Study|Withdrawal by Subject|5|||
146913453|NCT03290300|529845286|FG000|Overall Study|Lost to Follow-up|3|||
146913454|NCT01001494|529845287|FG000|Overall Study|Adverse Event|8|||
146974657|NCT01066039|530069633|FG000|Overall Study|Protocol Violation|2|||
146913455|NCT01001494|529845288|FG001|Overall Study|Adverse Event|4|||
146913456|NCT01001494|529845289|FG002|Overall Study|Adverse Event|6|||
146913457|NCT01001494|529845287|FG000|Overall Study|Protocol Violation|0|||
146913458|NCT01001494|529845288|FG001|Overall Study|Protocol Violation|1|||
146913459|NCT01001494|529845289|FG002|Overall Study|Protocol Violation|1|||
146913460|NCT01001494|529845287|FG000|Overall Study|Lost to Follow-up|2|||
146913461|NCT01001494|529845288|FG001|Overall Study|Lost to Follow-up|0|||
146913462|NCT01001494|529845289|FG002|Overall Study|Lost to Follow-up|1|||
146913463|NCT01001494|529845287|FG000|Overall Study|Withdrawal by Subject|9|||
146913464|NCT01001494|529845288|FG001|Overall Study|Withdrawal by Subject|7|||
146913465|NCT01001494|529845289|FG002|Overall Study|Withdrawal by Subject|17|||
146913466|NCT01001494|529845287|FG000|Overall Study|COPD exacerbation|3|||
146913467|NCT01001494|529845288|FG001|Overall Study|COPD exacerbation|4|||
146913468|NCT01001494|529845289|FG002|Overall Study|COPD exacerbation|5|||
146913469|NCT01001494|529845287|FG000|Overall Study|Lack of Efficacy|2|||
146913470|NCT01001494|529845288|FG001|Overall Study|Lack of Efficacy|0|||
146913471|NCT01001494|529845289|FG002|Overall Study|Lack of Efficacy|8|||
146913472|NCT01001494|529845287|FG000|Overall Study|Other|0|||
146913473|NCT01001494|529845288|FG001|Overall Study|Other|1|||
146913474|NCT01001494|529845289|FG002|Overall Study|Other|3|||
146913475|NCT03176966|529845297|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
146913476|NCT03176966|529845298|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
146913477|NCT03176966|529845297|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
146913478|NCT03176966|529845298|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
146913479|NCT03176966|529845297|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
146913480|NCT03176966|529845298|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
146913481|NCT03176966|529845297|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
146913482|NCT03176966|529845298|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
146913483|NCT03176966|529845297|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
146913484|NCT03176966|529845298|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
146913485|NCT03176966|529845297|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
146913486|NCT03176966|529845298|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
146913487|NCT03176966|529845297|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
146913488|NCT03176966|529845298|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
146913489|NCT01520922|529845299|FG000|Treatment Phase|Physician Decision|2|||
146913490|NCT01520922|529845300|FG001|Treatment Phase|Physician Decision|1|||
146913491|NCT01520922|529845299|FG000|Treatment Phase|Progression|0|||
146913492|NCT01520922|529845300|FG001|Treatment Phase|Progression|2|||
146913493|NCT01520922|529845299|FG000|Treatment Phase|Adverse Event|3|||
146913494|NCT01520922|529845300|FG001|Treatment Phase|Adverse Event|5|||
146913495|NCT01520922|529845299|FG000|Follow up|Lost to Follow-up|0|||
146913496|NCT01520922|529845300|FG001|Follow up|Lost to Follow-up|1|||
146913497|NCT01520922|529845299|FG000|Survival Follow-up|Withdrawal by Subject|1|||
146913498|NCT01520922|529845300|FG001|Survival Follow-up|Withdrawal by Subject|0|||
146913499|NCT01696877|529845303|FG000|Overall Study|Adverse Event|0|||
146913500|NCT01696877|529845304|FG001|Overall Study|Adverse Event|1|||
146913501|NCT00515463|529845305|FG000|Overall Study|Physician Decision|4|||
146913502|NCT00515463|529845306|FG001|Overall Study|Physician Decision|2|||
146913503|NCT00515463|529845305|FG000|Overall Study|Adverse Event|1|||
146913504|NCT00515463|529845306|FG001|Overall Study|Adverse Event|2|||
146913505|NCT00515463|529845305|FG000|Overall Study|Withdrawal by Subject|3|||
146913506|NCT00515463|529845306|FG001|Overall Study|Withdrawal by Subject|4|||
146913507|NCT00515463|529845305|FG000|Overall Study|Lost to Follow-up|6|||
146913508|NCT00515463|529845306|FG001|Overall Study|Lost to Follow-up|5|||
146913509|NCT00515463|529845305|FG000|Overall Study|Other|0|||
146913510|NCT00515463|529845306|FG001|Overall Study|Other|1|||
146913511|NCT00916721|529845307|FG000|Overall Study|Lost to Follow-up|0|||
146913512|NCT00916721|529845308|FG001|Overall Study|Lost to Follow-up|1|||
146913513|NCT00916721|529845307|FG000|Overall Study|Adverse Event|6|||
146913514|NCT00916721|529845308|FG001|Overall Study|Adverse Event|3|||
146913515|NCT00916721|529845307|FG000|Overall Study|Withdrawal by Subject|2|||
146913516|NCT00916721|529845308|FG001|Overall Study|Withdrawal by Subject|2|||
146913517|NCT00916721|529845307|FG000|Overall Study|Protocol Violation|2|||
146913518|NCT00916721|529845308|FG001|Overall Study|Protocol Violation|4|||
146974658|NCT01066039|530069633|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
146913519|NCT01903434|529845312|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
146913520|NCT01903434|529845313|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
146913521|NCT01903434|529845312|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
146913522|NCT01903434|529845313|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
146913523|NCT01469052|529845316|FG000|Overall Study|Adverse Event|2|||
146913524|NCT01469052|529845317|FG001|Overall Study|Adverse Event|3|||
146974659|NCT01066039|530069633|FG000|Overall Study|Investigator's Request|1|||
146913525|NCT01469052|529845318|FG002|Overall Study|Adverse Event|0|||
146913526|NCT01469052|529845319|FG003|Overall Study|Adverse Event|2|||
146913527|NCT01469052|529845320|FG004|Overall Study|Adverse Event|0|||
146913528|NCT01469052|529845321|FG005|Overall Study|Adverse Event|1|||
146913529|NCT01469052|529845316|FG000|Overall Study|Progressive disease|3|||
146913530|NCT01469052|529845317|FG001|Overall Study|Progressive disease|0|||
146913531|NCT01469052|529845318|FG002|Overall Study|Progressive disease|5|||
146508190|NCT02720744|528364583|FG000|Overall Study|Excluded Concomitant Medication|0|||
146508191|NCT02720744|528364584|FG001|Overall Study|Excluded Concomitant Medication|1|||
146508192|NCT01482962|528364585|FG000|Overall Study|Progressive Disease|65|||
146508193|NCT01482962|528364586|FG001|Overall Study|Progressive Disease|53|||
146508194|NCT01482962|528364585|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
146508195|NCT01482962|528364586|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
146508196|NCT01482962|528364585|FG000|Overall Study|Adverse Event|18|||
146508197|NCT01482962|528364586|FG001|Overall Study|Adverse Event|22|||
146508198|NCT01482962|528364585|FG000|Overall Study|Withdrawal by Participant|8|||
146913532|NCT01469052|529845319|FG003|Overall Study|Progressive disease|3|||
146913533|NCT01469052|529845320|FG004|Overall Study|Progressive disease|7|||
146913534|NCT01469052|529845321|FG005|Overall Study|Progressive disease|2|||
146913535|NCT01469052|529845316|FG000|Overall Study|Lack of Efficacy|0|||
146913536|NCT01469052|529845317|FG001|Overall Study|Lack of Efficacy|0|||
146913537|NCT01469052|529845318|FG002|Overall Study|Lack of Efficacy|0|||
146913538|NCT01469052|529845319|FG003|Overall Study|Lack of Efficacy|0|||
146913539|NCT01469052|529845320|FG004|Overall Study|Lack of Efficacy|0|||
146913540|NCT01469052|529845321|FG005|Overall Study|Lack of Efficacy|2|||
146913541|NCT01469052|529845316|FG000|Overall Study|Moved to rollover protocol|1|||
146913542|NCT01469052|529845317|FG001|Overall Study|Moved to rollover protocol|0|||
146913543|NCT01469052|529845318|FG002|Overall Study|Moved to rollover protocol|1|||
146913544|NCT01469052|529845319|FG003|Overall Study|Moved to rollover protocol|0|||
146913545|NCT01469052|529845320|FG004|Overall Study|Moved to rollover protocol|0|||
146913546|NCT01469052|529845321|FG005|Overall Study|Moved to rollover protocol|1|||
146913547|NCT01469052|529845316|FG000|Overall Study|Other|0|||
146913548|NCT01469052|529845317|FG001|Overall Study|Other|1|||
146913549|NCT01469052|529845318|FG002|Overall Study|Other|0|||
146913550|NCT01469052|529845319|FG003|Overall Study|Other|0|||
146913551|NCT01469052|529845320|FG004|Overall Study|Other|1|||
146913552|NCT01469052|529845321|FG005|Overall Study|Other|0|||
146913553|NCT02269319|529845322|FG000|Overall Study|Lost to Follow-up|4|||
146913554|NCT02269319|529845323|FG001|Overall Study|Lost to Follow-up|3|||
146913555|NCT02269319|529845322|FG000|Overall Study|Adverse Event|0|||
146913556|NCT02269319|529845323|FG001|Overall Study|Adverse Event|1|||
146913557|NCT02269319|529845322|FG000|Overall Study|Instructions not followed|1|||
146913558|NCT02269319|529845323|FG001|Overall Study|Instructions not followed|0|||
146913559|NCT03575468|529845326|FG000|Overall Study|Withdrawal by Subject|3|||
146913560|NCT03575468|529845327|FG001|Overall Study|Withdrawal by Subject|0|||
146913561|NCT03575468|529845326|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
146913562|NCT03575468|529845327|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
146913563|NCT03575468|529845326|FG000|Overall Study|Lost to Follow-up|13|||
146913564|NCT03575468|529845327|FG001|Overall Study|Lost to Follow-up|17|||
146913565|NCT00404768|529845328|FG000|Part A and B|Withdrawn due to labor progression|1|||
146913566|NCT00404768|529845329|FG001|Part A and B|Withdrawn due to labor progression|0|||
146913567|NCT00404768|529845330|FG002|Part A and B|Withdrawn due to labor progression|0|||
146913568|NCT00404768|529845331|FG003|Part A and B|Withdrawn due to labor progression|0|||
146913569|NCT00404768|529845328|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
146913570|NCT00404768|529845329|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
146913571|NCT00404768|529845330|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
146913572|NCT00404768|529845331|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
146913573|NCT00404768|529845328|FG000|Part C|Adverse Event|0|||
146913574|NCT00404768|529845329|FG001|Part C|Adverse Event|0|||
146913575|NCT00404768|529845330|FG002|Part C|Adverse Event|0|||
146913576|NCT00404768|529845331|FG003|Part C|Adverse Event|3|||
146913577|NCT00404768|529845328|FG000|Part C|Lost to Follow-up|0|||
146913578|NCT00404768|529845329|FG001|Part C|Lost to Follow-up|0|||
146913579|NCT00404768|529845330|FG002|Part C|Lost to Follow-up|3|||
146913580|NCT00404768|529845331|FG003|Part C|Lost to Follow-up|1|||
146913581|NCT00404768|529845328|FG000|Part C|Withdrawal by Subject|0|||
146913582|NCT00404768|529845329|FG001|Part C|Withdrawal by Subject|0|||
146913583|NCT00404768|529845330|FG002|Part C|Withdrawal by Subject|2|||
146913584|NCT00404768|529845331|FG003|Part C|Withdrawal by Subject|1|||
146913585|NCT00404768|529845328|FG000|Part C|Early withdrawal from study medication|0|||
146913586|NCT00404768|529845329|FG001|Part C|Early withdrawal from study medication|0|||
146913587|NCT00404768|529845330|FG002|Part C|Early withdrawal from study medication|1|||
146913588|NCT00404768|529845331|FG003|Part C|Early withdrawal from study medication|0|||
146913589|NCT00404768|529845328|FG000|Part C|Participant did not respond to therapy|0|||
146913590|NCT00404768|529845329|FG001|Part C|Participant did not respond to therapy|0|||
146913591|NCT00404768|529845330|FG002|Part C|Participant did not respond to therapy|1|||
146913592|NCT00404768|529845331|FG003|Part C|Participant did not respond to therapy|1|||
146913593|NCT00404768|529845328|FG000|Part C|Physician withdrew the study medication|0|||
146913594|NCT00404768|529845329|FG001|Part C|Physician withdrew the study medication|0|||
146913595|NCT00404768|529845330|FG002|Part C|Physician withdrew the study medication|1|||
146913596|NCT00404768|529845331|FG003|Part C|Physician withdrew the study medication|0|||
146508199|NCT01482962|528364586|FG001|Overall Study|Withdrawal by Participant|13|||
146508200|NCT01482962|528364585|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
146568047|NCT04540367|528591741|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
146913597|NCT00404768|529845328|FG000|Part C|Participant delivered baby|0|||
146913598|NCT00404768|529845329|FG001|Part C|Participant delivered baby|0|||
146913599|NCT00404768|529845330|FG002|Part C|Participant delivered baby|0|||
146913600|NCT00404768|529845331|FG003|Part C|Participant delivered baby|1|||
146913601|NCT00404768|529845328|FG000|Part C|Unsatisfactory uterine response to IP|0|||
146913602|NCT00404768|529845329|FG001|Part C|Unsatisfactory uterine response to IP|0|||
146913603|NCT00404768|529845330|FG002|Part C|Unsatisfactory uterine response to IP|0|||
146913604|NCT00404768|529845331|FG003|Part C|Unsatisfactory uterine response to IP|1|||
146913605|NCT00404768|529845328|FG000|Part C|Active labor|0|||
146913606|NCT00404768|529845329|FG001|Part C|Active labor|0|||
146913607|NCT00404768|529845330|FG002|Part C|Active labor|0|||
146913608|NCT00404768|529845331|FG003|Part C|Active labor|1|||
146913609|NCT00404768|529845328|FG000|Part C|Lack of Efficacy|0|||
146913610|NCT00404768|529845329|FG001|Part C|Lack of Efficacy|0|||
146913611|NCT00404768|529845330|FG002|Part C|Lack of Efficacy|0|||
146913612|NCT00404768|529845331|FG003|Part C|Lack of Efficacy|2|||
146913613|NCT00404768|529845328|FG000|Part C|Treatment failure|0|||
146913614|NCT00404768|529845329|FG001|Part C|Treatment failure|0|||
146913615|NCT00404768|529845330|FG002|Part C|Treatment failure|0|||
146913616|NCT00404768|529845331|FG003|Part C|Treatment failure|1|||
146913617|NCT00404768|529845328|FG000|Part C|Investigator discretion|0|||
146913618|NCT00404768|529845329|FG001|Part C|Investigator discretion|0|||
146974660|NCT01066039|530069633|FG000|Overall Study|Dropout due to Insulin Administration|1|||
146974661|NCT01066039|530069633|FG000|Overall Study|Additional Antihypertensive Required|4|||
146568048|NCT04540367|528591742|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
146568049|NCT04540367|528591743|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
146568050|NCT04540367|528591740|FG000|Overall Study|Adverse Event|0|||
146568051|NCT04540367|528591741|FG001|Overall Study|Adverse Event|0|||
146568052|NCT04540367|528591742|FG002|Overall Study|Adverse Event|1|||
146568053|NCT04540367|528591743|FG003|Overall Study|Adverse Event|1|||
146568054|NCT00907621|528591747|FG000|Overall Study|Lost to Follow-up|6|||
146568055|NCT00907621|528591748|FG001|Overall Study|Lost to Follow-up|3|||
146568056|NCT00907621|528591747|FG000|Overall Study|intercurrent febrile illness|1|||
146568057|NCT00907621|528591748|FG001|Overall Study|intercurrent febrile illness|1|||
146568058|NCT00902330|528591753|FG000|Overall Study|Too overwhelmed by treatment|2|||
146568059|NCT00902330|528591754|FG001|Overall Study|Too overwhelmed by treatment|5|||
146568060|NCT00902330|528591753|FG000|Overall Study|Adverse Event|1|||
146568061|NCT00902330|528591754|FG001|Overall Study|Adverse Event|0|||
146568062|NCT00902330|528591753|FG000|Overall Study|No post baseline data|1|||
146568063|NCT00902330|528591754|FG001|Overall Study|No post baseline data|0|||
146568064|NCT00165789|528591755|FG000|Overall Study|Adverse Event|0|||
146568065|NCT00165789|528591756|FG001|Overall Study|Adverse Event|3|||
146568066|NCT00165789|528591757|FG002|Overall Study|Adverse Event|0|||
146568067|NCT00165789|528591758|FG003|Overall Study|Adverse Event|12|||
146568068|NCT00165789|528591755|FG000|Overall Study|Withdrawal by Subject|0|||
146568069|NCT00165789|528591756|FG001|Overall Study|Withdrawal by Subject|1|||
146568070|NCT00165789|528591757|FG002|Overall Study|Withdrawal by Subject|1|||
146568071|NCT00165789|528591758|FG003|Overall Study|Withdrawal by Subject|2|||
146568072|NCT01816048|528591759|FG000|Overall Study|Adverse Event|1|||
146568073|NCT01816048|528591759|FG000|Overall Study|Death|1|||
146568074|NCT01816048|528591759|FG000|Overall Study|Withdrawal by Subject|1|||
146568075|NCT01816048|528591759|FG000|Overall Study|Disease Progression|3|||
146568076|NCT04290624|528591760|FG000|Overall Study|Adverse Event|1|||
146568077|NCT04290624|528591761|FG001|Overall Study|Adverse Event|0|||
146568078|NCT01847443|528591762|FG000|Study Period 1|Withdrawal by Subject|0|||
146568079|NCT01847443|528591763|FG001|Study Period 1|Withdrawal by Subject|1|||
146568080|NCT01847443|528591764|FG002|Study Period 1|Withdrawal by Subject|0|||
146568081|NCT01847443|528591765|FG003|Study Period 1|Withdrawal by Subject|0|||
146568082|NCT01847443|528591762|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
146568083|NCT01847443|528591763|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
146568084|NCT01847443|528591764|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
146568085|NCT01847443|528591765|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
146568086|NCT01847443|528591762|FG000|Washout Period Before Study Period 2|Other reason|1|||
146568087|NCT01847443|528591763|FG001|Washout Period Before Study Period 2|Other reason|0|||
146650134|NCT03011892|528895015|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
146650135|NCT03011892|528895016|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
146650136|NCT03011892|528895017|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
146650137|NCT03011892|528895018|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
146913619|NCT00404768|529845330|FG002|Part C|Investigator discretion|0|||
146913620|NCT00404768|529845331|FG003|Part C|Investigator discretion|1|||
146913621|NCT00404768|529845328|FG000|Part C|Researcher suspended study medication|0|||
146913622|NCT00404768|529845329|FG001|Part C|Researcher suspended study medication|0|||
146913623|NCT00404768|529845330|FG002|Part C|Researcher suspended study medication|0|||
146913624|NCT00404768|529845331|FG003|Part C|Researcher suspended study medication|1|||
146913625|NCT04773041|529845334|FG000|Overall Study|Unable to data match|1|||
146913626|NCT04773041|529845335|FG001|Overall Study|Unable to data match|0|||
146913627|NCT04773041|529845336|FG002|Overall Study|Unable to data match|0|||
146913632|NCT02699515|529847021|FG000|Overall Study|Death|3|||
146913633|NCT02699515|529847022|FG001|Overall Study|Death|3|||
146913634|NCT02699515|529847023|FG002|Overall Study|Death|3|||
146913635|NCT02699515|529847024|FG003|Overall Study|Death|23|||
146913636|NCT02699515|529847025|FG004|Overall Study|Death|22|||
146913637|NCT02699515|529847026|FG005|Overall Study|Death|23|||
146913638|NCT02699515|529847027|FG006|Overall Study|Death|3|||
146913639|NCT02699515|529847028|FG007|Overall Study|Death|5|||
146913640|NCT02699515|529847021|FG000|Overall Study|Withdrawal by Subject|0|||
146913641|NCT02699515|529847022|FG001|Overall Study|Withdrawal by Subject|0|||
146913642|NCT02699515|529847023|FG002|Overall Study|Withdrawal by Subject|3|||
146913643|NCT02699515|529847024|FG003|Overall Study|Withdrawal by Subject|1|||
146913644|NCT02699515|529847025|FG004|Overall Study|Withdrawal by Subject|5|||
146913645|NCT02699515|529847026|FG005|Overall Study|Withdrawal by Subject|3|||
146913646|NCT02699515|529847027|FG006|Overall Study|Withdrawal by Subject|0|||
146913647|NCT02699515|529847028|FG007|Overall Study|Withdrawal by Subject|1|||
146913648|NCT02699515|529847021|FG000|Overall Study|Other|1|||
146913649|NCT02699515|529847022|FG001|Overall Study|Other|0|||
146913650|NCT02699515|529847023|FG002|Overall Study|Other|1|||
146913651|NCT02699515|529847024|FG003|Overall Study|Other|6|||
146913652|NCT02699515|529847025|FG004|Overall Study|Other|4|||
146913653|NCT02699515|529847026|FG005|Overall Study|Other|3|||
146913654|NCT02699515|529847027|FG006|Overall Study|Other|0|||
146913655|NCT02699515|529847028|FG007|Overall Study|Other|0|||
146913656|NCT01240811|529847035|FG000|Overall Study|Physician Decision|0|||
146913657|NCT01240811|529847036|FG001|Overall Study|Physician Decision|1|||
146913658|NCT01240811|529847037|FG002|Overall Study|Physician Decision|0|||
146913659|NCT01240811|529847035|FG000|Overall Study|Withdrawal by Subject|0|||
146913660|NCT01240811|529847036|FG001|Overall Study|Withdrawal by Subject|0|||
146913661|NCT01240811|529847037|FG002|Overall Study|Withdrawal by Subject|1|||
146913662|NCT03032068|529847040|FG000|Overall Study|Adverse Event|1|||
146913663|NCT03918642|529847042|FG000|Overall Study|Lost to Follow-up|12|||
146913664|NCT03918642|529847043|FG001|Overall Study|Lost to Follow-up|10|||
146568088|NCT01847443|528591764|FG002|Washout Period Before Study Period 2|Other reason|0|||
146568089|NCT01847443|528591765|FG003|Washout Period Before Study Period 2|Other reason|0|||
146568090|NCT01847443|528591762|FG000|Washout Period Before Study Period 3|Other reason|1|||
146568091|NCT01847443|528591763|FG001|Washout Period Before Study Period 3|Other reason|0|||
146568092|NCT01847443|528591764|FG002|Washout Period Before Study Period 3|Other reason|0|||
146568093|NCT01847443|528591765|FG003|Washout Period Before Study Period 3|Other reason|0|||
146568094|NCT01847443|528591762|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
146568095|NCT01847443|528591763|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
146568096|NCT01847443|528591764|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
146568097|NCT01847443|528591765|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
146568098|NCT01847443|528591762|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
146568099|NCT01847443|528591763|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
146568100|NCT01847443|528591764|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
146568101|NCT01847443|528591765|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
146568102|NCT03571971|528591766|FG000|Overall Study|Lost to Follow-up|2|||
146568103|NCT03571971|528591767|FG001|Overall Study|Lost to Follow-up|2|||
146913665|NCT01988012|529847045|FG000|Overall Study|Adverse Event|5|||
146913666|NCT01988012|529847045|FG000|Overall Study|Insufficient Therapeutic Response|3|||
146913667|NCT01988012|529847045|FG000|Overall Study|Patient Withdrawal of Consent|4|||
146568104|NCT03571971|528591766|FG000|Overall Study|Protocol Violation|2|||
146568105|NCT03571971|528591767|FG001|Overall Study|Protocol Violation|3|||
146568106|NCT03571971|528591766|FG000|Overall Study|Withdrawal by Subject|2|||
146568107|NCT03571971|528591767|FG001|Overall Study|Withdrawal by Subject|0|||
146568108|NCT03571971|528591766|FG000|Overall Study|Incomplete primary outcome data|2|||
146568109|NCT03571971|528591767|FG001|Overall Study|Incomplete primary outcome data|0|||
146568110|NCT04067492|528591768|FG000|Overall Study|Lost to Follow-up|0|||
146568111|NCT04067492|528591769|FG001|Overall Study|Lost to Follow-up|0|||
146913668|NCT01988012|529847045|FG000|Overall Study|Lost to Follow-up|1|||
146913669|NCT01988012|529847045|FG000|Overall Study|Physician Decision|1|||
146913670|NCT01988012|529847045|FG000|Overall Study|Protocol Violation|1|||
146913671|NCT01228071|529847048|FG000|Overall Study|Protocol Violation|1|||
146913672|NCT01228071|529847048|FG000|Overall Study|Withdrawal by Subject|1|||
146913673|NCT03238248|529847054|FG000|Overall Study|Death|5|||
146913674|NCT03238248|529847054|FG000|Overall Study|Withdrawal by Subject|7|||
146913675|NCT03238248|529847054|FG000|Overall Study|Participant proceeding to transplant|10|||
146913676|NCT03238248|529847054|FG000|Overall Study|Lack of Efficacy|4|||
146913677|NCT03238248|529847054|FG000|Overall Study|Physician Decision|3|||
146650138|NCT03011892|528895019|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
146650139|NCT03011892|528895020|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
146650140|NCT03011892|528895021|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
146650141|NCT03011892|528895022|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
146650142|NCT03011892|528895023|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
146650143|NCT03011892|528895024|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
146650144|NCT03011892|528895025|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
146650145|NCT03011892|528895014|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
146650146|NCT03011892|528895015|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
146650147|NCT03011892|528895016|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
146650148|NCT03011892|528895017|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
146769984|NCT00843882|529326656|FG001|Step 1|Patient and physician's decision|0|||
146769985|NCT00843882|529326657|FG002|Step 1|Patient and physician's decision|1|||
146769986|NCT00843882|529326655|FG000|Step 1|Other complicating disease|1|||
146769987|NCT00843882|529326656|FG001|Step 1|Other complicating disease|3|||
146769988|NCT00843882|529326657|FG002|Step 1|Other complicating disease|4|||
146769989|NCT00843882|529326655|FG000|Step 1|Alternative therapy|0|||
146769990|NCT00843882|529326656|FG001|Step 1|Alternative therapy|1|||
146769991|NCT00843882|529326657|FG002|Step 1|Alternative therapy|1|||
146769992|NCT00843882|529326655|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
146769993|NCT00843882|529326656|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
146769994|NCT00843882|529326657|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
146769995|NCT00843882|529326655|FG000|Step 1|Off treatment reason unknown|0|||
146769996|NCT00843882|529326656|FG001|Step 1|Off treatment reason unknown|1|||
146769997|NCT00843882|529326657|FG002|Step 1|Off treatment reason unknown|4|||
146769998|NCT00843882|529326655|FG000|Step 1|Never started treatment|2|||
146769999|NCT00843882|529326656|FG001|Step 1|Never started treatment|0|||
146770000|NCT00843882|529326657|FG002|Step 1|Never started treatment|0|||
146770001|NCT00843882|529326655|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
146974662|NCT01066039|530069633|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
146974663|NCT01066039|530069633|FG000|Overall Study|Failure to Control Blood Pressure|1|||
146650149|NCT03011892|528895018|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
146650150|NCT03011892|528895019|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
146650151|NCT03011892|528895020|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
146650152|NCT03011892|528895021|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
146650153|NCT03011892|528895022|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
146650154|NCT03011892|528895023|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
146650155|NCT03011892|528895024|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
146650156|NCT03011892|528895025|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
146650157|NCT03011892|528895014|FG000|Open Label (OL) Period|Reason not specified|0|||
146974664|NCT01066039|530069633|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
146974665|NCT02574260|530069638|FG000|Overall Study|Disease Progression|1|||
146974666|NCT03022799|530069641|FG000|Overall Study|Adverse Event|0|||
146974667|NCT03022799|530069642|FG001|Overall Study|Adverse Event|0|||
146974668|NCT03022799|530069643|FG002|Overall Study|Adverse Event|0|||
146974669|NCT03022799|530069644|FG003|Overall Study|Adverse Event|0|||
146974670|NCT03022799|530069645|FG004|Overall Study|Adverse Event|0|||
146974671|NCT03022799|530069646|FG005|Overall Study|Adverse Event|0|||
146974672|NCT03022799|530069647|FG006|Overall Study|Adverse Event|0|||
146974673|NCT03022799|530069648|FG007|Overall Study|Adverse Event|0|||
146974674|NCT03022799|530069649|FG008|Overall Study|Adverse Event|0|||
146974675|NCT03022799|530069650|FG009|Overall Study|Adverse Event|1|||
146974676|NCT03022799|530069651|FG010|Overall Study|Adverse Event|1|||
146974677|NCT03022799|530069652|FG011|Overall Study|Adverse Event|0|||
146974678|NCT03022799|530069653|FG012|Overall Study|Adverse Event|0|||
146974679|NCT00883129|530069657|FG000|Overall Study|Adverse Event|7|||
146974680|NCT00883129|530069658|FG001|Overall Study|Adverse Event|15|||
146974681|NCT00883129|530069657|FG000|Overall Study|Withdrawal by Subject|8|||
146974682|NCT00883129|530069658|FG001|Overall Study|Withdrawal by Subject|9|||
146974683|NCT00883129|530069657|FG000|Overall Study|Non-compliance|3|||
146974684|NCT00883129|530069658|FG001|Overall Study|Non-compliance|6|||
146974685|NCT00883129|530069657|FG000|Overall Study|Lost to Follow-up|1|||
146974686|NCT00883129|530069658|FG001|Overall Study|Lost to Follow-up|2|||
146974687|NCT00883129|530069657|FG000|Overall Study|Death|1|||
146974688|NCT00883129|530069658|FG001|Overall Study|Death|2|||
146974689|NCT00883129|530069657|FG000|Overall Study|Defined Treatment Failure|0|||
146974690|NCT00883129|530069658|FG001|Overall Study|Defined Treatment Failure|2|||
146974691|NCT03273257|530069659|FG000|Overall Study|Death|0|||
146770002|NCT00843882|529326656|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
146770003|NCT00843882|529326657|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
146770004|NCT00843882|529326655|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
146770005|NCT00843882|529326656|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
146770006|NCT00843882|529326657|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
146770007|NCT00843882|529326655|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
146974692|NCT03273257|530069660|FG001|Overall Study|Death|1|||
146974693|NCT03273257|530069659|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
146568112|NCT04067492|528591770|FG002|Overall Study|Lost to Follow-up|0|||
146974694|NCT03273257|530069660|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
146974695|NCT03273257|530069659|FG000|Overall Study|Study terminated|3|||
146974696|NCT03273257|530069660|FG001|Overall Study|Study terminated|2|||
146974697|NCT01185639|530069662|FG000|Overall Study|Progressed and didn't receive therapy|2|||
146974698|NCT02200614|530069663|FG000|Double Blind Treatment|Adverse Event|86|||
146974699|NCT02200614|530069664|FG001|Double Blind Treatment|Adverse Event|48|||
146974700|NCT02200614|530069663|FG000|Double Blind Treatment|Confirmed metastasis|120|||
146974701|NCT02200614|530069664|FG001|Double Blind Treatment|Confirmed metastasis|140|||
146974702|NCT02200614|530069663|FG000|Double Blind Treatment|Judgment of the investigator|59|||
146974703|NCT02200614|530069664|FG001|Double Blind Treatment|Judgment of the investigator|99|||
146974704|NCT02200614|530069663|FG000|Double Blind Treatment|Metastasis by local reading|1|||
146974705|NCT02200614|530069664|FG001|Double Blind Treatment|Metastasis by local reading|3|||
146974706|NCT02200614|530069663|FG000|Double Blind Treatment|Other reason|6|||
146974707|NCT02200614|530069664|FG001|Double Blind Treatment|Other reason|2|||
146974708|NCT02200614|530069663|FG000|Double Blind Treatment|Personal reason|77|||
146974709|NCT02200614|530069664|FG001|Double Blind Treatment|Personal reason|85|||
146974710|NCT02200614|530069663|FG000|Double Blind Treatment|Protocol deviation|14|||
146974711|NCT02200614|530069664|FG001|Double Blind Treatment|Protocol deviation|7|||
146974712|NCT02200614|530069663|FG000|Double Blind Treatment|Not treated|1|||
146974713|NCT02200614|530069664|FG001|Double Blind Treatment|Not treated|0|||
146974714|NCT02200614|530069663|FG000|Open Label|Adverse Event|41|||
146974715|NCT02200614|530069664|FG001|Open Label|Adverse Event|11|||
146974716|NCT02200614|530069663|FG000|Open Label|Confirmed metastasis|1|||
146974717|NCT02200614|530069664|FG001|Open Label|Confirmed metastasis|0|||
146974718|NCT02200614|530069663|FG000|Open Label|Judgment of the investigator|29|||
146974719|NCT02200614|530069664|FG001|Open Label|Judgment of the investigator|2|||
146974720|NCT02200614|530069663|FG000|Open Label|Metastasis by local reading|138|||
146974721|NCT02200614|530069664|FG001|Open Label|Metastasis by local reading|27|||
146974722|NCT02200614|530069663|FG000|Open Label|Other reason|22|||
146974723|NCT02200614|530069664|FG001|Open Label|Other reason|4|||
146974724|NCT02200614|530069663|FG000|Open Label|Personal reason|60|||
146974725|NCT02200614|530069664|FG001|Open Label|Personal reason|8|||
146974726|NCT02200614|530069663|FG000|Open Label|Protocol deviation|3|||
146974727|NCT02200614|530069664|FG001|Open Label|Protocol deviation|2|||
146974728|NCT02200614|530069663|FG000|Open Label|Missing|2|||
146974729|NCT02200614|530069664|FG001|Open Label|Missing|2|||
146974730|NCT01898884|530069665|FG000|Multiple Dose Period|Adverse Event|0|||
146974731|NCT01898884|530069666|FG001|Multiple Dose Period|Adverse Event|0|||
146974732|NCT01898884|530069667|FG002|Multiple Dose Period|Adverse Event|0|||
146974733|NCT01898884|530069668|FG003|Multiple Dose Period|Adverse Event|0|||
146974734|NCT01898884|530069669|FG004|Multiple Dose Period|Adverse Event|0|||
146974735|NCT01898884|530069670|FG005|Multiple Dose Period|Adverse Event|0|||
146974736|NCT01898884|530069671|FG006|Multiple Dose Period|Adverse Event|1|||
146974737|NCT01898884|530069672|FG007|Multiple Dose Period|Adverse Event|0|||
146974738|NCT01898884|530069673|FG008|Multiple Dose Period|Adverse Event|0|||
146974739|NCT01898884|530069665|FG000|Multiple Dose Period|Randomized Not Treated|0|||
146974740|NCT01898884|530069666|FG001|Multiple Dose Period|Randomized Not Treated|0|||
146974741|NCT01898884|530069667|FG002|Multiple Dose Period|Randomized Not Treated|0|||
146974742|NCT01898884|530069668|FG003|Multiple Dose Period|Randomized Not Treated|0|||
146568113|NCT04067492|528591771|FG003|Overall Study|Lost to Follow-up|0|||
146568114|NCT04067492|528591772|FG004|Overall Study|Lost to Follow-up|0|||
146568115|NCT04067492|528591773|FG005|Overall Study|Lost to Follow-up|1|||
146568116|NCT04067492|528591768|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
146568117|NCT04067492|528591769|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
146568118|NCT04067492|528591770|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
146568119|NCT04067492|528591771|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
146568120|NCT04067492|528591772|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
146568121|NCT04067492|528591773|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
146568122|NCT04067492|528591768|FG000|Overall Study|COVID-19 epidemiological situation|0|||
146568123|NCT04067492|528591769|FG001|Overall Study|COVID-19 epidemiological situation|0|||
146568124|NCT04067492|528591770|FG002|Overall Study|COVID-19 epidemiological situation|0|||
146568125|NCT04067492|528591771|FG003|Overall Study|COVID-19 epidemiological situation|1|||
146568126|NCT04067492|528591772|FG004|Overall Study|COVID-19 epidemiological situation|0|||
146568127|NCT04067492|528591773|FG005|Overall Study|COVID-19 epidemiological situation|0|||
146568128|NCT03950856|528591781|FG000|Overall Study|Death|1|||
146568129|NCT03950856|528591782|FG001|Overall Study|Death|2|||
146974743|NCT01898884|530069669|FG004|Multiple Dose Period|Randomized Not Treated|0|||
146974744|NCT01898884|530069670|FG005|Multiple Dose Period|Randomized Not Treated|0|||
146974745|NCT01898884|530069671|FG006|Multiple Dose Period|Randomized Not Treated|0|||
146974746|NCT01898884|530069672|FG007|Multiple Dose Period|Randomized Not Treated|0|||
146913678|NCT03238248|529847054|FG000|Overall Study|Transitioning to another study|1|||
146568130|NCT03950856|528591783|FG002|Overall Study|Death|0|||
146568131|NCT03950856|528591784|FG003|Overall Study|Death|0|||
146568132|NCT03950856|528591781|FG000|Overall Study|Lost to Follow-up|5|||
146568133|NCT03950856|528591782|FG001|Overall Study|Lost to Follow-up|6|||
146568134|NCT03950856|528591783|FG002|Overall Study|Lost to Follow-up|8|||
146913679|NCT03238248|529847054|FG000|Overall Study|No longer benefiting|1|||
146568135|NCT03950856|528591784|FG003|Overall Study|Lost to Follow-up|2|||
146568136|NCT03950856|528591781|FG000|Overall Study|Protocol Violation|2|||
146568137|NCT03950856|528591782|FG001|Overall Study|Protocol Violation|0|||
146568138|NCT03950856|528591783|FG002|Overall Study|Protocol Violation|0|||
146568139|NCT03950856|528591784|FG003|Overall Study|Protocol Violation|1|||
146568140|NCT03950856|528591781|FG000|Overall Study|Withdrawal by Subject|4|||
146568141|NCT03950856|528591782|FG001|Overall Study|Withdrawal by Subject|1|||
146568142|NCT03950856|528591783|FG002|Overall Study|Withdrawal by Subject|3|||
146568143|NCT03950856|528591784|FG003|Overall Study|Withdrawal by Subject|1|||
146568144|NCT03950856|528591781|FG000|Overall Study|Unable to phone|7|||
146568145|NCT03950856|528591782|FG001|Overall Study|Unable to phone|6|||
146568146|NCT03950856|528591783|FG002|Overall Study|Unable to phone|7|||
146568147|NCT03950856|528591784|FG003|Overall Study|Unable to phone|2|||
146568148|NCT00656370|528591785|FG000|Overall Study|Screen Failures|7|||
146568149|NCT00656370|528591785|FG000|Overall Study|Alternates|3|||
146568150|NCT03402841|528591791|FG000|Overall Study|Withdrawal by Subject|3|||
146568151|NCT03402841|528591791|FG000|Overall Study|Lost to Follow-up|2|||
146568152|NCT03402841|528591791|FG000|Overall Study|Death|146|||
146568153|NCT03984188|528591794|FG000|Overall Study|Death|2|||
146568154|NCT03984188|528591795|FG001|Overall Study|Death|4|||
146568155|NCT03984188|528591794|FG000|Overall Study|Physician Decision|0|||
146568156|NCT03984188|528591795|FG001|Overall Study|Physician Decision|2|||
146568157|NCT03984188|528591794|FG000|Overall Study|Lost to Follow-up|3|||
146913680|NCT03238248|529847054|FG000|Overall Study|Other complicating disease|1|||
146913681|NCT03238248|529847054|FG000|Overall Study|Adverse Event|5|||
146913682|NCT03238248|529847054|FG000|Overall Study|Disease progression|26|||
146913683|NCT03238248|529847054|FG000|Overall Study|N/A participant is still on treatment|1|||
146913684|NCT03238248|529847054|FG000|Overall Study|Decline in condition|1|||
146913685|NCT03238248|529847054|FG000|Overall Study|Alternative therapy|2|||
146913686|NCT02241512|529847061|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
146913687|NCT02241512|529847062|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
146913688|NCT02345161|529847065|FG000|Overall Study|Withdrawal by Subject|25|||
146913689|NCT02345161|529847066|FG001|Overall Study|Withdrawal by Subject|33|||
146913690|NCT02345161|529847065|FG000|Overall Study|Adverse Event|16|||
146913691|NCT02345161|529847066|FG001|Overall Study|Adverse Event|19|||
146913692|NCT02345161|529847065|FG000|Overall Study|Physician Decision|4|||
146913693|NCT02345161|529847066|FG001|Overall Study|Physician Decision|4|||
146913694|NCT02345161|529847065|FG000|Overall Study|Lost to Follow-up|0|||
146913695|NCT02345161|529847066|FG001|Overall Study|Lost to Follow-up|1|||
146913696|NCT00972244|529847069|FG000|Overall Study|Incorrect Enrolment|1|||
146913697|NCT00972244|529847070|FG001|Overall Study|Incorrect Enrolment|0|||
146913698|NCT00972244|529847071|FG002|Overall Study|Incorrect Enrolment|0|||
146913699|NCT00972244|529847072|FG003|Overall Study|Incorrect Enrolment|0|||
146913700|NCT00972244|529847073|FG004|Overall Study|Incorrect Enrolment|0|||
146913701|NCT00972244|529847069|FG000|Overall Study|Adverse Event|0|||
146913702|NCT00972244|529847070|FG001|Overall Study|Adverse Event|1|||
146974747|NCT01898884|530069673|FG008|Multiple Dose Period|Randomized Not Treated|1|||
146974748|NCT00434148|530069674|FG000|Overall Study|Adverse Event|18|||
146974749|NCT00434148|530069675|FG001|Overall Study|Adverse Event|18|||
146974750|NCT00434148|530069674|FG000|Overall Study|Lack of Efficacy|25|||
146508201|NCT01482962|528364586|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
146508202|NCT01482962|528364585|FG000|Overall Study|Other Reason|1|||
146508203|NCT01482962|528364586|FG001|Overall Study|Other Reason|5|||
146508204|NCT01482962|528364585|FG000|Overall Study|Study Terminated by Sponsor|5|||
146508205|NCT01482962|528364586|FG001|Overall Study|Study Terminated by Sponsor|2|||
146508206|NCT01482962|528364585|FG000|Overall Study|Did not Receive Study Drug|1|||
146508207|NCT01482962|528364586|FG001|Overall Study|Did not Receive Study Drug|6|||
146508208|NCT02407457|528364587|FG000|1 Month|Death|3|||
146508209|NCT02407457|528364588|FG001|1 Month|Death|0|||
146508210|NCT02407457|528364587|FG000|1 Month|Lost to Follow-up|1|||
146508211|NCT02407457|528364588|FG001|1 Month|Lost to Follow-up|1|||
146508212|NCT02407457|528364587|FG000|1 Month|missed visit|2|||
146508213|NCT02407457|528364588|FG001|1 Month|missed visit|5|||
146508214|NCT02407457|528364587|FG000|6-Month|Death|2|||
146568158|NCT03984188|528591795|FG001|Overall Study|Lost to Follow-up|2|||
146568159|NCT03984188|528591794|FG000|Overall Study|Withdrawal by Subject|6|||
146568160|NCT03984188|528591795|FG001|Overall Study|Withdrawal by Subject|0|||
146568161|NCT03384875|528591796|FG000|Overall Study|Death|1|||
146508215|NCT02407457|528364588|FG001|6-Month|Death|8|||
146508216|NCT02407457|528364587|FG000|6-Month|Lost to Follow-up|2|||
146508217|NCT02407457|528364588|FG001|6-Month|Lost to Follow-up|2|||
146568162|NCT03384875|528591797|FG001|Overall Study|Death|1|||
146568163|NCT03384875|528591798|FG002|Overall Study|Death|0|||
146974751|NCT00434148|530069675|FG001|Overall Study|Lack of Efficacy|28|||
146913703|NCT00972244|529847071|FG002|Overall Study|Adverse Event|1|||
146913704|NCT00972244|529847072|FG003|Overall Study|Adverse Event|0|||
146913705|NCT00972244|529847073|FG004|Overall Study|Adverse Event|0|||
146913706|NCT00972244|529847069|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
146913707|NCT00972244|529847070|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
146913708|NCT00972244|529847071|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
146913709|NCT00972244|529847072|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
146913710|NCT00972244|529847073|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
146913711|NCT00972244|529847069|FG000|Overall Study|Withdrawal by Subject|1|||
146913712|NCT00972244|529847070|FG001|Overall Study|Withdrawal by Subject|2|||
146913713|NCT00972244|529847071|FG002|Overall Study|Withdrawal by Subject|1|||
146913714|NCT00972244|529847072|FG003|Overall Study|Withdrawal by Subject|0|||
146913715|NCT00972244|529847073|FG004|Overall Study|Withdrawal by Subject|1|||
146913716|NCT00972244|529847069|FG000|Overall Study|Safety|0|||
146913717|NCT00972244|529847070|FG001|Overall Study|Safety|0|||
146913718|NCT00972244|529847071|FG002|Overall Study|Safety|0|||
146913719|NCT00972244|529847072|FG003|Overall Study|Safety|0|||
146913720|NCT00972244|529847073|FG004|Overall Study|Safety|1|||
146913721|NCT00972244|529847069|FG000|Overall Study|Death|1|||
146913722|NCT00972244|529847070|FG001|Overall Study|Death|0|||
146913723|NCT00972244|529847071|FG002|Overall Study|Death|0|||
146913724|NCT00972244|529847072|FG003|Overall Study|Death|0|||
146913725|NCT00972244|529847073|FG004|Overall Study|Death|0|||
146913726|NCT00972244|529847069|FG000|Overall Study|Various|0|||
146913727|NCT00972244|529847070|FG001|Overall Study|Various|0|||
146913728|NCT00972244|529847071|FG002|Overall Study|Various|0|||
146913729|NCT00972244|529847072|FG003|Overall Study|Various|0|||
146913730|NCT00972244|529847073|FG004|Overall Study|Various|2|||
146913731|NCT00090285|529847074|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
146913732|NCT00090285|529847075|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
146913733|NCT00090285|529847076|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
146913734|NCT00090285|529847077|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
146913735|NCT00090285|529847078|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
146913736|NCT00090285|529847079|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
146913737|NCT00090285|529847074|FG000|Base Study Vaccination Period|Adverse Event|2|||
146913738|NCT00090285|529847075|FG001|Base Study Vaccination Period|Adverse Event|4|||
146913739|NCT00090285|529847076|FG002|Base Study Vaccination Period|Adverse Event|0|||
146913740|NCT00090285|529847077|FG003|Base Study Vaccination Period|Adverse Event|0|||
146913741|NCT00090285|529847078|FG004|Base Study Vaccination Period|Adverse Event|0|||
146913742|NCT00090285|529847079|FG005|Base Study Vaccination Period|Adverse Event|0|||
146913743|NCT00090285|529847074|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
146913744|NCT00090285|529847075|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
146913745|NCT00090285|529847076|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
146913746|NCT00090285|529847077|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
146913747|NCT00090285|529847078|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
146913748|NCT00090285|529847079|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
146913749|NCT00090285|529847074|FG000|Base Study Vaccination Period|Protocol Violation|2|||
146913750|NCT00090285|529847075|FG001|Base Study Vaccination Period|Protocol Violation|3|||
146913751|NCT00090285|529847076|FG002|Base Study Vaccination Period|Protocol Violation|0|||
146913752|NCT00090285|529847077|FG003|Base Study Vaccination Period|Protocol Violation|0|||
146913753|NCT00090285|529847078|FG004|Base Study Vaccination Period|Protocol Violation|0|||
146913754|NCT00090285|529847079|FG005|Base Study Vaccination Period|Protocol Violation|0|||
146913755|NCT00090285|529847074|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
146913756|NCT00090285|529847075|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
146913757|NCT00090285|529847076|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
146913758|NCT00090285|529847077|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
146913759|NCT00090285|529847078|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
146913760|NCT00090285|529847079|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
146913761|NCT00090285|529847074|FG000|Base Study Vaccination Period|Uncooperative|2|||
146913762|NCT00090285|529847075|FG001|Base Study Vaccination Period|Uncooperative|2|||
146913763|NCT00090285|529847076|FG002|Base Study Vaccination Period|Uncooperative|0|||
146913764|NCT00090285|529847077|FG003|Base Study Vaccination Period|Uncooperative|0|||
146913765|NCT00090285|529847078|FG004|Base Study Vaccination Period|Uncooperative|0|||
146913766|NCT00090285|529847079|FG005|Base Study Vaccination Period|Uncooperative|0|||
146913767|NCT00090285|529847074|FG000|Base Study Vaccination Period|Moved|20|||
146508218|NCT02407457|528364587|FG000|6-Month|missed visit|16|||
146508219|NCT02407457|528364588|FG001|6-Month|missed visit|14|||
146508220|NCT02407457|528364587|FG000|6-Month|Open Repair|0|||
146508221|NCT02407457|528364588|FG001|6-Month|Open Repair|1|||
146508222|NCT02407457|528364587|FG000|1 Year|Death|6|||
146508223|NCT02407457|528364588|FG001|1 Year|Death|11|||
146508224|NCT02407457|528364587|FG000|1 Year|Lost to Follow-up|3|||
146508225|NCT02407457|528364588|FG001|1 Year|Lost to Follow-up|2|||
146508226|NCT02407457|528364587|FG000|1 Year|Missed Visit|24|||
146508227|NCT02407457|528364588|FG001|1 Year|Missed Visit|14|||
146913768|NCT00090285|529847075|FG001|Base Study Vaccination Period|Moved|21|||
146913769|NCT00090285|529847076|FG002|Base Study Vaccination Period|Moved|0|||
146913770|NCT00090285|529847077|FG003|Base Study Vaccination Period|Moved|0|||
146913771|NCT00090285|529847078|FG004|Base Study Vaccination Period|Moved|0|||
146913772|NCT00090285|529847079|FG005|Base Study Vaccination Period|Moved|0|||
146913773|NCT00090285|529847074|FG000|Base Study Vaccination Period|Site Terminated|1|||
146913774|NCT00090285|529847075|FG001|Base Study Vaccination Period|Site Terminated|0|||
146913775|NCT00090285|529847076|FG002|Base Study Vaccination Period|Site Terminated|0|||
146913776|NCT00090285|529847077|FG003|Base Study Vaccination Period|Site Terminated|0|||
146913777|NCT00090285|529847078|FG004|Base Study Vaccination Period|Site Terminated|0|||
146913778|NCT00090285|529847079|FG005|Base Study Vaccination Period|Site Terminated|0|||
146913779|NCT00090285|529847074|FG000|Base Study Vaccination Period|Other|2|||
146913780|NCT00090285|529847075|FG001|Base Study Vaccination Period|Other|2|||
146913781|NCT00090285|529847076|FG002|Base Study Vaccination Period|Other|0|||
146913782|NCT00090285|529847077|FG003|Base Study Vaccination Period|Other|0|||
146913783|NCT00090285|529847078|FG004|Base Study Vaccination Period|Other|0|||
146913784|NCT00090285|529847079|FG005|Base Study Vaccination Period|Other|0|||
146913785|NCT00090285|529847074|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
146913786|NCT00090285|529847075|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
146913787|NCT00090285|529847076|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
146913788|NCT00090285|529847077|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
146913789|NCT00090285|529847078|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
146913790|NCT00090285|529847079|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
146913791|NCT00090285|529847074|FG000|Base Study Vaccination Period|HIV positive|1|||
146913792|NCT00090285|529847075|FG001|Base Study Vaccination Period|HIV positive|1|||
146913793|NCT00090285|529847076|FG002|Base Study Vaccination Period|HIV positive|0|||
146913794|NCT00090285|529847077|FG003|Base Study Vaccination Period|HIV positive|0|||
146913795|NCT00090285|529847078|FG004|Base Study Vaccination Period|HIV positive|0|||
146913796|NCT00090285|529847079|FG005|Base Study Vaccination Period|HIV positive|0|||
146913797|NCT00090285|529847074|FG000|Base Study Follow-up Period|Adverse Event|3|||
146913798|NCT00090285|529847075|FG001|Base Study Follow-up Period|Adverse Event|10|||
146913799|NCT00090285|529847076|FG002|Base Study Follow-up Period|Adverse Event|0|||
146913800|NCT00090285|529847077|FG003|Base Study Follow-up Period|Adverse Event|0|||
146913801|NCT00090285|529847078|FG004|Base Study Follow-up Period|Adverse Event|0|||
146913802|NCT00090285|529847079|FG005|Base Study Follow-up Period|Adverse Event|0|||
146913803|NCT00090285|529847074|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
146913804|NCT00090285|529847075|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
146913805|NCT00090285|529847076|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
146913806|NCT00090285|529847077|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
146568164|NCT03384875|528591796|FG000|Overall Study|Reason not provided|1|||
146568165|NCT03384875|528591797|FG001|Overall Study|Reason not provided|0|||
146568166|NCT03384875|528591798|FG002|Overall Study|Reason not provided|0|||
146568167|NCT01047007|528593384|FG000|Overall Study|Adverse Event|0|||
146568168|NCT01047007|528593385|FG001|Overall Study|Adverse Event|2|||
146568169|NCT01047007|528593386|FG002|Overall Study|Adverse Event|1|||
146568170|NCT01047007|528593387|FG003|Overall Study|Adverse Event|0|||
146568171|NCT01047007|528593384|FG000|Overall Study|Progressive Disease|2|||
146568172|NCT01047007|528593385|FG001|Overall Study|Progressive Disease|4|||
146568173|NCT01047007|528593386|FG002|Overall Study|Progressive Disease|1|||
146568174|NCT01047007|528593387|FG003|Overall Study|Progressive Disease|0|||
146568175|NCT04099277|528593388|FG000|Overall Study|Physician Decision|1|||
146568176|NCT04099277|528593388|FG000|Overall Study|Withdrawal by Subject|1|||
146568177|NCT03759600|528593397|FG000|Overall Study|Adverse Event|2|||
146568178|NCT03759600|528593397|FG000|Overall Study|Progressive Disease|15|||
146568179|NCT03759600|528593397|FG000|Overall Study|Site Terminated by Sponsor|3|||
146568180|NCT03257358|528593398|FG000|Overall Study|Adverse Event|25|||
146568181|NCT03257358|528593399|FG001|Overall Study|Adverse Event|12|||
146568182|NCT03257358|528593398|FG000|Overall Study|Lack of Efficacy|1|||
146568183|NCT03257358|528593399|FG001|Overall Study|Lack of Efficacy|1|||
146568184|NCT03257358|528593398|FG000|Overall Study|Lost to Follow-up|12|||
146568185|NCT03257358|528593399|FG001|Overall Study|Lost to Follow-up|4|||
146568186|NCT03257358|528593398|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
146568187|NCT03257358|528593399|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
146913807|NCT00090285|529847078|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
146913808|NCT00090285|529847079|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
146913809|NCT00090285|529847074|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
146913810|NCT00090285|529847075|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
146913811|NCT00090285|529847076|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
146568188|NCT03257358|528593398|FG000|Overall Study|Physician Decision|2|||
146568189|NCT03257358|528593399|FG001|Overall Study|Physician Decision|2|||
146568190|NCT03257358|528593398|FG000|Overall Study|Protocol Violation|5|||
146568191|NCT03257358|528593399|FG001|Overall Study|Protocol Violation|3|||
146568192|NCT03257358|528593398|FG000|Overall Study|Technical problems|4|||
146568193|NCT03257358|528593399|FG001|Overall Study|Technical problems|1|||
146568194|NCT03257358|528593398|FG000|Overall Study|Withdrawal by Subject|8|||
146568195|NCT03257358|528593399|FG001|Overall Study|Withdrawal by Subject|3|||
146568196|NCT03257358|528593398|FG000|Overall Study|Withdrawal of informed consent|9|||
146568197|NCT03257358|528593399|FG001|Overall Study|Withdrawal of informed consent|5|||
146568198|NCT03257358|528593398|FG000|Overall Study|New therapy for study indication|1|||
146568199|NCT03257358|528593399|FG001|Overall Study|New therapy for study indication|0|||
146568200|NCT03257358|528593398|FG000|Overall Study|No longer requires treatment|0|||
146568201|NCT03257358|528593399|FG001|Overall Study|No longer requires treatment|1|||
146568202|NCT00305877|528593400|FG000|Overall Study|Lack of Efficacy|6|||
146568203|NCT00305877|528593401|FG001|Overall Study|Lack of Efficacy|9|||
146568204|NCT00305877|528593400|FG000|Overall Study|Adverse Event|9|||
146568205|NCT00305877|528593401|FG001|Overall Study|Adverse Event|14|||
146568206|NCT00305877|528593400|FG000|Overall Study|Death|0|||
146568207|NCT00305877|528593401|FG001|Overall Study|Death|1|||
146568208|NCT00305877|528593400|FG000|Overall Study|Withdrawal by Subject|4|||
146568209|NCT00305877|528593401|FG001|Overall Study|Withdrawal by Subject|2|||
146568210|NCT00305877|528593400|FG000|Overall Study|Physician Decision|1|||
146568211|NCT00305877|528593401|FG001|Overall Study|Physician Decision|1|||
146568212|NCT00305877|528593400|FG000|Overall Study|Never start treatment|2|||
146568213|NCT00305877|528593401|FG001|Overall Study|Never start treatment|5|||
146568214|NCT00305877|528593400|FG000|Overall Study|Ineligible|2|||
146568215|NCT00305877|528593401|FG001|Overall Study|Ineligible|1|||
146568216|NCT00305877|528593400|FG000|Overall Study|Transportation issue with daily RT|0|||
146568217|NCT00305877|528593401|FG001|Overall Study|Transportation issue with daily RT|1|||
146568218|NCT01248793|528593402|FG000|Overall Study|Lost to Follow-up|0|||
146568219|NCT01248793|528593403|FG001|Overall Study|Lost to Follow-up|1|||
146568220|NCT01248793|528593402|FG000|Overall Study|Adverse Event|1|||
146568221|NCT01248793|528593403|FG001|Overall Study|Adverse Event|1|||
146568222|NCT01248793|528593402|FG000|Overall Study|Protocol Violation|0|||
146568223|NCT01248793|528593403|FG001|Overall Study|Protocol Violation|1|||
146568224|NCT01248793|528593402|FG000|Overall Study|Withdrawal by Subject|3|||
146568225|NCT01248793|528593403|FG001|Overall Study|Withdrawal by Subject|3|||
146568226|NCT02332187|528593404|FG000|Overall Study|Withdrawal by Subject|2|||
146568227|NCT02332187|528593405|FG001|Overall Study|Withdrawal by Subject|2|||
146568228|NCT02332187|528593404|FG000|Overall Study|Adverse Event|0|||
146568229|NCT02332187|528593405|FG001|Overall Study|Adverse Event|1|||
146568230|NCT00355030|528593412|FG000|Study Period 1 Treatment|Adverse Event|1|||
146568231|NCT00355030|528593413|FG001|Study Period 1 Treatment|Adverse Event|1|||
146568232|NCT00355030|528593412|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
146568233|NCT00355030|528593413|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
146568234|NCT00355030|528593412|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
146568235|NCT00355030|528593413|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
146568236|NCT00355030|528593412|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
146568237|NCT00355030|528593413|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
146568238|NCT00355030|528593412|FG000|Study Period 1 Treatment|Physician Decision|0|||
146568239|NCT00355030|528593413|FG001|Study Period 1 Treatment|Physician Decision|1|||
146568240|NCT00355030|528593412|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
146568241|NCT00355030|528593413|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
146568242|NCT00355030|528593412|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
146568243|NCT00355030|528593413|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
146568244|NCT00355030|528593412|FG000|Study Period 1 Treatment|Other|2|||
146568245|NCT00355030|528593413|FG001|Study Period 1 Treatment|Other|6|||
146913812|NCT00090285|529847077|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
146913813|NCT00090285|529847078|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
146913814|NCT00090285|529847079|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
146913815|NCT00090285|529847074|FG000|Base Study Follow-up Period|Moved|41|||
146913816|NCT00090285|529847075|FG001|Base Study Follow-up Period|Moved|36|||
146913817|NCT00090285|529847076|FG002|Base Study Follow-up Period|Moved|0|||
146913818|NCT00090285|529847077|FG003|Base Study Follow-up Period|Moved|0|||
146913819|NCT00090285|529847078|FG004|Base Study Follow-up Period|Moved|0|||
146913820|NCT00090285|529847079|FG005|Base Study Follow-up Period|Moved|0|||
146568246|NCT00355030|528593412|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
146568247|NCT00355030|528593413|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
146568248|NCT00355030|528593412|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
146568249|NCT00355030|528593413|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
146913821|NCT00090285|529847074|FG000|Base Study Follow-up Period|Other|2|||
146568250|NCT00339040|528593414|FG000|Stage I|Not able to attend clinic|1|||
146913822|NCT00090285|529847075|FG001|Base Study Follow-up Period|Other|0|||
146568251|NCT00339040|528593415|FG001|Stage I|Not able to attend clinic|0|||
146568252|NCT00339040|528593414|FG000|Stage I|Protocol Violation|1|||
146568253|NCT00339040|528593415|FG001|Stage I|Protocol Violation|1|||
146568254|NCT00339040|528593414|FG000|Stage II|Lost to Follow-up|3|||
146568255|NCT00339040|528593415|FG001|Stage II|Lost to Follow-up|0|||
146568256|NCT00339040|528593414|FG000|Stage II|Withdrawal by Subject|1|||
146568257|NCT00339040|528593415|FG001|Stage II|Withdrawal by Subject|2|||
146568258|NCT00339040|528593414|FG000|Stage II|Protocol Violation|3|||
146568259|NCT00339040|528593415|FG001|Stage II|Protocol Violation|0|||
146568260|NCT00339040|528593414|FG000|Stage II|Not able to attend clinic|1|||
146568261|NCT00339040|528593415|FG001|Stage II|Not able to attend clinic|0|||
146568262|NCT00339040|528593414|FG000|Stage II|Site closing|2|||
146568263|NCT00339040|528593415|FG001|Stage II|Site closing|0|||
146568264|NCT01747915|528593416|FG000|Overall Study|Other|1|||
146568265|NCT01747915|528593417|FG001|Overall Study|Other|1|||
146568266|NCT01747915|528593418|FG002|Overall Study|Other|1|||
146568267|NCT01747915|528593416|FG000|Overall Study|Adverse Event|8|||
146568268|NCT01747915|528593417|FG001|Overall Study|Adverse Event|5|||
146568269|NCT01747915|528593418|FG002|Overall Study|Adverse Event|2|||
146568270|NCT01747915|528593416|FG000|Overall Study|Death|0|||
146568271|NCT01747915|528593417|FG001|Overall Study|Death|0|||
146568272|NCT01747915|528593418|FG002|Overall Study|Death|1|||
146568273|NCT01747915|528593416|FG000|Overall Study|Lack of Efficacy|0|||
146568274|NCT01747915|528593417|FG001|Overall Study|Lack of Efficacy|1|||
146568275|NCT01747915|528593418|FG002|Overall Study|Lack of Efficacy|0|||
146568276|NCT01747915|528593416|FG000|Overall Study|Lost to Follow-up|1|||
146568277|NCT01747915|528593417|FG001|Overall Study|Lost to Follow-up|0|||
146568278|NCT01747915|528593418|FG002|Overall Study|Lost to Follow-up|0|||
146568279|NCT01747915|528593416|FG000|Overall Study|Withdrawal by Subject|4|||
146568280|NCT01747915|528593417|FG001|Overall Study|Withdrawal by Subject|4|||
146568281|NCT01747915|528593418|FG002|Overall Study|Withdrawal by Subject|1|||
146568282|NCT01747915|528593416|FG000|Overall Study|Protocol Violation|1|||
146568283|NCT01747915|528593417|FG001|Overall Study|Protocol Violation|0|||
146568284|NCT01747915|528593418|FG002|Overall Study|Protocol Violation|0|||
146568285|NCT01747915|528593416|FG000|Overall Study|Pregnancy|0|||
146568286|NCT01747915|528593417|FG001|Overall Study|Pregnancy|0|||
146568287|NCT01747915|528593418|FG002|Overall Study|Pregnancy|1|||
146568288|NCT02391311|528593421|FG000|Overall Study|Lost to Follow-up|2|||
146568289|NCT02391311|528593422|FG001|Overall Study|Lost to Follow-up|1|||
146568290|NCT02391311|528593421|FG000|Overall Study|deemed ineligible after baseline|1|||
146568291|NCT02391311|528593422|FG001|Overall Study|deemed ineligible after baseline|1|||
146568292|NCT03183063|528593423|FG000|Overall Study|Withdrawal by Subject|2|||
146568293|NCT03183063|528593424|FG001|Overall Study|Withdrawal by Subject|0|||
146568294|NCT03183063|528593425|FG002|Overall Study|Withdrawal by Subject|0|||
146568295|NCT03183063|528593423|FG000|Overall Study|Physician Decision|3|||
146568296|NCT03183063|528593424|FG001|Overall Study|Physician Decision|4|||
146568297|NCT03183063|528593425|FG002|Overall Study|Physician Decision|4|||
146568298|NCT00688467|528593426|FG000|Treatment Period 1|Adverse Event|2|||
146568299|NCT00688467|528593427|FG001|Treatment Period 1|Adverse Event|1|||
146568300|NCT00688467|528593426|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
146568301|NCT00688467|528593427|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
146568302|NCT00688467|528593426|FG000|Treatment Period 2|Protocol Violation|0|||
146568303|NCT00688467|528593427|FG001|Treatment Period 2|Protocol Violation|1|||
146568304|NCT00688467|528593426|FG000|Treatment Period 2|Adverse Event|0|||
146568305|NCT00688467|528593427|FG001|Treatment Period 2|Adverse Event|1|||
146568306|NCT00690794|528593432|FG000|Overall Study|Adverse Event|12|||
146568307|NCT00690794|528593433|FG001|Overall Study|Adverse Event|10|||
146568308|NCT00690794|528593432|FG000|Overall Study|Lost to Follow-up|1|||
146568309|NCT00690794|528593433|FG001|Overall Study|Lost to Follow-up|4|||
146568310|NCT00690794|528593432|FG000|Overall Study|Withdrawal by Subject|0|||
146568311|NCT00690794|528593433|FG001|Overall Study|Withdrawal by Subject|9|||
146568312|NCT00690794|528593432|FG000|Overall Study|Protocol Violation|6|||
146568313|NCT00690794|528593433|FG001|Overall Study|Protocol Violation|7|||
146568314|NCT00690794|528593432|FG000|Overall Study|Noncompliance|1|||
146568315|NCT00690794|528593433|FG001|Overall Study|Noncompliance|2|||
146568316|NCT00690794|528593432|FG000|Overall Study|Other not specified|1|||
146568317|NCT00690794|528593433|FG001|Overall Study|Other not specified|3|||
146568318|NCT01073293|528593434|FG000|Overall Study|Lost to Follow-up|0|||
146568319|NCT01073293|528593435|FG001|Overall Study|Lost to Follow-up|1|||
146568320|NCT01073293|528593434|FG000|Overall Study|Withdrawal by Subject|5|||
146568321|NCT01073293|528593435|FG001|Overall Study|Withdrawal by Subject|10|||
146974752|NCT00434148|530069674|FG000|Overall Study|Withdrawal by Subject|15|||
146568322|NCT00305448|528593436|FG000|Overall Study|Protocol Violation|0|||
146568323|NCT00305448|528593437|FG001|Overall Study|Protocol Violation|1|||
146568324|NCT00305448|528593438|FG002|Overall Study|Protocol Violation|0|||
146568325|NCT00305448|528593436|FG000|Overall Study|Withdrawal by Subject|2|||
146568326|NCT00305448|528593437|FG001|Overall Study|Withdrawal by Subject|0|||
146568327|NCT00305448|528593438|FG002|Overall Study|Withdrawal by Subject|1|||
146568328|NCT00305448|528593436|FG000|Overall Study|Adverse Event|1|||
146974753|NCT00434148|530069675|FG001|Overall Study|Withdrawal by Subject|15|||
146568329|NCT00305448|528593437|FG001|Overall Study|Adverse Event|0|||
146568330|NCT00305448|528593438|FG002|Overall Study|Adverse Event|1|||
146568331|NCT00305448|528593436|FG000|Overall Study|Disease Progression|27|||
146568332|NCT00305448|528593437|FG001|Overall Study|Disease Progression|31|||
146568333|NCT00305448|528593438|FG002|Overall Study|Disease Progression|28|||
146568334|NCT00305448|528593436|FG000|Overall Study|Subjective Disease Progression|1|||
146568335|NCT00305448|528593437|FG001|Overall Study|Subjective Disease Progression|2|||
146650158|NCT03011892|528895015|FG001|Open Label (OL) Period|Reason not specified|0|||
146650159|NCT03011892|528895016|FG002|Open Label (OL) Period|Reason not specified|0|||
146650160|NCT03011892|528895017|FG003|Open Label (OL) Period|Reason not specified|0|||
146650161|NCT03011892|528895018|FG004|Open Label (OL) Period|Reason not specified|0|||
146650162|NCT03011892|528895019|FG005|Open Label (OL) Period|Reason not specified|0|||
146650163|NCT03011892|528895020|FG006|Open Label (OL) Period|Reason not specified|0|||
146650164|NCT03011892|528895021|FG007|Open Label (OL) Period|Reason not specified|1|||
146650165|NCT03011892|528895022|FG008|Open Label (OL) Period|Reason not specified|0|||
146650166|NCT03011892|528895023|FG009|Open Label (OL) Period|Reason not specified|0|||
146650167|NCT03011892|528895024|FG010|Open Label (OL) Period|Reason not specified|0|||
146650168|NCT03011892|528895025|FG011|Open Label (OL) Period|Reason not specified|0|||
146650169|NCT00384111|528895038|FG000|Overall Study|Disease Progression|3|||
146650170|NCT00384111|528895038|FG000|Overall Study|Adverse Event|1|||
146650171|NCT00384111|528895038|FG000|Overall Study|Investigator Decision|3|||
146650172|NCT00384111|528895038|FG000|Overall Study|Study Terminated by the Sponsor|19|||
146913823|NCT00090285|529847076|FG002|Base Study Follow-up Period|Other|0|||
146913824|NCT00090285|529847077|FG003|Base Study Follow-up Period|Other|0|||
146913825|NCT00090285|529847078|FG004|Base Study Follow-up Period|Other|0|||
146913826|NCT00090285|529847079|FG005|Base Study Follow-up Period|Other|0|||
146913827|NCT00090285|529847074|FG000|Base Study Follow-up Period|Protocol Violation|1|||
146913828|NCT00090285|529847075|FG001|Base Study Follow-up Period|Protocol Violation|0|||
146508228|NCT02407457|528364587|FG000|1 Year|Open Repair|0|||
146508229|NCT02407457|528364588|FG001|1 Year|Open Repair|1|||
146508230|NCT02407457|528364587|FG000|2-year|Death|14|||
146508231|NCT02407457|528364588|FG001|2-year|Death|8|||
146508232|NCT02407457|528364587|FG000|2-year|Lost to Follow-up|7|||
146508233|NCT02407457|528364588|FG001|2-year|Lost to Follow-up|10|||
146508234|NCT02407457|528364587|FG000|2-year|Missed Visit|13|||
146508235|NCT02407457|528364588|FG001|2-year|Missed Visit|15|||
146508236|NCT02407457|528364587|FG000|2-year|Open Repair|0|||
146508237|NCT02407457|528364588|FG001|2-year|Open Repair|2|||
146508238|NCT02407457|528364587|FG000|3-year|Death|11|||
146508239|NCT02407457|528364588|FG001|3-year|Death|10|||
146508240|NCT02407457|528364587|FG000|3-year|Lost to Follow-up|9|||
146508241|NCT02407457|528364588|FG001|3-year|Lost to Follow-up|10|||
146508242|NCT02407457|528364587|FG000|3-year|Missed Visit|19|||
146508243|NCT02407457|528364588|FG001|3-year|Missed Visit|16|||
146508244|NCT02407457|528364587|FG000|4-year|Death|18|||
146508245|NCT02407457|528364588|FG001|4-year|Death|10|||
146508246|NCT02407457|528364587|FG000|4-year|Lost to Follow-up|10|||
146508247|NCT02407457|528364588|FG001|4-year|Lost to Follow-up|12|||
146508248|NCT02407457|528364587|FG000|4-year|Missed Visit|18|||
146508249|NCT02407457|528364588|FG001|4-year|Missed Visit|16|||
146508250|NCT02407457|528364587|FG000|5-year|Death|10|||
146508251|NCT02407457|528364588|FG001|5-year|Death|3|||
146508252|NCT02407457|528364587|FG000|5-year|Lost to Follow-up|22|||
146508253|NCT02407457|528364588|FG001|5-year|Lost to Follow-up|13|||
146508254|NCT02407457|528364587|FG000|5-year|Missed Visit|9|||
146508255|NCT02407457|528364588|FG001|5-year|Missed Visit|1|||
146508256|NCT03332628|528364605|FG000|Overall Study|Physician Decision|2|||
146508257|NCT02505334|528364608|FG000|Main Treatment Period|Adverse Event|3|||
146508258|NCT02505334|528364609|FG001|Main Treatment Period|Adverse Event|3|||
146508259|NCT02505334|528364608|FG000|Main Treatment Period|Lack of Efficacy|7|||
146508260|NCT02505334|528364609|FG001|Main Treatment Period|Lack of Efficacy|17|||
146508261|NCT02505334|528364608|FG000|Main Treatment Period|Protocol Violation|0|||
146508262|NCT02505334|528364609|FG001|Main Treatment Period|Protocol Violation|1|||
146508263|NCT02505334|528364608|FG000|Main Treatment Period|Withdrawal by Subject|1|||
146508264|NCT02505334|528364609|FG001|Main Treatment Period|Withdrawal by Subject|8|||
146508265|NCT02505334|528364608|FG000|Main Treatment Period|Unclassified|4|||
146508266|NCT02505334|528364609|FG001|Main Treatment Period|Unclassified|10|||
146508267|NCT02505334|528364608|FG000|Extension Treatment Period|Adverse Event|5|||
146508268|NCT02505334|528364609|FG001|Extension Treatment Period|Adverse Event|0|||
146913829|NCT00090285|529847076|FG002|Base Study Follow-up Period|Protocol Violation|0|||
146913830|NCT00090285|529847077|FG003|Base Study Follow-up Period|Protocol Violation|0|||
146913831|NCT00090285|529847078|FG004|Base Study Follow-up Period|Protocol Violation|0|||
146508269|NCT02505334|528364608|FG000|Extension Treatment Period|Lack of Efficacy|4|||
146650173|NCT00906971|528895039|FG000|Overall Study|Withdrawal by Subject|8|||
146650174|NCT00906971|528895040|FG001|Overall Study|Withdrawal by Subject|2|||
146650175|NCT00906971|528895039|FG000|Overall Study|Lost to Follow-up|0|||
146508270|NCT02505334|528364609|FG001|Extension Treatment Period|Lack of Efficacy|0|||
146508271|NCT02505334|528364608|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
146508272|NCT02505334|528364609|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
146508273|NCT02505334|528364608|FG000|Extension Treatment Period|Unclassified|3|||
146508274|NCT02505334|528364609|FG001|Extension Treatment Period|Unclassified|0|||
146508275|NCT01629823|528364613|FG000|Trial Period|Missed visit|11|||
146508276|NCT01629823|528364614|FG001|Trial Period|Missed visit|9|||
146508277|NCT01629823|528364615|FG002|Trial Period|Missed visit|8|||
146508278|NCT01629823|528364613|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
146508279|NCT01629823|528364614|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
146508280|NCT01629823|528364615|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
146508281|NCT01629823|528364613|FG000|Trial Period|Pregnancy|1|||
146508282|NCT01629823|528364614|FG001|Trial Period|Pregnancy|0|||
146508283|NCT01629823|528364615|FG002|Trial Period|Pregnancy|0|||
146508284|NCT01629823|528364613|FG000|Trial Period|Adverse Event|0|||
146508285|NCT01629823|528364614|FG001|Trial Period|Adverse Event|1|||
146508286|NCT01629823|528364615|FG002|Trial Period|Adverse Event|0|||
146508287|NCT01629823|528364613|FG000|Trial Period|Out-of-window visit|0|||
146508288|NCT01629823|528364614|FG001|Trial Period|Out-of-window visit|2|||
146508289|NCT01629823|528364615|FG002|Trial Period|Out-of-window visit|0|||
146508290|NCT01629823|528364613|FG000|Trial Period|Failed to hold medication|0|||
146508291|NCT01629823|528364614|FG001|Trial Period|Failed to hold medication|0|||
146508292|NCT01629823|528364615|FG002|Trial Period|Failed to hold medication|1|||
146508293|NCT01629823|528364613|FG000|Washout Period|Safety|2|||
146508294|NCT01629823|528364614|FG001|Washout Period|Safety|5|||
146508295|NCT01629823|528364615|FG002|Washout Period|Safety|0|||
146508296|NCT01629823|528364613|FG000|Washout Period|Pregnancy|1|||
146508297|NCT01629823|528364614|FG001|Washout Period|Pregnancy|0|||
146508298|NCT01629823|528364615|FG002|Washout Period|Pregnancy|0|||
146508299|NCT01629823|528364613|FG000|Washout Period|Protocol Violation|0|||
146508300|NCT01629823|528364614|FG001|Washout Period|Protocol Violation|1|||
146508301|NCT01629823|528364615|FG002|Washout Period|Protocol Violation|0|||
146508302|NCT00525902|528364616|FG000|Overall Study|Lack of Efficacy|1|||
146508303|NCT02258542|528364617|FG000|Overall Study|eg. not made to the visit|7|||
146508304|NCT02258542|528364618|FG001|Overall Study|eg. not made to the visit|4|||
146508305|NCT02258542|528364619|FG002|Overall Study|eg. not made to the visit|0|||
146508306|NCT02258542|528364620|FG003|Overall Study|eg. not made to the visit|1|||
146508307|NCT02258542|528364617|FG000|Overall Study|study specific discount. criteria|1|||
146508308|NCT02258542|528364618|FG001|Overall Study|study specific discount. criteria|1|||
146508309|NCT02258542|528364619|FG002|Overall Study|study specific discount. criteria|0|||
146508310|NCT02258542|528364620|FG003|Overall Study|study specific discount. criteria|0|||
146508311|NCT02258542|528364617|FG000|Overall Study|Withdrawal by Subject|20|||
146508312|NCT02258542|528364618|FG001|Overall Study|Withdrawal by Subject|20|||
146508313|NCT02258542|528364619|FG002|Overall Study|Withdrawal by Subject|7|||
146508314|NCT02258542|528364620|FG003|Overall Study|Withdrawal by Subject|1|||
146508315|NCT02258542|528364617|FG000|Overall Study|Lost to Follow-up|5|||
146508316|NCT02258542|528364618|FG001|Overall Study|Lost to Follow-up|12|||
146508317|NCT02258542|528364619|FG002|Overall Study|Lost to Follow-up|1|||
146508318|NCT02258542|528364620|FG003|Overall Study|Lost to Follow-up|2|||
146508319|NCT02258542|528364617|FG000|Overall Study|Death|5|||
146508320|NCT02258542|528364618|FG001|Overall Study|Death|4|||
146508321|NCT02258542|528364619|FG002|Overall Study|Death|0|||
146508322|NCT02258542|528364620|FG003|Overall Study|Death|1|||
146508323|NCT02258542|528364617|FG000|Overall Study|Adverse Event|3|||
146508324|NCT02258542|528364618|FG001|Overall Study|Adverse Event|4|||
146508325|NCT02258542|528364619|FG002|Overall Study|Adverse Event|0|||
146508326|NCT02258542|528364620|FG003|Overall Study|Adverse Event|0|||
146508327|NCT02258542|528364617|FG000|Overall Study|Protocol Violation|1|||
146508328|NCT02258542|528364618|FG001|Overall Study|Protocol Violation|2|||
146508329|NCT02258542|528364619|FG002|Overall Study|Protocol Violation|0|||
146508330|NCT02258542|528364620|FG003|Overall Study|Protocol Violation|0|||
146508331|NCT02258542|528364617|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146508332|NCT02258542|528364618|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
146508333|NCT02258542|528364619|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
146508334|NCT02258542|528364620|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
146508335|NCT03235115|528364624|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
146508336|NCT03235115|528364625|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
146508337|NCT03235115|528364626|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
146508338|NCT03235115|528364627|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
146508339|NCT03235115|528364628|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
146508340|NCT03235115|528364629|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
146508341|NCT04972968|528364631|FG000|Overall Study|Adverse Event|3|||
146508342|NCT04972968|528364632|FG001|Overall Study|Adverse Event|1|||
146508343|NCT04972968|528364633|FG002|Overall Study|Adverse Event|1|||
146508344|NCT04972968|528364634|FG003|Overall Study|Adverse Event|7|||
146650176|NCT00906971|528895040|FG001|Overall Study|Lost to Follow-up|1|||
146508345|NCT04972968|528364631|FG000|Overall Study|Lack of Efficacy|2|||
146508346|NCT04972968|528364632|FG001|Overall Study|Lack of Efficacy|1|||
146508347|NCT04972968|528364633|FG002|Overall Study|Lack of Efficacy|0|||
146508348|NCT04972968|528364634|FG003|Overall Study|Lack of Efficacy|0|||
146508349|NCT04972968|528364631|FG000|Overall Study|Withdrawal by Subject|7|||
146508350|NCT04972968|528364632|FG001|Overall Study|Withdrawal by Subject|4|||
146508351|NCT04972968|528364633|FG002|Overall Study|Withdrawal by Subject|3|||
146508352|NCT04972968|528364634|FG003|Overall Study|Withdrawal by Subject|2|||
146508353|NCT04972968|528364631|FG000|Overall Study|Study Terminated by Sponsor|25|||
146508354|NCT04972968|528364632|FG001|Overall Study|Study Terminated by Sponsor|28|||
146508355|NCT04972968|528364633|FG002|Overall Study|Study Terminated by Sponsor|32|||
146508356|NCT04972968|528364634|FG003|Overall Study|Study Terminated by Sponsor|27|||
146568336|NCT00305448|528593438|FG002|Overall Study|Subjective Disease Progression|2|||
146568337|NCT00305448|528593436|FG000|Overall Study|Tumor Marker Elevation|0|||
146913832|NCT00090285|529847079|FG005|Base Study Follow-up Period|Protocol Violation|0|||
146913833|NCT00090285|529847074|FG000|Base Study Follow-up Period|Uncooperative|3|||
146913834|NCT00090285|529847075|FG001|Base Study Follow-up Period|Uncooperative|4|||
146913835|NCT00090285|529847076|FG002|Base Study Follow-up Period|Uncooperative|0|||
146913836|NCT00090285|529847077|FG003|Base Study Follow-up Period|Uncooperative|0|||
146913837|NCT00090285|529847078|FG004|Base Study Follow-up Period|Uncooperative|0|||
146568338|NCT00305448|528593437|FG001|Overall Study|Tumor Marker Elevation|0|||
146568339|NCT00305448|528593438|FG002|Overall Study|Tumor Marker Elevation|1|||
146568340|NCT01343888|528593439|FG000|Overall Study|Adverse Event|12|||
146568341|NCT01343888|528593440|FG001|Overall Study|Adverse Event|22|||
146568342|NCT01343888|528593441|FG002|Overall Study|Adverse Event|5|||
146568343|NCT01343888|528593439|FG000|Overall Study|Lack of Efficacy|9|||
146568344|NCT01343888|528593440|FG001|Overall Study|Lack of Efficacy|9|||
146568345|NCT01343888|528593441|FG002|Overall Study|Lack of Efficacy|13|||
146568346|NCT01343888|528593439|FG000|Overall Study|Lost to Follow-up|0|||
146568347|NCT01343888|528593440|FG001|Overall Study|Lost to Follow-up|2|||
146568348|NCT01343888|528593441|FG002|Overall Study|Lost to Follow-up|1|||
146568349|NCT01343888|528593439|FG000|Overall Study|Protocol Violation|0|||
146568350|NCT01343888|528593440|FG001|Overall Study|Protocol Violation|2|||
146568351|NCT01343888|528593441|FG002|Overall Study|Protocol Violation|0|||
146568352|NCT01343888|528593439|FG000|Overall Study|Withdrawal by Subject|4|||
146568353|NCT01343888|528593440|FG001|Overall Study|Withdrawal by Subject|4|||
146568354|NCT01343888|528593441|FG002|Overall Study|Withdrawal by Subject|2|||
146568355|NCT01343888|528593439|FG000|Overall Study|other than stated above|0|||
146568356|NCT01343888|528593440|FG001|Overall Study|other than stated above|0|||
146568357|NCT01343888|528593441|FG002|Overall Study|other than stated above|1|||
146568358|NCT00077974|528593442|FG000|Overall Study|Adverse Event|22|||
146568359|NCT00077974|528593442|FG000|Overall Study|Protocol Violation|1|||
146568360|NCT00077974|528593442|FG000|Overall Study|Withdrawal by Subject|3|||
146568361|NCT00077974|528593442|FG000|Overall Study|Lack of Efficacy|76|||
146568362|NCT00077974|528593442|FG000|Overall Study|Decision of Sponsor|2|||
146568363|NCT04108273|528593454|FG000|Overall Study|COVID Pandemic|1|||
146568364|NCT04108273|528593455|FG001|Overall Study|COVID Pandemic|0|||
146568365|NCT00506142|528593456|FG000|Overall Study|Adverse Event|8|||
146568366|NCT00506142|528593457|FG001|Overall Study|Adverse Event|7|||
146568367|NCT00506142|528593456|FG000|Overall Study|Lack of Efficacy|21|||
146568368|NCT00506142|528593457|FG001|Overall Study|Lack of Efficacy|7|||
146650177|NCT01551420|528895041|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
146650178|NCT01551420|528895042|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
146650179|NCT01551420|528895041|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
146650180|NCT01551420|528895042|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
146650181|NCT01551420|528895041|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
146650182|NCT01551420|528895042|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
146650183|NCT01551420|528895041|FG000|Screened for Part B Eligibility|Declined participation|8|||
146650184|NCT01551420|528895042|FG001|Screened for Part B Eligibility|Declined participation|1|||
146913838|NCT00090285|529847079|FG005|Base Study Follow-up Period|Uncooperative|0|||
146913839|NCT00090285|529847074|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
146913840|NCT00090285|529847075|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
146913841|NCT00090285|529847076|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
146913842|NCT00090285|529847077|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
146913843|NCT00090285|529847078|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
146568369|NCT00506142|528593456|FG000|Overall Study|Withdrawal by Subject|4|||
146568370|NCT00506142|528593457|FG001|Overall Study|Withdrawal by Subject|5|||
146568371|NCT00506142|528593456|FG000|Overall Study|Physician Decision|1|||
146568372|NCT00506142|528593457|FG001|Overall Study|Physician Decision|0|||
146568373|NCT00506142|528593456|FG000|Overall Study|New health condition|1|||
146568374|NCT00506142|528593457|FG001|Overall Study|New health condition|0|||
146568375|NCT03500211|528593462|FG000|Overall Study|Withdrawal by Subject|1|||
146568376|NCT03500211|528593463|FG001|Overall Study|Withdrawal by Subject|1|||
146650185|NCT01551420|528895041|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
146770008|NCT00843882|529326656|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
146913844|NCT00090285|529847079|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
146913845|NCT00090285|529847074|FG000|Extension 1|Adverse Event|0|||
146913846|NCT00090285|529847075|FG001|Extension 1|Adverse Event|0|||
146568377|NCT04460183|528593464|FG000|Overall Study|Lost to Follow-up|3|||
146568378|NCT04460183|528593465|FG001|Overall Study|Lost to Follow-up|1|||
146568379|NCT04460183|528593464|FG000|Overall Study|Withdrawal by Subject|1|||
146568380|NCT04460183|528593465|FG001|Overall Study|Withdrawal by Subject|0|||
146568381|NCT00487981|528593466|FG000|Overall Study|Hypothyroidism diagnosis|1|||
146568382|NCT03848416|528593467|FG000|Overall Study|Withdrawal by Subject|1|||
146568383|NCT03848416|528593468|FG001|Overall Study|Withdrawal by Subject|0|||
146568384|NCT03848416|528593469|FG002|Overall Study|Withdrawal by Subject|0|||
146568385|NCT03848416|528593467|FG000|Overall Study|Death|0|||
146568386|NCT03848416|528593468|FG001|Overall Study|Death|0|||
146770009|NCT00843882|529326657|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
146770010|NCT00843882|529326655|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
146770011|NCT00843882|529326656|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
146770012|NCT00843882|529326657|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
146770013|NCT00843882|529326655|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
146770014|NCT00843882|529326656|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
146770015|NCT00843882|529326657|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
146770016|NCT00843882|529326655|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
146770017|NCT00843882|529326656|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
146770018|NCT00843882|529326657|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
146770019|NCT00843882|529326655|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
146770020|NCT00843882|529326656|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
146770021|NCT00843882|529326657|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
146770022|NCT00256243|529326658|FG000|Overall Study|Lost to Follow-up|2|||
146770023|NCT00256243|529326658|FG000|Overall Study|Death|7|||
146770024|NCT00256243|529326658|FG000|Overall Study|Not treated|1|||
146770025|NCT02248480|529326659|FG000|Overall Study|Lack of Efficacy|4|||
146770026|NCT02248480|529326660|FG001|Overall Study|Lack of Efficacy|6|||
146770027|NCT02248480|529326659|FG000|Overall Study|Adverse Event|11|||
146770028|NCT02248480|529326660|FG001|Overall Study|Adverse Event|2|||
146770029|NCT02248480|529326659|FG000|Overall Study|Withdrawal by Subject|2|||
146770030|NCT02248480|529326660|FG001|Overall Study|Withdrawal by Subject|4|||
146770031|NCT02248480|529326659|FG000|Overall Study|Entry Criteria Not Met|0|||
146770032|NCT02248480|529326660|FG001|Overall Study|Entry Criteria Not Met|1|||
146770033|NCT02248480|529326659|FG000|Overall Study|Other:Physician Decision|0|||
146770034|NCT02248480|529326660|FG001|Overall Study|Other:Physician Decision|1|||
146770035|NCT04795752|529326661|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
146770036|NCT04795752|529326662|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
146770037|NCT04795752|529326661|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
146770038|NCT04795752|529326662|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
146770039|NCT04795752|529326661|FG000|Primary Endpoint Phase|Physician Decision|2|||
146770040|NCT04795752|529326662|FG001|Primary Endpoint Phase|Physician Decision|0|||
146770041|NCT04795752|529326661|FG000|Primary Endpoint Phase|Other|4|||
146770042|NCT04795752|529326662|FG001|Primary Endpoint Phase|Other|1|||
146770043|NCT04795752|529326661|FG000|Primary Endpoint Phase|Protocol Violation|1|||
146770044|NCT04795752|529326662|FG001|Primary Endpoint Phase|Protocol Violation|0|||
146770045|NCT04795752|529326661|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
146770046|NCT04795752|529326662|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
146770047|NCT04795752|529326661|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
146770048|NCT04795752|529326662|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
146770049|NCT04795752|529326661|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
146770050|NCT04795752|529326662|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
146770051|NCT04795752|529326661|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
146770052|NCT04795752|529326662|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
146508357|NCT04972968|528364631|FG000|Overall Study|Other|1|||
146508358|NCT04972968|528364632|FG001|Overall Study|Other|0|||
146508359|NCT04972968|528364633|FG002|Overall Study|Other|1|||
146508360|NCT04972968|528364634|FG003|Overall Study|Other|1|||
146508361|NCT01698879|528364635|FG000|Overall Study|Withdrawal by Subject|1|||
146508362|NCT01698879|528364636|FG001|Overall Study|Withdrawal by Subject|0|||
146508363|NCT01698879|528364637|FG002|Overall Study|Withdrawal by Subject|0|||
146508364|NCT01317797|528364642|FG000|Overall Study|Other|0|||
146508365|NCT01317797|528364643|FG001|Overall Study|Other|1|||
146508366|NCT01317797|528364644|FG002|Overall Study|Other|0|||
146508367|NCT01317797|528364642|FG000|Overall Study|Withdrawal of Patient|0|||
146508368|NCT01317797|528364643|FG001|Overall Study|Withdrawal of Patient|0|||
146508369|NCT01317797|528364644|FG002|Overall Study|Withdrawal of Patient|1|||
146508370|NCT04250714|528366140|FG000|Overall Study|Treatment - withdrawal by subject|14|||
146508371|NCT04250714|528366140|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
146508372|NCT04250714|528366140|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
146508373|NCT04250714|528366140|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
146508374|NCT04250714|528366140|FG000|Overall Study|Treatment - Death|1|||
146508375|NCT04250714|528366140|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
146508376|NCT04250714|528366140|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
146508377|NCT04250714|528366140|FG000|Overall Study|Attempt|2|||
146508378|NCT04250714|528366140|FG000|Overall Study|Intent|7|||
146508379|NCT04439357|528366141|FG000|Overall Study|Disease Progression|4|||
146770053|NCT04795752|529326661|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
146508380|NCT01458951|528366142|FG000|Overall Study|Other|1|||
146508381|NCT01458951|528366143|FG001|Overall Study|Other|0|||
146508382|NCT01458951|528366144|FG002|Overall Study|Other|0|||
146508383|NCT01458951|528366142|FG000|Overall Study|Protocol Violation|5|||
146770054|NCT04795752|529326662|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
146770055|NCT00792948|529326663|FG000|Overall Study|Adverse Event|6|||
146568387|NCT03848416|528593469|FG002|Overall Study|Death|1|||
146568388|NCT02808429|528593475|FG000|Overall Study|Lost to Follow-up|1|||
146568389|NCT02808429|528593476|FG001|Overall Study|Lost to Follow-up|0|||
146568390|NCT02808429|528593477|FG002|Overall Study|Lost to Follow-up|0|||
146568391|NCT02808429|528593475|FG000|Overall Study|Protocol Violation|0|||
146568392|NCT02808429|528593476|FG001|Overall Study|Protocol Violation|1|||
146568393|NCT02808429|528593477|FG002|Overall Study|Protocol Violation|0|||
146568394|NCT02808429|528593475|FG000|Overall Study|Premature study termination by sponsor|2|||
146568395|NCT02808429|528593476|FG001|Overall Study|Premature study termination by sponsor|0|||
146568396|NCT02808429|528593477|FG002|Overall Study|Premature study termination by sponsor|1|||
146568397|NCT02808429|528593475|FG000|Overall Study|Relocation|0|||
146568398|NCT02808429|528593476|FG001|Overall Study|Relocation|0|||
146568399|NCT02808429|528593477|FG002|Overall Study|Relocation|1|||
146568400|NCT00856609|528593481|FG000|Overall Study|Adverse Event|1|||
146568401|NCT00856609|528593482|FG001|Overall Study|Adverse Event|0|||
146568402|NCT01788943|528593483|FG000|Overall Study|Withdrawal by Subject|1|||
146568403|NCT01788943|528593484|FG001|Overall Study|Withdrawal by Subject|0|||
146568404|NCT00783432|528593485|FG000|Overall Study|Adverse Event|22|||
146568405|NCT00783432|528593486|FG001|Overall Study|Adverse Event|17|||
146568406|NCT00783432|528593485|FG000|Overall Study|Lack of Efficacy|20|||
146568407|NCT00783432|528593486|FG001|Overall Study|Lack of Efficacy|21|||
146568408|NCT00783432|528593485|FG000|Overall Study|Lost to Follow-up|11|||
146568409|NCT00783432|528593486|FG001|Overall Study|Lost to Follow-up|6|||
146568410|NCT00783432|528593485|FG000|Overall Study|Withdrawal by Subject|23|||
146568411|NCT00783432|528593486|FG001|Overall Study|Withdrawal by Subject|20|||
146568412|NCT00783432|528593485|FG000|Overall Study|subject moved|3|||
146568413|NCT00783432|528593486|FG001|Overall Study|subject moved|5|||
146568414|NCT00783432|528593485|FG000|Overall Study|Protocol Violation|6|||
146568415|NCT00783432|528593486|FG001|Overall Study|Protocol Violation|9|||
146568416|NCT01436110|528593487|FG000|Overall Study|Lack of Efficacy|23|||
146568417|NCT01436110|528593488|FG001|Overall Study|Lack of Efficacy|14|||
146568418|NCT01436110|528593489|FG002|Overall Study|Lack of Efficacy|9|||
146568419|NCT01436110|528593487|FG000|Overall Study|Withdrawal by Subject|6|||
146568420|NCT01436110|528593488|FG001|Overall Study|Withdrawal by Subject|8|||
146568421|NCT01436110|528593489|FG002|Overall Study|Withdrawal by Subject|4|||
146568422|NCT01436110|528593487|FG000|Overall Study|Adverse Event|2|||
146568423|NCT01436110|528593488|FG001|Overall Study|Adverse Event|1|||
146568424|NCT01436110|528593489|FG002|Overall Study|Adverse Event|2|||
146568425|NCT01436110|528593487|FG000|Overall Study|Physician Decision|3|||
146568426|NCT01436110|528593488|FG001|Overall Study|Physician Decision|1|||
146568427|NCT01436110|528593489|FG002|Overall Study|Physician Decision|1|||
146568428|NCT01436110|528593487|FG000|Overall Study|Lost to Follow-up|1|||
146568429|NCT01436110|528593488|FG001|Overall Study|Lost to Follow-up|1|||
146568430|NCT01436110|528593489|FG002|Overall Study|Lost to Follow-up|3|||
146568431|NCT01436110|528593487|FG000|Overall Study|Protocol Violation|3|||
146568432|NCT01436110|528593488|FG001|Overall Study|Protocol Violation|1|||
146568433|NCT01436110|528593489|FG002|Overall Study|Protocol Violation|1|||
146568434|NCT01436110|528593487|FG000|Overall Study|Did Not Receive Trial Medication|1|||
146568435|NCT01436110|528593488|FG001|Overall Study|Did Not Receive Trial Medication|0|||
146568436|NCT01436110|528593489|FG002|Overall Study|Did Not Receive Trial Medication|3|||
146568437|NCT03273907|528593490|FG000|Overall Study|Death|1|||
146568438|NCT03273907|528593490|FG000|Overall Study|Lost to Follow-up|4|||
146568439|NCT03273907|528593490|FG000|Overall Study|Withdrawal by Subject|2|||
146568440|NCT03273907|528593490|FG000|Overall Study|COVID 19|2|||
146568441|NCT01088503|528593491|FG000|Overall Study|Withdrawal by Subject|118|||
146568442|NCT01088503|528593492|FG001|Overall Study|Withdrawal by Subject|327|||
146568443|NCT01088503|528593493|FG002|Overall Study|Withdrawal by Subject|10|||
146650186|NCT01551420|528895042|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
146650187|NCT01551420|528895041|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
146650188|NCT01551420|528895042|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
146650189|NCT01551420|528895041|FG000|Home Use (Part B)|Withdrawal by staff|0|||
146650190|NCT01551420|528895042|FG001|Home Use (Part B)|Withdrawal by staff|1|||
146650191|NCT00169442|528895043|FG000|Overall Study|Withdrawal by Subject|0|||
146650192|NCT00169442|528895044|FG001|Overall Study|Withdrawal by Subject|0|||
146650193|NCT00169442|528895045|FG002|Overall Study|Withdrawal by Subject|1|||
146650194|NCT00169442|528895046|FG003|Overall Study|Withdrawal by Subject|0|||
146568444|NCT01088503|528593491|FG000|Overall Study|Death|64|||
146568445|NCT01088503|528593492|FG001|Overall Study|Death|358|||
146568446|NCT01088503|528593493|FG002|Overall Study|Death|7|||
146568447|NCT00110214|528593494|FG000|Overall Study|Never started treatment|21|||
146568448|NCT00110214|528593495|FG001|Overall Study|Never started treatment|20|||
146568449|NCT00110214|528593494|FG000|Overall Study|Disease progression or death|260|||
146568450|NCT00110214|528593495|FG001|Overall Study|Disease progression or death|151|||
146568451|NCT00110214|528593494|FG000|Overall Study|Adverse Event|115|||
146568452|NCT00110214|528593495|FG001|Overall Study|Adverse Event|192|||
146568453|NCT00110214|528593494|FG000|Overall Study|Refused further treatment|52|||
146568454|NCT00110214|528593495|FG001|Overall Study|Refused further treatment|65|||
146650195|NCT00169442|528895047|FG004|Overall Study|Withdrawal by Subject|0|||
146913847|NCT00090285|529847076|FG002|Extension 1|Adverse Event|2|||
146913848|NCT00090285|529847077|FG003|Extension 1|Adverse Event|0|||
146913849|NCT00090285|529847078|FG004|Extension 1|Adverse Event|0|||
146913850|NCT00090285|529847079|FG005|Extension 1|Adverse Event|0|||
146913851|NCT00090285|529847074|FG000|Extension 1|Lost to Follow-up|0|||
146913852|NCT00090285|529847075|FG001|Extension 1|Lost to Follow-up|0|||
146913853|NCT00090285|529847076|FG002|Extension 1|Lost to Follow-up|35|||
146913854|NCT00090285|529847077|FG003|Extension 1|Lost to Follow-up|0|||
146913855|NCT00090285|529847078|FG004|Extension 1|Lost to Follow-up|0|||
146913856|NCT00090285|529847079|FG005|Extension 1|Lost to Follow-up|0|||
146913857|NCT00090285|529847074|FG000|Extension 1|Withdrawal by Subject|0|||
146913858|NCT00090285|529847075|FG001|Extension 1|Withdrawal by Subject|0|||
146913859|NCT00090285|529847076|FG002|Extension 1|Withdrawal by Subject|13|||
146913860|NCT00090285|529847077|FG003|Extension 1|Withdrawal by Subject|1|||
146913861|NCT00090285|529847078|FG004|Extension 1|Withdrawal by Subject|0|||
146913862|NCT00090285|529847079|FG005|Extension 1|Withdrawal by Subject|0|||
146913863|NCT00090285|529847074|FG000|Extension 1|Other|0|||
146913864|NCT00090285|529847075|FG001|Extension 1|Other|0|||
146913865|NCT00090285|529847076|FG002|Extension 1|Other|4|||
146913866|NCT00090285|529847077|FG003|Extension 1|Other|0|||
146913867|NCT00090285|529847078|FG004|Extension 1|Other|0|||
146913868|NCT00090285|529847079|FG005|Extension 1|Other|0|||
146913869|NCT00090285|529847074|FG000|Extension 1|Moved|0|||
146913870|NCT00090285|529847075|FG001|Extension 1|Moved|0|||
146913871|NCT00090285|529847076|FG002|Extension 1|Moved|3|||
146913872|NCT00090285|529847077|FG003|Extension 1|Moved|0|||
146913873|NCT00090285|529847078|FG004|Extension 1|Moved|0|||
146913874|NCT00090285|529847079|FG005|Extension 1|Moved|0|||
146913875|NCT00090285|529847074|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
146913876|NCT00090285|529847075|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
146913877|NCT00090285|529847076|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
146913878|NCT00090285|529847077|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
146913879|NCT00090285|529847078|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
146913880|NCT00090285|529847079|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
146913881|NCT00090285|529847074|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
146913882|NCT00090285|529847075|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
146913883|NCT00090285|529847076|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
146913884|NCT00090285|529847077|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
146913885|NCT00090285|529847078|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
146913886|NCT00090285|529847079|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
146913887|NCT00090285|529847074|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
146913888|NCT00090285|529847075|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
146913889|NCT00090285|529847076|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
146913890|NCT00090285|529847077|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
146913891|NCT00090285|529847078|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
146913892|NCT00090285|529847079|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
146913893|NCT00090285|529847074|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
146913894|NCT00090285|529847075|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
146913895|NCT00090285|529847076|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
146913896|NCT00090285|529847077|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
146508384|NCT01458951|528366143|FG001|Overall Study|Protocol Violation|1|||
146508385|NCT01458951|528366144|FG002|Overall Study|Protocol Violation|0|||
146508386|NCT01458951|528366142|FG000|Overall Study|Withdrawal by Subject|2|||
146508387|NCT01458951|528366143|FG001|Overall Study|Withdrawal by Subject|0|||
146508388|NCT01458951|528366144|FG002|Overall Study|Withdrawal by Subject|2|||
146508389|NCT01458951|528366142|FG000|Overall Study|Adverse Event|7|||
146508390|NCT01458951|528366143|FG001|Overall Study|Adverse Event|0|||
146508391|NCT01458951|528366144|FG002|Overall Study|Adverse Event|2|||
146508392|NCT01458951|528366142|FG000|Overall Study|Insufficient Clinical Response|17|||
146508393|NCT01458951|528366143|FG001|Overall Study|Insufficient Clinical Response|0|||
146508394|NCT01458951|528366144|FG002|Overall Study|Insufficient Clinical Response|11|||
146508395|NCT04392167|528366151|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
146508396|NCT03117881|528366154|FG000|Baseline|Withdrawal by Subject|21|||
146508397|NCT03117881|528366155|FG001|Baseline|Withdrawal by Subject|10|||
146508398|NCT03117881|528366156|FG002|Baseline|Withdrawal by Subject|0|||
146508399|NCT03117881|528366154|FG000|Baseline|Lost to Follow-up|22|||
146508400|NCT03117881|528366155|FG001|Baseline|Lost to Follow-up|25|||
146508401|NCT03117881|528366156|FG002|Baseline|Lost to Follow-up|0|||
146913897|NCT00090285|529847078|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
146913898|NCT00090285|529847079|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
146913899|NCT02855411|529847087|FG000|Overall Study|Study terminated by sponsor|21|||
146913900|NCT02855411|529847087|FG000|Overall Study|Does not meet entrance criteria|14|||
146913901|NCT00907881|529847088|FG000|Overall Study|Lost to Follow-up|59|||
146913902|NCT00907881|529847088|FG000|Overall Study|Noncompliance|5|||
146913903|NCT00907881|529847088|FG000|Overall Study|Withdrawal by Subject|5|||
146913904|NCT00907881|529847088|FG000|Overall Study|Protocol Violation|1|||
146974754|NCT00434148|530069674|FG000|Overall Study|Protocol Violation|4|||
146508402|NCT03117881|528366154|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
146770056|NCT00792948|529326663|FG000|Overall Study|Death|4|||
146508403|NCT03117881|528366155|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
146508404|NCT03117881|528366156|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
146508405|NCT03117881|528366154|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
146508406|NCT03117881|528366155|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
146508407|NCT03117881|528366156|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
146508408|NCT03117881|528366154|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
146508409|NCT03117881|528366155|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
146508410|NCT03117881|528366156|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
146508411|NCT03117881|528366154|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
146508412|NCT03117881|528366155|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
146508413|NCT03117881|528366156|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
146508414|NCT03117881|528366154|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
146508415|NCT03117881|528366155|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
146508416|NCT03117881|528366156|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
146508417|NCT03117881|528366154|FG000|6-Month Follow-Up|Did not complete test|53|||
146508418|NCT03117881|528366155|FG001|6-Month Follow-Up|Did not complete test|25|||
146508419|NCT03117881|528366156|FG002|6-Month Follow-Up|Did not complete test|7|||
146508420|NCT03117881|528366154|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
146508421|NCT03117881|528366155|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
146508422|NCT03117881|528366156|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
146508423|NCT03117881|528366154|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
146508424|NCT03117881|528366155|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
146508425|NCT03117881|528366156|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
146508426|NCT03117881|528366154|FG000|12-Month Follow-Up|Did not complete test|40|||
146508427|NCT03117881|528366155|FG001|12-Month Follow-Up|Did not complete test|0|||
146508428|NCT03117881|528366156|FG002|12-Month Follow-Up|Did not complete test|0|||
146508429|NCT00473824|528366157|FG000|Overall Study|Virologic Breakthrough|1|||
146508430|NCT00473824|528366158|FG001|Overall Study|Virologic Breakthrough|0|||
146508431|NCT00473824|528366157|FG000|Overall Study|Adverse Event|1|||
146508432|NCT00473824|528366158|FG001|Overall Study|Adverse Event|0|||
146508433|NCT00473824|528366157|FG000|Overall Study|Death|1|||
146508434|NCT00473824|528366158|FG001|Overall Study|Death|0|||
146508435|NCT00473824|528366157|FG000|Overall Study|Lost to Follow-up|1|||
146508436|NCT00473824|528366158|FG001|Overall Study|Lost to Follow-up|0|||
146508437|NCT00473824|528366157|FG000|Overall Study|Withdrawal by physician|1|||
146508438|NCT00473824|528366158|FG001|Overall Study|Withdrawal by physician|0|||
146508439|NCT02560623|528366159|FG000|Overall Study|Unable to swallow sponge|0|||
146508440|NCT02560623|528366160|FG001|Overall Study|Unable to swallow sponge|1|||
146508441|NCT02560623|528366161|FG002|Overall Study|Unable to swallow sponge|0|||
146508442|NCT02560623|528366162|FG003|Overall Study|Unable to swallow sponge|0|||
146508443|NCT02560623|528366159|FG000|Overall Study|Intervention prior to sponge administration|0|||
146508444|NCT02560623|528366160|FG001|Overall Study|Intervention prior to sponge administration|1|||
146508445|NCT02560623|528366161|FG002|Overall Study|Intervention prior to sponge administration|0|||
146508446|NCT02560623|528366162|FG003|Overall Study|Intervention prior to sponge administration|0|||
146508447|NCT03181503|528366165|FG000|Overall Study|Adverse Event|2|||
146508448|NCT03181503|528366166|FG001|Overall Study|Adverse Event|2|||
146508449|NCT03181503|528366165|FG000|Overall Study|Protocol Violation|1|||
146508450|NCT03181503|528366166|FG001|Overall Study|Protocol Violation|0|||
146508451|NCT03181503|528366165|FG000|Overall Study|Withdrawal by Subject|3|||
146508452|NCT03181503|528366166|FG001|Overall Study|Withdrawal by Subject|0|||
146508453|NCT03181503|528366165|FG000|Overall Study|Lost to Follow-up|1|||
146508454|NCT03181503|528366166|FG001|Overall Study|Lost to Follow-up|1|||
146508455|NCT01892085|528366169|FG000|Overall Study|Death|4|||
146508456|NCT01892085|528366170|FG001|Overall Study|Death|1|||
146508457|NCT01892085|528366171|FG002|Overall Study|Death|3|||
146508458|NCT01892085|528366169|FG000|Overall Study|Withdrawal by Subject|2|||
146508459|NCT01892085|528366170|FG001|Overall Study|Withdrawal by Subject|0|||
146568455|NCT00110214|528593494|FG000|Overall Study|Other (not specified)|61|||
146568456|NCT00110214|528593495|FG001|Overall Study|Other (not specified)|75|||
146508460|NCT01892085|528366171|FG002|Overall Study|Withdrawal by Subject|2|||
146508461|NCT01549041|528366172|FG000|Overall Study|Lack of Efficacy|2|||
146508462|NCT01549041|528366173|FG001|Overall Study|Lack of Efficacy|4|||
146508463|NCT01549041|528366172|FG000|Overall Study|Adverse Event|0|||
146508464|NCT01549041|528366173|FG001|Overall Study|Adverse Event|4|||
146508465|NCT01199822|528366178|FG000|Overall Study|Investigator discontinued therapy|0|||
146508466|NCT01199822|528366179|FG001|Overall Study|Investigator discontinued therapy|1|||
146508467|NCT01199822|528366180|FG002|Overall Study|Investigator discontinued therapy|0|||
146508468|NCT00480493|528366181|FG000|Overall Study|moved|2|||
146508469|NCT00480493|528366182|FG001|Overall Study|moved|7|||
146508470|NCT04027075|528366183|FG000|Overall Study|Lost to Follow-up|41|||
146508471|NCT04027075|528366184|FG001|Overall Study|Lost to Follow-up|22|||
146508472|NCT02844907|528366185|FG000|With Dexamethasone|No IV access|1|||
146508473|NCT00550862|528366186|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
146568457|NCT01847092|528593496|FG000|Overall Study|Adverse Event|12|||
146568458|NCT01847092|528593497|FG001|Overall Study|Adverse Event|3|||
146508474|NCT00550862|528366187|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
146508475|NCT00550862|528366188|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
146508476|NCT00550862|528366189|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
146508477|NCT00550862|528366190|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
146508478|NCT00550862|528366186|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
146508479|NCT00550862|528366187|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
146508480|NCT00550862|528366188|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
146508481|NCT00550862|528366189|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
146508482|NCT00550862|528366190|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
146508483|NCT00550862|528366186|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
146508484|NCT00550862|528366187|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
146508485|NCT00550862|528366188|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
146508486|NCT00550862|528366189|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
146508487|NCT00550862|528366190|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
146508488|NCT00550862|528366186|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
146508489|NCT00550862|528366187|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
146508490|NCT00550862|528366188|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
146508491|NCT00550862|528366189|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
146508492|NCT00550862|528366190|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
146508493|NCT00550862|528366186|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
146508494|NCT00550862|528366187|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
146508495|NCT00550862|528366188|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
146508496|NCT00550862|528366189|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
146508497|NCT00550862|528366190|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
146508498|NCT00550862|528366186|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
146508499|NCT00550862|528366187|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
146508500|NCT00550862|528366188|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
146508501|NCT00550862|528366189|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
146508502|NCT00550862|528366190|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
146508503|NCT00550862|528366186|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
146508504|NCT00550862|528366187|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
146508505|NCT00550862|528366188|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
146508506|NCT00550862|528366189|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
146508507|NCT00550862|528366190|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
146508508|NCT00550862|528366186|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
146508509|NCT00550862|528366187|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
146508510|NCT00550862|528366188|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
146508511|NCT00550862|528366189|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
146508512|NCT00550862|528366190|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
146508513|NCT00550862|528366186|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
146508514|NCT00550862|528366187|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
146508515|NCT00550862|528366188|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
146508516|NCT00550862|528366189|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
146508517|NCT00550862|528366190|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
146508518|NCT00550862|528366186|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
146508519|NCT00550862|528366187|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
146508520|NCT00550862|528366188|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
146508521|NCT00550862|528366189|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
146508522|NCT00550862|528366190|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
146508523|NCT00455520|528366192|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
146508524|NCT00455520|528366193|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
146508525|NCT00455520|528366192|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
146508526|NCT00455520|528366193|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
146508527|NCT00455520|528366192|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
146508528|NCT00455520|528366193|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
146508529|NCT00455520|528366192|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
146508530|NCT00455520|528366193|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
146508531|NCT00455520|528366192|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
146508532|NCT00455520|528366193|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
146508533|NCT00455520|528366192|FG000|Open Label Tapentadol Extended Release|All other|33|||
146508534|NCT00455520|528366193|FG001|Open Label Tapentadol Extended Release|All other|0|||
146974755|NCT00434148|530069675|FG001|Overall Study|Protocol Violation|0|||
146913905|NCT00907881|529847088|FG000|Overall Study|Missing discontinuation information|15|||
146913906|NCT01327339|529847098|FG000|Overall Study|Protocol Violation|8|||
146913907|NCT02795767|529847101|FG000|Overall Study|Received Commercial Emicizumab|1|||
146913908|NCT02795767|529847102|FG001|Overall Study|Received Commercial Emicizumab|0|||
146913909|NCT02795767|529847103|FG002|Overall Study|Received Commercial Emicizumab|0|||
146913910|NCT00700752|529847108|FG000|First Intervention|Withdrawal by Subject|0|||
146913911|NCT00700752|529847109|FG001|First Intervention|Withdrawal by Subject|2|||
146913912|NCT03964415|529847110|FG000|Overall Study|Sponsor's decision|1563|||
146913913|NCT03964415|529847111|FG001|Overall Study|Sponsor's decision|1528|||
146913914|NCT03964415|529847110|FG000|Overall Study|Lost to Follow-up|139|||
146913915|NCT03964415|529847111|FG001|Overall Study|Lost to Follow-up|146|||
146913916|NCT03964415|529847110|FG000|Overall Study|Withdrawal by Subject|68|||
146913917|NCT03964415|529847111|FG001|Overall Study|Withdrawal by Subject|72|||
146913918|NCT03964415|529847110|FG000|Overall Study|Physician Decision|34|||
146913919|NCT03964415|529847111|FG001|Overall Study|Physician Decision|48|||
146913920|NCT03964415|529847110|FG000|Overall Study|Adverse Event|3|||
146913921|NCT03964415|529847111|FG001|Overall Study|Adverse Event|0|||
146913922|NCT03964415|529847110|FG000|Overall Study|Death|4|||
146913923|NCT03964415|529847111|FG001|Overall Study|Death|6|||
146913924|NCT03964415|529847110|FG000|Overall Study|Protocol Violation|1|||
146913925|NCT03964415|529847111|FG001|Overall Study|Protocol Violation|4|||
146913926|NCT03964415|529847110|FG000|Overall Study|Other|35|||
146913927|NCT03964415|529847111|FG001|Overall Study|Other|38|||
146913928|NCT03964415|529847110|FG000|Overall Study|Randomized but not treated|6|||
146913929|NCT03964415|529847111|FG001|Overall Study|Randomized but not treated|7|||
146913930|NCT01302769|529847112|FG000|Overall Study|Lost to Follow-up|1|||
146913931|NCT01302769|529847113|FG001|Overall Study|Lost to Follow-up|1|||
146568459|NCT01847092|528593496|FG000|Overall Study|Withdrawal by Subject|5|||
146568460|NCT01847092|528593497|FG001|Overall Study|Withdrawal by Subject|5|||
146568461|NCT01847092|528593496|FG000|Overall Study|Protocol Specified|8|||
146568462|NCT01847092|528593497|FG001|Overall Study|Protocol Specified|0|||
146568463|NCT01847092|528593496|FG000|Overall Study|Physician Decision|1|||
146568464|NCT01847092|528593497|FG001|Overall Study|Physician Decision|1|||
146568465|NCT01847092|528593496|FG000|Overall Study|Protocol Violation|0|||
146568466|NCT01847092|528593497|FG001|Overall Study|Protocol Violation|2|||
146568467|NCT03604497|528593499|FG000|Overall Study|Protocol Violation|52|||
146568468|NCT00811954|528593500|FG000|Overall Study|Death|10|||
146568469|NCT00811954|528593501|FG001|Overall Study|Death|6|||
146568470|NCT00811954|528593502|FG002|Overall Study|Death|13|||
146568471|NCT00811954|528593500|FG000|Overall Study|Lost to Follow-up|29|||
146568472|NCT00811954|528593501|FG001|Overall Study|Lost to Follow-up|23|||
146568473|NCT00811954|528593502|FG002|Overall Study|Lost to Follow-up|34|||
146568474|NCT00811954|528593500|FG000|Overall Study|Not able to get to clinic|28|||
146568475|NCT00811954|528593501|FG001|Overall Study|Not able to get to clinic|35|||
146568476|NCT00811954|528593502|FG002|Overall Study|Not able to get to clinic|30|||
146568477|NCT00811954|528593500|FG000|Overall Study|Not willing to adhere to requirements|12|||
146568478|NCT00811954|528593501|FG001|Overall Study|Not willing to adhere to requirements|2|||
146568479|NCT00811954|528593502|FG002|Overall Study|Not willing to adhere to requirements|16|||
146568480|NCT00811954|528593500|FG000|Overall Study|Withdraw consent prior study completion|4|||
146568481|NCT00811954|528593501|FG001|Overall Study|Withdraw consent prior study completion|6|||
146568482|NCT00811954|528593502|FG002|Overall Study|Withdraw consent prior study completion|5|||
146568483|NCT00811954|528593500|FG000|Overall Study|Site Closure|4|||
146568484|NCT00811954|528593501|FG001|Overall Study|Site Closure|0|||
146568485|NCT00811954|528593502|FG002|Overall Study|Site Closure|1|||
146568486|NCT00811954|528593500|FG000|Overall Study|Severe Debilitation|2|||
146568487|NCT00811954|528593501|FG001|Overall Study|Severe Debilitation|0|||
146913932|NCT01426386|529847122|FG000|Overall Study|Adverse Event|0|||
146508535|NCT00455520|528366192|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
146508536|NCT00455520|528366193|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
146508537|NCT00455520|528366192|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
146508538|NCT00455520|528366193|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
146508539|NCT00455520|528366192|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
146508540|NCT00455520|528366193|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
146508541|NCT00455520|528366192|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
146508542|NCT00455520|528366193|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
146508543|NCT00455520|528366192|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
146568488|NCT00811954|528593502|FG002|Overall Study|Severe Debilitation|1|||
146913933|NCT01426386|529847123|FG001|Overall Study|Adverse Event|1|||
146913934|NCT01426386|529847124|FG002|Overall Study|Adverse Event|0|||
146913935|NCT01426386|529847125|FG003|Overall Study|Adverse Event|0|||
146913936|NCT01426386|529847126|FG004|Overall Study|Adverse Event|0|||
146568489|NCT00811954|528593500|FG000|Overall Study|Complete Protocol: No follow-up|0|||
146568490|NCT00811954|528593501|FG001|Overall Study|Complete Protocol: No follow-up|0|||
146913937|NCT01426386|529847127|FG005|Overall Study|Adverse Event|0|||
146568491|NCT00811954|528593502|FG002|Overall Study|Complete Protocol: No follow-up|1|||
146568492|NCT01016067|528593503|FG000|Overall Study|Lost to Follow-up|1|||
146568493|NCT01016067|528593504|FG001|Overall Study|Lost to Follow-up|2|||
146568494|NCT01016067|528593503|FG000|Overall Study|Physician Decision|1|||
146568495|NCT01016067|528593504|FG001|Overall Study|Physician Decision|1|||
146568496|NCT01016067|528593503|FG000|Overall Study|Withdrew due to Relocation|0|||
146568497|NCT01016067|528593504|FG001|Overall Study|Withdrew due to Relocation|1|||
146568498|NCT00186628|528593506|FG000|Overall Study|Death|2|||
146913938|NCT01426386|529847122|FG000|Overall Study|Did not attend scheduled visit|1|||
146913939|NCT01426386|529847123|FG001|Overall Study|Did not attend scheduled visit|4|||
146913940|NCT01426386|529847124|FG002|Overall Study|Did not attend scheduled visit|0|||
146913941|NCT01426386|529847125|FG003|Overall Study|Did not attend scheduled visit|0|||
146913942|NCT01426386|529847126|FG004|Overall Study|Did not attend scheduled visit|2|||
146913943|NCT01426386|529847127|FG005|Overall Study|Did not attend scheduled visit|1|||
146568499|NCT00186628|528593506|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
146568500|NCT00696878|528593514|FG000|Overall Study|Adverse Event|8|||
146568501|NCT00696878|528593514|FG000|Overall Study|Withdrawal by Subject|87|||
146568502|NCT00696878|528593514|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
146568503|NCT00696878|528593514|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
146568504|NCT00696878|528593514|FG000|Overall Study|Trial stopped|32|||
146568505|NCT00696878|528593514|FG000|Overall Study|Other reason (not specified)|55|||
146568506|NCT01378117|528593515|FG000|Overall Study|withdrawal|2|||
146568507|NCT01378117|528593516|FG001|Overall Study|withdrawal|1|||
146568508|NCT01378117|528593517|FG002|Overall Study|withdrawal|2|||
146568509|NCT01378117|528593515|FG000|Overall Study|discharged before med given|2|||
146568510|NCT01378117|528593516|FG001|Overall Study|discharged before med given|0|||
146568511|NCT01378117|528593517|FG002|Overall Study|discharged before med given|1|||
146568512|NCT01374425|528593519|FG000|Overall Study|Radiographic Disease Progression|86|||
146568513|NCT01374425|528593520|FG001|Overall Study|Radiographic Disease Progression|81|||
146568514|NCT01374425|528593519|FG000|Overall Study|Clinical Disease Progression|9|||
146568515|NCT01374425|528593520|FG001|Overall Study|Clinical Disease Progression|6|||
146568516|NCT01374425|528593519|FG000|Overall Study|Adverse Event|29|||
146568517|NCT01374425|528593520|FG001|Overall Study|Adverse Event|18|||
146568518|NCT01374425|528593519|FG000|Overall Study|Death (Progression of Disease)|1|||
146568519|NCT01374425|528593520|FG001|Overall Study|Death (Progression of Disease)|0|||
146568520|NCT01374425|528593519|FG000|Overall Study|Death (Adverse Event)|2|||
146568521|NCT01374425|528593520|FG001|Overall Study|Death (Adverse Event)|4|||
146568522|NCT01374425|528593519|FG000|Overall Study|Withdrawal by Subject|6|||
146568523|NCT01374425|528593520|FG001|Overall Study|Withdrawal by Subject|7|||
146568524|NCT01374425|528593519|FG000|Overall Study|Refused Treatment|10|||
146568525|NCT01374425|528593520|FG001|Overall Study|Refused Treatment|24|||
146568526|NCT01374425|528593519|FG000|Overall Study|Protocol Violation|2|||
146568527|NCT01374425|528593520|FG001|Overall Study|Protocol Violation|3|||
146568528|NCT01374425|528593519|FG000|Overall Study|Sponsor Decision|0|||
146568529|NCT01374425|528593520|FG001|Overall Study|Sponsor Decision|1|||
146568530|NCT01374425|528593519|FG000|Overall Study|Lost to Follow-up|2|||
146568531|NCT01374425|528593520|FG001|Overall Study|Lost to Follow-up|1|||
146568532|NCT01374425|528593519|FG000|Overall Study|Other|41|||
146568533|NCT01374425|528593520|FG001|Overall Study|Other|43|||
146568534|NCT00546481|528593521|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
146568535|NCT00546481|528593522|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
146568536|NCT00546481|528593523|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
146568537|NCT00546481|528593521|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
146568538|NCT00546481|528593522|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
146568539|NCT00546481|528593523|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
146568540|NCT00546481|528593521|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
146568541|NCT00546481|528593522|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
146568542|NCT00546481|528593523|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
146568543|NCT00546481|528593521|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
146568544|NCT00546481|528593522|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
146650196|NCT00169442|528895048|FG005|Overall Study|Withdrawal by Subject|0|||
146650197|NCT00169442|528895043|FG000|Overall Study|Migrated/moved from study area|0|||
146650198|NCT00169442|528895044|FG001|Overall Study|Migrated/moved from study area|0|||
146650199|NCT00169442|528895045|FG002|Overall Study|Migrated/moved from study area|0|||
146650200|NCT00169442|528895046|FG003|Overall Study|Migrated/moved from study area|0|||
146650201|NCT00169442|528895047|FG004|Overall Study|Migrated/moved from study area|0|||
146650202|NCT00169442|528895048|FG005|Overall Study|Migrated/moved from study area|2|||
146650203|NCT00169442|528895043|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
146650204|NCT00169442|528895044|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
146650205|NCT00169442|528895045|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
146650206|NCT00169442|528895046|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
146650207|NCT00169442|528895047|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
146650208|NCT00169442|528895048|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
146913944|NCT01426386|529847122|FG000|Overall Study|Poor response|2|||
146568545|NCT00546481|528593523|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
146568546|NCT00546481|528593521|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
146568547|NCT00546481|528593522|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
146568548|NCT00546481|528593523|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
146568549|NCT00546481|528593521|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
146568550|NCT00546481|528593522|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
146568551|NCT00546481|528593523|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
146568552|NCT00546481|528593521|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
146568553|NCT00546481|528593522|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
146568554|NCT00546481|528593523|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
146568555|NCT00546481|528593521|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
146568556|NCT00546481|528593522|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
146568557|NCT00546481|528593523|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
146568558|NCT00546481|528593521|FG000|Maintenance Phase (CERA)|Other Reason|0|||
146568559|NCT00546481|528593522|FG001|Maintenance Phase (CERA)|Other Reason|0|||
146568560|NCT00546481|528593523|FG002|Maintenance Phase (CERA)|Other Reason|1|||
146568561|NCT00950651|528593526|FG000|Overall Study|Adverse Event|17|||
146568562|NCT00950651|528593527|FG001|Overall Study|Adverse Event|20|||
146568563|NCT00950651|528593526|FG000|Overall Study|Death|1|||
146568564|NCT00950651|528593527|FG001|Overall Study|Death|0|||
146568565|NCT00950651|528593526|FG000|Overall Study|Lack of Efficacy|2|||
146568566|NCT00950651|528593527|FG001|Overall Study|Lack of Efficacy|2|||
146568567|NCT00950651|528593526|FG000|Overall Study|Protocol Violation|3|||
146568568|NCT00950651|528593527|FG001|Overall Study|Protocol Violation|4|||
146568569|NCT00950651|528593526|FG000|Overall Study|Withdrawal by Subject|8|||
146568570|NCT00950651|528593527|FG001|Overall Study|Withdrawal by Subject|9|||
146568571|NCT02761642|528593528|FG000|Overall Study|Did not Receive Study Treatment|3|||
146568572|NCT02761642|528593528|FG000|Overall Study|Adverse Event|13|||
146568573|NCT02761642|528593528|FG000|Overall Study|Withdrawal by Subject|2|||
146568574|NCT02761642|528593528|FG000|Overall Study|Non-compliant|7|||
146568575|NCT02761642|528593528|FG000|Overall Study|Death|3|||
146568576|NCT02761642|528593528|FG000|Overall Study|Lack of Efficacy|20|||
146568577|NCT02761642|528593528|FG000|Overall Study|Physician Decision|1|||
146568578|NCT02761642|528593528|FG000|Overall Study|Reason Unspecified|21|||
146568579|NCT03783780|528593529|FG000|Overall Study|Withdrawn prior to completion|1|||
146568580|NCT03247829|528595395|FG000|Overall Study|Death|3|||
146568581|NCT03247829|528595396|FG001|Overall Study|Death|4|||
146568582|NCT03247829|528595395|FG000|Overall Study|Enter Hospice Care|1|||
146568583|NCT03247829|528595396|FG001|Overall Study|Enter Hospice Care|0|||
146568584|NCT03247829|528595395|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
146568585|NCT03247829|528595396|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
146568586|NCT03247829|528595395|FG000|Overall Study|LVAD Explant|1|||
146568587|NCT03247829|528595396|FG001|Overall Study|LVAD Explant|1|||
146568588|NCT03247829|528595395|FG000|Overall Study|Transplant|1|||
146568589|NCT03247829|528595396|FG001|Overall Study|Transplant|1|||
146568590|NCT00272792|528595398|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
146568591|NCT00272792|528595399|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
146568592|NCT00272792|528595398|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
146568593|NCT00272792|528595399|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
146568594|NCT00272792|528595398|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
146568595|NCT00272792|528595399|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
146568596|NCT00272792|528595398|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
146568597|NCT00272792|528595399|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
146568598|NCT00427011|528595402|FG000|Overall Study|Adverse Event|10|||
146568599|NCT00427011|528595402|FG000|Overall Study|Withdrawal by Subject|1|||
146568600|NCT00427011|528595402|FG000|Overall Study|Lack of Efficacy|2|||
146568601|NCT00427011|528595402|FG000|Overall Study|Other|12|||
146568602|NCT00288015|528595403|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
146568603|NCT00288015|528595403|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
146568604|NCT00288015|528595403|FG000|First Response Assessment|Withdrawal by Subject|1|||
146568605|NCT00288015|528595403|FG000|First Response Assessment|Death|1|||
146568606|NCT00288015|528595403|FG000|First Response Assessment|Physician Decision|2|||
146568607|NCT00288015|528595403|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
146568608|NCT00288015|528595403|FG000|Follow up for Survival x 2 Years|Death|13|||
146568609|NCT00288015|528595403|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
146568610|NCT00288015|528595403|FG000|Follow up for Survival x 2 Years|Other|9|||
146568611|NCT00443703|528595404|FG000|Overall Study|Never Treated|3|||
146568612|NCT00443703|528595405|FG001|Overall Study|Never Treated|1|||
146568613|NCT00443703|528595404|FG000|Overall Study|Adverse Event|7|||
146568614|NCT00443703|528595405|FG001|Overall Study|Adverse Event|3|||
146568615|NCT00443703|528595404|FG000|Overall Study|Lack of Efficacy|3|||
146568616|NCT00443703|528595405|FG001|Overall Study|Lack of Efficacy|1|||
146568617|NCT00443703|528595404|FG000|Overall Study|Lost to Follow-up|0|||
146568618|NCT00443703|528595405|FG001|Overall Study|Lost to Follow-up|4|||
146568619|NCT00443703|528595404|FG000|Overall Study|Physician Decision|4|||
146913945|NCT01426386|529847123|FG001|Overall Study|Poor response|1|||
146913946|NCT01426386|529847124|FG002|Overall Study|Poor response|2|||
146913947|NCT01426386|529847125|FG003|Overall Study|Poor response|0|||
146913948|NCT01426386|529847126|FG004|Overall Study|Poor response|1|||
146913949|NCT01426386|529847127|FG005|Overall Study|Poor response|0|||
146913950|NCT01426386|529847122|FG000|Overall Study|Personal reasons|0|||
146913951|NCT01426386|529847123|FG001|Overall Study|Personal reasons|0|||
146508544|NCT00455520|528366193|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
146508545|NCT00455520|528366192|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
146508546|NCT00455520|528366193|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
146508547|NCT00986986|528366195|FG000|Overall Study|Lost to Follow-up|0|||
146508548|NCT00986986|528366196|FG001|Overall Study|Lost to Follow-up|1|||
146508549|NCT00955968|528366201|FG000|Overall Study|Death|2|||
146508550|NCT00955968|528366202|FG001|Overall Study|Death|4|||
146508551|NCT00955968|528366201|FG000|Overall Study|Withdrawal by Subject|35|||
146508552|NCT00955968|528366202|FG001|Overall Study|Withdrawal by Subject|31|||
146508553|NCT00955968|528366201|FG000|Overall Study|Lost to Follow-up|45|||
146508554|NCT00955968|528366202|FG001|Overall Study|Lost to Follow-up|39|||
146508555|NCT00955968|528366201|FG000|Overall Study|Site closed|55|||
146508556|NCT00955968|528366202|FG001|Overall Study|Site closed|52|||
146508557|NCT01068626|528366205|FG000|Overall Study|Adverse Event|3|||
146508558|NCT01068626|528366206|FG001|Overall Study|Adverse Event|0|||
146508559|NCT01068626|528366205|FG000|Overall Study|Withdrawal by Subject|0|||
146508560|NCT01068626|528366206|FG001|Overall Study|Withdrawal by Subject|2|||
146508561|NCT01785849|528366207|FG000|Overall Study|Death|7|||
146508562|NCT01785849|528366208|FG001|Overall Study|Death|9|||
146508563|NCT01785849|528366207|FG000|Overall Study|Protocol Specified Criteria|29|||
146508564|NCT01785849|528366208|FG001|Overall Study|Protocol Specified Criteria|1|||
146508565|NCT01785849|528366207|FG000|Overall Study|Withdrawal by Subject|15|||
146508566|NCT01785849|528366208|FG001|Overall Study|Withdrawal by Subject|12|||
146508567|NCT01785849|528366207|FG000|Overall Study|Sponsor Decision|0|||
146508568|NCT01785849|528366208|FG001|Overall Study|Sponsor Decision|1|||
146508569|NCT01785849|528366207|FG000|Overall Study|Lost to Follow-up|10|||
146508570|NCT01785849|528366208|FG001|Overall Study|Lost to Follow-up|11|||
146508571|NCT01940900|528366209|FG000|Overall Study|Physician Decision|4|||
146508572|NCT01940900|528366210|FG001|Overall Study|Physician Decision|0|||
146508573|NCT01940900|528366209|FG000|Overall Study|Adverse Event|10|||
146508574|NCT01940900|528366210|FG001|Overall Study|Adverse Event|15|||
146508575|NCT01940900|528366209|FG000|Overall Study|Withdrawal by Subject|11|||
146508576|NCT01940900|528366210|FG001|Overall Study|Withdrawal by Subject|15|||
146508577|NCT01940900|528366209|FG000|Overall Study|Lost to Follow-up|1|||
146508578|NCT01940900|528366210|FG001|Overall Study|Lost to Follow-up|0|||
146508579|NCT01940900|528366209|FG000|Overall Study|Sponsor Decision|1|||
146508580|NCT01940900|528366210|FG001|Overall Study|Sponsor Decision|0|||
146508581|NCT01940900|528366209|FG000|Overall Study|subject non-compliance|1|||
146508582|NCT01940900|528366210|FG001|Overall Study|subject non-compliance|1|||
146508583|NCT01940900|528366209|FG000|Overall Study|other|1|||
146508584|NCT01940900|528366210|FG001|Overall Study|other|0|||
146508585|NCT02431806|528366213|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
146508586|NCT02431806|528366214|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
146508587|NCT02431806|528366215|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
146508588|NCT02431806|528366216|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
146508589|NCT02431806|528366213|FG000|Double-blind Treatment Period|Adverse Event|4|||
146508590|NCT02431806|528366214|FG001|Double-blind Treatment Period|Adverse Event|7|||
146508591|NCT02431806|528366215|FG002|Double-blind Treatment Period|Adverse Event|11|||
146508592|NCT02431806|528366216|FG003|Double-blind Treatment Period|Adverse Event|7|||
146508593|NCT02431806|528366213|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
146508594|NCT02431806|528366214|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
146508595|NCT02431806|528366215|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
146508596|NCT02431806|528366216|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
146508597|NCT02431806|528366213|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
146508598|NCT02431806|528366214|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
146508599|NCT02431806|528366215|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
146508600|NCT02431806|528366216|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
146508601|NCT02431806|528366213|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
146508602|NCT02431806|528366214|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
146913952|NCT01426386|529847124|FG002|Overall Study|Personal reasons|0|||
146913953|NCT01426386|529847125|FG003|Overall Study|Personal reasons|0|||
146508603|NCT02431806|528366215|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
146508604|NCT02431806|528366216|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
146508605|NCT02431806|528366213|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
146508606|NCT02431806|528366214|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
146568620|NCT00443703|528595405|FG001|Overall Study|Physician Decision|2|||
146913954|NCT01426386|529847126|FG004|Overall Study|Personal reasons|1|||
146913955|NCT01426386|529847127|FG005|Overall Study|Personal reasons|0|||
146913956|NCT02792777|529847129|FG000|Overall Study|Withdrawal by Subject|2|||
146568621|NCT00443703|528595404|FG000|Overall Study|Protocol Violation|1|||
146568622|NCT00443703|528595405|FG001|Overall Study|Protocol Violation|1|||
146568623|NCT00443703|528595404|FG000|Overall Study|Withdrawal by Subject|9|||
146568624|NCT00443703|528595405|FG001|Overall Study|Withdrawal by Subject|6|||
146568625|NCT00443703|528595404|FG000|Overall Study|Progressive Disease|1|||
146568626|NCT00443703|528595405|FG001|Overall Study|Progressive Disease|0|||
146568627|NCT01669902|528595410|FG000|Overall Study|Adverse Event|11|||
146568628|NCT01669902|528595410|FG000|Overall Study|Lack of Efficacy|10|||
146568629|NCT01669902|528595410|FG000|Overall Study|Other|8|||
146913957|NCT02792777|529847130|FG001|Overall Study|Withdrawal by Subject|0|||
146913958|NCT02792777|529847129|FG000|Overall Study|Recording malfunction|2|||
146913959|NCT02792777|529847130|FG001|Overall Study|Recording malfunction|0|||
146913960|NCT02792777|529847129|FG000|Overall Study|Later determined to be ineligible|2|||
146913961|NCT02792777|529847130|FG001|Overall Study|Later determined to be ineligible|0|||
146913962|NCT02792777|529847129|FG000|Overall Study|Participant interviewed twice|1|||
146913963|NCT02792777|529847130|FG001|Overall Study|Participant interviewed twice|0|||
146913964|NCT02795156|529847131|FG000|Overall Study|Progressive Disease|22|||
146913965|NCT02795156|529847132|FG001|Overall Study|Progressive Disease|7|||
146913966|NCT02795156|529847133|FG002|Overall Study|Progressive Disease|34|||
146508607|NCT02431806|528366215|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
146508608|NCT02431806|528366216|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
146508609|NCT02431806|528366213|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
146508610|NCT02431806|528366214|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
146508611|NCT02431806|528366215|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
146508612|NCT02431806|528366216|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
146508613|NCT00742508|528366217|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
146508614|NCT00742508|528366218|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
146508615|NCT00742508|528366217|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
146508616|NCT00742508|528366218|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
146508617|NCT00742508|528366217|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
146508618|NCT00742508|528366218|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
146508619|NCT00742508|528366217|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
146508620|NCT00742508|528366218|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
146508621|NCT00742508|528366217|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
146508622|NCT00742508|528366218|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
146508623|NCT04450407|528366221|FG000|Overall Study|Withdrawal by Subject|10|||
146508624|NCT04450407|528366222|FG001|Overall Study|Withdrawal by Subject|1|||
146508625|NCT04450407|528366223|FG002|Overall Study|Withdrawal by Subject|4|||
146508626|NCT04450407|528366221|FG000|Overall Study|Adverse Event|0|||
146508627|NCT04450407|528366222|FG001|Overall Study|Adverse Event|0|||
146508628|NCT04450407|528366223|FG002|Overall Study|Adverse Event|1|||
146508629|NCT04450407|528366221|FG000|Overall Study|Lost to Follow-up|1|||
146508630|NCT04450407|528366222|FG001|Overall Study|Lost to Follow-up|0|||
146508631|NCT04450407|528366223|FG002|Overall Study|Lost to Follow-up|0|||
146508632|NCT04450407|528366221|FG000|Overall Study|Physician Decision|0|||
146508633|NCT04450407|528366222|FG001|Overall Study|Physician Decision|0|||
146508634|NCT04450407|528366223|FG002|Overall Study|Physician Decision|1|||
146508635|NCT04450407|528366221|FG000|Overall Study|Pregnancy|1|||
146508636|NCT04450407|528366222|FG001|Overall Study|Pregnancy|0|||
146508637|NCT04450407|528366223|FG002|Overall Study|Pregnancy|0|||
146508638|NCT04450407|528366221|FG000|Overall Study|Protocol Violation|2|||
146508639|NCT04450407|528366222|FG001|Overall Study|Protocol Violation|0|||
146508640|NCT04450407|528366223|FG002|Overall Study|Protocol Violation|0|||
146508641|NCT04450407|528366221|FG000|Overall Study|Investigational site terminated by sponsor|3|||
146508642|NCT04450407|528366222|FG001|Overall Study|Investigational site terminated by sponsor|0|||
146508643|NCT04450407|528366223|FG002|Overall Study|Investigational site terminated by sponsor|2|||
146508644|NCT00474045|528366224|FG000|Overall Study|Adverse Event|18|||
146508645|NCT00474045|528366225|FG001|Overall Study|Adverse Event|8|||
146508646|NCT00474045|528366224|FG000|Overall Study|Unclassified|1|||
146508647|NCT00474045|528366225|FG001|Overall Study|Unclassified|3|||
146508648|NCT00474045|528366224|FG000|Overall Study|Lack of Efficacy|0|||
146508649|NCT00474045|528366225|FG001|Overall Study|Lack of Efficacy|9|||
146508650|NCT00474045|528366224|FG000|Overall Study|Lost to Follow-up|1|||
146508651|NCT00474045|528366225|FG001|Overall Study|Lost to Follow-up|1|||
146508652|NCT00474045|528366224|FG000|Overall Study|Protocol Violation|10|||
146508653|NCT00474045|528366225|FG001|Overall Study|Protocol Violation|12|||
146508654|NCT00474045|528366224|FG000|Overall Study|Withdrawal by Subject|16|||
146508655|NCT00474045|528366225|FG001|Overall Study|Withdrawal by Subject|18|||
146508656|NCT00474045|528366224|FG000|Overall Study|Withdrawal criteria|60|||
146508657|NCT00474045|528366225|FG001|Overall Study|Withdrawal criteria|50|||
146508658|NCT02009397|528366228|FG000|Overall Study|Protocol Violation|6|||
146568630|NCT00457392|528595411|FG000|Overall Study|Objective Progression or Relapse|229|||
146913967|NCT02795156|529847134|FG003|Overall Study|Progressive Disease|7|||
146913968|NCT02795156|529847131|FG000|Overall Study|Adverse Event|13|||
146913969|NCT02795156|529847132|FG001|Overall Study|Adverse Event|2|||
146913970|NCT02795156|529847133|FG002|Overall Study|Adverse Event|3|||
146913971|NCT02795156|529847134|FG003|Overall Study|Adverse Event|2|||
146913972|NCT02795156|529847131|FG000|Overall Study|Death|1|||
146913973|NCT02795156|529847132|FG001|Overall Study|Death|1|||
146913974|NCT02795156|529847133|FG002|Overall Study|Death|1|||
146650209|NCT00169442|528895043|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
146913975|NCT02795156|529847134|FG003|Overall Study|Death|0|||
146974756|NCT00434148|530069674|FG000|Overall Study|Administrative problems|6|||
146974757|NCT00434148|530069675|FG001|Overall Study|Administrative problems|10|||
146974758|NCT00434148|530069674|FG000|Overall Study|Lost to Follow-up|0|||
146974759|NCT00434148|530069675|FG001|Overall Study|Lost to Follow-up|1|||
146974760|NCT00434148|530069674|FG000|Overall Study|Condition no longer requires study drug|1|||
146974761|NCT00434148|530069675|FG001|Overall Study|Condition no longer requires study drug|0|||
146974762|NCT00434148|530069674|FG000|Overall Study|Abnormal test procedure result|0|||
146974763|NCT00434148|530069675|FG001|Overall Study|Abnormal test procedure result|1|||
146974764|NCT01142466|530071570|FG000|Overall Study|Adverse Event|2|||
146974765|NCT01142466|530071571|FG001|Overall Study|Adverse Event|1|||
146974766|NCT01142466|530071570|FG000|Overall Study|Withdrawal by Subject|1|||
146974767|NCT01142466|530071571|FG001|Overall Study|Withdrawal by Subject|1|||
146974768|NCT02414854|530071576|FG000|Overall Study|Adverse Event|9|||
146974769|NCT02414854|530071577|FG001|Overall Study|Adverse Event|7|||
146974770|NCT02414854|530071578|FG002|Overall Study|Adverse Event|1|||
146974771|NCT02414854|530071579|FG003|Overall Study|Adverse Event|12|||
146974772|NCT02414854|530071576|FG000|Overall Study|Poor compliance to protocol|1|||
146974773|NCT02414854|530071577|FG001|Overall Study|Poor compliance to protocol|1|||
146974774|NCT02414854|530071578|FG002|Overall Study|Poor compliance to protocol|2|||
146974775|NCT02414854|530071579|FG003|Overall Study|Poor compliance to protocol|2|||
146974776|NCT02414854|530071576|FG000|Overall Study|Other than specified above|12|||
146974777|NCT02414854|530071577|FG001|Overall Study|Other than specified above|37|||
146974778|NCT02414854|530071578|FG002|Overall Study|Other than specified above|17|||
146508659|NCT02009397|528366228|FG000|Overall Study|Death|8|||
146508660|NCT02009397|528366228|FG000|Overall Study|Lost to Follow-up|6|||
146508661|NCT03589976|528366232|FG000|Overall Study|Death|5|||
146508662|NCT03589976|528366233|FG001|Overall Study|Death|1|||
146508663|NCT03589976|528366232|FG000|Overall Study|Adverse Event|5|||
146508664|NCT03589976|528366233|FG001|Overall Study|Adverse Event|1|||
146508665|NCT03589976|528366232|FG000|Overall Study|Withdrawal by Subject|4|||
146508666|NCT03589976|528366233|FG001|Overall Study|Withdrawal by Subject|1|||
146508667|NCT03589976|528366232|FG000|Overall Study|Lost to Follow-up|1|||
146508668|NCT03589976|528366233|FG001|Overall Study|Lost to Follow-up|0|||
146508669|NCT03589976|528366232|FG000|Overall Study|Other|4|||
146508670|NCT03589976|528366233|FG001|Overall Study|Other|3|||
146508671|NCT02089334|528366234|FG000|Overall Study|Withdrawal by Subject|0|||
146508672|NCT02089334|528366235|FG001|Overall Study|Withdrawal by Subject|0|||
146508673|NCT02089334|528366236|FG002|Overall Study|Withdrawal by Subject|0|||
146508674|NCT02089334|528366237|FG003|Overall Study|Withdrawal by Subject|2|||
146508675|NCT02089334|528366234|FG000|Overall Study|Adverse Event|0|||
146508676|NCT02089334|528366235|FG001|Overall Study|Adverse Event|0|||
146508677|NCT02089334|528366236|FG002|Overall Study|Adverse Event|0|||
146508678|NCT02089334|528366237|FG003|Overall Study|Adverse Event|2|||
146508679|NCT02089334|528366234|FG000|Overall Study|Progressive disease|0|||
146508680|NCT02089334|528366235|FG001|Overall Study|Progressive disease|0|||
146508681|NCT02089334|528366236|FG002|Overall Study|Progressive disease|0|||
146508682|NCT02089334|528366237|FG003|Overall Study|Progressive disease|2|||
146508683|NCT02089334|528366234|FG000|Overall Study|Physician Decision|0|||
146508684|NCT02089334|528366235|FG001|Overall Study|Physician Decision|0|||
146508685|NCT02089334|528366236|FG002|Overall Study|Physician Decision|1|||
146508686|NCT02089334|528366237|FG003|Overall Study|Physician Decision|1|||
146508687|NCT00710684|528366240|FG000|Overall Study|Adverse Event|11|||
146508688|NCT00710684|528366241|FG001|Overall Study|Adverse Event|19|||
146508689|NCT00710684|528366242|FG002|Overall Study|Adverse Event|16|||
146508690|NCT00710684|528366240|FG000|Overall Study|Lack of Efficacy|4|||
146508691|NCT00710684|528366241|FG001|Overall Study|Lack of Efficacy|3|||
146508692|NCT00710684|528366242|FG002|Overall Study|Lack of Efficacy|5|||
146508693|NCT00710684|528366240|FG000|Overall Study|Protocol Violation|5|||
146508694|NCT00710684|528366241|FG001|Overall Study|Protocol Violation|5|||
146508695|NCT00710684|528366242|FG002|Overall Study|Protocol Violation|5|||
146508696|NCT00710684|528366240|FG000|Overall Study|Lost to Follow-up|4|||
146508697|NCT00710684|528366241|FG001|Overall Study|Lost to Follow-up|6|||
146913976|NCT02795156|529847131|FG000|Overall Study|Physician Decision|1|||
146974779|NCT02414854|530071579|FG003|Overall Study|Other than specified above|37|||
146974780|NCT01355523|530071580|FG000|Overall Study|Withdrawal by Subject|1|||
146508698|NCT00710684|528366242|FG002|Overall Study|Lost to Follow-up|7|||
146508699|NCT00710684|528366240|FG000|Overall Study|Physician Decision|0|||
146508700|NCT00710684|528366241|FG001|Overall Study|Physician Decision|2|||
146508701|NCT00710684|528366242|FG002|Overall Study|Physician Decision|4|||
146913977|NCT02795156|529847132|FG001|Overall Study|Physician Decision|0|||
146913978|NCT02795156|529847133|FG002|Overall Study|Physician Decision|1|||
146568631|NCT00457392|528595412|FG001|Overall Study|Objective Progression or Relapse|296|||
146568632|NCT00457392|528595411|FG000|Overall Study|Death|106|||
146568633|NCT00457392|528595412|FG001|Overall Study|Death|106|||
146568634|NCT00457392|528595411|FG000|Overall Study|Adverse Event|84|||
146568635|NCT00457392|528595412|FG001|Overall Study|Adverse Event|41|||
146913979|NCT02795156|529847134|FG003|Overall Study|Physician Decision|0|||
146913980|NCT02795156|529847131|FG000|Overall Study|Withdrawal by Subject|2|||
146913981|NCT02795156|529847132|FG001|Overall Study|Withdrawal by Subject|0|||
146913982|NCT02795156|529847133|FG002|Overall Study|Withdrawal by Subject|3|||
146913983|NCT02795156|529847134|FG003|Overall Study|Withdrawal by Subject|0|||
146913984|NCT01137435|529847135|FG000|Overall Study|Lost to Follow-up|24|||
146913985|NCT01137435|529847135|FG000|Overall Study|Off label usage|4|||
146913986|NCT01416610|529847143|FG000|Overall Study|Adverse Event|4|||
146913987|NCT01416610|529847143|FG000|Overall Study|Adverse Event -Patient decision|3|||
146913988|NCT01416610|529847143|FG000|Overall Study|Lack of Efficacy|4|||
146913989|NCT01416610|529847143|FG000|Overall Study|No reason given|5|||
146913990|NCT01416610|529847143|FG000|Overall Study|Withdrawal by Subject|13|||
146913991|NCT01416610|529847143|FG000|Overall Study|Lost to Follow-up|7|||
146913992|NCT01416610|529847143|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
146913993|NCT02961764|529847144|FG000|Overall Study|Protocol Violation|0|||
146913994|NCT02961764|529847145|FG001|Overall Study|Protocol Violation|1|||
146913995|NCT02961764|529847144|FG000|Overall Study|Death|2|||
146913996|NCT02961764|529847145|FG001|Overall Study|Death|0|||
146913997|NCT02961764|529847144|FG000|Overall Study|Lost to Follow-up|35|||
146913998|NCT02961764|529847145|FG001|Overall Study|Lost to Follow-up|24|||
146913999|NCT02961764|529847144|FG000|Overall Study|Withdrawal by Subject|2|||
146914000|NCT02961764|529847145|FG001|Overall Study|Withdrawal by Subject|0|||
146914001|NCT03461289|529847146|FG000|Overall Study|Death|1|||
146914002|NCT02698423|529847147|FG000|Overall Study|Lost to Follow-up|19|||
146914003|NCT02698423|529847148|FG001|Overall Study|Lost to Follow-up|24|||
146914004|NCT02749370|529847150|FG000|Overall Study|Withdrawal by Subject|11|||
146914005|NCT02749370|529847150|FG000|Overall Study|Lost to Follow-up|3|||
146914006|NCT01519427|529847154|FG000|Overall Study|disease progression|2|||
146914007|NCT03894904|529847155|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
146914008|NCT03894904|529847156|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
146914009|NCT03894904|529847155|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
146914010|NCT03894904|529847156|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
146914011|NCT02190435|529847160|FG000|Overall Study|First 12 patients were lead-ins|12|||
146914012|NCT02190435|529847161|FG001|Overall Study|First 12 patients were lead-ins|0|||
146914013|NCT02190435|529847160|FG000|Overall Study|3 consented screen fails|3|||
146914014|NCT02190435|529847161|FG001|Overall Study|3 consented screen fails|0|||
146914015|NCT02260193|529847166|FG000|Overall Study|Lack of Efficacy|0|||
146914016|NCT02260193|529847167|FG001|Overall Study|Lack of Efficacy|1|||
146914017|NCT02260193|529847168|FG002|Overall Study|Lack of Efficacy|6|||
146914018|NCT02260193|529847166|FG000|Overall Study|Adverse Event|3|||
146914019|NCT02260193|529847167|FG001|Overall Study|Adverse Event|4|||
146914020|NCT02260193|529847168|FG002|Overall Study|Adverse Event|1|||
146914021|NCT02260193|529847166|FG000|Overall Study|Protocol Violation|0|||
146914022|NCT02260193|529847167|FG001|Overall Study|Protocol Violation|4|||
146914023|NCT02260193|529847168|FG002|Overall Study|Protocol Violation|0|||
146914024|NCT02260193|529847166|FG000|Overall Study|Withdrawal by Subject|3|||
146914025|NCT02260193|529847167|FG001|Overall Study|Withdrawal by Subject|0|||
146914026|NCT02260193|529847168|FG002|Overall Study|Withdrawal by Subject|2|||
146914027|NCT02260193|529847166|FG000|Overall Study|Kidney Transplantation|0|||
146914028|NCT02260193|529847167|FG001|Overall Study|Kidney Transplantation|0|||
146914029|NCT02260193|529847168|FG002|Overall Study|Kidney Transplantation|1|||
146914030|NCT00336492|529847169|FG000|Overall Study|Adverse Event|4|||
146914031|NCT00336492|529847170|FG001|Overall Study|Adverse Event|3|||
146914032|NCT00336492|529847171|FG002|Overall Study|Adverse Event|6|||
146914033|NCT00336492|529847169|FG000|Overall Study|Lack of Efficacy|6|||
146914034|NCT00336492|529847170|FG001|Overall Study|Lack of Efficacy|1|||
146914035|NCT00336492|529847171|FG002|Overall Study|Lack of Efficacy|4|||
146914036|NCT00336492|529847169|FG000|Overall Study|Other|5|||
146914037|NCT00336492|529847170|FG001|Overall Study|Other|0|||
146914038|NCT00336492|529847171|FG002|Overall Study|Other|1|||
146914039|NCT01781026|529847172|FG000|Overall Study|Lack of Efficacy|2|||
146914040|NCT02160977|529847175|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
146914041|NCT02160977|529847176|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
146914042|NCT02160977|529847175|FG000|Three Months After Surgery|Lost to Follow-up|0|||
146914043|NCT02160977|529847176|FG001|Three Months After Surgery|Lost to Follow-up|2|||
146914044|NCT02160977|529847175|FG000|Six Months After Surgery|Lost to Follow-up|2|||
146914045|NCT02160977|529847176|FG001|Six Months After Surgery|Lost to Follow-up|1|||
146914046|NCT05270694|529848464|FG000|Overall Study|Death|1|||
146914047|NCT05270694|529848464|FG000|Overall Study|Medical issues impacted ability to participate|2|||
146568636|NCT00457392|528595411|FG000|Overall Study|Global Deterioration of Health Status|22|||
146914048|NCT05270694|529848464|FG000|Overall Study|Lost to Follow-up|3|||
146568637|NCT00457392|528595412|FG001|Overall Study|Global Deterioration of Health Status|8|||
146568638|NCT00457392|528595411|FG000|Overall Study|Withdrawal by Subject|14|||
146568639|NCT00457392|528595412|FG001|Overall Study|Withdrawal by Subject|8|||
146914049|NCT05270694|529848464|FG000|Overall Study|Withdrawal by Subject|3|||
146914050|NCT00128206|529848469|FG000|Overall Study|Lost to Follow-up|137|||
146914051|NCT00128206|529848470|FG001|Overall Study|Lost to Follow-up|118|||
146914052|NCT00128206|529848469|FG000|Overall Study|Adverse Event|0|||
146914053|NCT00128206|529848470|FG001|Overall Study|Adverse Event|2|||
146914054|NCT01597622|529848473|FG000|Overall Study|Adverse Event|7|||
146914055|NCT01597622|529848473|FG000|Overall Study|Lack of Efficacy|3|||
146914056|NCT01597622|529848473|FG000|Overall Study|Protocol Violation|1|||
146914057|NCT01597622|529848473|FG000|Overall Study|Lost to Follow-up|1|||
146914058|NCT01597622|529848473|FG000|Overall Study|Investigator Discretion|5|||
146914059|NCT01597622|529848473|FG000|Overall Study|Withdrawal by Subject|20|||
146914060|NCT01597622|529848473|FG000|Overall Study|Death|1|||
146914061|NCT03132805|529848476|FG000|Overall Study|Lost to Follow-up|142|||
146914062|NCT03132805|529848477|FG001|Overall Study|Lost to Follow-up|141|||
146914063|NCT03132805|529848478|FG002|Overall Study|Lost to Follow-up|113|||
146914064|NCT03009539|529848479|FG000|Overall Study|Lost to Follow-up|132|||
146914065|NCT03009539|529848480|FG001|Overall Study|Lost to Follow-up|113|||
146914066|NCT03009539|529848481|FG002|Overall Study|Lost to Follow-up|132|||
146914067|NCT03009539|529848482|FG003|Overall Study|Lost to Follow-up|113|||
146914068|NCT03151148|529848483|FG000|Overall Study|Lost to Follow-up|1|||
146914069|NCT03151148|529848484|FG001|Overall Study|Lost to Follow-up|0|||
146914070|NCT03151148|529848483|FG000|Overall Study|Withdrawal by Subject|1|||
146914071|NCT03151148|529848484|FG001|Overall Study|Withdrawal by Subject|0|||
146914072|NCT00710034|529848485|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
146914073|NCT00710034|529848486|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
146914074|NCT00710034|529848485|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
146914075|NCT00710034|529848486|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
146914076|NCT00710034|529848485|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
146914077|NCT00710034|529848486|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
146914078|NCT00710034|529848485|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
146914079|NCT00710034|529848486|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
146914080|NCT00710034|529848485|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
146914081|NCT00710034|529848486|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
146914082|NCT00710034|529848485|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
146914083|NCT00710034|529848486|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
146914084|NCT00710034|529848485|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
146914085|NCT00710034|529848486|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
146914086|NCT00710034|529848485|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
146914087|NCT00710034|529848486|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
146914088|NCT00710034|529848485|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
146914089|NCT00710034|529848486|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
146914090|NCT00710034|529848485|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
146914091|NCT00710034|529848486|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
146914092|NCT00710034|529848485|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
146914093|NCT00710034|529848486|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
146914094|NCT00494871|529848487|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
146914095|NCT00494871|529848488|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
146914096|NCT00494871|529848487|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
146914097|NCT00494871|529848488|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
146914098|NCT00494871|529848487|FG000|Double-blind (DB) Treatment Period|Death|8|||
146914099|NCT00494871|529848488|FG001|Double-blind (DB) Treatment Period|Death|3|||
146914100|NCT00494871|529848487|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
146914101|NCT00494871|529848488|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
146914102|NCT00494871|529848487|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
146914103|NCT00494871|529848488|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
146914104|NCT00494871|529848487|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
146914105|NCT00494871|529848488|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
146914106|NCT00494871|529848487|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
146914107|NCT00494871|529848488|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
146914108|NCT00494871|529848487|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
146914109|NCT00494871|529848488|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
146914110|NCT00494871|529848487|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
146914111|NCT00494871|529848488|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
146914112|NCT00494871|529848487|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
146914113|NCT00494871|529848488|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
146914114|NCT00494871|529848487|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
146914115|NCT00494871|529848488|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
146974781|NCT01355523|530071581|FG001|Overall Study|Withdrawal by Subject|4|||
146974782|NCT01355523|530071580|FG000|Overall Study|Lost to Follow-up|0|||
146974783|NCT01355523|530071581|FG001|Overall Study|Lost to Follow-up|2|||
146974784|NCT01355523|530071580|FG000|Overall Study|Protocol Violation|0|||
146974785|NCT01355523|530071581|FG001|Overall Study|Protocol Violation|2|||
146974786|NCT01355523|530071580|FG000|Overall Study|Adverse Event|0|||
146974787|NCT01355523|530071581|FG001|Overall Study|Adverse Event|2|||
146974788|NCT04575038|530071582|FG000|Overall Study|Withdrawal by Subject|1|||
146974789|NCT04575038|530071583|FG001|Overall Study|Withdrawal by Subject|1|||
146974790|NCT02766088|530071584|FG000|Overall Study|Sponsor study termination|498|||
146974791|NCT02766088|530071584|FG000|Overall Study|Migrated/moved from the study area|1|||
146974792|NCT02766088|530071584|FG000|Overall Study|Lost to Follow-up|5|||
146974793|NCT02766088|530071584|FG000|Overall Study|Other|1|||
146974794|NCT02766088|530071584|FG000|Overall Study|Death|1|||
146974795|NCT01222715|530071585|FG000|Overall Study|Adverse Event|0|||
146974796|NCT01222715|530071586|FG001|Overall Study|Adverse Event|4|||
146974797|NCT01222715|530071585|FG000|Overall Study|Death|0|||
146974798|NCT01222715|530071586|FG001|Overall Study|Death|1|||
146974799|NCT01222715|530071585|FG000|Overall Study|Lack of Efficacy|22|||
146974800|NCT01222715|530071586|FG001|Overall Study|Lack of Efficacy|14|||
146974801|NCT01222715|530071585|FG000|Overall Study|Physician Decision|12|||
146974802|NCT01222715|530071586|FG001|Overall Study|Physician Decision|2|||
146974803|NCT01222715|530071585|FG000|Overall Study|Refusal of further protocol therapy|0|||
146974804|NCT01222715|530071586|FG001|Overall Study|Refusal of further protocol therapy|4|||
146974805|NCT01222715|530071585|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
146974806|NCT01222715|530071586|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
146974807|NCT01222715|530071585|FG000|Overall Study|Ineligible|0|||
146974808|NCT01222715|530071586|FG001|Overall Study|Ineligible|1|||
146974809|NCT01222715|530071585|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
146974810|NCT01222715|530071586|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
146974811|NCT03555890|530071593|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
146974812|NCT03555890|530071594|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
146974813|NCT03555890|530071595|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
146974814|NCT03555890|530071596|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
146974815|NCT04682639|530071597|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
146974816|NCT04682639|530071598|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
146974817|NCT04682639|530071599|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
146974818|NCT04682639|530071600|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
146974819|NCT04682639|530071601|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
146974820|NCT04682639|530071597|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
146974821|NCT04682639|530071598|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
146974822|NCT04682639|530071599|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
146974823|NCT04682639|530071600|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146974824|NCT04682639|530071601|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146974825|NCT04682639|530071597|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
146974826|NCT04682639|530071598|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146974827|NCT04682639|530071599|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146974828|NCT04682639|530071600|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146974829|NCT04682639|530071601|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146974830|NCT04682639|530071597|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
146974831|NCT04682639|530071598|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
146974832|NCT04682639|530071599|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
146974833|NCT04682639|530071600|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
146974834|NCT04682639|530071601|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
146974835|NCT04682639|530071597|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
146974836|NCT04682639|530071598|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
146974837|NCT04682639|530071599|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
146974838|NCT04682639|530071600|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
146974839|NCT04682639|530071601|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
146974840|NCT04682639|530071597|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
146974841|NCT04682639|530071598|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
146974842|NCT04682639|530071599|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
146974843|NCT04682639|530071600|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
146974844|NCT04682639|530071601|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
146974845|NCT04682639|530071597|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
146974846|NCT04682639|530071598|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
146974847|NCT04682639|530071599|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
146974848|NCT04682639|530071600|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
146974849|NCT04682639|530071601|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
146974850|NCT04682639|530071597|FG000|OLE Period (28 Weeks)|Other|1|||
146974851|NCT04682639|530071598|FG001|OLE Period (28 Weeks)|Other|2|||
146974852|NCT04682639|530071599|FG002|OLE Period (28 Weeks)|Other|0|||
146974853|NCT04682639|530071600|FG003|OLE Period (28 Weeks)|Other|0|||
146974854|NCT04682639|530071601|FG004|OLE Period (28 Weeks)|Other|1|||
146568640|NCT00457392|528595411|FG000|Overall Study|Lost to Follow-up|6|||
146568641|NCT00457392|528595412|FG001|Overall Study|Lost to Follow-up|7|||
146568642|NCT00457392|528595411|FG000|Overall Study|Protocol Violation|4|||
146568643|NCT00457392|528595412|FG001|Overall Study|Protocol Violation|3|||
146568644|NCT00457392|528595411|FG000|Overall Study|Other|7|||
146568645|NCT00457392|528595412|FG001|Overall Study|Other|4|||
146568646|NCT00457392|528595411|FG000|Overall Study|Study Terminated by Sponsor|1|||
146568647|NCT00457392|528595412|FG001|Overall Study|Study Terminated by Sponsor|4|||
146568648|NCT00457392|528595411|FG000|Overall Study|Randomized, Not Treated|7|||
146568649|NCT00457392|528595412|FG001|Overall Study|Randomized, Not Treated|3|||
146568650|NCT00980148|528595413|FG000|Overall Study|Discharged from facility|89|||
146568651|NCT00980148|528595414|FG001|Overall Study|Discharged from facility|96|||
146568652|NCT00980148|528595413|FG000|Overall Study|Received other antichlamydia treatment|20|||
146568653|NCT00980148|528595414|FG001|Overall Study|Received other antichlamydia treatment|14|||
146568654|NCT00980148|528595413|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
146568655|NCT00980148|528595414|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
146770057|NCT00792948|529326663|FG000|Overall Study|Withdrawal by Subject|3|||
146974855|NCT04682639|530071597|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
146974856|NCT04682639|530071598|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
146974857|NCT04682639|530071599|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
146974858|NCT04682639|530071600|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
146974859|NCT04682639|530071601|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
146974860|NCT04682639|530071597|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
146974861|NCT04682639|530071598|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
146974862|NCT04682639|530071599|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
146974863|NCT04682639|530071600|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
146974864|NCT04682639|530071601|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
146974865|NCT04682639|530071597|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
146974866|NCT04682639|530071598|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
146974867|NCT04682639|530071599|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
146974868|NCT04682639|530071600|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
146974869|NCT04682639|530071601|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
146974870|NCT04682639|530071597|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
146974871|NCT04682639|530071598|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
146974872|NCT04682639|530071599|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
146974873|NCT04682639|530071600|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
146974874|NCT04682639|530071601|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
146974875|NCT01383954|530071602|FG000|Overall Study|Lack of Efficacy|2|||
146974876|NCT01383954|530071602|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
146974877|NCT01383954|530071602|FG000|Overall Study|Adverse Event|1|||
146974878|NCT01383954|530071602|FG000|Overall Study|Reason Not Specified|9|||
146974879|NCT03471182|530071603|FG000|Overall Study|Withdrawal by Subject|1|||
146974880|NCT03471182|530071604|FG001|Overall Study|Withdrawal by Subject|1|||
146974881|NCT03471182|530071605|FG002|Overall Study|Withdrawal by Subject|0|||
146974882|NCT03471182|530071603|FG000|Overall Study|Technical failure|2|||
146974883|NCT03471182|530071604|FG001|Overall Study|Technical failure|0|||
146974884|NCT03471182|530071605|FG002|Overall Study|Technical failure|0|||
146974885|NCT04440163|530071608|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
146974886|NCT04440163|530071609|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
146974887|NCT04440163|530071610|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
146974888|NCT04440163|530071611|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
146974889|NCT04440163|530071612|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
146974890|NCT04440163|530071613|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
146974891|NCT04440163|530071614|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
146974892|NCT04440163|530071615|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
146974893|NCT04440163|530071608|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
146974894|NCT04440163|530071609|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
146974895|NCT04440163|530071610|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
146974896|NCT04440163|530071611|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
146974897|NCT04440163|530071612|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
146974898|NCT04440163|530071613|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
146568656|NCT00980148|528595413|FG000|Overall Study|Various other reasons|8|||
146568657|NCT00980148|528595414|FG001|Overall Study|Various other reasons|9|||
146568658|NCT01462929|528595415|FG000|Overall Study|Adverse Event|3|||
146974899|NCT04440163|530071614|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
146974900|NCT04440163|530071615|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
146914116|NCT00494871|529848487|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
146914117|NCT00494871|529848488|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
146914118|NCT00494871|529848487|FG000|Follow-up (FU) Period|Adverse Event|1|||
146914119|NCT00494871|529848488|FG001|Follow-up (FU) Period|Adverse Event|1|||
146914120|NCT00494871|529848487|FG000|Follow-up (FU) Period|Death|13|||
146914121|NCT00494871|529848488|FG001|Follow-up (FU) Period|Death|12|||
146914122|NCT00494871|529848487|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
146914123|NCT00494871|529848488|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
146914124|NCT00494871|529848487|FG000|Follow-up (FU) Period|Physician Decision|0|||
146914125|NCT00494871|529848488|FG001|Follow-up (FU) Period|Physician Decision|1|||
146914126|NCT00494871|529848487|FG000|Follow-up (FU) Period|Protocol Violation|1|||
146914127|NCT00494871|529848488|FG001|Follow-up (FU) Period|Protocol Violation|0|||
146914128|NCT00494871|529848487|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
146914129|NCT00494871|529848488|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
146914130|NCT00494871|529848487|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
146914131|NCT00494871|529848488|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
146914132|NCT04543955|529848489|FG000|Overall Study|Company cancelled study|1|||
146508702|NCT00710684|528366240|FG000|Overall Study|Withdrawal by Subject|24|||
146508703|NCT00710684|528366241|FG001|Overall Study|Withdrawal by Subject|18|||
146508704|NCT00710684|528366242|FG002|Overall Study|Withdrawal by Subject|11|||
146508705|NCT00710684|528366240|FG000|Overall Study|Missing|1|||
146508706|NCT00710684|528366241|FG001|Overall Study|Missing|0|||
146508707|NCT00710684|528366242|FG002|Overall Study|Missing|0|||
146508708|NCT00710684|528366240|FG000|Overall Study|Did not continue after week 24|25|||
146508709|NCT00710684|528366241|FG001|Overall Study|Did not continue after week 24|21|||
146508710|NCT00710684|528366242|FG002|Overall Study|Did not continue after week 24|16|||
146508711|NCT00514904|528366243|FG000|Overall Study|Withdrawal by Subject|3|||
146508712|NCT00514904|528366244|FG001|Overall Study|Withdrawal by Subject|2|||
146508713|NCT00514904|528366243|FG000|Overall Study|Lost to Follow-up|21|||
146508714|NCT00514904|528366244|FG001|Overall Study|Lost to Follow-up|3|||
146508715|NCT01645891|528366252|FG000|Overall Study|Adverse Event|6|||
146508716|NCT01645891|528366253|FG001|Overall Study|Adverse Event|10|||
146508717|NCT01645891|528366252|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
146508718|NCT01645891|528366253|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
146508719|NCT01645891|528366252|FG000|Overall Study|Withdrawal by Subject|3|||
146508720|NCT01645891|528366253|FG001|Overall Study|Withdrawal by Subject|3|||
146508721|NCT01645891|528366252|FG000|Overall Study|Protocol Violation|4|||
146508722|NCT01645891|528366253|FG001|Overall Study|Protocol Violation|0|||
146508723|NCT01645891|528366252|FG000|Overall Study|Lost to Follow-up|4|||
146508724|NCT01645891|528366253|FG001|Overall Study|Lost to Follow-up|1|||
146508725|NCT01645891|528366252|FG000|Overall Study|Death|0|||
146508726|NCT01645891|528366253|FG001|Overall Study|Death|2|||
146508727|NCT04814368|528366254|FG000|Overall Study|Study Terminated by Sponsor|0|||
146508728|NCT04814368|528366255|FG001|Overall Study|Study Terminated by Sponsor|3|||
146508729|NCT04814368|528366256|FG002|Overall Study|Study Terminated by Sponsor|0|||
146508730|NCT04814368|528366257|FG003|Overall Study|Study Terminated by Sponsor|2|||
146508731|NCT04814368|528366254|FG000|Overall Study|Subject Decision|1|||
146508732|NCT04814368|528366255|FG001|Overall Study|Subject Decision|2|||
146508733|NCT04814368|528366256|FG002|Overall Study|Subject Decision|0|||
146508734|NCT04814368|528366257|FG003|Overall Study|Subject Decision|0|||
146508735|NCT01173055|528366258|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
146508736|NCT01173055|528366259|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
146508737|NCT01173055|528366258|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
146508738|NCT01173055|528366259|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
146508739|NCT04216589|528366261|FG000|Overall Study|Withdrawal by Subject|2|||
146508740|NCT04216589|528366261|FG000|Overall Study|Protocol Violation|1|||
146508741|NCT04216589|528366261|FG000|Overall Study|Incarceration|1|||
146508742|NCT03721835|528366262|FG000|Overall Study|Participant not able to return|1|||
146914133|NCT04543955|529848490|FG001|Overall Study|Company cancelled study|0|||
146914134|NCT00859898|529848492|FG000|Overall Study|Lack of Efficacy|0|||
146914135|NCT00859898|529848493|FG001|Overall Study|Lack of Efficacy|1|||
146508743|NCT03721835|528366262|FG000|Overall Study|Lost to Follow-up|1|||
146508744|NCT03721835|528366262|FG000|Overall Study|Revision of the components of the study device|2|||
146508745|NCT03721835|528366262|FG000|Overall Study|Sponsor terminated study|6|||
146508746|NCT03721835|528366262|FG000|Overall Study|Death|1|||
146508747|NCT03721835|528366262|FG000|Overall Study|Sponsor decision|1|||
146508748|NCT01306045|528366267|FG000|Met General Eligibility Criteria|Screen failures|193|||
146508749|NCT01306045|528366268|FG001|Met General Eligibility Criteria|Screen failures|11|||
146508750|NCT01306045|528366269|FG002|Met General Eligibility Criteria|Screen failures|8|||
146508751|NCT04550832|528367668|FG000|Overall Study|Adverse Event|0|||
146508752|NCT04550832|528367669|FG001|Overall Study|Adverse Event|0|||
146508753|NCT04550832|528367670|FG002|Overall Study|Adverse Event|2|||
146508754|NCT04550832|528367671|FG003|Overall Study|Adverse Event|0|||
146508755|NCT04550832|528367672|FG004|Overall Study|Adverse Event|1|||
146508756|NCT04823130|528367673|FG000|Overall Study|Withdrawal by Subject|2|||
146568659|NCT01462929|528595416|FG001|Overall Study|Adverse Event|3|||
146974901|NCT04440163|530071608|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
146974902|NCT04440163|530071609|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
146974903|NCT04440163|530071610|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
146974904|NCT04440163|530071611|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
146974905|NCT04440163|530071612|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
146974906|NCT04440163|530071613|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
146974907|NCT04440163|530071614|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
146974908|NCT04440163|530071615|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
146974909|NCT04440163|530071608|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
146974910|NCT04440163|530071609|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
146974911|NCT04440163|530071610|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
146974912|NCT04440163|530071611|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
146974913|NCT04440163|530071612|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
146974914|NCT04440163|530071613|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
146974915|NCT04440163|530071614|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
146974916|NCT04440163|530071615|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
146974917|NCT04440163|530071608|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
146974918|NCT04440163|530071609|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
146974919|NCT04440163|530071610|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
146974920|NCT04440163|530071611|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
146974921|NCT04440163|530071612|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
146974922|NCT04440163|530071613|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
146974923|NCT04440163|530071614|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
146974924|NCT04440163|530071615|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
146508757|NCT04823130|528367674|FG001|Overall Study|Withdrawal by Subject|3|||
146508758|NCT04823130|528367673|FG000|Overall Study|Failure to meet inclusion criteria|6|||
146508759|NCT04823130|528367674|FG001|Overall Study|Failure to meet inclusion criteria|4|||
146508760|NCT04823130|528367673|FG000|Overall Study|Other-unspecified|1|||
146508761|NCT04823130|528367674|FG001|Overall Study|Other-unspecified|0|||
146508762|NCT03315455|528367676|FG000|Overall Study|Ongoing in the Study|13|||
146508763|NCT03315455|528367677|FG001|Overall Study|Ongoing in the Study|24|||
146508764|NCT03315455|528367678|FG002|Overall Study|Ongoing in the Study|17|||
146568660|NCT01462929|528595417|FG002|Overall Study|Adverse Event|4|||
146568661|NCT01462929|528595415|FG000|Overall Study|Withdrawal by Subject|2|||
146568662|NCT01462929|528595416|FG001|Overall Study|Withdrawal by Subject|1|||
146568663|NCT01462929|528595417|FG002|Overall Study|Withdrawal by Subject|0|||
146508765|NCT03315455|528367679|FG003|Overall Study|Ongoing in the Study|15|||
146568664|NCT01462929|528595415|FG000|Overall Study|Lack of Efficacy|0|||
146568665|NCT01462929|528595416|FG001|Overall Study|Lack of Efficacy|0|||
146568666|NCT01462929|528595417|FG002|Overall Study|Lack of Efficacy|1|||
146568667|NCT01309204|528595422|FG000|Overall Study|Adverse Event|48|||
146568668|NCT01309204|528595423|FG001|Overall Study|Adverse Event|58|||
146650210|NCT00169442|528895044|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
146508766|NCT03315455|528367676|FG000|Overall Study|Withdrawal by Subject|0|||
146508767|NCT03315455|528367677|FG001|Overall Study|Withdrawal by Subject|1|||
146508768|NCT03315455|528367678|FG002|Overall Study|Withdrawal by Subject|0|||
146508769|NCT03315455|528367679|FG003|Overall Study|Withdrawal by Subject|0|||
146508770|NCT01573767|528367686|FG000|Overall Study|Adverse Event|0|||
146508771|NCT01573767|528367687|FG001|Overall Study|Adverse Event|1|||
146508772|NCT01573767|528367688|FG002|Overall Study|Adverse Event|0|||
146508773|NCT01573767|528367689|FG003|Overall Study|Adverse Event|1|||
146508774|NCT01573767|528367686|FG000|Overall Study|Lack of Efficacy|18|||
146508775|NCT01573767|528367687|FG001|Overall Study|Lack of Efficacy|15|||
146508776|NCT01573767|528367688|FG002|Overall Study|Lack of Efficacy|12|||
146508777|NCT01573767|528367689|FG003|Overall Study|Lack of Efficacy|17|||
146508778|NCT01573767|528367686|FG000|Overall Study|Protocol Violation|3|||
146508779|NCT01573767|528367687|FG001|Overall Study|Protocol Violation|1|||
146508780|NCT01573767|528367688|FG002|Overall Study|Protocol Violation|1|||
146508781|NCT01573767|528367689|FG003|Overall Study|Protocol Violation|3|||
146508782|NCT01573767|528367686|FG000|Overall Study|Lost to Follow-up|0|||
146508783|NCT01573767|528367687|FG001|Overall Study|Lost to Follow-up|1|||
146508784|NCT01573767|528367688|FG002|Overall Study|Lost to Follow-up|1|||
146568669|NCT01309204|528595422|FG000|Overall Study|Lost to Follow-up|2|||
146568670|NCT01309204|528595423|FG001|Overall Study|Lost to Follow-up|2|||
146568671|NCT01309204|528595422|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
146974925|NCT04440163|530071608|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
146974926|NCT04440163|530071609|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
146974927|NCT04440163|530071610|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
146508785|NCT01573767|528367689|FG003|Overall Study|Lost to Follow-up|1|||
146568672|NCT01309204|528595423|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
146508786|NCT01573767|528367686|FG000|Overall Study|Physician Decision|1|||
146508787|NCT01573767|528367687|FG001|Overall Study|Physician Decision|2|||
146914136|NCT00859898|529848494|FG002|Overall Study|Lack of Efficacy|1|||
146914137|NCT00859898|529848492|FG000|Overall Study|Adverse Event|4|||
146914138|NCT00859898|529848493|FG001|Overall Study|Adverse Event|9|||
146914139|NCT00859898|529848494|FG002|Overall Study|Adverse Event|8|||
146914140|NCT00859898|529848492|FG000|Overall Study|Withdrawal by Subject|11|||
146914141|NCT00859898|529848493|FG001|Overall Study|Withdrawal by Subject|8|||
146914142|NCT00859898|529848494|FG002|Overall Study|Withdrawal by Subject|11|||
146914143|NCT00859898|529848492|FG000|Overall Study|Death|0|||
146914144|NCT00859898|529848493|FG001|Overall Study|Death|0|||
146914145|NCT00859898|529848494|FG002|Overall Study|Death|1|||
146914146|NCT00859898|529848492|FG000|Overall Study|Lost to Follow-up|10|||
146914147|NCT00859898|529848493|FG001|Overall Study|Lost to Follow-up|11|||
146914148|NCT00859898|529848494|FG002|Overall Study|Lost to Follow-up|5|||
146914149|NCT00859898|529848492|FG000|Overall Study|poor/non-compliance|2|||
146914150|NCT00859898|529848493|FG001|Overall Study|poor/non-compliance|0|||
146914151|NCT00859898|529848494|FG002|Overall Study|poor/non-compliance|0|||
146914152|NCT00859898|529848492|FG000|Overall Study|No longer meets criteria|0|||
146914153|NCT00859898|529848493|FG001|Overall Study|No longer meets criteria|1|||
146914154|NCT00859898|529848494|FG002|Overall Study|No longer meets criteria|0|||
146914155|NCT00859898|529848492|FG000|Overall Study|non-specified|1|||
146914156|NCT00859898|529848493|FG001|Overall Study|non-specified|1|||
146914157|NCT00859898|529848494|FG002|Overall Study|non-specified|1|||
146914158|NCT04230486|529848495|FG000|Overall Study|Screen Failure|1|||
146914159|NCT03215264|529848496|FG000|Dose Level 2|Adverse Event|0|||
146914160|NCT03215264|529848497|FG001|Dose Level 2|Adverse Event|1|||
146914161|NCT03215264|529848498|FG002|Dose Level 2|Adverse Event|0|||
146914162|NCT03215264|529848496|FG000|Dose Level 3|Withdrawal by Subject|0|||
146914163|NCT03215264|529848497|FG001|Dose Level 3|Withdrawal by Subject|0|||
146914164|NCT03215264|529848498|FG002|Dose Level 3|Withdrawal by Subject|1|||
146914165|NCT02145156|529848500|FG000|Overall Study|No match to vaccination records|60|||
146914166|NCT02145156|529848501|FG001|Overall Study|No match to vaccination records|52|||
146914167|NCT02145156|529848502|FG002|Overall Study|No match to vaccination records|41|||
146914168|NCT02417233|529848505|FG000|Overall Study|Death|4|||
146914169|NCT02417233|529848506|FG001|Overall Study|Death|10|||
146914170|NCT02417233|529848507|FG002|Overall Study|Death|14|||
146914171|NCT02417233|529848505|FG000|Overall Study|Lost to Follow-up|27|||
146568673|NCT01309204|528595422|FG000|Overall Study|Inadequate control of IOP|4|||
146568674|NCT01309204|528595423|FG001|Overall Study|Inadequate control of IOP|4|||
146568675|NCT01309204|528595422|FG000|Overall Study|Other|4|||
146508788|NCT01573767|528367688|FG002|Overall Study|Physician Decision|0|||
146508789|NCT01573767|528367689|FG003|Overall Study|Physician Decision|2|||
146508790|NCT01573767|528367686|FG000|Overall Study|Withdrawal by Subject|0|||
146568676|NCT01309204|528595423|FG001|Overall Study|Other|1|||
146508791|NCT01573767|528367687|FG001|Overall Study|Withdrawal by Subject|1|||
146508792|NCT01573767|528367688|FG002|Overall Study|Withdrawal by Subject|0|||
146508793|NCT01573767|528367689|FG003|Overall Study|Withdrawal by Subject|0|||
146508794|NCT00308750|528367692|FG000|Overall Study|Adverse Event|9|||
146508795|NCT00308750|528367693|FG001|Overall Study|Adverse Event|9|||
146508796|NCT00308750|528367694|FG002|Overall Study|Adverse Event|13|||
146508797|NCT00308750|528367692|FG000|Overall Study|Withdrawal by Subject|6|||
146508798|NCT00308750|528367693|FG001|Overall Study|Withdrawal by Subject|2|||
146508799|NCT00308750|528367694|FG002|Overall Study|Withdrawal by Subject|3|||
146508800|NCT00308750|528367692|FG000|Overall Study|Physician Decision|3|||
146508801|NCT00308750|528367693|FG001|Overall Study|Physician Decision|4|||
146508802|NCT00308750|528367694|FG002|Overall Study|Physician Decision|3|||
146508803|NCT00308750|528367692|FG000|Overall Study|Sponsor Decision|1|||
146508804|NCT00308750|528367693|FG001|Overall Study|Sponsor Decision|0|||
146508805|NCT00308750|528367694|FG002|Overall Study|Sponsor Decision|0|||
146508806|NCT00308750|528367692|FG000|Overall Study|Disease Progression|47|||
146508807|NCT00308750|528367693|FG001|Overall Study|Disease Progression|24|||
146508808|NCT00308750|528367694|FG002|Overall Study|Disease Progression|28|||
146508809|NCT00308750|528367692|FG000|Overall Study|Unrelated Complication|3|||
146508810|NCT00308750|528367693|FG001|Overall Study|Unrelated Complication|0|||
146508811|NCT00308750|528367694|FG002|Overall Study|Unrelated Complication|1|||
146508812|NCT00308750|528367692|FG000|Overall Study|Death|1|||
146508813|NCT00308750|528367693|FG001|Overall Study|Death|0|||
146508814|NCT00308750|528367694|FG002|Overall Study|Death|1|||
146508815|NCT00308750|528367692|FG000|Overall Study|Protocol Violation|1|||
146568677|NCT00925002|528595424|FG000|Overall Study|Other|1|||
146568678|NCT00925002|528595425|FG001|Overall Study|Other|4|||
146568679|NCT00925002|528595426|FG002|Overall Study|Other|0|||
146914172|NCT02417233|529848506|FG001|Overall Study|Lost to Follow-up|39|||
146508816|NCT00308750|528367693|FG001|Overall Study|Protocol Violation|0|||
146508817|NCT00308750|528367694|FG002|Overall Study|Protocol Violation|0|||
146508818|NCT00308750|528367692|FG000|Overall Study|New Primary Disease Identified|1|||
146568680|NCT00925002|528595424|FG000|Overall Study|Death|1|||
146568681|NCT00925002|528595425|FG001|Overall Study|Death|1|||
146914173|NCT02417233|529848507|FG002|Overall Study|Lost to Follow-up|34|||
146914174|NCT02417233|529848505|FG000|Overall Study|Protocol Violation|2|||
146914175|NCT02417233|529848506|FG001|Overall Study|Protocol Violation|0|||
146508819|NCT00308750|528367693|FG001|Overall Study|New Primary Disease Identified|1|||
146508820|NCT00308750|528367694|FG002|Overall Study|New Primary Disease Identified|0|||
146508821|NCT01358578|528367695|FG000|Induction Period|Adverse Event|2|||
146508822|NCT01358578|528367696|FG001|Induction Period|Adverse Event|4|||
146508823|NCT01358578|528367697|FG002|Induction Period|Adverse Event|2|||
146508824|NCT01358578|528367698|FG003|Induction Period|Adverse Event|6|||
146508825|NCT01358578|528367699|FG004|Induction Period|Adverse Event|0|||
146508826|NCT01358578|528367700|FG005|Induction Period|Adverse Event|0|||
146508827|NCT01358578|528367695|FG000|Induction Period|Lack of Efficacy|0|||
146508828|NCT01358578|528367696|FG001|Induction Period|Lack of Efficacy|0|||
146508829|NCT01358578|528367697|FG002|Induction Period|Lack of Efficacy|9|||
146508830|NCT01358578|528367698|FG003|Induction Period|Lack of Efficacy|1|||
146508831|NCT01358578|528367699|FG004|Induction Period|Lack of Efficacy|0|||
146508832|NCT01358578|528367700|FG005|Induction Period|Lack of Efficacy|0|||
146508833|NCT01358578|528367695|FG000|Induction Period|Lost to Follow-up|0|||
146508834|NCT01358578|528367696|FG001|Induction Period|Lost to Follow-up|0|||
146508835|NCT01358578|528367697|FG002|Induction Period|Lost to Follow-up|1|||
146508836|NCT01358578|528367698|FG003|Induction Period|Lost to Follow-up|4|||
146508837|NCT01358578|528367699|FG004|Induction Period|Lost to Follow-up|0|||
146508838|NCT01358578|528367700|FG005|Induction Period|Lost to Follow-up|0|||
146508839|NCT01358578|528367695|FG000|Induction Period|Physician Decision|2|||
146508840|NCT01358578|528367696|FG001|Induction Period|Physician Decision|1|||
146508841|NCT01358578|528367697|FG002|Induction Period|Physician Decision|2|||
146508842|NCT01358578|528367698|FG003|Induction Period|Physician Decision|0|||
146508843|NCT01358578|528367699|FG004|Induction Period|Physician Decision|0|||
146508844|NCT01358578|528367700|FG005|Induction Period|Physician Decision|0|||
146508845|NCT01358578|528367695|FG000|Induction Period|Protocol Deviation|3|||
146508846|NCT01358578|528367696|FG001|Induction Period|Protocol Deviation|5|||
146508847|NCT01358578|528367697|FG002|Induction Period|Protocol Deviation|0|||
146508848|NCT01358578|528367698|FG003|Induction Period|Protocol Deviation|3|||
146508849|NCT01358578|528367699|FG004|Induction Period|Protocol Deviation|0|||
146508850|NCT01358578|528367700|FG005|Induction Period|Protocol Deviation|0|||
146508851|NCT01358578|528367695|FG000|Induction Period|technical problems|0|||
146508852|NCT01358578|528367696|FG001|Induction Period|technical problems|0|||
146508853|NCT01358578|528367697|FG002|Induction Period|technical problems|1|||
146508854|NCT01358578|528367698|FG003|Induction Period|technical problems|1|||
146508855|NCT01358578|528367699|FG004|Induction Period|technical problems|0|||
146508856|NCT01358578|528367700|FG005|Induction Period|technical problems|0|||
146508857|NCT01358578|528367695|FG000|Induction Period|Withdrawal by Subject|5|||
146508858|NCT01358578|528367696|FG001|Induction Period|Withdrawal by Subject|5|||
146508859|NCT01358578|528367697|FG002|Induction Period|Withdrawal by Subject|10|||
146508860|NCT01358578|528367698|FG003|Induction Period|Withdrawal by Subject|6|||
146508861|NCT01358578|528367699|FG004|Induction Period|Withdrawal by Subject|0|||
146508862|NCT01358578|528367700|FG005|Induction Period|Withdrawal by Subject|0|||
146508863|NCT01358578|528367695|FG000|Maintenance Period|Adverse Event|2|||
146508864|NCT01358578|528367696|FG001|Maintenance Period|Adverse Event|7|||
146508865|NCT01358578|528367697|FG002|Maintenance Period|Adverse Event|0|||
146508866|NCT01358578|528367698|FG003|Maintenance Period|Adverse Event|6|||
146508867|NCT01358578|528367699|FG004|Maintenance Period|Adverse Event|4|||
146508868|NCT01358578|528367700|FG005|Maintenance Period|Adverse Event|3|||
146508869|NCT01358578|528367695|FG000|Maintenance Period|Lack of Efficacy|10|||
146508870|NCT01358578|528367696|FG001|Maintenance Period|Lack of Efficacy|2|||
146508871|NCT01358578|528367697|FG002|Maintenance Period|Lack of Efficacy|0|||
146508872|NCT01358578|528367698|FG003|Maintenance Period|Lack of Efficacy|11|||
146508873|NCT01358578|528367699|FG004|Maintenance Period|Lack of Efficacy|3|||
146508874|NCT01358578|528367700|FG005|Maintenance Period|Lack of Efficacy|0|||
146508875|NCT01358578|528367695|FG000|Maintenance Period|Lost to Follow-up|4|||
146508876|NCT01358578|528367696|FG001|Maintenance Period|Lost to Follow-up|0|||
146508877|NCT01358578|528367697|FG002|Maintenance Period|Lost to Follow-up|0|||
146508878|NCT01358578|528367698|FG003|Maintenance Period|Lost to Follow-up|5|||
146508879|NCT01358578|528367699|FG004|Maintenance Period|Lost to Follow-up|1|||
146508880|NCT01358578|528367700|FG005|Maintenance Period|Lost to Follow-up|1|||
146508881|NCT01358578|528367695|FG000|Maintenance Period|Non-compliance with study treatment|3|||
146508882|NCT01358578|528367696|FG001|Maintenance Period|Non-compliance with study treatment|1|||
146508883|NCT01358578|528367697|FG002|Maintenance Period|Non-compliance with study treatment|0|||
146508884|NCT01358578|528367698|FG003|Maintenance Period|Non-compliance with study treatment|2|||
146508885|NCT01358578|528367699|FG004|Maintenance Period|Non-compliance with study treatment|1|||
146508886|NCT01358578|528367700|FG005|Maintenance Period|Non-compliance with study treatment|2|||
146508887|NCT01358578|528367695|FG000|Maintenance Period|Physician Decision|0|||
146508888|NCT01358578|528367696|FG001|Maintenance Period|Physician Decision|1|||
146508889|NCT01358578|528367697|FG002|Maintenance Period|Physician Decision|0|||
146508890|NCT01358578|528367698|FG003|Maintenance Period|Physician Decision|1|||
146508891|NCT01358578|528367699|FG004|Maintenance Period|Physician Decision|0|||
146508892|NCT01358578|528367700|FG005|Maintenance Period|Physician Decision|0|||
146568682|NCT00925002|528595426|FG002|Overall Study|Death|5|||
146568683|NCT00925002|528595424|FG000|Overall Study|Adverse Event|3|||
146914176|NCT02417233|529848507|FG002|Overall Study|Protocol Violation|2|||
146914177|NCT02417233|529848505|FG000|Overall Study|Withdrawal by Subject|2|||
146914178|NCT02417233|529848506|FG001|Overall Study|Withdrawal by Subject|1|||
146914179|NCT02417233|529848507|FG002|Overall Study|Withdrawal by Subject|8|||
146914180|NCT02417233|529848505|FG000|Overall Study|Relocation out of study area|1|||
146914181|NCT02417233|529848506|FG001|Overall Study|Relocation out of study area|0|||
146914182|NCT02417233|529848507|FG002|Overall Study|Relocation out of study area|1|||
146914183|NCT02417233|529848505|FG000|Overall Study|Mentally unstable|0|||
146914184|NCT02417233|529848506|FG001|Overall Study|Mentally unstable|1|||
146914185|NCT02417233|529848507|FG002|Overall Study|Mentally unstable|0|||
146914186|NCT01264965|529848508|FG000|Overall Study|Withdrawal by Subject|10|||
146914187|NCT00532883|529848509|FG000|Overall Study|Adverse Event|1|||
146914188|NCT00532883|529848510|FG001|Overall Study|Adverse Event|0|||
146914189|NCT00532883|529848511|FG002|Overall Study|Adverse Event|0|||
146914190|NCT00532883|529848512|FG003|Overall Study|Adverse Event|1|||
146914191|NCT00532883|529848509|FG000|Overall Study|Lost to Follow-up|1|||
146914192|NCT00532883|529848510|FG001|Overall Study|Lost to Follow-up|1|||
146914193|NCT00532883|529848511|FG002|Overall Study|Lost to Follow-up|1|||
146914194|NCT00532883|529848512|FG003|Overall Study|Lost to Follow-up|0|||
146914195|NCT00532883|529848509|FG000|Overall Study|Withdrawal by Subject|0|||
146914196|NCT00532883|529848510|FG001|Overall Study|Withdrawal by Subject|1|||
146914197|NCT00532883|529848511|FG002|Overall Study|Withdrawal by Subject|1|||
146508893|NCT01358578|528367695|FG000|Maintenance Period|Pregnancy|1|||
146508894|NCT01358578|528367696|FG001|Maintenance Period|Pregnancy|0|||
146508895|NCT01358578|528367697|FG002|Maintenance Period|Pregnancy|0|||
146508896|NCT01358578|528367698|FG003|Maintenance Period|Pregnancy|0|||
146508897|NCT01358578|528367699|FG004|Maintenance Period|Pregnancy|0|||
146508898|NCT01358578|528367700|FG005|Maintenance Period|Pregnancy|0|||
146508899|NCT01358578|528367695|FG000|Maintenance Period|Protocol deviation|7|||
146508900|NCT01358578|528367696|FG001|Maintenance Period|Protocol deviation|4|||
146508901|NCT01358578|528367697|FG002|Maintenance Period|Protocol deviation|0|||
146508902|NCT01358578|528367698|FG003|Maintenance Period|Protocol deviation|2|||
146508903|NCT01358578|528367699|FG004|Maintenance Period|Protocol deviation|2|||
146508904|NCT01358578|528367700|FG005|Maintenance Period|Protocol deviation|2|||
146508905|NCT01358578|528367695|FG000|Maintenance Period|Withdrawal by Subject|12|||
146508906|NCT01358578|528367696|FG001|Maintenance Period|Withdrawal by Subject|7|||
146508907|NCT01358578|528367697|FG002|Maintenance Period|Withdrawal by Subject|2|||
146508908|NCT01358578|528367698|FG003|Maintenance Period|Withdrawal by Subject|15|||
146508909|NCT01358578|528367699|FG004|Maintenance Period|Withdrawal by Subject|6|||
146508910|NCT01358578|528367700|FG005|Maintenance Period|Withdrawal by Subject|3|||
146508911|NCT01358578|528367695|FG000|Follow-up Period|Adverse Event|1|||
146508912|NCT01358578|528367696|FG001|Follow-up Period|Adverse Event|1|||
146914198|NCT00532883|529848512|FG003|Overall Study|Withdrawal by Subject|0|||
146914199|NCT00532883|529848509|FG000|Overall Study|Subject was Nonadherent|0|||
146914200|NCT00532883|529848510|FG001|Overall Study|Subject was Nonadherent|1|||
146914201|NCT00532883|529848511|FG002|Overall Study|Subject was Nonadherent|1|||
146914202|NCT00532883|529848512|FG003|Overall Study|Subject was Nonadherent|0|||
146914203|NCT00532883|529848509|FG000|Overall Study|Early Study Termination|4|||
146914204|NCT00532883|529848510|FG001|Overall Study|Early Study Termination|4|||
146914205|NCT00532883|529848511|FG002|Overall Study|Early Study Termination|1|||
146914206|NCT00532883|529848512|FG003|Overall Study|Early Study Termination|4|||
146914207|NCT03799718|529848513|FG000|Overall Study|Adverse Event|2|||
146914208|NCT05232097|529848514|FG000|Overall Study|Physician Decision|1|||
146914209|NCT01172288|529848515|FG000|Overall Study|Adverse Event|1|||
146914210|NCT01172288|529848516|FG001|Overall Study|Adverse Event|0|||
146914211|NCT01172288|529848515|FG000|Overall Study|Protocol Violation|0|||
146914212|NCT01172288|529848516|FG001|Overall Study|Protocol Violation|1|||
146914213|NCT00871858|529848519|FG000|Overall Study|Protocol Violation|3|||
146914214|NCT00871858|529848520|FG001|Overall Study|Protocol Violation|4|||
146914215|NCT00871858|529848519|FG000|Overall Study|Adverse Event|1|||
146914216|NCT00871858|529848520|FG001|Overall Study|Adverse Event|1|||
146914217|NCT00871858|529848519|FG000|Overall Study|Withdrawal by Subject|1|||
146914218|NCT00871858|529848520|FG001|Overall Study|Withdrawal by Subject|1|||
146914219|NCT00871858|529848519|FG000|Overall Study|Lost to Follow-up|0|||
146914220|NCT00871858|529848520|FG001|Overall Study|Lost to Follow-up|1|||
146914221|NCT01188798|529848521|FG000|Overall Study|Death|0|||
146914222|NCT01188798|529848522|FG001|Overall Study|Death|1|||
146914223|NCT01188798|529848521|FG000|Overall Study|Required additional transplant|1|||
146914224|NCT01188798|529848522|FG001|Overall Study|Required additional transplant|1|||
146914225|NCT01188798|529848521|FG000|Overall Study|Protocol closure|1|||
146914226|NCT01188798|529848522|FG001|Overall Study|Protocol closure|1|||
146914227|NCT01097330|529848523|FG000|Overall Study|Study terminated early|7|||
146508913|NCT01358578|528367697|FG002|Follow-up Period|Adverse Event|0|||
146508914|NCT01358578|528367698|FG003|Follow-up Period|Adverse Event|0|||
146508915|NCT01358578|528367699|FG004|Follow-up Period|Adverse Event|0|||
146914228|NCT01097330|529848524|FG001|Overall Study|Study terminated early|5|||
146914229|NCT03694522|529848530|FG000|Overall Study|Withdrawal by Subject|8|||
146914230|NCT03694522|529848531|FG001|Overall Study|Withdrawal by Subject|10|||
146914231|NCT03694522|529848530|FG000|Overall Study|Physician Decision|53|||
146914232|NCT03694522|529848531|FG001|Overall Study|Physician Decision|54|||
146914233|NCT03694522|529848530|FG000|Overall Study|Other|1|||
146914234|NCT03694522|529848531|FG001|Overall Study|Other|1|||
146914235|NCT03694522|529848530|FG000|Overall Study|Lost to Follow-up|0|||
146914236|NCT03694522|529848531|FG001|Overall Study|Lost to Follow-up|1|||
146914237|NCT02760407|529848532|FG000|Overall Study|Death|2|||
146914238|NCT02760407|529848533|FG001|Overall Study|Death|3|||
146914239|NCT02760407|529848534|FG002|Overall Study|Death|1|||
146914240|NCT02760407|529848535|FG003|Overall Study|Death|1|||
146914241|NCT02760407|529848532|FG000|Overall Study|Lost to Follow-up|1|||
146914242|NCT02760407|529848533|FG001|Overall Study|Lost to Follow-up|7|||
146914243|NCT02760407|529848534|FG002|Overall Study|Lost to Follow-up|4|||
146914244|NCT02760407|529848535|FG003|Overall Study|Lost to Follow-up|6|||
146914245|NCT02760407|529848532|FG000|Overall Study|Withdrawal by Subject|25|||
146914246|NCT02760407|529848533|FG001|Overall Study|Withdrawal by Subject|31|||
146914247|NCT02760407|529848534|FG002|Overall Study|Withdrawal by Subject|37|||
146914248|NCT02760407|529848535|FG003|Overall Study|Withdrawal by Subject|25|||
146914249|NCT02760407|529848532|FG000|Overall Study|Violation of Eligibility criteria|0|||
146914250|NCT02760407|529848533|FG001|Overall Study|Violation of Eligibility criteria|0|||
146914251|NCT02760407|529848534|FG002|Overall Study|Violation of Eligibility criteria|1|||
146914252|NCT02760407|529848535|FG003|Overall Study|Violation of Eligibility criteria|1|||
146914253|NCT02760407|529848532|FG000|Overall Study|Personal reasons|0|||
146914254|NCT02760407|529848533|FG001|Overall Study|Personal reasons|0|||
146914255|NCT02760407|529848534|FG002|Overall Study|Personal reasons|0|||
146914256|NCT02760407|529848535|FG003|Overall Study|Personal reasons|1|||
146914257|NCT02760407|529848532|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
146914258|NCT02760407|529848533|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
146914259|NCT02760407|529848534|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
146914260|NCT02760407|529848535|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
146914261|NCT02760407|529848532|FG000|Overall Study|Use of prohibited Medication|0|||
146914262|NCT02760407|529848533|FG001|Overall Study|Use of prohibited Medication|0|||
146914263|NCT02760407|529848534|FG002|Overall Study|Use of prohibited Medication|1|||
146914264|NCT02760407|529848535|FG003|Overall Study|Use of prohibited Medication|0|||
146914265|NCT02760407|529848532|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
146914266|NCT02760407|529848533|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
146914267|NCT02760407|529848534|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
146914268|NCT02760407|529848535|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
146914269|NCT02760407|529848532|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
146914270|NCT02760407|529848533|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
146914271|NCT02760407|529848534|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
146914272|NCT02760407|529848535|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
146914273|NCT02760407|529848532|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
146914274|NCT02760407|529848533|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
146914275|NCT02760407|529848534|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
146914276|NCT02760407|529848535|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
146914277|NCT02760407|529848532|FG000|Overall Study|Inadequately Enrolled|0|||
146914278|NCT02760407|529848533|FG001|Overall Study|Inadequately Enrolled|0|||
146914279|NCT02760407|529848534|FG002|Overall Study|Inadequately Enrolled|0|||
146914280|NCT02760407|529848535|FG003|Overall Study|Inadequately Enrolled|1|||
146914281|NCT02760407|529848532|FG000|Overall Study|Withdrawal By PI's Decision|0|||
146914282|NCT02760407|529848533|FG001|Overall Study|Withdrawal By PI's Decision|1|||
146914283|NCT02760407|529848534|FG002|Overall Study|Withdrawal By PI's Decision|0|||
146914284|NCT02760407|529848535|FG003|Overall Study|Withdrawal By PI's Decision|0|||
146914285|NCT02760407|529848532|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
146508916|NCT01358578|528367700|FG005|Follow-up Period|Adverse Event|0|||
146508917|NCT01358578|528367695|FG000|Follow-up Period|Lack of Efficacy|3|||
146508918|NCT01358578|528367696|FG001|Follow-up Period|Lack of Efficacy|0|||
146508919|NCT01358578|528367697|FG002|Follow-up Period|Lack of Efficacy|4|||
146508920|NCT01358578|528367698|FG003|Follow-up Period|Lack of Efficacy|1|||
146508921|NCT01358578|528367699|FG004|Follow-up Period|Lack of Efficacy|0|||
146508922|NCT01358578|528367700|FG005|Follow-up Period|Lack of Efficacy|0|||
146508923|NCT01358578|528367695|FG000|Follow-up Period|Lost to Follow-up|0|||
146508924|NCT01358578|528367696|FG001|Follow-up Period|Lost to Follow-up|1|||
146508925|NCT01358578|528367697|FG002|Follow-up Period|Lost to Follow-up|0|||
146508926|NCT01358578|528367698|FG003|Follow-up Period|Lost to Follow-up|4|||
146508927|NCT01358578|528367699|FG004|Follow-up Period|Lost to Follow-up|0|||
146508928|NCT01358578|528367700|FG005|Follow-up Period|Lost to Follow-up|0|||
146568684|NCT00925002|528595425|FG001|Overall Study|Adverse Event|1|||
146974928|NCT04440163|530071611|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
146974929|NCT04440163|530071612|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
146974930|NCT04440163|530071613|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
146974931|NCT04440163|530071614|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
146974932|NCT04440163|530071615|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
146974933|NCT04440163|530071608|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
146974934|NCT04440163|530071609|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
146974935|NCT04440163|530071610|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
146974936|NCT04440163|530071611|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
146974937|NCT04440163|530071612|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
146974938|NCT04440163|530071613|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
146974939|NCT04440163|530071614|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
146974940|NCT04440163|530071615|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
146974941|NCT04440163|530071608|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
146974942|NCT04440163|530071609|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
146974943|NCT04440163|530071610|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
146974944|NCT04440163|530071611|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
146974945|NCT04440163|530071612|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
146974946|NCT04440163|530071613|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
146974947|NCT04440163|530071614|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
146974948|NCT04440163|530071615|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
146974949|NCT04440163|530071608|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
146974950|NCT04440163|530071609|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
146974951|NCT04440163|530071610|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
146974952|NCT04440163|530071611|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
146974953|NCT04440163|530071612|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
146974954|NCT04440163|530071613|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
146974955|NCT04440163|530071614|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
146974956|NCT04440163|530071615|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
146974957|NCT04440163|530071608|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
146974958|NCT04440163|530071609|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
146974959|NCT04440163|530071610|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
146974960|NCT04440163|530071611|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
146974961|NCT04440163|530071612|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
146974962|NCT04440163|530071613|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
146974963|NCT04440163|530071614|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
146974964|NCT04440163|530071615|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
146974965|NCT04440163|530071608|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
146974966|NCT04440163|530071609|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
146974967|NCT04440163|530071610|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
146974968|NCT04440163|530071611|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
146974969|NCT04440163|530071612|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
146974970|NCT04440163|530071613|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
146974971|NCT04440163|530071614|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
146974972|NCT04440163|530071615|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
146974973|NCT04440163|530071608|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
146974974|NCT04440163|530071609|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
146974975|NCT04440163|530071610|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
146974976|NCT04440163|530071611|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
146974977|NCT04440163|530071612|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
146974978|NCT04440163|530071613|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
146974979|NCT04440163|530071614|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
146974980|NCT04440163|530071615|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
146974981|NCT00068406|530071618|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
146974982|NCT00068406|530071618|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
146974983|NCT02018042|530071619|FG000|Overall Study|Withdrawal by Subject|1|||
146974984|NCT01850108|530071623|FG000|Overall Study|Lost to Follow-up|4|||
146974985|NCT01850108|530071623|FG000|Overall Study|Not eligible|1|||
146974986|NCT01850108|530071623|FG000|Overall Study|Failed engraftment|2|||
146974987|NCT01850108|530071623|FG000|Overall Study|Physician Decision|1|||
146974988|NCT03273712|530071627|FG000|Overall Study|Death|5|||
146974989|NCT03273712|530071627|FG000|Overall Study|Adverse Event|1|||
146508929|NCT01358578|528367695|FG000|Follow-up Period|non- compliance with study treatment|1|||
146568685|NCT00925002|528595426|FG002|Overall Study|Adverse Event|2|||
146974990|NCT03273712|530071627|FG000|Overall Study|Disease Progression|1|||
146974991|NCT00666718|530071629|FG000|Overall Study|Adverse Event|0|||
146974992|NCT00666718|530071630|FG001|Overall Study|Adverse Event|1|||
146974993|NCT00666718|530071629|FG000|Overall Study|Death|1|||
146974994|NCT00666718|530071630|FG001|Overall Study|Death|0|||
146974995|NCT00666718|530071629|FG000|Overall Study|Lost to Follow-up|1|||
146974996|NCT00666718|530071630|FG001|Overall Study|Lost to Follow-up|0|||
146974997|NCT00666718|530071629|FG000|Overall Study|Entry Criteria Not Met|2|||
146974998|NCT00666718|530071630|FG001|Overall Study|Entry Criteria Not Met|0|||
146974999|NCT00666718|530071629|FG000|Overall Study|Protocol Violation|1|||
146975000|NCT00666718|530071630|FG001|Overall Study|Protocol Violation|3|||
146975001|NCT00666718|530071629|FG000|Overall Study|Withdrawal by Subject|7|||
146975002|NCT00666718|530071630|FG001|Overall Study|Withdrawal by Subject|12|||
146975003|NCT00666718|530071629|FG000|Overall Study|Physician Decision|0|||
146975004|NCT00666718|530071630|FG001|Overall Study|Physician Decision|2|||
146568686|NCT00925002|528595424|FG000|Overall Study|Participant withdrew consent|1|||
146568687|NCT00925002|528595425|FG001|Overall Study|Participant withdrew consent|3|||
146568688|NCT00925002|528595426|FG002|Overall Study|Participant withdrew consent|3|||
146568689|NCT00002766|528595429|FG000|Overall Study|Withdrawal by Subject|0|||
146975005|NCT00963599|530071631|FG000|Overall Study|Adverse Event|2|||
146975006|NCT00963599|530071632|FG001|Overall Study|Adverse Event|0|||
146975007|NCT00963599|530071633|FG002|Overall Study|Adverse Event|1|||
146975008|NCT00963599|530071634|FG003|Overall Study|Adverse Event|2|||
146975009|NCT00963599|530071631|FG000|Overall Study|Lack of Efficacy|0|||
146975010|NCT00963599|530071632|FG001|Overall Study|Lack of Efficacy|2|||
146975011|NCT00963599|530071633|FG002|Overall Study|Lack of Efficacy|1|||
146975012|NCT00963599|530071634|FG003|Overall Study|Lack of Efficacy|4|||
146975013|NCT00963599|530071631|FG000|Overall Study|Lost to Follow-up|0|||
146975014|NCT00963599|530071632|FG001|Overall Study|Lost to Follow-up|1|||
146975015|NCT00963599|530071633|FG002|Overall Study|Lost to Follow-up|1|||
146975016|NCT00963599|530071634|FG003|Overall Study|Lost to Follow-up|1|||
146975017|NCT00963599|530071631|FG000|Overall Study|Protocol Violation|2|||
146975018|NCT00963599|530071632|FG001|Overall Study|Protocol Violation|2|||
146975019|NCT00963599|530071633|FG002|Overall Study|Protocol Violation|3|||
146975020|NCT00963599|530071634|FG003|Overall Study|Protocol Violation|4|||
146975021|NCT00963599|530071631|FG000|Overall Study|Withdrawal by Subject|2|||
146975022|NCT00963599|530071632|FG001|Overall Study|Withdrawal by Subject|1|||
146975023|NCT00963599|530071633|FG002|Overall Study|Withdrawal by Subject|3|||
146975024|NCT00963599|530071634|FG003|Overall Study|Withdrawal by Subject|3|||
146975025|NCT00190684|530071642|FG000|Overall Study|Adverse Event|86|||
146975026|NCT00190684|530071642|FG000|Overall Study|Satisfactory response|80|||
146975027|NCT00190684|530071642|FG000|Overall Study|Lack of efficacy|204|||
146975028|NCT00190684|530071642|FG000|Overall Study|Lost to Follow-up|232|||
146975029|NCT00190684|530071642|FG000|Overall Study|Patient moved|60|||
146975030|NCT00190684|530071642|FG000|Overall Study|Patient Decision|432|||
146975031|NCT00190684|530071642|FG000|Overall Study|Clinical relapse|67|||
146975032|NCT00190684|530071642|FG000|Overall Study|Sponsor's decision|17|||
146568690|NCT00002766|528595430|FG001|Overall Study|Withdrawal by Subject|1|||
146568691|NCT00002766|528595429|FG000|Overall Study|Patient Not Treated|1|||
146568692|NCT00002766|528595430|FG001|Overall Study|Patient Not Treated|2|||
146568693|NCT00002766|528595429|FG000|Overall Study|Adverse Event|1|||
146568694|NCT00002766|528595430|FG001|Overall Study|Adverse Event|1|||
146568695|NCT00002766|528595429|FG000|Overall Study|Protocol Violation|1|||
146568696|NCT00002766|528595430|FG001|Overall Study|Protocol Violation|0|||
146568697|NCT00328172|528595431|FG000|Overall Study|Adverse Event|3|||
146568698|NCT00328172|528595432|FG001|Overall Study|Adverse Event|2|||
146568699|NCT00328172|528595433|FG002|Overall Study|Adverse Event|1|||
146568700|NCT00328172|528595434|FG003|Overall Study|Adverse Event|2|||
146568701|NCT00328172|528595435|FG004|Overall Study|Adverse Event|1|||
146568702|NCT00328172|528595431|FG000|Overall Study|Protocol Violation|0|||
146568703|NCT00328172|528595432|FG001|Overall Study|Protocol Violation|1|||
146568704|NCT00328172|528595433|FG002|Overall Study|Protocol Violation|1|||
146568705|NCT00328172|528595434|FG003|Overall Study|Protocol Violation|0|||
146568706|NCT00328172|528595435|FG004|Overall Study|Protocol Violation|0|||
146568707|NCT00328172|528595431|FG000|Overall Study|Lost to Follow-up|1|||
146568708|NCT00328172|528595432|FG001|Overall Study|Lost to Follow-up|1|||
146568709|NCT00328172|528595433|FG002|Overall Study|Lost to Follow-up|2|||
146568710|NCT00328172|528595434|FG003|Overall Study|Lost to Follow-up|1|||
146568711|NCT00328172|528595435|FG004|Overall Study|Lost to Follow-up|1|||
146568712|NCT00328172|528595431|FG000|Overall Study|Withdrawal by Subject|1|||
146975033|NCT00190684|530071642|FG000|Overall Study|Physician Decision|84|||
146975034|NCT00190684|530071642|FG000|Overall Study|Protocol Violation|123|||
146568713|NCT00328172|528595432|FG001|Overall Study|Withdrawal by Subject|1|||
146568714|NCT00328172|528595433|FG002|Overall Study|Withdrawal by Subject|1|||
146975035|NCT00190684|530071642|FG000|Overall Study|Study Period III Completed|103|||
146975036|NCT00190684|530071642|FG000|Overall Study|Study Period V Completed|1|||
146975037|NCT03496207|530071643|FG000|Base Study|Adverse Event|0|||
146975038|NCT03496207|530071644|FG001|Base Study|Adverse Event|0|||
146975039|NCT03496207|530071645|FG002|Base Study|Adverse Event|1|||
146975040|NCT03496207|530071646|FG003|Base Study|Adverse Event|1|||
146975041|NCT03496207|530071647|FG004|Base Study|Adverse Event|4|||
146975042|NCT03496207|530071643|FG000|Base Study|Death|0|||
146650211|NCT00169442|528895045|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
146650212|NCT00169442|528895046|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
146650213|NCT00169442|528895047|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
146508930|NCT01358578|528367696|FG001|Follow-up Period|non- compliance with study treatment|0|||
146508931|NCT01358578|528367697|FG002|Follow-up Period|non- compliance with study treatment|0|||
146508932|NCT01358578|528367698|FG003|Follow-up Period|non- compliance with study treatment|0|||
146508933|NCT01358578|528367699|FG004|Follow-up Period|non- compliance with study treatment|0|||
146508934|NCT01358578|528367700|FG005|Follow-up Period|non- compliance with study treatment|0|||
146508935|NCT01358578|528367695|FG000|Follow-up Period|Pregnancy|1|||
146508936|NCT01358578|528367696|FG001|Follow-up Period|Pregnancy|0|||
146508937|NCT01358578|528367697|FG002|Follow-up Period|Pregnancy|0|||
146508938|NCT01358578|528367698|FG003|Follow-up Period|Pregnancy|0|||
146508939|NCT01358578|528367699|FG004|Follow-up Period|Pregnancy|0|||
146508940|NCT01358578|528367700|FG005|Follow-up Period|Pregnancy|0|||
146508941|NCT01358578|528367695|FG000|Follow-up Period|Withdrawal by Subject|3|||
146508942|NCT01358578|528367696|FG001|Follow-up Period|Withdrawal by Subject|3|||
146508943|NCT01358578|528367697|FG002|Follow-up Period|Withdrawal by Subject|1|||
146508944|NCT01358578|528367698|FG003|Follow-up Period|Withdrawal by Subject|12|||
146508945|NCT01358578|528367699|FG004|Follow-up Period|Withdrawal by Subject|0|||
146508946|NCT01358578|528367700|FG005|Follow-up Period|Withdrawal by Subject|0|||
146508947|NCT01358578|528367695|FG000|Follow-up Period|Physician Decision|1|||
146508948|NCT01358578|528367696|FG001|Follow-up Period|Physician Decision|1|||
146508949|NCT01358578|528367697|FG002|Follow-up Period|Physician Decision|0|||
146508950|NCT01358578|528367698|FG003|Follow-up Period|Physician Decision|2|||
146508951|NCT01358578|528367699|FG004|Follow-up Period|Physician Decision|0|||
146508952|NCT01358578|528367700|FG005|Follow-up Period|Physician Decision|0|||
146508953|NCT03605849|528367701|FG000|Overall Study|Adverse Event|20|||
146508954|NCT03605849|528367702|FG001|Overall Study|Adverse Event|21|||
146508955|NCT03605849|528367703|FG002|Overall Study|Adverse Event|29|||
146508956|NCT03605849|528367704|FG003|Overall Study|Adverse Event|11|||
146508957|NCT03605849|528367701|FG000|Overall Study|Lack of Efficacy|4|||
146508958|NCT03605849|528367702|FG001|Overall Study|Lack of Efficacy|7|||
146508959|NCT03605849|528367703|FG002|Overall Study|Lack of Efficacy|9|||
146508960|NCT03605849|528367704|FG003|Overall Study|Lack of Efficacy|2|||
146508961|NCT03605849|528367701|FG000|Overall Study|Lost to Follow-up|8|||
146508962|NCT03605849|528367702|FG001|Overall Study|Lost to Follow-up|8|||
146508963|NCT03605849|528367703|FG002|Overall Study|Lost to Follow-up|14|||
146508964|NCT03605849|528367704|FG003|Overall Study|Lost to Follow-up|11|||
146508965|NCT03605849|528367701|FG000|Overall Study|Non-compliance With IMP|6|||
146508966|NCT03605849|528367702|FG001|Overall Study|Non-compliance With IMP|5|||
146508967|NCT03605849|528367703|FG002|Overall Study|Non-compliance With IMP|2|||
146508968|NCT03605849|528367704|FG003|Overall Study|Non-compliance With IMP|1|||
146508969|NCT03605849|528367701|FG000|Overall Study|Protocol Deviation|1|||
146508970|NCT03605849|528367702|FG001|Overall Study|Protocol Deviation|2|||
146508971|NCT03605849|528367703|FG002|Overall Study|Protocol Deviation|1|||
146508972|NCT03605849|528367704|FG003|Overall Study|Protocol Deviation|3|||
146508973|NCT03605849|528367701|FG000|Overall Study|Withdrawal by Subject|33|||
146508974|NCT03605849|528367702|FG001|Overall Study|Withdrawal by Subject|28|||
146508975|NCT03605849|528367703|FG002|Overall Study|Withdrawal by Subject|30|||
146508976|NCT03605849|528367704|FG003|Overall Study|Withdrawal by Subject|28|||
146508977|NCT03605849|528367701|FG000|Overall Study|Site Terminated by Sponsor|0|||
146508978|NCT03605849|528367702|FG001|Overall Study|Site Terminated by Sponsor|0|||
146508979|NCT03605849|528367703|FG002|Overall Study|Site Terminated by Sponsor|0|||
146508980|NCT03605849|528367704|FG003|Overall Study|Site Terminated by Sponsor|1|||
146508981|NCT03605849|528367701|FG000|Overall Study|Physician Decision|2|||
146508982|NCT03605849|528367702|FG001|Overall Study|Physician Decision|1|||
146508983|NCT03605849|528367703|FG002|Overall Study|Physician Decision|2|||
146508984|NCT03605849|528367704|FG003|Overall Study|Physician Decision|1|||
146508985|NCT03605849|528367701|FG000|Overall Study|Enrolled, but not Treated|2|||
146508986|NCT03605849|528367702|FG001|Overall Study|Enrolled, but not Treated|2|||
146508987|NCT03605849|528367703|FG002|Overall Study|Enrolled, but not Treated|3|||
146508988|NCT03605849|528367704|FG003|Overall Study|Enrolled, but not Treated|2|||
146508989|NCT03605849|528367701|FG000|Overall Study|Other (COVID-19 Related)|0|||
146508990|NCT03605849|528367702|FG001|Overall Study|Other (COVID-19 Related)|1|||
146508991|NCT03605849|528367703|FG002|Overall Study|Other (COVID-19 Related)|1|||
146508992|NCT03605849|528367704|FG003|Overall Study|Other (COVID-19 Related)|0|||
146508993|NCT03605849|528367701|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
146508994|NCT03605849|528367702|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
146650214|NCT00169442|528895048|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
146508995|NCT03605849|528367703|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
146508996|NCT03605849|528367704|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
146508997|NCT02304380|528367705|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
146508998|NCT02304380|528367706|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
146508999|NCT02304380|528367707|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
146509000|NCT02304380|528367708|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
146914286|NCT02760407|529848533|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
146914287|NCT02760407|529848534|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
146914288|NCT02760407|529848535|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
146914289|NCT02760407|529848532|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
146914290|NCT02760407|529848533|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
146914291|NCT02760407|529848534|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
146914292|NCT02760407|529848535|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
146914293|NCT02760407|529848532|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
146914294|NCT02760407|529848533|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
146914295|NCT02760407|529848534|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
146914296|NCT02760407|529848535|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
146914297|NCT02760407|529848532|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
146914298|NCT02760407|529848533|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
146914299|NCT02760407|529848534|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
146914300|NCT02760407|529848535|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
146914301|NCT02760407|529848532|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
146914302|NCT02760407|529848533|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
146914303|NCT02760407|529848534|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
146914304|NCT02760407|529848535|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
146975043|NCT03496207|530071644|FG001|Base Study|Death|0|||
146975044|NCT03496207|530071645|FG002|Base Study|Death|0|||
146975045|NCT03496207|530071646|FG003|Base Study|Death|0|||
146975046|NCT03496207|530071647|FG004|Base Study|Death|1|||
146975047|NCT03496207|530071643|FG000|Base Study|Withdrawal by Subject|0|||
146975048|NCT03496207|530071644|FG001|Base Study|Withdrawal by Subject|0|||
146975049|NCT03496207|530071645|FG002|Base Study|Withdrawal by Subject|1|||
146975050|NCT03496207|530071646|FG003|Base Study|Withdrawal by Subject|0|||
146975051|NCT03496207|530071647|FG004|Base Study|Withdrawal by Subject|1|||
146914305|NCT02760407|529848532|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
146914306|NCT02760407|529848533|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
146914307|NCT02760407|529848534|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
146914308|NCT02760407|529848535|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
146914309|NCT02760407|529848532|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
146914310|NCT02760407|529848533|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
146914311|NCT02760407|529848534|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
146914312|NCT02760407|529848535|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
146914313|NCT02760407|529848532|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
146914314|NCT02760407|529848533|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
146914315|NCT02760407|529848534|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
146914316|NCT02760407|529848535|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
146914317|NCT02760407|529848532|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
146914318|NCT02760407|529848533|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
146914319|NCT02760407|529848534|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
146914320|NCT02760407|529848535|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
146914321|NCT02522377|529848536|FG000|Overall Study|Withdrawal by Subject|1|||
146914322|NCT02522377|529848537|FG001|Overall Study|Withdrawal by Subject|0|||
146914323|NCT02522377|529848536|FG000|Overall Study|Remission Achieved|3|||
146914324|NCT02522377|529848537|FG001|Overall Study|Remission Achieved|0|||
146914325|NCT01158950|529848538|FG000|1st Intervention (1 Day)|Physician Decision|1|||
146914326|NCT01158950|529848539|FG001|1st Intervention (1 Day)|Physician Decision|2|||
146914327|NCT02116972|529848542|FG000|Overall Study|Adverse Event|4|||
146914328|NCT02116972|529848543|FG001|Overall Study|Adverse Event|4|||
146914329|NCT02116972|529848544|FG002|Overall Study|Adverse Event|1|||
146914330|NCT02116972|529848542|FG000|Overall Study|Withdrawal by Subject|1|||
146975052|NCT03496207|530071643|FG000|Extension Period|Adverse Event|0|||
146975053|NCT03496207|530071644|FG001|Extension Period|Adverse Event|0|||
146975054|NCT03496207|530071645|FG002|Extension Period|Adverse Event|0|||
146975055|NCT03496207|530071646|FG003|Extension Period|Adverse Event|1|||
146975056|NCT03496207|530071647|FG004|Extension Period|Adverse Event|1|||
146975057|NCT03496207|530071643|FG000|Extension Period|Death|1|||
146975058|NCT03496207|530071644|FG001|Extension Period|Death|0|||
146975059|NCT03496207|530071645|FG002|Extension Period|Death|0|||
146975060|NCT03496207|530071646|FG003|Extension Period|Death|1|||
146975061|NCT03496207|530071647|FG004|Extension Period|Death|2|||
146650215|NCT04463069|528895051|FG000|Overall Study|Withdrawal by Subject|2|||
146975062|NCT03496207|530071643|FG000|Extension Period|Withdrawal by Subject|1|||
146975063|NCT03496207|530071644|FG001|Extension Period|Withdrawal by Subject|0|||
146975064|NCT03496207|530071645|FG002|Extension Period|Withdrawal by Subject|0|||
146975065|NCT03496207|530071646|FG003|Extension Period|Withdrawal by Subject|1|||
146975066|NCT03496207|530071647|FG004|Extension Period|Withdrawal by Subject|1|||
146975067|NCT03496207|530071643|FG000|Extension Period|Elevated hemoglobin levels|0|||
146975068|NCT03496207|530071644|FG001|Extension Period|Elevated hemoglobin levels|0|||
146975069|NCT03496207|530071645|FG002|Extension Period|Elevated hemoglobin levels|0|||
146975070|NCT03496207|530071646|FG003|Extension Period|Elevated hemoglobin levels|0|||
146975071|NCT03496207|530071647|FG004|Extension Period|Elevated hemoglobin levels|1|||
146975072|NCT00068445|530071648|FG000|Randomization|Cancel|1|||
146975073|NCT00068445|530071649|FG001|Randomization|Cancel|3|||
146975074|NCT00068445|530071648|FG000|Randomization|Ineligible|1|||
146975075|NCT00068445|530071649|FG001|Randomization|Ineligible|1|||
146975076|NCT00068445|530071648|FG000|Treatment|Refused Further Treatment|13|||
146975077|NCT00068445|530071649|FG001|Treatment|Refused Further Treatment|10|||
146975078|NCT00068445|530071648|FG000|Treatment|Adverse Event|7|||
146975079|NCT00068445|530071649|FG001|Treatment|Adverse Event|1|||
146975080|NCT00068445|530071648|FG000|Treatment|Other (Specifics not available)|9|||
146975081|NCT00068445|530071649|FG001|Treatment|Other (Specifics not available)|5|||
146975082|NCT01155284|530071650|FG000|Overall Study|Withdrawal by Subject|4|||
146975083|NCT01155284|530071651|FG001|Overall Study|Withdrawal by Subject|3|||
146975084|NCT01155284|530071650|FG000|Overall Study|Lost to Follow-up|1|||
146975085|NCT01155284|530071651|FG001|Overall Study|Lost to Follow-up|2|||
146975086|NCT01155284|530071650|FG000|Overall Study|Physician Decision|1|||
146975087|NCT01155284|530071651|FG001|Overall Study|Physician Decision|0|||
146975088|NCT01155284|530071650|FG000|Overall Study|Adverse Event|1|||
146975089|NCT01155284|530071651|FG001|Overall Study|Adverse Event|0|||
146975090|NCT01896700|530071652|FG000|Overall Study|Adverse Event|4|||
146975091|NCT01896700|530071653|FG001|Overall Study|Adverse Event|5|||
146975092|NCT01896700|530071652|FG000|Overall Study|Withdrawal by Subject|0|||
146975093|NCT01896700|530071653|FG001|Overall Study|Withdrawal by Subject|1|||
146975094|NCT00123487|530071654|FG000|Randomized|Death prior to starting treatment|0|||
146975095|NCT00123487|530071655|FG001|Randomized|Death prior to starting treatment|1|||
146975096|NCT00123487|530071654|FG000|Randomized|SAE prior to starting treatment|1|||
146975097|NCT00123487|530071655|FG001|Randomized|SAE prior to starting treatment|0|||
146975098|NCT00123487|530071654|FG000|Treated With Study Drug|Adverse Event|23|||
146975099|NCT00123487|530071655|FG001|Treated With Study Drug|Adverse Event|22|||
146975100|NCT00123487|530071654|FG000|Treated With Study Drug|Disease Progression|141|||
146975101|NCT00123487|530071655|FG001|Treated With Study Drug|Disease Progression|122|||
146975102|NCT00123487|530071654|FG000|Treated With Study Drug|Physician Decision|8|||
146975103|NCT00123487|530071655|FG001|Treated With Study Drug|Physician Decision|9|||
146975104|NCT00123487|530071654|FG000|Treated With Study Drug|Other|59|||
146975105|NCT00123487|530071655|FG001|Treated With Study Drug|Other|58|||
146975106|NCT00123487|530071654|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
146975107|NCT00123487|530071655|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
146975108|NCT00123487|530071654|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
146975109|NCT00123487|530071655|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
146975110|NCT00123487|530071654|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
146975111|NCT00123487|530071655|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
146975112|NCT00423488|530071656|FG000|Overall Study|No evidence of study drug intake|2|||
146975113|NCT00423488|530071657|FG001|Overall Study|No evidence of study drug intake|1|||
146975114|NCT00423488|530071656|FG000|Overall Study|No post baseline data|3|||
146975115|NCT00423488|530071657|FG001|Overall Study|No post baseline data|0|||
146975116|NCT00886782|530071658|FG000|Overall Study|Disease progression|3|||
146975117|NCT00886782|530071659|FG001|Overall Study|Disease progression|3|||
146975118|NCT00886782|530071660|FG002|Overall Study|Disease progression|3|||
146975119|NCT00886782|530071658|FG000|Overall Study|Study drug toxicity|0|||
146975120|NCT00886782|530071659|FG001|Overall Study|Study drug toxicity|0|||
146975121|NCT00886782|530071660|FG002|Overall Study|Study drug toxicity|1|||
146975122|NCT00886782|530071658|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
146975123|NCT00886782|530071659|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
146975124|NCT00886782|530071660|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
146975125|NCT01255722|530071661|FG000|Overall Study|Adverse Event|0|||
146975126|NCT01255722|530071662|FG001|Overall Study|Adverse Event|1|||
146975127|NCT01255722|530071663|FG002|Overall Study|Adverse Event|1|||
146975128|NCT01255722|530071661|FG000|Overall Study|asymptomatic patient|1|||
146975129|NCT01255722|530071662|FG001|Overall Study|asymptomatic patient|0|||
146975130|NCT01255722|530071663|FG002|Overall Study|asymptomatic patient|0|||
146975131|NCT01255722|530071661|FG000|Overall Study|beta-blocker contraindicated|2|||
146975132|NCT01255722|530071662|FG001|Overall Study|beta-blocker contraindicated|0|||
146975133|NCT01255722|530071663|FG002|Overall Study|beta-blocker contraindicated|0|||
146975134|NCT03835975|530071666|FG000|Overall Study|Lost to Follow-up|1|||
146975135|NCT03835975|530071667|FG001|Overall Study|Lost to Follow-up|1|||
146975136|NCT03835975|530071668|FG002|Overall Study|Lost to Follow-up|0|||
146975137|NCT03835975|530071669|FG003|Overall Study|Lost to Follow-up|0|||
146975138|NCT03835975|530071670|FG004|Overall Study|Lost to Follow-up|0|||
146975139|NCT03835975|530071666|FG000|Overall Study|No longer met eligibility criteria|0|||
146975140|NCT03835975|530071667|FG001|Overall Study|No longer met eligibility criteria|1|||
146975141|NCT03835975|530071668|FG002|Overall Study|No longer met eligibility criteria|0|||
146975142|NCT03835975|530071669|FG003|Overall Study|No longer met eligibility criteria|0|||
146975143|NCT03835975|530071670|FG004|Overall Study|No longer met eligibility criteria|0|||
146975144|NCT03835975|530071666|FG000|Overall Study|Protocol Violation|1|||
146975145|NCT03835975|530071667|FG001|Overall Study|Protocol Violation|1|||
146975146|NCT03835975|530071668|FG002|Overall Study|Protocol Violation|2|||
146975147|NCT03835975|530071669|FG003|Overall Study|Protocol Violation|0|||
146975148|NCT03835975|530071670|FG004|Overall Study|Protocol Violation|0|||
146975149|NCT03835975|530071666|FG000|Overall Study|Withdrawal by Subject|1|||
146975150|NCT03835975|530071667|FG001|Overall Study|Withdrawal by Subject|0|||
146975151|NCT03835975|530071668|FG002|Overall Study|Withdrawal by Subject|1|||
146975152|NCT03835975|530071669|FG003|Overall Study|Withdrawal by Subject|1|||
146975153|NCT03835975|530071670|FG004|Overall Study|Withdrawal by Subject|0|||
146975154|NCT00370396|530071676|FG000|Overall Study|Withdrawal by Subject|0|||
146975155|NCT00370396|530071677|FG001|Overall Study|Withdrawal by Subject|0|||
146975156|NCT00370396|530071678|FG002|Overall Study|Withdrawal by Subject|1|||
146975157|NCT00370396|530071676|FG000|Overall Study|Lost to Follow-up|11|||
146975158|NCT00370396|530071677|FG001|Overall Study|Lost to Follow-up|1|||
146975159|NCT00370396|530071678|FG002|Overall Study|Lost to Follow-up|0|||
146975160|NCT04529499|530071681|FG000|Overall Study|Withdrawal by Subject|9|||
146975161|NCT04529499|530071682|FG001|Overall Study|Withdrawal by Subject|11|||
146975162|NCT04529499|530071681|FG000|Overall Study|Physician Decision|1|||
146975163|NCT04529499|530071682|FG001|Overall Study|Physician Decision|2|||
146975164|NCT04529499|530071681|FG000|Overall Study|Adverse Event|4|||
146975165|NCT04529499|530071682|FG001|Overall Study|Adverse Event|4|||
146975166|NCT04529499|530071681|FG000|Overall Study|Death|14|||
146975167|NCT04529499|530071682|FG001|Overall Study|Death|11|||
146975168|NCT04529499|530071681|FG000|Overall Study|Lost to Follow-up|1|||
146975169|NCT04529499|530071682|FG001|Overall Study|Lost to Follow-up|1|||
146975170|NCT04529499|530071681|FG000|Overall Study|Others|7|||
146975171|NCT04529499|530071682|FG001|Overall Study|Others|11|||
146975172|NCT02441179|530071683|FG000|Overall Study|Withdrawal by Subject|1|||
146975173|NCT02441179|530071684|FG001|Overall Study|Withdrawal by Subject|1|||
146975174|NCT01494649|530071686|FG000|Overall Study|Lost to Follow-up|0|||
146975175|NCT01494649|530071687|FG001|Overall Study|Lost to Follow-up|1|||
146975176|NCT03467971|530071688|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146975177|NCT03467971|530071689|FG001|Treatment Period 2|Withdrawal by Subject|1|||
146975178|NCT01656967|530071690|FG000|Overall Study|faulty monitor|1|||
146975179|NCT01656967|530071691|FG001|Overall Study|faulty monitor|0|||
146975180|NCT01656967|530071690|FG000|Overall Study|unsuccessful ETT insertion|3|||
146975181|NCT01656967|530071691|FG001|Overall Study|unsuccessful ETT insertion|2|||
146975182|NCT00479765|530071692|FG000|Overall Study|study terminated|4|||
146975183|NCT05166512|530071693|FG000|Randomized|Lost to Follow-up|2|||
146975184|NCT05166512|530071694|FG001|Randomized|Lost to Follow-up|0|||
146975185|NCT05166512|530071693|FG000|Randomized|Withdrawal by Subject|1|||
146975186|NCT05166512|530071694|FG001|Randomized|Withdrawal by Subject|0|||
146975187|NCT05166512|530071693|FG000|Baseline Data Collection|Lost to Follow-up|0|||
146975188|NCT05166512|530071694|FG001|Baseline Data Collection|Lost to Follow-up|3|||
146975189|NCT05166512|530071693|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
146975190|NCT05166512|530071694|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
146975191|NCT05166512|530071693|FG000|Baseline Data Collection|Protocol Violation|2|||
146975192|NCT05166512|530071694|FG001|Baseline Data Collection|Protocol Violation|0|||
146770058|NCT00792948|529326663|FG000|Overall Study|Ineligible|2|||
146914331|NCT02116972|529848543|FG001|Overall Study|Withdrawal by Subject|1|||
146914332|NCT02116972|529848544|FG002|Overall Study|Withdrawal by Subject|5|||
146914333|NCT02116972|529848542|FG000|Overall Study|Protocol Violation|1|||
146914334|NCT02116972|529848543|FG001|Overall Study|Protocol Violation|0|||
146914335|NCT02116972|529848544|FG002|Overall Study|Protocol Violation|1|||
146914336|NCT02116972|529848542|FG000|Overall Study|Lost to Follow-up|4|||
146914337|NCT02116972|529848543|FG001|Overall Study|Lost to Follow-up|3|||
146914338|NCT02116972|529848544|FG002|Overall Study|Lost to Follow-up|1|||
146914339|NCT02116972|529848542|FG000|Overall Study|Lack of Efficacy|6|||
146914340|NCT02116972|529848543|FG001|Overall Study|Lack of Efficacy|6|||
146914341|NCT02116972|529848544|FG002|Overall Study|Lack of Efficacy|5|||
146914342|NCT02116972|529848542|FG000|Overall Study|scheduling conflicts and relocation|3|||
146914343|NCT02116972|529848543|FG001|Overall Study|scheduling conflicts and relocation|3|||
146914344|NCT02116972|529848544|FG002|Overall Study|scheduling conflicts and relocation|6|||
146914345|NCT00863928|529848545|FG000|Overall Study|Protocol Violation|26|||
146975193|NCT05166512|530071693|FG000|4 Month Data Collection|Lost to Follow-up|1|||
146975194|NCT05166512|530071694|FG001|4 Month Data Collection|Lost to Follow-up|0|||
146975195|NCT05166512|530071693|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
146975196|NCT05166512|530071694|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
146975197|NCT05166512|530071693|FG000|12 Month Data Collection|Lost to Follow-up|3|||
146914346|NCT00863928|529848546|FG001|Overall Study|Protocol Violation|0|||
146914347|NCT00863928|529848545|FG000|Overall Study|Withdrawal by Subject|3|||
146914348|NCT00863928|529848546|FG001|Overall Study|Withdrawal by Subject|0|||
146914349|NCT00863928|529848545|FG000|Overall Study|surgery cancellation|4|||
146914350|NCT00863928|529848546|FG001|Overall Study|surgery cancellation|0|||
146914351|NCT00863928|529848545|FG000|Overall Study|medication allergy|3|||
146914352|NCT00863928|529848546|FG001|Overall Study|medication allergy|0|||
146914353|NCT02124798|529848547|FG000|Overall Study|Adverse Event|3|||
146914354|NCT02124798|529848547|FG000|Overall Study|Lost to Follow-up|1|||
146914355|NCT01797432|529848548|FG000|Overall Study|Lost to Follow-up|1|||
146914356|NCT01797432|529848548|FG000|Overall Study|Adverse Event|1|||
146914357|NCT01797432|529848548|FG000|Overall Study|Withdrawal by Subject|1|||
146914358|NCT01797432|529848548|FG000|Overall Study|lived too far from study site|1|||
146914359|NCT02746679|529848553|FG000|Overall Study|Lost to Follow-up|4|||
146914360|NCT02746679|529848554|FG001|Overall Study|Lost to Follow-up|6|||
146914361|NCT00487279|529848555|FG000|Overall Study|Death|1|||
146914362|NCT00487279|529848556|FG001|Overall Study|Death|0|||
146914363|NCT00487279|529848555|FG000|Overall Study|Withdrawal by Subject|0|||
146914364|NCT00487279|529848556|FG001|Overall Study|Withdrawal by Subject|2|||
146914365|NCT00501852|529848557|FG000|Overall Study|Adverse Event|3|||
146914366|NCT00501852|529848557|FG000|Overall Study|Withdrawal by Subject|2|||
146914367|NCT01422304|529848560|FG000|Overall Study|Adverse Event|0|||
146914368|NCT01422304|529848561|FG001|Overall Study|Adverse Event|1|||
146914369|NCT01422304|529848560|FG000|Overall Study|Lost to Follow-up|14|||
146914370|NCT01422304|529848561|FG001|Overall Study|Lost to Follow-up|20|||
146914371|NCT01422304|529848560|FG000|Overall Study|Never Entered Follow-up|2|||
146914372|NCT01422304|529848561|FG001|Overall Study|Never Entered Follow-up|1|||
146914373|NCT01422304|529848560|FG000|Overall Study|Protocol Violation|1|||
146914374|NCT01422304|529848561|FG001|Overall Study|Protocol Violation|0|||
146914375|NCT01422304|529848560|FG000|Overall Study|Withdrawal by Subject|4|||
146914376|NCT01422304|529848561|FG001|Overall Study|Withdrawal by Subject|2|||
146914377|NCT01422304|529848560|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
146914378|NCT01422304|529848561|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
146914379|NCT01422304|529848560|FG000|Overall Study|Not Treated|3|||
146914380|NCT01422304|529848561|FG001|Overall Study|Not Treated|11|||
146914381|NCT02508701|529848565|FG000|Overall Study|Lost to Follow-up|9|||
146914382|NCT02508701|529848566|FG001|Overall Study|Lost to Follow-up|5|||
146914383|NCT02508701|529848567|FG002|Overall Study|Lost to Follow-up|5|||
146914384|NCT02508701|529848568|FG003|Overall Study|Lost to Follow-up|3|||
146914385|NCT00530712|529848569|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
146914386|NCT00530712|529848569|FG000|30 Day Follow-up Visit|Missed Visit|5|||
146914387|NCT00530712|529848569|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
146914388|NCT00530712|529848569|FG000|6 Month Follow-up Visit|Missed Visit|3|||
146914389|NCT00530712|529848569|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
146914390|NCT00530712|529848569|FG000|6 Month Follow-up Visit|Death|2|||
146914391|NCT00530712|529848569|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
146914392|NCT00530712|529848569|FG000|12 Month Follow-up Visit|Missed Visit|3|||
146914393|NCT00530712|529848569|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
146914394|NCT00530712|529848569|FG000|12 Month Follow-up Visit|Death|9|||
146914395|NCT03117049|529848574|FG000|Overall Study|Continued the follow-up period|109|||
146914396|NCT03117049|529848575|FG001|Overall Study|Continued the follow-up period|129|||
146914397|NCT03117049|529848574|FG000|Overall Study|Died|82|||
146914398|NCT03117049|529848575|FG001|Overall Study|Died|93|||
146914399|NCT03117049|529848574|FG000|Overall Study|Consent withdrawal|7|||
146914400|NCT03117049|529848575|FG001|Overall Study|Consent withdrawal|6|||
146914401|NCT03117049|529848574|FG000|Overall Study|Missing contact|3|||
146914402|NCT03117049|529848575|FG001|Overall Study|Missing contact|3|||
146914403|NCT00839098|529848576|FG000|Overall Study|Withdrawal by Subject|2|||
146914404|NCT00839098|529848577|FG001|Overall Study|Withdrawal by Subject|1|||
146914405|NCT00839098|529848578|FG002|Overall Study|Withdrawal by Subject|7|||
146914406|NCT02399475|529848583|FG000|Overall Study|Physician Decision|1|||
146914407|NCT02399475|529848584|FG001|Overall Study|Physician Decision|0|||
146914408|NCT00935220|529848585|FG000|Overall Study|Adverse Event|1|||
146914409|NCT00935220|529848585|FG000|Overall Study|Other reason (not specified)|1|||
146914410|NCT01415440|529848588|FG000|Overall Study|Lost to Follow-up|0|||
146914411|NCT01415440|529848589|FG001|Overall Study|Lost to Follow-up|1|||
146914412|NCT01415440|529848590|FG002|Overall Study|Lost to Follow-up|2|||
146914413|NCT01415440|529848588|FG000|Overall Study|Physician Decision|3|||
146914414|NCT01415440|529848589|FG001|Overall Study|Physician Decision|0|||
146914415|NCT01415440|529848590|FG002|Overall Study|Physician Decision|0|||
146914416|NCT01415440|529848588|FG000|Overall Study|Withdrawal by Subject|1|||
146914417|NCT01415440|529848589|FG001|Overall Study|Withdrawal by Subject|0|||
146914418|NCT01415440|529848590|FG002|Overall Study|Withdrawal by Subject|0|||
146914419|NCT00633139|529848591|FG000|Overall Study|Non compliance|0|||
146914420|NCT00633139|529848592|FG001|Overall Study|Non compliance|0|||
146914421|NCT00633139|529848593|FG002|Overall Study|Non compliance|1|||
146914422|NCT00633139|529848591|FG000|Overall Study|Withdrawal by Subject|0|||
146914423|NCT00633139|529848592|FG001|Overall Study|Withdrawal by Subject|1|||
146914424|NCT00633139|529848593|FG002|Overall Study|Withdrawal by Subject|0|||
146914425|NCT02658656|529848594|FG000|Screening|Failed eligibility criteria|0|||
146914426|NCT02658656|529848595|FG001|Screening|Failed eligibility criteria|0|||
146914427|NCT02658656|529848596|FG002|Screening|Failed eligibility criteria|263|||
146914428|NCT02658656|529848594|FG000|Randomization|Withdrawal by Subject|8|||
146914429|NCT02658656|529848595|FG001|Randomization|Withdrawal by Subject|7|||
146975198|NCT05166512|530071694|FG001|12 Month Data Collection|Lost to Follow-up|1|||
146975199|NCT05166512|530071693|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
146975200|NCT05166512|530071694|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
146975201|NCT00420849|530071695|FG000|Overall Study|Lack of Efficacy|154|||
146975202|NCT00420849|530071695|FG000|Overall Study|Adverse Event|107|||
146975203|NCT00420849|530071695|FG000|Overall Study|Withdrawal by Subject|28|||
146975204|NCT00420849|530071695|FG000|Overall Study|Death|18|||
146975205|NCT00420849|530071695|FG000|Overall Study|Other|14|||
146975206|NCT00420849|530071695|FG000|Overall Study|Transplant|8|||
146975207|NCT00420849|530071695|FG000|Overall Study|Protocol Violation|1|||
146975208|NCT00420849|530071695|FG000|Overall Study|Lost to Follow-up|1|||
146975209|NCT00725725|530071696|FG000|Overall Study|Adverse Event|1|||
146975210|NCT00725725|530071697|FG001|Overall Study|Adverse Event|3|||
146975211|NCT00725725|530071698|FG002|Overall Study|Adverse Event|2|||
146975212|NCT00725725|530071696|FG000|Overall Study|Lost to Follow-up|2|||
146975213|NCT00725725|530071697|FG001|Overall Study|Lost to Follow-up|0|||
146975214|NCT00725725|530071698|FG002|Overall Study|Lost to Follow-up|2|||
146975215|NCT00725725|530071696|FG000|Overall Study|Withdrawal by Subject|1|||
146975216|NCT00725725|530071697|FG001|Overall Study|Withdrawal by Subject|0|||
146975217|NCT00725725|530071698|FG002|Overall Study|Withdrawal by Subject|1|||
146975218|NCT00725725|530071696|FG000|Overall Study|Protocol Violation|0|||
146975219|NCT00725725|530071697|FG001|Overall Study|Protocol Violation|1|||
146975220|NCT00725725|530071698|FG002|Overall Study|Protocol Violation|0|||
146975221|NCT01619085|530071699|FG000|Overall Study|Adverse Event|231|||
146975222|NCT01619085|530071699|FG000|Overall Study|Protocol Violation|4|||
146975223|NCT01619085|530071699|FG000|Overall Study|Lost to Follow-up|3|||
146975224|NCT01619085|530071699|FG000|Overall Study|Withdrawal by Subject|45|||
146975225|NCT01619085|530071699|FG000|Overall Study|Other than specified|96|||
146975226|NCT01619085|530071699|FG000|Overall Study|Not treated|1|||
146975227|NCT01619085|530071699|FG000|Overall Study|Death|145|||
146975228|NCT01345058|530071700|FG000|Overall Study|Withdrawal by Subject|1|||
146975229|NCT01345058|530071701|FG001|Overall Study|Withdrawal by Subject|0|||
146975230|NCT01345058|530071700|FG000|Overall Study|Participant Reported Increase in Events|1|||
146975231|NCT01345058|530071701|FG001|Overall Study|Participant Reported Increase in Events|0|||
146975232|NCT01345058|530071700|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
146914430|NCT02658656|529848596|FG002|Randomization|Withdrawal by Subject|0|||
146914431|NCT02658656|529848594|FG000|Randomization|Lost to Follow-up|1|||
146914432|NCT02658656|529848595|FG001|Randomization|Lost to Follow-up|3|||
146914433|NCT02658656|529848596|FG002|Randomization|Lost to Follow-up|0|||
146914434|NCT02658656|529848594|FG000|Randomization|Adverse Event|4|||
146914435|NCT02658656|529848595|FG001|Randomization|Adverse Event|0|||
146914436|NCT02658656|529848596|FG002|Randomization|Adverse Event|0|||
146914437|NCT02658656|529848594|FG000|Randomization|Administrative Termination|3|||
146914438|NCT02658656|529848595|FG001|Randomization|Administrative Termination|1|||
146914439|NCT02658656|529848596|FG002|Randomization|Administrative Termination|0|||
146914440|NCT02658656|529848594|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
146914441|NCT02658656|529848595|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
146914442|NCT02658656|529848596|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
146914443|NCT02658656|529848594|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
146914444|NCT02658656|529848595|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
146914445|NCT02658656|529848596|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
146914446|NCT02658656|529848594|FG000|Randomization|Not eligible for Randomization|1|||
146975233|NCT01345058|530071701|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
146975234|NCT01345058|530071700|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
146975235|NCT01345058|530071701|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
146914447|NCT02658656|529848595|FG001|Randomization|Not eligible for Randomization|0|||
146914448|NCT02658656|529848596|FG002|Randomization|Not eligible for Randomization|0|||
146914449|NCT02658656|529848594|FG000|Randomization|Protocol Violation|1|||
146914450|NCT02658656|529848595|FG001|Randomization|Protocol Violation|0|||
146975236|NCT01345058|530071700|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
146914451|NCT02658656|529848596|FG002|Randomization|Protocol Violation|0|||
146975237|NCT01345058|530071701|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
146975238|NCT00000135|530071702|FG000|Overall Study|Death|27|||
146975239|NCT00000135|530071703|FG001|Overall Study|Death|14|||
146975240|NCT00944125|530071706|FG000|3 to 6 Months|Withdrawal by Subject|0|||
146975241|NCT00944125|530071707|FG001|3 to 6 Months|Withdrawal by Subject|2|||
146975242|NCT00944125|530071706|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
146975243|NCT00944125|530071707|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
146914452|NCT01118143|529848597|FG000|Overall Study|Withdrawal by Subject|2|||
146914453|NCT01118143|529848598|FG001|Overall Study|Withdrawal by Subject|5|||
146914454|NCT02112448|529848599|FG000|Overall Study|lab values precluding use of ketorolac|2|||
146914455|NCT02112448|529848600|FG001|Overall Study|lab values precluding use of ketorolac|2|||
146914456|NCT02112448|529848599|FG000|Overall Study|Protocol Violation|1|||
146914457|NCT02112448|529848600|FG001|Overall Study|Protocol Violation|2|||
146914458|NCT02112448|529848599|FG000|Overall Study|Physician Decision|4|||
146914459|NCT02112448|529848600|FG001|Overall Study|Physician Decision|6|||
146650216|NCT04463069|528895052|FG001|Overall Study|Withdrawal by Subject|10|||
146914460|NCT02112448|529848599|FG000|Overall Study|required heparin so could not use ketoro|1|||
146914461|NCT02112448|529848600|FG001|Overall Study|required heparin so could not use ketoro|0|||
146914462|NCT01614769|529849992|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
146914463|NCT01614769|529849993|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
146914464|NCT01614769|529849994|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
146914465|NCT01614769|529849995|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
146914466|NCT01614769|529849996|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
146914467|NCT01614769|529849997|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
146914468|NCT01614769|529849992|FG000|Period 1|Protocol Violation|0|||
146914469|NCT01614769|529849993|FG001|Period 1|Protocol Violation|0|||
146914470|NCT01614769|529849994|FG002|Period 1|Protocol Violation|0|||
146914471|NCT01614769|529849995|FG003|Period 1|Protocol Violation|1|||
146914472|NCT01614769|529849996|FG004|Period 1|Protocol Violation|0|||
146914473|NCT01614769|529849997|FG005|Period 1|Protocol Violation|0|||
146914474|NCT01614769|529849992|FG000|Period 1|Withdrawal by Subject|1|||
146914475|NCT01614769|529849993|FG001|Period 1|Withdrawal by Subject|0|||
146914476|NCT01614769|529849994|FG002|Period 1|Withdrawal by Subject|0|||
146914477|NCT01614769|529849995|FG003|Period 1|Withdrawal by Subject|0|||
146914478|NCT01614769|529849996|FG004|Period 1|Withdrawal by Subject|0|||
146914479|NCT01614769|529849997|FG005|Period 1|Withdrawal by Subject|0|||
146914480|NCT01614769|529849992|FG000|Period 3|Withdrawal by Subject|0|||
146914481|NCT01614769|529849993|FG001|Period 3|Withdrawal by Subject|0|||
146914482|NCT01614769|529849994|FG002|Period 3|Withdrawal by Subject|1|||
146914483|NCT01614769|529849995|FG003|Period 3|Withdrawal by Subject|0|||
146914484|NCT01614769|529849996|FG004|Period 3|Withdrawal by Subject|0|||
146914485|NCT01614769|529849997|FG005|Period 3|Withdrawal by Subject|0|||
146914486|NCT01958671|529850004|FG000|Overall Study|Adverse Event|1|||
146914487|NCT01958671|529850005|FG001|Overall Study|Adverse Event|1|||
146914488|NCT01958671|529850006|FG002|Overall Study|Adverse Event|5|||
146914489|NCT01958671|529850004|FG000|Overall Study|Death|1|||
146914490|NCT01958671|529850005|FG001|Overall Study|Death|0|||
146914491|NCT01958671|529850006|FG002|Overall Study|Death|0|||
146914492|NCT01958671|529850004|FG000|Overall Study|Excluded medication|0|||
146914493|NCT01958671|529850005|FG001|Overall Study|Excluded medication|0|||
146914494|NCT01958671|529850006|FG002|Overall Study|Excluded medication|1|||
146914495|NCT01958671|529850004|FG000|Overall Study|Hyperglycemia|0|||
146914496|NCT01958671|529850005|FG001|Overall Study|Hyperglycemia|0|||
146914497|NCT01958671|529850006|FG002|Overall Study|Hyperglycemia|2|||
146914498|NCT01958671|529850004|FG000|Overall Study|Lost to Follow-up|7|||
146914499|NCT01958671|529850005|FG001|Overall Study|Lost to Follow-up|11|||
146914500|NCT01958671|529850006|FG002|Overall Study|Lost to Follow-up|7|||
146914501|NCT01958671|529850004|FG000|Overall Study|Non-compliance with study drug|1|||
146914502|NCT01958671|529850005|FG001|Overall Study|Non-compliance with study drug|1|||
146914503|NCT01958671|529850006|FG002|Overall Study|Non-compliance with study drug|1|||
146914504|NCT01958671|529850004|FG000|Overall Study|Pregnancy|0|||
146914505|NCT01958671|529850005|FG001|Overall Study|Pregnancy|0|||
146914506|NCT01958671|529850006|FG002|Overall Study|Pregnancy|1|||
146914507|NCT01958671|529850004|FG000|Overall Study|Protocol Violation|0|||
146914508|NCT01958671|529850005|FG001|Overall Study|Protocol Violation|1|||
146914509|NCT01958671|529850006|FG002|Overall Study|Protocol Violation|0|||
146914510|NCT01958671|529850004|FG000|Overall Study|Study site terminated by sponsor|1|||
146914511|NCT01958671|529850005|FG001|Overall Study|Study site terminated by sponsor|0|||
146914512|NCT01958671|529850006|FG002|Overall Study|Study site terminated by sponsor|1|||
146914513|NCT01958671|529850004|FG000|Overall Study|Participant moved|0|||
146914514|NCT01958671|529850005|FG001|Overall Study|Participant moved|0|||
146914515|NCT01958671|529850006|FG002|Overall Study|Participant moved|1|||
146914516|NCT01958671|529850004|FG000|Overall Study|Withdrawal by Subject|8|||
146914517|NCT01958671|529850005|FG001|Overall Study|Withdrawal by Subject|10|||
146914518|NCT01958671|529850006|FG002|Overall Study|Withdrawal by Subject|13|||
146914519|NCT01070303|529850008|FG000|Overall Study|Adverse Event|39|||
146914520|NCT01070303|529850008|FG000|Overall Study|Withdrawal by Subject|20|||
146914521|NCT01070303|529850008|FG000|Overall Study|Lost to Follow-up|9|||
146914522|NCT01070303|529850008|FG000|Overall Study|Protocol Violation|0|||
146650217|NCT04463069|528895051|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
146914523|NCT01070303|529850008|FG000|Overall Study|Lack of Efficacy|2|||
146914524|NCT01070303|529850008|FG000|Overall Study|Administrative Reason|1|||
146914525|NCT01070303|529850008|FG000|Overall Study|Other|18|||
146914526|NCT01849848|529850009|FG000|Overall Study|Physician Decision|1|||
146914527|NCT01849848|529850009|FG000|Overall Study|Progression of the primary disease|3|||
146975244|NCT03125629|530071708|FG000|Overall Study|Withdrawal by Subject|2|||
146975245|NCT03125629|530071708|FG000|Overall Study|Equipment malfunction|1|||
146975246|NCT00743119|530071709|FG000|Overall Study|unreliable|3|||
146975247|NCT00743119|530071709|FG000|Overall Study|Withdrawal by Subject|1|||
146975248|NCT04816877|530071710|FG000|Overall Study|Withdrawal by Subject|1|||
146975249|NCT04816877|530071711|FG001|Overall Study|Withdrawal by Subject|0|||
146975250|NCT00759759|530071712|FG000|Overall Study|didn't return for period 2|1|||
146975251|NCT00759759|530071713|FG001|Overall Study|didn't return for period 2|0|||
146975252|NCT00759759|530071712|FG000|Overall Study|Didn't receive drug in period 2|1|||
146975253|NCT00759759|530071713|FG001|Overall Study|Didn't receive drug in period 2|0|||
146975254|NCT00759759|530071712|FG000|Overall Study|Withdrawal by Subject|2|||
146975255|NCT00759759|530071713|FG001|Overall Study|Withdrawal by Subject|1|||
146975256|NCT01861717|530071717|FG000|Overall Study|Lost to Follow-up|1|||
146975257|NCT01861717|530071717|FG000|Overall Study|Withdrawal by Subject|1|||
146975258|NCT00833976|530073492|FG000|Overall Study|Withdrawal by Subject|5|||
146975259|NCT00833976|530073492|FG000|Overall Study|Lost to Follow-up|4|||
146975260|NCT00833976|530073492|FG000|Overall Study|Did not meet eligibility criteria|41|||
146975261|NCT00833976|530073492|FG000|Overall Study|Physician Decision|1|||
146975262|NCT03724916|530073495|FG000|Overall Study|Withdrawal by Subject|0|||
146975263|NCT03724916|530073496|FG001|Overall Study|Withdrawal by Subject|1|||
146975264|NCT03724916|530073497|FG002|Overall Study|Withdrawal by Subject|1|||
146975265|NCT03724916|530073498|FG003|Overall Study|Withdrawal by Subject|2|||
146975266|NCT03724916|530073495|FG000|Overall Study|Randomized but not Treated|1|||
146975267|NCT03724916|530073496|FG001|Overall Study|Randomized but not Treated|0|||
146975268|NCT03724916|530073497|FG002|Overall Study|Randomized but not Treated|0|||
146650218|NCT04463069|528895052|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
146650219|NCT02055365|528896677|FG000|Overall Study|Prematurely Withdrawn|1|||
146914528|NCT02202031|529850012|FG000|Overall Study|Lost to Follow-up|1|||
146914529|NCT02202031|529850013|FG001|Overall Study|Lost to Follow-up|0|||
146914530|NCT02202031|529850012|FG000|Overall Study|Too Busy|1|||
146914531|NCT02202031|529850013|FG001|Overall Study|Too Busy|3|||
146914532|NCT02202031|529850012|FG000|Overall Study|Illness/Medical Reason|0|||
146914533|NCT02202031|529850013|FG001|Overall Study|Illness/Medical Reason|2|||
146914534|NCT02202031|529850012|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
146914535|NCT02202031|529850013|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
146914536|NCT02184143|529850014|FG000|Overall Study|Withdrawal by Subject|4|||
146914537|NCT02184143|529850015|FG001|Overall Study|Withdrawal by Subject|4|||
146914538|NCT02184143|529850014|FG000|Overall Study|Lost to Follow-up|5|||
146914539|NCT02184143|529850015|FG001|Overall Study|Lost to Follow-up|3|||
146914540|NCT02184143|529850014|FG000|Overall Study|Death|1|||
146914541|NCT02184143|529850015|FG001|Overall Study|Death|0|||
146914542|NCT00321984|529850016|FG000|Overall Study|Adverse Event|9|||
146914543|NCT00321984|529850017|FG001|Overall Study|Adverse Event|6|||
146914544|NCT00321984|529850018|FG002|Overall Study|Adverse Event|8|||
146914545|NCT00321984|529850016|FG000|Overall Study|Protocol Violation|0|||
146914546|NCT00321984|529850017|FG001|Overall Study|Protocol Violation|1|||
146914547|NCT00321984|529850018|FG002|Overall Study|Protocol Violation|1|||
146914548|NCT00321984|529850016|FG000|Overall Study|Lost to Follow-up|2|||
146914549|NCT00321984|529850017|FG001|Overall Study|Lost to Follow-up|4|||
146914550|NCT00321984|529850018|FG002|Overall Study|Lost to Follow-up|2|||
146914551|NCT00321984|529850016|FG000|Overall Study|Withdrawal by Subject|8|||
146914552|NCT00321984|529850017|FG001|Overall Study|Withdrawal by Subject|6|||
146914553|NCT00321984|529850018|FG002|Overall Study|Withdrawal by Subject|5|||
146914554|NCT00321984|529850016|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
146914555|NCT00321984|529850017|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
146914556|NCT00321984|529850018|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
146914557|NCT00321984|529850016|FG000|Overall Study|Lack of Efficacy|3|||
146914558|NCT00321984|529850017|FG001|Overall Study|Lack of Efficacy|1|||
146914559|NCT00321984|529850018|FG002|Overall Study|Lack of Efficacy|3|||
146914560|NCT00321984|529850016|FG000|Overall Study|Noncompliant|0|||
146914561|NCT00321984|529850017|FG001|Overall Study|Noncompliant|0|||
146914562|NCT00321984|529850018|FG002|Overall Study|Noncompliant|2|||
146914563|NCT00321984|529850016|FG000|Overall Study|Pregnancy|0|||
146914564|NCT00321984|529850017|FG001|Overall Study|Pregnancy|1|||
146914565|NCT00321984|529850018|FG002|Overall Study|Pregnancy|0|||
146914566|NCT00321984|529850016|FG000|Overall Study|Per Subject Request|1|||
146914567|NCT00321984|529850017|FG001|Overall Study|Per Subject Request|0|||
146914568|NCT00321984|529850018|FG002|Overall Study|Per Subject Request|0|||
146914569|NCT00321984|529850016|FG000|Overall Study|Per Investigator Request|1|||
146975269|NCT03724916|530073498|FG003|Overall Study|Randomized but not Treated|0|||
146975270|NCT02464059|530073503|FG000|Overall Study|Lost to Follow-up|6|||
146975271|NCT01272193|530073504|FG000|Overall Study|Adverse Event|1|||
146975272|NCT01272193|530073505|FG001|Overall Study|Adverse Event|1|||
146914570|NCT00321984|529850017|FG001|Overall Study|Per Investigator Request|0|||
146914571|NCT00321984|529850018|FG002|Overall Study|Per Investigator Request|0|||
146914572|NCT00321984|529850016|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
146914573|NCT00321984|529850017|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
146975273|NCT01272193|530073504|FG000|Overall Study|Lack of Efficacy|0|||
146975274|NCT01272193|530073505|FG001|Overall Study|Lack of Efficacy|3|||
146975275|NCT01272193|530073504|FG000|Overall Study|Withdrawal Criteria|1|||
146975276|NCT01272193|530073505|FG001|Overall Study|Withdrawal Criteria|1|||
146975277|NCT01272193|530073504|FG000|Overall Study|Unclassified|8|||
146975278|NCT01272193|530073505|FG001|Overall Study|Unclassified|7|||
146975279|NCT00350519|530073514|FG000|Overall Study|Death|0|||
146975280|NCT00350519|530073515|FG001|Overall Study|Death|1|||
146975281|NCT00350519|530073514|FG000|Overall Study|Physician Decision|0|||
146914574|NCT00321984|529850018|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
146914575|NCT02214186|529850019|FG000|Overall Study|Lost to Follow-up|1|||
146914576|NCT02214186|529850020|FG001|Overall Study|Lost to Follow-up|1|||
146914577|NCT02214186|529850019|FG000|Overall Study|Protocol Violation|1|||
146914578|NCT02214186|529850020|FG001|Overall Study|Protocol Violation|1|||
146914579|NCT01469013|529850021|FG000|Part A (Treatment Period)|Adverse Event|1|||
146914580|NCT01469013|529850022|FG001|Part A (Treatment Period)|Adverse Event|0|||
146914581|NCT01469013|529850023|FG002|Part A (Treatment Period)|Adverse Event|0|||
146914582|NCT01469013|529850024|FG003|Part A (Treatment Period)|Adverse Event|0|||
146914583|NCT01469013|529850025|FG004|Part A (Treatment Period)|Adverse Event|1|||
146914584|NCT01469013|529850026|FG005|Part A (Treatment Period)|Adverse Event|0|||
146914585|NCT01469013|529850027|FG006|Part A (Treatment Period)|Adverse Event|0|||
146914586|NCT01469013|529850028|FG007|Part A (Treatment Period)|Adverse Event|0|||
146914587|NCT01469013|529850029|FG008|Part A (Treatment Period)|Adverse Event|0|||
146914588|NCT01469013|529850030|FG009|Part A (Treatment Period)|Adverse Event|0|||
146914589|NCT01469013|529850031|FG010|Part A (Treatment Period)|Adverse Event|0|||
146914590|NCT01469013|529850032|FG011|Part A (Treatment Period)|Adverse Event|0|||
146914591|NCT01469013|529850033|FG012|Part A (Treatment Period)|Adverse Event|0|||
146914592|NCT01469013|529850021|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
146914593|NCT01469013|529850022|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
146914594|NCT01469013|529850023|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
146914595|NCT01469013|529850024|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
146914596|NCT01469013|529850025|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
146914597|NCT01469013|529850026|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
146914598|NCT01469013|529850027|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
146914599|NCT01469013|529850028|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
146914600|NCT01469013|529850029|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
146914601|NCT01469013|529850030|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
146914602|NCT01469013|529850031|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
146914603|NCT01469013|529850032|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
146914604|NCT01469013|529850033|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
146914605|NCT01469013|529850021|FG000|Part B (Extension Period)|Adverse Event|0|||
146914606|NCT01469013|529850022|FG001|Part B (Extension Period)|Adverse Event|0|||
146914607|NCT01469013|529850023|FG002|Part B (Extension Period)|Adverse Event|0|||
146914608|NCT01469013|529850024|FG003|Part B (Extension Period)|Adverse Event|0|||
146914609|NCT01469013|529850025|FG004|Part B (Extension Period)|Adverse Event|0|||
146914610|NCT01469013|529850026|FG005|Part B (Extension Period)|Adverse Event|2|||
146914611|NCT01469013|529850027|FG006|Part B (Extension Period)|Adverse Event|5|||
146914612|NCT01469013|529850028|FG007|Part B (Extension Period)|Adverse Event|5|||
146914613|NCT01469013|529850029|FG008|Part B (Extension Period)|Adverse Event|3|||
146914614|NCT01469013|529850030|FG009|Part B (Extension Period)|Adverse Event|3|||
146914615|NCT01469013|529850031|FG010|Part B (Extension Period)|Adverse Event|1|||
146914616|NCT01469013|529850032|FG011|Part B (Extension Period)|Adverse Event|6|||
146914617|NCT01469013|529850033|FG012|Part B (Extension Period)|Adverse Event|3|||
146914618|NCT01469013|529850021|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
146914619|NCT01469013|529850022|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
146914620|NCT01469013|529850023|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
146914621|NCT01469013|529850024|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
146914622|NCT01469013|529850025|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
146914623|NCT01469013|529850026|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
146914624|NCT01469013|529850027|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
146914625|NCT01469013|529850028|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
146975282|NCT00350519|530073515|FG001|Overall Study|Physician Decision|1|||
146975283|NCT00350519|530073514|FG000|Overall Study|Protocol Violation|1|||
146975284|NCT00350519|530073515|FG001|Overall Study|Protocol Violation|2|||
146975285|NCT00350519|530073514|FG000|Overall Study|Withdrawal by Subject|3|||
146975286|NCT00350519|530073515|FG001|Overall Study|Withdrawal by Subject|2|||
146975287|NCT04388527|530073516|FG000|Overall Study|Death|14|||
146914626|NCT01469013|529850029|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
146914627|NCT01469013|529850030|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
146914628|NCT01469013|529850031|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
146914629|NCT01469013|529850032|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
146914630|NCT01469013|529850033|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
146914631|NCT01734993|529850041|FG000|Overall Study|Adverse Event|1|||
146914632|NCT01734993|529850041|FG000|Overall Study|Lack of Efficacy|1|||
146975288|NCT04388527|530073516|FG000|Overall Study|Withdrawal by Subject|2|||
146975344|NCT02261974|530073543|FG000|Overall Study|Withdrawal by Subject|3|||
146975345|NCT02261974|530073544|FG001|Overall Study|Withdrawal by Subject|2|||
146975346|NCT02261974|530073543|FG000|Overall Study|Pregnancy|0|||
146975347|NCT02261974|530073544|FG001|Overall Study|Pregnancy|1|||
146975348|NCT02261974|530073543|FG000|Overall Study|Missed treatment cut-off date|6|||
146975349|NCT02261974|530073544|FG001|Overall Study|Missed treatment cut-off date|3|||
146975350|NCT02261974|530073543|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
146975351|NCT02261974|530073544|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
146975352|NCT02261974|530073543|FG000|Overall Study|Lost to Follow-up|2|||
146975353|NCT02261974|530073544|FG001|Overall Study|Lost to Follow-up|0|||
146975354|NCT02261974|530073543|FG000|Overall Study|Adverse Event|1|||
146975355|NCT02261974|530073544|FG001|Overall Study|Adverse Event|0|||
146975356|NCT01440595|530073545|FG000|Overall Study|Lost to Follow-up|0|||
146975357|NCT01440595|530073546|FG001|Overall Study|Lost to Follow-up|1|||
146975358|NCT01440595|530073547|FG002|Overall Study|Lost to Follow-up|0|||
146975359|NCT01440595|530073545|FG000|Overall Study|Study terminated by sponsor.|1|||
146975360|NCT01440595|530073546|FG001|Overall Study|Study terminated by sponsor.|2|||
146975361|NCT01440595|530073547|FG002|Overall Study|Study terminated by sponsor.|1|||
146975362|NCT01347879|530073548|FG000|Overall Study|Adverse Event|0|||
146975363|NCT01347879|530073549|FG001|Overall Study|Adverse Event|12|||
146975364|NCT01347879|530073548|FG000|Overall Study|Lost to Follow-up|2|||
146975365|NCT01347879|530073549|FG001|Overall Study|Lost to Follow-up|0|||
146975366|NCT01347879|530073548|FG000|Overall Study|Withdrawal by Subject|3|||
146975367|NCT01347879|530073549|FG001|Overall Study|Withdrawal by Subject|2|||
146975368|NCT01347879|530073548|FG000|Overall Study|Other|2|||
146975369|NCT01347879|530073549|FG001|Overall Study|Other|3|||
146975370|NCT04736576|530073552|FG000|Overall Study|Progressive disease|3|||
146975371|NCT04736576|530073553|FG001|Overall Study|Progressive disease|1|||
146975372|NCT04736576|530073552|FG000|Overall Study|Death|1|||
146975373|NCT04736576|530073553|FG001|Overall Study|Death|0|||
146975374|NCT00720304|530073556|FG000|Overall Study|Withdrawal by Subject|14|||
146975375|NCT00720304|530073557|FG001|Overall Study|Withdrawal by Subject|1|||
146975376|NCT00720304|530073556|FG000|Overall Study|Death|1|||
146975377|NCT00720304|530073557|FG001|Overall Study|Death|0|||
146975378|NCT00720304|530073556|FG000|Overall Study|Physician Decision|5|||
146975379|NCT00720304|530073557|FG001|Overall Study|Physician Decision|2|||
146975380|NCT00720304|530073556|FG000|Overall Study|Adverse Event|3|||
146975381|NCT00720304|530073557|FG001|Overall Study|Adverse Event|1|||
146975382|NCT00720304|530073556|FG000|Overall Study|Disease progression|6|||
146975383|NCT00720304|530073557|FG001|Overall Study|Disease progression|1|||
146975384|NCT04330482|530073560|FG000|Overall Study|Lost to Follow-up|2|||
146975385|NCT04330482|530073561|FG001|Overall Study|Lost to Follow-up|1|||
146975386|NCT04330482|530073560|FG000|Overall Study|Withdrawal by Subject|0|||
146975387|NCT04330482|530073561|FG001|Overall Study|Withdrawal by Subject|3|||
146975388|NCT00996918|530073562|FG000|Overall Study|Lack of Efficacy|1|||
146975389|NCT00996918|530073563|FG001|Overall Study|Lack of Efficacy|1|||
146975390|NCT00996918|530073564|FG002|Overall Study|Lack of Efficacy|2|||
146975391|NCT00996918|530073565|FG003|Overall Study|Lack of Efficacy|2|||
146975392|NCT00996918|530073566|FG004|Overall Study|Lack of Efficacy|0|||
146975393|NCT00996918|530073562|FG000|Overall Study|Adverse Event|2|||
146975394|NCT00996918|530073563|FG001|Overall Study|Adverse Event|5|||
146975395|NCT00996918|530073564|FG002|Overall Study|Adverse Event|2|||
146975396|NCT00996918|530073565|FG003|Overall Study|Adverse Event|6|||
146975397|NCT00996918|530073566|FG004|Overall Study|Adverse Event|0|||
146975398|NCT00996918|530073562|FG000|Overall Study|Withdrawal by Subject|1|||
146975399|NCT00996918|530073563|FG001|Overall Study|Withdrawal by Subject|4|||
146975400|NCT00996918|530073564|FG002|Overall Study|Withdrawal by Subject|3|||
146975401|NCT00996918|530073565|FG003|Overall Study|Withdrawal by Subject|3|||
146975402|NCT00996918|530073566|FG004|Overall Study|Withdrawal by Subject|2|||
146975403|NCT00996918|530073562|FG000|Overall Study|Physician Decision|1|||
146975404|NCT00996918|530073563|FG001|Overall Study|Physician Decision|0|||
146975405|NCT00996918|530073564|FG002|Overall Study|Physician Decision|0|||
146975406|NCT00996918|530073565|FG003|Overall Study|Physician Decision|0|||
146975407|NCT00996918|530073566|FG004|Overall Study|Physician Decision|0|||
146975408|NCT00996918|530073562|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
146975409|NCT00996918|530073563|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
146975410|NCT00996918|530073564|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
146975411|NCT00996918|530073565|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
146975412|NCT00996918|530073566|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
146975413|NCT00996918|530073562|FG000|Overall Study|Loss of Caregiver|0|||
146975414|NCT00996918|530073563|FG001|Overall Study|Loss of Caregiver|1|||
146975415|NCT00996918|530073564|FG002|Overall Study|Loss of Caregiver|0|||
146975416|NCT00996918|530073565|FG003|Overall Study|Loss of Caregiver|0|||
146975417|NCT00996918|530073566|FG004|Overall Study|Loss of Caregiver|0|||
146975418|NCT00996918|530073562|FG000|Overall Study|Other|3|||
146975419|NCT00996918|530073563|FG001|Overall Study|Other|1|||
146975420|NCT00996918|530073564|FG002|Overall Study|Other|0|||
146975421|NCT00996918|530073565|FG003|Overall Study|Other|0|||
146975422|NCT00996918|530073566|FG004|Overall Study|Other|0|||
146975423|NCT01333475|530073569|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
146975424|NCT01333475|530073570|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
146975425|NCT01333475|530073569|FG000|Overall Study|Toxicity|1|||
146975426|NCT01333475|530073570|FG001|Overall Study|Toxicity|3|||
146975427|NCT04440007|530073571|FG000|Overall Study|Adverse Event|0|||
146975428|NCT04440007|530073572|FG001|Overall Study|Adverse Event|1|||
146975429|NCT04440007|530073571|FG000|Overall Study|Lost to Follow-up|1|||
146975430|NCT04440007|530073572|FG001|Overall Study|Lost to Follow-up|3|||
146975431|NCT04440007|530073571|FG000|Overall Study|Death|7|||
146975432|NCT04440007|530073572|FG001|Overall Study|Death|2|||
146975433|NCT04440007|530073571|FG000|Overall Study|Physician Decision|1|||
146975434|NCT04440007|530073572|FG001|Overall Study|Physician Decision|1|||
146975435|NCT04440007|530073571|FG000|Overall Study|Withdrawal by Subject|2|||
146975436|NCT04440007|530073572|FG001|Overall Study|Withdrawal by Subject|1|||
146975437|NCT04440007|530073571|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
146975438|NCT04440007|530073572|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
146975439|NCT04440007|530073571|FG000|Overall Study|Discontinued prior to dosing|0|||
146975440|NCT04440007|530073572|FG001|Overall Study|Discontinued prior to dosing|2|||
146975441|NCT01466673|530073573|FG000|Overall Study|Non-compliance with study treatment|2|||
146975442|NCT01466673|530073574|FG001|Overall Study|Non-compliance with study treatment|0|||
146975443|NCT01466673|530073573|FG000|Overall Study|Lost to Follow-up|3|||
146975444|NCT01466673|530073574|FG001|Overall Study|Lost to Follow-up|5|||
146975445|NCT01466673|530073573|FG000|Overall Study|Adverse Event|2|||
146975446|NCT01466673|530073574|FG001|Overall Study|Adverse Event|1|||
146975447|NCT02981602|530073575|FG000|Overall Study|Adverse Event|0|||
146975448|NCT02981602|530073576|FG001|Overall Study|Adverse Event|0|||
146975449|NCT02981602|530073577|FG002|Overall Study|Adverse Event|0|||
146975450|NCT02981602|530073578|FG003|Overall Study|Adverse Event|1|||
146975451|NCT02981602|530073579|FG004|Overall Study|Adverse Event|0|||
146975452|NCT02725671|530073580|FG000|Overall Study|Lost to Follow-up|1|||
146975453|NCT02525562|530073582|FG000|Overall Study|Death|9|||
146975454|NCT02525562|530073583|FG001|Overall Study|Death|0|||
146975455|NCT02525562|530073584|FG002|Overall Study|Death|0|||
146975456|NCT02525562|530073582|FG000|Overall Study|Lost to Follow-up|19|||
146975457|NCT02525562|530073583|FG001|Overall Study|Lost to Follow-up|0|||
146975458|NCT02525562|530073584|FG002|Overall Study|Lost to Follow-up|0|||
146975459|NCT02525562|530073582|FG000|Overall Study|Withdrawal by Subject|37|||
146975460|NCT02525562|530073583|FG001|Overall Study|Withdrawal by Subject|0|||
146975461|NCT02525562|530073584|FG002|Overall Study|Withdrawal by Subject|0|||
146975462|NCT02525562|530073582|FG000|Overall Study|Revision/Removal of Study Device|4|||
146975463|NCT02525562|530073583|FG001|Overall Study|Revision/Removal of Study Device|0|||
146975464|NCT02525562|530073584|FG002|Overall Study|Revision/Removal of Study Device|0|||
146975465|NCT02525562|530073582|FG000|Overall Study|Study Closed by Sponsor|154|||
146975466|NCT02525562|530073583|FG001|Overall Study|Study Closed by Sponsor|0|||
146975467|NCT02525562|530073584|FG002|Overall Study|Study Closed by Sponsor|0|||
146975468|NCT02983227|530073585|FG000|Overall Study|Adverse Event|21|||
146975469|NCT02983227|530073586|FG001|Overall Study|Adverse Event|3|||
146975470|NCT02983227|530073585|FG000|Overall Study|Death|3|||
146975471|NCT02983227|530073586|FG001|Overall Study|Death|0|||
146975472|NCT02983227|530073585|FG000|Overall Study|Lack of Efficacy|8|||
146975473|NCT02983227|530073586|FG001|Overall Study|Lack of Efficacy|1|||
146975474|NCT02983227|530073585|FG000|Overall Study|Lost to Follow-up|3|||
146975475|NCT02983227|530073586|FG001|Overall Study|Lost to Follow-up|0|||
146770140|NCT00818454|529327380|FG003|Washout Period of 1 Week|Protocol Violation|0|||
146770141|NCT00818454|529327377|FG000|Washout Period of 1 Week|Other|1|||
146770142|NCT00818454|529327378|FG001|Washout Period of 1 Week|Other|2|||
146770143|NCT00818454|529327379|FG002|Washout Period of 1 Week|Other|0|||
146770144|NCT00818454|529327380|FG003|Washout Period of 1 Week|Other|0|||
146770145|NCT00818454|529327377|FG000|Treatment Period 2|Other|2|||
146770146|NCT00818454|529327378|FG001|Treatment Period 2|Other|1|||
146770147|NCT00818454|529327379|FG002|Treatment Period 2|Other|0|||
146770148|NCT00818454|529327380|FG003|Treatment Period 2|Other|0|||
146770149|NCT00818454|529327377|FG000|Treatment Period 3|Adverse Event|0|||
146770150|NCT00818454|529327378|FG001|Treatment Period 3|Adverse Event|0|||
146770151|NCT00818454|529327379|FG002|Treatment Period 3|Adverse Event|0|||
146770152|NCT00818454|529327380|FG003|Treatment Period 3|Adverse Event|1|||
146770153|NCT00799396|529327382|FG000|Clopidogrel Treatment|Adverse Event|6|||
146770154|NCT00799396|529327382|FG000|Clopidogrel Treatment|Physician Decision|5|||
146770155|NCT00799396|529327382|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
146770156|NCT00799396|529327382|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
146975476|NCT02983227|530073585|FG000|Overall Study|Multiple Reasons|2|||
146975477|NCT02983227|530073586|FG001|Overall Study|Multiple Reasons|1|||
146975478|NCT02983227|530073585|FG000|Overall Study|Physician Decision|3|||
146975479|NCT02983227|530073586|FG001|Overall Study|Physician Decision|1|||
146975480|NCT02983227|530073585|FG000|Overall Study|Withdrawal by Subject|19|||
146975481|NCT02983227|530073586|FG001|Overall Study|Withdrawal by Subject|8|||
146975482|NCT01706770|530073587|FG000|Overall Study|Lost to Follow-up|1|||
146975483|NCT01706770|530073588|FG001|Overall Study|Lost to Follow-up|0|||
146975484|NCT01706770|530073587|FG000|Overall Study|Physician Decision|1|||
146975485|NCT01706770|530073588|FG001|Overall Study|Physician Decision|0|||
146975486|NCT02164539|530073589|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
146975487|NCT02164539|530073590|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
146975488|NCT02164539|530073591|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
146975489|NCT02164539|530073592|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
146975490|NCT02164539|530073593|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
146975491|NCT02164539|530073594|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
146975492|NCT02164539|530073595|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
146975493|NCT02164539|530073589|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
146975494|NCT02164539|530073590|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
146975495|NCT02164539|530073591|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
146975496|NCT02164539|530073592|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
146975497|NCT02164539|530073593|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
146975498|NCT02164539|530073594|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
146975499|NCT02164539|530073595|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
146975500|NCT02164539|530073589|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
146975501|NCT02164539|530073590|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
146975502|NCT02164539|530073591|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
146975503|NCT02164539|530073592|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
146975504|NCT02164539|530073593|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
146975505|NCT02164539|530073594|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
146975506|NCT02164539|530073595|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
146975507|NCT02164539|530073589|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
146975508|NCT02164539|530073590|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
146975509|NCT02164539|530073591|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
146975510|NCT02164539|530073592|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
146975511|NCT02164539|530073593|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
146975512|NCT02164539|530073594|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
146975513|NCT02164539|530073595|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
146975514|NCT02164539|530073589|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
146975515|NCT02164539|530073590|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
146975516|NCT02164539|530073591|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
146975517|NCT02164539|530073592|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
146975518|NCT02164539|530073593|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
146975519|NCT02164539|530073594|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
146975520|NCT02164539|530073595|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
146975521|NCT02164539|530073589|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
146975522|NCT02164539|530073590|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
146975523|NCT02164539|530073591|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
146975524|NCT02164539|530073592|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
146975525|NCT02164539|530073593|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
146975526|NCT02164539|530073594|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
146975527|NCT02164539|530073595|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
146975528|NCT02643966|530073596|FG000|First Screening Round|ineligible|1|||
146975529|NCT02643966|530073596|FG000|First Screening Round|excluded from analysis|2|||
146975530|NCT02643966|530073596|FG000|First Screening Round|Lost to Follow-up|56|||
146975531|NCT02643966|530073596|FG000|First Screening Round|Withdrawal by Subject|28|||
146975532|NCT02643966|530073596|FG000|First Screening Round|Death|1|||
146975533|NCT02643966|530073596|FG000|Between First and Second Screening|Lost to Follow-up|65|||
146975534|NCT02643966|530073596|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
146975535|NCT02643966|530073596|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
146975536|NCT02643966|530073596|FG000|Second Screening Round|Withdrawal by Subject|20|||
146975537|NCT02643966|530073596|FG000|Second Screening Round|Lost to Follow-up|57|||
146975538|NCT02643966|530073596|FG000|Second Screening Round|Physician Decision|2|||
146975539|NCT02643966|530073596|FG000|Second Screening Round|Death|4|||
146975540|NCT02643966|530073596|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
146975541|NCT02643966|530073596|FG000|Between Second and Third Screening|Death|1|||
146975542|NCT02643966|530073596|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
146975543|NCT02643966|530073596|FG000|Third Screening Round|PI excluded|2|||
146975544|NCT02643966|530073596|FG000|Third Screening Round|Lost to Follow-up|241|||
146975545|NCT03070431|530073599|FG000|Overall Study|Withdrawal by Subject|2|||
146975546|NCT03070431|530073599|FG000|Overall Study|Lost to Follow-up|2|||
146975547|NCT01542736|530073602|FG000|Overall Study|Death|1|||
146975548|NCT01783483|530073603|FG000|Overall Study|Death|3|||
146975549|NCT01783483|530073604|FG001|Overall Study|Death|3|||
146975550|NCT01783483|530073603|FG000|Overall Study|Lost to Follow-up|14|||
146975551|NCT01783483|530073604|FG001|Overall Study|Lost to Follow-up|10|||
146975552|NCT01783483|530073603|FG000|Overall Study|Withdrawal by Subject|2|||
146975553|NCT01783483|530073604|FG001|Overall Study|Withdrawal by Subject|1|||
146975554|NCT01783483|530073603|FG000|Overall Study|Physician Decision|1|||
146975555|NCT01783483|530073604|FG001|Overall Study|Physician Decision|1|||
146975556|NCT02065791|530073605|FG000|Overall Study|Closed Site|1|||
146975557|NCT02065791|530073606|FG001|Overall Study|Closed Site|1|||
146975558|NCT02065791|530073605|FG000|Overall Study|Withdrawal by Subject|11|||
146975559|NCT02065791|530073606|FG001|Overall Study|Withdrawal by Subject|5|||
146975560|NCT02065791|530073605|FG000|Overall Study|Lost to Follow-up|13|||
146975561|NCT02065791|530073606|FG001|Overall Study|Lost to Follow-up|9|||
146975562|NCT00975884|530073607|FG000|Overall Study|Adverse Event|1|||
146975563|NCT00975884|530073608|FG001|Overall Study|Adverse Event|0|||
146975564|NCT00975884|530073607|FG000|Overall Study|Lost to Follow-up|5|||
146975565|NCT00975884|530073608|FG001|Overall Study|Lost to Follow-up|3|||
146975566|NCT00975884|530073607|FG000|Overall Study|Withdrawal by Subject|9|||
146975567|NCT00975884|530073608|FG001|Overall Study|Withdrawal by Subject|9|||
146975568|NCT00975884|530073607|FG000|Overall Study|Other|1|||
146975569|NCT00975884|530073608|FG001|Overall Study|Other|3|||
146975570|NCT00051636|530073609|FG000|Period 1 - Core|Adverse Event|2|||
146975571|NCT00051636|530073610|FG001|Period 1 - Core|Adverse Event|2|||
146975572|NCT00051636|530073609|FG000|Period 1 - Core|Protocol Violation|1|||
146975573|NCT00051636|530073610|FG001|Period 1 - Core|Protocol Violation|0|||
146975574|NCT00051636|530073609|FG000|Period 1 - Core|Withdrawal by Subject|1|||
146975575|NCT00051636|530073610|FG001|Period 1 - Core|Withdrawal by Subject|2|||
146975576|NCT00051636|530073609|FG000|Period 1 - Core|Lost to Follow-up|0|||
146975577|NCT00051636|530073610|FG001|Period 1 - Core|Lost to Follow-up|2|||
146975578|NCT00051636|530073609|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
146975579|NCT00051636|530073610|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
146975580|NCT00051636|530073609|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
146975581|NCT00051636|530073610|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
146975582|NCT00051636|530073609|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
146975583|NCT00051636|530073610|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
146975584|NCT00051636|530073609|FG000|Period 2- Extended Observation Period|Death|4|||
146975585|NCT00051636|530073610|FG001|Period 2- Extended Observation Period|Death|5|||
146975586|NCT00051636|530073609|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
146975587|NCT00051636|530073610|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
146975588|NCT01174368|530073611|FG000|Overall Study|Withdrawal by Subject|1|||
146975589|NCT00363129|530073616|FG000|Overall Study|Withdrawal by Subject|11|||
146975590|NCT00363129|530073617|FG001|Overall Study|Withdrawal by Subject|18|||
146975591|NCT00363129|530073616|FG000|Overall Study|Adverse Event|8|||
146975592|NCT00363129|530073617|FG001|Overall Study|Adverse Event|3|||
146975593|NCT00363129|530073616|FG000|Overall Study|Alternate Treatment|2|||
146975594|NCT00363129|530073617|FG001|Overall Study|Alternate Treatment|4|||
146975595|NCT00363129|530073616|FG000|Overall Study|Other Medical Problems|2|||
146975596|NCT00363129|530073617|FG001|Overall Study|Other Medical Problems|4|||
146975597|NCT00363129|530073616|FG000|Overall Study|Death|0|||
146975598|NCT00363129|530073617|FG001|Overall Study|Death|1|||
146975599|NCT00363129|530073616|FG000|Overall Study|Other Reasons|6|||
146975600|NCT00363129|530073617|FG001|Overall Study|Other Reasons|3|||
146975601|NCT03707522|530073618|FG000|Overall Study|Lost to Follow-up|24|||
146975602|NCT03707522|530073619|FG001|Overall Study|Lost to Follow-up|27|||
146975603|NCT03707522|530073620|FG002|Overall Study|Lost to Follow-up|41|||
146975604|NCT03707522|530073621|FG003|Overall Study|Lost to Follow-up|36|||
146975605|NCT00383019|530073622|FG000|Overall Study|Adverse Event|5|||
146975606|NCT00383019|530073623|FG001|Overall Study|Adverse Event|1|||
146975607|NCT00383019|530073622|FG000|Overall Study|Withdrawal by Subject|0|||
146975608|NCT00383019|530073623|FG001|Overall Study|Withdrawal by Subject|1|||
146975609|NCT02278952|530073624|FG000|Overall Study|Insufficient Sample|6|||
146975610|NCT00659581|530073625|FG000|Overall Study|Adverse Event|1006|||
146975611|NCT00659581|530073625|FG000|Overall Study|Lack of Efficacy|1183|||
146975612|NCT00659581|530073625|FG000|Overall Study|Other|6393|||
146975613|NCT02989610|530073629|FG000|Overall Study|Withdrawal by Subject|20|||
146975614|NCT02989610|530073629|FG000|Overall Study|Departure of PI from Site|8|||
146975615|NCT02989610|530073629|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
146975616|NCT02989610|530073629|FG000|Overall Study|Lost to Follow-up|3|||
146975617|NCT02989610|530073629|FG000|Overall Study|Death|3|||
146975618|NCT02989610|530073629|FG000|Overall Study|System Explant|3|||
146975619|NCT02989610|530073629|FG000|Overall Study|Subject Non-Compliance|2|||
146975620|NCT02989610|530073629|FG000|Overall Study|System Revision|2|||
146975621|NCT02989610|530073629|FG000|Overall Study|PI Left, Study Closing|1|||
146975622|NCT02989610|530073629|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
146975623|NCT02989610|530073629|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
146568939|NCT00940602|528595501|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
146770157|NCT00799396|529327382|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
146975624|NCT04508621|530073632|FG000|Overall Study|Adverse Event|39|||
146975625|NCT04508621|530073633|FG001|Overall Study|Adverse Event|16|||
146975626|NCT04508621|530073632|FG000|Overall Study|Lack of Efficacy|2|||
146975627|NCT04508621|530073633|FG001|Overall Study|Lack of Efficacy|8|||
146975628|NCT04508621|530073632|FG000|Overall Study|Physician Decision|0|||
146975629|NCT04508621|530073633|FG001|Overall Study|Physician Decision|1|||
146975630|NCT04508621|530073632|FG000|Overall Study|Withdrawal by Subject|10|||
146568940|NCT00940602|528595502|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
146568941|NCT01463033|528595503|FG000|Overall Study|Lost to Follow-up|4|||
146568942|NCT01463033|528595504|FG001|Overall Study|Lost to Follow-up|4|||
146568943|NCT01463033|528595503|FG000|Overall Study|Death|3|||
146568944|NCT01463033|528595504|FG001|Overall Study|Death|2|||
146568945|NCT01368614|528595505|FG000|Screening Period|Screen Failure|58|||
146568946|NCT01368614|528595506|FG001|Screening Period|Screen Failure|0|||
146568947|NCT01368614|528595507|FG002|Screening Period|Screen Failure|0|||
146568948|NCT01368614|528595508|FG003|Screening Period|Screen Failure|0|||
146568949|NCT01368614|528595505|FG000|Study Period|Withdrawal by Subject|0|||
146568950|NCT01368614|528595506|FG001|Study Period|Withdrawal by Subject|1|||
146568951|NCT01368614|528595507|FG002|Study Period|Withdrawal by Subject|1|||
146568952|NCT01368614|528595508|FG003|Study Period|Withdrawal by Subject|3|||
146650227|NCT04966910|528896683|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
146650228|NCT04966910|528896684|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
146650229|NCT04966910|528896685|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
146650230|NCT04966910|528896686|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
146650231|NCT04966910|528896683|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
146650232|NCT04966910|528896684|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
146650233|NCT04966910|528896685|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
146650234|NCT04966910|528896686|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
146650235|NCT04966910|528896683|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
146650236|NCT04966910|528896684|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
146650237|NCT04966910|528896685|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
146650238|NCT04966910|528896686|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
146650239|NCT00002931|528896690|FG000|Overall Study|rapidly progressing disease during|2|||
146650240|NCT02276027|528896691|FG000|Overall Study|Death|1|||
146650241|NCT02276027|528896692|FG001|Overall Study|Death|0|||
146650242|NCT02276027|528896693|FG002|Overall Study|Death|0|||
146650243|NCT02276027|528896694|FG003|Overall Study|Death|2|||
146650244|NCT02276027|528896691|FG000|Overall Study|Physician Decision|0|||
146650245|NCT02276027|528896692|FG001|Overall Study|Physician Decision|0|||
146650246|NCT02276027|528896693|FG002|Overall Study|Physician Decision|0|||
146650247|NCT02276027|528896694|FG003|Overall Study|Physician Decision|1|||
146650248|NCT02276027|528896691|FG000|Overall Study|Progressive disease|1|||
146650249|NCT02276027|528896692|FG001|Overall Study|Progressive disease|13|||
146650250|NCT02276027|528896693|FG002|Overall Study|Progressive disease|12|||
146650251|NCT02276027|528896694|FG003|Overall Study|Progressive disease|14|||
146650252|NCT02276027|528896691|FG000|Overall Study|Subject/guardian decision|0|||
146914693|NCT01879618|529850056|FG000|Overall Study|Does not meet entrance criteria|1|||
146914694|NCT01879618|529850056|FG000|Overall Study|Withdrawal by Subject|1|||
146914695|NCT01879618|529850056|FG000|Overall Study|Surgery;changed schedule; not available|8|||
146914696|NCT01879618|529850056|FG000|Overall Study|Protocol Violation|6|||
146914697|NCT01879618|529850056|FG000|Overall Study|Adverse Event|5|||
146914698|NCT01171521|529850059|FG000|Overall Study|Lost to Follow-up|5|||
146914699|NCT01171521|529850059|FG000|Overall Study|screen failure|1|||
146914700|NCT01927562|529850060|FG000|Overall Study|Lost to Follow-up|30|||
146914701|NCT01927562|529850060|FG000|Overall Study|Withdrawal by Subject|3|||
146914702|NCT01927562|529850060|FG000|Overall Study|Physician Decision|5|||
146914703|NCT00492921|529850061|FG000|Overall Study|Death|1|||
146914704|NCT00492921|529850062|FG001|Overall Study|Death|0|||
146914705|NCT00492921|529850063|FG002|Overall Study|Death|1|||
146914706|NCT00652093|529850064|FG000|Overall Study|Withdrawal by Subject|0|||
146914707|NCT00652093|529850065|FG001|Overall Study|Withdrawal by Subject|0|||
146914708|NCT00652093|529850066|FG002|Overall Study|Withdrawal by Subject|1|||
146914709|NCT00652093|529850067|FG003|Overall Study|Withdrawal by Subject|0|||
146914710|NCT00652093|529850068|FG004|Overall Study|Withdrawal by Subject|1|||
146914711|NCT00652093|529850069|FG005|Overall Study|Withdrawal by Subject|0|||
146914712|NCT00652093|529850064|FG000|Overall Study|Physician Decision|0|||
146914713|NCT00652093|529850065|FG001|Overall Study|Physician Decision|0|||
146914714|NCT00652093|529850066|FG002|Overall Study|Physician Decision|0|||
146914715|NCT00652093|529850067|FG003|Overall Study|Physician Decision|0|||
146914716|NCT00652093|529850068|FG004|Overall Study|Physician Decision|1|||
146650253|NCT02276027|528896692|FG001|Overall Study|Subject/guardian decision|1|||
146650254|NCT02276027|528896693|FG002|Overall Study|Subject/guardian decision|0|||
146568953|NCT01368614|528595505|FG000|Study Period|Lost to Follow-up|0|||
146568954|NCT01368614|528595506|FG001|Study Period|Lost to Follow-up|0|||
146568955|NCT01368614|528595507|FG002|Study Period|Lost to Follow-up|1|||
146650255|NCT02276027|528896694|FG003|Overall Study|Subject/guardian decision|3|||
146650256|NCT02276027|528896691|FG000|Overall Study|Adverse Event|0|||
146650257|NCT02276027|528896692|FG001|Overall Study|Adverse Event|2|||
146914717|NCT00652093|529850069|FG005|Overall Study|Physician Decision|0|||
146914718|NCT00469014|529850070|FG000|Initial Phase Randomization|Disease Progression|0|||
146914719|NCT00469014|529850071|FG001|Initial Phase Randomization|Disease Progression|1|||
146914720|NCT00469014|529850072|FG002|Initial Phase Randomization|Disease Progression|1|||
146914721|NCT00469014|529850073|FG003|Initial Phase Randomization|Disease Progression|0|||
146975631|NCT04508621|530073633|FG001|Overall Study|Withdrawal by Subject|14|||
146975632|NCT04508621|530073632|FG000|Overall Study|Lost to Follow-up|12|||
146975633|NCT04508621|530073633|FG001|Overall Study|Lost to Follow-up|9|||
146975634|NCT04508621|530073632|FG000|Overall Study|COVID-19 related crisis|3|||
146975635|NCT04508621|530073633|FG001|Overall Study|COVID-19 related crisis|0|||
146975636|NCT04508621|530073632|FG000|Overall Study|Subject non-compliance|1|||
146975637|NCT04508621|530073633|FG001|Overall Study|Subject non-compliance|0|||
146975638|NCT04355767|530073634|FG000|Overall Study|Withdrawal by Subject|2|||
146975639|NCT04355767|530073635|FG001|Overall Study|Withdrawal by Subject|2|||
146975640|NCT04355767|530073634|FG000|Overall Study|Death|5|||
146975641|NCT04355767|530073635|FG001|Overall Study|Death|1|||
146975642|NCT01999322|530073636|FG000|Overall Study|Adverse Event|1|||
146975643|NCT01999322|530073637|FG001|Overall Study|Adverse Event|0|||
146975644|NCT03053622|530075558|FG000|Overall Study|Lost to Follow-up|0|||
146975645|NCT03053622|530075559|FG001|Overall Study|Lost to Follow-up|0|||
146568956|NCT01368614|528595508|FG003|Study Period|Lost to Follow-up|0|||
146568957|NCT00244621|528595509|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
146568958|NCT00244621|528595510|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
146568959|NCT00244621|528595511|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
146568960|NCT00244621|528595509|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
146568961|NCT00244621|528595510|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
146568962|NCT00244621|528595511|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146568963|NCT00244621|528595509|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
146568964|NCT00244621|528595510|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
146568965|NCT00244621|528595511|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
146975646|NCT03053622|530075560|FG002|Overall Study|Lost to Follow-up|0|||
146975647|NCT03053622|530075561|FG003|Overall Study|Lost to Follow-up|1|||
146975648|NCT02598622|530075562|FG000|Overall Study|Withdrawal by Subject|3|||
146568966|NCT00244621|528595509|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
146568967|NCT00244621|528595510|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
146568968|NCT00244621|528595511|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
146568969|NCT00244621|528595509|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
146975649|NCT02598622|530075563|FG001|Overall Study|Withdrawal by Subject|0|||
146568970|NCT00244621|528595510|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
146568971|NCT00244621|528595511|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
146568972|NCT00244621|528595509|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
146568973|NCT00244621|528595510|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
146568974|NCT00244621|528595511|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
146568975|NCT00244621|528595509|FG000|Open-label Treatment Period|Adverse Event|0|||
146568976|NCT00244621|528595510|FG001|Open-label Treatment Period|Adverse Event|0|||
146568977|NCT00244621|528595511|FG002|Open-label Treatment Period|Adverse Event|1|||
146568978|NCT00244621|528595509|FG000|Open-label Treatment Period|Moved abroad|0|||
146568979|NCT00244621|528595510|FG001|Open-label Treatment Period|Moved abroad|0|||
146568980|NCT00244621|528595511|FG002|Open-label Treatment Period|Moved abroad|1|||
146568981|NCT01847755|528595515|FG000|Overall Study|Adverse Event|2|||
146568982|NCT01847755|528595515|FG000|Overall Study|Withdrawal by Subject|2|||
146568983|NCT01847755|528595515|FG000|Overall Study|Physician Decision|1|||
146568984|NCT01193101|528595516|FG000|Overall Study|Adverse Event|0|||
146568985|NCT01193101|528595517|FG001|Overall Study|Adverse Event|1|||
146568986|NCT01193101|528595518|FG002|Overall Study|Adverse Event|1|||
146568987|NCT01193101|528595519|FG003|Overall Study|Adverse Event|3|||
146568988|NCT01193101|528595516|FG000|Overall Study|Lack of Efficacy|3|||
146568989|NCT01193101|528595517|FG001|Overall Study|Lack of Efficacy|1|||
146568990|NCT01193101|528595518|FG002|Overall Study|Lack of Efficacy|0|||
146568991|NCT01193101|528595519|FG003|Overall Study|Lack of Efficacy|8|||
146568992|NCT01193101|528595516|FG000|Overall Study|Withdrawal by Subject|2|||
146568993|NCT01193101|528595517|FG001|Overall Study|Withdrawal by Subject|4|||
146568994|NCT01193101|528595518|FG002|Overall Study|Withdrawal by Subject|1|||
146568995|NCT01193101|528595519|FG003|Overall Study|Withdrawal by Subject|1|||
146568996|NCT01193101|528595516|FG000|Overall Study|Administrative problems|0|||
146568997|NCT01193101|528595517|FG001|Overall Study|Administrative problems|0|||
146568998|NCT01193101|528595518|FG002|Overall Study|Administrative problems|1|||
146568999|NCT01193101|528595519|FG003|Overall Study|Administrative problems|0|||
146569000|NCT01193101|528595516|FG000|Overall Study|Abnormal test procedure results|0|||
146569001|NCT01193101|528595517|FG001|Overall Study|Abnormal test procedure results|1|||
146569002|NCT01193101|528595518|FG002|Overall Study|Abnormal test procedure results|0|||
146569003|NCT01193101|528595519|FG003|Overall Study|Abnormal test procedure results|0|||
146569004|NCT02347085|528595520|FG000|Overall Study|Adverse Event|2|||
146569005|NCT02347085|528595520|FG000|Overall Study|Lack of Efficacy|1|||
146569006|NCT02347085|528595520|FG000|Overall Study|Withdrawal by Subject|4|||
146569007|NCT02347085|528595520|FG000|Overall Study|Lost to Follow-up|1|||
146770158|NCT01867216|529327383|FG000|Overall Study|Withdrawal by Subject|2|||
146569008|NCT02347085|528595520|FG000|Overall Study|Protocol Criteria|2|||
146569009|NCT02271529|528595521|FG000|Overall Study|Withdrawal by Subject|1|||
146975650|NCT02598622|530075562|FG000|Overall Study|Physician Decision|3|||
146975651|NCT02598622|530075563|FG001|Overall Study|Physician Decision|0|||
146975652|NCT00681824|530075567|FG000|Overall Study|withdrawn by investigator|0|||
146975653|NCT00681824|530075568|FG001|Overall Study|withdrawn by investigator|0|||
146975654|NCT00681824|530075569|FG002|Overall Study|withdrawn by investigator|1|||
146975655|NCT00681824|530075567|FG000|Overall Study|scheduling conflict|1|||
146975656|NCT00681824|530075568|FG001|Overall Study|scheduling conflict|0|||
146975657|NCT00681824|530075569|FG002|Overall Study|scheduling conflict|0|||
146975658|NCT00681824|530075567|FG000|Overall Study|Death|0|||
146975659|NCT00681824|530075568|FG001|Overall Study|Death|1|||
146975660|NCT00681824|530075569|FG002|Overall Study|Death|0|||
146975661|NCT03591107|530075572|FG000|Overall Study|Same patient in both arms|1|||
146975662|NCT03591107|530075573|FG001|Overall Study|Same patient in both arms|1|||
146975663|NCT03591107|530075572|FG000|Overall Study|Sought care at other clinics|0|||
146975664|NCT03591107|530075573|FG001|Overall Study|Sought care at other clinics|2|||
146975665|NCT03591107|530075572|FG000|Overall Study|Discharged from clinic|0|||
146975666|NCT03591107|530075573|FG001|Overall Study|Discharged from clinic|1|||
146975667|NCT03591107|530075572|FG000|Overall Study|Withdrawal by Subject|0|||
146975668|NCT03591107|530075573|FG001|Overall Study|Withdrawal by Subject|1|||
146975669|NCT01902134|530075574|FG000|Overall Study|Adverse Event|3|||
146975670|NCT01902134|530075575|FG001|Overall Study|Adverse Event|1|||
146975671|NCT01902134|530075576|FG002|Overall Study|Adverse Event|2|||
146975672|NCT01902134|530075577|FG003|Overall Study|Adverse Event|1|||
146975673|NCT01902134|530075578|FG004|Overall Study|Adverse Event|1|||
146975674|NCT01902134|530075579|FG005|Overall Study|Adverse Event|3|||
146975675|NCT01902134|530075574|FG000|Overall Study|Lack of Efficacy|0|||
146975676|NCT01902134|530075575|FG001|Overall Study|Lack of Efficacy|0|||
146975677|NCT01902134|530075576|FG002|Overall Study|Lack of Efficacy|2|||
146975678|NCT01902134|530075577|FG003|Overall Study|Lack of Efficacy|0|||
146975679|NCT01902134|530075578|FG004|Overall Study|Lack of Efficacy|0|||
146975680|NCT01902134|530075579|FG005|Overall Study|Lack of Efficacy|1|||
146975681|NCT01902134|530075574|FG000|Overall Study|Physician Decision|0|||
146975682|NCT01902134|530075575|FG001|Overall Study|Physician Decision|1|||
146975683|NCT01902134|530075576|FG002|Overall Study|Physician Decision|0|||
146975684|NCT01902134|530075577|FG003|Overall Study|Physician Decision|0|||
146975685|NCT01902134|530075578|FG004|Overall Study|Physician Decision|0|||
146975686|NCT01902134|530075579|FG005|Overall Study|Physician Decision|0|||
146975687|NCT01902134|530075574|FG000|Overall Study|Protocol Violation|0|||
146975688|NCT01902134|530075575|FG001|Overall Study|Protocol Violation|0|||
146975689|NCT01902134|530075576|FG002|Overall Study|Protocol Violation|0|||
146975690|NCT01902134|530075577|FG003|Overall Study|Protocol Violation|0|||
146975691|NCT01902134|530075578|FG004|Overall Study|Protocol Violation|0|||
146975692|NCT01902134|530075579|FG005|Overall Study|Protocol Violation|1|||
146975693|NCT01902134|530075574|FG000|Overall Study|Withdrawal by Subject|4|||
146975694|NCT01902134|530075575|FG001|Overall Study|Withdrawal by Subject|8|||
146975695|NCT01902134|530075576|FG002|Overall Study|Withdrawal by Subject|9|||
146975696|NCT01902134|530075577|FG003|Overall Study|Withdrawal by Subject|1|||
146975697|NCT01902134|530075578|FG004|Overall Study|Withdrawal by Subject|5|||
146975698|NCT01902134|530075579|FG005|Overall Study|Withdrawal by Subject|4|||
146975699|NCT01902134|530075574|FG000|Overall Study|no compliance|1|||
146975700|NCT01902134|530075575|FG001|Overall Study|no compliance|0|||
146975701|NCT01902134|530075576|FG002|Overall Study|no compliance|0|||
146975702|NCT01902134|530075577|FG003|Overall Study|no compliance|0|||
146975703|NCT01902134|530075578|FG004|Overall Study|no compliance|0|||
146975704|NCT01902134|530075579|FG005|Overall Study|no compliance|0|||
146975705|NCT01902134|530075574|FG000|Overall Study|Other|0|||
146975706|NCT01902134|530075575|FG001|Overall Study|Other|1|||
146975707|NCT01902134|530075576|FG002|Overall Study|Other|2|||
146975708|NCT01902134|530075577|FG003|Overall Study|Other|0|||
146975709|NCT01902134|530075578|FG004|Overall Study|Other|1|||
146770159|NCT01867216|529327384|FG001|Overall Study|Withdrawal by Subject|0|||
146770160|NCT01867216|529327385|FG002|Overall Study|Withdrawal by Subject|0|||
146770161|NCT01867216|529327386|FG003|Overall Study|Withdrawal by Subject|0|||
146770162|NCT01867216|529327387|FG004|Overall Study|Withdrawal by Subject|1|||
146770163|NCT01867216|529327388|FG005|Overall Study|Withdrawal by Subject|0|||
146770164|NCT01867216|529327389|FG006|Overall Study|Withdrawal by Subject|1|||
146770165|NCT01867216|529327383|FG000|Overall Study|Physician Decision|1|||
146770166|NCT01867216|529327384|FG001|Overall Study|Physician Decision|0|||
146770167|NCT01867216|529327385|FG002|Overall Study|Physician Decision|0|||
146770168|NCT01867216|529327386|FG003|Overall Study|Physician Decision|0|||
146770169|NCT01867216|529327387|FG004|Overall Study|Physician Decision|0|||
146770170|NCT01867216|529327388|FG005|Overall Study|Physician Decision|0|||
146770171|NCT01867216|529327389|FG006|Overall Study|Physician Decision|0|||
146975710|NCT01902134|530075579|FG005|Overall Study|Other|0|||
146975711|NCT00305110|530075580|FG000|Overall Study|Missing data|29|||
146975712|NCT00736099|530075585|FG000|Overall Study|Adverse Event|61|||
146975713|NCT00736099|530075586|FG001|Overall Study|Adverse Event|18|||
146975714|NCT00736099|530075585|FG000|Overall Study|Protocol Violation|10|||
146975715|NCT00736099|530075586|FG001|Overall Study|Protocol Violation|4|||
146975716|NCT00736099|530075585|FG000|Overall Study|Lost to Follow-up|12|||
146975717|NCT00736099|530075586|FG001|Overall Study|Lost to Follow-up|5|||
146975718|NCT00736099|530075585|FG000|Overall Study|Withdrawal by Subject|42|||
146975719|NCT00736099|530075586|FG001|Overall Study|Withdrawal by Subject|13|||
146975720|NCT00736099|530075585|FG000|Overall Study|Lack of Efficacy|15|||
146975721|NCT00736099|530075586|FG001|Overall Study|Lack of Efficacy|8|||
146975722|NCT00736099|530075585|FG000|Overall Study|Other reason|43|||
146975723|NCT00736099|530075586|FG001|Overall Study|Other reason|10|||
146975724|NCT01637961|530075587|FG000|Overall Study|Ineligible: wrong primary|1|||
146975725|NCT01637961|530075587|FG000|Overall Study|Ineligible: inadequate pathology|1|||
146975726|NCT03101293|530075588|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
146975727|NCT03101293|530075589|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
146975728|NCT03451331|530075598|FG000|Overall Study|Withdrawal by Subject|1|||
146975729|NCT03451331|530075599|FG001|Overall Study|Withdrawal by Subject|0|||
146975730|NCT03451331|530075598|FG000|Overall Study|Unable to start treatment.|1|||
146975731|NCT03451331|530075599|FG001|Overall Study|Unable to start treatment.|1|||
146975732|NCT02773446|530075600|FG000|First Admission|Withdrawal by Subject|0|||
146975733|NCT02773446|530075601|FG001|First Admission|Withdrawal by Subject|0|||
146975734|NCT02773446|530075602|FG002|First Admission|Withdrawal by Subject|0|||
146975735|NCT02773446|530075603|FG003|First Admission|Withdrawal by Subject|1|||
146975736|NCT02773446|530075604|FG004|First Admission|Withdrawal by Subject|0|||
146975737|NCT02773446|530075605|FG005|First Admission|Withdrawal by Subject|0|||
146975738|NCT02773446|530075600|FG000|First Admission|Lost to Follow-up|1|||
146975739|NCT02773446|530075601|FG001|First Admission|Lost to Follow-up|0|||
146975740|NCT02773446|530075602|FG002|First Admission|Lost to Follow-up|0|||
146975741|NCT02773446|530075603|FG003|First Admission|Lost to Follow-up|0|||
146975742|NCT02773446|530075604|FG004|First Admission|Lost to Follow-up|0|||
146975743|NCT02773446|530075605|FG005|First Admission|Lost to Follow-up|0|||
146975744|NCT04023994|530075606|FG000|Overall Study|Lost to Follow-up|0|||
146975745|NCT04023994|530075607|FG001|Overall Study|Lost to Follow-up|1|||
146975746|NCT04023994|530075608|FG002|Overall Study|Lost to Follow-up|2|||
146975747|NCT04023994|530075609|FG003|Overall Study|Lost to Follow-up|0|||
146975748|NCT04023994|530075610|FG004|Overall Study|Lost to Follow-up|0|||
146975749|NCT04023994|530075611|FG005|Overall Study|Lost to Follow-up|0|||
146975750|NCT04023994|530075606|FG000|Overall Study|Withdrawal by Subject|0|||
146975751|NCT04023994|530075607|FG001|Overall Study|Withdrawal by Subject|0|||
146975752|NCT04023994|530075608|FG002|Overall Study|Withdrawal by Subject|0|||
146975753|NCT04023994|530075609|FG003|Overall Study|Withdrawal by Subject|1|||
146975754|NCT04023994|530075610|FG004|Overall Study|Withdrawal by Subject|0|||
146975755|NCT04023994|530075611|FG005|Overall Study|Withdrawal by Subject|0|||
146975756|NCT01613131|530075612|FG000|Overall Study|Withdrawal by Subject|3|||
146975757|NCT01613131|530075613|FG001|Overall Study|Withdrawal by Subject|5|||
146975758|NCT01020305|530075614|FG000|Overall Study|Adverse Event|2|||
146975759|NCT00467818|530075615|FG000|Overall Study|Adverse Event|1|||
146975760|NCT00467818|530075616|FG001|Overall Study|Adverse Event|0|||
146975761|NCT00467818|530075615|FG000|Overall Study|Lost to Follow-up|2|||
146975762|NCT00467818|530075616|FG001|Overall Study|Lost to Follow-up|2|||
146975763|NCT01017029|530075617|FG000|Overall Study|Lost to Follow-up|1|||
146975764|NCT01017029|530075618|FG001|Overall Study|Lost to Follow-up|0|||
146975765|NCT01017029|530075617|FG000|Overall Study|Administrative problem|0|||
146975766|NCT01017029|530075618|FG001|Overall Study|Administrative problem|1|||
146975767|NCT01017029|530075617|FG000|Overall Study|Death|3|||
146975768|NCT01017029|530075618|FG001|Overall Study|Death|1|||
146975769|NCT00618774|530075621|FG000|Overall Study|Adverse Event|5|||
146975770|NCT00618774|530075622|FG001|Overall Study|Adverse Event|3|||
146975771|NCT00618774|530075621|FG000|Overall Study|Withdrawal by Subject|1|||
146975772|NCT00618774|530075622|FG001|Overall Study|Withdrawal by Subject|0|||
146975773|NCT02770716|530075623|FG000|Overall Study|Death|101|||
146975774|NCT02770716|530075624|FG001|Overall Study|Death|45|||
146975775|NCT02770716|530075623|FG000|Overall Study|Withdrawal by Subject|4|||
146975776|NCT02770716|530075624|FG001|Overall Study|Withdrawal by Subject|2|||
146975777|NCT02770716|530075623|FG000|Overall Study|Lost to Follow-up|1|||
146975778|NCT02770716|530075624|FG001|Overall Study|Lost to Follow-up|0|||
146975779|NCT02770716|530075623|FG000|Overall Study|Various reasons|6|||
146975780|NCT02770716|530075624|FG001|Overall Study|Various reasons|2|||
146975781|NCT02753400|530075626|FG000|Overall Study|Adverse Event|3|||
146975782|NCT02753400|530075627|FG001|Overall Study|Adverse Event|0|||
146975783|NCT02753400|530075626|FG000|Overall Study|Withdrawal by Subject|2|||
146975784|NCT02753400|530075627|FG001|Overall Study|Withdrawal by Subject|1|||
146975785|NCT03989115|530075628|FG000|Overall Study|Withdrawal by Subject|2|||
146975786|NCT03989115|530075629|FG001|Overall Study|Withdrawal by Subject|1|||
146975787|NCT03989115|530075630|FG002|Overall Study|Withdrawal by Subject|3|||
146975788|NCT03989115|530075631|FG003|Overall Study|Withdrawal by Subject|0|||
146975789|NCT03989115|530075632|FG004|Overall Study|Withdrawal by Subject|17|||
146975790|NCT03989115|530075633|FG005|Overall Study|Withdrawal by Subject|1|||
146975791|NCT03989115|530075634|FG006|Overall Study|Withdrawal by Subject|0|||
146975792|NCT03989115|530075635|FG007|Overall Study|Withdrawal by Subject|0|||
146975793|NCT03989115|530075628|FG000|Overall Study|Sponsor decision to terminate the study|1|||
146975794|NCT03989115|530075629|FG001|Overall Study|Sponsor decision to terminate the study|1|||
146975795|NCT03989115|530075630|FG002|Overall Study|Sponsor decision to terminate the study|0|||
146975796|NCT03989115|530075631|FG003|Overall Study|Sponsor decision to terminate the study|1|||
146975797|NCT03989115|530075632|FG004|Overall Study|Sponsor decision to terminate the study|11|||
146975798|NCT03989115|530075633|FG005|Overall Study|Sponsor decision to terminate the study|0|||
146975799|NCT03989115|530075634|FG006|Overall Study|Sponsor decision to terminate the study|2|||
146975800|NCT03989115|530075635|FG007|Overall Study|Sponsor decision to terminate the study|1|||
146975801|NCT03989115|530075628|FG000|Overall Study|Lost to Follow-up|2|||
146975802|NCT03989115|530075629|FG001|Overall Study|Lost to Follow-up|0|||
146975803|NCT03989115|530075630|FG002|Overall Study|Lost to Follow-up|0|||
146975804|NCT03989115|530075631|FG003|Overall Study|Lost to Follow-up|0|||
146975805|NCT03989115|530075632|FG004|Overall Study|Lost to Follow-up|1|||
146975806|NCT03989115|530075633|FG005|Overall Study|Lost to Follow-up|0|||
146975807|NCT03989115|530075634|FG006|Overall Study|Lost to Follow-up|0|||
146975808|NCT03989115|530075635|FG007|Overall Study|Lost to Follow-up|0|||
146975809|NCT03989115|530075628|FG000|Overall Study|Death|2|||
146975810|NCT03989115|530075629|FG001|Overall Study|Death|2|||
146975811|NCT03989115|530075630|FG002|Overall Study|Death|9|||
146975812|NCT03989115|530075631|FG003|Overall Study|Death|6|||
146975813|NCT03989115|530075632|FG004|Overall Study|Death|31|||
146975814|NCT03989115|530075633|FG005|Overall Study|Death|6|||
146975815|NCT03989115|530075634|FG006|Overall Study|Death|2|||
146975816|NCT03989115|530075635|FG007|Overall Study|Death|3|||
146975817|NCT03989115|530075628|FG000|Overall Study|Other|1|||
146975818|NCT03989115|530075629|FG001|Overall Study|Other|2|||
146975819|NCT03989115|530075630|FG002|Overall Study|Other|0|||
146975820|NCT03989115|530075631|FG003|Overall Study|Other|0|||
146975821|NCT03989115|530075632|FG004|Overall Study|Other|5|||
146975822|NCT03989115|530075633|FG005|Overall Study|Other|0|||
146975823|NCT03989115|530075634|FG006|Overall Study|Other|0|||
146975824|NCT03989115|530075635|FG007|Overall Study|Other|0|||
146975825|NCT02354976|530075644|FG000|Overall Study|Other - reason not specified|1|||
146975826|NCT02354976|530075645|FG001|Overall Study|Other - reason not specified|0|||
146975827|NCT02354976|530075646|FG002|Overall Study|Other - reason not specified|1|||
146975828|NCT02354976|530075644|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
146975829|NCT02354976|530075645|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
146975830|NCT02354976|530075646|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
146975831|NCT02354976|530075644|FG000|Overall Study|Adverse Event|1|||
146975832|NCT02354976|530075645|FG001|Overall Study|Adverse Event|0|||
146975833|NCT02354976|530075646|FG002|Overall Study|Adverse Event|2|||
146975834|NCT03118765|530075647|FG000|Overall Study|Withdrawal by Subject|0|||
146975835|NCT03118765|530075648|FG001|Overall Study|Withdrawal by Subject|0|||
146975836|NCT03118765|530075649|FG002|Overall Study|Withdrawal by Subject|1|||
146975837|NCT03118765|530075650|FG003|Overall Study|Withdrawal by Subject|0|||
146975838|NCT03118765|530075651|FG004|Overall Study|Withdrawal by Subject|0|||
146975839|NCT03118765|530075647|FG000|Overall Study|Adverse Event|1|||
146975840|NCT03118765|530075648|FG001|Overall Study|Adverse Event|1|||
146975841|NCT03118765|530075649|FG002|Overall Study|Adverse Event|1|||
146975842|NCT03118765|530075650|FG003|Overall Study|Adverse Event|1|||
146975843|NCT03118765|530075651|FG004|Overall Study|Adverse Event|1|||
146975844|NCT03118765|530075647|FG000|Overall Study|Non compliance with Study Procedures|0|||
146975845|NCT03118765|530075648|FG001|Overall Study|Non compliance with Study Procedures|0|||
146975846|NCT03118765|530075649|FG002|Overall Study|Non compliance with Study Procedures|0|||
146975847|NCT03118765|530075650|FG003|Overall Study|Non compliance with Study Procedures|1|||
146975848|NCT03118765|530075651|FG004|Overall Study|Non compliance with Study Procedures|0|||
146975849|NCT03118765|530075647|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
146975850|NCT03118765|530075648|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
146975851|NCT03118765|530075649|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
146975852|NCT03118765|530075650|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
146650258|NCT02276027|528896693|FG002|Overall Study|Adverse Event|8|||
146650259|NCT02276027|528896694|FG003|Overall Study|Adverse Event|2|||
146650260|NCT03224598|528896695|FG000|Overall Study|Lost to Follow-up|0|||
146650261|NCT03224598|528896696|FG001|Overall Study|Lost to Follow-up|2|||
146650262|NCT03224598|528896697|FG002|Overall Study|Lost to Follow-up|0|||
146650263|NCT03224598|528896695|FG000|Overall Study|Other|0|||
146650264|NCT03224598|528896696|FG001|Overall Study|Other|1|||
146975853|NCT03118765|530075651|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
146975854|NCT03118765|530075647|FG000|Overall Study|COPD Exacerbation|1|||
146975855|NCT03118765|530075648|FG001|Overall Study|COPD Exacerbation|0|||
146975856|NCT03118765|530075649|FG002|Overall Study|COPD Exacerbation|0|||
146975857|NCT03118765|530075650|FG003|Overall Study|COPD Exacerbation|1|||
146650265|NCT03224598|528896697|FG002|Overall Study|Other|0|||
146975858|NCT03118765|530075651|FG004|Overall Study|COPD Exacerbation|0|||
146975859|NCT03118765|530075647|FG000|Overall Study|Lost to Follow-up|1|||
146975860|NCT03118765|530075648|FG001|Overall Study|Lost to Follow-up|0|||
146975861|NCT03118765|530075649|FG002|Overall Study|Lost to Follow-up|1|||
146975862|NCT03118765|530075650|FG003|Overall Study|Lost to Follow-up|0|||
146975863|NCT03118765|530075651|FG004|Overall Study|Lost to Follow-up|0|||
146975864|NCT03118765|530075647|FG000|Overall Study|Sponsor Decision|1|||
146650266|NCT02446171|528896707|FG000|Overall Study|Withdrawal by Subject|0|||
146650267|NCT02446171|528896708|FG001|Overall Study|Withdrawal by Subject|0|||
146770172|NCT01867216|529327383|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
146770173|NCT01867216|529327384|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
146770174|NCT01867216|529327385|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
146770175|NCT01867216|529327386|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
146770176|NCT01867216|529327387|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
146770177|NCT01867216|529327388|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
146770178|NCT01867216|529327389|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
146770179|NCT03454529|529327390|FG000|Overall Study|Did not receive treatment|6|||
146770180|NCT03454529|529327390|FG000|Overall Study|Received < 80% doses|1|||
146770181|NCT01145885|529327391|FG000|Overall Study|Progressive Disease|7|||
146770182|NCT02880241|529327392|FG000|Overall Study|Lack of Efficacy|1|||
146770183|NCT02880241|529327393|FG001|Overall Study|Lack of Efficacy|0|||
146770184|NCT02880241|529327394|FG002|Overall Study|Lack of Efficacy|0|||
146770185|NCT02880241|529327395|FG003|Overall Study|Lack of Efficacy|0|||
146770186|NCT02880241|529327396|FG004|Overall Study|Lack of Efficacy|0|||
146770187|NCT02880241|529327397|FG005|Overall Study|Lack of Efficacy|0|||
146770188|NCT00057837|529327398|FG000|Overall Study|Progression/relapse|12|||
146770189|NCT00057837|529327399|FG001|Overall Study|Progression/relapse|14|||
146770190|NCT00057837|529327398|FG000|Overall Study|Adverse Event|2|||
146770191|NCT00057837|529327399|FG001|Overall Study|Adverse Event|12|||
146770192|NCT00057837|529327398|FG000|Overall Study|Death|5|||
146770193|NCT00057837|529327399|FG001|Overall Study|Death|4|||
146770194|NCT00057837|529327398|FG000|Overall Study|Withdrawal by Subject|5|||
146770195|NCT00057837|529327399|FG001|Overall Study|Withdrawal by Subject|3|||
146770196|NCT00057837|529327398|FG000|Overall Study|Alternative therapy|0|||
146770197|NCT00057837|529327399|FG001|Overall Study|Alternative therapy|1|||
146770198|NCT00057837|529327398|FG000|Overall Study|Other complicating disease|2|||
146770199|NCT00057837|529327399|FG001|Overall Study|Other complicating disease|1|||
146770200|NCT00057837|529327398|FG000|Overall Study|Physician Decision|1|||
146770201|NCT00057837|529327399|FG001|Overall Study|Physician Decision|0|||
146770202|NCT00057837|529327398|FG000|Overall Study|Ineligible|3|||
146770203|NCT00057837|529327399|FG001|Overall Study|Ineligible|3|||
146770204|NCT00057837|529327398|FG000|Overall Study|Never started treatment|1|||
146770205|NCT00057837|529327399|FG001|Overall Study|Never started treatment|1|||
146770206|NCT02537522|529327400|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
146770207|NCT02537522|529327401|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
146770208|NCT02537522|529327402|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
146770209|NCT02537522|529327403|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
146770210|NCT02537522|529327400|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
146770211|NCT02537522|529327401|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
146770212|NCT02537522|529327402|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
146770213|NCT02537522|529327403|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
146770214|NCT02537522|529327400|FG000|Phase I - Contralateral|incorrect randomization|0|||
146770215|NCT02537522|529327401|FG001|Phase I - Contralateral|incorrect randomization|1|||
146770216|NCT02537522|529327402|FG002|Phase I - Contralateral|incorrect randomization|0|||
146770217|NCT02537522|529327403|FG003|Phase I - Contralateral|incorrect randomization|0|||
146770218|NCT02537522|529327400|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
146770219|NCT02537522|529327401|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
146770220|NCT02537522|529327402|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
146770221|NCT02537522|529327403|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
146914722|NCT00469014|529850070|FG000|Initial Phase Randomization|No Response|1|||
146914723|NCT00469014|529850071|FG001|Initial Phase Randomization|No Response|0|||
146914724|NCT00469014|529850072|FG002|Initial Phase Randomization|No Response|0|||
146914725|NCT00469014|529850073|FG003|Initial Phase Randomization|No Response|1|||
146914726|NCT00469014|529850070|FG000|Adaptive Randomization|Not Evaluable|1|||
146914727|NCT00469014|529850071|FG001|Adaptive Randomization|Not Evaluable|0|||
146914728|NCT00469014|529850072|FG002|Adaptive Randomization|Not Evaluable|0|||
146914729|NCT00469014|529850073|FG003|Adaptive Randomization|Not Evaluable|1|||
146914730|NCT00469014|529850070|FG000|Adaptive Randomization|No Response|0|||
146569010|NCT01904721|528595523|FG000|Overall Study|Other Reasons|0|||
146569011|NCT01904721|528595524|FG001|Overall Study|Other Reasons|0|||
146569012|NCT01904721|528595525|FG002|Overall Study|Other Reasons|1|||
146569013|NCT01904721|528595526|FG003|Overall Study|Other Reasons|1|||
146569014|NCT01904721|528595527|FG004|Overall Study|Other Reasons|2|||
146569015|NCT01904721|528595528|FG005|Overall Study|Other Reasons|2|||
146569016|NCT01904721|528595529|FG006|Overall Study|Other Reasons|2|||
146569017|NCT01904721|528595523|FG000|Overall Study|Personal Reasons|0|||
146569018|NCT01904721|528595524|FG001|Overall Study|Personal Reasons|0|||
146569019|NCT01904721|528595525|FG002|Overall Study|Personal Reasons|0|||
146569020|NCT01904721|528595526|FG003|Overall Study|Personal Reasons|0|||
146569021|NCT01904721|528595527|FG004|Overall Study|Personal Reasons|2|||
146569022|NCT01904721|528595528|FG005|Overall Study|Personal Reasons|3|||
146975865|NCT03118765|530075648|FG001|Overall Study|Sponsor Decision|0|||
146975866|NCT03118765|530075649|FG002|Overall Study|Sponsor Decision|1|||
146975867|NCT03118765|530075650|FG003|Overall Study|Sponsor Decision|0|||
146975868|NCT03118765|530075651|FG004|Overall Study|Sponsor Decision|1|||
146975869|NCT01612702|530075652|FG000|Overall Study|Protocol Violation|11|||
146975870|NCT01612702|530075653|FG001|Overall Study|Protocol Violation|11|||
146975871|NCT03674827|530075654|FG000|Treatment Phase|Adverse Event|0|||
146975872|NCT03674827|530075655|FG001|Treatment Phase|Adverse Event|0|||
146975873|NCT03674827|530075656|FG002|Treatment Phase|Adverse Event|0|||
146975874|NCT03674827|530075657|FG003|Treatment Phase|Adverse Event|0|||
146975875|NCT03674827|530075658|FG004|Treatment Phase|Adverse Event|0|||
146975876|NCT03674827|530075659|FG005|Treatment Phase|Adverse Event|2|||
146975877|NCT03674827|530075654|FG000|Treatment Phase|Death|2|||
146975878|NCT03674827|530075655|FG001|Treatment Phase|Death|0|||
146975879|NCT03674827|530075656|FG002|Treatment Phase|Death|0|||
146975880|NCT03674827|530075657|FG003|Treatment Phase|Death|0|||
146975881|NCT03674827|530075658|FG004|Treatment Phase|Death|1|||
146975882|NCT03674827|530075659|FG005|Treatment Phase|Death|0|||
146975883|NCT03674827|530075654|FG000|Treatment Phase|Progressive Disease|0|||
146975884|NCT03674827|530075655|FG001|Treatment Phase|Progressive Disease|4|||
146975885|NCT03674827|530075656|FG002|Treatment Phase|Progressive Disease|3|||
146975886|NCT03674827|530075657|FG003|Treatment Phase|Progressive Disease|4|||
146975887|NCT03674827|530075658|FG004|Treatment Phase|Progressive Disease|4|||
146975888|NCT03674827|530075659|FG005|Treatment Phase|Progressive Disease|9|||
146975889|NCT03674827|530075654|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
146975890|NCT03674827|530075655|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
146770222|NCT02537522|529327400|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
146770223|NCT02537522|529327401|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
146975891|NCT03674827|530075656|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
146975892|NCT03674827|530075657|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
146975893|NCT03674827|530075658|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
146975894|NCT03674827|530075659|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
146975895|NCT03674827|530075654|FG000|Treatment Phase|Withdrawal by Subject|0|||
146975896|NCT03674827|530075655|FG001|Treatment Phase|Withdrawal by Subject|0|||
146975897|NCT03674827|530075656|FG002|Treatment Phase|Withdrawal by Subject|0|||
146975898|NCT03674827|530075657|FG003|Treatment Phase|Withdrawal by Subject|0|||
146975899|NCT03674827|530075658|FG004|Treatment Phase|Withdrawal by Subject|0|||
146975900|NCT03674827|530075659|FG005|Treatment Phase|Withdrawal by Subject|1|||
146975901|NCT03674827|530075654|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
146975902|NCT03674827|530075655|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
146975903|NCT03674827|530075656|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
146975904|NCT03674827|530075657|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
146770224|NCT02537522|529327402|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
146770225|NCT02537522|529327403|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
146770226|NCT05001945|529327406|FG000|Overall Study|Adverse Event|0|||
146770227|NCT05001945|529327407|FG001|Overall Study|Adverse Event|0|||
146770228|NCT05001945|529327408|FG002|Overall Study|Adverse Event|0|||
146770229|NCT05001945|529327409|FG003|Overall Study|Adverse Event|1|||
146770230|NCT05001945|529327410|FG004|Overall Study|Adverse Event|0|||
146770231|NCT05001945|529327411|FG005|Overall Study|Adverse Event|0|||
146770232|NCT05001945|529327412|FG006|Overall Study|Adverse Event|0|||
146770233|NCT05001945|529327413|FG007|Overall Study|Adverse Event|0|||
146770234|NCT05001945|529327406|FG000|Overall Study|Lost to Follow-up|0|||
146770235|NCT05001945|529327407|FG001|Overall Study|Lost to Follow-up|1|||
146770236|NCT05001945|529327408|FG002|Overall Study|Lost to Follow-up|1|||
146770237|NCT05001945|529327409|FG003|Overall Study|Lost to Follow-up|2|||
146770238|NCT05001945|529327410|FG004|Overall Study|Lost to Follow-up|0|||
146770239|NCT05001945|529327411|FG005|Overall Study|Lost to Follow-up|1|||
146770240|NCT05001945|529327412|FG006|Overall Study|Lost to Follow-up|0|||
146975905|NCT03674827|530075658|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
146975906|NCT03674827|530075659|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
146975907|NCT03674827|530075654|FG000|Treatment Phase|Other|0|||
146975908|NCT03674827|530075655|FG001|Treatment Phase|Other|1|||
146975909|NCT03674827|530075656|FG002|Treatment Phase|Other|0|||
146975910|NCT03674827|530075657|FG003|Treatment Phase|Other|0|||
146975911|NCT03674827|530075658|FG004|Treatment Phase|Other|0|||
146975912|NCT03674827|530075659|FG005|Treatment Phase|Other|1|||
146770241|NCT05001945|529327413|FG007|Overall Study|Lost to Follow-up|0|||
146770242|NCT05001945|529327406|FG000|Overall Study|Protocol Violation|1|||
146770243|NCT05001945|529327407|FG001|Overall Study|Protocol Violation|0|||
146770244|NCT05001945|529327408|FG002|Overall Study|Protocol Violation|1|||
146770245|NCT05001945|529327409|FG003|Overall Study|Protocol Violation|1|||
146770246|NCT05001945|529327410|FG004|Overall Study|Protocol Violation|0|||
146770247|NCT05001945|529327411|FG005|Overall Study|Protocol Violation|1|||
146770248|NCT05001945|529327412|FG006|Overall Study|Protocol Violation|0|||
146770249|NCT05001945|529327413|FG007|Overall Study|Protocol Violation|0|||
146975913|NCT03674827|530075654|FG000|Long-Term Follow-up Phase|Death|2|||
146975914|NCT03674827|530075655|FG001|Long-Term Follow-up Phase|Death|4|||
146650268|NCT02446171|528896709|FG002|Overall Study|Withdrawal by Subject|2|||
146650269|NCT02446171|528896710|FG003|Overall Study|Withdrawal by Subject|0|||
146650270|NCT01142089|528896711|FG000|Overall Study|Physician Decision|1|||
146650271|NCT01142089|528896712|FG001|Overall Study|Physician Decision|0|||
146650272|NCT01142089|528896711|FG000|Overall Study|Withdrawal by Subject|1|||
146650273|NCT01142089|528896712|FG001|Overall Study|Withdrawal by Subject|2|||
146650274|NCT01142089|528896711|FG000|Overall Study|Use of prohibited medications|0|||
146650275|NCT01142089|528896712|FG001|Overall Study|Use of prohibited medications|1|||
146914731|NCT00469014|529850071|FG001|Adaptive Randomization|No Response|1|||
146914732|NCT00469014|529850072|FG002|Adaptive Randomization|No Response|0|||
146914733|NCT00469014|529850073|FG003|Adaptive Randomization|No Response|0|||
146914734|NCT00469014|529850070|FG000|Adaptive Randomization|Death|0|||
146914735|NCT00469014|529850071|FG001|Adaptive Randomization|Death|0|||
146914736|NCT00469014|529850072|FG002|Adaptive Randomization|Death|1|||
146914737|NCT00469014|529850073|FG003|Adaptive Randomization|Death|0|||
146914738|NCT00864227|529850074|FG000|Overall Study|Withdrawal by Subject|1|||
146914739|NCT00864227|529850074|FG000|Overall Study|Disease Relapse/Progression|3|||
146914740|NCT00866294|529850077|FG000|Overall Study|Adverse Event|12|||
146914741|NCT00866294|529850078|FG001|Overall Study|Adverse Event|13|||
146914742|NCT00866294|529850079|FG002|Overall Study|Adverse Event|9|||
146914743|NCT00866294|529850077|FG000|Overall Study|Lack of Efficacy|7|||
146914744|NCT00866294|529850078|FG001|Overall Study|Lack of Efficacy|1|||
146914745|NCT00866294|529850079|FG002|Overall Study|Lack of Efficacy|0|||
146914746|NCT00866294|529850077|FG000|Overall Study|Protocol Violation|2|||
146914747|NCT00866294|529850078|FG001|Overall Study|Protocol Violation|0|||
146914748|NCT00866294|529850079|FG002|Overall Study|Protocol Violation|0|||
146914749|NCT00866294|529850077|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
146914750|NCT00866294|529850078|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
146914751|NCT00866294|529850079|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
146914752|NCT00866294|529850077|FG000|Overall Study|Lost to Follow-up|1|||
146914753|NCT00866294|529850078|FG001|Overall Study|Lost to Follow-up|3|||
146914754|NCT00866294|529850079|FG002|Overall Study|Lost to Follow-up|0|||
146914755|NCT00866294|529850077|FG000|Overall Study|Physician Decision|6|||
146914756|NCT00866294|529850078|FG001|Overall Study|Physician Decision|2|||
146914757|NCT00866294|529850079|FG002|Overall Study|Physician Decision|1|||
146914758|NCT03241173|529850080|FG000|Overall Study|Death|3|||
146914759|NCT03241173|529850081|FG001|Overall Study|Death|2|||
146914760|NCT03241173|529850082|FG002|Overall Study|Death|4|||
146914761|NCT03241173|529850083|FG003|Overall Study|Death|4|||
146914762|NCT03241173|529850084|FG004|Overall Study|Death|2|||
146914763|NCT03241173|529850085|FG005|Overall Study|Death|2|||
146914764|NCT03241173|529850086|FG006|Overall Study|Death|3|||
146914765|NCT03241173|529850087|FG007|Overall Study|Death|1|||
146914766|NCT03241173|529850088|FG008|Overall Study|Death|0|||
146914767|NCT03241173|529850089|FG009|Overall Study|Death|5|||
146914768|NCT03241173|529850090|FG010|Overall Study|Death|4|||
146914769|NCT03241173|529850091|FG011|Overall Study|Death|3|||
146914770|NCT03241173|529850092|FG012|Overall Study|Death|0|||
146914771|NCT03241173|529850093|FG013|Overall Study|Death|0|||
146914772|NCT03241173|529850094|FG014|Overall Study|Death|0|||
146914773|NCT03241173|529850080|FG000|Overall Study|Withdrawal by Subject|0|||
146914774|NCT03241173|529850081|FG001|Overall Study|Withdrawal by Subject|0|||
146914775|NCT03241173|529850082|FG002|Overall Study|Withdrawal by Subject|1|||
146914776|NCT03241173|529850083|FG003|Overall Study|Withdrawal by Subject|0|||
146914777|NCT03241173|529850084|FG004|Overall Study|Withdrawal by Subject|0|||
146914778|NCT03241173|529850085|FG005|Overall Study|Withdrawal by Subject|1|||
146914779|NCT03241173|529850086|FG006|Overall Study|Withdrawal by Subject|0|||
146914780|NCT03241173|529850087|FG007|Overall Study|Withdrawal by Subject|0|||
146914781|NCT03241173|529850088|FG008|Overall Study|Withdrawal by Subject|0|||
146914782|NCT03241173|529850089|FG009|Overall Study|Withdrawal by Subject|0|||
146914783|NCT03241173|529850090|FG010|Overall Study|Withdrawal by Subject|0|||
146914784|NCT03241173|529850091|FG011|Overall Study|Withdrawal by Subject|0|||
146914785|NCT03241173|529850092|FG012|Overall Study|Withdrawal by Subject|0|||
146914786|NCT03241173|529850093|FG013|Overall Study|Withdrawal by Subject|0|||
146914787|NCT03241173|529850094|FG014|Overall Study|Withdrawal by Subject|0|||
146914788|NCT03241173|529850080|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
146914789|NCT03241173|529850081|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
146914790|NCT03241173|529850082|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
146914791|NCT03241173|529850083|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
146650276|NCT01142089|528896711|FG000|Overall Study|Noncompliance with study procedures|2|||
146914792|NCT03241173|529850084|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
146650277|NCT01142089|528896712|FG001|Overall Study|Noncompliance with study procedures|1|||
146650278|NCT01142089|528896711|FG000|Overall Study|Patient required rescue medication|8|||
146914793|NCT03241173|529850085|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
146914794|NCT03241173|529850086|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
146975915|NCT03674827|530075656|FG002|Long-Term Follow-up Phase|Death|2|||
146975916|NCT03674827|530075657|FG003|Long-Term Follow-up Phase|Death|3|||
146975917|NCT03674827|530075658|FG004|Long-Term Follow-up Phase|Death|2|||
146975918|NCT03674827|530075659|FG005|Long-Term Follow-up Phase|Death|6|||
146975919|NCT03674827|530075654|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
146975920|NCT03674827|530075655|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
146975921|NCT03674827|530075656|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
146975922|NCT03674827|530075657|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
146975923|NCT03674827|530075658|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
146975924|NCT03674827|530075659|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
146975925|NCT03674827|530075654|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
146975926|NCT03674827|530075655|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
146975927|NCT03674827|530075656|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
146975928|NCT03674827|530075657|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
146975929|NCT03674827|530075658|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
146975930|NCT03674827|530075659|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
146975931|NCT00527397|530075660|FG000|Overall Study|Adverse Event|3|||
146975932|NCT00527397|530075660|FG000|Overall Study|Lack of Efficacy|1|||
146975933|NCT00527397|530075660|FG000|Overall Study|Protocol Violation|1|||
146975934|NCT00527397|530075660|FG000|Overall Study|Withdrawal by Subject|6|||
146975935|NCT00527397|530075660|FG000|Overall Study|Study terminated by sponsor|13|||
146975936|NCT04130919|530075663|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
146975937|NCT04130919|530075664|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
146975938|NCT04130919|530075665|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
146975939|NCT04130919|530075666|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
146975940|NCT04130919|530075667|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
146975941|NCT04130919|530075668|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
146975942|NCT04130919|530075663|FG000|Blinded Treatment Phase|Adverse Event|0|||
146975943|NCT04130919|530075664|FG001|Blinded Treatment Phase|Adverse Event|0|||
146975944|NCT04130919|530075665|FG002|Blinded Treatment Phase|Adverse Event|1|||
146975945|NCT04130919|530075666|FG003|Blinded Treatment Phase|Adverse Event|0|||
146975946|NCT04130919|530075667|FG004|Blinded Treatment Phase|Adverse Event|0|||
146975947|NCT04130919|530075668|FG005|Blinded Treatment Phase|Adverse Event|0|||
146975948|NCT04130919|530075663|FG000|Blinded Treatment Phase|Disease worsening|0|||
146975949|NCT04130919|530075664|FG001|Blinded Treatment Phase|Disease worsening|0|||
146975950|NCT04130919|530075665|FG002|Blinded Treatment Phase|Disease worsening|1|||
146975951|NCT04130919|530075666|FG003|Blinded Treatment Phase|Disease worsening|0|||
146975952|NCT04130919|530075667|FG004|Blinded Treatment Phase|Disease worsening|0|||
146975953|NCT04130919|530075668|FG005|Blinded Treatment Phase|Disease worsening|0|||
146975954|NCT04130919|530075663|FG000|Blinded Treatment Phase|Investigator's decision|0|||
146975955|NCT04130919|530075664|FG001|Blinded Treatment Phase|Investigator's decision|1|||
146975956|NCT04130919|530075665|FG002|Blinded Treatment Phase|Investigator's decision|0|||
146975957|NCT04130919|530075666|FG003|Blinded Treatment Phase|Investigator's decision|0|||
146975958|NCT04130919|530075667|FG004|Blinded Treatment Phase|Investigator's decision|0|||
146975959|NCT04130919|530075668|FG005|Blinded Treatment Phase|Investigator's decision|0|||
146975960|NCT04130919|530075663|FG000|Blinded Treatment Phase|Withdrew consent|1|||
146975961|NCT04130919|530075664|FG001|Blinded Treatment Phase|Withdrew consent|0|||
146975962|NCT04130919|530075665|FG002|Blinded Treatment Phase|Withdrew consent|0|||
146975963|NCT04130919|530075666|FG003|Blinded Treatment Phase|Withdrew consent|0|||
146975964|NCT04130919|530075667|FG004|Blinded Treatment Phase|Withdrew consent|0|||
146975965|NCT04130919|530075668|FG005|Blinded Treatment Phase|Withdrew consent|0|||
146975966|NCT04130919|530075663|FG000|Open-label Treatment Phase|Withdrew consent|0|||
146975967|NCT04130919|530075664|FG001|Open-label Treatment Phase|Withdrew consent|0|||
146975968|NCT04130919|530075665|FG002|Open-label Treatment Phase|Withdrew consent|0|||
146975969|NCT04130919|530075666|FG003|Open-label Treatment Phase|Withdrew consent|1|||
146975970|NCT04130919|530075667|FG004|Open-label Treatment Phase|Withdrew consent|1|||
146975971|NCT04130919|530075668|FG005|Open-label Treatment Phase|Withdrew consent|1|||
146975972|NCT04130919|530075663|FG000|Open-label Treatment Phase|Disease worsening|0|||
146975973|NCT04130919|530075664|FG001|Open-label Treatment Phase|Disease worsening|0|||
146975974|NCT04130919|530075665|FG002|Open-label Treatment Phase|Disease worsening|0|||
146975975|NCT04130919|530075666|FG003|Open-label Treatment Phase|Disease worsening|1|||
146975976|NCT04130919|530075667|FG004|Open-label Treatment Phase|Disease worsening|0|||
146975977|NCT04130919|530075668|FG005|Open-label Treatment Phase|Disease worsening|1|||
146975978|NCT04130919|530075663|FG000|Open-label Treatment Phase|Investigator's decision|0|||
146975979|NCT04130919|530075664|FG001|Open-label Treatment Phase|Investigator's decision|0|||
146975980|NCT04130919|530075665|FG002|Open-label Treatment Phase|Investigator's decision|0|||
146975981|NCT04130919|530075666|FG003|Open-label Treatment Phase|Investigator's decision|1|||
146975982|NCT04130919|530075667|FG004|Open-label Treatment Phase|Investigator's decision|0|||
146975983|NCT04130919|530075668|FG005|Open-label Treatment Phase|Investigator's decision|0|||
146975984|NCT04130919|530075663|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
146975985|NCT04130919|530075664|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
146569023|NCT01904721|528595529|FG006|Overall Study|Personal Reasons|3|||
146650279|NCT01142089|528896712|FG001|Overall Study|Patient required rescue medication|17|||
146650280|NCT02907892|528896717|FG000|Overall Study|Lost to Follow-up|27|||
146650281|NCT02907892|528896718|FG001|Overall Study|Lost to Follow-up|40|||
146650282|NCT01974765|528896719|FG000|Overall Study|Withdrawal by Subject|1|||
146650283|NCT01974765|528896719|FG000|Overall Study|Death|1|||
146650284|NCT01974765|528896719|FG000|Overall Study|Adverse Event|2|||
146975986|NCT04130919|530075665|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
146975987|NCT04130919|530075666|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
146975988|NCT04130919|530075667|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
146975989|NCT04130919|530075668|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
146975990|NCT04130919|530075663|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
146975991|NCT04130919|530075664|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
146975992|NCT04130919|530075665|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
146975993|NCT04130919|530075666|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
146975994|NCT04130919|530075667|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
146975995|NCT04130919|530075668|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
146975996|NCT02400905|530075669|FG000|Overall Study|Death|24|||
146975997|NCT02400905|530075669|FG000|Overall Study|Lost to Follow-up|18|||
146975998|NCT02400905|530075669|FG000|Overall Study|Withdrawal by Subject|16|||
146975999|NCT02400905|530075669|FG000|Overall Study|Physician Decision|4|||
146976000|NCT02400905|530075669|FG000|Overall Study|Other|1|||
146976001|NCT00061945|530075672|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
146976002|NCT00061945|530075673|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
146976003|NCT00061945|530075672|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
146976004|NCT00061945|530075673|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
146976005|NCT00061945|530075672|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
146976006|NCT00061945|530075673|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
146976007|NCT00061945|530075672|FG000|Course IV: Alemtuzumab|Early exits|6|||
146976008|NCT00061945|530075673|FG001|Course IV: Alemtuzumab|Early exits|15|||
146976009|NCT01039584|530075674|FG000|Overall Study|Withdrawal by Subject|4|||
146976010|NCT01039584|530075675|FG001|Overall Study|Withdrawal by Subject|2|||
146976011|NCT01039584|530075676|FG002|Overall Study|Withdrawal by Subject|1|||
146976012|NCT01039584|530075674|FG000|Overall Study|Protocol Violation|10|||
146976013|NCT01039584|530075675|FG001|Overall Study|Protocol Violation|4|||
146976014|NCT01039584|530075676|FG002|Overall Study|Protocol Violation|6|||
146976015|NCT01039584|530075674|FG000|Overall Study|Lost to Follow-up|5|||
146976016|NCT01039584|530075675|FG001|Overall Study|Lost to Follow-up|3|||
146569024|NCT01904721|528595523|FG000|Overall Study|Lost to Follow-up|0|||
146569025|NCT01904721|528595524|FG001|Overall Study|Lost to Follow-up|0|||
146569026|NCT01904721|528595525|FG002|Overall Study|Lost to Follow-up|0|||
146569027|NCT01904721|528595526|FG003|Overall Study|Lost to Follow-up|0|||
146569028|NCT01904721|528595527|FG004|Overall Study|Lost to Follow-up|1|||
146569029|NCT01904721|528595528|FG005|Overall Study|Lost to Follow-up|3|||
146569030|NCT01904721|528595529|FG006|Overall Study|Lost to Follow-up|1|||
146569031|NCT01904721|528595523|FG000|Overall Study|Lack of Efficacy|0|||
146569032|NCT01904721|528595524|FG001|Overall Study|Lack of Efficacy|0|||
146569033|NCT01904721|528595525|FG002|Overall Study|Lack of Efficacy|0|||
146569034|NCT01904721|528595526|FG003|Overall Study|Lack of Efficacy|0|||
146569035|NCT01904721|528595527|FG004|Overall Study|Lack of Efficacy|0|||
146569036|NCT01904721|528595528|FG005|Overall Study|Lack of Efficacy|0|||
146569037|NCT01904721|528595529|FG006|Overall Study|Lack of Efficacy|1|||
146569038|NCT01904721|528595523|FG000|Overall Study|Adverse Event|0|||
146569039|NCT01904721|528595524|FG001|Overall Study|Adverse Event|0|||
146569040|NCT01904721|528595525|FG002|Overall Study|Adverse Event|0|||
146569041|NCT01904721|528595526|FG003|Overall Study|Adverse Event|0|||
146569042|NCT01904721|528595527|FG004|Overall Study|Adverse Event|3|||
146569043|NCT01904721|528595528|FG005|Overall Study|Adverse Event|1|||
146569044|NCT01904721|528595529|FG006|Overall Study|Adverse Event|0|||
146569045|NCT01957865|528595530|FG000|Overall Study|Found HIV negative|0|||
146569046|NCT01957865|528595531|FG001|Overall Study|Found HIV negative|0|||
146650285|NCT03328182|528896722|FG000|Overall Study|Withdrawal by Subject|1|||
146976017|NCT01039584|530075676|FG002|Overall Study|Lost to Follow-up|4|||
146976018|NCT01039584|530075674|FG000|Overall Study|Negative Baseline culture for Candida|59|||
146976019|NCT01039584|530075675|FG001|Overall Study|Negative Baseline culture for Candida|59|||
146976020|NCT01039584|530075676|FG002|Overall Study|Negative Baseline culture for Candida|24|||
146976021|NCT01039584|530075674|FG000|Overall Study|Lack of Efficacy|7|||
146569047|NCT01957865|528595532|FG002|Overall Study|Found HIV negative|1|||
146569048|NCT01957865|528595530|FG000|Overall Study|Lost to Follow-up|0|||
146569049|NCT01957865|528595531|FG001|Overall Study|Lost to Follow-up|2|||
146569050|NCT01957865|528595532|FG002|Overall Study|Lost to Follow-up|2|||
146569051|NCT00811720|528595536|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
146650286|NCT03328182|528896722|FG000|Overall Study|Protocol Violation|2|||
146569052|NCT00811720|528595537|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
146650287|NCT03328182|528896722|FG000|Overall Study|No Product Evaluated|1|||
146914795|NCT03241173|529850087|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
146914796|NCT03241173|529850088|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
146914797|NCT03241173|529850089|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
146569053|NCT00811720|528595536|FG000|All Treated Patients|Adverse Event|20|||
146569054|NCT00811720|528595537|FG001|All Treated Patients|Adverse Event|62|||
146569055|NCT00811720|528595536|FG000|All Treated Patients|Lack of Efficacy|22|||
146569056|NCT00811720|528595537|FG001|All Treated Patients|Lack of Efficacy|18|||
146569057|NCT00811720|528595536|FG000|All Treated Patients|Non-compliance|0|||
146770250|NCT05001945|529327406|FG000|Overall Study|Withdrawal by Subject|0|||
146976022|NCT01039584|530075675|FG001|Overall Study|Lack of Efficacy|6|||
146976023|NCT01039584|530075676|FG002|Overall Study|Lack of Efficacy|10|||
146976024|NCT01039584|530075674|FG000|Overall Study|other|1|||
146976025|NCT01039584|530075675|FG001|Overall Study|other|3|||
146976026|NCT01039584|530075676|FG002|Overall Study|other|1|||
146914798|NCT03241173|529850090|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
146976027|NCT01039584|530075674|FG000|Overall Study|Pap smear with significant pathology|10|||
146976028|NCT01039584|530075675|FG001|Overall Study|Pap smear with significant pathology|10|||
146976029|NCT01039584|530075676|FG002|Overall Study|Pap smear with significant pathology|3|||
146976030|NCT01039584|530075674|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
146976031|NCT01039584|530075675|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
146976032|NCT01039584|530075676|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
146976033|NCT03672396|530075679|FG000|Overall Study|Withdrawal by Subject|4|||
146976034|NCT03672396|530075679|FG000|Overall Study|Physician Decision|1|||
146976035|NCT03672396|530075679|FG000|Overall Study|Adverse Event|1|||
146976036|NCT04380701|530075682|FG000|Overall Study|Pregnancy|0|||
146976037|NCT04380701|530075683|FG001|Overall Study|Pregnancy|0|||
146976038|NCT04380701|530075684|FG002|Overall Study|Pregnancy|0|||
146976039|NCT04380701|530075685|FG003|Overall Study|Pregnancy|0|||
146976040|NCT04380701|530075686|FG004|Overall Study|Pregnancy|0|||
146976041|NCT04380701|530075687|FG005|Overall Study|Pregnancy|0|||
146976042|NCT04380701|530075688|FG006|Overall Study|Pregnancy|0|||
146976043|NCT04380701|530075689|FG007|Overall Study|Pregnancy|0|||
146976044|NCT04380701|530075690|FG008|Overall Study|Pregnancy|0|||
146976045|NCT04380701|530075691|FG009|Overall Study|Pregnancy|0|||
146976046|NCT04380701|530075692|FG010|Overall Study|Pregnancy|0|||
146976047|NCT04380701|530075693|FG011|Overall Study|Pregnancy|0|||
146976048|NCT04380701|530075694|FG012|Overall Study|Pregnancy|0|||
146976049|NCT04380701|530075695|FG013|Overall Study|Pregnancy|0|||
146976050|NCT04380701|530075696|FG014|Overall Study|Pregnancy|0|||
146976051|NCT04380701|530075697|FG015|Overall Study|Pregnancy|0|||
146976052|NCT04380701|530075698|FG016|Overall Study|Pregnancy|0|||
146976053|NCT04380701|530075699|FG017|Overall Study|Pregnancy|0|||
146976054|NCT04380701|530075700|FG018|Overall Study|Pregnancy|0|||
146976055|NCT04380701|530075701|FG019|Overall Study|Pregnancy|0|||
146976056|NCT04380701|530075702|FG020|Overall Study|Pregnancy|0|||
146976057|NCT04380701|530075703|FG021|Overall Study|Pregnancy|0|||
146976058|NCT04380701|530075704|FG022|Overall Study|Pregnancy|0|||
146976059|NCT04380701|530075705|FG023|Overall Study|Pregnancy|0|||
146976060|NCT04380701|530075706|FG024|Overall Study|Pregnancy|0|||
146976061|NCT04380701|530075707|FG025|Overall Study|Pregnancy|0|||
146976062|NCT04380701|530075708|FG026|Overall Study|Pregnancy|0|||
146976063|NCT04380701|530075709|FG027|Overall Study|Pregnancy|0|||
146976064|NCT04380701|530075710|FG028|Overall Study|Pregnancy|0|||
146976065|NCT04380701|530075711|FG029|Overall Study|Pregnancy|0|||
146976066|NCT04380701|530075712|FG030|Overall Study|Pregnancy|0|||
146770251|NCT05001945|529327407|FG001|Overall Study|Withdrawal by Subject|0|||
146914799|NCT03241173|529850091|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
146914800|NCT03241173|529850092|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
146914801|NCT03241173|529850093|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
146976067|NCT04380701|530075713|FG031|Overall Study|Pregnancy|0|||
146976068|NCT04380701|530075714|FG032|Overall Study|Pregnancy|1|||
146976069|NCT04380701|530075715|FG033|Overall Study|Pregnancy|0|||
146976070|NCT04380701|530075682|FG000|Overall Study|Lost to Follow-up|0|||
146976071|NCT04380701|530075683|FG001|Overall Study|Lost to Follow-up|0|||
146976072|NCT04380701|530075684|FG002|Overall Study|Lost to Follow-up|0|||
146976073|NCT04380701|530075685|FG003|Overall Study|Lost to Follow-up|0|||
146569058|NCT00811720|528595537|FG001|All Treated Patients|Non-compliance|14|||
146976074|NCT04380701|530075686|FG004|Overall Study|Lost to Follow-up|0|||
146770252|NCT05001945|529327408|FG002|Overall Study|Withdrawal by Subject|0|||
146976075|NCT04380701|530075687|FG005|Overall Study|Lost to Follow-up|0|||
146976076|NCT04380701|530075688|FG006|Overall Study|Lost to Follow-up|0|||
146976077|NCT04380701|530075689|FG007|Overall Study|Lost to Follow-up|0|||
146569059|NCT00811720|528595536|FG000|All Treated Patients|Protocol Violation|9|||
146976078|NCT04380701|530075690|FG008|Overall Study|Lost to Follow-up|0|||
146976079|NCT04380701|530075691|FG009|Overall Study|Lost to Follow-up|0|||
146976080|NCT04380701|530075692|FG010|Overall Study|Lost to Follow-up|0|||
146976081|NCT04380701|530075693|FG011|Overall Study|Lost to Follow-up|0|||
146976082|NCT04380701|530075694|FG012|Overall Study|Lost to Follow-up|0|||
146976083|NCT04380701|530075695|FG013|Overall Study|Lost to Follow-up|0|||
146770253|NCT05001945|529327409|FG003|Overall Study|Withdrawal by Subject|1|||
146770254|NCT05001945|529327410|FG004|Overall Study|Withdrawal by Subject|1|||
146770255|NCT05001945|529327411|FG005|Overall Study|Withdrawal by Subject|1|||
146770256|NCT05001945|529327412|FG006|Overall Study|Withdrawal by Subject|0|||
146770257|NCT05001945|529327413|FG007|Overall Study|Withdrawal by Subject|1|||
146770258|NCT05001945|529327406|FG000|Overall Study|Not specified by Investigator|0|||
146770259|NCT05001945|529327407|FG001|Overall Study|Not specified by Investigator|3|||
146770260|NCT05001945|529327408|FG002|Overall Study|Not specified by Investigator|0|||
146770261|NCT05001945|529327409|FG003|Overall Study|Not specified by Investigator|0|||
146770262|NCT05001945|529327410|FG004|Overall Study|Not specified by Investigator|1|||
146770263|NCT05001945|529327411|FG005|Overall Study|Not specified by Investigator|0|||
146770264|NCT05001945|529327412|FG006|Overall Study|Not specified by Investigator|0|||
146770265|NCT05001945|529327413|FG007|Overall Study|Not specified by Investigator|0|||
146770266|NCT02570711|529327414|FG000|Overall Study|Death|1|||
146770267|NCT02570711|529327415|FG001|Overall Study|Death|0|||
146770268|NCT02570711|529327414|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
146770269|NCT02570711|529327415|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
146770270|NCT00585533|529327416|FG000|Overall Study|objective or symptomatic progression|9|||
146770271|NCT03482011|529327417|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
146770272|NCT03482011|529327418|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
146770273|NCT03482011|529327419|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
146770274|NCT03482011|529327420|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
146770275|NCT03482011|529327421|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
146770276|NCT03482011|529327422|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
146770277|NCT03482011|529327423|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
146770278|NCT03482011|529327424|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
146770279|NCT03482011|529327417|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
146770280|NCT03482011|529327418|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
146770281|NCT03482011|529327419|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146770282|NCT03482011|529327420|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146770283|NCT03482011|529327421|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146770284|NCT03482011|529327422|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146770285|NCT03482011|529327423|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146770286|NCT03482011|529327424|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146770287|NCT03482011|529327417|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
146770288|NCT03482011|529327418|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
146770289|NCT03482011|529327419|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
146770290|NCT03482011|529327420|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
146770291|NCT03482011|529327421|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
146770292|NCT03482011|529327422|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
146770293|NCT03482011|529327423|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
146770294|NCT03482011|529327424|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
146770295|NCT03482011|529327417|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
146770296|NCT03482011|529327418|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
146770297|NCT03482011|529327419|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
146770298|NCT03482011|529327420|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
146770299|NCT03482011|529327421|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
146770300|NCT03482011|529327422|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
146770301|NCT03482011|529327423|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
146770302|NCT03482011|529327424|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
146770303|NCT03482011|529327417|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
146770304|NCT03482011|529327418|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
146770305|NCT03482011|529327419|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146770306|NCT03482011|529327420|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146770307|NCT03482011|529327421|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146770308|NCT03482011|529327422|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146770309|NCT03482011|529327423|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146770310|NCT03482011|529327424|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146770311|NCT03482011|529327417|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
146770312|NCT03482011|529327418|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
146770313|NCT03482011|529327419|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
146770314|NCT03482011|529327420|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
146770315|NCT03482011|529327421|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
146770316|NCT03482011|529327422|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
146770317|NCT03482011|529327423|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
146770318|NCT03482011|529327424|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
146770319|NCT03482011|529327417|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
146770320|NCT03482011|529327418|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
146770321|NCT03482011|529327419|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
146770322|NCT03482011|529327420|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
146770323|NCT03482011|529327421|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
146914802|NCT03241173|529850094|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
146914803|NCT03241173|529850080|FG000|Overall Study|Lost to Follow-up|0|||
146569060|NCT00811720|528595537|FG001|All Treated Patients|Protocol Violation|16|||
146569061|NCT00811720|528595536|FG000|All Treated Patients|Withdrawal by Subject|28|||
146569062|NCT00811720|528595537|FG001|All Treated Patients|Withdrawal by Subject|34|||
146569063|NCT00811720|528595536|FG000|All Treated Patients|Lost to Follow-up|10|||
146569064|NCT00811720|528595537|FG001|All Treated Patients|Lost to Follow-up|16|||
146569065|NCT00811720|528595536|FG000|All Treated Patients|Other Reason|7|||
146569066|NCT00811720|528595537|FG001|All Treated Patients|Other Reason|4|||
146569067|NCT01077063|528595538|FG000|Overall Study|Adverse Event|3|||
146569068|NCT01077063|528595539|FG001|Overall Study|Adverse Event|0|||
146569069|NCT01077063|528595538|FG000|Overall Study|Death|1|||
146569070|NCT01077063|528595539|FG001|Overall Study|Death|1|||
146569071|NCT01077063|528595538|FG000|Overall Study|Withdrawal by Subject|0|||
146914804|NCT03241173|529850081|FG001|Overall Study|Lost to Follow-up|0|||
146914805|NCT03241173|529850082|FG002|Overall Study|Lost to Follow-up|0|||
146914806|NCT03241173|529850083|FG003|Overall Study|Lost to Follow-up|0|||
146914807|NCT03241173|529850084|FG004|Overall Study|Lost to Follow-up|1|||
146914808|NCT03241173|529850085|FG005|Overall Study|Lost to Follow-up|0|||
146914809|NCT03241173|529850086|FG006|Overall Study|Lost to Follow-up|0|||
146914810|NCT03241173|529850087|FG007|Overall Study|Lost to Follow-up|0|||
146914811|NCT03241173|529850088|FG008|Overall Study|Lost to Follow-up|0|||
146914812|NCT03241173|529850089|FG009|Overall Study|Lost to Follow-up|1|||
146914813|NCT03241173|529850090|FG010|Overall Study|Lost to Follow-up|0|||
146914814|NCT03241173|529850091|FG011|Overall Study|Lost to Follow-up|0|||
146914815|NCT03241173|529850092|FG012|Overall Study|Lost to Follow-up|0|||
146914816|NCT03241173|529850093|FG013|Overall Study|Lost to Follow-up|0|||
146914817|NCT03241173|529850094|FG014|Overall Study|Lost to Follow-up|0|||
146914818|NCT01632878|529850095|FG000|Screening|Physician Decision|268|||
146914819|NCT01632878|529850095|FG000|Treatment|Lost to Follow-up|41|||
146914820|NCT01632878|529850095|FG000|Treatment|Withdrawal by Subject|36|||
146914821|NCT01632878|529850095|FG000|Treatment|Physician Decision|34|||
146914822|NCT01632878|529850095|FG000|Treatment|missing information|4|||
146914823|NCT01632878|529850095|FG000|Treatment|no information on study completion|43|||
146914824|NCT02119104|529850097|FG000|Overall Study|Protocol Violation|16|||
146914825|NCT00081289|529850100|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
146914826|NCT00081289|529850101|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
146914827|NCT00081289|529850100|FG000|Overall Study|Ineligible / no protocol treatment|3|||
146914828|NCT00081289|529850101|FG001|Overall Study|Ineligible / no protocol treatment|4|||
146914829|NCT01558089|529850102|FG000|Overall Study|Adverse Event|1|||
146914830|NCT01558089|529850102|FG000|Overall Study|Lack of Efficacy|1|||
146914831|NCT01558089|529850102|FG000|Overall Study|Lost to Follow-up|5|||
146914832|NCT01558089|529850102|FG000|Overall Study|Withdrawal by Subject|6|||
146914833|NCT00651118|529850111|FG000|Overall Study|Adverse Event|4|||
146914834|NCT00651118|529850112|FG001|Overall Study|Adverse Event|0|||
146914835|NCT00651118|529850113|FG002|Overall Study|Adverse Event|1|||
146914836|NCT00651118|529850114|FG003|Overall Study|Adverse Event|1|||
146914837|NCT00651118|529850111|FG000|Overall Study|Protocol Violation|2|||
146914838|NCT00651118|529850112|FG001|Overall Study|Protocol Violation|2|||
146914839|NCT00651118|529850113|FG002|Overall Study|Protocol Violation|6|||
146914840|NCT00651118|529850114|FG003|Overall Study|Protocol Violation|2|||
146914841|NCT00651118|529850111|FG000|Overall Study|Lost to Follow-up|2|||
146914842|NCT00651118|529850112|FG001|Overall Study|Lost to Follow-up|0|||
146914843|NCT00651118|529850113|FG002|Overall Study|Lost to Follow-up|1|||
146914844|NCT00651118|529850114|FG003|Overall Study|Lost to Follow-up|2|||
146914845|NCT00651118|529850111|FG000|Overall Study|administrative|1|||
146914846|NCT00651118|529850112|FG001|Overall Study|administrative|4|||
146914847|NCT00651118|529850113|FG002|Overall Study|administrative|2|||
146914848|NCT00651118|529850114|FG003|Overall Study|administrative|1|||
146914849|NCT00651118|529850111|FG000|Overall Study|Withdrawal by Subject|0|||
146914850|NCT00651118|529850112|FG001|Overall Study|Withdrawal by Subject|1|||
146914851|NCT00651118|529850113|FG002|Overall Study|Withdrawal by Subject|1|||
146914852|NCT00651118|529850114|FG003|Overall Study|Withdrawal by Subject|1|||
146914853|NCT00798967|529850117|FG000|Overall Study|Adverse Event|2|||
146914854|NCT00798967|529850118|FG001|Overall Study|Adverse Event|3|||
146914855|NCT00798967|529850117|FG000|Overall Study|Withdrawal by Subject|0|||
146914856|NCT00798967|529850118|FG001|Overall Study|Withdrawal by Subject|1|||
146914857|NCT00798967|529850117|FG000|Overall Study|Physician Decision|1|||
146569072|NCT01077063|528595539|FG001|Overall Study|Withdrawal by Subject|2|||
146569073|NCT02750930|528595540|FG000|Overall Study|Study closed/terminated|8|||
146914858|NCT00798967|529850118|FG001|Overall Study|Physician Decision|0|||
146914859|NCT00798967|529850117|FG000|Overall Study|Randomized in error by site|1|||
146914860|NCT00798967|529850118|FG001|Overall Study|Randomized in error by site|0|||
146914861|NCT03141307|529850121|FG000|In-Hospital|Withdrawal by Subject|0|||
146914862|NCT03141307|529850122|FG001|In-Hospital|Withdrawal by Subject|2|||
146914863|NCT03141307|529850121|FG000|In-Hospital|Protocol Violation|4|||
146914864|NCT03141307|529850122|FG001|In-Hospital|Protocol Violation|0|||
146914865|NCT03141307|529850121|FG000|Follow-Up|Lost to Follow-up|97|||
146914866|NCT03141307|529850122|FG001|Follow-Up|Lost to Follow-up|54|||
146914867|NCT00227877|529850123|FG000|Pre-visit Assessment|Technical difficulties|7|||
146914868|NCT00227877|529850124|FG001|Pre-visit Assessment|Technical difficulties|3|||
146914869|NCT00227877|529850125|FG002|Pre-visit Assessment|Technical difficulties|0|||
146914870|NCT00227877|529850126|FG003|Pre-visit Assessment|Technical difficulties|0|||
146914871|NCT00227877|529850123|FG000|Post-visit Checklist|Lost to Follow-up|24|||
146914872|NCT00227877|529850124|FG001|Post-visit Checklist|Lost to Follow-up|13|||
146914873|NCT00227877|529850125|FG002|Post-visit Checklist|Lost to Follow-up|1|||
146914874|NCT00227877|529850126|FG003|Post-visit Checklist|Lost to Follow-up|0|||
146914875|NCT00227877|529850123|FG000|3-months Follow-up|Completed late|135|||
146914876|NCT00227877|529850124|FG001|3-months Follow-up|Completed late|128|||
146914877|NCT00227877|529850125|FG002|3-months Follow-up|Completed late|34|||
146914878|NCT00227877|529850126|FG003|3-months Follow-up|Completed late|8|||
146914879|NCT00227877|529850123|FG000|3-months Follow-up|Lost to Follow-up|178|||
146914880|NCT00227877|529850124|FG001|3-months Follow-up|Lost to Follow-up|139|||
146914881|NCT00227877|529850125|FG002|3-months Follow-up|Lost to Follow-up|18|||
146914882|NCT00227877|529850126|FG003|3-months Follow-up|Lost to Follow-up|13|||
146914883|NCT00227877|529850123|FG000|12-months Follow-up|Completed late|78|||
146914884|NCT00227877|529850124|FG001|12-months Follow-up|Completed late|74|||
146914885|NCT00227877|529850125|FG002|12-months Follow-up|Completed late|1|||
146914886|NCT00227877|529850126|FG003|12-months Follow-up|Completed late|0|||
146914887|NCT00227877|529850123|FG000|12-months Follow-up|Lost to Follow-up|232|||
146914888|NCT00227877|529850124|FG001|12-months Follow-up|Lost to Follow-up|189|||
146914889|NCT00227877|529850125|FG002|12-months Follow-up|Lost to Follow-up|30|||
146914890|NCT00227877|529850126|FG003|12-months Follow-up|Lost to Follow-up|26|||
146914891|NCT03090737|529850127|FG000|Overall Study|Other reasons|1|||
146914892|NCT03090737|529850127|FG000|Overall Study|Completed treatment as per protocol|17|||
146914893|NCT03090737|529850127|FG000|Overall Study|Maximum clinical benefit|2|||
146914894|NCT03090737|529850127|FG000|Overall Study|Adverse event unrelated to study drug|7|||
146914895|NCT03090737|529850127|FG000|Overall Study|Study drug toxicity|4|||
146914896|NCT03090737|529850127|FG000|Overall Study|Disease progression|98|||
146914897|NCT03103750|529850130|FG000|Overall Study|Adverse Event|1|||
146914898|NCT03103750|529850131|FG001|Overall Study|Adverse Event|0|||
146914899|NCT03103750|529850130|FG000|Overall Study|Lost to Follow-up|1|||
146914900|NCT03103750|529850131|FG001|Overall Study|Lost to Follow-up|0|||
146914901|NCT03103750|529850130|FG000|Overall Study|PET Equipment Related|2|||
146914902|NCT03103750|529850131|FG001|Overall Study|PET Equipment Related|2|||
146914903|NCT01663740|529850132|FG000|Overall Study|Lost to Follow-up|1|||
146914904|NCT01663740|529850133|FG001|Overall Study|Lost to Follow-up|4|||
146914905|NCT01663740|529850132|FG000|Overall Study|Other|9|||
146914906|NCT01663740|529850133|FG001|Overall Study|Other|2|||
146914907|NCT01663740|529850132|FG000|Overall Study|Inclusion/Exclusion not met|1|||
146914908|NCT01663740|529850133|FG001|Overall Study|Inclusion/Exclusion not met|0|||
146914909|NCT01663740|529850132|FG000|Overall Study|Death|0|||
146914910|NCT01663740|529850133|FG001|Overall Study|Death|1|||
146914911|NCT01663740|529850132|FG000|Overall Study|Withdrawal by Subject|2|||
146914912|NCT01663740|529850133|FG001|Overall Study|Withdrawal by Subject|1|||
146914913|NCT01663740|529850132|FG000|Overall Study|No end of study status|3|||
146914914|NCT01663740|529850133|FG001|Overall Study|No end of study status|0|||
146914915|NCT02522481|529850134|FG000|Overall Study|discontinued|1|||
146914916|NCT02522481|529850134|FG000|Overall Study|Not dosed|2|||
146914917|NCT03123939|529850137|FG000|Overall Study|Lack of Efficacy|6|||
146914918|NCT03123939|529850137|FG000|Overall Study|Death|5|||
146914919|NCT03123939|529850137|FG000|Overall Study|Physician Decision|2|||
146914920|NCT03123939|529850137|FG000|Overall Study|Subject/guardian decision|2|||
146914921|NCT03123939|529850137|FG000|Overall Study|Lost to Follow-up|1|||
146914922|NCT03123939|529850137|FG000|Overall Study|New therapy for study indication|1|||
146914923|NCT03123939|529850137|FG000|Overall Study|Protocol deviation|1|||
146914924|NCT03123939|529850137|FG000|Overall Study|Progressive disease|18|||
146914925|NCT03123939|529850137|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
146914926|NCT03123939|529850137|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
146914927|NCT01522651|529850138|FG000|Overall Study|Adverse Event|3|||
146914928|NCT01522651|529850139|FG001|Overall Study|Adverse Event|4|||
146914929|NCT01522651|529850140|FG002|Overall Study|Adverse Event|4|||
146914930|NCT01522651|529850141|FG003|Overall Study|Adverse Event|5|||
146914931|NCT01522651|529850142|FG004|Overall Study|Adverse Event|4|||
146914932|NCT01522651|529850138|FG000|Overall Study|Cardioversion|1|||
146914933|NCT01522651|529850139|FG001|Overall Study|Cardioversion|0|||
146914934|NCT01522651|529850140|FG002|Overall Study|Cardioversion|0|||
146914935|NCT01522651|529850141|FG003|Overall Study|Cardioversion|0|||
146914936|NCT01522651|529850142|FG004|Overall Study|Cardioversion|0|||
146914937|NCT01522651|529850138|FG000|Overall Study|Device Malfunction|0|||
146914938|NCT01522651|529850139|FG001|Overall Study|Device Malfunction|1|||
146914939|NCT01522651|529850140|FG002|Overall Study|Device Malfunction|0|||
146914940|NCT01522651|529850141|FG003|Overall Study|Device Malfunction|0|||
146914941|NCT01522651|529850142|FG004|Overall Study|Device Malfunction|0|||
146914942|NCT01522651|529850138|FG000|Overall Study|Investigator's Discretion|0|||
146976084|NCT04380701|530075696|FG014|Overall Study|Lost to Follow-up|0|||
146976085|NCT04380701|530075697|FG015|Overall Study|Lost to Follow-up|0|||
146976086|NCT04380701|530075698|FG016|Overall Study|Lost to Follow-up|0|||
146976087|NCT04380701|530075699|FG017|Overall Study|Lost to Follow-up|0|||
146976088|NCT04380701|530075700|FG018|Overall Study|Lost to Follow-up|0|||
146976089|NCT04380701|530075701|FG019|Overall Study|Lost to Follow-up|0|||
146976090|NCT04380701|530075702|FG020|Overall Study|Lost to Follow-up|1|||
146976091|NCT04380701|530075703|FG021|Overall Study|Lost to Follow-up|0|||
146976092|NCT04380701|530075704|FG022|Overall Study|Lost to Follow-up|0|||
146976093|NCT04380701|530075705|FG023|Overall Study|Lost to Follow-up|1|||
146976094|NCT04380701|530075706|FG024|Overall Study|Lost to Follow-up|0|||
146976095|NCT04380701|530075707|FG025|Overall Study|Lost to Follow-up|0|||
146976096|NCT04380701|530075708|FG026|Overall Study|Lost to Follow-up|0|||
146976097|NCT04380701|530075709|FG027|Overall Study|Lost to Follow-up|0|||
146976098|NCT04380701|530075710|FG028|Overall Study|Lost to Follow-up|0|||
146976099|NCT04380701|530075711|FG029|Overall Study|Lost to Follow-up|1|||
146976100|NCT04380701|530075712|FG030|Overall Study|Lost to Follow-up|0|||
146976101|NCT04380701|530075713|FG031|Overall Study|Lost to Follow-up|0|||
146976102|NCT04380701|530075714|FG032|Overall Study|Lost to Follow-up|0|||
146976103|NCT04380701|530075715|FG033|Overall Study|Lost to Follow-up|1|||
146976104|NCT04380701|530075682|FG000|Overall Study|Private reason(s)|0|||
146976105|NCT04380701|530075683|FG001|Overall Study|Private reason(s)|0|||
146976106|NCT04380701|530075684|FG002|Overall Study|Private reason(s)|0|||
146976107|NCT04380701|530075685|FG003|Overall Study|Private reason(s)|0|||
146976108|NCT04380701|530075686|FG004|Overall Study|Private reason(s)|0|||
146976109|NCT04380701|530075687|FG005|Overall Study|Private reason(s)|0|||
146976110|NCT04380701|530075688|FG006|Overall Study|Private reason(s)|1|||
146976111|NCT04380701|530075689|FG007|Overall Study|Private reason(s)|0|||
146976112|NCT04380701|530075690|FG008|Overall Study|Private reason(s)|1|||
146976113|NCT04380701|530075691|FG009|Overall Study|Private reason(s)|1|||
146976114|NCT04380701|530075692|FG010|Overall Study|Private reason(s)|0|||
146976115|NCT04380701|530075693|FG011|Overall Study|Private reason(s)|0|||
146976116|NCT04380701|530075694|FG012|Overall Study|Private reason(s)|0|||
146976117|NCT04380701|530075695|FG013|Overall Study|Private reason(s)|0|||
146976118|NCT04380701|530075696|FG014|Overall Study|Private reason(s)|0|||
146976119|NCT04380701|530075697|FG015|Overall Study|Private reason(s)|0|||
146976120|NCT04380701|530075698|FG016|Overall Study|Private reason(s)|0|||
146976121|NCT04380701|530075699|FG017|Overall Study|Private reason(s)|0|||
146976122|NCT04380701|530075700|FG018|Overall Study|Private reason(s)|0|||
146976123|NCT04380701|530075701|FG019|Overall Study|Private reason(s)|0|||
146976124|NCT04380701|530075702|FG020|Overall Study|Private reason(s)|0|||
146976125|NCT04380701|530075703|FG021|Overall Study|Private reason(s)|0|||
146976126|NCT04380701|530075704|FG022|Overall Study|Private reason(s)|0|||
146976127|NCT04380701|530075705|FG023|Overall Study|Private reason(s)|1|||
146976128|NCT04380701|530075706|FG024|Overall Study|Private reason(s)|0|||
146976129|NCT04380701|530075707|FG025|Overall Study|Private reason(s)|0|||
146976130|NCT04380701|530075708|FG026|Overall Study|Private reason(s)|0|||
146976131|NCT04380701|530075709|FG027|Overall Study|Private reason(s)|0|||
146976132|NCT04380701|530075710|FG028|Overall Study|Private reason(s)|0|||
146976133|NCT04380701|530075711|FG029|Overall Study|Private reason(s)|1|||
146976134|NCT04380701|530075712|FG030|Overall Study|Private reason(s)|0|||
146569074|NCT00553631|528595541|FG000|Overall Study|Withdrawal by Subject|0|||
146569075|NCT00553631|528595542|FG001|Overall Study|Withdrawal by Subject|1|||
146569076|NCT00553631|528595541|FG000|Overall Study|Lost to Follow-up|1|||
146569077|NCT00553631|528595542|FG001|Overall Study|Lost to Follow-up|0|||
146569078|NCT03768427|528595543|FG000|Overall Study|Death|0|||
146569079|NCT03768427|528595544|FG001|Overall Study|Death|0|||
146914943|NCT01522651|529850139|FG001|Overall Study|Investigator's Discretion|1|||
146914944|NCT01522651|529850140|FG002|Overall Study|Investigator's Discretion|0|||
146914945|NCT01522651|529850141|FG003|Overall Study|Investigator's Discretion|0|||
146914946|NCT01522651|529850142|FG004|Overall Study|Investigator's Discretion|0|||
146914947|NCT01522651|529850138|FG000|Overall Study|Protocol Violation|3|||
146914948|NCT01522651|529850139|FG001|Overall Study|Protocol Violation|0|||
146914949|NCT01522651|529850140|FG002|Overall Study|Protocol Violation|0|||
146914950|NCT01522651|529850141|FG003|Overall Study|Protocol Violation|0|||
146976135|NCT04380701|530075713|FG031|Overall Study|Private reason(s)|0|||
146976136|NCT04380701|530075714|FG032|Overall Study|Private reason(s)|0|||
146976137|NCT04380701|530075715|FG033|Overall Study|Private reason(s)|0|||
146976138|NCT04380701|530075682|FG000|Overall Study|Withdrawal by Subject|0|||
146976139|NCT04380701|530075683|FG001|Overall Study|Withdrawal by Subject|0|||
146976140|NCT04380701|530075684|FG002|Overall Study|Withdrawal by Subject|0|||
146569080|NCT03768427|528595545|FG002|Overall Study|Death|1|||
146976141|NCT04380701|530075685|FG003|Overall Study|Withdrawal by Subject|0|||
146976142|NCT04380701|530075686|FG004|Overall Study|Withdrawal by Subject|0|||
146976143|NCT04380701|530075687|FG005|Overall Study|Withdrawal by Subject|0|||
146976144|NCT04380701|530075688|FG006|Overall Study|Withdrawal by Subject|1|||
146976145|NCT04380701|530075689|FG007|Overall Study|Withdrawal by Subject|1|||
146976146|NCT04380701|530075690|FG008|Overall Study|Withdrawal by Subject|0|||
146976147|NCT04380701|530075691|FG009|Overall Study|Withdrawal by Subject|0|||
146569081|NCT03768427|528595546|FG003|Overall Study|Death|0|||
146914951|NCT01522651|529850142|FG004|Overall Study|Protocol Violation|0|||
146569082|NCT03768427|528595543|FG000|Overall Study|Lost to Follow-up|2|||
146650288|NCT04531462|528896723|FG000|Overall Study|Withdrawal by Subject|3|||
146650289|NCT04531462|528896724|FG001|Overall Study|Withdrawal by Subject|1|||
146650290|NCT04531462|528896723|FG000|Overall Study|Adverse Event|3|||
146650291|NCT04531462|528896724|FG001|Overall Study|Adverse Event|3|||
146650292|NCT00504582|528896725|FG000|Overall Study|Lost to Follow-up|1|||
146650293|NCT00504582|528896726|FG001|Overall Study|Lost to Follow-up|0|||
146650294|NCT00504582|528896727|FG002|Overall Study|Lost to Follow-up|0|||
146650295|NCT00348933|528896730|FG000|Overall Study|Withdrawal by Subject|10|||
146650296|NCT00348933|528896730|FG000|Overall Study|Lost to Follow-up|6|||
146650297|NCT00348933|528896730|FG000|Overall Study|Protocol Violation|2|||
146650298|NCT00348933|528896730|FG000|Overall Study|Adverse Event|7|||
146770324|NCT03482011|529327422|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
146770325|NCT03482011|529327423|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
146770326|NCT03482011|529327424|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
146770327|NCT03482011|529327417|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146770328|NCT03482011|529327418|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146770329|NCT03482011|529327419|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146770330|NCT03482011|529327420|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146770331|NCT03482011|529327421|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
146770332|NCT03482011|529327422|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146569083|NCT03768427|528595544|FG001|Overall Study|Lost to Follow-up|0|||
146569084|NCT03768427|528595545|FG002|Overall Study|Lost to Follow-up|0|||
146569085|NCT03768427|528595546|FG003|Overall Study|Lost to Follow-up|0|||
146569086|NCT03768427|528595543|FG000|Overall Study|Physician Decision|3|||
146569087|NCT03768427|528595544|FG001|Overall Study|Physician Decision|2|||
146569088|NCT03768427|528595545|FG002|Overall Study|Physician Decision|4|||
146569089|NCT03768427|528595546|FG003|Overall Study|Physician Decision|4|||
146569090|NCT03768427|528595543|FG000|Overall Study|Withdrawal by Subject|7|||
146569091|NCT03768427|528595544|FG001|Overall Study|Withdrawal by Subject|2|||
146569092|NCT03768427|528595545|FG002|Overall Study|Withdrawal by Subject|6|||
146569093|NCT03768427|528595546|FG003|Overall Study|Withdrawal by Subject|7|||
146569094|NCT02756403|528595549|FG000|Overall Study|Unable to swallow medication|0|||
146569095|NCT02756403|528595550|FG001|Overall Study|Unable to swallow medication|1|||
146569096|NCT02756403|528595551|FG002|Overall Study|Unable to swallow medication|1|||
146569097|NCT02756403|528595552|FG003|Overall Study|Unable to swallow medication|1|||
146569098|NCT02756403|528595549|FG000|Overall Study|Did not complete Procedure|0|||
146569099|NCT02756403|528595550|FG001|Overall Study|Did not complete Procedure|1|||
146569100|NCT02756403|528595551|FG002|Overall Study|Did not complete Procedure|0|||
146569101|NCT02756403|528595552|FG003|Overall Study|Did not complete Procedure|0|||
146569102|NCT02756403|528595549|FG000|Overall Study|Changed Mind About Procedure|0|||
146650299|NCT01264081|528896731|FG000|Participants Screened|Screening failures|30|||
146650300|NCT01264081|528896731|FG000|Started Treatment|Withdrawal by Subject|1|||
146650301|NCT01264081|528896731|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
146848141|NCT02535091|529614020|FG002|Overall Study|Pregnancy|7|||
146848142|NCT03223662|529614021|FG000|Overall Study|Physician Decision|1|||
146848143|NCT03223662|529614021|FG000|Overall Study|Study closure|1|||
146848144|NCT02643472|529614022|FG000|Overall Study|Death|2|||
146848145|NCT02643472|529614023|FG001|Overall Study|Death|5|||
146848146|NCT02643472|529614022|FG000|Overall Study|Withdrawal by Subject|3|||
146848147|NCT02643472|529614023|FG001|Overall Study|Withdrawal by Subject|2|||
146848148|NCT02643472|529614022|FG000|Overall Study|Protocol Violation|0|||
146848149|NCT02643472|529614023|FG001|Overall Study|Protocol Violation|1|||
146848150|NCT02643472|529614022|FG000|Overall Study|Lost to Follow-up|22|||
146848151|NCT02643472|529614023|FG001|Overall Study|Lost to Follow-up|26|||
146848152|NCT01258595|529614024|FG000|Overall Study|Lost to Follow-up|1|||
146848153|NCT01258595|529614025|FG001|Overall Study|Lost to Follow-up|0|||
146848154|NCT01258595|529614024|FG000|Overall Study|Withdrawal by Subject|0|||
146848155|NCT01258595|529614025|FG001|Overall Study|Withdrawal by Subject|1|||
146848156|NCT01215188|529614026|FG000|Overall Study|Lost to Follow-up|22|||
146848157|NCT01215188|529614027|FG001|Overall Study|Lost to Follow-up|22|||
146848158|NCT01215188|529614028|FG002|Overall Study|Lost to Follow-up|16|||
146848159|NCT01215188|529614026|FG000|Overall Study|Adverse Event|1|||
146848160|NCT01215188|529614027|FG001|Overall Study|Adverse Event|1|||
146848161|NCT01215188|529614028|FG002|Overall Study|Adverse Event|3|||
146848162|NCT01215188|529614026|FG000|Overall Study|Physician Decision|2|||
146848163|NCT01215188|529614027|FG001|Overall Study|Physician Decision|1|||
146848164|NCT01215188|529614028|FG002|Overall Study|Physician Decision|0|||
146848165|NCT01215188|529614026|FG000|Overall Study|Lack of Efficacy|0|||
146848166|NCT01215188|529614027|FG001|Overall Study|Lack of Efficacy|0|||
146848167|NCT01215188|529614028|FG002|Overall Study|Lack of Efficacy|1|||
146848168|NCT01215188|529614026|FG000|Overall Study|Protocol Violation|1|||
146848169|NCT01215188|529614027|FG001|Overall Study|Protocol Violation|1|||
146848170|NCT01215188|529614028|FG002|Overall Study|Protocol Violation|1|||
146848171|NCT01215188|529614026|FG000|Overall Study|Withdrawal by Subject|32|||
146848172|NCT01215188|529614027|FG001|Overall Study|Withdrawal by Subject|34|||
146569103|NCT02756403|528595550|FG001|Overall Study|Changed Mind About Procedure|0|||
146569104|NCT02756403|528595551|FG002|Overall Study|Changed Mind About Procedure|1|||
146569105|NCT02756403|528595552|FG003|Overall Study|Changed Mind About Procedure|0|||
146569106|NCT02756403|528595549|FG000|Overall Study|Protocol Violation|0|||
146569107|NCT02756403|528595550|FG001|Overall Study|Protocol Violation|1|||
146569108|NCT02756403|528595551|FG002|Overall Study|Protocol Violation|0|||
146569109|NCT02756403|528595552|FG003|Overall Study|Protocol Violation|1|||
146569110|NCT01644643|528595553|FG000|Overall Study|Death|1|||
146569111|NCT01644643|528595554|FG001|Overall Study|Death|0|||
146569112|NCT01644643|528595555|FG002|Overall Study|Death|3|||
146569113|NCT01644643|528595556|FG003|Overall Study|Death|3|||
146569114|NCT01644643|528595553|FG000|Overall Study|Lost to Follow-up|0|||
146569115|NCT01644643|528595554|FG001|Overall Study|Lost to Follow-up|0|||
146569116|NCT01644643|528595555|FG002|Overall Study|Lost to Follow-up|0|||
146569117|NCT01644643|528595556|FG003|Overall Study|Lost to Follow-up|4|||
146650302|NCT01489111|528896732|FG000|Overall Study|Withdrawal criterion|1|||
146650303|NCT02716896|528896733|FG000|Overall Study|Physician Decision|0|||
146650304|NCT02716896|528896734|FG001|Overall Study|Physician Decision|1|||
146650305|NCT01727700|528896735|FG000|Overall Study|Adverse Event|0|||
146650306|NCT01727700|528896736|FG001|Overall Study|Adverse Event|7|||
146650307|NCT01727700|528896737|FG002|Overall Study|Adverse Event|1|||
146650308|NCT01727700|528896735|FG000|Overall Study|Particpant withdrew consent|0|||
146650309|NCT01727700|528896736|FG001|Overall Study|Particpant withdrew consent|3|||
146650310|NCT01727700|528896737|FG002|Overall Study|Particpant withdrew consent|1|||
146650311|NCT01727700|528896735|FG000|Overall Study|Protocol Violation|2|||
146650312|NCT01727700|528896736|FG001|Overall Study|Protocol Violation|0|||
146650313|NCT01727700|528896737|FG002|Overall Study|Protocol Violation|0|||
146650314|NCT01757691|528896742|FG000|Overall Study|Administrative problems|2|||
146650315|NCT01757691|528896743|FG001|Overall Study|Administrative problems|0|||
146650316|NCT00464490|528896748|FG000|Overall Study|Physician Decision|11|||
146650317|NCT00464490|528896749|FG001|Overall Study|Physician Decision|11|||
146650318|NCT03188042|528896750|FG000|Overall Study|Withdrawal by Subject|1|||
146650319|NCT03188042|528896751|FG001|Overall Study|Withdrawal by Subject|1|||
146650320|NCT03860935|528896752|FG000|Overall Study|Withdrawal of Consent|15|||
146770333|NCT03482011|529327423|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146770334|NCT03482011|529327424|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
146770335|NCT03482011|529327417|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
146770336|NCT03482011|529327418|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
146770337|NCT03482011|529327419|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
146770338|NCT03482011|529327420|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
146770339|NCT03482011|529327421|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
146770340|NCT03482011|529327422|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
146770341|NCT03482011|529327423|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
146770342|NCT03482011|529327424|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
146770343|NCT03482011|529327417|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146770344|NCT03482011|529327418|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146770345|NCT03482011|529327419|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146770346|NCT03482011|529327420|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
146770347|NCT03482011|529327421|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
146770348|NCT03482011|529327422|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
146770349|NCT03482011|529327423|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
146770350|NCT03482011|529327424|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
146770351|NCT03482011|529327417|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146770352|NCT03482011|529327418|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146770353|NCT03482011|529327419|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146770354|NCT03482011|529327420|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
146770355|NCT03482011|529327421|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146770356|NCT03482011|529327422|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
146770357|NCT03482011|529327423|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
146770358|NCT03482011|529327424|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
146770359|NCT03482011|529327417|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
146770360|NCT03482011|529327418|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
146770361|NCT03482011|529327419|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
146770362|NCT03482011|529327420|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
146770363|NCT03482011|529327421|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
146650321|NCT03860935|528896753|FG001|Overall Study|Withdrawal of Consent|6|||
146650322|NCT03860935|528896752|FG000|Overall Study|Death|75|||
146770364|NCT03482011|529327422|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
146569118|NCT01644643|528595553|FG000|Overall Study|Withdrawal by Subject|1|||
146569119|NCT01644643|528595554|FG001|Overall Study|Withdrawal by Subject|0|||
146569120|NCT01644643|528595555|FG002|Overall Study|Withdrawal by Subject|2|||
146650323|NCT03860935|528896753|FG001|Overall Study|Death|51|||
146770365|NCT03482011|529327423|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
146770366|NCT03482011|529327424|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
146770367|NCT03482011|529327417|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
146976148|NCT04380701|530075692|FG010|Overall Study|Withdrawal by Subject|0|||
146976149|NCT04380701|530075693|FG011|Overall Study|Withdrawal by Subject|1|||
146976150|NCT04380701|530075694|FG012|Overall Study|Withdrawal by Subject|0|||
146976151|NCT04380701|530075695|FG013|Overall Study|Withdrawal by Subject|1|||
146976152|NCT04380701|530075696|FG014|Overall Study|Withdrawal by Subject|0|||
146976153|NCT04380701|530075697|FG015|Overall Study|Withdrawal by Subject|0|||
146976154|NCT04380701|530075698|FG016|Overall Study|Withdrawal by Subject|1|||
146976155|NCT04380701|530075699|FG017|Overall Study|Withdrawal by Subject|0|||
146976156|NCT04380701|530075700|FG018|Overall Study|Withdrawal by Subject|0|||
146976157|NCT04380701|530075701|FG019|Overall Study|Withdrawal by Subject|0|||
146976158|NCT04380701|530075702|FG020|Overall Study|Withdrawal by Subject|0|||
146976159|NCT04380701|530075703|FG021|Overall Study|Withdrawal by Subject|0|||
146976160|NCT04380701|530075704|FG022|Overall Study|Withdrawal by Subject|2|||
146569121|NCT01644643|528595556|FG003|Overall Study|Withdrawal by Subject|1|||
146569122|NCT01644643|528595553|FG000|Overall Study|Other Eligibility criteria|0|||
146976161|NCT04380701|530075705|FG023|Overall Study|Withdrawal by Subject|2|||
146976162|NCT04380701|530075706|FG024|Overall Study|Withdrawal by Subject|1|||
146976163|NCT04380701|530075707|FG025|Overall Study|Withdrawal by Subject|1|||
146976164|NCT04380701|530075708|FG026|Overall Study|Withdrawal by Subject|0|||
146976165|NCT04380701|530075709|FG027|Overall Study|Withdrawal by Subject|0|||
146976166|NCT04380701|530075710|FG028|Overall Study|Withdrawal by Subject|0|||
146976167|NCT04380701|530075711|FG029|Overall Study|Withdrawal by Subject|0|||
146976168|NCT04380701|530075712|FG030|Overall Study|Withdrawal by Subject|0|||
146976169|NCT04380701|530075713|FG031|Overall Study|Withdrawal by Subject|0|||
146976170|NCT04380701|530075714|FG032|Overall Study|Withdrawal by Subject|0|||
146976171|NCT04380701|530075715|FG033|Overall Study|Withdrawal by Subject|0|||
146976172|NCT04380701|530075682|FG000|Overall Study|Adverse Event|0|||
146976173|NCT04380701|530075683|FG001|Overall Study|Adverse Event|0|||
146976174|NCT04380701|530075684|FG002|Overall Study|Adverse Event|0|||
146976175|NCT04380701|530075685|FG003|Overall Study|Adverse Event|0|||
146976176|NCT04380701|530075686|FG004|Overall Study|Adverse Event|0|||
146976177|NCT04380701|530075687|FG005|Overall Study|Adverse Event|1|||
146976178|NCT04380701|530075688|FG006|Overall Study|Adverse Event|0|||
146976179|NCT04380701|530075689|FG007|Overall Study|Adverse Event|0|||
146976180|NCT04380701|530075690|FG008|Overall Study|Adverse Event|0|||
146976181|NCT04380701|530075691|FG009|Overall Study|Adverse Event|0|||
146976182|NCT04380701|530075692|FG010|Overall Study|Adverse Event|0|||
146976183|NCT04380701|530075693|FG011|Overall Study|Adverse Event|0|||
146976184|NCT04380701|530075694|FG012|Overall Study|Adverse Event|0|||
146976185|NCT04380701|530075695|FG013|Overall Study|Adverse Event|0|||
146976186|NCT04380701|530075696|FG014|Overall Study|Adverse Event|0|||
146569123|NCT01644643|528595554|FG001|Overall Study|Other Eligibility criteria|0|||
146569124|NCT01644643|528595555|FG002|Overall Study|Other Eligibility criteria|0|||
146569125|NCT01644643|528595556|FG003|Overall Study|Other Eligibility criteria|2|||
146569126|NCT00527618|528595557|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
146569127|NCT00527618|528595558|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
146569128|NCT00527618|528595557|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
146569129|NCT00527618|528595558|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
146569130|NCT00527618|528595557|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
146569131|NCT00527618|528595558|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
146569132|NCT00527618|528595557|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
146569133|NCT00527618|528595558|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
146569134|NCT00527618|528595557|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
146569135|NCT00527618|528595558|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
146569136|NCT00527618|528595557|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
146569137|NCT00527618|528595558|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
146770368|NCT03482011|529327418|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
146976187|NCT04380701|530075697|FG015|Overall Study|Adverse Event|1|||
146976188|NCT04380701|530075698|FG016|Overall Study|Adverse Event|0|||
146976189|NCT04380701|530075699|FG017|Overall Study|Adverse Event|0|||
146976190|NCT04380701|530075700|FG018|Overall Study|Adverse Event|0|||
146976191|NCT04380701|530075701|FG019|Overall Study|Adverse Event|1|||
146976192|NCT04380701|530075702|FG020|Overall Study|Adverse Event|0|||
146976193|NCT04380701|530075703|FG021|Overall Study|Adverse Event|0|||
146976194|NCT04380701|530075704|FG022|Overall Study|Adverse Event|0|||
146976195|NCT04380701|530075705|FG023|Overall Study|Adverse Event|0|||
146976196|NCT04380701|530075706|FG024|Overall Study|Adverse Event|0|||
146976197|NCT04380701|530075707|FG025|Overall Study|Adverse Event|0|||
146976198|NCT04380701|530075708|FG026|Overall Study|Adverse Event|0|||
146976199|NCT04380701|530075709|FG027|Overall Study|Adverse Event|0|||
146976200|NCT04380701|530075710|FG028|Overall Study|Adverse Event|0|||
146976201|NCT04380701|530075711|FG029|Overall Study|Adverse Event|0|||
146976202|NCT04380701|530075712|FG030|Overall Study|Adverse Event|0|||
146976203|NCT04380701|530075713|FG031|Overall Study|Adverse Event|0|||
146976204|NCT04380701|530075714|FG032|Overall Study|Adverse Event|0|||
146976205|NCT04380701|530075715|FG033|Overall Study|Adverse Event|0|||
146569138|NCT01490918|528595561|FG000|Overall Study|Lost to Follow-up|2|||
146569139|NCT01490918|528595562|FG001|Overall Study|Lost to Follow-up|1|||
146569140|NCT01490918|528595563|FG002|Overall Study|Lost to Follow-up|0|||
146569141|NCT01490918|528595561|FG000|Overall Study|Withdrawal by Subject|7|||
146569142|NCT01490918|528595562|FG001|Overall Study|Withdrawal by Subject|8|||
146569143|NCT01490918|528595563|FG002|Overall Study|Withdrawal by Subject|3|||
146569144|NCT01490918|528595561|FG000|Overall Study|Adverse Event|0|||
146569145|NCT01490918|528595562|FG001|Overall Study|Adverse Event|0|||
146569146|NCT01490918|528595563|FG002|Overall Study|Adverse Event|1|||
146569147|NCT01490918|528595561|FG000|Overall Study|other cause|4|||
146569148|NCT01490918|528595562|FG001|Overall Study|other cause|5|||
146569149|NCT01490918|528595563|FG002|Overall Study|other cause|8|||
146770369|NCT03482011|529327419|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
146976206|NCT04380701|530075682|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
146976207|NCT04380701|530075683|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
146976208|NCT04380701|530075684|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
146976209|NCT04380701|530075685|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
146976210|NCT04380701|530075686|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
146976211|NCT04380701|530075687|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
146976212|NCT04380701|530075688|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
146976213|NCT04380701|530075689|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
146976214|NCT04380701|530075690|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
146976215|NCT04380701|530075691|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
146976216|NCT04380701|530075692|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
146976217|NCT04380701|530075693|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
146976218|NCT04380701|530075694|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
146976219|NCT04380701|530075695|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
146976220|NCT04380701|530075696|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
146976221|NCT04380701|530075697|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
146976222|NCT04380701|530075698|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
146976223|NCT04380701|530075699|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
146976224|NCT04380701|530075700|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
146976225|NCT04380701|530075701|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
146976226|NCT04380701|530075702|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
146976227|NCT04380701|530075703|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
146976228|NCT04380701|530075704|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
146976229|NCT04380701|530075705|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
146976230|NCT04380701|530075706|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
146976231|NCT04380701|530075707|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
146976232|NCT04380701|530075708|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
146976233|NCT04380701|530075709|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
146976234|NCT04380701|530075710|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
146976235|NCT04380701|530075711|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
146976236|NCT04380701|530075712|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
146976237|NCT04380701|530075713|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
146976238|NCT04380701|530075714|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
146976239|NCT04380701|530075715|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
146976240|NCT04380701|530075682|FG000|Overall Study|Physician Decision|0|||
146976241|NCT04380701|530075683|FG001|Overall Study|Physician Decision|0|||
146976242|NCT04380701|530075684|FG002|Overall Study|Physician Decision|0|||
146976243|NCT04380701|530075685|FG003|Overall Study|Physician Decision|0|||
146976244|NCT04380701|530075686|FG004|Overall Study|Physician Decision|0|||
146976245|NCT04380701|530075687|FG005|Overall Study|Physician Decision|0|||
146976246|NCT04380701|530075688|FG006|Overall Study|Physician Decision|0|||
146976247|NCT04380701|530075689|FG007|Overall Study|Physician Decision|0|||
146976248|NCT04380701|530075690|FG008|Overall Study|Physician Decision|0|||
146976249|NCT04380701|530075691|FG009|Overall Study|Physician Decision|0|||
146976250|NCT04380701|530075692|FG010|Overall Study|Physician Decision|0|||
146976251|NCT04380701|530075693|FG011|Overall Study|Physician Decision|0|||
146976252|NCT04380701|530075694|FG012|Overall Study|Physician Decision|0|||
146976253|NCT04380701|530075695|FG013|Overall Study|Physician Decision|0|||
146976254|NCT04380701|530075696|FG014|Overall Study|Physician Decision|0|||
146976255|NCT04380701|530075697|FG015|Overall Study|Physician Decision|0|||
146976256|NCT04380701|530075698|FG016|Overall Study|Physician Decision|0|||
146976257|NCT04380701|530075699|FG017|Overall Study|Physician Decision|0|||
146976258|NCT04380701|530075700|FG018|Overall Study|Physician Decision|0|||
146976259|NCT04380701|530075701|FG019|Overall Study|Physician Decision|0|||
146976260|NCT04380701|530075702|FG020|Overall Study|Physician Decision|0|||
146976261|NCT04380701|530075703|FG021|Overall Study|Physician Decision|0|||
146569150|NCT00776789|528595564|FG000|Overall Study|Consent refusal|2|||
146569151|NCT00776789|528595565|FG001|Overall Study|Consent refusal|2|||
146569152|NCT00776789|528595564|FG000|Overall Study|Poor quality video|1|||
146569153|NCT00776789|528595565|FG001|Overall Study|Poor quality video|1|||
146569154|NCT00648037|528595568|FG000|Overall Study|Not Treated|1|||
146976262|NCT04380701|530075704|FG022|Overall Study|Physician Decision|0|||
146976263|NCT04380701|530075705|FG023|Overall Study|Physician Decision|0|||
146976264|NCT04380701|530075706|FG024|Overall Study|Physician Decision|2|||
146976265|NCT04380701|530075707|FG025|Overall Study|Physician Decision|0|||
146976266|NCT04380701|530075708|FG026|Overall Study|Physician Decision|0|||
146976267|NCT04380701|530075709|FG027|Overall Study|Physician Decision|0|||
146976268|NCT04380701|530075710|FG028|Overall Study|Physician Decision|0|||
146976269|NCT04380701|530075711|FG029|Overall Study|Physician Decision|0|||
146976270|NCT04380701|530075712|FG030|Overall Study|Physician Decision|0|||
146976271|NCT04380701|530075713|FG031|Overall Study|Physician Decision|0|||
146976272|NCT04380701|530075714|FG032|Overall Study|Physician Decision|0|||
146976273|NCT04380701|530075715|FG033|Overall Study|Physician Decision|0|||
146976274|NCT04380701|530075682|FG000|Overall Study|Death|0|||
146976275|NCT04380701|530075683|FG001|Overall Study|Death|0|||
146976276|NCT04380701|530075684|FG002|Overall Study|Death|0|||
146976277|NCT04380701|530075685|FG003|Overall Study|Death|0|||
146976278|NCT04380701|530075686|FG004|Overall Study|Death|0|||
146976279|NCT04380701|530075687|FG005|Overall Study|Death|0|||
146976280|NCT04380701|530075688|FG006|Overall Study|Death|0|||
146976281|NCT04380701|530075689|FG007|Overall Study|Death|0|||
146976282|NCT04380701|530075690|FG008|Overall Study|Death|0|||
146976283|NCT04380701|530075691|FG009|Overall Study|Death|0|||
146976284|NCT04380701|530075692|FG010|Overall Study|Death|0|||
146976285|NCT04380701|530075693|FG011|Overall Study|Death|0|||
146976286|NCT04380701|530075694|FG012|Overall Study|Death|0|||
146976287|NCT04380701|530075695|FG013|Overall Study|Death|0|||
146976288|NCT04380701|530075696|FG014|Overall Study|Death|0|||
146976289|NCT04380701|530075697|FG015|Overall Study|Death|0|||
146976290|NCT04380701|530075698|FG016|Overall Study|Death|0|||
146976291|NCT04380701|530075699|FG017|Overall Study|Death|0|||
146976292|NCT04380701|530075700|FG018|Overall Study|Death|0|||
146976293|NCT04380701|530075701|FG019|Overall Study|Death|0|||
146976294|NCT04380701|530075702|FG020|Overall Study|Death|0|||
146976295|NCT04380701|530075703|FG021|Overall Study|Death|0|||
146976296|NCT04380701|530075704|FG022|Overall Study|Death|0|||
146976297|NCT04380701|530075705|FG023|Overall Study|Death|0|||
146976298|NCT04380701|530075706|FG024|Overall Study|Death|1|||
146976299|NCT04380701|530075707|FG025|Overall Study|Death|0|||
146976300|NCT04380701|530075708|FG026|Overall Study|Death|0|||
146976301|NCT04380701|530075709|FG027|Overall Study|Death|0|||
146976302|NCT04380701|530075710|FG028|Overall Study|Death|0|||
146976303|NCT04380701|530075711|FG029|Overall Study|Death|0|||
146976304|NCT04380701|530075712|FG030|Overall Study|Death|0|||
146976305|NCT04380701|530075713|FG031|Overall Study|Death|0|||
146976306|NCT04380701|530075714|FG032|Overall Study|Death|0|||
146976307|NCT04380701|530075715|FG033|Overall Study|Death|0|||
146976308|NCT04380701|530075682|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976309|NCT04380701|530075683|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976310|NCT04380701|530075684|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976311|NCT04380701|530075685|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976312|NCT04380701|530075686|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976313|NCT04380701|530075687|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976314|NCT04380701|530075688|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976315|NCT04380701|530075689|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976316|NCT04380701|530075690|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146650324|NCT04461600|528896754|FG000|Overall Study|Death|6|||
146650325|NCT04461600|528896755|FG001|Overall Study|Death|5|||
146650326|NCT04461600|528896754|FG000|Overall Study|Withdrawal by Subject|0|||
146650327|NCT04461600|528896755|FG001|Overall Study|Withdrawal by Subject|1|||
146650328|NCT04575597|528896759|FG000|Overall Study|Death|0|||
146650329|NCT04575597|528896760|FG001|Overall Study|Death|0|||
146650330|NCT04575597|528896761|FG002|Overall Study|Death|0|||
146650331|NCT04575597|528896762|FG003|Overall Study|Death|1|||
146650332|NCT04575597|528896763|FG004|Overall Study|Death|3|||
146650333|NCT04575597|528896764|FG005|Overall Study|Death|14|||
146770370|NCT03482011|529327420|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
146976317|NCT04380701|530075691|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976318|NCT04380701|530075692|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976319|NCT04380701|530075693|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976320|NCT04380701|530075694|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976321|NCT04380701|530075695|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976322|NCT04380701|530075696|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976323|NCT04380701|530075697|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976324|NCT04380701|530075698|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976325|NCT04380701|530075699|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976326|NCT04380701|530075700|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976327|NCT04380701|530075701|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146650334|NCT04575597|528896759|FG000|Overall Study|Lost to Follow-up|2|||
146650335|NCT04575597|528896760|FG001|Overall Study|Lost to Follow-up|1|||
146650336|NCT04575597|528896761|FG002|Overall Study|Lost to Follow-up|1|||
146914952|NCT01522651|529850138|FG000|Overall Study|Reason Not Specified|0|||
146914953|NCT01522651|529850139|FG001|Overall Study|Reason Not Specified|0|||
146914954|NCT01522651|529850140|FG002|Overall Study|Reason Not Specified|0|||
146914955|NCT01522651|529850141|FG003|Overall Study|Reason Not Specified|1|||
146914956|NCT01522651|529850142|FG004|Overall Study|Reason Not Specified|0|||
146914957|NCT01522651|529850138|FG000|Overall Study|Participant Non-Compliance|1|||
146914958|NCT01522651|529850139|FG001|Overall Study|Participant Non-Compliance|0|||
146914959|NCT01522651|529850140|FG002|Overall Study|Participant Non-Compliance|0|||
146914960|NCT01522651|529850141|FG003|Overall Study|Participant Non-Compliance|0|||
146914961|NCT01522651|529850142|FG004|Overall Study|Participant Non-Compliance|0|||
146914962|NCT01522651|529850138|FG000|Overall Study|Withdrew Consent|1|||
146976328|NCT04380701|530075702|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976329|NCT04380701|530075703|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
146976330|NCT04380701|530075704|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
146976331|NCT04380701|530075705|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
146976332|NCT04380701|530075706|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
146976333|NCT04380701|530075707|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976334|NCT04380701|530075708|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976335|NCT04380701|530075709|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976336|NCT04380701|530075710|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976337|NCT04380701|530075711|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976338|NCT04380701|530075712|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146569155|NCT00648037|528595568|FG000|Overall Study|Withdrawal by Subject|1|||
146569156|NCT00648037|528595568|FG000|Overall Study|Adverse Event|11|||
146569157|NCT00648037|528595568|FG000|Overall Study|Relapse|2|||
146569158|NCT00648037|528595568|FG000|Overall Study|Other|1|||
146569159|NCT02967679|528595569|FG000|Overall Study|Adverse Event|1|||
146569160|NCT00114127|528595574|FG000|Overall Study|Adverse Event|2|||
146569161|NCT00114127|528595575|FG001|Overall Study|Adverse Event|1|||
146569162|NCT00114127|528595574|FG000|Overall Study|Lost to Follow-up|1|||
146569163|NCT00114127|528595575|FG001|Overall Study|Lost to Follow-up|0|||
146569164|NCT00114127|528595574|FG000|Overall Study|Withdrawal by Subject|1|||
146569165|NCT00114127|528595575|FG001|Overall Study|Withdrawal by Subject|3|||
146569166|NCT03391882|528595576|FG000|Study Overall|Adverse Event|3|||
146569167|NCT03391882|528595577|FG001|Study Overall|Adverse Event|6|||
146569168|NCT03391882|528595578|FG002|Study Overall|Adverse Event|1|||
146569169|NCT03391882|528595579|FG003|Study Overall|Adverse Event|1|||
146569170|NCT03391882|528595580|FG004|Study Overall|Adverse Event|3|||
146569171|NCT03391882|528595581|FG005|Study Overall|Adverse Event|1|||
146569172|NCT03391882|528595576|FG000|Study Overall|Lack of Efficacy|13|||
146569173|NCT03391882|528595577|FG001|Study Overall|Lack of Efficacy|9|||
146569174|NCT03391882|528595578|FG002|Study Overall|Lack of Efficacy|0|||
146569175|NCT03391882|528595579|FG003|Study Overall|Lack of Efficacy|0|||
146569176|NCT03391882|528595580|FG004|Study Overall|Lack of Efficacy|0|||
146569177|NCT03391882|528595581|FG005|Study Overall|Lack of Efficacy|0|||
146569178|NCT03391882|528595576|FG000|Study Overall|Withdrawal by Subject|3|||
146569179|NCT03391882|528595577|FG001|Study Overall|Withdrawal by Subject|3|||
146569180|NCT03391882|528595578|FG002|Study Overall|Withdrawal by Subject|2|||
146569181|NCT03391882|528595579|FG003|Study Overall|Withdrawal by Subject|2|||
146569182|NCT03391882|528595580|FG004|Study Overall|Withdrawal by Subject|1|||
146569183|NCT03391882|528595581|FG005|Study Overall|Withdrawal by Subject|3|||
146569184|NCT03391882|528595576|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
146569185|NCT03391882|528595577|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
146569186|NCT03391882|528595578|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
146569187|NCT03391882|528595579|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
146569188|NCT03391882|528595580|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
146569189|NCT03391882|528595581|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
146569190|NCT03391882|528595576|FG000|Study Overall|Protocol Violation|1|||
146569191|NCT03391882|528595577|FG001|Study Overall|Protocol Violation|0|||
146569192|NCT03391882|528595578|FG002|Study Overall|Protocol Violation|0|||
146569193|NCT03391882|528595579|FG003|Study Overall|Protocol Violation|0|||
146569194|NCT03391882|528595580|FG004|Study Overall|Protocol Violation|0|||
146569195|NCT03391882|528595581|FG005|Study Overall|Protocol Violation|0|||
146569196|NCT03391882|528595576|FG000|Part A - Titration Phase|Adverse Event|3|||
146569197|NCT03391882|528595577|FG001|Part A - Titration Phase|Adverse Event|6|||
146569198|NCT03391882|528595578|FG002|Part A - Titration Phase|Adverse Event|0|||
146569199|NCT03391882|528595579|FG003|Part A - Titration Phase|Adverse Event|0|||
146569200|NCT03391882|528595580|FG004|Part A - Titration Phase|Adverse Event|0|||
146569201|NCT03391882|528595581|FG005|Part A - Titration Phase|Adverse Event|0|||
146569202|NCT03391882|528595576|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
146569203|NCT03391882|528595577|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
146569204|NCT03391882|528595578|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
146914963|NCT01522651|529850139|FG001|Overall Study|Withdrew Consent|1|||
146914964|NCT01522651|529850140|FG002|Overall Study|Withdrew Consent|0|||
146569205|NCT03391882|528595579|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
146569206|NCT03391882|528595580|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
146569207|NCT03391882|528595581|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
146569208|NCT03391882|528595576|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
146569209|NCT03391882|528595577|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
146569210|NCT03391882|528595578|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
146569211|NCT03391882|528595579|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
146569212|NCT03391882|528595580|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
146569213|NCT03391882|528595581|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
146569214|NCT03391882|528595576|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
146569215|NCT03391882|528595577|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
146569216|NCT03391882|528595578|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
146569217|NCT03391882|528595579|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
146569218|NCT03391882|528595580|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
146569219|NCT03391882|528595581|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
146569220|NCT03391882|528595576|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
146569221|NCT03391882|528595577|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
146569222|NCT03391882|528595578|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
146569223|NCT03391882|528595579|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
146569224|NCT03391882|528595580|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
146569225|NCT03391882|528595581|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
146569226|NCT03391882|528595576|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
146914965|NCT01522651|529850141|FG003|Overall Study|Withdrew Consent|1|||
146914966|NCT01522651|529850142|FG004|Overall Study|Withdrew Consent|1|||
146914967|NCT01522651|529850138|FG000|Overall Study|Randomized but Never Treated|0|||
146569227|NCT03391882|528595577|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
146914968|NCT01522651|529850139|FG001|Overall Study|Randomized but Never Treated|1|||
146914969|NCT01522651|529850140|FG002|Overall Study|Randomized but Never Treated|0|||
146914970|NCT01522651|529850141|FG003|Overall Study|Randomized but Never Treated|1|||
146914971|NCT01522651|529850142|FG004|Overall Study|Randomized but Never Treated|1|||
146914972|NCT04267562|529851933|FG000|Assessed for Eligibility|Screen Failure|64|||
146914973|NCT04267562|529851933|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
146914974|NCT04267562|529851933|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
146914975|NCT04267562|529851933|FG000|Assessed for Eligibility|Site closure|6|||
146914976|NCT04267562|529851933|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
146914977|NCT04267562|529851933|FG000|Assessed for Eligibility|Physician Decision|1|||
146914978|NCT04267562|529851933|FG000|Month 24|Elective hysterectomy|1|||
146914979|NCT04267562|529851933|FG000|Month 24|Lost to Follow-up|1|||
146914980|NCT04267562|529851933|FG000|Month 36|Elective hysterectomy|2|||
146914981|NCT04267562|529851933|FG000|Month 36|Lost to Follow-up|3|||
146914982|NCT00408421|529851938|FG000|Treatment Initial Randomization|Adverse Event|5|||
146914983|NCT00408421|529851939|FG001|Treatment Initial Randomization|Adverse Event|9|||
146914984|NCT00408421|529851940|FG002|Treatment Initial Randomization|Adverse Event|0|||
146914985|NCT00408421|529851938|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
146914986|NCT00408421|529851939|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
146914987|NCT00408421|529851940|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
146914988|NCT00408421|529851938|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
146914989|NCT00408421|529851939|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
146914990|NCT00408421|529851940|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
146914991|NCT00408421|529851938|FG000|Treatment Initial Randomization|Physician Decision|1|||
146914992|NCT00408421|529851939|FG001|Treatment Initial Randomization|Physician Decision|0|||
146914993|NCT00408421|529851940|FG002|Treatment Initial Randomization|Physician Decision|0|||
146914994|NCT00408421|529851938|FG000|Treatment Initial Randomization|Protocol Violation|0|||
146914995|NCT00408421|529851939|FG001|Treatment Initial Randomization|Protocol Violation|1|||
146914996|NCT00408421|529851940|FG002|Treatment Initial Randomization|Protocol Violation|0|||
146914997|NCT00408421|529851938|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
146914998|NCT00408421|529851939|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
146914999|NCT00408421|529851940|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
146915000|NCT00408421|529851938|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
146915001|NCT00408421|529851939|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
146915002|NCT00408421|529851940|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
146915003|NCT00408421|529851938|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
146915004|NCT00408421|529851939|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
146915005|NCT00408421|529851940|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
146915006|NCT00408421|529851938|FG000|Treatment Re-Randomization|Adverse Event|2|||
146915007|NCT00408421|529851939|FG001|Treatment Re-Randomization|Adverse Event|2|||
146569228|NCT03391882|528595578|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
146569229|NCT03391882|528595579|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
146569230|NCT03391882|528595580|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
146650337|NCT04575597|528896762|FG003|Overall Study|Lost to Follow-up|2|||
146915008|NCT00408421|529851940|FG002|Treatment Re-Randomization|Adverse Event|4|||
146569231|NCT03391882|528595581|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
146569232|NCT03391882|528595576|FG000|Part B - Treatment Phase|Adverse Event|0|||
146569233|NCT03391882|528595577|FG001|Part B - Treatment Phase|Adverse Event|0|||
146569234|NCT03391882|528595578|FG002|Part B - Treatment Phase|Adverse Event|1|||
146569235|NCT03391882|528595579|FG003|Part B - Treatment Phase|Adverse Event|1|||
146569236|NCT03391882|528595580|FG004|Part B - Treatment Phase|Adverse Event|3|||
146569237|NCT03391882|528595581|FG005|Part B - Treatment Phase|Adverse Event|1|||
146569238|NCT03391882|528595576|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
146569239|NCT03391882|528595577|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
146569240|NCT03391882|528595578|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
146569241|NCT03391882|528595579|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
146569242|NCT03391882|528595580|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
146569243|NCT03391882|528595581|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
146569244|NCT00543985|528595582|FG000|Overall Study|Withdrawal by Subject|4|||
146569245|NCT01280968|528595583|FG000|Overall Study|Lost to Follow-up|8|||
146569246|NCT01280968|528595584|FG001|Overall Study|Lost to Follow-up|2|||
146569247|NCT01280968|528595583|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
146569248|NCT01280968|528595584|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
146569249|NCT01280968|528595583|FG000|Overall Study|Commuting Problems|2|||
146569250|NCT01280968|528595584|FG001|Overall Study|Commuting Problems|0|||
146569251|NCT01280968|528595583|FG000|Overall Study|Anxiety|2|||
146569252|NCT01280968|528595584|FG001|Overall Study|Anxiety|0|||
146569253|NCT01280968|528595583|FG000|Overall Study|Adverse Event|1|||
146569254|NCT01280968|528595584|FG001|Overall Study|Adverse Event|0|||
146569255|NCT01280968|528595583|FG000|Overall Study|Scheduling Conflicts|1|||
146569256|NCT01280968|528595584|FG001|Overall Study|Scheduling Conflicts|1|||
146569257|NCT01280968|528595583|FG000|Overall Study|Pre-existing Neurological Condition|1|||
146569258|NCT01280968|528595584|FG001|Overall Study|Pre-existing Neurological Condition|0|||
146569259|NCT01280968|528595583|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
146569260|NCT01280968|528595584|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
146569261|NCT00038948|528595585|FG000|Overall Study|Adverse Event|131|||
146569262|NCT00038948|528595586|FG001|Overall Study|Adverse Event|43|||
146569263|NCT00038948|528595585|FG000|Overall Study|Lost to Follow-up|4|||
146569264|NCT00038948|528595586|FG001|Overall Study|Lost to Follow-up|4|||
146569265|NCT00038948|528595585|FG000|Overall Study|Nonmedical event|5|||
146569266|NCT00038948|528595586|FG001|Overall Study|Nonmedical event|7|||
146569267|NCT00038948|528595585|FG000|Overall Study|Withdrawal by Subject|23|||
146569268|NCT00038948|528595586|FG001|Overall Study|Withdrawal by Subject|10|||
146569269|NCT00038948|528595585|FG000|Overall Study|Protocol Violation|3|||
146569270|NCT00038948|528595586|FG001|Overall Study|Protocol Violation|7|||
146569271|NCT00038948|528595585|FG000|Overall Study|Lack of Efficacy|3|||
146569272|NCT00038948|528595586|FG001|Overall Study|Lack of Efficacy|6|||
146569273|NCT01404234|528595587|FG000|Overall Study|Withdrawal by Subject|2|||
146569274|NCT02670473|528595588|FG000|Overall Study|Withdrawal by Subject|1|||
146569275|NCT01214837|528595589|FG000|Overall Study|Death|0|||
146569276|NCT01214837|528595590|FG001|Overall Study|Death|0|||
146569277|NCT01214837|528595591|FG002|Overall Study|Death|1|||
146569278|NCT01214837|528595589|FG000|Overall Study|Adverse Event|1|||
146509198|NCT00835679|528367763|FG001|Overall Study|Withdrawal by Subject|0|||
146509199|NCT00835679|528367764|FG002|Overall Study|Withdrawal by Subject|0|||
146509200|NCT00835679|528367765|FG003|Overall Study|Withdrawal by Subject|0|||
146509201|NCT05020899|528367768|FG000|8 Week Follow-up|Lost to Follow-up|3|||
146509202|NCT05020899|528367769|FG001|8 Week Follow-up|Lost to Follow-up|6|||
146509203|NCT05020899|528367768|FG000|12 Week Follow-up|Lost to Follow-up|1|||
146509204|NCT05020899|528367769|FG001|12 Week Follow-up|Lost to Follow-up|0|||
146509205|NCT05020899|528367768|FG000|12 Week Follow-up|Death|0|||
146569279|NCT01214837|528595590|FG001|Overall Study|Adverse Event|2|||
146569280|NCT01214837|528595591|FG002|Overall Study|Adverse Event|1|||
146569281|NCT01214837|528595589|FG000|Overall Study|Withdrawal by Subject|27|||
146569282|NCT01214837|528595590|FG001|Overall Study|Withdrawal by Subject|36|||
146569283|NCT01214837|528595591|FG002|Overall Study|Withdrawal by Subject|28|||
146509206|NCT05020899|528367769|FG001|12 Week Follow-up|Death|1|||
146509207|NCT03619902|528367770|FG000|Overall Study|Termination of Study by Investigator|1|||
146569284|NCT01214837|528595589|FG000|Overall Study|Lost to Follow-up|20|||
146569285|NCT01214837|528595590|FG001|Overall Study|Lost to Follow-up|15|||
146569286|NCT01214837|528595591|FG002|Overall Study|Lost to Follow-up|21|||
146569287|NCT01214837|528595589|FG000|Overall Study|Inappropriate Enrolment|0|||
146569288|NCT01214837|528595590|FG001|Overall Study|Inappropriate Enrolment|1|||
146569289|NCT01214837|528595591|FG002|Overall Study|Inappropriate Enrolment|2|||
146569290|NCT01214837|528595589|FG000|Overall Study|Administrative Reason|2|||
146569291|NCT01214837|528595590|FG001|Overall Study|Administrative Reason|6|||
146569292|NCT01214837|528595591|FG002|Overall Study|Administrative Reason|4|||
146569293|NCT01214837|528595589|FG000|Overall Study|Protocol Violation|3|||
146569294|NCT01214837|528595590|FG001|Overall Study|Protocol Violation|1|||
146569295|NCT01214837|528595591|FG002|Overall Study|Protocol Violation|5|||
146650338|NCT04575597|528896763|FG004|Overall Study|Lost to Follow-up|10|||
146509208|NCT03619902|528367770|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
146650339|NCT04575597|528896764|FG005|Overall Study|Lost to Follow-up|8|||
146650340|NCT04575597|528896759|FG000|Overall Study|Withdrawal by Subject|2|||
146650341|NCT04575597|528896760|FG001|Overall Study|Withdrawal by Subject|2|||
146650342|NCT04575597|528896761|FG002|Overall Study|Withdrawal by Subject|4|||
146650343|NCT04575597|528896762|FG003|Overall Study|Withdrawal by Subject|2|||
146650344|NCT04575597|528896763|FG004|Overall Study|Withdrawal by Subject|25|||
146650345|NCT04575597|528896764|FG005|Overall Study|Withdrawal by Subject|28|||
146650346|NCT04575597|528896759|FG000|Overall Study|Not Recorded|0|||
146650347|NCT04575597|528896760|FG001|Overall Study|Not Recorded|0|||
146650348|NCT04575597|528896761|FG002|Overall Study|Not Recorded|0|||
146650349|NCT04575597|528896762|FG003|Overall Study|Not Recorded|0|||
146650350|NCT04575597|528896763|FG004|Overall Study|Not Recorded|0|||
146650351|NCT04575597|528896764|FG005|Overall Study|Not Recorded|2|||
146650352|NCT04575597|528896759|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146650353|NCT04575597|528896760|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146650354|NCT04575597|528896761|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146650355|NCT04575597|528896762|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146650356|NCT04575597|528896763|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
146650357|NCT04575597|528896764|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
146650358|NCT01268579|528896765|FG000|Overall Study|Adverse Event|1|||
146650359|NCT01268579|528896765|FG000|Overall Study|Withdrawal by Subject|2|||
146650360|NCT01209832|528896766|FG000|Period 1|Sponsor Decision and was not dosed|1|||
146650361|NCT01209832|528896766|FG000|Period 2|Sponsor Decision|1|||
146650362|NCT02692651|528896767|FG000|Study Treatment|Death|7|||
146650363|NCT02692651|528896768|FG001|Study Treatment|Death|3|||
146650364|NCT02692651|528896767|FG000|Study Treatment|comfort care|1|||
146650365|NCT02692651|528896768|FG001|Study Treatment|comfort care|1|||
146650366|NCT02692651|528896767|FG000|Study Treatment|Protocol violation per treating team preference|8|||
146650367|NCT02692651|528896768|FG001|Study Treatment|Protocol violation per treating team preference|6|||
146650368|NCT02692651|528896767|FG000|Post Study Treatment Follow-up|Death|4|||
146650369|NCT02692651|528896768|FG001|Post Study Treatment Follow-up|Death|4|||
146650370|NCT02480712|528896769|FG000|Overall Study|Enrolled but Never Treated|1|||
146650371|NCT02480712|528896769|FG000|Overall Study|Lost to Follow-up|5|||
146650372|NCT02480712|528896769|FG000|Overall Study|Withdrew Consent|3|||
146650373|NCT02480712|528896769|FG000|Overall Study|Death|1|||
146650374|NCT02480712|528896769|FG000|Overall Study|Lack of Efficacy|1|||
146650375|NCT01087788|528896776|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
146650376|NCT01087788|528896777|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
146650377|NCT01087788|528896778|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
146650378|NCT01087788|528896776|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
146650379|NCT01087788|528896777|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
146650380|NCT01087788|528896778|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
146650381|NCT01087788|528896776|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
146650382|NCT01087788|528896777|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
146650383|NCT01087788|528896778|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
146650384|NCT01087788|528896776|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
146650385|NCT01087788|528896777|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
146650386|NCT01087788|528896778|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
146650387|NCT01087788|528896776|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
146650388|NCT01087788|528896777|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
146650389|NCT01087788|528896778|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
146650390|NCT01087788|528896776|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
146650391|NCT01087788|528896777|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
146650392|NCT01087788|528896778|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
146650393|NCT01087788|528896776|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
146650394|NCT01087788|528896777|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
146650395|NCT01087788|528896778|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
146650396|NCT01087788|528896776|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
146650397|NCT01087788|528896777|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
146650398|NCT01087788|528896778|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
146650399|NCT01087788|528896776|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
146650400|NCT01087788|528896777|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
146650401|NCT01087788|528896778|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
146650402|NCT01087788|528896776|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
146650403|NCT01087788|528896777|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
146650404|NCT01087788|528896778|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
146650405|NCT01087788|528896776|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
146650406|NCT01087788|528896777|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
146650407|NCT01087788|528896778|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
146650408|NCT01087788|528896776|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
146650409|NCT01087788|528896777|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
146650410|NCT01087788|528896778|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
146650411|NCT01087788|528896776|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
146650412|NCT01087788|528896777|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
146650413|NCT01087788|528896778|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
146650414|NCT01087788|528896776|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
146650415|NCT01087788|528896777|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
146650416|NCT01087788|528896778|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
146650417|NCT01087788|528896776|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
146650418|NCT01087788|528896777|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
146915009|NCT00408421|529851938|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
146915010|NCT00408421|529851939|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
146915011|NCT00408421|529851940|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
146915012|NCT00408421|529851938|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
146915013|NCT00408421|529851939|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
146915014|NCT00408421|529851940|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
146915015|NCT00408421|529851938|FG000|Treatment Re-Randomization|Physician Decision|1|||
146915016|NCT00408421|529851939|FG001|Treatment Re-Randomization|Physician Decision|3|||
146915017|NCT00408421|529851940|FG002|Treatment Re-Randomization|Physician Decision|0|||
146915018|NCT00408421|529851938|FG000|Treatment Re-Randomization|Protocol Violation|1|||
146915019|NCT00408421|529851939|FG001|Treatment Re-Randomization|Protocol Violation|1|||
146915020|NCT00408421|529851940|FG002|Treatment Re-Randomization|Protocol Violation|0|||
146915021|NCT00408421|529851938|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
146915022|NCT00408421|529851939|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
146915023|NCT00408421|529851940|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
146915024|NCT02115815|529851947|FG000|Overall Study|Withdrawal by Subject|2|||
146915025|NCT02115815|529851948|FG001|Overall Study|Withdrawal by Subject|0|||
146915026|NCT02115815|529851949|FG002|Overall Study|Withdrawal by Subject|0|||
146915027|NCT02115815|529851950|FG003|Overall Study|Withdrawal by Subject|0|||
146915028|NCT02115815|529851951|FG004|Overall Study|Withdrawal by Subject|0|||
146915029|NCT02115815|529851952|FG005|Overall Study|Withdrawal by Subject|0|||
146915030|NCT02115815|529851953|FG006|Overall Study|Withdrawal by Subject|0|||
146915031|NCT02115815|529851947|FG000|Overall Study|Not enough drug to dose participant|0|||
146915032|NCT02115815|529851948|FG001|Overall Study|Not enough drug to dose participant|0|||
146915033|NCT02115815|529851949|FG002|Overall Study|Not enough drug to dose participant|0|||
146915034|NCT02115815|529851950|FG003|Overall Study|Not enough drug to dose participant|0|||
146915035|NCT02115815|529851951|FG004|Overall Study|Not enough drug to dose participant|0|||
146915036|NCT02115815|529851952|FG005|Overall Study|Not enough drug to dose participant|1|||
146915037|NCT02115815|529851953|FG006|Overall Study|Not enough drug to dose participant|0|||
146915038|NCT02115815|529851947|FG000|Overall Study|Missed appointment, randomized in error|0|||
146915039|NCT02115815|529851948|FG001|Overall Study|Missed appointment, randomized in error|0|||
146915040|NCT02115815|529851949|FG002|Overall Study|Missed appointment, randomized in error|0|||
146915041|NCT02115815|529851950|FG003|Overall Study|Missed appointment, randomized in error|0|||
146915042|NCT02115815|529851951|FG004|Overall Study|Missed appointment, randomized in error|0|||
146915043|NCT02115815|529851952|FG005|Overall Study|Missed appointment, randomized in error|1|||
146915044|NCT02115815|529851953|FG006|Overall Study|Missed appointment, randomized in error|0|||
146915045|NCT01989546|529851954|FG000|Overall Study|Clinical Progression|1|||
146915046|NCT01989546|529851954|FG000|Overall Study|Disease progression on study|8|||
146915047|NCT04439838|529851955|FG000|Overall Study|Withdrawal by Subject|0|||
146915048|NCT04439838|529851956|FG001|Overall Study|Withdrawal by Subject|0|||
146915049|NCT04439838|529851957|FG002|Overall Study|Withdrawal by Subject|0|||
146915050|NCT04439838|529851958|FG003|Overall Study|Withdrawal by Subject|0|||
146915051|NCT04439838|529851959|FG004|Overall Study|Withdrawal by Subject|0|||
146915052|NCT04439838|529851960|FG005|Overall Study|Withdrawal by Subject|0|||
146915053|NCT04439838|529851961|FG006|Overall Study|Withdrawal by Subject|0|||
146915054|NCT04439838|529851962|FG007|Overall Study|Withdrawal by Subject|0|||
146915055|NCT04439838|529851963|FG008|Overall Study|Withdrawal by Subject|1|||
146915056|NCT02778867|529851964|FG000|Phase 1|Withdrawal by Subject|2|||
146915057|NCT02778867|529851965|FG001|Phase 1|Withdrawal by Subject|3|||
146915058|NCT02778867|529851966|FG002|Phase 1|Withdrawal by Subject|0|||
146915059|NCT02778867|529851967|FG003|Phase 1|Withdrawal by Subject|0|||
146915060|NCT02778867|529851964|FG000|Phase 2|Withdrawal by Subject|0|||
146915061|NCT02778867|529851965|FG001|Phase 2|Withdrawal by Subject|0|||
146915062|NCT02778867|529851966|FG002|Phase 2|Withdrawal by Subject|1|||
146650419|NCT01087788|528896778|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
146650420|NCT01087788|528896776|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
146650421|NCT01087788|528896777|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
146650422|NCT01087788|528896778|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
146650423|NCT01087788|528896776|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
146650424|NCT01087788|528896777|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
146650425|NCT01087788|528896778|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
146569296|NCT01214837|528595589|FG000|Overall Study|Unable to Classify|1|||
146569297|NCT01214837|528595590|FG001|Overall Study|Unable to Classify|3|||
146569298|NCT01214837|528595591|FG002|Overall Study|Unable to Classify|0|||
146569299|NCT00887159|528597234|FG000|Overall Study|Disease progression|6|||
146569300|NCT00887159|528597235|FG001|Overall Study|Disease progression|39|||
146569301|NCT00887159|528597236|FG002|Overall Study|Disease progression|33|||
146569302|NCT00887159|528597234|FG000|Overall Study|Adverse Event|3|||
146569303|NCT00887159|528597235|FG001|Overall Study|Adverse Event|4|||
146569304|NCT00887159|528597236|FG002|Overall Study|Adverse Event|17|||
146569305|NCT00887159|528597234|FG000|Overall Study|Death|2|||
146569306|NCT00887159|528597235|FG001|Overall Study|Death|2|||
146569307|NCT00887159|528597236|FG002|Overall Study|Death|0|||
146569308|NCT00887159|528597234|FG000|Overall Study|Withdrawal by Subject|4|||
146569309|NCT00887159|528597235|FG001|Overall Study|Withdrawal by Subject|4|||
146569310|NCT00887159|528597236|FG002|Overall Study|Withdrawal by Subject|2|||
146569311|NCT00887159|528597234|FG000|Overall Study|Alternative therapy|2|||
146569312|NCT00887159|528597235|FG001|Overall Study|Alternative therapy|0|||
146569313|NCT00887159|528597236|FG002|Overall Study|Alternative therapy|0|||
146569314|NCT00887159|528597234|FG000|Overall Study|Physician Decision|1|||
146569315|NCT00887159|528597235|FG001|Overall Study|Physician Decision|1|||
146569316|NCT00887159|528597236|FG002|Overall Study|Physician Decision|0|||
146569317|NCT00887159|528597234|FG000|Overall Study|Sympomatic deterioration|1|||
146569318|NCT00887159|528597235|FG001|Overall Study|Sympomatic deterioration|0|||
146569319|NCT00887159|528597236|FG002|Overall Study|Sympomatic deterioration|0|||
146569320|NCT00887159|528597234|FG000|Overall Study|Treatment delayed|1|||
146569321|NCT00887159|528597235|FG001|Overall Study|Treatment delayed|1|||
146569322|NCT00887159|528597236|FG002|Overall Study|Treatment delayed|0|||
146569323|NCT00887159|528597234|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
146569324|NCT00887159|528597235|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
146569325|NCT00887159|528597236|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
146569326|NCT00887159|528597234|FG000|Overall Study|Received more tx instead of observation|1|||
146569327|NCT00887159|528597235|FG001|Overall Study|Received more tx instead of observation|0|||
146770371|NCT03482011|529327421|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
146770372|NCT03482011|529327422|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
146770373|NCT03482011|529327423|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
146770374|NCT03482011|529327424|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
146770375|NCT03482011|529327417|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
146770376|NCT03482011|529327418|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
146770377|NCT03482011|529327419|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
146770378|NCT03482011|529327420|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
146770379|NCT03482011|529327421|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
146770380|NCT03482011|529327422|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
146770381|NCT03482011|529327423|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
146770382|NCT03482011|529327424|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
146770383|NCT03482011|529327417|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
146770384|NCT03482011|529327418|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
146770385|NCT03482011|529327419|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
146770386|NCT03482011|529327420|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
146770387|NCT03482011|529327421|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
146770388|NCT03482011|529327422|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
146770389|NCT03482011|529327423|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
146770390|NCT03482011|529327424|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
146770391|NCT00468052|529327425|FG000|Overall Study|Protocol Violation|7|||
146770392|NCT00468052|529327426|FG001|Overall Study|Protocol Violation|8|||
146770393|NCT02709655|529327427|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
146770394|NCT02709655|529327428|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
146770395|NCT02709655|529327429|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
146770396|NCT02709655|529327430|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
146770397|NCT02709655|529327431|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
146915063|NCT02778867|529851967|FG003|Phase 2|Withdrawal by Subject|0|||
146915064|NCT02778867|529851964|FG000|Phase 2|Physician Decision|0|||
146915065|NCT02778867|529851965|FG001|Phase 2|Physician Decision|0|||
146915066|NCT02778867|529851966|FG002|Phase 2|Physician Decision|0|||
146915067|NCT02778867|529851967|FG003|Phase 2|Physician Decision|1|||
146915068|NCT02778867|529851964|FG000|Phase 2|Adverse Event|0|||
146569328|NCT00887159|528597236|FG002|Overall Study|Received more tx instead of observation|0|||
146569329|NCT00887159|528597234|FG000|Overall Study|Ineligible|5|||
146569330|NCT00887159|528597235|FG001|Overall Study|Ineligible|1|||
146569331|NCT00887159|528597236|FG002|Overall Study|Ineligible|0|||
146569332|NCT00887159|528597234|FG000|Overall Study|Never started assigned therapy|3|||
146569333|NCT00887159|528597235|FG001|Overall Study|Never started assigned therapy|3|||
146569334|NCT00887159|528597236|FG002|Overall Study|Never started assigned therapy|4|||
146569335|NCT06164691|528597238|FG000|Overall Study|Withdrawal by Subject|2|||
146770398|NCT02709655|529327427|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
146915069|NCT02778867|529851965|FG001|Phase 2|Adverse Event|0|||
146569336|NCT06164691|528597239|FG001|Overall Study|Withdrawal by Subject|0|||
146569337|NCT06164691|528597240|FG002|Overall Study|Withdrawal by Subject|0|||
146569338|NCT00812955|528597241|FG000|Overall Study|Adverse Event|7|||
146976339|NCT04380701|530075713|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976340|NCT04380701|530075714|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976341|NCT04380701|530075715|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146976342|NCT03001011|530075716|FG000|Overall Study|Adverse Event|9|||
146569339|NCT00812955|528597242|FG001|Overall Study|Adverse Event|6|||
146569340|NCT00812955|528597243|FG002|Overall Study|Adverse Event|3|||
146569341|NCT00812955|528597244|FG003|Overall Study|Adverse Event|4|||
146569342|NCT00812955|528597241|FG000|Overall Study|Lost to Follow-up|2|||
146569343|NCT00812955|528597242|FG001|Overall Study|Lost to Follow-up|1|||
146569344|NCT00812955|528597243|FG002|Overall Study|Lost to Follow-up|1|||
146569345|NCT00812955|528597244|FG003|Overall Study|Lost to Follow-up|2|||
146569346|NCT00812955|528597241|FG000|Overall Study|Withdrawal by Subject|1|||
146569347|NCT00812955|528597242|FG001|Overall Study|Withdrawal by Subject|0|||
146569348|NCT00812955|528597243|FG002|Overall Study|Withdrawal by Subject|1|||
146569349|NCT00812955|528597244|FG003|Overall Study|Withdrawal by Subject|2|||
146569350|NCT00812955|528597241|FG000|Overall Study|randomized in error|0|||
146569351|NCT00812955|528597242|FG001|Overall Study|randomized in error|0|||
146569352|NCT00812955|528597243|FG002|Overall Study|randomized in error|1|||
146569353|NCT00812955|528597244|FG003|Overall Study|randomized in error|0|||
146569354|NCT01673646|528597249|FG000|Overall Study|Adverse Event|2|||
146569355|NCT01673646|528597250|FG001|Overall Study|Adverse Event|1|||
146569356|NCT01673646|528597251|FG002|Overall Study|Adverse Event|1|||
146569357|NCT01673646|528597249|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146976343|NCT03001011|530075717|FG001|Overall Study|Adverse Event|3|||
146569358|NCT01673646|528597250|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146569359|NCT01673646|528597251|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146569360|NCT01673646|528597249|FG000|Overall Study|Condition no longer requires study drug|0|||
146569361|NCT01673646|528597250|FG001|Overall Study|Condition no longer requires study drug|1|||
146569362|NCT01673646|528597251|FG002|Overall Study|Condition no longer requires study drug|0|||
146569363|NCT01673646|528597249|FG000|Overall Study|Withdrawal by Subject|0|||
146569364|NCT01673646|528597250|FG001|Overall Study|Withdrawal by Subject|2|||
146569365|NCT01673646|528597251|FG002|Overall Study|Withdrawal by Subject|2|||
146569366|NCT01673646|528597249|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
146569367|NCT01673646|528597250|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
146569368|NCT01673646|528597251|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
146569369|NCT00461708|528597252|FG000|Overall Study|Adverse Event|17|||
146569370|NCT00461708|528597253|FG001|Overall Study|Adverse Event|7|||
146569371|NCT00461708|528597252|FG000|Overall Study|Lack of Efficacy|68|||
146569372|NCT00461708|528597253|FG001|Overall Study|Lack of Efficacy|20|||
146569373|NCT00461708|528597252|FG000|Overall Study|Physician Decision|10|||
146569374|NCT00461708|528597253|FG001|Overall Study|Physician Decision|4|||
146569375|NCT00461708|528597252|FG000|Overall Study|Withdrawal by Subject|8|||
146569376|NCT00461708|528597253|FG001|Overall Study|Withdrawal by Subject|2|||
146569377|NCT00461708|528597252|FG000|Overall Study|Other|4|||
146569378|NCT00461708|528597253|FG001|Overall Study|Other|4|||
146569379|NCT00461708|528597252|FG000|Overall Study|Death|8|||
146569380|NCT00461708|528597253|FG001|Overall Study|Death|1|||
146569381|NCT01464879|528597254|FG000|Overall Study|Physician Decision|1|||
146569382|NCT01464879|528597254|FG000|Overall Study|Non-compliance|1|||
146569383|NCT00800982|528597261|FG000|Overall Study|Lost to Follow-up|1|||
146569384|NCT00800982|528597262|FG001|Overall Study|Lost to Follow-up|2|||
146569385|NCT00800982|528597261|FG000|Overall Study|Withdrawal by Subject|0|||
146569386|NCT00800982|528597262|FG001|Overall Study|Withdrawal by Subject|1|||
146569387|NCT00800982|528597261|FG000|Overall Study|Patient moved out of state|1|||
146976344|NCT03001011|530075716|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
146976345|NCT03001011|530075717|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
146976346|NCT03001011|530075716|FG000|Overall Study|Other than specified above|3|||
146569388|NCT00800982|528597262|FG001|Overall Study|Patient moved out of state|0|||
146569389|NCT01824290|528597263|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
146569390|NCT01824290|528597264|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
146569391|NCT01824290|528597265|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
146569392|NCT01824290|528597266|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
146569393|NCT01824290|528597263|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
146569394|NCT01824290|528597264|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
146569395|NCT01824290|528597265|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
146569396|NCT01824290|528597266|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
146569397|NCT01824290|528597263|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
146569398|NCT01824290|528597264|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
146569399|NCT01824290|528597265|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
146569400|NCT01824290|528597266|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
146976347|NCT03001011|530075717|FG001|Overall Study|Other than specified above|8|||
146569401|NCT01824290|528597263|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
146569402|NCT01824290|528597264|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
146569403|NCT01824290|528597265|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
146569404|NCT01824290|528597266|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
146569405|NCT01824290|528597263|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
146569406|NCT01824290|528597264|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
146569407|NCT01824290|528597265|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
146569408|NCT01824290|528597266|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
146569409|NCT01824290|528597263|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
146569410|NCT01824290|528597264|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
146569411|NCT01824290|528597265|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
146569412|NCT01824290|528597266|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
146569413|NCT03188263|528597268|FG000|Overall Study|Withdrawal by Subject|3|||
146569414|NCT03188263|528597269|FG001|Overall Study|Withdrawal by Subject|0|||
146770399|NCT02709655|529327428|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
146770400|NCT02709655|529327429|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
146770401|NCT02709655|529327430|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
146770402|NCT02709655|529327431|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
146770403|NCT02709655|529327427|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
146915070|NCT02778867|529851966|FG002|Phase 2|Adverse Event|0|||
146569415|NCT03188263|528597268|FG000|Overall Study|Physician Decision|1|||
146569416|NCT03188263|528597269|FG001|Overall Study|Physician Decision|0|||
146569417|NCT00699413|528597270|FG000|Overall Study|Withdrawal by Subject|0|||
146569418|NCT00699413|528597271|FG001|Overall Study|Withdrawal by Subject|2|||
146569419|NCT00699413|528597270|FG000|Overall Study|Study terminated by sponsor|4|||
146569420|NCT00699413|528597271|FG001|Overall Study|Study terminated by sponsor|2|||
146569421|NCT02779777|528597272|FG000|Overall Study|Disease Progression|1|||
146569422|NCT02779777|528597273|FG001|Overall Study|Disease Progression|0|||
146569423|NCT02779777|528597274|FG002|Overall Study|Disease Progression|0|||
146569424|NCT02779777|528597272|FG000|Overall Study|Adverse Event|3|||
146569425|NCT02779777|528597273|FG001|Overall Study|Adverse Event|1|||
146569426|NCT02779777|528597274|FG002|Overall Study|Adverse Event|0|||
146569427|NCT02779777|528597272|FG000|Overall Study|Physician Decision|9|||
146569428|NCT02779777|528597273|FG001|Overall Study|Physician Decision|0|||
146569429|NCT02779777|528597274|FG002|Overall Study|Physician Decision|1|||
146569430|NCT02779777|528597272|FG000|Overall Study|Withdrawal by Subject|1|||
146569431|NCT02779777|528597273|FG001|Overall Study|Withdrawal by Subject|0|||
146569432|NCT02779777|528597274|FG002|Overall Study|Withdrawal by Subject|0|||
146569433|NCT00881894|528597275|FG000|Overall Study|Consent withdrawn|0|||
146569434|NCT00881894|528597276|FG001|Overall Study|Consent withdrawn|1|||
146569435|NCT00881894|528597275|FG000|Overall Study|Other reasons for premature termination|1|||
146569436|NCT00881894|528597276|FG001|Overall Study|Other reasons for premature termination|2|||
146569437|NCT00469833|528597277|FG000|Overall Study|No IV access|2|||
146569438|NCT01253369|528597278|FG000|Overall Study|Adverse Event|4|||
146569439|NCT01253369|528597278|FG000|Overall Study|Withdrawal by Subject|2|||
146569440|NCT01253369|528597278|FG000|Overall Study|Death|1|||
146569441|NCT01253369|528597278|FG000|Overall Study|Progressive disease|23|||
146569442|NCT01253369|528597278|FG000|Overall Study|Not Evaluable|3|||
146569443|NCT03289533|528597279|FG000|Overall Study|Death|12|||
146569444|NCT03289533|528597279|FG000|Overall Study|Terminated from study by sponsor|10|||
146569445|NCT00539240|528597280|FG000|Overall Study|Withdrawal by Subject|0|||
146569446|NCT00539240|528597281|FG001|Overall Study|Withdrawal by Subject|2|||
146569447|NCT00539240|528597282|FG002|Overall Study|Withdrawal by Subject|0|||
146569448|NCT00539240|528597280|FG000|Overall Study|Protocol Violation|1|||
146569449|NCT00539240|528597281|FG001|Overall Study|Protocol Violation|1|||
146569450|NCT00539240|528597282|FG002|Overall Study|Protocol Violation|4|||
146569451|NCT00539240|528597280|FG000|Overall Study|Lost to Follow-up|2|||
146569452|NCT00539240|528597281|FG001|Overall Study|Lost to Follow-up|3|||
146569453|NCT00539240|528597282|FG002|Overall Study|Lost to Follow-up|1|||
146569454|NCT00539240|528597280|FG000|Overall Study|Adverse Event|3|||
146569455|NCT00539240|528597281|FG001|Overall Study|Adverse Event|1|||
146569456|NCT00539240|528597282|FG002|Overall Study|Adverse Event|10|||
146915071|NCT02778867|529851967|FG003|Phase 2|Adverse Event|1|||
146569457|NCT01284959|528597284|FG000|Overall Study|Withdrawal by Subject|1|||
146569458|NCT01284959|528597285|FG001|Overall Study|Withdrawal by Subject|0|||
146569459|NCT01284959|528597286|FG002|Overall Study|Withdrawal by Subject|0|||
146569460|NCT01284959|528597284|FG000|Overall Study|Adverse Event|0|||
146770404|NCT02709655|529327428|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
146569461|NCT01284959|528597285|FG001|Overall Study|Adverse Event|0|||
146569462|NCT01284959|528597286|FG002|Overall Study|Adverse Event|1|||
146569463|NCT01055613|528597287|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
146569464|NCT01055613|528597288|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146569465|NCT01055613|528597287|FG000|Overall Study|Unacceptable lens fit|1|||
146569466|NCT01055613|528597288|FG001|Overall Study|Unacceptable lens fit|0|||
146569467|NCT01055613|528597287|FG000|Overall Study|Discomfort|2|||
146569468|NCT01055613|528597288|FG001|Overall Study|Discomfort|1|||
146569469|NCT01055613|528597287|FG000|Overall Study|Lost to Follow-up|1|||
146569470|NCT01055613|528597288|FG001|Overall Study|Lost to Follow-up|1|||
146569471|NCT01055613|528597287|FG000|Overall Study|Protocol Violation|1|||
146569472|NCT01055613|528597288|FG001|Overall Study|Protocol Violation|1|||
146569473|NCT01055613|528597287|FG000|Overall Study|Subject Disinterest|1|||
146650426|NCT01087788|528896776|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
146650427|NCT01087788|528896777|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
146650428|NCT01087788|528896778|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
146650429|NCT01087788|528896776|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
146650430|NCT01087788|528896777|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
146915072|NCT00960440|529851968|FG000|Overall Study|Death|0|||
146915073|NCT00960440|529851969|FG001|Overall Study|Death|0|||
146915074|NCT00960440|529851970|FG002|Overall Study|Death|0|||
146915075|NCT00960440|529851971|FG003|Overall Study|Death|1|||
146915076|NCT00960440|529851968|FG000|Overall Study|Adverse Event|12|||
146915077|NCT00960440|529851969|FG001|Overall Study|Adverse Event|12|||
146915078|NCT00960440|529851970|FG002|Overall Study|Adverse Event|4|||
146915079|NCT00960440|529851971|FG003|Overall Study|Adverse Event|4|||
146915080|NCT00960440|529851968|FG000|Overall Study|Lack of Efficacy|2|||
146915081|NCT00960440|529851969|FG001|Overall Study|Lack of Efficacy|5|||
146915082|NCT00960440|529851970|FG002|Overall Study|Lack of Efficacy|3|||
146915083|NCT00960440|529851971|FG003|Overall Study|Lack of Efficacy|8|||
146915084|NCT00960440|529851968|FG000|Overall Study|Protocol Violation|2|||
146569474|NCT01055613|528597288|FG001|Overall Study|Subject Disinterest|1|||
146569475|NCT00363311|528597289|FG000|Overall Study|Adverse Event|6|||
146650431|NCT01087788|528896778|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
146650432|NCT01087788|528896776|FG000|24-weeks Dose-blind Period|Patient moved|0|||
146650433|NCT01087788|528896777|FG001|24-weeks Dose-blind Period|Patient moved|0|||
146770405|NCT02709655|529327429|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
146770406|NCT02709655|529327430|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
146770407|NCT02709655|529327431|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
146770408|NCT02709655|529327427|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
146770409|NCT02709655|529327428|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
146770410|NCT02709655|529327429|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
146770411|NCT02709655|529327430|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
146770412|NCT02709655|529327431|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
146770413|NCT02709655|529327427|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
146770414|NCT02709655|529327428|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
146770415|NCT02709655|529327429|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
146770416|NCT02709655|529327430|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
146770417|NCT02709655|529327431|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
146770418|NCT02709655|529327427|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
146770419|NCT02709655|529327428|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
146770420|NCT02709655|529327429|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
146770421|NCT02709655|529327430|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
146770422|NCT02709655|529327431|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
146770423|NCT02709655|529327427|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
146770424|NCT02709655|529327428|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
146770425|NCT02709655|529327429|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
146770426|NCT02709655|529327430|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
146770427|NCT02709655|529327431|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
146770428|NCT02709655|529327427|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
146770429|NCT02709655|529327428|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
146770430|NCT02709655|529327429|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
146770431|NCT02709655|529327430|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
146770432|NCT02709655|529327431|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
146770433|NCT02709655|529327427|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
146770434|NCT02709655|529327428|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
146770435|NCT02709655|529327429|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
146770436|NCT02709655|529327430|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
146770437|NCT02709655|529327431|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
146770438|NCT02709655|529327427|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
146770439|NCT02709655|529327428|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
146770440|NCT02709655|529327429|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
146770441|NCT02709655|529327430|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
146770442|NCT02709655|529327431|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
146770443|NCT02709655|529327427|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
146770444|NCT02709655|529327428|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
146915085|NCT00960440|529851969|FG001|Overall Study|Protocol Violation|8|||
146915086|NCT00960440|529851970|FG002|Overall Study|Protocol Violation|3|||
146569476|NCT00363311|528597290|FG001|Overall Study|Adverse Event|4|||
146569477|NCT00363311|528597289|FG000|Overall Study|Lost to Follow-up|3|||
146569478|NCT00363311|528597290|FG001|Overall Study|Lost to Follow-up|0|||
146569479|NCT00363311|528597289|FG000|Overall Study|Protocol Violation|1|||
146569480|NCT00363311|528597290|FG001|Overall Study|Protocol Violation|2|||
146569481|NCT00363311|528597289|FG000|Overall Study|Withdrawal by Subject|12|||
146770445|NCT02709655|529327429|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
146770446|NCT02709655|529327430|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
146770447|NCT02709655|529327431|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
146770448|NCT02709655|529327427|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
146770449|NCT02709655|529327428|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
146770450|NCT02709655|529327429|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
146770451|NCT02709655|529327430|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
146770452|NCT02709655|529327431|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
146770453|NCT02709655|529327427|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
146770454|NCT02709655|529327428|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
146770455|NCT02709655|529327429|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
146569482|NCT00363311|528597290|FG001|Overall Study|Withdrawal by Subject|6|||
146569483|NCT00363311|528597289|FG000|Overall Study|Physician Decision|1|||
146569484|NCT00363311|528597290|FG001|Overall Study|Physician Decision|1|||
146569485|NCT00363311|528597289|FG000|Overall Study|Sponsor Terminated Study|2|||
146569486|NCT00363311|528597290|FG001|Overall Study|Sponsor Terminated Study|2|||
146569487|NCT00363311|528597289|FG000|Overall Study|Disease Progression|46|||
146569488|NCT00363311|528597290|FG001|Overall Study|Disease Progression|26|||
146569489|NCT00363311|528597289|FG000|Overall Study|Non-Compliance|1|||
146569490|NCT00363311|528597290|FG001|Overall Study|Non-Compliance|1|||
146569491|NCT00363311|528597289|FG000|Overall Study|Participant Refused Biopsy|1|||
146569492|NCT00363311|528597290|FG001|Overall Study|Participant Refused Biopsy|0|||
146569493|NCT00363311|528597289|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
146569494|NCT00363311|528597290|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
146569495|NCT00363311|528597289|FG000|Overall Study|Participant Opted for Treatment|1|||
146569496|NCT00363311|528597290|FG001|Overall Study|Participant Opted for Treatment|0|||
146569497|NCT00363311|528597289|FG000|Overall Study|Participant Moved to Another Country|1|||
146569498|NCT00363311|528597290|FG001|Overall Study|Participant Moved to Another Country|0|||
146569499|NCT00363311|528597289|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
146569500|NCT00363311|528597290|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
146569501|NCT00363311|528597289|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
146569502|NCT00363311|528597290|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
146770456|NCT02709655|529327430|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
146770457|NCT02709655|529327431|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
146770458|NCT02709655|529327427|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
146770459|NCT02709655|529327428|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
146770460|NCT02709655|529327429|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
146770461|NCT02709655|529327430|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
146770462|NCT02709655|529327431|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
146770463|NCT02709655|529327427|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
146770464|NCT02709655|529327428|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
146770465|NCT02709655|529327429|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
146770466|NCT02709655|529327430|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
146770467|NCT02709655|529327431|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
146770468|NCT02709655|529327427|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
146770469|NCT02709655|529327428|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
146770470|NCT02709655|529327429|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
146770471|NCT02709655|529327430|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
146976348|NCT01021137|530075718|FG000|Overall Study|Lost to Follow-up|9|||
146569503|NCT00363311|528597289|FG000|Overall Study|Participant Moved to Louisiana|0|||
146569504|NCT00363311|528597290|FG001|Overall Study|Participant Moved to Louisiana|1|||
146569505|NCT02103062|528597295|FG000|Overall Study|Adverse Event|1|||
146569506|NCT02103062|528597296|FG001|Overall Study|Adverse Event|2|||
146569507|NCT02103062|528597295|FG000|Overall Study|Progressive Disease|17|||
146569508|NCT02103062|528597296|FG001|Overall Study|Progressive Disease|20|||
146569509|NCT02103062|528597295|FG000|Overall Study|Death|0|||
146569510|NCT02103062|528597296|FG001|Overall Study|Death|1|||
146770472|NCT02709655|529327431|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
146770473|NCT00026312|529327432|FG000|Overall Study|Adverse Event|0|||
146770474|NCT00026312|529327433|FG001|Overall Study|Adverse Event|32|||
146569511|NCT01182298|528597297|FG000|Overall Study|Lack of Efficacy|4|||
146569512|NCT01182298|528597297|FG000|Overall Study|Withdrawal by Subject|2|||
146569513|NCT01595529|528597298|FG000|Overall Study|Adverse Event|2|||
146569514|NCT01595529|528597299|FG001|Overall Study|Adverse Event|0|||
146569515|NCT01595529|528597298|FG000|Overall Study|Subject Non-Compliant|2|||
146569516|NCT01595529|528597299|FG001|Overall Study|Subject Non-Compliant|0|||
146569517|NCT01595529|528597298|FG000|Overall Study|Lost to Follow-up|8|||
146509209|NCT00808639|528367772|FG000|Overall Study|Disease progression before surgery.|1|||
146509210|NCT00191282|528367775|FG000|Overall Study|Adverse Event|5|||
146915087|NCT00960440|529851971|FG003|Overall Study|Protocol Violation|4|||
146915088|NCT00960440|529851968|FG000|Overall Study|Withdrawal by Subject|9|||
146915089|NCT00960440|529851969|FG001|Overall Study|Withdrawal by Subject|5|||
146915090|NCT00960440|529851970|FG002|Overall Study|Withdrawal by Subject|2|||
146915091|NCT00960440|529851971|FG003|Overall Study|Withdrawal by Subject|1|||
146915092|NCT00960440|529851968|FG000|Overall Study|Other|1|||
146915093|NCT00960440|529851969|FG001|Overall Study|Other|1|||
146915094|NCT00960440|529851970|FG002|Overall Study|Other|1|||
146915095|NCT00960440|529851971|FG003|Overall Study|Other|0|||
146915096|NCT03504774|529851972|FG000|Overall Study|Adverse Event|2|||
146915097|NCT03504774|529851973|FG001|Overall Study|Adverse Event|0|||
146915098|NCT03504774|529851972|FG000|Overall Study|Lost to Follow-up|0|||
146915099|NCT03504774|529851973|FG001|Overall Study|Lost to Follow-up|1|||
146915100|NCT03504774|529851972|FG000|Overall Study|Protocol Violation|11|||
146915101|NCT03504774|529851973|FG001|Overall Study|Protocol Violation|3|||
146915102|NCT03504774|529851972|FG000|Overall Study|failed wk 52 DBPCFC|1|||
146915103|NCT03504774|529851973|FG001|Overall Study|failed wk 52 DBPCFC|0|||
146915104|NCT01781429|529851974|FG000|Overall Study|Death|0|||
146915105|NCT01781429|529851975|FG001|Overall Study|Death|0|||
146915106|NCT01781429|529851976|FG002|Overall Study|Death|0|||
146915107|NCT01781429|529851977|FG003|Overall Study|Death|0|||
146915108|NCT01781429|529851978|FG004|Overall Study|Death|0|||
146915109|NCT01781429|529851979|FG005|Overall Study|Death|0|||
146915110|NCT01781429|529851980|FG006|Overall Study|Death|0|||
146915111|NCT01781429|529851981|FG007|Overall Study|Death|0|||
146915112|NCT01781429|529851982|FG008|Overall Study|Death|0|||
146915113|NCT01781429|529851983|FG009|Overall Study|Death|1|||
146915114|NCT01781429|529851984|FG010|Overall Study|Death|0|||
146915115|NCT01781429|529851985|FG011|Overall Study|Death|0|||
146915116|NCT01781429|529851986|FG012|Overall Study|Death|1|||
146915117|NCT01781429|529851987|FG013|Overall Study|Death|0|||
146915118|NCT01781429|529851988|FG014|Overall Study|Death|1|||
146915119|NCT01781429|529851989|FG015|Overall Study|Death|0|||
146915120|NCT01781429|529851974|FG000|Overall Study|Withdrawal by Subject|0|||
146915121|NCT01781429|529851975|FG001|Overall Study|Withdrawal by Subject|0|||
146915122|NCT01781429|529851976|FG002|Overall Study|Withdrawal by Subject|0|||
146915123|NCT01781429|529851977|FG003|Overall Study|Withdrawal by Subject|0|||
146915124|NCT01781429|529851978|FG004|Overall Study|Withdrawal by Subject|0|||
146915125|NCT01781429|529851979|FG005|Overall Study|Withdrawal by Subject|0|||
146915126|NCT01781429|529851980|FG006|Overall Study|Withdrawal by Subject|0|||
146915127|NCT01781429|529851981|FG007|Overall Study|Withdrawal by Subject|0|||
146915128|NCT01781429|529851982|FG008|Overall Study|Withdrawal by Subject|1|||
146915129|NCT01781429|529851983|FG009|Overall Study|Withdrawal by Subject|3|||
146915130|NCT01781429|529851984|FG010|Overall Study|Withdrawal by Subject|1|||
146915131|NCT01781429|529851985|FG011|Overall Study|Withdrawal by Subject|1|||
146915132|NCT01781429|529851986|FG012|Overall Study|Withdrawal by Subject|5|||
146915133|NCT01781429|529851987|FG013|Overall Study|Withdrawal by Subject|2|||
146915134|NCT01781429|529851988|FG014|Overall Study|Withdrawal by Subject|3|||
146915135|NCT01781429|529851989|FG015|Overall Study|Withdrawal by Subject|0|||
146915136|NCT01781429|529851974|FG000|Overall Study|Disease Progression|1|||
146915137|NCT01781429|529851975|FG001|Overall Study|Disease Progression|0|||
146915138|NCT01781429|529851976|FG002|Overall Study|Disease Progression|1|||
146915139|NCT01781429|529851977|FG003|Overall Study|Disease Progression|1|||
146915140|NCT01781429|529851978|FG004|Overall Study|Disease Progression|1|||
146915141|NCT01781429|529851979|FG005|Overall Study|Disease Progression|4|||
146915142|NCT01781429|529851980|FG006|Overall Study|Disease Progression|7|||
146915143|NCT01781429|529851981|FG007|Overall Study|Disease Progression|4|||
146915144|NCT01781429|529851982|FG008|Overall Study|Disease Progression|6|||
146915145|NCT01781429|529851983|FG009|Overall Study|Disease Progression|15|||
146509211|NCT00191282|528367776|FG001|Overall Study|Adverse Event|6|||
146915146|NCT01781429|529851984|FG010|Overall Study|Disease Progression|15|||
146915147|NCT01781429|529851985|FG011|Overall Study|Disease Progression|15|||
146915148|NCT01781429|529851986|FG012|Overall Study|Disease Progression|15|||
146915149|NCT01781429|529851987|FG013|Overall Study|Disease Progression|4|||
146915150|NCT01781429|529851988|FG014|Overall Study|Disease Progression|11|||
146915151|NCT01781429|529851989|FG015|Overall Study|Disease Progression|0|||
146915152|NCT01781429|529851974|FG000|Overall Study|Unacceptable Toxicity|0|||
146915153|NCT01781429|529851975|FG001|Overall Study|Unacceptable Toxicity|0|||
146915154|NCT01781429|529851976|FG002|Overall Study|Unacceptable Toxicity|0|||
146915155|NCT01781429|529851977|FG003|Overall Study|Unacceptable Toxicity|0|||
146915156|NCT01781429|529851978|FG004|Overall Study|Unacceptable Toxicity|0|||
146915157|NCT01781429|529851979|FG005|Overall Study|Unacceptable Toxicity|0|||
146915158|NCT01781429|529851980|FG006|Overall Study|Unacceptable Toxicity|0|||
146915159|NCT01781429|529851981|FG007|Overall Study|Unacceptable Toxicity|0|||
146509212|NCT00191282|528367775|FG000|Overall Study|Death|51|||
146915160|NCT01781429|529851982|FG008|Overall Study|Unacceptable Toxicity|0|||
146915161|NCT01781429|529851983|FG009|Overall Study|Unacceptable Toxicity|0|||
146915162|NCT01781429|529851984|FG010|Overall Study|Unacceptable Toxicity|0|||
146509213|NCT00191282|528367776|FG001|Overall Study|Death|51|||
146509214|NCT00191282|528367775|FG000|Overall Study|Lack of Efficacy|11|||
146509215|NCT00191282|528367776|FG001|Overall Study|Lack of Efficacy|6|||
146509216|NCT00191282|528367775|FG000|Overall Study|Noncompliance|14|||
146509217|NCT00191282|528367776|FG001|Overall Study|Noncompliance|17|||
146509218|NCT00191282|528367775|FG000|Overall Study|Patient moved|11|||
146509219|NCT00191282|528367776|FG001|Overall Study|Patient moved|14|||
146509220|NCT00191282|528367775|FG000|Overall Study|Withdrawal by Subject|59|||
146509221|NCT00191282|528367776|FG001|Overall Study|Withdrawal by Subject|44|||
146509222|NCT00191282|528367775|FG000|Overall Study|Physician Decision|18|||
146509223|NCT00191282|528367776|FG001|Overall Study|Physician Decision|15|||
146509224|NCT00191282|528367775|FG000|Overall Study|Protocol entry criteria not met|14|||
146509225|NCT00191282|528367776|FG001|Overall Study|Protocol entry criteria not met|9|||
146509226|NCT00191282|528367775|FG000|Overall Study|Protocol Violation|9|||
146509227|NCT00191282|528367776|FG001|Overall Study|Protocol Violation|12|||
146509228|NCT00191282|528367775|FG000|Overall Study|Severity of outcome|2|||
146509229|NCT00191282|528367776|FG001|Overall Study|Severity of outcome|5|||
146509230|NCT00191282|528367775|FG000|Overall Study|Sponsor's decision|2|||
146509231|NCT00191282|528367776|FG001|Overall Study|Sponsor's decision|2|||
146509232|NCT00191282|528367775|FG000|Overall Study|Lost to Follow-up|24|||
146509233|NCT00191282|528367776|FG001|Overall Study|Lost to Follow-up|31|||
146509234|NCT04756154|528367777|FG000|Overall Study|Did not meet treatment day baseline|30|||
146509235|NCT04756154|528367778|FG001|Overall Study|Did not meet treatment day baseline|28|||
146509236|NCT04756154|528367779|FG002|Overall Study|Did not meet treatment day baseline|7|||
146509237|NCT04756154|528367777|FG000|Overall Study|Did not return for final sample collection|1|||
146509238|NCT04756154|528367778|FG001|Overall Study|Did not return for final sample collection|1|||
146509239|NCT04756154|528367779|FG002|Overall Study|Did not return for final sample collection|0|||
146509240|NCT04778059|528367780|FG000|Overall Study|Death|2|||
146509241|NCT04778059|528367781|FG001|Overall Study|Death|2|||
146509242|NCT04778059|528367782|FG002|Overall Study|Death|1|||
146509243|NCT04778059|528367783|FG003|Overall Study|Death|1|||
146509244|NCT04778059|528367784|FG004|Overall Study|Death|1|||
146509245|NCT04778059|528367780|FG000|Overall Study|Lost to Follow-up|0|||
146509246|NCT04778059|528367781|FG001|Overall Study|Lost to Follow-up|0|||
146509247|NCT04778059|528367782|FG002|Overall Study|Lost to Follow-up|0|||
146509248|NCT04778059|528367783|FG003|Overall Study|Lost to Follow-up|0|||
146509249|NCT04778059|528367784|FG004|Overall Study|Lost to Follow-up|1|||
146509250|NCT04778059|528367780|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
146509251|NCT04778059|528367781|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
146509252|NCT04778059|528367782|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
146509253|NCT04778059|528367783|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
146509254|NCT04778059|528367784|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
146509255|NCT02832375|528367785|FG000|Overall Study|Lost to Follow-up|1|||
146509256|NCT02832375|528367786|FG001|Overall Study|Lost to Follow-up|0|||
146509257|NCT02832375|528367785|FG000|Overall Study|Withdrawal of Consent|1|||
146509258|NCT02832375|528367786|FG001|Overall Study|Withdrawal of Consent|0|||
146509259|NCT00084318|528367792|FG000|Overall Study|Withdrawal by Subject|5|||
146509260|NCT00084318|528367793|FG001|Overall Study|Withdrawal by Subject|2|||
146509261|NCT00084318|528367792|FG000|Overall Study|Protocol Violation|15|||
146915163|NCT01781429|529851985|FG011|Overall Study|Unacceptable Toxicity|2|||
146915164|NCT01781429|529851986|FG012|Overall Study|Unacceptable Toxicity|0|||
146915165|NCT01781429|529851987|FG013|Overall Study|Unacceptable Toxicity|0|||
146915166|NCT01781429|529851988|FG014|Overall Study|Unacceptable Toxicity|0|||
146915167|NCT01781429|529851989|FG015|Overall Study|Unacceptable Toxicity|0|||
146915168|NCT01781429|529851974|FG000|Overall Study|Patient Condition Changed|0|||
146915169|NCT01781429|529851975|FG001|Overall Study|Patient Condition Changed|0|||
146915170|NCT01781429|529851976|FG002|Overall Study|Patient Condition Changed|0|||
146915171|NCT01781429|529851977|FG003|Overall Study|Patient Condition Changed|0|||
146915172|NCT01781429|529851978|FG004|Overall Study|Patient Condition Changed|0|||
146915173|NCT01781429|529851979|FG005|Overall Study|Patient Condition Changed|0|||
146915174|NCT01781429|529851980|FG006|Overall Study|Patient Condition Changed|0|||
146915175|NCT01781429|529851981|FG007|Overall Study|Patient Condition Changed|0|||
146915176|NCT01781429|529851982|FG008|Overall Study|Patient Condition Changed|0|||
146509262|NCT00084318|528367793|FG001|Overall Study|Protocol Violation|11|||
146509263|NCT00084318|528367792|FG000|Overall Study|No protocol treatment|2|||
146509264|NCT00084318|528367793|FG001|Overall Study|No protocol treatment|0|||
146509265|NCT03430895|528367794|FG000|Overall Study|Not Treated|2|||
146770475|NCT00026312|529327432|FG000|Overall Study|Death|1|||
146509266|NCT03026530|528367795|FG000|Overall Study|Lost to Follow-up|19|||
146509267|NCT03026530|528367796|FG001|Overall Study|Lost to Follow-up|24|||
146509268|NCT03026530|528367795|FG000|Overall Study|Protocol Violation|2|||
146976349|NCT01021137|530075719|FG001|Overall Study|Lost to Follow-up|4|||
146509269|NCT03026530|528367796|FG001|Overall Study|Protocol Violation|5|||
146509270|NCT03301740|528367797|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
146509271|NCT03301740|528367798|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
146915177|NCT01781429|529851983|FG009|Overall Study|Patient Condition Changed|4|||
146976350|NCT01021137|530075720|FG002|Overall Study|Lost to Follow-up|2|||
146569518|NCT01595529|528597299|FG001|Overall Study|Lost to Follow-up|14|||
146569519|NCT01595529|528597298|FG000|Overall Study|Protocol Violation|1|||
146569520|NCT01595529|528597299|FG001|Overall Study|Protocol Violation|2|||
146569521|NCT01595529|528597298|FG000|Overall Study|Physician Decision|1|||
146569522|NCT01595529|528597299|FG001|Overall Study|Physician Decision|0|||
146569523|NCT01595529|528597298|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
146569524|NCT01595529|528597299|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
146569525|NCT01595529|528597298|FG000|Overall Study|Administrative Decision|1|||
146976351|NCT01021137|530075721|FG003|Overall Study|Lost to Follow-up|6|||
146976352|NCT01021137|530075718|FG000|Overall Study|Withdrawal by Subject|1|||
146976353|NCT01021137|530075719|FG001|Overall Study|Withdrawal by Subject|0|||
146976354|NCT01021137|530075720|FG002|Overall Study|Withdrawal by Subject|0|||
146976355|NCT01021137|530075721|FG003|Overall Study|Withdrawal by Subject|3|||
146976356|NCT03125915|530075728|FG000|1 Month Follow up|Lost to Follow-up|3|||
146976357|NCT03125915|530075729|FG001|1 Month Follow up|Lost to Follow-up|3|||
146976358|NCT03125915|530075730|FG002|1 Month Follow up|Lost to Follow-up|2|||
146976359|NCT03125915|530075731|FG003|1 Month Follow up|Lost to Follow-up|3|||
146976360|NCT03125915|530075728|FG000|3 Month Follow-up|Lost to Follow-up|6|||
146976361|NCT03125915|530075729|FG001|3 Month Follow-up|Lost to Follow-up|4|||
146976362|NCT03125915|530075730|FG002|3 Month Follow-up|Lost to Follow-up|4|||
146976363|NCT03125915|530075731|FG003|3 Month Follow-up|Lost to Follow-up|2|||
146976364|NCT03125915|530075728|FG000|6 Month Follow-up|Lost to Follow-up|7|||
146569526|NCT01595529|528597299|FG001|Overall Study|Administrative Decision|0|||
146569527|NCT01595529|528597298|FG000|Overall Study|Entry Failure/Screening Failure|6|||
146569528|NCT01595529|528597299|FG001|Overall Study|Entry Failure/Screening Failure|1|||
146976365|NCT03125915|530075729|FG001|6 Month Follow-up|Lost to Follow-up|3|||
146976366|NCT03125915|530075730|FG002|6 Month Follow-up|Lost to Follow-up|6|||
146976367|NCT03125915|530075731|FG003|6 Month Follow-up|Lost to Follow-up|3|||
146976368|NCT02176642|530075736|FG000|Overall Study|Withdrawal by Subject|0|||
146976369|NCT02176642|530075737|FG001|Overall Study|Withdrawal by Subject|1|||
146976370|NCT01309828|530075739|FG000|Overall Study|Adverse Event|10|||
146976371|NCT01309828|530075740|FG001|Overall Study|Adverse Event|11|||
146976372|NCT01309828|530075739|FG000|Overall Study|Voluntary Withdrawal|5|||
146976373|NCT01309828|530075740|FG001|Overall Study|Voluntary Withdrawal|4|||
146976374|NCT01309828|530075739|FG000|Overall Study|Major Protocol Deviation|0|||
146976375|NCT01309828|530075740|FG001|Overall Study|Major Protocol Deviation|1|||
146976376|NCT01309828|530075739|FG000|Overall Study|Other|1|||
146976377|NCT01309828|530075740|FG001|Overall Study|Other|0|||
146976378|NCT00295620|530075741|FG000|Overall Study|Lost to Follow-up|9|||
146976379|NCT00295620|530075742|FG001|Overall Study|Lost to Follow-up|5|||
146569529|NCT02629861|528597305|FG000|Overall Study|Adverse Event|7|||
146569530|NCT02629861|528597306|FG001|Overall Study|Adverse Event|5|||
146569531|NCT02629861|528597307|FG002|Overall Study|Adverse Event|4|||
146569532|NCT02629861|528597305|FG000|Overall Study|Withdrawal by Subject|5|||
146569533|NCT02629861|528597306|FG001|Overall Study|Withdrawal by Subject|8|||
146569534|NCT02629861|528597307|FG002|Overall Study|Withdrawal by Subject|13|||
146569535|NCT02629861|528597305|FG000|Overall Study|Protocol Violation|2|||
146569536|NCT02629861|528597306|FG001|Overall Study|Protocol Violation|3|||
146569537|NCT02629861|528597307|FG002|Overall Study|Protocol Violation|7|||
146569538|NCT02629861|528597305|FG000|Overall Study|Lost to Follow-up|12|||
146569539|NCT02629861|528597306|FG001|Overall Study|Lost to Follow-up|9|||
146569540|NCT02629861|528597307|FG002|Overall Study|Lost to Follow-up|4|||
146569541|NCT02629861|528597305|FG000|Overall Study|Other|1|||
146569542|NCT02629861|528597306|FG001|Overall Study|Other|1|||
146569543|NCT02629861|528597307|FG002|Overall Study|Other|0|||
146569544|NCT02629861|528597305|FG000|Overall Study|Pregnancy|2|||
146569545|NCT02629861|528597306|FG001|Overall Study|Pregnancy|1|||
146569546|NCT02629861|528597307|FG002|Overall Study|Pregnancy|0|||
146569547|NCT00959907|528597308|FG000|Overall Study|Protocol Violation|0|||
146569548|NCT00959907|528597309|FG001|Overall Study|Protocol Violation|1|||
146569549|NCT00959907|528597308|FG000|Overall Study|Adverse Event|1|||
146569550|NCT00959907|528597309|FG001|Overall Study|Adverse Event|0|||
146569551|NCT00959907|528597308|FG000|Overall Study|Withdrawal by Subject|2|||
146569552|NCT00959907|528597309|FG001|Overall Study|Withdrawal by Subject|0|||
146976380|NCT00295620|530075741|FG000|Overall Study|Withdrawal by Subject|37|||
146976381|NCT00295620|530075742|FG001|Overall Study|Withdrawal by Subject|50|||
146569553|NCT03958331|528597310|FG000|Overall Study|Withdrawal by Subject|3|||
146976382|NCT00295620|530075741|FG000|Overall Study|Death|206|||
146976383|NCT00295620|530075742|FG001|Overall Study|Death|207|||
146976384|NCT00295620|530075741|FG000|Overall Study|Other reasons|10|||
146569554|NCT03958331|528597311|FG001|Overall Study|Withdrawal by Subject|1|||
146569555|NCT03958331|528597312|FG002|Overall Study|Withdrawal by Subject|5|||
146569556|NCT03958331|528597310|FG000|Overall Study|Weaned from medicine|2|||
146569557|NCT03958331|528597311|FG001|Overall Study|Weaned from medicine|0|||
146569558|NCT03958331|528597312|FG002|Overall Study|Weaned from medicine|0|||
146569559|NCT03958331|528597310|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
146976385|NCT00295620|530075742|FG001|Overall Study|Other reasons|9|||
146976386|NCT00295620|530075741|FG000|Overall Study|Discontinuation by sponsor|580|||
146569560|NCT03958331|528597311|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
146569561|NCT03958331|528597312|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
146569562|NCT00730886|528597313|FG000|Overall Study|Lost to Follow-up|1|||
146569563|NCT00730886|528597314|FG001|Overall Study|Lost to Follow-up|0|||
146569564|NCT00730886|528597313|FG000|Overall Study|Physician Decision|1|||
146569565|NCT00730886|528597314|FG001|Overall Study|Physician Decision|0|||
146569566|NCT01991483|528597315|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
146569567|NCT01991483|528597316|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
146569568|NCT01991483|528597317|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
146569569|NCT01991483|528597318|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
146569570|NCT01991483|528597315|FG000|Dose Level 600 mg|Physician Decision|0|||
146650434|NCT01087788|528896778|FG002|24-weeks Dose-blind Period|Patient moved|1|||
146650435|NCT01087788|528896776|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
146915178|NCT01781429|529851984|FG010|Overall Study|Patient Condition Changed|0|||
146915179|NCT01781429|529851985|FG011|Overall Study|Patient Condition Changed|1|||
146915180|NCT01781429|529851986|FG012|Overall Study|Patient Condition Changed|0|||
146915181|NCT01781429|529851987|FG013|Overall Study|Patient Condition Changed|1|||
146915182|NCT01781429|529851988|FG014|Overall Study|Patient Condition Changed|0|||
146915183|NCT01781429|529851989|FG015|Overall Study|Patient Condition Changed|0|||
146915184|NCT01781429|529851974|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
146915185|NCT01781429|529851975|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
146915186|NCT01781429|529851976|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
146915187|NCT01781429|529851977|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
146915188|NCT01781429|529851978|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
146915189|NCT01781429|529851979|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
146915190|NCT01781429|529851980|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
146915191|NCT01781429|529851981|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
146915192|NCT01781429|529851982|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
146915193|NCT01781429|529851983|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
146915194|NCT01781429|529851984|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
146915195|NCT01781429|529851985|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
146915196|NCT01781429|529851986|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
146915197|NCT01781429|529851987|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
146915198|NCT01781429|529851988|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
146915199|NCT01781429|529851989|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
146915200|NCT01781429|529851974|FG000|Overall Study|Enrolled, but not treated|0|||
146915201|NCT01781429|529851975|FG001|Overall Study|Enrolled, but not treated|0|||
146915202|NCT01781429|529851976|FG002|Overall Study|Enrolled, but not treated|0|||
146915203|NCT01781429|529851977|FG003|Overall Study|Enrolled, but not treated|0|||
146915204|NCT01781429|529851978|FG004|Overall Study|Enrolled, but not treated|0|||
146915205|NCT01781429|529851979|FG005|Overall Study|Enrolled, but not treated|0|||
146915206|NCT01781429|529851980|FG006|Overall Study|Enrolled, but not treated|0|||
146915207|NCT01781429|529851981|FG007|Overall Study|Enrolled, but not treated|0|||
146915208|NCT01781429|529851982|FG008|Overall Study|Enrolled, but not treated|0|||
146915209|NCT01781429|529851983|FG009|Overall Study|Enrolled, but not treated|0|||
146915210|NCT01781429|529851984|FG010|Overall Study|Enrolled, but not treated|1|||
146915211|NCT01781429|529851985|FG011|Overall Study|Enrolled, but not treated|0|||
146915212|NCT01781429|529851986|FG012|Overall Study|Enrolled, but not treated|0|||
146915213|NCT01781429|529851987|FG013|Overall Study|Enrolled, but not treated|0|||
146915214|NCT01781429|529851988|FG014|Overall Study|Enrolled, but not treated|0|||
146915215|NCT01781429|529851989|FG015|Overall Study|Enrolled, but not treated|0|||
146915216|NCT01035606|529851992|FG000|Overall Study|change in health, job demands,family|3|||
146915217|NCT01035606|529851993|FG001|Overall Study|change in health, job demands,family|3|||
146915218|NCT01035606|529851994|FG002|Overall Study|change in health, job demands,family|4|||
146915219|NCT01809262|529851995|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
146915220|NCT01809262|529851996|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
146915221|NCT01809262|529851997|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
146915222|NCT01809262|529851998|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
146915223|NCT01809262|529851999|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
146915224|NCT01809262|529852000|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
146915225|NCT01809262|529852001|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
146915226|NCT01809262|529852002|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
146569571|NCT01991483|528597316|FG001|Dose Level 600 mg|Physician Decision|0|||
146650436|NCT01087788|528896777|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
146650437|NCT01087788|528896778|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
146915227|NCT01809262|529852003|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
146915228|NCT01809262|529852004|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
146650438|NCT01087788|528896776|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
146915229|NCT01809262|529851995|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146915230|NCT01809262|529851996|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
146569572|NCT01991483|528597317|FG002|Dose Level 600 mg|Physician Decision|1|||
146770476|NCT00026312|529327433|FG001|Overall Study|Death|7|||
146569573|NCT01991483|528597318|FG003|Dose Level 600 mg|Physician Decision|0|||
146569574|NCT01991483|528597315|FG000|Dose Level 1000 mg|Protocol Violation|0|||
146569575|NCT01991483|528597316|FG001|Dose Level 1000 mg|Protocol Violation|0|||
146569576|NCT01991483|528597317|FG002|Dose Level 1000 mg|Protocol Violation|0|||
146569577|NCT01991483|528597318|FG003|Dose Level 1000 mg|Protocol Violation|1|||
146915231|NCT01809262|529851997|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146915232|NCT01809262|529851998|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146915233|NCT01809262|529851999|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146915234|NCT01809262|529852000|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146915235|NCT01809262|529852001|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146915236|NCT01809262|529852002|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146915237|NCT01809262|529852003|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146915238|NCT01809262|529852004|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146915239|NCT01505491|529852005|FG000|Overall Study|Other reason not listed|1|||
146915240|NCT01505491|529852006|FG001|Overall Study|Other reason not listed|0|||
146915241|NCT01505491|529852007|FG002|Overall Study|Other reason not listed|0|||
146915242|NCT01505491|529852005|FG000|Overall Study|Withdrawal by Subject|1|||
146915243|NCT01505491|529852006|FG001|Overall Study|Withdrawal by Subject|1|||
146915244|NCT01505491|529852007|FG002|Overall Study|Withdrawal by Subject|4|||
146915245|NCT01505491|529852005|FG000|Overall Study|Lost to Follow-up|0|||
146915246|NCT01505491|529852006|FG001|Overall Study|Lost to Follow-up|0|||
146915247|NCT01505491|529852007|FG002|Overall Study|Lost to Follow-up|1|||
146915248|NCT01740440|529852010|FG000|Overall Study|Lost to Follow-up|3|||
146915249|NCT01063751|529852012|FG000|Overall Study|Censored from analyses|42|||
146569578|NCT02030821|528597321|FG000|Overall Study|Physician Decision|2|||
146569579|NCT02030821|528597322|FG001|Overall Study|Physician Decision|2|||
146569580|NCT02030821|528597323|FG002|Overall Study|Physician Decision|5|||
146569581|NCT02030821|528597324|FG003|Overall Study|Physician Decision|2|||
146569582|NCT00716274|528597330|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
146569583|NCT00716274|528597331|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
146569584|NCT00716274|528597332|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
146569585|NCT00716274|528597333|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
146569586|NCT00716274|528597334|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
146569587|NCT00716274|528597335|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
146569588|NCT00716274|528597330|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
146569589|NCT00716274|528597331|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
146569590|NCT00716274|528597332|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
146569591|NCT00716274|528597333|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
146569592|NCT00716274|528597334|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
146569593|NCT00716274|528597335|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
146569594|NCT00716274|528597330|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
146569595|NCT00716274|528597331|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
146569596|NCT00716274|528597332|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
146569597|NCT00716274|528597333|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
146569598|NCT00716274|528597334|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
146569599|NCT00716274|528597335|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
146569600|NCT00716274|528597330|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
146569601|NCT00716274|528597331|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
146569602|NCT00716274|528597332|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
146569603|NCT00716274|528597333|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
146569604|NCT00716274|528597334|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
146569605|NCT00716274|528597335|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
146569606|NCT00716274|528597330|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
146569607|NCT00716274|528597331|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
146569608|NCT00716274|528597332|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
146569609|NCT00716274|528597333|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
146569610|NCT00716274|528597334|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
146569611|NCT00716274|528597335|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
146915250|NCT01063751|529852012|FG000|Overall Study|Withdrawal by Subject|34|||
146915251|NCT01063751|529852012|FG000|Overall Study|Lost to Follow-up|30|||
146915252|NCT01063751|529852012|FG000|Overall Study|Death|13|||
146770477|NCT00026312|529327432|FG000|Overall Study|Lack of Efficacy|19|||
146915253|NCT01063751|529852012|FG000|Overall Study|Sponsored Terminated Study|60|||
146915254|NCT01063751|529852012|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
146569612|NCT00716274|528597330|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
146569613|NCT00716274|528597331|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
146569614|NCT00716274|528597332|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
146569615|NCT00716274|528597333|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
146770478|NCT00026312|529327433|FG001|Overall Study|Lack of Efficacy|114|||
146770479|NCT00026312|529327432|FG000|Overall Study|Lost to Follow-up|0|||
146915255|NCT01063751|529852012|FG000|Overall Study|Investigator site closed|10|||
146915256|NCT01063751|529852012|FG000|Overall Study|Revision|6|||
146915257|NCT01063751|529852012|FG000|Overall Study|Physician Decision|4|||
146915258|NCT03408873|529852018|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
146915259|NCT03408873|529852018|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
146915260|NCT03408873|529852018|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
146915261|NCT03408873|529852018|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
146915262|NCT03408873|529852018|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
146915263|NCT03408873|529852018|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
146915264|NCT00406315|529852024|FG000|Overall Study|Death|1|||
146915265|NCT00406315|529852024|FG000|Overall Study|Adverse Event|39|||
146915266|NCT00406315|529852024|FG000|Overall Study|Laboratory Abnormality|4|||
146915267|NCT00406315|529852024|FG000|Overall Study|Lack of Efficacy|13|||
146915268|NCT00406315|529852024|FG000|Overall Study|Other|33|||
146915269|NCT00406315|529852024|FG000|Overall Study|Lost to Follow-up|21|||
146915270|NCT00406315|529852024|FG000|Overall Study|Withdrawal by Subject|30|||
146915271|NCT01312428|529852026|FG000|Overall Study|Study Termination|3|||
146915272|NCT01312428|529852027|FG001|Overall Study|Study Termination|4|||
146915273|NCT01797783|529852028|FG000|Overall Study|Adverse Event|1|||
146915274|NCT01797783|529852029|FG001|Overall Study|Adverse Event|1|||
146915275|NCT01797783|529852028|FG000|Overall Study|Withdrawal by Subject|1|||
146915276|NCT01797783|529852029|FG001|Overall Study|Withdrawal by Subject|0|||
146915277|NCT01525849|529852036|FG000|Overall Study|Lost to Follow-up|3|||
146915278|NCT01525849|529852037|FG001|Overall Study|Lost to Follow-up|2|||
146915279|NCT01525849|529852036|FG000|Overall Study|Withdrawal by Subject|1|||
146915280|NCT01525849|529852037|FG001|Overall Study|Withdrawal by Subject|9|||
146915281|NCT01525849|529852036|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
146915282|NCT01525849|529852037|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
146915283|NCT01525849|529852036|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
146915284|NCT01525849|529852037|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
146915285|NCT00339183|529852038|FG000|Overall Study|Adverse Event|5|||
146915286|NCT00339183|529852039|FG001|Overall Study|Adverse Event|3|||
146915287|NCT00339183|529852038|FG000|Overall Study|Withdrawal by Subject|16|||
146915288|NCT00339183|529852039|FG001|Overall Study|Withdrawal by Subject|19|||
146915289|NCT00339183|529852038|FG000|Overall Study|Physician Decision|2|||
146915290|NCT00339183|529852039|FG001|Overall Study|Physician Decision|4|||
146915291|NCT00339183|529852038|FG000|Overall Study|Lost to Follow-up|17|||
146915292|NCT00339183|529852039|FG001|Overall Study|Lost to Follow-up|17|||
146915293|NCT00339183|529852038|FG000|Overall Study|Protocol-specified criteria|12|||
146915294|NCT00339183|529852039|FG001|Overall Study|Protocol-specified criteria|8|||
146915295|NCT00339183|529852038|FG000|Overall Study|Missing reason|3|||
146915296|NCT00339183|529852039|FG001|Overall Study|Missing reason|1|||
146915297|NCT00339183|529852038|FG000|Overall Study|Other|46|||
146915298|NCT00339183|529852039|FG001|Overall Study|Other|40|||
146915299|NCT00339183|529852038|FG000|Overall Study|Ongoing|20|||
146915300|NCT00339183|529852039|FG001|Overall Study|Ongoing|13|||
146915301|NCT00793819|529852040|FG000|Overall Study|Adverse Event|8|||
146915302|NCT00793819|529852041|FG001|Overall Study|Adverse Event|4|||
146915303|NCT00793819|529852040|FG000|Overall Study|Lack of Efficacy|1|||
146915304|NCT00793819|529852041|FG001|Overall Study|Lack of Efficacy|1|||
146915305|NCT00793819|529852040|FG000|Overall Study|Withdrawal by Subject|4|||
146915306|NCT00793819|529852041|FG001|Overall Study|Withdrawal by Subject|3|||
146915307|NCT00793819|529852040|FG000|Overall Study|Lost to Follow-up|1|||
146915308|NCT00793819|529852041|FG001|Overall Study|Lost to Follow-up|1|||
146915309|NCT00446446|529852042|FG000|Overall Study|Death|10|||
146915310|NCT00446446|529852042|FG000|Overall Study|Withdrawal by Subject|6|||
146915311|NCT00446446|529852042|FG000|Overall Study|Other|4|||
146915312|NCT00446446|529852042|FG000|Overall Study|Disease Progession|2|||
146915313|NCT00446446|529852042|FG000|Overall Study|Adverse Event|1|||
146915314|NCT00446446|529852042|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
146915315|NCT00611130|529852047|FG000|Overall Study|Lost to Follow-up|25|||
146915316|NCT00611130|529852048|FG001|Overall Study|Lost to Follow-up|29|||
146915317|NCT00611130|529852047|FG000|Overall Study|Protocol noncompliance|7|||
146915318|NCT00611130|529852048|FG001|Overall Study|Protocol noncompliance|6|||
146509272|NCT03301740|528367797|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
146509273|NCT03301740|528367798|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
146915319|NCT00611130|529852047|FG000|Overall Study|Withdrawal by Subject|6|||
146915320|NCT00611130|529852048|FG001|Overall Study|Withdrawal by Subject|5|||
146915321|NCT00611130|529852047|FG000|Overall Study|Other|5|||
146915322|NCT00611130|529852048|FG001|Overall Study|Other|4|||
146915323|NCT00611130|529852047|FG000|Overall Study|Incarceration|3|||
146509274|NCT02637713|528367799|FG000|Overall Study|Screen Failure|2|||
146509275|NCT00778102|528367804|FG000|Overall Study|Adverse Event|8|||
146509276|NCT00778102|528367805|FG001|Overall Study|Adverse Event|5|||
146915324|NCT00611130|529852048|FG001|Overall Study|Incarceration|2|||
146915325|NCT00611130|529852047|FG000|Overall Study|Administrative|1|||
146915326|NCT00611130|529852048|FG001|Overall Study|Administrative|1|||
146915327|NCT00611130|529852047|FG000|Overall Study|Adverse Event|1|||
146915328|NCT00611130|529852048|FG001|Overall Study|Adverse Event|0|||
146915329|NCT00611130|529852047|FG000|Overall Study|Death|1|||
146915330|NCT00611130|529852048|FG001|Overall Study|Death|0|||
146915331|NCT03662334|529852050|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
146915332|NCT03662334|529852051|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
146915333|NCT01024465|529852057|FG000|Overall Study|Adverse Event|2|||
146915334|NCT01024465|529852057|FG000|Overall Study|Physician Decision|1|||
146915335|NCT03078608|529852061|FG000|Overall Study|Death|1|||
146915336|NCT03078608|529852062|FG001|Overall Study|Death|2|||
146915337|NCT03078608|529852063|FG002|Overall Study|Death|0|||
146915338|NCT03078608|529852064|FG003|Overall Study|Death|0|||
146915339|NCT03078608|529852061|FG000|Overall Study|Withdrawal by Subject|8|||
146915340|NCT03078608|529852062|FG001|Overall Study|Withdrawal by Subject|1|||
146915341|NCT03078608|529852063|FG002|Overall Study|Withdrawal by Subject|0|||
146915342|NCT03078608|529852064|FG003|Overall Study|Withdrawal by Subject|0|||
146915343|NCT03078608|529852061|FG000|Overall Study|Lost to Follow-up|5|||
146915344|NCT03078608|529852062|FG001|Overall Study|Lost to Follow-up|8|||
146915345|NCT03078608|529852063|FG002|Overall Study|Lost to Follow-up|4|||
146915346|NCT03078608|529852064|FG003|Overall Study|Lost to Follow-up|1|||
146915347|NCT00723840|529852065|FG000|Overall Study|Lost to Follow-up|2|||
146915348|NCT00723840|529852065|FG000|Overall Study|Failure to return|18|||
146915349|NCT00723840|529852065|FG000|Overall Study|Withdrawal by Subject|55|||
146915350|NCT00723840|529852065|FG000|Overall Study|Serious Adverse Events|3|||
146915351|NCT00723840|529852065|FG000|Overall Study|Other Medical Event|2|||
146915352|NCT00723840|529852065|FG000|Overall Study|Unspecified reason|2|||
146915353|NCT01400971|529852069|FG000|Overall Study|Death|82|||
146915354|NCT01400971|529852069|FG000|Overall Study|Lost to Follow-up|196|||
146915355|NCT01400971|529852069|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
146915356|NCT01400971|529852069|FG000|Overall Study|Physician Decision|57|||
146915357|NCT01400971|529852069|FG000|Overall Study|Withdrawal by Subject|158|||
146915358|NCT01400971|529852069|FG000|Overall Study|Other|422|||
146915359|NCT01161524|529852072|FG000|Core Study (23 Weeks)|Adverse Event|3|||
146915360|NCT01161524|529852073|FG001|Core Study (23 Weeks)|Adverse Event|0|||
146915361|NCT01161524|529852074|FG002|Core Study (23 Weeks)|Adverse Event|0|||
146915362|NCT01161524|529852072|FG000|Core Study (23 Weeks)|Other|1|||
146915363|NCT01161524|529852073|FG001|Core Study (23 Weeks)|Other|0|||
146915364|NCT01161524|529852074|FG002|Core Study (23 Weeks)|Other|0|||
146915365|NCT01161524|529852072|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
146915366|NCT01161524|529852073|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
146915367|NCT01161524|529852074|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
146915368|NCT01161524|529852072|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
146915369|NCT01161524|529852073|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
146915370|NCT01161524|529852074|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
146915371|NCT01161524|529852072|FG000|Core Study (23 Weeks)|Subject Choice|3|||
146915372|NCT01161524|529852073|FG001|Core Study (23 Weeks)|Subject Choice|2|||
146915373|NCT01161524|529852074|FG002|Core Study (23 Weeks)|Subject Choice|0|||
146915374|NCT01161524|529852072|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
146915375|NCT01161524|529852073|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
146915376|NCT01161524|529852074|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
146915377|NCT01161524|529852072|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
146915378|NCT01161524|529852073|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
146915379|NCT01161524|529852074|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
146915380|NCT01161524|529852072|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
146915381|NCT01161524|529852073|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
146915382|NCT01161524|529852074|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
146915383|NCT01161524|529852072|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
146915384|NCT01161524|529852073|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
146915385|NCT01161524|529852074|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
146915386|NCT01161524|529852072|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
146915387|NCT01161524|529852073|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
146915388|NCT01161524|529852074|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
146915389|NCT00642616|529852075|FG000|Overall Study|Adverse Event|2|||
146915390|NCT00642616|529852076|FG001|Overall Study|Adverse Event|0|||
146915391|NCT00642616|529852077|FG002|Overall Study|Adverse Event|1|||
146915392|NCT00642616|529852078|FG003|Overall Study|Adverse Event|0|||
146915393|NCT00642616|529852075|FG000|Overall Study|Study Terminated by Sponsor|7|||
146915394|NCT00642616|529852076|FG001|Overall Study|Study Terminated by Sponsor|6|||
146915395|NCT00642616|529852077|FG002|Overall Study|Study Terminated by Sponsor|4|||
146915396|NCT00642616|529852078|FG003|Overall Study|Study Terminated by Sponsor|5|||
146509277|NCT00778102|528367804|FG000|Overall Study|Death|1|||
146915397|NCT00642616|529852075|FG000|Overall Study|Withdrawal by Subject|0|||
146915398|NCT00642616|529852076|FG001|Overall Study|Withdrawal by Subject|1|||
146915399|NCT00642616|529852077|FG002|Overall Study|Withdrawal by Subject|1|||
146915400|NCT00642616|529852078|FG003|Overall Study|Withdrawal by Subject|1|||
146915401|NCT00642616|529852075|FG000|Overall Study|Protocol Violation|0|||
146915402|NCT00642616|529852076|FG001|Overall Study|Protocol Violation|0|||
146915403|NCT00642616|529852077|FG002|Overall Study|Protocol Violation|2|||
146976387|NCT00295620|530075742|FG001|Overall Study|Discontinuation by sponsor|593|||
146976388|NCT00295620|530075741|FG000|Overall Study|Protocol Violation|30|||
146976389|NCT00295620|530075742|FG001|Overall Study|Protocol Violation|32|||
146976390|NCT00217971|530075743|FG000|Overall Study|Adverse Event|1|||
146976391|NCT00217971|530075744|FG001|Overall Study|Adverse Event|1|||
146976392|NCT00217971|530075743|FG000|Overall Study|Lost to Follow-up|15|||
146976393|NCT00217971|530075744|FG001|Overall Study|Lost to Follow-up|19|||
146976394|NCT00217971|530075743|FG000|Overall Study|Physician Decision|0|||
146976395|NCT00217971|530075744|FG001|Overall Study|Physician Decision|1|||
146976396|NCT00217971|530075743|FG000|Overall Study|Withdrawal by Subject|7|||
146976397|NCT00217971|530075744|FG001|Overall Study|Withdrawal by Subject|12|||
146976398|NCT00217971|530075743|FG000|Overall Study|non compliant|1|||
146976399|NCT00217971|530075744|FG001|Overall Study|non compliant|0|||
146976400|NCT00084617|530075756|FG000|Overall Study|Withdrawal by Subject|7|||
146976401|NCT00084617|530075756|FG000|Overall Study|Lack of Efficacy|1|||
146976402|NCT00084617|530075756|FG000|Overall Study|Protocol Violation|1|||
146976403|NCT01625286|530075757|FG000|Overall Study|Adverse Event|0|||
146976404|NCT01625286|530075758|FG001|Overall Study|Adverse Event|0|||
146976405|NCT01625286|530075759|FG002|Overall Study|Adverse Event|0|||
146976406|NCT01625286|530075760|FG003|Overall Study|Adverse Event|0|||
146976407|NCT01625286|530075761|FG004|Overall Study|Adverse Event|1|||
146976408|NCT01625286|530075762|FG005|Overall Study|Adverse Event|2|||
146976409|NCT01625286|530075763|FG006|Overall Study|Adverse Event|1|||
146976410|NCT01625286|530075757|FG000|Overall Study|Death|0|||
146976411|NCT01625286|530075758|FG001|Overall Study|Death|0|||
146976412|NCT01625286|530075759|FG002|Overall Study|Death|1|||
146976413|NCT01625286|530075760|FG003|Overall Study|Death|1|||
146976414|NCT01625286|530075761|FG004|Overall Study|Death|0|||
146976415|NCT01625286|530075762|FG005|Overall Study|Death|11|||
146976416|NCT01625286|530075763|FG006|Overall Study|Death|16|||
146976417|NCT01625286|530075757|FG000|Overall Study|Withdrawal by Subject|0|||
146976418|NCT01625286|530075758|FG001|Overall Study|Withdrawal by Subject|1|||
146976419|NCT01625286|530075759|FG002|Overall Study|Withdrawal by Subject|0|||
146976420|NCT01625286|530075760|FG003|Overall Study|Withdrawal by Subject|1|||
146976421|NCT01625286|530075761|FG004|Overall Study|Withdrawal by Subject|0|||
146976422|NCT01625286|530075762|FG005|Overall Study|Withdrawal by Subject|0|||
146976423|NCT01625286|530075763|FG006|Overall Study|Withdrawal by Subject|1|||
146976424|NCT01625286|530075757|FG000|Overall Study|Any reason not specifically recorded|0|||
146976425|NCT01625286|530075758|FG001|Overall Study|Any reason not specifically recorded|0|||
146976426|NCT01625286|530075759|FG002|Overall Study|Any reason not specifically recorded|0|||
146650439|NCT01087788|528896777|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
146650440|NCT01087788|528896778|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
146915404|NCT00642616|529852078|FG003|Overall Study|Protocol Violation|0|||
146915405|NCT00642616|529852075|FG000|Overall Study|Physician Decision|0|||
146915406|NCT00642616|529852076|FG001|Overall Study|Physician Decision|0|||
146915407|NCT00642616|529852077|FG002|Overall Study|Physician Decision|1|||
146915408|NCT00642616|529852078|FG003|Overall Study|Physician Decision|1|||
146915409|NCT00399802|529852083|FG000|Overall Study|Adverse Event|0|||
146915410|NCT00399802|529852084|FG001|Overall Study|Adverse Event|2|||
146915411|NCT00399802|529852083|FG000|Overall Study|Participant discontinued by mistake|0|||
146915412|NCT00399802|529852084|FG001|Overall Study|Participant discontinued by mistake|1|||
146915413|NCT00542815|529852085|FG000|Overall Study|Adverse Event|19|||
146915414|NCT00542815|529852086|FG001|Overall Study|Adverse Event|6|||
146915415|NCT00542815|529852087|FG002|Overall Study|Adverse Event|9|||
146915416|NCT00542815|529852085|FG000|Overall Study|Death|10|||
146915417|NCT00542815|529852086|FG001|Overall Study|Death|7|||
146915418|NCT00542815|529852087|FG002|Overall Study|Death|3|||
146915419|NCT00542815|529852085|FG000|Overall Study|Lack of Efficacy|9|||
146915420|NCT00542815|529852086|FG001|Overall Study|Lack of Efficacy|2|||
146915421|NCT00542815|529852087|FG002|Overall Study|Lack of Efficacy|0|||
146915422|NCT00542815|529852085|FG000|Overall Study|Physician Decision|2|||
146915423|NCT00542815|529852086|FG001|Overall Study|Physician Decision|1|||
146976427|NCT01625286|530075760|FG003|Overall Study|Any reason not specifically recorded|0|||
146509278|NCT00778102|528367805|FG001|Overall Study|Death|1|||
146509279|NCT00778102|528367804|FG000|Overall Study|Lost to Follow-up|1|||
146509280|NCT00778102|528367805|FG001|Overall Study|Lost to Follow-up|0|||
146770480|NCT00026312|529327433|FG001|Overall Study|Lost to Follow-up|5|||
146915424|NCT00542815|529852087|FG002|Overall Study|Physician Decision|0|||
146915425|NCT00542815|529852085|FG000|Overall Study|Protocol Violation|1|||
146915426|NCT00542815|529852086|FG001|Overall Study|Protocol Violation|1|||
146915427|NCT00542815|529852087|FG002|Overall Study|Protocol Violation|2|||
146976428|NCT01625286|530075761|FG004|Overall Study|Any reason not specifically recorded|0|||
146976429|NCT01625286|530075762|FG005|Overall Study|Any reason not specifically recorded|1|||
146976430|NCT01625286|530075763|FG006|Overall Study|Any reason not specifically recorded|0|||
146976431|NCT01625286|530075757|FG000|Overall Study|Progressive disease|6|||
146976432|NCT01625286|530075758|FG001|Overall Study|Progressive disease|3|||
146976433|NCT01625286|530075759|FG002|Overall Study|Progressive disease|4|||
146976434|NCT01625286|530075760|FG003|Overall Study|Progressive disease|5|||
146976435|NCT01625286|530075761|FG004|Overall Study|Progressive disease|5|||
146976436|NCT01625286|530075762|FG005|Overall Study|Progressive disease|0|||
146976437|NCT01625286|530075763|FG006|Overall Study|Progressive disease|0|||
146976438|NCT01625286|530075757|FG000|Overall Study|Lost to Follow-up|0|||
146569616|NCT00716274|528597334|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
146569617|NCT00716274|528597335|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
146569618|NCT00716274|528597330|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
146569619|NCT00716274|528597331|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
146569620|NCT00716274|528597332|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
146569621|NCT00716274|528597333|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
146569622|NCT00716274|528597334|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
146569623|NCT00716274|528597335|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
146569624|NCT00716274|528597330|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
146569625|NCT00716274|528597331|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
146569626|NCT00716274|528597332|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
146569627|NCT00716274|528597333|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
146569628|NCT00716274|528597334|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
146569629|NCT00716274|528597335|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
146569630|NCT00716274|528597330|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
146569631|NCT00716274|528597331|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
146569632|NCT00716274|528597332|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
146569633|NCT00716274|528597333|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
146569634|NCT00716274|528597334|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
146569635|NCT00716274|528597335|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
146569636|NCT00716274|528597330|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
146569637|NCT00716274|528597331|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
146569638|NCT00716274|528597332|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
146569639|NCT00716274|528597333|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
146569640|NCT00716274|528597334|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
146569641|NCT00716274|528597335|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
146569642|NCT04021290|528597341|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
146569643|NCT04021290|528597342|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
146569644|NCT04021290|528597343|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
146569645|NCT04021290|528597341|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
146569646|NCT04021290|528597342|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
146569647|NCT04021290|528597343|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
146569648|NCT04021290|528597341|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
146569649|NCT04021290|528597342|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
146569650|NCT04021290|528597343|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
146569651|NCT04021290|528597341|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
146569652|NCT04021290|528597342|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
146569653|NCT04021290|528597343|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
146569654|NCT04021290|528597341|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
146569655|NCT04021290|528597342|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
146569656|NCT04021290|528597343|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
146569657|NCT04021290|528597341|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
146569658|NCT04021290|528597342|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
146569659|NCT04021290|528597343|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
146569660|NCT04021290|528597341|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
146569661|NCT04021290|528597342|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
146569662|NCT04021290|528597343|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
146569663|NCT04021290|528597341|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
146569664|NCT04021290|528597342|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
146569665|NCT04021290|528597343|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
146569666|NCT04021290|528597341|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
146569667|NCT04021290|528597342|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
146569668|NCT04021290|528597343|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
146569669|NCT04021290|528597341|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
146569670|NCT04021290|528597342|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
146650441|NCT01087788|528896776|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
146650442|NCT01087788|528896777|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
146650443|NCT01087788|528896778|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
146650444|NCT01087788|528896776|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
146650445|NCT01087788|528896777|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
146650446|NCT01087788|528896778|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
146650447|NCT01087788|528896776|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
146650448|NCT01087788|528896777|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
146976439|NCT01625286|530075758|FG001|Overall Study|Lost to Follow-up|0|||
146770481|NCT00026312|529327432|FG000|Overall Study|Physician Decision|1|||
146976440|NCT01625286|530075759|FG002|Overall Study|Lost to Follow-up|0|||
146915428|NCT00542815|529852085|FG000|Overall Study|Withdrawal by Subject|41|||
146915429|NCT00542815|529852086|FG001|Overall Study|Withdrawal by Subject|5|||
146915430|NCT00542815|529852087|FG002|Overall Study|Withdrawal by Subject|8|||
146915431|NCT00542815|529852085|FG000|Overall Study|Other reasons|24|||
146915432|NCT00542815|529852086|FG001|Overall Study|Other reasons|10|||
146915433|NCT00542815|529852087|FG002|Overall Study|Other reasons|10|||
146915434|NCT01041573|529852090|FG000|Overall Study|Withdrawal by Subject|2|||
146915435|NCT01041573|529852091|FG001|Overall Study|Withdrawal by Subject|5|||
146915436|NCT01041573|529852092|FG002|Overall Study|Withdrawal by Subject|2|||
146915437|NCT01041573|529852093|FG003|Overall Study|Withdrawal by Subject|0|||
146915438|NCT01041573|529852090|FG000|Overall Study|Death|1|||
146915439|NCT01041573|529852091|FG001|Overall Study|Death|0|||
146915440|NCT01041573|529852092|FG002|Overall Study|Death|0|||
146915441|NCT01041573|529852093|FG003|Overall Study|Death|0|||
146915442|NCT01041573|529852090|FG000|Overall Study|Lost to Follow-up|0|||
146915443|NCT01041573|529852091|FG001|Overall Study|Lost to Follow-up|1|||
146915444|NCT01041573|529852092|FG002|Overall Study|Lost to Follow-up|2|||
146915445|NCT01041573|529852093|FG003|Overall Study|Lost to Follow-up|1|||
146915446|NCT01041573|529852090|FG000|Overall Study|Adverse Event|0|||
146915447|NCT01041573|529852091|FG001|Overall Study|Adverse Event|2|||
146915448|NCT01041573|529852092|FG002|Overall Study|Adverse Event|0|||
146915449|NCT01041573|529852093|FG003|Overall Study|Adverse Event|0|||
146915450|NCT01041573|529852090|FG000|Overall Study|relocation|1|||
146915451|NCT01041573|529852091|FG001|Overall Study|relocation|4|||
146915452|NCT01041573|529852092|FG002|Overall Study|relocation|3|||
146915453|NCT01041573|529852093|FG003|Overall Study|relocation|1|||
146915454|NCT01041573|529852090|FG000|Overall Study|further blood extraction|0|||
146915455|NCT01041573|529852091|FG001|Overall Study|further blood extraction|1|||
146915456|NCT01041573|529852092|FG002|Overall Study|further blood extraction|0|||
146915457|NCT01041573|529852093|FG003|Overall Study|further blood extraction|0|||
146915458|NCT01041573|529852090|FG000|Overall Study|positive to anti-HCV|1|||
146915459|NCT01041573|529852091|FG001|Overall Study|positive to anti-HCV|0|||
146915460|NCT01041573|529852092|FG002|Overall Study|positive to anti-HCV|0|||
146915461|NCT01041573|529852093|FG003|Overall Study|positive to anti-HCV|0|||
146915462|NCT02955186|529852094|FG000|Overall Study|Withdrawal by Subject|6|||
146915463|NCT02955186|529852095|FG001|Overall Study|Withdrawal by Subject|2|||
146915464|NCT02955186|529852094|FG000|Overall Study|Protocol Violation|1|||
146915465|NCT02955186|529852095|FG001|Overall Study|Protocol Violation|0|||
146915466|NCT01276847|529852098|FG000|Overall Study|Withdrawal by Subject|1|||
146915467|NCT01276847|529852099|FG001|Overall Study|Withdrawal by Subject|0|||
146915468|NCT01276847|529852100|FG002|Overall Study|Withdrawal by Subject|0|||
146915469|NCT01618656|529852101|FG000|Overall Study|Withdrawal by Subject|7|||
146915470|NCT01618656|529852102|FG001|Overall Study|Withdrawal by Subject|3|||
146915471|NCT01618656|529852101|FG000|Overall Study|Physician Decision|1|||
146915472|NCT01618656|529852102|FG001|Overall Study|Physician Decision|1|||
146915473|NCT01899144|529852103|FG000|Treatment Period 2|Other|1|||
146915474|NCT01899144|529852103|FG000|Treatment Period 3|Other|2|||
146915475|NCT01899144|529852103|FG000|Treatment Period 5|Other|1|||
146915476|NCT00751881|529852106|FG000|Core Treatment Period|Not treated|1|||
146915477|NCT00751881|529852107|FG001|Core Treatment Period|Not treated|1|||
146915478|NCT00751881|529852108|FG002|Core Treatment Period|Not treated|2|||
146915479|NCT00751881|529852106|FG000|Core Treatment Period|Adverse Event|26|||
146915480|NCT00751881|529852107|FG001|Core Treatment Period|Adverse Event|54|||
146915481|NCT00751881|529852108|FG002|Core Treatment Period|Adverse Event|58|||
146915482|NCT00751881|529852106|FG000|Core Treatment Period|Lack of Efficacy|37|||
146915483|NCT00751881|529852107|FG001|Core Treatment Period|Lack of Efficacy|30|||
146915484|NCT00751881|529852108|FG002|Core Treatment Period|Lack of Efficacy|20|||
146915485|NCT00751881|529852106|FG000|Core Treatment Period|Poor compliance to protocol|15|||
146915486|NCT00751881|529852107|FG001|Core Treatment Period|Poor compliance to protocol|3|||
146915487|NCT00751881|529852108|FG002|Core Treatment Period|Poor compliance to protocol|4|||
146915488|NCT00751881|529852106|FG000|Core Treatment Period|Lost to Follow-up|6|||
146915489|NCT00751881|529852107|FG001|Core Treatment Period|Lost to Follow-up|4|||
146915490|NCT00751881|529852108|FG002|Core Treatment Period|Lost to Follow-up|3|||
146915491|NCT00751881|529852106|FG000|Core Treatment Period|Other: protocol deviation|3|||
146915492|NCT00751881|529852107|FG001|Core Treatment Period|Other: protocol deviation|3|||
146915493|NCT00751881|529852108|FG002|Core Treatment Period|Other: protocol deviation|7|||
146915494|NCT00751881|529852106|FG000|Core Treatment Period|Other: wish to parent|5|||
146915495|NCT00751881|529852107|FG001|Core Treatment Period|Other: wish to parent|7|||
146915496|NCT00751881|529852108|FG002|Core Treatment Period|Other: wish to parent|4|||
146915497|NCT00751881|529852106|FG000|Core Treatment Period|Other: personal/family constraints|6|||
146915498|NCT00751881|529852107|FG001|Core Treatment Period|Other: personal/family constraints|7|||
146915499|NCT00751881|529852108|FG002|Core Treatment Period|Other: personal/family constraints|10|||
146915500|NCT00751881|529852106|FG000|Core Treatment Period|Other: MS treatment change|6|||
146915501|NCT00751881|529852107|FG001|Core Treatment Period|Other: MS treatment change|4|||
146915502|NCT00751881|529852108|FG002|Core Treatment Period|Other: MS treatment change|4|||
146915503|NCT00751881|529852106|FG000|Core Treatment Period|Other: tolerability complaints|2|||
146976441|NCT01625286|530075760|FG003|Overall Study|Lost to Follow-up|0|||
146650449|NCT01087788|528896778|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
146650450|NCT01087788|528896776|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
146650451|NCT01087788|528896777|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
146650452|NCT01087788|528896778|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
146650453|NCT01087788|528896776|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
146650454|NCT01087788|528896777|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
146650455|NCT01087788|528896778|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
146650456|NCT01087788|528896776|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
146650457|NCT01087788|528896777|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
146650458|NCT01087788|528896778|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
146650459|NCT01087788|528896776|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
146650460|NCT01087788|528896777|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
146650461|NCT01087788|528896778|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
146650462|NCT01087788|528896776|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
146650463|NCT01087788|528896777|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
146650464|NCT01087788|528896778|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
146650465|NCT01087788|528896776|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
146650466|NCT01087788|528896777|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
146650467|NCT01087788|528896778|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
146650468|NCT01087788|528896776|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
146650469|NCT01087788|528896777|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
146650470|NCT01087788|528896778|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
146650471|NCT01087788|528896776|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
146650472|NCT01087788|528896777|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
146650473|NCT01087788|528896778|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
146650474|NCT04604132|528896779|FG000|Overall Study|Adverse Event|2|||
146509281|NCT00778102|528367804|FG000|Overall Study|Violation of Selection Criteria|1|||
146509282|NCT00778102|528367805|FG001|Overall Study|Violation of Selection Criteria|1|||
146509283|NCT00778102|528367804|FG000|Overall Study|Protocol Violation|0|||
146509284|NCT00778102|528367805|FG001|Overall Study|Protocol Violation|1|||
146509285|NCT00778102|528367804|FG000|Overall Study|Refused Treatment|2|||
146509286|NCT00778102|528367805|FG001|Overall Study|Refused Treatment|3|||
146509287|NCT00778102|528367804|FG000|Overall Study|Withdrawal by Subject|1|||
146509288|NCT00778102|528367805|FG001|Overall Study|Withdrawal by Subject|1|||
146509289|NCT00778102|528367804|FG000|Overall Study|Administrative Reason|7|||
146509290|NCT00778102|528367805|FG001|Overall Study|Administrative Reason|10|||
146509291|NCT03976323|528367808|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
146509292|NCT03976323|528367809|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
146509293|NCT03976323|528367810|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
146509294|NCT03976323|528367808|FG000|Induction Phase|Death|80|||
146509295|NCT03976323|528367809|FG001|Induction Phase|Death|0|||
146509296|NCT03976323|528367810|FG002|Induction Phase|Death|0|||
146509297|NCT03976323|528367808|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
146509298|NCT03976323|528367809|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
146509299|NCT03976323|528367810|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
146509300|NCT03976323|528367808|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146509301|NCT03976323|528367809|FG001|Maintenance Phase|Withdrawal by Subject|9|||
146509302|NCT03976323|528367810|FG002|Maintenance Phase|Withdrawal by Subject|3|||
146509303|NCT03976323|528367808|FG000|Maintenance Phase|Physician Decision|0|||
146509304|NCT03976323|528367809|FG001|Maintenance Phase|Physician Decision|0|||
146509305|NCT03976323|528367810|FG002|Maintenance Phase|Physician Decision|1|||
146509306|NCT03976323|528367808|FG000|Maintenance Phase|Death|0|||
146509307|NCT03976323|528367809|FG001|Maintenance Phase|Death|228|||
146509308|NCT03976323|528367810|FG002|Maintenance Phase|Death|234|||
146509309|NCT02294461|528367811|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
146509310|NCT02294461|528367812|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
146509311|NCT02294461|528367813|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
146509312|NCT02294461|528367811|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
146509313|NCT02294461|528367812|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
146509314|NCT02294461|528367813|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
146509315|NCT02294461|528367811|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
146509316|NCT02294461|528367812|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
146509317|NCT02294461|528367813|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
146509318|NCT02294461|528367811|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
146509319|NCT02294461|528367812|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
146509320|NCT02294461|528367813|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
146509321|NCT02294461|528367811|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
146509322|NCT02294461|528367812|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
146509323|NCT02294461|528367813|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
146770482|NCT00026312|529327433|FG001|Overall Study|Physician Decision|37|||
146915504|NCT00751881|529852107|FG001|Core Treatment Period|Other: tolerability complaints|0|||
146915505|NCT00751881|529852108|FG002|Core Treatment Period|Other: tolerability complaints|0|||
146915506|NCT00751881|529852106|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
146915507|NCT00751881|529852107|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
146915508|NCT00751881|529852108|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
146915509|NCT00751881|529852106|FG000|Extension Study Period|Adverse Event|18|||
146915510|NCT00751881|529852107|FG001|Extension Study Period|Adverse Event|20|||
146915511|NCT00751881|529852108|FG002|Extension Study Period|Adverse Event|21|||
146915512|NCT00751881|529852106|FG000|Extension Study Period|Lack of Efficacy|14|||
146915513|NCT00751881|529852107|FG001|Extension Study Period|Lack of Efficacy|10|||
146915514|NCT00751881|529852108|FG002|Extension Study Period|Lack of Efficacy|20|||
146915515|NCT00751881|529852106|FG000|Extension Study Period|Lost to Follow-up|4|||
146915516|NCT00751881|529852107|FG001|Extension Study Period|Lost to Follow-up|9|||
146915517|NCT00751881|529852108|FG002|Extension Study Period|Lost to Follow-up|6|||
146915518|NCT00751881|529852106|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
146915519|NCT00751881|529852107|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
146915520|NCT00751881|529852108|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
146915521|NCT00751881|529852106|FG000|Extension Study Period|Other than specified above|26|||
146915522|NCT00751881|529852107|FG001|Extension Study Period|Other than specified above|30|||
146915523|NCT00751881|529852108|FG002|Extension Study Period|Other than specified above|18|||
146915524|NCT04770155|529852109|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
146915525|NCT04770155|529852110|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
146915526|NCT04770155|529852111|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
146915527|NCT04770155|529852112|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
146915528|NCT04770155|529852113|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
146915529|NCT04770155|529852114|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
146915530|NCT04770155|529852115|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
146915531|NCT04770155|529852116|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
146569671|NCT04021290|528597343|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
146569672|NCT04021290|528597341|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
146569673|NCT04021290|528597342|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
146569674|NCT04021290|528597343|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
146915532|NCT02021812|529852117|FG000|Overall Study|Death|8|||
146569675|NCT04021290|528597341|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
146569676|NCT04021290|528597342|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
146915533|NCT02021812|529852117|FG000|Overall Study|Withdrawal by Subject|3|||
146915534|NCT02021812|529852117|FG000|Overall Study|Lost to Follow-up|2|||
146915535|NCT02021812|529852117|FG000|Overall Study|Refuse to return, COVD 19|2|||
146915536|NCT00564629|529852118|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
146915537|NCT00564629|529852119|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
146915538|NCT03634072|529852120|FG000|Overall Study|Early termination of overall study|1|||
146915539|NCT03634072|529852121|FG001|Overall Study|Early termination of overall study|0|||
146915540|NCT01765764|529852122|FG000|Treatment Period|Adverse Event|1|||
146915541|NCT01765764|529852123|FG001|Treatment Period|Adverse Event|2|||
146915542|NCT01765764|529852124|FG002|Treatment Period|Adverse Event|1|||
146915543|NCT01765764|529852122|FG000|Treatment Period|Lost to Follow-up|0|||
146915544|NCT01765764|529852123|FG001|Treatment Period|Lost to Follow-up|3|||
146915545|NCT01765764|529852124|FG002|Treatment Period|Lost to Follow-up|2|||
146915546|NCT01765764|529852122|FG000|Treatment Period|Personal Reasons|1|||
146915547|NCT01765764|529852123|FG001|Treatment Period|Personal Reasons|2|||
146915548|NCT01765764|529852124|FG002|Treatment Period|Personal Reasons|1|||
146915549|NCT01765764|529852122|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
146915550|NCT01765764|529852123|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
146915551|NCT01765764|529852124|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
146569677|NCT04021290|528597343|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
146569678|NCT01174563|528597353|FG000|Overall Study|Progressive Disease|45|||
146569679|NCT01174563|528597353|FG000|Overall Study|Death|5|||
146569680|NCT01174563|528597353|FG000|Overall Study|Investigator's Discretion|5|||
146569681|NCT01174563|528597353|FG000|Overall Study|Participant Withdrew Consent|3|||
146569682|NCT01174563|528597353|FG000|Overall Study|Rash Adverse Event|1|||
146569683|NCT01174563|528597353|FG000|Overall Study|Sponsor's decision|1|||
146569684|NCT00444106|528597354|FG000|Overall Study|Lost to Follow-up|2|||
146569685|NCT00444106|528597355|FG001|Overall Study|Lost to Follow-up|1|||
146569686|NCT00444106|528597356|FG002|Overall Study|Lost to Follow-up|0|||
146569687|NCT00444106|528597354|FG000|Overall Study|Abnormal Test Procedure Results|0|||
146915552|NCT02144220|529852129|FG000|Overall Study|technology incompatibility|9|||
146915553|NCT02144220|529852129|FG000|Overall Study|Lack of Efficacy|4|||
146915554|NCT02144220|529852129|FG000|Overall Study|Physician Decision|3|||
146650475|NCT04604132|528896780|FG001|Overall Study|Adverse Event|0|||
146650476|NCT04604132|528896781|FG002|Overall Study|Adverse Event|0|||
146650477|NCT04604132|528896782|FG003|Overall Study|Adverse Event|1|||
146650478|NCT04604132|528896783|FG004|Overall Study|Adverse Event|2|||
146650479|NCT04604132|528896779|FG000|Overall Study|Study terminated by sponsor|0|||
146650480|NCT04604132|528896780|FG001|Overall Study|Study terminated by sponsor|0|||
146650481|NCT04604132|528896781|FG002|Overall Study|Study terminated by sponsor|0|||
146650482|NCT04604132|528896782|FG003|Overall Study|Study terminated by sponsor|0|||
146650483|NCT04604132|528896783|FG004|Overall Study|Study terminated by sponsor|1|||
146650484|NCT04604132|528896779|FG000|Overall Study|Progressive disease: Clinical progression|0|||
146650485|NCT04604132|528896780|FG001|Overall Study|Progressive disease: Clinical progression|0|||
146650486|NCT04604132|528896781|FG002|Overall Study|Progressive disease: Clinical progression|1|||
146650487|NCT04604132|528896782|FG003|Overall Study|Progressive disease: Clinical progression|0|||
146770483|NCT00026312|529327432|FG000|Overall Study|Protocol Violation|0|||
146770484|NCT00026312|529327433|FG001|Overall Study|Protocol Violation|3|||
146770485|NCT00026312|529327432|FG000|Overall Study|Withdrawal by Subject|1|||
146770486|NCT00026312|529327433|FG001|Overall Study|Withdrawal by Subject|6|||
146770487|NCT00026312|529327432|FG000|Overall Study|Ineligible|4|||
146770488|NCT00026312|529327433|FG001|Overall Study|Ineligible|5|||
146770489|NCT00026312|529327432|FG000|Overall Study|Entry onto another COG study|0|||
146770490|NCT00026312|529327433|FG001|Overall Study|Entry onto another COG study|1|||
146770491|NCT00026312|529327432|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
146770492|NCT00026312|529327433|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
146770493|NCT02445391|529327434|FG000|Overall Study|No active protocol treatment|3|||
146770494|NCT02445391|529327435|FG001|Overall Study|No active protocol treatment|0|||
146770495|NCT02445391|529327436|FG002|Overall Study|No active protocol treatment|0|||
146770496|NCT02445391|529327434|FG000|Overall Study|Adverse Event|0|||
146770497|NCT02445391|529327435|FG001|Overall Study|Adverse Event|21|||
146770498|NCT02445391|529327436|FG002|Overall Study|Adverse Event|12|||
146770499|NCT02445391|529327434|FG000|Overall Study|Alternative therapy|0|||
146770500|NCT02445391|529327435|FG001|Overall Study|Alternative therapy|0|||
146770501|NCT02445391|529327436|FG002|Overall Study|Alternative therapy|1|||
146770502|NCT02445391|529327434|FG000|Overall Study|Disease progression|0|||
146770503|NCT02445391|529327435|FG001|Overall Study|Disease progression|7|||
146770504|NCT02445391|529327436|FG002|Overall Study|Disease progression|22|||
146770505|NCT02445391|529327434|FG000|Overall Study|Complicating disease|0|||
146770506|NCT02445391|529327435|FG001|Overall Study|Complicating disease|2|||
146770507|NCT02445391|529327436|FG002|Overall Study|Complicating disease|1|||
146770508|NCT02445391|529327434|FG000|Overall Study|Withdrawal by Subject|0|||
146770509|NCT02445391|529327435|FG001|Overall Study|Withdrawal by Subject|4|||
146770510|NCT02445391|529327436|FG002|Overall Study|Withdrawal by Subject|9|||
146770511|NCT02445391|529327434|FG000|Overall Study|Financial issue|0|||
146770512|NCT02445391|529327435|FG001|Overall Study|Financial issue|0|||
146770513|NCT02445391|529327436|FG002|Overall Study|Financial issue|2|||
146770514|NCT02445391|529327434|FG000|Overall Study|Still on treatment|0|||
146509324|NCT02294461|528367811|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
146509325|NCT02294461|528367812|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
146509326|NCT02294461|528367813|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
146509327|NCT02294461|528367811|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
146509328|NCT02294461|528367812|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
146509329|NCT02294461|528367813|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
146509330|NCT02294461|528367811|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
146509331|NCT02294461|528367812|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
146509332|NCT02294461|528367813|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
146509333|NCT02294461|528367811|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
146509334|NCT02294461|528367812|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
146509335|NCT02294461|528367813|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
146509336|NCT02294461|528367811|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
146509337|NCT02294461|528367812|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
146509338|NCT02294461|528367813|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
146509339|NCT02294461|528367811|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
146509340|NCT02294461|528367812|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
146509341|NCT02294461|528367813|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
146509342|NCT02294461|528367811|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
146509343|NCT02294461|528367812|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
146770515|NCT02445391|529327435|FG001|Overall Study|Still on treatment|7|||
146770516|NCT02445391|529327436|FG002|Overall Study|Still on treatment|16|||
146650488|NCT04604132|528896783|FG004|Overall Study|Progressive disease: Clinical progression|0|||
146650489|NCT04604132|528896779|FG000|Overall Study|Progressive disease: Radiological progression|8|||
146770517|NCT02445391|529327434|FG000|Overall Study|Not start protocol therapy|0|||
146770518|NCT02445391|529327435|FG001|Overall Study|Not start protocol therapy|12|||
146770519|NCT02445391|529327436|FG002|Overall Study|Not start protocol therapy|9|||
146569688|NCT00444106|528597355|FG001|Overall Study|Abnormal Test Procedure Results|0|||
146569689|NCT00444106|528597356|FG002|Overall Study|Abnormal Test Procedure Results|1|||
146569690|NCT01634152|528597357|FG000|Overall Study|Adverse Event|2|||
146915555|NCT02144220|529852129|FG000|Overall Study|Withdrawal by Subject|2|||
146915556|NCT02144220|529852129|FG000|Overall Study|Protocol Violation|1|||
146915557|NCT01952015|529852132|FG000|Induction|Protocol Violation|1|||
146915558|NCT01952015|529852132|FG000|Maintenance|Adverse Event|2|||
146915559|NCT01952015|529852132|FG000|Treatment Period 3|Physician Decision|9|||
146915560|NCT01597193|529852133|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
146915561|NCT01597193|529852134|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
146915562|NCT01597193|529852135|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
146915563|NCT01597193|529852136|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
146915564|NCT01597193|529852137|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
146915565|NCT01597193|529852138|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
146915566|NCT01597193|529852139|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
146915567|NCT01597193|529852133|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
146915568|NCT01597193|529852134|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
146915569|NCT01597193|529852135|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
146915570|NCT01597193|529852136|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
146915571|NCT01597193|529852137|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
146915572|NCT01597193|529852138|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
146915573|NCT01597193|529852139|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
146915574|NCT01597193|529852133|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
146915575|NCT01597193|529852134|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
146915576|NCT01597193|529852135|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
146915577|NCT01597193|529852136|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
146915578|NCT01597193|529852137|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
146915579|NCT01597193|529852138|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
146915580|NCT01597193|529852139|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
146915581|NCT01597193|529852133|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
146915582|NCT01597193|529852134|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
146915583|NCT01597193|529852135|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
146915584|NCT01597193|529852136|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
146915585|NCT01597193|529852137|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
146915586|NCT01597193|529852138|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
146915587|NCT01597193|529852139|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
146915588|NCT01597193|529852133|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
146915589|NCT01597193|529852134|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
146915590|NCT01597193|529852135|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
146569691|NCT01634152|528597358|FG001|Overall Study|Adverse Event|0|||
146569692|NCT01634152|528597359|FG002|Overall Study|Adverse Event|2|||
146569693|NCT01634152|528597357|FG000|Overall Study|Consent withdrawn not due to AE|1|||
146569694|NCT01634152|528597358|FG001|Overall Study|Consent withdrawn not due to AE|0|||
146569695|NCT01634152|528597359|FG002|Overall Study|Consent withdrawn not due to AE|1|||
146569696|NCT01634152|528597357|FG000|Overall Study|Not treated|0|||
146569697|NCT01634152|528597358|FG001|Overall Study|Not treated|1|||
146569698|NCT01634152|528597359|FG002|Overall Study|Not treated|0|||
146569699|NCT01634152|528597357|FG000|Overall Study|Other reason not defined above|1|||
146569700|NCT01634152|528597358|FG001|Overall Study|Other reason not defined above|0|||
146569701|NCT01634152|528597359|FG002|Overall Study|Other reason not defined above|1|||
146569702|NCT01152437|528597363|FG000|Overall Study|Other Adverse Event|8|||
146569703|NCT01152437|528597364|FG001|Overall Study|Other Adverse Event|1|||
146569704|NCT01152437|528597365|FG002|Overall Study|Other Adverse Event|7|||
146569705|NCT01152437|528597363|FG000|Overall Study|Not treated|0|||
146569706|NCT01152437|528597364|FG001|Overall Study|Not treated|1|||
146569707|NCT01152437|528597365|FG002|Overall Study|Not treated|2|||
146569708|NCT01152437|528597363|FG000|Overall Study|Progressive disease|27|||
146569709|NCT01152437|528597364|FG001|Overall Study|Progressive disease|13|||
146569710|NCT01152437|528597365|FG002|Overall Study|Progressive disease|32|||
146569711|NCT01152437|528597363|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
146569712|NCT01152437|528597364|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
146569713|NCT01152437|528597365|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
146569714|NCT02015039|528597366|FG000|Overall Study|Not eligible|0|||
146569715|NCT02015039|528597367|FG001|Overall Study|Not eligible|1|||
146569716|NCT00279214|528597372|FG000|Overall Study|Physician Decision|3|||
146569717|NCT00279214|528597373|FG001|Overall Study|Physician Decision|2|||
146569718|NCT01897532|528597375|FG000|Discontinuation From Treatment|Not Treated|7|||
146569719|NCT01897532|528597376|FG001|Discontinuation From Treatment|Not Treated|5|||
146569720|NCT01897532|528597375|FG000|Discontinuation From Treatment|Other reason than specified|196|||
146650490|NCT04604132|528896780|FG001|Overall Study|Progressive disease: Radiological progression|7|||
146915591|NCT01597193|529852136|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
146915592|NCT01597193|529852137|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
146915593|NCT01597193|529852138|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
146915594|NCT01597193|529852139|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
146915595|NCT03184701|529852141|FG000|Overall Study|Death|3|||
146915596|NCT03184701|529852141|FG000|Overall Study|Physician Decision|3|||
146915597|NCT03184701|529852141|FG000|Overall Study|Withdrawal by Subject|6|||
146915598|NCT03184701|529852141|FG000|Overall Study|Lost to Follow-up|5|||
146915599|NCT03242759|529852142|FG000|Overall Study|Adverse Event|5|||
146915600|NCT03242759|529852143|FG001|Overall Study|Adverse Event|1|||
146915601|NCT03242759|529852142|FG000|Overall Study|Withdrawal by Subject|4|||
146915602|NCT03242759|529852143|FG001|Overall Study|Withdrawal by Subject|3|||
146915603|NCT03242759|529852142|FG000|Overall Study|Lost to Follow-up|3|||
146915604|NCT03242759|529852143|FG001|Overall Study|Lost to Follow-up|1|||
146915605|NCT03242759|529852142|FG000|Overall Study|Administrative problems|1|||
146915606|NCT03242759|529852143|FG001|Overall Study|Administrative problems|1|||
146915607|NCT03242759|529852142|FG000|Overall Study|Death|22|||
146915608|NCT03242759|529852143|FG001|Overall Study|Death|0|||
146915609|NCT03242759|529852142|FG000|Overall Study|Change visit schedule|0|||
146915610|NCT03242759|529852143|FG001|Overall Study|Change visit schedule|1|||
146915611|NCT00064662|529852144|FG000|Overall Study|Death|1|||
146915612|NCT00064662|529852145|FG001|Overall Study|Death|1|||
146915613|NCT00064662|529852144|FG000|Overall Study|Lost to Follow-up|57|||
146915614|NCT00064662|529852145|FG001|Overall Study|Lost to Follow-up|44|||
146915615|NCT00064662|529852144|FG000|Overall Study|Withdrawal by Subject|14|||
146915616|NCT00064662|529852145|FG001|Overall Study|Withdrawal by Subject|14|||
146915617|NCT00064662|529852144|FG000|Overall Study|Administratively withdrawn|2|||
146915618|NCT00064662|529852145|FG001|Overall Study|Administratively withdrawn|2|||
146915619|NCT01254604|529853488|FG000|Overall Study|Lost to Follow-up|1|||
146915620|NCT01254604|529853489|FG001|Overall Study|Lost to Follow-up|1|||
146915621|NCT01254604|529853488|FG000|Overall Study|Protocol Violation|2|||
146915622|NCT01254604|529853489|FG001|Overall Study|Protocol Violation|2|||
146915623|NCT01254604|529853488|FG000|Overall Study|Withdrawal by Subject|2|||
146915624|NCT01254604|529853489|FG001|Overall Study|Withdrawal by Subject|4|||
146915625|NCT01254604|529853488|FG000|Overall Study|Adverse Event|3|||
146915626|NCT01254604|529853489|FG001|Overall Study|Adverse Event|2|||
146915627|NCT03074162|529853490|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
146509344|NCT02294461|528367813|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
146509345|NCT02294461|528367811|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
146509346|NCT02294461|528367812|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
146509347|NCT02294461|528367813|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
146509348|NCT02294461|528367811|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
146509349|NCT02294461|528367812|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
146509350|NCT02294461|528367813|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
146509351|NCT04676412|528368938|FG000|Overall Study|Death|28|||
146509352|NCT04676412|528368939|FG001|Overall Study|Death|31|||
146509353|NCT04676412|528368938|FG000|Overall Study|Lost to Follow-up|1|||
146509354|NCT04676412|528368939|FG001|Overall Study|Lost to Follow-up|2|||
146509355|NCT04676412|528368938|FG000|Overall Study|Sponsor Decision|20|||
146509356|NCT04676412|528368939|FG001|Overall Study|Sponsor Decision|23|||
146509357|NCT04676412|528368938|FG000|Overall Study|Withdrawal by Subject|0|||
146509358|NCT04676412|528368939|FG001|Overall Study|Withdrawal by Subject|2|||
146509359|NCT01371877|528368945|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
146509360|NCT01371877|528368946|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
146509361|NCT05932225|528368947|FG000|Overall Study|Lost to Follow-up|0|||
146509362|NCT05932225|528368948|FG001|Overall Study|Lost to Follow-up|1|||
146509363|NCT05932225|528368949|FG002|Overall Study|Lost to Follow-up|0|||
146509364|NCT05932225|528368947|FG000|Overall Study|Withdrawal by Subject|1|||
146509365|NCT05932225|528368948|FG001|Overall Study|Withdrawal by Subject|0|||
146509366|NCT05932225|528368949|FG002|Overall Study|Withdrawal by Subject|0|||
146509367|NCT05932225|528368947|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
146915628|NCT03074162|529853491|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
146915629|NCT03074162|529853492|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
146976442|NCT01625286|530075761|FG004|Overall Study|Lost to Follow-up|0|||
146509368|NCT05932225|528368948|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
146509369|NCT05932225|528368949|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
146509370|NCT01027897|528368950|FG000|Overall Study|Protocol Violation|1|||
146509371|NCT01027897|528368950|FG000|Overall Study|Withdrawal by Subject|1|||
146509372|NCT02667626|528368951|FG000|Overall Study|Withdrawal by Subject|0|||
146915630|NCT03074162|529853493|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
146915631|NCT03074162|529853494|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
146915632|NCT03074162|529853495|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
146915633|NCT03074162|529853490|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
146915634|NCT03074162|529853491|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
146915635|NCT03074162|529853492|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
146915636|NCT03074162|529853493|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
146976443|NCT01625286|530075762|FG005|Overall Study|Lost to Follow-up|0|||
146915637|NCT03074162|529853494|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
146915638|NCT03074162|529853495|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
146915639|NCT03074162|529853490|FG000|Period 3|Withdrawal by Subject|1|||
146915640|NCT03074162|529853491|FG001|Period 3|Withdrawal by Subject|0|||
146915641|NCT03074162|529853492|FG002|Period 3|Withdrawal by Subject|0|||
146915642|NCT03074162|529853493|FG003|Period 3|Withdrawal by Subject|0|||
146915643|NCT03074162|529853494|FG004|Period 3|Withdrawal by Subject|1|||
146915644|NCT03074162|529853495|FG005|Period 3|Withdrawal by Subject|0|||
146915645|NCT02948777|529853501|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
146915646|NCT03242928|529853502|FG000|Overall Study|Adverse Event|2|||
146915647|NCT03242928|529853503|FG001|Overall Study|Adverse Event|1|||
146915648|NCT03242928|529853502|FG000|Overall Study|Lost to Follow-up|2|||
146915649|NCT03242928|529853503|FG001|Overall Study|Lost to Follow-up|0|||
146915650|NCT03242928|529853502|FG000|Overall Study|Physician Decision|0|||
146915651|NCT03242928|529853503|FG001|Overall Study|Physician Decision|1|||
146915652|NCT03242928|529853502|FG000|Overall Study|Withdrawal by Subject|5|||
146915653|NCT03242928|529853503|FG001|Overall Study|Withdrawal by Subject|3|||
146915654|NCT00625365|529853507|FG000|Overall Study|Withdrawal by Subject|1|||
146915655|NCT00625365|529853507|FG000|Overall Study|No IV access|5|||
146915656|NCT00625365|529853507|FG000|Overall Study|VSD|1|||
146915657|NCT01703286|529853515|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
146915658|NCT01703286|529853516|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
146915659|NCT01703286|529853517|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
146915660|NCT01703286|529853518|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
146915661|NCT01703286|529853519|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
146915662|NCT01703286|529853520|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
146915663|NCT01703286|529853515|FG000|Period 2 Including Washout|Adverse Event|0|||
146915664|NCT01703286|529853516|FG001|Period 2 Including Washout|Adverse Event|0|||
146915665|NCT01703286|529853517|FG002|Period 2 Including Washout|Adverse Event|0|||
146915666|NCT01703286|529853518|FG003|Period 2 Including Washout|Adverse Event|1|||
146915667|NCT01703286|529853519|FG004|Period 2 Including Washout|Adverse Event|0|||
146915668|NCT01703286|529853520|FG005|Period 2 Including Washout|Adverse Event|0|||
146915669|NCT02421120|529853521|FG000|Overall Study|Adverse Event|1|||
146915670|NCT00931892|529853522|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
146915671|NCT00931892|529853523|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
146915672|NCT01876732|529853524|FG000|Overall Study|MMA was not over 800mg/dL|75|||
146915673|NCT02207530|529853525|FG000|Overall Study|Worsening condition under investigation|78|||
146915674|NCT02207530|529853525|FG000|Overall Study|Patient decision to stop study treatment|5|||
146915675|NCT02207530|529853525|FG000|Overall Study|Adverse Event|8|||
146915676|NCT00305006|529853526|FG000|Overall Study|Withdrawal by Subject|1|||
146915677|NCT00305006|529853527|FG001|Overall Study|Withdrawal by Subject|0|||
146915678|NCT00305006|529853526|FG000|Overall Study|Failure to complete pretest|0|||
146915679|NCT00305006|529853527|FG001|Overall Study|Failure to complete pretest|1|||
146569721|NCT01897532|528597376|FG001|Discontinuation From Treatment|Other reason than specified|176|||
146569722|NCT01897532|528597375|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
146569723|NCT01897532|528597376|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
146569724|NCT01897532|528597375|FG000|Discontinuation From Treatment|Non compliance|24|||
146569725|NCT01897532|528597376|FG001|Discontinuation From Treatment|Non compliance|15|||
146569726|NCT01897532|528597375|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
146569727|NCT01897532|528597376|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
146569728|NCT01897532|528597375|FG000|Discontinuation From Trial|Not Treated|7|||
146569729|NCT01897532|528597376|FG001|Discontinuation From Trial|Not Treated|5|||
146569730|NCT01897532|528597375|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
146569731|NCT01897532|528597376|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
146569732|NCT00953706|528597379|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
146569733|NCT00953706|528597380|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
146569734|NCT00953706|528597381|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
146569735|NCT00953706|528597382|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
146569736|NCT00953706|528597379|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
146569737|NCT00953706|528597380|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
146915680|NCT01996319|529853528|FG000|Overall Study|Protocol Violation|1|||
146915681|NCT01996319|529853529|FG001|Overall Study|Protocol Violation|0|||
146915682|NCT01996319|529853528|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
146915683|NCT01996319|529853529|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
146976444|NCT01625286|530075763|FG006|Overall Study|Lost to Follow-up|1|||
146569738|NCT00953706|528597381|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
146915684|NCT01996319|529853528|FG000|Overall Study|Adverse Event|2|||
146915685|NCT01996319|529853529|FG001|Overall Study|Adverse Event|2|||
146915686|NCT06094296|529853530|FG000|Overall Study|Progressive Disease|1|||
146915687|NCT06094296|529853531|FG001|Overall Study|Progressive Disease|0|||
146915688|NCT06094296|529853532|FG002|Overall Study|Progressive Disease|0|||
146915689|NCT06094296|529853533|FG003|Overall Study|Progressive Disease|0|||
146915690|NCT00986258|529853534|FG000|Observation Period|Not eligible to be dosed|11|||
146915691|NCT00986258|529853534|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
146915692|NCT00986258|529853534|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
146915693|NCT00986258|529853534|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
146915694|NCT00986258|529853534|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
146915695|NCT00986258|529853534|FG000|Titration and Optimal Dose Period|Other|1|||
146915696|NCT00986258|529853534|FG000|Maintenance Period|Adverse Event|5|||
146915697|NCT00986258|529853534|FG000|Maintenance Period|Lack of Efficacy|2|||
146915698|NCT00986258|529853534|FG000|Maintenance Period|Withdrawal by Subject|2|||
146915699|NCT03332667|529853535|FG000|Overall Study|Adverse Event|0|||
146915700|NCT03332667|529853536|FG001|Overall Study|Adverse Event|0|||
146915701|NCT03332667|529853537|FG002|Overall Study|Adverse Event|2|||
146915702|NCT03332667|529853538|FG003|Overall Study|Adverse Event|1|||
146915703|NCT03332667|529853535|FG000|Overall Study|Withdrawal by Subject|2|||
146915704|NCT03332667|529853536|FG001|Overall Study|Withdrawal by Subject|1|||
146915705|NCT03332667|529853537|FG002|Overall Study|Withdrawal by Subject|5|||
146915706|NCT03332667|529853538|FG003|Overall Study|Withdrawal by Subject|1|||
146915707|NCT03332667|529853535|FG000|Overall Study|Disease Progression or Relapse|2|||
146915708|NCT03332667|529853536|FG001|Overall Study|Disease Progression or Relapse|1|||
146915709|NCT03332667|529853537|FG002|Overall Study|Disease Progression or Relapse|3|||
146915710|NCT03332667|529853538|FG003|Overall Study|Disease Progression or Relapse|0|||
146915711|NCT03332667|529853535|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
146915712|NCT03332667|529853536|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
146915713|NCT03332667|529853537|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
146915714|NCT03332667|529853538|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
146915715|NCT03332667|529853535|FG000|Overall Study|No Treatment Received|0|||
146915716|NCT03332667|529853536|FG001|Overall Study|No Treatment Received|0|||
146915717|NCT03332667|529853537|FG002|Overall Study|No Treatment Received|1|||
146915718|NCT03332667|529853538|FG003|Overall Study|No Treatment Received|0|||
146915719|NCT04964063|529853539|FG000|Overall Study|Adverse Event|4|||
146915720|NCT04964063|529853539|FG000|Overall Study|Lost to Follow-up|47|||
146915721|NCT04964063|529853539|FG000|Overall Study|Withdrawal by Subject|5|||
146915722|NCT04964063|529853539|FG000|Overall Study|Baseline Tasks Expired|41|||
146915723|NCT04964063|529853539|FG000|Overall Study|Participant withdrawn in error|1|||
146915724|NCT01120093|529853542|FG000|Treatment Period 1|Adverse Event|0|||
146915725|NCT01120093|529853543|FG001|Treatment Period 1|Adverse Event|0|||
146915726|NCT01120093|529853544|FG002|Treatment Period 1|Adverse Event|1|||
146915727|NCT01120093|529853545|FG003|Treatment Period 1|Adverse Event|0|||
146915728|NCT01120093|529853546|FG004|Treatment Period 1|Adverse Event|1|||
146915729|NCT01120093|529853542|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146915730|NCT01120093|529853543|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146915731|NCT01120093|529853544|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146915732|NCT01120093|529853545|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146915733|NCT01120093|529853546|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146915734|NCT01120093|529853542|FG000|Treatment Period 2|Adverse Event|0|||
146915735|NCT01120093|529853543|FG001|Treatment Period 2|Adverse Event|0|||
146915736|NCT01120093|529853544|FG002|Treatment Period 2|Adverse Event|0|||
146915737|NCT01120093|529853545|FG003|Treatment Period 2|Adverse Event|1|||
146915738|NCT01120093|529853546|FG004|Treatment Period 2|Adverse Event|0|||
146915739|NCT01120093|529853542|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146976445|NCT00928135|530075764|FG000|Overall Study|Withdrawal by Subject|1|||
146569739|NCT00953706|528597382|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
146569740|NCT00953706|528597379|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
146569741|NCT00953706|528597380|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
146569742|NCT00953706|528597381|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
146569743|NCT00953706|528597382|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
146569744|NCT00953706|528597379|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
146569745|NCT00953706|528597380|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
146569746|NCT00953706|528597381|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
146569747|NCT00953706|528597382|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
146569748|NCT00953706|528597379|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
146915740|NCT01120093|529853543|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146915741|NCT01120093|529853544|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146915742|NCT01120093|529853545|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146915743|NCT01120093|529853546|FG004|Treatment Period 2|Withdrawal by Subject|1|||
146976446|NCT00928135|530075765|FG001|Overall Study|Withdrawal by Subject|0|||
146915744|NCT01120093|529853542|FG000|Treatment Period 3|Lack of Efficacy|0|||
146915745|NCT01120093|529853543|FG001|Treatment Period 3|Lack of Efficacy|0|||
146915746|NCT01120093|529853544|FG002|Treatment Period 3|Lack of Efficacy|0|||
146915747|NCT01120093|529853545|FG003|Treatment Period 3|Lack of Efficacy|1|||
146915748|NCT01120093|529853546|FG004|Treatment Period 3|Lack of Efficacy|0|||
146915749|NCT01120093|529853542|FG000|Treatment Period 3|Adverse Event|0|||
146569749|NCT00953706|528597380|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
146569750|NCT00953706|528597381|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
146569751|NCT00953706|528597382|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
146569752|NCT00953706|528597379|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
146569753|NCT00953706|528597380|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
146569754|NCT00953706|528597381|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
146569755|NCT00953706|528597382|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
146569756|NCT00953706|528597379|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
146569757|NCT00953706|528597380|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
146569758|NCT00953706|528597381|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
146569759|NCT00953706|528597382|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
146569760|NCT00953706|528597379|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
146569761|NCT00953706|528597380|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
146569762|NCT00953706|528597381|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
146569763|NCT00953706|528597382|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
146569764|NCT00953706|528597379|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
146569765|NCT00953706|528597380|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
146650491|NCT04604132|528896781|FG002|Overall Study|Progressive disease: Radiological progression|10|||
146650492|NCT04604132|528896782|FG003|Overall Study|Progressive disease: Radiological progression|4|||
146650493|NCT04604132|528896783|FG004|Overall Study|Progressive disease: Radiological progression|3|||
146650494|NCT04604132|528896779|FG000|Overall Study|Death|3|||
146650495|NCT04604132|528896780|FG001|Overall Study|Death|1|||
146650496|NCT04604132|528896781|FG002|Overall Study|Death|2|||
146650497|NCT04604132|528896782|FG003|Overall Study|Death|1|||
146650498|NCT04604132|528896783|FG004|Overall Study|Death|0|||
146650499|NCT00952380|528896784|FG000|Overall Study|Other|0|||
146650500|NCT00952380|528896785|FG001|Overall Study|Other|0|||
146650501|NCT00952380|528896786|FG002|Overall Study|Other|0|||
146650502|NCT00952380|528896787|FG003|Overall Study|Other|0|||
146650503|NCT00952380|528896788|FG004|Overall Study|Other|1|||
146650504|NCT00952380|528896784|FG000|Overall Study|Withdrawal by Subject|0|||
146650505|NCT00952380|528896785|FG001|Overall Study|Withdrawal by Subject|0|||
146650506|NCT00952380|528896786|FG002|Overall Study|Withdrawal by Subject|1|||
146650507|NCT00952380|528896787|FG003|Overall Study|Withdrawal by Subject|0|||
146650508|NCT00952380|528896788|FG004|Overall Study|Withdrawal by Subject|2|||
146650509|NCT00952380|528896784|FG000|Overall Study|Adverse Event|0|||
146650510|NCT00952380|528896785|FG001|Overall Study|Adverse Event|1|||
146650511|NCT00952380|528896786|FG002|Overall Study|Adverse Event|0|||
146650512|NCT00952380|528896787|FG003|Overall Study|Adverse Event|0|||
146650513|NCT00952380|528896788|FG004|Overall Study|Adverse Event|3|||
146650514|NCT00952380|528896784|FG000|Overall Study|Physician Decision|0|||
146650515|NCT00952380|528896785|FG001|Overall Study|Physician Decision|0|||
146650516|NCT00952380|528896786|FG002|Overall Study|Physician Decision|1|||
146650517|NCT00952380|528896787|FG003|Overall Study|Physician Decision|2|||
146650518|NCT00952380|528896788|FG004|Overall Study|Physician Decision|0|||
146650519|NCT00952380|528896784|FG000|Overall Study|Non-compliant to protocol|0|||
146650520|NCT00952380|528896785|FG001|Overall Study|Non-compliant to protocol|0|||
146650521|NCT00952380|528896786|FG002|Overall Study|Non-compliant to protocol|0|||
146650522|NCT00952380|528896787|FG003|Overall Study|Non-compliant to protocol|1|||
146650523|NCT00952380|528896788|FG004|Overall Study|Non-compliant to protocol|0|||
146650524|NCT00534313|528896792|FG000|Short-term Period|Adverse Event|1|||
146650525|NCT00534313|528896793|FG001|Short-term Period|Adverse Event|2|||
146650526|NCT00534313|528896794|FG002|Short-term Period|Adverse Event|1|||
146650527|NCT00534313|528896795|FG003|Short-term Period|Adverse Event|3|||
146650528|NCT00534313|528896792|FG000|Short-term Period|Lack of Efficacy|3|||
146650529|NCT00534313|528896793|FG001|Short-term Period|Lack of Efficacy|4|||
146650530|NCT00534313|528896794|FG002|Short-term Period|Lack of Efficacy|0|||
146650531|NCT00534313|528896795|FG003|Short-term Period|Lack of Efficacy|3|||
146650532|NCT00534313|528896792|FG000|Short-term Period|Participant not meeting study criteria|0|||
146650533|NCT00534313|528896793|FG001|Short-term Period|Participant not meeting study criteria|0|||
146650534|NCT00534313|528896794|FG002|Short-term Period|Participant not meeting study criteria|0|||
146650535|NCT00534313|528896795|FG003|Short-term Period|Participant not meeting study criteria|1|||
146650536|NCT00534313|528896792|FG000|Short-term Period|Participant withdrew consent|2|||
146650537|NCT00534313|528896793|FG001|Short-term Period|Participant withdrew consent|0|||
146650538|NCT00534313|528896794|FG002|Short-term Period|Participant withdrew consent|0|||
146650539|NCT00534313|528896795|FG003|Short-term Period|Participant withdrew consent|2|||
146650540|NCT00534313|528896792|FG000|Short-term Period|Pregnancy|0|||
146650541|NCT00534313|528896793|FG001|Short-term Period|Pregnancy|0|||
146650542|NCT00534313|528896794|FG002|Short-term Period|Pregnancy|1|||
146650543|NCT00534313|528896795|FG003|Short-term Period|Pregnancy|0|||
146650544|NCT00534313|528896792|FG000|Long-term Period|Adverse Event|2|||
146650545|NCT00534313|528896793|FG001|Long-term Period|Adverse Event|1|||
146569766|NCT00953706|528597381|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
146569767|NCT00953706|528597382|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
146569768|NCT00953706|528597379|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
146569769|NCT00953706|528597380|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
146569770|NCT00953706|528597381|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
146569771|NCT00953706|528597382|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
146569772|NCT00953706|528597379|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
146569773|NCT00953706|528597380|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
146569774|NCT00953706|528597381|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
146569775|NCT00953706|528597382|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
146569776|NCT01088906|528597383|FG000|Overall Study|Inclusion error|1|||
146569777|NCT01088906|528597383|FG000|Overall Study|Did not receive study treatment|3|||
146569778|NCT01088906|528597383|FG000|Overall Study|Missing data|1|||
146569779|NCT00457626|528597384|FG000|Overall Study|Adverse Event|3|||
146569780|NCT00457626|528597384|FG000|Overall Study|Administrative Problems|2|||
146569781|NCT00457626|528597384|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
146569782|NCT01783444|528599003|FG000|Treatment Phase|Adverse Event|9|||
146569783|NCT01783444|528599004|FG001|Treatment Phase|Adverse Event|20|||
146569784|NCT01783444|528599005|FG002|Treatment Phase|Adverse Event|19|||
146569785|NCT01783444|528599003|FG000|Treatment Phase|Disease Progression|76|||
146569786|NCT01783444|528599004|FG001|Treatment Phase|Disease Progression|66|||
146569787|NCT01783444|528599005|FG002|Treatment Phase|Disease Progression|64|||
146569788|NCT01783444|528599003|FG000|Treatment Phase|Death|2|||
146569789|NCT01783444|528599004|FG001|Treatment Phase|Death|2|||
146569790|NCT01783444|528599005|FG002|Treatment Phase|Death|2|||
146569791|NCT01783444|528599003|FG000|Treatment Phase|Protocol Violation|1|||
146569792|NCT01783444|528599004|FG001|Treatment Phase|Protocol Violation|1|||
146569793|NCT01783444|528599005|FG002|Treatment Phase|Protocol Violation|2|||
146569794|NCT01783444|528599003|FG000|Treatment Phase|Withdrawal by Subject|6|||
146569795|NCT01783444|528599004|FG001|Treatment Phase|Withdrawal by Subject|8|||
146915750|NCT01120093|529853543|FG001|Treatment Period 3|Adverse Event|0|||
146915751|NCT01120093|529853544|FG002|Treatment Period 3|Adverse Event|0|||
146569796|NCT01783444|528599005|FG002|Treatment Phase|Withdrawal by Subject|9|||
146569797|NCT01783444|528599003|FG000|Treatment Phase|Administrative problems|2|||
146915752|NCT01120093|529853545|FG003|Treatment Period 3|Adverse Event|0|||
146915753|NCT01120093|529853546|FG004|Treatment Period 3|Adverse Event|1|||
146915754|NCT01120093|529853542|FG000|Treatment Period 3|Withdrawal by Subject|0|||
146915755|NCT01120093|529853543|FG001|Treatment Period 3|Withdrawal by Subject|0|||
146915756|NCT01120093|529853544|FG002|Treatment Period 3|Withdrawal by Subject|1|||
146915757|NCT01120093|529853545|FG003|Treatment Period 3|Withdrawal by Subject|0|||
146915758|NCT01120093|529853546|FG004|Treatment Period 3|Withdrawal by Subject|0|||
146915759|NCT01120093|529853542|FG000|Treatment Period 4|Adverse Event|1|||
146915760|NCT01120093|529853543|FG001|Treatment Period 4|Adverse Event|0|||
146915761|NCT01120093|529853544|FG002|Treatment Period 4|Adverse Event|0|||
146915762|NCT01120093|529853545|FG003|Treatment Period 4|Adverse Event|0|||
146915763|NCT01120093|529853546|FG004|Treatment Period 4|Adverse Event|0|||
146915764|NCT01120093|529853542|FG000|Treatment Period 5|Adverse Event|0|||
146915765|NCT01120093|529853543|FG001|Treatment Period 5|Adverse Event|1|||
146915766|NCT01120093|529853544|FG002|Treatment Period 5|Adverse Event|0|||
146915767|NCT01120093|529853545|FG003|Treatment Period 5|Adverse Event|1|||
146915768|NCT01120093|529853546|FG004|Treatment Period 5|Adverse Event|0|||
146915769|NCT03649321|529853547|FG000|Overall Study|Withdrawal by Subject|1|||
146915770|NCT03649321|529853548|FG001|Overall Study|Withdrawal by Subject|0|||
146915771|NCT03649321|529853547|FG000|Overall Study|Death|1|||
146915772|NCT03649321|529853548|FG001|Overall Study|Death|0|||
146569798|NCT01783444|528599004|FG001|Treatment Phase|Administrative problems|0|||
146569799|NCT01783444|528599005|FG002|Treatment Phase|Administrative problems|1|||
146569800|NCT01783444|528599003|FG000|Treatment Phase|Physician Decision|8|||
146569801|NCT01783444|528599004|FG001|Treatment Phase|Physician Decision|6|||
146569802|NCT01783444|528599005|FG002|Treatment Phase|Physician Decision|5|||
146569803|NCT01783444|528599003|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
146915773|NCT00431847|529853554|FG000|Overall Study|completion of less than two study visits|6|||
146976447|NCT03338673|530075768|FG000|Overall Study|Lost to Follow-up|1|||
146976448|NCT03338673|530075769|FG001|Overall Study|Lost to Follow-up|1|||
146569804|NCT01783444|528599004|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
146569805|NCT01783444|528599005|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
146569806|NCT01783444|528599003|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
146569807|NCT01783444|528599004|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
146569808|NCT01783444|528599005|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
146915774|NCT00431847|529853555|FG001|Overall Study|completion of less than two study visits|3|||
146915775|NCT00431847|529853556|FG002|Overall Study|completion of less than two study visits|4|||
146915776|NCT00431847|529853557|FG003|Overall Study|completion of less than two study visits|14|||
146915777|NCT00431847|529853558|FG004|Overall Study|completion of less than two study visits|0|||
146976449|NCT00678379|530077365|FG000|Overall Study|Injection performed after tonsillectomy|2|||
146569809|NCT01783444|528599003|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
146569810|NCT01783444|528599004|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
146569811|NCT01783444|528599005|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
146569812|NCT01783444|528599003|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
146569813|NCT01783444|528599004|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
146569814|NCT01783444|528599005|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
146569815|NCT01783444|528599003|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
146569816|NCT01783444|528599004|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
146569817|NCT01783444|528599005|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
146569818|NCT01783444|528599003|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
146569819|NCT01783444|528599004|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
146569820|NCT01783444|528599005|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
146569821|NCT00552071|528599006|FG000|Overall Study|Adverse Event|1|||
146569822|NCT00552071|528599007|FG001|Overall Study|Adverse Event|0|||
146569823|NCT00552071|528599006|FG000|Overall Study|Lack of Efficacy|1|||
146569824|NCT00552071|528599007|FG001|Overall Study|Lack of Efficacy|0|||
146569825|NCT00552071|528599006|FG000|Overall Study|Physician Decision|1|||
146569826|NCT00552071|528599007|FG001|Overall Study|Physician Decision|0|||
146569827|NCT00552071|528599006|FG000|Overall Study|Pregnancy|1|||
146569828|NCT00552071|528599007|FG001|Overall Study|Pregnancy|0|||
146569829|NCT00552071|528599006|FG000|Overall Study|Death|0|||
146569830|NCT00552071|528599007|FG001|Overall Study|Death|1|||
146569831|NCT00552071|528599006|FG000|Overall Study|Withdrawal by Subject|0|||
146569832|NCT00552071|528599007|FG001|Overall Study|Withdrawal by Subject|1|||
146569833|NCT00937495|528599012|FG000|Overall Study|Protocol Violation|2|||
146569834|NCT00441272|528599013|FG000|Overall Study|Study terminated prior to enrollment|25|||
146569835|NCT00441272|528599014|FG001|Overall Study|Study terminated prior to enrollment|25|||
146569836|NCT01856322|528599015|FG000|Overall Study|off study due to lack of accrual|0|||
146569837|NCT01856322|528599016|FG001|Overall Study|off study due to lack of accrual|0|||
146569838|NCT01856322|528599017|FG002|Overall Study|off study due to lack of accrual|3|||
146569839|NCT00954447|528599019|FG000|Overall Study|Adverse Event|33|||
146569840|NCT00954447|528599020|FG001|Overall Study|Adverse Event|25|||
146569841|NCT00954447|528599019|FG000|Overall Study|Lack of Efficacy|17|||
146569842|NCT00954447|528599020|FG001|Overall Study|Lack of Efficacy|3|||
146569843|NCT00954447|528599019|FG000|Overall Study|Protocol Violation|5|||
146569844|NCT00954447|528599020|FG001|Overall Study|Protocol Violation|7|||
146569845|NCT00954447|528599019|FG000|Overall Study|Lost to Follow-up|8|||
146569846|NCT00954447|528599020|FG001|Overall Study|Lost to Follow-up|14|||
146569847|NCT00954447|528599019|FG000|Overall Study|Withdrawal by Subject|26|||
146569848|NCT00954447|528599020|FG001|Overall Study|Withdrawal by Subject|21|||
146569849|NCT00954447|528599019|FG000|Overall Study|Other|21|||
146569850|NCT00954447|528599020|FG001|Overall Study|Other|18|||
146569851|NCT04592341|528599021|FG000|Overall Study|Physician Decision|5|||
146569852|NCT04592341|528599021|FG000|Overall Study|Study Terminated by Sponsor|5|||
146569853|NCT04592341|528599021|FG000|Overall Study|Withdrawal by Subject|53|||
146569854|NCT04592341|528599021|FG000|Overall Study|Lost to Follow-up|3|||
146569855|NCT04592341|528599021|FG000|Overall Study|Death|1|||
146569856|NCT04592341|528599021|FG000|Overall Study|Adverse Event|5|||
146569857|NCT04592341|528599021|FG000|Overall Study|other|4|||
146569858|NCT00692003|528599022|FG000|Overall Study|Sponsor Decision|5|||
146569859|NCT00692003|528599023|FG001|Overall Study|Sponsor Decision|1|||
146569860|NCT01535287|528599026|FG000|Overall Study|drug not prepared in time|5|||
146569861|NCT01535287|528599027|FG001|Overall Study|drug not prepared in time|6|||
146569862|NCT00517699|528599028|FG000|Overall Study|Withdrawal by Subject|1|||
146569863|NCT00517699|528599028|FG000|Overall Study|Lack of Efficacy|1|||
146569864|NCT00517699|528599028|FG000|Overall Study|Administrative error|1|||
146569865|NCT00517699|528599028|FG000|Overall Study|Study terminated by Sponsor|2|||
146569866|NCT03341637|528599029|FG000|Overall Study|Lost to Follow-up|1|||
146569867|NCT03341637|528599030|FG001|Overall Study|Lost to Follow-up|0|||
146569868|NCT03341637|528599029|FG000|Overall Study|Withdrawal by Subject|3|||
146569869|NCT03341637|528599030|FG001|Overall Study|Withdrawal by Subject|3|||
146569870|NCT03341637|528599029|FG000|Overall Study|Reason not Specified|1|||
146569871|NCT03341637|528599030|FG001|Overall Study|Reason not Specified|1|||
146569872|NCT01815424|528599041|FG000|Week 0 to 16|Adverse Event|1|||
146915778|NCT00431847|529853554|FG000|Overall Study|Protocol Violation|0|||
146915779|NCT00431847|529853555|FG001|Overall Study|Protocol Violation|0|||
146569873|NCT01815424|528599042|FG001|Week 0 to 16|Adverse Event|3|||
146569874|NCT01815424|528599043|FG002|Week 0 to 16|Adverse Event|3|||
146569875|NCT01815424|528599044|FG003|Week 0 to 16|Adverse Event|0|||
146569876|NCT01815424|528599045|FG004|Week 0 to 16|Adverse Event|0|||
146569877|NCT01815424|528599041|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
146569878|NCT01815424|528599042|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
146569879|NCT01815424|528599043|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
146915780|NCT00431847|529853556|FG002|Overall Study|Protocol Violation|0|||
146915781|NCT00431847|529853557|FG003|Overall Study|Protocol Violation|0|||
146569880|NCT01815424|528599044|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
146569881|NCT01815424|528599045|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
146569882|NCT01815424|528599041|FG000|Week 0 to 16|Lost to Follow-up|0|||
146569883|NCT01815424|528599042|FG001|Week 0 to 16|Lost to Follow-up|1|||
146569884|NCT01815424|528599043|FG002|Week 0 to 16|Lost to Follow-up|0|||
146569885|NCT01815424|528599044|FG003|Week 0 to 16|Lost to Follow-up|0|||
146569886|NCT01815424|528599045|FG004|Week 0 to 16|Lost to Follow-up|0|||
146569887|NCT01815424|528599041|FG000|Week 0 to 16|Withdrawal by Subject|0|||
146569888|NCT01815424|528599042|FG001|Week 0 to 16|Withdrawal by Subject|0|||
146569889|NCT01815424|528599043|FG002|Week 0 to 16|Withdrawal by Subject|1|||
146569890|NCT01815424|528599044|FG003|Week 0 to 16|Withdrawal by Subject|0|||
146569891|NCT01815424|528599045|FG004|Week 0 to 16|Withdrawal by Subject|0|||
146569892|NCT01815424|528599041|FG000|Week 0 to 16|Other|1|||
146569893|NCT01815424|528599042|FG001|Week 0 to 16|Other|0|||
146569894|NCT01815424|528599043|FG002|Week 0 to 16|Other|3|||
146650546|NCT00534313|528896794|FG002|Long-term Period|Adverse Event|0|||
146650547|NCT00534313|528896795|FG003|Long-term Period|Adverse Event|1|||
146650548|NCT00534313|528896792|FG000|Long-term Period|Lack of Efficacy|14|||
146650549|NCT00534313|528896793|FG001|Long-term Period|Lack of Efficacy|10|||
146650550|NCT00534313|528896794|FG002|Long-term Period|Lack of Efficacy|14|||
146650551|NCT00534313|528896795|FG003|Long-term Period|Lack of Efficacy|12|||
146650552|NCT00534313|528896792|FG000|Long-term Period|Lost to Follow-up|1|||
146650553|NCT00534313|528896793|FG001|Long-term Period|Lost to Follow-up|2|||
146650554|NCT00534313|528896794|FG002|Long-term Period|Lost to Follow-up|0|||
146650555|NCT00534313|528896795|FG003|Long-term Period|Lost to Follow-up|0|||
146650556|NCT00534313|528896792|FG000|Long-term Period|Withdrawal by Subject|2|||
146650557|NCT00534313|528896793|FG001|Long-term Period|Withdrawal by Subject|2|||
146650558|NCT00534313|528896794|FG002|Long-term Period|Withdrawal by Subject|0|||
146650559|NCT00534313|528896795|FG003|Long-term Period|Withdrawal by Subject|0|||
146650560|NCT00534313|528896792|FG000|Long-term Period|No longer meets study criteria|0|||
146650561|NCT00534313|528896793|FG001|Long-term Period|No longer meets study criteria|1|||
146650562|NCT00534313|528896794|FG002|Long-term Period|No longer meets study criteria|0|||
146650563|NCT00534313|528896795|FG003|Long-term Period|No longer meets study criteria|0|||
146770520|NCT03215927|529328607|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
146770521|NCT03215927|529328608|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
146770522|NCT03215927|529328607|FG000|Open Label Extension|Adverse Event|1|||
146569895|NCT01815424|528599044|FG003|Week 0 to 16|Other|0|||
146569896|NCT01815424|528599045|FG004|Week 0 to 16|Other|0|||
146569897|NCT01815424|528599041|FG000|Week 0 to 16|Protocol Violation|1|||
146569898|NCT01815424|528599042|FG001|Week 0 to 16|Protocol Violation|0|||
146569899|NCT01815424|528599043|FG002|Week 0 to 16|Protocol Violation|0|||
146569900|NCT01815424|528599044|FG003|Week 0 to 16|Protocol Violation|0|||
146569901|NCT01815424|528599045|FG004|Week 0 to 16|Protocol Violation|0|||
146569902|NCT01815424|528599041|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
146569903|NCT01815424|528599042|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
146569904|NCT01815424|528599043|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
146569905|NCT01815424|528599044|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
146569906|NCT01815424|528599045|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
146569907|NCT01815424|528599041|FG000|Week 16 to 52|Other|0|||
146569908|NCT01815424|528599042|FG001|Week 16 to 52|Other|1|||
146569909|NCT01815424|528599043|FG002|Week 16 to 52|Other|0|||
146569910|NCT01815424|528599044|FG003|Week 16 to 52|Other|0|||
146569911|NCT01815424|528599045|FG004|Week 16 to 52|Other|0|||
146569912|NCT01815424|528599041|FG000|Week 16 to 52|Adverse Event|0|||
146569913|NCT01815424|528599042|FG001|Week 16 to 52|Adverse Event|0|||
146569914|NCT01815424|528599043|FG002|Week 16 to 52|Adverse Event|0|||
146569915|NCT01815424|528599044|FG003|Week 16 to 52|Adverse Event|0|||
146569916|NCT01815424|528599045|FG004|Week 16 to 52|Adverse Event|1|||
146569917|NCT01815424|528599041|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
146569918|NCT01815424|528599042|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
146569919|NCT01815424|528599043|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
146569920|NCT01815424|528599044|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
146569921|NCT01815424|528599045|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
146569922|NCT01815424|528599041|FG000|Week 16 to 52|Lost to Follow-up|0|||
146569923|NCT01815424|528599042|FG001|Week 16 to 52|Lost to Follow-up|2|||
146569924|NCT01815424|528599043|FG002|Week 16 to 52|Lost to Follow-up|0|||
146650564|NCT00534313|528896792|FG000|Long-term Period|Poor compliance/noncompliance|0|||
146650565|NCT00534313|528896793|FG001|Long-term Period|Poor compliance/noncompliance|1|||
146650566|NCT00534313|528896794|FG002|Long-term Period|Poor compliance/noncompliance|1|||
146569925|NCT01815424|528599044|FG003|Week 16 to 52|Lost to Follow-up|2|||
146569926|NCT01815424|528599045|FG004|Week 16 to 52|Lost to Follow-up|1|||
146569927|NCT01815424|528599041|FG000|Week 16 to 52|Withdrawal by Subject|1|||
146569928|NCT01815424|528599042|FG001|Week 16 to 52|Withdrawal by Subject|2|||
146650567|NCT00534313|528896795|FG003|Long-term Period|Poor compliance/noncompliance|0|||
146650568|NCT00534313|528896792|FG000|Long-term Period|Administrative reason by sponsor|17|||
146770523|NCT03215927|529328608|FG001|Open Label Extension|Adverse Event|0|||
146569929|NCT01815424|528599043|FG002|Week 16 to 52|Withdrawal by Subject|0|||
146915782|NCT00431847|529853558|FG004|Overall Study|Protocol Violation|1|||
146915783|NCT02142894|529853559|FG000|Overall Study|Protocol Violation|8|||
146915784|NCT02137772|529853563|FG000|Overall Study|Adverse Event|6|||
146915785|NCT02137772|529853564|FG001|Overall Study|Adverse Event|3|||
146915786|NCT02137772|529853563|FG000|Overall Study|Death|71|||
146915787|NCT02137772|529853564|FG001|Overall Study|Death|44|||
146915788|NCT02137772|529853563|FG000|Overall Study|Lost to Follow-up|8|||
146569930|NCT01815424|528599044|FG003|Week 16 to 52|Withdrawal by Subject|0|||
146569931|NCT01815424|528599045|FG004|Week 16 to 52|Withdrawal by Subject|0|||
146569932|NCT04723355|528599046|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
146569933|NCT04723355|528599046|FG000|Overall Study|Errors in the informed consent form|2|||
146569934|NCT03374358|528599047|FG000|Overall Study|Withdrawal by Subject|0|||
146569935|NCT03374358|528599048|FG001|Overall Study|Withdrawal by Subject|2|||
146569936|NCT01127633|528599049|FG000|Overall Study|Adverse Event|74|||
146569937|NCT01127633|528599050|FG001|Overall Study|Adverse Event|73|||
146569938|NCT01127633|528599049|FG000|Overall Study|Death|40|||
146569939|NCT01127633|528599050|FG001|Overall Study|Death|43|||
146569940|NCT01127633|528599049|FG000|Overall Study|Lost to Follow-up|4|||
146569941|NCT01127633|528599050|FG001|Overall Study|Lost to Follow-up|0|||
146569942|NCT01127633|528599049|FG000|Overall Study|Parent/Caregiver Decision|246|||
146569943|NCT01127633|528599050|FG001|Overall Study|Parent/Caregiver Decision|228|||
146569944|NCT01127633|528599049|FG000|Overall Study|Physician Decision|60|||
146569945|NCT01127633|528599050|FG001|Overall Study|Physician Decision|45|||
146569946|NCT01127633|528599049|FG000|Overall Study|Withdrawal by Subject|57|||
146569947|NCT01127633|528599050|FG001|Overall Study|Withdrawal by Subject|72|||
146569948|NCT01127633|528599049|FG000|Overall Study|Sponsor Decision|163|||
146569949|NCT01127633|528599050|FG001|Overall Study|Sponsor Decision|195|||
146569950|NCT01127633|528599049|FG000|Overall Study|Protocol Violation|8|||
146569951|NCT01127633|528599050|FG001|Overall Study|Protocol Violation|16|||
146569952|NCT01127633|528599049|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
146569953|NCT01127633|528599050|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
146569954|NCT01127633|528599049|FG000|Overall Study|Not treated|1|||
146569955|NCT01127633|528599050|FG001|Overall Study|Not treated|0|||
146569956|NCT02805790|528599054|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
146569957|NCT02805790|528599055|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
146569958|NCT01639469|528599060|FG000|Overall Study|Death|4|||
146569959|NCT01639469|528599061|FG001|Overall Study|Death|2|||
146569960|NCT01639469|528599060|FG000|Overall Study|Lost to Follow-up|1|||
146569961|NCT01639469|528599061|FG001|Overall Study|Lost to Follow-up|1|||
146569962|NCT01119443|528599062|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
146569963|NCT01119443|528599063|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
146569964|NCT00420381|528599064|FG000|Overall Study|Protocol Violation|1|||
146569965|NCT02329743|528599065|FG000|Overall Study|Adverse Event|1|||
146569966|NCT02329743|528599066|FG001|Overall Study|Adverse Event|1|||
146569967|NCT02329743|528599067|FG002|Overall Study|Adverse Event|3|||
146569968|NCT02329743|528599065|FG000|Overall Study|Lost to Follow-up|1|||
146569969|NCT02329743|528599066|FG001|Overall Study|Lost to Follow-up|0|||
146569970|NCT02329743|528599067|FG002|Overall Study|Lost to Follow-up|1|||
146569971|NCT02329743|528599065|FG000|Overall Study|Withdrawal by Subject|4|||
146569972|NCT02329743|528599066|FG001|Overall Study|Withdrawal by Subject|4|||
146569973|NCT02329743|528599067|FG002|Overall Study|Withdrawal by Subject|1|||
146569974|NCT02329743|528599065|FG000|Overall Study|Other|0|||
146569975|NCT02329743|528599066|FG001|Overall Study|Other|2|||
146569976|NCT02329743|528599067|FG002|Overall Study|Other|3|||
146569977|NCT01428219|528599068|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
146569978|NCT02071771|528599069|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
146569979|NCT02071771|528599070|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
146569980|NCT02071771|528599069|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
146650569|NCT00534313|528896793|FG001|Long-term Period|Administrative reason by sponsor|15|||
146915789|NCT02137772|529853564|FG001|Overall Study|Lost to Follow-up|4|||
146915790|NCT02137772|529853563|FG000|Overall Study|Physician Decision|15|||
146915791|NCT02137772|529853564|FG001|Overall Study|Physician Decision|5|||
146915792|NCT02137772|529853563|FG000|Overall Study|Withdrawal by Subject|28|||
146569981|NCT02071771|528599070|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
146569982|NCT02078752|528599071|FG000|Overall Study|Death|0|||
146569983|NCT02078752|528599072|FG001|Overall Study|Death|3|||
146569984|NCT02078752|528599073|FG002|Overall Study|Death|0|||
146569985|NCT02078752|528599074|FG003|Overall Study|Death|0|||
146569986|NCT02078752|528599075|FG004|Overall Study|Death|0|||
146569987|NCT02078752|528599076|FG005|Overall Study|Death|1|||
146569988|NCT02078752|528599077|FG006|Overall Study|Death|0|||
146915793|NCT02137772|529853564|FG001|Overall Study|Withdrawal by Subject|17|||
146915794|NCT02137772|529853563|FG000|Overall Study|Non-compliance with study drug|1|||
146915795|NCT02137772|529853564|FG001|Overall Study|Non-compliance with study drug|0|||
146569989|NCT02078752|528599078|FG007|Overall Study|Death|1|||
146569990|NCT02078752|528599079|FG008|Overall Study|Death|0|||
146569991|NCT02078752|528599080|FG009|Overall Study|Death|4|||
146569992|NCT02078752|528599071|FG000|Overall Study|Lost to Follow-up|1|||
146915796|NCT02137772|529853563|FG000|Overall Study|Not treated|3|||
146569993|NCT02078752|528599072|FG001|Overall Study|Lost to Follow-up|0|||
146569994|NCT02078752|528599073|FG002|Overall Study|Lost to Follow-up|0|||
146569995|NCT02078752|528599074|FG003|Overall Study|Lost to Follow-up|1|||
146569996|NCT02078752|528599075|FG004|Overall Study|Lost to Follow-up|0|||
146569997|NCT02078752|528599076|FG005|Overall Study|Lost to Follow-up|0|||
146569998|NCT02078752|528599077|FG006|Overall Study|Lost to Follow-up|0|||
146915797|NCT02137772|529853564|FG001|Overall Study|Not treated|2|||
146915798|NCT00455858|529853565|FG000|Overall Study|Lost to Follow-up|2|||
146915799|NCT00455858|529853565|FG000|Overall Study|Protocol Violation|1|||
146915800|NCT00455858|529853565|FG000|Overall Study|Lack of Efficacy|1|||
146915801|NCT00455858|529853565|FG000|Overall Study|Well controlled FPG without insulin|1|||
146915802|NCT00455858|529853565|FG000|Overall Study|Withdrawal|1|||
146915803|NCT02092389|529853566|FG000|Overall Study|Adverse Event|1|||
146915804|NCT02092389|529853566|FG000|Overall Study|Other|5|||
146915805|NCT01844700|529853567|FG000|Overall Study|Lack of Efficacy|1|||
146915806|NCT01844700|529853568|FG001|Overall Study|Lack of Efficacy|0|||
146915807|NCT01844700|529853567|FG000|Overall Study|refused medication switch|1|||
146915808|NCT01844700|529853568|FG001|Overall Study|refused medication switch|0|||
146915809|NCT01844700|529853567|FG000|Overall Study|Withdrawal by Subject|1|||
146915810|NCT01844700|529853568|FG001|Overall Study|Withdrawal by Subject|0|||
146915811|NCT01844700|529853567|FG000|Overall Study|stopped taking meds|0|||
146915812|NCT01844700|529853568|FG001|Overall Study|stopped taking meds|1|||
146915813|NCT01242020|529853569|FG000|Overall Study|Withdrawal by Subject|2|||
146915814|NCT01242020|529853570|FG001|Overall Study|Withdrawal by Subject|0|||
146915815|NCT01242020|529853569|FG000|Overall Study|Failed screening|1|||
146915816|NCT01242020|529853570|FG001|Overall Study|Failed screening|0|||
146915817|NCT02680847|529853571|FG000|Overall Study|Other|2|||
146915818|NCT02680847|529853572|FG001|Overall Study|Other|0|||
146915819|NCT02680847|529853573|FG002|Overall Study|Other|0|||
146915820|NCT02680847|529853571|FG000|Overall Study|No longer met eligibility criteria|2|||
146915821|NCT02680847|529853572|FG001|Overall Study|No longer met eligibility criteria|2|||
146915822|NCT02680847|529853573|FG002|Overall Study|No longer met eligibility criteria|0|||
146915823|NCT02680847|529853571|FG000|Overall Study|Unwilling to participate in study|1|||
146915824|NCT02680847|529853572|FG001|Overall Study|Unwilling to participate in study|1|||
146915825|NCT02680847|529853573|FG002|Overall Study|Unwilling to participate in study|0|||
146915826|NCT02680847|529853571|FG000|Overall Study|Lack of Efficacy|0|||
146915827|NCT02680847|529853572|FG001|Overall Study|Lack of Efficacy|0|||
146915828|NCT02680847|529853573|FG002|Overall Study|Lack of Efficacy|2|||
146915829|NCT02680847|529853571|FG000|Overall Study|Adverse Event|0|||
146915830|NCT02680847|529853572|FG001|Overall Study|Adverse Event|0|||
146915831|NCT02680847|529853573|FG002|Overall Study|Adverse Event|1|||
146976450|NCT00678379|530077366|FG001|Overall Study|Injection performed after tonsillectomy|0|||
146569999|NCT02078752|528599078|FG007|Overall Study|Lost to Follow-up|0|||
146570000|NCT02078752|528599079|FG008|Overall Study|Lost to Follow-up|0|||
146570001|NCT02078752|528599080|FG009|Overall Study|Lost to Follow-up|0|||
146570002|NCT02078752|528599071|FG000|Overall Study|Withdrawal by Subject|1|||
146570003|NCT02078752|528599072|FG001|Overall Study|Withdrawal by Subject|1|||
146570004|NCT02078752|528599073|FG002|Overall Study|Withdrawal by Subject|1|||
146570005|NCT02078752|528599074|FG003|Overall Study|Withdrawal by Subject|1|||
146570006|NCT02078752|528599075|FG004|Overall Study|Withdrawal by Subject|0|||
146570007|NCT02078752|528599076|FG005|Overall Study|Withdrawal by Subject|3|||
146570008|NCT02078752|528599077|FG006|Overall Study|Withdrawal by Subject|2|||
146570009|NCT02078752|528599078|FG007|Overall Study|Withdrawal by Subject|1|||
146570010|NCT02078752|528599079|FG008|Overall Study|Withdrawal by Subject|0|||
146570011|NCT02078752|528599080|FG009|Overall Study|Withdrawal by Subject|1|||
146570012|NCT02078752|528599071|FG000|Overall Study|Other|0|||
146570013|NCT02078752|528599072|FG001|Overall Study|Other|3|||
146570014|NCT02078752|528599073|FG002|Overall Study|Other|0|||
146570015|NCT02078752|528599074|FG003|Overall Study|Other|0|||
146570016|NCT02078752|528599075|FG004|Overall Study|Other|1|||
146570017|NCT02078752|528599076|FG005|Overall Study|Other|0|||
146915832|NCT02375698|529853574|FG000|Overall Study|Withdrawal by Subject|0|||
146915833|NCT02375698|529853575|FG001|Overall Study|Withdrawal by Subject|2|||
146915834|NCT02375698|529853574|FG000|Overall Study|Physician Decision|2|||
146976451|NCT00678379|530077367|FG002|Overall Study|Injection performed after tonsillectomy|1|||
146976452|NCT00678379|530077365|FG000|Overall Study|Incomplete Data|4|||
146570018|NCT02078752|528599077|FG006|Overall Study|Other|0|||
146570019|NCT02078752|528599078|FG007|Overall Study|Other|1|||
146570020|NCT02078752|528599079|FG008|Overall Study|Other|0|||
146570021|NCT02078752|528599080|FG009|Overall Study|Other|0|||
146570022|NCT02078752|528599071|FG000|Overall Study|Study terminated by sponsor|0|||
146570023|NCT02078752|528599072|FG001|Overall Study|Study terminated by sponsor|0|||
146570024|NCT02078752|528599073|FG002|Overall Study|Study terminated by sponsor|0|||
146570025|NCT02078752|528599074|FG003|Overall Study|Study terminated by sponsor|0|||
146570026|NCT02078752|528599075|FG004|Overall Study|Study terminated by sponsor|0|||
146570027|NCT02078752|528599076|FG005|Overall Study|Study terminated by sponsor|0|||
146915835|NCT02375698|529853575|FG001|Overall Study|Physician Decision|0|||
146915836|NCT01595646|529853580|FG000|Overall Study|Withdrawal by Subject|1|||
146915837|NCT01595646|529853581|FG001|Overall Study|Withdrawal by Subject|0|||
146570028|NCT02078752|528599077|FG006|Overall Study|Study terminated by sponsor|0|||
146570029|NCT02078752|528599078|FG007|Overall Study|Study terminated by sponsor|0|||
146570030|NCT02078752|528599079|FG008|Overall Study|Study terminated by sponsor|0|||
146570031|NCT02078752|528599080|FG009|Overall Study|Study terminated by sponsor|5|||
146570032|NCT00775268|528599097|FG000|Baseline|Drug not synthesize dose|1|||
146570033|NCT00775268|528599098|FG001|Baseline|Drug not synthesize dose|0|||
146570034|NCT00775268|528599097|FG000|Baseline|Not treated-ineligible per CT|0|||
146570035|NCT00775268|528599098|FG001|Baseline|Not treated-ineligible per CT|1|||
146570036|NCT00775268|528599097|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
146570037|NCT00775268|528599098|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
146570038|NCT00775268|528599097|FG000|After Completion|Participant missed scan appointment|1|||
146570039|NCT00775268|528599098|FG001|After Completion|Participant missed scan appointment|0|||
146570040|NCT00825994|528599099|FG000|Overall Study|Withdrawal by Subject|2|||
146570041|NCT00825994|528599099|FG000|Overall Study|Lost to Follow-up|1|||
146570042|NCT00825994|528599099|FG000|Overall Study|Protocol Violation|1|||
146570043|NCT00825994|528599099|FG000|Overall Study|Placebo Responder at V2|1|||
146570044|NCT00616642|528599103|FG000|Overall Study|Withdrawal by Subject|0|||
146570045|NCT00616642|528599104|FG001|Overall Study|Withdrawal by Subject|1|||
146570046|NCT01881009|528599110|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
146570047|NCT01881009|528599111|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
146915838|NCT01595646|529853582|FG002|Overall Study|Withdrawal by Subject|0|||
146915839|NCT04172831|529853584|FG000|Overall Study|Adverse Event|21|||
146915840|NCT04172831|529853585|FG001|Overall Study|Adverse Event|9|||
146915841|NCT04172831|529853584|FG000|Overall Study|Lack of Efficacy|2|||
146915842|NCT04172831|529853585|FG001|Overall Study|Lack of Efficacy|8|||
146915843|NCT04172831|529853584|FG000|Overall Study|Physician Decision|0|||
146915844|NCT04172831|529853585|FG001|Overall Study|Physician Decision|1|||
146915845|NCT04172831|529853584|FG000|Overall Study|Withdrawal by Subject|12|||
146915846|NCT04172831|529853585|FG001|Overall Study|Withdrawal by Subject|11|||
146915847|NCT04172831|529853584|FG000|Overall Study|Lost to Follow-up|4|||
146915848|NCT04172831|529853585|FG001|Overall Study|Lost to Follow-up|9|||
146915849|NCT04172831|529853584|FG000|Overall Study|COVID-19 related crisis|3|||
146915850|NCT04172831|529853585|FG001|Overall Study|COVID-19 related crisis|3|||
146915851|NCT04172831|529853584|FG000|Overall Study|Subject non-compliance|1|||
146915852|NCT04172831|529853585|FG001|Overall Study|Subject non-compliance|1|||
146915853|NCT04172831|529853584|FG000|Overall Study|Family emergency|1|||
146915854|NCT04172831|529853585|FG001|Overall Study|Family emergency|0|||
146915855|NCT01651260|529853586|FG000|Overall Study|unable to apply product|3|||
146915856|NCT02239094|529853587|FG000|Overall Study|Withdrawal by Subject|1|||
146915857|NCT02239094|529853587|FG000|Overall Study|Remitted before started|1|||
146915858|NCT03648996|529853590|FG000|Overall Study|Withdrawal by Subject|0|||
146915859|NCT03648996|529853591|FG001|Overall Study|Withdrawal by Subject|2|||
146915860|NCT03648996|529853592|FG002|Overall Study|Withdrawal by Subject|2|||
146915861|NCT03648996|529853590|FG000|Overall Study|Physician Decision|2|||
146915862|NCT03648996|529853591|FG001|Overall Study|Physician Decision|0|||
146915863|NCT03648996|529853592|FG002|Overall Study|Physician Decision|0|||
146915864|NCT00365976|529853602|FG000|Overall Study|Withdrawal by Subject|1|||
146915865|NCT00365976|529853603|FG001|Overall Study|Withdrawal by Subject|5|||
146915866|NCT01963117|529853604|FG000|Overall Study|Death|1|||
146915867|NCT01780389|529853605|FG000|Overall Study|Adverse Event|1|||
146915868|NCT01095250|529853606|FG000|Overall Study|administrative reasons|8|||
146915869|NCT01095250|529853607|FG001|Overall Study|administrative reasons|10|||
146915870|NCT01095250|529853608|FG002|Overall Study|administrative reasons|7|||
146915871|NCT01095250|529853609|FG003|Overall Study|administrative reasons|5|||
146915872|NCT01095250|529853606|FG000|Overall Study|Withdrawal by Subject|0|||
146915873|NCT01095250|529853607|FG001|Overall Study|Withdrawal by Subject|0|||
146915874|NCT01095250|529853608|FG002|Overall Study|Withdrawal by Subject|1|||
146915875|NCT01095250|529853609|FG003|Overall Study|Withdrawal by Subject|0|||
146976453|NCT00678379|530077366|FG001|Overall Study|Incomplete Data|3|||
146570048|NCT05518461|528599113|FG000|Overall Study|Lost to Follow-up|25|||
146570049|NCT03326063|528599115|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
146570050|NCT03326063|528599116|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
146570051|NCT01876381|528599117|FG000|Overall Study|Lack of Efficacy|5|||
146570052|NCT01876381|528599117|FG000|Overall Study|Physician Decision|1|||
146570053|NCT01876381|528599117|FG000|Overall Study|Withdrawal by Subject|1|||
146915876|NCT01000064|529853610|FG000|Overall Study|Withdrawal by Subject|1|||
146915877|NCT01000064|529853611|FG001|Overall Study|Withdrawal by Subject|1|||
146570054|NCT00332696|528599118|FG000|Overall Study|Death|24|||
146570055|NCT00332696|528599119|FG001|Overall Study|Death|14|||
146570056|NCT00332696|528599118|FG000|Overall Study|Insufficient therapeutic effect|4|||
146570057|NCT00332696|528599119|FG001|Overall Study|Insufficient therapeutic effect|11|||
146570058|NCT00332696|528599118|FG000|Overall Study|Adverse Event|1|||
146570059|NCT00332696|528599119|FG001|Overall Study|Adverse Event|2|||
146915878|NCT02518620|529853612|FG000|Overall Study|Adverse Event|23|||
146915879|NCT02518620|529853613|FG001|Overall Study|Adverse Event|11|||
146915880|NCT02518620|529853612|FG000|Overall Study|Lack of Efficacy|2|||
146509373|NCT02667626|528368952|FG001|Overall Study|Withdrawal by Subject|1|||
146509374|NCT01032070|528368956|FG000|Overall Study|Disease progression|13|||
146509375|NCT01032070|528368957|FG001|Overall Study|Disease progression|8|||
146509376|NCT01032070|528368956|FG000|Overall Study|Medical or ethical reasons|0|||
146509377|NCT01032070|528368957|FG001|Overall Study|Medical or ethical reasons|2|||
146509378|NCT01032070|528368956|FG000|Overall Study|Withdrawal by Subject|0|||
146915881|NCT02518620|529853613|FG001|Overall Study|Lack of Efficacy|0|||
146915882|NCT02518620|529853612|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146915883|NCT02518620|529853613|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146915884|NCT02518620|529853612|FG000|Overall Study|Physician Decision|1|||
146915885|NCT02518620|529853613|FG001|Overall Study|Physician Decision|1|||
146915886|NCT02518620|529853612|FG000|Overall Study|Sponsor's Decision|0|||
146915887|NCT02518620|529853613|FG001|Overall Study|Sponsor's Decision|3|||
146915888|NCT02518620|529853612|FG000|Overall Study|Lost to Follow-up|1|||
146915889|NCT02518620|529853613|FG001|Overall Study|Lost to Follow-up|1|||
146915890|NCT02518620|529853612|FG000|Overall Study|Withdrawal by Subject|17|||
146915891|NCT02518620|529853613|FG001|Overall Study|Withdrawal by Subject|9|||
146915892|NCT02518620|529853612|FG000|Overall Study|Death|1|||
146915893|NCT02518620|529853613|FG001|Overall Study|Death|0|||
146915894|NCT02518620|529853612|FG000|Overall Study|Pregnancy Wish|3|||
146915895|NCT02518620|529853613|FG001|Overall Study|Pregnancy Wish|0|||
146915896|NCT02518620|529853612|FG000|Overall Study|Pregnancy|1|||
146915897|NCT02518620|529853613|FG001|Overall Study|Pregnancy|0|||
146915898|NCT02518620|529853612|FG000|Overall Study|Relocation|2|||
146915899|NCT02518620|529853613|FG001|Overall Study|Relocation|1|||
146915900|NCT03625986|529855841|FG000|Randomization Period|Lost to Follow-up|7|||
146915901|NCT03625986|529855842|FG001|Randomization Period|Lost to Follow-up|12|||
146915902|NCT03625986|529855841|FG000|Randomization Period|Withdrawal by Subject|10|||
146915903|NCT03625986|529855842|FG001|Randomization Period|Withdrawal by Subject|6|||
146915904|NCT01937130|529855843|FG000|Overall Study|Withdrawal by Subject|0|||
146915905|NCT01937130|529855844|FG001|Overall Study|Withdrawal by Subject|0|||
146915906|NCT01937130|529855845|FG002|Overall Study|Withdrawal by Subject|0|||
146915907|NCT01937130|529855846|FG003|Overall Study|Withdrawal by Subject|1|||
146915908|NCT01937130|529855843|FG000|Overall Study|Adverse Event|0|||
146915909|NCT01937130|529855844|FG001|Overall Study|Adverse Event|1|||
146915910|NCT01937130|529855845|FG002|Overall Study|Adverse Event|0|||
146915911|NCT01937130|529855846|FG003|Overall Study|Adverse Event|1|||
146915912|NCT01937130|529855843|FG000|Overall Study|Death|1|||
146915913|NCT01937130|529855844|FG001|Overall Study|Death|1|||
146915914|NCT01937130|529855845|FG002|Overall Study|Death|1|||
146915915|NCT01937130|529855846|FG003|Overall Study|Death|0|||
146915916|NCT01937130|529855843|FG000|Overall Study|Lost to Follow-up|2|||
146915917|NCT01937130|529855844|FG001|Overall Study|Lost to Follow-up|0|||
146915918|NCT01937130|529855845|FG002|Overall Study|Lost to Follow-up|2|||
146915919|NCT01937130|529855846|FG003|Overall Study|Lost to Follow-up|0|||
146915920|NCT01937130|529855843|FG000|Overall Study|Physician Decision|0|||
146915921|NCT01937130|529855844|FG001|Overall Study|Physician Decision|1|||
146915922|NCT01937130|529855845|FG002|Overall Study|Physician Decision|0|||
146915923|NCT01937130|529855846|FG003|Overall Study|Physician Decision|0|||
146915924|NCT01937130|529855843|FG000|Overall Study|Patients unable to swallow|0|||
146915925|NCT01937130|529855844|FG001|Overall Study|Patients unable to swallow|1|||
146915926|NCT01937130|529855845|FG002|Overall Study|Patients unable to swallow|0|||
146915927|NCT01937130|529855846|FG003|Overall Study|Patients unable to swallow|0|||
146915928|NCT01937130|529855843|FG000|Overall Study|Patient lost to FU due to death|2|||
146915929|NCT01937130|529855844|FG001|Overall Study|Patient lost to FU due to death|0|||
146915930|NCT01937130|529855845|FG002|Overall Study|Patient lost to FU due to death|0|||
146915931|NCT01937130|529855846|FG003|Overall Study|Patient lost to FU due to death|0|||
146915932|NCT01850563|529855847|FG000|Overall Study|Not eligible|3|||
146915933|NCT01850563|529855848|FG001|Overall Study|Not eligible|0|||
146915934|NCT04359823|529855849|FG000|Overall Study|Lost to Follow-up|0|||
146915935|NCT04359823|529855850|FG001|Overall Study|Lost to Follow-up|1|||
146915936|NCT04359823|529855849|FG000|Overall Study|Withdrawal by Subject|0|||
146915937|NCT04359823|529855850|FG001|Overall Study|Withdrawal by Subject|1|||
146915938|NCT04191967|529855851|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
146915939|NCT04191967|529855851|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
146915940|NCT01431144|529855852|FG000|Overall Study|Implant mobility and removal|2|||
146915941|NCT01431144|529855853|FG001|Overall Study|Implant mobility and removal|0|||
146915942|NCT02322892|529855854|FG000|Overall Study|Surgery cancelled|1|||
146915943|NCT02322892|529855855|FG001|Overall Study|Surgery cancelled|2|||
146915944|NCT02322892|529855854|FG000|Overall Study|Met exclusion criteria|0|||
146915945|NCT02322892|529855855|FG001|Overall Study|Met exclusion criteria|1|||
146915946|NCT02322892|529855854|FG000|Overall Study|Protocol Violation|1|||
146915947|NCT02322892|529855855|FG001|Overall Study|Protocol Violation|0|||
146915948|NCT02125331|529855856|FG000|Overall Study|Protocol Violation|1|||
146915949|NCT02125331|529855857|FG001|Overall Study|Protocol Violation|0|||
146915950|NCT02125331|529855856|FG000|Overall Study|technical problem|2|||
146915951|NCT02125331|529855857|FG001|Overall Study|technical problem|0|||
146915952|NCT02125331|529855856|FG000|Overall Study|screen failure|2|||
146570060|NCT00332696|528599118|FG000|Overall Study|Condition does not justify treatment|0|||
146570061|NCT00332696|528599119|FG001|Overall Study|Condition does not justify treatment|2|||
146570062|NCT00332696|528599118|FG000|Overall Study|Lost to Follow-up|0|||
146570063|NCT00332696|528599119|FG001|Overall Study|Lost to Follow-up|1|||
146570064|NCT00332696|528599118|FG000|Overall Study|Withdrawal by Subject|1|||
146570065|NCT00332696|528599119|FG001|Overall Study|Withdrawal by Subject|0|||
146570066|NCT00382174|528599120|FG000|Overall Study|Lost to Follow-up|1|||
146570067|NCT00382174|528599121|FG001|Overall Study|Lost to Follow-up|4|||
146570068|NCT00382174|528599122|FG002|Overall Study|Lost to Follow-up|5|||
146570069|NCT00382174|528599120|FG000|Overall Study|Adverse Event|1|||
146570070|NCT00382174|528599121|FG001|Overall Study|Adverse Event|4|||
146570071|NCT00382174|528599122|FG002|Overall Study|Adverse Event|5|||
146570072|NCT00382174|528599120|FG000|Overall Study|Withdrawal by Subject|1|||
146570073|NCT00382174|528599121|FG001|Overall Study|Withdrawal by Subject|4|||
146570074|NCT00382174|528599122|FG002|Overall Study|Withdrawal by Subject|5|||
146570075|NCT00382174|528599120|FG000|Overall Study|Non compliance|1|||
146570076|NCT00382174|528599121|FG001|Overall Study|Non compliance|0|||
146570077|NCT00382174|528599122|FG002|Overall Study|Non compliance|1|||
146570078|NCT00382174|528599120|FG000|Overall Study|Physician Decision|0|||
146570079|NCT00382174|528599121|FG001|Overall Study|Physician Decision|2|||
146570080|NCT00382174|528599122|FG002|Overall Study|Physician Decision|2|||
146570081|NCT00382174|528599120|FG000|Overall Study|Failed to meet criteria|0|||
146570082|NCT00382174|528599121|FG001|Overall Study|Failed to meet criteria|1|||
146570083|NCT00382174|528599122|FG002|Overall Study|Failed to meet criteria|1|||
146570084|NCT00382174|528599120|FG000|Overall Study|Wounds merged|0|||
146570085|NCT00382174|528599121|FG001|Overall Study|Wounds merged|2|||
146570086|NCT00382174|528599122|FG002|Overall Study|Wounds merged|2|||
146570087|NCT02750514|528599123|FG000|Track 1|Disease progression|20|||
146570088|NCT02750514|528599124|FG001|Track 1|Disease progression|1|||
146570089|NCT02750514|528599125|FG002|Track 1|Disease progression|0|||
146570090|NCT02750514|528599126|FG003|Track 1|Disease progression|1|||
146570091|NCT02750514|528599127|FG004|Track 1|Disease progression|0|||
146570092|NCT02750514|528599123|FG000|Track 1|Adverse event unrelated to study drug|1|||
146570093|NCT02750514|528599124|FG001|Track 1|Adverse event unrelated to study drug|0|||
146570094|NCT02750514|528599125|FG002|Track 1|Adverse event unrelated to study drug|0|||
146570095|NCT02750514|528599126|FG003|Track 1|Adverse event unrelated to study drug|0|||
146570096|NCT02750514|528599127|FG004|Track 1|Adverse event unrelated to study drug|0|||
146570097|NCT02750514|528599123|FG000|Track 1|Study drug toxicity|4|||
146570098|NCT02750514|528599124|FG001|Track 1|Study drug toxicity|1|||
146570099|NCT02750514|528599125|FG002|Track 1|Study drug toxicity|0|||
146570100|NCT02750514|528599126|FG003|Track 1|Study drug toxicity|1|||
146570101|NCT02750514|528599127|FG004|Track 1|Study drug toxicity|0|||
146570102|NCT02750514|528599123|FG000|Track 1|Participant request to discontinue|1|||
146570103|NCT02750514|528599124|FG001|Track 1|Participant request to discontinue|0|||
146570104|NCT02750514|528599125|FG002|Track 1|Participant request to discontinue|0|||
146570105|NCT02750514|528599126|FG003|Track 1|Participant request to discontinue|0|||
146570106|NCT02750514|528599127|FG004|Track 1|Participant request to discontinue|0|||
146570107|NCT02750514|528599123|FG000|Track 1|Other reasons|1|||
146570108|NCT02750514|528599124|FG001|Track 1|Other reasons|0|||
146570109|NCT02750514|528599125|FG002|Track 1|Other reasons|0|||
146570110|NCT02750514|528599126|FG003|Track 1|Other reasons|0|||
146570111|NCT02750514|528599127|FG004|Track 1|Other reasons|0|||
146570112|NCT02750514|528599123|FG000|Track 2|Disease progression|4|||
146570113|NCT02750514|528599124|FG001|Track 2|Disease progression|5|||
146650570|NCT00534313|528896794|FG002|Long-term Period|Administrative reason by sponsor|26|||
146650571|NCT00534313|528896795|FG003|Long-term Period|Administrative reason by sponsor|18|||
146650572|NCT00534313|528896792|FG000|Long-term Period|Other|1|||
146650573|NCT00534313|528896793|FG001|Long-term Period|Other|2|||
146650574|NCT00534313|528896794|FG002|Long-term Period|Other|2|||
146650575|NCT00534313|528896795|FG003|Long-term Period|Other|2|||
146976454|NCT00678379|530077367|FG002|Overall Study|Incomplete Data|3|||
146570114|NCT02750514|528599125|FG002|Track 2|Disease progression|2|||
146570115|NCT02750514|528599126|FG003|Track 2|Disease progression|5|||
146570116|NCT02750514|528599127|FG004|Track 2|Disease progression|0|||
146570117|NCT02750514|528599123|FG000|Track 2|Adverse event unrelated to study drug|1|||
146570118|NCT02750514|528599124|FG001|Track 2|Adverse event unrelated to study drug|0|||
146570119|NCT02750514|528599125|FG002|Track 2|Adverse event unrelated to study drug|0|||
146570120|NCT02750514|528599126|FG003|Track 2|Adverse event unrelated to study drug|0|||
146570121|NCT02750514|528599127|FG004|Track 2|Adverse event unrelated to study drug|0|||
146650576|NCT00927940|528896796|FG000|Overall Study|Death|1|||
146650577|NCT03007888|528896797|FG000|First Intervention (14 Days)|Adverse Event|1|||
146650578|NCT03007888|528896798|FG001|First Intervention (14 Days)|Adverse Event|0|||
146650579|NCT00827931|528896800|FG000|Overall Study|Death|3|||
146650580|NCT00827931|528896801|FG001|Overall Study|Death|5|||
146570122|NCT02750514|528599123|FG000|Track 2|Study drug toxicity|1|||
146570123|NCT02750514|528599124|FG001|Track 2|Study drug toxicity|2|||
146650581|NCT00827931|528896800|FG000|Overall Study|Adverse Event|1|||
146570124|NCT02750514|528599125|FG002|Track 2|Study drug toxicity|0|||
146915953|NCT02125331|529855857|FG001|Overall Study|screen failure|0|||
146570125|NCT02750514|528599126|FG003|Track 2|Study drug toxicity|2|||
146570126|NCT02750514|528599127|FG004|Track 2|Study drug toxicity|0|||
146570127|NCT02750514|528599123|FG000|Track 2|Participant withdrew consent|0|||
146570128|NCT02750514|528599124|FG001|Track 2|Participant withdrew consent|1|||
146570129|NCT02750514|528599125|FG002|Track 2|Participant withdrew consent|0|||
146570130|NCT02750514|528599126|FG003|Track 2|Participant withdrew consent|0|||
146570131|NCT02750514|528599127|FG004|Track 2|Participant withdrew consent|0|||
146570132|NCT02750514|528599123|FG000|Track 3|Disease progression|0|||
146570133|NCT02750514|528599124|FG001|Track 3|Disease progression|24|||
146570134|NCT02750514|528599125|FG002|Track 3|Disease progression|13|||
146570135|NCT02750514|528599126|FG003|Track 3|Disease progression|14|||
146570136|NCT02750514|528599127|FG004|Track 3|Disease progression|0|||
146570137|NCT02750514|528599123|FG000|Track 3|Adverse event unrelated to study drug|0|||
146570138|NCT02750514|528599124|FG001|Track 3|Adverse event unrelated to study drug|1|||
146570139|NCT02750514|528599125|FG002|Track 3|Adverse event unrelated to study drug|1|||
146570140|NCT02750514|528599126|FG003|Track 3|Adverse event unrelated to study drug|1|||
146570141|NCT02750514|528599127|FG004|Track 3|Adverse event unrelated to study drug|0|||
146570142|NCT02750514|528599123|FG000|Track 3|Study drug toxicity|0|||
146570143|NCT02750514|528599124|FG001|Track 3|Study drug toxicity|3|||
146570144|NCT02750514|528599125|FG002|Track 3|Study drug toxicity|0|||
146570145|NCT02750514|528599126|FG003|Track 3|Study drug toxicity|1|||
146570146|NCT02750514|528599127|FG004|Track 3|Study drug toxicity|0|||
146570147|NCT02750514|528599123|FG000|Track 3|Participant request to discontinue|0|||
146570148|NCT02750514|528599124|FG001|Track 3|Participant request to discontinue|2|||
146570149|NCT02750514|528599125|FG002|Track 3|Participant request to discontinue|0|||
146570150|NCT02750514|528599126|FG003|Track 3|Participant request to discontinue|0|||
146570151|NCT02750514|528599127|FG004|Track 3|Participant request to discontinue|0|||
146570152|NCT02750514|528599123|FG000|Track 3|Participant withdrew consent|0|||
146570153|NCT02750514|528599124|FG001|Track 3|Participant withdrew consent|3|||
146570154|NCT02750514|528599125|FG002|Track 3|Participant withdrew consent|1|||
146570155|NCT02750514|528599126|FG003|Track 3|Participant withdrew consent|0|||
146570156|NCT02750514|528599127|FG004|Track 3|Participant withdrew consent|0|||
146570157|NCT02750514|528599123|FG000|Track 3|Other reasons|0|||
146570158|NCT02750514|528599124|FG001|Track 3|Other reasons|3|||
146570159|NCT02750514|528599125|FG002|Track 3|Other reasons|0|||
146570160|NCT02750514|528599126|FG003|Track 3|Other reasons|0|||
146570161|NCT02750514|528599127|FG004|Track 3|Other reasons|0|||
146570162|NCT02750514|528599123|FG000|Track 4|Study drug toxicity|0|||
146570163|NCT02750514|528599124|FG001|Track 4|Study drug toxicity|6|||
146570164|NCT02750514|528599125|FG002|Track 4|Study drug toxicity|0|||
146570165|NCT02750514|528599126|FG003|Track 4|Study drug toxicity|5|||
146570166|NCT02750514|528599127|FG004|Track 4|Study drug toxicity|0|||
146570167|NCT02750514|528599123|FG000|Track 4|Participant request to discontinue|0|||
146570168|NCT02750514|528599124|FG001|Track 4|Participant request to discontinue|1|||
146570169|NCT02750514|528599125|FG002|Track 4|Participant request to discontinue|0|||
146570170|NCT02750514|528599126|FG003|Track 4|Participant request to discontinue|1|||
146570171|NCT02750514|528599127|FG004|Track 4|Participant request to discontinue|0|||
146570172|NCT02750514|528599123|FG000|Track 4|Participant withdrew consent|0|||
146570173|NCT02750514|528599124|FG001|Track 4|Participant withdrew consent|1|||
146570174|NCT02750514|528599125|FG002|Track 4|Participant withdrew consent|0|||
146570175|NCT02750514|528599126|FG003|Track 4|Participant withdrew consent|0|||
146570176|NCT02750514|528599127|FG004|Track 4|Participant withdrew consent|0|||
146570177|NCT02750514|528599123|FG000|Track 4|Other reasons|0|||
146570178|NCT02750514|528599124|FG001|Track 4|Other reasons|5|||
146570179|NCT02750514|528599125|FG002|Track 4|Other reasons|0|||
146570180|NCT02750514|528599126|FG003|Track 4|Other reasons|3|||
146915954|NCT02078713|529855858|FG000|Overall Study|Lost to Follow-up|49|||
146915955|NCT02078713|529855859|FG001|Overall Study|Lost to Follow-up|55|||
146570181|NCT02750514|528599127|FG004|Track 4|Other reasons|0|||
146570182|NCT02750514|528599123|FG000|Track 4|Disease progression|0|||
146570183|NCT02750514|528599124|FG001|Track 4|Disease progression|33|||
146570184|NCT02750514|528599125|FG002|Track 4|Disease progression|0|||
146570185|NCT02750514|528599126|FG003|Track 4|Disease progression|32|||
146915956|NCT02078713|529855860|FG002|Overall Study|Lost to Follow-up|0|||
146915957|NCT02078713|529855861|FG003|Overall Study|Lost to Follow-up|0|||
146570186|NCT02750514|528599127|FG004|Track 4|Disease progression|0|||
146570187|NCT02750514|528599123|FG000|Track 4|Adverse event unrelated to study drug|0|||
146570188|NCT02750514|528599124|FG001|Track 4|Adverse event unrelated to study drug|5|||
146570189|NCT02750514|528599125|FG002|Track 4|Adverse event unrelated to study drug|0|||
146570190|NCT02750514|528599126|FG003|Track 4|Adverse event unrelated to study drug|0|||
146570191|NCT02750514|528599127|FG004|Track 4|Adverse event unrelated to study drug|0|||
146570192|NCT02750514|528599123|FG000|Track 4|Death|0|||
146570193|NCT02750514|528599124|FG001|Track 4|Death|0|||
146570194|NCT02750514|528599125|FG002|Track 4|Death|0|||
146570195|NCT02750514|528599126|FG003|Track 4|Death|1|||
146570196|NCT02750514|528599127|FG004|Track 4|Death|0|||
146570197|NCT02750514|528599123|FG000|Track 5|Disease progression|0|||
146570198|NCT02750514|528599124|FG001|Track 5|Disease progression|0|||
146570199|NCT02750514|528599125|FG002|Track 5|Disease progression|0|||
146915958|NCT02078713|529855858|FG000|Overall Study|Pregnant at baseline|3|||
146915959|NCT02078713|529855859|FG001|Overall Study|Pregnant at baseline|5|||
146915960|NCT02078713|529855860|FG002|Overall Study|Pregnant at baseline|0|||
146915961|NCT02078713|529855861|FG003|Overall Study|Pregnant at baseline|0|||
146915962|NCT02078713|529855858|FG000|Overall Study|Enrolled twice|0|||
146570200|NCT02750514|528599126|FG003|Track 5|Disease progression|0|||
146570201|NCT02750514|528599127|FG004|Track 5|Disease progression|34|||
146570202|NCT02750514|528599123|FG000|Track 5|Adverse event unrelated to study drug|0|||
146570203|NCT02750514|528599124|FG001|Track 5|Adverse event unrelated to study drug|0|||
146570204|NCT02750514|528599125|FG002|Track 5|Adverse event unrelated to study drug|0|||
146570205|NCT02750514|528599126|FG003|Track 5|Adverse event unrelated to study drug|0|||
146570206|NCT02750514|528599127|FG004|Track 5|Adverse event unrelated to study drug|2|||
146570207|NCT02750514|528599123|FG000|Track 5|Study drug toxicity|0|||
146570208|NCT02750514|528599124|FG001|Track 5|Study drug toxicity|0|||
146570209|NCT02750514|528599125|FG002|Track 5|Study drug toxicity|0|||
146570210|NCT02750514|528599126|FG003|Track 5|Study drug toxicity|0|||
146570211|NCT02750514|528599127|FG004|Track 5|Study drug toxicity|2|||
146570212|NCT02750514|528599123|FG000|Track 5|Participant request to discontinue|0|||
146570213|NCT02750514|528599124|FG001|Track 5|Participant request to discontinue|0|||
146570214|NCT02750514|528599125|FG002|Track 5|Participant request to discontinue|0|||
146570215|NCT02750514|528599126|FG003|Track 5|Participant request to discontinue|0|||
146570216|NCT02750514|528599127|FG004|Track 5|Participant request to discontinue|3|||
146570217|NCT02750514|528599123|FG000|Track 5|Other reasons|0|||
146570218|NCT02750514|528599124|FG001|Track 5|Other reasons|0|||
146570219|NCT02750514|528599125|FG002|Track 5|Other reasons|0|||
146570220|NCT02750514|528599126|FG003|Track 5|Other reasons|0|||
146570221|NCT02750514|528599127|FG004|Track 5|Other reasons|2|||
146570222|NCT02230189|528599128|FG000|Overall Study|Withdrawal by Subject|3|||
146570223|NCT02230189|528599129|FG001|Overall Study|Withdrawal by Subject|0|||
146570224|NCT02230189|528599130|FG002|Overall Study|Withdrawal by Subject|1|||
146570225|NCT02230189|528599128|FG000|Overall Study|Lost to Follow-up|1|||
146570226|NCT02230189|528599129|FG001|Overall Study|Lost to Follow-up|0|||
146570227|NCT02230189|528599130|FG002|Overall Study|Lost to Follow-up|0|||
146570228|NCT02230189|528599128|FG000|Overall Study|Physician Decision|1|||
146570229|NCT02230189|528599129|FG001|Overall Study|Physician Decision|0|||
146570230|NCT02230189|528599130|FG002|Overall Study|Physician Decision|0|||
146570231|NCT03894891|528599133|FG000|Overall Study|Withdrawal by Subject|1|||
146570232|NCT03894891|528599133|FG000|Overall Study|Completed protocol treatment per protocol|5|||
146570233|NCT04422431|528599140|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
146570234|NCT04422431|528599140|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
146570235|NCT04422431|528599140|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
146570236|NCT04422431|528599140|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
146570237|NCT04422431|528599140|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
146570238|NCT04422431|528599140|FG000|Extension Period (48 Weeks)|Other than specified|2|||
146570239|NCT01900665|528599141|FG000|Placebo Controlled Period|Death|9|||
146915963|NCT02078713|529855859|FG001|Overall Study|Enrolled twice|1|||
146915964|NCT02078713|529855860|FG002|Overall Study|Enrolled twice|0|||
146915965|NCT02078713|529855861|FG003|Overall Study|Enrolled twice|0|||
146915966|NCT00696657|529855862|FG000|Overall Study|Protocol Violation|0|||
146915967|NCT00696657|529855863|FG001|Overall Study|Protocol Violation|0|||
146915968|NCT00696657|529855864|FG002|Overall Study|Protocol Violation|0|||
146570240|NCT01900665|528599142|FG001|Placebo Controlled Period|Death|16|||
146570241|NCT01900665|528599141|FG000|Placebo Controlled Period|Adverse Event|48|||
146570242|NCT01900665|528599142|FG001|Placebo Controlled Period|Adverse Event|39|||
146570243|NCT01900665|528599141|FG000|Placebo Controlled Period|Protocol Violation|1|||
146570244|NCT01900665|528599142|FG001|Placebo Controlled Period|Protocol Violation|7|||
146650582|NCT00827931|528896801|FG001|Overall Study|Adverse Event|0|||
146650583|NCT00827931|528896800|FG000|Overall Study|Lost to Follow-up|1|||
146570245|NCT01900665|528599141|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
146570246|NCT01900665|528599142|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
146915969|NCT00696657|529855865|FG003|Overall Study|Protocol Violation|0|||
146570247|NCT01900665|528599141|FG000|Placebo Controlled Period|Physician Decision|11|||
146570248|NCT01900665|528599142|FG001|Placebo Controlled Period|Physician Decision|7|||
146570249|NCT01900665|528599141|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
146650584|NCT00827931|528896801|FG001|Overall Study|Lost to Follow-up|0|||
146570250|NCT01900665|528599142|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
146570251|NCT01900665|528599141|FG000|Placebo Controlled Period|Caregiver Decision|33|||
146570252|NCT01900665|528599142|FG001|Placebo Controlled Period|Caregiver Decision|41|||
146570253|NCT01900665|528599141|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
146570254|NCT01900665|528599142|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
146915970|NCT00696657|529855866|FG004|Overall Study|Protocol Violation|0|||
146915971|NCT00696657|529855867|FG005|Overall Study|Protocol Violation|1|||
146915972|NCT00696657|529855868|FG006|Overall Study|Protocol Violation|0|||
146570255|NCT01900665|528599141|FG000|Open Label Period|Adverse Event|16|||
146976455|NCT01440647|530077370|FG000|Overall Study|Death|2|||
146976456|NCT01440647|530077371|FG001|Overall Study|Death|3|||
146976457|NCT04335110|530077383|FG000|Overall Study|Withdrawal by Subject|1|||
146976458|NCT04335110|530077384|FG001|Overall Study|Withdrawal by Subject|1|||
146976459|NCT04335110|530077383|FG000|Overall Study|Death|0|||
146976460|NCT04335110|530077384|FG001|Overall Study|Death|1|||
146976461|NCT04006847|530077387|FG000|Overall Study|Product issue|1|||
146976462|NCT03333382|530077396|FG000|Overall Study|Lost to Follow-up|1|||
146976463|NCT03333382|530077397|FG001|Overall Study|Lost to Follow-up|0|||
146976464|NCT02454972|530077400|FG000|Overall Study|Progressive disease|17|||
146976465|NCT02454972|530077401|FG001|Overall Study|Progressive disease|16|||
146976466|NCT02454972|530077402|FG002|Overall Study|Progressive disease|59|||
146976467|NCT02454972|530077403|FG003|Overall Study|Progressive disease|23|||
146976468|NCT02454972|530077404|FG004|Overall Study|Progressive disease|16|||
146976469|NCT02454972|530077405|FG005|Overall Study|Progressive disease|12|||
146976470|NCT02454972|530077406|FG006|Overall Study|Progressive disease|19|||
146976471|NCT02454972|530077407|FG007|Overall Study|Progressive disease|27|||
146976472|NCT02454972|530077408|FG008|Overall Study|Progressive disease|0|||
146976473|NCT02454972|530077400|FG000|Overall Study|Death|0|||
146976474|NCT02454972|530077401|FG001|Overall Study|Death|0|||
146976475|NCT02454972|530077402|FG002|Overall Study|Death|5|||
146976476|NCT02454972|530077403|FG003|Overall Study|Death|1|||
146976477|NCT02454972|530077404|FG004|Overall Study|Death|0|||
146976478|NCT02454972|530077405|FG005|Overall Study|Death|0|||
146509379|NCT01032070|528368957|FG001|Overall Study|Withdrawal by Subject|2|||
146509380|NCT01935128|528368958|FG000|Overall Study|Death|1|||
146509381|NCT01935128|528368958|FG000|Overall Study|Adverse Event|6|||
146509382|NCT00204477|528368971|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
146509383|NCT00204477|528368972|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
146509384|NCT00204477|528368971|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
146509385|NCT00204477|528368972|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
146509386|NCT00150800|528368973|FG000|Overall Study|Adverse Event|89|||
146509387|NCT00150800|528368973|FG000|Overall Study|Death|18|||
146509388|NCT00150800|528368973|FG000|Overall Study|Lack of Efficacy|166|||
146509389|NCT00150800|528368973|FG000|Overall Study|Lost to Follow-up|58|||
146509390|NCT00150800|528368973|FG000|Overall Study|Subject's choice|90|||
146509391|NCT00150800|528368973|FG000|Overall Study|No compliance|18|||
146509392|NCT00150800|528368973|FG000|Overall Study|IP misshandling|1|||
146509393|NCT00150800|528368973|FG000|Overall Study|Site closure|24|||
146509394|NCT00150800|528368973|FG000|Overall Study|Protocol non-adherence|2|||
146509395|NCT00150800|528368973|FG000|Overall Study|Nobody to accompany patient|1|||
146509396|NCT00150800|528368973|FG000|Overall Study|Distance too long for patient|1|||
146509397|NCT00150800|528368973|FG000|Overall Study|Neurosurgery|2|||
146509398|NCT00150800|528368973|FG000|Overall Study|BRV monotherapy|1|||
146509399|NCT00150800|528368973|FG000|Overall Study|Visit refusal|3|||
146509400|NCT00150800|528368973|FG000|Overall Study|Sponsor's request|2|||
146509401|NCT00150800|528368973|FG000|Overall Study|Generalized Epilepsy|1|||
146509402|NCT00150800|528368973|FG000|Overall Study|Moved from area/country|8|||
146509403|NCT00150800|528368973|FG000|Overall Study|PI retiring|2|||
146509404|NCT00150800|528368973|FG000|Overall Study|PI leaving site|2|||
146509405|NCT00150800|528368973|FG000|Overall Study|Patient insurance|1|||
146509406|NCT00150800|528368973|FG000|Overall Study|Surgical intervention|4|||
146509407|NCT00150800|528368973|FG000|Overall Study|Pregnancy planned|1|||
146509408|NCT00150800|528368973|FG000|Overall Study|PI discontinuation request|1|||
146509409|NCT01966068|528368976|FG000|Overall Study|Withdrawal by Subject|57|||
146509410|NCT01966068|528368976|FG000|Overall Study|Lost to Follow-up|81|||
146509411|NCT01790828|528368978|FG000|Overall Study|Other|34|||
146509412|NCT00138073|528368983|FG000|Overall Study|lack of resources|55|||
146509413|NCT01037127|528368985|FG000|Overall Study|Lost to Follow-up|2|||
146509414|NCT01037127|528368986|FG001|Overall Study|Lost to Follow-up|4|||
146509415|NCT01037127|528368985|FG000|Overall Study|Physician Decision|1|||
146509416|NCT01037127|528368986|FG001|Overall Study|Physician Decision|0|||
146509417|NCT01037127|528368985|FG000|Overall Study|Study Closed Terminated|2|||
146509418|NCT01037127|528368986|FG001|Overall Study|Study Closed Terminated|17|||
146509419|NCT02847182|528368993|FG000|Overall Study|Withdrawal by Subject|0|||
146509420|NCT02847182|528368994|FG001|Overall Study|Withdrawal by Subject|1|||
146509421|NCT02345889|528368995|FG000|Overall Study|Inadequate Bowel Prep|17|||
146509422|NCT02345889|528368996|FG001|Overall Study|Inadequate Bowel Prep|16|||
146509423|NCT02345889|528368997|FG002|Overall Study|Inadequate Bowel Prep|18|||
146509424|NCT02345889|528368998|FG003|Overall Study|Inadequate Bowel Prep|14|||
146509425|NCT02345889|528368995|FG000|Overall Study|Polyposis identified during procedure|1|||
146509426|NCT02345889|528368996|FG001|Overall Study|Polyposis identified during procedure|1|||
146509427|NCT02345889|528368997|FG002|Overall Study|Polyposis identified during procedure|0|||
146509428|NCT02345889|528368998|FG003|Overall Study|Polyposis identified during procedure|1|||
146509429|NCT02345889|528368995|FG000|Overall Study|Recognized ineligible post-randomization|1|||
146976479|NCT02454972|530077406|FG006|Overall Study|Death|0|||
146976480|NCT02454972|530077407|FG007|Overall Study|Death|0|||
146976481|NCT02454972|530077408|FG008|Overall Study|Death|95|||
146976482|NCT02454972|530077400|FG000|Overall Study|Physician Decision|0|||
146650585|NCT00827931|528896800|FG000|Overall Study|Withdrawal by Subject|0|||
146650586|NCT00827931|528896801|FG001|Overall Study|Withdrawal by Subject|1|||
146650587|NCT00827931|528896800|FG000|Overall Study|Other|1|||
146650588|NCT00827931|528896801|FG001|Overall Study|Other|0|||
146650589|NCT00492063|528896802|FG000|Overall Study|Death|0|||
146650590|NCT00492063|528896803|FG001|Overall Study|Death|0|||
146650591|NCT00492063|528896804|FG002|Overall Study|Death|1|||
146650592|NCT00492063|528896805|FG003|Overall Study|Death|2|||
146650593|NCT00492063|528896802|FG000|Overall Study|Withdrawal by Subject|4|||
146650594|NCT00492063|528896803|FG001|Overall Study|Withdrawal by Subject|3|||
146650595|NCT00492063|528896804|FG002|Overall Study|Withdrawal by Subject|5|||
146650596|NCT00492063|528896805|FG003|Overall Study|Withdrawal by Subject|4|||
146650597|NCT00492063|528896802|FG000|Overall Study|Lost to Follow-up|6|||
146650598|NCT00492063|528896803|FG001|Overall Study|Lost to Follow-up|11|||
146650599|NCT00492063|528896804|FG002|Overall Study|Lost to Follow-up|5|||
146650600|NCT00492063|528896805|FG003|Overall Study|Lost to Follow-up|3|||
146650601|NCT00492063|528896802|FG000|Overall Study|Protocol Violation|0|||
146650602|NCT00492063|528896803|FG001|Overall Study|Protocol Violation|0|||
146570256|NCT01900665|528599142|FG001|Open Label Period|Adverse Event|20|||
146570257|NCT01900665|528599141|FG000|Open Label Period|Death|5|||
146570258|NCT01900665|528599142|FG001|Open Label Period|Death|6|||
146570259|NCT01900665|528599141|FG000|Open Label Period|Lost to Follow-up|1|||
146570260|NCT01900665|528599142|FG001|Open Label Period|Lost to Follow-up|1|||
146570261|NCT01900665|528599141|FG000|Open Label Period|Parent/Caregiver Decision|33|||
146570262|NCT01900665|528599142|FG001|Open Label Period|Parent/Caregiver Decision|34|||
146570263|NCT01900665|528599141|FG000|Open Label Period|Physician Decision|4|||
146570264|NCT01900665|528599142|FG001|Open Label Period|Physician Decision|4|||
146570265|NCT01900665|528599141|FG000|Open Label Period|Protocol Violation|0|||
146570266|NCT01900665|528599142|FG001|Open Label Period|Protocol Violation|1|||
146570267|NCT01900665|528599141|FG000|Open Label Period|Sponsor Decision|802|||
146570268|NCT01900665|528599142|FG001|Open Label Period|Sponsor Decision|765|||
146570269|NCT01900665|528599141|FG000|Open Label Period|Withdrawal by Subject|20|||
146570270|NCT01900665|528599142|FG001|Open Label Period|Withdrawal by Subject|28|||
146570271|NCT04046939|528599143|FG000|Primary Assessment Period|Adverse Event|1|||
146570272|NCT04046939|528599144|FG001|Primary Assessment Period|Adverse Event|0|||
146570273|NCT04046939|528599145|FG002|Primary Assessment Period|Adverse Event|0|||
146570274|NCT04046939|528599146|FG003|Primary Assessment Period|Adverse Event|0|||
146570275|NCT04046939|528599143|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
146570276|NCT04046939|528599144|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
146570277|NCT04046939|528599145|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
146570278|NCT04046939|528599146|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
146570279|NCT04046939|528599143|FG000|Primary Assessment Period|Physician Decision|0|||
146650603|NCT00492063|528896804|FG002|Overall Study|Protocol Violation|0|||
146650604|NCT00492063|528896805|FG003|Overall Study|Protocol Violation|1|||
146650605|NCT01870076|528896806|FG000|Overall Study|Withdrawal by Subject|1|||
146650606|NCT01870076|528896807|FG001|Overall Study|Withdrawal by Subject|0|||
146650607|NCT01870076|528896808|FG002|Overall Study|Withdrawal by Subject|1|||
146650608|NCT01870076|528896809|FG003|Overall Study|Withdrawal by Subject|0|||
146650609|NCT00608569|528896812|FG000|Overall Study|Death|4|||
146650610|NCT00608569|528896813|FG001|Overall Study|Death|3|||
146650611|NCT00608569|528896812|FG000|Overall Study|Lost to Follow-up|4|||
146650612|NCT00608569|528896813|FG001|Overall Study|Lost to Follow-up|5|||
146650613|NCT00608569|528896812|FG000|Overall Study|Withdrawal by Subject|1|||
146650614|NCT00608569|528896813|FG001|Overall Study|Withdrawal by Subject|0|||
146650615|NCT00608569|528896812|FG000|Overall Study|Adverse Event|1|||
146650616|NCT00608569|528896813|FG001|Overall Study|Adverse Event|0|||
146650617|NCT00608569|528896812|FG000|Overall Study|Unable to adhere with study requirements|0|||
146650618|NCT00608569|528896813|FG001|Overall Study|Unable to adhere with study requirements|1|||
146650619|NCT02312687|528896816|FG000|Overall Study|Other, Not Specified|1|||
146650620|NCT03645434|528896825|FG000|Period 1|Adverse Event|0|||
146650621|NCT03645434|528896826|FG001|Period 1|Adverse Event|0|||
146650622|NCT03645434|528896827|FG002|Period 1|Adverse Event|0|||
146650623|NCT03645434|528896828|FG003|Period 1|Adverse Event|1|||
146650624|NCT03645434|528896829|FG004|Period 1|Adverse Event|0|||
146650625|NCT03645434|528896830|FG005|Period 1|Adverse Event|0|||
146650626|NCT03645434|528896825|FG000|Period 1|COPD exacerbation|0|||
146650627|NCT03645434|528896826|FG001|Period 1|COPD exacerbation|0|||
146650628|NCT03645434|528896827|FG002|Period 1|COPD exacerbation|0|||
146650629|NCT03645434|528896828|FG003|Period 1|COPD exacerbation|0|||
146650630|NCT03645434|528896829|FG004|Period 1|COPD exacerbation|1|||
146650631|NCT03645434|528896830|FG005|Period 1|COPD exacerbation|0|||
146650632|NCT00167778|528896831|FG000|Overall Study|Withdrawal by Subject|1|||
146650633|NCT02654717|528896832|FG000|Overall Study|Adverse Event|2|||
146650634|NCT02654717|528896833|FG001|Overall Study|Adverse Event|2|||
146570280|NCT04046939|528599144|FG001|Primary Assessment Period|Physician Decision|0|||
146570281|NCT04046939|528599145|FG002|Primary Assessment Period|Physician Decision|1|||
146570282|NCT04046939|528599146|FG003|Primary Assessment Period|Physician Decision|0|||
146570283|NCT04046939|528599143|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
146570284|NCT04046939|528599144|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
146570285|NCT04046939|528599145|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
146570286|NCT04046939|528599146|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
146570287|NCT05414175|528599151|FG000|Overall Study|Withdrawal by Subject|1|||
146570288|NCT05414175|528599151|FG000|Overall Study|Other Reasons|1|||
146570289|NCT00027560|528599152|FG000|Overall Study|Withdrawal by Subject|1|||
146570290|NCT03559270|528599156|FG000|Overall Study|Adverse Event|6|||
146570291|NCT03559270|528599157|FG001|Overall Study|Adverse Event|5|||
146570292|NCT03559270|528599158|FG002|Overall Study|Adverse Event|3|||
146570293|NCT03559270|528599159|FG003|Overall Study|Adverse Event|0|||
146570294|NCT03559270|528599156|FG000|Overall Study|Lack of Efficacy|34|||
146570295|NCT03559270|528599157|FG001|Overall Study|Lack of Efficacy|52|||
146570296|NCT03559270|528599158|FG002|Overall Study|Lack of Efficacy|37|||
146570297|NCT03559270|528599159|FG003|Overall Study|Lack of Efficacy|2|||
146570298|NCT03559270|528599156|FG000|Overall Study|Death|0|||
146570299|NCT03559270|528599157|FG001|Overall Study|Death|2|||
146570300|NCT03559270|528599158|FG002|Overall Study|Death|0|||
146570301|NCT03559270|528599159|FG003|Overall Study|Death|0|||
146570302|NCT03559270|528599156|FG000|Overall Study|Lost to Follow-up|16|||
146570303|NCT03559270|528599157|FG001|Overall Study|Lost to Follow-up|4|||
146570304|NCT03559270|528599158|FG002|Overall Study|Lost to Follow-up|12|||
146570305|NCT03559270|528599159|FG003|Overall Study|Lost to Follow-up|3|||
146570306|NCT03559270|528599156|FG000|Overall Study|Sponsor Decision|38|||
146570307|NCT03559270|528599157|FG001|Overall Study|Sponsor Decision|31|||
146570308|NCT03559270|528599158|FG002|Overall Study|Sponsor Decision|35|||
146570309|NCT03559270|528599159|FG003|Overall Study|Sponsor Decision|18|||
146570310|NCT03559270|528599156|FG000|Overall Study|Withdrawal by Subject|19|||
146570311|NCT03559270|528599157|FG001|Overall Study|Withdrawal by Subject|21|||
146570312|NCT03559270|528599158|FG002|Overall Study|Withdrawal by Subject|18|||
146570313|NCT03559270|528599159|FG003|Overall Study|Withdrawal by Subject|7|||
146570314|NCT03559270|528599156|FG000|Overall Study|Physician Decision|3|||
146570315|NCT03559270|528599157|FG001|Overall Study|Physician Decision|2|||
146570316|NCT03559270|528599158|FG002|Overall Study|Physician Decision|1|||
146570317|NCT03559270|528599159|FG003|Overall Study|Physician Decision|0|||
146570318|NCT03559270|528599156|FG000|Overall Study|Pregnancy|0|||
146570319|NCT03559270|528599157|FG001|Overall Study|Pregnancy|1|||
146570320|NCT03559270|528599158|FG002|Overall Study|Pregnancy|0|||
146570321|NCT03559270|528599159|FG003|Overall Study|Pregnancy|0|||
146570322|NCT03559270|528599156|FG000|Overall Study|Protocol Violation|1|||
146570323|NCT03559270|528599157|FG001|Overall Study|Protocol Violation|0|||
146570324|NCT03559270|528599158|FG002|Overall Study|Protocol Violation|2|||
146570325|NCT03559270|528599159|FG003|Overall Study|Protocol Violation|0|||
146570326|NCT02393859|528600795|FG000|Overall Study|Decision by Sponsor|2|||
146570327|NCT02393859|528600796|FG001|Overall Study|Decision by Sponsor|4|||
146570328|NCT02393859|528600795|FG000|Overall Study|Withdrawal by Subject|11|||
146570329|NCT02393859|528600796|FG001|Overall Study|Withdrawal by Subject|6|||
146570330|NCT02393859|528600795|FG000|Overall Study|Death|27|||
146570331|NCT02393859|528600796|FG001|Overall Study|Death|10|||
146570332|NCT02393859|528600795|FG000|Overall Study|Lost to Follow-up|1|||
146570333|NCT02393859|528600796|FG001|Overall Study|Lost to Follow-up|1|||
146570334|NCT00856323|528600797|FG000|Overall Study|Withdrawal by Subject|2|||
146570335|NCT01833494|528600799|FG000|Overall Study|Adverse Event|24|||
146570336|NCT01833494|528600799|FG000|Overall Study|Physician Decision|6|||
146570337|NCT01833494|528600799|FG000|Overall Study|Withdrawal by Subject|6|||
146570338|NCT01833494|528600799|FG000|Overall Study|Decrease in serum phosphorus|4|||
146570339|NCT01833494|528600799|FG000|Overall Study|Decrease in serum calcium|4|||
146570340|NCT01833494|528600799|FG000|Overall Study|Increase in serum ferritin|1|||
146570341|NCT01694433|528600804|FG000|Overall Study|Adverse Event|7|||
146570342|NCT01694433|528600805|FG001|Overall Study|Adverse Event|0|||
146570343|NCT01694433|528600804|FG000|Overall Study|Physician Decision|1|||
146570344|NCT01694433|528600805|FG001|Overall Study|Physician Decision|0|||
146570345|NCT01694433|528600804|FG000|Overall Study|Withdrawal by Subject|3|||
146570346|NCT01694433|528600805|FG001|Overall Study|Withdrawal by Subject|4|||
146570347|NCT00374595|528600808|FG000|Overall Study|Death|23|||
146570348|NCT00374595|528600808|FG000|Overall Study|Withdrawal by Subject|39|||
146570349|NCT00374595|528600808|FG000|Overall Study|Lost to Follow-up|3|||
146570350|NCT00374595|528600808|FG000|Overall Study|too much time commitment|1|||
146570351|NCT00374595|528600808|FG000|Overall Study|transfer care to other clinical site|1|||
146570352|NCT00374595|528600808|FG000|Overall Study|relocation|3|||
146570353|NCT03745768|528600809|FG000|Overall Study|discontinued study|2|||
146570354|NCT03745768|528600810|FG001|Overall Study|discontinued study|0|||
146570355|NCT00443118|528600811|FG000|Overall Study|unknown primary outcome|3|||
146570356|NCT00443118|528600812|FG001|Overall Study|unknown primary outcome|1|||
146570357|NCT00443118|528600813|FG002|Overall Study|unknown primary outcome|0|||
146570358|NCT00443118|528600811|FG000|Overall Study|Withdrawal by Subject|1|||
146570359|NCT00443118|528600812|FG001|Overall Study|Withdrawal by Subject|0|||
146570360|NCT00443118|528600813|FG002|Overall Study|Withdrawal by Subject|0|||
146570361|NCT04512001|528600814|FG000|Week 0 to Week 24|Adverse Event|14|||
146570362|NCT04512001|528600815|FG001|Week 0 to Week 24|Adverse Event|10|||
146570363|NCT04512001|528600816|FG002|Week 0 to Week 24|Adverse Event|0|||
146570364|NCT04512001|528600817|FG003|Week 0 to Week 24|Adverse Event|0|||
146570365|NCT04512001|528600818|FG004|Week 0 to Week 24|Adverse Event|0|||
146570366|NCT04512001|528600814|FG000|Week 0 to Week 24|Death|0|||
146570367|NCT04512001|528600815|FG001|Week 0 to Week 24|Death|2|||
146570368|NCT04512001|528600816|FG002|Week 0 to Week 24|Death|0|||
146570369|NCT04512001|528600817|FG003|Week 0 to Week 24|Death|0|||
146570370|NCT04512001|528600818|FG004|Week 0 to Week 24|Death|0|||
146570371|NCT04512001|528600814|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
146570372|NCT04512001|528600815|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
146570373|NCT04512001|528600816|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
146570374|NCT04512001|528600817|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
146570375|NCT04512001|528600818|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
146570376|NCT04512001|528600814|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
146570377|NCT04512001|528600815|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
146570378|NCT04512001|528600816|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
146570379|NCT04512001|528600817|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
146570380|NCT04512001|528600818|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
146570381|NCT04512001|528600814|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
146570382|NCT04512001|528600815|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
146570383|NCT04512001|528600816|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
146570384|NCT04512001|528600817|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
146570385|NCT04512001|528600818|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
146570386|NCT04512001|528600814|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
146570387|NCT04512001|528600815|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
146570388|NCT04512001|528600816|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
146570389|NCT04512001|528600817|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
146570390|NCT04512001|528600818|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
146570391|NCT04512001|528600814|FG000|Week 24 to Week 63|Adverse Event|0|||
146570392|NCT04512001|528600815|FG001|Week 24 to Week 63|Adverse Event|0|||
146570393|NCT04512001|528600816|FG002|Week 24 to Week 63|Adverse Event|13|||
146570394|NCT04512001|528600817|FG003|Week 24 to Week 63|Adverse Event|8|||
146570395|NCT04512001|528600818|FG004|Week 24 to Week 63|Adverse Event|6|||
146570396|NCT04512001|528600814|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
146570397|NCT04512001|528600815|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
146570398|NCT04512001|528600816|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
146570399|NCT04512001|528600817|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
146570400|NCT04512001|528600818|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
146570401|NCT04512001|528600814|FG000|Week 24 to Week 63|Death|0|||
146570402|NCT04512001|528600815|FG001|Week 24 to Week 63|Death|0|||
146570403|NCT04512001|528600816|FG002|Week 24 to Week 63|Death|0|||
146570404|NCT04512001|528600817|FG003|Week 24 to Week 63|Death|1|||
146570405|NCT04512001|528600818|FG004|Week 24 to Week 63|Death|1|||
146570406|NCT04512001|528600814|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
146570407|NCT04512001|528600815|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
146570408|NCT04512001|528600816|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
146570409|NCT04512001|528600817|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
146570410|NCT04512001|528600818|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
146570411|NCT04512001|528600814|FG000|Week 24 to Week 63|Miscellaneous|0|||
146570412|NCT04512001|528600815|FG001|Week 24 to Week 63|Miscellaneous|0|||
146570413|NCT04512001|528600816|FG002|Week 24 to Week 63|Miscellaneous|3|||
146570414|NCT04512001|528600817|FG003|Week 24 to Week 63|Miscellaneous|2|||
146570415|NCT04512001|528600818|FG004|Week 24 to Week 63|Miscellaneous|1|||
146570416|NCT02776683|528600819|FG000|Pre-switch Period|Protocol Violation|1|||
146570417|NCT02776683|528600820|FG001|Pre-switch Period|Protocol Violation|0|||
146570418|NCT02776683|528600819|FG000|Pre-switch Period|Adverse Event|21|||
146570419|NCT02776683|528600820|FG001|Pre-switch Period|Adverse Event|0|||
146570420|NCT02776683|528600819|FG000|Pre-switch Period|Withdrawal by Subject|9|||
146570421|NCT02776683|528600820|FG001|Pre-switch Period|Withdrawal by Subject|0|||
146570422|NCT02776683|528600819|FG000|Pre-switch Period|Physician Decision|7|||
146570423|NCT02776683|528600820|FG001|Pre-switch Period|Physician Decision|0|||
146570424|NCT02776683|528600819|FG000|Pre-switch Period|Progressive disease|39|||
146570425|NCT02776683|528600820|FG001|Pre-switch Period|Progressive disease|0|||
146570426|NCT02776683|528600819|FG000|Pre-switch Period|Other than listed|3|||
146570427|NCT02776683|528600820|FG001|Pre-switch Period|Other than listed|0|||
146570428|NCT02776683|528600819|FG000|Post-switch Period|Adverse Event|0|||
146570429|NCT02776683|528600820|FG001|Post-switch Period|Adverse Event|3|||
146570430|NCT02776683|528600819|FG000|Post-switch Period|Withdrawal by Subject|0|||
146976483|NCT02454972|530077401|FG001|Overall Study|Physician Decision|1|||
146570431|NCT02776683|528600820|FG001|Post-switch Period|Withdrawal by Subject|2|||
146570432|NCT02776683|528600819|FG000|Post-switch Period|Physician Decision|0|||
146570433|NCT02776683|528600820|FG001|Post-switch Period|Physician Decision|3|||
146570434|NCT02776683|528600819|FG000|Post-switch Period|Progressive disease|0|||
146570435|NCT02776683|528600820|FG001|Post-switch Period|Progressive disease|20|||
146570436|NCT02776683|528600819|FG000|Post-switch Period|Other than listed|0|||
146570437|NCT02776683|528600820|FG001|Post-switch Period|Other than listed|15|||
146976484|NCT02454972|530077402|FG002|Overall Study|Physician Decision|2|||
146976485|NCT02454972|530077403|FG003|Overall Study|Physician Decision|1|||
146976486|NCT02454972|530077404|FG004|Overall Study|Physician Decision|2|||
146976487|NCT02454972|530077405|FG005|Overall Study|Physician Decision|0|||
146976488|NCT02454972|530077406|FG006|Overall Study|Physician Decision|0|||
146976489|NCT02454972|530077407|FG007|Overall Study|Physician Decision|1|||
146976490|NCT02454972|530077408|FG008|Overall Study|Physician Decision|0|||
146976491|NCT02454972|530077400|FG000|Overall Study|Non treatment-related adverse event|2|||
146976492|NCT02454972|530077401|FG001|Overall Study|Non treatment-related adverse event|0|||
146976493|NCT02454972|530077402|FG002|Overall Study|Non treatment-related adverse event|1|||
146976494|NCT02454972|530077403|FG003|Overall Study|Non treatment-related adverse event|0|||
146976495|NCT02454972|530077404|FG004|Overall Study|Non treatment-related adverse event|0|||
146976496|NCT02454972|530077405|FG005|Overall Study|Non treatment-related adverse event|1|||
146976497|NCT02454972|530077406|FG006|Overall Study|Non treatment-related adverse event|0|||
146976498|NCT02454972|530077407|FG007|Overall Study|Non treatment-related adverse event|1|||
146976499|NCT02454972|530077408|FG008|Overall Study|Non treatment-related adverse event|0|||
146976500|NCT02454972|530077400|FG000|Overall Study|Treatment-related adverse events|0|||
146976501|NCT02454972|530077401|FG001|Overall Study|Treatment-related adverse events|1|||
146976502|NCT02454972|530077402|FG002|Overall Study|Treatment-related adverse events|1|||
146976503|NCT02454972|530077403|FG003|Overall Study|Treatment-related adverse events|0|||
146976504|NCT02454972|530077404|FG004|Overall Study|Treatment-related adverse events|2|||
146976505|NCT02454972|530077405|FG005|Overall Study|Treatment-related adverse events|0|||
146976506|NCT02454972|530077406|FG006|Overall Study|Treatment-related adverse events|0|||
146976507|NCT02454972|530077407|FG007|Overall Study|Treatment-related adverse events|2|||
146976508|NCT02454972|530077408|FG008|Overall Study|Treatment-related adverse events|0|||
146976509|NCT02454972|530077400|FG000|Overall Study|Patient moves to compassionate use|0|||
146976510|NCT02454972|530077401|FG001|Overall Study|Patient moves to compassionate use|0|||
146976511|NCT02454972|530077402|FG002|Overall Study|Patient moves to compassionate use|0|||
146976512|NCT02454972|530077403|FG003|Overall Study|Patient moves to compassionate use|0|||
146976513|NCT02454972|530077404|FG004|Overall Study|Patient moves to compassionate use|0|||
146976514|NCT02454972|530077405|FG005|Overall Study|Patient moves to compassionate use|0|||
146976515|NCT02454972|530077406|FG006|Overall Study|Patient moves to compassionate use|2|||
146976516|NCT02454972|530077407|FG007|Overall Study|Patient moves to compassionate use|0|||
146976517|NCT02454972|530077408|FG008|Overall Study|Patient moves to compassionate use|0|||
146976518|NCT02454972|530077400|FG000|Overall Study|Withdrawal by Subject|0|||
146976519|NCT02454972|530077401|FG001|Overall Study|Withdrawal by Subject|1|||
146976520|NCT02454972|530077402|FG002|Overall Study|Withdrawal by Subject|5|||
146976521|NCT02454972|530077403|FG003|Overall Study|Withdrawal by Subject|2|||
146976522|NCT02454972|530077404|FG004|Overall Study|Withdrawal by Subject|3|||
146976523|NCT02454972|530077405|FG005|Overall Study|Withdrawal by Subject|2|||
146976524|NCT02454972|530077406|FG006|Overall Study|Withdrawal by Subject|0|||
146976525|NCT02454972|530077407|FG007|Overall Study|Withdrawal by Subject|1|||
146976526|NCT02454972|530077408|FG008|Overall Study|Withdrawal by Subject|2|||
146976527|NCT02454972|530077400|FG000|Overall Study|Multiple delay/holds on treatment|0|||
146976528|NCT02454972|530077401|FG001|Overall Study|Multiple delay/holds on treatment|0|||
146976529|NCT02454972|530077402|FG002|Overall Study|Multiple delay/holds on treatment|0|||
146570438|NCT04232943|528600821|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
146570439|NCT04232943|528600822|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
146570440|NCT04232943|528600823|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
146570441|NCT04232943|528600821|FG000|Overall Study|Withdrawal by Subject|1|||
146570442|NCT04232943|528600822|FG001|Overall Study|Withdrawal by Subject|1|||
146570443|NCT04232943|528600823|FG002|Overall Study|Withdrawal by Subject|0|||
146976530|NCT02454972|530077403|FG003|Overall Study|Multiple delay/holds on treatment|1|||
146976531|NCT02454972|530077404|FG004|Overall Study|Multiple delay/holds on treatment|0|||
146570444|NCT01664247|528600828|FG000|Overall Study|Adverse Event|5|||
146570445|NCT01664247|528600829|FG001|Overall Study|Adverse Event|3|||
146570446|NCT01664247|528600828|FG000|Overall Study|Protocol Violation|3|||
146570447|NCT01664247|528600829|FG001|Overall Study|Protocol Violation|5|||
146650635|NCT02654717|528896832|FG000|Overall Study|Protocol Violation|1|||
146650636|NCT02654717|528896833|FG001|Overall Study|Protocol Violation|2|||
146650637|NCT02654717|528896832|FG000|Overall Study|Withdrawal by Subject|0|||
146650638|NCT02654717|528896833|FG001|Overall Study|Withdrawal by Subject|1|||
146650639|NCT02654717|528896832|FG000|Overall Study|Non-permitted medication|3|||
146650640|NCT02654717|528896833|FG001|Overall Study|Non-permitted medication|0|||
146650641|NCT00336583|528898051|FG000|Overall Study|Lost to Follow-up|1|||
146650642|NCT00336583|528898051|FG000|Overall Study|Death|1|||
146770524|NCT03215927|529328607|FG000|Open Label Extension|Lack of Efficacy|1|||
146976532|NCT02454972|530077405|FG005|Overall Study|Multiple delay/holds on treatment|0|||
146570448|NCT01664247|528600828|FG000|Overall Study|Withdrawal Criteria|1|||
146650643|NCT02054481|528898052|FG000|Overall Study|Adverse Event|1|||
146650644|NCT02054481|528898053|FG001|Overall Study|Adverse Event|1|||
146650645|NCT02054481|528898054|FG002|Overall Study|Adverse Event|0|||
146770525|NCT03215927|529328608|FG001|Open Label Extension|Lack of Efficacy|0|||
146650646|NCT02054481|528898055|FG003|Overall Study|Adverse Event|1|||
146570449|NCT01664247|528600829|FG001|Overall Study|Withdrawal Criteria|4|||
146570450|NCT01664247|528600828|FG000|Overall Study|Unclassified|5|||
146570451|NCT01664247|528600829|FG001|Overall Study|Unclassified|29|||
146570452|NCT01023217|528600831|FG000|Overall Study|Withdrawal by Subject|1|||
146570453|NCT01023217|528600832|FG001|Overall Study|Withdrawal by Subject|0|||
146570454|NCT01106157|528600833|FG000|Overall Study|Withdrawal by Subject|1|||
146570455|NCT01106157|528600834|FG001|Overall Study|Withdrawal by Subject|0|||
146570456|NCT02298868|528600839|FG000|Overall Study|Adverse Event|1|||
146570457|NCT02298868|528600839|FG000|Overall Study|Death|1|||
146570458|NCT02298868|528600839|FG000|Overall Study|Patient underwent transplant|1|||
146570459|NCT01000506|528600840|FG000|Overall Study|Adverse Event|6|||
146570460|NCT01000506|528600841|FG001|Overall Study|Adverse Event|5|||
146570461|NCT01000506|528600842|FG002|Overall Study|Adverse Event|8|||
146570462|NCT01000506|528600843|FG003|Overall Study|Adverse Event|9|||
146570463|NCT01000506|528600840|FG000|Overall Study|Lack of Efficacy|8|||
146570464|NCT01000506|528600841|FG001|Overall Study|Lack of Efficacy|6|||
146570465|NCT01000506|528600842|FG002|Overall Study|Lack of Efficacy|4|||
146570466|NCT01000506|528600843|FG003|Overall Study|Lack of Efficacy|4|||
146570467|NCT01000506|528600840|FG000|Overall Study|Protocol Violation|1|||
146570468|NCT01000506|528600841|FG001|Overall Study|Protocol Violation|1|||
146570469|NCT01000506|528600842|FG002|Overall Study|Protocol Violation|0|||
146570470|NCT01000506|528600843|FG003|Overall Study|Protocol Violation|0|||
146570471|NCT01000506|528600840|FG000|Overall Study|Lost to Follow-up|1|||
146570472|NCT01000506|528600841|FG001|Overall Study|Lost to Follow-up|1|||
146570473|NCT01000506|528600842|FG002|Overall Study|Lost to Follow-up|4|||
146570474|NCT01000506|528600843|FG003|Overall Study|Lost to Follow-up|0|||
146570475|NCT01000506|528600840|FG000|Overall Study|Physician Decision|1|||
146570476|NCT01000506|528600841|FG001|Overall Study|Physician Decision|3|||
146570477|NCT01000506|528600842|FG002|Overall Study|Physician Decision|3|||
146570478|NCT01000506|528600843|FG003|Overall Study|Physician Decision|3|||
146570479|NCT01000506|528600840|FG000|Overall Study|Withdrawal by Subject|11|||
146570480|NCT01000506|528600841|FG001|Overall Study|Withdrawal by Subject|8|||
146570481|NCT01000506|528600842|FG002|Overall Study|Withdrawal by Subject|2|||
146570482|NCT01000506|528600843|FG003|Overall Study|Withdrawal by Subject|7|||
146570483|NCT03064074|528600844|FG000|Overall Study|Physician Decision|0|||
146570484|NCT03064074|528600845|FG001|Overall Study|Physician Decision|0|||
146570485|NCT03064074|528600846|FG002|Overall Study|Physician Decision|0|||
146915973|NCT00696657|529855869|FG007|Overall Study|Protocol Violation|0|||
146915974|NCT00696657|529855870|FG008|Overall Study|Protocol Violation|1|||
146915975|NCT00696657|529855862|FG000|Overall Study|Lack of Efficacy|0|||
146915976|NCT00696657|529855863|FG001|Overall Study|Lack of Efficacy|1|||
146915977|NCT00696657|529855864|FG002|Overall Study|Lack of Efficacy|0|||
146915978|NCT00696657|529855865|FG003|Overall Study|Lack of Efficacy|0|||
146915979|NCT00696657|529855866|FG004|Overall Study|Lack of Efficacy|0|||
146915980|NCT00696657|529855867|FG005|Overall Study|Lack of Efficacy|0|||
146915981|NCT00696657|529855868|FG006|Overall Study|Lack of Efficacy|0|||
146915982|NCT00696657|529855869|FG007|Overall Study|Lack of Efficacy|0|||
146915983|NCT00696657|529855870|FG008|Overall Study|Lack of Efficacy|0|||
146915984|NCT00696657|529855862|FG000|Overall Study|Withdrawal criteria|1|||
146976533|NCT02454972|530077406|FG006|Overall Study|Multiple delay/holds on treatment|0|||
146650647|NCT02054481|528898052|FG000|Overall Study|Lost to Follow-up|1|||
146650648|NCT02054481|528898053|FG001|Overall Study|Lost to Follow-up|0|||
146650649|NCT02054481|528898054|FG002|Overall Study|Lost to Follow-up|0|||
146650650|NCT02054481|528898055|FG003|Overall Study|Lost to Follow-up|0|||
146650651|NCT02054481|528898052|FG000|Overall Study|Other reason|2|||
146650652|NCT02054481|528898053|FG001|Overall Study|Other reason|1|||
146650653|NCT02054481|528898054|FG002|Overall Study|Other reason|2|||
146650654|NCT02054481|528898055|FG003|Overall Study|Other reason|0|||
146650655|NCT02320903|528898056|FG000|Overall Study|Withdrawal by Subject|0|||
146770526|NCT03215927|529328607|FG000|Open Label Extension|Death|0|||
146650656|NCT02320903|528898057|FG001|Overall Study|Withdrawal by Subject|9|||
146650657|NCT02320903|528898058|FG002|Overall Study|Withdrawal by Subject|9|||
146650658|NCT02320903|528898056|FG000|Overall Study|Exited therapy; no longer eligible|8|||
146650659|NCT02320903|528898057|FG001|Overall Study|Exited therapy; no longer eligible|2|||
146650660|NCT02320903|528898058|FG002|Overall Study|Exited therapy; no longer eligible|2|||
146770527|NCT03215927|529328608|FG001|Open Label Extension|Death|1|||
146570486|NCT03064074|528600847|FG003|Overall Study|Physician Decision|1|||
146570487|NCT02141672|528600848|FG000|Overall Study|Adverse Event|0|||
146650661|NCT02320903|528898056|FG000|Overall Study|Lost to Follow-up|0|||
146650662|NCT02320903|528898057|FG001|Overall Study|Lost to Follow-up|5|||
146650663|NCT02320903|528898058|FG002|Overall Study|Lost to Follow-up|5|||
146650664|NCT00883688|528898059|FG000|Overall Study|Ineligible|2|||
146915985|NCT00696657|529855863|FG001|Overall Study|Withdrawal criteria|3|||
146915986|NCT00696657|529855864|FG002|Overall Study|Withdrawal criteria|2|||
146570488|NCT02141672|528600849|FG001|Overall Study|Adverse Event|1|||
146570489|NCT02141672|528600850|FG002|Overall Study|Adverse Event|0|||
146570490|NCT02141672|528600848|FG000|Overall Study|Death|10|||
146570491|NCT02141672|528600849|FG001|Overall Study|Death|2|||
146570492|NCT02141672|528600850|FG002|Overall Study|Death|1|||
146915987|NCT00696657|529855865|FG003|Overall Study|Withdrawal criteria|2|||
146915988|NCT00696657|529855866|FG004|Overall Study|Withdrawal criteria|0|||
146915989|NCT00696657|529855867|FG005|Overall Study|Withdrawal criteria|0|||
146915990|NCT00696657|529855868|FG006|Overall Study|Withdrawal criteria|1|||
146915991|NCT00696657|529855869|FG007|Overall Study|Withdrawal criteria|1|||
146915992|NCT00696657|529855870|FG008|Overall Study|Withdrawal criteria|2|||
146915993|NCT00696657|529855862|FG000|Overall Study|Unclassified|0|||
146915994|NCT00696657|529855863|FG001|Overall Study|Unclassified|1|||
146915995|NCT00696657|529855864|FG002|Overall Study|Unclassified|3|||
146915996|NCT00696657|529855865|FG003|Overall Study|Unclassified|2|||
146915997|NCT00696657|529855866|FG004|Overall Study|Unclassified|4|||
146915998|NCT00696657|529855867|FG005|Overall Study|Unclassified|2|||
146915999|NCT00696657|529855868|FG006|Overall Study|Unclassified|0|||
146916000|NCT00696657|529855869|FG007|Overall Study|Unclassified|0|||
146916001|NCT00696657|529855870|FG008|Overall Study|Unclassified|1|||
146916002|NCT00696657|529855862|FG000|Overall Study|Adverse Event|0|||
146916003|NCT00696657|529855863|FG001|Overall Study|Adverse Event|0|||
146916004|NCT00696657|529855864|FG002|Overall Study|Adverse Event|3|||
146916005|NCT00696657|529855865|FG003|Overall Study|Adverse Event|7|||
146916006|NCT00696657|529855866|FG004|Overall Study|Adverse Event|6|||
146916007|NCT00696657|529855867|FG005|Overall Study|Adverse Event|9|||
146916008|NCT00696657|529855868|FG006|Overall Study|Adverse Event|14|||
146916009|NCT00696657|529855869|FG007|Overall Study|Adverse Event|2|||
146916010|NCT00696657|529855870|FG008|Overall Study|Adverse Event|5|||
146916011|NCT02601001|529855871|FG000|Dosing Period 2|Adverse Event|0|||
146916012|NCT02601001|529855872|FG001|Dosing Period 2|Adverse Event|0|||
146916013|NCT02601001|529855873|FG002|Dosing Period 2|Adverse Event|0|||
146916014|NCT02601001|529855874|FG003|Dosing Period 2|Adverse Event|0|||
146916015|NCT02601001|529855875|FG004|Dosing Period 2|Adverse Event|0|||
146916016|NCT02601001|529855876|FG005|Dosing Period 2|Adverse Event|0|||
146916017|NCT02601001|529855877|FG006|Dosing Period 2|Adverse Event|1|||
146916018|NCT01790438|529855878|FG000|Overall Study|Adverse Event|3|||
146916019|NCT01790438|529855879|FG001|Overall Study|Adverse Event|2|||
146916020|NCT01790438|529855878|FG000|Overall Study|Death|4|||
146916021|NCT01790438|529855879|FG001|Overall Study|Death|0|||
146916022|NCT01790438|529855878|FG000|Overall Study|Lost to Follow-up|5|||
146916023|NCT01790438|529855879|FG001|Overall Study|Lost to Follow-up|2|||
146916024|NCT01790438|529855878|FG000|Overall Study|Withdrawal by Subject|13|||
146916025|NCT01790438|529855879|FG001|Overall Study|Withdrawal by Subject|2|||
146916026|NCT01790438|529855878|FG000|Overall Study|Physician Decision|3|||
146916027|NCT01790438|529855879|FG001|Overall Study|Physician Decision|1|||
146916028|NCT01790438|529855878|FG000|Overall Study|Sponsor Decision|0|||
146916029|NCT01790438|529855879|FG001|Overall Study|Sponsor Decision|3|||
146916030|NCT01790438|529855878|FG000|Overall Study|Protocol Required Discontinuation|7|||
146916031|NCT01790438|529855879|FG001|Overall Study|Protocol Required Discontinuation|1|||
146916032|NCT02433210|529855885|FG000|Overall Study|Physician Decision|1|||
146916033|NCT02433210|529855886|FG001|Overall Study|Physician Decision|0|||
146916034|NCT02433210|529855887|FG002|Overall Study|Physician Decision|0|||
146916035|NCT01115569|529855888|FG000|Conversion/Titration Phase|Adverse Event|59|||
146916036|NCT01115569|529855889|FG001|Conversion/Titration Phase|Adverse Event|0|||
146916037|NCT01115569|529855888|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
146916038|NCT01115569|529855889|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
146916039|NCT01115569|529855888|FG000|Conversion/Titration Phase|Physician Decision|5|||
146916040|NCT01115569|529855889|FG001|Conversion/Titration Phase|Physician Decision|0|||
146916041|NCT01115569|529855888|FG000|Conversion/Titration Phase|Protocol Violation|68|||
146916042|NCT01115569|529855889|FG001|Conversion/Titration Phase|Protocol Violation|0|||
146976534|NCT02454972|530077407|FG007|Overall Study|Multiple delay/holds on treatment|0|||
146976535|NCT02454972|530077408|FG008|Overall Study|Multiple delay/holds on treatment|0|||
146976536|NCT02454972|530077400|FG000|Overall Study|Never treated|0|||
146570493|NCT02141672|528600848|FG000|Overall Study|Lack of Efficacy|0|||
146570494|NCT02141672|528600849|FG001|Overall Study|Lack of Efficacy|0|||
146570495|NCT02141672|528600850|FG002|Overall Study|Lack of Efficacy|2|||
146570496|NCT02141672|528600848|FG000|Overall Study|Lost to Follow-up|1|||
146570497|NCT02141672|528600849|FG001|Overall Study|Lost to Follow-up|1|||
146570498|NCT02141672|528600850|FG002|Overall Study|Lost to Follow-up|3|||
146570499|NCT02141672|528600848|FG000|Overall Study|Physician Decision|1|||
146570500|NCT02141672|528600849|FG001|Overall Study|Physician Decision|2|||
146570501|NCT02141672|528600850|FG002|Overall Study|Physician Decision|5|||
146570502|NCT02141672|528600848|FG000|Overall Study|Protocol Violation|0|||
146916043|NCT01115569|529855888|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
146916044|NCT01115569|529855889|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
146916045|NCT01115569|529855888|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
146916046|NCT01115569|529855889|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
146976537|NCT02454972|530077401|FG001|Overall Study|Never treated|0|||
146976538|NCT02454972|530077402|FG002|Overall Study|Never treated|3|||
146916047|NCT01115569|529855888|FG000|Maintenance Phase|Adverse Event|0|||
146916048|NCT01115569|529855889|FG001|Maintenance Phase|Adverse Event|43|||
146916049|NCT01115569|529855888|FG000|Maintenance Phase|Lost to Follow-up|0|||
146916050|NCT01115569|529855889|FG001|Maintenance Phase|Lost to Follow-up|8|||
146570503|NCT02141672|528600849|FG001|Overall Study|Protocol Violation|0|||
146570504|NCT02141672|528600850|FG002|Overall Study|Protocol Violation|1|||
146570505|NCT02141672|528600848|FG000|Overall Study|Withdrawal by Subject|3|||
146570506|NCT02141672|528600849|FG001|Overall Study|Withdrawal by Subject|2|||
146570507|NCT02141672|528600850|FG002|Overall Study|Withdrawal by Subject|5|||
146570508|NCT02141672|528600848|FG000|Overall Study|refused to follow-up|1|||
146570509|NCT02141672|528600849|FG001|Overall Study|refused to follow-up|0|||
146570510|NCT02141672|528600850|FG002|Overall Study|refused to follow-up|1|||
146570511|NCT01194245|528600851|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
146570512|NCT01194245|528600852|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
146570513|NCT01194245|528600853|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
146570514|NCT01194245|528600854|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
146570515|NCT01194245|528600855|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
146570516|NCT01194245|528600851|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
146570517|NCT01194245|528600852|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
146570518|NCT01194245|528600853|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
146570519|NCT01194245|528600854|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
146570520|NCT01194245|528600855|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
146570521|NCT01194245|528600851|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
146570522|NCT01194245|528600852|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
146570523|NCT01194245|528600853|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
146570524|NCT01194245|528600854|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
146570525|NCT01194245|528600855|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
146570526|NCT01194245|528600851|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
146570527|NCT01194245|528600852|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
146570528|NCT01194245|528600853|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
146570529|NCT01194245|528600854|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
146570530|NCT01194245|528600855|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
146570531|NCT01194245|528600851|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146570532|NCT01194245|528600852|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146570533|NCT01194245|528600853|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146570534|NCT01194245|528600854|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146570535|NCT01194245|528600855|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
146570536|NCT01194245|528600851|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146570537|NCT01194245|528600852|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146570538|NCT01194245|528600853|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
146570539|NCT01194245|528600854|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
146570540|NCT01194245|528600855|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
146570541|NCT01118780|528600856|FG000|Overall Study|Adverse Event|15|||
146570542|NCT01118780|528600857|FG001|Overall Study|Adverse Event|15|||
146570543|NCT01118780|528600856|FG000|Overall Study|Death|1|||
146570544|NCT01118780|528600857|FG001|Overall Study|Death|0|||
146570545|NCT01118780|528600856|FG000|Overall Study|Lack of Efficacy|2|||
146570546|NCT01118780|528600857|FG001|Overall Study|Lack of Efficacy|6|||
146570547|NCT01118780|528600856|FG000|Overall Study|Physician Decision|2|||
146570548|NCT01118780|528600857|FG001|Overall Study|Physician Decision|0|||
146570549|NCT01118780|528600856|FG000|Overall Study|Protocol Violation|3|||
146570550|NCT01118780|528600857|FG001|Overall Study|Protocol Violation|6|||
146570551|NCT01118780|528600856|FG000|Overall Study|Withdrawal by Subject|13|||
146570552|NCT01118780|528600857|FG001|Overall Study|Withdrawal by Subject|8|||
146570553|NCT03962855|528600860|FG000|Overall Study|Death|0|||
146570554|NCT03962855|528600861|FG001|Overall Study|Death|1|||
146570555|NCT03962855|528600860|FG000|Overall Study|Lost to Follow-up|0|||
146570556|NCT03962855|528600861|FG001|Overall Study|Lost to Follow-up|1|||
146570557|NCT03962855|528600860|FG000|Overall Study|Adverse Event|0|||
146570558|NCT03962855|528600861|FG001|Overall Study|Adverse Event|1|||
146570559|NCT03962855|528600860|FG000|Overall Study|Physician Decision|0|||
146570560|NCT03962855|528600861|FG001|Overall Study|Physician Decision|2|||
146570561|NCT02216526|528600865|FG000|Overall Study|Adverse Event|1|||
146570562|NCT02216526|528600866|FG001|Overall Study|Adverse Event|1|||
146570563|NCT02216526|528600867|FG002|Overall Study|Adverse Event|0|||
146570564|NCT02216526|528600865|FG000|Overall Study|Death|0|||
146570565|NCT02216526|528600866|FG001|Overall Study|Death|1|||
146570566|NCT02216526|528600867|FG002|Overall Study|Death|3|||
146570567|NCT02216526|528600865|FG000|Overall Study|Protocol Violation|2|||
146570568|NCT02216526|528600866|FG001|Overall Study|Protocol Violation|0|||
146570569|NCT02216526|528600867|FG002|Overall Study|Protocol Violation|2|||
146570570|NCT02216526|528600865|FG000|Overall Study|Hospitalization|2|||
146570571|NCT02216526|528600866|FG001|Overall Study|Hospitalization|1|||
146570572|NCT02216526|528600867|FG002|Overall Study|Hospitalization|3|||
146570573|NCT01882465|528600868|FG000|Period 1|Lens Discomfort|0|||
146570574|NCT01882465|528600869|FG001|Period 1|Lens Discomfort|0|||
146570575|NCT01882465|528600870|FG002|Period 1|Lens Discomfort|0|||
146570576|NCT01882465|528600871|FG003|Period 1|Lens Discomfort|1|||
146570577|NCT01882465|528600872|FG004|Period 1|Lens Discomfort|0|||
146570578|NCT01882465|528600873|FG005|Period 1|Lens Discomfort|0|||
146570579|NCT01882465|528600874|FG006|Period 1|Lens Discomfort|0|||
146570580|NCT01882465|528600868|FG000|Period 1|Withdrawal by Subject|0|||
146570581|NCT01882465|528600869|FG001|Period 1|Withdrawal by Subject|0|||
146570582|NCT01882465|528600870|FG002|Period 1|Withdrawal by Subject|0|||
146570583|NCT01882465|528600871|FG003|Period 1|Withdrawal by Subject|0|||
146570584|NCT01882465|528600872|FG004|Period 1|Withdrawal by Subject|0|||
146570585|NCT01882465|528600873|FG005|Period 1|Withdrawal by Subject|0|||
146570586|NCT01882465|528600874|FG006|Period 1|Withdrawal by Subject|1|||
146570587|NCT01882465|528600868|FG000|Period 2|Protocol Violation|0|||
146570588|NCT01882465|528600869|FG001|Period 2|Protocol Violation|0|||
146570589|NCT01882465|528600870|FG002|Period 2|Protocol Violation|0|||
146570590|NCT01882465|528600871|FG003|Period 2|Protocol Violation|0|||
146570591|NCT01882465|528600872|FG004|Period 2|Protocol Violation|1|||
146570592|NCT01882465|528600873|FG005|Period 2|Protocol Violation|0|||
146570593|NCT01882465|528600874|FG006|Period 2|Protocol Violation|0|||
146570594|NCT03824392|528600875|FG000|Overall Study|Adverse Event|1|||
146570595|NCT03824392|528600876|FG001|Overall Study|Adverse Event|0|||
146570596|NCT03824392|528600877|FG002|Overall Study|Adverse Event|0|||
146570597|NCT03824392|528600878|FG003|Overall Study|Adverse Event|0|||
146570598|NCT03824392|528600875|FG000|Overall Study|Investigator Decision|0|||
146570599|NCT03824392|528600876|FG001|Overall Study|Investigator Decision|1|||
146570600|NCT03824392|528600877|FG002|Overall Study|Investigator Decision|0|||
146570601|NCT03824392|528600878|FG003|Overall Study|Investigator Decision|0|||
146570602|NCT03824392|528600875|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
146570603|NCT03824392|528600876|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
146570604|NCT03824392|528600877|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
146570605|NCT03824392|528600878|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
146570606|NCT00532844|528600880|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
146570607|NCT00532844|528600881|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
146570608|NCT00532844|528600880|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
146570609|NCT00532844|528600881|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
146570610|NCT00532844|528600880|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
146570611|NCT00532844|528600881|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
146570612|NCT00532844|528600880|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
146570613|NCT00532844|528600881|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
146570614|NCT00532844|528600880|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
146570615|NCT00532844|528600881|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
146570616|NCT04389866|528600887|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
146570617|NCT04389866|528600888|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
146570618|NCT04940130|528600892|FG000|Overall Study|Travel|1|||
146570619|NCT04940130|528600893|FG001|Overall Study|Travel|0|||
146570620|NCT04940130|528600894|FG002|Overall Study|Travel|2|||
146570621|NCT04940130|528600892|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
146570622|NCT04940130|528600893|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
146570623|NCT04940130|528600894|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
146570624|NCT04940130|528600892|FG000|Overall Study|Adverse Event|0|||
146570625|NCT04940130|528600893|FG001|Overall Study|Adverse Event|0|||
146570626|NCT04940130|528600894|FG002|Overall Study|Adverse Event|2|||
146570627|NCT04940130|528600892|FG000|Overall Study|Disease progression/treatment failure|0|||
146570628|NCT04940130|528600893|FG001|Overall Study|Disease progression/treatment failure|0|||
146570629|NCT04940130|528600894|FG002|Overall Study|Disease progression/treatment failure|1|||
146570630|NCT04940130|528600892|FG000|Overall Study|Participant refusal|0|||
146570631|NCT04940130|528600893|FG001|Overall Study|Participant refusal|0|||
146570632|NCT04940130|528600894|FG002|Overall Study|Participant refusal|1|||
146570633|NCT02240121|528600897|FG000|Overall Study|Protocol Violation|1|||
146650665|NCT03086967|528898066|FG000|Overall Study|Screen Failure|2|||
146650666|NCT03086967|528898067|FG001|Overall Study|Screen Failure|2|||
146650667|NCT01475071|528898074|FG000|Overall Study|Physician Decision|1|||
146650668|NCT01475071|528898074|FG000|Overall Study|Withdrawal by Subject|6|||
146650669|NCT01475071|528898074|FG000|Overall Study|Lost to Follow-up|1|||
146650670|NCT01752036|528898076|FG000|Overall Study|Death|2|||
146570634|NCT02240121|528600898|FG001|Overall Study|Protocol Violation|2|||
146570635|NCT02240121|528600897|FG000|Overall Study|Physician Decision|0|||
146570636|NCT02240121|528600898|FG001|Overall Study|Physician Decision|1|||
146570637|NCT02240121|528600897|FG000|Overall Study|Change in protocol interpretation|1|||
146570638|NCT02240121|528600898|FG001|Overall Study|Change in protocol interpretation|0|||
146570639|NCT02240121|528600897|FG000|Overall Study|Lack of Efficacy|2|||
146570640|NCT02240121|528600898|FG001|Overall Study|Lack of Efficacy|3|||
146570641|NCT02240121|528600897|FG000|Overall Study|Site closed|1|||
146650671|NCT02230527|528898077|FG000|Overall Study|Withdrawal by Subject|1|||
146650672|NCT02230527|528898078|FG001|Overall Study|Withdrawal by Subject|1|||
146650673|NCT02230527|528898077|FG000|Overall Study|Death|1|||
146650674|NCT02230527|528898078|FG001|Overall Study|Death|0|||
146570642|NCT02240121|528600898|FG001|Overall Study|Site closed|1|||
146570643|NCT02240121|528600897|FG000|Overall Study|Pregnancy|1|||
146570644|NCT02240121|528600898|FG001|Overall Study|Pregnancy|0|||
146570645|NCT02240121|528600897|FG000|Overall Study|Adverse Event|2|||
146570646|NCT02240121|528600898|FG001|Overall Study|Adverse Event|4|||
146570647|NCT02240121|528600897|FG000|Overall Study|Withdrawal by Subject|6|||
146570648|NCT02240121|528600898|FG001|Overall Study|Withdrawal by Subject|2|||
146570649|NCT02240121|528600897|FG000|Overall Study|Lost to Follow-up|3|||
146570650|NCT02240121|528600898|FG001|Overall Study|Lost to Follow-up|4|||
146570651|NCT02240121|528600897|FG000|Overall Study|Other than specified|1|||
146570652|NCT02240121|528600898|FG001|Overall Study|Other than specified|3|||
146570653|NCT00251693|528600902|FG000|Overall Study|Adverse Event|17|||
146570654|NCT00251693|528600903|FG001|Overall Study|Adverse Event|9|||
146570655|NCT00251693|528600904|FG002|Overall Study|Adverse Event|9|||
146570656|NCT00251693|528600902|FG000|Overall Study|Protocol Violation|2|||
146570657|NCT00251693|528600903|FG001|Overall Study|Protocol Violation|0|||
146570658|NCT00251693|528600904|FG002|Overall Study|Protocol Violation|2|||
146570659|NCT00251693|528600902|FG000|Overall Study|Lost to Follow-up|12|||
146570660|NCT00251693|528600903|FG001|Overall Study|Lost to Follow-up|7|||
146570661|NCT00251693|528600904|FG002|Overall Study|Lost to Follow-up|8|||
146570662|NCT00251693|528600902|FG000|Overall Study|Withdrawal by Subject|11|||
146570663|NCT00251693|528600903|FG001|Overall Study|Withdrawal by Subject|17|||
146570664|NCT00251693|528600904|FG002|Overall Study|Withdrawal by Subject|14|||
146570665|NCT00251693|528600902|FG000|Overall Study|Lack of Efficacy|0|||
146570666|NCT00251693|528600903|FG001|Overall Study|Lack of Efficacy|1|||
146570667|NCT00251693|528600904|FG002|Overall Study|Lack of Efficacy|0|||
146570668|NCT00251693|528600902|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
146570669|NCT00251693|528600903|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
146570670|NCT00251693|528600904|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
146570671|NCT00251693|528600902|FG000|Overall Study|Noncompliant|0|||
146570672|NCT00251693|528600903|FG001|Overall Study|Noncompliant|0|||
146570673|NCT00251693|528600904|FG002|Overall Study|Noncompliant|2|||
146570674|NCT00251693|528600902|FG000|Overall Study|Possible Barrett's esophagus|3|||
146570675|NCT00251693|528600903|FG001|Overall Study|Possible Barrett's esophagus|5|||
146570676|NCT00251693|528600904|FG002|Overall Study|Possible Barrett's esophagus|2|||
146570677|NCT00251693|528600902|FG000|Overall Study|Subject request/subject unavailable|1|||
146570678|NCT00251693|528600903|FG001|Overall Study|Subject request/subject unavailable|2|||
146570679|NCT00251693|528600904|FG002|Overall Study|Subject request/subject unavailable|0|||
146570680|NCT00251693|528600902|FG000|Overall Study|Abnormal laboratory findings|0|||
146570681|NCT00251693|528600903|FG001|Overall Study|Abnormal laboratory findings|0|||
146570682|NCT00251693|528600904|FG002|Overall Study|Abnormal laboratory findings|1|||
146570683|NCT01030822|528600905|FG000|Overall Study|Moved/migrated from study area|6|||
146570684|NCT01030822|528600906|FG001|Overall Study|Moved/migrated from study area|7|||
146570685|NCT01030822|528600907|FG002|Overall Study|Moved/migrated from study area|3|||
146570686|NCT01030822|528600905|FG000|Overall Study|Withdrawal by Subject|16|||
146570687|NCT01030822|528600906|FG001|Overall Study|Withdrawal by Subject|13|||
146570688|NCT01030822|528600907|FG002|Overall Study|Withdrawal by Subject|16|||
146570689|NCT01030822|528600905|FG000|Overall Study|Lost to Follow-up|9|||
146570690|NCT01030822|528600906|FG001|Overall Study|Lost to Follow-up|4|||
146570691|NCT01030822|528600907|FG002|Overall Study|Lost to Follow-up|7|||
146570692|NCT00401843|528600908|FG000|Overall Study|Achieved Complete Response|1|||
146570693|NCT00401843|528600909|FG001|Overall Study|Achieved Complete Response|5|||
146570694|NCT00401843|528600910|FG002|Overall Study|Achieved Complete Response|11|||
146570695|NCT00401843|528600908|FG000|Overall Study|Adverse Event|7|||
146570696|NCT00401843|528600909|FG001|Overall Study|Adverse Event|26|||
146570697|NCT00401843|528600910|FG002|Overall Study|Adverse Event|27|||
146570698|NCT00401843|528600908|FG000|Overall Study|Death|0|||
146570699|NCT00401843|528600909|FG001|Overall Study|Death|8|||
146570700|NCT00401843|528600910|FG002|Overall Study|Death|10|||
146570701|NCT00401843|528600908|FG000|Overall Study|Disease progression|10|||
146570702|NCT00401843|528600909|FG001|Overall Study|Disease progression|60|||
146570703|NCT00401843|528600910|FG002|Overall Study|Disease progression|49|||
146570704|NCT00401843|528600908|FG000|Overall Study|End of Study|1|||
146570705|NCT00401843|528600909|FG001|Overall Study|End of Study|1|||
146570706|NCT00401843|528600910|FG002|Overall Study|End of Study|2|||
146570707|NCT00401843|528600908|FG000|Overall Study|Lost to Follow-up|0|||
146570708|NCT00401843|528600909|FG001|Overall Study|Lost to Follow-up|0|||
146570709|NCT00401843|528600910|FG002|Overall Study|Lost to Follow-up|2|||
146570710|NCT00401843|528600908|FG000|Overall Study|Other Unspecified|0|||
146570711|NCT00401843|528600909|FG001|Overall Study|Other Unspecified|3|||
146916051|NCT01115569|529855888|FG000|Maintenance Phase|Physician Decision|0|||
146570712|NCT00401843|528600910|FG002|Overall Study|Other Unspecified|5|||
146570713|NCT00401843|528600908|FG000|Overall Study|Physician Decision|0|||
146570714|NCT00401843|528600909|FG001|Overall Study|Physician Decision|16|||
146570715|NCT00401843|528600910|FG002|Overall Study|Physician Decision|10|||
146570716|NCT00401843|528600908|FG000|Overall Study|Protocol Violation|0|||
146570717|NCT00401843|528600909|FG001|Overall Study|Protocol Violation|0|||
146570718|NCT00401843|528600910|FG002|Overall Study|Protocol Violation|1|||
146916052|NCT01115569|529855889|FG001|Maintenance Phase|Physician Decision|3|||
146916053|NCT01115569|529855888|FG000|Maintenance Phase|Protocol Violation|0|||
146916054|NCT01115569|529855889|FG001|Maintenance Phase|Protocol Violation|9|||
146509430|NCT02345889|528368996|FG001|Overall Study|Recognized ineligible post-randomization|0|||
146509431|NCT02345889|528368997|FG002|Overall Study|Recognized ineligible post-randomization|2|||
146509432|NCT02345889|528368998|FG003|Overall Study|Recognized ineligible post-randomization|1|||
146509433|NCT02345889|528368995|FG000|Overall Study|Ulcerative Colitis identified|1|||
146509434|NCT02345889|528368996|FG001|Overall Study|Ulcerative Colitis identified|0|||
146509435|NCT02345889|528368997|FG002|Overall Study|Ulcerative Colitis identified|0|||
146509436|NCT02345889|528368998|FG003|Overall Study|Ulcerative Colitis identified|0|||
146509437|NCT02345889|528368995|FG000|Overall Study|Cecum not intubated|1|||
146509438|NCT02345889|528368996|FG001|Overall Study|Cecum not intubated|0|||
146509439|NCT02345889|528368997|FG002|Overall Study|Cecum not intubated|0|||
146509440|NCT02345889|528368998|FG003|Overall Study|Cecum not intubated|0|||
146509441|NCT04325698|528369000|FG000|Overall Study|Study Terminated By Sponsor|1|||
146509442|NCT04325698|528369001|FG001|Overall Study|Study Terminated By Sponsor|1|||
146509443|NCT04325698|528369000|FG000|Overall Study|Withdrawal by Subject|0|||
146509444|NCT04325698|528369001|FG001|Overall Study|Withdrawal by Subject|2|||
146509445|NCT00962091|528369002|FG000|Overall Study|Withdrawal by Subject|1|||
146509446|NCT00962091|528369003|FG001|Overall Study|Withdrawal by Subject|2|||
146509447|NCT00962091|528369004|FG002|Overall Study|Withdrawal by Subject|1|||
146509448|NCT00962091|528369005|FG003|Overall Study|Withdrawal by Subject|1|||
146509449|NCT00962091|528369006|FG004|Overall Study|Withdrawal by Subject|0|||
146509450|NCT00962091|528369007|FG005|Overall Study|Withdrawal by Subject|1|||
146509451|NCT00962091|528369008|FG006|Overall Study|Withdrawal by Subject|0|||
146509452|NCT00962091|528369002|FG000|Overall Study|Adverse Event|0|||
146509453|NCT00962091|528369003|FG001|Overall Study|Adverse Event|0|||
146509454|NCT00962091|528369004|FG002|Overall Study|Adverse Event|0|||
146509455|NCT00962091|528369005|FG003|Overall Study|Adverse Event|0|||
146509456|NCT00962091|528369006|FG004|Overall Study|Adverse Event|0|||
146509457|NCT00962091|528369007|FG005|Overall Study|Adverse Event|0|||
146509458|NCT00962091|528369008|FG006|Overall Study|Adverse Event|1|||
146509459|NCT04253782|528369009|FG000|Overall Study|Death|2|||
146509460|NCT04253782|528369010|FG001|Overall Study|Death|0|||
146509461|NCT02326298|528369013|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146509462|NCT02326298|528369014|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146509463|NCT02326298|528369015|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
146509464|NCT02326298|528369016|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146509465|NCT02326298|528369017|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146509466|NCT02326298|528369018|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146509467|NCT02326298|528369019|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146509468|NCT02326298|528369020|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146509469|NCT02326298|528369021|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146509470|NCT02326298|528369022|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146509471|NCT02326298|528369023|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146509472|NCT02326298|528369024|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146509473|NCT02326298|528369025|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146509474|NCT02326298|528369026|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146509475|NCT02326298|528369013|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
146509476|NCT02326298|528369014|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
146509477|NCT02326298|528369015|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
146509478|NCT02326298|528369016|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
146509479|NCT02326298|528369017|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
146509480|NCT02326298|528369018|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
146509481|NCT02326298|528369019|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
146509482|NCT02326298|528369020|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
146509483|NCT02326298|528369021|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
146509484|NCT02326298|528369022|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
146509485|NCT02326298|528369023|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
146509486|NCT02326298|528369024|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
146509487|NCT02326298|528369025|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
146509488|NCT02326298|528369026|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
146509489|NCT02326298|528369013|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
146509490|NCT02326298|528369014|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
146509491|NCT02326298|528369015|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146509492|NCT02326298|528369016|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146509493|NCT02326298|528369017|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146509494|NCT02326298|528369018|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146509495|NCT02326298|528369019|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146509496|NCT02326298|528369020|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146509497|NCT02326298|528369021|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146570719|NCT00401843|528600908|FG000|Overall Study|Withdrawal by Subject|1|||
146570720|NCT00401843|528600909|FG001|Overall Study|Withdrawal by Subject|5|||
146570721|NCT00401843|528600910|FG002|Overall Study|Withdrawal by Subject|5|||
146570722|NCT00401843|528600908|FG000|Overall Study|Withdrawal of consent to study agent|1|||
146570723|NCT00401843|528600909|FG001|Overall Study|Withdrawal of consent to study agent|15|||
146570724|NCT00401843|528600910|FG002|Overall Study|Withdrawal of consent to study agent|17|||
146570725|NCT00401843|528600908|FG000|Overall Study|Randomized but not Treated|0|||
146570726|NCT00401843|528600909|FG001|Overall Study|Randomized but not Treated|2|||
146570727|NCT00401843|528600910|FG002|Overall Study|Randomized but not Treated|3|||
146570728|NCT00401843|528600908|FG000|Overall Study|Received incorrect treatment|0|||
146570729|NCT00401843|528600909|FG001|Overall Study|Received incorrect treatment|3|||
146570730|NCT00401843|528600910|FG002|Overall Study|Received incorrect treatment|0|||
146570731|NCT01508910|528600911|FG000|Treatment|Death|2|||
146570732|NCT01508910|528600912|FG001|Treatment|Death|3|||
146570733|NCT01508910|528600913|FG002|Treatment|Death|2|||
146570734|NCT01508910|528600914|FG003|Treatment|Death|0|||
146570735|NCT01508910|528600911|FG000|Treatment|Lost to Follow-up|0|||
146570736|NCT01508910|528600912|FG001|Treatment|Lost to Follow-up|0|||
146570737|NCT01508910|528600913|FG002|Treatment|Lost to Follow-up|2|||
146570738|NCT01508910|528600914|FG003|Treatment|Lost to Follow-up|1|||
146570739|NCT01508910|528600911|FG000|Treatment|Withdrawal by Subject|0|||
146570740|NCT01508910|528600912|FG001|Treatment|Withdrawal by Subject|1|||
146570741|NCT01508910|528600913|FG002|Treatment|Withdrawal by Subject|6|||
146570742|NCT01508910|528600914|FG003|Treatment|Withdrawal by Subject|1|||
146570743|NCT01508910|528600911|FG000|Treatment|Sponsor Decision|0|||
146570744|NCT01508910|528600912|FG001|Treatment|Sponsor Decision|0|||
146570745|NCT01508910|528600913|FG002|Treatment|Sponsor Decision|0|||
146570746|NCT01508910|528600914|FG003|Treatment|Sponsor Decision|1|||
146570747|NCT01932788|528600927|FG000|Overall Study|Protocol Violation|18|||
146570748|NCT01932788|528600928|FG001|Overall Study|Protocol Violation|0|||
146570749|NCT01932788|528600927|FG000|Overall Study|Lost to Follow-up|18|||
146570750|NCT01932788|528600928|FG001|Overall Study|Lost to Follow-up|46|||
146570751|NCT01932788|528600927|FG000|Overall Study|Lack of Efficacy|2|||
146570752|NCT01932788|528600928|FG001|Overall Study|Lack of Efficacy|0|||
146570753|NCT01932788|528600927|FG000|Overall Study|Withdrawal by Subject|0|||
146570754|NCT01932788|528600928|FG001|Overall Study|Withdrawal by Subject|5|||
146570755|NCT01171677|528600929|FG000|Overall Study|Withdrawal by Subject|0|||
146570756|NCT01171677|528600930|FG001|Overall Study|Withdrawal by Subject|3|||
146570757|NCT01171677|528600929|FG000|Overall Study|Adverse Event|1|||
146570758|NCT01171677|528600930|FG001|Overall Study|Adverse Event|0|||
146570759|NCT01171677|528600929|FG000|Overall Study|completed <70% IntenSati classes|5|||
146570760|NCT01171677|528600930|FG001|Overall Study|completed <70% IntenSati classes|0|||
146570761|NCT03092479|528600933|FG000|Overall Study|Lost to Follow-up|3|||
146570762|NCT03092479|528600934|FG001|Overall Study|Lost to Follow-up|2|||
146570763|NCT03092479|528600933|FG000|Overall Study|Withdrawal by Subject|4|||
146570764|NCT03092479|528600934|FG001|Overall Study|Withdrawal by Subject|0|||
146570765|NCT03913130|528600937|FG000|Overall Study|Sponsor Decision|1|||
146570766|NCT05653700|528600938|FG000|Overall Study|Non Responders|9|||
146570767|NCT05653700|528600939|FG001|Overall Study|Non Responders|0|||
146570768|NCT01085214|528600942|FG000|Overall Study|Alternate treatment required|1|||
146570769|NCT02317627|528600957|FG000|Overall Study|Withdrawal by Subject|0|||
146570770|NCT02317627|528600958|FG001|Overall Study|Withdrawal by Subject|1|||
146570771|NCT02317627|528600959|FG002|Overall Study|Withdrawal by Subject|1|||
146570772|NCT02317627|528600957|FG000|Overall Study|Lost to Follow-up|2|||
146570773|NCT02317627|528600958|FG001|Overall Study|Lost to Follow-up|0|||
146570774|NCT02317627|528600959|FG002|Overall Study|Lost to Follow-up|0|||
146570775|NCT02317627|528600957|FG000|Overall Study|Stopped by Investigator|0|||
146570776|NCT02317627|528600958|FG001|Overall Study|Stopped by Investigator|1|||
146570777|NCT02317627|528600959|FG002|Overall Study|Stopped by Investigator|0|||
146570778|NCT02317627|528600957|FG000|Overall Study|Adverse Event|0|||
146570779|NCT02317627|528600958|FG001|Overall Study|Adverse Event|2|||
146570780|NCT02317627|528600959|FG002|Overall Study|Adverse Event|3|||
146570781|NCT02317627|528600957|FG000|Overall Study|Non-compliance with study drug|0|||
146916055|NCT01115569|529855888|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146570782|NCT02317627|528600958|FG001|Overall Study|Non-compliance with study drug|1|||
146570783|NCT02317627|528600959|FG002|Overall Study|Non-compliance with study drug|0|||
146570784|NCT04749914|528600960|FG000|Period 1|Adverse Event|1|||
146570785|NCT04749914|528600961|FG001|Period 1|Adverse Event|0|||
146916056|NCT01115569|529855889|FG001|Maintenance Phase|Withdrawal by Subject|27|||
146570786|NCT04749914|528600962|FG002|Period 1|Adverse Event|0|||
146570787|NCT04749914|528600963|FG003|Period 1|Adverse Event|0|||
146570788|NCT04749914|528600960|FG000|Period 1|Withdrawal by Subject|1|||
146570789|NCT04749914|528600961|FG001|Period 1|Withdrawal by Subject|0|||
146570790|NCT04749914|528600962|FG002|Period 1|Withdrawal by Subject|1|||
146916057|NCT01115569|529855888|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
146570791|NCT04749914|528600963|FG003|Period 1|Withdrawal by Subject|0|||
146570792|NCT00403130|528600964|FG000|2 Years From Start of Treatment|Not Eligible|3|||
146570793|NCT00403130|528600964|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
146570794|NCT00403130|528600964|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
146570795|NCT00403130|528600964|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
146570796|NCT00806260|528600965|FG000|Period 1 (1 Day)|Adverse Event|0|||
146570797|NCT00806260|528600966|FG001|Period 1 (1 Day)|Adverse Event|0|||
146570798|NCT00806260|528600967|FG002|Period 1 (1 Day)|Adverse Event|0|||
146570799|NCT00806260|528600968|FG003|Period 1 (1 Day)|Adverse Event|0|||
146570800|NCT00806260|528600969|FG004|Period 1 (1 Day)|Adverse Event|3|||
146570801|NCT00806260|528600970|FG005|Period 1 (1 Day)|Adverse Event|0|||
146570802|NCT00806260|528600965|FG000|Period 2|Adverse Event|0|||
146570803|NCT00806260|528600966|FG001|Period 2|Adverse Event|0|||
146570804|NCT00806260|528600967|FG002|Period 2|Adverse Event|0|||
146570805|NCT00806260|528600968|FG003|Period 2|Adverse Event|1|||
146570806|NCT00806260|528600969|FG004|Period 2|Adverse Event|0|||
146570807|NCT00806260|528600970|FG005|Period 2|Adverse Event|0|||
146570808|NCT00806260|528600965|FG000|Period 2|Protocol Violation|1|||
146570809|NCT00806260|528600966|FG001|Period 2|Protocol Violation|0|||
146570810|NCT00806260|528600967|FG002|Period 2|Protocol Violation|1|||
146570811|NCT00806260|528600968|FG003|Period 2|Protocol Violation|0|||
146570812|NCT00806260|528600969|FG004|Period 2|Protocol Violation|0|||
146570813|NCT00806260|528600970|FG005|Period 2|Protocol Violation|0|||
146570814|NCT00806260|528600965|FG000|Period 2|Need to take concomitant medication|1|||
146570815|NCT00806260|528600966|FG001|Period 2|Need to take concomitant medication|0|||
146570816|NCT00806260|528600967|FG002|Period 2|Need to take concomitant medication|0|||
146570817|NCT00806260|528600968|FG003|Period 2|Need to take concomitant medication|0|||
146570818|NCT00806260|528600969|FG004|Period 2|Need to take concomitant medication|0|||
146570819|NCT00806260|528600970|FG005|Period 2|Need to take concomitant medication|0|||
146570820|NCT00806260|528600965|FG000|Period 2|sponsor request|0|||
146570821|NCT00806260|528600966|FG001|Period 2|sponsor request|0|||
146570822|NCT00806260|528600967|FG002|Period 2|sponsor request|1|||
146570823|NCT00806260|528600968|FG003|Period 2|sponsor request|1|||
146570824|NCT00806260|528600969|FG004|Period 2|sponsor request|0|||
146570825|NCT00806260|528600970|FG005|Period 2|sponsor request|0|||
146570826|NCT00806260|528600965|FG000|Period 3|Protocol Violation|0|||
146570827|NCT00806260|528600966|FG001|Period 3|Protocol Violation|1|||
146570828|NCT00806260|528600967|FG002|Period 3|Protocol Violation|1|||
146570829|NCT00806260|528600968|FG003|Period 3|Protocol Violation|0|||
146570830|NCT00806260|528600969|FG004|Period 3|Protocol Violation|0|||
146570831|NCT00806260|528600970|FG005|Period 3|Protocol Violation|0|||
146570832|NCT00806260|528600965|FG000|Period 3|Pregnancy|1|||
146570833|NCT00806260|528600966|FG001|Period 3|Pregnancy|0|||
146570834|NCT00806260|528600967|FG002|Period 3|Pregnancy|0|||
146570835|NCT00806260|528600968|FG003|Period 3|Pregnancy|0|||
146570836|NCT00806260|528600969|FG004|Period 3|Pregnancy|0|||
146570837|NCT00806260|528600970|FG005|Period 3|Pregnancy|0|||
146570838|NCT00237042|528600971|FG000|Treatment|Became ineligible post-randomization|0|||
146570839|NCT00237042|528600972|FG001|Treatment|Became ineligible post-randomization|1|||
146570840|NCT00237042|528600973|FG002|Treatment|Became ineligible post-randomization|16|||
146570841|NCT00237042|528600971|FG000|Treatment|Moved out of state|1|||
146570842|NCT00237042|528600972|FG001|Treatment|Moved out of state|1|||
146570843|NCT00237042|528600973|FG002|Treatment|Moved out of state|1|||
146570844|NCT00237042|528600971|FG000|Treatment|Completed no treatment|5|||
146570845|NCT00237042|528600972|FG001|Treatment|Completed no treatment|5|||
146570846|NCT00237042|528600973|FG002|Treatment|Completed no treatment|21|||
146570847|NCT00237042|528600971|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
146570848|NCT00237042|528600972|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
146650675|NCT02230527|528898077|FG000|Overall Study|Lost to Follow-up|2|||
146650676|NCT02230527|528898078|FG001|Overall Study|Lost to Follow-up|1|||
146650677|NCT02230527|528898077|FG000|Overall Study|Other|1|||
146650678|NCT02230527|528898078|FG001|Overall Study|Other|0|||
146650679|NCT01011478|528898079|FG000|Overall Study|No follow up data|12|||
146650680|NCT01011478|528898080|FG001|Overall Study|No follow up data|7|||
146650681|NCT02278471|528898081|FG000|Overall Study|Lost to Follow-up|6|||
146650682|NCT02278471|528898082|FG001|Overall Study|Lost to Follow-up|15|||
146770528|NCT03779048|529328609|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
146770529|NCT03779048|529328610|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
146770530|NCT03779048|529328611|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
146770531|NCT03779048|529328609|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
146976539|NCT02454972|530077403|FG003|Overall Study|Never treated|1|||
146570849|NCT00237042|528600973|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
146570850|NCT00237042|528600971|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
146570851|NCT00237042|528600972|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
146570852|NCT00237042|528600973|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
146570853|NCT01074931|528600974|FG000|Overall Study|Economic reasons|1|||
146570854|NCT01074931|528600974|FG000|Overall Study|Death|5|||
146570855|NCT03132467|528600975|FG000|Overall Study|Adverse Event|2|||
146570856|NCT03132467|528600975|FG000|Overall Study|Withdrawal by Subject|2|||
146570857|NCT05223673|528600976|FG000|Overall Study|Protocol Violation|1|||
146650683|NCT02278471|528898081|FG000|Overall Study|Death|2|||
146650684|NCT02278471|528898082|FG001|Overall Study|Death|2|||
146570858|NCT05223673|528600976|FG000|Overall Study|Study termination|6|||
146570859|NCT04790279|528602593|FG000|Overall Study|Did not meet medication start criteria|27|||
146570860|NCT04790279|528602594|FG001|Overall Study|Did not meet medication start criteria|15|||
146570861|NCT04790279|528602593|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
146570862|NCT04790279|528602594|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
146570863|NCT04790279|528602593|FG000|Overall Study|Protocol Violation|8|||
146570864|NCT04790279|528602594|FG001|Overall Study|Protocol Violation|3|||
146570865|NCT04790279|528602593|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
146570866|NCT04790279|528602594|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
146570867|NCT00678288|528602611|FG000|Overall Study|Adverse Event|0|||
146570868|NCT00678288|528602612|FG001|Overall Study|Adverse Event|2|||
146570869|NCT00678288|528602611|FG000|Overall Study|Withdrawal by Subject|1|||
146570870|NCT00678288|528602612|FG001|Overall Study|Withdrawal by Subject|1|||
146570871|NCT00678288|528602611|FG000|Overall Study|Study terminated by the sponsor|2|||
146570872|NCT00678288|528602612|FG001|Overall Study|Study terminated by the sponsor|0|||
146570873|NCT00678288|528602611|FG000|Overall Study|Not compliant with study medication|0|||
146570874|NCT00678288|528602612|FG001|Overall Study|Not compliant with study medication|1|||
146570875|NCT00678288|528602611|FG000|Overall Study|Switch to commercial drug|0|||
146570876|NCT00678288|528602612|FG001|Overall Study|Switch to commercial drug|1|||
146570877|NCT00678288|528602611|FG000|Overall Study|Reason not reported|1|||
146570878|NCT00678288|528602612|FG001|Overall Study|Reason not reported|0|||
146570879|NCT00678288|528602611|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
146570880|NCT00678288|528602612|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
146570881|NCT04472650|528602623|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
146570882|NCT04472650|528602624|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
146570883|NCT02549989|528602627|FG000|Overall Study|Adverse Event|4|||
146570884|NCT02549989|528602627|FG000|Overall Study|Death|1|||
146570885|NCT02549989|528602627|FG000|Overall Study|Lack of Efficacy|19|||
146570886|NCT02549989|528602627|FG000|Overall Study|Withdrawal by Subject|3|||
146570887|NCT02628444|528602631|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
146570888|NCT02628444|528602632|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
146650685|NCT02278471|528898081|FG000|Overall Study|Withdrawal by Subject|0|||
146650686|NCT02278471|528898082|FG001|Overall Study|Withdrawal by Subject|3|||
146509498|NCT02326298|528369022|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146509499|NCT02326298|528369023|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146509500|NCT02326298|528369024|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146509501|NCT02326298|528369025|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146509502|NCT02326298|528369026|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146509503|NCT02326298|528369013|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
146509504|NCT02326298|528369014|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
146509505|NCT02326298|528369015|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146509506|NCT02326298|528369016|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146509507|NCT02326298|528369017|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146509508|NCT02326298|528369018|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146509509|NCT02326298|528369019|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146509510|NCT02326298|528369020|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146509511|NCT02326298|528369021|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146509512|NCT02326298|528369022|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146509513|NCT02326298|528369023|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146509514|NCT02326298|528369024|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146509515|NCT02326298|528369025|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146509516|NCT02326298|528369026|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146509517|NCT02326298|528369013|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
146509518|NCT02326298|528369014|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
146509519|NCT02326298|528369015|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
146509520|NCT02326298|528369016|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
146509521|NCT02326298|528369017|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
146509522|NCT02326298|528369018|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
146509523|NCT02326298|528369019|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
146509524|NCT02326298|528369020|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
146509525|NCT02326298|528369021|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
146509526|NCT02326298|528369022|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
146509527|NCT02326298|528369023|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
146509528|NCT02326298|528369024|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
146509529|NCT02326298|528369025|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
146570889|NCT02628444|528602633|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
146976540|NCT02454972|530077404|FG004|Overall Study|Never treated|1|||
146570890|NCT02628444|528602634|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
146570891|NCT02628444|528602635|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
146570892|NCT02628444|528602636|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
146570893|NCT02628444|528602637|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
146570894|NCT02628444|528602638|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
146570895|NCT02628444|528602639|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
146570896|NCT02628444|528602631|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
146570897|NCT02628444|528602632|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
146570898|NCT02628444|528602633|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
146570899|NCT02628444|528602634|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
146570900|NCT02628444|528602635|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
146570901|NCT02628444|528602636|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
146570902|NCT02628444|528602637|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
146570903|NCT02628444|528602638|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
146570904|NCT02628444|528602639|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
146570905|NCT02628444|528602631|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
146570906|NCT02628444|528602632|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
146570907|NCT02628444|528602633|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
146570908|NCT02628444|528602634|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
146570909|NCT02628444|528602635|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
146570910|NCT02628444|528602636|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
146570911|NCT02628444|528602637|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
146570912|NCT02628444|528602638|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
146570913|NCT02628444|528602639|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
146570914|NCT02628444|528602631|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
146570915|NCT02628444|528602632|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
146570916|NCT02628444|528602633|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
146570917|NCT02628444|528602634|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
146570918|NCT02628444|528602635|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
146570919|NCT02628444|528602636|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
146570920|NCT02628444|528602637|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
146570921|NCT02628444|528602638|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
146570922|NCT02628444|528602639|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
146570923|NCT02628444|528602631|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
146570924|NCT02628444|528602632|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
146570925|NCT02628444|528602633|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
146570926|NCT02628444|528602634|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
146570927|NCT02628444|528602635|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
146570928|NCT02628444|528602636|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
146570929|NCT02628444|528602637|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
146570930|NCT02628444|528602638|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
146570931|NCT02628444|528602639|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
146570932|NCT02628444|528602631|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
146570933|NCT02628444|528602632|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
146570934|NCT02628444|528602633|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
146570935|NCT02628444|528602634|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
146570936|NCT02628444|528602635|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
146570937|NCT02628444|528602636|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
146570938|NCT02628444|528602637|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
146570939|NCT02628444|528602638|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
146570940|NCT02628444|528602639|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
146570941|NCT02628444|528602631|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
146570942|NCT02628444|528602632|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
146570943|NCT02628444|528602633|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
146570944|NCT02628444|528602634|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
146650687|NCT00640835|528898083|FG000|Overall Study|Adverse Event|5|||
146650688|NCT00640835|528898084|FG001|Overall Study|Adverse Event|3|||
146650689|NCT00640835|528898083|FG000|Overall Study|Withdrawal by Subject|12|||
146976541|NCT02454972|530077405|FG005|Overall Study|Never treated|0|||
146976542|NCT02454972|530077406|FG006|Overall Study|Never treated|0|||
146570945|NCT02628444|528602635|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
146570946|NCT02628444|528602636|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
146570947|NCT02628444|528602637|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
146570948|NCT02628444|528602638|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
146570949|NCT02628444|528602639|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
146570950|NCT02628444|528602631|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
146570951|NCT02628444|528602632|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
146570952|NCT02628444|528602633|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
146570953|NCT02628444|528602634|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
146570954|NCT02628444|528602635|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
146570955|NCT02628444|528602636|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
146570956|NCT02628444|528602637|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
146916058|NCT01115569|529855889|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
146916059|NCT01115569|529855888|FG000|Maintenance Phase|Administrative|0|||
146570957|NCT02628444|528602638|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
146570958|NCT02628444|528602639|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
146570959|NCT02628444|528602631|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
146570960|NCT02628444|528602632|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
146570961|NCT02628444|528602633|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
146570962|NCT02628444|528602634|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
146570963|NCT02628444|528602635|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
146570964|NCT02628444|528602636|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
146570965|NCT02628444|528602637|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
146570966|NCT02628444|528602638|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
146570967|NCT02628444|528602639|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
146570968|NCT02628444|528602631|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
146570969|NCT02628444|528602632|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
146570970|NCT02628444|528602633|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
146570971|NCT02628444|528602634|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
146570972|NCT02628444|528602635|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
146570973|NCT02628444|528602636|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
146570974|NCT02628444|528602637|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
146570975|NCT02628444|528602638|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
146570976|NCT02628444|528602639|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
146570977|NCT01333722|528602640|FG000|Overall Study|Lack of Efficacy|0|||
146570978|NCT01333722|528602641|FG001|Overall Study|Lack of Efficacy|2|||
146570979|NCT01333722|528602640|FG000|Overall Study|Withdrawal by Subject|0|||
146570980|NCT01333722|528602641|FG001|Overall Study|Withdrawal by Subject|1|||
146570981|NCT00784368|528602644|FG000|Overall Study|Physician Decision|0|||
146570982|NCT00784368|528602645|FG001|Overall Study|Physician Decision|0|||
146570983|NCT00784368|528602646|FG002|Overall Study|Physician Decision|6|||
146570984|NCT00784368|528602644|FG000|Overall Study|Lack of Efficacy|2|||
146570985|NCT00784368|528602645|FG001|Overall Study|Lack of Efficacy|0|||
146570986|NCT00784368|528602646|FG002|Overall Study|Lack of Efficacy|1|||
146570987|NCT00784368|528602644|FG000|Overall Study|Adverse Event|6|||
146570988|NCT00784368|528602645|FG001|Overall Study|Adverse Event|9|||
146570989|NCT00784368|528602646|FG002|Overall Study|Adverse Event|2|||
146570990|NCT00784368|528602644|FG000|Overall Study|Diagnosis of fever|0|||
146570991|NCT00784368|528602645|FG001|Overall Study|Diagnosis of fever|0|||
146570992|NCT00784368|528602646|FG002|Overall Study|Diagnosis of fever|1|||
146570993|NCT00784368|528602644|FG000|Overall Study|Worsening of complications|0|||
146570994|NCT00784368|528602645|FG001|Overall Study|Worsening of complications|0|||
146570995|NCT00784368|528602646|FG002|Overall Study|Worsening of complications|1|||
146570996|NCT00784368|528602644|FG000|Overall Study|Worsening of symptoms|0|||
146570997|NCT00784368|528602645|FG001|Overall Study|Worsening of symptoms|1|||
146570998|NCT00784368|528602646|FG002|Overall Study|Worsening of symptoms|0|||
146570999|NCT00784368|528602644|FG000|Overall Study|Withdrawal of informed consent|0|||
146571000|NCT00784368|528602645|FG001|Overall Study|Withdrawal of informed consent|1|||
146571001|NCT00784368|528602646|FG002|Overall Study|Withdrawal of informed consent|0|||
146571002|NCT02079909|528602647|FG000|Overall Study|Adverse Event|23|||
146571003|NCT02079909|528602648|FG001|Overall Study|Adverse Event|23|||
146571004|NCT02079909|528602649|FG002|Overall Study|Adverse Event|7|||
146650690|NCT00640835|528898084|FG001|Overall Study|Withdrawal by Subject|14|||
146650691|NCT00640835|528898083|FG000|Overall Study|Physician Decision|10|||
146650692|NCT00640835|528898084|FG001|Overall Study|Physician Decision|14|||
146650693|NCT00640835|528898083|FG000|Overall Study|Sponsor's Decision|11|||
146571005|NCT02079909|528602647|FG000|Overall Study|Withdrawal by Subject|9|||
146571006|NCT02079909|528602648|FG001|Overall Study|Withdrawal by Subject|17|||
146916060|NCT01115569|529855889|FG001|Maintenance Phase|Administrative|1|||
146571007|NCT02079909|528602649|FG002|Overall Study|Withdrawal by Subject|4|||
146571008|NCT02079909|528602647|FG000|Overall Study|Lost to Follow-up|2|||
146571009|NCT02079909|528602648|FG001|Overall Study|Lost to Follow-up|3|||
146916061|NCT03123354|529855890|FG000|Overall Study|Physician Decision|6|||
146571010|NCT02079909|528602649|FG002|Overall Study|Lost to Follow-up|1|||
146571011|NCT02079909|528602647|FG000|Overall Study|Death|2|||
146571012|NCT02079909|528602648|FG001|Overall Study|Death|2|||
146571013|NCT02079909|528602649|FG002|Overall Study|Death|0|||
146571014|NCT02079909|528602647|FG000|Overall Study|Lack of Efficacy|0|||
146571015|NCT02079909|528602648|FG001|Overall Study|Lack of Efficacy|0|||
146571016|NCT02079909|528602649|FG002|Overall Study|Lack of Efficacy|1|||
146571017|NCT02079909|528602647|FG000|Overall Study|Protocol Violation|0|||
146571018|NCT02079909|528602648|FG001|Overall Study|Protocol Violation|1|||
146571019|NCT02079909|528602649|FG002|Overall Study|Protocol Violation|1|||
146571020|NCT02079909|528602647|FG000|Overall Study|Physician Decision|0|||
146571021|NCT02079909|528602648|FG001|Overall Study|Physician Decision|1|||
146571022|NCT02079909|528602649|FG002|Overall Study|Physician Decision|1|||
146571023|NCT02079909|528602647|FG000|Overall Study|Relocation etc.|2|||
146571024|NCT02079909|528602648|FG001|Overall Study|Relocation etc.|2|||
146571025|NCT02079909|528602649|FG002|Overall Study|Relocation etc.|3|||
146571026|NCT00720356|528602654|FG000|Registration to Study|Determined to have methylated MGMT|67|||
146571027|NCT00720356|528602654|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
146571028|NCT00720356|528602654|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
146571029|NCT00720356|528602654|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
146571030|NCT00720356|528602654|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
146571031|NCT00720356|528602654|FG000|Follow up Until Death|Withdrawal by Subject|1|||
146571032|NCT00720356|528602654|FG000|Follow up Until Death|Alive at last data collection|4|||
146571033|NCT02237001|528602657|FG000|Overall Study|Lost to Follow-up|2|||
146571034|NCT02237001|528602657|FG000|Overall Study|Withdrawal by Subject|1|||
146571035|NCT02237001|528602657|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
146571036|NCT02237001|528602657|FG000|Overall Study|Re-operation|4|||
146571037|NCT02237001|528602657|FG000|Overall Study|Incarceration|1|||
146571038|NCT01713582|528602658|FG000|Overall Study|Disease progression|3|||
146571039|NCT01713582|528602659|FG001|Overall Study|Disease progression|3|||
146571040|NCT01713582|528602660|FG002|Overall Study|Disease progression|3|||
146571041|NCT01713582|528602661|FG003|Overall Study|Disease progression|2|||
146571042|NCT01713582|528602662|FG004|Overall Study|Disease progression|3|||
146571043|NCT01713582|528602663|FG005|Overall Study|Disease progression|3|||
146571044|NCT01713582|528602664|FG006|Overall Study|Disease progression|3|||
146571045|NCT01713582|528602665|FG007|Overall Study|Disease progression|3|||
146571046|NCT01713582|528602666|FG008|Overall Study|Disease progression|3|||
146571047|NCT01713582|528602667|FG009|Overall Study|Disease progression|11|||
146571048|NCT01713582|528602668|FG010|Overall Study|Disease progression|10|||
146571049|NCT01713582|528602669|FG011|Overall Study|Disease progression|5|||
146571050|NCT01713582|528602670|FG012|Overall Study|Disease progression|3|||
146571051|NCT01713582|528602671|FG013|Overall Study|Disease progression|3|||
146571052|NCT01713582|528602672|FG014|Overall Study|Disease progression|6|||
146571053|NCT01713582|528602673|FG015|Overall Study|Disease progression|6|||
146571054|NCT01713582|528602674|FG016|Overall Study|Disease progression|5|||
146571055|NCT01713582|528602675|FG017|Overall Study|Disease progression|2|||
146571056|NCT01713582|528602676|FG018|Overall Study|Disease progression|3|||
146571057|NCT01713582|528602677|FG019|Overall Study|Disease progression|5|||
146916062|NCT03650452|529855891|FG000|Overall Study|Physician Decision|1|||
146916063|NCT03650452|529855892|FG001|Overall Study|Physician Decision|0|||
146916064|NCT03650452|529855891|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
146916065|NCT03650452|529855892|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146916066|NCT03650452|529855891|FG000|Overall Study|Adverse Event|3|||
146916067|NCT03650452|529855892|FG001|Overall Study|Adverse Event|4|||
146571058|NCT01713582|528602678|FG020|Overall Study|Disease progression|15|||
146571059|NCT01713582|528602658|FG000|Overall Study|Death|0|||
146571060|NCT01713582|528602659|FG001|Overall Study|Death|0|||
146571061|NCT01713582|528602660|FG002|Overall Study|Death|0|||
146916068|NCT03650452|529855891|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
146916069|NCT03650452|529855892|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
146916070|NCT02531373|529855902|FG000|Overall Study|Lack of Efficacy|0|||
146916071|NCT02531373|529855903|FG001|Overall Study|Lack of Efficacy|0|||
146916072|NCT02531373|529855904|FG002|Overall Study|Lack of Efficacy|0|||
146571062|NCT01713582|528602661|FG003|Overall Study|Death|1|||
146916073|NCT02531373|529855905|FG003|Overall Study|Lack of Efficacy|0|||
146916074|NCT02531373|529855906|FG004|Overall Study|Lack of Efficacy|3|||
146571063|NCT01713582|528602662|FG004|Overall Study|Death|1|||
146571064|NCT01713582|528602663|FG005|Overall Study|Death|3|||
146916075|NCT02531373|529855907|FG005|Overall Study|Lack of Efficacy|2|||
146916076|NCT02531373|529855908|FG006|Overall Study|Lack of Efficacy|4|||
146571065|NCT01713582|528602664|FG006|Overall Study|Death|3|||
146571066|NCT01713582|528602665|FG007|Overall Study|Death|2|||
146571067|NCT01713582|528602666|FG008|Overall Study|Death|3|||
146571068|NCT01713582|528602667|FG009|Overall Study|Death|4|||
146571069|NCT01713582|528602668|FG010|Overall Study|Death|3|||
146571070|NCT01713582|528602669|FG011|Overall Study|Death|0|||
146916077|NCT02531373|529855909|FG007|Overall Study|Lack of Efficacy|8|||
146916078|NCT02531373|529855910|FG008|Overall Study|Lack of Efficacy|5|||
146571071|NCT01713582|528602670|FG012|Overall Study|Death|0|||
146571072|NCT01713582|528602671|FG013|Overall Study|Death|0|||
146571073|NCT01713582|528602672|FG014|Overall Study|Death|0|||
146571074|NCT01713582|528602673|FG015|Overall Study|Death|0|||
146571075|NCT01713582|528602674|FG016|Overall Study|Death|0|||
146571076|NCT01713582|528602675|FG017|Overall Study|Death|0|||
146571077|NCT01713582|528602676|FG018|Overall Study|Death|0|||
146571078|NCT01713582|528602677|FG019|Overall Study|Death|0|||
146571079|NCT01713582|528602678|FG020|Overall Study|Death|0|||
146571080|NCT01713582|528602658|FG000|Overall Study|Adverse event-related|0|||
146571081|NCT01713582|528602659|FG001|Overall Study|Adverse event-related|0|||
146571082|NCT01713582|528602660|FG002|Overall Study|Adverse event-related|0|||
146571083|NCT01713582|528602661|FG003|Overall Study|Adverse event-related|0|||
146571084|NCT01713582|528602662|FG004|Overall Study|Adverse event-related|0|||
146571085|NCT01713582|528602663|FG005|Overall Study|Adverse event-related|0|||
146571086|NCT01713582|528602664|FG006|Overall Study|Adverse event-related|0|||
146571087|NCT01713582|528602665|FG007|Overall Study|Adverse event-related|0|||
146571088|NCT01713582|528602666|FG008|Overall Study|Adverse event-related|0|||
146571089|NCT01713582|528602667|FG009|Overall Study|Adverse event-related|1|||
146571090|NCT01713582|528602668|FG010|Overall Study|Adverse event-related|1|||
146571091|NCT01713582|528602669|FG011|Overall Study|Adverse event-related|0|||
146571092|NCT01713582|528602670|FG012|Overall Study|Adverse event-related|0|||
146571093|NCT01713582|528602671|FG013|Overall Study|Adverse event-related|0|||
146571094|NCT01713582|528602672|FG014|Overall Study|Adverse event-related|0|||
146571095|NCT01713582|528602673|FG015|Overall Study|Adverse event-related|0|||
146571096|NCT01713582|528602674|FG016|Overall Study|Adverse event-related|0|||
146571097|NCT01713582|528602675|FG017|Overall Study|Adverse event-related|0|||
146571098|NCT01713582|528602676|FG018|Overall Study|Adverse event-related|1|||
146571099|NCT01713582|528602677|FG019|Overall Study|Adverse event-related|0|||
146571100|NCT01713582|528602678|FG020|Overall Study|Adverse event-related|0|||
146571101|NCT01713582|528602658|FG000|Overall Study|Adverse event-unrelated|0|||
146571102|NCT01713582|528602659|FG001|Overall Study|Adverse event-unrelated|0|||
146571103|NCT01713582|528602660|FG002|Overall Study|Adverse event-unrelated|0|||
146571104|NCT01713582|528602661|FG003|Overall Study|Adverse event-unrelated|0|||
146571105|NCT01713582|528602662|FG004|Overall Study|Adverse event-unrelated|0|||
146571106|NCT01713582|528602663|FG005|Overall Study|Adverse event-unrelated|1|||
146571107|NCT01713582|528602664|FG006|Overall Study|Adverse event-unrelated|1|||
146571108|NCT01713582|528602665|FG007|Overall Study|Adverse event-unrelated|1|||
146571109|NCT01713582|528602666|FG008|Overall Study|Adverse event-unrelated|0|||
146571110|NCT01713582|528602667|FG009|Overall Study|Adverse event-unrelated|0|||
146571111|NCT01713582|528602668|FG010|Overall Study|Adverse event-unrelated|0|||
146571112|NCT01713582|528602669|FG011|Overall Study|Adverse event-unrelated|0|||
146571113|NCT01713582|528602670|FG012|Overall Study|Adverse event-unrelated|0|||
146571114|NCT01713582|528602671|FG013|Overall Study|Adverse event-unrelated|1|||
146571115|NCT01713582|528602672|FG014|Overall Study|Adverse event-unrelated|1|||
146571116|NCT01713582|528602673|FG015|Overall Study|Adverse event-unrelated|0|||
146571117|NCT01713582|528602674|FG016|Overall Study|Adverse event-unrelated|0|||
146571118|NCT01713582|528602675|FG017|Overall Study|Adverse event-unrelated|0|||
146571119|NCT01713582|528602676|FG018|Overall Study|Adverse event-unrelated|0|||
146571120|NCT01713582|528602677|FG019|Overall Study|Adverse event-unrelated|0|||
146571121|NCT01713582|528602678|FG020|Overall Study|Adverse event-unrelated|0|||
146571122|NCT01713582|528602658|FG000|Overall Study|Withdrawal of consent|0|||
146571123|NCT01713582|528602659|FG001|Overall Study|Withdrawal of consent|0|||
146571124|NCT01713582|528602660|FG002|Overall Study|Withdrawal of consent|1|||
146571125|NCT01713582|528602661|FG003|Overall Study|Withdrawal of consent|0|||
146571126|NCT01713582|528602662|FG004|Overall Study|Withdrawal of consent|0|||
146571127|NCT01713582|528602663|FG005|Overall Study|Withdrawal of consent|1|||
146571128|NCT01713582|528602664|FG006|Overall Study|Withdrawal of consent|0|||
146571129|NCT01713582|528602665|FG007|Overall Study|Withdrawal of consent|0|||
146571130|NCT01713582|528602666|FG008|Overall Study|Withdrawal of consent|0|||
146770532|NCT03779048|529328610|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
146916079|NCT02531373|529855902|FG000|Overall Study|Lost to Follow-up|0|||
146916080|NCT02531373|529855903|FG001|Overall Study|Lost to Follow-up|0|||
146916081|NCT02531373|529855904|FG002|Overall Study|Lost to Follow-up|0|||
146916082|NCT02531373|529855905|FG003|Overall Study|Lost to Follow-up|0|||
146916083|NCT02531373|529855906|FG004|Overall Study|Lost to Follow-up|0|||
146916084|NCT02531373|529855907|FG005|Overall Study|Lost to Follow-up|2|||
146976543|NCT02454972|530077407|FG007|Overall Study|Never treated|0|||
146571131|NCT01713582|528602667|FG009|Overall Study|Withdrawal of consent|1|||
146571132|NCT01713582|528602668|FG010|Overall Study|Withdrawal of consent|0|||
146571133|NCT01713582|528602669|FG011|Overall Study|Withdrawal of consent|0|||
146571134|NCT01713582|528602670|FG012|Overall Study|Withdrawal of consent|0|||
146571135|NCT01713582|528602671|FG013|Overall Study|Withdrawal of consent|0|||
146571136|NCT01713582|528602672|FG014|Overall Study|Withdrawal of consent|0|||
146916085|NCT02531373|529855908|FG006|Overall Study|Lost to Follow-up|2|||
146650694|NCT00640835|528898084|FG001|Overall Study|Sponsor's Decision|7|||
146650695|NCT00640835|528898083|FG000|Overall Study|Protocol Violation|2|||
146650696|NCT00640835|528898084|FG001|Overall Study|Protocol Violation|2|||
146650697|NCT00640835|528898083|FG000|Overall Study|Lost to Follow-up|17|||
146976544|NCT02454972|530077408|FG008|Overall Study|Never treated|5|||
146976545|NCT02454972|530077400|FG000|Overall Study|Lost to Follow-up|0|||
146571137|NCT01713582|528602673|FG015|Overall Study|Withdrawal of consent|0|||
146571138|NCT01713582|528602674|FG016|Overall Study|Withdrawal of consent|0|||
146571139|NCT01713582|528602675|FG017|Overall Study|Withdrawal of consent|0|||
146571140|NCT01713582|528602676|FG018|Overall Study|Withdrawal of consent|1|||
146571141|NCT01713582|528602677|FG019|Overall Study|Withdrawal of consent|0|||
146571142|NCT01713582|528602678|FG020|Overall Study|Withdrawal of consent|0|||
146571143|NCT01713582|528602658|FG000|Overall Study|Lack of Efficacy|0|||
146571144|NCT01713582|528602659|FG001|Overall Study|Lack of Efficacy|0|||
146571145|NCT01713582|528602660|FG002|Overall Study|Lack of Efficacy|0|||
146571146|NCT01713582|528602661|FG003|Overall Study|Lack of Efficacy|0|||
146571147|NCT01713582|528602662|FG004|Overall Study|Lack of Efficacy|0|||
146571148|NCT01713582|528602663|FG005|Overall Study|Lack of Efficacy|0|||
146571149|NCT01713582|528602664|FG006|Overall Study|Lack of Efficacy|0|||
146571150|NCT01713582|528602665|FG007|Overall Study|Lack of Efficacy|0|||
146571151|NCT01713582|528602666|FG008|Overall Study|Lack of Efficacy|0|||
146571152|NCT01713582|528602667|FG009|Overall Study|Lack of Efficacy|1|||
146571153|NCT01713582|528602668|FG010|Overall Study|Lack of Efficacy|2|||
146571154|NCT01713582|528602669|FG011|Overall Study|Lack of Efficacy|0|||
146571155|NCT01713582|528602670|FG012|Overall Study|Lack of Efficacy|0|||
146571156|NCT01713582|528602671|FG013|Overall Study|Lack of Efficacy|0|||
146571157|NCT01713582|528602672|FG014|Overall Study|Lack of Efficacy|0|||
146571158|NCT01713582|528602673|FG015|Overall Study|Lack of Efficacy|0|||
146571159|NCT01713582|528602674|FG016|Overall Study|Lack of Efficacy|0|||
146571160|NCT01713582|528602675|FG017|Overall Study|Lack of Efficacy|0|||
146571161|NCT01713582|528602676|FG018|Overall Study|Lack of Efficacy|0|||
146571162|NCT01713582|528602677|FG019|Overall Study|Lack of Efficacy|0|||
146571163|NCT01713582|528602678|FG020|Overall Study|Lack of Efficacy|0|||
146571164|NCT01713582|528602658|FG000|Overall Study|Withdrawal by Subject|0|||
146571165|NCT01713582|528602659|FG001|Overall Study|Withdrawal by Subject|0|||
146571166|NCT01713582|528602660|FG002|Overall Study|Withdrawal by Subject|0|||
146571167|NCT01713582|528602661|FG003|Overall Study|Withdrawal by Subject|0|||
146571168|NCT01713582|528602662|FG004|Overall Study|Withdrawal by Subject|0|||
146571169|NCT01713582|528602663|FG005|Overall Study|Withdrawal by Subject|0|||
146571170|NCT01713582|528602664|FG006|Overall Study|Withdrawal by Subject|0|||
146571171|NCT01713582|528602665|FG007|Overall Study|Withdrawal by Subject|0|||
146571172|NCT01713582|528602666|FG008|Overall Study|Withdrawal by Subject|0|||
146571173|NCT01713582|528602667|FG009|Overall Study|Withdrawal by Subject|0|||
146571174|NCT01713582|528602668|FG010|Overall Study|Withdrawal by Subject|0|||
146571175|NCT01713582|528602669|FG011|Overall Study|Withdrawal by Subject|0|||
146571176|NCT01713582|528602670|FG012|Overall Study|Withdrawal by Subject|0|||
146571177|NCT01713582|528602671|FG013|Overall Study|Withdrawal by Subject|0|||
146571178|NCT01713582|528602672|FG014|Overall Study|Withdrawal by Subject|0|||
146571179|NCT01713582|528602673|FG015|Overall Study|Withdrawal by Subject|0|||
146571180|NCT01713582|528602674|FG016|Overall Study|Withdrawal by Subject|0|||
146571181|NCT01713582|528602675|FG017|Overall Study|Withdrawal by Subject|1|||
146571182|NCT01713582|528602676|FG018|Overall Study|Withdrawal by Subject|0|||
146571183|NCT01713582|528602677|FG019|Overall Study|Withdrawal by Subject|0|||
146571184|NCT01713582|528602678|FG020|Overall Study|Withdrawal by Subject|0|||
146571185|NCT01713582|528602658|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
146571186|NCT01713582|528602659|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
146571187|NCT01713582|528602660|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
146571188|NCT01713582|528602661|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
146571189|NCT01713582|528602662|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
146571190|NCT01713582|528602663|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
146571191|NCT01713582|528602664|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
146571192|NCT01713582|528602665|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
146571193|NCT01713582|528602666|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
146571194|NCT01713582|528602667|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
146571195|NCT01713582|528602668|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
146571196|NCT01713582|528602669|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
146571197|NCT01713582|528602670|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
146976546|NCT02454972|530077401|FG001|Overall Study|Lost to Follow-up|0|||
146571198|NCT01713582|528602671|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
146571199|NCT01713582|528602672|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
146571200|NCT01713582|528602673|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
146571201|NCT01713582|528602674|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
146571202|NCT01713582|528602675|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
146571203|NCT01713582|528602676|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
146770533|NCT03779048|529328611|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
146770534|NCT03779048|529328609|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
146916086|NCT02531373|529855909|FG007|Overall Study|Lost to Follow-up|0|||
146916087|NCT02531373|529855910|FG008|Overall Study|Lost to Follow-up|0|||
146509530|NCT02326298|528369026|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
146509531|NCT02326298|528369013|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146509532|NCT02326298|528369014|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146509533|NCT02326298|528369015|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146509534|NCT02326298|528369016|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146509535|NCT02326298|528369017|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146509536|NCT02326298|528369018|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146509537|NCT02326298|528369019|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
146509538|NCT02326298|528369020|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146509539|NCT02326298|528369021|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146509540|NCT02326298|528369022|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146509541|NCT02326298|528369023|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146509542|NCT02326298|528369024|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146509543|NCT02326298|528369025|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146509544|NCT02326298|528369026|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146509545|NCT02326298|528369013|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
146509546|NCT02326298|528369014|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
146509547|NCT02326298|528369015|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
146509548|NCT02326298|528369016|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
146509549|NCT02326298|528369017|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
146509550|NCT02326298|528369018|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
146509551|NCT02326298|528369019|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
146509552|NCT02326298|528369020|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
146509553|NCT02326298|528369021|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
146509554|NCT02326298|528369022|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
146509555|NCT02326298|528369023|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
146509556|NCT02326298|528369024|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
146509557|NCT02326298|528369025|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
146509558|NCT02326298|528369026|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
146509559|NCT02326298|528369013|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
146509560|NCT02326298|528369014|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
146509561|NCT02326298|528369015|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
146509562|NCT02326298|528369016|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
146509563|NCT02326298|528369017|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
146509564|NCT02326298|528369018|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
146509565|NCT02326298|528369019|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
146509566|NCT02326298|528369020|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
146509567|NCT02326298|528369021|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
146509568|NCT02326298|528369022|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
146509569|NCT02326298|528369023|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
146509570|NCT02326298|528369024|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
146509571|NCT02326298|528369025|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
146509572|NCT02326298|528369026|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
146509573|NCT02326298|528369013|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146509574|NCT02326298|528369014|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146509575|NCT02326298|528369015|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146509576|NCT02326298|528369016|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146509577|NCT02326298|528369017|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146509578|NCT02326298|528369018|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146509579|NCT02326298|528369019|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
146509580|NCT02326298|528369020|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146509581|NCT02326298|528369021|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146509582|NCT02326298|528369022|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146509583|NCT02326298|528369023|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146509584|NCT02326298|528369024|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146509585|NCT02326298|528369025|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146916088|NCT02531373|529855902|FG000|Overall Study|Physician Decision|0|||
146916089|NCT02531373|529855903|FG001|Overall Study|Physician Decision|0|||
146916090|NCT02531373|529855904|FG002|Overall Study|Physician Decision|0|||
146916091|NCT02531373|529855905|FG003|Overall Study|Physician Decision|0|||
146916092|NCT02531373|529855906|FG004|Overall Study|Physician Decision|2|||
146916093|NCT02531373|529855907|FG005|Overall Study|Physician Decision|1|||
146916094|NCT02531373|529855908|FG006|Overall Study|Physician Decision|0|||
146916095|NCT02531373|529855909|FG007|Overall Study|Physician Decision|0|||
146916096|NCT02531373|529855910|FG008|Overall Study|Physician Decision|0|||
146916097|NCT02531373|529855902|FG000|Overall Study|Protocol Violation|0|||
146916098|NCT02531373|529855903|FG001|Overall Study|Protocol Violation|0|||
146916099|NCT02531373|529855904|FG002|Overall Study|Protocol Violation|0|||
146916100|NCT02531373|529855905|FG003|Overall Study|Protocol Violation|0|||
146916101|NCT02531373|529855906|FG004|Overall Study|Protocol Violation|0|||
146916102|NCT02531373|529855907|FG005|Overall Study|Protocol Violation|1|||
146916103|NCT02531373|529855908|FG006|Overall Study|Protocol Violation|1|||
146916104|NCT02531373|529855909|FG007|Overall Study|Protocol Violation|0|||
146916105|NCT02531373|529855910|FG008|Overall Study|Protocol Violation|1|||
146916106|NCT02531373|529855902|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146916107|NCT02531373|529855903|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146916108|NCT02531373|529855904|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146916109|NCT02531373|529855905|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146916110|NCT02531373|529855906|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
146916111|NCT02531373|529855907|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
146916112|NCT02531373|529855908|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
146976547|NCT02454972|530077402|FG002|Overall Study|Lost to Follow-up|0|||
146976548|NCT02454972|530077403|FG003|Overall Study|Lost to Follow-up|0|||
146976549|NCT02454972|530077404|FG004|Overall Study|Lost to Follow-up|0|||
146509586|NCT02326298|528369026|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146509587|NCT02326298|528369013|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
146509588|NCT02326298|528369014|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
146509589|NCT02326298|528369015|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
146509590|NCT02326298|528369016|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
146509591|NCT02326298|528369017|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
146509592|NCT02326298|528369018|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
146509593|NCT02326298|528369019|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
146509594|NCT02326298|528369020|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
146509595|NCT02326298|528369021|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
146509596|NCT02326298|528369022|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
146509597|NCT02326298|528369023|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
146509598|NCT02326298|528369024|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
146509599|NCT02326298|528369025|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
146509600|NCT02326298|528369026|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
146509601|NCT02326298|528369013|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146509602|NCT02326298|528369014|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146509603|NCT02326298|528369015|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146509604|NCT02326298|528369016|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146509605|NCT02326298|528369017|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146509606|NCT02326298|528369018|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146509607|NCT02326298|528369019|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
146509608|NCT02326298|528369020|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
146509609|NCT02326298|528369021|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146509610|NCT02326298|528369022|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146509611|NCT02326298|528369023|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146509612|NCT02326298|528369024|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146509613|NCT02326298|528369025|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146509614|NCT02326298|528369026|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146509615|NCT02326298|528369013|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146509616|NCT02326298|528369014|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146509617|NCT02326298|528369015|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146509618|NCT02326298|528369016|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146509619|NCT02326298|528369017|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146509620|NCT02326298|528369018|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146509621|NCT02326298|528369019|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146509622|NCT02326298|528369020|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
146509623|NCT02326298|528369021|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146509624|NCT02326298|528369022|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146650698|NCT00640835|528898084|FG001|Overall Study|Lost to Follow-up|13|||
146976550|NCT02454972|530077405|FG005|Overall Study|Lost to Follow-up|0|||
146976551|NCT02454972|530077406|FG006|Overall Study|Lost to Follow-up|0|||
146916113|NCT02531373|529855909|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
146571204|NCT01713582|528602677|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
146571205|NCT01713582|528602678|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
146571206|NCT01713582|528602658|FG000|Overall Study|Disease progression and adverse event|0|||
146571207|NCT01713582|528602659|FG001|Overall Study|Disease progression and adverse event|0|||
146571208|NCT01713582|528602660|FG002|Overall Study|Disease progression and adverse event|0|||
146571209|NCT01713582|528602661|FG003|Overall Study|Disease progression and adverse event|0|||
146571210|NCT01713582|528602662|FG004|Overall Study|Disease progression and adverse event|0|||
146571211|NCT01713582|528602663|FG005|Overall Study|Disease progression and adverse event|0|||
146916114|NCT02531373|529855910|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
146916115|NCT02531373|529855902|FG000|Overall Study|Withdrawal by Subject|0|||
146571212|NCT01713582|528602664|FG006|Overall Study|Disease progression and adverse event|0|||
146571213|NCT01713582|528602665|FG007|Overall Study|Disease progression and adverse event|0|||
146571214|NCT01713582|528602666|FG008|Overall Study|Disease progression and adverse event|0|||
146571215|NCT01713582|528602667|FG009|Overall Study|Disease progression and adverse event|0|||
146571216|NCT01713582|528602668|FG010|Overall Study|Disease progression and adverse event|0|||
146571217|NCT01713582|528602669|FG011|Overall Study|Disease progression and adverse event|0|||
146571218|NCT01713582|528602670|FG012|Overall Study|Disease progression and adverse event|0|||
146571219|NCT01713582|528602671|FG013|Overall Study|Disease progression and adverse event|0|||
146571220|NCT01713582|528602672|FG014|Overall Study|Disease progression and adverse event|0|||
146571221|NCT01713582|528602673|FG015|Overall Study|Disease progression and adverse event|0|||
146571222|NCT01713582|528602674|FG016|Overall Study|Disease progression and adverse event|1|||
146571223|NCT01713582|528602675|FG017|Overall Study|Disease progression and adverse event|0|||
146571224|NCT01713582|528602676|FG018|Overall Study|Disease progression and adverse event|0|||
146571225|NCT01713582|528602677|FG019|Overall Study|Disease progression and adverse event|0|||
146571226|NCT01713582|528602678|FG020|Overall Study|Disease progression and adverse event|0|||
146571227|NCT04776161|528602679|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
146571228|NCT04776161|528602680|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
146571229|NCT04776161|528602681|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
146571230|NCT04776161|528602679|FG000|Overall Study|Withdrawal by Subject|1|||
146571231|NCT04776161|528602680|FG001|Overall Study|Withdrawal by Subject|0|||
146571232|NCT04776161|528602681|FG002|Overall Study|Withdrawal by Subject|1|||
146571233|NCT04776161|528602679|FG000|Overall Study|Adverse Event|0|||
146571234|NCT04776161|528602680|FG001|Overall Study|Adverse Event|1|||
146571235|NCT04776161|528602681|FG002|Overall Study|Adverse Event|1|||
146571236|NCT00342628|528602684|FG000|Overall Study|Withdrawal by Subject|19|||
146571237|NCT00342628|528602685|FG001|Overall Study|Withdrawal by Subject|19|||
146571238|NCT00342628|528602686|FG002|Overall Study|Withdrawal by Subject|18|||
146571239|NCT00342628|528602684|FG000|Overall Study|Death|1|||
146571240|NCT00342628|528602685|FG001|Overall Study|Death|1|||
146571241|NCT00342628|528602686|FG002|Overall Study|Death|0|||
146571242|NCT00342628|528602684|FG000|Overall Study|moved residence|0|||
146571243|NCT00342628|528602685|FG001|Overall Study|moved residence|1|||
146571244|NCT00342628|528602686|FG002|Overall Study|moved residence|1|||
146571245|NCT03427814|528602687|FG000|Overall Study|Withdrawal by Subject|4|||
146571246|NCT03427814|528602688|FG001|Overall Study|Withdrawal by Subject|4|||
146571247|NCT03427814|528602687|FG000|Overall Study|Lost to Follow-up|0|||
146571248|NCT03427814|528602688|FG001|Overall Study|Lost to Follow-up|2|||
146571249|NCT03427814|528602687|FG000|Overall Study|Death|42|||
146571250|NCT03427814|528602688|FG001|Overall Study|Death|31|||
146571251|NCT03427814|528602687|FG000|Overall Study|Sponsor's Decision|1|||
146571252|NCT03427814|528602688|FG001|Overall Study|Sponsor's Decision|0|||
146571253|NCT03427814|528602687|FG000|Overall Study|Investigator's Decision|1|||
146571254|NCT03427814|528602688|FG001|Overall Study|Investigator's Decision|2|||
146571255|NCT03427814|528602687|FG000|Overall Study|Disease progression|1|||
146571256|NCT03427814|528602688|FG001|Overall Study|Disease progression|0|||
146571257|NCT03427814|528602687|FG000|Overall Study|Treatment Completed|0|||
146571258|NCT03427814|528602688|FG001|Overall Study|Treatment Completed|1|||
146571259|NCT03427814|528602687|FG000|Overall Study|Sponsor's Decision to End study|21|||
146571260|NCT03427814|528602688|FG001|Overall Study|Sponsor's Decision to End study|25|||
146571261|NCT03427814|528602687|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
146571262|NCT03427814|528602688|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
146571263|NCT03846427|528602689|FG000|Overall Study|Death|13|||
146571264|NCT03846427|528602689|FG000|Overall Study|Withdrawal by Subject|3|||
146571265|NCT03846427|528602689|FG000|Overall Study|Physician Decision|1|||
146571266|NCT01334554|528602690|FG000|Overall Study|Adverse Event|4|||
146571267|NCT01334554|528602691|FG001|Overall Study|Adverse Event|2|||
146571268|NCT01944020|528602693|FG000|Overall Study|Withdrawal by Subject|5|||
146571269|NCT01944020|528602694|FG001|Overall Study|Withdrawal by Subject|0|||
146916116|NCT02531373|529855903|FG001|Overall Study|Withdrawal by Subject|0|||
146916117|NCT02531373|529855904|FG002|Overall Study|Withdrawal by Subject|0|||
146571270|NCT01979614|528602695|FG000|Overall Study|Adverse Event|1|||
146571271|NCT01979614|528602696|FG001|Overall Study|Adverse Event|1|||
146571272|NCT00661830|528602697|FG000|Overall Study|Death|37|||
146571273|NCT00661830|528602698|FG001|Overall Study|Death|33|||
146571274|NCT00661830|528602697|FG000|Overall Study|Lost to Follow-up|1|||
146571275|NCT00661830|528602698|FG001|Overall Study|Lost to Follow-up|3|||
146571276|NCT00661830|528602697|FG000|Overall Study|Withdrawal by Subject|1|||
146571277|NCT00661830|528602698|FG001|Overall Study|Withdrawal by Subject|1|||
146571278|NCT00661830|528602697|FG000|Overall Study|Other reason|1|||
146571279|NCT00661830|528602698|FG001|Overall Study|Other reason|5|||
146571280|NCT00488514|528602699|FG000|Overall Study|Adverse Event|41|||
146571281|NCT00488514|528602699|FG000|Overall Study|Lost to Follow-up|44|||
146571282|NCT00488514|528602699|FG000|Overall Study|Protocol Violation|32|||
146571283|NCT00488514|528602699|FG000|Overall Study|Withdrawal by Subject|106|||
146571284|NCT00488514|528602699|FG000|Overall Study|Lack of Efficacy|28|||
146571285|NCT00488514|528602699|FG000|Overall Study|Did not meet criteria for treatment|30|||
146571286|NCT00488514|528602699|FG000|Overall Study|Postive drug screen|1|||
146571287|NCT00488514|528602699|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
146571288|NCT00488514|528602699|FG000|Overall Study|Investigator decision|1|||
146571289|NCT00488514|528602699|FG000|Overall Study|Participant had too few migraines|5|||
146571290|NCT00488514|528602699|FG000|Overall Study|Increase in number of migraines|2|||
146571291|NCT00488514|528602699|FG000|Overall Study|Increased use of concomitant medication|1|||
146571292|NCT04971967|528602704|FG000|Overall Study|Lost to Follow-up|6|||
146571293|NCT04971967|528602705|FG001|Overall Study|Lost to Follow-up|7|||
146571294|NCT00938912|528602708|FG000|Overall Study|Withdrawal by Subject|28|||
146571295|NCT00938912|528602708|FG000|Overall Study|Lost to Follow-up|4|||
146571296|NCT00938912|528602708|FG000|Overall Study|Lack of Efficacy|43|||
146571297|NCT00938912|528602708|FG000|Overall Study|Adverse event, non-fatal|24|||
146571298|NCT00938912|528602708|FG000|Overall Study|Adverse event, fatal|1|||
146571299|NCT00938912|528602708|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
146571300|NCT00938912|528602708|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
146571301|NCT00938912|528602708|FG000|Overall Study|Participant needed prohibit medication|1|||
146571302|NCT00938912|528602708|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
146571303|NCT00938912|528602708|FG000|Overall Study|Did not meet Eligibility criteria|1|||
146571304|NCT00938912|528602708|FG000|Overall Study|Participant relocated not related to AE|1|||
146571305|NCT00938912|528602708|FG000|Overall Study|Participant moved to another city|1|||
146571306|NCT00938912|528602708|FG000|Overall Study|Participant experienced break through seizures|1|||
146571307|NCT00938912|528602708|FG000|Overall Study|No longer wished to participate in the study|1|||
146571308|NCT00938912|528602708|FG000|Overall Study|Protocol Deviation|2|||
146571309|NCT01475721|528602709|FG000|Overall Study|Death|3|||
146571310|NCT01475721|528602710|FG001|Overall Study|Death|6|||
146571311|NCT01475721|528602709|FG000|Overall Study|Withdrawal by Subject|8|||
146571312|NCT01475721|528602710|FG001|Overall Study|Withdrawal by Subject|8|||
146571313|NCT00803738|528602711|FG000|Overall Study|Adverse Event|3|||
146571314|NCT00803738|528602712|FG001|Overall Study|Adverse Event|5|||
146571315|NCT00803738|528602711|FG000|Overall Study|Lost to Follow-up|4|||
146571316|NCT00803738|528602712|FG001|Overall Study|Lost to Follow-up|4|||
146571317|NCT00803738|528602711|FG000|Overall Study|Protocol Violation|18|||
146571318|NCT00803738|528602712|FG001|Overall Study|Protocol Violation|10|||
146571319|NCT00803738|528602711|FG000|Overall Study|Withdrawal by Subject|1|||
146571320|NCT00803738|528602712|FG001|Overall Study|Withdrawal by Subject|4|||
146571321|NCT00803738|528602711|FG000|Overall Study|Lack of Efficacy|10|||
146571322|NCT00803738|528602712|FG001|Overall Study|Lack of Efficacy|16|||
146650699|NCT00640835|528898083|FG000|Overall Study|Other Reason|19|||
146650700|NCT00640835|528898084|FG001|Overall Study|Other Reason|4|||
146650701|NCT01437995|528898085|FG000|Overall Study|Lost to Follow-up|11|||
146650702|NCT01437995|528898086|FG001|Overall Study|Lost to Follow-up|18|||
146650703|NCT01437995|528898087|FG002|Overall Study|Lost to Follow-up|20|||
146916118|NCT02531373|529855905|FG003|Overall Study|Withdrawal by Subject|0|||
146916119|NCT02531373|529855906|FG004|Overall Study|Withdrawal by Subject|3|||
146916120|NCT02531373|529855907|FG005|Overall Study|Withdrawal by Subject|0|||
146916121|NCT02531373|529855908|FG006|Overall Study|Withdrawal by Subject|0|||
146571323|NCT00803738|528602711|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
146571324|NCT00803738|528602712|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
146571325|NCT00803738|528602711|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
146571326|NCT00803738|528602712|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
146571327|NCT01048242|528602713|FG000|Overall Study|See study flow chart|4|||
146571328|NCT01048242|528602714|FG001|Overall Study|See study flow chart|2|||
146571329|NCT02364037|528602715|FG000|Overall Study|Withdrawal by Subject|7|||
146571330|NCT02364037|528602716|FG001|Overall Study|Withdrawal by Subject|4|||
146571331|NCT02364037|528602715|FG000|Overall Study|Lost to Follow-up|37|||
146571332|NCT02364037|528602716|FG001|Overall Study|Lost to Follow-up|49|||
146571333|NCT01772550|528602717|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
146571334|NCT01772550|528602718|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
146571335|NCT01772550|528602719|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
146650704|NCT04618770|528898088|FG000|Overall Study|Censored from Analysis|12|||
146650705|NCT04618770|528898088|FG000|Overall Study|Early Termination|25|||
146916122|NCT02531373|529855909|FG007|Overall Study|Withdrawal by Subject|0|||
146916123|NCT02531373|529855910|FG008|Overall Study|Withdrawal by Subject|0|||
146916124|NCT00623467|529855911|FG000|Overall Study|Lost to Follow-up|1|||
146916125|NCT00623467|529855911|FG000|Overall Study|Protocol Violation|4|||
146916126|NCT00623467|529855911|FG000|Overall Study|Withdrawal by Subject|2|||
146916127|NCT02834403|529855920|FG000|Overall Study|Physician Decision|2|||
146916128|NCT02834403|529855921|FG001|Overall Study|Physician Decision|1|||
146916129|NCT02834403|529855922|FG002|Overall Study|Physician Decision|2|||
146916130|NCT02834403|529855923|FG003|Overall Study|Physician Decision|1|||
146916131|NCT02834403|529855924|FG004|Overall Study|Physician Decision|1|||
146916132|NCT02834403|529855925|FG005|Overall Study|Physician Decision|2|||
146916133|NCT02834403|529855926|FG006|Overall Study|Physician Decision|12|||
146916134|NCT02834403|529855920|FG000|Overall Study|Adverse Event|0|||
146916135|NCT02834403|529855921|FG001|Overall Study|Adverse Event|0|||
146916136|NCT02834403|529855922|FG002|Overall Study|Adverse Event|0|||
146916137|NCT02834403|529855923|FG003|Overall Study|Adverse Event|0|||
146916138|NCT02834403|529855924|FG004|Overall Study|Adverse Event|1|||
146916139|NCT02834403|529855925|FG005|Overall Study|Adverse Event|1|||
146916140|NCT02834403|529855926|FG006|Overall Study|Adverse Event|3|||
146916141|NCT02834403|529855920|FG000|Overall Study|Withdrawal by Subject|0|||
146916142|NCT02834403|529855921|FG001|Overall Study|Withdrawal by Subject|1|||
146916143|NCT02834403|529855922|FG002|Overall Study|Withdrawal by Subject|0|||
146916144|NCT02834403|529855923|FG003|Overall Study|Withdrawal by Subject|0|||
146916145|NCT02834403|529855924|FG004|Overall Study|Withdrawal by Subject|1|||
146916146|NCT02834403|529855925|FG005|Overall Study|Withdrawal by Subject|0|||
146916147|NCT02834403|529855926|FG006|Overall Study|Withdrawal by Subject|0|||
146916148|NCT02834403|529855920|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
146916149|NCT02834403|529855921|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
146916150|NCT02834403|529855922|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
146916151|NCT02834403|529855923|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
146916152|NCT02834403|529855924|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
146916153|NCT02834403|529855925|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
146916154|NCT02834403|529855926|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
146916155|NCT00273858|529855933|FG000|Overall Study|Not completed 24 month observation time|334|||
146916156|NCT00273858|529855933|FG000|Overall Study|Lost to Follow-up|101|||
146916157|NCT00273858|529855933|FG000|Overall Study|Withdrawal by Subject|21|||
146916158|NCT00273858|529855933|FG000|Overall Study|Adverse Event|81|||
146916159|NCT02232516|529855938|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
146916160|NCT02232516|529855938|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
146916161|NCT02232516|529855938|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
146916162|NCT02232516|529855938|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
146916163|NCT02232516|529855938|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
146916164|NCT02232516|529855938|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
146916165|NCT02232516|529855938|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
146916166|NCT02232516|529855938|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
146916167|NCT02232516|529855938|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
146916168|NCT02232516|529855938|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
146916169|NCT02232516|529855938|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
146916170|NCT02232516|529855938|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
146916171|NCT02232516|529855938|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
146916172|NCT02232516|529855938|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
146916173|NCT02232516|529855938|FG000|Survival Follow-up|Death|15|||
146916174|NCT02232516|529855938|FG000|Survival Follow-up|Withdrawal by Subject|3|||
146916175|NCT02232516|529855938|FG000|Survival Follow-up|Lost to Follow-up|1|||
146916176|NCT02232516|529855938|FG000|Survival Follow-up|Still in follow-up|5|||
146916177|NCT05058664|529855939|FG000|Overall Study|No follow-up data provided|4|||
146916178|NCT05058664|529855940|FG001|Overall Study|No follow-up data provided|0|||
146916179|NCT05058664|529855941|FG002|Overall Study|No follow-up data provided|2|||
146916180|NCT05058664|529855939|FG000|Overall Study|Withdrawal by Subject|0|||
146916181|NCT05058664|529855940|FG001|Overall Study|Withdrawal by Subject|0|||
146916182|NCT05058664|529855941|FG002|Overall Study|Withdrawal by Subject|1|||
146916183|NCT02853331|529855943|FG000|Overall Study|Death|59|||
146916184|NCT02853331|529855944|FG001|Overall Study|Death|95|||
146916185|NCT02853331|529855943|FG000|Overall Study|Withdrawal by Subject|5|||
146916186|NCT02853331|529855944|FG001|Overall Study|Withdrawal by Subject|9|||
146916187|NCT02853331|529855943|FG000|Overall Study|Ongoing in study|368|||
146916188|NCT02853331|529855944|FG001|Overall Study|Ongoing in study|325|||
146916189|NCT01455428|529855945|FG000|Overall Study|Protocol Violation|2|||
146916190|NCT01455428|529855946|FG001|Overall Study|Protocol Violation|1|||
146916191|NCT01455428|529855945|FG000|Overall Study|Adverse Event|6|||
146916192|NCT01455428|529855946|FG001|Overall Study|Adverse Event|2|||
146916193|NCT01455428|529855945|FG000|Overall Study|Lost to Follow-up|1|||
146916194|NCT01455428|529855946|FG001|Overall Study|Lost to Follow-up|1|||
146916195|NCT01455428|529855945|FG000|Overall Study|Withdrawal by Subject|2|||
146916196|NCT01455428|529855946|FG001|Overall Study|Withdrawal by Subject|5|||
146916197|NCT01455428|529855945|FG000|Overall Study|Did not meet entrance criteria|0|||
146916198|NCT01455428|529855946|FG001|Overall Study|Did not meet entrance criteria|2|||
146916199|NCT01455428|529855945|FG000|Overall Study|Insufficient clinical response|0|||
146916200|NCT01455428|529855946|FG001|Overall Study|Insufficient clinical response|2|||
146916201|NCT01455428|529855945|FG000|Overall Study|Did not receive treatment|1|||
146916202|NCT01455428|529855946|FG001|Overall Study|Did not receive treatment|1|||
146916203|NCT01455428|529855945|FG000|Overall Study|Other|2|||
146916204|NCT01455428|529855946|FG001|Overall Study|Other|4|||
146916205|NCT02062151|529855949|FG000|Overall Study|screen failure|1|||
146916206|NCT00257192|529855950|FG000|Overall Study|Adverse Event|21|||
146916207|NCT00257192|529855951|FG001|Overall Study|Adverse Event|10|||
146916208|NCT00257192|529855950|FG000|Overall Study|Laboratory abnormality|1|||
146916209|NCT00257192|529855951|FG001|Overall Study|Laboratory abnormality|1|||
146916210|NCT00257192|529855950|FG000|Overall Study|Lost to Follow-up|3|||
146916211|NCT00257192|529855951|FG001|Overall Study|Lost to Follow-up|3|||
146916212|NCT00257192|529855950|FG000|Overall Study|Insufficient clinical response|18|||
146916213|NCT00257192|529855951|FG001|Overall Study|Insufficient clinical response|18|||
146916214|NCT00257192|529855950|FG000|Overall Study|Withdrawal by Subject|14|||
146916215|NCT00257192|529855951|FG001|Overall Study|Withdrawal by Subject|2|||
146916216|NCT00257192|529855950|FG000|Overall Study|Randomized but not treated|0|||
146916217|NCT00257192|529855951|FG001|Overall Study|Randomized but not treated|1|||
146916218|NCT00257192|529855950|FG000|Overall Study|Study terminated by sponsor|1|||
146916219|NCT00257192|529855951|FG001|Overall Study|Study terminated by sponsor|0|||
146916220|NCT00257192|529855950|FG000|Overall Study|Miscellaneous|0|||
146916221|NCT00257192|529855951|FG001|Overall Study|Miscellaneous|4|||
146916222|NCT00570739|529855952|FG000|Overall Study|Adverse Event|8|||
146916223|NCT00570739|529855953|FG001|Overall Study|Adverse Event|6|||
146916224|NCT00570739|529855954|FG002|Overall Study|Adverse Event|2|||
146916225|NCT00570739|529855955|FG003|Overall Study|Adverse Event|2|||
146916226|NCT00570739|529855952|FG000|Overall Study|Lost to Follow-up|4|||
146916227|NCT00570739|529855953|FG001|Overall Study|Lost to Follow-up|5|||
146916228|NCT00570739|529855954|FG002|Overall Study|Lost to Follow-up|4|||
146916229|NCT00570739|529855955|FG003|Overall Study|Lost to Follow-up|1|||
146916230|NCT00570739|529855952|FG000|Overall Study|Physician Decision|1|||
146916231|NCT00570739|529855953|FG001|Overall Study|Physician Decision|1|||
146916232|NCT00570739|529855954|FG002|Overall Study|Physician Decision|0|||
146916233|NCT00570739|529855955|FG003|Overall Study|Physician Decision|0|||
146916234|NCT00570739|529855952|FG000|Overall Study|Withdrawal by Subject|7|||
146916235|NCT00570739|529855953|FG001|Overall Study|Withdrawal by Subject|7|||
146916236|NCT00570739|529855954|FG002|Overall Study|Withdrawal by Subject|3|||
146916237|NCT00570739|529855955|FG003|Overall Study|Withdrawal by Subject|5|||
146916238|NCT00570739|529855952|FG000|Overall Study|Required restricted medication|0|||
146916239|NCT00570739|529855953|FG001|Overall Study|Required restricted medication|0|||
146916240|NCT00570739|529855954|FG002|Overall Study|Required restricted medication|1|||
146916241|NCT00570739|529855955|FG003|Overall Study|Required restricted medication|0|||
146916242|NCT00570739|529855952|FG000|Overall Study|Met discontinuation criteria|1|||
146916243|NCT00570739|529855953|FG001|Overall Study|Met discontinuation criteria|0|||
146916244|NCT00570739|529855954|FG002|Overall Study|Met discontinuation criteria|1|||
146916245|NCT00570739|529855955|FG003|Overall Study|Met discontinuation criteria|1|||
146916246|NCT00570739|529855952|FG000|Overall Study|Other|0|||
146916247|NCT00570739|529855953|FG001|Overall Study|Other|2|||
146916248|NCT00570739|529855954|FG002|Overall Study|Other|5|||
146916249|NCT00570739|529855955|FG003|Overall Study|Other|3|||
146916250|NCT02086565|529855957|FG000|Overall Study|Lost to Follow-up|9|||
146916251|NCT02086565|529855958|FG001|Overall Study|Lost to Follow-up|7|||
146916252|NCT02086565|529855957|FG000|Overall Study|Withdrawal by Subject|2|||
146916253|NCT02086565|529855958|FG001|Overall Study|Withdrawal by Subject|1|||
146916254|NCT02086565|529855957|FG000|Overall Study|Death|3|||
146916255|NCT02086565|529855958|FG001|Overall Study|Death|2|||
146916256|NCT02086565|529855957|FG000|Overall Study|withdrawn by research team|2|||
146916257|NCT02086565|529855958|FG001|Overall Study|withdrawn by research team|2|||
146916258|NCT00751101|529855959|FG000|Overall Study|Withdrawal by Subject|1|||
146650706|NCT04456673|528898089|FG000|Overall Study|Adverse Event|7|||
146650707|NCT04456673|528898090|FG001|Overall Study|Adverse Event|14|||
146916259|NCT00751101|529855960|FG001|Overall Study|Withdrawal by Subject|0|||
146916260|NCT00751101|529855959|FG000|Overall Study|No HFS / Never Started Patch/|0|||
146916261|NCT00751101|529855960|FG001|Overall Study|No HFS / Never Started Patch/|4|||
146916262|NCT00751101|529855959|FG000|Overall Study|Never began capecitabine|1|||
146916263|NCT00751101|529855960|FG001|Overall Study|Never began capecitabine|0|||
146976552|NCT02454972|530077407|FG007|Overall Study|Lost to Follow-up|0|||
146916264|NCT00751101|529855959|FG000|Overall Study|Physician Decision|0|||
146916265|NCT00751101|529855960|FG001|Overall Study|Physician Decision|1|||
146916266|NCT00739297|529855961|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
146916267|NCT00739297|529855962|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
146916268|NCT00739297|529855963|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
146916269|NCT00739297|529855964|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
146650708|NCT04456673|528898089|FG000|Overall Study|Poor compliance to protocol|1|||
146650709|NCT04456673|528898090|FG001|Overall Study|Poor compliance to protocol|0|||
146650710|NCT04456673|528898089|FG000|Overall Study|Withdrawal by Subject|31|||
146650711|NCT04456673|528898090|FG001|Overall Study|Withdrawal by Subject|23|||
146650712|NCT04456673|528898089|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
146509625|NCT02326298|528369023|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146509626|NCT02326298|528369024|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146509627|NCT02326298|528369025|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146509628|NCT02326298|528369026|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146509629|NCT02326298|528369013|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
146509630|NCT02326298|528369014|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
146509631|NCT02326298|528369015|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
146509632|NCT02326298|528369016|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
146509633|NCT02326298|528369017|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
146509634|NCT02326298|528369018|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
146509635|NCT02326298|528369019|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
146509636|NCT02326298|528369020|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
146509637|NCT02326298|528369021|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
146509638|NCT02326298|528369022|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
146509639|NCT02326298|528369023|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
146509640|NCT02326298|528369024|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
146509641|NCT02326298|528369025|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
146509642|NCT02326298|528369026|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
146509643|NCT02326298|528369013|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
146509644|NCT02326298|528369014|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
146509645|NCT02326298|528369015|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
146509646|NCT02326298|528369016|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
146509647|NCT02326298|528369017|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
146509648|NCT02326298|528369018|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
146509649|NCT02326298|528369019|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
146509650|NCT02326298|528369020|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
146509651|NCT02326298|528369021|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
146509652|NCT02326298|528369022|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
146509653|NCT02326298|528369023|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
146509654|NCT02326298|528369024|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
146509655|NCT02326298|528369025|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
146509656|NCT02326298|528369026|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
146509657|NCT02326298|528369013|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146509658|NCT02326298|528369014|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146509659|NCT02326298|528369015|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146509660|NCT02326298|528369016|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146509661|NCT02326298|528369017|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146509662|NCT02326298|528369018|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146509663|NCT02326298|528369019|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146509664|NCT02326298|528369020|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146509665|NCT02326298|528369021|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146509666|NCT02326298|528369022|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146509667|NCT02326298|528369023|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146509668|NCT02326298|528369024|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
146509669|NCT02326298|528369025|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
146509670|NCT02326298|528369026|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
146509671|NCT02326298|528369013|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146509672|NCT02326298|528369014|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146509673|NCT02326298|528369015|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146509674|NCT02326298|528369016|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146509675|NCT02326298|528369017|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146509676|NCT02326298|528369018|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146509677|NCT02326298|528369019|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146509678|NCT02326298|528369020|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146509679|NCT02326298|528369021|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146650713|NCT04456673|528898090|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
146650714|NCT04391049|528898091|FG000|Overall Study|Protocol Violation|1|||
146650715|NCT03874429|528898092|FG000|Overall Study|Adverse Event|2|||
146650716|NCT03874429|528898093|FG001|Overall Study|Adverse Event|2|||
146650717|NCT03874429|528898092|FG000|Overall Study|Lack of Efficacy|0|||
146650718|NCT03874429|528898093|FG001|Overall Study|Lack of Efficacy|1|||
146650719|NCT03874429|528898092|FG000|Overall Study|Covid-19 pandemic|4|||
146916270|NCT00739297|529855965|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
146916271|NCT00739297|529855966|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
146916272|NCT00739297|529855967|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
146916273|NCT00739297|529855961|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
146916274|NCT00739297|529855962|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
146916275|NCT00739297|529855963|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
146916276|NCT00739297|529855964|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
146916277|NCT00739297|529855965|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
146916278|NCT00739297|529855966|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
146916279|NCT00739297|529855967|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
146916280|NCT01921270|529855970|FG000|Overall Study|Withdrawal by Subject|1|||
146916281|NCT00844428|529855971|FG000|Screening Period|Screen Failure|3|||
146916282|NCT00844428|529855971|FG000|Extension Treatment Period|Death|1|||
146916283|NCT00844428|529855971|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
146916284|NCT00789477|529855972|FG000|Overall Study|Withdrawal by Subject|2|||
146916285|NCT00789477|529855973|FG001|Overall Study|Withdrawal by Subject|1|||
146916286|NCT00789477|529855974|FG002|Overall Study|Withdrawal by Subject|3|||
146916287|NCT00789477|529855975|FG003|Overall Study|Withdrawal by Subject|2|||
146916288|NCT00789477|529855976|FG004|Overall Study|Withdrawal by Subject|3|||
146916289|NCT00789477|529855972|FG000|Overall Study|Protocol Violation|1|||
146916290|NCT00789477|529855973|FG001|Overall Study|Protocol Violation|0|||
146916291|NCT00789477|529855974|FG002|Overall Study|Protocol Violation|0|||
146916292|NCT00789477|529855975|FG003|Overall Study|Protocol Violation|1|||
146916293|NCT00789477|529855976|FG004|Overall Study|Protocol Violation|0|||
146916294|NCT00789477|529855972|FG000|Overall Study|Adverse Event|3|||
146916295|NCT00789477|529855973|FG001|Overall Study|Adverse Event|3|||
146916296|NCT00789477|529855974|FG002|Overall Study|Adverse Event|1|||
146916297|NCT00789477|529855975|FG003|Overall Study|Adverse Event|0|||
146916298|NCT00789477|529855976|FG004|Overall Study|Adverse Event|0|||
146916299|NCT00789477|529855972|FG000|Overall Study|Death|1|||
146916300|NCT00789477|529855973|FG001|Overall Study|Death|1|||
146916301|NCT00789477|529855974|FG002|Overall Study|Death|2|||
146916302|NCT00789477|529855975|FG003|Overall Study|Death|2|||
146916303|NCT00789477|529855976|FG004|Overall Study|Death|0|||
146916304|NCT00789477|529855972|FG000|Overall Study|Lost to Follow-up|0|||
146916305|NCT00789477|529855973|FG001|Overall Study|Lost to Follow-up|1|||
146916306|NCT00789477|529855974|FG002|Overall Study|Lost to Follow-up|4|||
146916307|NCT00789477|529855975|FG003|Overall Study|Lost to Follow-up|2|||
146916308|NCT00789477|529855976|FG004|Overall Study|Lost to Follow-up|4|||
146916309|NCT00789477|529855972|FG000|Overall Study|Lack of Efficacy|2|||
146916310|NCT00789477|529855973|FG001|Overall Study|Lack of Efficacy|0|||
146916311|NCT00789477|529855974|FG002|Overall Study|Lack of Efficacy|0|||
146916312|NCT00789477|529855975|FG003|Overall Study|Lack of Efficacy|0|||
146916313|NCT00789477|529855976|FG004|Overall Study|Lack of Efficacy|0|||
146916314|NCT00789477|529855972|FG000|Overall Study|Other|2|||
146916315|NCT00789477|529855973|FG001|Overall Study|Other|0|||
146916316|NCT00789477|529855974|FG002|Overall Study|Other|1|||
146916317|NCT00789477|529855975|FG003|Overall Study|Other|3|||
146916318|NCT00789477|529855976|FG004|Overall Study|Other|0|||
146916319|NCT00772967|529855977|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
146916320|NCT00772967|529855978|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
146916321|NCT00772967|529855979|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
146916322|NCT00772967|529855980|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
146916323|NCT00772967|529855981|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
146916324|NCT00772967|529855982|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
146916325|NCT00772967|529855977|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
146916326|NCT00772967|529855978|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
146916327|NCT00772967|529855979|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
146916328|NCT00772967|529855980|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
146916329|NCT00772967|529855981|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
146650720|NCT03874429|528898093|FG001|Overall Study|Covid-19 pandemic|2|||
146650721|NCT00775203|528898094|FG000|Overall Study|Adverse Event|25|||
146916330|NCT00772967|529855982|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
146916331|NCT00772967|529855977|FG000|Crossover Treatment 3|Adverse Event|0|||
146916332|NCT00772967|529855978|FG001|Crossover Treatment 3|Adverse Event|0|||
146916333|NCT00772967|529855979|FG002|Crossover Treatment 3|Adverse Event|0|||
146916334|NCT00772967|529855980|FG003|Crossover Treatment 3|Adverse Event|0|||
146916335|NCT00772967|529855981|FG004|Crossover Treatment 3|Adverse Event|1|||
146916336|NCT00772967|529855982|FG005|Crossover Treatment 3|Adverse Event|0|||
146916337|NCT01345786|529855988|FG000|Overall Study|Adverse Event|0|||
146650722|NCT00775203|528898095|FG001|Overall Study|Adverse Event|6|||
146650723|NCT00775203|528898094|FG000|Overall Study|Lack of Efficacy|8|||
146916338|NCT01345786|529855989|FG001|Overall Study|Adverse Event|1|||
146916339|NCT01345786|529855990|FG002|Overall Study|Adverse Event|3|||
146976553|NCT02454972|530077408|FG008|Overall Study|Lost to Follow-up|2|||
146976554|NCT02454972|530077400|FG000|Overall Study|Study termination|0|||
146976555|NCT02454972|530077401|FG001|Overall Study|Study termination|0|||
146976556|NCT02454972|530077402|FG002|Overall Study|Study termination|0|||
146976557|NCT02454972|530077403|FG003|Overall Study|Study termination|0|||
146976558|NCT02454972|530077404|FG004|Overall Study|Study termination|0|||
146976559|NCT02454972|530077405|FG005|Overall Study|Study termination|0|||
146976560|NCT02454972|530077406|FG006|Overall Study|Study termination|0|||
146976561|NCT02454972|530077407|FG007|Overall Study|Study termination|0|||
146976562|NCT02454972|530077408|FG008|Overall Study|Study termination|6|||
146976563|NCT00787566|530077409|FG000|Overall Study|AE related to chemotherapy|0|||
146976564|NCT00787566|530077410|FG001|Overall Study|AE related to chemotherapy|1|||
146976565|NCT00787566|530077411|FG002|Overall Study|AE related to chemotherapy|0|||
146976566|NCT01070966|530077419|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
146976567|NCT01070966|530077419|FG000|Participants for Safety Evaluation|Off-label use|9|||
146976568|NCT01070966|530077419|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
146976569|NCT01070966|530077419|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
146976570|NCT01070966|530077419|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
146976571|NCT01070966|530077419|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
146976572|NCT01070966|530077419|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
146976573|NCT01070966|530077419|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
146976574|NCT01725113|530077421|FG000|Overall Study|Kidney Transplant|1|||
146976575|NCT01725113|530077422|FG001|Overall Study|Kidney Transplant|1|||
146976576|NCT01725113|530077421|FG000|Overall Study|Withdrawal by Subject|0|||
146976577|NCT01725113|530077422|FG001|Overall Study|Withdrawal by Subject|1|||
146976578|NCT01415921|530077424|FG000|Overall Study|Adverse Event|0|||
146976579|NCT01415921|530077425|FG001|Overall Study|Adverse Event|1|||
146976580|NCT01415921|530077424|FG000|Overall Study|Physician Decision|1|||
146976581|NCT01415921|530077425|FG001|Overall Study|Physician Decision|1|||
146976582|NCT01415921|530077424|FG000|Overall Study|Withdrawal by Subject|0|||
146976583|NCT01415921|530077425|FG001|Overall Study|Withdrawal by Subject|1|||
146976584|NCT01415921|530077424|FG000|Overall Study|Other|2|||
146976585|NCT01415921|530077425|FG001|Overall Study|Other|0|||
146976586|NCT02117479|530077431|FG000|Overall Study|Death|13|||
146976587|NCT02117479|530077432|FG001|Overall Study|Death|8|||
146976588|NCT02117479|530077431|FG000|Overall Study|Adverse Event|8|||
146976589|NCT02117479|530077432|FG001|Overall Study|Adverse Event|16|||
146976590|NCT02117479|530077431|FG000|Overall Study|Subject decision|8|||
146976591|NCT02117479|530077432|FG001|Overall Study|Subject decision|9|||
146976592|NCT02117479|530077431|FG000|Overall Study|Disease progression|104|||
146976593|NCT02117479|530077432|FG001|Overall Study|Disease progression|108|||
146976594|NCT02117479|530077431|FG000|Overall Study|Noncompliance with study treatment|1|||
146976595|NCT02117479|530077432|FG001|Overall Study|Noncompliance with study treatment|0|||
146976596|NCT02117479|530077431|FG000|Overall Study|Study terminated by the sponsor|4|||
146976597|NCT02117479|530077432|FG001|Overall Study|Study terminated by the sponsor|6|||
146976598|NCT02117479|530077431|FG000|Overall Study|Physician Decision|7|||
146976599|NCT02117479|530077432|FG001|Overall Study|Physician Decision|2|||
146976600|NCT02117479|530077431|FG000|Overall Study|Other unspecified|11|||
146976601|NCT02117479|530077432|FG001|Overall Study|Other unspecified|7|||
146976602|NCT01453374|530077433|FG000|Overall Study|Adverse Event|7|||
146916340|NCT01345786|529855991|FG003|Overall Study|Adverse Event|1|||
146916341|NCT01345786|529855988|FG000|Overall Study|Subject withdrew consent|2|||
146916342|NCT01345786|529855989|FG001|Overall Study|Subject withdrew consent|2|||
146916343|NCT01345786|529855990|FG002|Overall Study|Subject withdrew consent|1|||
146916344|NCT01345786|529855991|FG003|Overall Study|Subject withdrew consent|0|||
146916345|NCT01345786|529855988|FG000|Overall Study|Noncompliance with protocol|1|||
146916346|NCT01345786|529855989|FG001|Overall Study|Noncompliance with protocol|0|||
146916347|NCT01345786|529855990|FG002|Overall Study|Noncompliance with protocol|1|||
146650724|NCT00775203|528898095|FG001|Overall Study|Lack of Efficacy|9|||
146916348|NCT01345786|529855991|FG003|Overall Study|Noncompliance with protocol|0|||
146916349|NCT01345786|529855988|FG000|Overall Study|Administrative|3|||
146916350|NCT01345786|529855989|FG001|Overall Study|Administrative|5|||
146916351|NCT01345786|529855990|FG002|Overall Study|Administrative|0|||
146916352|NCT01345786|529855991|FG003|Overall Study|Administrative|0|||
146916353|NCT01345786|529855988|FG000|Overall Study|Lost to Follow-up|0|||
146976603|NCT01453374|530077433|FG000|Overall Study|Lack of Efficacy|1|||
146976604|NCT01453374|530077433|FG000|Overall Study|Lost to Follow-up|3|||
146976605|NCT01453374|530077433|FG000|Overall Study|Withdrawal by Subject|5|||
146976606|NCT01453374|530077433|FG000|Overall Study|Incarcerated|2|||
146916354|NCT01345786|529855989|FG001|Overall Study|Lost to Follow-up|0|||
146976607|NCT02629133|530077435|FG000|Overall Study|Lost to Follow-up|3|||
146976608|NCT02629133|530077436|FG001|Overall Study|Lost to Follow-up|1|||
146976609|NCT02629133|530077435|FG000|Overall Study|Withdrawal by Subject|1|||
146976610|NCT02629133|530077436|FG001|Overall Study|Withdrawal by Subject|1|||
146976611|NCT03216954|530077437|FG000|Overall Study|Adverse Event|0|||
146916355|NCT01345786|529855990|FG002|Overall Study|Lost to Follow-up|0|||
146916356|NCT01345786|529855991|FG003|Overall Study|Lost to Follow-up|2|||
146916357|NCT01605396|529855998|FG000|Overall Study|Adverse Event|5|||
146916358|NCT01605396|529855999|FG001|Overall Study|Adverse Event|3|||
146916359|NCT01605396|529855998|FG000|Overall Study|Lost to Follow-up|1|||
146916360|NCT01605396|529855999|FG001|Overall Study|Lost to Follow-up|0|||
146916361|NCT01605396|529855998|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146916362|NCT01605396|529855999|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146916363|NCT01605396|529855998|FG000|Overall Study|Physician Decision|2|||
146916364|NCT01605396|529855999|FG001|Overall Study|Physician Decision|2|||
146916365|NCT01605396|529855998|FG000|Overall Study|Progressive Disease|23|||
146916366|NCT01605396|529855999|FG001|Overall Study|Progressive Disease|27|||
146916367|NCT01605396|529855998|FG000|Overall Study|Withdrawal by Subject|4|||
146916368|NCT01605396|529855999|FG001|Overall Study|Withdrawal by Subject|2|||
146916369|NCT01605396|529855998|FG000|Overall Study|Transfer Off Study|4|||
146916370|NCT01605396|529855999|FG001|Overall Study|Transfer Off Study|5|||
146916371|NCT04598165|529856001|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
146916372|NCT04598165|529856002|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
146916373|NCT04598165|529856001|FG000|Completed 6-week Follow-up|Death|2|||
146916374|NCT04598165|529856002|FG001|Completed 6-week Follow-up|Death|1|||
146916375|NCT04598165|529856001|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
146916376|NCT04598165|529856002|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
146916377|NCT04598165|529856001|FG000|Completed 6-week Follow-up|Ineligible|4|||
146916378|NCT04598165|529856002|FG001|Completed 6-week Follow-up|Ineligible|3|||
146916379|NCT04598165|529856001|FG000|Completed 6-week Follow-up|Partner refusal|0|||
146916380|NCT04598165|529856002|FG001|Completed 6-week Follow-up|Partner refusal|1|||
146916381|NCT04598165|529856001|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
146916382|NCT04598165|529856002|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
146916383|NCT01323673|529856003|FG000|Overall Study|Adverse Event|0|||
146916384|NCT01323673|529856004|FG001|Overall Study|Adverse Event|1|||
146916385|NCT01323673|529856003|FG000|Overall Study|Lost to Follow-up|0|||
146916386|NCT01323673|529856004|FG001|Overall Study|Lost to Follow-up|1|||
146916387|NCT01323673|529856003|FG000|Overall Study|Protocol Violation|1|||
146916388|NCT01323673|529856004|FG001|Overall Study|Protocol Violation|0|||
146916389|NCT01323673|529856003|FG000|Overall Study|Withdrawal by Subject|2|||
146916390|NCT01323673|529856004|FG001|Overall Study|Withdrawal by Subject|3|||
146916391|NCT03844633|529856005|FG000|1 Week FU|Lost to Follow-up|0|||
146916392|NCT03844633|529856006|FG001|1 Week FU|Lost to Follow-up|1|||
146916393|NCT03844633|529856007|FG002|1 Week FU|Lost to Follow-up|4|||
146916394|NCT03844633|529856005|FG000|12-month Follow-up|Lost to Follow-up|7|||
146916395|NCT03844633|529856006|FG001|12-month Follow-up|Lost to Follow-up|5|||
146916396|NCT03844633|529856007|FG002|12-month Follow-up|Lost to Follow-up|8|||
146916397|NCT02588248|529856008|FG000|Overall Study|Physician Decision|4|||
146916398|NCT02588248|529856009|FG001|Overall Study|Physician Decision|3|||
146916399|NCT00705224|529856012|FG000|Overall Study|Adverse Event|1|||
146916400|NCT00705224|529856012|FG000|Overall Study|Lack of Efficacy|2|||
146916401|NCT00705224|529856012|FG000|Overall Study|Withdrawal by Subject|3|||
146916402|NCT00705224|529856012|FG000|Overall Study|Lost to Follow-up|5|||
146916403|NCT03596177|529856013|FG000|Single Blind Period|Withdrawal by Subject|1|||
146916404|NCT03596177|529856014|FG001|Single Blind Period|Withdrawal by Subject|1|||
146916405|NCT03596177|529856013|FG000|Single Blind Period|Other|1|||
146916406|NCT03596177|529856014|FG001|Single Blind Period|Other|0|||
146916407|NCT03596177|529856013|FG000|Double Blind Period|Withdrawal by Subject|0|||
146916408|NCT03596177|529856014|FG001|Double Blind Period|Withdrawal by Subject|1|||
146916409|NCT03596177|529856013|FG000|Double Blind Period|Other|0|||
146916410|NCT03596177|529856014|FG001|Double Blind Period|Other|4|||
146916411|NCT03596177|529856013|FG000|Double Blind Period|Death during safety follow-up|0|||
146916412|NCT03596177|529856014|FG001|Double Blind Period|Death during safety follow-up|1|||
146916413|NCT02566525|529856016|FG000|Overall Study|Protocol Violation|3|||
146916414|NCT02566525|529856017|FG001|Overall Study|Protocol Violation|5|||
146916415|NCT00337467|529856020|FG000|Overall Study|Adverse Event|3|||
146916416|NCT00337467|529856020|FG000|Overall Study|Subject Withdrew Consent|2|||
146916417|NCT00337467|529856020|FG000|Overall Study|Pregnancy|1|||
146916418|NCT00337467|529856020|FG000|Overall Study|Lost to Follow-up|2|||
146916419|NCT00337467|529856020|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
146916420|NCT03141086|529856021|FG000|Overall Study|Study Terminated By Sponsor|1|||
146916421|NCT03141086|529856022|FG001|Overall Study|Study Terminated By Sponsor|1|||
146916422|NCT03141086|529856021|FG000|Overall Study|Withdrawal by Subject|0|||
146916423|NCT03141086|529856022|FG001|Overall Study|Withdrawal by Subject|1|||
146916424|NCT03141086|529856021|FG000|Overall Study|Protocol Violation|0|||
146916425|NCT03141086|529856022|FG001|Overall Study|Protocol Violation|1|||
146916426|NCT03141086|529856021|FG000|Overall Study|Adverse Event|0|||
146916427|NCT03141086|529856022|FG001|Overall Study|Adverse Event|2|||
146916428|NCT04083222|529856024|FG000|Overall Study|Voluntary Withdrawal|0|||
146916429|NCT04083222|529856025|FG001|Overall Study|Voluntary Withdrawal|1|||
146916430|NCT04083222|529856024|FG000|Overall Study|Reason not Specified|0|||
146916431|NCT04083222|529856025|FG001|Overall Study|Reason not Specified|1|||
146916432|NCT04430582|529856026|FG000|Overall Study|Found to meet exclusionary criteria|1|||
146916433|NCT04430582|529856027|FG001|Overall Study|Found to meet exclusionary criteria|0|||
146916434|NCT04430582|529856026|FG000|Overall Study|Withdrawal by Subject|0|||
146916435|NCT04430582|529856027|FG001|Overall Study|Withdrawal by Subject|1|||
146916436|NCT03607682|529856028|FG000|Overall Study|Withdrawal by Subject|1|||
146916437|NCT03607682|529856028|FG000|Overall Study|Disease progression|1|||
146916438|NCT04400318|529857946|FG000|Overall Study|Adverse Event|1|||
146916439|NCT04400318|529857947|FG001|Overall Study|Adverse Event|0|||
146916440|NCT04400318|529857946|FG000|Overall Study|Withdrawal by Subject|1|||
146916441|NCT04400318|529857947|FG001|Overall Study|Withdrawal by Subject|1|||
146916442|NCT04400318|529857946|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
146916443|NCT04400318|529857947|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
146916444|NCT00165646|529857952|FG000|Overall Study|Adverse Event|1|||
146916445|NCT00165646|529857953|FG001|Overall Study|Adverse Event|1|||
146916446|NCT00165646|529857954|FG002|Overall Study|Adverse Event|1|||
146916447|NCT00165646|529857952|FG000|Overall Study|Lack of Efficacy|1|||
146916448|NCT00165646|529857953|FG001|Overall Study|Lack of Efficacy|2|||
146916449|NCT00165646|529857954|FG002|Overall Study|Lack of Efficacy|0|||
146916450|NCT00165646|529857952|FG000|Overall Study|Withdrawal by Subject|0|||
146916451|NCT00165646|529857953|FG001|Overall Study|Withdrawal by Subject|2|||
146916452|NCT00165646|529857954|FG002|Overall Study|Withdrawal by Subject|1|||
146916453|NCT00165646|529857952|FG000|Overall Study|Physician Decision|2|||
146916454|NCT00165646|529857953|FG001|Overall Study|Physician Decision|0|||
146916455|NCT00165646|529857954|FG002|Overall Study|Physician Decision|2|||
146916456|NCT00165646|529857952|FG000|Overall Study|Protocol Violation|1|||
146916457|NCT00165646|529857953|FG001|Overall Study|Protocol Violation|0|||
146916458|NCT00165646|529857954|FG002|Overall Study|Protocol Violation|0|||
146916459|NCT01605071|529857955|FG000|Overall Study|Withdrawal by Subject|3|||
146916460|NCT01605071|529857956|FG001|Overall Study|Withdrawal by Subject|2|||
146916461|NCT00392171|529857957|FG000|Overall Study|Did not meet inclusion criteria|4|||
146916462|NCT00392171|529857957|FG000|Overall Study|Disease progression|101|||
146916463|NCT03470922|529857959|FG000|Overall Study|Death|107|||
146916464|NCT03470922|529857960|FG001|Overall Study|Death|118|||
146916465|NCT03470922|529857959|FG000|Overall Study|Lost to Follow-up|5|||
146916466|NCT03470922|529857960|FG001|Overall Study|Lost to Follow-up|5|||
146916467|NCT03470922|529857959|FG000|Overall Study|Participant Withdrew Consent|4|||
146916468|NCT03470922|529857960|FG001|Overall Study|Participant Withdrew Consent|9|||
146916469|NCT03470922|529857959|FG000|Overall Study|Other reasons|1|||
146916470|NCT03470922|529857960|FG001|Overall Study|Other reasons|0|||
146916471|NCT03470922|529857959|FG000|Overall Study|Not reported|1|||
146916472|NCT03470922|529857960|FG001|Overall Study|Not reported|0|||
146916473|NCT01931462|529857961|FG000|Overall Study|Withdrawal by Subject|1|||
146916474|NCT02819310|529857962|FG000|Overall Study|Withdrawal by Subject|37|||
146916475|NCT02819310|529857962|FG000|Overall Study|Lost to Follow-up|16|||
146916476|NCT02819310|529857962|FG000|Overall Study|Adverse Event|13|||
146916477|NCT02819310|529857962|FG000|Overall Study|Lack of Efficacy|5|||
146916478|NCT02819310|529857962|FG000|Overall Study|Physician Decision|8|||
146916479|NCT02819310|529857962|FG000|Overall Study|Protocol Violation|30|||
146916480|NCT01793051|529857967|FG000|Overall Study|Withdrawal by Subject|6|||
146916481|NCT01793051|529857968|FG001|Overall Study|Withdrawal by Subject|4|||
146916482|NCT01793051|529857967|FG000|Overall Study|Adverse Event|0|||
146916483|NCT01793051|529857968|FG001|Overall Study|Adverse Event|2|||
146916484|NCT01793051|529857967|FG000|Overall Study|Too ill to continue|1|||
146916485|NCT01793051|529857968|FG001|Overall Study|Too ill to continue|0|||
146916486|NCT01793051|529857967|FG000|Overall Study|Switched chemo|1|||
146916487|NCT01793051|529857968|FG001|Overall Study|Switched chemo|1|||
146916488|NCT01793051|529857967|FG000|Overall Study|Lack of compliance|1|||
146916489|NCT01793051|529857968|FG001|Overall Study|Lack of compliance|0|||
146976612|NCT03216954|530077438|FG001|Overall Study|Adverse Event|0|||
146976613|NCT03216954|530077439|FG002|Overall Study|Adverse Event|1|||
146571336|NCT01772550|528602717|FG000|Overall Study|Adverse Event|0|||
146571337|NCT01772550|528602718|FG001|Overall Study|Adverse Event|0|||
146571338|NCT01772550|528602719|FG002|Overall Study|Adverse Event|1|||
146571339|NCT00559104|528602720|FG000|Overall Study|Lack of Efficacy|9|||
146571340|NCT00559104|528602721|FG001|Overall Study|Lack of Efficacy|0|||
146571341|NCT00387088|528602722|FG000|Overall Study|Adverse Event|143|||
146571342|NCT00387088|528602723|FG001|Overall Study|Adverse Event|156|||
146571343|NCT00387088|528602722|FG000|Overall Study|Protocol Violation|47|||
146571344|NCT00387088|528602723|FG001|Overall Study|Protocol Violation|35|||
146571345|NCT00387088|528602722|FG000|Overall Study|Withdrawal by Subject|20|||
146916490|NCT01793051|529857967|FG000|Overall Study|Requested to be removed from the study|1|||
146916491|NCT01793051|529857968|FG001|Overall Study|Requested to be removed from the study|1|||
146916492|NCT00059215|529857970|FG000|Overall Study|Adverse Event|5|||
146916493|NCT00059215|529857971|FG001|Overall Study|Adverse Event|5|||
146916494|NCT00059215|529857972|FG002|Overall Study|Adverse Event|9|||
146916495|NCT00059215|529857973|FG003|Overall Study|Adverse Event|9|||
146916496|NCT00059215|529857970|FG000|Overall Study|Death|0|||
146976614|NCT03216954|530077440|FG003|Overall Study|Adverse Event|0|||
146976615|NCT03216954|530077441|FG004|Overall Study|Adverse Event|1|||
146571346|NCT00387088|528602723|FG001|Overall Study|Withdrawal by Subject|35|||
146571347|NCT00387088|528602722|FG000|Overall Study|Lack of Efficacy|28|||
146650725|NCT00775203|528898094|FG000|Overall Study|Withdrawal by Subject|11|||
146650726|NCT00775203|528898095|FG001|Overall Study|Withdrawal by Subject|9|||
146650727|NCT00775203|528898094|FG000|Overall Study|Lost to Follow-up|11|||
146650728|NCT00775203|528898095|FG001|Overall Study|Lost to Follow-up|15|||
146650729|NCT00775203|528898094|FG000|Overall Study|Administrative reason|2|||
146650730|NCT00775203|528898095|FG001|Overall Study|Administrative reason|0|||
146650731|NCT00775203|528898094|FG000|Overall Study|Noncompliance|4|||
146650732|NCT00775203|528898095|FG001|Overall Study|Noncompliance|2|||
146650733|NCT00775203|528898094|FG000|Overall Study|Protocol Violation|0|||
146650734|NCT00775203|528898095|FG001|Overall Study|Protocol Violation|1|||
146650735|NCT00775203|528898094|FG000|Overall Study|Entered other study|1|||
146650736|NCT00775203|528898095|FG001|Overall Study|Entered other study|0|||
146650737|NCT00775203|528898094|FG000|Overall Study|Physician Decision|0|||
146650738|NCT00775203|528898095|FG001|Overall Study|Physician Decision|1|||
146650739|NCT00704522|528898096|FG000|Overall Study|Lack of Efficacy|65|||
146650740|NCT00704522|528898097|FG001|Overall Study|Lack of Efficacy|17|||
146650741|NCT00704522|528898096|FG000|Overall Study|Failure to appear again at hospital|56|||
146650742|NCT00704522|528898097|FG001|Overall Study|Failure to appear again at hospital|10|||
146650743|NCT00704522|528898096|FG000|Overall Study|Withdrawal by Subject|17|||
146650744|NCT00704522|528898097|FG001|Overall Study|Withdrawal by Subject|8|||
146650745|NCT00704522|528898096|FG000|Overall Study|Adverse Event|9|||
146650746|NCT00704522|528898097|FG001|Overall Study|Adverse Event|1|||
146650747|NCT00704522|528898096|FG000|Overall Study|Undefined causes|9|||
146650748|NCT00704522|528898097|FG001|Overall Study|Undefined causes|7|||
146650749|NCT00704522|528898096|FG000|Overall Study|No information on therapy end|27|||
146650750|NCT00704522|528898097|FG001|Overall Study|No information on therapy end|2|||
146650751|NCT04896229|528898099|FG000|Overall Study|Lost to Follow-up|113|||
146650752|NCT04896229|528898100|FG001|Overall Study|Lost to Follow-up|113|||
146650753|NCT04395001|528898101|FG000|Overall Study|Lost to Follow-up|8|||
146650754|NCT04395001|528898102|FG001|Overall Study|Lost to Follow-up|9|||
146650755|NCT04395001|528898103|FG002|Overall Study|Lost to Follow-up|5|||
146650756|NCT04395001|528898101|FG000|Overall Study|Withdrawal by Subject|3|||
146650757|NCT04395001|528898102|FG001|Overall Study|Withdrawal by Subject|1|||
146650758|NCT04395001|528898103|FG002|Overall Study|Withdrawal by Subject|3|||
146650759|NCT04395001|528898101|FG000|Overall Study|missed appointment|7|||
146650760|NCT04395001|528898102|FG001|Overall Study|missed appointment|4|||
146650761|NCT04395001|528898103|FG002|Overall Study|missed appointment|1|||
146650762|NCT04418661|528898104|FG000|Overall Study|Adverse Event|0|||
146650763|NCT04418661|528898105|FG001|Overall Study|Adverse Event|1|||
146650764|NCT04418661|528898106|FG002|Overall Study|Adverse Event|5|||
146650765|NCT04418661|528898107|FG003|Overall Study|Adverse Event|3|||
146650766|NCT04418661|528898108|FG004|Overall Study|Adverse Event|0|||
146650767|NCT04418661|528898109|FG005|Overall Study|Adverse Event|2|||
146650768|NCT04418661|528898104|FG000|Overall Study|Progressive disease|4|||
146650769|NCT04418661|528898105|FG001|Overall Study|Progressive disease|11|||
146650770|NCT04418661|528898106|FG002|Overall Study|Progressive disease|6|||
146650771|NCT04418661|528898107|FG003|Overall Study|Progressive disease|11|||
146650772|NCT04418661|528898108|FG004|Overall Study|Progressive disease|1|||
146650773|NCT04418661|528898109|FG005|Overall Study|Progressive disease|12|||
146650774|NCT04418661|528898104|FG000|Overall Study|Withdrawal by Subject|0|||
146650775|NCT04418661|528898105|FG001|Overall Study|Withdrawal by Subject|1|||
146650776|NCT04418661|528898106|FG002|Overall Study|Withdrawal by Subject|0|||
146650777|NCT04418661|528898107|FG003|Overall Study|Withdrawal by Subject|1|||
146650778|NCT04418661|528898108|FG004|Overall Study|Withdrawal by Subject|0|||
146650779|NCT04418661|528898109|FG005|Overall Study|Withdrawal by Subject|0|||
146650780|NCT04418661|528898104|FG000|Overall Study|Other|0|||
146650781|NCT04418661|528898105|FG001|Overall Study|Other|0|||
146650782|NCT04418661|528898106|FG002|Overall Study|Other|1|||
146650783|NCT04418661|528898107|FG003|Overall Study|Other|3|||
146650784|NCT04418661|528898108|FG004|Overall Study|Other|0|||
146650785|NCT04418661|528898109|FG005|Overall Study|Other|1|||
146650786|NCT00329901|528898113|FG000|Overall Study|Withdrawal by Subject|4|||
146650787|NCT00329901|528898114|FG001|Overall Study|Withdrawal by Subject|3|||
146650788|NCT00329901|528898115|FG002|Overall Study|Withdrawal by Subject|2|||
146650789|NCT00329901|528898113|FG000|Overall Study|Lost to Follow-up|2|||
146650790|NCT00329901|528898114|FG001|Overall Study|Lost to Follow-up|0|||
146650791|NCT00329901|528898115|FG002|Overall Study|Lost to Follow-up|1|||
146650792|NCT00329901|528898113|FG000|Overall Study|Protocol Violation|1|||
146650793|NCT00329901|528898114|FG001|Overall Study|Protocol Violation|0|||
146650794|NCT00329901|528898115|FG002|Overall Study|Protocol Violation|1|||
146650795|NCT00329901|528898113|FG000|Overall Study|Unable to classify|2|||
146650796|NCT00329901|528898114|FG001|Overall Study|Unable to classify|2|||
146650797|NCT00329901|528898115|FG002|Overall Study|Unable to classify|0|||
146650798|NCT00992589|528898116|FG000|Open-Label Phase|Adverse Event|4|||
146650799|NCT00992589|528898117|FG001|Open-Label Phase|Adverse Event|0|||
146650800|NCT00992589|528898118|FG002|Open-Label Phase|Adverse Event|0|||
146650801|NCT00992589|528898119|FG003|Open-Label Phase|Adverse Event|0|||
146650802|NCT00992589|528898116|FG000|Open-Label Phase|Withdrawal by Subject|20|||
146650803|NCT00992589|528898117|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146976616|NCT03216954|530077437|FG000|Overall Study|Withdrawal by Subject|2|||
146976617|NCT03216954|530077438|FG001|Overall Study|Withdrawal by Subject|0|||
146976618|NCT03216954|530077439|FG002|Overall Study|Withdrawal by Subject|0|||
146976619|NCT03216954|530077440|FG003|Overall Study|Withdrawal by Subject|0|||
146976620|NCT03216954|530077441|FG004|Overall Study|Withdrawal by Subject|0|||
146976621|NCT03216954|530077437|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
146976622|NCT03216954|530077438|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
146976623|NCT03216954|530077439|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
146976624|NCT03216954|530077440|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
146976625|NCT03216954|530077441|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
146976626|NCT01238822|530077444|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
146976627|NCT05180630|530077445|FG000|First Intervention|Physician Decision|0|||
146976628|NCT05180630|530077446|FG001|First Intervention|Physician Decision|0|||
146976629|NCT05180630|530077447|FG002|First Intervention|Physician Decision|3|||
146976630|NCT00709735|530077450|FG000|Overall Study|Lost to Follow-up|1|||
146976631|NCT00709735|530077451|FG001|Overall Study|Lost to Follow-up|1|||
146976632|NCT00709735|530077450|FG000|Overall Study|Relapse into Opioid Abuse|0|||
146976633|NCT00709735|530077451|FG001|Overall Study|Relapse into Opioid Abuse|1|||
146976634|NCT00709735|530077450|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
146976635|NCT00709735|530077451|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
146976636|NCT00849524|530077454|FG000|Overall Study|Lack of Efficacy|3|||
146976637|NCT01027884|530077457|FG000|Overall Study|Adverse Event|2|||
146976638|NCT01027884|530077458|FG001|Overall Study|Adverse Event|1|||
146976639|NCT01027884|530077457|FG000|Overall Study|Protocol Violation|1|||
146976640|NCT01027884|530077458|FG001|Overall Study|Protocol Violation|0|||
146976641|NCT01027884|530077457|FG000|Overall Study|Non-compliance|1|||
146976642|NCT01027884|530077458|FG001|Overall Study|Non-compliance|1|||
146976643|NCT01027884|530077457|FG000|Overall Study|Withdrawal by Subject|0|||
146976644|NCT01027884|530077458|FG001|Overall Study|Withdrawal by Subject|1|||
146976645|NCT01027884|530077457|FG000|Overall Study|Lost to Follow-up|0|||
146976646|NCT01027884|530077458|FG001|Overall Study|Lost to Follow-up|1|||
146976647|NCT01027884|530077457|FG000|Overall Study|Spinal fixation surgery|0|||
146976648|NCT01027884|530077458|FG001|Overall Study|Spinal fixation surgery|3|||
146976649|NCT03636542|530077459|FG000|Overall Study|Lost to Follow-up|1|||
146976650|NCT03636542|530077460|FG001|Overall Study|Lost to Follow-up|1|||
146976651|NCT03636542|530077459|FG000|Overall Study|Physician Decision|0|||
146976652|NCT03636542|530077460|FG001|Overall Study|Physician Decision|1|||
146976653|NCT03636542|530077459|FG000|Overall Study|Withdrawal by Subject|1|||
146976654|NCT03636542|530077460|FG001|Overall Study|Withdrawal by Subject|0|||
146976655|NCT02059187|530077461|FG000|Overall Study|Adverse Event|0|||
146976656|NCT02059187|530077462|FG001|Overall Study|Adverse Event|3|||
146976657|NCT02059187|530077461|FG000|Overall Study|Death|1|||
146976658|NCT02059187|530077462|FG001|Overall Study|Death|1|||
146976659|NCT02059187|530077461|FG000|Overall Study|Lost to Follow-up|9|||
146976660|NCT02059187|530077462|FG001|Overall Study|Lost to Follow-up|8|||
146976661|NCT02059187|530077461|FG000|Overall Study|Non-compliance with study drug|1|||
146976662|NCT02059187|530077462|FG001|Overall Study|Non-compliance with study drug|0|||
146976663|NCT02059187|530077461|FG000|Overall Study|Physician Decision|1|||
146976664|NCT02059187|530077462|FG001|Overall Study|Physician Decision|2|||
146976665|NCT02059187|530077461|FG000|Overall Study|Protocol Violation|1|||
146976666|NCT02059187|530077462|FG001|Overall Study|Protocol Violation|0|||
146976667|NCT02059187|530077461|FG000|Overall Study|Withdrawal by Subject|12|||
146976668|NCT02059187|530077462|FG001|Overall Study|Withdrawal by Subject|8|||
146976669|NCT02624518|530077463|FG000|Overall Study|Physician Decision|1|||
146976670|NCT02729194|530077464|FG000|Overall Study|Withdrawal by Subject|3|||
146976671|NCT00845026|530077465|FG000|Study Period III|Adverse Event|23|||
146976672|NCT00845026|530077466|FG001|Study Period III|Adverse Event|19|||
146976673|NCT00845026|530077465|FG000|Study Period III|Perceived lack of efficacy|27|||
146976674|NCT00845026|530077466|FG001|Study Period III|Perceived lack of efficacy|15|||
146976675|NCT00845026|530077465|FG000|Study Period III|Withdrawal by Subject|19|||
146976676|NCT00845026|530077466|FG001|Study Period III|Withdrawal by Subject|15|||
146571348|NCT00387088|528602723|FG001|Overall Study|Lack of Efficacy|67|||
146770535|NCT03779048|529328610|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
146976677|NCT00845026|530077465|FG000|Study Period III|Entry Criteria not met|8|||
146976678|NCT00845026|530077466|FG001|Study Period III|Entry Criteria not met|11|||
146976679|NCT00845026|530077465|FG000|Study Period III|Lost to Follow-up|4|||
146976680|NCT00845026|530077466|FG001|Study Period III|Lost to Follow-up|5|||
146976681|NCT00845026|530077465|FG000|Study Period III|Protocol Violation|8|||
146976682|NCT00845026|530077466|FG001|Study Period III|Protocol Violation|1|||
146976683|NCT00845026|530077465|FG000|Study Period III|Scheduled conflict|3|||
146976684|NCT00845026|530077466|FG001|Study Period III|Scheduled conflict|1|||
146976685|NCT00845026|530077465|FG000|Study Period III|Subject is moving or has moved|2|||
146976686|NCT00845026|530077466|FG001|Study Period III|Subject is moving or has moved|4|||
146571349|NCT00387088|528602722|FG000|Overall Study|Lost to Follow-up|22|||
146509680|NCT02326298|528369022|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146650804|NCT00992589|528898118|FG002|Open-Label Phase|Withdrawal by Subject|0|||
146650805|NCT00992589|528898119|FG003|Open-Label Phase|Withdrawal by Subject|0|||
146650806|NCT00992589|528898116|FG000|Open-Label Phase|Lost to Follow-up|1|||
146650807|NCT00992589|528898117|FG001|Open-Label Phase|Lost to Follow-up|0|||
146650808|NCT00992589|528898118|FG002|Open-Label Phase|Lost to Follow-up|0|||
146650809|NCT00992589|528898119|FG003|Open-Label Phase|Lost to Follow-up|0|||
146650810|NCT00992589|528898116|FG000|Open-Label Phase|Protocol Violation|3|||
146650811|NCT00992589|528898117|FG001|Open-Label Phase|Protocol Violation|0|||
146650812|NCT00992589|528898118|FG002|Open-Label Phase|Protocol Violation|0|||
146650813|NCT00992589|528898119|FG003|Open-Label Phase|Protocol Violation|0|||
146650814|NCT00992589|528898116|FG000|Open-Label Phase|Physician Decision|4|||
146650815|NCT00992589|528898117|FG001|Open-Label Phase|Physician Decision|0|||
146650816|NCT00992589|528898118|FG002|Open-Label Phase|Physician Decision|0|||
146650817|NCT00992589|528898119|FG003|Open-Label Phase|Physician Decision|0|||
146650818|NCT00992589|528898116|FG000|Open-Label Phase|Other|45|||
146650819|NCT00992589|528898117|FG001|Open-Label Phase|Other|0|||
146650820|NCT00992589|528898118|FG002|Open-Label Phase|Other|0|||
146650821|NCT00992589|528898119|FG003|Open-Label Phase|Other|0|||
146650822|NCT00992589|528898116|FG000|Double-Blind Phase|Adverse Event|0|||
146650823|NCT00992589|528898117|FG001|Double-Blind Phase|Adverse Event|6|||
146650824|NCT00992589|528898118|FG002|Double-Blind Phase|Adverse Event|2|||
146650825|NCT00992589|528898119|FG003|Double-Blind Phase|Adverse Event|3|||
146650826|NCT00992589|528898116|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
146650827|NCT00992589|528898117|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
146650828|NCT00992589|528898118|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
146650829|NCT00992589|528898119|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
146650830|NCT00992589|528898116|FG000|Double-Blind Phase|Lost to Follow-up|0|||
146650831|NCT00992589|528898117|FG001|Double-Blind Phase|Lost to Follow-up|0|||
146650832|NCT00992589|528898118|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146650833|NCT00992589|528898119|FG003|Double-Blind Phase|Lost to Follow-up|2|||
146650834|NCT00992589|528898116|FG000|Double-Blind Phase|Other|0|||
146650835|NCT00992589|528898117|FG001|Double-Blind Phase|Other|1|||
146650836|NCT00992589|528898118|FG002|Double-Blind Phase|Other|6|||
146650837|NCT00992589|528898119|FG003|Double-Blind Phase|Other|3|||
146650838|NCT00045942|528898120|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
146650839|NCT00045942|528898121|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
146650840|NCT00045942|528898122|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
146650841|NCT00045942|528898123|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
146650842|NCT00045942|528898124|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
146650843|NCT00045942|528898125|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
146650844|NCT00045942|528898126|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
146650845|NCT00045942|528898127|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
146650846|NCT00045942|528898128|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
146650847|NCT00045942|528898120|FG000|PKC412A2104 (Core)|Adverse Event|5|||
146650848|NCT00045942|528898121|FG001|PKC412A2104 (Core)|Adverse Event|0|||
146650849|NCT00045942|528898122|FG002|PKC412A2104 (Core)|Adverse Event|0|||
146650850|NCT00045942|528898123|FG003|PKC412A2104 (Core)|Adverse Event|0|||
146650851|NCT00045942|528898124|FG004|PKC412A2104 (Core)|Adverse Event|0|||
146650852|NCT00045942|528898125|FG005|PKC412A2104 (Core)|Adverse Event|0|||
146650853|NCT00045942|528898126|FG006|PKC412A2104 (Core)|Adverse Event|0|||
146650854|NCT00045942|528898127|FG007|PKC412A2104 (Core)|Adverse Event|0|||
146650855|NCT00045942|528898128|FG008|PKC412A2104 (Core)|Adverse Event|0|||
146650856|NCT00045942|528898120|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
146650857|NCT00045942|528898121|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
146650858|NCT00045942|528898122|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
146650859|NCT00045942|528898123|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
146650860|NCT00045942|528898124|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
146650861|NCT00045942|528898125|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
146650862|NCT00045942|528898126|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
146916497|NCT00059215|529857971|FG001|Overall Study|Death|0|||
146916498|NCT00059215|529857972|FG002|Overall Study|Death|3|||
146916499|NCT00059215|529857973|FG003|Overall Study|Death|0|||
146916500|NCT00059215|529857970|FG000|Overall Study|Lost to Follow-up|1|||
146916501|NCT00059215|529857971|FG001|Overall Study|Lost to Follow-up|2|||
146916502|NCT00059215|529857972|FG002|Overall Study|Lost to Follow-up|0|||
146916503|NCT00059215|529857973|FG003|Overall Study|Lost to Follow-up|0|||
146916504|NCT00059215|529857970|FG000|Overall Study|Withdrawal by Subject|4|||
146916505|NCT00059215|529857971|FG001|Overall Study|Withdrawal by Subject|4|||
146650863|NCT00045942|528898127|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
146650864|NCT00045942|528898128|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
146650865|NCT00045942|528898120|FG000|PKC412A2104 (Core)|Death|1|||
146650866|NCT00045942|528898121|FG001|PKC412A2104 (Core)|Death|0|||
146650867|NCT00045942|528898122|FG002|PKC412A2104 (Core)|Death|0|||
146650868|NCT00045942|528898123|FG003|PKC412A2104 (Core)|Death|0|||
146650869|NCT00045942|528898124|FG004|PKC412A2104 (Core)|Death|0|||
146650870|NCT00045942|528898125|FG005|PKC412A2104 (Core)|Death|0|||
146650871|NCT00045942|528898126|FG006|PKC412A2104 (Core)|Death|0|||
146916506|NCT00059215|529857972|FG002|Overall Study|Withdrawal by Subject|1|||
146976687|NCT00845026|530077465|FG000|Study Period III|Transportation issues|1|||
146976688|NCT00845026|530077466|FG001|Study Period III|Transportation issues|1|||
146976689|NCT00845026|530077465|FG000|Study Period IV|Adverse Event|4|||
146976690|NCT00845026|530077466|FG001|Study Period IV|Adverse Event|0|||
146976691|NCT00845026|530077465|FG000|Study Period IV|Perceived lack of efficacy|2|||
146976692|NCT00845026|530077466|FG001|Study Period IV|Perceived lack of efficacy|1|||
146976693|NCT00845026|530077465|FG000|Study Period IV|Protocol Violation|3|||
146976694|NCT00845026|530077466|FG001|Study Period IV|Protocol Violation|1|||
146976695|NCT00845026|530077465|FG000|Study Period IV|Lost to Follow-up|1|||
146976696|NCT00845026|530077466|FG001|Study Period IV|Lost to Follow-up|0|||
146976697|NCT00845026|530077465|FG000|Study Period IV|Withdrawal by Subject|4|||
146976698|NCT00845026|530077466|FG001|Study Period IV|Withdrawal by Subject|1|||
146976699|NCT00845026|530077465|FG000|Study Period IV|Entry Criteria Not Met|1|||
146976700|NCT00845026|530077466|FG001|Study Period IV|Entry Criteria Not Met|0|||
146976701|NCT00845026|530077465|FG000|Study Period IV|Subject is moving or has moved|0|||
146976702|NCT00845026|530077466|FG001|Study Period IV|Subject is moving or has moved|1|||
146976703|NCT00845026|530077465|FG000|Study Period IV|Scheduling conflict|1|||
146976704|NCT00845026|530077466|FG001|Study Period IV|Scheduling conflict|0|||
146976705|NCT03012815|530077467|FG000|Overall Study|Lost to Follow-up|1|||
146976706|NCT03012815|530077468|FG001|Overall Study|Lost to Follow-up|0|||
146976707|NCT03012815|530077467|FG000|Overall Study|Physician Decision|3|||
146976708|NCT03012815|530077468|FG001|Overall Study|Physician Decision|2|||
146976709|NCT03012815|530077467|FG000|Overall Study|Adverse Event|1|||
146976710|NCT03012815|530077468|FG001|Overall Study|Adverse Event|0|||
146976711|NCT01462695|530077469|FG000|Overall Study|Adverse Event|1|||
146976712|NCT01462695|530077470|FG001|Overall Study|Adverse Event|1|||
146976713|NCT01462695|530077469|FG000|Overall Study|Death|2|||
146976714|NCT01462695|530077470|FG001|Overall Study|Death|0|||
146976715|NCT01462695|530077469|FG000|Overall Study|Lack of Efficacy|6|||
146976716|NCT01462695|530077470|FG001|Overall Study|Lack of Efficacy|12|||
146976717|NCT01462695|530077469|FG000|Overall Study|Physician Decision|5|||
146976718|NCT01462695|530077470|FG001|Overall Study|Physician Decision|0|||
146976719|NCT01462695|530077469|FG000|Overall Study|Withdrawal by Subject|2|||
146976720|NCT01462695|530077470|FG001|Overall Study|Withdrawal by Subject|0|||
146976721|NCT01462695|530077469|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
146976722|NCT01462695|530077470|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
146976723|NCT00879970|530077471|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
146976724|NCT00879970|530077472|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
146976725|NCT00879970|530077473|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
146976726|NCT00879970|530077474|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
146976727|NCT00879970|530077475|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
146976728|NCT00879970|530077471|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
146976729|NCT00879970|530077472|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
146976730|NCT00879970|530077473|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
146976731|NCT00879970|530077474|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
146976732|NCT00879970|530077475|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
146976733|NCT00879970|530077471|FG000|Period 1 TZD Randomization|Death|2|||
146976734|NCT00879970|530077472|FG001|Period 1 TZD Randomization|Death|1|||
146976735|NCT00879970|530077473|FG002|Period 1 TZD Randomization|Death|0|||
146976736|NCT00879970|530077474|FG003|Period 1 TZD Randomization|Death|0|||
146976737|NCT00879970|530077475|FG004|Period 1 TZD Randomization|Death|0|||
146976738|NCT00879970|530077471|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
146976739|NCT00879970|530077472|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
146976740|NCT00879970|530077473|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
146976741|NCT00879970|530077474|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
146976742|NCT00879970|530077475|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
146976743|NCT00879970|530077471|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
146976744|NCT00879970|530077472|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
146976745|NCT00879970|530077473|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
146976746|NCT00879970|530077474|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
146976747|NCT00879970|530077475|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
146770536|NCT03779048|529328611|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
146770537|NCT00465816|529328612|FG000|Overall Study|Lost to Follow-up|0|||
146976748|NCT00879970|530077471|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
146976749|NCT00879970|530077472|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
146976750|NCT00879970|530077473|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
146976751|NCT00879970|530077474|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
146976752|NCT00879970|530077475|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
146976753|NCT00879970|530077471|FG000|Period 2 Vitamin D Randomization|Death|0|||
146770538|NCT00465816|529328613|FG001|Overall Study|Lost to Follow-up|0|||
146976754|NCT00879970|530077472|FG001|Period 2 Vitamin D Randomization|Death|0|||
146976755|NCT00879970|530077473|FG002|Period 2 Vitamin D Randomization|Death|0|||
146976756|NCT00879970|530077474|FG003|Period 2 Vitamin D Randomization|Death|2|||
146976757|NCT00879970|530077475|FG004|Period 2 Vitamin D Randomization|Death|0|||
146976758|NCT00558519|530077476|FG000|Overall Study|Ph+|20|||
146976759|NCT00558519|530077476|FG000|Overall Study|Ineligible|1|||
146976760|NCT00558519|530077476|FG000|Overall Study|Insufficient data|1|||
146976761|NCT00558519|530077476|FG000|Overall Study|Never received treatment|1|||
146976762|NCT02556632|530077481|FG000|Overall Study|Lost to Follow-up|1|||
146976763|NCT02556632|530077482|FG001|Overall Study|Lost to Follow-up|0|||
146976764|NCT02556632|530077483|FG002|Overall Study|Lost to Follow-up|0|||
146976765|NCT02556632|530077481|FG000|Overall Study|Disliked Intervention|1|||
146976766|NCT02556632|530077482|FG001|Overall Study|Disliked Intervention|1|||
146976767|NCT02556632|530077483|FG002|Overall Study|Disliked Intervention|1|||
146976768|NCT02556632|530077481|FG000|Overall Study|No Reason|1|||
146976769|NCT02556632|530077482|FG001|Overall Study|No Reason|0|||
146976770|NCT02556632|530077483|FG002|Overall Study|No Reason|1|||
146976771|NCT02556632|530077481|FG000|Overall Study|Personal Issues|0|||
146976772|NCT02556632|530077482|FG001|Overall Study|Personal Issues|1|||
146976773|NCT02556632|530077483|FG002|Overall Study|Personal Issues|1|||
146976774|NCT02556632|530077481|FG000|Overall Study|Changed Mind|0|||
146976775|NCT02556632|530077482|FG001|Overall Study|Changed Mind|1|||
146976776|NCT02556632|530077483|FG002|Overall Study|Changed Mind|0|||
146976777|NCT02556632|530077481|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
146976778|NCT02556632|530077482|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
146976779|NCT02556632|530077483|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
146976780|NCT02556632|530077481|FG000|Overall Study|Unrelated Adverse Event|1|||
146976781|NCT02556632|530077482|FG001|Overall Study|Unrelated Adverse Event|0|||
146976782|NCT02556632|530077483|FG002|Overall Study|Unrelated Adverse Event|3|||
146976783|NCT02556632|530077481|FG000|Overall Study|Related Adverse Event|0|||
146976784|NCT02556632|530077482|FG001|Overall Study|Related Adverse Event|1|||
146976785|NCT02556632|530077483|FG002|Overall Study|Related Adverse Event|0|||
146976786|NCT02556632|530077481|FG000|Overall Study|Possibly Related Adverse Event|0|||
146976787|NCT02556632|530077482|FG001|Overall Study|Possibly Related Adverse Event|0|||
146976788|NCT02556632|530077483|FG002|Overall Study|Possibly Related Adverse Event|1|||
146976789|NCT02556632|530077481|FG000|Overall Study|Did Not Start RT|0|||
146976790|NCT02556632|530077482|FG001|Overall Study|Did Not Start RT|1|||
146976791|NCT02556632|530077483|FG002|Overall Study|Did Not Start RT|0|||
146976792|NCT02556632|530077481|FG000|Overall Study|Ineligible|0|||
146976793|NCT02556632|530077482|FG001|Overall Study|Ineligible|1|||
146976794|NCT02556632|530077483|FG002|Overall Study|Ineligible|0|||
146976795|NCT02556632|530077481|FG000|Overall Study|Disliked Study Procedures|0|||
146976796|NCT02556632|530077482|FG001|Overall Study|Disliked Study Procedures|0|||
146976797|NCT02556632|530077483|FG002|Overall Study|Disliked Study Procedures|1|||
146976798|NCT02556632|530077481|FG000|Overall Study|Treatment or Change Delay|0|||
146976799|NCT02556632|530077482|FG001|Overall Study|Treatment or Change Delay|0|||
146976800|NCT02556632|530077483|FG002|Overall Study|Treatment or Change Delay|1|||
146976801|NCT00808015|530077484|FG000|Overall Study|Death|1|||
146976802|NCT00808015|530077484|FG000|Overall Study|Lack of Efficacy|58|||
146976803|NCT00808015|530077484|FG000|Overall Study|Lost to Follow-up|76|||
146976804|NCT00808015|530077484|FG000|Overall Study|Participants not willing to participate|158|||
146976805|NCT00808015|530077484|FG000|Overall Study|Adverse Event|22|||
146976806|NCT00808015|530077484|FG000|Overall Study|Other|25|||
146976807|NCT00808015|530077484|FG000|Overall Study|Enrolled but not treated|4|||
146976808|NCT04556838|530077490|FG000|Overall Study|Withdrawal by Subject|3|||
146976809|NCT04556838|530077491|FG001|Overall Study|Withdrawal by Subject|1|||
146976810|NCT04556838|530077492|FG002|Overall Study|Withdrawal by Subject|2|||
146976811|NCT04556838|530077490|FG000|Overall Study|Adverse Event|0|||
146976812|NCT04556838|530077491|FG001|Overall Study|Adverse Event|1|||
146976813|NCT04556838|530077492|FG002|Overall Study|Adverse Event|1|||
146976814|NCT04556838|530077490|FG000|Overall Study|Lost to Follow-up|0|||
146976815|NCT04556838|530077491|FG001|Overall Study|Lost to Follow-up|0|||
146976816|NCT04556838|530077492|FG002|Overall Study|Lost to Follow-up|2|||
146976817|NCT04556838|530077490|FG000|Overall Study|Subject travel|0|||
146976818|NCT04556838|530077491|FG001|Overall Study|Subject travel|1|||
146976819|NCT04556838|530077492|FG002|Overall Study|Subject travel|0|||
146976820|NCT04556838|530077490|FG000|Overall Study|Physician Decision|1|||
146976821|NCT04556838|530077491|FG001|Overall Study|Physician Decision|0|||
146976822|NCT04556838|530077492|FG002|Overall Study|Physician Decision|0|||
146976823|NCT04523831|530077493|FG000|Overall Study|Lost to Follow-up|15|||
146976824|NCT04523831|530077494|FG001|Overall Study|Lost to Follow-up|17|||
146976825|NCT04523831|530077493|FG000|Overall Study|Death|0|||
146976826|NCT04523831|530077494|FG001|Overall Study|Death|3|||
146976827|NCT04523831|530077493|FG000|Overall Study|Adverse Event|2|||
146976828|NCT04523831|530077494|FG001|Overall Study|Adverse Event|0|||
146976829|NCT00995930|530077495|FG000|Overall Study|Protocol deviation|2|||
146976830|NCT00995930|530077496|FG001|Overall Study|Protocol deviation|5|||
146976831|NCT00995930|530077495|FG000|Overall Study|Death|0|||
146976832|NCT00995930|530077496|FG001|Overall Study|Death|1|||
146976833|NCT00995930|530077495|FG000|Overall Study|Administrative problems|4|||
146976834|NCT00995930|530077496|FG001|Overall Study|Administrative problems|2|||
146976835|NCT00995930|530077495|FG000|Overall Study|Lost to Follow-up|1|||
146650872|NCT00045942|528898127|FG007|PKC412A2104 (Core)|Death|0|||
146650873|NCT00045942|528898128|FG008|PKC412A2104 (Core)|Death|0|||
146916507|NCT00059215|529857973|FG003|Overall Study|Withdrawal by Subject|3|||
146916508|NCT00059215|529857970|FG000|Overall Study|Protocol Violation|1|||
146916509|NCT00059215|529857971|FG001|Overall Study|Protocol Violation|0|||
146916510|NCT00059215|529857972|FG002|Overall Study|Protocol Violation|1|||
146916511|NCT00059215|529857973|FG003|Overall Study|Protocol Violation|0|||
146916512|NCT00059215|529857970|FG000|Overall Study|Protocol entry criteria not met|1|||
146916513|NCT00059215|529857971|FG001|Overall Study|Protocol entry criteria not met|1|||
146916514|NCT00059215|529857972|FG002|Overall Study|Protocol entry criteria not met|0|||
146916515|NCT00059215|529857973|FG003|Overall Study|Protocol entry criteria not met|2|||
146916516|NCT00059215|529857970|FG000|Overall Study|Physician Decision|1|||
146916517|NCT00059215|529857971|FG001|Overall Study|Physician Decision|2|||
146916518|NCT00059215|529857972|FG002|Overall Study|Physician Decision|1|||
146916519|NCT00059215|529857973|FG003|Overall Study|Physician Decision|1|||
146916520|NCT04494633|529857978|FG000|Overall Study|Lost to Follow-up|5|||
146916521|NCT04494633|529857979|FG001|Overall Study|Lost to Follow-up|3|||
146916522|NCT04494633|529857978|FG000|Overall Study|Protocol Violation|1|||
146916523|NCT04494633|529857979|FG001|Overall Study|Protocol Violation|1|||
146916524|NCT04907539|529857980|FG000|Overall Study|Consent withdrawn|1|||
146916525|NCT04907539|529857981|FG001|Overall Study|Consent withdrawn|0|||
146916526|NCT04907539|529857980|FG000|Overall Study|Death|14|||
146916527|NCT04907539|529857981|FG001|Overall Study|Death|3|||
146916528|NCT01881620|529857984|FG000|Overall Study|Protocol Violation|4|||
146916529|NCT00414310|529857987|FG000|Overall Study|Not treated|1|||
146916530|NCT00414310|529857988|FG001|Overall Study|Not treated|0|||
146916531|NCT01808118|529857989|FG000|Period 1|Adverse Event|15|||
146916532|NCT01808118|529857990|FG001|Period 1|Adverse Event|0|||
146916533|NCT01808118|529857991|FG002|Period 1|Adverse Event|0|||
146916534|NCT01808118|529857989|FG000|Period 1|Withdrew consent|24|||
146916535|NCT01808118|529857990|FG001|Period 1|Withdrew consent|0|||
146916536|NCT01808118|529857991|FG002|Period 1|Withdrew consent|0|||
146916537|NCT01808118|529857989|FG000|Period 1|Lost to Follow-up|9|||
146916538|NCT01808118|529857990|FG001|Period 1|Lost to Follow-up|0|||
146916539|NCT01808118|529857991|FG002|Period 1|Lost to Follow-up|0|||
146916540|NCT01808118|529857989|FG000|Period 1|Did not meet criteria for remission|303|||
146916541|NCT01808118|529857990|FG001|Period 1|Did not meet criteria for remission|0|||
146916542|NCT01808118|529857991|FG002|Period 1|Did not meet criteria for remission|0|||
146916543|NCT01808118|529857989|FG000|Period 1|Enrolled in error|7|||
146916544|NCT01808118|529857990|FG001|Period 1|Enrolled in error|0|||
146916545|NCT01808118|529857991|FG002|Period 1|Enrolled in error|0|||
146916546|NCT01808118|529857989|FG000|Period 1|Did not meet inclusion criteria|3|||
146916547|NCT01808118|529857990|FG001|Period 1|Did not meet inclusion criteria|0|||
146916548|NCT01808118|529857991|FG002|Period 1|Did not meet inclusion criteria|0|||
146916549|NCT01808118|529857989|FG000|Period 1|Non-conformance with inclusion criteria|3|||
146916550|NCT01808118|529857990|FG001|Period 1|Non-conformance with inclusion criteria|0|||
146916551|NCT01808118|529857991|FG002|Period 1|Non-conformance with inclusion criteria|0|||
146916552|NCT01808118|529857989|FG000|Period 1|Investigator decision: site closure|2|||
146916553|NCT01808118|529857990|FG001|Period 1|Investigator decision: site closure|0|||
146916554|NCT01808118|529857991|FG002|Period 1|Investigator decision: site closure|0|||
146916555|NCT01808118|529857989|FG000|Period 1|Non-compliance per sponsor|1|||
146976836|NCT00995930|530077496|FG001|Overall Study|Lost to Follow-up|2|||
146976837|NCT00995930|530077495|FG000|Overall Study|Withdrawal by Subject|3|||
146571350|NCT00387088|528602723|FG001|Overall Study|Lost to Follow-up|28|||
146571351|NCT00387088|528602722|FG000|Overall Study|Other|58|||
146571352|NCT00387088|528602723|FG001|Overall Study|Other|52|||
146571353|NCT02897115|528602728|FG000|Overall Study|Early termination of study by sponsor|11|||
146571354|NCT02897115|528602729|FG001|Overall Study|Early termination of study by sponsor|8|||
146571355|NCT03432494|528602735|FG000|Overall Study|Death|1|||
146571356|NCT03432494|528602735|FG000|Overall Study|Noncompliance|1|||
146571357|NCT00856635|528602736|FG000|Overall Study|Lost to Follow-up|2|||
146571358|NCT00856635|528602737|FG001|Overall Study|Lost to Follow-up|5|||
146571359|NCT00856635|528602736|FG000|Overall Study|Pregnancy|1|||
146571360|NCT00856635|528602737|FG001|Overall Study|Pregnancy|0|||
146571361|NCT00856635|528602736|FG000|Overall Study|Withdrawal by Subject|3|||
146571362|NCT00856635|528602737|FG001|Overall Study|Withdrawal by Subject|1|||
146571363|NCT00856635|528602736|FG000|Overall Study|Serious Adverse Event|1|||
146571364|NCT00856635|528602737|FG001|Overall Study|Serious Adverse Event|0|||
146571365|NCT00856635|528602736|FG000|Overall Study|Other|1|||
146571366|NCT00856635|528602737|FG001|Overall Study|Other|0|||
146571367|NCT00856635|528602736|FG000|Overall Study|Discontinued at Randomization|2|||
146650874|NCT00045942|528898120|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
146916556|NCT01808118|529857990|FG001|Period 1|Non-compliance per sponsor|0|||
146916557|NCT01808118|529857991|FG002|Period 1|Non-compliance per sponsor|0|||
146916558|NCT01808118|529857989|FG000|Period 1|Lack of Efficacy|1|||
146916559|NCT01808118|529857990|FG001|Period 1|Lack of Efficacy|0|||
146916560|NCT01808118|529857991|FG002|Period 1|Lack of Efficacy|0|||
146916561|NCT01808118|529857989|FG000|Period 2|Adverse Event|0|||
146976838|NCT00995930|530077496|FG001|Overall Study|Withdrawal by Subject|4|||
146976839|NCT00995930|530077495|FG000|Overall Study|Adverse Event|11|||
146976840|NCT00995930|530077496|FG001|Overall Study|Adverse Event|14|||
146976841|NCT01458119|530077497|FG000|Overall Study|Physician Decision|4|||
146976842|NCT01458119|530077497|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
146976843|NCT01458119|530077497|FG000|Overall Study|Pregnancy|1|||
146976844|NCT01458119|530077497|FG000|Overall Study|Death|2|||
146976845|NCT01458119|530077497|FG000|Overall Study|Adverse Event|1|||
146976846|NCT01458119|530077497|FG000|Overall Study|Consent Withdrawn by Participant|8|||
146976847|NCT01458119|530077497|FG000|Overall Study|Non-compliance With Study Drug|3|||
146976848|NCT03033069|530077498|FG000|Overall Study|Adverse Event|6|||
146976849|NCT03033069|530077499|FG001|Overall Study|Adverse Event|7|||
146976850|NCT03033069|530077500|FG002|Overall Study|Adverse Event|4|||
146976851|NCT03033069|530077501|FG003|Overall Study|Adverse Event|6|||
146976852|NCT03033069|530077498|FG000|Overall Study|Lack of Efficacy|0|||
146976853|NCT03033069|530077499|FG001|Overall Study|Lack of Efficacy|0|||
146976854|NCT03033069|530077500|FG002|Overall Study|Lack of Efficacy|1|||
146976855|NCT03033069|530077501|FG003|Overall Study|Lack of Efficacy|0|||
146976856|NCT03033069|530077498|FG000|Overall Study|Lost to Follow-up|6|||
146976857|NCT03033069|530077499|FG001|Overall Study|Lost to Follow-up|5|||
146976858|NCT03033069|530077500|FG002|Overall Study|Lost to Follow-up|5|||
146976859|NCT03033069|530077501|FG003|Overall Study|Lost to Follow-up|6|||
146976860|NCT03033069|530077498|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146976861|NCT03033069|530077499|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146976862|NCT03033069|530077500|FG002|Overall Study|Non-Compliance With Study Drug|1|||
146976863|NCT03033069|530077501|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146976864|NCT03033069|530077498|FG000|Overall Study|Protocol Deviation|0|||
146976865|NCT03033069|530077499|FG001|Overall Study|Protocol Deviation|1|||
146976866|NCT03033069|530077500|FG002|Overall Study|Protocol Deviation|0|||
146976867|NCT03033069|530077501|FG003|Overall Study|Protocol Deviation|0|||
146976868|NCT03033069|530077498|FG000|Overall Study|Withdrawal by Subject|10|||
146976869|NCT03033069|530077499|FG001|Overall Study|Withdrawal by Subject|10|||
146976870|NCT03033069|530077500|FG002|Overall Study|Withdrawal by Subject|11|||
146976871|NCT03033069|530077501|FG003|Overall Study|Withdrawal by Subject|6|||
146976872|NCT03033069|530077498|FG000|Overall Study|Withdrawal By Caregiver|1|||
146976873|NCT03033069|530077499|FG001|Overall Study|Withdrawal By Caregiver|0|||
146976874|NCT03033069|530077500|FG002|Overall Study|Withdrawal By Caregiver|0|||
146976875|NCT03033069|530077501|FG003|Overall Study|Withdrawal By Caregiver|0|||
146976876|NCT03033069|530077498|FG000|Overall Study|Reason not Specified|0|||
146976877|NCT03033069|530077499|FG001|Overall Study|Reason not Specified|1|||
146976878|NCT03033069|530077500|FG002|Overall Study|Reason not Specified|0|||
146976879|NCT03033069|530077501|FG003|Overall Study|Reason not Specified|1|||
146976880|NCT02623426|530077506|FG000|Overall Study|Lost to Follow-up|0|||
146976881|NCT02623426|530077507|FG001|Overall Study|Lost to Follow-up|0|||
146650875|NCT00045942|528898121|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
146650876|NCT00045942|528898122|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
146650877|NCT00045942|528898123|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
146650878|NCT00045942|528898124|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
146650879|NCT00045942|528898125|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
146650880|NCT00045942|528898126|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
146650881|NCT00045942|528898127|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
146650882|NCT00045942|528898128|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
146916562|NCT01808118|529857990|FG001|Period 2|Adverse Event|4|||
146916563|NCT01808118|529857991|FG002|Period 2|Adverse Event|0|||
146916564|NCT01808118|529857989|FG000|Period 2|Withdrew consent|0|||
146916565|NCT01808118|529857990|FG001|Period 2|Withdrew consent|7|||
146916566|NCT01808118|529857991|FG002|Period 2|Withdrew consent|6|||
146916567|NCT01808118|529857989|FG000|Period 2|Lost to Follow-up|0|||
146916568|NCT01808118|529857990|FG001|Period 2|Lost to Follow-up|0|||
146976882|NCT02623426|530077508|FG002|Overall Study|Lost to Follow-up|1|||
146976883|NCT02623426|530077506|FG000|Overall Study|Withdrawal by Subject|1|||
146650883|NCT00045942|528898120|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
146650884|NCT00045942|528898121|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
146770539|NCT00465816|529328614|FG002|Overall Study|Lost to Follow-up|2|||
146770540|NCT01765543|529328627|FG000|Overall Study|Death|1|||
146770541|NCT01765543|529328627|FG000|Overall Study|Withdrawal by Subject|2|||
146976884|NCT02623426|530077507|FG001|Overall Study|Withdrawal by Subject|2|||
146976885|NCT02623426|530077508|FG002|Overall Study|Withdrawal by Subject|2|||
146976886|NCT02094937|530077509|FG000|8 Weeks in Period 1|Adverse Event|9|||
146976887|NCT02094937|530077510|FG001|8 Weeks in Period 1|Adverse Event|0|||
146770542|NCT00507689|529328628|FG000|Pre-Randomization Period|Adverse Event|1|||
146976888|NCT02094937|530077511|FG002|8 Weeks in Period 1|Adverse Event|0|||
146976889|NCT02094937|530077512|FG003|8 Weeks in Period 1|Adverse Event|0|||
146976890|NCT02094937|530077509|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
146976891|NCT02094937|530077510|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
146976892|NCT02094937|530077511|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
146916569|NCT01808118|529857991|FG002|Period 2|Lost to Follow-up|2|||
146916570|NCT01808118|529857989|FG000|Period 2|Investigator no longer conducting trials|0|||
146976893|NCT02094937|530077512|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
146976894|NCT02094937|530077509|FG000|8 Weeks in Period 1|Protocol Violation|2|||
146976895|NCT02094937|530077510|FG001|8 Weeks in Period 1|Protocol Violation|0|||
146976896|NCT02094937|530077511|FG002|8 Weeks in Period 1|Protocol Violation|0|||
146976897|NCT02094937|530077512|FG003|8 Weeks in Period 1|Protocol Violation|0|||
146976898|NCT02094937|530077509|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
146976899|NCT02094937|530077510|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
146976900|NCT02094937|530077511|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
146976901|NCT02094937|530077512|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
146976902|NCT02094937|530077509|FG000|8 Weeks in Period 1|Physician Decision|1|||
146976903|NCT02094937|530077510|FG001|8 Weeks in Period 1|Physician Decision|0|||
146976904|NCT02094937|530077511|FG002|8 Weeks in Period 1|Physician Decision|0|||
146976905|NCT02094937|530077512|FG003|8 Weeks in Period 1|Physician Decision|0|||
146976906|NCT02094937|530077509|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
146976907|NCT02094937|530077510|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
146976908|NCT02094937|530077511|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
146976909|NCT02094937|530077512|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
146976910|NCT02094937|530077509|FG000|12 Weeks in Period 2|Adverse Event|0|||
146976911|NCT02094937|530077510|FG001|12 Weeks in Period 2|Adverse Event|2|||
146976912|NCT02094937|530077511|FG002|12 Weeks in Period 2|Adverse Event|4|||
146976913|NCT02094937|530077512|FG003|12 Weeks in Period 2|Adverse Event|1|||
146976914|NCT02094937|530077509|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
146976915|NCT02094937|530077510|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
146976916|NCT02094937|530077511|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
146976917|NCT02094937|530077512|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
146976918|NCT02094937|530077509|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
146976919|NCT02094937|530077510|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
146650885|NCT00045942|528898122|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
146650886|NCT00045942|528898123|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
146650887|NCT00045942|528898124|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
146650888|NCT00045942|528898125|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
146650889|NCT00045942|528898126|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
146650890|NCT00045942|528898127|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
146650891|NCT00045942|528898128|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
146650892|NCT00045942|528898120|FG000|PKC412A2104E1|Lack of Efficacy|0|||
146650893|NCT00045942|528898121|FG001|PKC412A2104E1|Lack of Efficacy|11|||
146650894|NCT00045942|528898122|FG002|PKC412A2104E1|Lack of Efficacy|11|||
146650895|NCT00045942|528898123|FG003|PKC412A2104E1|Lack of Efficacy|23|||
146650896|NCT00045942|528898124|FG004|PKC412A2104E1|Lack of Efficacy|17|||
146650897|NCT00045942|528898125|FG005|PKC412A2104E1|Lack of Efficacy|0|||
146650898|NCT00045942|528898126|FG006|PKC412A2104E1|Lack of Efficacy|0|||
146650899|NCT00045942|528898127|FG007|PKC412A2104E1|Lack of Efficacy|0|||
146650900|NCT00045942|528898128|FG008|PKC412A2104E1|Lack of Efficacy|0|||
146650901|NCT00045942|528898120|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
146650902|NCT00045942|528898121|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
146650903|NCT00045942|528898122|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
146650904|NCT00045942|528898123|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
146650905|NCT00045942|528898124|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
146650906|NCT00045942|528898125|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
146650907|NCT00045942|528898126|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
146650908|NCT00045942|528898127|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
146650909|NCT00045942|528898128|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
146650910|NCT00045942|528898120|FG000|PKC412A2104E1|Adverse Event|0|||
146650911|NCT00045942|528898121|FG001|PKC412A2104E1|Adverse Event|1|||
146650912|NCT00045942|528898122|FG002|PKC412A2104E1|Adverse Event|1|||
146650913|NCT00045942|528898123|FG003|PKC412A2104E1|Adverse Event|3|||
146650914|NCT00045942|528898124|FG004|PKC412A2104E1|Adverse Event|6|||
146650915|NCT00045942|528898125|FG005|PKC412A2104E1|Adverse Event|0|||
146650916|NCT00045942|528898126|FG006|PKC412A2104E1|Adverse Event|0|||
146650917|NCT00045942|528898127|FG007|PKC412A2104E1|Adverse Event|0|||
146650918|NCT00045942|528898128|FG008|PKC412A2104E1|Adverse Event|0|||
146650919|NCT00045942|528898120|FG000|PKC412A2104E1|Death|0|||
146650920|NCT00045942|528898121|FG001|PKC412A2104E1|Death|4|||
146650921|NCT00045942|528898122|FG002|PKC412A2104E1|Death|1|||
146650922|NCT00045942|528898123|FG003|PKC412A2104E1|Death|1|||
146650923|NCT00045942|528898124|FG004|PKC412A2104E1|Death|1|||
146650924|NCT00045942|528898125|FG005|PKC412A2104E1|Death|0|||
146976920|NCT02094937|530077511|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
146976921|NCT02094937|530077512|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
146976922|NCT02094937|530077509|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
146976923|NCT02094937|530077510|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
146976924|NCT02094937|530077511|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
146650925|NCT00045942|528898126|FG006|PKC412A2104E1|Death|0|||
146650926|NCT00045942|528898127|FG007|PKC412A2104E1|Death|0|||
146650927|NCT00045942|528898128|FG008|PKC412A2104E1|Death|0|||
146650928|NCT00045942|528898120|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
146650929|NCT00045942|528898121|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
146650930|NCT00045942|528898122|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
146650931|NCT00045942|528898123|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
146650932|NCT00045942|528898124|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
146650933|NCT00045942|528898125|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
146650934|NCT00045942|528898126|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
146650935|NCT00045942|528898127|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
146650936|NCT00045942|528898128|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
146650937|NCT00045942|528898120|FG000|PKC412A2104E2|Lost to Follow-up|0|||
146650938|NCT00045942|528898121|FG001|PKC412A2104E2|Lost to Follow-up|0|||
146650939|NCT00045942|528898122|FG002|PKC412A2104E2|Lost to Follow-up|0|||
146650940|NCT00045942|528898123|FG003|PKC412A2104E2|Lost to Follow-up|0|||
146650941|NCT00045942|528898124|FG004|PKC412A2104E2|Lost to Follow-up|0|||
146650942|NCT00045942|528898125|FG005|PKC412A2104E2|Lost to Follow-up|0|||
146650943|NCT00045942|528898126|FG006|PKC412A2104E2|Lost to Follow-up|0|||
146650944|NCT00045942|528898127|FG007|PKC412A2104E2|Lost to Follow-up|3|||
146650945|NCT00045942|528898128|FG008|PKC412A2104E2|Lost to Follow-up|0|||
146650946|NCT00045942|528898120|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
146650947|NCT00045942|528898121|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
146650948|NCT00045942|528898122|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
146650949|NCT00045942|528898123|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
146650950|NCT00045942|528898124|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
146650951|NCT00045942|528898125|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
146650952|NCT00045942|528898126|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
146650953|NCT00045942|528898127|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
146650954|NCT00045942|528898128|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
146650955|NCT00045942|528898120|FG000|PKC412A2104E2|Lack of Efficacy|0|||
146650956|NCT00045942|528898121|FG001|PKC412A2104E2|Lack of Efficacy|0|||
146650957|NCT00045942|528898122|FG002|PKC412A2104E2|Lack of Efficacy|0|||
146650958|NCT00045942|528898123|FG003|PKC412A2104E2|Lack of Efficacy|0|||
146650959|NCT00045942|528898124|FG004|PKC412A2104E2|Lack of Efficacy|0|||
146650960|NCT00045942|528898125|FG005|PKC412A2104E2|Lack of Efficacy|3|||
146650961|NCT00045942|528898126|FG006|PKC412A2104E2|Lack of Efficacy|2|||
146650962|NCT00045942|528898127|FG007|PKC412A2104E2|Lack of Efficacy|2|||
146650963|NCT00045942|528898128|FG008|PKC412A2104E2|Lack of Efficacy|6|||
146650964|NCT00045942|528898120|FG000|PKC412A2104E2|Adverse Event|0|||
146650965|NCT00045942|528898121|FG001|PKC412A2104E2|Adverse Event|0|||
146650966|NCT00045942|528898122|FG002|PKC412A2104E2|Adverse Event|0|||
146650967|NCT00045942|528898123|FG003|PKC412A2104E2|Adverse Event|0|||
146650968|NCT00045942|528898124|FG004|PKC412A2104E2|Adverse Event|0|||
146650969|NCT00045942|528898125|FG005|PKC412A2104E2|Adverse Event|4|||
146650970|NCT00045942|528898126|FG006|PKC412A2104E2|Adverse Event|3|||
146650971|NCT00045942|528898127|FG007|PKC412A2104E2|Adverse Event|1|||
146650972|NCT00045942|528898128|FG008|PKC412A2104E2|Adverse Event|0|||
146650973|NCT00045942|528898120|FG000|PKC412A2104E2|Death|0|||
146650974|NCT00045942|528898121|FG001|PKC412A2104E2|Death|0|||
146650975|NCT00045942|528898122|FG002|PKC412A2104E2|Death|0|||
146650976|NCT00045942|528898123|FG003|PKC412A2104E2|Death|0|||
146916571|NCT01808118|529857990|FG001|Period 2|Investigator no longer conducting trials|1|||
146916572|NCT01808118|529857991|FG002|Period 2|Investigator no longer conducting trials|0|||
146916573|NCT01808118|529857989|FG000|Period 2|Switched to other therapy|0|||
146916574|NCT01808118|529857990|FG001|Period 2|Switched to other therapy|1|||
146916575|NCT01808118|529857991|FG002|Period 2|Switched to other therapy|0|||
146916576|NCT01993329|529857995|FG000|Period 2|Adverse Event|0|||
146916577|NCT01993329|529857996|FG001|Period 2|Adverse Event|0|||
146916578|NCT01993329|529857997|FG002|Period 2|Adverse Event|0|||
146916579|NCT01993329|529857998|FG003|Period 2|Adverse Event|0|||
146916580|NCT01993329|529857999|FG004|Period 2|Adverse Event|0|||
146916581|NCT01993329|529858000|FG005|Period 2|Adverse Event|1|||
146916582|NCT01993329|529857995|FG000|Wash-out|Personal reasons|0|||
146916583|NCT01993329|529857996|FG001|Wash-out|Personal reasons|1|||
146916584|NCT01993329|529857997|FG002|Wash-out|Personal reasons|0|||
146916585|NCT01993329|529857998|FG003|Wash-out|Personal reasons|0|||
146976925|NCT02094937|530077512|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
146650977|NCT00045942|528898124|FG004|PKC412A2104E2|Death|0|||
146650978|NCT00045942|528898125|FG005|PKC412A2104E2|Death|1|||
146650979|NCT00045942|528898126|FG006|PKC412A2104E2|Death|2|||
146650980|NCT00045942|528898127|FG007|PKC412A2104E2|Death|0|||
146650981|NCT00045942|528898128|FG008|PKC412A2104E2|Death|0|||
146650982|NCT01101308|528898129|FG000|Period 1|Adverse Event|2|||
146650983|NCT01101308|528898130|FG001|Period 1|Adverse Event|1|||
146650984|NCT01101308|528898129|FG000|Period 1|Positive for cotinine|1|||
146650985|NCT01101308|528898130|FG001|Period 1|Positive for cotinine|0|||
146650986|NCT02984943|528898131|FG000|Overall Study|Withdrawal by Subject|3|||
146650987|NCT02984943|528898131|FG000|Overall Study|Physician Decision|1|||
146650988|NCT00711516|528898136|FG000|Overall Study|Adverse Event|1|||
146650989|NCT00711516|528898137|FG001|Overall Study|Adverse Event|1|||
146916586|NCT01993329|529857999|FG004|Wash-out|Personal reasons|0|||
146916587|NCT01993329|529858000|FG005|Wash-out|Personal reasons|0|||
146916588|NCT05070429|529858001|FG000|Overall Study|Death|0|||
146916589|NCT05070429|529858002|FG001|Overall Study|Death|4|||
146916590|NCT05070429|529858001|FG000|Overall Study|Withdrawal by Subject|2|||
146916591|NCT05070429|529858002|FG001|Overall Study|Withdrawal by Subject|1|||
146916592|NCT05070429|529858001|FG000|Overall Study|Other|15|||
146916593|NCT05070429|529858002|FG001|Overall Study|Other|5|||
146916594|NCT02311478|529858003|FG000|Overall Study|Withdrawal by Subject|1|||
146916595|NCT02311478|529858003|FG000|Overall Study|Lost to Follow-up|5|||
146916596|NCT02311478|529858003|FG000|Overall Study|Failed IUD Insertion|1|||
146916597|NCT03276936|529858004|FG000|Overall Study|Adverse Event|4|||
146916598|NCT03276936|529858005|FG001|Overall Study|Adverse Event|2|||
146916599|NCT03276936|529858004|FG000|Overall Study|Lost to Follow-up|16|||
146916600|NCT03276936|529858005|FG001|Overall Study|Lost to Follow-up|13|||
146916601|NCT03276936|529858004|FG000|Overall Study|Withdrawal by Subject|30|||
146916602|NCT03276936|529858005|FG001|Overall Study|Withdrawal by Subject|20|||
146916603|NCT03276936|529858004|FG000|Overall Study|Not mentioned|6|||
146916604|NCT03276936|529858005|FG001|Overall Study|Not mentioned|3|||
146916605|NCT03041116|529858006|FG000|Double-blind|Death|0|||
146916606|NCT03041116|529858007|FG001|Double-blind|Death|2|||
146916607|NCT03041116|529858006|FG000|Double-blind|Withdrawal by Subject|0|||
146916608|NCT03041116|529858007|FG001|Double-blind|Withdrawal by Subject|4|||
146916609|NCT03041116|529858006|FG000|Open-label|Death|1|||
146916610|NCT03041116|529858007|FG001|Open-label|Death|0|||
146916611|NCT03041116|529858006|FG000|Open-label|Termination of the study by Sponsor|39|||
146916612|NCT03041116|529858007|FG001|Open-label|Termination of the study by Sponsor|37|||
146916613|NCT03041116|529858006|FG000|Open-label|Withdrawal by Subject|1|||
146916614|NCT03041116|529858007|FG001|Open-label|Withdrawal by Subject|0|||
146916615|NCT00943319|529858008|FG000|Overall Study|Death|1|||
146916616|NCT02043301|529858009|FG000|Overall Study|Discontinued|0|||
146916617|NCT02043301|529858010|FG001|Overall Study|Discontinued|1|||
146916618|NCT02043301|529858011|FG002|Overall Study|Discontinued|0|||
146916619|NCT03097328|529858012|FG000|Overall Study|Still on Therapy|2|||
146916620|NCT03097328|529858012|FG000|Overall Study|Progressive Disease|29|||
146916621|NCT03097328|529858012|FG000|Overall Study|Adverse Event|4|||
146916622|NCT03097328|529858012|FG000|Overall Study|Withdrawal by Subject|1|||
146916623|NCT03097328|529858012|FG000|Overall Study|Physician Decision|1|||
146916624|NCT03097328|529858012|FG000|Overall Study|Patient Decision|1|||
146916625|NCT03097328|529858012|FG000|Overall Study|Ineligible for Study Drug|1|||
146916626|NCT01798134|529858013|FG000|Overall Study|Lost to Follow-up|1|||
146916627|NCT01798134|529858013|FG000|Overall Study|Withdrawal by Subject|3|||
146916628|NCT01798134|529858013|FG000|Overall Study|Death|2|||
146916629|NCT01798134|529858013|FG000|Overall Study|Adverse Event|3|||
146916630|NCT01798134|529858013|FG000|Overall Study|Physician Decision|3|||
146916631|NCT01798134|529858013|FG000|Overall Study|Liver transplant/surgery|4|||
146916632|NCT02653976|529858014|FG000|Overall Study|Withdrawal by Subject|5|||
146916633|NCT02653976|529858014|FG000|Overall Study|Death|4|||
146916634|NCT02023164|529858015|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
146916635|NCT02023164|529858016|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
146916636|NCT02436577|529858017|FG000|Overall Study|Protocol Deviation|0|||
146916637|NCT02436577|529858018|FG001|Overall Study|Protocol Deviation|1|||
146916638|NCT02436577|529858019|FG002|Overall Study|Protocol Deviation|0|||
146916639|NCT02436577|529858020|FG003|Overall Study|Protocol Deviation|0|||
146916640|NCT02436577|529858021|FG004|Overall Study|Protocol Deviation|0|||
146916641|NCT02436577|529858022|FG005|Overall Study|Protocol Deviation|0|||
146916642|NCT03703375|529858023|FG000|Randomization Period|Withdrawal by Subject|0|||
146916643|NCT03703375|529858024|FG001|Randomization Period|Withdrawal by Subject|0|||
146916644|NCT03703375|529858025|FG002|Randomization Period|Withdrawal by Subject|0|||
146916645|NCT03703375|529858026|FG003|Randomization Period|Withdrawal by Subject|1|||
146916646|NCT03703375|529858023|FG000|Randomization Period|Completed safety run-in treatment|7|||
146916647|NCT03703375|529858024|FG001|Randomization Period|Completed safety run-in treatment|0|||
146916648|NCT03703375|529858025|FG002|Randomization Period|Completed safety run-in treatment|0|||
146916649|NCT03703375|529858026|FG003|Randomization Period|Completed safety run-in treatment|0|||
146916650|NCT03703375|529858023|FG000|Treatment Period|Other Reasons|0|||
146916651|NCT03703375|529858024|FG001|Treatment Period|Other Reasons|1|||
146916652|NCT03703375|529858025|FG002|Treatment Period|Other Reasons|0|||
146916653|NCT03703375|529858026|FG003|Treatment Period|Other Reasons|3|||
146916654|NCT03703375|529858023|FG000|Treatment Period|Consent Withdrawal|0|||
146916655|NCT03703375|529858024|FG001|Treatment Period|Consent Withdrawal|0|||
146916656|NCT03703375|529858025|FG002|Treatment Period|Consent Withdrawal|0|||
146916657|NCT03703375|529858026|FG003|Treatment Period|Consent Withdrawal|1|||
146770543|NCT00507689|529328629|FG001|Pre-Randomization Period|Adverse Event|0|||
146916658|NCT03703375|529858023|FG000|Treatment Period|Death|1|||
146916659|NCT03703375|529858024|FG001|Treatment Period|Death|0|||
146916660|NCT03703375|529858025|FG002|Treatment Period|Death|1|||
146916661|NCT03703375|529858026|FG003|Treatment Period|Death|2|||
146916662|NCT03703375|529858023|FG000|Treatment Period|Toxicity of Study Treatment|2|||
146916663|NCT03703375|529858024|FG001|Treatment Period|Toxicity of Study Treatment|0|||
146916664|NCT03703375|529858025|FG002|Treatment Period|Toxicity of Study Treatment|4|||
146916665|NCT03703375|529858026|FG003|Treatment Period|Toxicity of Study Treatment|1|||
146976926|NCT02094937|530077509|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
146976927|NCT02094937|530077510|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
146976928|NCT02094937|530077511|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
146976929|NCT02094937|530077512|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
146976930|NCT03751124|530077515|FG000|Overall Study|Adverse Event|4|||
146976931|NCT03751124|530077516|FG001|Overall Study|Adverse Event|3|||
146976932|NCT03751124|530077515|FG000|Overall Study|Protocol Deviation|0|||
146976933|NCT03751124|530077516|FG001|Overall Study|Protocol Deviation|1|||
146976934|NCT03751124|530077515|FG000|Overall Study|Lost to Follow-up|6|||
146976935|NCT03751124|530077516|FG001|Overall Study|Lost to Follow-up|4|||
146976936|NCT03751124|530077515|FG000|Overall Study|Withdrawal by Subject|6|||
146976937|NCT03751124|530077516|FG001|Overall Study|Withdrawal by Subject|8|||
146976938|NCT03751124|530077515|FG000|Overall Study|Lack of Efficacy|1|||
146976939|NCT03751124|530077516|FG001|Overall Study|Lack of Efficacy|1|||
146976940|NCT03751124|530077515|FG000|Overall Study|Pregnancy|0|||
146976941|NCT03751124|530077516|FG001|Overall Study|Pregnancy|1|||
146976942|NCT03751124|530077515|FG000|Overall Study|Other|9|||
146976943|NCT03751124|530077516|FG001|Overall Study|Other|9|||
146976944|NCT03751124|530077515|FG000|Overall Study|Participants who did not receive any study drug|0|||
146976945|NCT03751124|530077516|FG001|Overall Study|Participants who did not receive any study drug|1|||
146976946|NCT00555399|530077527|FG000|Overall Study|Withdrawal by Subject|0|||
146976947|NCT00555399|530077528|FG001|Overall Study|Withdrawal by Subject|0|||
146976948|NCT00555399|530077529|FG002|Overall Study|Withdrawal by Subject|1|||
146976949|NCT00555399|530077530|FG003|Overall Study|Withdrawal by Subject|0|||
146976950|NCT00555399|530077531|FG004|Overall Study|Withdrawal by Subject|0|||
146976951|NCT00555399|530077532|FG005|Overall Study|Withdrawal by Subject|0|||
146976952|NCT00555399|530077533|FG006|Overall Study|Withdrawal by Subject|0|||
146976953|NCT00555399|530077534|FG007|Overall Study|Withdrawal by Subject|0|||
146976954|NCT00555399|530077535|FG008|Overall Study|Withdrawal by Subject|0|||
146976955|NCT00555399|530077536|FG009|Overall Study|Withdrawal by Subject|0|||
146976956|NCT00555399|530077537|FG010|Overall Study|Withdrawal by Subject|0|||
146976957|NCT00555399|530077538|FG011|Overall Study|Withdrawal by Subject|1|||
146976958|NCT00555399|530077527|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
146976959|NCT00555399|530077528|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
146976960|NCT00555399|530077529|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
146976961|NCT00555399|530077530|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
146976962|NCT00555399|530077531|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
146976963|NCT00555399|530077532|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
146976964|NCT00555399|530077533|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
146976965|NCT00555399|530077534|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
146976966|NCT00555399|530077535|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
146976967|NCT00555399|530077536|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
146976968|NCT00555399|530077537|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
146976969|NCT00555399|530077538|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
146976970|NCT05458895|530077539|FG000|Overall Study|Withdrawal by Subject|8|||
146976971|NCT05458895|530077539|FG000|Overall Study|Lost to Follow-up|17|||
146976972|NCT05458895|530077539|FG000|Overall Study|Pregnancy|2|||
146976973|NCT05458895|530077539|FG000|Overall Study|Withdrawal by Study Team|1|||
146976974|NCT04639310|530077540|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
146976975|NCT04639310|530077541|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
146976976|NCT01246973|530079277|FG000|Overall Study|Other|38|||
146976977|NCT01246973|530079278|FG001|Overall Study|Other|25|||
146976978|NCT01246973|530079277|FG000|Overall Study|Adverse Event|16|||
146976979|NCT01246973|530079278|FG001|Overall Study|Adverse Event|9|||
146976980|NCT01246973|530079277|FG000|Overall Study|Withdrawal by Subject|7|||
146976981|NCT01246973|530079278|FG001|Overall Study|Withdrawal by Subject|13|||
146976982|NCT01416142|530079279|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
146976983|NCT01416142|530079280|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
146976984|NCT01416142|530079281|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
146976985|NCT01326702|530079283|FG000|Overall Study|Other|1|||
146976986|NCT01326702|530079284|FG001|Overall Study|Other|0|||
146976987|NCT01326702|530079285|FG002|Overall Study|Other|0|||
146976988|NCT01326702|530079286|FG003|Overall Study|Other|0|||
146976989|NCT01326702|530079287|FG004|Overall Study|Other|0|||
146976990|NCT01326702|530079288|FG005|Overall Study|Other|1|||
146976991|NCT01326702|530079289|FG006|Overall Study|Other|0|||
146976992|NCT01326702|530079283|FG000|Overall Study|progressive disease|1|||
146976993|NCT01326702|530079284|FG001|Overall Study|progressive disease|1|||
146976994|NCT01326702|530079285|FG002|Overall Study|progressive disease|3|||
146976995|NCT01326702|530079286|FG003|Overall Study|progressive disease|1|||
146976996|NCT01326702|530079287|FG004|Overall Study|progressive disease|3|||
146976997|NCT01326702|530079288|FG005|Overall Study|progressive disease|2|||
146976998|NCT01326702|530079289|FG006|Overall Study|progressive disease|3|||
146976999|NCT01326702|530079283|FG000|Overall Study|Death|0|||
146650990|NCT00711516|528898136|FG000|Overall Study|Withdrawal by Subject|0|||
146650991|NCT00711516|528898137|FG001|Overall Study|Withdrawal by Subject|1|||
146650992|NCT00711516|528898136|FG000|Overall Study|Protocol Violation|0|||
146650993|NCT00711516|528898137|FG001|Overall Study|Protocol Violation|1|||
146650994|NCT01895361|528898141|FG000|Overall Study|Adverse Event|1|||
146650995|NCT01895361|528898142|FG001|Overall Study|Adverse Event|1|||
146650996|NCT01895361|528898143|FG002|Overall Study|Adverse Event|3|||
146650997|NCT01895361|528898141|FG000|Overall Study|Death|2|||
146650998|NCT01895361|528898142|FG001|Overall Study|Death|1|||
146650999|NCT01895361|528898143|FG002|Overall Study|Death|2|||
146651000|NCT01895361|528898141|FG000|Overall Study|Lost to Follow-up|4|||
146651001|NCT01895361|528898142|FG001|Overall Study|Lost to Follow-up|4|||
146651002|NCT01895361|528898143|FG002|Overall Study|Lost to Follow-up|6|||
146651003|NCT01895361|528898141|FG000|Overall Study|Non-compliance with study|1|||
146651004|NCT01895361|528898142|FG001|Overall Study|Non-compliance with study|3|||
146651005|NCT01895361|528898143|FG002|Overall Study|Non-compliance with study|1|||
146770544|NCT00507689|529328628|FG000|Pre-Randomization Period|Physician Decision|1|||
146770545|NCT00507689|529328629|FG001|Pre-Randomization Period|Physician Decision|0|||
146770546|NCT00507689|529328628|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
146770547|NCT00507689|529328629|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
146770548|NCT00507689|529328628|FG000|Randomized Period|Adverse Event|1|||
146770549|NCT00507689|529328629|FG001|Randomized Period|Adverse Event|1|||
146770550|NCT00507689|529328628|FG000|Randomized Period|Withdrawal by Subject|0|||
146770551|NCT00507689|529328629|FG001|Randomized Period|Withdrawal by Subject|1|||
146916666|NCT03703375|529858023|FG000|Treatment Period|Progression|32|||
146916667|NCT03703375|529858024|FG001|Treatment Period|Progression|1|||
146916668|NCT03703375|529858025|FG002|Treatment Period|Progression|7|||
146916669|NCT03703375|529858026|FG003|Treatment Period|Progression|11|||
146916670|NCT03703375|529858023|FG000|Treatment Period|Completed treatment|7|||
146916671|NCT03703375|529858024|FG001|Treatment Period|Completed treatment|2|||
146916672|NCT03703375|529858025|FG002|Treatment Period|Completed treatment|0|||
146916673|NCT03703375|529858026|FG003|Treatment Period|Completed treatment|0|||
146916674|NCT01675011|529858027|FG000|Overall Study|Trial terminated by Sponsor|3|||
146916675|NCT01675011|529858028|FG001|Overall Study|Trial terminated by Sponsor|1|||
146916676|NCT00615290|529858029|FG000|Overall Study|Adverse Event|2|||
146916677|NCT00615290|529858029|FG000|Overall Study|Lost to Follow-up|3|||
146916678|NCT00615290|529858029|FG000|Overall Study|Withdrawal by Subject|1|||
146916679|NCT00615290|529858029|FG000|Overall Study|Other|2|||
146916680|NCT01623531|529858037|FG000|Overall Study|Death|1|||
146916681|NCT01623531|529858038|FG001|Overall Study|Death|0|||
146916682|NCT01623531|529858037|FG000|Overall Study|Protocol Violation|2|||
146916683|NCT01623531|529858038|FG001|Overall Study|Protocol Violation|1|||
146916684|NCT01623531|529858037|FG000|Overall Study|Missing data at primary outcome time poi|1|||
146916685|NCT01623531|529858038|FG001|Overall Study|Missing data at primary outcome time poi|1|||
146916686|NCT04184622|529858040|FG000|Primary Treatment Period|Adverse Event|6|||
146916687|NCT04184622|529858041|FG001|Primary Treatment Period|Adverse Event|4|||
146916688|NCT04184622|529858042|FG002|Primary Treatment Period|Adverse Event|8|||
146916689|NCT04184622|529858043|FG003|Primary Treatment Period|Adverse Event|6|||
146916690|NCT04184622|529858040|FG000|Primary Treatment Period|Death|4|||
146916691|NCT04184622|529858041|FG001|Primary Treatment Period|Death|4|||
146916692|NCT04184622|529858042|FG002|Primary Treatment Period|Death|2|||
146916693|NCT04184622|529858043|FG003|Primary Treatment Period|Death|1|||
146916694|NCT04184622|529858040|FG000|Primary Treatment Period|Lost to Follow-up|41|||
146916695|NCT04184622|529858041|FG001|Primary Treatment Period|Lost to Follow-up|17|||
146916696|NCT04184622|529858042|FG002|Primary Treatment Period|Lost to Follow-up|15|||
146916697|NCT04184622|529858043|FG003|Primary Treatment Period|Lost to Follow-up|13|||
146916698|NCT04184622|529858040|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
146916699|NCT04184622|529858041|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
146916700|NCT04184622|529858042|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
146916701|NCT04184622|529858043|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
146916702|NCT04184622|529858040|FG000|Primary Treatment Period|Physician Decision|0|||
146916703|NCT04184622|529858041|FG001|Primary Treatment Period|Physician Decision|0|||
146916704|NCT04184622|529858042|FG002|Primary Treatment Period|Physician Decision|3|||
146916705|NCT04184622|529858043|FG003|Primary Treatment Period|Physician Decision|1|||
146916706|NCT04184622|529858040|FG000|Primary Treatment Period|Pregnancy|4|||
146651006|NCT01895361|528898141|FG000|Overall Study|Physician Decision|2|||
146916707|NCT04184622|529858041|FG001|Primary Treatment Period|Pregnancy|3|||
146916708|NCT04184622|529858042|FG002|Primary Treatment Period|Pregnancy|4|||
146651007|NCT01895361|528898142|FG001|Overall Study|Physician Decision|2|||
146651008|NCT01895361|528898143|FG002|Overall Study|Physician Decision|2|||
146651009|NCT01895361|528898141|FG000|Overall Study|Withdrawal by Subject|7|||
146916709|NCT04184622|529858043|FG003|Primary Treatment Period|Pregnancy|1|||
146651010|NCT01895361|528898142|FG001|Overall Study|Withdrawal by Subject|6|||
146770552|NCT00424762|529328637|FG000|Overall Study|Withdrawal by Subject|18|||
146916710|NCT04184622|529858040|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
146916711|NCT04184622|529858041|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
146651011|NCT01895361|528898143|FG002|Overall Study|Withdrawal by Subject|6|||
146651012|NCT01895361|528898141|FG000|Overall Study|Lack of Efficacy|0|||
146651013|NCT01895361|528898142|FG001|Overall Study|Lack of Efficacy|1|||
146651014|NCT01895361|528898143|FG002|Overall Study|Lack of Efficacy|0|||
146651015|NCT01895361|528898141|FG000|Overall Study|Reasons different from categories above|7|||
146651016|NCT01895361|528898142|FG001|Overall Study|Reasons different from categories above|3|||
146651017|NCT01895361|528898143|FG002|Overall Study|Reasons different from categories above|4|||
146651018|NCT05463198|528898153|FG000|Overall Study|Withdrawal by Subject|19|||
146651019|NCT05463198|528898153|FG000|Overall Study|Procedure Notes Missing|18|||
146651020|NCT01860846|528898154|FG000|Overall Study|Lost to Follow-up|33|||
146651021|NCT02239120|528898157|FG000|Overall Study|Death|56|||
146651022|NCT02239120|528898158|FG001|Overall Study|Death|58|||
146651023|NCT02239120|528898157|FG000|Overall Study|Lost to Follow-up|19|||
146651024|NCT02239120|528898158|FG001|Overall Study|Lost to Follow-up|14|||
146651025|NCT00466687|528898159|FG000|Overall Study|Adverse Event|1|||
146651026|NCT00466687|528898159|FG000|Overall Study|Other complicating illness|3|||
146651027|NCT00466687|528898159|FG000|Overall Study|Withdrawal by Subject|1|||
146651028|NCT00466687|528898159|FG000|Overall Study|Disease progression|29|||
146651029|NCT00046891|528898160|FG000|Overall Study|Cancels|5|||
146651030|NCT00046891|528898161|FG001|Overall Study|Cancels|9|||
146651031|NCT00046891|528898160|FG000|Overall Study|Ineligible|1|||
146651032|NCT00046891|528898161|FG001|Overall Study|Ineligible|1|||
146651033|NCT00046891|528898160|FG000|Overall Study|Withdrawal by Subject|18|||
146651034|NCT00046891|528898161|FG001|Overall Study|Withdrawal by Subject|15|||
146651035|NCT00046891|528898160|FG000|Overall Study|Adverse Event|5|||
146651036|NCT00046891|528898161|FG001|Overall Study|Adverse Event|5|||
146651037|NCT01514370|528898163|FG000|Overall Study|Protocol Violation|2|||
146651038|NCT01514370|528898164|FG001|Overall Study|Protocol Violation|3|||
146651039|NCT01514370|528898163|FG000|Overall Study|Lost to Follow-up|0|||
146651040|NCT01514370|528898164|FG001|Overall Study|Lost to Follow-up|2|||
146651041|NCT01514370|528898163|FG000|Overall Study|Withdrawal by Subject|2|||
146651042|NCT01514370|528898164|FG001|Overall Study|Withdrawal by Subject|1|||
146651043|NCT01514370|528898163|FG000|Overall Study|Adverse Event|1|||
146651044|NCT01514370|528898164|FG001|Overall Study|Adverse Event|3|||
146651045|NCT01514370|528898163|FG000|Overall Study|Other|6|||
146651046|NCT01514370|528898164|FG001|Overall Study|Other|7|||
146651047|NCT01159431|528898165|FG000|Overall Study|Adverse Event|1|||
146651048|NCT01159431|528898166|FG001|Overall Study|Adverse Event|2|||
146651049|NCT01159431|528898165|FG000|Overall Study|non-compliance|1|||
146651050|NCT01159431|528898166|FG001|Overall Study|non-compliance|1|||
146651051|NCT01159431|528898165|FG000|Overall Study|Lack of Efficacy|0|||
146651052|NCT01159431|528898166|FG001|Overall Study|Lack of Efficacy|3|||
146651053|NCT00604214|528898169|FG000|Baseline to Day 28|Death|223|||
146651054|NCT00604214|528898170|FG001|Baseline to Day 28|Death|202|||
146651055|NCT00604214|528898169|FG000|Baseline to Day 28|Lost to Follow-up|2|||
146651056|NCT00604214|528898170|FG001|Baseline to Day 28|Lost to Follow-up|4|||
146651057|NCT00604214|528898169|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
146651058|NCT00604214|528898170|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
146651059|NCT00604214|528898169|FG000|Day 29 to Day 90|Death|64|||
146651060|NCT00604214|528898170|FG001|Day 29 to Day 90|Death|67|||
146651061|NCT00604214|528898169|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
146651062|NCT00604214|528898170|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
146651063|NCT00604214|528898169|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
146651064|NCT00604214|528898170|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
146651065|NCT00604214|528898169|FG000|Day 91 to Day 180|Death|19|||
146651066|NCT00604214|528898170|FG001|Day 91 to Day 180|Death|23|||
146651067|NCT00604214|528898169|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
146916712|NCT04184622|529858042|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
146916713|NCT04184622|529858043|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
146916714|NCT04184622|529858040|FG000|Additional Treatment Period|Adverse Event|1|||
146916715|NCT04184622|529858041|FG001|Additional Treatment Period|Adverse Event|2|||
146916716|NCT04184622|529858042|FG002|Additional Treatment Period|Adverse Event|1|||
146916717|NCT04184622|529858043|FG003|Additional Treatment Period|Adverse Event|0|||
146916718|NCT04184622|529858040|FG000|Additional Treatment Period|Death|0|||
146770553|NCT00424762|529328638|FG001|Overall Study|Withdrawal by Subject|19|||
146916719|NCT04184622|529858041|FG001|Additional Treatment Period|Death|0|||
146651068|NCT00604214|528898170|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
146651069|NCT00604214|528898169|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
146651070|NCT00604214|528898170|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
146651071|NCT00534599|528898171|FG000|Overall Study|Adverse Event|25|||
146651072|NCT00534599|528898172|FG001|Overall Study|Adverse Event|4|||
146651073|NCT00534599|528898171|FG000|Overall Study|Incorrect enrollment|2|||
146651074|NCT00534599|528898172|FG001|Overall Study|Incorrect enrollment|1|||
146651075|NCT00534599|528898171|FG000|Overall Study|Mis-randomization|2|||
146651076|NCT00534599|528898172|FG001|Overall Study|Mis-randomization|2|||
146651077|NCT00534599|528898171|FG000|Overall Study|Developed study-specific d/c criteria|5|||
146651078|NCT00534599|528898172|FG001|Overall Study|Developed study-specific d/c criteria|0|||
146770554|NCT00424762|529328637|FG000|Overall Study|Lost to Follow-up|2|||
146916720|NCT04184622|529858042|FG002|Additional Treatment Period|Death|1|||
146977000|NCT01326702|530079284|FG001|Overall Study|Death|1|||
146977001|NCT01326702|530079285|FG002|Overall Study|Death|0|||
146977002|NCT01326702|530079286|FG003|Overall Study|Death|0|||
146977003|NCT01326702|530079287|FG004|Overall Study|Death|0|||
146977004|NCT01326702|530079288|FG005|Overall Study|Death|0|||
146977005|NCT01326702|530079289|FG006|Overall Study|Death|0|||
146977006|NCT01326702|530079283|FG000|Overall Study|Adverse Event|0|||
146977007|NCT01326702|530079284|FG001|Overall Study|Adverse Event|0|||
146977008|NCT01326702|530079285|FG002|Overall Study|Adverse Event|1|||
146977009|NCT01326702|530079286|FG003|Overall Study|Adverse Event|1|||
146977010|NCT01326702|530079287|FG004|Overall Study|Adverse Event|0|||
146977011|NCT01326702|530079288|FG005|Overall Study|Adverse Event|3|||
146977012|NCT01326702|530079289|FG006|Overall Study|Adverse Event|1|||
146977013|NCT01326702|530079283|FG000|Overall Study|Withdrawal by Subject|0|||
146977014|NCT01326702|530079284|FG001|Overall Study|Withdrawal by Subject|0|||
146977015|NCT01326702|530079285|FG002|Overall Study|Withdrawal by Subject|1|||
146977016|NCT01326702|530079286|FG003|Overall Study|Withdrawal by Subject|0|||
146977017|NCT01326702|530079287|FG004|Overall Study|Withdrawal by Subject|1|||
146977018|NCT01326702|530079288|FG005|Overall Study|Withdrawal by Subject|1|||
146651079|NCT00534599|528898171|FG000|Overall Study|Lack of Efficacy|0|||
146651080|NCT00534599|528898172|FG001|Overall Study|Lack of Efficacy|1|||
146651081|NCT00534599|528898171|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
146916721|NCT04184622|529858043|FG003|Additional Treatment Period|Death|1|||
146916722|NCT04184622|529858040|FG000|Additional Treatment Period|Lost to Follow-up|6|||
146916723|NCT04184622|529858041|FG001|Additional Treatment Period|Lost to Follow-up|4|||
146916724|NCT04184622|529858042|FG002|Additional Treatment Period|Lost to Follow-up|8|||
146916725|NCT04184622|529858043|FG003|Additional Treatment Period|Lost to Follow-up|6|||
146916726|NCT04184622|529858040|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
146916727|NCT04184622|529858041|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
146916728|NCT04184622|529858042|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
146916729|NCT04184622|529858043|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
146916730|NCT04184622|529858040|FG000|Additional Treatment Period|Physician Decision|0|||
146916731|NCT04184622|529858041|FG001|Additional Treatment Period|Physician Decision|0|||
146916732|NCT04184622|529858042|FG002|Additional Treatment Period|Physician Decision|1|||
146916733|NCT04184622|529858043|FG003|Additional Treatment Period|Physician Decision|0|||
146916734|NCT04184622|529858040|FG000|Additional Treatment Period|Pregnancy|0|||
146916735|NCT04184622|529858041|FG001|Additional Treatment Period|Pregnancy|0|||
146916736|NCT04184622|529858042|FG002|Additional Treatment Period|Pregnancy|0|||
146916737|NCT04184622|529858043|FG003|Additional Treatment Period|Pregnancy|1|||
146916738|NCT04184622|529858040|FG000|Additional Treatment Period|Protocol deviation|0|||
146916739|NCT04184622|529858041|FG001|Additional Treatment Period|Protocol deviation|0|||
146916740|NCT04184622|529858042|FG002|Additional Treatment Period|Protocol deviation|1|||
146916741|NCT04184622|529858043|FG003|Additional Treatment Period|Protocol deviation|0|||
146916742|NCT04184622|529858040|FG000|Additional Treatment Period|Site closed|1|||
146916743|NCT04184622|529858041|FG001|Additional Treatment Period|Site closed|0|||
146916744|NCT04184622|529858042|FG002|Additional Treatment Period|Site closed|1|||
146916745|NCT04184622|529858043|FG003|Additional Treatment Period|Site closed|0|||
146916746|NCT04184622|529858040|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
146916747|NCT04184622|529858041|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
146916748|NCT04184622|529858042|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
146916749|NCT04184622|529858043|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
146916750|NCT04184622|529858040|FG000|Safety Follow-up Period|Adverse Event|6|||
146916751|NCT04184622|529858041|FG001|Safety Follow-up Period|Adverse Event|8|||
146916752|NCT04184622|529858042|FG002|Safety Follow-up Period|Adverse Event|9|||
146916753|NCT04184622|529858043|FG003|Safety Follow-up Period|Adverse Event|16|||
146916754|NCT04184622|529858040|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
146916755|NCT04184622|529858041|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
146916756|NCT04184622|529858042|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
146916757|NCT04184622|529858043|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
146916758|NCT04184622|529858040|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
146916759|NCT04184622|529858041|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
146916760|NCT04184622|529858042|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
146916761|NCT04184622|529858043|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
146916762|NCT04184622|529858040|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
146916763|NCT04184622|529858041|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
146916764|NCT04184622|529858042|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
146916765|NCT04184622|529858043|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
146916766|NCT04184622|529858040|FG000|Safety Follow-up Period|Physician Decision|1|||
146916767|NCT04184622|529858041|FG001|Safety Follow-up Period|Physician Decision|0|||
146651082|NCT00534599|528898172|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
146977019|NCT01326702|530079289|FG006|Overall Study|Withdrawal by Subject|3|||
146977020|NCT01326702|530079283|FG000|Overall Study|Not Treated|0|||
146977021|NCT01326702|530079284|FG001|Overall Study|Not Treated|0|||
146977022|NCT01326702|530079285|FG002|Overall Study|Not Treated|0|||
146977023|NCT01326702|530079286|FG003|Overall Study|Not Treated|1|||
146977024|NCT01326702|530079287|FG004|Overall Study|Not Treated|0|||
146977025|NCT01326702|530079288|FG005|Overall Study|Not Treated|1|||
146977026|NCT01326702|530079289|FG006|Overall Study|Not Treated|0|||
146977027|NCT02082912|530079290|FG000|Overall Study|Physician Decision|0|||
146977028|NCT02082912|530079291|FG001|Overall Study|Physician Decision|1|||
146977029|NCT01835132|530079297|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
146977030|NCT00265083|530079298|FG000|Overall Study|Adverse Event|5|||
146977031|NCT00265083|530079299|FG001|Overall Study|Adverse Event|13|||
146977032|NCT00265083|530079300|FG002|Overall Study|Adverse Event|15|||
146977033|NCT00265083|530079298|FG000|Overall Study|Lost to Follow-up|3|||
146977034|NCT00265083|530079299|FG001|Overall Study|Lost to Follow-up|4|||
146977035|NCT00265083|530079300|FG002|Overall Study|Lost to Follow-up|4|||
146977036|NCT00265083|530079298|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
146977037|NCT00265083|530079299|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
146977038|NCT00265083|530079300|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
146977039|NCT00265083|530079298|FG000|Overall Study|Other|1|||
146977040|NCT00265083|530079299|FG001|Overall Study|Other|12|||
146977041|NCT00265083|530079300|FG002|Overall Study|Other|9|||
146977042|NCT03208933|530079301|FG000|Overall Study|Death|3|||
146977043|NCT03208933|530079301|FG000|Overall Study|Withdrawal by Subject|3|||
146977044|NCT03208933|530079301|FG000|Overall Study|Adverse Event|1|||
146977045|NCT03208933|530079301|FG000|Overall Study|Lost to Follow-up|2|||
146977046|NCT03208933|530079301|FG000|Overall Study|Physician Decision|3|||
146977047|NCT03208933|530079301|FG000|Overall Study|Protocol Violation|1|||
146977048|NCT00782275|530079304|FG000|Overall Study|Adverse Event|11|||
146977049|NCT00782275|530079304|FG000|Overall Study|Withdrawal by Subject|1|||
146977050|NCT00782275|530079304|FG000|Overall Study|Progressive Disease|21|||
146977051|NCT00782275|530079304|FG000|Overall Study|Physician Decision|4|||
146977052|NCT00782275|530079304|FG000|Overall Study|Not started treatment|1|||
146977053|NCT00782275|530079304|FG000|Overall Study|Other|3|||
146977054|NCT04378010|530079305|FG000|Overall Study|Adverse Event|8|||
146977055|NCT04378010|530079306|FG001|Overall Study|Adverse Event|14|||
146977056|NCT04378010|530079307|FG002|Overall Study|Adverse Event|4|||
146977057|NCT04378010|530079305|FG000|Overall Study|Withdrawal by Subject|0|||
146977058|NCT04378010|530079306|FG001|Overall Study|Withdrawal by Subject|2|||
146977059|NCT04378010|530079307|FG002|Overall Study|Withdrawal by Subject|1|||
146977060|NCT04378010|530079305|FG000|Overall Study|Protocol Violation|2|||
146977061|NCT04378010|530079306|FG001|Overall Study|Protocol Violation|1|||
146977062|NCT04378010|530079307|FG002|Overall Study|Protocol Violation|4|||
146977063|NCT04378010|530079305|FG000|Overall Study|Study terminated by Sponsor|22|||
146977064|NCT04378010|530079306|FG001|Overall Study|Study terminated by Sponsor|16|||
146977065|NCT04378010|530079307|FG002|Overall Study|Study terminated by Sponsor|22|||
146977066|NCT04378010|530079305|FG000|Overall Study|Subject inability to complete study visit|0|||
146977067|NCT04378010|530079306|FG001|Overall Study|Subject inability to complete study visit|0|||
146977068|NCT04378010|530079307|FG002|Overall Study|Subject inability to complete study visit|1|||
146977069|NCT04378010|530079305|FG000|Overall Study|Subject never dosed|0|||
146977070|NCT04378010|530079306|FG001|Overall Study|Subject never dosed|1|||
146977071|NCT04378010|530079307|FG002|Overall Study|Subject never dosed|0|||
146977072|NCT02019979|530079308|FG000|Overall Study|study terminated|14|||
146977073|NCT02513459|530079309|FG000|Overall Study|Adverse Event|7|||
146977074|NCT02513459|530079309|FG000|Overall Study|Withdrew consent|5|||
146977075|NCT02513459|530079309|FG000|Overall Study|Loss of efficacy|2|||
146977076|NCT02513459|530079309|FG000|Overall Study|Pregnancy|2|||
146977077|NCT02513459|530079309|FG000|Overall Study|Subject decision|2|||
146977078|NCT02513459|530079309|FG000|Overall Study|Lack of response|1|||
146977079|NCT02513459|530079309|FG000|Overall Study|Reproductive plans|1|||
146977080|NCT02513459|530079309|FG000|Overall Study|Surgery planned-- not done|1|||
146977081|NCT03237611|530079310|FG000|Overall Study|Withdrawal by Subject|1|||
146977082|NCT03237611|530079310|FG000|Overall Study|Ineligible|1|||
146977083|NCT00923195|530079314|FG000|Overall Study|Death|0|||
146977084|NCT00923195|530079315|FG001|Overall Study|Death|1|||
146977085|NCT00525031|530079316|FG000|Overall Study|Disease Progression|1|||
146977086|NCT00525031|530079317|FG001|Overall Study|Disease Progression|1|||
146977087|NCT00830063|530079320|FG000|Overall Study|Adverse Event|7|||
146977088|NCT00830063|530079321|FG001|Overall Study|Adverse Event|13|||
146977089|NCT00830063|530079322|FG002|Overall Study|Adverse Event|16|||
146977090|NCT00830063|530079323|FG003|Overall Study|Adverse Event|13|||
146977091|NCT00830063|530079320|FG000|Overall Study|Death|1|||
146977092|NCT00830063|530079321|FG001|Overall Study|Death|0|||
146977093|NCT00830063|530079322|FG002|Overall Study|Death|0|||
146977094|NCT00830063|530079323|FG003|Overall Study|Death|0|||
146977095|NCT00830063|530079320|FG000|Overall Study|Lost to Follow-up|0|||
146977096|NCT00830063|530079321|FG001|Overall Study|Lost to Follow-up|0|||
146977097|NCT00830063|530079322|FG002|Overall Study|Lost to Follow-up|3|||
146977098|NCT00830063|530079323|FG003|Overall Study|Lost to Follow-up|1|||
146977099|NCT00830063|530079320|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
146977100|NCT00830063|530079321|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
146977101|NCT00830063|530079322|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
146916768|NCT04184622|529858042|FG002|Safety Follow-up Period|Physician Decision|0|||
146916769|NCT04184622|529858043|FG003|Safety Follow-up Period|Physician Decision|1|||
146916770|NCT04184622|529858040|FG000|Safety Follow-up Period|Pregnancy|1|||
146916771|NCT04184622|529858041|FG001|Safety Follow-up Period|Pregnancy|3|||
146916772|NCT04184622|529858042|FG002|Safety Follow-up Period|Pregnancy|0|||
146916773|NCT04184622|529858043|FG003|Safety Follow-up Period|Pregnancy|6|||
146916774|NCT04184622|529858040|FG000|Safety Follow-up Period|Protocol deviation|1|||
146916775|NCT04184622|529858041|FG001|Safety Follow-up Period|Protocol deviation|0|||
146916776|NCT04184622|529858042|FG002|Safety Follow-up Period|Protocol deviation|0|||
146916777|NCT04184622|529858043|FG003|Safety Follow-up Period|Protocol deviation|0|||
146916778|NCT04184622|529858040|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
146916779|NCT04184622|529858041|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
146916780|NCT04184622|529858042|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
146916781|NCT04184622|529858043|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
146916782|NCT02795988|529858044|FG000|Phase 1b|Withdrawal by Subject|0|||
146916783|NCT02795988|529858045|FG001|Phase 1b|Withdrawal by Subject|1|||
146916784|NCT02795988|529858046|FG002|Phase 1b|Withdrawal by Subject|0|||
146916785|NCT02795988|529858047|FG003|Phase 1b|Withdrawal by Subject|0|||
146916786|NCT02795988|529858048|FG004|Phase 1b|Withdrawal by Subject|0|||
146916787|NCT02795988|529858049|FG005|Phase 1b|Withdrawal by Subject|0|||
146916788|NCT02795988|529858050|FG006|Phase 1b|Withdrawal by Subject|0|||
146916789|NCT02795988|529858044|FG000|Phase 1b|Death|1|||
146916790|NCT02795988|529858045|FG001|Phase 1b|Death|2|||
146916791|NCT02795988|529858046|FG002|Phase 1b|Death|1|||
146916792|NCT02795988|529858047|FG003|Phase 1b|Death|0|||
146916793|NCT02795988|529858048|FG004|Phase 1b|Death|0|||
146916794|NCT02795988|529858049|FG005|Phase 1b|Death|0|||
146916795|NCT02795988|529858050|FG006|Phase 1b|Death|0|||
146916796|NCT02795988|529858044|FG000|Phase 1b|Physician Decision|0|||
146916797|NCT02795988|529858045|FG001|Phase 1b|Physician Decision|0|||
146916798|NCT02795988|529858046|FG002|Phase 1b|Physician Decision|1|||
146916799|NCT02795988|529858047|FG003|Phase 1b|Physician Decision|0|||
146916800|NCT02795988|529858048|FG004|Phase 1b|Physician Decision|0|||
146916801|NCT02795988|529858049|FG005|Phase 1b|Physician Decision|0|||
146916802|NCT02795988|529858050|FG006|Phase 1b|Physician Decision|0|||
146916803|NCT02795988|529858044|FG000|Phase 1b|Progressive Disease|2|||
146916804|NCT02795988|529858045|FG001|Phase 1b|Progressive Disease|2|||
146916805|NCT02795988|529858046|FG002|Phase 1b|Progressive Disease|0|||
146916806|NCT02795988|529858047|FG003|Phase 1b|Progressive Disease|0|||
146916807|NCT02795988|529858048|FG004|Phase 1b|Progressive Disease|0|||
146916808|NCT02795988|529858049|FG005|Phase 1b|Progressive Disease|0|||
146916809|NCT02795988|529858050|FG006|Phase 1b|Progressive Disease|0|||
146916810|NCT02795988|529858044|FG000|Phase 2|Withdrawal by Subject|0|||
146916811|NCT02795988|529858045|FG001|Phase 2|Withdrawal by Subject|0|||
146916812|NCT02795988|529858046|FG002|Phase 2|Withdrawal by Subject|0|||
146916813|NCT02795988|529858047|FG003|Phase 2|Withdrawal by Subject|1|||
146916814|NCT02795988|529858048|FG004|Phase 2|Withdrawal by Subject|0|||
146916815|NCT02795988|529858049|FG005|Phase 2|Withdrawal by Subject|0|||
146916816|NCT02795988|529858050|FG006|Phase 2|Withdrawal by Subject|0|||
146916817|NCT02795988|529858044|FG000|Phase 2|Death|0|||
146916818|NCT02795988|529858045|FG001|Phase 2|Death|0|||
146916819|NCT02795988|529858046|FG002|Phase 2|Death|0|||
146916820|NCT02795988|529858047|FG003|Phase 2|Death|17|||
146916821|NCT02795988|529858048|FG004|Phase 2|Death|17|||
146916822|NCT02795988|529858049|FG005|Phase 2|Death|0|||
146916823|NCT02795988|529858050|FG006|Phase 2|Death|0|||
146916824|NCT02795988|529858044|FG000|Phase 2|Other|0|||
146916825|NCT02795988|529858045|FG001|Phase 2|Other|0|||
146916826|NCT02795988|529858046|FG002|Phase 2|Other|0|||
146916827|NCT02795988|529858047|FG003|Phase 2|Other|1|||
146916828|NCT02795988|529858048|FG004|Phase 2|Other|0|||
146916829|NCT02795988|529858049|FG005|Phase 2|Other|0|||
146916830|NCT02795988|529858050|FG006|Phase 2|Other|0|||
146916831|NCT02795988|529858044|FG000|Phase 2 Extension|Death|0|||
146916832|NCT02795988|529858045|FG001|Phase 2 Extension|Death|0|||
146916833|NCT02795988|529858046|FG002|Phase 2 Extension|Death|0|||
146916834|NCT02795988|529858047|FG003|Phase 2 Extension|Death|0|||
146916835|NCT02795988|529858048|FG004|Phase 2 Extension|Death|0|||
146916836|NCT02795988|529858049|FG005|Phase 2 Extension|Death|5|||
146916837|NCT02795988|529858050|FG006|Phase 2 Extension|Death|6|||
146916838|NCT02795988|529858044|FG000|Phase 2 Extension|Other reasons|0|||
146916839|NCT02795988|529858045|FG001|Phase 2 Extension|Other reasons|0|||
146916840|NCT02795988|529858046|FG002|Phase 2 Extension|Other reasons|0|||
146916841|NCT02795988|529858047|FG003|Phase 2 Extension|Other reasons|0|||
146916842|NCT02795988|529858048|FG004|Phase 2 Extension|Other reasons|0|||
146916843|NCT02795988|529858049|FG005|Phase 2 Extension|Other reasons|2|||
146916844|NCT02795988|529858050|FG006|Phase 2 Extension|Other reasons|1|||
146916845|NCT02341014|529858051|FG000|Overall Study|Adverse Event|0|||
146916846|NCT02341014|529858052|FG001|Overall Study|Adverse Event|1|||
146916847|NCT02341014|529858053|FG002|Overall Study|Adverse Event|0|||
146916848|NCT02341014|529858054|FG003|Overall Study|Adverse Event|0|||
146916849|NCT02341014|529858055|FG004|Overall Study|Adverse Event|2|||
146916850|NCT04705597|529858056|FG000|Overall Study|Death|16|||
146916851|NCT04705597|529858057|FG001|Overall Study|Death|9|||
146651083|NCT00534599|528898171|FG000|Overall Study|Protocol Violation|1|||
146651084|NCT00534599|528898172|FG001|Overall Study|Protocol Violation|3|||
146651085|NCT00534599|528898171|FG000|Overall Study|Lost to Follow-up|11|||
146651086|NCT00534599|528898172|FG001|Overall Study|Lost to Follow-up|14|||
146651087|NCT00534599|528898171|FG000|Overall Study|Withdrawal by Subject|4|||
146651088|NCT00534599|528898172|FG001|Overall Study|Withdrawal by Subject|6|||
146651089|NCT00534599|528898171|FG000|Overall Study|Other|7|||
146651090|NCT00534599|528898172|FG001|Overall Study|Other|0|||
146651091|NCT00773383|528900391|FG000|Overall Study|Adverse Event|4|||
146651092|NCT00773383|528900391|FG000|Overall Study|Death|1|||
146651093|NCT00773383|528900391|FG000|Overall Study|Progression of Disease|23|||
146651094|NCT00773383|528900391|FG000|Overall Study|Other|2|||
146651095|NCT00773383|528900391|FG000|Overall Study|No study dose received|1|||
146651096|NCT03384693|528900392|FG000|Overall Study|Adverse Event|3|||
146977102|NCT00830063|530079323|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
146977103|NCT00830063|530079320|FG000|Overall Study|Lack of Efficacy|51|||
146977104|NCT00830063|530079321|FG001|Overall Study|Lack of Efficacy|23|||
146977105|NCT00830063|530079322|FG002|Overall Study|Lack of Efficacy|25|||
146977106|NCT00830063|530079323|FG003|Overall Study|Lack of Efficacy|32|||
146977107|NCT00830063|530079320|FG000|Overall Study|Other|5|||
146651097|NCT03811093|528900410|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
146651098|NCT03811093|528900411|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
146651099|NCT03811093|528900410|FG000|Overall Study|Unable to measure body fat percentage|2|||
146651100|NCT03811093|528900411|FG001|Overall Study|Unable to measure body fat percentage|0|||
146651101|NCT01095094|528900413|FG000|Overall Study|Withdrawal by Subject|1|||
146651102|NCT01095094|528900413|FG000|Overall Study|Death|1|||
146651103|NCT01095094|528900413|FG000|Overall Study|Physician Decision|1|||
146651104|NCT03699475|528900415|FG000|Overall Study|Death|1|||
146651105|NCT00137839|528900416|FG000|Overall Study|Adverse Event|7|||
146651106|NCT00137839|528900416|FG000|Overall Study|Physician Decision|7|||
146651107|NCT00137839|528900416|FG000|Overall Study|Death|8|||
146977108|NCT00830063|530079321|FG001|Overall Study|Other|5|||
146977109|NCT00830063|530079322|FG002|Overall Study|Other|8|||
146977110|NCT00830063|530079323|FG003|Overall Study|Other|6|||
146977111|NCT00830063|530079320|FG000|Overall Study|Withdrawal by Subject|16|||
146977112|NCT00830063|530079321|FG001|Overall Study|Withdrawal by Subject|10|||
146977113|NCT00830063|530079322|FG002|Overall Study|Withdrawal by Subject|16|||
146977114|NCT00830063|530079323|FG003|Overall Study|Withdrawal by Subject|13|||
146977115|NCT00830063|530079320|FG000|Overall Study|Protocol Violation|1|||
146977116|NCT00830063|530079321|FG001|Overall Study|Protocol Violation|0|||
146977117|NCT00830063|530079322|FG002|Overall Study|Protocol Violation|3|||
146977118|NCT00830063|530079323|FG003|Overall Study|Protocol Violation|2|||
146977119|NCT00830063|530079320|FG000|Overall Study|Randomized But Not Treated|0|||
146977120|NCT00830063|530079321|FG001|Overall Study|Randomized But Not Treated|2|||
146977121|NCT00830063|530079322|FG002|Overall Study|Randomized But Not Treated|0|||
146977122|NCT00830063|530079323|FG003|Overall Study|Randomized But Not Treated|2|||
146977123|NCT02140164|530079326|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
146977124|NCT01814761|530079327|FG000|Overall Study|Other Reasons|1|||
146977125|NCT01814761|530079328|FG001|Overall Study|Other Reasons|10|||
146977126|NCT01814761|530079327|FG000|Overall Study|Ocular Adverse Event|6|||
146977127|NCT01814761|530079328|FG001|Overall Study|Ocular Adverse Event|15|||
146977128|NCT01814761|530079327|FG000|Overall Study|Lost to Follow-up|1|||
146977129|NCT01814761|530079328|FG001|Overall Study|Lost to Follow-up|5|||
146977130|NCT01872689|530079343|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
146977131|NCT01872689|530079344|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
146977132|NCT01872689|530079345|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
146977133|NCT01872689|530079346|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
146977134|NCT01872689|530079343|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
146977135|NCT01872689|530079344|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
146977136|NCT01872689|530079345|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
146651108|NCT00137839|528900416|FG000|Overall Study|Disease Progression|60|||
146651109|NCT00137839|528900416|FG000|Overall Study|Not Start Treatment|1|||
146651110|NCT00137839|528900416|FG000|Overall Study|Prolonged Treatment Delay|1|||
146651111|NCT00528970|528900417|FG000|Overall Study|Adverse Event|6|||
146651112|NCT00528970|528900418|FG001|Overall Study|Adverse Event|8|||
146651113|NCT00528970|528900419|FG002|Overall Study|Adverse Event|5|||
146651114|NCT00528970|528900417|FG000|Overall Study|Lost to Follow-up|0|||
146651115|NCT00528970|528900418|FG001|Overall Study|Lost to Follow-up|0|||
146977137|NCT01872689|530079346|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
146977138|NCT01872689|530079343|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
146977139|NCT01872689|530079344|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
147013205|NCT02048813|530210053|FG001|Overall Study|Disease progression|3|||
146651116|NCT00528970|528900419|FG002|Overall Study|Lost to Follow-up|1|||
146651117|NCT00528970|528900417|FG000|Overall Study|Other than specified|2|||
146651118|NCT00528970|528900418|FG001|Overall Study|Other than specified|3|||
146651119|NCT00528970|528900419|FG002|Overall Study|Other than specified|3|||
146651120|NCT00528970|528900417|FG000|Overall Study|Protocol Violation|2|||
146651121|NCT00528970|528900418|FG001|Overall Study|Protocol Violation|1|||
146651122|NCT00528970|528900419|FG002|Overall Study|Protocol Violation|4|||
146651123|NCT00528970|528900417|FG000|Overall Study|Lack of Efficacy|0|||
146651124|NCT00528970|528900418|FG001|Overall Study|Lack of Efficacy|0|||
146651125|NCT00528970|528900419|FG002|Overall Study|Lack of Efficacy|1|||
146651126|NCT00528970|528900417|FG000|Overall Study|Withdrawal by Subject|4|||
146651127|NCT00528970|528900418|FG001|Overall Study|Withdrawal by Subject|3|||
146651128|NCT00528970|528900419|FG002|Overall Study|Withdrawal by Subject|5|||
146651129|NCT00528970|528900417|FG000|Overall Study|Randomized but not treated|0|||
146651130|NCT00528970|528900418|FG001|Overall Study|Randomized but not treated|0|||
146651131|NCT00528970|528900419|FG002|Overall Study|Randomized but not treated|1|||
146651132|NCT01122394|528900427|FG000|Overall Study|Withdrawal by Subject|1|||
146651133|NCT01122394|528900428|FG001|Overall Study|Withdrawal by Subject|1|||
146651134|NCT01122394|528900427|FG000|Overall Study|Lost to Follow-up|2|||
146651135|NCT01122394|528900428|FG001|Overall Study|Lost to Follow-up|2|||
146651136|NCT01122394|528900427|FG000|Overall Study|Adverse Event|0|||
146651137|NCT01122394|528900428|FG001|Overall Study|Adverse Event|1|||
146651138|NCT03739242|528900429|FG000|Overall Study|Withdrawal by Subject|1|||
146651139|NCT03739242|528900430|FG001|Overall Study|Withdrawal by Subject|1|||
146651140|NCT03739242|528900429|FG000|Overall Study|Protocol Violation|0|||
146651141|NCT03739242|528900430|FG001|Overall Study|Protocol Violation|1|||
146651142|NCT00039871|528900431|FG000|Overall Study|Adverse Event|165|||
146651143|NCT00039871|528900431|FG000|Overall Study|Lost to Follow-up|18|||
146651144|NCT00039871|528900431|FG000|Overall Study|Protocol Violation|24|||
146651145|NCT00039871|528900431|FG000|Overall Study|Withdrawal by Subject|97|||
146651146|NCT00039871|528900431|FG000|Overall Study|Did not meet eligibility criteria|11|||
146651147|NCT00039871|528900431|FG000|Overall Study|Administrative|1|||
146651148|NCT00039871|528900431|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
146651149|NCT00039871|528900431|FG000|Overall Study|Never entered follow-up|7|||
146651150|NCT02446743|528900432|FG000|Overall Study|Withdrawal by Subject|1|||
146651151|NCT02446743|528900433|FG001|Overall Study|Withdrawal by Subject|1|||
146651152|NCT02446743|528900432|FG000|Overall Study|Lost to Follow-up|1|||
146916852|NCT04705597|529858056|FG000|Overall Study|Lost to Follow-up|1|||
146916853|NCT04705597|529858057|FG001|Overall Study|Lost to Follow-up|0|||
146916854|NCT04705597|529858056|FG000|Overall Study|Withdrawal by Subject|1|||
146916855|NCT04705597|529858057|FG001|Overall Study|Withdrawal by Subject|2|||
146916856|NCT00390780|529858061|FG000|Overall Study|Not completed|10|||
146916857|NCT00390780|529858062|FG001|Overall Study|Not completed|4|||
146916858|NCT00390780|529858061|FG000|Overall Study|Protocol Violation|6|||
146916859|NCT00390780|529858062|FG001|Overall Study|Protocol Violation|4|||
146916860|NCT00390780|529858061|FG000|Overall Study|Lost to Follow-up|3|||
146916861|NCT00390780|529858062|FG001|Overall Study|Lost to Follow-up|6|||
146916862|NCT00390780|529858061|FG000|Overall Study|Adverse Event|2|||
146916863|NCT00390780|529858062|FG001|Overall Study|Adverse Event|3|||
146916864|NCT00390780|529858061|FG000|Overall Study|Death|1|||
146916865|NCT00390780|529858062|FG001|Overall Study|Death|3|||
146916866|NCT00390780|529858061|FG000|Overall Study|Withdrawal by Subject|1|||
146916867|NCT00390780|529858062|FG001|Overall Study|Withdrawal by Subject|2|||
146916868|NCT00390780|529858061|FG000|Overall Study|Inclusion criteria not satisfied|0|||
146916869|NCT00390780|529858062|FG001|Overall Study|Inclusion criteria not satisfied|2|||
146916870|NCT00390780|529858061|FG000|Overall Study|Lost to follow up and other reasons|0|||
146916871|NCT00390780|529858062|FG001|Overall Study|Lost to follow up and other reasons|1|||
146916872|NCT00390780|529858061|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
146916873|NCT00390780|529858062|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
146916874|NCT00390780|529858061|FG000|Overall Study|SAE, death|0|||
146916875|NCT00390780|529858062|FG001|Overall Study|SAE, death|1|||
146916876|NCT01070550|529858064|FG000|Overall Study|Adverse Event|43|||
146916877|NCT01070550|529858065|FG001|Overall Study|Adverse Event|1|||
146916878|NCT01070550|529858066|FG002|Overall Study|Adverse Event|3|||
146916879|NCT01070550|529858067|FG003|Overall Study|Adverse Event|0|||
146916880|NCT01070550|529858068|FG004|Overall Study|Adverse Event|0|||
146916881|NCT01070550|529858069|FG005|Overall Study|Adverse Event|0|||
146916882|NCT01070550|529858064|FG000|Overall Study|Death|20|||
146916883|NCT01070550|529858065|FG001|Overall Study|Death|4|||
146916884|NCT01070550|529858066|FG002|Overall Study|Death|3|||
146916885|NCT01070550|529858067|FG003|Overall Study|Death|0|||
146651153|NCT02446743|528900433|FG001|Overall Study|Lost to Follow-up|0|||
146651154|NCT02446743|528900432|FG000|Overall Study|Adverse Event|1|||
146651155|NCT02446743|528900433|FG001|Overall Study|Adverse Event|1|||
146770555|NCT00424762|529328638|FG001|Overall Study|Lost to Follow-up|3|||
146770556|NCT00723450|529328639|FG000|Open-Label Phase|Adverse Event|26|||
146916886|NCT01070550|529858068|FG004|Overall Study|Death|0|||
146916887|NCT01070550|529858069|FG005|Overall Study|Death|0|||
146916888|NCT01070550|529858064|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
146916889|NCT01070550|529858065|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
146916890|NCT01070550|529858066|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
146916891|NCT01070550|529858067|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
146770557|NCT00723450|529328640|FG001|Open-Label Phase|Adverse Event|0|||
146651156|NCT02446743|528900432|FG000|Overall Study|Other|2|||
146651157|NCT02446743|528900433|FG001|Overall Study|Other|3|||
146651158|NCT03361176|528900434|FG000|Overall Study|Lost to Follow-up|1|||
146651159|NCT03361176|528900435|FG001|Overall Study|Lost to Follow-up|2|||
146651160|NCT03361176|528900434|FG000|Overall Study|Adverse Event|0|||
146651161|NCT03361176|528900435|FG001|Overall Study|Adverse Event|2|||
146651162|NCT03361176|528900434|FG000|Overall Study|Withdrawal by Subject|0|||
146651163|NCT03361176|528900435|FG001|Overall Study|Withdrawal by Subject|1|||
146651164|NCT02478398|528900436|FG000|Overall Study|Adverse Event|20|||
146651165|NCT02478398|528900437|FG001|Overall Study|Adverse Event|5|||
146651166|NCT02478398|528900436|FG000|Overall Study|Lost to Follow-up|5|||
146651167|NCT02478398|528900437|FG001|Overall Study|Lost to Follow-up|4|||
146651168|NCT02478398|528900436|FG000|Overall Study|Non-Compliance With Study Drug|5|||
146651169|NCT02478398|528900437|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146651170|NCT02478398|528900436|FG000|Overall Study|Protocol Violation|3|||
146651171|NCT02478398|528900437|FG001|Overall Study|Protocol Violation|1|||
146651172|NCT02478398|528900436|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
146651173|NCT02478398|528900437|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
146916892|NCT01070550|529858068|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
146916893|NCT01070550|529858069|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
146916894|NCT01070550|529858064|FG000|Overall Study|Early termination|3|||
146916895|NCT01070550|529858065|FG001|Overall Study|Early termination|0|||
146916896|NCT01070550|529858066|FG002|Overall Study|Early termination|0|||
146916897|NCT01070550|529858067|FG003|Overall Study|Early termination|0|||
146916898|NCT01070550|529858068|FG004|Overall Study|Early termination|0|||
146916899|NCT01070550|529858069|FG005|Overall Study|Early termination|0|||
146916900|NCT01070550|529858064|FG000|Overall Study|Failed to return|450|||
146916901|NCT01070550|529858065|FG001|Overall Study|Failed to return|33|||
146916902|NCT01070550|529858066|FG002|Overall Study|Failed to return|144|||
146916903|NCT01070550|529858067|FG003|Overall Study|Failed to return|40|||
146916904|NCT01070550|529858068|FG004|Overall Study|Failed to return|1|||
146916905|NCT01070550|529858069|FG005|Overall Study|Failed to return|2|||
146916906|NCT01070550|529858064|FG000|Overall Study|Incomplete treatment|2|||
146916907|NCT01070550|529858065|FG001|Overall Study|Incomplete treatment|0|||
146916908|NCT01070550|529858066|FG002|Overall Study|Incomplete treatment|0|||
146916909|NCT01070550|529858067|FG003|Overall Study|Incomplete treatment|0|||
146916910|NCT01070550|529858068|FG004|Overall Study|Incomplete treatment|0|||
146916911|NCT01070550|529858069|FG005|Overall Study|Incomplete treatment|0|||
146916912|NCT01070550|529858064|FG000|Overall Study|Lab test not done|22|||
146916913|NCT01070550|529858065|FG001|Overall Study|Lab test not done|3|||
146916914|NCT01070550|529858066|FG002|Overall Study|Lab test not done|4|||
146916915|NCT01070550|529858067|FG003|Overall Study|Lab test not done|1|||
146916916|NCT01070550|529858068|FG004|Overall Study|Lab test not done|0|||
146916917|NCT01070550|529858069|FG005|Overall Study|Lab test not done|1|||
146916918|NCT01070550|529858064|FG000|Overall Study|Lack of Efficacy|65|||
146916919|NCT01070550|529858065|FG001|Overall Study|Lack of Efficacy|1|||
146916920|NCT01070550|529858066|FG002|Overall Study|Lack of Efficacy|5|||
146916921|NCT01070550|529858067|FG003|Overall Study|Lack of Efficacy|5|||
146916922|NCT01070550|529858068|FG004|Overall Study|Lack of Efficacy|0|||
146916923|NCT01070550|529858069|FG005|Overall Study|Lack of Efficacy|1|||
146916924|NCT01070550|529858064|FG000|Overall Study|Miscellaneous|12|||
146916925|NCT01070550|529858065|FG001|Overall Study|Miscellaneous|2|||
146916926|NCT01070550|529858066|FG002|Overall Study|Miscellaneous|3|||
146916927|NCT01070550|529858067|FG003|Overall Study|Miscellaneous|1|||
146916928|NCT01070550|529858068|FG004|Overall Study|Miscellaneous|0|||
146916929|NCT01070550|529858069|FG005|Overall Study|Miscellaneous|0|||
146916930|NCT01070550|529858064|FG000|Overall Study|New treatment started|3|||
146916931|NCT01070550|529858065|FG001|Overall Study|New treatment started|1|||
146916932|NCT01070550|529858066|FG002|Overall Study|New treatment started|0|||
146916933|NCT01070550|529858067|FG003|Overall Study|New treatment started|2|||
146916934|NCT01070550|529858068|FG004|Overall Study|New treatment started|0|||
146916935|NCT01070550|529858069|FG005|Overall Study|New treatment started|0|||
146916936|NCT01070550|529858064|FG000|Overall Study|Non-responders|493|||
146916937|NCT01070550|529858065|FG001|Overall Study|Non-responders|4|||
146916938|NCT01070550|529858066|FG002|Overall Study|Non-responders|21|||
146916939|NCT01070550|529858067|FG003|Overall Study|Non-responders|20|||
146916940|NCT01070550|529858068|FG004|Overall Study|Non-responders|0|||
146916941|NCT01070550|529858069|FG005|Overall Study|Non-responders|2|||
146916942|NCT01070550|529858064|FG000|Overall Study|Not categorized|33|||
146916943|NCT01070550|529858065|FG001|Overall Study|Not categorized|2|||
146916944|NCT01070550|529858066|FG002|Overall Study|Not categorized|6|||
146916945|NCT01070550|529858067|FG003|Overall Study|Not categorized|1|||
146916946|NCT01070550|529858068|FG004|Overall Study|Not categorized|0|||
146916947|NCT01070550|529858069|FG005|Overall Study|Not categorized|1|||
146916948|NCT01070550|529858064|FG000|Overall Study|Protocol Violation|15|||
146977140|NCT01872689|530079345|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
146916949|NCT01070550|529858065|FG001|Overall Study|Protocol Violation|1|||
146651174|NCT02478398|528900436|FG000|Overall Study|Withdrawal By Participant|10|||
146651175|NCT02478398|528900437|FG001|Overall Study|Withdrawal By Participant|4|||
146977141|NCT01872689|530079346|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
146916950|NCT01070550|529858066|FG002|Overall Study|Protocol Violation|1|||
146916951|NCT01070550|529858067|FG003|Overall Study|Protocol Violation|1|||
146916952|NCT01070550|529858068|FG004|Overall Study|Protocol Violation|0|||
146916953|NCT01070550|529858069|FG005|Overall Study|Protocol Violation|0|||
146916954|NCT01070550|529858064|FG000|Overall Study|Relapse|44|||
146916955|NCT01070550|529858065|FG001|Overall Study|Relapse|5|||
146916956|NCT01070550|529858066|FG002|Overall Study|Relapse|14|||
146916957|NCT01070550|529858067|FG003|Overall Study|Relapse|4|||
146916958|NCT01070550|529858068|FG004|Overall Study|Relapse|0|||
146916959|NCT01070550|529858069|FG005|Overall Study|Relapse|0|||
146916960|NCT01070550|529858064|FG000|Overall Study|Result not available|3|||
146916961|NCT01070550|529858065|FG001|Overall Study|Result not available|1|||
146916962|NCT01070550|529858066|FG002|Overall Study|Result not available|3|||
146916963|NCT01070550|529858067|FG003|Overall Study|Result not available|0|||
146916964|NCT01070550|529858068|FG004|Overall Study|Result not available|0|||
146916965|NCT01070550|529858069|FG005|Overall Study|Result not available|0|||
146916966|NCT01070550|529858064|FG000|Overall Study|Screen failure|1|||
146916967|NCT01070550|529858065|FG001|Overall Study|Screen failure|0|||
146916968|NCT01070550|529858066|FG002|Overall Study|Screen failure|0|||
146916969|NCT01070550|529858067|FG003|Overall Study|Screen failure|0|||
146916970|NCT01070550|529858068|FG004|Overall Study|Screen failure|0|||
146916971|NCT01070550|529858069|FG005|Overall Study|Screen failure|0|||
146916972|NCT01070550|529858064|FG000|Overall Study|Sponsor decision|1|||
146916973|NCT01070550|529858065|FG001|Overall Study|Sponsor decision|0|||
146916974|NCT01070550|529858066|FG002|Overall Study|Sponsor decision|0|||
146916975|NCT01070550|529858067|FG003|Overall Study|Sponsor decision|0|||
146916976|NCT01070550|529858068|FG004|Overall Study|Sponsor decision|0|||
146916977|NCT01070550|529858069|FG005|Overall Study|Sponsor decision|0|||
146916978|NCT01070550|529858064|FG000|Overall Study|Treatment duration shortened|1|||
146916979|NCT01070550|529858065|FG001|Overall Study|Treatment duration shortened|0|||
146916980|NCT01070550|529858066|FG002|Overall Study|Treatment duration shortened|0|||
146916981|NCT01070550|529858067|FG003|Overall Study|Treatment duration shortened|0|||
146916982|NCT01070550|529858068|FG004|Overall Study|Treatment duration shortened|0|||
146916983|NCT01070550|529858069|FG005|Overall Study|Treatment duration shortened|0|||
146916984|NCT01070550|529858064|FG000|Overall Study|Treatment interrupted|7|||
146916985|NCT01070550|529858065|FG001|Overall Study|Treatment interrupted|0|||
146916986|NCT01070550|529858066|FG002|Overall Study|Treatment interrupted|1|||
146916987|NCT01070550|529858067|FG003|Overall Study|Treatment interrupted|1|||
146916988|NCT01070550|529858068|FG004|Overall Study|Treatment interrupted|0|||
146916989|NCT01070550|529858069|FG005|Overall Study|Treatment interrupted|0|||
146916990|NCT01070550|529858064|FG000|Overall Study|Treatment not started|14|||
146916991|NCT01070550|529858065|FG001|Overall Study|Treatment not started|2|||
146916992|NCT01070550|529858066|FG002|Overall Study|Treatment not started|4|||
146916993|NCT01070550|529858067|FG003|Overall Study|Treatment not started|0|||
146916994|NCT01070550|529858068|FG004|Overall Study|Treatment not started|0|||
146916995|NCT01070550|529858069|FG005|Overall Study|Treatment not started|0|||
146916996|NCT01070550|529858064|FG000|Overall Study|Treatment restarted|0|||
146916997|NCT01070550|529858065|FG001|Overall Study|Treatment restarted|1|||
146916998|NCT01070550|529858066|FG002|Overall Study|Treatment restarted|0|||
146916999|NCT01070550|529858067|FG003|Overall Study|Treatment restarted|0|||
146917000|NCT01070550|529858068|FG004|Overall Study|Treatment restarted|0|||
146917001|NCT01070550|529858069|FG005|Overall Study|Treatment restarted|0|||
146917002|NCT01070550|529858064|FG000|Overall Study|Treatment stopped|3|||
146917003|NCT01070550|529858065|FG001|Overall Study|Treatment stopped|0|||
146917004|NCT01070550|529858066|FG002|Overall Study|Treatment stopped|0|||
146917005|NCT01070550|529858067|FG003|Overall Study|Treatment stopped|0|||
146917006|NCT01070550|529858068|FG004|Overall Study|Treatment stopped|0|||
146917007|NCT01070550|529858069|FG005|Overall Study|Treatment stopped|0|||
146917008|NCT01070550|529858064|FG000|Overall Study|Treatment unavailable|1|||
146917009|NCT01070550|529858065|FG001|Overall Study|Treatment unavailable|0|||
146917010|NCT01070550|529858066|FG002|Overall Study|Treatment unavailable|0|||
146917011|NCT01070550|529858067|FG003|Overall Study|Treatment unavailable|0|||
146917012|NCT01070550|529858068|FG004|Overall Study|Treatment unavailable|0|||
146917013|NCT01070550|529858069|FG005|Overall Study|Treatment unavailable|0|||
146917014|NCT01070550|529858064|FG000|Overall Study|Treatment was stopped early|7|||
146917015|NCT01070550|529858065|FG001|Overall Study|Treatment was stopped early|0|||
146917016|NCT01070550|529858066|FG002|Overall Study|Treatment was stopped early|0|||
146917017|NCT01070550|529858067|FG003|Overall Study|Treatment was stopped early|0|||
146917018|NCT01070550|529858068|FG004|Overall Study|Treatment was stopped early|0|||
146917019|NCT01070550|529858069|FG005|Overall Study|Treatment was stopped early|0|||
146917020|NCT01070550|529858064|FG000|Overall Study|Other|5|||
146917021|NCT01070550|529858065|FG001|Overall Study|Other|0|||
146917022|NCT01070550|529858066|FG002|Overall Study|Other|0|||
146917023|NCT01070550|529858067|FG003|Overall Study|Other|1|||
146917024|NCT01070550|529858068|FG004|Overall Study|Other|0|||
146917025|NCT01070550|529858069|FG005|Overall Study|Other|0|||
146917026|NCT01070550|529858064|FG000|Overall Study|Withdrawal by Subject|35|||
146651176|NCT00635024|528900438|FG000|Overall Study|Adverse Event|1|||
146651177|NCT02142387|528900439|FG000|Overall Study|<19 years old|49|||
146651178|NCT02142387|528900440|FG001|Overall Study|<19 years old|326|||
146651179|NCT02142387|528900439|FG000|Overall Study|non-cardiac etiology|504|||
146651180|NCT02142387|528900440|FG001|Overall Study|non-cardiac etiology|3431|||
146651181|NCT02142387|528900439|FG000|Overall Study|CPR not performed|74|||
146651182|NCT02142387|528900440|FG001|Overall Study|CPR not performed|473|||
146651183|NCT02142387|528900439|FG000|Overall Study|witnessed by paramedic|139|||
146651184|NCT02142387|528900440|FG001|Overall Study|witnessed by paramedic|917|||
146651185|NCT02142387|528900439|FG000|Overall Study|incomplete data|1|||
146651186|NCT02142387|528900440|FG001|Overall Study|incomplete data|9|||
146651187|NCT02142387|528900439|FG000|Overall Study|occurred not at home|298|||
146651188|NCT02142387|528900440|FG001|Overall Study|occurred not at home|2474|||
146651189|NCT03490981|528900441|FG000|Overall Study|Lost to Follow-up|1|||
146651190|NCT03490981|528900442|FG001|Overall Study|Lost to Follow-up|2|||
146651191|NCT00420641|528900445|FG000|Overall Study|Adverse Event|3|||
146651192|NCT00420641|528900446|FG001|Overall Study|Adverse Event|25|||
146651193|NCT00420641|528900447|FG002|Overall Study|Adverse Event|10|||
146651194|NCT00420641|528900445|FG000|Overall Study|Lost to Follow-up|2|||
146651195|NCT00420641|528900446|FG001|Overall Study|Lost to Follow-up|4|||
146651196|NCT00420641|528900447|FG002|Overall Study|Lost to Follow-up|2|||
146651197|NCT00420641|528900445|FG000|Overall Study|Protocol Violation|8|||
146651198|NCT00420641|528900446|FG001|Overall Study|Protocol Violation|8|||
146651199|NCT00420641|528900447|FG002|Overall Study|Protocol Violation|7|||
146651200|NCT00420641|528900445|FG000|Overall Study|Withdrawal by Subject|15|||
146651201|NCT00420641|528900446|FG001|Overall Study|Withdrawal by Subject|21|||
146651202|NCT00420641|528900447|FG002|Overall Study|Withdrawal by Subject|14|||
146651203|NCT00420641|528900445|FG000|Overall Study|Lack of Efficacy|6|||
146651204|NCT00420641|528900446|FG001|Overall Study|Lack of Efficacy|5|||
146651205|NCT00420641|528900447|FG002|Overall Study|Lack of Efficacy|4|||
146651206|NCT00420641|528900445|FG000|Overall Study|Non-compliance|7|||
146651207|NCT00420641|528900446|FG001|Overall Study|Non-compliance|5|||
146651208|NCT00420641|528900447|FG002|Overall Study|Non-compliance|4|||
146651209|NCT00420641|528900445|FG000|Overall Study|Other|4|||
146651210|NCT00420641|528900446|FG001|Overall Study|Other|4|||
146651211|NCT00420641|528900447|FG002|Overall Study|Other|3|||
146917027|NCT01070550|529858065|FG001|Overall Study|Withdrawal by Subject|0|||
146917028|NCT01070550|529858066|FG002|Overall Study|Withdrawal by Subject|3|||
146917029|NCT01070550|529858067|FG003|Overall Study|Withdrawal by Subject|0|||
146917030|NCT01070550|529858068|FG004|Overall Study|Withdrawal by Subject|0|||
146917031|NCT01070550|529858069|FG005|Overall Study|Withdrawal by Subject|0|||
146917032|NCT01585961|529858071|FG000|Overall Study|Death|6|||
146917033|NCT01585961|529858071|FG000|Overall Study|Physician Decision|1|||
146917034|NCT01585961|529858071|FG000|Overall Study|Decision to use non-study catheter|1|||
146917035|NCT01585961|529858071|FG000|Overall Study|Withdrawal by Subject|1|||
146917036|NCT01585961|529858071|FG000|Overall Study|Lost to Follow-up|23|||
146917037|NCT01585961|529858071|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
146917038|NCT01258348|529858072|FG000|Overall Study|Adverse Event|1|||
146917039|NCT01258348|529858073|FG001|Overall Study|Adverse Event|1|||
146917040|NCT01258348|529858074|FG002|Overall Study|Adverse Event|3|||
146917041|NCT01258348|529858075|FG003|Overall Study|Adverse Event|2|||
146917042|NCT01258348|529858076|FG004|Overall Study|Adverse Event|4|||
146917043|NCT01258348|529858072|FG000|Overall Study|Progressive Disease|0|||
146917044|NCT01258348|529858073|FG001|Overall Study|Progressive Disease|3|||
146917045|NCT01258348|529858074|FG002|Overall Study|Progressive Disease|0|||
146917046|NCT01258348|529858075|FG003|Overall Study|Progressive Disease|2|||
146917047|NCT01258348|529858076|FG004|Overall Study|Progressive Disease|2|||
146917048|NCT01258348|529858072|FG000|Overall Study|Physician Decision|0|||
146917049|NCT01258348|529858073|FG001|Overall Study|Physician Decision|0|||
146917050|NCT01258348|529858074|FG002|Overall Study|Physician Decision|0|||
146917051|NCT01258348|529858075|FG003|Overall Study|Physician Decision|2|||
146917052|NCT01258348|529858076|FG004|Overall Study|Physician Decision|0|||
146917053|NCT01258348|529858072|FG000|Overall Study|Withdrawal by Subject|0|||
146917054|NCT01258348|529858073|FG001|Overall Study|Withdrawal by Subject|1|||
146917055|NCT01258348|529858074|FG002|Overall Study|Withdrawal by Subject|0|||
146917056|NCT01258348|529858075|FG003|Overall Study|Withdrawal by Subject|0|||
146917057|NCT01258348|529858076|FG004|Overall Study|Withdrawal by Subject|0|||
146917058|NCT02606045|529858079|FG000|Overall Study|Study closed before treament could begin|1|||
146917059|NCT02606045|529858080|FG001|Overall Study|Study closed before treament could begin|2|||
146917060|NCT01671085|529858081|FG000|Overall Study|Withdrawal by Subject|1|||
146917061|NCT01671085|529858082|FG001|Overall Study|Withdrawal by Subject|0|||
146917062|NCT00637273|529858083|FG000|Overall Study|Adverse Event|11|||
146917063|NCT00637273|529858084|FG001|Overall Study|Adverse Event|5|||
146917064|NCT00637273|529858085|FG002|Overall Study|Adverse Event|7|||
146917065|NCT00637273|529858083|FG000|Overall Study|Lost to Follow-up|8|||
146917066|NCT00637273|529858084|FG001|Overall Study|Lost to Follow-up|9|||
146917067|NCT00637273|529858085|FG002|Overall Study|Lost to Follow-up|13|||
146917068|NCT00637273|529858083|FG000|Overall Study|Protocol Violation|2|||
146917069|NCT00637273|529858084|FG001|Overall Study|Protocol Violation|4|||
146651212|NCT03459690|528900454|FG000|Overall Study|Lost to Follow-up|0|||
146651213|NCT03459690|528900455|FG001|Overall Study|Lost to Follow-up|1|||
146651214|NCT03459690|528900454|FG000|Overall Study|Withdrawal by Subject|1|||
146651215|NCT03459690|528900455|FG001|Overall Study|Withdrawal by Subject|1|||
146651216|NCT02586506|528900456|FG000|Overall Study|Protocol Violation|6|||
146651217|NCT02586506|528900456|FG000|Overall Study|Lost to Follow-up|1|||
146651218|NCT02586506|528900456|FG000|Overall Study|Other Reason|2|||
146651219|NCT02536404|528900464|FG000|Overall Study|Adverse Event|5|||
146651220|NCT02536404|528900465|FG001|Overall Study|Adverse Event|0|||
146651221|NCT02536404|528900464|FG000|Overall Study|Withdrawal by Subject|4|||
146651222|NCT02536404|528900465|FG001|Overall Study|Withdrawal by Subject|1|||
146651223|NCT02536404|528900464|FG000|Overall Study|Physician Decision|10|||
146651224|NCT02536404|528900465|FG001|Overall Study|Physician Decision|0|||
146651225|NCT02536404|528900464|FG000|Overall Study|Sponsor decision|1|||
146651226|NCT02536404|528900465|FG001|Overall Study|Sponsor decision|0|||
146651227|NCT02158364|528900466|FG000|Overall Study|Case report forms uncollected|10|||
146651228|NCT02158364|528900466|FG000|Overall Study|Protocol Deviation|50|||
146651229|NCT04381988|528900469|FG000|Overall Study|The study was terminated|4|||
146651230|NCT04381988|528900470|FG001|Overall Study|The study was terminated|0|||
146651231|NCT01944839|528900471|FG000|Overall Study|Physician Decision|2|||
146651232|NCT01944839|528900472|FG001|Overall Study|Physician Decision|2|||
146651233|NCT01944839|528900471|FG000|Overall Study|Protocol Violation|0|||
146651234|NCT01944839|528900472|FG001|Overall Study|Protocol Violation|1|||
146651235|NCT01944839|528900471|FG000|Overall Study|Adverse Event|10|||
146651236|NCT01944839|528900472|FG001|Overall Study|Adverse Event|5|||
146651237|NCT01944839|528900471|FG000|Overall Study|Withdrawal by Subject|9|||
146651238|NCT01944839|528900472|FG001|Overall Study|Withdrawal by Subject|17|||
146770558|NCT00723450|529328641|FG002|Open-Label Phase|Adverse Event|0|||
146770559|NCT00723450|529328639|FG000|Open-Label Phase|Lack of Efficacy|18|||
146917070|NCT00637273|529858085|FG002|Overall Study|Protocol Violation|1|||
146917071|NCT00637273|529858083|FG000|Overall Study|Withdrawal of Consent|18|||
146917072|NCT00637273|529858084|FG001|Overall Study|Withdrawal of Consent|6|||
146917073|NCT00637273|529858085|FG002|Overall Study|Withdrawal of Consent|18|||
146917074|NCT00637273|529858083|FG000|Overall Study|Investigator Decision|1|||
146917075|NCT00637273|529858084|FG001|Overall Study|Investigator Decision|3|||
146917076|NCT00637273|529858085|FG002|Overall Study|Investigator Decision|1|||
146917077|NCT00637273|529858083|FG000|Overall Study|Administrative|2|||
146917078|NCT00637273|529858084|FG001|Overall Study|Administrative|0|||
146917079|NCT00637273|529858085|FG002|Overall Study|Administrative|0|||
146917080|NCT00637273|529858083|FG000|Overall Study|Loss of Glucose Control|1|||
146917081|NCT00637273|529858084|FG001|Overall Study|Loss of Glucose Control|1|||
146917082|NCT00637273|529858085|FG002|Overall Study|Loss of Glucose Control|1|||
146917083|NCT01702363|529858087|FG000|Overall Study|Adverse Event|14|||
146917084|NCT01702363|529858087|FG000|Overall Study|Lack of Efficacy|4|||
146917085|NCT01702363|529858087|FG000|Overall Study|Withdrawal by Subject|2|||
146917086|NCT00002663|529858088|FG000|Overall Study|Death|4|||
146917087|NCT00002663|529858089|FG001|Overall Study|Death|1|||
146917088|NCT00002663|529858090|FG002|Overall Study|Death|1|||
146917089|NCT00002663|529858091|FG003|Overall Study|Death|0|||
146917090|NCT00002663|529858092|FG004|Overall Study|Death|0|||
146917091|NCT00002663|529858093|FG005|Overall Study|Death|13|||
146917092|NCT00002663|529858094|FG006|Overall Study|Death|0|||
146917093|NCT00002663|529858095|FG007|Overall Study|Death|1|||
146917094|NCT00002663|529858096|FG008|Overall Study|Death|1|||
146917095|NCT00002663|529858097|FG009|Overall Study|Death|1|||
146917096|NCT00002663|529858088|FG000|Overall Study|Lost to Follow-up|3|||
146917097|NCT00002663|529858089|FG001|Overall Study|Lost to Follow-up|0|||
146917098|NCT00002663|529858090|FG002|Overall Study|Lost to Follow-up|0|||
146917099|NCT00002663|529858091|FG003|Overall Study|Lost to Follow-up|1|||
146917100|NCT00002663|529858092|FG004|Overall Study|Lost to Follow-up|0|||
146917101|NCT00002663|529858093|FG005|Overall Study|Lost to Follow-up|1|||
146917102|NCT00002663|529858094|FG006|Overall Study|Lost to Follow-up|0|||
146917103|NCT00002663|529858095|FG007|Overall Study|Lost to Follow-up|0|||
146917104|NCT00002663|529858096|FG008|Overall Study|Lost to Follow-up|0|||
146917105|NCT00002663|529858097|FG009|Overall Study|Lost to Follow-up|0|||
146917106|NCT00002663|529858088|FG000|Overall Study|Other|0|||
146977142|NCT01872689|530079343|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
146917107|NCT00002663|529858089|FG001|Overall Study|Other|1|||
146917108|NCT00002663|529858090|FG002|Overall Study|Other|0|||
146917109|NCT00002663|529858091|FG003|Overall Study|Other|0|||
146917110|NCT00002663|529858092|FG004|Overall Study|Other|0|||
146651239|NCT01944839|528900471|FG000|Overall Study|Lost to Follow-up|1|||
146651240|NCT01944839|528900472|FG001|Overall Study|Lost to Follow-up|0|||
146651241|NCT01944839|528900471|FG000|Overall Study|Subject non-compliance|0|||
146651242|NCT01944839|528900472|FG001|Overall Study|Subject non-compliance|3|||
146651243|NCT00609362|528900473|FG000|Overall Study|Withdrawal by Subject|2|||
146651244|NCT00609362|528900474|FG001|Overall Study|Withdrawal by Subject|1|||
146651245|NCT00609362|528900473|FG000|Overall Study|Adverse Event|1|||
146651246|NCT00609362|528900474|FG001|Overall Study|Adverse Event|0|||
146651247|NCT05093790|528900475|FG000|Overall Study|Failure to meet continuation criteria|0|||
146977143|NCT01872689|530079344|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
146977144|NCT01872689|530079345|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
146977145|NCT01872689|530079346|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
146977146|NCT01872689|530079343|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
146977147|NCT01872689|530079344|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
146977148|NCT01872689|530079345|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
146977149|NCT01872689|530079346|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
146977150|NCT01872689|530079343|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
146977151|NCT01872689|530079344|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
146977152|NCT01872689|530079345|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
146977153|NCT01872689|530079346|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
146977154|NCT01872689|530079343|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
146977155|NCT01872689|530079344|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
146977156|NCT01872689|530079345|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
146977157|NCT01872689|530079346|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
146977158|NCT01872689|530079343|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
146977159|NCT01872689|530079344|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
146977160|NCT01872689|530079345|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
146977161|NCT01872689|530079346|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
146977162|NCT01872689|530079343|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
146977163|NCT01872689|530079344|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
146977164|NCT01872689|530079345|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
146977165|NCT01872689|530079346|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
146977166|NCT01872689|530079343|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
146977167|NCT01872689|530079344|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
146977168|NCT01872689|530079345|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
146977169|NCT01872689|530079346|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
146977170|NCT01872689|530079343|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
146977171|NCT01872689|530079344|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
146977172|NCT01872689|530079345|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
146977173|NCT01872689|530079346|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
146977174|NCT01872689|530079343|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
146977175|NCT01872689|530079344|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
146977176|NCT01872689|530079345|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
146977177|NCT01872689|530079346|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
146977178|NCT01872689|530079343|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
146977179|NCT01872689|530079344|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
146977180|NCT01872689|530079345|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
146977181|NCT01872689|530079346|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
146977182|NCT01872689|530079343|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
146977183|NCT01872689|530079344|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
146977184|NCT01872689|530079345|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
146977185|NCT01872689|530079346|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
146977186|NCT00660790|530079349|FG000|Baseline to 3 Months|Death|1|||
146977187|NCT00660790|530079349|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
146977188|NCT00660790|530079349|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
146977189|NCT00686374|530079354|FG000|Overall Study|Lack of Efficacy|10|||
146977190|NCT00686374|530079354|FG000|Overall Study|Adverse Event|8|||
146977191|NCT00686374|530079354|FG000|Overall Study|Withdrew consent|5|||
146977192|NCT00686374|530079354|FG000|Overall Study|Lost to Follow-up|1|||
146977193|NCT00686374|530079354|FG000|Overall Study|Missing reason|33|||
146977194|NCT00686374|530079354|FG000|Overall Study|Other, not specified|4|||
146571368|NCT00856635|528602737|FG001|Overall Study|Discontinued at Randomization|2|||
146571369|NCT01244035|528602739|FG000|Part 1: Period 1|Adverse Event|0|||
146571370|NCT01244035|528602740|FG001|Part 1: Period 1|Adverse Event|0|||
146571371|NCT01244035|528602741|FG002|Part 1: Period 1|Adverse Event|0|||
146571372|NCT01244035|528602742|FG003|Part 1: Period 1|Adverse Event|0|||
146571373|NCT01244035|528602743|FG004|Part 1: Period 1|Adverse Event|0|||
146571374|NCT01244035|528602744|FG005|Part 1: Period 1|Adverse Event|1|||
146571375|NCT01244035|528602739|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
146571376|NCT01244035|528602740|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
146571377|NCT01244035|528602741|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
146571378|NCT01244035|528602742|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
146571379|NCT01244035|528602743|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
146571380|NCT01244035|528602744|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
146977195|NCT02143947|530079355|FG000|Overall Study|Lost to Follow-up|4|||
146571381|NCT01244035|528602739|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
146571382|NCT01244035|528602740|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
146770560|NCT00723450|529328640|FG001|Open-Label Phase|Lack of Efficacy|0|||
146977196|NCT02143947|530079356|FG001|Overall Study|Lost to Follow-up|2|||
146977197|NCT01244815|530079359|FG000|Overall Study|Not Treated|0|||
146977198|NCT01244815|530079360|FG001|Overall Study|Not Treated|1|||
146977199|NCT01244815|530079361|FG002|Overall Study|Not Treated|0|||
146977200|NCT01244815|530079362|FG003|Overall Study|Not Treated|0|||
146977201|NCT01244815|530079359|FG000|Overall Study|Adverse Event|4|||
146977202|NCT01244815|530079360|FG001|Overall Study|Adverse Event|7|||
146977203|NCT01244815|530079361|FG002|Overall Study|Adverse Event|5|||
146977204|NCT01244815|530079362|FG003|Overall Study|Adverse Event|5|||
146977205|NCT01244815|530079359|FG000|Overall Study|Treatment Failure|0|||
146977206|NCT01244815|530079360|FG001|Overall Study|Treatment Failure|0|||
146977207|NCT01244815|530079361|FG002|Overall Study|Treatment Failure|0|||
146977208|NCT01244815|530079362|FG003|Overall Study|Treatment Failure|1|||
146977209|NCT01244815|530079359|FG000|Overall Study|Lost to Follow-up|3|||
146977210|NCT01244815|530079360|FG001|Overall Study|Lost to Follow-up|2|||
146977211|NCT01244815|530079361|FG002|Overall Study|Lost to Follow-up|3|||
146977212|NCT01244815|530079362|FG003|Overall Study|Lost to Follow-up|2|||
146977213|NCT01244815|530079359|FG000|Overall Study|Withdrawal by Subject|0|||
146977214|NCT01244815|530079360|FG001|Overall Study|Withdrawal by Subject|2|||
146977215|NCT01244815|530079361|FG002|Overall Study|Withdrawal by Subject|0|||
146977216|NCT01244815|530079362|FG003|Overall Study|Withdrawal by Subject|3|||
146977217|NCT01244815|530079359|FG000|Overall Study|Protocol Violation|7|||
146977218|NCT01244815|530079360|FG001|Overall Study|Protocol Violation|4|||
146977219|NCT01244815|530079361|FG002|Overall Study|Protocol Violation|3|||
146977220|NCT01244815|530079362|FG003|Overall Study|Protocol Violation|1|||
146977221|NCT01244815|530079359|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
146977222|NCT01244815|530079360|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
146977223|NCT01244815|530079361|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
146977224|NCT01244815|530079362|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
146977225|NCT01808209|530079364|FG000|Overall Study|Lost to Follow-up|0|||
146977226|NCT01808209|530079365|FG001|Overall Study|Lost to Follow-up|1|||
146977227|NCT00697112|530079366|FG000|Overall Study|Adverse Event|8|||
146977228|NCT00697112|530079366|FG000|Overall Study|Lost to Follow-up|1|||
146977229|NCT00697112|530079366|FG000|Overall Study|Did not meet inclusion criteria|1|||
146977230|NCT01427920|530079371|FG000|Overall Study|Adverse Event|1|||
146977231|NCT01427920|530079372|FG001|Overall Study|Adverse Event|2|||
146977232|NCT01427920|530079371|FG000|Overall Study|Lack of Efficacy|1|||
146977233|NCT01427920|530079372|FG001|Overall Study|Lack of Efficacy|0|||
146977234|NCT01427920|530079371|FG000|Overall Study|Protocol Violation|1|||
146977235|NCT01427920|530079372|FG001|Overall Study|Protocol Violation|3|||
146977236|NCT01427920|530079371|FG000|Overall Study|Withdrawal Criteria|4|||
146977237|NCT01427920|530079372|FG001|Overall Study|Withdrawal Criteria|4|||
146977238|NCT01427920|530079371|FG000|Overall Study|Unclassified|2|||
146977239|NCT01427920|530079372|FG001|Overall Study|Unclassified|8|||
146977240|NCT04228302|530079373|FG000|Overall Study|Adverse Event|0|||
146977241|NCT04228302|530079374|FG001|Overall Study|Adverse Event|0|||
146977242|NCT04228302|530079375|FG002|Overall Study|Adverse Event|0|||
146977243|NCT04228302|530079376|FG003|Overall Study|Adverse Event|0|||
146977244|NCT04228302|530079377|FG004|Overall Study|Adverse Event|1|||
146917111|NCT00002663|529858093|FG005|Overall Study|Other|1|||
146917112|NCT00002663|529858094|FG006|Overall Study|Other|1|||
146917113|NCT00002663|529858095|FG007|Overall Study|Other|0|||
146917114|NCT00002663|529858096|FG008|Overall Study|Other|0|||
146917115|NCT00002663|529858097|FG009|Overall Study|Other|0|||
146917116|NCT00002663|529858088|FG000|Overall Study|Physician Decision|0|||
146917117|NCT00002663|529858089|FG001|Overall Study|Physician Decision|0|||
146917118|NCT00002663|529858090|FG002|Overall Study|Physician Decision|0|||
146917119|NCT00002663|529858091|FG003|Overall Study|Physician Decision|0|||
146917120|NCT00002663|529858092|FG004|Overall Study|Physician Decision|1|||
146917121|NCT00002663|529858093|FG005|Overall Study|Physician Decision|0|||
146917122|NCT00002663|529858094|FG006|Overall Study|Physician Decision|0|||
146917123|NCT00002663|529858095|FG007|Overall Study|Physician Decision|0|||
146977245|NCT04228302|530079378|FG005|Overall Study|Adverse Event|0|||
146977246|NCT03066440|530079381|FG000|Overall Study|Physician Decision|1|||
146977247|NCT03066440|530079382|FG001|Overall Study|Physician Decision|1|||
146977248|NCT03066440|530079381|FG000|Overall Study|Protocol Violation|0|||
146977249|NCT03066440|530079382|FG001|Overall Study|Protocol Violation|2|||
146977250|NCT04991311|530079383|FG000|Overall Study|Adverse Event|1|||
146977251|NCT03876873|530079384|FG000|Overall Study|Physician Decision|0|||
146977252|NCT03876873|530079385|FG001|Overall Study|Physician Decision|1|||
146770561|NCT00723450|529328641|FG002|Open-Label Phase|Lack of Efficacy|0|||
146917124|NCT00002663|529858096|FG008|Overall Study|Physician Decision|1|||
146977253|NCT01223196|530079388|FG000|Overall Study|Lost to Follow-up|2|||
146977254|NCT01223196|530079389|FG001|Overall Study|Lost to Follow-up|0|||
146977255|NCT01223196|530079388|FG000|Overall Study|Physician Decision|1|||
146917125|NCT00002663|529858097|FG009|Overall Study|Physician Decision|1|||
146917126|NCT00002663|529858088|FG000|Overall Study|Adverse Event|0|||
146917127|NCT00002663|529858089|FG001|Overall Study|Adverse Event|0|||
146917128|NCT00002663|529858090|FG002|Overall Study|Adverse Event|0|||
146977256|NCT01223196|530079389|FG001|Overall Study|Physician Decision|0|||
146977257|NCT01223196|530079388|FG000|Overall Study|Withdrawal by Subject|1|||
146917129|NCT00002663|529858091|FG003|Overall Study|Adverse Event|1|||
146917130|NCT00002663|529858092|FG004|Overall Study|Adverse Event|0|||
146917131|NCT00002663|529858093|FG005|Overall Study|Adverse Event|0|||
146917132|NCT00002663|529858094|FG006|Overall Study|Adverse Event|0|||
146917133|NCT00002663|529858095|FG007|Overall Study|Adverse Event|1|||
146917134|NCT00002663|529858096|FG008|Overall Study|Adverse Event|0|||
146917135|NCT00002663|529858097|FG009|Overall Study|Adverse Event|0|||
146651248|NCT05093790|528900476|FG001|Overall Study|Failure to meet continuation criteria|0|||
146651249|NCT05093790|528900477|FG002|Overall Study|Failure to meet continuation criteria|1|||
146651250|NCT05093790|528900478|FG003|Overall Study|Failure to meet continuation criteria|0|||
146651251|NCT05093790|528900475|FG000|Overall Study|Adverse Event|1|||
146651252|NCT05093790|528900476|FG001|Overall Study|Adverse Event|0|||
146651253|NCT05093790|528900477|FG002|Overall Study|Adverse Event|0|||
146651254|NCT05093790|528900478|FG003|Overall Study|Adverse Event|0|||
146651255|NCT00924170|528900479|FG000|Overall Study|Refused further treatment|0|||
146651256|NCT00924170|528900480|FG001|Overall Study|Refused further treatment|1|||
146651257|NCT00924170|528900479|FG000|Overall Study|Physician Decision|0|||
146917136|NCT00525148|529858101|FG000|Overall Study|Other Adverse Event|3|||
146651258|NCT00924170|528900480|FG001|Overall Study|Physician Decision|1|||
146651259|NCT00924170|528900479|FG000|Overall Study|Progressive disease|3|||
146651260|NCT00924170|528900480|FG001|Overall Study|Progressive disease|6|||
146651261|NCT00924170|528900479|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
146651262|NCT00924170|528900480|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
146651263|NCT00924170|528900479|FG000|Overall Study|Death|1|||
146651264|NCT00924170|528900480|FG001|Overall Study|Death|0|||
146651265|NCT04098224|528900481|FG000|Overall Study|Adverse Event|1|||
146651266|NCT04098224|528900482|FG001|Overall Study|Adverse Event|0|||
146651267|NCT04098224|528900481|FG000|Overall Study|Physician Decision|1|||
146651268|NCT04098224|528900482|FG001|Overall Study|Physician Decision|0|||
146651269|NCT04098224|528900481|FG000|Overall Study|Patient not required enteral feeding|1|||
146651270|NCT04098224|528900482|FG001|Overall Study|Patient not required enteral feeding|0|||
146651271|NCT04098224|528900481|FG000|Overall Study|Patient failure nasogastric tube|1|||
146651272|NCT04098224|528900482|FG001|Overall Study|Patient failure nasogastric tube|0|||
146651273|NCT04098224|528900481|FG000|Overall Study|Patient early extubation|1|||
146651274|NCT04098224|528900482|FG001|Overall Study|Patient early extubation|3|||
146651275|NCT01587898|528900483|FG000|Overall Study|Adverse Event|1|||
146651276|NCT01587898|528900484|FG001|Overall Study|Adverse Event|1|||
146651277|NCT01587898|528900485|FG002|Overall Study|Adverse Event|0|||
146651278|NCT01587898|528900486|FG003|Overall Study|Adverse Event|0|||
146651279|NCT01587898|528900483|FG000|Overall Study|Protocol Violation|0|||
146651280|NCT01587898|528900484|FG001|Overall Study|Protocol Violation|2|||
146651281|NCT01587898|528900485|FG002|Overall Study|Protocol Violation|1|||
146917137|NCT00525148|529858102|FG001|Overall Study|Other Adverse Event|5|||
146917138|NCT00525148|529858103|FG002|Overall Study|Other Adverse Event|1|||
146917139|NCT00525148|529858104|FG003|Overall Study|Other Adverse Event|8|||
146917140|NCT00525148|529858101|FG000|Overall Study|Progressive disease|18|||
146917141|NCT00525148|529858102|FG001|Overall Study|Progressive disease|30|||
146917142|NCT00525148|529858103|FG002|Overall Study|Progressive disease|6|||
146917143|NCT00525148|529858104|FG003|Overall Study|Progressive disease|49|||
146917144|NCT00525148|529858101|FG000|Overall Study|Refused continuation of study medication|0|||
146917145|NCT00525148|529858102|FG001|Overall Study|Refused continuation of study medication|2|||
146917146|NCT00525148|529858103|FG002|Overall Study|Refused continuation of study medication|0|||
146917147|NCT00525148|529858104|FG003|Overall Study|Refused continuation of study medication|1|||
146917148|NCT00525148|529858101|FG000|Overall Study|Other than stated|2|||
146917149|NCT00525148|529858102|FG001|Overall Study|Other than stated|1|||
146917150|NCT00525148|529858103|FG002|Overall Study|Other than stated|0|||
146917151|NCT00525148|529858104|FG003|Overall Study|Other than stated|3|||
146917152|NCT03015610|529858105|FG000|Overall Study|Lost to Follow-up|1|||
146917153|NCT03015610|529858106|FG001|Overall Study|Lost to Follow-up|5|||
146917154|NCT01603641|529858107|FG000|Overall Study|Did not Receive Treatment|3|||
146917155|NCT01603641|529858107|FG000|Overall Study|Adverse Event|1|||
146917156|NCT01603641|529858107|FG000|Overall Study|Lack of Efficacy|1|||
146917157|NCT01603641|529858107|FG000|Overall Study|Lost to Follow-up|6|||
146917158|NCT01603641|529858107|FG000|Overall Study|Personal Reasons|18|||
146917159|NCT01603641|529858107|FG000|Overall Study|Other Miscellaneous Reasons|6|||
146917160|NCT05100199|529858114|FG000|Overall Study|Lost to Follow-up|5|||
146917161|NCT05100199|529858115|FG001|Overall Study|Lost to Follow-up|8|||
146917162|NCT05100199|529858116|FG002|Overall Study|Lost to Follow-up|3|||
146651282|NCT01587898|528900486|FG003|Overall Study|Protocol Violation|1|||
146651283|NCT01587898|528900483|FG000|Overall Study|Lost to Follow-up|0|||
146651284|NCT01587898|528900484|FG001|Overall Study|Lost to Follow-up|0|||
146651285|NCT01587898|528900485|FG002|Overall Study|Lost to Follow-up|0|||
146651286|NCT01587898|528900486|FG003|Overall Study|Lost to Follow-up|1|||
146651287|NCT01587898|528900483|FG000|Overall Study|Withdrawal by Subject|2|||
146651288|NCT01587898|528900484|FG001|Overall Study|Withdrawal by Subject|1|||
146651289|NCT01587898|528900485|FG002|Overall Study|Withdrawal by Subject|0|||
146917163|NCT05100199|529858117|FG003|Overall Study|Lost to Follow-up|6|||
146917164|NCT05100199|529858114|FG000|Overall Study|Withdrawal by Subject|3|||
146571383|NCT01244035|528602741|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
146571384|NCT01244035|528602742|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
146571385|NCT01244035|528602743|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
146571386|NCT01244035|528602744|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
146571387|NCT01244035|528602739|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
146571388|NCT01244035|528602740|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
146571389|NCT01244035|528602741|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
146571390|NCT01244035|528602742|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
146571391|NCT01244035|528602743|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
146571392|NCT01244035|528602744|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
146571393|NCT01244035|528602739|FG000|Part 1: Period 3|Adverse Event|0|||
146571394|NCT01244035|528602740|FG001|Part 1: Period 3|Adverse Event|0|||
146571395|NCT01244035|528602741|FG002|Part 1: Period 3|Adverse Event|0|||
146571396|NCT01244035|528602742|FG003|Part 1: Period 3|Adverse Event|0|||
146571397|NCT01244035|528602743|FG004|Part 1: Period 3|Adverse Event|0|||
146571398|NCT01244035|528602744|FG005|Part 1: Period 3|Adverse Event|1|||
146571399|NCT01244035|528602739|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
146571400|NCT01244035|528602740|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
146571401|NCT01244035|528602741|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
146571402|NCT01244035|528602742|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
146571403|NCT01244035|528602743|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
146571404|NCT01244035|528602744|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
146571405|NCT01244035|528602739|FG000|Part 1: Period 3|Protocol Deviation|0|||
146571406|NCT01244035|528602740|FG001|Part 1: Period 3|Protocol Deviation|1|||
146571407|NCT01244035|528602741|FG002|Part 1: Period 3|Protocol Deviation|0|||
146571408|NCT01244035|528602742|FG003|Part 1: Period 3|Protocol Deviation|0|||
146571409|NCT01244035|528602743|FG004|Part 1: Period 3|Protocol Deviation|0|||
146571410|NCT01244035|528602744|FG005|Part 1: Period 3|Protocol Deviation|0|||
146571411|NCT02383862|528602746|FG000|3 Month Follow up|Lost to Follow-up|23|||
146571412|NCT02383862|528602747|FG001|3 Month Follow up|Lost to Follow-up|21|||
146571413|NCT00347932|528602748|FG000|Overall Study|Adverse Event|4|||
146571414|NCT00347932|528602749|FG001|Overall Study|Adverse Event|5|||
146571415|NCT00347932|528602748|FG000|Overall Study|Lack of Efficacy|3|||
146571416|NCT00347932|528602749|FG001|Overall Study|Lack of Efficacy|14|||
146571417|NCT00347932|528602748|FG000|Overall Study|Lost to Follow-up|10|||
146571418|NCT00347932|528602749|FG001|Overall Study|Lost to Follow-up|9|||
146571419|NCT00347932|528602748|FG000|Overall Study|Withdrawal by Subject|10|||
146571420|NCT00347932|528602749|FG001|Overall Study|Withdrawal by Subject|16|||
146571421|NCT00347932|528602748|FG000|Overall Study|Did not meet inclusion criteria|4|||
146571422|NCT00347932|528602749|FG001|Overall Study|Did not meet inclusion criteria|8|||
146571423|NCT00400517|528602750|FG000|Overall Study|Withdrawal by Subject|1|||
146571424|NCT00400517|528602750|FG000|Overall Study|Physician Decision|1|||
146571425|NCT02457247|528602751|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
146571426|NCT02457247|528602752|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
146571427|NCT02457247|528602753|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
146571428|NCT02457247|528602754|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
146571429|NCT02457247|528602751|FG000|Period 1|Significant Protocol Deviation|1|||
146571430|NCT02457247|528602752|FG001|Period 1|Significant Protocol Deviation|1|||
146917165|NCT05100199|529858115|FG001|Overall Study|Withdrawal by Subject|3|||
146917166|NCT05100199|529858116|FG002|Overall Study|Withdrawal by Subject|9|||
146917167|NCT05100199|529858117|FG003|Overall Study|Withdrawal by Subject|7|||
146917168|NCT05100199|529858114|FG000|Overall Study|Other|0|||
146917169|NCT05100199|529858115|FG001|Overall Study|Other|0|||
146917170|NCT05100199|529858116|FG002|Overall Study|Other|1|||
146917171|NCT05100199|529858117|FG003|Overall Study|Other|1|||
146917172|NCT01905397|529858118|FG000|Overall Study|Death|0|||
146917173|NCT01905397|529858119|FG001|Overall Study|Death|1|||
146917174|NCT01905397|529858118|FG000|Overall Study|Withdrawal by Subject|2|||
146571431|NCT02457247|528602753|FG002|Period 1|Significant Protocol Deviation|0|||
146571432|NCT02457247|528602754|FG003|Period 1|Significant Protocol Deviation|0|||
146571433|NCT02457247|528602751|FG000|Period 1|Voluntary Withdrawal|1|||
146571434|NCT02457247|528602752|FG001|Period 1|Voluntary Withdrawal|0|||
146571435|NCT02457247|528602753|FG002|Period 1|Voluntary Withdrawal|0|||
146571436|NCT02457247|528602754|FG003|Period 1|Voluntary Withdrawal|0|||
146571437|NCT02457247|528602751|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
146571438|NCT02457247|528602752|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
146651290|NCT01587898|528900486|FG003|Overall Study|Withdrawal by Subject|0|||
146571439|NCT02457247|528602753|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
146571440|NCT02457247|528602754|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
146917175|NCT01905397|529858119|FG001|Overall Study|Withdrawal by Subject|0|||
146917176|NCT01905397|529858118|FG000|Overall Study|Surgery canceled/aborted|9|||
146917177|NCT01905397|529858119|FG001|Overall Study|Surgery canceled/aborted|5|||
146571441|NCT02457247|528602751|FG000|Period 2|Significant Protocol Deviation|1|||
146571442|NCT02457247|528602752|FG001|Period 2|Significant Protocol Deviation|0|||
146571443|NCT02457247|528602753|FG002|Period 2|Significant Protocol Deviation|0|||
146917178|NCT01905397|529858118|FG000|Overall Study|Incision < 7 cm|2|||
146917179|NCT01905397|529858119|FG001|Overall Study|Incision < 7 cm|0|||
146571444|NCT02457247|528602754|FG003|Period 2|Significant Protocol Deviation|0|||
146571445|NCT02457247|528602751|FG000|Period 2|Lost to Follow-up|0|||
146571446|NCT02457247|528602752|FG001|Period 2|Lost to Follow-up|1|||
146571447|NCT02457247|528602753|FG002|Period 2|Lost to Follow-up|0|||
146571448|NCT02457247|528602754|FG003|Period 2|Lost to Follow-up|0|||
146571449|NCT02457247|528602751|FG000|Period 2|Voluntary Withdrawal|1|||
146571450|NCT02457247|528602752|FG001|Period 2|Voluntary Withdrawal|1|||
146571451|NCT02457247|528602753|FG002|Period 2|Voluntary Withdrawal|0|||
146571452|NCT02457247|528602754|FG003|Period 2|Voluntary Withdrawal|0|||
146571453|NCT02954887|528602755|FG000|Overall Study|Withdrawal by Subject|3|||
146651291|NCT01587898|528900483|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
146651292|NCT01587898|528900484|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
146651293|NCT01587898|528900485|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
146651294|NCT01587898|528900486|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
146651295|NCT00502203|528900487|FG000|Overall Study|Inevaluable|1|||
146651296|NCT01903252|528900490|FG000|Double-Blind Induction|Adverse Event|20|||
146651297|NCT01903252|528900491|FG001|Double-Blind Induction|Adverse Event|18|||
146651298|NCT01903252|528900492|FG002|Double-Blind Induction|Adverse Event|0|||
146651299|NCT01903252|528900493|FG003|Double-Blind Induction|Adverse Event|0|||
146651300|NCT01903252|528900494|FG004|Double-Blind Induction|Adverse Event|0|||
146651301|NCT01903252|528900495|FG005|Double-Blind Induction|Adverse Event|0|||
146651302|NCT01903252|528900490|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
146651303|NCT01903252|528900491|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
146651304|NCT01903252|528900492|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
146651305|NCT01903252|528900493|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
146651306|NCT01903252|528900494|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
146651307|NCT01903252|528900495|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
146651308|NCT01903252|528900490|FG000|Double-Blind Induction|Physician Decision|2|||
146651309|NCT01903252|528900491|FG001|Double-Blind Induction|Physician Decision|3|||
146651310|NCT01903252|528900492|FG002|Double-Blind Induction|Physician Decision|0|||
146651311|NCT01903252|528900493|FG003|Double-Blind Induction|Physician Decision|0|||
146651312|NCT01903252|528900494|FG004|Double-Blind Induction|Physician Decision|0|||
146651313|NCT01903252|528900495|FG005|Double-Blind Induction|Physician Decision|0|||
146651314|NCT01903252|528900490|FG000|Double-Blind Induction|non-compliance,|7|||
146651315|NCT01903252|528900491|FG001|Double-Blind Induction|non-compliance,|7|||
146651316|NCT01903252|528900492|FG002|Double-Blind Induction|non-compliance,|0|||
146651317|NCT01903252|528900493|FG003|Double-Blind Induction|non-compliance,|0|||
146651318|NCT01903252|528900494|FG004|Double-Blind Induction|non-compliance,|0|||
146651319|NCT01903252|528900495|FG005|Double-Blind Induction|non-compliance,|0|||
146651320|NCT01903252|528900490|FG000|Extended Induction, Open-Label|Adverse Event|0|||
146651321|NCT01903252|528900491|FG001|Extended Induction, Open-Label|Adverse Event|0|||
146651322|NCT01903252|528900492|FG002|Extended Induction, Open-Label|Adverse Event|17|||
146651323|NCT01903252|528900493|FG003|Extended Induction, Open-Label|Adverse Event|0|||
146651324|NCT01903252|528900494|FG004|Extended Induction, Open-Label|Adverse Event|0|||
146651325|NCT01903252|528900495|FG005|Extended Induction, Open-Label|Adverse Event|0|||
146651326|NCT01903252|528900490|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
146651327|NCT01903252|528900491|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
146651328|NCT01903252|528900492|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
146651329|NCT01903252|528900493|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
146651330|NCT01903252|528900494|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
146651331|NCT01903252|528900495|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
146651332|NCT01903252|528900490|FG000|Extended Induction, Open-Label|Physician Decision|0|||
146651333|NCT01903252|528900491|FG001|Extended Induction, Open-Label|Physician Decision|0|||
146651334|NCT01903252|528900492|FG002|Extended Induction, Open-Label|Physician Decision|1|||
146651335|NCT01903252|528900493|FG003|Extended Induction, Open-Label|Physician Decision|0|||
146651336|NCT01903252|528900494|FG004|Extended Induction, Open-Label|Physician Decision|0|||
146651337|NCT01903252|528900495|FG005|Extended Induction, Open-Label|Physician Decision|0|||
146651338|NCT01903252|528900490|FG000|Maintenance, Open-Label|Adverse Event|0|||
146571454|NCT02954887|528602755|FG000|Overall Study|Lack of Efficacy|3|||
146651339|NCT01903252|528900491|FG001|Maintenance, Open-Label|Adverse Event|0|||
146770562|NCT00723450|529328639|FG000|Open-Label Phase|Protocol Violation|35|||
146917180|NCT01905397|529858118|FG000|Overall Study|Wrong treatment|1|||
146917181|NCT01905397|529858119|FG001|Overall Study|Wrong treatment|1|||
146917182|NCT01905397|529858118|FG000|Overall Study|Device not applied|3|||
146571455|NCT02954887|528602755|FG000|Overall Study|Other|1|||
146571456|NCT02803203|528602756|FG000|Overall Study|Adverse Event|4|||
146651340|NCT01903252|528900492|FG002|Maintenance, Open-Label|Adverse Event|0|||
146651341|NCT01903252|528900493|FG003|Maintenance, Open-Label|Adverse Event|3|||
146651342|NCT01903252|528900494|FG004|Maintenance, Open-Label|Adverse Event|9|||
146651343|NCT01903252|528900495|FG005|Maintenance, Open-Label|Adverse Event|14|||
146651344|NCT01903252|528900490|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
146651345|NCT01903252|528900491|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
146651346|NCT01903252|528900492|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
146917183|NCT01905397|529858119|FG001|Overall Study|Device not applied|0|||
146571457|NCT02803203|528602756|FG000|Overall Study|Death|4|||
146571458|NCT02803203|528602756|FG000|Overall Study|Progressive disease|29|||
146571459|NCT02803203|528602756|FG000|Overall Study|Withdrawal by Subject|8|||
146571460|NCT02803203|528602756|FG000|Overall Study|Complete resection of target disease|2|||
146571461|NCT02803203|528602756|FG000|Overall Study|Switched to commercial Osi|1|||
146571462|NCT02803203|528602756|FG000|Overall Study|Participant moved away|1|||
146571463|NCT00600067|528602757|FG000|Overall Study|Adverse Event|0|||
146571464|NCT00600067|528602758|FG001|Overall Study|Adverse Event|1|||
146571465|NCT00600067|528602757|FG000|Overall Study|Lost to Follow-up|2|||
146571466|NCT00600067|528602758|FG001|Overall Study|Lost to Follow-up|3|||
146571467|NCT00600067|528602757|FG000|Overall Study|protocol non-compliance|0|||
146571468|NCT00600067|528602758|FG001|Overall Study|protocol non-compliance|3|||
146571469|NCT00600067|528602757|FG000|Overall Study|Lack of Efficacy|1|||
146571470|NCT00600067|528602758|FG001|Overall Study|Lack of Efficacy|0|||
146571471|NCT01220401|528602761|FG000|Overall Study|Withdrawal by Subject|2|||
146571472|NCT01220401|528602761|FG000|Overall Study|Protocol Violation|1|||
146571473|NCT00833027|528602763|FG000|Overall Study|Adverse Event|33|||
146571474|NCT00833027|528602763|FG000|Overall Study|Death|1|||
146571475|NCT00833027|528602763|FG000|Overall Study|Lack of Efficacy|12|||
146571476|NCT00833027|528602763|FG000|Overall Study|Lost to Follow-up|24|||
146571477|NCT00833027|528602763|FG000|Overall Study|Protocol Violation|115|||
146571478|NCT00833027|528602763|FG000|Overall Study|Withdrawal by Subject|16|||
146571479|NCT00833027|528602763|FG000|Overall Study|Missing|10|||
146571480|NCT03069716|528602764|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
146571481|NCT03069716|528602765|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
146571482|NCT03069716|528602766|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
146571483|NCT03069716|528602764|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
146571484|NCT03069716|528602765|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
146571485|NCT03069716|528602766|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
146571486|NCT03069716|528602764|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
146571487|NCT03069716|528602765|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
146571488|NCT03069716|528602766|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
146571489|NCT03069716|528602764|FG000|Randomized Treatment|Withdrawal by Subject|0|||
146571490|NCT03069716|528602765|FG001|Randomized Treatment|Withdrawal by Subject|2|||
146571491|NCT03069716|528602766|FG002|Randomized Treatment|Withdrawal by Subject|0|||
146571492|NCT01985022|528602769|FG000|Overall Study|Lost to Follow-up|0|||
146571493|NCT01985022|528602770|FG001|Overall Study|Lost to Follow-up|1|||
146571494|NCT01985022|528602769|FG000|Overall Study|Protocol Violation|0|||
146571495|NCT01985022|528602770|FG001|Overall Study|Protocol Violation|1|||
146571496|NCT01985022|528602769|FG000|Overall Study|Withdrawal by Subject|4|||
146571497|NCT01985022|528602770|FG001|Overall Study|Withdrawal by Subject|1|||
146571498|NCT02573948|528602773|FG000|Longitudinal Cohort|Death|9|||
146571499|NCT02573948|528602773|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
146571500|NCT02573948|528602773|FG000|Longitudinal Cohort|Incarcerated|25|||
146571501|NCT01673126|528602774|FG000|Overall Study|change of diagnosis|4|||
146571502|NCT01673126|528602775|FG001|Overall Study|change of diagnosis|3|||
146571503|NCT01913327|528602786|FG000|Overall Study|Withdrawal by Subject|0|||
146571504|NCT01913327|528602787|FG001|Overall Study|Withdrawal by Subject|1|||
146571505|NCT00628446|528604464|FG000|Overall Study|Lost to Follow-up|3|||
146571506|NCT00628446|528604464|FG000|Overall Study|Withdrawal by Subject|1|||
146571507|NCT00628446|528604464|FG000|Overall Study|Protocol Violation|3|||
146571508|NCT00756275|528604465|FG000|Overall Study|Lost to Follow-up|25|||
146571509|NCT00756275|528604466|FG001|Overall Study|Lost to Follow-up|21|||
146571510|NCT00756275|528604465|FG000|Overall Study|Withdrawal by Subject|4|||
146571511|NCT00756275|528604466|FG001|Overall Study|Withdrawal by Subject|7|||
146571512|NCT00682929|528604469|FG000|Overall Study|Adverse Event|4|||
146571513|NCT00682929|528604470|FG001|Overall Study|Adverse Event|1|||
146571514|NCT00682929|528604471|FG002|Overall Study|Adverse Event|1|||
146571515|NCT00682929|528604469|FG000|Overall Study|Withdrawal by Subject|1|||
146571516|NCT00682929|528604470|FG001|Overall Study|Withdrawal by Subject|2|||
146571517|NCT00682929|528604471|FG002|Overall Study|Withdrawal by Subject|1|||
146571518|NCT00682929|528604469|FG000|Overall Study|dosing compliance < 80%|0|||
146571519|NCT00682929|528604470|FG001|Overall Study|dosing compliance < 80%|2|||
146571520|NCT00682929|528604471|FG002|Overall Study|dosing compliance < 80%|0|||
146571521|NCT00682929|528604469|FG000|Overall Study|lag in DEA renewal|1|||
146571522|NCT00682929|528604470|FG001|Overall Study|lag in DEA renewal|0|||
146571523|NCT00682929|528604471|FG002|Overall Study|lag in DEA renewal|0|||
146571524|NCT00456755|528604472|FG000|Overall Study|Lost to Follow-up|2|||
146571525|NCT00456755|528604473|FG001|Overall Study|Lost to Follow-up|1|||
146571526|NCT04072835|528604474|FG000|Overall Study|Overall trial ended|603|||
146571527|NCT04072835|528604474|FG000|Overall Study|Ablation|97|||
146571528|NCT04072835|528604474|FG000|Overall Study|Withdrawal of consent|66|||
146571529|NCT04072835|528604474|FG000|Overall Study|Physician Decision|50|||
146571530|NCT04072835|528604474|FG000|Overall Study|Lost to Follow-up|39|||
146571531|NCT04072835|528604474|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
146571532|NCT04072835|528604474|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
146571533|NCT04072835|528604474|FG000|Overall Study|Adverse Event|25|||
146509681|NCT02326298|528369023|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146509682|NCT02326298|528369024|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
146509683|NCT02326298|528369025|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
146509684|NCT02326298|528369026|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146509685|NCT02326298|528369013|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146509686|NCT02326298|528369014|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146509687|NCT02326298|528369015|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146509688|NCT02326298|528369016|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146509689|NCT02326298|528369017|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146509690|NCT02326298|528369018|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146509691|NCT02326298|528369019|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146509692|NCT02326298|528369020|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146509693|NCT02326298|528369021|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146509694|NCT02326298|528369022|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146509695|NCT02326298|528369023|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146509696|NCT02326298|528369024|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146509697|NCT02326298|528369025|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
146509698|NCT02326298|528369026|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
146509699|NCT02326298|528369013|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146509700|NCT02326298|528369014|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146509701|NCT02326298|528369015|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146509702|NCT02326298|528369016|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146509703|NCT02326298|528369017|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146509704|NCT02326298|528369018|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146509705|NCT02326298|528369019|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146509706|NCT02326298|528369020|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146509707|NCT02326298|528369021|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146509708|NCT02326298|528369022|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146509709|NCT02326298|528369023|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146509710|NCT02326298|528369024|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
146509711|NCT02326298|528369025|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
146509712|NCT02326298|528369026|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
146509713|NCT02326298|528369013|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146509714|NCT02326298|528369014|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146509715|NCT02326298|528369015|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146509716|NCT02326298|528369016|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146509717|NCT02326298|528369017|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146509718|NCT02326298|528369018|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146509719|NCT02326298|528369019|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146509720|NCT02326298|528369020|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146509721|NCT02326298|528369021|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146509722|NCT02326298|528369022|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146509723|NCT02326298|528369023|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146509724|NCT02326298|528369024|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
146509725|NCT02326298|528369025|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
146509726|NCT02326298|528369026|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
146509727|NCT02326298|528369013|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146509728|NCT02326298|528369014|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146509729|NCT02326298|528369015|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146509730|NCT02326298|528369016|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146509731|NCT02326298|528369017|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146509732|NCT02326298|528369018|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146509733|NCT02326298|528369019|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146509734|NCT02326298|528369020|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146509735|NCT02326298|528369021|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146509736|NCT02326298|528369022|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146509737|NCT02326298|528369023|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146509738|NCT02326298|528369024|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
146509739|NCT02326298|528369025|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
146509740|NCT02326298|528369026|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
146509741|NCT02044874|528369028|FG000|Overall Study|Adverse Event|5|||
146509742|NCT02044874|528369029|FG001|Overall Study|Adverse Event|6|||
146917184|NCT01905397|529858118|FG000|Overall Study|Dressing not applied in operating room|1|||
146571534|NCT04072835|528604474|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
146571535|NCT04072835|528604474|FG000|Overall Study|Death|11|||
146571536|NCT04072835|528604474|FG000|Overall Study|Participant felt the drug did not work|8|||
146571537|NCT04072835|528604474|FG000|Overall Study|Participant tolerability|5|||
146571538|NCT04072835|528604474|FG000|Overall Study|Missing|5|||
146571539|NCT04072835|528604474|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
146571540|NCT04072835|528604474|FG000|Overall Study|Pregnancy|3|||
146571541|NCT02477527|528604475|FG000|Overall Study|Lost to Follow-up|2|||
146571542|NCT02477527|528604475|FG000|Overall Study|Withdrawal by Subject|1|||
146571543|NCT02477527|528604475|FG000|Overall Study|Screen Failure|3|||
146571544|NCT00592631|528604478|FG000|Overall Study|Lost to Follow-up|0|||
146571545|NCT00592631|528604479|FG001|Overall Study|Lost to Follow-up|2|||
146571546|NCT03389308|528604480|FG000|Overall Study|Withdrawal by Subject|5|||
146571547|NCT03389308|528604480|FG000|Overall Study|Lost to Follow-up|3|||
146571548|NCT03389308|528604480|FG000|Overall Study|Adverse Event|2|||
146571549|NCT03389308|528604480|FG000|Overall Study|Sponsor Request|2|||
146571550|NCT03198767|528604482|FG000|Overall Study|Protocol Violation|0|||
146571551|NCT03198767|528604483|FG001|Overall Study|Protocol Violation|0|||
146571552|NCT03198767|528604484|FG002|Overall Study|Protocol Violation|0|||
146571553|NCT03198767|528604485|FG003|Overall Study|Protocol Violation|6|||
146571554|NCT03198767|528604486|FG004|Overall Study|Protocol Violation|0|||
146571555|NCT03198767|528604487|FG005|Overall Study|Protocol Violation|0|||
146571556|NCT03198767|528604488|FG006|Overall Study|Protocol Violation|0|||
146571557|NCT02639247|528604491|FG000|Overall Study|Lost to Follow-up|2|||
146571558|NCT02639247|528604492|FG001|Overall Study|Lost to Follow-up|1|||
146571559|NCT02639247|528604491|FG000|Overall Study|Death|2|||
146571560|NCT02639247|528604492|FG001|Overall Study|Death|0|||
146571561|NCT02639247|528604491|FG000|Overall Study|Withdrew Consent|0|||
146571562|NCT02639247|528604492|FG001|Overall Study|Withdrew Consent|1|||
146571563|NCT02639247|528604491|FG000|Overall Study|Protocol Violation|1|||
146571564|NCT02639247|528604492|FG001|Overall Study|Protocol Violation|0|||
146571565|NCT02651116|528604495|FG000|Overall Study|Adverse Event|0|||
146571566|NCT02651116|528604496|FG001|Overall Study|Adverse Event|1|||
146571567|NCT02651116|528604495|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
146571568|NCT02651116|528604496|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
146571569|NCT00041470|528604504|FG000|Overall Study|Loss of Funding|38|||
146571570|NCT00739310|528604505|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
146571571|NCT00739310|528604505|FG000|Overall Study|Withdrawal by Subject|1|||
146571572|NCT00739310|528604505|FG000|Overall Study|Lost to Follow-up|2|||
146571573|NCT01061385|528604506|FG000|Overall Study|Lost to Follow-up|1|||
146571574|NCT01061385|528604507|FG001|Overall Study|Lost to Follow-up|0|||
146571575|NCT01061385|528604506|FG000|Overall Study|subject decision not related to AE|0|||
146571576|NCT01061385|528604507|FG001|Overall Study|subject decision not related to AE|1|||
146571577|NCT02655887|528604514|FG000|Overall Study|Lost to Follow-up|3|||
146571578|NCT02655887|528604514|FG000|Overall Study|Death|4|||
146571579|NCT02655887|528604514|FG000|Overall Study|Withdrawal by Subject|3|||
146571580|NCT02655887|528604514|FG000|Overall Study|Missed 12-month follow-up visit|4|||
146571581|NCT02948582|528604515|FG000|Washout Period 1|Adverse Event|0|||
146571582|NCT02948582|528604516|FG001|Washout Period 1|Adverse Event|2|||
146571583|NCT02948582|528604517|FG002|Washout Period 1|Adverse Event|0|||
146571584|NCT02948582|528604518|FG003|Washout Period 1|Adverse Event|0|||
146571585|NCT02948582|528604519|FG004|Washout Period 1|Adverse Event|0|||
146651347|NCT01903252|528900493|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
146651348|NCT01903252|528900494|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
146651349|NCT01903252|528900495|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
146651350|NCT01903252|528900490|FG000|Maintenance, Open-Label|Other|0|||
146651351|NCT01903252|528900491|FG001|Maintenance, Open-Label|Other|0|||
146571586|NCT02948582|528604520|FG005|Washout Period 1|Adverse Event|0|||
146571587|NCT02948582|528604515|FG000|Washout Period 1|Protocol Violation|0|||
146571588|NCT02948582|528604516|FG001|Washout Period 1|Protocol Violation|0|||
146571589|NCT02948582|528604517|FG002|Washout Period 1|Protocol Violation|0|||
146571590|NCT02948582|528604518|FG003|Washout Period 1|Protocol Violation|0|||
146651352|NCT01903252|528900492|FG002|Maintenance, Open-Label|Other|0|||
146571591|NCT02948582|528604519|FG004|Washout Period 1|Protocol Violation|0|||
146571592|NCT02948582|528604520|FG005|Washout Period 1|Protocol Violation|1|||
146571593|NCT02948582|528604515|FG000|Washout Period 2|Adverse Event|0|||
146571594|NCT02948582|528604516|FG001|Washout Period 2|Adverse Event|1|||
146571595|NCT02948582|528604517|FG002|Washout Period 2|Adverse Event|0|||
146571596|NCT02948582|528604518|FG003|Washout Period 2|Adverse Event|0|||
146571597|NCT02948582|528604519|FG004|Washout Period 2|Adverse Event|0|||
146571598|NCT02948582|528604520|FG005|Washout Period 2|Adverse Event|0|||
146571599|NCT02948582|528604515|FG000|Washout Period 2|personal reasons|0|||
146571600|NCT02948582|528604516|FG001|Washout Period 2|personal reasons|0|||
146571601|NCT02948582|528604517|FG002|Washout Period 2|personal reasons|0|||
146571602|NCT02948582|528604518|FG003|Washout Period 2|personal reasons|1|||
146571603|NCT02948582|528604519|FG004|Washout Period 2|personal reasons|0|||
146571604|NCT02948582|528604520|FG005|Washout Period 2|personal reasons|0|||
146651353|NCT01903252|528900493|FG003|Maintenance, Open-Label|Other|2|||
146651354|NCT01903252|528900494|FG004|Maintenance, Open-Label|Other|6|||
146651355|NCT01903252|528900495|FG005|Maintenance, Open-Label|Other|2|||
146651356|NCT01239732|528900496|FG000|Overall Study|Termination of study per protocol|667|||
146651357|NCT01239732|528900496|FG000|Overall Study|Death|226|||
146651358|NCT01239732|528900496|FG000|Overall Study|Withdrawal by Subject|87|||
146651359|NCT01239732|528900496|FG000|Overall Study|Adverse Event|6|||
146651360|NCT01239732|528900496|FG000|Overall Study|Protocol Violation|3|||
146651361|NCT01239732|528900496|FG000|Overall Study|Participant non compliance|5|||
146651362|NCT01239732|528900496|FG000|Overall Study|Study termination by sponsor|2|||
146651363|NCT01239732|528900496|FG000|Overall Study|Investigator's decision|4|||
146651364|NCT01239732|528900496|FG000|Overall Study|Treatment failure|2|||
146651365|NCT01239732|528900496|FG000|Overall Study|Other|19|||
146651366|NCT01381562|528900497|FG000|Overall Study|Adverse Event|0|||
146651367|NCT01381562|528900498|FG001|Overall Study|Adverse Event|1|||
146651368|NCT01381562|528900499|FG002|Overall Study|Adverse Event|0|||
146651369|NCT02660138|528900500|FG000|Overall Study|Adverse Event|0|||
146651370|NCT02660138|528900501|FG001|Overall Study|Adverse Event|3|||
146651371|NCT02660138|528900502|FG002|Overall Study|Adverse Event|2|||
146651372|NCT02660138|528900500|FG000|Overall Study|Lack of Efficacy|1|||
146651373|NCT02660138|528900501|FG001|Overall Study|Lack of Efficacy|2|||
146571605|NCT02948582|528604515|FG000|Washout Period 4|Adverse Event|1|||
146571606|NCT02948582|528604516|FG001|Washout Period 4|Adverse Event|0|||
146917185|NCT01905397|529858119|FG001|Overall Study|Dressing not applied in operating room|0|||
146571607|NCT02948582|528604517|FG002|Washout Period 4|Adverse Event|1|||
146571608|NCT02948582|528604518|FG003|Washout Period 4|Adverse Event|0|||
146571609|NCT02948582|528604519|FG004|Washout Period 4|Adverse Event|0|||
146571610|NCT02948582|528604520|FG005|Washout Period 4|Adverse Event|0|||
146571611|NCT04419467|528604523|FG000|Overall Study|Not treated with IP|0|||
146571612|NCT04419467|528604524|FG001|Overall Study|Not treated with IP|0|||
146571613|NCT04419467|528604525|FG002|Overall Study|Not treated with IP|2|||
146571614|NCT04419467|528604523|FG000|Overall Study|Adverse Event|0|||
146571615|NCT04419467|528604524|FG001|Overall Study|Adverse Event|2|||
146571616|NCT04419467|528604525|FG002|Overall Study|Adverse Event|0|||
146571617|NCT04419467|528604523|FG000|Overall Study|Death|1|||
146571618|NCT04419467|528604524|FG001|Overall Study|Death|0|||
146571619|NCT04419467|528604525|FG002|Overall Study|Death|0|||
146571620|NCT04419467|528604523|FG000|Overall Study|Lost to Follow-up|0|||
146571621|NCT04419467|528604524|FG001|Overall Study|Lost to Follow-up|1|||
146571622|NCT04419467|528604525|FG002|Overall Study|Lost to Follow-up|2|||
146571623|NCT04419467|528604523|FG000|Overall Study|Withdrawal by Subject|0|||
146571624|NCT04419467|528604524|FG001|Overall Study|Withdrawal by Subject|0|||
146571625|NCT04419467|528604525|FG002|Overall Study|Withdrawal by Subject|4|||
146571626|NCT04419467|528604523|FG000|Overall Study|Pandemic related|0|||
146571627|NCT04419467|528604524|FG001|Overall Study|Pandemic related|0|||
146571628|NCT04419467|528604525|FG002|Overall Study|Pandemic related|1|||
146571629|NCT04419467|528604523|FG000|Overall Study|Reason not known|1|||
146571630|NCT04419467|528604524|FG001|Overall Study|Reason not known|0|||
146571631|NCT04419467|528604525|FG002|Overall Study|Reason not known|0|||
146571632|NCT01925768|528604526|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
146571633|NCT01925768|528604527|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146571634|NCT01925768|528604526|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
146571635|NCT01925768|528604527|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
146651374|NCT02660138|528900502|FG002|Overall Study|Lack of Efficacy|1|||
146651375|NCT02660138|528900500|FG000|Overall Study|Withdrawal by Subject|7|||
146651376|NCT02660138|528900501|FG001|Overall Study|Withdrawal by Subject|6|||
146651377|NCT02660138|528900502|FG002|Overall Study|Withdrawal by Subject|6|||
146651378|NCT02660138|528900500|FG000|Overall Study|Lost to Follow-up|4|||
146571636|NCT01925768|528604526|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
146571637|NCT01925768|528604527|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
146571638|NCT01925768|528604526|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
146571639|NCT01925768|528604527|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
146571640|NCT01925768|528604526|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
146571641|NCT01925768|528604527|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
146571642|NCT01925768|528604526|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
146571643|NCT01925768|528604527|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
146571644|NCT01925768|528604526|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
146571645|NCT01925768|528604527|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
146651379|NCT02660138|528900501|FG001|Overall Study|Lost to Follow-up|4|||
146651380|NCT02660138|528900502|FG002|Overall Study|Lost to Follow-up|1|||
146651381|NCT02660138|528900500|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
146651382|NCT02660138|528900501|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
146917186|NCT01905397|529858118|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
146651383|NCT02660138|528900502|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
146651384|NCT02660138|528900500|FG000|Overall Study|Other|1|||
146651385|NCT02660138|528900501|FG001|Overall Study|Other|1|||
146651386|NCT02660138|528900502|FG002|Overall Study|Other|0|||
146917187|NCT01905397|529858119|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
146917188|NCT00231062|529858124|FG000|Overall Study|Physician Decision|6|||
146917189|NCT00590681|529858128|FG000|Overall Study|Withdrawal by Subject|7|||
146917190|NCT00590681|529858128|FG000|Overall Study|Adverse Event|8|||
146917191|NCT00590681|529858128|FG000|Overall Study|Death|3|||
146571646|NCT01925768|528604526|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
146571647|NCT01925768|528604527|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
146571648|NCT01925768|528604526|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
146571649|NCT01925768|528604527|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
146571650|NCT01925768|528604526|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
146571651|NCT01925768|528604527|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
146571652|NCT01925768|528604526|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
146571653|NCT01925768|528604527|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
146571654|NCT04571060|528604552|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
146571655|NCT04571060|528604553|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
146571656|NCT04571060|528604552|FG000|Overall Study|Never treated migraine|47|||
146571657|NCT04571060|528604553|FG001|Overall Study|Never treated migraine|36|||
146571658|NCT04571060|528604552|FG000|Overall Study|Protocol Violation|4|||
146571659|NCT04571060|528604553|FG001|Overall Study|Protocol Violation|2|||
146571660|NCT04571060|528604552|FG000|Overall Study|Withdrawal by Subject|6|||
146571661|NCT04571060|528604553|FG001|Overall Study|Withdrawal by Subject|2|||
146571662|NCT04571060|528604552|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
146571663|NCT04571060|528604553|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
146571664|NCT00087698|528604560|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
146571665|NCT00087698|528604560|FG000|Overall Study|Death from Other Causes|3|||
146571666|NCT00087698|528604560|FG000|Overall Study|Adverse Event|4|||
146571667|NCT00087698|528604560|FG000|Overall Study|Withdrawal by Subject|4|||
146571668|NCT00087698|528604560|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
146571669|NCT00087698|528604560|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
146571670|NCT00087698|528604560|FG000|Overall Study|Clinical Relapse|1|||
146571671|NCT00087698|528604560|FG000|Overall Study|Death from Study Disease|2|||
146571672|NCT00087698|528604560|FG000|Overall Study|Death from Study Drug Toxicity|2|||
146571673|NCT00087698|528604560|FG000|Overall Study|Protocol Violation|1|||
146571674|NCT03943290|528604564|FG000|Overall Study|Sponsor Terminated Study|6|||
146571675|NCT03943290|528604565|FG001|Overall Study|Sponsor Terminated Study|1|||
146571676|NCT03943290|528604566|FG002|Overall Study|Sponsor Terminated Study|11|||
146571677|NCT03943290|528604567|FG003|Overall Study|Sponsor Terminated Study|6|||
146571678|NCT03943290|528604568|FG004|Overall Study|Sponsor Terminated Study|7|||
146571679|NCT03943290|528604569|FG005|Overall Study|Sponsor Terminated Study|6|||
146571680|NCT03943290|528604570|FG006|Overall Study|Sponsor Terminated Study|6|||
146571681|NCT03943290|528604571|FG007|Overall Study|Sponsor Terminated Study|7|||
146571682|NCT03943290|528604572|FG008|Overall Study|Sponsor Terminated Study|8|||
146571683|NCT03943290|528604564|FG000|Overall Study|Lost to Follow-up|1|||
146571684|NCT03943290|528604565|FG001|Overall Study|Lost to Follow-up|0|||
146571685|NCT03943290|528604566|FG002|Overall Study|Lost to Follow-up|1|||
146571686|NCT03943290|528604567|FG003|Overall Study|Lost to Follow-up|0|||
146571687|NCT03943290|528604568|FG004|Overall Study|Lost to Follow-up|0|||
146571688|NCT03943290|528604569|FG005|Overall Study|Lost to Follow-up|0|||
146571689|NCT03943290|528604570|FG006|Overall Study|Lost to Follow-up|0|||
146571690|NCT03943290|528604571|FG007|Overall Study|Lost to Follow-up|1|||
146571691|NCT03943290|528604572|FG008|Overall Study|Lost to Follow-up|0|||
146571692|NCT03943290|528604564|FG000|Overall Study|Withdrawal by Subject|0|||
146571693|NCT03943290|528604565|FG001|Overall Study|Withdrawal by Subject|0|||
146571694|NCT03943290|528604566|FG002|Overall Study|Withdrawal by Subject|1|||
146571695|NCT03943290|528604567|FG003|Overall Study|Withdrawal by Subject|0|||
146571696|NCT03943290|528604568|FG004|Overall Study|Withdrawal by Subject|0|||
146571697|NCT03943290|528604569|FG005|Overall Study|Withdrawal by Subject|0|||
146571698|NCT03943290|528604570|FG006|Overall Study|Withdrawal by Subject|0|||
146571699|NCT03943290|528604571|FG007|Overall Study|Withdrawal by Subject|0|||
146571700|NCT03943290|528604572|FG008|Overall Study|Withdrawal by Subject|0|||
146571701|NCT04179305|528604576|FG000|Overall Study|Death|1|||
146571702|NCT04179305|528604577|FG001|Overall Study|Death|1|||
146571703|NCT04179305|528604578|FG002|Overall Study|Death|0|||
146571704|NCT04179305|528604579|FG003|Overall Study|Death|0|||
146571705|NCT04179305|528604576|FG000|Overall Study|Lost to Follow-up|1|||
146571706|NCT04179305|528604577|FG001|Overall Study|Lost to Follow-up|1|||
146571707|NCT04179305|528604578|FG002|Overall Study|Lost to Follow-up|0|||
146917192|NCT00590681|529858128|FG000|Overall Study|Lost to Follow-up|1|||
146917193|NCT00590681|529858128|FG000|Overall Study|disease progression|1|||
146571708|NCT04179305|528604579|FG003|Overall Study|Lost to Follow-up|0|||
146571709|NCT04179305|528604576|FG000|Overall Study|Withdrawal by Subject|0|||
146571710|NCT04179305|528604577|FG001|Overall Study|Withdrawal by Subject|1|||
146571711|NCT04179305|528604578|FG002|Overall Study|Withdrawal by Subject|0|||
146571712|NCT04179305|528604579|FG003|Overall Study|Withdrawal by Subject|0|||
146571713|NCT04179305|528604576|FG000|Overall Study|Did not have scan|1|||
146571714|NCT04179305|528604577|FG001|Overall Study|Did not have scan|0|||
146571715|NCT04179305|528604578|FG002|Overall Study|Did not have scan|0|||
146571716|NCT04179305|528604579|FG003|Overall Study|Did not have scan|0|||
146571717|NCT04179305|528604576|FG000|Overall Study|In hospice care|3|||
146571718|NCT04179305|528604577|FG001|Overall Study|In hospice care|0|||
146571719|NCT04179305|528604578|FG002|Overall Study|In hospice care|0|||
146571720|NCT04179305|528604579|FG003|Overall Study|In hospice care|0|||
146571721|NCT03192137|528604582|FG000|Overall Study|Adverse Event|10|||
146571722|NCT03192137|528604583|FG001|Overall Study|Adverse Event|11|||
146571723|NCT03192137|528604582|FG000|Overall Study|Physician Decision|1|||
146571724|NCT03192137|528604583|FG001|Overall Study|Physician Decision|0|||
146571725|NCT03192137|528604582|FG000|Overall Study|Lack of Efficacy|20|||
146571726|NCT03192137|528604583|FG001|Overall Study|Lack of Efficacy|37|||
146571727|NCT03192137|528604582|FG000|Overall Study|Withdrawal by Subject|3|||
146571728|NCT03192137|528604583|FG001|Overall Study|Withdrawal by Subject|3|||
146571729|NCT03192137|528604582|FG000|Overall Study|Protocol Violation|4|||
146571730|NCT03192137|528604583|FG001|Overall Study|Protocol Violation|3|||
146571731|NCT03192137|528604582|FG000|Overall Study|Surgery Cancelled|4|||
146571732|NCT03192137|528604583|FG001|Overall Study|Surgery Cancelled|1|||
146571733|NCT03192137|528604582|FG000|Overall Study|Other - Various Administrative Reasons|8|||
146571734|NCT03192137|528604583|FG001|Overall Study|Other - Various Administrative Reasons|3|||
146571735|NCT02737501|528604586|FG000|Randomized Phase|Died|41|||
146571736|NCT02737501|528604587|FG001|Randomized Phase|Died|29|||
146571737|NCT02737501|528604588|FG002|Randomized Phase|Died|0|||
146571738|NCT02737501|528604586|FG000|Randomized Phase|Withdrawal by Subject|16|||
146571739|NCT02737501|528604587|FG001|Randomized Phase|Withdrawal by Subject|6|||
146571740|NCT02737501|528604588|FG002|Randomized Phase|Withdrawal by Subject|0|||
146571741|NCT02737501|528604586|FG000|Randomized Phase|Lost to Follow-up|0|||
146571742|NCT02737501|528604587|FG001|Randomized Phase|Lost to Follow-up|1|||
146571743|NCT02737501|528604588|FG002|Randomized Phase|Lost to Follow-up|0|||
146571744|NCT02737501|528604586|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
146571745|NCT02737501|528604587|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
146571746|NCT02737501|528604588|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
146571747|NCT02737501|528604586|FG000|Randomized Phase|Reason not Specified|1|||
146571748|NCT02737501|528604587|FG001|Randomized Phase|Reason not Specified|1|||
146571749|NCT02737501|528604588|FG002|Randomized Phase|Reason not Specified|0|||
146571750|NCT02737501|528604586|FG000|Randomized Phase|Never Treated|1|||
146571751|NCT02737501|528604587|FG001|Randomized Phase|Never Treated|1|||
146571752|NCT02737501|528604588|FG002|Randomized Phase|Never Treated|0|||
146571753|NCT02737501|528604586|FG000|Crossover Phase|Died|0|||
146571754|NCT02737501|528604587|FG001|Crossover Phase|Died|0|||
146571755|NCT02737501|528604588|FG002|Crossover Phase|Died|22|||
146571756|NCT02737501|528604586|FG000|Crossover Phase|Withdrew Consent|0|||
146571757|NCT02737501|528604587|FG001|Crossover Phase|Withdrew Consent|0|||
146571758|NCT02737501|528604588|FG002|Crossover Phase|Withdrew Consent|9|||
146571759|NCT02737501|528604586|FG000|Crossover Phase|Physician Decision|0|||
146571760|NCT02737501|528604587|FG001|Crossover Phase|Physician Decision|0|||
146571761|NCT02737501|528604588|FG002|Crossover Phase|Physician Decision|1|||
146571762|NCT02737501|528604586|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
146571763|NCT02737501|528604587|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
146571764|NCT02737501|528604588|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
146571765|NCT01261975|528604589|FG000|Overall Study|Surgical complication|1|||
146571766|NCT01070979|528604592|FG000|Overall Study|Adverse Event|2|||
146571767|NCT01070979|528604593|FG001|Overall Study|Adverse Event|3|||
146571768|NCT01070979|528604594|FG002|Overall Study|Adverse Event|3|||
146571769|NCT01070979|528604592|FG000|Overall Study|Lost to Follow-up|2|||
146571770|NCT01070979|528604593|FG001|Overall Study|Lost to Follow-up|1|||
146571771|NCT01070979|528604594|FG002|Overall Study|Lost to Follow-up|1|||
146571772|NCT01070979|528604592|FG000|Overall Study|Protocol Violation|0|||
146571773|NCT01070979|528604593|FG001|Overall Study|Protocol Violation|2|||
146571774|NCT01070979|528604594|FG002|Overall Study|Protocol Violation|6|||
146571775|NCT01070979|528604592|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
146651387|NCT02660138|528900500|FG000|Overall Study|Not treated|0|||
146651388|NCT02660138|528900501|FG001|Overall Study|Not treated|1|||
146509743|NCT02044874|528369030|FG002|Overall Study|Adverse Event|6|||
146509744|NCT02044874|528369028|FG000|Overall Study|Withdrawal by Subject|8|||
146509745|NCT02044874|528369029|FG001|Overall Study|Withdrawal by Subject|16|||
146509746|NCT02044874|528369030|FG002|Overall Study|Withdrawal by Subject|23|||
146509747|NCT02044874|528369028|FG000|Overall Study|Physician Decision|0|||
146509748|NCT02044874|528369029|FG001|Overall Study|Physician Decision|2|||
146509749|NCT02044874|528369030|FG002|Overall Study|Physician Decision|1|||
146509750|NCT02044874|528369028|FG000|Overall Study|Lost to Follow-up|10|||
146509751|NCT02044874|528369029|FG001|Overall Study|Lost to Follow-up|27|||
146509752|NCT02044874|528369030|FG002|Overall Study|Lost to Follow-up|21|||
146509753|NCT02044874|528369028|FG000|Overall Study|Sponsor Decision|0|||
146509754|NCT02044874|528369029|FG001|Overall Study|Sponsor Decision|1|||
146509755|NCT02044874|528369030|FG002|Overall Study|Sponsor Decision|1|||
146509756|NCT02044874|528369028|FG000|Overall Study|Other|7|||
146651389|NCT02660138|528900502|FG002|Overall Study|Not treated|0|||
146651390|NCT00308581|528900507|FG000|Induction Phase|Adverse Event|0|||
146651391|NCT00308581|528900508|FG001|Induction Phase|Adverse Event|0|||
146651392|NCT00308581|528900509|FG002|Induction Phase|Adverse Event|37|||
146651393|NCT00308581|528900507|FG000|Induction Phase|Lack of Efficacy|0|||
146651394|NCT00308581|528900508|FG001|Induction Phase|Lack of Efficacy|0|||
146651395|NCT00308581|528900509|FG002|Induction Phase|Lack of Efficacy|121|||
146651396|NCT00308581|528900507|FG000|Induction Phase|Withdrawal by Subject|0|||
146651397|NCT00308581|528900508|FG001|Induction Phase|Withdrawal by Subject|0|||
146651398|NCT00308581|528900509|FG002|Induction Phase|Withdrawal by Subject|5|||
146651399|NCT00308581|528900507|FG000|Induction Phase|Unknown reason|0|||
146651400|NCT00308581|528900508|FG001|Induction Phase|Unknown reason|0|||
146651401|NCT00308581|528900509|FG002|Induction Phase|Unknown reason|3|||
146651402|NCT00308581|528900507|FG000|Randomized Maintenance Phase|Adverse Event|10|||
146651403|NCT00308581|528900508|FG001|Randomized Maintenance Phase|Adverse Event|17|||
146651404|NCT00308581|528900509|FG002|Randomized Maintenance Phase|Adverse Event|0|||
146651405|NCT00308581|528900507|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
146651406|NCT00308581|528900508|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
146651407|NCT00308581|528900509|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
146651408|NCT00308581|528900507|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
146651409|NCT00308581|528900508|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
146651410|NCT00308581|528900509|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
146651411|NCT00308581|528900507|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
146651412|NCT00308581|528900508|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
146651413|NCT00308581|528900509|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
146651414|NCT00308581|528900507|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
146651415|NCT00308581|528900508|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
146651416|NCT00308581|528900509|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
146651417|NCT00308581|528900507|FG000|Randomized Maintenance Phase|Unknown reason|3|||
146651418|NCT00308581|528900508|FG001|Randomized Maintenance Phase|Unknown reason|0|||
146651419|NCT00308581|528900509|FG002|Randomized Maintenance Phase|Unknown reason|0|||
146651420|NCT00899353|528900510|FG000|Overall Study|Adverse Event|2|||
146651421|NCT00899353|528900510|FG000|Overall Study|Lost to Follow-up|1|||
146651422|NCT00899353|528900510|FG000|Overall Study|Withdrawal by Subject|2|||
146651423|NCT01892384|528900521|FG000|Overall Study|Withdrawal by Subject|1|||
146651424|NCT01892384|528900522|FG001|Overall Study|Withdrawal by Subject|1|||
146651425|NCT01892384|528900523|FG002|Overall Study|Withdrawal by Subject|0|||
146651426|NCT01892384|528900524|FG003|Overall Study|Withdrawal by Subject|0|||
146651427|NCT00592774|528900525|FG000|Overall Study|Adverse Event|5|||
146651428|NCT00592774|528900526|FG001|Overall Study|Adverse Event|19|||
146651429|NCT00592774|528900527|FG002|Overall Study|Adverse Event|2|||
146651430|NCT00592774|528900528|FG003|Overall Study|Adverse Event|14|||
146651431|NCT00592774|528900529|FG004|Overall Study|Adverse Event|8|||
146509757|NCT02044874|528369029|FG001|Overall Study|Other|3|||
146509758|NCT02044874|528369030|FG002|Overall Study|Other|8|||
146509759|NCT02889835|528369031|FG000|Overall Study|Lost to Follow-up|13|||
146509760|NCT02889835|528369032|FG001|Overall Study|Lost to Follow-up|13|||
146509761|NCT02889835|528369033|FG002|Overall Study|Lost to Follow-up|13|||
146509762|NCT02889835|528369031|FG000|Overall Study|Withdrawal by Subject|2|||
146509763|NCT02889835|528369032|FG001|Overall Study|Withdrawal by Subject|2|||
146509764|NCT02889835|528369033|FG002|Overall Study|Withdrawal by Subject|2|||
146509765|NCT02889835|528369031|FG000|Overall Study|Protocol Violation|1|||
146509766|NCT02889835|528369032|FG001|Overall Study|Protocol Violation|1|||
146509767|NCT02889835|528369033|FG002|Overall Study|Protocol Violation|1|||
146509768|NCT02889835|528369031|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
146509769|NCT02889835|528369032|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
146509770|NCT02889835|528369033|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
146509771|NCT02889835|528369031|FG000|Overall Study|Death|1|||
146509772|NCT02889835|528369032|FG001|Overall Study|Death|1|||
146509773|NCT02889835|528369033|FG002|Overall Study|Death|1|||
146509774|NCT05072964|528369034|FG000|Overall Study|Withdrawal by Subject|4|||
146509775|NCT05072964|528369034|FG000|Overall Study|Death|1|||
146509776|NCT01047332|528369037|FG000|Overall Study|SEMS Obstruction|11|||
146509777|NCT01047332|528369038|FG001|Overall Study|SEMS Obstruction|20|||
146509778|NCT01047332|528369037|FG000|Overall Study|Died Unobstructed|38|||
146509779|NCT01047332|528369038|FG001|Overall Study|Died Unobstructed|41|||
146509780|NCT01047332|528369037|FG000|Overall Study|Lost to Follow-up|8|||
146509781|NCT01047332|528369038|FG001|Overall Study|Lost to Follow-up|3|||
146509782|NCT03521817|528369043|FG000|Overall Study|Protocol Violation|0|||
146509783|NCT03521817|528369044|FG001|Overall Study|Protocol Violation|1|||
146509784|NCT01328548|528369046|FG000|Overall Study|Death|3|||
146509785|NCT01328548|528369047|FG001|Overall Study|Death|0|||
146509786|NCT01328548|528369046|FG000|Overall Study|Protocol Violation|1|||
146509787|NCT01328548|528369047|FG001|Overall Study|Protocol Violation|0|||
146509788|NCT04506905|528369050|FG000|Overall Study|Lost to Follow-up|1|||
146651432|NCT00592774|528900525|FG000|Overall Study|Protocol Violation|0|||
146651433|NCT00592774|528900526|FG001|Overall Study|Protocol Violation|1|||
146651434|NCT00592774|528900527|FG002|Overall Study|Protocol Violation|0|||
146651435|NCT00592774|528900528|FG003|Overall Study|Protocol Violation|0|||
146651436|NCT00592774|528900529|FG004|Overall Study|Protocol Violation|1|||
146651437|NCT00592774|528900525|FG000|Overall Study|Withdrawal by Subject|3|||
146651438|NCT00592774|528900526|FG001|Overall Study|Withdrawal by Subject|7|||
146651439|NCT00592774|528900527|FG002|Overall Study|Withdrawal by Subject|0|||
146651440|NCT00592774|528900528|FG003|Overall Study|Withdrawal by Subject|0|||
146651441|NCT00592774|528900529|FG004|Overall Study|Withdrawal by Subject|0|||
146651442|NCT00592774|528900525|FG000|Overall Study|Lack of Efficacy|3|||
146651443|NCT00592774|528900526|FG001|Overall Study|Lack of Efficacy|3|||
146651444|NCT00592774|528900527|FG002|Overall Study|Lack of Efficacy|0|||
146651445|NCT00592774|528900528|FG003|Overall Study|Lack of Efficacy|0|||
146651446|NCT00592774|528900529|FG004|Overall Study|Lack of Efficacy|2|||
146651447|NCT00592774|528900525|FG000|Overall Study|Physician Decision|0|||
146651448|NCT00592774|528900526|FG001|Overall Study|Physician Decision|1|||
146651449|NCT00592774|528900527|FG002|Overall Study|Physician Decision|1|||
146651450|NCT00592774|528900528|FG003|Overall Study|Physician Decision|0|||
146651451|NCT00592774|528900529|FG004|Overall Study|Physician Decision|1|||
146651452|NCT00592774|528900525|FG000|Overall Study|Other|0|||
146651453|NCT00592774|528900526|FG001|Overall Study|Other|1|||
146651454|NCT00592774|528900527|FG002|Overall Study|Other|1|||
146571776|NCT01070979|528604593|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
146651455|NCT00592774|528900528|FG003|Overall Study|Other|0|||
146651456|NCT00592774|528900529|FG004|Overall Study|Other|2|||
146651457|NCT01924429|528900535|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
146651458|NCT01924429|528900536|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
146651459|NCT03985878|528900539|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
146651460|NCT03985878|528900539|FG000|Overall Study|Study Terminated by Sponsor|12|||
146651461|NCT03985878|528900539|FG000|Overall Study|Withdrawal by Subject|1|||
146651462|NCT01606878|528900540|FG000|Overall Study|Adverse Event|1|||
146651463|NCT01606878|528900541|FG001|Overall Study|Adverse Event|1|||
146651464|NCT01606878|528900542|FG002|Overall Study|Adverse Event|0|||
146651465|NCT01606878|528900543|FG003|Overall Study|Adverse Event|0|||
146651466|NCT01606878|528900544|FG004|Overall Study|Adverse Event|0|||
146651467|NCT01606878|528900545|FG005|Overall Study|Adverse Event|0|||
146651468|NCT01606878|528900546|FG006|Overall Study|Adverse Event|1|||
146651469|NCT01606878|528900547|FG007|Overall Study|Adverse Event|0|||
146571777|NCT01070979|528604594|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
146571778|NCT01070979|528604592|FG000|Overall Study|Withdrawal by Subject|3|||
146571779|NCT01070979|528604593|FG001|Overall Study|Withdrawal by Subject|1|||
146571780|NCT01070979|528604594|FG002|Overall Study|Withdrawal by Subject|1|||
146571781|NCT01070979|528604592|FG000|Overall Study|No study drug taken|0|||
146571782|NCT01070979|528604593|FG001|Overall Study|No study drug taken|1|||
146571783|NCT01070979|528604594|FG002|Overall Study|No study drug taken|0|||
146571784|NCT00142792|528604595|FG000|Overall Study|Death|0|||
146571785|NCT00142792|528604596|FG001|Overall Study|Death|0|||
146571786|NCT00142792|528604597|FG002|Overall Study|Death|1|||
146571787|NCT00142792|528604595|FG000|Overall Study|Withdrawal by Subject|3|||
146571788|NCT00142792|528604596|FG001|Overall Study|Withdrawal by Subject|2|||
146571789|NCT00142792|528604597|FG002|Overall Study|Withdrawal by Subject|3|||
146571790|NCT00142792|528604595|FG000|Overall Study|Lost to Follow-up|8|||
146571791|NCT00142792|528604596|FG001|Overall Study|Lost to Follow-up|11|||
146571792|NCT00142792|528604597|FG002|Overall Study|Lost to Follow-up|7|||
146571793|NCT00142792|528604595|FG000|Overall Study|No category|1|||
146571794|NCT00142792|528604596|FG001|Overall Study|No category|2|||
146571795|NCT00142792|528604597|FG002|Overall Study|No category|1|||
146651470|NCT01606878|528900548|FG008|Overall Study|Adverse Event|1|||
146651471|NCT01606878|528900549|FG009|Overall Study|Adverse Event|3|||
146917194|NCT01259297|529858129|FG000|Double Blind Randomized Period|Death|1|||
146917195|NCT01259297|529858130|FG001|Double Blind Randomized Period|Death|1|||
146917196|NCT01259297|529858131|FG002|Double Blind Randomized Period|Death|1|||
146571796|NCT04819113|528604598|FG000|Overall Study|Withdrawal by parent/guardian|3|||
146571797|NCT04819113|528604598|FG000|Overall Study|Lost to Follow-up|1|||
146651472|NCT01606878|528900550|FG010|Overall Study|Adverse Event|0|||
146651473|NCT01606878|528900540|FG000|Overall Study|Lack of Efficacy|1|||
146651474|NCT01606878|528900541|FG001|Overall Study|Lack of Efficacy|1|||
146651475|NCT01606878|528900542|FG002|Overall Study|Lack of Efficacy|1|||
146917197|NCT01259297|529858132|FG003|Double Blind Randomized Period|Death|2|||
146571798|NCT04819113|528604598|FG000|Overall Study|Withdrawn before vaccination|2|||
146651476|NCT01606878|528900543|FG003|Overall Study|Lack of Efficacy|2|||
146651477|NCT01606878|528900544|FG004|Overall Study|Lack of Efficacy|1|||
146651478|NCT01606878|528900545|FG005|Overall Study|Lack of Efficacy|2|||
146651479|NCT01606878|528900546|FG006|Overall Study|Lack of Efficacy|1|||
146651480|NCT01606878|528900547|FG007|Overall Study|Lack of Efficacy|2|||
146651481|NCT01606878|528900548|FG008|Overall Study|Lack of Efficacy|2|||
146651482|NCT01606878|528900549|FG009|Overall Study|Lack of Efficacy|0|||
146651483|NCT01606878|528900550|FG010|Overall Study|Lack of Efficacy|1|||
146571799|NCT00437268|528604599|FG000|Overall Study|Adverse Event|1|||
146571800|NCT00437268|528604600|FG001|Overall Study|Adverse Event|1|||
146571801|NCT00437268|528604599|FG000|Overall Study|Withdrawal by Subject|2|||
146571802|NCT00437268|528604600|FG001|Overall Study|Withdrawal by Subject|2|||
146571803|NCT00437268|528604599|FG000|Overall Study|Progressive disease|9|||
146571804|NCT00437268|528604600|FG001|Overall Study|Progressive disease|9|||
146571805|NCT00437268|528604599|FG000|Overall Study|Physician Decision|1|||
146977258|NCT01223196|530079389|FG001|Overall Study|Withdrawal by Subject|0|||
146977259|NCT02598193|530079390|FG000|Overall Study|Adverse Event|13|||
146571806|NCT00437268|528604600|FG001|Overall Study|Physician Decision|0|||
146571807|NCT00437268|528604599|FG000|Overall Study|Death|0|||
146571808|NCT00437268|528604600|FG001|Overall Study|Death|1|||
146571809|NCT00444925|528604605|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
146571810|NCT00444925|528604606|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
146571811|NCT00444925|528604607|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
146571812|NCT00444925|528604605|FG000|Double-blind Treatment Period|Death|2|||
146571813|NCT00444925|528604606|FG001|Double-blind Treatment Period|Death|0|||
146571814|NCT00444925|528604607|FG002|Double-blind Treatment Period|Death|0|||
146571815|NCT00444925|528604605|FG000|Double-blind Treatment Period|Adverse Event|6|||
146571816|NCT00444925|528604606|FG001|Double-blind Treatment Period|Adverse Event|28|||
146571817|NCT00444925|528604607|FG002|Double-blind Treatment Period|Adverse Event|44|||
146571818|NCT00444925|528604605|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
146571819|NCT00444925|528604606|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
146571820|NCT00444925|528604607|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
146571821|NCT00444925|528604605|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
146571822|NCT00444925|528604606|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
146571823|NCT00444925|528604607|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
146571824|NCT00444925|528604605|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
146571825|NCT00444925|528604606|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
146571826|NCT00444925|528604607|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
146571827|NCT00444925|528604605|FG000|Double-blind Treatment Period|Other|7|||
146571828|NCT00444925|528604606|FG001|Double-blind Treatment Period|Other|7|||
146571829|NCT00444925|528604607|FG002|Double-blind Treatment Period|Other|12|||
146571830|NCT01342094|528604610|FG000|Overall Study|Adverse Event|5|||
146571831|NCT01342094|528604611|FG001|Overall Study|Adverse Event|0|||
146571832|NCT01342094|528604610|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
146571833|NCT01342094|528604611|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
146571834|NCT01342094|528604610|FG000|Overall Study|Withdrawal by Subject|0|||
146571835|NCT01342094|528604611|FG001|Overall Study|Withdrawal by Subject|2|||
146571836|NCT02806414|528604612|FG000|Overall Study|Lost to Follow-up|2|||
146571837|NCT00810277|528606742|FG000|Overall Study|Adverse Event|1|||
146571838|NCT00532129|528606745|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
146571839|NCT00532129|528606745|FG000|Treatment Period|Physician Decision|15|||
146571840|NCT00532129|528606745|FG000|Treatment Period|Disease progression|3|||
146571841|NCT00532129|528606745|FG000|Treatment Period|Protocol Violation|1|||
146571842|NCT00532129|528606745|FG000|Treatment Period|Other|5|||
146571843|NCT00532129|528606745|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
146571844|NCT00532129|528606745|FG000|Follow-up Period|Disease progression|57|||
146571845|NCT00532129|528606745|FG000|Follow-up Period|Lost to Follow-up|1|||
146571846|NCT00532129|528606745|FG000|Follow-up Period|Other|6|||
146571847|NCT04551898|528606746|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
146571848|NCT04551898|528606747|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
146571849|NCT04551898|528606748|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
146571850|NCT04551898|528606749|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
146571851|NCT04551898|528606746|FG000|Overall Study|Withdrawal by Subject|5|||
146571852|NCT04551898|528606747|FG001|Overall Study|Withdrawal by Subject|1|||
146571853|NCT04551898|528606748|FG002|Overall Study|Withdrawal by Subject|2|||
146571854|NCT04551898|528606749|FG003|Overall Study|Withdrawal by Subject|2|||
146571855|NCT04551898|528606746|FG000|Overall Study|Lost to Follow-up|2|||
146571856|NCT04551898|528606747|FG001|Overall Study|Lost to Follow-up|1|||
146571857|NCT04551898|528606748|FG002|Overall Study|Lost to Follow-up|2|||
146571858|NCT04551898|528606749|FG003|Overall Study|Lost to Follow-up|2|||
146571859|NCT04551898|528606746|FG000|Overall Study|Death|1|||
146571860|NCT04551898|528606747|FG001|Overall Study|Death|0|||
146571861|NCT04551898|528606748|FG002|Overall Study|Death|0|||
146571862|NCT04551898|528606749|FG003|Overall Study|Death|0|||
146651484|NCT01606878|528900540|FG000|Overall Study|Physician Decision|1|||
146651485|NCT01606878|528900541|FG001|Overall Study|Physician Decision|0|||
146651486|NCT01606878|528900542|FG002|Overall Study|Physician Decision|2|||
146651487|NCT01606878|528900543|FG003|Overall Study|Physician Decision|1|||
146770563|NCT00723450|529328640|FG001|Open-Label Phase|Protocol Violation|0|||
146571863|NCT04551898|528606746|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
146571864|NCT04551898|528606747|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
146977260|NCT02598193|530079390|FG000|Overall Study|Withdrawal by Subject|1|||
146977261|NCT02598193|530079390|FG000|Overall Study|Listed in active lung transplant list|1|||
146977262|NCT02598193|530079390|FG000|Overall Study|Does not want to take Nintedanib|1|||
146977263|NCT02487979|530079391|FG000|Overall Study|Physician Decision|2|||
146977264|NCT02487979|530079391|FG000|Overall Study|Withdrawal by Subject|2|||
146977265|NCT02487979|530079391|FG000|Overall Study|Progressive Disease|17|||
146977266|NCT00447694|530079392|FG000|Overall Study|Adverse Event|2|||
146571865|NCT04551898|528606748|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
146571866|NCT04551898|528606749|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
146571867|NCT00551031|528606750|FG000|Overall Study|Adverse Event|0|||
146571868|NCT00551031|528606751|FG001|Overall Study|Adverse Event|1|||
146571869|NCT00551031|528606752|FG002|Overall Study|Adverse Event|0|||
146571870|NCT00551031|528606753|FG003|Overall Study|Adverse Event|0|||
146571871|NCT00551031|528606754|FG004|Overall Study|Adverse Event|0|||
146571872|NCT00551031|528606750|FG000|Overall Study|Protocol Violation|1|||
146571873|NCT00551031|528606751|FG001|Overall Study|Protocol Violation|1|||
146571874|NCT00551031|528606752|FG002|Overall Study|Protocol Violation|0|||
146571875|NCT00551031|528606753|FG003|Overall Study|Protocol Violation|0|||
146571876|NCT00551031|528606754|FG004|Overall Study|Protocol Violation|0|||
146571877|NCT00551031|528606750|FG000|Overall Study|Lost to Follow-up|0|||
146571878|NCT00551031|528606751|FG001|Overall Study|Lost to Follow-up|1|||
146571879|NCT00551031|528606752|FG002|Overall Study|Lost to Follow-up|0|||
146571880|NCT00551031|528606753|FG003|Overall Study|Lost to Follow-up|1|||
146571881|NCT00551031|528606754|FG004|Overall Study|Lost to Follow-up|1|||
146571882|NCT00551031|528606750|FG000|Overall Study|Withdrawal by Subject|0|||
146571883|NCT00551031|528606751|FG001|Overall Study|Withdrawal by Subject|4|||
146571884|NCT00551031|528606752|FG002|Overall Study|Withdrawal by Subject|1|||
146571885|NCT00551031|528606753|FG003|Overall Study|Withdrawal by Subject|2|||
146571886|NCT00551031|528606754|FG004|Overall Study|Withdrawal by Subject|0|||
146571887|NCT00551031|528606750|FG000|Overall Study|Serious Adverse Event|0|||
146571888|NCT00551031|528606751|FG001|Overall Study|Serious Adverse Event|2|||
146571889|NCT00551031|528606752|FG002|Overall Study|Serious Adverse Event|1|||
146571890|NCT00551031|528606753|FG003|Overall Study|Serious Adverse Event|0|||
146571891|NCT00551031|528606754|FG004|Overall Study|Serious Adverse Event|0|||
146571892|NCT00551031|528606750|FG000|Overall Study|Did not receive vaccine|1|||
146571893|NCT00551031|528606751|FG001|Overall Study|Did not receive vaccine|2|||
146571894|NCT00551031|528606752|FG002|Overall Study|Did not receive vaccine|0|||
146571895|NCT00551031|528606753|FG003|Overall Study|Did not receive vaccine|0|||
146571896|NCT00551031|528606754|FG004|Overall Study|Did not receive vaccine|0|||
146571897|NCT01336712|528606767|FG000|Overall Study|Death|2|||
146571898|NCT01336712|528606767|FG000|Overall Study|Lack of Efficacy|1|||
146571899|NCT00399568|528606768|FG000|Overall Study|Adverse Event|1|||
146571900|NCT00399568|528606769|FG001|Overall Study|Adverse Event|2|||
146571901|NCT00399568|528606768|FG000|Overall Study|Withdrawal by Subject|7|||
146571902|NCT00399568|528606769|FG001|Overall Study|Withdrawal by Subject|3|||
146571903|NCT00399568|528606768|FG000|Overall Study|Protocol non-compliance|2|||
146571904|NCT00399568|528606769|FG001|Overall Study|Protocol non-compliance|2|||
146571905|NCT00399568|528606768|FG000|Overall Study|Lost to Follow-up|2|||
146571906|NCT00399568|528606769|FG001|Overall Study|Lost to Follow-up|2|||
146571907|NCT00841776|528606772|FG000|Overall Study|Lack of Efficacy|0|||
146571908|NCT00841776|528606773|FG001|Overall Study|Lack of Efficacy|1|||
146571909|NCT00841776|528606772|FG000|Overall Study|Lost to Follow-up|2|||
146571910|NCT00841776|528606773|FG001|Overall Study|Lost to Follow-up|1|||
146571911|NCT00841776|528606772|FG000|Overall Study|Withdrawal by Subject|0|||
146571912|NCT00841776|528606773|FG001|Overall Study|Withdrawal by Subject|1|||
146571913|NCT04567524|528606774|FG000|Overall Study|Adverse Event|1|||
146571914|NCT04567524|528606775|FG001|Overall Study|Adverse Event|1|||
146571915|NCT04567524|528606776|FG002|Overall Study|Adverse Event|0|||
146571916|NCT04567524|528606777|FG003|Overall Study|Adverse Event|0|||
146571917|NCT04567524|528606774|FG000|Overall Study|Withdrawal by Subject|2|||
146571918|NCT04567524|528606775|FG001|Overall Study|Withdrawal by Subject|0|||
146571919|NCT04567524|528606776|FG002|Overall Study|Withdrawal by Subject|0|||
146571920|NCT04567524|528606777|FG003|Overall Study|Withdrawal by Subject|1|||
146571921|NCT01147393|528606780|FG000|Dose Level 1|Dose limiting Toxicity|2|||
146571922|NCT01147393|528606780|FG000|Dose Level -1|Dose Limited Toxicity|1|||
146571923|NCT03688919|528606787|FG000|Overall Study|Lost to Follow-up|2|||
146571924|NCT03688919|528606788|FG001|Overall Study|Lost to Follow-up|1|||
146571925|NCT03688919|528606787|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
146571926|NCT03688919|528606788|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
146571927|NCT00570323|528606795|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
146571928|NCT00570323|528606796|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
146571929|NCT00570323|528606795|FG000|Started Treatment After Randomization|Protocol Violation|1|||
146770564|NCT00723450|529328641|FG002|Open-Label Phase|Protocol Violation|0|||
146977267|NCT00447694|530079392|FG000|Overall Study|Abnormal laboratory value|1|||
146571930|NCT00570323|528606796|FG001|Started Treatment After Randomization|Protocol Violation|0|||
146917198|NCT01259297|529858133|FG004|Double Blind Randomized Period|Death|1|||
146917199|NCT01259297|529858134|FG005|Double Blind Randomized Period|Death|5|||
146917200|NCT01259297|529858135|FG006|Double Blind Randomized Period|Death|2|||
146917201|NCT01259297|529858136|FG007|Double Blind Randomized Period|Death|1|||
146917202|NCT01259297|529858129|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
146917203|NCT01259297|529858130|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
146917204|NCT01259297|529858131|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
146571931|NCT00570323|528606795|FG000|Started Treatment After Randomization|Physician Decision|1|||
146571932|NCT00570323|528606796|FG001|Started Treatment After Randomization|Physician Decision|0|||
146571933|NCT00570323|528606795|FG000|Complete Study After Start|Lost to Follow-up|0|||
146571934|NCT00570323|528606796|FG001|Complete Study After Start|Lost to Follow-up|1|||
146571935|NCT00570323|528606795|FG000|Complete Study After Start|Withdrawal by Subject|2|||
146571936|NCT00570323|528606796|FG001|Complete Study After Start|Withdrawal by Subject|0|||
146571937|NCT00570323|528606795|FG000|Complete Study After Start|Physician Decision|1|||
146571938|NCT00570323|528606796|FG001|Complete Study After Start|Physician Decision|0|||
146571939|NCT04263766|528606797|FG000|Overall Study|Withdrawal by Subject|6|||
146571940|NCT04263766|528606798|FG001|Overall Study|Withdrawal by Subject|4|||
146571941|NCT04263766|528606797|FG000|Overall Study|Lack of Efficacy|1|||
146571942|NCT04263766|528606798|FG001|Overall Study|Lack of Efficacy|3|||
146571943|NCT01891396|528606800|FG000|Overall Study|Withdrawal by Subject|4|||
146571944|NCT01891396|528606801|FG001|Overall Study|Withdrawal by Subject|4|||
146571945|NCT01891396|528606802|FG002|Overall Study|Withdrawal by Subject|3|||
146571946|NCT01891396|528606800|FG000|Overall Study|Lost to Follow-up|0|||
146571947|NCT01891396|528606801|FG001|Overall Study|Lost to Follow-up|1|||
146571948|NCT01891396|528606802|FG002|Overall Study|Lost to Follow-up|0|||
146571949|NCT03462758|528606803|FG000|Overall Study|Chose no or other method of contraception|20|||
146571950|NCT03462758|528606804|FG001|Overall Study|Chose no or other method of contraception|23|||
146571951|NCT03462758|528606803|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
146571952|NCT03462758|528606804|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
146571953|NCT03462758|528606803|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
146571954|NCT03462758|528606804|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
146571955|NCT03462758|528606803|FG000|Overall Study|Medical contraindication|2|||
146571956|NCT03462758|528606804|FG001|Overall Study|Medical contraindication|2|||
146571957|NCT03462758|528606803|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
146571958|NCT03462758|528606804|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
146571959|NCT02820844|528606805|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
146571960|NCT02820844|528606806|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
146571961|NCT02820844|528606807|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
146571962|NCT02820844|528606808|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
146571963|NCT02820844|528606809|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
146571964|NCT02820844|528606810|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
146571965|NCT02820844|528606805|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
146571966|NCT02820844|528606806|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
146571967|NCT02820844|528606807|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
146571968|NCT02820844|528606808|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
146571969|NCT02820844|528606809|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
146571970|NCT02820844|528606810|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
146571971|NCT02820844|528606805|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
146571972|NCT02820844|528606806|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
146571973|NCT02820844|528606807|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
146571974|NCT02820844|528606808|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
146571975|NCT02820844|528606809|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
146571976|NCT02820844|528606810|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
146571977|NCT02820844|528606805|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
146571978|NCT02820844|528606806|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
146571979|NCT02820844|528606807|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
146571980|NCT02820844|528606808|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
146571981|NCT02820844|528606809|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
146571982|NCT02820844|528606810|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
146571983|NCT02820844|528606805|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
146571984|NCT02820844|528606806|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
146571985|NCT02820844|528606807|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
146571986|NCT02820844|528606808|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
146571987|NCT02820844|528606809|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
146571988|NCT02820844|528606810|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
146571989|NCT02820844|528606805|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
146571990|NCT02820844|528606806|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
146770565|NCT00723450|529328639|FG000|Open-Label Phase|Lost to Follow-up|7|||
146770566|NCT00723450|529328640|FG001|Open-Label Phase|Lost to Follow-up|0|||
146917205|NCT01259297|529858132|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
146917206|NCT01259297|529858133|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
146917207|NCT01259297|529858134|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
146917208|NCT01259297|529858135|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
146917209|NCT01259297|529858136|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
146917210|NCT01259297|529858129|FG000|Double Blind Randomized Period|Other reasons|0|||
146509789|NCT04506905|528369051|FG001|Overall Study|Lost to Follow-up|0|||
146509790|NCT04506905|528369052|FG002|Overall Study|Lost to Follow-up|0|||
146509791|NCT04506905|528369053|FG003|Overall Study|Lost to Follow-up|1|||
146509792|NCT04506905|528369054|FG004|Overall Study|Lost to Follow-up|0|||
146509793|NCT04506905|528369055|FG005|Overall Study|Lost to Follow-up|0|||
146509794|NCT04506905|528369056|FG006|Overall Study|Lost to Follow-up|0|||
146509795|NCT04506905|528369057|FG007|Overall Study|Lost to Follow-up|0|||
146509796|NCT04506905|528369058|FG008|Overall Study|Lost to Follow-up|0|||
146509797|NCT04506905|528369050|FG000|Overall Study|Withdrawal by Subject|0|||
146509798|NCT04506905|528369051|FG001|Overall Study|Withdrawal by Subject|0|||
146509799|NCT04506905|528369052|FG002|Overall Study|Withdrawal by Subject|0|||
146509800|NCT04506905|528369053|FG003|Overall Study|Withdrawal by Subject|2|||
146509801|NCT04506905|528369054|FG004|Overall Study|Withdrawal by Subject|0|||
146509802|NCT04506905|528369055|FG005|Overall Study|Withdrawal by Subject|0|||
146509803|NCT04506905|528369056|FG006|Overall Study|Withdrawal by Subject|0|||
146509804|NCT04506905|528369057|FG007|Overall Study|Withdrawal by Subject|0|||
146509805|NCT04506905|528369058|FG008|Overall Study|Withdrawal by Subject|0|||
146509806|NCT00073983|528369059|FG000|Overall Study|not evaluable|1|||
146571991|NCT02820844|528606807|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
146571992|NCT02820844|528606808|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
146571993|NCT02820844|528606809|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
146571994|NCT02820844|528606810|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
146571995|NCT02820844|528606805|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
146571996|NCT02820844|528606806|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
146571997|NCT02820844|528606807|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
146571998|NCT02820844|528606808|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
146571999|NCT02820844|528606809|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
146572000|NCT02820844|528606810|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
146572001|NCT02820844|528606805|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146572002|NCT02820844|528606806|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146572003|NCT02820844|528606807|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
146572004|NCT02820844|528606808|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
146572005|NCT02820844|528606809|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146572006|NCT02820844|528606810|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146572007|NCT02820844|528606805|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
146572008|NCT02820844|528606806|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
146572009|NCT02820844|528606807|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
146572010|NCT02820844|528606808|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
146572011|NCT02820844|528606809|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
146572012|NCT02820844|528606810|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
146572013|NCT02820844|528606805|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146572014|NCT02820844|528606806|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146572015|NCT02820844|528606807|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146572016|NCT02820844|528606808|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146572017|NCT02820844|528606809|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146572018|NCT02820844|528606810|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
146572019|NCT02266147|528606812|FG000|PART 1: Dose Escalation|Physician Decision|0|||
146572020|NCT02266147|528606813|FG001|PART 1: Dose Escalation|Physician Decision|0|||
146572021|NCT02266147|528606814|FG002|PART 1: Dose Escalation|Physician Decision|1|||
146572022|NCT02266147|528606815|FG003|PART 1: Dose Escalation|Physician Decision|0|||
146572023|NCT02266147|528606812|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
146572024|NCT02266147|528606813|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
146572025|NCT02266147|528606814|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
146572026|NCT02266147|528606815|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
146572027|NCT02266147|528606812|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
146572028|NCT02266147|528606813|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
146572029|NCT02266147|528606814|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
146572030|NCT02266147|528606815|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
146572031|NCT02266147|528606812|FG000|PART 1: Dose Escalation|Other|1|||
146572032|NCT02266147|528606813|FG001|PART 1: Dose Escalation|Other|1|||
146572033|NCT02266147|528606814|FG002|PART 1: Dose Escalation|Other|0|||
146572034|NCT02266147|528606815|FG003|PART 1: Dose Escalation|Other|0|||
146572035|NCT02266147|528606812|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
146572036|NCT02266147|528606813|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
146572037|NCT02266147|528606814|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
146572038|NCT02266147|528606815|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
146572039|NCT02266147|528606812|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
146572040|NCT02266147|528606813|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
146572041|NCT02266147|528606814|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
146572042|NCT02266147|528606815|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
146572043|NCT00573391|528606816|FG000|Overall Study|study stopped|2|||
146572044|NCT00573391|528606817|FG001|Overall Study|study stopped|2|||
146572045|NCT00573391|528606816|FG000|Overall Study|Death|1|||
146572046|NCT00573391|528606817|FG001|Overall Study|Death|0|||
146572047|NCT00413660|528606820|FG000|Up To Week 12|Adverse Event|1|||
146572048|NCT00413660|528606821|FG001|Up To Week 12|Adverse Event|3|||
146572049|NCT00413660|528606822|FG002|Up To Week 12|Adverse Event|1|||
146572050|NCT00413660|528606823|FG003|Up To Week 12|Adverse Event|4|||
146572051|NCT00413660|528606824|FG004|Up To Week 12|Adverse Event|6|||
146572052|NCT00413660|528606825|FG005|Up To Week 12|Adverse Event|4|||
146572053|NCT00413660|528606826|FG006|Up To Week 12|Adverse Event|1|||
146572054|NCT00413660|528606827|FG007|Up To Week 12|Adverse Event|0|||
146572055|NCT00413660|528606828|FG008|Up To Week 12|Adverse Event|0|||
146572056|NCT00413660|528606829|FG009|Up To Week 12|Adverse Event|0|||
146572057|NCT00413660|528606830|FG010|Up To Week 12|Adverse Event|0|||
146572058|NCT00413660|528606820|FG000|Up To Week 12|Lack of Efficacy|2|||
146572059|NCT00413660|528606821|FG001|Up To Week 12|Lack of Efficacy|0|||
146572060|NCT00413660|528606822|FG002|Up To Week 12|Lack of Efficacy|0|||
146572061|NCT00413660|528606823|FG003|Up To Week 12|Lack of Efficacy|0|||
146572062|NCT00413660|528606824|FG004|Up To Week 12|Lack of Efficacy|0|||
146572063|NCT00413660|528606825|FG005|Up To Week 12|Lack of Efficacy|0|||
146572064|NCT00413660|528606826|FG006|Up To Week 12|Lack of Efficacy|5|||
146572065|NCT00413660|528606827|FG007|Up To Week 12|Lack of Efficacy|0|||
146572066|NCT00413660|528606828|FG008|Up To Week 12|Lack of Efficacy|0|||
146572067|NCT00413660|528606829|FG009|Up To Week 12|Lack of Efficacy|0|||
146572068|NCT00413660|528606830|FG010|Up To Week 12|Lack of Efficacy|0|||
146572069|NCT00413660|528606820|FG000|Up To Week 12|Lost to Follow-up|0|||
146572070|NCT00413660|528606821|FG001|Up To Week 12|Lost to Follow-up|1|||
146572071|NCT00413660|528606822|FG002|Up To Week 12|Lost to Follow-up|0|||
146572072|NCT00413660|528606823|FG003|Up To Week 12|Lost to Follow-up|0|||
146572073|NCT00413660|528606824|FG004|Up To Week 12|Lost to Follow-up|1|||
146572074|NCT00413660|528606825|FG005|Up To Week 12|Lost to Follow-up|0|||
146572075|NCT00413660|528606826|FG006|Up To Week 12|Lost to Follow-up|0|||
146572076|NCT00413660|528606827|FG007|Up To Week 12|Lost to Follow-up|0|||
146572077|NCT00413660|528606828|FG008|Up To Week 12|Lost to Follow-up|0|||
146572078|NCT00413660|528606829|FG009|Up To Week 12|Lost to Follow-up|0|||
146572079|NCT00413660|528606830|FG010|Up To Week 12|Lost to Follow-up|0|||
146572080|NCT00413660|528606820|FG000|Up To Week 12|Withdrawal by Subject|0|||
146572081|NCT00413660|528606821|FG001|Up To Week 12|Withdrawal by Subject|2|||
146572082|NCT00413660|528606822|FG002|Up To Week 12|Withdrawal by Subject|0|||
146572083|NCT00413660|528606823|FG003|Up To Week 12|Withdrawal by Subject|2|||
146572084|NCT00413660|528606824|FG004|Up To Week 12|Withdrawal by Subject|0|||
146572085|NCT00413660|528606825|FG005|Up To Week 12|Withdrawal by Subject|2|||
146572086|NCT00413660|528606826|FG006|Up To Week 12|Withdrawal by Subject|2|||
146572087|NCT00413660|528606827|FG007|Up To Week 12|Withdrawal by Subject|0|||
146572088|NCT00413660|528606828|FG008|Up To Week 12|Withdrawal by Subject|0|||
146572089|NCT00413660|528606829|FG009|Up To Week 12|Withdrawal by Subject|0|||
146572090|NCT00413660|528606830|FG010|Up To Week 12|Withdrawal by Subject|0|||
146572091|NCT00413660|528606820|FG000|Up To Week 12|Randomized, Not Treated|1|||
146572092|NCT00413660|528606821|FG001|Up To Week 12|Randomized, Not Treated|0|||
146572093|NCT00413660|528606822|FG002|Up To Week 12|Randomized, Not Treated|0|||
146572094|NCT00413660|528606823|FG003|Up To Week 12|Randomized, Not Treated|1|||
146572095|NCT00413660|528606824|FG004|Up To Week 12|Randomized, Not Treated|0|||
146572096|NCT00413660|528606825|FG005|Up To Week 12|Randomized, Not Treated|0|||
146572097|NCT00413660|528606826|FG006|Up To Week 12|Randomized, Not Treated|0|||
146917211|NCT01259297|529858130|FG001|Double Blind Randomized Period|Other reasons|1|||
146917212|NCT01259297|529858131|FG002|Double Blind Randomized Period|Other reasons|0|||
146917213|NCT01259297|529858132|FG003|Double Blind Randomized Period|Other reasons|0|||
146917214|NCT01259297|529858133|FG004|Double Blind Randomized Period|Other reasons|1|||
146572098|NCT00413660|528606827|FG007|Up To Week 12|Randomized, Not Treated|0|||
146572099|NCT00413660|528606828|FG008|Up To Week 12|Randomized, Not Treated|0|||
146572100|NCT00413660|528606829|FG009|Up To Week 12|Randomized, Not Treated|0|||
146572101|NCT00413660|528606830|FG010|Up To Week 12|Randomized, Not Treated|0|||
146572102|NCT00413660|528606820|FG000|Up To Week 12|Other|3|||
146572103|NCT00413660|528606821|FG001|Up To Week 12|Other|1|||
146572104|NCT00413660|528606822|FG002|Up To Week 12|Other|6|||
146572105|NCT00413660|528606823|FG003|Up To Week 12|Other|1|||
146572106|NCT00413660|528606824|FG004|Up To Week 12|Other|2|||
146917215|NCT01259297|529858134|FG005|Double Blind Randomized Period|Other reasons|2|||
146572107|NCT00413660|528606825|FG005|Up To Week 12|Other|4|||
146572108|NCT00413660|528606826|FG006|Up To Week 12|Other|3|||
146572109|NCT00413660|528606827|FG007|Up To Week 12|Other|0|||
146572110|NCT00413660|528606828|FG008|Up To Week 12|Other|0|||
146572111|NCT00413660|528606829|FG009|Up To Week 12|Other|0|||
146572112|NCT00413660|528606830|FG010|Up To Week 12|Other|0|||
146572113|NCT00413660|528606820|FG000|Post Week 12|Adverse Event|2|||
146572114|NCT00413660|528606821|FG001|Post Week 12|Adverse Event|0|||
146572115|NCT00413660|528606822|FG002|Post Week 12|Adverse Event|2|||
146572116|NCT00413660|528606823|FG003|Post Week 12|Adverse Event|1|||
146572117|NCT00413660|528606824|FG004|Post Week 12|Adverse Event|4|||
146572118|NCT00413660|528606825|FG005|Post Week 12|Adverse Event|2|||
146572119|NCT00413660|528606826|FG006|Post Week 12|Adverse Event|2|||
146572120|NCT00413660|528606827|FG007|Post Week 12|Adverse Event|0|||
146572121|NCT00413660|528606828|FG008|Post Week 12|Adverse Event|0|||
146572122|NCT00413660|528606829|FG009|Post Week 12|Adverse Event|0|||
146572123|NCT00413660|528606830|FG010|Post Week 12|Adverse Event|0|||
146572124|NCT00413660|528606820|FG000|Post Week 12|Lack of Efficacy|0|||
146572125|NCT00413660|528606821|FG001|Post Week 12|Lack of Efficacy|0|||
146572126|NCT00413660|528606822|FG002|Post Week 12|Lack of Efficacy|1|||
146572127|NCT00413660|528606823|FG003|Post Week 12|Lack of Efficacy|0|||
146572128|NCT00413660|528606824|FG004|Post Week 12|Lack of Efficacy|0|||
146572129|NCT00413660|528606825|FG005|Post Week 12|Lack of Efficacy|0|||
146572130|NCT00413660|528606826|FG006|Post Week 12|Lack of Efficacy|0|||
146572131|NCT00413660|528606827|FG007|Post Week 12|Lack of Efficacy|0|||
146572132|NCT00413660|528606828|FG008|Post Week 12|Lack of Efficacy|0|||
146572133|NCT00413660|528606829|FG009|Post Week 12|Lack of Efficacy|1|||
146572134|NCT00413660|528606830|FG010|Post Week 12|Lack of Efficacy|0|||
146572135|NCT00413660|528606820|FG000|Post Week 12|Lost to Follow-up|0|||
146572136|NCT00413660|528606821|FG001|Post Week 12|Lost to Follow-up|1|||
146572137|NCT00413660|528606822|FG002|Post Week 12|Lost to Follow-up|1|||
146572138|NCT00413660|528606823|FG003|Post Week 12|Lost to Follow-up|0|||
146917216|NCT01259297|529858135|FG006|Double Blind Randomized Period|Other reasons|3|||
146917217|NCT01259297|529858136|FG007|Double Blind Randomized Period|Other reasons|1|||
146917218|NCT02229864|529858139|FG000|Overall Study|Death|2|||
146572139|NCT00413660|528606824|FG004|Post Week 12|Lost to Follow-up|0|||
146917219|NCT02229864|529858139|FG000|Overall Study|Lost to Follow-up|1|||
146572140|NCT00413660|528606825|FG005|Post Week 12|Lost to Follow-up|0|||
146572141|NCT00413660|528606826|FG006|Post Week 12|Lost to Follow-up|0|||
146572142|NCT00413660|528606827|FG007|Post Week 12|Lost to Follow-up|0|||
146572143|NCT00413660|528606828|FG008|Post Week 12|Lost to Follow-up|0|||
146572144|NCT00413660|528606829|FG009|Post Week 12|Lost to Follow-up|0|||
146572145|NCT00413660|528606830|FG010|Post Week 12|Lost to Follow-up|0|||
146572146|NCT00413660|528606820|FG000|Post Week 12|Withdrawal by Subject|0|||
146572147|NCT00413660|528606821|FG001|Post Week 12|Withdrawal by Subject|1|||
146572148|NCT00413660|528606822|FG002|Post Week 12|Withdrawal by Subject|1|||
146572149|NCT00413660|528606823|FG003|Post Week 12|Withdrawal by Subject|0|||
146572150|NCT00413660|528606824|FG004|Post Week 12|Withdrawal by Subject|1|||
146572151|NCT00413660|528606825|FG005|Post Week 12|Withdrawal by Subject|0|||
146572152|NCT00413660|528606826|FG006|Post Week 12|Withdrawal by Subject|0|||
146572153|NCT00413660|528606827|FG007|Post Week 12|Withdrawal by Subject|0|||
146572154|NCT00413660|528606828|FG008|Post Week 12|Withdrawal by Subject|0|||
146572155|NCT00413660|528606829|FG009|Post Week 12|Withdrawal by Subject|0|||
146572156|NCT00413660|528606830|FG010|Post Week 12|Withdrawal by Subject|1|||
146572157|NCT00413660|528606820|FG000|Post Week 12|Other|1|||
146572158|NCT00413660|528606821|FG001|Post Week 12|Other|2|||
146572159|NCT00413660|528606822|FG002|Post Week 12|Other|3|||
146572160|NCT00413660|528606823|FG003|Post Week 12|Other|0|||
146572161|NCT00413660|528606824|FG004|Post Week 12|Other|1|||
146572162|NCT00413660|528606825|FG005|Post Week 12|Other|1|||
146572163|NCT00413660|528606826|FG006|Post Week 12|Other|1|||
146572164|NCT00413660|528606827|FG007|Post Week 12|Other|0|||
146572165|NCT00413660|528606828|FG008|Post Week 12|Other|0|||
146572166|NCT00413660|528606829|FG009|Post Week 12|Other|0|||
146917220|NCT01096550|529858140|FG000|Overall Study|discontinued site|10|||
146572167|NCT00413660|528606830|FG010|Post Week 12|Other|0|||
146917221|NCT01096550|529858141|FG001|Overall Study|discontinued site|11|||
146572168|NCT03896477|528606831|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
146572169|NCT03896477|528606832|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
146572170|NCT03896477|528606833|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
146572171|NCT03896477|528606831|FG000|Overall Study|Parent Requested Withdrawal|8|||
146770567|NCT00723450|529328641|FG002|Open-Label Phase|Lost to Follow-up|0|||
146572172|NCT03896477|528606832|FG001|Overall Study|Parent Requested Withdrawal|12|||
146572173|NCT03896477|528606833|FG002|Overall Study|Parent Requested Withdrawal|9|||
146770568|NCT00723450|529328639|FG000|Open-Label Phase|Physician Decision|2|||
146572174|NCT03896477|528606831|FG000|Overall Study|Adverse Event|0|||
146572175|NCT03896477|528606832|FG001|Overall Study|Adverse Event|0|||
146572176|NCT03896477|528606833|FG002|Overall Study|Adverse Event|1|||
146572177|NCT03896477|528606831|FG000|Overall Study|Death|1|||
146572178|NCT03896477|528606832|FG001|Overall Study|Death|0|||
146572179|NCT03896477|528606833|FG002|Overall Study|Death|0|||
146572180|NCT03896477|528606831|FG000|Overall Study|Other|5|||
146572181|NCT03896477|528606832|FG001|Overall Study|Other|6|||
146572182|NCT03896477|528606833|FG002|Overall Study|Other|7|||
146572183|NCT03896477|528606831|FG000|Overall Study|Lost to Follow-up|2|||
146572184|NCT03896477|528606832|FG001|Overall Study|Lost to Follow-up|1|||
146572185|NCT03896477|528606833|FG002|Overall Study|Lost to Follow-up|1|||
146572186|NCT01791517|528606835|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
146572187|NCT01791517|528606836|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
146572188|NCT01791517|528606837|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
146572189|NCT01791517|528606838|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
146572190|NCT01791517|528606839|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
146572191|NCT01791517|528606840|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
146572192|NCT01791517|528606841|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
146572193|NCT01791517|528606842|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
146572194|NCT01791517|528606843|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
146572195|NCT01791517|528606844|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
146572196|NCT01791517|528606845|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
146572197|NCT01791517|528606846|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
146572198|NCT01791517|528606835|FG000|Phase I: Period 1|Adverse Event|0|||
146572199|NCT01791517|528606836|FG001|Phase I: Period 1|Adverse Event|0|||
146572200|NCT01791517|528606837|FG002|Phase I: Period 1|Adverse Event|1|||
146572201|NCT01791517|528606838|FG003|Phase I: Period 1|Adverse Event|1|||
146572202|NCT01791517|528606839|FG004|Phase I: Period 1|Adverse Event|0|||
146572203|NCT01791517|528606840|FG005|Phase I: Period 1|Adverse Event|0|||
146572204|NCT01791517|528606841|FG006|Phase I: Period 1|Adverse Event|0|||
146572205|NCT01791517|528606842|FG007|Phase I: Period 1|Adverse Event|0|||
146572206|NCT01791517|528606843|FG008|Phase I: Period 1|Adverse Event|0|||
146572207|NCT01791517|528606844|FG009|Phase I: Period 1|Adverse Event|0|||
146572208|NCT01791517|528606845|FG010|Phase I: Period 1|Adverse Event|0|||
146572209|NCT01791517|528606846|FG011|Phase I: Period 1|Adverse Event|0|||
146572210|NCT01791517|528606835|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
146572211|NCT01791517|528606836|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146572212|NCT01791517|528606837|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146572213|NCT01791517|528606838|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146572214|NCT01791517|528606839|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146572215|NCT01791517|528606840|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146572216|NCT01791517|528606841|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146572217|NCT01791517|528606842|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146572218|NCT01791517|528606843|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146572219|NCT01791517|528606844|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146572220|NCT01791517|528606845|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146572221|NCT01791517|528606846|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146572222|NCT01791517|528606835|FG000|Phase I: Period 1|Protocol Violation|0|||
146572223|NCT01791517|528606836|FG001|Phase I: Period 1|Protocol Violation|1|||
146572224|NCT01791517|528606837|FG002|Phase I: Period 1|Protocol Violation|0|||
146572225|NCT01791517|528606838|FG003|Phase I: Period 1|Protocol Violation|0|||
146572226|NCT01791517|528606839|FG004|Phase I: Period 1|Protocol Violation|0|||
146572227|NCT01791517|528606840|FG005|Phase I: Period 1|Protocol Violation|0|||
146572228|NCT01791517|528606841|FG006|Phase I: Period 1|Protocol Violation|0|||
146572229|NCT01791517|528606842|FG007|Phase I: Period 1|Protocol Violation|0|||
146572230|NCT01791517|528606843|FG008|Phase I: Period 1|Protocol Violation|0|||
146572231|NCT01791517|528606844|FG009|Phase I: Period 1|Protocol Violation|0|||
146572232|NCT01791517|528606845|FG010|Phase I: Period 1|Protocol Violation|0|||
146572233|NCT01791517|528606846|FG011|Phase I: Period 1|Protocol Violation|0|||
146572234|NCT01791517|528606835|FG000|Phase I: Period 1|Lost to Follow-up|0|||
146572235|NCT01791517|528606836|FG001|Phase I: Period 1|Lost to Follow-up|0|||
146572236|NCT01791517|528606837|FG002|Phase I: Period 1|Lost to Follow-up|0|||
146572237|NCT01791517|528606838|FG003|Phase I: Period 1|Lost to Follow-up|1|||
146572238|NCT01791517|528606839|FG004|Phase I: Period 1|Lost to Follow-up|0|||
146572239|NCT01791517|528606840|FG005|Phase I: Period 1|Lost to Follow-up|0|||
146572240|NCT01791517|528606841|FG006|Phase I: Period 1|Lost to Follow-up|1|||
146572241|NCT01791517|528606842|FG007|Phase I: Period 1|Lost to Follow-up|0|||
146572242|NCT01791517|528606843|FG008|Phase I: Period 1|Lost to Follow-up|1|||
146572243|NCT01791517|528606844|FG009|Phase I: Period 1|Lost to Follow-up|1|||
146572244|NCT01791517|528606845|FG010|Phase I: Period 1|Lost to Follow-up|0|||
146572245|NCT01791517|528606846|FG011|Phase I: Period 1|Lost to Follow-up|0|||
146572246|NCT01791517|528606835|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
146572247|NCT01791517|528606836|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
146572248|NCT01791517|528606837|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
146572249|NCT01791517|528606838|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
146572250|NCT01791517|528606839|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
146572251|NCT01791517|528606840|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
146572252|NCT01791517|528606841|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
146572253|NCT01791517|528606842|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
146572254|NCT01791517|528606843|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
146572255|NCT01791517|528606844|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
146572256|NCT01791517|528606845|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
146572257|NCT01791517|528606846|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
146572258|NCT01791517|528606835|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
146572259|NCT01791517|528606836|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146572260|NCT01791517|528606837|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146572261|NCT01791517|528606838|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146572262|NCT01791517|528606839|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146572263|NCT01791517|528606840|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146572264|NCT01791517|528606841|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146572265|NCT01791517|528606842|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146572266|NCT01791517|528606843|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146572267|NCT01791517|528606844|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146572268|NCT01791517|528606845|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146572269|NCT01791517|528606846|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146572270|NCT01791517|528606835|FG000|Phase I: Period 2|Protocol Violation|0|||
146572271|NCT01791517|528606836|FG001|Phase I: Period 2|Protocol Violation|0|||
146572272|NCT01791517|528606837|FG002|Phase I: Period 2|Protocol Violation|0|||
146572273|NCT01791517|528606838|FG003|Phase I: Period 2|Protocol Violation|1|||
146572274|NCT01791517|528606839|FG004|Phase I: Period 2|Protocol Violation|0|||
146572275|NCT01791517|528606840|FG005|Phase I: Period 2|Protocol Violation|0|||
146572276|NCT01791517|528606841|FG006|Phase I: Period 2|Protocol Violation|0|||
146572277|NCT01791517|528606842|FG007|Phase I: Period 2|Protocol Violation|0|||
146572278|NCT01791517|528606843|FG008|Phase I: Period 2|Protocol Violation|0|||
146572279|NCT01791517|528606844|FG009|Phase I: Period 2|Protocol Violation|0|||
146572280|NCT01791517|528606845|FG010|Phase I: Period 2|Protocol Violation|0|||
146572281|NCT01791517|528606846|FG011|Phase I: Period 2|Protocol Violation|0|||
146572282|NCT01791517|528606835|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
146572283|NCT01791517|528606836|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
146572284|NCT01791517|528606837|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
146917222|NCT01096550|529858140|FG000|Overall Study|non-regular treatment track at clinic|1|||
146917223|NCT01096550|529858141|FG001|Overall Study|non-regular treatment track at clinic|1|||
146917224|NCT01096550|529858140|FG000|Overall Study|clinic readmission|1|||
146917225|NCT01096550|529858141|FG001|Overall Study|clinic readmission|1|||
146917226|NCT01096550|529858140|FG000|Overall Study|Withdrawal by Subject|0|||
146572285|NCT01791517|528606838|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
146572286|NCT01791517|528606839|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
146572287|NCT01791517|528606840|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
146572288|NCT01791517|528606841|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
146572289|NCT01791517|528606842|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
146572290|NCT01791517|528606843|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
146572291|NCT01791517|528606844|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
146572292|NCT01791517|528606845|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
146651488|NCT01606878|528900544|FG004|Overall Study|Physician Decision|1|||
146651489|NCT01606878|528900545|FG005|Overall Study|Physician Decision|1|||
146651490|NCT01606878|528900546|FG006|Overall Study|Physician Decision|2|||
146651491|NCT01606878|528900547|FG007|Overall Study|Physician Decision|0|||
146651492|NCT01606878|528900548|FG008|Overall Study|Physician Decision|1|||
146651493|NCT01606878|528900549|FG009|Overall Study|Physician Decision|0|||
146651494|NCT01606878|528900550|FG010|Overall Study|Physician Decision|0|||
146651495|NCT01606878|528900540|FG000|Overall Study|Withdrawal by Subject|3|||
146651496|NCT01606878|528900541|FG001|Overall Study|Withdrawal by Subject|2|||
146651497|NCT01606878|528900542|FG002|Overall Study|Withdrawal by Subject|2|||
146651498|NCT01606878|528900543|FG003|Overall Study|Withdrawal by Subject|0|||
146651499|NCT01606878|528900544|FG004|Overall Study|Withdrawal by Subject|1|||
146651500|NCT01606878|528900545|FG005|Overall Study|Withdrawal by Subject|1|||
146651501|NCT01606878|528900546|FG006|Overall Study|Withdrawal by Subject|2|||
146651502|NCT01606878|528900547|FG007|Overall Study|Withdrawal by Subject|1|||
146651503|NCT01606878|528900548|FG008|Overall Study|Withdrawal by Subject|2|||
146917227|NCT01096550|529858141|FG001|Overall Study|Withdrawal by Subject|1|||
146651504|NCT01606878|528900549|FG009|Overall Study|Withdrawal by Subject|0|||
146651505|NCT01606878|528900550|FG010|Overall Study|Withdrawal by Subject|2|||
146651506|NCT00129311|528900553|FG000|Overall Study|Withdrawal by Subject|12|||
146572293|NCT01791517|528606846|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
146651507|NCT00129311|528900554|FG001|Overall Study|Withdrawal by Subject|19|||
146651508|NCT00853970|528900564|FG000|Overall Study|Withdrawal by Subject|2|||
146770569|NCT00723450|529328640|FG001|Open-Label Phase|Physician Decision|0|||
146572294|NCT01791517|528606835|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146572295|NCT01791517|528606836|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146572296|NCT01791517|528606837|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146651509|NCT00853970|528900565|FG001|Overall Study|Withdrawal by Subject|1|||
146651510|NCT00853970|528900564|FG000|Overall Study|Cancelled surgery|4|||
146770570|NCT00723450|529328641|FG002|Open-Label Phase|Physician Decision|0|||
146917228|NCT01096550|529858140|FG000|Overall Study|non-African American participant|13|||
146651511|NCT00853970|528900565|FG001|Overall Study|Cancelled surgery|2|||
146651512|NCT04085367|528902162|FG000|Overall Study|Adverse Event|1|||
146651513|NCT04085367|528902163|FG001|Overall Study|Adverse Event|1|||
146651514|NCT04085367|528902162|FG000|Overall Study|Withdrawal by Subject|13|||
146651515|NCT04085367|528902163|FG001|Overall Study|Withdrawal by Subject|4|||
146651516|NCT04085367|528902162|FG000|Overall Study|Lost to Follow-up|3|||
146651517|NCT04085367|528902163|FG001|Overall Study|Lost to Follow-up|1|||
146651518|NCT04085367|528902162|FG000|Overall Study|Other unspecified|2|||
146651519|NCT04085367|528902163|FG001|Overall Study|Other unspecified|1|||
146651520|NCT04085367|528902162|FG000|Overall Study|Status Unknown|1|||
146651521|NCT04085367|528902163|FG001|Overall Study|Status Unknown|1|||
146651522|NCT03603509|528902165|FG000|Overall Study|Lost to Follow-up|3|||
146651523|NCT03603509|528902166|FG001|Overall Study|Lost to Follow-up|4|||
146651524|NCT00130442|528902169|FG000|Overall Study|Withdrawal by Subject|0|||
146651525|NCT00130442|528902170|FG001|Overall Study|Withdrawal by Subject|1|||
146651526|NCT00130442|528902169|FG000|Overall Study|did not meet criteria|1|||
146572297|NCT01791517|528606838|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146651527|NCT00130442|528902170|FG001|Overall Study|did not meet criteria|1|||
146651528|NCT00814333|528902172|FG000|Enrollment|Lost to Follow-up|1|||
146651529|NCT00814333|528902173|FG001|Enrollment|Lost to Follow-up|0|||
146651530|NCT01527357|528902174|FG000|Overall Study|Death|8|||
146651531|NCT01527357|528902175|FG001|Overall Study|Death|2|||
146651532|NCT01527357|528902174|FG000|Overall Study|Lost to Follow-up|6|||
146651533|NCT01527357|528902175|FG001|Overall Study|Lost to Follow-up|4|||
146651534|NCT01527357|528902174|FG000|Overall Study|Withdrew Consent|1|||
146651535|NCT01527357|528902175|FG001|Overall Study|Withdrew Consent|1|||
146651536|NCT01527357|528902174|FG000|Overall Study|Non-compliance|0|||
146651537|NCT01527357|528902175|FG001|Overall Study|Non-compliance|1|||
146651538|NCT01527357|528902174|FG000|Overall Study|No Day 29 Visit|0|||
146651539|NCT01527357|528902175|FG001|Overall Study|No Day 29 Visit|1|||
146651540|NCT01527357|528902174|FG000|Overall Study|Did Not Receive Treatment|2|||
146651541|NCT01527357|528902175|FG001|Overall Study|Did Not Receive Treatment|0|||
146651542|NCT00910247|528902176|FG000|Overall Study|Adverse Event|15|||
146651543|NCT00910247|528902176|FG000|Overall Study|Death|2|||
146651544|NCT00910247|528902176|FG000|Overall Study|Lost to Follow-up|10|||
146651545|NCT00910247|528902176|FG000|Overall Study|Physician Decision|3|||
146651546|NCT00910247|528902176|FG000|Overall Study|Protocol Violation|10|||
146770571|NCT00723450|529328639|FG000|Open-Label Phase|Withdrawal by Subject|37|||
146770572|NCT00723450|529328640|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146572298|NCT01791517|528606839|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146572299|NCT01791517|528606840|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146572300|NCT01791517|528606841|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146572301|NCT01791517|528606842|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146572302|NCT01791517|528606843|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146572303|NCT01791517|528606844|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146572304|NCT01791517|528606845|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
146572305|NCT01791517|528606846|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146572306|NCT01791517|528606835|FG000|Phase I: Period 2|Lens Discomfort|0|||
146572307|NCT01791517|528606836|FG001|Phase I: Period 2|Lens Discomfort|0|||
146572308|NCT01791517|528606837|FG002|Phase I: Period 2|Lens Discomfort|0|||
146572309|NCT01791517|528606838|FG003|Phase I: Period 2|Lens Discomfort|0|||
146572310|NCT01791517|528606839|FG004|Phase I: Period 2|Lens Discomfort|0|||
146572311|NCT01791517|528606840|FG005|Phase I: Period 2|Lens Discomfort|1|||
146572312|NCT01791517|528606841|FG006|Phase I: Period 2|Lens Discomfort|0|||
146572313|NCT01791517|528606842|FG007|Phase I: Period 2|Lens Discomfort|0|||
146572314|NCT01791517|528606843|FG008|Phase I: Period 2|Lens Discomfort|0|||
146572315|NCT01791517|528606844|FG009|Phase I: Period 2|Lens Discomfort|0|||
146572316|NCT01791517|528606845|FG010|Phase I: Period 2|Lens Discomfort|0|||
146572317|NCT01791517|528606846|FG011|Phase I: Period 2|Lens Discomfort|0|||
146572318|NCT01791517|528606835|FG000|Phase I: Period 2|Lost to Follow-up|0|||
146572319|NCT01791517|528606836|FG001|Phase I: Period 2|Lost to Follow-up|3|||
146572320|NCT01791517|528606837|FG002|Phase I: Period 2|Lost to Follow-up|2|||
146572321|NCT01791517|528606838|FG003|Phase I: Period 2|Lost to Follow-up|0|||
146572322|NCT01791517|528606839|FG004|Phase I: Period 2|Lost to Follow-up|0|||
146572323|NCT01791517|528606840|FG005|Phase I: Period 2|Lost to Follow-up|0|||
146572324|NCT01791517|528606841|FG006|Phase I: Period 2|Lost to Follow-up|0|||
146572325|NCT01791517|528606842|FG007|Phase I: Period 2|Lost to Follow-up|0|||
146572326|NCT01791517|528606843|FG008|Phase I: Period 2|Lost to Follow-up|0|||
146572327|NCT01791517|528606844|FG009|Phase I: Period 2|Lost to Follow-up|0|||
146572328|NCT01791517|528606845|FG010|Phase I: Period 2|Lost to Follow-up|0|||
146651547|NCT00910247|528902176|FG000|Overall Study|Withdrawal by Subject|25|||
146651548|NCT00910247|528902176|FG000|Overall Study|Not collected|4|||
146651549|NCT02519855|528902178|FG000|Overall Study|Adverse Event|0|||
146651550|NCT02519855|528902179|FG001|Overall Study|Adverse Event|1|||
146651551|NCT02519855|528902178|FG000|Overall Study|Lost to Follow-up|3|||
146651552|NCT02519855|528902179|FG001|Overall Study|Lost to Follow-up|3|||
146651553|NCT00003830|528902180|FG000|Overall Study|No follow up data|3|||
146651554|NCT00003830|528902181|FG001|Overall Study|No follow up data|0|||
146572329|NCT01791517|528606846|FG011|Phase I: Period 2|Lost to Follow-up|0|||
146572330|NCT01791517|528606835|FG000|Phase I: Period 3|Lens Discomfort|0|||
146572331|NCT01791517|528606836|FG001|Phase I: Period 3|Lens Discomfort|0|||
146572332|NCT01791517|528606837|FG002|Phase I: Period 3|Lens Discomfort|0|||
146572333|NCT01791517|528606838|FG003|Phase I: Period 3|Lens Discomfort|0|||
146572334|NCT01791517|528606839|FG004|Phase I: Period 3|Lens Discomfort|0|||
146572335|NCT01791517|528606840|FG005|Phase I: Period 3|Lens Discomfort|0|||
146572336|NCT01791517|528606841|FG006|Phase I: Period 3|Lens Discomfort|0|||
146572337|NCT01791517|528606842|FG007|Phase I: Period 3|Lens Discomfort|0|||
146572338|NCT01791517|528606843|FG008|Phase I: Period 3|Lens Discomfort|0|||
146572339|NCT01791517|528606844|FG009|Phase I: Period 3|Lens Discomfort|0|||
146572340|NCT01791517|528606845|FG010|Phase I: Period 3|Lens Discomfort|0|||
146572341|NCT01791517|528606846|FG011|Phase I: Period 3|Lens Discomfort|1|||
146572342|NCT01791517|528606835|FG000|Phase I: Period 3|Lost to Follow-up|0|||
146572343|NCT01791517|528606836|FG001|Phase I: Period 3|Lost to Follow-up|1|||
146572344|NCT01791517|528606837|FG002|Phase I: Period 3|Lost to Follow-up|0|||
146572345|NCT01791517|528606838|FG003|Phase I: Period 3|Lost to Follow-up|0|||
146572346|NCT01791517|528606839|FG004|Phase I: Period 3|Lost to Follow-up|1|||
146572347|NCT01791517|528606840|FG005|Phase I: Period 3|Lost to Follow-up|0|||
146572348|NCT01791517|528606841|FG006|Phase I: Period 3|Lost to Follow-up|0|||
146572349|NCT01791517|528606842|FG007|Phase I: Period 3|Lost to Follow-up|0|||
146917229|NCT01096550|529858141|FG001|Overall Study|non-African American participant|6|||
146917230|NCT01096550|529858140|FG000|Overall Study|Lost to Follow-up|12|||
146917231|NCT01096550|529858141|FG001|Overall Study|Lost to Follow-up|9|||
146917232|NCT04229446|529858148|FG000|Overall Study|Death|12|||
146917233|NCT04229446|529858149|FG001|Overall Study|Death|10|||
146917234|NCT04229446|529858148|FG000|Overall Study|Lost to Follow-up|5|||
146572350|NCT01791517|528606843|FG008|Phase I: Period 3|Lost to Follow-up|0|||
146572351|NCT01791517|528606844|FG009|Phase I: Period 3|Lost to Follow-up|0|||
146572352|NCT01791517|528606845|FG010|Phase I: Period 3|Lost to Follow-up|0|||
146572353|NCT01791517|528606846|FG011|Phase I: Period 3|Lost to Follow-up|0|||
146572354|NCT01791517|528606835|FG000|Phase I: Period 3|Adverse Event|0|||
146572355|NCT01791517|528606836|FG001|Phase I: Period 3|Adverse Event|0|||
146572356|NCT01791517|528606837|FG002|Phase I: Period 3|Adverse Event|0|||
146572357|NCT01791517|528606838|FG003|Phase I: Period 3|Adverse Event|1|||
146572358|NCT01791517|528606839|FG004|Phase I: Period 3|Adverse Event|0|||
146572359|NCT01791517|528606840|FG005|Phase I: Period 3|Adverse Event|0|||
146572360|NCT01791517|528606841|FG006|Phase I: Period 3|Adverse Event|0|||
146572361|NCT01791517|528606842|FG007|Phase I: Period 3|Adverse Event|0|||
146572362|NCT01791517|528606843|FG008|Phase I: Period 3|Adverse Event|0|||
146572363|NCT01791517|528606844|FG009|Phase I: Period 3|Adverse Event|0|||
146572364|NCT01791517|528606845|FG010|Phase I: Period 3|Adverse Event|0|||
146572365|NCT01791517|528606846|FG011|Phase I: Period 3|Adverse Event|0|||
146572366|NCT01791517|528606835|FG000|Phase II|Lost to Follow-up|1|||
146572367|NCT01791517|528606836|FG001|Phase II|Lost to Follow-up|0|||
146572368|NCT01791517|528606837|FG002|Phase II|Lost to Follow-up|1|||
146572369|NCT01791517|528606838|FG003|Phase II|Lost to Follow-up|0|||
146572370|NCT01791517|528606839|FG004|Phase II|Lost to Follow-up|1|||
146572371|NCT01791517|528606840|FG005|Phase II|Lost to Follow-up|2|||
146572372|NCT01791517|528606841|FG006|Phase II|Lost to Follow-up|0|||
146572373|NCT01791517|528606842|FG007|Phase II|Lost to Follow-up|1|||
146572374|NCT01791517|528606843|FG008|Phase II|Lost to Follow-up|1|||
146572375|NCT01791517|528606844|FG009|Phase II|Lost to Follow-up|1|||
146572376|NCT01791517|528606845|FG010|Phase II|Lost to Follow-up|0|||
146572377|NCT01791517|528606846|FG011|Phase II|Lost to Follow-up|0|||
146572378|NCT01791517|528606835|FG000|Phase II|Withdrawal by Subject|1|||
146572379|NCT01791517|528606836|FG001|Phase II|Withdrawal by Subject|0|||
146572380|NCT01791517|528606837|FG002|Phase II|Withdrawal by Subject|0|||
146572381|NCT01791517|528606838|FG003|Phase II|Withdrawal by Subject|0|||
146572382|NCT01791517|528606839|FG004|Phase II|Withdrawal by Subject|0|||
146572383|NCT01791517|528606840|FG005|Phase II|Withdrawal by Subject|2|||
146572384|NCT01791517|528606841|FG006|Phase II|Withdrawal by Subject|0|||
146572385|NCT01791517|528606842|FG007|Phase II|Withdrawal by Subject|1|||
146572386|NCT01791517|528606843|FG008|Phase II|Withdrawal by Subject|0|||
146572387|NCT01791517|528606844|FG009|Phase II|Withdrawal by Subject|0|||
146572388|NCT01791517|528606845|FG010|Phase II|Withdrawal by Subject|1|||
146572389|NCT01791517|528606846|FG011|Phase II|Withdrawal by Subject|0|||
146917235|NCT04229446|529858149|FG001|Overall Study|Lost to Follow-up|8|||
146917236|NCT02410902|529860080|FG000|Overall Study|Adverse Event|2|||
146572390|NCT01791517|528606835|FG000|Phase II|Lack of Efficacy|0|||
146572391|NCT01791517|528606836|FG001|Phase II|Lack of Efficacy|0|||
146572392|NCT01791517|528606837|FG002|Phase II|Lack of Efficacy|0|||
146572393|NCT01791517|528606838|FG003|Phase II|Lack of Efficacy|0|||
146572394|NCT01791517|528606839|FG004|Phase II|Lack of Efficacy|1|||
146572395|NCT01791517|528606840|FG005|Phase II|Lack of Efficacy|0|||
146572396|NCT01791517|528606841|FG006|Phase II|Lack of Efficacy|0|||
146572397|NCT01791517|528606842|FG007|Phase II|Lack of Efficacy|0|||
146572398|NCT01791517|528606843|FG008|Phase II|Lack of Efficacy|0|||
146572399|NCT01791517|528606844|FG009|Phase II|Lack of Efficacy|0|||
146917237|NCT02410902|529860081|FG001|Overall Study|Adverse Event|3|||
146917238|NCT02410902|529860080|FG000|Overall Study|Lost to Follow-up|4|||
146917239|NCT02410902|529860081|FG001|Overall Study|Lost to Follow-up|1|||
146917240|NCT02410902|529860080|FG000|Overall Study|Protocol Violation|1|||
146917241|NCT02410902|529860081|FG001|Overall Study|Protocol Violation|4|||
146572400|NCT01791517|528606845|FG010|Phase II|Lack of Efficacy|0|||
146572401|NCT01791517|528606846|FG011|Phase II|Lack of Efficacy|0|||
146572402|NCT01791517|528606835|FG000|Phase II|Adverse Event|0|||
146572403|NCT01791517|528606836|FG001|Phase II|Adverse Event|0|||
146572404|NCT01791517|528606837|FG002|Phase II|Adverse Event|0|||
146572405|NCT01791517|528606838|FG003|Phase II|Adverse Event|0|||
146572406|NCT01791517|528606839|FG004|Phase II|Adverse Event|0|||
146572407|NCT01791517|528606840|FG005|Phase II|Adverse Event|0|||
146572408|NCT01791517|528606841|FG006|Phase II|Adverse Event|2|||
146572409|NCT01791517|528606842|FG007|Phase II|Adverse Event|1|||
146572410|NCT01791517|528606843|FG008|Phase II|Adverse Event|0|||
146572411|NCT01791517|528606844|FG009|Phase II|Adverse Event|1|||
146572412|NCT01791517|528606845|FG010|Phase II|Adverse Event|0|||
146572413|NCT01791517|528606846|FG011|Phase II|Adverse Event|0|||
146572414|NCT01791517|528606835|FG000|Phase II|Lens Handling Difficulties|0|||
146572415|NCT01791517|528606836|FG001|Phase II|Lens Handling Difficulties|0|||
146572416|NCT01791517|528606837|FG002|Phase II|Lens Handling Difficulties|0|||
146572417|NCT01791517|528606838|FG003|Phase II|Lens Handling Difficulties|0|||
146572418|NCT01791517|528606839|FG004|Phase II|Lens Handling Difficulties|0|||
146572419|NCT01791517|528606840|FG005|Phase II|Lens Handling Difficulties|0|||
146572420|NCT01791517|528606841|FG006|Phase II|Lens Handling Difficulties|0|||
146572421|NCT01791517|528606842|FG007|Phase II|Lens Handling Difficulties|0|||
146572422|NCT01791517|528606843|FG008|Phase II|Lens Handling Difficulties|1|||
146572423|NCT01791517|528606844|FG009|Phase II|Lens Handling Difficulties|0|||
146572424|NCT01791517|528606845|FG010|Phase II|Lens Handling Difficulties|0|||
146572425|NCT01791517|528606846|FG011|Phase II|Lens Handling Difficulties|0|||
146572426|NCT01791517|528606835|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
146572427|NCT01791517|528606836|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
146572428|NCT01791517|528606837|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
146572429|NCT01791517|528606838|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
146572430|NCT01791517|528606839|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
146572431|NCT01791517|528606840|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
146572432|NCT01791517|528606841|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
146572433|NCT01791517|528606842|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
146572434|NCT01791517|528606843|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
146572435|NCT01791517|528606844|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
146572436|NCT01791517|528606845|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
146572437|NCT01791517|528606846|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
146572438|NCT01791517|528606835|FG000|Phase II|Pre-Existing Ocular Issue|0|||
146572439|NCT01791517|528606836|FG001|Phase II|Pre-Existing Ocular Issue|0|||
146572440|NCT01791517|528606837|FG002|Phase II|Pre-Existing Ocular Issue|0|||
146572441|NCT01791517|528606838|FG003|Phase II|Pre-Existing Ocular Issue|0|||
146572442|NCT01791517|528606839|FG004|Phase II|Pre-Existing Ocular Issue|0|||
146572443|NCT01791517|528606840|FG005|Phase II|Pre-Existing Ocular Issue|0|||
146572444|NCT01791517|528606841|FG006|Phase II|Pre-Existing Ocular Issue|0|||
146572445|NCT01791517|528606842|FG007|Phase II|Pre-Existing Ocular Issue|0|||
146572446|NCT01791517|528606843|FG008|Phase II|Pre-Existing Ocular Issue|0|||
146917242|NCT02410902|529860080|FG000|Overall Study|Withdrawal by Subject|6|||
146572447|NCT01791517|528606844|FG009|Phase II|Pre-Existing Ocular Issue|0|||
146572448|NCT01791517|528606845|FG010|Phase II|Pre-Existing Ocular Issue|0|||
146572449|NCT01791517|528606846|FG011|Phase II|Pre-Existing Ocular Issue|1|||
146572450|NCT00589797|528606847|FG000|Overall Study|Death|1|||
146572451|NCT00589797|528606848|FG001|Overall Study|Death|0|||
146572452|NCT00589797|528606847|FG000|Overall Study|Lost to Follow-up|12|||
146572453|NCT00589797|528606848|FG001|Overall Study|Lost to Follow-up|9|||
146572454|NCT00589797|528606847|FG000|Overall Study|Physician Decision|8|||
146572455|NCT00589797|528606848|FG001|Overall Study|Physician Decision|3|||
146572456|NCT00589797|528606847|FG000|Overall Study|Withdrawal by Subject|6|||
146572457|NCT00589797|528606848|FG001|Overall Study|Withdrawal by Subject|5|||
146572458|NCT00589797|528606847|FG000|Overall Study|Non-Randomized Training Subjects|46|||
146572459|NCT00589797|528606848|FG001|Overall Study|Non-Randomized Training Subjects|6|||
146572460|NCT03230318|528606853|FG000|Overall Study|Radiographic disease progression|72|||
146572461|NCT03230318|528606854|FG001|Overall Study|Radiographic disease progression|19|||
146572462|NCT03230318|528606853|FG000|Overall Study|Clinical progression|17|||
146572463|NCT03230318|528606854|FG001|Overall Study|Clinical progression|7|||
146572464|NCT03230318|528606853|FG000|Overall Study|Adverse Event|5|||
146572465|NCT03230318|528606854|FG001|Overall Study|Adverse Event|3|||
146572466|NCT03230318|528606853|FG000|Overall Study|Physician Decision|2|||
146572467|NCT03230318|528606854|FG001|Overall Study|Physician Decision|3|||
146572468|NCT03230318|528606853|FG000|Overall Study|Death|3|||
146572469|NCT03230318|528606854|FG001|Overall Study|Death|2|||
146572470|NCT03230318|528606853|FG000|Overall Study|Lost to Follow-up|1|||
146572471|NCT03230318|528606854|FG001|Overall Study|Lost to Follow-up|0|||
146572472|NCT03230318|528606853|FG000|Overall Study|Withdrawal by Subject|1|||
146572473|NCT03230318|528606854|FG001|Overall Study|Withdrawal by Subject|3|||
147013235|NCT01708954|530210056|FG002|Step 1|Withdrawal by Subject|3|||
146572474|NCT03230318|528606853|FG000|Overall Study|Other|3|||
146572475|NCT03230318|528606854|FG001|Overall Study|Other|7|||
146572476|NCT04011735|528606856|FG000|Overall Study|Withdrawal by Subject|1|||
146572477|NCT04011735|528606857|FG001|Overall Study|Withdrawal by Subject|0|||
146572478|NCT04011735|528606858|FG002|Overall Study|Withdrawal by Subject|1|||
146572479|NCT04011735|528606856|FG000|Overall Study|Met exclusion criteria after study entry|0|||
146572480|NCT04011735|528606857|FG001|Overall Study|Met exclusion criteria after study entry|1|||
146572481|NCT04011735|528606858|FG002|Overall Study|Met exclusion criteria after study entry|0|||
146572482|NCT01459666|528606864|FG000|Overall Study|PI left institution|5|||
146572483|NCT01459666|528606865|FG001|Overall Study|PI left institution|4|||
146572484|NCT01492088|528606866|FG000|Overall Study|Withdrawal by Patient|0|||
146572485|NCT01492088|528606867|FG001|Overall Study|Withdrawal by Patient|2|||
146572486|NCT01492088|528606868|FG002|Overall Study|Withdrawal by Patient|0|||
146572487|NCT01492088|528606866|FG000|Overall Study|Death|1|||
146572488|NCT01492088|528606867|FG001|Overall Study|Death|6|||
146572489|NCT01492088|528606868|FG002|Overall Study|Death|2|||
146572490|NCT01492088|528606866|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
146572491|NCT01492088|528606867|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
146572492|NCT01492088|528606868|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
146572493|NCT01492088|528606866|FG000|Overall Study|Alive at Last Follow-up|0|||
146572494|NCT01492088|528606867|FG001|Overall Study|Alive at Last Follow-up|6|||
146572495|NCT01492088|528606868|FG002|Overall Study|Alive at Last Follow-up|11|||
146572496|NCT00533429|528606869|FG000|Overall Study|Adverse Event|3|||
146572497|NCT00533429|528606870|FG001|Overall Study|Adverse Event|1|||
146572498|NCT00533429|528606869|FG000|Overall Study|Death|1|||
146572499|NCT00533429|528606870|FG001|Overall Study|Death|0|||
146572500|NCT00533429|528606869|FG000|Overall Study|Withdrawal by Subject|2|||
146572501|NCT00533429|528606870|FG001|Overall Study|Withdrawal by Subject|0|||
146572502|NCT00533429|528606869|FG000|Overall Study|Progressive Disease|12|||
146572503|NCT00533429|528606870|FG001|Overall Study|Progressive Disease|13|||
146572504|NCT00533429|528606869|FG000|Overall Study|Symptomatic deterioration|1|||
146572505|NCT00533429|528606870|FG001|Overall Study|Symptomatic deterioration|2|||
146572506|NCT02379052|528606871|FG000|Overall Study|Protocol Violation|0|||
146572507|NCT02379052|528606872|FG001|Overall Study|Protocol Violation|1|||
146572508|NCT02379052|528606871|FG000|Overall Study|Adverse Event|0|||
146572509|NCT02379052|528606872|FG001|Overall Study|Adverse Event|1|||
146572510|NCT02379052|528606871|FG000|Overall Study|Physician Decision|1|||
146572511|NCT02379052|528606872|FG001|Overall Study|Physician Decision|1|||
146572512|NCT02379052|528606871|FG000|Overall Study|Withdrawal by Subject|2|||
146572513|NCT02379052|528606872|FG001|Overall Study|Withdrawal by Subject|0|||
146572514|NCT02379052|528606871|FG000|Overall Study|Lost to Follow-up|2|||
146572515|NCT02379052|528606872|FG001|Overall Study|Lost to Follow-up|1|||
146572516|NCT02379052|528606871|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
146572517|NCT02379052|528606872|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
146572518|NCT02379052|528606871|FG000|Overall Study|Subject was Incarcerated|0|||
146572519|NCT02379052|528606872|FG001|Overall Study|Subject was Incarcerated|1|||
146572520|NCT00127855|528606873|FG000|Primary Vaccination Course|Adverse Event|0|||
146572521|NCT00127855|528606874|FG001|Primary Vaccination Course|Adverse Event|0|||
146572522|NCT00127855|528606875|FG002|Primary Vaccination Course|Adverse Event|1|||
146572523|NCT00127855|528606876|FG003|Primary Vaccination Course|Adverse Event|0|||
146572524|NCT00127855|528606877|FG004|Primary Vaccination Course|Adverse Event|0|||
146572525|NCT00127855|528606873|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
146572526|NCT00127855|528606874|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
146572527|NCT00127855|528606875|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
146572528|NCT00127855|528606876|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
146572529|NCT00127855|528606877|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
146572530|NCT00127855|528606873|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
146572531|NCT00127855|528606874|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
146572532|NCT00127855|528606875|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
146572533|NCT00127855|528606876|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
146770573|NCT00723450|529328641|FG002|Open-Label Phase|Withdrawal by Subject|0|||
146917243|NCT02410902|529860081|FG001|Overall Study|Withdrawal by Subject|8|||
146917244|NCT02410902|529860080|FG000|Overall Study|Non-Compliance|8|||
146917245|NCT02410902|529860081|FG001|Overall Study|Non-Compliance|2|||
146917246|NCT00953043|529860082|FG000|Overall Study|Withdrawal by Subject|4|||
146917247|NCT00953043|529860083|FG001|Overall Study|Withdrawal by Subject|0|||
146572534|NCT00127855|528606877|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
146572535|NCT00127855|528606873|FG000|Primary Vaccination Course|Other|0|||
146572536|NCT00127855|528606874|FG001|Primary Vaccination Course|Other|0|||
146572537|NCT00127855|528606875|FG002|Primary Vaccination Course|Other|0|||
146572538|NCT00127855|528606876|FG003|Primary Vaccination Course|Other|0|||
146572539|NCT00127855|528606877|FG004|Primary Vaccination Course|Other|1|||
146572540|NCT02343302|528606878|FG000|Overall Study|Physician Decision|1|||
146572541|NCT02343302|528606879|FG001|Overall Study|Physician Decision|1|||
146572542|NCT01887717|528606880|FG000|Overall Study|Withdrawal by Subject|1|||
146917248|NCT00953043|529860082|FG000|Overall Study|Physician Decision|0|||
146572543|NCT01887717|528606881|FG001|Overall Study|Withdrawal by Subject|7|||
146572544|NCT01887717|528606880|FG000|Overall Study|Physician Decision|0|||
146572545|NCT01887717|528606881|FG001|Overall Study|Physician Decision|2|||
146572546|NCT01887717|528606880|FG000|Overall Study|Administrative reasons|5|||
146572547|NCT01887717|528606881|FG001|Overall Study|Administrative reasons|2|||
146572548|NCT00920556|528606884|FG000|Overall Study|Adverse Event|16|||
146572549|NCT00920556|528606884|FG000|Overall Study|Physician Decision|7|||
146572550|NCT00920556|528606884|FG000|Overall Study|Withdrawal by Subject|1|||
146572551|NCT01299389|528606885|FG000|Double-blind|Adverse Event|45|||
146572552|NCT01299389|528606886|FG001|Double-blind|Adverse Event|27|||
146572553|NCT01299389|528606887|FG002|Double-blind|Adverse Event|0|||
146572554|NCT01299389|528606888|FG003|Double-blind|Adverse Event|0|||
146917249|NCT00953043|529860083|FG001|Overall Study|Physician Decision|2|||
146917250|NCT00747617|529860085|FG000|Overall Study|Lost to Follow-up|3|||
146917251|NCT00747617|529860086|FG001|Overall Study|Lost to Follow-up|1|||
146917252|NCT01746732|529860087|FG000|Lead-In Period|Withdrawal by Subject|1|||
146572555|NCT01299389|528606885|FG000|Double-blind|Lack of Efficacy|45|||
146572556|NCT01299389|528606886|FG001|Double-blind|Lack of Efficacy|21|||
146572557|NCT01299389|528606887|FG002|Double-blind|Lack of Efficacy|0|||
146572558|NCT01299389|528606888|FG003|Double-blind|Lack of Efficacy|0|||
146572559|NCT01299389|528606885|FG000|Double-blind|Lost to Follow-up|2|||
146572560|NCT01299389|528606886|FG001|Double-blind|Lost to Follow-up|1|||
146572561|NCT01299389|528606887|FG002|Double-blind|Lost to Follow-up|0|||
146572562|NCT01299389|528606888|FG003|Double-blind|Lost to Follow-up|0|||
146572563|NCT01299389|528606885|FG000|Double-blind|Withdrawal by Subject|16|||
146572564|NCT01299389|528606886|FG001|Double-blind|Withdrawal by Subject|13|||
146572565|NCT01299389|528606887|FG002|Double-blind|Withdrawal by Subject|0|||
146572566|NCT01299389|528606888|FG003|Double-blind|Withdrawal by Subject|0|||
146651555|NCT00003830|528902180|FG000|Overall Study|Sentinel node positive patients|829|||
146651556|NCT00003830|528902181|FG001|Overall Study|Sentinel node positive patients|793|||
146651557|NCT05347147|528902182|FG000|Overall Study|Lost to Follow-up|0|||
146651558|NCT05347147|528902183|FG001|Overall Study|Lost to Follow-up|1|||
146651559|NCT05347147|528902182|FG000|Overall Study|Sponsor request|3|||
146651560|NCT05347147|528902183|FG001|Overall Study|Sponsor request|3|||
146917253|NCT01746732|529860088|FG001|Lead-In Period|Withdrawal by Subject|0|||
146917254|NCT01746732|529860089|FG002|Lead-In Period|Withdrawal by Subject|0|||
146572567|NCT01299389|528606885|FG000|Double-blind|Other|1|||
146572568|NCT01299389|528606886|FG001|Double-blind|Other|1|||
146572569|NCT01299389|528606887|FG002|Double-blind|Other|0|||
146572570|NCT01299389|528606888|FG003|Double-blind|Other|0|||
146572571|NCT01299389|528606885|FG000|Double-blind|"fail to meet study population criteria"|0|||
146572572|NCT01299389|528606886|FG001|Double-blind|"fail to meet study population criteria"|1|||
146572573|NCT01299389|528606887|FG002|Double-blind|"fail to meet study population criteria"|0|||
146572574|NCT01299389|528606888|FG003|Double-blind|"fail to meet study population criteria"|0|||
146572575|NCT01299389|528606885|FG000|Post-observational|Other|0|||
146572576|NCT01299389|528606886|FG001|Post-observational|Other|0|||
146572577|NCT01299389|528606887|FG002|Post-observational|Other|12|||
146572578|NCT01299389|528606888|FG003|Post-observational|Other|6|||
146572579|NCT02834819|528606889|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
146572580|NCT02834819|528606890|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
146572581|NCT04245709|528606891|FG000|Overall Study|Adverse Event|13|||
146572582|NCT04245709|528606891|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
146572583|NCT03637491|528606892|FG000|Overall Study|Death|9|||
146572584|NCT03637491|528606893|FG001|Overall Study|Death|9|||
146572585|NCT03637491|528606894|FG002|Overall Study|Death|5|||
146572586|NCT03637491|528606895|FG003|Overall Study|Death|3|||
146572587|NCT03637491|528606892|FG000|Overall Study|Lost to Follow-up|0|||
146572588|NCT03637491|528606893|FG001|Overall Study|Lost to Follow-up|1|||
146572589|NCT03637491|528606894|FG002|Overall Study|Lost to Follow-up|0|||
146572590|NCT03637491|528606895|FG003|Overall Study|Lost to Follow-up|1|||
146572591|NCT03637491|528606892|FG000|Overall Study|Study Terminated By Sponsor|0|||
146572592|NCT03637491|528606893|FG001|Overall Study|Study Terminated By Sponsor|2|||
146572593|NCT03637491|528606894|FG002|Overall Study|Study Terminated By Sponsor|1|||
146572594|NCT03637491|528606895|FG003|Overall Study|Study Terminated By Sponsor|0|||
146572595|NCT03637491|528606892|FG000|Overall Study|Withdrawal by Subject|1|||
146572596|NCT03637491|528606893|FG001|Overall Study|Withdrawal by Subject|0|||
146572597|NCT03637491|528606894|FG002|Overall Study|Withdrawal by Subject|1|||
146572598|NCT03637491|528606895|FG003|Overall Study|Withdrawal by Subject|2|||
146572599|NCT00889707|528606901|FG000|Overall Study|Adverse Event|1|||
146572600|NCT00889707|528606902|FG001|Overall Study|Adverse Event|0|||
146572601|NCT00889707|528606901|FG000|Overall Study|Withdrawal by Subject|4|||
146572602|NCT00889707|528606902|FG001|Overall Study|Withdrawal by Subject|3|||
146572603|NCT00889707|528606901|FG000|Overall Study|Lost to Follow-up|0|||
146651561|NCT05347147|528902182|FG000|Overall Study|Study termination|2|||
146651562|NCT05347147|528902183|FG001|Overall Study|Study termination|1|||
146572604|NCT00889707|528606902|FG001|Overall Study|Lost to Follow-up|2|||
146572605|NCT00889707|528606901|FG000|Overall Study|Lack of Efficacy|2|||
146651563|NCT03565367|528902184|FG000|Overall Study|No scan due to technical issues|4|||
146651564|NCT03565367|528902185|FG001|Overall Study|No scan due to technical issues|0|||
146651565|NCT00923364|528902190|FG000|Overall Study|Death|3|||
146917255|NCT01746732|529860087|FG000|Period 1|Physician Decision|0|||
146917256|NCT01746732|529860088|FG001|Period 1|Physician Decision|1|||
146651566|NCT00923364|528902191|FG001|Overall Study|Death|0|||
146651567|NCT00923364|528902190|FG000|Overall Study|Did not go to transplant|1|||
146651568|NCT00923364|528902191|FG001|Overall Study|Did not go to transplant|0|||
146651569|NCT01397825|528902192|FG000|Overall Study|Progressive Disease|10|||
146651570|NCT01397825|528902193|FG001|Overall Study|Progressive Disease|3|||
146917257|NCT01746732|529860089|FG002|Period 1|Physician Decision|0|||
146917258|NCT01746732|529860087|FG000|Period 2|Withdrawal by Subject|0|||
146917259|NCT01746732|529860088|FG001|Period 2|Withdrawal by Subject|0|||
146917260|NCT01746732|529860089|FG002|Period 2|Withdrawal by Subject|2|||
146917261|NCT01746732|529860087|FG000|Period 2|Adverse Event|0|||
146572606|NCT00889707|528606902|FG001|Overall Study|Lack of Efficacy|5|||
146572607|NCT02185534|528606903|FG000|First Period|Withdrawal by Subject|0|||
146572608|NCT02185534|528606904|FG001|First Period|Withdrawal by Subject|0|||
146572609|NCT02185534|528606905|FG002|First Period|Withdrawal by Subject|0|||
146572610|NCT02185534|528606906|FG003|First Period|Withdrawal by Subject|1|||
146572611|NCT02185534|528606907|FG004|First Period|Withdrawal by Subject|0|||
146572612|NCT02185534|528606908|FG005|First Period|Withdrawal by Subject|0|||
146572613|NCT02185534|528606903|FG000|First Washout Period|Withdrawal by Subject|1|||
146572614|NCT02185534|528606904|FG001|First Washout Period|Withdrawal by Subject|0|||
146572615|NCT02185534|528606905|FG002|First Washout Period|Withdrawal by Subject|0|||
146572616|NCT02185534|528606906|FG003|First Washout Period|Withdrawal by Subject|0|||
146572617|NCT02185534|528606907|FG004|First Washout Period|Withdrawal by Subject|1|||
146572618|NCT02185534|528606908|FG005|First Washout Period|Withdrawal by Subject|0|||
146572619|NCT02185534|528606903|FG000|First Washout Period|Protocol Violation|0|||
146572620|NCT02185534|528606904|FG001|First Washout Period|Protocol Violation|0|||
146572621|NCT02185534|528606905|FG002|First Washout Period|Protocol Violation|0|||
146572622|NCT02185534|528606906|FG003|First Washout Period|Protocol Violation|0|||
146572623|NCT02185534|528606907|FG004|First Washout Period|Protocol Violation|0|||
146572624|NCT02185534|528606908|FG005|First Washout Period|Protocol Violation|1|||
146572625|NCT03465722|528606909|FG000|Overall Study|Withdrawal by Subject|21|||
146572626|NCT03465722|528606910|FG001|Overall Study|Withdrawal by Subject|14|||
146572627|NCT03465722|528606909|FG000|Overall Study|Death|89|||
146572628|NCT03465722|528606910|FG001|Overall Study|Death|87|||
146572629|NCT03465722|528606909|FG000|Overall Study|Lost to Follow-up|5|||
146572630|NCT03465722|528606910|FG001|Overall Study|Lost to Follow-up|3|||
146572631|NCT03465722|528606909|FG000|Overall Study|Administrative/Other|33|||
146572632|NCT03465722|528606910|FG001|Overall Study|Administrative/Other|32|||
146572633|NCT03465722|528606909|FG000|Overall Study|Not treated|1|||
146572634|NCT03465722|528606910|FG001|Overall Study|Not treated|2|||
146572635|NCT03465722|528606909|FG000|Overall Study|Sponsor decision|91|||
146572636|NCT03465722|528606910|FG001|Overall Study|Sponsor decision|98|||
146572637|NCT02041299|528606914|FG000|Overall Study|Adverse Event|9|||
146572638|NCT02041299|528606915|FG001|Overall Study|Adverse Event|3|||
146572639|NCT02041299|528606914|FG000|Overall Study|Lost to Follow-up|4|||
146572640|NCT02041299|528606915|FG001|Overall Study|Lost to Follow-up|1|||
146572641|NCT02041299|528606914|FG000|Overall Study|Physician Decision|1|||
146572642|NCT02041299|528606915|FG001|Overall Study|Physician Decision|1|||
146572643|NCT02041299|528606914|FG000|Overall Study|Withdrawal by Subject|13|||
146572644|NCT02041299|528606915|FG001|Overall Study|Withdrawal by Subject|7|||
146572645|NCT02041299|528606914|FG000|Overall Study|Protocol Violation|11|||
146572646|NCT02041299|528606915|FG001|Overall Study|Protocol Violation|4|||
146572647|NCT02041299|528606914|FG000|Overall Study|Termination of the study|7|||
146572648|NCT02041299|528606915|FG001|Overall Study|Termination of the study|3|||
146572649|NCT02041299|528606914|FG000|Overall Study|Required bone marrow transplant|0|||
146572650|NCT02041299|528606915|FG001|Overall Study|Required bone marrow transplant|1|||
146651571|NCT01397825|528902194|FG002|Overall Study|Progressive Disease|11|||
146977268|NCT00447694|530079392|FG000|Overall Study|Abnormal test procedure result|1|||
146977269|NCT00447694|530079392|FG000|Overall Study|Withdrawal by Subject|2|||
146977270|NCT01169987|530079393|FG000|Overall Study|Withdrawal by Subject|3|||
146572651|NCT02041299|528606914|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
146572652|NCT02041299|528606915|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
146977271|NCT01169987|530079393|FG000|Overall Study|Lost to Follow-up|24|||
146572653|NCT02389465|528606916|FG000|Overall Study|Lost to Follow-up|1|||
146572654|NCT02389465|528606917|FG001|Overall Study|Lost to Follow-up|3|||
146572655|NCT02389465|528606918|FG002|Overall Study|Lost to Follow-up|3|||
146572656|NCT02389465|528606919|FG003|Overall Study|Lost to Follow-up|0|||
146572657|NCT02389465|528606916|FG000|Overall Study|Physician Decision|0|||
146572658|NCT02389465|528606917|FG001|Overall Study|Physician Decision|0|||
146572659|NCT02389465|528606918|FG002|Overall Study|Physician Decision|0|||
146651572|NCT01397825|528902195|FG003|Overall Study|Progressive Disease|1|||
146651573|NCT01397825|528902196|FG004|Overall Study|Progressive Disease|0|||
146770574|NCT00723450|529328639|FG000|Randomized Phase|Adverse Event|0|||
146917262|NCT01746732|529860088|FG001|Period 2|Adverse Event|0|||
146917263|NCT01746732|529860089|FG002|Period 2|Adverse Event|1|||
146651574|NCT01397825|528902192|FG000|Overall Study|Symptomatic Deterioration|2|||
146651575|NCT01397825|528902193|FG001|Overall Study|Symptomatic Deterioration|0|||
146651576|NCT01397825|528902194|FG002|Overall Study|Symptomatic Deterioration|4|||
146651577|NCT01397825|528902195|FG003|Overall Study|Symptomatic Deterioration|0|||
146651578|NCT01397825|528902196|FG004|Overall Study|Symptomatic Deterioration|0|||
146651579|NCT01397825|528902192|FG000|Overall Study|Adverse Event|0|||
146651580|NCT01397825|528902193|FG001|Overall Study|Adverse Event|1|||
146651581|NCT01397825|528902194|FG002|Overall Study|Adverse Event|5|||
146651582|NCT01397825|528902195|FG003|Overall Study|Adverse Event|1|||
146651583|NCT01397825|528902196|FG004|Overall Study|Adverse Event|0|||
146651584|NCT01397825|528902192|FG000|Overall Study|Withdrawal by Subject|1|||
146651585|NCT01397825|528902193|FG001|Overall Study|Withdrawal by Subject|0|||
146651586|NCT01397825|528902194|FG002|Overall Study|Withdrawal by Subject|5|||
146651587|NCT01397825|528902195|FG003|Overall Study|Withdrawal by Subject|1|||
146651588|NCT01397825|528902196|FG004|Overall Study|Withdrawal by Subject|0|||
146572660|NCT02389465|528606919|FG003|Overall Study|Physician Decision|1|||
146572661|NCT02389465|528606916|FG000|Overall Study|Withdrawal by Subject|0|||
146572662|NCT02389465|528606917|FG001|Overall Study|Withdrawal by Subject|1|||
146572663|NCT02389465|528606918|FG002|Overall Study|Withdrawal by Subject|2|||
146572664|NCT02389465|528606919|FG003|Overall Study|Withdrawal by Subject|2|||
146572665|NCT01635998|528606920|FG000|Overall Study|Death|1|||
146572666|NCT01635998|528606921|FG001|Overall Study|Death|1|||
146572667|NCT01635998|528606920|FG000|Overall Study|Lost to Follow-up|2|||
146572668|NCT01635998|528606921|FG001|Overall Study|Lost to Follow-up|1|||
146572669|NCT01635998|528606920|FG000|Overall Study|Withdrawal by Subject|1|||
146572670|NCT01635998|528606921|FG001|Overall Study|Withdrawal by Subject|5|||
146572671|NCT00846846|528606922|FG000|Overall Study|Death|56|||
146572672|NCT00846846|528606922|FG000|Overall Study|Withdrawal by Subject|19|||
146572673|NCT00003631|528606923|FG000|Overall Study|Patient not treated|1|||
146572674|NCT00003631|528606924|FG001|Overall Study|Patient not treated|0|||
146572675|NCT00003631|528606925|FG002|Overall Study|Patient not treated|1|||
146572676|NCT00003631|528606923|FG000|Overall Study|Protocol Violation|1|||
146572677|NCT00003631|528606924|FG001|Overall Study|Protocol Violation|0|||
146572678|NCT00003631|528606925|FG002|Overall Study|Protocol Violation|0|||
146572679|NCT00003631|528606923|FG000|Overall Study|Adverse Event|1|||
146572680|NCT00003631|528606924|FG001|Overall Study|Adverse Event|1|||
146572681|NCT00003631|528606925|FG002|Overall Study|Adverse Event|5|||
146572682|NCT00003631|528606923|FG000|Overall Study|Death|0|||
146572683|NCT00003631|528606924|FG001|Overall Study|Death|0|||
146572684|NCT00003631|528606925|FG002|Overall Study|Death|1|||
146572685|NCT00003631|528606923|FG000|Overall Study|Evaluable for toxicity only|0|||
146572686|NCT00003631|528606924|FG001|Overall Study|Evaluable for toxicity only|0|||
146572687|NCT00003631|528606925|FG002|Overall Study|Evaluable for toxicity only|2|||
146572688|NCT04339413|528606926|FG000|Overall Study|Reason Not Specified|2|||
146572689|NCT04339413|528606927|FG001|Overall Study|Reason Not Specified|7|||
146572690|NCT04339413|528606926|FG000|Overall Study|Study Terminated by Sponsor|30|||
146572691|NCT04339413|528606927|FG001|Overall Study|Study Terminated by Sponsor|33|||
146572692|NCT04339413|528606926|FG000|Overall Study|Progressive Disease|9|||
146572693|NCT04339413|528606927|FG001|Overall Study|Progressive Disease|6|||
146572694|NCT04339413|528606926|FG000|Overall Study|Withdrawal by Subject|9|||
146572695|NCT04339413|528606927|FG001|Overall Study|Withdrawal by Subject|10|||
146572696|NCT04339413|528606926|FG000|Overall Study|Physician Decision|3|||
146572697|NCT04339413|528606927|FG001|Overall Study|Physician Decision|1|||
146572698|NCT04339413|528606926|FG000|Overall Study|Death|2|||
146572699|NCT04339413|528606927|FG001|Overall Study|Death|0|||
146572700|NCT04339413|528606926|FG000|Overall Study|Adverse Event|3|||
146572701|NCT04339413|528606927|FG001|Overall Study|Adverse Event|0|||
146572702|NCT03718325|528608090|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
146572703|NCT03718325|528608091|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
146572704|NCT03718325|528608092|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
146572705|NCT03718325|528608090|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
146572706|NCT03718325|528608091|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
146572707|NCT03718325|528608092|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
146572708|NCT03145064|528608093|FG000|Overall Study|Death|24|||
146572709|NCT03145064|528608093|FG000|Overall Study|Lost to Follow-up|3|||
146572710|NCT03145064|528608093|FG000|Overall Study|Withdrawal by Subject|6|||
146651589|NCT01931670|528902198|FG000|Treatment Period|Exclusionary Medication Received|1|||
146917264|NCT01746732|529860087|FG000|Period 2|Lost to Follow-up|0|||
146917265|NCT01746732|529860088|FG001|Period 2|Lost to Follow-up|0|||
146572711|NCT03145064|528608093|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
146651590|NCT01931670|528902199|FG001|Treatment Period|Exclusionary Medication Received|1|||
146651591|NCT01931670|528902200|FG002|Treatment Period|Exclusionary Medication Received|1|||
146651592|NCT01931670|528902198|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
146917266|NCT01746732|529860089|FG002|Period 2|Lost to Follow-up|1|||
146917267|NCT02279524|529860090|FG000|Overall Study|Withdrawal by Subject|3|||
146572712|NCT03145064|528608093|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
146572713|NCT01396187|528608094|FG000|Overall Study|Adverse Event|0|||
146572714|NCT01396187|528608095|FG001|Overall Study|Adverse Event|1|||
146572715|NCT01396187|528608096|FG002|Overall Study|Adverse Event|0|||
146572716|NCT01396187|528608097|FG003|Overall Study|Adverse Event|0|||
146572717|NCT01396187|528608098|FG004|Overall Study|Adverse Event|0|||
146572718|NCT01396187|528608094|FG000|Overall Study|Withdrawal by Subject|0|||
146572719|NCT01396187|528608095|FG001|Overall Study|Withdrawal by Subject|1|||
146572720|NCT01396187|528608096|FG002|Overall Study|Withdrawal by Subject|1|||
146572721|NCT01396187|528608097|FG003|Overall Study|Withdrawal by Subject|0|||
146572722|NCT01396187|528608098|FG004|Overall Study|Withdrawal by Subject|0|||
146572723|NCT01396187|528608094|FG000|Overall Study|Other|1|||
146572724|NCT01396187|528608095|FG001|Overall Study|Other|1|||
146572725|NCT01396187|528608096|FG002|Overall Study|Other|0|||
146572726|NCT01396187|528608097|FG003|Overall Study|Other|0|||
146572727|NCT01396187|528608098|FG004|Overall Study|Other|1|||
146572728|NCT01898286|528608099|FG000|Overall Study|Withdrawal by Subject|1|||
146572729|NCT01898286|528608099|FG000|Overall Study|Protocol Violation|1|||
146572730|NCT01898286|528608099|FG000|Overall Study|Lost to Follow-up|1|||
146572731|NCT02257242|528608100|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
146572732|NCT02257242|528608101|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
146572733|NCT02257242|528608102|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
146572734|NCT02257242|528608103|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
146572735|NCT02257242|528608104|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
146572736|NCT02257242|528608105|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
146572737|NCT02257242|528608106|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
146572738|NCT02257242|528608107|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
146572739|NCT02257242|528608108|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
146572740|NCT02964273|528608113|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
146572741|NCT02964273|528608114|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
146572742|NCT02964273|528608115|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
146572743|NCT02964273|528608116|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
146572744|NCT02964273|528608113|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
146572745|NCT02964273|528608114|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
146572746|NCT02964273|528608115|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
146572747|NCT02964273|528608116|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
146572748|NCT02964273|528608113|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
146572749|NCT02964273|528608114|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
146572750|NCT02964273|528608115|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
146572751|NCT02964273|528608116|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
146572752|NCT02964273|528608113|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
146572753|NCT02964273|528608114|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
146917268|NCT02279524|529860091|FG001|Overall Study|Withdrawal by Subject|6|||
146917269|NCT02279524|529860092|FG002|Overall Study|Withdrawal by Subject|3|||
146917270|NCT02279524|529860090|FG000|Overall Study|Adverse Event|4|||
146572754|NCT02964273|528608115|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
146572755|NCT02964273|528608116|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
146572756|NCT02964273|528608113|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
146572757|NCT02964273|528608114|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
146572758|NCT02964273|528608115|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
146572759|NCT02964273|528608116|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
146572760|NCT02964273|528608113|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
146572761|NCT02964273|528608114|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
146572762|NCT02964273|528608115|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
146572763|NCT02964273|528608116|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
146572764|NCT01453036|528608117|FG000|Overall Study|Lost to Follow-up|26|||
146572765|NCT01453036|528608118|FG001|Overall Study|Lost to Follow-up|115|||
146572766|NCT01453036|528608119|FG002|Overall Study|Lost to Follow-up|31|||
146572767|NCT04245449|528608121|FG000|Overall Study|COVID shutdown|7|||
146651593|NCT01931670|528902199|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
146651594|NCT01931670|528902200|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
146651595|NCT01931670|528902198|FG000|Treatment Period|Subject Noncompliant|4|||
146651596|NCT01931670|528902199|FG001|Treatment Period|Subject Noncompliant|9|||
146770575|NCT00723450|529328640|FG001|Randomized Phase|Adverse Event|26|||
146770576|NCT00723450|529328641|FG002|Randomized Phase|Adverse Event|17|||
146917271|NCT02279524|529860091|FG001|Overall Study|Adverse Event|3|||
146572768|NCT02236572|528608122|FG000|Overall Study|Withdrawal by Subject|1|||
146572769|NCT02236572|528608122|FG000|Overall Study|Protocol Violation|1|||
146572770|NCT02236572|528608122|FG000|Overall Study|Lost to Follow-up|1|||
146572771|NCT00442416|528608123|FG000|Overall Study|Adverse Event|4|||
146572772|NCT00442416|528608124|FG001|Overall Study|Adverse Event|1|||
146572773|NCT00442416|528608123|FG000|Overall Study|Death|1|||
146572774|NCT00442416|528608124|FG001|Overall Study|Death|0|||
146572775|NCT00442416|528608123|FG000|Overall Study|Lack of Efficacy|2|||
146572776|NCT00442416|528608124|FG001|Overall Study|Lack of Efficacy|0|||
146572777|NCT00442416|528608123|FG000|Overall Study|Protocol Violation|2|||
146572778|NCT00442416|528608124|FG001|Overall Study|Protocol Violation|3|||
146572779|NCT00442416|528608123|FG000|Overall Study|Withdrew consent|1|||
146572780|NCT00442416|528608124|FG001|Overall Study|Withdrew consent|2|||
146572781|NCT00442416|528608123|FG000|Overall Study|Administrative/Other|27|||
146572782|NCT00442416|528608124|FG001|Overall Study|Administrative/Other|33|||
146572783|NCT01853462|528608127|FG000|Overall Study|Withdrawal by Subject|1|||
146572784|NCT01853462|528608128|FG001|Overall Study|Withdrawal by Subject|1|||
146572785|NCT00955474|528608130|FG000|Overall Study|Physician Decision|7|||
146572786|NCT00955474|528608131|FG001|Overall Study|Physician Decision|5|||
146572787|NCT03386435|528608134|FG000|Overall Study|Protocol Violation|5|||
146572788|NCT03386435|528608135|FG001|Overall Study|Protocol Violation|7|||
146572789|NCT04068922|528608136|FG000|Overall Study|Lost to Follow-up|5|||
146572790|NCT04068922|528608136|FG000|Overall Study|Withdrawal by Subject|7|||
146572791|NCT04068922|528608136|FG000|Overall Study|Adverse Event|1|||
146572792|NCT00625586|528608137|FG000|Overall Study|Adverse Event|1|||
146572793|NCT00625586|528608137|FG000|Overall Study|Progressive disease|1|||
146572794|NCT03542266|528608138|FG000|Treatment Phase|Withdrawal by Subject|1|||
146572795|NCT03542266|528608138|FG000|Treatment Phase|Adverse Event|1|||
146572796|NCT03542266|528608138|FG000|Treatment Phase|PD|1|||
146572797|NCT00657267|528608151|FG000|Overall Study|Progressive disease|45|||
146572798|NCT00657267|528608151|FG000|Overall Study|Adverse Event|9|||
146572799|NCT02382991|528608152|FG000|Overall Study|Adverse Event|1|||
146572800|NCT02382991|528608153|FG001|Overall Study|Adverse Event|2|||
146572801|NCT02382991|528608152|FG000|Overall Study|Lost to Follow-up|1|||
146572802|NCT02382991|528608153|FG001|Overall Study|Lost to Follow-up|0|||
146572803|NCT02382991|528608152|FG000|Overall Study|Withdrawal by Subject|0|||
146572804|NCT02382991|528608153|FG001|Overall Study|Withdrawal by Subject|1|||
146572805|NCT00786422|528608155|FG000|Rivaroxaban Treatment|Death|2|||
146572806|NCT00786422|528608155|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
146572807|NCT00786422|528608155|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
146572808|NCT00786422|528608155|FG000|Rivaroxaban Treatment|Physician Decision|1|||
146572809|NCT00786422|528608155|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
146572810|NCT00786422|528608155|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
146572811|NCT00786422|528608155|FG000|Rivaroxaban Treatment|Adverse Event|2|||
146572812|NCT00786422|528608155|FG000|Follow-up Period|Death|1|||
146572813|NCT00786422|528608155|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
146572814|NCT03484429|528608156|FG000|Overall Study|Withdrawal by Subject|1|||
146572815|NCT03484429|528608157|FG001|Overall Study|Withdrawal by Subject|0|||
146572816|NCT03484429|528608156|FG000|Overall Study|Adverse Event|2|||
146572817|NCT03484429|528608157|FG001|Overall Study|Adverse Event|0|||
146572818|NCT04466384|528608158|FG000|First Phase|Protocol Violation|1|||
146572819|NCT04466384|528608159|FG001|First Phase|Protocol Violation|0|||
146572820|NCT04466384|528608158|FG000|First Phase|Missing data|1|||
146572821|NCT04466384|528608159|FG001|First Phase|Missing data|0|||
146572822|NCT04466384|528608158|FG000|Cross Over Phase|Physician Decision|1|||
146572823|NCT04466384|528608159|FG001|Cross Over Phase|Physician Decision|0|||
146572824|NCT04466384|528608158|FG000|Cross Over Phase|Withdrawal by Subject|0|||
146572825|NCT04466384|528608159|FG001|Cross Over Phase|Withdrawal by Subject|1|||
146572826|NCT00943761|528608160|FG000|Overall Study|Lost to Follow-up|2|||
146572827|NCT00943761|528608161|FG001|Overall Study|Lost to Follow-up|0|||
146572828|NCT00943761|528608160|FG000|Overall Study|Withdrawal by Subject|2|||
146572829|NCT00943761|528608161|FG001|Overall Study|Withdrawal by Subject|1|||
146572830|NCT02268383|528608162|FG000|Overall Study|Death|12|||
146572831|NCT02268383|528608162|FG000|Overall Study|Lost to Follow-up|2|||
146572832|NCT02268383|528608162|FG000|Overall Study|Withdrawal by Subject|9|||
146572833|NCT02268383|528608162|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
146572834|NCT02268383|528608162|FG000|Overall Study|Protocol deviation|3|||
146770577|NCT00723450|529328639|FG000|Randomized Phase|Lack of Efficacy|0|||
146572835|NCT02268383|528608162|FG000|Overall Study|Sponsor decision|22|||
146572836|NCT02268383|528608162|FG000|Overall Study|Not reported|12|||
146572837|NCT04162470|528608163|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
146770578|NCT00723450|529328640|FG001|Randomized Phase|Lack of Efficacy|11|||
146770579|NCT00723450|529328641|FG002|Randomized Phase|Lack of Efficacy|11|||
146572838|NCT03382912|528608164|FG000|Overall Study|Physician Decision|0|||
146572839|NCT03382912|528608165|FG001|Overall Study|Physician Decision|1|||
146572840|NCT03382912|528608164|FG000|Overall Study|Sponsor Decision|6|||
146572841|NCT03382912|528608165|FG001|Overall Study|Sponsor Decision|6|||
146572842|NCT03382912|528608164|FG000|Overall Study|Withdrawal by Subject|0|||
146917272|NCT02279524|529860092|FG002|Overall Study|Adverse Event|2|||
146917273|NCT02279524|529860090|FG000|Overall Study|Lost to Follow-up|1|||
146917274|NCT02279524|529860091|FG001|Overall Study|Lost to Follow-up|1|||
146917275|NCT02279524|529860092|FG002|Overall Study|Lost to Follow-up|0|||
146572843|NCT03382912|528608165|FG001|Overall Study|Withdrawal by Subject|5|||
146572844|NCT04570384|528608166|FG000|Overall Study|Adverse Event|2|||
146572845|NCT04570384|528608167|FG001|Overall Study|Adverse Event|1|||
146572846|NCT04570384|528608166|FG000|Overall Study|Death|2|||
146572847|NCT04570384|528608167|FG001|Overall Study|Death|5|||
146572848|NCT04570384|528608166|FG000|Overall Study|Lost to Follow-up|1|||
146572849|NCT04570384|528608167|FG001|Overall Study|Lost to Follow-up|0|||
146572850|NCT04570384|528608166|FG000|Overall Study|Other|1|||
146572851|NCT04570384|528608167|FG001|Overall Study|Other|0|||
146572852|NCT04570384|528608166|FG000|Overall Study|Protocol Violation|0|||
146572853|NCT04570384|528608167|FG001|Overall Study|Protocol Violation|1|||
146572854|NCT04570384|528608166|FG000|Overall Study|Sponsor Decision|1|||
146572855|NCT04570384|528608167|FG001|Overall Study|Sponsor Decision|0|||
146572856|NCT04570384|528608166|FG000|Overall Study|Withdrawal by Subject|4|||
146572857|NCT04570384|528608167|FG001|Overall Study|Withdrawal by Subject|2|||
146572858|NCT00326001|528608168|FG000|Overall Study|Adverse Event|4|||
146572859|NCT00326001|528608169|FG001|Overall Study|Adverse Event|5|||
146572860|NCT00326001|528608168|FG000|Overall Study|Physician Decision|3|||
146572861|NCT00326001|528608169|FG001|Overall Study|Physician Decision|3|||
146572862|NCT05005273|528608170|FG000|Overall Study|Study Terminated|1|||
146572863|NCT05005273|528608171|FG001|Overall Study|Study Terminated|0|||
146572864|NCT03265145|528608172|FG000|Overall Study|Protocol Violation|2|||
146572865|NCT03265145|528608173|FG001|Overall Study|Protocol Violation|0|||
146572866|NCT03265145|528608172|FG000|Overall Study|Adverse Event|1|||
146572867|NCT03265145|528608173|FG001|Overall Study|Adverse Event|0|||
146572868|NCT03265145|528608172|FG000|Overall Study|Withdrawal by Subject|23|||
146572869|NCT03265145|528608173|FG001|Overall Study|Withdrawal by Subject|19|||
146917276|NCT02279524|529860090|FG000|Overall Study|Disallowed medication|1|||
146917277|NCT02279524|529860091|FG001|Overall Study|Disallowed medication|1|||
146917278|NCT02279524|529860092|FG002|Overall Study|Disallowed medication|2|||
146917279|NCT02279524|529860090|FG000|Overall Study|Bariatric surgery|1|||
146917280|NCT02279524|529860091|FG001|Overall Study|Bariatric surgery|0|||
146917281|NCT02279524|529860092|FG002|Overall Study|Bariatric surgery|0|||
146917282|NCT03509207|529860093|FG000|Overall Study|Death|2|||
146917283|NCT02817555|529860094|FG000|Overall Study|Death|1|||
146977272|NCT01169987|530079393|FG000|Overall Study|Other|4|||
146977273|NCT00829439|530079394|FG000|Overall Study|Adverse Event|0|||
146977274|NCT00829439|530079395|FG001|Overall Study|Adverse Event|0|||
146977275|NCT00829439|530079396|FG002|Overall Study|Adverse Event|1|||
146977276|NCT00829439|530079397|FG003|Overall Study|Adverse Event|0|||
146977277|NCT00386100|530079398|FG000|Overall Study|Did not receive study medication|6|||
146977278|NCT00386100|530079399|FG001|Overall Study|Did not receive study medication|4|||
146977279|NCT00386100|530079398|FG000|Overall Study|Adverse Event|15|||
146977280|NCT00386100|530079399|FG001|Overall Study|Adverse Event|25|||
146572870|NCT03265145|528608172|FG000|Overall Study|Death|12|||
146572871|NCT03265145|528608173|FG001|Overall Study|Death|12|||
146917284|NCT02817555|529860095|FG001|Overall Study|Death|3|||
146917285|NCT02817555|529860094|FG000|Overall Study|moved away|1|||
146917286|NCT02817555|529860095|FG001|Overall Study|moved away|0|||
146917287|NCT02817555|529860094|FG000|Overall Study|transplant|1|||
146917288|NCT02817555|529860095|FG001|Overall Study|transplant|1|||
146917289|NCT02817555|529860094|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
146917290|NCT02817555|529860095|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
146917291|NCT01043185|529860096|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
146572872|NCT03265145|528608172|FG000|Overall Study|Lost to Follow-up|13|||
146572873|NCT03265145|528608173|FG001|Overall Study|Lost to Follow-up|9|||
146572874|NCT03265145|528608172|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
146572875|NCT03265145|528608173|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
146572876|NCT03265145|528608172|FG000|Overall Study|Switched back to previous medication|1|||
146572877|NCT03265145|528608173|FG001|Overall Study|Switched back to previous medication|0|||
146572878|NCT03265145|528608172|FG000|Overall Study|Did not want to take medication|1|||
146977281|NCT00386100|530079398|FG000|Overall Study|Death|0|||
146977282|NCT00386100|530079399|FG001|Overall Study|Death|1|||
146977283|NCT00386100|530079398|FG000|Overall Study|Insufficient therapeutic effect|30|||
146977284|NCT00386100|530079399|FG001|Overall Study|Insufficient therapeutic effect|6|||
146977285|NCT00386100|530079398|FG000|Overall Study|Lost to Follow-up|29|||
146977286|NCT00386100|530079399|FG001|Overall Study|Lost to Follow-up|29|||
146977287|NCT00386100|530079398|FG000|Overall Study|Non-compliance|18|||
146572879|NCT03265145|528608173|FG001|Overall Study|Did not want to take medication|0|||
146917292|NCT01043185|529860097|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
146917293|NCT01043185|529860098|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
146917294|NCT01043185|529860099|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
146917295|NCT01043185|529860100|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
146917296|NCT01043185|529860101|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
146572880|NCT03265145|528608172|FG000|Overall Study|Subject could not afford medication|0|||
146572881|NCT03265145|528608173|FG001|Overall Study|Subject could not afford medication|1|||
146572882|NCT03265145|528608172|FG000|Overall Study|Site closed|2|||
146572883|NCT03265145|528608173|FG001|Overall Study|Site closed|3|||
146572884|NCT03265145|528608172|FG000|Overall Study|Incorrectly randomized|16|||
146572885|NCT03265145|528608173|FG001|Overall Study|Incorrectly randomized|6|||
146572886|NCT03265145|528608172|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
146572887|NCT03265145|528608173|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
146572888|NCT03265145|528608172|FG000|Overall Study|Physician Decision|0|||
146572889|NCT03265145|528608173|FG001|Overall Study|Physician Decision|3|||
146572890|NCT03265145|528608172|FG000|Overall Study|Subject transferred to another facility|0|||
146572891|NCT03265145|528608173|FG001|Overall Study|Subject transferred to another facility|1|||
146572892|NCT04409834|528608174|FG000|Overall Study|Death|55|||
146572893|NCT04409834|528608175|FG001|Overall Study|Death|62|||
146572894|NCT02112656|528608176|FG000|Overall Study|Death|78|||
146572895|NCT02112656|528608177|FG001|Overall Study|Death|82|||
146572896|NCT02112656|528608176|FG000|Overall Study|Withdrawal by Subject|9|||
146572897|NCT02112656|528608177|FG001|Overall Study|Withdrawal by Subject|11|||
146572898|NCT02112656|528608176|FG000|Overall Study|Lost to Follow-up|2|||
146572899|NCT02112656|528608177|FG001|Overall Study|Lost to Follow-up|4|||
146572900|NCT02112656|528608176|FG000|Overall Study|Noncompliance|1|||
146572901|NCT02112656|528608177|FG001|Overall Study|Noncompliance|2|||
146572902|NCT04749745|528608178|FG000|Overall Study|Withdrawal by Subject|1|||
146572903|NCT04749745|528608179|FG001|Overall Study|Withdrawal by Subject|0|||
146572904|NCT01365455|528608184|FG000|Induction Period|Adverse Event|5|||
146572905|NCT01365455|528608185|FG001|Induction Period|Adverse Event|3|||
146572906|NCT01365455|528608186|FG002|Induction Period|Adverse Event|4|||
146572907|NCT01365455|528608187|FG003|Induction Period|Adverse Event|0|||
146572908|NCT01365455|528608188|FG004|Induction Period|Adverse Event|0|||
146572909|NCT01365455|528608184|FG000|Induction Period|Lack of Efficacy|1|||
146572910|NCT01365455|528608185|FG001|Induction Period|Lack of Efficacy|1|||
146572911|NCT01365455|528608186|FG002|Induction Period|Lack of Efficacy|0|||
146572912|NCT01365455|528608187|FG003|Induction Period|Lack of Efficacy|0|||
146572913|NCT01365455|528608188|FG004|Induction Period|Lack of Efficacy|0|||
146572914|NCT01365455|528608184|FG000|Induction Period|Pregnancy|0|||
146572915|NCT01365455|528608185|FG001|Induction Period|Pregnancy|1|||
146572916|NCT01365455|528608186|FG002|Induction Period|Pregnancy|0|||
146572917|NCT01365455|528608187|FG003|Induction Period|Pregnancy|0|||
146572918|NCT01365455|528608188|FG004|Induction Period|Pregnancy|0|||
146572919|NCT01365455|528608184|FG000|Induction Period|Protocol deviation|0|||
146977288|NCT00386100|530079399|FG001|Overall Study|Non-compliance|19|||
146572920|NCT01365455|528608185|FG001|Induction Period|Protocol deviation|1|||
146572921|NCT01365455|528608186|FG002|Induction Period|Protocol deviation|1|||
146572922|NCT01365455|528608187|FG003|Induction Period|Protocol deviation|0|||
146572923|NCT01365455|528608188|FG004|Induction Period|Protocol deviation|0|||
146572924|NCT01365455|528608184|FG000|Induction Period|Subject/guardian decision|9|||
146572925|NCT01365455|528608185|FG001|Induction Period|Subject/guardian decision|1|||
146572926|NCT01365455|528608186|FG002|Induction Period|Subject/guardian decision|8|||
146572927|NCT01365455|528608187|FG003|Induction Period|Subject/guardian decision|0|||
146572928|NCT01365455|528608188|FG004|Induction Period|Subject/guardian decision|0|||
146572929|NCT01365455|528608184|FG000|Induction Period|Lost to Follow-up|0|||
146572930|NCT01365455|528608185|FG001|Induction Period|Lost to Follow-up|0|||
146572931|NCT01365455|528608186|FG002|Induction Period|Lost to Follow-up|3|||
146572932|NCT01365455|528608187|FG003|Induction Period|Lost to Follow-up|0|||
146572933|NCT01365455|528608188|FG004|Induction Period|Lost to Follow-up|0|||
146572934|NCT01365455|528608184|FG000|Maintenance Period|Adverse Event|12|||
146572935|NCT01365455|528608185|FG001|Maintenance Period|Adverse Event|5|||
146572936|NCT01365455|528608186|FG002|Maintenance Period|Adverse Event|1|||
146572937|NCT01365455|528608187|FG003|Maintenance Period|Adverse Event|2|||
146572938|NCT01365455|528608188|FG004|Maintenance Period|Adverse Event|4|||
146572939|NCT01365455|528608184|FG000|Maintenance Period|Lack of Efficacy|10|||
146572940|NCT01365455|528608185|FG001|Maintenance Period|Lack of Efficacy|2|||
146572941|NCT01365455|528608186|FG002|Maintenance Period|Lack of Efficacy|0|||
146572942|NCT01365455|528608187|FG003|Maintenance Period|Lack of Efficacy|2|||
146572943|NCT01365455|528608188|FG004|Maintenance Period|Lack of Efficacy|2|||
146572944|NCT01365455|528608184|FG000|Maintenance Period|Lost to Follow-up|2|||
146572945|NCT01365455|528608185|FG001|Maintenance Period|Lost to Follow-up|4|||
146572946|NCT01365455|528608186|FG002|Maintenance Period|Lost to Follow-up|0|||
146572947|NCT01365455|528608187|FG003|Maintenance Period|Lost to Follow-up|0|||
146651597|NCT01931670|528902200|FG002|Treatment Period|Subject Noncompliant|5|||
146651598|NCT01931670|528902198|FG000|Treatment Period|Adverse Event|19|||
146977289|NCT00386100|530079398|FG000|Overall Study|Protocol Violation|5|||
146977290|NCT00386100|530079399|FG001|Overall Study|Protocol Violation|3|||
146572948|NCT01365455|528608188|FG004|Maintenance Period|Lost to Follow-up|3|||
146572949|NCT01365455|528608184|FG000|Maintenance Period|Non-compliance with study treatment|0|||
146572950|NCT01365455|528608185|FG001|Maintenance Period|Non-compliance with study treatment|0|||
146651599|NCT01931670|528902199|FG001|Treatment Period|Adverse Event|8|||
146572951|NCT01365455|528608186|FG002|Maintenance Period|Non-compliance with study treatment|0|||
146572952|NCT01365455|528608187|FG003|Maintenance Period|Non-compliance with study treatment|1|||
146572953|NCT01365455|528608188|FG004|Maintenance Period|Non-compliance with study treatment|0|||
146572954|NCT01365455|528608184|FG000|Maintenance Period|Physician Decision|0|||
146572955|NCT01365455|528608185|FG001|Maintenance Period|Physician Decision|1|||
146572956|NCT01365455|528608186|FG002|Maintenance Period|Physician Decision|0|||
146572957|NCT01365455|528608187|FG003|Maintenance Period|Physician Decision|0|||
146572958|NCT01365455|528608188|FG004|Maintenance Period|Physician Decision|1|||
146572959|NCT01365455|528608184|FG000|Maintenance Period|Pregnancy|0|||
146572960|NCT01365455|528608185|FG001|Maintenance Period|Pregnancy|4|||
146572961|NCT01365455|528608186|FG002|Maintenance Period|Pregnancy|0|||
146572962|NCT01365455|528608187|FG003|Maintenance Period|Pregnancy|0|||
146572963|NCT01365455|528608188|FG004|Maintenance Period|Pregnancy|2|||
146572964|NCT01365455|528608184|FG000|Maintenance Period|Protocol deviation|1|||
146572965|NCT01365455|528608185|FG001|Maintenance Period|Protocol deviation|1|||
146572966|NCT01365455|528608186|FG002|Maintenance Period|Protocol deviation|0|||
146572967|NCT01365455|528608187|FG003|Maintenance Period|Protocol deviation|0|||
146572968|NCT01365455|528608188|FG004|Maintenance Period|Protocol deviation|0|||
146572969|NCT01365455|528608184|FG000|Maintenance Period|Subject/guardian decision|4|||
146572970|NCT01365455|528608185|FG001|Maintenance Period|Subject/guardian decision|6|||
146572971|NCT01365455|528608186|FG002|Maintenance Period|Subject/guardian decision|2|||
146572972|NCT01365455|528608187|FG003|Maintenance Period|Subject/guardian decision|4|||
146572973|NCT01365455|528608188|FG004|Maintenance Period|Subject/guardian decision|1|||
146572974|NCT03965403|528608189|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
146572975|NCT03073525|528609778|FG000|Overall Study|Withdrawal by Subject|0|||
146572976|NCT03073525|528609779|FG001|Overall Study|Withdrawal by Subject|0|||
146572977|NCT03073525|528609780|FG002|Overall Study|Withdrawal by Subject|3|||
146572978|NCT01976299|528609781|FG000|Overall Study|Withdrawal by Subject|3|||
146572979|NCT01976299|528609782|FG001|Overall Study|Withdrawal by Subject|1|||
146572980|NCT01976299|528609781|FG000|Overall Study|Death|4|||
146572981|NCT01976299|528609782|FG001|Overall Study|Death|2|||
146917297|NCT01043185|529860102|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
146917298|NCT01043185|529860103|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
146917299|NCT01043185|529860104|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
146572982|NCT01976299|528609781|FG000|Overall Study|Lost to Follow-up|7|||
146572983|NCT01976299|528609782|FG001|Overall Study|Lost to Follow-up|1|||
146572984|NCT01976299|528609781|FG000|Overall Study|See clarification above in comments|9|||
146651600|NCT01931670|528902200|FG002|Treatment Period|Adverse Event|21|||
146651601|NCT01931670|528902198|FG000|Treatment Period|Lack of Efficacy|11|||
146651602|NCT01931670|528902199|FG001|Treatment Period|Lack of Efficacy|2|||
146651603|NCT01931670|528902200|FG002|Treatment Period|Lack of Efficacy|2|||
146651604|NCT01931670|528902198|FG000|Treatment Period|Pregnancy|7|||
146651605|NCT01931670|528902199|FG001|Treatment Period|Pregnancy|2|||
146651606|NCT01931670|528902200|FG002|Treatment Period|Pregnancy|0|||
146651607|NCT01931670|528902198|FG000|Treatment Period|Other|8|||
146651608|NCT01931670|528902199|FG001|Treatment Period|Other|7|||
146651609|NCT01931670|528902200|FG002|Treatment Period|Other|2|||
146651610|NCT01931670|528902198|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
146651611|NCT01931670|528902199|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
146651612|NCT01931670|528902200|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
146651613|NCT01931670|528902198|FG000|Treatment Period|Lost to Follow-up|19|||
146651614|NCT01931670|528902199|FG001|Treatment Period|Lost to Follow-up|5|||
146651615|NCT01931670|528902200|FG002|Treatment Period|Lost to Follow-up|7|||
146651616|NCT01931670|528902198|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
146651617|NCT01931670|528902199|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
146651618|NCT01931670|528902200|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
146770580|NCT00723450|529328639|FG000|Randomized Phase|Protocol Violation|0|||
146770581|NCT00723450|529328640|FG001|Randomized Phase|Protocol Violation|9|||
146770582|NCT00723450|529328641|FG002|Randomized Phase|Protocol Violation|13|||
146917300|NCT01043185|529860105|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
146770583|NCT00723450|529328639|FG000|Randomized Phase|Lost to Follow-up|0|||
146770584|NCT00723450|529328640|FG001|Randomized Phase|Lost to Follow-up|2|||
146770585|NCT00723450|529328641|FG002|Randomized Phase|Lost to Follow-up|3|||
146770586|NCT00723450|529328639|FG000|Randomized Phase|Physician Decision|0|||
146572985|NCT01976299|528609782|FG001|Overall Study|See clarification above in comments|2|||
146572986|NCT03692403|528609783|FG000|Overall Study|Withdrawal by Subject|1|||
146572987|NCT03692403|528609784|FG001|Overall Study|Withdrawal by Subject|0|||
146770587|NCT00723450|529328640|FG001|Randomized Phase|Physician Decision|3|||
146917301|NCT00137436|529860106|FG000|Overall Study|Adverse Event|13|||
146917302|NCT00137436|529860106|FG000|Overall Study|Death|2|||
146572988|NCT03692403|528609785|FG002|Overall Study|Withdrawal by Subject|1|||
146651619|NCT01931670|528902198|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
146651620|NCT01931670|528902199|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
146917303|NCT00137436|529860106|FG000|Overall Study|Lack of Efficacy|17|||
146917304|NCT00137436|529860106|FG000|Overall Study|Withdrawal by Subject|6|||
146917305|NCT00137436|529860106|FG000|Overall Study|Other|5|||
146917306|NCT01432262|529860107|FG000|Overall Study|Withdrawal by Subject|2|||
146917307|NCT01432262|529860108|FG001|Overall Study|Withdrawal by Subject|1|||
146917308|NCT04657016|529860109|FG000|Overall Study|Adverse Event|2|||
146917309|NCT04657016|529860110|FG001|Overall Study|Adverse Event|4|||
146917310|NCT04657016|529860109|FG000|Overall Study|Death|1|||
146917311|NCT04657016|529860110|FG001|Overall Study|Death|1|||
146917312|NCT04657016|529860109|FG000|Overall Study|Lost to Follow-up|24|||
146917313|NCT04657016|529860110|FG001|Overall Study|Lost to Follow-up|12|||
146917314|NCT04657016|529860109|FG000|Overall Study|Physician Decision|1|||
146917315|NCT04657016|529860110|FG001|Overall Study|Physician Decision|2|||
146917316|NCT04657016|529860109|FG000|Overall Study|Pregnancy|2|||
146917317|NCT04657016|529860110|FG001|Overall Study|Pregnancy|2|||
146917318|NCT04657016|529860109|FG000|Overall Study|Protocol Deviation|1|||
146917319|NCT04657016|529860110|FG001|Overall Study|Protocol Deviation|0|||
146917320|NCT04657016|529860109|FG000|Overall Study|Withdrawal by Subject|28|||
146917321|NCT04657016|529860110|FG001|Overall Study|Withdrawal by Subject|14|||
146917322|NCT04657016|529860109|FG000|Overall Study|Other - as reported by the investigator|6|||
146917323|NCT04657016|529860110|FG001|Overall Study|Other - as reported by the investigator|0|||
146917324|NCT00701727|529860111|FG000|First Treatment Period|Adverse Event|0|||
146917325|NCT00701727|529860112|FG001|First Treatment Period|Adverse Event|0|||
146917326|NCT00701727|529860111|FG000|First Treatment Period|Withdrawal by Subject|1|||
146917327|NCT00701727|529860112|FG001|First Treatment Period|Withdrawal by Subject|0|||
146917328|NCT00701727|529860111|FG000|First Treatment Period|sponsor decision|0|||
146917329|NCT00701727|529860112|FG001|First Treatment Period|sponsor decision|1|||
146917330|NCT00701727|529860111|FG000|First Treatment Period|Lost to Follow-up|0|||
146917331|NCT00701727|529860112|FG001|First Treatment Period|Lost to Follow-up|1|||
146917332|NCT00701727|529860111|FG000|Second Treatment Period|Withdrawal by Subject|2|||
146917333|NCT00701727|529860112|FG001|Second Treatment Period|Withdrawal by Subject|0|||
146917334|NCT01104558|529860115|FG000|Overall Study|Protocol Violation|6|||
146917335|NCT01104558|529860115|FG000|Overall Study|Missing of primary efficacy assessment|10|||
146917336|NCT01104558|529860115|FG000|Overall Study|Missing of genetic analysis results|1|||
146917337|NCT00523341|529860119|FG000|Overall Study|Withdrawal by Subject|399|||
146917338|NCT00523341|529860120|FG001|Overall Study|Withdrawal by Subject|427|||
146917339|NCT00523341|529860119|FG000|Overall Study|Other|181|||
146917340|NCT00523341|529860120|FG001|Overall Study|Other|198|||
146917341|NCT00523341|529860119|FG000|Overall Study|Adverse Event|122|||
146917342|NCT00523341|529860120|FG001|Overall Study|Adverse Event|155|||
146917343|NCT00523341|529860119|FG000|Overall Study|Death|101|||
146917344|NCT00523341|529860120|FG001|Overall Study|Death|110|||
146917345|NCT00523341|529860119|FG000|Overall Study|Lost to Follow-up|73|||
146917346|NCT00523341|529860120|FG001|Overall Study|Lost to Follow-up|61|||
146917347|NCT00523341|529860119|FG000|Overall Study|Non-compliance|20|||
146572989|NCT03692403|528609786|FG003|Overall Study|Withdrawal by Subject|0|||
146572990|NCT03692403|528609783|FG000|Overall Study|Adverse Event|0|||
146572991|NCT03692403|528609784|FG001|Overall Study|Adverse Event|0|||
146572992|NCT03692403|528609785|FG002|Overall Study|Adverse Event|0|||
146572993|NCT03692403|528609786|FG003|Overall Study|Adverse Event|1|||
146572994|NCT03692403|528609783|FG000|Overall Study|Pregnancy|0|||
146572995|NCT03692403|528609784|FG001|Overall Study|Pregnancy|1|||
146572996|NCT03692403|528609785|FG002|Overall Study|Pregnancy|0|||
146572997|NCT03692403|528609786|FG003|Overall Study|Pregnancy|0|||
146572998|NCT03692403|528609783|FG000|Overall Study|Other|0|||
146572999|NCT03692403|528609784|FG001|Overall Study|Other|0|||
146573000|NCT03692403|528609785|FG002|Overall Study|Other|1|||
146573001|NCT03692403|528609786|FG003|Overall Study|Other|0|||
146573002|NCT02848092|528609788|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
146573003|NCT02848092|528609789|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
146573004|NCT02848092|528609788|FG000|1-month Post-training Follow-up|Adverse Event|2|||
146573005|NCT02848092|528609789|FG001|1-month Post-training Follow-up|Adverse Event|1|||
146573006|NCT02848092|528609788|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
146573007|NCT02848092|528609789|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
146573008|NCT02848092|528609788|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
146573009|NCT02848092|528609789|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
146917348|NCT00523341|529860120|FG001|Overall Study|Non-compliance|13|||
146917349|NCT00523341|529860119|FG000|Overall Study|Physician Decision|14|||
146917350|NCT00523341|529860120|FG001|Overall Study|Physician Decision|13|||
146917351|NCT00523341|529860119|FG000|Overall Study|Requirement for Alternative Therapy|4|||
146917352|NCT00523341|529860120|FG001|Overall Study|Requirement for Alternative Therapy|14|||
146917353|NCT00523341|529860119|FG000|Overall Study|Protocol Deviation|6|||
146917354|NCT00523341|529860120|FG001|Overall Study|Protocol Deviation|5|||
146917355|NCT00523341|529860119|FG000|Overall Study|Ineligibility Determined|3|||
146917356|NCT00523341|529860120|FG001|Overall Study|Ineligibility Determined|4|||
146917357|NCT00523341|529860119|FG000|Overall Study|Disease Progression|1|||
146917358|NCT00523341|529860120|FG001|Overall Study|Disease Progression|0|||
146917359|NCT00912015|529860123|FG000|Overall Study|Lack of Efficacy|1|||
146917360|NCT00912015|529860124|FG001|Overall Study|Lack of Efficacy|0|||
146651621|NCT01931670|528902200|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
146651622|NCT01931670|528902198|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
146651623|NCT01931670|528902199|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
146651624|NCT01931670|528902200|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
146651625|NCT01931670|528902198|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
146651626|NCT01931670|528902199|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
146651627|NCT01931670|528902200|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
146651628|NCT01931670|528902198|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
146651629|NCT01931670|528902199|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
146651630|NCT01931670|528902200|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
146651631|NCT01931670|528902198|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
146651632|NCT01931670|528902199|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
146651633|NCT01931670|528902200|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
146651634|NCT00976508|528902202|FG000|Overall Study|Death|7|||
146651635|NCT00976508|528902203|FG001|Overall Study|Death|1|||
146651636|NCT00976508|528902202|FG000|Overall Study|Lost to Follow-up|1|||
146651637|NCT00976508|528902203|FG001|Overall Study|Lost to Follow-up|0|||
146651638|NCT00976508|528902202|FG000|Overall Study|Withdrawal by Subject|1|||
146651639|NCT00976508|528902203|FG001|Overall Study|Withdrawal by Subject|0|||
146651640|NCT00976508|528902202|FG000|Overall Study|Disease Progression|4|||
146651641|NCT00976508|528902203|FG001|Overall Study|Disease Progression|4|||
146651642|NCT00976508|528902202|FG000|Overall Study|Subject Enrolled in Hospice|1|||
146651643|NCT00976508|528902203|FG001|Overall Study|Subject Enrolled in Hospice|0|||
146651644|NCT00976508|528902202|FG000|Overall Study|Terminated by the Sponsor|0|||
146651645|NCT00976508|528902203|FG001|Overall Study|Terminated by the Sponsor|1|||
146651646|NCT04352127|528902204|FG000|Overall Study|Unable to obtain readings|4|||
146651647|NCT04352127|528902205|FG001|Overall Study|Unable to obtain readings|1|||
146651648|NCT01992159|528902206|FG000|Overall Study|Withdrawal by Subject|4|||
146651649|NCT01992159|528902207|FG001|Overall Study|Withdrawal by Subject|7|||
146651650|NCT01992159|528902208|FG002|Overall Study|Withdrawal by Subject|0|||
146651651|NCT01992159|528902209|FG003|Overall Study|Withdrawal by Subject|3|||
146651652|NCT01992159|528902206|FG000|Overall Study|Adverse Event|0|||
146651653|NCT01992159|528902207|FG001|Overall Study|Adverse Event|1|||
146573010|NCT02848092|528609788|FG000|1-month Post-training Follow-up|fatigue|0|||
146573011|NCT02848092|528609789|FG001|1-month Post-training Follow-up|fatigue|1|||
146573012|NCT02848092|528609788|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
146573013|NCT02848092|528609789|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
146573014|NCT02848092|528609788|FG000|6-month Post-training Follow-up|Adverse Event|1|||
146573015|NCT02848092|528609789|FG001|6-month Post-training Follow-up|Adverse Event|1|||
146573016|NCT02848092|528609788|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
146573017|NCT02848092|528609789|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
146573018|NCT02848092|528609788|FG000|6-month Post-training Follow-up|frustrated with task|1|||
146573019|NCT02848092|528609789|FG001|6-month Post-training Follow-up|frustrated with task|0|||
146573020|NCT02848092|528609788|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
146573021|NCT02848092|528609789|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
146573022|NCT02848092|528609788|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
146573023|NCT02848092|528609789|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
146573024|NCT01349673|528609796|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
146573025|NCT01349673|528609796|FG000|Overall Study|No Longer Qualified For Study|1|||
146573026|NCT01349673|528609796|FG000|Overall Study|Site Closure|10|||
146573027|NCT01349673|528609796|FG000|Overall Study|Withdrawal by Subject|21|||
146573028|NCT01349673|528609796|FG000|Overall Study|Lost to Follow-up|6|||
146573029|NCT01349673|528609796|FG000|Overall Study|Adverse Event|17|||
146573030|NCT01349673|528609796|FG000|Overall Study|Study Terminated By Sponsor|50|||
146573031|NCT01349673|528609796|FG000|Overall Study|Lack of Efficacy|8|||
146573032|NCT01665911|528609797|FG000|Overall Study|Protocol Violation|4|||
146573033|NCT01665911|528609797|FG000|Overall Study|Withdrawal by Subject|1|||
146573034|NCT01665911|528609797|FG000|Overall Study|Adverse Event|1|||
146573035|NCT01724216|528609804|FG000|Overall Study|Scan was not completed|1|||
146573036|NCT00564733|528609805|FG000|Overall Study|Withdrawal by Subject|4|||
146573037|NCT00564733|528609805|FG000|Overall Study|Ineligible|5|||
146573038|NCT01484496|528609808|FG000|Period 1|Protocol Violation|3|||
146573039|NCT01484496|528609809|FG001|Period 1|Protocol Violation|4|||
146573040|NCT01484496|528609810|FG002|Period 1|Protocol Violation|0|||
146651654|NCT01992159|528902208|FG002|Overall Study|Adverse Event|0|||
146651655|NCT01992159|528902209|FG003|Overall Study|Adverse Event|1|||
146651656|NCT01992159|528902206|FG000|Overall Study|Death|0|||
146651657|NCT01992159|528902207|FG001|Overall Study|Death|0|||
146651658|NCT01992159|528902208|FG002|Overall Study|Death|1|||
146651659|NCT01992159|528902209|FG003|Overall Study|Death|0|||
146651660|NCT03023046|528902213|FG000|Overall Study|Withdrawal by Subject|1|||
146651661|NCT01205581|528902214|FG000|Overall Study|Withdrawal by Subject|1|||
146651662|NCT01205581|528902215|FG001|Overall Study|Withdrawal by Subject|0|||
146651663|NCT01205581|528902216|FG002|Overall Study|Withdrawal by Subject|0|||
146651664|NCT01205581|528902217|FG003|Overall Study|Withdrawal by Subject|0|||
146651665|NCT01205581|528902218|FG004|Overall Study|Withdrawal by Subject|0|||
146651666|NCT01205581|528902219|FG005|Overall Study|Withdrawal by Subject|0|||
146651667|NCT01236118|528902220|FG000|Overall Study|Adverse Event|2|||
146651668|NCT01236118|528902221|FG001|Overall Study|Adverse Event|0|||
146651669|NCT01236118|528902222|FG002|Overall Study|Adverse Event|2|||
146651670|NCT01236118|528902220|FG000|Overall Study|Physician Decision|0|||
146651671|NCT01236118|528902221|FG001|Overall Study|Physician Decision|1|||
146651672|NCT01236118|528902222|FG002|Overall Study|Physician Decision|0|||
146651673|NCT01236118|528902220|FG000|Overall Study|Withdrawal by Subject|0|||
146651674|NCT01236118|528902221|FG001|Overall Study|Withdrawal by Subject|0|||
146651675|NCT01236118|528902222|FG002|Overall Study|Withdrawal by Subject|1|||
146651676|NCT04535167|528902223|FG000|Treatment|Adverse Event|0|||
146651677|NCT04535167|528902224|FG001|Treatment|Adverse Event|0|||
146651678|NCT04535167|528902225|FG002|Treatment|Adverse Event|0|||
146651679|NCT04535167|528902226|FG003|Treatment|Adverse Event|0|||
146651680|NCT04535167|528902227|FG004|Treatment|Adverse Event|0|||
146651681|NCT04535167|528902228|FG005|Treatment|Adverse Event|0|||
146651682|NCT04535167|528902229|FG006|Treatment|Adverse Event|1|||
146651683|NCT04535167|528902223|FG000|Follow-Up|Death|0|||
146651684|NCT04535167|528902224|FG001|Follow-Up|Death|0|||
146651685|NCT04535167|528902225|FG002|Follow-Up|Death|0|||
146651686|NCT04535167|528902226|FG003|Follow-Up|Death|0|||
146651687|NCT04535167|528902227|FG004|Follow-Up|Death|0|||
146651688|NCT04535167|528902228|FG005|Follow-Up|Death|0|||
146651689|NCT04535167|528902229|FG006|Follow-Up|Death|1|||
146651690|NCT04535167|528902223|FG000|Follow-Up|Lost to Follow-up|0|||
146651691|NCT04535167|528902224|FG001|Follow-Up|Lost to Follow-up|0|||
146651692|NCT04535167|528902225|FG002|Follow-Up|Lost to Follow-up|0|||
146651693|NCT04535167|528902226|FG003|Follow-Up|Lost to Follow-up|1|||
146651694|NCT04535167|528902227|FG004|Follow-Up|Lost to Follow-up|0|||
146651695|NCT04535167|528902228|FG005|Follow-Up|Lost to Follow-up|0|||
146651696|NCT04535167|528902229|FG006|Follow-Up|Lost to Follow-up|0|||
146651697|NCT00075270|528902230|FG000|Overall Study|Withdrawal by Subject|28|||
146651698|NCT00075270|528902231|FG001|Overall Study|Withdrawal by Subject|21|||
146651699|NCT00075270|528902230|FG000|Overall Study|Lost to Follow-up|25|||
146651700|NCT00075270|528902231|FG001|Overall Study|Lost to Follow-up|28|||
146651701|NCT00075270|528902230|FG000|Overall Study|Protocol Violation|0|||
146651702|NCT00075270|528902231|FG001|Overall Study|Protocol Violation|2|||
146651703|NCT00075270|528902230|FG000|Overall Study|Death|198|||
146651704|NCT00075270|528902231|FG001|Overall Study|Death|215|||
146651705|NCT00075270|528902230|FG000|Overall Study|Other/Unknown|9|||
146651706|NCT00075270|528902231|FG001|Overall Study|Other/Unknown|5|||
146651707|NCT00075270|528902230|FG000|Overall Study|Missing|26|||
146651708|NCT00075270|528902231|FG001|Overall Study|Missing|13|||
146651709|NCT02160002|528902232|FG000|Overall Study|Withdrawal by Subject|2|||
146651710|NCT02160002|528902233|FG001|Overall Study|Withdrawal by Subject|1|||
146651711|NCT00713310|528902236|FG000|Overall Study|Adverse Event|5|||
146651712|NCT00713310|528902237|FG001|Overall Study|Adverse Event|2|||
146651713|NCT00713310|528902236|FG000|Overall Study|Lack of Efficacy|0|||
146770588|NCT00723450|529328641|FG002|Randomized Phase|Physician Decision|1|||
146770589|NCT00723450|529328639|FG000|Randomized Phase|Withdrawal by Subject|0|||
146573041|NCT01484496|528609811|FG003|Period 1|Protocol Violation|0|||
146573042|NCT01484496|528609808|FG000|Period 1|Physician Decision|5|||
146573043|NCT01484496|528609809|FG001|Period 1|Physician Decision|1|||
146573044|NCT01484496|528609810|FG002|Period 1|Physician Decision|0|||
146573045|NCT01484496|528609811|FG003|Period 1|Physician Decision|0|||
146573046|NCT01484496|528609808|FG000|Period 1|Lack of Efficacy|10|||
146573047|NCT01484496|528609809|FG001|Period 1|Lack of Efficacy|15|||
146573048|NCT01484496|528609810|FG002|Period 1|Lack of Efficacy|0|||
146573049|NCT01484496|528609811|FG003|Period 1|Lack of Efficacy|0|||
146573050|NCT01484496|528609808|FG000|Period 1|Adverse Event|25|||
146651714|NCT00713310|528902237|FG001|Overall Study|Lack of Efficacy|2|||
146651715|NCT00713310|528902236|FG000|Overall Study|Withdrawal by Subject|0|||
146651716|NCT00713310|528902237|FG001|Overall Study|Withdrawal by Subject|2|||
146651717|NCT05508074|528902238|FG000|Overall Study|Death|2|||
146573051|NCT01484496|528609809|FG001|Period 1|Adverse Event|40|||
146573052|NCT01484496|528609810|FG002|Period 1|Adverse Event|0|||
146573053|NCT01484496|528609811|FG003|Period 1|Adverse Event|0|||
146651718|NCT05508074|528902239|FG001|Overall Study|Death|5|||
146651719|NCT05508074|528902238|FG000|Overall Study|Withdrawal by Subject|1|||
146651720|NCT05508074|528902239|FG001|Overall Study|Withdrawal by Subject|2|||
146651721|NCT05508074|528902238|FG000|Overall Study|Adverse Event|0|||
146651722|NCT05508074|528902239|FG001|Overall Study|Adverse Event|1|||
146651723|NCT05508074|528902238|FG000|Overall Study|Physician Decision|0|||
146573054|NCT01484496|528609808|FG000|Period 1|Withdrawal by Subject|15|||
146573055|NCT01484496|528609809|FG001|Period 1|Withdrawal by Subject|12|||
146651724|NCT05508074|528902239|FG001|Overall Study|Physician Decision|1|||
146651725|NCT05508074|528902238|FG000|Overall Study|wrongly randomized|0|||
146651726|NCT05508074|528902239|FG001|Overall Study|wrongly randomized|1|||
146651727|NCT05508074|528902238|FG000|Overall Study|non-compliance|0|||
146651728|NCT05508074|528902239|FG001|Overall Study|non-compliance|1|||
146917361|NCT00912015|529860125|FG002|Overall Study|Lack of Efficacy|0|||
146917362|NCT00912015|529860126|FG003|Overall Study|Lack of Efficacy|0|||
146573056|NCT01484496|528609810|FG002|Period 1|Withdrawal by Subject|0|||
146573057|NCT01484496|528609811|FG003|Period 1|Withdrawal by Subject|0|||
146573058|NCT01484496|528609808|FG000|Period 1|Lost to Follow-up|2|||
146573059|NCT01484496|528609809|FG001|Period 1|Lost to Follow-up|6|||
146573060|NCT01484496|528609810|FG002|Period 1|Lost to Follow-up|0|||
146573061|NCT01484496|528609811|FG003|Period 1|Lost to Follow-up|0|||
146573062|NCT01484496|528609808|FG000|Period 1|Positive Pregnancy|1|||
146573063|NCT01484496|528609809|FG001|Period 1|Positive Pregnancy|6|||
146573064|NCT01484496|528609810|FG002|Period 1|Positive Pregnancy|0|||
146573065|NCT01484496|528609811|FG003|Period 1|Positive Pregnancy|0|||
146573066|NCT01484496|528609808|FG000|Period 1|Treatment Failure|3|||
146573067|NCT01484496|528609809|FG001|Period 1|Treatment Failure|6|||
146573068|NCT01484496|528609810|FG002|Period 1|Treatment Failure|0|||
146573069|NCT01484496|528609811|FG003|Period 1|Treatment Failure|0|||
146573070|NCT01484496|528609808|FG000|Period 1|Lack of Compliance|2|||
146573071|NCT01484496|528609809|FG001|Period 1|Lack of Compliance|1|||
146573072|NCT01484496|528609810|FG002|Period 1|Lack of Compliance|0|||
146573073|NCT01484496|528609811|FG003|Period 1|Lack of Compliance|0|||
146573074|NCT01484496|528609808|FG000|Period 1|Unable to Visit Site|0|||
146573075|NCT01484496|528609809|FG001|Period 1|Unable to Visit Site|2|||
146573076|NCT01484496|528609810|FG002|Period 1|Unable to Visit Site|0|||
146573077|NCT01484496|528609811|FG003|Period 1|Unable to Visit Site|0|||
146573078|NCT01484496|528609808|FG000|Period 2|Lack of Efficacy|0|||
146573079|NCT01484496|528609809|FG001|Period 2|Lack of Efficacy|0|||
146573080|NCT01484496|528609810|FG002|Period 2|Lack of Efficacy|1|||
146573081|NCT01484496|528609811|FG003|Period 2|Lack of Efficacy|3|||
146651729|NCT05028361|528902240|FG000|Overall Study|Withdrawal by Subject|1|||
146651730|NCT05028361|528902241|FG001|Overall Study|Withdrawal by Subject|0|||
146651731|NCT01993836|528902242|FG000|Overall Study|Surgery Cancelled|3|||
146651732|NCT01993836|528902243|FG001|Overall Study|Surgery Cancelled|0|||
146651733|NCT01993836|528902244|FG002|Overall Study|Surgery Cancelled|0|||
146651734|NCT01993836|528902242|FG000|Overall Study|Physician Decision|2|||
146651735|NCT01993836|528902243|FG001|Overall Study|Physician Decision|1|||
146651736|NCT01993836|528902244|FG002|Overall Study|Physician Decision|0|||
146651737|NCT01993836|528902242|FG000|Overall Study|Death|0|||
146651738|NCT01993836|528902243|FG001|Overall Study|Death|2|||
146651739|NCT01993836|528902244|FG002|Overall Study|Death|0|||
146651740|NCT01993836|528902242|FG000|Overall Study|Withdrawal by Subject|12|||
146651741|NCT01993836|528902243|FG001|Overall Study|Withdrawal by Subject|10|||
146651742|NCT01993836|528902244|FG002|Overall Study|Withdrawal by Subject|5|||
146651743|NCT00686634|528902245|FG000|Overall Study|Protocol Violation|6|||
146651744|NCT00779259|528902246|FG000|Quinine Alone|Adverse Event|2|||
146651745|NCT01107379|528902252|FG000|Overall Study|Withdrawal by Subject|18|||
146651746|NCT01107379|528902252|FG000|Overall Study|Lost to Follow-up|3|||
146651747|NCT04559529|528902253|FG000|First Intervention (1 Day)|Adverse Event|0|||
146651748|NCT04559529|528902254|FG001|First Intervention (1 Day)|Adverse Event|0|||
146651749|NCT04559529|528902255|FG002|First Intervention (1 Day)|Adverse Event|0|||
146651750|NCT04559529|528902256|FG003|First Intervention (1 Day)|Adverse Event|1|||
146651751|NCT04559529|528902253|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
146651752|NCT04559529|528902254|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
146651753|NCT04559529|528902255|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
146651754|NCT04559529|528902256|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
146651755|NCT04559529|528902253|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
146651756|NCT04559529|528902254|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
146651757|NCT04559529|528902255|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
146651758|NCT04559529|528902256|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
146651759|NCT01203852|528902259|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
146651760|NCT01203852|528902259|FG000|Washout 2 Weeks|Physician Decision|46|||
146651761|NCT01878149|528902262|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
146651762|NCT01878149|528902263|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
146651763|NCT04672252|528902266|FG000|Overall Study|Protocol Violation|1|||
146651764|NCT04672252|528902267|FG001|Overall Study|Protocol Violation|0|||
146651765|NCT01738477|528902274|FG000|Overall Study|Lost to Follow-up|1|||
146651766|NCT01738477|528902275|FG001|Overall Study|Lost to Follow-up|4|||
146651767|NCT01302834|528902278|FG000|Overall Study|Protocol Violation|17|||
146651768|NCT01302834|528902279|FG001|Overall Study|Protocol Violation|23|||
146917363|NCT00912015|529860123|FG000|Overall Study|Withdrawal by Subject|8|||
146917364|NCT00912015|529860124|FG001|Overall Study|Withdrawal by Subject|8|||
146573082|NCT01484496|528609808|FG000|Period 2|Adverse Event|0|||
146917365|NCT00912015|529860125|FG002|Overall Study|Withdrawal by Subject|3|||
146573083|NCT01484496|528609809|FG001|Period 2|Adverse Event|0|||
146573084|NCT01484496|528609810|FG002|Period 2|Adverse Event|5|||
146651769|NCT01302834|528902278|FG000|Overall Study|HIV positive|1|||
146651770|NCT01302834|528902279|FG001|Overall Study|HIV positive|3|||
146651771|NCT00899392|528902280|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
146651772|NCT00899392|528902281|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
146573085|NCT01484496|528609811|FG003|Period 2|Adverse Event|13|||
146573086|NCT01484496|528609808|FG000|Period 2|Other|0|||
146573087|NCT01484496|528609809|FG001|Period 2|Other|0|||
146573088|NCT01484496|528609810|FG002|Period 2|Other|9|||
146573089|NCT01484496|528609811|FG003|Period 2|Other|6|||
146573090|NCT00506779|528609812|FG000|Overall Study|Withdrawal by Subject|1|||
146573091|NCT00506779|528609813|FG001|Overall Study|Withdrawal by Subject|0|||
146573092|NCT00506779|528609814|FG002|Overall Study|Withdrawal by Subject|1|||
146573093|NCT00506779|528609815|FG003|Overall Study|Withdrawal by Subject|0|||
146573094|NCT00506779|528609812|FG000|Overall Study|Adverse Event|0|||
146573095|NCT00506779|528609813|FG001|Overall Study|Adverse Event|1|||
146573096|NCT00506779|528609814|FG002|Overall Study|Adverse Event|1|||
146573097|NCT00506779|528609815|FG003|Overall Study|Adverse Event|1|||
146573098|NCT01645735|528609816|FG000|Overall Study|Physician Decision|2|||
146573099|NCT01645735|528609817|FG001|Overall Study|Physician Decision|0|||
146573100|NCT01645735|528609816|FG000|Overall Study|Withdrawal by Subject|1|||
146573101|NCT01645735|528609817|FG001|Overall Study|Withdrawal by Subject|0|||
146573102|NCT01645735|528609816|FG000|Overall Study|Protocol Violation|1|||
146573103|NCT01645735|528609817|FG001|Overall Study|Protocol Violation|0|||
146573104|NCT01645735|528609816|FG000|Overall Study|Adverse Event|0|||
146573105|NCT01645735|528609817|FG001|Overall Study|Adverse Event|1|||
146573106|NCT01456130|528609819|FG000|Overall Study|Adverse Event|4|||
146573107|NCT01456130|528609819|FG000|Overall Study|Voluntary Withdrawal|1|||
146573108|NCT01456130|528609819|FG000|Overall Study|Lack of Efficacy|4|||
146573109|NCT01456130|528609819|FG000|Overall Study|Other|1|||
146573110|NCT04908683|528609824|FG000|Overall Study|Failure to meet continuation criteria|34|||
146573111|NCT04908683|528609825|FG001|Overall Study|Failure to meet continuation criteria|22|||
146573112|NCT04908683|528609824|FG000|Overall Study|Initiated prohibited medication|3|||
146573113|NCT04908683|528609825|FG001|Overall Study|Initiated prohibited medication|0|||
146573114|NCT04908683|528609824|FG000|Overall Study|Randomized by mistake|1|||
146573115|NCT04908683|528609825|FG001|Overall Study|Randomized by mistake|0|||
146573116|NCT04908683|528609824|FG000|Overall Study|Lost to Follow-up|679|||
146573117|NCT04908683|528609825|FG001|Overall Study|Lost to Follow-up|341|||
146573118|NCT04908683|528609824|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
146573119|NCT04908683|528609825|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
146573120|NCT04908683|528609824|FG000|Overall Study|Physician Decision|44|||
146573121|NCT04908683|528609825|FG001|Overall Study|Physician Decision|35|||
146573122|NCT04908683|528609824|FG000|Overall Study|Technical problems|12|||
146573123|NCT04908683|528609825|FG001|Overall Study|Technical problems|9|||
146573124|NCT04908683|528609824|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
146573125|NCT04908683|528609825|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
146573126|NCT04908683|528609824|FG000|Overall Study|Protocol Violation|2|||
146573127|NCT04908683|528609825|FG001|Overall Study|Protocol Violation|0|||
146573128|NCT04908683|528609824|FG000|Overall Study|Withdrawal by Subject|1188|||
146573129|NCT04908683|528609825|FG001|Overall Study|Withdrawal by Subject|570|||
146573130|NCT04908683|528609824|FG000|Overall Study|Site Closure by Sponsor|6|||
146573131|NCT04908683|528609825|FG001|Overall Study|Site Closure by Sponsor|3|||
146573132|NCT04908683|528609824|FG000|Overall Study|Adverse Event|21|||
146573133|NCT04908683|528609825|FG001|Overall Study|Adverse Event|11|||
146573134|NCT04908683|528609824|FG000|Overall Study|Death|101|||
146573135|NCT04908683|528609825|FG001|Overall Study|Death|61|||
146573136|NCT04908683|528609824|FG000|Overall Study|Sponsor's decision|14398|||
146573137|NCT04908683|528609825|FG001|Overall Study|Sponsor's decision|7205|||
146573138|NCT04908683|528609824|FG000|Overall Study|Other|92|||
146573139|NCT04908683|528609825|FG001|Overall Study|Other|50|||
146573140|NCT04908683|528609824|FG000|Overall Study|Randomized not vaccinated|108|||
146573141|NCT04908683|528609825|FG001|Overall Study|Randomized not vaccinated|52|||
146573142|NCT02831855|528609826|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
146573143|NCT02831855|528609827|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
146573144|NCT02831855|528609828|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
146573145|NCT02831855|528609826|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
146573146|NCT02831855|528609827|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
146573147|NCT02831855|528609828|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
146573148|NCT02831855|528609826|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
146573149|NCT02831855|528609827|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
146573150|NCT02831855|528609828|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
146651773|NCT02437110|528902282|FG000|Screening|Lost to Follow-up|3|||
146651774|NCT02437110|528902282|FG000|Screening|Physician Decision|1|||
146651775|NCT02437110|528902282|FG000|ART|Adverse Event|3|||
146917366|NCT00912015|529860126|FG003|Overall Study|Withdrawal by Subject|0|||
146573151|NCT02831855|528609826|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
146573152|NCT02831855|528609827|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
146573153|NCT02831855|528609828|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
146573154|NCT02831855|528609826|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
146651776|NCT02437110|528902282|FG000|ART|Protocol Violation|3|||
146651777|NCT02437110|528902282|FG000|ART|Withdrawal by Subject|4|||
146573155|NCT02831855|528609827|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
146573156|NCT02831855|528609828|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
146573157|NCT02831855|528609826|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
146573158|NCT02831855|528609827|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
146573159|NCT02831855|528609828|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
146573160|NCT02831855|528609826|FG000|Open Label Phase (24 Weeks)|Other|4|||
146573161|NCT02831855|528609827|FG001|Open Label Phase (24 Weeks)|Other|0|||
146573162|NCT02831855|528609828|FG002|Open Label Phase (24 Weeks)|Other|0|||
146770590|NCT00723450|529328640|FG001|Randomized Phase|Withdrawal by Subject|14|||
146770591|NCT00723450|529328641|FG002|Randomized Phase|Withdrawal by Subject|22|||
146770592|NCT01135511|529328642|FG000|Overall Study|Adverse Event|0|||
146770593|NCT01135511|529328643|FG001|Overall Study|Adverse Event|1|||
146770594|NCT01135511|529328644|FG002|Overall Study|Adverse Event|2|||
146770595|NCT01135511|529328645|FG003|Overall Study|Adverse Event|0|||
146770596|NCT01135511|529328646|FG004|Overall Study|Adverse Event|0|||
146770597|NCT01135511|529328647|FG005|Overall Study|Adverse Event|1|||
146573163|NCT02831855|528609826|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
146573164|NCT02831855|528609827|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
146573165|NCT02831855|528609828|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
146573166|NCT02831855|528609826|FG000|Double Blind Phase (24 Weeks)|Death|0|||
146573167|NCT02831855|528609827|FG001|Double Blind Phase (24 Weeks)|Death|0|||
146573168|NCT02831855|528609828|FG002|Double Blind Phase (24 Weeks)|Death|2|||
146573169|NCT02831855|528609826|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
146573170|NCT02831855|528609827|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
146573171|NCT02831855|528609828|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
146573172|NCT02831855|528609826|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
146573173|NCT02831855|528609827|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
146573174|NCT02831855|528609828|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
146573175|NCT02831855|528609826|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
146573176|NCT02831855|528609827|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
146573177|NCT02831855|528609828|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
146573178|NCT02831855|528609826|FG000|Double Blind Phase (24 Weeks)|Other|0|||
146573179|NCT02831855|528609827|FG001|Double Blind Phase (24 Weeks)|Other|2|||
146573180|NCT02831855|528609828|FG002|Double Blind Phase (24 Weeks)|Other|5|||
146573181|NCT02831855|528609826|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
146573182|NCT02831855|528609827|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
146573183|NCT02831855|528609828|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
146573184|NCT02831855|528609826|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
146573185|NCT02831855|528609827|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
146573186|NCT02831855|528609828|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
146573187|NCT02831855|528609826|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
146573188|NCT02831855|528609827|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
146573189|NCT02831855|528609828|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
146573190|NCT02688192|528609829|FG000|Overall Study|Lost to Follow-up|11|||
146573191|NCT02688192|528609830|FG001|Overall Study|Lost to Follow-up|5|||
146573192|NCT02688192|528609829|FG000|Overall Study|Physician Decision|1|||
146573193|NCT02688192|528609830|FG001|Overall Study|Physician Decision|0|||
146573194|NCT00075764|528609831|FG000|Overall Study|Adverse Event|5|||
146573195|NCT00075764|528609832|FG001|Overall Study|Adverse Event|12|||
146573196|NCT00075764|528609831|FG000|Overall Study|Death|4|||
146573197|NCT00075764|528609832|FG001|Overall Study|Death|8|||
146573198|NCT00075764|528609831|FG000|Overall Study|Withdrawal by Subject|28|||
146573199|NCT00075764|528609832|FG001|Overall Study|Withdrawal by Subject|18|||
146573200|NCT00075764|528609831|FG000|Overall Study|Progression|269|||
146573201|NCT00075764|528609832|FG001|Overall Study|Progression|274|||
146573202|NCT00075764|528609831|FG000|Overall Study|Still on treatment|8|||
146573203|NCT00075764|528609832|FG001|Overall Study|Still on treatment|15|||
146573204|NCT00075764|528609831|FG000|Overall Study|Delinquent|4|||
146770598|NCT01135511|529328648|FG006|Overall Study|Adverse Event|0|||
146770599|NCT01135511|529328649|FG007|Overall Study|Adverse Event|1|||
146770600|NCT01135511|529328650|FG008|Overall Study|Adverse Event|0|||
146917367|NCT00912015|529860123|FG000|Overall Study|Protocol Violation|1|||
146770601|NCT01135511|529328642|FG000|Overall Study|Lack of Efficacy|0|||
146917368|NCT00912015|529860124|FG001|Overall Study|Protocol Violation|0|||
146917369|NCT00912015|529860125|FG002|Overall Study|Protocol Violation|0|||
146573205|NCT00075764|528609832|FG001|Overall Study|Delinquent|2|||
146573206|NCT00075764|528609831|FG000|Overall Study|Not protocol specified|27|||
146573207|NCT00075764|528609832|FG001|Overall Study|Not protocol specified|19|||
146573208|NCT00075764|528609831|FG000|Overall Study|Under review|0|||
146573209|NCT00075764|528609832|FG001|Overall Study|Under review|1|||
146573210|NCT02817594|528609836|FG000|Overall Study|Withdrawal by Subject|1|||
146573211|NCT02817594|528609836|FG000|Overall Study|Other|1|||
146573212|NCT02817594|528609836|FG000|Overall Study|Did Not Receive Treatment|1|||
146573213|NCT02010593|528609837|FG000|Overall Study|Lost to Follow-up|1|||
146573214|NCT02010593|528609838|FG001|Overall Study|Lost to Follow-up|0|||
146917370|NCT00912015|529860126|FG003|Overall Study|Protocol Violation|1|||
146573215|NCT02010593|528609837|FG000|Overall Study|Physician Decision|1|||
146573216|NCT02010593|528609838|FG001|Overall Study|Physician Decision|0|||
146573217|NCT02010593|528609837|FG000|Overall Study|Unable to adhere to visit schedule|0|||
146573218|NCT02010593|528609838|FG001|Overall Study|Unable to adhere to visit schedule|2|||
146573219|NCT01773967|528609839|FG000|Overall Study|Lost to Follow-up|15|||
146573220|NCT01773967|528609840|FG001|Overall Study|Lost to Follow-up|13|||
146573221|NCT01135459|528609841|FG000|Overall Study|Adverse Event|8|||
146573222|NCT01135459|528609842|FG001|Overall Study|Adverse Event|10|||
146573223|NCT01135459|528609841|FG000|Overall Study|Lack of Efficacy|3|||
146573224|NCT01135459|528609842|FG001|Overall Study|Lack of Efficacy|1|||
146573225|NCT01135459|528609841|FG000|Overall Study|Withdrawal by Subject|2|||
146573226|NCT01135459|528609842|FG001|Overall Study|Withdrawal by Subject|3|||
146573227|NCT01135459|528609841|FG000|Overall Study|Protocol Violation|5|||
146573228|NCT01135459|528609842|FG001|Overall Study|Protocol Violation|3|||
146573229|NCT01135459|528609841|FG000|Overall Study|Lost to Follow-up|2|||
146573230|NCT01135459|528609842|FG001|Overall Study|Lost to Follow-up|1|||
146573231|NCT01135459|528609841|FG000|Overall Study|Non-compliance to study procedures|0|||
146573232|NCT01135459|528609842|FG001|Overall Study|Non-compliance to study procedures|1|||
146573233|NCT01135459|528609841|FG000|Overall Study|Other than specified|1|||
146573234|NCT01135459|528609842|FG001|Overall Study|Other than specified|1|||
146573235|NCT01057693|528609844|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
146573236|NCT01057693|528609845|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
146573237|NCT01057693|528609846|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
146573238|NCT01057693|528609844|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
146573239|NCT01057693|528609845|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
146573240|NCT01057693|528609846|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
146573241|NCT01057693|528609844|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
146573242|NCT01057693|528609845|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
146573243|NCT01057693|528609846|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
146573244|NCT01057693|528609844|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
146573245|NCT01057693|528609845|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
146573246|NCT01057693|528609846|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
146573247|NCT01057693|528609844|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
146573248|NCT01057693|528609845|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
146573249|NCT01057693|528609846|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
146573250|NCT01057693|528609844|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
146573251|NCT01057693|528609845|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
146573252|NCT01057693|528609846|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
146573253|NCT01057693|528609844|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
146573254|NCT01057693|528609845|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
146651778|NCT02437110|528902282|FG000|ART|Lost to follow-up prior to start of intervention|1|||
146651779|NCT02437110|528902282|FG000|ART|Physician decision prior to start of intervention|2|||
146651780|NCT02437110|528902282|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
146651781|NCT02437110|528902282|FG000|Post-ART|Lost to Follow-up|3|||
146651782|NCT02437110|528902282|FG000|Post-ART|Protocol Violation|4|||
146651783|NCT02437110|528902282|FG000|Post-ART|Withdrawal by Subject|3|||
146651784|NCT03735238|528902283|FG000|Overall Study|Did not want to participate in research|3|||
146651785|NCT03735238|528902283|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
146651786|NCT01431638|528902284|FG000|Overall Study|Adverse Event|1|||
146651787|NCT01431638|528902285|FG001|Overall Study|Adverse Event|3|||
147013236|NCT01708954|530210054|FG000|Step 1|Other complicating disease|0|||
146573255|NCT01057693|528609846|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
146573256|NCT01057693|528609844|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
146573257|NCT01057693|528609845|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
146573258|NCT01057693|528609846|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
146573259|NCT01057693|528609844|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
146573260|NCT01057693|528609845|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
146573261|NCT01057693|528609846|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
146573262|NCT01057693|528609844|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
146573263|NCT01057693|528609845|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
146573264|NCT01057693|528609846|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
146573265|NCT01057693|528609844|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
146573266|NCT01057693|528609845|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
146573267|NCT01057693|528609846|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
146573268|NCT01057693|528609844|FG000|Between Single-Blind and Double-Blind|Other|6|||
146651788|NCT01431638|528902286|FG002|Overall Study|Adverse Event|1|||
146651789|NCT01431638|528902284|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146651790|NCT01431638|528902285|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146651791|NCT01431638|528902286|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
146770602|NCT01135511|529328643|FG001|Overall Study|Lack of Efficacy|1|||
146770603|NCT01135511|529328644|FG002|Overall Study|Lack of Efficacy|1|||
146917371|NCT00912015|529860123|FG000|Overall Study|Adverse Event|6|||
146917372|NCT00912015|529860124|FG001|Overall Study|Adverse Event|0|||
146917373|NCT00912015|529860125|FG002|Overall Study|Adverse Event|0|||
146917374|NCT00912015|529860126|FG003|Overall Study|Adverse Event|1|||
146573269|NCT01057693|528609845|FG001|Between Single-Blind and Double-Blind|Other|0|||
146573270|NCT01057693|528609846|FG002|Between Single-Blind and Double-Blind|Other|0|||
146573271|NCT01057693|528609844|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
146573272|NCT01057693|528609845|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
146573273|NCT01057693|528609846|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
146573274|NCT01057693|528609844|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
146573275|NCT01057693|528609845|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
146573276|NCT01057693|528609846|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
146573277|NCT01057693|528609844|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
146573278|NCT01057693|528609845|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
146573279|NCT01057693|528609846|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
146573280|NCT01057693|528609844|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
146573281|NCT01057693|528609845|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
146573282|NCT01057693|528609846|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
146573283|NCT01057693|528609844|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
146573284|NCT01057693|528609845|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
146573285|NCT01057693|528609846|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
146573286|NCT01057693|528609844|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
146573287|NCT01057693|528609845|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
146573288|NCT01057693|528609846|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
146573289|NCT01057693|528609844|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
146573290|NCT01057693|528609845|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
146573291|NCT01057693|528609846|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
146573292|NCT02413996|528609847|FG000|Overall Study|not comfortable with the intervention|9|||
146573293|NCT02413996|528609848|FG001|Overall Study|not comfortable with the intervention|2|||
146573294|NCT00709319|528609849|FG000|Overall Study|Death|4|||
146573295|NCT00709319|528609849|FG000|Overall Study|Withdrawal by Subject|2|||
146573296|NCT00090779|528609853|FG000|Step 1|Withdrawal by Subject|4|||
146573297|NCT00090779|528609854|FG001|Step 1|Withdrawal by Subject|2|||
146573298|NCT00090779|528609853|FG000|Step 1|Lost to Follow-up|3|||
146573299|NCT00090779|528609854|FG001|Step 1|Lost to Follow-up|2|||
146573300|NCT00090779|528609853|FG000|Step 1|Death|0|||
146573301|NCT00090779|528609854|FG001|Step 1|Death|2|||
146573302|NCT00090779|528609853|FG000|Step 1|Physician Decision|1|||
146573303|NCT00090779|528609854|FG001|Step 1|Physician Decision|0|||
146573304|NCT00090779|528609853|FG000|Step 1|Pregnancy|1|||
146573305|NCT00090779|528609854|FG001|Step 1|Pregnancy|0|||
146573306|NCT00090779|528609853|FG000|Step 1|Non-compliance to study requirements|0|||
146573307|NCT00090779|528609854|FG001|Step 1|Non-compliance to study requirements|1|||
146573308|NCT00090779|528609853|FG000|Step 1|Subject relocated|2|||
146573309|NCT00090779|528609854|FG001|Step 1|Subject relocated|8|||
146573310|NCT00090779|528609853|FG000|Step 2|Off study per study closure|6|||
146573311|NCT00090779|528609854|FG001|Step 2|Off study per study closure|16|||
146573312|NCT00090779|528609853|FG000|Step 2|Subject relocated|0|||
146573313|NCT00090779|528609854|FG001|Step 2|Subject relocated|1|||
146573314|NCT00090779|528609853|FG000|Step 2|Non-compliance to study requirements|0|||
146573315|NCT00090779|528609854|FG001|Step 2|Non-compliance to study requirements|1|||
146573316|NCT00090779|528609853|FG000|Step 3|Initiation of ART and off extended study|3|||
146573317|NCT00090779|528609854|FG001|Step 3|Initiation of ART and off extended study|2|||
146573318|NCT00090779|528609853|FG000|Step 3|Off extended study due to study closure|4|||
146573319|NCT00090779|528609854|FG001|Step 3|Off extended study due to study closure|3|||
146573320|NCT04860869|528609861|FG000|Overall Study|Withdrawal by Subject|1|||
146573321|NCT04860869|528609862|FG001|Overall Study|Withdrawal by Subject|0|||
146573322|NCT00590967|528609866|FG000|Overall Study|Withdrawal by Subject|1|||
146573323|NCT00590967|528609867|FG001|Overall Study|Withdrawal by Subject|1|||
146573324|NCT00590967|528609866|FG000|Overall Study|Ineligible|1|||
146573325|NCT00590967|528609867|FG001|Overall Study|Ineligible|0|||
146573326|NCT00590967|528609866|FG000|Overall Study|Poor performance status|0|||
146573327|NCT00590967|528609867|FG001|Overall Study|Poor performance status|1|||
146573328|NCT00590967|528609866|FG000|Overall Study|Non-compliant|0|||
146573329|NCT00590967|528609867|FG001|Overall Study|Non-compliant|2|||
146573330|NCT00590967|528609866|FG000|Overall Study|Did not sign consent form|0|||
146917375|NCT05137041|529860127|FG000|Overall Study|Lost to Follow-up|1|||
146573331|NCT00590967|528609867|FG001|Overall Study|Did not sign consent form|1|||
146573332|NCT00590967|528609866|FG000|Overall Study|Did not receive chemo per protocol|1|||
146573333|NCT00590967|528609867|FG001|Overall Study|Did not receive chemo per protocol|0|||
146573334|NCT01881789|528609868|FG000|Overall Study|Withdrawal by Subject|0|||
146573335|NCT01881789|528609869|FG001|Overall Study|Withdrawal by Subject|2|||
146573336|NCT01881789|528609870|FG002|Overall Study|Withdrawal by Subject|1|||
146573337|NCT01881789|528609871|FG003|Overall Study|Withdrawal by Subject|0|||
146573338|NCT01881789|528609872|FG004|Overall Study|Withdrawal by Subject|1|||
146573339|NCT01881789|528609873|FG005|Overall Study|Withdrawal by Subject|1|||
146573340|NCT01881789|528609868|FG000|Overall Study|Study Terminated by Sponsor|0|||
146917376|NCT05137041|529860128|FG001|Overall Study|Lost to Follow-up|1|||
146917377|NCT05137041|529860127|FG000|Overall Study|Withdrawal by Subject|0|||
146917378|NCT05137041|529860128|FG001|Overall Study|Withdrawal by Subject|2|||
146917379|NCT05137041|529860127|FG000|Overall Study|Reason not Specified|0|||
146573341|NCT01881789|528609869|FG001|Overall Study|Study Terminated by Sponsor|0|||
146573342|NCT01881789|528609870|FG002|Overall Study|Study Terminated by Sponsor|0|||
146573343|NCT01881789|528609871|FG003|Overall Study|Study Terminated by Sponsor|0|||
146573344|NCT01881789|528609872|FG004|Overall Study|Study Terminated by Sponsor|0|||
146573345|NCT01881789|528609873|FG005|Overall Study|Study Terminated by Sponsor|1|||
146573346|NCT01881789|528609868|FG000|Overall Study|Other|3|||
146573347|NCT01881789|528609869|FG001|Overall Study|Other|5|||
146573348|NCT01881789|528609870|FG002|Overall Study|Other|2|||
146573349|NCT01881789|528609871|FG003|Overall Study|Other|3|||
146573350|NCT01881789|528609872|FG004|Overall Study|Other|1|||
146573351|NCT01881789|528609873|FG005|Overall Study|Other|1|||
146573352|NCT01151020|528609874|FG000|Overall Study|Death|25|||
146573353|NCT01151020|528609874|FG000|Overall Study|Conversion to open repair|1|||
146573354|NCT01151020|528609874|FG000|Overall Study|Lost to Follow-up|4|||
146573355|NCT01151020|528609874|FG000|Overall Study|Withdrawal by Subject|22|||
146573356|NCT01151020|528609874|FG000|Overall Study|Patients did not receive the device|2|||
146573357|NCT03606486|528609875|FG000|Overall Study|Unable to collect sample|5|||
146573358|NCT01737762|528609884|FG000|Overall Study|Adverse Event|2|||
146573359|NCT01737762|528609885|FG001|Overall Study|Adverse Event|2|||
146573360|NCT01737762|528609884|FG000|Overall Study|Lost to Follow-up|1|||
146573361|NCT01737762|528609885|FG001|Overall Study|Lost to Follow-up|0|||
146573362|NCT01737762|528609884|FG000|Overall Study|Withdrawal by Subject|2|||
146573363|NCT01737762|528609885|FG001|Overall Study|Withdrawal by Subject|2|||
146573364|NCT01737762|528609884|FG000|Overall Study|Progressive disease|1|||
146573365|NCT01737762|528609885|FG001|Overall Study|Progressive disease|2|||
146573366|NCT01737762|528609884|FG000|Overall Study|Physician Decision|1|||
146573367|NCT01737762|528609885|FG001|Overall Study|Physician Decision|1|||
146573368|NCT01737762|528609884|FG000|Overall Study|Moved from area|2|||
146573369|NCT01737762|528609885|FG001|Overall Study|Moved from area|1|||
146573370|NCT01737762|528609884|FG000|Overall Study|Trial termination|11|||
146573371|NCT01737762|528609885|FG001|Overall Study|Trial termination|9|||
146573372|NCT00503425|528609886|FG000|Overall Study|Participant files lost|6|||
146573373|NCT00503425|528609886|FG000|Overall Study|Adverse Event|5|||
146573374|NCT00503425|528609886|FG000|Overall Study|Lack of Efficacy|25|||
146573375|NCT00503425|528609886|FG000|Overall Study|Withdrawal by Subject|8|||
146573376|NCT00503425|528609886|FG000|Overall Study|Lost to Follow-up|3|||
146573377|NCT00503425|528609886|FG000|Overall Study|Death|3|||
146573378|NCT00503425|528609886|FG000|Overall Study|Missing Data/Unknown|4|||
146573379|NCT02148263|528609887|FG000|Overall Study|Withdrawal by Subject|3|||
146573380|NCT02148263|528609888|FG001|Overall Study|Withdrawal by Subject|2|||
146573381|NCT00003869|528609889|FG000|Overall Study|Adverse Event|14|||
146573382|NCT00003869|528609890|FG001|Overall Study|Adverse Event|3|||
146573383|NCT00003869|528609889|FG000|Overall Study|Withdrawal by Subject|21|||
146573384|NCT00003869|528609890|FG001|Overall Study|Withdrawal by Subject|3|||
146573385|NCT00003869|528609889|FG000|Overall Study|Death|1|||
146573386|NCT00003869|528609890|FG001|Overall Study|Death|2|||
146573387|NCT00003869|528609889|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
146573388|NCT00003869|528609890|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
146573389|NCT01964378|528609891|FG000|Overall Study|Disc. due to death before first dosing|0|||
146573390|NCT01964378|528609892|FG001|Overall Study|Disc. due to death before first dosing|1|||
146573391|NCT01964378|528609891|FG000|Overall Study|Disc. due to AE before first dosing|1|||
146573392|NCT01964378|528609892|FG001|Overall Study|Disc. due to AE before first dosing|0|||
146573393|NCT01964378|528609891|FG000|Overall Study|Death|3|||
146573394|NCT01964378|528609892|FG001|Overall Study|Death|2|||
146573395|NCT01964378|528609891|FG000|Overall Study|Adverse Event|12|||
146573396|NCT01964378|528609892|FG001|Overall Study|Adverse Event|5|||
146573397|NCT01964378|528609891|FG000|Overall Study|Lack of Efficacy|0|||
146573398|NCT01964378|528609892|FG001|Overall Study|Lack of Efficacy|1|||
146917380|NCT05137041|529860128|FG001|Overall Study|Reason not Specified|1|||
146917381|NCT02090114|529860129|FG000|Overall Study|Withdrawal by Subject|3|||
146573399|NCT01964378|528609891|FG000|Overall Study|Protocol Violation|0|||
146573400|NCT01964378|528609892|FG001|Overall Study|Protocol Violation|1|||
146573401|NCT01964378|528609891|FG000|Overall Study|Lost to Follow-up|0|||
146573402|NCT01964378|528609892|FG001|Overall Study|Lost to Follow-up|1|||
146573403|NCT01964378|528609891|FG000|Overall Study|Withdrawal by Subject|7|||
146573404|NCT01964378|528609892|FG001|Overall Study|Withdrawal by Subject|5|||
146573405|NCT01964378|528609891|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
146573406|NCT01964378|528609892|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
146573407|NCT01964378|528609891|FG000|Overall Study|Other|1|||
146573408|NCT01964378|528609892|FG001|Overall Study|Other|2|||
146573409|NCT00326599|528609893|FG000|Overall Study|Withdrawal by Subject|1|||
146573410|NCT00326599|528609894|FG001|Overall Study|Withdrawal by Subject|0|||
146573411|NCT00326599|528609895|FG002|Overall Study|Withdrawal by Subject|5|||
146573412|NCT00326599|528609896|FG003|Overall Study|Withdrawal by Subject|2|||
146573413|NCT00326599|528609893|FG000|Overall Study|Adverse Event|1|||
146573414|NCT00326599|528609894|FG001|Overall Study|Adverse Event|0|||
146573415|NCT00326599|528609895|FG002|Overall Study|Adverse Event|32|||
146573416|NCT00326599|528609896|FG003|Overall Study|Adverse Event|3|||
146573417|NCT00326599|528609893|FG000|Overall Study|Disease Progression|3|||
146573418|NCT00326599|528609894|FG001|Overall Study|Disease Progression|1|||
146573419|NCT00326599|528609895|FG002|Overall Study|Disease Progression|13|||
146573420|NCT00326599|528609896|FG003|Overall Study|Disease Progression|11|||
146573421|NCT00326599|528609893|FG000|Overall Study|Alternate Treatment|1|||
146573422|NCT00326599|528609894|FG001|Overall Study|Alternate Treatment|0|||
146573423|NCT00326599|528609895|FG002|Overall Study|Alternate Treatment|0|||
146573424|NCT00326599|528609896|FG003|Overall Study|Alternate Treatment|0|||
146573425|NCT00326599|528609893|FG000|Overall Study|Death|0|||
146573426|NCT00326599|528609894|FG001|Overall Study|Death|0|||
146573427|NCT00326599|528609895|FG002|Overall Study|Death|1|||
146573428|NCT00326599|528609896|FG003|Overall Study|Death|2|||
146573429|NCT00326599|528609893|FG000|Overall Study|Other Unspecified Reason|0|||
146573430|NCT00326599|528609894|FG001|Overall Study|Other Unspecified Reason|0|||
146573431|NCT00326599|528609895|FG002|Overall Study|Other Unspecified Reason|2|||
146573432|NCT00326599|528609896|FG003|Overall Study|Other Unspecified Reason|1|||
146573433|NCT03364231|528609897|FG000|Overall Study|Adverse Event|1|||
146573434|NCT03364231|528609898|FG001|Overall Study|Adverse Event|4|||
146573435|NCT03364231|528609897|FG000|Overall Study|Death|1|||
146573436|NCT03364231|528609898|FG001|Overall Study|Death|0|||
146573437|NCT03364231|528609897|FG000|Overall Study|Investigator Decision|2|||
146573438|NCT03364231|528609898|FG001|Overall Study|Investigator Decision|2|||
146573439|NCT03364231|528609897|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
146573440|NCT03364231|528609898|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
146573441|NCT03364231|528609897|FG000|Overall Study|Withdrawal of Subject Consent|1|||
146573442|NCT03364231|528609898|FG001|Overall Study|Withdrawal of Subject Consent|0|||
146573443|NCT03364231|528609897|FG000|Overall Study|Reason Not Specified|1|||
146573444|NCT03364231|528609898|FG001|Overall Study|Reason Not Specified|0|||
146573445|NCT03364231|528609897|FG000|Overall Study|Disease Progression|0|||
146573446|NCT03364231|528609898|FG001|Overall Study|Disease Progression|6|||
146573447|NCT02503085|528609904|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
146573448|NCT02503085|528609905|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
146573449|NCT02503085|528609906|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
146573450|NCT02503085|528609907|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
146573451|NCT01162473|528609909|FG000|Overall Study|Adverse Event|2|||
146573452|NCT01162473|528609910|FG001|Overall Study|Adverse Event|1|||
146573453|NCT01162473|528609909|FG000|Overall Study|Withdrawal by Subject|0|||
146573454|NCT01162473|528609910|FG001|Overall Study|Withdrawal by Subject|4|||
146573455|NCT03328832|528609911|FG000|Overall Study|Lost to Follow-up|0|||
146573456|NCT03328832|528609912|FG001|Overall Study|Lost to Follow-up|1|||
146573457|NCT02012218|528609918|FG000|Overall Study|Withdrawal by Subject|1|||
146573458|NCT02012218|528609919|FG001|Overall Study|Withdrawal by Subject|0|||
146573459|NCT02012218|528609920|FG002|Overall Study|Withdrawal by Subject|1|||
146573460|NCT02012218|528609921|FG003|Overall Study|Withdrawal by Subject|1|||
146573461|NCT02012218|528609922|FG004|Overall Study|Withdrawal by Subject|1|||
146573462|NCT02012218|528609918|FG000|Overall Study|Adverse Event|1|||
146573463|NCT02012218|528609919|FG001|Overall Study|Adverse Event|0|||
146573464|NCT02012218|528609920|FG002|Overall Study|Adverse Event|0|||
146573465|NCT02012218|528609921|FG003|Overall Study|Adverse Event|1|||
146573466|NCT02012218|528609922|FG004|Overall Study|Adverse Event|0|||
146573467|NCT02012218|528609918|FG000|Overall Study|Lost to Follow-up|0|||
146573468|NCT02012218|528609919|FG001|Overall Study|Lost to Follow-up|1|||
146573469|NCT02012218|528609920|FG002|Overall Study|Lost to Follow-up|1|||
146573470|NCT02012218|528609921|FG003|Overall Study|Lost to Follow-up|0|||
146573471|NCT02012218|528609922|FG004|Overall Study|Lost to Follow-up|0|||
146573472|NCT02012218|528609918|FG000|Overall Study|Protocol Specified|1|||
146573473|NCT02012218|528609919|FG001|Overall Study|Protocol Specified|0|||
146573474|NCT02012218|528609920|FG002|Overall Study|Protocol Specified|0|||
146573475|NCT02012218|528609921|FG003|Overall Study|Protocol Specified|0|||
146573476|NCT02012218|528609922|FG004|Overall Study|Protocol Specified|0|||
146573477|NCT02012218|528609918|FG000|Overall Study|Protocol Deviation|1|||
146573478|NCT02012218|528609919|FG001|Overall Study|Protocol Deviation|0|||
146573479|NCT02012218|528609920|FG002|Overall Study|Protocol Deviation|0|||
146573480|NCT02012218|528609921|FG003|Overall Study|Protocol Deviation|0|||
146573481|NCT02012218|528609922|FG004|Overall Study|Protocol Deviation|0|||
146573482|NCT04951622|528609925|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
146573483|NCT04951622|528609926|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
146573484|NCT04951622|528609927|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
146573485|NCT04951622|528609928|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
146573486|NCT04951622|528609929|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
146573487|NCT04951622|528609925|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
146573488|NCT04951622|528609926|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
146573489|NCT04951622|528609927|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
146651792|NCT01431638|528902284|FG000|Overall Study|Participants condition no longer requires study drug|0|||
146651793|NCT01431638|528902285|FG001|Overall Study|Participants condition no longer requires study drug|1|||
146651794|NCT01431638|528902286|FG002|Overall Study|Participants condition no longer requires study drug|0|||
146651795|NCT01431638|528902284|FG000|Overall Study|Participant withdrew consent|14|||
146651796|NCT01431638|528902285|FG001|Overall Study|Participant withdrew consent|5|||
146651797|NCT01431638|528902286|FG002|Overall Study|Participant withdrew consent|8|||
146651798|NCT01431638|528902284|FG000|Overall Study|Lost to Follow-up|7|||
146651799|NCT01431638|528902285|FG001|Overall Study|Lost to Follow-up|9|||
146651800|NCT01431638|528902286|FG002|Overall Study|Lost to Follow-up|7|||
146651801|NCT01431638|528902284|FG000|Overall Study|Administrative problems|1|||
146651802|NCT01431638|528902285|FG001|Overall Study|Administrative problems|4|||
146573490|NCT04951622|528609928|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
146573491|NCT04951622|528609929|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
146573492|NCT04951622|528609925|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
146573493|NCT04951622|528609926|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
146573494|NCT04951622|528609927|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
146651803|NCT01431638|528902286|FG002|Overall Study|Administrative problems|6|||
146651804|NCT01431638|528902284|FG000|Overall Study|Death|1|||
146651805|NCT01431638|528902285|FG001|Overall Study|Death|0|||
146651806|NCT01431638|528902286|FG002|Overall Study|Death|0|||
146651807|NCT01431638|528902284|FG000|Overall Study|Protocol deviation|1|||
146651808|NCT01431638|528902285|FG001|Overall Study|Protocol deviation|1|||
146573495|NCT04951622|528609928|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
146573496|NCT04951622|528609929|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
146573497|NCT04951622|528609925|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
146573498|NCT04951622|528609926|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
146573499|NCT04951622|528609927|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
146573500|NCT04951622|528609928|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
146573501|NCT04951622|528609929|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
146573502|NCT04951622|528609925|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
146573503|NCT04951622|528609926|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
146573504|NCT04951622|528609927|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
146573505|NCT04951622|528609928|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
146573506|NCT04951622|528609929|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
146573507|NCT04951622|528609925|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
146573508|NCT04951622|528609926|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
146573509|NCT04951622|528609927|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
146573510|NCT04951622|528609928|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
146573511|NCT04951622|528609929|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
146573512|NCT04951622|528609925|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
146573513|NCT04951622|528609926|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
146573514|NCT04951622|528609927|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
146573515|NCT04951622|528609928|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
146573516|NCT04951622|528609929|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
146573517|NCT04951622|528609925|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
146573518|NCT04951622|528609926|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
146573519|NCT04951622|528609927|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
146573520|NCT04951622|528609928|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
146573521|NCT04951622|528609929|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
146573522|NCT04951622|528609925|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
146573523|NCT04951622|528609926|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
146573524|NCT04951622|528609927|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
146573525|NCT04951622|528609928|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
146573526|NCT04951622|528609929|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
146573527|NCT04951622|528609925|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
146573528|NCT04951622|528609926|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
146573529|NCT04951622|528609927|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
146573530|NCT04951622|528609928|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
146573531|NCT04951622|528609929|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
146573532|NCT04951622|528609925|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
146573533|NCT04951622|528609926|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
146573534|NCT04951622|528609927|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
146573535|NCT04951622|528609928|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
146573536|NCT04951622|528609929|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
146573537|NCT04951622|528609925|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
146573538|NCT04951622|528609926|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
146651809|NCT01431638|528902286|FG002|Overall Study|Protocol deviation|4|||
146651810|NCT01431638|528902284|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
146651811|NCT01431638|528902285|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
146651812|NCT01431638|528902286|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
146651813|NCT01261780|528902287|FG000|Overall Study|Withdrawal by Subject|1|||
146651814|NCT01261780|528902288|FG001|Overall Study|Withdrawal by Subject|0|||
146651815|NCT01261780|528902287|FG000|Overall Study|Event not related to subject|1|||
146651816|NCT01261780|528902288|FG001|Overall Study|Event not related to subject|2|||
146651817|NCT03400956|528902290|FG000|Treatment Period 1|Adverse Event|0|||
146651818|NCT03400956|528902291|FG001|Treatment Period 1|Adverse Event|1|||
146651819|NCT03400956|528902292|FG002|Treatment Period 1|Adverse Event|0|||
146651820|NCT03400956|528902290|FG000|Treatment Period 1|Lost to Follow-up|0|||
146651821|NCT03400956|528902291|FG001|Treatment Period 1|Lost to Follow-up|0|||
146651822|NCT03400956|528902292|FG002|Treatment Period 1|Lost to Follow-up|1|||
146651823|NCT03400956|528902290|FG000|Treatment Period 1|Protocol Violation|0|||
146651824|NCT03400956|528902291|FG001|Treatment Period 1|Protocol Violation|2|||
146651825|NCT03400956|528902292|FG002|Treatment Period 1|Protocol Violation|0|||
146651826|NCT03400956|528902290|FG000|Treatment Period 1|Study terminated by sponsor|3|||
146651827|NCT03400956|528902291|FG001|Treatment Period 1|Study terminated by sponsor|1|||
146651828|NCT03400956|528902292|FG002|Treatment Period 1|Study terminated by sponsor|1|||
146651829|NCT03400956|528902290|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146917382|NCT02090114|529860130|FG001|Overall Study|Withdrawal by Subject|6|||
146917383|NCT02090114|529860131|FG002|Overall Study|Withdrawal by Subject|2|||
146917384|NCT02090114|529860132|FG003|Overall Study|Withdrawal by Subject|1|||
146573539|NCT04951622|528609927|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
146573540|NCT04951622|528609928|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
146573541|NCT04951622|528609929|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
146573542|NCT04951622|528609925|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
146573543|NCT04951622|528609926|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
146573544|NCT04951622|528609927|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
146573545|NCT04951622|528609928|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
146573546|NCT04951622|528609929|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
146573547|NCT04951622|528609925|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
146573548|NCT04951622|528609926|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
146573549|NCT04951622|528609927|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
146573550|NCT04951622|528609928|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
146573551|NCT04951622|528609929|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
146573552|NCT04951622|528609925|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
146573553|NCT04951622|528609926|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
146573554|NCT04951622|528609927|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
146573555|NCT04951622|528609928|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
146573556|NCT04951622|528609929|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
146573557|NCT04951622|528609925|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
146573558|NCT04951622|528609926|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
146573559|NCT04951622|528609927|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
146573560|NCT04951622|528609928|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
146573561|NCT04951622|528609929|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
146573562|NCT04951622|528609925|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
146573563|NCT04951622|528609926|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
146573564|NCT04951622|528609927|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
146573565|NCT04951622|528609928|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
146573566|NCT04951622|528609929|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
146573567|NCT04951622|528609925|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
146573568|NCT04951622|528609926|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
146573569|NCT04951622|528609927|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
146573570|NCT04951622|528609928|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
146573571|NCT04951622|528609929|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
146651830|NCT03400956|528902291|FG001|Treatment Period 1|Withdrawal by Subject|2|||
146651831|NCT03400956|528902292|FG002|Treatment Period 1|Withdrawal by Subject|4|||
146651832|NCT03400956|528902290|FG000|Treatment Period 1|Other|1|||
146651833|NCT03400956|528902291|FG001|Treatment Period 1|Other|2|||
146651834|NCT03400956|528902292|FG002|Treatment Period 1|Other|3|||
146651835|NCT03400956|528902290|FG000|Post-treatment Period 1|Adverse Event|0|||
146651836|NCT03400956|528902291|FG001|Post-treatment Period 1|Adverse Event|0|||
146651837|NCT03400956|528902292|FG002|Post-treatment Period 1|Adverse Event|1|||
146651838|NCT03400956|528902290|FG000|Post-treatment Period 1|Physician Decision|2|||
146651839|NCT03400956|528902291|FG001|Post-treatment Period 1|Physician Decision|3|||
146651840|NCT03400956|528902292|FG002|Post-treatment Period 1|Physician Decision|0|||
146651841|NCT03400956|528902290|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
146573572|NCT04951622|528609925|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
146573573|NCT04951622|528609926|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
146917385|NCT02090114|529860129|FG000|Overall Study|Physician Decision|5|||
146917386|NCT02090114|529860130|FG001|Overall Study|Physician Decision|0|||
146917387|NCT02090114|529860131|FG002|Overall Study|Physician Decision|1|||
146917388|NCT02090114|529860132|FG003|Overall Study|Physician Decision|1|||
146917389|NCT02090114|529860129|FG000|Overall Study|Adverse Event|1|||
146917390|NCT02090114|529860130|FG001|Overall Study|Adverse Event|2|||
146917391|NCT02090114|529860131|FG002|Overall Study|Adverse Event|2|||
146573574|NCT04951622|528609927|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
146573575|NCT04951622|528609928|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
146573576|NCT04951622|528609929|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
146573577|NCT04951622|528609925|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
146573578|NCT04951622|528609926|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
146573579|NCT04951622|528609927|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
146573580|NCT04951622|528609928|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
146573581|NCT04951622|528609929|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
146573582|NCT04267926|528611417|FG000|Overall Study|abnormal labs. No longer eligible|0|||
146573583|NCT04267926|528611418|FG001|Overall Study|abnormal labs. No longer eligible|0|||
146573584|NCT04267926|528611419|FG002|Overall Study|abnormal labs. No longer eligible|1|||
146573585|NCT04267926|528611417|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
146573586|NCT04267926|528611418|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
146573587|NCT04267926|528611419|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
146573588|NCT02489318|528611422|FG000|Randomized|Withdrawal by Subject|0|||
146573589|NCT02489318|528611423|FG001|Randomized|Withdrawal by Subject|1|||
146573590|NCT02489318|528611422|FG000|Treated|Adverse Event|19|||
146573591|NCT02489318|528611423|FG001|Treated|Adverse Event|62|||
146573592|NCT02489318|528611422|FG000|Treated|Death|13|||
146573593|NCT02489318|528611423|FG001|Treated|Death|11|||
146573594|NCT02489318|528611422|FG000|Treated|Physician Decision|4|||
146573595|NCT02489318|528611423|FG001|Treated|Physician Decision|6|||
146573596|NCT02489318|528611422|FG000|Treated|Protocol Violation|1|||
146573597|NCT02489318|528611423|FG001|Treated|Protocol Violation|2|||
146573598|NCT02489318|528611422|FG000|Treated|Withdrawal by Subject|37|||
146573599|NCT02489318|528611423|FG001|Treated|Withdrawal by Subject|36|||
146573600|NCT02489318|528611422|FG000|Treated|Other: Progressive Disease|245|||
146573601|NCT02489318|528611423|FG001|Treated|Other: Progressive Disease|138|||
146573602|NCT02489318|528611422|FG000|Treated|Other|0|||
146573603|NCT02489318|528611423|FG001|Treated|Other|2|||
146573604|NCT02489318|528611422|FG000|Treated|Ongoing|0|||
146573605|NCT02489318|528611423|FG001|Treated|Ongoing|267|||
146573606|NCT01306643|528611424|FG000|Overall Study|Adverse Event|5|||
146573607|NCT01306643|528611424|FG000|Overall Study|Disease Progression|7|||
146573608|NCT01306643|528611424|FG000|Overall Study|Other: Change in Eligibility Status|1|||
146573609|NCT02479880|528611427|FG000|Overall Study|Study Terminated by Sponsor|13|||
146573610|NCT02479880|528611428|FG001|Overall Study|Study Terminated by Sponsor|12|||
146573611|NCT02479880|528611427|FG000|Overall Study|Pregnancy|0|||
146573612|NCT02479880|528611428|FG001|Overall Study|Pregnancy|1|||
146573613|NCT00355368|528611429|FG000|Overall Study|Protocol Violation|8|||
146573614|NCT00355368|528611430|FG001|Overall Study|Protocol Violation|7|||
146573615|NCT00355368|528611429|FG000|Overall Study|cardiac arrest prior to intubation|2|||
146573616|NCT00355368|528611430|FG001|Overall Study|cardiac arrest prior to intubation|2|||
146573617|NCT03801928|528611431|FG000|Overall Study|Adverse Event|1|||
146573618|NCT03801928|528611432|FG001|Overall Study|Adverse Event|0|||
146573619|NCT03801928|528611433|FG002|Overall Study|Adverse Event|1|||
146573620|NCT03801928|528611434|FG003|Overall Study|Adverse Event|2|||
146573621|NCT03801928|528611435|FG004|Overall Study|Adverse Event|0|||
146573622|NCT03801928|528611436|FG005|Overall Study|Adverse Event|2|||
146573623|NCT03801928|528611431|FG000|Overall Study|Lack of Efficacy|0|||
146573624|NCT03801928|528611432|FG001|Overall Study|Lack of Efficacy|0|||
146573625|NCT03801928|528611433|FG002|Overall Study|Lack of Efficacy|1|||
146573626|NCT03801928|528611434|FG003|Overall Study|Lack of Efficacy|0|||
146573627|NCT03801928|528611435|FG004|Overall Study|Lack of Efficacy|0|||
146573628|NCT03801928|528611436|FG005|Overall Study|Lack of Efficacy|0|||
146917392|NCT02090114|529860132|FG003|Overall Study|Adverse Event|0|||
146917393|NCT02090114|529860129|FG000|Overall Study|Progressive Disease|20|||
146573629|NCT03801928|528611431|FG000|Overall Study|Lost to Follow-up|5|||
146573630|NCT03801928|528611432|FG001|Overall Study|Lost to Follow-up|1|||
146573631|NCT03801928|528611433|FG002|Overall Study|Lost to Follow-up|1|||
146573632|NCT03801928|528611434|FG003|Overall Study|Lost to Follow-up|4|||
146573633|NCT03801928|528611435|FG004|Overall Study|Lost to Follow-up|4|||
146573634|NCT03801928|528611436|FG005|Overall Study|Lost to Follow-up|2|||
146573635|NCT03801928|528611431|FG000|Overall Study|Withdrawal by Subject|0|||
146917394|NCT02090114|529860130|FG001|Overall Study|Progressive Disease|21|||
146651842|NCT03400956|528902291|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
146651843|NCT03400956|528902292|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
146573636|NCT03801928|528611432|FG001|Overall Study|Withdrawal by Subject|0|||
146573637|NCT03801928|528611433|FG002|Overall Study|Withdrawal by Subject|2|||
146573638|NCT03801928|528611434|FG003|Overall Study|Withdrawal by Subject|1|||
146573639|NCT03801928|528611435|FG004|Overall Study|Withdrawal by Subject|0|||
146573640|NCT03801928|528611436|FG005|Overall Study|Withdrawal by Subject|0|||
146573641|NCT03801928|528611431|FG000|Overall Study|Other|0|||
146651844|NCT03400956|528902290|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
146651845|NCT03400956|528902291|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
146573642|NCT03801928|528611432|FG001|Overall Study|Other|2|||
146573643|NCT03801928|528611433|FG002|Overall Study|Other|0|||
146573644|NCT03801928|528611434|FG003|Overall Study|Other|1|||
146573645|NCT03801928|528611435|FG004|Overall Study|Other|0|||
146573646|NCT03801928|528611436|FG005|Overall Study|Other|1|||
146573647|NCT02370368|528611439|FG000|Overall Study|Adverse Event|1|||
146573648|NCT02370368|528611440|FG001|Overall Study|Adverse Event|2|||
146573649|NCT02370368|528611439|FG000|Overall Study|Withdrawal by Subject|5|||
146573650|NCT02370368|528611440|FG001|Overall Study|Withdrawal by Subject|4|||
146573651|NCT03369665|528611441|FG000|Overall Study|Adverse Event|3|||
146573652|NCT03369665|528611441|FG000|Overall Study|Lost to Follow-up|7|||
146573653|NCT03369665|528611441|FG000|Overall Study|Withdrawal by Subject|15|||
146573654|NCT03369665|528611441|FG000|Overall Study|Progression Disease|2|||
146573655|NCT03369665|528611441|FG000|Overall Study|Not classified|3|||
146573656|NCT05197049|528611442|FG000|Overall Study|Death|0|||
146573657|NCT05197049|528611443|FG001|Overall Study|Death|1|||
146573658|NCT05197049|528611444|FG002|Overall Study|Death|0|||
146573659|NCT05197049|528611442|FG000|Overall Study|Lost to Follow-up|3|||
146573660|NCT05197049|528611443|FG001|Overall Study|Lost to Follow-up|1|||
146573661|NCT05197049|528611444|FG002|Overall Study|Lost to Follow-up|0|||
146573662|NCT05197049|528611442|FG000|Overall Study|Withdrawal by Subject|15|||
146573663|NCT05197049|528611443|FG001|Overall Study|Withdrawal by Subject|3|||
146573664|NCT05197049|528611444|FG002|Overall Study|Withdrawal by Subject|1|||
146573665|NCT05197049|528611442|FG000|Overall Study|GCP non-compliance|1|||
146573666|NCT05197049|528611443|FG001|Overall Study|GCP non-compliance|2|||
146573667|NCT05197049|528611444|FG002|Overall Study|GCP non-compliance|0|||
146573668|NCT00579553|528611445|FG000|Overall Study|Lost to Follow-up|16|||
146573669|NCT00579553|528611446|FG001|Overall Study|Lost to Follow-up|13|||
146573670|NCT03748641|528611447|FG000|Overall Study|Ongoing|155|||
146573671|NCT03748641|528611448|FG001|Overall Study|Ongoing|148|||
146573672|NCT03748641|528611449|FG002|Overall Study|Ongoing|66|||
146573673|NCT03748641|528611450|FG003|Overall Study|Ongoing|79|||
146573674|NCT03748641|528611451|FG004|Overall Study|Ongoing|84|||
146573675|NCT03748641|528611447|FG000|Overall Study|Death|54|||
146573676|NCT03748641|528611448|FG001|Overall Study|Death|59|||
146573677|NCT03748641|528611449|FG002|Overall Study|Death|51|||
146573678|NCT03748641|528611450|FG003|Overall Study|Death|42|||
146573679|NCT03748641|528611451|FG004|Overall Study|Death|9|||
146573680|NCT03748641|528611447|FG000|Overall Study|Lost to Follow-up|0|||
146573681|NCT03748641|528611448|FG001|Overall Study|Lost to Follow-up|2|||
146573682|NCT03748641|528611449|FG002|Overall Study|Lost to Follow-up|1|||
146573683|NCT03748641|528611450|FG003|Overall Study|Lost to Follow-up|0|||
146573684|NCT03748641|528611451|FG004|Overall Study|Lost to Follow-up|0|||
146573685|NCT03748641|528611447|FG000|Overall Study|Withdrawal by Subject|3|||
146573686|NCT03748641|528611448|FG001|Overall Study|Withdrawal by Subject|2|||
146573687|NCT03748641|528611449|FG002|Overall Study|Withdrawal by Subject|5|||
146573688|NCT03748641|528611450|FG003|Overall Study|Withdrawal by Subject|3|||
146573689|NCT03748641|528611451|FG004|Overall Study|Withdrawal by Subject|2|||
146573690|NCT04834726|528611452|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
146573691|NCT04834726|528611453|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
146573692|NCT04834726|528611454|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
146573693|NCT04834726|528611455|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
146573694|NCT04834726|528611456|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
146573695|NCT04834726|528611457|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
146573696|NCT04834726|528611458|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
146573697|NCT04834726|528611459|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
146573698|NCT04834726|528611460|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
146651846|NCT03400956|528902292|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
146573699|NCT01144416|528611472|FG000|Intervention Period|Adverse Event|5|||
146573700|NCT01144416|528611473|FG001|Intervention Period|Adverse Event|6|||
146573701|NCT01144416|528611472|FG000|Intervention Period|Insufficient ovarian response|11|||
146573702|NCT01144416|528611473|FG001|Intervention Period|Insufficient ovarian response|17|||
146573703|NCT01144416|528611472|FG000|Intervention Period|Risk of OHSS|0|||
146651847|NCT03400956|528902290|FG000|Post-treatment Period 1|Other|4|||
146651848|NCT03400956|528902291|FG001|Post-treatment Period 1|Other|3|||
146573704|NCT01144416|528611473|FG001|Intervention Period|Risk of OHSS|1|||
146573705|NCT01144416|528611472|FG000|Intervention Period|Too high ovarian response|4|||
146573706|NCT01144416|528611473|FG001|Intervention Period|Too high ovarian response|2|||
146573707|NCT01144416|528611472|FG000|Intervention Period|No/too few/bad oocytes|7|||
146573708|NCT01144416|528611473|FG001|Intervention Period|No/too few/bad oocytes|5|||
146573709|NCT01144416|528611472|FG000|Intervention Period|No or abnormal fertilization|25|||
146573710|NCT01144416|528611473|FG001|Intervention Period|No or abnormal fertilization|10|||
146573711|NCT01144416|528611472|FG000|Intervention Period|No/too few/bad quality embryos|3|||
146573712|NCT01144416|528611473|FG001|Intervention Period|No/too few/bad quality embryos|3|||
146573713|NCT01144416|528611472|FG000|Intervention Period|Other|7|||
146573714|NCT01144416|528611473|FG001|Intervention Period|Other|5|||
146573715|NCT00124072|528611474|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
146573716|NCT00124072|528611475|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
146573717|NCT00124072|528611476|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
146573718|NCT00124072|528611477|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
146573719|NCT00124072|528611474|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
146573720|NCT00124072|528611475|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
146573721|NCT00124072|528611476|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
146573722|NCT00124072|528611477|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
146573723|NCT00124072|528611474|FG000|Overall Study|Death|499|||
146573724|NCT00124072|528611475|FG001|Overall Study|Death|484|||
146573725|NCT00124072|528611476|FG002|Overall Study|Death|471|||
146573726|NCT00124072|528611477|FG003|Overall Study|Death|480|||
146573727|NCT04872569|528611478|FG000|Overall Study|Withdrawal by Subject|2|||
146573728|NCT04417257|528611479|FG000|Pilot Phase 2|Adverse Event|2|||
146573729|NCT04417257|528611480|FG001|Pilot Phase 2|Adverse Event|0|||
146573730|NCT04417257|528611479|FG000|Pilot Phase 2|Death|14|||
146573731|NCT04417257|528611480|FG001|Pilot Phase 2|Death|11|||
146573732|NCT04417257|528611479|FG000|Pilot Phase 2|Lost to Follow-up|3|||
146573733|NCT04417257|528611480|FG001|Pilot Phase 2|Lost to Follow-up|5|||
146573734|NCT04417257|528611479|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
146573735|NCT04417257|528611480|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
146573736|NCT04417257|528611479|FG000|Pilot Phase 2|Hepatic impairment|1|||
146573737|NCT04417257|528611480|FG001|Pilot Phase 2|Hepatic impairment|0|||
146573738|NCT04417257|528611479|FG000|Pilot Phase 2|Unblinding|1|||
146573739|NCT04417257|528611480|FG001|Pilot Phase 2|Unblinding|0|||
146573740|NCT04417257|528611479|FG000|Pilot Phase 2|All other|0|||
146573741|NCT04417257|528611480|FG001|Pilot Phase 2|All other|2|||
146573742|NCT04417257|528611479|FG000|Phase 3 Extension|Death|3|||
146573743|NCT04417257|528611480|FG001|Phase 3 Extension|Death|1|||
146573744|NCT04417257|528611479|FG000|Phase 3 Extension|Lost to Follow-up|4|||
146573745|NCT04417257|528611480|FG001|Phase 3 Extension|Lost to Follow-up|2|||
146573746|NCT04417257|528611479|FG000|Phase 3 Extension|Patient withdrawal|2|||
146573747|NCT04417257|528611480|FG001|Phase 3 Extension|Patient withdrawal|2|||
146573748|NCT04417257|528611479|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
146573749|NCT04417257|528611480|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
146573750|NCT00714948|528611486|FG000|Overall Study|Adverse Event|2|||
146573751|NCT02708680|528611489|FG000|Overall Study|Withdrawal by Subject|4|||
146573752|NCT02708680|528611490|FG001|Overall Study|Withdrawal by Subject|12|||
146573753|NCT02708680|528611491|FG002|Overall Study|Withdrawal by Subject|12|||
146573754|NCT02708680|528611489|FG000|Overall Study|Death|4|||
146573755|NCT02708680|528611490|FG001|Overall Study|Death|19|||
146573756|NCT02708680|528611491|FG002|Overall Study|Death|21|||
146573757|NCT02708680|528611489|FG000|Overall Study|Lost to Follow-up|0|||
146573758|NCT02708680|528611490|FG001|Overall Study|Lost to Follow-up|3|||
146573759|NCT02708680|528611491|FG002|Overall Study|Lost to Follow-up|3|||
146573760|NCT02708680|528611489|FG000|Overall Study|Study Terminated By Sponsor|0|||
146573761|NCT02708680|528611490|FG001|Overall Study|Study Terminated By Sponsor|5|||
146573762|NCT02708680|528611491|FG002|Overall Study|Study Terminated By Sponsor|4|||
146573763|NCT02708680|528611489|FG000|Overall Study|Other than Specified|0|||
146573764|NCT02708680|528611490|FG001|Overall Study|Other than Specified|0|||
146573765|NCT02708680|528611491|FG002|Overall Study|Other than Specified|1|||
146573766|NCT02708680|528611489|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
146573767|NCT02708680|528611490|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
146573768|NCT02708680|528611491|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
146573769|NCT01342926|528611492|FG000|Overall Study|Adverse Event|5|||
146573770|NCT01342926|528611493|FG001|Overall Study|Adverse Event|8|||
146573771|NCT01342926|528611494|FG002|Overall Study|Adverse Event|10|||
146573772|NCT01342926|528611495|FG003|Overall Study|Adverse Event|7|||
146573773|NCT01342926|528611492|FG000|Overall Study|Lost to Follow-up|0|||
146573774|NCT01342926|528611493|FG001|Overall Study|Lost to Follow-up|1|||
146573775|NCT01342926|528611494|FG002|Overall Study|Lost to Follow-up|1|||
146573776|NCT01342926|528611495|FG003|Overall Study|Lost to Follow-up|0|||
146573777|NCT01342926|528611492|FG000|Overall Study|Investigator Discretion|2|||
146573778|NCT01342926|528611493|FG001|Overall Study|Investigator Discretion|2|||
146573779|NCT01342926|528611494|FG002|Overall Study|Investigator Discretion|0|||
146573780|NCT01342926|528611495|FG003|Overall Study|Investigator Discretion|0|||
146573781|NCT01342926|528611492|FG000|Overall Study|Withdrawal by Subject|2|||
146573782|NCT01342926|528611493|FG001|Overall Study|Withdrawal by Subject|4|||
146573783|NCT01342926|528611494|FG002|Overall Study|Withdrawal by Subject|3|||
146573784|NCT01342926|528611495|FG003|Overall Study|Withdrawal by Subject|5|||
146573785|NCT03390504|528611500|FG000|Overall Study|Lost to Follow-up|2|||
146573786|NCT03390504|528611501|FG001|Overall Study|Lost to Follow-up|4|||
146573787|NCT03390504|528611502|FG002|Overall Study|Lost to Follow-up|0|||
146573788|NCT03390504|528611503|FG003|Overall Study|Lost to Follow-up|1|||
146573789|NCT03390504|528611500|FG000|Overall Study|Withdrawal by Subject|3|||
146573790|NCT03390504|528611501|FG001|Overall Study|Withdrawal by Subject|15|||
146573791|NCT03390504|528611502|FG002|Overall Study|Withdrawal by Subject|5|||
146573792|NCT03390504|528611503|FG003|Overall Study|Withdrawal by Subject|2|||
146573793|NCT03390504|528611500|FG000|Overall Study|Other|1|||
146573794|NCT03390504|528611501|FG001|Overall Study|Other|2|||
146573795|NCT03390504|528611502|FG002|Overall Study|Other|2|||
146573796|NCT03390504|528611503|FG003|Overall Study|Other|6|||
146573797|NCT00980538|528611504|FG000|Overall Study|Lost to Follow-up|20|||
146573798|NCT00980538|528611504|FG000|Overall Study|Sponsor's Decision|4|||
146573799|NCT00980538|528611504|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
146573800|NCT00980538|528611504|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
146573801|NCT00980538|528611504|FG000|Overall Study|Switch to Commercially Available Medication|25|||
146573802|NCT00980538|528611504|FG000|Overall Study|Participant Non-Compliant|9|||
146573803|NCT00980538|528611504|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
146573804|NCT00980538|528611504|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
146573805|NCT00980538|528611504|FG000|Overall Study|Other|60|||
146573806|NCT00980538|528611504|FG000|Overall Study|Other|1|||
146573807|NCT01544348|528611505|FG000|Overall Study|Lost to Follow-up|1|||
146573808|NCT01544348|528611506|FG001|Overall Study|Lost to Follow-up|0|||
146573809|NCT01544348|528611507|FG002|Overall Study|Lost to Follow-up|0|||
146573810|NCT01544348|528611508|FG003|Overall Study|Lost to Follow-up|0|||
146573811|NCT01544348|528611509|FG004|Overall Study|Lost to Follow-up|0|||
146573812|NCT01544348|528611510|FG005|Overall Study|Lost to Follow-up|0|||
146573813|NCT01544348|528611511|FG006|Overall Study|Lost to Follow-up|1|||
146573814|NCT01544348|528611512|FG007|Overall Study|Lost to Follow-up|0|||
146573815|NCT01544348|528611505|FG000|Overall Study|Withdrawal by Subject|1|||
146573816|NCT01544348|528611506|FG001|Overall Study|Withdrawal by Subject|0|||
146573817|NCT01544348|528611507|FG002|Overall Study|Withdrawal by Subject|0|||
146573818|NCT01544348|528611508|FG003|Overall Study|Withdrawal by Subject|0|||
146573819|NCT01544348|528611509|FG004|Overall Study|Withdrawal by Subject|1|||
146573820|NCT01544348|528611510|FG005|Overall Study|Withdrawal by Subject|2|||
146573821|NCT01544348|528611511|FG006|Overall Study|Withdrawal by Subject|1|||
146573822|NCT01544348|528611512|FG007|Overall Study|Withdrawal by Subject|0|||
146573823|NCT01544348|528611505|FG000|Overall Study|Physician Decision|0|||
146573824|NCT01544348|528611506|FG001|Overall Study|Physician Decision|0|||
146573825|NCT01544348|528611507|FG002|Overall Study|Physician Decision|0|||
146573826|NCT01544348|528611508|FG003|Overall Study|Physician Decision|0|||
146573827|NCT01544348|528611509|FG004|Overall Study|Physician Decision|0|||
146573828|NCT01544348|528611510|FG005|Overall Study|Physician Decision|1|||
146573829|NCT01544348|528611511|FG006|Overall Study|Physician Decision|0|||
146573830|NCT01544348|528611512|FG007|Overall Study|Physician Decision|0|||
146573831|NCT01445847|528611513|FG000|Overall Study|Protocol Violation|13|||
146573832|NCT01445847|528611514|FG001|Overall Study|Protocol Violation|14|||
146573833|NCT01445847|528611513|FG000|Overall Study|Missed Data|1|||
146917395|NCT02090114|529860131|FG002|Overall Study|Progressive Disease|23|||
146573834|NCT01445847|528611514|FG001|Overall Study|Missed Data|0|||
146573835|NCT00707993|528611515|FG000|Overall Study|Adverse Event|16|||
146573836|NCT00707993|528611516|FG001|Overall Study|Adverse Event|20|||
146573837|NCT00707993|528611515|FG000|Overall Study|Protocol Violation|4|||
146573838|NCT00707993|528611516|FG001|Overall Study|Protocol Violation|7|||
146573839|NCT00707993|528611515|FG000|Overall Study|Lost to Follow-up|0|||
146573840|NCT00707993|528611516|FG001|Overall Study|Lost to Follow-up|4|||
146573841|NCT00707993|528611515|FG000|Overall Study|Withdrawal by Subject|12|||
146573842|NCT00707993|528611516|FG001|Overall Study|Withdrawal by Subject|16|||
146573843|NCT00707993|528611515|FG000|Overall Study|Hyperglycemic Rescue|55|||
146573844|NCT00707993|528611516|FG001|Overall Study|Hyperglycemic Rescue|47|||
146573845|NCT00707993|528611515|FG000|Overall Study|Other|2|||
146573846|NCT00707993|528611516|FG001|Overall Study|Other|0|||
146573847|NCT03654274|528611520|FG000|Overall Study|Adverse Event|19|||
146573848|NCT03654274|528611521|FG001|Overall Study|Adverse Event|23|||
146573849|NCT03654274|528611522|FG002|Overall Study|Adverse Event|24|||
146573850|NCT03654274|528611520|FG000|Overall Study|Protocol Deviation|0|||
146573851|NCT03654274|528611521|FG001|Overall Study|Protocol Deviation|2|||
146573852|NCT03654274|528611522|FG002|Overall Study|Protocol Deviation|0|||
146573853|NCT03654274|528611520|FG000|Overall Study|Lost to Follow-up|8|||
146573854|NCT03654274|528611521|FG001|Overall Study|Lost to Follow-up|6|||
146573855|NCT03654274|528611522|FG002|Overall Study|Lost to Follow-up|5|||
146573856|NCT03654274|528611520|FG000|Overall Study|Withdrawal by Subject|46|||
146573857|NCT03654274|528611521|FG001|Overall Study|Withdrawal by Subject|25|||
146917396|NCT02090114|529860132|FG003|Overall Study|Progressive Disease|6|||
146573858|NCT03654274|528611522|FG002|Overall Study|Withdrawal by Subject|33|||
146573859|NCT03654274|528611520|FG000|Overall Study|Lack of Efficacy|4|||
146573860|NCT03654274|528611521|FG001|Overall Study|Lack of Efficacy|5|||
146573861|NCT03654274|528611522|FG002|Overall Study|Lack of Efficacy|7|||
146573862|NCT03654274|528611520|FG000|Overall Study|Pregnancy|2|||
146573863|NCT03654274|528611521|FG001|Overall Study|Pregnancy|2|||
146573864|NCT03654274|528611522|FG002|Overall Study|Pregnancy|1|||
146573865|NCT03654274|528611520|FG000|Overall Study|Other|27|||
146573866|NCT03654274|528611521|FG001|Overall Study|Other|29|||
146917397|NCT02090114|529860129|FG000|Overall Study|Death|1|||
146917398|NCT02090114|529860130|FG001|Overall Study|Death|0|||
146917399|NCT02090114|529860131|FG002|Overall Study|Death|1|||
146917400|NCT02090114|529860132|FG003|Overall Study|Death|0|||
146917401|NCT01356602|529860133|FG000|Overall Study|Protocol Deviation|0|||
146917402|NCT01356602|529860134|FG001|Overall Study|Protocol Deviation|1|||
146917403|NCT01356602|529860135|FG002|Overall Study|Protocol Deviation|1|||
146917404|NCT01356602|529860133|FG000|Overall Study|Administrative Problems|1|||
146917405|NCT01356602|529860134|FG001|Overall Study|Administrative Problems|4|||
146917406|NCT01356602|529860135|FG002|Overall Study|Administrative Problems|5|||
146917407|NCT01356602|529860133|FG000|Overall Study|Lost to Follow-up|4|||
146917408|NCT01356602|529860134|FG001|Overall Study|Lost to Follow-up|5|||
146573867|NCT03654274|528611522|FG002|Overall Study|Other|32|||
146573868|NCT03654274|528611520|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
146573869|NCT03654274|528611521|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
146573870|NCT03654274|528611522|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
146573871|NCT01265992|528611525|FG000|Overall Study|Lost to Follow-up|1|||
146573872|NCT01265992|528611525|FG000|Overall Study|Withdrawal by Subject|1|||
146573873|NCT01265992|528611525|FG000|Overall Study|Adverse Event|1|||
146573874|NCT01265992|528611525|FG000|Overall Study|Administrative reasons|2|||
146573875|NCT01265992|528611525|FG000|Overall Study|Stopped treatment|3|||
146573876|NCT01265992|528611525|FG000|Overall Study|Did not receive treatment|1|||
146573877|NCT01102491|528611526|FG000|Overall Study|Protocol Violation|11|||
146573878|NCT01102491|528611527|FG001|Overall Study|Protocol Violation|12|||
146573879|NCT01837680|528611528|FG000|Overall Study|Lost to Follow-up|2|||
146573880|NCT01837680|528611529|FG001|Overall Study|Lost to Follow-up|2|||
146573881|NCT01837680|528611528|FG000|Overall Study|lack of insurance|0|||
146573882|NCT01837680|528611529|FG001|Overall Study|lack of insurance|2|||
146573883|NCT01837680|528611528|FG000|Overall Study|allergic reaction|6|||
146573884|NCT01837680|528611529|FG001|Overall Study|allergic reaction|0|||
146573885|NCT01837680|528611528|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
146573886|NCT01837680|528611529|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
146573887|NCT03008070|528611530|FG000|Overall Study|Adverse Event|3|||
146573888|NCT03008070|528611531|FG001|Overall Study|Adverse Event|3|||
146573889|NCT03008070|528611532|FG002|Overall Study|Adverse Event|3|||
146573890|NCT03008070|528611530|FG000|Overall Study|Lost to Follow-up|1|||
146573891|NCT03008070|528611531|FG001|Overall Study|Lost to Follow-up|1|||
146573892|NCT03008070|528611532|FG002|Overall Study|Lost to Follow-up|0|||
146573893|NCT03008070|528611530|FG000|Overall Study|Non compliance|0|||
146573894|NCT03008070|528611531|FG001|Overall Study|Non compliance|1|||
146573895|NCT03008070|528611532|FG002|Overall Study|Non compliance|1|||
146573896|NCT03008070|528611530|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
146573897|NCT03008070|528611531|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
146573898|NCT03008070|528611532|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
146573899|NCT03008070|528611530|FG000|Overall Study|Withdrawal by Subject|2|||
146573900|NCT03008070|528611531|FG001|Overall Study|Withdrawal by Subject|0|||
146573901|NCT03008070|528611532|FG002|Overall Study|Withdrawal by Subject|1|||
146573902|NCT03008070|528611530|FG000|Overall Study|Use of prohibited drug|0|||
146917409|NCT01356602|529860135|FG002|Overall Study|Lost to Follow-up|6|||
146917410|NCT01356602|529860133|FG000|Overall Study|Withdrawal by Subject|4|||
146573903|NCT03008070|528611531|FG001|Overall Study|Use of prohibited drug|0|||
146573904|NCT03008070|528611532|FG002|Overall Study|Use of prohibited drug|2|||
146573905|NCT03960684|528611533|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
146573906|NCT02151786|528611534|FG000|Overall Study|Unavailability of Case Report Form|26|||
146573907|NCT02151786|528611534|FG000|Overall Study|Outside the Contract Period|1|||
146573908|NCT02151786|528611534|FG000|Overall Study|Randomized, not Treated|1|||
146573909|NCT02151786|528611534|FG000|Overall Study|Unavailability of Information|8|||
146573910|NCT03761056|528611538|FG000|Overall Study|Death|8|||
146573911|NCT03761056|528611538|FG000|Overall Study|Enrolled but never treated|2|||
146573912|NCT03761056|528611538|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
146573913|NCT03761056|528611538|FG000|Overall Study|Investigator decision|1|||
146573914|NCT03941483|528611539|FG000|Overall Study|Miscellaneous|2|||
146917411|NCT01356602|529860134|FG001|Overall Study|Withdrawal by Subject|3|||
146917412|NCT01356602|529860135|FG002|Overall Study|Withdrawal by Subject|7|||
146573915|NCT03941483|528611540|FG001|Overall Study|Miscellaneous|3|||
146573916|NCT03941483|528611541|FG002|Overall Study|Miscellaneous|0|||
146917413|NCT01356602|529860133|FG000|Overall Study|Lack of Efficacy|0|||
146573917|NCT03941483|528611539|FG000|Overall Study|Study Terminated by Sponsor|1|||
146573918|NCT03941483|528611540|FG001|Overall Study|Study Terminated by Sponsor|0|||
146573919|NCT03941483|528611541|FG002|Overall Study|Study Terminated by Sponsor|0|||
146573920|NCT03941483|528611539|FG000|Overall Study|Withdrawal by Subject|1|||
146573921|NCT03941483|528611540|FG001|Overall Study|Withdrawal by Subject|4|||
146573922|NCT03941483|528611541|FG002|Overall Study|Withdrawal by Subject|1|||
146573923|NCT03941483|528611539|FG000|Overall Study|Lost to Follow-up|2|||
146573924|NCT03941483|528611540|FG001|Overall Study|Lost to Follow-up|1|||
146573925|NCT03941483|528611541|FG002|Overall Study|Lost to Follow-up|8|||
146573926|NCT03941483|528611539|FG000|Overall Study|Death|3|||
146573927|NCT03941483|528611540|FG001|Overall Study|Death|2|||
146573928|NCT03941483|528611541|FG002|Overall Study|Death|6|||
146573929|NCT02685826|528611543|FG000|Overall Study|Adverse Event|2|||
146573930|NCT02685826|528611544|FG001|Overall Study|Adverse Event|0|||
146573931|NCT02685826|528611545|FG002|Overall Study|Adverse Event|1|||
146573932|NCT02685826|528611543|FG000|Overall Study|Progressive Disease|2|||
146573933|NCT02685826|528611544|FG001|Overall Study|Progressive Disease|1|||
146573934|NCT02685826|528611545|FG002|Overall Study|Progressive Disease|0|||
146573935|NCT02685826|528611543|FG000|Overall Study|Withdrawal by Subject|2|||
146573936|NCT02685826|528611544|FG001|Overall Study|Withdrawal by Subject|0|||
146573937|NCT02685826|528611545|FG002|Overall Study|Withdrawal by Subject|0|||
146573938|NCT02685826|528611543|FG000|Overall Study|Full Clinical Hold by FDA|19|||
146573939|NCT02685826|528611544|FG001|Overall Study|Full Clinical Hold by FDA|9|||
146573940|NCT02685826|528611545|FG002|Overall Study|Full Clinical Hold by FDA|20|||
146573941|NCT03154476|528611546|FG000|Overall Study|Lost to Follow-up|4|||
146573942|NCT03154476|528611547|FG001|Overall Study|Lost to Follow-up|4|||
146917414|NCT01356602|529860134|FG001|Overall Study|Lack of Efficacy|1|||
146917415|NCT01356602|529860135|FG002|Overall Study|Lack of Efficacy|4|||
146917416|NCT01356602|529860133|FG000|Overall Study|Adverse Event|0|||
146573943|NCT01444430|528611548|FG000|Overall Study|Withdrawal by Subject|53|||
146573944|NCT01444430|528611549|FG001|Overall Study|Withdrawal by Subject|72|||
146573945|NCT01444430|528611548|FG000|Overall Study|Death|6|||
146573946|NCT01444430|528611549|FG001|Overall Study|Death|8|||
146573947|NCT01444430|528611548|FG000|Overall Study|Lost to Follow-up|2|||
146573948|NCT01444430|528611549|FG001|Overall Study|Lost to Follow-up|0|||
146573949|NCT01444430|528611548|FG000|Overall Study|CRF termination module not completed.|0|||
146573950|NCT01444430|528611549|FG001|Overall Study|CRF termination module not completed.|1|||
146573951|NCT03816176|528611550|FG000|Overall Study|Miscellaneous|5|||
146573952|NCT03816176|528611550|FG000|Overall Study|Lack of Efficacy|4|||
146573953|NCT03816176|528611550|FG000|Overall Study|Adverse Event|3|||
146573954|NCT00972023|528612676|FG000|Overall Study|Withdrawal by Subject|1|||
146573955|NCT02595879|528612677|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
146573956|NCT02595879|528612678|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
146573957|NCT00600106|528612679|FG000|Overall Study|Withdrawal by Subject|1|||
146573958|NCT00600106|528612680|FG001|Overall Study|Withdrawal by Subject|1|||
146573959|NCT05554146|528612681|FG000|Overall Study|Adverse Event|0|||
146573960|NCT05554146|528612682|FG001|Overall Study|Adverse Event|1|||
146573961|NCT05554146|528612683|FG002|Overall Study|Adverse Event|0|||
146573962|NCT05554146|528612684|FG003|Overall Study|Adverse Event|0|||
146573963|NCT05554146|528612681|FG000|Overall Study|Protocol Violation|0|||
146573964|NCT05554146|528612682|FG001|Overall Study|Protocol Violation|1|||
146573965|NCT05554146|528612683|FG002|Overall Study|Protocol Violation|0|||
146573966|NCT05554146|528612684|FG003|Overall Study|Protocol Violation|0|||
146573967|NCT05554146|528612681|FG000|Overall Study|No longer interested in participating|0|||
146573968|NCT05554146|528612682|FG001|Overall Study|No longer interested in participating|0|||
146573969|NCT05554146|528612683|FG002|Overall Study|No longer interested in participating|1|||
146573970|NCT05554146|528612684|FG003|Overall Study|No longer interested in participating|0|||
146573971|NCT05554146|528612681|FG000|Overall Study|Lost to Follow-up|1|||
146573972|NCT05554146|528612682|FG001|Overall Study|Lost to Follow-up|0|||
146573973|NCT05554146|528612683|FG002|Overall Study|Lost to Follow-up|0|||
146917417|NCT01356602|529860134|FG001|Overall Study|Adverse Event|1|||
146917418|NCT01356602|529860135|FG002|Overall Study|Adverse Event|1|||
146917419|NCT02849990|529860136|FG000|Overall Study|Adverse Event|1|||
146573974|NCT05554146|528612684|FG003|Overall Study|Lost to Follow-up|0|||
146573975|NCT01465386|528612694|FG000|Overall Study|Lack of Efficacy|3|||
146573976|NCT01465386|528612694|FG000|Overall Study|Adverse Event|1|||
146573977|NCT01279044|528612695|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
146651849|NCT03400956|528902292|FG002|Post-treatment Period 1|Other|4|||
146573978|NCT01279044|528612696|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
146573979|NCT01279044|528612697|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
146573980|NCT01279044|528612695|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
146573981|NCT01279044|528612696|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
146573982|NCT01279044|528612697|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
146573983|NCT01279044|528612695|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
146573984|NCT01279044|528612696|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
146917420|NCT02849990|529860136|FG000|Overall Study|Withdrawal by Subject|1|||
146573985|NCT01279044|528612697|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
146573986|NCT01408277|528612698|FG000|Overall Study|Adverse Event|3|||
146573987|NCT01408277|528612699|FG001|Overall Study|Adverse Event|4|||
146573988|NCT01408277|528612698|FG000|Overall Study|Lost to Follow-up|1|||
146573989|NCT01408277|528612699|FG001|Overall Study|Lost to Follow-up|0|||
146573990|NCT01408277|528612698|FG000|Overall Study|Withdrawal by Subject|2|||
146573991|NCT01408277|528612699|FG001|Overall Study|Withdrawal by Subject|0|||
146573992|NCT01408277|528612698|FG000|Overall Study|Protocol Violation|2|||
146573993|NCT01408277|528612699|FG001|Overall Study|Protocol Violation|0|||
146573994|NCT02840253|528612700|FG000|Overall Study|Unsuccessful block|4|||
146573995|NCT03783962|528612701|FG000|Overall Study|Lost to Follow-up|3|||
146573996|NCT03783962|528612702|FG001|Overall Study|Lost to Follow-up|6|||
146573997|NCT03783962|528612701|FG000|Overall Study|Protocol Violation|0|||
146573998|NCT03783962|528612702|FG001|Overall Study|Protocol Violation|1|||
146573999|NCT02763059|528612705|FG000|Overall Study|Lost to Follow-up|4|||
146574000|NCT02763059|528612706|FG001|Overall Study|Lost to Follow-up|1|||
146574001|NCT02763059|528612707|FG002|Overall Study|Lost to Follow-up|6|||
146574002|NCT02763059|528612705|FG000|Overall Study|Withdrawal by Subject|1|||
146574003|NCT02763059|528612706|FG001|Overall Study|Withdrawal by Subject|0|||
146574004|NCT02763059|528612707|FG002|Overall Study|Withdrawal by Subject|3|||
146574005|NCT01775553|528612710|FG000|Overall Study|Adverse Event|1|||
146574006|NCT01775553|528612710|FG000|Overall Study|Disease Progression|12|||
146574007|NCT03810014|528612714|FG000|Overall Study|Pregnancy|2|||
146574008|NCT03810014|528612715|FG001|Overall Study|Pregnancy|2|||
146574009|NCT03810014|528612716|FG002|Overall Study|Pregnancy|0|||
146574010|NCT03810014|528612717|FG003|Overall Study|Pregnancy|2|||
146574011|NCT02534883|528612719|FG000|Overall Study|Early Termination|8|||
146574012|NCT02534883|528612720|FG001|Overall Study|Early Termination|3|||
146574013|NCT00886769|528612721|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
146574014|NCT00886769|528612722|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
146574015|NCT00778336|528612723|FG000|Index Procedure-Discharge|Death|6|||
146574016|NCT00778336|528612724|FG001|Index Procedure-Discharge|Death|3|||
146574017|NCT00778336|528612725|FG002|Index Procedure-Discharge|Death|2|||
146574018|NCT00778336|528612726|FG003|Index Procedure-Discharge|Death|0|||
146574019|NCT00778336|528612723|FG000|3 Month Follow Up|Lost to Follow-up|15|||
146574020|NCT00778336|528612724|FG001|3 Month Follow Up|Lost to Follow-up|20|||
146574021|NCT00778336|528612725|FG002|3 Month Follow Up|Lost to Follow-up|3|||
146574022|NCT00778336|528612726|FG003|3 Month Follow Up|Lost to Follow-up|0|||
146574023|NCT00778336|528612723|FG000|3 Month Follow Up|Death|8|||
146574024|NCT00778336|528612724|FG001|3 Month Follow Up|Death|3|||
146574025|NCT00778336|528612725|FG002|3 Month Follow Up|Death|2|||
146574026|NCT00778336|528612726|FG003|3 Month Follow Up|Death|0|||
146574027|NCT00414076|528612727|FG000|Overall Study|Progression|1|||
146574028|NCT00414076|528612728|FG001|Overall Study|Progression|2|||
146574029|NCT00414076|528612727|FG000|Overall Study|Withdrawal by Subject|1|||
146574030|NCT00414076|528612728|FG001|Overall Study|Withdrawal by Subject|3|||
146574031|NCT00414076|528612727|FG000|Overall Study|Adverse Event|1|||
146574032|NCT00414076|528612728|FG001|Overall Study|Adverse Event|0|||
146574033|NCT04108208|528612729|FG000|Overall Study|Withdrawal by Subject|2|||
146574034|NCT04108208|528612730|FG001|Overall Study|Withdrawal by Subject|6|||
146574035|NCT04108208|528612729|FG000|Overall Study|other-ongoing|20|||
146574036|NCT04108208|528612730|FG001|Overall Study|other-ongoing|40|||
146574037|NCT04108208|528612729|FG000|Overall Study|Death|1|||
146574038|NCT04108208|528612730|FG001|Overall Study|Death|4|||
146574039|NCT04108208|528612729|FG000|Overall Study|Lost to Follow-up|2|||
146574040|NCT04108208|528612730|FG001|Overall Study|Lost to Follow-up|0|||
146574041|NCT03670355|528612731|FG000|Overall Study|Adverse Event|1|||
146574042|NCT03670355|528612732|FG001|Overall Study|Adverse Event|0|||
146574043|NCT03670355|528612731|FG000|Overall Study|Unable to comply with study procedures|0|||
146574044|NCT03670355|528612732|FG001|Overall Study|Unable to comply with study procedures|1|||
146574045|NCT03670355|528612731|FG000|Overall Study|Participant refused|0|||
146574046|NCT03670355|528612732|FG001|Overall Study|Participant refused|1|||
146574047|NCT03517436|528612733|FG000|Overall Study|Death|3|||
146574048|NCT03517436|528612733|FG000|Overall Study|Withdrawal by Subject|4|||
146574049|NCT03517436|528612733|FG000|Overall Study|Did not receive study valve.|1|||
146574050|NCT04181827|528612734|FG000|Overall Study|Ongoing|124|||
146574051|NCT04181827|528612735|FG001|Overall Study|Ongoing|157|||
146574052|NCT04181827|528612734|FG000|Overall Study|Death|82|||
146574053|NCT04181827|528612735|FG001|Overall Study|Death|50|||
146574054|NCT04181827|528612734|FG000|Overall Study|Lost to Follow-up|0|||
146574055|NCT04181827|528612735|FG001|Overall Study|Lost to Follow-up|1|||
146574056|NCT04181827|528612734|FG000|Overall Study|Withdrawal by Subject|5|||
146574057|NCT04181827|528612735|FG001|Overall Study|Withdrawal by Subject|0|||
146574058|NCT04587869|528612736|FG000|Overall Study|Death|1|||
146574059|NCT04587869|528612737|FG001|Overall Study|Death|0|||
146574060|NCT04587869|528612736|FG000|Overall Study|Lost to Follow-up|27|||
146574061|NCT04587869|528612737|FG001|Overall Study|Lost to Follow-up|34|||
146574062|NCT04587869|528612736|FG000|Overall Study|Grant Termination|13|||
146574063|NCT04587869|528612737|FG001|Overall Study|Grant Termination|25|||
146574064|NCT04587869|528612736|FG000|Overall Study|too busy|2|||
146917421|NCT02678741|529860137|FG000|Overall Study|Death|4|||
146917422|NCT02678741|529860137|FG000|Overall Study|Withdrawal by Subject|1|||
146917423|NCT02678741|529860137|FG000|Overall Study|ineligible|3|||
146917424|NCT02678741|529860137|FG000|Overall Study|Not RECIST Measurable|2|||
146917425|NCT02678741|529860137|FG000|Overall Study|Lack of Efficacy|10|||
146917426|NCT01795898|529860138|FG000|Overall Study|Adverse Event|27|||
146917427|NCT01795898|529860138|FG000|Overall Study|Lost to Follow-up|20|||
146917428|NCT01795898|529860138|FG000|Overall Study|Withdrawal of consent|6|||
146917429|NCT01795898|529860138|FG000|Overall Study|Diagnosed with metastasis|1|||
146977291|NCT00386100|530079398|FG000|Overall Study|Withdrawal by Subject|32|||
146977292|NCT00386100|530079399|FG001|Overall Study|Withdrawal by Subject|31|||
146977293|NCT00386100|530079398|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
146977294|NCT00386100|530079399|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
146977295|NCT00386100|530079398|FG000|Overall Study|BMD <2.5|1|||
146977296|NCT00386100|530079399|FG001|Overall Study|BMD <2.5|0|||
146977297|NCT00386100|530079398|FG000|Overall Study|Consecutive elevated Hba1C|1|||
146977298|NCT00386100|530079399|FG001|Overall Study|Consecutive elevated Hba1C|0|||
146977299|NCT00386100|530079398|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
146977300|NCT00386100|530079399|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
146977301|NCT00386100|530079398|FG000|Overall Study|Laboratory findings|1|||
146977302|NCT00386100|530079399|FG001|Overall Study|Laboratory findings|0|||
146977303|NCT00386100|530079398|FG000|Overall Study|Participant's concern due to CPK levels|1|||
146977304|NCT00386100|530079399|FG001|Overall Study|Participant's concern due to CPK levels|0|||
146977305|NCT00386100|530079398|FG000|Overall Study|Participant moving out of state|2|||
146574065|NCT04587869|528612737|FG001|Overall Study|too busy|0|||
146574066|NCT04587869|528612736|FG000|Overall Study|Withdrawal by Subject|2|||
146574067|NCT04587869|528612737|FG001|Overall Study|Withdrawal by Subject|2|||
146574068|NCT04587869|528612736|FG000|Overall Study|Other|1|||
146574069|NCT04587869|528612737|FG001|Overall Study|Other|0|||
146574070|NCT04538664|528612745|FG000|Overall Study|Withdrawal by Subject|5|||
146574071|NCT04538664|528612746|FG001|Overall Study|Withdrawal by Subject|9|||
146574072|NCT04538664|528612745|FG000|Overall Study|Lost to Follow-up|2|||
146574073|NCT04538664|528612746|FG001|Overall Study|Lost to Follow-up|1|||
146574074|NCT04538664|528612745|FG000|Overall Study|Ongoing|106|||
146574075|NCT04538664|528612746|FG001|Overall Study|Ongoing|115|||
146574076|NCT03929913|528612747|FG000|Overall Study|Death|4|||
146574077|NCT03929913|528612747|FG000|Overall Study|Lost to Follow-up|1|||
146574078|NCT03929913|528612747|FG000|Overall Study|Failed Procedure|2|||
146574079|NCT00642707|528612748|FG000|Overall Study|Adverse Event|0|||
146574080|NCT00642707|528612749|FG001|Overall Study|Adverse Event|0|||
146574081|NCT00642707|528612750|FG002|Overall Study|Adverse Event|0|||
146574082|NCT00642707|528612751|FG003|Overall Study|Adverse Event|2|||
146574083|NCT00642707|528612748|FG000|Overall Study|Withdrawal by Subject|1|||
146574084|NCT00642707|528612749|FG001|Overall Study|Withdrawal by Subject|0|||
146574085|NCT00642707|528612750|FG002|Overall Study|Withdrawal by Subject|0|||
146574086|NCT00642707|528612751|FG003|Overall Study|Withdrawal by Subject|0|||
146574087|NCT02891226|528612752|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
146574088|NCT02891226|528612753|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
146574089|NCT02891226|528612754|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
146574090|NCT02891226|528612755|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146574091|NCT02891226|528612756|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146574092|NCT02891226|528612757|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146574093|NCT02891226|528612758|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146574094|NCT02891226|528612759|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146574095|NCT02891226|528612760|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146574096|NCT02891226|528612761|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146574097|NCT02891226|528612762|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146574098|NCT02891226|528612763|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146574099|NCT02891226|528612764|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146574100|NCT02891226|528612765|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146574101|NCT02891226|528612766|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146574102|NCT02891226|528612767|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146574103|NCT02891226|528612752|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
146574104|NCT02891226|528612753|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
146574105|NCT02891226|528612754|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146574106|NCT02891226|528612755|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146574107|NCT02891226|528612756|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146574108|NCT02891226|528612757|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146574109|NCT02891226|528612758|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146574110|NCT02891226|528612759|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146574111|NCT02891226|528612760|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146574112|NCT02891226|528612761|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146574113|NCT02891226|528612762|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146574114|NCT02891226|528612763|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146574115|NCT02891226|528612764|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146917430|NCT01795898|529860138|FG000|Overall Study|No pain|1|||
146574116|NCT02891226|528612765|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146574117|NCT02891226|528612766|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146574118|NCT02891226|528612767|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146574119|NCT02891226|528612752|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146574120|NCT02891226|528612753|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146574121|NCT02891226|528612754|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146574122|NCT02891226|528612755|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
146574123|NCT02891226|528612756|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146574124|NCT02891226|528612757|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146574125|NCT02891226|528612758|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146574126|NCT02891226|528612759|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146574127|NCT02891226|528612760|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146574128|NCT02891226|528612761|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146574129|NCT02891226|528612762|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146574130|NCT02891226|528612763|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146574131|NCT02891226|528612764|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146574132|NCT02891226|528612765|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146574133|NCT02891226|528612766|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146574134|NCT02891226|528612767|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146917431|NCT01795898|529860138|FG000|Overall Study|Death|1|||
146917432|NCT01795898|529860138|FG000|Overall Study|Withdrew consent & had adverse events|3|||
146917433|NCT01795898|529860138|FG000|Overall Study|Physician Decision|1|||
146917434|NCT01984346|529860139|FG000|Overall Study|Physician Decision|4|||
146917435|NCT01984346|529860140|FG001|Overall Study|Physician Decision|2|||
146917436|NCT01984346|529860139|FG000|Overall Study|Withdrawal by Subject|2|||
146977306|NCT00386100|530079399|FG001|Overall Study|Participant moving out of state|0|||
146977307|NCT00386100|530079398|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
146977308|NCT00386100|530079399|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
146977309|NCT00386100|530079398|FG000|Overall Study|Didn't meet entry criteria|1|||
146977310|NCT00386100|530079399|FG001|Overall Study|Didn't meet entry criteria|1|||
146977311|NCT00386100|530079398|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
146977312|NCT00386100|530079399|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
146977313|NCT00386100|530079398|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
146977314|NCT00386100|530079399|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
146977315|NCT00386100|530079398|FG000|Overall Study|Bad metabolic control & patient security|1|||
146977316|NCT00386100|530079399|FG001|Overall Study|Bad metabolic control & patient security|0|||
146977317|NCT00386100|530079398|FG000|Overall Study|Bone loss by DXA bone scan|1|||
146977318|NCT00386100|530079399|FG001|Overall Study|Bone loss by DXA bone scan|0|||
146977319|NCT00386100|530079398|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
146977320|NCT00386100|530079399|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
146977321|NCT00386100|530079398|FG000|Overall Study|7.6% bone loss|1|||
146977322|NCT00386100|530079399|FG001|Overall Study|7.6% bone loss|0|||
146977323|NCT00386100|530079398|FG000|Overall Study|Osteoporosis|0|||
146977324|NCT00386100|530079399|FG001|Overall Study|Osteoporosis|1|||
146977325|NCT00386100|530079398|FG000|Overall Study|Positive pregnancy test|1|||
146977326|NCT00386100|530079399|FG001|Overall Study|Positive pregnancy test|3|||
146977327|NCT00386100|530079398|FG000|Overall Study|Out of country for 5 months|1|||
146977328|NCT00386100|530079399|FG001|Overall Study|Out of country for 5 months|0|||
146977329|NCT00386100|530079398|FG000|Overall Study|Hb1Ac >8%|0|||
146977330|NCT00386100|530079399|FG001|Overall Study|Hb1Ac >8%|1|||
146977331|NCT00386100|530079398|FG000|Overall Study|Participant randomized in error|1|||
146977332|NCT00386100|530079399|FG001|Overall Study|Participant randomized in error|0|||
146977333|NCT01493531|530079409|FG000|Overall Study|Adverse Event|4|||
146977334|NCT01493531|530079410|FG001|Overall Study|Adverse Event|12|||
146977335|NCT01493531|530079411|FG002|Overall Study|Adverse Event|9|||
146977336|NCT01493531|530079409|FG000|Overall Study|Gout flare|3|||
146977337|NCT01493531|530079410|FG001|Overall Study|Gout flare|0|||
146977338|NCT01493531|530079411|FG002|Overall Study|Gout flare|2|||
146574135|NCT02891226|528612752|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146574136|NCT02891226|528612753|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146574137|NCT02891226|528612754|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
146770604|NCT01135511|529328645|FG003|Overall Study|Lack of Efficacy|2|||
146917437|NCT01984346|529860140|FG001|Overall Study|Withdrawal by Subject|2|||
146917438|NCT01984346|529860139|FG000|Overall Study|Enrollment Closed|8|||
146917439|NCT01984346|529860140|FG001|Overall Study|Enrollment Closed|1|||
146917440|NCT01984346|529860139|FG000|Overall Study|Insurance Coverage|1|||
146977339|NCT01493531|530079409|FG000|Overall Study|Protocol Violation|8|||
146977340|NCT01493531|530079410|FG001|Overall Study|Protocol Violation|15|||
146977341|NCT01493531|530079411|FG002|Overall Study|Protocol Violation|12|||
146977342|NCT01493531|530079409|FG000|Overall Study|Sponsor terminated study|5|||
146977343|NCT01493531|530079410|FG001|Overall Study|Sponsor terminated study|2|||
146977344|NCT01493531|530079411|FG002|Overall Study|Sponsor terminated study|3|||
146977345|NCT01493531|530079409|FG000|Overall Study|Lost to Follow-up|5|||
146977346|NCT01493531|530079410|FG001|Overall Study|Lost to Follow-up|7|||
146977347|NCT01493531|530079411|FG002|Overall Study|Lost to Follow-up|11|||
146977348|NCT01493531|530079409|FG000|Overall Study|Withdrawal by Subject|16|||
146977349|NCT01493531|530079410|FG001|Overall Study|Withdrawal by Subject|13|||
146977350|NCT01493531|530079411|FG002|Overall Study|Withdrawal by Subject|11|||
146977351|NCT01493531|530079409|FG000|Overall Study|Death|0|||
146977352|NCT01493531|530079410|FG001|Overall Study|Death|1|||
146977353|NCT01493531|530079411|FG002|Overall Study|Death|0|||
146977354|NCT01946282|530079412|FG000|Year 1|Did not return FIT kit|4186|||
146977355|NCT01946282|530079413|FG001|Year 1|Did not return FIT kit|608|||
146977356|NCT01946282|530079414|FG002|Year 1|Did not return FIT kit|654|||
146977357|NCT01946282|530079412|FG000|Year 2|Did not return FIT kit|803|||
146977358|NCT01946282|530079413|FG001|Year 2|Did not return FIT kit|131|||
146977359|NCT01946282|530079414|FG002|Year 2|Did not return FIT kit|115|||
146977360|NCT01946282|530079412|FG000|Year 3|Did not return FIT kit|288|||
146977361|NCT01946282|530079413|FG001|Year 3|Did not return FIT kit|43|||
146977362|NCT01946282|530079414|FG002|Year 3|Did not return FIT kit|30|||
146977363|NCT03031431|530079415|FG000|Overall Study|Infant removed by maternal request|1|||
146977364|NCT03670537|530079420|FG000|Overall Study|Protocol Violation|1|||
146977365|NCT04133519|530079421|FG000|Overall Study|Withdrawal by Subject|5|||
146977366|NCT04133519|530079422|FG001|Overall Study|Withdrawal by Subject|4|||
146977367|NCT04133519|530079421|FG000|Overall Study|Protocol Violation|0|||
146977368|NCT04133519|530079422|FG001|Overall Study|Protocol Violation|1|||
146977369|NCT04133519|530079421|FG000|Overall Study|Never started treatment|1|||
146977370|NCT04133519|530079422|FG001|Overall Study|Never started treatment|1|||
146977371|NCT02217345|530079423|FG000|Overall Study|Lost to Follow-up|2|||
146977372|NCT02217345|530079424|FG001|Overall Study|Lost to Follow-up|1|||
146977373|NCT02217345|530079423|FG000|Overall Study|Withdrawal by Subject|3|||
146977374|NCT02217345|530079424|FG001|Overall Study|Withdrawal by Subject|2|||
146977375|NCT02217345|530079423|FG000|Overall Study|Adverse Event|2|||
146977376|NCT02217345|530079424|FG001|Overall Study|Adverse Event|1|||
146977377|NCT02217345|530079423|FG000|Overall Study|Physician Decision|0|||
146977378|NCT02217345|530079424|FG001|Overall Study|Physician Decision|1|||
146977379|NCT00789828|530079429|FG000|Core Period (48 Weeks)|Administrative problems|0|||
146977380|NCT00789828|530079430|FG001|Core Period (48 Weeks)|Administrative problems|1|||
146977381|NCT00789828|530079429|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
146977382|NCT00789828|530079430|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
146977383|NCT00789828|530079429|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
146977384|NCT00789828|530079430|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
146977385|NCT00789828|530079429|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
146977386|NCT00789828|530079430|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
146977387|NCT00789828|530079429|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
146977388|NCT00789828|530079430|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
146977389|NCT00789828|530079429|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
146977390|NCT00789828|530079430|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
146977391|NCT00789828|530079429|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
146977392|NCT00789828|530079430|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
146977393|NCT00789828|530079429|FG000|Open-label Extension Period (4 Years)|Death|1|||
146977394|NCT00789828|530079430|FG001|Open-label Extension Period (4 Years)|Death|0|||
146977395|NCT00789828|530079429|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
146977396|NCT00789828|530079430|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
146977397|NCT00789828|530079429|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
146977398|NCT00789828|530079430|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
146977399|NCT01133392|530079431|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
146977400|NCT01133392|530079432|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
146977401|NCT01133392|530079431|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
146977402|NCT01133392|530079432|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
146977403|NCT03185949|530079433|FG000|ITT Analysis|Withdrawal by Subject|4|||
146977404|NCT03185949|530079434|FG001|ITT Analysis|Withdrawal by Subject|3|||
146977405|NCT03185949|530079433|FG000|PP Analysis|Protocol Violation|2|||
146977406|NCT03185949|530079434|FG001|PP Analysis|Protocol Violation|2|||
146977407|NCT03185949|530079433|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
146977408|NCT03185949|530079434|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
146977409|NCT05788237|530079440|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
146977410|NCT05788237|530079441|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
146977411|NCT05788237|530079442|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
146977412|NCT05788237|530079443|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
146977413|NCT05788237|530079440|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
146977414|NCT05788237|530079441|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
146977415|NCT05788237|530079442|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
146651850|NCT03400956|528902290|FG000|Treatment Period 2|Adverse Event|2|||
146977416|NCT05788237|530079443|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
146977417|NCT05788237|530079440|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
146574138|NCT02891226|528612755|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146574139|NCT02891226|528612756|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146574140|NCT02891226|528612757|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146574141|NCT02891226|528612758|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146574142|NCT02891226|528612759|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146574143|NCT02891226|528612760|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146917441|NCT01984346|529860140|FG001|Overall Study|Insurance Coverage|0|||
146917442|NCT01984346|529860139|FG000|Overall Study|Intra-operative Exclusion|2|||
146917443|NCT01984346|529860140|FG001|Overall Study|Intra-operative Exclusion|0|||
146917444|NCT00536731|529860141|FG000|Overall Study|Adverse Event|3|||
146917445|NCT00536731|529860142|FG001|Overall Study|Adverse Event|2|||
146917446|NCT00536731|529860143|FG002|Overall Study|Adverse Event|3|||
146917447|NCT00536731|529860141|FG000|Overall Study|Withdrawal by Subject|0|||
146917448|NCT00536731|529860142|FG001|Overall Study|Withdrawal by Subject|2|||
146917449|NCT00536731|529860143|FG002|Overall Study|Withdrawal by Subject|0|||
146917450|NCT00536731|529860141|FG000|Overall Study|Intake of prohibited conc. medication|0|||
146917451|NCT00536731|529860142|FG001|Overall Study|Intake of prohibited conc. medication|0|||
146917452|NCT00536731|529860143|FG002|Overall Study|Intake of prohibited conc. medication|1|||
146917453|NCT00536731|529860141|FG000|Overall Study|Safety reasons|0|||
146917454|NCT00536731|529860142|FG001|Overall Study|Safety reasons|0|||
146917455|NCT00536731|529860143|FG002|Overall Study|Safety reasons|1|||
146917456|NCT00536731|529860141|FG000|Overall Study|Other|1|||
146917457|NCT00536731|529860142|FG001|Overall Study|Other|1|||
146917458|NCT00536731|529860143|FG002|Overall Study|Other|0|||
146917459|NCT00372190|529860144|FG000|Overall Study|Lost to Follow-up|3|||
146917460|NCT00372190|529860145|FG001|Overall Study|Lost to Follow-up|1|||
146917461|NCT00109733|529860147|FG000|Overall Study|Protocol Violation|0|||
146917462|NCT00109733|529860148|FG001|Overall Study|Protocol Violation|1|||
146917463|NCT00109733|529860147|FG000|Overall Study|Stopped taking study drug|1|||
146917464|NCT00109733|529860148|FG001|Overall Study|Stopped taking study drug|1|||
146917465|NCT00109733|529860147|FG000|Overall Study|Non-compliant|0|||
146917466|NCT00109733|529860148|FG001|Overall Study|Non-compliant|1|||
146917467|NCT00109733|529860147|FG000|Overall Study|Could not commit time for study|1|||
146917468|NCT00109733|529860148|FG001|Overall Study|Could not commit time for study|1|||
146917469|NCT00069576|529860161|FG000|Original Trial|Lost to Follow-up|25|||
146917470|NCT00069576|529860162|FG001|Original Trial|Lost to Follow-up|33|||
146917471|NCT00069576|529860161|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
146917472|NCT00069576|529860162|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
146917473|NCT00905307|529860163|FG000|Overall Study|Switched to Open Label Rescue|7|||
146917474|NCT00905307|529860164|FG001|Overall Study|Switched to Open Label Rescue|17|||
146917475|NCT00905307|529860165|FG002|Overall Study|Switched to Open Label Rescue|11|||
146917476|NCT00905307|529860166|FG003|Overall Study|Switched to Open Label Rescue|11|||
146917477|NCT00905307|529860167|FG004|Overall Study|Switched to Open Label Rescue|4|||
146917478|NCT00905307|529860168|FG005|Overall Study|Switched to Open Label Rescue|15|||
146917479|NCT00905307|529860163|FG000|Overall Study|Lost to Follow-up|0|||
146917480|NCT00905307|529860164|FG001|Overall Study|Lost to Follow-up|0|||
146917481|NCT00905307|529860165|FG002|Overall Study|Lost to Follow-up|0|||
146917482|NCT00905307|529860166|FG003|Overall Study|Lost to Follow-up|0|||
146917483|NCT00905307|529860167|FG004|Overall Study|Lost to Follow-up|1|||
146917484|NCT00905307|529860168|FG005|Overall Study|Lost to Follow-up|1|||
146917485|NCT00905307|529860163|FG000|Overall Study|Adverse Event|3|||
146917486|NCT00905307|529860164|FG001|Overall Study|Adverse Event|4|||
146917487|NCT00905307|529860165|FG002|Overall Study|Adverse Event|5|||
146917488|NCT00905307|529860166|FG003|Overall Study|Adverse Event|11|||
146917489|NCT00905307|529860167|FG004|Overall Study|Adverse Event|3|||
146917490|NCT00905307|529860168|FG005|Overall Study|Adverse Event|5|||
146917491|NCT00905307|529860163|FG000|Overall Study|Withdrawal by Subject|5|||
146917492|NCT00905307|529860164|FG001|Overall Study|Withdrawal by Subject|13|||
146917493|NCT00905307|529860165|FG002|Overall Study|Withdrawal by Subject|15|||
146917494|NCT00905307|529860166|FG003|Overall Study|Withdrawal by Subject|11|||
146917495|NCT00905307|529860167|FG004|Overall Study|Withdrawal by Subject|4|||
146917496|NCT00905307|529860168|FG005|Overall Study|Withdrawal by Subject|13|||
146917497|NCT00905307|529860163|FG000|Overall Study|Protocol Violation|1|||
146917498|NCT00905307|529860164|FG001|Overall Study|Protocol Violation|0|||
146917499|NCT00905307|529860165|FG002|Overall Study|Protocol Violation|1|||
146917500|NCT00905307|529860166|FG003|Overall Study|Protocol Violation|0|||
146917501|NCT00905307|529860167|FG004|Overall Study|Protocol Violation|0|||
146917502|NCT00905307|529860168|FG005|Overall Study|Protocol Violation|0|||
146917503|NCT00905307|529860163|FG000|Overall Study|Lack of Efficacy|6|||
146917504|NCT00905307|529860164|FG001|Overall Study|Lack of Efficacy|3|||
146917505|NCT00905307|529860165|FG002|Overall Study|Lack of Efficacy|5|||
146917506|NCT00905307|529860166|FG003|Overall Study|Lack of Efficacy|4|||
146574144|NCT02891226|528612761|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146917507|NCT00905307|529860167|FG004|Overall Study|Lack of Efficacy|4|||
146917508|NCT00905307|529860168|FG005|Overall Study|Lack of Efficacy|8|||
146917509|NCT03838367|529860169|FG000|Overall Study|Early termination of study|3|||
147013237|NCT01708954|530210055|FG001|Step 1|Other complicating disease|2|||
146917510|NCT03838367|529860170|FG001|Overall Study|Early termination of study|4|||
146917511|NCT03838367|529860171|FG002|Overall Study|Early termination of study|3|||
146917512|NCT03838367|529860172|FG003|Overall Study|Early termination of study|0|||
146917513|NCT03406104|529860173|FG000|Overall Study|Lost to Follow-up|2|||
146574145|NCT02891226|528612762|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146574146|NCT02891226|528612763|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146574147|NCT02891226|528612764|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146574148|NCT02891226|528612765|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146574149|NCT02891226|528612766|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146574150|NCT02891226|528612767|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146574151|NCT02891226|528612752|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146574152|NCT02891226|528612753|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146574153|NCT02891226|528612754|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146574154|NCT02891226|528612755|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
146574155|NCT02891226|528612756|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146574156|NCT02891226|528612757|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146574157|NCT02891226|528612758|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146574158|NCT02891226|528612759|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146574159|NCT02891226|528612760|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146574160|NCT02891226|528612761|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146574161|NCT02891226|528612762|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146574162|NCT02891226|528612763|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146574163|NCT02891226|528612764|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146574164|NCT02891226|528612765|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146574165|NCT02891226|528612766|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146574166|NCT02891226|528612767|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146574167|NCT02891226|528612752|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146574168|NCT02891226|528612753|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146574169|NCT02891226|528612754|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146574170|NCT02891226|528612755|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
146574171|NCT02891226|528612756|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146574172|NCT02891226|528612757|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146574173|NCT02891226|528612758|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146574174|NCT02891226|528612759|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146574175|NCT02891226|528612760|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146574176|NCT02891226|528612761|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146574177|NCT02891226|528612762|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146574178|NCT02891226|528612763|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146574179|NCT02891226|528612764|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146574180|NCT02891226|528612765|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146574181|NCT02891226|528612766|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146574182|NCT02891226|528612767|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146574183|NCT02891226|528612752|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146574184|NCT02891226|528612753|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146574185|NCT02891226|528612754|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146574186|NCT02891226|528612755|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146574187|NCT02891226|528612756|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146574188|NCT02891226|528612757|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146574189|NCT02891226|528612758|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
146574190|NCT02891226|528612759|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
146574191|NCT02891226|528612760|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
146574192|NCT02891226|528612761|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
146574193|NCT02891226|528612762|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146574194|NCT02891226|528612763|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146574195|NCT02891226|528612764|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146574196|NCT02891226|528612765|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146574197|NCT02891226|528612766|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146574198|NCT02891226|528612767|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146574199|NCT02891226|528612752|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146574200|NCT02891226|528612753|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146574201|NCT02891226|528612754|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146574202|NCT02891226|528612755|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146574203|NCT02891226|528612756|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146574204|NCT02891226|528612757|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
146917514|NCT03406104|529860173|FG000|Overall Study|Withdrawal by Subject|2|||
146917515|NCT03406104|529860173|FG000|Overall Study|due to Covid patient did not want to travel|1|||
146574205|NCT02891226|528612758|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146574206|NCT02891226|528612759|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146574207|NCT02891226|528612760|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146574208|NCT02891226|528612761|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
146574209|NCT02891226|528612762|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146574210|NCT02891226|528612763|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146574211|NCT02891226|528612764|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146574212|NCT02891226|528612765|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146574213|NCT02891226|528612766|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146574214|NCT02891226|528612767|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146574215|NCT02891226|528612752|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146574216|NCT02891226|528612753|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146574217|NCT02891226|528612754|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146574218|NCT02891226|528612755|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146574219|NCT02891226|528612756|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146574220|NCT02891226|528612757|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146574221|NCT02891226|528612758|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
146574222|NCT02891226|528612759|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
146574223|NCT02891226|528612760|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
146574224|NCT02891226|528612761|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
146574225|NCT02891226|528612762|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146917516|NCT03406104|529860173|FG000|Overall Study|Death|2|||
146574226|NCT02891226|528612763|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146574227|NCT02891226|528612764|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146574228|NCT02891226|528612765|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146574229|NCT02891226|528612766|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146574230|NCT02891226|528612767|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146574231|NCT02891226|528612752|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146574232|NCT02891226|528612753|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146574233|NCT02891226|528612754|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146574234|NCT02891226|528612755|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146574235|NCT02891226|528612756|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
146574236|NCT02891226|528612757|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146574237|NCT02891226|528612758|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146574238|NCT02891226|528612759|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146574239|NCT02891226|528612760|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146574240|NCT02891226|528612761|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146574241|NCT02891226|528612762|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146574242|NCT02891226|528612763|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146574243|NCT02891226|528612764|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146574244|NCT02891226|528612765|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146574245|NCT02891226|528612766|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146574246|NCT02891226|528612767|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146574247|NCT02891226|528612752|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146574248|NCT02891226|528612753|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146574249|NCT02891226|528612754|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146574250|NCT02891226|528612755|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146651851|NCT03400956|528902291|FG001|Treatment Period 2|Adverse Event|1|||
146917517|NCT00114972|529860174|FG000|Overall Study|Withdrawal by Subject|40|||
146917518|NCT00114972|529860175|FG001|Overall Study|Withdrawal by Subject|7|||
146917519|NCT00114972|529860174|FG000|Overall Study|Lost to Follow-up|8|||
146917520|NCT00114972|529860175|FG001|Overall Study|Lost to Follow-up|5|||
146917521|NCT02890329|529860176|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
146917522|NCT02890329|529860177|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
146917523|NCT02890329|529860178|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
146917524|NCT02890329|529860179|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
146917525|NCT02890329|529860180|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
146917526|NCT02890329|529860181|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
146917527|NCT02890329|529860176|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
146917528|NCT02890329|529860177|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
146917529|NCT02890329|529860178|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
146917530|NCT02890329|529860179|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
146917531|NCT02890329|529860180|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
146917532|NCT02890329|529860181|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
146917533|NCT02890329|529860176|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
146917534|NCT02890329|529860177|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
146917535|NCT02890329|529860178|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
146917536|NCT02890329|529860179|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
146917537|NCT02890329|529860180|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
146917538|NCT02890329|529860181|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
146917539|NCT02890329|529860176|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
146977418|NCT05788237|530079441|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
146574251|NCT02891226|528612756|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146574252|NCT02891226|528612757|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146917540|NCT02890329|529860177|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
146917541|NCT02890329|529860178|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
146917542|NCT02890329|529860179|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
146917543|NCT02890329|529860180|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
146917544|NCT02890329|529860181|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
146917545|NCT00933335|529860182|FG000|Overall Study|Lost to Follow-up|1|||
146574253|NCT02891226|528612758|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
146574254|NCT02891226|528612759|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146574255|NCT02891226|528612760|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146574256|NCT02891226|528612761|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146574257|NCT02891226|528612762|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146574258|NCT02891226|528612763|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146574259|NCT02891226|528612764|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146574260|NCT02891226|528612765|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146574261|NCT02891226|528612766|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146574262|NCT02891226|528612767|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146574263|NCT02891226|528612752|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146574264|NCT02891226|528612753|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146574265|NCT02891226|528612754|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146574266|NCT02891226|528612755|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146574267|NCT02891226|528612756|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146574268|NCT02891226|528612757|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146574269|NCT02891226|528612758|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146574270|NCT02891226|528612759|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
146574271|NCT02891226|528612760|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
146574272|NCT02891226|528612761|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
146574273|NCT02891226|528612762|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146574274|NCT02891226|528612763|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146574275|NCT02891226|528612764|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146574276|NCT02891226|528612765|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146574277|NCT02891226|528612766|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146574278|NCT02891226|528612767|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146574279|NCT02891226|528612752|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146574280|NCT02891226|528612753|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146574281|NCT02891226|528612754|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146574282|NCT02891226|528612755|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146574283|NCT02891226|528612756|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146574284|NCT02891226|528612757|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146574285|NCT02891226|528612758|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146574286|NCT02891226|528612759|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
146574287|NCT02891226|528612760|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146574288|NCT02891226|528612761|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146574289|NCT02891226|528612762|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146574290|NCT02891226|528612763|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146574291|NCT02891226|528612764|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146574292|NCT02891226|528612765|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146574293|NCT02891226|528612766|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146574294|NCT02891226|528612767|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146574295|NCT02891226|528612752|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146574296|NCT02891226|528612753|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146574297|NCT02891226|528612754|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146574298|NCT02891226|528612755|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146574299|NCT02891226|528612756|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146574300|NCT02891226|528612757|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146574301|NCT02891226|528612758|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146574302|NCT02891226|528612759|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146574303|NCT02891226|528612760|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
146574304|NCT02891226|528612761|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146574305|NCT02891226|528612762|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146574306|NCT02891226|528612763|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146574307|NCT02891226|528612764|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146574308|NCT02891226|528612765|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146574309|NCT02891226|528612766|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146574310|NCT02891226|528612767|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146574311|NCT02891226|528612752|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146574312|NCT02891226|528612753|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146574313|NCT02891226|528612754|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146574314|NCT02891226|528612755|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146917546|NCT00933335|529860183|FG001|Overall Study|Lost to Follow-up|3|||
146917547|NCT00933335|529860182|FG000|Overall Study|Withdrawal by Subject|0|||
146574315|NCT02891226|528612756|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146574316|NCT02891226|528612757|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146574317|NCT02891226|528612758|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146574318|NCT02891226|528612759|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146574319|NCT02891226|528612760|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146574320|NCT02891226|528612761|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
146574321|NCT02891226|528612762|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146574322|NCT02891226|528612763|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146574323|NCT02891226|528612764|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146574324|NCT02891226|528612765|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146574325|NCT02891226|528612766|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146574326|NCT02891226|528612767|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146574327|NCT02891226|528612752|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146574328|NCT02891226|528612753|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146574329|NCT02891226|528612754|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146574330|NCT02891226|528612755|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146574331|NCT02891226|528612756|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146574332|NCT02891226|528612757|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146574333|NCT02891226|528612758|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146574334|NCT02891226|528612759|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146574335|NCT02891226|528612760|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146574336|NCT02891226|528612761|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
146574337|NCT02891226|528612762|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146574338|NCT02891226|528612763|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146574339|NCT02891226|528612764|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146574340|NCT02891226|528612765|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146574341|NCT02891226|528612766|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146574342|NCT02891226|528612767|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146574343|NCT02891226|528612752|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146574344|NCT02891226|528612753|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146574345|NCT02891226|528612754|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146574346|NCT02891226|528612755|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146574347|NCT02891226|528612756|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146574348|NCT02891226|528612757|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146574349|NCT02891226|528612758|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146574350|NCT02891226|528612759|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146574351|NCT02891226|528612760|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146574352|NCT02891226|528612761|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146574353|NCT02891226|528612762|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
146574354|NCT02891226|528612763|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146574355|NCT02891226|528612764|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146574356|NCT02891226|528612765|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146574357|NCT02891226|528612766|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146574358|NCT02891226|528612767|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146574359|NCT02891226|528612752|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146917548|NCT00933335|529860183|FG001|Overall Study|Withdrawal by Subject|1|||
146917549|NCT00933335|529860182|FG000|Overall Study|Progressive Disease|0|||
146917550|NCT00933335|529860183|FG001|Overall Study|Progressive Disease|11|||
146917551|NCT00933335|529860182|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
146574360|NCT02891226|528612753|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146574361|NCT02891226|528612754|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146574362|NCT02891226|528612755|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146574363|NCT02891226|528612756|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146574364|NCT02891226|528612757|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146574365|NCT02891226|528612758|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146574366|NCT02891226|528612759|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146574367|NCT02891226|528612760|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146574368|NCT02891226|528612761|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146574369|NCT02891226|528612762|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
146574370|NCT02891226|528612763|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146574371|NCT02891226|528612764|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146574372|NCT02891226|528612765|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146574373|NCT02891226|528612766|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146574374|NCT02891226|528612767|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146574375|NCT02891226|528612752|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146574376|NCT02891226|528612753|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146574377|NCT02891226|528612754|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146574378|NCT02891226|528612755|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146574379|NCT02891226|528612756|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146574380|NCT02891226|528612757|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146574381|NCT02891226|528612758|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146574382|NCT02891226|528612759|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146574383|NCT02891226|528612760|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146574384|NCT02891226|528612761|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146574385|NCT02891226|528612762|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
146574386|NCT02891226|528612763|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146574387|NCT02891226|528612764|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146574388|NCT02891226|528612765|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146574389|NCT02891226|528612766|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146574390|NCT02891226|528612767|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146574391|NCT02891226|528612752|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146574392|NCT02891226|528612753|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146574393|NCT02891226|528612754|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146574394|NCT02891226|528612755|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146574395|NCT02891226|528612756|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146574396|NCT02891226|528612757|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146574397|NCT02891226|528612758|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146574398|NCT02891226|528612759|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146917552|NCT00933335|529860183|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
146917553|NCT00933335|529860182|FG000|Overall Study|Co-morbid Illness|1|||
146917554|NCT00933335|529860183|FG001|Overall Study|Co-morbid Illness|0|||
146917555|NCT03880227|529860184|FG000|First Visit|Withdrawal by Subject|1|||
146917556|NCT03880227|529860185|FG001|First Visit|Withdrawal by Subject|0|||
146917557|NCT03880227|529860186|FG002|First Visit|Withdrawal by Subject|0|||
146917558|NCT03880227|529860187|FG003|First Visit|Withdrawal by Subject|0|||
146917559|NCT03880227|529860184|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
146917560|NCT03880227|529860185|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
146917561|NCT03880227|529860186|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
146917562|NCT03880227|529860187|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
146917563|NCT03880227|529860184|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
146917564|NCT03880227|529860185|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
146917565|NCT03880227|529860186|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
146917566|NCT03880227|529860187|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
146917567|NCT03880227|529860184|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
146917568|NCT03880227|529860185|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
146917569|NCT03880227|529860186|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
146917570|NCT03880227|529860187|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
146917571|NCT00504166|529860188|FG000|Overall Study|Adverse Event|1|||
146917572|NCT00504166|529860189|FG001|Overall Study|Adverse Event|4|||
146917573|NCT00504166|529860188|FG000|Overall Study|Withdrawal by Subject|3|||
146917574|NCT00504166|529860189|FG001|Overall Study|Withdrawal by Subject|6|||
146917575|NCT00504166|529860188|FG000|Overall Study|Physician Decision|1|||
146917576|NCT00504166|529860189|FG001|Overall Study|Physician Decision|1|||
146917577|NCT00504166|529860188|FG000|Overall Study|Lost to Follow-up|1|||
146917578|NCT00504166|529860189|FG001|Overall Study|Lost to Follow-up|3|||
146917579|NCT02650284|529860190|FG000|Overall Study|Lost to Follow-up|3|||
146917580|NCT02650284|529860191|FG001|Overall Study|Lost to Follow-up|3|||
146917581|NCT02650284|529860190|FG000|Overall Study|Consent incorrectly taken|0|||
146917582|NCT02650284|529860191|FG001|Overall Study|Consent incorrectly taken|1|||
146917583|NCT04590937|529860192|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
146917584|NCT02084134|529860200|FG000|Overall Study|Protocol Violation|4|||
146917585|NCT02084134|529860201|FG001|Overall Study|Protocol Violation|2|||
146917586|NCT02084134|529860200|FG000|Overall Study|Death|0|||
146917587|NCT02084134|529860201|FG001|Overall Study|Death|1|||
146917588|NCT02807454|529860202|FG000|Overall Study|Adverse Event|1|||
146917589|NCT02807454|529860203|FG001|Overall Study|Adverse Event|0|||
146917590|NCT02807454|529860202|FG000|Overall Study|Withdrawal by Subject|0|||
146917591|NCT02807454|529860203|FG001|Overall Study|Withdrawal by Subject|1|||
146917592|NCT02807454|529860202|FG000|Overall Study|Progressive Disease|30|||
146917593|NCT02807454|529860203|FG001|Overall Study|Progressive Disease|3|||
146917594|NCT02807454|529860202|FG000|Overall Study|Other Reasons|1|||
146574399|NCT02891226|528612760|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146574400|NCT02891226|528612761|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146574401|NCT02891226|528612762|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
146574402|NCT02891226|528612763|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146574403|NCT02891226|528612764|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146574404|NCT02891226|528612765|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146574405|NCT02891226|528612766|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146574406|NCT02891226|528612767|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146574407|NCT02891226|528612752|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146574408|NCT02891226|528612753|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146574409|NCT02891226|528612754|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146574410|NCT02891226|528612755|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146574411|NCT02891226|528612756|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146574412|NCT02891226|528612757|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146574413|NCT02891226|528612758|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146574414|NCT02891226|528612759|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146574415|NCT02891226|528612760|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146574416|NCT02891226|528612761|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146574417|NCT02891226|528612762|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
146574418|NCT02891226|528612763|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146574419|NCT02891226|528612764|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146574420|NCT02891226|528612765|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146574421|NCT02891226|528612766|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146574422|NCT02891226|528612767|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146574423|NCT02891226|528612752|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146574424|NCT02891226|528612753|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146574425|NCT02891226|528612754|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146574426|NCT02891226|528612755|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146574427|NCT02891226|528612756|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146574428|NCT02891226|528612757|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146574429|NCT02891226|528612758|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146574430|NCT02891226|528612759|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146574431|NCT02891226|528612760|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146574432|NCT02891226|528612761|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146574433|NCT02891226|528612762|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
146574434|NCT02891226|528612763|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146574435|NCT02891226|528612764|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146574436|NCT02891226|528612765|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146917595|NCT02807454|529860203|FG001|Overall Study|Other Reasons|1|||
146917596|NCT05468086|529860204|FG000|Overall Study|Withdrawal by Subject|3|||
146917597|NCT05468086|529860204|FG000|Overall Study|Subject was found ineligible after consent|1|||
146917598|NCT01165203|529860205|FG000|Active Phase|Serious Adverse Event|1|||
146917599|NCT01165203|529860206|FG001|Active Phase|Serious Adverse Event|0|||
146917600|NCT01165203|529860205|FG000|Active Phase|Withdrawal by Subject|2|||
146917601|NCT01165203|529860206|FG001|Active Phase|Withdrawal by Subject|1|||
146917602|NCT01165203|529860205|FG000|Active Phase|Migrated/moved from study area|0|||
146917603|NCT01165203|529860206|FG001|Active Phase|Migrated/moved from study area|1|||
146917604|NCT01165203|529860205|FG000|Active Phase|Lost to Follow-up|2|||
146917605|NCT01165203|529860206|FG001|Active Phase|Lost to Follow-up|0|||
146917606|NCT01165203|529860205|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
146917607|NCT01165203|529860206|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
146917608|NCT01165203|529860205|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
146917609|NCT01165203|529860206|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
146917610|NCT01165203|529860205|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
146917611|NCT01165203|529860206|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
146917612|NCT01165203|529860205|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
146917613|NCT01165203|529860206|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
146917614|NCT01165203|529860205|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
146917615|NCT01165203|529860206|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
146917616|NCT01070784|529860207|FG000|Overall Study|Withdrawal by Subject|6|||
146917617|NCT01070784|529860208|FG001|Overall Study|Withdrawal by Subject|9|||
146917618|NCT01070784|529860207|FG000|Overall Study|Adverse Event|14|||
146917619|NCT01070784|529860208|FG001|Overall Study|Adverse Event|9|||
146917620|NCT02815397|529860210|FG000|Overall Study|Physician Decision|2|||
146917621|NCT00085540|529860211|FG000|Overall Study|Withdrawal by Subject|0|||
146917622|NCT00085540|529860212|FG001|Overall Study|Withdrawal by Subject|1|||
146574437|NCT02891226|528612766|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146574438|NCT02891226|528612767|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146574439|NCT02891226|528612752|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146574440|NCT02891226|528612753|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146574441|NCT02891226|528612754|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146574442|NCT02891226|528612755|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146574443|NCT02891226|528612756|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146574444|NCT02891226|528612757|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146574445|NCT02891226|528612758|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146574446|NCT02891226|528612759|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146574447|NCT02891226|528612760|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146574448|NCT02891226|528612761|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146574449|NCT02891226|528612762|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
146574450|NCT02891226|528612763|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146574451|NCT02891226|528612764|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146574452|NCT02891226|528612765|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146574453|NCT02891226|528612766|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146574454|NCT02891226|528612767|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146574455|NCT02891226|528612752|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146574456|NCT02891226|528612753|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146574457|NCT02891226|528612754|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146574458|NCT02891226|528612755|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146770605|NCT01135511|529328646|FG004|Overall Study|Lack of Efficacy|0|||
146770606|NCT01135511|529328647|FG005|Overall Study|Lack of Efficacy|0|||
146574459|NCT02891226|528612756|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146574460|NCT02891226|528612757|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146574461|NCT02891226|528612758|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146574462|NCT02891226|528612759|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146574463|NCT02891226|528612760|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146574464|NCT02891226|528612761|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146574465|NCT02891226|528612762|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
146770607|NCT01135511|529328648|FG006|Overall Study|Lack of Efficacy|0|||
146770608|NCT01135511|529328649|FG007|Overall Study|Lack of Efficacy|0|||
146917623|NCT00085540|529860211|FG000|Overall Study|Protocol Violation|0|||
146917624|NCT00085540|529860212|FG001|Overall Study|Protocol Violation|1|||
146917625|NCT01518192|529860213|FG000|Overall Study|Lost to Follow-up|29|||
146917626|NCT01518192|529860214|FG001|Overall Study|Lost to Follow-up|26|||
146917627|NCT01518192|529860215|FG002|Overall Study|Lost to Follow-up|35|||
146917628|NCT00783705|529860216|FG000|Overall Study|Adverse Event|2|||
146917629|NCT00783705|529860217|FG001|Overall Study|Adverse Event|0|||
146917630|NCT00783705|529860216|FG000|Overall Study|Withdrawal by Subject|3|||
146917631|NCT00783705|529860217|FG001|Overall Study|Withdrawal by Subject|2|||
146917632|NCT00783705|529860216|FG000|Overall Study|Lost to Follow-up|1|||
146917633|NCT00783705|529860217|FG001|Overall Study|Lost to Follow-up|3|||
146917634|NCT00426751|529860218|FG000|Overall Study|Adverse Event|8|||
146917635|NCT00426751|529860219|FG001|Overall Study|Adverse Event|1|||
146917636|NCT00426751|529860218|FG000|Overall Study|Lost to Follow-up|7|||
146917637|NCT00426751|529860219|FG001|Overall Study|Lost to Follow-up|6|||
146917638|NCT00426751|529860218|FG000|Overall Study|Consent Withdrawn|0|||
146917639|NCT00426751|529860219|FG001|Overall Study|Consent Withdrawn|1|||
146917640|NCT00426751|529860218|FG000|Overall Study|Other Reasons|7|||
146917641|NCT00426751|529860219|FG001|Overall Study|Other Reasons|12|||
146917642|NCT01200511|529860224|FG000|Overall Study|Lost to Follow-up|3|||
146917643|NCT01200511|529860224|FG000|Overall Study|Withdrawal by Subject|1|||
146917644|NCT01200511|529860224|FG000|Overall Study|Adverse Event|1|||
146917645|NCT03288779|529860225|FG000|Overall Study|Withdrawal by Subject|3|||
146917646|NCT01355068|529860229|FG000|First Intervention Period|Adverse Event|0|||
146917647|NCT01355068|529860230|FG001|First Intervention Period|Adverse Event|1|||
146917648|NCT01355068|529860229|FG000|First Intervention Period|Withdrawal by Subject|0|||
146917649|NCT01355068|529860230|FG001|First Intervention Period|Withdrawal by Subject|1|||
146917650|NCT02504892|529860231|FG000|Overall Study|Adverse event-pneumonitis|2|||
146917651|NCT00524745|529860232|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
146917652|NCT00524745|529860233|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
146917653|NCT00524745|529860234|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
146917654|NCT00524745|529860235|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
146917655|NCT00237796|529860236|FG000|Overall Study|Baseline and one other ILSS required|10|||
147013238|NCT01708954|530210056|FG002|Step 1|Other complicating disease|0|||
146977419|NCT05788237|530079442|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
146977420|NCT05788237|530079443|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
146977421|NCT05788237|530079440|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
146977422|NCT05788237|530079441|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
146977423|NCT05788237|530079442|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
146977424|NCT05788237|530079443|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
146977425|NCT05788237|530079440|FG000|SSA (Approximately 2 Months)|Death|0|||
146977426|NCT05788237|530079441|FG001|SSA (Approximately 2 Months)|Death|1|||
146977427|NCT05788237|530079442|FG002|SSA (Approximately 2 Months)|Death|0|||
146977428|NCT05788237|530079443|FG003|SSA (Approximately 2 Months)|Death|0|||
146977429|NCT05788237|530079440|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
146977430|NCT05788237|530079441|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
146977431|NCT05788237|530079442|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
146977432|NCT05788237|530079443|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
146977433|NCT05788237|530079440|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
146977434|NCT05788237|530079441|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
146977435|NCT05788237|530079442|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
146977436|NCT05788237|530079443|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
146977437|NCT05788237|530079440|FG000|SSB (Approximately 1 Month)|Other|0|||
146977438|NCT05788237|530079441|FG001|SSB (Approximately 1 Month)|Other|0|||
146977439|NCT05788237|530079442|FG002|SSB (Approximately 1 Month)|Other|0|||
146977440|NCT05788237|530079443|FG003|SSB (Approximately 1 Month)|Other|1|||
146977441|NCT01835470|530080942|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
146651852|NCT03400956|528902292|FG002|Treatment Period 2|Adverse Event|1|||
146977442|NCT01835470|530080942|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
146977443|NCT01011907|530080943|FG000|Overall Study|Withdrawal by Subject|13|||
146977444|NCT01011907|530080944|FG001|Overall Study|Withdrawal by Subject|11|||
146977445|NCT01011907|530080943|FG000|Overall Study|Adverse Event|1|||
146977446|NCT01011907|530080944|FG001|Overall Study|Adverse Event|4|||
146977447|NCT00304954|530080945|FG000|Overall Study|Withdrawal by Subject|0|||
146977448|NCT00304954|530080946|FG001|Overall Study|Withdrawal by Subject|0|||
146977449|NCT00304954|530080947|FG002|Overall Study|Withdrawal by Subject|1|||
146977450|NCT00304954|530080948|FG003|Overall Study|Withdrawal by Subject|0|||
146977451|NCT00304954|530080945|FG000|Overall Study|Adverse Event|1|||
146977452|NCT00304954|530080946|FG001|Overall Study|Adverse Event|0|||
146977453|NCT00304954|530080947|FG002|Overall Study|Adverse Event|0|||
146977454|NCT00304954|530080948|FG003|Overall Study|Adverse Event|0|||
146977455|NCT01406873|530080953|FG000|Overall Study|Withdrawal by Subject|1|||
146977456|NCT01406873|530080954|FG001|Overall Study|Withdrawal by Subject|1|||
146574466|NCT02891226|528612763|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146574467|NCT02891226|528612764|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146574468|NCT02891226|528612765|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146574469|NCT02891226|528612766|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146574470|NCT02891226|528612767|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146574471|NCT02891226|528612752|FG000|Follow-up Period|Withdrawal by Subject|0|||
146574472|NCT02891226|528612753|FG001|Follow-up Period|Withdrawal by Subject|0|||
146574473|NCT02891226|528612754|FG002|Follow-up Period|Withdrawal by Subject|0|||
146574474|NCT02891226|528612755|FG003|Follow-up Period|Withdrawal by Subject|0|||
146574475|NCT02891226|528612756|FG004|Follow-up Period|Withdrawal by Subject|0|||
146574476|NCT02891226|528612757|FG005|Follow-up Period|Withdrawal by Subject|0|||
146574477|NCT02891226|528612758|FG006|Follow-up Period|Withdrawal by Subject|0|||
146574478|NCT02891226|528612759|FG007|Follow-up Period|Withdrawal by Subject|0|||
146574479|NCT02891226|528612760|FG008|Follow-up Period|Withdrawal by Subject|0|||
146574480|NCT02891226|528612761|FG009|Follow-up Period|Withdrawal by Subject|0|||
146574481|NCT02891226|528612762|FG010|Follow-up Period|Withdrawal by Subject|0|||
146574482|NCT02891226|528612763|FG011|Follow-up Period|Withdrawal by Subject|1|||
146574483|NCT02891226|528612764|FG012|Follow-up Period|Withdrawal by Subject|0|||
146574484|NCT02891226|528612765|FG013|Follow-up Period|Withdrawal by Subject|0|||
146574485|NCT02891226|528612766|FG014|Follow-up Period|Withdrawal by Subject|1|||
146574486|NCT02891226|528612767|FG015|Follow-up Period|Withdrawal by Subject|1|||
146574487|NCT03381287|528612771|FG000|Overall Study|Withdrawal by Subject|0|||
146574488|NCT03381287|528612772|FG001|Overall Study|Withdrawal by Subject|1|||
146574489|NCT03381287|528612773|FG002|Overall Study|Withdrawal by Subject|0|||
146574490|NCT03381287|528612774|FG003|Overall Study|Withdrawal by Subject|0|||
146574491|NCT03381287|528612771|FG000|Overall Study|Adverse Event|0|||
146574492|NCT03381287|528612772|FG001|Overall Study|Adverse Event|0|||
146977457|NCT00207714|530080955|FG000|Overall Study|Adverse Event|6|||
146977458|NCT00207714|530080956|FG001|Overall Study|Adverse Event|2|||
146977459|NCT00207714|530080957|FG002|Overall Study|Adverse Event|4|||
146977460|NCT00207714|530080958|FG003|Overall Study|Adverse Event|3|||
146977461|NCT00207714|530080959|FG004|Overall Study|Adverse Event|1|||
146977462|NCT00207714|530080955|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
146977463|NCT00207714|530080956|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
146977464|NCT00207714|530080957|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
146977465|NCT00207714|530080958|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
146977466|NCT00207714|530080959|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
146977467|NCT00207714|530080955|FG000|Overall Study|Other|3|||
146977468|NCT00207714|530080956|FG001|Overall Study|Other|2|||
146977469|NCT00207714|530080957|FG002|Overall Study|Other|5|||
146977470|NCT00207714|530080958|FG003|Overall Study|Other|1|||
146977471|NCT00207714|530080959|FG004|Overall Study|Other|0|||
146977472|NCT03627195|530080960|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
146977473|NCT03627195|530080961|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
146977474|NCT03627195|530080962|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
146977475|NCT03627195|530080963|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
146977476|NCT03627195|530080964|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
146977477|NCT03627195|530080965|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
146977478|NCT02290028|530080968|FG000|Overall Study|Death|217|||
146977479|NCT02290028|530080968|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
146977480|NCT02290028|530080968|FG000|Overall Study|No longer under care of study physician|76|||
146977481|NCT02290028|530080968|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
146977482|NCT02290028|530080968|FG000|Overall Study|Withdrawal by Subject|52|||
146977483|NCT02290028|530080968|FG000|Overall Study|Study site closure|44|||
146977484|NCT02290028|530080968|FG000|Overall Study|Lost to Follow-up|34|||
146977485|NCT02290028|530080968|FG000|Overall Study|Miscellaneous|10|||
146977486|NCT02290028|530080968|FG000|Overall Study|Transition to EP PASSION|1295|||
146977487|NCT02290028|530080968|FG000|Overall Study|Planned study completion at 12 months|257|||
146977488|NCT03862625|530080969|FG000|Overall Study|Lost to Follow-up|0|||
146977489|NCT03862625|530080970|FG001|Overall Study|Lost to Follow-up|1|||
146977490|NCT00856778|530080972|FG000|Overall Study|Adverse Event|7|||
146977491|NCT00856778|530080972|FG000|Overall Study|Withdrawal by Subject|10|||
146977492|NCT00856778|530080972|FG000|Overall Study|Study deviation|2|||
146977493|NCT00856778|530080972|FG000|Overall Study|Lost to Follow-up|5|||
146977494|NCT01681771|530080973|FG000|Overall Study|Lost to Follow-up|4|||
146574493|NCT03381287|528612773|FG002|Overall Study|Adverse Event|0|||
146574494|NCT03381287|528612774|FG003|Overall Study|Adverse Event|1|||
146574495|NCT03381287|528612771|FG000|Overall Study|Physician Decision|0|||
146574496|NCT03381287|528612772|FG001|Overall Study|Physician Decision|0|||
146574497|NCT03381287|528612773|FG002|Overall Study|Physician Decision|0|||
146574498|NCT03381287|528612774|FG003|Overall Study|Physician Decision|1|||
146574499|NCT02454530|528612779|FG000|Overall Study|Other|8|||
146977495|NCT01681771|530080974|FG001|Overall Study|Lost to Follow-up|2|||
146574500|NCT02454530|528612780|FG001|Overall Study|Other|13|||
146574501|NCT02454530|528612779|FG000|Overall Study|Missing information|56|||
146574502|NCT02454530|528612780|FG001|Overall Study|Missing information|69|||
146574503|NCT02454530|528612779|FG000|Overall Study|Death|2|||
146574504|NCT02454530|528612780|FG001|Overall Study|Death|41|||
146574505|NCT02454530|528612779|FG000|Overall Study|Lost to Follow-up|4|||
146574506|NCT02454530|528612780|FG001|Overall Study|Lost to Follow-up|4|||
146574507|NCT02137070|528612782|FG000|Overall Study|Adverse Event|12|||
146574508|NCT02137070|528612783|FG001|Overall Study|Adverse Event|3|||
146574509|NCT02137070|528612782|FG000|Overall Study|Death|2|||
146574510|NCT02137070|528612783|FG001|Overall Study|Death|0|||
146574511|NCT02137070|528612782|FG000|Overall Study|Lost to Follow-up|24|||
146574512|NCT02137070|528612783|FG001|Overall Study|Lost to Follow-up|9|||
146574513|NCT02137070|528612782|FG000|Overall Study|Physician Decision|0|||
146574514|NCT02137070|528612783|FG001|Overall Study|Physician Decision|1|||
146574515|NCT02137070|528612782|FG000|Overall Study|Protocol Violation|18|||
146574516|NCT02137070|528612783|FG001|Overall Study|Protocol Violation|4|||
146574517|NCT02137070|528612782|FG000|Overall Study|Withdrawal by Subject|18|||
146574518|NCT02137070|528612783|FG001|Overall Study|Withdrawal by Subject|1|||
146574519|NCT03533660|528612784|FG000|Overall Study|Withdrawal by Subject|2|||
146574520|NCT03533660|528612785|FG001|Overall Study|Withdrawal by Subject|2|||
146574521|NCT03533660|528612784|FG000|Overall Study|Death|2|||
146574522|NCT03533660|528612785|FG001|Overall Study|Death|4|||
146574523|NCT03533660|528612784|FG000|Overall Study|Adverse Event|0|||
146574524|NCT03533660|528612785|FG001|Overall Study|Adverse Event|2|||
146574525|NCT00996658|528612786|FG000|Overall Study|Adverse Event|2|||
146574526|NCT00996658|528612787|FG001|Overall Study|Adverse Event|5|||
146574527|NCT00996658|528612786|FG000|Overall Study|Protocol Violation|0|||
146574528|NCT00996658|528612787|FG001|Overall Study|Protocol Violation|1|||
146574529|NCT00996658|528612786|FG000|Overall Study|Lost to Follow-up|2|||
146574530|NCT00996658|528612787|FG001|Overall Study|Lost to Follow-up|5|||
146574531|NCT00996658|528612786|FG000|Overall Study|Non-compliance issues|3|||
146574532|NCT00996658|528612787|FG001|Overall Study|Non-compliance issues|3|||
146574533|NCT00996658|528612786|FG000|Overall Study|Other|9|||
146574534|NCT00996658|528612787|FG001|Overall Study|Other|7|||
146574535|NCT04487080|528612797|FG000|Overall Study|Withdrawal by Subject|19|||
146574536|NCT04487080|528612798|FG001|Overall Study|Withdrawal by Subject|18|||
146977496|NCT04242186|530080977|FG000|Overall Study|Death|5|||
146977497|NCT00550420|530080978|FG000|Overall Study|Adverse Event|28|||
146977498|NCT00550420|530080978|FG000|Overall Study|Lost to Follow-up|8|||
146977499|NCT00550420|530080978|FG000|Overall Study|Protocol Violation|11|||
146977500|NCT00550420|530080978|FG000|Overall Study|Withdrawal by Subject|30|||
146977501|NCT00550420|530080978|FG000|Overall Study|Still in study at termination|206|||
146977502|NCT00550420|530080978|FG000|Overall Study|Missing|2|||
146977503|NCT00550420|530080978|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
146977504|NCT00550420|530080978|FG000|Overall Study|Investigators opinion|1|||
146977505|NCT00550420|530080978|FG000|Overall Study|Lack of curative effect|1|||
146977506|NCT00550420|530080978|FG000|Overall Study|Unethical stop of enrollment|2|||
146977507|NCT00550420|530080978|FG000|Overall Study|Caregiver's decision to withdraw|1|||
146977508|NCT00550420|530080978|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
146574537|NCT04487080|528612799|FG002|Overall Study|Withdrawal by Subject|13|||
146574538|NCT04487080|528612797|FG000|Overall Study|Lost to Follow-up|3|||
146574539|NCT04487080|528612798|FG001|Overall Study|Lost to Follow-up|1|||
146574540|NCT04487080|528612799|FG002|Overall Study|Lost to Follow-up|0|||
146574541|NCT04487080|528612797|FG000|Overall Study|Ongoing|313|||
146574542|NCT04487080|528612798|FG001|Overall Study|Ongoing|297|||
146574543|NCT04487080|528612799|FG002|Overall Study|Ongoing|149|||
146574544|NCT02842086|528612800|FG000|Overall Study|Randomized but Never Treated|6|||
146574545|NCT02842086|528612801|FG001|Overall Study|Randomized but Never Treated|6|||
146574546|NCT02842086|528612800|FG000|Overall Study|Still in Double-Blind Phase|7|||
146917656|NCT00237796|529860237|FG001|Overall Study|Baseline and one other ILSS required|5|||
146917657|NCT01770353|529860238|FG000|Overall Study|Progressive disease|2|||
146917658|NCT01770353|529860239|FG001|Overall Study|Progressive disease|1|||
146917659|NCT01770353|529860238|FG000|Overall Study|Adverse Event|0|||
146917660|NCT01770353|529860239|FG001|Overall Study|Adverse Event|1|||
146574547|NCT02842086|528612801|FG001|Overall Study|Still in Double-Blind Phase|3|||
146574548|NCT02842086|528612800|FG000|Overall Study|Adverse Event|18|||
146574549|NCT02842086|528612801|FG001|Overall Study|Adverse Event|20|||
146574550|NCT02842086|528612800|FG000|Overall Study|Death|3|||
146574551|NCT02842086|528612801|FG001|Overall Study|Death|3|||
146574552|NCT02842086|528612800|FG000|Overall Study|Investigator's Discretion|9|||
146574553|NCT02842086|528612801|FG001|Overall Study|Investigator's Discretion|13|||
146574554|NCT02842086|528612800|FG000|Overall Study|Non-Compliance with Study Drug|9|||
146574555|NCT02842086|528612801|FG001|Overall Study|Non-Compliance with Study Drug|8|||
146574556|NCT02842086|528612800|FG000|Overall Study|Protocol Violation|8|||
146574557|NCT02842086|528612801|FG001|Overall Study|Protocol Violation|4|||
146574558|NCT02842086|528612800|FG000|Overall Study|Withdrew Consent|205|||
146574559|NCT02842086|528612801|FG001|Overall Study|Withdrew Consent|194|||
146917661|NCT01770353|529860238|FG000|Overall Study|Protocol Violation|1|||
146574560|NCT02842086|528612800|FG000|Overall Study|Lost to Follow-up|274|||
146574561|NCT02842086|528612801|FG001|Overall Study|Lost to Follow-up|236|||
146574562|NCT02842086|528612800|FG000|Overall Study|HIV-1 Infection|5|||
146574563|NCT02842086|528612801|FG001|Overall Study|HIV-1 Infection|6|||
146917662|NCT01770353|529860239|FG001|Overall Study|Protocol Violation|0|||
146917663|NCT01770353|529860238|FG000|Overall Study|Physician Decision|0|||
146917664|NCT01770353|529860239|FG001|Overall Study|Physician Decision|3|||
146574564|NCT03451851|528612802|FG000|PCP: Week 0 -16|Adverse Event|1|||
146574565|NCT03451851|528612803|FG001|PCP: Week 0 -16|Adverse Event|0|||
146574566|NCT03451851|528612804|FG002|PCP: Week 0 -16|Adverse Event|0|||
146574567|NCT03451851|528612805|FG003|PCP: Week 0 -16|Adverse Event|0|||
146574568|NCT03451851|528612806|FG004|PCP: Week 0 -16|Adverse Event|0|||
146574569|NCT03451851|528612807|FG005|PCP: Week 0 -16|Adverse Event|0|||
146574570|NCT03451851|528612808|FG006|PCP: Week 0 -16|Adverse Event|1|||
146574571|NCT03451851|528612809|FG007|PCP: Week 0 -16|Adverse Event|0|||
146574572|NCT03451851|528612802|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
146574573|NCT03451851|528612803|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
146574574|NCT03451851|528612804|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
146574575|NCT03451851|528612805|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
146574576|NCT03451851|528612806|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
146574577|NCT03451851|528612807|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
146574578|NCT03451851|528612808|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
146574579|NCT03451851|528612809|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
146574580|NCT03451851|528612802|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
146574581|NCT03451851|528612803|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
146917665|NCT01770353|529860238|FG000|Overall Study|Clinical deterioration|3|||
146917666|NCT01770353|529860239|FG001|Overall Study|Clinical deterioration|6|||
146917667|NCT01770353|529860238|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
146977509|NCT00550420|530080978|FG000|Overall Study|Exclusion criteria|1|||
146574582|NCT03451851|528612804|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
146977510|NCT00550420|530080978|FG000|Overall Study|Prohibited medicine|1|||
146977511|NCT00331773|530080979|FG000|Overall Study|Withdrawal by Subject|6|||
146977512|NCT00331773|530080980|FG001|Overall Study|Withdrawal by Subject|4|||
146977513|NCT00331773|530080979|FG000|Overall Study|Protocol Violation|10|||
146977514|NCT00331773|530080980|FG001|Overall Study|Protocol Violation|3|||
146574583|NCT03451851|528612805|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
146917668|NCT01770353|529860239|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
146977515|NCT01792284|530080981|FG000|Lead-in Period|Adverse Event|15|||
146977516|NCT01792284|530080982|FG001|Lead-in Period|Adverse Event|0|||
146574584|NCT03451851|528612806|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
146574585|NCT03451851|528612807|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
146574586|NCT03451851|528612808|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
146574587|NCT03451851|528612809|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
146574588|NCT03451851|528612802|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
146574589|NCT03451851|528612803|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
146574590|NCT03451851|528612804|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
146574591|NCT03451851|528612805|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
146574592|NCT03451851|528612806|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
146574593|NCT03451851|528612807|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
146574594|NCT03451851|528612808|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
146574595|NCT03451851|528612809|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
146574596|NCT03451851|528612802|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
146574597|NCT03451851|528612803|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
146574598|NCT03451851|528612804|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
146574599|NCT03451851|528612805|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
146574600|NCT03451851|528612806|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
146574601|NCT03451851|528612807|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
146574602|NCT03451851|528612808|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
146574603|NCT03451851|528612809|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
146574604|NCT03451851|528612802|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
146574605|NCT03451851|528612803|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
146574606|NCT03451851|528612804|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
146574607|NCT03451851|528612805|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
146574608|NCT03451851|528612806|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
146574609|NCT03451851|528612807|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
146574610|NCT03451851|528612808|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
146574611|NCT03451851|528612809|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
146574612|NCT03581292|528612810|FG000|Overall Study|Physician Decision|9|||
146574613|NCT03581292|528612811|FG001|Overall Study|Physician Decision|5|||
146574614|NCT03581292|528612810|FG000|Overall Study|Withdrawal by Subject|3|||
146574615|NCT03581292|528612811|FG001|Overall Study|Withdrawal by Subject|0|||
146574616|NCT03581292|528612810|FG000|Overall Study|Withdrawal before Therapy Start|1|||
146574617|NCT03581292|528612811|FG001|Overall Study|Withdrawal before Therapy Start|0|||
146574618|NCT07214935|528612812|FG000|Overall Study|Adverse Event|1|||
146574619|NCT07214935|528612813|FG001|Overall Study|Adverse Event|1|||
146574620|NCT07214935|528612814|FG002|Overall Study|Adverse Event|1|||
146574621|NCT07214935|528612815|FG003|Overall Study|Adverse Event|0|||
146574622|NCT07214935|528612812|FG000|Overall Study|Lost to Follow-up|0|||
146574623|NCT07214935|528612813|FG001|Overall Study|Lost to Follow-up|1|||
146574624|NCT07214935|528612814|FG002|Overall Study|Lost to Follow-up|0|||
146574625|NCT07214935|528612815|FG003|Overall Study|Lost to Follow-up|0|||
146574626|NCT07214935|528612812|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
146574627|NCT07214935|528612813|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
146574628|NCT07214935|528612814|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
146574629|NCT07214935|528612815|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
146574630|NCT07214935|528612812|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
146770609|NCT01135511|529328650|FG008|Overall Study|Lack of Efficacy|0|||
146770610|NCT01135511|529328642|FG000|Overall Study|Protocol Violation|0|||
146917669|NCT00376688|529860240|FG000|Overall Study|Adverse Event|3|||
146917670|NCT00376688|529860240|FG000|Overall Study|Death|1|||
146917671|NCT02574312|529860241|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
146917672|NCT02574312|529860242|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
146917673|NCT05128162|529860243|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
146917674|NCT05128162|529860243|FG000|Overall Study|Physician Decision|1|||
146917675|NCT00370149|529860244|FG000|Overall Study|Physician Decision|16|||
146917676|NCT00370149|529860245|FG001|Overall Study|Physician Decision|16|||
146917677|NCT00370149|529860244|FG000|Overall Study|Protocol Violation|1|||
146917678|NCT00370149|529860245|FG001|Overall Study|Protocol Violation|0|||
146917679|NCT00370149|529860244|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
146917680|NCT00370149|529860245|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
146917681|NCT00370149|529860244|FG000|Overall Study|Pre-existing infection|0|||
146917682|NCT00370149|529860245|FG001|Overall Study|Pre-existing infection|1|||
146917683|NCT00370149|529860244|FG000|Overall Study|Antibiotic coated dressing placed|0|||
146917684|NCT00370149|529860245|FG001|Overall Study|Antibiotic coated dressing placed|1|||
146917685|NCT00620321|529861465|FG000|Overall Study|Adverse Event|1|||
146917686|NCT00620321|529861466|FG001|Overall Study|Adverse Event|1|||
146917687|NCT00620321|529861465|FG000|Overall Study|Death|1|||
146574631|NCT07214935|528612813|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
146574632|NCT07214935|528612814|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
146574633|NCT07214935|528612815|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
146574634|NCT04609553|528614334|FG000|Overall Study|Lost to Follow-up|27|||
146574635|NCT04609553|528614335|FG001|Overall Study|Lost to Follow-up|31|||
146574636|NCT04609553|528614336|FG002|Overall Study|Lost to Follow-up|24|||
146574637|NCT04609553|528614334|FG000|Overall Study|Discontinued|12|||
146574638|NCT04609553|528614335|FG001|Overall Study|Discontinued|10|||
146574639|NCT04609553|528614336|FG002|Overall Study|Discontinued|9|||
146574640|NCT01147965|528614340|FG000|Overall Study|Progressive Disease|3|||
146574641|NCT01147965|528614341|FG001|Overall Study|Progressive Disease|3|||
146574642|NCT01147965|528614342|FG002|Overall Study|Progressive Disease|5|||
146574643|NCT01147965|528614343|FG003|Overall Study|Progressive Disease|9|||
146574644|NCT01147965|528614344|FG004|Overall Study|Progressive Disease|5|||
146574645|NCT01147965|528614345|FG005|Overall Study|Progressive Disease|5|||
146574646|NCT01147965|528614340|FG000|Overall Study|Death|0|||
146574647|NCT01147965|528614341|FG001|Overall Study|Death|0|||
146574648|NCT01147965|528614342|FG002|Overall Study|Death|1|||
146574649|NCT01147965|528614343|FG003|Overall Study|Death|1|||
146574650|NCT01147965|528614344|FG004|Overall Study|Death|0|||
146574651|NCT01147965|528614345|FG005|Overall Study|Death|2|||
146574652|NCT01147965|528614340|FG000|Overall Study|Withdrawal by Subject|0|||
146574653|NCT01147965|528614341|FG001|Overall Study|Withdrawal by Subject|0|||
146574654|NCT01147965|528614342|FG002|Overall Study|Withdrawal by Subject|1|||
146574655|NCT01147965|528614343|FG003|Overall Study|Withdrawal by Subject|1|||
146574656|NCT01147965|528614344|FG004|Overall Study|Withdrawal by Subject|0|||
146574657|NCT01147965|528614345|FG005|Overall Study|Withdrawal by Subject|0|||
146574658|NCT01147965|528614340|FG000|Overall Study|Administration Of Alternative Therapy|0|||
146574659|NCT01147965|528614341|FG001|Overall Study|Administration Of Alternative Therapy|0|||
146574660|NCT01147965|528614342|FG002|Overall Study|Administration Of Alternative Therapy|0|||
146574661|NCT01147965|528614343|FG003|Overall Study|Administration Of Alternative Therapy|0|||
146574662|NCT01147965|528614344|FG004|Overall Study|Administration Of Alternative Therapy|0|||
146574663|NCT01147965|528614345|FG005|Overall Study|Administration Of Alternative Therapy|1|||
146574664|NCT01147965|528614340|FG000|Overall Study|Other|0|||
146574665|NCT01147965|528614341|FG001|Overall Study|Other|0|||
146574666|NCT01147965|528614342|FG002|Overall Study|Other|0|||
146574667|NCT01147965|528614343|FG003|Overall Study|Other|3|||
146574668|NCT01147965|528614344|FG004|Overall Study|Other|1|||
146574669|NCT01147965|528614345|FG005|Overall Study|Other|0|||
146574670|NCT01650831|528614348|FG000|Overall Study|Screen failure|1|||
146574671|NCT02522429|528614349|FG000|Overall Study|Lost to Follow-up|8|||
146574672|NCT02522429|528614349|FG000|Overall Study|Adverse Event|2|||
146574673|NCT02522429|528614349|FG000|Overall Study|Death|1|||
146574674|NCT02522429|528614349|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
146574675|NCT04988295|528614352|FG000|Overall Study|Withdrawal by Subject|9|||
146574676|NCT04988295|528614353|FG001|Overall Study|Withdrawal by Subject|29|||
146574677|NCT04988295|528614354|FG002|Overall Study|Withdrawal by Subject|6|||
146917688|NCT00620321|529861466|FG001|Overall Study|Death|1|||
146917689|NCT00620321|529861465|FG000|Overall Study|Physician Decision|0|||
146917690|NCT00620321|529861466|FG001|Overall Study|Physician Decision|7|||
146574678|NCT04988295|528614355|FG003|Overall Study|Withdrawal by Subject|0|||
146574679|NCT04988295|528614352|FG000|Overall Study|Lost to Follow-up|1|||
146574680|NCT04988295|528614353|FG001|Overall Study|Lost to Follow-up|0|||
146574681|NCT04988295|528614354|FG002|Overall Study|Lost to Follow-up|0|||
146574682|NCT04988295|528614355|FG003|Overall Study|Lost to Follow-up|0|||
146574683|NCT04988295|528614352|FG000|Overall Study|Study participation ongoing|186|||
146574684|NCT04988295|528614353|FG001|Overall Study|Study participation ongoing|169|||
146574685|NCT04988295|528614354|FG002|Overall Study|Study participation ongoing|99|||
146574686|NCT04988295|528614355|FG003|Overall Study|Study participation ongoing|119|||
146574687|NCT01273038|528614358|FG000|Second Intervention (14 Days)|Adverse Event|0|||
146574688|NCT01273038|528614359|FG001|Second Intervention (14 Days)|Adverse Event|1|||
146574689|NCT01273038|528614358|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
146574690|NCT01273038|528614359|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
146574691|NCT02197572|528614360|FG000|Overall Study|Progressive Disease|28|||
146574692|NCT02197572|528614360|FG000|Overall Study|Withdrawal by Subject|9|||
146574693|NCT02197572|528614360|FG000|Overall Study|Adverse Event|3|||
146574694|NCT02197572|528614360|FG000|Overall Study|Reason Not Specified|4|||
146574695|NCT03458325|528614366|FG000|Overall Study|Withdrawal by Subject|1|||
146574696|NCT00175916|528614367|FG000|Overall Study|Death|19|||
146574697|NCT00175916|528614367|FG000|Overall Study|Adverse Event|81|||
146574698|NCT00175916|528614367|FG000|Overall Study|Lack of Efficacy|354|||
146574699|NCT00175916|528614367|FG000|Overall Study|Lost to Follow-up|17|||
146574700|NCT00175916|528614367|FG000|Overall Study|Subject Choice|98|||
146574701|NCT00175916|528614367|FG000|Overall Study|Lack of compliance|8|||
146574702|NCT00175916|528614367|FG000|Overall Study|Patient cannot record seizures|1|||
146574703|NCT00175916|528614367|FG000|Overall Study|Sponsor decision|17|||
146917691|NCT00620321|529861465|FG000|Overall Study|Progressive Disease|5|||
146574704|NCT00175916|528614367|FG000|Overall Study|Vigabatrin intake|1|||
146574705|NCT00175916|528614367|FG000|Overall Study|Suicidal behaviour|1|||
146574706|NCT00175916|528614367|FG000|Overall Study|Withdrawal by Subject|1|||
146574707|NCT00175916|528614367|FG000|Overall Study|Seizure - free|4|||
146574708|NCT00175916|528614367|FG000|Overall Study|Administrative reason|1|||
146574709|NCT00175916|528614367|FG000|Overall Study|Pregnancy|1|||
146574710|NCT00175916|528614367|FG000|Overall Study|Patient's request|2|||
146574711|NCT00175916|528614367|FG000|Overall Study|Treating physiciant's choice|1|||
146574712|NCT00175916|528614367|FG000|Overall Study|Moved overseas|1|||
146574713|NCT00175916|528614367|FG000|Overall Study|Loss of job and economic burden|1|||
146574714|NCT00175916|528614367|FG000|Overall Study|Site was closed|9|||
146574715|NCT00175916|528614367|FG000|Overall Study|Patient went to prison|1|||
146574716|NCT04024436|528614368|FG000|Overall Study|Death|10|||
146574717|NCT04024436|528614369|FG001|Overall Study|Death|14|||
146574718|NCT04024436|528614370|FG002|Overall Study|Death|2|||
146574719|NCT04024436|528614371|FG003|Overall Study|Death|7|||
146574720|NCT04024436|528614368|FG000|Overall Study|Loss to follow up|1|||
146574721|NCT04024436|528614369|FG001|Overall Study|Loss to follow up|0|||
146574722|NCT04024436|528614370|FG002|Overall Study|Loss to follow up|0|||
146574723|NCT04024436|528614371|FG003|Overall Study|Loss to follow up|1|||
146574724|NCT04024436|528614368|FG000|Overall Study|Withdrawal of consent|2|||
146574725|NCT04024436|528614369|FG001|Overall Study|Withdrawal of consent|0|||
146574726|NCT04024436|528614370|FG002|Overall Study|Withdrawal of consent|0|||
146574727|NCT04024436|528614371|FG003|Overall Study|Withdrawal of consent|1|||
146574728|NCT04024436|528614368|FG000|Overall Study|Study termination by sponsor|4|||
146574729|NCT04024436|528614369|FG001|Overall Study|Study termination by sponsor|6|||
146574730|NCT04024436|528614370|FG002|Overall Study|Study termination by sponsor|2|||
146574731|NCT04024436|528614371|FG003|Overall Study|Study termination by sponsor|11|||
146574732|NCT04024436|528614368|FG000|Overall Study|Reason Not Specified|0|||
146574733|NCT04024436|528614369|FG001|Overall Study|Reason Not Specified|1|||
146574734|NCT04024436|528614370|FG002|Overall Study|Reason Not Specified|0|||
146574735|NCT04024436|528614371|FG003|Overall Study|Reason Not Specified|2|||
146574736|NCT01169337|528614372|FG000|Overall Study|Lack of Efficacy|5|||
146574737|NCT01169337|528614373|FG001|Overall Study|Lack of Efficacy|7|||
146574738|NCT01169337|528614374|FG002|Overall Study|Lack of Efficacy|0|||
146574739|NCT01169337|528614372|FG000|Overall Study|Adverse Event|12|||
146574740|NCT01169337|528614373|FG001|Overall Study|Adverse Event|18|||
146574741|NCT01169337|528614374|FG002|Overall Study|Adverse Event|0|||
146574742|NCT01169337|528614372|FG000|Overall Study|Death|2|||
146574743|NCT01169337|528614373|FG001|Overall Study|Death|0|||
146574744|NCT01169337|528614374|FG002|Overall Study|Death|0|||
146574745|NCT01169337|528614372|FG000|Overall Study|Withdrawal by Subject|11|||
146574746|NCT01169337|528614373|FG001|Overall Study|Withdrawal by Subject|11|||
146574747|NCT01169337|528614374|FG002|Overall Study|Withdrawal by Subject|6|||
146574748|NCT01169337|528614372|FG000|Overall Study|Noncompliance|2|||
146574749|NCT01169337|528614373|FG001|Overall Study|Noncompliance|0|||
146574750|NCT01169337|528614374|FG002|Overall Study|Noncompliance|0|||
146574751|NCT01169337|528614372|FG000|Overall Study|Other complicating disease|1|||
146574752|NCT01169337|528614373|FG001|Overall Study|Other complicating disease|1|||
146574753|NCT01169337|528614374|FG002|Overall Study|Other complicating disease|0|||
146574754|NCT01169337|528614372|FG000|Overall Study|Physician Decision|1|||
146574755|NCT01169337|528614373|FG001|Overall Study|Physician Decision|5|||
146574756|NCT01169337|528614374|FG002|Overall Study|Physician Decision|0|||
146574757|NCT01169337|528614372|FG000|Overall Study|Alternative therapy|0|||
146574758|NCT01169337|528614373|FG001|Overall Study|Alternative therapy|2|||
146574759|NCT01169337|528614374|FG002|Overall Study|Alternative therapy|0|||
146574760|NCT01169337|528614372|FG000|Overall Study|Changed hospital|0|||
146574761|NCT01169337|528614373|FG001|Overall Study|Changed hospital|1|||
146574762|NCT01169337|528614374|FG002|Overall Study|Changed hospital|0|||
146574763|NCT01169337|528614372|FG000|Overall Study|Never started treatment|0|||
146574764|NCT01169337|528614373|FG001|Overall Study|Never started treatment|2|||
146651853|NCT03400956|528902290|FG000|Treatment Period 2|Lost to Follow-up|1|||
146917692|NCT00620321|529861466|FG001|Overall Study|Progressive Disease|5|||
146574765|NCT01169337|528614374|FG002|Overall Study|Never started treatment|0|||
146574766|NCT01169337|528614372|FG000|Overall Study|Reason not reported|1|||
146574767|NCT01169337|528614373|FG001|Overall Study|Reason not reported|0|||
146574768|NCT01169337|528614374|FG002|Overall Study|Reason not reported|0|||
146574769|NCT01169337|528614372|FG000|Overall Study|Continuing lenalidomide|9|||
146574770|NCT01169337|528614373|FG001|Overall Study|Continuing lenalidomide|43|||
146574771|NCT01169337|528614374|FG002|Overall Study|Continuing lenalidomide|0|||
146574772|NCT01134614|528614375|FG000|Overall Study|Still on treatment as of March 2013|21|||
146574773|NCT01134614|528614376|FG001|Overall Study|Still on treatment as of March 2013|13|||
146574774|NCT01134614|528614375|FG000|Overall Study|Progressive disease|60|||
146574775|NCT01134614|528614376|FG001|Overall Study|Progressive disease|54|||
146574776|NCT01134614|528614375|FG000|Overall Study|Adverse Event|26|||
146574777|NCT01134614|528614376|FG001|Overall Study|Adverse Event|39|||
146574778|NCT01134614|528614375|FG000|Overall Study|Death|5|||
146574779|NCT01134614|528614376|FG001|Overall Study|Death|8|||
146574780|NCT01134614|528614375|FG000|Overall Study|Withdrawal by Subject|3|||
146574781|NCT01134614|528614376|FG001|Overall Study|Withdrawal by Subject|2|||
146574782|NCT01134614|528614375|FG000|Overall Study|Alternative therapy|2|||
146574783|NCT01134614|528614376|FG001|Overall Study|Alternative therapy|0|||
146574784|NCT01134614|528614375|FG000|Overall Study|Complicating disease|2|||
146574785|NCT01134614|528614376|FG001|Overall Study|Complicating disease|1|||
146574786|NCT01134614|528614375|FG000|Overall Study|Physician's decision|0|||
146574787|NCT01134614|528614376|FG001|Overall Study|Physician's decision|1|||
146574788|NCT01134614|528614375|FG000|Overall Study|Never started treatment|4|||
146574789|NCT01134614|528614376|FG001|Overall Study|Never started treatment|1|||
146574790|NCT01134614|528614375|FG000|Overall Study|Pt received tx not allowed on study|0|||
146574791|NCT01134614|528614376|FG001|Overall Study|Pt received tx not allowed on study|1|||
146574792|NCT01134614|528614375|FG000|Overall Study|Symptomatic deterioration|0|||
146574793|NCT01134614|528614376|FG001|Overall Study|Symptomatic deterioration|1|||
146574794|NCT01134614|528614375|FG000|Overall Study|Patient in hospice care|0|||
146574795|NCT01134614|528614376|FG001|Overall Study|Patient in hospice care|1|||
146574796|NCT00540592|528614377|FG000|Overall Study|Adverse Event|0|||
146574797|NCT00540592|528614378|FG001|Overall Study|Adverse Event|1|||
146574798|NCT00540592|528614379|FG002|Overall Study|Adverse Event|0|||
146574799|NCT00540592|528614380|FG003|Overall Study|Adverse Event|0|||
146574800|NCT00540592|528614381|FG004|Overall Study|Adverse Event|1|||
146574801|NCT00540592|528614382|FG005|Overall Study|Adverse Event|0|||
146574802|NCT00540592|528614383|FG006|Overall Study|Adverse Event|0|||
146574803|NCT00540592|528614384|FG007|Overall Study|Adverse Event|1|||
146574804|NCT00540592|528614385|FG008|Overall Study|Adverse Event|1|||
146574805|NCT00540592|528614386|FG009|Overall Study|Adverse Event|2|||
146574806|NCT00540592|528614377|FG000|Overall Study|Lost to Follow-up|2|||
146574807|NCT00540592|528614378|FG001|Overall Study|Lost to Follow-up|0|||
146574808|NCT00540592|528614379|FG002|Overall Study|Lost to Follow-up|0|||
146574809|NCT00540592|528614380|FG003|Overall Study|Lost to Follow-up|0|||
146574810|NCT00540592|528614381|FG004|Overall Study|Lost to Follow-up|0|||
146574811|NCT00540592|528614382|FG005|Overall Study|Lost to Follow-up|0|||
146574812|NCT00540592|528614383|FG006|Overall Study|Lost to Follow-up|0|||
146574813|NCT00540592|528614384|FG007|Overall Study|Lost to Follow-up|0|||
146574814|NCT00540592|528614385|FG008|Overall Study|Lost to Follow-up|0|||
146574815|NCT00540592|528614386|FG009|Overall Study|Lost to Follow-up|0|||
146574816|NCT00540592|528614377|FG000|Overall Study|Withdrawal by Subject|0|||
146574817|NCT00540592|528614378|FG001|Overall Study|Withdrawal by Subject|0|||
146574818|NCT00540592|528614379|FG002|Overall Study|Withdrawal by Subject|1|||
146574819|NCT00540592|528614380|FG003|Overall Study|Withdrawal by Subject|1|||
146574820|NCT00540592|528614381|FG004|Overall Study|Withdrawal by Subject|0|||
146574821|NCT00540592|528614382|FG005|Overall Study|Withdrawal by Subject|0|||
146574822|NCT00540592|528614383|FG006|Overall Study|Withdrawal by Subject|0|||
146574823|NCT00540592|528614384|FG007|Overall Study|Withdrawal by Subject|0|||
146574824|NCT00540592|528614385|FG008|Overall Study|Withdrawal by Subject|0|||
146574825|NCT00540592|528614386|FG009|Overall Study|Withdrawal by Subject|0|||
146574826|NCT02168101|528614391|FG000|Overall Study|Death|2|||
146574827|NCT02168101|528614392|FG001|Overall Study|Death|2|||
146574828|NCT02168101|528614393|FG002|Overall Study|Death|1|||
146574829|NCT05507567|528614394|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
146574830|NCT05507567|528614395|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
146574831|NCT05507567|528614396|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
146574832|NCT05507567|528614394|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
146574833|NCT05507567|528614395|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
146574834|NCT05507567|528614396|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
146574835|NCT05507567|528614394|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
146574836|NCT05507567|528614395|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
146574837|NCT05507567|528614396|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
146574838|NCT05507567|528614394|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
146574839|NCT05507567|528614395|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
146574840|NCT05507567|528614396|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
146574841|NCT03901963|528614397|FG000|Overall Study|Lost to Follow-up|1|||
146574842|NCT03901963|528614398|FG001|Overall Study|Lost to Follow-up|1|||
146574843|NCT03901963|528614397|FG000|Overall Study|Physician Decision|1|||
146574844|NCT03901963|528614398|FG001|Overall Study|Physician Decision|2|||
146574845|NCT03901963|528614397|FG000|Overall Study|Protocol Violation|1|||
146574846|NCT03901963|528614398|FG001|Overall Study|Protocol Violation|1|||
146574847|NCT03901963|528614397|FG000|Overall Study|Withdrawal by Subject|4|||
146574848|NCT03901963|528614398|FG001|Overall Study|Withdrawal by Subject|11|||
146574849|NCT03901963|528614397|FG000|Overall Study|Ongoing|84|||
146574850|NCT03901963|528614398|FG001|Overall Study|Ongoing|73|||
146574851|NCT03901963|528614397|FG000|Overall Study|Randomized but not treated|3|||
146574852|NCT03901963|528614398|FG001|Overall Study|Randomized but not treated|3|||
146574853|NCT01722994|528614401|FG000|Overall Study|Missing data|25|||
146574854|NCT01722994|528614402|FG001|Overall Study|Missing data|17|||
146574855|NCT01206140|528614406|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
146574856|NCT01206140|528614407|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
146574857|NCT01803880|528614408|FG000|Overall Study|Adverse Event|1|||
146574858|NCT01803880|528614409|FG001|Overall Study|Adverse Event|0|||
146574859|NCT01803880|528614410|FG002|Overall Study|Adverse Event|0|||
146574860|NCT01803880|528614408|FG000|Overall Study|Withdrawal by Subject|1|||
146574861|NCT01803880|528614409|FG001|Overall Study|Withdrawal by Subject|1|||
146574862|NCT01803880|528614410|FG002|Overall Study|Withdrawal by Subject|4|||
146574863|NCT01803880|528614408|FG000|Overall Study|Physician Decision|0|||
146574864|NCT01803880|528614409|FG001|Overall Study|Physician Decision|0|||
146574865|NCT01803880|528614410|FG002|Overall Study|Physician Decision|1|||
146574866|NCT01803880|528614408|FG000|Overall Study|Unable to return for follow-up visits|0|||
146574867|NCT01803880|528614409|FG001|Overall Study|Unable to return for follow-up visits|1|||
146574868|NCT01803880|528614410|FG002|Overall Study|Unable to return for follow-up visits|2|||
146574869|NCT01803880|528614408|FG000|Overall Study|Lost to Follow-up|1|||
146574870|NCT01803880|528614409|FG001|Overall Study|Lost to Follow-up|2|||
146574871|NCT01803880|528614410|FG002|Overall Study|Lost to Follow-up|3|||
146574872|NCT01803880|528614408|FG000|Overall Study|Protocol Violation|1|||
146574873|NCT01803880|528614409|FG001|Overall Study|Protocol Violation|0|||
146574874|NCT01803880|528614410|FG002|Overall Study|Protocol Violation|0|||
146574875|NCT01803880|528614408|FG000|Overall Study|Early study termination|0|||
146574876|NCT01803880|528614409|FG001|Overall Study|Early study termination|6|||
146574877|NCT01803880|528614410|FG002|Overall Study|Early study termination|5|||
146574878|NCT01803880|528614408|FG000|Overall Study|Incomplete data entry by sites|2|||
146574879|NCT01803880|528614409|FG001|Overall Study|Incomplete data entry by sites|0|||
146574880|NCT01803880|528614410|FG002|Overall Study|Incomplete data entry by sites|0|||
146574881|NCT01766037|528614411|FG000|Overall Study|Adverse Event|1|||
146574882|NCT01766037|528614412|FG001|Overall Study|Adverse Event|0|||
146574883|NCT01766037|528614411|FG000|Overall Study|Lack of Efficacy|1|||
146574884|NCT01766037|528614412|FG001|Overall Study|Lack of Efficacy|0|||
146574885|NCT01766037|528614411|FG000|Overall Study|Lost to Follow-up|0|||
146574886|NCT01766037|528614412|FG001|Overall Study|Lost to Follow-up|10|||
146574887|NCT01766037|528614411|FG000|Overall Study|Physician Decision|0|||
146574888|NCT01766037|528614412|FG001|Overall Study|Physician Decision|1|||
146574889|NCT01766037|528614411|FG000|Overall Study|Withdrawal by Subject|18|||
146574890|NCT01766037|528614412|FG001|Overall Study|Withdrawal by Subject|16|||
146574891|NCT01766037|528614411|FG000|Overall Study|Moved from area|5|||
146574892|NCT01766037|528614412|FG001|Overall Study|Moved from area|0|||
146574893|NCT01766037|528614411|FG000|Overall Study|medical - unrelated|1|||
146574894|NCT01766037|528614412|FG001|Overall Study|medical - unrelated|2|||
146574895|NCT01766037|528614411|FG000|Overall Study|nausea / discomfort|3|||
146574896|NCT01766037|528614412|FG001|Overall Study|nausea / discomfort|0|||
146574897|NCT05226598|528614414|FG000|Overall Study|Death|186|||
146574898|NCT05226598|528614415|FG001|Overall Study|Death|191|||
146574899|NCT05226598|528614414|FG000|Overall Study|Withdrawal by Subject|6|||
146574900|NCT05226598|528614415|FG001|Overall Study|Withdrawal by Subject|6|||
146574901|NCT05226598|528614414|FG000|Overall Study|Ongoing|174|||
146574902|NCT05226598|528614415|FG001|Overall Study|Ongoing|176|||
146574903|NCT02959463|528614416|FG000|Overall Study|Adverse Event|1|||
146574904|NCT02959463|528614417|FG001|Overall Study|Adverse Event|1|||
146574905|NCT02959463|528614416|FG000|Overall Study|Death|1|||
146574906|NCT02959463|528614417|FG001|Overall Study|Death|0|||
146574907|NCT02959463|528614416|FG000|Overall Study|Withdrawal by Subject|1|||
146574908|NCT02959463|528614417|FG001|Overall Study|Withdrawal by Subject|0|||
146574909|NCT01672879|528614418|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
146574910|NCT01672879|528614419|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
146574911|NCT01672879|528614420|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
146574912|NCT01672879|528614418|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
146574913|NCT01672879|528614419|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
146574914|NCT01672879|528614420|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
146574915|NCT01672879|528614418|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
146574916|NCT01672879|528614419|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
146574917|NCT01672879|528614420|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
146574918|NCT01672879|528614418|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
146574919|NCT01672879|528614419|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
146574920|NCT01672879|528614420|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
146574921|NCT01672879|528614418|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
146574922|NCT01672879|528614419|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
146574923|NCT01672879|528614420|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
146574924|NCT01672879|528614418|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
146574925|NCT01672879|528614419|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
146574926|NCT01672879|528614420|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
146574927|NCT01672879|528614418|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
146574928|NCT01672879|528614419|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
146574929|NCT01672879|528614420|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
146651854|NCT03400956|528902291|FG001|Treatment Period 2|Lost to Follow-up|1|||
146651855|NCT03400956|528902292|FG002|Treatment Period 2|Lost to Follow-up|0|||
146574930|NCT01672879|528614418|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
146574931|NCT01672879|528614419|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
146574932|NCT01672879|528614420|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
146574933|NCT01672879|528614418|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
146574934|NCT01672879|528614419|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
146574935|NCT01672879|528614420|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
146574936|NCT01672879|528614418|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
146574937|NCT01672879|528614419|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
146574938|NCT01672879|528614420|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
146574939|NCT01672879|528614418|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
146574940|NCT01672879|528614419|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
146574941|NCT01672879|528614420|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
146574942|NCT01672879|528614418|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
146574943|NCT01672879|528614419|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
146574944|NCT01672879|528614420|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
146574945|NCT01672879|528614418|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
146574946|NCT01672879|528614419|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
146574947|NCT01672879|528614420|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
146574948|NCT05384834|528614425|FG000|Overall Study|Lost to Follow-up|43|||
146574949|NCT05384834|528614425|FG000|Overall Study|Withdrawal by Subject|5|||
146574950|NCT03951766|528614426|FG000|Treatment Phase|Lost to Follow-up|1|||
146574951|NCT03951766|528614426|FG000|Follow-up Phase|Lost to Follow-up|10|||
146574952|NCT01871545|528614427|FG000|Overall Study|Death|2|||
146574953|NCT01871545|528614428|FG001|Overall Study|Death|0|||
146574954|NCT01871545|528614427|FG000|Overall Study|Lack of Efficacy|11|||
146574955|NCT01871545|528614428|FG001|Overall Study|Lack of Efficacy|2|||
146574956|NCT01871545|528614427|FG000|Overall Study|Physician Decision|4|||
146574957|NCT01871545|528614428|FG001|Overall Study|Physician Decision|0|||
146574958|NCT01871545|528614427|FG000|Overall Study|Withdrawal by Subject|0|||
146574959|NCT01871545|528614428|FG001|Overall Study|Withdrawal by Subject|1|||
146574960|NCT01523743|528614429|FG000|Period 1|Adverse Event|1|||
146574961|NCT01523743|528614430|FG001|Period 1|Adverse Event|0|||
146574962|NCT01523743|528614429|FG000|Period 1|Withdrawal by Subject|6|||
146574963|NCT01523743|528614430|FG001|Period 1|Withdrawal by Subject|2|||
146574964|NCT01523743|528614429|FG000|Period 1|Lost to Follow-up|1|||
146574965|NCT01523743|528614430|FG001|Period 1|Lost to Follow-up|0|||
146574966|NCT01523743|528614429|FG000|Period 1|Lack of Efficacy|1|||
146574967|NCT01523743|528614430|FG001|Period 1|Lack of Efficacy|0|||
146574968|NCT01523743|528614429|FG000|Period 1|Felt unable to empty bladder|1|||
146574969|NCT01523743|528614430|FG001|Period 1|Felt unable to empty bladder|0|||
146574970|NCT01523743|528614429|FG000|Period 2|Withdrawal by Subject|0|||
146574971|NCT01523743|528614430|FG001|Period 2|Withdrawal by Subject|2|||
146574972|NCT01523743|528614429|FG000|Period 2|Adverse Event|1|||
146917693|NCT00620321|529861465|FG000|Overall Study|Sponsor Decision|0|||
146917694|NCT00620321|529861466|FG001|Overall Study|Sponsor Decision|1|||
146574973|NCT01523743|528614430|FG001|Period 2|Adverse Event|0|||
146574974|NCT05710640|528614433|FG000|Overall Study|Physician Decision|0|||
146574975|NCT05710640|528614434|FG001|Overall Study|Physician Decision|1|||
146574976|NCT05710640|528614433|FG000|Overall Study|Withdrawal by Subject|1|||
146574977|NCT05710640|528614434|FG001|Overall Study|Withdrawal by Subject|0|||
146574978|NCT05710640|528614433|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
146574979|NCT05710640|528614434|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
146574980|NCT04188509|528614435|FG000|Overall Study|Adverse Event|2|||
146574981|NCT04188509|528614435|FG000|Overall Study|Lost to Follow-up|1|||
146574982|NCT04188509|528614435|FG000|Overall Study|Withdrawal of Consent|1|||
146574983|NCT04188509|528614435|FG000|Overall Study|Discretion of Investigator|1|||
146574984|NCT04188509|528614435|FG000|Overall Study|Noncompliance|3|||
146574985|NCT04188509|528614435|FG000|Overall Study|Sponsor Decision|127|||
146574986|NCT04188509|528614435|FG000|Overall Study|Other|2|||
146917695|NCT00620321|529861465|FG000|Overall Study|Withdrawal by Subject|1|||
146917696|NCT00620321|529861466|FG001|Overall Study|Withdrawal by Subject|1|||
146917697|NCT01755195|529861467|FG000|Overall Study|Participant noncompliance|2|||
146917698|NCT01755195|529861467|FG000|Overall Study|Switched to alternative treatment|4|||
146574987|NCT04847843|528614436|FG000|Overall Study|Scheduling Conflicts|6|||
146574988|NCT04847843|528614437|FG001|Overall Study|Scheduling Conflicts|9|||
146574989|NCT04847843|528614436|FG000|Overall Study|Withdrawal by Subject|1|||
146574990|NCT04847843|528614437|FG001|Overall Study|Withdrawal by Subject|0|||
146574991|NCT04847843|528614436|FG000|Overall Study|Lost to Follow-up|1|||
146574992|NCT04847843|528614437|FG001|Overall Study|Lost to Follow-up|1|||
146917699|NCT01755195|529861467|FG000|Overall Study|Withdrawal by Subject|1|||
146574993|NCT04847843|528614436|FG000|Overall Study|Pregnancy|0|||
146574994|NCT04847843|528614437|FG001|Overall Study|Pregnancy|2|||
146574995|NCT04847843|528614436|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
146574996|NCT04847843|528614437|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
146574997|NCT02734004|528614438|FG000|Overall Study|Death|36|||
146574998|NCT02734004|528614439|FG001|Overall Study|Death|24|||
146574999|NCT02734004|528614440|FG002|Overall Study|Death|26|||
146575000|NCT02734004|528614441|FG003|Overall Study|Death|35|||
146575001|NCT02734004|528614442|FG004|Overall Study|Death|13|||
146575002|NCT02734004|528614443|FG005|Overall Study|Death|17|||
146575003|NCT02734004|528614444|FG006|Overall Study|Death|20|||
146575004|NCT02734004|528614438|FG000|Overall Study|Lost to Follow-up|1|||
146575005|NCT02734004|528614439|FG001|Overall Study|Lost to Follow-up|1|||
146575006|NCT02734004|528614440|FG002|Overall Study|Lost to Follow-up|0|||
146575007|NCT02734004|528614441|FG003|Overall Study|Lost to Follow-up|0|||
146977517|NCT01792284|530080983|FG002|Lead-in Period|Adverse Event|0|||
146977518|NCT01792284|530080981|FG000|Lead-in Period|Lost to Follow-up|2|||
146977519|NCT01792284|530080982|FG001|Lead-in Period|Lost to Follow-up|0|||
146977520|NCT01792284|530080983|FG002|Lead-in Period|Lost to Follow-up|0|||
146977521|NCT01792284|530080981|FG000|Lead-in Period|Protocol Violation|1|||
146575008|NCT02734004|528614442|FG004|Overall Study|Lost to Follow-up|1|||
146575009|NCT02734004|528614443|FG005|Overall Study|Lost to Follow-up|0|||
146575010|NCT02734004|528614444|FG006|Overall Study|Lost to Follow-up|0|||
146575011|NCT02734004|528614438|FG000|Overall Study|Withdrawal by Subject|3|||
146575012|NCT02734004|528614439|FG001|Overall Study|Withdrawal by Subject|1|||
146575013|NCT02734004|528614440|FG002|Overall Study|Withdrawal by Subject|1|||
146575014|NCT02734004|528614441|FG003|Overall Study|Withdrawal by Subject|1|||
146977522|NCT01792284|530080982|FG001|Lead-in Period|Protocol Violation|0|||
146977523|NCT01792284|530080983|FG002|Lead-in Period|Protocol Violation|0|||
146977524|NCT01792284|530080981|FG000|Lead-in Period|Withdrawal by Subject|10|||
146977525|NCT01792284|530080982|FG001|Lead-in Period|Withdrawal by Subject|0|||
146977526|NCT01792284|530080983|FG002|Lead-in Period|Withdrawal by Subject|0|||
146977527|NCT01792284|530080981|FG000|Lead-in Period|Physician Decision|1|||
146977528|NCT01792284|530080982|FG001|Lead-in Period|Physician Decision|0|||
146575015|NCT02734004|528614442|FG004|Overall Study|Withdrawal by Subject|3|||
146575016|NCT02734004|528614443|FG005|Overall Study|Withdrawal by Subject|0|||
146575017|NCT02734004|528614444|FG006|Overall Study|Withdrawal by Subject|2|||
146575018|NCT02734004|528614438|FG000|Overall Study|Other|0|||
146575019|NCT02734004|528614439|FG001|Overall Study|Other|8|||
146575020|NCT02734004|528614440|FG002|Overall Study|Other|7|||
146575021|NCT02734004|528614441|FG003|Overall Study|Other|4|||
146575022|NCT02734004|528614442|FG004|Overall Study|Other|34|||
146575023|NCT02734004|528614443|FG005|Overall Study|Other|14|||
146575024|NCT02734004|528614444|FG006|Overall Study|Other|10|||
146575025|NCT05615220|528614445|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
146575026|NCT05615220|528614446|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
146575027|NCT05615220|528614447|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
146575028|NCT05615220|528614445|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
146575029|NCT05615220|528614446|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
146575030|NCT05615220|528614447|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
146575031|NCT05615220|528614445|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
146575032|NCT05615220|528614446|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
146575033|NCT05615220|528614447|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
146575034|NCT05615220|528614445|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
146575035|NCT05615220|528614446|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
146575036|NCT05615220|528614447|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
146575037|NCT05615220|528614445|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
146575038|NCT05615220|528614446|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
146575039|NCT05615220|528614447|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
146575040|NCT05615220|528614445|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
146575041|NCT05615220|528614446|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
146575042|NCT05615220|528614447|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
146575043|NCT05615220|528614445|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
146575044|NCT05615220|528614446|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
146575045|NCT05615220|528614447|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
146575046|NCT05615220|528614445|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
146575047|NCT05615220|528614446|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
146575048|NCT05615220|528614447|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
146575049|NCT05615220|528614445|FG000|Open label stabilization Part (12 weeks)|Other|6|||
146575050|NCT05615220|528614446|FG001|Open label stabilization Part (12 weeks)|Other|0|||
146977529|NCT01792284|530080983|FG002|Lead-in Period|Physician Decision|0|||
146977530|NCT01792284|530080981|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
146977531|NCT01792284|530080982|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
146977532|NCT01792284|530080983|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
146977533|NCT01792284|530080981|FG000|Randomization Period 1|Withdrawal by Subject|0|||
146575051|NCT05615220|528614447|FG002|Open label stabilization Part (12 weeks)|Other|0|||
146575052|NCT05615220|528614445|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
146575053|NCT05615220|528614446|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
146575054|NCT05615220|528614447|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
146575055|NCT05615220|528614445|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
146575056|NCT05615220|528614446|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
146575057|NCT05615220|528614447|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
146575058|NCT05615220|528614445|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
146575059|NCT05615220|528614446|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
146575060|NCT05615220|528614447|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
146575061|NCT05615220|528614445|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
146575062|NCT05615220|528614446|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
146575063|NCT05615220|528614447|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
146575064|NCT05615220|528614445|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
146575065|NCT05615220|528614446|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
146575066|NCT05615220|528614447|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
146575067|NCT05615220|528614445|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
146575068|NCT05615220|528614446|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
146575069|NCT05615220|528614447|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
146575070|NCT01282866|528614456|FG000|Overall Study|Adverse Event|1|||
146575071|NCT01541865|528614458|FG000|Overall Study|Lost to Follow-up|11|||
146917700|NCT01755195|529861467|FG000|Overall Study|Participant refused to start treatment|1|||
146917701|NCT01755195|529861467|FG000|Overall Study|Participant has been consented for another trial|1|||
146575072|NCT01541865|528614458|FG000|Overall Study|Withdrawal by Subject|9|||
146575073|NCT01541865|528614458|FG000|Overall Study|Adverse Event|1|||
146575074|NCT01541865|528614458|FG000|Overall Study|Protocol Violation|1|||
146575075|NCT01393899|528614462|FG000|Overall Study|Study terminated by sponsor|1|||
146575076|NCT01393899|528614463|FG001|Overall Study|Study terminated by sponsor|0|||
146575077|NCT01393899|528614464|FG002|Overall Study|Study terminated by sponsor|1|||
146575078|NCT01393899|528614462|FG000|Overall Study|Other|1|||
146575079|NCT01393899|528614463|FG001|Overall Study|Other|0|||
146575080|NCT01393899|528614464|FG002|Overall Study|Other|0|||
146575081|NCT01393899|528614462|FG000|Overall Study|Withdrawal by Subject|2|||
146575082|NCT01393899|528614463|FG001|Overall Study|Withdrawal by Subject|2|||
146575083|NCT01393899|528614464|FG002|Overall Study|Withdrawal by Subject|1|||
146917702|NCT01755195|529861467|FG000|Overall Study|Refused further treatment|3|||
146917703|NCT01755195|529861467|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
146917704|NCT02340819|529861468|FG000|Overall Study|Adverse Event|1|||
146917705|NCT02340819|529861468|FG000|Overall Study|Withdrawal by Subject|2|||
146575084|NCT01393899|528614462|FG000|Overall Study|Lost to Follow-up|0|||
146575085|NCT01393899|528614463|FG001|Overall Study|Lost to Follow-up|0|||
146575086|NCT01393899|528614464|FG002|Overall Study|Lost to Follow-up|1|||
146575087|NCT01393899|528614462|FG000|Overall Study|Does not meet entrance criteria|1|||
146575088|NCT01393899|528614463|FG001|Overall Study|Does not meet entrance criteria|0|||
146575089|NCT01393899|528614464|FG002|Overall Study|Does not meet entrance criteria|1|||
146575090|NCT01393899|528614462|FG000|Overall Study|Lack of Efficacy|26|||
146575091|NCT01393899|528614463|FG001|Overall Study|Lack of Efficacy|21|||
146575092|NCT01393899|528614464|FG002|Overall Study|Lack of Efficacy|16|||
146575093|NCT01393899|528614462|FG000|Overall Study|Adverse Event|1|||
146575094|NCT01393899|528614463|FG001|Overall Study|Adverse Event|5|||
146575095|NCT01393899|528614464|FG002|Overall Study|Adverse Event|3|||
146575096|NCT00049257|528614467|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
146575097|NCT00049257|528614467|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
146575098|NCT00049257|528614467|FG000|Carboplatin, Paclitaxel|Death|2|||
146575099|NCT00049257|528614467|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
146575100|NCT04721158|528614468|FG000|Overall Study|Lost to Follow-up|4|||
146575101|NCT04721158|528614468|FG000|Overall Study|Device did not connect|1|||
146917706|NCT02340819|529861468|FG000|Overall Study|Discontinued with other reason|1|||
146575102|NCT00132301|528614469|FG000|Overall Study|Death|7|||
146575103|NCT00132301|528614470|FG001|Overall Study|Death|6|||
146575104|NCT00132301|528614469|FG000|Overall Study|Withdrawal by Subject|5|||
146575105|NCT00132301|528614470|FG001|Overall Study|Withdrawal by Subject|2|||
146575106|NCT00132301|528614469|FG000|Overall Study|Physician Decision|1|||
146575107|NCT00132301|528614470|FG001|Overall Study|Physician Decision|1|||
146575108|NCT00132301|528614469|FG000|Overall Study|Lost to Follow-up|5|||
146575109|NCT00132301|528614470|FG001|Overall Study|Lost to Follow-up|3|||
146575110|NCT00132301|528614469|FG000|Overall Study|Other|1|||
146575111|NCT00132301|528614470|FG001|Overall Study|Other|1|||
146575112|NCT00132301|528614469|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
146575113|NCT00132301|528614470|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
146575114|NCT03462719|528614478|FG000|Overall Study|Withdrawal by Subject|4|||
146575115|NCT03462719|528614479|FG001|Overall Study|Withdrawal by Subject|3|||
146575116|NCT03462719|528614478|FG000|Overall Study|Ongoing|87|||
146575117|NCT03462719|528614479|FG001|Overall Study|Ongoing|72|||
146917707|NCT00051558|529861469|FG000|Overall Study|Adverse Event|30|||
146917708|NCT00051558|529861470|FG001|Overall Study|Adverse Event|18|||
146917709|NCT00051558|529861469|FG000|Overall Study|Withdrawal by Subject|29|||
146917710|NCT00051558|529861470|FG001|Overall Study|Withdrawal by Subject|42|||
146917711|NCT00051558|529861469|FG000|Overall Study|Death|9|||
146575118|NCT01402869|528614482|FG000|Overall Study|Required Tooth Extraction|0|||
146575119|NCT01402869|528614483|FG001|Overall Study|Required Tooth Extraction|0|||
146575120|NCT01402869|528614484|FG002|Overall Study|Required Tooth Extraction|1|||
146575121|NCT01142388|528616020|FG000|Overall Study|Lack of Efficacy|21|||
146575122|NCT01142388|528616021|FG001|Overall Study|Lack of Efficacy|31|||
146575123|NCT01142388|528616020|FG000|Overall Study|Adverse Event|9|||
146575124|NCT01142388|528616021|FG001|Overall Study|Adverse Event|5|||
146575125|NCT01142388|528616020|FG000|Overall Study|Death|3|||
146575126|NCT01142388|528616021|FG001|Overall Study|Death|2|||
146575127|NCT01142388|528616020|FG000|Overall Study|Withdrawal by Subject|5|||
146575128|NCT01142388|528616021|FG001|Overall Study|Withdrawal by Subject|3|||
146575129|NCT01142388|528616020|FG000|Overall Study|Alternative therapy|1|||
146575130|NCT01142388|528616021|FG001|Overall Study|Alternative therapy|0|||
146575131|NCT01142388|528616020|FG000|Overall Study|Other complications|0|||
146575132|NCT01142388|528616021|FG001|Overall Study|Other complications|2|||
146575133|NCT01142388|528616020|FG000|Overall Study|Other|1|||
146575134|NCT01142388|528616021|FG001|Overall Study|Other|1|||
146575135|NCT01142388|528616020|FG000|Overall Study|Never started therapy|7|||
146575136|NCT01142388|528616021|FG001|Overall Study|Never started therapy|3|||
146575137|NCT05730725|528616024|FG000|Overall Study|Withdrawal by Subject|3|||
146575138|NCT05730725|528616025|FG001|Overall Study|Withdrawal by Subject|0|||
146575139|NCT05730725|528616026|FG002|Overall Study|Withdrawal by Subject|0|||
146575140|NCT05730725|528616027|FG003|Overall Study|Withdrawal by Subject|1|||
146575141|NCT05730725|528616024|FG000|Overall Study|Not Reported|1|||
146575142|NCT05730725|528616025|FG001|Overall Study|Not Reported|1|||
146575143|NCT05730725|528616026|FG002|Overall Study|Not Reported|1|||
146575144|NCT05730725|528616027|FG003|Overall Study|Not Reported|1|||
146575145|NCT05265728|528616028|FG000|Overall Study|Adverse Event|1|||
146575146|NCT05265728|528616028|FG000|Overall Study|Study Terminated by Sponsor|5|||
146575147|NCT05265728|528616028|FG000|Overall Study|Withdrawal by Subject|2|||
146575148|NCT03687957|528616029|FG000|Overall Study|Withdrawal by Subject|0|||
146575149|NCT03687957|528616030|FG001|Overall Study|Withdrawal by Subject|0|||
146575150|NCT03687957|528616031|FG002|Overall Study|Withdrawal by Subject|0|||
146575151|NCT03687957|528616032|FG003|Overall Study|Withdrawal by Subject|2|||
146575152|NCT03687957|528616033|FG004|Overall Study|Withdrawal by Subject|0|||
146575153|NCT03687957|528616034|FG005|Overall Study|Withdrawal by Subject|0|||
146575154|NCT03687957|528616035|FG006|Overall Study|Withdrawal by Subject|3|||
146575155|NCT03687957|528616036|FG007|Overall Study|Withdrawal by Subject|1|||
146575156|NCT03687957|528616037|FG008|Overall Study|Withdrawal by Subject|1|||
146575157|NCT03687957|528616038|FG009|Overall Study|Withdrawal by Subject|0|||
146575158|NCT03687957|528616029|FG000|Overall Study|Disease progression|0|||
146575159|NCT03687957|528616030|FG001|Overall Study|Disease progression|1|||
146575160|NCT03687957|528616031|FG002|Overall Study|Disease progression|1|||
146575161|NCT03687957|528616032|FG003|Overall Study|Disease progression|2|||
146575162|NCT03687957|528616033|FG004|Overall Study|Disease progression|2|||
146575163|NCT03687957|528616034|FG005|Overall Study|Disease progression|0|||
146575164|NCT03687957|528616035|FG006|Overall Study|Disease progression|2|||
146575165|NCT03687957|528616036|FG007|Overall Study|Disease progression|1|||
146575166|NCT03687957|528616037|FG008|Overall Study|Disease progression|0|||
146575167|NCT03687957|528616038|FG009|Overall Study|Disease progression|0|||
146575168|NCT03687957|528616029|FG000|Overall Study|Physician Decision|0|||
146575169|NCT03687957|528616030|FG001|Overall Study|Physician Decision|0|||
146575170|NCT03687957|528616031|FG002|Overall Study|Physician Decision|0|||
146575171|NCT03687957|528616032|FG003|Overall Study|Physician Decision|2|||
146575172|NCT03687957|528616033|FG004|Overall Study|Physician Decision|1|||
146575173|NCT03687957|528616034|FG005|Overall Study|Physician Decision|0|||
146575174|NCT03687957|528616035|FG006|Overall Study|Physician Decision|1|||
146575175|NCT03687957|528616036|FG007|Overall Study|Physician Decision|0|||
146575176|NCT03687957|528616037|FG008|Overall Study|Physician Decision|0|||
146575177|NCT03687957|528616038|FG009|Overall Study|Physician Decision|0|||
146575178|NCT03687957|528616029|FG000|Overall Study|New malignancy|0|||
146575179|NCT03687957|528616030|FG001|Overall Study|New malignancy|0|||
146575180|NCT03687957|528616031|FG002|Overall Study|New malignancy|0|||
146575181|NCT03687957|528616032|FG003|Overall Study|New malignancy|0|||
146575182|NCT03687957|528616033|FG004|Overall Study|New malignancy|1|||
146575183|NCT03687957|528616034|FG005|Overall Study|New malignancy|0|||
146575184|NCT03687957|528616035|FG006|Overall Study|New malignancy|0|||
146575185|NCT03687957|528616036|FG007|Overall Study|New malignancy|0|||
146575186|NCT03687957|528616037|FG008|Overall Study|New malignancy|0|||
146575187|NCT03687957|528616038|FG009|Overall Study|New malignancy|0|||
146575188|NCT03687957|528616029|FG000|Overall Study|Adverse Event|0|||
146575189|NCT03687957|528616030|FG001|Overall Study|Adverse Event|0|||
146770611|NCT01135511|529328643|FG001|Overall Study|Protocol Violation|0|||
146575190|NCT03687957|528616031|FG002|Overall Study|Adverse Event|0|||
146575191|NCT03687957|528616032|FG003|Overall Study|Adverse Event|0|||
146575192|NCT03687957|528616033|FG004|Overall Study|Adverse Event|0|||
146575193|NCT03687957|528616034|FG005|Overall Study|Adverse Event|2|||
146575194|NCT03687957|528616035|FG006|Overall Study|Adverse Event|0|||
146575195|NCT03687957|528616036|FG007|Overall Study|Adverse Event|3|||
146575196|NCT03687957|528616037|FG008|Overall Study|Adverse Event|0|||
146575197|NCT03687957|528616038|FG009|Overall Study|Adverse Event|0|||
146575198|NCT03687957|528616029|FG000|Overall Study|Patient went on hospice|0|||
146575199|NCT03687957|528616030|FG001|Overall Study|Patient went on hospice|0|||
146575200|NCT03687957|528616031|FG002|Overall Study|Patient went on hospice|0|||
146575201|NCT03687957|528616032|FG003|Overall Study|Patient went on hospice|0|||
146575202|NCT03687957|528616033|FG004|Overall Study|Patient went on hospice|0|||
146575203|NCT03687957|528616034|FG005|Overall Study|Patient went on hospice|0|||
146575204|NCT03687957|528616035|FG006|Overall Study|Patient went on hospice|1|||
146575205|NCT03687957|528616036|FG007|Overall Study|Patient went on hospice|0|||
146575206|NCT03687957|528616037|FG008|Overall Study|Patient went on hospice|0|||
146977534|NCT01792284|530080982|FG001|Randomization Period 1|Withdrawal by Subject|1|||
146977535|NCT01792284|530080983|FG002|Randomization Period 1|Withdrawal by Subject|1|||
146977536|NCT01792284|530080981|FG000|Randomization Period 1|Physician Decision|0|||
146977537|NCT01792284|530080982|FG001|Randomization Period 1|Physician Decision|1|||
146977538|NCT01792284|530080983|FG002|Randomization Period 1|Physician Decision|1|||
146977539|NCT01792284|530080981|FG000|Randomization Period 1|Adverse Event|0|||
146977540|NCT01792284|530080982|FG001|Randomization Period 1|Adverse Event|0|||
146977541|NCT01792284|530080983|FG002|Randomization Period 1|Adverse Event|2|||
146977542|NCT01792284|530080981|FG000|Randomization Period 1|Lost to Follow-up|0|||
146977543|NCT01792284|530080982|FG001|Randomization Period 1|Lost to Follow-up|0|||
146977544|NCT01792284|530080983|FG002|Randomization Period 1|Lost to Follow-up|1|||
146977545|NCT01792284|530080981|FG000|Randomization Period 2|Protocol Violation|0|||
146977546|NCT01792284|530080982|FG001|Randomization Period 2|Protocol Violation|1|||
146977547|NCT01792284|530080983|FG002|Randomization Period 2|Protocol Violation|0|||
146977548|NCT01792284|530080981|FG000|Randomization Period 2|Withdrawal by Subject|0|||
146977549|NCT01792284|530080982|FG001|Randomization Period 2|Withdrawal by Subject|2|||
146977550|NCT01792284|530080983|FG002|Randomization Period 2|Withdrawal by Subject|0|||
146977551|NCT00379587|530080989|FG000|Overall Study|Lost to Follow-up|2|||
146977552|NCT00054275|530080992|FG000|Overall Study|Withdrawal by Subject|4|||
146977553|NCT00054275|530080992|FG000|Overall Study|Adverse Event|5|||
146977554|NCT00054275|530080992|FG000|Overall Study|Progressive disease in cycle 1|1|||
146977555|NCT00054275|530080992|FG000|Overall Study|Physician Decision|1|||
146977556|NCT00755937|530080993|FG000|Recruitment|Unknown if infliximab received|164|||
146977557|NCT00755937|530080993|FG000|Observational Follow-up|Lost to Follow-up|148|||
146977558|NCT01106352|530080994|FG000|Overall Study|Subjects untreated|0|||
146977559|NCT01106352|530080995|FG001|Overall Study|Subjects untreated|0|||
146977560|NCT01106352|530080996|FG002|Overall Study|Subjects untreated|0|||
146977561|NCT01106352|530080997|FG003|Overall Study|Subjects untreated|3|||
146977562|NCT01106352|530080998|FG004|Overall Study|Subjects untreated|4|||
146977563|NCT01106352|530080994|FG000|Overall Study|Sponsor Decision|1|||
146575207|NCT03687957|528616038|FG009|Overall Study|Patient went on hospice|0|||
146575208|NCT03687957|528616029|FG000|Overall Study|Death|0|||
146575209|NCT03687957|528616030|FG001|Overall Study|Death|0|||
146575210|NCT03687957|528616031|FG002|Overall Study|Death|0|||
146575211|NCT03687957|528616032|FG003|Overall Study|Death|0|||
146575212|NCT03687957|528616033|FG004|Overall Study|Death|0|||
146575213|NCT03687957|528616034|FG005|Overall Study|Death|0|||
146575214|NCT03687957|528616035|FG006|Overall Study|Death|0|||
146575215|NCT03687957|528616036|FG007|Overall Study|Death|1|||
146575216|NCT03687957|528616037|FG008|Overall Study|Death|0|||
146575217|NCT03687957|528616038|FG009|Overall Study|Death|0|||
146917712|NCT00051558|529861470|FG001|Overall Study|Death|15|||
146917713|NCT00051558|529861469|FG000|Overall Study|Lost to Follow-up|4|||
146575220|NCT03052608|528616044|FG000|Treatment Phase|Adverse Event|10|||
146575221|NCT03052608|528616045|FG001|Treatment Phase|Adverse Event|12|||
146575222|NCT03052608|528616044|FG000|Treatment Phase|Death|6|||
146575223|NCT03052608|528616045|FG001|Treatment Phase|Death|4|||
146575224|NCT03052608|528616044|FG000|Treatment Phase|Withdrawal by Subject|4|||
146575225|NCT03052608|528616045|FG001|Treatment Phase|Withdrawal by Subject|12|||
146575226|NCT03052608|528616044|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
146575227|NCT03052608|528616045|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
146651856|NCT03400956|528902290|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146917714|NCT00051558|529861470|FG001|Overall Study|Lost to Follow-up|13|||
146917715|NCT00051558|529861469|FG000|Overall Study|Protocol Violation|3|||
146917716|NCT00051558|529861470|FG001|Overall Study|Protocol Violation|4|||
146917717|NCT00051558|529861469|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
146917718|NCT00051558|529861470|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
146917719|NCT00051558|529861469|FG000|Overall Study|Sponsor Decision|6|||
146917720|NCT00051558|529861470|FG001|Overall Study|Sponsor Decision|1|||
146917721|NCT00051558|529861469|FG000|Overall Study|Other|2|||
146917722|NCT00051558|529861470|FG001|Overall Study|Other|1|||
146917723|NCT00051558|529861469|FG000|Overall Study|Significant Lab Value|2|||
146917724|NCT00051558|529861470|FG001|Overall Study|Significant Lab Value|0|||
146917725|NCT00051558|529861469|FG000|Overall Study|Physician Decision|5|||
146977564|NCT01106352|530080995|FG001|Overall Study|Sponsor Decision|0|||
146977565|NCT01106352|530080996|FG002|Overall Study|Sponsor Decision|0|||
146977566|NCT01106352|530080997|FG003|Overall Study|Sponsor Decision|0|||
146977567|NCT01106352|530080998|FG004|Overall Study|Sponsor Decision|0|||
146977568|NCT01106352|530080994|FG000|Overall Study|Too ill to come in for the visit|0|||
146575228|NCT03052608|528616044|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
146575229|NCT03052608|528616045|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
146575230|NCT03052608|528616044|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
146575231|NCT03052608|528616045|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
146575232|NCT03052608|528616044|FG000|Treatment Phase|Ongoing|103|||
146575233|NCT03052608|528616045|FG001|Treatment Phase|Ongoing|31|||
146575234|NCT03052608|528616044|FG000|Long-Term Follow-up Phase|Death|23|||
146575235|NCT03052608|528616045|FG001|Long-Term Follow-up Phase|Death|28|||
146575236|NCT03052608|528616044|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
146575237|NCT03052608|528616045|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
146575238|NCT03052608|528616044|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
146575239|NCT03052608|528616045|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
146575240|NCT03052608|528616044|FG000|Long-Term Follow-up Phase|Ongoing|122|||
146575241|NCT03052608|528616045|FG001|Long-Term Follow-up Phase|Ongoing|99|||
146575242|NCT04667949|528616046|FG000|Overall Study|Adverse Event|0|||
146575243|NCT04667949|528616047|FG001|Overall Study|Adverse Event|2|||
146575244|NCT04667949|528616046|FG000|Overall Study|Lost to Follow-up|0|||
146575245|NCT04667949|528616047|FG001|Overall Study|Lost to Follow-up|1|||
146575246|NCT04667949|528616046|FG000|Overall Study|Physician Decision|0|||
146575247|NCT04667949|528616047|FG001|Overall Study|Physician Decision|2|||
146575248|NCT04667949|528616046|FG000|Overall Study|Subject decision|1|||
146575249|NCT04667949|528616047|FG001|Overall Study|Subject decision|7|||
146575250|NCT02213926|528616048|FG000|Overall Study|Death|59|||
146575251|NCT02213926|528616048|FG000|Overall Study|Withdrawal by Subject|10|||
146575252|NCT02213926|528616048|FG000|Overall Study|study terminated by sponsor|51|||
146575253|NCT02213926|528616048|FG000|Overall Study|Lost to Follow-up|3|||
146575254|NCT02213926|528616048|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
146575255|NCT05887908|528616049|FG000|Overall Study|Adverse Event|6|||
146575256|NCT05887908|528616050|FG001|Overall Study|Adverse Event|1|||
146575257|NCT05887908|528616051|FG002|Overall Study|Adverse Event|1|||
146575258|NCT05887908|528616049|FG000|Overall Study|Physician Decision|4|||
146575259|NCT05887908|528616050|FG001|Overall Study|Physician Decision|1|||
146575260|NCT05887908|528616051|FG002|Overall Study|Physician Decision|0|||
146575261|NCT05887908|528616049|FG000|Overall Study|Withdrawal by Subject|3|||
146575262|NCT05887908|528616050|FG001|Overall Study|Withdrawal by Subject|2|||
146575263|NCT05887908|528616051|FG002|Overall Study|Withdrawal by Subject|3|||
146575264|NCT05887908|528616049|FG000|Overall Study|Ineligibility after the start of the study|4|||
146575265|NCT05887908|528616050|FG001|Overall Study|Ineligibility after the start of the study|1|||
146575266|NCT05887908|528616051|FG002|Overall Study|Ineligibility after the start of the study|0|||
146575267|NCT05887908|528616049|FG000|Overall Study|Subject non-compliance|4|||
146575268|NCT05887908|528616050|FG001|Overall Study|Subject non-compliance|0|||
146575269|NCT05887908|528616051|FG002|Overall Study|Subject non-compliance|4|||
146575270|NCT05887908|528616049|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
146575271|NCT05887908|528616050|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
146575272|NCT05887908|528616051|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
146575273|NCT05887908|528616049|FG000|Overall Study|Pregnancy|0|||
146575274|NCT05887908|528616050|FG001|Overall Study|Pregnancy|1|||
146575275|NCT05887908|528616051|FG002|Overall Study|Pregnancy|0|||
146575276|NCT05887908|528616049|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
146575277|NCT05887908|528616050|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
146575278|NCT05887908|528616051|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
146575279|NCT05887908|528616049|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
146575280|NCT05887908|528616050|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
146575281|NCT05887908|528616051|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
146575282|NCT05887908|528616049|FG000|Overall Study|Other Reason|3|||
146575283|NCT05887908|528616050|FG001|Overall Study|Other Reason|3|||
146575284|NCT05887908|528616051|FG002|Overall Study|Other Reason|3|||
146575285|NCT02630693|528616052|FG000|Overall Study|No receive treatment|0|||
146575286|NCT02630693|528616053|FG001|Overall Study|No receive treatment|1|||
146575287|NCT04423939|528616054|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
146575288|NCT04423939|528616055|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
146575289|NCT04423939|528616054|FG000|Overall Study|Death|3|||
146575290|NCT04423939|528616055|FG001|Overall Study|Death|0|||
146575291|NCT04423939|528616054|FG000|Overall Study|Withdrawal by Subject|3|||
146575292|NCT04423939|528616055|FG001|Overall Study|Withdrawal by Subject|0|||
146575293|NCT04423939|528616054|FG000|Overall Study|Caregiver to patient who died|0|||
146977569|NCT01106352|530080995|FG001|Overall Study|Too ill to come in for the visit|0|||
146977570|NCT01106352|530080996|FG002|Overall Study|Too ill to come in for the visit|1|||
146575294|NCT04423939|528616055|FG001|Overall Study|Caregiver to patient who died|3|||
146575295|NCT04423939|528616054|FG000|Overall Study|Caregiver to patient who withdrew|0|||
146575296|NCT04423939|528616055|FG001|Overall Study|Caregiver to patient who withdrew|3|||
146575297|NCT05338710|528616056|FG000|Overall Study|Withdrawal by Subject|3|||
146575298|NCT04503551|528616057|FG000|Overall Study|Withdrawal by Subject|5|||
146575299|NCT04503551|528616058|FG001|Overall Study|Withdrawal by Subject|3|||
146575300|NCT04503551|528616057|FG000|Overall Study|Physician Decision|1|||
146575301|NCT04503551|528616058|FG001|Overall Study|Physician Decision|0|||
146575302|NCT04503551|528616057|FG000|Overall Study|Death|0|||
146575303|NCT04503551|528616058|FG001|Overall Study|Death|1|||
146575304|NCT04503551|528616057|FG000|Overall Study|Lost to Follow-up|1|||
146575305|NCT04503551|528616058|FG001|Overall Study|Lost to Follow-up|2|||
146575306|NCT04503551|528616057|FG000|Overall Study|Ongoing at Week 52|99|||
146575307|NCT04503551|528616058|FG001|Overall Study|Ongoing at Week 52|62|||
146575308|NCT04158375|528616066|FG000|Overall Study|Withdrawal by Subject|0|||
146575309|NCT04158375|528616067|FG001|Overall Study|Withdrawal by Subject|3|||
146575310|NCT04158375|528616068|FG002|Overall Study|Withdrawal by Subject|0|||
146575311|NCT01152788|528616069|FG000|Overall Study|Withdrawal by Subject|0|||
146575312|NCT01152788|528616070|FG001|Overall Study|Withdrawal by Subject|3|||
146575313|NCT01152788|528616069|FG000|Overall Study|No treatment|0|||
146575314|NCT01152788|528616070|FG001|Overall Study|No treatment|1|||
146575315|NCT01272037|528616078|FG000|Overall Study|Death|25|||
146575316|NCT01272037|528616079|FG001|Overall Study|Death|28|||
146575317|NCT01272037|528616078|FG000|Overall Study|Adverse Event|12|||
146575318|NCT01272037|528616079|FG001|Overall Study|Adverse Event|7|||
146575319|NCT01272037|528616078|FG000|Overall Study|Withdrawal by Subject|175|||
146575320|NCT01272037|528616079|FG001|Overall Study|Withdrawal by Subject|93|||
146575321|NCT01272037|528616078|FG000|Overall Study|Disease progression|70|||
146575322|NCT01272037|528616079|FG001|Overall Study|Disease progression|111|||
146575323|NCT01272037|528616078|FG000|Overall Study|Other reason|42|||
146575324|NCT01272037|528616079|FG001|Overall Study|Other reason|41|||
146575325|NCT01272037|528616078|FG000|Overall Study|Delinquent data|24|||
146575326|NCT01272037|528616079|FG001|Overall Study|Delinquent data|19|||
146575327|NCT01272037|528616078|FG000|Overall Study|Reason under review|33|||
146575328|NCT01272037|528616079|FG001|Overall Study|Reason under review|29|||
146575329|NCT01272037|528616078|FG000|Overall Study|On treatment|626|||
146575330|NCT01272037|528616079|FG001|Overall Study|On treatment|632|||
146917726|NCT00051558|529861470|FG001|Overall Study|Physician Decision|0|||
146917727|NCT01701583|529861474|FG000|Overall Study|Withdrawal by Subject|2|||
146917728|NCT01701583|529861475|FG001|Overall Study|Withdrawal by Subject|0|||
146917729|NCT01441440|529861476|FG000|Overall Study|Death|1|||
146917730|NCT01441440|529861477|FG001|Overall Study|Death|0|||
146917731|NCT01441440|529861478|FG002|Overall Study|Death|1|||
146917732|NCT01441440|529861476|FG000|Overall Study|Adverse Event|2|||
146917733|NCT01441440|529861477|FG001|Overall Study|Adverse Event|9|||
146917734|NCT01441440|529861478|FG002|Overall Study|Adverse Event|9|||
146917735|NCT01441440|529861476|FG000|Overall Study|Lost to Follow-up|0|||
146917736|NCT01441440|529861477|FG001|Overall Study|Lost to Follow-up|2|||
146917737|NCT01441440|529861478|FG002|Overall Study|Lost to Follow-up|1|||
146917738|NCT01441440|529861476|FG000|Overall Study|Withdrawal by Subject|11|||
146917739|NCT01441440|529861477|FG001|Overall Study|Withdrawal by Subject|9|||
146917740|NCT01441440|529861478|FG002|Overall Study|Withdrawal by Subject|9|||
146917741|NCT01441440|529861476|FG000|Overall Study|Pregnancy|1|||
146917742|NCT01441440|529861477|FG001|Overall Study|Pregnancy|0|||
146917743|NCT01441440|529861478|FG002|Overall Study|Pregnancy|0|||
146917744|NCT01441440|529861476|FG000|Overall Study|Lack of Efficacy|1|||
146917745|NCT01441440|529861477|FG001|Overall Study|Lack of Efficacy|0|||
146917746|NCT01441440|529861478|FG002|Overall Study|Lack of Efficacy|1|||
146917747|NCT01441440|529861476|FG000|Overall Study|Moving|0|||
146917748|NCT01441440|529861477|FG001|Overall Study|Moving|1|||
146917749|NCT01441440|529861478|FG002|Overall Study|Moving|1|||
146917750|NCT01441440|529861476|FG000|Overall Study|Work-related matter|0|||
146917751|NCT01441440|529861477|FG001|Overall Study|Work-related matter|1|||
146917752|NCT01441440|529861478|FG002|Overall Study|Work-related matter|0|||
146917753|NCT01441440|529861476|FG000|Overall Study|Difficllty in keeping the schedule|1|||
146917754|NCT01441440|529861477|FG001|Overall Study|Difficllty in keeping the schedule|1|||
146917755|NCT01441440|529861478|FG002|Overall Study|Difficllty in keeping the schedule|0|||
146917756|NCT01345123|529861479|FG000|Overall Study|participants no longer with health plan|79|||
146917757|NCT01345123|529861480|FG001|Overall Study|participants no longer with health plan|85|||
146917758|NCT01345123|529861481|FG002|Overall Study|participants no longer with health plan|88|||
146575331|NCT01890265|528616080|FG000|Overall Study|Other (Unspecified reason)|0|||
146575332|NCT01890265|528616081|FG001|Overall Study|Other (Unspecified reason)|1|||
146575333|NCT01890265|528616082|FG002|Overall Study|Other (Unspecified reason)|0|||
146575334|NCT01890265|528616083|FG003|Overall Study|Other (Unspecified reason)|0|||
146575335|NCT01890265|528616084|FG004|Overall Study|Other (Unspecified reason)|0|||
146575336|NCT01890265|528616085|FG005|Overall Study|Other (Unspecified reason)|0|||
146575337|NCT01890265|528616080|FG000|Overall Study|Progressive disease|6|||
146575338|NCT01890265|528616081|FG001|Overall Study|Progressive disease|6|||
146917759|NCT00883558|529861482|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
146575339|NCT01890265|528616082|FG002|Overall Study|Progressive disease|0|||
146575340|NCT01890265|528616083|FG003|Overall Study|Progressive disease|0|||
146575341|NCT01890265|528616084|FG004|Overall Study|Progressive disease|0|||
146575342|NCT01890265|528616085|FG005|Overall Study|Progressive disease|0|||
146575343|NCT01890265|528616080|FG000|Overall Study|Adverse Event|2|||
146575344|NCT01890265|528616081|FG001|Overall Study|Adverse Event|1|||
146575345|NCT01890265|528616082|FG002|Overall Study|Adverse Event|0|||
146575346|NCT01890265|528616083|FG003|Overall Study|Adverse Event|0|||
146575347|NCT01890265|528616084|FG004|Overall Study|Adverse Event|0|||
146575348|NCT01890265|528616085|FG005|Overall Study|Adverse Event|0|||
146575349|NCT01890265|528616080|FG000|Overall Study|Death|2|||
146575350|NCT01890265|528616081|FG001|Overall Study|Death|3|||
146575351|NCT01890265|528616082|FG002|Overall Study|Death|1|||
146575352|NCT01890265|528616083|FG003|Overall Study|Death|0|||
146575353|NCT01890265|528616084|FG004|Overall Study|Death|0|||
146575354|NCT01890265|528616085|FG005|Overall Study|Death|0|||
146575355|NCT01890265|528616080|FG000|Overall Study|Withdrawal by Subject|0|||
146575356|NCT01890265|528616081|FG001|Overall Study|Withdrawal by Subject|2|||
146575357|NCT01890265|528616082|FG002|Overall Study|Withdrawal by Subject|3|||
146575358|NCT01890265|528616083|FG003|Overall Study|Withdrawal by Subject|0|||
146575359|NCT01890265|528616084|FG004|Overall Study|Withdrawal by Subject|2|||
146575360|NCT01890265|528616085|FG005|Overall Study|Withdrawal by Subject|0|||
146575361|NCT04585269|528616088|FG000|Intervention|Withdrawal by Subject|9|||
146575362|NCT04585269|528616089|FG001|Intervention|Withdrawal by Subject|0|||
146575363|NCT04585269|528616088|FG000|Intervention|Unable to schedule|15|||
146575364|NCT04585269|528616089|FG001|Intervention|Unable to schedule|0|||
146575365|NCT04585269|528616088|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
146977571|NCT01106352|530080997|FG003|Overall Study|Too ill to come in for the visit|0|||
146575366|NCT04585269|528616089|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
146575367|NCT04585269|528616088|FG000|FU Time 2 (3 months)|Death|2|||
146575368|NCT04585269|528616089|FG001|FU Time 2 (3 months)|Death|2|||
146575369|NCT04585269|528616088|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
146977572|NCT01106352|530080998|FG004|Overall Study|Too ill to come in for the visit|0|||
146977573|NCT01106352|530080994|FG000|Overall Study|Lost to Follow-up|0|||
146977574|NCT01106352|530080995|FG001|Overall Study|Lost to Follow-up|0|||
146977575|NCT01106352|530080996|FG002|Overall Study|Lost to Follow-up|0|||
146977576|NCT01106352|530080997|FG003|Overall Study|Lost to Follow-up|0|||
146977577|NCT01106352|530080998|FG004|Overall Study|Lost to Follow-up|1|||
146977578|NCT01106352|530080994|FG000|Overall Study|Death|0|||
146977579|NCT01106352|530080995|FG001|Overall Study|Death|0|||
146977580|NCT01106352|530080996|FG002|Overall Study|Death|1|||
146977581|NCT01106352|530080997|FG003|Overall Study|Death|3|||
146977582|NCT01106352|530080998|FG004|Overall Study|Death|1|||
146977583|NCT01106352|530080994|FG000|Overall Study|Disease progression|0|||
146977584|NCT01106352|530080995|FG001|Overall Study|Disease progression|0|||
146977585|NCT01106352|530080996|FG002|Overall Study|Disease progression|0|||
146977586|NCT01106352|530080997|FG003|Overall Study|Disease progression|1|||
146977587|NCT01106352|530080998|FG004|Overall Study|Disease progression|0|||
146977588|NCT01106352|530080994|FG000|Overall Study|Withdrawal by Subject|0|||
146977589|NCT01106352|530080995|FG001|Overall Study|Withdrawal by Subject|0|||
146575370|NCT04585269|528616089|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
146575371|NCT04585269|528616088|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
146575372|NCT04585269|528616089|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
146575373|NCT04585269|528616088|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
146575374|NCT04585269|528616089|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
146575375|NCT04585269|528616088|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
146575376|NCT04585269|528616089|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
146575377|NCT04585269|528616088|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
146575378|NCT04585269|528616089|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
146575379|NCT04271540|528616093|FG000|Overall Study|Lost to Follow-up|1|||
146575380|NCT04271540|528616093|FG000|Overall Study|Screen Fail|5|||
146575381|NCT03307785|528616094|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
146575382|NCT03307785|528616095|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146575383|NCT03307785|528616096|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146575384|NCT03307785|528616097|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146575385|NCT03307785|528616098|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146575386|NCT03307785|528616099|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146575387|NCT03307785|528616100|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146575388|NCT03307785|528616101|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146575389|NCT03307785|528616102|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146770612|NCT01135511|529328644|FG002|Overall Study|Protocol Violation|3|||
146977590|NCT01106352|530080996|FG002|Overall Study|Withdrawal by Subject|0|||
146977591|NCT01106352|530080997|FG003|Overall Study|Withdrawal by Subject|3|||
146977592|NCT01106352|530080998|FG004|Overall Study|Withdrawal by Subject|2|||
146977593|NCT01106352|530080994|FG000|Overall Study|Went on hospice|0|||
146977594|NCT01106352|530080995|FG001|Overall Study|Went on hospice|0|||
146977595|NCT01106352|530080996|FG002|Overall Study|Went on hospice|0|||
146977596|NCT01106352|530080997|FG003|Overall Study|Went on hospice|1|||
146575390|NCT03307785|528616103|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146575391|NCT03307785|528616104|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146575392|NCT03307785|528616105|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146575393|NCT03307785|528616106|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146575394|NCT03307785|528616094|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
146575395|NCT03307785|528616095|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
146575396|NCT03307785|528616096|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146575397|NCT03307785|528616097|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146575398|NCT03307785|528616098|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146575399|NCT03307785|528616099|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146575400|NCT03307785|528616100|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146575401|NCT03307785|528616101|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146575402|NCT03307785|528616102|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146575403|NCT03307785|528616103|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146575404|NCT03307785|528616104|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146575405|NCT03307785|528616105|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146575406|NCT03307785|528616106|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146575407|NCT03307785|528616094|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
146575408|NCT03307785|528616095|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
146575409|NCT03307785|528616096|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
146575410|NCT03307785|528616097|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
146575411|NCT03307785|528616098|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
146575412|NCT03307785|528616099|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
146575413|NCT03307785|528616100|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
146575414|NCT03307785|528616101|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
146575415|NCT03307785|528616102|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
146575416|NCT03307785|528616103|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
146575417|NCT03307785|528616104|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
146575418|NCT03307785|528616105|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
146575419|NCT03307785|528616106|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
146575420|NCT03307785|528616094|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
146575421|NCT03307785|528616095|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
146575422|NCT03307785|528616096|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146575423|NCT03307785|528616097|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146977597|NCT01106352|530080998|FG004|Overall Study|Went on hospice|0|||
146977598|NCT01106352|530080994|FG000|Overall Study|Subject entered hospice|0|||
146977599|NCT01106352|530080995|FG001|Overall Study|Subject entered hospice|0|||
146575424|NCT03307785|528616098|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146575425|NCT03307785|528616099|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146575426|NCT03307785|528616100|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146575427|NCT03307785|528616101|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146575428|NCT03307785|528616102|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146575429|NCT03307785|528616103|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146575430|NCT03307785|528616104|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146575431|NCT03307785|528616105|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146575432|NCT03307785|528616106|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146575433|NCT03307785|528616094|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146575434|NCT03307785|528616095|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146575435|NCT03307785|528616096|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
146575436|NCT03307785|528616097|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146575437|NCT03307785|528616098|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146575438|NCT03307785|528616099|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146575439|NCT03307785|528616100|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146575440|NCT03307785|528616101|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146575441|NCT03307785|528616102|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146575442|NCT03307785|528616103|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146575443|NCT03307785|528616104|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146575444|NCT03307785|528616105|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146575445|NCT03307785|528616106|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146575446|NCT03307785|528616094|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
146977600|NCT01106352|530080996|FG002|Overall Study|Subject entered hospice|0|||
146977601|NCT01106352|530080997|FG003|Overall Study|Subject entered hospice|1|||
146977602|NCT01106352|530080998|FG004|Overall Study|Subject entered hospice|0|||
146977603|NCT01106352|530080994|FG000|Overall Study|Home hospice since July 2013|0|||
146575447|NCT03307785|528616095|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
146575448|NCT03307785|528616096|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
146575449|NCT03307785|528616097|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
146575450|NCT03307785|528616098|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
146575451|NCT03307785|528616099|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
146575452|NCT03307785|528616100|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
146575453|NCT03307785|528616101|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
146575454|NCT03307785|528616102|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
146575455|NCT03307785|528616103|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
146575456|NCT03307785|528616104|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
146575457|NCT03307785|528616105|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
146575458|NCT03307785|528616106|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
146575459|NCT03307785|528616094|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146575460|NCT03307785|528616095|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146575461|NCT03307785|528616096|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
146575462|NCT03307785|528616097|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146575463|NCT03307785|528616098|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146575464|NCT03307785|528616099|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146575465|NCT03307785|528616100|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146575466|NCT03307785|528616101|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146575467|NCT03307785|528616102|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146575468|NCT03307785|528616103|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146575469|NCT03307785|528616104|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146575470|NCT03307785|528616105|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146575471|NCT03307785|528616106|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146575472|NCT03307785|528616094|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146575473|NCT03307785|528616095|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146575474|NCT03307785|528616096|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
146575475|NCT03307785|528616097|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146575476|NCT03307785|528616098|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146575477|NCT03307785|528616099|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146575478|NCT03307785|528616100|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146575479|NCT03307785|528616101|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146575480|NCT03307785|528616102|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146575481|NCT03307785|528616103|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146575482|NCT03307785|528616104|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146575483|NCT03307785|528616105|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146575484|NCT03307785|528616106|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146575485|NCT03307785|528616094|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146575486|NCT03307785|528616095|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146575487|NCT03307785|528616096|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
146575488|NCT03307785|528616097|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146575489|NCT03307785|528616098|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146575490|NCT03307785|528616099|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146575491|NCT03307785|528616100|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146575492|NCT03307785|528616101|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146575493|NCT03307785|528616102|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146575494|NCT03307785|528616103|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146575495|NCT03307785|528616104|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146575496|NCT03307785|528616105|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146575497|NCT03307785|528616106|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146575498|NCT03307785|528616094|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146575499|NCT03307785|528616095|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146575500|NCT03307785|528616096|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146575501|NCT03307785|528616097|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
146575502|NCT03307785|528616098|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
146575503|NCT03307785|528616099|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146575504|NCT03307785|528616100|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146575505|NCT03307785|528616101|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146575506|NCT03307785|528616102|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146575507|NCT03307785|528616103|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146575508|NCT03307785|528616104|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146575509|NCT03307785|528616105|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146575510|NCT03307785|528616106|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146575511|NCT03307785|528616094|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
146575512|NCT03307785|528616095|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
146575513|NCT03307785|528616096|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
146575514|NCT03307785|528616097|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
146575515|NCT03307785|528616098|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
146575516|NCT03307785|528616099|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
146575517|NCT03307785|528616100|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
146575518|NCT03307785|528616101|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
146575519|NCT03307785|528616102|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
146575520|NCT03307785|528616103|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
146575521|NCT03307785|528616104|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
146575522|NCT03307785|528616105|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
146575523|NCT03307785|528616106|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
146977604|NCT01106352|530080995|FG001|Overall Study|Home hospice since July 2013|0|||
146575524|NCT03307785|528616094|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146575525|NCT03307785|528616095|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146575526|NCT03307785|528616096|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146575527|NCT03307785|528616097|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
146575528|NCT03307785|528616098|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146651857|NCT03400956|528902291|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146651858|NCT03400956|528902292|FG002|Treatment Period 2|Withdrawal by Subject|3|||
146651859|NCT03400956|528902290|FG000|Treatment Period 2|Other|1|||
146651860|NCT03400956|528902291|FG001|Treatment Period 2|Other|1|||
146651861|NCT03400956|528902292|FG002|Treatment Period 2|Other|0|||
146651862|NCT03400956|528902290|FG000|Follow-up Period|Withdrawal by Subject|0|||
146651863|NCT03400956|528902291|FG001|Follow-up Period|Withdrawal by Subject|0|||
146651864|NCT03400956|528902292|FG002|Follow-up Period|Withdrawal by Subject|1|||
146651865|NCT03400956|528902290|FG000|Follow-up Period|Other|0|||
146977605|NCT01106352|530080996|FG002|Overall Study|Home hospice since July 2013|0|||
146575529|NCT03307785|528616099|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146575530|NCT03307785|528616100|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146575531|NCT03307785|528616101|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146575532|NCT03307785|528616102|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146575533|NCT03307785|528616103|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146575534|NCT03307785|528616104|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146575535|NCT03307785|528616105|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146575536|NCT03307785|528616106|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146575537|NCT03307785|528616094|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146575538|NCT03307785|528616095|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146651866|NCT03400956|528902291|FG001|Follow-up Period|Other|0|||
146977606|NCT01106352|530080997|FG003|Overall Study|Home hospice since July 2013|1|||
146977607|NCT01106352|530080998|FG004|Overall Study|Home hospice since July 2013|0|||
146977608|NCT03547531|530080999|FG000|Overall Study|not coming in data collection : sick|2|||
146977609|NCT03547531|530081000|FG001|Overall Study|not coming in data collection : sick|2|||
146977610|NCT03547531|530080999|FG000|Overall Study|having family occasion|0|||
146977611|NCT03547531|530081000|FG001|Overall Study|having family occasion|2|||
146977612|NCT03944707|530081008|FG000|Overall Study|Adverse Event|0|||
146977613|NCT03944707|530081009|FG001|Overall Study|Adverse Event|2|||
146977614|NCT03944707|530081008|FG000|Overall Study|Study terminated by sponsor|12|||
146977615|NCT03944707|530081009|FG001|Overall Study|Study terminated by sponsor|7|||
146977616|NCT03944707|530081008|FG000|Overall Study|Subject decision|0|||
146977617|NCT03944707|530081009|FG001|Overall Study|Subject decision|1|||
146977618|NCT03402126|530081010|FG000|Overall Study|Lost to Follow-up|6|||
146977619|NCT03402126|530081010|FG000|Overall Study|Protocol Violation|10|||
146977620|NCT03402126|530081010|FG000|Overall Study|Sponsor request/Study termination|29|||
146977621|NCT03402126|530081010|FG000|Overall Study|Study product no longer in use|1|||
146977622|NCT03402126|530081010|FG000|Overall Study|Technical problems|1|||
146977623|NCT03402126|530081010|FG000|Overall Study|Withdrawal by Subject|6|||
146977624|NCT03402126|530081010|FG000|Overall Study|Physician Decision|2|||
146977625|NCT03402126|530081010|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
146977626|NCT03402126|530081010|FG000|Overall Study|Death|4|||
146651867|NCT03400956|528902292|FG002|Follow-up Period|Other|1|||
146651868|NCT02048241|528902293|FG000|Overall Study|Withdrawal by Subject|0|||
146651869|NCT02048241|528902294|FG001|Overall Study|Withdrawal by Subject|1|||
146651870|NCT03044574|528902297|FG000|Overall Study|Lost to Follow-up|37|||
146977627|NCT02444182|530081011|FG000|Overall Study|non-compliance|2|||
146977628|NCT02444182|530081012|FG001|Overall Study|non-compliance|1|||
146977629|NCT02444182|530081011|FG000|Overall Study|Lost to Follow-up|0|||
146977630|NCT02444182|530081012|FG001|Overall Study|Lost to Follow-up|4|||
146977631|NCT01959230|530081015|FG000|Overall Study|Failure to follow study procedures|0|||
146575539|NCT03307785|528616096|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146575540|NCT03307785|528616097|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146575541|NCT03307785|528616098|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
146575542|NCT03307785|528616099|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146575543|NCT03307785|528616100|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146575544|NCT03307785|528616101|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146575545|NCT03307785|528616102|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146575546|NCT03307785|528616103|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146575547|NCT03307785|528616104|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146917760|NCT00883558|529861483|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
146917761|NCT00883558|529861484|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
146917762|NCT00883558|529861482|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
146917763|NCT00883558|529861483|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
146917764|NCT00883558|529861484|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
146575548|NCT03307785|528616105|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146917765|NCT00883558|529861482|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
146917766|NCT00883558|529861483|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
146917767|NCT00883558|529861484|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
146917768|NCT00883558|529861482|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
146917769|NCT00883558|529861483|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
146917770|NCT00883558|529861484|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
146917771|NCT00883558|529861482|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
146917772|NCT00883558|529861483|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
146917773|NCT00883558|529861484|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
146917774|NCT00366548|529861486|FG000|Infant Series|Adverse Event|1|||
146917775|NCT00366548|529861487|FG001|Infant Series|Adverse Event|3|||
146917776|NCT00366548|529861486|FG000|Infant Series|Protocol Violation|0|||
146917777|NCT00366548|529861487|FG001|Infant Series|Protocol Violation|1|||
146917778|NCT00366548|529861486|FG000|Infant Series|Withdrawal by Subject|3|||
146917779|NCT00366548|529861487|FG001|Infant Series|Withdrawal by Subject|1|||
146917780|NCT00366548|529861486|FG000|After Infant Series|Withdrawal by Subject|3|||
146917781|NCT00366548|529861487|FG001|After Infant Series|Withdrawal by Subject|1|||
146917782|NCT00366548|529861486|FG000|After Infant Series|Adverse Event|2|||
146917783|NCT00366548|529861487|FG001|After Infant Series|Adverse Event|0|||
146917784|NCT00366548|529861486|FG000|After Infant Series|Lost to Follow-up|1|||
146917785|NCT00366548|529861487|FG001|After Infant Series|Lost to Follow-up|0|||
146917786|NCT01252134|529861488|FG000|Period 1, 8 Hours|Personal Reasons|0|||
146917787|NCT01252134|529861489|FG001|Period 1, 8 Hours|Personal Reasons|1|||
146917788|NCT01252134|529861490|FG002|Period 1, 8 Hours|Personal Reasons|1|||
146917789|NCT01252134|529861491|FG003|Period 1, 8 Hours|Personal Reasons|0|||
146917790|NCT01252134|529861492|FG004|Period 1, 8 Hours|Personal Reasons|0|||
146917791|NCT01252134|529861493|FG005|Period 1, 8 Hours|Personal Reasons|0|||
146917792|NCT02273050|529861495|FG000|Overall Study|Adverse Event|4|||
146917793|NCT02273050|529861496|FG001|Overall Study|Adverse Event|3|||
146917794|NCT02273050|529861497|FG002|Overall Study|Adverse Event|3|||
146917795|NCT02273050|529861495|FG000|Overall Study|Death|0|||
146917796|NCT02273050|529861496|FG001|Overall Study|Death|0|||
146917797|NCT02273050|529861497|FG002|Overall Study|Death|1|||
146917798|NCT02273050|529861495|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
146917799|NCT02273050|529861496|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
146917800|NCT02273050|529861497|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
146917801|NCT02273050|529861495|FG000|Overall Study|Lack of Efficacy|0|||
146917802|NCT02273050|529861496|FG001|Overall Study|Lack of Efficacy|1|||
146917803|NCT02273050|529861497|FG002|Overall Study|Lack of Efficacy|1|||
146917804|NCT02273050|529861495|FG000|Overall Study|Withdrawal by Subject|17|||
146917805|NCT02273050|529861496|FG001|Overall Study|Withdrawal by Subject|14|||
146917806|NCT02273050|529861497|FG002|Overall Study|Withdrawal by Subject|16|||
146917807|NCT02273050|529861495|FG000|Overall Study|Lost to Follow-up|0|||
146917808|NCT02273050|529861496|FG001|Overall Study|Lost to Follow-up|2|||
146917809|NCT02273050|529861497|FG002|Overall Study|Lost to Follow-up|3|||
146917810|NCT02273050|529861495|FG000|Overall Study|Protocol Violation|3|||
146917811|NCT02273050|529861496|FG001|Overall Study|Protocol Violation|1|||
146917812|NCT02273050|529861497|FG002|Overall Study|Protocol Violation|4|||
146917813|NCT00972478|529861498|FG000|Overall Study|Adverse Event|3|||
146917814|NCT00972478|529861499|FG001|Overall Study|Adverse Event|16|||
146917815|NCT00972478|529861498|FG000|Overall Study|Withdrawal by Subject|1|||
146917816|NCT00972478|529861499|FG001|Overall Study|Withdrawal by Subject|8|||
146917817|NCT00972478|529861498|FG000|Overall Study|Progression/Relapse|0|||
146917818|NCT00972478|529861499|FG001|Overall Study|Progression/Relapse|2|||
146917819|NCT00972478|529861498|FG000|Overall Study|Death|0|||
146977632|NCT01959230|530081016|FG001|Overall Study|Failure to follow study procedures|1|||
146575549|NCT03307785|528616106|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146575550|NCT03307785|528616094|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146575551|NCT03307785|528616095|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146575552|NCT03307785|528616096|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146575553|NCT03307785|528616097|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146575554|NCT03307785|528616098|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146575555|NCT03307785|528616099|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
146575556|NCT03307785|528616100|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146575557|NCT03307785|528616101|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146575558|NCT03307785|528616102|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146575559|NCT03307785|528616103|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146575560|NCT03307785|528616104|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146575561|NCT03307785|528616105|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146575562|NCT03307785|528616106|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146575563|NCT03307785|528616094|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146575564|NCT03307785|528616095|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146575565|NCT03307785|528616096|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146575566|NCT03307785|528616097|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146575567|NCT03307785|528616098|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146575568|NCT03307785|528616099|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
146575569|NCT03307785|528616100|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146575570|NCT03307785|528616101|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146575571|NCT03307785|528616102|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146575572|NCT03307785|528616103|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146575573|NCT03307785|528616104|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146575574|NCT03307785|528616105|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146575575|NCT03307785|528616106|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146575576|NCT03307785|528616094|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146575577|NCT03307785|528616095|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146575578|NCT03307785|528616096|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146575579|NCT03307785|528616097|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146575580|NCT03307785|528616098|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146575581|NCT03307785|528616099|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
146575582|NCT03307785|528616100|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146575583|NCT03307785|528616101|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146575584|NCT03307785|528616102|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146575585|NCT03307785|528616103|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146575586|NCT03307785|528616104|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146575587|NCT03307785|528616105|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146575588|NCT03307785|528616106|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146575589|NCT03307785|528616094|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146651871|NCT03044574|528902298|FG001|Overall Study|Lost to Follow-up|45|||
146651872|NCT01077375|528902310|FG000|Overall Study|Adverse Event|2|||
146917820|NCT00972478|529861499|FG001|Overall Study|Death|2|||
146917821|NCT00972478|529861498|FG000|Overall Study|Not protocol specified|1|||
146917822|NCT00972478|529861499|FG001|Overall Study|Not protocol specified|1|||
146917823|NCT00972478|529861498|FG000|Overall Study|Ineligible|1|||
146917824|NCT00972478|529861499|FG001|Overall Study|Ineligible|7|||
146917825|NCT00972478|529861498|FG000|Overall Study|Not start protocol treatment|1|||
146917826|NCT00972478|529861499|FG001|Overall Study|Not start protocol treatment|2|||
146917827|NCT02561000|529861500|FG000|Overall Study|Withdrawal by Subject|2|||
146917828|NCT02561000|529861501|FG001|Overall Study|Withdrawal by Subject|3|||
146917829|NCT02561000|529861502|FG002|Overall Study|Withdrawal by Subject|0|||
146917830|NCT02561000|529861500|FG000|Overall Study|Adverse Event|0|||
146917831|NCT02561000|529861501|FG001|Overall Study|Adverse Event|1|||
146917832|NCT02561000|529861502|FG002|Overall Study|Adverse Event|0|||
146917833|NCT03952468|529861503|FG000|Overall Study|Death|0|||
146917834|NCT03952468|529861504|FG001|Overall Study|Death|1|||
146917835|NCT03952468|529861503|FG000|Overall Study|Adverse Event|0|||
146917836|NCT03952468|529861504|FG001|Overall Study|Adverse Event|1|||
146917837|NCT03952468|529861503|FG000|Overall Study|Physician Decision|1|||
146917838|NCT03952468|529861504|FG001|Overall Study|Physician Decision|0|||
146917839|NCT03952468|529861503|FG000|Overall Study|Lost to Follow-up|3|||
146917840|NCT03952468|529861504|FG001|Overall Study|Lost to Follow-up|4|||
146917841|NCT03952468|529861503|FG000|Overall Study|Withdrawal by Subject|2|||
146917842|NCT03952468|529861504|FG001|Overall Study|Withdrawal by Subject|1|||
146917843|NCT01234402|529861505|FG000|Overall Study|Lost to Follow-up|0|||
146917844|NCT01234402|529861506|FG001|Overall Study|Lost to Follow-up|1|||
146917845|NCT01234402|529861507|FG002|Overall Study|Lost to Follow-up|3|||
147013239|NCT01708954|530210054|FG000|Step 1|Crossed over to Step 2|2|||
146977633|NCT01959230|530081015|FG000|Overall Study|Administrative reasons|2|||
146977634|NCT01959230|530081016|FG001|Overall Study|Administrative reasons|0|||
146977635|NCT01959230|530081015|FG000|Overall Study|Withdrawal by Subject|2|||
146977636|NCT01959230|530081016|FG001|Overall Study|Withdrawal by Subject|0|||
146977637|NCT01965535|530081017|FG000|Overall Study|Lack of Efficacy|2|||
146977638|NCT01965535|530081018|FG001|Overall Study|Lack of Efficacy|1|||
146977639|NCT01825876|530081019|FG000|Period 2|Withdrawal by Subject|0|||
146977640|NCT01825876|530081020|FG001|Period 2|Withdrawal by Subject|1|||
146977641|NCT03751020|530081023|FG000|Overall Study|Withdrawal by Subject|2|||
146977642|NCT03751020|530081024|FG001|Overall Study|Withdrawal by Subject|0|||
146977643|NCT03751020|530081025|FG002|Overall Study|Withdrawal by Subject|0|||
146977644|NCT03751020|530081023|FG000|Overall Study|Lost to Follow-up|7|||
146977645|NCT03751020|530081024|FG001|Overall Study|Lost to Follow-up|4|||
146977646|NCT03751020|530081025|FG002|Overall Study|Lost to Follow-up|10|||
146977647|NCT01889862|530081026|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
146977648|NCT01889862|530081027|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
146977649|NCT01889862|530081028|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
146977650|NCT01889862|530081029|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
146977651|NCT01889862|530081030|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
146977652|NCT01889862|530081026|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
146977653|NCT01889862|530081027|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
146977654|NCT01889862|530081028|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
146977655|NCT01889862|530081029|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
146977656|NCT01889862|530081030|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
146977657|NCT01889862|530081026|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
146977658|NCT01889862|530081027|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
146977659|NCT01889862|530081028|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
146977660|NCT01889862|530081029|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
146977661|NCT01889862|530081030|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
146977662|NCT01889862|530081026|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
146977663|NCT01889862|530081027|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
146977664|NCT01889862|530081028|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
146977665|NCT01889862|530081029|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
146977666|NCT01889862|530081030|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
146977667|NCT01889862|530081026|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
146977668|NCT01889862|530081027|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
146977669|NCT01889862|530081028|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
146977670|NCT01889862|530081029|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
146977671|NCT01889862|530081030|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
146977672|NCT01889862|530081026|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
146977673|NCT01889862|530081027|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
146977674|NCT01889862|530081028|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
146977675|NCT01889862|530081029|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
146977676|NCT01889862|530081030|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
146977677|NCT01889862|530081026|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
146977678|NCT01889862|530081027|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
146977679|NCT01889862|530081028|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
146977680|NCT01889862|530081029|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
146977681|NCT01889862|530081030|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
146977682|NCT01889862|530081026|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
146977683|NCT01889862|530081027|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
146977684|NCT01889862|530081028|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
146977685|NCT01889862|530081029|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
146977686|NCT01889862|530081030|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
146977687|NCT01889862|530081026|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
146977688|NCT01889862|530081027|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
146977689|NCT01889862|530081028|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
146651873|NCT01077375|528902311|FG001|Overall Study|Adverse Event|15|||
146651874|NCT01077375|528902310|FG000|Overall Study|Lack of Efficacy|6|||
146651875|NCT01077375|528902311|FG001|Overall Study|Lack of Efficacy|8|||
146977690|NCT01889862|530081029|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
146977691|NCT01889862|530081030|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
146977692|NCT01889862|530081026|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
146977693|NCT01889862|530081027|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
146977694|NCT01889862|530081028|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
146977695|NCT01889862|530081029|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
146977696|NCT01889862|530081030|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
146977697|NCT00528879|530081031|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
146977698|NCT00528879|530081032|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
146977699|NCT00528879|530081033|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
146977700|NCT00528879|530081034|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
146977701|NCT00528879|530081031|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
146651876|NCT01077375|528902310|FG000|Overall Study|Withdrawal by Subject|0|||
146575590|NCT03307785|528616095|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146575591|NCT03307785|528616096|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146575592|NCT03307785|528616097|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146575593|NCT03307785|528616098|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146575594|NCT03307785|528616099|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
146575595|NCT03307785|528616100|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146575596|NCT03307785|528616101|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146575597|NCT03307785|528616102|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146575598|NCT03307785|528616103|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146575599|NCT03307785|528616104|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146575600|NCT03307785|528616105|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146575601|NCT03307785|528616106|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146575602|NCT03307785|528616094|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146575603|NCT03307785|528616095|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146575604|NCT03307785|528616096|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146575605|NCT03307785|528616097|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146575606|NCT03307785|528616098|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146575607|NCT03307785|528616099|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
146575608|NCT03307785|528616100|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146575609|NCT03307785|528616101|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146575610|NCT03307785|528616102|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146575611|NCT03307785|528616103|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146575612|NCT03307785|528616104|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146575613|NCT03307785|528616105|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146575614|NCT03307785|528616106|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146575615|NCT03307785|528616094|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
146575616|NCT03307785|528616095|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
146575617|NCT03307785|528616096|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
146651877|NCT01077375|528902311|FG001|Overall Study|Withdrawal by Subject|6|||
146651878|NCT01077375|528902310|FG000|Overall Study|Lost to Follow-up|2|||
146651879|NCT01077375|528902311|FG001|Overall Study|Lost to Follow-up|5|||
146651880|NCT01077375|528902310|FG000|Overall Study|Other Reason|0|||
146651881|NCT01077375|528902311|FG001|Overall Study|Other Reason|1|||
146651882|NCT03353740|528902315|FG000|Overall Study|Images for these participants not viable|52|||
146651883|NCT02232880|528902316|FG000|Overall Study|study stopped prior to randomization|1|||
146736234|NCT00279201|529205304|FG003|Intensification Addendum|Physician Decision|1|||
146736235|NCT00279201|529205305|FG004|Intensification Addendum|Physician Decision|3|||
146736236|NCT00279201|529205306|FG005|Intensification Addendum|Physician Decision|2|||
146736237|NCT00279201|529205301|FG000|Intensification Addendum|Sponsor Decision|0|||
146917846|NCT01234402|529861505|FG000|Overall Study|Withdrawal by Subject|1|||
146917847|NCT01234402|529861506|FG001|Overall Study|Withdrawal by Subject|3|||
146917848|NCT01234402|529861507|FG002|Overall Study|Withdrawal by Subject|4|||
146917849|NCT01234402|529861505|FG000|Overall Study|Never treated: Death|0|||
146917850|NCT01234402|529861506|FG001|Overall Study|Never treated: Death|0|||
146917851|NCT01234402|529861507|FG002|Overall Study|Never treated: Death|1|||
146917852|NCT01234402|529861505|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
146917853|NCT01234402|529861506|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
146917854|NCT01234402|529861507|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
146917855|NCT01234402|529861505|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
146917856|NCT01234402|529861506|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
146917857|NCT01234402|529861507|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
146917858|NCT00365716|529861508|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
146917859|NCT00365716|529861509|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
146917860|NCT00365716|529861510|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
146917861|NCT00365716|529861511|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
146917862|NCT00365716|529861512|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
146917863|NCT00365716|529861513|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
146917864|NCT00365716|529861514|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
146917865|NCT00365716|529861508|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
146917866|NCT00365716|529861509|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
146917867|NCT00365716|529861510|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
146917868|NCT00365716|529861511|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
146977702|NCT00528879|530081032|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
146977703|NCT00528879|530081033|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
146917869|NCT00365716|529861512|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
146917870|NCT00365716|529861513|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
146917871|NCT00365716|529861514|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
146917872|NCT00365716|529861508|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
146917873|NCT00365716|529861509|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
146917874|NCT00365716|529861510|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
146917875|NCT00365716|529861511|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
146917876|NCT00365716|529861512|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
146575618|NCT03307785|528616097|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
146575619|NCT03307785|528616098|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
146575620|NCT03307785|528616099|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
146575621|NCT03307785|528616100|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
146575622|NCT03307785|528616101|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
146917877|NCT00365716|529861513|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
146917878|NCT00365716|529861514|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
146917879|NCT00365716|529861508|FG000|Base Study (Day 1 to Month 7)|Other|0|||
146917880|NCT00365716|529861509|FG001|Base Study (Day 1 to Month 7)|Other|1|||
146917881|NCT00365716|529861510|FG002|Base Study (Day 1 to Month 7)|Other|0|||
146917882|NCT00365716|529861511|FG003|Base Study (Day 1 to Month 7)|Other|0|||
146917883|NCT00365716|529861512|FG004|Base Study (Day 1 to Month 7)|Other|0|||
146917884|NCT00365716|529861513|FG005|Base Study (Day 1 to Month 7)|Other|0|||
146917885|NCT00365716|529861514|FG006|Base Study (Day 1 to Month 7)|Other|0|||
146917886|NCT00365716|529861508|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
146917887|NCT00365716|529861509|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
146917888|NCT00365716|529861510|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
146917889|NCT00365716|529861511|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
146917890|NCT00365716|529861512|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
146917891|NCT00365716|529861513|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
146917892|NCT00365716|529861514|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
146917893|NCT00365716|529861508|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
146917894|NCT00365716|529861509|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
146917895|NCT00365716|529861510|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
146917896|NCT00365716|529861511|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
146917897|NCT00365716|529861512|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
146917898|NCT00365716|529861513|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
146917899|NCT00365716|529861514|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
146917900|NCT00365716|529861508|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
146917901|NCT00365716|529861509|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
146917902|NCT00365716|529861510|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
146917903|NCT00365716|529861511|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
146917904|NCT00365716|529861512|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
146917905|NCT00365716|529861513|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
146917906|NCT00365716|529861514|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
146917907|NCT00365716|529861508|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
146917908|NCT00365716|529861509|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
146917909|NCT00365716|529861510|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
146917910|NCT00365716|529861511|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
146917911|NCT00365716|529861512|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
146917912|NCT00365716|529861513|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
146917913|NCT00365716|529861514|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
146917914|NCT00365716|529861508|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
146917915|NCT00365716|529861509|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
146917916|NCT00365716|529861510|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
146917917|NCT00365716|529861511|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
146917918|NCT00365716|529861512|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
146917919|NCT00365716|529861513|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
146917920|NCT00365716|529861514|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
146917921|NCT00365716|529861508|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
146917922|NCT00365716|529861509|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
146917923|NCT00365716|529861510|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
146575623|NCT03307785|528616102|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
146575624|NCT03307785|528616103|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
146575625|NCT03307785|528616104|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
146575626|NCT03307785|528616105|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
146575627|NCT03307785|528616106|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
146575628|NCT03307785|528616094|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146575629|NCT03307785|528616095|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146575630|NCT03307785|528616096|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146575631|NCT03307785|528616097|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146575632|NCT03307785|528616098|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146575633|NCT03307785|528616099|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146575634|NCT03307785|528616100|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
146575635|NCT03307785|528616101|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146575636|NCT03307785|528616102|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146575637|NCT03307785|528616103|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146575638|NCT03307785|528616104|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146575639|NCT03307785|528616105|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146575640|NCT03307785|528616106|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146575641|NCT03307785|528616094|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146575642|NCT03307785|528616095|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146575643|NCT03307785|528616096|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146575644|NCT03307785|528616097|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146575645|NCT03307785|528616098|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146575646|NCT03307785|528616099|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146575647|NCT03307785|528616100|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146575648|NCT03307785|528616101|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
146575649|NCT03307785|528616102|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146575650|NCT03307785|528616103|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146575651|NCT03307785|528616104|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146575652|NCT03307785|528616105|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146575653|NCT03307785|528616106|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146575654|NCT03307785|528616094|FG000|PACT Phase: Up to 19 Months|Death|0|||
146575655|NCT03307785|528616095|FG001|PACT Phase: Up to 19 Months|Death|0|||
146575656|NCT03307785|528616096|FG002|PACT Phase: Up to 19 Months|Death|0|||
146575657|NCT03307785|528616097|FG003|PACT Phase: Up to 19 Months|Death|0|||
146575658|NCT03307785|528616098|FG004|PACT Phase: Up to 19 Months|Death|0|||
146575659|NCT03307785|528616099|FG005|PACT Phase: Up to 19 Months|Death|0|||
146575660|NCT03307785|528616100|FG006|PACT Phase: Up to 19 Months|Death|0|||
146575661|NCT03307785|528616101|FG007|PACT Phase: Up to 19 Months|Death|0|||
146575662|NCT03307785|528616102|FG008|PACT Phase: Up to 19 Months|Death|0|||
146575663|NCT03307785|528616103|FG009|PACT Phase: Up to 19 Months|Death|0|||
146575664|NCT03307785|528616104|FG010|PACT Phase: Up to 19 Months|Death|0|||
146575665|NCT03307785|528616105|FG011|PACT Phase: Up to 19 Months|Death|0|||
146575666|NCT03307785|528616106|FG012|PACT Phase: Up to 19 Months|Death|1|||
146575667|NCT05526521|528616110|FG000|Overall Study|Withdrawal by Subject|0|||
146575668|NCT05526521|528616111|FG001|Overall Study|Withdrawal by Subject|1|||
146575669|NCT05526521|528616112|FG002|Overall Study|Withdrawal by Subject|0|||
146575670|NCT05526521|528616113|FG003|Overall Study|Withdrawal by Subject|0|||
146575671|NCT03919929|528616114|FG000|Overall Study|Withdrawal by Subject|0|||
146575672|NCT03919929|528616115|FG001|Overall Study|Withdrawal by Subject|4|||
146575673|NCT03919929|528616114|FG000|Overall Study|Screen Failure|0|||
146575674|NCT03919929|528616115|FG001|Overall Study|Screen Failure|5|||
146575675|NCT00100802|528616119|FG000|Overall Study|Adverse Event|9|||
146575676|NCT00100802|528616119|FG000|Overall Study|Death|1|||
146575677|NCT00100802|528616119|FG000|Overall Study|Lack of Efficacy|47|||
146575678|NCT00100802|528616119|FG000|Overall Study|Physician Decision|5|||
146575679|NCT00100802|528616119|FG000|Overall Study|Protocol Violation|1|||
146575680|NCT00100802|528616119|FG000|Overall Study|Withdrawal by Subject|5|||
146575681|NCT00100802|528616119|FG000|Overall Study|Ineligible|12|||
146575682|NCT00325130|528616151|FG000|Overall Study|Lost to Follow-up|6|||
146575683|NCT00325130|528616152|FG001|Overall Study|Lost to Follow-up|14|||
146575684|NCT00325130|528616151|FG000|Overall Study|Withdrawal by Subject|12|||
146575685|NCT00325130|528616152|FG001|Overall Study|Withdrawal by Subject|14|||
146575686|NCT00325130|528616151|FG000|Overall Study|Protocol Deviation|0|||
146575687|NCT00325130|528616152|FG001|Overall Study|Protocol Deviation|1|||
146575688|NCT00325130|528616151|FG000|Overall Study|Moved|0|||
146575689|NCT00325130|528616152|FG001|Overall Study|Moved|1|||
146575690|NCT00325130|528616151|FG000|Overall Study|Patient Discontinued for Other|1|||
146575691|NCT00325130|528616152|FG001|Overall Study|Patient Discontinued for Other|0|||
146575692|NCT00928187|528616156|FG000|Overall Study|Death|1|||
146575693|NCT00928187|528616157|FG001|Overall Study|Death|2|||
146575694|NCT00928187|528616158|FG002|Overall Study|Death|3|||
146575695|NCT00928187|528616156|FG000|Overall Study|Lost to Follow-up|1|||
146575696|NCT00928187|528616157|FG001|Overall Study|Lost to Follow-up|2|||
146575697|NCT00928187|528616158|FG002|Overall Study|Lost to Follow-up|1|||
146575698|NCT00928187|528616156|FG000|Overall Study|Withdrawal by Subject|0|||
146575699|NCT00928187|528616157|FG001|Overall Study|Withdrawal by Subject|1|||
146575700|NCT00928187|528616158|FG002|Overall Study|Withdrawal by Subject|1|||
146575701|NCT00928187|528616156|FG000|Overall Study|Protocol Violation|0|||
146575702|NCT00928187|528616157|FG001|Overall Study|Protocol Violation|1|||
146575703|NCT00928187|528616158|FG002|Overall Study|Protocol Violation|0|||
146575704|NCT02524145|528616162|FG000|Overall Study|Withdrawal by Subject|2|||
146575705|NCT02524145|528616163|FG001|Overall Study|Withdrawal by Subject|2|||
146917924|NCT00365716|529861511|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
146917925|NCT00365716|529861512|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
146917926|NCT00365716|529861513|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
146917927|NCT00365716|529861514|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
146917928|NCT00365716|529861508|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
146575706|NCT02524145|528616164|FG002|Overall Study|Withdrawal by Subject|3|||
146575707|NCT00620373|528616876|FG000|Overall Study|Unverified cancer status|33|||
146575708|NCT01897727|528616877|FG000|Overall Study|Exclusion: central sleep apnea|0|||
146575709|NCT01897727|528616878|FG001|Overall Study|Exclusion: central sleep apnea|1|||
146575710|NCT01061723|528616879|FG000|Overall Study|Adverse Event|0|||
146575711|NCT01061723|528616880|FG001|Overall Study|Adverse Event|2|||
146575712|NCT01061723|528616881|FG002|Overall Study|Adverse Event|5|||
146575713|NCT01061723|528616882|FG003|Overall Study|Adverse Event|5|||
146575714|NCT01061723|528616883|FG004|Overall Study|Adverse Event|2|||
146575715|NCT01061723|528616884|FG005|Overall Study|Adverse Event|6|||
146575716|NCT01061723|528616879|FG000|Overall Study|Lack of Efficacy|2|||
146575717|NCT01061723|528616880|FG001|Overall Study|Lack of Efficacy|3|||
146575718|NCT01061723|528616881|FG002|Overall Study|Lack of Efficacy|4|||
146575719|NCT01061723|528616882|FG003|Overall Study|Lack of Efficacy|2|||
146575720|NCT01061723|528616883|FG004|Overall Study|Lack of Efficacy|1|||
146575721|NCT01061723|528616884|FG005|Overall Study|Lack of Efficacy|1|||
146575722|NCT01061723|528616879|FG000|Overall Study|Randomized but not treated|0|||
146977704|NCT00528879|530081034|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
146977705|NCT00528879|530081031|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
146917929|NCT00365716|529861509|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
146917930|NCT00365716|529861510|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
146917931|NCT00365716|529861511|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
146917932|NCT00365716|529861512|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
146917933|NCT00365716|529861513|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
146917934|NCT00365716|529861514|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
146977706|NCT00528879|530081032|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
146977707|NCT00528879|530081033|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
146977708|NCT00528879|530081034|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
146977709|NCT00528879|530081031|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
146977710|NCT00528879|530081032|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
146977711|NCT00528879|530081033|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
146977712|NCT00528879|530081034|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
146977713|NCT00528879|530081031|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
146977714|NCT00528879|530081032|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
146977715|NCT00528879|530081033|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
146977716|NCT00528879|530081034|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
146977717|NCT00528879|530081031|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
146977718|NCT00528879|530081032|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
146977719|NCT00528879|530081033|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
146977720|NCT00528879|530081034|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
146977721|NCT00528879|530081031|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
146977722|NCT00528879|530081032|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
146977723|NCT00528879|530081033|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
146977724|NCT00528879|530081034|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
146977725|NCT00528879|530081031|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
146977726|NCT00528879|530081032|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
146977727|NCT00528879|530081033|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
146977728|NCT00528879|530081034|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
146977729|NCT00528879|530081031|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
147013240|NCT01708954|530210055|FG001|Step 1|Crossed over to Step 2|0|||
146575723|NCT01061723|528616880|FG001|Overall Study|Randomized but not treated|0|||
146575724|NCT01061723|528616881|FG002|Overall Study|Randomized but not treated|0|||
146575725|NCT01061723|528616882|FG003|Overall Study|Randomized but not treated|0|||
146575726|NCT01061723|528616883|FG004|Overall Study|Randomized but not treated|0|||
146575727|NCT01061723|528616884|FG005|Overall Study|Randomized but not treated|1|||
146575728|NCT01061723|528616879|FG000|Overall Study|Other than specified above|2|||
146575729|NCT01061723|528616880|FG001|Overall Study|Other than specified above|1|||
146575730|NCT01061723|528616881|FG002|Overall Study|Other than specified above|1|||
146575731|NCT01061723|528616882|FG003|Overall Study|Other than specified above|1|||
146575732|NCT01061723|528616883|FG004|Overall Study|Other than specified above|0|||
146575733|NCT01061723|528616884|FG005|Overall Study|Other than specified above|1|||
146651884|NCT02233946|528903695|FG000|Baseline|Withdrawal by Subject|2|||
146575734|NCT00293813|528616885|FG000|Overall Study|Physician Decision|0|||
146575735|NCT00293813|528616886|FG001|Overall Study|Physician Decision|1|||
146575736|NCT00293813|528616887|FG002|Overall Study|Physician Decision|0|||
146917935|NCT00365716|529861508|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
146917936|NCT00365716|529861509|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
146917937|NCT00365716|529861510|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
146917938|NCT00365716|529861511|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
146917939|NCT00365716|529861512|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
146575737|NCT00293813|528616885|FG000|Overall Study|Adverse Event|3|||
146575738|NCT00293813|528616886|FG001|Overall Study|Adverse Event|1|||
146575739|NCT00293813|528616887|FG002|Overall Study|Adverse Event|1|||
146575740|NCT00293813|528616885|FG000|Overall Study|Withdrawal by Subject|7|||
146575741|NCT00293813|528616886|FG001|Overall Study|Withdrawal by Subject|4|||
146575742|NCT00293813|528616887|FG002|Overall Study|Withdrawal by Subject|4|||
146575743|NCT00293813|528616885|FG000|Overall Study|Lost to Follow-up|3|||
146575744|NCT00293813|528616886|FG001|Overall Study|Lost to Follow-up|2|||
146575745|NCT00293813|528616887|FG002|Overall Study|Lost to Follow-up|3|||
146575746|NCT00293813|528616885|FG000|Overall Study|Noncompliance|0|||
146575747|NCT00293813|528616886|FG001|Overall Study|Noncompliance|1|||
146575748|NCT00293813|528616887|FG002|Overall Study|Noncompliance|0|||
146575749|NCT00460655|528616892|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
146575750|NCT00460655|528616893|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146575751|NCT00460655|528616894|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146575752|NCT00460655|528616895|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146575753|NCT00460655|528616892|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
146575754|NCT00460655|528616893|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146575755|NCT00460655|528616894|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146575756|NCT00460655|528616895|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146575757|NCT00460655|528616892|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
146575758|NCT00460655|528616893|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
146575759|NCT00460655|528616894|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
146575760|NCT00460655|528616895|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
146575761|NCT00460655|528616892|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
146575762|NCT00460655|528616893|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
146575763|NCT00460655|528616894|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
146575764|NCT00460655|528616895|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
146575765|NCT00460655|528616892|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
146575766|NCT00460655|528616893|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
146575767|NCT00460655|528616894|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
146575768|NCT00460655|528616895|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
146575769|NCT00460655|528616892|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
146575770|NCT00460655|528616893|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
146575771|NCT00460655|528616894|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
146575772|NCT00460655|528616895|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
146575773|NCT00910910|528616896|FG000|Overall Study|Adverse Event|63|||
146575774|NCT00910910|528616897|FG001|Overall Study|Adverse Event|35|||
146575775|NCT00910910|528616896|FG000|Overall Study|PD without histologic change|27|||
146575776|NCT00910910|528616897|FG001|Overall Study|PD without histologic change|23|||
146575777|NCT00910910|528616896|FG000|Overall Study|PD with histologic change|0|||
146575778|NCT00910910|528616897|FG001|Overall Study|PD with histologic change|2|||
146575779|NCT00910910|528616896|FG000|Overall Study|Withdrawal by Subject|7|||
146575780|NCT00910910|528616897|FG001|Overall Study|Withdrawal by Subject|5|||
146917940|NCT00365716|529861513|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
146917941|NCT00365716|529861514|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
146917942|NCT00365716|529861508|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
146917943|NCT00365716|529861509|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
146917944|NCT00365716|529861510|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
146575781|NCT00910910|528616896|FG000|Overall Study|Lost to Follow-up|2|||
146575782|NCT00910910|528616897|FG001|Overall Study|Lost to Follow-up|2|||
146575783|NCT00910910|528616896|FG000|Overall Study|Death|9|||
146917945|NCT00365716|529861511|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
146917946|NCT00365716|529861512|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
146917947|NCT00365716|529861513|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
146917948|NCT00365716|529861514|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
146917949|NCT00365716|529861508|FG000|Extension 1|Lost to Follow-up|0|||
146917950|NCT00365716|529861509|FG001|Extension 1|Lost to Follow-up|0|||
146917951|NCT00365716|529861510|FG002|Extension 1|Lost to Follow-up|0|||
146575784|NCT00910910|528616897|FG001|Overall Study|Death|3|||
146575785|NCT00910910|528616896|FG000|Overall Study|Protocol Violation|2|||
146575786|NCT00910910|528616897|FG001|Overall Study|Protocol Violation|2|||
146575787|NCT00910910|528616896|FG000|Overall Study|Completed 13 cycles of treatment|0|||
146575788|NCT00910910|528616897|FG001|Overall Study|Completed 13 cycles of treatment|118|||
146575789|NCT00910910|528616896|FG000|Overall Study|Other|114|||
146575790|NCT00910910|528616897|FG001|Overall Study|Other|32|||
146575791|NCT00910910|528616896|FG000|Overall Study|Untreated before cycle 1|1|||
146575792|NCT00910910|528616897|FG001|Overall Study|Untreated before cycle 1|2|||
146575793|NCT01973231|528616898|FG000|Overall Study|Protocol Violation|1|||
146575794|NCT01973231|528616899|FG001|Overall Study|Protocol Violation|1|||
146575795|NCT01973231|528616898|FG000|Overall Study|Lost to Follow-up|1|||
146575796|NCT01973231|528616899|FG001|Overall Study|Lost to Follow-up|1|||
146575797|NCT01973231|528616898|FG000|Overall Study|unclassified|2|||
146575798|NCT01973231|528616899|FG001|Overall Study|unclassified|1|||
146575799|NCT01973231|528616898|FG000|Overall Study|Withdrawal by Subject|7|||
146575800|NCT01973231|528616899|FG001|Overall Study|Withdrawal by Subject|9|||
146575801|NCT01194219|528616901|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
146575802|NCT01194219|528616902|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
146575803|NCT01194219|528616903|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
146575804|NCT01194219|528616904|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
146575805|NCT01194219|528616905|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
146575806|NCT01194219|528616906|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
146575807|NCT01194219|528616907|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
146575808|NCT01194219|528616908|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
146575809|NCT01194219|528616909|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
146575810|NCT01194219|528616910|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
146575811|NCT01194219|528616901|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
146575812|NCT01194219|528616902|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
146575813|NCT01194219|528616903|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
146575814|NCT01194219|528616904|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
146575815|NCT01194219|528616905|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
146917952|NCT00365716|529861511|FG003|Extension 1|Lost to Follow-up|0|||
146917953|NCT00365716|529861512|FG004|Extension 1|Lost to Follow-up|0|||
146917954|NCT00365716|529861513|FG005|Extension 1|Lost to Follow-up|1|||
146917955|NCT00365716|529861514|FG006|Extension 1|Lost to Follow-up|0|||
146917956|NCT00365716|529861508|FG000|Extension 1|Other|0|||
146917957|NCT00365716|529861509|FG001|Extension 1|Other|0|||
146917958|NCT00365716|529861510|FG002|Extension 1|Other|0|||
146917959|NCT00365716|529861511|FG003|Extension 1|Other|0|||
146917960|NCT00365716|529861512|FG004|Extension 1|Other|0|||
146917961|NCT00365716|529861513|FG005|Extension 1|Other|9|||
146917962|NCT00365716|529861514|FG006|Extension 1|Other|0|||
146917963|NCT00365716|529861508|FG000|Extension 1|Moved|0|||
146917964|NCT00365716|529861509|FG001|Extension 1|Moved|0|||
146917965|NCT00365716|529861510|FG002|Extension 1|Moved|0|||
146917966|NCT00365716|529861511|FG003|Extension 1|Moved|0|||
146917967|NCT00365716|529861512|FG004|Extension 1|Moved|0|||
146917968|NCT00365716|529861513|FG005|Extension 1|Moved|4|||
146917969|NCT00365716|529861514|FG006|Extension 1|Moved|0|||
146917970|NCT00365716|529861508|FG000|Extension 1|Withdrawal by Subject|0|||
146917971|NCT00365716|529861509|FG001|Extension 1|Withdrawal by Subject|0|||
146917972|NCT00365716|529861510|FG002|Extension 1|Withdrawal by Subject|0|||
146917973|NCT00365716|529861511|FG003|Extension 1|Withdrawal by Subject|0|||
146917974|NCT00365716|529861512|FG004|Extension 1|Withdrawal by Subject|0|||
146917975|NCT00365716|529861513|FG005|Extension 1|Withdrawal by Subject|3|||
146917976|NCT00365716|529861514|FG006|Extension 1|Withdrawal by Subject|0|||
146917977|NCT00365716|529861508|FG000|Extension 1|Pregnancy|0|||
146917978|NCT00365716|529861509|FG001|Extension 1|Pregnancy|0|||
146917979|NCT00365716|529861510|FG002|Extension 1|Pregnancy|0|||
146917980|NCT00365716|529861511|FG003|Extension 1|Pregnancy|0|||
146917981|NCT00365716|529861512|FG004|Extension 1|Pregnancy|0|||
146917982|NCT00365716|529861513|FG005|Extension 1|Pregnancy|4|||
146917983|NCT00365716|529861514|FG006|Extension 1|Pregnancy|0|||
146917984|NCT00365716|529861508|FG000|Extension 1|Protocol Violation|0|||
146917985|NCT00365716|529861509|FG001|Extension 1|Protocol Violation|0|||
146917986|NCT00365716|529861510|FG002|Extension 1|Protocol Violation|0|||
146917987|NCT00365716|529861511|FG003|Extension 1|Protocol Violation|0|||
146917988|NCT00365716|529861512|FG004|Extension 1|Protocol Violation|0|||
146917989|NCT00365716|529861513|FG005|Extension 1|Protocol Violation|1|||
146917990|NCT00365716|529861514|FG006|Extension 1|Protocol Violation|0|||
146917991|NCT00365716|529861508|FG000|Extension 2|Lost to Follow-up|0|||
146917992|NCT00365716|529861509|FG001|Extension 2|Lost to Follow-up|0|||
146917993|NCT00365716|529861510|FG002|Extension 2|Lost to Follow-up|0|||
146917994|NCT00365716|529861511|FG003|Extension 2|Lost to Follow-up|0|||
146917995|NCT00365716|529861512|FG004|Extension 2|Lost to Follow-up|0|||
146917996|NCT00365716|529861513|FG005|Extension 2|Lost to Follow-up|0|||
146917997|NCT00365716|529861514|FG006|Extension 2|Lost to Follow-up|2|||
146917998|NCT00365716|529861508|FG000|Extension 2|Other|0|||
146575816|NCT01194219|528616906|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
146651885|NCT02233946|528903696|FG001|Baseline|Withdrawal by Subject|0|||
146917999|NCT00365716|529861509|FG001|Extension 2|Other|0|||
146918000|NCT00365716|529861510|FG002|Extension 2|Other|0|||
146918001|NCT00365716|529861511|FG003|Extension 2|Other|0|||
146918002|NCT00365716|529861512|FG004|Extension 2|Other|0|||
146918003|NCT00365716|529861513|FG005|Extension 2|Other|0|||
146918004|NCT00365716|529861514|FG006|Extension 2|Other|3|||
146918005|NCT00365716|529861508|FG000|Extension 2|Withdrawal by Subject|0|||
146918006|NCT00365716|529861509|FG001|Extension 2|Withdrawal by Subject|0|||
146918007|NCT00365716|529861510|FG002|Extension 2|Withdrawal by Subject|0|||
146918008|NCT00365716|529861511|FG003|Extension 2|Withdrawal by Subject|0|||
146575817|NCT01194219|528616907|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
146575818|NCT01194219|528616908|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
146575819|NCT01194219|528616909|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
146575820|NCT01194219|528616910|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
146575821|NCT01194219|528616901|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
146575822|NCT01194219|528616902|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146575823|NCT01194219|528616903|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146575824|NCT01194219|528616904|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146575825|NCT01194219|528616905|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146575826|NCT01194219|528616906|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146575827|NCT01194219|528616907|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146575828|NCT01194219|528616908|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146575829|NCT01194219|528616909|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146575830|NCT01194219|528616910|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146575831|NCT01194219|528616901|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
146575832|NCT01194219|528616902|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
146575833|NCT01194219|528616903|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
146575834|NCT01194219|528616904|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
146575835|NCT01194219|528616905|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
146575836|NCT01194219|528616906|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
146575837|NCT01194219|528616907|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
146575838|NCT01194219|528616908|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
146575839|NCT01194219|528616909|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
146575840|NCT01194219|528616910|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
146575841|NCT01194219|528616901|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146575842|NCT01194219|528616902|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
146918009|NCT00365716|529861512|FG004|Extension 2|Withdrawal by Subject|0|||
146575843|NCT01194219|528616903|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146575844|NCT01194219|528616904|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146575845|NCT01194219|528616905|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146575846|NCT01194219|528616906|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146575847|NCT01194219|528616907|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146575848|NCT01194219|528616908|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146575849|NCT01194219|528616909|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146575850|NCT01194219|528616910|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146575851|NCT01194219|528616901|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
146575852|NCT01194219|528616902|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
146575853|NCT01194219|528616903|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
146575854|NCT01194219|528616904|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
146575855|NCT01194219|528616905|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
146575856|NCT01194219|528616906|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
146575857|NCT01194219|528616907|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
146575858|NCT01194219|528616908|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
146918010|NCT00365716|529861513|FG005|Extension 2|Withdrawal by Subject|0|||
146918011|NCT00365716|529861514|FG006|Extension 2|Withdrawal by Subject|5|||
146918012|NCT02280291|529861515|FG000|Overall Study|Lost to Follow-up|2|||
146918013|NCT02280291|529861516|FG001|Overall Study|Lost to Follow-up|1|||
146918014|NCT02280291|529861517|FG002|Overall Study|Lost to Follow-up|3|||
146918015|NCT02280291|529861518|FG003|Overall Study|Lost to Follow-up|8|||
146918016|NCT02280291|529861515|FG000|Overall Study|Protocol Violation|1|||
146918017|NCT02280291|529861516|FG001|Overall Study|Protocol Violation|0|||
146918018|NCT02280291|529861517|FG002|Overall Study|Protocol Violation|0|||
146918019|NCT02280291|529861518|FG003|Overall Study|Protocol Violation|0|||
146918020|NCT02280291|529861515|FG000|Overall Study|Other|1|||
146918021|NCT02280291|529861516|FG001|Overall Study|Other|1|||
146918022|NCT02280291|529861517|FG002|Overall Study|Other|0|||
146918023|NCT02280291|529861518|FG003|Overall Study|Other|0|||
146918024|NCT00506077|529861520|FG000|Treatment Period 1|Adverse Event|2|||
146918025|NCT00506077|529861521|FG001|Treatment Period 1|Adverse Event|1|||
146918026|NCT00506077|529861520|FG000|Treatment Period 1|Lost to Follow-up|0|||
146918027|NCT00506077|529861521|FG001|Treatment Period 1|Lost to Follow-up|2|||
146918028|NCT00506077|529861520|FG000|Treatment Period 1|Withdrawal by Subject|2|||
146918029|NCT00506077|529861521|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146918030|NCT00506077|529861520|FG000|Treatment Period 2|Adverse Event|0|||
146918031|NCT00506077|529861521|FG001|Treatment Period 2|Adverse Event|1|||
146918032|NCT00506077|529861520|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146918033|NCT00506077|529861521|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146918034|NCT00316303|529861523|FG000|Overall Study|Lost to Follow-up|11|||
146918035|NCT00316303|529861524|FG001|Overall Study|Lost to Follow-up|16|||
147013241|NCT01708954|530210056|FG002|Step 1|Crossed over to Step 2|0|||
146977730|NCT00528879|530081032|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
146977731|NCT00528879|530081033|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
146977732|NCT00528879|530081034|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
146977733|NCT00528879|530081031|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
146977734|NCT00528879|530081032|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
146977735|NCT00528879|530081033|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
146977736|NCT00528879|530081034|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
146977737|NCT00528879|530081031|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
146977738|NCT00528879|530081032|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
146977739|NCT00528879|530081033|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
146977740|NCT00528879|530081034|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
146977741|NCT00528879|530081031|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
146977742|NCT00528879|530081032|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
146977743|NCT00528879|530081033|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
146977744|NCT00528879|530081034|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
146977745|NCT00528879|530081031|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
146977746|NCT00528879|530081032|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
146977747|NCT00528879|530081033|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
146977748|NCT00528879|530081034|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
146977749|NCT00528879|530081031|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
146977750|NCT00528879|530081032|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
146977751|NCT00528879|530081033|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
146977752|NCT00528879|530081034|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
146977753|NCT00528879|530081031|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
146977754|NCT00528879|530081032|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
146977755|NCT00528879|530081033|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
146977756|NCT00528879|530081034|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
146977757|NCT00528879|530081031|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
146977758|NCT00528879|530081032|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
146977759|NCT00528879|530081033|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
146977760|NCT00528879|530081034|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
146977761|NCT00971204|530081035|FG000|Overall Study|Did not meet all criteria-not treated|14|||
146977762|NCT00971204|530081035|FG000|Overall Study|Lost to Follow-up|10|||
146977763|NCT01256398|530081036|FG000|Overall Study|Withdrawal by Subject|1|||
146977764|NCT01364298|530081041|FG000|Overall Study|Adverse Event|3|||
146977765|NCT01364298|530081042|FG001|Overall Study|Adverse Event|4|||
146977766|NCT01364298|530081041|FG000|Overall Study|Lack of adherence to treatment|1|||
146977767|NCT01364298|530081042|FG001|Overall Study|Lack of adherence to treatment|3|||
146977768|NCT01364298|530081041|FG000|Overall Study|Lack of Efficacy|1|||
146977769|NCT01364298|530081042|FG001|Overall Study|Lack of Efficacy|0|||
146977770|NCT01364298|530081041|FG000|Overall Study|Lost to Follow-up|5|||
146977771|NCT01364298|530081042|FG001|Overall Study|Lost to Follow-up|10|||
146977772|NCT01364298|530081041|FG000|Overall Study|Withdrawal by Subject|3|||
146977773|NCT01364298|530081042|FG001|Overall Study|Withdrawal by Subject|3|||
146977774|NCT01364298|530081041|FG000|Overall Study|Other|1|||
146977775|NCT01364298|530081042|FG001|Overall Study|Other|3|||
146977776|NCT03550794|530081043|FG000|Overall Study|No longer met inclusion criteria|1|||
146977777|NCT03550794|530081044|FG001|Overall Study|No longer met inclusion criteria|2|||
146977778|NCT03550794|530081043|FG000|Overall Study|Goals of care changed|1|||
146977779|NCT03550794|530081044|FG001|Overall Study|Goals of care changed|0|||
146918036|NCT01293032|529861527|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
146918037|NCT01293032|529861528|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
146918038|NCT01293032|529861529|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
146918039|NCT01293032|529861530|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
146918040|NCT01293032|529861527|FG000|Treatment|Adverse Event|0|||
146918041|NCT01293032|529861528|FG001|Treatment|Adverse Event|0|||
146918042|NCT01293032|529861529|FG002|Treatment|Adverse Event|1|||
146918043|NCT01293032|529861530|FG003|Treatment|Adverse Event|1|||
146918044|NCT01293032|529861527|FG000|Treatment|Withdrawal by Subject|2|||
146918045|NCT01293032|529861528|FG001|Treatment|Withdrawal by Subject|4|||
146918046|NCT01293032|529861529|FG002|Treatment|Withdrawal by Subject|0|||
146918047|NCT01293032|529861530|FG003|Treatment|Withdrawal by Subject|0|||
146918048|NCT01293032|529861527|FG000|Treatment|Disease Progression, relapse|0|||
146918049|NCT01293032|529861528|FG001|Treatment|Disease Progression, relapse|1|||
146977780|NCT03550794|530081043|FG000|Overall Study|Withdrawal by Subject|2|||
146977781|NCT03550794|530081044|FG001|Overall Study|Withdrawal by Subject|0|||
146977782|NCT03550794|530081043|FG000|Overall Study|Death|0|||
146977783|NCT03550794|530081044|FG001|Overall Study|Death|1|||
146977784|NCT01864525|530081045|FG000|Overall Study|Adverse Event|1|||
146977785|NCT01864525|530081046|FG001|Overall Study|Adverse Event|0|||
146977786|NCT01890785|530081047|FG000|Third Intervention|Withdrawal by Subject|0|||
146918050|NCT01293032|529861529|FG002|Treatment|Disease Progression, relapse|0|||
146977787|NCT01890785|530081048|FG001|Third Intervention|Withdrawal by Subject|1|||
146977788|NCT01890785|530081049|FG002|Third Intervention|Withdrawal by Subject|0|||
146977789|NCT01890785|530081050|FG003|Third Intervention|Withdrawal by Subject|0|||
146977790|NCT01890785|530081051|FG004|Third Intervention|Withdrawal by Subject|0|||
146977791|NCT01890785|530081052|FG005|Third Intervention|Withdrawal by Subject|0|||
146977792|NCT03296553|530081053|FG000|Overall Study|Withdrawal by Subject|1|||
146977793|NCT03296553|530081054|FG001|Overall Study|Withdrawal by Subject|1|||
146977794|NCT03296553|530081053|FG000|Overall Study|Death|1|||
146977795|NCT03296553|530081054|FG001|Overall Study|Death|0|||
146977796|NCT00065065|530081055|FG000|Overall Study|Adverse Event|3|||
146977797|NCT00065065|530081056|FG001|Overall Study|Adverse Event|2|||
146977798|NCT00065065|530081055|FG000|Overall Study|Withdrawal by Subject|1|||
146977799|NCT00065065|530081056|FG001|Overall Study|Withdrawal by Subject|5|||
146977800|NCT00065065|530081055|FG000|Overall Study|Lack of Efficacy|4|||
146977801|NCT00065065|530081056|FG001|Overall Study|Lack of Efficacy|11|||
146977802|NCT00065065|530081055|FG000|Overall Study|Other|2|||
146977803|NCT00065065|530081056|FG001|Overall Study|Other|2|||
146977804|NCT04363736|530081057|FG000|Overall Study|Withdrawal by Subject|1|||
146977805|NCT04363736|530081058|FG001|Overall Study|Withdrawal by Subject|0|||
146977806|NCT04363736|530081057|FG000|Overall Study|Lost to Follow-up|10|||
146977807|NCT04363736|530081058|FG001|Overall Study|Lost to Follow-up|7|||
146977808|NCT04363736|530081057|FG000|Overall Study|Death|8|||
146977809|NCT04363736|530081058|FG001|Overall Study|Death|6|||
146977810|NCT01050673|530081059|FG000|Overall Study|Physician Decision|4|||
146977811|NCT01050673|530081060|FG001|Overall Study|Physician Decision|5|||
146977812|NCT01254045|530081061|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
146977813|NCT01254045|530081062|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
146977814|NCT01254045|530081063|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
146977815|NCT01254045|530081064|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
146977816|NCT01254045|530081065|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
146977817|NCT01254045|530081066|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
146977818|NCT00520351|530081067|FG000|First Intervention|Withdrawal by Subject|1|||
146977819|NCT00520351|530081068|FG001|First Intervention|Withdrawal by Subject|1|||
146977820|NCT03797222|530081070|FG000|Overall Study|Withdrawal by Subject|1|||
146977821|NCT03439293|530081072|FG000|Overall Study|Death|22|||
146977822|NCT03439293|530081072|FG000|Overall Study|Withdrawal by Subject|8|||
146977823|NCT03439293|530081072|FG000|Overall Study|Lost to Follow-up|2|||
146977824|NCT03439293|530081072|FG000|Overall Study|Reason Not Specified|28|||
146977825|NCT03439293|530081072|FG000|Overall Study|Missing|1|||
146977826|NCT04288115|530081079|FG000|Overall Study|Withdrawal by Subject|0|||
146977827|NCT04288115|530081080|FG001|Overall Study|Withdrawal by Subject|1|||
146977828|NCT04288115|530081079|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
146977829|NCT04288115|530081080|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
146977830|NCT00729365|530081082|FG000|Overall Study|Physician Decision|33|||
146977831|NCT00729365|530081083|FG001|Overall Study|Physician Decision|6|||
146977832|NCT00729365|530081084|FG002|Overall Study|Physician Decision|7|||
146977833|NCT00869089|530081087|FG000|Overall Study|Lost to Follow-up|1|||
146977834|NCT00869089|530081087|FG000|Overall Study|Withdrawal by Subject|1|||
146977835|NCT00869089|530081087|FG000|Overall Study|Screen Fail|1|||
146977836|NCT02766400|530081088|FG000|Overall Study|Death|1|||
146977837|NCT02766400|530081089|FG001|Overall Study|Death|2|||
146977838|NCT02766400|530081088|FG000|Overall Study|Withdrawal by Subject|1|||
146977839|NCT02766400|530081089|FG001|Overall Study|Withdrawal by Subject|0|||
146977840|NCT01374906|530081090|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146977841|NCT01374906|530081091|FG001|Overall Study|Abnormal laboratory value(s)|3|||
146977842|NCT01374906|530081090|FG000|Overall Study|Administrative problems|2|||
146977843|NCT01374906|530081091|FG001|Overall Study|Administrative problems|2|||
146977844|NCT01374906|530081090|FG000|Overall Study|Adverse Event|10|||
146977845|NCT01374906|530081091|FG001|Overall Study|Adverse Event|11|||
146977846|NCT01374906|530081090|FG000|Overall Study|Death|0|||
146977847|NCT01374906|530081091|FG001|Overall Study|Death|2|||
146977848|NCT01374906|530081090|FG000|Overall Study|Protocol Violation|2|||
146977849|NCT01374906|530081091|FG001|Overall Study|Protocol Violation|2|||
146977850|NCT01374906|530081090|FG000|Overall Study|Withdrawal by Subject|15|||
146977851|NCT01374906|530081091|FG001|Overall Study|Withdrawal by Subject|9|||
146977852|NCT01374906|530081090|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
146977853|NCT01374906|530081091|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
146770613|NCT01135511|529328645|FG003|Overall Study|Protocol Violation|0|||
146977854|NCT00430638|530081096|FG000|Overall Study|Adverse Event|15|||
146977855|NCT00430638|530081097|FG001|Overall Study|Adverse Event|15|||
146977856|NCT00430638|530081096|FG000|Overall Study|Uncontrolled blood pressure|48|||
146977857|NCT00430638|530081097|FG001|Overall Study|Uncontrolled blood pressure|13|||
146977858|NCT00430638|530081096|FG000|Overall Study|Lost to Follow-up|1|||
146977859|NCT00430638|530081097|FG001|Overall Study|Lost to Follow-up|7|||
146977860|NCT00430638|530081096|FG000|Overall Study|Protocol Violation|6|||
146977861|NCT00430638|530081097|FG001|Overall Study|Protocol Violation|4|||
146977862|NCT00430638|530081096|FG000|Overall Study|Withdrawal by Subject|4|||
146918051|NCT01293032|529861530|FG003|Treatment|Disease Progression, relapse|0|||
146977863|NCT00430638|530081097|FG001|Overall Study|Withdrawal by Subject|6|||
146977864|NCT00430638|530081096|FG000|Overall Study|Non-compliant|2|||
146977865|NCT00430638|530081097|FG001|Overall Study|Non-compliant|1|||
146977866|NCT00430638|530081096|FG000|Overall Study|Other|2|||
146977867|NCT00430638|530081097|FG001|Overall Study|Other|2|||
146977868|NCT02367781|530081098|FG000|Overall Study|Withdrawal by Subject|20|||
146977869|NCT02367781|530081099|FG001|Overall Study|Withdrawal by Subject|13|||
146977870|NCT02367781|530081098|FG000|Overall Study|Protocol Violation|0|||
146977871|NCT02367781|530081099|FG001|Overall Study|Protocol Violation|1|||
146977872|NCT02367781|530081098|FG000|Overall Study|Physician Decision|7|||
146575859|NCT01194219|528616909|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
146918052|NCT01106534|529861533|FG000|Overall Study|Withdrawal by Subject|18|||
146918053|NCT01106534|529861533|FG000|Overall Study|Lost to Follow-up|2|||
146918054|NCT01106534|529861533|FG000|Overall Study|Death|16|||
146918055|NCT01106534|529861533|FG000|Overall Study|Physician Decision|1|||
146918056|NCT02985450|529861541|FG000|Overall Study|Lost to Follow-up|7|||
146918057|NCT05590793|529861542|FG000|Overall Study|Withdrawal by Subject|6|||
146918058|NCT05590793|529861542|FG000|Overall Study|Physician Decision|1|||
146918059|NCT04060667|529861543|FG000|Overall Study|Lost to Follow-up|75|||
146918060|NCT04060667|529861544|FG001|Overall Study|Lost to Follow-up|10|||
146918061|NCT04488822|529861545|FG000|Overall Study|Adverse Event|8|||
146918062|NCT04488822|529861545|FG000|Overall Study|Withdrawal by Subject|1|||
146918063|NCT02691247|529861556|FG000|Overall Study|Withdrawal by Subject|1|||
146918064|NCT02691247|529861557|FG001|Overall Study|Withdrawal by Subject|2|||
146918065|NCT02691247|529861558|FG002|Overall Study|Withdrawal by Subject|2|||
146918066|NCT02691247|529861556|FG000|Overall Study|Lost to Follow-up|2|||
146918067|NCT02691247|529861557|FG001|Overall Study|Lost to Follow-up|0|||
146918068|NCT02691247|529861558|FG002|Overall Study|Lost to Follow-up|1|||
146918069|NCT02552355|529861559|FG000|Overall Study|Adverse Event|0|||
146918070|NCT02552355|529861560|FG001|Overall Study|Adverse Event|2|||
146918071|NCT02552355|529861561|FG002|Overall Study|Adverse Event|2|||
146918072|NCT02552355|529861562|FG003|Overall Study|Adverse Event|0|||
146918073|NCT02552355|529861559|FG000|Overall Study|Withdrawal by Subject|0|||
146918074|NCT02552355|529861560|FG001|Overall Study|Withdrawal by Subject|0|||
146918075|NCT02552355|529861561|FG002|Overall Study|Withdrawal by Subject|0|||
146918076|NCT02552355|529861562|FG003|Overall Study|Withdrawal by Subject|1|||
146918077|NCT01519245|529861563|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
146918078|NCT01519245|529861564|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
146918079|NCT00803244|529861567|FG000|Overall Study|Adverse Event|1|||
146918080|NCT00803244|529861568|FG001|Overall Study|Adverse Event|2|||
146918081|NCT00803244|529861567|FG000|Overall Study|Withdrawal by Subject|2|||
146918082|NCT00803244|529861568|FG001|Overall Study|Withdrawal by Subject|3|||
146918083|NCT00803244|529861567|FG000|Overall Study|Any other reason not above-mentioned|4|||
146918084|NCT00803244|529861568|FG001|Overall Study|Any other reason not above-mentioned|10|||
146575860|NCT01194219|528616910|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
146575861|NCT01194219|528616901|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
146575862|NCT01194219|528616902|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
146575863|NCT01194219|528616903|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
146575864|NCT01194219|528616904|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
146575865|NCT01194219|528616905|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
146575866|NCT01194219|528616906|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
146575867|NCT01194219|528616907|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
146575868|NCT01194219|528616908|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
146575869|NCT01194219|528616909|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
146575870|NCT01194219|528616910|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
146575871|NCT01194219|528616901|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
146575872|NCT01194219|528616902|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
146575873|NCT01194219|528616903|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
146575874|NCT01194219|528616904|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
146575875|NCT01194219|528616905|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
146575876|NCT01194219|528616906|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
146918085|NCT03321929|529861570|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
146918086|NCT00616239|529861571|FG000|Overall Study|Withdrawal by Subject|2|||
146918087|NCT01052012|529861572|FG000|Overall Study|Not treated|2|||
146918088|NCT01052012|529861573|FG001|Overall Study|Not treated|5|||
146575877|NCT01194219|528616907|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
146918089|NCT01052012|529861574|FG002|Overall Study|Not treated|0|||
146918090|NCT01052012|529861575|FG003|Overall Study|Not treated|0|||
146918091|NCT01052012|529861576|FG004|Overall Study|Not treated|11|||
146575878|NCT01194219|528616908|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
146918092|NCT01052012|529861577|FG005|Overall Study|Not treated|8|||
146977873|NCT02367781|530081099|FG001|Overall Study|Physician Decision|0|||
146977874|NCT02367781|530081098|FG000|Overall Study|Randomized in Error|5|||
146977875|NCT02367781|530081099|FG001|Overall Study|Randomized in Error|4|||
146918093|NCT01052012|529861572|FG000|Overall Study|Adverse Event|1|||
146918094|NCT01052012|529861573|FG001|Overall Study|Adverse Event|0|||
146918095|NCT01052012|529861574|FG002|Overall Study|Adverse Event|0|||
146918096|NCT01052012|529861575|FG003|Overall Study|Adverse Event|1|||
146918097|NCT01052012|529861576|FG004|Overall Study|Adverse Event|0|||
146918098|NCT01052012|529861577|FG005|Overall Study|Adverse Event|0|||
146918099|NCT01052012|529861572|FG000|Overall Study|Lost to Follow-up|0|||
146918100|NCT01052012|529861573|FG001|Overall Study|Lost to Follow-up|0|||
146918101|NCT01052012|529861574|FG002|Overall Study|Lost to Follow-up|0|||
146918102|NCT01052012|529861575|FG003|Overall Study|Lost to Follow-up|0|||
146918103|NCT01052012|529861576|FG004|Overall Study|Lost to Follow-up|1|||
146918104|NCT01052012|529861577|FG005|Overall Study|Lost to Follow-up|0|||
146918105|NCT01052012|529861572|FG000|Overall Study|Withdrawal by Subject|1|||
146918106|NCT01052012|529861573|FG001|Overall Study|Withdrawal by Subject|1|||
146918107|NCT01052012|529861574|FG002|Overall Study|Withdrawal by Subject|0|||
146977876|NCT02367781|530081098|FG000|Overall Study|Non-Compliance|1|||
146977877|NCT02367781|530081099|FG001|Overall Study|Non-Compliance|0|||
146977878|NCT02367781|530081098|FG000|Overall Study|Lost to Follow-up|1|||
146977879|NCT02367781|530081099|FG001|Overall Study|Lost to Follow-up|2|||
146977880|NCT02367781|530081098|FG000|Overall Study|Death|330|||
146977881|NCT02367781|530081099|FG001|Overall Study|Death|176|||
146977882|NCT02367781|530081098|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
146977883|NCT02367781|530081099|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
146977884|NCT02367781|530081098|FG000|Overall Study|Prolonged Hospitalization|1|||
146977885|NCT02367781|530081099|FG001|Overall Study|Prolonged Hospitalization|0|||
146977886|NCT02367781|530081098|FG000|Overall Study|Death Prior First Dose|1|||
146977887|NCT02367781|530081099|FG001|Overall Study|Death Prior First Dose|0|||
146977888|NCT02367781|530081098|FG000|Overall Study|Administrative-Change Facility|1|||
146977889|NCT02367781|530081099|FG001|Overall Study|Administrative-Change Facility|0|||
146977890|NCT02367781|530081098|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
146977891|NCT02367781|530081099|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
146977892|NCT02367781|530081098|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
146977893|NCT02367781|530081099|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
146977894|NCT02367781|530081098|FG000|Overall Study|Study Terminated by Sponsor|3|||
146977895|NCT02367781|530081099|FG001|Overall Study|Study Terminated by Sponsor|1|||
146977896|NCT02367781|530081098|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
146977897|NCT02367781|530081099|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
146977898|NCT02367781|530081098|FG000|Overall Study|Sponsor Decision|2|||
146977899|NCT02367781|530081099|FG001|Overall Study|Sponsor Decision|0|||
146977900|NCT02367781|530081098|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
146977901|NCT02367781|530081099|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
146977902|NCT01529749|530081100|FG000|Overall Study|Lost to Follow-up|0|||
146977903|NCT01529749|530081101|FG001|Overall Study|Lost to Follow-up|1|||
146977904|NCT01529749|530081102|FG002|Overall Study|Lost to Follow-up|1|||
146977905|NCT01529749|530081103|FG003|Overall Study|Lost to Follow-up|0|||
146977906|NCT01529749|530081100|FG000|Overall Study|Physician Decision|0|||
146977907|NCT01529749|530081101|FG001|Overall Study|Physician Decision|0|||
146977908|NCT01529749|530081102|FG002|Overall Study|Physician Decision|0|||
146977909|NCT01529749|530081103|FG003|Overall Study|Physician Decision|1|||
146977910|NCT01529749|530081100|FG000|Overall Study|Withdrawal by Subject|0|||
146977911|NCT01529749|530081101|FG001|Overall Study|Withdrawal by Subject|1|||
146977912|NCT01529749|530081102|FG002|Overall Study|Withdrawal by Subject|1|||
146977913|NCT01529749|530081103|FG003|Overall Study|Withdrawal by Subject|0|||
146977914|NCT01529749|530081100|FG000|Overall Study|Protocol Violation|0|||
146977915|NCT01529749|530081101|FG001|Overall Study|Protocol Violation|0|||
146977916|NCT01529749|530081102|FG002|Overall Study|Protocol Violation|0|||
146977917|NCT01529749|530081103|FG003|Overall Study|Protocol Violation|1|||
146977918|NCT00378482|530081104|FG000|Overall Study|Lost to Follow-up|1|||
146977919|NCT00378482|530081104|FG000|Overall Study|Lack of Efficacy|8|||
146977920|NCT00378482|530081104|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
146977921|NCT00378482|530081104|FG000|Overall Study|Withdrawal by Subject|4|||
146977922|NCT00378482|530081104|FG000|Overall Study|Adverse Event|9|||
146977923|NCT05166421|530081105|FG000|Overall Study|Other|3|||
146977924|NCT05166421|530081106|FG001|Overall Study|Other|1|||
146977925|NCT05166421|530081107|FG002|Overall Study|Other|1|||
146977926|NCT05166421|530081105|FG000|Overall Study|Withdrawal by Subject|5|||
146977927|NCT05166421|530081106|FG001|Overall Study|Withdrawal by Subject|3|||
146977928|NCT05166421|530081107|FG002|Overall Study|Withdrawal by Subject|6|||
146977929|NCT05166421|530081105|FG000|Overall Study|Lost to Follow-up|4|||
146770614|NCT01135511|529328646|FG004|Overall Study|Protocol Violation|0|||
146918108|NCT01052012|529861575|FG003|Overall Study|Withdrawal by Subject|0|||
146918109|NCT01052012|529861576|FG004|Overall Study|Withdrawal by Subject|3|||
146918110|NCT01052012|529861577|FG005|Overall Study|Withdrawal by Subject|1|||
146918111|NCT01052012|529861572|FG000|Overall Study|Physician Decision|0|||
146977930|NCT05166421|530081106|FG001|Overall Study|Lost to Follow-up|1|||
146977931|NCT05166421|530081107|FG002|Overall Study|Lost to Follow-up|7|||
146977932|NCT01335399|530082173|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
146977933|NCT01335399|530082174|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
146977934|NCT01335399|530082173|FG000|Pre-treatment Period|Participant request to discontinue|0|||
146977935|NCT01335399|530082174|FG001|Pre-treatment Period|Participant request to discontinue|1|||
146977936|NCT01335399|530082173|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
146977937|NCT01335399|530082174|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
146977938|NCT01335399|530082173|FG000|Pre-treatment Period|Consent withdrawal|3|||
146977939|NCT01335399|530082174|FG001|Pre-treatment Period|Consent withdrawal|0|||
146977940|NCT01335399|530082173|FG000|Treatment Period|Disease progression|117|||
146977941|NCT01335399|530082174|FG001|Treatment Period|Disease progression|145|||
146977942|NCT01335399|530082173|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
146977943|NCT01335399|530082174|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
146977944|NCT01335399|530082173|FG000|Treatment Period|Study drug toxicity|52|||
146977945|NCT01335399|530082174|FG001|Treatment Period|Study drug toxicity|64|||
146977946|NCT01335399|530082173|FG000|Treatment Period|Participant request to discontinue|30|||
146977947|NCT01335399|530082174|FG001|Treatment Period|Participant request to discontinue|22|||
146977948|NCT01335399|530082173|FG000|Treatment Period|Other reasons|30|||
146977949|NCT01335399|530082174|FG001|Treatment Period|Other reasons|30|||
146977950|NCT01335399|530082173|FG000|Treatment Period|Consent withdrawal|10|||
146977951|NCT01335399|530082174|FG001|Treatment Period|Consent withdrawal|7|||
146977952|NCT01335399|530082173|FG000|Treatment Period|Death|7|||
146977953|NCT01335399|530082174|FG001|Treatment Period|Death|6|||
146977954|NCT01335399|530082173|FG000|Treatment Period|Poor/Non-compliance|3|||
146977955|NCT01335399|530082174|FG001|Treatment Period|Poor/Non-compliance|4|||
146977956|NCT01335399|530082173|FG000|Treatment Period|Lost to Follow-up|2|||
146977957|NCT01335399|530082174|FG001|Treatment Period|Lost to Follow-up|2|||
146977958|NCT01335399|530082173|FG000|Treatment Period|Maximum clinical benefit|1|||
146977959|NCT01335399|530082174|FG001|Treatment Period|Maximum clinical benefit|1|||
146977960|NCT01335399|530082173|FG000|Treatment Period|No longer meet study criteria|1|||
146977961|NCT01335399|530082174|FG001|Treatment Period|No longer meet study criteria|1|||
146977962|NCT01335399|530082173|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
146977963|NCT01335399|530082174|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
146977964|NCT03202511|530082176|FG000|Overall Study|Withdrawal by Subject|1|||
146977965|NCT03202511|530082177|FG001|Overall Study|Withdrawal by Subject|0|||
146977966|NCT00096382|530082178|FG000|Overall Study|Not treated|1|||
146977967|NCT00096382|530082179|FG001|Overall Study|Not treated|0|||
146977968|NCT00096382|530082178|FG000|Overall Study|Death during treatment|1|||
146977969|NCT00096382|530082179|FG001|Overall Study|Death during treatment|0|||
146977970|NCT01270841|530082180|FG000|Overall Study|Adverse Event|0|||
146977971|NCT01270841|530082181|FG001|Overall Study|Adverse Event|1|||
146977972|NCT01270841|530082182|FG002|Overall Study|Adverse Event|0|||
146977973|NCT01270841|530082183|FG003|Overall Study|Adverse Event|3|||
146977974|NCT01270841|530082180|FG000|Overall Study|Withdrawal by Subject|3|||
146977975|NCT01270841|530082181|FG001|Overall Study|Withdrawal by Subject|2|||
146977976|NCT01270841|530082182|FG002|Overall Study|Withdrawal by Subject|3|||
146977977|NCT01270841|530082183|FG003|Overall Study|Withdrawal by Subject|3|||
146977978|NCT01270841|530082180|FG000|Overall Study|Lost to Follow-up|3|||
146977979|NCT01270841|530082181|FG001|Overall Study|Lost to Follow-up|1|||
146977980|NCT01270841|530082182|FG002|Overall Study|Lost to Follow-up|4|||
146977981|NCT01270841|530082183|FG003|Overall Study|Lost to Follow-up|2|||
146977982|NCT01270841|530082180|FG000|Overall Study|Physician Decision|0|||
146977983|NCT01270841|530082181|FG001|Overall Study|Physician Decision|1|||
146977984|NCT01270841|530082182|FG002|Overall Study|Physician Decision|0|||
146977985|NCT01270841|530082183|FG003|Overall Study|Physician Decision|0|||
146977986|NCT01270841|530082180|FG000|Overall Study|Did not qualify|6|||
146977987|NCT01270841|530082181|FG001|Overall Study|Did not qualify|3|||
146977988|NCT01270841|530082182|FG002|Overall Study|Did not qualify|4|||
146977989|NCT01270841|530082183|FG003|Overall Study|Did not qualify|5|||
146977990|NCT01270841|530082180|FG000|Overall Study|Protocol Violation|1|||
146977991|NCT01270841|530082181|FG001|Overall Study|Protocol Violation|5|||
146977992|NCT01270841|530082182|FG002|Overall Study|Protocol Violation|0|||
146977993|NCT01270841|530082183|FG003|Overall Study|Protocol Violation|0|||
146977994|NCT01270841|530082180|FG000|Overall Study|Enrolled in error|0|||
146977995|NCT01270841|530082181|FG001|Overall Study|Enrolled in error|1|||
146977996|NCT01270841|530082182|FG002|Overall Study|Enrolled in error|0|||
146977997|NCT01270841|530082183|FG003|Overall Study|Enrolled in error|0|||
146575879|NCT01194219|528616909|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
146575880|NCT01194219|528616910|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
146575881|NCT01194219|528616901|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
146977998|NCT01375010|530082184|FG000|Overall Study|Lost to Follow-up|8|||
146977999|NCT01375010|530082185|FG001|Overall Study|Lost to Follow-up|2|||
146978000|NCT01375010|530082184|FG000|Overall Study|Withdrawal by Subject|4|||
146978001|NCT01375010|530082185|FG001|Overall Study|Withdrawal by Subject|2|||
146978002|NCT02614703|530082186|FG000|Overall Study|Withdrawal by Subject|7|||
146978003|NCT02614703|530082187|FG001|Overall Study|Withdrawal by Subject|1|||
146918112|NCT01052012|529861573|FG001|Overall Study|Physician Decision|0|||
146918113|NCT01052012|529861574|FG002|Overall Study|Physician Decision|0|||
146918114|NCT01052012|529861575|FG003|Overall Study|Physician Decision|0|||
146918115|NCT01052012|529861576|FG004|Overall Study|Physician Decision|0|||
146918116|NCT01052012|529861577|FG005|Overall Study|Physician Decision|1|||
146918117|NCT01052012|529861572|FG000|Overall Study|Other|0|||
146918118|NCT01052012|529861573|FG001|Overall Study|Other|0|||
146918119|NCT01052012|529861574|FG002|Overall Study|Other|0|||
146918120|NCT01052012|529861575|FG003|Overall Study|Other|0|||
146918121|NCT01052012|529861576|FG004|Overall Study|Other|1|||
146918122|NCT01052012|529861577|FG005|Overall Study|Other|0|||
146918123|NCT02873715|529861578|FG000|Overall Study|Lost to Follow-up|84|||
146918124|NCT02873715|529861579|FG001|Overall Study|Lost to Follow-up|94|||
146918125|NCT02873715|529861578|FG000|Overall Study|Withdrawal by Subject|7|||
146918126|NCT02873715|529861579|FG001|Overall Study|Withdrawal by Subject|26|||
146918127|NCT00443430|529861582|FG000|Overall Study|Lack of Efficacy|3|||
146918128|NCT00443430|529861583|FG001|Overall Study|Lack of Efficacy|3|||
146918129|NCT00443430|529861582|FG000|Overall Study|Adverse Event|1|||
146918130|NCT00443430|529861583|FG001|Overall Study|Adverse Event|1|||
146918131|NCT00592501|529861584|FG000|Overall Study|Withdrawal by Subject|1|||
146918132|NCT00592501|529861584|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
146918133|NCT00053846|529861585|FG000|Overall Study|Changed mind|8|||
146918134|NCT00053846|529861586|FG001|Overall Study|Changed mind|13|||
146918135|NCT00053846|529861585|FG000|Overall Study|Became too ill|8|||
146918136|NCT00053846|529861586|FG001|Overall Study|Became too ill|7|||
146918137|NCT00053846|529861585|FG000|Overall Study|Expired|5|||
146918138|NCT00053846|529861586|FG001|Overall Study|Expired|0|||
146918139|NCT00053846|529861585|FG000|Overall Study|Became ineligible|3|||
146918140|NCT00053846|529861586|FG001|Overall Study|Became ineligible|1|||
146918141|NCT00053846|529861585|FG000|Overall Study|Did not return data|1|||
146918142|NCT00053846|529861586|FG001|Overall Study|Did not return data|2|||
146918143|NCT00053846|529861585|FG000|Overall Study|Quit due to side effects|1|||
146918144|NCT00053846|529861586|FG001|Overall Study|Quit due to side effects|3|||
146918145|NCT00053846|529861585|FG000|Overall Study|Pills too large|0|||
146918146|NCT00053846|529861586|FG001|Overall Study|Pills too large|1|||
146918147|NCT01929044|529861590|FG000|Overall Study|Adverse Event|1|||
146918148|NCT01929044|529861591|FG001|Overall Study|Adverse Event|0|||
146918149|NCT01929044|529861590|FG000|Overall Study|Protocol Violation|9|||
146918150|NCT01929044|529861591|FG001|Overall Study|Protocol Violation|14|||
146918151|NCT01929044|529861590|FG000|Overall Study|Not Treated|1|||
146918152|NCT01929044|529861591|FG001|Overall Study|Not Treated|3|||
146918153|NCT01555463|529861594|FG000|Treatment|Adverse Event|6|||
146918154|NCT01555463|529861595|FG001|Treatment|Adverse Event|12|||
146918155|NCT01555463|529861594|FG000|Treatment|Withdrawal by Subject|24|||
146918156|NCT01555463|529861595|FG001|Treatment|Withdrawal by Subject|36|||
146918157|NCT01555463|529861594|FG000|Treatment|Lost to Follow-up|28|||
146918158|NCT01555463|529861595|FG001|Treatment|Lost to Follow-up|23|||
146918159|NCT01555463|529861594|FG000|Treatment|Protocol Violation|4|||
146918160|NCT01555463|529861595|FG001|Treatment|Protocol Violation|5|||
146918161|NCT01555463|529861594|FG000|Treatment|Other reason|2|||
146918162|NCT01555463|529861595|FG001|Treatment|Other reason|3|||
146918163|NCT01555463|529861594|FG000|Follow up|Adverse Event|2|||
146918164|NCT01555463|529861595|FG001|Follow up|Adverse Event|5|||
146918165|NCT01555463|529861594|FG000|Follow up|Death|0|||
146918166|NCT01555463|529861595|FG001|Follow up|Death|1|||
146918167|NCT01555463|529861594|FG000|Follow up|Withdrawal by Subject|22|||
146918168|NCT01555463|529861595|FG001|Follow up|Withdrawal by Subject|22|||
146918169|NCT01555463|529861594|FG000|Follow up|Lost to Follow-up|9|||
146918170|NCT01555463|529861595|FG001|Follow up|Lost to Follow-up|10|||
146918171|NCT01555463|529861594|FG000|Follow up|Protocol Violation|2|||
146918172|NCT01555463|529861595|FG001|Follow up|Protocol Violation|4|||
146918173|NCT01555463|529861594|FG000|Follow up|Other reason|3|||
146918174|NCT01555463|529861595|FG001|Follow up|Other reason|3|||
146918175|NCT04333433|529861596|FG000|Overall Study|Withdrawal by Subject|6|||
146918176|NCT04333433|529861597|FG001|Overall Study|Withdrawal by Subject|3|||
146918177|NCT04333433|529861596|FG000|Overall Study|Death|3|||
146918178|NCT04333433|529861597|FG001|Overall Study|Death|0|||
146918179|NCT04333433|529861596|FG000|Overall Study|Lost to Follow-up|6|||
146918180|NCT04333433|529861597|FG001|Overall Study|Lost to Follow-up|1|||
146918181|NCT04333433|529861596|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
146918182|NCT04333433|529861597|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
146918183|NCT02026271|529861598|FG000|Overall Study|Adverse Event|2|||
146978004|NCT02402933|530082188|FG000|Overall Study|Withdrawal by Subject|4|||
146918184|NCT02026271|529861599|FG001|Overall Study|Adverse Event|3|||
146918185|NCT02026271|529861600|FG002|Overall Study|Adverse Event|2|||
146918186|NCT02026271|529861601|FG003|Overall Study|Adverse Event|3|||
146918187|NCT02026271|529861602|FG004|Overall Study|Adverse Event|0|||
146918188|NCT02026271|529861598|FG000|Overall Study|Withdrawal by Subject|0|||
146918189|NCT02026271|529861599|FG001|Overall Study|Withdrawal by Subject|0|||
146918190|NCT02026271|529861600|FG002|Overall Study|Withdrawal by Subject|0|||
146575882|NCT01194219|528616902|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
146575883|NCT01194219|528616903|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
146575884|NCT01194219|528616904|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
146575885|NCT01194219|528616905|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
146575886|NCT01194219|528616906|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
146575887|NCT01194219|528616907|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
146575888|NCT01194219|528616908|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
146575889|NCT01194219|528616909|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
146575890|NCT01194219|528616910|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
146575891|NCT01194219|528616901|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
146575892|NCT01194219|528616902|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
146575893|NCT01194219|528616903|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
146575894|NCT01194219|528616904|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
146575895|NCT01194219|528616905|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
146575896|NCT01194219|528616906|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
146575897|NCT01194219|528616907|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
146575898|NCT01194219|528616908|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
146575899|NCT01194219|528616909|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
146575900|NCT01194219|528616910|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
146575901|NCT01194219|528616901|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
146575902|NCT01194219|528616902|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
146575903|NCT01194219|528616903|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
146575904|NCT01194219|528616904|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
146575905|NCT01194219|528616905|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
146575906|NCT01194219|528616906|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
146575907|NCT01194219|528616907|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
146575908|NCT01194219|528616908|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
146575909|NCT01194219|528616909|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
146575910|NCT01194219|528616910|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
146575911|NCT01194219|528616901|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
146575912|NCT01194219|528616902|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
146575913|NCT01194219|528616903|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
146575914|NCT01194219|528616904|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
146575915|NCT01194219|528616905|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
146575916|NCT01194219|528616906|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
146575917|NCT01194219|528616907|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
146575918|NCT01194219|528616908|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
146575919|NCT01194219|528616909|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
146575920|NCT01194219|528616910|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
146575921|NCT01194219|528616901|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146575922|NCT01194219|528616902|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146575923|NCT01194219|528616903|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
146575924|NCT01194219|528616904|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146575925|NCT01194219|528616905|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146575926|NCT01194219|528616906|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146575927|NCT01194219|528616907|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146575928|NCT01194219|528616908|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146575929|NCT01194219|528616909|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146575930|NCT01194219|528616910|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146575931|NCT01194219|528616901|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146575932|NCT01194219|528616902|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146575933|NCT01194219|528616903|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146575934|NCT01194219|528616904|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
146575935|NCT01194219|528616905|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146575936|NCT01194219|528616906|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146575937|NCT01194219|528616907|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146575938|NCT01194219|528616908|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146575939|NCT01194219|528616909|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146575940|NCT01194219|528616910|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146575941|NCT01194219|528616901|FG000|Maintenance Phase Weeks16-32|Other|0|||
146575942|NCT01194219|528616902|FG001|Maintenance Phase Weeks16-32|Other|0|||
146575943|NCT01194219|528616903|FG002|Maintenance Phase Weeks16-32|Other|2|||
146575944|NCT01194219|528616904|FG003|Maintenance Phase Weeks16-32|Other|1|||
146575945|NCT01194219|528616905|FG004|Maintenance Phase Weeks16-32|Other|0|||
146575946|NCT01194219|528616906|FG005|Maintenance Phase Weeks16-32|Other|0|||
146575947|NCT01194219|528616907|FG006|Maintenance Phase Weeks16-32|Other|0|||
146575948|NCT01194219|528616908|FG007|Maintenance Phase Weeks16-32|Other|0|||
146575949|NCT01194219|528616909|FG008|Maintenance Phase Weeks16-32|Other|0|||
146575950|NCT01194219|528616910|FG009|Maintenance Phase Weeks16-32|Other|0|||
146575951|NCT01194219|528616901|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
146575952|NCT01194219|528616902|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
146575953|NCT01194219|528616903|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
146575954|NCT01194219|528616904|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
146575955|NCT01194219|528616905|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
146575956|NCT01194219|528616906|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
146575957|NCT01194219|528616907|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
146575958|NCT01194219|528616908|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
146575959|NCT01194219|528616909|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
146575960|NCT01194219|528616910|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
146575961|NCT01194219|528616901|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
146575962|NCT01194219|528616902|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
146575963|NCT01194219|528616903|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
146575964|NCT01194219|528616904|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
146575965|NCT01194219|528616905|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
146575966|NCT01194219|528616906|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
146575967|NCT01194219|528616907|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
146575968|NCT01194219|528616908|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
146575969|NCT01194219|528616909|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
146575970|NCT01194219|528616910|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
146575971|NCT01194219|528616901|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
146575972|NCT01194219|528616902|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
146575973|NCT01194219|528616903|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
146575974|NCT01194219|528616904|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
146575975|NCT01194219|528616905|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
146575976|NCT01194219|528616906|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
146918191|NCT02026271|529861601|FG003|Overall Study|Withdrawal by Subject|0|||
146918192|NCT02026271|529861602|FG004|Overall Study|Withdrawal by Subject|1|||
146918193|NCT02275026|529861603|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
146918194|NCT02275026|529861603|FG000|Overall Study|Withdrawal by Subject|4|||
146918195|NCT02275026|529861603|FG000|Overall Study|Ineligible due to medical history|13|||
146918196|NCT02275026|529861603|FG000|Overall Study|MRI malfunction precluded testing|1|||
146918197|NCT02275026|529861603|FG000|Overall Study|Ineligible after MRI findings|1|||
146918198|NCT02275026|529861603|FG000|Overall Study|Lost to Follow-up|2|||
146918199|NCT02275026|529861603|FG000|Overall Study|Scanner failure|1|||
146918200|NCT00374907|529861606|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
146918201|NCT00374907|529861607|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
146918202|NCT00374907|529861606|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
146918203|NCT00374907|529861607|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
146918204|NCT00374907|529861606|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
146918205|NCT00374907|529861607|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
146575977|NCT01194219|528616907|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
146575978|NCT01194219|528616908|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
146575979|NCT01194219|528616909|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
146918206|NCT00374907|529861606|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
146918207|NCT00374907|529861607|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
146918208|NCT00374907|529861606|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
146918209|NCT00374907|529861607|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
146918210|NCT01108809|529861608|FG000|Overall Study|Adverse Event|3|||
146575980|NCT01194219|528616910|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
146575981|NCT01194219|528616901|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
146575982|NCT01194219|528616902|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
146575983|NCT01194219|528616903|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
146575984|NCT01194219|528616904|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
146575985|NCT01194219|528616905|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
146575986|NCT01194219|528616906|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
146575987|NCT01194219|528616907|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
146575988|NCT01194219|528616908|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
146575989|NCT01194219|528616909|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
146575990|NCT01194219|528616910|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
146575991|NCT01194219|528616901|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
146575992|NCT01194219|528616902|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
146918211|NCT01108809|529861608|FG000|Overall Study|Lost to Follow-up|1|||
146918212|NCT00001262|529861613|FG000|Overall Study|Death|10|||
146918213|NCT00001262|529861614|FG001|Overall Study|Death|11|||
146575993|NCT01194219|528616903|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
146575994|NCT01194219|528616904|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
146575995|NCT01194219|528616905|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
146575996|NCT01194219|528616906|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
146575997|NCT01194219|528616907|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
146575998|NCT01194219|528616908|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
146575999|NCT01194219|528616909|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
146576000|NCT01194219|528616910|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
146576001|NCT01194219|528616901|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146576002|NCT01194219|528616902|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146576003|NCT01194219|528616903|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146576004|NCT01194219|528616904|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146576005|NCT01194219|528616905|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146576006|NCT01194219|528616906|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146576007|NCT01194219|528616907|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146576008|NCT01194219|528616908|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
146576009|NCT01194219|528616909|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146576010|NCT01194219|528616910|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146576011|NCT01194219|528616901|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146576012|NCT01194219|528616902|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146576013|NCT01194219|528616903|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146576014|NCT01194219|528616904|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146576015|NCT01194219|528616905|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146918214|NCT00001262|529861615|FG002|Overall Study|Death|0|||
146918215|NCT00001262|529861613|FG000|Overall Study|Withdrawal by Subject|0|||
146918216|NCT00001262|529861614|FG001|Overall Study|Withdrawal by Subject|3|||
146918217|NCT00001262|529861615|FG002|Overall Study|Withdrawal by Subject|0|||
146918218|NCT00576693|529861619|FG000|Overall Study|Lost to Follow-up|7|||
146576016|NCT01194219|528616906|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146576017|NCT01194219|528616907|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
146576018|NCT01194219|528616908|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146576019|NCT01194219|528616909|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146576020|NCT01194219|528616910|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146576021|NCT01194219|528616901|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
146576022|NCT01194219|528616902|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
146576023|NCT01194219|528616903|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
146576024|NCT01194219|528616904|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
146576025|NCT01194219|528616905|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
146918219|NCT00576693|529861620|FG001|Overall Study|Lost to Follow-up|11|||
146978005|NCT02402933|530082188|FG000|Overall Study|Discontinued; Site Termination|10|||
146978006|NCT00854620|530082197|FG000|Overall Study|Adverse Event|1|||
146576026|NCT01194219|528616906|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
146576027|NCT01194219|528616907|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
146576028|NCT01194219|528616908|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
146918220|NCT00576693|529861619|FG000|Overall Study|Withdrawal by Subject|3|||
146978007|NCT02962882|530082201|FG000|Overall Study|Adverse Event|2|||
146918221|NCT00576693|529861620|FG001|Overall Study|Withdrawal by Subject|13|||
146918222|NCT01413178|529861621|FG000|Overall Study|Toxicity|1|||
146978008|NCT02962882|530082201|FG000|Overall Study|Withdrawal by Subject|2|||
146576029|NCT01194219|528616909|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
146576030|NCT01194219|528616910|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
146918223|NCT01413178|529861622|FG001|Overall Study|Toxicity|0|||
146918224|NCT01413178|529861621|FG000|Overall Study|Ineligible|0|||
146918225|NCT01413178|529861622|FG001|Overall Study|Ineligible|2|||
146918226|NCT00540449|529861623|FG000|Overall Study|Adverse Event|12|||
146918227|NCT00540449|529861624|FG001|Overall Study|Adverse Event|32|||
146918228|NCT00540449|529861623|FG000|Overall Study|Sponsor's Decision|1|||
146918229|NCT00540449|529861624|FG001|Overall Study|Sponsor's Decision|1|||
146918230|NCT00540449|529861623|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
146918231|NCT00540449|529861624|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
146978009|NCT02962882|530082201|FG000|Overall Study|Transfer from ICU|32|||
146978010|NCT03763331|530082204|FG000|Overall Study|Lost to Follow-up|1|||
146978011|NCT03763331|530082205|FG001|Overall Study|Lost to Follow-up|0|||
146576031|NCT01194219|528616901|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
146576032|NCT01194219|528616902|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
146918232|NCT00540449|529861623|FG000|Overall Study|Lost to Follow-up|19|||
146918233|NCT00540449|529861624|FG001|Overall Study|Lost to Follow-up|17|||
146918234|NCT00540449|529861623|FG000|Overall Study|Subject Non-Compliant|7|||
146918235|NCT00540449|529861624|FG001|Overall Study|Subject Non-Compliant|5|||
146978012|NCT03763331|530082204|FG000|Overall Study|Withdrawal by Subject|1|||
146978013|NCT03763331|530082205|FG001|Overall Study|Withdrawal by Subject|0|||
146576033|NCT01194219|528616903|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
146978014|NCT03763331|530082204|FG000|Overall Study|Non-compliance|0|||
146978015|NCT03763331|530082205|FG001|Overall Study|Non-compliance|3|||
146978016|NCT01155063|530082206|FG000|Overall Study|Adverse Event|1|||
146978017|NCT01155063|530082206|FG000|Overall Study|Withdrawal by Subject|1|||
146978018|NCT01155063|530082206|FG000|Overall Study|Study terminated by sponsor|87|||
146978019|NCT00936884|530082207|FG000|Double-blind|Withdrawal by Subject|6|||
146978020|NCT00936884|530082208|FG001|Double-blind|Withdrawal by Subject|4|||
146978021|NCT00936884|530082209|FG002|Double-blind|Withdrawal by Subject|0|||
146978022|NCT00936884|530082207|FG000|Double-blind|Death|2|||
146978023|NCT00936884|530082208|FG001|Double-blind|Death|1|||
146978024|NCT00936884|530082209|FG002|Double-blind|Death|0|||
146978025|NCT00936884|530082207|FG000|Double-blind|Lack of Efficacy|1|||
146576034|NCT01194219|528616904|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
146576035|NCT01194219|528616905|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
146576036|NCT01194219|528616906|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
146576037|NCT01194219|528616907|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
146576038|NCT01194219|528616908|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
146576039|NCT01194219|528616909|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
146978026|NCT00936884|530082208|FG001|Double-blind|Lack of Efficacy|1|||
146978027|NCT00936884|530082209|FG002|Double-blind|Lack of Efficacy|0|||
146978028|NCT00936884|530082207|FG000|Double-blind|Adverse Event|1|||
146978029|NCT00936884|530082208|FG001|Double-blind|Adverse Event|0|||
146978030|NCT00936884|530082209|FG002|Double-blind|Adverse Event|0|||
146978031|NCT00936884|530082207|FG000|Double-blind|Physician Decision|1|||
146978032|NCT00936884|530082208|FG001|Double-blind|Physician Decision|0|||
146978033|NCT00936884|530082209|FG002|Double-blind|Physician Decision|0|||
146978034|NCT00936884|530082207|FG000|Double-blind|No post baseline diary entry|1|||
146978035|NCT00936884|530082208|FG001|Double-blind|No post baseline diary entry|0|||
146978036|NCT00936884|530082209|FG002|Double-blind|No post baseline diary entry|0|||
146978037|NCT00936884|530082207|FG000|Double-blind|Did not receive study drug|0|||
146576040|NCT01194219|528616910|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
146576041|NCT01194219|528616901|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
146576042|NCT01194219|528616902|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
146576043|NCT01194219|528616903|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
146576044|NCT01194219|528616904|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
146576045|NCT01194219|528616905|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
146576046|NCT01194219|528616906|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
146576047|NCT01194219|528616907|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
146576048|NCT01194219|528616908|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
146576049|NCT01194219|528616909|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
146576050|NCT01194219|528616910|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
146576051|NCT01194219|528616901|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
146576052|NCT01194219|528616902|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
146576053|NCT01194219|528616903|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
146576054|NCT01194219|528616904|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
146978038|NCT00936884|530082208|FG001|Double-blind|Did not receive study drug|1|||
146978039|NCT00936884|530082209|FG002|Double-blind|Did not receive study drug|0|||
146978040|NCT01314703|530082210|FG000|Overall Study|screen failure and closed enrollment|8|||
146978041|NCT00597584|530082211|FG000|Overall Study|Adverse Event|4|||
146576055|NCT01194219|528616905|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
146576056|NCT01194219|528616906|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
146576057|NCT01194219|528616907|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
146576058|NCT01194219|528616908|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
146576059|NCT01194219|528616909|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
146576060|NCT01194219|528616910|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
146576061|NCT01194219|528616901|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
146576062|NCT01194219|528616902|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
146576063|NCT01194219|528616903|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
146576064|NCT01194219|528616904|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
146576065|NCT01194219|528616905|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
146576066|NCT01194219|528616906|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
146576067|NCT01194219|528616907|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
146576068|NCT01194219|528616908|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
146576069|NCT01194219|528616909|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
146576070|NCT01194219|528616910|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
146978042|NCT00597584|530082212|FG001|Overall Study|Adverse Event|2|||
146978043|NCT00597584|530082211|FG000|Overall Study|Death|53|||
146978044|NCT00597584|530082212|FG001|Overall Study|Death|30|||
146978045|NCT00597584|530082211|FG000|Overall Study|Lack of Efficacy|1|||
146978046|NCT00597584|530082212|FG001|Overall Study|Lack of Efficacy|0|||
146978047|NCT00597584|530082211|FG000|Overall Study|Lost to Follow-up|2|||
146978048|NCT00597584|530082212|FG001|Overall Study|Lost to Follow-up|4|||
146576071|NCT01194219|528616901|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
146576072|NCT01194219|528616902|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
146576073|NCT01194219|528616903|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
146576074|NCT01194219|528616904|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
146576075|NCT01194219|528616905|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
146576076|NCT01194219|528616906|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
146576077|NCT01194219|528616907|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
146576078|NCT01194219|528616908|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
146576079|NCT01194219|528616909|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
146576080|NCT01194219|528616910|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
146576081|NCT01194219|528616901|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146576082|NCT01194219|528616902|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146576083|NCT01194219|528616903|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146576084|NCT01194219|528616904|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146576085|NCT01194219|528616905|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146576086|NCT01194219|528616906|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146576087|NCT01194219|528616907|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146576088|NCT01194219|528616908|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146576089|NCT01194219|528616909|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
146576090|NCT01194219|528616910|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146576091|NCT01194219|528616901|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
146576092|NCT01194219|528616902|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
146576093|NCT01194219|528616903|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
146576094|NCT01194219|528616904|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
146576095|NCT01194219|528616905|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
146576096|NCT01194219|528616906|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
146576097|NCT01194219|528616907|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
146576098|NCT01194219|528616908|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
146576099|NCT01194219|528616909|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
146576100|NCT01194219|528616910|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
146576101|NCT01081951|528616911|FG000|Overall Study|Death|54|||
146576102|NCT01081951|528616912|FG001|Overall Study|Death|47|||
146576103|NCT01081951|528616911|FG000|Overall Study|Withdrawal by Subject|2|||
146576104|NCT01081951|528616912|FG001|Overall Study|Withdrawal by Subject|6|||
146576105|NCT01081951|528616911|FG000|Overall Study|Allocated treatment but did not take it|0|||
146576106|NCT01081951|528616912|FG001|Overall Study|Allocated treatment but did not take it|1|||
146576107|NCT01081951|528616911|FG000|Overall Study|Lost to Follow-up|0|||
146576108|NCT01081951|528616912|FG001|Overall Study|Lost to Follow-up|1|||
146576109|NCT01671956|528616915|FG000|Overall Study|Disease progression|0|||
146576110|NCT01671956|528616916|FG001|Overall Study|Disease progression|1|||
146576111|NCT01671956|528616915|FG000|Overall Study|Withdrawal by Subject|1|||
146576112|NCT01671956|528616916|FG001|Overall Study|Withdrawal by Subject|1|||
146576113|NCT01671956|528616915|FG000|Overall Study|Adverse Event|1|||
146576114|NCT01671956|528616916|FG001|Overall Study|Adverse Event|0|||
146576115|NCT04266912|528616928|FG000|Overall Study|Withdrawal by Subject|1|||
146576116|NCT04266912|528616929|FG001|Overall Study|Withdrawal by Subject|0|||
146576117|NCT04266912|528616930|FG002|Overall Study|Withdrawal by Subject|0|||
146576118|NCT04266912|528616931|FG003|Overall Study|Withdrawal by Subject|0|||
146576119|NCT04266912|528616928|FG000|Overall Study|Progression|6|||
146576120|NCT04266912|528616929|FG001|Overall Study|Progression|6|||
146576121|NCT04266912|528616930|FG002|Overall Study|Progression|0|||
146576122|NCT04266912|528616931|FG003|Overall Study|Progression|10|||
146576123|NCT05696444|528616932|FG000|Treatment|Physician Decision|0|||
146576124|NCT05696444|528616933|FG001|Treatment|Physician Decision|1|||
146576125|NCT05696444|528616934|FG002|Treatment|Physician Decision|0|||
146576126|NCT05696444|528616932|FG000|30 Days|Death|1|||
146576127|NCT05696444|528616933|FG001|30 Days|Death|1|||
146576128|NCT05696444|528616934|FG002|30 Days|Death|0|||
146576129|NCT05696444|528616932|FG000|30 Days|Missed Visit|1|||
146576130|NCT05696444|528616933|FG001|30 Days|Missed Visit|1|||
146576131|NCT05696444|528616934|FG002|30 Days|Missed Visit|1|||
146576132|NCT05200572|528616935|FG000|Overall Study|Withdrawal by Subject|14|||
146576133|NCT00316706|528618139|FG000|Overall Study|Lost to Follow-up|38|||
146576134|NCT00316706|528618140|FG001|Overall Study|Lost to Follow-up|48|||
146576135|NCT00283803|528618146|FG000|Overall Study|Physician Decision|9|||
146576136|NCT00283803|528618146|FG000|Overall Study|Withdrawal by Subject|4|||
146576137|NCT01127607|528618147|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
146576138|NCT01127607|528618148|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
146576139|NCT01127607|528618147|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
146576140|NCT01127607|528618148|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
146576141|NCT03640325|528618149|FG000|Overall Study|Withdrawal by Subject|4|||
146576142|NCT03640325|528618150|FG001|Overall Study|Withdrawal by Subject|1|||
146576143|NCT03640325|528618151|FG002|Overall Study|Withdrawal by Subject|0|||
146576144|NCT03640325|528618149|FG000|Overall Study|Lost to Follow-up|4|||
146770615|NCT01135511|529328647|FG005|Overall Study|Protocol Violation|0|||
146770616|NCT01135511|529328648|FG006|Overall Study|Protocol Violation|0|||
146770617|NCT01135511|529328649|FG007|Overall Study|Protocol Violation|0|||
146770618|NCT01135511|529328650|FG008|Overall Study|Protocol Violation|0|||
146770619|NCT01135511|529328642|FG000|Overall Study|Pregnancy|0|||
146770620|NCT01135511|529328643|FG001|Overall Study|Pregnancy|0|||
146770621|NCT01135511|529328644|FG002|Overall Study|Pregnancy|0|||
146770622|NCT01135511|529328645|FG003|Overall Study|Pregnancy|1|||
146770623|NCT01135511|529328646|FG004|Overall Study|Pregnancy|0|||
146770624|NCT01135511|529328647|FG005|Overall Study|Pregnancy|0|||
146770625|NCT01135511|529328648|FG006|Overall Study|Pregnancy|0|||
146770626|NCT01135511|529328649|FG007|Overall Study|Pregnancy|0|||
146770627|NCT01135511|529328650|FG008|Overall Study|Pregnancy|0|||
146576145|NCT03640325|528618150|FG001|Overall Study|Lost to Follow-up|5|||
146918236|NCT00540449|529861623|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
146918237|NCT00540449|529861624|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
146918238|NCT00540449|529861623|FG000|Overall Study|Withdrawal by Subject|10|||
146918239|NCT00540449|529861624|FG001|Overall Study|Withdrawal by Subject|10|||
146576146|NCT03640325|528618151|FG002|Overall Study|Lost to Follow-up|21|||
146576147|NCT03640325|528618149|FG000|Overall Study|Death|5|||
146576148|NCT03640325|528618150|FG001|Overall Study|Death|5|||
146576149|NCT03640325|528618151|FG002|Overall Study|Death|0|||
146576150|NCT03493451|528618152|FG000|Overall Study|Death|11|||
146576151|NCT03493451|528618153|FG001|Overall Study|Death|26|||
146576152|NCT03493451|528618154|FG002|Overall Study|Death|3|||
146576153|NCT03493451|528618152|FG000|Overall Study|Lost to Follow-up|1|||
146576154|NCT03493451|528618153|FG001|Overall Study|Lost to Follow-up|4|||
146576155|NCT03493451|528618154|FG002|Overall Study|Lost to Follow-up|1|||
146576156|NCT03493451|528618152|FG000|Overall Study|Withdrawal by Subject|1|||
146576157|NCT03493451|528618153|FG001|Overall Study|Withdrawal by Subject|1|||
146576158|NCT03493451|528618154|FG002|Overall Study|Withdrawal by Subject|2|||
146576159|NCT03493451|528618152|FG000|Overall Study|Progressive Disease|1|||
146576160|NCT03493451|528618153|FG001|Overall Study|Progressive Disease|0|||
146576161|NCT03493451|528618154|FG002|Overall Study|Progressive Disease|0|||
146576162|NCT03493451|528618152|FG000|Overall Study|Transferred to long term extension study|8|||
146576163|NCT03493451|528618153|FG001|Overall Study|Transferred to long term extension study|13|||
146576164|NCT03493451|528618154|FG002|Overall Study|Transferred to long term extension study|5|||
146576165|NCT01133756|528618158|FG000|Overall Study|Adverse Event|1|||
146576166|NCT01133756|528618159|FG001|Overall Study|Adverse Event|2|||
146576167|NCT01133756|528618160|FG002|Overall Study|Adverse Event|1|||
146576168|NCT01133756|528618158|FG000|Overall Study|Investigator Decision|1|||
146576169|NCT01133756|528618159|FG001|Overall Study|Investigator Decision|0|||
146576170|NCT01133756|528618160|FG002|Overall Study|Investigator Decision|0|||
146576171|NCT01133756|528618158|FG000|Overall Study|Withdrawal by Subject|0|||
146576172|NCT01133756|528618159|FG001|Overall Study|Withdrawal by Subject|1|||
146576173|NCT01133756|528618160|FG002|Overall Study|Withdrawal by Subject|0|||
146576174|NCT01133756|528618158|FG000|Overall Study|Progression of Disease|0|||
146576175|NCT01133756|528618159|FG001|Overall Study|Progression of Disease|0|||
146576176|NCT01133756|528618160|FG002|Overall Study|Progression of Disease|1|||
146576177|NCT01566149|528618161|FG000|Overall Study|Adverse Event|0|||
146576178|NCT01566149|528618162|FG001|Overall Study|Adverse Event|1|||
146576179|NCT01566149|528618161|FG000|Overall Study|Non-compliance with study medication|2|||
146576180|NCT01566149|528618162|FG001|Overall Study|Non-compliance with study medication|0|||
146576181|NCT01566149|528618161|FG000|Overall Study|Protocol Violation|0|||
146576182|NCT01566149|528618162|FG001|Overall Study|Protocol Violation|1|||
146576183|NCT01566149|528618161|FG000|Overall Study|Withdrawal by Subject|1|||
146576184|NCT01566149|528618162|FG001|Overall Study|Withdrawal by Subject|0|||
146576185|NCT03941873|528618176|FG000|Overall Study|Death|0|||
146576186|NCT03941873|528618177|FG001|Overall Study|Death|12|||
146576187|NCT03941873|528618178|FG002|Overall Study|Death|2|||
146576188|NCT03941873|528618179|FG003|Overall Study|Death|53|||
146576189|NCT03941873|528618176|FG000|Overall Study|Withdrawal by Subject|1|||
146576190|NCT03941873|528618177|FG001|Overall Study|Withdrawal by Subject|1|||
146576191|NCT03941873|528618178|FG002|Overall Study|Withdrawal by Subject|0|||
146576192|NCT03941873|528618179|FG003|Overall Study|Withdrawal by Subject|5|||
146576193|NCT03941873|528618176|FG000|Overall Study|Lost to Follow-up|1|||
146576194|NCT03941873|528618177|FG001|Overall Study|Lost to Follow-up|2|||
146576195|NCT03941873|528618178|FG002|Overall Study|Lost to Follow-up|0|||
146576196|NCT03941873|528618179|FG003|Overall Study|Lost to Follow-up|0|||
146576197|NCT03941873|528618176|FG000|Overall Study|Sponsor Decision|0|||
146770628|NCT01135511|529328642|FG000|Overall Study|could not visit the clinic|0|||
146770629|NCT01135511|529328643|FG001|Overall Study|could not visit the clinic|1|||
146770630|NCT01135511|529328644|FG002|Overall Study|could not visit the clinic|2|||
146770631|NCT01135511|529328645|FG003|Overall Study|could not visit the clinic|0|||
146918240|NCT00540449|529861623|FG000|Overall Study|Other|1|||
146918241|NCT00540449|529861624|FG001|Overall Study|Other|4|||
146770632|NCT01135511|529328646|FG004|Overall Study|could not visit the clinic|0|||
146770633|NCT01135511|529328647|FG005|Overall Study|could not visit the clinic|0|||
146770634|NCT01135511|529328648|FG006|Overall Study|could not visit the clinic|0|||
146918242|NCT03643432|529861625|FG000|Overall Study|Lost to Follow-up|1|||
146918243|NCT03643432|529861626|FG001|Overall Study|Lost to Follow-up|0|||
146918244|NCT05306873|529862783|FG000|Stage 2|Study stopped|1|||
146918245|NCT05306873|529862784|FG001|Stage 2|Study stopped|1|||
146576198|NCT03941873|528618177|FG001|Overall Study|Sponsor Decision|6|||
146576199|NCT03941873|528618178|FG002|Overall Study|Sponsor Decision|0|||
146576200|NCT03941873|528618179|FG003|Overall Study|Sponsor Decision|15|||
146576201|NCT03276728|528618180|FG000|Overall Study|Lost to Follow-up|0|||
146576202|NCT03276728|528618181|FG001|Overall Study|Lost to Follow-up|0|||
146576203|NCT03276728|528618182|FG002|Overall Study|Lost to Follow-up|2|||
146576204|NCT03276728|528618183|FG003|Overall Study|Lost to Follow-up|2|||
146576205|NCT03276728|528618184|FG004|Overall Study|Lost to Follow-up|0|||
146576206|NCT03276728|528618185|FG005|Overall Study|Lost to Follow-up|0|||
146576207|NCT03276728|528618186|FG006|Overall Study|Lost to Follow-up|0|||
146576208|NCT03276728|528618187|FG007|Overall Study|Lost to Follow-up|0|||
146576209|NCT03276728|528618180|FG000|Overall Study|Withdrawal by Subject|0|||
146576210|NCT03276728|528618181|FG001|Overall Study|Withdrawal by Subject|0|||
146576211|NCT03276728|528618182|FG002|Overall Study|Withdrawal by Subject|0|||
146576212|NCT03276728|528618183|FG003|Overall Study|Withdrawal by Subject|3|||
146576213|NCT03276728|528618184|FG004|Overall Study|Withdrawal by Subject|0|||
146576214|NCT03276728|528618185|FG005|Overall Study|Withdrawal by Subject|0|||
146576215|NCT03276728|528618186|FG006|Overall Study|Withdrawal by Subject|0|||
146576216|NCT03276728|528618187|FG007|Overall Study|Withdrawal by Subject|0|||
146576217|NCT03276728|528618180|FG000|Overall Study|Decision by sponsor|0|||
146576218|NCT03276728|528618181|FG001|Overall Study|Decision by sponsor|0|||
146576219|NCT03276728|528618182|FG002|Overall Study|Decision by sponsor|0|||
146576220|NCT03276728|528618183|FG003|Overall Study|Decision by sponsor|0|||
146576221|NCT03276728|528618184|FG004|Overall Study|Decision by sponsor|1|||
146576222|NCT03276728|528618185|FG005|Overall Study|Decision by sponsor|0|||
146576223|NCT03276728|528618186|FG006|Overall Study|Decision by sponsor|2|||
146576224|NCT03276728|528618187|FG007|Overall Study|Decision by sponsor|1|||
146576225|NCT02982772|528618190|FG000|Intervention|Lost to Follow-up|19|||
146576226|NCT02982772|528618191|FG001|Intervention|Lost to Follow-up|13|||
146576227|NCT02982772|528618190|FG000|1M Follow-Up|Lost to Follow-up|21|||
146576228|NCT02982772|528618191|FG001|1M Follow-Up|Lost to Follow-up|18|||
146576229|NCT02982772|528618190|FG000|3M Follow-Up|Lost to Follow-up|17|||
146576230|NCT02982772|528618191|FG001|3M Follow-Up|Lost to Follow-up|11|||
146576231|NCT02982772|528618190|FG000|6M Follow-Up|Lost to Follow-up|11|||
146576232|NCT02982772|528618191|FG001|6M Follow-Up|Lost to Follow-up|9|||
146576233|NCT02982772|528618190|FG000|12M Follow-Up|Lost to Follow-up|11|||
146576234|NCT02982772|528618191|FG001|12M Follow-Up|Lost to Follow-up|5|||
146576235|NCT01234480|528618192|FG000|Overall Study|Pregnancy|88|||
146576236|NCT01234480|528618192|FG000|Overall Study|>36/Normal History|50|||
146576237|NCT01234480|528618192|FG000|Overall Study|Age|3|||
146576238|NCT01234480|528618192|FG000|Overall Study|HPV Vaccine History|28|||
146576239|NCT01234480|528618192|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
146576240|NCT01234480|528618192|FG000|Overall Study|Hysterectomy|2|||
146576241|NCT01234480|528618192|FG000|Overall Study|Hysterectomy post enrollment|1|||
146576242|NCT01234480|528618192|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
146576243|NCT01234480|528618192|FG000|Overall Study|Informed Consent Form Violation|30|||
146576244|NCT01234480|528618192|FG000|Overall Study|Incorrect Visit|3|||
146576245|NCT01234480|528618192|FG000|Overall Study|No Florida Lab License|20|||
146576246|NCT01234480|528618192|FG000|Overall Study|Out of Window|42|||
146576247|NCT01234480|528618192|FG000|Overall Study|Sample Processing/Storage|92|||
146576248|NCT01234480|528618192|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
146576249|NCT01234480|528618192|FG000|Overall Study|Site/Subject non-compliance|44|||
146576250|NCT01234480|528618192|FG000|Overall Study|Missing Sample|9|||
146576251|NCT02974140|528618193|FG000|Overall Study|Adverse Event|2|||
146576252|NCT02974140|528618193|FG000|Overall Study|Lost to Follow-up|1|||
146576253|NCT02974140|528618193|FG000|Overall Study|Study Terminated by Sponsor|36|||
146576254|NCT00617084|528618194|FG000|Overall Study|Withdrawal by Subject|5|||
146576255|NCT00617084|528618195|FG001|Overall Study|Withdrawal by Subject|7|||
146576256|NCT00617084|528618194|FG000|Overall Study|Missed 12 Months visit|16|||
146576257|NCT00617084|528618195|FG001|Overall Study|Missed 12 Months visit|19|||
146576258|NCT03370419|528618196|FG000|Overall Study|Lost to Follow-up|16|||
146576259|NCT01693250|528618207|FG000|Overall Study|Lost to Follow-up|2|||
146576260|NCT01693250|528618208|FG001|Overall Study|Lost to Follow-up|2|||
146576261|NCT02297815|528618213|FG000|Overall Study|Lost to Follow-up|236|||
146576262|NCT02297815|528618214|FG001|Overall Study|Lost to Follow-up|140|||
146576263|NCT03650413|528618215|FG000|Overall Study|Adverse Event|1|||
146576264|NCT03650413|528618215|FG000|Overall Study|Lack of Efficacy|17|||
146918246|NCT05306873|529862785|FG002|Stage 2|Study stopped|0|||
146576265|NCT03650413|528618215|FG000|Overall Study|Other|9|||
146576266|NCT03650413|528618215|FG000|Overall Study|Physician Decision|2|||
146576267|NCT03650413|528618215|FG000|Overall Study|Study Terminated By Sponsor|16|||
146576268|NCT03650413|528618215|FG000|Overall Study|Withdrawal by Subject|16|||
146576269|NCT00310375|528618216|FG000|Primary Reporting Phase|Adverse Event|28|||
146576270|NCT00310375|528618217|FG001|Primary Reporting Phase|Adverse Event|22|||
146576271|NCT00310375|528618218|FG002|Primary Reporting Phase|Adverse Event|0|||
146576272|NCT00310375|528618216|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
146576273|NCT00310375|528618217|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
146576274|NCT00310375|528618218|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
146576275|NCT00310375|528618216|FG000|Primary Reporting Phase|Pregnancy|2|||
146576276|NCT00310375|528618217|FG001|Primary Reporting Phase|Pregnancy|2|||
146576277|NCT00310375|528618218|FG002|Primary Reporting Phase|Pregnancy|0|||
146576278|NCT00310375|528618216|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
146576279|NCT00310375|528618217|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
146576280|NCT00310375|528618218|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
146576281|NCT00310375|528618216|FG000|Primary Reporting Phase|Protocol Violation|8|||
146576282|NCT00310375|528618217|FG001|Primary Reporting Phase|Protocol Violation|5|||
146576283|NCT00310375|528618218|FG002|Primary Reporting Phase|Protocol Violation|0|||
146576284|NCT00310375|528618216|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
146770635|NCT01135511|529328649|FG007|Overall Study|could not visit the clinic|0|||
146576285|NCT00310375|528618217|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
146576286|NCT00310375|528618218|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
146576287|NCT00310375|528618216|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
146576288|NCT00310375|528618217|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
146576289|NCT00310375|528618218|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
146576290|NCT00310375|528618216|FG000|Primary Reporting Phase|Physician Decision|5|||
146576291|NCT00310375|528618217|FG001|Primary Reporting Phase|Physician Decision|3|||
146576292|NCT00310375|528618218|FG002|Primary Reporting Phase|Physician Decision|0|||
146576293|NCT00310375|528618216|FG000|Primary Reporting Phase|Request of the sponsor|2|||
146576294|NCT00310375|528618217|FG001|Primary Reporting Phase|Request of the sponsor|2|||
146576295|NCT00310375|528618218|FG002|Primary Reporting Phase|Request of the sponsor|0|||
146576296|NCT00310375|528618216|FG000|Primary Reporting Phase|Failed to return|1|||
146576297|NCT00310375|528618217|FG001|Primary Reporting Phase|Failed to return|3|||
146576298|NCT00310375|528618218|FG002|Primary Reporting Phase|Failed to return|0|||
146576299|NCT00310375|528618216|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
146576300|NCT00310375|528618217|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
146576301|NCT00310375|528618218|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
146576302|NCT00310375|528618216|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
146576303|NCT00310375|528618217|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
146576304|NCT00310375|528618218|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
146576305|NCT00310375|528618216|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
146770636|NCT01135511|529328650|FG008|Overall Study|could not visit the clinic|0|||
146576306|NCT00310375|528618217|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
146576307|NCT00310375|528618218|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
146576308|NCT00310375|528618216|FG000|Primary Reporting Phase|Site closure|3|||
146576309|NCT00310375|528618217|FG001|Primary Reporting Phase|Site closure|0|||
146576310|NCT00310375|528618218|FG002|Primary Reporting Phase|Site closure|0|||
146576311|NCT00310375|528618216|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
146576312|NCT00310375|528618217|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
146576313|NCT00310375|528618218|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
146576314|NCT00310375|528618216|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
146576315|NCT00310375|528618217|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
146576316|NCT00310375|528618218|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
146576317|NCT00310375|528618216|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
146576318|NCT00310375|528618217|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
146576319|NCT00310375|528618218|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
146576320|NCT00310375|528618216|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
146576321|NCT00310375|528618217|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
146576322|NCT00310375|528618218|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
146576323|NCT03726658|528618220|FG000|Overall Study|Lost to Follow-up|0|||
146576324|NCT03726658|528618221|FG001|Overall Study|Lost to Follow-up|0|||
146770637|NCT01135511|529328642|FG000|Overall Study|noncompliance with study drug taken|0|||
146770638|NCT01135511|529328643|FG001|Overall Study|noncompliance with study drug taken|0|||
146770639|NCT01135511|529328644|FG002|Overall Study|noncompliance with study drug taken|0|||
146770640|NCT01135511|529328645|FG003|Overall Study|noncompliance with study drug taken|0|||
146576325|NCT03726658|528618222|FG002|Overall Study|Lost to Follow-up|2|||
146576326|NCT03726658|528618223|FG003|Overall Study|Lost to Follow-up|0|||
146918247|NCT05306873|529862786|FG003|Stage 2|Study stopped|0|||
146918248|NCT05306873|529862783|FG000|Stage 2|Stage 2 Treatment Failure|2|||
146918249|NCT05306873|529862784|FG001|Stage 2|Stage 2 Treatment Failure|3|||
146918250|NCT05306873|529862785|FG002|Stage 2|Stage 2 Treatment Failure|0|||
146918251|NCT05306873|529862786|FG003|Stage 2|Stage 2 Treatment Failure|0|||
146918252|NCT05306873|529862783|FG000|Stage 2|Logistical issues due to participant moving|1|||
146918253|NCT05306873|529862784|FG001|Stage 2|Logistical issues due to participant moving|0|||
146918254|NCT05306873|529862785|FG002|Stage 2|Logistical issues due to participant moving|0|||
146918255|NCT05306873|529862786|FG003|Stage 2|Logistical issues due to participant moving|0|||
146576327|NCT03726658|528618224|FG004|Overall Study|Lost to Follow-up|0|||
146576328|NCT03726658|528618225|FG005|Overall Study|Lost to Follow-up|1|||
146576329|NCT03726658|528618226|FG006|Overall Study|Lost to Follow-up|1|||
146576330|NCT03726658|528618220|FG000|Overall Study|Withdrawal by Subject|1|||
146576331|NCT03726658|528618221|FG001|Overall Study|Withdrawal by Subject|0|||
146576332|NCT03726658|528618222|FG002|Overall Study|Withdrawal by Subject|0|||
146576333|NCT03726658|528618223|FG003|Overall Study|Withdrawal by Subject|0|||
146576334|NCT03726658|528618224|FG004|Overall Study|Withdrawal by Subject|6|||
146576335|NCT03726658|528618225|FG005|Overall Study|Withdrawal by Subject|4|||
146576336|NCT03726658|528618226|FG006|Overall Study|Withdrawal by Subject|2|||
146576337|NCT03726658|528618220|FG000|Overall Study|Pregnancy|0|||
146576338|NCT03726658|528618221|FG001|Overall Study|Pregnancy|0|||
146576339|NCT03726658|528618222|FG002|Overall Study|Pregnancy|0|||
146576340|NCT03726658|528618223|FG003|Overall Study|Pregnancy|0|||
146576341|NCT03726658|528618224|FG004|Overall Study|Pregnancy|0|||
146576342|NCT03726658|528618225|FG005|Overall Study|Pregnancy|0|||
146576343|NCT03726658|528618226|FG006|Overall Study|Pregnancy|1|||
146576344|NCT03726658|528618220|FG000|Overall Study|Not Reported|0|||
146576345|NCT03726658|528618221|FG001|Overall Study|Not Reported|0|||
146576346|NCT03726658|528618222|FG002|Overall Study|Not Reported|0|||
146576347|NCT03726658|528618223|FG003|Overall Study|Not Reported|0|||
146576348|NCT03726658|528618224|FG004|Overall Study|Not Reported|0|||
146576349|NCT03726658|528618225|FG005|Overall Study|Not Reported|0|||
146576350|NCT03726658|528618226|FG006|Overall Study|Not Reported|1|||
146576351|NCT00412958|528618227|FG000|Overall Study|Withdrawal by Subject|3|||
146576352|NCT00412958|528618228|FG001|Overall Study|Withdrawal by Subject|0|||
146576353|NCT00412958|528618229|FG002|Overall Study|Withdrawal by Subject|0|||
146576354|NCT00412958|528618230|FG003|Overall Study|Withdrawal by Subject|1|||
146576355|NCT00412958|528618227|FG000|Overall Study|Adverse Event|0|||
146576356|NCT00412958|528618228|FG001|Overall Study|Adverse Event|1|||
146576357|NCT00412958|528618229|FG002|Overall Study|Adverse Event|0|||
146576358|NCT00412958|528618230|FG003|Overall Study|Adverse Event|0|||
146576359|NCT00412958|528618227|FG000|Overall Study|Lost to Follow-up|0|||
146576360|NCT00412958|528618228|FG001|Overall Study|Lost to Follow-up|1|||
146576361|NCT00412958|528618229|FG002|Overall Study|Lost to Follow-up|0|||
146576362|NCT00412958|528618230|FG003|Overall Study|Lost to Follow-up|0|||
146576363|NCT00412958|528618227|FG000|Overall Study|Death|0|||
146918256|NCT05306873|529862783|FG000|Stage 3|Stage 3 Treatment Failure|0|||
146918257|NCT05306873|529862784|FG001|Stage 3|Stage 3 Treatment Failure|0|||
146918258|NCT05306873|529862785|FG002|Stage 3|Stage 3 Treatment Failure|0|||
146576364|NCT00412958|528618228|FG001|Overall Study|Death|1|||
146576365|NCT00412958|528618229|FG002|Overall Study|Death|0|||
146576366|NCT00412958|528618230|FG003|Overall Study|Death|0|||
146576367|NCT00412958|528618227|FG000|Overall Study|Transport issue|0|||
146576368|NCT00412958|528618228|FG001|Overall Study|Transport issue|1|||
146576369|NCT00412958|528618229|FG002|Overall Study|Transport issue|0|||
146576370|NCT00412958|528618230|FG003|Overall Study|Transport issue|0|||
146576371|NCT01318135|528618231|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
146576372|NCT01318135|528618232|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146576373|NCT01318135|528618233|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146576374|NCT01318135|528618234|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146576375|NCT01318135|528618235|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146576376|NCT01318135|528618236|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146576377|NCT01318135|528618237|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146576378|NCT01318135|528618238|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146576379|NCT01318135|528618231|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
146576380|NCT01318135|528618232|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
146576381|NCT01318135|528618233|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
146576382|NCT01318135|528618234|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
146576383|NCT01318135|528618235|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
146770641|NCT01135511|529328646|FG004|Overall Study|noncompliance with study drug taken|1|||
146770642|NCT01135511|529328647|FG005|Overall Study|noncompliance with study drug taken|0|||
146770643|NCT01135511|529328648|FG006|Overall Study|noncompliance with study drug taken|0|||
146918259|NCT05306873|529862786|FG003|Stage 3|Stage 3 Treatment Failure|1|||
146918260|NCT05306873|529862783|FG000|Stage 3|Study Stopped|0|||
146576384|NCT01318135|528618236|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
146576385|NCT01318135|528618237|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
146576386|NCT01318135|528618238|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
146576387|NCT01318135|528618231|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
146576388|NCT01318135|528618232|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
146576389|NCT01318135|528618233|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
146576390|NCT01318135|528618234|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
146576391|NCT01318135|528618235|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
146576392|NCT01318135|528618236|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
146770644|NCT01135511|529328649|FG007|Overall Study|noncompliance with study drug taken|0|||
146576393|NCT01318135|528618237|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
146576394|NCT01318135|528618238|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
146576395|NCT01318135|528618231|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
146576396|NCT01318135|528618232|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
146576397|NCT01318135|528618233|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
146576398|NCT01318135|528618234|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
146978049|NCT00597584|530082211|FG000|Overall Study|Physician Decision|3|||
146978050|NCT00597584|530082212|FG001|Overall Study|Physician Decision|0|||
146978051|NCT00597584|530082211|FG000|Overall Study|Pregnancy|2|||
146978052|NCT00597584|530082212|FG001|Overall Study|Pregnancy|0|||
146576399|NCT01318135|528618235|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
146576400|NCT01318135|528618236|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
146978053|NCT00597584|530082211|FG000|Overall Study|Withdrawal by Subject|44|||
146978054|NCT00597584|530082212|FG001|Overall Study|Withdrawal by Subject|12|||
146978055|NCT00597584|530082211|FG000|Overall Study|Discontinued Dialysis|0|||
146978056|NCT00597584|530082212|FG001|Overall Study|Discontinued Dialysis|1|||
146978057|NCT00597584|530082211|FG000|Overall Study|Lost ability to consent|1|||
146978058|NCT00597584|530082212|FG001|Overall Study|Lost ability to consent|1|||
146978059|NCT00597584|530082211|FG000|Overall Study|Never dosed|1|||
146978060|NCT00597584|530082212|FG001|Overall Study|Never dosed|0|||
146978061|NCT00597584|530082211|FG000|Overall Study|Relocation|8|||
146978062|NCT00597584|530082212|FG001|Overall Study|Relocation|6|||
146978063|NCT00597584|530082211|FG000|Overall Study|Renal transplant|9|||
146978064|NCT00597584|530082212|FG001|Overall Study|Renal transplant|7|||
146978065|NCT00881959|530082219|FG000|Overall Study|Lost to Follow-up|2|||
146978066|NCT00881959|530082220|FG001|Overall Study|Lost to Follow-up|4|||
146978067|NCT02791659|530082221|FG000|Overall Study|Protocol Violation|0|||
146978068|NCT02791659|530082222|FG001|Overall Study|Protocol Violation|1|||
146978069|NCT01456052|530082223|FG000|Overall Study|Adverse Event|1|||
146978070|NCT01456052|530082224|FG001|Overall Study|Adverse Event|1|||
146978071|NCT01456052|530082225|FG002|Overall Study|Adverse Event|2|||
146978072|NCT01456052|530082223|FG000|Overall Study|Consent withdrawn|0|||
146576401|NCT01318135|528618237|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
146576402|NCT01318135|528618238|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
146576403|NCT01318135|528618231|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
146576404|NCT01318135|528618232|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
146576405|NCT01318135|528618233|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
146576406|NCT01318135|528618234|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
146576407|NCT01318135|528618235|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
146576408|NCT01318135|528618236|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
146576409|NCT01318135|528618237|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
146576410|NCT01318135|528618238|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
146576411|NCT01318135|528618231|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
146576412|NCT01318135|528618232|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
146576413|NCT01318135|528618233|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
146576414|NCT01318135|528618234|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
146576415|NCT01318135|528618235|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
146576416|NCT01318135|528618236|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
146576417|NCT01318135|528618237|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
146576418|NCT01318135|528618238|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
146576419|NCT01318135|528618231|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
146576420|NCT01318135|528618232|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
146576421|NCT01318135|528618233|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
146576422|NCT01318135|528618234|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
146576423|NCT01318135|528618235|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
146576424|NCT01318135|528618236|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
146576425|NCT01318135|528618237|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
146576426|NCT01318135|528618238|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
146576427|NCT01071954|528618240|FG000|Overall Study|Noncompliance|4|||
146576428|NCT01071954|528618240|FG000|Overall Study|Adverse Event|1|||
146576429|NCT01071954|528618240|FG000|Overall Study|Withdrawal by Subject|11|||
146576430|NCT01071954|528618240|FG000|Overall Study|Requirement for Alternative Therapy|5|||
146576431|NCT01071954|528618240|FG000|Overall Study|Administrative Decision|5|||
146576432|NCT01071954|528618240|FG000|Overall Study|Protocol Specified Criteria|1|||
146576433|NCT03782064|528618244|FG000|Overall Study|Lack of Efficacy|2|||
146576434|NCT03782064|528618244|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
146978073|NCT01456052|530082224|FG001|Overall Study|Consent withdrawn|2|||
146978074|NCT01456052|530082225|FG002|Overall Study|Consent withdrawn|1|||
146978075|NCT01456052|530082223|FG000|Overall Study|Protocol Violation|0|||
146978076|NCT01456052|530082224|FG001|Overall Study|Protocol Violation|1|||
146978077|NCT01456052|530082225|FG002|Overall Study|Protocol Violation|0|||
146978078|NCT01456052|530082223|FG000|Overall Study|Physician Decision|1|||
146918261|NCT05306873|529862784|FG001|Stage 3|Study Stopped|0|||
146918262|NCT05306873|529862785|FG002|Stage 3|Study Stopped|1|||
146918263|NCT05306873|529862786|FG003|Stage 3|Study Stopped|0|||
146918264|NCT04920084|529862794|FG000|Overall Study|Adverse Event|1|||
146918265|NCT04920084|529862794|FG000|Overall Study|Lost to Follow-up|2|||
146918266|NCT04920084|529862794|FG000|Overall Study|Withdrawal by Subject|2|||
146918267|NCT00074412|529862795|FG000|Overall Study|Death|30|||
146918268|NCT00074412|529862796|FG001|Overall Study|Death|26|||
146918269|NCT00074412|529862795|FG000|Overall Study|Lost to Follow-up|52|||
146918270|NCT00074412|529862796|FG001|Overall Study|Lost to Follow-up|58|||
146918271|NCT02361762|529862797|FG000|Overall Study|Withdrawal by Subject|0|||
146918272|NCT02361762|529862798|FG001|Overall Study|Withdrawal by Subject|1|||
146576435|NCT00363142|528618245|FG000|Overall Study|Adverse Event|2|||
146576436|NCT00363142|528618246|FG001|Overall Study|Adverse Event|0|||
146576437|NCT00363142|528618245|FG000|Overall Study|Lack of Efficacy|0|||
146576438|NCT00363142|528618246|FG001|Overall Study|Lack of Efficacy|1|||
146978079|NCT01456052|530082224|FG001|Overall Study|Physician Decision|0|||
146978080|NCT01456052|530082225|FG002|Overall Study|Physician Decision|1|||
146978081|NCT01456052|530082223|FG000|Overall Study|Treatment Failure|0|||
146978082|NCT01456052|530082224|FG001|Overall Study|Treatment Failure|1|||
146978083|NCT01456052|530082225|FG002|Overall Study|Treatment Failure|1|||
146918273|NCT02361762|529862797|FG000|Overall Study|Lost to Follow-up|0|||
146978084|NCT00623623|530082226|FG000|Overall Study|Previous enrolment into this study|1|||
146978085|NCT00623623|530082227|FG001|Overall Study|Previous enrolment into this study|1|||
146978086|NCT02265952|530082229|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
146978087|NCT02265952|530082230|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
146978088|NCT02265952|530082229|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
146978089|NCT02265952|530082230|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
146978090|NCT01042977|530082231|FG000|Overall Study|Adverse Event|4|||
146978091|NCT01042977|530082232|FG001|Overall Study|Adverse Event|12|||
146978092|NCT01042977|530082231|FG000|Overall Study|Death|2|||
146978093|NCT01042977|530082232|FG001|Overall Study|Death|1|||
146978094|NCT01042977|530082231|FG000|Overall Study|Withdrawal by Subject|8|||
146978095|NCT01042977|530082232|FG001|Overall Study|Withdrawal by Subject|16|||
146978096|NCT01042977|530082231|FG000|Overall Study|Lost to Follow-up|0|||
146978097|NCT01042977|530082232|FG001|Overall Study|Lost to Follow-up|2|||
146978098|NCT01042977|530082231|FG000|Overall Study|Poor/non-compliance|3|||
146978099|NCT01042977|530082232|FG001|Overall Study|Poor/non-compliance|4|||
146978100|NCT01042977|530082231|FG000|Overall Study|Subject no longer meets study criteria|15|||
146978101|NCT01042977|530082232|FG001|Overall Study|Subject no longer meets study criteria|13|||
146978102|NCT01042977|530082231|FG000|Overall Study|Incorrect enrollment|6|||
146978103|NCT01042977|530082232|FG001|Overall Study|Incorrect enrollment|4|||
146978104|NCT01042977|530082231|FG000|Overall Study|Safety|0|||
146978105|NCT01042977|530082232|FG001|Overall Study|Safety|2|||
146576439|NCT00363142|528618245|FG000|Overall Study|Lost to Follow-up|1|||
146576440|NCT00363142|528618246|FG001|Overall Study|Lost to Follow-up|0|||
146576441|NCT00363142|528618245|FG000|Overall Study|Non-compliance|1|||
146576442|NCT00363142|528618246|FG001|Overall Study|Non-compliance|1|||
146576443|NCT00363142|528618245|FG000|Overall Study|Withdrawal by Subject|3|||
146576444|NCT00363142|528618246|FG001|Overall Study|Withdrawal by Subject|1|||
146576445|NCT00049322|528618250|FG000|Overall Study|disease burden|0|||
146576446|NCT00049322|528618251|FG001|Overall Study|disease burden|3|||
146576447|NCT00049322|528618250|FG000|Overall Study|Adverse Event|1|||
146576448|NCT00049322|528618251|FG001|Overall Study|Adverse Event|0|||
146576449|NCT00049322|528618250|FG000|Overall Study|refused angio|0|||
146576450|NCT00049322|528618251|FG001|Overall Study|refused angio|3|||
146918274|NCT02361762|529862798|FG001|Overall Study|Lost to Follow-up|1|||
146978106|NCT01042977|530082231|FG000|Overall Study|Administrative reason by sponsor|0|||
146978107|NCT01042977|530082232|FG001|Overall Study|Administrative reason by sponsor|1|||
146978108|NCT01042977|530082231|FG000|Overall Study|Various|3|||
146978109|NCT01042977|530082232|FG001|Overall Study|Various|0|||
146978110|NCT02499354|530082233|FG000|Overall Study|Withdrawal by Subject|1|||
146978111|NCT02499354|530082234|FG001|Overall Study|Withdrawal by Subject|0|||
146978112|NCT04356573|530082236|FG000|Overall Study|Didn't Qualify|1|||
146978113|NCT04356573|530082237|FG001|Overall Study|Didn't Qualify|0|||
146978114|NCT02424565|530082238|FG000|Period 1 (D0)|Protocol Violation|0|||
146978115|NCT02424565|530082239|FG001|Period 1 (D0)|Protocol Violation|1|||
146978116|NCT01677910|530082240|FG000|Double-Blind Treatment Period|Adverse Event|6|||
146978117|NCT01677910|530082241|FG001|Double-Blind Treatment Period|Adverse Event|2|||
146978118|NCT01677910|530082242|FG002|Double-Blind Treatment Period|Adverse Event|3|||
146576451|NCT03994211|528618252|FG000|Core Phase|Adverse Event|0|||
146918275|NCT00028002|529862801|FG000|Overall Study|Withdrawal by Subject|3|||
146576452|NCT03994211|528618253|FG001|Core Phase|Adverse Event|1|||
146918276|NCT00028002|529862801|FG000|Overall Study|Ineligible|8|||
146978119|NCT01677910|530082243|FG003|Double-Blind Treatment Period|Adverse Event|0|||
146978120|NCT01677910|530082240|FG000|Double-Blind Treatment Period|Physician Decision|0|||
146978121|NCT01677910|530082241|FG001|Double-Blind Treatment Period|Physician Decision|0|||
146576453|NCT03994211|528618254|FG002|Core Phase|Adverse Event|0|||
146978122|NCT01677910|530082242|FG002|Double-Blind Treatment Period|Physician Decision|1|||
146978123|NCT01677910|530082243|FG003|Double-Blind Treatment Period|Physician Decision|0|||
146978124|NCT01677910|530082240|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
146978125|NCT01677910|530082241|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
146978126|NCT01677910|530082242|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
146978127|NCT01677910|530082243|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
146978128|NCT01677910|530082240|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
146978129|NCT01677910|530082241|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
146978130|NCT01677910|530082242|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
146978131|NCT01677910|530082243|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
146978132|NCT01677910|530082240|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
146978133|NCT01677910|530082241|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
146978134|NCT01677910|530082242|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
146978135|NCT01677910|530082243|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
146978136|NCT01677910|530082240|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
146978137|NCT01677910|530082241|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
146978138|NCT01677910|530082242|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
146978139|NCT01677910|530082243|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
146978140|NCT01677910|530082240|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
146978141|NCT01677910|530082241|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
146978142|NCT01677910|530082242|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
146978143|NCT01677910|530082243|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
146978144|NCT01677910|530082240|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
146978145|NCT01677910|530082241|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
146978146|NCT01677910|530082242|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
146978147|NCT01677910|530082243|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
146978148|NCT01677910|530082240|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
146978149|NCT01677910|530082241|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
146978150|NCT01677910|530082242|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
146978151|NCT01677910|530082243|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
146978152|NCT01677910|530082240|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
146978153|NCT01677910|530082241|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
146978154|NCT01677910|530082242|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
146978155|NCT01677910|530082243|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
146978156|NCT03650400|530082244|FG000|Overall Study|Study terminated by sponsor|0|||
146978157|NCT03650400|530082245|FG001|Overall Study|Study terminated by sponsor|5|||
146978158|NCT00751998|530082252|FG000|Overall Study|Lost to Follow-up|7|||
146576454|NCT03994211|528618252|FG000|Extension Phase|Adverse Event|0|||
146576455|NCT03994211|528618253|FG001|Extension Phase|Adverse Event|0|||
146576456|NCT03994211|528618254|FG002|Extension Phase|Adverse Event|1|||
146576457|NCT03994211|528618252|FG000|Extension Phase|Physician Decision|0|||
146576458|NCT03994211|528618253|FG001|Extension Phase|Physician Decision|0|||
146576459|NCT03994211|528618254|FG002|Extension Phase|Physician Decision|1|||
146576460|NCT03994211|528618252|FG000|Extension Phase|Progressive Disease|0|||
146576461|NCT03994211|528618253|FG001|Extension Phase|Progressive Disease|0|||
146576462|NCT03994211|528618254|FG002|Extension Phase|Progressive Disease|20|||
146576463|NCT03994211|528618252|FG000|Extension Phase|Withdrawal by Subject|0|||
146576464|NCT03994211|528618253|FG001|Extension Phase|Withdrawal by Subject|0|||
146576465|NCT03994211|528618254|FG002|Extension Phase|Withdrawal by Subject|2|||
146576466|NCT02625220|528618255|FG000|Overall Study|Adverse Event|2|||
146576467|NCT02625220|528618255|FG000|Overall Study|Lost to Follow-up|2|||
146576468|NCT02625220|528618255|FG000|Overall Study|Protocol Violation|1|||
146576469|NCT02625220|528618255|FG000|Overall Study|Study discontinued at site|2|||
146978159|NCT00751998|530082252|FG000|Overall Study|Death|11|||
146978160|NCT00751998|530082252|FG000|Overall Study|Withdrawal by Subject|2|||
146978161|NCT04126733|530082253|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
146978162|NCT04126733|530082253|FG000|Treatment Period|Adverse Event|8|||
146978163|NCT04126733|530082253|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
146978164|NCT04126733|530082253|FG000|Treatment Period|Physician Decision|5|||
146978165|NCT04126733|530082253|FG000|Treatment Period|Death|1|||
146978166|NCT04126733|530082253|FG000|Treatment Period|Other Reasons|2|||
146978167|NCT04126733|530082253|FG000|Active Follow-up Period|Death|13|||
146978168|NCT04126733|530082253|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
146978169|NCT04126733|530082253|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
146978170|NCT04126733|530082253|FG000|Active Follow-up Period|Other Reasons|1|||
146978171|NCT04126733|530082253|FG000|Long-term Follow-up Period|Death|22|||
146978172|NCT04126733|530082253|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
146978173|NCT04126733|530082253|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
146978174|NCT02410837|530082254|FG000|Overall Study|Death|387|||
146978175|NCT02410837|530082254|FG000|Overall Study|Lost to Follow-up|50|||
146576470|NCT01140867|528618256|FG000|Overall Study|Adverse Event|22|||
146978176|NCT02410837|530082254|FG000|Overall Study|Withdrawal by Subject|44|||
146978177|NCT02410837|530082254|FG000|Overall Study|Physician Decision|6|||
146978178|NCT02410837|530082254|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
146978179|NCT00078819|530082259|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
146978180|NCT00078819|530082260|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
146978181|NCT00078819|530082261|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
146978182|NCT00078819|530082262|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
146978183|NCT00078819|530082259|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
146978184|NCT00078819|530082260|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
146978185|NCT00078819|530082261|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
146978186|NCT00078819|530082262|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
146978187|NCT00078819|530082259|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
146978188|NCT00078819|530082260|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
146978189|NCT00078819|530082261|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
146978190|NCT00078819|530082262|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
146978191|NCT00078819|530082259|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
146978192|NCT00078819|530082260|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
146978193|NCT00078819|530082261|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
146978194|NCT00078819|530082262|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
146651886|NCT02233946|528903695|FG000|3-months Follow-up|Lost to Follow-up|53|||
146651887|NCT02233946|528903696|FG001|3-months Follow-up|Lost to Follow-up|29|||
146651888|NCT02233946|528903695|FG000|6-months Follow-up|Lost to Follow-up|21|||
146651889|NCT02233946|528903696|FG001|6-months Follow-up|Lost to Follow-up|2|||
146651890|NCT02233946|528903695|FG000|9-month Follow-up|Lost to Follow-up|20|||
146651891|NCT02233946|528903696|FG001|9-month Follow-up|Lost to Follow-up|11|||
146651892|NCT02233946|528903695|FG000|12-month Follow-up|Lost to Follow-up|28|||
146651893|NCT02233946|528903696|FG001|12-month Follow-up|Lost to Follow-up|11|||
146651894|NCT01879579|528903697|FG000|Overall Study|Phone incompatible with texting platform|3|||
146651895|NCT01879579|528903698|FG001|Overall Study|Phone incompatible with texting platform|0|||
146651896|NCT01879579|528903697|FG000|Overall Study|Did not enroll in texting platform|1|||
146651897|NCT01879579|528903698|FG001|Overall Study|Did not enroll in texting platform|0|||
146651898|NCT01879579|528903697|FG000|Overall Study|Did not initiate insulin treatment|1|||
146651899|NCT01879579|528903698|FG001|Overall Study|Did not initiate insulin treatment|0|||
146651900|NCT01879579|528903697|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
146651901|NCT01879579|528903698|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
146651902|NCT01879579|528903697|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
146651903|NCT01879579|528903698|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
146651904|NCT02927067|528903699|FG000|Overall Study|Withdrawn Consent|20|||
146651905|NCT02927067|528903700|FG001|Overall Study|Withdrawn Consent|12|||
146651906|NCT02927067|528903699|FG000|Overall Study|Death|18|||
146651907|NCT02927067|528903700|FG001|Overall Study|Death|31|||
146651908|NCT02927067|528903699|FG000|Overall Study|Adverse Event|13|||
146651909|NCT02927067|528903700|FG001|Overall Study|Adverse Event|10|||
146651910|NCT02927067|528903699|FG000|Overall Study|Noncompliance|5|||
146651911|NCT02927067|528903700|FG001|Overall Study|Noncompliance|2|||
146651912|NCT02927067|528903699|FG000|Overall Study|Reason not Specified|4|||
146651913|NCT02927067|528903700|FG001|Overall Study|Reason not Specified|6|||
146651914|NCT02292784|528903703|FG000|Overall Study|Lost to Follow-up|1|||
146651915|NCT02292784|528903704|FG001|Overall Study|Lost to Follow-up|17|||
146651916|NCT02292784|528903705|FG002|Overall Study|Lost to Follow-up|18|||
146651917|NCT02292784|528903703|FG000|Overall Study|Withdrawal by Subject|0|||
146651918|NCT02292784|528903704|FG001|Overall Study|Withdrawal by Subject|3|||
146651919|NCT02292784|528903705|FG002|Overall Study|Withdrawal by Subject|3|||
146651920|NCT00134784|528903706|FG000|Overall Study|Withdrawal by Subject|2|||
146651921|NCT00134784|528903707|FG001|Overall Study|Withdrawal by Subject|2|||
146651922|NCT00134784|528903708|FG002|Overall Study|Withdrawal by Subject|2|||
146651923|NCT00134784|528903709|FG003|Overall Study|Withdrawal by Subject|1|||
146651924|NCT02919969|528903710|FG000|Overall Study|Lack of Efficacy|22|||
146651925|NCT02919969|528903710|FG000|Overall Study|Death|4|||
146651926|NCT02919969|528903710|FG000|Overall Study|Physician Decision|3|||
146651927|NCT02919969|528903710|FG000|Overall Study|Withdrawal by Subject|2|||
146651928|NCT03621475|528903711|FG000|Overall Study|No longer required restraints at initiation|0|||
146651929|NCT03621475|528903712|FG001|Overall Study|No longer required restraints at initiation|1|||
147013242|NCT01708954|530210054|FG000|Step 1|Symptomatic deterioration|1|||
146651930|NCT01842633|528903713|FG000|Overall Study|Screen Failure|1|||
146651931|NCT01842633|528903714|FG001|Overall Study|Screen Failure|0|||
146651932|NCT01842633|528903715|FG002|Overall Study|Screen Failure|0|||
146651933|NCT01842633|528903713|FG000|Overall Study|Adverse Event|1|||
146651934|NCT01842633|528903714|FG001|Overall Study|Adverse Event|1|||
146651935|NCT01842633|528903715|FG002|Overall Study|Adverse Event|0|||
146651936|NCT01842633|528903713|FG000|Overall Study|Withdrawal by Subject|0|||
146651937|NCT01842633|528903714|FG001|Overall Study|Withdrawal by Subject|1|||
146651938|NCT01842633|528903715|FG002|Overall Study|Withdrawal by Subject|0|||
146576471|NCT01140867|528618256|FG000|Overall Study|Lack of Efficacy|3|||
146576472|NCT01140867|528618256|FG000|Overall Study|Lost to Follow-up|2|||
146576473|NCT01140867|528618256|FG000|Overall Study|Withdrawal by Subject|1|||
146576474|NCT01140867|528618256|FG000|Overall Study|Protocol Violation|1|||
146576475|NCT01140867|528618256|FG000|Overall Study|Uncooperative patient|2|||
146576476|NCT01140867|528618256|FG000|Overall Study|Medication Noncompliance|2|||
146576477|NCT01926444|528618257|FG000|Overall Study|Colonoscopy not performed|0|||
146576478|NCT01926444|528618258|FG001|Overall Study|Colonoscopy not performed|0|||
146576479|NCT01926444|528618259|FG002|Overall Study|Colonoscopy not performed|4|||
146576480|NCT01926444|528618260|FG003|Overall Study|Colonoscopy not performed|2|||
146576481|NCT01232127|528618262|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
146576482|NCT01232127|528618263|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
146576483|NCT01232127|528618264|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
146576484|NCT03035864|528618267|FG000|Treatment Period|Adverse Event|1|||
146576485|NCT03035864|528618268|FG001|Treatment Period|Adverse Event|0|||
146576486|NCT03035864|528618267|FG000|Treatment Period|Other|3|||
146576487|NCT03035864|528618268|FG001|Treatment Period|Other|1|||
146576488|NCT03035864|528618267|FG000|Follow-up Period|Adverse Event|1|||
146576489|NCT03035864|528618268|FG001|Follow-up Period|Adverse Event|0|||
146576490|NCT03035864|528618267|FG000|Follow-up Period|Lost to Follow-up|6|||
146576491|NCT03035864|528618268|FG001|Follow-up Period|Lost to Follow-up|2|||
146576492|NCT03035864|528618267|FG000|Follow-up Period|Physician Decision|1|||
146576493|NCT03035864|528618268|FG001|Follow-up Period|Physician Decision|0|||
146576494|NCT03035864|528618267|FG000|Follow-up Period|Other|3|||
146576495|NCT03035864|528618268|FG001|Follow-up Period|Other|2|||
146576496|NCT02720523|528618269|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
146576497|NCT02720523|528618270|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
146576498|NCT02720523|528618271|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
146576499|NCT02720523|528618272|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
146576500|NCT02720523|528618273|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
146576501|NCT02720523|528618274|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
146576502|NCT02720523|528618275|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
146576503|NCT02720523|528618269|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
146576504|NCT02720523|528618270|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
146576505|NCT02720523|528618271|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
146576506|NCT02720523|528618272|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
146576507|NCT02720523|528618273|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
146576508|NCT02720523|528618274|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
146576509|NCT02720523|528618275|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
146576510|NCT02720523|528618269|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
146576511|NCT02720523|528618270|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
146576512|NCT02720523|528618271|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
146576513|NCT02720523|528618272|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
146576514|NCT02720523|528618273|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
146576515|NCT02720523|528618274|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
146576516|NCT02720523|528618275|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
146576517|NCT02720523|528618269|FG000|Period 1: Placebo-controlled Period|Other|0|||
146576518|NCT02720523|528618270|FG001|Period 1: Placebo-controlled Period|Other|0|||
146576519|NCT02720523|528618271|FG002|Period 1: Placebo-controlled Period|Other|1|||
146576520|NCT02720523|528618272|FG003|Period 1: Placebo-controlled Period|Other|1|||
146576521|NCT02720523|528618273|FG004|Period 1: Placebo-controlled Period|Other|0|||
146576522|NCT02720523|528618274|FG005|Period 1: Placebo-controlled Period|Other|0|||
146576523|NCT02720523|528618275|FG006|Period 1: Placebo-controlled Period|Other|0|||
146576524|NCT02720523|528618269|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
146576525|NCT02720523|528618270|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
146576526|NCT02720523|528618271|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
146576527|NCT02720523|528618272|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
146576528|NCT02720523|528618273|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
146576529|NCT02720523|528618274|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
146918277|NCT02163993|529862805|FG000|Treatment Period|Adverse Event|0|||
146576530|NCT02720523|528618275|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
146576531|NCT02720523|528618269|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
146576532|NCT02720523|528618270|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
146576533|NCT02720523|528618271|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
146576534|NCT02720523|528618272|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
146576535|NCT02720523|528618273|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
146576536|NCT02720523|528618274|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
146576537|NCT02720523|528618275|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
146576538|NCT02720523|528618269|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
146918278|NCT02163993|529862806|FG001|Treatment Period|Adverse Event|1|||
146918279|NCT02163993|529862807|FG002|Treatment Period|Adverse Event|0|||
146918280|NCT02163993|529862808|FG003|Treatment Period|Adverse Event|0|||
146576539|NCT02720523|528618270|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
146576540|NCT02720523|528618271|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
146576541|NCT02720523|528618272|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
146576542|NCT02720523|528618273|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
146576543|NCT02720523|528618274|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
146576544|NCT02720523|528618275|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
146576545|NCT02720523|528618269|FG000|Period 2: Long-term Extension Period|Other|0|||
146576546|NCT02720523|528618270|FG001|Period 2: Long-term Extension Period|Other|0|||
146576547|NCT02720523|528618271|FG002|Period 2: Long-term Extension Period|Other|0|||
146576548|NCT02720523|528618272|FG003|Period 2: Long-term Extension Period|Other|0|||
146576549|NCT02720523|528618273|FG004|Period 2: Long-term Extension Period|Other|2|||
146576550|NCT02720523|528618274|FG005|Period 2: Long-term Extension Period|Other|0|||
146576551|NCT02720523|528618275|FG006|Period 2: Long-term Extension Period|Other|3|||
146576552|NCT00577707|528618280|FG000|Overall Study|Withdrawal by Subject|3|||
146576553|NCT03299244|528618281|FG000|Overall Study|Withdrawal by Subject|34|||
146576554|NCT03299244|528618282|FG001|Overall Study|Withdrawal by Subject|29|||
146576555|NCT03299244|528618281|FG000|Overall Study|Decision by Sponsor|4|||
146576556|NCT03299244|528618282|FG001|Overall Study|Decision by Sponsor|5|||
146576557|NCT03299244|528618281|FG000|Overall Study|Death|9|||
146576558|NCT03299244|528618282|FG001|Overall Study|Death|4|||
146576559|NCT03146663|528618283|FG000|Overall Study|Did not receive study treatment|1|||
146576560|NCT03146663|528618284|FG001|Overall Study|Did not receive study treatment|1|||
146576561|NCT00980460|528618285|FG000|Overall Study|Death|0|||
146576562|NCT00980460|528618286|FG001|Overall Study|Death|0|||
146576563|NCT00980460|528618287|FG002|Overall Study|Death|1|||
146576564|NCT00980460|528618288|FG003|Overall Study|Death|2|||
146576565|NCT00980460|528618289|FG004|Overall Study|Death|1|||
146576566|NCT00980460|528618285|FG000|Overall Study|Lack of Efficacy|0|||
146576567|NCT00980460|528618286|FG001|Overall Study|Lack of Efficacy|0|||
146576568|NCT00980460|528618287|FG002|Overall Study|Lack of Efficacy|10|||
146576569|NCT00980460|528618288|FG003|Overall Study|Lack of Efficacy|6|||
146576570|NCT00980460|528618289|FG004|Overall Study|Lack of Efficacy|8|||
146576571|NCT00980460|528618285|FG000|Overall Study|Lost to Follow-up|0|||
146576572|NCT00980460|528618286|FG001|Overall Study|Lost to Follow-up|0|||
146576573|NCT00980460|528618287|FG002|Overall Study|Lost to Follow-up|0|||
146576574|NCT00980460|528618288|FG003|Overall Study|Lost to Follow-up|1|||
146576575|NCT00980460|528618289|FG004|Overall Study|Lost to Follow-up|0|||
146576576|NCT00980460|528618285|FG000|Overall Study|Physician Decision|0|||
146576577|NCT00980460|528618286|FG001|Overall Study|Physician Decision|0|||
146576578|NCT00980460|528618287|FG002|Overall Study|Physician Decision|11|||
146576579|NCT00980460|528618288|FG003|Overall Study|Physician Decision|5|||
146576580|NCT00980460|528618289|FG004|Overall Study|Physician Decision|3|||
146770645|NCT01135511|529328650|FG008|Overall Study|noncompliance with study drug taken|0|||
146770646|NCT01135511|529328642|FG000|Overall Study|Withdrawal by Subject|0|||
146770647|NCT01135511|529328643|FG001|Overall Study|Withdrawal by Subject|0|||
146770648|NCT01135511|529328644|FG002|Overall Study|Withdrawal by Subject|0|||
146770649|NCT01135511|529328645|FG003|Overall Study|Withdrawal by Subject|0|||
146770650|NCT01135511|529328646|FG004|Overall Study|Withdrawal by Subject|0|||
146770651|NCT01135511|529328647|FG005|Overall Study|Withdrawal by Subject|0|||
146770652|NCT01135511|529328648|FG006|Overall Study|Withdrawal by Subject|1|||
146576581|NCT00980460|528618285|FG000|Overall Study|Withdrawal by Subject|0|||
146576582|NCT00980460|528618286|FG001|Overall Study|Withdrawal by Subject|0|||
146576583|NCT00980460|528618287|FG002|Overall Study|Withdrawal by Subject|1|||
146576584|NCT00980460|528618288|FG003|Overall Study|Withdrawal by Subject|0|||
146576585|NCT00980460|528618289|FG004|Overall Study|Withdrawal by Subject|0|||
146576586|NCT00980460|528618285|FG000|Overall Study|Ineligible|0|||
146576587|NCT00980460|528618286|FG001|Overall Study|Ineligible|2|||
146576588|NCT00980460|528618287|FG002|Overall Study|Ineligible|3|||
146576589|NCT00980460|528618288|FG003|Overall Study|Ineligible|1|||
146576590|NCT00980460|528618289|FG004|Overall Study|Ineligible|4|||
146576591|NCT00980460|528618285|FG000|Overall Study|Refusal of further therapy|0|||
146576592|NCT00980460|528618286|FG001|Overall Study|Refusal of further therapy|2|||
146576593|NCT00980460|528618287|FG002|Overall Study|Refusal of further therapy|3|||
146770653|NCT01135511|529328649|FG007|Overall Study|Withdrawal by Subject|0|||
146576594|NCT00980460|528618288|FG003|Overall Study|Refusal of further therapy|2|||
146576595|NCT00980460|528618289|FG004|Overall Study|Refusal of further therapy|0|||
146576596|NCT00980460|528618285|FG000|Overall Study|No therapy within 42 days of resection|0|||
146576597|NCT00980460|528618286|FG001|Overall Study|No therapy within 42 days of resection|0|||
146576598|NCT00980460|528618287|FG002|Overall Study|No therapy within 42 days of resection|3|||
146576599|NCT00980460|528618288|FG003|Overall Study|No therapy within 42 days of resection|1|||
146576600|NCT00980460|528618289|FG004|Overall Study|No therapy within 42 days of resection|0|||
146576601|NCT00980460|528618285|FG000|Overall Study|No transplant by protocol timepoints|0|||
146576602|NCT00980460|528618286|FG001|Overall Study|No transplant by protocol timepoints|0|||
146576603|NCT00980460|528618287|FG002|Overall Study|No transplant by protocol timepoints|3|||
146576604|NCT00980460|528618288|FG003|Overall Study|No transplant by protocol timepoints|0|||
146651939|NCT01842633|528903713|FG000|Overall Study|Technical issues|1|||
146651940|NCT01842633|528903714|FG001|Overall Study|Technical issues|0|||
146651941|NCT01842633|528903715|FG002|Overall Study|Technical issues|0|||
146651942|NCT00706849|528903721|FG000|Treatment Period|Adverse Event|0|||
146576605|NCT00980460|528618289|FG004|Overall Study|No transplant by protocol timepoints|0|||
146576606|NCT00662831|528619680|FG000|Overall Study|Death|4|||
146576607|NCT00662831|528619681|FG001|Overall Study|Death|1|||
146576608|NCT00662831|528619680|FG000|Overall Study|Lack of Efficacy|6|||
146576609|NCT00662831|528619681|FG001|Overall Study|Lack of Efficacy|6|||
146576610|NCT00662831|528619680|FG000|Overall Study|Lost to Follow-up|1|||
146576611|NCT00662831|528619681|FG001|Overall Study|Lost to Follow-up|0|||
146576612|NCT00662831|528619680|FG000|Overall Study|Withdrawal by Subject|2|||
146576613|NCT00662831|528619681|FG001|Overall Study|Withdrawal by Subject|1|||
146576614|NCT00662831|528619680|FG000|Overall Study|Other|62|||
146576615|NCT00662831|528619681|FG001|Overall Study|Other|31|||
146576616|NCT00662831|528619680|FG000|Overall Study|Protocol Violation|8|||
146576617|NCT00662831|528619681|FG001|Overall Study|Protocol Violation|4|||
146576618|NCT00662831|528619680|FG000|Overall Study|Adverse Event|23|||
146576619|NCT00662831|528619681|FG001|Overall Study|Adverse Event|16|||
146576620|NCT00294671|528619682|FG000|Overall Study|Lack of Efficacy|11|||
146576621|NCT00294671|528619683|FG001|Overall Study|Lack of Efficacy|23|||
146576622|NCT00294671|528619682|FG000|Overall Study|Liver transplant|7|||
146576623|NCT00294671|528619683|FG001|Overall Study|Liver transplant|9|||
146576624|NCT00294671|528619682|FG000|Overall Study|Drug related adverse event (AE)|4|||
146576625|NCT00294671|528619683|FG001|Overall Study|Drug related adverse event (AE)|2|||
146576626|NCT00294671|528619682|FG000|Overall Study|Non-drug related AE|3|||
146576627|NCT00294671|528619683|FG001|Overall Study|Non-drug related AE|2|||
146576628|NCT00294671|528619682|FG000|Overall Study|Lost to Follow-up|1|||
146576629|NCT00294671|528619683|FG001|Overall Study|Lost to Follow-up|3|||
146576630|NCT00294671|528619682|FG000|Overall Study|Non-compliance|1|||
146576631|NCT00294671|528619683|FG001|Overall Study|Non-compliance|0|||
146576632|NCT00294671|528619682|FG000|Overall Study|Death|0|||
146576633|NCT00294671|528619683|FG001|Overall Study|Death|1|||
146576634|NCT01734785|528619684|FG000|Open-Label Period|Adverse Event|0|||
146576635|NCT01734785|528619685|FG001|Open-Label Period|Adverse Event|0|||
146576636|NCT01734785|528619686|FG002|Open-Label Period|Adverse Event|0|||
146576637|NCT01734785|528619687|FG003|Open-Label Period|Adverse Event|9|||
146576638|NCT01734785|528619684|FG000|Open-Label Period|Lack of Efficacy|0|||
146576639|NCT01734785|528619685|FG001|Open-Label Period|Lack of Efficacy|0|||
146576640|NCT01734785|528619686|FG002|Open-Label Period|Lack of Efficacy|0|||
146576641|NCT01734785|528619687|FG003|Open-Label Period|Lack of Efficacy|1|||
146576642|NCT01734785|528619684|FG000|Open-Label Period|Protocol Violation|0|||
146576643|NCT01734785|528619685|FG001|Open-Label Period|Protocol Violation|0|||
146576644|NCT01734785|528619686|FG002|Open-Label Period|Protocol Violation|0|||
146576645|NCT01734785|528619687|FG003|Open-Label Period|Protocol Violation|13|||
146576646|NCT01734785|528619684|FG000|Open-Label Period|Lost to Follow-up|0|||
146576647|NCT01734785|528619685|FG001|Open-Label Period|Lost to Follow-up|0|||
146576648|NCT01734785|528619686|FG002|Open-Label Period|Lost to Follow-up|0|||
146576649|NCT01734785|528619687|FG003|Open-Label Period|Lost to Follow-up|14|||
146576650|NCT01734785|528619684|FG000|Open-Label Period|Withdrawal by Subject|0|||
146576651|NCT01734785|528619685|FG001|Open-Label Period|Withdrawal by Subject|0|||
146576652|NCT01734785|528619686|FG002|Open-Label Period|Withdrawal by Subject|0|||
146576653|NCT01734785|528619687|FG003|Open-Label Period|Withdrawal by Subject|12|||
146651943|NCT00706849|528903722|FG001|Treatment Period|Adverse Event|9|||
146651944|NCT00706849|528903721|FG000|Treatment Period|Other|0|||
146651945|NCT00706849|528903722|FG001|Treatment Period|Other|1|||
146651946|NCT00706849|528903721|FG000|Follow-up Period|Withdrawal by Subject|0|||
146651947|NCT00706849|528903722|FG001|Follow-up Period|Withdrawal by Subject|2|||
146651948|NCT00706849|528903721|FG000|Follow-up Period|Protocol non-compliance|0|||
146770654|NCT01135511|529328650|FG008|Overall Study|Withdrawal by Subject|1|||
146770655|NCT00545077|529328652|FG000|Overall Study|Treatment not received|5|||
146918281|NCT02163993|529862809|FG004|Treatment Period|Adverse Event|1|||
146918282|NCT02163993|529862805|FG000|Treatment Period|Lost to Follow-up|2|||
146918283|NCT02163993|529862806|FG001|Treatment Period|Lost to Follow-up|3|||
146576654|NCT01734785|528619684|FG000|Open-Label Period|Other Reasons|0|||
146576655|NCT01734785|528619685|FG001|Open-Label Period|Other Reasons|0|||
146576656|NCT01734785|528619686|FG002|Open-Label Period|Other Reasons|0|||
146576657|NCT01734785|528619687|FG003|Open-Label Period|Other Reasons|224|||
146576658|NCT01734785|528619684|FG000|Double-Blind Period|Adverse Event|0|||
146576659|NCT01734785|528619685|FG001|Double-Blind Period|Adverse Event|3|||
146576660|NCT01734785|528619686|FG002|Double-Blind Period|Adverse Event|2|||
146651949|NCT00706849|528903722|FG001|Follow-up Period|Protocol non-compliance|1|||
146576661|NCT01734785|528619687|FG003|Double-Blind Period|Adverse Event|0|||
146576662|NCT01734785|528619684|FG000|Double-Blind Period|Lack of Efficacy|0|||
146576663|NCT01734785|528619685|FG001|Double-Blind Period|Lack of Efficacy|1|||
146576664|NCT01734785|528619686|FG002|Double-Blind Period|Lack of Efficacy|0|||
146576665|NCT01734785|528619687|FG003|Double-Blind Period|Lack of Efficacy|0|||
146576666|NCT01734785|528619684|FG000|Double-Blind Period|Protocol Violation|0|||
146576667|NCT01734785|528619685|FG001|Double-Blind Period|Protocol Violation|1|||
146576668|NCT01734785|528619686|FG002|Double-Blind Period|Protocol Violation|1|||
146576669|NCT01734785|528619687|FG003|Double-Blind Period|Protocol Violation|0|||
146576670|NCT01734785|528619684|FG000|Double-Blind Period|Lost to Follow-up|2|||
146576671|NCT01734785|528619685|FG001|Double-Blind Period|Lost to Follow-up|4|||
146576672|NCT01734785|528619686|FG002|Double-Blind Period|Lost to Follow-up|2|||
146576673|NCT01734785|528619687|FG003|Double-Blind Period|Lost to Follow-up|0|||
146576674|NCT01734785|528619684|FG000|Double-Blind Period|Withdrawal by Subject|2|||
146576675|NCT01734785|528619685|FG001|Double-Blind Period|Withdrawal by Subject|0|||
146576676|NCT01734785|528619686|FG002|Double-Blind Period|Withdrawal by Subject|0|||
146576677|NCT01734785|528619687|FG003|Double-Blind Period|Withdrawal by Subject|0|||
146576678|NCT01734785|528619684|FG000|Double-Blind Period|Not treated|1|||
146576679|NCT01734785|528619685|FG001|Double-Blind Period|Not treated|0|||
146576680|NCT01734785|528619686|FG002|Double-Blind Period|Not treated|0|||
146576681|NCT01734785|528619687|FG003|Double-Blind Period|Not treated|0|||
146576682|NCT02013778|528619693|FG000|Overall Study|Death|4|||
146576683|NCT02013778|528619693|FG000|Overall Study|Withdrawal by Subject|1|||
146576684|NCT02013778|528619693|FG000|Overall Study|Physician Decision|1|||
146576685|NCT02013778|528619693|FG000|Overall Study|Adverse Event|1|||
146576686|NCT03308968|528619694|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
146576687|NCT03308968|528619695|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
146576688|NCT03308968|528619696|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
146576689|NCT03308968|528619694|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
146576690|NCT03308968|528619695|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
146576691|NCT03308968|528619696|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
146576692|NCT03308968|528619694|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
146576693|NCT03308968|528619695|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
146576694|NCT03308968|528619696|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
146576695|NCT03308968|528619694|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
146576696|NCT03308968|528619695|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
146576697|NCT03308968|528619696|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
146576698|NCT03308968|528619694|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
146576699|NCT03308968|528619695|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
146576700|NCT03308968|528619696|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
146576701|NCT03308968|528619694|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
146576702|NCT03308968|528619695|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
146576703|NCT03308968|528619696|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
146576704|NCT03308968|528619694|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
146576705|NCT03308968|528619695|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
146576706|NCT03308968|528619696|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
146576707|NCT03308968|528619694|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
146576708|NCT03308968|528619695|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
146576709|NCT03308968|528619696|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
146576710|NCT03308968|528619694|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
146576711|NCT03308968|528619695|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
146576712|NCT03308968|528619696|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
146576713|NCT03308968|528619694|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
146576714|NCT03308968|528619695|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
146576715|NCT03308968|528619696|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
146576716|NCT03308968|528619694|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
146576717|NCT03308968|528619695|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
146576718|NCT03308968|528619696|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
146576719|NCT03308968|528619694|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
146576720|NCT03308968|528619695|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
146576721|NCT03308968|528619696|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
146576722|NCT03308968|528619694|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
146576723|NCT03308968|528619695|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
146576724|NCT03308968|528619696|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
146576725|NCT03308968|528619694|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
146576726|NCT03308968|528619695|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
146576727|NCT03308968|528619696|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
146576728|NCT01961297|528619697|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
146576729|NCT01961297|528619698|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
146576730|NCT02482298|528619699|FG000|Overall Study|Withdrawal by Subject|2|||
146576731|NCT02482298|528619700|FG001|Overall Study|Withdrawal by Subject|1|||
146576732|NCT02482298|528619701|FG002|Overall Study|Withdrawal by Subject|2|||
146576733|NCT02482298|528619699|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
146576734|NCT02482298|528619700|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
146576735|NCT02482298|528619701|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
146576736|NCT02482298|528619699|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
146651950|NCT02616601|528903723|FG000|Overall Study|Withdrawal by Subject|4|||
147013243|NCT01708954|530210055|FG001|Step 1|Symptomatic deterioration|0|||
146576737|NCT02482298|528619700|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
146576738|NCT02482298|528619701|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
146576739|NCT02482298|528619699|FG000|Overall Study|Lost to Follow-up|0|||
146576740|NCT02482298|528619700|FG001|Overall Study|Lost to Follow-up|1|||
146576741|NCT02482298|528619701|FG002|Overall Study|Lost to Follow-up|0|||
146576742|NCT01582009|528619704|FG000|Overall Study|Withdrawal by Subject|1|||
146576743|NCT01582009|528619704|FG000|Overall Study|Physician Decision|1|||
146576744|NCT03050450|528619707|FG000|Overall Study|Physician Decision|1|||
146576745|NCT03050450|528619708|FG001|Overall Study|Physician Decision|0|||
146576746|NCT03050450|528619709|FG002|Overall Study|Physician Decision|0|||
146576747|NCT03050450|528619710|FG003|Overall Study|Physician Decision|0|||
146576748|NCT03050450|528619711|FG004|Overall Study|Physician Decision|0|||
146576749|NCT03592771|528619712|FG000|Overall Study|Adverse Event|2|||
146576750|NCT03592771|528619713|FG001|Overall Study|Adverse Event|0|||
146576751|NCT03592771|528619714|FG002|Overall Study|Adverse Event|1|||
146576752|NCT03592771|528619712|FG000|Overall Study|Death|0|||
146576753|NCT03592771|528619713|FG001|Overall Study|Death|1|||
146576754|NCT03592771|528619714|FG002|Overall Study|Death|1|||
146576755|NCT03592771|528619712|FG000|Overall Study|Lost to Follow-up|5|||
146576756|NCT03592771|528619713|FG001|Overall Study|Lost to Follow-up|11|||
146576757|NCT03592771|528619714|FG002|Overall Study|Lost to Follow-up|15|||
146576758|NCT03592771|528619712|FG000|Overall Study|Withdrawal by Subject|0|||
146576759|NCT03592771|528619713|FG001|Overall Study|Withdrawal by Subject|2|||
146576760|NCT03592771|528619714|FG002|Overall Study|Withdrawal by Subject|0|||
146576761|NCT00735553|528619715|FG000|Overall Study|Study prematurely terminated|77|||
146576762|NCT02705105|528619716|FG000|Treatment|Objective Disease Progression|1|||
146576763|NCT02705105|528619717|FG001|Treatment|Objective Disease Progression|50|||
146576764|NCT02705105|528619716|FG000|Treatment|Withdrawal by Subject|3|||
146576765|NCT02705105|528619717|FG001|Treatment|Withdrawal by Subject|5|||
146576766|NCT02705105|528619716|FG000|Treatment|Adverse Event|0|||
146576767|NCT02705105|528619717|FG001|Treatment|Adverse Event|17|||
146576768|NCT02705105|528619716|FG000|Treatment|Clinical Disease Progression|0|||
146576769|NCT02705105|528619717|FG001|Treatment|Clinical Disease Progression|32|||
146576770|NCT02705105|528619716|FG000|Treatment|Physician Decision|0|||
146576771|NCT02705105|528619717|FG001|Treatment|Physician Decision|3|||
146576772|NCT02705105|528619716|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
146576773|NCT02705105|528619717|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
146576774|NCT02705105|528619716|FG000|Follow-Up|Death|3|||
146576775|NCT02705105|528619717|FG001|Follow-Up|Death|68|||
146576776|NCT02705105|528619716|FG000|Follow-Up|Withdrawal by Subject|1|||
146576777|NCT02705105|528619717|FG001|Follow-Up|Withdrawal by Subject|14|||
146576778|NCT02705105|528619716|FG000|Follow-Up|Study Terminated|0|||
146576779|NCT02705105|528619717|FG001|Follow-Up|Study Terminated|26|||
146576780|NCT02705105|528619716|FG000|Follow-Up|Discontinued per Amendment 3|0|||
146576781|NCT02705105|528619717|FG001|Follow-Up|Discontinued per Amendment 3|2|||
146576782|NCT04556591|528619719|FG000|Overall Study|Lost to Follow-up|1|||
146576783|NCT04556591|528619720|FG001|Overall Study|Lost to Follow-up|0|||
146576784|NCT04556591|528619719|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
146576785|NCT04556591|528619720|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
146576786|NCT03332173|528619721|FG000|Overall Study|Death|7|||
146576787|NCT03332173|528619721|FG000|Overall Study|Withdrawal by Subject|6|||
146576788|NCT03332173|528619721|FG000|Overall Study|Lost to Follow-up|2|||
146576789|NCT03332173|528619721|FG000|Overall Study|Transferred to long-term extension study|29|||
146576790|NCT01485796|528619722|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
146576791|NCT01485796|528619722|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
146576792|NCT01485796|528619722|FG000|Period 2: Epoch 2|Adverse Event|3|||
146576793|NCT01485796|528619722|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
146576794|NCT01485796|528619722|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
146576795|NCT01485796|528619722|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
146576796|NCT01485796|528619722|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
146576797|NCT01485796|528619722|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
146576798|NCT04830215|528619723|FG000|Overall Study|Adverse Event|6|||
146576799|NCT04830215|528619723|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
146576800|NCT04830215|528619723|FG000|Overall Study|Withdrawal by Subject|3|||
146918284|NCT02163993|529862807|FG002|Treatment Period|Lost to Follow-up|1|||
146918285|NCT02163993|529862808|FG003|Treatment Period|Lost to Follow-up|3|||
146918286|NCT02163993|529862809|FG004|Treatment Period|Lost to Follow-up|1|||
146918287|NCT02163993|529862805|FG000|Treatment Period|Physician Decision|1|||
146918288|NCT02163993|529862806|FG001|Treatment Period|Physician Decision|0|||
146918289|NCT02163993|529862807|FG002|Treatment Period|Physician Decision|0|||
146576801|NCT04830215|528619723|FG000|Overall Study|Protocol Deviation|1|||
146576802|NCT00211172|528619726|FG000|Overall Study|Died or lost health plan eligibility|39|||
146576803|NCT00211172|528619727|FG001|Overall Study|Died or lost health plan eligibility|32|||
146576804|NCT00770562|528619730|FG000|Overall Study|Did not take treatment|1|||
146576805|NCT00770562|528619731|FG001|Overall Study|Did not take treatment|1|||
146576806|NCT01643408|528619732|FG000|Overall Study|Adverse Event|12|||
146576807|NCT01643408|528619732|FG000|Overall Study|Other|2|||
146576808|NCT00292045|528619736|FG000|Core Study (Through Week 13)|Adverse Event|1|||
146576809|NCT00292045|528619736|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
146576810|NCT04474197|528619737|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
146576811|NCT04474197|528619738|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
146576812|NCT04474197|528619739|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
146576813|NCT04474197|528619740|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
146576814|NCT00606411|528619741|FG000|Overall Study|Adverse Event|1|||
146576815|NCT00606411|528619742|FG001|Overall Study|Adverse Event|2|||
146576816|NCT00606411|528619741|FG000|Overall Study|Lack of Adherence|1|||
146576817|NCT00606411|528619742|FG001|Overall Study|Lack of Adherence|1|||
146576818|NCT00606411|528619741|FG000|Overall Study|Lack of Efficacy|1|||
146576819|NCT00606411|528619742|FG001|Overall Study|Lack of Efficacy|1|||
146576820|NCT00606411|528619741|FG000|Overall Study|Withdrawal by Subject|2|||
146576821|NCT00606411|528619742|FG001|Overall Study|Withdrawal by Subject|0|||
146576822|NCT00606411|528619741|FG000|Overall Study|Lost to Follow-up|1|||
146576823|NCT00606411|528619742|FG001|Overall Study|Lost to Follow-up|2|||
146576824|NCT00606411|528619741|FG000|Overall Study|Move out of state|0|||
146576825|NCT00606411|528619742|FG001|Overall Study|Move out of state|1|||
146576826|NCT00624468|528619744|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
146576827|NCT00624468|528619745|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
146576828|NCT00624468|528619746|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
146576829|NCT00624468|528619747|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
146576830|NCT00624468|528619744|FG000|Double-blind Period|Withdrew Prematurely|1|||
146576831|NCT00624468|528619745|FG001|Double-blind Period|Withdrew Prematurely|1|||
146576832|NCT00624468|528619746|FG002|Double-blind Period|Withdrew Prematurely|0|||
146576833|NCT00624468|528619747|FG003|Double-blind Period|Withdrew Prematurely|0|||
146576834|NCT00624468|528619744|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
146576835|NCT00624468|528619745|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
146576836|NCT00624468|528619746|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
146576837|NCT00624468|528619747|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
146576838|NCT00624468|528619744|FG000|Safety Follow-up (SFU) Period|Other|0|||
146576839|NCT00624468|528619745|FG001|Safety Follow-up (SFU) Period|Other|0|||
146576840|NCT00624468|528619746|FG002|Safety Follow-up (SFU) Period|Other|1|||
146576841|NCT00624468|528619747|FG003|Safety Follow-up (SFU) Period|Other|1|||
146576842|NCT00635349|528619749|FG000|Overall Study|Other|8|||
146576843|NCT00635349|528619750|FG001|Overall Study|Other|6|||
146576844|NCT00635349|528619749|FG000|Overall Study|Protocol Violation|18|||
146576845|NCT00635349|528619750|FG001|Overall Study|Protocol Violation|22|||
146576846|NCT00635349|528619749|FG000|Overall Study|Withdrawal by Subject|3|||
146576847|NCT00635349|528619750|FG001|Overall Study|Withdrawal by Subject|8|||
146576848|NCT00635349|528619749|FG000|Overall Study|Lost to Follow-up|4|||
146576849|NCT00635349|528619750|FG001|Overall Study|Lost to Follow-up|3|||
146576850|NCT00635349|528619749|FG000|Overall Study|Adverse Event|11|||
146576851|NCT00635349|528619750|FG001|Overall Study|Adverse Event|9|||
146576852|NCT02569476|528619753|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
146576853|NCT02569476|528619753|FG000|Overall Study|Death|33|||
146576854|NCT02569476|528619753|FG000|Overall Study|Withdrawal by Subject|9|||
146576855|NCT02569476|528619753|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
146576856|NCT02569476|528619753|FG000|Overall Study|Palliative care|1|||
146576857|NCT02569476|528619753|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
146576858|NCT02569476|528619753|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
146576859|NCT00703963|528619754|FG000|Overall Study|Withdrawal by Subject|7|||
146576860|NCT00703963|528619755|FG001|Overall Study|Withdrawal by Subject|13|||
146576861|NCT00703963|528619754|FG000|Overall Study|Physician Decision|0|||
146576862|NCT00703963|528619755|FG001|Overall Study|Physician Decision|1|||
146576863|NCT01340664|528619756|FG000|Overall Study|Adverse Event|0|||
146576864|NCT01340664|528619757|FG001|Overall Study|Adverse Event|1|||
146576865|NCT01340664|528619758|FG002|Overall Study|Adverse Event|7|||
146576866|NCT01340664|528619756|FG000|Overall Study|Lost to Follow-up|2|||
146576867|NCT01340664|528619757|FG001|Overall Study|Lost to Follow-up|0|||
146576868|NCT01340664|528619758|FG002|Overall Study|Lost to Follow-up|2|||
146576869|NCT01340664|528619756|FG000|Overall Study|Withdrawal by Subject|2|||
146576870|NCT01340664|528619757|FG001|Overall Study|Withdrawal by Subject|4|||
146576871|NCT01340664|528619758|FG002|Overall Study|Withdrawal by Subject|0|||
146576872|NCT01340664|528619756|FG000|Overall Study|Glycemic withdrawal criteria|2|||
146576873|NCT01340664|528619757|FG001|Overall Study|Glycemic withdrawal criteria|0|||
146576874|NCT01340664|528619758|FG002|Overall Study|Glycemic withdrawal criteria|0|||
146576875|NCT01340664|528619756|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
146576876|NCT01340664|528619757|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
146576877|NCT01340664|528619758|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
146576878|NCT01340664|528619756|FG000|Overall Study|Other|1|||
146576879|NCT01340664|528619757|FG001|Overall Study|Other|2|||
146770656|NCT00545077|529328653|FG001|Overall Study|Treatment not received|1|||
146770657|NCT00545077|529328652|FG000|Overall Study|Disease Progression|131|||
146770658|NCT00545077|529328653|FG001|Overall Study|Disease Progression|98|||
146770659|NCT00545077|529328652|FG000|Overall Study|Withdrawal by Subject|3|||
146576880|NCT01340664|528619758|FG002|Overall Study|Other|2|||
146576881|NCT02528942|528619764|FG000|Overall Study|Did not meet imaging criteria|9|||
146576882|NCT02528942|528619764|FG000|Overall Study|Lost to Follow-up|25|||
146576883|NCT04599803|528619765|FG000|Overall Study|Withdrawal by Subject|5|||
146576884|NCT04599803|528619765|FG000|Overall Study|Lost to Follow-up|26|||
146576885|NCT00881530|528619766|FG000|Overall Study|Adverse Event|5|||
146576886|NCT00881530|528619767|FG001|Overall Study|Adverse Event|1|||
146576887|NCT00881530|528619768|FG002|Overall Study|Adverse Event|1|||
146576888|NCT00881530|528619769|FG003|Overall Study|Adverse Event|4|||
146576889|NCT00881530|528619770|FG004|Overall Study|Adverse Event|10|||
146576890|NCT00881530|528619771|FG005|Overall Study|Adverse Event|2|||
146576891|NCT00881530|528619766|FG000|Overall Study|Lack of Efficacy|1|||
146576892|NCT00881530|528619767|FG001|Overall Study|Lack of Efficacy|0|||
146576893|NCT00881530|528619768|FG002|Overall Study|Lack of Efficacy|0|||
146576894|NCT00881530|528619769|FG003|Overall Study|Lack of Efficacy|0|||
146576895|NCT00881530|528619770|FG004|Overall Study|Lack of Efficacy|1|||
146576896|NCT00881530|528619771|FG005|Overall Study|Lack of Efficacy|1|||
146576897|NCT00881530|528619766|FG000|Overall Study|Not compliant with the protocol|0|||
146576898|NCT00881530|528619767|FG001|Overall Study|Not compliant with the protocol|0|||
146576899|NCT00881530|528619768|FG002|Overall Study|Not compliant with the protocol|0|||
146576900|NCT00881530|528619769|FG003|Overall Study|Not compliant with the protocol|0|||
146576901|NCT00881530|528619770|FG004|Overall Study|Not compliant with the protocol|2|||
146576902|NCT00881530|528619771|FG005|Overall Study|Not compliant with the protocol|0|||
146576903|NCT00881530|528619766|FG000|Overall Study|Lost to Follow-up|0|||
146576904|NCT00881530|528619767|FG001|Overall Study|Lost to Follow-up|1|||
146576905|NCT00881530|528619768|FG002|Overall Study|Lost to Follow-up|1|||
146576906|NCT00881530|528619769|FG003|Overall Study|Lost to Follow-up|3|||
146576907|NCT00881530|528619770|FG004|Overall Study|Lost to Follow-up|1|||
146576908|NCT00881530|528619771|FG005|Overall Study|Lost to Follow-up|0|||
146576909|NCT00881530|528619766|FG000|Overall Study|Refused to continue medication|7|||
146576910|NCT00881530|528619767|FG001|Overall Study|Refused to continue medication|2|||
146576911|NCT00881530|528619768|FG002|Overall Study|Refused to continue medication|1|||
146576912|NCT00881530|528619769|FG003|Overall Study|Refused to continue medication|2|||
146576913|NCT00881530|528619770|FG004|Overall Study|Refused to continue medication|0|||
146576914|NCT00881530|528619771|FG005|Overall Study|Refused to continue medication|0|||
146576915|NCT00881530|528619766|FG000|Overall Study|Other reason not defined above|1|||
146576916|NCT00881530|528619767|FG001|Overall Study|Other reason not defined above|1|||
146576917|NCT00881530|528619768|FG002|Overall Study|Other reason not defined above|2|||
146576918|NCT00881530|528619769|FG003|Overall Study|Other reason not defined above|0|||
146576919|NCT00881530|528619770|FG004|Overall Study|Other reason not defined above|0|||
146576920|NCT00881530|528619771|FG005|Overall Study|Other reason not defined above|2|||
146576921|NCT00763256|528619772|FG000|Overall Study|Didn't return for appointments|7|||
146576922|NCT00763256|528619773|FG001|Overall Study|Didn't return for appointments|10|||
146576923|NCT04396795|528619774|FG000|Month 1|Lost to Follow-up|2|||
146576924|NCT04396795|528619775|FG001|Month 1|Lost to Follow-up|3|||
146576925|NCT04396795|528619774|FG000|Month 3|Lost to Follow-up|1|||
146576926|NCT04396795|528619775|FG001|Month 3|Lost to Follow-up|3|||
146576927|NCT04396795|528619774|FG000|Month 6|Lost to Follow-up|3|||
146576928|NCT04396795|528619775|FG001|Month 6|Lost to Follow-up|3|||
146576929|NCT01637584|528619776|FG000|Overall Study|Withdrawal by Subject|1|||
146576930|NCT01637584|528619777|FG001|Overall Study|Withdrawal by Subject|3|||
146576931|NCT02366923|528619778|FG000|Overall Study|Withdrawal by Subject|1|||
146576932|NCT02366923|528619778|FG000|Overall Study|Positive Slit Lamp Findings|2|||
146576933|NCT02366923|528619778|FG000|Overall Study|High Astigmatism|3|||
146576934|NCT00995436|528619782|FG000|Overall Study|Withdrawal by Subject|2|||
146576935|NCT00995436|528619783|FG001|Overall Study|Withdrawal by Subject|5|||
146576936|NCT00995436|528619784|FG002|Overall Study|Withdrawal by Subject|0|||
146576937|NCT02725476|528619785|FG000|Overall Study|Physician Decision|2|||
146770660|NCT00545077|529328653|FG001|Overall Study|Withdrawal by Subject|14|||
146918290|NCT02163993|529862808|FG003|Treatment Period|Physician Decision|0|||
146918291|NCT02163993|529862809|FG004|Treatment Period|Physician Decision|0|||
146576938|NCT02725476|528619786|FG001|Overall Study|Physician Decision|0|||
146576939|NCT02725476|528619785|FG000|Overall Study|Adverse Event|1|||
146576940|NCT02725476|528619786|FG001|Overall Study|Adverse Event|1|||
146918292|NCT02163993|529862805|FG000|Treatment Period|Protocol Violation|2|||
146576941|NCT00289289|528619787|FG000|Overall Study|Withdrawal by Subject|5|||
146576942|NCT00289289|528619788|FG001|Overall Study|Withdrawal by Subject|3|||
146576943|NCT00289289|528619789|FG002|Overall Study|Withdrawal by Subject|15|||
146576944|NCT00289289|528619787|FG000|Overall Study|Lost to Follow-up|1|||
146770661|NCT00545077|529328652|FG000|Overall Study|Physician Decision|6|||
146918293|NCT02163993|529862806|FG001|Treatment Period|Protocol Violation|1|||
146576945|NCT00289289|528619788|FG001|Overall Study|Lost to Follow-up|0|||
146576946|NCT00289289|528619789|FG002|Overall Study|Lost to Follow-up|1|||
146918294|NCT02163993|529862807|FG002|Treatment Period|Protocol Violation|0|||
146918295|NCT02163993|529862808|FG003|Treatment Period|Protocol Violation|1|||
146918296|NCT02163993|529862809|FG004|Treatment Period|Protocol Violation|2|||
146918297|NCT02163993|529862805|FG000|Treatment Period|Withdrawal by Subject|6|||
146576947|NCT00289289|528619787|FG000|Overall Study|Death|4|||
146576948|NCT00289289|528619788|FG001|Overall Study|Death|2|||
146576949|NCT00289289|528619789|FG002|Overall Study|Death|5|||
146576950|NCT00289289|528619787|FG000|Overall Study|No implant attempted|0|||
146576951|NCT00289289|528619788|FG001|Overall Study|No implant attempted|0|||
146576952|NCT00289289|528619789|FG002|Overall Study|No implant attempted|1|||
146576953|NCT00289289|528619787|FG000|Overall Study|Physician Decision|1|||
146576954|NCT00289289|528619788|FG001|Overall Study|Physician Decision|0|||
146576955|NCT00289289|528619789|FG002|Overall Study|Physician Decision|6|||
146576956|NCT00289289|528619787|FG000|Overall Study|Non-study device implanted|2|||
146576957|NCT00289289|528619788|FG001|Overall Study|Non-study device implanted|1|||
146918298|NCT02163993|529862806|FG001|Treatment Period|Withdrawal by Subject|4|||
146576958|NCT00289289|528619789|FG002|Overall Study|Non-study device implanted|3|||
146576959|NCT00289289|528619787|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
146576960|NCT00289289|528619788|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
146576961|NCT00289289|528619789|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
146576962|NCT00289289|528619787|FG000|Overall Study|Other Exit Reason|6|||
146576963|NCT00289289|528619788|FG001|Overall Study|Other Exit Reason|4|||
146576964|NCT00289289|528619789|FG002|Overall Study|Other Exit Reason|12|||
146576965|NCT01445613|528619790|FG000|30-day Follow-up|Withdrawal by Subject|6|||
146576966|NCT01445613|528619790|FG000|30-day Follow-up|Physician Decision|3|||
146576967|NCT01445613|528619790|FG000|30-day Follow-up|Missed visit|23|||
146576968|NCT01445613|528619790|FG000|30-day Follow-up|Death|3|||
146576969|NCT01445613|528619790|FG000|1-year Follow-up|Withdrawal by Subject|12|||
146576970|NCT01445613|528619790|FG000|1-year Follow-up|Missed visit|29|||
146576971|NCT01445613|528619790|FG000|1-year Follow-up|Lost to Follow-up|2|||
146576972|NCT01445613|528619790|FG000|1-year Follow-up|Death|30|||
146576973|NCT01445613|528619790|FG000|1-year Follow-up|Physician Decision|2|||
146576974|NCT01445613|528619790|FG000|1-year Follow-up|Received a non-study stent|2|||
146576975|NCT03666988|528619791|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
146576976|NCT03666988|528619792|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
146576977|NCT03666988|528619793|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
146576978|NCT03666988|528619794|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
146576979|NCT03666988|528619795|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
146576980|NCT03666988|528619796|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
146576981|NCT03666988|528619791|FG000|Part 1 (Up to 28 Months)|Other|0|||
146576982|NCT03666988|528619792|FG001|Part 1 (Up to 28 Months)|Other|1|||
146576983|NCT03666988|528619793|FG002|Part 1 (Up to 28 Months)|Other|1|||
146576984|NCT03666988|528619794|FG003|Part 1 (Up to 28 Months)|Other|0|||
146576985|NCT03666988|528619795|FG004|Part 1 (Up to 28 Months)|Other|0|||
146576986|NCT03666988|528619796|FG005|Part 1 (Up to 28 Months)|Other|0|||
146576987|NCT03666988|528619791|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
146576988|NCT03666988|528619792|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
146576989|NCT03666988|528619793|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
146576990|NCT03666988|528619794|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
146576991|NCT03666988|528619795|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
146576992|NCT03666988|528619796|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
146576993|NCT03666988|528619791|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
146576994|NCT03666988|528619792|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
146576995|NCT03666988|528619793|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
146576996|NCT03666988|528619794|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
146576997|NCT03666988|528619795|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
146918299|NCT02163993|529862807|FG002|Treatment Period|Withdrawal by Subject|1|||
146576998|NCT03666988|528619796|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
146576999|NCT03666988|528619791|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
146770662|NCT00545077|529328653|FG001|Overall Study|Physician Decision|3|||
146918300|NCT02163993|529862808|FG003|Treatment Period|Withdrawal by Subject|4|||
146978195|NCT00078819|530082259|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
146918301|NCT02163993|529862809|FG004|Treatment Period|Withdrawal by Subject|1|||
146918302|NCT02163993|529862805|FG000|Treatment Period|Not treated|1|||
146577000|NCT03666988|528619792|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
146577001|NCT03666988|528619793|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
146577002|NCT03666988|528619794|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
146577003|NCT03666988|528619795|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
146577004|NCT03666988|528619796|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
146577005|NCT05588440|528619803|FG000|Overall Study|Sponsor Decision|2|||
146577006|NCT05588440|528619804|FG001|Overall Study|Sponsor Decision|0|||
146918303|NCT02163993|529862806|FG001|Treatment Period|Not treated|0|||
146577007|NCT05588440|528619805|FG002|Overall Study|Sponsor Decision|1|||
146577008|NCT05588440|528619803|FG000|Overall Study|Death|1|||
146577009|NCT05588440|528619804|FG001|Overall Study|Death|1|||
146577010|NCT05588440|528619805|FG002|Overall Study|Death|1|||
146577011|NCT05588440|528619803|FG000|Overall Study|Screen Fail|0|||
146577012|NCT05588440|528619804|FG001|Overall Study|Screen Fail|1|||
146577013|NCT05588440|528619805|FG002|Overall Study|Screen Fail|1|||
146577014|NCT05588440|528619803|FG000|Overall Study|Withdrawal by Subject|0|||
146577015|NCT05588440|528619804|FG001|Overall Study|Withdrawal by Subject|0|||
146577016|NCT05588440|528619805|FG002|Overall Study|Withdrawal by Subject|1|||
146577017|NCT02142803|528619806|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
146577018|NCT02142803|528619807|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
146577019|NCT02142803|528619808|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
146577020|NCT02142803|528619809|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
146577021|NCT01154452|528619810|FG000|Phase Ib|Not Treated|1|||
146577022|NCT01154452|528619811|FG001|Phase Ib|Not Treated|0|||
146577023|NCT01154452|528619812|FG002|Phase Ib|Not Treated|0|||
146577024|NCT01154452|528619813|FG003|Phase Ib|Not Treated|0|||
146577025|NCT01154452|528619810|FG000|Phase Ib|Adverse Event|2|||
146577026|NCT01154452|528619811|FG001|Phase Ib|Adverse Event|1|||
146577027|NCT01154452|528619812|FG002|Phase Ib|Adverse Event|0|||
146577028|NCT01154452|528619813|FG003|Phase Ib|Adverse Event|0|||
146577029|NCT01154452|528619810|FG000|Phase II|Withdrawal by Subject|0|||
146577030|NCT01154452|528619811|FG001|Phase II|Withdrawal by Subject|0|||
146577031|NCT01154452|528619812|FG002|Phase II|Withdrawal by Subject|1|||
146577032|NCT01154452|528619813|FG003|Phase II|Withdrawal by Subject|2|||
146577033|NCT01154452|528619810|FG000|Phase II|Adverse Event|0|||
146577034|NCT01154452|528619811|FG001|Phase II|Adverse Event|0|||
146577035|NCT01154452|528619812|FG002|Phase II|Adverse Event|4|||
146577036|NCT01154452|528619813|FG003|Phase II|Adverse Event|4|||
146577037|NCT03706430|528619814|FG000|Overall Study|No A-Line placed|5|||
146577038|NCT03706430|528619814|FG000|Overall Study|Subject had gel nail polish|1|||
146577039|NCT03706430|528619814|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
146577040|NCT03706430|528619814|FG000|Overall Study|Cancelled Case|6|||
146577041|NCT03706430|528619814|FG000|Overall Study|Physician Decision|2|||
146577042|NCT00145626|528619815|FG000|Overall Study|Did not have NK infusions|2|||
146577043|NCT00145626|528619815|FG000|Overall Study|Turned 2 years old before treatment|1|||
146577044|NCT00145626|528619815|FG000|Overall Study|Death|1|||
146577045|NCT00145626|528619815|FG000|Overall Study|Withdrawal by Subject|1|||
146577046|NCT01392573|528619816|FG000|Overall Study|Adverse Event|1|||
146577047|NCT01392573|528619817|FG001|Overall Study|Adverse Event|3|||
146577048|NCT01392573|528619816|FG000|Overall Study|Lack of Efficacy|1|||
146577049|NCT01392573|528619817|FG001|Overall Study|Lack of Efficacy|2|||
146577050|NCT01392573|528619816|FG000|Overall Study|Protocol Violation|0|||
146577051|NCT01392573|528619817|FG001|Overall Study|Protocol Violation|2|||
146577052|NCT01392573|528619816|FG000|Overall Study|Withdrawal Criteria|13|||
146577053|NCT01392573|528619817|FG001|Overall Study|Withdrawal Criteria|15|||
146577054|NCT01392573|528619816|FG000|Overall Study|Site closure|8|||
146577055|NCT01392573|528619817|FG001|Overall Study|Site closure|7|||
146577056|NCT01392573|528619816|FG000|Overall Study|Unclassified|9|||
146577057|NCT01392573|528619817|FG001|Overall Study|Unclassified|6|||
146577058|NCT00436436|528619818|FG000|Overall Study|Progression|4|||
146577059|NCT00436436|528619818|FG000|Overall Study|Adverse Event|2|||
146577060|NCT00436436|528619818|FG000|Overall Study|Death|6|||
146577061|NCT02709720|528619819|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
146577062|NCT02709720|528619819|FG000|Overall Study|Protocol Violation|1|||
146577063|NCT02709720|528619819|FG000|Overall Study|Not take study medication|1|||
146577064|NCT00200967|528619820|FG000|First Treatment Period|Withdrawal by Subject|5|||
146577065|NCT00200967|528619821|FG001|First Treatment Period|Withdrawal by Subject|1|||
146577066|NCT00200967|528619820|FG000|First Treatment Period|Pregnancy|1|||
146577067|NCT00200967|528619821|FG001|First Treatment Period|Pregnancy|0|||
146577068|NCT00200967|528619820|FG000|Wash-out Period|Lost to Follow-up|0|||
146577069|NCT00200967|528619821|FG001|Wash-out Period|Lost to Follow-up|1|||
146577070|NCT00200967|528619820|FG000|Second Treatment Period|Withdrawal by Subject|1|||
146577071|NCT00200967|528619821|FG001|Second Treatment Period|Withdrawal by Subject|2|||
146577072|NCT00200967|528619820|FG000|Run-out Period|Lost to Follow-up|1|||
146577073|NCT00200967|528619821|FG001|Run-out Period|Lost to Follow-up|0|||
146978196|NCT00078819|530082260|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
146978197|NCT00078819|530082261|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
146577074|NCT05823974|528622072|FG000|Overall Study|Lost to Follow-up|0|||
146577075|NCT05823974|528622073|FG001|Overall Study|Lost to Follow-up|3|||
146577076|NCT05823974|528622074|FG002|Overall Study|Lost to Follow-up|1|||
146577077|NCT05823974|528622075|FG003|Overall Study|Lost to Follow-up|0|||
146577078|NCT05823974|528622076|FG004|Overall Study|Lost to Follow-up|1|||
146577079|NCT05823974|528622077|FG005|Overall Study|Lost to Follow-up|0|||
146577080|NCT05823974|528622078|FG006|Overall Study|Lost to Follow-up|1|||
146577081|NCT05823974|528622079|FG007|Overall Study|Lost to Follow-up|0|||
146577082|NCT05823974|528622080|FG008|Overall Study|Lost to Follow-up|0|||
146577083|NCT05823974|528622081|FG009|Overall Study|Lost to Follow-up|1|||
146577084|NCT05823974|528622082|FG010|Overall Study|Lost to Follow-up|1|||
146577085|NCT05823974|528622083|FG011|Overall Study|Lost to Follow-up|0|||
146577086|NCT05823974|528622084|FG012|Overall Study|Lost to Follow-up|1|||
146577087|NCT05823974|528622085|FG013|Overall Study|Lost to Follow-up|2|||
146577088|NCT05823974|528622086|FG014|Overall Study|Lost to Follow-up|1|||
146577089|NCT05823974|528622087|FG015|Overall Study|Lost to Follow-up|1|||
146577090|NCT05823974|528622088|FG016|Overall Study|Lost to Follow-up|1|||
146577091|NCT05823974|528622089|FG017|Overall Study|Lost to Follow-up|0|||
146577092|NCT05823974|528622090|FG018|Overall Study|Lost to Follow-up|0|||
146577093|NCT05823974|528622091|FG019|Overall Study|Lost to Follow-up|2|||
146577094|NCT05823974|528622092|FG020|Overall Study|Lost to Follow-up|0|||
146577095|NCT05823974|528622072|FG000|Overall Study|Physician Decision|0|||
146577096|NCT05823974|528622073|FG001|Overall Study|Physician Decision|0|||
146577097|NCT05823974|528622074|FG002|Overall Study|Physician Decision|0|||
146577098|NCT05823974|528622075|FG003|Overall Study|Physician Decision|0|||
146577099|NCT05823974|528622076|FG004|Overall Study|Physician Decision|0|||
146577100|NCT05823974|528622077|FG005|Overall Study|Physician Decision|0|||
146577101|NCT05823974|528622078|FG006|Overall Study|Physician Decision|0|||
146577102|NCT05823974|528622079|FG007|Overall Study|Physician Decision|0|||
146577103|NCT05823974|528622080|FG008|Overall Study|Physician Decision|0|||
146577104|NCT05823974|528622081|FG009|Overall Study|Physician Decision|0|||
146577105|NCT05823974|528622082|FG010|Overall Study|Physician Decision|0|||
146577106|NCT05823974|528622083|FG011|Overall Study|Physician Decision|0|||
146577107|NCT05823974|528622084|FG012|Overall Study|Physician Decision|0|||
146577108|NCT05823974|528622085|FG013|Overall Study|Physician Decision|0|||
146577109|NCT05823974|528622086|FG014|Overall Study|Physician Decision|0|||
146577110|NCT05823974|528622087|FG015|Overall Study|Physician Decision|1|||
146577111|NCT05823974|528622088|FG016|Overall Study|Physician Decision|0|||
146577112|NCT05823974|528622089|FG017|Overall Study|Physician Decision|1|||
146577113|NCT05823974|528622090|FG018|Overall Study|Physician Decision|1|||
146577114|NCT05823974|528622091|FG019|Overall Study|Physician Decision|0|||
146577115|NCT05823974|528622092|FG020|Overall Study|Physician Decision|0|||
146577116|NCT05823974|528622072|FG000|Overall Study|Withdrawal by Subject|1|||
146577117|NCT05823974|528622073|FG001|Overall Study|Withdrawal by Subject|1|||
146577118|NCT05823974|528622074|FG002|Overall Study|Withdrawal by Subject|2|||
146577119|NCT05823974|528622075|FG003|Overall Study|Withdrawal by Subject|0|||
146577120|NCT05823974|528622076|FG004|Overall Study|Withdrawal by Subject|2|||
146577121|NCT05823974|528622077|FG005|Overall Study|Withdrawal by Subject|3|||
146577122|NCT05823974|528622078|FG006|Overall Study|Withdrawal by Subject|1|||
146577123|NCT05823974|528622079|FG007|Overall Study|Withdrawal by Subject|1|||
146577124|NCT05823974|528622080|FG008|Overall Study|Withdrawal by Subject|2|||
146577125|NCT05823974|528622081|FG009|Overall Study|Withdrawal by Subject|1|||
146577126|NCT05823974|528622082|FG010|Overall Study|Withdrawal by Subject|1|||
146577127|NCT05823974|528622083|FG011|Overall Study|Withdrawal by Subject|0|||
146577128|NCT05823974|528622084|FG012|Overall Study|Withdrawal by Subject|0|||
146577129|NCT05823974|528622085|FG013|Overall Study|Withdrawal by Subject|1|||
146577130|NCT05823974|528622086|FG014|Overall Study|Withdrawal by Subject|1|||
146577131|NCT05823974|528622087|FG015|Overall Study|Withdrawal by Subject|3|||
146577132|NCT05823974|528622088|FG016|Overall Study|Withdrawal by Subject|0|||
146577133|NCT05823974|528622089|FG017|Overall Study|Withdrawal by Subject|2|||
146577134|NCT05823974|528622090|FG018|Overall Study|Withdrawal by Subject|2|||
146577135|NCT05823974|528622091|FG019|Overall Study|Withdrawal by Subject|0|||
146577136|NCT05823974|528622092|FG020|Overall Study|Withdrawal by Subject|1|||
146577137|NCT05823974|528622072|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577138|NCT05823974|528622073|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577139|NCT05823974|528622074|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146577140|NCT05823974|528622075|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577141|NCT05823974|528622076|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577142|NCT05823974|528622077|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577143|NCT05823974|528622078|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577144|NCT05823974|528622079|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577145|NCT05823974|528622080|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577146|NCT05823974|528622081|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577147|NCT05823974|528622082|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577148|NCT05823974|528622083|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577149|NCT05823974|528622084|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577150|NCT05823974|528622085|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577151|NCT05823974|528622086|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146577152|NCT05823974|528622087|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577153|NCT05823974|528622088|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577154|NCT05823974|528622089|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577155|NCT05823974|528622090|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577156|NCT05823974|528622091|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577157|NCT05823974|528622092|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146577158|NCT05823974|528622072|FG000|Overall Study|Other|0|||
146577159|NCT05823974|528622073|FG001|Overall Study|Other|1|||
146577160|NCT05823974|528622074|FG002|Overall Study|Other|1|||
146577161|NCT05823974|528622075|FG003|Overall Study|Other|1|||
146770663|NCT00545077|529328652|FG000|Overall Study|Lost to Follow-up|2|||
146577162|NCT05823974|528622076|FG004|Overall Study|Other|0|||
146577163|NCT05823974|528622077|FG005|Overall Study|Other|1|||
146577164|NCT05823974|528622078|FG006|Overall Study|Other|1|||
146577165|NCT05823974|528622079|FG007|Overall Study|Other|1|||
146577166|NCT05823974|528622080|FG008|Overall Study|Other|1|||
146577167|NCT05823974|528622081|FG009|Overall Study|Other|0|||
146577168|NCT05823974|528622082|FG010|Overall Study|Other|0|||
146577169|NCT05823974|528622083|FG011|Overall Study|Other|0|||
146577170|NCT05823974|528622084|FG012|Overall Study|Other|2|||
146577171|NCT05823974|528622085|FG013|Overall Study|Other|1|||
146577172|NCT05823974|528622086|FG014|Overall Study|Other|0|||
146577173|NCT05823974|528622087|FG015|Overall Study|Other|1|||
146577174|NCT05823974|528622088|FG016|Overall Study|Other|0|||
146577175|NCT05823974|528622089|FG017|Overall Study|Other|0|||
146577176|NCT05823974|528622090|FG018|Overall Study|Other|0|||
146577177|NCT05823974|528622091|FG019|Overall Study|Other|0|||
146577178|NCT05823974|528622092|FG020|Overall Study|Other|0|||
146577179|NCT01238991|528622097|FG000|Overall Study|Adverse Event|1|||
146577180|NCT01238991|528622098|FG001|Overall Study|Adverse Event|0|||
146577181|NCT01238991|528622099|FG002|Overall Study|Adverse Event|3|||
146577182|NCT01238991|528622100|FG003|Overall Study|Adverse Event|1|||
146577183|NCT01238991|528622101|FG004|Overall Study|Adverse Event|1|||
146577184|NCT01238991|528622102|FG005|Overall Study|Adverse Event|0|||
146577185|NCT01238991|528622103|FG006|Overall Study|Adverse Event|1|||
146577186|NCT01238991|528622104|FG007|Overall Study|Adverse Event|1|||
146577187|NCT01238991|528622105|FG008|Overall Study|Adverse Event|0|||
146577188|NCT01238991|528622106|FG009|Overall Study|Adverse Event|0|||
146577189|NCT01238991|528622097|FG000|Overall Study|Death|0|||
146577190|NCT01238991|528622098|FG001|Overall Study|Death|0|||
146577191|NCT01238991|528622099|FG002|Overall Study|Death|0|||
146577192|NCT01238991|528622100|FG003|Overall Study|Death|1|||
146577193|NCT01238991|528622101|FG004|Overall Study|Death|0|||
146577194|NCT01238991|528622102|FG005|Overall Study|Death|0|||
146577195|NCT01238991|528622103|FG006|Overall Study|Death|0|||
146577196|NCT01238991|528622104|FG007|Overall Study|Death|0|||
146577197|NCT01238991|528622105|FG008|Overall Study|Death|0|||
146577198|NCT01238991|528622106|FG009|Overall Study|Death|0|||
146577199|NCT01238991|528622097|FG000|Overall Study|Lack of Efficacy|0|||
146577200|NCT01238991|528622098|FG001|Overall Study|Lack of Efficacy|0|||
146577201|NCT01238991|528622099|FG002|Overall Study|Lack of Efficacy|1|||
146577202|NCT01238991|528622100|FG003|Overall Study|Lack of Efficacy|0|||
146770664|NCT00545077|529328653|FG001|Overall Study|Lost to Follow-up|0|||
146770665|NCT00545077|529328652|FG000|Overall Study|Protocol Violation|1|||
146770666|NCT00545077|529328653|FG001|Overall Study|Protocol Violation|0|||
146577203|NCT01238991|528622101|FG004|Overall Study|Lack of Efficacy|0|||
146577204|NCT01238991|528622102|FG005|Overall Study|Lack of Efficacy|0|||
146577205|NCT01238991|528622103|FG006|Overall Study|Lack of Efficacy|0|||
146577206|NCT01238991|528622104|FG007|Overall Study|Lack of Efficacy|0|||
146577207|NCT01238991|528622105|FG008|Overall Study|Lack of Efficacy|1|||
146577208|NCT01238991|528622106|FG009|Overall Study|Lack of Efficacy|0|||
146577209|NCT01238991|528622097|FG000|Overall Study|Withdrawal by Subject|0|||
146577210|NCT01238991|528622098|FG001|Overall Study|Withdrawal by Subject|0|||
146577211|NCT01238991|528622099|FG002|Overall Study|Withdrawal by Subject|1|||
146577212|NCT01238991|528622100|FG003|Overall Study|Withdrawal by Subject|0|||
146577213|NCT01238991|528622101|FG004|Overall Study|Withdrawal by Subject|0|||
146577214|NCT01238991|528622102|FG005|Overall Study|Withdrawal by Subject|0|||
146770667|NCT00545077|529328652|FG000|Overall Study|Adverse Event|0|||
146770668|NCT00545077|529328653|FG001|Overall Study|Adverse Event|31|||
146577215|NCT01238991|528622103|FG006|Overall Study|Withdrawal by Subject|0|||
146577216|NCT01238991|528622104|FG007|Overall Study|Withdrawal by Subject|0|||
146577217|NCT01238991|528622105|FG008|Overall Study|Withdrawal by Subject|0|||
146577218|NCT01238991|528622106|FG009|Overall Study|Withdrawal by Subject|0|||
146577219|NCT01238991|528622097|FG000|Overall Study|Study Terminated by Sponsor|0|||
146577220|NCT01238991|528622098|FG001|Overall Study|Study Terminated by Sponsor|0|||
146577221|NCT01238991|528622099|FG002|Overall Study|Study Terminated by Sponsor|0|||
146577222|NCT01238991|528622100|FG003|Overall Study|Study Terminated by Sponsor|0|||
146577223|NCT01238991|528622101|FG004|Overall Study|Study Terminated by Sponsor|1|||
146577224|NCT01238991|528622102|FG005|Overall Study|Study Terminated by Sponsor|0|||
146577225|NCT01238991|528622103|FG006|Overall Study|Study Terminated by Sponsor|7|||
146577226|NCT01238991|528622104|FG007|Overall Study|Study Terminated by Sponsor|4|||
146770669|NCT00545077|529328652|FG000|Overall Study|Death|0|||
146770670|NCT00545077|529328653|FG001|Overall Study|Death|8|||
146770671|NCT03260140|529328654|FG000|Overall Study|Death|4|||
146577227|NCT01238991|528622105|FG008|Overall Study|Study Terminated by Sponsor|2|||
146577228|NCT01238991|528622106|FG009|Overall Study|Study Terminated by Sponsor|2|||
146577229|NCT01238991|528622097|FG000|Overall Study|Caregiver's request|0|||
146577230|NCT01238991|528622098|FG001|Overall Study|Caregiver's request|0|||
146577231|NCT01238991|528622099|FG002|Overall Study|Caregiver's request|0|||
146577232|NCT01238991|528622100|FG003|Overall Study|Caregiver's request|0|||
146577233|NCT01238991|528622101|FG004|Overall Study|Caregiver's request|0|||
146577234|NCT01238991|528622102|FG005|Overall Study|Caregiver's request|0|||
146577235|NCT01238991|528622103|FG006|Overall Study|Caregiver's request|0|||
146577236|NCT01238991|528622104|FG007|Overall Study|Caregiver's request|0|||
146577237|NCT01238991|528622105|FG008|Overall Study|Caregiver's request|1|||
146577238|NCT01238991|528622106|FG009|Overall Study|Caregiver's request|0|||
146577239|NCT01238991|528622097|FG000|Overall Study|Admission to a nursing home|1|||
146577240|NCT01238991|528622098|FG001|Overall Study|Admission to a nursing home|0|||
146577241|NCT01238991|528622099|FG002|Overall Study|Admission to a nursing home|1|||
146577242|NCT01238991|528622100|FG003|Overall Study|Admission to a nursing home|0|||
146577243|NCT01238991|528622101|FG004|Overall Study|Admission to a nursing home|0|||
146577244|NCT01238991|528622102|FG005|Overall Study|Admission to a nursing home|0|||
146577245|NCT01238991|528622103|FG006|Overall Study|Admission to a nursing home|0|||
146577246|NCT01238991|528622104|FG007|Overall Study|Admission to a nursing home|0|||
146577247|NCT01238991|528622105|FG008|Overall Study|Admission to a nursing home|0|||
146577248|NCT01238991|528622106|FG009|Overall Study|Admission to a nursing home|0|||
146577249|NCT02222688|528622110|FG000|Overall Study|Withdrawal by Subject|0|||
146577250|NCT02222688|528622111|FG001|Overall Study|Withdrawal by Subject|0|||
146577251|NCT02222688|528622112|FG002|Overall Study|Withdrawal by Subject|0|||
146577252|NCT02222688|528622113|FG003|Overall Study|Withdrawal by Subject|2|||
146577253|NCT02222688|528622114|FG004|Overall Study|Withdrawal by Subject|1|||
146577254|NCT02222688|528622115|FG005|Overall Study|Withdrawal by Subject|0|||
146577255|NCT02222688|528622116|FG006|Overall Study|Withdrawal by Subject|1|||
146577256|NCT02222688|528622110|FG000|Overall Study|Disease progression|1|||
146577257|NCT02222688|528622111|FG001|Overall Study|Disease progression|0|||
146577258|NCT02222688|528622112|FG002|Overall Study|Disease progression|0|||
146577259|NCT02222688|528622113|FG003|Overall Study|Disease progression|0|||
146577260|NCT02222688|528622114|FG004|Overall Study|Disease progression|0|||
146577261|NCT02222688|528622115|FG005|Overall Study|Disease progression|0|||
146577262|NCT02222688|528622116|FG006|Overall Study|Disease progression|0|||
146577263|NCT03037476|528622126|FG000|Overall Study|Lost to Follow-up|63|||
146577264|NCT03037476|528622127|FG001|Overall Study|Lost to Follow-up|46|||
146577265|NCT02141633|528622128|FG000|Overall Study|Physician Decision|1|||
146577266|NCT02141633|528622129|FG001|Overall Study|Physician Decision|0|||
146577267|NCT03053440|528622132|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
146577268|NCT03053440|528622133|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
146577269|NCT03053440|528622132|FG000|Overall Study|Death|18|||
146577270|NCT03053440|528622133|FG001|Overall Study|Death|14|||
146577271|NCT03053440|528622132|FG000|Overall Study|Withdrawal by Subject|9|||
146577272|NCT03053440|528622133|FG001|Overall Study|Withdrawal by Subject|8|||
146577273|NCT03053440|528622132|FG000|Overall Study|Lost to Follow-up|1|||
146577274|NCT03053440|528622133|FG001|Overall Study|Lost to Follow-up|0|||
146577275|NCT03053440|528622132|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
146577276|NCT03053440|528622133|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
146577277|NCT03053440|528622132|FG000|Overall Study|Physician Decision|2|||
146577278|NCT03053440|528622133|FG001|Overall Study|Physician Decision|1|||
146577279|NCT03053440|528622132|FG000|Overall Study|Participant Randomized but died before dosing|1|||
146577280|NCT03053440|528622133|FG001|Overall Study|Participant Randomized but died before dosing|0|||
146577281|NCT01188551|528622134|FG000|Overall Study|Pharmacy issues|1|||
146577282|NCT01188551|528622135|FG001|Overall Study|Pharmacy issues|0|||
146577283|NCT01188551|528622136|FG002|Overall Study|Pharmacy issues|0|||
146577284|NCT01188551|528622137|FG003|Overall Study|Pharmacy issues|0|||
146577285|NCT00391053|528622138|FG000|Overall Study|Serious Adverse Events|1|||
146577286|NCT00391053|528622139|FG001|Overall Study|Serious Adverse Events|0|||
146577287|NCT00391053|528622140|FG002|Overall Study|Serious Adverse Events|1|||
146577288|NCT00391053|528622141|FG003|Overall Study|Serious Adverse Events|4|||
146577289|NCT00391053|528622138|FG000|Overall Study|Protocol Violation|2|||
146577290|NCT00391053|528622139|FG001|Overall Study|Protocol Violation|0|||
146577291|NCT00391053|528622140|FG002|Overall Study|Protocol Violation|0|||
146577292|NCT00391053|528622141|FG003|Overall Study|Protocol Violation|0|||
146577293|NCT00391053|528622138|FG000|Overall Study|Lost to Follow-up|1|||
146577294|NCT00391053|528622139|FG001|Overall Study|Lost to Follow-up|0|||
146577295|NCT00391053|528622140|FG002|Overall Study|Lost to Follow-up|0|||
146577296|NCT00391053|528622141|FG003|Overall Study|Lost to Follow-up|5|||
146577297|NCT00391053|528622138|FG000|Overall Study|Withdrawal by Subject|5|||
146577298|NCT00391053|528622139|FG001|Overall Study|Withdrawal by Subject|1|||
146577299|NCT00391053|528622140|FG002|Overall Study|Withdrawal by Subject|1|||
146577300|NCT00391053|528622141|FG003|Overall Study|Withdrawal by Subject|1|||
146577301|NCT02140970|528622143|FG000|Overall Study|Lost to Follow-up|1|||
146577302|NCT02140970|528622144|FG001|Overall Study|Lost to Follow-up|2|||
146577303|NCT02140970|528622143|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
146577304|NCT02140970|528622144|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
146577305|NCT02140970|528622143|FG000|Overall Study|Did not meet inclusion criteria|0|||
146577306|NCT02140970|528622144|FG001|Overall Study|Did not meet inclusion criteria|1|||
146577307|NCT05069597|528622145|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
146577308|NCT05069597|528622146|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
146577309|NCT01014767|528622147|FG000|Overall Study|PI left institution, data unavailable|12|||
146577310|NCT01014767|528622148|FG001|Overall Study|PI left institution, data unavailable|1|||
146577311|NCT01014767|528622149|FG002|Overall Study|PI left institution, data unavailable|4|||
146978198|NCT00078819|530082262|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
146978199|NCT00078819|530082259|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
146577312|NCT01014767|528622150|FG003|Overall Study|PI left institution, data unavailable|1|||
146577313|NCT00131352|528622151|FG000|Initial Treatment Period|Adverse Event|1|||
146577314|NCT00131352|528622152|FG001|Initial Treatment Period|Adverse Event|3|||
146577315|NCT00131352|528622151|FG000|Initial Treatment Period|Non-compliant|1|||
146577316|NCT00131352|528622152|FG001|Initial Treatment Period|Non-compliant|2|||
146577317|NCT00131352|528622151|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
146577318|NCT00131352|528622152|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
146577319|NCT00131352|528622151|FG000|Initial Treatment Period|Lack of Efficacy|6|||
146577320|NCT00131352|528622152|FG001|Initial Treatment Period|Lack of Efficacy|4|||
146577321|NCT00131352|528622151|FG000|Initial Treatment Period|Other|0|||
146577322|NCT00131352|528622152|FG001|Initial Treatment Period|Other|2|||
146577323|NCT00131352|528622151|FG000|Repeat Treatment Period|Adverse Event|1|||
146577324|NCT00131352|528622152|FG001|Repeat Treatment Period|Adverse Event|0|||
146577325|NCT00131352|528622151|FG000|Repeat Treatment Period|Other|1|||
146577326|NCT00131352|528622152|FG001|Repeat Treatment Period|Other|0|||
146577327|NCT02553928|528622153|FG000|Overall Study|Adverse Event|2|||
146577328|NCT02553928|528622154|FG001|Overall Study|Adverse Event|1|||
146577329|NCT02553928|528622153|FG000|Overall Study|Lost to Follow-up|0|||
146577330|NCT02553928|528622154|FG001|Overall Study|Lost to Follow-up|1|||
146577331|NCT02553928|528622153|FG000|Overall Study|Administrative reason(s)|0|||
146577332|NCT02553928|528622154|FG001|Overall Study|Administrative reason(s)|1|||
146577333|NCT02526212|528622155|FG000|Overall Study|Incarceration|1|||
146577334|NCT02526212|528622156|FG001|Overall Study|Incarceration|0|||
146577335|NCT02526212|528622155|FG000|Overall Study|Lost to Follow-up|1|||
146577336|NCT02526212|528622156|FG001|Overall Study|Lost to Follow-up|0|||
146577337|NCT02526212|528622155|FG000|Overall Study|Death|0|||
146577338|NCT02526212|528622156|FG001|Overall Study|Death|1|||
146577339|NCT00040742|528622157|FG000|Overall Study|Death|0|||
146577340|NCT00040742|528622158|FG001|Overall Study|Death|0|||
146577341|NCT00040742|528622159|FG002|Overall Study|Death|1|||
146577342|NCT00040742|528622160|FG003|Overall Study|Death|0|||
146577343|NCT00040742|528622157|FG000|Overall Study|Adverse Event|15|||
146577344|NCT00040742|528622158|FG001|Overall Study|Adverse Event|16|||
146577345|NCT00040742|528622159|FG002|Overall Study|Adverse Event|21|||
146577346|NCT00040742|528622160|FG003|Overall Study|Adverse Event|9|||
146577347|NCT00040742|528622157|FG000|Overall Study|Withdrawal by Subject|7|||
146577348|NCT00040742|528622158|FG001|Overall Study|Withdrawal by Subject|15|||
146577349|NCT00040742|528622159|FG002|Overall Study|Withdrawal by Subject|10|||
146577350|NCT00040742|528622160|FG003|Overall Study|Withdrawal by Subject|13|||
146577351|NCT00040742|528622157|FG000|Overall Study|Chemotoxicity|4|||
146577352|NCT00040742|528622158|FG001|Overall Study|Chemotoxicity|3|||
146577353|NCT00040742|528622159|FG002|Overall Study|Chemotoxicity|5|||
146577354|NCT00040742|528622160|FG003|Overall Study|Chemotoxicity|2|||
146577355|NCT00040742|528622157|FG000|Overall Study|Incomplete Forms|6|||
146577356|NCT00040742|528622158|FG001|Overall Study|Incomplete Forms|10|||
146577357|NCT00040742|528622159|FG002|Overall Study|Incomplete Forms|4|||
146577358|NCT00040742|528622160|FG003|Overall Study|Incomplete Forms|5|||
146577359|NCT00040742|528622157|FG000|Overall Study|Other medical|7|||
146577360|NCT00040742|528622158|FG001|Overall Study|Other medical|5|||
146577361|NCT00040742|528622159|FG002|Overall Study|Other medical|5|||
146577362|NCT00040742|528622160|FG003|Overall Study|Other medical|5|||
146577363|NCT01434654|528622162|FG000|Overall Study|Withdrawal by Subject|1|||
146577364|NCT01434654|528622163|FG001|Overall Study|Withdrawal by Subject|0|||
146577365|NCT01434654|528622162|FG000|Overall Study|Lost to Follow-up|1|||
146577366|NCT01434654|528622163|FG001|Overall Study|Lost to Follow-up|0|||
146577367|NCT00645840|528622164|FG000|Overall Study|Protocol Violation|3|||
146577368|NCT00402324|528622165|FG000|Overall Study|Lost to Follow-up|11|||
146577369|NCT00402324|528622166|FG001|Overall Study|Lost to Follow-up|11|||
146577370|NCT00402324|528622165|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
146978200|NCT00078819|530082260|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
146978201|NCT00078819|530082261|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
146577371|NCT00402324|528622166|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
146577372|NCT00402324|528622165|FG000|Overall Study|Protocol Violation|8|||
146577373|NCT00402324|528622166|FG001|Overall Study|Protocol Violation|7|||
146577374|NCT00402324|528622165|FG000|Overall Study|Withdrawal by Subject|5|||
146577375|NCT00402324|528622166|FG001|Overall Study|Withdrawal by Subject|2|||
146577376|NCT00402324|528622165|FG000|Overall Study|Physician Decision|2|||
146577377|NCT00402324|528622166|FG001|Overall Study|Physician Decision|4|||
146577378|NCT00402324|528622165|FG000|Overall Study|Sponsor Decision|4|||
146577379|NCT00402324|528622166|FG001|Overall Study|Sponsor Decision|5|||
146577380|NCT00402324|528622165|FG000|Overall Study|Lack of Efficacy|1|||
146577381|NCT00402324|528622166|FG001|Overall Study|Lack of Efficacy|4|||
146577382|NCT00402324|528622165|FG000|Overall Study|Adverse Event|6|||
146577383|NCT00402324|528622166|FG001|Overall Study|Adverse Event|4|||
146577384|NCT00402324|528622165|FG000|Overall Study|Death|1|||
146577385|NCT00402324|528622166|FG001|Overall Study|Death|0|||
146577386|NCT01823198|528622167|FG000|Overall Study|Physician Decision|0|||
146577387|NCT01823198|528622168|FG001|Overall Study|Physician Decision|1|||
146577388|NCT01823198|528622169|FG002|Overall Study|Physician Decision|0|||
146577389|NCT01823198|528622170|FG003|Overall Study|Physician Decision|0|||
146577390|NCT01823198|528622171|FG004|Overall Study|Physician Decision|0|||
146577391|NCT01823198|528622172|FG005|Overall Study|Physician Decision|3|||
146577392|NCT01823198|528622173|FG006|Overall Study|Physician Decision|3|||
146577393|NCT01119066|528622174|FG000|Overall Study|Withdrawal by Subject|4|||
146577394|NCT01119066|528622175|FG001|Overall Study|Withdrawal by Subject|6|||
146577395|NCT01119066|528622176|FG002|Overall Study|Withdrawal by Subject|0|||
146577396|NCT01119066|528622177|FG003|Overall Study|Withdrawal by Subject|0|||
146577397|NCT01119066|528622174|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
146577398|NCT01119066|528622175|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
146577399|NCT01119066|528622176|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
146577400|NCT01119066|528622177|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
146577401|NCT01119066|528622174|FG000|Overall Study|Relapse identified before transplant|1|||
146577402|NCT01119066|528622175|FG001|Overall Study|Relapse identified before transplant|0|||
146577403|NCT01119066|528622176|FG002|Overall Study|Relapse identified before transplant|0|||
146577404|NCT01119066|528622177|FG003|Overall Study|Relapse identified before transplant|0|||
146577405|NCT01119066|528622174|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
146577406|NCT01119066|528622175|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
146577407|NCT01119066|528622176|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
146577408|NCT01119066|528622177|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
146577409|NCT01119066|528622174|FG000|Overall Study|Relapse identified before transplant|0|||
146577410|NCT01119066|528622175|FG001|Overall Study|Relapse identified before transplant|4|||
146577411|NCT01119066|528622176|FG002|Overall Study|Relapse identified before transplant|0|||
146577412|NCT01119066|528622177|FG003|Overall Study|Relapse identified before transplant|0|||
146577413|NCT02441101|528622178|FG000|Overall Study|Withdrawal by Subject|1|||
146577414|NCT02441101|528622179|FG001|Overall Study|Withdrawal by Subject|0|||
146577415|NCT02441101|528622178|FG000|Overall Study|Lost to Follow-up|1|||
146577416|NCT02441101|528622179|FG001|Overall Study|Lost to Follow-up|0|||
146577417|NCT02441101|528622178|FG000|Overall Study|PI relocated and study terminated|1|||
146577418|NCT02441101|528622179|FG001|Overall Study|PI relocated and study terminated|0|||
146577419|NCT03012828|528622180|FG000|Overall Study|Lost to Follow-up|1|||
146577420|NCT03012828|528622181|FG001|Overall Study|Lost to Follow-up|0|||
146577421|NCT03012828|528622182|FG002|Overall Study|Lost to Follow-up|1|||
146577422|NCT03012828|528622183|FG003|Overall Study|Lost to Follow-up|0|||
146577423|NCT03012828|528622184|FG004|Overall Study|Lost to Follow-up|1|||
146577424|NCT03012828|528622185|FG005|Overall Study|Lost to Follow-up|0|||
146577425|NCT03012828|528622180|FG000|Overall Study|Withdrawal by Subject|0|||
146577426|NCT03012828|528622181|FG001|Overall Study|Withdrawal by Subject|0|||
146577427|NCT03012828|528622182|FG002|Overall Study|Withdrawal by Subject|1|||
146577428|NCT03012828|528622183|FG003|Overall Study|Withdrawal by Subject|0|||
146577429|NCT03012828|528622184|FG004|Overall Study|Withdrawal by Subject|0|||
146577430|NCT03012828|528622185|FG005|Overall Study|Withdrawal by Subject|1|||
146577431|NCT03012828|528622180|FG000|Overall Study|Non-compliance with protocol|0|||
146577432|NCT03012828|528622181|FG001|Overall Study|Non-compliance with protocol|0|||
146577433|NCT03012828|528622182|FG002|Overall Study|Non-compliance with protocol|0|||
146577434|NCT03012828|528622183|FG003|Overall Study|Non-compliance with protocol|0|||
146577435|NCT03012828|528622184|FG004|Overall Study|Non-compliance with protocol|1|||
146577436|NCT03012828|528622185|FG005|Overall Study|Non-compliance with protocol|0|||
146577437|NCT03012828|528622180|FG000|Overall Study|Delay to last visit would delay DBL|0|||
146577438|NCT03012828|528622181|FG001|Overall Study|Delay to last visit would delay DBL|0|||
146577439|NCT03012828|528622182|FG002|Overall Study|Delay to last visit would delay DBL|0|||
146577440|NCT03012828|528622183|FG003|Overall Study|Delay to last visit would delay DBL|0|||
146577441|NCT03012828|528622184|FG004|Overall Study|Delay to last visit would delay DBL|0|||
146577442|NCT03012828|528622185|FG005|Overall Study|Delay to last visit would delay DBL|1|||
146577443|NCT01509846|528622186|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
146577444|NCT01509846|528622187|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
146577445|NCT01509846|528622188|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
146577446|NCT01509846|528622189|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
146577447|NCT01509846|528622190|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
146577448|NCT01509846|528622186|FG000|Received Vaccination 2|Illness|0|||
146577449|NCT01509846|528622187|FG001|Received Vaccination 2|Illness|0|||
146577450|NCT01509846|528622188|FG002|Received Vaccination 2|Illness|0|||
146577451|NCT01509846|528622189|FG003|Received Vaccination 2|Illness|0|||
146577452|NCT01509846|528622190|FG004|Received Vaccination 2|Illness|1|||
146577453|NCT01509846|528622186|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
146577454|NCT01509846|528622187|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
146577455|NCT01509846|528622188|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
146651951|NCT02616601|528903724|FG001|Overall Study|Withdrawal by Subject|4|||
146577456|NCT01509846|528622189|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
146577457|NCT01509846|528622190|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
146577458|NCT01509846|528622186|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
146577459|NCT01509846|528622187|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
146577460|NCT01509846|528622188|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
146577461|NCT01509846|528622189|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
146577462|NCT01509846|528622190|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
146577463|NCT01509846|528622186|FG000|Received Vaccination 3|Pregnancy|0|||
146577464|NCT01509846|528622187|FG001|Received Vaccination 3|Pregnancy|0|||
146577465|NCT01509846|528622188|FG002|Received Vaccination 3|Pregnancy|0|||
146577466|NCT01509846|528622189|FG003|Received Vaccination 3|Pregnancy|1|||
146577467|NCT01509846|528622190|FG004|Received Vaccination 3|Pregnancy|0|||
146577468|NCT01509846|528622186|FG000|Received Vaccination 3|Lost to Follow-up|0|||
146577469|NCT01509846|528622187|FG001|Received Vaccination 3|Lost to Follow-up|0|||
146577470|NCT01509846|528622188|FG002|Received Vaccination 3|Lost to Follow-up|1|||
146577471|NCT01509846|528622189|FG003|Received Vaccination 3|Lost to Follow-up|0|||
146577472|NCT01509846|528622190|FG004|Received Vaccination 3|Lost to Follow-up|0|||
146577473|NCT03900728|528622191|FG000|Overall Study|No text responses|0|||
146577474|NCT03900728|528622192|FG001|Overall Study|No text responses|0|||
146577475|NCT03900728|528622193|FG002|Overall Study|No text responses|4|||
146577476|NCT02544750|528622195|FG000|Overall Study|Physician Decision|3|||
146577477|NCT02544750|528622196|FG001|Overall Study|Physician Decision|1|||
146577478|NCT02544750|528622195|FG000|Overall Study|Other reasons|69|||
146577479|NCT02544750|528622196|FG001|Overall Study|Other reasons|39|||
146577480|NCT02544750|528622195|FG000|Overall Study|Met withdrawal criteria|2|||
146577481|NCT02544750|528622196|FG001|Overall Study|Met withdrawal criteria|2|||
146577482|NCT02544750|528622195|FG000|Overall Study|Transition To Commercial Product|1|||
146577483|NCT02544750|528622196|FG001|Overall Study|Transition To Commercial Product|0|||
146577484|NCT02544750|528622195|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
146577485|NCT02544750|528622196|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
146577486|NCT02544750|528622195|FG000|Overall Study|Adverse Event|8|||
146577487|NCT02544750|528622196|FG001|Overall Study|Adverse Event|10|||
146577488|NCT02544750|528622195|FG000|Overall Study|Withdrawal by Subject|10|||
146577489|NCT02544750|528622196|FG001|Overall Study|Withdrawal by Subject|4|||
146577490|NCT02544750|528622195|FG000|Overall Study|Lost to Follow-up|1|||
146577491|NCT02544750|528622196|FG001|Overall Study|Lost to Follow-up|0|||
146577492|NCT02484443|528622199|FG000|Overall Study|Lack of Efficacy|28|||
146577493|NCT02484443|528622199|FG000|Overall Study|Physician Decision|2|||
146577494|NCT02484443|528622199|FG000|Overall Study|Ineligible|2|||
146577495|NCT02969915|528622200|FG000|Overall Study|Death|104|||
146577496|NCT02969915|528622201|FG001|Overall Study|Death|125|||
146577497|NCT02969915|528622200|FG000|Overall Study|Lost to Follow-up|108|||
146577498|NCT02969915|528622201|FG001|Overall Study|Lost to Follow-up|112|||
146577499|NCT02969915|528622200|FG000|Overall Study|Censored due to COVID-19|481|||
146577500|NCT02969915|528622201|FG001|Overall Study|Censored due to COVID-19|471|||
146577501|NCT02595866|528622202|FG000|Overall Study|Adverse Event|2|||
146577502|NCT02595866|528622203|FG001|Overall Study|Adverse Event|5|||
146577503|NCT02595866|528622202|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
146577504|NCT02595866|528622203|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
146577505|NCT02595866|528622202|FG000|Overall Study|Death|0|||
146577506|NCT02595866|528622203|FG001|Overall Study|Death|1|||
146577507|NCT02595866|528622202|FG000|Overall Study|Incarceration|1|||
146577508|NCT02595866|528622203|FG001|Overall Study|Incarceration|0|||
146577509|NCT02595866|528622202|FG000|Overall Study|Lack of Efficacy|17|||
146577510|NCT02595866|528622203|FG001|Overall Study|Lack of Efficacy|7|||
146577511|NCT02595866|528622202|FG000|Overall Study|Physician Decision|4|||
146577512|NCT02595866|528622203|FG001|Overall Study|Physician Decision|3|||
146577513|NCT02595866|528622202|FG000|Overall Study|Switched to Alternative Treatment|1|||
146577514|NCT02595866|528622203|FG001|Overall Study|Switched to Alternative Treatment|0|||
146577515|NCT02595866|528622202|FG000|Overall Study|Study Terminated|0|||
146770672|NCT03260140|529328655|FG001|Overall Study|Death|1|||
146770673|NCT03260140|529328654|FG000|Overall Study|Withdrawal by Subject|1|||
146577516|NCT02595866|528622203|FG001|Overall Study|Study Terminated|4|||
146577517|NCT02595866|528622202|FG000|Overall Study|Withdrawal by Subject|6|||
146770674|NCT03260140|529328655|FG001|Overall Study|Withdrawal by Subject|4|||
146577518|NCT02595866|528622203|FG001|Overall Study|Withdrawal by Subject|1|||
146577519|NCT02520388|528622204|FG000|Overall Study|Physician Decision|1|||
146577520|NCT02520388|528622205|FG001|Overall Study|Physician Decision|0|||
146577521|NCT02520388|528622204|FG000|Overall Study|Subject or parent/guardian request|0|||
146577522|NCT02520388|528622205|FG001|Overall Study|Subject or parent/guardian request|6|||
146577523|NCT02520388|528622204|FG000|Overall Study|Adverse Event|1|||
146577524|NCT02520388|528622205|FG001|Overall Study|Adverse Event|4|||
146577525|NCT02520388|528622204|FG000|Overall Study|Lost to Follow-up|3|||
146577526|NCT02520388|528622205|FG001|Overall Study|Lost to Follow-up|2|||
146577527|NCT02520388|528622204|FG000|Overall Study|Other (reason not defined)|4|||
146770675|NCT05283395|529328658|FG000|Overall Study|Adverse Event|4|||
146770676|NCT05283395|529328659|FG001|Overall Study|Adverse Event|4|||
146918304|NCT02163993|529862807|FG002|Treatment Period|Not treated|0|||
146577528|NCT02520388|528622205|FG001|Overall Study|Other (reason not defined)|4|||
146577529|NCT03162796|528622208|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
146577530|NCT03162796|528622209|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
146577531|NCT03162796|528622210|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
146577532|NCT03162796|528622208|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
146577533|NCT03162796|528622209|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
146577534|NCT03162796|528622210|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
146577535|NCT03162796|528622208|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
146577536|NCT03162796|528622209|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
146577537|NCT03162796|528622210|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
146577538|NCT03162796|528622208|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
146577539|NCT03162796|528622209|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
146577540|NCT03162796|528622210|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
146577541|NCT03162796|528622208|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
146577542|NCT03162796|528622209|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
146577543|NCT03162796|528622210|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
146577544|NCT03162796|528622208|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
146577545|NCT03162796|528622209|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
146577546|NCT03162796|528622210|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
146577547|NCT03162796|528622208|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
146577548|NCT03162796|528622209|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
146577549|NCT03162796|528622210|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
146577550|NCT03162796|528622208|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
146577551|NCT03162796|528622209|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
146577552|NCT03162796|528622210|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
146577553|NCT03162796|528622208|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
146577554|NCT03162796|528622209|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
146918305|NCT02163993|529862808|FG003|Treatment Period|Not treated|1|||
146577555|NCT03162796|528622210|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
146577556|NCT03162796|528622208|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
146577557|NCT03162796|528622209|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
146770677|NCT05283395|529328660|FG002|Overall Study|Adverse Event|0|||
146577558|NCT03162796|528622210|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
146577559|NCT03162796|528622208|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
146577560|NCT03162796|528622209|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
146577561|NCT03162796|528622210|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
146577562|NCT02342288|528622211|FG000|Overall Study|no protocol anesthesiologist available|3|||
146577563|NCT02342288|528622212|FG001|Overall Study|no protocol anesthesiologist available|2|||
146577564|NCT02342288|528622211|FG000|Overall Study|anesthesia leak in system|1|||
146577565|NCT02342288|528622212|FG001|Overall Study|anesthesia leak in system|0|||
146577566|NCT02342288|528622211|FG000|Overall Study|Withdrawal by Subject|1|||
146577567|NCT02342288|528622212|FG001|Overall Study|Withdrawal by Subject|0|||
146577568|NCT02342288|528622211|FG000|Overall Study|coordinator contaminated with blood|0|||
146577569|NCT02342288|528622212|FG001|Overall Study|coordinator contaminated with blood|1|||
146577570|NCT02342288|528622211|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
146577571|NCT02342288|528622212|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
146577572|NCT02342288|528622211|FG000|Overall Study|coordinator not available|0|||
146577573|NCT02342288|528622212|FG001|Overall Study|coordinator not available|2|||
146577574|NCT02375373|528622213|FG000|Overall Study|Withdrawal by Subject|11|||
146577575|NCT00407602|528622214|FG000|Overall Study|Death - unrelated to device|1|||
146577576|NCT00407602|528622214|FG000|Overall Study|Device explanted|5|||
146577577|NCT00407602|528622214|FG000|Overall Study|Withdrawal by Subject|1|||
146577578|NCT00431444|528622215|FG000|Overall Study|Protocol Violation|1|||
146577579|NCT00431444|528622216|FG001|Overall Study|Protocol Violation|4|||
146577580|NCT00431444|528622215|FG000|Overall Study|Adverse Event|2|||
146577581|NCT00431444|528622216|FG001|Overall Study|Adverse Event|1|||
146577582|NCT00431444|528622215|FG000|Overall Study|Withdrawal by Subject|1|||
146577583|NCT00431444|528622216|FG001|Overall Study|Withdrawal by Subject|1|||
146918306|NCT02163993|529862809|FG004|Treatment Period|Not treated|2|||
146918307|NCT02163993|529862805|FG000|Post-treatment Period|Adverse Event|0|||
146918308|NCT02163993|529862806|FG001|Post-treatment Period|Adverse Event|0|||
146577584|NCT00431444|528622215|FG000|Overall Study|Lost to Follow-up|1|||
146577585|NCT00431444|528622216|FG001|Overall Study|Lost to Follow-up|0|||
146577586|NCT00431444|528622215|FG000|Overall Study|Administrative Problems|0|||
146577587|NCT00431444|528622216|FG001|Overall Study|Administrative Problems|1|||
146577588|NCT02517398|528622235|FG000|Overall Study|Death|2|||
146577589|NCT02517398|528622236|FG001|Overall Study|Death|3|||
146577590|NCT02517398|528622237|FG002|Overall Study|Death|4|||
146577591|NCT02517398|528622238|FG003|Overall Study|Death|2|||
146577592|NCT02517398|528622239|FG004|Overall Study|Death|3|||
146918309|NCT02163993|529862807|FG002|Post-treatment Period|Adverse Event|1|||
146577593|NCT02517398|528622240|FG005|Overall Study|Death|8|||
146577594|NCT02517398|528622241|FG006|Overall Study|Death|3|||
146577595|NCT02517398|528622242|FG007|Overall Study|Death|2|||
146918310|NCT02163993|529862808|FG003|Post-treatment Period|Adverse Event|0|||
146918311|NCT02163993|529862809|FG004|Post-treatment Period|Adverse Event|0|||
146577596|NCT02517398|528622243|FG008|Overall Study|Death|6|||
146577597|NCT02517398|528622244|FG009|Overall Study|Death|24|||
146577598|NCT02517398|528622245|FG010|Overall Study|Death|53|||
146577599|NCT02517398|528622246|FG011|Overall Study|Death|25|||
146577600|NCT02517398|528622247|FG012|Overall Study|Death|73|||
146577601|NCT02517398|528622248|FG013|Overall Study|Death|29|||
146577602|NCT02517398|528622249|FG014|Overall Study|Death|26|||
146577603|NCT02517398|528622250|FG015|Overall Study|Death|23|||
146577604|NCT02517398|528622251|FG016|Overall Study|Death|26|||
146577605|NCT02517398|528622252|FG017|Overall Study|Death|25|||
146577606|NCT02517398|528622253|FG018|Overall Study|Death|22|||
146577607|NCT02517398|528622254|FG019|Overall Study|Death|7|||
146577608|NCT02517398|528622255|FG020|Overall Study|Death|26|||
146577609|NCT02517398|528622256|FG021|Overall Study|Death|30|||
146577610|NCT02517398|528622257|FG022|Overall Study|Death|20|||
146577611|NCT02517398|528622235|FG000|Overall Study|Other|0|||
146577612|NCT02517398|528622236|FG001|Overall Study|Other|0|||
146577613|NCT02517398|528622237|FG002|Overall Study|Other|0|||
146577614|NCT02517398|528622238|FG003|Overall Study|Other|1|||
146577615|NCT02517398|528622239|FG004|Overall Study|Other|0|||
146577616|NCT02517398|528622240|FG005|Overall Study|Other|0|||
146577617|NCT02517398|528622241|FG006|Overall Study|Other|0|||
146577618|NCT02517398|528622242|FG007|Overall Study|Other|0|||
146577619|NCT02517398|528622243|FG008|Overall Study|Other|0|||
146577620|NCT02517398|528622244|FG009|Overall Study|Other|1|||
146577621|NCT02517398|528622245|FG010|Overall Study|Other|0|||
146577622|NCT02517398|528622246|FG011|Overall Study|Other|0|||
146577623|NCT02517398|528622247|FG012|Overall Study|Other|0|||
146577624|NCT02517398|528622248|FG013|Overall Study|Other|1|||
146577625|NCT02517398|528622249|FG014|Overall Study|Other|0|||
146577626|NCT02517398|528622250|FG015|Overall Study|Other|1|||
146577627|NCT02517398|528622251|FG016|Overall Study|Other|1|||
146577628|NCT02517398|528622252|FG017|Overall Study|Other|0|||
146577629|NCT02517398|528622253|FG018|Overall Study|Other|0|||
146577630|NCT02517398|528622254|FG019|Overall Study|Other|1|||
146577631|NCT02517398|528622255|FG020|Overall Study|Other|0|||
146577632|NCT02517398|528622256|FG021|Overall Study|Other|0|||
146577633|NCT02517398|528622257|FG022|Overall Study|Other|0|||
146577634|NCT02517398|528622235|FG000|Overall Study|Lost to Follow-up|0|||
146577635|NCT02517398|528622236|FG001|Overall Study|Lost to Follow-up|0|||
146577636|NCT02517398|528622237|FG002|Overall Study|Lost to Follow-up|0|||
146577637|NCT02517398|528622238|FG003|Overall Study|Lost to Follow-up|0|||
146577638|NCT02517398|528622239|FG004|Overall Study|Lost to Follow-up|0|||
146577639|NCT02517398|528622240|FG005|Overall Study|Lost to Follow-up|0|||
146577640|NCT02517398|528622241|FG006|Overall Study|Lost to Follow-up|0|||
146577641|NCT02517398|528622242|FG007|Overall Study|Lost to Follow-up|0|||
146577642|NCT02517398|528622243|FG008|Overall Study|Lost to Follow-up|0|||
146577643|NCT02517398|528622244|FG009|Overall Study|Lost to Follow-up|1|||
146577644|NCT02517398|528622245|FG010|Overall Study|Lost to Follow-up|0|||
146577645|NCT02517398|528622246|FG011|Overall Study|Lost to Follow-up|2|||
146577646|NCT02517398|528622247|FG012|Overall Study|Lost to Follow-up|2|||
146577647|NCT02517398|528622248|FG013|Overall Study|Lost to Follow-up|0|||
146577648|NCT02517398|528622249|FG014|Overall Study|Lost to Follow-up|1|||
146577649|NCT02517398|528622250|FG015|Overall Study|Lost to Follow-up|1|||
146577650|NCT02517398|528622251|FG016|Overall Study|Lost to Follow-up|0|||
146577651|NCT02517398|528622252|FG017|Overall Study|Lost to Follow-up|3|||
146577652|NCT02517398|528622253|FG018|Overall Study|Lost to Follow-up|1|||
146577653|NCT02517398|528622254|FG019|Overall Study|Lost to Follow-up|0|||
146577654|NCT02517398|528622255|FG020|Overall Study|Lost to Follow-up|1|||
146577655|NCT02517398|528622256|FG021|Overall Study|Lost to Follow-up|0|||
146577656|NCT02517398|528622257|FG022|Overall Study|Lost to Follow-up|2|||
146577657|NCT02517398|528622235|FG000|Overall Study|Withdrew Consent|0|||
146577658|NCT02517398|528622236|FG001|Overall Study|Withdrew Consent|0|||
146918312|NCT02163993|529862805|FG000|Post-treatment Period|Lost to Follow-up|2|||
146577659|NCT02517398|528622237|FG002|Overall Study|Withdrew Consent|0|||
146577660|NCT02517398|528622238|FG003|Overall Study|Withdrew Consent|0|||
146577661|NCT02517398|528622239|FG004|Overall Study|Withdrew Consent|0|||
146577662|NCT02517398|528622240|FG005|Overall Study|Withdrew Consent|0|||
146577663|NCT02517398|528622241|FG006|Overall Study|Withdrew Consent|1|||
146577664|NCT02517398|528622242|FG007|Overall Study|Withdrew Consent|0|||
146577665|NCT02517398|528622243|FG008|Overall Study|Withdrew Consent|0|||
146577666|NCT02517398|528622244|FG009|Overall Study|Withdrew Consent|2|||
146651952|NCT02616601|528903725|FG002|Overall Study|Withdrawal by Subject|3|||
146577667|NCT02517398|528622245|FG010|Overall Study|Withdrew Consent|7|||
146577668|NCT02517398|528622246|FG011|Overall Study|Withdrew Consent|1|||
146577669|NCT02517398|528622247|FG012|Overall Study|Withdrew Consent|5|||
146577670|NCT02517398|528622248|FG013|Overall Study|Withdrew Consent|4|||
146577671|NCT02517398|528622249|FG014|Overall Study|Withdrew Consent|2|||
146577672|NCT02517398|528622250|FG015|Overall Study|Withdrew Consent|5|||
146770678|NCT05283395|529328658|FG000|Overall Study|Patient Lost to Follow-Up|0|||
146770679|NCT05283395|529328659|FG001|Overall Study|Patient Lost to Follow-Up|0|||
146770680|NCT05283395|529328660|FG002|Overall Study|Patient Lost to Follow-Up|1|||
146918313|NCT02163993|529862806|FG001|Post-treatment Period|Lost to Follow-up|2|||
146577673|NCT02517398|528622251|FG016|Overall Study|Withdrew Consent|4|||
146577674|NCT02517398|528622252|FG017|Overall Study|Withdrew Consent|2|||
146577675|NCT02517398|528622253|FG018|Overall Study|Withdrew Consent|3|||
146577676|NCT02517398|528622254|FG019|Overall Study|Withdrew Consent|2|||
146577677|NCT02517398|528622255|FG020|Overall Study|Withdrew Consent|9|||
146577678|NCT02517398|528622256|FG021|Overall Study|Withdrew Consent|3|||
146577679|NCT02517398|528622257|FG022|Overall Study|Withdrew Consent|1|||
146577680|NCT03554018|528622258|FG000|Overall Study|Lost to Follow-up|3|||
146577681|NCT03554018|528622259|FG001|Overall Study|Lost to Follow-up|7|||
146577682|NCT02131662|528622260|FG000|Overall Study|Protocol Violation|1|||
146577683|NCT02131662|528622261|FG001|Overall Study|Protocol Violation|0|||
146577684|NCT02131662|528622262|FG002|Overall Study|Protocol Violation|0|||
146577685|NCT02131662|528622263|FG003|Overall Study|Protocol Violation|0|||
146577686|NCT02131662|528622264|FG004|Overall Study|Protocol Violation|0|||
146577687|NCT02131662|528622260|FG000|Overall Study|Other|2|||
146577688|NCT02131662|528622261|FG001|Overall Study|Other|4|||
146577689|NCT02131662|528622262|FG002|Overall Study|Other|3|||
146577690|NCT02131662|528622263|FG003|Overall Study|Other|3|||
146577691|NCT02131662|528622264|FG004|Overall Study|Other|4|||
146577692|NCT02131662|528622260|FG000|Overall Study|Adverse Event|0|||
146577693|NCT02131662|528622261|FG001|Overall Study|Adverse Event|1|||
146577694|NCT02131662|528622262|FG002|Overall Study|Adverse Event|1|||
146577695|NCT02131662|528622263|FG003|Overall Study|Adverse Event|1|||
146577696|NCT02131662|528622264|FG004|Overall Study|Adverse Event|3|||
146577697|NCT02131662|528622260|FG000|Overall Study|Pregnancy|0|||
146577698|NCT02131662|528622261|FG001|Overall Study|Pregnancy|1|||
146577699|NCT02131662|528622262|FG002|Overall Study|Pregnancy|0|||
146577700|NCT02131662|528622263|FG003|Overall Study|Pregnancy|1|||
146577701|NCT02131662|528622264|FG004|Overall Study|Pregnancy|0|||
146577702|NCT02131662|528622260|FG000|Overall Study|Wish for pregnancy|0|||
146577703|NCT02131662|528622261|FG001|Overall Study|Wish for pregnancy|0|||
146577704|NCT02131662|528622262|FG002|Overall Study|Wish for pregnancy|0|||
146577705|NCT02131662|528622263|FG003|Overall Study|Wish for pregnancy|0|||
146577706|NCT02131662|528622264|FG004|Overall Study|Wish for pregnancy|1|||
146577707|NCT02131662|528622260|FG000|Overall Study|Lack of Efficacy|1|||
146577708|NCT02131662|528622261|FG001|Overall Study|Lack of Efficacy|0|||
146577709|NCT02131662|528622262|FG002|Overall Study|Lack of Efficacy|0|||
146577710|NCT02131662|528622263|FG003|Overall Study|Lack of Efficacy|0|||
146577711|NCT02131662|528622264|FG004|Overall Study|Lack of Efficacy|1|||
146577712|NCT02131662|528622260|FG000|Overall Study|Withdrawal by Subject|1|||
146577713|NCT02131662|528622261|FG001|Overall Study|Withdrawal by Subject|5|||
146577714|NCT02131662|528622262|FG002|Overall Study|Withdrawal by Subject|1|||
146577715|NCT02131662|528622263|FG003|Overall Study|Withdrawal by Subject|5|||
146577716|NCT02131662|528622264|FG004|Overall Study|Withdrawal by Subject|6|||
146577717|NCT02131662|528622260|FG000|Overall Study|Lost to Follow-up|1|||
146577718|NCT02131662|528622261|FG001|Overall Study|Lost to Follow-up|3|||
146577719|NCT02131662|528622262|FG002|Overall Study|Lost to Follow-up|0|||
146577720|NCT02131662|528622263|FG003|Overall Study|Lost to Follow-up|9|||
146577721|NCT02131662|528622264|FG004|Overall Study|Lost to Follow-up|0|||
146577722|NCT02131662|528622260|FG000|Overall Study|Not treated|2|||
146577723|NCT02131662|528622261|FG001|Overall Study|Not treated|0|||
146577724|NCT02131662|528622262|FG002|Overall Study|Not treated|2|||
146577725|NCT02131662|528622263|FG003|Overall Study|Not treated|2|||
146577726|NCT02131662|528622264|FG004|Overall Study|Not treated|3|||
146577727|NCT00130039|528622270|FG000|Overall Study|Withdrawal by Subject|15|||
146577728|NCT00130039|528622271|FG001|Overall Study|Withdrawal by Subject|11|||
146577729|NCT00130039|528622270|FG000|Overall Study|Lost to Follow-up|3|||
146577730|NCT00130039|528622271|FG001|Overall Study|Lost to Follow-up|1|||
146577731|NCT00130039|528622270|FG000|Overall Study|Adverse Event|4|||
146577732|NCT00130039|528622271|FG001|Overall Study|Adverse Event|2|||
146577733|NCT00130039|528622270|FG000|Overall Study|Physician Decision|3|||
146577734|NCT00130039|528622271|FG001|Overall Study|Physician Decision|0|||
146577735|NCT00130039|528622270|FG000|Overall Study|clinical events without follow up MRI|5|||
146577736|NCT00130039|528622271|FG001|Overall Study|clinical events without follow up MRI|4|||
146577737|NCT01928433|528622272|FG000|Overall Study|Adverse Event|5|||
146577738|NCT01928433|528622273|FG001|Overall Study|Adverse Event|2|||
146577739|NCT01928433|528622274|FG002|Overall Study|Adverse Event|5|||
146577740|NCT01928433|528622272|FG000|Overall Study|Protocol Violation|0|||
146577741|NCT01928433|528622273|FG001|Overall Study|Protocol Violation|0|||
146577742|NCT01928433|528622274|FG002|Overall Study|Protocol Violation|2|||
146577743|NCT01928433|528622272|FG000|Overall Study|Lack of Efficacy|5|||
146577744|NCT01928433|528622273|FG001|Overall Study|Lack of Efficacy|4|||
146577745|NCT01928433|528622274|FG002|Overall Study|Lack of Efficacy|4|||
146577746|NCT01928433|528622272|FG000|Overall Study|Withdrawal by Subject|0|||
146577747|NCT01928433|528622273|FG001|Overall Study|Withdrawal by Subject|4|||
146651953|NCT02616601|528903723|FG000|Overall Study|Adverse Event|2|||
146918314|NCT02163993|529862807|FG002|Post-treatment Period|Lost to Follow-up|3|||
146577748|NCT01928433|528622274|FG002|Overall Study|Withdrawal by Subject|0|||
146577749|NCT01928433|528622272|FG000|Overall Study|Negative screening urine culture|7|||
146577750|NCT01928433|528622273|FG001|Overall Study|Negative screening urine culture|6|||
146577751|NCT01928433|528622274|FG002|Overall Study|Negative screening urine culture|10|||
146577752|NCT01928433|528622272|FG000|Overall Study|Lost to Follow-up|0|||
146577753|NCT01928433|528622273|FG001|Overall Study|Lost to Follow-up|2|||
146577754|NCT01928433|528622274|FG002|Overall Study|Lost to Follow-up|3|||
146577755|NCT01928433|528622272|FG000|Overall Study|Other reasons|3|||
146577756|NCT01928433|528622273|FG001|Overall Study|Other reasons|3|||
146577757|NCT01928433|528622274|FG002|Overall Study|Other reasons|4|||
146577758|NCT01740687|528622275|FG000|Overall Study|Lost to Follow-up|11|||
146577759|NCT01740687|528622275|FG000|Overall Study|Withdrawal by Subject|2|||
146577760|NCT01740687|528622275|FG000|Overall Study|other reason|22|||
146577761|NCT01740687|528622275|FG000|Overall Study|treatment not received|2|||
146577762|NCT01016132|528622277|FG000|Overall Study|Discomfort|1|||
146577763|NCT01198574|528622279|FG000|Overall Study|Resigned from schools|4|||
146577764|NCT01198574|528622280|FG001|Overall Study|Resigned from schools|1|||
146577765|NCT01198574|528622281|FG002|Overall Study|Resigned from schools|1|||
146577766|NCT01198574|528622282|FG003|Overall Study|Resigned from schools|4|||
146577767|NCT00556439|528622283|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
146577768|NCT00556439|528622284|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
146577769|NCT00556439|528622285|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
146577770|NCT00556439|528622286|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
146577771|NCT00556439|528622283|FG000|Study Entry to Week 12|Physician Decision|1|||
146577772|NCT00556439|528622284|FG001|Study Entry to Week 12|Physician Decision|0|||
146577773|NCT00556439|528622285|FG002|Study Entry to Week 12|Physician Decision|0|||
146577774|NCT00556439|528622286|FG003|Study Entry to Week 12|Physician Decision|0|||
146577775|NCT00556439|528622283|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
146577776|NCT00556439|528622284|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
146577777|NCT00556439|528622285|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
146577778|NCT00556439|528622286|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
146577779|NCT00556439|528622283|FG000|Study Entry to Week 12|Recurrent infection|1|||
146577780|NCT00556439|528622284|FG001|Study Entry to Week 12|Recurrent infection|0|||
146577781|NCT00556439|528622285|FG002|Study Entry to Week 12|Recurrent infection|0|||
146577782|NCT00556439|528622286|FG003|Study Entry to Week 12|Recurrent infection|0|||
146577783|NCT00556439|528622283|FG000|Study Entry to Week 12|Malignancy|0|||
146577784|NCT00556439|528622284|FG001|Study Entry to Week 12|Malignancy|0|||
146577785|NCT00556439|528622285|FG002|Study Entry to Week 12|Malignancy|1|||
146577786|NCT00556439|528622286|FG003|Study Entry to Week 12|Malignancy|0|||
146577787|NCT00556439|528622283|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
146577788|NCT00556439|528622284|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
146577789|NCT00556439|528622285|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
146577790|NCT00556439|528622286|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
146577791|NCT00556439|528622283|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
146577792|NCT00556439|528622284|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
146577793|NCT00556439|528622285|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
146577794|NCT00556439|528622286|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
146577795|NCT00556439|528622283|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
146577796|NCT00556439|528622284|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
146577797|NCT00556439|528622285|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
146577798|NCT00556439|528622286|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
146577799|NCT00556439|528622283|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
146577800|NCT00556439|528622284|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
146577801|NCT00556439|528622285|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
146577802|NCT00556439|528622286|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
146577803|NCT02100423|528622287|FG000|Overall Study|Death|1|||
146577804|NCT02100423|528622287|FG000|Overall Study|Withdrawal by Subject|3|||
146577805|NCT02100423|528622287|FG000|Overall Study|Adverse Event|1|||
146577806|NCT02100423|528622287|FG000|Overall Study|Physician Decision|1|||
146577807|NCT03744910|528624361|FG000|Overall Study|Withdrew Consent|1|||
146577808|NCT03744910|528624362|FG001|Overall Study|Withdrew Consent|8|||
146577809|NCT03744910|528624361|FG000|Overall Study|Physician Decision|5|||
146577810|NCT03744910|528624362|FG001|Overall Study|Physician Decision|4|||
146577811|NCT03744910|528624361|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
146577812|NCT03744910|528624362|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
146577813|NCT03744910|528624361|FG000|Overall Study|Lost to Follow-up|0|||
146577814|NCT03744910|528624362|FG001|Overall Study|Lost to Follow-up|1|||
146577815|NCT03744910|528624361|FG000|Overall Study|Other-unspecified|4|||
146577816|NCT03744910|528624362|FG001|Overall Study|Other-unspecified|1|||
146577817|NCT02744612|528624363|FG000|Overall Study|Withdrawal by Subject|0|||
146577818|NCT02744612|528624364|FG001|Overall Study|Withdrawal by Subject|2|||
146577819|NCT02220855|528624366|FG000|Overall Study|Adverse Event|8|||
146918315|NCT02163993|529862808|FG003|Post-treatment Period|Lost to Follow-up|1|||
146918316|NCT02163993|529862809|FG004|Post-treatment Period|Lost to Follow-up|0|||
146577820|NCT02220855|528624366|FG000|Overall Study|Disease Progression|5|||
146577821|NCT02220855|528624366|FG000|Overall Study|Withdrawal by Subject|1|||
146577822|NCT03280303|528624367|FG000|Overall Study|Death|505|||
146577823|NCT03280303|528624367|FG000|Overall Study|Study terminated by sponsor|383|||
146577824|NCT03280303|528624367|FG000|Overall Study|Other|148|||
146577825|NCT03280303|528624367|FG000|Overall Study|No longer willing to participate in study|101|||
146577826|NCT03280303|528624367|FG000|Overall Study|Lost to follow up|39|||
146577827|NCT03280303|528624367|FG000|Overall Study|Adverse Event|20|||
146577828|NCT03419897|528624368|FG000|Overall Study|Death|180|||
146577829|NCT03419897|528624368|FG000|Overall Study|Lost to Follow-up|1|||
146577830|NCT03419897|528624368|FG000|Overall Study|Withdrawal by Subject|6|||
146577831|NCT03419897|528624368|FG000|Overall Study|Sponsor Decision|61|||
146577832|NCT03419897|528624368|FG000|Overall Study|Physician Decision|1|||
146577833|NCT01945216|528624371|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
146577834|NCT01945216|528624371|FG000|Overall Study|Protocol Violation|42|||
146577835|NCT01945216|528624371|FG000|Overall Study|CRF not assured by investigators|5|||
146577836|NCT01905943|528624375|FG000|Overall Study|Withdrawal of consent|90|||
146577837|NCT01905943|528624375|FG000|Overall Study|Lost to Follow-up|16|||
146577838|NCT01905943|528624375|FG000|Overall Study|Investigator discretion|7|||
146577839|NCT01905943|528624375|FG000|Overall Study|Death|186|||
146577840|NCT01905943|528624375|FG000|Overall Study|Adverse Event|3|||
146577841|NCT01905943|528624375|FG000|Overall Study|Other|12|||
146577842|NCT02574078|528624376|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146577843|NCT02574078|528624377|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146577844|NCT02574078|528624378|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146577845|NCT02574078|528624379|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146577846|NCT02574078|528624380|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146577847|NCT02574078|528624381|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
146577848|NCT02574078|528624382|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
146577849|NCT02574078|528624383|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146577850|NCT02574078|528624384|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
146577851|NCT02574078|528624385|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146577852|NCT02574078|528624386|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146577853|NCT02574078|528624387|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146577854|NCT02574078|528624388|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146577855|NCT02574078|528624376|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
146577856|NCT02574078|528624377|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
146577857|NCT02574078|528624378|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
146577858|NCT02574078|528624379|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
146577859|NCT02574078|528624380|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
146577860|NCT02574078|528624381|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
146577861|NCT02574078|528624382|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
146577862|NCT02574078|528624383|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
146577863|NCT02574078|528624384|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
146577864|NCT02574078|528624385|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
146577865|NCT02574078|528624386|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
146577866|NCT02574078|528624387|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
146577867|NCT02574078|528624388|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
146577868|NCT02574078|528624376|FG000|Pre-Treatment Period|Other reasons|0|||
146577869|NCT02574078|528624377|FG001|Pre-Treatment Period|Other reasons|0|||
146577870|NCT02574078|528624378|FG002|Pre-Treatment Period|Other reasons|0|||
146577871|NCT02574078|528624379|FG003|Pre-Treatment Period|Other reasons|0|||
146577872|NCT02574078|528624380|FG004|Pre-Treatment Period|Other reasons|0|||
146577873|NCT02574078|528624381|FG005|Pre-Treatment Period|Other reasons|0|||
146577874|NCT02574078|528624382|FG006|Pre-Treatment Period|Other reasons|2|||
146577875|NCT02574078|528624383|FG007|Pre-Treatment Period|Other reasons|0|||
146577876|NCT02574078|528624384|FG008|Pre-Treatment Period|Other reasons|0|||
146577877|NCT02574078|528624385|FG009|Pre-Treatment Period|Other reasons|0|||
146577878|NCT02574078|528624386|FG010|Pre-Treatment Period|Other reasons|2|||
146577879|NCT02574078|528624387|FG011|Pre-Treatment Period|Other reasons|0|||
146577880|NCT02574078|528624388|FG012|Pre-Treatment Period|Other reasons|0|||
146577881|NCT02574078|528624376|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
146577882|NCT02574078|528624377|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
146577883|NCT02574078|528624378|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
146577884|NCT02574078|528624379|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
146577885|NCT02574078|528624380|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
146651954|NCT02616601|528903724|FG001|Overall Study|Adverse Event|0|||
146918317|NCT02163993|529862805|FG000|Post-treatment Period|Protocol Violation|0|||
147013244|NCT01708954|530210056|FG002|Step 1|Symptomatic deterioration|1|||
146577886|NCT02574078|528624381|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
146577887|NCT02574078|528624382|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
146577888|NCT02574078|528624383|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
146577889|NCT02574078|528624384|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
146577890|NCT02574078|528624385|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
146577891|NCT02574078|528624386|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
146577892|NCT02574078|528624387|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
146577893|NCT02574078|528624388|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
146577894|NCT02574078|528624376|FG000|Treatment Period|Disease progression|6|||
146577895|NCT02574078|528624377|FG001|Treatment Period|Disease progression|4|||
146577896|NCT02574078|528624378|FG002|Treatment Period|Disease progression|7|||
146577897|NCT02574078|528624379|FG003|Treatment Period|Disease progression|18|||
146577898|NCT02574078|528624380|FG004|Treatment Period|Disease progression|16|||
146577899|NCT02574078|528624381|FG005|Treatment Period|Disease progression|26|||
146577900|NCT02574078|528624382|FG006|Treatment Period|Disease progression|5|||
146577901|NCT02574078|528624383|FG007|Treatment Period|Disease progression|9|||
146577902|NCT02574078|528624384|FG008|Treatment Period|Disease progression|8|||
146577903|NCT02574078|528624385|FG009|Treatment Period|Disease progression|5|||
146577904|NCT02574078|528624386|FG010|Treatment Period|Disease progression|20|||
146577905|NCT02574078|528624387|FG011|Treatment Period|Disease progression|29|||
146577906|NCT02574078|528624388|FG012|Treatment Period|Disease progression|2|||
146918318|NCT02163993|529862806|FG001|Post-treatment Period|Protocol Violation|0|||
146918319|NCT02163993|529862807|FG002|Post-treatment Period|Protocol Violation|0|||
146918320|NCT02163993|529862808|FG003|Post-treatment Period|Protocol Violation|0|||
146918321|NCT02163993|529862809|FG004|Post-treatment Period|Protocol Violation|1|||
146918322|NCT02163993|529862805|FG000|Post-treatment Period|Withdrawal by Subject|2|||
146918323|NCT02163993|529862806|FG001|Post-treatment Period|Withdrawal by Subject|4|||
146577907|NCT02574078|528624376|FG000|Treatment Period|Study drug toxicity|1|||
146577908|NCT02574078|528624377|FG001|Treatment Period|Study drug toxicity|1|||
146577909|NCT02574078|528624378|FG002|Treatment Period|Study drug toxicity|0|||
146577910|NCT02574078|528624379|FG003|Treatment Period|Study drug toxicity|5|||
146577911|NCT02574078|528624380|FG004|Treatment Period|Study drug toxicity|3|||
146577912|NCT02574078|528624381|FG005|Treatment Period|Study drug toxicity|1|||
146577913|NCT02574078|528624382|FG006|Treatment Period|Study drug toxicity|2|||
146577914|NCT02574078|528624383|FG007|Treatment Period|Study drug toxicity|0|||
146577915|NCT02574078|528624384|FG008|Treatment Period|Study drug toxicity|2|||
146577916|NCT02574078|528624385|FG009|Treatment Period|Study drug toxicity|1|||
146577917|NCT02574078|528624386|FG010|Treatment Period|Study drug toxicity|16|||
146577918|NCT02574078|528624387|FG011|Treatment Period|Study drug toxicity|2|||
146577919|NCT02574078|528624388|FG012|Treatment Period|Study drug toxicity|4|||
146577920|NCT02574078|528624376|FG000|Treatment Period|Death|2|||
146577921|NCT02574078|528624377|FG001|Treatment Period|Death|0|||
146577922|NCT02574078|528624378|FG002|Treatment Period|Death|0|||
146577923|NCT02574078|528624379|FG003|Treatment Period|Death|0|||
146577924|NCT02574078|528624380|FG004|Treatment Period|Death|1|||
146577925|NCT02574078|528624381|FG005|Treatment Period|Death|1|||
146577926|NCT02574078|528624382|FG006|Treatment Period|Death|1|||
146577927|NCT02574078|528624383|FG007|Treatment Period|Death|1|||
146577928|NCT02574078|528624384|FG008|Treatment Period|Death|7|||
146577929|NCT02574078|528624385|FG009|Treatment Period|Death|1|||
146577930|NCT02574078|528624386|FG010|Treatment Period|Death|0|||
146577931|NCT02574078|528624387|FG011|Treatment Period|Death|2|||
146577932|NCT02574078|528624388|FG012|Treatment Period|Death|1|||
146577933|NCT02574078|528624376|FG000|Treatment Period|Adverse event unrelated to drug|0|||
146577934|NCT02574078|528624377|FG001|Treatment Period|Adverse event unrelated to drug|0|||
146577935|NCT02574078|528624378|FG002|Treatment Period|Adverse event unrelated to drug|1|||
146577936|NCT02574078|528624379|FG003|Treatment Period|Adverse event unrelated to drug|0|||
146577937|NCT02574078|528624380|FG004|Treatment Period|Adverse event unrelated to drug|2|||
146577938|NCT02574078|528624381|FG005|Treatment Period|Adverse event unrelated to drug|3|||
146577939|NCT02574078|528624382|FG006|Treatment Period|Adverse event unrelated to drug|0|||
146577940|NCT02574078|528624383|FG007|Treatment Period|Adverse event unrelated to drug|0|||
146577941|NCT02574078|528624384|FG008|Treatment Period|Adverse event unrelated to drug|1|||
146577942|NCT02574078|528624385|FG009|Treatment Period|Adverse event unrelated to drug|2|||
146577943|NCT02574078|528624386|FG010|Treatment Period|Adverse event unrelated to drug|4|||
146577944|NCT02574078|528624387|FG011|Treatment Period|Adverse event unrelated to drug|1|||
146577945|NCT02574078|528624388|FG012|Treatment Period|Adverse event unrelated to drug|0|||
146577946|NCT02574078|528624376|FG000|Treatment Period|Administrative reason by Sponsor|0|||
146577947|NCT02574078|528624377|FG001|Treatment Period|Administrative reason by Sponsor|1|||
146577948|NCT02574078|528624378|FG002|Treatment Period|Administrative reason by Sponsor|0|||
146577949|NCT02574078|528624379|FG003|Treatment Period|Administrative reason by Sponsor|0|||
146577950|NCT02574078|528624380|FG004|Treatment Period|Administrative reason by Sponsor|0|||
146577951|NCT02574078|528624381|FG005|Treatment Period|Administrative reason by Sponsor|0|||
146577952|NCT02574078|528624382|FG006|Treatment Period|Administrative reason by Sponsor|1|||
146577953|NCT02574078|528624383|FG007|Treatment Period|Administrative reason by Sponsor|0|||
146577954|NCT02574078|528624384|FG008|Treatment Period|Administrative reason by Sponsor|0|||
146577955|NCT02574078|528624385|FG009|Treatment Period|Administrative reason by Sponsor|0|||
146918324|NCT02163993|529862807|FG002|Post-treatment Period|Withdrawal by Subject|0|||
146577956|NCT02574078|528624386|FG010|Treatment Period|Administrative reason by Sponsor|0|||
146577957|NCT02574078|528624387|FG011|Treatment Period|Administrative reason by Sponsor|0|||
146577958|NCT02574078|528624388|FG012|Treatment Period|Administrative reason by Sponsor|3|||
146577959|NCT02574078|528624376|FG000|Treatment Period|Other reasons|1|||
146577960|NCT02574078|528624377|FG001|Treatment Period|Other reasons|0|||
146577961|NCT02574078|528624378|FG002|Treatment Period|Other reasons|1|||
146577962|NCT02574078|528624379|FG003|Treatment Period|Other reasons|3|||
146577963|NCT02574078|528624380|FG004|Treatment Period|Other reasons|3|||
146577964|NCT02574078|528624381|FG005|Treatment Period|Other reasons|1|||
146577965|NCT02574078|528624382|FG006|Treatment Period|Other reasons|2|||
146577966|NCT02574078|528624383|FG007|Treatment Period|Other reasons|1|||
146577967|NCT02574078|528624384|FG008|Treatment Period|Other reasons|3|||
146577968|NCT02574078|528624385|FG009|Treatment Period|Other reasons|1|||
146577969|NCT02574078|528624386|FG010|Treatment Period|Other reasons|1|||
146577970|NCT02574078|528624387|FG011|Treatment Period|Other reasons|3|||
146577971|NCT02574078|528624388|FG012|Treatment Period|Other reasons|1|||
146577972|NCT02574078|528624376|FG000|Treatment Period|Participant request to stop drug|0|||
146577973|NCT02574078|528624377|FG001|Treatment Period|Participant request to stop drug|0|||
146577974|NCT02574078|528624378|FG002|Treatment Period|Participant request to stop drug|0|||
146577975|NCT02574078|528624379|FG003|Treatment Period|Participant request to stop drug|2|||
146577976|NCT02574078|528624380|FG004|Treatment Period|Participant request to stop drug|4|||
146577977|NCT02574078|528624381|FG005|Treatment Period|Participant request to stop drug|0|||
146577978|NCT02574078|528624382|FG006|Treatment Period|Participant request to stop drug|1|||
146577979|NCT02574078|528624383|FG007|Treatment Period|Participant request to stop drug|0|||
146577980|NCT02574078|528624384|FG008|Treatment Period|Participant request to stop drug|3|||
146577981|NCT02574078|528624385|FG009|Treatment Period|Participant request to stop drug|2|||
146577982|NCT02574078|528624386|FG010|Treatment Period|Participant request to stop drug|2|||
146577983|NCT02574078|528624387|FG011|Treatment Period|Participant request to stop drug|4|||
146577984|NCT02574078|528624388|FG012|Treatment Period|Participant request to stop drug|1|||
146577985|NCT02574078|528624376|FG000|Treatment Period|Participant withdrew consent|0|||
146577986|NCT02574078|528624377|FG001|Treatment Period|Participant withdrew consent|0|||
146577987|NCT02574078|528624378|FG002|Treatment Period|Participant withdrew consent|0|||
146577988|NCT02574078|528624379|FG003|Treatment Period|Participant withdrew consent|0|||
146577989|NCT02574078|528624380|FG004|Treatment Period|Participant withdrew consent|1|||
146577990|NCT02574078|528624381|FG005|Treatment Period|Participant withdrew consent|1|||
146577991|NCT02574078|528624382|FG006|Treatment Period|Participant withdrew consent|0|||
146577992|NCT02574078|528624383|FG007|Treatment Period|Participant withdrew consent|1|||
146577993|NCT02574078|528624384|FG008|Treatment Period|Participant withdrew consent|0|||
146577994|NCT02574078|528624385|FG009|Treatment Period|Participant withdrew consent|2|||
146577995|NCT02574078|528624386|FG010|Treatment Period|Participant withdrew consent|1|||
146577996|NCT02574078|528624387|FG011|Treatment Period|Participant withdrew consent|4|||
146577997|NCT02574078|528624388|FG012|Treatment Period|Participant withdrew consent|1|||
146577998|NCT02574078|528624376|FG000|Treatment Period|Participant no longer meets criteria|0|||
146577999|NCT02574078|528624377|FG001|Treatment Period|Participant no longer meets criteria|0|||
146578000|NCT02574078|528624378|FG002|Treatment Period|Participant no longer meets criteria|0|||
146578001|NCT02574078|528624379|FG003|Treatment Period|Participant no longer meets criteria|0|||
146578002|NCT02574078|528624380|FG004|Treatment Period|Participant no longer meets criteria|1|||
146578003|NCT02574078|528624381|FG005|Treatment Period|Participant no longer meets criteria|0|||
146578004|NCT02574078|528624382|FG006|Treatment Period|Participant no longer meets criteria|0|||
146578005|NCT02574078|528624383|FG007|Treatment Period|Participant no longer meets criteria|0|||
146578006|NCT02574078|528624384|FG008|Treatment Period|Participant no longer meets criteria|0|||
146578007|NCT02574078|528624385|FG009|Treatment Period|Participant no longer meets criteria|1|||
146578008|NCT02574078|528624386|FG010|Treatment Period|Participant no longer meets criteria|1|||
146578009|NCT02574078|528624387|FG011|Treatment Period|Participant no longer meets criteria|1|||
146578010|NCT02574078|528624388|FG012|Treatment Period|Participant no longer meets criteria|0|||
146578011|NCT02574078|528624376|FG000|Treatment Period|Lost to Follow-up|0|||
146578012|NCT02574078|528624377|FG001|Treatment Period|Lost to Follow-up|0|||
146578013|NCT02574078|528624378|FG002|Treatment Period|Lost to Follow-up|0|||
146578014|NCT02574078|528624379|FG003|Treatment Period|Lost to Follow-up|0|||
146578015|NCT02574078|528624380|FG004|Treatment Period|Lost to Follow-up|0|||
146578016|NCT02574078|528624381|FG005|Treatment Period|Lost to Follow-up|0|||
146578017|NCT02574078|528624382|FG006|Treatment Period|Lost to Follow-up|0|||
146578018|NCT02574078|528624383|FG007|Treatment Period|Lost to Follow-up|0|||
146578019|NCT02574078|528624384|FG008|Treatment Period|Lost to Follow-up|0|||
146578020|NCT02574078|528624385|FG009|Treatment Period|Lost to Follow-up|1|||
146578021|NCT02574078|528624386|FG010|Treatment Period|Lost to Follow-up|0|||
146578022|NCT02574078|528624387|FG011|Treatment Period|Lost to Follow-up|1|||
146578023|NCT02574078|528624388|FG012|Treatment Period|Lost to Follow-up|0|||
146578024|NCT02574078|528624376|FG000|Treatment Period|Maximum clinical benefit|0|||
146578025|NCT02574078|528624377|FG001|Treatment Period|Maximum clinical benefit|0|||
146578026|NCT02574078|528624378|FG002|Treatment Period|Maximum clinical benefit|0|||
146578027|NCT02574078|528624379|FG003|Treatment Period|Maximum clinical benefit|0|||
146578028|NCT02574078|528624380|FG004|Treatment Period|Maximum clinical benefit|0|||
146578029|NCT02574078|528624381|FG005|Treatment Period|Maximum clinical benefit|0|||
146918325|NCT02163993|529862808|FG003|Post-treatment Period|Withdrawal by Subject|1|||
146918326|NCT02163993|529862809|FG004|Post-treatment Period|Withdrawal by Subject|2|||
146918327|NCT02750813|529862810|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
146918328|NCT02750813|529862811|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
146578030|NCT02574078|528624382|FG006|Treatment Period|Maximum clinical benefit|0|||
146578031|NCT02574078|528624383|FG007|Treatment Period|Maximum clinical benefit|0|||
146578032|NCT02574078|528624384|FG008|Treatment Period|Maximum clinical benefit|0|||
146578033|NCT02574078|528624385|FG009|Treatment Period|Maximum clinical benefit|1|||
146578034|NCT02574078|528624386|FG010|Treatment Period|Maximum clinical benefit|0|||
146578035|NCT02574078|528624387|FG011|Treatment Period|Maximum clinical benefit|0|||
146578036|NCT02574078|528624388|FG012|Treatment Period|Maximum clinical benefit|0|||
146578037|NCT05935878|528624389|FG000|Overall Study|Death|1|||
146578038|NCT05935878|528624390|FG001|Overall Study|Death|2|||
146578039|NCT05935878|528624389|FG000|Overall Study|Withdrawal by Subject|5|||
146578040|NCT05935878|528624390|FG001|Overall Study|Withdrawal by Subject|5|||
146578041|NCT05935878|528624389|FG000|Overall Study|Revision of implant|1|||
146578042|NCT05935878|528624390|FG001|Overall Study|Revision of implant|1|||
146578043|NCT05935878|528624389|FG000|Overall Study|Mobile bearing dislocation|0|||
146578044|NCT05935878|528624390|FG001|Overall Study|Mobile bearing dislocation|1|||
146578045|NCT03015363|528624399|FG000|Overall Study|Physician Decision|14|||
146578046|NCT03015363|528624399|FG000|Overall Study|Withdrawal by Subject|3|||
146578047|NCT00958360|528624400|FG000|Overall Study|Withdrawal by Subject|3|||
146578048|NCT00958360|528624401|FG001|Overall Study|Withdrawal by Subject|1|||
146578049|NCT00958360|528624400|FG000|Overall Study|Death|6|||
146578050|NCT00958360|528624401|FG001|Overall Study|Death|7|||
146578051|NCT00958360|528624400|FG000|Overall Study|Physician Decision|2|||
146578052|NCT00958360|528624401|FG001|Overall Study|Physician Decision|1|||
146578053|NCT00958360|528624400|FG000|Overall Study|Lost to Follow-up|0|||
146578054|NCT00958360|528624401|FG001|Overall Study|Lost to Follow-up|1|||
146578055|NCT03107052|528624402|FG000|Overall Study|Adverse Event|6|||
146578056|NCT03107052|528624403|FG001|Overall Study|Adverse Event|1|||
146578057|NCT03107052|528624404|FG002|Overall Study|Adverse Event|2|||
146578058|NCT03107052|528624402|FG000|Overall Study|Withdrawal by Subject|9|||
146578059|NCT03107052|528624403|FG001|Overall Study|Withdrawal by Subject|5|||
146578060|NCT03107052|528624404|FG002|Overall Study|Withdrawal by Subject|8|||
146578061|NCT03107052|528624402|FG000|Overall Study|Protocol Violation|6|||
146578062|NCT03107052|528624403|FG001|Overall Study|Protocol Violation|0|||
146578063|NCT03107052|528624404|FG002|Overall Study|Protocol Violation|3|||
146578064|NCT03107052|528624402|FG000|Overall Study|Lost to Follow-up|4|||
146578065|NCT03107052|528624403|FG001|Overall Study|Lost to Follow-up|0|||
146578066|NCT03107052|528624404|FG002|Overall Study|Lost to Follow-up|1|||
146578067|NCT03107052|528624402|FG000|Overall Study|Lack of Efficacy|23|||
146578068|NCT03107052|528624403|FG001|Overall Study|Lack of Efficacy|7|||
146578069|NCT03107052|528624404|FG002|Overall Study|Lack of Efficacy|4|||
146578070|NCT03107052|528624402|FG000|Overall Study|Other than specified|4|||
146578071|NCT03107052|528624403|FG001|Overall Study|Other than specified|2|||
146578072|NCT03107052|528624404|FG002|Overall Study|Other than specified|0|||
146578073|NCT03107052|528624402|FG000|Overall Study|Study terminated due to futility|67|||
146578074|NCT03107052|528624403|FG001|Overall Study|Study terminated due to futility|31|||
146578075|NCT03107052|528624404|FG002|Overall Study|Study terminated due to futility|23|||
146578076|NCT02263326|528624405|FG000|Overall Study|Lost to Follow-up|1|||
146578077|NCT02263326|528624406|FG001|Overall Study|Lost to Follow-up|1|||
146578078|NCT00500357|528624407|FG000|Overall Study|Death|1|||
146578079|NCT00078806|528624408|FG000|Part 1A|Adverse Event|2|||
146578080|NCT00078806|528624409|FG001|Part 1A|Adverse Event|0|||
146578081|NCT00078806|528624410|FG002|Part 1A|Adverse Event|0|||
146578082|NCT00078806|528624411|FG003|Part 1A|Adverse Event|0|||
146578083|NCT00078806|528624408|FG000|Part 1A|Lack of Efficacy|7|||
146578084|NCT00078806|528624409|FG001|Part 1A|Lack of Efficacy|0|||
146578085|NCT00078806|528624410|FG002|Part 1A|Lack of Efficacy|0|||
146578086|NCT00078806|528624411|FG003|Part 1A|Lack of Efficacy|0|||
146918329|NCT02750813|529862810|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
146578087|NCT00078806|528624408|FG000|Part 1A|Other|1|||
146578088|NCT00078806|528624409|FG001|Part 1A|Other|0|||
146578089|NCT00078806|528624410|FG002|Part 1A|Other|0|||
146578090|NCT00078806|528624411|FG003|Part 1A|Other|0|||
146578091|NCT00078806|528624408|FG000|Part 1B|Adverse Event|1|||
146578092|NCT00078806|528624409|FG001|Part 1B|Adverse Event|0|||
146578093|NCT00078806|528624410|FG002|Part 1B|Adverse Event|0|||
146578094|NCT00078806|528624411|FG003|Part 1B|Adverse Event|0|||
146578095|NCT00078806|528624408|FG000|Part 1B|Lack of Efficacy|7|||
146578096|NCT00078806|528624409|FG001|Part 1B|Lack of Efficacy|0|||
146578097|NCT00078806|528624410|FG002|Part 1B|Lack of Efficacy|0|||
146578098|NCT00078806|528624411|FG003|Part 1B|Lack of Efficacy|0|||
146578099|NCT00078806|528624408|FG000|Part 2|Adverse Event|0|||
146578100|NCT00078806|528624409|FG001|Part 2|Adverse Event|1|||
146578101|NCT00078806|528624410|FG002|Part 2|Adverse Event|0|||
146578102|NCT00078806|528624411|FG003|Part 2|Adverse Event|0|||
146578103|NCT01893411|528624414|FG000|Overall Study|Protocol Violation|1|||
146578104|NCT01893411|528624415|FG001|Overall Study|Protocol Violation|0|||
146578105|NCT01893411|528624416|FG002|Overall Study|Protocol Violation|0|||
146578106|NCT01893411|528624414|FG000|Overall Study|Physician Decision|1|||
146578107|NCT01893411|528624415|FG001|Overall Study|Physician Decision|1|||
146578108|NCT01893411|528624416|FG002|Overall Study|Physician Decision|2|||
146578109|NCT01893411|528624414|FG000|Overall Study|Lack of Efficacy|2|||
146578110|NCT01893411|528624415|FG001|Overall Study|Lack of Efficacy|1|||
146578111|NCT01893411|528624416|FG002|Overall Study|Lack of Efficacy|0|||
146578112|NCT01893411|528624414|FG000|Overall Study|Other|3|||
146578113|NCT01893411|528624415|FG001|Overall Study|Other|1|||
146578114|NCT01893411|528624416|FG002|Overall Study|Other|3|||
146578115|NCT01893411|528624414|FG000|Overall Study|Adverse Event|1|||
146578116|NCT01893411|528624415|FG001|Overall Study|Adverse Event|0|||
146578117|NCT01893411|528624416|FG002|Overall Study|Adverse Event|0|||
146578118|NCT01893411|528624414|FG000|Overall Study|Withdrawal by Subject|7|||
146578119|NCT01893411|528624415|FG001|Overall Study|Withdrawal by Subject|4|||
146578120|NCT01893411|528624416|FG002|Overall Study|Withdrawal by Subject|3|||
146578121|NCT01893411|528624414|FG000|Overall Study|Lost to Follow-up|2|||
146578122|NCT01893411|528624415|FG001|Overall Study|Lost to Follow-up|0|||
146578123|NCT01893411|528624416|FG002|Overall Study|Lost to Follow-up|1|||
146578124|NCT02397915|528624417|FG000|Period 1|Protocol Violation|0|||
146578125|NCT02397915|528624418|FG001|Period 1|Protocol Violation|1|||
146578126|NCT02397915|528624419|FG002|Period 1|Protocol Violation|0|||
146578127|NCT02397915|528624420|FG003|Period 1|Protocol Violation|0|||
146578128|NCT02397915|528624417|FG000|Period 1|Physician Decision|1|||
146578129|NCT02397915|528624418|FG001|Period 1|Physician Decision|0|||
146578130|NCT02397915|528624419|FG002|Period 1|Physician Decision|0|||
146578131|NCT02397915|528624420|FG003|Period 1|Physician Decision|0|||
146578132|NCT00368745|528624421|FG000|Double-blind Treatment Period|Adverse Event|6|||
146578133|NCT00368745|528624422|FG001|Double-blind Treatment Period|Adverse Event|6|||
146578134|NCT00368745|528624421|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
146578135|NCT00368745|528624422|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
146578136|NCT00368745|528624421|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
146578137|NCT00368745|528624422|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
146578138|NCT00368745|528624421|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
146578139|NCT00368745|528624422|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
146578140|NCT00368745|528624421|FG000|Double-blind Treatment Period|Other|7|||
146578141|NCT00368745|528624422|FG001|Double-blind Treatment Period|Other|6|||
146578142|NCT03292874|528624423|FG000|Overall Study|Due to pandemic|5|||
146578143|NCT00161616|528624424|FG000|Overall Study|Withdrawal by Subject|6|||
146578144|NCT00161616|528624425|FG001|Overall Study|Withdrawal by Subject|5|||
146578145|NCT00161616|528624424|FG000|Overall Study|Physician Decision|1|||
146578146|NCT00161616|528624425|FG001|Overall Study|Physician Decision|0|||
146578147|NCT00161616|528624424|FG000|Overall Study|Death|1|||
146578148|NCT00161616|528624425|FG001|Overall Study|Death|1|||
146578149|NCT00161616|528624424|FG000|Overall Study|Lost to Follow-up|17|||
146578150|NCT00161616|528624425|FG001|Overall Study|Lost to Follow-up|13|||
146578151|NCT00161616|528624424|FG000|Overall Study|Protocol deviation|1|||
146578152|NCT00161616|528624425|FG001|Overall Study|Protocol deviation|0|||
146578153|NCT00933608|528624427|FG000|Overall Study|Adverse Event|4|||
146578154|NCT00933608|528624428|FG001|Overall Study|Adverse Event|2|||
146578155|NCT00933608|528624427|FG000|Overall Study|Physician Decision|1|||
146578156|NCT00933608|528624428|FG001|Overall Study|Physician Decision|0|||
146578157|NCT02719691|528624431|FG000|Overall Study|Physician Decision|0|||
146578158|NCT02719691|528624432|FG001|Overall Study|Physician Decision|0|||
146578159|NCT02719691|528624433|FG002|Overall Study|Physician Decision|1|||
146578160|NCT02719691|528624434|FG003|Overall Study|Physician Decision|0|||
146578161|NCT02719691|528624435|FG004|Overall Study|Physician Decision|0|||
146578162|NCT02719691|528624436|FG005|Overall Study|Physician Decision|0|||
146578163|NCT02719691|528624437|FG006|Overall Study|Physician Decision|0|||
146578164|NCT02719691|528624431|FG000|Overall Study|Withdrawal by Subject|0|||
146578165|NCT02719691|528624432|FG001|Overall Study|Withdrawal by Subject|0|||
146578166|NCT02719691|528624433|FG002|Overall Study|Withdrawal by Subject|0|||
146918330|NCT02750813|529862811|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
146578167|NCT02719691|528624434|FG003|Overall Study|Withdrawal by Subject|0|||
146578168|NCT02719691|528624435|FG004|Overall Study|Withdrawal by Subject|0|||
146578169|NCT02719691|528624436|FG005|Overall Study|Withdrawal by Subject|1|||
146578170|NCT02719691|528624437|FG006|Overall Study|Withdrawal by Subject|0|||
146578171|NCT00336284|528624438|FG000|Overall Study|Death|52|||
146578172|NCT00336284|528624439|FG001|Overall Study|Death|26|||
146578173|NCT00336284|528624438|FG000|Overall Study|Lost to Follow-up|82|||
146918331|NCT00903032|529862812|FG000|Overall Study|Withdrawal by Subject|5|||
146578174|NCT00336284|528624439|FG001|Overall Study|Lost to Follow-up|61|||
146578175|NCT00336284|528624438|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
146578176|NCT00336284|528624439|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
146578177|NCT00861757|528624444|FG000|Overall Study|Adverse Event|1|||
146578178|NCT00861757|528624445|FG001|Overall Study|Adverse Event|5|||
146918332|NCT00903032|529862813|FG001|Overall Study|Withdrawal by Subject|3|||
146578179|NCT00861757|528624446|FG002|Overall Study|Adverse Event|7|||
146578180|NCT00861757|528624447|FG003|Overall Study|Adverse Event|2|||
146578181|NCT00861757|528624444|FG000|Overall Study|Entry Criteria Not Met|1|||
146578182|NCT00861757|528624445|FG001|Overall Study|Entry Criteria Not Met|2|||
146578183|NCT00861757|528624446|FG002|Overall Study|Entry Criteria Not Met|1|||
146578184|NCT00861757|528624447|FG003|Overall Study|Entry Criteria Not Met|1|||
146578185|NCT00861757|528624444|FG000|Overall Study|Lack of Efficacy|3|||
146578186|NCT00861757|528624445|FG001|Overall Study|Lack of Efficacy|1|||
146578187|NCT00861757|528624446|FG002|Overall Study|Lack of Efficacy|0|||
146578188|NCT00861757|528624447|FG003|Overall Study|Lack of Efficacy|1|||
146578189|NCT00861757|528624444|FG000|Overall Study|Lost to Follow-up|1|||
146578190|NCT00861757|528624445|FG001|Overall Study|Lost to Follow-up|0|||
146578191|NCT00861757|528624446|FG002|Overall Study|Lost to Follow-up|1|||
146578192|NCT00861757|528624447|FG003|Overall Study|Lost to Follow-up|1|||
146578193|NCT00861757|528624444|FG000|Overall Study|Physician Decision|0|||
146578194|NCT00861757|528624445|FG001|Overall Study|Physician Decision|0|||
146578195|NCT00861757|528624446|FG002|Overall Study|Physician Decision|0|||
146578196|NCT00861757|528624447|FG003|Overall Study|Physician Decision|1|||
146578197|NCT00861757|528624444|FG000|Overall Study|Protocol Violation|2|||
146578198|NCT00861757|528624445|FG001|Overall Study|Protocol Violation|2|||
146578199|NCT00861757|528624446|FG002|Overall Study|Protocol Violation|4|||
146578200|NCT00861757|528624447|FG003|Overall Study|Protocol Violation|1|||
146578201|NCT00861757|528624444|FG000|Overall Study|Withdrawal by Subject|1|||
146578202|NCT00861757|528624445|FG001|Overall Study|Withdrawal by Subject|5|||
146578203|NCT00861757|528624446|FG002|Overall Study|Withdrawal by Subject|5|||
146578204|NCT00861757|528624447|FG003|Overall Study|Withdrawal by Subject|2|||
146578205|NCT01521923|528624451|FG000|Overall Study|AE, serious fatal|1|||
146578206|NCT01521923|528624452|FG001|Overall Study|AE, serious fatal|0|||
146578207|NCT01521923|528624453|FG002|Overall Study|AE, serious fatal|0|||
146578208|NCT01521923|528624454|FG003|Overall Study|AE, serious fatal|0|||
146578209|NCT01521923|528624451|FG000|Overall Study|SAE, non-fatal|0|||
146578210|NCT01521923|528624452|FG001|Overall Study|SAE, non-fatal|2|||
146578211|NCT01521923|528624453|FG002|Overall Study|SAE, non-fatal|2|||
146578212|NCT01521923|528624454|FG003|Overall Study|SAE, non-fatal|0|||
146578213|NCT01521923|528624451|FG000|Overall Study|AE, non-serious, non-fatal|1|||
146578214|NCT01521923|528624452|FG001|Overall Study|AE, non-serious, non-fatal|3|||
146578215|NCT01521923|528624453|FG002|Overall Study|AE, non-serious, non-fatal|6|||
146578216|NCT01521923|528624454|FG003|Overall Study|AE, non-serious, non-fatal|2|||
146578217|NCT01521923|528624451|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
146578218|NCT01521923|528624452|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
146578219|NCT01521923|528624453|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
146578220|NCT01521923|528624454|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
146578221|NCT01521923|528624451|FG000|Overall Study|Lack of Efficacy|1|||
146578222|NCT01521923|528624452|FG001|Overall Study|Lack of Efficacy|1|||
146578223|NCT01521923|528624453|FG002|Overall Study|Lack of Efficacy|0|||
146578224|NCT01521923|528624454|FG003|Overall Study|Lack of Efficacy|0|||
146578225|NCT01521923|528624451|FG000|Overall Study|Protocol Violation|0|||
146578226|NCT01521923|528624452|FG001|Overall Study|Protocol Violation|0|||
146578227|NCT01521923|528624453|FG002|Overall Study|Protocol Violation|1|||
146578228|NCT01521923|528624454|FG003|Overall Study|Protocol Violation|0|||
146578229|NCT01521923|528624451|FG000|Overall Study|Lost to Follow-up|1|||
146578230|NCT01521923|528624452|FG001|Overall Study|Lost to Follow-up|0|||
146578231|NCT01521923|528624453|FG002|Overall Study|Lost to Follow-up|2|||
146578232|NCT01521923|528624454|FG003|Overall Study|Lost to Follow-up|1|||
146578233|NCT01521923|528624451|FG000|Overall Study|Withdrawal by Subject|1|||
146578234|NCT01521923|528624452|FG001|Overall Study|Withdrawal by Subject|1|||
146578235|NCT01521923|528624453|FG002|Overall Study|Withdrawal by Subject|1|||
146578236|NCT01521923|528624454|FG003|Overall Study|Withdrawal by Subject|2|||
146578237|NCT01521923|528624451|FG000|Overall Study|Other|2|||
146578238|NCT01521923|528624452|FG001|Overall Study|Other|1|||
146578239|NCT01521923|528624453|FG002|Overall Study|Other|3|||
146578240|NCT01521923|528624454|FG003|Overall Study|Other|6|||
146578241|NCT01521923|528624451|FG000|Overall Study|AE, captured in Period 1|0|||
146578242|NCT01521923|528624452|FG001|Overall Study|AE, captured in Period 1|1|||
146578243|NCT01521923|528624453|FG002|Overall Study|AE, captured in Period 1|0|||
146578244|NCT01521923|528624454|FG003|Overall Study|AE, captured in Period 1|1|||
146578245|NCT02403817|528624457|FG000|Overall Study|Withdrawal by Subject|5|||
146918333|NCT00903032|529862812|FG000|Overall Study|Lost to Follow-up|2|||
146578246|NCT02403817|528624458|FG001|Overall Study|Withdrawal by Subject|0|||
146651955|NCT02616601|528903725|FG002|Overall Study|Adverse Event|2|||
146918334|NCT00903032|529862813|FG001|Overall Study|Lost to Follow-up|2|||
146578247|NCT00473889|528624461|FG000|Overall Study|Did not receive study medication|1|||
146578248|NCT00473889|528624462|FG001|Overall Study|Did not receive study medication|4|||
146578249|NCT00473889|528624461|FG000|Overall Study|Adverse Event|30|||
146578250|NCT00473889|528624462|FG001|Overall Study|Adverse Event|17|||
146578251|NCT00473889|528624461|FG000|Overall Study|Protocol Violation|4|||
146578252|NCT00473889|528624462|FG001|Overall Study|Protocol Violation|2|||
146578253|NCT00473889|528624461|FG000|Overall Study|Lack of Efficacy|28|||
146918335|NCT03539458|529862815|FG000|Overall Study|Death|1|||
146578254|NCT00473889|528624462|FG001|Overall Study|Lack of Efficacy|29|||
146578255|NCT00473889|528624461|FG000|Overall Study|Lost to Follow-up|2|||
146578256|NCT00473889|528624462|FG001|Overall Study|Lost to Follow-up|1|||
146578257|NCT00473889|528624461|FG000|Overall Study|Physician Decision|10|||
146578258|NCT00473889|528624462|FG001|Overall Study|Physician Decision|5|||
146578259|NCT00473889|528624461|FG000|Overall Study|Trial Terminated|3|||
146578260|NCT00473889|528624462|FG001|Overall Study|Trial Terminated|6|||
146578261|NCT00473889|528624461|FG000|Overall Study|Withdrawal by Subject|5|||
146578262|NCT00473889|528624462|FG001|Overall Study|Withdrawal by Subject|0|||
146578263|NCT04908384|528624466|FG000|Overall Study|Lost to Follow-up|4|||
146578264|NCT04908384|528624467|FG001|Overall Study|Lost to Follow-up|4|||
146578265|NCT04908384|528624468|FG002|Overall Study|Lost to Follow-up|0|||
146578266|NCT04908384|528624469|FG003|Overall Study|Lost to Follow-up|0|||
146578267|NCT01947283|528624470|FG000|Overall Study|Death|1|||
146578268|NCT01947283|528624471|FG001|Overall Study|Death|1|||
146578269|NCT01947283|528624472|FG002|Overall Study|Death|1|||
146578270|NCT01947283|528624473|FG003|Overall Study|Death|0|||
146578271|NCT01947283|528624474|FG004|Overall Study|Death|0|||
146578272|NCT01947283|528624475|FG005|Overall Study|Death|0|||
146578273|NCT01947283|528624476|FG006|Overall Study|Death|0|||
146578274|NCT01947283|528624470|FG000|Overall Study|Lost to Follow-up|4|||
146578275|NCT01947283|528624471|FG001|Overall Study|Lost to Follow-up|6|||
146578276|NCT01947283|528624472|FG002|Overall Study|Lost to Follow-up|5|||
146578277|NCT01947283|528624473|FG003|Overall Study|Lost to Follow-up|5|||
146578278|NCT01947283|528624474|FG004|Overall Study|Lost to Follow-up|0|||
146578279|NCT01947283|528624475|FG005|Overall Study|Lost to Follow-up|2|||
146578280|NCT01947283|528624476|FG006|Overall Study|Lost to Follow-up|5|||
146578281|NCT01947283|528624470|FG000|Overall Study|Withdrawal by Subject|10|||
146578282|NCT01947283|528624471|FG001|Overall Study|Withdrawal by Subject|8|||
146578283|NCT01947283|528624472|FG002|Overall Study|Withdrawal by Subject|4|||
146578284|NCT01947283|528624473|FG003|Overall Study|Withdrawal by Subject|1|||
146578285|NCT01947283|528624474|FG004|Overall Study|Withdrawal by Subject|0|||
146578286|NCT01947283|528624475|FG005|Overall Study|Withdrawal by Subject|0|||
146578287|NCT01947283|528624476|FG006|Overall Study|Withdrawal by Subject|2|||
146578288|NCT01947283|528624470|FG000|Overall Study|No Clinical Recording|12|||
146578289|NCT01947283|528624471|FG001|Overall Study|No Clinical Recording|6|||
146578290|NCT01947283|528624472|FG002|Overall Study|No Clinical Recording|8|||
146578291|NCT01947283|528624473|FG003|Overall Study|No Clinical Recording|10|||
146578292|NCT01947283|528624474|FG004|Overall Study|No Clinical Recording|0|||
146578293|NCT01947283|528624475|FG005|Overall Study|No Clinical Recording|0|||
146578294|NCT01947283|528624476|FG006|Overall Study|No Clinical Recording|0|||
146578295|NCT01947283|528624470|FG000|Overall Study|Non-coding Clinical Recording language|0|||
146578296|NCT01947283|528624471|FG001|Overall Study|Non-coding Clinical Recording language|0|||
146578297|NCT01947283|528624472|FG002|Overall Study|Non-coding Clinical Recording language|0|||
146578298|NCT01947283|528624473|FG003|Overall Study|Non-coding Clinical Recording language|1|||
146578299|NCT01947283|528624474|FG004|Overall Study|Non-coding Clinical Recording language|0|||
146578300|NCT01947283|528624475|FG005|Overall Study|Non-coding Clinical Recording language|0|||
146578301|NCT01947283|528624476|FG006|Overall Study|Non-coding Clinical Recording language|0|||
146578302|NCT01947283|528624470|FG000|Overall Study|Missing Follow-up Assessment|2|||
146578303|NCT01947283|528624471|FG001|Overall Study|Missing Follow-up Assessment|2|||
146578304|NCT01947283|528624472|FG002|Overall Study|Missing Follow-up Assessment|3|||
146578305|NCT01947283|528624473|FG003|Overall Study|Missing Follow-up Assessment|0|||
146578306|NCT01947283|528624474|FG004|Overall Study|Missing Follow-up Assessment|0|||
146578307|NCT01947283|528624475|FG005|Overall Study|Missing Follow-up Assessment|2|||
146978202|NCT00078819|530082262|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
146578308|NCT01947283|528624476|FG006|Overall Study|Missing Follow-up Assessment|0|||
146578309|NCT01947283|528624470|FG000|Overall Study|No patients were enrolled in study|0|||
146578310|NCT01947283|528624471|FG001|Overall Study|No patients were enrolled in study|0|||
146578311|NCT01947283|528624472|FG002|Overall Study|No patients were enrolled in study|0|||
146578312|NCT01947283|528624473|FG003|Overall Study|No patients were enrolled in study|0|||
146578313|NCT01947283|528624474|FG004|Overall Study|No patients were enrolled in study|0|||
146578314|NCT01947283|528624475|FG005|Overall Study|No patients were enrolled in study|3|||
146578315|NCT01947283|528624476|FG006|Overall Study|No patients were enrolled in study|1|||
146578316|NCT00430989|528624477|FG000|Overall Study|Lost to Follow-up|2|||
146578317|NCT00430989|528624478|FG001|Overall Study|Lost to Follow-up|3|||
146578318|NCT00430989|528624477|FG000|Overall Study|Withdrawal by Subject|15|||
146578319|NCT00430989|528624478|FG001|Overall Study|Withdrawal by Subject|14|||
146578320|NCT00430989|528624477|FG000|Overall Study|Protocol Violation|30|||
146578321|NCT00430989|528624478|FG001|Overall Study|Protocol Violation|37|||
146578322|NCT00430989|528624477|FG000|Overall Study|Not eligible|13|||
146578323|NCT00430989|528624478|FG001|Overall Study|Not eligible|6|||
146578324|NCT05002985|528624479|FG000|Overall Study|Withdrawal by Subject|1|||
146578325|NCT03782259|528624480|FG000|Overall Study|Lost to Follow-up|1|||
146578326|NCT03782259|528624481|FG001|Overall Study|Lost to Follow-up|1|||
146578327|NCT03782259|528624480|FG000|Overall Study|Moved out of state|0|||
146651956|NCT02616601|528903723|FG000|Overall Study|Death|1|||
146578328|NCT03782259|528624481|FG001|Overall Study|Moved out of state|2|||
146578329|NCT03782259|528624480|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
146578330|NCT03782259|528624481|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
146578331|NCT03782259|528624480|FG000|Overall Study|Subject discontinued intervention|1|||
146578332|NCT03782259|528624481|FG001|Overall Study|Subject discontinued intervention|0|||
146578333|NCT00603941|528624485|FG000|Overall Study|Disease progression|6|||
146578334|NCT00603941|528624486|FG001|Overall Study|Disease progression|7|||
146578335|NCT00603941|528624487|FG002|Overall Study|Disease progression|1|||
146578336|NCT00603941|528624485|FG000|Overall Study|Adverse Event|1|||
146578337|NCT00603941|528624486|FG001|Overall Study|Adverse Event|0|||
146578338|NCT00603941|528624487|FG002|Overall Study|Adverse Event|1|||
146578339|NCT00603941|528624485|FG000|Overall Study|Physician Decision|0|||
146578340|NCT00603941|528624486|FG001|Overall Study|Physician Decision|1|||
146578341|NCT00603941|528624487|FG002|Overall Study|Physician Decision|0|||
146578342|NCT00603941|528624485|FG000|Overall Study|Withdrawal by Subject|0|||
146578343|NCT00603941|528624486|FG001|Overall Study|Withdrawal by Subject|2|||
146578344|NCT00603941|528624487|FG002|Overall Study|Withdrawal by Subject|0|||
146578345|NCT00833469|528624488|FG000|Overall Study|Withdrawal by Subject|1|||
146578346|NCT00833469|528624488|FG000|Overall Study|Lost to Follow-up|1|||
146578347|NCT01642901|528624489|FG000|12-month Follow-up|Withdrawal by Subject|1|||
146578348|NCT01642901|528624490|FG001|12-month Follow-up|Withdrawal by Subject|0|||
146578349|NCT02707965|528624491|FG000|Overall Study|Withdrawal by Subject|0|||
146578350|NCT02707965|528624492|FG001|Overall Study|Withdrawal by Subject|0|||
146578351|NCT02707965|528624493|FG002|Overall Study|Withdrawal by Subject|1|||
146578352|NCT02707965|528624494|FG003|Overall Study|Withdrawal by Subject|0|||
146578353|NCT02707965|528624495|FG004|Overall Study|Withdrawal by Subject|0|||
146578354|NCT02707965|528624496|FG005|Overall Study|Withdrawal by Subject|0|||
146578355|NCT02707965|528624497|FG006|Overall Study|Withdrawal by Subject|0|||
146578356|NCT02707965|528624498|FG007|Overall Study|Withdrawal by Subject|2|||
146578357|NCT02707965|528624499|FG008|Overall Study|Withdrawal by Subject|0|||
146578358|NCT02707965|528624500|FG009|Overall Study|Withdrawal by Subject|0|||
146578359|NCT02707965|528624501|FG010|Overall Study|Withdrawal by Subject|0|||
146578360|NCT02707965|528624502|FG011|Overall Study|Withdrawal by Subject|0|||
146770681|NCT05283395|529328658|FG000|Overall Study|Patient Withdrawal|2|||
146770682|NCT05283395|529328659|FG001|Overall Study|Patient Withdrawal|4|||
146770683|NCT05283395|529328660|FG002|Overall Study|Patient Withdrawal|2|||
146770684|NCT05283395|529328658|FG000|Overall Study|Investigator Decision|1|||
146578361|NCT02707965|528624503|FG012|Overall Study|Withdrawal by Subject|0|||
146578362|NCT02707965|528624504|FG013|Overall Study|Withdrawal by Subject|0|||
146770685|NCT05283395|529328659|FG001|Overall Study|Investigator Decision|0|||
146770686|NCT05283395|529328660|FG002|Overall Study|Investigator Decision|1|||
146770687|NCT05283395|529328658|FG000|Overall Study|Enrolled in error|0|||
146770688|NCT05283395|529328659|FG001|Overall Study|Enrolled in error|0|||
146770689|NCT05283395|529328660|FG002|Overall Study|Enrolled in error|1|||
146770690|NCT01063972|529328661|FG000|Overall Study|Death|12|||
146770691|NCT01063972|529328662|FG001|Overall Study|Death|11|||
146770692|NCT01063972|529328661|FG000|Overall Study|Incarcerated|2|||
146770693|NCT01063972|529328662|FG001|Overall Study|Incarcerated|1|||
146770694|NCT00712335|529328663|FG000|Overall Study|Withdrawal by Subject|0|||
146770695|NCT00712335|529328664|FG001|Overall Study|Withdrawal by Subject|7|||
146770696|NCT00712335|529328665|FG002|Overall Study|Withdrawal by Subject|2|||
146770697|NCT00712335|529328666|FG003|Overall Study|Withdrawal by Subject|3|||
146770698|NCT00712335|529328667|FG004|Overall Study|Withdrawal by Subject|0|||
146578363|NCT02707965|528624505|FG014|Overall Study|Withdrawal by Subject|0|||
146578364|NCT02707965|528624506|FG015|Overall Study|Withdrawal by Subject|0|||
146578365|NCT02707965|528624491|FG000|Overall Study|PI decisions|0|||
146578366|NCT02707965|528624492|FG001|Overall Study|PI decisions|0|||
146578367|NCT02707965|528624493|FG002|Overall Study|PI decisions|0|||
146578368|NCT02707965|528624494|FG003|Overall Study|PI decisions|0|||
146578369|NCT02707965|528624495|FG004|Overall Study|PI decisions|0|||
146578370|NCT02707965|528624496|FG005|Overall Study|PI decisions|0|||
146578371|NCT02707965|528624497|FG006|Overall Study|PI decisions|0|||
146578372|NCT02707965|528624498|FG007|Overall Study|PI decisions|0|||
146770699|NCT00712335|529328663|FG000|Overall Study|Lost to Follow-up|2|||
146578373|NCT02707965|528624499|FG008|Overall Study|PI decisions|0|||
146770700|NCT00712335|529328664|FG001|Overall Study|Lost to Follow-up|5|||
146578374|NCT02707965|528624500|FG009|Overall Study|PI decisions|0|||
146578375|NCT02707965|528624501|FG010|Overall Study|PI decisions|0|||
146770701|NCT00712335|529328665|FG002|Overall Study|Lost to Follow-up|0|||
146578376|NCT02707965|528624502|FG011|Overall Study|PI decisions|0|||
146578377|NCT02707965|528624503|FG012|Overall Study|PI decisions|0|||
146770702|NCT00712335|529328666|FG003|Overall Study|Lost to Follow-up|1|||
146770703|NCT00712335|529328667|FG004|Overall Study|Lost to Follow-up|0|||
146770704|NCT00712335|529328663|FG000|Overall Study|Protocol Violation|1|||
146770705|NCT00712335|529328664|FG001|Overall Study|Protocol Violation|2|||
146578378|NCT02707965|528624504|FG013|Overall Study|PI decisions|0|||
146578379|NCT02707965|528624505|FG014|Overall Study|PI decisions|2|||
146651957|NCT02616601|528903724|FG001|Overall Study|Death|0|||
146651958|NCT02616601|528903725|FG002|Overall Study|Death|0|||
146918336|NCT02042404|529862818|FG000|Overall Study|Death|1|||
146578380|NCT02707965|528624506|FG015|Overall Study|PI decisions|0|||
146578381|NCT02707965|528624491|FG000|Overall Study|Protocol deviation|1|||
146578382|NCT02707965|528624492|FG001|Overall Study|Protocol deviation|1|||
146578383|NCT02707965|528624493|FG002|Overall Study|Protocol deviation|0|||
146578384|NCT02707965|528624494|FG003|Overall Study|Protocol deviation|0|||
146578385|NCT02707965|528624495|FG004|Overall Study|Protocol deviation|0|||
146578386|NCT02707965|528624496|FG005|Overall Study|Protocol deviation|0|||
146578387|NCT02707965|528624497|FG006|Overall Study|Protocol deviation|0|||
146918337|NCT02042404|529862819|FG001|Overall Study|Death|0|||
146918338|NCT02042404|529862818|FG000|Overall Study|Unrelated Adverse Event|3|||
146918339|NCT02042404|529862819|FG001|Overall Study|Unrelated Adverse Event|0|||
146918340|NCT02042404|529862818|FG000|Overall Study|Inability to meet time requirements|1|||
146918341|NCT02042404|529862819|FG001|Overall Study|Inability to meet time requirements|0|||
146578388|NCT02707965|528624498|FG007|Overall Study|Protocol deviation|1|||
146578389|NCT02707965|528624499|FG008|Overall Study|Protocol deviation|0|||
146578390|NCT02707965|528624500|FG009|Overall Study|Protocol deviation|0|||
146578391|NCT02707965|528624501|FG010|Overall Study|Protocol deviation|0|||
146578392|NCT02707965|528624502|FG011|Overall Study|Protocol deviation|0|||
146578393|NCT02707965|528624503|FG012|Overall Study|Protocol deviation|0|||
146578394|NCT02707965|528624504|FG013|Overall Study|Protocol deviation|0|||
146578395|NCT02707965|528624505|FG014|Overall Study|Protocol deviation|0|||
146578396|NCT02707965|528624506|FG015|Overall Study|Protocol deviation|0|||
146578397|NCT02943070|528624507|FG000|Overall Study|Physician Decision|1|||
146578398|NCT02943070|528624507|FG000|Overall Study|Adverse Event|2|||
146578399|NCT02943070|528624507|FG000|Overall Study|Death|2|||
146578400|NCT02943070|528624507|FG000|Overall Study|Withdrawal by Subject|3|||
146578401|NCT02943070|528624507|FG000|Overall Study|Lost to Follow-up|4|||
146578402|NCT02943070|528624507|FG000|Overall Study|Retreatment or TURP|13|||
146578403|NCT02943070|528624507|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
146578404|NCT00570778|528624508|FG000|Overall Study|Protocol deviation|2|||
146578405|NCT00570778|528624509|FG001|Overall Study|Protocol deviation|1|||
146578406|NCT00570778|528624510|FG002|Overall Study|Protocol deviation|2|||
146578407|NCT00570778|528624511|FG003|Overall Study|Protocol deviation|2|||
146578408|NCT00570778|528624508|FG000|Overall Study|Adverse Event|0|||
146578409|NCT00570778|528624509|FG001|Overall Study|Adverse Event|1|||
146578410|NCT00570778|528624510|FG002|Overall Study|Adverse Event|4|||
146578411|NCT00570778|528624511|FG003|Overall Study|Adverse Event|1|||
146578412|NCT00570778|528624508|FG000|Overall Study|Subject withdrew consent|0|||
146578413|NCT00570778|528624509|FG001|Overall Study|Subject withdrew consent|1|||
146578414|NCT00570778|528624510|FG002|Overall Study|Subject withdrew consent|0|||
146578415|NCT00570778|528624511|FG003|Overall Study|Subject withdrew consent|1|||
146578416|NCT00570778|528624508|FG000|Overall Study|Abnormal test procedure|1|||
146578417|NCT00570778|528624509|FG001|Overall Study|Abnormal test procedure|0|||
146578418|NCT00570778|528624510|FG002|Overall Study|Abnormal test procedure|0|||
146578419|NCT00570778|528624511|FG003|Overall Study|Abnormal test procedure|0|||
146578420|NCT00570778|528624508|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146578421|NCT00570778|528624509|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146578422|NCT00570778|528624510|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146578423|NCT00570778|528624511|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
146578424|NCT00570778|528624508|FG000|Overall Study|Lost to Follow-up|0|||
146578425|NCT00570778|528624509|FG001|Overall Study|Lost to Follow-up|0|||
146578426|NCT00570778|528624510|FG002|Overall Study|Lost to Follow-up|1|||
146578427|NCT00570778|528624511|FG003|Overall Study|Lost to Follow-up|0|||
146578428|NCT00570778|528624508|FG000|Overall Study|Subject no longer requires study drug|0|||
146578429|NCT00570778|528624509|FG001|Overall Study|Subject no longer requires study drug|1|||
146578430|NCT00570778|528624510|FG002|Overall Study|Subject no longer requires study drug|0|||
146578431|NCT00570778|528624511|FG003|Overall Study|Subject no longer requires study drug|0|||
146578432|NCT00711594|528624512|FG000|Overall Study|Progressive disease|2|||
146578433|NCT00711594|528624513|FG001|Overall Study|Progressive disease|2|||
146578434|NCT00711594|528624514|FG002|Overall Study|Progressive disease|6|||
146578435|NCT00711594|528624515|FG003|Overall Study|Progressive disease|44|||
146578436|NCT00711594|528624512|FG000|Overall Study|Other Adverse Event|1|||
146578437|NCT00711594|528624513|FG001|Overall Study|Other Adverse Event|0|||
146578438|NCT00711594|528624514|FG002|Overall Study|Other Adverse Event|0|||
146578439|NCT00711594|528624515|FG003|Overall Study|Other Adverse Event|16|||
146578440|NCT00711594|528624512|FG000|Overall Study|Withdrawal by Subject|0|||
146578441|NCT00711594|528624513|FG001|Overall Study|Withdrawal by Subject|1|||
146651959|NCT02616601|528903723|FG000|Overall Study|Lost to Follow-up|1|||
146578442|NCT00711594|528624514|FG002|Overall Study|Withdrawal by Subject|0|||
146578443|NCT00711594|528624515|FG003|Overall Study|Withdrawal by Subject|2|||
146578444|NCT02443337|528624521|FG000|Overall Study|Adverse Event|0|||
146918342|NCT00718419|529862820|FG000|Overall Study|Adverse Event|2|||
146578445|NCT02443337|528624522|FG001|Overall Study|Adverse Event|1|||
146918343|NCT00718419|529862821|FG001|Overall Study|Adverse Event|1|||
146918344|NCT00718419|529862820|FG000|Overall Study|Physician Decision|1|||
146978203|NCT00078819|530082259|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
146578446|NCT02443337|528624521|FG000|Overall Study|Clinical Progressive Disease|3|||
146578447|NCT02443337|528624522|FG001|Overall Study|Clinical Progressive Disease|0|||
146578448|NCT02443337|528624521|FG000|Overall Study|Withdrawal by Subject|2|||
146578449|NCT02443337|528624522|FG001|Overall Study|Withdrawal by Subject|1|||
146578450|NCT02096952|528624523|FG000|Overall Study|Adverse Event|1|||
146578451|NCT00988052|528624532|FG000|Overall Study|Missing|1|||
146578452|NCT00988052|528624533|FG001|Overall Study|Missing|0|||
146578453|NCT00988052|528624532|FG000|Overall Study|Teva requested subject withdrawal|3|||
146578454|NCT00988052|528624533|FG001|Overall Study|Teva requested subject withdrawal|1|||
146578455|NCT00988052|528624532|FG000|Overall Study|Death|1|||
146578456|NCT00988052|528624533|FG001|Overall Study|Death|3|||
146578457|NCT00988052|528624532|FG000|Overall Study|Protocol Violation|6|||
146578458|NCT00988052|528624533|FG001|Overall Study|Protocol Violation|5|||
146578459|NCT00988052|528624532|FG000|Overall Study|Pregnancy|6|||
146578460|NCT00988052|528624533|FG001|Overall Study|Pregnancy|6|||
146578461|NCT00988052|528624532|FG000|Overall Study|Lack of Efficacy|8|||
146578462|NCT00988052|528624533|FG001|Overall Study|Lack of Efficacy|7|||
146578463|NCT00988052|528624532|FG000|Overall Study|Lost to Follow-up|6|||
146578464|NCT00988052|528624533|FG001|Overall Study|Lost to Follow-up|11|||
146578465|NCT00988052|528624532|FG000|Overall Study|Physician Decision|27|||
146578466|NCT00988052|528624533|FG001|Overall Study|Physician Decision|28|||
146578467|NCT00988052|528624532|FG000|Overall Study|Adverse Event|35|||
146578468|NCT00988052|528624533|FG001|Overall Study|Adverse Event|28|||
146578469|NCT00988052|528624532|FG000|Overall Study|Withdrawal by Subject|90|||
146578470|NCT00988052|528624533|FG001|Overall Study|Withdrawal by Subject|91|||
146578471|NCT00988052|528624532|FG000|Overall Study|Study terminated by sponsor|240|||
146578472|NCT00988052|528624533|FG001|Overall Study|Study terminated by sponsor|236|||
146578473|NCT02446769|528624535|FG000|Screening Period|Screen Failure|11|||
146578474|NCT02446769|528624536|FG001|Screening Period|Screen Failure|0|||
146578475|NCT02446769|528624537|FG002|Screening Period|Screen Failure|0|||
146578476|NCT02446769|528624535|FG000|Study Period|Randomized in Error|0|||
146578477|NCT02446769|528624536|FG001|Study Period|Randomized in Error|2|||
146578478|NCT02446769|528624537|FG002|Study Period|Randomized in Error|0|||
146578479|NCT04482439|528624538|FG000|Overall Study|Lost to Follow-up|1|||
146578480|NCT04482439|528624538|FG000|Overall Study|Unrelated illness|1|||
146578481|NCT03072043|528624541|FG000|Overall Study|Death|0|||
146578482|NCT03072043|528624542|FG001|Overall Study|Death|0|||
146578483|NCT03072043|528624543|FG002|Overall Study|Death|3|||
146578484|NCT03072043|528624541|FG000|Overall Study|Adverse Event|0|||
146578485|NCT03072043|528624542|FG001|Overall Study|Adverse Event|0|||
146578486|NCT03072043|528624543|FG002|Overall Study|Adverse Event|2|||
146578487|NCT03072043|528624541|FG000|Overall Study|Withdrawal by Subject|0|||
146578488|NCT03072043|528624542|FG001|Overall Study|Withdrawal by Subject|0|||
146578489|NCT03072043|528624543|FG002|Overall Study|Withdrawal by Subject|4|||
146578490|NCT01277822|528624544|FG000|Overall Study|Adverse Event|2|||
146578491|NCT01277822|528624545|FG001|Overall Study|Adverse Event|1|||
146578492|NCT01277822|528624544|FG000|Overall Study|Withdrawal by Subject|6|||
146578493|NCT01277822|528624545|FG001|Overall Study|Withdrawal by Subject|7|||
146578494|NCT01277822|528624544|FG000|Overall Study|Physician Decision|1|||
146578495|NCT01277822|528624545|FG001|Overall Study|Physician Decision|1|||
146578496|NCT01277822|528624544|FG000|Overall Study|Protocol Violation|1|||
146578497|NCT01277822|528624545|FG001|Overall Study|Protocol Violation|0|||
146578498|NCT01277822|528624544|FG000|Overall Study|Lost to Follow-up|2|||
146578499|NCT01277822|528624545|FG001|Overall Study|Lost to Follow-up|1|||
146578500|NCT01277822|528624544|FG000|Overall Study|Contraindicated medication used|2|||
146578501|NCT01277822|528624545|FG001|Overall Study|Contraindicated medication used|1|||
146578502|NCT01277822|528624544|FG000|Overall Study|Participant moved|1|||
146578503|NCT01277822|528624545|FG001|Overall Study|Participant moved|0|||
146578504|NCT02923531|528624546|FG000|Overall Study|Adverse Event|4|||
146578505|NCT02923531|528624546|FG000|Overall Study|Clinical Deterioration|1|||
146578506|NCT02923531|528624546|FG000|Overall Study|Disease Progression|3|||
146578507|NCT02923531|528624546|FG000|Overall Study|Study Termination|1|||
146578508|NCT00997984|528624547|FG000|Overall Study|Adverse Event|1|||
146578509|NCT00997984|528624548|FG001|Overall Study|Adverse Event|8|||
146578510|NCT00997984|528624549|FG002|Overall Study|Adverse Event|8|||
146578511|NCT00997984|528624547|FG000|Overall Study|Protocol Violation|1|||
146578512|NCT00997984|528624548|FG001|Overall Study|Protocol Violation|3|||
146578513|NCT00997984|528624549|FG002|Overall Study|Protocol Violation|0|||
146578514|NCT00997984|528624547|FG000|Overall Study|Withdrawal by Subject|6|||
146578515|NCT00997984|528624548|FG001|Overall Study|Withdrawal by Subject|9|||
146578516|NCT00997984|528624549|FG002|Overall Study|Withdrawal by Subject|5|||
146578517|NCT00997984|528624547|FG000|Overall Study|Lost to Follow-up|8|||
146578518|NCT00997984|528624548|FG001|Overall Study|Lost to Follow-up|5|||
146578519|NCT00997984|528624549|FG002|Overall Study|Lost to Follow-up|4|||
146578520|NCT00997984|528624547|FG000|Overall Study|Lack of Efficacy|20|||
146578521|NCT00997984|528624548|FG001|Overall Study|Lack of Efficacy|6|||
146578522|NCT00997984|528624549|FG002|Overall Study|Lack of Efficacy|3|||
146651960|NCT02616601|528903724|FG001|Overall Study|Lost to Follow-up|0|||
146578523|NCT00997984|528624547|FG000|Overall Study|Met exclusion criteria|1|||
146578524|NCT00997984|528624548|FG001|Overall Study|Met exclusion criteria|0|||
146578525|NCT00997984|528624549|FG002|Overall Study|Met exclusion criteria|0|||
146578526|NCT00997984|528624547|FG000|Overall Study|non-compliance|0|||
146578527|NCT00997984|528624548|FG001|Overall Study|non-compliance|2|||
146578528|NCT00997984|528624549|FG002|Overall Study|non-compliance|3|||
146578529|NCT00997984|528624547|FG000|Overall Study|Wrong medication dispensed|0|||
146578530|NCT00997984|528624548|FG001|Overall Study|Wrong medication dispensed|1|||
146578531|NCT00997984|528624549|FG002|Overall Study|Wrong medication dispensed|0|||
146578532|NCT00997984|528624547|FG000|Overall Study|Suicidal ideation|0|||
146578533|NCT00997984|528624548|FG001|Overall Study|Suicidal ideation|0|||
146578534|NCT00997984|528624549|FG002|Overall Study|Suicidal ideation|1|||
146578535|NCT00997984|528624547|FG000|Overall Study|Work schedule|0|||
146578536|NCT00997984|528624548|FG001|Overall Study|Work schedule|0|||
146578537|NCT00997984|528624549|FG002|Overall Study|Work schedule|2|||
146578538|NCT02997865|528624551|FG000|Overall Study|Death|2|||
146578539|NCT02997865|528624552|FG001|Overall Study|Death|1|||
146578540|NCT02997865|528624551|FG000|Overall Study|Lost to Follow-up|6|||
146578541|NCT02997865|528624552|FG001|Overall Study|Lost to Follow-up|3|||
146578542|NCT02997865|528624551|FG000|Overall Study|Withdrawal by Subject|5|||
146578543|NCT02997865|528624552|FG001|Overall Study|Withdrawal by Subject|0|||
146578544|NCT00295646|528624555|FG000|Overall Study|Protocol Violation|18|||
146578545|NCT00295646|528624556|FG001|Overall Study|Protocol Violation|20|||
146578546|NCT00295646|528624557|FG002|Overall Study|Protocol Violation|20|||
146578547|NCT00295646|528624558|FG003|Overall Study|Protocol Violation|18|||
146578548|NCT00295646|528624555|FG000|Overall Study|Withdrawal by Subject|8|||
146578549|NCT00295646|528624556|FG001|Overall Study|Withdrawal by Subject|9|||
146578550|NCT00295646|528624557|FG002|Overall Study|Withdrawal by Subject|11|||
146578551|NCT00295646|528624558|FG003|Overall Study|Withdrawal by Subject|14|||
146578552|NCT00295646|528624555|FG000|Overall Study|Lost to Follow-up|0|||
146578553|NCT00295646|528624556|FG001|Overall Study|Lost to Follow-up|5|||
146578554|NCT00295646|528624557|FG002|Overall Study|Lost to Follow-up|1|||
146578555|NCT00295646|528624558|FG003|Overall Study|Lost to Follow-up|5|||
146578556|NCT00295646|528624555|FG000|Overall Study|Death|9|||
146578557|NCT00295646|528624556|FG001|Overall Study|Death|7|||
146578558|NCT00295646|528624557|FG002|Overall Study|Death|18|||
146578559|NCT00295646|528624558|FG003|Overall Study|Death|8|||
146578560|NCT02243371|528624563|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
146578561|NCT02243371|528624564|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
146578562|NCT02243371|528624563|FG000|Overall Study|Death (unrelated)|2|||
146578563|NCT02243371|528624564|FG001|Overall Study|Death (unrelated)|4|||
146578564|NCT02243371|528624563|FG000|Overall Study|Adverse Event (unrelated)|0|||
146578565|NCT02243371|528624564|FG001|Overall Study|Adverse Event (unrelated)|1|||
146578566|NCT02243371|528624563|FG000|Overall Study|Lack of Clinical Benefit|0|||
146578567|NCT02243371|528624564|FG001|Overall Study|Lack of Clinical Benefit|1|||
146578568|NCT02243371|528624563|FG000|Overall Study|Withdrawal by Subject|0|||
146578569|NCT02243371|528624564|FG001|Overall Study|Withdrawal by Subject|2|||
146578570|NCT01945996|528624565|FG000|Overall Study|Lost to Follow-up|3|||
146578571|NCT01945996|528624566|FG001|Overall Study|Lost to Follow-up|5|||
146578572|NCT00271856|528624568|FG000|Overall Study|Withdrawal by Subject|1|||
146578573|NCT00271856|528624569|FG001|Overall Study|Withdrawal by Subject|7|||
146578574|NCT00271856|528624568|FG000|Overall Study|Lost to Follow-up|10|||
146578575|NCT00271856|528624569|FG001|Overall Study|Lost to Follow-up|11|||
146578576|NCT04677543|528624570|FG000|Overall Study|Withdrawal by Subject|4|||
146578577|NCT04677543|528624571|FG001|Overall Study|Withdrawal by Subject|1|||
146578578|NCT04677543|528624570|FG000|Overall Study|Physician Decision|0|||
146578579|NCT04677543|528624571|FG001|Overall Study|Physician Decision|1|||
146578580|NCT04677543|528624570|FG000|Overall Study|Adverse Event|0|||
146578581|NCT04677543|528624571|FG001|Overall Study|Adverse Event|1|||
146578582|NCT00854724|528626220|FG000|First Intervention|Withdrawal by Subject|1|||
146578583|NCT00854724|528626221|FG001|First Intervention|Withdrawal by Subject|1|||
146578584|NCT00854724|528626220|FG000|Washout|Protocol Violation|1|||
146578585|NCT00854724|528626221|FG001|Washout|Protocol Violation|0|||
146578586|NCT00854724|528626220|FG000|Washout|Withdrawal by Subject|0|||
146578587|NCT00854724|528626221|FG001|Washout|Withdrawal by Subject|1|||
146578588|NCT00854724|528626220|FG000|Second Intervention|Protocol Violation|1|||
146578589|NCT00854724|528626221|FG001|Second Intervention|Protocol Violation|0|||
146578590|NCT00854724|528626220|FG000|Second Intervention|Physician Decision|0|||
146578591|NCT00854724|528626221|FG001|Second Intervention|Physician Decision|1|||
146578592|NCT01498692|528626230|FG000|Overall Study|Death|4|||
146578593|NCT01498692|528626230|FG000|Overall Study|Withdrawal by Subject|1|||
146578594|NCT01498692|528626230|FG000|Overall Study|Missed 12-month visit|3|||
146578595|NCT04729972|528626231|FG000|Overall Study|Adverse Event|1|||
146578596|NCT00590122|528626232|FG000|Overall Study|swallowed oral dissolving dose|1|||
146578597|NCT00590122|528626233|FG001|Overall Study|swallowed oral dissolving dose|0|||
146578598|NCT01208324|528626234|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
146578599|NCT01208324|528626235|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
146578600|NCT01208324|528626236|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
146578601|NCT01208324|528626237|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
146578602|NCT01701362|528626238|FG000|Overall Study|Adverse events not related to study drug|1|||
146578603|NCT01701362|528626239|FG001|Overall Study|Adverse events not related to study drug|6|||
146578604|NCT01701362|528626238|FG000|Overall Study|Adverse events related to study drug|12|||
146578605|NCT01701362|528626239|FG001|Overall Study|Adverse events related to study drug|10|||
146578606|NCT01701362|528626238|FG000|Overall Study|Protocol Violation|5|||
146578607|NCT01701362|528626239|FG001|Overall Study|Protocol Violation|3|||
146578608|NCT01701362|528626238|FG000|Overall Study|No longer willing to participate|8|||
146578609|NCT01701362|528626239|FG001|Overall Study|No longer willing to participate|14|||
146578610|NCT01701362|528626238|FG000|Overall Study|Lost to Follow-up|6|||
146578611|NCT01701362|528626239|FG001|Overall Study|Lost to Follow-up|9|||
146578612|NCT01701362|528626238|FG000|Overall Study|Insufficient clinical response|6|||
146578613|NCT01701362|528626239|FG001|Overall Study|Insufficient clinical response|6|||
146578614|NCT01701362|528626238|FG000|Overall Study|Death|0|||
146578615|NCT01701362|528626239|FG001|Overall Study|Death|1|||
146578616|NCT01701362|528626238|FG000|Overall Study|Randomized but not treated|1|||
146578617|NCT01701362|528626239|FG001|Overall Study|Randomized but not treated|2|||
146578618|NCT01701362|528626238|FG000|Overall Study|Reasons other than those mentioned above|3|||
146578619|NCT01701362|528626239|FG001|Overall Study|Reasons other than those mentioned above|5|||
146578620|NCT00249808|528626240|FG000|Overall Study|Other|27|||
146578621|NCT00249808|528626240|FG000|Overall Study|Protocol Violation|3|||
146578622|NCT00249808|528626240|FG000|Overall Study|Lost to Follow-up|8|||
146578623|NCT00249808|528626240|FG000|Overall Study|Adverse Event|81|||
146578624|NCT00249808|528626240|FG000|Overall Study|Lack of Efficacy|52|||
146578625|NCT00249808|528626240|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
146578626|NCT03654040|528626241|FG000|Overall Study|Death|1|||
146578627|NCT03654040|528626242|FG001|Overall Study|Death|0|||
146578628|NCT03654040|528626241|FG000|Overall Study|Withdrawal by Subject|1|||
146578629|NCT03654040|528626242|FG001|Overall Study|Withdrawal by Subject|0|||
146578630|NCT03654040|528626241|FG000|Overall Study|Study terminated by sponsor|8|||
146578631|NCT03654040|528626242|FG001|Overall Study|Study terminated by sponsor|2|||
146578632|NCT03654040|528626241|FG000|Overall Study|Failure to initiate study therapy|2|||
146578633|NCT03654040|528626242|FG001|Overall Study|Failure to initiate study therapy|0|||
146578634|NCT03654040|528626241|FG000|Overall Study|Transplanted at another center|2|||
146578635|NCT03654040|528626242|FG001|Overall Study|Transplanted at another center|0|||
146578636|NCT03654040|528626241|FG000|Overall Study|Failure to meet eligibility criteria|14|||
146578637|NCT03654040|528626242|FG001|Overall Study|Failure to meet eligibility criteria|2|||
146578638|NCT03654040|528626241|FG000|Overall Study|No longer transplant candidate|1|||
146578639|NCT03654040|528626242|FG001|Overall Study|No longer transplant candidate|0|||
146578640|NCT03654040|528626241|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
146578641|NCT03654040|528626242|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
146578642|NCT03654040|528626241|FG000|Overall Study|Recipient ineligible|0|||
146578643|NCT03654040|528626242|FG001|Overall Study|Recipient ineligible|2|||
146578644|NCT03654040|528626241|FG000|Overall Study|Received deceased liver|0|||
146578645|NCT03654040|528626242|FG001|Overall Study|Received deceased liver|1|||
146578646|NCT01709110|528626243|FG000|Overall Study|Adverse Event|56|||
146578647|NCT01709110|528626244|FG001|Overall Study|Adverse Event|48|||
146578648|NCT01709110|528626243|FG000|Overall Study|Death|14|||
146578649|NCT01709110|528626244|FG001|Overall Study|Death|6|||
146578650|NCT01709110|528626243|FG000|Overall Study|Lost to Follow-up|7|||
146578651|NCT01709110|528626244|FG001|Overall Study|Lost to Follow-up|5|||
146578652|NCT01709110|528626243|FG000|Overall Study|Protocol Violation|4|||
146578653|NCT01709110|528626244|FG001|Overall Study|Protocol Violation|6|||
146578654|NCT01709110|528626243|FG000|Overall Study|Withdrawal by Subject|96|||
146578655|NCT01709110|528626244|FG001|Overall Study|Withdrawal by Subject|89|||
146578656|NCT01709110|528626243|FG000|Overall Study|Physician Decision|4|||
146578657|NCT01709110|528626244|FG001|Overall Study|Physician Decision|10|||
146578658|NCT01709110|528626243|FG000|Overall Study|Sponsor Decision|2|||
146578659|NCT01709110|528626244|FG001|Overall Study|Sponsor Decision|2|||
146578660|NCT01709110|528626243|FG000|Overall Study|Lack of Efficacy|1|||
146578661|NCT01709110|528626244|FG001|Overall Study|Lack of Efficacy|1|||
146578662|NCT01709110|528626243|FG000|Overall Study|Caregiver Decision|1|||
146578663|NCT01709110|528626244|FG001|Overall Study|Caregiver Decision|1|||
146578664|NCT00485758|528626254|FG000|Overall Study|Adverse Event|102|||
146578665|NCT00485758|528626255|FG001|Overall Study|Adverse Event|31|||
146578666|NCT00485758|528626254|FG000|Overall Study|Death|0|||
146578667|NCT00485758|528626255|FG001|Overall Study|Death|1|||
146578668|NCT00485758|528626254|FG000|Overall Study|Lost to Follow-up|5|||
146578669|NCT00485758|528626255|FG001|Overall Study|Lost to Follow-up|1|||
146578670|NCT00485758|528626254|FG000|Overall Study|Physician Decision|3|||
146578671|NCT00485758|528626255|FG001|Overall Study|Physician Decision|3|||
146578672|NCT00485758|528626254|FG000|Overall Study|Protocol Violation|11|||
146578673|NCT00485758|528626255|FG001|Overall Study|Protocol Violation|2|||
146578674|NCT00485758|528626254|FG000|Overall Study|Withdrawal by Subject|32|||
146578675|NCT00485758|528626255|FG001|Overall Study|Withdrawal by Subject|27|||
146578676|NCT00485758|528626254|FG000|Overall Study|Study Terminated by Sponsor|3|||
146918345|NCT00718419|529862821|FG001|Overall Study|Physician Decision|6|||
146918346|NCT00718419|529862820|FG000|Overall Study|Sponsor decision|0|||
146918347|NCT00718419|529862821|FG001|Overall Study|Sponsor decision|1|||
146918348|NCT00718419|529862820|FG000|Overall Study|Withdrawal by Subject|0|||
146578677|NCT00485758|528626255|FG001|Overall Study|Study Terminated by Sponsor|0|||
146578678|NCT04123093|528626256|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
146578679|NCT04123093|528626257|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
146578680|NCT04123093|528626256|FG000|Phase 2|Physician Decision|0|||
146578681|NCT04123093|528626257|FG001|Phase 2|Physician Decision|1|||
146578682|NCT04123093|528626256|FG000|Phase 2|Withdrawal by Subject|0|||
146578683|NCT04123093|528626257|FG001|Phase 2|Withdrawal by Subject|1|||
146578684|NCT00984165|528626258|FG000|Overall Study|Death on study|2|||
146578685|NCT00984165|528626259|FG001|Overall Study|Death on study|0|||
146578686|NCT00984165|528626260|FG002|Overall Study|Death on study|0|||
146578687|NCT00984165|528626261|FG003|Overall Study|Death on study|0|||
146578688|NCT00984165|528626258|FG000|Overall Study|Disease progression on study|5|||
146578689|NCT00984165|528626259|FG001|Overall Study|Disease progression on study|1|||
146578690|NCT00984165|528626260|FG002|Overall Study|Disease progression on study|0|||
146578691|NCT00984165|528626261|FG003|Overall Study|Disease progression on study|0|||
146578692|NCT00984165|528626258|FG000|Overall Study|Death of recipient|0|||
146578693|NCT00984165|528626259|FG001|Overall Study|Death of recipient|0|||
146578694|NCT00984165|528626260|FG002|Overall Study|Death of recipient|0|||
146578695|NCT00984165|528626261|FG003|Overall Study|Death of recipient|1|||
146578696|NCT00984165|528626258|FG000|Overall Study|New protocol|0|||
146578697|NCT00984165|528626259|FG001|Overall Study|New protocol|0|||
146578698|NCT00984165|528626260|FG002|Overall Study|New protocol|0|||
146578699|NCT00984165|528626261|FG003|Overall Study|New protocol|1|||
146578700|NCT00984165|528626258|FG000|Overall Study|P+/donor pair removed from protocol|0|||
146578701|NCT00984165|528626259|FG001|Overall Study|P+/donor pair removed from protocol|0|||
146578702|NCT00984165|528626260|FG002|Overall Study|P+/donor pair removed from protocol|0|||
146578703|NCT00984165|528626261|FG003|Overall Study|P+/donor pair removed from protocol|1|||
146978204|NCT00078819|530082260|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
146978205|NCT00078819|530082261|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
146978206|NCT00078819|530082262|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
146978207|NCT00078819|530082259|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
146978208|NCT00078819|530082260|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
146978209|NCT00078819|530082261|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
146978210|NCT00078819|530082262|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
146578704|NCT00984165|528626258|FG000|Overall Study|removed with a pair recipient|0|||
146578705|NCT00984165|528626259|FG001|Overall Study|removed with a pair recipient|0|||
146578706|NCT00984165|528626260|FG002|Overall Study|removed with a pair recipient|0|||
146578707|NCT00984165|528626261|FG003|Overall Study|removed with a pair recipient|1|||
146578708|NCT00135330|528626262|FG000|Overall Study|Adverse Event|2|||
146578709|NCT00135330|528626263|FG001|Overall Study|Adverse Event|5|||
146578710|NCT00135330|528626264|FG002|Overall Study|Adverse Event|1|||
146578711|NCT00135330|528626262|FG000|Overall Study|Lost to Follow-up|0|||
146578712|NCT00135330|528626263|FG001|Overall Study|Lost to Follow-up|2|||
146578713|NCT00135330|528626264|FG002|Overall Study|Lost to Follow-up|3|||
146578714|NCT00135330|528626262|FG000|Overall Study|Physician Decision|1|||
146578715|NCT00135330|528626263|FG001|Overall Study|Physician Decision|1|||
146578716|NCT00135330|528626264|FG002|Overall Study|Physician Decision|0|||
146578717|NCT00135330|528626262|FG000|Overall Study|Protocol Violation|4|||
146578718|NCT00135330|528626263|FG001|Overall Study|Protocol Violation|3|||
146578719|NCT00135330|528626264|FG002|Overall Study|Protocol Violation|3|||
146578720|NCT00135330|528626262|FG000|Overall Study|Patient Decision|5|||
146578721|NCT00135330|528626263|FG001|Overall Study|Patient Decision|1|||
146578722|NCT00135330|528626264|FG002|Overall Study|Patient Decision|4|||
146578723|NCT00135330|528626262|FG000|Overall Study|Sponsor Decision|0|||
146578724|NCT00135330|528626263|FG001|Overall Study|Sponsor Decision|1|||
146918349|NCT00718419|529862821|FG001|Overall Study|Withdrawal by Subject|5|||
146918350|NCT00718419|529862820|FG000|Overall Study|Progressive Disease|7|||
146578725|NCT00135330|528626264|FG002|Overall Study|Sponsor Decision|0|||
146918351|NCT00718419|529862821|FG001|Overall Study|Progressive Disease|25|||
146918352|NCT00718419|529862820|FG000|Overall Study|Death Due to Progressive Disease|2|||
146918353|NCT00718419|529862821|FG001|Overall Study|Death Due to Progressive Disease|0|||
146978211|NCT02555618|530082263|FG000|Overall Study|Sponsor's Circumstances|1|||
146578726|NCT02229825|528626271|FG000|Overall Study|Personal Reasons|0|||
146578727|NCT02229825|528626272|FG001|Overall Study|Personal Reasons|1|||
146578728|NCT02229825|528626271|FG000|Overall Study|Refused continuing medication|7|||
146578729|NCT02229825|528626272|FG001|Overall Study|Refused continuing medication|6|||
146578730|NCT02229825|528626271|FG000|Overall Study|Lost to Follow-up|1|||
146578731|NCT02229825|528626272|FG001|Overall Study|Lost to Follow-up|2|||
146578732|NCT02229825|528626271|FG000|Overall Study|Protocol Violation|1|||
146578733|NCT02229825|528626272|FG001|Overall Study|Protocol Violation|1|||
146918354|NCT00718419|529862820|FG000|Overall Study|Death Due to Study Drug Related|0|||
146918355|NCT00718419|529862821|FG001|Overall Study|Death Due to Study Drug Related|1|||
146578734|NCT02229825|528626271|FG000|Overall Study|Lack of Efficacy|4|||
146578735|NCT02229825|528626272|FG001|Overall Study|Lack of Efficacy|10|||
146578736|NCT02229825|528626271|FG000|Overall Study|Adverse Event|11|||
146578737|NCT02229825|528626272|FG001|Overall Study|Adverse Event|9|||
146578738|NCT02229825|528626271|FG000|Overall Study|Not treated|0|||
146578739|NCT02229825|528626272|FG001|Overall Study|Not treated|1|||
146578740|NCT01390298|528626277|FG000|Overall Study|Death|1|||
146578741|NCT01390298|528626277|FG000|Overall Study|long term ICU admission|1|||
146578742|NCT01390298|528626277|FG000|Overall Study|Withdrawal by Subject|14|||
146578743|NCT01390298|528626277|FG000|Overall Study|Lost to Follow-up|7|||
146578744|NCT01390298|528626277|FG000|Overall Study|Surgery cancelled|1|||
146578745|NCT03520920|528626286|FG000|Overall Study|Death|13|||
146578746|NCT03520920|528626287|FG001|Overall Study|Death|1|||
146578747|NCT03520920|528626288|FG002|Overall Study|Death|0|||
146578748|NCT03520920|528626286|FG000|Overall Study|Withdrawal by Subject|2|||
146578749|NCT03520920|528626287|FG001|Overall Study|Withdrawal by Subject|1|||
146578750|NCT03520920|528626288|FG002|Overall Study|Withdrawal by Subject|0|||
146578751|NCT03520920|528626286|FG000|Overall Study|Study Terminated by the Sponsor|5|||
146578752|NCT03520920|528626287|FG001|Overall Study|Study Terminated by the Sponsor|14|||
146578753|NCT03520920|528626288|FG002|Overall Study|Study Terminated by the Sponsor|5|||
146578754|NCT00405392|528626289|FG000|Overall Study|Adverse Event|15|||
146578755|NCT00405392|528626290|FG001|Overall Study|Adverse Event|14|||
146578756|NCT00405392|528626289|FG000|Overall Study|Did not meet Eligibility criteria|7|||
146578757|NCT00405392|528626290|FG001|Overall Study|Did not meet Eligibility criteria|2|||
146578758|NCT00405392|528626289|FG000|Overall Study|Withdrawal by Subject|4|||
146578759|NCT00405392|528626290|FG001|Overall Study|Withdrawal by Subject|3|||
146578760|NCT00405392|528626289|FG000|Overall Study|Lost to Follow-up|1|||
146578761|NCT00405392|528626290|FG001|Overall Study|Lost to Follow-up|2|||
146578762|NCT00405392|528626289|FG000|Overall Study|Data missing|2|||
146578763|NCT00405392|528626290|FG001|Overall Study|Data missing|0|||
146578764|NCT00405392|528626289|FG000|Overall Study|Non-compliance|0|||
146578765|NCT00405392|528626290|FG001|Overall Study|Non-compliance|1|||
146578766|NCT00405392|528626289|FG000|Overall Study|Other|1|||
146578767|NCT00405392|528626290|FG001|Overall Study|Other|5|||
146578768|NCT05420961|528626293|FG000|Overall Study|Withdrawal by Subject|2|||
146578769|NCT05420961|528626294|FG001|Overall Study|Withdrawal by Subject|1|||
146578770|NCT05420961|528626295|FG002|Overall Study|Withdrawal by Subject|1|||
146578771|NCT05420961|528626296|FG003|Overall Study|Withdrawal by Subject|0|||
146578772|NCT05420961|528626297|FG004|Overall Study|Withdrawal by Subject|0|||
146578773|NCT05420961|528626293|FG000|Overall Study|Lost to Follow-up|0|||
146578774|NCT05420961|528626294|FG001|Overall Study|Lost to Follow-up|0|||
146578775|NCT05420961|528626295|FG002|Overall Study|Lost to Follow-up|1|||
146578776|NCT05420961|528626296|FG003|Overall Study|Lost to Follow-up|0|||
146651961|NCT02616601|528903725|FG002|Overall Study|Lost to Follow-up|1|||
146651962|NCT02616601|528903723|FG000|Overall Study|Non-Compliance with Test Article|1|||
146651963|NCT02616601|528903724|FG001|Overall Study|Non-Compliance with Test Article|0|||
146651964|NCT02616601|528903725|FG002|Overall Study|Non-Compliance with Test Article|1|||
146651965|NCT03718299|528903726|FG000|Overall Study|Adverse Event|1|||
146578777|NCT05420961|528626297|FG004|Overall Study|Lost to Follow-up|0|||
146578778|NCT05420961|528626293|FG000|Overall Study|Randomized by mistake without study treatment|0|||
146578779|NCT05420961|528626294|FG001|Overall Study|Randomized by mistake without study treatment|0|||
146578780|NCT05420961|528626295|FG002|Overall Study|Randomized by mistake without study treatment|1|||
146578781|NCT05420961|528626296|FG003|Overall Study|Randomized by mistake without study treatment|0|||
146578782|NCT05420961|528626297|FG004|Overall Study|Randomized by mistake without study treatment|1|||
146578783|NCT00803361|528626298|FG000|Overall Study|Adverse Event|13|||
146578784|NCT00803361|528626299|FG001|Overall Study|Adverse Event|3|||
146578785|NCT00803361|528626298|FG000|Overall Study|Lack of Efficacy|4|||
146578786|NCT00803361|528626299|FG001|Overall Study|Lack of Efficacy|13|||
146651966|NCT03718299|528903726|FG000|Overall Study|Withdrawal by Subject|6|||
146578787|NCT00803361|528626298|FG000|Overall Study|Lost to Follow-up|1|||
146578788|NCT00803361|528626299|FG001|Overall Study|Lost to Follow-up|2|||
146578789|NCT00803361|528626298|FG000|Overall Study|Physician Decision|1|||
146578790|NCT00803361|528626299|FG001|Overall Study|Physician Decision|0|||
146578791|NCT00803361|528626298|FG000|Overall Study|Protocol Violation|2|||
146578792|NCT00803361|528626299|FG001|Overall Study|Protocol Violation|4|||
146578793|NCT00803361|528626298|FG000|Overall Study|Withdrawal by Subject|5|||
146578794|NCT00803361|528626299|FG001|Overall Study|Withdrawal by Subject|6|||
146578795|NCT01437111|528626303|FG000|Overall Study|Adverse Event|2|||
146578796|NCT01437111|528626303|FG000|Overall Study|Withdrawal by Subject|4|||
146578797|NCT01437111|528626303|FG000|Overall Study|Not reported|5|||
146578798|NCT01437111|528626303|FG000|Overall Study|Physician Decision|1|||
146578799|NCT01437111|528626303|FG000|Overall Study|Lost to Follow-up|5|||
146578800|NCT01437111|528626303|FG000|Overall Study|Protocol Violation|1|||
146578801|NCT02131311|528626304|FG000|Overall Study|Adverse Event|2|||
146578802|NCT02131311|528626304|FG000|Overall Study|Protocol Violation|1|||
146578803|NCT02131311|528626304|FG000|Overall Study|Lost to Follow-up|1|||
146578804|NCT02623205|528626305|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
146651967|NCT03718299|528903726|FG000|Overall Study|Physician Decision|2|||
146651968|NCT03718299|528903726|FG000|Overall Study|Lost to Follow-up|1|||
146651969|NCT04389970|528903727|FG000|Overall Study|Lost to Follow-up|1|||
146651970|NCT01343823|528903728|FG000|Overall Study|Study Terminated|1|||
146651971|NCT01343823|528903729|FG001|Overall Study|Study Terminated|0|||
146651972|NCT01343823|528903730|FG002|Overall Study|Study Terminated|0|||
146651973|NCT01343823|528903731|FG003|Overall Study|Study Terminated|1|||
146651974|NCT01343823|528903728|FG000|Overall Study|Withdrawal by Subject|1|||
146651975|NCT01343823|528903729|FG001|Overall Study|Withdrawal by Subject|0|||
146651976|NCT01343823|528903730|FG002|Overall Study|Withdrawal by Subject|0|||
146651977|NCT01343823|528903731|FG003|Overall Study|Withdrawal by Subject|0|||
146651978|NCT02047318|528903743|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
146918356|NCT00718419|529862820|FG000|Overall Study|Death Due to Adverse Events|1|||
146918357|NCT00718419|529862821|FG001|Overall Study|Death Due to Adverse Events|0|||
146918358|NCT01675531|529862822|FG000|Overall Study|Adverse Event|9|||
146918359|NCT01675531|529862822|FG000|Overall Study|Withdrawal by Subject|7|||
146918360|NCT01675531|529862822|FG000|Overall Study|Lack of Efficacy|1|||
146918361|NCT01675531|529862822|FG000|Overall Study|Protocol Violation|8|||
146918362|NCT00726323|529862823|FG000|Overall Study|Withdrawal by Subject|3|||
146918363|NCT00726323|529862824|FG001|Overall Study|Withdrawal by Subject|1|||
146918364|NCT00726323|529862823|FG000|Overall Study|Physician Decision|1|||
146918365|NCT00726323|529862824|FG001|Overall Study|Physician Decision|0|||
146918366|NCT00726323|529862823|FG000|Overall Study|Progressive disease|23|||
146918367|NCT00726323|529862824|FG001|Overall Study|Progressive disease|16|||
146578805|NCT02623205|528626306|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
146578806|NCT02473471|528626310|FG000|Overall Study|poor oral hygiene|2|||
146578807|NCT02473471|528626310|FG000|Overall Study|Lost to Follow-up|1|||
146578808|NCT03082677|528626311|FG000|Overall Study|Not Treated|2|||
146578809|NCT01667133|528626313|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
146578810|NCT01667133|528626314|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
146578811|NCT01667133|528626315|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
146578812|NCT01667133|528626316|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
146578813|NCT01667133|528626317|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
146578814|NCT01667133|528626318|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
146578815|NCT01667133|528626319|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
146578816|NCT01667133|528626320|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
146578817|NCT01667133|528626321|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
146578818|NCT01667133|528626322|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
146578819|NCT01667133|528626323|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
146578820|NCT01667133|528626324|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
146578821|NCT01667133|528626313|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146578822|NCT01667133|528626314|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146578823|NCT01667133|528626315|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
146578824|NCT01667133|528626316|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146578825|NCT01667133|528626317|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146578826|NCT01667133|528626318|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146578827|NCT01667133|528626319|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146578828|NCT01667133|528626320|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146578829|NCT01667133|528626321|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146578830|NCT01667133|528626322|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146578831|NCT01667133|528626323|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146578832|NCT01667133|528626324|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146578833|NCT01667133|528626313|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
146578834|NCT01667133|528626314|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
146578835|NCT01667133|528626315|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
146578836|NCT01667133|528626316|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
146578837|NCT01667133|528626317|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
146578838|NCT01667133|528626318|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
146578839|NCT01667133|528626319|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
146578840|NCT01667133|528626320|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
146651979|NCT02047318|528903743|FG000|Core Study Period|Adverse Event|1|||
146918368|NCT00726323|529862823|FG000|Overall Study|Clinical progression|0|||
146918369|NCT00726323|529862824|FG001|Overall Study|Clinical progression|3|||
146918370|NCT00726323|529862823|FG000|Overall Study|Adverse Event|9|||
146918371|NCT00726323|529862824|FG001|Overall Study|Adverse Event|9|||
146578841|NCT01667133|528626321|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
146918372|NCT00726323|529862823|FG000|Overall Study|Death|1|||
146918373|NCT00726323|529862824|FG001|Overall Study|Death|0|||
146918374|NCT00726323|529862823|FG000|Overall Study|Participant wished to discontinue|0|||
146578842|NCT01667133|528626322|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
146578843|NCT01667133|528626323|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
146578844|NCT01667133|528626324|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
146578845|NCT01667133|528626313|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146578846|NCT01667133|528626314|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146651980|NCT02047318|528903743|FG000|Core Study Period|Withdrawal by caregiver|3|||
146578847|NCT01667133|528626315|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146578848|NCT01667133|528626316|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
146578849|NCT01667133|528626317|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146578850|NCT01667133|528626318|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146578851|NCT01667133|528626319|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146578852|NCT01667133|528626320|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146578853|NCT01667133|528626321|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146578854|NCT01667133|528626322|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146578855|NCT01667133|528626323|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146578856|NCT01667133|528626324|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146578857|NCT01667133|528626313|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
146651981|NCT02047318|528903743|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
146918375|NCT00726323|529862824|FG001|Overall Study|Participant wished to discontinue|1|||
146918376|NCT00726323|529862823|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
146578858|NCT01667133|528626314|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
146578859|NCT01667133|528626315|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
146578860|NCT01667133|528626316|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
146578861|NCT01667133|528626317|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
146578862|NCT01667133|528626318|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
146578863|NCT01667133|528626319|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
146578864|NCT01667133|528626320|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
146578865|NCT01667133|528626321|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
146578866|NCT01667133|528626322|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
146578867|NCT01667133|528626323|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
146578868|NCT01667133|528626324|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
146578869|NCT01667133|528626313|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146578870|NCT01667133|528626314|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146578871|NCT01667133|528626315|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146578872|NCT01667133|528626316|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146578873|NCT01667133|528626317|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146578874|NCT01667133|528626318|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146578875|NCT01667133|528626319|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146578876|NCT01667133|528626320|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146578877|NCT01667133|528626321|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146578878|NCT01667133|528626322|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
146578879|NCT01667133|528626323|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146578880|NCT01667133|528626324|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146578881|NCT01667133|528626313|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
146578882|NCT01667133|528626314|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
146578883|NCT01667133|528626315|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
146578884|NCT01667133|528626316|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
146578885|NCT01667133|528626317|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
146578886|NCT01667133|528626318|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
146578887|NCT01667133|528626319|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
146578888|NCT01667133|528626320|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
146578889|NCT01667133|528626321|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
146578890|NCT01667133|528626322|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
146578891|NCT01667133|528626323|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
146578892|NCT01667133|528626324|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
146578893|NCT01667133|528626313|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146578894|NCT01667133|528626314|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146578895|NCT01667133|528626315|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146578896|NCT01667133|528626316|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146578897|NCT01667133|528626317|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146578898|NCT01667133|528626318|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146578899|NCT01667133|528626319|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146578900|NCT01667133|528626320|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146578901|NCT01667133|528626321|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146578902|NCT01667133|528626322|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
146578903|NCT01667133|528626323|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146578904|NCT01667133|528626324|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146651982|NCT02296138|528903744|FG000|Overall Study|Adverse Event|348|||
146651983|NCT02296138|528903745|FG001|Overall Study|Adverse Event|259|||
146651984|NCT02296138|528903744|FG000|Overall Study|Lack of Efficacy|59|||
146651985|NCT02296138|528903745|FG001|Overall Study|Lack of Efficacy|37|||
146578905|NCT01667133|528626313|FG000|Phase 2: Dose-expansion|Death|0|||
146578906|NCT01667133|528626314|FG001|Phase 2: Dose-expansion|Death|0|||
146578907|NCT01667133|528626315|FG002|Phase 2: Dose-expansion|Death|0|||
146578908|NCT01667133|528626316|FG003|Phase 2: Dose-expansion|Death|0|||
146578909|NCT01667133|528626317|FG004|Phase 2: Dose-expansion|Death|0|||
146578910|NCT01667133|528626318|FG005|Phase 2: Dose-expansion|Death|0|||
146578911|NCT01667133|528626319|FG006|Phase 2: Dose-expansion|Death|0|||
146578912|NCT01667133|528626320|FG007|Phase 2: Dose-expansion|Death|0|||
146651986|NCT02296138|528903744|FG000|Overall Study|Protocol Violation|35|||
146651987|NCT02296138|528903745|FG001|Overall Study|Protocol Violation|36|||
146651988|NCT02296138|528903744|FG000|Overall Study|Lost to Follow-up|9|||
146651989|NCT02296138|528903745|FG001|Overall Study|Lost to Follow-up|12|||
146651990|NCT02296138|528903744|FG000|Overall Study|Withdrawal by Subject|184|||
146651991|NCT02296138|528903745|FG001|Overall Study|Withdrawal by Subject|131|||
146651992|NCT02296138|528903744|FG000|Overall Study|Not Treated|1|||
146651993|NCT02296138|528903745|FG001|Overall Study|Not Treated|1|||
146651994|NCT02296138|528903744|FG000|Overall Study|Patients with data irregularities|10|||
146651995|NCT02296138|528903745|FG001|Overall Study|Patients with data irregularities|11|||
146651996|NCT02296138|528903744|FG000|Overall Study|Other than specified|15|||
146918377|NCT00726323|529862824|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
146918378|NCT02918266|529862835|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
146918379|NCT02918266|529862836|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
146918380|NCT02918266|529862837|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
146918381|NCT02918266|529862838|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
146918382|NCT02918266|529862839|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
146918383|NCT02918266|529862840|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
146918384|NCT02918266|529862841|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
146918385|NCT02918266|529862842|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
146918386|NCT02918266|529862843|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
146918387|NCT02918266|529862844|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
146918388|NCT02918266|529862845|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
146918389|NCT00358917|529862848|FG000|Overall Study|Adverse Event|14|||
146918390|NCT00358917|529862849|FG001|Overall Study|Adverse Event|21|||
146918391|NCT00358917|529862848|FG000|Overall Study|Withdrawal by Subject|5|||
146918392|NCT00358917|529862849|FG001|Overall Study|Withdrawal by Subject|7|||
146918393|NCT00358917|529862848|FG000|Overall Study|Lost to Follow-up|20|||
146918394|NCT00358917|529862849|FG001|Overall Study|Lost to Follow-up|17|||
146578913|NCT01667133|528626321|FG008|Phase 2: Dose-expansion|Death|0|||
146578914|NCT01667133|528626322|FG009|Phase 2: Dose-expansion|Death|1|||
146578915|NCT01667133|528626323|FG010|Phase 2: Dose-expansion|Death|0|||
146578916|NCT01667133|528626324|FG011|Phase 2: Dose-expansion|Death|0|||
146578917|NCT01667133|528626313|FG000|Phase 2: Dose-expansion|Other|0|||
146578918|NCT01667133|528626314|FG001|Phase 2: Dose-expansion|Other|0|||
146578919|NCT01667133|528626315|FG002|Phase 2: Dose-expansion|Other|0|||
146578920|NCT01667133|528626316|FG003|Phase 2: Dose-expansion|Other|0|||
146578921|NCT01667133|528626317|FG004|Phase 2: Dose-expansion|Other|0|||
146578922|NCT01667133|528626318|FG005|Phase 2: Dose-expansion|Other|0|||
146578923|NCT01667133|528626319|FG006|Phase 2: Dose-expansion|Other|0|||
146578924|NCT01667133|528626320|FG007|Phase 2: Dose-expansion|Other|0|||
146578925|NCT01667133|528626321|FG008|Phase 2: Dose-expansion|Other|0|||
146578926|NCT01667133|528626322|FG009|Phase 2: Dose-expansion|Other|0|||
146578927|NCT01667133|528626323|FG010|Phase 2: Dose-expansion|Other|0|||
146578928|NCT01667133|528626324|FG011|Phase 2: Dose-expansion|Other|1|||
146578929|NCT00255723|528626330|FG000|Overall Study|Adverse Event|1|||
146578930|NCT00255723|528626331|FG001|Overall Study|Adverse Event|1|||
146578931|NCT00255723|528626330|FG000|Overall Study|Death|0|||
146578932|NCT00255723|528626331|FG001|Overall Study|Death|1|||
146578933|NCT00255723|528626330|FG000|Overall Study|Response Data Not Available|1|||
146578934|NCT00255723|528626331|FG001|Overall Study|Response Data Not Available|0|||
146578935|NCT03711370|528626333|FG000|Overall Study|Lost to Follow-up|16|||
146578936|NCT03711370|528626334|FG001|Overall Study|Lost to Follow-up|10|||
146578937|NCT03711370|528626333|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
146578938|NCT03711370|528626334|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
146578939|NCT01169701|528626337|FG000|Overall Study|Lost to Follow-up|1|||
146578940|NCT01169701|528626338|FG001|Overall Study|Lost to Follow-up|1|||
146578941|NCT01169701|528626337|FG000|Overall Study|Withdrawal by Subject|1|||
146578942|NCT01169701|528626338|FG001|Overall Study|Withdrawal by Subject|3|||
146578943|NCT01169701|528626337|FG000|Overall Study|Adverse Event|1|||
146578944|NCT01169701|528626338|FG001|Overall Study|Adverse Event|2|||
146651997|NCT02296138|528903745|FG001|Overall Study|Other than specified|13|||
146651998|NCT01653132|528903746|FG000|First Intervention|Protocol Violation|1|||
146651999|NCT01653132|528903747|FG001|First Intervention|Protocol Violation|0|||
146652000|NCT02677324|528903748|FG000|Overall Study|Disease Progression|6|||
146578945|NCT01169701|528626337|FG000|Overall Study|Exclusion criteria|2|||
146918395|NCT00358917|529862848|FG000|Overall Study|Noncompliance|12|||
146918396|NCT00358917|529862849|FG001|Overall Study|Noncompliance|11|||
146918397|NCT00358917|529862848|FG000|Overall Study|Death|2|||
146918398|NCT00358917|529862849|FG001|Overall Study|Death|3|||
146578946|NCT01169701|528626338|FG001|Overall Study|Exclusion criteria|0|||
146578947|NCT01169701|528626337|FG000|Overall Study|Death|0|||
146578948|NCT01169701|528626338|FG001|Overall Study|Death|1|||
146578949|NCT01169701|528626337|FG000|Overall Study|Administrative problems|0|||
146578950|NCT01169701|528626338|FG001|Overall Study|Administrative problems|1|||
146578951|NCT01169701|528626337|FG000|Overall Study|Serious adverse event|0|||
146652001|NCT02677324|528903748|FG000|Overall Study|Inability to Swallow pills|1|||
146578952|NCT01169701|528626338|FG001|Overall Study|Serious adverse event|1|||
146578953|NCT01169701|528626337|FG000|Overall Study|Sponsor decision|0|||
146578954|NCT01169701|528626338|FG001|Overall Study|Sponsor decision|1|||
146578955|NCT01536561|528626339|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
146578956|NCT01536561|528626339|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
146578957|NCT01536561|528626339|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
146578958|NCT01536561|528626339|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
146578959|NCT01536561|528626339|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
146578960|NCT01536561|528626339|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
146578961|NCT04188834|528626340|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
146578962|NCT00553436|528626341|FG000|Overall Study|Conversion to another procedure|1|||
146578963|NCT01030952|528626342|FG000|Overall Study|Protocol Violation|0|||
146578964|NCT01030952|528626343|FG001|Overall Study|Protocol Violation|1|||
146578965|NCT01030952|528626342|FG000|Overall Study|Informed consent withdrawal|1|||
146578966|NCT01030952|528626343|FG001|Overall Study|Informed consent withdrawal|0|||
146578967|NCT01030952|528626342|FG000|Overall Study|Lost to Follow-up|0|||
146578968|NCT01030952|528626343|FG001|Overall Study|Lost to Follow-up|1|||
146578969|NCT01030952|528626342|FG000|Overall Study|Unexplained|1|||
146578970|NCT01030952|528626343|FG001|Overall Study|Unexplained|1|||
146578971|NCT02455336|528626346|FG000|Overall Study|Withdrawal by Subject|0|||
146578972|NCT02455336|528626347|FG001|Overall Study|Withdrawal by Subject|2|||
146578973|NCT02455336|528626346|FG000|Overall Study|Adverse Event|3|||
146578974|NCT02455336|528626347|FG001|Overall Study|Adverse Event|0|||
146578975|NCT02455336|528626346|FG000|Overall Study|Non-responder to treatment|2|||
146578976|NCT02455336|528626347|FG001|Overall Study|Non-responder to treatment|0|||
146578977|NCT00391430|528626348|FG000|Overall Study|Withdrawal by Subject|3|||
146578978|NCT00391430|528626349|FG001|Overall Study|Withdrawal by Subject|0|||
146578979|NCT00391430|528626350|FG002|Overall Study|Withdrawal by Subject|12|||
146578980|NCT02467192|528626351|FG000|Overall Study|Death|1|||
146578981|NCT02467192|528626351|FG000|Overall Study|revealed to have pneumonia before|2|||
146578982|NCT00809926|528626353|FG000|Overall Study|Adverse Event|18|||
146578983|NCT00809926|528626354|FG001|Overall Study|Adverse Event|10|||
146578984|NCT00809926|528626353|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
146578985|NCT00809926|528626354|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
146578986|NCT00809926|528626353|FG000|Overall Study|Patient withdrew consent|8|||
146578987|NCT00809926|528626354|FG001|Overall Study|Patient withdrew consent|6|||
146578988|NCT00809926|528626353|FG000|Overall Study|Lost to Follow-up|2|||
146578989|NCT00809926|528626354|FG001|Overall Study|Lost to Follow-up|1|||
146578990|NCT00809926|528626353|FG000|Overall Study|Administrative Problems|0|||
146578991|NCT00809926|528626354|FG001|Overall Study|Administrative Problems|1|||
146578992|NCT00809926|528626353|FG000|Overall Study|Protocol deviation|0|||
146578993|NCT00809926|528626354|FG001|Overall Study|Protocol deviation|2|||
146578994|NCT01963767|528626370|FG000|Overall Study|Withdrawal by Subject|4|||
146578995|NCT01963767|528626371|FG001|Overall Study|Withdrawal by Subject|2|||
146578996|NCT01963767|528626370|FG000|Overall Study|Adverse Event|2|||
146918399|NCT00358917|529862848|FG000|Overall Study|Virologic failure|11|||
146918400|NCT00358917|529862849|FG001|Overall Study|Virologic failure|8|||
146918401|NCT00358917|529862848|FG000|Overall Study|Unable to Continue Participation|2|||
146918402|NCT00358917|529862849|FG001|Overall Study|Unable to Continue Participation|2|||
146918403|NCT01757704|529862855|FG000|Overall Study|Protocol Violation|1|||
146918404|NCT01757704|529862856|FG001|Overall Study|Protocol Violation|3|||
146918405|NCT02749721|529862857|FG000|Screening|Withdrawal by Subject|1|||
146918406|NCT02749721|529862857|FG000|Screening|Lost to Follow-up|2|||
146918407|NCT02749721|529862857|FG000|Screening|Protocol Violation|3|||
146918408|NCT02749721|529862857|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
146918409|NCT02749721|529862857|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
146918410|NCT02582749|529862862|FG000|Overall Study|Study terminated by funder|5|||
146578997|NCT01963767|528626371|FG001|Overall Study|Adverse Event|0|||
146578998|NCT01082081|528626374|FG000|Overall Study|Lost to Follow-up|0|||
146578999|NCT01082081|528626375|FG001|Overall Study|Lost to Follow-up|0|||
146579000|NCT01082081|528626376|FG002|Overall Study|Lost to Follow-up|1|||
146579001|NCT01082081|528626374|FG000|Overall Study|Withdrawal by Subject|0|||
146918411|NCT02582749|529862863|FG001|Overall Study|Study terminated by funder|10|||
146918412|NCT02582749|529862862|FG000|Overall Study|Withdrawal by Subject|0|||
146579002|NCT01082081|528626375|FG001|Overall Study|Withdrawal by Subject|0|||
146579003|NCT01082081|528626376|FG002|Overall Study|Withdrawal by Subject|1|||
146579004|NCT01082081|528626374|FG000|Overall Study|Other Reason|0|||
146652002|NCT02677324|528903748|FG000|Overall Study|Non-compliance|1|||
146652003|NCT02677324|528903748|FG000|Overall Study|Lack of Efficacy|1|||
146918413|NCT02582749|529862863|FG001|Overall Study|Withdrawal by Subject|1|||
146579005|NCT01082081|528626375|FG001|Overall Study|Other Reason|1|||
146579006|NCT01082081|528626376|FG002|Overall Study|Other Reason|0|||
146579007|NCT00670930|528626377|FG000|Overall Study|Adminstrative Problem|0|||
146579008|NCT00670930|528626378|FG001|Overall Study|Adminstrative Problem|1|||
146579009|NCT00670930|528626377|FG000|Overall Study|Lost to Follow-up|1|||
146652004|NCT02677324|528903748|FG000|Overall Study|Medical insurance coverage|1|||
146579010|NCT00670930|528626378|FG001|Overall Study|Lost to Follow-up|0|||
146579011|NCT03159468|528626383|FG000|Overall Study|Withdrawal by Subject|0|||
146579012|NCT03159468|528626384|FG001|Overall Study|Withdrawal by Subject|0|||
146579013|NCT03159468|528626385|FG002|Overall Study|Withdrawal by Subject|3|||
146579014|NCT03159468|528626386|FG003|Overall Study|Withdrawal by Subject|0|||
146579015|NCT03159468|528626387|FG004|Overall Study|Withdrawal by Subject|0|||
146579016|NCT03159468|528626388|FG005|Overall Study|Withdrawal by Subject|0|||
146579017|NCT02712983|528628405|FG000|Treatment Phase|Adverse Event|3|||
146579018|NCT02712983|528628406|FG001|Treatment Phase|Adverse Event|1|||
146579019|NCT02712983|528628407|FG002|Treatment Phase|Adverse Event|1|||
146579020|NCT02712983|528628408|FG003|Treatment Phase|Adverse Event|4|||
146579021|NCT02712983|528628409|FG004|Treatment Phase|Adverse Event|3|||
146579022|NCT02712983|528628410|FG005|Treatment Phase|Adverse Event|0|||
146579023|NCT02712983|528628411|FG006|Treatment Phase|Adverse Event|6|||
146579024|NCT02712983|528628412|FG007|Treatment Phase|Adverse Event|6|||
146579025|NCT02712983|528628413|FG008|Treatment Phase|Adverse Event|1|||
146579026|NCT02712983|528628405|FG000|Treatment Phase|Protocol Deviation|0|||
146579027|NCT02712983|528628406|FG001|Treatment Phase|Protocol Deviation|0|||
146579028|NCT02712983|528628407|FG002|Treatment Phase|Protocol Deviation|0|||
146579029|NCT02712983|528628408|FG003|Treatment Phase|Protocol Deviation|2|||
146579030|NCT02712983|528628409|FG004|Treatment Phase|Protocol Deviation|0|||
146579031|NCT02712983|528628410|FG005|Treatment Phase|Protocol Deviation|0|||
146579032|NCT02712983|528628411|FG006|Treatment Phase|Protocol Deviation|1|||
146579033|NCT02712983|528628412|FG007|Treatment Phase|Protocol Deviation|0|||
146579034|NCT02712983|528628413|FG008|Treatment Phase|Protocol Deviation|0|||
146579035|NCT02712983|528628405|FG000|Treatment Phase|Technical Problems|0|||
146579036|NCT02712983|528628406|FG001|Treatment Phase|Technical Problems|0|||
146579037|NCT02712983|528628407|FG002|Treatment Phase|Technical Problems|0|||
146579038|NCT02712983|528628408|FG003|Treatment Phase|Technical Problems|0|||
146978212|NCT02555618|530082264|FG001|Overall Study|Sponsor's Circumstances|0|||
146579039|NCT02712983|528628409|FG004|Treatment Phase|Technical Problems|0|||
146579040|NCT02712983|528628410|FG005|Treatment Phase|Technical Problems|0|||
146579041|NCT02712983|528628411|FG006|Treatment Phase|Technical Problems|1|||
146579042|NCT02712983|528628412|FG007|Treatment Phase|Technical Problems|0|||
146579043|NCT02712983|528628413|FG008|Treatment Phase|Technical Problems|0|||
146579044|NCT02712983|528628405|FG000|Treatment Phase|Physician Decision|0|||
146579045|NCT02712983|528628406|FG001|Treatment Phase|Physician Decision|0|||
146579046|NCT02712983|528628407|FG002|Treatment Phase|Physician Decision|0|||
146579047|NCT02712983|528628408|FG003|Treatment Phase|Physician Decision|0|||
146579048|NCT02712983|528628409|FG004|Treatment Phase|Physician Decision|0|||
146579049|NCT02712983|528628410|FG005|Treatment Phase|Physician Decision|0|||
146579050|NCT02712983|528628411|FG006|Treatment Phase|Physician Decision|0|||
146579051|NCT02712983|528628412|FG007|Treatment Phase|Physician Decision|1|||
146579052|NCT02712983|528628413|FG008|Treatment Phase|Physician Decision|1|||
146579053|NCT02712983|528628405|FG000|Treatment Phase|Subject Decision|2|||
146579054|NCT02712983|528628406|FG001|Treatment Phase|Subject Decision|0|||
146579055|NCT02712983|528628407|FG002|Treatment Phase|Subject Decision|0|||
146579056|NCT02712983|528628408|FG003|Treatment Phase|Subject Decision|2|||
146579057|NCT02712983|528628409|FG004|Treatment Phase|Subject Decision|1|||
146579058|NCT02712983|528628410|FG005|Treatment Phase|Subject Decision|0|||
146579059|NCT02712983|528628411|FG006|Treatment Phase|Subject Decision|1|||
146579060|NCT02712983|528628412|FG007|Treatment Phase|Subject Decision|2|||
146579061|NCT02712983|528628413|FG008|Treatment Phase|Subject Decision|0|||
146579062|NCT02712983|528628405|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
146579063|NCT02712983|528628406|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
146579064|NCT02712983|528628407|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
146978213|NCT01325532|530082267|FG000|Overall Study|Withdrawal by Subject|2|||
146978214|NCT01325532|530082268|FG001|Overall Study|Withdrawal by Subject|0|||
146770706|NCT00712335|529328665|FG002|Overall Study|Protocol Violation|1|||
146579065|NCT02712983|528628408|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
146579066|NCT02712983|528628409|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
146579067|NCT02712983|528628410|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
146579068|NCT02712983|528628411|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
146579069|NCT02712983|528628412|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
146579070|NCT02712983|528628413|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
146579071|NCT02712983|528628405|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
146579072|NCT02712983|528628406|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
146579073|NCT02712983|528628407|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
146579074|NCT02712983|528628408|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
146579075|NCT02712983|528628409|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
146579076|NCT02712983|528628410|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
146579077|NCT02712983|528628411|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
146579078|NCT02712983|528628412|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
146978215|NCT03196791|530082271|FG000|Overall Study|Protocol Violation|7|||
146579079|NCT02712983|528628413|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
146579080|NCT02712983|528628405|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
146579081|NCT02712983|528628406|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
146579082|NCT02712983|528628407|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
146579083|NCT02712983|528628408|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
146579084|NCT02712983|528628409|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
146978216|NCT03196791|530082272|FG001|Overall Study|Protocol Violation|3|||
146978217|NCT03196791|530082271|FG000|Overall Study|Withdrawal by Subject|3|||
146978218|NCT03196791|530082272|FG001|Overall Study|Withdrawal by Subject|2|||
146978219|NCT01280981|530082278|FG000|Overall Study|Withdrawal by Subject|11|||
146978220|NCT01280981|530082278|FG000|Overall Study|Protocol Violation|2|||
146978221|NCT01280981|530082278|FG000|Overall Study|Lack of Efficacy|13|||
146978222|NCT01280981|530082278|FG000|Overall Study|Lost to Follow-up|3|||
146978223|NCT01280981|530082278|FG000|Overall Study|Adverse Event|6|||
146978224|NCT01280981|530082278|FG000|Overall Study|Irregular or discontinued menses|3|||
146978225|NCT01280981|530082278|FG000|Overall Study|Failed to return|45|||
146978226|NCT01280981|530082278|FG000|Overall Study|Non-compliance with protocol|3|||
146579085|NCT02712983|528628410|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
146579086|NCT02712983|528628411|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
146579087|NCT02712983|528628412|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
146579088|NCT02712983|528628413|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
146579089|NCT05360966|528628418|FG000|Overall Study|Adverse Event|5|||
146579090|NCT05360966|528628419|FG001|Overall Study|Adverse Event|5|||
146579091|NCT05360966|528628418|FG000|Overall Study|Withdrawal of Consent|5|||
146579092|NCT05360966|528628419|FG001|Overall Study|Withdrawal of Consent|3|||
146579093|NCT05360966|528628418|FG000|Overall Study|Noncompliance|2|||
146579094|NCT05360966|528628419|FG001|Overall Study|Noncompliance|1|||
146579095|NCT05360966|528628418|FG000|Overall Study|Lost to Follow-up|2|||
146579096|NCT05360966|528628419|FG001|Overall Study|Lost to Follow-up|3|||
146579097|NCT05360966|528628418|FG000|Overall Study|Protocol Deviation|2|||
146579098|NCT05360966|528628419|FG001|Overall Study|Protocol Deviation|1|||
146579099|NCT05360966|528628418|FG000|Overall Study|As specified in the Clinical Study Report|1|||
146579100|NCT05360966|528628419|FG001|Overall Study|As specified in the Clinical Study Report|3|||
146579101|NCT05258890|528628421|FG000|Overall Study|Patient withdrawal|6|||
146579102|NCT05258890|528628422|FG001|Overall Study|Patient withdrawal|7|||
146579103|NCT05258890|528628421|FG000|Overall Study|Patient lost to follow-up|10|||
146579104|NCT05258890|528628422|FG001|Overall Study|Patient lost to follow-up|3|||
146579105|NCT05258890|528628421|FG000|Overall Study|Social network member withdrawal|1|||
146579106|NCT05258890|528628422|FG001|Overall Study|Social network member withdrawal|0|||
146579107|NCT05258890|528628421|FG000|Overall Study|Social network member lost to follow-up|5|||
146579108|NCT05258890|528628422|FG001|Overall Study|Social network member lost to follow-up|0|||
146579109|NCT05959447|528628423|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
146579110|NCT05959447|528628424|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
146579111|NCT05959447|528628423|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
146579112|NCT05959447|528628424|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
146579113|NCT05959447|528628423|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
146579114|NCT05959447|528628424|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
146918414|NCT02213198|529862864|FG000|Baseline|No show for intake|7|||
146918415|NCT02213198|529862865|FG001|Baseline|No show for intake|9|||
146918416|NCT02213198|529862864|FG000|Baseline|Withdrawal by Subject|34|||
146918417|NCT02213198|529862865|FG001|Baseline|Withdrawal by Subject|11|||
146918418|NCT02213198|529862864|FG000|Baseline|transferred out of clinic|7|||
146918419|NCT02213198|529862865|FG001|Baseline|transferred out of clinic|9|||
146918420|NCT02213198|529862864|FG000|Baseline|Lost to Follow-up|40|||
146918421|NCT02213198|529862865|FG001|Baseline|Lost to Follow-up|21|||
146918422|NCT02213198|529862864|FG000|Baseline|incarcerated,violent|0|||
146918423|NCT02213198|529862865|FG001|Baseline|incarcerated,violent|1|||
146579115|NCT05959447|528628423|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
146579116|NCT05959447|528628424|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
146579117|NCT00566982|528628425|FG000|Overall Study|Adverse Event|6|||
146978227|NCT01280981|530082278|FG000|Overall Study|Withdrawal of consent|3|||
146978228|NCT01280981|530082278|FG000|Overall Study|Elective surgery|2|||
146978229|NCT01280981|530082278|FG000|Overall Study|Study site closure|1|||
146579118|NCT00566982|528628426|FG001|Overall Study|Adverse Event|48|||
146579119|NCT00566982|528628425|FG000|Overall Study|Withdrawal by Subject|1|||
146918424|NCT02213198|529862864|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
146918425|NCT02213198|529862865|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
146918426|NCT02213198|529862864|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
146978230|NCT01749033|530082280|FG000|Overall Study|Did not receive allocated intervention|3|||
146978231|NCT01749033|530082281|FG001|Overall Study|Did not receive allocated intervention|3|||
146579120|NCT00566982|528628426|FG001|Overall Study|Withdrawal by Subject|14|||
146579121|NCT00566982|528628425|FG000|Overall Study|Protocol Violation|1|||
146579122|NCT00566982|528628426|FG001|Overall Study|Protocol Violation|4|||
146770707|NCT00712335|529328666|FG003|Overall Study|Protocol Violation|0|||
146918427|NCT02213198|529862865|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
146918428|NCT02213198|529862864|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
146918429|NCT02213198|529862865|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
146918430|NCT02213198|529862864|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
146918431|NCT02213198|529862865|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
146579123|NCT00566982|528628425|FG000|Overall Study|Lost to Follow-up|0|||
146579124|NCT00566982|528628426|FG001|Overall Study|Lost to Follow-up|1|||
146579125|NCT00566982|528628425|FG000|Overall Study|Other-family problems & doctor's request|0|||
146579126|NCT00566982|528628426|FG001|Overall Study|Other-family problems & doctor's request|2|||
146579127|NCT00443872|528628429|FG000|Overall Study|Protocol Violation|7|||
146579128|NCT00443872|528628429|FG000|Overall Study|Lost to Follow-up|2|||
146579129|NCT00443872|528628429|FG000|Overall Study|Adverse Event|8|||
146579130|NCT02789345|528628430|FG000|Overall Study|Adverse Event|0|||
146579131|NCT02789345|528628431|FG001|Overall Study|Adverse Event|0|||
146579132|NCT02789345|528628432|FG002|Overall Study|Adverse Event|1|||
146579133|NCT02789345|528628430|FG000|Overall Study|Death|0|||
146579134|NCT02789345|528628431|FG001|Overall Study|Death|0|||
146579135|NCT02789345|528628432|FG002|Overall Study|Death|1|||
146579136|NCT02789345|528628430|FG000|Overall Study|Physician Decision|2|||
146579137|NCT02789345|528628431|FG001|Overall Study|Physician Decision|0|||
146579138|NCT02789345|528628432|FG002|Overall Study|Physician Decision|1|||
146579139|NCT02789345|528628430|FG000|Overall Study|Progressive Disease|1|||
146579140|NCT02789345|528628431|FG001|Overall Study|Progressive Disease|3|||
146579141|NCT02789345|528628432|FG002|Overall Study|Progressive Disease|14|||
146579142|NCT00700622|528628439|FG000|Overall Study|Adverse Event|4|||
146579143|NCT00700622|528628440|FG001|Overall Study|Adverse Event|0|||
146579144|NCT00700622|528628439|FG000|Overall Study|Lost to Follow-up|0|||
146579145|NCT00700622|528628440|FG001|Overall Study|Lost to Follow-up|1|||
146579146|NCT00700622|528628439|FG000|Overall Study|Physician Decision|2|||
146579147|NCT00700622|528628440|FG001|Overall Study|Physician Decision|1|||
146579148|NCT00700622|528628439|FG000|Overall Study|Protocol Violation|0|||
146579149|NCT00700622|528628440|FG001|Overall Study|Protocol Violation|1|||
146579150|NCT00700622|528628439|FG000|Overall Study|Withdrawal by Subject|4|||
146579151|NCT00700622|528628440|FG001|Overall Study|Withdrawal by Subject|1|||
146579152|NCT00700622|528628439|FG000|Overall Study|Other|3|||
146579153|NCT00700622|528628440|FG001|Overall Study|Other|1|||
146579154|NCT00383331|528628441|FG000|Overall Study|Protocol Violation|0|||
146579155|NCT00383331|528628442|FG001|Overall Study|Protocol Violation|1|||
146579156|NCT02253433|528628443|FG000|Overall Study|Unable to Contact|9|||
146579157|NCT02253433|528628444|FG001|Overall Study|Unable to Contact|16|||
146579158|NCT02253433|528628443|FG000|Overall Study|Death|1|||
146579159|NCT02253433|528628444|FG001|Overall Study|Death|1|||
146579160|NCT02253433|528628443|FG000|Overall Study|No Longer Interested|3|||
146579161|NCT02253433|528628444|FG001|Overall Study|No Longer Interested|15|||
146579162|NCT02253433|528628443|FG000|Overall Study|Out of Study Area|2|||
146579163|NCT02253433|528628444|FG001|Overall Study|Out of Study Area|7|||
146579164|NCT02253433|528628443|FG000|Overall Study|Uncomfortable with home visitors|0|||
146579165|NCT02253433|528628444|FG001|Overall Study|Uncomfortable with home visitors|3|||
146579166|NCT02253433|528628443|FG000|Overall Study|Unstable Housing/Homeless|0|||
146579167|NCT02253433|528628444|FG001|Overall Study|Unstable Housing/Homeless|7|||
146579168|NCT02253433|528628443|FG000|Overall Study|Too Busy|0|||
146579169|NCT02253433|528628444|FG001|Overall Study|Too Busy|4|||
146579170|NCT02253433|528628443|FG000|Overall Study|Medical or Other Concerns|1|||
146579171|NCT02253433|528628444|FG001|Overall Study|Medical or Other Concerns|2|||
146579172|NCT00372619|528628454|FG000|Overall Study|Ineligible|0|||
146579173|NCT00372619|528628455|FG001|Overall Study|Ineligible|0|||
146579174|NCT00372619|528628456|FG002|Overall Study|Ineligible|0|||
146579175|NCT00372619|528628457|FG003|Overall Study|Ineligible|0|||
146579176|NCT00372619|528628458|FG004|Overall Study|Ineligible|0|||
146579177|NCT00372619|528628459|FG005|Overall Study|Ineligible|2|||
146579178|NCT00372619|528628460|FG006|Overall Study|Ineligible|0|||
146579179|NCT00372619|528628454|FG000|Overall Study|Inevaluable|0|||
146579180|NCT00372619|528628455|FG001|Overall Study|Inevaluable|0|||
146579181|NCT00372619|528628456|FG002|Overall Study|Inevaluable|0|||
146770708|NCT00712335|529328667|FG004|Overall Study|Protocol Violation|0|||
146770709|NCT00712335|529328663|FG000|Overall Study|Lack of Efficacy|0|||
146918432|NCT02213198|529862864|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
146579182|NCT00372619|528628457|FG003|Overall Study|Inevaluable|0|||
146579183|NCT00372619|528628458|FG004|Overall Study|Inevaluable|0|||
146579184|NCT00372619|528628459|FG005|Overall Study|Inevaluable|1|||
146579185|NCT00372619|528628460|FG006|Overall Study|Inevaluable|0|||
146579186|NCT00066222|528628461|FG000|Overall Study|No protocol treatment received|1|||
146579187|NCT01703091|528628473|FG000|Overall Study|Adverse Event|5|||
146579188|NCT01703091|528628474|FG001|Overall Study|Adverse Event|3|||
146579189|NCT01703091|528628473|FG000|Overall Study|Physician Decision|2|||
146579190|NCT01703091|528628474|FG001|Overall Study|Physician Decision|1|||
146579191|NCT01703091|528628473|FG000|Overall Study|Withdrawal by Subject|1|||
146579192|NCT01703091|528628474|FG001|Overall Study|Withdrawal by Subject|0|||
146770710|NCT00712335|529328664|FG001|Overall Study|Lack of Efficacy|0|||
146770711|NCT00712335|529328665|FG002|Overall Study|Lack of Efficacy|1|||
146770712|NCT00712335|529328666|FG003|Overall Study|Lack of Efficacy|1|||
146918433|NCT02213198|529862865|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
146918434|NCT02213198|529862864|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
146918435|NCT02213198|529862865|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
146918436|NCT03283163|529862866|FG000|Overall Study|Lost to Follow-up|1|||
146579193|NCT01703091|528628473|FG000|Overall Study|Sponsor Decision|1|||
146579194|NCT01703091|528628474|FG001|Overall Study|Sponsor Decision|0|||
146579195|NCT03902392|528628475|FG000|Overall Study|Lost to Follow-up|7|||
146579196|NCT03902392|528628476|FG001|Overall Study|Lost to Follow-up|7|||
146579197|NCT00244725|528628477|FG000|Overall Study|Lost to Follow-up|3|||
146579198|NCT00244725|528628478|FG001|Overall Study|Lost to Follow-up|4|||
146579199|NCT00244725|528628479|FG002|Overall Study|Lost to Follow-up|9|||
146579200|NCT00244725|528628480|FG003|Overall Study|Lost to Follow-up|2|||
146579201|NCT00244725|528628477|FG000|Overall Study|Withdrawal by Subject|9|||
146579202|NCT00244725|528628478|FG001|Overall Study|Withdrawal by Subject|7|||
146579203|NCT00244725|528628479|FG002|Overall Study|Withdrawal by Subject|7|||
146579204|NCT00244725|528628480|FG003|Overall Study|Withdrawal by Subject|8|||
146579205|NCT00244725|528628477|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
146579206|NCT00244725|528628478|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
146579207|NCT00244725|528628479|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
146579208|NCT00244725|528628480|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
146579209|NCT00244725|528628477|FG000|Overall Study|Physician Decision|3|||
146579210|NCT00244725|528628478|FG001|Overall Study|Physician Decision|0|||
146579211|NCT00244725|528628479|FG002|Overall Study|Physician Decision|1|||
146579212|NCT00244725|528628480|FG003|Overall Study|Physician Decision|2|||
146579213|NCT00244725|528628477|FG000|Overall Study|Adverse Events|3|||
146579214|NCT00244725|528628478|FG001|Overall Study|Adverse Events|1|||
146579215|NCT00244725|528628479|FG002|Overall Study|Adverse Events|4|||
146579216|NCT00244725|528628480|FG003|Overall Study|Adverse Events|4|||
146579217|NCT00244725|528628477|FG000|Overall Study|Withdrwal by participant|1|||
146579218|NCT00244725|528628478|FG001|Overall Study|Withdrwal by participant|0|||
146579219|NCT00244725|528628479|FG002|Overall Study|Withdrwal by participant|0|||
146579220|NCT00244725|528628480|FG003|Overall Study|Withdrwal by participant|1|||
146579221|NCT00244725|528628477|FG000|Overall Study|Liver function test abnormality|2|||
146579222|NCT00244725|528628478|FG001|Overall Study|Liver function test abnormality|0|||
146579223|NCT00244725|528628479|FG002|Overall Study|Liver function test abnormality|0|||
146579224|NCT00244725|528628480|FG003|Overall Study|Liver function test abnormality|1|||
146579225|NCT00244725|528628477|FG000|Overall Study|Sponsor withdrew the participant|1|||
146579226|NCT00244725|528628478|FG001|Overall Study|Sponsor withdrew the participant|0|||
146579227|NCT00244725|528628479|FG002|Overall Study|Sponsor withdrew the participant|0|||
146579228|NCT00244725|528628480|FG003|Overall Study|Sponsor withdrew the participant|1|||
146579229|NCT00244725|528628477|FG000|Overall Study|Mediciation Error|0|||
146579230|NCT00244725|528628478|FG001|Overall Study|Mediciation Error|1|||
146770713|NCT00712335|529328667|FG004|Overall Study|Lack of Efficacy|0|||
146770714|NCT00712335|529328663|FG000|Overall Study|Other Reason|0|||
146770715|NCT00712335|529328664|FG001|Overall Study|Other Reason|3|||
146579231|NCT00244725|528628479|FG002|Overall Study|Mediciation Error|0|||
146579232|NCT00244725|528628480|FG003|Overall Study|Mediciation Error|0|||
146579233|NCT00244725|528628477|FG000|Overall Study|Rehab Refused to allow participantion|0|||
146579234|NCT00244725|528628478|FG001|Overall Study|Rehab Refused to allow participantion|1|||
146579235|NCT00244725|528628479|FG002|Overall Study|Rehab Refused to allow participantion|0|||
146579236|NCT00244725|528628480|FG003|Overall Study|Rehab Refused to allow participantion|0|||
146579237|NCT00244725|528628477|FG000|Overall Study|Headache|0|||
146579238|NCT00244725|528628478|FG001|Overall Study|Headache|1|||
146579239|NCT00244725|528628479|FG002|Overall Study|Headache|0|||
146579240|NCT00244725|528628480|FG003|Overall Study|Headache|0|||
146579241|NCT00244725|528628477|FG000|Overall Study|Received prohibited medication|0|||
146579242|NCT00244725|528628478|FG001|Overall Study|Received prohibited medication|1|||
146579243|NCT00244725|528628479|FG002|Overall Study|Received prohibited medication|0|||
146579244|NCT00244725|528628480|FG003|Overall Study|Received prohibited medication|1|||
146579245|NCT00244725|528628477|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
146579246|NCT00244725|528628478|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
146579247|NCT00244725|528628479|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
146579248|NCT00244725|528628480|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
146770716|NCT00712335|529328665|FG002|Overall Study|Other Reason|1|||
146579249|NCT00244725|528628477|FG000|Overall Study|Administrative reason|0|||
146579250|NCT00244725|528628478|FG001|Overall Study|Administrative reason|0|||
146579251|NCT00244725|528628479|FG002|Overall Study|Administrative reason|1|||
146579252|NCT00244725|528628480|FG003|Overall Study|Administrative reason|0|||
146579253|NCT00244725|528628477|FG000|Overall Study|Vomit|0|||
146770717|NCT00712335|529328666|FG003|Overall Study|Other Reason|0|||
146579254|NCT00244725|528628478|FG001|Overall Study|Vomit|0|||
146579255|NCT00244725|528628479|FG002|Overall Study|Vomit|1|||
146579256|NCT00244725|528628480|FG003|Overall Study|Vomit|0|||
146579257|NCT00244725|528628477|FG000|Overall Study|Failed to follow-up|0|||
146579258|NCT00244725|528628478|FG001|Overall Study|Failed to follow-up|0|||
146579259|NCT00244725|528628479|FG002|Overall Study|Failed to follow-up|1|||
146579260|NCT00244725|528628480|FG003|Overall Study|Failed to follow-up|1|||
146579261|NCT03799952|528628481|FG000|Overall Study|Program was too easy, discontinued|1|||
146579262|NCT03799952|528628482|FG001|Overall Study|Program was too easy, discontinued|0|||
146579263|NCT03799952|528628481|FG000|Overall Study|Lost to Follow-up|0|||
146579264|NCT03799952|528628482|FG001|Overall Study|Lost to Follow-up|2|||
146579265|NCT03248167|528628483|FG000|Overall Study|Withdrawal by Subject|2|||
146579266|NCT03248167|528628484|FG001|Overall Study|Withdrawal by Subject|2|||
146579267|NCT03248167|528628483|FG000|Overall Study|Physician Decision|0|||
146579268|NCT03248167|528628484|FG001|Overall Study|Physician Decision|1|||
146579269|NCT03248167|528628483|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
146579270|NCT03248167|528628484|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
146579271|NCT03248167|528628483|FG000|Overall Study|Lost to Follow-up|1|||
146579272|NCT03248167|528628484|FG001|Overall Study|Lost to Follow-up|0|||
146579273|NCT02122146|528628485|FG000|Part 1: Dose Escalation|Death|0|||
146579274|NCT02122146|528628486|FG001|Part 1: Dose Escalation|Death|1|||
146579275|NCT02122146|528628487|FG002|Part 1: Dose Escalation|Death|1|||
146579276|NCT02122146|528628488|FG003|Part 1: Dose Escalation|Death|0|||
146579277|NCT02122146|528628489|FG004|Part 1: Dose Escalation|Death|0|||
146579278|NCT02122146|528628490|FG005|Part 1: Dose Escalation|Death|0|||
146579279|NCT02122146|528628491|FG006|Part 1: Dose Escalation|Death|0|||
146579280|NCT02122146|528628492|FG007|Part 1: Dose Escalation|Death|0|||
146579281|NCT02122146|528628485|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
146652005|NCT02677324|528903748|FG000|Overall Study|Adverse Event|1|||
146579282|NCT02122146|528628486|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
146579283|NCT02122146|528628487|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
146579284|NCT02122146|528628488|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
146579285|NCT02122146|528628489|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
146579286|NCT02122146|528628490|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
146579287|NCT02122146|528628491|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
146579288|NCT02122146|528628492|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
146579289|NCT02122146|528628485|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146579290|NCT02122146|528628486|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146579291|NCT02122146|528628487|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146579292|NCT02122146|528628488|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
146579293|NCT02122146|528628489|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146579294|NCT02122146|528628490|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146579295|NCT02122146|528628491|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146579296|NCT02122146|528628492|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146579297|NCT02122146|528628485|FG000|Part 1: Dose Escalation|Other|1|||
146579298|NCT02122146|528628486|FG001|Part 1: Dose Escalation|Other|0|||
146579299|NCT02122146|528628487|FG002|Part 1: Dose Escalation|Other|0|||
146579300|NCT02122146|528628488|FG003|Part 1: Dose Escalation|Other|0|||
146579301|NCT02122146|528628489|FG004|Part 1: Dose Escalation|Other|0|||
146579302|NCT02122146|528628490|FG005|Part 1: Dose Escalation|Other|1|||
146579303|NCT02122146|528628491|FG006|Part 1: Dose Escalation|Other|1|||
146579304|NCT02122146|528628492|FG007|Part 1: Dose Escalation|Other|2|||
146579305|NCT01107392|528628493|FG000|Overall Study|Adverse Event|2|||
146579306|NCT01107392|528628494|FG001|Overall Study|Adverse Event|0|||
146579307|NCT01107392|528628493|FG000|Overall Study|Personal Reasons|2|||
146579308|NCT01107392|528628494|FG001|Overall Study|Personal Reasons|3|||
146579309|NCT01107392|528628493|FG000|Overall Study|Administrative decision|1|||
146579310|NCT01107392|528628494|FG001|Overall Study|Administrative decision|0|||
146579311|NCT02584452|528628495|FG000|Overall Study|Physician Decision|1|||
146579312|NCT02584452|528628496|FG001|Overall Study|Physician Decision|1|||
146579313|NCT02584452|528628495|FG000|Overall Study|Lost to Follow-up|1|||
146579314|NCT02584452|528628496|FG001|Overall Study|Lost to Follow-up|1|||
146579315|NCT00177294|528628497|FG000|Overall Study|Withdrawal by Subject|7|||
146579316|NCT00177294|528628498|FG001|Overall Study|Withdrawal by Subject|5|||
146579317|NCT02998671|528628499|FG000|Period 1|Study Terminated By Sponsor|2|||
146652006|NCT02677324|528903748|FG000|Overall Study|IgM Myeloma diagnosis|1|||
146579318|NCT02998671|528628500|FG001|Period 1|Study Terminated By Sponsor|1|||
146652007|NCT00761150|528903751|FG000|Open-label Period|Adverse Event|36|||
146579319|NCT02998671|528628501|FG002|Period 1|Study Terminated By Sponsor|0|||
146579320|NCT02998671|528628502|FG003|Period 1|Study Terminated By Sponsor|0|||
146579321|NCT02998671|528628503|FG004|Period 1|Study Terminated By Sponsor|1|||
146579322|NCT02998671|528628499|FG000|Period 1|Withdrawal by Subject|1|||
146579323|NCT02998671|528628500|FG001|Period 1|Withdrawal by Subject|2|||
146579324|NCT02998671|528628501|FG002|Period 1|Withdrawal by Subject|0|||
146579325|NCT02998671|528628502|FG003|Period 1|Withdrawal by Subject|0|||
146579326|NCT02998671|528628503|FG004|Period 1|Withdrawal by Subject|2|||
146579327|NCT02998671|528628499|FG000|Period 1|Pregnancy|1|||
146579328|NCT02998671|528628500|FG001|Period 1|Pregnancy|0|||
146579329|NCT02998671|528628501|FG002|Period 1|Pregnancy|0|||
146652008|NCT00761150|528903752|FG001|Open-label Period|Adverse Event|0|||
146579330|NCT02998671|528628502|FG003|Period 1|Pregnancy|0|||
146579331|NCT02998671|528628503|FG004|Period 1|Pregnancy|0|||
146579332|NCT02998671|528628499|FG000|Period 1|Adverse Event|0|||
146579333|NCT02998671|528628500|FG001|Period 1|Adverse Event|0|||
146579334|NCT02998671|528628501|FG002|Period 1|Adverse Event|0|||
146579335|NCT02998671|528628502|FG003|Period 1|Adverse Event|0|||
146579336|NCT02998671|528628503|FG004|Period 1|Adverse Event|1|||
146579337|NCT02998671|528628499|FG000|Period 2|Adverse Event|0|||
146579338|NCT02998671|528628500|FG001|Period 2|Adverse Event|1|||
146579339|NCT02998671|528628501|FG002|Period 2|Adverse Event|0|||
146579340|NCT02998671|528628502|FG003|Period 2|Adverse Event|0|||
146579341|NCT02998671|528628503|FG004|Period 2|Adverse Event|0|||
146579342|NCT02998671|528628499|FG000|Period 2|Study Terminated By Sponsor|3|||
146579343|NCT02998671|528628500|FG001|Period 2|Study Terminated By Sponsor|5|||
146579344|NCT02998671|528628501|FG002|Period 2|Study Terminated By Sponsor|1|||
146579345|NCT02998671|528628502|FG003|Period 2|Study Terminated By Sponsor|3|||
146579346|NCT02998671|528628503|FG004|Period 2|Study Terminated By Sponsor|0|||
146579347|NCT02998671|528628499|FG000|Period 2|Withdrawal by Subject|0|||
146579348|NCT02998671|528628500|FG001|Period 2|Withdrawal by Subject|1|||
146579349|NCT02998671|528628501|FG002|Period 2|Withdrawal by Subject|0|||
146579350|NCT02998671|528628502|FG003|Period 2|Withdrawal by Subject|0|||
146579351|NCT02998671|528628503|FG004|Period 2|Withdrawal by Subject|0|||
146579352|NCT02998671|528628499|FG000|Period 2|Lost to Follow-up|0|||
146579353|NCT02998671|528628500|FG001|Period 2|Lost to Follow-up|0|||
146579354|NCT02998671|528628501|FG002|Period 2|Lost to Follow-up|0|||
146579355|NCT02998671|528628502|FG003|Period 2|Lost to Follow-up|1|||
146579356|NCT02998671|528628503|FG004|Period 2|Lost to Follow-up|0|||
146579357|NCT01603043|528628506|FG000|Overall Study|Study Futility|7|||
146579358|NCT01603043|528628507|FG001|Overall Study|Study Futility|3|||
146579359|NCT04532294|528628508|FG000|Overall Study|Withdrawal by Subject|0|||
146579360|NCT04532294|528628509|FG001|Overall Study|Withdrawal by Subject|0|||
146579361|NCT04532294|528628510|FG002|Overall Study|Withdrawal by Subject|1|||
146579362|NCT04532294|528628508|FG000|Overall Study|Participants Not Dosed|0|||
146579363|NCT04532294|528628509|FG001|Overall Study|Participants Not Dosed|0|||
146579364|NCT04532294|528628510|FG002|Overall Study|Participants Not Dosed|2|||
146579365|NCT03089047|528628511|FG000|Overall Study|Lost to Follow-up|1|||
146579366|NCT03089047|528628512|FG001|Overall Study|Lost to Follow-up|0|||
146579367|NCT03599518|528628513|FG000|Overall Study|Clinical progression|0|||
146579368|NCT03599518|528628514|FG001|Overall Study|Clinical progression|0|||
146579369|NCT03599518|528628515|FG002|Overall Study|Clinical progression|0|||
146579370|NCT03599518|528628516|FG003|Overall Study|Clinical progression|0|||
146579371|NCT03599518|528628517|FG004|Overall Study|Clinical progression|1|||
146579372|NCT03599518|528628513|FG000|Overall Study|Adverse Event|0|||
146579373|NCT03599518|528628514|FG001|Overall Study|Adverse Event|0|||
146579374|NCT03599518|528628515|FG002|Overall Study|Adverse Event|0|||
146579375|NCT03599518|528628516|FG003|Overall Study|Adverse Event|0|||
146579376|NCT03599518|528628517|FG004|Overall Study|Adverse Event|1|||
146579377|NCT03599518|528628513|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
146579378|NCT03599518|528628514|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
146579379|NCT03599518|528628515|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
146579380|NCT03599518|528628516|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
146579381|NCT03599518|528628517|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
146579382|NCT03599518|528628513|FG000|Overall Study|Participant withdrawal from study treatment|0|||
146579383|NCT03599518|528628514|FG001|Overall Study|Participant withdrawal from study treatment|0|||
146579384|NCT03599518|528628515|FG002|Overall Study|Participant withdrawal from study treatment|1|||
146579385|NCT03599518|528628516|FG003|Overall Study|Participant withdrawal from study treatment|0|||
146579386|NCT03599518|528628517|FG004|Overall Study|Participant withdrawal from study treatment|0|||
146579387|NCT00375505|528628518|FG000|Overall Study|Adverse Event|1|||
146579388|NCT00375505|528628519|FG001|Overall Study|Adverse Event|2|||
146770718|NCT00712335|529328667|FG004|Overall Study|Other Reason|0|||
146770719|NCT03401112|529328668|FG000|Overall Study|Adverse Event|1|||
146579389|NCT00429182|528628525|FG000|Overall Study|Not evaluable, Disease Progression|2|||
146579390|NCT00429182|528628525|FG000|Overall Study|Not eligible|5|||
146579391|NCT03497039|528628526|FG000|Overall Study|Withdrawal by Subject|1|||
146579392|NCT03497039|528628527|FG001|Overall Study|Withdrawal by Subject|0|||
146579393|NCT03497039|528628526|FG000|Overall Study|Protocol Violation|0|||
146579394|NCT03497039|528628527|FG001|Overall Study|Protocol Violation|1|||
146579395|NCT00861692|528628529|FG000|Overall Study|Death|6|||
146579396|NCT03292640|528628530|FG000|Overall Study|Withdrawal by Subject|17|||
146579397|NCT03292640|528628531|FG001|Overall Study|Withdrawal by Subject|16|||
146579398|NCT03292640|528628530|FG000|Overall Study|Adverse Event|20|||
146579399|NCT03292640|528628531|FG001|Overall Study|Adverse Event|2|||
146579400|NCT03292640|528628530|FG000|Overall Study|Lost to Follow-up|24|||
146579401|NCT03292640|528628531|FG001|Overall Study|Lost to Follow-up|24|||
146579402|NCT05111002|528628536|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
146579403|NCT05111002|528628537|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
146579404|NCT05111002|528628536|FG000|Secondary Outcome|Lost to Follow-up|1|||
146579405|NCT05111002|528628537|FG001|Secondary Outcome|Lost to Follow-up|0|||
146579406|NCT04380753|528628538|FG000|Overall Study|Participants continuing study|4|||
146579407|NCT04380753|528628538|FG000|Overall Study|Death|2|||
146579408|NCT04776720|528628543|FG000|Overall Study|COVID Related|4|||
146579409|NCT04776720|528628544|FG001|Overall Study|COVID Related|2|||
146579410|NCT04776720|528628543|FG000|Overall Study|Adverse Event|2|||
146579411|NCT04776720|528628544|FG001|Overall Study|Adverse Event|0|||
146579412|NCT04776720|528628543|FG000|Overall Study|Serious Adverse Event|0|||
146579413|NCT04776720|528628544|FG001|Overall Study|Serious Adverse Event|1|||
146579414|NCT04776720|528628543|FG000|Overall Study|Too Busy|3|||
146579415|NCT04776720|528628544|FG001|Overall Study|Too Busy|1|||
146579416|NCT04776720|528628543|FG000|Overall Study|Lost to Follow-up|1|||
146579417|NCT04776720|528628544|FG001|Overall Study|Lost to Follow-up|2|||
146579418|NCT04776720|528628543|FG000|Overall Study|Family|2|||
146579419|NCT04776720|528628544|FG001|Overall Study|Family|2|||
146579420|NCT04776720|528628543|FG000|Overall Study|No remote technology access|0|||
146579421|NCT04776720|528628544|FG001|Overall Study|No remote technology access|1|||
146579422|NCT04776720|528628543|FG000|Overall Study|Withdrawal by Subject|1|||
146579423|NCT04776720|528628544|FG001|Overall Study|Withdrawal by Subject|0|||
146579424|NCT04776720|528628543|FG000|Overall Study|Cannot tolerate intervention|1|||
146579425|NCT04776720|528628544|FG001|Overall Study|Cannot tolerate intervention|0|||
146579426|NCT04776720|528628543|FG000|Overall Study|Incomplete outcome data|6|||
146579427|NCT04776720|528628544|FG001|Overall Study|Incomplete outcome data|1|||
146579428|NCT02712996|528628549|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
146579429|NCT02712996|528628550|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
146579430|NCT01451749|528628556|FG000|Overall Study|Protocol Violation|14|||
146579431|NCT01451749|528628557|FG001|Overall Study|Protocol Violation|7|||
146579432|NCT01451749|528628556|FG000|Overall Study|Lost to Follow-up|15|||
146579433|NCT01451749|528628557|FG001|Overall Study|Lost to Follow-up|5|||
146579434|NCT01451749|528628556|FG000|Overall Study|Meet the exclusion criteria,and|1|||
146579435|NCT01451749|528628557|FG001|Overall Study|Meet the exclusion criteria,and|1|||
146579436|NCT01451749|528628556|FG000|Overall Study|Adverse Event|2|||
146579437|NCT01451749|528628557|FG001|Overall Study|Adverse Event|0|||
146579438|NCT01451749|528628556|FG000|Overall Study|Withdrawal by Subject|0|||
146579439|NCT01451749|528628557|FG001|Overall Study|Withdrawal by Subject|1|||
146579440|NCT00972517|528628558|FG000|Overall Study|Adverse Event|0|||
146579441|NCT00972517|528628559|FG001|Overall Study|Adverse Event|0|||
146579442|NCT00972517|528628560|FG002|Overall Study|Adverse Event|0|||
146579443|NCT00972517|528628561|FG003|Overall Study|Adverse Event|1|||
146579444|NCT00972517|528628562|FG004|Overall Study|Adverse Event|0|||
146579445|NCT00972517|528628563|FG005|Overall Study|Adverse Event|0|||
146579446|NCT00972517|528628558|FG000|Overall Study|Withdrawal by Subject|0|||
146579447|NCT00972517|528628559|FG001|Overall Study|Withdrawal by Subject|1|||
146579448|NCT00972517|528628560|FG002|Overall Study|Withdrawal by Subject|0|||
146579449|NCT00972517|528628561|FG003|Overall Study|Withdrawal by Subject|2|||
146579450|NCT00972517|528628562|FG004|Overall Study|Withdrawal by Subject|1|||
146579451|NCT00972517|528628563|FG005|Overall Study|Withdrawal by Subject|0|||
146579452|NCT02311881|528628564|FG000|Overall Study|Did not meet the study criteria|2|||
146579453|NCT02311881|528628565|FG001|Overall Study|Did not meet the study criteria|2|||
146579454|NCT02311881|528628566|FG002|Overall Study|Did not meet the study criteria|0|||
146579455|NCT02311881|528628564|FG000|Overall Study|Adverse Event|7|||
146579456|NCT02311881|528628565|FG001|Overall Study|Adverse Event|15|||
146579457|NCT02311881|528628566|FG002|Overall Study|Adverse Event|8|||
146579458|NCT02311881|528628564|FG000|Overall Study|Lost to Follow-up|3|||
146579459|NCT02311881|528628565|FG001|Overall Study|Lost to Follow-up|3|||
146579460|NCT02311881|528628566|FG002|Overall Study|Lost to Follow-up|2|||
146579461|NCT02311881|528628564|FG000|Overall Study|Protocol Violation|1|||
146579462|NCT02311881|528628565|FG001|Overall Study|Protocol Violation|2|||
146579463|NCT02311881|528628566|FG002|Overall Study|Protocol Violation|3|||
146579464|NCT02311881|528628564|FG000|Overall Study|Withdrawal of consent|14|||
146579465|NCT02311881|528628565|FG001|Overall Study|Withdrawal of consent|16|||
146918437|NCT03283163|529862866|FG000|Overall Study|other life commitments|6|||
146918438|NCT03283163|529862866|FG000|Overall Study|COVID-19 institution wide halting|1|||
146579466|NCT02311881|528628566|FG002|Overall Study|Withdrawal of consent|17|||
146579467|NCT02311881|528628564|FG000|Overall Study|Other|0|||
146579468|NCT02311881|528628565|FG001|Overall Study|Other|0|||
146579469|NCT02311881|528628566|FG002|Overall Study|Other|1|||
146918439|NCT03283163|529862866|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
146579470|NCT02311881|528628564|FG000|Overall Study|Lack of Efficacy|1|||
146579471|NCT02311881|528628565|FG001|Overall Study|Lack of Efficacy|2|||
146579472|NCT02311881|528628566|FG002|Overall Study|Lack of Efficacy|0|||
146579473|NCT02311881|528628564|FG000|Overall Study|Subject has border line pregnancy test|1|||
146579474|NCT02311881|528628565|FG001|Overall Study|Subject has border line pregnancy test|0|||
146579475|NCT02311881|528628566|FG002|Overall Study|Subject has border line pregnancy test|0|||
146579476|NCT02311881|528628564|FG000|Overall Study|Withdrawal by Subject|3|||
146579477|NCT02311881|528628565|FG001|Overall Study|Withdrawal by Subject|1|||
146918440|NCT03283163|529862866|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
146579478|NCT02311881|528628566|FG002|Overall Study|Withdrawal by Subject|4|||
146579479|NCT02311881|528628564|FG000|Overall Study|Sponsor Decision|1|||
146579480|NCT02311881|528628565|FG001|Overall Study|Sponsor Decision|1|||
146579481|NCT02311881|528628566|FG002|Overall Study|Sponsor Decision|1|||
146579482|NCT02311881|528628564|FG000|Overall Study|Protocol Deviation|1|||
146579483|NCT02311881|528628565|FG001|Overall Study|Protocol Deviation|0|||
146579484|NCT02311881|528628566|FG002|Overall Study|Protocol Deviation|0|||
146579485|NCT02311881|528628564|FG000|Overall Study|Non-Compliance|1|||
146579486|NCT02311881|528628565|FG001|Overall Study|Non-Compliance|0|||
146579487|NCT02311881|528628566|FG002|Overall Study|Non-Compliance|2|||
146579488|NCT02311881|528628564|FG000|Overall Study|Physician Decision|0|||
146579489|NCT02311881|528628565|FG001|Overall Study|Physician Decision|0|||
146579490|NCT02311881|528628566|FG002|Overall Study|Physician Decision|1|||
146579491|NCT02311881|528628564|FG000|Overall Study|Medical Monitor Discretion|0|||
146579492|NCT02311881|528628565|FG001|Overall Study|Medical Monitor Discretion|0|||
146579493|NCT02311881|528628566|FG002|Overall Study|Medical Monitor Discretion|1|||
146579494|NCT02311881|528628564|FG000|Overall Study|Participant taking another medication|0|||
146579495|NCT02311881|528628565|FG001|Overall Study|Participant taking another medication|0|||
146579496|NCT02311881|528628566|FG002|Overall Study|Participant taking another medication|1|||
146579497|NCT02311881|528628564|FG000|Overall Study|Serious Adverse Event|0|||
146579498|NCT02311881|528628565|FG001|Overall Study|Serious Adverse Event|1|||
146579499|NCT02311881|528628566|FG002|Overall Study|Serious Adverse Event|0|||
146579500|NCT00790582|528628571|FG000|Overall Study|Death|14|||
146579501|NCT00790582|528628572|FG001|Overall Study|Death|32|||
146579502|NCT00790582|528628571|FG000|Overall Study|Physician Decision|7|||
146579503|NCT00790582|528628572|FG001|Overall Study|Physician Decision|1|||
146579504|NCT00790582|528628571|FG000|Overall Study|Lost to Follow-up|3|||
146579505|NCT00790582|528628572|FG001|Overall Study|Lost to Follow-up|3|||
146579506|NCT00790582|528628571|FG000|Overall Study|Withdrawal by Subject|7|||
146579507|NCT00790582|528628572|FG001|Overall Study|Withdrawal by Subject|51|||
146579508|NCT02949024|528628573|FG000|Overall Study|Withdrawal by Subject|0|||
146579509|NCT02949024|528628574|FG001|Overall Study|Withdrawal by Subject|1|||
146579510|NCT01027650|528628575|FG000|Overall Study|Personal Reasons|0|||
146579511|NCT01027650|528628576|FG001|Overall Study|Personal Reasons|0|||
146579512|NCT01027650|528628577|FG002|Overall Study|Personal Reasons|0|||
146579513|NCT01027650|528628578|FG003|Overall Study|Personal Reasons|0|||
146579514|NCT01027650|528628579|FG004|Overall Study|Personal Reasons|2|||
146579515|NCT01027650|528628580|FG005|Overall Study|Personal Reasons|1|||
146579516|NCT01027650|528628581|FG006|Overall Study|Personal Reasons|0|||
146579517|NCT01027650|528628582|FG007|Overall Study|Personal Reasons|0|||
146579518|NCT01027650|528628575|FG000|Overall Study|Lost to Follow-up|0|||
146579519|NCT01027650|528628576|FG001|Overall Study|Lost to Follow-up|0|||
146579520|NCT01027650|528628577|FG002|Overall Study|Lost to Follow-up|0|||
146579521|NCT01027650|528628578|FG003|Overall Study|Lost to Follow-up|0|||
146579522|NCT01027650|528628579|FG004|Overall Study|Lost to Follow-up|0|||
146579523|NCT01027650|528628580|FG005|Overall Study|Lost to Follow-up|0|||
146579524|NCT01027650|528628581|FG006|Overall Study|Lost to Follow-up|1|||
146579525|NCT01027650|528628582|FG007|Overall Study|Lost to Follow-up|0|||
146579526|NCT01027650|528628575|FG000|Overall Study|Lack of Efficacy|0|||
146579527|NCT01027650|528628576|FG001|Overall Study|Lack of Efficacy|0|||
146579528|NCT01027650|528628577|FG002|Overall Study|Lack of Efficacy|0|||
146579529|NCT01027650|528628578|FG003|Overall Study|Lack of Efficacy|0|||
146579530|NCT01027650|528628579|FG004|Overall Study|Lack of Efficacy|0|||
146579531|NCT01027650|528628580|FG005|Overall Study|Lack of Efficacy|1|||
146579532|NCT01027650|528628581|FG006|Overall Study|Lack of Efficacy|0|||
146579533|NCT01027650|528628582|FG007|Overall Study|Lack of Efficacy|0|||
146579534|NCT00912782|528628583|FG000|Overall Study|Death|2|||
146579535|NCT00912782|528628584|FG001|Overall Study|Death|1|||
146579536|NCT00912782|528628583|FG000|Overall Study|Lost to Follow-up|0|||
146579537|NCT00912782|528628584|FG001|Overall Study|Lost to Follow-up|1|||
146579538|NCT00912782|528628583|FG000|Overall Study|Did not receive vascular access type|1|||
146579539|NCT00912782|528628584|FG001|Overall Study|Did not receive vascular access type|2|||
146579540|NCT00912782|528628583|FG000|Overall Study|Relocated before study completion|0|||
146579541|NCT00912782|528628584|FG001|Overall Study|Relocated before study completion|1|||
146579542|NCT01132651|528630495|FG000|Overall Study|Lost to Follow-up|1|||
146579543|NCT01132651|528630496|FG001|Overall Study|Lost to Follow-up|1|||
146579544|NCT00948857|528630497|FG000|Overall Study|Lost to Follow-up|1|||
146918441|NCT04238663|529862867|FG000|Overall Study|Lost to Follow-up|0|||
146918442|NCT04238663|529862868|FG001|Overall Study|Lost to Follow-up|1|||
146579545|NCT00948857|528630498|FG001|Overall Study|Lost to Follow-up|0|||
146918443|NCT04238663|529862869|FG002|Overall Study|Lost to Follow-up|0|||
146579546|NCT03430843|528630499|FG000|Overall Study|Death|233|||
146579547|NCT03430843|528630500|FG001|Overall Study|Death|233|||
146579548|NCT03430843|528630499|FG000|Overall Study|Sponsor Decision|17|||
146579549|NCT03430843|528630500|FG001|Overall Study|Sponsor Decision|6|||
146579550|NCT03430843|528630499|FG000|Overall Study|Withdrawal by Subject|5|||
146579551|NCT03430843|528630500|FG001|Overall Study|Withdrawal by Subject|14|||
146579552|NCT03430843|528630499|FG000|Overall Study|Lost to Follow-up|1|||
146770720|NCT03401112|529328669|FG001|Overall Study|Adverse Event|2|||
146770721|NCT03401112|529328670|FG002|Overall Study|Adverse Event|3|||
146770722|NCT03401112|529328671|FG003|Overall Study|Adverse Event|2|||
146770723|NCT03401112|529328672|FG004|Overall Study|Adverse Event|0|||
146770724|NCT03401112|529328668|FG000|Overall Study|Lost to Follow-up|1|||
146770725|NCT03401112|529328669|FG001|Overall Study|Lost to Follow-up|0|||
146770726|NCT03401112|529328670|FG002|Overall Study|Lost to Follow-up|0|||
146770727|NCT03401112|529328671|FG003|Overall Study|Lost to Follow-up|0|||
146770728|NCT03401112|529328672|FG004|Overall Study|Lost to Follow-up|0|||
146770729|NCT03401112|529328668|FG000|Overall Study|Noncompliance|1|||
146770730|NCT03401112|529328669|FG001|Overall Study|Noncompliance|2|||
146770731|NCT03401112|529328670|FG002|Overall Study|Noncompliance|3|||
146770732|NCT03401112|529328671|FG003|Overall Study|Noncompliance|0|||
146770733|NCT03401112|529328672|FG004|Overall Study|Noncompliance|0|||
146770734|NCT03401112|529328668|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
146770735|NCT03401112|529328669|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
146770736|NCT03401112|529328670|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
146770737|NCT03401112|529328671|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
146770738|NCT03401112|529328672|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
146770739|NCT03401112|529328668|FG000|Overall Study|Withdrawal by Subject|0|||
146770740|NCT03401112|529328669|FG001|Overall Study|Withdrawal by Subject|3|||
146770741|NCT03401112|529328670|FG002|Overall Study|Withdrawal by Subject|2|||
146770742|NCT03401112|529328671|FG003|Overall Study|Withdrawal by Subject|1|||
146770743|NCT03401112|529328672|FG004|Overall Study|Withdrawal by Subject|0|||
146770744|NCT03401112|529328668|FG000|Overall Study|Physician Decision|0|||
146770745|NCT03401112|529328669|FG001|Overall Study|Physician Decision|0|||
146579553|NCT03430843|528630500|FG001|Overall Study|Lost to Follow-up|3|||
146579554|NCT05396014|528630505|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
146579555|NCT05396014|528630506|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579556|NCT05396014|528630507|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579557|NCT05396014|528630508|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579558|NCT05396014|528630509|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579559|NCT05396014|528630510|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579560|NCT05396014|528630511|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579561|NCT05396014|528630512|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579562|NCT05396014|528630513|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579563|NCT05396014|528630514|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579564|NCT05396014|528630515|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579565|NCT05396014|528630516|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579566|NCT05396014|528630517|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579567|NCT05396014|528630518|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
146579568|NCT05396014|528630519|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579569|NCT05396014|528630520|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579570|NCT05396014|528630521|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579571|NCT05396014|528630522|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579572|NCT05396014|528630523|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579573|NCT05396014|528630524|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579574|NCT05396014|528630525|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579575|NCT05396014|528630526|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579576|NCT05396014|528630527|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579577|NCT05396014|528630528|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146770746|NCT03401112|529328670|FG002|Overall Study|Physician Decision|0|||
146770747|NCT03401112|529328671|FG003|Overall Study|Physician Decision|2|||
146770748|NCT03401112|529328672|FG004|Overall Study|Physician Decision|0|||
146770749|NCT03401112|529328668|FG000|Overall Study|Study was Terminated by Sponsor|0|||
146770750|NCT03401112|529328669|FG001|Overall Study|Study was Terminated by Sponsor|0|||
146770751|NCT03401112|529328670|FG002|Overall Study|Study was Terminated by Sponsor|0|||
146770752|NCT03401112|529328671|FG003|Overall Study|Study was Terminated by Sponsor|1|||
146770753|NCT03401112|529328672|FG004|Overall Study|Study was Terminated by Sponsor|0|||
146770754|NCT03401112|529328668|FG000|Overall Study|Day 1 Assessment not Done|1|||
146770755|NCT03401112|529328669|FG001|Overall Study|Day 1 Assessment not Done|0|||
146770756|NCT03401112|529328670|FG002|Overall Study|Day 1 Assessment not Done|0|||
146770757|NCT03401112|529328671|FG003|Overall Study|Day 1 Assessment not Done|0|||
146770758|NCT03401112|529328672|FG004|Overall Study|Day 1 Assessment not Done|0|||
146770759|NCT03401112|529328668|FG000|Overall Study|Not Dosed|0|||
146770760|NCT03401112|529328669|FG001|Overall Study|Not Dosed|0|||
146770761|NCT03401112|529328670|FG002|Overall Study|Not Dosed|1|||
146579578|NCT05396014|528630529|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146770762|NCT03401112|529328671|FG003|Overall Study|Not Dosed|0|||
146770763|NCT03401112|529328672|FG004|Overall Study|Not Dosed|0|||
146770764|NCT03401112|529328668|FG000|Overall Study|Missed Clinical Visit|0|||
146770765|NCT03401112|529328669|FG001|Overall Study|Missed Clinical Visit|0|||
146770766|NCT03401112|529328670|FG002|Overall Study|Missed Clinical Visit|1|||
146918444|NCT00968253|529862870|FG000|Overall Study|Death|0|||
146918445|NCT00968253|529862871|FG001|Overall Study|Death|0|||
146918446|NCT00968253|529862872|FG002|Overall Study|Death|2|||
146918447|NCT00968253|529862870|FG000|Overall Study|Withdrawal by Subject|0|||
146918448|NCT00968253|529862871|FG001|Overall Study|Withdrawal by Subject|0|||
146918449|NCT00968253|529862872|FG002|Overall Study|Withdrawal by Subject|1|||
146579579|NCT05396014|528630530|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579580|NCT05396014|528630531|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
146579581|NCT05396014|528630532|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579582|NCT05396014|528630533|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579583|NCT05396014|528630534|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579584|NCT05396014|528630535|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579585|NCT05396014|528630536|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579586|NCT05396014|528630537|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579587|NCT05396014|528630538|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579588|NCT05396014|528630539|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579589|NCT05396014|528630540|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579590|NCT05396014|528630541|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579591|NCT05396014|528630542|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579592|NCT05396014|528630543|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579593|NCT05396014|528630544|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
146579594|NCT05396014|528630545|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579595|NCT05396014|528630546|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579596|NCT05396014|528630547|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146579597|NCT05396014|528630505|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
146579598|NCT05396014|528630506|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579599|NCT05396014|528630507|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579600|NCT05396014|528630508|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579601|NCT05396014|528630509|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579602|NCT05396014|528630510|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579603|NCT05396014|528630511|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579604|NCT05396014|528630512|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579605|NCT05396014|528630513|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579606|NCT05396014|528630514|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579607|NCT05396014|528630515|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579608|NCT05396014|528630516|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579609|NCT05396014|528630517|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579610|NCT05396014|528630518|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
146579611|NCT05396014|528630519|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579612|NCT05396014|528630520|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579613|NCT05396014|528630521|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579614|NCT05396014|528630522|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579615|NCT05396014|528630523|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579616|NCT05396014|528630524|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579617|NCT05396014|528630525|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579618|NCT05396014|528630526|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579619|NCT05396014|528630527|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579620|NCT05396014|528630528|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579621|NCT05396014|528630529|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579622|NCT05396014|528630530|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579623|NCT05396014|528630531|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
146579624|NCT05396014|528630532|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579625|NCT05396014|528630533|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579626|NCT05396014|528630534|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579627|NCT05396014|528630535|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579628|NCT05396014|528630536|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579629|NCT05396014|528630537|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579630|NCT05396014|528630538|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146918450|NCT00968253|529862870|FG000|Overall Study|Disease Progression|0|||
146918451|NCT00968253|529862871|FG001|Overall Study|Disease Progression|3|||
146918452|NCT00968253|529862872|FG002|Overall Study|Disease Progression|3|||
146579631|NCT05396014|528630539|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579632|NCT05396014|528630540|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579633|NCT05396014|528630541|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579634|NCT05396014|528630542|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146918453|NCT00968253|529862870|FG000|Overall Study|Adverse Event|0|||
146918454|NCT00968253|529862871|FG001|Overall Study|Adverse Event|0|||
146918455|NCT00968253|529862872|FG002|Overall Study|Adverse Event|1|||
146579635|NCT05396014|528630543|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579636|NCT05396014|528630544|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
146918456|NCT03987620|529862875|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
146918457|NCT03987620|529862876|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
146918458|NCT03987620|529862875|FG000|Overall Study|Adverse Event|3|||
146918459|NCT03987620|529862876|FG001|Overall Study|Adverse Event|0|||
146918460|NCT03987620|529862875|FG000|Overall Study|Lost to Follow-up|1|||
146918461|NCT03987620|529862876|FG001|Overall Study|Lost to Follow-up|2|||
146918462|NCT03987620|529862875|FG000|Overall Study|Physician Decision|0|||
146579637|NCT05396014|528630545|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579638|NCT05396014|528630546|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579639|NCT05396014|528630547|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146579640|NCT05396014|528630505|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
146579641|NCT05396014|528630506|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579642|NCT05396014|528630507|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579643|NCT05396014|528630508|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579644|NCT05396014|528630509|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579645|NCT05396014|528630510|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579646|NCT05396014|528630511|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579647|NCT05396014|528630512|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579648|NCT05396014|528630513|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579649|NCT05396014|528630514|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579650|NCT05396014|528630515|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579651|NCT05396014|528630516|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579652|NCT05396014|528630517|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579653|NCT05396014|528630518|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
146579654|NCT05396014|528630519|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579655|NCT05396014|528630520|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579656|NCT05396014|528630521|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579657|NCT05396014|528630522|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579658|NCT05396014|528630523|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579659|NCT05396014|528630524|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579660|NCT05396014|528630525|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579661|NCT05396014|528630526|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579662|NCT05396014|528630527|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579663|NCT05396014|528630528|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579664|NCT05396014|528630529|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146770767|NCT03401112|529328671|FG003|Overall Study|Missed Clinical Visit|0|||
146579665|NCT05396014|528630530|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579666|NCT05396014|528630531|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
146579667|NCT05396014|528630532|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579668|NCT05396014|528630533|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579669|NCT05396014|528630534|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579670|NCT05396014|528630535|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579671|NCT05396014|528630536|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579672|NCT05396014|528630537|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579673|NCT05396014|528630538|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579674|NCT05396014|528630539|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579675|NCT05396014|528630540|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579676|NCT05396014|528630541|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579677|NCT05396014|528630542|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579678|NCT05396014|528630543|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579679|NCT05396014|528630544|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
146579680|NCT05396014|528630545|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579681|NCT05396014|528630546|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579682|NCT05396014|528630547|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146579683|NCT05396014|528630505|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579684|NCT05396014|528630506|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579685|NCT05396014|528630507|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579686|NCT05396014|528630508|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579687|NCT05396014|528630509|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579688|NCT05396014|528630510|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579689|NCT05396014|528630511|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579690|NCT05396014|528630512|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579691|NCT05396014|528630513|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579692|NCT05396014|528630514|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146770768|NCT03401112|529328672|FG004|Overall Study|Missed Clinical Visit|0|||
146579693|NCT05396014|528630515|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146918463|NCT03987620|529862876|FG001|Overall Study|Physician Decision|1|||
146918464|NCT03987620|529862875|FG000|Overall Study|Pregnancy|1|||
146579694|NCT05396014|528630516|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579695|NCT05396014|528630517|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579696|NCT05396014|528630518|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579697|NCT05396014|528630519|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579698|NCT05396014|528630520|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579699|NCT05396014|528630521|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579700|NCT05396014|528630522|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579701|NCT05396014|528630523|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579702|NCT05396014|528630524|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579703|NCT05396014|528630525|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579704|NCT05396014|528630526|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579705|NCT05396014|528630527|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579706|NCT05396014|528630528|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579707|NCT05396014|528630529|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579708|NCT05396014|528630530|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579709|NCT05396014|528630531|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
146579710|NCT05396014|528630532|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579711|NCT05396014|528630533|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579712|NCT05396014|528630534|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579713|NCT05396014|528630535|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579714|NCT05396014|528630536|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579715|NCT05396014|528630537|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579716|NCT05396014|528630538|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579717|NCT05396014|528630539|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579718|NCT05396014|528630540|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579719|NCT05396014|528630541|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579720|NCT05396014|528630542|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579721|NCT05396014|528630543|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579722|NCT05396014|528630544|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
146579723|NCT05396014|528630545|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579724|NCT05396014|528630546|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579725|NCT05396014|528630547|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146579726|NCT05396014|528630505|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579727|NCT05396014|528630506|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579728|NCT05396014|528630507|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579729|NCT05396014|528630508|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579730|NCT05396014|528630509|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579731|NCT05396014|528630510|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579732|NCT05396014|528630511|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579733|NCT05396014|528630512|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579734|NCT05396014|528630513|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579735|NCT05396014|528630514|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579736|NCT05396014|528630515|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579737|NCT05396014|528630516|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579738|NCT05396014|528630517|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579739|NCT05396014|528630518|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579740|NCT05396014|528630519|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579741|NCT05396014|528630520|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579742|NCT05396014|528630521|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579743|NCT05396014|528630522|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579744|NCT05396014|528630523|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579745|NCT05396014|528630524|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579746|NCT05396014|528630525|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579747|NCT05396014|528630526|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579748|NCT05396014|528630527|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579749|NCT05396014|528630528|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579750|NCT05396014|528630529|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579751|NCT05396014|528630530|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579752|NCT05396014|528630531|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
146579753|NCT05396014|528630532|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579754|NCT05396014|528630533|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146918465|NCT03987620|529862876|FG001|Overall Study|Pregnancy|0|||
146918466|NCT03987620|529862875|FG000|Overall Study|Withdrawal by Subject|7|||
146918467|NCT03987620|529862876|FG001|Overall Study|Withdrawal by Subject|1|||
146579755|NCT05396014|528630534|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579756|NCT05396014|528630535|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579757|NCT05396014|528630536|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579758|NCT05396014|528630537|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579759|NCT05396014|528630538|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579760|NCT05396014|528630539|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579761|NCT05396014|528630540|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579762|NCT05396014|528630541|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579763|NCT05396014|528630542|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579764|NCT05396014|528630543|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579765|NCT05396014|528630544|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579766|NCT05396014|528630545|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579767|NCT05396014|528630546|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579768|NCT05396014|528630547|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146579769|NCT05396014|528630505|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579770|NCT05396014|528630506|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579771|NCT05396014|528630507|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579772|NCT05396014|528630508|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579773|NCT05396014|528630509|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579774|NCT05396014|528630510|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579775|NCT05396014|528630511|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579776|NCT05396014|528630512|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579777|NCT05396014|528630513|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579778|NCT05396014|528630514|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579779|NCT05396014|528630515|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579780|NCT05396014|528630516|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579781|NCT05396014|528630517|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579782|NCT05396014|528630518|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
146579783|NCT05396014|528630519|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579784|NCT05396014|528630520|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579785|NCT05396014|528630521|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579786|NCT05396014|528630522|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579787|NCT05396014|528630523|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579788|NCT05396014|528630524|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579789|NCT05396014|528630525|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579790|NCT05396014|528630526|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579791|NCT05396014|528630527|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579792|NCT05396014|528630528|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579793|NCT05396014|528630529|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579794|NCT05396014|528630530|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579795|NCT05396014|528630531|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579796|NCT05396014|528630532|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579797|NCT05396014|528630533|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579798|NCT05396014|528630534|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579799|NCT05396014|528630535|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579800|NCT05396014|528630536|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579801|NCT05396014|528630537|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579802|NCT05396014|528630538|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579803|NCT05396014|528630539|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579804|NCT05396014|528630540|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579805|NCT05396014|528630541|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579806|NCT05396014|528630542|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579807|NCT05396014|528630543|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579808|NCT05396014|528630544|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579809|NCT05396014|528630545|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579810|NCT05396014|528630546|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579811|NCT05396014|528630547|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146579812|NCT05396014|528630505|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
146579813|NCT05396014|528630506|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579814|NCT05396014|528630507|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579815|NCT05396014|528630508|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579816|NCT05396014|528630509|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579817|NCT05396014|528630510|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579818|NCT05396014|528630511|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579819|NCT05396014|528630512|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579820|NCT05396014|528630513|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579821|NCT05396014|528630514|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579822|NCT05396014|528630515|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579823|NCT05396014|528630516|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579824|NCT05396014|528630517|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579825|NCT05396014|528630518|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
146579826|NCT05396014|528630519|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579827|NCT05396014|528630520|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579828|NCT05396014|528630521|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579829|NCT05396014|528630522|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579830|NCT05396014|528630523|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579831|NCT05396014|528630524|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579832|NCT05396014|528630525|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579833|NCT05396014|528630526|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579834|NCT05396014|528630527|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579835|NCT05396014|528630528|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579836|NCT05396014|528630529|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579837|NCT05396014|528630530|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579838|NCT05396014|528630531|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579839|NCT05396014|528630532|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579840|NCT05396014|528630533|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579841|NCT05396014|528630534|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579842|NCT05396014|528630535|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579843|NCT05396014|528630536|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579844|NCT05396014|528630537|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579845|NCT05396014|528630538|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579846|NCT05396014|528630539|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579847|NCT05396014|528630540|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579848|NCT05396014|528630541|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579849|NCT05396014|528630542|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579850|NCT05396014|528630543|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579851|NCT05396014|528630544|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
146579852|NCT05396014|528630545|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579853|NCT05396014|528630546|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579854|NCT05396014|528630547|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146579855|NCT05396014|528630505|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
146579856|NCT05396014|528630506|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579857|NCT05396014|528630507|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579858|NCT05396014|528630508|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579859|NCT05396014|528630509|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579860|NCT05396014|528630510|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579861|NCT05396014|528630511|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579862|NCT05396014|528630512|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579863|NCT05396014|528630513|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579864|NCT05396014|528630514|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579865|NCT05396014|528630515|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579866|NCT05396014|528630516|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579867|NCT05396014|528630517|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579868|NCT05396014|528630518|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146770769|NCT03401112|529328668|FG000|Overall Study|Missed Doses|0|||
146770770|NCT03401112|529328669|FG001|Overall Study|Missed Doses|0|||
146770771|NCT03401112|529328670|FG002|Overall Study|Missed Doses|1|||
146770772|NCT03401112|529328671|FG003|Overall Study|Missed Doses|0|||
146579869|NCT05396014|528630519|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579870|NCT05396014|528630520|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579871|NCT05396014|528630521|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579872|NCT05396014|528630522|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579873|NCT05396014|528630523|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146770773|NCT03401112|529328672|FG004|Overall Study|Missed Doses|0|||
146770774|NCT01264679|529328673|FG000|Overall Study|Participation in Another Clinical Trial|1|||
146770775|NCT01264679|529328673|FG000|Overall Study|Physician Decision|1|||
146770776|NCT01264679|529328673|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
146770777|NCT01264679|529328673|FG000|Overall Study|Withdrawal by Subject|1|||
146579874|NCT05396014|528630524|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579875|NCT05396014|528630525|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579876|NCT05396014|528630526|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579877|NCT05396014|528630527|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146918468|NCT03987620|529862875|FG000|Overall Study|Other|2|||
146918469|NCT03987620|529862876|FG001|Overall Study|Other|5|||
146918470|NCT02149836|529862877|FG000|Overall Study|Withdrawal by Subject|1|||
146918471|NCT03860844|529862878|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
146918472|NCT03860844|529862879|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
146918473|NCT03860844|529862880|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
146918474|NCT03860844|529862878|FG000|Overall Study|Progressive disease|5|||
146918475|NCT03860844|529862879|FG001|Overall Study|Progressive disease|3|||
146579878|NCT05396014|528630528|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579879|NCT05396014|528630529|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579880|NCT05396014|528630530|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579881|NCT05396014|528630531|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
146579882|NCT05396014|528630532|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579883|NCT05396014|528630533|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579884|NCT05396014|528630534|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579885|NCT05396014|528630535|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579886|NCT05396014|528630536|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579887|NCT05396014|528630537|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579888|NCT05396014|528630538|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579889|NCT05396014|528630539|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579890|NCT05396014|528630540|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579891|NCT05396014|528630541|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579892|NCT05396014|528630542|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579893|NCT05396014|528630543|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579894|NCT05396014|528630544|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579895|NCT05396014|528630545|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579896|NCT05396014|528630546|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579897|NCT05396014|528630547|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146579898|NCT05396014|528630505|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579899|NCT05396014|528630506|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579900|NCT05396014|528630507|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579901|NCT05396014|528630508|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579902|NCT05396014|528630509|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579903|NCT05396014|528630510|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579904|NCT05396014|528630511|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579905|NCT05396014|528630512|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579906|NCT05396014|528630513|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579907|NCT05396014|528630514|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579908|NCT05396014|528630515|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579909|NCT05396014|528630516|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579910|NCT05396014|528630517|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579911|NCT05396014|528630518|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
146579912|NCT05396014|528630519|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579913|NCT05396014|528630520|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579914|NCT05396014|528630521|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579915|NCT05396014|528630522|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579916|NCT05396014|528630523|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579917|NCT05396014|528630524|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579918|NCT05396014|528630525|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579919|NCT05396014|528630526|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579920|NCT05396014|528630527|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579921|NCT05396014|528630528|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579922|NCT05396014|528630529|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579923|NCT05396014|528630530|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579924|NCT05396014|528630531|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579925|NCT05396014|528630532|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579926|NCT05396014|528630533|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579927|NCT05396014|528630534|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579928|NCT05396014|528630535|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146918476|NCT03860844|529862880|FG002|Overall Study|Progressive disease|4|||
146918477|NCT03860844|529862878|FG000|Overall Study|Other, Not related to COVID-19|0|||
146918478|NCT03860844|529862879|FG001|Overall Study|Other, Not related to COVID-19|1|||
146918479|NCT03860844|529862880|FG002|Overall Study|Other, Not related to COVID-19|0|||
146579929|NCT05396014|528630536|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579930|NCT05396014|528630537|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579931|NCT05396014|528630538|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579932|NCT05396014|528630539|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146918480|NCT01678807|529862888|FG000|Overall Study|Adverse Event|4|||
146918481|NCT01678807|529862889|FG001|Overall Study|Adverse Event|4|||
146918482|NCT01678807|529862890|FG002|Overall Study|Adverse Event|0|||
146918483|NCT01678807|529862888|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
146918484|NCT01678807|529862889|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
146918485|NCT01678807|529862890|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
146918486|NCT02429427|529862891|FG000|Overall Study|Adverse Event|220|||
146918487|NCT02429427|529862892|FG001|Overall Study|Adverse Event|92|||
146918488|NCT02429427|529862891|FG000|Overall Study|Protocol Violation|10|||
146918489|NCT02429427|529862892|FG001|Overall Study|Protocol Violation|6|||
146918490|NCT02429427|529862891|FG000|Overall Study|Lost to Follow-up|15|||
146918491|NCT02429427|529862892|FG001|Overall Study|Lost to Follow-up|6|||
146918492|NCT02429427|529862891|FG000|Overall Study|Withdrawal by Subject|64|||
146918493|NCT02429427|529862892|FG001|Overall Study|Withdrawal by Subject|34|||
146579933|NCT05396014|528630540|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579934|NCT05396014|528630541|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579935|NCT05396014|528630542|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579936|NCT05396014|528630543|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579937|NCT05396014|528630544|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579938|NCT05396014|528630545|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579939|NCT05396014|528630546|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579940|NCT05396014|528630547|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146579941|NCT05396014|528630505|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579942|NCT05396014|528630506|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579943|NCT05396014|528630507|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579944|NCT05396014|528630508|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
146579945|NCT05396014|528630509|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579946|NCT05396014|528630510|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146579947|NCT05396014|528630511|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146579948|NCT05396014|528630512|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579949|NCT05396014|528630513|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
146579950|NCT05396014|528630514|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146579951|NCT05396014|528630515|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579952|NCT05396014|528630516|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579953|NCT05396014|528630517|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579954|NCT05396014|528630518|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579955|NCT05396014|528630519|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579956|NCT05396014|528630520|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146579957|NCT05396014|528630521|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579958|NCT05396014|528630522|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579959|NCT05396014|528630523|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579960|NCT05396014|528630524|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579961|NCT05396014|528630525|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579962|NCT05396014|528630526|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579963|NCT05396014|528630527|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146579964|NCT05396014|528630528|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146579965|NCT05396014|528630529|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146579966|NCT05396014|528630530|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
146579967|NCT05396014|528630531|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579968|NCT05396014|528630532|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579969|NCT05396014|528630533|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579970|NCT05396014|528630534|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579971|NCT05396014|528630535|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146579972|NCT05396014|528630536|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146579973|NCT05396014|528630537|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579974|NCT05396014|528630538|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579975|NCT05396014|528630539|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146579976|NCT05396014|528630540|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579977|NCT05396014|528630541|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579978|NCT05396014|528630542|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146918494|NCT02429427|529862891|FG000|Overall Study|Other|62|||
146918495|NCT02429427|529862892|FG001|Overall Study|Other|41|||
146918496|NCT03488472|529864429|FG000|Overall Study|disease progression additional mets|1|||
146918497|NCT04467164|529864430|FG000|Washout (1 Week)|Lost to Follow-up|2|||
146918498|NCT04467164|529864431|FG001|Washout (1 Week)|Lost to Follow-up|0|||
146918499|NCT02273752|529864432|FG000|Overall Study|Trial was terminated early|2|||
146918500|NCT03100942|529864433|FG000|Randomized Treatment Period|Withdrew Consent|4|||
146918501|NCT03100942|529864434|FG001|Randomized Treatment Period|Withdrew Consent|5|||
146579979|NCT05396014|528630543|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579980|NCT05396014|528630544|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146579981|NCT05396014|528630545|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
146579982|NCT05396014|528630546|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
146579983|NCT05396014|528630547|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146579984|NCT05396014|528630505|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146579985|NCT05396014|528630506|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146579986|NCT05396014|528630507|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146579987|NCT05396014|528630508|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146579988|NCT05396014|528630509|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146579989|NCT05396014|528630510|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146579990|NCT05396014|528630511|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146579991|NCT05396014|528630512|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146579992|NCT05396014|528630513|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
146579993|NCT05396014|528630514|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146579994|NCT05396014|528630515|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146579995|NCT05396014|528630516|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146579996|NCT05396014|528630517|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146579997|NCT05396014|528630518|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146579998|NCT05396014|528630519|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146579999|NCT05396014|528630520|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146580000|NCT05396014|528630521|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146580001|NCT05396014|528630522|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146580002|NCT05396014|528630523|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146580003|NCT05396014|528630524|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146580004|NCT05396014|528630525|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146580005|NCT05396014|528630526|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146580006|NCT05396014|528630527|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
146580007|NCT05396014|528630528|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146580008|NCT05396014|528630529|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146580009|NCT05396014|528630530|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146580010|NCT05396014|528630531|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146580011|NCT05396014|528630532|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146580012|NCT05396014|528630533|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146580013|NCT05396014|528630534|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146580014|NCT05396014|528630535|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146580015|NCT05396014|528630536|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146580016|NCT05396014|528630537|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146580017|NCT05396014|528630538|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146580018|NCT05396014|528630539|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146580019|NCT05396014|528630540|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
146580020|NCT05396014|528630541|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146918502|NCT03100942|529864435|FG002|Randomized Treatment Period|Withdrew Consent|3|||
146580021|NCT05396014|528630542|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146580022|NCT05396014|528630543|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146580023|NCT05396014|528630544|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146580024|NCT05396014|528630545|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146580025|NCT05396014|528630546|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
146580026|NCT05396014|528630547|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146580027|NCT05396014|528630505|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580028|NCT05396014|528630506|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580029|NCT05396014|528630507|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146652009|NCT00761150|528903753|FG002|Open-label Period|Adverse Event|0|||
146918503|NCT03100942|529864436|FG003|Randomized Treatment Period|Withdrew Consent|3|||
146918504|NCT03100942|529864437|FG004|Randomized Treatment Period|Withdrew Consent|0|||
146918505|NCT03100942|529864438|FG005|Randomized Treatment Period|Withdrew Consent|0|||
146918506|NCT03100942|529864439|FG006|Randomized Treatment Period|Withdrew Consent|0|||
146918507|NCT03100942|529864433|FG000|Randomized Treatment Period|Adverse Event|5|||
146918508|NCT03100942|529864434|FG001|Randomized Treatment Period|Adverse Event|2|||
146918509|NCT03100942|529864435|FG002|Randomized Treatment Period|Adverse Event|1|||
146918510|NCT03100942|529864436|FG003|Randomized Treatment Period|Adverse Event|0|||
146918511|NCT03100942|529864437|FG004|Randomized Treatment Period|Adverse Event|0|||
146918512|NCT03100942|529864438|FG005|Randomized Treatment Period|Adverse Event|0|||
146918513|NCT03100942|529864439|FG006|Randomized Treatment Period|Adverse Event|0|||
146652010|NCT00761150|528903751|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
146918514|NCT03100942|529864433|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
146918515|NCT03100942|529864434|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
146918516|NCT03100942|529864435|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
146918517|NCT03100942|529864436|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
146918518|NCT03100942|529864437|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
146580030|NCT05396014|528630508|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580031|NCT05396014|528630509|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580032|NCT05396014|528630510|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580033|NCT05396014|528630511|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580034|NCT05396014|528630512|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580035|NCT05396014|528630513|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580036|NCT05396014|528630514|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580037|NCT05396014|528630515|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580038|NCT05396014|528630516|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580039|NCT05396014|528630517|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580040|NCT05396014|528630518|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
146580041|NCT05396014|528630519|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580042|NCT05396014|528630520|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580043|NCT05396014|528630521|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580044|NCT05396014|528630522|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580045|NCT05396014|528630523|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580046|NCT05396014|528630524|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580047|NCT05396014|528630525|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580048|NCT05396014|528630526|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580049|NCT05396014|528630527|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580050|NCT05396014|528630528|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580051|NCT05396014|528630529|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580052|NCT05396014|528630530|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580053|NCT05396014|528630531|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
146580054|NCT05396014|528630532|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580055|NCT05396014|528630533|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580056|NCT05396014|528630534|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580057|NCT05396014|528630535|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580058|NCT05396014|528630536|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580059|NCT05396014|528630537|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580060|NCT05396014|528630538|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580061|NCT05396014|528630539|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
146580062|NCT05396014|528630540|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580063|NCT05396014|528630541|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580064|NCT05396014|528630542|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580065|NCT05396014|528630543|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580066|NCT05396014|528630544|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580067|NCT05396014|528630545|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580068|NCT05396014|528630546|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146580069|NCT05396014|528630547|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
146580070|NCT05396014|528630505|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580071|NCT05396014|528630506|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580072|NCT05396014|528630507|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580073|NCT05396014|528630508|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580074|NCT05396014|528630509|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580075|NCT05396014|528630510|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580076|NCT05396014|528630511|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580077|NCT05396014|528630512|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580078|NCT05396014|528630513|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580079|NCT05396014|528630514|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580080|NCT05396014|528630515|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580081|NCT05396014|528630516|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580082|NCT05396014|528630517|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580083|NCT05396014|528630518|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580084|NCT05396014|528630519|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580085|NCT05396014|528630520|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580086|NCT05396014|528630521|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580087|NCT05396014|528630522|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580088|NCT05396014|528630523|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146918519|NCT03100942|529864438|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
146918520|NCT03100942|529864439|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
146580089|NCT05396014|528630524|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580090|NCT05396014|528630525|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580091|NCT05396014|528630526|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580092|NCT05396014|528630527|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146918521|NCT03100942|529864433|FG000|Randomized Treatment Period|Protocol Violation|0|||
146918522|NCT03100942|529864434|FG001|Randomized Treatment Period|Protocol Violation|1|||
146918523|NCT03100942|529864435|FG002|Randomized Treatment Period|Protocol Violation|1|||
146918524|NCT03100942|529864436|FG003|Randomized Treatment Period|Protocol Violation|1|||
146918525|NCT03100942|529864437|FG004|Randomized Treatment Period|Protocol Violation|0|||
146918526|NCT03100942|529864438|FG005|Randomized Treatment Period|Protocol Violation|0|||
146918527|NCT03100942|529864439|FG006|Randomized Treatment Period|Protocol Violation|0|||
146918528|NCT03100942|529864433|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
146918529|NCT03100942|529864434|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
146918530|NCT03100942|529864435|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
146918531|NCT03100942|529864436|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
146918532|NCT03100942|529864437|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
146918533|NCT03100942|529864438|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
146918534|NCT03100942|529864439|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
146918535|NCT03100942|529864433|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
146918536|NCT03100942|529864434|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
146918537|NCT03100942|529864435|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
146918538|NCT03100942|529864436|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
146918539|NCT03100942|529864437|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
146918540|NCT03100942|529864438|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
146918541|NCT03100942|529864439|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
146918542|NCT03100942|529864433|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
146918543|NCT03100942|529864434|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
146918544|NCT03100942|529864435|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
146918545|NCT03100942|529864436|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
146918546|NCT03100942|529864437|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
146580093|NCT05396014|528630528|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580094|NCT05396014|528630529|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580095|NCT05396014|528630530|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580096|NCT05396014|528630531|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
146580097|NCT05396014|528630532|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580098|NCT05396014|528630533|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580099|NCT05396014|528630534|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580100|NCT05396014|528630535|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580101|NCT05396014|528630536|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580102|NCT05396014|528630537|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580103|NCT05396014|528630538|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580104|NCT05396014|528630539|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580105|NCT05396014|528630540|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580106|NCT05396014|528630541|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580107|NCT05396014|528630542|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580108|NCT05396014|528630543|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580109|NCT05396014|528630544|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580110|NCT05396014|528630545|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580111|NCT05396014|528630546|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580112|NCT05396014|528630547|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146580113|NCT03062280|528630548|FG000|Overall Study|Adverse Event|1|||
146580114|NCT03062280|528630548|FG000|Overall Study|Death|1|||
146580115|NCT03062280|528630548|FG000|Overall Study|Fertility Treatment|2|||
146580116|NCT03062280|528630548|FG000|Overall Study|Physician Decision|2|||
146580117|NCT03062280|528630548|FG000|Overall Study|Pregnancy|5|||
146580118|NCT03062280|528630548|FG000|Overall Study|Withdrawal by Subject|11|||
146580119|NCT04439539|528630549|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
146580120|NCT04439539|528630550|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
146580121|NCT04439539|528630551|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
146580122|NCT04439539|528630549|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
146580123|NCT04439539|528630550|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
146580124|NCT04439539|528630551|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
146580125|NCT04439539|528630549|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
146580126|NCT04439539|528630550|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
146580127|NCT04439539|528630551|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
146580128|NCT04551963|528630561|FG000|Overall Study|Physician Decision|1|||
146580129|NCT04551963|528630562|FG001|Overall Study|Physician Decision|1|||
146580130|NCT04551963|528630561|FG000|Overall Study|Death|1|||
146580131|NCT04551963|528630562|FG001|Overall Study|Death|0|||
146652011|NCT00761150|528903752|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
146918547|NCT03100942|529864438|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
146918548|NCT03100942|529864439|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
146580132|NCT03379259|528630563|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
146580133|NCT03379259|528630564|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
146580134|NCT03379259|528630565|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
146580135|NCT03379259|528630566|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
146580136|NCT03379259|528630567|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
146580137|NCT03379259|528630568|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
146580138|NCT03379259|528630563|FG000|Overall Study|Death|0|||
146580139|NCT03379259|528630564|FG001|Overall Study|Death|1|||
146580140|NCT03379259|528630565|FG002|Overall Study|Death|2|||
146580141|NCT03379259|528630566|FG003|Overall Study|Death|1|||
146580142|NCT03379259|528630567|FG004|Overall Study|Death|4|||
146580143|NCT03379259|528630568|FG005|Overall Study|Death|2|||
146580144|NCT03379259|528630563|FG000|Overall Study|Withdrawal by Subject|0|||
146580145|NCT03379259|528630564|FG001|Overall Study|Withdrawal by Subject|0|||
146580146|NCT03379259|528630565|FG002|Overall Study|Withdrawal by Subject|1|||
146580147|NCT03379259|528630566|FG003|Overall Study|Withdrawal by Subject|0|||
146580148|NCT03379259|528630567|FG004|Overall Study|Withdrawal by Subject|2|||
146580149|NCT03379259|528630568|FG005|Overall Study|Withdrawal by Subject|0|||
146580150|NCT03379259|528630563|FG000|Overall Study|Study terminated by sponsor|0|||
146580151|NCT03379259|528630564|FG001|Overall Study|Study terminated by sponsor|0|||
146580152|NCT03379259|528630565|FG002|Overall Study|Study terminated by sponsor|0|||
146580153|NCT03379259|528630566|FG003|Overall Study|Study terminated by sponsor|1|||
146580154|NCT03379259|528630567|FG004|Overall Study|Study terminated by sponsor|1|||
146580155|NCT03379259|528630568|FG005|Overall Study|Study terminated by sponsor|4|||
146580156|NCT03379259|528630563|FG000|Overall Study|Disease progression|0|||
146580157|NCT03379259|528630564|FG001|Overall Study|Disease progression|0|||
146580158|NCT03379259|528630565|FG002|Overall Study|Disease progression|0|||
146918549|NCT01429792|529864440|FG000|Overall Study|Other Reasons|67|||
146918550|NCT01429792|529864440|FG000|Overall Study|Unknown Disposition|94|||
146918551|NCT01429792|529864440|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
146918552|NCT01429792|529864440|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
146918553|NCT01429792|529864440|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
146918554|NCT01429792|529864440|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
146918555|NCT01429792|529864440|FG000|Overall Study|Withdrawal by Subject|70|||
146918556|NCT01429792|529864440|FG000|Overall Study|Lost to Follow-up|88|||
146918557|NCT01617681|529864441|FG000|Period 1 Double Blind|Adverse Event|2|||
146918558|NCT01617681|529864442|FG001|Period 1 Double Blind|Adverse Event|0|||
146918559|NCT01617681|529864443|FG002|Period 1 Double Blind|Adverse Event|0|||
146918560|NCT01617681|529864444|FG003|Period 1 Double Blind|Adverse Event|2|||
146918561|NCT01617681|529864445|FG004|Period 1 Double Blind|Adverse Event|0|||
146918562|NCT01617681|529864441|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
146918563|NCT01617681|529864442|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
146918564|NCT01617681|529864443|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
146918565|NCT01617681|529864444|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
146918566|NCT01617681|529864445|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
146918567|NCT01617681|529864441|FG000|Period 2 Open Label|Adverse Event|0|||
146918568|NCT01617681|529864442|FG001|Period 2 Open Label|Adverse Event|0|||
146918569|NCT01617681|529864443|FG002|Period 2 Open Label|Adverse Event|0|||
146918570|NCT01617681|529864444|FG003|Period 2 Open Label|Adverse Event|0|||
146918571|NCT01617681|529864445|FG004|Period 2 Open Label|Adverse Event|3|||
146918572|NCT01617681|529864441|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
146918573|NCT01617681|529864442|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
146580159|NCT03379259|528630566|FG003|Overall Study|Disease progression|1|||
146580160|NCT03379259|528630567|FG004|Overall Study|Disease progression|0|||
146580161|NCT03379259|528630568|FG005|Overall Study|Disease progression|1|||
146580162|NCT03379259|528630563|FG000|Overall Study|Lost to Follow-up|0|||
146580163|NCT03379259|528630564|FG001|Overall Study|Lost to Follow-up|0|||
146580164|NCT03379259|528630565|FG002|Overall Study|Lost to Follow-up|0|||
146580165|NCT03379259|528630566|FG003|Overall Study|Lost to Follow-up|0|||
146580166|NCT03379259|528630567|FG004|Overall Study|Lost to Follow-up|1|||
146580167|NCT03379259|528630568|FG005|Overall Study|Lost to Follow-up|0|||
146580168|NCT03379259|528630563|FG000|Overall Study|Deteriorating condition|0|||
146580169|NCT03379259|528630564|FG001|Overall Study|Deteriorating condition|0|||
146580170|NCT03379259|528630565|FG002|Overall Study|Deteriorating condition|0|||
146580171|NCT03379259|528630566|FG003|Overall Study|Deteriorating condition|0|||
146580172|NCT03379259|528630567|FG004|Overall Study|Deteriorating condition|1|||
146580173|NCT03379259|528630568|FG005|Overall Study|Deteriorating condition|0|||
146580174|NCT03850093|528630569|FG000|Overall Study|Withdrawal by Subject|1|||
146580175|NCT03850093|528630570|FG001|Overall Study|Withdrawal by Subject|0|||
146580176|NCT03850093|528630571|FG002|Overall Study|Withdrawal by Subject|2|||
146918574|NCT01617681|529864443|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
146918575|NCT01617681|529864444|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
146580177|NCT02836717|528630572|FG000|Test Phase|Lack of Efficacy|14|||
146918576|NCT01617681|529864445|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
146918577|NCT00879814|529864450|FG000|Overall Study|Adverse Event|0|||
146918578|NCT00879814|529864451|FG001|Overall Study|Adverse Event|1|||
146918579|NCT00879814|529864452|FG002|Overall Study|Adverse Event|0|||
146580178|NCT02836717|528630573|FG001|Test Phase|Lack of Efficacy|8|||
146580179|NCT02836717|528630574|FG002|Test Phase|Lack of Efficacy|0|||
146580180|NCT02836717|528630572|FG000|Study Phase|Adverse Event|2|||
146580181|NCT02836717|528630573|FG001|Study Phase|Adverse Event|0|||
146580182|NCT02836717|528630574|FG002|Study Phase|Adverse Event|0|||
146580183|NCT02836717|528630572|FG000|Study Phase|Lack of Efficacy|8|||
146580184|NCT02836717|528630573|FG001|Study Phase|Lack of Efficacy|6|||
146580185|NCT02836717|528630574|FG002|Study Phase|Lack of Efficacy|1|||
146580186|NCT02836717|528630572|FG000|Study Phase|Withdrawal by Subject|1|||
146580187|NCT02836717|528630573|FG001|Study Phase|Withdrawal by Subject|0|||
146580188|NCT02836717|528630574|FG002|Study Phase|Withdrawal by Subject|0|||
146580189|NCT02836717|528630572|FG000|Study Phase|Death|1|||
146580190|NCT02836717|528630573|FG001|Study Phase|Death|0|||
146580191|NCT02836717|528630574|FG002|Study Phase|Death|0|||
146580192|NCT02836717|528630572|FG000|Study Phase|abdominal surgeries|2|||
146580193|NCT02836717|528630573|FG001|Study Phase|abdominal surgeries|1|||
146580194|NCT02836717|528630574|FG002|Study Phase|abdominal surgeries|0|||
146580195|NCT01309997|528630577|FG000|Overall Study|Adverse Event|1|||
146580196|NCT01309997|528630578|FG001|Overall Study|Adverse Event|0|||
146580197|NCT01309997|528630577|FG000|Overall Study|Death|1|||
146580198|NCT01309997|528630578|FG001|Overall Study|Death|3|||
146580199|NCT01309997|528630577|FG000|Overall Study|Lack of Efficacy|2|||
146580200|NCT01309997|528630578|FG001|Overall Study|Lack of Efficacy|2|||
146580201|NCT01309997|528630577|FG000|Overall Study|Withdrawal by Subject|1|||
146580202|NCT01309997|528630578|FG001|Overall Study|Withdrawal by Subject|1|||
146580203|NCT00282087|528630579|FG000|Overall Study|Death|1|||
146580204|NCT03226249|528630580|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
146580205|NCT03226249|528630580|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
146580206|NCT03226249|528630580|FG000|Survival Follow-up|Patients still in follow-up.|30|||
146580207|NCT01532921|528630583|FG000|Overall Study|Death|3|||
146580208|NCT01532921|528630583|FG000|Overall Study|Withdrawal by Subject|2|||
146580209|NCT01532921|528630583|FG000|Overall Study|Lost to Follow-up|3|||
146580210|NCT01532921|528630583|FG000|Overall Study|Physician Decision|7|||
146580211|NCT01532921|528630583|FG000|Overall Study|Device was explanted during procedure|1|||
146580212|NCT03462641|528630584|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
146580213|NCT03462641|528630585|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
146580214|NCT03462641|528630584|FG000|Visit 2|Withdrawal by Subject|0|||
146580215|NCT03462641|528630585|FG001|Visit 2|Withdrawal by Subject|1|||
146580216|NCT01804049|528630586|FG000|Overall Study|Adverse Event|2|||
146580217|NCT01804049|528630587|FG001|Overall Study|Adverse Event|10|||
146580218|NCT01804049|528630586|FG000|Overall Study|Lost to Follow-up|2|||
146580219|NCT01804049|528630587|FG001|Overall Study|Lost to Follow-up|1|||
146580220|NCT01804049|528630586|FG000|Overall Study|Decreased interest/personal|4|||
146580221|NCT01804049|528630587|FG001|Overall Study|Decreased interest/personal|5|||
146580222|NCT01804049|528630586|FG000|Overall Study|Other health concerns|2|||
146580223|NCT01804049|528630587|FG001|Overall Study|Other health concerns|7|||
146580224|NCT01804049|528630586|FG000|Overall Study|Moved out of area|0|||
146580225|NCT01804049|528630587|FG001|Overall Study|Moved out of area|7|||
146580226|NCT01804049|528630586|FG000|Overall Study|other MD recommended|1|||
146580227|NCT01804049|528630587|FG001|Overall Study|other MD recommended|1|||
146580228|NCT01804049|528630586|FG000|Overall Study|Enrollment in dual studies|0|||
146580229|NCT01804049|528630587|FG001|Overall Study|Enrollment in dual studies|1|||
146580230|NCT00070109|528630588|FG000|Overall Study|Death|1|||
146580231|NCT00070109|528630589|FG001|Overall Study|Death|1|||
146580232|NCT00070109|528630590|FG002|Overall Study|Death|0|||
146580233|NCT00070109|528630591|FG003|Overall Study|Death|0|||
146580234|NCT00070109|528630592|FG004|Overall Study|Death|1|||
146652012|NCT00761150|528903753|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
146652013|NCT00761150|528903751|FG000|Open-label Period|Lost to Follow-up|7|||
146652014|NCT00761150|528903752|FG001|Open-label Period|Lost to Follow-up|0|||
146652015|NCT00761150|528903753|FG002|Open-label Period|Lost to Follow-up|0|||
146580235|NCT00070109|528630588|FG000|Overall Study|Lack of Efficacy|6|||
146580236|NCT00070109|528630589|FG001|Overall Study|Lack of Efficacy|4|||
146580237|NCT00070109|528630590|FG002|Overall Study|Lack of Efficacy|5|||
146580238|NCT00070109|528630591|FG003|Overall Study|Lack of Efficacy|15|||
146580239|NCT00070109|528630592|FG004|Overall Study|Lack of Efficacy|5|||
146580240|NCT00070109|528630588|FG000|Overall Study|Physician Decision|1|||
146580241|NCT00070109|528630589|FG001|Overall Study|Physician Decision|0|||
146580242|NCT00070109|528630590|FG002|Overall Study|Physician Decision|0|||
146580243|NCT00070109|528630591|FG003|Overall Study|Physician Decision|0|||
146580244|NCT00070109|528630592|FG004|Overall Study|Physician Decision|0|||
146580245|NCT00070109|528630588|FG000|Overall Study|Withdrawal by Subject|0|||
146580246|NCT00070109|528630589|FG001|Overall Study|Withdrawal by Subject|1|||
146652016|NCT00761150|528903751|FG000|Open-label Period|Lack of Efficacy|4|||
146652017|NCT00761150|528903752|FG001|Open-label Period|Lack of Efficacy|0|||
146580247|NCT00070109|528630590|FG002|Overall Study|Withdrawal by Subject|1|||
146580248|NCT00070109|528630591|FG003|Overall Study|Withdrawal by Subject|0|||
146580249|NCT00070109|528630592|FG004|Overall Study|Withdrawal by Subject|0|||
146580250|NCT00070109|528630588|FG000|Overall Study|Adverse Event|0|||
146580251|NCT00070109|528630589|FG001|Overall Study|Adverse Event|0|||
146580252|NCT00070109|528630590|FG002|Overall Study|Adverse Event|2|||
146580253|NCT00070109|528630591|FG003|Overall Study|Adverse Event|4|||
146580254|NCT00070109|528630592|FG004|Overall Study|Adverse Event|2|||
146580255|NCT00070109|528630588|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
146580256|NCT00070109|528630589|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
146580257|NCT00070109|528630590|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
146580258|NCT00070109|528630591|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
146580259|NCT00070109|528630592|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
146580260|NCT00588237|528630598|FG000|Overall Study|Evaluable for toxicity only|3|||
146580261|NCT00588237|528630598|FG000|Overall Study|Patien not treated|1|||
146580262|NCT02201329|528630601|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
146580263|NCT02201329|528630601|FG000|Overall Study|Withdrawal by Subject|2|||
146580264|NCT01262638|528630602|FG000|Overall Study|Adverse Event|3|||
146580265|NCT01262638|528630603|FG001|Overall Study|Adverse Event|4|||
146580266|NCT01262638|528630604|FG002|Overall Study|Adverse Event|3|||
146580267|NCT01262638|528630605|FG003|Overall Study|Adverse Event|4|||
146580268|NCT01262638|528630602|FG000|Overall Study|Protocol Violation|1|||
146580269|NCT01262638|528630603|FG001|Overall Study|Protocol Violation|0|||
146580270|NCT01262638|528630604|FG002|Overall Study|Protocol Violation|0|||
146580271|NCT01262638|528630605|FG003|Overall Study|Protocol Violation|1|||
146580272|NCT01262638|528630602|FG000|Overall Study|Withdrawal by Subject|2|||
146580273|NCT01262638|528630603|FG001|Overall Study|Withdrawal by Subject|1|||
146580274|NCT01262638|528630604|FG002|Overall Study|Withdrawal by Subject|0|||
146580275|NCT01262638|528630605|FG003|Overall Study|Withdrawal by Subject|1|||
146580276|NCT01262638|528630602|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
146580277|NCT01262638|528630603|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
146580278|NCT01262638|528630604|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
146580279|NCT01262638|528630605|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
146580280|NCT01262638|528630602|FG000|Overall Study|Lost to Follow-up|1|||
146580281|NCT01262638|528630603|FG001|Overall Study|Lost to Follow-up|1|||
146580282|NCT01262638|528630604|FG002|Overall Study|Lost to Follow-up|1|||
146580283|NCT01262638|528630605|FG003|Overall Study|Lost to Follow-up|1|||
146580284|NCT01262638|528630602|FG000|Overall Study|Participant Went Out of Town|0|||
146580285|NCT01262638|528630603|FG001|Overall Study|Participant Went Out of Town|0|||
146580286|NCT01262638|528630604|FG002|Overall Study|Participant Went Out of Town|1|||
146580287|NCT01262638|528630605|FG003|Overall Study|Participant Went Out of Town|0|||
146580288|NCT03472495|528630611|FG000|Overall Study|Treatment no longer indicated|1|||
146580289|NCT03472495|528630612|FG001|Overall Study|Treatment no longer indicated|2|||
146580290|NCT03472495|528630611|FG000|Overall Study|Physician Decision|0|||
146580291|NCT03472495|528630612|FG001|Overall Study|Physician Decision|2|||
146580292|NCT01001767|528630615|FG000|Overall Study|no baseline study performed|1|||
146580293|NCT01001767|528630616|FG001|Overall Study|no baseline study performed|0|||
146580294|NCT01001767|528630615|FG000|Overall Study|Protocol Violation|1|||
146580295|NCT01001767|528630616|FG001|Overall Study|Protocol Violation|0|||
146580296|NCT01001767|528630615|FG000|Overall Study|Lost to Follow-up|1|||
146580297|NCT01001767|528630616|FG001|Overall Study|Lost to Follow-up|0|||
146580298|NCT01001767|528630615|FG000|Overall Study|Physician Decision|1|||
146580299|NCT01001767|528630616|FG001|Overall Study|Physician Decision|0|||
146580300|NCT00851552|528630618|FG000|Overall Study|Death|2|||
146580301|NCT00851552|528630618|FG000|Overall Study|Adverse Event|1|||
146580302|NCT00851552|528630618|FG000|Overall Study|Disease Progression|4|||
146580303|NCT02689206|528630619|FG000|Overall Study|Adverse Event|0|||
146580304|NCT02689206|528630620|FG001|Overall Study|Adverse Event|0|||
146580305|NCT02689206|528630621|FG002|Overall Study|Adverse Event|1|||
146580306|NCT02689206|528630622|FG003|Overall Study|Adverse Event|0|||
146580307|NCT02689206|528630623|FG004|Overall Study|Adverse Event|2|||
146580308|NCT02689206|528630619|FG000|Overall Study|Protocol Violation|1|||
146580309|NCT02689206|528630620|FG001|Overall Study|Protocol Violation|0|||
146580310|NCT02689206|528630621|FG002|Overall Study|Protocol Violation|0|||
146652018|NCT00761150|528903753|FG002|Open-label Period|Lack of Efficacy|0|||
146652019|NCT00761150|528903751|FG000|Open-label Period|Withdrawal by Subject|5|||
146652020|NCT00761150|528903752|FG001|Open-label Period|Withdrawal by Subject|0|||
146652021|NCT00761150|528903753|FG002|Open-label Period|Withdrawal by Subject|0|||
146652022|NCT00761150|528903751|FG000|Open-label Period|Noncompliance|2|||
146652023|NCT00761150|528903752|FG001|Open-label Period|Noncompliance|0|||
146652024|NCT00761150|528903753|FG002|Open-label Period|Noncompliance|0|||
146652025|NCT00761150|528903751|FG000|Open-label Period|Other|5|||
146652026|NCT00761150|528903752|FG001|Open-label Period|Other|0|||
146918580|NCT00879814|529864453|FG003|Overall Study|Adverse Event|0|||
146580311|NCT02689206|528630622|FG003|Overall Study|Protocol Violation|1|||
146580312|NCT02689206|528630623|FG004|Overall Study|Protocol Violation|2|||
146580313|NCT02689206|528630619|FG000|Overall Study|Other: Reached stopping criteria|0|||
146580314|NCT02689206|528630620|FG001|Overall Study|Other: Reached stopping criteria|1|||
146652027|NCT00761150|528903753|FG002|Open-label Period|Other|0|||
146580315|NCT02689206|528630621|FG002|Overall Study|Other: Reached stopping criteria|2|||
146652028|NCT00761150|528903751|FG000|Double-blind Period|Lack of Efficacy|0|||
146652029|NCT00761150|528903752|FG001|Double-blind Period|Lack of Efficacy|2|||
146652030|NCT00761150|528903753|FG002|Double-blind Period|Lack of Efficacy|19|||
146652031|NCT00761150|528903751|FG000|Double-blind Period|Adverse Event|0|||
146652032|NCT00761150|528903752|FG001|Double-blind Period|Adverse Event|3|||
146652033|NCT00761150|528903753|FG002|Double-blind Period|Adverse Event|3|||
146652034|NCT00761150|528903751|FG000|Double-blind Period|Withdrawal by Subject|0|||
146652035|NCT00761150|528903752|FG001|Double-blind Period|Withdrawal by Subject|3|||
146580316|NCT02689206|528630622|FG003|Overall Study|Other: Reached stopping criteria|3|||
146580317|NCT02689206|528630623|FG004|Overall Study|Other: Reached stopping criteria|4|||
146580318|NCT02689206|528630619|FG000|Overall Study|Physician Decision|1|||
146580319|NCT02689206|528630620|FG001|Overall Study|Physician Decision|0|||
146580320|NCT02689206|528630621|FG002|Overall Study|Physician Decision|0|||
146580321|NCT02689206|528630622|FG003|Overall Study|Physician Decision|0|||
146580322|NCT02689206|528630623|FG004|Overall Study|Physician Decision|0|||
146580323|NCT02689206|528630619|FG000|Overall Study|Withdrawal by Subject|1|||
146580324|NCT02689206|528630620|FG001|Overall Study|Withdrawal by Subject|0|||
146580325|NCT02689206|528630621|FG002|Overall Study|Withdrawal by Subject|1|||
146580326|NCT02689206|528630622|FG003|Overall Study|Withdrawal by Subject|0|||
146580327|NCT02689206|528630623|FG004|Overall Study|Withdrawal by Subject|0|||
146580328|NCT01479764|528630625|FG000|Randomized|Adverse Event|1|||
146580329|NCT01479764|528630626|FG001|Randomized|Adverse Event|1|||
146580330|NCT01479764|528630625|FG000|Randomized|Withdrawal by Subject|1|||
146580331|NCT01479764|528630626|FG001|Randomized|Withdrawal by Subject|0|||
146918581|NCT00879814|529864450|FG000|Overall Study|Lost to Follow-up|1|||
146918582|NCT00879814|529864451|FG001|Overall Study|Lost to Follow-up|0|||
146918583|NCT00879814|529864452|FG002|Overall Study|Lost to Follow-up|0|||
146918584|NCT00879814|529864453|FG003|Overall Study|Lost to Follow-up|2|||
146918585|NCT00879814|529864450|FG000|Overall Study|Participant Failed to Return|0|||
146918586|NCT00879814|529864451|FG001|Overall Study|Participant Failed to Return|0|||
146918587|NCT00879814|529864452|FG002|Overall Study|Participant Failed to Return|0|||
146918588|NCT00879814|529864453|FG003|Overall Study|Participant Failed to Return|1|||
146918589|NCT00879814|529864450|FG000|Overall Study|Withdrawal by Subject|3|||
146918590|NCT00879814|529864451|FG001|Overall Study|Withdrawal by Subject|1|||
146918591|NCT00879814|529864452|FG002|Overall Study|Withdrawal by Subject|1|||
146918592|NCT00879814|529864453|FG003|Overall Study|Withdrawal by Subject|2|||
146918593|NCT00879814|529864450|FG000|Overall Study|Physician Decision|0|||
146918594|NCT00879814|529864451|FG001|Overall Study|Physician Decision|0|||
146918595|NCT00879814|529864452|FG002|Overall Study|Physician Decision|1|||
146918596|NCT00879814|529864453|FG003|Overall Study|Physician Decision|0|||
146918597|NCT00879814|529864450|FG000|Overall Study|Other|0|||
146978232|NCT01749033|530082282|FG002|Overall Study|Did not receive allocated intervention|0|||
146580332|NCT01479764|528630625|FG000|Treated|Lost to Follow-up|0|||
146580333|NCT01479764|528630626|FG001|Treated|Lost to Follow-up|2|||
146580334|NCT01916824|528630627|FG000|Overall Study|Lost to Follow-up|3|||
146580335|NCT01916824|528630628|FG001|Overall Study|Lost to Follow-up|6|||
146580336|NCT01916824|528630627|FG000|Overall Study|Physician Decision|2|||
146580337|NCT01916824|528630628|FG001|Overall Study|Physician Decision|0|||
146580338|NCT01916824|528630627|FG000|Overall Study|Withdrawal by Subject|2|||
146580339|NCT01916824|528630628|FG001|Overall Study|Withdrawal by Subject|3|||
146580340|NCT00771927|528630629|FG000|Overall Study|Adverse Event|100|||
146580341|NCT00771927|528630630|FG001|Overall Study|Adverse Event|105|||
146580342|NCT00771927|528630629|FG000|Overall Study|Lack of Efficacy|70|||
146580343|NCT00771927|528630630|FG001|Overall Study|Lack of Efficacy|42|||
146580344|NCT00771927|528630629|FG000|Overall Study|Lost to Follow-up|46|||
146580345|NCT00771927|528630630|FG001|Overall Study|Lost to Follow-up|46|||
146580346|NCT00771927|528630629|FG000|Overall Study|Withdrawal by Subject|16|||
146580347|NCT00771927|528630630|FG001|Overall Study|Withdrawal by Subject|17|||
146580348|NCT00771927|528630629|FG000|Overall Study|Other reason|23|||
146580349|NCT00771927|528630630|FG001|Overall Study|Other reason|27|||
146580350|NCT03835481|528630631|FG000|Double-blind Period|Other not stated below|0|||
146652036|NCT00761150|528903753|FG002|Double-blind Period|Withdrawal by Subject|2|||
146652037|NCT00761150|528903751|FG000|Double-blind Period|Lost to Follow-up|0|||
146652038|NCT00761150|528903752|FG001|Double-blind Period|Lost to Follow-up|2|||
146580351|NCT03835481|528630632|FG001|Double-blind Period|Other not stated below|0|||
146580352|NCT03835481|528630633|FG002|Double-blind Period|Other not stated below|0|||
146652039|NCT00761150|528903753|FG002|Double-blind Period|Lost to Follow-up|1|||
146918598|NCT00879814|529864451|FG001|Overall Study|Other|0|||
146580353|NCT03835481|528630634|FG003|Double-blind Period|Other not stated below|1|||
146580354|NCT03835481|528630635|FG004|Double-blind Period|Other not stated below|1|||
146580355|NCT03835481|528630631|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
146652040|NCT00761150|528903751|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
146580356|NCT03835481|528630632|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
146580357|NCT03835481|528630633|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
146652041|NCT00761150|528903752|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
146918599|NCT00879814|529864452|FG002|Overall Study|Other|1|||
146918600|NCT00879814|529864453|FG003|Overall Study|Other|0|||
146918601|NCT00630812|529864464|FG000|Randomisation to First Dose|Adverse Event|1|||
146580358|NCT03835481|528630634|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
146580359|NCT03835481|528630635|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
146580360|NCT03835481|528630631|FG000|Double-blind Period|Withdrawal by Subject|0|||
146580361|NCT03835481|528630632|FG001|Double-blind Period|Withdrawal by Subject|0|||
146580362|NCT03835481|528630633|FG002|Double-blind Period|Withdrawal by Subject|1|||
146580363|NCT03835481|528630634|FG003|Double-blind Period|Withdrawal by Subject|0|||
146580364|NCT03835481|528630635|FG004|Double-blind Period|Withdrawal by Subject|5|||
146580365|NCT03835481|528630631|FG000|Double-blind Period|Lost to Follow-up|0|||
146580366|NCT03835481|528630632|FG001|Double-blind Period|Lost to Follow-up|0|||
146580367|NCT03835481|528630633|FG002|Double-blind Period|Lost to Follow-up|0|||
146580368|NCT03835481|528630634|FG003|Double-blind Period|Lost to Follow-up|1|||
146580369|NCT03835481|528630635|FG004|Double-blind Period|Lost to Follow-up|0|||
146580370|NCT03835481|528630631|FG000|Double-blind Period|Protocol Violation|0|||
146580371|NCT03835481|528630632|FG001|Double-blind Period|Protocol Violation|2|||
146580372|NCT03835481|528630633|FG002|Double-blind Period|Protocol Violation|0|||
146580373|NCT03835481|528630634|FG003|Double-blind Period|Protocol Violation|1|||
146580374|NCT03835481|528630635|FG004|Double-blind Period|Protocol Violation|0|||
146580375|NCT03835481|528630631|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
146580376|NCT03835481|528630632|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
146580377|NCT03835481|528630633|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
146580378|NCT03835481|528630634|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
146580379|NCT03835481|528630635|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
146580380|NCT03835481|528630631|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
146580381|NCT03835481|528630632|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
146580382|NCT03835481|528630633|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
146580383|NCT03835481|528630634|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
146580384|NCT03835481|528630635|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
146580385|NCT03835481|528630631|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
146580386|NCT03835481|528630632|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
146580387|NCT03835481|528630633|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
146580388|NCT03835481|528630634|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
146580389|NCT03835481|528630635|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
146580390|NCT03835481|528630631|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
146580391|NCT03835481|528630632|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
146580392|NCT03835481|528630633|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
146580393|NCT03835481|528630634|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
146580394|NCT03835481|528630635|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
146580395|NCT03835481|528630631|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
146580396|NCT03835481|528630632|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
146580397|NCT03835481|528630633|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
146580398|NCT03835481|528630634|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
146580399|NCT03835481|528630635|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
146580400|NCT03835481|528630631|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
146580401|NCT03835481|528630632|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
146580402|NCT03835481|528630633|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
146580403|NCT03835481|528630634|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
146580404|NCT03835481|528630635|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
146580405|NCT00191945|528630637|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
146580406|NCT00191945|528630638|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
146580407|NCT00191945|528630637|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
146580408|NCT00191945|528630638|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
146580409|NCT00191945|528630637|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
146580410|NCT00191945|528630638|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
146580411|NCT00191945|528630637|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
146580412|NCT00191945|528630638|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
146580413|NCT02063984|528630639|FG000|Overall Study|Lost to Follow-up|6|||
146580414|NCT02063984|528630640|FG001|Overall Study|Lost to Follow-up|5|||
146580415|NCT00958347|528630643|FG000|Overall Study|Death|43|||
146580416|NCT00958347|528630643|FG000|Overall Study|Withdrawal by Subject|23|||
146580417|NCT00958347|528630643|FG000|Overall Study|Lost to Follow-up|15|||
146580418|NCT00958347|528630643|FG000|Overall Study|revision/removal|10|||
146580419|NCT00958347|528630643|FG000|Overall Study|study termination|135|||
146580420|NCT02146131|528630644|FG000|Overall Study|Physician Decision|61|||
146580421|NCT02146131|528630645|FG001|Overall Study|Physician Decision|56|||
146580422|NCT02567799|528630646|FG000|Concurrent Chemoradiotherapy|Death|1|||
146580423|NCT02567799|528630647|FG001|Concurrent Chemoradiotherapy|Death|0|||
146652042|NCT00761150|528903753|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
146580424|NCT02567799|528630648|FG002|Concurrent Chemoradiotherapy|Death|0|||
146652043|NCT00761150|528903751|FG000|Double-blind Period|Noncompliance|0|||
146580425|NCT02567799|528630646|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
146580426|NCT02567799|528630647|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
146580427|NCT02567799|528630648|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
146580428|NCT02567799|528630646|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
146580429|NCT02567799|528630647|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
146580430|NCT02567799|528630648|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
146580431|NCT02567799|528630646|FG000|Follow-up|Death|1|||
146580432|NCT02567799|528630647|FG001|Follow-up|Death|0|||
146580433|NCT02567799|528630648|FG002|Follow-up|Death|1|||
146580434|NCT02567799|528630646|FG000|Follow-up|Progressive Disease|1|||
146580435|NCT02567799|528630647|FG001|Follow-up|Progressive Disease|1|||
146580436|NCT02567799|528630648|FG002|Follow-up|Progressive Disease|3|||
146580437|NCT05356910|528630651|FG000|Overall Study|Lost to Follow-up|10|||
146580438|NCT05356910|528630652|FG001|Overall Study|Lost to Follow-up|19|||
146580439|NCT05356910|528630653|FG002|Overall Study|Lost to Follow-up|0|||
146580440|NCT05356910|528630654|FG003|Overall Study|Lost to Follow-up|0|||
146580441|NCT05356910|528630651|FG000|Overall Study|Withdrawal by Subject|4|||
146580442|NCT05356910|528630652|FG001|Overall Study|Withdrawal by Subject|2|||
146580443|NCT05356910|528630653|FG002|Overall Study|Withdrawal by Subject|0|||
146580444|NCT05356910|528630654|FG003|Overall Study|Withdrawal by Subject|0|||
146580445|NCT03306433|528630657|FG000|Overall Study|Lost to Follow-up|3|||
146580446|NCT03306433|528630657|FG000|Overall Study|Patient did not have teeth extracted|1|||
146580447|NCT03306433|528630657|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
146580448|NCT00819156|528630658|FG000|Overall Study|Adverse Event|1|||
146580449|NCT00819156|528630659|FG001|Overall Study|Adverse Event|4|||
146580450|NCT00819156|528630660|FG002|Overall Study|Adverse Event|2|||
146580451|NCT00819156|528630661|FG003|Overall Study|Adverse Event|1|||
146580452|NCT00819156|528630662|FG004|Overall Study|Adverse Event|2|||
146580453|NCT00819156|528630663|FG005|Overall Study|Adverse Event|3|||
146580454|NCT00819156|528630658|FG000|Overall Study|Withdrawal by Subject|0|||
146580455|NCT00819156|528630659|FG001|Overall Study|Withdrawal by Subject|3|||
146580456|NCT00819156|528630660|FG002|Overall Study|Withdrawal by Subject|2|||
146580457|NCT00819156|528630661|FG003|Overall Study|Withdrawal by Subject|0|||
146580458|NCT00819156|528630662|FG004|Overall Study|Withdrawal by Subject|1|||
146580459|NCT00819156|528630663|FG005|Overall Study|Withdrawal by Subject|0|||
146580460|NCT00819156|528630658|FG000|Overall Study|Protocol Violation|1|||
146580461|NCT00819156|528630659|FG001|Overall Study|Protocol Violation|0|||
146580462|NCT00819156|528630660|FG002|Overall Study|Protocol Violation|1|||
146580463|NCT00819156|528630661|FG003|Overall Study|Protocol Violation|0|||
146580464|NCT00819156|528630662|FG004|Overall Study|Protocol Violation|0|||
146580465|NCT00819156|528630663|FG005|Overall Study|Protocol Violation|1|||
146580466|NCT00819156|528630658|FG000|Overall Study|Lost to Follow-up|0|||
146580467|NCT00819156|528630659|FG001|Overall Study|Lost to Follow-up|1|||
146580468|NCT00819156|528630660|FG002|Overall Study|Lost to Follow-up|0|||
146580469|NCT00819156|528630661|FG003|Overall Study|Lost to Follow-up|0|||
146580470|NCT00819156|528630662|FG004|Overall Study|Lost to Follow-up|0|||
146580471|NCT00819156|528630663|FG005|Overall Study|Lost to Follow-up|2|||
146580472|NCT00819156|528630658|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
146580473|NCT00819156|528630659|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
146580474|NCT00819156|528630660|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
146580475|NCT00819156|528630661|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
146580476|NCT00819156|528630662|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
146580477|NCT00819156|528630663|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
146580478|NCT00819156|528630658|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
146580479|NCT00819156|528630659|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
146580480|NCT00819156|528630660|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
146580481|NCT00819156|528630661|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
146580482|NCT00819156|528630662|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
146580483|NCT00819156|528630663|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
146580484|NCT00819156|528630658|FG000|Overall Study|Prostate-specific antigen progression|0|||
146580485|NCT00819156|528630659|FG001|Overall Study|Prostate-specific antigen progression|0|||
146580486|NCT00819156|528630660|FG002|Overall Study|Prostate-specific antigen progression|0|||
146580487|NCT00819156|528630661|FG003|Overall Study|Prostate-specific antigen progression|0|||
146580488|NCT00819156|528630662|FG004|Overall Study|Prostate-specific antigen progression|1|||
146580489|NCT00819156|528630663|FG005|Overall Study|Prostate-specific antigen progression|0|||
146580490|NCT00803595|528630664|FG000|Overall Study|Adverse Event|3|||
146580491|NCT00803595|528630665|FG001|Overall Study|Adverse Event|4|||
146580492|NCT00803595|528630666|FG002|Overall Study|Adverse Event|1|||
146580493|NCT00803595|528630664|FG000|Overall Study|Protocol Violation|7|||
146580494|NCT00803595|528630665|FG001|Overall Study|Protocol Violation|2|||
146580495|NCT00803595|528630666|FG002|Overall Study|Protocol Violation|12|||
146580496|NCT00803595|528630664|FG000|Overall Study|Withdrawal by Subject|5|||
146580497|NCT00803595|528630665|FG001|Overall Study|Withdrawal by Subject|2|||
146580498|NCT00803595|528630666|FG002|Overall Study|Withdrawal by Subject|3|||
146580499|NCT02195700|528630670|FG000|Overall Study|Protocol Violation|0|||
146580500|NCT02195700|528630671|FG001|Overall Study|Protocol Violation|2|||
146580501|NCT02195700|528630670|FG000|Overall Study|Noncompliance|1|||
146580502|NCT02195700|528630671|FG001|Overall Study|Noncompliance|0|||
146580503|NCT02195700|528630670|FG000|Overall Study|Adverse Event|1|||
146580504|NCT02195700|528630671|FG001|Overall Study|Adverse Event|2|||
146580505|NCT02195700|528630670|FG000|Overall Study|Withdrawal by Subject|3|||
146580506|NCT02195700|528630671|FG001|Overall Study|Withdrawal by Subject|2|||
146580507|NCT02195700|528630670|FG000|Overall Study|Lost to Follow-up|1|||
146580508|NCT02195700|528630671|FG001|Overall Study|Lost to Follow-up|1|||
146580509|NCT01597908|528630672|FG000|Randomized Phase|Death|217|||
146580510|NCT01597908|528630673|FG001|Randomized Phase|Death|238|||
146580511|NCT01597908|528630674|FG002|Randomized Phase|Death|0|||
146580512|NCT01597908|528630672|FG000|Randomized Phase|Sponsor Decision|93|||
146580513|NCT01597908|528630673|FG001|Randomized Phase|Sponsor Decision|39|||
146580514|NCT01597908|528630674|FG002|Randomized Phase|Sponsor Decision|0|||
146580515|NCT01597908|528630672|FG000|Randomized Phase|Lost to Follow-up|9|||
146580516|NCT01597908|528630673|FG001|Randomized Phase|Lost to Follow-up|16|||
146580517|NCT01597908|528630674|FG002|Randomized Phase|Lost to Follow-up|0|||
146580518|NCT01597908|528630672|FG000|Randomized Phase|Physician Decision|6|||
146580519|NCT01597908|528630673|FG001|Randomized Phase|Physician Decision|3|||
146580520|NCT01597908|528630674|FG002|Randomized Phase|Physician Decision|0|||
146580521|NCT01597908|528630672|FG000|Randomized Phase|Withdrawal by Subject|26|||
146580522|NCT01597908|528630673|FG001|Randomized Phase|Withdrawal by Subject|22|||
146580523|NCT01597908|528630674|FG002|Randomized Phase|Withdrawal by Subject|0|||
146580524|NCT01597908|528630672|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
146580525|NCT01597908|528630673|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
146580526|NCT01597908|528630674|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
146580527|NCT01597908|528630672|FG000|Crossover Phase|Death|0|||
146580528|NCT01597908|528630673|FG001|Crossover Phase|Death|0|||
146580529|NCT01597908|528630674|FG002|Crossover Phase|Death|11|||
146580530|NCT01597908|528630672|FG000|Crossover Phase|Withdrawal by Subject|0|||
146580531|NCT01597908|528630673|FG001|Crossover Phase|Withdrawal by Subject|0|||
146580532|NCT01597908|528630674|FG002|Crossover Phase|Withdrawal by Subject|3|||
146580533|NCT01597908|528630672|FG000|Crossover Phase|Sponsor Decision|0|||
146580534|NCT01597908|528630673|FG001|Crossover Phase|Sponsor Decision|0|||
146580535|NCT01597908|528630674|FG002|Crossover Phase|Sponsor Decision|20|||
146580536|NCT02931838|528630675|FG000|Overall Study|Reason not provided by investigator|1|||
146580537|NCT02931838|528630676|FG001|Overall Study|Reason not provided by investigator|0|||
146580538|NCT02931838|528630677|FG002|Overall Study|Reason not provided by investigator|1|||
146580539|NCT02931838|528630678|FG003|Overall Study|Reason not provided by investigator|0|||
146580540|NCT02931838|528630679|FG004|Overall Study|Reason not provided by investigator|0|||
146580541|NCT02931838|528630680|FG005|Overall Study|Reason not provided by investigator|0|||
146580542|NCT02931838|528630675|FG000|Overall Study|Poor/non-compliance|0|||
146580543|NCT02931838|528630676|FG001|Overall Study|Poor/non-compliance|0|||
146580544|NCT02931838|528630677|FG002|Overall Study|Poor/non-compliance|1|||
146580545|NCT02931838|528630678|FG003|Overall Study|Poor/non-compliance|0|||
146580546|NCT02931838|528630679|FG004|Overall Study|Poor/non-compliance|0|||
146580547|NCT02931838|528630680|FG005|Overall Study|Poor/non-compliance|0|||
146580548|NCT02931838|528630675|FG000|Overall Study|Lack of Efficacy|5|||
146580549|NCT02931838|528630676|FG001|Overall Study|Lack of Efficacy|4|||
146580550|NCT02931838|528630677|FG002|Overall Study|Lack of Efficacy|0|||
146580551|NCT02931838|528630678|FG003|Overall Study|Lack of Efficacy|0|||
146580552|NCT02931838|528630679|FG004|Overall Study|Lack of Efficacy|0|||
146580553|NCT02931838|528630680|FG005|Overall Study|Lack of Efficacy|1|||
146580554|NCT02931838|528630675|FG000|Overall Study|Lost to Follow-up|1|||
146580555|NCT02931838|528630676|FG001|Overall Study|Lost to Follow-up|0|||
146580556|NCT02931838|528630677|FG002|Overall Study|Lost to Follow-up|1|||
146580557|NCT02931838|528630678|FG003|Overall Study|Lost to Follow-up|1|||
146580558|NCT02931838|528630679|FG004|Overall Study|Lost to Follow-up|2|||
146580559|NCT02931838|528630680|FG005|Overall Study|Lost to Follow-up|0|||
146580560|NCT02931838|528630675|FG000|Overall Study|Subject request to discontinue treatment|4|||
146580561|NCT02931838|528630676|FG001|Overall Study|Subject request to discontinue treatment|3|||
146580562|NCT02931838|528630677|FG002|Overall Study|Subject request to discontinue treatment|3|||
146580563|NCT02931838|528630678|FG003|Overall Study|Subject request to discontinue treatment|0|||
146580564|NCT02931838|528630679|FG004|Overall Study|Subject request to discontinue treatment|1|||
146580565|NCT02931838|528630680|FG005|Overall Study|Subject request to discontinue treatment|0|||
146580566|NCT02931838|528630675|FG000|Overall Study|Withdrawal by Subject|1|||
146580567|NCT02931838|528630676|FG001|Overall Study|Withdrawal by Subject|2|||
146580568|NCT02931838|528630677|FG002|Overall Study|Withdrawal by Subject|0|||
146580569|NCT02931838|528630678|FG003|Overall Study|Withdrawal by Subject|1|||
146580570|NCT02931838|528630679|FG004|Overall Study|Withdrawal by Subject|0|||
146580571|NCT02931838|528630680|FG005|Overall Study|Withdrawal by Subject|0|||
146580572|NCT02931838|528630675|FG000|Overall Study|Adverse Event|2|||
146770778|NCT03475316|529328674|FG000|6 Month Intervention|Adverse Event|2|||
146580573|NCT02931838|528630676|FG001|Overall Study|Adverse Event|1|||
146580574|NCT02931838|528630677|FG002|Overall Study|Adverse Event|2|||
146580575|NCT02931838|528630678|FG003|Overall Study|Adverse Event|1|||
146580576|NCT02931838|528630679|FG004|Overall Study|Adverse Event|3|||
146580577|NCT02931838|528630680|FG005|Overall Study|Adverse Event|1|||
146580578|NCT00104728|528630681|FG000|Overall Study|screen failures|19|||
146580579|NCT02709577|528630682|FG000|Overall Study|non-accommodating anatomy|0|||
146580580|NCT02709577|528630683|FG001|Overall Study|non-accommodating anatomy|1|||
146580581|NCT02709577|528630684|FG002|Overall Study|non-accommodating anatomy|0|||
146580582|NCT02709577|528630685|FG003|Overall Study|non-accommodating anatomy|0|||
146580583|NCT02709577|528630682|FG000|Overall Study|procedural complication|0|||
146580584|NCT02709577|528630683|FG001|Overall Study|procedural complication|1|||
146580585|NCT02709577|528630684|FG002|Overall Study|procedural complication|0|||
146580586|NCT02709577|528630685|FG003|Overall Study|procedural complication|0|||
146580587|NCT02709577|528630682|FG000|Overall Study|Withdrawal by Subject|2|||
146580588|NCT02709577|528630683|FG001|Overall Study|Withdrawal by Subject|3|||
146580589|NCT02709577|528630684|FG002|Overall Study|Withdrawal by Subject|2|||
146580590|NCT02709577|528630685|FG003|Overall Study|Withdrawal by Subject|0|||
146580591|NCT01042158|528630686|FG000|Overall Study|Physician Decision|1|||
146580592|NCT01575808|528630687|FG000|Overall Study|Death|2|||
146580593|NCT01575808|528630688|FG001|Overall Study|Death|0|||
146580594|NCT01575808|528630687|FG000|Overall Study|Withdrawal by Subject|1|||
146580595|NCT01575808|528630688|FG001|Overall Study|Withdrawal by Subject|0|||
146580596|NCT00064259|528631985|FG000|Overall Study|Adverse Event|1|||
146580597|NCT00064259|528631986|FG001|Overall Study|Adverse Event|0|||
146580598|NCT00064259|528631987|FG002|Overall Study|Adverse Event|0|||
146580599|NCT00064259|528631988|FG003|Overall Study|Adverse Event|1|||
146580600|NCT01519791|528631996|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
146580601|NCT01519791|528631997|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
146580602|NCT01519791|528631996|FG000|Overall Study|Protocol Violation|6|||
146580603|NCT01519791|528631997|FG001|Overall Study|Protocol Violation|19|||
146580604|NCT01519791|528631996|FG000|Overall Study|Other Reason|87|||
146580605|NCT01519791|528631997|FG001|Overall Study|Other Reason|222|||
146580606|NCT01519791|528631996|FG000|Overall Study|subjects randomized in error|2|||
146580607|NCT01519791|528631997|FG001|Overall Study|subjects randomized in error|0|||
146580608|NCT01519791|528631996|FG000|Overall Study|Lack of Efficacy|16|||
146580609|NCT01519791|528631997|FG001|Overall Study|Lack of Efficacy|20|||
146580610|NCT01519791|528631996|FG000|Overall Study|SAE, non-fatal|6|||
146580611|NCT01519791|528631997|FG001|Overall Study|SAE, non-fatal|22|||
146580612|NCT01519791|528631996|FG000|Overall Study|AE, serious fatal|0|||
146580613|NCT01519791|528631997|FG001|Overall Study|AE, serious fatal|1|||
146580614|NCT01519791|528631996|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
146580615|NCT01519791|528631997|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
146580616|NCT01519791|528631996|FG000|Overall Study|AE, non-serious non-fatal|12|||
146580617|NCT01519791|528631997|FG001|Overall Study|AE, non-serious non-fatal|31|||
146580618|NCT01519791|528631996|FG000|Overall Study|Withdrawal by Subject|15|||
146580619|NCT01519791|528631997|FG001|Overall Study|Withdrawal by Subject|37|||
146580620|NCT01519791|528631996|FG000|Overall Study|Lost to Follow-up|6|||
146580621|NCT01519791|528631997|FG001|Overall Study|Lost to Follow-up|14|||
146580622|NCT03206970|528632000|FG000|Overall Study|Death|21|||
146580623|NCT03206970|528632000|FG000|Overall Study|Withdrawal by Subject|13|||
146580624|NCT03206970|528632000|FG000|Overall Study|Lost to Follow-up|3|||
146580625|NCT03206970|528632000|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
146580626|NCT00375427|528632001|FG000|Overall Study|Adverse Event|21|||
146580627|NCT00375427|528632002|FG001|Overall Study|Adverse Event|27|||
146580628|NCT00375427|528632001|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146580629|NCT00375427|528632002|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146580630|NCT00375427|528632001|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146580631|NCT00375427|528632002|FG001|Overall Study|Abnormal laboratory value(s)|2|||
146580632|NCT00375427|528632001|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146580633|NCT00375427|528632002|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
146580634|NCT00375427|528632001|FG000|Overall Study|Patient no longer requires study drug|3|||
146580635|NCT00375427|528632002|FG001|Overall Study|Patient no longer requires study drug|7|||
146580636|NCT00375427|528632001|FG000|Overall Study|Protocol Violation|10|||
146580637|NCT00375427|528632002|FG001|Overall Study|Protocol Violation|8|||
146580638|NCT00375427|528632001|FG000|Overall Study|Withdrawal by Subject|9|||
146580639|NCT00375427|528632002|FG001|Overall Study|Withdrawal by Subject|13|||
146580640|NCT00375427|528632001|FG000|Overall Study|Lost to Follow-up|1|||
146580641|NCT00375427|528632002|FG001|Overall Study|Lost to Follow-up|1|||
146580642|NCT00375427|528632001|FG000|Overall Study|Administrative reasons|0|||
146580643|NCT00375427|528632002|FG001|Overall Study|Administrative reasons|1|||
146580644|NCT00375427|528632001|FG000|Overall Study|Death|11|||
146580645|NCT00375427|528632002|FG001|Overall Study|Death|10|||
146580646|NCT00716482|528632011|FG000|Overall Study|Lost to Follow-up|6|||
146770779|NCT03475316|529328675|FG001|6 Month Intervention|Adverse Event|1|||
146580647|NCT00716482|528632011|FG000|Overall Study|Inadequate acquisition or analysis|50|||
146770780|NCT03475316|529328674|FG000|6 Month Intervention|Withdrawal by Subject|2|||
146580648|NCT00716482|528632011|FG000|Overall Study|no pathology obtained|10|||
146580649|NCT00716482|528632011|FG000|Overall Study|technical/machine error|28|||
146580650|NCT00716482|528632011|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
146580651|NCT02550288|528632012|FG000|Overall Study|Adverse Event|0|||
146580652|NCT02550288|528632013|FG001|Overall Study|Adverse Event|1|||
146580653|NCT02550288|528632014|FG002|Overall Study|Adverse Event|0|||
146580654|NCT02550288|528632015|FG003|Overall Study|Adverse Event|0|||
146580655|NCT02550288|528632016|FG004|Overall Study|Adverse Event|0|||
146580656|NCT02550288|528632012|FG000|Overall Study|Physician Decision|0|||
146580657|NCT02550288|528632013|FG001|Overall Study|Physician Decision|0|||
146580658|NCT02550288|528632014|FG002|Overall Study|Physician Decision|0|||
146580659|NCT02550288|528632015|FG003|Overall Study|Physician Decision|1|||
146580660|NCT02550288|528632016|FG004|Overall Study|Physician Decision|0|||
146580661|NCT02550288|528632012|FG000|Overall Study|Protocol Violation|2|||
146580662|NCT02550288|528632013|FG001|Overall Study|Protocol Violation|2|||
146580663|NCT02550288|528632014|FG002|Overall Study|Protocol Violation|1|||
146580664|NCT02550288|528632015|FG003|Overall Study|Protocol Violation|0|||
146580665|NCT02550288|528632016|FG004|Overall Study|Protocol Violation|3|||
146580666|NCT02550288|528632012|FG000|Overall Study|Participant moved|0|||
146580667|NCT02550288|528632013|FG001|Overall Study|Participant moved|0|||
146580668|NCT02550288|528632014|FG002|Overall Study|Participant moved|0|||
146580669|NCT02550288|528632015|FG003|Overall Study|Participant moved|1|||
146580670|NCT02550288|528632016|FG004|Overall Study|Participant moved|0|||
146580671|NCT02550288|528632012|FG000|Overall Study|Withdrawal by Subject|0|||
146580672|NCT02550288|528632013|FG001|Overall Study|Withdrawal by Subject|0|||
146580673|NCT02550288|528632014|FG002|Overall Study|Withdrawal by Subject|0|||
146580674|NCT02550288|528632015|FG003|Overall Study|Withdrawal by Subject|1|||
146580675|NCT02550288|528632016|FG004|Overall Study|Withdrawal by Subject|0|||
146580676|NCT01524224|528632017|FG000|Overall Study|Progressive Disease|1|||
146580677|NCT01524224|528632018|FG001|Overall Study|Progressive Disease|0|||
146580678|NCT01524224|528632019|FG002|Overall Study|Progressive Disease|2|||
146580679|NCT01524224|528632020|FG003|Overall Study|Progressive Disease|1|||
146580680|NCT01524224|528632021|FG004|Overall Study|Progressive Disease|2|||
146580681|NCT01524224|528632022|FG005|Overall Study|Progressive Disease|1|||
146580682|NCT01524224|528632023|FG006|Overall Study|Progressive Disease|1|||
146580683|NCT01524224|528632024|FG007|Overall Study|Progressive Disease|5|||
146580684|NCT01524224|528632017|FG000|Overall Study|Withdrawal by Subject|2|||
146580685|NCT01524224|528632018|FG001|Overall Study|Withdrawal by Subject|0|||
146580686|NCT01524224|528632019|FG002|Overall Study|Withdrawal by Subject|0|||
146580687|NCT01524224|528632020|FG003|Overall Study|Withdrawal by Subject|0|||
146580688|NCT01524224|528632021|FG004|Overall Study|Withdrawal by Subject|0|||
146580689|NCT01524224|528632022|FG005|Overall Study|Withdrawal by Subject|0|||
146580690|NCT01524224|528632023|FG006|Overall Study|Withdrawal by Subject|2|||
146580691|NCT01524224|528632024|FG007|Overall Study|Withdrawal by Subject|0|||
146580692|NCT01524224|528632017|FG000|Overall Study|Adverse Event|0|||
146580693|NCT01524224|528632018|FG001|Overall Study|Adverse Event|1|||
146580694|NCT01524224|528632019|FG002|Overall Study|Adverse Event|0|||
146580695|NCT01524224|528632020|FG003|Overall Study|Adverse Event|0|||
146580696|NCT01524224|528632021|FG004|Overall Study|Adverse Event|0|||
146580697|NCT01524224|528632022|FG005|Overall Study|Adverse Event|1|||
146580698|NCT01524224|528632023|FG006|Overall Study|Adverse Event|0|||
146580699|NCT01524224|528632024|FG007|Overall Study|Adverse Event|0|||
146580700|NCT01524224|528632017|FG000|Overall Study|Physician Decision|0|||
146580701|NCT01524224|528632018|FG001|Overall Study|Physician Decision|0|||
146580702|NCT01524224|528632019|FG002|Overall Study|Physician Decision|0|||
146580703|NCT01524224|528632020|FG003|Overall Study|Physician Decision|1|||
146580704|NCT01524224|528632021|FG004|Overall Study|Physician Decision|1|||
146580705|NCT01524224|528632022|FG005|Overall Study|Physician Decision|0|||
146918602|NCT00630812|529864465|FG001|Randomisation to First Dose|Adverse Event|1|||
146580706|NCT01524224|528632023|FG006|Overall Study|Physician Decision|0|||
146918603|NCT00630812|529864464|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
146580707|NCT01524224|528632024|FG007|Overall Study|Physician Decision|1|||
146580708|NCT01524224|528632017|FG000|Overall Study|Sponsor Decision|0|||
146580709|NCT01524224|528632018|FG001|Overall Study|Sponsor Decision|0|||
146580710|NCT01524224|528632019|FG002|Overall Study|Sponsor Decision|0|||
146580711|NCT01524224|528632020|FG003|Overall Study|Sponsor Decision|0|||
146652044|NCT00761150|528903752|FG001|Double-blind Period|Noncompliance|1|||
146652045|NCT00761150|528903753|FG002|Double-blind Period|Noncompliance|0|||
146580712|NCT01524224|528632021|FG004|Overall Study|Sponsor Decision|1|||
146580713|NCT01524224|528632022|FG005|Overall Study|Sponsor Decision|0|||
146580714|NCT01524224|528632023|FG006|Overall Study|Sponsor Decision|0|||
146580715|NCT01524224|528632024|FG007|Overall Study|Sponsor Decision|0|||
146580716|NCT03517371|528632026|FG000|Overall Study|Adverse Event|8|||
146580717|NCT03517371|528632027|FG001|Overall Study|Adverse Event|9|||
146580718|NCT03517371|528632026|FG000|Overall Study|Lost to Follow-up|1|||
146580719|NCT03517371|528632027|FG001|Overall Study|Lost to Follow-up|2|||
146580720|NCT03517371|528632026|FG000|Overall Study|Withdrawal by Subject|4|||
146580721|NCT03517371|528632027|FG001|Overall Study|Withdrawal by Subject|4|||
146580722|NCT03517371|528632026|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
146580723|NCT03517371|528632027|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
146580724|NCT03517371|528632026|FG000|Overall Study|COVID restrictions|2|||
146652046|NCT00761150|528903751|FG000|Double-blind Period|Other|0|||
146978233|NCT01749033|530082280|FG000|Overall Study|Lost to Follow-up|0|||
146770781|NCT03475316|529328675|FG001|6 Month Intervention|Withdrawal by Subject|0|||
146580725|NCT03517371|528632027|FG001|Overall Study|COVID restrictions|0|||
146580726|NCT03517371|528632026|FG000|Overall Study|Receiving DBS Surgery|0|||
146580727|NCT03517371|528632027|FG001|Overall Study|Receiving DBS Surgery|1|||
146580728|NCT02318368|528632028|FG000|Overall Study|Withdrawal by Subject|2|||
146580729|NCT02318368|528632029|FG001|Overall Study|Withdrawal by Subject|0|||
146580730|NCT02318368|528632028|FG000|Overall Study|Study terminated by the sponsor|5|||
146580731|NCT02318368|528632029|FG001|Overall Study|Study terminated by the sponsor|2|||
146580732|NCT02318368|528632028|FG000|Overall Study|Death|0|||
146580733|NCT02318368|528632029|FG001|Overall Study|Death|1|||
146580734|NCT01901614|528632030|FG000|Overall Study|Adverse Event|0|||
146580735|NCT01901614|528632031|FG001|Overall Study|Adverse Event|1|||
146580736|NCT01901614|528632030|FG000|Overall Study|Lost to Follow-up|1|||
146580737|NCT01901614|528632031|FG001|Overall Study|Lost to Follow-up|0|||
146580738|NCT01901614|528632030|FG000|Overall Study|Screen Fail|1|||
146580739|NCT01901614|528632031|FG001|Overall Study|Screen Fail|0|||
146580740|NCT03629223|528632032|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
146580741|NCT03629223|528632033|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
146580742|NCT03629223|528632034|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
146580743|NCT03629223|528632035|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
146580744|NCT03629223|528632036|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
146580745|NCT03629223|528632037|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
146580746|NCT03629223|528632032|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
146580747|NCT03629223|528632033|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
146580748|NCT03629223|528632034|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
146580749|NCT03629223|528632035|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
146580750|NCT03629223|528632036|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
146580751|NCT03629223|528632037|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
146580752|NCT03629223|528632032|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
146580753|NCT03629223|528632033|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
146580754|NCT03629223|528632034|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
146580755|NCT03629223|528632035|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
146580756|NCT03629223|528632036|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
146580757|NCT03629223|528632037|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
146580758|NCT03629223|528632032|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
146580759|NCT03629223|528632033|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
146580760|NCT03629223|528632034|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
146580761|NCT03629223|528632035|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
146580762|NCT03629223|528632036|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
146580763|NCT03629223|528632037|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
146580764|NCT03629223|528632032|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
146580765|NCT03629223|528632033|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
146580766|NCT03629223|528632034|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
146580767|NCT03629223|528632035|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
146580768|NCT03629223|528632036|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
146580769|NCT03629223|528632037|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
146580770|NCT02674464|528632038|FG000|Overall Study|Death|10|||
146580771|NCT02674464|528632039|FG001|Overall Study|Death|21|||
146580772|NCT02674464|528632038|FG000|Overall Study|Withdrawal by Subject|24|||
146580773|NCT02674464|528632039|FG001|Overall Study|Withdrawal by Subject|44|||
146580774|NCT02674464|528632038|FG000|Overall Study|Lost to Follow-up|97|||
146580775|NCT02674464|528632039|FG001|Overall Study|Lost to Follow-up|92|||
146580776|NCT02674464|528632038|FG000|Overall Study|Outside survey window|6|||
146580777|NCT02674464|528632039|FG001|Overall Study|Outside survey window|3|||
146580778|NCT00783835|528632040|FG000|Overall Study|Adverse Event|3|||
146580779|NCT00783835|528632040|FG000|Overall Study|Medical Criteria|1|||
146580780|NCT00783835|528632040|FG000|Overall Study|Withdrawal by Subject|2|||
146580781|NCT00783835|528632040|FG000|Overall Study|Lost to Follow-up|1|||
146580782|NCT00783835|528632040|FG000|Overall Study|Participant not Adherent|3|||
146580783|NCT01555073|528632041|FG000|Overall Study|Lost to Follow-up|1|||
146580784|NCT01555073|528632042|FG001|Overall Study|Lost to Follow-up|2|||
146580785|NCT01555073|528632043|FG002|Overall Study|Lost to Follow-up|0|||
146580786|NCT01555073|528632044|FG003|Overall Study|Lost to Follow-up|5|||
146580787|NCT01369199|528632047|FG000|Overall Study|Withdrawal by Subject|1|||
146580788|NCT01369199|528632047|FG000|Overall Study|Lost to Follow-up|2|||
146580789|NCT01071252|528632048|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
146580790|NCT01071252|528632049|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
146580791|NCT01071252|528632050|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
146580792|NCT01071252|528632051|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
146580793|NCT01071252|528632052|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
146580794|NCT01071252|528632048|FG000|Overall Study|Withdrawal by Subject|8|||
146580795|NCT01071252|528632049|FG001|Overall Study|Withdrawal by Subject|2|||
146580796|NCT01071252|528632050|FG002|Overall Study|Withdrawal by Subject|1|||
146580797|NCT01071252|528632051|FG003|Overall Study|Withdrawal by Subject|2|||
146580798|NCT01071252|528632052|FG004|Overall Study|Withdrawal by Subject|3|||
146580799|NCT01071252|528632048|FG000|Overall Study|administrative problems|1|||
146580800|NCT01071252|528632049|FG001|Overall Study|administrative problems|1|||
146580801|NCT01071252|528632050|FG002|Overall Study|administrative problems|0|||
146580802|NCT01071252|528632051|FG003|Overall Study|administrative problems|2|||
146580803|NCT01071252|528632052|FG004|Overall Study|administrative problems|1|||
146580804|NCT01071252|528632048|FG000|Overall Study|Lost to Follow-up|1|||
146580805|NCT01071252|528632049|FG001|Overall Study|Lost to Follow-up|0|||
146580806|NCT01071252|528632050|FG002|Overall Study|Lost to Follow-up|1|||
146580807|NCT01071252|528632051|FG003|Overall Study|Lost to Follow-up|2|||
146580808|NCT01071252|528632052|FG004|Overall Study|Lost to Follow-up|0|||
146580809|NCT01071252|528632048|FG000|Overall Study|Adverse Event|1|||
146580810|NCT01071252|528632049|FG001|Overall Study|Adverse Event|1|||
146580811|NCT01071252|528632050|FG002|Overall Study|Adverse Event|0|||
146580812|NCT01071252|528632051|FG003|Overall Study|Adverse Event|1|||
146580813|NCT01071252|528632052|FG004|Overall Study|Adverse Event|0|||
146580814|NCT01071252|528632048|FG000|Overall Study|Death|0|||
146580815|NCT01071252|528632049|FG001|Overall Study|Death|0|||
146580816|NCT01071252|528632050|FG002|Overall Study|Death|0|||
146580817|NCT01071252|528632051|FG003|Overall Study|Death|0|||
146580818|NCT01071252|528632052|FG004|Overall Study|Death|1|||
146580819|NCT01066104|528632053|FG000|Overall Study|Adverse Event|1|||
146580820|NCT01066104|528632054|FG001|Overall Study|Adverse Event|1|||
146580821|NCT01066104|528632053|FG000|Overall Study|Protocol Violation|1|||
146580822|NCT01066104|528632054|FG001|Overall Study|Protocol Violation|0|||
146580823|NCT04660552|528632055|FG000|Overall Study|Withdrawal by Subject|3|||
146580824|NCT04660552|528632056|FG001|Overall Study|Withdrawal by Subject|1|||
146580825|NCT00470262|528632057|FG000|Overall Study|Withdrawal by Subject|2|||
146580826|NCT00470262|528632058|FG001|Overall Study|Withdrawal by Subject|0|||
146580827|NCT04004221|528632061|FG000|Overall Study|Death|89|||
146580828|NCT04004221|528632061|FG000|Overall Study|Withdrawal by Subject|5|||
146580829|NCT04004221|528632061|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
146580830|NCT04004221|528632061|FG000|Overall Study|Sponsor Decision|9|||
146580831|NCT04004221|528632061|FG000|Overall Study|Participant refused to enter LTE|1|||
146580832|NCT01970241|528632062|FG000|Overall Study|Withdrawal by Subject|2|||
146580833|NCT01970241|528632063|FG001|Overall Study|Withdrawal by Subject|0|||
146580834|NCT01970241|528632062|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
146580835|NCT01970241|528632063|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
146580836|NCT02036580|528632066|FG000|Overall Study|Withdrawal by Subject|0|||
146580837|NCT02036580|528632067|FG001|Overall Study|Withdrawal by Subject|1|||
146580838|NCT02036580|528632068|FG002|Overall Study|Withdrawal by Subject|0|||
146580839|NCT02036580|528632066|FG000|Overall Study|Adverse Event|1|||
146580840|NCT02036580|528632067|FG001|Overall Study|Adverse Event|0|||
146580841|NCT02036580|528632068|FG002|Overall Study|Adverse Event|0|||
146580842|NCT00992056|528632069|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
146580843|NCT00992056|528632070|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
146580844|NCT00992056|528632069|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
146580845|NCT00992056|528632070|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
146580846|NCT01558596|528632075|FG000|Overall Study|Withdrawal by Subject|1|||
146580847|NCT01558596|528632076|FG001|Overall Study|Withdrawal by Subject|0|||
146580848|NCT01558596|528632075|FG000|Overall Study|surgery elsewhere or cancelled|1|||
146580849|NCT01558596|528632076|FG001|Overall Study|surgery elsewhere or cancelled|1|||
146580850|NCT01558596|528632075|FG000|Overall Study|Protocol Violation|1|||
146580851|NCT01558596|528632076|FG001|Overall Study|Protocol Violation|0|||
146580852|NCT02038946|528632077|FG000|Overall Study|Death|5|||
146580853|NCT02038946|528632077|FG000|Overall Study|Withdrawal by Subject|3|||
146580854|NCT02038946|528632077|FG000|Overall Study|Lost to Follow-up|2|||
146580855|NCT02038946|528632077|FG000|Overall Study|Other reasons|2|||
146580856|NCT01270880|528632089|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
146580857|NCT01221753|528632096|FG000|Overall Study|Adverse Event|1|||
146580858|NCT04552288|528632098|FG000|Overall Study|Death|3|||
146580859|NCT04552288|528632098|FG000|Overall Study|Lost to Follow-up|6|||
146580860|NCT04552288|528632098|FG000|Overall Study|Physician Decision|3|||
146580861|NCT04552288|528632098|FG000|Overall Study|Protocol Violation|9|||
146580862|NCT04552288|528632098|FG000|Overall Study|Withdrawal by Subject|6|||
146580863|NCT04552288|528632098|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
146580864|NCT01831466|528632099|FG000|Overall Study|Protocol Violation|1|||
146580865|NCT01831466|528632100|FG001|Overall Study|Protocol Violation|1|||
146652047|NCT00761150|528903752|FG001|Double-blind Period|Other|3|||
146652048|NCT00761150|528903753|FG002|Double-blind Period|Other|3|||
146652049|NCT03312751|528903754|FG000|Overall Study|Death|7|||
146580866|NCT01831466|528632101|FG002|Overall Study|Protocol Violation|2|||
146580867|NCT01831466|528632102|FG003|Overall Study|Protocol Violation|0|||
146580868|NCT01831466|528632103|FG004|Overall Study|Protocol Violation|0|||
146652050|NCT03312751|528903755|FG001|Overall Study|Death|9|||
146580869|NCT01831466|528632104|FG005|Overall Study|Protocol Violation|1|||
146580870|NCT01831466|528632105|FG006|Overall Study|Protocol Violation|0|||
146580871|NCT01831466|528632106|FG007|Overall Study|Protocol Violation|0|||
146580872|NCT01831466|528632107|FG008|Overall Study|Protocol Violation|0|||
146580873|NCT01831466|528632108|FG009|Overall Study|Protocol Violation|0|||
146580874|NCT01831466|528632109|FG010|Overall Study|Protocol Violation|0|||
146580875|NCT01831466|528632110|FG011|Overall Study|Protocol Violation|0|||
146580876|NCT01831466|528632099|FG000|Overall Study|Other|2|||
146580877|NCT01831466|528632100|FG001|Overall Study|Other|3|||
146580878|NCT01831466|528632101|FG002|Overall Study|Other|2|||
146580879|NCT01831466|528632102|FG003|Overall Study|Other|2|||
146580880|NCT01831466|528632103|FG004|Overall Study|Other|2|||
146580881|NCT01831466|528632104|FG005|Overall Study|Other|1|||
146580882|NCT01831466|528632105|FG006|Overall Study|Other|0|||
146580883|NCT01831466|528632106|FG007|Overall Study|Other|0|||
146580884|NCT01831466|528632107|FG008|Overall Study|Other|0|||
146580885|NCT01831466|528632108|FG009|Overall Study|Other|0|||
146580886|NCT01831466|528632109|FG010|Overall Study|Other|0|||
146580887|NCT01831466|528632110|FG011|Overall Study|Other|0|||
146580888|NCT01831466|528632099|FG000|Overall Study|Non-compliance with study treatment|2|||
146580889|NCT01831466|528632100|FG001|Overall Study|Non-compliance with study treatment|1|||
146580890|NCT01831466|528632101|FG002|Overall Study|Non-compliance with study treatment|1|||
146580891|NCT01831466|528632102|FG003|Overall Study|Non-compliance with study treatment|0|||
146580892|NCT01831466|528632103|FG004|Overall Study|Non-compliance with study treatment|0|||
146580893|NCT01831466|528632104|FG005|Overall Study|Non-compliance with study treatment|1|||
146580894|NCT01831466|528632105|FG006|Overall Study|Non-compliance with study treatment|0|||
146580895|NCT01831466|528632106|FG007|Overall Study|Non-compliance with study treatment|0|||
146580896|NCT01831466|528632107|FG008|Overall Study|Non-compliance with study treatment|0|||
146580897|NCT01831466|528632108|FG009|Overall Study|Non-compliance with study treatment|0|||
146580898|NCT01831466|528632109|FG010|Overall Study|Non-compliance with study treatment|0|||
146580899|NCT01831466|528632110|FG011|Overall Study|Non-compliance with study treatment|0|||
146580900|NCT01831466|528632099|FG000|Overall Study|Death|0|||
146580901|NCT01831466|528632100|FG001|Overall Study|Death|1|||
146580902|NCT01831466|528632101|FG002|Overall Study|Death|0|||
146580903|NCT01831466|528632102|FG003|Overall Study|Death|0|||
146580904|NCT01831466|528632103|FG004|Overall Study|Death|0|||
146580905|NCT01831466|528632104|FG005|Overall Study|Death|0|||
146580906|NCT01831466|528632105|FG006|Overall Study|Death|0|||
146580907|NCT01831466|528632106|FG007|Overall Study|Death|0|||
146580908|NCT01831466|528632107|FG008|Overall Study|Death|0|||
146580909|NCT01831466|528632108|FG009|Overall Study|Death|0|||
146580910|NCT01831466|528632109|FG010|Overall Study|Death|0|||
146580911|NCT01831466|528632110|FG011|Overall Study|Death|0|||
146580912|NCT01831466|528632099|FG000|Overall Study|Withdrawal by Subject|6|||
146580913|NCT01831466|528632100|FG001|Overall Study|Withdrawal by Subject|3|||
146580914|NCT01831466|528632101|FG002|Overall Study|Withdrawal by Subject|3|||
146580915|NCT01831466|528632102|FG003|Overall Study|Withdrawal by Subject|3|||
146580916|NCT01831466|528632103|FG004|Overall Study|Withdrawal by Subject|3|||
146580917|NCT01831466|528632104|FG005|Overall Study|Withdrawal by Subject|5|||
146580918|NCT01831466|528632105|FG006|Overall Study|Withdrawal by Subject|0|||
146580919|NCT01831466|528632106|FG007|Overall Study|Withdrawal by Subject|0|||
146580920|NCT01831466|528632107|FG008|Overall Study|Withdrawal by Subject|0|||
146580921|NCT01831466|528632108|FG009|Overall Study|Withdrawal by Subject|1|||
146580922|NCT01831466|528632109|FG010|Overall Study|Withdrawal by Subject|0|||
146580923|NCT01831466|528632110|FG011|Overall Study|Withdrawal by Subject|1|||
146580924|NCT01831466|528632099|FG000|Overall Study|Lost to Follow-up|0|||
146580925|NCT01831466|528632100|FG001|Overall Study|Lost to Follow-up|1|||
146580926|NCT01831466|528632101|FG002|Overall Study|Lost to Follow-up|4|||
146580927|NCT01831466|528632102|FG003|Overall Study|Lost to Follow-up|2|||
146580928|NCT01831466|528632103|FG004|Overall Study|Lost to Follow-up|0|||
146580929|NCT01831466|528632104|FG005|Overall Study|Lost to Follow-up|3|||
146580930|NCT01831466|528632105|FG006|Overall Study|Lost to Follow-up|0|||
146580931|NCT01831466|528632106|FG007|Overall Study|Lost to Follow-up|0|||
146580932|NCT01831466|528632107|FG008|Overall Study|Lost to Follow-up|0|||
146580933|NCT01831466|528632108|FG009|Overall Study|Lost to Follow-up|1|||
146580934|NCT01831466|528632109|FG010|Overall Study|Lost to Follow-up|0|||
146580935|NCT01831466|528632110|FG011|Overall Study|Lost to Follow-up|1|||
146580936|NCT01831466|528632099|FG000|Overall Study|Lack of Efficacy|5|||
146580937|NCT01831466|528632100|FG001|Overall Study|Lack of Efficacy|8|||
146580938|NCT01831466|528632101|FG002|Overall Study|Lack of Efficacy|7|||
146580939|NCT01831466|528632102|FG003|Overall Study|Lack of Efficacy|6|||
146580940|NCT01831466|528632103|FG004|Overall Study|Lack of Efficacy|9|||
146580941|NCT01831466|528632104|FG005|Overall Study|Lack of Efficacy|8|||
146580942|NCT01831466|528632105|FG006|Overall Study|Lack of Efficacy|1|||
146580943|NCT01831466|528632106|FG007|Overall Study|Lack of Efficacy|1|||
146770782|NCT03475316|529328674|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
146580944|NCT01831466|528632107|FG008|Overall Study|Lack of Efficacy|2|||
146580945|NCT01831466|528632108|FG009|Overall Study|Lack of Efficacy|2|||
146580946|NCT01831466|528632109|FG010|Overall Study|Lack of Efficacy|2|||
146580947|NCT01831466|528632110|FG011|Overall Study|Lack of Efficacy|0|||
146580948|NCT01831466|528632099|FG000|Overall Study|Adverse Event|0|||
146580949|NCT01831466|528632100|FG001|Overall Study|Adverse Event|0|||
146580950|NCT01831466|528632101|FG002|Overall Study|Adverse Event|4|||
146580951|NCT01831466|528632102|FG003|Overall Study|Adverse Event|6|||
146580952|NCT01831466|528632103|FG004|Overall Study|Adverse Event|3|||
146580953|NCT01831466|528632104|FG005|Overall Study|Adverse Event|7|||
146580954|NCT01831466|528632105|FG006|Overall Study|Adverse Event|0|||
146580955|NCT01831466|528632106|FG007|Overall Study|Adverse Event|1|||
146580956|NCT01831466|528632107|FG008|Overall Study|Adverse Event|1|||
146580957|NCT01831466|528632108|FG009|Overall Study|Adverse Event|1|||
146580958|NCT01831466|528632109|FG010|Overall Study|Adverse Event|0|||
146580959|NCT01831466|528632110|FG011|Overall Study|Adverse Event|2|||
146580960|NCT02798315|528632111|FG000|Overall Study|Failure to return|1|||
146580961|NCT00005947|528632112|FG000|Overall Study|Death|54|||
146580962|NCT00005947|528632113|FG001|Overall Study|Death|40|||
146580963|NCT00005947|528632112|FG000|Overall Study|Patient Refused to Continue|2|||
146580964|NCT00005947|528632113|FG001|Overall Study|Patient Refused to Continue|1|||
146580965|NCT00005947|528632112|FG000|Overall Study|Site Closure|1|||
146580966|NCT00005947|528632113|FG001|Overall Study|Site Closure|0|||
146580967|NCT03335150|528632117|FG000|Overall Study|Withdrawal by Subject|10|||
146580968|NCT03335150|528632118|FG001|Overall Study|Withdrawal by Subject|4|||
146580969|NCT03335150|528632117|FG000|Overall Study|Adverse Event|0|||
146580970|NCT03335150|528632118|FG001|Overall Study|Adverse Event|1|||
146580971|NCT02218697|528632123|FG000|Overall Study|Adverse Event|0|||
146580972|NCT02218697|528632124|FG001|Overall Study|Adverse Event|2|||
146580973|NCT02218697|528632123|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
146580974|NCT02218697|528632124|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
146580975|NCT02218697|528632123|FG000|Overall Study|Withdrawal by Subject|2|||
146580976|NCT02218697|528632124|FG001|Overall Study|Withdrawal by Subject|3|||
146580977|NCT01059864|528632125|FG000|Open-Label Run-In Phase|Adverse Event|7|||
146580978|NCT01059864|528632126|FG001|Open-Label Run-In Phase|Adverse Event|0|||
146580979|NCT01059864|528632127|FG002|Open-Label Run-In Phase|Adverse Event|0|||
146580980|NCT01059864|528632125|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
146580981|NCT01059864|528632126|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
146580982|NCT01059864|528632127|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
146580983|NCT01059864|528632125|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
146580984|NCT01059864|528632126|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
146580985|NCT01059864|528632127|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
146580986|NCT01059864|528632125|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
146580987|NCT01059864|528632126|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
146580988|NCT01059864|528632127|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
146580989|NCT01059864|528632125|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
146580990|NCT01059864|528632126|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
146580991|NCT01059864|528632127|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
146580992|NCT01059864|528632125|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
146580993|NCT01059864|528632126|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
146580994|NCT01059864|528632127|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
146580995|NCT00451958|528632128|FG000|CS21A (NCT00451958)|Adverse Event|21|||
146580996|NCT00451958|528632129|FG001|CS21A (NCT00451958)|Adverse Event|34|||
146580997|NCT00451958|528632130|FG002|CS21A (NCT00451958)|Adverse Event|14|||
146580998|NCT00451958|528632131|FG003|CS21A (NCT00451958)|Adverse Event|17|||
146580999|NCT00451958|528632132|FG004|CS21A (NCT00451958)|Adverse Event|0|||
146581000|NCT00451958|528632128|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
146581001|NCT00451958|528632129|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
146581002|NCT00451958|528632130|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
146581003|NCT00451958|528632131|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
146581004|NCT00451958|528632132|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
146581005|NCT00451958|528632128|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
146581006|NCT00451958|528632129|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
146581007|NCT00451958|528632130|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
146581008|NCT00451958|528632131|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
146581009|NCT00451958|528632132|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
146581010|NCT00451958|528632128|FG000|CS21A (NCT00451958)|Physician Decision|2|||
146581011|NCT00451958|528632129|FG001|CS21A (NCT00451958)|Physician Decision|4|||
146581012|NCT00451958|528632130|FG002|CS21A (NCT00451958)|Physician Decision|4|||
146581013|NCT00451958|528632131|FG003|CS21A (NCT00451958)|Physician Decision|4|||
146652051|NCT03312751|528903754|FG000|Overall Study|Study discontinuation due to other reason|0|||
146652052|NCT03312751|528903755|FG001|Overall Study|Study discontinuation due to other reason|1|||
146652053|NCT00282464|528903756|FG000|Overall Study|Adverse Event|26|||
146581014|NCT00451958|528632132|FG004|CS21A (NCT00451958)|Physician Decision|0|||
146581015|NCT00451958|528632128|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
146581016|NCT00451958|528632129|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
146581017|NCT00451958|528632130|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
146581018|NCT00451958|528632131|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
146581019|NCT00451958|528632132|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
146581020|NCT00451958|528632128|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
146581021|NCT00451958|528632129|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
146581022|NCT00451958|528632130|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
146581023|NCT00451958|528632131|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
146581024|NCT00451958|528632132|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
146581025|NCT02175277|528632133|FG000|Overall Study|Protocol-specified Criteria|1|||
146581026|NCT02482428|528633629|FG000|Overall Study|Lost to Follow-up|4|||
146581027|NCT02482428|528633630|FG001|Overall Study|Lost to Follow-up|9|||
146581028|NCT02482428|528633631|FG002|Overall Study|Lost to Follow-up|1|||
146581029|NCT02482428|528633632|FG003|Overall Study|Lost to Follow-up|2|||
146581030|NCT02482428|528633633|FG004|Overall Study|Lost to Follow-up|4|||
146581031|NCT02482428|528633629|FG000|Overall Study|Physician Decision|0|||
146581032|NCT02482428|528633630|FG001|Overall Study|Physician Decision|0|||
146581033|NCT02482428|528633631|FG002|Overall Study|Physician Decision|0|||
146581034|NCT02482428|528633632|FG003|Overall Study|Physician Decision|0|||
146581035|NCT02482428|528633633|FG004|Overall Study|Physician Decision|1|||
146581036|NCT02482428|528633629|FG000|Overall Study|protocol deviation|1|||
146581037|NCT02482428|528633630|FG001|Overall Study|protocol deviation|1|||
146581038|NCT02482428|528633631|FG002|Overall Study|protocol deviation|0|||
146581039|NCT02482428|528633632|FG003|Overall Study|protocol deviation|0|||
146581040|NCT02482428|528633633|FG004|Overall Study|protocol deviation|0|||
146581041|NCT02482428|528633629|FG000|Overall Study|subject/guardian decision|4|||
146581042|NCT02482428|528633630|FG001|Overall Study|subject/guardian decision|2|||
146581043|NCT02482428|528633631|FG002|Overall Study|subject/guardian decision|0|||
146581044|NCT02482428|528633632|FG003|Overall Study|subject/guardian decision|0|||
146581045|NCT02482428|528633633|FG004|Overall Study|subject/guardian decision|2|||
146581046|NCT02547038|528633634|FG000|Overall Study|Lost to Follow-up|3|||
146581047|NCT02547038|528633635|FG001|Overall Study|Lost to Follow-up|2|||
146581048|NCT00516893|528633636|FG000|Overall Study|Lost to Follow-up|4|||
146581049|NCT00516893|528633636|FG000|Overall Study|Adverse Event|3|||
146581050|NCT00516893|528633636|FG000|Overall Study|Withdrawal by Subject|2|||
146581051|NCT00516893|528633636|FG000|Overall Study|Noncompliance|2|||
146581052|NCT00516893|528633636|FG000|Overall Study|Death|1|||
146581053|NCT00516893|528633636|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
146581054|NCT00516893|528633636|FG000|Overall Study|Relocated|1|||
146581055|NCT00516893|528633636|FG000|Overall Study|Pregnancy|1|||
146581056|NCT00516893|528633636|FG000|Overall Study|Received Medication From Another Study|1|||
146581057|NCT00301262|528633639|FG000|Double Blind Phase (DB)|Adverse Event|1|||
146581058|NCT00301262|528633640|FG001|Double Blind Phase (DB)|Adverse Event|0|||
146581059|NCT00301262|528633639|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
146581060|NCT00301262|528633640|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
146581061|NCT00301262|528633639|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
146581062|NCT00301262|528633640|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
146581063|NCT00301262|528633639|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
146581064|NCT00301262|528633640|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
146581065|NCT00301262|528633639|FG000|Double Blind Phase (DB)|Other|1|||
146581066|NCT00301262|528633640|FG001|Double Blind Phase (DB)|Other|4|||
146581067|NCT00301262|528633639|FG000|Open Label Phase (OL)|Adverse Event|1|||
146581068|NCT00301262|528633640|FG001|Open Label Phase (OL)|Adverse Event|0|||
146581069|NCT00301262|528633639|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
146581070|NCT00301262|528633640|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
146581071|NCT00301262|528633639|FG000|Open Label Phase (OL)|Other|2|||
146581072|NCT00301262|528633640|FG001|Open Label Phase (OL)|Other|0|||
146581073|NCT01443364|528633641|FG000|Overall Study|Lack of Efficacy|14|||
146581074|NCT01443364|528633641|FG000|Overall Study|Lost to Follow-up|3|||
146581075|NCT01443364|528633641|FG000|Overall Study|Withdrawal by Subject|5|||
146581076|NCT01443364|528633641|FG000|Overall Study|Other Reason|4|||
146581077|NCT01443364|528633641|FG000|Overall Study|SAE, non-fatal|6|||
146581078|NCT01443364|528633641|FG000|Overall Study|AE, non-serious non-fatal|8|||
146581079|NCT01443364|528633641|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
146581080|NCT00623233|528633642|FG000|Overall Study|Adverse Event|10|||
146581081|NCT00623233|528633642|FG000|Overall Study|Physician Decision|10|||
146581082|NCT00623233|528633642|FG000|Overall Study|Lost to Follow-up|1|||
146581083|NCT00623233|528633642|FG000|Overall Study|Withdrawal by Subject|3|||
146581084|NCT00559845|528633643|FG000|Overall Study|Withdrew Consent|1|||
146581085|NCT00559845|528633643|FG000|Overall Study|Disease Progression|1|||
146581086|NCT00559845|528633643|FG000|Overall Study|Adverse Event|3|||
146581087|NCT00559845|528633643|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
146581088|NCT00559845|528633643|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
146581089|NCT00459875|528633644|FG000|Overall Study|Ineligible participant|1|||
146581090|NCT00459875|528633644|FG000|Overall Study|Adverse Event|2|||
146581091|NCT02150057|528633645|FG000|Overall Study|Lost to Follow-up|6|||
146581092|NCT02150057|528633646|FG001|Overall Study|Lost to Follow-up|4|||
146581093|NCT01696994|528633647|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
146581094|NCT01696994|528633648|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
146581095|NCT01696994|528633647|FG000|Overall Study|Died Before Randomization|1|||
146581096|NCT01696994|528633648|FG001|Overall Study|Died Before Randomization|2|||
146581097|NCT01696994|528633647|FG000|Overall Study|Died Before ASU (Control)|73|||
146581098|NCT01696994|528633648|FG001|Overall Study|Died Before ASU (Control)|0|||
146581099|NCT01696994|528633647|FG000|Overall Study|No Ovaries at Baseline|4807|||
146581100|NCT01696994|528633648|FG001|Overall Study|No Ovaries at Baseline|4851|||
146581101|NCT01696994|528633647|FG000|Overall Study|Refused ASU (Control)|311|||
146581102|NCT01696994|528633648|FG001|Overall Study|Refused ASU (Control)|0|||
146581103|NCT01696994|528633647|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
146581104|NCT01696994|528633648|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
146581105|NCT00576628|528633651|FG000|Overall Study|Adverse Event|11|||
146581106|NCT00576628|528633651|FG000|Overall Study|Death|2|||
146581107|NCT00576628|528633651|FG000|Overall Study|Failure to return|1|||
146581108|NCT00576628|528633651|FG000|Overall Study|Refused Treatment|8|||
146581109|NCT00576628|528633651|FG000|Overall Study|Pregnancy|1|||
146581110|NCT00576628|528633651|FG000|Overall Study|RBC transfusion|1|||
146581111|NCT00576628|528633651|FG000|Overall Study|Progression of Kidney Disease|1|||
146581112|NCT00576628|528633651|FG000|Overall Study|Progression of Renal Failure|1|||
146581113|NCT00576628|528633651|FG000|Overall Study|The patient move into other town|1|||
146581114|NCT00576628|528633651|FG000|Overall Study|Transplantation|1|||
146581115|NCT00576628|528633651|FG000|Overall Study|Dialysis|15|||
146581116|NCT03645421|528633654|FG000|Overall Study|Adverse Event|0|||
146581117|NCT03645421|528633655|FG001|Overall Study|Adverse Event|0|||
146581118|NCT03645421|528633656|FG002|Overall Study|Adverse Event|4|||
146581119|NCT03645421|528633657|FG003|Overall Study|Adverse Event|1|||
146581120|NCT03645421|528633654|FG000|Overall Study|Withdrawal by patient|0|||
146581121|NCT03645421|528633655|FG001|Overall Study|Withdrawal by patient|0|||
146581122|NCT03645421|528633656|FG002|Overall Study|Withdrawal by patient|0|||
146581123|NCT03645421|528633657|FG003|Overall Study|Withdrawal by patient|3|||
146581124|NCT03645421|528633654|FG000|Overall Study|Study specific withdrawal criteria|0|||
146581125|NCT03645421|528633655|FG001|Overall Study|Study specific withdrawal criteria|0|||
146581126|NCT03645421|528633656|FG002|Overall Study|Study specific withdrawal criteria|1|||
146581127|NCT03645421|528633657|FG003|Overall Study|Study specific withdrawal criteria|0|||
146581128|NCT03636893|528633662|FG000|Overall Study|Death|0|||
146581129|NCT03636893|528633663|FG001|Overall Study|Death|1|||
146581130|NCT03636893|528633662|FG000|Overall Study|Protocol Violation|0|||
146581131|NCT03636893|528633663|FG001|Overall Study|Protocol Violation|3|||
146581132|NCT03636893|528633662|FG000|Overall Study|Withdrawal by Subject|1|||
146581133|NCT03636893|528633663|FG001|Overall Study|Withdrawal by Subject|2|||
146581134|NCT03636893|528633662|FG000|Overall Study|Refusal to surgery|4|||
146581135|NCT03636893|528633663|FG001|Overall Study|Refusal to surgery|3|||
146581136|NCT03636893|528633662|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
146581137|NCT03636893|528633663|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
146581138|NCT03636893|528633662|FG000|Overall Study|Adverse Event|1|||
146581139|NCT03636893|528633663|FG001|Overall Study|Adverse Event|1|||
146581140|NCT00224120|528633664|FG000|Overall Study|Adverse Event|10|||
146581141|NCT00224120|528633665|FG001|Overall Study|Adverse Event|4|||
146581142|NCT00224120|528633664|FG000|Overall Study|Protocol Violation|1|||
146581143|NCT00224120|528633665|FG001|Overall Study|Protocol Violation|0|||
146581144|NCT00224120|528633664|FG000|Overall Study|Withdrawal by Subject|5|||
146581145|NCT00224120|528633665|FG001|Overall Study|Withdrawal by Subject|10|||
146581146|NCT00224120|528633664|FG000|Overall Study|Lack of Efficacy|0|||
146581147|NCT00224120|528633665|FG001|Overall Study|Lack of Efficacy|2|||
146581148|NCT00224120|528633664|FG000|Overall Study|Lost to Follow-up|2|||
146581149|NCT00224120|528633665|FG001|Overall Study|Lost to Follow-up|3|||
146581150|NCT00224120|528633664|FG000|Overall Study|Other|4|||
146581151|NCT00224120|528633665|FG001|Overall Study|Other|5|||
146581152|NCT00104416|528633666|FG000|Double-Blind Phase|Adverse Event|2|||
146581153|NCT00104416|528633667|FG001|Double-Blind Phase|Adverse Event|1|||
146581154|NCT00104416|528633668|FG002|Double-Blind Phase|Adverse Event|0|||
146581155|NCT00104416|528633669|FG003|Double-Blind Phase|Adverse Event|0|||
146581156|NCT00104416|528633670|FG004|Double-Blind Phase|Adverse Event|0|||
146581157|NCT00104416|528633666|FG000|Double-Blind Phase|Lost to Follow-up|0|||
146581158|NCT00104416|528633667|FG001|Double-Blind Phase|Lost to Follow-up|1|||
146581159|NCT00104416|528633668|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146581160|NCT00104416|528633669|FG003|Double-Blind Phase|Lost to Follow-up|0|||
146581161|NCT00104416|528633670|FG004|Double-Blind Phase|Lost to Follow-up|0|||
146581162|NCT00104416|528633666|FG000|Double-Blind Phase|Protocol Violation|0|||
146581163|NCT00104416|528633667|FG001|Double-Blind Phase|Protocol Violation|1|||
146581164|NCT00104416|528633668|FG002|Double-Blind Phase|Protocol Violation|0|||
146581165|NCT00104416|528633669|FG003|Double-Blind Phase|Protocol Violation|0|||
146770783|NCT03475316|529328675|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
146581166|NCT00104416|528633670|FG004|Double-Blind Phase|Protocol Violation|0|||
146581167|NCT00104416|528633666|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
146581168|NCT00104416|528633667|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
146581169|NCT00104416|528633668|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
146581170|NCT00104416|528633669|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
146581171|NCT00104416|528633670|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
146581172|NCT00104416|528633666|FG000|Double-Blind Phase|Pregnancy|1|||
146581173|NCT00104416|528633667|FG001|Double-Blind Phase|Pregnancy|0|||
146581174|NCT00104416|528633668|FG002|Double-Blind Phase|Pregnancy|0|||
146581175|NCT00104416|528633669|FG003|Double-Blind Phase|Pregnancy|0|||
146581176|NCT00104416|528633670|FG004|Double-Blind Phase|Pregnancy|0|||
146581177|NCT00104416|528633666|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
146581178|NCT00104416|528633667|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
146581179|NCT00104416|528633668|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
146581180|NCT00104416|528633669|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
146581181|NCT00104416|528633670|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
146581182|NCT00104416|528633666|FG000|Continuation Phase|Adverse Event|0|||
146581183|NCT00104416|528633667|FG001|Continuation Phase|Adverse Event|0|||
146581184|NCT00104416|528633668|FG002|Continuation Phase|Adverse Event|2|||
146581185|NCT00104416|528633669|FG003|Continuation Phase|Adverse Event|0|||
146581186|NCT00104416|528633670|FG004|Continuation Phase|Adverse Event|2|||
146581187|NCT00104416|528633666|FG000|Continuation Phase|Lost to Follow-up|0|||
146581188|NCT00104416|528633667|FG001|Continuation Phase|Lost to Follow-up|0|||
146581189|NCT00104416|528633668|FG002|Continuation Phase|Lost to Follow-up|1|||
146581190|NCT00104416|528633669|FG003|Continuation Phase|Lost to Follow-up|0|||
146581191|NCT00104416|528633670|FG004|Continuation Phase|Lost to Follow-up|1|||
146581192|NCT00104416|528633666|FG000|Continuation Phase|Withdrawal by Subject|0|||
146581193|NCT00104416|528633667|FG001|Continuation Phase|Withdrawal by Subject|0|||
146581194|NCT00104416|528633668|FG002|Continuation Phase|Withdrawal by Subject|2|||
146581195|NCT00104416|528633669|FG003|Continuation Phase|Withdrawal by Subject|1|||
146581196|NCT00104416|528633670|FG004|Continuation Phase|Withdrawal by Subject|1|||
146581197|NCT00104416|528633666|FG000|Continuation Phase|Pregnancy|0|||
146581198|NCT00104416|528633667|FG001|Continuation Phase|Pregnancy|0|||
146581199|NCT00104416|528633668|FG002|Continuation Phase|Pregnancy|1|||
146581200|NCT00104416|528633669|FG003|Continuation Phase|Pregnancy|1|||
146581201|NCT00104416|528633670|FG004|Continuation Phase|Pregnancy|0|||
146581202|NCT00104416|528633666|FG000|Continuation Phase|Non-compliance|0|||
146581203|NCT00104416|528633667|FG001|Continuation Phase|Non-compliance|0|||
146581204|NCT00104416|528633668|FG002|Continuation Phase|Non-compliance|0|||
146581205|NCT00104416|528633669|FG003|Continuation Phase|Non-compliance|0|||
146581206|NCT00104416|528633670|FG004|Continuation Phase|Non-compliance|1|||
146581207|NCT00438360|528633671|FG000|Overall Study|Adverse Event|6|||
146581208|NCT00438360|528633672|FG001|Overall Study|Adverse Event|1|||
146581209|NCT00438360|528633671|FG000|Overall Study|Lack of Efficacy|42|||
146581210|NCT00438360|528633672|FG001|Overall Study|Lack of Efficacy|27|||
146581211|NCT00438360|528633671|FG000|Overall Study|Other|24|||
146581212|NCT00438360|528633672|FG001|Overall Study|Other|15|||
146581213|NCT04560816|528633674|FG000|Overall Study|Withdrawal by Subject|1|||
146581214|NCT04560816|528633675|FG001|Overall Study|Withdrawal by Subject|1|||
146581215|NCT04560816|528633676|FG002|Overall Study|Withdrawal by Subject|1|||
146581216|NCT04560816|528633677|FG003|Overall Study|Withdrawal by Subject|0|||
146581217|NCT04560816|528633678|FG004|Overall Study|Withdrawal by Subject|3|||
146581218|NCT04560816|528633679|FG005|Overall Study|Withdrawal by Subject|0|||
146581219|NCT04560816|528633674|FG000|Overall Study|Lost to Follow-up|1|||
146581220|NCT04560816|528633675|FG001|Overall Study|Lost to Follow-up|0|||
146581221|NCT04560816|528633676|FG002|Overall Study|Lost to Follow-up|0|||
146581222|NCT04560816|528633677|FG003|Overall Study|Lost to Follow-up|0|||
146581223|NCT04560816|528633678|FG004|Overall Study|Lost to Follow-up|0|||
146581224|NCT04560816|528633679|FG005|Overall Study|Lost to Follow-up|0|||
146581225|NCT04560816|528633674|FG000|Overall Study|Protocol Violation|1|||
146581226|NCT04560816|528633675|FG001|Overall Study|Protocol Violation|0|||
146581227|NCT04560816|528633676|FG002|Overall Study|Protocol Violation|0|||
146581228|NCT04560816|528633677|FG003|Overall Study|Protocol Violation|0|||
146581229|NCT04560816|528633678|FG004|Overall Study|Protocol Violation|0|||
146581230|NCT04560816|528633679|FG005|Overall Study|Protocol Violation|0|||
146581231|NCT01147250|528633682|FG000|Overall Study|Lost to Follow-up|14|||
146581232|NCT01147250|528633683|FG001|Overall Study|Lost to Follow-up|11|||
146581233|NCT01147250|528633682|FG000|Overall Study|Withdrawal by Subject|83|||
146581234|NCT01147250|528633683|FG001|Overall Study|Withdrawal by Subject|88|||
146581235|NCT01147250|528633682|FG000|Overall Study|Site termination by sponsor|13|||
146581236|NCT01147250|528633683|FG001|Overall Study|Site termination by sponsor|5|||
146581237|NCT01147250|528633682|FG000|Overall Study|Other than specified|0|||
146581238|NCT01147250|528633683|FG001|Overall Study|Other than specified|1|||
146581239|NCT02684617|528633684|FG000|Overall Study|Adverse Event|1|||
146581240|NCT02684617|528633685|FG001|Overall Study|Adverse Event|0|||
146581241|NCT02684617|528633686|FG002|Overall Study|Adverse Event|1|||
146581242|NCT02684617|528633684|FG000|Overall Study|Death|8|||
146581243|NCT02684617|528633685|FG001|Overall Study|Death|16|||
146978234|NCT01749033|530082281|FG001|Overall Study|Lost to Follow-up|2|||
146581244|NCT02684617|528633686|FG002|Overall Study|Death|28|||
146581245|NCT02684617|528633684|FG000|Overall Study|Withdrawal by Subject|2|||
146581246|NCT02684617|528633685|FG001|Overall Study|Withdrawal by Subject|0|||
146581247|NCT02684617|528633686|FG002|Overall Study|Withdrawal by Subject|4|||
146581248|NCT02684617|528633684|FG000|Overall Study|Screen Failure|1|||
146581249|NCT02684617|528633685|FG001|Overall Study|Screen Failure|0|||
146581250|NCT02684617|528633686|FG002|Overall Study|Screen Failure|2|||
146581251|NCT02684617|528633684|FG000|Overall Study|Study Terminated by Sponsor|6|||
146581252|NCT02684617|528633685|FG001|Overall Study|Study Terminated by Sponsor|1|||
146581253|NCT02684617|528633686|FG002|Overall Study|Study Terminated by Sponsor|5|||
146978235|NCT01749033|530082282|FG002|Overall Study|Lost to Follow-up|1|||
146581254|NCT01164891|528633690|FG000|Overall Study|Disease Progression|5|||
146581255|NCT01164891|528633690|FG000|Overall Study|Adverse Event|1|||
146581256|NCT00441142|528633691|FG000|Overall Study|Adverse Event|2|||
146581257|NCT00441142|528633692|FG001|Overall Study|Adverse Event|3|||
146581258|NCT00441142|528633693|FG002|Overall Study|Adverse Event|3|||
146581259|NCT00441142|528633694|FG003|Overall Study|Adverse Event|22|||
146581260|NCT00441142|528633691|FG000|Overall Study|Lack of Efficacy|3|||
146581261|NCT00441142|528633692|FG001|Overall Study|Lack of Efficacy|3|||
146581262|NCT00441142|528633693|FG002|Overall Study|Lack of Efficacy|17|||
146581263|NCT00441142|528633694|FG003|Overall Study|Lack of Efficacy|32|||
146581264|NCT00441142|528633691|FG000|Overall Study|Withdrawal by Subject|0|||
146581265|NCT00441142|528633692|FG001|Overall Study|Withdrawal by Subject|0|||
146581266|NCT00441142|528633693|FG002|Overall Study|Withdrawal by Subject|2|||
146581267|NCT00441142|528633694|FG003|Overall Study|Withdrawal by Subject|10|||
146581268|NCT00441142|528633691|FG000|Overall Study|Patient still receiving active study tx|1|||
146581269|NCT00441142|528633692|FG001|Overall Study|Patient still receiving active study tx|0|||
146581270|NCT00441142|528633693|FG002|Overall Study|Patient still receiving active study tx|0|||
146581271|NCT00441142|528633694|FG003|Overall Study|Patient still receiving active study tx|2|||
146581272|NCT00441142|528633691|FG000|Overall Study|Physician Decision|0|||
146581273|NCT00441142|528633692|FG001|Overall Study|Physician Decision|1|||
146581274|NCT00441142|528633693|FG002|Overall Study|Physician Decision|0|||
146581275|NCT00441142|528633694|FG003|Overall Study|Physician Decision|1|||
146581276|NCT00441142|528633691|FG000|Overall Study|Death|0|||
146581277|NCT00441142|528633692|FG001|Overall Study|Death|0|||
146581278|NCT00441142|528633693|FG002|Overall Study|Death|0|||
146581279|NCT00441142|528633694|FG003|Overall Study|Death|1|||
146581280|NCT03985943|528633695|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
146581281|NCT03985943|528633696|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
146581282|NCT03985943|528633697|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
146581283|NCT03985943|528633698|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
146581284|NCT03985943|528633699|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
146581285|NCT03985943|528633700|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
146581286|NCT03985943|528633695|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
146581287|NCT03985943|528633696|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
146581288|NCT03985943|528633697|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146581289|NCT03985943|528633698|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146581290|NCT03985943|528633699|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146581291|NCT03985943|528633700|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146581292|NCT03985943|528633695|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
146581293|NCT03985943|528633696|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
146581294|NCT03985943|528633697|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
146581295|NCT03985943|528633698|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
146581296|NCT03985943|528633699|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
146581297|NCT03985943|528633700|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
146581298|NCT03985943|528633695|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
146581299|NCT03985943|528633696|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
146581300|NCT03985943|528633697|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
146581301|NCT03985943|528633698|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
146581302|NCT03985943|528633699|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
146581303|NCT03985943|528633700|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
146581304|NCT03985943|528633695|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146581305|NCT03985943|528633696|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
146581306|NCT03985943|528633697|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146581307|NCT03985943|528633698|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146581308|NCT03985943|528633699|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146581309|NCT03985943|528633700|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146581310|NCT03985943|528633695|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
146581311|NCT03985943|528633696|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
146581312|NCT03985943|528633697|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
146581313|NCT03985943|528633698|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
146581314|NCT03985943|528633699|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
146581315|NCT03985943|528633700|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
146581316|NCT03985943|528633695|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
146581317|NCT03985943|528633696|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
146581318|NCT03985943|528633697|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
146581319|NCT03985943|528633698|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
146581320|NCT03985943|528633699|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
146652054|NCT00282464|528903757|FG001|Overall Study|Adverse Event|20|||
146581321|NCT03985943|528633700|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
146581322|NCT03985943|528633695|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
146581323|NCT03985943|528633696|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
146581324|NCT03985943|528633697|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
146581325|NCT03985943|528633698|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
146581326|NCT03985943|528633699|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
146581327|NCT03985943|528633700|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
146581328|NCT03985943|528633695|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
146581329|NCT03985943|528633696|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
146581330|NCT03985943|528633697|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
146581331|NCT03985943|528633698|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
146581332|NCT03985943|528633699|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
146581333|NCT03985943|528633700|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
146581334|NCT03985943|528633695|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
146581335|NCT03985943|528633696|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
146581336|NCT03985943|528633697|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
146581337|NCT03985943|528633698|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
146581338|NCT03985943|528633699|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
146581339|NCT03985943|528633700|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
146581340|NCT03985943|528633695|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
146581341|NCT03985943|528633696|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
146581342|NCT03985943|528633697|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
146581343|NCT03985943|528633698|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
146581344|NCT03985943|528633699|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
146581345|NCT03985943|528633700|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
146581346|NCT03985943|528633695|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146581347|NCT03985943|528633696|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146581348|NCT03985943|528633697|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146581349|NCT03985943|528633698|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
146581350|NCT03985943|528633699|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
146581351|NCT03985943|528633700|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
146581352|NCT03985943|528633695|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
146581353|NCT03985943|528633696|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
146581354|NCT03985943|528633697|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
146581355|NCT03985943|528633698|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
146581356|NCT03985943|528633699|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
146581357|NCT03985943|528633700|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
146581358|NCT03985943|528633695|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
146581359|NCT03985943|528633696|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
146581360|NCT03985943|528633697|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
146581361|NCT03985943|528633698|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
146581362|NCT03985943|528633699|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
146581363|NCT03985943|528633700|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
146581364|NCT03985943|528633695|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
146581365|NCT03985943|528633696|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
146581366|NCT03985943|528633697|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
146581367|NCT03985943|528633698|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
146581368|NCT03985943|528633699|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
146581369|NCT03985943|528633700|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
146581370|NCT00338286|528633701|FG000|Overall Study|Withdrawal by Subject|50|||
146581371|NCT00338286|528633702|FG001|Overall Study|Withdrawal by Subject|54|||
146581372|NCT00338286|528633701|FG000|Overall Study|Lost to Follow-up|80|||
146581373|NCT00338286|528633702|FG001|Overall Study|Lost to Follow-up|66|||
146581374|NCT00338286|528633701|FG000|Overall Study|Other|103|||
146581375|NCT00338286|528633702|FG001|Overall Study|Other|93|||
146581376|NCT01265563|528633703|FG000|Overall Study|Withdrawal by Subject|0|||
146581377|NCT01265563|528633704|FG001|Overall Study|Withdrawal by Subject|1|||
146581378|NCT01265563|528633705|FG002|Overall Study|Withdrawal by Subject|1|||
146581379|NCT01265563|528633706|FG003|Overall Study|Withdrawal by Subject|0|||
146581380|NCT01265563|528633707|FG004|Overall Study|Withdrawal by Subject|2|||
146581381|NCT03248531|528633708|FG000|Overall Study|Adverse Event|0|||
146581382|NCT03248531|528633709|FG001|Overall Study|Adverse Event|0|||
146581383|NCT03248531|528633710|FG002|Overall Study|Adverse Event|1|||
146581384|NCT03248531|528633708|FG000|Overall Study|Lost to Follow-up|1|||
146581385|NCT03248531|528633709|FG001|Overall Study|Lost to Follow-up|0|||
146581386|NCT03248531|528633710|FG002|Overall Study|Lost to Follow-up|5|||
146978236|NCT03056001|530082286|FG000|Overall Study|Death|24|||
146978237|NCT02295280|530082288|FG000|Overall Study|Adverse Event|0|||
146581387|NCT03248531|528633708|FG000|Overall Study|Withdrawal by Subject|3|||
146581388|NCT03248531|528633709|FG001|Overall Study|Withdrawal by Subject|3|||
146581389|NCT03248531|528633710|FG002|Overall Study|Withdrawal by Subject|2|||
146581390|NCT03248531|528633708|FG000|Overall Study|Sponsor Request|0|||
146581391|NCT03248531|528633709|FG001|Overall Study|Sponsor Request|2|||
146581392|NCT03248531|528633710|FG002|Overall Study|Sponsor Request|0|||
146581393|NCT04075513|528633713|FG000|Overall Study|Withdrawal by Subject|2|||
146581394|NCT04075513|528633714|FG001|Overall Study|Withdrawal by Subject|2|||
146581395|NCT04075513|528633713|FG000|Overall Study|Lack of Efficacy|1|||
146581396|NCT04075513|528633714|FG001|Overall Study|Lack of Efficacy|0|||
146581397|NCT04075513|528633713|FG000|Overall Study|Lost to Follow-up|4|||
146581398|NCT04075513|528633714|FG001|Overall Study|Lost to Follow-up|2|||
146581399|NCT04075513|528633713|FG000|Overall Study|Switch to insulin pump|1|||
146581400|NCT04075513|528633714|FG001|Overall Study|Switch to insulin pump|0|||
146581401|NCT05411822|528633716|FG000|Overall Study|Withdrawal by Subject|2|||
146581402|NCT05411822|528633717|FG001|Overall Study|Withdrawal by Subject|1|||
146581403|NCT05312697|528633718|FG000|Overall Study|Sponsor Terminated Trial|2|||
146581404|NCT04283656|528633719|FG000|Overall Study|Adverse Event|1|||
146581405|NCT04283656|528633720|FG001|Overall Study|Adverse Event|0|||
146581406|NCT04283656|528633719|FG000|Overall Study|Lost to Follow-up|0|||
146581407|NCT04283656|528633720|FG001|Overall Study|Lost to Follow-up|1|||
146581408|NCT00964002|528633723|FG000|Overall Study|Protocol Violation|8|||
146581409|NCT00976716|528633729|FG000|Overall Study|Adverse Event|1|||
146581410|NCT04222699|528633730|FG000|Overall Study|Lost to Follow-up|2|||
146581411|NCT03583359|528633736|FG000|Overall Study|Withdrawal by Subject|15|||
146581412|NCT03583359|528633737|FG001|Overall Study|Withdrawal by Subject|6|||
146581413|NCT03583359|528633736|FG000|Overall Study|Lost to Follow-up|12|||
146581414|NCT03583359|528633737|FG001|Overall Study|Lost to Follow-up|3|||
146581415|NCT03583359|528633736|FG000|Overall Study|Adverse Event|0|||
146581416|NCT03583359|528633737|FG001|Overall Study|Adverse Event|1|||
146581417|NCT03583359|528633736|FG000|Overall Study|Protocol Violation|0|||
146581418|NCT03583359|528633737|FG001|Overall Study|Protocol Violation|1|||
146581419|NCT03583359|528633736|FG000|Overall Study|Other|2|||
146581420|NCT03583359|528633737|FG001|Overall Study|Other|1|||
146581421|NCT00703846|528633743|FG000|Overall Study|Adverse Event|8|||
146581422|NCT00703846|528633743|FG000|Overall Study|Lost to Follow-up|55|||
146581423|NCT00703846|528633743|FG000|Overall Study|Lack of Efficacy|15|||
146581424|NCT00703846|528633743|FG000|Overall Study|Noncompliance with Study Treatment|2|||
146581425|NCT00703846|528633743|FG000|Overall Study|Withdrawal by Subject|40|||
146581426|NCT00703846|528633743|FG000|Overall Study|Death|1|||
146581427|NCT00703846|528633743|FG000|Overall Study|Other|14|||
146581428|NCT00703846|528633743|FG000|Overall Study|Did Not Receive Study Drug|2|||
146581429|NCT04601532|528633744|FG000|Overall Study|Lost to Follow-up|1|||
146581430|NCT04601532|528633745|FG001|Overall Study|Lost to Follow-up|2|||
146581431|NCT04601532|528633744|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
146581432|NCT04601532|528633745|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
146581433|NCT02566785|528633746|FG000|Overall Study|Lost to Follow-up|0|||
146581434|NCT02566785|528633747|FG001|Overall Study|Lost to Follow-up|2|||
146581435|NCT02566785|528633746|FG000|Overall Study|Worsening condition|1|||
146581436|NCT02566785|528633747|FG001|Overall Study|Worsening condition|1|||
146581437|NCT00837161|528633750|FG000|Overall Study|refused hysterectomy|2|||
146581438|NCT01659996|528633751|FG000|Overall Study|Protocol Violation|3|||
146581439|NCT01659996|528633752|FG001|Overall Study|Protocol Violation|3|||
146581440|NCT01659996|528633753|FG002|Overall Study|Protocol Violation|3|||
146581441|NCT01659996|528633751|FG000|Overall Study|Lost to Follow-up|1|||
146581442|NCT01659996|528633752|FG001|Overall Study|Lost to Follow-up|3|||
146581443|NCT01659996|528633753|FG002|Overall Study|Lost to Follow-up|2|||
146581444|NCT01659996|528633751|FG000|Overall Study|Adverse Event|0|||
146581445|NCT01659996|528633752|FG001|Overall Study|Adverse Event|0|||
146581446|NCT01659996|528633753|FG002|Overall Study|Adverse Event|1|||
146581447|NCT01659996|528633751|FG000|Overall Study|Withdrawal by Subject|4|||
146581448|NCT01659996|528633752|FG001|Overall Study|Withdrawal by Subject|1|||
146581449|NCT01659996|528633753|FG002|Overall Study|Withdrawal by Subject|5|||
146581450|NCT03206918|528633754|FG000|Overall Study|Death|11|||
146581451|NCT03206918|528633754|FG000|Overall Study|Withdrawal by Subject|5|||
146581452|NCT03206918|528633754|FG000|Overall Study|Study terminated by sponsor|12|||
146581453|NCT03206918|528633754|FG000|Overall Study|Lost to Follow-up|3|||
146581454|NCT03206918|528633754|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
146581455|NCT02701764|528633755|FG000|Overall Study|Lost to Follow-up|0|||
146581456|NCT02701764|528633756|FG001|Overall Study|Lost to Follow-up|1|||
146581457|NCT03823287|528633757|FG000|Overall Study|Withdrawal by Subject|25|||
146581458|NCT03823287|528633758|FG001|Overall Study|Withdrawal by Subject|17|||
146581459|NCT03823287|528633757|FG000|Overall Study|Death|13|||
146581460|NCT03823287|528633758|FG001|Overall Study|Death|7|||
146581461|NCT03823287|528633757|FG000|Overall Study|Lost to Follow-up|7|||
146581462|NCT03823287|528633758|FG001|Overall Study|Lost to Follow-up|8|||
146581463|NCT03823287|528633757|FG000|Overall Study|Adverse Event|6|||
146581464|NCT03823287|528633758|FG001|Overall Study|Adverse Event|8|||
146581465|NCT03823287|528633757|FG000|Overall Study|Physician Decision|5|||
146581466|NCT03823287|528633758|FG001|Overall Study|Physician Decision|2|||
146581467|NCT03823287|528633757|FG000|Overall Study|Lack of Efficacy|2|||
146581468|NCT03823287|528633758|FG001|Overall Study|Lack of Efficacy|0|||
146581469|NCT03823287|528633757|FG000|Overall Study|Other|2|||
146581470|NCT03823287|528633758|FG001|Overall Study|Other|4|||
146581471|NCT03110029|528633765|FG000|Overall Study|Withdrawal by Subject|1|||
146581472|NCT03110029|528633766|FG001|Overall Study|Withdrawal by Subject|1|||
146581473|NCT03281629|528633767|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
146581474|NCT03281629|528633768|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
146581475|NCT03281629|528633767|FG000|Overall Study|Death|0|||
146581476|NCT03281629|528633768|FG001|Overall Study|Death|1|||
146581477|NCT03281629|528633767|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
146581478|NCT03281629|528633768|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
146581479|NCT00782171|528635901|FG000|Overall Study|Lost to Follow-up|2|||
146581480|NCT00782171|528635902|FG001|Overall Study|Lost to Follow-up|2|||
146581481|NCT00782171|528635901|FG000|Overall Study|Withdrawal by Subject|2|||
146581482|NCT00782171|528635902|FG001|Overall Study|Withdrawal by Subject|1|||
146581483|NCT00782171|528635901|FG000|Overall Study|complications|3|||
146581484|NCT00782171|528635902|FG001|Overall Study|complications|1|||
146581485|NCT00782171|528635901|FG000|Overall Study|others|7|||
146581486|NCT00782171|528635902|FG001|Overall Study|others|9|||
146581487|NCT00782171|528635901|FG000|Overall Study|not eligible|8|||
146581488|NCT00782171|528635902|FG001|Overall Study|not eligible|6|||
146581489|NCT03522246|528635905|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
146581490|NCT03522246|528635906|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
146581491|NCT03522246|528635907|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
146581492|NCT03522246|528635908|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
146581493|NCT03522246|528635909|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
146581494|NCT00489424|528635912|FG000|Overall Study|Adverse Event|3|||
146581495|NCT00489424|528635913|FG001|Overall Study|Adverse Event|3|||
146581496|NCT00489424|528635914|FG002|Overall Study|Adverse Event|4|||
146581497|NCT00489424|528635912|FG000|Overall Study|Lack of Efficacy|1|||
146581498|NCT00489424|528635913|FG001|Overall Study|Lack of Efficacy|0|||
146581499|NCT00489424|528635914|FG002|Overall Study|Lack of Efficacy|0|||
146581500|NCT00489424|528635912|FG000|Overall Study|Administrative problems|0|||
146581501|NCT00489424|528635913|FG001|Overall Study|Administrative problems|2|||
146581502|NCT00489424|528635914|FG002|Overall Study|Administrative problems|1|||
146581503|NCT01558115|528635915|FG000|Overall Study|Withdrawal by Subject|3|||
146581504|NCT01558115|528635915|FG000|Overall Study|Study closed due to poor enrollment|4|||
146581505|NCT01436656|528635916|FG000|Dose Escalation|Death|1|||
146581506|NCT01436656|528635917|FG001|Dose Escalation|Death|3|||
146581507|NCT01436656|528635918|FG002|Dose Escalation|Death|1|||
146581508|NCT01436656|528635919|FG003|Dose Escalation|Death|0|||
146581509|NCT01436656|528635920|FG004|Dose Escalation|Death|2|||
146581510|NCT01436656|528635921|FG005|Dose Escalation|Death|1|||
146581511|NCT01436656|528635922|FG006|Dose Escalation|Death|1|||
146581512|NCT01436656|528635923|FG007|Dose Escalation|Death|1|||
146581513|NCT01436656|528635924|FG008|Dose Escalation|Death|1|||
146581514|NCT01436656|528635925|FG009|Dose Escalation|Death|0|||
146581515|NCT01436656|528635926|FG010|Dose Escalation|Death|0|||
146581516|NCT01436656|528635927|FG011|Dose Escalation|Death|0|||
146581517|NCT01436656|528635928|FG012|Dose Escalation|Death|0|||
146581518|NCT01436656|528635929|FG013|Dose Escalation|Death|0|||
146581519|NCT01436656|528635930|FG014|Dose Escalation|Death|0|||
146581520|NCT01436656|528635931|FG015|Dose Escalation|Death|0|||
146581521|NCT01436656|528635932|FG016|Dose Escalation|Death|0|||
146581522|NCT01436656|528635933|FG017|Dose Escalation|Death|0|||
146581523|NCT01436656|528635916|FG000|Dose Escalation|Protocol Violation|0|||
146581524|NCT01436656|528635917|FG001|Dose Escalation|Protocol Violation|0|||
146581525|NCT01436656|528635918|FG002|Dose Escalation|Protocol Violation|0|||
146581526|NCT01436656|528635919|FG003|Dose Escalation|Protocol Violation|0|||
146581527|NCT01436656|528635920|FG004|Dose Escalation|Protocol Violation|0|||
146581528|NCT01436656|528635921|FG005|Dose Escalation|Protocol Violation|1|||
146581529|NCT01436656|528635922|FG006|Dose Escalation|Protocol Violation|0|||
146581530|NCT01436656|528635923|FG007|Dose Escalation|Protocol Violation|0|||
146581531|NCT01436656|528635924|FG008|Dose Escalation|Protocol Violation|0|||
146581532|NCT01436656|528635925|FG009|Dose Escalation|Protocol Violation|0|||
146581533|NCT01436656|528635926|FG010|Dose Escalation|Protocol Violation|0|||
146581534|NCT01436656|528635927|FG011|Dose Escalation|Protocol Violation|0|||
146581535|NCT01436656|528635928|FG012|Dose Escalation|Protocol Violation|0|||
146581536|NCT01436656|528635929|FG013|Dose Escalation|Protocol Violation|0|||
146581537|NCT01436656|528635930|FG014|Dose Escalation|Protocol Violation|0|||
146581538|NCT01436656|528635931|FG015|Dose Escalation|Protocol Violation|0|||
146581539|NCT01436656|528635932|FG016|Dose Escalation|Protocol Violation|0|||
146581540|NCT01436656|528635933|FG017|Dose Escalation|Protocol Violation|0|||
146581541|NCT01436656|528635916|FG000|Dose Escalation|Withdrawal by Subject|0|||
146581542|NCT01436656|528635917|FG001|Dose Escalation|Withdrawal by Subject|0|||
146581543|NCT01436656|528635918|FG002|Dose Escalation|Withdrawal by Subject|0|||
146918604|NCT00630812|529864465|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
146581544|NCT01436656|528635919|FG003|Dose Escalation|Withdrawal by Subject|0|||
146581545|NCT01436656|528635920|FG004|Dose Escalation|Withdrawal by Subject|1|||
146581546|NCT01436656|528635921|FG005|Dose Escalation|Withdrawal by Subject|0|||
146581547|NCT01436656|528635922|FG006|Dose Escalation|Withdrawal by Subject|0|||
146581548|NCT01436656|528635923|FG007|Dose Escalation|Withdrawal by Subject|2|||
146581549|NCT01436656|528635924|FG008|Dose Escalation|Withdrawal by Subject|0|||
146581550|NCT01436656|528635925|FG009|Dose Escalation|Withdrawal by Subject|1|||
146581551|NCT01436656|528635926|FG010|Dose Escalation|Withdrawal by Subject|1|||
146581552|NCT01436656|528635927|FG011|Dose Escalation|Withdrawal by Subject|0|||
146581553|NCT01436656|528635928|FG012|Dose Escalation|Withdrawal by Subject|0|||
146581554|NCT01436656|528635929|FG013|Dose Escalation|Withdrawal by Subject|0|||
146581555|NCT01436656|528635930|FG014|Dose Escalation|Withdrawal by Subject|0|||
146581556|NCT01436656|528635931|FG015|Dose Escalation|Withdrawal by Subject|0|||
146581557|NCT01436656|528635932|FG016|Dose Escalation|Withdrawal by Subject|0|||
146581558|NCT01436656|528635933|FG017|Dose Escalation|Withdrawal by Subject|0|||
146581559|NCT01436656|528635916|FG000|Dose Escalation|Administrative problems|0|||
146581560|NCT01436656|528635917|FG001|Dose Escalation|Administrative problems|1|||
146581561|NCT01436656|528635918|FG002|Dose Escalation|Administrative problems|0|||
146581562|NCT01436656|528635919|FG003|Dose Escalation|Administrative problems|0|||
146581563|NCT01436656|528635920|FG004|Dose Escalation|Administrative problems|0|||
146581564|NCT01436656|528635921|FG005|Dose Escalation|Administrative problems|0|||
146581565|NCT01436656|528635922|FG006|Dose Escalation|Administrative problems|0|||
146581566|NCT01436656|528635923|FG007|Dose Escalation|Administrative problems|0|||
146581567|NCT01436656|528635924|FG008|Dose Escalation|Administrative problems|0|||
146581568|NCT01436656|528635925|FG009|Dose Escalation|Administrative problems|0|||
146581569|NCT01436656|528635926|FG010|Dose Escalation|Administrative problems|0|||
146581570|NCT01436656|528635927|FG011|Dose Escalation|Administrative problems|0|||
146581571|NCT01436656|528635928|FG012|Dose Escalation|Administrative problems|0|||
146581572|NCT01436656|528635929|FG013|Dose Escalation|Administrative problems|0|||
146581573|NCT01436656|528635930|FG014|Dose Escalation|Administrative problems|0|||
146581574|NCT01436656|528635931|FG015|Dose Escalation|Administrative problems|0|||
146581575|NCT01436656|528635932|FG016|Dose Escalation|Administrative problems|0|||
146581576|NCT01436656|528635933|FG017|Dose Escalation|Administrative problems|0|||
146581577|NCT01436656|528635916|FG000|Dose Escalation|Lost to Follow-up|1|||
146581578|NCT01436656|528635917|FG001|Dose Escalation|Lost to Follow-up|0|||
146581579|NCT01436656|528635918|FG002|Dose Escalation|Lost to Follow-up|0|||
146581580|NCT01436656|528635919|FG003|Dose Escalation|Lost to Follow-up|0|||
146581581|NCT01436656|528635920|FG004|Dose Escalation|Lost to Follow-up|1|||
146581582|NCT01436656|528635921|FG005|Dose Escalation|Lost to Follow-up|0|||
146581583|NCT01436656|528635922|FG006|Dose Escalation|Lost to Follow-up|0|||
146581584|NCT01436656|528635923|FG007|Dose Escalation|Lost to Follow-up|0|||
146581585|NCT01436656|528635924|FG008|Dose Escalation|Lost to Follow-up|0|||
146581586|NCT01436656|528635925|FG009|Dose Escalation|Lost to Follow-up|0|||
146581587|NCT01436656|528635926|FG010|Dose Escalation|Lost to Follow-up|0|||
146581588|NCT01436656|528635927|FG011|Dose Escalation|Lost to Follow-up|0|||
146581589|NCT01436656|528635928|FG012|Dose Escalation|Lost to Follow-up|0|||
146581590|NCT01436656|528635929|FG013|Dose Escalation|Lost to Follow-up|0|||
146581591|NCT01436656|528635930|FG014|Dose Escalation|Lost to Follow-up|0|||
146581592|NCT01436656|528635931|FG015|Dose Escalation|Lost to Follow-up|0|||
146581593|NCT01436656|528635932|FG016|Dose Escalation|Lost to Follow-up|0|||
146581594|NCT01436656|528635933|FG017|Dose Escalation|Lost to Follow-up|0|||
146581595|NCT01436656|528635916|FG000|Dose Escalation|New anti-cancer therapy|1|||
146581596|NCT01436656|528635917|FG001|Dose Escalation|New anti-cancer therapy|0|||
146581597|NCT01436656|528635918|FG002|Dose Escalation|New anti-cancer therapy|0|||
146581598|NCT01436656|528635919|FG003|Dose Escalation|New anti-cancer therapy|0|||
146581599|NCT01436656|528635920|FG004|Dose Escalation|New anti-cancer therapy|0|||
146581600|NCT01436656|528635921|FG005|Dose Escalation|New anti-cancer therapy|0|||
146581601|NCT01436656|528635922|FG006|Dose Escalation|New anti-cancer therapy|0|||
146581602|NCT01436656|528635923|FG007|Dose Escalation|New anti-cancer therapy|0|||
146581603|NCT01436656|528635924|FG008|Dose Escalation|New anti-cancer therapy|1|||
146581604|NCT01436656|528635925|FG009|Dose Escalation|New anti-cancer therapy|1|||
146581605|NCT01436656|528635926|FG010|Dose Escalation|New anti-cancer therapy|0|||
146581606|NCT01436656|528635927|FG011|Dose Escalation|New anti-cancer therapy|0|||
146581607|NCT01436656|528635928|FG012|Dose Escalation|New anti-cancer therapy|0|||
146581608|NCT01436656|528635929|FG013|Dose Escalation|New anti-cancer therapy|0|||
146581609|NCT01436656|528635930|FG014|Dose Escalation|New anti-cancer therapy|0|||
146581610|NCT01436656|528635931|FG015|Dose Escalation|New anti-cancer therapy|0|||
146581611|NCT01436656|528635932|FG016|Dose Escalation|New anti-cancer therapy|0|||
146581612|NCT01436656|528635933|FG017|Dose Escalation|New anti-cancer therapy|0|||
146581613|NCT01436656|528635916|FG000|Dose Expansion|Adverse Event|0|||
146581614|NCT01436656|528635917|FG001|Dose Expansion|Adverse Event|0|||
146581615|NCT01436656|528635918|FG002|Dose Expansion|Adverse Event|0|||
146581616|NCT01436656|528635919|FG003|Dose Expansion|Adverse Event|0|||
146581617|NCT01436656|528635920|FG004|Dose Expansion|Adverse Event|0|||
146581618|NCT01436656|528635921|FG005|Dose Expansion|Adverse Event|0|||
146581619|NCT01436656|528635922|FG006|Dose Expansion|Adverse Event|0|||
146581620|NCT01436656|528635923|FG007|Dose Expansion|Adverse Event|0|||
146581621|NCT01436656|528635924|FG008|Dose Expansion|Adverse Event|0|||
146581622|NCT01436656|528635925|FG009|Dose Expansion|Adverse Event|0|||
146581623|NCT01436656|528635926|FG010|Dose Expansion|Adverse Event|0|||
146581624|NCT01436656|528635927|FG011|Dose Expansion|Adverse Event|1|||
146581625|NCT01436656|528635928|FG012|Dose Expansion|Adverse Event|0|||
146581626|NCT01436656|528635929|FG013|Dose Expansion|Adverse Event|0|||
146581627|NCT01436656|528635930|FG014|Dose Expansion|Adverse Event|0|||
146581628|NCT01436656|528635931|FG015|Dose Expansion|Adverse Event|0|||
146581629|NCT01436656|528635932|FG016|Dose Expansion|Adverse Event|0|||
146581630|NCT01436656|528635933|FG017|Dose Expansion|Adverse Event|0|||
146581631|NCT01436656|528635916|FG000|Dose Expansion|Withdrawal by Subject|0|||
146581632|NCT01436656|528635917|FG001|Dose Expansion|Withdrawal by Subject|0|||
146581633|NCT01436656|528635918|FG002|Dose Expansion|Withdrawal by Subject|0|||
146581634|NCT01436656|528635919|FG003|Dose Expansion|Withdrawal by Subject|0|||
146581635|NCT01436656|528635920|FG004|Dose Expansion|Withdrawal by Subject|0|||
146581636|NCT01436656|528635921|FG005|Dose Expansion|Withdrawal by Subject|0|||
146581637|NCT01436656|528635922|FG006|Dose Expansion|Withdrawal by Subject|0|||
146581638|NCT01436656|528635923|FG007|Dose Expansion|Withdrawal by Subject|0|||
146581639|NCT01436656|528635924|FG008|Dose Expansion|Withdrawal by Subject|0|||
146581640|NCT01436656|528635925|FG009|Dose Expansion|Withdrawal by Subject|0|||
146581641|NCT01436656|528635926|FG010|Dose Expansion|Withdrawal by Subject|0|||
146581642|NCT01436656|528635927|FG011|Dose Expansion|Withdrawal by Subject|1|||
146581643|NCT01436656|528635928|FG012|Dose Expansion|Withdrawal by Subject|3|||
146581644|NCT01436656|528635929|FG013|Dose Expansion|Withdrawal by Subject|1|||
146581645|NCT01436656|528635930|FG014|Dose Expansion|Withdrawal by Subject|2|||
146581646|NCT01436656|528635931|FG015|Dose Expansion|Withdrawal by Subject|0|||
146581647|NCT01436656|528635932|FG016|Dose Expansion|Withdrawal by Subject|1|||
146581648|NCT01436656|528635933|FG017|Dose Expansion|Withdrawal by Subject|1|||
146581649|NCT01436656|528635916|FG000|Dose Expansion|Death|0|||
146581650|NCT01436656|528635917|FG001|Dose Expansion|Death|0|||
146581651|NCT01436656|528635918|FG002|Dose Expansion|Death|0|||
146581652|NCT01436656|528635919|FG003|Dose Expansion|Death|0|||
146581653|NCT01436656|528635920|FG004|Dose Expansion|Death|0|||
146581654|NCT01436656|528635921|FG005|Dose Expansion|Death|0|||
146581655|NCT01436656|528635922|FG006|Dose Expansion|Death|0|||
146581656|NCT01436656|528635923|FG007|Dose Expansion|Death|0|||
146581657|NCT01436656|528635924|FG008|Dose Expansion|Death|0|||
146581658|NCT01436656|528635925|FG009|Dose Expansion|Death|0|||
146581659|NCT01436656|528635926|FG010|Dose Expansion|Death|0|||
146581660|NCT01436656|528635927|FG011|Dose Expansion|Death|0|||
146581661|NCT01436656|528635928|FG012|Dose Expansion|Death|1|||
146581662|NCT01436656|528635929|FG013|Dose Expansion|Death|0|||
146581663|NCT01436656|528635930|FG014|Dose Expansion|Death|3|||
146581664|NCT01436656|528635931|FG015|Dose Expansion|Death|0|||
146581665|NCT01436656|528635932|FG016|Dose Expansion|Death|3|||
146581666|NCT01436656|528635933|FG017|Dose Expansion|Death|3|||
146581667|NCT01436656|528635916|FG000|Dose Expansion|Lost to Follow-up|0|||
146581668|NCT01436656|528635917|FG001|Dose Expansion|Lost to Follow-up|0|||
146581669|NCT01436656|528635918|FG002|Dose Expansion|Lost to Follow-up|0|||
146581670|NCT01436656|528635919|FG003|Dose Expansion|Lost to Follow-up|0|||
146581671|NCT01436656|528635920|FG004|Dose Expansion|Lost to Follow-up|0|||
146581672|NCT01436656|528635921|FG005|Dose Expansion|Lost to Follow-up|0|||
146581673|NCT01436656|528635922|FG006|Dose Expansion|Lost to Follow-up|0|||
146581674|NCT01436656|528635923|FG007|Dose Expansion|Lost to Follow-up|0|||
146581675|NCT01436656|528635924|FG008|Dose Expansion|Lost to Follow-up|0|||
146581676|NCT01436656|528635925|FG009|Dose Expansion|Lost to Follow-up|0|||
146581677|NCT01436656|528635926|FG010|Dose Expansion|Lost to Follow-up|0|||
146581678|NCT01436656|528635927|FG011|Dose Expansion|Lost to Follow-up|0|||
146581679|NCT01436656|528635928|FG012|Dose Expansion|Lost to Follow-up|0|||
146581680|NCT01436656|528635929|FG013|Dose Expansion|Lost to Follow-up|0|||
146581681|NCT01436656|528635930|FG014|Dose Expansion|Lost to Follow-up|0|||
146581682|NCT01436656|528635931|FG015|Dose Expansion|Lost to Follow-up|0|||
146581683|NCT01436656|528635932|FG016|Dose Expansion|Lost to Follow-up|0|||
146581684|NCT01436656|528635933|FG017|Dose Expansion|Lost to Follow-up|3|||
146581685|NCT01436656|528635916|FG000|Dose Expansion|Disease progression|0|||
146581686|NCT01436656|528635917|FG001|Dose Expansion|Disease progression|0|||
146581687|NCT01436656|528635918|FG002|Dose Expansion|Disease progression|0|||
146581688|NCT01436656|528635919|FG003|Dose Expansion|Disease progression|0|||
146581689|NCT01436656|528635920|FG004|Dose Expansion|Disease progression|0|||
146581690|NCT01436656|528635921|FG005|Dose Expansion|Disease progression|0|||
146581691|NCT01436656|528635922|FG006|Dose Expansion|Disease progression|0|||
146581692|NCT01436656|528635923|FG007|Dose Expansion|Disease progression|0|||
146581693|NCT01436656|528635924|FG008|Dose Expansion|Disease progression|0|||
146581694|NCT01436656|528635925|FG009|Dose Expansion|Disease progression|0|||
146918605|NCT00630812|529864464|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
146581695|NCT01436656|528635926|FG010|Dose Expansion|Disease progression|0|||
146581696|NCT01436656|528635927|FG011|Dose Expansion|Disease progression|3|||
146581697|NCT01436656|528635928|FG012|Dose Expansion|Disease progression|1|||
146581698|NCT01436656|528635929|FG013|Dose Expansion|Disease progression|0|||
146581699|NCT01436656|528635930|FG014|Dose Expansion|Disease progression|1|||
146581700|NCT01436656|528635931|FG015|Dose Expansion|Disease progression|0|||
146581701|NCT01436656|528635932|FG016|Dose Expansion|Disease progression|0|||
146581702|NCT01436656|528635933|FG017|Dose Expansion|Disease progression|1|||
146581703|NCT01436656|528635916|FG000|Dose Expansion|New cancer therapy|0|||
146581704|NCT01436656|528635917|FG001|Dose Expansion|New cancer therapy|0|||
146581705|NCT01436656|528635918|FG002|Dose Expansion|New cancer therapy|0|||
146581706|NCT01436656|528635919|FG003|Dose Expansion|New cancer therapy|0|||
146581707|NCT01436656|528635920|FG004|Dose Expansion|New cancer therapy|0|||
146581708|NCT01436656|528635921|FG005|Dose Expansion|New cancer therapy|0|||
146581709|NCT01436656|528635922|FG006|Dose Expansion|New cancer therapy|0|||
146581710|NCT01436656|528635923|FG007|Dose Expansion|New cancer therapy|0|||
146581711|NCT01436656|528635924|FG008|Dose Expansion|New cancer therapy|0|||
146581712|NCT01436656|528635925|FG009|Dose Expansion|New cancer therapy|0|||
146581713|NCT01436656|528635926|FG010|Dose Expansion|New cancer therapy|0|||
146581714|NCT01436656|528635927|FG011|Dose Expansion|New cancer therapy|1|||
146581715|NCT01436656|528635928|FG012|Dose Expansion|New cancer therapy|1|||
146581716|NCT01436656|528635929|FG013|Dose Expansion|New cancer therapy|0|||
146581717|NCT01436656|528635930|FG014|Dose Expansion|New cancer therapy|2|||
146581718|NCT01436656|528635931|FG015|Dose Expansion|New cancer therapy|0|||
146581719|NCT01436656|528635932|FG016|Dose Expansion|New cancer therapy|0|||
146581720|NCT01436656|528635933|FG017|Dose Expansion|New cancer therapy|0|||
146581721|NCT00880269|528635934|FG000|Overall Study|Protocol Violation|1|||
146581722|NCT00880269|528635935|FG001|Overall Study|Protocol Violation|0|||
146581723|NCT00880269|528635934|FG000|Overall Study|Disease Progression|13|||
146581724|NCT00880269|528635935|FG001|Overall Study|Disease Progression|11|||
146581725|NCT00880269|528635934|FG000|Overall Study|New Cancer Therapy|1|||
146581726|NCT00880269|528635935|FG001|Overall Study|New Cancer Therapy|0|||
146581727|NCT00880269|528635934|FG000|Overall Study|Death|4|||
146581728|NCT00880269|528635935|FG001|Overall Study|Death|2|||
146581729|NCT00880269|528635934|FG000|Overall Study|Lost to Follow-up|0|||
146581730|NCT00880269|528635935|FG001|Overall Study|Lost to Follow-up|1|||
146581731|NCT00880269|528635934|FG000|Overall Study|Withdrawal by Subject|3|||
146581732|NCT00880269|528635935|FG001|Overall Study|Withdrawal by Subject|4|||
146581733|NCT00880269|528635934|FG000|Overall Study|Adverse Event|10|||
146581734|NCT00880269|528635935|FG001|Overall Study|Adverse Event|9|||
146581735|NCT02516982|528635939|FG000|Overall Study|Called in to antenatal appointment|32|||
146581736|NCT02516982|528635940|FG001|Overall Study|Called in to antenatal appointment|35|||
146581737|NCT02516982|528635941|FG002|Overall Study|Called in to antenatal appointment|0|||
146581738|NCT02516982|528635942|FG003|Overall Study|Called in to antenatal appointment|0|||
146581739|NCT02516982|528635939|FG000|Overall Study|Withdrawal by Subject|0|||
146581740|NCT02516982|528635940|FG001|Overall Study|Withdrawal by Subject|0|||
146581741|NCT02516982|528635941|FG002|Overall Study|Withdrawal by Subject|1|||
146581742|NCT02516982|528635942|FG003|Overall Study|Withdrawal by Subject|2|||
146581743|NCT02516982|528635939|FG000|Overall Study|Protocol Violation|0|||
146581744|NCT02516982|528635940|FG001|Overall Study|Protocol Violation|0|||
146581745|NCT02516982|528635941|FG002|Overall Study|Protocol Violation|1|||
146581746|NCT02516982|528635942|FG003|Overall Study|Protocol Violation|1|||
146581747|NCT02516982|528635939|FG000|Overall Study|Did not install the app|0|||
146581748|NCT02516982|528635940|FG001|Overall Study|Did not install the app|0|||
146581749|NCT02516982|528635941|FG002|Overall Study|Did not install the app|46|||
146581750|NCT02516982|528635942|FG003|Overall Study|Did not install the app|47|||
146581751|NCT01951586|528635947|FG000|Overall Study|Death|61|||
146581752|NCT01951586|528635948|FG001|Overall Study|Death|120|||
146581753|NCT01951586|528635947|FG000|Overall Study|Withdrawal by Subject|8|||
146581754|NCT01951586|528635948|FG001|Overall Study|Withdrawal by Subject|17|||
146581755|NCT01951586|528635947|FG000|Overall Study|Lost to Follow-up|0|||
146581756|NCT01951586|528635948|FG001|Overall Study|Lost to Follow-up|1|||
146581757|NCT01951586|528635947|FG000|Overall Study|Sponsor Decision|9|||
146581758|NCT01951586|528635948|FG001|Overall Study|Sponsor Decision|10|||
146581759|NCT00962741|528635949|FG000|Overall Study|Failed to return|3|||
146581760|NCT00962741|528635949|FG000|Overall Study|Lost to Follow-up|2|||
146581761|NCT00962741|528635949|FG000|Overall Study|Withdrawal by Subject|1|||
146581762|NCT00962741|528635949|FG000|Overall Study|Lack of Efficacy|1|||
146581763|NCT00962741|528635949|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
146581764|NCT02120781|528635950|FG000|Overall Study|Physician Decision|2|||
146581765|NCT02120781|528635951|FG001|Overall Study|Physician Decision|0|||
146581766|NCT02120781|528635950|FG000|Overall Study|Completion not documented|2|||
146581767|NCT02120781|528635951|FG001|Overall Study|Completion not documented|1|||
146581768|NCT00654745|528635956|FG000|Overall Study|Adverse Event|12|||
146581769|NCT00654745|528635956|FG000|Overall Study|Lost to Follow-up|7|||
146581770|NCT00654745|528635956|FG000|Overall Study|Protocol Violation|11|||
146581771|NCT00654745|528635956|FG000|Overall Study|Withdrawal by Subject|10|||
146581772|NCT00654745|528635956|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
146581773|NCT00748618|528635957|FG000|Overall Study|Adverse Event|1|||
146581774|NCT00748618|528635958|FG001|Overall Study|Adverse Event|0|||
146581775|NCT00466947|528635959|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
146581776|NCT00466947|528635960|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
146581777|NCT00466947|528635959|FG000|Study End Analysis Period|Adverse Event|35|||
146581778|NCT00466947|528635960|FG001|Study End Analysis Period|Adverse Event|43|||
146581779|NCT00466947|528635959|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
146581780|NCT00466947|528635960|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
146581781|NCT00466947|528635959|FG000|Study End Analysis Period|Physician Decision|29|||
146581782|NCT00466947|528635960|FG001|Study End Analysis Period|Physician Decision|29|||
146581783|NCT00466947|528635959|FG000|Study End Analysis Period|Protocol Violation|9|||
146581784|NCT00466947|528635960|FG001|Study End Analysis Period|Protocol Violation|17|||
146581785|NCT00466947|528635959|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
146581786|NCT00466947|528635960|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
146581787|NCT00466947|528635959|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
146581788|NCT00466947|528635960|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
146581789|NCT00466947|528635959|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
146581790|NCT00466947|528635960|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
146581791|NCT00466947|528635959|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
146581792|NCT00466947|528635960|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
146581793|NCT01995526|528635961|FG000|Overall Study|Physician Decision|1|||
146581794|NCT01977729|528635965|FG000|Overall Study|Study terminated|1|||
146581795|NCT03286543|528635966|FG000|Consented|Screen failure before randomization|2|||
146581796|NCT03286543|528635967|FG001|Consented|Screen failure before randomization|0|||
146581797|NCT03286543|528635968|FG002|Consented|Screen failure before randomization|0|||
146581798|NCT03286543|528635966|FG000|Consented|Screen failure before enrollment|4|||
146581799|NCT03286543|528635967|FG001|Consented|Screen failure before enrollment|0|||
146581800|NCT03286543|528635968|FG002|Consented|Screen failure before enrollment|0|||
146581801|NCT03286543|528635966|FG000|Consented|TKA cancelled after enrollment|1|||
146581802|NCT03286543|528635967|FG001|Consented|TKA cancelled after enrollment|0|||
146581803|NCT03286543|528635968|FG002|Consented|TKA cancelled after enrollment|0|||
146581804|NCT03286543|528635966|FG000|Consented|Withdrawn from study|12|||
146581805|NCT03286543|528635967|FG001|Consented|Withdrawn from study|0|||
146581806|NCT03286543|528635968|FG002|Consented|Withdrawn from study|0|||
146581807|NCT03286543|528635966|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
146581808|NCT03286543|528635967|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
146581809|NCT03286543|528635968|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
146581810|NCT03286543|528635966|FG000|Study Enrollment|Withdrawn from study|0|||
146581811|NCT03286543|528635967|FG001|Study Enrollment|Withdrawn from study|6|||
146581812|NCT03286543|528635968|FG002|Study Enrollment|Withdrawn from study|6|||
146581813|NCT00758069|528635969|FG000|Overall Study|Lack of Efficacy|0|||
146581814|NCT00758069|528635970|FG001|Overall Study|Lack of Efficacy|0|||
146581815|NCT00758069|528635971|FG002|Overall Study|Lack of Efficacy|1|||
146581816|NCT00758069|528635969|FG000|Overall Study|Incorrect Study Drug|1|||
146581817|NCT00758069|528635970|FG001|Overall Study|Incorrect Study Drug|0|||
146581818|NCT00758069|528635971|FG002|Overall Study|Incorrect Study Drug|0|||
146581819|NCT02277691|528635972|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
146581820|NCT02277691|528635972|FG000|Overall Study|Voluntary Withdrawal|7|||
146581821|NCT02277691|528635972|FG000|Overall Study|Lack of Efficacy|5|||
146581822|NCT02277691|528635972|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
146581823|NCT04952597|528635973|FG000|Overall Study|Death|12|||
146581824|NCT04952597|528635974|FG001|Overall Study|Death|13|||
146581825|NCT04952597|528635975|FG002|Overall Study|Death|14|||
146581826|NCT04952597|528635973|FG000|Overall Study|Withdrawal by Subject|1|||
146581827|NCT04952597|528635974|FG001|Overall Study|Withdrawal by Subject|0|||
146581828|NCT04952597|528635975|FG002|Overall Study|Withdrawal by Subject|3|||
146581829|NCT04952597|528635973|FG000|Overall Study|Lost to Follow-up|0|||
146581830|NCT04952597|528635974|FG001|Overall Study|Lost to Follow-up|1|||
146581831|NCT04952597|528635975|FG002|Overall Study|Lost to Follow-up|1|||
146581832|NCT00022763|528635983|FG000|Overall Study|Adverse Event|1|||
146581833|NCT00022763|528635984|FG001|Overall Study|Adverse Event|2|||
146581834|NCT00022763|528635983|FG000|Overall Study|Injection Site Reactions|0|||
146581835|NCT00022763|528635984|FG001|Overall Study|Injection Site Reactions|2|||
146581836|NCT00022763|528635983|FG000|Overall Study|Death|0|||
146581837|NCT00022763|528635984|FG001|Overall Study|Death|1|||
146581838|NCT00022763|528635983|FG000|Overall Study|Lost to Follow-up|0|||
146581839|NCT00022763|528635984|FG001|Overall Study|Lost to Follow-up|3|||
146581840|NCT00022763|528635983|FG000|Overall Study|Withdrawal by Subject|4|||
146581841|NCT00022763|528635984|FG001|Overall Study|Withdrawal by Subject|7|||
146581842|NCT00022763|528635983|FG000|Overall Study|Insufficient Therapy|1|||
146581843|NCT00022763|528635984|FG001|Overall Study|Insufficient Therapy|0|||
146581844|NCT00022763|528635983|FG000|Overall Study|Admin|3|||
146581845|NCT00022763|528635984|FG001|Overall Study|Admin|2|||
146652055|NCT00282464|528903756|FG000|Overall Study|Lack of Efficacy|8|||
146581846|NCT04908865|528635985|FG000|Overall Study|Adverse Event|2|||
146581847|NCT04908865|528635985|FG000|Overall Study|Lack of Efficacy|5|||
146581848|NCT04908865|528635985|FG000|Overall Study|Lost to Follow-up|1|||
146652056|NCT00282464|528903757|FG001|Overall Study|Lack of Efficacy|8|||
146581849|NCT02141399|528635986|FG000|Overall Study|Adverse Event|158|||
146581850|NCT02141399|528635986|FG000|Overall Study|Lack of Efficacy|62|||
146581851|NCT02141399|528635986|FG000|Overall Study|Lost to Follow-up|151|||
146581852|NCT02141399|528635986|FG000|Overall Study|Non-compliance with study drug|18|||
146581853|NCT02141399|528635986|FG000|Overall Study|Other|45|||
146581854|NCT02141399|528635986|FG000|Overall Study|Physician Decision|17|||
146581855|NCT02141399|528635986|FG000|Overall Study|Pregnancy|3|||
146581856|NCT02141399|528635986|FG000|Overall Study|Protocol Violation|38|||
146581857|NCT02141399|528635986|FG000|Overall Study|Withdrawal by Subject|238|||
146581858|NCT02141399|528635986|FG000|Overall Study|Failure to meet eligibility criteria|14|||
146581859|NCT04445519|528635987|FG000|Overall Study|Due to adaptive design|3|||
146581860|NCT04445519|528635988|FG001|Overall Study|Due to adaptive design|0|||
146581861|NCT04445519|528635989|FG002|Overall Study|Due to adaptive design|0|||
146581862|NCT04445519|528635987|FG000|Overall Study|Lost to Follow-up|0|||
146581863|NCT04445519|528635988|FG001|Overall Study|Lost to Follow-up|1|||
146581864|NCT04445519|528635989|FG002|Overall Study|Lost to Follow-up|4|||
146581865|NCT04445519|528635987|FG000|Overall Study|Sponsor or IRB Decision|0|||
146581866|NCT04445519|528635988|FG001|Overall Study|Sponsor or IRB Decision|1|||
146581867|NCT04445519|528635989|FG002|Overall Study|Sponsor or IRB Decision|2|||
146581868|NCT04445519|528635987|FG000|Overall Study|Withdrawal by Subject|0|||
146581869|NCT04445519|528635988|FG001|Overall Study|Withdrawal by Subject|3|||
146581870|NCT04445519|528635989|FG002|Overall Study|Withdrawal by Subject|3|||
146581871|NCT04445519|528635987|FG000|Overall Study|Adverse Event|0|||
146770784|NCT03475316|529328674|FG000|9 Months|Study stopped due to COVID pandemic|3|||
146770785|NCT03475316|529328675|FG001|9 Months|Study stopped due to COVID pandemic|4|||
146770786|NCT00424645|529328676|FG000|Overall Study|Death|1|||
146770787|NCT00424645|529328677|FG001|Overall Study|Death|0|||
146770788|NCT01179334|529328678|FG000|Treatment Period|Adverse Event|1|||
146770789|NCT01179334|529328679|FG001|Treatment Period|Adverse Event|0|||
146770790|NCT01179334|529328678|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
146770791|NCT01179334|529328679|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
146770792|NCT01179334|529328678|FG000|Long-term Extension (LTE) Period|Death|3|||
146770793|NCT01179334|529328679|FG001|Long-term Extension (LTE) Period|Death|0|||
146770794|NCT01179334|529328678|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
146770795|NCT01179334|529328679|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
146770796|NCT04177394|529328680|FG000|Overall Study|Death|16|||
146770797|NCT04177394|529328680|FG000|Overall Study|Withdrawal by Subject|19|||
146770798|NCT04177394|529328680|FG000|Overall Study|Missed visits|61|||
146770799|NCT04177394|529328680|FG000|Overall Study|Expected Visits|15|||
146770800|NCT00258895|529328681|FG000|Overall Study|Lost to Follow-up|3|||
146770801|NCT00258895|529328682|FG001|Overall Study|Lost to Follow-up|1|||
146770802|NCT00258895|529328681|FG000|Overall Study|Protocol Violation|6|||
146770803|NCT00258895|529328682|FG001|Overall Study|Protocol Violation|2|||
146770804|NCT00258895|529328681|FG000|Overall Study|Withdrawal by Subject|1|||
146770805|NCT00258895|529328682|FG001|Overall Study|Withdrawal by Subject|0|||
146770806|NCT00547118|529328685|FG000|Overall Study|Did not qualify prior to starting drug|1|||
146770807|NCT00547118|529328686|FG001|Overall Study|Did not qualify prior to starting drug|1|||
146770808|NCT00547118|529328685|FG000|Overall Study|Study suspended|7|||
146770809|NCT00547118|529328686|FG001|Overall Study|Study suspended|8|||
146770810|NCT01595321|529328687|FG000|Overall Study|Adverse Event|1|||
146581872|NCT04445519|528635988|FG001|Overall Study|Adverse Event|8|||
146581873|NCT04445519|528635989|FG002|Overall Study|Adverse Event|6|||
146581874|NCT04445519|528635987|FG000|Overall Study|Other Reason|0|||
146581875|NCT04445519|528635988|FG001|Overall Study|Other Reason|1|||
146581876|NCT04445519|528635989|FG002|Overall Study|Other Reason|1|||
146581877|NCT04445519|528635987|FG000|Overall Study|Protocol Violation|0|||
146581878|NCT04445519|528635988|FG001|Overall Study|Protocol Violation|0|||
146581879|NCT04445519|528635989|FG002|Overall Study|Protocol Violation|1|||
146581880|NCT01345929|528635990|FG000|Overall Study|Withdrawal by Subject|9|||
146581881|NCT01345929|528635991|FG001|Overall Study|Withdrawal by Subject|8|||
146581882|NCT01345929|528635990|FG000|Overall Study|Lost to Follow-up|9|||
146770811|NCT01595321|529328688|FG001|Overall Study|Adverse Event|1|||
146770812|NCT01595321|529328689|FG002|Overall Study|Adverse Event|1|||
146770813|NCT01595321|529328687|FG000|Overall Study|Lack of Efficacy|0|||
146770814|NCT01595321|529328688|FG001|Overall Study|Lack of Efficacy|0|||
146770815|NCT01595321|529328689|FG002|Overall Study|Lack of Efficacy|4|||
146770816|NCT00834834|529328690|FG000|Overall Study|Withdrawal by Subject|4|||
146581883|NCT01345929|528635991|FG001|Overall Study|Lost to Follow-up|9|||
146581884|NCT01345929|528635990|FG000|Overall Study|Adverse Event|0|||
146770817|NCT00834834|529328691|FG001|Overall Study|Withdrawal by Subject|3|||
146770818|NCT00373529|529328692|FG000|Overall Study|Physician Decision|19|||
146770819|NCT00373529|529328692|FG000|Overall Study|Withdrawal by Subject|7|||
146770820|NCT00373529|529328692|FG000|Overall Study|Adverse Event|7|||
146770821|NCT00373529|529328692|FG000|Overall Study|Treatment failure|36|||
146770822|NCT00373529|529328692|FG000|Overall Study|Disease recurrence|10|||
146770823|NCT00373529|529328692|FG000|Overall Study|Death|16|||
146978238|NCT02295280|530082289|FG001|Overall Study|Adverse Event|1|||
146581885|NCT01345929|528635991|FG001|Overall Study|Adverse Event|1|||
146581886|NCT01345929|528635990|FG000|Overall Study|Didn't meet eligibility criteria|2|||
146581887|NCT01345929|528635991|FG001|Overall Study|Didn't meet eligibility criteria|0|||
146581888|NCT01345929|528635990|FG000|Overall Study|40,000 CFU/ML|1|||
146581889|NCT01345929|528635991|FG001|Overall Study|40,000 CFU/ML|0|||
146581890|NCT01345929|528635990|FG000|Overall Study|Patient withdrawal|0|||
146581891|NCT01345929|528635991|FG001|Overall Study|Patient withdrawal|1|||
146581892|NCT02819297|528635996|FG000|Overall Study|Withdrawal by Subject|25|||
146581893|NCT02819297|528635997|FG001|Overall Study|Withdrawal by Subject|13|||
146581894|NCT02819297|528635996|FG000|Overall Study|Lost to Follow-up|12|||
146581895|NCT02819297|528635997|FG001|Overall Study|Lost to Follow-up|14|||
146581896|NCT02819297|528635996|FG000|Overall Study|Adverse Event|12|||
146581897|NCT02819297|528635997|FG001|Overall Study|Adverse Event|10|||
146581898|NCT02819297|528635996|FG000|Overall Study|Physician Decision|5|||
146581899|NCT02819297|528635997|FG001|Overall Study|Physician Decision|5|||
146581900|NCT02819297|528635996|FG000|Overall Study|Lack of Efficacy|5|||
146581901|NCT02819297|528635997|FG001|Overall Study|Lack of Efficacy|8|||
146581902|NCT02819297|528635996|FG000|Overall Study|Protocol Violation|1|||
146581903|NCT02819297|528635997|FG001|Overall Study|Protocol Violation|2|||
146581904|NCT02858440|528635998|FG000|Overall Study|Lost to Follow-up|3|||
146581905|NCT02858440|528635998|FG000|Overall Study|Protocol Violation|2|||
146581906|NCT02858440|528635998|FG000|Overall Study|Consent withdrawal|3|||
146581907|NCT02858440|528635998|FG000|Overall Study|Migrated/moved from study area|4|||
146581908|NCT01670279|528635999|FG000|Overall Study|Adverse Event|0|||
146581909|NCT01670279|528636000|FG001|Overall Study|Adverse Event|1|||
146581910|NCT01670279|528636001|FG002|Overall Study|Adverse Event|0|||
146581911|NCT01670279|528636002|FG003|Overall Study|Adverse Event|0|||
146581912|NCT01670279|528635999|FG000|Overall Study|Physician Decision|0|||
146581913|NCT01670279|528636000|FG001|Overall Study|Physician Decision|1|||
146581914|NCT01670279|528636001|FG002|Overall Study|Physician Decision|0|||
146581915|NCT01670279|528636002|FG003|Overall Study|Physician Decision|0|||
146581916|NCT01670279|528635999|FG000|Overall Study|Participant met withdrawal criteria|0|||
146581917|NCT01670279|528636000|FG001|Overall Study|Participant met withdrawal criteria|0|||
146581918|NCT01670279|528636001|FG002|Overall Study|Participant met withdrawal criteria|0|||
146581919|NCT01670279|528636002|FG003|Overall Study|Participant met withdrawal criteria|1|||
146581920|NCT01534351|528636005|FG000|Overall Study|Study Terminated Early|1|||
146581921|NCT01534351|528636006|FG001|Overall Study|Study Terminated Early|0|||
146581922|NCT01534351|528636007|FG002|Overall Study|Study Terminated Early|0|||
146581923|NCT02702609|528636008|FG000|Overall Study|Lost to Follow-up|8|||
146581924|NCT02702609|528636009|FG001|Overall Study|Lost to Follow-up|4|||
146581925|NCT02702609|528636008|FG000|Overall Study|Physician Decision|1|||
146581926|NCT02702609|528636009|FG001|Overall Study|Physician Decision|0|||
146581927|NCT00935493|528636010|FG000|Overall Study|Lost to Follow-up|1|||
146581928|NCT00935493|528636011|FG001|Overall Study|Lost to Follow-up|1|||
146581929|NCT00935493|528636012|FG002|Overall Study|Lost to Follow-up|1|||
146581930|NCT00935493|528636010|FG000|Overall Study|Treatment Discontinued|0|||
146581931|NCT00935493|528636011|FG001|Overall Study|Treatment Discontinued|1|||
146581932|NCT00935493|528636012|FG002|Overall Study|Treatment Discontinued|0|||
146581933|NCT04153981|528636013|FG000|Overall Study|Death|1|||
146581934|NCT04153981|528636013|FG000|Overall Study|Withdrawal by Subject|24|||
146581935|NCT04153981|528636013|FG000|Overall Study|Lost to Follow-up|1|||
146581936|NCT04153981|528636013|FG000|Overall Study|Physician Decision|1|||
146581937|NCT04153981|528636013|FG000|Overall Study|Due to Unavailable Glucometer|1|||
146581938|NCT04153981|528636013|FG000|Overall Study|Covid 19|52|||
146581939|NCT04153981|528636013|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
146581940|NCT04153981|528636013|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
146581941|NCT02027311|528636016|FG000|Overall Study|Protocol Violation|3|||
146581942|NCT02027311|528636017|FG001|Overall Study|Protocol Violation|2|||
146581943|NCT03928418|528636018|FG000|Overall Study|Lost to Follow-up|5|||
146581944|NCT03928418|528636019|FG001|Overall Study|Lost to Follow-up|3|||
146581945|NCT03928418|528636020|FG002|Overall Study|Lost to Follow-up|5|||
146581946|NCT03928418|528636018|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
146581947|NCT03928418|528636019|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
146581948|NCT03928418|528636020|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
146581949|NCT02091362|528636030|FG000|Period 1|Protocol Violation|1|||
146581950|NCT02091362|528636031|FG001|Period 1|Protocol Violation|0|||
146581951|NCT02091362|528636030|FG000|Period 1|Withdrawal by Subject|2|||
146581952|NCT02091362|528636031|FG001|Period 1|Withdrawal by Subject|3|||
146581953|NCT02091362|528636030|FG000|Period 1|Lost to Follow-up|0|||
146652057|NCT00282464|528903756|FG000|Overall Study|Lost to Follow-up|10|||
146652058|NCT00282464|528903757|FG001|Overall Study|Lost to Follow-up|10|||
146581954|NCT02091362|528636031|FG001|Period 1|Lost to Follow-up|1|||
146581955|NCT02091362|528636030|FG000|Period 1|Adverse Event|2|||
146581956|NCT02091362|528636031|FG001|Period 1|Adverse Event|0|||
146581957|NCT02091362|528636030|FG000|Wash-out|Lost to Follow-up|1|||
146581958|NCT02091362|528636031|FG001|Wash-out|Lost to Follow-up|1|||
146581959|NCT02091362|528636030|FG000|Wash-out|Withdrawal by Subject|0|||
146581960|NCT02091362|528636031|FG001|Wash-out|Withdrawal by Subject|2|||
146581961|NCT02091362|528636030|FG000|Period 2|Adverse Event|1|||
146581962|NCT02091362|528636031|FG001|Period 2|Adverse Event|0|||
146581963|NCT02091362|528636030|FG000|Period 2|Lost to Follow-up|0|||
146581964|NCT02091362|528636031|FG001|Period 2|Lost to Follow-up|1|||
146581965|NCT02091362|528636030|FG000|Period 2|Withdrawal by Subject|1|||
146581966|NCT02091362|528636031|FG001|Period 2|Withdrawal by Subject|1|||
146581967|NCT00690430|528636032|FG000|Core Phase|Abnormal Laboratory value|0|||
146581968|NCT00690430|528636033|FG001|Core Phase|Abnormal Laboratory value|1|||
146581969|NCT00690430|528636034|FG002|Core Phase|Abnormal Laboratory value|0|||
146581970|NCT00690430|528636032|FG000|Core Phase|Adverse Event|5|||
146581971|NCT00690430|528636033|FG001|Core Phase|Adverse Event|1|||
146581972|NCT00690430|528636034|FG002|Core Phase|Adverse Event|0|||
146581973|NCT00690430|528636032|FG000|Core Phase|Death|0|||
146581974|NCT00690430|528636033|FG001|Core Phase|Death|2|||
146581975|NCT00690430|528636034|FG002|Core Phase|Death|0|||
146918606|NCT00630812|529864465|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
146918607|NCT00630812|529864464|FG000|Randomisation to First Dose|Protocol Violation|4|||
146918608|NCT00630812|529864465|FG001|Randomisation to First Dose|Protocol Violation|1|||
146918609|NCT00630812|529864464|FG000|Double Blind Treatment Period|Adverse Event|13|||
146918610|NCT00630812|529864465|FG001|Double Blind Treatment Period|Adverse Event|5|||
146581976|NCT00690430|528636032|FG000|Core Phase|Protocol Violation|1|||
146581977|NCT00690430|528636033|FG001|Core Phase|Protocol Violation|0|||
146581978|NCT00690430|528636034|FG002|Core Phase|Protocol Violation|0|||
146581979|NCT00690430|528636032|FG000|Core Phase|Withdrawal by Subject|3|||
146581980|NCT00690430|528636033|FG001|Core Phase|Withdrawal by Subject|3|||
146581981|NCT00690430|528636034|FG002|Core Phase|Withdrawal by Subject|0|||
146581982|NCT00690430|528636032|FG000|Core Phase|Subject no longer requires study drug|1|||
146581983|NCT00690430|528636033|FG001|Core Phase|Subject no longer requires study drug|0|||
146581984|NCT00690430|528636034|FG002|Core Phase|Subject no longer requires study drug|0|||
146581985|NCT00690430|528636032|FG000|Core Phase|Lack of Efficacy|8|||
146581986|NCT00690430|528636033|FG001|Core Phase|Lack of Efficacy|10|||
146581987|NCT00690430|528636034|FG002|Core Phase|Lack of Efficacy|0|||
146581988|NCT00690430|528636032|FG000|Core Phase|Administrative Problems|0|||
146581989|NCT00690430|528636033|FG001|Core Phase|Administrative Problems|1|||
146581990|NCT00690430|528636034|FG002|Core Phase|Administrative Problems|0|||
146581991|NCT00690430|528636032|FG000|Core Phase|Early Termination|0|||
146581992|NCT00690430|528636033|FG001|Core Phase|Early Termination|5|||
146581993|NCT00690430|528636034|FG002|Core Phase|Early Termination|0|||
146581994|NCT00690430|528636032|FG000|Extension Phase|Lack of Efficacy|3|||
146581995|NCT00690430|528636033|FG001|Extension Phase|Lack of Efficacy|1|||
146581996|NCT00690430|528636034|FG002|Extension Phase|Lack of Efficacy|4|||
146581997|NCT00690430|528636032|FG000|Extension Phase|Abnormal Lab Values|1|||
146581998|NCT00690430|528636033|FG001|Extension Phase|Abnormal Lab Values|0|||
146581999|NCT00690430|528636034|FG002|Extension Phase|Abnormal Lab Values|0|||
146582000|NCT00690430|528636032|FG000|Extension Phase|Abnormal test procedure results|1|||
146582001|NCT00690430|528636033|FG001|Extension Phase|Abnormal test procedure results|0|||
146582002|NCT00690430|528636034|FG002|Extension Phase|Abnormal test procedure results|0|||
146582003|NCT00690430|528636032|FG000|Extension Phase|Administrative Problems|0|||
146582004|NCT00690430|528636033|FG001|Extension Phase|Administrative Problems|1|||
146582005|NCT00690430|528636034|FG002|Extension Phase|Administrative Problems|1|||
146582006|NCT00690430|528636032|FG000|Extension Phase|Adverse Event|2|||
146582007|NCT00690430|528636033|FG001|Extension Phase|Adverse Event|1|||
146582008|NCT00690430|528636034|FG002|Extension Phase|Adverse Event|2|||
146582009|NCT00690430|528636032|FG000|Extension Phase|Death|1|||
146582010|NCT00690430|528636033|FG001|Extension Phase|Death|1|||
146582011|NCT00690430|528636034|FG002|Extension Phase|Death|1|||
146582012|NCT00690430|528636032|FG000|Extension Phase|Withdrawal by Subject|0|||
146582013|NCT00690430|528636033|FG001|Extension Phase|Withdrawal by Subject|0|||
146582014|NCT00690430|528636034|FG002|Extension Phase|Withdrawal by Subject|2|||
146582015|NCT00690430|528636032|FG000|Extension Phase|Early Termination|10|||
146582016|NCT00690430|528636033|FG001|Extension Phase|Early Termination|1|||
146582017|NCT00690430|528636034|FG002|Extension Phase|Early Termination|3|||
146582018|NCT02125838|528636037|FG000|Overall Study|Lost to Follow-up|4|||
146582019|NCT02125838|528636038|FG001|Overall Study|Lost to Follow-up|4|||
146918611|NCT00630812|529864464|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
146582020|NCT02565147|528636039|FG000|Overall Study|Withdrawal by Subject|5|||
146582021|NCT02565147|528636040|FG001|Overall Study|Withdrawal by Subject|1|||
146582022|NCT02565147|528636039|FG000|Overall Study|Lost to Follow-up|0|||
146582023|NCT02565147|528636040|FG001|Overall Study|Lost to Follow-up|1|||
146582024|NCT02565147|528636039|FG000|Overall Study|Death|1|||
146582025|NCT02565147|528636040|FG001|Overall Study|Death|1|||
146582026|NCT00787839|528636041|FG000|Overall Study|Failure to have the OGTT was most common|404|||
146582027|NCT00286091|528636048|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
146582028|NCT00286091|528636049|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
146582029|NCT00286091|528636048|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
146582030|NCT00286091|528636049|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
146582031|NCT00286091|528636048|FG000|Double-blind Treatment Phase|Death|58|||
146770824|NCT00373529|529328692|FG000|Overall Study|Need for treatment prohibited by study|1|||
146770825|NCT00373529|529328692|FG000|Overall Study|Other|8|||
146582032|NCT00286091|528636049|FG001|Double-blind Treatment Phase|Death|65|||
146582033|NCT00286091|528636048|FG000|Double-blind Treatment Phase|Adverse Event|28|||
146582034|NCT00286091|528636049|FG001|Double-blind Treatment Phase|Adverse Event|40|||
146582035|NCT00286091|528636048|FG000|Double-blind Treatment Phase|Disease Progression|22|||
146582036|NCT00286091|528636049|FG001|Double-blind Treatment Phase|Disease Progression|35|||
146582037|NCT00286091|528636048|FG000|Double-blind Treatment Phase|Other|25|||
146582038|NCT00286091|528636049|FG001|Double-blind Treatment Phase|Other|33|||
146582039|NCT00286091|528636048|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
146582040|NCT00286091|528636049|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
146582041|NCT00286091|528636048|FG000|Double-blind Treatment Phase|Noncompliance|8|||
146582042|NCT00286091|528636049|FG001|Double-blind Treatment Phase|Noncompliance|8|||
146582043|NCT00286091|528636048|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
146582044|NCT00286091|528636049|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
146582045|NCT00286091|528636048|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
146582046|NCT00286091|528636049|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
146582047|NCT00286091|528636048|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
146582048|NCT00286091|528636049|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
146582049|NCT00286091|528636048|FG000|Open-label Treatment Phase|Physician Decision|24|||
146582050|NCT00286091|528636049|FG001|Open-label Treatment Phase|Physician Decision|21|||
146582051|NCT00286091|528636048|FG000|Open-label Treatment Phase|Adverse Event|5|||
146582052|NCT00286091|528636049|FG001|Open-label Treatment Phase|Adverse Event|16|||
146582053|NCT00286091|528636048|FG000|Open-label Treatment Phase|Other|11|||
146582054|NCT00286091|528636049|FG001|Open-label Treatment Phase|Other|11|||
146582055|NCT00286091|528636048|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
146582056|NCT00286091|528636049|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
146918612|NCT00630812|529864465|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
146918613|NCT00630812|529864464|FG000|Double Blind Treatment Period|Physician Decision|2|||
146918614|NCT00630812|529864465|FG001|Double Blind Treatment Period|Physician Decision|1|||
146582057|NCT00286091|528636048|FG000|Open-label Treatment Phase|Death|10|||
146582058|NCT00286091|528636049|FG001|Open-label Treatment Phase|Death|7|||
146582059|NCT00286091|528636048|FG000|Open-label Treatment Phase|Disease Progression|9|||
146582060|NCT00286091|528636049|FG001|Open-label Treatment Phase|Disease Progression|3|||
146582061|NCT00286091|528636048|FG000|Open-label Treatment Phase|Noncompliance|3|||
146582062|NCT00286091|528636049|FG001|Open-label Treatment Phase|Noncompliance|1|||
146582063|NCT00286091|528636048|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
146582064|NCT00286091|528636049|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
146582065|NCT00286091|528636048|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
146582066|NCT00286091|528636049|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
146582067|NCT00286091|528636048|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
146582068|NCT00286091|528636049|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
146582069|NCT02936869|528636052|FG000|Overall Study|Lost to Follow-up|1|||
146582070|NCT02936869|528636053|FG001|Overall Study|Lost to Follow-up|3|||
146582071|NCT02936869|528636052|FG000|Overall Study|Death|0|||
146582072|NCT02936869|528636053|FG001|Overall Study|Death|1|||
146582073|NCT02936869|528636052|FG000|Overall Study|Legal Case|0|||
146582074|NCT02936869|528636053|FG001|Overall Study|Legal Case|1|||
146582075|NCT02936869|528636052|FG000|Overall Study|Protocol Violation|1|||
146582076|NCT02936869|528636053|FG001|Overall Study|Protocol Violation|0|||
146582077|NCT00335738|528636054|FG000|Overall Study|Physician Decision|6|||
146582078|NCT00335738|528636055|FG001|Overall Study|Physician Decision|0|||
146582079|NCT00335738|528636054|FG000|Overall Study|Withdrawal by Subject|2|||
146582080|NCT00335738|528636055|FG001|Overall Study|Withdrawal by Subject|0|||
146582081|NCT00335738|528636054|FG000|Overall Study|Ineligible|3|||
146582082|NCT00335738|528636055|FG001|Overall Study|Ineligible|4|||
146582083|NCT00506454|528636062|FG000|Overall Study|Withdrawal by Subject|1|||
146582084|NCT00506454|528636063|FG001|Overall Study|Withdrawal by Subject|1|||
146582085|NCT00902850|528636065|FG000|Overall Study|Physician Decision|2|||
146582086|NCT00902850|528636066|FG001|Overall Study|Physician Decision|2|||
146582087|NCT00260832|528636067|FG000|Overall Study|Adverse Event|26|||
146582088|NCT00260832|528636068|FG001|Overall Study|Adverse Event|19|||
146582089|NCT00260832|528636067|FG000|Overall Study|Progression|116|||
146582090|NCT00260832|528636068|FG001|Overall Study|Progression|96|||
146582091|NCT00260832|528636067|FG000|Overall Study|Withdrawal by Subject|15|||
146582092|NCT00260832|528636068|FG001|Overall Study|Withdrawal by Subject|17|||
146582093|NCT00260832|528636067|FG000|Overall Study|Physician Decision|15|||
146582094|NCT00260832|528636068|FG001|Overall Study|Physician Decision|9|||
146582095|NCT00260832|528636067|FG000|Overall Study|Death|43|||
146582096|NCT00260832|528636068|FG001|Overall Study|Death|62|||
146582097|NCT00260832|528636067|FG000|Overall Study|Other|10|||
146582098|NCT00260832|528636068|FG001|Overall Study|Other|7|||
146582099|NCT00260832|528636067|FG000|Overall Study|Protocol Violation|3|||
146918615|NCT00630812|529864464|FG000|Double Blind Treatment Period|Protocol Violation|1|||
146582100|NCT00260832|528636068|FG001|Overall Study|Protocol Violation|1|||
146582101|NCT03745638|528636069|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
146582102|NCT03745638|528636070|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
146582103|NCT03745638|528636071|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
146582104|NCT03745638|528636072|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146582105|NCT03745638|528636073|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146582106|NCT03745638|528636074|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146582107|NCT03745638|528636075|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146582108|NCT03745638|528636069|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
146582109|NCT03745638|528636070|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146582110|NCT03745638|528636071|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146582111|NCT03745638|528636072|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146582112|NCT03745638|528636073|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146582113|NCT03745638|528636074|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146582114|NCT03745638|528636075|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146582115|NCT03745638|528636069|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
146582116|NCT03745638|528636070|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
146582117|NCT03745638|528636071|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
146582118|NCT03745638|528636072|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146582119|NCT03745638|528636073|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146582120|NCT03745638|528636074|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146582121|NCT03745638|528636075|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146582122|NCT03745638|528636069|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
146582123|NCT03745638|528636070|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
146582124|NCT03745638|528636071|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146582125|NCT03745638|528636072|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146582126|NCT03745638|528636073|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146582127|NCT03745638|528636074|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146582128|NCT03745638|528636075|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146582129|NCT03745638|528636069|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
146582130|NCT03745638|528636070|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
146582131|NCT03745638|528636071|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
146582132|NCT03745638|528636072|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
146582133|NCT03745638|528636073|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
146582134|NCT03745638|528636074|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
146582135|NCT03745638|528636075|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
146582136|NCT03745638|528636069|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146582137|NCT03745638|528636070|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
146582138|NCT03745638|528636071|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146582139|NCT03745638|528636072|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146582140|NCT03745638|528636073|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146582141|NCT03745638|528636074|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146582142|NCT03745638|528636075|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146582143|NCT03745638|528636069|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
146582144|NCT03745638|528636070|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
146582145|NCT03745638|528636071|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
146582146|NCT03745638|528636072|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146582147|NCT03745638|528636073|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146582148|NCT03745638|528636074|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146582149|NCT03745638|528636075|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146582150|NCT03745638|528636069|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
146582151|NCT03745638|528636070|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
146582152|NCT03745638|528636071|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
146582153|NCT03745638|528636072|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
146582154|NCT03745638|528636073|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
146582155|NCT03745638|528636074|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
146582156|NCT03745638|528636075|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
146582157|NCT03745638|528636069|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146582158|NCT03745638|528636070|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146582159|NCT03745638|528636071|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146582160|NCT03745638|528636072|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146582161|NCT03745638|528636073|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146582162|NCT03745638|528636074|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
146582163|NCT03745638|528636075|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
146582164|NCT03745638|528636069|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146582165|NCT03745638|528636070|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146582166|NCT03745638|528636071|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146582167|NCT03745638|528636072|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
146582168|NCT03745638|528636073|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146582169|NCT03745638|528636074|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
146582170|NCT03745638|528636075|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
146582171|NCT03745638|528636069|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146582172|NCT03745638|528636070|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146582173|NCT03745638|528636071|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146582174|NCT03745638|528636072|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
146582175|NCT03745638|528636073|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
146582176|NCT03745638|528636074|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
146582177|NCT03745638|528636075|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
146582178|NCT03745638|528636069|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146582179|NCT03745638|528636070|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146582180|NCT03745638|528636071|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146582181|NCT03745638|528636072|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146582182|NCT03745638|528636073|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
146582183|NCT03745638|528636074|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
146582184|NCT03745638|528636075|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146582185|NCT03745638|528636069|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146582186|NCT03745638|528636070|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146582187|NCT03745638|528636071|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146582188|NCT03745638|528636072|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146582189|NCT03745638|528636073|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146582190|NCT03745638|528636074|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
146582191|NCT03745638|528636075|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146582192|NCT03745638|528636069|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146582193|NCT03745638|528636070|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146582194|NCT03745638|528636071|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146582195|NCT03745638|528636072|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
146582196|NCT03745638|528636073|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
146582197|NCT03745638|528636074|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
146582198|NCT03745638|528636075|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
146582199|NCT03745638|528636069|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
146582200|NCT03745638|528636070|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
146582201|NCT03745638|528636071|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
146582202|NCT03745638|528636072|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
146582203|NCT03745638|528636073|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
146582204|NCT03745638|528636074|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
146582205|NCT03745638|528636075|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
146582206|NCT03098433|528636076|FG000|Overall Study|Withdrawal by Subject|10|||
146582207|NCT03604172|528636078|FG000|Overall Study|Lost to Follow-up|1|||
146582208|NCT03604172|528636079|FG001|Overall Study|Lost to Follow-up|2|||
146582209|NCT02676895|528636080|FG000|Overall Study|Administrative reason|1|||
146582210|NCT02676895|528636081|FG001|Overall Study|Administrative reason|0|||
146582211|NCT02676895|528636082|FG002|Overall Study|Administrative reason|0|||
146582212|NCT02676895|528636080|FG000|Overall Study|Protocol Violation|1|||
146582213|NCT02676895|528636081|FG001|Overall Study|Protocol Violation|0|||
146582214|NCT02676895|528636082|FG002|Overall Study|Protocol Violation|0|||
146582215|NCT02676895|528636080|FG000|Overall Study|Adverse Event|0|||
146582216|NCT02676895|528636081|FG001|Overall Study|Adverse Event|3|||
146582217|NCT02676895|528636082|FG002|Overall Study|Adverse Event|1|||
146582218|NCT02676895|528636080|FG000|Overall Study|Lost to Follow-up|0|||
146582219|NCT02676895|528636081|FG001|Overall Study|Lost to Follow-up|0|||
146582220|NCT02676895|528636082|FG002|Overall Study|Lost to Follow-up|1|||
146582221|NCT02676895|528636080|FG000|Overall Study|Withdrawal by Subject|0|||
146582222|NCT02676895|528636081|FG001|Overall Study|Withdrawal by Subject|0|||
146582223|NCT02676895|528636082|FG002|Overall Study|Withdrawal by Subject|1|||
146582224|NCT00182078|528636086|FG000|Overall Study|Withdrawal by Subject|1|||
146582225|NCT00182078|528636087|FG001|Overall Study|Withdrawal by Subject|0|||
146582226|NCT00395486|528636088|FG000|Overall Study|Adverse Event|1|||
146582227|NCT00395486|528636089|FG001|Overall Study|Adverse Event|2|||
146582228|NCT00395486|528636088|FG000|Overall Study|Withdrawal by Subject|5|||
146582229|NCT00395486|528636089|FG001|Overall Study|Withdrawal by Subject|2|||
146582230|NCT00395486|528636088|FG000|Overall Study|Lost to Follow-up|0|||
146582231|NCT00395486|528636089|FG001|Overall Study|Lost to Follow-up|1|||
146582232|NCT01814046|528636093|FG000|Drug Administration|Death due to complications of RSV|1|||
146582233|NCT01814046|528636094|FG001|Drug Administration|Death due to complications of RSV|0|||
146582234|NCT01814046|528636095|FG002|Drug Administration|Death due to complications of RSV|0|||
146582235|NCT00564902|528636096|FG000|Overall Study|Withdrawal by Subject|0|||
146582236|NCT00564902|528636097|FG001|Overall Study|Withdrawal by Subject|3|||
146582237|NCT00564902|528636098|FG002|Overall Study|Withdrawal by Subject|4|||
146582238|NCT00564902|528636096|FG000|Overall Study|Death|1|||
146582239|NCT00564902|528636097|FG001|Overall Study|Death|1|||
146582240|NCT00564902|528636098|FG002|Overall Study|Death|0|||
146582241|NCT02097719|528636102|FG000|Overall Study|Subject Withdrew Consent|1|||
146582242|NCT02097719|528636103|FG001|Overall Study|Subject Withdrew Consent|0|||
146582243|NCT02097719|528636102|FG000|Overall Study|Lost to Follow-up|0|||
146582244|NCT02097719|528636103|FG001|Overall Study|Lost to Follow-up|1|||
146582245|NCT02097719|528636102|FG000|Overall Study|Adverse Event|2|||
146582246|NCT02097719|528636103|FG001|Overall Study|Adverse Event|0|||
146582247|NCT01854775|528636106|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
146582248|NCT01854775|528636107|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
146582249|NCT01854775|528636108|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
146582250|NCT01854775|528636106|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
146582251|NCT01854775|528636107|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
146582252|NCT01854775|528636108|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
146582253|NCT01854775|528636106|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
146582254|NCT01854775|528636107|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
146582255|NCT01854775|528636108|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
146582256|NCT01854775|528636106|FG000|Extension Phase|Pregnancy|3|||
146582257|NCT01854775|528636107|FG001|Extension Phase|Pregnancy|0|||
146582258|NCT01854775|528636108|FG002|Extension Phase|Pregnancy|0|||
146582259|NCT01854775|528636106|FG000|Extension Phase|Investigator's Discretion|1|||
146582260|NCT01854775|528636107|FG001|Extension Phase|Investigator's Discretion|0|||
146582261|NCT01854775|528636108|FG002|Extension Phase|Investigator's Discretion|0|||
146582262|NCT01854775|528636106|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
146582263|NCT01854775|528636107|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
146582264|NCT01854775|528636108|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
146582265|NCT01854775|528636106|FG000|Extension Phase|Lost to Follow-up|2|||
146582266|NCT01854775|528636107|FG001|Extension Phase|Lost to Follow-up|0|||
146582267|NCT01854775|528636108|FG002|Extension Phase|Lost to Follow-up|0|||
146582268|NCT01854775|528636106|FG000|Extension Phase|Still on Study|32|||
146582269|NCT01854775|528636107|FG001|Extension Phase|Still on Study|47|||
146582270|NCT01854775|528636108|FG002|Extension Phase|Still on Study|18|||
146582271|NCT00984594|528636110|FG000|Overall Study|Lost to Follow-up|1|||
146582272|NCT00984594|528636111|FG001|Overall Study|Lost to Follow-up|0|||
146582273|NCT00984594|528636110|FG000|Overall Study|Withdrawal by Subject|0|||
146582274|NCT00984594|528636111|FG001|Overall Study|Withdrawal by Subject|1|||
146582275|NCT00875485|528637836|FG000|Challenge Dose Epoch|Pregnancy|1|||
146582276|NCT00875485|528637837|FG001|Challenge Dose Epoch|Pregnancy|0|||
146582277|NCT01271010|528637838|FG000|Overall Study|Reason not specified|11|||
146582278|NCT01271010|528637838|FG000|Overall Study|Start of new CLL therapy|1|||
146582279|NCT01271010|528637838|FG000|Overall Study|Protocol Violation|1|||
146582280|NCT01271010|528637838|FG000|Overall Study|Death|2|||
146582281|NCT01271010|528637838|FG000|Overall Study|Progression and relapse of disease|1|||
146582282|NCT01271010|528637838|FG000|Overall Study|Withdrawal by Subject|18|||
146582283|NCT01271010|528637838|FG000|Overall Study|Disease progression|27|||
146582284|NCT01631747|528637839|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
146582285|NCT01631747|528637840|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
146582286|NCT01631747|528637839|FG000|Live Birth|Pregnancy Termination|1|||
146582287|NCT01631747|528637840|FG001|Live Birth|Pregnancy Termination|0|||
146582288|NCT01631747|528637839|FG000|Live Birth|MIscarriage|2|||
146582289|NCT01631747|528637840|FG001|Live Birth|MIscarriage|0|||
146582290|NCT01631747|528637839|FG000|Live Birth|Stillbirth|1|||
146582291|NCT01631747|528637840|FG001|Live Birth|Stillbirth|1|||
146582292|NCT01631747|528637839|FG000|One Year Infant Outcomes|Patient Refused|13|||
146582293|NCT01631747|528637840|FG001|One Year Infant Outcomes|Patient Refused|9|||
146582294|NCT01456195|528637841|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
146978239|NCT02875067|530082290|FG000|Overall Study|Withdrawal by Subject|1|||
146978240|NCT02875067|530082290|FG000|Overall Study|Withdrawal by Termination of Study|5|||
146652059|NCT00282464|528903756|FG000|Overall Study|Withdrawal by Subject|24|||
146582295|NCT01456195|528637842|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
146582296|NCT01456195|528637843|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
146582297|NCT01456195|528637841|FG000|Overall Study|Lost to Follow-up|3|||
146582298|NCT01456195|528637842|FG001|Overall Study|Lost to Follow-up|1|||
146582299|NCT01456195|528637843|FG002|Overall Study|Lost to Follow-up|3|||
146582300|NCT01456195|528637841|FG000|Overall Study|Voluntary Withdrawal|5|||
146582301|NCT01456195|528637842|FG001|Overall Study|Voluntary Withdrawal|3|||
146582302|NCT01456195|528637843|FG002|Overall Study|Voluntary Withdrawal|7|||
146582303|NCT01456195|528637841|FG000|Overall Study|Lack of Efficacy|0|||
146582304|NCT01456195|528637842|FG001|Overall Study|Lack of Efficacy|1|||
146582305|NCT01456195|528637843|FG002|Overall Study|Lack of Efficacy|0|||
146582306|NCT01456195|528637841|FG000|Overall Study|Other Reasons|2|||
146582307|NCT01456195|528637842|FG001|Overall Study|Other Reasons|1|||
146582308|NCT01456195|528637843|FG002|Overall Study|Other Reasons|3|||
146582309|NCT02109432|528637844|FG000|Overall Study|Withdrawal by Subject|1|||
146582310|NCT02908685|528637851|FG000|Part 1 OLE|Withdrawal by Subject|0|||
146582311|NCT02908685|528637852|FG001|Part 1 OLE|Withdrawal by Subject|0|||
146582312|NCT02908685|528637853|FG002|Part 1 OLE|Withdrawal by Subject|0|||
146582313|NCT02908685|528637854|FG003|Part 1 OLE|Withdrawal by Subject|0|||
146582314|NCT02908685|528637855|FG004|Part 1 OLE|Withdrawal by Subject|0|||
146582315|NCT02908685|528637856|FG005|Part 1 OLE|Withdrawal by Subject|0|||
146582316|NCT02908685|528637857|FG006|Part 1 OLE|Withdrawal by Subject|0|||
146582317|NCT02908685|528637858|FG007|Part 1 OLE|Withdrawal by Subject|0|||
146582318|NCT02908685|528637859|FG008|Part 1 OLE|Withdrawal by Subject|0|||
146582319|NCT02908685|528637860|FG009|Part 1 OLE|Withdrawal by Subject|0|||
146582320|NCT02908685|528637861|FG010|Part 1 OLE|Withdrawal by Subject|2|||
146582321|NCT02908685|528637862|FG011|Part 1 OLE|Withdrawal by Subject|1|||
146582322|NCT02908685|528637863|FG012|Part 1 OLE|Withdrawal by Subject|0|||
146582323|NCT02908685|528637864|FG013|Part 1 OLE|Withdrawal by Subject|0|||
146582324|NCT02908685|528637851|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146582325|NCT02908685|528637852|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146582326|NCT02908685|528637853|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146582327|NCT02908685|528637854|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146582328|NCT02908685|528637855|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146582329|NCT02908685|528637856|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146582330|NCT02908685|528637857|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146582331|NCT02908685|528637858|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146582332|NCT02908685|528637859|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146582333|NCT02908685|528637860|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146582334|NCT02908685|528637861|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146582335|NCT02908685|528637862|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146582336|NCT02908685|528637863|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
146582337|NCT02908685|528637864|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
146582338|NCT02908685|528637851|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146582339|NCT02908685|528637852|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146582340|NCT02908685|528637853|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146582341|NCT02908685|528637854|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146582342|NCT02908685|528637855|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146582343|NCT02908685|528637856|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146582344|NCT02908685|528637857|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146582345|NCT02908685|528637858|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146582346|NCT02908685|528637859|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146582347|NCT02908685|528637860|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146582348|NCT02908685|528637861|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146582349|NCT02908685|528637862|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146582350|NCT02908685|528637863|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
146582351|NCT02908685|528637864|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146582352|NCT02908685|528637851|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146582353|NCT02908685|528637852|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146582354|NCT02908685|528637853|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146582355|NCT02908685|528637854|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146582356|NCT02908685|528637855|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146582357|NCT02908685|528637856|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146582358|NCT02908685|528637857|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146582359|NCT02908685|528637858|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146582360|NCT02908685|528637859|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146582361|NCT02908685|528637860|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146582362|NCT02908685|528637861|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146582363|NCT02908685|528637862|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146582364|NCT02908685|528637863|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
146582365|NCT02908685|528637864|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146582366|NCT02908685|528637851|FG000|Part 2 OLE: > Month 24|Death|0|||
146582367|NCT02908685|528637852|FG001|Part 2 OLE: > Month 24|Death|0|||
146582368|NCT02908685|528637853|FG002|Part 2 OLE: > Month 24|Death|0|||
146582369|NCT02908685|528637854|FG003|Part 2 OLE: > Month 24|Death|0|||
146582370|NCT02908685|528637855|FG004|Part 2 OLE: > Month 24|Death|0|||
146582371|NCT02908685|528637856|FG005|Part 2 OLE: > Month 24|Death|0|||
146582372|NCT02908685|528637857|FG006|Part 2 OLE: > Month 24|Death|0|||
146582373|NCT02908685|528637858|FG007|Part 2 OLE: > Month 24|Death|0|||
146582374|NCT02908685|528637859|FG008|Part 2 OLE: > Month 24|Death|0|||
146582375|NCT02908685|528637860|FG009|Part 2 OLE: > Month 24|Death|0|||
146582376|NCT02908685|528637861|FG010|Part 2 OLE: > Month 24|Death|0|||
146582377|NCT02908685|528637862|FG011|Part 2 OLE: > Month 24|Death|0|||
146582378|NCT02908685|528637863|FG012|Part 2 OLE: > Month 24|Death|1|||
146582379|NCT02908685|528637864|FG013|Part 2 OLE: > Month 24|Death|0|||
146582380|NCT02908685|528637851|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
146582381|NCT02908685|528637852|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
146582382|NCT02908685|528637853|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
146582383|NCT02908685|528637854|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
146582384|NCT02908685|528637855|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
146582385|NCT02908685|528637856|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
146582386|NCT02908685|528637857|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
146582387|NCT02908685|528637858|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
146582388|NCT02908685|528637859|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
146582389|NCT02908685|528637860|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
146582390|NCT02908685|528637861|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
146582391|NCT02908685|528637862|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
146582392|NCT02908685|528637863|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
146582393|NCT02908685|528637864|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
146582394|NCT02908685|528637851|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146582395|NCT02908685|528637852|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146582396|NCT02908685|528637853|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146582397|NCT02908685|528637854|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146582398|NCT02908685|528637855|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146582399|NCT02908685|528637856|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146582400|NCT02908685|528637857|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146582401|NCT02908685|528637858|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146582402|NCT02908685|528637859|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146582403|NCT02908685|528637860|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146582404|NCT02908685|528637861|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146582405|NCT02908685|528637862|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146582406|NCT02908685|528637863|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
146582407|NCT02908685|528637864|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
146582408|NCT02954406|528637865|FG000|Overall Study|Adverse Event|0|||
146582409|NCT02954406|528637866|FG001|Overall Study|Adverse Event|1|||
146582410|NCT02954406|528637867|FG002|Overall Study|Adverse Event|0|||
146582411|NCT02954406|528637868|FG003|Overall Study|Adverse Event|0|||
146582412|NCT02954406|528637869|FG004|Overall Study|Adverse Event|1|||
146582413|NCT02954406|528637870|FG005|Overall Study|Adverse Event|0|||
146582414|NCT02954406|528637871|FG006|Overall Study|Adverse Event|0|||
146582415|NCT02954406|528637872|FG007|Overall Study|Adverse Event|0|||
146582416|NCT02954406|528637873|FG008|Overall Study|Adverse Event|1|||
146582417|NCT02954406|528637874|FG009|Overall Study|Adverse Event|1|||
146582418|NCT02954406|528637875|FG010|Overall Study|Adverse Event|0|||
146582419|NCT02954406|528637865|FG000|Overall Study|Progressive Disease|3|||
146582420|NCT02954406|528637866|FG001|Overall Study|Progressive Disease|4|||
146582421|NCT02954406|528637867|FG002|Overall Study|Progressive Disease|3|||
146582422|NCT02954406|528637868|FG003|Overall Study|Progressive Disease|4|||
146582423|NCT02954406|528637869|FG004|Overall Study|Progressive Disease|3|||
146582424|NCT02954406|528637870|FG005|Overall Study|Progressive Disease|3|||
146582425|NCT02954406|528637871|FG006|Overall Study|Progressive Disease|2|||
146582426|NCT02954406|528637872|FG007|Overall Study|Progressive Disease|2|||
146582427|NCT02954406|528637873|FG008|Overall Study|Progressive Disease|1|||
146582428|NCT02954406|528637874|FG009|Overall Study|Progressive Disease|1|||
146582429|NCT02954406|528637875|FG010|Overall Study|Progressive Disease|0|||
146582430|NCT02954406|528637865|FG000|Overall Study|Symptomatic Deterioration|0|||
146582431|NCT02954406|528637866|FG001|Overall Study|Symptomatic Deterioration|1|||
146582432|NCT02954406|528637867|FG002|Overall Study|Symptomatic Deterioration|0|||
146582433|NCT02954406|528637868|FG003|Overall Study|Symptomatic Deterioration|0|||
146582434|NCT02954406|528637869|FG004|Overall Study|Symptomatic Deterioration|0|||
146582435|NCT02954406|528637870|FG005|Overall Study|Symptomatic Deterioration|0|||
146582436|NCT02954406|528637871|FG006|Overall Study|Symptomatic Deterioration|0|||
146582437|NCT02954406|528637872|FG007|Overall Study|Symptomatic Deterioration|0|||
146582438|NCT02954406|528637873|FG008|Overall Study|Symptomatic Deterioration|0|||
146582439|NCT02954406|528637874|FG009|Overall Study|Symptomatic Deterioration|0|||
146770826|NCT00373529|529328692|FG000|Overall Study|Failed independent confirmation of AML|3|||
146770827|NCT00373529|529328692|FG000|Overall Study|Consent violation|1|||
146582440|NCT02954406|528637875|FG010|Overall Study|Symptomatic Deterioration|0|||
146582441|NCT02954406|528637865|FG000|Overall Study|Death|0|||
146582442|NCT02954406|528637866|FG001|Overall Study|Death|0|||
146582443|NCT02954406|528637867|FG002|Overall Study|Death|0|||
146582444|NCT02954406|528637868|FG003|Overall Study|Death|0|||
146582445|NCT02954406|528637869|FG004|Overall Study|Death|1|||
146582446|NCT02954406|528637870|FG005|Overall Study|Death|0|||
146582447|NCT02954406|528637871|FG006|Overall Study|Death|0|||
146582448|NCT02954406|528637872|FG007|Overall Study|Death|0|||
146582449|NCT02954406|528637873|FG008|Overall Study|Death|1|||
146582450|NCT02954406|528637874|FG009|Overall Study|Death|1|||
146582451|NCT02954406|528637875|FG010|Overall Study|Death|0|||
146582452|NCT02954406|528637865|FG000|Overall Study|Reason Not Specified|0|||
146582453|NCT02954406|528637866|FG001|Overall Study|Reason Not Specified|0|||
146582454|NCT02954406|528637867|FG002|Overall Study|Reason Not Specified|3|||
146582455|NCT02954406|528637868|FG003|Overall Study|Reason Not Specified|2|||
146582456|NCT02954406|528637869|FG004|Overall Study|Reason Not Specified|2|||
146582457|NCT02954406|528637870|FG005|Overall Study|Reason Not Specified|0|||
146582458|NCT02954406|528637871|FG006|Overall Study|Reason Not Specified|1|||
146582459|NCT02954406|528637872|FG007|Overall Study|Reason Not Specified|0|||
146582460|NCT02954406|528637873|FG008|Overall Study|Reason Not Specified|1|||
146582461|NCT02954406|528637874|FG009|Overall Study|Reason Not Specified|0|||
146582462|NCT02954406|528637875|FG010|Overall Study|Reason Not Specified|0|||
146582463|NCT04683029|528637882|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
146582464|NCT04683029|528637883|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
146582465|NCT04683029|528637884|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
146582466|NCT04683029|528637885|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
146582467|NCT04683029|528637882|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
146582468|NCT04683029|528637883|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
146582469|NCT04683029|528637884|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
146582470|NCT04683029|528637885|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
146582471|NCT04683029|528637882|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
146582472|NCT04683029|528637883|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
146582473|NCT04683029|528637884|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
146582474|NCT04683029|528637885|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
146582475|NCT04299308|528637886|FG000|Overall Study|Withdrawal by Subject|1|||
146582476|NCT04299308|528637887|FG001|Overall Study|Withdrawal by Subject|0|||
146582477|NCT04299308|528637886|FG000|Overall Study|issue with PET image (1)|1|||
146582478|NCT04299308|528637887|FG001|Overall Study|issue with PET image (1)|0|||
146582479|NCT00814580|528637888|FG000|Overall Study|Adverse Event|6|||
146582480|NCT00814580|528637889|FG001|Overall Study|Adverse Event|15|||
146582481|NCT00814580|528637888|FG000|Overall Study|Lack of Efficacy|18|||
146582482|NCT00814580|528637889|FG001|Overall Study|Lack of Efficacy|25|||
146582483|NCT00814580|528637888|FG000|Overall Study|Protocol Violation|2|||
146582484|NCT00814580|528637889|FG001|Overall Study|Protocol Violation|0|||
146582485|NCT00814580|528637888|FG000|Overall Study|Withdrawal by Subject|2|||
146582486|NCT00814580|528637889|FG001|Overall Study|Withdrawal by Subject|2|||
146582487|NCT00814580|528637888|FG000|Overall Study|Other|1|||
146582488|NCT00814580|528637889|FG001|Overall Study|Other|3|||
146582489|NCT00814580|528637888|FG000|Overall Study|Did Not Take Drug|2|||
146582490|NCT00814580|528637889|FG001|Overall Study|Did Not Take Drug|2|||
146582491|NCT02920528|528637894|FG000|Overall Study|Incomplete Data|1|||
146582492|NCT02920528|528637895|FG001|Overall Study|Incomplete Data|1|||
146582493|NCT02920528|528637896|FG002|Overall Study|Incomplete Data|1|||
146582494|NCT02920528|528637894|FG000|Overall Study|Adverse Event|0|||
146582495|NCT02920528|528637895|FG001|Overall Study|Adverse Event|0|||
146582496|NCT02920528|528637896|FG002|Overall Study|Adverse Event|3|||
146652060|NCT00282464|528903757|FG001|Overall Study|Withdrawal by Subject|10|||
146978241|NCT02713243|530082292|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
146978242|NCT02713243|530082293|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
146978243|NCT02713243|530082292|FG000|Overall Study|Administrative problems|0|||
146978244|NCT02713243|530082293|FG001|Overall Study|Administrative problems|1|||
146978245|NCT02713243|530082292|FG000|Overall Study|Protocol deviation|0|||
146978246|NCT02713243|530082293|FG001|Overall Study|Protocol deviation|1|||
146978247|NCT03056352|530082294|FG000|Overall Study|Lost to Follow-up|1|||
146978248|NCT02971605|530082295|FG000|Overall Study|Withdrawal by Subject|1|||
146978249|NCT00597207|530082296|FG000|Overall Study|Lost to Follow-up|5|||
146978250|NCT00597207|530082297|FG001|Overall Study|Lost to Follow-up|7|||
146978251|NCT03077828|530082300|FG000|Treatment Cycles|Death|1|||
146978252|NCT03077828|530082300|FG000|Treatment Cycles|Withdrawal by Subject|1|||
146978253|NCT03077828|530082300|FG000|Treatment Cycles|Screen Fail|2|||
146978254|NCT03077828|530082300|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
146978255|NCT03077828|530082300|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
146978256|NCT03077828|530082300|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
146978257|NCT03077828|530082300|FG000|Follow-up|Patients still in follow-up|15|||
146978258|NCT05037409|530082302|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
146978259|NCT05037409|530082303|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
146582497|NCT02920528|528637894|FG000|Overall Study|Did not meet inclusion criteria|2|||
146582498|NCT02920528|528637895|FG001|Overall Study|Did not meet inclusion criteria|0|||
146582499|NCT02920528|528637896|FG002|Overall Study|Did not meet inclusion criteria|1|||
146582500|NCT01340625|528637897|FG000|First Intervention|Adverse Event|1|||
146582501|NCT01340625|528637898|FG001|First Intervention|Adverse Event|0|||
146582502|NCT01340625|528637897|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
146582503|NCT01340625|528637898|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
146582504|NCT01986231|528637899|FG000|Overall Study|Adverse Event|1|||
146582505|NCT02003638|528637900|FG000|Overall Study|Withdrawal by Subject|1|||
146582506|NCT02003638|528637901|FG001|Overall Study|Withdrawal by Subject|0|||
146582507|NCT03249909|528637902|FG000|Overall Study|Withdrawal by Subject|3|||
146582508|NCT03249909|528637903|FG001|Overall Study|Withdrawal by Subject|0|||
146582509|NCT03249909|528637904|FG002|Overall Study|Withdrawal by Subject|0|||
146582510|NCT03249909|528637902|FG000|Overall Study|Adverse Event|3|||
146582511|NCT03249909|528637903|FG001|Overall Study|Adverse Event|0|||
146582512|NCT03249909|528637904|FG002|Overall Study|Adverse Event|0|||
146582513|NCT03249909|528637902|FG000|Overall Study|Lost to Follow-up|0|||
146582514|NCT03249909|528637903|FG001|Overall Study|Lost to Follow-up|1|||
146582515|NCT03249909|528637904|FG002|Overall Study|Lost to Follow-up|0|||
146582516|NCT00606034|528637905|FG000|Overall Study|incarceration|1|||
146582517|NCT05286658|528637907|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
146582518|NCT05286658|528637907|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
146582519|NCT03423238|528637912|FG000|Overall Study|Lost to Follow-up|1|||
146582520|NCT03423238|528637913|FG001|Overall Study|Lost to Follow-up|0|||
146582521|NCT03423238|528637912|FG000|Overall Study|Withdrawal by Subject|1|||
146582522|NCT03423238|528637913|FG001|Overall Study|Withdrawal by Subject|0|||
146582523|NCT04470050|528637915|FG000|Double-blind Treatment Phase|Adverse Event|0|||
146582524|NCT04470050|528637916|FG001|Double-blind Treatment Phase|Adverse Event|0|||
146582525|NCT04470050|528637917|FG002|Double-blind Treatment Phase|Adverse Event|0|||
146582526|NCT04470050|528637918|FG003|Double-blind Treatment Phase|Adverse Event|1|||
146582527|NCT04470050|528637919|FG004|Double-blind Treatment Phase|Adverse Event|0|||
146582528|NCT04470050|528637920|FG005|Double-blind Treatment Phase|Adverse Event|0|||
146582529|NCT04470050|528637921|FG006|Double-blind Treatment Phase|Adverse Event|0|||
146582530|NCT04470050|528637915|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
146582531|NCT04470050|528637916|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
146582532|NCT04470050|528637917|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
146582533|NCT04470050|528637918|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
146582534|NCT04470050|528637919|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
146582535|NCT04470050|528637920|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
146582536|NCT04470050|528637921|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
146582537|NCT04470050|528637915|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
146582538|NCT04470050|528637916|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
146582539|NCT04470050|528637917|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
146582540|NCT04470050|528637918|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
146582541|NCT04470050|528637919|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
146582542|NCT04470050|528637920|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
146582543|NCT04470050|528637921|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
146582544|NCT03640507|528637922|FG000|Overall Study|Withdrawal by Subject|0|||
146582545|NCT03640507|528637923|FG001|Overall Study|Withdrawal by Subject|0|||
146582546|NCT03640507|528637924|FG002|Overall Study|Withdrawal by Subject|1|||
146582547|NCT03028129|528637927|FG000|Overall Study|Adverse Event|13|||
146582548|NCT03028129|528637928|FG001|Overall Study|Adverse Event|2|||
146582549|NCT03028129|528637927|FG000|Overall Study|Lost to Follow-up|50|||
146582550|NCT03028129|528637928|FG001|Overall Study|Lost to Follow-up|38|||
146582551|NCT03028129|528637927|FG000|Overall Study|Physician Decision|0|||
146582552|NCT03028129|528637928|FG001|Overall Study|Physician Decision|1|||
146582553|NCT03028129|528637927|FG000|Overall Study|Protocol Violation|1|||
146582554|NCT03028129|528637928|FG001|Overall Study|Protocol Violation|1|||
146582555|NCT03028129|528637927|FG000|Overall Study|Withdrawal by Subject|62|||
146582556|NCT03028129|528637928|FG001|Overall Study|Withdrawal by Subject|45|||
146582557|NCT01076205|528637929|FG000|Overall Study|Adverse Drug Reaction|299|||
146582558|NCT01076205|528637929|FG000|Overall Study|Lack of Effectiveness|1423|||
146582559|NCT01076205|528637929|FG000|Overall Study|Other Reason|1075|||
146582560|NCT01076205|528637929|FG000|Overall Study|Unknown Reason|71|||
146582561|NCT01076205|528637929|FG000|Overall Study|Lost to Follow-up|3151|||
146582562|NCT02993822|528637935|FG000|Overall Study|Lack of Efficacy|1|||
146582563|NCT02993822|528637936|FG001|Overall Study|Lack of Efficacy|1|||
146582564|NCT02993822|528637937|FG002|Overall Study|Lack of Efficacy|0|||
146770828|NCT00442117|529328693|FG000|Overall Study|Adverse Event|3|||
146770829|NCT00442117|529328694|FG001|Overall Study|Adverse Event|2|||
146770830|NCT00442117|529328693|FG000|Overall Study|Lack of Efficacy|2|||
146770831|NCT00442117|529328694|FG001|Overall Study|Lack of Efficacy|6|||
146918616|NCT00630812|529864465|FG001|Double Blind Treatment Period|Protocol Violation|0|||
146582565|NCT02993822|528637938|FG003|Overall Study|Lack of Efficacy|0|||
146582566|NCT02993822|528637935|FG000|Overall Study|Protocol Violation|1|||
146582567|NCT02993822|528637936|FG001|Overall Study|Protocol Violation|0|||
146582568|NCT02993822|528637937|FG002|Overall Study|Protocol Violation|0|||
146582569|NCT02993822|528637938|FG003|Overall Study|Protocol Violation|0|||
146582570|NCT02993822|528637935|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
146582571|NCT02993822|528637936|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
146582572|NCT02993822|528637937|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
146582573|NCT02993822|528637938|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
146582574|NCT02993822|528637935|FG000|Overall Study|Adverse Event|3|||
146770832|NCT00442117|529328693|FG000|Overall Study|Lost to Follow-up|1|||
146582575|NCT02993822|528637936|FG001|Overall Study|Adverse Event|1|||
146582576|NCT02993822|528637937|FG002|Overall Study|Adverse Event|7|||
146582577|NCT02993822|528637938|FG003|Overall Study|Adverse Event|0|||
146582578|NCT02993822|528637935|FG000|Overall Study|Withdrawal by Subject|4|||
146582579|NCT02993822|528637936|FG001|Overall Study|Withdrawal by Subject|2|||
146582580|NCT02993822|528637937|FG002|Overall Study|Withdrawal by Subject|2|||
146582581|NCT02993822|528637938|FG003|Overall Study|Withdrawal by Subject|3|||
146582582|NCT02993822|528637935|FG000|Overall Study|Lost to Follow-up|1|||
146582583|NCT02993822|528637936|FG001|Overall Study|Lost to Follow-up|0|||
146582584|NCT02993822|528637937|FG002|Overall Study|Lost to Follow-up|1|||
146582585|NCT02993822|528637938|FG003|Overall Study|Lost to Follow-up|0|||
146582586|NCT01939977|528637939|FG000|Overall Study|Adverse Event|4|||
146582587|NCT01939977|528637940|FG001|Overall Study|Adverse Event|3|||
146582588|NCT01939977|528637939|FG000|Overall Study|Lack of Efficacy|3|||
146582589|NCT01939977|528637940|FG001|Overall Study|Lack of Efficacy|0|||
146582590|NCT01939977|528637939|FG000|Overall Study|Physician Decision|1|||
146582591|NCT01939977|528637940|FG001|Overall Study|Physician Decision|1|||
146582592|NCT01939977|528637939|FG000|Overall Study|Withdrawal by Subject|0|||
146582593|NCT01939977|528637940|FG001|Overall Study|Withdrawal by Subject|2|||
146582594|NCT01939977|528637939|FG000|Overall Study|Did not meet inclusion criteria|1|||
146582595|NCT01939977|528637940|FG001|Overall Study|Did not meet inclusion criteria|0|||
146582596|NCT01939977|528637939|FG000|Overall Study|Did not receive study medication|0|||
146582597|NCT01939977|528637940|FG001|Overall Study|Did not receive study medication|1|||
146582598|NCT01696981|528637951|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
146582599|NCT01696981|528637952|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
146582600|NCT01696981|528637951|FG000|Overall Study|Died Before Randomization|3|||
146582601|NCT01696981|528637952|FG001|Overall Study|Died Before Randomization|8|||
146582602|NCT01696981|528637951|FG000|Overall Study|Died Before ASU (Control)|278|||
146582603|NCT01696981|528637952|FG001|Overall Study|Died Before ASU (Control)|0|||
146582604|NCT01696981|528637951|FG000|Overall Study|Refused ASU (Control)|920|||
146582605|NCT01696981|528637952|FG001|Overall Study|Refused ASU (Control)|0|||
146582606|NCT01696981|528637951|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
146582607|NCT01696981|528637952|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
146582608|NCT00851890|528637955|FG000|Overall Study|Lost to Follow-up|0|||
146582609|NCT00851890|528637956|FG001|Overall Study|Lost to Follow-up|1|||
146582610|NCT00851890|528637957|FG002|Overall Study|Lost to Follow-up|0|||
146582611|NCT00851890|528637958|FG003|Overall Study|Lost to Follow-up|1|||
146582612|NCT03135431|528637959|FG000|Overall Study|Study Surgeon not available|2|||
146582613|NCT03135431|528637960|FG001|Overall Study|Study Surgeon not available|0|||
146582614|NCT02597452|528637962|FG000|Overall Study|testing incomplete|30|||
146582615|NCT03122145|528637963|FG000|Overall Study|Concurrent respiratory disease|3|||
146582616|NCT03122145|528637964|FG001|Overall Study|Concurrent respiratory disease|0|||
146582617|NCT00281099|528637965|FG000|Overall Study|Death|46|||
146582618|NCT00281099|528637966|FG001|Overall Study|Death|57|||
146582619|NCT00281099|528637965|FG000|Overall Study|Lost to Follow-up|10|||
146582620|NCT00281099|528637966|FG001|Overall Study|Lost to Follow-up|19|||
146582621|NCT00281099|528637965|FG000|Overall Study|Withdrawal by Subject|65|||
146582622|NCT00281099|528637966|FG001|Overall Study|Withdrawal by Subject|70|||
146582623|NCT00281099|528637965|FG000|Overall Study|Physician Decision|79|||
146582624|NCT00281099|528637966|FG001|Overall Study|Physician Decision|72|||
146582625|NCT00281099|528637965|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
146582626|NCT00281099|528637966|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
146582627|NCT03108521|528637970|FG000|Overall Study|Lost to Follow-up|3|||
146582628|NCT03108521|528637971|FG001|Overall Study|Lost to Follow-up|0|||
146582629|NCT03108521|528637970|FG000|Overall Study|Lack of Efficacy|2|||
146582630|NCT03108521|528637971|FG001|Overall Study|Lack of Efficacy|0|||
146582631|NCT03108521|528637970|FG000|Overall Study|Physician Decision|4|||
146582632|NCT03108521|528637971|FG001|Overall Study|Physician Decision|0|||
146582633|NCT03108521|528637970|FG000|Overall Study|Adverse Event|3|||
146582634|NCT03108521|528637971|FG001|Overall Study|Adverse Event|0|||
146582635|NCT06899737|528637977|FG000|Overall Study|Lost to Follow-up|19|||
146582636|NCT06899737|528637978|FG001|Overall Study|Lost to Follow-up|7|||
146582637|NCT00334737|528637984|FG000|Hospital Phase|Death|1|||
146582638|NCT00334737|528637985|FG001|Hospital Phase|Death|2|||
146582639|NCT00334737|528637986|FG002|Hospital Phase|Death|3|||
146582640|NCT00334737|528637984|FG000|Hospital Phase|Withdrawal by Subject|0|||
146582641|NCT00334737|528637985|FG001|Hospital Phase|Withdrawal by Subject|0|||
146770833|NCT00442117|529328694|FG001|Overall Study|Lost to Follow-up|2|||
146582642|NCT00334737|528637986|FG002|Hospital Phase|Withdrawal by Subject|1|||
146582643|NCT00334737|528637984|FG000|Hospital Phase|Did not receive study drug|1|||
146582644|NCT00334737|528637985|FG001|Hospital Phase|Did not receive study drug|0|||
146582645|NCT00334737|528637986|FG002|Hospital Phase|Did not receive study drug|0|||
146582646|NCT00334737|528637984|FG000|Follow up Phase|Lost to Follow-up|5|||
146582647|NCT00334737|528637985|FG001|Follow up Phase|Lost to Follow-up|3|||
146582648|NCT00334737|528637986|FG002|Follow up Phase|Lost to Follow-up|6|||
146582649|NCT02316353|528637987|FG000|Overall Study|Pregnancy|1|||
146582650|NCT02316353|528637988|FG001|Overall Study|Pregnancy|3|||
146582651|NCT02316353|528637987|FG000|Overall Study|Adverse Event|1|||
146582652|NCT02316353|528637988|FG001|Overall Study|Adverse Event|3|||
146582653|NCT02316353|528637987|FG000|Overall Study|Withdrawal by Subject|6|||
146582654|NCT02316353|528637988|FG001|Overall Study|Withdrawal by Subject|2|||
146582655|NCT00375674|528637989|FG000|Overall Study|Other|26|||
146582656|NCT00375674|528637990|FG001|Overall Study|Other|18|||
146582657|NCT00375674|528637989|FG000|Overall Study|Death|67|||
146582658|NCT00375674|528637990|FG001|Overall Study|Death|76|||
146582659|NCT00375674|528637989|FG000|Overall Study|Participants refused further follow-up|31|||
146582660|NCT00375674|528637990|FG001|Overall Study|Participants refused further follow-up|30|||
146582661|NCT00375674|528637989|FG000|Overall Study|Lost to Follow-up|17|||
146582662|NCT00375674|528637990|FG001|Overall Study|Lost to Follow-up|15|||
146582663|NCT00375674|528637989|FG000|Overall Study|Enrolled but not treated|3|||
146582664|NCT00375674|528637990|FG001|Overall Study|Enrolled but not treated|2|||
146582665|NCT01691014|528639680|FG000|Overall Study|Premature Termination|1|||
146582666|NCT01691014|528639681|FG001|Overall Study|Premature Termination|6|||
146582667|NCT01691014|528639682|FG002|Overall Study|Premature Termination|0|||
146582668|NCT01691014|528639683|FG003|Overall Study|Premature Termination|3|||
146582669|NCT01691014|528639680|FG000|Overall Study|Other|0|||
146582670|NCT01691014|528639681|FG001|Overall Study|Other|0|||
146582671|NCT01691014|528639682|FG002|Overall Study|Other|2|||
146582672|NCT01691014|528639683|FG003|Overall Study|Other|0|||
146582673|NCT01691014|528639680|FG000|Overall Study|Withdrawal by Subject|0|||
146582674|NCT01691014|528639681|FG001|Overall Study|Withdrawal by Subject|1|||
146582675|NCT01691014|528639682|FG002|Overall Study|Withdrawal by Subject|1|||
146582676|NCT01691014|528639683|FG003|Overall Study|Withdrawal by Subject|1|||
146582677|NCT01691014|528639680|FG000|Overall Study|Adverse Event|0|||
146582678|NCT01691014|528639681|FG001|Overall Study|Adverse Event|5|||
146582679|NCT01691014|528639682|FG002|Overall Study|Adverse Event|1|||
146582680|NCT01691014|528639683|FG003|Overall Study|Adverse Event|1|||
146582681|NCT01691014|528639680|FG000|Overall Study|Lack of Efficacy|2|||
146582682|NCT01691014|528639681|FG001|Overall Study|Lack of Efficacy|3|||
146582683|NCT01691014|528639682|FG002|Overall Study|Lack of Efficacy|7|||
146582684|NCT01691014|528639683|FG003|Overall Study|Lack of Efficacy|0|||
146582685|NCT03372551|528639684|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
146582686|NCT03372551|528639685|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
146582687|NCT00066703|528639686|FG000|Overall Study|Adverse Event|80|||
146582688|NCT00066703|528639687|FG001|Overall Study|Adverse Event|111|||
146582689|NCT00066703|528639686|FG000|Overall Study|Death|3|||
146582690|NCT00066703|528639687|FG001|Overall Study|Death|0|||
146582691|NCT00066703|528639686|FG000|Overall Study|Lack of Efficacy|114|||
146582692|NCT00066703|528639687|FG001|Overall Study|Lack of Efficacy|69|||
146978260|NCT05037409|530082304|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
146582693|NCT00066703|528639686|FG000|Overall Study|Lost to Follow-up|31|||
146582694|NCT00066703|528639687|FG001|Overall Study|Lost to Follow-up|28|||
146582695|NCT00066703|528639686|FG000|Overall Study|Withdrawal by Subject|38|||
146582696|NCT00066703|528639687|FG001|Overall Study|Withdrawal by Subject|63|||
146582697|NCT00066703|528639686|FG000|Overall Study|Treatment ongoing|346|||
146582698|NCT00066703|528639687|FG001|Overall Study|Treatment ongoing|311|||
146582699|NCT01696968|528639688|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
146582700|NCT01696968|528639689|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
146582701|NCT01696968|528639688|FG000|Overall Study|Died Before Randomization|3|||
146582702|NCT01696968|528639689|FG001|Overall Study|Died Before Randomization|8|||
146582703|NCT01696968|528639688|FG000|Overall Study|Died Before ASU (Control)|278|||
146582704|NCT01696968|528639689|FG001|Overall Study|Died Before ASU (Control)|0|||
146978261|NCT03499249|530082305|FG000|Overall Study|Physician Decision|1|||
146978262|NCT00435825|530082310|FG000|Overall Study|Abnormality of Laboratory Test|0|||
146582705|NCT01696968|528639688|FG000|Overall Study|Refused ASU (Control)|920|||
146582706|NCT01696968|528639689|FG001|Overall Study|Refused ASU (Control)|0|||
146582707|NCT01696968|528639688|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
146582708|NCT01696968|528639689|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
146582709|NCT03727646|528639690|FG000|Overall Study|Adverse Event|1|||
146582710|NCT03727646|528639691|FG001|Overall Study|Adverse Event|0|||
146582711|NCT04753658|528639694|FG000|Overall Study|Progressive disease|7|||
146582712|NCT04753658|528639694|FG000|Overall Study|Other|7|||
146582713|NCT04753658|528639694|FG000|Overall Study|Adverse Event|1|||
146582714|NCT05659719|528639695|FG000|Overall Study|At sponsor's request|0|||
146582715|NCT05659719|528639696|FG001|Overall Study|At sponsor's request|0|||
146582716|NCT05659719|528639697|FG002|Overall Study|At sponsor's request|0|||
146582717|NCT05659719|528639698|FG003|Overall Study|At sponsor's request|95|||
146582718|NCT05659719|528639695|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
146582719|NCT05659719|528639696|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
146582720|NCT05659719|528639697|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
146582721|NCT05659719|528639698|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
146582722|NCT05659719|528639695|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
146978263|NCT00435825|530082311|FG001|Overall Study|Abnormality of Laboratory Test|1|||
146978264|NCT00435825|530082312|FG002|Overall Study|Abnormality of Laboratory Test|0|||
146582723|NCT05659719|528639696|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
146582724|NCT05659719|528639697|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
146582725|NCT05659719|528639698|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
146582726|NCT05659719|528639695|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
146582727|NCT05659719|528639696|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
146582728|NCT05659719|528639697|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
146582729|NCT05659719|528639698|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
146582730|NCT05659719|528639695|FG000|Overall Study|Lost to Follow-up|0|||
146582731|NCT05659719|528639696|FG001|Overall Study|Lost to Follow-up|0|||
146582732|NCT05659719|528639697|FG002|Overall Study|Lost to Follow-up|0|||
146582733|NCT05659719|528639698|FG003|Overall Study|Lost to Follow-up|2|||
146582734|NCT05659719|528639695|FG000|Overall Study|Moved to another observational study|0|||
146582735|NCT05659719|528639696|FG001|Overall Study|Moved to another observational study|0|||
146582736|NCT05659719|528639697|FG002|Overall Study|Moved to another observational study|0|||
146582737|NCT05659719|528639698|FG003|Overall Study|Moved to another observational study|1|||
146582738|NCT05659719|528639695|FG000|Overall Study|The child was enrolled in an interventional study|0|||
146582739|NCT05659719|528639696|FG001|Overall Study|The child was enrolled in an interventional study|0|||
146582740|NCT05659719|528639697|FG002|Overall Study|The child was enrolled in an interventional study|0|||
146582741|NCT05659719|528639698|FG003|Overall Study|The child was enrolled in an interventional study|55|||
146582742|NCT05659719|528639695|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
146582743|NCT05659719|528639696|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
146582744|NCT05659719|528639697|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
146582745|NCT05659719|528639698|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
146582746|NCT05659719|528639695|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
146582747|NCT05659719|528639696|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
146582748|NCT05659719|528639697|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
146582749|NCT05659719|528639698|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
146582750|NCT05924165|528639705|FG000|Overall Study|Physician Decision|2|||
146582751|NCT05924165|528639706|FG001|Overall Study|Physician Decision|3|||
146582752|NCT01681186|528639707|FG000|Washout Period From Second Intervention|Adverse Event|0|||
146582753|NCT01681186|528639708|FG001|Washout Period From Second Intervention|Adverse Event|0|||
146582754|NCT01681186|528639709|FG002|Washout Period From Second Intervention|Adverse Event|0|||
146582755|NCT01681186|528639710|FG003|Washout Period From Second Intervention|Adverse Event|0|||
146582756|NCT01681186|528639711|FG004|Washout Period From Second Intervention|Adverse Event|0|||
146582757|NCT01681186|528639712|FG005|Washout Period From Second Intervention|Adverse Event|0|||
146582758|NCT01681186|528639713|FG006|Washout Period From Second Intervention|Adverse Event|1|||
146582759|NCT01681186|528639714|FG007|Washout Period From Second Intervention|Adverse Event|0|||
146582760|NCT01681186|528639707|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
146582761|NCT01681186|528639708|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
146582762|NCT01681186|528639709|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
146582763|NCT01681186|528639710|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
146582764|NCT01681186|528639711|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
146582765|NCT01681186|528639712|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
146582766|NCT01681186|528639713|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
146582767|NCT01681186|528639714|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
146582768|NCT01681186|528639707|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
146582769|NCT01681186|528639708|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
146582770|NCT01681186|528639709|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
146582771|NCT01681186|528639710|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
146582772|NCT01681186|528639711|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
146582773|NCT01681186|528639712|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
146582774|NCT01681186|528639713|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
146582775|NCT01681186|528639714|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
146582776|NCT01681186|528639707|FG000|Fourth Intervention|Protocol Violation|0|||
146582777|NCT01681186|528639708|FG001|Fourth Intervention|Protocol Violation|0|||
146582778|NCT01681186|528639709|FG002|Fourth Intervention|Protocol Violation|0|||
146582779|NCT01681186|528639710|FG003|Fourth Intervention|Protocol Violation|0|||
146582780|NCT01681186|528639711|FG004|Fourth Intervention|Protocol Violation|0|||
146582781|NCT01681186|528639712|FG005|Fourth Intervention|Protocol Violation|0|||
146582782|NCT01681186|528639713|FG006|Fourth Intervention|Protocol Violation|0|||
146582783|NCT01681186|528639714|FG007|Fourth Intervention|Protocol Violation|1|||
146978265|NCT00435825|530082313|FG003|Overall Study|Abnormality of Laboratory Test|0|||
146918617|NCT00630812|529864464|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
146918618|NCT00630812|529864465|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
146918619|NCT00630812|529864464|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
146918620|NCT00630812|529864465|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
146918621|NCT00630812|529864464|FG000|Double Blind Treatment Period|Non-compliance|0|||
146918622|NCT00630812|529864465|FG001|Double Blind Treatment Period|Non-compliance|1|||
146918623|NCT03430245|529864468|FG000|Overall Study|Withdrawal by Subject|6|||
146918624|NCT03430245|529864468|FG000|Overall Study|Lost to Follow-up|1|||
146918625|NCT05628181|529864469|FG000|Overall Study|Death|2|||
146978266|NCT00435825|530082310|FG000|Overall Study|Insufficient Therapeutic Response|3|||
146978267|NCT00435825|530082311|FG001|Overall Study|Insufficient Therapeutic Response|1|||
146978268|NCT00435825|530082312|FG002|Overall Study|Insufficient Therapeutic Response|0|||
146582784|NCT05160415|528639715|FG000|Overall Study|Withdrawal by Subject|3|||
146582785|NCT02582814|528639722|FG000|Overall Study|Study-specific withdrawal criteria|1|||
146582786|NCT02582814|528639723|FG001|Overall Study|Study-specific withdrawal criteria|0|||
146582787|NCT02582814|528639722|FG000|Overall Study|Withdrawal by Subject|4|||
146582788|NCT02582814|528639723|FG001|Overall Study|Withdrawal by Subject|3|||
146582789|NCT02582814|528639722|FG000|Overall Study|Adverse Event|4|||
146582790|NCT02582814|528639723|FG001|Overall Study|Adverse Event|4|||
146582791|NCT04308239|528639728|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
146582792|NCT04308239|528639729|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
146582793|NCT04308239|528639728|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
146582794|NCT04308239|528639729|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
146582795|NCT04308239|528639728|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
146582796|NCT04308239|528639729|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
146582797|NCT04308239|528639728|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
146582798|NCT04308239|528639729|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
146582799|NCT00316225|528639732|FG000|Overall Study|Adverse Event|2|||
146582800|NCT00316225|528639732|FG000|Overall Study|Physician Decision|3|||
146582801|NCT00316225|528639732|FG000|Overall Study|Progressive Disease|15|||
146582802|NCT00316225|528639732|FG000|Overall Study|Withdrawal by Subject|3|||
146582803|NCT00316225|528639732|FG000|Overall Study|Death|2|||
146582804|NCT01814878|528639733|FG000|Overall Study|Adverse Event|16|||
146582805|NCT01814878|528639734|FG001|Overall Study|Adverse Event|5|||
146582806|NCT01814878|528639733|FG000|Overall Study|Withdrawal by Subject|20|||
146582807|NCT01814878|528639734|FG001|Overall Study|Withdrawal by Subject|16|||
146582808|NCT01814878|528639733|FG000|Overall Study|Protocol Violation|5|||
146582809|NCT01814878|528639734|FG001|Overall Study|Protocol Violation|5|||
146582810|NCT01814878|528639733|FG000|Overall Study|Physician Decision|3|||
146582811|NCT01814878|528639734|FG001|Overall Study|Physician Decision|1|||
146582812|NCT01814878|528639733|FG000|Overall Study|Screening failure (drop-out)|0|||
146582813|NCT01814878|528639734|FG001|Overall Study|Screening failure (drop-out)|3|||
146582814|NCT01814878|528639733|FG000|Overall Study|Other|2|||
146582815|NCT01814878|528639734|FG001|Overall Study|Other|0|||
146582816|NCT00878254|528639739|FG000|Overall Study|Physician Decision|1|||
146582817|NCT00878254|528639739|FG000|Overall Study|Death|1|||
146582818|NCT00878254|528639739|FG000|Overall Study|Withdrawal by Subject|1|||
146582819|NCT00194077|528639743|FG000|Overall Study|Lack of Efficacy|22|||
146582820|NCT00194077|528639744|FG001|Overall Study|Lack of Efficacy|29|||
146582821|NCT00194077|528639743|FG000|Overall Study|Study nonadherence|1|||
146582822|NCT00194077|528639744|FG001|Overall Study|Study nonadherence|0|||
146582823|NCT00194077|528639743|FG000|Overall Study|Withdrawal by Subject|1|||
146582824|NCT00194077|528639744|FG001|Overall Study|Withdrawal by Subject|1|||
146582825|NCT03470194|528639747|FG000|Overall Study|Lost to Follow-up|11|||
146582826|NCT03470194|528639748|FG001|Overall Study|Lost to Follow-up|17|||
146582827|NCT05332392|528639749|FG000|Overall Study|Did not meet inclusion criteria|25|||
146582828|NCT05332392|528639749|FG000|Overall Study|Principal Investigator's decision|17|||
146582829|NCT05332392|528639749|FG000|Overall Study|Adverse Event|1|||
146582830|NCT05332392|528639749|FG000|Overall Study|Subject's decision|1|||
146582831|NCT01268046|528639750|FG000|Overall Study|Withdrawal by Subject|1|||
146582832|NCT01268046|528639751|FG001|Overall Study|Withdrawal by Subject|0|||
146582833|NCT01268046|528639752|FG002|Overall Study|Withdrawal by Subject|0|||
146582834|NCT01268046|528639753|FG003|Overall Study|Withdrawal by Subject|1|||
146582835|NCT01268046|528639750|FG000|Overall Study|Lost to Follow-up|0|||
146582836|NCT01268046|528639751|FG001|Overall Study|Lost to Follow-up|0|||
146918626|NCT05628181|529864470|FG001|Overall Study|Death|4|||
146582837|NCT01268046|528639752|FG002|Overall Study|Lost to Follow-up|1|||
146582838|NCT01268046|528639753|FG003|Overall Study|Lost to Follow-up|0|||
146582839|NCT01450696|528639755|FG000|Overall Study|Never Treated|1|||
146582840|NCT01450696|528639756|FG001|Overall Study|Never Treated|1|||
146582841|NCT01450696|528639755|FG000|Overall Study|Death|77|||
146770834|NCT00442117|529328693|FG000|Overall Study|Withdrawal by Subject|2|||
146918627|NCT05628181|529864471|FG002|Overall Study|Death|0|||
146918628|NCT04102098|529864472|FG000|Main Study Period|Ongoing in study|302|||
146582842|NCT01450696|528639756|FG001|Overall Study|Death|84|||
146582843|NCT01450696|528639755|FG000|Overall Study|Lost to Follow-up|3|||
146582844|NCT01450696|528639756|FG001|Overall Study|Lost to Follow-up|3|||
146582845|NCT01450696|528639755|FG000|Overall Study|Non-Compliance|1|||
146582846|NCT01450696|528639756|FG001|Overall Study|Non-Compliance|0|||
146582847|NCT01450696|528639755|FG000|Overall Study|Withdrawal by Subject|13|||
146582848|NCT01450696|528639756|FG001|Overall Study|Withdrawal by Subject|2|||
146582849|NCT01450696|528639755|FG000|Overall Study|Study Terminated by Sponsor|53|||
146582850|NCT01450696|528639756|FG001|Overall Study|Study Terminated by Sponsor|58|||
146582851|NCT03818607|528639757|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
146582852|NCT03818607|528639758|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
146582853|NCT03818607|528639757|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
146582854|NCT03818607|528639758|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
146582855|NCT03818607|528639757|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
146582856|NCT03818607|528639758|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
146582857|NCT05730335|528639763|FG000|Overall Study|Lost to Follow-up|8|||
146582858|NCT05730335|528639763|FG000|Overall Study|Withdrawal by Subject|6|||
146582859|NCT00615719|528639772|FG000|Overall Study|Physician Decision|5|||
146582860|NCT03748706|528639773|FG000|Overall Study|Lost to Follow-up|1|||
146582861|NCT00842153|528639774|FG000|Overall Study|Adverse Event|0|||
146582862|NCT00842153|528639775|FG001|Overall Study|Adverse Event|1|||
146582863|NCT00842153|528639774|FG000|Overall Study|Lost to Follow-up|1|||
146582864|NCT00842153|528639775|FG001|Overall Study|Lost to Follow-up|2|||
146582865|NCT01355679|528639777|FG000|Overall Study|benign tumor types found at biopsy|2|||
146582866|NCT05319600|528639779|FG000|Overall Study|Withdrawal by Subject|1|||
146582867|NCT05319600|528639780|FG001|Overall Study|Withdrawal by Subject|0|||
146582868|NCT05319600|528639779|FG000|Overall Study|Lost to Follow-up|0|||
146582869|NCT05319600|528639780|FG001|Overall Study|Lost to Follow-up|4|||
146582870|NCT05141175|528639787|FG000|Overall Study|Withdrawal by Subject|1|||
146582871|NCT01104545|528639793|FG000|Overall Study|Adverse Event|0|||
146582872|NCT01104545|528639794|FG001|Overall Study|Adverse Event|1|||
146582873|NCT01104545|528639795|FG002|Overall Study|Adverse Event|2|||
146582874|NCT00923351|528639796|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
146582875|NCT00923351|528639797|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
146582876|NCT00923351|528639798|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
146582877|NCT01262560|528639805|FG000|Overall Study|Protocol Violation|0|||
146582878|NCT01262560|528639806|FG001|Overall Study|Protocol Violation|1|||
146582879|NCT01262560|528639807|FG002|Overall Study|Protocol Violation|2|||
146582880|NCT02443116|528639812|FG000|Part 1|Adverse Event|2|||
146582881|NCT02443116|528639813|FG001|Part 1|Adverse Event|3|||
146582882|NCT02443116|528639814|FG002|Part 1|Adverse Event|0|||
146582883|NCT02443116|528639815|FG003|Part 1|Adverse Event|0|||
146582884|NCT02443116|528639816|FG004|Part 1|Adverse Event|0|||
146582885|NCT02443116|528639817|FG005|Part 1|Adverse Event|0|||
146582886|NCT02443116|528639818|FG006|Part 1|Adverse Event|0|||
146582887|NCT02443116|528639819|FG007|Part 1|Adverse Event|0|||
146918629|NCT04102098|529864473|FG001|Main Study Period|Ongoing in study|291|||
146918630|NCT04102098|529864472|FG000|Main Study Period|Death|20|||
146918631|NCT04102098|529864473|FG001|Main Study Period|Death|27|||
146582888|NCT02443116|528639820|FG008|Part 1|Adverse Event|0|||
146582889|NCT02443116|528639812|FG000|Part 1|Withdrew informed consent|0|||
146582890|NCT02443116|528639813|FG001|Part 1|Withdrew informed consent|1|||
146582891|NCT02443116|528639814|FG002|Part 1|Withdrew informed consent|0|||
146582892|NCT02443116|528639815|FG003|Part 1|Withdrew informed consent|0|||
146582893|NCT02443116|528639816|FG004|Part 1|Withdrew informed consent|0|||
146582894|NCT02443116|528639817|FG005|Part 1|Withdrew informed consent|0|||
146582895|NCT02443116|528639818|FG006|Part 1|Withdrew informed consent|0|||
146582896|NCT02443116|528639819|FG007|Part 1|Withdrew informed consent|0|||
146582897|NCT02443116|528639820|FG008|Part 1|Withdrew informed consent|0|||
146918632|NCT04102098|529864472|FG000|Main Study Period|Lost to Follow-up|1|||
146582898|NCT02443116|528639812|FG000|Part 1|Lost to Follow-up|0|||
146582899|NCT02443116|528639813|FG001|Part 1|Lost to Follow-up|0|||
146652061|NCT00282464|528903756|FG000|Overall Study|laboratory abnormality|1|||
146652062|NCT00282464|528903757|FG001|Overall Study|laboratory abnormality|2|||
146652063|NCT00282464|528903756|FG000|Overall Study|Protocol Violation|0|||
146652064|NCT00282464|528903757|FG001|Overall Study|Protocol Violation|7|||
146918633|NCT04102098|529864473|FG001|Main Study Period|Lost to Follow-up|1|||
146582900|NCT02443116|528639814|FG002|Part 1|Lost to Follow-up|2|||
146582901|NCT02443116|528639815|FG003|Part 1|Lost to Follow-up|0|||
146582902|NCT02443116|528639816|FG004|Part 1|Lost to Follow-up|0|||
146582903|NCT02443116|528639817|FG005|Part 1|Lost to Follow-up|0|||
146582904|NCT02443116|528639818|FG006|Part 1|Lost to Follow-up|0|||
146582905|NCT02443116|528639819|FG007|Part 1|Lost to Follow-up|0|||
146582906|NCT02443116|528639820|FG008|Part 1|Lost to Follow-up|0|||
146652065|NCT00282464|528903756|FG000|Overall Study|Patient moved|1|||
146918634|NCT04102098|529864472|FG000|Main Study Period|Physician Decision|0|||
146582907|NCT02443116|528639812|FG000|Part 1|Participant moved out of state|0|||
146582908|NCT02443116|528639813|FG001|Part 1|Participant moved out of state|0|||
146582909|NCT02443116|528639814|FG002|Part 1|Participant moved out of state|1|||
146582910|NCT02443116|528639815|FG003|Part 1|Participant moved out of state|0|||
146582911|NCT02443116|528639816|FG004|Part 1|Participant moved out of state|0|||
146582912|NCT02443116|528639817|FG005|Part 1|Participant moved out of state|0|||
146582913|NCT02443116|528639818|FG006|Part 1|Participant moved out of state|0|||
146582914|NCT02443116|528639819|FG007|Part 1|Participant moved out of state|0|||
146582915|NCT02443116|528639820|FG008|Part 1|Participant moved out of state|0|||
146582916|NCT02443116|528639812|FG000|Part 1|Participant enrolled in another clinical trial|0|||
146582917|NCT02443116|528639813|FG001|Part 1|Participant enrolled in another clinical trial|0|||
146582918|NCT02443116|528639814|FG002|Part 1|Participant enrolled in another clinical trial|1|||
146582919|NCT02443116|528639815|FG003|Part 1|Participant enrolled in another clinical trial|0|||
146582920|NCT02443116|528639816|FG004|Part 1|Participant enrolled in another clinical trial|0|||
146582921|NCT02443116|528639817|FG005|Part 1|Participant enrolled in another clinical trial|0|||
146582922|NCT02443116|528639818|FG006|Part 1|Participant enrolled in another clinical trial|0|||
146582923|NCT02443116|528639819|FG007|Part 1|Participant enrolled in another clinical trial|0|||
146582924|NCT02443116|528639820|FG008|Part 1|Participant enrolled in another clinical trial|0|||
146582925|NCT02443116|528639812|FG000|Part 2|Adverse Event|0|||
146582926|NCT02443116|528639813|FG001|Part 2|Adverse Event|0|||
146582927|NCT02443116|528639814|FG002|Part 2|Adverse Event|0|||
146582928|NCT02443116|528639815|FG003|Part 2|Adverse Event|0|||
146582929|NCT02443116|528639816|FG004|Part 2|Adverse Event|1|||
146582930|NCT02443116|528639817|FG005|Part 2|Adverse Event|1|||
146582931|NCT02443116|528639818|FG006|Part 2|Adverse Event|2|||
146582932|NCT02443116|528639819|FG007|Part 2|Adverse Event|0|||
146582933|NCT02443116|528639820|FG008|Part 2|Adverse Event|0|||
146582934|NCT02443116|528639812|FG000|Part 2|Withdrew informed consent|0|||
146582935|NCT02443116|528639813|FG001|Part 2|Withdrew informed consent|0|||
146582936|NCT02443116|528639814|FG002|Part 2|Withdrew informed consent|0|||
146582937|NCT02443116|528639815|FG003|Part 2|Withdrew informed consent|0|||
146582938|NCT02443116|528639816|FG004|Part 2|Withdrew informed consent|0|||
146582939|NCT02443116|528639817|FG005|Part 2|Withdrew informed consent|1|||
146582940|NCT02443116|528639818|FG006|Part 2|Withdrew informed consent|1|||
146582941|NCT02443116|528639819|FG007|Part 2|Withdrew informed consent|0|||
146582942|NCT02443116|528639820|FG008|Part 2|Withdrew informed consent|0|||
146582943|NCT02443116|528639812|FG000|Part 2|Inability to comply with protocol|0|||
146582944|NCT02443116|528639813|FG001|Part 2|Inability to comply with protocol|0|||
146582945|NCT02443116|528639814|FG002|Part 2|Inability to comply with protocol|0|||
146582946|NCT02443116|528639815|FG003|Part 2|Inability to comply with protocol|1|||
146582947|NCT02443116|528639816|FG004|Part 2|Inability to comply with protocol|0|||
146582948|NCT02443116|528639817|FG005|Part 2|Inability to comply with protocol|0|||
146582949|NCT02443116|528639818|FG006|Part 2|Inability to comply with protocol|0|||
146582950|NCT02443116|528639819|FG007|Part 2|Inability to comply with protocol|0|||
146582951|NCT02443116|528639820|FG008|Part 2|Inability to comply with protocol|0|||
146582952|NCT02443116|528639812|FG000|Part 2|Lost to Follow-up|0|||
146582953|NCT02443116|528639813|FG001|Part 2|Lost to Follow-up|0|||
146582954|NCT02443116|528639814|FG002|Part 2|Lost to Follow-up|0|||
146582955|NCT02443116|528639815|FG003|Part 2|Lost to Follow-up|1|||
146582956|NCT02443116|528639816|FG004|Part 2|Lost to Follow-up|0|||
146582957|NCT02443116|528639817|FG005|Part 2|Lost to Follow-up|0|||
146918635|NCT04102098|529864473|FG001|Main Study Period|Physician Decision|1|||
146918636|NCT04102098|529864472|FG000|Main Study Period|Withdrawal by Subject|11|||
146918637|NCT04102098|529864473|FG001|Main Study Period|Withdrawal by Subject|14|||
146918638|NCT04102098|529864472|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
146582958|NCT02443116|528639818|FG006|Part 2|Lost to Follow-up|0|||
146582959|NCT02443116|528639819|FG007|Part 2|Lost to Follow-up|0|||
146582960|NCT02443116|528639820|FG008|Part 2|Lost to Follow-up|0|||
146582961|NCT02443116|528639812|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
146582962|NCT02443116|528639813|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
146582963|NCT02443116|528639814|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
146582964|NCT02443116|528639815|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
146582965|NCT02443116|528639816|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
146582966|NCT02443116|528639817|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
146582967|NCT02443116|528639818|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
146582968|NCT02443116|528639819|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
146918639|NCT04102098|529864473|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
146918640|NCT04102098|529864472|FG000|Crossover: AS Who Crossed Over|Death|11|||
146918641|NCT04102098|529864473|FG001|Crossover: AS Who Crossed Over|Death|0|||
146582969|NCT02443116|528639820|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
146582970|NCT02443116|528639812|FG000|Part 3|Adverse Event|0|||
146582971|NCT02443116|528639813|FG001|Part 3|Adverse Event|0|||
146582972|NCT02443116|528639814|FG002|Part 3|Adverse Event|0|||
146582973|NCT02443116|528639815|FG003|Part 3|Adverse Event|0|||
146582974|NCT02443116|528639816|FG004|Part 3|Adverse Event|0|||
146582975|NCT02443116|528639817|FG005|Part 3|Adverse Event|0|||
146582976|NCT02443116|528639818|FG006|Part 3|Adverse Event|0|||
146582977|NCT02443116|528639819|FG007|Part 3|Adverse Event|0|||
146582978|NCT02443116|528639820|FG008|Part 3|Adverse Event|1|||
146582979|NCT02443116|528639812|FG000|Part 3|Withdrew informed consent|0|||
146582980|NCT02443116|528639813|FG001|Part 3|Withdrew informed consent|0|||
146582981|NCT02443116|528639814|FG002|Part 3|Withdrew informed consent|0|||
146582982|NCT02443116|528639815|FG003|Part 3|Withdrew informed consent|0|||
146582983|NCT02443116|528639816|FG004|Part 3|Withdrew informed consent|0|||
146582984|NCT02443116|528639817|FG005|Part 3|Withdrew informed consent|0|||
146582985|NCT02443116|528639818|FG006|Part 3|Withdrew informed consent|0|||
146582986|NCT02443116|528639819|FG007|Part 3|Withdrew informed consent|3|||
146582987|NCT02443116|528639820|FG008|Part 3|Withdrew informed consent|2|||
146582988|NCT02443116|528639812|FG000|Part 3|Lost to Follow-up|0|||
146582989|NCT02443116|528639813|FG001|Part 3|Lost to Follow-up|0|||
146582990|NCT02443116|528639814|FG002|Part 3|Lost to Follow-up|0|||
146582991|NCT02443116|528639815|FG003|Part 3|Lost to Follow-up|0|||
146582992|NCT02443116|528639816|FG004|Part 3|Lost to Follow-up|0|||
146582993|NCT02443116|528639817|FG005|Part 3|Lost to Follow-up|0|||
146582994|NCT02443116|528639818|FG006|Part 3|Lost to Follow-up|0|||
146582995|NCT02443116|528639819|FG007|Part 3|Lost to Follow-up|1|||
146582996|NCT02443116|528639820|FG008|Part 3|Lost to Follow-up|2|||
146582997|NCT04295759|528639821|FG000|Overall Study|Lack of Efficacy|9|||
146582998|NCT04295759|528639821|FG000|Overall Study|Death|1|||
146582999|NCT04295759|528639821|FG000|Overall Study|Withdrawal by Subject|2|||
146583000|NCT04295759|528639821|FG000|Overall Study|Deemed ineligible|1|||
146583001|NCT02470585|528639822|FG000|Overall Study|Death|224|||
146583002|NCT02470585|528639823|FG001|Overall Study|Death|227|||
146583003|NCT02470585|528639824|FG002|Overall Study|Death|199|||
146583004|NCT02470585|528639822|FG000|Overall Study|Withdrew consent|21|||
146583005|NCT02470585|528639823|FG001|Overall Study|Withdrew consent|22|||
146583006|NCT02470585|528639824|FG002|Overall Study|Withdrew consent|31|||
146583007|NCT02470585|528639822|FG000|Overall Study|Lost to Follow-up|8|||
146583008|NCT02470585|528639823|FG001|Overall Study|Lost to Follow-up|15|||
146583009|NCT02470585|528639824|FG002|Overall Study|Lost to Follow-up|13|||
146583010|NCT02470585|528639822|FG000|Overall Study|Sponsor discontinued study|117|||
146583011|NCT02470585|528639823|FG001|Overall Study|Sponsor discontinued study|110|||
146583012|NCT02470585|528639824|FG002|Overall Study|Sponsor discontinued study|122|||
146583013|NCT02470585|528639822|FG000|Overall Study|Other, not specified|5|||
146583014|NCT02470585|528639823|FG001|Overall Study|Other, not specified|7|||
146583015|NCT02470585|528639824|FG002|Overall Study|Other, not specified|14|||
146583016|NCT02470585|528639822|FG000|Overall Study|Missing due to site non-compliance|0|||
146583017|NCT02470585|528639823|FG001|Overall Study|Missing due to site non-compliance|2|||
146583018|NCT02470585|528639824|FG002|Overall Study|Missing due to site non-compliance|3|||
146583019|NCT00465972|528639825|FG000|Overall Study|Withdrawal by Subject|2|||
146583020|NCT00465972|528639826|FG001|Overall Study|Withdrawal by Subject|1|||
146583021|NCT00349349|528639827|FG000|Overall Study|Adverse Event|5|||
146583022|NCT00349349|528639828|FG001|Overall Study|Adverse Event|6|||
146583023|NCT00349349|528639829|FG002|Overall Study|Adverse Event|2|||
146583024|NCT00349349|528639827|FG000|Overall Study|Withdrawal by Subject|5|||
146583025|NCT00349349|528639828|FG001|Overall Study|Withdrawal by Subject|2|||
146583026|NCT00349349|528639829|FG002|Overall Study|Withdrawal by Subject|1|||
146583027|NCT00349349|528639827|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
146583028|NCT00349349|528639828|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
146583029|NCT00349349|528639829|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
146652066|NCT00282464|528903757|FG001|Overall Study|Patient moved|0|||
146652067|NCT00282464|528903756|FG000|Overall Study|patient non-compliant|3|||
146652068|NCT00282464|528903757|FG001|Overall Study|patient non-compliant|0|||
146652069|NCT00282464|528903756|FG000|Overall Study|patient no show|0|||
146652070|NCT00282464|528903757|FG001|Overall Study|patient no show|1|||
146652071|NCT00282464|528903756|FG000|Overall Study|patient incarcerated|0|||
146652072|NCT00282464|528903757|FG001|Overall Study|patient incarcerated|1|||
146652073|NCT00282464|528903756|FG000|Overall Study|family crisis|0|||
146652074|NCT00282464|528903757|FG001|Overall Study|family crisis|1|||
146652075|NCT00282464|528903756|FG000|Overall Study|dispensed wrong kit|0|||
146652076|NCT00282464|528903757|FG001|Overall Study|dispensed wrong kit|1|||
146583030|NCT00349349|528639827|FG000|Overall Study|Death|13|||
146583031|NCT00349349|528639828|FG001|Overall Study|Death|10|||
146652077|NCT00282464|528903756|FG000|Overall Study|dropped due to missed visits|0|||
146583032|NCT00349349|528639829|FG002|Overall Study|Death|1|||
146583033|NCT00349349|528639827|FG000|Overall Study|Other Treatment Selected|2|||
146583034|NCT00349349|528639828|FG001|Overall Study|Other Treatment Selected|0|||
146583035|NCT00349349|528639829|FG002|Overall Study|Other Treatment Selected|0|||
146583036|NCT00349349|528639827|FG000|Overall Study|Participant Reduced General Condition|0|||
146583037|NCT00349349|528639828|FG001|Overall Study|Participant Reduced General Condition|1|||
146652078|NCT00282464|528903757|FG001|Overall Study|dropped due to missed visits|1|||
146652079|NCT00475423|528903758|FG000|Overall Study|Protocol Violation|5|||
146583038|NCT00349349|528639829|FG002|Overall Study|Participant Reduced General Condition|0|||
146583039|NCT00349349|528639827|FG000|Overall Study|Physician Decision|1|||
146652080|NCT00475423|528903758|FG000|Overall Study|Adverse Event|4|||
146583040|NCT00349349|528639828|FG001|Overall Study|Physician Decision|2|||
146583041|NCT00349349|528639829|FG002|Overall Study|Physician Decision|1|||
146583042|NCT00349349|528639827|FG000|Overall Study|No Response|0|||
146583043|NCT00349349|528639828|FG001|Overall Study|No Response|3|||
146583044|NCT00349349|528639829|FG002|Overall Study|No Response|0|||
146583045|NCT00349349|528639827|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
146583046|NCT00349349|528639828|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
146583047|NCT00349349|528639829|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
146583048|NCT03028415|528639830|FG000|Overall Study|Lost to Follow-up|6|||
146583049|NCT03028415|528639831|FG001|Overall Study|Lost to Follow-up|3|||
146583050|NCT03028415|528639830|FG000|Overall Study|Withdrawal by Subject|1|||
146583051|NCT03028415|528639831|FG001|Overall Study|Withdrawal by Subject|0|||
146583052|NCT03028415|528639830|FG000|Overall Study|Discontinued due to COVID-19|1|||
146583053|NCT03028415|528639831|FG001|Overall Study|Discontinued due to COVID-19|0|||
146583054|NCT01108731|528639839|FG000|Overall Study|Withdrawal by Subject|1|||
146583055|NCT01108731|528639840|FG001|Overall Study|Withdrawal by Subject|1|||
146583056|NCT01108731|528639839|FG000|Overall Study|Adverse Event|3|||
146583057|NCT01108731|528639840|FG001|Overall Study|Adverse Event|3|||
146583058|NCT01063062|528639841|FG000|Overall Study|Patient withdrew consent|0|||
146583059|NCT01063062|528639842|FG001|Overall Study|Patient withdrew consent|1|||
146583060|NCT01063062|528639841|FG000|Overall Study|Adverse Event|2|||
146583061|NCT01063062|528639842|FG001|Overall Study|Adverse Event|4|||
146583062|NCT01063062|528639841|FG000|Overall Study|Protocol Violation|5|||
146583063|NCT01063062|528639842|FG001|Overall Study|Protocol Violation|4|||
146583064|NCT01063062|528639841|FG000|Overall Study|Investigator's request|1|||
146583065|NCT01063062|528639842|FG001|Overall Study|Investigator's request|0|||
146583066|NCT01063062|528639841|FG000|Overall Study|Lost to Follow-up|0|||
146583067|NCT01063062|528639842|FG001|Overall Study|Lost to Follow-up|2|||
146583068|NCT01063062|528639841|FG000|Overall Study|Miscellaneous reason|0|||
146583069|NCT01063062|528639842|FG001|Overall Study|Miscellaneous reason|1|||
146583070|NCT02015481|528639843|FG000|Overall Study|Death|1|||
146583071|NCT01352221|528639850|FG000|Double-blind Phase|Adverse Event|6|||
146583072|NCT01352221|528639851|FG001|Double-blind Phase|Adverse Event|4|||
146583073|NCT01352221|528639852|FG002|Double-blind Phase|Adverse Event|0|||
146583074|NCT01352221|528639853|FG003|Double-blind Phase|Adverse Event|0|||
146583075|NCT01352221|528639850|FG000|Double-blind Phase|Withdrawal by Subject|3|||
146583076|NCT01352221|528639851|FG001|Double-blind Phase|Withdrawal by Subject|5|||
146583077|NCT01352221|528639852|FG002|Double-blind Phase|Withdrawal by Subject|0|||
146583078|NCT01352221|528639853|FG003|Double-blind Phase|Withdrawal by Subject|0|||
146583079|NCT01352221|528639850|FG000|Double-blind Phase|Lost to Follow-up|0|||
146583080|NCT01352221|528639851|FG001|Double-blind Phase|Lost to Follow-up|1|||
146583081|NCT01352221|528639852|FG002|Double-blind Phase|Lost to Follow-up|0|||
146583082|NCT01352221|528639853|FG003|Double-blind Phase|Lost to Follow-up|0|||
146583083|NCT01352221|528639850|FG000|Double-blind Phase|Protocol Violation|0|||
146583084|NCT01352221|528639851|FG001|Double-blind Phase|Protocol Violation|1|||
146583085|NCT01352221|528639852|FG002|Double-blind Phase|Protocol Violation|0|||
146583086|NCT01352221|528639853|FG003|Double-blind Phase|Protocol Violation|0|||
146583087|NCT01352221|528639850|FG000|Open-label Phase|Physician Decision|0|||
146583088|NCT01352221|528639851|FG001|Open-label Phase|Physician Decision|0|||
146583089|NCT01352221|528639852|FG002|Open-label Phase|Physician Decision|2|||
146583090|NCT01352221|528639853|FG003|Open-label Phase|Physician Decision|1|||
146652081|NCT00475423|528903758|FG000|Overall Study|Withdrawal by Subject|6|||
146652082|NCT00475423|528903758|FG000|Overall Study|Lack of Efficacy|8|||
146652083|NCT00475423|528903758|FG000|Overall Study|Death|1|||
146652084|NCT00475423|528903758|FG000|Overall Study|Reason not specified|1|||
146652085|NCT00475423|528903758|FG000|Overall Study|Lost to Follow-up|7|||
146918642|NCT04102098|529864472|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
146583091|NCT01352221|528639850|FG000|Open-label Phase|Pregnancy|0|||
146583092|NCT01352221|528639851|FG001|Open-label Phase|Pregnancy|0|||
146918643|NCT04102098|529864473|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
146583093|NCT01352221|528639852|FG002|Open-label Phase|Pregnancy|1|||
146583094|NCT01352221|528639853|FG003|Open-label Phase|Pregnancy|0|||
146583095|NCT01352221|528639850|FG000|Open-label Phase|Adverse Event|0|||
146583096|NCT01352221|528639851|FG001|Open-label Phase|Adverse Event|0|||
146652086|NCT01214174|528903759|FG000|Overall Study|Withdrawal by Subject|0|||
146652087|NCT01214174|528903760|FG001|Overall Study|Withdrawal by Subject|0|||
146583097|NCT01352221|528639852|FG002|Open-label Phase|Adverse Event|8|||
146583098|NCT01352221|528639853|FG003|Open-label Phase|Adverse Event|4|||
146583099|NCT01352221|528639850|FG000|Open-label Phase|Withdrawal by Subject|0|||
146583100|NCT01352221|528639851|FG001|Open-label Phase|Withdrawal by Subject|0|||
146583101|NCT01352221|528639852|FG002|Open-label Phase|Withdrawal by Subject|1|||
146583102|NCT01352221|528639853|FG003|Open-label Phase|Withdrawal by Subject|6|||
146583103|NCT01352221|528639850|FG000|Open-label Phase|Worsening of IBD|0|||
146583104|NCT01352221|528639851|FG001|Open-label Phase|Worsening of IBD|0|||
146583105|NCT01352221|528639852|FG002|Open-label Phase|Worsening of IBD|1|||
146583106|NCT01352221|528639853|FG003|Open-label Phase|Worsening of IBD|0|||
146652088|NCT01214174|528903761|FG002|Overall Study|Withdrawal by Subject|1|||
146652089|NCT02496676|528903766|FG000|Phase 1 - Period 1|Adverse Event|0|||
146583107|NCT01170273|528639855|FG000|Overall Study|Lost to Follow-up|6|||
146583108|NCT01170273|528639856|FG001|Overall Study|Lost to Follow-up|8|||
146583109|NCT01170273|528639855|FG000|Overall Study|Protocol Violation|1|||
146583110|NCT01170273|528639856|FG001|Overall Study|Protocol Violation|0|||
146583111|NCT01170273|528639855|FG000|Overall Study|Death|1|||
146583112|NCT01170273|528639856|FG001|Overall Study|Death|0|||
146583113|NCT01170273|528639855|FG000|Overall Study|Adverse Event|0|||
146583114|NCT01170273|528639856|FG001|Overall Study|Adverse Event|1|||
146583115|NCT01673854|528639857|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
146583116|NCT01673854|528639857|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
146583117|NCT01673854|528639857|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
146583118|NCT01673854|528639857|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
146583119|NCT01673854|528639857|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
146583120|NCT01673854|528639857|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
146583121|NCT01673854|528639857|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
146583122|NCT01673854|528639857|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
146583123|NCT01673854|528639857|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
146583124|NCT01673854|528639857|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
146583125|NCT01673854|528639857|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
146583126|NCT01673854|528639857|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
146583127|NCT05897242|528641702|FG000|Overall Study|Lost to Follow-up|6|||
146583128|NCT05897242|528641703|FG001|Overall Study|Lost to Follow-up|1|||
146583129|NCT05897242|528641702|FG000|Overall Study|Incomplete|1|||
146583130|NCT05897242|528641703|FG001|Overall Study|Incomplete|0|||
146583131|NCT05897242|528641702|FG000|Overall Study|Withdrawal by Subject|1|||
146583132|NCT05897242|528641703|FG001|Overall Study|Withdrawal by Subject|0|||
146583133|NCT00809835|528641704|FG000|Overall Study|Lost to Follow-up|7|||
146583134|NCT00809835|528641705|FG001|Overall Study|Lost to Follow-up|6|||
146583135|NCT00809835|528641706|FG002|Overall Study|Lost to Follow-up|10|||
146583136|NCT00809835|528641707|FG003|Overall Study|Lost to Follow-up|2|||
146583137|NCT00809835|528641704|FG000|Overall Study|Withdrawal by Subject|1|||
146583138|NCT00809835|528641705|FG001|Overall Study|Withdrawal by Subject|1|||
146583139|NCT00809835|528641706|FG002|Overall Study|Withdrawal by Subject|1|||
146583140|NCT00809835|528641707|FG003|Overall Study|Withdrawal by Subject|0|||
146583141|NCT03530995|528641711|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
146583142|NCT03530995|528641712|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
146583143|NCT03530995|528641711|FG000|Part 1 Period 3|Protocol Violation|1|||
146583144|NCT03530995|528641712|FG001|Part 1 Period 3|Protocol Violation|0|||
146583145|NCT03530995|528641711|FG000|Part 1 Period 4|Physician Decision|1|||
146583146|NCT03530995|528641712|FG001|Part 1 Period 4|Physician Decision|0|||
146583147|NCT03530995|528641711|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
146583148|NCT03530995|528641712|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
146583149|NCT04848220|528641715|FG000|Overall Study|Unable to proceed to study procedure|0|||
146583150|NCT04848220|528641716|FG001|Overall Study|Unable to proceed to study procedure|1|||
146583151|NCT04848220|528641717|FG002|Overall Study|Unable to proceed to study procedure|0|||
146583152|NCT04848220|528641715|FG000|Overall Study|Fractional flow not significant|0|||
146583153|NCT04848220|528641716|FG001|Overall Study|Fractional flow not significant|1|||
146583154|NCT04848220|528641717|FG002|Overall Study|Fractional flow not significant|0|||
146583155|NCT02557100|528641728|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
146583156|NCT02557100|528641729|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
146583157|NCT02557100|528641730|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
146583158|NCT02557100|528641728|FG000|Single Blind Treatment Period|Death|0|||
146583159|NCT02557100|528641729|FG001|Single Blind Treatment Period|Death|1|||
146583160|NCT02557100|528641730|FG002|Single Blind Treatment Period|Death|0|||
146583161|NCT02557100|528641728|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
146583162|NCT02557100|528641729|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
146583163|NCT02557100|528641730|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
146583164|NCT02557100|528641728|FG000|Single Blind Treatment Period|Adverse Event|0|||
146583165|NCT02557100|528641729|FG001|Single Blind Treatment Period|Adverse Event|1|||
146583166|NCT02557100|528641730|FG002|Single Blind Treatment Period|Adverse Event|0|||
146583167|NCT02557100|528641728|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
146583168|NCT02557100|528641729|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
146583169|NCT02557100|528641730|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
146583170|NCT02557100|528641728|FG000|Cumulative Abatacept Period|Other Reasons|0|||
146652090|NCT02496676|528903767|FG001|Phase 1 - Period 1|Adverse Event|1|||
146652091|NCT02496676|528903766|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
146583171|NCT02557100|528641729|FG001|Cumulative Abatacept Period|Other Reasons|0|||
146978269|NCT00435825|530082313|FG003|Overall Study|Insufficient Therapeutic Response|3|||
146583172|NCT02557100|528641730|FG002|Cumulative Abatacept Period|Other Reasons|1|||
146583173|NCT02557100|528641728|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
146583174|NCT02557100|528641729|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
146652092|NCT02496676|528903767|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
146583175|NCT02557100|528641730|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
146583176|NCT02557100|528641728|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
146583177|NCT02557100|528641729|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
146583178|NCT02557100|528641730|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
146583179|NCT00510718|528641731|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
146583180|NCT00510718|528641732|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
146583181|NCT00510718|528641731|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
146583182|NCT00510718|528641732|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
146583183|NCT00510718|528641731|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
146583184|NCT00510718|528641732|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
146583185|NCT00510718|528641731|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
146583186|NCT00510718|528641732|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
146583187|NCT00510718|528641731|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
146583188|NCT00510718|528641732|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
146583189|NCT00510718|528641731|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
146583190|NCT00510718|528641732|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
146583191|NCT05791565|528641740|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
146583192|NCT05791565|528641741|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
146583193|NCT02388165|528641742|FG000|Overall Study|Study terminated by sponsor|5|||
146583194|NCT02388165|528641743|FG001|Overall Study|Study terminated by sponsor|5|||
146583195|NCT02388165|528641742|FG000|Overall Study|Other|11|||
146583196|NCT02388165|528641743|FG001|Overall Study|Other|13|||
146583197|NCT02388165|528641742|FG000|Overall Study|No longer meet eligibility criteria|40|||
146583198|NCT02388165|528641743|FG001|Overall Study|No longer meet eligibility criteria|43|||
146583199|NCT02388165|528641742|FG000|Overall Study|Withdrawal of consent|31|||
146583200|NCT02388165|528641743|FG001|Overall Study|Withdrawal of consent|32|||
146583201|NCT02388165|528641742|FG000|Overall Study|Lost to Follow-up|19|||
146583202|NCT02388165|528641743|FG001|Overall Study|Lost to Follow-up|20|||
146583203|NCT02388165|528641742|FG000|Overall Study|Death|13|||
146583204|NCT02388165|528641743|FG001|Overall Study|Death|10|||
146583205|NCT02388165|528641742|FG000|Overall Study|Adverse Event|3|||
146583206|NCT02388165|528641743|FG001|Overall Study|Adverse Event|5|||
146583207|NCT02388165|528641742|FG000|Overall Study|Did not meet entrance criteria|5|||
146583208|NCT02388165|528641743|FG001|Overall Study|Did not meet entrance criteria|2|||
146583209|NCT00705250|528641744|FG000|Overall Study|Withdrawal by Subject|1|||
146583210|NCT00705250|528641744|FG000|Overall Study|Patient died in car accident|1|||
146583211|NCT01406938|528641745|FG000|Induction Period|Subject/guardian decision|6|||
146583212|NCT01406938|528641746|FG001|Induction Period|Subject/guardian decision|8|||
146583213|NCT01406938|528641747|FG002|Induction Period|Subject/guardian decision|0|||
146583214|NCT01406938|528641748|FG003|Induction Period|Subject/guardian decision|0|||
146583215|NCT01406938|528641749|FG004|Induction Period|Subject/guardian decision|0|||
146583216|NCT01406938|528641750|FG005|Induction Period|Subject/guardian decision|0|||
146583217|NCT01406938|528641745|FG000|Induction Period|Protocol deviation|1|||
146583218|NCT01406938|528641746|FG001|Induction Period|Protocol deviation|0|||
146583219|NCT01406938|528641747|FG002|Induction Period|Protocol deviation|0|||
146583220|NCT01406938|528641748|FG003|Induction Period|Protocol deviation|0|||
146583221|NCT01406938|528641749|FG004|Induction Period|Protocol deviation|0|||
146583222|NCT01406938|528641750|FG005|Induction Period|Protocol deviation|0|||
146583223|NCT01406938|528641745|FG000|Induction Period|Adverse Event|8|||
146583224|NCT01406938|528641746|FG001|Induction Period|Adverse Event|9|||
146583225|NCT01406938|528641747|FG002|Induction Period|Adverse Event|0|||
146583226|NCT01406938|528641748|FG003|Induction Period|Adverse Event|0|||
146583227|NCT01406938|528641749|FG004|Induction Period|Adverse Event|0|||
146583228|NCT01406938|528641750|FG005|Induction Period|Adverse Event|0|||
146583229|NCT01406938|528641745|FG000|Induction Period|Lack of Efficacy|1|||
146583230|NCT01406938|528641746|FG001|Induction Period|Lack of Efficacy|0|||
146583231|NCT01406938|528641747|FG002|Induction Period|Lack of Efficacy|0|||
146583232|NCT01406938|528641748|FG003|Induction Period|Lack of Efficacy|0|||
146583233|NCT01406938|528641749|FG004|Induction Period|Lack of Efficacy|0|||
146583234|NCT01406938|528641750|FG005|Induction Period|Lack of Efficacy|0|||
146583235|NCT01406938|528641745|FG000|Induction Period|Lost to Follow-up|2|||
146583236|NCT01406938|528641746|FG001|Induction Period|Lost to Follow-up|3|||
146583237|NCT01406938|528641747|FG002|Induction Period|Lost to Follow-up|0|||
146583238|NCT01406938|528641748|FG003|Induction Period|Lost to Follow-up|0|||
146583239|NCT01406938|528641749|FG004|Induction Period|Lost to Follow-up|0|||
146583240|NCT01406938|528641750|FG005|Induction Period|Lost to Follow-up|0|||
146583241|NCT01406938|528641745|FG000|Maintenance Period|Adverse Event|0|||
146583242|NCT01406938|528641746|FG001|Maintenance Period|Adverse Event|0|||
146583243|NCT01406938|528641747|FG002|Maintenance Period|Adverse Event|2|||
146583244|NCT01406938|528641748|FG003|Maintenance Period|Adverse Event|8|||
146583245|NCT01406938|528641749|FG004|Maintenance Period|Adverse Event|4|||
146583246|NCT01406938|528641750|FG005|Maintenance Period|Adverse Event|2|||
146583247|NCT01406938|528641745|FG000|Maintenance Period|Death|0|||
146583248|NCT01406938|528641746|FG001|Maintenance Period|Death|0|||
146583249|NCT01406938|528641747|FG002|Maintenance Period|Death|0|||
146583250|NCT01406938|528641748|FG003|Maintenance Period|Death|0|||
146583251|NCT01406938|528641749|FG004|Maintenance Period|Death|1|||
146583252|NCT01406938|528641750|FG005|Maintenance Period|Death|0|||
146583253|NCT01406938|528641745|FG000|Maintenance Period|Subject/guardian decision|0|||
146583254|NCT01406938|528641746|FG001|Maintenance Period|Subject/guardian decision|0|||
146583255|NCT01406938|528641747|FG002|Maintenance Period|Subject/guardian decision|11|||
146583256|NCT01406938|528641748|FG003|Maintenance Period|Subject/guardian decision|7|||
146583257|NCT01406938|528641749|FG004|Maintenance Period|Subject/guardian decision|10|||
146583258|NCT01406938|528641750|FG005|Maintenance Period|Subject/guardian decision|7|||
146583259|NCT01406938|528641745|FG000|Maintenance Period|Protocol Violation|0|||
146583260|NCT01406938|528641746|FG001|Maintenance Period|Protocol Violation|0|||
146583261|NCT01406938|528641747|FG002|Maintenance Period|Protocol Violation|2|||
146583262|NCT01406938|528641748|FG003|Maintenance Period|Protocol Violation|2|||
146583263|NCT01406938|528641749|FG004|Maintenance Period|Protocol Violation|2|||
146583264|NCT01406938|528641750|FG005|Maintenance Period|Protocol Violation|2|||
146583265|NCT01406938|528641745|FG000|Maintenance Period|Pregnancy|0|||
146583266|NCT01406938|528641746|FG001|Maintenance Period|Pregnancy|0|||
146583267|NCT01406938|528641747|FG002|Maintenance Period|Pregnancy|0|||
146583268|NCT01406938|528641748|FG003|Maintenance Period|Pregnancy|0|||
146583269|NCT01406938|528641749|FG004|Maintenance Period|Pregnancy|1|||
146583270|NCT01406938|528641750|FG005|Maintenance Period|Pregnancy|0|||
146583271|NCT01406938|528641745|FG000|Maintenance Period|Lost to Follow-up|0|||
146583272|NCT01406938|528641746|FG001|Maintenance Period|Lost to Follow-up|0|||
146583273|NCT01406938|528641747|FG002|Maintenance Period|Lost to Follow-up|0|||
146583274|NCT01406938|528641748|FG003|Maintenance Period|Lost to Follow-up|0|||
146583275|NCT01406938|528641749|FG004|Maintenance Period|Lost to Follow-up|4|||
146583276|NCT01406938|528641750|FG005|Maintenance Period|Lost to Follow-up|0|||
146583277|NCT01406938|528641745|FG000|Maintenance Period|Lack of Efficacy|0|||
146583278|NCT01406938|528641746|FG001|Maintenance Period|Lack of Efficacy|0|||
146583279|NCT01406938|528641747|FG002|Maintenance Period|Lack of Efficacy|2|||
146583280|NCT01406938|528641748|FG003|Maintenance Period|Lack of Efficacy|1|||
146583281|NCT01406938|528641749|FG004|Maintenance Period|Lack of Efficacy|3|||
146583282|NCT01406938|528641750|FG005|Maintenance Period|Lack of Efficacy|5|||
146583283|NCT01406938|528641745|FG000|Follow up|Lack of Efficacy|3|||
146583284|NCT01406938|528641746|FG001|Follow up|Lack of Efficacy|2|||
146583285|NCT01406938|528641747|FG002|Follow up|Lack of Efficacy|1|||
146583286|NCT01406938|528641748|FG003|Follow up|Lack of Efficacy|0|||
146583287|NCT01406938|528641749|FG004|Follow up|Lack of Efficacy|0|||
146583288|NCT01406938|528641750|FG005|Follow up|Lack of Efficacy|0|||
146583289|NCT01406938|528641745|FG000|Follow up|Patient/guardian decision|4|||
146583290|NCT01406938|528641746|FG001|Follow up|Patient/guardian decision|2|||
146583291|NCT01406938|528641747|FG002|Follow up|Patient/guardian decision|4|||
146583292|NCT01406938|528641748|FG003|Follow up|Patient/guardian decision|2|||
146583293|NCT01406938|528641749|FG004|Follow up|Patient/guardian decision|4|||
146583294|NCT01406938|528641750|FG005|Follow up|Patient/guardian decision|1|||
146583295|NCT01406938|528641745|FG000|Follow up|Protocol Violation|0|||
146583296|NCT01406938|528641746|FG001|Follow up|Protocol Violation|0|||
146583297|NCT01406938|528641747|FG002|Follow up|Protocol Violation|1|||
146583298|NCT01406938|528641748|FG003|Follow up|Protocol Violation|0|||
146583299|NCT01406938|528641749|FG004|Follow up|Protocol Violation|0|||
146583300|NCT01406938|528641750|FG005|Follow up|Protocol Violation|0|||
146583301|NCT01406938|528641745|FG000|Follow up|Physician Decision|0|||
146583302|NCT01406938|528641746|FG001|Follow up|Physician Decision|0|||
146583303|NCT01406938|528641747|FG002|Follow up|Physician Decision|2|||
146583304|NCT01406938|528641748|FG003|Follow up|Physician Decision|0|||
146583305|NCT01406938|528641749|FG004|Follow up|Physician Decision|3|||
146583306|NCT01406938|528641750|FG005|Follow up|Physician Decision|1|||
146583307|NCT01406938|528641745|FG000|Follow up|Lost to Follow-up|1|||
146583308|NCT01406938|528641746|FG001|Follow up|Lost to Follow-up|1|||
146583309|NCT01406938|528641747|FG002|Follow up|Lost to Follow-up|0|||
146583310|NCT01406938|528641748|FG003|Follow up|Lost to Follow-up|1|||
146583311|NCT01406938|528641749|FG004|Follow up|Lost to Follow-up|2|||
146583312|NCT01406938|528641750|FG005|Follow up|Lost to Follow-up|1|||
146583313|NCT01576146|528641755|FG000|Extension Period 1|Adverse Event|2|||
146583314|NCT01576146|528641755|FG000|Extension Period 1|Death|2|||
146583315|NCT01576146|528641755|FG000|Extension Period 1|Physician Decision|2|||
146583316|NCT01576146|528641755|FG000|Extension Period 1|Withdrawal by Subject|1|||
146583317|NCT01576146|528641755|FG000|Extension Period 1|Lost to Follow-up|1|||
146583318|NCT01576146|528641755|FG000|Extension Period 1|Parathyroidectomy|1|||
146583319|NCT01576146|528641755|FG000|Extension Period 1|Renal Transplant|1|||
146583320|NCT01576146|528641755|FG000|Extension Period 2|Sponsor Decision|13|||
146583321|NCT01576146|528641755|FG000|Extension Period 2|Death|1|||
146583322|NCT01576146|528641755|FG000|Extension Period 2|Adverse Event|1|||
146583323|NCT01576146|528641755|FG000|Extension Period 2|Renal Transplant|1|||
146583324|NCT01576146|528641755|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
146583325|NCT01667224|528641758|FG000|Overall Study|Withdrawal by Subject|3|||
146583326|NCT01667224|528641759|FG001|Overall Study|Withdrawal by Subject|1|||
146583327|NCT01667224|528641758|FG000|Overall Study|Protocol Violation|1|||
146583328|NCT01667224|528641759|FG001|Overall Study|Protocol Violation|1|||
146583329|NCT01811485|528641762|FG000|Overall Study|Adverse Event|1|||
146583330|NCT01811485|528641763|FG001|Overall Study|Adverse Event|3|||
146583331|NCT01811485|528641764|FG002|Overall Study|Adverse Event|2|||
146583332|NCT01811485|528641762|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146583333|NCT01811485|528641763|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146583334|NCT01811485|528641764|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
146583335|NCT01811485|528641762|FG000|Overall Study|Administrative problems|1|||
146583336|NCT01811485|528641763|FG001|Overall Study|Administrative problems|0|||
146583337|NCT01811485|528641764|FG002|Overall Study|Administrative problems|0|||
146583338|NCT01811485|528641762|FG000|Overall Study|Protocol Deviation|0|||
146583339|NCT01811485|528641763|FG001|Overall Study|Protocol Deviation|1|||
146583340|NCT01811485|528641764|FG002|Overall Study|Protocol Deviation|0|||
146583341|NCT01545934|528641765|FG000|Overall Study|Withdrawal by Subject|4|||
146583342|NCT01545934|528641766|FG001|Overall Study|Withdrawal by Subject|3|||
146583343|NCT01545934|528641765|FG000|Overall Study|Lost to Follow-up|1|||
146583344|NCT01545934|528641766|FG001|Overall Study|Lost to Follow-up|0|||
146583345|NCT03654404|528641767|FG000|Overall Study|Death|1|||
146583346|NCT03654404|528641767|FG000|Overall Study|Lost to Follow-up|2|||
146583347|NCT03654404|528641767|FG000|Overall Study|Withdrawal by Subject|5|||
146918644|NCT04742907|529864480|FG000|Overall Study|Adverse Event|1|||
146918645|NCT04742907|529864481|FG001|Overall Study|Adverse Event|0|||
146918646|NCT04742907|529864482|FG002|Overall Study|Adverse Event|1|||
146918647|NCT04742907|529864480|FG000|Overall Study|Lost to Follow-up|3|||
146583348|NCT03299881|528641768|FG000|Overall Study|Study Termination|17|||
146583349|NCT03299881|528641769|FG001|Overall Study|Study Termination|13|||
146583350|NCT01474772|528641770|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
146583351|NCT01474772|528641771|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
146583352|NCT01474772|528641770|FG000|Period 1|AE not Related to Study Drug|1|||
146583353|NCT01474772|528641771|FG001|Period 1|AE not Related to Study Drug|0|||
146583354|NCT01474772|528641770|FG000|Period 1|Withdrawal by Subject|3|||
146583355|NCT01474772|528641771|FG001|Period 1|Withdrawal by Subject|1|||
146583356|NCT01474772|528641770|FG000|Period 1|Lost to Follow-up|1|||
146583357|NCT01474772|528641771|FG001|Period 1|Lost to Follow-up|0|||
146583358|NCT01474772|528641770|FG000|Period 1|Reason not Specified|1|||
146583359|NCT01474772|528641771|FG001|Period 1|Reason not Specified|1|||
146583360|NCT01474772|528641770|FG000|Washout|AE not Related to Study Drug|2|||
146583361|NCT01474772|528641771|FG001|Washout|AE not Related to Study Drug|0|||
146583362|NCT01474772|528641770|FG000|Washout|Withdrawal by Subject|1|||
146583363|NCT01474772|528641771|FG001|Washout|Withdrawal by Subject|0|||
146583364|NCT01474772|528641770|FG000|Washout|Lost to Follow-up|0|||
146583365|NCT01474772|528641771|FG001|Washout|Lost to Follow-up|1|||
146583366|NCT01474772|528641770|FG000|Washout|Reason not Specified|0|||
146583367|NCT01474772|528641771|FG001|Washout|Reason not Specified|1|||
146583368|NCT01474772|528641770|FG000|Period 2|Death|0|||
146583369|NCT01474772|528641771|FG001|Period 2|Death|1|||
146583370|NCT01474772|528641770|FG000|Period 2|AE Related to Study Drug|0|||
146583371|NCT01474772|528641771|FG001|Period 2|AE Related to Study Drug|1|||
146583372|NCT01474772|528641770|FG000|Period 2|AE not Related to Study Drug|4|||
146583373|NCT01474772|528641771|FG001|Period 2|AE not Related to Study Drug|1|||
146583374|NCT01474772|528641770|FG000|Period 2|Lack of Efficacy|1|||
146583375|NCT01474772|528641771|FG001|Period 2|Lack of Efficacy|0|||
146583376|NCT01474772|528641770|FG000|Period 2|Withdrawal by Subject|3|||
146583377|NCT01474772|528641771|FG001|Period 2|Withdrawal by Subject|4|||
146583378|NCT01474772|528641770|FG000|Period 2|Lost to Follow-up|1|||
146583379|NCT01474772|528641771|FG001|Period 2|Lost to Follow-up|1|||
146583380|NCT01474772|528641770|FG000|Period 2|Reason not Specified|0|||
146583381|NCT01474772|528641771|FG001|Period 2|Reason not Specified|2|||
146583382|NCT01474772|528641770|FG000|Follow-up|AE not Related to Study Drug|0|||
146583383|NCT01474772|528641771|FG001|Follow-up|AE not Related to Study Drug|1|||
146583384|NCT03195660|528641772|FG000|Overall Study|The study was terminated|2|||
146583385|NCT03367403|528641773|FG000|Overall Study|Adverse Event|20|||
146583386|NCT03367403|528641774|FG001|Overall Study|Adverse Event|6|||
146583387|NCT03367403|528641775|FG002|Overall Study|Adverse Event|2|||
146583388|NCT03367403|528641773|FG000|Overall Study|Withdrawal by Subject|12|||
146583389|NCT03367403|528641774|FG001|Overall Study|Withdrawal by Subject|13|||
146583390|NCT03367403|528641775|FG002|Overall Study|Withdrawal by Subject|1|||
146583391|NCT03367403|528641773|FG000|Overall Study|Death|1|||
146583392|NCT03367403|528641774|FG001|Overall Study|Death|2|||
146583393|NCT03367403|528641775|FG002|Overall Study|Death|0|||
146583394|NCT03367403|528641773|FG000|Overall Study|Physician Decision|0|||
146583395|NCT03367403|528641774|FG001|Overall Study|Physician Decision|1|||
146583396|NCT03367403|528641775|FG002|Overall Study|Physician Decision|0|||
146652093|NCT02514473|528903771|FG000|Overall Study|Adverse Event|0|||
146583397|NCT03367403|528641773|FG000|Overall Study|Protocol Violation|1|||
146583398|NCT03367403|528641774|FG001|Overall Study|Protocol Violation|1|||
146583399|NCT03367403|528641775|FG002|Overall Study|Protocol Violation|0|||
146918648|NCT04742907|529864481|FG001|Overall Study|Lost to Follow-up|3|||
146918649|NCT04742907|529864482|FG002|Overall Study|Lost to Follow-up|2|||
146583400|NCT03367403|528641773|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
146583401|NCT03367403|528641774|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
146583402|NCT03367403|528641775|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
146583403|NCT03367403|528641773|FG000|Overall Study|COVID-19|3|||
146583404|NCT03367403|528641774|FG001|Overall Study|COVID-19|6|||
146583405|NCT03367403|528641775|FG002|Overall Study|COVID-19|0|||
146583406|NCT03367403|528641773|FG000|Overall Study|Abuse of Alcohol Intake|0|||
146583407|NCT03367403|528641774|FG001|Overall Study|Abuse of Alcohol Intake|1|||
146583408|NCT03367403|528641775|FG002|Overall Study|Abuse of Alcohol Intake|0|||
146583409|NCT03367403|528641773|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
146583410|NCT03367403|528641774|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
146583411|NCT03367403|528641775|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
146583412|NCT01822899|528641776|FG000|Overall Study|Adverse Event|6|||
146583413|NCT01822899|528641777|FG001|Overall Study|Adverse Event|5|||
146583414|NCT01822899|528641776|FG000|Overall Study|Lack of Efficacy|6|||
146583415|NCT01822899|528641777|FG001|Overall Study|Lack of Efficacy|3|||
146583416|NCT01822899|528641776|FG000|Overall Study|Protocol Violation|6|||
146583417|NCT01822899|528641777|FG001|Overall Study|Protocol Violation|3|||
146583418|NCT01822899|528641776|FG000|Overall Study|Lost to Follow-up|1|||
146583419|NCT01822899|528641777|FG001|Overall Study|Lost to Follow-up|0|||
146583420|NCT01822899|528641776|FG000|Overall Study|Withdrawal by Subject|5|||
146583421|NCT01822899|528641777|FG001|Overall Study|Withdrawal by Subject|7|||
146583422|NCT00759876|528641778|FG000|Overall Study|Sponsor terminated study early|36|||
146583423|NCT02314156|528641779|FG000|Overall Study|Adverse Event|1|||
146583424|NCT02314156|528641780|FG001|Overall Study|Adverse Event|0|||
146583425|NCT02314156|528641779|FG000|Overall Study|Withdrawal by Subject|1|||
146583426|NCT02314156|528641780|FG001|Overall Study|Withdrawal by Subject|0|||
146583427|NCT02846389|528641781|FG000|Overall Study|Withdrawal by Subject|1|||
146583428|NCT02846389|528641782|FG001|Overall Study|Withdrawal by Subject|1|||
146583429|NCT02321319|528641784|FG000|Overall Study|Product discontinued|5|||
146583430|NCT02249091|528641785|FG000|Overall Study|Lack of Efficacy|8|||
146583431|NCT02249091|528641786|FG001|Overall Study|Lack of Efficacy|3|||
146583432|NCT02249091|528641785|FG000|Overall Study|Physician Decision|4|||
146583433|NCT02249091|528641786|FG001|Overall Study|Physician Decision|1|||
146583434|NCT02249091|528641785|FG000|Overall Study|Withdrawal by Subject|2|||
146583435|NCT02249091|528641786|FG001|Overall Study|Withdrawal by Subject|2|||
146583436|NCT02249091|528641785|FG000|Overall Study|Death|3|||
146583437|NCT02249091|528641786|FG001|Overall Study|Death|4|||
146583438|NCT02249091|528641785|FG000|Overall Study|Adverse Event|1|||
146583439|NCT02249091|528641786|FG001|Overall Study|Adverse Event|0|||
146583440|NCT02249091|528641785|FG000|Overall Study|Stable disease with following SCT|0|||
146583441|NCT02249091|528641786|FG001|Overall Study|Stable disease with following SCT|1|||
146583442|NCT02249091|528641785|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
146583443|NCT02249091|528641786|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
146583444|NCT02249091|528641785|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
146583445|NCT02249091|528641786|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
146583446|NCT02249091|528641785|FG000|Overall Study|Refractory AML|1|||
146583447|NCT02249091|528641786|FG001|Overall Study|Refractory AML|1|||
146583448|NCT05059301|528641787|FG000|Overall Study|Adverse Event|0|||
146583449|NCT05059301|528641788|FG001|Overall Study|Adverse Event|2|||
146583450|NCT05059301|528641789|FG002|Overall Study|Adverse Event|2|||
146583451|NCT05059301|528641787|FG000|Overall Study|Lost to Follow-up|2|||
146583452|NCT05059301|528641788|FG001|Overall Study|Lost to Follow-up|3|||
146583453|NCT05059301|528641789|FG002|Overall Study|Lost to Follow-up|3|||
146583454|NCT02957747|528641790|FG000|Overall Study|Withdrawal by Subject|0|||
146583455|NCT02957747|528641791|FG001|Overall Study|Withdrawal by Subject|3|||
146583456|NCT02957747|528641790|FG000|Overall Study|Lost to Follow-up|10|||
146583457|NCT02957747|528641791|FG001|Overall Study|Lost to Follow-up|5|||
146583458|NCT00853242|528641792|FG000|Overall Study|Adverse Event|0|||
146583459|NCT00853242|528641793|FG001|Overall Study|Adverse Event|1|||
146583460|NCT00853242|528641794|FG002|Overall Study|Adverse Event|1|||
146583461|NCT00853242|528641795|FG003|Overall Study|Adverse Event|0|||
146583462|NCT00853242|528641796|FG004|Overall Study|Adverse Event|3|||
146583463|NCT00853242|528641797|FG005|Overall Study|Adverse Event|1|||
146583464|NCT00853242|528641798|FG006|Overall Study|Adverse Event|1|||
146583465|NCT00853242|528641792|FG000|Overall Study|Noncompliant|0|||
146583466|NCT00853242|528641793|FG001|Overall Study|Noncompliant|0|||
146583467|NCT00853242|528641794|FG002|Overall Study|Noncompliant|0|||
146583468|NCT00853242|528641795|FG003|Overall Study|Noncompliant|0|||
146652094|NCT02514473|528903772|FG001|Overall Study|Adverse Event|2|||
146583469|NCT00853242|528641796|FG004|Overall Study|Noncompliant|1|||
146583470|NCT00853242|528641797|FG005|Overall Study|Noncompliant|0|||
146583471|NCT00853242|528641798|FG006|Overall Study|Noncompliant|0|||
146583472|NCT00853242|528641792|FG000|Overall Study|Withdrawal by Subject|1|||
146583473|NCT00853242|528641793|FG001|Overall Study|Withdrawal by Subject|2|||
146583474|NCT00853242|528641794|FG002|Overall Study|Withdrawal by Subject|0|||
146583475|NCT00853242|528641795|FG003|Overall Study|Withdrawal by Subject|4|||
146583476|NCT00853242|528641796|FG004|Overall Study|Withdrawal by Subject|0|||
146583477|NCT00853242|528641797|FG005|Overall Study|Withdrawal by Subject|0|||
146583478|NCT00853242|528641798|FG006|Overall Study|Withdrawal by Subject|2|||
146583479|NCT00853242|528641792|FG000|Overall Study|Other|2|||
146583480|NCT00853242|528641793|FG001|Overall Study|Other|0|||
146583481|NCT00853242|528641794|FG002|Overall Study|Other|2|||
146583482|NCT00853242|528641795|FG003|Overall Study|Other|0|||
146583483|NCT00853242|528641796|FG004|Overall Study|Other|0|||
146583484|NCT00853242|528641797|FG005|Overall Study|Other|1|||
146652095|NCT02514473|528903771|FG000|Overall Study|Withdrawal by Subject|2|||
146652096|NCT02514473|528903772|FG001|Overall Study|Withdrawal by Subject|1|||
146652097|NCT02514473|528903771|FG000|Overall Study|Lost to Follow-up|0|||
146652098|NCT02514473|528903772|FG001|Overall Study|Lost to Follow-up|1|||
146652099|NCT02514473|528903771|FG000|Overall Study|Other|1|||
146652100|NCT02514473|528903772|FG001|Overall Study|Other|1|||
146652101|NCT00548405|528903773|FG000|Overall Study|Adverse Event|6|||
146652102|NCT00548405|528903774|FG001|Overall Study|Adverse Event|2|||
146652103|NCT00548405|528903775|FG002|Overall Study|Adverse Event|0|||
146652104|NCT00548405|528903773|FG000|Overall Study|Lack of Efficacy|6|||
146652105|NCT00548405|528903774|FG001|Overall Study|Lack of Efficacy|0|||
146652106|NCT00548405|528903775|FG002|Overall Study|Lack of Efficacy|0|||
146652107|NCT00548405|528903773|FG000|Overall Study|Physician Decision|3|||
146652108|NCT00548405|528903774|FG001|Overall Study|Physician Decision|4|||
146652109|NCT00548405|528903775|FG002|Overall Study|Physician Decision|1|||
146652110|NCT00548405|528903773|FG000|Overall Study|Pregnancy|1|||
146652111|NCT00548405|528903774|FG001|Overall Study|Pregnancy|0|||
146652112|NCT00548405|528903775|FG002|Overall Study|Pregnancy|0|||
146652113|NCT00548405|528903773|FG000|Overall Study|Protocol Violation|1|||
146652114|NCT00548405|528903774|FG001|Overall Study|Protocol Violation|0|||
146652115|NCT00548405|528903775|FG002|Overall Study|Protocol Violation|0|||
146652116|NCT00548405|528903773|FG000|Overall Study|Withdrawal by Subject|36|||
146652117|NCT00548405|528903774|FG001|Overall Study|Withdrawal by Subject|12|||
146652118|NCT00548405|528903775|FG002|Overall Study|Withdrawal by Subject|5|||
146652119|NCT00548405|528903773|FG000|Overall Study|Lost to Follow-up|1|||
146652120|NCT00548405|528903774|FG001|Overall Study|Lost to Follow-up|1|||
146652121|NCT00548405|528903775|FG002|Overall Study|Lost to Follow-up|2|||
146652122|NCT00548405|528903773|FG000|Overall Study|Death|0|||
146652123|NCT00548405|528903774|FG001|Overall Study|Death|1|||
146652124|NCT00548405|528903775|FG002|Overall Study|Death|1|||
146652125|NCT00548405|528903773|FG000|Overall Study|Sponsor decision|1|||
146652126|NCT00548405|528903774|FG001|Overall Study|Sponsor decision|0|||
146652127|NCT00548405|528903775|FG002|Overall Study|Sponsor decision|0|||
146652128|NCT00548405|528903773|FG000|Overall Study|Randomized but not treated|1|||
146652129|NCT00548405|528903774|FG001|Overall Study|Randomized but not treated|0|||
146652130|NCT00548405|528903775|FG002|Overall Study|Randomized but not treated|0|||
146652131|NCT01624870|528903776|FG000|Overall Study|Death|19|||
146652132|NCT01624870|528903776|FG000|Overall Study|Withdrawal by Subject|1|||
146652133|NCT01624870|528903776|FG000|Overall Study|CoreValve not implanted|6|||
146652134|NCT01624870|528903776|FG000|Overall Study|Lost to follow up|1|||
146652135|NCT02582684|528903781|FG000|Overall Study|Unable to contact subject/parent|4|||
146652136|NCT02582684|528903781|FG000|Overall Study|Subject not able to get to clinic|10|||
146652137|NCT02582684|528903781|FG000|Overall Study|Subject withdrew consent|1|||
146652138|NCT02582684|528903781|FG000|Overall Study|Found to be ineligible after enrollment|2|||
146652139|NCT03836001|528903782|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
146652140|NCT03836001|528903783|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
146652141|NCT03836001|528903784|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
146652142|NCT03836001|528903782|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
146652143|NCT03836001|528903783|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
146652144|NCT03836001|528903784|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
146918650|NCT04742907|529864480|FG000|Overall Study|Physician Decision|0|||
146918651|NCT04742907|529864481|FG001|Overall Study|Physician Decision|1|||
146652145|NCT03836001|528903782|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
146652146|NCT03836001|528903783|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
146652147|NCT03836001|528903784|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
146652148|NCT03836001|528903782|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
146652149|NCT03836001|528903783|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
146652150|NCT03836001|528903784|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
146652151|NCT01642732|528903785|FG000|Overall Study|Withdrawal by Subject|1|||
146583485|NCT00853242|528641798|FG006|Overall Study|Other|2|||
146583486|NCT01035463|528641799|FG000|Overall Study|Adverse Event|0|||
146583487|NCT01035463|528641800|FG001|Overall Study|Adverse Event|0|||
146652152|NCT03562767|528903790|FG000|Overall Study|Physician Decision|2|||
146652153|NCT03562767|528903791|FG001|Overall Study|Physician Decision|0|||
146652154|NCT03562767|528903792|FG002|Overall Study|Physician Decision|0|||
146652155|NCT03562767|528903790|FG000|Overall Study|Logistic Reason|1|||
146918652|NCT04742907|529864482|FG002|Overall Study|Physician Decision|0|||
146652156|NCT03562767|528903791|FG001|Overall Study|Logistic Reason|3|||
146652157|NCT03562767|528903792|FG002|Overall Study|Logistic Reason|0|||
146652158|NCT04658940|528903798|FG000|Overall Study|Withdrawal by Subject|1|||
146652159|NCT01700439|528903799|FG000|Overall Study|Lost to Follow-up|47|||
146652160|NCT01700439|528903799|FG000|Overall Study|Withdrawal by Subject|183|||
146652161|NCT01700439|528903799|FG000|Overall Study|Death|186|||
146652162|NCT01829243|528903800|FG000|First Intervention|Screen Failure|4|||
146652163|NCT01829243|528903801|FG001|First Intervention|Screen Failure|2|||
146652164|NCT00053898|528903804|FG000|Overall Study|No follow-up data from any source|9|||
146652165|NCT00053898|528903805|FG001|Overall Study|No follow-up data from any source|12|||
146652166|NCT00053898|528903804|FG000|Overall Study|Follow-up from telephone contact only|5|||
146652167|NCT00053898|528903805|FG001|Overall Study|Follow-up from telephone contact only|1|||
146583488|NCT01035463|528641801|FG002|Overall Study|Adverse Event|4|||
146583489|NCT01035463|528641802|FG003|Overall Study|Adverse Event|1|||
146583490|NCT01035463|528641803|FG004|Overall Study|Adverse Event|5|||
146583491|NCT01035463|528641804|FG005|Overall Study|Adverse Event|7|||
146583492|NCT01035463|528641799|FG000|Overall Study|Withdrawal by Subject|0|||
146583493|NCT01035463|528641800|FG001|Overall Study|Withdrawal by Subject|2|||
146583494|NCT01035463|528641801|FG002|Overall Study|Withdrawal by Subject|1|||
146583495|NCT01035463|528641802|FG003|Overall Study|Withdrawal by Subject|0|||
146583496|NCT01035463|528641803|FG004|Overall Study|Withdrawal by Subject|1|||
146583497|NCT01035463|528641804|FG005|Overall Study|Withdrawal by Subject|4|||
146583498|NCT01035463|528641799|FG000|Overall Study|Disease progression|0|||
146583499|NCT01035463|528641800|FG001|Overall Study|Disease progression|0|||
146583500|NCT01035463|528641801|FG002|Overall Study|Disease progression|0|||
146583501|NCT01035463|528641802|FG003|Overall Study|Disease progression|0|||
146583502|NCT01035463|528641803|FG004|Overall Study|Disease progression|0|||
146583503|NCT01035463|528641804|FG005|Overall Study|Disease progression|3|||
146583504|NCT01035463|528641799|FG000|Overall Study|Other Malignancy|0|||
146583505|NCT01035463|528641800|FG001|Overall Study|Other Malignancy|0|||
146583506|NCT01035463|528641801|FG002|Overall Study|Other Malignancy|0|||
146583507|NCT01035463|528641802|FG003|Overall Study|Other Malignancy|0|||
146583508|NCT01035463|528641803|FG004|Overall Study|Other Malignancy|0|||
146583509|NCT01035463|528641804|FG005|Overall Study|Other Malignancy|2|||
146583510|NCT01035463|528641799|FG000|Overall Study|Other|0|||
146583511|NCT01035463|528641800|FG001|Overall Study|Other|0|||
146583512|NCT01035463|528641801|FG002|Overall Study|Other|0|||
146583513|NCT01035463|528641802|FG003|Overall Study|Other|1|||
146583514|NCT01035463|528641803|FG004|Overall Study|Other|0|||
146583515|NCT01035463|528641804|FG005|Overall Study|Other|2|||
146583516|NCT02516098|528641805|FG000|Period 1|Protocol Violation|1|||
146583517|NCT02516098|528641806|FG001|Period 1|Protocol Violation|0|||
146583518|NCT02516098|528641805|FG000|Washout After Period 1|Adverse Event|0|||
146583519|NCT02516098|528641806|FG001|Washout After Period 1|Adverse Event|1|||
146583520|NCT02516098|528641805|FG000|Period 2|Withdrawal by Subject|0|||
146583521|NCT02516098|528641806|FG001|Period 2|Withdrawal by Subject|1|||
146583522|NCT01092780|528641807|FG000|Washout Period 1|Adverse Event|0|||
146583523|NCT01092780|528641808|FG001|Washout Period 1|Adverse Event|1|||
146583524|NCT01092780|528641809|FG002|Washout Period 1|Adverse Event|0|||
146583525|NCT01092780|528641810|FG003|Washout Period 1|Adverse Event|0|||
146583526|NCT01092780|528641807|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
146583527|NCT01092780|528641808|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
146583528|NCT01092780|528641809|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
146583529|NCT01092780|528641810|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
146583530|NCT01092780|528641807|FG000|Washout Period 2|Adverse Event|0|||
146583531|NCT01092780|528641808|FG001|Washout Period 2|Adverse Event|1|||
146583532|NCT01092780|528641809|FG002|Washout Period 2|Adverse Event|1|||
146583533|NCT01092780|528641810|FG003|Washout Period 2|Adverse Event|0|||
146583534|NCT01734395|528641811|FG000|Overall Study|Other|65|||
146583535|NCT01734395|528641811|FG000|Overall Study|Lost to Follow-up|287|||
146652168|NCT00266877|528903806|FG000|Overall Study|Death|1|||
146652169|NCT00266877|528903807|FG001|Overall Study|Death|1|||
146652170|NCT00266877|528903808|FG002|Overall Study|Death|1|||
146652171|NCT00266877|528903806|FG000|Overall Study|Adverse Event|6|||
146652172|NCT00266877|528903807|FG001|Overall Study|Adverse Event|4|||
146652173|NCT00266877|528903808|FG002|Overall Study|Adverse Event|1|||
146978270|NCT00435825|530082310|FG000|Overall Study|Other Protocol Violation|1|||
146978271|NCT00435825|530082311|FG001|Overall Study|Other Protocol Violation|0|||
146978272|NCT00435825|530082312|FG002|Overall Study|Other Protocol Violation|0|||
146583536|NCT01734395|528641811|FG000|Overall Study|Lack of Efficacy|5|||
146583537|NCT01734395|528641811|FG000|Overall Study|Adverse Event|40|||
146583538|NCT01734395|528641811|FG000|Overall Study|Withdrawal by Subject|10|||
146583539|NCT01734395|528641811|FG000|Overall Study|Missing the reasons for not completed|3|||
146583540|NCT01257230|528641812|FG000|Overall Study|Not Treated|0|||
146583541|NCT01257230|528641813|FG001|Overall Study|Not Treated|0|||
146583542|NCT01257230|528641814|FG002|Overall Study|Not Treated|1|||
146583543|NCT01257230|528641812|FG000|Overall Study|Adverse Event|2|||
146583544|NCT01257230|528641813|FG001|Overall Study|Adverse Event|0|||
146652174|NCT00266877|528903806|FG000|Overall Study|Physician Decision|2|||
146652175|NCT00266877|528903807|FG001|Overall Study|Physician Decision|1|||
146583545|NCT01257230|528641814|FG002|Overall Study|Adverse Event|0|||
146583546|NCT01257230|528641812|FG000|Overall Study|Lack of Efficacy|0|||
146583547|NCT01257230|528641813|FG001|Overall Study|Lack of Efficacy|1|||
146583548|NCT01257230|528641814|FG002|Overall Study|Lack of Efficacy|0|||
146583549|NCT01257230|528641812|FG000|Overall Study|Protocol Violation|3|||
146583550|NCT01257230|528641813|FG001|Overall Study|Protocol Violation|0|||
146583551|NCT01257230|528641814|FG002|Overall Study|Protocol Violation|1|||
146583552|NCT01257230|528641812|FG000|Overall Study|Withdrawal by Subject|0|||
146583553|NCT01257230|528641813|FG001|Overall Study|Withdrawal by Subject|4|||
146583554|NCT01257230|528641814|FG002|Overall Study|Withdrawal by Subject|1|||
146583555|NCT01257230|528641812|FG000|Overall Study|Other reason not defined above|1|||
146583556|NCT01257230|528641813|FG001|Overall Study|Other reason not defined above|5|||
146583557|NCT01257230|528641814|FG002|Overall Study|Other reason not defined above|3|||
146583558|NCT04026009|528641817|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146583559|NCT04026009|528641818|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146583560|NCT04026009|528641819|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
146583561|NCT04026009|528641820|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
146583562|NCT04026009|528641821|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
146583563|NCT04026009|528641817|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
146583564|NCT04026009|528641818|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
146583565|NCT04026009|528641819|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
146583566|NCT04026009|528641820|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
146583567|NCT04026009|528641821|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
146918653|NCT04742907|529864480|FG000|Overall Study|Protocol Violation|1|||
146583568|NCT02466425|528641824|FG000|Overall Study|Adverse Event|3|||
146583569|NCT02466425|528641825|FG001|Overall Study|Adverse Event|11|||
146583570|NCT02466425|528641824|FG000|Overall Study|Lack of Efficacy|4|||
146583571|NCT02466425|528641825|FG001|Overall Study|Lack of Efficacy|1|||
146583572|NCT02466425|528641824|FG000|Overall Study|Lost to Follow-up|3|||
146583573|NCT02466425|528641825|FG001|Overall Study|Lost to Follow-up|0|||
146583574|NCT02466425|528641824|FG000|Overall Study|Protocol Violation|1|||
146583575|NCT02466425|528641825|FG001|Overall Study|Protocol Violation|0|||
146583576|NCT02466425|528641824|FG000|Overall Study|Withdrawal by Subject|0|||
146583577|NCT02466425|528641825|FG001|Overall Study|Withdrawal by Subject|1|||
146583578|NCT02466425|528641824|FG000|Overall Study|Other|1|||
146583579|NCT02466425|528641825|FG001|Overall Study|Other|3|||
146583580|NCT02466425|528641824|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
146583581|NCT02466425|528641825|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146583582|NCT01721486|528641830|FG000|Overall Study|Protocol Violation|1|||
146583583|NCT01721486|528641831|FG001|Overall Study|Protocol Violation|0|||
146583584|NCT01721486|528641830|FG000|Overall Study|Physician Decision|0|||
146583585|NCT01721486|528641831|FG001|Overall Study|Physician Decision|1|||
146583586|NCT00582712|528641832|FG000|Overall Study|Adverse Event|1|||
146583587|NCT00582712|528641832|FG000|Overall Study|Lack of Efficacy|1|||
146583588|NCT00582712|528641832|FG000|Overall Study|Withdrawal by Subject|1|||
146583589|NCT00582712|528641832|FG000|Overall Study|Complicating disease requiring treatment|1|||
146583590|NCT01901289|528641833|FG000|Overall Study|Death|32|||
146583591|NCT01901289|528641833|FG000|Overall Study|Lost to Follow-up|16|||
146583592|NCT01901289|528641833|FG000|Overall Study|Withdrawal by Subject|35|||
146583593|NCT01901289|528641833|FG000|Overall Study|Other type of endpoint met|2|||
146583594|NCT01813058|528641835|FG000|Overall Study|Withdrawal by Subject|5|||
146583595|NCT01813058|528641836|FG001|Overall Study|Withdrawal by Subject|4|||
146583596|NCT03585764|528641837|FG000|Overall Study|Death|3|||
146583597|NCT03585764|528641838|FG001|Overall Study|Death|2|||
146583598|NCT03585764|528641839|FG002|Overall Study|Death|3|||
146583599|NCT03585764|528641840|FG003|Overall Study|Death|0|||
146583600|NCT03585764|528641837|FG000|Overall Study|Lost to Follow-up|0|||
146583601|NCT03585764|528641838|FG001|Overall Study|Lost to Follow-up|1|||
146583602|NCT03585764|528641839|FG002|Overall Study|Lost to Follow-up|0|||
146918654|NCT04742907|529864481|FG001|Overall Study|Protocol Violation|1|||
146918655|NCT04742907|529864482|FG002|Overall Study|Protocol Violation|1|||
146652176|NCT00266877|528903808|FG002|Overall Study|Physician Decision|1|||
146918656|NCT04742907|529864480|FG000|Overall Study|Withdrawal by Subject|5|||
146918657|NCT04742907|529864481|FG001|Overall Study|Withdrawal by Subject|6|||
146652177|NCT00266877|528903806|FG000|Overall Study|Withdrawal by Subject|3|||
146583603|NCT03585764|528641840|FG003|Overall Study|Lost to Follow-up|0|||
146583604|NCT03585764|528641837|FG000|Overall Study|Physician Decision|0|||
146583605|NCT03585764|528641838|FG001|Overall Study|Physician Decision|0|||
146583606|NCT03585764|528641839|FG002|Overall Study|Physician Decision|2|||
146583607|NCT03585764|528641840|FG003|Overall Study|Physician Decision|0|||
146583608|NCT01581021|528641841|FG000|Overall Study|Lost to Follow-up|4|||
146583609|NCT01581021|528641842|FG001|Overall Study|Lost to Follow-up|6|||
146583610|NCT01581021|528641841|FG000|Overall Study|More than 2 hooks in thoracic|3|||
146583611|NCT01581021|528641842|FG001|Overall Study|More than 2 hooks in thoracic|0|||
146583612|NCT01581021|528641841|FG000|Overall Study|Neuromuscular|2|||
146652178|NCT00266877|528903807|FG001|Overall Study|Withdrawal by Subject|1|||
146918658|NCT04742907|529864482|FG002|Overall Study|Withdrawal by Subject|4|||
146918659|NCT04742907|529864480|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
146583613|NCT01581021|528641842|FG001|Overall Study|Neuromuscular|1|||
146583614|NCT01581021|528641841|FG000|Overall Study|Not Randomized|1|||
146583615|NCT01581021|528641842|FG001|Overall Study|Not Randomized|2|||
146583616|NCT01581021|528641841|FG000|Overall Study|Lenke 6 Classification|0|||
146583617|NCT01581021|528641842|FG001|Overall Study|Lenke 6 Classification|1|||
146583618|NCT01581021|528641841|FG000|Overall Study|Lack of Efficacy|0|||
146918660|NCT04742907|529864481|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
146918661|NCT04742907|529864482|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
146918662|NCT04742907|529864480|FG000|Overall Study|Did Not Receive the Study Drug|2|||
146918663|NCT04742907|529864481|FG001|Overall Study|Did Not Receive the Study Drug|4|||
146918664|NCT04742907|529864482|FG002|Overall Study|Did Not Receive the Study Drug|4|||
146918665|NCT01428063|529864484|FG000|Overall Study|Lack of Efficacy|8|||
146918666|NCT01428063|529864485|FG001|Overall Study|Lack of Efficacy|4|||
146918667|NCT01428063|529864486|FG002|Overall Study|Lack of Efficacy|1|||
146918668|NCT01428063|529864484|FG000|Overall Study|Adverse Event|2|||
146918669|NCT01428063|529864485|FG001|Overall Study|Adverse Event|3|||
146918670|NCT01428063|529864486|FG002|Overall Study|Adverse Event|0|||
146918671|NCT01428063|529864484|FG000|Overall Study|Lost to Follow-up|0|||
146918672|NCT01428063|529864485|FG001|Overall Study|Lost to Follow-up|2|||
146918673|NCT01428063|529864486|FG002|Overall Study|Lost to Follow-up|0|||
146918674|NCT01428063|529864484|FG000|Overall Study|No longer meets study criteria|0|||
146918675|NCT01428063|529864485|FG001|Overall Study|No longer meets study criteria|1|||
146918676|NCT01428063|529864486|FG002|Overall Study|No longer meets study criteria|0|||
146918677|NCT05761444|529864487|FG000|Overall Study|Protocol Violation|2|||
146918678|NCT05761444|529864488|FG001|Overall Study|Protocol Violation|1|||
146918679|NCT05761444|529864487|FG000|Overall Study|Adverse Event|2|||
146918680|NCT05761444|529864488|FG001|Overall Study|Adverse Event|2|||
146918681|NCT05761444|529864487|FG000|Overall Study|Withdrawal by Subject|3|||
146918682|NCT05761444|529864488|FG001|Overall Study|Withdrawal by Subject|2|||
146918683|NCT05761444|529864487|FG000|Overall Study|Other|1|||
146918684|NCT05761444|529864488|FG001|Overall Study|Other|0|||
146918685|NCT03508622|529864489|FG000|Overall Study|Protocol Violation|1|||
146918686|NCT03508622|529864490|FG001|Overall Study|Protocol Violation|0|||
146918687|NCT03508622|529864489|FG000|Overall Study|Withdrawal by Subject|1|||
146918688|NCT03508622|529864490|FG001|Overall Study|Withdrawal by Subject|0|||
146918689|NCT03508622|529864489|FG000|Overall Study|Lost to Follow-up|16|||
146918690|NCT03508622|529864490|FG001|Overall Study|Lost to Follow-up|0|||
146918691|NCT03508622|529864489|FG000|Overall Study|Incomplete data|0|||
146918692|NCT03508622|529864490|FG001|Overall Study|Incomplete data|24|||
146918693|NCT01005719|529864491|FG000|Period 1|Adverse Event|0|||
146918694|NCT01005719|529864492|FG001|Period 1|Adverse Event|0|||
146918695|NCT01005719|529864493|FG002|Period 1|Adverse Event|0|||
146918696|NCT01005719|529864494|FG003|Period 1|Adverse Event|1|||
146918697|NCT01005719|529864495|FG004|Period 1|Adverse Event|0|||
146918698|NCT01005719|529864496|FG005|Period 1|Adverse Event|0|||
146918699|NCT01005719|529864491|FG000|Period 1|Delay in completing study procedures|0|||
146918700|NCT01005719|529864492|FG001|Period 1|Delay in completing study procedures|0|||
146918701|NCT01005719|529864493|FG002|Period 1|Delay in completing study procedures|0|||
146583619|NCT01581021|528641842|FG001|Overall Study|Lack of Efficacy|1|||
146583620|NCT03403361|528641843|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
146583621|NCT01932372|528641844|FG000|Overall Study|Not meeting eligibility criteria|33|||
146583622|NCT01932372|528641845|FG001|Overall Study|Not meeting eligibility criteria|179|||
146583623|NCT01917929|528641850|FG000|Overall Study|Death|8|||
146652179|NCT00266877|528903808|FG002|Overall Study|Withdrawal by Subject|1|||
146652180|NCT00266877|528903806|FG000|Overall Study|Disease Progression|72|||
146652181|NCT00266877|528903807|FG001|Overall Study|Disease Progression|37|||
146652182|NCT00266877|528903808|FG002|Overall Study|Disease Progression|23|||
146652183|NCT00266877|528903806|FG000|Overall Study|Symptomatic Deterioration|6|||
146652184|NCT00266877|528903807|FG001|Overall Study|Symptomatic Deterioration|3|||
146652185|NCT00266877|528903808|FG002|Overall Study|Symptomatic Deterioration|1|||
146652186|NCT00266877|528903806|FG000|Overall Study|Hospitalization|1|||
146652187|NCT00266877|528903807|FG001|Overall Study|Hospitalization|0|||
146652188|NCT00266877|528903808|FG002|Overall Study|Hospitalization|0|||
146652189|NCT00266877|528903806|FG000|Overall Study|Concomitant Radiotherapy|0|||
146652190|NCT00266877|528903807|FG001|Overall Study|Concomitant Radiotherapy|1|||
146652191|NCT00266877|528903808|FG002|Overall Study|Concomitant Radiotherapy|0|||
146652192|NCT00821327|528903813|FG000|Overall Study|Adverse Event|13|||
146770835|NCT00442117|529328694|FG001|Overall Study|Withdrawal by Subject|2|||
146583624|NCT01917929|528641850|FG000|Overall Study|Lost to Follow-up|19|||
146918702|NCT01005719|529864494|FG003|Period 1|Delay in completing study procedures|0|||
146652193|NCT00821327|528903813|FG000|Overall Study|Patient Request|1|||
146770836|NCT00442117|529328693|FG000|Overall Study|Major Deviation|25|||
146918703|NCT01005719|529864495|FG004|Period 1|Delay in completing study procedures|0|||
146918704|NCT01005719|529864496|FG005|Period 1|Delay in completing study procedures|1|||
146918705|NCT01005719|529864491|FG000|Period 2|Adverse Event|0|||
146918706|NCT01005719|529864492|FG001|Period 2|Adverse Event|0|||
146652194|NCT00821327|528903813|FG000|Overall Study|Investigator Request|2|||
146652195|NCT00821327|528903813|FG000|Overall Study|Sponsor Request|1|||
146652196|NCT00821327|528903813|FG000|Overall Study|Disease Progression|13|||
146652197|NCT00821327|528903813|FG000|Overall Study|Other/Unknown|5|||
146652198|NCT02119676|528903814|FG000|Overall Study|Adverse Event|9|||
146652199|NCT02119676|528903815|FG001|Overall Study|Adverse Event|17|||
146652200|NCT02119676|528903816|FG002|Overall Study|Adverse Event|10|||
146652201|NCT02119676|528903817|FG003|Overall Study|Adverse Event|10|||
146652202|NCT02119676|528903814|FG000|Overall Study|Disease progression|53|||
146652203|NCT02119676|528903815|FG001|Overall Study|Disease progression|55|||
146652204|NCT02119676|528903816|FG002|Overall Study|Disease progression|68|||
146652205|NCT02119676|528903817|FG003|Overall Study|Disease progression|73|||
146652206|NCT02119676|528903814|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
146918707|NCT01005719|529864493|FG002|Period 2|Adverse Event|0|||
146918708|NCT01005719|529864494|FG003|Period 2|Adverse Event|0|||
146918709|NCT01005719|529864495|FG004|Period 2|Adverse Event|1|||
146918710|NCT01005719|529864496|FG005|Period 2|Adverse Event|1|||
146918711|NCT02499146|529864497|FG000|Overall Study|Lost to Follow-up|1|||
146918712|NCT02499146|529864497|FG000|Overall Study|Withdrawal by Subject|1|||
146918713|NCT02499146|529864497|FG000|Overall Study|Other|2|||
146918714|NCT02499146|529864497|FG000|Overall Study|Ongoing at date of cut-off|9|||
146918715|NCT02499146|529864497|FG000|Overall Study|Began other treatment/therapy|13|||
146583625|NCT01917929|528641850|FG000|Overall Study|Withdrawal by Subject|33|||
146583626|NCT01917929|528641850|FG000|Overall Study|Adverse Event|6|||
146583627|NCT01917929|528641850|FG000|Overall Study|Investigative Site Terminated|35|||
146583628|NCT01917929|528641850|FG000|Overall Study|Censored because study device not implanted|6|||
146583629|NCT01917929|528641850|FG000|Overall Study|Censored because surgery not performed|3|||
146583630|NCT01917929|528641850|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
146583631|NCT01917929|528641850|FG000|Overall Study|Sponsor terminated study|175|||
146583632|NCT00673231|528641851|FG000|Overall Study|Withdrawal by Subject|14|||
146583633|NCT00673231|528641852|FG001|Overall Study|Withdrawal by Subject|10|||
146583634|NCT00673231|528641853|FG002|Overall Study|Withdrawal by Subject|8|||
146583635|NCT00673231|528641854|FG003|Overall Study|Withdrawal by Subject|6|||
146583636|NCT00673231|528641851|FG000|Overall Study|Adverse Event|6|||
146583637|NCT00673231|528641852|FG001|Overall Study|Adverse Event|5|||
146583638|NCT00673231|528641853|FG002|Overall Study|Adverse Event|9|||
146583639|NCT00673231|528641854|FG003|Overall Study|Adverse Event|6|||
146583640|NCT00673231|528641851|FG000|Overall Study|Lost to Follow-up|1|||
146583641|NCT00673231|528641852|FG001|Overall Study|Lost to Follow-up|2|||
146583642|NCT00673231|528641853|FG002|Overall Study|Lost to Follow-up|1|||
146583643|NCT00673231|528641854|FG003|Overall Study|Lost to Follow-up|2|||
146583644|NCT00673231|528641851|FG000|Overall Study|Death|0|||
146583645|NCT00673231|528641852|FG001|Overall Study|Death|0|||
146583646|NCT00673231|528641853|FG002|Overall Study|Death|1|||
146583647|NCT00673231|528641854|FG003|Overall Study|Death|0|||
146583648|NCT00673231|528641851|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
146583649|NCT00673231|528641852|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
146583650|NCT00673231|528641853|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
146583651|NCT00673231|528641854|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
146583652|NCT03594747|528641858|FG000|Overall Study|Death|78|||
146583653|NCT03594747|528641859|FG001|Overall Study|Death|86|||
146583654|NCT03594747|528641860|FG002|Overall Study|Death|87|||
146583655|NCT03594747|528641858|FG000|Overall Study|Withdrawal by Subject|5|||
146583656|NCT03594747|528641859|FG001|Overall Study|Withdrawal by Subject|2|||
146652207|NCT02119676|528903815|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
146652208|NCT02119676|528903816|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
146652209|NCT02119676|528903817|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
146652210|NCT02119676|528903814|FG000|Overall Study|Physician Decision|4|||
146652211|NCT02119676|528903815|FG001|Overall Study|Physician Decision|2|||
146652212|NCT02119676|528903816|FG002|Overall Study|Physician Decision|3|||
146918716|NCT03161678|529864498|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
146918717|NCT03161678|529864499|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
146978273|NCT00435825|530082313|FG003|Overall Study|Other Protocol Violation|0|||
146978274|NCT00435825|530082310|FG000|Overall Study|Refused treatment|2|||
146918718|NCT03161678|529864500|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
146583657|NCT03594747|528641860|FG002|Overall Study|Withdrawal by Subject|11|||
146583658|NCT03594747|528641858|FG000|Overall Study|Lost to Follow-up|4|||
146583659|NCT03594747|528641859|FG001|Overall Study|Lost to Follow-up|1|||
146583660|NCT03594747|528641860|FG002|Overall Study|Lost to Follow-up|1|||
146583661|NCT03594747|528641858|FG000|Overall Study|Physician Decision|0|||
146583662|NCT03594747|528641859|FG001|Overall Study|Physician Decision|1|||
146583663|NCT03594747|528641860|FG002|Overall Study|Physician Decision|0|||
146652213|NCT02119676|528903817|FG003|Overall Study|Physician Decision|2|||
146652214|NCT02119676|528903814|FG000|Overall Study|Death|9|||
146652215|NCT02119676|528903815|FG001|Overall Study|Death|3|||
146918719|NCT03161678|529864501|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
146978275|NCT00435825|530082311|FG001|Overall Study|Refused treatment|0|||
146978276|NCT00435825|530082312|FG002|Overall Study|Refused treatment|0|||
146583664|NCT03594747|528641858|FG000|Overall Study|Sponsor decision|23|||
146583665|NCT03594747|528641859|FG001|Overall Study|Sponsor decision|17|||
146583666|NCT03594747|528641860|FG002|Overall Study|Sponsor decision|16|||
146583667|NCT03594747|528641858|FG000|Overall Study|Did not meet inclusion criteria|0|||
146583668|NCT03594747|528641859|FG001|Overall Study|Did not meet inclusion criteria|0|||
146583669|NCT03594747|528641860|FG002|Overall Study|Did not meet inclusion criteria|1|||
146583670|NCT03594747|528641858|FG000|Overall Study|Transfer to long term extension study|10|||
146583671|NCT03594747|528641859|FG001|Overall Study|Transfer to long term extension study|12|||
146583672|NCT03594747|528641860|FG002|Overall Study|Transfer to long term extension study|5|||
146583673|NCT02907216|528641861|FG000|Overall Study|No benefit to be obtained by continuing|0|||
146583674|NCT02907216|528641862|FG001|Overall Study|No benefit to be obtained by continuing|1|||
146583675|NCT02907216|528641861|FG000|Overall Study|Withdrawal by Subject|1|||
146583676|NCT02907216|528641862|FG001|Overall Study|Withdrawal by Subject|0|||
146583677|NCT02095873|528641864|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
146583678|NCT02095873|528641865|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
146583679|NCT02095873|528641864|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
146583680|NCT02095873|528641865|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
146583681|NCT02095873|528641864|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
146583682|NCT02095873|528641865|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
146583683|NCT00792740|528641866|FG000|Overall Study|Disease Worsening|3|||
146583684|NCT00792740|528641867|FG001|Overall Study|Disease Worsening|2|||
146583685|NCT00792740|528641866|FG000|Overall Study|Personal Reason|1|||
146583686|NCT00792740|528641867|FG001|Overall Study|Personal Reason|0|||
146583687|NCT00792740|528641866|FG000|Overall Study|Adverse Event|1|||
146583688|NCT00792740|528641867|FG001|Overall Study|Adverse Event|3|||
146583689|NCT00792740|528641866|FG000|Overall Study|Patient's withdrawal of consent|0|||
146583690|NCT00792740|528641867|FG001|Overall Study|Patient's withdrawal of consent|1|||
146583691|NCT00792740|528641866|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
146583692|NCT00792740|528641867|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
146583693|NCT00792740|528641866|FG000|Overall Study|Other reasons|0|||
146583694|NCT00792740|528641867|FG001|Overall Study|Other reasons|1|||
146583695|NCT02485639|528641872|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
146583696|NCT02485639|528641872|FG000|Overall Study|Early termination|4|||
146583697|NCT02485639|528641872|FG000|Overall Study|Withdrawal by Subject|4|||
146583698|NCT02016716|528641873|FG000|Overall Study|Withdrawal by Subject|5|||
146583699|NCT02016716|528641874|FG001|Overall Study|Withdrawal by Subject|5|||
146583700|NCT02016716|528641875|FG002|Overall Study|Withdrawal by Subject|5|||
146583701|NCT02016716|528641873|FG000|Overall Study|Protocol-specified Criteria|0|||
146583702|NCT02016716|528641874|FG001|Overall Study|Protocol-specified Criteria|1|||
146583703|NCT02016716|528641875|FG002|Overall Study|Protocol-specified Criteria|0|||
146652216|NCT02119676|528903816|FG002|Overall Study|Death|2|||
146652217|NCT02119676|528903817|FG003|Overall Study|Death|1|||
146652218|NCT02119676|528903814|FG000|Overall Study|Noncompliance|0|||
146918720|NCT03161678|529864502|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
146918721|NCT03161678|529864503|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
146918722|NCT03161678|529864498|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
146918723|NCT03161678|529864499|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
146918724|NCT03161678|529864500|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
146918725|NCT03161678|529864501|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
146918726|NCT03161678|529864502|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
146918727|NCT03161678|529864503|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
146918728|NCT03161678|529864498|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
146918729|NCT03161678|529864499|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
146918730|NCT03161678|529864500|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
146918731|NCT03161678|529864501|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
146918732|NCT03161678|529864502|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
146918733|NCT03161678|529864503|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
146918734|NCT03161678|529864498|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
146918735|NCT03161678|529864499|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
146918736|NCT03161678|529864500|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
146918737|NCT03161678|529864501|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
146918738|NCT03161678|529864502|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
146583704|NCT02016716|528641873|FG000|Overall Study|Lost to Follow-up|1|||
146583705|NCT02016716|528641874|FG001|Overall Study|Lost to Follow-up|2|||
146652219|NCT02119676|528903815|FG001|Overall Study|Noncompliance|1|||
146978277|NCT00435825|530082313|FG003|Overall Study|Refused treatment|5|||
146583706|NCT02016716|528641875|FG002|Overall Study|Lost to Follow-up|1|||
146583707|NCT03479541|528641880|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
146583708|NCT03479541|528641881|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
146583709|NCT03479541|528641882|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
146918739|NCT03161678|529864503|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
146918740|NCT00752609|529864504|FG000|Overall Study|Adverse Event|2|||
146918741|NCT00752609|529864505|FG001|Overall Study|Adverse Event|2|||
146583710|NCT03479541|528641883|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
146583711|NCT03479541|528641880|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
146583712|NCT03479541|528641881|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
146583713|NCT03479541|528641882|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
146583714|NCT03479541|528641883|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
146583715|NCT03479541|528641880|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
146583716|NCT03479541|528641881|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
146583717|NCT03479541|528641882|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
146583718|NCT03479541|528641883|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
146583719|NCT03479541|528641880|FG000|Home Monitoring|Lost to Follow-up|0|||
146583720|NCT03479541|528641881|FG001|Home Monitoring|Lost to Follow-up|0|||
146583721|NCT03479541|528641882|FG002|Home Monitoring|Lost to Follow-up|8|||
146583722|NCT03479541|528641883|FG003|Home Monitoring|Lost to Follow-up|12|||
146583723|NCT03479541|528641880|FG000|Home Monitoring|Withdrawal by Subject|0|||
146583724|NCT03479541|528641881|FG001|Home Monitoring|Withdrawal by Subject|0|||
146583725|NCT03479541|528641882|FG002|Home Monitoring|Withdrawal by Subject|17|||
146583726|NCT03479541|528641883|FG003|Home Monitoring|Withdrawal by Subject|30|||
146583727|NCT03479541|528641880|FG000|Home Monitoring|Early Termination - PI Decision|0|||
146583728|NCT03479541|528641881|FG001|Home Monitoring|Early Termination - PI Decision|0|||
146583729|NCT03479541|528641882|FG002|Home Monitoring|Early Termination - PI Decision|4|||
146583730|NCT03479541|528641883|FG003|Home Monitoring|Early Termination - PI Decision|6|||
146583731|NCT02147197|528641885|FG000|Overall Study|Adverse Event|1|||
146583732|NCT02147197|528641886|FG001|Overall Study|Adverse Event|0|||
146583733|NCT02147197|528641887|FG002|Overall Study|Adverse Event|0|||
146583734|NCT02147197|528641885|FG000|Overall Study|Withdrawal of Consent|4|||
146583735|NCT02147197|528641886|FG001|Overall Study|Withdrawal of Consent|3|||
146583736|NCT02147197|528641887|FG002|Overall Study|Withdrawal of Consent|2|||
146583737|NCT02147197|528641885|FG000|Overall Study|Lost to Follow-up|2|||
146583738|NCT02147197|528641886|FG001|Overall Study|Lost to Follow-up|3|||
146583739|NCT02147197|528641887|FG002|Overall Study|Lost to Follow-up|1|||
146583740|NCT02147197|528641885|FG000|Overall Study|Protocol Violation|1|||
146583741|NCT02147197|528641886|FG001|Overall Study|Protocol Violation|0|||
146583742|NCT02147197|528641887|FG002|Overall Study|Protocol Violation|3|||
146583743|NCT02147197|528641885|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146583744|NCT02147197|528641886|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146583745|NCT02147197|528641887|FG002|Overall Study|Other Miscellaneous Reasons|3|||
146583746|NCT02923830|528644294|FG000|Overall Study|Physician Decision|13|||
146583747|NCT02923830|528644295|FG001|Overall Study|Physician Decision|15|||
146583748|NCT01751906|528644302|FG000|Overall Study|Lost to Follow-up|151|||
146583749|NCT01751906|528644303|FG001|Overall Study|Lost to Follow-up|68|||
146583750|NCT01751906|528644302|FG000|Overall Study|Withdrawal by Subject|22|||
146583751|NCT01751906|528644303|FG001|Overall Study|Withdrawal by Subject|18|||
146583752|NCT01751906|528644302|FG000|Overall Study|Physician Decision|5|||
146583753|NCT01751906|528644303|FG001|Overall Study|Physician Decision|2|||
146583754|NCT01751906|528644302|FG000|Overall Study|Death|84|||
146583755|NCT01751906|528644303|FG001|Overall Study|Death|43|||
146583756|NCT01751906|528644302|FG000|Overall Study|Denied on premises for follow-up by law|1|||
146583757|NCT01751906|528644303|FG001|Overall Study|Denied on premises for follow-up by law|0|||
146583758|NCT00394251|528644304|FG000|Overall Study|Adverse Event|7|||
146583759|NCT00394251|528644305|FG001|Overall Study|Adverse Event|5|||
146583760|NCT00394251|528644304|FG000|Overall Study|Unacceptable Toxicity|20|||
146583761|NCT00394251|528644305|FG001|Overall Study|Unacceptable Toxicity|18|||
146583762|NCT00394251|528644304|FG000|Overall Study|Physician Decision|1|||
146583763|NCT00394251|528644305|FG001|Overall Study|Physician Decision|1|||
146583764|NCT00394251|528644304|FG000|Overall Study|Protocol Violation|0|||
146583765|NCT00394251|528644305|FG001|Overall Study|Protocol Violation|1|||
146583766|NCT00394251|528644304|FG000|Overall Study|Withdrawal by Subject|7|||
146583767|NCT00394251|528644305|FG001|Overall Study|Withdrawal by Subject|11|||
146583768|NCT00394251|528644304|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
146583769|NCT00394251|528644305|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
146583770|NCT04644276|528644306|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
146583771|NCT04644276|528644307|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
146583772|NCT04644276|528644308|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
146583773|NCT00923975|528644312|FG000|Overall Study|Did not meet inclusion criteria|1|||
146583774|NCT01005316|528644315|FG000|Overall Study|Adverse Event|0|||
146583775|NCT01005316|528644316|FG001|Overall Study|Adverse Event|0|||
146978278|NCT00435825|530082310|FG000|Overall Study|Failure to return|5|||
146583776|NCT01005316|528644317|FG002|Overall Study|Adverse Event|0|||
146583777|NCT01005316|528644318|FG003|Overall Study|Adverse Event|1|||
146583778|NCT01005316|528644315|FG000|Overall Study|Death|20|||
146583779|NCT01005316|528644316|FG001|Overall Study|Death|5|||
146583780|NCT01005316|528644317|FG002|Overall Study|Death|1|||
146583781|NCT01005316|528644318|FG003|Overall Study|Death|15|||
146583782|NCT01005316|528644315|FG000|Overall Study|Study Termination|5|||
146583783|NCT01005316|528644316|FG001|Overall Study|Study Termination|63|||
146583784|NCT01005316|528644317|FG002|Overall Study|Study Termination|9|||
146583785|NCT01005316|528644318|FG003|Overall Study|Study Termination|85|||
146583786|NCT01005316|528644315|FG000|Overall Study|Lost to Follow-up|1|||
146583787|NCT01005316|528644316|FG001|Overall Study|Lost to Follow-up|3|||
146583788|NCT01005316|528644317|FG002|Overall Study|Lost to Follow-up|0|||
146583789|NCT01005316|528644318|FG003|Overall Study|Lost to Follow-up|2|||
146583790|NCT01005316|528644315|FG000|Overall Study|Physician Decision|6|||
146583791|NCT01005316|528644316|FG001|Overall Study|Physician Decision|0|||
146583792|NCT01005316|528644317|FG002|Overall Study|Physician Decision|0|||
146583793|NCT01005316|528644318|FG003|Overall Study|Physician Decision|0|||
146583794|NCT01005316|528644315|FG000|Overall Study|Sponsor Decision|6|||
146583795|NCT01005316|528644316|FG001|Overall Study|Sponsor Decision|3|||
146583796|NCT01005316|528644317|FG002|Overall Study|Sponsor Decision|0|||
146583797|NCT01005316|528644318|FG003|Overall Study|Sponsor Decision|0|||
146583798|NCT01005316|528644315|FG000|Overall Study|Withdrawal by Subject|1|||
146583799|NCT01005316|528644316|FG001|Overall Study|Withdrawal by Subject|1|||
146583800|NCT01005316|528644317|FG002|Overall Study|Withdrawal by Subject|0|||
146583801|NCT01005316|528644318|FG003|Overall Study|Withdrawal by Subject|2|||
146583802|NCT01005316|528644315|FG000|Overall Study|Consented to Another Study|2|||
146583803|NCT01005316|528644316|FG001|Overall Study|Consented to Another Study|0|||
146583804|NCT01005316|528644317|FG002|Overall Study|Consented to Another Study|0|||
146583805|NCT01005316|528644318|FG003|Overall Study|Consented to Another Study|0|||
146583806|NCT01005316|528644315|FG000|Overall Study|Delisted|8|||
146583807|NCT01005316|528644316|FG001|Overall Study|Delisted|0|||
146583808|NCT01005316|528644317|FG002|Overall Study|Delisted|0|||
146583809|NCT01005316|528644318|FG003|Overall Study|Delisted|0|||
146583810|NCT01005316|528644315|FG000|Overall Study|Transferred Care|1|||
146583811|NCT01005316|528644316|FG001|Overall Study|Transferred Care|0|||
146583812|NCT01005316|528644317|FG002|Overall Study|Transferred Care|1|||
146583813|NCT01005316|528644318|FG003|Overall Study|Transferred Care|3|||
146583814|NCT01005316|528644315|FG000|Overall Study|Retransplanted|0|||
146583815|NCT01005316|528644316|FG001|Overall Study|Retransplanted|1|||
146583816|NCT01005316|528644317|FG002|Overall Study|Retransplanted|0|||
146583817|NCT01005316|528644318|FG003|Overall Study|Retransplanted|0|||
146583818|NCT00632827|528644319|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
146583819|NCT00632827|528644319|FG000|Overall Study|Death|2|||
146583820|NCT00632827|528644319|FG000|Overall Study|Adverse Event|5|||
146583821|NCT00632827|528644319|FG000|Overall Study|Lost to Follow-up|1|||
146583822|NCT01126268|528644327|FG000|Overall Study|Adverse Event|1|||
146583823|NCT01205061|528644328|FG000|Overall Study|Adverse Event|4|||
146583824|NCT01205061|528644328|FG000|Overall Study|Withdrawal by Subject|11|||
146583825|NCT01205061|528644328|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
146583826|NCT01205061|528644328|FG000|Overall Study|Lost to Follow-up|9|||
146652220|NCT02119676|528903816|FG002|Overall Study|Noncompliance|0|||
146652221|NCT02119676|528903817|FG003|Overall Study|Noncompliance|0|||
146652222|NCT02119676|528903814|FG000|Overall Study|Lost to Follow-up|0|||
146652223|NCT02119676|528903815|FG001|Overall Study|Lost to Follow-up|0|||
146652224|NCT02119676|528903816|FG002|Overall Study|Lost to Follow-up|1|||
146652225|NCT02119676|528903817|FG003|Overall Study|Lost to Follow-up|0|||
146652226|NCT02119676|528903814|FG000|Overall Study|Protocol deviation|0|||
146652227|NCT02119676|528903815|FG001|Overall Study|Protocol deviation|0|||
146652228|NCT02119676|528903816|FG002|Overall Study|Protocol deviation|1|||
146652229|NCT02119676|528903817|FG003|Overall Study|Protocol deviation|0|||
146652230|NCT02119676|528903814|FG000|Overall Study|Other, unspecified|2|||
146652231|NCT02119676|528903815|FG001|Overall Study|Other, unspecified|1|||
146652232|NCT02119676|528903816|FG002|Overall Study|Other, unspecified|3|||
146652233|NCT02119676|528903817|FG003|Overall Study|Other, unspecified|4|||
146652234|NCT02119676|528903814|FG000|Overall Study|Did not receive study med|2|||
146652235|NCT02119676|528903815|FG001|Overall Study|Did not receive study med|2|||
146652236|NCT02119676|528903816|FG002|Overall Study|Did not receive study med|4|||
146652237|NCT02119676|528903817|FG003|Overall Study|Did not receive study med|5|||
146978279|NCT00435825|530082311|FG001|Overall Study|Failure to return|0|||
146652238|NCT01089361|528903818|FG000|Overall Study|Death|1|||
146583827|NCT01205061|528644328|FG000|Overall Study|Other|1|||
146583828|NCT00765037|528644329|FG000|Overall Study|Lost to Follow-up|5|||
146583829|NCT00765037|528644329|FG000|Overall Study|Adverse Event|1|||
146583830|NCT01988662|528644334|FG000|Overall Study|Subject/guardian decision|1|||
146652239|NCT01089361|528903819|FG001|Overall Study|Death|0|||
146583831|NCT01988662|528644335|FG001|Overall Study|Subject/guardian decision|1|||
146583832|NCT01988662|528644334|FG000|Overall Study|Adverse Event|3|||
146583833|NCT01988662|528644335|FG001|Overall Study|Adverse Event|1|||
146583834|NCT03425006|528644336|FG000|Overall Study|Withdrawal by Subject|1|||
146583835|NCT03425006|528644336|FG000|Overall Study|Physician Decision|1|||
146583836|NCT03425006|528644336|FG000|Overall Study|Death|1|||
146583837|NCT01177553|528644337|FG000|Overall Study|babies not yet 6 months of age|1|||
146652240|NCT00278915|528903822|FG000|Overall Study|Disease progression|1|||
146652241|NCT01007253|528903823|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
146583838|NCT01177553|528644338|FG001|Overall Study|babies not yet 6 months of age|0|||
146583839|NCT03831191|528644349|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
146918742|NCT00752609|529864504|FG000|Overall Study|Withdrawal by Subject|3|||
146918743|NCT00752609|529864505|FG001|Overall Study|Withdrawal by Subject|0|||
146918744|NCT00752609|529864504|FG000|Overall Study|Physician Decision|1|||
146918745|NCT00752609|529864505|FG001|Overall Study|Physician Decision|0|||
146918746|NCT00752609|529864504|FG000|Overall Study|Death|1|||
146918747|NCT00752609|529864505|FG001|Overall Study|Death|0|||
146918748|NCT00752609|529864504|FG000|Overall Study|Met exclusion criteria|1|||
146918749|NCT00752609|529864505|FG001|Overall Study|Met exclusion criteria|0|||
146918750|NCT00752609|529864504|FG000|Overall Study|Received Aranesp in error|1|||
146918751|NCT00752609|529864505|FG001|Overall Study|Received Aranesp in error|0|||
146583840|NCT03831191|528644350|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
146583841|NCT03831191|528644351|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
146583842|NCT03831191|528644352|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
146583843|NCT03831191|528644353|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
146583844|NCT03831191|528644354|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
146583845|NCT03831191|528644355|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
146583846|NCT03831191|528644356|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
146583847|NCT03831191|528644357|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
146583848|NCT03831191|528644358|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
146583849|NCT03831191|528644359|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
146583850|NCT03831191|528644360|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
146583851|NCT03831191|528644361|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
146583852|NCT03831191|528644362|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
146583853|NCT03831191|528644363|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
146583854|NCT03831191|528644349|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
146583855|NCT03831191|528644350|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
146583856|NCT03831191|528644351|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146583857|NCT03831191|528644352|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146583858|NCT03831191|528644353|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146583859|NCT03831191|528644354|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146583860|NCT03831191|528644355|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146583861|NCT03831191|528644356|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146583862|NCT03831191|528644357|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146583863|NCT03831191|528644358|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146583864|NCT03831191|528644359|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146583865|NCT03831191|528644360|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146583866|NCT03831191|528644361|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146583867|NCT03831191|528644362|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146583868|NCT03831191|528644363|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146583869|NCT03831191|528644349|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
146583870|NCT03831191|528644350|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
146583871|NCT03831191|528644351|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
146583872|NCT03831191|528644352|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
146583873|NCT03831191|528644353|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
146583874|NCT03831191|528644354|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
146583875|NCT03831191|528644355|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
146583876|NCT03831191|528644356|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
146583877|NCT03831191|528644357|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
146583878|NCT03831191|528644358|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
146583879|NCT03831191|528644359|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
146583880|NCT03831191|528644360|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
146583881|NCT03831191|528644361|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
146583882|NCT03831191|528644362|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
146583883|NCT03831191|528644363|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
146583884|NCT03831191|528644349|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
146583885|NCT03831191|528644350|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
146583886|NCT03831191|528644351|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
146583887|NCT03831191|528644352|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
146583888|NCT03831191|528644353|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
146652242|NCT01007253|528903824|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
146583889|NCT03831191|528644354|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
146583890|NCT03831191|528644355|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
146583891|NCT03831191|528644356|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
146583892|NCT03831191|528644357|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
146583893|NCT03831191|528644358|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
146978280|NCT00435825|530082312|FG002|Overall Study|Failure to return|4|||
146583894|NCT03831191|528644359|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
146583895|NCT03831191|528644360|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
146652243|NCT01007253|528903825|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
146583896|NCT03831191|528644361|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
146978281|NCT00435825|530082313|FG003|Overall Study|Failure to return|0|||
146918752|NCT05114590|529864506|FG000|Overall Study|Adverse Event|1|||
146918753|NCT05114590|529864506|FG000|Overall Study|Investigator decision|1|||
146978282|NCT00435825|530082310|FG000|Overall Study|Did not receive study drug|1|||
146583897|NCT03831191|528644362|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
146583898|NCT03831191|528644363|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
146583899|NCT03831191|528644349|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
146583900|NCT03831191|528644350|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
146583901|NCT03831191|528644351|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
146583902|NCT03831191|528644352|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
146583903|NCT03831191|528644353|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146583904|NCT03831191|528644354|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146583905|NCT03831191|528644355|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146583906|NCT03831191|528644356|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146583907|NCT03831191|528644357|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146583908|NCT03831191|528644358|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146583909|NCT03831191|528644359|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146583910|NCT03831191|528644360|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146583911|NCT03831191|528644361|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146583912|NCT03831191|528644362|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146583913|NCT03831191|528644363|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146583914|NCT03831191|528644349|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
146583915|NCT03831191|528644350|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
146583916|NCT03831191|528644351|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
146583917|NCT03831191|528644352|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
146583918|NCT03831191|528644353|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146583919|NCT03831191|528644354|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146583920|NCT03831191|528644355|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146583921|NCT03831191|528644356|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146583922|NCT03831191|528644357|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146583923|NCT03831191|528644358|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146583924|NCT03831191|528644359|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146583925|NCT03831191|528644360|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146583926|NCT03831191|528644361|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146583927|NCT03831191|528644362|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146583928|NCT03831191|528644363|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146583929|NCT03831191|528644349|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
146583930|NCT03831191|528644350|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
146583931|NCT03831191|528644351|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
146583932|NCT03831191|528644352|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
146583933|NCT03831191|528644353|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
146583934|NCT03831191|528644354|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
146583935|NCT03831191|528644355|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
146583936|NCT03831191|528644356|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
146583937|NCT03831191|528644357|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
146583938|NCT03831191|528644358|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
146583939|NCT03831191|528644359|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
146583940|NCT03831191|528644360|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
146583941|NCT03831191|528644361|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
146583942|NCT03831191|528644362|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
146583943|NCT03831191|528644363|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
146583944|NCT03831191|528644349|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
146583945|NCT03831191|528644350|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
146583946|NCT03831191|528644351|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
146583947|NCT03831191|528644352|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
146583948|NCT03831191|528644353|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
146583949|NCT03831191|528644354|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
146918754|NCT05114590|529864506|FG000|Overall Study|Lost to Follow-up|5|||
146918755|NCT05114590|529864506|FG000|Overall Study|Withdrawal by Subject|5|||
146918756|NCT05114590|529864506|FG000|Overall Study|Other|2|||
146918757|NCT00938327|529864508|FG000|Overall Study|Adverse Event|2|||
146918758|NCT00938327|529864508|FG000|Overall Study|Protocol Violation|1|||
146918759|NCT00938327|529864508|FG000|Overall Study|Withdrawal by Subject|4|||
146918760|NCT00938327|529864508|FG000|Overall Study|Lost to Follow-up|37|||
146918761|NCT00938327|529864508|FG000|Overall Study|2nd dose received outside of the study|7|||
146918762|NCT00938327|529864508|FG000|Overall Study|Vaccine not received as out of stock|9|||
146978283|NCT00435825|530082311|FG001|Overall Study|Did not receive study drug|0|||
146978284|NCT00435825|530082312|FG002|Overall Study|Did not receive study drug|2|||
146583950|NCT03831191|528644355|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
146583951|NCT03831191|528644356|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
146770837|NCT00442117|529328694|FG001|Overall Study|Major Deviation|20|||
146918763|NCT01425190|529864509|FG000|Overall Study|Full dose not consumed.|1|||
146918764|NCT01425190|529864510|FG001|Overall Study|Full dose not consumed.|0|||
146978285|NCT00435825|530082313|FG003|Overall Study|Did not receive study drug|0|||
146583952|NCT03831191|528644357|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
146583953|NCT03831191|528644358|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
146583954|NCT03831191|528644359|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
146583955|NCT03831191|528644360|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
146583956|NCT03831191|528644361|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
146583957|NCT03831191|528644362|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
146583958|NCT03831191|528644363|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
146583959|NCT03831191|528644349|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146583960|NCT03831191|528644350|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146583961|NCT03831191|528644351|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146583962|NCT03831191|528644352|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146583963|NCT03831191|528644353|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146583964|NCT03831191|528644354|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146583965|NCT03831191|528644355|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146583966|NCT03831191|528644356|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146583967|NCT03831191|528644357|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146583968|NCT03831191|528644358|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146583969|NCT03831191|528644359|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146583970|NCT03831191|528644360|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146583971|NCT03831191|528644361|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146583972|NCT03831191|528644362|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146583973|NCT03831191|528644363|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
146583974|NCT03831191|528644349|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146583975|NCT03831191|528644350|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146583976|NCT03831191|528644351|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146583977|NCT03831191|528644352|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146583978|NCT03831191|528644353|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146583979|NCT03831191|528644354|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146583980|NCT03831191|528644355|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146583981|NCT03831191|528644356|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146583982|NCT03831191|528644357|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146583983|NCT03831191|528644358|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146583984|NCT03831191|528644359|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146583985|NCT03831191|528644360|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146583986|NCT03831191|528644361|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146583987|NCT03831191|528644362|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146583988|NCT03831191|528644363|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
146583989|NCT03070171|528644366|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
146583990|NCT03070171|528644367|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
146583991|NCT03070171|528644366|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
146583992|NCT03070171|528644367|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
146583993|NCT02300558|528644371|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
146583994|NCT02300558|528644371|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
146583995|NCT02300558|528644371|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
146583996|NCT02300558|528644371|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
146583997|NCT01471028|528644372|FG000|VTI-208|Adverse Event|39|||
146583998|NCT01471028|528644373|FG001|VTI-208|Adverse Event|41|||
146583999|NCT01471028|528644372|FG000|VTI-208|Withdrawal by Subject|0|||
146584000|NCT01471028|528644373|FG001|VTI-208|Withdrawal by Subject|2|||
146584001|NCT01471028|528644372|FG000|VTI-208|Lost to Follow-up|1|||
146584002|NCT01471028|528644373|FG001|VTI-208|Lost to Follow-up|1|||
146584003|NCT01471028|528644372|FG000|VTI-208E|Death|7|||
146584004|NCT01471028|528644373|FG001|VTI-208E|Death|10|||
146584005|NCT01471028|528644372|FG000|VTI-208E|Withdrawal by Subject|1|||
146584006|NCT01471028|528644373|FG001|VTI-208E|Withdrawal by Subject|0|||
146584007|NCT01471028|528644372|FG000|VTI-208E|Lost to Follow-up|0|||
146584008|NCT01471028|528644373|FG001|VTI-208E|Lost to Follow-up|2|||
146584009|NCT00695955|528644374|FG000|Cohort 1|Adverse Event|26|||
146584010|NCT00695955|528644374|FG000|Cohort 1|Protocol Violation|2|||
146584011|NCT00695955|528644374|FG000|Cohort 1|Lost to Follow-up|30|||
146584012|NCT00695955|528644374|FG000|Cohort 1|Withdrawal by Subject|25|||
146584013|NCT00695955|528644374|FG000|Cohort 1|Lack of Efficacy|3|||
146584014|NCT00695955|528644374|FG000|Cohort 1|Other|16|||
146584015|NCT00695955|528644374|FG000|Cohort 2|Adverse Event|24|||
146584016|NCT00695955|528644374|FG000|Cohort 2|Protocol Violation|5|||
146584017|NCT00695955|528644374|FG000|Cohort 2|Lost to Follow-up|38|||
146584018|NCT00695955|528644374|FG000|Cohort 2|Withdrawal by Subject|28|||
146652244|NCT01007253|528903826|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
146652245|NCT02093351|528905189|FG000|Part A|Adverse Event|0|||
146584019|NCT00695955|528644374|FG000|Cohort 2|Lack of Efficacy|4|||
146584020|NCT00695955|528644374|FG000|Cohort 2|Other|5|||
146584021|NCT00610857|528644378|FG000|Overall Study|Not evaluable for response|2|||
146584022|NCT01626118|528644381|FG000|Overall Study|Lack of Efficacy|1|||
146584023|NCT01626118|528644382|FG001|Overall Study|Lack of Efficacy|0|||
146584024|NCT01626118|528644383|FG002|Overall Study|Lack of Efficacy|1|||
146584025|NCT01626118|528644384|FG003|Overall Study|Lack of Efficacy|3|||
146584026|NCT01626118|528644381|FG000|Overall Study|Lost to Follow-up|1|||
146584027|NCT01626118|528644382|FG001|Overall Study|Lost to Follow-up|0|||
146584028|NCT01626118|528644383|FG002|Overall Study|Lost to Follow-up|0|||
146584029|NCT01626118|528644384|FG003|Overall Study|Lost to Follow-up|0|||
146584030|NCT01626118|528644381|FG000|Overall Study|Adverse Event|0|||
146584031|NCT01626118|528644382|FG001|Overall Study|Adverse Event|1|||
146584032|NCT01626118|528644383|FG002|Overall Study|Adverse Event|1|||
146584033|NCT01626118|528644384|FG003|Overall Study|Adverse Event|0|||
146584034|NCT01626118|528644381|FG000|Overall Study|Investigator Decision|0|||
146584035|NCT01626118|528644382|FG001|Overall Study|Investigator Decision|1|||
146584036|NCT01626118|528644383|FG002|Overall Study|Investigator Decision|0|||
146584037|NCT01626118|528644384|FG003|Overall Study|Investigator Decision|0|||
146584038|NCT00888329|528644385|FG000|Overall Study|Physician Decision|6|||
146584039|NCT00888329|528644386|FG001|Overall Study|Physician Decision|9|||
146584040|NCT00002540|528644387|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
146584041|NCT00002540|528644388|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
146584042|NCT00002540|528644387|FG000|Overall Study|Died Before Randomization|2|||
146584043|NCT00002540|528644388|FG001|Overall Study|Died Before Randomization|6|||
146584044|NCT00002540|528644387|FG000|Overall Study|Died Before ASU (Control)|202|||
146584045|NCT00002540|528644388|FG001|Overall Study|Died Before ASU (Control)|0|||
146584046|NCT00002540|528644387|FG000|Overall Study|Refused ASU (Control)|597|||
146584047|NCT00002540|528644388|FG001|Overall Study|Refused ASU (Control)|0|||
146584048|NCT00002540|528644387|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
146584049|NCT00002540|528644388|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
146584050|NCT04826094|528644389|FG000|Overall Study|Lost to Follow-up|2|||
146584051|NCT04826094|528644390|FG001|Overall Study|Lost to Follow-up|1|||
146584052|NCT04826094|528644391|FG002|Overall Study|Lost to Follow-up|0|||
146584053|NCT04826094|528644392|FG003|Overall Study|Lost to Follow-up|0|||
146584054|NCT04826094|528644393|FG004|Overall Study|Lost to Follow-up|1|||
146584055|NCT04826094|528644394|FG005|Overall Study|Lost to Follow-up|3|||
146584056|NCT04826094|528644395|FG006|Overall Study|Lost to Follow-up|1|||
146584057|NCT04826094|528644396|FG007|Overall Study|Lost to Follow-up|1|||
146584058|NCT04826094|528644389|FG000|Overall Study|Participant withdrew consent|1|||
146584059|NCT04826094|528644390|FG001|Overall Study|Participant withdrew consent|0|||
146584060|NCT04826094|528644391|FG002|Overall Study|Participant withdrew consent|0|||
146584061|NCT04826094|528644392|FG003|Overall Study|Participant withdrew consent|1|||
146584062|NCT04826094|528644393|FG004|Overall Study|Participant withdrew consent|1|||
146584063|NCT04826094|528644394|FG005|Overall Study|Participant withdrew consent|1|||
146584064|NCT04826094|528644395|FG006|Overall Study|Participant withdrew consent|0|||
146584065|NCT04826094|528644396|FG007|Overall Study|Participant withdrew consent|1|||
146584066|NCT04826094|528644389|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
146584067|NCT04826094|528644390|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
146584068|NCT04826094|528644391|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
146584069|NCT04826094|528644392|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
146584070|NCT04826094|528644393|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
146584071|NCT04826094|528644394|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
146584072|NCT04826094|528644395|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
146584073|NCT04826094|528644396|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
146584074|NCT04826094|528644389|FG000|Overall Study|Withdrawn by Investigator|0|||
146584075|NCT04826094|528644390|FG001|Overall Study|Withdrawn by Investigator|0|||
146584076|NCT04826094|528644391|FG002|Overall Study|Withdrawn by Investigator|0|||
146584077|NCT04826094|528644392|FG003|Overall Study|Withdrawn by Investigator|0|||
146584078|NCT04826094|528644393|FG004|Overall Study|Withdrawn by Investigator|0|||
146584079|NCT04826094|528644394|FG005|Overall Study|Withdrawn by Investigator|1|||
146584080|NCT04826094|528644395|FG006|Overall Study|Withdrawn by Investigator|0|||
146584081|NCT04826094|528644396|FG007|Overall Study|Withdrawn by Investigator|1|||
146584082|NCT04826094|528644389|FG000|Overall Study|Other: Moved from area|1|||
146584083|NCT04826094|528644390|FG001|Overall Study|Other: Moved from area|1|||
146584084|NCT04826094|528644391|FG002|Overall Study|Other: Moved from area|1|||
146584085|NCT04826094|528644392|FG003|Overall Study|Other: Moved from area|0|||
146584086|NCT04826094|528644393|FG004|Overall Study|Other: Moved from area|0|||
146584087|NCT04826094|528644394|FG005|Overall Study|Other: Moved from area|0|||
146584088|NCT04826094|528644395|FG006|Overall Study|Other: Moved from area|0|||
146584089|NCT04826094|528644396|FG007|Overall Study|Other: Moved from area|0|||
146584090|NCT04826094|528644389|FG000|Overall Study|Other: Declined|0|||
146584091|NCT04826094|528644390|FG001|Overall Study|Other: Declined|0|||
146584092|NCT04826094|528644391|FG002|Overall Study|Other: Declined|0|||
146584093|NCT04826094|528644392|FG003|Overall Study|Other: Declined|0|||
146584094|NCT04826094|528644393|FG004|Overall Study|Other: Declined|1|||
146584095|NCT04826094|528644394|FG005|Overall Study|Other: Declined|0|||
146584096|NCT04826094|528644395|FG006|Overall Study|Other: Declined|0|||
146584097|NCT04826094|528644396|FG007|Overall Study|Other: Declined|0|||
146584098|NCT04826094|528644389|FG000|Overall Study|Other: Vaccine not administered|0|||
146584099|NCT04826094|528644390|FG001|Overall Study|Other: Vaccine not administered|0|||
146584100|NCT04826094|528644391|FG002|Overall Study|Other: Vaccine not administered|1|||
146584101|NCT04826094|528644392|FG003|Overall Study|Other: Vaccine not administered|0|||
146584102|NCT04826094|528644393|FG004|Overall Study|Other: Vaccine not administered|0|||
146584103|NCT04826094|528644394|FG005|Overall Study|Other: Vaccine not administered|1|||
146584104|NCT04826094|528644395|FG006|Overall Study|Other: Vaccine not administered|1|||
146584105|NCT04826094|528644396|FG007|Overall Study|Other: Vaccine not administered|3|||
146584106|NCT02151903|528644397|FG000|Overall Study|Withdrawal by Subject|1|||
146584107|NCT02151903|528644398|FG001|Overall Study|Withdrawal by Subject|0|||
146584108|NCT02151903|528644397|FG000|Overall Study|Progressive disease|2|||
146584109|NCT02151903|528644398|FG001|Overall Study|Progressive disease|1|||
146584110|NCT01864148|528644399|FG000|Overall Study|Other|2|||
146584111|NCT01864148|528644400|FG001|Overall Study|Other|1|||
146584112|NCT01864148|528644401|FG002|Overall Study|Other|1|||
146584113|NCT01864148|528644402|FG003|Overall Study|Other|3|||
146584114|NCT01864148|528644403|FG004|Overall Study|Other|1|||
146584115|NCT01864148|528644399|FG000|Overall Study|Death|0|||
146584116|NCT01864148|528644400|FG001|Overall Study|Death|0|||
146584117|NCT01864148|528644401|FG002|Overall Study|Death|0|||
146584118|NCT01864148|528644402|FG003|Overall Study|Death|1|||
146584119|NCT01864148|528644403|FG004|Overall Study|Death|0|||
146584120|NCT01864148|528644399|FG000|Overall Study|Investigator Decision|5|||
146584121|NCT01864148|528644400|FG001|Overall Study|Investigator Decision|0|||
146584122|NCT01864148|528644401|FG002|Overall Study|Investigator Decision|0|||
146584123|NCT01864148|528644402|FG003|Overall Study|Investigator Decision|4|||
146584124|NCT01864148|528644403|FG004|Overall Study|Investigator Decision|6|||
146584125|NCT01864148|528644399|FG000|Overall Study|Withdrawal by Subject|9|||
146584126|NCT01864148|528644400|FG001|Overall Study|Withdrawal by Subject|2|||
146584127|NCT01864148|528644401|FG002|Overall Study|Withdrawal by Subject|6|||
146584128|NCT01864148|528644402|FG003|Overall Study|Withdrawal by Subject|8|||
146584129|NCT01864148|528644403|FG004|Overall Study|Withdrawal by Subject|8|||
146584130|NCT01864148|528644399|FG000|Overall Study|Lost to Follow-up|0|||
146584131|NCT01864148|528644400|FG001|Overall Study|Lost to Follow-up|0|||
146584132|NCT01864148|528644401|FG002|Overall Study|Lost to Follow-up|0|||
146584133|NCT01864148|528644402|FG003|Overall Study|Lost to Follow-up|2|||
146584134|NCT01864148|528644403|FG004|Overall Study|Lost to Follow-up|1|||
146584135|NCT01864148|528644399|FG000|Overall Study|Adverse Event|4|||
146584136|NCT01864148|528644400|FG001|Overall Study|Adverse Event|2|||
146584137|NCT01864148|528644401|FG002|Overall Study|Adverse Event|4|||
146584138|NCT01864148|528644402|FG003|Overall Study|Adverse Event|7|||
146584139|NCT01864148|528644403|FG004|Overall Study|Adverse Event|7|||
146584140|NCT01864148|528644399|FG000|Overall Study|Not Dosed|0|||
146584141|NCT01864148|528644400|FG001|Overall Study|Not Dosed|0|||
146584142|NCT01864148|528644401|FG002|Overall Study|Not Dosed|0|||
146584143|NCT01864148|528644402|FG003|Overall Study|Not Dosed|1|||
146584144|NCT01864148|528644403|FG004|Overall Study|Not Dosed|0|||
146584145|NCT01500252|528644404|FG000|Overall Study|Death|4|||
146584146|NCT01500252|528644405|FG001|Overall Study|Death|2|||
146584147|NCT01500252|528644404|FG000|Overall Study|Lost to Follow-up|5|||
146584148|NCT01500252|528644405|FG001|Overall Study|Lost to Follow-up|4|||
146584149|NCT00778375|528644407|FG000|Overall Study|Ineligible|3|||
146584150|NCT03490292|528644408|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
146584151|NCT03490292|528644409|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
146584152|NCT03490292|528644408|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
146584153|NCT03490292|528644409|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
146584154|NCT03490292|528644408|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
146584155|NCT03490292|528644409|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
146584156|NCT03490292|528644408|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
146584157|NCT03490292|528644409|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
146652246|NCT02093351|528905190|FG001|Part A|Adverse Event|1|||
146652247|NCT02093351|528905191|FG002|Part A|Adverse Event|1|||
146652248|NCT02093351|528905192|FG003|Part A|Adverse Event|0|||
146652249|NCT02093351|528905189|FG000|Part A|Condition under investigation worsened|2|||
146978286|NCT00435825|530082310|FG000|Overall Study|Did not enter follow-up|0|||
146584158|NCT03490292|528644408|FG000|1 Year Follow Up Post Last Dose|Death|1|||
146584159|NCT03490292|528644409|FG001|1 Year Follow Up Post Last Dose|Death|1|||
146584160|NCT01421303|528644410|FG000|Overall Study|Lost to Follow-up|13|||
146584161|NCT01421303|528644410|FG000|Overall Study|Non compliance with study procedure|1|||
146584162|NCT01421303|528644410|FG000|Overall Study|Other|7|||
146584163|NCT01421303|528644410|FG000|Overall Study|Withdrawal by Subject|1|||
146584164|NCT06003777|528644411|FG000|Period 1|Adverse Event|0|||
146584165|NCT06003777|528644412|FG001|Period 1|Adverse Event|0|||
146584166|NCT06003777|528644413|FG002|Period 1|Adverse Event|1|||
146584167|NCT06003777|528644414|FG003|Period 1|Adverse Event|0|||
146584168|NCT06003777|528644415|FG004|Period 1|Adverse Event|0|||
146584169|NCT06003777|528644416|FG005|Period 1|Adverse Event|0|||
146652250|NCT02093351|528905190|FG001|Part A|Condition under investigation worsened|0|||
146584170|NCT06003777|528644417|FG006|Period 1|Adverse Event|0|||
146584171|NCT06003777|528644418|FG007|Period 1|Adverse Event|0|||
146584172|NCT06003777|528644419|FG008|Period 1|Adverse Event|0|||
146584173|NCT06003777|528644420|FG009|Period 1|Adverse Event|0|||
146584174|NCT06003777|528644421|FG010|Period 1|Adverse Event|0|||
146584175|NCT06003777|528644422|FG011|Period 1|Adverse Event|0|||
146584176|NCT06003777|528644411|FG000|Period 1|Withdrawal by Subject|0|||
146584177|NCT06003777|528644412|FG001|Period 1|Withdrawal by Subject|0|||
146584178|NCT06003777|528644413|FG002|Period 1|Withdrawal by Subject|0|||
146584179|NCT06003777|528644414|FG003|Period 1|Withdrawal by Subject|0|||
146584180|NCT06003777|528644415|FG004|Period 1|Withdrawal by Subject|1|||
146584181|NCT06003777|528644416|FG005|Period 1|Withdrawal by Subject|0|||
146584182|NCT06003777|528644417|FG006|Period 1|Withdrawal by Subject|0|||
146584183|NCT06003777|528644418|FG007|Period 1|Withdrawal by Subject|0|||
146584184|NCT06003777|528644419|FG008|Period 1|Withdrawal by Subject|0|||
146584185|NCT06003777|528644420|FG009|Period 1|Withdrawal by Subject|0|||
146584186|NCT06003777|528644421|FG010|Period 1|Withdrawal by Subject|0|||
146584187|NCT06003777|528644422|FG011|Period 1|Withdrawal by Subject|0|||
146584188|NCT06003777|528644411|FG000|Period 2|Withdrawal by Subject|0|||
146584189|NCT06003777|528644412|FG001|Period 2|Withdrawal by Subject|0|||
146584190|NCT06003777|528644413|FG002|Period 2|Withdrawal by Subject|0|||
146584191|NCT06003777|528644414|FG003|Period 2|Withdrawal by Subject|0|||
146584192|NCT06003777|528644415|FG004|Period 2|Withdrawal by Subject|0|||
146584193|NCT06003777|528644416|FG005|Period 2|Withdrawal by Subject|0|||
146584194|NCT06003777|528644417|FG006|Period 2|Withdrawal by Subject|0|||
146584195|NCT06003777|528644418|FG007|Period 2|Withdrawal by Subject|0|||
146584196|NCT06003777|528644419|FG008|Period 2|Withdrawal by Subject|1|||
146584197|NCT06003777|528644420|FG009|Period 2|Withdrawal by Subject|0|||
146584198|NCT06003777|528644421|FG010|Period 2|Withdrawal by Subject|0|||
146584199|NCT06003777|528644422|FG011|Period 2|Withdrawal by Subject|0|||
146584200|NCT06003777|528644411|FG000|Period 3|Adverse Event|0|||
146584201|NCT06003777|528644412|FG001|Period 3|Adverse Event|0|||
146584202|NCT06003777|528644413|FG002|Period 3|Adverse Event|0|||
146584203|NCT06003777|528644414|FG003|Period 3|Adverse Event|0|||
146584204|NCT06003777|528644415|FG004|Period 3|Adverse Event|0|||
146918765|NCT01425190|529864511|FG002|Overall Study|Full dose not consumed.|0|||
146918766|NCT01035255|529864513|FG000|Overall Study|Death|724|||
146918767|NCT01035255|529864514|FG001|Overall Study|Death|844|||
146918768|NCT01035255|529864513|FG000|Overall Study|Lost to Follow-up|2|||
146918769|NCT01035255|529864514|FG001|Overall Study|Lost to Follow-up|5|||
146918770|NCT01035255|529864513|FG000|Overall Study|patient's request|15|||
146918771|NCT01035255|529864514|FG001|Overall Study|patient's request|13|||
146918772|NCT00195260|529864517|FG000|Part 1: Dose Escalation|Adverse Event|0|||
146918773|NCT00195260|529864518|FG001|Part 1: Dose Escalation|Adverse Event|1|||
146918774|NCT00195260|529864519|FG002|Part 1: Dose Escalation|Adverse Event|0|||
146918775|NCT00195260|529864520|FG003|Part 1: Dose Escalation|Adverse Event|1|||
146918776|NCT00195260|529864521|FG004|Part 1: Dose Escalation|Adverse Event|1|||
146918777|NCT00195260|529864522|FG005|Part 1: Dose Escalation|Adverse Event|0|||
146918778|NCT00195260|529864523|FG006|Part 1: Dose Escalation|Adverse Event|3|||
146918779|NCT00195260|529864524|FG007|Part 1: Dose Escalation|Adverse Event|0|||
146918780|NCT00195260|529864525|FG008|Part 1: Dose Escalation|Adverse Event|0|||
146918781|NCT00195260|529864526|FG009|Part 1: Dose Escalation|Adverse Event|0|||
146918782|NCT00195260|529864527|FG010|Part 1: Dose Escalation|Adverse Event|0|||
146918783|NCT00195260|529864517|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146918784|NCT00195260|529864518|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146918785|NCT00195260|529864519|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146918786|NCT00195260|529864520|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146584205|NCT06003777|528644416|FG005|Period 3|Adverse Event|0|||
146584206|NCT06003777|528644417|FG006|Period 3|Adverse Event|1|||
146584207|NCT06003777|528644418|FG007|Period 3|Adverse Event|0|||
146584208|NCT06003777|528644419|FG008|Period 3|Adverse Event|0|||
146584209|NCT06003777|528644420|FG009|Period 3|Adverse Event|0|||
146584210|NCT06003777|528644421|FG010|Period 3|Adverse Event|0|||
146652251|NCT02093351|528905191|FG002|Part A|Condition under investigation worsened|2|||
146652252|NCT02093351|528905192|FG003|Part A|Condition under investigation worsened|0|||
146652253|NCT02093351|528905189|FG000|Part A|Death|0|||
146918787|NCT00195260|529864521|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
146918788|NCT00195260|529864522|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146584211|NCT06003777|528644422|FG011|Period 3|Adverse Event|0|||
146918789|NCT00195260|529864523|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146584212|NCT06003777|528644411|FG000|Period 4|No longer met eligibility criteria|0|||
146584213|NCT06003777|528644412|FG001|Period 4|No longer met eligibility criteria|0|||
146584214|NCT06003777|528644413|FG002|Period 4|No longer met eligibility criteria|1|||
146584215|NCT06003777|528644414|FG003|Period 4|No longer met eligibility criteria|0|||
146918790|NCT00195260|529864524|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
146584216|NCT06003777|528644415|FG004|Period 4|No longer met eligibility criteria|0|||
146584217|NCT06003777|528644416|FG005|Period 4|No longer met eligibility criteria|0|||
146584218|NCT06003777|528644417|FG006|Period 4|No longer met eligibility criteria|0|||
146652254|NCT02093351|528905190|FG001|Part A|Death|1|||
146584219|NCT06003777|528644418|FG007|Period 4|No longer met eligibility criteria|0|||
146584220|NCT06003777|528644419|FG008|Period 4|No longer met eligibility criteria|0|||
146584221|NCT06003777|528644420|FG009|Period 4|No longer met eligibility criteria|0|||
146584222|NCT06003777|528644421|FG010|Period 4|No longer met eligibility criteria|0|||
146584223|NCT06003777|528644422|FG011|Period 4|No longer met eligibility criteria|0|||
146584224|NCT06003777|528644411|FG000|Period 4|Withdrawal by Subject|0|||
146584225|NCT06003777|528644412|FG001|Period 4|Withdrawal by Subject|1|||
146584226|NCT06003777|528644413|FG002|Period 4|Withdrawal by Subject|0|||
146584227|NCT06003777|528644414|FG003|Period 4|Withdrawal by Subject|0|||
146584228|NCT06003777|528644415|FG004|Period 4|Withdrawal by Subject|0|||
146584229|NCT06003777|528644416|FG005|Period 4|Withdrawal by Subject|0|||
146584230|NCT06003777|528644417|FG006|Period 4|Withdrawal by Subject|0|||
146584231|NCT06003777|528644418|FG007|Period 4|Withdrawal by Subject|0|||
146584232|NCT06003777|528644419|FG008|Period 4|Withdrawal by Subject|0|||
146584233|NCT06003777|528644420|FG009|Period 4|Withdrawal by Subject|0|||
146584234|NCT06003777|528644421|FG010|Period 4|Withdrawal by Subject|0|||
146584235|NCT06003777|528644422|FG011|Period 4|Withdrawal by Subject|0|||
146584236|NCT00904670|528644423|FG000|Open Label Phase|Withdrawal by Subject|2|||
146584237|NCT00904670|528644424|FG001|Open Label Phase|Withdrawal by Subject|0|||
146584238|NCT00904670|528644423|FG000|Open Label Phase|Adverse Event|2|||
146584239|NCT00904670|528644424|FG001|Open Label Phase|Adverse Event|0|||
146584240|NCT00904670|528644423|FG000|Open Label Phase|Lack of Efficacy|1|||
146584241|NCT00904670|528644424|FG001|Open Label Phase|Lack of Efficacy|0|||
146584242|NCT00904670|528644423|FG000|Open Label Phase|Lost to Follow-up|1|||
146584243|NCT00904670|528644424|FG001|Open Label Phase|Lost to Follow-up|0|||
146584244|NCT00054327|528644427|FG000|Overall Study|Engraftment failure|1|||
146584245|NCT00054327|528644428|FG001|Overall Study|Engraftment failure|0|||
146584246|NCT00054327|528644429|FG002|Overall Study|Engraftment failure|0|||
146584247|NCT00054327|528644430|FG003|Overall Study|Engraftment failure|0|||
146584248|NCT00054327|528644431|FG004|Overall Study|Engraftment failure|0|||
146584249|NCT00054327|528644432|FG005|Overall Study|Engraftment failure|0|||
146584250|NCT00613327|528644436|FG000|Overall Study|Adverse Event|38|||
146584251|NCT00613327|528644436|FG000|Overall Study|Lost to Follow-up|8|||
146584252|NCT00613327|528644436|FG000|Overall Study|Withdrawal by Subject|6|||
146584253|NCT00613327|528644436|FG000|Overall Study|Protocol Violation|2|||
146584254|NCT00613327|528644436|FG000|Overall Study|Other|47|||
146584255|NCT00344318|528644437|FG000|Overall Study|Adverse Event|0|||
146584256|NCT00344318|528644438|FG001|Overall Study|Adverse Event|3|||
146584257|NCT00344318|528644439|FG002|Overall Study|Adverse Event|0|||
146584258|NCT00344318|528644440|FG003|Overall Study|Adverse Event|1|||
146584259|NCT00344318|528644437|FG000|Overall Study|Withdrawal by Subject|2|||
146584260|NCT00344318|528644438|FG001|Overall Study|Withdrawal by Subject|2|||
146584261|NCT00344318|528644439|FG002|Overall Study|Withdrawal by Subject|0|||
146584262|NCT00344318|528644440|FG003|Overall Study|Withdrawal by Subject|2|||
146584263|NCT00344318|528644437|FG000|Overall Study|Lost to Follow-up|2|||
146584264|NCT00344318|528644438|FG001|Overall Study|Lost to Follow-up|0|||
146584265|NCT00344318|528644439|FG002|Overall Study|Lost to Follow-up|1|||
146584266|NCT00344318|528644440|FG003|Overall Study|Lost to Follow-up|0|||
146584267|NCT01606176|528644445|FG000|Overall Study|Adverse Event|2|||
146584268|NCT01606176|528644446|FG001|Overall Study|Adverse Event|3|||
146584269|NCT01606176|528644445|FG000|Overall Study|Disease progression|1|||
146918791|NCT00195260|529864525|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146918792|NCT00195260|529864526|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146918793|NCT00195260|529864527|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146584270|NCT01606176|528644446|FG001|Overall Study|Disease progression|0|||
146584271|NCT01606176|528644445|FG000|Overall Study|Withdrawal by Subject|1|||
146918794|NCT00195260|529864517|FG000|Part 1: Dose Escalation|Death|0|||
146918795|NCT00195260|529864518|FG001|Part 1: Dose Escalation|Death|0|||
146918796|NCT00195260|529864519|FG002|Part 1: Dose Escalation|Death|0|||
146918797|NCT00195260|529864520|FG003|Part 1: Dose Escalation|Death|0|||
146918798|NCT00195260|529864521|FG004|Part 1: Dose Escalation|Death|0|||
146918799|NCT00195260|529864522|FG005|Part 1: Dose Escalation|Death|0|||
146918800|NCT00195260|529864523|FG006|Part 1: Dose Escalation|Death|0|||
146918801|NCT00195260|529864524|FG007|Part 1: Dose Escalation|Death|1|||
146918802|NCT00195260|529864525|FG008|Part 1: Dose Escalation|Death|0|||
146978287|NCT00435825|530082311|FG001|Overall Study|Did not enter follow-up|4|||
146584272|NCT01606176|528644446|FG001|Overall Study|Withdrawal by Subject|0|||
146584273|NCT00361231|528644447|FG000|Overall Study|Physician Decision|3|||
146584274|NCT00361231|528644447|FG000|Overall Study|Symptomatic deterioration|5|||
146584275|NCT00361231|528644447|FG000|Overall Study|Radiographic disease progression|16|||
146584276|NCT00361231|528644447|FG000|Overall Study|Withdrawal by Subject|4|||
146584277|NCT00361231|528644447|FG000|Overall Study|Adverse Event|6|||
146584278|NCT01814397|528644450|FG000|Overall Study|Adverse Event|7|||
146584279|NCT01814397|528644450|FG000|Overall Study|Withdrawal by Subject|7|||
146652255|NCT02093351|528905191|FG002|Part A|Death|0|||
146584280|NCT00244933|528644451|FG000|Overall Study|Not response evaluable|2|||
146652256|NCT02093351|528905192|FG003|Part A|Death|0|||
146918803|NCT00195260|529864526|FG009|Part 1: Dose Escalation|Death|0|||
146918804|NCT00195260|529864527|FG010|Part 1: Dose Escalation|Death|0|||
146584281|NCT04731298|528644452|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
146584282|NCT04731298|528644453|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
146584283|NCT01208961|528644454|FG000|High-Fat Period III|Protocol Violation|1|||
146584284|NCT01208961|528644455|FG001|High-Fat Period III|Protocol Violation|0|||
146584285|NCT03213938|528644456|FG000|Overall Study|Lost to Follow-up|4|||
146584286|NCT03213938|528644457|FG001|Overall Study|Lost to Follow-up|3|||
146584287|NCT03213938|528644456|FG000|Overall Study|Lack of Efficacy|1|||
146584288|NCT03213938|528644457|FG001|Overall Study|Lack of Efficacy|0|||
146584289|NCT03213938|528644456|FG000|Overall Study|Decline to participate|5|||
146584290|NCT03213938|528644457|FG001|Overall Study|Decline to participate|4|||
146584291|NCT03213938|528644456|FG000|Overall Study|Without reason|4|||
146584292|NCT03213938|528644457|FG001|Overall Study|Without reason|5|||
146584293|NCT02487654|528644459|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
146584294|NCT02487654|528644460|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
146584295|NCT02487654|528644459|FG000|Overall Study|Withdrawal by Subject|3|||
146584296|NCT02487654|528644460|FG001|Overall Study|Withdrawal by Subject|7|||
146584297|NCT04238481|528644461|FG000|Overall Study|Miscellaneous|0|||
146584298|NCT04238481|528644462|FG001|Overall Study|Miscellaneous|1|||
146584299|NCT04238481|528644463|FG002|Overall Study|Miscellaneous|0|||
146584300|NCT04238481|528644464|FG003|Overall Study|Miscellaneous|0|||
146584301|NCT02152371|528644465|FG000|Overall Study|Adverse Event|6|||
146584302|NCT02152371|528644466|FG001|Overall Study|Adverse Event|2|||
146584303|NCT02152371|528644465|FG000|Overall Study|Withdrawal by Subject|3|||
146584304|NCT02152371|528644466|FG001|Overall Study|Withdrawal by Subject|7|||
146584305|NCT02152371|528644465|FG000|Overall Study|Protocol Violation|2|||
146584306|NCT02152371|528644466|FG001|Overall Study|Protocol Violation|3|||
146584307|NCT02152371|528644465|FG000|Overall Study|Lost to Follow-up|1|||
146584308|NCT02152371|528644466|FG001|Overall Study|Lost to Follow-up|0|||
146584309|NCT02152371|528644465|FG000|Overall Study|Lack of Efficacy|0|||
146584310|NCT02152371|528644466|FG001|Overall Study|Lack of Efficacy|1|||
146584311|NCT02152371|528644465|FG000|Overall Study|Physician Decision|0|||
146584312|NCT02152371|528644466|FG001|Overall Study|Physician Decision|2|||
146584313|NCT02152371|528644465|FG000|Overall Study|Reason Not Given|0|||
146584314|NCT02152371|528644466|FG001|Overall Study|Reason Not Given|1|||
146584315|NCT00350870|528644467|FG000|Overall Study|Withdrawal by Subject|21|||
146584316|NCT00350870|528644468|FG001|Overall Study|Withdrawal by Subject|17|||
146584317|NCT00350870|528644469|FG002|Overall Study|Withdrawal by Subject|15|||
146584318|NCT00350870|528644470|FG003|Overall Study|Withdrawal by Subject|14|||
146918805|NCT00195260|529864517|FG000|Part 1: Dose Escalation|Disease Progression|3|||
146918806|NCT00195260|529864518|FG001|Part 1: Dose Escalation|Disease Progression|2|||
146918807|NCT00195260|529864519|FG002|Part 1: Dose Escalation|Disease Progression|5|||
146918808|NCT00195260|529864520|FG003|Part 1: Dose Escalation|Disease Progression|6|||
146918809|NCT00195260|529864521|FG004|Part 1: Dose Escalation|Disease Progression|4|||
146918810|NCT00195260|529864522|FG005|Part 1: Dose Escalation|Disease Progression|6|||
146918811|NCT00195260|529864523|FG006|Part 1: Dose Escalation|Disease Progression|7|||
146918812|NCT00195260|529864524|FG007|Part 1: Dose Escalation|Disease Progression|4|||
146918813|NCT00195260|529864525|FG008|Part 1: Dose Escalation|Disease Progression|0|||
146918814|NCT00195260|529864526|FG009|Part 1: Dose Escalation|Disease Progression|0|||
146918815|NCT00195260|529864527|FG010|Part 1: Dose Escalation|Disease Progression|0|||
146918816|NCT00195260|529864517|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
146918817|NCT00195260|529864518|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
146918818|NCT00195260|529864519|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
146918819|NCT00195260|529864520|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
146918820|NCT00195260|529864521|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
146918821|NCT00195260|529864522|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
146918822|NCT00195260|529864523|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
146918823|NCT00195260|529864524|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
146918824|NCT00195260|529864525|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
146918825|NCT00195260|529864526|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
146584319|NCT00350870|528644467|FG000|Overall Study|Physician Decision|1|||
146584320|NCT00350870|528644468|FG001|Overall Study|Physician Decision|0|||
146584321|NCT00350870|528644469|FG002|Overall Study|Physician Decision|1|||
146584322|NCT00350870|528644470|FG003|Overall Study|Physician Decision|1|||
146918826|NCT00195260|529864527|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
146918827|NCT00195260|529864517|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
146918828|NCT00195260|529864518|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
146918829|NCT00195260|529864519|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
146918830|NCT00195260|529864520|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
146918831|NCT00195260|529864521|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
146584323|NCT00349921|528644471|FG000|First Spinal Injection|Physician Decision|1|||
146584324|NCT00349921|528644472|FG001|First Spinal Injection|Physician Decision|0|||
146584325|NCT00349921|528644473|FG002|First Spinal Injection|Physician Decision|0|||
146584326|NCT00349921|528644474|FG003|First Spinal Injection|Physician Decision|0|||
146584327|NCT00349921|528644471|FG000|First Spinal Injection|Adverse Event|0|||
146584328|NCT00349921|528644472|FG001|First Spinal Injection|Adverse Event|0|||
146584329|NCT00349921|528644473|FG002|First Spinal Injection|Adverse Event|1|||
146584330|NCT00349921|528644474|FG003|First Spinal Injection|Adverse Event|0|||
146584331|NCT05285644|528644475|FG000|Overall Study|Adverse Event|3|||
146584332|NCT05285644|528644476|FG001|Overall Study|Adverse Event|3|||
146584333|NCT05285644|528644475|FG000|Overall Study|Withdrawal of Consent|2|||
146584334|NCT05285644|528644476|FG001|Overall Study|Withdrawal of Consent|5|||
146584335|NCT05285644|528644475|FG000|Overall Study|Noncompliance|0|||
146584336|NCT05285644|528644476|FG001|Overall Study|Noncompliance|4|||
146584337|NCT05285644|528644475|FG000|Overall Study|Lost to Follow-up|4|||
146584338|NCT05285644|528644476|FG001|Overall Study|Lost to Follow-up|6|||
146584339|NCT05285644|528644475|FG000|Overall Study|Disallowed Concurrent Medication|1|||
146584340|NCT05285644|528644476|FG001|Overall Study|Disallowed Concurrent Medication|1|||
146584341|NCT05285644|528644475|FG000|Overall Study|Investigator Decision|2|||
146584342|NCT05285644|528644476|FG001|Overall Study|Investigator Decision|0|||
146584343|NCT05285644|528644475|FG000|Overall Study|Protocol Deviation|1|||
146584344|NCT05285644|528644476|FG001|Overall Study|Protocol Deviation|0|||
146584345|NCT05285644|528644475|FG000|Overall Study|As specified in the Clinical Study Report|7|||
146584346|NCT05285644|528644476|FG001|Overall Study|As specified in the Clinical Study Report|3|||
146584347|NCT00107900|528644479|FG000|Overall Study|Adverse Event|3|||
146584348|NCT00107900|528644480|FG001|Overall Study|Adverse Event|2|||
146584349|NCT00107900|528644481|FG002|Overall Study|Adverse Event|10|||
146584350|NCT00107900|528644482|FG003|Overall Study|Adverse Event|3|||
146584351|NCT00107900|528644483|FG004|Overall Study|Adverse Event|5|||
146584352|NCT00107900|528644484|FG005|Overall Study|Adverse Event|3|||
146584353|NCT00107900|528644479|FG000|Overall Study|Death|0|||
146584354|NCT00107900|528644480|FG001|Overall Study|Death|0|||
146584355|NCT00107900|528644481|FG002|Overall Study|Death|0|||
146584356|NCT00107900|528644482|FG003|Overall Study|Death|0|||
146584357|NCT00107900|528644483|FG004|Overall Study|Death|1|||
146584358|NCT00107900|528644484|FG005|Overall Study|Death|0|||
146584359|NCT00107900|528644479|FG000|Overall Study|Lost to Follow-up|4|||
146584360|NCT00107900|528644480|FG001|Overall Study|Lost to Follow-up|1|||
146584361|NCT00107900|528644481|FG002|Overall Study|Lost to Follow-up|3|||
146584362|NCT00107900|528644482|FG003|Overall Study|Lost to Follow-up|2|||
146584363|NCT00107900|528644483|FG004|Overall Study|Lost to Follow-up|5|||
146584364|NCT00107900|528644484|FG005|Overall Study|Lost to Follow-up|5|||
146584365|NCT00107900|528644479|FG000|Overall Study|Protocol Violation|1|||
146584366|NCT00107900|528644480|FG001|Overall Study|Protocol Violation|0|||
146584367|NCT00107900|528644481|FG002|Overall Study|Protocol Violation|5|||
146584368|NCT00107900|528644482|FG003|Overall Study|Protocol Violation|5|||
146584369|NCT00107900|528644483|FG004|Overall Study|Protocol Violation|7|||
146584370|NCT00107900|528644484|FG005|Overall Study|Protocol Violation|0|||
146584371|NCT00107900|528644479|FG000|Overall Study|Withdrawal by Subject|1|||
146584372|NCT00107900|528644480|FG001|Overall Study|Withdrawal by Subject|0|||
146584373|NCT00107900|528644481|FG002|Overall Study|Withdrawal by Subject|5|||
146584374|NCT00107900|528644482|FG003|Overall Study|Withdrawal by Subject|0|||
146584375|NCT00107900|528644483|FG004|Overall Study|Withdrawal by Subject|1|||
146584376|NCT00107900|528644484|FG005|Overall Study|Withdrawal by Subject|1|||
146584377|NCT00107900|528644479|FG000|Overall Study|Administrative Reasons|1|||
146584378|NCT00107900|528644480|FG001|Overall Study|Administrative Reasons|0|||
146584379|NCT00107900|528644481|FG002|Overall Study|Administrative Reasons|2|||
146584380|NCT00107900|528644482|FG003|Overall Study|Administrative Reasons|2|||
146584381|NCT00107900|528644483|FG004|Overall Study|Administrative Reasons|2|||
146584382|NCT00107900|528644484|FG005|Overall Study|Administrative Reasons|0|||
146584383|NCT00511433|528646379|FG000|Overall Study|Adverse Event|5|||
146584384|NCT00511433|528646380|FG001|Overall Study|Adverse Event|0|||
146918832|NCT00195260|529864522|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
146918833|NCT00195260|529864523|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
146918834|NCT00195260|529864524|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
146918835|NCT00195260|529864525|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
146918836|NCT00195260|529864526|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
146918837|NCT00195260|529864527|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
146918838|NCT00195260|529864517|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
146584385|NCT00511433|528646379|FG000|Overall Study|Other Reason|1|||
146584386|NCT00511433|528646380|FG001|Overall Study|Other Reason|1|||
146652257|NCT02093351|528905189|FG000|Part B|Patient decision|0|||
146652258|NCT02093351|528905190|FG001|Part B|Patient decision|0|||
146918839|NCT00195260|529864518|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
146584387|NCT01380535|528646381|FG000|Overall Study|Adverse Event|3|||
146978288|NCT00435825|530082312|FG002|Overall Study|Did not enter follow-up|1|||
146978289|NCT00435825|530082313|FG003|Overall Study|Did not enter follow-up|3|||
146584388|NCT01380535|528646382|FG001|Overall Study|Adverse Event|3|||
146584389|NCT01380535|528646381|FG000|Overall Study|Death|3|||
146584390|NCT01380535|528646382|FG001|Overall Study|Death|0|||
146584391|NCT01380535|528646381|FG000|Overall Study|Study site closed|0|||
146584392|NCT01380535|528646382|FG001|Overall Study|Study site closed|5|||
146584393|NCT01380535|528646381|FG000|Overall Study|Withdrawal by Subject|1|||
146584394|NCT01380535|528646382|FG001|Overall Study|Withdrawal by Subject|2|||
146584395|NCT01380535|528646381|FG000|Overall Study|Protocol Violation|0|||
146584396|NCT01380535|528646382|FG001|Overall Study|Protocol Violation|2|||
146584397|NCT01380535|528646381|FG000|Overall Study|Lack of Efficacy|0|||
146584398|NCT01380535|528646382|FG001|Overall Study|Lack of Efficacy|3|||
146584399|NCT03100539|528646383|FG000|Overall Study|Lost to Follow-up|60|||
146584400|NCT03100539|528646384|FG001|Overall Study|Lost to Follow-up|54|||
146584401|NCT03100539|528646385|FG002|Overall Study|Lost to Follow-up|17|||
146584402|NCT03100539|528646383|FG000|Overall Study|Uncollected|8|||
146584403|NCT03100539|528646384|FG001|Overall Study|Uncollected|8|||
146584404|NCT03100539|528646385|FG002|Overall Study|Uncollected|0|||
146584405|NCT03100539|528646383|FG000|Overall Study|Ally Health|0|||
146584406|NCT03100539|528646384|FG001|Overall Study|Ally Health|0|||
146584407|NCT03100539|528646385|FG002|Overall Study|Ally Health|3|||
146584408|NCT03100539|528646383|FG000|Overall Study|Disinterest|0|||
146584409|NCT03100539|528646384|FG001|Overall Study|Disinterest|0|||
146584410|NCT03100539|528646385|FG002|Overall Study|Disinterest|22|||
146584411|NCT03100539|528646383|FG000|Overall Study|Veteran Health|0|||
146584412|NCT03100539|528646384|FG001|Overall Study|Veteran Health|0|||
146584413|NCT03100539|528646385|FG002|Overall Study|Veteran Health|8|||
146584414|NCT03100539|528646383|FG000|Overall Study|Moved|0|||
146584415|NCT03100539|528646384|FG001|Overall Study|Moved|0|||
146584416|NCT03100539|528646385|FG002|Overall Study|Moved|1|||
146584417|NCT03100539|528646383|FG000|Overall Study|Scheduling Conflicts|0|||
146584418|NCT03100539|528646384|FG001|Overall Study|Scheduling Conflicts|0|||
146584419|NCT03100539|528646385|FG002|Overall Study|Scheduling Conflicts|12|||
146584420|NCT02596958|528646386|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
146584421|NCT02596958|528646386|FG000|Overall Study|Cancer Progression|441|||
146584422|NCT02596958|528646386|FG000|Overall Study|Death From Cancer|112|||
146584423|NCT02596958|528646386|FG000|Overall Study|Death From Other Cause|33|||
146584424|NCT02596958|528646386|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
146584425|NCT02596958|528646386|FG000|Overall Study|Administrative Reasons/Other|231|||
146770838|NCT00442117|529328693|FG000|Overall Study|Non compliance with protocol|3|||
146770839|NCT00442117|529328694|FG001|Overall Study|Non compliance with protocol|5|||
146770840|NCT00442117|529328693|FG000|Overall Study|Met Withdrawal Criteria|2|||
146918840|NCT00195260|529864519|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
146584426|NCT02596958|528646386|FG000|Overall Study|Lost to Follow-up|33|||
146584427|NCT02596958|528646386|FG000|Overall Study|Missing|32|||
146584428|NCT02596958|528646386|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
146584429|NCT02242435|528646387|FG000|Overall Study|Lost to Follow-up|3|||
146584430|NCT02242435|528646388|FG001|Overall Study|Lost to Follow-up|4|||
146584431|NCT02242435|528646387|FG000|Overall Study|Adverse Event|3|||
146584432|NCT02242435|528646388|FG001|Overall Study|Adverse Event|2|||
146584433|NCT02242435|528646387|FG000|Overall Study|Withdrawal by Subject|13|||
146584434|NCT02242435|528646388|FG001|Overall Study|Withdrawal by Subject|8|||
146584435|NCT02242435|528646387|FG000|Overall Study|Death|0|||
146584436|NCT02242435|528646388|FG001|Overall Study|Death|1|||
146584437|NCT02242435|528646387|FG000|Overall Study|Protocol Violation|1|||
146584438|NCT02242435|528646388|FG001|Overall Study|Protocol Violation|0|||
146584439|NCT02242435|528646387|FG000|Overall Study|Physician Decision|0|||
146584440|NCT02242435|528646388|FG001|Overall Study|Physician Decision|1|||
146584441|NCT01110330|528646391|FG000|Overall Study|Adverse Event|0|||
146584442|NCT01110330|528646392|FG001|Overall Study|Adverse Event|4|||
146584443|NCT01110330|528646393|FG002|Overall Study|Adverse Event|3|||
146584444|NCT01110330|528646391|FG000|Overall Study|Lack of Efficacy|3|||
146584445|NCT01110330|528646392|FG001|Overall Study|Lack of Efficacy|1|||
146584446|NCT01110330|528646393|FG002|Overall Study|Lack of Efficacy|1|||
146584447|NCT01110330|528646391|FG000|Overall Study|Lost to Follow-up|9|||
146584448|NCT01110330|528646392|FG001|Overall Study|Lost to Follow-up|10|||
146584449|NCT01110330|528646393|FG002|Overall Study|Lost to Follow-up|15|||
146584450|NCT01110330|528646391|FG000|Overall Study|Physician Decision|0|||
146584451|NCT01110330|528646392|FG001|Overall Study|Physician Decision|1|||
146584452|NCT01110330|528646393|FG002|Overall Study|Physician Decision|0|||
146584453|NCT01110330|528646391|FG000|Overall Study|Protocol Violation|2|||
146584454|NCT01110330|528646392|FG001|Overall Study|Protocol Violation|0|||
146584455|NCT01110330|528646393|FG002|Overall Study|Protocol Violation|4|||
146584456|NCT01110330|528646391|FG000|Overall Study|Withdrawal by Subject|0|||
146584457|NCT01110330|528646392|FG001|Overall Study|Withdrawal by Subject|6|||
146584458|NCT01110330|528646393|FG002|Overall Study|Withdrawal by Subject|2|||
146584459|NCT01110330|528646391|FG000|Overall Study|Other|1|||
146584460|NCT01110330|528646392|FG001|Overall Study|Other|1|||
146584461|NCT01110330|528646393|FG002|Overall Study|Other|1|||
146584462|NCT03350035|528646414|FG000|Overall Study|Lack of Efficacy|2|||
146918841|NCT00195260|529864520|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
146584463|NCT03350035|528646415|FG001|Overall Study|Lack of Efficacy|0|||
146918842|NCT00195260|529864521|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
146584464|NCT03350035|528646416|FG002|Overall Study|Lack of Efficacy|0|||
146584465|NCT03350035|528646414|FG000|Overall Study|Subject discharged to hospice|0|||
146584466|NCT03350035|528646415|FG001|Overall Study|Subject discharged to hospice|0|||
146584467|NCT03350035|528646416|FG002|Overall Study|Subject discharged to hospice|1|||
146584468|NCT04115748|528646417|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
146584469|NCT04115748|528646418|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
146584470|NCT04115748|528646419|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
146584471|NCT04115748|528646420|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
146584472|NCT04115748|528646421|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
146584473|NCT04115748|528646422|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
146584474|NCT04115748|528646423|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
146584475|NCT04115748|528646424|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
146584476|NCT04115748|528646425|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
146584477|NCT04115748|528646426|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
146584478|NCT04115748|528646417|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146584479|NCT04115748|528646418|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146584480|NCT04115748|528646419|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146584481|NCT04115748|528646420|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
146584482|NCT04115748|528646421|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146584483|NCT04115748|528646422|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146584484|NCT04115748|528646423|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146584485|NCT04115748|528646424|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146584486|NCT04115748|528646425|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146584487|NCT04115748|528646426|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146584488|NCT04115748|528646417|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
146584489|NCT04115748|528646418|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
146584490|NCT04115748|528646419|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
146584491|NCT04115748|528646420|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
146584492|NCT04115748|528646421|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
146584493|NCT04115748|528646422|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
146584494|NCT04115748|528646423|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
146584495|NCT04115748|528646424|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
146584496|NCT04115748|528646425|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
146584497|NCT04115748|528646426|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
146584498|NCT04115748|528646417|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146584499|NCT04115748|528646418|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146584500|NCT04115748|528646419|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146584501|NCT04115748|528646420|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146584502|NCT04115748|528646421|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146584503|NCT04115748|528646422|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146584504|NCT04115748|528646423|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146584505|NCT04115748|528646424|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146584506|NCT04115748|528646425|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
146584507|NCT04115748|528646426|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146584508|NCT00713349|528646427|FG000|Overall Study|Protocol Violation|1|||
146584509|NCT03764631|528646428|FG000|Overall Study|Personal Reasons|3|||
146584510|NCT03764631|528646429|FG001|Overall Study|Personal Reasons|2|||
146584511|NCT03764631|528646428|FG000|Overall Study|Switching Therapy|3|||
146584512|NCT03764631|528646429|FG001|Overall Study|Switching Therapy|3|||
146584513|NCT03764631|528646428|FG000|Overall Study|Adverse Event|0|||
146584514|NCT03764631|528646429|FG001|Overall Study|Adverse Event|1|||
146918843|NCT00195260|529864522|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
146918844|NCT00195260|529864523|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
146918845|NCT00195260|529864524|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
146918846|NCT00195260|529864525|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
146918847|NCT00195260|529864526|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
146918848|NCT00195260|529864527|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
146918849|NCT00195260|529864517|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
146918850|NCT00195260|529864518|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
146918851|NCT00195260|529864519|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
146918852|NCT00195260|529864520|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
146918853|NCT00195260|529864521|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
146918854|NCT00195260|529864522|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
146918855|NCT00195260|529864523|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
146918856|NCT00195260|529864524|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
146918857|NCT00195260|529864525|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
146918858|NCT00195260|529864526|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
146584515|NCT03764631|528646428|FG000|Overall Study|Lost to Follow-up|33|||
146584516|NCT03764631|528646429|FG001|Overall Study|Lost to Follow-up|41|||
146584517|NCT03764631|528646428|FG000|Overall Study|No data as study site was closed|2|||
146584518|NCT03764631|528646429|FG001|Overall Study|No data as study site was closed|6|||
146584519|NCT01200407|528646430|FG000|Overall Study|Lost to Follow-up|56|||
146584520|NCT01200407|528646430|FG000|Overall Study|Adverse Event|3|||
146584521|NCT01200407|528646430|FG000|Overall Study|Withdrawal by Subject|4|||
146584522|NCT01200407|528646430|FG000|Overall Study|Other|19|||
146584523|NCT02974855|528646433|FG000|Overall Study|Adverse Event|0|||
146584524|NCT02974855|528646434|FG001|Overall Study|Adverse Event|1|||
146584525|NCT02974855|528646435|FG002|Overall Study|Adverse Event|0|||
146584526|NCT02974855|528646436|FG003|Overall Study|Adverse Event|1|||
146584527|NCT00633074|528646437|FG000|Overall Study|Adverse Event|1|||
146584528|NCT00633074|528646438|FG001|Overall Study|Adverse Event|0|||
146584529|NCT02752633|528646440|FG000|Overall Study|Withdrawal by Subject|1|||
146584530|NCT01843673|528646441|FG000|Overall Study|Lack of Efficacy|2|||
146584531|NCT01843673|528646441|FG000|Overall Study|Withdrawal by Subject|4|||
146584532|NCT03275246|528646442|FG000|Overall Study|Protocol Violation|5|||
146584533|NCT03275246|528646442|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
146584534|NCT00433966|528646445|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
146584535|NCT00433966|528646446|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
146584536|NCT00433966|528646447|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
146584537|NCT00433966|528646448|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
146584538|NCT00433966|528646445|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
146584539|NCT00433966|528646446|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
146584540|NCT00433966|528646447|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
146584541|NCT00433966|528646448|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
146584542|NCT00433966|528646445|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
146584543|NCT00433966|528646446|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
146584544|NCT00433966|528646447|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
146584545|NCT00433966|528646448|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
146584546|NCT00433966|528646445|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
146584547|NCT00433966|528646446|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
146584548|NCT00433966|528646447|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
146584549|NCT00433966|528646448|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
146652259|NCT02093351|528905191|FG002|Part B|Patient decision|0|||
146652260|NCT02093351|528905192|FG003|Part B|Patient decision|3|||
146652261|NCT02093351|528905189|FG000|Part B|Disease progression|0|||
146652262|NCT02093351|528905190|FG001|Part B|Disease progression|0|||
146652263|NCT02093351|528905191|FG002|Part B|Disease progression|0|||
146652264|NCT02093351|528905192|FG003|Part B|Disease progression|4|||
146652265|NCT02093351|528905189|FG000|Part B|Complete response|0|||
146652266|NCT02093351|528905190|FG001|Part B|Complete response|0|||
146652267|NCT02093351|528905191|FG002|Part B|Complete response|0|||
146652268|NCT02093351|528905192|FG003|Part B|Complete response|1|||
146652269|NCT02093351|528905189|FG000|Part B|Adverse event + disease progression|0|||
146652270|NCT02093351|528905190|FG001|Part B|Adverse event + disease progression|0|||
146652271|NCT02093351|528905191|FG002|Part B|Adverse event + disease progression|0|||
146652272|NCT02093351|528905192|FG003|Part B|Adverse event + disease progression|1|||
146652273|NCT02093351|528905189|FG000|Part B|Lack of therapeutic response|0|||
146652274|NCT02093351|528905190|FG001|Part B|Lack of therapeutic response|0|||
146652275|NCT02093351|528905191|FG002|Part B|Lack of therapeutic response|0|||
146652276|NCT02093351|528905192|FG003|Part B|Lack of therapeutic response|12|||
146652277|NCT02093351|528905189|FG000|Part B|Condition under investigation worsened|0|||
146652278|NCT02093351|528905190|FG001|Part B|Condition under investigation worsened|0|||
146652279|NCT02093351|528905191|FG002|Part B|Condition under investigation worsened|0|||
146652280|NCT02093351|528905192|FG003|Part B|Condition under investigation worsened|39|||
146652281|NCT02093351|528905189|FG000|Part B|Adverse Event|0|||
146652282|NCT02093351|528905190|FG001|Part B|Adverse Event|0|||
146652283|NCT02093351|528905191|FG002|Part B|Adverse Event|0|||
146652284|NCT02093351|528905192|FG003|Part B|Adverse Event|2|||
146652285|NCT02093351|528905189|FG000|Part B|Death|0|||
146918859|NCT00195260|529864527|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
146918860|NCT00195260|529864517|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
146652286|NCT02093351|528905190|FG001|Part B|Death|0|||
146652287|NCT02093351|528905191|FG002|Part B|Death|0|||
146652288|NCT02093351|528905192|FG003|Part B|Death|1|||
146652289|NCT01099709|528905193|FG000|Period 1|Withdrawal by Subject|0|||
146652290|NCT01099709|528905194|FG001|Period 1|Withdrawal by Subject|1|||
146652291|NCT01099709|528905193|FG000|Period 1|Positive cotinine test|0|||
146918861|NCT00195260|529864518|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
146652292|NCT01099709|528905194|FG001|Period 1|Positive cotinine test|1|||
146584550|NCT00433966|528646445|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
146584551|NCT00433966|528646446|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
146652293|NCT01099709|528905193|FG000|Period 1|Adverse Event|1|||
146652294|NCT01099709|528905194|FG001|Period 1|Adverse Event|0|||
146652295|NCT01611454|528905195|FG000|Overall Study|Lack of Efficacy|18|||
146652296|NCT01611454|528905196|FG001|Overall Study|Lack of Efficacy|10|||
146918862|NCT00195260|529864519|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
146918863|NCT00195260|529864520|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
146584552|NCT00433966|528646447|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
146584553|NCT00433966|528646448|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
146584554|NCT02570152|528646449|FG000|Overall Study|Protocol Violation|2|||
146584555|NCT02570152|528646449|FG000|Overall Study|Migrated/moved from study area|13|||
146584556|NCT03497975|528646451|FG000|Overall Study|Withdrew Consent|34|||
146584557|NCT03497975|528646452|FG001|Overall Study|Withdrew Consent|35|||
146584558|NCT03497975|528646451|FG000|Overall Study|Lost to Follow-up|7|||
146584559|NCT03497975|528646452|FG001|Overall Study|Lost to Follow-up|7|||
146584560|NCT03497975|528646451|FG000|Overall Study|Physician Decision|4|||
146584561|NCT03497975|528646452|FG001|Overall Study|Physician Decision|5|||
146584562|NCT03497975|528646451|FG000|Overall Study|Discontinued|42|||
146584563|NCT03497975|528646452|FG001|Overall Study|Discontinued|39|||
146584564|NCT03497975|528646451|FG000|Overall Study|Reason Not Specified|15|||
146584565|NCT03497975|528646452|FG001|Overall Study|Reason Not Specified|14|||
146584566|NCT01296711|528646453|FG000|Overall Study|Adverse Event|3|||
146584567|NCT01296711|528646454|FG001|Overall Study|Adverse Event|1|||
146584568|NCT01296711|528646455|FG002|Overall Study|Adverse Event|4|||
146584569|NCT01296711|528646456|FG003|Overall Study|Adverse Event|3|||
146584570|NCT01296711|528646457|FG004|Overall Study|Adverse Event|1|||
146584571|NCT01296711|528646458|FG005|Overall Study|Adverse Event|6|||
146584572|NCT01296711|528646459|FG006|Overall Study|Adverse Event|11|||
146584573|NCT01296711|528646460|FG007|Overall Study|Adverse Event|3|||
146584574|NCT01296711|528646453|FG000|Overall Study|Lack of Efficacy|1|||
146584575|NCT01296711|528646454|FG001|Overall Study|Lack of Efficacy|4|||
146584576|NCT01296711|528646455|FG002|Overall Study|Lack of Efficacy|1|||
146584577|NCT01296711|528646456|FG003|Overall Study|Lack of Efficacy|1|||
146584578|NCT01296711|528646457|FG004|Overall Study|Lack of Efficacy|1|||
146584579|NCT01296711|528646458|FG005|Overall Study|Lack of Efficacy|0|||
146584580|NCT01296711|528646459|FG006|Overall Study|Lack of Efficacy|2|||
146584581|NCT01296711|528646460|FG007|Overall Study|Lack of Efficacy|3|||
146584582|NCT01296711|528646453|FG000|Overall Study|Lost to Follow-up|0|||
146584583|NCT01296711|528646454|FG001|Overall Study|Lost to Follow-up|0|||
146584584|NCT01296711|528646455|FG002|Overall Study|Lost to Follow-up|1|||
146584585|NCT01296711|528646456|FG003|Overall Study|Lost to Follow-up|1|||
146584586|NCT01296711|528646457|FG004|Overall Study|Lost to Follow-up|2|||
146584587|NCT01296711|528646458|FG005|Overall Study|Lost to Follow-up|0|||
146584588|NCT01296711|528646459|FG006|Overall Study|Lost to Follow-up|4|||
146584589|NCT01296711|528646460|FG007|Overall Study|Lost to Follow-up|2|||
146584590|NCT01296711|528646453|FG000|Overall Study|Protocol Violation|0|||
146584591|NCT01296711|528646454|FG001|Overall Study|Protocol Violation|0|||
146584592|NCT01296711|528646455|FG002|Overall Study|Protocol Violation|0|||
146584593|NCT01296711|528646456|FG003|Overall Study|Protocol Violation|1|||
146584594|NCT01296711|528646457|FG004|Overall Study|Protocol Violation|1|||
146584595|NCT01296711|528646458|FG005|Overall Study|Protocol Violation|0|||
146584596|NCT01296711|528646459|FG006|Overall Study|Protocol Violation|0|||
146584597|NCT01296711|528646460|FG007|Overall Study|Protocol Violation|0|||
146584598|NCT01296711|528646453|FG000|Overall Study|Withdrawal by Subject|4|||
146584599|NCT01296711|528646454|FG001|Overall Study|Withdrawal by Subject|2|||
146584600|NCT01296711|528646455|FG002|Overall Study|Withdrawal by Subject|2|||
146584601|NCT01296711|528646456|FG003|Overall Study|Withdrawal by Subject|1|||
146584602|NCT01296711|528646457|FG004|Overall Study|Withdrawal by Subject|1|||
146584603|NCT01296711|528646458|FG005|Overall Study|Withdrawal by Subject|1|||
146584604|NCT01296711|528646459|FG006|Overall Study|Withdrawal by Subject|2|||
146584605|NCT01296711|528646460|FG007|Overall Study|Withdrawal by Subject|1|||
146584606|NCT01296711|528646453|FG000|Overall Study|Study termination|8|||
146584607|NCT01296711|528646454|FG001|Overall Study|Study termination|1|||
146584608|NCT01296711|528646455|FG002|Overall Study|Study termination|5|||
146584609|NCT01296711|528646456|FG003|Overall Study|Study termination|4|||
146584610|NCT01296711|528646457|FG004|Overall Study|Study termination|4|||
146584611|NCT01296711|528646458|FG005|Overall Study|Study termination|4|||
146584612|NCT01296711|528646459|FG006|Overall Study|Study termination|8|||
146584613|NCT01296711|528646460|FG007|Overall Study|Study termination|10|||
146584614|NCT01296711|528646453|FG000|Overall Study|Continued elevated liver enzymes|0|||
146584615|NCT01296711|528646454|FG001|Overall Study|Continued elevated liver enzymes|0|||
146584616|NCT01296711|528646455|FG002|Overall Study|Continued elevated liver enzymes|0|||
146584617|NCT01296711|528646456|FG003|Overall Study|Continued elevated liver enzymes|1|||
146584618|NCT01296711|528646457|FG004|Overall Study|Continued elevated liver enzymes|0|||
146584619|NCT01296711|528646458|FG005|Overall Study|Continued elevated liver enzymes|0|||
146584620|NCT01296711|528646459|FG006|Overall Study|Continued elevated liver enzymes|0|||
146584621|NCT01296711|528646460|FG007|Overall Study|Continued elevated liver enzymes|0|||
146584622|NCT01296711|528646453|FG000|Overall Study|Methotrexate discontinued|0|||
146918864|NCT00195260|529864521|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
146584623|NCT01296711|528646454|FG001|Overall Study|Methotrexate discontinued|0|||
146584624|NCT01296711|528646455|FG002|Overall Study|Methotrexate discontinued|0|||
146584625|NCT01296711|528646456|FG003|Overall Study|Methotrexate discontinued|1|||
146584626|NCT01296711|528646457|FG004|Overall Study|Methotrexate discontinued|0|||
146584627|NCT01296711|528646458|FG005|Overall Study|Methotrexate discontinued|0|||
146584628|NCT01296711|528646459|FG006|Overall Study|Methotrexate discontinued|0|||
146584629|NCT01296711|528646460|FG007|Overall Study|Methotrexate discontinued|0|||
146584630|NCT01296711|528646453|FG000|Overall Study|Investigator discretion|0|||
146584631|NCT01296711|528646454|FG001|Overall Study|Investigator discretion|0|||
146584632|NCT01296711|528646455|FG002|Overall Study|Investigator discretion|0|||
146584633|NCT01296711|528646456|FG003|Overall Study|Investigator discretion|0|||
146584634|NCT01296711|528646457|FG004|Overall Study|Investigator discretion|0|||
146584635|NCT01296711|528646458|FG005|Overall Study|Investigator discretion|0|||
146584636|NCT01296711|528646459|FG006|Overall Study|Investigator discretion|1|||
146584637|NCT01296711|528646460|FG007|Overall Study|Investigator discretion|0|||
146584638|NCT01296711|528646453|FG000|Overall Study|Other|0|||
146584639|NCT01296711|528646454|FG001|Overall Study|Other|0|||
146584640|NCT01296711|528646455|FG002|Overall Study|Other|0|||
146584641|NCT01296711|528646456|FG003|Overall Study|Other|0|||
146584642|NCT01296711|528646457|FG004|Overall Study|Other|0|||
146584643|NCT01296711|528646458|FG005|Overall Study|Other|0|||
146584644|NCT01296711|528646459|FG006|Overall Study|Other|1|||
146584645|NCT01296711|528646460|FG007|Overall Study|Other|0|||
146584646|NCT01296711|528646453|FG000|Overall Study|Required restricted steroid injections|0|||
146584647|NCT01296711|528646454|FG001|Overall Study|Required restricted steroid injections|0|||
146584648|NCT01296711|528646455|FG002|Overall Study|Required restricted steroid injections|0|||
146584649|NCT01296711|528646456|FG003|Overall Study|Required restricted steroid injections|0|||
146584650|NCT01296711|528646457|FG004|Overall Study|Required restricted steroid injections|0|||
146584651|NCT01296711|528646458|FG005|Overall Study|Required restricted steroid injections|0|||
146584652|NCT01296711|528646459|FG006|Overall Study|Required restricted steroid injections|1|||
146584653|NCT01296711|528646460|FG007|Overall Study|Required restricted steroid injections|0|||
146584654|NCT01296711|528646453|FG000|Overall Study|Ongoing missed appointments|0|||
146584655|NCT01296711|528646454|FG001|Overall Study|Ongoing missed appointments|0|||
146584656|NCT01296711|528646455|FG002|Overall Study|Ongoing missed appointments|0|||
146584657|NCT01296711|528646456|FG003|Overall Study|Ongoing missed appointments|0|||
146584658|NCT01296711|528646457|FG004|Overall Study|Ongoing missed appointments|0|||
146584659|NCT01296711|528646458|FG005|Overall Study|Ongoing missed appointments|0|||
146584660|NCT01296711|528646459|FG006|Overall Study|Ongoing missed appointments|1|||
146652297|NCT00920907|528905197|FG000|Induction Period|Adverse Event|0|||
146652298|NCT00920907|528905198|FG001|Induction Period|Adverse Event|2|||
146652299|NCT00920907|528905197|FG000|Induction Period|Death|1|||
146652300|NCT00920907|528905198|FG001|Induction Period|Death|1|||
146652301|NCT00920907|528905197|FG000|Induction Period|Disease Progression|12|||
146652302|NCT00920907|528905198|FG001|Induction Period|Disease Progression|11|||
146652303|NCT00920907|528905197|FG000|Induction Period|Study Drug Toxicity|8|||
146652304|NCT00920907|528905198|FG001|Induction Period|Study Drug Toxicity|6|||
146652305|NCT00920907|528905197|FG000|Induction Period|No longer meets study criteria|0|||
146652306|NCT00920907|528905198|FG001|Induction Period|No longer meets study criteria|1|||
146918865|NCT00195260|529864522|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
146918866|NCT00195260|529864523|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
146918867|NCT00195260|529864524|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
146584661|NCT01296711|528646460|FG007|Overall Study|Ongoing missed appointments|0|||
146584662|NCT01296711|528646453|FG000|Overall Study|Failure to comply with visits|0|||
146584663|NCT01296711|528646454|FG001|Overall Study|Failure to comply with visits|0|||
146584664|NCT01296711|528646455|FG002|Overall Study|Failure to comply with visits|0|||
146584665|NCT01296711|528646456|FG003|Overall Study|Failure to comply with visits|0|||
146584666|NCT01296711|528646457|FG004|Overall Study|Failure to comply with visits|0|||
146584667|NCT01296711|528646458|FG005|Overall Study|Failure to comply with visits|0|||
146584668|NCT01296711|528646459|FG006|Overall Study|Failure to comply with visits|0|||
146584669|NCT01296711|528646460|FG007|Overall Study|Failure to comply with visits|1|||
146584670|NCT01296711|528646453|FG000|Overall Study|Patient decision due to transport|0|||
146652307|NCT00920907|528905197|FG000|Induction Period|Withdrawal by Subject|1|||
146652308|NCT00920907|528905198|FG001|Induction Period|Withdrawal by Subject|1|||
146652309|NCT00920907|528905197|FG000|Maintenance Period|Disease Progression|3|||
146652310|NCT00920907|528905198|FG001|Maintenance Period|Disease Progression|7|||
146918868|NCT00195260|529864525|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
146652311|NCT00920907|528905197|FG000|Maintenance Period|Administrative (study closure)|7|||
146652312|NCT00920907|528905198|FG001|Maintenance Period|Administrative (study closure)|2|||
146652313|NCT00920907|528905197|FG000|Maintenance Period|Study Drug Toxicity|0|||
146652314|NCT00920907|528905198|FG001|Maintenance Period|Study Drug Toxicity|2|||
146652315|NCT00920907|528905197|FG000|Maintenance Period|Death|1|||
146652316|NCT00920907|528905198|FG001|Maintenance Period|Death|1|||
146918869|NCT00195260|529864526|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
146584671|NCT01296711|528646454|FG001|Overall Study|Patient decision due to transport|0|||
146584672|NCT01296711|528646455|FG002|Overall Study|Patient decision due to transport|0|||
146584673|NCT01296711|528646456|FG003|Overall Study|Patient decision due to transport|0|||
146584674|NCT01296711|528646457|FG004|Overall Study|Patient decision due to transport|0|||
146584675|NCT01296711|528646458|FG005|Overall Study|Patient decision due to transport|0|||
146584676|NCT01296711|528646459|FG006|Overall Study|Patient decision due to transport|0|||
146584677|NCT01296711|528646460|FG007|Overall Study|Patient decision due to transport|1|||
146584678|NCT02120300|528646463|FG000|Overall Study|Enrolled but Never Treated|2|||
146584679|NCT02120300|528646464|FG001|Overall Study|Enrolled but Never Treated|0|||
146584680|NCT02120300|528646465|FG002|Overall Study|Enrolled but Never Treated|0|||
146584681|NCT02120300|528646466|FG003|Overall Study|Enrolled but Never Treated|0|||
146584682|NCT02120300|528646463|FG000|Overall Study|Lack of Efficacy|0|||
146584683|NCT02120300|528646464|FG001|Overall Study|Lack of Efficacy|0|||
146584684|NCT02120300|528646465|FG002|Overall Study|Lack of Efficacy|0|||
146584685|NCT02120300|528646466|FG003|Overall Study|Lack of Efficacy|1|||
146584686|NCT02120300|528646463|FG000|Overall Study|Lost to Follow-up|1|||
146584687|NCT02120300|528646464|FG001|Overall Study|Lost to Follow-up|0|||
146584688|NCT02120300|528646465|FG002|Overall Study|Lost to Follow-up|0|||
146584689|NCT02120300|528646466|FG003|Overall Study|Lost to Follow-up|0|||
146584690|NCT00700882|528646469|FG000|Overall Study|Never received treatment|6|||
146584691|NCT00700882|528646469|FG000|Overall Study|Ineligible|2|||
146584692|NCT00700882|528646469|FG000|Overall Study|No KIT mutation|51|||
146584693|NCT01832493|528646473|FG000|Overall Study|Physician Decision|2|||
146584694|NCT01832493|528646473|FG000|Overall Study|Protocol Violation|4|||
146584695|NCT01832493|528646473|FG000|Overall Study|Unable to place LV lead|2|||
146584696|NCT01732510|528646474|FG000|Overall Study|Adverse Event|0|||
146584697|NCT01732510|528646475|FG001|Overall Study|Adverse Event|1|||
146584698|NCT01732510|528646476|FG002|Overall Study|Adverse Event|1|||
146584699|NCT01732510|528646477|FG003|Overall Study|Adverse Event|0|||
146584700|NCT01732510|528646478|FG004|Overall Study|Adverse Event|0|||
146584701|NCT01732510|528646479|FG005|Overall Study|Adverse Event|0|||
146584702|NCT01732510|528646480|FG006|Overall Study|Adverse Event|1|||
146584703|NCT01732510|528646474|FG000|Overall Study|Protocol Violation|0|||
146584704|NCT01732510|528646475|FG001|Overall Study|Protocol Violation|0|||
146584705|NCT01732510|528646476|FG002|Overall Study|Protocol Violation|0|||
146584706|NCT01732510|528646477|FG003|Overall Study|Protocol Violation|1|||
146584707|NCT01732510|528646478|FG004|Overall Study|Protocol Violation|0|||
146584708|NCT01732510|528646479|FG005|Overall Study|Protocol Violation|0|||
146584709|NCT01732510|528646480|FG006|Overall Study|Protocol Violation|0|||
146584710|NCT01732510|528646474|FG000|Overall Study|Withdrawal by Subject|1|||
146584711|NCT01732510|528646475|FG001|Overall Study|Withdrawal by Subject|3|||
146584712|NCT01732510|528646476|FG002|Overall Study|Withdrawal by Subject|2|||
146584713|NCT01732510|528646477|FG003|Overall Study|Withdrawal by Subject|1|||
146584714|NCT01732510|528646478|FG004|Overall Study|Withdrawal by Subject|5|||
146584715|NCT01732510|528646479|FG005|Overall Study|Withdrawal by Subject|0|||
146584716|NCT01732510|528646480|FG006|Overall Study|Withdrawal by Subject|1|||
146584717|NCT01732510|528646474|FG000|Overall Study|Lost to Follow-up|0|||
146584718|NCT01732510|528646475|FG001|Overall Study|Lost to Follow-up|0|||
146584719|NCT01732510|528646476|FG002|Overall Study|Lost to Follow-up|1|||
146584720|NCT01732510|528646477|FG003|Overall Study|Lost to Follow-up|1|||
146584721|NCT01732510|528646478|FG004|Overall Study|Lost to Follow-up|0|||
146584722|NCT01732510|528646479|FG005|Overall Study|Lost to Follow-up|1|||
146584723|NCT01732510|528646480|FG006|Overall Study|Lost to Follow-up|0|||
146584724|NCT01732510|528646474|FG000|Overall Study|Physician Decision|0|||
146584725|NCT01732510|528646475|FG001|Overall Study|Physician Decision|1|||
146584726|NCT01732510|528646476|FG002|Overall Study|Physician Decision|0|||
146584727|NCT01732510|528646477|FG003|Overall Study|Physician Decision|0|||
146584728|NCT01732510|528646478|FG004|Overall Study|Physician Decision|0|||
146584729|NCT01732510|528646479|FG005|Overall Study|Physician Decision|0|||
146584730|NCT01732510|528646480|FG006|Overall Study|Physician Decision|0|||
146584731|NCT01732510|528646474|FG000|Overall Study|Pregnancy|0|||
146978290|NCT00435825|530082310|FG000|Overall Study|Did not complete full follow-up period|6|||
146978291|NCT00435825|530082311|FG001|Overall Study|Did not complete full follow-up period|6|||
146584732|NCT01732510|528646475|FG001|Overall Study|Pregnancy|0|||
146584733|NCT01732510|528646476|FG002|Overall Study|Pregnancy|0|||
146584734|NCT01732510|528646477|FG003|Overall Study|Pregnancy|1|||
146584735|NCT01732510|528646478|FG004|Overall Study|Pregnancy|0|||
146584736|NCT01732510|528646479|FG005|Overall Study|Pregnancy|0|||
146978292|NCT00435825|530082312|FG002|Overall Study|Did not complete full follow-up period|4|||
146584737|NCT01732510|528646480|FG006|Overall Study|Pregnancy|0|||
146584738|NCT01732510|528646474|FG000|Overall Study|Study Terminated By Sponsor|0|||
146978293|NCT00435825|530082313|FG003|Overall Study|Did not complete full follow-up period|5|||
146978294|NCT01963676|530083993|FG000|Overall Study|Withdrawal by Subject|1|||
146584739|NCT01732510|528646475|FG001|Overall Study|Study Terminated By Sponsor|0|||
146584740|NCT01732510|528646476|FG002|Overall Study|Study Terminated By Sponsor|0|||
146584741|NCT01732510|528646477|FG003|Overall Study|Study Terminated By Sponsor|1|||
146584742|NCT01732510|528646478|FG004|Overall Study|Study Terminated By Sponsor|0|||
146584743|NCT01732510|528646479|FG005|Overall Study|Study Terminated By Sponsor|12|||
146584744|NCT01732510|528646480|FG006|Overall Study|Study Terminated By Sponsor|6|||
146584745|NCT00313144|528646481|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
146584746|NCT00313144|528646481|FG000|Overall Study|Death|7|||
146584747|NCT00313144|528646481|FG000|Overall Study|Lost to Follow-up|5|||
146584748|NCT00313144|528646481|FG000|Overall Study|Withdrawal by Subject|4|||
146978295|NCT01963676|530083994|FG001|Overall Study|Withdrawal by Subject|0|||
146584749|NCT00313144|528646481|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
146584750|NCT00313144|528646481|FG000|Overall Study|Physician Decision|4|||
146584751|NCT00313144|528646481|FG000|Overall Study|Adverse event - transient|5|||
146584752|NCT00313144|528646481|FG000|Overall Study|Liver transplant|1|||
146584753|NCT00313144|528646481|FG000|Overall Study|Insurance (homecare provider) change|1|||
146584754|NCT00313144|528646481|FG000|Overall Study|Change to different product|1|||
146584755|NCT00313144|528646481|FG000|Overall Study|Due to termination of the study|66|||
146584756|NCT00656058|528646486|FG000|Overall Study|Withdrawal by Subject|2|||
146584757|NCT00656058|528646486|FG000|Overall Study|Withdrawal by Subject|4|||
146584758|NCT00404755|528646487|FG000|Phase I (Bupropion)|Adverse Event|3|||
146584759|NCT00404755|528646487|FG000|Phase I (Bupropion)|Other|1|||
146584760|NCT00404755|528646487|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
146584761|NCT05145322|528646488|FG000|Overall Study|Lost to Follow-up|4|||
146584762|NCT05145322|528646489|FG001|Overall Study|Lost to Follow-up|5|||
146584763|NCT06359028|528646490|FG000|Overall Study|Adverse Event|1|||
146584764|NCT06359028|528646491|FG001|Overall Study|Adverse Event|0|||
146584765|NCT06359028|528646490|FG000|Overall Study|Withdrawal by Subject|1|||
146584766|NCT06359028|528646491|FG001|Overall Study|Withdrawal by Subject|0|||
146584767|NCT04700540|528646492|FG000|Overall Study|Withdrawal by Subject|12|||
146584768|NCT04700540|528646493|FG001|Overall Study|Withdrawal by Subject|8|||
146584769|NCT04700540|528646492|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
146584770|NCT04700540|528646493|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
146584771|NCT02952313|528646494|FG000|Primary Endpoint|Lost to Follow-up|4|||
146584772|NCT02952313|528646494|FG000|Primary Endpoint|Withdrawal by Subject|1|||
146584773|NCT02952313|528646494|FG000|Primary Endpoint|Lack of Efficacy|1|||
146584774|NCT02952313|528646494|FG000|Primary Endpoint|Missed visit|1|||
146584775|NCT02952313|528646494|FG000|Long-term Follow-up|Lost to Follow-up|12|||
146584776|NCT02952313|528646494|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
146584777|NCT02952313|528646494|FG000|Long-term Follow-up|Lack of Efficacy|6|||
146584778|NCT02952313|528646494|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
146584779|NCT02952313|528646494|FG000|Long-term Follow-up|Physician Decision|1|||
146584780|NCT02952313|528646494|FG000|Long-term Follow-up|Death|1|||
146584781|NCT04382586|528646495|FG000|Overall Study|Death|3|||
146584782|NCT04382586|528646496|FG001|Overall Study|Death|4|||
146584783|NCT04382586|528646495|FG000|Overall Study|Lost to Follow-up|11|||
146584784|NCT04382586|528646496|FG001|Overall Study|Lost to Follow-up|8|||
146584785|NCT04382586|528646495|FG000|Overall Study|Withdrawal by Subject|3|||
146584786|NCT04382586|528646496|FG001|Overall Study|Withdrawal by Subject|1|||
146584787|NCT04382586|528646495|FG000|Overall Study|Physician Decision|0|||
146584788|NCT04382586|528646496|FG001|Overall Study|Physician Decision|3|||
146584789|NCT02265536|528646498|FG000|Overall Study|Adverse Event|1|||
146584790|NCT02265536|528646499|FG001|Overall Study|Adverse Event|0|||
146584791|NCT02265536|528646500|FG002|Overall Study|Adverse Event|0|||
146584792|NCT02265536|528646501|FG003|Overall Study|Adverse Event|0|||
146584793|NCT02265536|528646502|FG004|Overall Study|Adverse Event|1|||
146584794|NCT02265536|528646503|FG005|Overall Study|Adverse Event|0|||
146584795|NCT02265536|528646498|FG000|Overall Study|Physician Decision|0|||
146584796|NCT02265536|528646499|FG001|Overall Study|Physician Decision|0|||
146584797|NCT02265536|528646500|FG002|Overall Study|Physician Decision|0|||
146584798|NCT02265536|528646501|FG003|Overall Study|Physician Decision|0|||
146584799|NCT02265536|528646502|FG004|Overall Study|Physician Decision|2|||
146584800|NCT02265536|528646503|FG005|Overall Study|Physician Decision|0|||
146584801|NCT02265536|528646498|FG000|Overall Study|Withdrawal by Subject|0|||
146584802|NCT02265536|528646499|FG001|Overall Study|Withdrawal by Subject|3|||
146584803|NCT02265536|528646500|FG002|Overall Study|Withdrawal by Subject|0|||
146584804|NCT02265536|528646501|FG003|Overall Study|Withdrawal by Subject|0|||
146584805|NCT02265536|528646502|FG004|Overall Study|Withdrawal by Subject|0|||
146584806|NCT02265536|528646503|FG005|Overall Study|Withdrawal by Subject|0|||
146584807|NCT00079391|528646508|FG000|Overall Study|Withdrawal by Subject|1|||
146584808|NCT02524275|528646509|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
146584809|NCT03763656|528646510|FG000|Overall Study|Physician Decision|1|||
146584810|NCT03763656|528646510|FG000|Overall Study|Protocol Violation|1|||
146584811|NCT03763656|528646510|FG000|Overall Study|Withdrawal by Subject|7|||
146584812|NCT00583752|528646511|FG000|Overall Study|Lost to Follow-up|5|||
146584813|NCT00583752|528646512|FG001|Overall Study|Lost to Follow-up|5|||
146584814|NCT01700959|528646513|FG000|Overall Study|Adverse Event|0|||
146584815|NCT01700959|528646514|FG001|Overall Study|Adverse Event|1|||
146584816|NCT01700959|528646515|FG002|Overall Study|Adverse Event|1|||
146584817|NCT01700959|528646516|FG003|Overall Study|Adverse Event|2|||
146652317|NCT00920907|528905197|FG000|Maintenance Period|Withdrawal by Subject|1|||
146652318|NCT00920907|528905198|FG001|Maintenance Period|Withdrawal by Subject|0|||
146584818|NCT01700959|528646517|FG004|Overall Study|Adverse Event|0|||
146584819|NCT01700959|528646518|FG005|Overall Study|Adverse Event|2|||
146584820|NCT01700959|528646513|FG000|Overall Study|Withdrawal by Subject|15|||
146584821|NCT01700959|528646514|FG001|Overall Study|Withdrawal by Subject|9|||
146584822|NCT01700959|528646515|FG002|Overall Study|Withdrawal by Subject|12|||
146584823|NCT01700959|528646516|FG003|Overall Study|Withdrawal by Subject|11|||
146584824|NCT01700959|528646517|FG004|Overall Study|Withdrawal by Subject|8|||
146584825|NCT01700959|528646518|FG005|Overall Study|Withdrawal by Subject|12|||
146584826|NCT01700959|528646513|FG000|Overall Study|Ineligible|2|||
146584827|NCT01700959|528646514|FG001|Overall Study|Ineligible|1|||
146584828|NCT01700959|528646515|FG002|Overall Study|Ineligible|2|||
146584829|NCT01700959|528646516|FG003|Overall Study|Ineligible|0|||
146584830|NCT01700959|528646517|FG004|Overall Study|Ineligible|0|||
146584831|NCT01700959|528646518|FG005|Overall Study|Ineligible|1|||
146584832|NCT01700959|528646513|FG000|Overall Study|Noncompliant|9|||
146584833|NCT01700959|528646514|FG001|Overall Study|Noncompliant|9|||
146584834|NCT01700959|528646515|FG002|Overall Study|Noncompliant|17|||
146584835|NCT01700959|528646516|FG003|Overall Study|Noncompliant|18|||
146584836|NCT01700959|528646517|FG004|Overall Study|Noncompliant|15|||
146584837|NCT01700959|528646518|FG005|Overall Study|Noncompliant|9|||
146584838|NCT01700959|528646513|FG000|Overall Study|Side effects|1|||
146584839|NCT01700959|528646514|FG001|Overall Study|Side effects|4|||
146584840|NCT01700959|528646515|FG002|Overall Study|Side effects|8|||
146584841|NCT01700959|528646516|FG003|Overall Study|Side effects|4|||
146584842|NCT01700959|528646517|FG004|Overall Study|Side effects|4|||
146584843|NCT01700959|528646518|FG005|Overall Study|Side effects|1|||
146584844|NCT00830375|528646519|FG000|Overall Study|Lost to Follow-up|1|||
146584845|NCT01331837|528646520|FG000|Overall Study|Death|30|||
146584846|NCT01331837|528646521|FG001|Overall Study|Death|34|||
146584847|NCT01331837|528646520|FG000|Overall Study|Lost to Follow-up|3|||
146584848|NCT01331837|528646521|FG001|Overall Study|Lost to Follow-up|1|||
146584849|NCT01331837|528646520|FG000|Overall Study|Info not recorded|10|||
146584850|NCT01331837|528646521|FG001|Overall Study|Info not recorded|16|||
146584851|NCT01331837|528646520|FG000|Overall Study|Withdrawal by Subject|13|||
146584852|NCT01331837|528646521|FG001|Overall Study|Withdrawal by Subject|16|||
146584853|NCT03724981|528649300|FG000|First Device|Protocol Violation|1|||
146584854|NCT03724981|528649301|FG001|First Device|Protocol Violation|1|||
146584855|NCT02640625|528649302|FG000|Overall Study|Adverse Event|1|||
146584856|NCT00197145|528649304|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
146584857|NCT00197145|528649305|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
146584858|NCT00197145|528649304|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
146584859|NCT00197145|528649305|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
146584860|NCT00197145|528649304|FG000|Period 1: Randomized Treatment Phase|Other|2|||
146584861|NCT00197145|528649305|FG001|Period 1: Randomized Treatment Phase|Other|2|||
146584862|NCT00197145|528649304|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
146584863|NCT00197145|528649305|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
146584864|NCT00197145|528649304|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
146584865|NCT00197145|528649305|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
146584866|NCT00197145|528649304|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
146584867|NCT00197145|528649305|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
146584868|NCT00197145|528649304|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
146584869|NCT00197145|528649305|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
146584870|NCT00197145|528649304|FG000|Period 2 : Open Label Phase|Other|1|||
146584871|NCT00197145|528649305|FG001|Period 2 : Open Label Phase|Other|0|||
146584872|NCT02370537|528649306|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
146584873|NCT02370537|528649307|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
146584874|NCT02370537|528649308|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
146584875|NCT02370537|528649306|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
146584876|NCT02370537|528649307|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
146584877|NCT02370537|528649308|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
146584878|NCT02370537|528649306|FG000|Part B|Not randomised to receive treatment|1|||
146584879|NCT02370537|528649307|FG001|Part B|Not randomised to receive treatment|2|||
146584880|NCT02370537|528649308|FG002|Part B|Not randomised to receive treatment|259|||
146584881|NCT02370537|528649306|FG000|Part B|Withdrawal by Subject|0|||
146584882|NCT02370537|528649307|FG001|Part B|Withdrawal by Subject|1|||
146584883|NCT02370537|528649308|FG002|Part B|Withdrawal by Subject|0|||
146584884|NCT00882583|528649320|FG000|Overall Study|Physician Decision|1|||
146918870|NCT00195260|529864527|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
146918871|NCT01379534|529864528|FG000|Treatment Phase|Withdrawal by Subject|2|||
146918872|NCT01379534|529864529|FG001|Treatment Phase|Withdrawal by Subject|2|||
146918873|NCT01379534|529864528|FG000|Treatment Phase|Progressive disease|13|||
146918874|NCT01379534|529864529|FG001|Treatment Phase|Progressive disease|22|||
146584885|NCT00882583|528649321|FG001|Overall Study|Physician Decision|0|||
146584886|NCT00882583|528649320|FG000|Overall Study|Adverse Event|0|||
146584887|NCT00882583|528649321|FG001|Overall Study|Adverse Event|1|||
146584888|NCT03596047|528649322|FG000|Overall Study|Withdrawal by Subject|7|||
146584889|NCT03596047|528649323|FG001|Overall Study|Withdrawal by Subject|4|||
146584890|NCT03596047|528649322|FG000|Overall Study|Lost to Follow-up|0|||
146584891|NCT03596047|528649323|FG001|Overall Study|Lost to Follow-up|2|||
146584892|NCT02589665|528649324|FG000|Induction Period|Did not receive drug|0|||
146770841|NCT00442117|529328694|FG001|Overall Study|Met Withdrawal Criteria|1|||
146770842|NCT04009577|529328695|FG000|Core Study|Adverse Event|1|||
146770843|NCT04009577|529328696|FG001|Core Study|Adverse Event|0|||
146770844|NCT04009577|529328697|FG002|Core Study|Adverse Event|2|||
146770845|NCT04009577|529328698|FG003|Core Study|Adverse Event|4|||
146770846|NCT04009577|529328695|FG000|Core Study|Withdrawal by Subject|0|||
146770847|NCT04009577|529328696|FG001|Core Study|Withdrawal by Subject|0|||
146770848|NCT04009577|529328697|FG002|Core Study|Withdrawal by Subject|2|||
146770849|NCT04009577|529328698|FG003|Core Study|Withdrawal by Subject|0|||
146770850|NCT04009577|529328695|FG000|Core Study|Other|0|||
146770851|NCT04009577|529328696|FG001|Core Study|Other|0|||
146770852|NCT04009577|529328697|FG002|Core Study|Other|0|||
146770853|NCT04009577|529328698|FG003|Core Study|Other|1|||
146770854|NCT04009577|529328695|FG000|Extension Phase|Adverse Event|0|||
146770855|NCT04009577|529328696|FG001|Extension Phase|Adverse Event|0|||
146770856|NCT04009577|529328697|FG002|Extension Phase|Adverse Event|0|||
146770857|NCT04009577|529328698|FG003|Extension Phase|Adverse Event|1|||
146770858|NCT04009577|529328695|FG000|Extension Phase|Inadequate therapeutic effect|0|||
146770859|NCT04009577|529328696|FG001|Extension Phase|Inadequate therapeutic effect|0|||
146770860|NCT04009577|529328697|FG002|Extension Phase|Inadequate therapeutic effect|1|||
146918875|NCT01379534|529864528|FG000|Treatment Phase|Adverse Event|7|||
146918876|NCT01379534|529864529|FG001|Treatment Phase|Adverse Event|7|||
146918877|NCT01379534|529864528|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
146770861|NCT04009577|529328698|FG003|Extension Phase|Inadequate therapeutic effect|0|||
146770862|NCT04009577|529328695|FG000|Extension Phase|Withdrawal by Subject|0|||
146770863|NCT04009577|529328696|FG001|Extension Phase|Withdrawal by Subject|0|||
146770864|NCT04009577|529328697|FG002|Extension Phase|Withdrawal by Subject|1|||
146770865|NCT04009577|529328698|FG003|Extension Phase|Withdrawal by Subject|0|||
146770866|NCT04009577|529328695|FG000|Extension Phase|Not Treated|0|||
146770867|NCT04009577|529328696|FG001|Extension Phase|Not Treated|0|||
146770868|NCT04009577|529328697|FG002|Extension Phase|Not Treated|2|||
146918878|NCT01379534|529864529|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
146584893|NCT02589665|528649325|FG001|Induction Period|Did not receive drug|0|||
146584894|NCT02589665|528649326|FG002|Induction Period|Did not receive drug|0|||
146584895|NCT02589665|528649327|FG003|Induction Period|Did not receive drug|1|||
146584896|NCT02589665|528649328|FG004|Induction Period|Did not receive drug|0|||
146584897|NCT02589665|528649329|FG005|Induction Period|Did not receive drug|0|||
146584898|NCT02589665|528649330|FG006|Induction Period|Did not receive drug|0|||
146584899|NCT02589665|528649331|FG007|Induction Period|Did not receive drug|0|||
146584900|NCT02589665|528649332|FG008|Induction Period|Did not receive drug|0|||
146584901|NCT02589665|528649333|FG009|Induction Period|Did not receive drug|0|||
146584902|NCT02589665|528649324|FG000|Induction Period|Adverse Event|3|||
146584903|NCT02589665|528649325|FG001|Induction Period|Adverse Event|0|||
146584904|NCT02589665|528649326|FG002|Induction Period|Adverse Event|2|||
146584905|NCT02589665|528649327|FG003|Induction Period|Adverse Event|2|||
146584906|NCT02589665|528649328|FG004|Induction Period|Adverse Event|0|||
146584907|NCT02589665|528649329|FG005|Induction Period|Adverse Event|0|||
146584908|NCT02589665|528649330|FG006|Induction Period|Adverse Event|0|||
146584909|NCT02589665|528649331|FG007|Induction Period|Adverse Event|0|||
146584910|NCT02589665|528649332|FG008|Induction Period|Adverse Event|0|||
146584911|NCT02589665|528649333|FG009|Induction Period|Adverse Event|0|||
146584912|NCT02589665|528649324|FG000|Induction Period|Withdrawal by Subject|0|||
146584913|NCT02589665|528649325|FG001|Induction Period|Withdrawal by Subject|1|||
146584914|NCT02589665|528649326|FG002|Induction Period|Withdrawal by Subject|0|||
146584915|NCT02589665|528649327|FG003|Induction Period|Withdrawal by Subject|1|||
146918879|NCT01379534|529864528|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
146584916|NCT02589665|528649328|FG004|Induction Period|Withdrawal by Subject|0|||
146584917|NCT02589665|528649329|FG005|Induction Period|Withdrawal by Subject|0|||
146770869|NCT04009577|529328698|FG003|Extension Phase|Not Treated|0|||
146770870|NCT00305695|529328704|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
146770871|NCT00305695|529328705|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
146770872|NCT00305695|529328704|FG000|Overall Study|Did not have baseline scan|1|||
146918880|NCT01379534|529864529|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
146770873|NCT00305695|529328705|FG001|Overall Study|Did not have baseline scan|1|||
146770874|NCT00841035|529328707|FG000|Phase 1 Overall Study|Physician Decision|13|||
146584918|NCT02589665|528649330|FG006|Induction Period|Withdrawal by Subject|0|||
146584919|NCT02589665|528649331|FG007|Induction Period|Withdrawal by Subject|0|||
146770875|NCT01390402|529328725|FG000|Overall Study|Death|1|||
146770876|NCT01390402|529328725|FG000|Overall Study|Disease Progression|4|||
146770877|NCT04789408|529328726|FG000|Overall Study|Death|4|||
146770878|NCT04789408|529328727|FG001|Overall Study|Death|3|||
146584920|NCT02589665|528649332|FG008|Induction Period|Withdrawal by Subject|0|||
146584921|NCT02589665|528649333|FG009|Induction Period|Withdrawal by Subject|0|||
146584922|NCT02589665|528649324|FG000|Induction Period|Protocol Violation|0|||
146584923|NCT02589665|528649325|FG001|Induction Period|Protocol Violation|1|||
146770879|NCT04789408|529328728|FG002|Overall Study|Death|6|||
146770880|NCT04789408|529328726|FG000|Overall Study|Did not meet eligibility criteria|1|||
146770881|NCT04789408|529328727|FG001|Overall Study|Did not meet eligibility criteria|0|||
146918881|NCT01379534|529864528|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
146918882|NCT01379534|529864529|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
146918883|NCT01379534|529864528|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
146584924|NCT02589665|528649326|FG002|Induction Period|Protocol Violation|0|||
146584925|NCT02589665|528649327|FG003|Induction Period|Protocol Violation|0|||
146584926|NCT02589665|528649328|FG004|Induction Period|Protocol Violation|0|||
146584927|NCT02589665|528649329|FG005|Induction Period|Protocol Violation|0|||
146584928|NCT02589665|528649330|FG006|Induction Period|Protocol Violation|0|||
146584929|NCT02589665|528649331|FG007|Induction Period|Protocol Violation|0|||
146584930|NCT02589665|528649332|FG008|Induction Period|Protocol Violation|0|||
146584931|NCT02589665|528649333|FG009|Induction Period|Protocol Violation|0|||
146584932|NCT02589665|528649324|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146584933|NCT02589665|528649325|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146584934|NCT02589665|528649326|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146584935|NCT02589665|528649327|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146584936|NCT02589665|528649328|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
146584937|NCT02589665|528649329|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
146584938|NCT02589665|528649330|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
146584939|NCT02589665|528649331|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146584940|NCT02589665|528649332|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146584941|NCT02589665|528649333|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146584942|NCT02589665|528649324|FG000|Maintenance Period|Withdrawal by Subject|0|||
146584943|NCT02589665|528649325|FG001|Maintenance Period|Withdrawal by Subject|0|||
146584944|NCT02589665|528649326|FG002|Maintenance Period|Withdrawal by Subject|0|||
146584945|NCT02589665|528649327|FG003|Maintenance Period|Withdrawal by Subject|0|||
146584946|NCT02589665|528649328|FG004|Maintenance Period|Withdrawal by Subject|4|||
146584947|NCT02589665|528649329|FG005|Maintenance Period|Withdrawal by Subject|2|||
146584948|NCT02589665|528649330|FG006|Maintenance Period|Withdrawal by Subject|4|||
146584949|NCT02589665|528649331|FG007|Maintenance Period|Withdrawal by Subject|0|||
146584950|NCT02589665|528649332|FG008|Maintenance Period|Withdrawal by Subject|0|||
146584951|NCT02589665|528649333|FG009|Maintenance Period|Withdrawal by Subject|0|||
146584952|NCT02589665|528649324|FG000|Maintenance Period|Lack of Efficacy|0|||
146584953|NCT02589665|528649325|FG001|Maintenance Period|Lack of Efficacy|0|||
146584954|NCT02589665|528649326|FG002|Maintenance Period|Lack of Efficacy|0|||
146584955|NCT02589665|528649327|FG003|Maintenance Period|Lack of Efficacy|0|||
146584956|NCT02589665|528649328|FG004|Maintenance Period|Lack of Efficacy|2|||
146584957|NCT02589665|528649329|FG005|Maintenance Period|Lack of Efficacy|1|||
146584958|NCT02589665|528649330|FG006|Maintenance Period|Lack of Efficacy|0|||
146584959|NCT02589665|528649331|FG007|Maintenance Period|Lack of Efficacy|0|||
146584960|NCT02589665|528649332|FG008|Maintenance Period|Lack of Efficacy|0|||
146584961|NCT02589665|528649333|FG009|Maintenance Period|Lack of Efficacy|0|||
146584962|NCT02589665|528649324|FG000|Maintenance Period|Adverse Event|0|||
146584963|NCT02589665|528649325|FG001|Maintenance Period|Adverse Event|0|||
146584964|NCT02589665|528649326|FG002|Maintenance Period|Adverse Event|0|||
146584965|NCT02589665|528649327|FG003|Maintenance Period|Adverse Event|0|||
146584966|NCT02589665|528649328|FG004|Maintenance Period|Adverse Event|0|||
146584967|NCT02589665|528649329|FG005|Maintenance Period|Adverse Event|0|||
146584968|NCT02589665|528649330|FG006|Maintenance Period|Adverse Event|2|||
146584969|NCT02589665|528649331|FG007|Maintenance Period|Adverse Event|0|||
146584970|NCT02589665|528649332|FG008|Maintenance Period|Adverse Event|0|||
146584971|NCT02589665|528649333|FG009|Maintenance Period|Adverse Event|0|||
146584972|NCT02589665|528649324|FG000|Maintenance Period|Lost to Follow-up|0|||
146584973|NCT02589665|528649325|FG001|Maintenance Period|Lost to Follow-up|0|||
146584974|NCT02589665|528649326|FG002|Maintenance Period|Lost to Follow-up|0|||
146584975|NCT02589665|528649327|FG003|Maintenance Period|Lost to Follow-up|0|||
146584976|NCT02589665|528649328|FG004|Maintenance Period|Lost to Follow-up|0|||
146584977|NCT02589665|528649329|FG005|Maintenance Period|Lost to Follow-up|1|||
146584978|NCT02589665|528649330|FG006|Maintenance Period|Lost to Follow-up|0|||
146584979|NCT02589665|528649331|FG007|Maintenance Period|Lost to Follow-up|0|||
146584980|NCT02589665|528649332|FG008|Maintenance Period|Lost to Follow-up|0|||
146584981|NCT02589665|528649333|FG009|Maintenance Period|Lost to Follow-up|0|||
146584982|NCT02589665|528649324|FG000|Maintenance Period|Physician Decision|0|||
146652319|NCT00920907|528905197|FG000|Maintenance Period|Adverse Event|0|||
146652320|NCT00920907|528905198|FG001|Maintenance Period|Adverse Event|1|||
146918884|NCT01379534|529864529|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
146584983|NCT02589665|528649325|FG001|Maintenance Period|Physician Decision|0|||
146584984|NCT02589665|528649326|FG002|Maintenance Period|Physician Decision|0|||
146584985|NCT02589665|528649327|FG003|Maintenance Period|Physician Decision|0|||
146584986|NCT02589665|528649328|FG004|Maintenance Period|Physician Decision|0|||
146584987|NCT02589665|528649329|FG005|Maintenance Period|Physician Decision|1|||
146584988|NCT02589665|528649330|FG006|Maintenance Period|Physician Decision|0|||
146584989|NCT02589665|528649331|FG007|Maintenance Period|Physician Decision|0|||
146584990|NCT02589665|528649332|FG008|Maintenance Period|Physician Decision|0|||
146584991|NCT02589665|528649333|FG009|Maintenance Period|Physician Decision|0|||
146584992|NCT02589665|528649324|FG000|Maintenance Period|Reason Not Collected|0|||
146584993|NCT02589665|528649325|FG001|Maintenance Period|Reason Not Collected|0|||
146584994|NCT02589665|528649326|FG002|Maintenance Period|Reason Not Collected|0|||
146584995|NCT02589665|528649327|FG003|Maintenance Period|Reason Not Collected|0|||
146584996|NCT02589665|528649328|FG004|Maintenance Period|Reason Not Collected|0|||
146584997|NCT02589665|528649329|FG005|Maintenance Period|Reason Not Collected|1|||
146584998|NCT02589665|528649330|FG006|Maintenance Period|Reason Not Collected|1|||
146584999|NCT02589665|528649331|FG007|Maintenance Period|Reason Not Collected|0|||
146585000|NCT02589665|528649332|FG008|Maintenance Period|Reason Not Collected|0|||
146978296|NCT01120600|530083997|FG000|Overall Study|Adverse Event|7|||
146978297|NCT01120600|530083998|FG001|Overall Study|Adverse Event|7|||
146978298|NCT01120600|530083997|FG000|Overall Study|Excessive Bone Loss|0|||
146978299|NCT01120600|530083998|FG001|Overall Study|Excessive Bone Loss|4|||
146978300|NCT01120600|530083997|FG000|Overall Study|Lost to Follow-up|1|||
146978301|NCT01120600|530083998|FG001|Overall Study|Lost to Follow-up|3|||
146978302|NCT01120600|530083997|FG000|Overall Study|Physician Decision|1|||
146978303|NCT01120600|530083998|FG001|Overall Study|Physician Decision|3|||
146978304|NCT01120600|530083997|FG000|Overall Study|Protocol Violation|0|||
146978305|NCT01120600|530083998|FG001|Overall Study|Protocol Violation|4|||
146978306|NCT01120600|530083997|FG000|Overall Study|Withdrawal by Subject|10|||
146585001|NCT02589665|528649333|FG009|Maintenance Period|Reason Not Collected|0|||
146585002|NCT02589665|528649324|FG000|Induction Extension Period|Adverse Event|0|||
146585003|NCT02589665|528649325|FG001|Induction Extension Period|Adverse Event|0|||
146585004|NCT02589665|528649326|FG002|Induction Extension Period|Adverse Event|0|||
146585005|NCT02589665|528649327|FG003|Induction Extension Period|Adverse Event|0|||
146585006|NCT02589665|528649328|FG004|Induction Extension Period|Adverse Event|0|||
146585007|NCT02589665|528649329|FG005|Induction Extension Period|Adverse Event|0|||
146585008|NCT02589665|528649330|FG006|Induction Extension Period|Adverse Event|0|||
146585009|NCT02589665|528649331|FG007|Induction Extension Period|Adverse Event|0|||
146585010|NCT02589665|528649332|FG008|Induction Extension Period|Adverse Event|4|||
146585011|NCT02589665|528649333|FG009|Induction Extension Period|Adverse Event|0|||
146585012|NCT02589665|528649324|FG000|Induction Extension Period|Lack of Efficacy|0|||
146585013|NCT02589665|528649325|FG001|Induction Extension Period|Lack of Efficacy|0|||
146585014|NCT02589665|528649326|FG002|Induction Extension Period|Lack of Efficacy|0|||
146585015|NCT02589665|528649327|FG003|Induction Extension Period|Lack of Efficacy|0|||
146585016|NCT02589665|528649328|FG004|Induction Extension Period|Lack of Efficacy|0|||
146585017|NCT02589665|528649329|FG005|Induction Extension Period|Lack of Efficacy|0|||
146585018|NCT02589665|528649330|FG006|Induction Extension Period|Lack of Efficacy|0|||
146585019|NCT02589665|528649331|FG007|Induction Extension Period|Lack of Efficacy|0|||
146585020|NCT02589665|528649332|FG008|Induction Extension Period|Lack of Efficacy|3|||
146585021|NCT02589665|528649333|FG009|Induction Extension Period|Lack of Efficacy|0|||
146585022|NCT02589665|528649324|FG000|Induction Extension Period|Withdrawal by Subject|0|||
146585023|NCT02589665|528649325|FG001|Induction Extension Period|Withdrawal by Subject|0|||
146585024|NCT02589665|528649326|FG002|Induction Extension Period|Withdrawal by Subject|0|||
146585025|NCT02589665|528649327|FG003|Induction Extension Period|Withdrawal by Subject|0|||
146585026|NCT02589665|528649328|FG004|Induction Extension Period|Withdrawal by Subject|0|||
146585027|NCT02589665|528649329|FG005|Induction Extension Period|Withdrawal by Subject|0|||
146585028|NCT02589665|528649330|FG006|Induction Extension Period|Withdrawal by Subject|0|||
146585029|NCT02589665|528649331|FG007|Induction Extension Period|Withdrawal by Subject|2|||
146585030|NCT02589665|528649332|FG008|Induction Extension Period|Withdrawal by Subject|3|||
146585031|NCT02589665|528649333|FG009|Induction Extension Period|Withdrawal by Subject|0|||
146585032|NCT02589665|528649324|FG000|Induction Extension Period|Physician Decision|0|||
146585033|NCT02589665|528649325|FG001|Induction Extension Period|Physician Decision|0|||
146585034|NCT02589665|528649326|FG002|Induction Extension Period|Physician Decision|0|||
146585035|NCT02589665|528649327|FG003|Induction Extension Period|Physician Decision|0|||
146585036|NCT02589665|528649328|FG004|Induction Extension Period|Physician Decision|0|||
146585037|NCT02589665|528649329|FG005|Induction Extension Period|Physician Decision|0|||
146585038|NCT02589665|528649330|FG006|Induction Extension Period|Physician Decision|0|||
146585039|NCT02589665|528649331|FG007|Induction Extension Period|Physician Decision|0|||
146978307|NCT01120600|530083998|FG001|Overall Study|Withdrawal by Subject|11|||
146978308|NCT00686790|530083999|FG000|Overall Study|Adverse Event|2|||
146978309|NCT00686790|530083999|FG000|Overall Study|Withdrawal by Subject|1|||
146585040|NCT02589665|528649332|FG008|Induction Extension Period|Physician Decision|1|||
146585041|NCT02589665|528649333|FG009|Induction Extension Period|Physician Decision|0|||
146585042|NCT02589665|528649324|FG000|Induction Extension Period|Reason Not Collected|0|||
146585043|NCT02589665|528649325|FG001|Induction Extension Period|Reason Not Collected|0|||
146585044|NCT02589665|528649326|FG002|Induction Extension Period|Reason Not Collected|0|||
146585045|NCT02589665|528649327|FG003|Induction Extension Period|Reason Not Collected|0|||
146585046|NCT02589665|528649328|FG004|Induction Extension Period|Reason Not Collected|0|||
146585047|NCT02589665|528649329|FG005|Induction Extension Period|Reason Not Collected|0|||
146978310|NCT00686790|530083999|FG000|Overall Study|Death|1|||
146978311|NCT00686790|530083999|FG000|Overall Study|Lost to Follow-up|12|||
146978312|NCT00382291|530084000|FG000|Overall Study|Adverse Event|1|||
146585048|NCT02589665|528649330|FG006|Induction Extension Period|Reason Not Collected|0|||
146585049|NCT02589665|528649331|FG007|Induction Extension Period|Reason Not Collected|0|||
146585050|NCT02589665|528649332|FG008|Induction Extension Period|Reason Not Collected|1|||
146585051|NCT02589665|528649333|FG009|Induction Extension Period|Reason Not Collected|0|||
146585052|NCT02589665|528649324|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146585053|NCT02589665|528649325|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146585054|NCT02589665|528649326|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146585055|NCT02589665|528649327|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146585056|NCT02589665|528649328|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146585057|NCT02589665|528649329|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146585058|NCT02589665|528649330|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146585059|NCT02589665|528649331|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146585060|NCT02589665|528649332|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146585061|NCT02589665|528649333|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
146585062|NCT02589665|528649324|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
146585063|NCT02589665|528649325|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
146585064|NCT02589665|528649326|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
146585065|NCT02589665|528649327|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
146585066|NCT02589665|528649328|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
146585067|NCT02589665|528649329|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
146585068|NCT02589665|528649330|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
146585069|NCT02589665|528649331|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
146585070|NCT02589665|528649332|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
146585071|NCT02589665|528649333|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
146585072|NCT02589665|528649324|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
146585073|NCT02589665|528649325|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
146585074|NCT02589665|528649326|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
146585075|NCT02589665|528649327|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
146585076|NCT02589665|528649328|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
146585077|NCT02589665|528649329|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
146585078|NCT02589665|528649330|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
146585079|NCT02589665|528649331|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
146585080|NCT02589665|528649332|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
146585081|NCT02589665|528649333|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
146585082|NCT02589665|528649324|FG000|Maintenance Extension Period|Adverse Event|0|||
146585083|NCT02589665|528649325|FG001|Maintenance Extension Period|Adverse Event|0|||
146585084|NCT02589665|528649326|FG002|Maintenance Extension Period|Adverse Event|0|||
146585085|NCT02589665|528649327|FG003|Maintenance Extension Period|Adverse Event|0|||
146585086|NCT02589665|528649328|FG004|Maintenance Extension Period|Adverse Event|0|||
146585087|NCT02589665|528649329|FG005|Maintenance Extension Period|Adverse Event|0|||
146585088|NCT02589665|528649330|FG006|Maintenance Extension Period|Adverse Event|0|||
146585089|NCT02589665|528649331|FG007|Maintenance Extension Period|Adverse Event|0|||
146585090|NCT02589665|528649332|FG008|Maintenance Extension Period|Adverse Event|0|||
146585091|NCT02589665|528649333|FG009|Maintenance Extension Period|Adverse Event|2|||
146585092|NCT02589665|528649324|FG000|Maintenance Extension Period|Non-responder|0|||
146585093|NCT02589665|528649325|FG001|Maintenance Extension Period|Non-responder|0|||
146585094|NCT02589665|528649326|FG002|Maintenance Extension Period|Non-responder|0|||
146585095|NCT02589665|528649327|FG003|Maintenance Extension Period|Non-responder|0|||
146585096|NCT02589665|528649328|FG004|Maintenance Extension Period|Non-responder|0|||
146585097|NCT02589665|528649329|FG005|Maintenance Extension Period|Non-responder|0|||
146585098|NCT02589665|528649330|FG006|Maintenance Extension Period|Non-responder|0|||
146585099|NCT02589665|528649331|FG007|Maintenance Extension Period|Non-responder|0|||
146585100|NCT02589665|528649332|FG008|Maintenance Extension Period|Non-responder|0|||
146585101|NCT02589665|528649333|FG009|Maintenance Extension Period|Non-responder|1|||
146585102|NCT00176488|528649336|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
146585103|NCT00327015|528649337|FG000|Overall Study|Lack of Efficacy|18|||
146585104|NCT00327015|528649338|FG001|Overall Study|Lack of Efficacy|18|||
146585105|NCT00327015|528649339|FG002|Overall Study|Lack of Efficacy|35|||
146585106|NCT00327015|528649340|FG003|Overall Study|Lack of Efficacy|29|||
146585107|NCT00327015|528649337|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
146585108|NCT00327015|528649338|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
146585109|NCT00327015|528649339|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
146585110|NCT00327015|528649340|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
146585111|NCT00327015|528649337|FG000|Overall Study|Lost to Follow-up|22|||
146652321|NCT01275339|528905199|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
146585112|NCT00327015|528649338|FG001|Overall Study|Lost to Follow-up|23|||
146585113|NCT00327015|528649339|FG002|Overall Study|Lost to Follow-up|29|||
146585114|NCT00327015|528649340|FG003|Overall Study|Lost to Follow-up|22|||
146585115|NCT00327015|528649337|FG000|Overall Study|Adverse Event|14|||
146585116|NCT00327015|528649338|FG001|Overall Study|Adverse Event|10|||
146585117|NCT00327015|528649339|FG002|Overall Study|Adverse Event|14|||
146585118|NCT00327015|528649340|FG003|Overall Study|Adverse Event|14|||
146585119|NCT00327015|528649337|FG000|Overall Study|Subject no longer meets study criteria|4|||
146585120|NCT00327015|528649338|FG001|Overall Study|Subject no longer meets study criteria|2|||
146585121|NCT00327015|528649339|FG002|Overall Study|Subject no longer meets study criteria|8|||
146585122|NCT00327015|528649340|FG003|Overall Study|Subject no longer meets study criteria|7|||
146585123|NCT00327015|528649337|FG000|Overall Study|Poor/Noncompliance|11|||
146585124|NCT00327015|528649338|FG001|Overall Study|Poor/Noncompliance|8|||
146585125|NCT00327015|528649339|FG002|Overall Study|Poor/Noncompliance|4|||
146585126|NCT00327015|528649340|FG003|Overall Study|Poor/Noncompliance|5|||
146585127|NCT00327015|528649337|FG000|Overall Study|Physician Decision|0|||
146585128|NCT00327015|528649338|FG001|Overall Study|Physician Decision|1|||
146585129|NCT00327015|528649339|FG002|Overall Study|Physician Decision|3|||
146585130|NCT00327015|528649340|FG003|Overall Study|Physician Decision|2|||
146585131|NCT00327015|528649337|FG000|Overall Study|Death|1|||
146585132|NCT00327015|528649338|FG001|Overall Study|Death|2|||
146585133|NCT00327015|528649339|FG002|Overall Study|Death|2|||
146585134|NCT00327015|528649340|FG003|Overall Study|Death|3|||
146585135|NCT00327015|528649337|FG000|Overall Study|Pregnancy|0|||
146585136|NCT00327015|528649338|FG001|Overall Study|Pregnancy|2|||
146585137|NCT00327015|528649339|FG002|Overall Study|Pregnancy|1|||
146585138|NCT00327015|528649340|FG003|Overall Study|Pregnancy|1|||
146585139|NCT00327015|528649337|FG000|Overall Study|Administrative Reason by Sponsor|1|||
146585140|NCT00327015|528649338|FG001|Overall Study|Administrative Reason by Sponsor|2|||
146585141|NCT00327015|528649339|FG002|Overall Study|Administrative Reason by Sponsor|2|||
146585142|NCT00327015|528649340|FG003|Overall Study|Administrative Reason by Sponsor|1|||
146585143|NCT02650804|528649341|FG000|Overall Study|Adverse Event|3|||
146585144|NCT02650804|528649342|FG001|Overall Study|Adverse Event|2|||
146585145|NCT02650804|528649341|FG000|Overall Study|Death|1|||
146585146|NCT02650804|528649342|FG001|Overall Study|Death|2|||
146585147|NCT02650804|528649341|FG000|Overall Study|Progressive Disease|7|||
146585148|NCT02650804|528649342|FG001|Overall Study|Progressive Disease|10|||
146585149|NCT02650804|528649341|FG000|Overall Study|Physician Decision|0|||
146585150|NCT02650804|528649342|FG001|Overall Study|Physician Decision|2|||
146585151|NCT02650804|528649341|FG000|Overall Study|Withdrawal by Subject|1|||
146585152|NCT02650804|528649342|FG001|Overall Study|Withdrawal by Subject|4|||
146585153|NCT02650804|528649341|FG000|Overall Study|Symptomatic deterioration|5|||
146585154|NCT02650804|528649342|FG001|Overall Study|Symptomatic deterioration|7|||
146585155|NCT02650804|528649341|FG000|Overall Study|Protocol Violation|0|||
146585156|NCT02650804|528649342|FG001|Overall Study|Protocol Violation|1|||
146585157|NCT01159171|528649345|FG000|Overall Study|Adverse Event|11|||
146585158|NCT01159171|528649345|FG000|Overall Study|Progression of Disease|28|||
146585159|NCT01159171|528649345|FG000|Overall Study|Protocol Violation|1|||
146585160|NCT01159171|528649345|FG000|Overall Study|Need for Surgery|5|||
146585161|NCT01159171|528649345|FG000|Overall Study|Medical Decision|4|||
146585162|NCT01159171|528649345|FG000|Overall Study|Death|1|||
146585163|NCT01892436|528649346|FG000|Overall Study|Withdrawal by Subject|8|||
146585164|NCT01892436|528649347|FG001|Overall Study|Withdrawal by Subject|15|||
146585165|NCT01892436|528649348|FG002|Overall Study|Withdrawal by Subject|4|||
146585166|NCT01892436|528649349|FG003|Overall Study|Withdrawal by Subject|4|||
146585167|NCT01892436|528649346|FG000|Overall Study|Death|1|||
146585168|NCT01892436|528649347|FG001|Overall Study|Death|1|||
146585169|NCT01892436|528649348|FG002|Overall Study|Death|0|||
146585170|NCT01892436|528649349|FG003|Overall Study|Death|0|||
146585171|NCT01892436|528649346|FG000|Overall Study|Physician Decision|2|||
146585172|NCT01892436|528649347|FG001|Overall Study|Physician Decision|1|||
146585173|NCT01892436|528649348|FG002|Overall Study|Physician Decision|0|||
146585174|NCT01892436|528649349|FG003|Overall Study|Physician Decision|1|||
146585175|NCT01892436|528649346|FG000|Overall Study|Pregnancy|0|||
146585176|NCT01892436|528649347|FG001|Overall Study|Pregnancy|2|||
146585177|NCT01892436|528649348|FG002|Overall Study|Pregnancy|1|||
146585178|NCT01892436|528649349|FG003|Overall Study|Pregnancy|0|||
146585179|NCT01892436|528649346|FG000|Overall Study|Technical problems|2|||
146652322|NCT01275339|528905200|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
146770882|NCT04789408|529328728|FG002|Overall Study|Did not meet eligibility criteria|0|||
146978313|NCT00382291|530084001|FG001|Overall Study|Adverse Event|2|||
146585180|NCT01892436|528649347|FG001|Overall Study|Technical problems|1|||
146585181|NCT01892436|528649348|FG002|Overall Study|Technical problems|1|||
146585182|NCT01892436|528649349|FG003|Overall Study|Technical problems|1|||
146585183|NCT01892436|528649346|FG000|Overall Study|Lack of Efficacy|1|||
146585184|NCT01892436|528649347|FG001|Overall Study|Lack of Efficacy|2|||
146585185|NCT01892436|528649348|FG002|Overall Study|Lack of Efficacy|2|||
146585186|NCT01892436|528649349|FG003|Overall Study|Lack of Efficacy|2|||
146585187|NCT01892436|528649346|FG000|Overall Study|Lost to Follow-up|1|||
146585188|NCT01892436|528649347|FG001|Overall Study|Lost to Follow-up|1|||
146585189|NCT01892436|528649348|FG002|Overall Study|Lost to Follow-up|1|||
146585190|NCT01892436|528649349|FG003|Overall Study|Lost to Follow-up|3|||
146585191|NCT01892436|528649346|FG000|Overall Study|non-compliance with treatment|1|||
146585192|NCT01892436|528649347|FG001|Overall Study|non-compliance with treatment|0|||
146585193|NCT01892436|528649348|FG002|Overall Study|non-compliance with treatment|0|||
146585194|NCT01892436|528649349|FG003|Overall Study|non-compliance with treatment|0|||
146978314|NCT00382291|530084002|FG002|Overall Study|Adverse Event|2|||
146585195|NCT01892436|528649346|FG000|Overall Study|Adverse Event|7|||
146585196|NCT01892436|528649347|FG001|Overall Study|Adverse Event|6|||
146585197|NCT01892436|528649348|FG002|Overall Study|Adverse Event|2|||
146585198|NCT01892436|528649349|FG003|Overall Study|Adverse Event|3|||
146585199|NCT00837265|528649353|FG000|Pilot Phase|Withdrawal by Subject|0|||
146585200|NCT00837265|528649354|FG001|Pilot Phase|Withdrawal by Subject|2|||
146585201|NCT00837265|528649355|FG002|Pilot Phase|Withdrawal by Subject|3|||
146585202|NCT00837265|528649356|FG003|Pilot Phase|Withdrawal by Subject|2|||
146585203|NCT00837265|528649357|FG004|Pilot Phase|Withdrawal by Subject|0|||
146585204|NCT00837265|528649358|FG005|Pilot Phase|Withdrawal by Subject|0|||
146585205|NCT00837265|528649359|FG006|Pilot Phase|Withdrawal by Subject|0|||
146585206|NCT00837265|528649353|FG000|Pilot Phase|Decision of the investigator|2|||
146585207|NCT00837265|528649354|FG001|Pilot Phase|Decision of the investigator|1|||
146585208|NCT00837265|528649355|FG002|Pilot Phase|Decision of the investigator|0|||
146585209|NCT00837265|528649356|FG003|Pilot Phase|Decision of the investigator|0|||
146585210|NCT00837265|528649357|FG004|Pilot Phase|Decision of the investigator|0|||
146585211|NCT00837265|528649358|FG005|Pilot Phase|Decision of the investigator|0|||
146585212|NCT00837265|528649359|FG006|Pilot Phase|Decision of the investigator|0|||
146585213|NCT00837265|528649353|FG000|Pilot Phase|Adverse Event|1|||
146585214|NCT00837265|528649354|FG001|Pilot Phase|Adverse Event|0|||
146585215|NCT00837265|528649355|FG002|Pilot Phase|Adverse Event|0|||
146585216|NCT00837265|528649356|FG003|Pilot Phase|Adverse Event|0|||
146585217|NCT00837265|528649357|FG004|Pilot Phase|Adverse Event|0|||
146585218|NCT00837265|528649358|FG005|Pilot Phase|Adverse Event|0|||
146585219|NCT00837265|528649359|FG006|Pilot Phase|Adverse Event|0|||
146585220|NCT00837265|528649353|FG000|Pilot Phase|Disease progression|0|||
146585221|NCT00837265|528649354|FG001|Pilot Phase|Disease progression|0|||
146585222|NCT00837265|528649355|FG002|Pilot Phase|Disease progression|0|||
146585223|NCT00837265|528649356|FG003|Pilot Phase|Disease progression|1|||
146585224|NCT00837265|528649357|FG004|Pilot Phase|Disease progression|0|||
146585225|NCT00837265|528649358|FG005|Pilot Phase|Disease progression|0|||
146585226|NCT00837265|528649359|FG006|Pilot Phase|Disease progression|0|||
146585227|NCT00837265|528649353|FG000|Pilot Phase|Participant left the city|0|||
146585228|NCT00837265|528649354|FG001|Pilot Phase|Participant left the city|0|||
146585229|NCT00837265|528649355|FG002|Pilot Phase|Participant left the city|0|||
146585230|NCT00837265|528649356|FG003|Pilot Phase|Participant left the city|1|||
146585231|NCT00837265|528649357|FG004|Pilot Phase|Participant left the city|0|||
146585232|NCT00837265|528649358|FG005|Pilot Phase|Participant left the city|0|||
146585233|NCT00837265|528649359|FG006|Pilot Phase|Participant left the city|0|||
146585234|NCT00837265|528649353|FG000|Main Phase|Withdrawal by Subject|0|||
146585235|NCT00837265|528649354|FG001|Main Phase|Withdrawal by Subject|0|||
146585236|NCT00837265|528649355|FG002|Main Phase|Withdrawal by Subject|0|||
146585237|NCT00837265|528649356|FG003|Main Phase|Withdrawal by Subject|0|||
146585238|NCT00837265|528649357|FG004|Main Phase|Withdrawal by Subject|4|||
146585239|NCT00837265|528649358|FG005|Main Phase|Withdrawal by Subject|2|||
146585240|NCT00837265|528649359|FG006|Main Phase|Withdrawal by Subject|1|||
146585241|NCT00837265|528649353|FG000|Main Phase|Decision of the investigator|0|||
146585242|NCT00837265|528649354|FG001|Main Phase|Decision of the investigator|0|||
146585243|NCT00837265|528649355|FG002|Main Phase|Decision of the investigator|0|||
146585244|NCT00837265|528649356|FG003|Main Phase|Decision of the investigator|0|||
146585245|NCT00837265|528649357|FG004|Main Phase|Decision of the investigator|0|||
146585246|NCT00837265|528649358|FG005|Main Phase|Decision of the investigator|2|||
146585247|NCT00837265|528649359|FG006|Main Phase|Decision of the investigator|1|||
146585248|NCT00837265|528649353|FG000|Main Phase|Adverse Event|0|||
146585249|NCT00837265|528649354|FG001|Main Phase|Adverse Event|0|||
146585250|NCT00837265|528649355|FG002|Main Phase|Adverse Event|0|||
146585251|NCT00837265|528649356|FG003|Main Phase|Adverse Event|0|||
146585252|NCT00837265|528649357|FG004|Main Phase|Adverse Event|0|||
146585253|NCT00837265|528649358|FG005|Main Phase|Adverse Event|1|||
146585254|NCT00837265|528649359|FG006|Main Phase|Adverse Event|0|||
146585255|NCT00837265|528649353|FG000|Main Phase|Death|0|||
146585256|NCT00837265|528649354|FG001|Main Phase|Death|0|||
146585257|NCT00837265|528649355|FG002|Main Phase|Death|0|||
146585258|NCT00837265|528649356|FG003|Main Phase|Death|0|||
146585259|NCT00837265|528649357|FG004|Main Phase|Death|2|||
146585260|NCT00837265|528649358|FG005|Main Phase|Death|0|||
146585261|NCT00837265|528649359|FG006|Main Phase|Death|1|||
146585262|NCT00837265|528649353|FG000|Main Phase|Lost to Follow-up|0|||
146585263|NCT00837265|528649354|FG001|Main Phase|Lost to Follow-up|0|||
146585264|NCT00837265|528649355|FG002|Main Phase|Lost to Follow-up|0|||
146585265|NCT00837265|528649356|FG003|Main Phase|Lost to Follow-up|0|||
146585266|NCT00837265|528649357|FG004|Main Phase|Lost to Follow-up|1|||
146585267|NCT00837265|528649358|FG005|Main Phase|Lost to Follow-up|0|||
146585268|NCT00837265|528649359|FG006|Main Phase|Lost to Follow-up|0|||
146585269|NCT00837265|528649353|FG000|Main Phase|Principal investigator resignation|0|||
146585270|NCT00837265|528649354|FG001|Main Phase|Principal investigator resignation|0|||
146978315|NCT00382291|530084000|FG000|Overall Study|Protocol Violation|1|||
146918885|NCT03007953|529864532|FG000|Overall Study|Withdrawal by Subject|5|||
146918886|NCT03007953|529864533|FG001|Overall Study|Withdrawal by Subject|2|||
146585271|NCT00837265|528649355|FG002|Main Phase|Principal investigator resignation|0|||
146585272|NCT00837265|528649356|FG003|Main Phase|Principal investigator resignation|0|||
146585273|NCT00837265|528649357|FG004|Main Phase|Principal investigator resignation|2|||
146585274|NCT00837265|528649358|FG005|Main Phase|Principal investigator resignation|0|||
146585275|NCT00837265|528649359|FG006|Main Phase|Principal investigator resignation|0|||
146585276|NCT00837265|528649353|FG000|Main Phase|Participant's personal reason|0|||
146585277|NCT00837265|528649354|FG001|Main Phase|Participant's personal reason|0|||
146585278|NCT00837265|528649355|FG002|Main Phase|Participant's personal reason|0|||
146585279|NCT00837265|528649356|FG003|Main Phase|Participant's personal reason|0|||
146585280|NCT00837265|528649357|FG004|Main Phase|Participant's personal reason|1|||
146585281|NCT00837265|528649358|FG005|Main Phase|Participant's personal reason|0|||
146585282|NCT00837265|528649359|FG006|Main Phase|Participant's personal reason|0|||
146585283|NCT02759107|528649365|FG000|Overall Study|Adverse Event|0|||
146585284|NCT02759107|528649366|FG001|Overall Study|Adverse Event|0|||
146585285|NCT02759107|528649367|FG002|Overall Study|Adverse Event|0|||
146585286|NCT02759107|528649368|FG003|Overall Study|Adverse Event|0|||
146585287|NCT02759107|528649369|FG004|Overall Study|Adverse Event|0|||
146585288|NCT02759107|528649370|FG005|Overall Study|Adverse Event|0|||
146585289|NCT02759107|528649371|FG006|Overall Study|Adverse Event|0|||
146585290|NCT02759107|528649372|FG007|Overall Study|Adverse Event|0|||
146585291|NCT02759107|528649373|FG008|Overall Study|Adverse Event|0|||
146585292|NCT02759107|528649374|FG009|Overall Study|Adverse Event|0|||
146585293|NCT02759107|528649375|FG010|Overall Study|Adverse Event|0|||
146585294|NCT02759107|528649376|FG011|Overall Study|Adverse Event|0|||
146585295|NCT02759107|528649377|FG012|Overall Study|Adverse Event|2|||
146585296|NCT02759107|528649378|FG013|Overall Study|Adverse Event|0|||
146585297|NCT02759107|528649379|FG014|Overall Study|Adverse Event|0|||
146585298|NCT02759107|528649380|FG015|Overall Study|Adverse Event|1|||
146585299|NCT02759107|528649381|FG016|Overall Study|Adverse Event|0|||
146585300|NCT02759107|528649382|FG017|Overall Study|Adverse Event|2|||
146585301|NCT02759107|528649365|FG000|Overall Study|Scheduling Conflict|0|||
146585302|NCT02759107|528649366|FG001|Overall Study|Scheduling Conflict|0|||
146585303|NCT02759107|528649367|FG002|Overall Study|Scheduling Conflict|0|||
146585304|NCT02759107|528649368|FG003|Overall Study|Scheduling Conflict|0|||
146585305|NCT02759107|528649369|FG004|Overall Study|Scheduling Conflict|0|||
146585306|NCT02759107|528649370|FG005|Overall Study|Scheduling Conflict|0|||
146585307|NCT02759107|528649371|FG006|Overall Study|Scheduling Conflict|0|||
146585308|NCT02759107|528649372|FG007|Overall Study|Scheduling Conflict|0|||
146585309|NCT02759107|528649373|FG008|Overall Study|Scheduling Conflict|0|||
146585310|NCT02759107|528649374|FG009|Overall Study|Scheduling Conflict|1|||
146585311|NCT02759107|528649375|FG010|Overall Study|Scheduling Conflict|0|||
146585312|NCT02759107|528649376|FG011|Overall Study|Scheduling Conflict|0|||
146585313|NCT02759107|528649377|FG012|Overall Study|Scheduling Conflict|0|||
146585314|NCT02759107|528649378|FG013|Overall Study|Scheduling Conflict|0|||
146585315|NCT02759107|528649379|FG014|Overall Study|Scheduling Conflict|0|||
146585316|NCT02759107|528649380|FG015|Overall Study|Scheduling Conflict|0|||
146585317|NCT02759107|528649381|FG016|Overall Study|Scheduling Conflict|0|||
146585318|NCT02759107|528649382|FG017|Overall Study|Scheduling Conflict|0|||
146585319|NCT02513485|528649383|FG000|Overall Study|Adverse Event|1|||
146585320|NCT02513485|528649384|FG001|Overall Study|Adverse Event|0|||
146585321|NCT00420004|528649386|FG000|Overall Study|Adverse Event|4|||
146585322|NCT00420004|528649387|FG001|Overall Study|Adverse Event|1|||
146585323|NCT00420004|528649388|FG002|Overall Study|Adverse Event|1|||
146585324|NCT00420004|528649386|FG000|Overall Study|Lack of Efficacy|5|||
146585325|NCT00420004|528649387|FG001|Overall Study|Lack of Efficacy|4|||
146585326|NCT00420004|528649388|FG002|Overall Study|Lack of Efficacy|1|||
146585327|NCT00420004|528649386|FG000|Overall Study|Lost to Follow-up|31|||
146585328|NCT00420004|528649387|FG001|Overall Study|Lost to Follow-up|12|||
146585329|NCT00420004|528649388|FG002|Overall Study|Lost to Follow-up|10|||
146585330|NCT00420004|528649386|FG000|Overall Study|Entry Criteria Not Met|0|||
146585331|NCT00420004|528649387|FG001|Overall Study|Entry Criteria Not Met|1|||
146585332|NCT00420004|528649388|FG002|Overall Study|Entry Criteria Not Met|0|||
146585333|NCT00420004|528649386|FG000|Overall Study|Physician Decision|14|||
146585334|NCT00420004|528649387|FG001|Overall Study|Physician Decision|4|||
146585335|NCT00420004|528649388|FG002|Overall Study|Physician Decision|2|||
146585336|NCT00420004|528649386|FG000|Overall Study|Protocol Violation|5|||
146585337|NCT00420004|528649387|FG001|Overall Study|Protocol Violation|4|||
146585338|NCT00420004|528649388|FG002|Overall Study|Protocol Violation|3|||
146585339|NCT00420004|528649386|FG000|Overall Study|Withdrawal by Subject|67|||
146585340|NCT00420004|528649387|FG001|Overall Study|Withdrawal by Subject|42|||
146585341|NCT00420004|528649388|FG002|Overall Study|Withdrawal by Subject|14|||
146585342|NCT00420004|528649386|FG000|Overall Study|Sponsor Decision|3|||
146585343|NCT00420004|528649387|FG001|Overall Study|Sponsor Decision|3|||
146585344|NCT00420004|528649388|FG002|Overall Study|Sponsor Decision|1|||
146585345|NCT03215758|528649391|FG000|Overall Study|Technical Problems|1|||
146585346|NCT03215758|528649392|FG001|Overall Study|Technical Problems|0|||
146585347|NCT03215758|528649391|FG000|Overall Study|Protocol deviation|0|||
146585348|NCT03215758|528649392|FG001|Overall Study|Protocol deviation|1|||
146585349|NCT03215758|528649391|FG000|Overall Study|Physician Decision|0|||
146585350|NCT03215758|528649392|FG001|Overall Study|Physician Decision|1|||
146585351|NCT03215758|528649391|FG000|Overall Study|Death|0|||
146585352|NCT03215758|528649392|FG001|Overall Study|Death|1|||
146585353|NCT03215758|528649391|FG000|Overall Study|Adverse Event|1|||
146585354|NCT03215758|528649392|FG001|Overall Study|Adverse Event|2|||
146585355|NCT03215758|528649391|FG000|Overall Study|Subject/Guardian Decision|3|||
146585356|NCT03215758|528649392|FG001|Overall Study|Subject/Guardian Decision|3|||
146585357|NCT03931382|528649404|FG000|Overall Study|Equipment malfunction|2|||
146585358|NCT03931382|528649405|FG001|Overall Study|Equipment malfunction|0|||
146585359|NCT03931382|528649406|FG002|Overall Study|Equipment malfunction|2|||
146585360|NCT03931382|528649404|FG000|Overall Study|Withdrawal by Subject|0|||
146585361|NCT03931382|528649405|FG001|Overall Study|Withdrawal by Subject|1|||
146585362|NCT03931382|528649406|FG002|Overall Study|Withdrawal by Subject|0|||
146585363|NCT01106651|528649412|FG000|Overall Study|Adverse Event|17|||
146585364|NCT01106651|528649413|FG001|Overall Study|Adverse Event|9|||
146585365|NCT01106651|528649414|FG002|Overall Study|Adverse Event|23|||
146585366|NCT01106651|528649412|FG000|Overall Study|Lost to Follow-up|8|||
146585367|NCT01106651|528649413|FG001|Overall Study|Lost to Follow-up|2|||
146585368|NCT01106651|528649414|FG002|Overall Study|Lost to Follow-up|6|||
146585369|NCT01106651|528649412|FG000|Overall Study|Physician Decision|4|||
146585370|NCT01106651|528649413|FG001|Overall Study|Physician Decision|3|||
146585371|NCT01106651|528649414|FG002|Overall Study|Physician Decision|1|||
146585372|NCT01106651|528649412|FG000|Overall Study|Protocol Violation|1|||
146585373|NCT01106651|528649413|FG001|Overall Study|Protocol Violation|2|||
146585374|NCT01106651|528649414|FG002|Overall Study|Protocol Violation|1|||
146585375|NCT01106651|528649412|FG000|Overall Study|Withdrawal by Subject|14|||
146585376|NCT01106651|528649413|FG001|Overall Study|Withdrawal by Subject|7|||
146585377|NCT01106651|528649414|FG002|Overall Study|Withdrawal by Subject|4|||
146585378|NCT01106651|528649412|FG000|Overall Study|Noncompliance with study drug|1|||
146585379|NCT01106651|528649413|FG001|Overall Study|Noncompliance with study drug|0|||
146585380|NCT01106651|528649414|FG002|Overall Study|Noncompliance with study drug|2|||
146585381|NCT01106651|528649412|FG000|Overall Study|Other|34|||
146585382|NCT01106651|528649413|FG001|Overall Study|Other|31|||
146585383|NCT01106651|528649414|FG002|Overall Study|Other|21|||
146585384|NCT01106651|528649412|FG000|Overall Study|Death|0|||
146585385|NCT01106651|528649413|FG001|Overall Study|Death|3|||
146585386|NCT01106651|528649414|FG002|Overall Study|Death|0|||
146585387|NCT03768089|528649415|FG000|Part A|Lost to Follow-up|0|||
146585388|NCT03768089|528649416|FG001|Part A|Lost to Follow-up|0|||
146585389|NCT03768089|528649417|FG002|Part A|Lost to Follow-up|0|||
146585390|NCT03768089|528649418|FG003|Part A|Lost to Follow-up|0|||
146585391|NCT03768089|528649419|FG004|Part A|Lost to Follow-up|1|||
146585392|NCT03768089|528649420|FG005|Part A|Lost to Follow-up|0|||
146585393|NCT03768089|528649421|FG006|Part A|Lost to Follow-up|0|||
146585394|NCT03768089|528649422|FG007|Part A|Lost to Follow-up|0|||
146585395|NCT03768089|528649423|FG008|Part A|Lost to Follow-up|0|||
146585396|NCT03768089|528649424|FG009|Part A|Lost to Follow-up|0|||
146585397|NCT03768089|528649425|FG010|Part A|Lost to Follow-up|0|||
146585398|NCT03768089|528649426|FG011|Part A|Lost to Follow-up|0|||
146585399|NCT03768089|528649427|FG012|Part A|Lost to Follow-up|0|||
146585400|NCT03768089|528649428|FG013|Part A|Lost to Follow-up|0|||
146585401|NCT03768089|528649429|FG014|Part A|Lost to Follow-up|0|||
146585402|NCT03768089|528649430|FG015|Part A|Lost to Follow-up|0|||
146585403|NCT03768089|528649431|FG016|Part A|Lost to Follow-up|0|||
146585404|NCT03768089|528649432|FG017|Part A|Lost to Follow-up|0|||
146585405|NCT03768089|528649415|FG000|Part C|Randomized, Never Dosed|0|||
146585406|NCT03768089|528649416|FG001|Part C|Randomized, Never Dosed|0|||
146585407|NCT03768089|528649417|FG002|Part C|Randomized, Never Dosed|0|||
146585408|NCT03768089|528649418|FG003|Part C|Randomized, Never Dosed|0|||
146585409|NCT03768089|528649419|FG004|Part C|Randomized, Never Dosed|0|||
146585410|NCT03768089|528649420|FG005|Part C|Randomized, Never Dosed|0|||
146585411|NCT03768089|528649421|FG006|Part C|Randomized, Never Dosed|0|||
146585412|NCT03768089|528649422|FG007|Part C|Randomized, Never Dosed|0|||
146585413|NCT03768089|528649423|FG008|Part C|Randomized, Never Dosed|0|||
146585414|NCT03768089|528649424|FG009|Part C|Randomized, Never Dosed|0|||
146585415|NCT03768089|528649425|FG010|Part C|Randomized, Never Dosed|0|||
146585416|NCT03768089|528649426|FG011|Part C|Randomized, Never Dosed|0|||
146585417|NCT03768089|528649427|FG012|Part C|Randomized, Never Dosed|0|||
146978316|NCT00382291|530084001|FG001|Overall Study|Protocol Violation|0|||
146585418|NCT03768089|528649428|FG013|Part C|Randomized, Never Dosed|0|||
146585419|NCT03768089|528649429|FG014|Part C|Randomized, Never Dosed|1|||
146585420|NCT03768089|528649430|FG015|Part C|Randomized, Never Dosed|0|||
146585421|NCT03768089|528649431|FG016|Part C|Randomized, Never Dosed|0|||
146585422|NCT03768089|528649432|FG017|Part C|Randomized, Never Dosed|0|||
146585423|NCT04590404|528649435|FG000|Overall Study|Death|16|||
146585424|NCT04590404|528649436|FG001|Overall Study|Death|17|||
146585425|NCT04590404|528649435|FG000|Overall Study|Withdrawal by Subject|7|||
146585426|NCT04590404|528649436|FG001|Overall Study|Withdrawal by Subject|2|||
146585427|NCT04154605|528649437|FG000|Overall Study|Procedure Canceled|1|||
146585428|NCT04154605|528649438|FG001|Overall Study|Procedure Canceled|1|||
146585429|NCT04154605|528649437|FG000|Overall Study|Missed follow up|1|||
146585430|NCT04154605|528649438|FG001|Overall Study|Missed follow up|1|||
146585431|NCT04154605|528649437|FG000|Overall Study|Withdrawal by Subject|1|||
146585432|NCT04154605|528649438|FG001|Overall Study|Withdrawal by Subject|0|||
146585433|NCT00675441|528649441|FG000|Overall Study|Withdrawal by Subject|2|||
146585434|NCT00675441|528649441|FG000|Overall Study|Death|1|||
146585435|NCT04154293|528649446|FG000|Overall Study|Withdrawal by Subject|2|||
146585436|NCT04154293|528649447|FG001|Overall Study|Withdrawal by Subject|3|||
146585437|NCT04154293|528649448|FG002|Overall Study|Withdrawal by Subject|1|||
146585438|NCT04154293|528649446|FG000|Overall Study|Physician Decision|0|||
146585439|NCT04154293|528649447|FG001|Overall Study|Physician Decision|0|||
146585440|NCT04154293|528649448|FG002|Overall Study|Physician Decision|1|||
146585441|NCT03703817|528649450|FG000|Overall Study|Not meeting eligibility criteria|7|||
146585442|NCT03703817|528649451|FG001|Overall Study|Not meeting eligibility criteria|4|||
146585443|NCT03194568|528649454|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
146585444|NCT03515551|528649457|FG000|Overall Study|Death|4|||
146585445|NCT03515551|528649458|FG001|Overall Study|Death|1|||
146585446|NCT03515551|528649459|FG002|Overall Study|Death|2|||
146585447|NCT03515551|528649460|FG003|Overall Study|Death|2|||
146585448|NCT03515551|528649461|FG004|Overall Study|Death|2|||
146585449|NCT03515551|528649462|FG005|Overall Study|Death|4|||
146585450|NCT03515551|528649463|FG006|Overall Study|Death|1|||
146585451|NCT03515551|528649457|FG000|Overall Study|Lost to Follow-up|0|||
146585452|NCT03515551|528649458|FG001|Overall Study|Lost to Follow-up|0|||
146585453|NCT03515551|528649459|FG002|Overall Study|Lost to Follow-up|1|||
146585454|NCT03515551|528649460|FG003|Overall Study|Lost to Follow-up|0|||
146585455|NCT03515551|528649461|FG004|Overall Study|Lost to Follow-up|0|||
146585456|NCT03515551|528649462|FG005|Overall Study|Lost to Follow-up|0|||
146585457|NCT03515551|528649463|FG006|Overall Study|Lost to Follow-up|0|||
146585458|NCT03515551|528649457|FG000|Overall Study|Withdrawal by Subject|0|||
146585459|NCT03515551|528649458|FG001|Overall Study|Withdrawal by Subject|1|||
146585460|NCT03515551|528649459|FG002|Overall Study|Withdrawal by Subject|0|||
146585461|NCT03515551|528649460|FG003|Overall Study|Withdrawal by Subject|0|||
146585462|NCT03515551|528649461|FG004|Overall Study|Withdrawal by Subject|0|||
146585463|NCT03515551|528649462|FG005|Overall Study|Withdrawal by Subject|0|||
146585464|NCT03515551|528649463|FG006|Overall Study|Withdrawal by Subject|1|||
146585465|NCT03515551|528649457|FG000|Overall Study|Study ended by sponsor|0|||
146585466|NCT03515551|528649458|FG001|Overall Study|Study ended by sponsor|0|||
146585467|NCT03515551|528649459|FG002|Overall Study|Study ended by sponsor|2|||
146585468|NCT03515551|528649460|FG003|Overall Study|Study ended by sponsor|1|||
146585469|NCT03515551|528649461|FG004|Overall Study|Study ended by sponsor|3|||
146585470|NCT03515551|528649462|FG005|Overall Study|Study ended by sponsor|0|||
146585471|NCT03515551|528649463|FG006|Overall Study|Study ended by sponsor|3|||
146585472|NCT03515551|528649457|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
146585473|NCT03515551|528649458|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
146585474|NCT03515551|528649459|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
146585475|NCT03515551|528649460|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
146585476|NCT03515551|528649461|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
146585477|NCT03515551|528649462|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
146585478|NCT03515551|528649463|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
146585479|NCT00920387|528649470|FG000|Stage 1|Adverse Event|1|||
146585480|NCT00920387|528649471|FG001|Stage 1|Adverse Event|0|||
146585481|NCT00920387|528649472|FG002|Stage 1|Adverse Event|0|||
146585482|NCT02241733|528649483|FG000|Overall Study|Lost to Follow-up|9|||
146585483|NCT02241733|528649484|FG001|Overall Study|Lost to Follow-up|4|||
146585484|NCT02241733|528649483|FG000|Overall Study|Physician Decision|6|||
146585485|NCT02241733|528649484|FG001|Overall Study|Physician Decision|2|||
146585486|NCT02241733|528649483|FG000|Overall Study|Withdrawal by Subject|0|||
146585487|NCT02241733|528649484|FG001|Overall Study|Withdrawal by Subject|2|||
146585488|NCT02241733|528649483|FG000|Overall Study|Death|0|||
146585489|NCT02241733|528649484|FG001|Overall Study|Death|2|||
146585490|NCT01866111|528649485|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
146652323|NCT01275339|528905201|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
146652324|NCT01275339|528905202|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
146585491|NCT01866111|528649486|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
146585492|NCT01866111|528649487|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
146585493|NCT01866111|528649488|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
146585494|NCT01866111|528649485|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
146585495|NCT01866111|528649486|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
146585496|NCT01866111|528649487|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
146652325|NCT01275339|528905199|FG000|Overall Study|Withdrawal by Subject|0|||
146585497|NCT01866111|528649488|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
146585498|NCT01866111|528649485|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
146918887|NCT03007953|529864532|FG000|Overall Study|Death|5|||
146918888|NCT03007953|529864533|FG001|Overall Study|Death|7|||
146652326|NCT01275339|528905200|FG001|Overall Study|Withdrawal by Subject|0|||
146652327|NCT01275339|528905201|FG002|Overall Study|Withdrawal by Subject|1|||
146652328|NCT01275339|528905202|FG003|Overall Study|Withdrawal by Subject|0|||
146652329|NCT02311582|528905203|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
146652330|NCT02311582|528905204|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
146652331|NCT02311582|528905205|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
146652332|NCT02311582|528905206|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
146652333|NCT02311582|528905207|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
146652334|NCT03404960|528905209|FG000|Overall Study|Adverse Event|0|||
146652335|NCT03404960|528905210|FG001|Overall Study|Adverse Event|2|||
146652336|NCT03404960|528905209|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
146652337|NCT03404960|528905210|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
146652338|NCT03404960|528905209|FG000|Overall Study|Bowel obstruction|0|||
146652339|NCT03404960|528905210|FG001|Overall Study|Bowel obstruction|1|||
146652340|NCT03404960|528905209|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
146652341|NCT03404960|528905210|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
146652342|NCT00246571|528905213|FG000|Overall Study|Adverse Event|7|||
146652343|NCT00246571|528905214|FG001|Overall Study|Adverse Event|0|||
146848173|NCT01215188|529614028|FG002|Overall Study|Withdrawal by Subject|31|||
146585499|NCT01866111|528649486|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
146585500|NCT01866111|528649487|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
146585501|NCT01866111|528649488|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
146585502|NCT01866111|528649485|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
146585503|NCT01866111|528649486|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
146585504|NCT01866111|528649487|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
146585505|NCT01866111|528649488|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
146585506|NCT01866111|528649485|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
146585507|NCT01866111|528649486|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
146585508|NCT01866111|528649487|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
146585509|NCT01866111|528649488|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
146585510|NCT01866111|528649485|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
146585511|NCT01866111|528649486|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
146585512|NCT01866111|528649487|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
146585513|NCT01866111|528649488|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
146585514|NCT01866111|528649485|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
146585515|NCT01866111|528649486|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
146585516|NCT01866111|528649487|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
146585517|NCT01866111|528649488|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
146585518|NCT01866111|528649485|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
146585519|NCT01866111|528649486|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
146585520|NCT01866111|528649487|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
146585521|NCT01866111|528649488|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
146585522|NCT01866111|528649485|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
146585523|NCT01866111|528649486|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
146585524|NCT01866111|528649487|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
146585525|NCT01866111|528649488|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
146585526|NCT01866111|528649485|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
146585527|NCT01866111|528649486|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
146585528|NCT01866111|528649487|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
146585529|NCT01866111|528649488|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
146585530|NCT01866111|528649485|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
146585531|NCT01866111|528649486|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
146585532|NCT01866111|528649487|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
146585533|NCT01866111|528649488|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
146585534|NCT01866111|528649485|FG000|Open-label Extension Study YKP3089C017|Death|1|||
146585535|NCT01866111|528649486|FG001|Open-label Extension Study YKP3089C017|Death|1|||
146585536|NCT01866111|528649487|FG002|Open-label Extension Study YKP3089C017|Death|3|||
146585537|NCT01866111|528649488|FG003|Open-label Extension Study YKP3089C017|Death|2|||
146585538|NCT01866111|528649485|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
146585539|NCT01866111|528649486|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
146585540|NCT01866111|528649487|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
146585541|NCT01866111|528649488|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
146652344|NCT00246571|528905213|FG000|Overall Study|Protocol Violation|0|||
146652345|NCT00246571|528905214|FG001|Overall Study|Protocol Violation|1|||
146652346|NCT00246571|528905213|FG000|Overall Study|Withdrawal by Subject|2|||
146652347|NCT00246571|528905214|FG001|Overall Study|Withdrawal by Subject|3|||
146585542|NCT01866111|528649485|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
146585543|NCT01866111|528649486|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
146585544|NCT01866111|528649487|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
146585545|NCT01866111|528649488|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
146585546|NCT01866111|528649485|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
146585547|NCT01866111|528649486|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
146585548|NCT01866111|528649487|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
146585549|NCT01866111|528649488|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
146585550|NCT00157196|528649489|FG000|Overall Study|Ongoing at data cut-off|9|||
146585551|NCT01252186|528649490|FG000|Overall Study|Adverse Event|9|||
146585552|NCT01252186|528649491|FG001|Overall Study|Adverse Event|6|||
146585553|NCT01252186|528649492|FG002|Overall Study|Adverse Event|8|||
146585554|NCT01252186|528649490|FG000|Overall Study|Withdrawal by Subject|2|||
146585555|NCT01252186|528649491|FG001|Overall Study|Withdrawal by Subject|5|||
146585556|NCT01252186|528649492|FG002|Overall Study|Withdrawal by Subject|2|||
146585557|NCT01252186|528649490|FG000|Overall Study|Physician Decision|0|||
146585558|NCT01252186|528649491|FG001|Overall Study|Physician Decision|0|||
146585559|NCT01252186|528649492|FG002|Overall Study|Physician Decision|1|||
146585560|NCT01252186|528649490|FG000|Overall Study|Non-compliance|0|||
146585561|NCT01252186|528649491|FG001|Overall Study|Non-compliance|3|||
146585562|NCT01252186|528649492|FG002|Overall Study|Non-compliance|4|||
146585563|NCT01252186|528649490|FG000|Overall Study|Protocol Violation|0|||
146585564|NCT01252186|528649491|FG001|Overall Study|Protocol Violation|0|||
146585565|NCT01252186|528649492|FG002|Overall Study|Protocol Violation|1|||
146585566|NCT01252186|528649490|FG000|Overall Study|Pregnancy|2|||
146585567|NCT01252186|528649491|FG001|Overall Study|Pregnancy|2|||
146585568|NCT01252186|528649492|FG002|Overall Study|Pregnancy|0|||
146585569|NCT01252186|528649490|FG000|Overall Study|Sponsor Request|2|||
146585570|NCT01252186|528649491|FG001|Overall Study|Sponsor Request|1|||
146585571|NCT01252186|528649492|FG002|Overall Study|Sponsor Request|0|||
146585572|NCT01252186|528649490|FG000|Overall Study|Lost to Follow-up|10|||
146585573|NCT01252186|528649491|FG001|Overall Study|Lost to Follow-up|10|||
146585574|NCT01252186|528649492|FG002|Overall Study|Lost to Follow-up|11|||
146585575|NCT01252186|528649490|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
146585576|NCT01252186|528649491|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
146585577|NCT01252186|528649492|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
146585578|NCT02791516|528649493|FG000|Overall Study|Withdrawal by Subject|1|||
146585579|NCT02791516|528649494|FG001|Overall Study|Withdrawal by Subject|1|||
146585580|NCT01439971|528649495|FG000|Overall Study|Required number in cohort dosed|0|||
146585581|NCT01439971|528649496|FG001|Overall Study|Required number in cohort dosed|1|||
146585582|NCT01439971|528649497|FG002|Overall Study|Required number in cohort dosed|2|||
146585583|NCT01439971|528649498|FG003|Overall Study|Required number in cohort dosed|0|||
146585584|NCT01439971|528649499|FG004|Overall Study|Required number in cohort dosed|1|||
146585585|NCT02628600|528649500|FG000|Overall Study|Death|2|||
146585586|NCT02628600|528649501|FG001|Overall Study|Death|1|||
146585587|NCT02628600|528649500|FG000|Overall Study|Adverse Event|3|||
146585588|NCT02628600|528649501|FG001|Overall Study|Adverse Event|20|||
146585589|NCT02628600|528649500|FG000|Overall Study|Protocol Violation|0|||
146585590|NCT02628600|528649501|FG001|Overall Study|Protocol Violation|1|||
146585591|NCT02628600|528649500|FG000|Overall Study|Lack of Efficacy|2|||
146585592|NCT02628600|528649501|FG001|Overall Study|Lack of Efficacy|0|||
146585593|NCT02628600|528649500|FG000|Overall Study|Withdrawal by Subject|13|||
146585594|NCT02628600|528649501|FG001|Overall Study|Withdrawal by Subject|8|||
146585595|NCT02628600|528649500|FG000|Overall Study|Lost to Follow-up|1|||
146585596|NCT02628600|528649501|FG001|Overall Study|Lost to Follow-up|0|||
146585597|NCT02628600|528649500|FG000|Overall Study|Physician Decision|2|||
146918889|NCT03007953|529864532|FG000|Overall Study|Lost to Follow-up|3|||
146918890|NCT03007953|529864533|FG001|Overall Study|Lost to Follow-up|2|||
146918891|NCT03007953|529864532|FG000|Overall Study|Enrolled in Hospice|3|||
146918892|NCT03007953|529864533|FG001|Overall Study|Enrolled in Hospice|2|||
146918893|NCT00829166|529864537|FG000|Overall Study|Death|305|||
146918894|NCT00829166|529864538|FG001|Overall Study|Death|333|||
146585598|NCT02628600|528649501|FG001|Overall Study|Physician Decision|2|||
146585599|NCT02628600|528649500|FG000|Overall Study|Other not specified|1|||
146585600|NCT02628600|528649501|FG001|Overall Study|Other not specified|0|||
146585601|NCT04283994|528649503|FG000|Overall Study|Death|11|||
146585602|NCT04283994|528649504|FG001|Overall Study|Death|20|||
146585603|NCT04283994|528649505|FG002|Overall Study|Death|11|||
146585604|NCT04283994|528649506|FG003|Overall Study|Death|0|||
146585605|NCT04283994|528649507|FG004|Overall Study|Death|0|||
146918895|NCT00829166|529864537|FG000|Overall Study|Lost to Follow-up|5|||
146918896|NCT00829166|529864538|FG001|Overall Study|Lost to Follow-up|4|||
146918897|NCT00829166|529864537|FG000|Overall Study|Physician's Decision|4|||
146585606|NCT04283994|528649508|FG005|Overall Study|Death|0|||
146585607|NCT04283994|528649509|FG006|Overall Study|Death|0|||
146585608|NCT04283994|528649503|FG000|Overall Study|Withdrawal by Subject|16|||
146585609|NCT04283994|528649504|FG001|Overall Study|Withdrawal by Subject|4|||
146918898|NCT00829166|529864538|FG001|Overall Study|Physician's Decision|3|||
146585610|NCT04283994|528649505|FG002|Overall Study|Withdrawal by Subject|6|||
146585611|NCT04283994|528649506|FG003|Overall Study|Withdrawal by Subject|1|||
146585612|NCT04283994|528649507|FG004|Overall Study|Withdrawal by Subject|0|||
146585613|NCT04283994|528649508|FG005|Overall Study|Withdrawal by Subject|1|||
146585614|NCT04283994|528649509|FG006|Overall Study|Withdrawal by Subject|0|||
146585615|NCT02578680|528650641|FG000|Overall Study|Death|329|||
146585616|NCT02578680|528650642|FG001|Overall Study|Death|181|||
146585617|NCT02578680|528650641|FG000|Overall Study|Lost to Follow-up|3|||
146585618|NCT02578680|528650642|FG001|Overall Study|Lost to Follow-up|1|||
146585619|NCT02578680|528650641|FG000|Overall Study|Physician Decision|0|||
146585620|NCT02578680|528650642|FG001|Overall Study|Physician Decision|1|||
146585621|NCT02578680|528650641|FG000|Overall Study|Protocol Violation|1|||
146585622|NCT02578680|528650642|FG001|Overall Study|Protocol Violation|1|||
146585623|NCT02578680|528650641|FG000|Overall Study|Sponsor Decision|64|||
146585624|NCT02578680|528650642|FG001|Overall Study|Sponsor Decision|13|||
146585625|NCT02578680|528650641|FG000|Overall Study|Withdrawal by Subject|13|||
146585626|NCT02578680|528650642|FG001|Overall Study|Withdrawal by Subject|9|||
146585627|NCT00306293|528650645|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
146585628|NCT00306293|528650646|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
146585629|NCT00306293|528650645|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
146585630|NCT00306293|528650646|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
146585631|NCT00306293|528650645|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
146585632|NCT00306293|528650646|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
146585633|NCT00306293|528650645|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
146585634|NCT00306293|528650646|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
146585635|NCT00306293|528650645|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
146585636|NCT00306293|528650646|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
146585637|NCT00306293|528650645|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
146585638|NCT00306293|528650646|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
146585639|NCT00306293|528650645|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
146585640|NCT00306293|528650646|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
146585641|NCT00306293|528650645|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
146585642|NCT00306293|528650646|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
146585643|NCT00185380|528650650|FG000|Overall Study|Adverse Event|41|||
146585644|NCT00185380|528650651|FG001|Overall Study|Adverse Event|43|||
146585645|NCT00185380|528650652|FG002|Overall Study|Adverse Event|48|||
146585646|NCT00185380|528650650|FG000|Overall Study|Lost to Follow-up|0|||
146585647|NCT00185380|528650651|FG001|Overall Study|Lost to Follow-up|4|||
146585648|NCT00185380|528650652|FG002|Overall Study|Lost to Follow-up|3|||
146585649|NCT00185380|528650650|FG000|Overall Study|Pregnancy|1|||
146585650|NCT00185380|528650651|FG001|Overall Study|Pregnancy|4|||
146585651|NCT00185380|528650652|FG002|Overall Study|Pregnancy|0|||
146585652|NCT00185380|528650650|FG000|Overall Study|Protocol Violation|2|||
146585653|NCT00185380|528650651|FG001|Overall Study|Protocol Violation|2|||
146585654|NCT00185380|528650652|FG002|Overall Study|Protocol Violation|1|||
146585655|NCT00185380|528650650|FG000|Overall Study|Withdrawal by Subject|1|||
146585656|NCT00185380|528650651|FG001|Overall Study|Withdrawal by Subject|2|||
146585657|NCT00185380|528650652|FG002|Overall Study|Withdrawal by Subject|0|||
146585658|NCT00185380|528650650|FG000|Overall Study|Failed insertion|1|||
146585659|NCT00185380|528650651|FG001|Overall Study|Failed insertion|1|||
146585660|NCT00185380|528650652|FG002|Overall Study|Failed insertion|2|||
146585661|NCT00185380|528650650|FG000|Overall Study|Planned pregnancy|9|||
146585662|NCT00185380|528650651|FG001|Overall Study|Planned pregnancy|12|||
146585663|NCT00185380|528650652|FG002|Overall Study|Planned pregnancy|12|||
146585664|NCT00185380|528650650|FG000|Overall Study|No need for contraception|3|||
146585665|NCT00185380|528650651|FG001|Overall Study|No need for contraception|3|||
146585666|NCT00185380|528650652|FG002|Overall Study|No need for contraception|3|||
146585667|NCT00185380|528650650|FG000|Overall Study|Could not attend visits|2|||
146585668|NCT00185380|528650651|FG001|Overall Study|Could not attend visits|0|||
146585669|NCT00185380|528650652|FG002|Overall Study|Could not attend visits|4|||
146585670|NCT00185380|528650650|FG000|Overall Study|personal reason|6|||
146585671|NCT00185380|528650651|FG001|Overall Study|personal reason|1|||
146652348|NCT00246571|528905213|FG000|Overall Study|Lack of Efficacy|84|||
146652349|NCT00246571|528905214|FG001|Overall Study|Lack of Efficacy|21|||
146585672|NCT00185380|528650652|FG002|Overall Study|personal reason|1|||
146585673|NCT00733291|528650653|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
146585674|NCT00733291|528650654|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
146585675|NCT00733291|528650655|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
146585676|NCT00733291|528650656|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
146585677|NCT01089413|528650660|FG000|Overall Study|Lost to Follow-up|1|||
146585678|NCT01089413|528650660|FG000|Overall Study|Progressive Disease|93|||
146585679|NCT01089413|528650660|FG000|Overall Study|Participant Withdrew Consent|1|||
146585680|NCT01089413|528650660|FG000|Overall Study|Unacceptable Toxicity|12|||
146585681|NCT01089413|528650660|FG000|Overall Study|Death|10|||
146585682|NCT01089413|528650660|FG000|Overall Study|Metastasectomy|13|||
146585683|NCT01089413|528650660|FG000|Overall Study|Other|71|||
146585684|NCT02526524|528650661|FG000|Overall Study|Withdrawal by Subject|3|||
146585685|NCT02526524|528650662|FG001|Overall Study|Withdrawal by Subject|3|||
146585686|NCT02526524|528650663|FG002|Overall Study|Withdrawal by Subject|6|||
146585687|NCT02526524|528650664|FG003|Overall Study|Withdrawal by Subject|1|||
146585688|NCT02526524|528650665|FG004|Overall Study|Withdrawal by Subject|9|||
146585689|NCT02526524|528650666|FG005|Overall Study|Withdrawal by Subject|5|||
146585690|NCT02526524|528650661|FG000|Overall Study|Adverse Event|3|||
146585691|NCT02526524|528650662|FG001|Overall Study|Adverse Event|2|||
146585692|NCT02526524|528650663|FG002|Overall Study|Adverse Event|4|||
146585693|NCT02526524|528650664|FG003|Overall Study|Adverse Event|2|||
146585694|NCT02526524|528650665|FG004|Overall Study|Adverse Event|6|||
146585695|NCT02526524|528650666|FG005|Overall Study|Adverse Event|8|||
146585696|NCT02526524|528650661|FG000|Overall Study|Lost to Follow-up|2|||
146585697|NCT02526524|528650662|FG001|Overall Study|Lost to Follow-up|3|||
146585698|NCT02526524|528650663|FG002|Overall Study|Lost to Follow-up|8|||
146585699|NCT02526524|528650664|FG003|Overall Study|Lost to Follow-up|1|||
146585700|NCT02526524|528650665|FG004|Overall Study|Lost to Follow-up|2|||
146585701|NCT02526524|528650666|FG005|Overall Study|Lost to Follow-up|5|||
146585702|NCT02526524|528650661|FG000|Overall Study|Protocol Violation|3|||
146585703|NCT02526524|528650662|FG001|Overall Study|Protocol Violation|1|||
146585704|NCT02526524|528650663|FG002|Overall Study|Protocol Violation|5|||
146585705|NCT02526524|528650664|FG003|Overall Study|Protocol Violation|3|||
146585706|NCT02526524|528650665|FG004|Overall Study|Protocol Violation|4|||
146585707|NCT02526524|528650666|FG005|Overall Study|Protocol Violation|3|||
146585708|NCT02526524|528650661|FG000|Overall Study|Loss of Glucose Control|0|||
146585709|NCT02526524|528650662|FG001|Overall Study|Loss of Glucose Control|0|||
146585710|NCT02526524|528650663|FG002|Overall Study|Loss of Glucose Control|3|||
146585711|NCT02526524|528650664|FG003|Overall Study|Loss of Glucose Control|0|||
146585712|NCT02526524|528650665|FG004|Overall Study|Loss of Glucose Control|2|||
146585713|NCT02526524|528650666|FG005|Overall Study|Loss of Glucose Control|0|||
146585714|NCT02526524|528650661|FG000|Overall Study|Physician Decision|0|||
146585715|NCT02526524|528650662|FG001|Overall Study|Physician Decision|0|||
146585716|NCT02526524|528650663|FG002|Overall Study|Physician Decision|0|||
146585717|NCT02526524|528650664|FG003|Overall Study|Physician Decision|0|||
146585718|NCT02526524|528650665|FG004|Overall Study|Physician Decision|1|||
146585719|NCT02526524|528650666|FG005|Overall Study|Physician Decision|0|||
146585720|NCT02526524|528650661|FG000|Overall Study|Sponsor Decision|1|||
146585721|NCT02526524|528650662|FG001|Overall Study|Sponsor Decision|0|||
146585722|NCT02526524|528650663|FG002|Overall Study|Sponsor Decision|0|||
146585723|NCT02526524|528650664|FG003|Overall Study|Sponsor Decision|0|||
146585724|NCT02526524|528650665|FG004|Overall Study|Sponsor Decision|0|||
146585725|NCT02526524|528650666|FG005|Overall Study|Sponsor Decision|0|||
146585726|NCT00470093|528650671|FG000|Overall Study|Adverse Event|2|||
146585727|NCT01610557|528650674|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
146585728|NCT01610557|528650675|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
146585729|NCT01610557|528650676|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
146585730|NCT01610557|528650677|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
146585731|NCT01610557|528650678|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
146585732|NCT01610557|528650674|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
146918899|NCT00829166|529864537|FG000|Overall Study|Subject's Decision|41|||
146918900|NCT00829166|529864538|FG001|Overall Study|Subject's Decision|55|||
146918901|NCT00829166|529864537|FG000|Overall Study|Sponsor's Decision|137|||
146918902|NCT00829166|529864538|FG001|Overall Study|Sponsor's Decision|98|||
146918903|NCT00829166|529864537|FG000|Overall Study|Reason Not Specified|3|||
146918904|NCT00829166|529864538|FG001|Overall Study|Reason Not Specified|3|||
146918905|NCT01635933|529864539|FG000|Overall Study|Adverse Event|1|||
146585733|NCT01610557|528650675|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
146585734|NCT01610557|528650676|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
146585735|NCT01610557|528650677|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
146585736|NCT01610557|528650678|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
146585737|NCT02039219|528650679|FG000|Treatment|Withdrawal by Subject|1|||
146585738|NCT02039219|528650680|FG001|Treatment|Withdrawal by Subject|0|||
146585739|NCT02039219|528650679|FG000|Treatment|Adverse Event|0|||
146585740|NCT02039219|528650680|FG001|Treatment|Adverse Event|1|||
146652350|NCT00246571|528905213|FG000|Overall Study|Death|17|||
146918906|NCT01635933|529864540|FG001|Overall Study|Adverse Event|0|||
146585741|NCT02039219|528650679|FG000|Treatment|Physician Decision|1|||
146585742|NCT02039219|528650680|FG001|Treatment|Physician Decision|0|||
146585743|NCT02039219|528650679|FG000|Treatment|Lost to Follow-up|0|||
146585744|NCT02039219|528650680|FG001|Treatment|Lost to Follow-up|1|||
146585745|NCT02039219|528650679|FG000|Treatment|Protocol Violation|1|||
146585746|NCT02039219|528650680|FG001|Treatment|Protocol Violation|0|||
146585747|NCT02039219|528650679|FG000|Treatment|Death|1|||
146585748|NCT02039219|528650680|FG001|Treatment|Death|0|||
146585749|NCT02039219|528650679|FG000|Follow up|Adverse Event|0|||
146585750|NCT02039219|528650680|FG001|Follow up|Adverse Event|1|||
146585751|NCT02226562|528650681|FG000|Overall Study|Lost to Follow-up|0|||
146585752|NCT02226562|528650682|FG001|Overall Study|Lost to Follow-up|1|||
146585753|NCT01466660|528650683|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
146585754|NCT01466660|528650684|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
146585755|NCT01466660|528650683|FG000|Overall Study|Worsening of underlying cancer disease|5|||
146585756|NCT01466660|528650684|FG001|Overall Study|Worsening of underlying cancer disease|2|||
146585757|NCT01466660|528650683|FG000|Overall Study|Other adverse event|19|||
146585758|NCT01466660|528650684|FG001|Overall Study|Other adverse event|18|||
146585759|NCT01466660|528650683|FG000|Overall Study|Protocol Violation|2|||
146585760|NCT01466660|528650684|FG001|Overall Study|Protocol Violation|1|||
146585761|NCT01466660|528650683|FG000|Overall Study|Refused continuation of trial medication|4|||
146585762|NCT01466660|528650684|FG001|Overall Study|Refused continuation of trial medication|3|||
146585763|NCT01466660|528650683|FG000|Overall Study|Other reason not defined above|10|||
146585764|NCT01466660|528650684|FG001|Overall Study|Other reason not defined above|8|||
146585765|NCT00129701|528650685|FG000|Overall Study|Withdrawal by Subject|33|||
146585766|NCT02750345|528650686|FG000|Intervention 1|Adverse Event|0|||
146585767|NCT02750345|528650687|FG001|Intervention 1|Adverse Event|0|||
146585768|NCT02750345|528650688|FG002|Intervention 1|Adverse Event|0|||
146585769|NCT02750345|528650689|FG003|Intervention 1|Adverse Event|0|||
146585770|NCT02750345|528650690|FG004|Intervention 1|Adverse Event|1|||
146585771|NCT02750345|528650691|FG005|Intervention 1|Adverse Event|0|||
146585772|NCT00608023|528650692|FG000|Overall Study|Withdrawal by Subject|8|||
146585773|NCT00608023|528650693|FG001|Overall Study|Withdrawal by Subject|10|||
146585774|NCT00608023|528650694|FG002|Overall Study|Withdrawal by Subject|7|||
146585775|NCT00608023|528650692|FG000|Overall Study|Adverse Event|1|||
146585776|NCT00608023|528650693|FG001|Overall Study|Adverse Event|4|||
146585777|NCT00608023|528650694|FG002|Overall Study|Adverse Event|5|||
146585778|NCT00608023|528650692|FG000|Overall Study|Lost to Follow-up|2|||
146585779|NCT00608023|528650693|FG001|Overall Study|Lost to Follow-up|2|||
146585780|NCT00608023|528650694|FG002|Overall Study|Lost to Follow-up|1|||
146585781|NCT00608023|528650692|FG000|Overall Study|Protocol Violation|1|||
146585782|NCT00608023|528650693|FG001|Overall Study|Protocol Violation|3|||
146585783|NCT00608023|528650694|FG002|Overall Study|Protocol Violation|1|||
146585784|NCT00608023|528650692|FG000|Overall Study|Unknown reason|0|||
146585785|NCT00608023|528650693|FG001|Overall Study|Unknown reason|3|||
146585786|NCT00608023|528650694|FG002|Overall Study|Unknown reason|0|||
146652351|NCT00246571|528905214|FG001|Overall Study|Death|3|||
146652352|NCT00246571|528905213|FG000|Overall Study|Sponsor|0|||
146652353|NCT00246571|528905214|FG001|Overall Study|Sponsor|1|||
146652354|NCT00246571|528905213|FG000|Overall Study|Did not meet entrance criteria|2|||
146652355|NCT00246571|528905214|FG001|Overall Study|Did not meet entrance criteria|1|||
146652356|NCT00246571|528905213|FG000|Overall Study|Laboratory abnormalities|1|||
146652357|NCT00246571|528905214|FG001|Overall Study|Laboratory abnormalities|0|||
146585787|NCT01328535|528650695|FG000|Overall Study|Ineligible|1|||
146585788|NCT03655054|528650698|FG000|Overall Study|Lost to Follow-up|1|||
146585789|NCT01054560|528650703|FG000|Overall Study|Death|10|||
146585790|NCT01054560|528650704|FG001|Overall Study|Death|21|||
146585791|NCT01054560|528650703|FG000|Overall Study|Lost to Follow-up|2|||
146585792|NCT01054560|528650704|FG001|Overall Study|Lost to Follow-up|5|||
146585793|NCT01054560|528650703|FG000|Overall Study|Withdrawal by Subject|0|||
146585794|NCT01054560|528650704|FG001|Overall Study|Withdrawal by Subject|2|||
146585795|NCT01054560|528650703|FG000|Overall Study|Physician Decision|1|||
146585796|NCT01054560|528650704|FG001|Overall Study|Physician Decision|0|||
146585797|NCT02135029|528650709|FG000|Overall Study|Adverse Event|2|||
146585798|NCT02135029|528650710|FG001|Overall Study|Adverse Event|2|||
146585799|NCT02135029|528650711|FG002|Overall Study|Adverse Event|2|||
146585800|NCT02135029|528650709|FG000|Overall Study|Lost to Follow-up|0|||
146585801|NCT02135029|528650710|FG001|Overall Study|Lost to Follow-up|1|||
146585802|NCT02135029|528650711|FG002|Overall Study|Lost to Follow-up|0|||
146585803|NCT02135029|528650709|FG000|Overall Study|Withdrawal by Subject|2|||
146585804|NCT02135029|528650710|FG001|Overall Study|Withdrawal by Subject|0|||
146585805|NCT02135029|528650711|FG002|Overall Study|Withdrawal by Subject|1|||
146585806|NCT02135029|528650709|FG000|Overall Study|Other|0|||
146652358|NCT00246571|528905213|FG000|Overall Study|Crossover participants|0|||
146585807|NCT02135029|528650710|FG001|Overall Study|Other|1|||
146585808|NCT02135029|528650711|FG002|Overall Study|Other|0|||
146585809|NCT02135029|528650709|FG000|Overall Study|Death|0|||
146585810|NCT02135029|528650710|FG001|Overall Study|Death|1|||
146585811|NCT02135029|528650711|FG002|Overall Study|Death|0|||
146585812|NCT00712725|528650712|FG000|Overall Study|Adverse Event|1|||
146585813|NCT00712725|528650713|FG001|Overall Study|Adverse Event|0|||
146585814|NCT00712725|528650714|FG002|Overall Study|Adverse Event|0|||
146585815|NCT00712725|528650715|FG003|Overall Study|Adverse Event|1|||
146585816|NCT00712725|528650716|FG004|Overall Study|Adverse Event|0|||
146585817|NCT00712725|528650717|FG005|Overall Study|Adverse Event|0|||
146652359|NCT00246571|528905214|FG001|Overall Study|Crossover participants|74|||
146585818|NCT00712725|528650718|FG006|Overall Study|Adverse Event|0|||
146585819|NCT00712725|528650719|FG007|Overall Study|Adverse Event|0|||
146585820|NCT00712725|528650712|FG000|Overall Study|Lost to Follow-up|3|||
146585821|NCT00712725|528650713|FG001|Overall Study|Lost to Follow-up|2|||
146585822|NCT00712725|528650714|FG002|Overall Study|Lost to Follow-up|1|||
146585823|NCT00712725|528650715|FG003|Overall Study|Lost to Follow-up|1|||
146585824|NCT00712725|528650716|FG004|Overall Study|Lost to Follow-up|2|||
146585825|NCT00712725|528650717|FG005|Overall Study|Lost to Follow-up|2|||
146585826|NCT00712725|528650718|FG006|Overall Study|Lost to Follow-up|3|||
146585827|NCT00712725|528650719|FG007|Overall Study|Lost to Follow-up|1|||
146585828|NCT00712725|528650712|FG000|Overall Study|Physician Decision|2|||
146585829|NCT00712725|528650713|FG001|Overall Study|Physician Decision|0|||
146585830|NCT00712725|528650714|FG002|Overall Study|Physician Decision|0|||
146585831|NCT00712725|528650715|FG003|Overall Study|Physician Decision|0|||
146585832|NCT00712725|528650716|FG004|Overall Study|Physician Decision|1|||
146585833|NCT00712725|528650717|FG005|Overall Study|Physician Decision|0|||
146585834|NCT00712725|528650718|FG006|Overall Study|Physician Decision|2|||
146585835|NCT00712725|528650719|FG007|Overall Study|Physician Decision|0|||
146585836|NCT00712725|528650712|FG000|Overall Study|Pregnancy|0|||
146585837|NCT00712725|528650713|FG001|Overall Study|Pregnancy|1|||
146585838|NCT00712725|528650714|FG002|Overall Study|Pregnancy|0|||
146585839|NCT00712725|528650715|FG003|Overall Study|Pregnancy|0|||
146585840|NCT00712725|528650716|FG004|Overall Study|Pregnancy|1|||
146585841|NCT00712725|528650717|FG005|Overall Study|Pregnancy|0|||
146585842|NCT00712725|528650718|FG006|Overall Study|Pregnancy|2|||
146585843|NCT00712725|528650719|FG007|Overall Study|Pregnancy|0|||
146585844|NCT00712725|528650712|FG000|Overall Study|Protocol Violation|2|||
146585845|NCT00712725|528650713|FG001|Overall Study|Protocol Violation|0|||
146585846|NCT00712725|528650714|FG002|Overall Study|Protocol Violation|1|||
146585847|NCT00712725|528650715|FG003|Overall Study|Protocol Violation|3|||
146585848|NCT00712725|528650716|FG004|Overall Study|Protocol Violation|2|||
146585849|NCT00712725|528650717|FG005|Overall Study|Protocol Violation|0|||
146585850|NCT00712725|528650718|FG006|Overall Study|Protocol Violation|1|||
146585851|NCT00712725|528650719|FG007|Overall Study|Protocol Violation|1|||
146585852|NCT00712725|528650712|FG000|Overall Study|Withdrawal by Subject|2|||
146585853|NCT00712725|528650713|FG001|Overall Study|Withdrawal by Subject|1|||
146585854|NCT00712725|528650714|FG002|Overall Study|Withdrawal by Subject|1|||
146585855|NCT00712725|528650715|FG003|Overall Study|Withdrawal by Subject|2|||
146585856|NCT00712725|528650716|FG004|Overall Study|Withdrawal by Subject|1|||
146585857|NCT00712725|528650717|FG005|Overall Study|Withdrawal by Subject|1|||
146585858|NCT00712725|528650718|FG006|Overall Study|Withdrawal by Subject|1|||
146585859|NCT00712725|528650719|FG007|Overall Study|Withdrawal by Subject|2|||
146585860|NCT00712725|528650712|FG000|Overall Study|Lack of Qualifying Event|16|||
146585861|NCT00712725|528650713|FG001|Overall Study|Lack of Qualifying Event|2|||
146585862|NCT00712725|528650714|FG002|Overall Study|Lack of Qualifying Event|6|||
146585863|NCT00712725|528650715|FG003|Overall Study|Lack of Qualifying Event|8|||
146585864|NCT00712725|528650716|FG004|Overall Study|Lack of Qualifying Event|11|||
146585865|NCT00712725|528650717|FG005|Overall Study|Lack of Qualifying Event|13|||
146585866|NCT00712725|528650718|FG006|Overall Study|Lack of Qualifying Event|11|||
146585867|NCT00712725|528650719|FG007|Overall Study|Lack of Qualifying Event|6|||
146585868|NCT00712725|528650712|FG000|Overall Study|Protocol Specified Criteria|3|||
146585869|NCT00712725|528650713|FG001|Overall Study|Protocol Specified Criteria|0|||
146585870|NCT00712725|528650714|FG002|Overall Study|Protocol Specified Criteria|1|||
146585871|NCT00712725|528650715|FG003|Overall Study|Protocol Specified Criteria|2|||
146585872|NCT00712725|528650716|FG004|Overall Study|Protocol Specified Criteria|1|||
146585873|NCT00712725|528650717|FG005|Overall Study|Protocol Specified Criteria|0|||
146585874|NCT00712725|528650718|FG006|Overall Study|Protocol Specified Criteria|2|||
146585875|NCT00712725|528650719|FG007|Overall Study|Protocol Specified Criteria|1|||
146770883|NCT04789408|529328726|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
146770884|NCT04789408|529328727|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
146585876|NCT03466099|528650720|FG000|Overall Study|Adverse Event|1|||
146585877|NCT03466099|528650721|FG001|Overall Study|Adverse Event|1|||
146585878|NCT03466099|528650722|FG002|Overall Study|Adverse Event|1|||
146585879|NCT03466099|528650720|FG000|Overall Study|Withdrawal by Subject|2|||
146585880|NCT03466099|528650721|FG001|Overall Study|Withdrawal by Subject|3|||
146585881|NCT03466099|528650722|FG002|Overall Study|Withdrawal by Subject|1|||
146585882|NCT03466099|528650720|FG000|Overall Study|Use of rescue medication|8|||
146770885|NCT04789408|529328728|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
146585883|NCT03466099|528650721|FG001|Overall Study|Use of rescue medication|9|||
146585884|NCT03466099|528650722|FG002|Overall Study|Use of rescue medication|13|||
146585885|NCT03466099|528650720|FG000|Overall Study|Rescued without meeting criteria|4|||
146585886|NCT03466099|528650721|FG001|Overall Study|Rescued without meeting criteria|1|||
146585887|NCT03466099|528650722|FG002|Overall Study|Rescued without meeting criteria|1|||
146585888|NCT03466099|528650720|FG000|Overall Study|Subject compliance|2|||
146585889|NCT03466099|528650721|FG001|Overall Study|Subject compliance|0|||
146585890|NCT03466099|528650722|FG002|Overall Study|Subject compliance|0|||
146585891|NCT03466099|528650720|FG000|Overall Study|Worsening disease|0|||
146585892|NCT03466099|528650721|FG001|Overall Study|Worsening disease|0|||
146585893|NCT03466099|528650722|FG002|Overall Study|Worsening disease|1|||
146585894|NCT03525600|528650725|FG000|Overall Study|Adverse Event|9|||
146585895|NCT03525600|528650726|FG001|Overall Study|Adverse Event|6|||
146585896|NCT03525600|528650727|FG002|Overall Study|Adverse Event|5|||
146585897|NCT03525600|528650728|FG003|Overall Study|Adverse Event|3|||
146585898|NCT03525600|528650725|FG000|Overall Study|Lost to Follow-up|2|||
146585899|NCT03525600|528650726|FG001|Overall Study|Lost to Follow-up|4|||
146585900|NCT03525600|528650727|FG002|Overall Study|Lost to Follow-up|4|||
146585901|NCT03525600|528650728|FG003|Overall Study|Lost to Follow-up|0|||
146585902|NCT03525600|528650725|FG000|Overall Study|Physician Decision|1|||
146585903|NCT03525600|528650726|FG001|Overall Study|Physician Decision|0|||
146585904|NCT03525600|528650727|FG002|Overall Study|Physician Decision|2|||
146585905|NCT03525600|528650728|FG003|Overall Study|Physician Decision|0|||
146585906|NCT03525600|528650725|FG000|Overall Study|Consent withdrawal|36|||
146585907|NCT03525600|528650726|FG001|Overall Study|Consent withdrawal|20|||
146585908|NCT03525600|528650727|FG002|Overall Study|Consent withdrawal|6|||
146585909|NCT03525600|528650728|FG003|Overall Study|Consent withdrawal|13|||
146585910|NCT03525600|528650725|FG000|Overall Study|Death|7|||
146585911|NCT03525600|528650726|FG001|Overall Study|Death|6|||
146585912|NCT03525600|528650727|FG002|Overall Study|Death|4|||
146585913|NCT03525600|528650728|FG003|Overall Study|Death|3|||
146585914|NCT03525600|528650725|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
146585915|NCT03525600|528650726|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
146585916|NCT03525600|528650727|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
146585917|NCT03525600|528650728|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
146585918|NCT03525600|528650725|FG000|Overall Study|Other|0|||
146585919|NCT03525600|528650726|FG001|Overall Study|Other|1|||
146585920|NCT03525600|528650727|FG002|Overall Study|Other|0|||
146585921|NCT03525600|528650728|FG003|Overall Study|Other|0|||
146585922|NCT01923363|528650731|FG000|Overall Study|Protocol Violation|1|||
146585923|NCT00290771|528650732|FG000|Overall Study|Disease progression|95|||
146585924|NCT00290771|528650733|FG001|Overall Study|Disease progression|73|||
146585925|NCT00290771|528650732|FG000|Overall Study|Death|11|||
146585926|NCT00290771|528650733|FG001|Overall Study|Death|10|||
146585927|NCT00290771|528650732|FG000|Overall Study|Adverse Event|12|||
146585928|NCT00290771|528650733|FG001|Overall Study|Adverse Event|6|||
146585929|NCT00290771|528650732|FG000|Overall Study|Withdrawal by Subject|5|||
146585930|NCT00290771|528650733|FG001|Overall Study|Withdrawal by Subject|6|||
146585931|NCT00290771|528650732|FG000|Overall Study|Administrative problems|2|||
146585932|NCT00290771|528650733|FG001|Overall Study|Administrative problems|1|||
146585933|NCT00290771|528650732|FG000|Overall Study|Protocol Violation|2|||
146585934|NCT00290771|528650733|FG001|Overall Study|Protocol Violation|0|||
146585935|NCT00290771|528650732|FG000|Overall Study|Lost to Follow-up|0|||
146585936|NCT00290771|528650733|FG001|Overall Study|Lost to Follow-up|1|||
146585937|NCT05129449|528650734|FG000|Overall Study|Protocol Violation|1|||
146585938|NCT01818258|528650738|FG000|Overall Study|Death|3|||
146585939|NCT01818258|528650739|FG001|Overall Study|Death|0|||
146585940|NCT01818258|528650738|FG000|Overall Study|Withdrawal by Subject|0|||
146585941|NCT01818258|528650739|FG001|Overall Study|Withdrawal by Subject|1|||
146585942|NCT01818258|528650738|FG000|Overall Study|Lost to Follow-up|0|||
146585943|NCT01818258|528650739|FG001|Overall Study|Lost to Follow-up|1|||
146585944|NCT01818258|528650738|FG000|Overall Study|Unable to Travel to Clinic|0|||
146585945|NCT01818258|528650739|FG001|Overall Study|Unable to Travel to Clinic|1|||
146585946|NCT02099344|528650742|FG000|Overall Study|Physician Decision|1|||
146585947|NCT02099344|528650743|FG001|Overall Study|Physician Decision|0|||
146585948|NCT03802630|528650744|FG000|Overall Study|Study terminated by sponsor|130|||
146585949|NCT03802630|528650745|FG001|Overall Study|Study terminated by sponsor|134|||
146585950|NCT03802630|528650744|FG000|Overall Study|Subject decision|16|||
146585951|NCT03802630|528650745|FG001|Overall Study|Subject decision|9|||
146585952|NCT03802630|528650744|FG000|Overall Study|Adverse Event|3|||
146585953|NCT03802630|528650745|FG001|Overall Study|Adverse Event|1|||
146585954|NCT03802630|528650744|FG000|Overall Study|Lost to Follow-up|2|||
146585955|NCT03802630|528650745|FG001|Overall Study|Lost to Follow-up|2|||
146585956|NCT03802630|528650744|FG000|Overall Study|Physician Decision|2|||
146585957|NCT03802630|528650745|FG001|Overall Study|Physician Decision|0|||
146585958|NCT03802630|528650744|FG000|Overall Study|Death|0|||
146585959|NCT03802630|528650745|FG001|Overall Study|Death|2|||
146585960|NCT01221623|528650751|FG000|Overall Study|Withdrawal by Subject|19|||
146585961|NCT01221623|528650752|FG001|Overall Study|Withdrawal by Subject|8|||
146585962|NCT01221623|528650751|FG000|Overall Study|Lost to Follow-up|7|||
146585963|NCT01221623|528650752|FG001|Overall Study|Lost to Follow-up|1|||
146585964|NCT01221623|528650751|FG000|Overall Study|Adverse Event|6|||
146585965|NCT01221623|528650752|FG001|Overall Study|Adverse Event|3|||
146585966|NCT01221623|528650751|FG000|Overall Study|Death|1|||
146585967|NCT01221623|528650752|FG001|Overall Study|Death|0|||
146585968|NCT01221623|528650751|FG000|Overall Study|Other|5|||
146585969|NCT01221623|528650752|FG001|Overall Study|Other|2|||
146585970|NCT00661726|528650753|FG000|Overall Study|Adverse Event|1|||
146585971|NCT00780143|528650754|FG000|Overall Study|Progressive disease|1|||
146585972|NCT00780143|528650754|FG000|Overall Study|Toxicity|1|||
146585973|NCT00780143|528650754|FG000|Overall Study|Adverse Event|1|||
146585974|NCT02644096|528650755|FG000|Overall Study|Withdrawal by Subject|28|||
146585975|NCT02644096|528650756|FG001|Overall Study|Withdrawal by Subject|25|||
146585976|NCT00322452|528650757|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146585977|NCT00322452|528650758|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146652360|NCT03422627|528905215|FG000|Overall Study|Protocol-specified Criteria|1|||
146652361|NCT03422627|528905216|FG001|Overall Study|Protocol-specified Criteria|1|||
146652362|NCT03422627|528905217|FG002|Overall Study|Protocol-specified Criteria|0|||
146652363|NCT03422627|528905218|FG003|Overall Study|Protocol-specified Criteria|0|||
146652364|NCT03422627|528905219|FG004|Overall Study|Protocol-specified Criteria|2|||
146652365|NCT03422627|528905215|FG000|Overall Study|Requirement for Alternative Therapy|1|||
146652366|NCT03422627|528905216|FG001|Overall Study|Requirement for Alternative Therapy|1|||
146652367|NCT03422627|528905217|FG002|Overall Study|Requirement for Alternative Therapy|2|||
146585978|NCT00322452|528650757|FG000|Overall Study|Lost to Follow-up|5|||
146585979|NCT00322452|528650758|FG001|Overall Study|Lost to Follow-up|2|||
146585980|NCT00322452|528650757|FG000|Overall Study|Withdrawal by Subject|19|||
146585981|NCT00322452|528650758|FG001|Overall Study|Withdrawal by Subject|46|||
146585982|NCT00322452|528650757|FG000|Overall Study|Death|223|||
146585983|NCT00322452|528650758|FG001|Overall Study|Death|227|||
146585984|NCT00526656|528650759|FG000|Overall Study|Death|1|||
146585985|NCT00526656|528650759|FG000|Overall Study|Refused surgery|1|||
146585986|NCT04091581|528650760|FG000|Overall Study|Lost to Follow-up|0|||
146585987|NCT04091581|528650761|FG001|Overall Study|Lost to Follow-up|1|||
146585988|NCT02438384|528650762|FG000|Overall Study|Lost to Follow-up|8|||
146585989|NCT02438384|528650763|FG001|Overall Study|Lost to Follow-up|6|||
146585990|NCT02438384|528650764|FG002|Overall Study|Lost to Follow-up|4|||
146585991|NCT03319953|528650765|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
146585992|NCT03319953|528650766|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
146585993|NCT03319953|528650767|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
146585994|NCT03319953|528650768|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
146585995|NCT03319953|528650765|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
146585996|NCT03319953|528650766|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
146585997|NCT03319953|528650767|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
146585998|NCT03319953|528650768|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
146585999|NCT01795495|528650770|FG000|Overall Study|Protocol Violation|1|||
146586000|NCT01795495|528650771|FG001|Overall Study|Protocol Violation|0|||
146586001|NCT01795495|528650772|FG002|Overall Study|Protocol Violation|1|||
146586002|NCT01795495|528650770|FG000|Overall Study|Physician Decision|0|||
146586003|NCT01795495|528650771|FG001|Overall Study|Physician Decision|0|||
146586004|NCT01795495|528650772|FG002|Overall Study|Physician Decision|1|||
146586005|NCT03315793|528650773|FG000|Overall Study|Adverse Event|4|||
146586006|NCT03315793|528650774|FG001|Overall Study|Adverse Event|2|||
146586007|NCT03315793|528650773|FG000|Overall Study|Protocol Deviation|1|||
146586008|NCT03315793|528650774|FG001|Overall Study|Protocol Deviation|0|||
146586009|NCT03315793|528650773|FG000|Overall Study|Difficult for regular visit|0|||
146586010|NCT03315793|528650774|FG001|Overall Study|Difficult for regular visit|1|||
146586011|NCT00790868|528652805|FG000|Overall Study|Withdrawal by Subject|4|||
146586012|NCT00790868|528652806|FG001|Overall Study|Withdrawal by Subject|5|||
146586013|NCT00790868|528652805|FG000|Overall Study|Lost to Follow-up|2|||
146586014|NCT00790868|528652806|FG001|Overall Study|Lost to Follow-up|12|||
146586015|NCT01579565|528652807|FG000|Randomized|Adverse Event|1|||
146586016|NCT01579565|528652808|FG001|Randomized|Adverse Event|3|||
146586017|NCT01579565|528652807|FG000|Randomized|Withdrawal by Subject|3|||
146586018|NCT01579565|528652808|FG001|Randomized|Withdrawal by Subject|0|||
146586019|NCT01579565|528652807|FG000|Randomized|inadequate preoperative pupil dilation|0|||
146586020|NCT01579565|528652808|FG001|Randomized|inadequate preoperative pupil dilation|1|||
146586021|NCT01579565|528652807|FG000|Randomized|prohibited preoperative eating|1|||
146586022|NCT01579565|528652808|FG001|Randomized|prohibited preoperative eating|0|||
146586023|NCT01579565|528652807|FG000|Randomized|prohibited preoperative medication|0|||
146586024|NCT01579565|528652808|FG001|Randomized|prohibited preoperative medication|1|||
146586025|NCT01579565|528652807|FG000|Treated|Physician Decision|0|||
146586026|NCT01579565|528652808|FG001|Treated|Physician Decision|1|||
146586027|NCT01579565|528652807|FG000|Treated|Lost to Follow-up|2|||
146586028|NCT01579565|528652808|FG001|Treated|Lost to Follow-up|1|||
146586029|NCT01579565|528652807|FG000|Treated|declined to return for final visit|0|||
146586030|NCT01579565|528652808|FG001|Treated|declined to return for final visit|1|||
146586031|NCT02791191|528652809|FG000|Overall Study|Adverse Event|2|||
146586032|NCT02791191|528652810|FG001|Overall Study|Adverse Event|4|||
146586033|NCT02791191|528652811|FG002|Overall Study|Adverse Event|5|||
146586034|NCT02791191|528652809|FG000|Overall Study|Lack of Efficacy|0|||
146586035|NCT02791191|528652810|FG001|Overall Study|Lack of Efficacy|1|||
146586036|NCT02791191|528652811|FG002|Overall Study|Lack of Efficacy|0|||
146586037|NCT02791191|528652809|FG000|Overall Study|Study Drug Non-Compliance|0|||
146586038|NCT02791191|528652810|FG001|Overall Study|Study Drug Non-Compliance|2|||
146586039|NCT02791191|528652811|FG002|Overall Study|Study Drug Non-Compliance|0|||
146586040|NCT02791191|528652809|FG000|Overall Study|Site Closed by Sponsor|1|||
146586041|NCT02791191|528652810|FG001|Overall Study|Site Closed by Sponsor|1|||
146586042|NCT02791191|528652811|FG002|Overall Study|Site Closed by Sponsor|3|||
146586043|NCT02791191|528652809|FG000|Overall Study|Progressive Disease|1|||
146586044|NCT02791191|528652810|FG001|Overall Study|Progressive Disease|0|||
146586045|NCT02791191|528652811|FG002|Overall Study|Progressive Disease|0|||
146586046|NCT02791191|528652809|FG000|Overall Study|Study Terminated by Sponsor|29|||
146586047|NCT02791191|528652810|FG001|Overall Study|Study Terminated by Sponsor|101|||
146586048|NCT02791191|528652811|FG002|Overall Study|Study Terminated by Sponsor|109|||
146586049|NCT02791191|528652809|FG000|Overall Study|Withdrawal by Subject|3|||
146586050|NCT02791191|528652810|FG001|Overall Study|Withdrawal by Subject|1|||
146586051|NCT02791191|528652811|FG002|Overall Study|Withdrawal by Subject|3|||
146586052|NCT02791191|528652809|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
146586053|NCT02791191|528652810|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
146586054|NCT02791191|528652811|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
146586055|NCT02290691|528652814|FG000|Overall Study|Noncompliance|0|||
146586056|NCT02290691|528652815|FG001|Overall Study|Noncompliance|1|||
146586057|NCT02290691|528652814|FG000|Overall Study|Withdrawal by Subject|1|||
146586058|NCT02290691|528652815|FG001|Overall Study|Withdrawal by Subject|1|||
146586059|NCT02290691|528652814|FG000|Overall Study|Lost to Follow-up|7|||
146586060|NCT02290691|528652815|FG001|Overall Study|Lost to Follow-up|7|||
146586061|NCT00978380|528652816|FG000|Overall Study|Protocol Violation|2|||
146586062|NCT00978380|528652816|FG000|Overall Study|Withdrawal criteria|9|||
146586063|NCT00978380|528652816|FG000|Overall Study|Unclassified|8|||
146586064|NCT02199314|528652817|FG000|Overall Study|Withdrawal by Subject|6|||
146586065|NCT02199314|528652817|FG000|Overall Study|Physician Decision|10|||
146586066|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Adverse Event|76|||
146586067|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Adverse Event|0|||
146586068|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Adverse Event|0|||
146586069|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Death|3|||
146586070|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Death|0|||
146586071|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Death|0|||
146586072|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
146586073|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
146586074|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
146586075|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Physician Decision|9|||
146586076|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Physician Decision|0|||
146586077|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Physician Decision|0|||
146586078|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
146586079|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
146586080|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
146586081|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Disease progression|45|||
146586082|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Disease progression|0|||
146586083|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Disease progression|0|||
146586084|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
146586085|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
146586086|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
146586087|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
146586088|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
146586089|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
146586090|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
146586091|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
146586092|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
146586093|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
146918907|NCT01635933|529864539|FG000|Overall Study|Lost to Follow-up|0|||
146918908|NCT01635933|529864540|FG001|Overall Study|Lost to Follow-up|5|||
146918909|NCT01635933|529864539|FG000|Overall Study|Subject decision|1|||
146918910|NCT01635933|529864540|FG001|Overall Study|Subject decision|1|||
146918911|NCT01635933|529864539|FG000|Overall Study|Noncompliance|0|||
146918912|NCT01635933|529864540|FG001|Overall Study|Noncompliance|1|||
146586094|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
146586095|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
146586096|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
146586097|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
146586098|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
146586099|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
146586100|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
146586101|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
146652368|NCT03422627|528905218|FG003|Overall Study|Requirement for Alternative Therapy|0|||
146586102|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
146586103|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
146586104|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
146586105|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
146586106|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
146586107|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
146586108|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
146918913|NCT01635933|529864539|FG000|Overall Study|No longer had transportation|0|||
146586109|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
146586110|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
146586111|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Promotor request|1|||
146586112|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Promotor request|0|||
146586113|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Promotor request|0|||
146586114|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
146586115|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
146586116|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
146586117|NCT01461928|528652818|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
146586118|NCT01461928|528652819|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
146586119|NCT01461928|528652820|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
146586120|NCT01461928|528652818|FG000|Maintenance I (24 Months)|Death|3|||
146586121|NCT01461928|528652819|FG001|Maintenance I (24 Months)|Death|0|||
146586122|NCT01461928|528652820|FG002|Maintenance I (24 Months)|Death|0|||
146586123|NCT01461928|528652818|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
146586124|NCT01461928|528652819|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
146586125|NCT01461928|528652820|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
146586126|NCT01461928|528652818|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
146586127|NCT01461928|528652819|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
146586128|NCT01461928|528652820|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
146586129|NCT01461928|528652818|FG000|Maintenance I (24 Months)|Diseases progression|91|||
146586130|NCT01461928|528652819|FG001|Maintenance I (24 Months)|Diseases progression|0|||
146586131|NCT01461928|528652820|FG002|Maintenance I (24 Months)|Diseases progression|0|||
146586132|NCT01461928|528652818|FG000|Maintenance I (24 Months)|Adverse Event|70|||
146586133|NCT01461928|528652819|FG001|Maintenance I (24 Months)|Adverse Event|0|||
146586134|NCT01461928|528652820|FG002|Maintenance I (24 Months)|Adverse Event|0|||
146586135|NCT01461928|528652818|FG000|Maintenance I (24 Months)|Physician Decision|9|||
146586136|NCT01461928|528652819|FG001|Maintenance I (24 Months)|Physician Decision|0|||
146586137|NCT01461928|528652820|FG002|Maintenance I (24 Months)|Physician Decision|0|||
146586138|NCT01461928|528652818|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
146586139|NCT01461928|528652819|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
146586140|NCT01461928|528652820|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
146586141|NCT01461928|528652818|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
146586142|NCT01461928|528652819|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
146586143|NCT01461928|528652820|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
146586144|NCT01461928|528652818|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
146586145|NCT01461928|528652819|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
146586146|NCT01461928|528652820|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
146586147|NCT01461928|528652818|FG000|Maintenance I (24 Months)|Not compliant|1|||
146586148|NCT01461928|528652819|FG001|Maintenance I (24 Months)|Not compliant|0|||
146586149|NCT01461928|528652820|FG002|Maintenance I (24 Months)|Not compliant|0|||
146586150|NCT01461928|528652818|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
146586151|NCT01461928|528652819|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
146586152|NCT01461928|528652820|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
146586153|NCT01461928|528652818|FG000|Maintenance II (15 Months)|Adverse Event|0|||
146586154|NCT01461928|528652819|FG001|Maintenance II (15 Months)|Adverse Event|2|||
146586155|NCT01461928|528652820|FG002|Maintenance II (15 Months)|Adverse Event|0|||
146586156|NCT01461928|528652818|FG000|Maintenance II (15 Months)|Death|0|||
146586157|NCT01461928|528652819|FG001|Maintenance II (15 Months)|Death|10|||
146586158|NCT01461928|528652820|FG002|Maintenance II (15 Months)|Death|8|||
146586159|NCT01461928|528652818|FG000|Maintenance II (15 Months)|Physician Decision|0|||
146586160|NCT01461928|528652819|FG001|Maintenance II (15 Months)|Physician Decision|0|||
146586161|NCT01461928|528652820|FG002|Maintenance II (15 Months)|Physician Decision|4|||
146586162|NCT01461928|528652818|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
146586163|NCT01461928|528652819|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
146586164|NCT01461928|528652820|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
146586165|NCT01461928|528652818|FG000|Maintenance II (15 Months)|Moved to another town|0|||
146586166|NCT01461928|528652819|FG001|Maintenance II (15 Months)|Moved to another town|1|||
146586167|NCT01461928|528652820|FG002|Maintenance II (15 Months)|Moved to another town|0|||
146586168|NCT01461928|528652818|FG000|Maintenance II (15 Months)|Disease progression|0|||
146586169|NCT01461928|528652819|FG001|Maintenance II (15 Months)|Disease progression|0|||
146586170|NCT01461928|528652820|FG002|Maintenance II (15 Months)|Disease progression|3|||
146770886|NCT01170026|529329780|FG000|Overall Study|Lost to Follow-up|4|||
146586171|NCT01461928|528652818|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
146586172|NCT01461928|528652819|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
146586173|NCT01461928|528652820|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
146586174|NCT01461928|528652818|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
146586175|NCT01461928|528652819|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
146586176|NCT01461928|528652820|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
146586177|NCT01461928|528652818|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
146586178|NCT01461928|528652819|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
146586179|NCT01461928|528652820|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
146586180|NCT01461928|528652818|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
146586181|NCT01461928|528652819|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
146586182|NCT01461928|528652820|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
146586183|NCT01461928|528652818|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
146586184|NCT01461928|528652819|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
146586185|NCT01461928|528652820|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
146586186|NCT00664560|528652821|FG000|Overall Study|Adverse Event|19|||
146586187|NCT00664560|528652822|FG001|Overall Study|Adverse Event|16|||
146586188|NCT00664560|528652823|FG002|Overall Study|Adverse Event|7|||
146586189|NCT00664560|528652821|FG000|Overall Study|Withdrawal by Subject|9|||
146586190|NCT00664560|528652822|FG001|Overall Study|Withdrawal by Subject|13|||
146586191|NCT00664560|528652823|FG002|Overall Study|Withdrawal by Subject|7|||
146586192|NCT00664560|528652821|FG000|Overall Study|Lost to Follow-up|0|||
146586193|NCT00664560|528652822|FG001|Overall Study|Lost to Follow-up|2|||
146586194|NCT00664560|528652823|FG002|Overall Study|Lost to Follow-up|0|||
146586195|NCT00664560|528652821|FG000|Overall Study|Other|11|||
146586196|NCT00664560|528652822|FG001|Overall Study|Other|4|||
146586197|NCT00664560|528652823|FG002|Overall Study|Other|5|||
146586198|NCT01289353|528652824|FG000|Overall Study|Lost to Follow-up|2|||
146586199|NCT01549886|528652825|FG000|Overall Study|Sponsor's decision|2|||
146586200|NCT01549886|528652826|FG001|Overall Study|Sponsor's decision|3|||
146586201|NCT00473668|528652827|FG000|Overall Study|Withdrawal by Subject|0|||
146586202|NCT00473668|528652828|FG001|Overall Study|Withdrawal by Subject|2|||
146586203|NCT00473668|528652829|FG002|Overall Study|Withdrawal by Subject|0|||
146586204|NCT00473668|528652827|FG000|Overall Study|Migrated/moved from study area|3|||
146586205|NCT00473668|528652828|FG001|Overall Study|Migrated/moved from study area|2|||
146586206|NCT00473668|528652829|FG002|Overall Study|Migrated/moved from study area|0|||
146586207|NCT00473668|528652827|FG000|Overall Study|Lost to Follow-up|0|||
146586208|NCT00473668|528652828|FG001|Overall Study|Lost to Follow-up|4|||
146586209|NCT00473668|528652829|FG002|Overall Study|Lost to Follow-up|6|||
146586210|NCT00473668|528652827|FG000|Overall Study|Other|2|||
146586211|NCT00473668|528652828|FG001|Overall Study|Other|3|||
146586212|NCT00473668|528652829|FG002|Overall Study|Other|4|||
146586213|NCT04569136|528652830|FG000|Overall Study|Lost to Follow-up|2|||
146586214|NCT04569136|528652831|FG001|Overall Study|Lost to Follow-up|0|||
146586215|NCT04569136|528652832|FG002|Overall Study|Lost to Follow-up|1|||
146586216|NCT03576066|528652834|FG000|Overall Study|Noncompliance with study drug|0|||
146586217|NCT03576066|528652835|FG001|Overall Study|Noncompliance with study drug|1|||
146586218|NCT00006164|528652836|FG000|Overall Study|Withdrew or lost to follow-up|70|||
146586219|NCT00006164|528652837|FG001|Overall Study|Withdrew or lost to follow-up|81|||
146586220|NCT00223808|528652838|FG000|Overall Study|<5 hrs therapy before discharge|3|||
146586221|NCT00223808|528652839|FG001|Overall Study|<5 hrs therapy before discharge|5|||
146586222|NCT00223808|528652840|FG002|Overall Study|<5 hrs therapy before discharge|5|||
146586223|NCT00365105|528652841|FG000|Overall Study|Protocol Violation|5|||
146586224|NCT00365105|528652842|FG001|Overall Study|Protocol Violation|8|||
146586225|NCT00191724|528652845|FG000|Overall Study|Adverse Event|0|||
146586226|NCT00191724|528652846|FG001|Overall Study|Adverse Event|0|||
146586227|NCT00191724|528652847|FG002|Overall Study|Adverse Event|1|||
146586228|NCT00191724|528652848|FG003|Overall Study|Adverse Event|0|||
146586229|NCT00191724|528652849|FG004|Overall Study|Adverse Event|0|||
146586230|NCT00191724|528652845|FG000|Overall Study|Lost to Follow-up|1|||
146586231|NCT00191724|528652846|FG001|Overall Study|Lost to Follow-up|1|||
146586232|NCT00191724|528652847|FG002|Overall Study|Lost to Follow-up|0|||
146586233|NCT00191724|528652848|FG003|Overall Study|Lost to Follow-up|2|||
146586234|NCT00191724|528652849|FG004|Overall Study|Lost to Follow-up|3|||
146918914|NCT01635933|529864540|FG001|Overall Study|No longer had transportation|1|||
146918915|NCT01544595|529864541|FG000|Status at Week 68|Adverse Event|3|||
146586235|NCT00191724|528652845|FG000|Overall Study|Withdrawal by Subject|0|||
146586236|NCT00191724|528652846|FG001|Overall Study|Withdrawal by Subject|0|||
146586237|NCT00191724|528652847|FG002|Overall Study|Withdrawal by Subject|0|||
146586238|NCT00191724|528652848|FG003|Overall Study|Withdrawal by Subject|1|||
146586239|NCT00191724|528652849|FG004|Overall Study|Withdrawal by Subject|0|||
146586240|NCT06422364|528652850|FG000|Overall Study|Withdrawn due to study closure|0|||
146586241|NCT06422364|528652851|FG001|Overall Study|Withdrawn due to study closure|2|||
146586242|NCT05260073|528652853|FG000|Overall Study|Physician Decision|1|||
146586243|NCT05260073|528652853|FG000|Overall Study|Withdrawal by Subject|6|||
146586244|NCT05260073|528652853|FG000|Overall Study|Lost to Follow-up|14|||
146586245|NCT03458910|528652854|FG000|Overall Study|Withdrawal by Subject|7|||
146586246|NCT03458910|528652855|FG001|Overall Study|Withdrawal by Subject|8|||
146586247|NCT03458910|528652856|FG002|Overall Study|Withdrawal by Subject|6|||
146586248|NCT03458910|528652857|FG003|Overall Study|Withdrawal by Subject|4|||
146770887|NCT01170026|529329781|FG001|Overall Study|Lost to Follow-up|2|||
146918916|NCT01544595|529864542|FG001|Status at Week 68|Adverse Event|2|||
146586249|NCT03458910|528652854|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
146586250|NCT03458910|528652855|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
146586251|NCT03458910|528652856|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
146586252|NCT03458910|528652857|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
146586253|NCT06004895|528652858|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
146586254|NCT06004895|528652858|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
146586255|NCT01463696|528652867|FG000|Overall Study|Adverse Event|0|||
146586256|NCT01463696|528652868|FG001|Overall Study|Adverse Event|1|||
146586257|NCT01463696|528652869|FG002|Overall Study|Adverse Event|0|||
146586258|NCT01463696|528652870|FG003|Overall Study|Adverse Event|2|||
146586259|NCT01463696|528652871|FG004|Overall Study|Adverse Event|0|||
146586260|NCT01463696|528652872|FG005|Overall Study|Adverse Event|1|||
146918917|NCT01544595|529864543|FG002|Status at Week 68|Adverse Event|1|||
146918918|NCT01544595|529864544|FG003|Status at Week 68|Adverse Event|0|||
146586261|NCT01463696|528652873|FG006|Overall Study|Adverse Event|3|||
146586262|NCT01463696|528652874|FG007|Overall Study|Adverse Event|2|||
146586263|NCT01463696|528652867|FG000|Overall Study|Lost to Follow-up|0|||
146586264|NCT01463696|528652868|FG001|Overall Study|Lost to Follow-up|0|||
146586265|NCT01463696|528652869|FG002|Overall Study|Lost to Follow-up|1|||
146586266|NCT01463696|528652870|FG003|Overall Study|Lost to Follow-up|0|||
146586267|NCT01463696|528652871|FG004|Overall Study|Lost to Follow-up|0|||
146586268|NCT01463696|528652872|FG005|Overall Study|Lost to Follow-up|0|||
146586269|NCT01463696|528652873|FG006|Overall Study|Lost to Follow-up|0|||
146586270|NCT01463696|528652874|FG007|Overall Study|Lost to Follow-up|0|||
146586271|NCT01463696|528652867|FG000|Overall Study|Progressive Disease|0|||
146586272|NCT01463696|528652868|FG001|Overall Study|Progressive Disease|1|||
146586273|NCT01463696|528652869|FG002|Overall Study|Progressive Disease|0|||
146586274|NCT01463696|528652870|FG003|Overall Study|Progressive Disease|1|||
146586275|NCT01463696|528652871|FG004|Overall Study|Progressive Disease|0|||
146586276|NCT01463696|528652872|FG005|Overall Study|Progressive Disease|1|||
146586277|NCT01463696|528652873|FG006|Overall Study|Progressive Disease|4|||
146586278|NCT01463696|528652874|FG007|Overall Study|Progressive Disease|2|||
146586279|NCT01463696|528652867|FG000|Overall Study|Withdrawal by Subject|0|||
146586280|NCT01463696|528652868|FG001|Overall Study|Withdrawal by Subject|0|||
146586281|NCT01463696|528652869|FG002|Overall Study|Withdrawal by Subject|0|||
146586282|NCT01463696|528652870|FG003|Overall Study|Withdrawal by Subject|1|||
146586283|NCT01463696|528652871|FG004|Overall Study|Withdrawal by Subject|1|||
146586284|NCT01463696|528652872|FG005|Overall Study|Withdrawal by Subject|1|||
146586285|NCT01463696|528652873|FG006|Overall Study|Withdrawal by Subject|2|||
146586286|NCT01463696|528652874|FG007|Overall Study|Withdrawal by Subject|0|||
146586287|NCT01463696|528652867|FG000|Overall Study|Not Treated|0|||
146586288|NCT01463696|528652868|FG001|Overall Study|Not Treated|0|||
146586289|NCT01463696|528652869|FG002|Overall Study|Not Treated|0|||
146586290|NCT01463696|528652870|FG003|Overall Study|Not Treated|0|||
146586291|NCT01463696|528652871|FG004|Overall Study|Not Treated|0|||
146586292|NCT01463696|528652872|FG005|Overall Study|Not Treated|0|||
146586293|NCT01463696|528652873|FG006|Overall Study|Not Treated|1|||
146586294|NCT01463696|528652874|FG007|Overall Study|Not Treated|0|||
146586295|NCT00967694|528652876|FG000|Overall Study|Withdrawal by Subject|6|||
146586296|NCT00152477|528652879|FG000|Chemotherapy Period|Adverse Event|9|||
146586297|NCT00152477|528652880|FG001|Chemotherapy Period|Adverse Event|4|||
146586298|NCT00152477|528652881|FG002|Chemotherapy Period|Adverse Event|5|||
146586299|NCT00152477|528652879|FG000|Chemotherapy Period|Death|1|||
146586300|NCT00152477|528652880|FG001|Chemotherapy Period|Death|3|||
146586301|NCT00152477|528652881|FG002|Chemotherapy Period|Death|3|||
146586302|NCT00152477|528652879|FG000|Chemotherapy Period|Lack of Efficacy|4|||
146586303|NCT00152477|528652880|FG001|Chemotherapy Period|Lack of Efficacy|5|||
146586304|NCT00152477|528652881|FG002|Chemotherapy Period|Lack of Efficacy|6|||
146586305|NCT00152477|528652879|FG000|Chemotherapy Period|Lost to Follow-up|1|||
146652369|NCT03422627|528905219|FG004|Overall Study|Requirement for Alternative Therapy|0|||
146918919|NCT01544595|529864545|FG004|Status at Week 68|Adverse Event|0|||
146918920|NCT01544595|529864546|FG005|Status at Week 68|Adverse Event|0|||
146918921|NCT01544595|529864541|FG000|Status at Week 68|Lack of Efficacy|1|||
146586306|NCT00152477|528652880|FG001|Chemotherapy Period|Lost to Follow-up|0|||
146586307|NCT00152477|528652881|FG002|Chemotherapy Period|Lost to Follow-up|1|||
146586308|NCT00152477|528652879|FG000|Chemotherapy Period|Protocol Violation|1|||
146586309|NCT00152477|528652880|FG001|Chemotherapy Period|Protocol Violation|1|||
146586310|NCT00152477|528652881|FG002|Chemotherapy Period|Protocol Violation|0|||
146586311|NCT00152477|528652879|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
146586312|NCT00152477|528652880|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
146586313|NCT00152477|528652881|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
146586314|NCT00152477|528652879|FG000|Chemotherapy Period|Progression of Disease|6|||
146586315|NCT00152477|528652880|FG001|Chemotherapy Period|Progression of Disease|8|||
146586316|NCT00152477|528652881|FG002|Chemotherapy Period|Progression of Disease|4|||
146918922|NCT01544595|529864542|FG001|Status at Week 68|Lack of Efficacy|0|||
146918923|NCT01544595|529864543|FG002|Status at Week 68|Lack of Efficacy|0|||
146918924|NCT01544595|529864544|FG003|Status at Week 68|Lack of Efficacy|0|||
146586317|NCT00152477|528652879|FG000|Chemotherapy Period|Investigator decision|0|||
146586318|NCT00152477|528652880|FG001|Chemotherapy Period|Investigator decision|0|||
146586319|NCT00152477|528652881|FG002|Chemotherapy Period|Investigator decision|1|||
146586320|NCT00152477|528652879|FG000|Chemotherapy Period|Patient condition worsened|1|||
146586321|NCT00152477|528652880|FG001|Chemotherapy Period|Patient condition worsened|0|||
146586322|NCT00152477|528652881|FG002|Chemotherapy Period|Patient condition worsened|0|||
146586323|NCT00152477|528652879|FG000|Monotherapy Period|Adverse Event|1|||
146586324|NCT00152477|528652880|FG001|Monotherapy Period|Adverse Event|0|||
146586325|NCT00152477|528652881|FG002|Monotherapy Period|Adverse Event|5|||
146586326|NCT00152477|528652879|FG000|Monotherapy Period|Death|2|||
146586327|NCT00152477|528652880|FG001|Monotherapy Period|Death|0|||
146586328|NCT00152477|528652881|FG002|Monotherapy Period|Death|1|||
146586329|NCT00152477|528652879|FG000|Monotherapy Period|Lack of Efficacy|7|||
146586330|NCT00152477|528652880|FG001|Monotherapy Period|Lack of Efficacy|16|||
146586331|NCT00152477|528652881|FG002|Monotherapy Period|Lack of Efficacy|10|||
146586332|NCT00152477|528652879|FG000|Monotherapy Period|Protocol Violation|0|||
146586333|NCT00152477|528652880|FG001|Monotherapy Period|Protocol Violation|1|||
146586334|NCT00152477|528652881|FG002|Monotherapy Period|Protocol Violation|0|||
146586335|NCT00152477|528652879|FG000|Monotherapy Period|Withdrawal by Subject|0|||
146586336|NCT00152477|528652880|FG001|Monotherapy Period|Withdrawal by Subject|0|||
146586337|NCT00152477|528652881|FG002|Monotherapy Period|Withdrawal by Subject|4|||
146586338|NCT00152477|528652879|FG000|Monotherapy Period|Progression of Disease|5|||
146770888|NCT03785782|529329793|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
146770889|NCT03785782|529329794|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
146770890|NCT03785782|529329793|FG000|Overall Study|Withdrawal by Subject|1|||
146770891|NCT03785782|529329794|FG001|Overall Study|Withdrawal by Subject|1|||
146770892|NCT03785782|529329793|FG000|Overall Study|insufficient image quality.|3|||
146770893|NCT03785782|529329794|FG001|Overall Study|insufficient image quality.|0|||
146770894|NCT03889925|529329795|FG000|Overall Study|Lost to Follow-up|11|||
146770895|NCT03889925|529329796|FG001|Overall Study|Lost to Follow-up|10|||
146770896|NCT00304031|529329798|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
146770897|NCT00304031|529329799|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
146770898|NCT00304031|529329800|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
146770899|NCT00304031|529329798|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
146770900|NCT00304031|529329799|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
146770901|NCT00304031|529329800|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
146770902|NCT00304031|529329798|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
146770903|NCT00304031|529329799|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
146770904|NCT00304031|529329800|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
146770905|NCT00304031|529329798|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
146770906|NCT00304031|529329799|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
146770907|NCT00304031|529329800|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
146770908|NCT00304031|529329798|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
146770909|NCT00304031|529329799|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
146770910|NCT00304031|529329800|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
146770911|NCT00304031|529329798|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
146770912|NCT00304031|529329799|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
146770913|NCT00304031|529329800|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
146770914|NCT00304031|529329798|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
146770915|NCT00304031|529329799|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
146770916|NCT00304031|529329800|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
146770917|NCT00304031|529329798|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
146770918|NCT00304031|529329799|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
146770919|NCT00304031|529329800|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
146770920|NCT00304031|529329798|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
146770921|NCT00304031|529329799|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
146770922|NCT00304031|529329800|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
146770923|NCT00493649|529329801|FG000|Overall Study|Adverse Event|44|||
146770924|NCT00493649|529329801|FG000|Overall Study|Patient Request|21|||
146770925|NCT00493649|529329801|FG000|Overall Study|Investigator Request|2|||
146770926|NCT00493649|529329801|FG000|Overall Study|Disease Progression|1|||
146770927|NCT00493649|529329801|FG000|Overall Study|Lost to Follow-up|1|||
146770928|NCT00493649|529329801|FG000|Overall Study|Other|13|||
146586339|NCT00152477|528652880|FG001|Monotherapy Period|Progression of Disease|11|||
146586340|NCT00152477|528652881|FG002|Monotherapy Period|Progression of Disease|12|||
146586341|NCT00152477|528652879|FG000|Monotherapy Period|Patient decision|0|||
146586342|NCT00152477|528652880|FG001|Monotherapy Period|Patient decision|1|||
146586343|NCT00152477|528652881|FG002|Monotherapy Period|Patient decision|1|||
146586344|NCT00152477|528652879|FG000|Monotherapy Period|Study personel decision|0|||
146586345|NCT00152477|528652880|FG001|Monotherapy Period|Study personel decision|0|||
146978317|NCT00382291|530084002|FG002|Overall Study|Protocol Violation|0|||
146586346|NCT00152477|528652881|FG002|Monotherapy Period|Study personel decision|1|||
146586347|NCT00425698|528652882|FG000|Overall Study|Adverse Event|3|||
146586348|NCT00425698|528652883|FG001|Overall Study|Adverse Event|1|||
146586349|NCT00425698|528652882|FG000|Overall Study|Withdrawal by Subject|0|||
146586350|NCT00425698|528652883|FG001|Overall Study|Withdrawal by Subject|1|||
146586351|NCT03905265|528652891|FG000|Overall Study|Withdrawal by Subject|1|||
146586352|NCT03905265|528652892|FG001|Overall Study|Withdrawal by Subject|1|||
146586353|NCT03905265|528652893|FG002|Overall Study|Withdrawal by Subject|0|||
146586354|NCT03905265|528652894|FG003|Overall Study|Withdrawal by Subject|0|||
146586355|NCT00960011|528652895|FG000|Overall Study|Death|5|||
146586356|NCT00960011|528652896|FG001|Overall Study|Death|0|||
146586357|NCT00960011|528652895|FG000|Overall Study|Lost to Follow-up|6|||
146586358|NCT00960011|528652896|FG001|Overall Study|Lost to Follow-up|2|||
146586359|NCT00758264|528652897|FG000|Active Phase|Withdrawal by Subject|0|||
146586360|NCT00758264|528652898|FG001|Active Phase|Withdrawal by Subject|0|||
146586361|NCT00758264|528652899|FG002|Active Phase|Withdrawal by Subject|1|||
146586362|NCT00758264|528652897|FG000|Active Phase|Lost to Follow-up|1|||
146586363|NCT00758264|528652898|FG001|Active Phase|Lost to Follow-up|0|||
146586364|NCT00758264|528652899|FG002|Active Phase|Lost to Follow-up|0|||
146586365|NCT00758264|528652897|FG000|Active Phase|Other|0|||
146586366|NCT00758264|528652898|FG001|Active Phase|Other|0|||
146586367|NCT00758264|528652899|FG002|Active Phase|Other|4|||
146586368|NCT00889603|528652900|FG000|Overall Study|Adverse Event|7|||
146586369|NCT00889603|528652900|FG000|Overall Study|Death|3|||
146586370|NCT00889603|528652900|FG000|Overall Study|Lost to Follow-up|19|||
146586371|NCT00889603|528652900|FG000|Overall Study|No longer willing to participant in stud|4|||
146586372|NCT00889603|528652900|FG000|Overall Study|Other|4|||
146586373|NCT02901054|528652906|FG000|Overall Study|Physician Decision|1|||
146586374|NCT02901054|528652906|FG000|Overall Study|Withdrawal by Subject|3|||
146586375|NCT00616018|528652907|FG000|Overall Study|Protocol Violation|3|||
146586376|NCT03718884|528652908|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
146586377|NCT03718884|528652909|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
146586378|NCT03718884|528652908|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
146586379|NCT03718884|528652909|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
146586380|NCT02839720|528652911|FG000|Overall Study|Adverse Event|2|||
146586381|NCT02839720|528652911|FG000|Overall Study|Non-compliance|2|||
146586382|NCT02839720|528652911|FG000|Overall Study|Intercurrent Illness|1|||
146586383|NCT02839720|528652911|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
146586384|NCT05248997|528652914|FG000|Overall Study|Lost to Follow-up|1|||
146586385|NCT05248997|528652915|FG001|Overall Study|Lost to Follow-up|1|||
146586386|NCT05248997|528652914|FG000|Overall Study|Randomized but not treated|32|||
146586387|NCT05248997|528652915|FG001|Overall Study|Randomized but not treated|25|||
146586388|NCT05593913|528652916|FG000|Overall Study|Insufficient image quality|39|||
146586389|NCT01453205|528652917|FG000|Overall Study|Lost to Follow-up|3|||
146586390|NCT01453205|528652918|FG001|Overall Study|Lost to Follow-up|0|||
146586391|NCT01453205|528652919|FG002|Overall Study|Lost to Follow-up|1|||
146586392|NCT01453205|528652917|FG000|Overall Study|Withdrawal by Subject|8|||
146586393|NCT01453205|528652918|FG001|Overall Study|Withdrawal by Subject|3|||
146586394|NCT01453205|528652919|FG002|Overall Study|Withdrawal by Subject|0|||
146586395|NCT01453205|528652917|FG000|Overall Study|Death|24|||
146586396|NCT01453205|528652918|FG001|Overall Study|Death|22|||
146586397|NCT01453205|528652919|FG002|Overall Study|Death|18|||
146586398|NCT01453205|528652917|FG000|Overall Study|Other|45|||
146586399|NCT01453205|528652918|FG001|Overall Study|Other|27|||
146586400|NCT01453205|528652919|FG002|Overall Study|Other|35|||
146586401|NCT02602275|528652920|FG000|Day 1|Physician Decision|0|||
146586402|NCT02602275|528652921|FG001|Day 1|Physician Decision|1|||
146586403|NCT04113018|528652928|FG000|Overall Study|Death|2|||
146586404|NCT04113018|528652928|FG000|Overall Study|Lost to Follow-up|1|||
146586405|NCT04113018|528652928|FG000|Overall Study|Still On Study (on study treatment)|24|||
146978318|NCT00382291|530084000|FG000|Overall Study|Temporary study suspension|2|||
146586406|NCT04113018|528652928|FG000|Overall Study|Still On Study (in follow up)|12|||
146586407|NCT05005013|528652929|FG000|Overall Study|Withdrawal by Subject|5|||
146586408|NCT05005013|528652930|FG001|Overall Study|Withdrawal by Subject|1|||
146586409|NCT05005013|528652929|FG000|Overall Study|Lost to Follow-up|3|||
146586410|NCT05005013|528652930|FG001|Overall Study|Lost to Follow-up|1|||
146586411|NCT05005013|528652929|FG000|Overall Study|Ineligibility|1|||
146586412|NCT05005013|528652930|FG001|Overall Study|Ineligibility|1|||
146586413|NCT02059499|528652931|FG000|Upto Week 20|Lost to Follow-up|2|||
146586414|NCT02059499|528652932|FG001|Upto Week 20|Lost to Follow-up|6|||
146586415|NCT02059499|528652933|FG002|Upto Week 20|Lost to Follow-up|0|||
146586416|NCT02059499|528652931|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
146586417|NCT02059499|528652932|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
146586418|NCT02059499|528652933|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
146586419|NCT02059499|528652931|FG000|Upto Week 20|Withdrawal by Subject|1|||
146586420|NCT02059499|528652932|FG001|Upto Week 20|Withdrawal by Subject|1|||
146586421|NCT02059499|528652933|FG002|Upto Week 20|Withdrawal by Subject|0|||
146978319|NCT00382291|530084001|FG001|Overall Study|Temporary study suspension|2|||
146586422|NCT02059499|528652931|FG000|Upto Week 20|No treatment per protocol criteria|0|||
146586423|NCT02059499|528652932|FG001|Upto Week 20|No treatment per protocol criteria|0|||
146586424|NCT02059499|528652933|FG002|Upto Week 20|No treatment per protocol criteria|5|||
146586425|NCT02059499|528652931|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
146586426|NCT02059499|528652932|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
146586427|NCT02059499|528652933|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
146586428|NCT02059499|528652931|FG000|Post-week 20|Lost to Follow-up|0|||
146586429|NCT02059499|528652932|FG001|Post-week 20|Lost to Follow-up|2|||
146586430|NCT02059499|528652933|FG002|Post-week 20|Lost to Follow-up|0|||
146586431|NCT02059499|528652931|FG000|Post-week 20|Withdrawal by Subject|0|||
146586432|NCT02059499|528652932|FG001|Post-week 20|Withdrawal by Subject|1|||
146586433|NCT02059499|528652933|FG002|Post-week 20|Withdrawal by Subject|0|||
146586434|NCT02059499|528652931|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
146586435|NCT02059499|528652932|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
146586436|NCT02059499|528652933|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
146586437|NCT04210245|528652934|FG000|Overall Study|Adverse Event|0|||
146586438|NCT04210245|528652935|FG001|Overall Study|Adverse Event|3|||
146586439|NCT04210245|528652936|FG002|Overall Study|Adverse Event|6|||
146586440|NCT04210245|528652937|FG003|Overall Study|Adverse Event|0|||
146586441|NCT04210245|528652934|FG000|Overall Study|Withdrawal by Subject|0|||
146586442|NCT04210245|528652935|FG001|Overall Study|Withdrawal by Subject|1|||
146586443|NCT04210245|528652936|FG002|Overall Study|Withdrawal by Subject|4|||
146586444|NCT04210245|528652937|FG003|Overall Study|Withdrawal by Subject|4|||
146586445|NCT04210245|528652934|FG000|Overall Study|Lost to Follow-up|0|||
146586446|NCT04210245|528652935|FG001|Overall Study|Lost to Follow-up|1|||
146586447|NCT04210245|528652936|FG002|Overall Study|Lost to Follow-up|1|||
146586448|NCT04210245|528652937|FG003|Overall Study|Lost to Follow-up|1|||
146586449|NCT04210245|528652934|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
146586450|NCT04210245|528652935|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
146586451|NCT04210245|528652936|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
146586452|NCT04210245|528652937|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
146586453|NCT06099223|528652938|FG000|Overall Study|Preoperative surveys missed|0|||
146586454|NCT06099223|528652939|FG001|Overall Study|Preoperative surveys missed|1|||
146586455|NCT02248649|528652940|FG000|Overall Study|Death|7|||
146586456|NCT02248649|528652941|FG001|Overall Study|Death|11|||
146586457|NCT02248649|528652940|FG000|Overall Study|Lost to Follow-up|14|||
146586458|NCT02248649|528652941|FG001|Overall Study|Lost to Follow-up|10|||
146586459|NCT01202188|528652950|FG000|Overall Study|Protocol deviation|14|||
146586460|NCT01202188|528652951|FG001|Overall Study|Protocol deviation|8|||
146586461|NCT01202188|528652952|FG002|Overall Study|Protocol deviation|12|||
146586462|NCT01202188|528652953|FG003|Overall Study|Protocol deviation|10|||
146586463|NCT01202188|528652954|FG004|Overall Study|Protocol deviation|11|||
146586464|NCT01202188|528652950|FG000|Overall Study|Subject withdrew consent|12|||
146586465|NCT01202188|528652951|FG001|Overall Study|Subject withdrew consent|13|||
146586466|NCT01202188|528652952|FG002|Overall Study|Subject withdrew consent|22|||
146586467|NCT01202188|528652953|FG003|Overall Study|Subject withdrew consent|11|||
146586468|NCT01202188|528652954|FG004|Overall Study|Subject withdrew consent|13|||
146586469|NCT01202188|528652950|FG000|Overall Study|Adverse Event|5|||
146586470|NCT01202188|528652951|FG001|Overall Study|Adverse Event|23|||
146586471|NCT01202188|528652952|FG002|Overall Study|Adverse Event|13|||
146586472|NCT01202188|528652953|FG003|Overall Study|Adverse Event|10|||
146586473|NCT01202188|528652954|FG004|Overall Study|Adverse Event|10|||
146586474|NCT01202188|528652950|FG000|Overall Study|Administrative problems|3|||
146586475|NCT01202188|528652951|FG001|Overall Study|Administrative problems|2|||
146586476|NCT01202188|528652952|FG002|Overall Study|Administrative problems|1|||
146586477|NCT01202188|528652953|FG003|Overall Study|Administrative problems|1|||
146918925|NCT01544595|529864545|FG004|Status at Week 68|Lack of Efficacy|0|||
146918926|NCT01544595|529864546|FG005|Status at Week 68|Lack of Efficacy|0|||
146918927|NCT01544595|529864541|FG000|Status at Week 68|Lost to Follow-up|1|||
146918928|NCT01544595|529864542|FG001|Status at Week 68|Lost to Follow-up|1|||
146918929|NCT01544595|529864543|FG002|Status at Week 68|Lost to Follow-up|0|||
146918930|NCT01544595|529864544|FG003|Status at Week 68|Lost to Follow-up|0|||
146918931|NCT01544595|529864545|FG004|Status at Week 68|Lost to Follow-up|0|||
146918932|NCT01544595|529864546|FG005|Status at Week 68|Lost to Follow-up|0|||
146918933|NCT01544595|529864541|FG000|Status at Week 68|Non-compliance with study treatment|1|||
146586478|NCT01202188|528652954|FG004|Overall Study|Administrative problems|2|||
146586479|NCT01202188|528652950|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146586480|NCT01202188|528652951|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
146586481|NCT01202188|528652952|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
146586482|NCT01202188|528652953|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
146586483|NCT01202188|528652954|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
146586484|NCT01202188|528652950|FG000|Overall Study|Lost to Follow-up|1|||
146918934|NCT01544595|529864542|FG001|Status at Week 68|Non-compliance with study treatment|0|||
146586485|NCT01202188|528652951|FG001|Overall Study|Lost to Follow-up|1|||
146586486|NCT01202188|528652952|FG002|Overall Study|Lost to Follow-up|0|||
146586487|NCT01202188|528652953|FG003|Overall Study|Lost to Follow-up|4|||
146586488|NCT01202188|528652954|FG004|Overall Study|Lost to Follow-up|1|||
146586489|NCT01202188|528652950|FG000|Overall Study|Death|1|||
146586490|NCT01202188|528652951|FG001|Overall Study|Death|1|||
146586491|NCT01202188|528652952|FG002|Overall Study|Death|1|||
146586492|NCT01202188|528652953|FG003|Overall Study|Death|1|||
146586493|NCT01202188|528652954|FG004|Overall Study|Death|0|||
146586494|NCT01202188|528652950|FG000|Overall Study|Abnormal test procedure result (s)|0|||
146586495|NCT01202188|528652951|FG001|Overall Study|Abnormal test procedure result (s)|0|||
146586496|NCT01202188|528652952|FG002|Overall Study|Abnormal test procedure result (s)|2|||
146586497|NCT01202188|528652953|FG003|Overall Study|Abnormal test procedure result (s)|0|||
146586498|NCT01202188|528652954|FG004|Overall Study|Abnormal test procedure result (s)|0|||
146586499|NCT00487942|528652955|FG000|Overall Study|Adverse Event|1|||
146586500|NCT00487942|528652956|FG001|Overall Study|Adverse Event|1|||
146586501|NCT00487942|528652957|FG002|Overall Study|Adverse Event|1|||
146586502|NCT00487942|528652958|FG003|Overall Study|Adverse Event|1|||
146586503|NCT00487942|528652955|FG000|Overall Study|Lost to Follow-up|1|||
146586504|NCT00487942|528652956|FG001|Overall Study|Lost to Follow-up|0|||
146586505|NCT00487942|528652957|FG002|Overall Study|Lost to Follow-up|0|||
146586506|NCT00487942|528652958|FG003|Overall Study|Lost to Follow-up|1|||
146586507|NCT00487942|528652955|FG000|Overall Study|Protocol Violation|1|||
146586508|NCT00487942|528652956|FG001|Overall Study|Protocol Violation|1|||
146586509|NCT00487942|528652957|FG002|Overall Study|Protocol Violation|0|||
146586510|NCT00487942|528652958|FG003|Overall Study|Protocol Violation|0|||
146586511|NCT00487942|528652955|FG000|Overall Study|Withdrawal by Subject|0|||
146586512|NCT00487942|528652956|FG001|Overall Study|Withdrawal by Subject|1|||
146586513|NCT00487942|528652957|FG002|Overall Study|Withdrawal by Subject|2|||
146586514|NCT00487942|528652958|FG003|Overall Study|Withdrawal by Subject|0|||
146586515|NCT00211757|528652959|FG000|Overall Study|Withdrawal by Subject|1|||
146586516|NCT00211757|528652960|FG001|Overall Study|Withdrawal by Subject|1|||
146586517|NCT00211757|528652959|FG000|Overall Study|Lack of Efficacy|0|||
146586518|NCT00211757|528652960|FG001|Overall Study|Lack of Efficacy|1|||
146586519|NCT02461290|528652964|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
146586520|NCT02461290|528652964|FG000|Overall Study|Lost to Follow-up|3|||
146586521|NCT01457014|528652965|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
146586522|NCT01457014|528652966|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
146586523|NCT01457014|528652967|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
146586524|NCT01457014|528652968|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
146586525|NCT01457014|528652965|FG000|First Night|Withdrawal by Subject|3|||
146586526|NCT01457014|528652966|FG001|First Night|Withdrawal by Subject|0|||
146586527|NCT01457014|528652967|FG002|First Night|Withdrawal by Subject|0|||
146586528|NCT01457014|528652968|FG003|First Night|Withdrawal by Subject|0|||
146586529|NCT04027049|528652969|FG000|Overall Study|Withdrawn by family|1|||
146586530|NCT04027049|528652970|FG001|Overall Study|Withdrawn by family|0|||
146586531|NCT04027049|528652969|FG000|Overall Study|Participant safety|1|||
146586532|NCT04027049|528652970|FG001|Overall Study|Participant safety|0|||
146586533|NCT02650128|528652971|FG000|Overall Study|Death|2|||
146586534|NCT00218634|528654389|FG000|Overall Study|Lost to Follow-up|8|||
146586535|NCT00218634|528654390|FG001|Overall Study|Lost to Follow-up|15|||
146586536|NCT00734604|528654391|FG000|Overall Study|Adverse Event|0|||
146586537|NCT00734604|528654392|FG001|Overall Study|Adverse Event|2|||
146586538|NCT00734604|528654393|FG002|Overall Study|Adverse Event|0|||
146586539|NCT00734604|528654394|FG003|Overall Study|Adverse Event|2|||
146586540|NCT00734604|528654395|FG004|Overall Study|Adverse Event|1|||
146586541|NCT00734604|528654396|FG005|Overall Study|Adverse Event|1|||
146586542|NCT00734604|528654391|FG000|Overall Study|Serious Adverse Event|1|||
146586543|NCT00734604|528654392|FG001|Overall Study|Serious Adverse Event|0|||
146586544|NCT00734604|528654393|FG002|Overall Study|Serious Adverse Event|1|||
146586545|NCT00734604|528654394|FG003|Overall Study|Serious Adverse Event|2|||
146918935|NCT01544595|529864543|FG002|Status at Week 68|Non-compliance with study treatment|0|||
146918936|NCT01544595|529864544|FG003|Status at Week 68|Non-compliance with study treatment|1|||
146918937|NCT01544595|529864545|FG004|Status at Week 68|Non-compliance with study treatment|0|||
146918938|NCT01544595|529864546|FG005|Status at Week 68|Non-compliance with study treatment|0|||
146918939|NCT01544595|529864541|FG000|Status at Week 68|Protocol Violation|2|||
146918940|NCT01544595|529864542|FG001|Status at Week 68|Protocol Violation|0|||
146586546|NCT00734604|528654395|FG004|Overall Study|Serious Adverse Event|0|||
146586547|NCT00734604|528654396|FG005|Overall Study|Serious Adverse Event|1|||
146586548|NCT00734604|528654391|FG000|Overall Study|Lost to Follow-up|1|||
146586549|NCT00734604|528654392|FG001|Overall Study|Lost to Follow-up|2|||
146586550|NCT00734604|528654393|FG002|Overall Study|Lost to Follow-up|2|||
146586551|NCT00734604|528654394|FG003|Overall Study|Lost to Follow-up|4|||
146586552|NCT00734604|528654395|FG004|Overall Study|Lost to Follow-up|2|||
146586553|NCT00734604|528654396|FG005|Overall Study|Lost to Follow-up|3|||
146586554|NCT00734604|528654391|FG000|Overall Study|Physician Decision|0|||
146586555|NCT00734604|528654392|FG001|Overall Study|Physician Decision|1|||
146586556|NCT00734604|528654393|FG002|Overall Study|Physician Decision|1|||
146586557|NCT00734604|528654394|FG003|Overall Study|Physician Decision|0|||
146586558|NCT00734604|528654395|FG004|Overall Study|Physician Decision|0|||
146586559|NCT00734604|528654396|FG005|Overall Study|Physician Decision|0|||
146586560|NCT00734604|528654391|FG000|Overall Study|Protocol Violation|0|||
146586561|NCT00734604|528654392|FG001|Overall Study|Protocol Violation|2|||
146586562|NCT00734604|528654393|FG002|Overall Study|Protocol Violation|0|||
146586563|NCT00734604|528654394|FG003|Overall Study|Protocol Violation|0|||
146586564|NCT00734604|528654395|FG004|Overall Study|Protocol Violation|1|||
146586565|NCT00734604|528654396|FG005|Overall Study|Protocol Violation|0|||
146586566|NCT00734604|528654391|FG000|Overall Study|Sponsor Decision|1|||
146586567|NCT00734604|528654392|FG001|Overall Study|Sponsor Decision|2|||
146586568|NCT00734604|528654393|FG002|Overall Study|Sponsor Decision|1|||
146586569|NCT00734604|528654394|FG003|Overall Study|Sponsor Decision|0|||
146586570|NCT00734604|528654395|FG004|Overall Study|Sponsor Decision|2|||
146586571|NCT00734604|528654396|FG005|Overall Study|Sponsor Decision|0|||
146586572|NCT00734604|528654391|FG000|Overall Study|Withdrawal by Subject|0|||
146586573|NCT00734604|528654392|FG001|Overall Study|Withdrawal by Subject|2|||
146586574|NCT00734604|528654393|FG002|Overall Study|Withdrawal by Subject|0|||
146586575|NCT00734604|528654394|FG003|Overall Study|Withdrawal by Subject|1|||
146586576|NCT00734604|528654395|FG004|Overall Study|Withdrawal by Subject|2|||
146586577|NCT00734604|528654396|FG005|Overall Study|Withdrawal by Subject|1|||
146586578|NCT00734604|528654391|FG000|Overall Study|Lack of Efficacy|0|||
146586579|NCT00734604|528654392|FG001|Overall Study|Lack of Efficacy|1|||
146586580|NCT00734604|528654393|FG002|Overall Study|Lack of Efficacy|1|||
146586581|NCT00734604|528654394|FG003|Overall Study|Lack of Efficacy|0|||
146586582|NCT00734604|528654395|FG004|Overall Study|Lack of Efficacy|0|||
146586583|NCT00734604|528654396|FG005|Overall Study|Lack of Efficacy|0|||
146586584|NCT01044745|528654397|FG000|Overall Study|Ineiligible|2|||
146586585|NCT00591149|528654404|FG000|Overall Study|Adverse Event|4|||
146586586|NCT00591149|528654404|FG000|Overall Study|Withdrawal by Subject|1|||
146586587|NCT02456636|528654405|FG000|Overall Study|Death|0|||
146586588|NCT02456636|528654406|FG001|Overall Study|Death|3|||
146586589|NCT02456636|528654407|FG002|Overall Study|Death|0|||
146586590|NCT02456636|528654405|FG000|Overall Study|Pregnancy|1|||
146586591|NCT02456636|528654406|FG001|Overall Study|Pregnancy|3|||
146586592|NCT02456636|528654407|FG002|Overall Study|Pregnancy|5|||
146586593|NCT02456636|528654405|FG000|Overall Study|Physician Decision|4|||
146586594|NCT02456636|528654406|FG001|Overall Study|Physician Decision|5|||
146586595|NCT02456636|528654407|FG002|Overall Study|Physician Decision|4|||
146586596|NCT02456636|528654405|FG000|Overall Study|Withdrawal by Subject|13|||
146586597|NCT02456636|528654406|FG001|Overall Study|Withdrawal by Subject|14|||
146586598|NCT02456636|528654407|FG002|Overall Study|Withdrawal by Subject|16|||
146586599|NCT02456636|528654405|FG000|Overall Study|Lost to Follow-up|50|||
146586600|NCT02456636|528654406|FG001|Overall Study|Lost to Follow-up|44|||
146586601|NCT02456636|528654407|FG002|Overall Study|Lost to Follow-up|50|||
146586602|NCT02379221|528654408|FG000|Overall Study|Lost to Follow-up|1|||
146586603|NCT02019108|528654409|FG000|Overall Study|Lost to Follow-up|5|||
146586604|NCT02019108|528654410|FG001|Overall Study|Lost to Follow-up|7|||
146586605|NCT05275010|528654420|FG000|Overall Study|Reason Not Specified|4|||
146586606|NCT05275010|528654421|FG001|Overall Study|Reason Not Specified|1|||
146586607|NCT05275010|528654420|FG000|Overall Study|Withdrawal by Subject|1|||
146586608|NCT05275010|528654421|FG001|Overall Study|Withdrawal by Subject|0|||
146586609|NCT05275010|528654420|FG000|Overall Study|Lost to Follow-up|0|||
146586610|NCT05275010|528654421|FG001|Overall Study|Lost to Follow-up|1|||
146586611|NCT04484649|528654424|FG000|Overall Study|Lost to Follow-up|2|||
146586612|NCT04484649|528654425|FG001|Overall Study|Lost to Follow-up|1|||
146586613|NCT04484649|528654424|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
146586614|NCT04484649|528654425|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
146586615|NCT04417218|528654436|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
146586616|NCT04417218|528654437|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
146586617|NCT01082874|528654440|FG000|Overall Study|Lost to Follow-up|10|||
146586618|NCT01082874|528654441|FG001|Overall Study|Lost to Follow-up|10|||
146586619|NCT01082874|528654442|FG002|Overall Study|Lost to Follow-up|6|||
146586620|NCT01082874|528654443|FG003|Overall Study|Lost to Follow-up|10|||
146586621|NCT01082874|528654440|FG000|Overall Study|Withdrawal by Subject|1|||
146586622|NCT01082874|528654441|FG001|Overall Study|Withdrawal by Subject|2|||
146586623|NCT01082874|528654442|FG002|Overall Study|Withdrawal by Subject|5|||
146586624|NCT01082874|528654443|FG003|Overall Study|Withdrawal by Subject|3|||
146586625|NCT00939029|528654451|FG000|Overall Study|Withdrawal by Subject|3|||
146586626|NCT00939029|528654452|FG001|Overall Study|Withdrawal by Subject|7|||
146586627|NCT00939029|528654451|FG000|Overall Study|Lost to Follow-up|3|||
146586628|NCT00939029|528654452|FG001|Overall Study|Lost to Follow-up|4|||
146586629|NCT00939029|528654451|FG000|Overall Study|Adverse Event|0|||
146586630|NCT00939029|528654452|FG001|Overall Study|Adverse Event|1|||
146586631|NCT03305419|528654454|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
146586632|NCT03305419|528654455|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
146586633|NCT03305419|528654456|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
146918941|NCT01544595|529864543|FG002|Status at Week 68|Protocol Violation|1|||
146918942|NCT01544595|529864544|FG003|Status at Week 68|Protocol Violation|1|||
146918943|NCT01544595|529864545|FG004|Status at Week 68|Protocol Violation|0|||
146918944|NCT01544595|529864546|FG005|Status at Week 68|Protocol Violation|0|||
146586634|NCT03305419|528654457|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
146652370|NCT03422627|528905215|FG000|Overall Study|Disease Progression|1|||
146652371|NCT03422627|528905216|FG001|Overall Study|Disease Progression|0|||
146652372|NCT03422627|528905217|FG002|Overall Study|Disease Progression|1|||
146652373|NCT03422627|528905218|FG003|Overall Study|Disease Progression|2|||
146652374|NCT03422627|528905219|FG004|Overall Study|Disease Progression|0|||
146652375|NCT03422627|528905215|FG000|Overall Study|Adverse Event|2|||
146652376|NCT03422627|528905216|FG001|Overall Study|Adverse Event|1|||
146652377|NCT03422627|528905217|FG002|Overall Study|Adverse Event|0|||
146652378|NCT03422627|528905218|FG003|Overall Study|Adverse Event|0|||
146652379|NCT03422627|528905219|FG004|Overall Study|Adverse Event|2|||
146652380|NCT03422627|528905215|FG000|Overall Study|Ineligibility Determined|0|||
146652381|NCT03422627|528905216|FG001|Overall Study|Ineligibility Determined|1|||
146652382|NCT03422627|528905217|FG002|Overall Study|Ineligibility Determined|0|||
146652383|NCT03422627|528905218|FG003|Overall Study|Ineligibility Determined|0|||
146652384|NCT03422627|528905219|FG004|Overall Study|Ineligibility Determined|0|||
146652385|NCT03422627|528905215|FG000|Overall Study|Death|0|||
146652386|NCT03422627|528905216|FG001|Overall Study|Death|1|||
146652387|NCT03422627|528905217|FG002|Overall Study|Death|1|||
146652388|NCT03422627|528905218|FG003|Overall Study|Death|0|||
146652389|NCT03422627|528905219|FG004|Overall Study|Death|0|||
146652390|NCT03422627|528905215|FG000|Overall Study|Withdrawal by Subject|0|||
146652391|NCT03422627|528905216|FG001|Overall Study|Withdrawal by Subject|0|||
146652392|NCT03422627|528905217|FG002|Overall Study|Withdrawal by Subject|0|||
146652393|NCT03422627|528905218|FG003|Overall Study|Withdrawal by Subject|1|||
146652394|NCT03422627|528905219|FG004|Overall Study|Withdrawal by Subject|0|||
146652395|NCT02455557|528905220|FG000|Overall Study|Withdrawal by Subject|2|||
146652396|NCT04656275|528905221|FG000|Overall Study|Study terminated by sponsor|2|||
146652397|NCT04656275|528905222|FG001|Overall Study|Study terminated by sponsor|4|||
146652398|NCT00934648|528905226|FG000|Overall Study|Failure to return|8|||
146652399|NCT00934648|528905226|FG000|Overall Study|Withdrawal by Subject|1|||
146586635|NCT03305419|528654458|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
146586636|NCT03305419|528654459|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
146586637|NCT03305419|528654460|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
146586638|NCT03305419|528654461|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
146586639|NCT03305419|528654454|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
146586640|NCT03305419|528654455|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
146586641|NCT03305419|528654456|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
146586642|NCT03305419|528654457|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
146586643|NCT03305419|528654458|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
146586644|NCT03305419|528654459|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
146586645|NCT03305419|528654460|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
146586646|NCT03305419|528654461|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
146586647|NCT03305419|528654454|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
146586648|NCT03305419|528654455|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
146586649|NCT03305419|528654456|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
146586650|NCT03305419|528654457|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
146586651|NCT03305419|528654458|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
146586652|NCT03305419|528654459|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
146586653|NCT03305419|528654460|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
146586654|NCT03305419|528654461|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
146586655|NCT03305419|528654454|FG000|Part B (14 Days)|Adverse Event|0|||
146586656|NCT03305419|528654455|FG001|Part B (14 Days)|Adverse Event|0|||
146586657|NCT03305419|528654456|FG002|Part B (14 Days)|Adverse Event|0|||
146586658|NCT03305419|528654457|FG003|Part B (14 Days)|Adverse Event|0|||
146586659|NCT03305419|528654458|FG004|Part B (14 Days)|Adverse Event|1|||
146586660|NCT03305419|528654459|FG005|Part B (14 Days)|Adverse Event|2|||
146586661|NCT03305419|528654460|FG006|Part B (14 Days)|Adverse Event|4|||
146586662|NCT03305419|528654461|FG007|Part B (14 Days)|Adverse Event|0|||
146652400|NCT02195687|528905227|FG000|Overall Study|Personal Reasons|1|||
146652401|NCT02195687|528905228|FG001|Overall Study|Personal Reasons|1|||
146652402|NCT02195687|528905227|FG000|Overall Study|Lost to Follow-up|4|||
146652403|NCT02195687|528905228|FG001|Overall Study|Lost to Follow-up|1|||
146652404|NCT04369924|528905231|FG000|Overall Study|Lost to Follow-up|302|||
146652405|NCT04369924|528905232|FG001|Overall Study|Lost to Follow-up|339|||
146918945|NCT01544595|529864541|FG000|Status at Week 68|Technical problems|1|||
146652406|NCT03828370|528905233|FG000|3 Month Follow-up|Lost to Follow-up|4|||
146652407|NCT03828370|528905234|FG001|3 Month Follow-up|Lost to Follow-up|12|||
146652408|NCT03828370|528905233|FG000|9 Month Follow up|Lost to Follow-up|12|||
146652409|NCT03828370|528905234|FG001|9 Month Follow up|Lost to Follow-up|20|||
146586663|NCT03305419|528654454|FG000|Part B (14 Days)|Physician Decision|0|||
146586664|NCT03305419|528654455|FG001|Part B (14 Days)|Physician Decision|0|||
146586665|NCT03305419|528654456|FG002|Part B (14 Days)|Physician Decision|0|||
146586666|NCT03305419|528654457|FG003|Part B (14 Days)|Physician Decision|0|||
146586667|NCT03305419|528654458|FG004|Part B (14 Days)|Physician Decision|2|||
146586668|NCT03305419|528654459|FG005|Part B (14 Days)|Physician Decision|8|||
146586669|NCT03305419|528654460|FG006|Part B (14 Days)|Physician Decision|1|||
146586670|NCT03305419|528654461|FG007|Part B (14 Days)|Physician Decision|0|||
146586671|NCT00075946|528654462|FG000|Overall Study|Path ineligible: undetermined histology|0|||
146586672|NCT00075946|528654463|FG001|Overall Study|Path ineligible: undetermined histology|0|||
146586673|NCT00075946|528654464|FG002|Overall Study|Path ineligible: undetermined histology|0|||
146586674|NCT00075946|528654465|FG003|Overall Study|Path ineligible: undetermined histology|0|||
146586675|NCT00075946|528654466|FG004|Overall Study|Path ineligible: undetermined histology|6|||
146586676|NCT00075946|528654462|FG000|Overall Study|Did not achieve response after induction|0|||
146586677|NCT00075946|528654463|FG001|Overall Study|Did not achieve response after induction|0|||
146586678|NCT00075946|528654464|FG002|Overall Study|Did not achieve response after induction|0|||
146586679|NCT00075946|528654465|FG003|Overall Study|Did not achieve response after induction|0|||
146586680|NCT00075946|528654466|FG004|Overall Study|Did not achieve response after induction|182|||
146586681|NCT00075946|528654462|FG000|Overall Study|Incorrectly randomized (no response)|5|||
146652410|NCT00290407|528905235|FG000|Overall Study|Physician Decision|2|||
146652411|NCT01933789|528905244|FG000|Overall Study|Death|0|||
146586682|NCT00075946|528654463|FG001|Overall Study|Incorrectly randomized (no response)|5|||
146586683|NCT00075946|528654464|FG002|Overall Study|Incorrectly randomized (no response)|5|||
146586684|NCT00075946|528654465|FG003|Overall Study|Incorrectly randomized (no response)|1|||
146586685|NCT00075946|528654466|FG004|Overall Study|Incorrectly randomized (no response)|0|||
146586686|NCT00075946|528654462|FG000|Overall Study|Adverse Event|2|||
146586687|NCT00075946|528654463|FG001|Overall Study|Adverse Event|10|||
146586688|NCT00075946|528654464|FG002|Overall Study|Adverse Event|0|||
146586689|NCT00075946|528654465|FG003|Overall Study|Adverse Event|2|||
146586690|NCT00075946|528654466|FG004|Overall Study|Adverse Event|0|||
146586691|NCT00075946|528654462|FG000|Overall Study|Death|0|||
146586692|NCT00075946|528654463|FG001|Overall Study|Death|1|||
146586693|NCT00075946|528654464|FG002|Overall Study|Death|0|||
146586694|NCT00075946|528654465|FG003|Overall Study|Death|0|||
146586695|NCT00075946|528654466|FG004|Overall Study|Death|0|||
146586696|NCT00075946|528654462|FG000|Overall Study|Withdrawal by Subject|23|||
146586697|NCT00075946|528654463|FG001|Overall Study|Withdrawal by Subject|58|||
146586698|NCT00075946|528654464|FG002|Overall Study|Withdrawal by Subject|4|||
146586699|NCT00075946|528654465|FG003|Overall Study|Withdrawal by Subject|9|||
146586700|NCT00075946|528654466|FG004|Overall Study|Withdrawal by Subject|0|||
146586701|NCT00075946|528654462|FG000|Overall Study|Alternative therapy|16|||
146586702|NCT00075946|528654463|FG001|Overall Study|Alternative therapy|2|||
146586703|NCT00075946|528654464|FG002|Overall Study|Alternative therapy|5|||
146586704|NCT00075946|528654465|FG003|Overall Study|Alternative therapy|0|||
146586705|NCT00075946|528654466|FG004|Overall Study|Alternative therapy|0|||
146586706|NCT00075946|528654462|FG000|Overall Study|Other complicating disease|7|||
146586707|NCT00075946|528654463|FG001|Overall Study|Other complicating disease|13|||
146586708|NCT00075946|528654464|FG002|Overall Study|Other complicating disease|1|||
146586709|NCT00075946|528654465|FG003|Overall Study|Other complicating disease|4|||
146586710|NCT00075946|528654466|FG004|Overall Study|Other complicating disease|0|||
146586711|NCT00075946|528654462|FG000|Overall Study|No response to retreatment|23|||
146586712|NCT00075946|528654463|FG001|Overall Study|No response to retreatment|0|||
146586713|NCT00075946|528654464|FG002|Overall Study|No response to retreatment|2|||
146586714|NCT00075946|528654465|FG003|Overall Study|No response to retreatment|0|||
146586715|NCT00075946|528654466|FG004|Overall Study|No response to retreatment|0|||
146586716|NCT00075946|528654462|FG000|Overall Study|Time to progression less than 6 months|15|||
146586717|NCT00075946|528654463|FG001|Overall Study|Time to progression less than 6 months|30|||
146586718|NCT00075946|528654464|FG002|Overall Study|Time to progression less than 6 months|8|||
146652412|NCT01933789|528905245|FG001|Overall Study|Death|0|||
146652413|NCT01933789|528905246|FG002|Overall Study|Death|0|||
146652414|NCT01933789|528905247|FG003|Overall Study|Death|0|||
146652415|NCT01933789|528905248|FG004|Overall Study|Death|21|||
146652416|NCT01933789|528905249|FG005|Overall Study|Death|32|||
146586719|NCT00075946|528654465|FG003|Overall Study|Time to progression less than 6 months|3|||
146586720|NCT00075946|528654466|FG004|Overall Study|Time to progression less than 6 months|0|||
146586721|NCT00075946|528654462|FG000|Overall Study|Other|57|||
146652417|NCT01933789|528905250|FG006|Overall Study|Death|0|||
146586722|NCT00075946|528654463|FG001|Overall Study|Other|32|||
146586723|NCT00075946|528654464|FG002|Overall Study|Other|3|||
146586724|NCT00075946|528654465|FG003|Overall Study|Other|11|||
146586725|NCT00075946|528654466|FG004|Overall Study|Other|0|||
146652418|NCT01933789|528905251|FG007|Overall Study|Death|0|||
146652419|NCT01933789|528905252|FG008|Overall Study|Death|0|||
146652420|NCT01933789|528905244|FG000|Overall Study|Lost to Follow-up|0|||
146652421|NCT01933789|528905245|FG001|Overall Study|Lost to Follow-up|0|||
146652422|NCT01933789|528905246|FG002|Overall Study|Lost to Follow-up|0|||
146652423|NCT01933789|528905247|FG003|Overall Study|Lost to Follow-up|1|||
146652424|NCT01933789|528905248|FG004|Overall Study|Lost to Follow-up|8|||
146652425|NCT01933789|528905249|FG005|Overall Study|Lost to Follow-up|9|||
146652426|NCT01933789|528905250|FG006|Overall Study|Lost to Follow-up|1|||
146652427|NCT01933789|528905251|FG007|Overall Study|Lost to Follow-up|4|||
146586726|NCT02210689|528654467|FG000|Overall Study|Withdrawal by Subject|7|||
146586727|NCT02210689|528654468|FG001|Overall Study|Withdrawal by Subject|4|||
146586728|NCT02210689|528654469|FG002|Overall Study|Withdrawal by Subject|2|||
146586729|NCT02210689|528654467|FG000|Overall Study|Adverse Event|0|||
146586730|NCT02210689|528654468|FG001|Overall Study|Adverse Event|1|||
146586731|NCT02210689|528654469|FG002|Overall Study|Adverse Event|0|||
146586732|NCT02210689|528654467|FG000|Overall Study|Protocol Violation|1|||
146586733|NCT02210689|528654468|FG001|Overall Study|Protocol Violation|0|||
146586734|NCT02210689|528654469|FG002|Overall Study|Protocol Violation|0|||
146586735|NCT02210689|528654467|FG000|Overall Study|Lost to Follow-up|11|||
146586736|NCT02210689|528654468|FG001|Overall Study|Lost to Follow-up|9|||
146586737|NCT02210689|528654469|FG002|Overall Study|Lost to Follow-up|5|||
146586738|NCT02210689|528654467|FG000|Overall Study|Pregnancy|0|||
146586739|NCT02210689|528654468|FG001|Overall Study|Pregnancy|1|||
146586740|NCT02210689|528654469|FG002|Overall Study|Pregnancy|0|||
146586741|NCT02210689|528654467|FG000|Overall Study|Lack of Efficacy|0|||
146586742|NCT02210689|528654468|FG001|Overall Study|Lack of Efficacy|1|||
146586743|NCT02210689|528654469|FG002|Overall Study|Lack of Efficacy|5|||
146586744|NCT02210689|528654467|FG000|Overall Study|Prohibited medication|2|||
146586745|NCT02210689|528654468|FG001|Overall Study|Prohibited medication|8|||
146586746|NCT02210689|528654469|FG002|Overall Study|Prohibited medication|1|||
146586747|NCT02210689|528654467|FG000|Overall Study|Negative Nugent score at baseline|6|||
146586748|NCT02210689|528654468|FG001|Overall Study|Negative Nugent score at baseline|2|||
146586749|NCT02210689|528654469|FG002|Overall Study|Negative Nugent score at baseline|2|||
146586750|NCT02210689|528654467|FG000|Overall Study|Other|25|||
146586751|NCT02210689|528654468|FG001|Overall Study|Other|21|||
146586752|NCT02210689|528654469|FG002|Overall Study|Other|8|||
146586753|NCT02231892|528654470|FG000|Overall Study|Lost to Follow-up|1|||
146586754|NCT02231892|528654471|FG001|Overall Study|Lost to Follow-up|0|||
146586755|NCT02231892|528654472|FG002|Overall Study|Lost to Follow-up|3|||
146586756|NCT02231892|528654470|FG000|Overall Study|Withdrawal by Subject|4|||
146586757|NCT02231892|528654471|FG001|Overall Study|Withdrawal by Subject|3|||
146586758|NCT02231892|528654472|FG002|Overall Study|Withdrawal by Subject|15|||
146586759|NCT02231892|528654470|FG000|Overall Study|Physician Decision|0|||
146586760|NCT02231892|528654471|FG001|Overall Study|Physician Decision|2|||
146586761|NCT02231892|528654472|FG002|Overall Study|Physician Decision|4|||
146586762|NCT02231892|528654470|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
146586763|NCT02231892|528654471|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
146586764|NCT02231892|528654472|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
146586765|NCT02231892|528654470|FG000|Overall Study|Participant motor threshold was >83%|0|||
146586766|NCT02231892|528654471|FG001|Overall Study|Participant motor threshold was >83%|0|||
146586767|NCT02231892|528654472|FG002|Overall Study|Participant motor threshold was >83%|9|||
146586768|NCT02231892|528654470|FG000|Overall Study|Could not find motor threshold|2|||
146586769|NCT02231892|528654471|FG001|Overall Study|Could not find motor threshold|0|||
146586770|NCT02231892|528654472|FG002|Overall Study|Could not find motor threshold|1|||
146586771|NCT02231892|528654470|FG000|Overall Study|Could not find reliable motor hotspot|0|||
146586772|NCT02231892|528654471|FG001|Overall Study|Could not find reliable motor hotspot|0|||
146586773|NCT02231892|528654472|FG002|Overall Study|Could not find reliable motor hotspot|1|||
146586774|NCT03832322|528654473|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
146586775|NCT03832322|528654474|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
146586776|NCT02186652|528654483|FG000|Overall Study|Lost to Follow-up|2|||
146586777|NCT02186652|528654484|FG001|Overall Study|Lost to Follow-up|0|||
146586778|NCT02247011|528654487|FG000|Overall Study|Poor quality of radiological results|125|||
146586779|NCT04470908|528654493|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
146586780|NCT01974206|528654494|FG000|Overall Study|Did Not Take Study Drug|0|||
146586781|NCT01974206|528654495|FG001|Overall Study|Did Not Take Study Drug|1|||
146586782|NCT01974206|528654494|FG000|Overall Study|Physician Decision|1|||
146586783|NCT01974206|528654495|FG001|Overall Study|Physician Decision|0|||
146586784|NCT01974206|528654494|FG000|Overall Study|Withdrawal by Subject|3|||
146586785|NCT01974206|528654495|FG001|Overall Study|Withdrawal by Subject|0|||
146586786|NCT01974206|528654494|FG000|Overall Study|Lost to Follow-up|1|||
146586787|NCT01974206|528654495|FG001|Overall Study|Lost to Follow-up|0|||
146586788|NCT01974206|528654494|FG000|Overall Study|Death|1|||
146586789|NCT01974206|528654495|FG001|Overall Study|Death|0|||
146586790|NCT03989349|528654498|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
146586791|NCT03989349|528654499|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146586792|NCT03989349|528654500|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146586793|NCT03989349|528654501|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146652428|NCT01933789|528905252|FG008|Overall Study|Lost to Follow-up|0|||
146586794|NCT03989349|528654502|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146652429|NCT01933789|528905244|FG000|Overall Study|Withdrawal by Subject|2|||
146586795|NCT03989349|528654503|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146586796|NCT03989349|528654498|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
146586797|NCT03989349|528654499|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
146586798|NCT03989349|528654500|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
146586799|NCT03989349|528654501|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
146586800|NCT03989349|528654502|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
146586801|NCT03989349|528654503|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
146586802|NCT03989349|528654498|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
146586803|NCT03989349|528654499|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
146586804|NCT03989349|528654500|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
146586805|NCT03989349|528654501|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
146586806|NCT03989349|528654502|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
146586807|NCT03989349|528654503|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
146586808|NCT03989349|528654498|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
146586809|NCT03989349|528654499|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
146586810|NCT03989349|528654500|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146586811|NCT03989349|528654501|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146586812|NCT03989349|528654502|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146586813|NCT03989349|528654503|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146586814|NCT03989349|528654498|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
146586815|NCT03989349|528654499|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
146586816|NCT03989349|528654500|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
146586817|NCT03989349|528654501|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
146586818|NCT03989349|528654502|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
146586819|NCT03989349|528654503|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
146586820|NCT03989349|528654498|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
146586821|NCT03989349|528654499|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
146586822|NCT03989349|528654500|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
146586823|NCT03989349|528654501|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
146586824|NCT03989349|528654502|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
146586825|NCT03989349|528654503|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
146586826|NCT03989349|528654498|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
146586827|NCT03989349|528654499|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
146586828|NCT03989349|528654500|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
146586829|NCT03989349|528654501|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
146586830|NCT03989349|528654502|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
146586831|NCT03989349|528654503|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
146586832|NCT03989349|528654498|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
146586833|NCT03989349|528654499|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
146586834|NCT03989349|528654500|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
146586835|NCT03989349|528654501|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
146586836|NCT03989349|528654502|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
146586837|NCT03989349|528654503|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
146586838|NCT03989349|528654498|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
146586839|NCT03989349|528654499|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
146586840|NCT03989349|528654500|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
146586841|NCT03989349|528654501|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
146586842|NCT03989349|528654502|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
146586843|NCT03989349|528654503|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
146586844|NCT03989349|528654498|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
146586845|NCT03989349|528654499|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
146586846|NCT03989349|528654500|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
146586847|NCT03989349|528654501|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
146586848|NCT03989349|528654502|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
146586849|NCT03989349|528654503|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
146586850|NCT03989349|528654498|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146586851|NCT03989349|528654499|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146586852|NCT03989349|528654500|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
146586853|NCT03989349|528654501|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146586854|NCT03989349|528654502|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
146586855|NCT03989349|528654503|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146586856|NCT03989349|528654498|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
146586857|NCT03989349|528654499|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
146586858|NCT03989349|528654500|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
146586859|NCT03989349|528654501|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
146586860|NCT03989349|528654502|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
146586861|NCT03989349|528654503|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
146586862|NCT03989349|528654498|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
146586863|NCT03989349|528654499|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
146586864|NCT03989349|528654500|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
146586865|NCT03989349|528654501|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
146586866|NCT03989349|528654502|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
146586867|NCT03989349|528654503|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
146586868|NCT03989349|528654498|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
146586869|NCT03989349|528654499|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
146586870|NCT03989349|528654500|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
146586871|NCT03989349|528654501|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
146586872|NCT03989349|528654502|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
146586873|NCT03989349|528654503|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
146586874|NCT01802580|528654506|FG000|Overall Study|Physician Decision|1|||
146586875|NCT01802580|528654507|FG001|Overall Study|Physician Decision|0|||
146586876|NCT01802580|528654506|FG000|Overall Study|Protocol Violation|2|||
146586877|NCT01802580|528654507|FG001|Overall Study|Protocol Violation|0|||
146586878|NCT01802580|528654506|FG000|Overall Study|Withdrawal by Subject|5|||
146586879|NCT01802580|528654507|FG001|Overall Study|Withdrawal by Subject|6|||
146586880|NCT01802580|528654506|FG000|Overall Study|Other|1|||
146586881|NCT01802580|528654507|FG001|Overall Study|Other|3|||
146586882|NCT01802580|528654506|FG000|Overall Study|Lack of Efficacy|0|||
146586883|NCT01802580|528654507|FG001|Overall Study|Lack of Efficacy|2|||
146586884|NCT03255967|528654508|FG000|Overall Study|Adverse Event|26|||
146586885|NCT03255967|528654509|FG001|Overall Study|Adverse Event|30|||
146586886|NCT03255967|528654508|FG000|Overall Study|Withdrawal by Subject|6|||
146586887|NCT03255967|528654509|FG001|Overall Study|Withdrawal by Subject|6|||
146586888|NCT03255967|528654508|FG000|Overall Study|Schedule conflict|6|||
146586889|NCT03255967|528654509|FG001|Overall Study|Schedule conflict|4|||
146586890|NCT03255967|528654508|FG000|Overall Study|POA did not sign consent form|2|||
146586891|NCT03255967|528654509|FG001|Overall Study|POA did not sign consent form|0|||
146586892|NCT00778258|528654512|FG000|Overall Study|Adverse Event|1|||
146586893|NCT00778258|528654513|FG001|Overall Study|Adverse Event|0|||
146586894|NCT00778258|528654514|FG002|Overall Study|Adverse Event|0|||
146586895|NCT00778258|528654515|FG003|Overall Study|Adverse Event|0|||
146586896|NCT00778258|528654516|FG004|Overall Study|Adverse Event|0|||
146586897|NCT00778258|528654517|FG005|Overall Study|Adverse Event|1|||
146586898|NCT00778258|528654518|FG006|Overall Study|Adverse Event|0|||
146586899|NCT00778258|528654519|FG007|Overall Study|Adverse Event|0|||
146586900|NCT00778258|528654520|FG008|Overall Study|Adverse Event|0|||
146586901|NCT00778258|528654512|FG000|Overall Study|Lost to Follow-up|0|||
146586902|NCT00778258|528654513|FG001|Overall Study|Lost to Follow-up|0|||
146586903|NCT00778258|528654514|FG002|Overall Study|Lost to Follow-up|2|||
146586904|NCT00778258|528654515|FG003|Overall Study|Lost to Follow-up|0|||
146586905|NCT00778258|528654516|FG004|Overall Study|Lost to Follow-up|0|||
146586906|NCT00778258|528654517|FG005|Overall Study|Lost to Follow-up|3|||
146586907|NCT00778258|528654518|FG006|Overall Study|Lost to Follow-up|2|||
146586908|NCT00778258|528654519|FG007|Overall Study|Lost to Follow-up|2|||
146586909|NCT00778258|528654520|FG008|Overall Study|Lost to Follow-up|0|||
146586910|NCT00778258|528654512|FG000|Overall Study|Withdrawal by Subject|6|||
146586911|NCT00778258|528654513|FG001|Overall Study|Withdrawal by Subject|2|||
146586912|NCT00778258|528654514|FG002|Overall Study|Withdrawal by Subject|8|||
146586913|NCT00778258|528654515|FG003|Overall Study|Withdrawal by Subject|2|||
146586914|NCT00778258|528654516|FG004|Overall Study|Withdrawal by Subject|0|||
146586915|NCT00778258|528654517|FG005|Overall Study|Withdrawal by Subject|6|||
146586916|NCT00778258|528654518|FG006|Overall Study|Withdrawal by Subject|12|||
146586917|NCT00778258|528654519|FG007|Overall Study|Withdrawal by Subject|12|||
146586918|NCT00778258|528654520|FG008|Overall Study|Withdrawal by Subject|4|||
146586919|NCT00778258|528654512|FG000|Overall Study|New Contraindication|0|||
146586920|NCT00778258|528654513|FG001|Overall Study|New Contraindication|0|||
146586921|NCT00778258|528654514|FG002|Overall Study|New Contraindication|0|||
146586922|NCT00778258|528654515|FG003|Overall Study|New Contraindication|0|||
146586923|NCT00778258|528654516|FG004|Overall Study|New Contraindication|0|||
146586924|NCT00778258|528654517|FG005|Overall Study|New Contraindication|0|||
146586925|NCT00778258|528654518|FG006|Overall Study|New Contraindication|0|||
146586926|NCT00778258|528654519|FG007|Overall Study|New Contraindication|1|||
146586927|NCT00778258|528654520|FG008|Overall Study|New Contraindication|0|||
146586928|NCT00778258|528654512|FG000|Overall Study|Non-compliance|0|||
146586929|NCT00778258|528654513|FG001|Overall Study|Non-compliance|0|||
146918946|NCT01544595|529864542|FG001|Status at Week 68|Technical problems|0|||
146652430|NCT01933789|528905245|FG001|Overall Study|Withdrawal by Subject|1|||
146652431|NCT01933789|528905246|FG002|Overall Study|Withdrawal by Subject|0|||
146652432|NCT01933789|528905247|FG003|Overall Study|Withdrawal by Subject|0|||
146652433|NCT01933789|528905248|FG004|Overall Study|Withdrawal by Subject|17|||
146652434|NCT01933789|528905249|FG005|Overall Study|Withdrawal by Subject|16|||
146652435|NCT01933789|528905250|FG006|Overall Study|Withdrawal by Subject|1|||
146652436|NCT01933789|528905251|FG007|Overall Study|Withdrawal by Subject|4|||
146652437|NCT01933789|528905252|FG008|Overall Study|Withdrawal by Subject|0|||
146652438|NCT01933789|528905244|FG000|Overall Study|Became Ineligible|4|||
146652439|NCT01933789|528905245|FG001|Overall Study|Became Ineligible|0|||
146586930|NCT00778258|528654514|FG002|Overall Study|Non-compliance|0|||
146586931|NCT00778258|528654515|FG003|Overall Study|Non-compliance|1|||
146586932|NCT00778258|528654516|FG004|Overall Study|Non-compliance|0|||
146586933|NCT00778258|528654517|FG005|Overall Study|Non-compliance|0|||
146586934|NCT00778258|528654518|FG006|Overall Study|Non-compliance|0|||
146586935|NCT00778258|528654519|FG007|Overall Study|Non-compliance|0|||
146586936|NCT00778258|528654520|FG008|Overall Study|Non-compliance|0|||
146586937|NCT00778258|528654512|FG000|Overall Study|Other|0|||
146586938|NCT00778258|528654513|FG001|Overall Study|Other|0|||
146586939|NCT00778258|528654514|FG002|Overall Study|Other|0|||
146586940|NCT00778258|528654515|FG003|Overall Study|Other|0|||
146586941|NCT00778258|528654516|FG004|Overall Study|Other|0|||
146586942|NCT00778258|528654517|FG005|Overall Study|Other|0|||
146586943|NCT00778258|528654518|FG006|Overall Study|Other|1|||
146586944|NCT00778258|528654519|FG007|Overall Study|Other|0|||
146586945|NCT00778258|528654520|FG008|Overall Study|Other|0|||
146586946|NCT02438683|528654521|FG000|Overall Study|Adverse Event|1|||
146586947|NCT02438683|528654522|FG001|Overall Study|Adverse Event|0|||
146586948|NCT02438683|528654523|FG002|Overall Study|Adverse Event|0|||
146586949|NCT02438683|528654524|FG003|Overall Study|Adverse Event|0|||
146586950|NCT02438683|528654525|FG004|Overall Study|Adverse Event|0|||
146586951|NCT02438683|528654526|FG005|Overall Study|Adverse Event|0|||
146586952|NCT04621240|528654527|FG000|Overall Study|Withdrawal by Subject|36|||
146586953|NCT02867813|528656443|FG000|Overall Study|Withdrawal by Subject|57|||
146586954|NCT02867813|528656444|FG001|Overall Study|Withdrawal by Subject|56|||
146586955|NCT02867813|528656443|FG000|Overall Study|Decision by Sponsor|7|||
146586956|NCT02867813|528656444|FG001|Overall Study|Decision by Sponsor|7|||
146586957|NCT02867813|528656443|FG000|Overall Study|Lost to Follow-up|91|||
146586958|NCT02867813|528656444|FG001|Overall Study|Lost to Follow-up|78|||
146586959|NCT02867813|528656443|FG000|Overall Study|Missing|2|||
146586960|NCT02867813|528656444|FG001|Overall Study|Missing|1|||
146586961|NCT02867813|528656443|FG000|Overall Study|Death|294|||
146586962|NCT02867813|528656444|FG001|Overall Study|Death|268|||
146586963|NCT02013206|528656445|FG000|Overall Study|Progressive disease (PD)|14|||
146586964|NCT02013206|528656446|FG001|Overall Study|Progressive disease (PD)|17|||
146586965|NCT02013206|528656445|FG000|Overall Study|Symptomatic deterioration|3|||
146586966|NCT02013206|528656446|FG001|Overall Study|Symptomatic deterioration|1|||
146586967|NCT02013206|528656445|FG000|Overall Study|Adverse Event|1|||
146586968|NCT02013206|528656446|FG001|Overall Study|Adverse Event|0|||
146586969|NCT02013206|528656445|FG000|Overall Study|Patient refusal|2|||
146586970|NCT02013206|528656446|FG001|Overall Study|Patient refusal|0|||
146586971|NCT02013206|528656445|FG000|Overall Study|Patient non-compliance|1|||
146586972|NCT02013206|528656446|FG001|Overall Study|Patient non-compliance|0|||
146586973|NCT02013206|528656445|FG000|Overall Study|Death|1|||
146586974|NCT02013206|528656446|FG001|Overall Study|Death|2|||
146586975|NCT02013206|528656445|FG000|Overall Study|Other reasons off treatment|5|||
146586976|NCT02013206|528656446|FG001|Overall Study|Other reasons off treatment|2|||
146586977|NCT01952665|528656447|FG000|Overall Study|Physician Decision|3|||
146586978|NCT01952665|528656448|FG001|Overall Study|Physician Decision|2|||
146586979|NCT01952665|528656447|FG000|Overall Study|Lost to Follow-up|1|||
146586980|NCT01952665|528656448|FG001|Overall Study|Lost to Follow-up|2|||
146586981|NCT01952665|528656447|FG000|Overall Study|Adverse Event|2|||
146586982|NCT01952665|528656448|FG001|Overall Study|Adverse Event|1|||
146586983|NCT01952665|528656447|FG000|Overall Study|Protocol Violation|0|||
146586984|NCT01952665|528656448|FG001|Overall Study|Protocol Violation|1|||
146586985|NCT01537081|528656449|FG000|Overall Study|Adverse Event|5|||
146586986|NCT01537081|528656450|FG001|Overall Study|Adverse Event|2|||
146586987|NCT01537081|528656451|FG002|Overall Study|Adverse Event|2|||
146586988|NCT01537081|528656449|FG000|Overall Study|Lack of Efficacy|2|||
146652440|NCT01933789|528905246|FG002|Overall Study|Became Ineligible|0|||
146770929|NCT03762668|529329802|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
146586989|NCT01537081|528656450|FG001|Overall Study|Lack of Efficacy|1|||
146586990|NCT01537081|528656451|FG002|Overall Study|Lack of Efficacy|0|||
146586991|NCT01537081|528656449|FG000|Overall Study|Lost to Follow-up|17|||
146586992|NCT01537081|528656450|FG001|Overall Study|Lost to Follow-up|15|||
146586993|NCT01537081|528656451|FG002|Overall Study|Lost to Follow-up|9|||
146586994|NCT01537081|528656449|FG000|Overall Study|Protocol Violation|3|||
146586995|NCT01537081|528656450|FG001|Overall Study|Protocol Violation|2|||
146652441|NCT01933789|528905247|FG003|Overall Study|Became Ineligible|0|||
146586996|NCT01537081|528656451|FG002|Overall Study|Protocol Violation|2|||
146586997|NCT01537081|528656449|FG000|Overall Study|Withdrawal by Subject|6|||
146586998|NCT01537081|528656450|FG001|Overall Study|Withdrawal by Subject|11|||
146586999|NCT01537081|528656451|FG002|Overall Study|Withdrawal by Subject|3|||
146587000|NCT01537081|528656449|FG000|Overall Study|Physician Decision|5|||
146587001|NCT01537081|528656450|FG001|Overall Study|Physician Decision|6|||
146587002|NCT01537081|528656451|FG002|Overall Study|Physician Decision|0|||
146587003|NCT01537081|528656449|FG000|Overall Study|Sponsor decision|0|||
146587004|NCT01537081|528656450|FG001|Overall Study|Sponsor decision|1|||
146587005|NCT01537081|528656451|FG002|Overall Study|Sponsor decision|0|||
146587006|NCT01537081|528656449|FG000|Overall Study|Assigned but never dosed|1|||
146587007|NCT01537081|528656450|FG001|Overall Study|Assigned but never dosed|0|||
146587008|NCT01537081|528656451|FG002|Overall Study|Assigned but never dosed|0|||
146587009|NCT01463111|528656454|FG000|Overall Study|Withdrawal by Subject|2|||
146587010|NCT01463111|528656454|FG000|Overall Study|Lost to Follow-up|5|||
146587011|NCT01463111|528656454|FG000|Overall Study|Physician Decision|2|||
146587012|NCT01559259|528656459|FG000|Overall Study|Withdrawal by Subject|0|||
146587013|NCT01559259|528656460|FG001|Overall Study|Withdrawal by Subject|0|||
146587014|NCT01559259|528656461|FG002|Overall Study|Withdrawal by Subject|0|||
146587015|NCT01559259|528656462|FG003|Overall Study|Withdrawal by Subject|1|||
146587016|NCT01559259|528656463|FG004|Overall Study|Withdrawal by Subject|0|||
146587017|NCT01559259|528656459|FG000|Overall Study|Adverse Event|0|||
146587018|NCT01559259|528656460|FG001|Overall Study|Adverse Event|1|||
146587019|NCT01559259|528656461|FG002|Overall Study|Adverse Event|1|||
146587020|NCT01559259|528656462|FG003|Overall Study|Adverse Event|0|||
146587021|NCT01559259|528656463|FG004|Overall Study|Adverse Event|0|||
146587022|NCT01995669|528656464|FG000|Overall Study|Progression|2|||
146587023|NCT01995669|528656465|FG001|Overall Study|Progression|1|||
146587024|NCT01995669|528656466|FG002|Overall Study|Progression|1|||
146587025|NCT01995669|528656467|FG003|Overall Study|Progression|13|||
146587026|NCT01995669|528656464|FG000|Overall Study|Adverse Event|0|||
146587027|NCT01995669|528656465|FG001|Overall Study|Adverse Event|0|||
146587028|NCT01995669|528656466|FG002|Overall Study|Adverse Event|0|||
146587029|NCT01995669|528656467|FG003|Overall Study|Adverse Event|3|||
146587030|NCT01995669|528656464|FG000|Overall Study|Death|0|||
146587031|NCT01995669|528656465|FG001|Overall Study|Death|0|||
146587032|NCT01995669|528656466|FG002|Overall Study|Death|0|||
146587033|NCT01995669|528656467|FG003|Overall Study|Death|6|||
146587034|NCT01995669|528656464|FG000|Overall Study|Withdrawal by Subject|0|||
146587035|NCT01995669|528656465|FG001|Overall Study|Withdrawal by Subject|0|||
146587036|NCT01995669|528656466|FG002|Overall Study|Withdrawal by Subject|0|||
146587037|NCT01995669|528656467|FG003|Overall Study|Withdrawal by Subject|6|||
146587038|NCT01995669|528656464|FG000|Overall Study|Insurance Expired|0|||
146587039|NCT01995669|528656465|FG001|Overall Study|Insurance Expired|0|||
146587040|NCT01995669|528656466|FG002|Overall Study|Insurance Expired|0|||
146587041|NCT01995669|528656467|FG003|Overall Study|Insurance Expired|1|||
146587042|NCT05425732|528656468|FG000|Overall Study|Death|4|||
146587043|NCT05425732|528656469|FG001|Overall Study|Death|2|||
146587044|NCT05425732|528656470|FG002|Overall Study|Death|0|||
146587045|NCT05425732|528656471|FG003|Overall Study|Death|0|||
146652442|NCT01933789|528905248|FG004|Overall Study|Became Ineligible|13|||
146587046|NCT05425732|528656468|FG000|Overall Study|Lost to Follow-up|10|||
146587047|NCT05425732|528656469|FG001|Overall Study|Lost to Follow-up|15|||
146652443|NCT01933789|528905249|FG005|Overall Study|Became Ineligible|10|||
146652444|NCT01933789|528905250|FG006|Overall Study|Became Ineligible|13|||
146652445|NCT01933789|528905251|FG007|Overall Study|Became Ineligible|6|||
146652446|NCT01933789|528905252|FG008|Overall Study|Became Ineligible|0|||
146652447|NCT01925989|528905255|FG000|Period 1|Sponsor Decision|1|||
146652448|NCT01925989|528905256|FG001|Period 1|Sponsor Decision|1|||
146652449|NCT01925989|528905257|FG002|Period 1|Sponsor Decision|0|||
146587048|NCT05425732|528656470|FG002|Overall Study|Lost to Follow-up|5|||
146587049|NCT05425732|528656471|FG003|Overall Study|Lost to Follow-up|3|||
146587050|NCT05425732|528656468|FG000|Overall Study|Physician Decision|0|||
146587051|NCT05425732|528656469|FG001|Overall Study|Physician Decision|2|||
146587052|NCT05425732|528656470|FG002|Overall Study|Physician Decision|0|||
146587053|NCT05425732|528656471|FG003|Overall Study|Physician Decision|0|||
146587054|NCT05425732|528656468|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
146587055|NCT05425732|528656469|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
146587056|NCT05425732|528656470|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146587057|NCT05425732|528656471|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146587058|NCT05425732|528656468|FG000|Overall Study|Withdrawal by Subject|4|||
146587059|NCT05425732|528656469|FG001|Overall Study|Withdrawal by Subject|8|||
146587060|NCT05425732|528656470|FG002|Overall Study|Withdrawal by Subject|1|||
146652450|NCT01925989|528905255|FG000|Period 1|Withdrawal by Subject|0|||
146587061|NCT05425732|528656471|FG003|Overall Study|Withdrawal by Subject|1|||
146587062|NCT05425732|528656468|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
146587063|NCT05425732|528656469|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
146652451|NCT01925989|528905256|FG001|Period 1|Withdrawal by Subject|1|||
146652452|NCT01925989|528905257|FG002|Period 1|Withdrawal by Subject|0|||
146587064|NCT05425732|528656470|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
146587065|NCT05425732|528656471|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
146587066|NCT00539513|528656474|FG000|Overall Study|Withdrawal by Subject|2|||
146587067|NCT00539513|528656475|FG001|Overall Study|Withdrawal by Subject|1|||
146587068|NCT00539513|528656474|FG000|Overall Study|Lost to Follow-up|0|||
146587069|NCT00539513|528656475|FG001|Overall Study|Lost to Follow-up|1|||
146652453|NCT00868517|528905258|FG000|Overall Study|Withdrawal by Subject|3|||
146652454|NCT00868517|528905259|FG001|Overall Study|Withdrawal by Subject|3|||
146652455|NCT00868517|528905260|FG002|Overall Study|Withdrawal by Subject|2|||
146652456|NCT00868517|528905258|FG000|Overall Study|Protocol Violation|1|||
146587070|NCT01328041|528656476|FG000|Overall Study|Adverse Event|7|||
146587071|NCT01328041|528656476|FG000|Overall Study|Lack of Efficacy|27|||
146587072|NCT01328041|528656476|FG000|Overall Study|Protocol Violation|7|||
146587073|NCT01328041|528656476|FG000|Overall Study|Lost to Follow-up|7|||
146587074|NCT01328041|528656476|FG000|Overall Study|Physician Decision|2|||
146587075|NCT01328041|528656476|FG000|Overall Study|Withdrawal by Subject|7|||
146587076|NCT00711113|528656477|FG000|Overall Study|Lost to Follow-up|9|||
146587077|NCT00711113|528656477|FG000|Overall Study|Implant lost|2|||
146587078|NCT00519376|528656482|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146652457|NCT00868517|528905259|FG001|Overall Study|Protocol Violation|1|||
146652458|NCT00868517|528905260|FG002|Overall Study|Protocol Violation|0|||
146652459|NCT05442775|528905261|FG000|Overall Study|Trial terminated|61|||
146652460|NCT05442775|528905261|FG000|Overall Study|Lack of Efficacy|4|||
146652461|NCT05442775|528905261|FG000|Overall Study|Withdrawal by Subject|4|||
146652462|NCT05442775|528905261|FG000|Overall Study|Death|1|||
146652463|NCT05442775|528905261|FG000|Overall Study|Participant removed at Sponsor request|1|||
146652464|NCT02963831|528905262|FG000|Overall Study|Progressive Disease|3|||
146652465|NCT02963831|528905263|FG001|Overall Study|Progressive Disease|3|||
146652466|NCT02963831|528905264|FG002|Overall Study|Progressive Disease|16|||
146652467|NCT02963831|528905265|FG003|Overall Study|Progressive Disease|27|||
146652468|NCT02963831|528905262|FG000|Overall Study|Withdrawal by Subject|1|||
146652469|NCT02963831|528905263|FG001|Overall Study|Withdrawal by Subject|0|||
146652470|NCT02963831|528905264|FG002|Overall Study|Withdrawal by Subject|2|||
146652471|NCT02963831|528905265|FG003|Overall Study|Withdrawal by Subject|4|||
146652472|NCT02963831|528905262|FG000|Overall Study|Adverse Event|0|||
146652473|NCT02963831|528905263|FG001|Overall Study|Adverse Event|1|||
146652474|NCT02963831|528905264|FG002|Overall Study|Adverse Event|1|||
146652475|NCT02963831|528905265|FG003|Overall Study|Adverse Event|2|||
146652476|NCT02963831|528905262|FG000|Overall Study|Death|0|||
146652477|NCT02963831|528905263|FG001|Overall Study|Death|0|||
146652478|NCT02963831|528905264|FG002|Overall Study|Death|0|||
146652479|NCT02963831|528905265|FG003|Overall Study|Death|2|||
146652480|NCT01966432|528905267|FG000|Overall Study|Lost to Follow-up|3|||
146652481|NCT01966432|528905268|FG001|Overall Study|Lost to Follow-up|2|||
146652482|NCT01966432|528905269|FG002|Overall Study|Lost to Follow-up|5|||
146652483|NCT01966432|528905267|FG000|Overall Study|Withdrawal by Subject|1|||
146587079|NCT00519376|528656483|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146587080|NCT00519376|528656484|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146587081|NCT00519376|528656485|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146587082|NCT00519376|528656486|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146587083|NCT00519376|528656487|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146587084|NCT00519376|528656488|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146587085|NCT00519376|528656489|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146587086|NCT00519376|528656490|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146587087|NCT00519376|528656491|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146587088|NCT00519376|528656492|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146652484|NCT01966432|528905268|FG001|Overall Study|Withdrawal by Subject|3|||
146587089|NCT00519376|528656493|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146587090|NCT00519376|528656494|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
146587091|NCT00519376|528656495|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146652485|NCT01966432|528905269|FG002|Overall Study|Withdrawal by Subject|0|||
146652486|NCT01966432|528905267|FG000|Overall Study|Subject Incarcerated|0|||
146652487|NCT01966432|528905268|FG001|Overall Study|Subject Incarcerated|0|||
146652488|NCT01966432|528905269|FG002|Overall Study|Subject Incarcerated|1|||
146652489|NCT01966432|528905267|FG000|Overall Study|SBIRT program ended|1|||
146652490|NCT01966432|528905268|FG001|Overall Study|SBIRT program ended|8|||
146652491|NCT01966432|528905269|FG002|Overall Study|SBIRT program ended|20|||
146652492|NCT02815280|528905276|FG000|Double-Blind Phase|Adverse Event|1|||
146652493|NCT02815280|528905277|FG001|Double-Blind Phase|Adverse Event|1|||
146652494|NCT02815280|528905276|FG000|Double-Blind Phase|Lost to Follow-up|10|||
146652495|NCT02815280|528905277|FG001|Double-Blind Phase|Lost to Follow-up|9|||
146652496|NCT02815280|528905276|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
146652497|NCT02815280|528905277|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
146652498|NCT02815280|528905276|FG000|Double-Blind Phase|Protocol Violation|2|||
146587092|NCT00519376|528656496|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146587093|NCT00519376|528656497|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146587094|NCT00519376|528656482|FG000|Treatment Period 4|Lost to Follow-up|0|||
146587095|NCT00519376|528656483|FG001|Treatment Period 4|Lost to Follow-up|0|||
146587096|NCT00519376|528656484|FG002|Treatment Period 4|Lost to Follow-up|1|||
146587097|NCT00519376|528656485|FG003|Treatment Period 4|Lost to Follow-up|0|||
146587098|NCT00519376|528656486|FG004|Treatment Period 4|Lost to Follow-up|0|||
146587099|NCT00519376|528656487|FG005|Treatment Period 4|Lost to Follow-up|0|||
146587100|NCT00519376|528656488|FG006|Treatment Period 4|Lost to Follow-up|0|||
146587101|NCT00519376|528656489|FG007|Treatment Period 4|Lost to Follow-up|0|||
146587102|NCT00519376|528656490|FG008|Treatment Period 4|Lost to Follow-up|0|||
146587103|NCT00519376|528656491|FG009|Treatment Period 4|Lost to Follow-up|0|||
146587104|NCT00519376|528656492|FG010|Treatment Period 4|Lost to Follow-up|0|||
146587105|NCT00519376|528656493|FG011|Treatment Period 4|Lost to Follow-up|0|||
146587106|NCT00519376|528656494|FG012|Treatment Period 4|Lost to Follow-up|0|||
146587107|NCT00519376|528656495|FG013|Treatment Period 4|Lost to Follow-up|0|||
146587108|NCT00519376|528656496|FG014|Treatment Period 4|Lost to Follow-up|0|||
146587109|NCT00519376|528656497|FG015|Treatment Period 4|Lost to Follow-up|0|||
146587110|NCT02688088|528656498|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
146587111|NCT02688088|528656499|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
146587112|NCT02688088|528656500|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
146587113|NCT02688088|528656501|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
146587114|NCT02688088|528656502|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
146587115|NCT02688088|528656498|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
146587116|NCT02688088|528656499|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
146587117|NCT02688088|528656500|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
146587118|NCT02688088|528656501|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
146587119|NCT02688088|528656502|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
146587120|NCT02688088|528656498|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
146587121|NCT02688088|528656499|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
146587122|NCT02688088|528656500|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
146587123|NCT02688088|528656501|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
146587124|NCT02688088|528656502|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
146587125|NCT02688088|528656498|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
146587126|NCT02688088|528656499|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
146587127|NCT02688088|528656500|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
146587128|NCT02688088|528656501|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
146587129|NCT02688088|528656502|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
146587130|NCT02688088|528656498|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
146587131|NCT02688088|528656499|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
146587132|NCT02688088|528656500|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
146587133|NCT02688088|528656501|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
146587134|NCT02688088|528656502|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
146587135|NCT02688088|528656498|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
146587136|NCT02688088|528656499|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
146587137|NCT02688088|528656500|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
146587138|NCT02688088|528656501|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
146587139|NCT02688088|528656502|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
146587140|NCT02688088|528656498|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
146587141|NCT02688088|528656499|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
146587142|NCT02688088|528656500|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
146587143|NCT02688088|528656501|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
146587144|NCT02688088|528656502|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
146587145|NCT02688088|528656498|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
146587146|NCT02688088|528656499|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
146587147|NCT02688088|528656500|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
146587148|NCT02688088|528656501|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
146587149|NCT02688088|528656502|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
146587150|NCT02688088|528656498|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
146587151|NCT02688088|528656499|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
146587152|NCT02688088|528656500|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
146587153|NCT02688088|528656501|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
146587154|NCT02688088|528656502|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
146587155|NCT01231321|528656506|FG000|Overall Study|Adverse Event|3|||
146587156|NCT01231321|528656506|FG000|Overall Study|Lack of Efficacy|2|||
146652499|NCT02815280|528905277|FG001|Double-Blind Phase|Protocol Violation|2|||
146652500|NCT02815280|528905276|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
146652501|NCT02815280|528905277|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
146587157|NCT04021524|528656507|FG000|Overall Study|Change in surgical intervention|0|||
146587158|NCT04021524|528656508|FG001|Overall Study|Change in surgical intervention|1|||
146587159|NCT00730041|528656512|FG000|Overall Study|Lost to Follow-up|0|||
146587160|NCT00730041|528656513|FG001|Overall Study|Lost to Follow-up|2|||
146587161|NCT02301546|528656514|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
146587162|NCT02301546|528656515|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
146587163|NCT02301546|528656514|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
146587164|NCT02301546|528656515|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
146587165|NCT02301546|528656514|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
146587166|NCT02301546|528656515|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
146587167|NCT02301546|528656514|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
146587168|NCT02301546|528656515|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
146587169|NCT02301546|528656514|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
146587170|NCT02301546|528656515|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
146587171|NCT02301546|528656514|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
146587172|NCT02301546|528656515|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
146587173|NCT02301546|528656514|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
146587174|NCT02301546|528656515|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
146587175|NCT01801436|528656518|FG000|Overall Study|Withdrawal by Subject|3|||
146587176|NCT01801436|528656518|FG000|Overall Study|Adverse Event|2|||
146587177|NCT01801436|528656518|FG000|Overall Study|Progressive disease|4|||
146587178|NCT02447250|528656521|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
146587179|NCT02447250|528656521|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
146587180|NCT02447250|528656521|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
146587181|NCT03632993|528656522|FG000|Overall Study|Withdrawal by Subject|1|||
146587182|NCT03632993|528656523|FG001|Overall Study|Withdrawal by Subject|0|||
146587183|NCT03632993|528656524|FG002|Overall Study|Withdrawal by Subject|0|||
146587184|NCT03632993|528656525|FG003|Overall Study|Withdrawal by Subject|0|||
146587185|NCT03632993|528656526|FG004|Overall Study|Withdrawal by Subject|0|||
146587186|NCT03632993|528656527|FG005|Overall Study|Withdrawal by Subject|0|||
146587187|NCT03632993|528656528|FG006|Overall Study|Withdrawal by Subject|0|||
146587188|NCT03632993|528656529|FG007|Overall Study|Withdrawal by Subject|0|||
146587189|NCT03632993|528656530|FG008|Overall Study|Withdrawal by Subject|0|||
146587190|NCT03632993|528656531|FG009|Overall Study|Withdrawal by Subject|1|||
146587191|NCT03632993|528656522|FG000|Overall Study|Protocol Non-compliance|0|||
146587192|NCT03632993|528656523|FG001|Overall Study|Protocol Non-compliance|1|||
146587193|NCT03632993|528656524|FG002|Overall Study|Protocol Non-compliance|0|||
146587194|NCT03632993|528656525|FG003|Overall Study|Protocol Non-compliance|0|||
146587195|NCT03632993|528656526|FG004|Overall Study|Protocol Non-compliance|0|||
146587196|NCT03632993|528656527|FG005|Overall Study|Protocol Non-compliance|0|||
146587197|NCT03632993|528656528|FG006|Overall Study|Protocol Non-compliance|0|||
146587198|NCT03632993|528656529|FG007|Overall Study|Protocol Non-compliance|0|||
146587199|NCT03632993|528656530|FG008|Overall Study|Protocol Non-compliance|0|||
146587200|NCT03632993|528656531|FG009|Overall Study|Protocol Non-compliance|0|||
146587201|NCT03632993|528656522|FG000|Overall Study|Lost to Follow-up|0|||
146587202|NCT03632993|528656523|FG001|Overall Study|Lost to Follow-up|0|||
146587203|NCT03632993|528656524|FG002|Overall Study|Lost to Follow-up|0|||
146587204|NCT03632993|528656525|FG003|Overall Study|Lost to Follow-up|0|||
146587205|NCT03632993|528656526|FG004|Overall Study|Lost to Follow-up|0|||
146587206|NCT03632993|528656527|FG005|Overall Study|Lost to Follow-up|1|||
146587207|NCT03632993|528656528|FG006|Overall Study|Lost to Follow-up|0|||
146587208|NCT03632993|528656529|FG007|Overall Study|Lost to Follow-up|1|||
146587209|NCT03632993|528656530|FG008|Overall Study|Lost to Follow-up|0|||
146587210|NCT03632993|528656531|FG009|Overall Study|Lost to Follow-up|0|||
146587211|NCT03632993|528656522|FG000|Overall Study|Adverse Event|0|||
146587212|NCT03632993|528656523|FG001|Overall Study|Adverse Event|0|||
146587213|NCT03632993|528656524|FG002|Overall Study|Adverse Event|0|||
146587214|NCT03632993|528656525|FG003|Overall Study|Adverse Event|0|||
146587215|NCT03632993|528656526|FG004|Overall Study|Adverse Event|0|||
146587216|NCT03632993|528656527|FG005|Overall Study|Adverse Event|1|||
146587217|NCT03632993|528656528|FG006|Overall Study|Adverse Event|0|||
146587218|NCT03632993|528656529|FG007|Overall Study|Adverse Event|1|||
146587219|NCT03632993|528656530|FG008|Overall Study|Adverse Event|0|||
146587220|NCT03632993|528656531|FG009|Overall Study|Adverse Event|0|||
146587221|NCT00920218|528656532|FG000|Overall Study|Serious Adverse Event|2|||
146587222|NCT00920218|528656533|FG001|Overall Study|Serious Adverse Event|0|||
146587223|NCT00920218|528656534|FG002|Overall Study|Serious Adverse Event|2|||
146587224|NCT00920218|528656535|FG003|Overall Study|Serious Adverse Event|1|||
146587225|NCT00920218|528656532|FG000|Overall Study|Withdrawal by Subject|0|||
146652502|NCT02815280|528905276|FG000|Open-Label Phase|Adverse Event|2|||
146587226|NCT00920218|528656533|FG001|Overall Study|Withdrawal by Subject|3|||
146587227|NCT00920218|528656534|FG002|Overall Study|Withdrawal by Subject|2|||
146587228|NCT00920218|528656535|FG003|Overall Study|Withdrawal by Subject|0|||
146587229|NCT00920218|528656532|FG000|Overall Study|Migrated/moved from study area|0|||
146587230|NCT00920218|528656533|FG001|Overall Study|Migrated/moved from study area|0|||
146587231|NCT00920218|528656534|FG002|Overall Study|Migrated/moved from study area|1|||
146587232|NCT00920218|528656535|FG003|Overall Study|Migrated/moved from study area|0|||
146587233|NCT00920218|528656532|FG000|Overall Study|Lost to Follow-up|0|||
146587234|NCT00920218|528656533|FG001|Overall Study|Lost to Follow-up|1|||
146587235|NCT00920218|528656534|FG002|Overall Study|Lost to Follow-up|0|||
146587236|NCT00920218|528656535|FG003|Overall Study|Lost to Follow-up|3|||
146587237|NCT00920218|528656532|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
146587238|NCT00920218|528656533|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
146587239|NCT00920218|528656534|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
146587240|NCT00920218|528656535|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
146587241|NCT00920218|528656532|FG000|Overall Study|Other|0|||
146587242|NCT00920218|528656533|FG001|Overall Study|Other|0|||
146587243|NCT00920218|528656534|FG002|Overall Study|Other|1|||
146587244|NCT00920218|528656535|FG003|Overall Study|Other|0|||
146587245|NCT00873041|528656536|FG000|Core Study|Adverse Event|2|||
146587246|NCT00873041|528656537|FG001|Core Study|Adverse Event|3|||
146587247|NCT00873041|528656538|FG002|Core Study|Adverse Event|1|||
146587248|NCT00873041|528656536|FG000|Core Study|Withdrawal by Subject|1|||
146587249|NCT00873041|528656537|FG001|Core Study|Withdrawal by Subject|2|||
146587250|NCT00873041|528656538|FG002|Core Study|Withdrawal by Subject|2|||
146587251|NCT00873041|528656536|FG000|Core Study|Lost to Follow-up|3|||
146587252|NCT00873041|528656537|FG001|Core Study|Lost to Follow-up|1|||
146587253|NCT00873041|528656538|FG002|Core Study|Lost to Follow-up|0|||
146587254|NCT00873041|528656536|FG000|Core Study|Abnormal laboratory value|0|||
146587255|NCT00873041|528656537|FG001|Core Study|Abnormal laboratory value|0|||
146587256|NCT00873041|528656538|FG002|Core Study|Abnormal laboratory value|1|||
146587257|NCT00873041|528656536|FG000|Core Study|Protocol deviation|1|||
146587258|NCT00873041|528656537|FG001|Core Study|Protocol deviation|0|||
146587259|NCT00873041|528656538|FG002|Core Study|Protocol deviation|1|||
146587260|NCT00873041|528656536|FG000|Extension Study|Adverse Event|1|||
146587261|NCT00873041|528656537|FG001|Extension Study|Adverse Event|0|||
146587262|NCT00873041|528656538|FG002|Extension Study|Adverse Event|1|||
146587263|NCT00873041|528656536|FG000|Extension Study|Administrative reasons|0|||
146587264|NCT00873041|528656537|FG001|Extension Study|Administrative reasons|0|||
146587265|NCT00873041|528656538|FG002|Extension Study|Administrative reasons|1|||
146587266|NCT00313313|528656539|FG000|Overall Study|Lack of Efficacy|14|||
146587267|NCT00313313|528656540|FG001|Overall Study|Lack of Efficacy|9|||
146587268|NCT00313313|528656541|FG002|Overall Study|Lack of Efficacy|20|||
146587269|NCT00313313|528656539|FG000|Overall Study|Withdrawal of consent by subject|18|||
146587270|NCT00313313|528656540|FG001|Overall Study|Withdrawal of consent by subject|17|||
146587271|NCT00313313|528656541|FG002|Overall Study|Withdrawal of consent by subject|31|||
146587272|NCT00313313|528656539|FG000|Overall Study|Lost to Follow-up|10|||
146587273|NCT00313313|528656540|FG001|Overall Study|Lost to Follow-up|7|||
146587274|NCT00313313|528656541|FG002|Overall Study|Lost to Follow-up|9|||
146587275|NCT00313313|528656539|FG000|Overall Study|Adverse Event|15|||
146587276|NCT00313313|528656540|FG001|Overall Study|Adverse Event|16|||
146587277|NCT00313313|528656541|FG002|Overall Study|Adverse Event|12|||
146587278|NCT00313313|528656539|FG000|Overall Study|Physician Decision|2|||
146587279|NCT00313313|528656540|FG001|Overall Study|Physician Decision|6|||
146587280|NCT00313313|528656541|FG002|Overall Study|Physician Decision|4|||
146587281|NCT00313313|528656539|FG000|Overall Study|Poor/Noncompliance|3|||
146587282|NCT00313313|528656540|FG001|Overall Study|Poor/Noncompliance|6|||
146587283|NCT00313313|528656541|FG002|Overall Study|Poor/Noncompliance|2|||
146587284|NCT00313313|528656539|FG000|Overall Study|Pregnancy|1|||
146587285|NCT00313313|528656540|FG001|Overall Study|Pregnancy|2|||
146587286|NCT00313313|528656541|FG002|Overall Study|Pregnancy|0|||
146587287|NCT00313313|528656539|FG000|Overall Study|Death|0|||
146587288|NCT00313313|528656540|FG001|Overall Study|Death|0|||
146587289|NCT00313313|528656541|FG002|Overall Study|Death|2|||
146587290|NCT00313313|528656539|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
146587291|NCT00313313|528656540|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
146587292|NCT00313313|528656541|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
146587293|NCT00368836|528656545|FG000|Phase II|Screen Failure|1|||
146587294|NCT00368836|528656545|FG000|Phase II|Withdrawal by Subject|1|||
146587295|NCT00368836|528656545|FG000|Phase II|unable to collect blood and/or breath|17|||
146587296|NCT00368836|528656545|FG000|Phase II|Protocol Violation|2|||
146587297|NCT01345591|528656554|FG000|Overall Study|Lost to Follow-up|1|||
146587298|NCT00090142|528656555|FG000|Treatment Period I|Lost to Follow-up|1|||
146587299|NCT00090142|528656556|FG001|Treatment Period I|Lost to Follow-up|2|||
146587300|NCT00090142|528656555|FG000|Treatment Period I|Protocol Violation|2|||
146587301|NCT00090142|528656556|FG001|Treatment Period I|Protocol Violation|0|||
146587302|NCT00090142|528656555|FG000|Treatment Period I|Withdrawal by Subject|2|||
146587303|NCT00090142|528656556|FG001|Treatment Period I|Withdrawal by Subject|0|||
146587304|NCT00090142|528656555|FG000|Treatment Period I|Other|0|||
146587305|NCT00090142|528656556|FG001|Treatment Period I|Other|1|||
146587306|NCT00090142|528656555|FG000|Treatment Period II|Other|1|||
146587307|NCT00090142|528656556|FG001|Treatment Period II|Other|0|||
146587308|NCT02442310|528656557|FG000|Overall Study|Adverse Event|2|||
146978320|NCT00382291|530084002|FG002|Overall Study|Temporary study suspension|5|||
146978321|NCT00382291|530084000|FG000|Overall Study|Withdrawal by Subject|0|||
146978322|NCT00382291|530084001|FG001|Overall Study|Withdrawal by Subject|2|||
146978323|NCT00382291|530084002|FG002|Overall Study|Withdrawal by Subject|0|||
146978324|NCT00382291|530084000|FG000|Overall Study|Physician Decision|0|||
146587309|NCT02442310|528656557|FG000|Overall Study|Withdrawal by Subject|1|||
146587310|NCT01126437|528656558|FG000|Overall Study|Not treated|11|||
146587311|NCT01126437|528656559|FG001|Overall Study|Not treated|18|||
146587312|NCT01126437|528656560|FG002|Overall Study|Not treated|19|||
146587313|NCT01126437|528656558|FG000|Overall Study|Sites with data irregularities/fraud|6|||
146587314|NCT01126437|528656559|FG001|Overall Study|Sites with data irregularities/fraud|6|||
146587315|NCT01126437|528656560|FG002|Overall Study|Sites with data irregularities/fraud|7|||
146587316|NCT01126437|528656558|FG000|Overall Study|Adverse Event|602|||
146587317|NCT01126437|528656559|FG001|Overall Study|Adverse Event|606|||
146587318|NCT01126437|528656560|FG002|Overall Study|Adverse Event|635|||
146587319|NCT01126437|528656558|FG000|Overall Study|Lack of Efficacy|65|||
146587320|NCT01126437|528656559|FG001|Overall Study|Lack of Efficacy|60|||
146587321|NCT01126437|528656560|FG002|Overall Study|Lack of Efficacy|59|||
146587322|NCT01126437|528656558|FG000|Overall Study|Protocol Violation|64|||
146587323|NCT01126437|528656559|FG001|Overall Study|Protocol Violation|66|||
146587324|NCT01126437|528656560|FG002|Overall Study|Protocol Violation|41|||
146587325|NCT01126437|528656558|FG000|Overall Study|Lost to Follow-up|52|||
146587326|NCT01126437|528656559|FG001|Overall Study|Lost to Follow-up|63|||
146587327|NCT01126437|528656560|FG002|Overall Study|Lost to Follow-up|55|||
146587328|NCT01126437|528656558|FG000|Overall Study|Withdrawal by Subject|331|||
146587329|NCT01126437|528656559|FG001|Overall Study|Withdrawal by Subject|335|||
146587330|NCT01126437|528656560|FG002|Overall Study|Withdrawal by Subject|319|||
146587331|NCT01126437|528656558|FG000|Overall Study|Other reason not specified|210|||
146587332|NCT01126437|528656559|FG001|Overall Study|Other reason not specified|176|||
146587333|NCT01126437|528656560|FG002|Overall Study|Other reason not specified|178|||
146587334|NCT00006046|528656566|FG000|Overall Study|Adverse Event|3|||
146587335|NCT00006046|528656567|FG001|Overall Study|Adverse Event|0|||
146587336|NCT00006046|528656568|FG002|Overall Study|Adverse Event|0|||
146587337|NCT00006046|528656569|FG003|Overall Study|Adverse Event|0|||
146587338|NCT00006046|528656570|FG004|Overall Study|Adverse Event|0|||
146587339|NCT00006046|528656566|FG000|Overall Study|Disease Progression|2|||
146587340|NCT00006046|528656567|FG001|Overall Study|Disease Progression|0|||
146587341|NCT00006046|528656568|FG002|Overall Study|Disease Progression|0|||
146587342|NCT00006046|528656569|FG003|Overall Study|Disease Progression|0|||
146587343|NCT00006046|528656570|FG004|Overall Study|Disease Progression|0|||
146587344|NCT00596154|528656571|FG000|Overall Study|Not Evaluable|2|||
146587345|NCT01846663|528656576|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
146587346|NCT01846663|528656577|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
146587347|NCT01846663|528656576|FG000|Overall Study|Withdrawal by Subject|1|||
146587348|NCT01846663|528656577|FG001|Overall Study|Withdrawal by Subject|0|||
146587349|NCT01846663|528656576|FG000|Overall Study|Adverse Event|1|||
146587350|NCT01846663|528656577|FG001|Overall Study|Adverse Event|2|||
146587351|NCT03888235|528656591|FG000|Overall Study|Lost to Follow-up|1|||
146587352|NCT03888235|528656592|FG001|Overall Study|Lost to Follow-up|1|||
146587353|NCT03888235|528656593|FG002|Overall Study|Lost to Follow-up|0|||
146587354|NCT01535599|528656594|FG000|Overall Study|Adverse Event|6|||
146587355|NCT01535599|528656595|FG001|Overall Study|Adverse Event|15|||
146587356|NCT01535599|528656594|FG000|Overall Study|Lost to Follow-up|3|||
146587357|NCT01535599|528656595|FG001|Overall Study|Lost to Follow-up|4|||
146587358|NCT01535599|528656594|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
146587359|NCT01535599|528656595|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
146587360|NCT01535599|528656594|FG000|Overall Study|Treatment Failure|33|||
146587361|NCT01535599|528656595|FG001|Overall Study|Treatment Failure|66|||
146587362|NCT01535599|528656594|FG000|Overall Study|BL Culture + for Group A Strep|0|||
146587363|NCT01535599|528656595|FG001|Overall Study|BL Culture + for Group A Strep|1|||
146587364|NCT01535599|528656594|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
146587365|NCT01535599|528656595|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
146587366|NCT01535599|528656594|FG000|Overall Study|Randomized in Error|2|||
146587367|NCT01535599|528656595|FG001|Overall Study|Randomized in Error|4|||
146587368|NCT01535599|528656594|FG000|Overall Study|Did not use product|1|||
146587369|NCT01535599|528656595|FG001|Overall Study|Did not use product|0|||
146587370|NCT01535599|528656594|FG000|Overall Study|Other|1|||
146587371|NCT01535599|528656595|FG001|Overall Study|Other|0|||
146587372|NCT01535599|528656594|FG000|Overall Study|Stopped medication|0|||
146587373|NCT01535599|528656595|FG001|Overall Study|Stopped medication|1|||
146587374|NCT01535599|528656594|FG000|Overall Study|Noncompliance|0|||
146587375|NCT01535599|528656595|FG001|Overall Study|Noncompliance|1|||
146587376|NCT02928029|528656612|FG000|Overall Study|Withdrawal by Subject|0|||
146587377|NCT02928029|528656613|FG001|Overall Study|Withdrawal by Subject|1|||
146587378|NCT02928029|528656612|FG000|Overall Study|Radiological progression|1|||
146587379|NCT02928029|528656613|FG001|Overall Study|Radiological progression|0|||
146978325|NCT00382291|530084001|FG001|Overall Study|Physician Decision|1|||
146587380|NCT02928029|528656612|FG000|Overall Study|Clinical progression|1|||
146587381|NCT02928029|528656613|FG001|Overall Study|Clinical progression|2|||
146587382|NCT02928029|528656612|FG000|Overall Study|AE not related to clinical progression|1|||
146587383|NCT02928029|528656613|FG001|Overall Study|AE not related to clinical progression|1|||
146587384|NCT00503776|528656614|FG000|Overall Study|Withdrawal by Subject|1|||
146587385|NCT00503776|528656615|FG001|Overall Study|Withdrawal by Subject|0|||
146587386|NCT00503776|528656616|FG002|Overall Study|Withdrawal by Subject|1|||
146587387|NCT00503776|528656617|FG003|Overall Study|Withdrawal by Subject|1|||
146587388|NCT00503776|528656614|FG000|Overall Study|Physician Decision|0|||
146587389|NCT00503776|528656615|FG001|Overall Study|Physician Decision|0|||
146587390|NCT00503776|528656616|FG002|Overall Study|Physician Decision|1|||
146587391|NCT00503776|528656617|FG003|Overall Study|Physician Decision|1|||
146587392|NCT05427539|528656620|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
146587393|NCT05427539|528656621|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
146587394|NCT05427539|528656620|FG000|Period 1|Withdrawal by Subject|1|||
146587395|NCT05427539|528656621|FG001|Period 1|Withdrawal by Subject|0|||
146587396|NCT02649218|528656629|FG000|Overall Study|Adverse Event|8|||
146587397|NCT02649218|528656629|FG000|Overall Study|Lack of Efficacy|8|||
146587398|NCT02649218|528656629|FG000|Overall Study|Pregnancy|3|||
146587399|NCT02649218|528656629|FG000|Overall Study|Protocol Violation|3|||
146587400|NCT02649218|528656629|FG000|Overall Study|Physician Decision|1|||
146587401|NCT02649218|528656629|FG000|Overall Study|Withdrawal by Subject|2|||
146587402|NCT01301066|528656633|FG000|Overall Study|Lost to Follow-up|5|||
146587403|NCT01301066|528656634|FG001|Overall Study|Lost to Follow-up|11|||
146587404|NCT01301066|528656633|FG000|Overall Study|Protocol Violation|8|||
146587405|NCT01301066|528656634|FG001|Overall Study|Protocol Violation|7|||
146587406|NCT01301066|528656633|FG000|Overall Study|Withdrawal by Subject|4|||
146587407|NCT01301066|528656634|FG001|Overall Study|Withdrawal by Subject|9|||
146587408|NCT01301066|528656633|FG000|Overall Study|Adverse Event|6|||
146587409|NCT01301066|528656634|FG001|Overall Study|Adverse Event|6|||
146587410|NCT01301066|528656633|FG000|Overall Study|Sponsor Decision|2|||
146587411|NCT01301066|528656634|FG001|Overall Study|Sponsor Decision|1|||
146587412|NCT01301066|528656633|FG000|Overall Study|Physician Decision|0|||
146587413|NCT01301066|528656634|FG001|Overall Study|Physician Decision|1|||
146587414|NCT01301066|528656633|FG000|Overall Study|Other|2|||
146587415|NCT01301066|528656634|FG001|Overall Study|Other|0|||
146587416|NCT00082368|528656639|FG000|Overall Study|Not treated-pt had poor IV access|1|||
146587417|NCT01846299|528656640|FG000|Overall Study|Physician Decision|4|||
146587418|NCT01846299|528656641|FG001|Overall Study|Physician Decision|2|||
146587419|NCT01846299|528656640|FG000|Overall Study|Protocol deviation|1|||
146587420|NCT01846299|528656641|FG001|Overall Study|Protocol deviation|0|||
146587421|NCT01846299|528656640|FG000|Overall Study|Death|1|||
146587422|NCT01846299|528656641|FG001|Overall Study|Death|2|||
146587423|NCT01846299|528656640|FG000|Overall Study|Lost to Follow-up|3|||
146587424|NCT01846299|528656641|FG001|Overall Study|Lost to Follow-up|0|||
146587425|NCT01846299|528656640|FG000|Overall Study|Withdrawal by Subject|1|||
146587426|NCT01846299|528656641|FG001|Overall Study|Withdrawal by Subject|6|||
146587427|NCT01846299|528656640|FG000|Overall Study|Adverse Event|2|||
146587428|NCT01846299|528656641|FG001|Overall Study|Adverse Event|0|||
146587429|NCT01330628|528656642|FG000|Overall Study|Death|2|||
146587430|NCT01330628|528656643|FG001|Overall Study|Death|3|||
146587431|NCT01330628|528656642|FG000|Overall Study|Lost to Follow-up|5|||
146587432|NCT01330628|528656643|FG001|Overall Study|Lost to Follow-up|6|||
146587433|NCT01330628|528656642|FG000|Overall Study|Adverse Event|44|||
146587434|NCT01330628|528656643|FG001|Overall Study|Adverse Event|25|||
146587435|NCT01330628|528656642|FG000|Overall Study|Withdrawn|18|||
146587436|NCT01330628|528656643|FG001|Overall Study|Withdrawn|6|||
146587437|NCT01330628|528656642|FG000|Overall Study|Didn't receive study treatment|1|||
146587438|NCT01330628|528656643|FG001|Overall Study|Didn't receive study treatment|0|||
146587439|NCT01740089|528658692|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
146587440|NCT01740089|528658693|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
146587441|NCT01740089|528658694|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
146587442|NCT01740089|528658692|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
146978326|NCT00382291|530084002|FG002|Overall Study|Physician Decision|0|||
146587443|NCT01740089|528658693|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
146587444|NCT01740089|528658694|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
146587445|NCT01740089|528658692|FG000|After 12 Weeks|Lack of Efficacy|3|||
146587446|NCT01740089|528658693|FG001|After 12 Weeks|Lack of Efficacy|1|||
146587447|NCT01740089|528658694|FG002|After 12 Weeks|Lack of Efficacy|4|||
146587448|NCT01740089|528658692|FG000|After 12 Weeks|Adverse Event|2|||
146587449|NCT01740089|528658693|FG001|After 12 Weeks|Adverse Event|0|||
146587450|NCT01740089|528658694|FG002|After 12 Weeks|Adverse Event|5|||
146587451|NCT01740089|528658692|FG000|After 12 Weeks|Protocol Violation|1|||
146587452|NCT01740089|528658693|FG001|After 12 Weeks|Protocol Violation|1|||
146587453|NCT01740089|528658694|FG002|After 12 Weeks|Protocol Violation|1|||
146587454|NCT01740089|528658692|FG000|After 12 Weeks|Withdrawal by Subject|1|||
146587455|NCT01740089|528658693|FG001|After 12 Weeks|Withdrawal by Subject|1|||
146652503|NCT02815280|528905277|FG001|Open-Label Phase|Adverse Event|3|||
146978327|NCT00382291|530084000|FG000|Overall Study|Lack of Efficacy|0|||
146587456|NCT01740089|528658694|FG002|After 12 Weeks|Withdrawal by Subject|1|||
146587457|NCT01448824|528658697|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
146587458|NCT01448824|528658698|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
146652504|NCT02815280|528905276|FG000|Open-Label Phase|Lost to Follow-up|18|||
146652505|NCT02815280|528905277|FG001|Open-Label Phase|Lost to Follow-up|9|||
146652506|NCT02815280|528905276|FG000|Open-Label Phase|Withdrawal by Subject|33|||
146652507|NCT02815280|528905277|FG001|Open-Label Phase|Withdrawal by Subject|18|||
146652508|NCT02815280|528905276|FG000|Open-Label Phase|Protocol Violation|3|||
146587459|NCT01448824|528658699|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
146587460|NCT01448824|528658700|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
146587461|NCT01448824|528658701|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
146587462|NCT01448824|528658702|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
146587463|NCT01448824|528658703|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
146587464|NCT01448824|528658704|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
146587465|NCT01448824|528658697|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
146587466|NCT01448824|528658698|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
146587467|NCT01448824|528658699|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
146587468|NCT01448824|528658700|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
146587469|NCT01448824|528658701|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
146587470|NCT01448824|528658702|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
146587471|NCT01448824|528658703|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
146587472|NCT01448824|528658704|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
146587473|NCT01448824|528658697|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
146587474|NCT01448824|528658698|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
146587475|NCT01448824|528658699|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
146587476|NCT01448824|528658700|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
146587477|NCT01448824|528658701|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
146587478|NCT01448824|528658702|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
146587479|NCT01448824|528658703|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
146587480|NCT01448824|528658704|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
146587481|NCT01448824|528658697|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
146587482|NCT01448824|528658698|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
146587483|NCT01448824|528658699|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
146587484|NCT01448824|528658700|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
146587485|NCT01448824|528658701|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
146587486|NCT01448824|528658702|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
146587487|NCT01448824|528658703|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
146587488|NCT01448824|528658704|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
146587489|NCT01448824|528658697|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
146587490|NCT01448824|528658698|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
146587491|NCT01448824|528658699|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
146587492|NCT01448824|528658700|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
146587493|NCT01448824|528658701|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
146587494|NCT01448824|528658702|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
146587495|NCT01448824|528658703|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
146587496|NCT01448824|528658704|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
146587497|NCT01448824|528658697|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
146587498|NCT01448824|528658698|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
146587499|NCT01448824|528658699|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
146587500|NCT01448824|528658700|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
146587501|NCT01448824|528658701|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
146587502|NCT01448824|528658702|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
146587503|NCT01448824|528658703|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
146587504|NCT01448824|528658704|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
146587505|NCT01448824|528658697|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
146587506|NCT01448824|528658698|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
146587507|NCT01448824|528658699|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
146587508|NCT01448824|528658700|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
146587509|NCT01448824|528658701|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
146587510|NCT01448824|528658702|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
146587511|NCT01448824|528658703|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
146587512|NCT01448824|528658704|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
146587513|NCT01448824|528658697|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
146652509|NCT02815280|528905277|FG001|Open-Label Phase|Protocol Violation|0|||
146587514|NCT01448824|528658698|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
146652510|NCT02815280|528905276|FG000|Open-Label Phase|Administrative|26|||
146652511|NCT02815280|528905277|FG001|Open-Label Phase|Administrative|12|||
146587515|NCT01448824|528658699|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
146587516|NCT01448824|528658700|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
146587517|NCT01448824|528658701|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
146587518|NCT01448824|528658702|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
146587519|NCT01448824|528658703|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
146587520|NCT01448824|528658704|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
146587521|NCT03285958|528658706|FG000|Overall Study|Lost to Follow-up|1|||
146587522|NCT03285958|528658707|FG001|Overall Study|Lost to Follow-up|1|||
146587523|NCT03285958|528658706|FG000|Overall Study|Withdrawal by Subject|1|||
146587524|NCT03285958|528658707|FG001|Overall Study|Withdrawal by Subject|0|||
146587525|NCT03285958|528658706|FG000|Overall Study|Not able to attend required orientation|3|||
146587526|NCT03285958|528658707|FG001|Overall Study|Not able to attend required orientation|0|||
146587527|NCT03116828|528658708|FG000|Overall Study|Adverse Event|1|||
146587528|NCT03116828|528658709|FG001|Overall Study|Adverse Event|10|||
146587529|NCT03116828|528658708|FG000|Overall Study|Withdrawal by Subject|4|||
146587530|NCT03116828|528658709|FG001|Overall Study|Withdrawal by Subject|8|||
146587531|NCT03116828|528658708|FG000|Overall Study|OTHER|3|||
146587532|NCT03116828|528658709|FG001|Overall Study|OTHER|3|||
146587533|NCT03002818|528658710|FG000|Overall Study|Decision of the investigator|1|||
146587534|NCT01606787|528658715|FG000|Overall Study|Withdrawal by Subject|4|||
146587535|NCT01606787|528658716|FG001|Overall Study|Withdrawal by Subject|5|||
146587536|NCT01606787|528658715|FG000|Overall Study|Surgery canceled|0|||
146587537|NCT01606787|528658716|FG001|Overall Study|Surgery canceled|2|||
146587538|NCT05312632|528658720|FG000|Overall Study|Adverse Event|12|||
146587539|NCT05312632|528658720|FG000|Overall Study|Withdrawal by Subject|10|||
146587540|NCT05312632|528658720|FG000|Overall Study|Lack of Efficacy|4|||
146587541|NCT05312632|528658720|FG000|Overall Study|Non-compliance with study procedures|9|||
146587542|NCT05312632|528658720|FG000|Overall Study|Other|4|||
146587543|NCT00489736|528658721|FG000|Overall Study|Lack of Efficacy|53|||
146587544|NCT00489736|528658722|FG001|Overall Study|Lack of Efficacy|14|||
146587545|NCT00489736|528658721|FG000|Overall Study|Adverse Event|32|||
146587546|NCT00489736|528658722|FG001|Overall Study|Adverse Event|45|||
146587547|NCT00489736|528658721|FG000|Overall Study|Poor compliance|6|||
146587548|NCT00489736|528658722|FG001|Overall Study|Poor compliance|2|||
146587549|NCT00489736|528658721|FG000|Overall Study|Not coded/ Not pre-specified|5|||
146587550|NCT00489736|528658722|FG001|Overall Study|Not coded/ Not pre-specified|8|||
146587551|NCT01681069|528658723|FG000|Overall Study|Withdrawal by Subject|4|||
146587552|NCT01681069|528658724|FG001|Overall Study|Withdrawal by Subject|5|||
146587553|NCT01681069|528658723|FG000|Overall Study|Protocol Violation|1|||
146587554|NCT01681069|528658724|FG001|Overall Study|Protocol Violation|1|||
146587555|NCT01681069|528658723|FG000|Overall Study|Adverse Event|0|||
146587556|NCT01681069|528658724|FG001|Overall Study|Adverse Event|1|||
146587557|NCT03883165|528658725|FG000|Overall Study|Withdrawal by Subject|4|||
146587558|NCT03883165|528658726|FG001|Overall Study|Withdrawal by Subject|3|||
146587559|NCT00245050|528658727|FG000|Overall Study|Adverse Event|3|||
146587560|NCT00245050|528658728|FG001|Overall Study|Adverse Event|2|||
146587561|NCT05526781|528658729|FG000|Overall Study|Lost to Follow-up|1|||
146587562|NCT02743949|528658730|FG000|Overall Study|Adverse Event|0|||
146587563|NCT02743949|528658731|FG001|Overall Study|Adverse Event|0|||
146587564|NCT02743949|528658732|FG002|Overall Study|Adverse Event|2|||
146587565|NCT02743949|528658730|FG000|Overall Study|Significant Protocol Deviation|2|||
146587566|NCT02743949|528658731|FG001|Overall Study|Significant Protocol Deviation|0|||
146587567|NCT02743949|528658732|FG002|Overall Study|Significant Protocol Deviation|1|||
146587568|NCT02743949|528658730|FG000|Overall Study|Voluntary Withdrawal|2|||
146587569|NCT02743949|528658731|FG001|Overall Study|Voluntary Withdrawal|1|||
146587570|NCT02743949|528658732|FG002|Overall Study|Voluntary Withdrawal|0|||
146587571|NCT01498575|528658733|FG000|Overall Sample|Withdrawal by Subject|60|||
146587572|NCT01498575|528658734|FG001|Overall Sample|Withdrawal by Subject|14|||
146587573|NCT01498575|528658733|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
146587574|NCT01498575|528658734|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
146587575|NCT01498575|528658733|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
146587576|NCT01498575|528658734|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
146587577|NCT01425359|528658753|FG000|Overall Study|Randomized but Not Treated|2|||
146587578|NCT01425359|528658754|FG001|Overall Study|Randomized but Not Treated|3|||
146587579|NCT01425359|528658753|FG000|Overall Study|Adverse Event|9|||
146587580|NCT01425359|528658754|FG001|Overall Study|Adverse Event|8|||
146587581|NCT01425359|528658753|FG000|Overall Study|Revascularization|0|||
146587582|NCT01425359|528658754|FG001|Overall Study|Revascularization|1|||
146587583|NCT01425359|528658753|FG000|Overall Study|Death|0|||
146587584|NCT01425359|528658754|FG001|Overall Study|Death|1|||
146587585|NCT01425359|528658753|FG000|Overall Study|Unsatisfactory Response|1|||
146587586|NCT01425359|528658754|FG001|Overall Study|Unsatisfactory Response|0|||
146736238|NCT00279201|529205302|FG001|Intensification Addendum|Sponsor Decision|0|||
146587587|NCT01425359|528658753|FG000|Overall Study|Protocol Violation|1|||
146587588|NCT01425359|528658754|FG001|Overall Study|Protocol Violation|2|||
146587589|NCT01425359|528658753|FG000|Overall Study|Subject Withdrew Consent|1|||
146587590|NCT01425359|528658754|FG001|Overall Study|Subject Withdrew Consent|2|||
146587591|NCT01425359|528658753|FG000|Overall Study|Investigator's Discretion|2|||
146587592|NCT01425359|528658754|FG001|Overall Study|Investigator's Discretion|0|||
146587593|NCT01425359|528658753|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
146587594|NCT01425359|528658754|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
146587595|NCT03172325|528658755|FG000|Overall Study|Adverse Event|2|||
146918947|NCT01544595|529864543|FG002|Status at Week 68|Technical problems|0|||
146918948|NCT01544595|529864544|FG003|Status at Week 68|Technical problems|1|||
146587596|NCT03172325|528658756|FG001|Overall Study|Adverse Event|3|||
146587597|NCT03172325|528658755|FG000|Overall Study|Positive PPD|1|||
146587598|NCT03172325|528658756|FG001|Overall Study|Positive PPD|0|||
146587599|NCT03172325|528658755|FG000|Overall Study|Poor Compliance|1|||
146587600|NCT03172325|528658756|FG001|Overall Study|Poor Compliance|1|||
146587601|NCT01229254|528658764|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
146587602|NCT01229254|528658765|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
146587603|NCT01229254|528658766|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
146587604|NCT01229254|528658764|FG000|Overall Study|Adverse Event|4|||
146587605|NCT01229254|528658765|FG001|Overall Study|Adverse Event|5|||
146587606|NCT01229254|528658766|FG002|Overall Study|Adverse Event|3|||
146587607|NCT01229254|528658764|FG000|Overall Study|Lost to Follow-up|3|||
146587608|NCT01229254|528658765|FG001|Overall Study|Lost to Follow-up|0|||
146587609|NCT01229254|528658766|FG002|Overall Study|Lost to Follow-up|1|||
146587610|NCT01229254|528658764|FG000|Overall Study|Physician Decision|0|||
146587611|NCT01229254|528658765|FG001|Overall Study|Physician Decision|3|||
146587612|NCT01229254|528658766|FG002|Overall Study|Physician Decision|0|||
146587613|NCT01229254|528658764|FG000|Overall Study|Protocol Violation|4|||
146587614|NCT01229254|528658765|FG001|Overall Study|Protocol Violation|6|||
146587615|NCT01229254|528658766|FG002|Overall Study|Protocol Violation|5|||
146587616|NCT01229254|528658764|FG000|Overall Study|Withdrawal by Subject|1|||
146587617|NCT01229254|528658765|FG001|Overall Study|Withdrawal by Subject|0|||
146587618|NCT01229254|528658766|FG002|Overall Study|Withdrawal by Subject|1|||
146587619|NCT01229254|528658764|FG000|Overall Study|Non-compliance with Study Drug|0|||
146587620|NCT01229254|528658765|FG001|Overall Study|Non-compliance with Study Drug|1|||
146587621|NCT01229254|528658766|FG002|Overall Study|Non-compliance with Study Drug|1|||
146587622|NCT01694121|528658767|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
146587623|NCT01694121|528658768|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
146587624|NCT00744978|528658769|FG000|Period 1|Lost to Follow-up|1|||
146587625|NCT00744978|528658770|FG001|Period 1|Lost to Follow-up|0|||
146587626|NCT00744978|528658769|FG000|Period 1|Withdrawal by Subject|0|||
146587627|NCT00744978|528658770|FG001|Period 1|Withdrawal by Subject|2|||
146587628|NCT00744978|528658769|FG000|Period 1|Other|0|||
146587629|NCT00744978|528658770|FG001|Period 1|Other|2|||
146587630|NCT00744978|528658769|FG000|Period 1|Adverse Event|4|||
146587631|NCT00744978|528658770|FG001|Period 1|Adverse Event|0|||
146587632|NCT00744978|528658769|FG000|Period 1|Randomized but not Treated|1|||
146587633|NCT00744978|528658770|FG001|Period 1|Randomized but not Treated|1|||
146587634|NCT00744978|528658769|FG000|Period 2|Adverse Event|0|||
146587635|NCT00744978|528658770|FG001|Period 2|Adverse Event|1|||
146587636|NCT00223977|528658773|FG000|Overall Study|Adverse Event|7|||
146587637|NCT00223977|528658774|FG001|Overall Study|Adverse Event|10|||
146587638|NCT00223977|528658775|FG002|Overall Study|Adverse Event|0|||
146587639|NCT00223977|528658773|FG000|Overall Study|Protocol Violation|0|||
146587640|NCT00223977|528658774|FG001|Overall Study|Protocol Violation|0|||
146587641|NCT00223977|528658775|FG002|Overall Study|Protocol Violation|1|||
146587642|NCT00223977|528658773|FG000|Overall Study|Withdrawal by Subject|1|||
146587643|NCT00223977|528658774|FG001|Overall Study|Withdrawal by Subject|1|||
146587644|NCT00223977|528658775|FG002|Overall Study|Withdrawal by Subject|2|||
146587645|NCT00223977|528658773|FG000|Overall Study|Other|1|||
146587646|NCT00223977|528658774|FG001|Overall Study|Other|0|||
146587647|NCT00223977|528658775|FG002|Overall Study|Other|0|||
146587648|NCT03359785|528658776|FG000|Overall Study|Protocol Violation|0|||
146587649|NCT03359785|528658777|FG001|Overall Study|Protocol Violation|1|||
146587650|NCT03359785|528658778|FG002|Overall Study|Protocol Violation|0|||
146587651|NCT03359785|528658779|FG003|Overall Study|Protocol Violation|0|||
146587652|NCT03359785|528658776|FG000|Overall Study|Early study termination due to study pause|0|||
146587653|NCT03359785|528658777|FG001|Overall Study|Early study termination due to study pause|0|||
146587654|NCT03359785|528658778|FG002|Overall Study|Early study termination due to study pause|2|||
146587655|NCT03359785|528658779|FG003|Overall Study|Early study termination due to study pause|0|||
146587656|NCT03359785|528658776|FG000|Overall Study|Withdrawal by Subject|2|||
146587657|NCT03359785|528658777|FG001|Overall Study|Withdrawal by Subject|2|||
146587658|NCT03359785|528658778|FG002|Overall Study|Withdrawal by Subject|0|||
146587659|NCT03359785|528658779|FG003|Overall Study|Withdrawal by Subject|0|||
146587660|NCT01895543|528658780|FG000|Overall Study|Withdrawal by Subject|43|||
146587661|NCT01895543|528658780|FG000|Overall Study|Lost to Follow-up|25|||
146587662|NCT01895543|528658780|FG000|Overall Study|Adverse Event|28|||
146587663|NCT01895543|528658780|FG000|Overall Study|Subject's substantial non-compliance|6|||
146587664|NCT01895543|528658780|FG000|Overall Study|Protocol Violation|1|||
146587665|NCT01895543|528658780|FG000|Overall Study|Physician Decision|2|||
146587666|NCT01895543|528658780|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
146587667|NCT03276026|528658788|FG000|Overall Study|Protocol Violation|1|||
146587668|NCT03276026|528658789|FG001|Overall Study|Protocol Violation|0|||
146587669|NCT03650803|528658791|FG000|Overall Study|Lost to Follow-up|6|||
146587670|NCT01534260|528658792|FG000|Overall Study|Adverse Event|1|||
146587671|NCT01534260|528658793|FG001|Overall Study|Adverse Event|8|||
146587672|NCT01534260|528658792|FG000|Overall Study|Death|2|||
146587673|NCT01534260|528658793|FG001|Overall Study|Death|0|||
146587674|NCT01534260|528658792|FG000|Overall Study|Lack of Efficacy|1|||
146587675|NCT01534260|528658793|FG001|Overall Study|Lack of Efficacy|1|||
146587676|NCT01534260|528658792|FG000|Overall Study|Withdrawal by Subject|1|||
146587677|NCT01534260|528658793|FG001|Overall Study|Withdrawal by Subject|3|||
146587678|NCT01534260|528658792|FG000|Overall Study|Disease Progression|8|||
146587679|NCT01534260|528658793|FG001|Overall Study|Disease Progression|6|||
146587680|NCT01534260|528658792|FG000|Overall Study|Physician Decision|3|||
146587681|NCT01534260|528658793|FG001|Overall Study|Physician Decision|1|||
146587682|NCT01534260|528658792|FG000|Overall Study|No treatment, per protocol|0|||
146587683|NCT01534260|528658793|FG001|Overall Study|No treatment, per protocol|1|||
146587684|NCT02359045|528658794|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
146587685|NCT02359045|528658795|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146587686|NCT02359045|528658794|FG000|Overall Study|Lost to Follow-up|1|||
146587687|NCT02359045|528658795|FG001|Overall Study|Lost to Follow-up|1|||
146587688|NCT02359045|528658794|FG000|Overall Study|Adverse Event|0|||
146587689|NCT02359045|528658795|FG001|Overall Study|Adverse Event|1|||
146587690|NCT01639339|528658799|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
146587691|NCT01639339|528658800|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
146587692|NCT01639339|528658799|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
146587693|NCT01639339|528658800|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
146587694|NCT01639339|528658799|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
146587695|NCT01639339|528658800|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
146587696|NCT01639339|528658799|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
146587697|NCT01639339|528658800|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
146587698|NCT01639339|528658799|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
146587699|NCT01639339|528658800|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
146587700|NCT01639339|528658799|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
146587701|NCT01639339|528658800|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
146587702|NCT01639339|528658799|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
146587703|NCT01639339|528658800|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
146587704|NCT01639339|528658799|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
146587705|NCT01639339|528658800|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
146587706|NCT01639339|528658799|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
146587707|NCT01639339|528658800|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
146587708|NCT01639339|528658799|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
146587709|NCT01639339|528658800|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
146587710|NCT00367744|528658801|FG000|Overall Study|Lost to Follow-up|4|||
146587711|NCT00367744|528658802|FG001|Overall Study|Lost to Follow-up|5|||
146587712|NCT00503581|528658809|FG000|Overall Study|Study closed|3|||
146587713|NCT00503581|528658810|FG001|Overall Study|Study closed|4|||
146587714|NCT00503581|528658811|FG002|Overall Study|Study closed|2|||
146587715|NCT04376684|528658812|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
146587716|NCT04376684|528658813|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
146587717|NCT04376684|528658814|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
146587718|NCT04376684|528658815|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
146587719|NCT04376684|528658812|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
146587720|NCT04376684|528658813|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
146587721|NCT04376684|528658814|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
146587722|NCT04376684|528658815|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
146587723|NCT04376684|528658812|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
146587724|NCT04376684|528658813|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
146587725|NCT04376684|528658814|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
146587726|NCT04376684|528658815|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
146587727|NCT04376684|528658812|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
146587728|NCT04376684|528658813|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
146587729|NCT04376684|528658814|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
146587730|NCT04376684|528658815|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
146587731|NCT04376684|528658812|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
146587732|NCT04376684|528658813|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
146587733|NCT04376684|528658814|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
146587734|NCT04376684|528658815|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
146587735|NCT04376684|528658812|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
146587736|NCT04376684|528658813|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
146652512|NCT02815280|528905276|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
146652513|NCT02815280|528905277|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
146652514|NCT02106923|528905289|FG000|Overall Study|Protocol Violation|0|||
146652515|NCT02106923|528905290|FG001|Overall Study|Protocol Violation|0|||
146652516|NCT02106923|528905291|FG002|Overall Study|Protocol Violation|0|||
146652517|NCT02106923|528905292|FG003|Overall Study|Protocol Violation|0|||
146587737|NCT04376684|528658814|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
146587738|NCT04376684|528658815|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
146587739|NCT04376684|528658812|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
146587740|NCT04376684|528658813|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
146587741|NCT04376684|528658814|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
146587742|NCT04376684|528658815|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
146587743|NCT01666119|528658816|FG000|Overall Study|Adverse Event|6|||
146587744|NCT01666119|528658816|FG000|Overall Study|Withdrawal by Subject|16|||
146587745|NCT01666119|528658816|FG000|Overall Study|Lost to Follow-up|7|||
146587746|NCT01666119|528658816|FG000|Overall Study|non compliance with study medication, pa|18|||
146587747|NCT01666119|528658816|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
146587748|NCT02979093|528658833|FG000|First Scan Session|Scanning data problems|1|||
146587749|NCT02979093|528658834|FG001|First Scan Session|Scanning data problems|2|||
146587750|NCT02979093|528658835|FG002|First Scan Session|Scanning data problems|2|||
146587751|NCT02979093|528658836|FG003|First Scan Session|Scanning data problems|0|||
146587752|NCT02979093|528658833|FG000|Second Scan Session|Scanning data problems|3|||
146587753|NCT02979093|528658834|FG001|Second Scan Session|Scanning data problems|0|||
146587754|NCT02979093|528658835|FG002|Second Scan Session|Scanning data problems|1|||
146587755|NCT02979093|528658836|FG003|Second Scan Session|Scanning data problems|3|||
146587756|NCT06107803|528658837|FG000|Overall Study|Adverse Event|1|||
146587757|NCT06107803|528658837|FG000|Overall Study|Withdrawal by Subject|2|||
146587758|NCT06107803|528658837|FG000|Overall Study|Protocol Violation|1|||
146587759|NCT05596734|528658838|FG000|Substudy A|Withdrawal by Subject|1|||
146587760|NCT05596734|528658839|FG001|Substudy A|Withdrawal by Subject|0|||
146587761|NCT05596734|528658840|FG002|Substudy A|Withdrawal by Subject|0|||
146587762|NCT05596734|528658841|FG003|Substudy A|Withdrawal by Subject|0|||
146587763|NCT05596734|528658842|FG004|Substudy A|Withdrawal by Subject|0|||
146587764|NCT05596734|528658843|FG005|Substudy A|Withdrawal by Subject|0|||
146587765|NCT05596734|528658844|FG006|Substudy A|Withdrawal by Subject|1|||
146587766|NCT05596734|528658845|FG007|Substudy A|Withdrawal by Subject|0|||
146587767|NCT05596734|528658846|FG008|Substudy A|Withdrawal by Subject|0|||
146587768|NCT05596734|528658847|FG009|Substudy A|Withdrawal by Subject|0|||
146587769|NCT05596734|528658848|FG010|Substudy A|Withdrawal by Subject|0|||
146587770|NCT05596734|528658849|FG011|Substudy A|Withdrawal by Subject|0|||
146587771|NCT05596734|528658850|FG012|Substudy A|Withdrawal by Subject|0|||
146587772|NCT05596734|528658851|FG013|Substudy A|Withdrawal by Subject|0|||
146587773|NCT05596734|528658852|FG014|Substudy A|Withdrawal by Subject|0|||
146587774|NCT05596734|528658853|FG015|Substudy A|Withdrawal by Subject|0|||
146587775|NCT05596734|528658854|FG016|Substudy A|Withdrawal by Subject|0|||
146587776|NCT05596734|528658855|FG017|Substudy A|Withdrawal by Subject|0|||
146587777|NCT05596734|528658856|FG018|Substudy A|Withdrawal by Subject|0|||
146587778|NCT05596734|528658857|FG019|Substudy A|Withdrawal by Subject|0|||
146587779|NCT05596734|528658858|FG020|Substudy A|Withdrawal by Subject|0|||
146587780|NCT05596734|528658859|FG021|Substudy A|Withdrawal by Subject|0|||
146587781|NCT05596734|528658860|FG022|Substudy A|Withdrawal by Subject|0|||
146587782|NCT05596734|528658861|FG023|Substudy A|Withdrawal by Subject|0|||
146587783|NCT05596734|528658838|FG000|Substudy A|Lost to Follow-up|1|||
146587784|NCT05596734|528658839|FG001|Substudy A|Lost to Follow-up|0|||
146587785|NCT05596734|528658840|FG002|Substudy A|Lost to Follow-up|1|||
146587786|NCT05596734|528658841|FG003|Substudy A|Lost to Follow-up|0|||
146587787|NCT05596734|528658842|FG004|Substudy A|Lost to Follow-up|0|||
146587788|NCT05596734|528658843|FG005|Substudy A|Lost to Follow-up|0|||
146587789|NCT05596734|528658844|FG006|Substudy A|Lost to Follow-up|0|||
146587790|NCT05596734|528658845|FG007|Substudy A|Lost to Follow-up|0|||
146978328|NCT00382291|530084001|FG001|Overall Study|Lack of Efficacy|0|||
146587791|NCT05596734|528658846|FG008|Substudy A|Lost to Follow-up|0|||
146587792|NCT05596734|528658847|FG009|Substudy A|Lost to Follow-up|0|||
146587793|NCT05596734|528658848|FG010|Substudy A|Lost to Follow-up|0|||
146652518|NCT02106923|528905293|FG004|Overall Study|Protocol Violation|0|||
146587794|NCT05596734|528658849|FG011|Substudy A|Lost to Follow-up|0|||
146587795|NCT05596734|528658850|FG012|Substudy A|Lost to Follow-up|0|||
146587796|NCT05596734|528658851|FG013|Substudy A|Lost to Follow-up|0|||
146587797|NCT05596734|528658852|FG014|Substudy A|Lost to Follow-up|0|||
146587798|NCT05596734|528658853|FG015|Substudy A|Lost to Follow-up|0|||
146587799|NCT05596734|528658854|FG016|Substudy A|Lost to Follow-up|0|||
146587800|NCT05596734|528658855|FG017|Substudy A|Lost to Follow-up|0|||
146587801|NCT05596734|528658856|FG018|Substudy A|Lost to Follow-up|0|||
146587802|NCT05596734|528658857|FG019|Substudy A|Lost to Follow-up|0|||
146587803|NCT05596734|528658858|FG020|Substudy A|Lost to Follow-up|0|||
146587804|NCT05596734|528658859|FG021|Substudy A|Lost to Follow-up|0|||
146587805|NCT05596734|528658860|FG022|Substudy A|Lost to Follow-up|0|||
146587806|NCT05596734|528658861|FG023|Substudy A|Lost to Follow-up|0|||
146652519|NCT02106923|528905294|FG005|Overall Study|Protocol Violation|1|||
146652520|NCT03485495|528905295|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
146652521|NCT03485495|528905296|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
146587807|NCT05596734|528658838|FG000|Substudy B|Withdrawal by Subject|0|||
146587808|NCT05596734|528658839|FG001|Substudy B|Withdrawal by Subject|0|||
146587809|NCT05596734|528658840|FG002|Substudy B|Withdrawal by Subject|0|||
146587810|NCT05596734|528658841|FG003|Substudy B|Withdrawal by Subject|0|||
146587811|NCT05596734|528658842|FG004|Substudy B|Withdrawal by Subject|0|||
146587812|NCT05596734|528658843|FG005|Substudy B|Withdrawal by Subject|0|||
146587813|NCT05596734|528658844|FG006|Substudy B|Withdrawal by Subject|0|||
146587814|NCT05596734|528658845|FG007|Substudy B|Withdrawal by Subject|0|||
146587815|NCT05596734|528658846|FG008|Substudy B|Withdrawal by Subject|0|||
146587816|NCT05596734|528658847|FG009|Substudy B|Withdrawal by Subject|0|||
146587817|NCT05596734|528658848|FG010|Substudy B|Withdrawal by Subject|0|||
146587818|NCT05596734|528658849|FG011|Substudy B|Withdrawal by Subject|0|||
146587819|NCT05596734|528658850|FG012|Substudy B|Withdrawal by Subject|1|||
146587820|NCT05596734|528658851|FG013|Substudy B|Withdrawal by Subject|0|||
146652522|NCT01323920|528905297|FG000|Overall Study|Death|5|||
146587821|NCT05596734|528658852|FG014|Substudy B|Withdrawal by Subject|1|||
146587822|NCT05596734|528658853|FG015|Substudy B|Withdrawal by Subject|2|||
146587823|NCT05596734|528658854|FG016|Substudy B|Withdrawal by Subject|2|||
146587824|NCT05596734|528658855|FG017|Substudy B|Withdrawal by Subject|1|||
146587825|NCT05596734|528658856|FG018|Substudy B|Withdrawal by Subject|2|||
146587826|NCT05596734|528658857|FG019|Substudy B|Withdrawal by Subject|0|||
146587827|NCT05596734|528658858|FG020|Substudy B|Withdrawal by Subject|0|||
146587828|NCT05596734|528658859|FG021|Substudy B|Withdrawal by Subject|0|||
146587829|NCT05596734|528658860|FG022|Substudy B|Withdrawal by Subject|0|||
146587830|NCT05596734|528658861|FG023|Substudy B|Withdrawal by Subject|1|||
146587831|NCT05596734|528658838|FG000|Substudy B|Physician Decision|0|||
146587832|NCT05596734|528658839|FG001|Substudy B|Physician Decision|0|||
146587833|NCT05596734|528658840|FG002|Substudy B|Physician Decision|0|||
146587834|NCT05596734|528658841|FG003|Substudy B|Physician Decision|0|||
146587835|NCT05596734|528658842|FG004|Substudy B|Physician Decision|0|||
146587836|NCT05596734|528658843|FG005|Substudy B|Physician Decision|0|||
146587837|NCT05596734|528658844|FG006|Substudy B|Physician Decision|0|||
146587838|NCT05596734|528658845|FG007|Substudy B|Physician Decision|0|||
146587839|NCT05596734|528658846|FG008|Substudy B|Physician Decision|0|||
146587840|NCT05596734|528658847|FG009|Substudy B|Physician Decision|0|||
146587841|NCT05596734|528658848|FG010|Substudy B|Physician Decision|0|||
146587842|NCT05596734|528658849|FG011|Substudy B|Physician Decision|0|||
146587843|NCT05596734|528658850|FG012|Substudy B|Physician Decision|0|||
146587844|NCT05596734|528658851|FG013|Substudy B|Physician Decision|0|||
146587845|NCT05596734|528658852|FG014|Substudy B|Physician Decision|0|||
146587846|NCT05596734|528658853|FG015|Substudy B|Physician Decision|1|||
146587847|NCT05596734|528658854|FG016|Substudy B|Physician Decision|0|||
146587848|NCT05596734|528658855|FG017|Substudy B|Physician Decision|0|||
146587849|NCT05596734|528658856|FG018|Substudy B|Physician Decision|0|||
146587850|NCT05596734|528658857|FG019|Substudy B|Physician Decision|0|||
146587851|NCT05596734|528658858|FG020|Substudy B|Physician Decision|0|||
146587852|NCT05596734|528658859|FG021|Substudy B|Physician Decision|0|||
146587853|NCT05596734|528658860|FG022|Substudy B|Physician Decision|0|||
146587854|NCT05596734|528658861|FG023|Substudy B|Physician Decision|0|||
146587855|NCT05596734|528658838|FG000|Substudy B|Lost to Follow-up|0|||
146587856|NCT05596734|528658839|FG001|Substudy B|Lost to Follow-up|0|||
146587857|NCT05596734|528658840|FG002|Substudy B|Lost to Follow-up|0|||
146587858|NCT05596734|528658841|FG003|Substudy B|Lost to Follow-up|0|||
146587859|NCT05596734|528658842|FG004|Substudy B|Lost to Follow-up|0|||
146587860|NCT05596734|528658843|FG005|Substudy B|Lost to Follow-up|0|||
146587861|NCT05596734|528658844|FG006|Substudy B|Lost to Follow-up|0|||
146587862|NCT05596734|528658845|FG007|Substudy B|Lost to Follow-up|0|||
146587863|NCT05596734|528658846|FG008|Substudy B|Lost to Follow-up|0|||
146587864|NCT05596734|528658847|FG009|Substudy B|Lost to Follow-up|0|||
146587865|NCT05596734|528658848|FG010|Substudy B|Lost to Follow-up|0|||
146587866|NCT05596734|528658849|FG011|Substudy B|Lost to Follow-up|0|||
146587867|NCT05596734|528658850|FG012|Substudy B|Lost to Follow-up|1|||
146587868|NCT05596734|528658851|FG013|Substudy B|Lost to Follow-up|0|||
146587869|NCT05596734|528658852|FG014|Substudy B|Lost to Follow-up|1|||
146587870|NCT05596734|528658853|FG015|Substudy B|Lost to Follow-up|1|||
146587871|NCT05596734|528658854|FG016|Substudy B|Lost to Follow-up|0|||
146652523|NCT01323920|528905297|FG000|Overall Study|Withdrawal by Subject|1|||
146587872|NCT05596734|528658855|FG017|Substudy B|Lost to Follow-up|0|||
146587873|NCT05596734|528658856|FG018|Substudy B|Lost to Follow-up|0|||
146652524|NCT03915860|528905299|FG000|Overall Study|Adverse Event|3|||
146652525|NCT03915860|528905299|FG000|Overall Study|Withdrawal by Subject|6|||
146587874|NCT05596734|528658857|FG019|Substudy B|Lost to Follow-up|0|||
146587875|NCT05596734|528658858|FG020|Substudy B|Lost to Follow-up|0|||
146587876|NCT05596734|528658859|FG021|Substudy B|Lost to Follow-up|0|||
146587877|NCT05596734|528658860|FG022|Substudy B|Lost to Follow-up|0|||
146587878|NCT05596734|528658861|FG023|Substudy B|Lost to Follow-up|0|||
146587879|NCT03219034|528658864|FG000|Overall Study|Lost to Follow-up|9|||
146587880|NCT03219034|528658865|FG001|Overall Study|Lost to Follow-up|13|||
146587881|NCT03219034|528658864|FG000|Overall Study|Additional dental work needed|1|||
146587882|NCT03219034|528658865|FG001|Overall Study|Additional dental work needed|0|||
146587883|NCT03219034|528658864|FG000|Overall Study|UPPP Surgery|1|||
146587884|NCT03219034|528658865|FG001|Overall Study|UPPP Surgery|0|||
146587885|NCT03219034|528658864|FG000|Overall Study|Dental sensitivity|0|||
146587886|NCT03219034|528658865|FG001|Overall Study|Dental sensitivity|1|||
146587887|NCT03219034|528658864|FG000|Overall Study|Death in family|0|||
146587888|NCT03219034|528658865|FG001|Overall Study|Death in family|1|||
146587889|NCT02136680|528658869|FG000|Overall Study|No Longer Interested|1|||
146587890|NCT02136680|528658870|FG001|Overall Study|No Longer Interested|1|||
146587891|NCT02136680|528658869|FG000|Overall Study|No longer receiving care at clinic|3|||
146587892|NCT02136680|528658870|FG001|Overall Study|No longer receiving care at clinic|5|||
146587893|NCT02136680|528658869|FG000|Overall Study|Moved away|5|||
146587894|NCT02136680|528658870|FG001|Overall Study|Moved away|4|||
146587895|NCT02136680|528658869|FG000|Overall Study|Unable to schedule|17|||
146587896|NCT02136680|528658870|FG001|Overall Study|Unable to schedule|16|||
146587897|NCT02136680|528658869|FG000|Overall Study|Study ended before interview due|6|||
146587898|NCT02136680|528658870|FG001|Overall Study|Study ended before interview due|3|||
146587899|NCT03559517|528658871|FG000|Overall Study|Withdrawal by Subject|1|||
146587900|NCT03559517|528658872|FG001|Overall Study|Withdrawal by Subject|0|||
146587901|NCT03559517|528658873|FG002|Overall Study|Withdrawal by Subject|0|||
146587902|NCT02825420|528658877|FG000|Overall Study|Death|30|||
146587903|NCT02825420|528658878|FG001|Overall Study|Death|12|||
146587904|NCT02825420|528658877|FG000|Overall Study|Progressive disease|6|||
146587905|NCT02825420|528658878|FG001|Overall Study|Progressive disease|1|||
146587906|NCT02825420|528658877|FG000|Overall Study|Lost to Follow-up|2|||
146587907|NCT02825420|528658878|FG001|Overall Study|Lost to Follow-up|2|||
146587908|NCT02825420|528658877|FG000|Overall Study|Withdrawal by Subject|1|||
146652526|NCT03915860|528905299|FG000|Overall Study|Lost to Follow-up|2|||
146978329|NCT00382291|530084002|FG002|Overall Study|Lack of Efficacy|1|||
146587909|NCT02825420|528658878|FG001|Overall Study|Withdrawal by Subject|1|||
146587910|NCT02825420|528658877|FG000|Overall Study|Protocol amendment not signed|1|||
146587911|NCT02825420|528658878|FG001|Overall Study|Protocol amendment not signed|1|||
146587912|NCT02825420|528658877|FG000|Overall Study|Physician Decision|1|||
146587913|NCT02825420|528658878|FG001|Overall Study|Physician Decision|0|||
146587914|NCT02825420|528658877|FG000|Overall Study|Did not receive PLD|2|||
146587915|NCT02825420|528658878|FG001|Overall Study|Did not receive PLD|0|||
146587916|NCT05243745|528660812|FG000|Overall Study|Withdrawal by Subject|0|||
146587917|NCT05243745|528660813|FG001|Overall Study|Withdrawal by Subject|0|||
146587918|NCT05243745|528660814|FG002|Overall Study|Withdrawal by Subject|0|||
146587919|NCT05243745|528660815|FG003|Overall Study|Withdrawal by Subject|1|||
146587920|NCT05243745|528660812|FG000|Overall Study|Unable to Attend Visit 6|0|||
146587921|NCT05243745|528660813|FG001|Overall Study|Unable to Attend Visit 6|0|||
146587922|NCT05243745|528660814|FG002|Overall Study|Unable to Attend Visit 6|1|||
146587923|NCT05243745|528660815|FG003|Overall Study|Unable to Attend Visit 6|0|||
146587924|NCT02998203|528660816|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
146587925|NCT02998203|528660817|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
146587926|NCT02998203|528660816|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
146587927|NCT02998203|528660817|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
146587928|NCT04187144|528660828|FG000|Overall Study|Lost to Follow-up|12|||
146587929|NCT04187144|528660829|FG001|Overall Study|Lost to Follow-up|11|||
146587930|NCT04187144|528660828|FG000|Overall Study|Withdrawal by Subject|20|||
146587931|NCT04187144|528660829|FG001|Overall Study|Withdrawal by Subject|18|||
146587932|NCT04187144|528660828|FG000|Overall Study|Adverse Event|19|||
146587933|NCT04187144|528660829|FG001|Overall Study|Adverse Event|4|||
146587934|NCT04187144|528660828|FG000|Overall Study|Physician Decision|5|||
146587935|NCT04187144|528660829|FG001|Overall Study|Physician Decision|3|||
146587936|NCT04187144|528660828|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
146587937|NCT04187144|528660829|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
146587938|NCT04187144|528660828|FG000|Overall Study|Protocol Deviation|1|||
146587939|NCT04187144|528660829|FG001|Overall Study|Protocol Deviation|4|||
146587940|NCT02264665|528660830|FG000|Overall Study|Other|0|||
146587941|NCT02264665|528660831|FG001|Overall Study|Other|0|||
146587942|NCT02264665|528660832|FG002|Overall Study|Other|3|||
146587943|NCT02264665|528660833|FG003|Overall Study|Other|0|||
146587944|NCT02264665|528660834|FG004|Overall Study|Other|0|||
146587945|NCT02264665|528660835|FG005|Overall Study|Other|0|||
146587946|NCT02264665|528660836|FG006|Overall Study|Other|0|||
146587947|NCT02264665|528660830|FG000|Overall Study|Death|9|||
146587948|NCT02264665|528660831|FG001|Overall Study|Death|8|||
146587949|NCT02264665|528660832|FG002|Overall Study|Death|13|||
146587950|NCT02264665|528660833|FG003|Overall Study|Death|5|||
146587951|NCT02264665|528660834|FG004|Overall Study|Death|0|||
146587952|NCT02264665|528660835|FG005|Overall Study|Death|0|||
146652527|NCT03915860|528905299|FG000|Overall Study|Other than specified|3|||
146587953|NCT02264665|528660836|FG006|Overall Study|Death|1|||
146652528|NCT01009281|528905300|FG000|Overall Study|Administrative problems|7|||
146587954|NCT02264665|528660830|FG000|Overall Study|Lost to Follow-up|1|||
146587955|NCT02264665|528660831|FG001|Overall Study|Lost to Follow-up|0|||
146587956|NCT02264665|528660832|FG002|Overall Study|Lost to Follow-up|2|||
146587957|NCT02264665|528660833|FG003|Overall Study|Lost to Follow-up|1|||
146587958|NCT02264665|528660834|FG004|Overall Study|Lost to Follow-up|0|||
146587959|NCT02264665|528660835|FG005|Overall Study|Lost to Follow-up|0|||
146587960|NCT02264665|528660836|FG006|Overall Study|Lost to Follow-up|0|||
146587961|NCT02264665|528660830|FG000|Overall Study|Participant decision|0|||
146587962|NCT02264665|528660831|FG001|Overall Study|Participant decision|0|||
146587963|NCT02264665|528660832|FG002|Overall Study|Participant decision|0|||
146587964|NCT02264665|528660833|FG003|Overall Study|Participant decision|1|||
146587965|NCT02264665|528660834|FG004|Overall Study|Participant decision|0|||
146587966|NCT02264665|528660835|FG005|Overall Study|Participant decision|0|||
146587967|NCT02264665|528660836|FG006|Overall Study|Participant decision|0|||
146587968|NCT02264665|528660830|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
146587969|NCT02264665|528660831|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
146652529|NCT03901456|528905302|FG000|Overall Study|Withdrawal by Subject|0|||
146652530|NCT03901456|528905303|FG001|Overall Study|Withdrawal by Subject|0|||
146652531|NCT03901456|528905304|FG002|Overall Study|Withdrawal by Subject|1|||
146587970|NCT02264665|528660832|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
146587971|NCT02264665|528660833|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
146587972|NCT02264665|528660834|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
146587973|NCT02264665|528660835|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
146587974|NCT02264665|528660836|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
146587975|NCT02264665|528660830|FG000|Overall Study|Data Missing|0|||
146587976|NCT02264665|528660831|FG001|Overall Study|Data Missing|0|||
146587977|NCT02264665|528660832|FG002|Overall Study|Data Missing|1|||
146587978|NCT02264665|528660833|FG003|Overall Study|Data Missing|0|||
146587979|NCT02264665|528660834|FG004|Overall Study|Data Missing|0|||
146587980|NCT02264665|528660835|FG005|Overall Study|Data Missing|0|||
146587981|NCT02264665|528660836|FG006|Overall Study|Data Missing|0|||
146587982|NCT00789581|528660837|FG000|AC Therapy|Adverse Event|2|||
146587983|NCT00789581|528660838|FG001|AC Therapy|Adverse Event|3|||
146587984|NCT00789581|528660837|FG000|AC Therapy|Withdrawal by Subject|4|||
146587985|NCT00789581|528660838|FG001|AC Therapy|Withdrawal by Subject|7|||
146587986|NCT00789581|528660837|FG000|AC Therapy|Disease recurrence|3|||
146587987|NCT00789581|528660838|FG001|AC Therapy|Disease recurrence|1|||
146587988|NCT00789581|528660837|FG000|AC Therapy|Intercurrent Illness|1|||
146587989|NCT00789581|528660838|FG001|AC Therapy|Intercurrent Illness|0|||
146587990|NCT00789581|528660837|FG000|AC Therapy|Never Treated|1|||
146587991|NCT00789581|528660838|FG001|AC Therapy|Never Treated|4|||
146587992|NCT00789581|528660837|FG000|AC Therapy|Other|0|||
146587993|NCT00789581|528660838|FG001|AC Therapy|Other|2|||
146587994|NCT00789581|528660837|FG000|Adjuvant Therapy|Never treated|2|||
146587995|NCT00789581|528660838|FG001|Adjuvant Therapy|Never treated|2|||
146587996|NCT00789581|528660837|FG000|Adjuvant Therapy|Adverse Event|20|||
146587997|NCT00789581|528660838|FG001|Adjuvant Therapy|Adverse Event|44|||
146587998|NCT00789581|528660837|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
146587999|NCT00789581|528660838|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
146588000|NCT00789581|528660837|FG000|Adjuvant Therapy|Disease recurrence|2|||
146588001|NCT00789581|528660838|FG001|Adjuvant Therapy|Disease recurrence|1|||
146588002|NCT00789581|528660837|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
146588003|NCT00789581|528660838|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
146588004|NCT00789581|528660837|FG000|Adjuvant Therapy|Protocol Violation|1|||
146588005|NCT00789581|528660838|FG001|Adjuvant Therapy|Protocol Violation|1|||
146588006|NCT00789581|528660837|FG000|Adjuvant Therapy|Other|0|||
146588007|NCT00789581|528660838|FG001|Adjuvant Therapy|Other|1|||
146588008|NCT01468207|528660839|FG000|Treatment Period 1|Adverse Event|1|||
146588009|NCT01468207|528660840|FG001|Treatment Period 1|Adverse Event|0|||
146588010|NCT01468207|528660841|FG002|Treatment Period 1|Adverse Event|0|||
146588011|NCT01468207|528660842|FG003|Treatment Period 1|Adverse Event|0|||
146588012|NCT01468207|528660843|FG004|Treatment Period 1|Adverse Event|0|||
146588013|NCT01468207|528660844|FG005|Treatment Period 1|Adverse Event|0|||
146588014|NCT01468207|528660839|FG000|Treatment Period 1|Protocol Violation|1|||
146588015|NCT01468207|528660840|FG001|Treatment Period 1|Protocol Violation|1|||
146588016|NCT01468207|528660841|FG002|Treatment Period 1|Protocol Violation|0|||
146588017|NCT01468207|528660842|FG003|Treatment Period 1|Protocol Violation|0|||
146588018|NCT01468207|528660843|FG004|Treatment Period 1|Protocol Violation|0|||
146588019|NCT01468207|528660844|FG005|Treatment Period 1|Protocol Violation|0|||
146588020|NCT01468207|528660839|FG000|Treatment Period 1|Withdrawal by Subject|5|||
146588021|NCT01468207|528660840|FG001|Treatment Period 1|Withdrawal by Subject|4|||
146588022|NCT01468207|528660841|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146588023|NCT01468207|528660842|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146652532|NCT03901456|528905302|FG000|Overall Study|Lost to Follow-up|0|||
146588024|NCT01468207|528660843|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146588025|NCT01468207|528660844|FG005|Treatment Period 1|Withdrawal by Subject|0|||
146588026|NCT01468207|528660839|FG000|Treatment Period 1|Lost to Follow-up|2|||
146588027|NCT01468207|528660840|FG001|Treatment Period 1|Lost to Follow-up|1|||
146588028|NCT01468207|528660841|FG002|Treatment Period 1|Lost to Follow-up|0|||
146588029|NCT01468207|528660842|FG003|Treatment Period 1|Lost to Follow-up|0|||
146588030|NCT01468207|528660843|FG004|Treatment Period 1|Lost to Follow-up|0|||
146588031|NCT01468207|528660844|FG005|Treatment Period 1|Lost to Follow-up|0|||
146588032|NCT01468207|528660839|FG000|Treatment Period 1|Other|0|||
146588033|NCT01468207|528660840|FG001|Treatment Period 1|Other|2|||
146588034|NCT01468207|528660841|FG002|Treatment Period 1|Other|0|||
146588035|NCT01468207|528660842|FG003|Treatment Period 1|Other|0|||
146588036|NCT01468207|528660843|FG004|Treatment Period 1|Other|0|||
146588037|NCT01468207|528660844|FG005|Treatment Period 1|Other|0|||
146588038|NCT01468207|528660839|FG000|Treatment Period 2|Adverse Event|0|||
146588039|NCT01468207|528660840|FG001|Treatment Period 2|Adverse Event|0|||
146588040|NCT01468207|528660841|FG002|Treatment Period 2|Adverse Event|6|||
146588041|NCT01468207|528660842|FG003|Treatment Period 2|Adverse Event|1|||
146588042|NCT01468207|528660843|FG004|Treatment Period 2|Adverse Event|2|||
146588043|NCT01468207|528660844|FG005|Treatment Period 2|Adverse Event|1|||
146588044|NCT01468207|528660839|FG000|Treatment Period 2|Lack of Efficacy|0|||
146588045|NCT01468207|528660840|FG001|Treatment Period 2|Lack of Efficacy|0|||
146588046|NCT01468207|528660841|FG002|Treatment Period 2|Lack of Efficacy|1|||
146588047|NCT01468207|528660842|FG003|Treatment Period 2|Lack of Efficacy|1|||
146588048|NCT01468207|528660843|FG004|Treatment Period 2|Lack of Efficacy|0|||
146588049|NCT01468207|528660844|FG005|Treatment Period 2|Lack of Efficacy|2|||
146588050|NCT01468207|528660839|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146588051|NCT01468207|528660840|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146652533|NCT03901456|528905303|FG001|Overall Study|Lost to Follow-up|1|||
146652534|NCT03901456|528905304|FG002|Overall Study|Lost to Follow-up|0|||
146652535|NCT02217527|528905307|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
146652536|NCT02217527|528905308|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
146652537|NCT02217527|528905307|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
146652538|NCT02217527|528905308|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
146652539|NCT00402233|528905309|FG000|Overall Study|Adverse Event|1|||
146652540|NCT00402233|528905310|FG001|Overall Study|Adverse Event|7|||
146652541|NCT00402233|528905311|FG002|Overall Study|Adverse Event|9|||
146652542|NCT00402233|528905312|FG003|Overall Study|Adverse Event|9|||
146652543|NCT00402233|528905309|FG000|Overall Study|Protocol Violation|0|||
146652544|NCT00402233|528905310|FG001|Overall Study|Protocol Violation|1|||
146652545|NCT00402233|528905311|FG002|Overall Study|Protocol Violation|0|||
146652546|NCT00402233|528905312|FG003|Overall Study|Protocol Violation|0|||
146652547|NCT00402233|528905309|FG000|Overall Study|Withdrawal by Subject|2|||
146652548|NCT00402233|528905310|FG001|Overall Study|Withdrawal by Subject|1|||
146652549|NCT00402233|528905311|FG002|Overall Study|Withdrawal by Subject|2|||
146652550|NCT00402233|528905312|FG003|Overall Study|Withdrawal by Subject|2|||
146652551|NCT00402233|528905309|FG000|Overall Study|Worsening of disease under study|2|||
146652552|NCT00402233|528905310|FG001|Overall Study|Worsening of disease under study|0|||
146652553|NCT00402233|528905311|FG002|Overall Study|Worsening of disease under study|0|||
146652554|NCT00402233|528905312|FG003|Overall Study|Worsening of disease under study|0|||
146652555|NCT00402233|528905309|FG000|Overall Study|Worsening of other pre-existing disease|0|||
146652556|NCT00402233|528905310|FG001|Overall Study|Worsening of other pre-existing disease|1|||
146652557|NCT00402233|528905311|FG002|Overall Study|Worsening of other pre-existing disease|0|||
146652558|NCT00402233|528905312|FG003|Overall Study|Worsening of other pre-existing disease|0|||
146652559|NCT00938886|528905313|FG000|Overall Study|Death|0|||
146652560|NCT00938886|528905314|FG001|Overall Study|Death|1|||
146652561|NCT00938886|528905313|FG000|Overall Study|Withdrawal by Subject|4|||
146652562|NCT00938886|528905314|FG001|Overall Study|Withdrawal by Subject|7|||
146652563|NCT00938886|528905313|FG000|Overall Study|Lost to Follow-up|3|||
146652564|NCT00938886|528905314|FG001|Overall Study|Lost to Follow-up|2|||
146652565|NCT03579602|528905315|FG000|Overall Study|Subject unable to receive study drug|0|||
146652566|NCT03579602|528905316|FG001|Overall Study|Subject unable to receive study drug|2|||
146652567|NCT03579602|528905315|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
146652568|NCT03579602|528905316|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
146652569|NCT02518464|528905318|FG000|Overall Study|Adverse Event|2|||
146652570|NCT01120067|528905321|FG000|Overall Study|Lost to Follow-up|3|||
146652571|NCT01120067|528905322|FG001|Overall Study|Lost to Follow-up|1|||
146652572|NCT01120067|528905321|FG000|Overall Study|fail to engage >3 sessions|2|||
146652573|NCT01120067|528905322|FG001|Overall Study|fail to engage >3 sessions|0|||
146652574|NCT03021564|528905326|FG000|Overall Study|Death|84|||
146652575|NCT03021564|528905327|FG001|Overall Study|Death|466|||
146652576|NCT03021564|528905326|FG000|Overall Study|Lost to Follow-up|0|||
146652577|NCT03021564|528905327|FG001|Overall Study|Lost to Follow-up|2|||
146652578|NCT02889562|528905328|FG000|Overall Study|Physician Decision|0|||
146652579|NCT02889562|528905329|FG001|Overall Study|Physician Decision|1|||
146652580|NCT02889562|528905328|FG000|Overall Study|Withdrawal by Subject|0|||
146652581|NCT02889562|528905329|FG001|Overall Study|Withdrawal by Subject|1|||
146736239|NCT00279201|529205303|FG002|Intensification Addendum|Sponsor Decision|0|||
146588052|NCT01468207|528660841|FG002|Treatment Period 2|Withdrawal by Subject|5|||
146588053|NCT01468207|528660842|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146588054|NCT01468207|528660843|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146588055|NCT01468207|528660844|FG005|Treatment Period 2|Withdrawal by Subject|2|||
146588056|NCT01468207|528660839|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
146588057|NCT01468207|528660840|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
146588058|NCT01468207|528660841|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
146588059|NCT01468207|528660842|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
146588060|NCT01468207|528660843|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
146588061|NCT01468207|528660844|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
146588062|NCT01468207|528660839|FG000|Treatment Period 2|Lost to Follow-up|0|||
146588063|NCT01468207|528660840|FG001|Treatment Period 2|Lost to Follow-up|0|||
146588064|NCT01468207|528660841|FG002|Treatment Period 2|Lost to Follow-up|5|||
146588065|NCT01468207|528660842|FG003|Treatment Period 2|Lost to Follow-up|1|||
146588066|NCT01468207|528660843|FG004|Treatment Period 2|Lost to Follow-up|0|||
146588067|NCT01468207|528660844|FG005|Treatment Period 2|Lost to Follow-up|0|||
146588068|NCT01468207|528660839|FG000|Treatment Period 2|Other|0|||
146588069|NCT01468207|528660840|FG001|Treatment Period 2|Other|0|||
146588070|NCT01468207|528660841|FG002|Treatment Period 2|Other|5|||
146588071|NCT01468207|528660842|FG003|Treatment Period 2|Other|1|||
146588072|NCT01468207|528660843|FG004|Treatment Period 2|Other|1|||
146588073|NCT01468207|528660844|FG005|Treatment Period 2|Other|2|||
146588074|NCT04225676|528660851|FG000|Overall Study|Physician Decision|1|||
146588075|NCT04225676|528660851|FG000|Overall Study|Lack of Efficacy|1|||
146588076|NCT04225676|528660851|FG000|Overall Study|Study terminated by sponsor|3|||
146588077|NCT03812185|528660857|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
146588078|NCT04085458|528660858|FG000|Overall Study|Other|1|||
146588079|NCT04085458|528660858|FG000|Overall Study|Withdrawal by Subject|2|||
146588080|NCT04085458|528660858|FG000|Overall Study|Adverse Event|2|||
146588081|NCT01921218|528660859|FG000|Overall Study|Death|2|||
146588082|NCT01921218|528660860|FG001|Overall Study|Death|1|||
146588083|NCT01921218|528660859|FG000|Overall Study|Withdrawal by Subject|0|||
146588084|NCT01921218|528660860|FG001|Overall Study|Withdrawal by Subject|2|||
146588085|NCT01921218|528660859|FG000|Overall Study|Kidney transplant|1|||
146588086|NCT01921218|528660860|FG001|Overall Study|Kidney transplant|1|||
146588087|NCT03389555|528660861|FG000|Overall Study|Protocol Violation|1|||
146588088|NCT03389555|528660862|FG001|Overall Study|Protocol Violation|3|||
146588089|NCT03389555|528660861|FG000|Overall Study|Death|1|||
146588090|NCT03389555|528660862|FG001|Overall Study|Death|0|||
146588091|NCT01885208|528660863|FG000|Overall Study|Unclassified|32|||
146588092|NCT01885208|528660864|FG001|Overall Study|Unclassified|38|||
146588093|NCT03224507|528660868|FG000|Overall Study|Death|3|||
146588094|NCT03224507|528660869|FG001|Overall Study|Death|0|||
146588095|NCT03224507|528660868|FG000|Overall Study|Lack of Efficacy|6|||
146588096|NCT03224507|528660869|FG001|Overall Study|Lack of Efficacy|0|||
146588097|NCT03224507|528660868|FG000|Overall Study|Withdrawal by Subject|6|||
146588098|NCT03224507|528660869|FG001|Overall Study|Withdrawal by Subject|0|||
146588099|NCT01032291|528660870|FG000|Safety Lead-in|Adverse Event|1|||
146588100|NCT01032291|528660871|FG001|Safety Lead-in|Adverse Event|0|||
146588101|NCT01032291|528660872|FG002|Safety Lead-in|Adverse Event|0|||
146588102|NCT01032291|528660870|FG000|Safety Lead-in|Death|1|||
146588103|NCT01032291|528660871|FG001|Safety Lead-in|Death|0|||
146588104|NCT01032291|528660872|FG002|Safety Lead-in|Death|0|||
146588105|NCT01032291|528660870|FG000|Proof of Concept|Adverse Event|0|||
146588106|NCT01032291|528660871|FG001|Proof of Concept|Adverse Event|5|||
146918949|NCT01544595|529864545|FG004|Status at Week 68|Technical problems|0|||
146918950|NCT01544595|529864546|FG005|Status at Week 68|Technical problems|0|||
146588107|NCT01032291|528660872|FG002|Proof of Concept|Adverse Event|1|||
146588108|NCT01032291|528660870|FG000|Proof of Concept|Death|0|||
146588109|NCT01032291|528660871|FG001|Proof of Concept|Death|1|||
146588110|NCT01032291|528660872|FG002|Proof of Concept|Death|2|||
146588111|NCT01032291|528660870|FG000|Proof of Concept|Lack of Efficacy|0|||
146588112|NCT01032291|528660871|FG001|Proof of Concept|Lack of Efficacy|1|||
146588113|NCT01032291|528660872|FG002|Proof of Concept|Lack of Efficacy|0|||
146588114|NCT01032291|528660870|FG000|Proof of Concept|Never Received Study Drug|0|||
146588115|NCT01032291|528660871|FG001|Proof of Concept|Never Received Study Drug|1|||
146588116|NCT01032291|528660872|FG002|Proof of Concept|Never Received Study Drug|0|||
146588117|NCT02449889|528660873|FG000|Overall Study|Adverse Event|1|||
146588118|NCT02449889|528660874|FG001|Overall Study|Adverse Event|2|||
146588119|NCT02449889|528660875|FG002|Overall Study|Adverse Event|0|||
146588120|NCT02449889|528660873|FG000|Overall Study|Protocol Violation|0|||
146588121|NCT02449889|528660874|FG001|Overall Study|Protocol Violation|4|||
146588122|NCT02449889|528660875|FG002|Overall Study|Protocol Violation|1|||
146588123|NCT01973387|528660876|FG000|Overall Study|Adverse Event|14|||
146588124|NCT01973387|528660877|FG001|Overall Study|Adverse Event|4|||
146588125|NCT01973387|528660876|FG000|Overall Study|Withdrawal by Subject|7|||
146588126|NCT01973387|528660877|FG001|Overall Study|Withdrawal by Subject|4|||
146588127|NCT01973387|528660876|FG000|Overall Study|Study terminated by sponsor|63|||
146588128|NCT01973387|528660877|FG001|Overall Study|Study terminated by sponsor|0|||
146588129|NCT01973387|528660876|FG000|Overall Study|Progressive disease or relapse|16|||
146588130|NCT01973387|528660877|FG001|Overall Study|Progressive disease or relapse|5|||
146588131|NCT01973387|528660876|FG000|Overall Study|Death|4|||
146588132|NCT01973387|528660877|FG001|Overall Study|Death|3|||
146588133|NCT01973387|528660876|FG000|Overall Study|Randomized, not treated|2|||
146588134|NCT01973387|528660877|FG001|Overall Study|Randomized, not treated|2|||
146588135|NCT03327220|528660878|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
146588136|NCT03327220|528660879|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
146588137|NCT03327220|528660878|FG000|Overall Study|Investigator Decision|2|||
146588138|NCT03327220|528660879|FG001|Overall Study|Investigator Decision|0|||
146588139|NCT03327220|528660878|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
146588140|NCT03327220|528660879|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
146588141|NCT03327220|528660878|FG000|Overall Study|Fungal infection|1|||
146588142|NCT03327220|528660879|FG001|Overall Study|Fungal infection|0|||
146588143|NCT03327220|528660878|FG000|Overall Study|Discharged to Rehabilitation|0|||
146588144|NCT03327220|528660879|FG001|Overall Study|Discharged to Rehabilitation|1|||
146588145|NCT03327220|528660878|FG000|Overall Study|Missing|1|||
146588146|NCT03327220|528660879|FG001|Overall Study|Missing|0|||
146588147|NCT00693017|528660880|FG000|Overall Study|Sponsor Decision|2|||
146588148|NCT00693017|528660881|FG001|Overall Study|Sponsor Decision|1|||
146588149|NCT00693017|528660880|FG000|Overall Study|Death|0|||
146588150|NCT00693017|528660881|FG001|Overall Study|Death|1|||
146588151|NCT00688324|528660883|FG000|Overall Study|Withdrawal by Subject|2|||
146588152|NCT00688324|528660883|FG000|Overall Study|Physician Decision|5|||
146588153|NCT00688324|528660883|FG000|Overall Study|Lost to Follow-up|1|||
146588154|NCT03176472|528660886|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
146588155|NCT03176472|528660887|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
146588156|NCT03176472|528660886|FG000|Double Blind Treatment Period|Adverse Event|0|||
146588157|NCT03176472|528660887|FG001|Double Blind Treatment Period|Adverse Event|5|||
146588158|NCT03176472|528660886|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
146588159|NCT03176472|528660887|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
146588160|NCT03176472|528660886|FG000|Double Blind Treatment Period|Physician Decision|0|||
146588161|NCT03176472|528660887|FG001|Double Blind Treatment Period|Physician Decision|1|||
146588162|NCT03176472|528660886|FG000|Double Blind Treatment Period|Protocol Violation|1|||
146588163|NCT03176472|528660887|FG001|Double Blind Treatment Period|Protocol Violation|0|||
146588164|NCT03176472|528660886|FG000|Double Blind Treatment Period|Not Provided|1|||
146588165|NCT03176472|528660887|FG001|Double Blind Treatment Period|Not Provided|0|||
146588166|NCT03176472|528660886|FG000|Open Label Extension|Withdrawal by Subject|3|||
146588167|NCT03176472|528660887|FG001|Open Label Extension|Withdrawal by Subject|4|||
146588168|NCT03176472|528660886|FG000|Open Label Extension|Adverse Event|2|||
146588169|NCT03176472|528660887|FG001|Open Label Extension|Adverse Event|4|||
146588170|NCT03176472|528660886|FG000|Open Label Extension|Lost to Follow-up|1|||
146588171|NCT03176472|528660887|FG001|Open Label Extension|Lost to Follow-up|2|||
146588172|NCT03176472|528660886|FG000|Open Label Extension|Protocol Violation|0|||
146588173|NCT03176472|528660887|FG001|Open Label Extension|Protocol Violation|1|||
146588174|NCT03176472|528660886|FG000|Open Label Extension|Not Provided|2|||
146588175|NCT03176472|528660887|FG001|Open Label Extension|Not Provided|1|||
146588176|NCT03272828|528660888|FG000|Overall Study|Lost to Follow-up|7|||
146588177|NCT03272828|528660889|FG001|Overall Study|Lost to Follow-up|7|||
146588178|NCT03272828|528660888|FG000|Overall Study|Withdrawal by Subject|2|||
146588179|NCT03272828|528660889|FG001|Overall Study|Withdrawal by Subject|0|||
146588180|NCT03272828|528660888|FG000|Overall Study|Deceased|1|||
146588181|NCT03272828|528660889|FG001|Overall Study|Deceased|1|||
146588182|NCT03272828|528660888|FG000|Overall Study|Failed implant|1|||
146588183|NCT03272828|528660889|FG001|Overall Study|Failed implant|2|||
146588184|NCT01972308|528660890|FG000|Overall Study|Withdrawal by Subject|0|||
146588185|NCT01972308|528660891|FG001|Overall Study|Withdrawal by Subject|1|||
146588186|NCT01972308|528660890|FG000|Overall Study|Lost to Follow-up|4|||
146588187|NCT01972308|528660891|FG001|Overall Study|Lost to Follow-up|6|||
146588188|NCT01972308|528660890|FG000|Overall Study|Death|4|||
146588189|NCT01972308|528660891|FG001|Overall Study|Death|1|||
146588190|NCT00847665|528660892|FG000|Overall Study|Withdrawal by Subject|1|||
146588191|NCT00847665|528660893|FG001|Overall Study|Withdrawal by Subject|0|||
146588192|NCT01562314|528660894|FG000|Overall Study|Adverse Event|10|||
146588193|NCT01562314|528660895|FG001|Overall Study|Adverse Event|5|||
146588194|NCT01562314|528660894|FG000|Overall Study|Met Withdrawal Criteria|3|||
146588195|NCT01562314|528660895|FG001|Overall Study|Met Withdrawal Criteria|2|||
146588196|NCT01562314|528660894|FG000|Overall Study|Withdrawal by Subject|0|||
146588197|NCT01562314|528660895|FG001|Overall Study|Withdrawal by Subject|1|||
146588198|NCT00585546|528660896|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
146588199|NCT00585546|528660896|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
146588200|NCT02851797|528660897|FG000|Overall Study|Withdrawal by Subject|4|||
146588201|NCT02851797|528660898|FG001|Overall Study|Withdrawal by Subject|2|||
146588202|NCT02851797|528660897|FG000|Overall Study|Adverse Event|3|||
146588203|NCT02851797|528660898|FG001|Overall Study|Adverse Event|0|||
146588204|NCT03077438|528660899|FG000|Overall Study|Protocol Violation|3|||
146588205|NCT03077438|528660900|FG001|Overall Study|Protocol Violation|5|||
146588206|NCT03077438|528660899|FG000|Overall Study|Withdrawal by Subject|3|||
146588207|NCT03077438|528660900|FG001|Overall Study|Withdrawal by Subject|6|||
146588208|NCT03077438|528660899|FG000|Overall Study|Lost to Follow-up|6|||
146588209|NCT03077438|528660900|FG001|Overall Study|Lost to Follow-up|3|||
146588210|NCT00813865|528660901|FG000|Overall Study|Failure to Respond|3|||
146588211|NCT00813865|528660901|FG000|Overall Study|Lost to Follow-up|3|||
146588212|NCT00813865|528660901|FG000|Overall Study|Withdrawal by Subject|1|||
146588213|NCT00624585|528660906|FG000|Overall Study|Death|3|||
146588214|NCT00624585|528660906|FG000|Overall Study|Disease Progression|6|||
146770930|NCT03762668|529329803|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
146770931|NCT00686855|529329807|FG000|Overall Study|Lost to Follow-up|1|||
146770932|NCT00686855|529329808|FG001|Overall Study|Lost to Follow-up|0|||
146770933|NCT00686855|529329807|FG000|Overall Study|Progressive GVHD|0|||
146770934|NCT00686855|529329808|FG001|Overall Study|Progressive GVHD|1|||
146770935|NCT02139046|529329811|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
146770936|NCT02139046|529329812|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
146770937|NCT02139046|529329813|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
146770938|NCT02139046|529329814|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
146770939|NCT02139046|529329815|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
146770940|NCT02139046|529329811|FG000|Overall Study|Major Protocol Deviation|9|||
146770941|NCT02139046|529329812|FG001|Overall Study|Major Protocol Deviation|10|||
146770942|NCT02139046|529329813|FG002|Overall Study|Major Protocol Deviation|16|||
146978330|NCT02266706|530084003|FG000|Overall Study|Withdrawal by Subject|0|||
146652582|NCT01470989|528905332|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
146652583|NCT01470989|528905333|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
146588215|NCT00624585|528660906|FG000|Overall Study|Adverse Event|3|||
146588216|NCT02256384|528660907|FG000|Overall Study|Withdrawal by Subject|12|||
146588217|NCT02256384|528660907|FG000|Overall Study|Equipment not capturing data|2|||
146588218|NCT04295681|528660910|FG000|Overall Study|Eligibility error|1|||
146588219|NCT04295681|528660911|FG001|Overall Study|Eligibility error|3|||
146588220|NCT04154345|528660912|FG000|Overall Study|Covid-19 pandemic|4|||
146588221|NCT04686084|528660917|FG000|Overall Study|Lost to Follow-up|1|||
146588222|NCT00676520|528660922|FG000|Overall Study|Withdrawal by Subject|163|||
146588223|NCT00676520|528660922|FG000|Overall Study|Lost to Follow-up|162|||
146588224|NCT00676520|528660922|FG000|Overall Study|Death|159|||
146588225|NCT00676520|528660922|FG000|Overall Study|Physician Decision|20|||
146588226|NCT00676520|528660922|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
146588227|NCT00676520|528660922|FG000|Overall Study|Other Reason|18|||
146588228|NCT00866047|528660924|FG000|Treatment Period|Progressive disease|13|||
146588229|NCT00866047|528660924|FG000|Treatment Period|Adverse Event|16|||
146588230|NCT00866047|528660924|FG000|Treatment Period|Physician Decision|14|||
146588231|NCT00866047|528660924|FG000|Treatment Period|Withdrawal by Subject|5|||
146588232|NCT00866047|528660924|FG000|Follow-up Period|Lost to Follow-up|5|||
146588233|NCT03773133|528660925|FG000|Overall Study|Screen Failure|8|||
146588234|NCT04659174|528660926|FG000|Overall Study|Sponsor decision to discontinue study|0|||
146588235|NCT04659174|528660927|FG001|Overall Study|Sponsor decision to discontinue study|2|||
146588236|NCT04659174|528660926|FG000|Overall Study|Lost to Follow-up|9|||
146588237|NCT04659174|528660927|FG001|Overall Study|Lost to Follow-up|11|||
146588238|NCT04659174|528660926|FG000|Overall Study|Adverse Event|8|||
146588239|NCT04659174|528660927|FG001|Overall Study|Adverse Event|5|||
146588240|NCT04659174|528660926|FG000|Overall Study|Withdrawal by Subject|17|||
146588241|NCT04659174|528660927|FG001|Overall Study|Withdrawal by Subject|33|||
146588242|NCT04659174|528660926|FG000|Overall Study|Progressive disease|0|||
146588243|NCT04659174|528660927|FG001|Overall Study|Progressive disease|2|||
146652584|NCT01470989|528905332|FG000|Overall Study|Adverse Event|2|||
146652585|NCT01470989|528905333|FG001|Overall Study|Adverse Event|5|||
146588244|NCT04659174|528660926|FG000|Overall Study|Other reasons|0|||
146588245|NCT04659174|528660927|FG001|Overall Study|Other reasons|2|||
146588246|NCT04659174|528660926|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
146652586|NCT01470989|528905332|FG000|Overall Study|Abnormal laboratory value|1|||
146652587|NCT01470989|528905333|FG001|Overall Study|Abnormal laboratory value|1|||
146652588|NCT01470989|528905332|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146770943|NCT02139046|529329814|FG003|Overall Study|Major Protocol Deviation|12|||
146978331|NCT02266706|530084004|FG001|Overall Study|Withdrawal by Subject|1|||
146588247|NCT04659174|528660927|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
146588248|NCT04659174|528660926|FG000|Overall Study|Alcohol or illegal drug use|0|||
146588249|NCT04659174|528660927|FG001|Overall Study|Alcohol or illegal drug use|3|||
146588250|NCT04659174|528660926|FG000|Overall Study|Violation of entry criteria|1|||
146588251|NCT04659174|528660927|FG001|Overall Study|Violation of entry criteria|0|||
146588252|NCT04659174|528660926|FG000|Overall Study|Death|0|||
146770944|NCT02139046|529329815|FG004|Overall Study|Major Protocol Deviation|6|||
146978332|NCT02266706|530084005|FG002|Overall Study|Withdrawal by Subject|1|||
146588253|NCT04659174|528660927|FG001|Overall Study|Death|1|||
146588254|NCT04730635|528660928|FG000|Overall Study|Lost to Follow-up|1|||
146588255|NCT04730635|528660929|FG001|Overall Study|Lost to Follow-up|0|||
146588256|NCT04730635|528660928|FG000|Overall Study|Withdrawal by Subject|0|||
146652589|NCT01470989|528905333|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
146588257|NCT04730635|528660929|FG001|Overall Study|Withdrawal by Subject|1|||
146588258|NCT03070223|528660930|FG000|Overall Study|Lost to Follow-up|34|||
146588259|NCT03070223|528660931|FG001|Overall Study|Lost to Follow-up|27|||
146588260|NCT03070223|528660930|FG000|Overall Study|Withdrawal by Subject|12|||
146588261|NCT03070223|528660931|FG001|Overall Study|Withdrawal by Subject|22|||
146588262|NCT03070223|528660930|FG000|Overall Study|Protocol Violation|0|||
146588263|NCT03070223|528660931|FG001|Overall Study|Protocol Violation|1|||
146588264|NCT04934800|528660932|FG000|Overall Study|Other|1|||
146588265|NCT04934800|528660932|FG000|Overall Study|Withdrawal by Subject|5|||
146588266|NCT04934800|528660932|FG000|Overall Study|Lack of Efficacy|1|||
146588267|NCT04934800|528660932|FG000|Overall Study|Adverse Event|9|||
146588268|NCT04934800|528660932|FG000|Overall Study|Lost to Follow-up|5|||
146588269|NCT04934800|528660932|FG000|Overall Study|Enrolled but not treated|1|||
146588270|NCT00516906|528660933|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
146588271|NCT00516906|528660934|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
146588272|NCT02684058|528660942|FG000|Treatment Period|Progressive disease|4|||
146588273|NCT02684058|528660943|FG001|Treatment Period|Progressive disease|10|||
146588274|NCT02684058|528660944|FG002|Treatment Period|Progressive disease|19|||
146588275|NCT02684058|528660942|FG000|Treatment Period|Adverse Event|3|||
146588276|NCT02684058|528660943|FG001|Treatment Period|Adverse Event|8|||
146588277|NCT02684058|528660944|FG002|Treatment Period|Adverse Event|1|||
146588278|NCT02684058|528660942|FG000|Treatment Period|Physician Decision|5|||
146588279|NCT02684058|528660943|FG001|Treatment Period|Physician Decision|1|||
146588280|NCT02684058|528660944|FG002|Treatment Period|Physician Decision|2|||
146588281|NCT02684058|528660942|FG000|Treatment Period|New therapy for study indication|1|||
146588282|NCT02684058|528660943|FG001|Treatment Period|New therapy for study indication|0|||
146588283|NCT02684058|528660944|FG002|Treatment Period|New therapy for study indication|0|||
146588284|NCT02684058|528660942|FG000|Treatment Period|Protocol deviation|0|||
146588285|NCT02684058|528660943|FG001|Treatment Period|Protocol deviation|1|||
146588286|NCT02684058|528660944|FG002|Treatment Period|Protocol deviation|0|||
146588287|NCT02684058|528660942|FG000|Treatment Period|Subject/guardian decision|4|||
146588288|NCT02684058|528660943|FG001|Treatment Period|Subject/guardian decision|3|||
146588289|NCT02684058|528660944|FG002|Treatment Period|Subject/guardian decision|0|||
146588290|NCT02684058|528660942|FG000|Treatment Period|Death|0|||
146588291|NCT02684058|528660943|FG001|Treatment Period|Death|0|||
146588292|NCT02684058|528660944|FG002|Treatment Period|Death|2|||
146588293|NCT02684058|528660942|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
146588294|NCT02684058|528660943|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
146588295|NCT02684058|528660944|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
146588296|NCT02684058|528660942|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
146588297|NCT02684058|528660943|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
146588298|NCT02684058|528660944|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
146588299|NCT02684058|528660942|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
146588300|NCT02684058|528660943|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
146588301|NCT02684058|528660944|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
146588302|NCT02684058|528660942|FG000|Post-treatment Efficacy Follow-up|Death|0|||
146588303|NCT02684058|528660943|FG001|Post-treatment Efficacy Follow-up|Death|0|||
146588304|NCT02684058|528660944|FG002|Post-treatment Efficacy Follow-up|Death|3|||
146652590|NCT01470989|528905332|FG000|Overall Study|Withdrawal by Subject|19|||
146652591|NCT01470989|528905333|FG001|Overall Study|Withdrawal by Subject|17|||
146652592|NCT01470989|528905332|FG000|Overall Study|Lost to Follow-up|18|||
146652593|NCT01470989|528905333|FG001|Overall Study|Lost to Follow-up|13|||
146652594|NCT01470989|528905332|FG000|Overall Study|Administrative problems|2|||
146588305|NCT02684058|528660942|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
146588306|NCT02684058|528660943|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
146588307|NCT02684058|528660944|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
146588308|NCT02684058|528660942|FG000|Post-treatment Survival Follow-up|Death|0|||
146588309|NCT02684058|528660943|FG001|Post-treatment Survival Follow-up|Death|0|||
146588310|NCT02684058|528660944|FG002|Post-treatment Survival Follow-up|Death|7|||
146588311|NCT02684058|528660942|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
146588312|NCT02684058|528660943|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
146588313|NCT02684058|528660944|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
146588314|NCT02684058|528660942|FG000|Crossover Treatment Period|Progressive disease|0|||
146588315|NCT02684058|528660943|FG001|Crossover Treatment Period|Progressive disease|1|||
146588316|NCT02684058|528660944|FG002|Crossover Treatment Period|Progressive disease|0|||
146588317|NCT00721578|528660945|FG000|Overall Study|Death|1|||
146588318|NCT00721578|528660946|FG001|Overall Study|Death|1|||
146588319|NCT00721578|528660945|FG000|Overall Study|Withdrawal by Subject|1|||
146588320|NCT00721578|528660946|FG001|Overall Study|Withdrawal by Subject|1|||
146588321|NCT05032690|528660955|FG000|Period 1|Adverse Event|0|||
146588322|NCT05032690|528660956|FG001|Period 1|Adverse Event|1|||
146588323|NCT05032690|528660957|FG002|Period 1|Adverse Event|0|||
146588324|NCT05032690|528660958|FG003|Period 1|Adverse Event|0|||
146588325|NCT05032690|528660955|FG000|Period 1|Withdrawal by Subject|1|||
146588326|NCT05032690|528660956|FG001|Period 1|Withdrawal by Subject|0|||
146588327|NCT05032690|528660957|FG002|Period 1|Withdrawal by Subject|0|||
146588328|NCT05032690|528660958|FG003|Period 1|Withdrawal by Subject|0|||
146588329|NCT05032690|528660955|FG000|Period 1|No longer meets eligibility criteria|0|||
146588330|NCT05032690|528660956|FG001|Period 1|No longer meets eligibility criteria|1|||
146588331|NCT05032690|528660957|FG002|Period 1|No longer meets eligibility criteria|0|||
146588332|NCT05032690|528660958|FG003|Period 1|No longer meets eligibility criteria|0|||
146588333|NCT05032690|528660955|FG000|Period 2|Adverse Event|1|||
146588334|NCT05032690|528660956|FG001|Period 2|Adverse Event|0|||
146588335|NCT05032690|528660957|FG002|Period 2|Adverse Event|0|||
146588336|NCT05032690|528660958|FG003|Period 2|Adverse Event|0|||
146588337|NCT05032690|528660955|FG000|Period 2|Withdrawal by Subject|0|||
146588338|NCT05032690|528660956|FG001|Period 2|Withdrawal by Subject|1|||
146588339|NCT05032690|528660957|FG002|Period 2|Withdrawal by Subject|0|||
146588340|NCT05032690|528660958|FG003|Period 2|Withdrawal by Subject|0|||
146588341|NCT05032690|528660955|FG000|Period 2|No longer meets eligibility criteria|0|||
146588342|NCT05032690|528660956|FG001|Period 2|No longer meets eligibility criteria|1|||
146588343|NCT05032690|528660957|FG002|Period 2|No longer meets eligibility criteria|0|||
146588344|NCT05032690|528660958|FG003|Period 2|No longer meets eligibility criteria|0|||
146588345|NCT05032690|528660955|FG000|Period 3|Adverse Event|0|||
146588346|NCT05032690|528660956|FG001|Period 3|Adverse Event|1|||
146588347|NCT05032690|528660957|FG002|Period 3|Adverse Event|0|||
146588348|NCT05032690|528660958|FG003|Period 3|Adverse Event|0|||
146588349|NCT05151445|528660959|FG000|Overall Study|Withdrawal by Subject|3|||
146588350|NCT00303446|528662936|FG000|Overall Study|Withdrawal by Subject|2|||
146588351|NCT00303446|528662937|FG001|Overall Study|Withdrawal by Subject|2|||
146588352|NCT00303446|528662936|FG000|Overall Study|Death|0|||
146588353|NCT00303446|528662937|FG001|Overall Study|Death|1|||
146588354|NCT00303446|528662936|FG000|Overall Study|Physician Decision|0|||
146588355|NCT00303446|528662937|FG001|Overall Study|Physician Decision|1|||
146588356|NCT04258995|528662938|FG000|Overall Study|Lost to Follow-up|1|||
146588357|NCT04258995|528662939|FG001|Overall Study|Lost to Follow-up|1|||
146588358|NCT00983515|528662945|FG000|Ritonavir Alone|liver panel out of range|6|||
146588359|NCT00983515|528662945|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
146588360|NCT03842969|528662948|FG000|Overall Study|Participant declined follow-up visit|0|||
146588361|NCT03842969|528662949|FG001|Overall Study|Participant declined follow-up visit|1|||
146588362|NCT03842969|528662950|FG002|Overall Study|Participant declined follow-up visit|0|||
146588363|NCT03842969|528662948|FG000|Overall Study|Sponsor's decision|12|||
146588364|NCT03842969|528662949|FG001|Overall Study|Sponsor's decision|99|||
146588365|NCT03842969|528662950|FG002|Overall Study|Sponsor's decision|61|||
146588366|NCT03842969|528662948|FG000|Overall Study|Pregnancy|0|||
146588367|NCT03842969|528662949|FG001|Overall Study|Pregnancy|0|||
146770945|NCT02139046|529329811|FG000|Overall Study|Lost to Follow-up|13|||
146770946|NCT02139046|529329812|FG001|Overall Study|Lost to Follow-up|16|||
146978333|NCT02266706|530084006|FG003|Overall Study|Withdrawal by Subject|0|||
146978334|NCT02266706|530084007|FG004|Overall Study|Withdrawal by Subject|0|||
146588368|NCT03842969|528662950|FG002|Overall Study|Pregnancy|1|||
146588369|NCT03842969|528662948|FG000|Overall Study|Death|1|||
146588370|NCT03842969|528662949|FG001|Overall Study|Death|0|||
146588371|NCT03842969|528662950|FG002|Overall Study|Death|1|||
146588372|NCT03842969|528662948|FG000|Overall Study|Withdrawal by Subject|3|||
146588373|NCT03842969|528662949|FG001|Overall Study|Withdrawal by Subject|30|||
146588374|NCT03842969|528662950|FG002|Overall Study|Withdrawal by Subject|18|||
146588375|NCT03842969|528662948|FG000|Overall Study|Protocol Violation|1|||
146588376|NCT03842969|528662949|FG001|Overall Study|Protocol Violation|1|||
146588377|NCT03842969|528662950|FG002|Overall Study|Protocol Violation|0|||
146588378|NCT03842969|528662948|FG000|Overall Study|Physician Decision|0|||
146588379|NCT03842969|528662949|FG001|Overall Study|Physician Decision|3|||
146588380|NCT03842969|528662950|FG002|Overall Study|Physician Decision|0|||
146588381|NCT03842969|528662948|FG000|Overall Study|Lost to Follow-up|0|||
146588382|NCT03842969|528662949|FG001|Overall Study|Lost to Follow-up|2|||
146588383|NCT03842969|528662950|FG002|Overall Study|Lost to Follow-up|0|||
146588384|NCT03842969|528662948|FG000|Overall Study|Adverse Event|0|||
146588385|NCT03842969|528662949|FG001|Overall Study|Adverse Event|2|||
146588386|NCT03842969|528662950|FG002|Overall Study|Adverse Event|0|||
146588387|NCT01962987|528662953|FG000|Overall Study|Adverse Event|4|||
146588388|NCT01962987|528662954|FG001|Overall Study|Adverse Event|4|||
146588389|NCT01962987|528662955|FG002|Overall Study|Adverse Event|0|||
146588390|NCT01962987|528662953|FG000|Overall Study|Lost to Follow-up|0|||
146588391|NCT01962987|528662954|FG001|Overall Study|Lost to Follow-up|0|||
146588392|NCT01962987|528662955|FG002|Overall Study|Lost to Follow-up|1|||
146588393|NCT01962987|528662953|FG000|Overall Study|Non compliance with dosing requirements|4|||
146588394|NCT01962987|528662954|FG001|Overall Study|Non compliance with dosing requirements|2|||
146588395|NCT01962987|528662955|FG002|Overall Study|Non compliance with dosing requirements|0|||
146588396|NCT01962987|528662953|FG000|Overall Study|Miscellaneous|1|||
146588397|NCT01962987|528662954|FG001|Overall Study|Miscellaneous|9|||
146770947|NCT02139046|529329813|FG002|Overall Study|Lost to Follow-up|16|||
146588398|NCT01962987|528662955|FG002|Overall Study|Miscellaneous|2|||
146588399|NCT01962987|528662953|FG000|Overall Study|Restricted medication|5|||
146588400|NCT01962987|528662954|FG001|Overall Study|Restricted medication|1|||
146588401|NCT01962987|528662955|FG002|Overall Study|Restricted medication|1|||
146588402|NCT01962987|528662953|FG000|Overall Study|Serious Adverse Event|1|||
146588403|NCT01962987|528662954|FG001|Overall Study|Serious Adverse Event|0|||
146588404|NCT01962987|528662955|FG002|Overall Study|Serious Adverse Event|0|||
146588405|NCT01962987|528662953|FG000|Overall Study|Withdrawal by Subject|11|||
146588406|NCT01962987|528662954|FG001|Overall Study|Withdrawal by Subject|10|||
146588407|NCT01962987|528662955|FG002|Overall Study|Withdrawal by Subject|6|||
146588408|NCT01962987|528662953|FG000|Overall Study|Randomized in Error|4|||
146588409|NCT01962987|528662954|FG001|Overall Study|Randomized in Error|2|||
146588410|NCT01962987|528662955|FG002|Overall Study|Randomized in Error|2|||
146588411|NCT01967823|528662956|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
146588412|NCT00413894|528662957|FG000|Overall Study|Withdrawal by Subject|10|||
146588413|NCT00413894|528662957|FG000|Overall Study|Administrative Reasons|1|||
146588414|NCT00413894|528662957|FG000|Overall Study|Hb <10 grams/deciliter|12|||
146588415|NCT00413894|528662957|FG000|Overall Study|Adverse Event|28|||
146588416|NCT00413894|528662957|FG000|Overall Study|Protocol Violation|11|||
146588417|NCT00413894|528662957|FG000|Overall Study|Other|18|||
146588418|NCT01942161|528662958|FG000|Overall Study|Adverse Event|1|||
146588419|NCT01942161|528662959|FG001|Overall Study|Adverse Event|2|||
146588420|NCT01942161|528662960|FG002|Overall Study|Adverse Event|5|||
146588421|NCT01942161|528662958|FG000|Overall Study|Physician Decision|3|||
146588422|NCT01942161|528662959|FG001|Overall Study|Physician Decision|1|||
146588423|NCT01942161|528662960|FG002|Overall Study|Physician Decision|0|||
146588424|NCT01942161|528662958|FG000|Overall Study|Protocol Violation|1|||
146588425|NCT01942161|528662959|FG001|Overall Study|Protocol Violation|0|||
146588426|NCT01942161|528662960|FG002|Overall Study|Protocol Violation|0|||
146588427|NCT01942161|528662958|FG000|Overall Study|Withdrawal by Subject|3|||
146588428|NCT01942161|528662959|FG001|Overall Study|Withdrawal by Subject|3|||
146588429|NCT01942161|528662960|FG002|Overall Study|Withdrawal by Subject|1|||
146588430|NCT05289271|528662961|FG000|Overall Study|Mistakenly allocated, untreated|1|||
146588431|NCT05289271|528662962|FG001|Overall Study|Mistakenly allocated, untreated|0|||
146588432|NCT01257568|528662963|FG000|Overall Study|Lost to Follow-up|2|||
146588433|NCT01257568|528662963|FG000|Overall Study|Withdrawal by Subject|6|||
146588434|NCT01257568|528662963|FG000|Overall Study|Terminated|1|||
146588435|NCT01257568|528662963|FG000|Overall Study|Component Revision|24|||
146588436|NCT00416715|528662965|FG000|Overall Study|Not evaluable for joint aches|7|||
146588437|NCT00416715|528662965|FG000|Overall Study|Vitamin D levels not evaluable|8|||
146588438|NCT00347438|528662966|FG000|Overall Study|Withdrawal by Subject|1|||
146588439|NCT00347438|528662966|FG000|Overall Study|Physician Decision|1|||
146588440|NCT03334851|528662967|FG000|Overall Study|Other|0|||
146588441|NCT03334851|528662968|FG001|Overall Study|Other|0|||
146588442|NCT03334851|528662969|FG002|Overall Study|Other|0|||
146588443|NCT03334851|528662970|FG003|Overall Study|Other|0|||
146588444|NCT03334851|528662971|FG004|Overall Study|Other|0|||
146588445|NCT03334851|528662972|FG005|Overall Study|Other|0|||
146588446|NCT03334851|528662973|FG006|Overall Study|Other|0|||
146588447|NCT03334851|528662974|FG007|Overall Study|Other|1|||
146588448|NCT03334851|528662975|FG008|Overall Study|Other|0|||
146588449|NCT03334851|528662976|FG009|Overall Study|Other|0|||
146588450|NCT03334851|528662977|FG010|Overall Study|Other|0|||
146588451|NCT03334851|528662978|FG011|Overall Study|Other|0|||
146588452|NCT03334851|528662979|FG012|Overall Study|Other|0|||
146588453|NCT03334851|528662967|FG000|Overall Study|Adverse Event|0|||
146588454|NCT03334851|528662968|FG001|Overall Study|Adverse Event|0|||
146588455|NCT03334851|528662969|FG002|Overall Study|Adverse Event|0|||
146588456|NCT03334851|528662970|FG003|Overall Study|Adverse Event|0|||
146588457|NCT03334851|528662971|FG004|Overall Study|Adverse Event|0|||
146588458|NCT03334851|528662972|FG005|Overall Study|Adverse Event|0|||
146588459|NCT03334851|528662973|FG006|Overall Study|Adverse Event|0|||
146588460|NCT03334851|528662974|FG007|Overall Study|Adverse Event|1|||
146588461|NCT03334851|528662975|FG008|Overall Study|Adverse Event|0|||
146588462|NCT03334851|528662976|FG009|Overall Study|Adverse Event|0|||
146588463|NCT03334851|528662977|FG010|Overall Study|Adverse Event|0|||
146588464|NCT03334851|528662978|FG011|Overall Study|Adverse Event|0|||
146588465|NCT03334851|528662979|FG012|Overall Study|Adverse Event|0|||
146588466|NCT03334851|528662967|FG000|Overall Study|Withdrawal by Subject|0|||
146588467|NCT03334851|528662968|FG001|Overall Study|Withdrawal by Subject|0|||
146588468|NCT03334851|528662969|FG002|Overall Study|Withdrawal by Subject|0|||
146588469|NCT03334851|528662970|FG003|Overall Study|Withdrawal by Subject|0|||
146588470|NCT03334851|528662971|FG004|Overall Study|Withdrawal by Subject|0|||
146588471|NCT03334851|528662972|FG005|Overall Study|Withdrawal by Subject|0|||
146588472|NCT03334851|528662973|FG006|Overall Study|Withdrawal by Subject|0|||
146588473|NCT03334851|528662974|FG007|Overall Study|Withdrawal by Subject|0|||
146588474|NCT03334851|528662975|FG008|Overall Study|Withdrawal by Subject|0|||
146588475|NCT03334851|528662976|FG009|Overall Study|Withdrawal by Subject|0|||
146588476|NCT03334851|528662977|FG010|Overall Study|Withdrawal by Subject|1|||
146588477|NCT03334851|528662978|FG011|Overall Study|Withdrawal by Subject|0|||
146588478|NCT03334851|528662979|FG012|Overall Study|Withdrawal by Subject|1|||
146588479|NCT03334851|528662967|FG000|Overall Study|Lost to Follow-up|0|||
146588480|NCT03334851|528662968|FG001|Overall Study|Lost to Follow-up|0|||
146588481|NCT03334851|528662969|FG002|Overall Study|Lost to Follow-up|0|||
146588482|NCT03334851|528662970|FG003|Overall Study|Lost to Follow-up|0|||
146588483|NCT03334851|528662971|FG004|Overall Study|Lost to Follow-up|0|||
146588484|NCT03334851|528662972|FG005|Overall Study|Lost to Follow-up|0|||
146588485|NCT03334851|528662973|FG006|Overall Study|Lost to Follow-up|0|||
146588486|NCT03334851|528662974|FG007|Overall Study|Lost to Follow-up|0|||
146588487|NCT03334851|528662975|FG008|Overall Study|Lost to Follow-up|0|||
146588488|NCT03334851|528662976|FG009|Overall Study|Lost to Follow-up|0|||
146588489|NCT03334851|528662977|FG010|Overall Study|Lost to Follow-up|2|||
146588490|NCT03334851|528662978|FG011|Overall Study|Lost to Follow-up|1|||
146588491|NCT03334851|528662979|FG012|Overall Study|Lost to Follow-up|0|||
146588492|NCT00666588|528662981|FG000|Overall Study|ineligible|2|||
146588493|NCT00666588|528662982|FG001|Overall Study|ineligible|0|||
146588494|NCT00666588|528662983|FG002|Overall Study|ineligible|0|||
146588495|NCT00666588|528662984|FG003|Overall Study|ineligible|2|||
146588496|NCT00666588|528662981|FG000|Overall Study|inevaluable|2|||
146588497|NCT00666588|528662982|FG001|Overall Study|inevaluable|0|||
146588498|NCT00666588|528662983|FG002|Overall Study|inevaluable|0|||
146588499|NCT00666588|528662984|FG003|Overall Study|inevaluable|0|||
146588500|NCT04043234|528662987|FG000|Overall Study|Lost to Follow-up|1|||
146588501|NCT04043234|528662987|FG000|Overall Study|Withdrawal by Subject|1|||
146588502|NCT03622112|528662991|FG000|Overall Study|Withdrawal by Subject|6|||
146588503|NCT03622112|528662992|FG001|Overall Study|Withdrawal by Subject|2|||
146588504|NCT03622112|528662993|FG002|Overall Study|Withdrawal by Subject|4|||
146588505|NCT03622112|528662994|FG003|Overall Study|Withdrawal by Subject|2|||
146588506|NCT03622112|528662995|FG004|Overall Study|Withdrawal by Subject|1|||
146588507|NCT03622112|528662996|FG005|Overall Study|Withdrawal by Subject|2|||
146588508|NCT03622112|528662997|FG006|Overall Study|Withdrawal by Subject|2|||
146588509|NCT03622112|528662991|FG000|Overall Study|Death|0|||
146588510|NCT03622112|528662992|FG001|Overall Study|Death|0|||
146588511|NCT03622112|528662993|FG002|Overall Study|Death|0|||
146588512|NCT03622112|528662994|FG003|Overall Study|Death|1|||
146588513|NCT03622112|528662995|FG004|Overall Study|Death|0|||
146652595|NCT01470989|528905333|FG001|Overall Study|Administrative problems|4|||
146652596|NCT01470989|528905332|FG000|Overall Study|Death|2|||
146588514|NCT03622112|528662996|FG005|Overall Study|Death|0|||
146588515|NCT03622112|528662997|FG006|Overall Study|Death|0|||
146588516|NCT03622112|528662991|FG000|Overall Study|Lost to Follow-up|1|||
146588517|NCT03622112|528662992|FG001|Overall Study|Lost to Follow-up|1|||
146588518|NCT03622112|528662993|FG002|Overall Study|Lost to Follow-up|0|||
146588519|NCT03622112|528662994|FG003|Overall Study|Lost to Follow-up|0|||
146588520|NCT03622112|528662995|FG004|Overall Study|Lost to Follow-up|0|||
146652597|NCT01470989|528905333|FG001|Overall Study|Death|2|||
146652598|NCT01470989|528905332|FG000|Overall Study|Protocol deviation|1|||
146652599|NCT01470989|528905333|FG001|Overall Study|Protocol deviation|2|||
146652600|NCT00969280|528905334|FG000|Overall Study|Protocol Violation|2|||
146652601|NCT00969280|528905335|FG001|Overall Study|Protocol Violation|1|||
146588521|NCT03622112|528662996|FG005|Overall Study|Lost to Follow-up|0|||
146588522|NCT03622112|528662997|FG006|Overall Study|Lost to Follow-up|0|||
146588523|NCT03622112|528662991|FG000|Overall Study|Study-specific withdrawal criteria|10|||
146652602|NCT00969280|528905334|FG000|Overall Study|Withdrawal by Subject|0|||
146652603|NCT00969280|528905335|FG001|Overall Study|Withdrawal by Subject|1|||
146652604|NCT00969280|528905334|FG000|Overall Study|infection of influenza A(H1N1)|0|||
146652605|NCT00969280|528905335|FG001|Overall Study|infection of influenza A(H1N1)|1|||
146588524|NCT03622112|528662992|FG001|Overall Study|Study-specific withdrawal criteria|8|||
146588525|NCT03622112|528662993|FG002|Overall Study|Study-specific withdrawal criteria|7|||
146588526|NCT03622112|528662994|FG003|Overall Study|Study-specific withdrawal criteria|6|||
146588527|NCT03622112|528662995|FG004|Overall Study|Study-specific withdrawal criteria|4|||
146588528|NCT03622112|528662996|FG005|Overall Study|Study-specific withdrawal criteria|18|||
146588529|NCT03622112|528662997|FG006|Overall Study|Study-specific withdrawal criteria|4|||
146588530|NCT03622112|528662991|FG000|Overall Study|Protocol Violation|2|||
146588531|NCT03622112|528662992|FG001|Overall Study|Protocol Violation|0|||
146588532|NCT03622112|528662993|FG002|Overall Study|Protocol Violation|1|||
146588533|NCT03622112|528662994|FG003|Overall Study|Protocol Violation|1|||
146588534|NCT03622112|528662995|FG004|Overall Study|Protocol Violation|0|||
146588535|NCT03622112|528662996|FG005|Overall Study|Protocol Violation|0|||
146588536|NCT03622112|528662997|FG006|Overall Study|Protocol Violation|0|||
146588537|NCT03622112|528662991|FG000|Overall Study|Adverse Event|6|||
146588538|NCT03622112|528662992|FG001|Overall Study|Adverse Event|8|||
146588539|NCT03622112|528662993|FG002|Overall Study|Adverse Event|4|||
146588540|NCT03622112|528662994|FG003|Overall Study|Adverse Event|11|||
146588541|NCT03622112|528662995|FG004|Overall Study|Adverse Event|4|||
146588542|NCT03622112|528662996|FG005|Overall Study|Adverse Event|20|||
146588543|NCT03622112|528662997|FG006|Overall Study|Adverse Event|2|||
146588544|NCT03622112|528662991|FG000|Overall Study|Reason not specified|0|||
146588545|NCT03622112|528662992|FG001|Overall Study|Reason not specified|1|||
146588546|NCT03622112|528662993|FG002|Overall Study|Reason not specified|0|||
146588547|NCT03622112|528662994|FG003|Overall Study|Reason not specified|1|||
146588548|NCT03622112|528662995|FG004|Overall Study|Reason not specified|1|||
146588549|NCT03622112|528662996|FG005|Overall Study|Reason not specified|2|||
146588550|NCT03622112|528662997|FG006|Overall Study|Reason not specified|1|||
146588551|NCT01165320|528662998|FG000|Overall Study|Clinical adverse experience|2|||
146588552|NCT01165320|528662999|FG001|Overall Study|Clinical adverse experience|1|||
146588553|NCT01165320|528663000|FG002|Overall Study|Clinical adverse experience|0|||
146588554|NCT01165320|528662998|FG000|Overall Study|Laboratory adverse experience|1|||
146588555|NCT01165320|528662999|FG001|Overall Study|Laboratory adverse experience|0|||
146588556|NCT01165320|528663000|FG002|Overall Study|Laboratory adverse experience|0|||
146588557|NCT01165320|528662998|FG000|Overall Study|Lack of Efficacy|0|||
146588558|NCT01165320|528662999|FG001|Overall Study|Lack of Efficacy|2|||
146588559|NCT01165320|528663000|FG002|Overall Study|Lack of Efficacy|0|||
146588560|NCT01165320|528662998|FG000|Overall Study|Reason unknown|0|||
146588561|NCT01165320|528662999|FG001|Overall Study|Reason unknown|1|||
146588562|NCT01165320|528663000|FG002|Overall Study|Reason unknown|0|||
146588563|NCT00385944|528663001|FG000|1st Maintenance Dose Period|Physician Decision|1|||
146588564|NCT00385944|528663002|FG001|1st Maintenance Dose Period|Physician Decision|0|||
146588565|NCT00385944|528663003|FG002|1st Maintenance Dose Period|Physician Decision|0|||
146588566|NCT00385944|528663001|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
146588567|NCT00385944|528663002|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
146588568|NCT00385944|528663003|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
146588569|NCT00385944|528663001|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
146588570|NCT00385944|528663002|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
146588571|NCT00385944|528663003|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
146588572|NCT00385944|528663001|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
146588573|NCT00385944|528663002|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
146588574|NCT00385944|528663003|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
146588575|NCT01155466|528663004|FG000|Overall Study|Adverse Event|13|||
146588576|NCT01155466|528663005|FG001|Overall Study|Adverse Event|15|||
146588577|NCT01155466|528663006|FG002|Overall Study|Adverse Event|6|||
146588578|NCT01155466|528663007|FG003|Overall Study|Adverse Event|17|||
146588579|NCT01155466|528663008|FG004|Overall Study|Adverse Event|18|||
146588580|NCT01155466|528663004|FG000|Overall Study|Lost to Follow-up|0|||
146588581|NCT01155466|528663005|FG001|Overall Study|Lost to Follow-up|0|||
146588582|NCT01155466|528663006|FG002|Overall Study|Lost to Follow-up|0|||
146588583|NCT01155466|528663007|FG003|Overall Study|Lost to Follow-up|0|||
146588584|NCT01155466|528663008|FG004|Overall Study|Lost to Follow-up|2|||
146588585|NCT01155466|528663004|FG000|Overall Study|Withdrawal by Subject|7|||
146588586|NCT01155466|528663005|FG001|Overall Study|Withdrawal by Subject|5|||
146588587|NCT01155466|528663006|FG002|Overall Study|Withdrawal by Subject|9|||
146588588|NCT01155466|528663007|FG003|Overall Study|Withdrawal by Subject|4|||
146588589|NCT01155466|528663008|FG004|Overall Study|Withdrawal by Subject|4|||
146588590|NCT01155466|528663004|FG000|Overall Study|Protocol Violation|0|||
146588591|NCT01155466|528663005|FG001|Overall Study|Protocol Violation|0|||
146588592|NCT01155466|528663006|FG002|Overall Study|Protocol Violation|2|||
146588593|NCT01155466|528663007|FG003|Overall Study|Protocol Violation|0|||
146588594|NCT01155466|528663008|FG004|Overall Study|Protocol Violation|1|||
146652606|NCT00217464|528905336|FG000|Overall Study|Progression|15|||
146652607|NCT00217464|528905336|FG000|Overall Study|Other|2|||
146652608|NCT02486718|528905337|FG000|Enrollment Phase|Death|19|||
146652609|NCT02486718|528905338|FG001|Enrollment Phase|Death|0|||
146652610|NCT02486718|528905339|FG002|Enrollment Phase|Death|0|||
146588595|NCT01155466|528663004|FG000|Overall Study|Administrative|0|||
146588596|NCT01155466|528663005|FG001|Overall Study|Administrative|3|||
146588597|NCT01155466|528663006|FG002|Overall Study|Administrative|0|||
146588598|NCT01155466|528663007|FG003|Overall Study|Administrative|0|||
146588599|NCT01155466|528663008|FG004|Overall Study|Administrative|0|||
146588600|NCT01155466|528663004|FG000|Overall Study|Randomized not treated|2|||
146588601|NCT01155466|528663005|FG001|Overall Study|Randomized not treated|2|||
146588602|NCT01155466|528663006|FG002|Overall Study|Randomized not treated|3|||
146588603|NCT01155466|528663007|FG003|Overall Study|Randomized not treated|0|||
146588604|NCT01155466|528663008|FG004|Overall Study|Randomized not treated|2|||
146588605|NCT00590824|528663009|FG000|Overall Study|Disease could not be resected|0|||
146588606|NCT00590824|528663010|FG001|Overall Study|Disease could not be resected|2|||
146588607|NCT00590824|528663011|FG002|Overall Study|Disease could not be resected|1|||
146588608|NCT00590824|528663012|FG003|Overall Study|Disease could not be resected|0|||
146588609|NCT00590824|528663009|FG000|Overall Study|Adverse Event|0|||
146588610|NCT00590824|528663010|FG001|Overall Study|Adverse Event|0|||
146588611|NCT00590824|528663011|FG002|Overall Study|Adverse Event|0|||
146588612|NCT00590824|528663012|FG003|Overall Study|Adverse Event|1|||
146588613|NCT02075047|528663013|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
146588614|NCT02075047|528663014|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
146588615|NCT02075047|528663013|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
146588616|NCT02075047|528663014|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
146588617|NCT02075047|528663013|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
146588618|NCT02075047|528663014|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
146588619|NCT02075047|528663013|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
146588620|NCT02075047|528663014|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
146588621|NCT02075047|528663013|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
146588622|NCT02075047|528663014|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
146588623|NCT02075047|528663013|FG000|Treatment Phase (4 Weeks)|Other|1|||
146588624|NCT02075047|528663014|FG001|Treatment Phase (4 Weeks)|Other|1|||
146588625|NCT02075047|528663013|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
146588626|NCT02075047|528663014|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
146588627|NCT02075047|528663013|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
146588628|NCT02075047|528663014|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
146588629|NCT02075047|528663013|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
146588630|NCT02075047|528663014|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
146588631|NCT02075047|528663013|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
146588632|NCT02075047|528663014|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
146588633|NCT02075047|528663013|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
146588634|NCT02075047|528663014|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
146588635|NCT02075047|528663013|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
146588636|NCT02075047|528663014|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
146588637|NCT02075047|528663013|FG000|Follow up Phase (5 Weeks)|Other|1|||
146588638|NCT02075047|528663014|FG001|Follow up Phase (5 Weeks)|Other|2|||
146588639|NCT02075047|528663013|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
146588640|NCT02075047|528663014|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
146588641|NCT01778049|528663022|FG000|Open Label Treatment Period|Adverse Event|5|||
146588642|NCT01778049|528663023|FG001|Open Label Treatment Period|Adverse Event|15|||
146588643|NCT01778049|528663024|FG002|Open Label Treatment Period|Adverse Event|0|||
146588644|NCT01778049|528663025|FG003|Open Label Treatment Period|Adverse Event|0|||
146588645|NCT01778049|528663026|FG004|Open Label Treatment Period|Adverse Event|0|||
146588646|NCT01778049|528663027|FG005|Open Label Treatment Period|Adverse Event|0|||
146588647|NCT01778049|528663022|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
146588648|NCT01778049|528663023|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
146588649|NCT01778049|528663024|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
146588650|NCT01778049|528663025|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
146588651|NCT01778049|528663026|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
146588652|NCT01778049|528663027|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
146588653|NCT01778049|528663022|FG000|Open Label Treatment Period|Protocol Violation|5|||
146588654|NCT01778049|528663023|FG001|Open Label Treatment Period|Protocol Violation|5|||
146588655|NCT01778049|528663024|FG002|Open Label Treatment Period|Protocol Violation|0|||
146588656|NCT01778049|528663025|FG003|Open Label Treatment Period|Protocol Violation|0|||
146588657|NCT01778049|528663026|FG004|Open Label Treatment Period|Protocol Violation|0|||
146588658|NCT01778049|528663027|FG005|Open Label Treatment Period|Protocol Violation|0|||
146588659|NCT01778049|528663022|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
146588660|NCT01778049|528663023|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
146588661|NCT01778049|528663024|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
146588662|NCT01778049|528663025|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
146588663|NCT01778049|528663026|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
146588664|NCT01778049|528663027|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
146588665|NCT01778049|528663022|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
146588666|NCT01778049|528663023|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
146588667|NCT01778049|528663024|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
146588668|NCT01778049|528663025|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
146588669|NCT01778049|528663026|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
146588670|NCT01778049|528663027|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
146588671|NCT01778049|528663022|FG000|Open Label Treatment Period|Not treated|2|||
146588672|NCT01778049|528663023|FG001|Open Label Treatment Period|Not treated|1|||
146588673|NCT01778049|528663024|FG002|Open Label Treatment Period|Not treated|0|||
146652611|NCT02486718|528905337|FG000|Enrollment Phase|Symptomatic deterioration|1|||
146652612|NCT02486718|528905338|FG001|Enrollment Phase|Symptomatic deterioration|0|||
146652613|NCT02486718|528905339|FG002|Enrollment Phase|Symptomatic deterioration|0|||
146588674|NCT01778049|528663025|FG003|Open Label Treatment Period|Not treated|0|||
146588675|NCT01778049|528663026|FG004|Open Label Treatment Period|Not treated|0|||
146588676|NCT01778049|528663027|FG005|Open Label Treatment Period|Not treated|0|||
146588677|NCT01778049|528663022|FG000|Open Label Treatment Period|Other reason not defined above|77|||
146588678|NCT01778049|528663023|FG001|Open Label Treatment Period|Other reason not defined above|94|||
146588679|NCT01778049|528663024|FG002|Open Label Treatment Period|Other reason not defined above|0|||
146588680|NCT01778049|528663025|FG003|Open Label Treatment Period|Other reason not defined above|0|||
146652614|NCT02486718|528905337|FG000|Enrollment Phase|Withdrawal by Subject|86|||
146652615|NCT02486718|528905338|FG001|Enrollment Phase|Withdrawal by Subject|0|||
146652616|NCT02486718|528905339|FG002|Enrollment Phase|Withdrawal by Subject|0|||
146588681|NCT01778049|528663026|FG004|Open Label Treatment Period|Other reason not defined above|0|||
146588682|NCT01778049|528663027|FG005|Open Label Treatment Period|Other reason not defined above|0|||
146588683|NCT01778049|528663022|FG000|Double Blind Treatment Period|Adverse Event|0|||
146588684|NCT01778049|528663023|FG001|Double Blind Treatment Period|Adverse Event|0|||
146588685|NCT01778049|528663024|FG002|Double Blind Treatment Period|Adverse Event|4|||
146588686|NCT01778049|528663025|FG003|Double Blind Treatment Period|Adverse Event|5|||
146588687|NCT01778049|528663026|FG004|Double Blind Treatment Period|Adverse Event|3|||
146588688|NCT01778049|528663027|FG005|Double Blind Treatment Period|Adverse Event|2|||
146588689|NCT01778049|528663022|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
146588690|NCT01778049|528663023|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
146588691|NCT01778049|528663024|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
146588692|NCT01778049|528663025|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
146588693|NCT01778049|528663026|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
146588694|NCT01778049|528663027|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
146588695|NCT01778049|528663022|FG000|Double Blind Treatment Period|Protocol Violation|0|||
146588696|NCT01778049|528663023|FG001|Double Blind Treatment Period|Protocol Violation|0|||
146588697|NCT01778049|528663024|FG002|Double Blind Treatment Period|Protocol Violation|2|||
146588698|NCT01778049|528663025|FG003|Double Blind Treatment Period|Protocol Violation|0|||
146588699|NCT01778049|528663026|FG004|Double Blind Treatment Period|Protocol Violation|0|||
146588700|NCT01778049|528663027|FG005|Double Blind Treatment Period|Protocol Violation|0|||
146588701|NCT01778049|528663022|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
146588702|NCT01778049|528663023|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
146588703|NCT01778049|528663024|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
146588704|NCT01778049|528663025|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
146588705|NCT01778049|528663026|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
146588706|NCT01778049|528663027|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
146588707|NCT01778049|528663022|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
146588708|NCT01778049|528663023|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
146588709|NCT01778049|528663024|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
146588710|NCT01778049|528663025|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
146588711|NCT01778049|528663026|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
146588712|NCT01778049|528663027|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
146588713|NCT01778049|528663022|FG000|Double Blind Treatment Period|Not treated|0|||
146588714|NCT01778049|528663023|FG001|Double Blind Treatment Period|Not treated|0|||
146588715|NCT01778049|528663024|FG002|Double Blind Treatment Period|Not treated|0|||
146588716|NCT01778049|528663025|FG003|Double Blind Treatment Period|Not treated|2|||
146588717|NCT01778049|528663026|FG004|Double Blind Treatment Period|Not treated|2|||
146588718|NCT01778049|528663027|FG005|Double Blind Treatment Period|Not treated|0|||
146588719|NCT01778049|528663022|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
146588720|NCT01778049|528663023|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
146588721|NCT01778049|528663024|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
146588722|NCT01778049|528663025|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
146588723|NCT01778049|528663026|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
146588724|NCT01778049|528663027|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
146588725|NCT00515294|528663031|FG000|Overall Study|Lost to Follow-up|3|||
146588726|NCT00515294|528663032|FG001|Overall Study|Lost to Follow-up|2|||
146588727|NCT00515294|528663033|FG002|Overall Study|Lost to Follow-up|3|||
146588728|NCT00515294|528663034|FG003|Overall Study|Lost to Follow-up|1|||
146588729|NCT00515294|528663031|FG000|Overall Study|Driver simulator problems|1|||
146588730|NCT00515294|528663032|FG001|Overall Study|Driver simulator problems|1|||
146588731|NCT00515294|528663033|FG002|Overall Study|Driver simulator problems|1|||
146652617|NCT02486718|528905337|FG000|Enrollment Phase|Protocol Violation|18|||
146588732|NCT00515294|528663034|FG003|Overall Study|Driver simulator problems|3|||
146588733|NCT00515294|528663031|FG000|Overall Study|Caffeine amount inaccurate|5|||
146588734|NCT00515294|528663032|FG001|Overall Study|Caffeine amount inaccurate|0|||
146588735|NCT00515294|528663033|FG002|Overall Study|Caffeine amount inaccurate|7|||
146588736|NCT00515294|528663034|FG003|Overall Study|Caffeine amount inaccurate|0|||
146588737|NCT03770728|528663037|FG000|Overall Study|Adverse Event|1|||
146588738|NCT03770728|528663038|FG001|Overall Study|Adverse Event|0|||
146588739|NCT03770728|528663039|FG002|Overall Study|Adverse Event|1|||
146588740|NCT03770728|528663040|FG003|Overall Study|Adverse Event|0|||
146652618|NCT02486718|528905338|FG001|Enrollment Phase|Protocol Violation|0|||
146588741|NCT03770728|528663037|FG000|Overall Study|Poor compliance to protocol|0|||
146588742|NCT03770728|528663038|FG001|Overall Study|Poor compliance to protocol|0|||
146588743|NCT03770728|528663039|FG002|Overall Study|Poor compliance to protocol|1|||
146588744|NCT03770728|528663040|FG003|Overall Study|Poor compliance to protocol|0|||
146588745|NCT03770728|528663037|FG000|Overall Study|Withdrawal by Subject|13|||
146588746|NCT03770728|528663038|FG001|Overall Study|Withdrawal by Subject|8|||
146652619|NCT02486718|528905339|FG002|Enrollment Phase|Protocol Violation|0|||
146588747|NCT03770728|528663039|FG002|Overall Study|Withdrawal by Subject|9|||
146588748|NCT03770728|528663040|FG003|Overall Study|Withdrawal by Subject|13|||
146588749|NCT03770728|528663037|FG000|Overall Study|Other than specified|24|||
146588750|NCT03770728|528663038|FG001|Overall Study|Other than specified|23|||
146588751|NCT03770728|528663039|FG002|Overall Study|Other than specified|21|||
146588752|NCT03770728|528663040|FG003|Overall Study|Other than specified|22|||
146588753|NCT02778555|528663044|FG000|Overall Study|Withdrawal by Subject|55|||
146588754|NCT02778555|528663045|FG001|Overall Study|Withdrawal by Subject|32|||
146588755|NCT02778555|528663046|FG002|Overall Study|Withdrawal by Subject|107|||
146588756|NCT02379988|528663047|FG000|Overall Study|Not eligible|1|||
146588757|NCT00107315|528663048|FG000|Overall Study|Disease Progression|9|||
146588758|NCT00107315|528663048|FG000|Overall Study|Adverse Event|4|||
146588759|NCT00107315|528663048|FG000|Overall Study|Withdrawal by Subject|2|||
146588760|NCT02509039|528663049|FG000|Overall Study|Adverse Event|0|||
146588761|NCT02509039|528663050|FG001|Overall Study|Adverse Event|1|||
146588762|NCT02509039|528663051|FG002|Overall Study|Adverse Event|1|||
146588763|NCT02509039|528663052|FG003|Overall Study|Adverse Event|1|||
146588764|NCT02509039|528663049|FG000|Overall Study|Withdrawal by Subject|0|||
146588765|NCT02509039|528663050|FG001|Overall Study|Withdrawal by Subject|0|||
146588766|NCT02509039|528663051|FG002|Overall Study|Withdrawal by Subject|1|||
146588767|NCT02509039|528663052|FG003|Overall Study|Withdrawal by Subject|0|||
146588768|NCT02509039|528663049|FG000|Overall Study|Progressive disease|2|||
146588769|NCT02509039|528663050|FG001|Overall Study|Progressive disease|2|||
146588770|NCT02509039|528663051|FG002|Overall Study|Progressive disease|1|||
146588771|NCT02509039|528663052|FG003|Overall Study|Progressive disease|5|||
146588772|NCT02509039|528663049|FG000|Overall Study|Study terminated by Sponsor|1|||
146588773|NCT02509039|528663050|FG001|Overall Study|Study terminated by Sponsor|0|||
146588774|NCT02509039|528663051|FG002|Overall Study|Study terminated by Sponsor|0|||
146588775|NCT02509039|528663052|FG003|Overall Study|Study terminated by Sponsor|0|||
146588776|NCT03943550|528663057|FG000|Overall Study|Adverse Event|0|||
146588777|NCT03943550|528663058|FG001|Overall Study|Adverse Event|0|||
146588778|NCT03943550|528663059|FG002|Overall Study|Adverse Event|1|||
146588779|NCT03943550|528663057|FG000|Overall Study|Lost to Follow-up|0|||
146588780|NCT03943550|528663058|FG001|Overall Study|Lost to Follow-up|0|||
146588781|NCT03943550|528663059|FG002|Overall Study|Lost to Follow-up|1|||
146588782|NCT03943550|528663057|FG000|Overall Study|Progressive Disease|0|||
146588783|NCT03943550|528663058|FG001|Overall Study|Progressive Disease|0|||
146588784|NCT03943550|528663059|FG002|Overall Study|Progressive Disease|2|||
146588785|NCT03943550|528663057|FG000|Overall Study|Participant Moved Out of the Country|0|||
146588786|NCT03943550|528663058|FG001|Overall Study|Participant Moved Out of the Country|1|||
146652620|NCT02486718|528905337|FG000|Enrollment Phase|Physician Decision|18|||
146652621|NCT02486718|528905338|FG001|Enrollment Phase|Physician Decision|0|||
146652622|NCT02486718|528905339|FG002|Enrollment Phase|Physician Decision|0|||
146652623|NCT02486718|528905337|FG000|Enrollment Phase|Reason not provided|41|||
146652624|NCT02486718|528905338|FG001|Enrollment Phase|Reason not provided|0|||
146652625|NCT02486718|528905339|FG002|Enrollment Phase|Reason not provided|0|||
146652626|NCT02486718|528905337|FG000|Enrollment Phase|Disease relapse|54|||
146652627|NCT02486718|528905338|FG001|Enrollment Phase|Disease relapse|0|||
146652628|NCT02486718|528905339|FG002|Enrollment Phase|Disease relapse|0|||
146652629|NCT02486718|528905337|FG000|Enrollment Phase|Lost to Follow-up|4|||
146652630|NCT02486718|528905338|FG001|Enrollment Phase|Lost to Follow-up|0|||
146652631|NCT02486718|528905339|FG002|Enrollment Phase|Lost to Follow-up|0|||
146652632|NCT02486718|528905337|FG000|Enrollment Phase|Adverse Event|34|||
146652633|NCT02486718|528905338|FG001|Enrollment Phase|Adverse Event|0|||
146652634|NCT02486718|528905339|FG002|Enrollment Phase|Adverse Event|0|||
146652635|NCT02486718|528905337|FG000|Randomized Phase|Withdrawal by Subject|0|||
146652636|NCT02486718|528905338|FG001|Randomized Phase|Withdrawal by Subject|44|||
146652637|NCT02486718|528905339|FG002|Randomized Phase|Withdrawal by Subject|47|||
146652638|NCT02486718|528905337|FG000|Randomized Phase|Protocol Violation|0|||
146652639|NCT02486718|528905338|FG001|Randomized Phase|Protocol Violation|2|||
146652640|NCT02486718|528905339|FG002|Randomized Phase|Protocol Violation|0|||
146652641|NCT02486718|528905337|FG000|Randomized Phase|Physician Decision|0|||
146652642|NCT02486718|528905338|FG001|Randomized Phase|Physician Decision|0|||
146652643|NCT02486718|528905339|FG002|Randomized Phase|Physician Decision|3|||
146652644|NCT02486718|528905337|FG000|Randomized Phase|Lost to Follow-up|0|||
146652645|NCT02486718|528905338|FG001|Randomized Phase|Lost to Follow-up|5|||
146652646|NCT02486718|528905339|FG002|Randomized Phase|Lost to Follow-up|11|||
146652647|NCT02486718|528905337|FG000|Randomized Phase|Disease Relapse|0|||
146652648|NCT02486718|528905338|FG001|Randomized Phase|Disease Relapse|1|||
146652649|NCT02486718|528905339|FG002|Randomized Phase|Disease Relapse|0|||
146652650|NCT02486718|528905337|FG000|Randomized Phase|Death|0|||
146652651|NCT02486718|528905338|FG001|Randomized Phase|Death|154|||
146918951|NCT01544595|529864541|FG000|Status at Week 68|Withdrawal by Subject|0|||
146588787|NCT03943550|528663059|FG002|Overall Study|Participant Moved Out of the Country|0|||
146588788|NCT00096226|528663060|FG000|Overall Study|Ineligible|2|||
146588789|NCT00096226|528663060|FG000|Overall Study|Protocol treatment not started|1|||
146588790|NCT04262882|528663061|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
146588791|NCT04262882|528663062|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
146588792|NCT04262882|528663061|FG000|Overall Study|Lost to Follow-up|1|||
146588793|NCT04262882|528663062|FG001|Overall Study|Lost to Follow-up|0|||
146588794|NCT01327053|528663067|FG000|Overall Study|Adverse Event|23|||
146588795|NCT01327053|528663068|FG001|Overall Study|Adverse Event|57|||
146588796|NCT01327053|528663067|FG000|Overall Study|Patient/guardian decision|11|||
146588797|NCT01327053|528663068|FG001|Overall Study|Patient/guardian decision|35|||
146588798|NCT01327053|528663067|FG000|Overall Study|Physician Decision|10|||
146588799|NCT01327053|528663068|FG001|Overall Study|Physician Decision|14|||
146588800|NCT01327053|528663067|FG000|Overall Study|Death|1|||
146588801|NCT01327053|528663068|FG001|Overall Study|Death|5|||
146588802|NCT01327053|528663067|FG000|Overall Study|Lost to Follow-up|2|||
146588803|NCT01327053|528663068|FG001|Overall Study|Lost to Follow-up|4|||
146588804|NCT01327053|528663067|FG000|Overall Study|Non-compliance with study treatment|0|||
146588805|NCT01327053|528663068|FG001|Overall Study|Non-compliance with study treatment|5|||
146588806|NCT01327053|528663067|FG000|Overall Study|Study terminated by Sponsor|1|||
146588807|NCT01327053|528663068|FG001|Overall Study|Study terminated by Sponsor|3|||
146588808|NCT01327053|528663067|FG000|Overall Study|Progressive disease|31|||
146588809|NCT01327053|528663068|FG001|Overall Study|Progressive disease|26|||
146588810|NCT01327053|528663067|FG000|Overall Study|Protocol Violation|0|||
146588811|NCT01327053|528663068|FG001|Overall Study|Protocol Violation|1|||
146588812|NCT01327053|528663067|FG000|Overall Study|Untreated|0|||
146588813|NCT01327053|528663068|FG001|Overall Study|Untreated|1|||
146588814|NCT01638013|528663069|FG000|Overall Study|Adverse Event|36|||
146588815|NCT01638013|528663070|FG001|Overall Study|Adverse Event|29|||
146588816|NCT01638013|528663071|FG002|Overall Study|Adverse Event|48|||
146588817|NCT01638013|528663069|FG000|Overall Study|Lack of Efficacy|39|||
146588818|NCT01638013|528663070|FG001|Overall Study|Lack of Efficacy|11|||
146588819|NCT01638013|528663071|FG002|Overall Study|Lack of Efficacy|14|||
146588820|NCT01638013|528663069|FG000|Overall Study|Protocol Violation|10|||
146588821|NCT01638013|528663070|FG001|Overall Study|Protocol Violation|7|||
146588822|NCT01638013|528663071|FG002|Overall Study|Protocol Violation|11|||
146588823|NCT01638013|528663069|FG000|Overall Study|Met discontinuation criteria|4|||
146588824|NCT01638013|528663070|FG001|Overall Study|Met discontinuation criteria|0|||
146588825|NCT01638013|528663071|FG002|Overall Study|Met discontinuation criteria|7|||
146588826|NCT01638013|528663069|FG000|Overall Study|Subject Lost to Follow up|1|||
146588827|NCT01638013|528663070|FG001|Overall Study|Subject Lost to Follow up|0|||
146588828|NCT01638013|528663071|FG002|Overall Study|Subject Lost to Follow up|1|||
146588829|NCT01638013|528663069|FG000|Overall Study|Miscellaneous|25|||
146588830|NCT01638013|528663070|FG001|Overall Study|Miscellaneous|19|||
146588831|NCT01638013|528663071|FG002|Overall Study|Miscellaneous|23|||
146588832|NCT01638013|528663069|FG000|Overall Study|Withdrawal of Consent|16|||
146588833|NCT01638013|528663070|FG001|Overall Study|Withdrawal of Consent|12|||
146588834|NCT01638013|528663071|FG002|Overall Study|Withdrawal of Consent|16|||
146588835|NCT01638013|528663069|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
146588836|NCT01638013|528663070|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
146588837|NCT01638013|528663071|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
146588838|NCT02298179|528663072|FG000|Overall Study|Lost to Follow-up|0|||
146588839|NCT02298179|528663073|FG001|Overall Study|Lost to Follow-up|0|||
146588840|NCT02298179|528663074|FG002|Overall Study|Lost to Follow-up|1|||
146588841|NCT02298179|528663075|FG003|Overall Study|Lost to Follow-up|0|||
146588842|NCT02298179|528663076|FG004|Overall Study|Lost to Follow-up|0|||
146588843|NCT02298179|528663077|FG005|Overall Study|Lost to Follow-up|0|||
146588844|NCT02298179|528663078|FG006|Overall Study|Lost to Follow-up|0|||
146588845|NCT02298179|528663079|FG007|Overall Study|Lost to Follow-up|1|||
146588846|NCT02298179|528663080|FG008|Overall Study|Lost to Follow-up|0|||
146588847|NCT02298179|528663081|FG009|Overall Study|Lost to Follow-up|0|||
146588848|NCT02298179|528663082|FG010|Overall Study|Lost to Follow-up|0|||
146588849|NCT02298179|528663083|FG011|Overall Study|Lost to Follow-up|0|||
146588850|NCT02226198|528664945|FG000|Lead-in Phase|Protocol Violation|1|||
146588851|NCT02226198|528664946|FG001|Lead-in Phase|Protocol Violation|0|||
146588852|NCT02226198|528664947|FG002|Lead-in Phase|Protocol Violation|0|||
146588853|NCT02226198|528664945|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
146588854|NCT02226198|528664946|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
146588855|NCT02226198|528664947|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
146588856|NCT01440517|528664951|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
146588857|NCT01288612|528664953|FG000|Overall Study|Unable to contact|11|||
146588858|NCT01288612|528664954|FG001|Overall Study|Unable to contact|16|||
146588859|NCT01288612|528664955|FG002|Overall Study|Unable to contact|20|||
146588860|NCT01288612|528664953|FG000|Overall Study|Declined|78|||
146588861|NCT01288612|528664954|FG001|Overall Study|Declined|63|||
146588862|NCT01288612|528664955|FG002|Overall Study|Declined|62|||
146588863|NCT01288612|528664953|FG000|Overall Study|Unable to intubate|0|||
146588864|NCT01288612|528664954|FG001|Overall Study|Unable to intubate|3|||
146588865|NCT01288612|528664955|FG002|Overall Study|Unable to intubate|0|||
146588866|NCT00840060|528664956|FG000|Overall Study|Withdrawal by Subject|1|||
146588867|NCT00840060|528664957|FG001|Overall Study|Withdrawal by Subject|0|||
146588868|NCT00840060|528664956|FG000|Overall Study|Change in emotional/behavioral status|0|||
146588869|NCT00840060|528664957|FG001|Overall Study|Change in emotional/behavioral status|1|||
146588870|NCT00871923|528664958|FG000|Overall Study|Death|1|||
146588871|NCT00871923|528664958|FG000|Overall Study|Withdrawal by Subject|1|||
146588872|NCT01263015|528664963|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
146588873|NCT01263015|528664964|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
146588874|NCT01263015|528664963|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
146588875|NCT01263015|528664964|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
146588876|NCT01263015|528664963|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
146588877|NCT01263015|528664964|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
146588878|NCT01263015|528664963|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
146588879|NCT01263015|528664964|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
146588880|NCT01263015|528664963|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
146588881|NCT01263015|528664964|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
146588882|NCT01263015|528664963|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
146588883|NCT01263015|528664964|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
146588884|NCT01263015|528664963|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
146588885|NCT01263015|528664964|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
146588886|NCT01263015|528664963|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
146588887|NCT01263015|528664964|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
146588888|NCT01263015|528664963|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
146588889|NCT01263015|528664964|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
146588890|NCT01263015|528664963|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
146588891|NCT01263015|528664964|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
146588892|NCT01263015|528664963|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
146588893|NCT01263015|528664964|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
146588894|NCT01263015|528664963|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
146588895|NCT01263015|528664964|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
146588896|NCT05599451|528664965|FG000|Overall Study|Not randomized|11|||
146588897|NCT05599451|528664966|FG001|Overall Study|Not randomized|0|||
146588898|NCT05599451|528664967|FG002|Overall Study|Not randomized|0|||
146588899|NCT05599451|528664968|FG003|Overall Study|Not randomized|0|||
146588900|NCT05599451|528664969|FG004|Overall Study|Not randomized|0|||
146588901|NCT05599451|528664965|FG000|Overall Study|Physician Decision|0|||
146588902|NCT05599451|528664966|FG001|Overall Study|Physician Decision|0|||
146588903|NCT05599451|528664967|FG002|Overall Study|Physician Decision|0|||
146588904|NCT05599451|528664968|FG003|Overall Study|Physician Decision|1|||
146588905|NCT05599451|528664969|FG004|Overall Study|Physician Decision|0|||
146588906|NCT02723006|528664970|FG000|Overall Study|Withdrawal by Subject|0|||
146588907|NCT02723006|528664971|FG001|Overall Study|Withdrawal by Subject|1|||
146588908|NCT02723006|528664972|FG002|Overall Study|Withdrawal by Subject|1|||
146588909|NCT02723006|528664970|FG000|Overall Study|Study Terminated by Sponsor|1|||
146588910|NCT02723006|528664971|FG001|Overall Study|Study Terminated by Sponsor|6|||
146588911|NCT02723006|528664972|FG002|Overall Study|Study Terminated by Sponsor|6|||
146588912|NCT03392883|528664979|FG000|Overall Study|Lost to Follow-up|122|||
146588913|NCT03392883|528664980|FG001|Overall Study|Lost to Follow-up|13|||
146588914|NCT03392883|528664981|FG002|Overall Study|Lost to Follow-up|9|||
146588915|NCT03392883|528664979|FG000|Overall Study|Death|4|||
146588916|NCT03392883|528664980|FG001|Overall Study|Death|0|||
146588917|NCT03392883|528664981|FG002|Overall Study|Death|0|||
146588918|NCT03392883|528664979|FG000|Overall Study|Lack of Efficacy|29|||
146588919|NCT03392883|528664980|FG001|Overall Study|Lack of Efficacy|0|||
146588920|NCT03392883|528664981|FG002|Overall Study|Lack of Efficacy|0|||
146588921|NCT03392883|528664979|FG000|Overall Study|Withdrawal by Subject|180|||
146588922|NCT03392883|528664980|FG001|Overall Study|Withdrawal by Subject|0|||
146588923|NCT03392883|528664981|FG002|Overall Study|Withdrawal by Subject|0|||
146588924|NCT03392883|528664979|FG000|Overall Study|Adverse Event|1|||
146588925|NCT03392883|528664980|FG001|Overall Study|Adverse Event|0|||
146588926|NCT03392883|528664981|FG002|Overall Study|Adverse Event|0|||
146588927|NCT01739933|528664991|FG000|Overall Study|Death|89|||
146588928|NCT01739933|528664992|FG001|Overall Study|Death|86|||
146588929|NCT01739933|528664991|FG000|Overall Study|Withdrawal by Subject|10|||
146588930|NCT01739933|528664992|FG001|Overall Study|Withdrawal by Subject|8|||
146588931|NCT01739933|528664991|FG000|Overall Study|Lost to Follow-up|3|||
146588932|NCT01739933|528664992|FG001|Overall Study|Lost to Follow-up|10|||
146588933|NCT01739933|528664991|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
146588934|NCT01739933|528664992|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
146588935|NCT03356977|528664993|FG000|Overall Study|Lost to Follow-up|3|||
146588936|NCT03356977|528664993|FG000|Overall Study|Withdrawal by parent/guardian|2|||
146588937|NCT00908115|528664999|FG000|Overall Study|Other|14|||
146588938|NCT01728077|528665001|FG000|Overall Study|Lack of Efficacy|3|||
146588939|NCT01728077|528665002|FG001|Overall Study|Lack of Efficacy|1|||
146588940|NCT01728077|528665001|FG000|Overall Study|Lost to Follow-up|1|||
146588941|NCT01728077|528665002|FG001|Overall Study|Lost to Follow-up|0|||
146588942|NCT01728077|528665001|FG000|Overall Study|Subject choice|2|||
146588943|NCT01728077|528665002|FG001|Overall Study|Subject choice|3|||
146588944|NCT01728077|528665001|FG000|Overall Study|Death|0|||
146588945|NCT01728077|528665002|FG001|Overall Study|Death|1|||
146588946|NCT01728077|528665001|FG000|Overall Study|Patient moving|1|||
146588947|NCT01728077|528665002|FG001|Overall Study|Patient moving|0|||
146588948|NCT01728077|528665001|FG000|Overall Study|Non compliance|1|||
146588949|NCT01728077|528665002|FG001|Overall Study|Non compliance|0|||
146588950|NCT00378599|528665003|FG000|Overall Study|Adverse Event|38|||
146588951|NCT00378599|528665003|FG000|Overall Study|Protocol Violation|2|||
146588952|NCT00378599|528665003|FG000|Overall Study|Treatment failure|7|||
146588953|NCT00378599|528665003|FG000|Overall Study|Withdrawal by Subject|5|||
146588954|NCT01007435|528665008|FG000|Overall Study|Adverse Event|16|||
146588955|NCT01007435|528665009|FG001|Overall Study|Adverse Event|25|||
146588956|NCT01007435|528665010|FG002|Overall Study|Adverse Event|47|||
146588957|NCT01007435|528665011|FG003|Overall Study|Adverse Event|31|||
146588958|NCT01007435|528665008|FG000|Overall Study|Death|2|||
146588959|NCT01007435|528665009|FG001|Overall Study|Death|4|||
146588960|NCT01007435|528665010|FG002|Overall Study|Death|2|||
146588961|NCT01007435|528665011|FG003|Overall Study|Death|1|||
146588962|NCT01007435|528665008|FG000|Overall Study|Insufficient Therapeutic Response|21|||
146588963|NCT01007435|528665009|FG001|Overall Study|Insufficient Therapeutic Response|7|||
146588964|NCT01007435|528665010|FG002|Overall Study|Insufficient Therapeutic Response|2|||
146588965|NCT01007435|528665011|FG003|Overall Study|Insufficient Therapeutic Response|9|||
146588966|NCT01007435|528665008|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
146588967|NCT01007435|528665009|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
146588968|NCT01007435|528665010|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
146588969|NCT01007435|528665011|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
146588970|NCT01007435|528665008|FG000|Overall Study|Other Protocol Violation|2|||
146588971|NCT01007435|528665009|FG001|Overall Study|Other Protocol Violation|0|||
146588972|NCT01007435|528665010|FG002|Overall Study|Other Protocol Violation|1|||
146588973|NCT01007435|528665011|FG003|Overall Study|Other Protocol Violation|0|||
146588974|NCT01007435|528665008|FG000|Overall Study|Refused Treatment|13|||
146588975|NCT01007435|528665009|FG001|Overall Study|Refused Treatment|13|||
146588976|NCT01007435|528665010|FG002|Overall Study|Refused Treatment|5|||
146588977|NCT01007435|528665011|FG003|Overall Study|Refused Treatment|8|||
146588978|NCT01007435|528665008|FG000|Overall Study|Failure to Return|5|||
146588979|NCT01007435|528665009|FG001|Overall Study|Failure to Return|4|||
146588980|NCT01007435|528665010|FG002|Overall Study|Failure to Return|3|||
146588981|NCT01007435|528665011|FG003|Overall Study|Failure to Return|6|||
146588982|NCT01007435|528665008|FG000|Overall Study|Reason not Specified|1|||
146588983|NCT01007435|528665009|FG001|Overall Study|Reason not Specified|1|||
146588984|NCT01007435|528665010|FG002|Overall Study|Reason not Specified|2|||
146588985|NCT01007435|528665011|FG003|Overall Study|Reason not Specified|1|||
146588986|NCT02545517|528665012|FG000|Overall Study|Death|2|||
146588987|NCT02545517|528665013|FG001|Overall Study|Death|2|||
146588988|NCT02545517|528665014|FG002|Overall Study|Death|1|||
146588989|NCT02545517|528665012|FG000|Overall Study|Lost to Follow-up|14|||
146588990|NCT02545517|528665013|FG001|Overall Study|Lost to Follow-up|13|||
146588991|NCT02545517|528665014|FG002|Overall Study|Lost to Follow-up|17|||
146652652|NCT02486718|528905339|FG002|Randomized Phase|Death|155|||
146652653|NCT02486718|528905337|FG000|Randomized Phase|Ongoing|0|||
146652654|NCT02486718|528905338|FG001|Randomized Phase|Ongoing|301|||
146588992|NCT02545517|528665012|FG000|Overall Study|Protocol Violation|0|||
146588993|NCT02545517|528665013|FG001|Overall Study|Protocol Violation|1|||
146588994|NCT02545517|528665014|FG002|Overall Study|Protocol Violation|1|||
146588995|NCT02545517|528665012|FG000|Overall Study|Withdrawal by Subject|5|||
146588996|NCT02545517|528665013|FG001|Overall Study|Withdrawal by Subject|8|||
146588997|NCT02545517|528665014|FG002|Overall Study|Withdrawal by Subject|9|||
146588998|NCT02545517|528665012|FG000|Overall Study|Administrative reason|5|||
146588999|NCT02545517|528665013|FG001|Overall Study|Administrative reason|6|||
146589000|NCT02545517|528665014|FG002|Overall Study|Administrative reason|10|||
146589001|NCT02545517|528665012|FG000|Overall Study|Other|2|||
146589002|NCT02545517|528665013|FG001|Overall Study|Other|4|||
146589003|NCT02545517|528665014|FG002|Overall Study|Other|3|||
146589004|NCT01529515|528665015|FG000|TRANSITION PHASE|Adverse Event|16|||
146589005|NCT01529515|528665016|FG001|TRANSITION PHASE|Adverse Event|0|||
146589006|NCT01529515|528665017|FG002|TRANSITION PHASE|Adverse Event|0|||
146652655|NCT02486718|528905339|FG002|Randomized Phase|Ongoing|282|||
146652656|NCT00527488|528905344|FG000|Overall Study|Withdrawn prior to dosing|0|||
146652657|NCT00527488|528905345|FG001|Overall Study|Withdrawn prior to dosing|1|||
146652658|NCT00527488|528905346|FG002|Overall Study|Withdrawn prior to dosing|1|||
146589007|NCT01529515|528665018|FG003|TRANSITION PHASE|Adverse Event|0|||
146589008|NCT01529515|528665015|FG000|TRANSITION PHASE|Death|1|||
146589009|NCT01529515|528665016|FG001|TRANSITION PHASE|Death|0|||
146589010|NCT01529515|528665017|FG002|TRANSITION PHASE|Death|0|||
146589011|NCT01529515|528665018|FG003|TRANSITION PHASE|Death|0|||
146589012|NCT01529515|528665015|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
146652659|NCT00527488|528905347|FG003|Overall Study|Withdrawn prior to dosing|0|||
146652660|NCT02545543|528905348|FG000|Overall Study|Lost to Follow-up|67|||
146589013|NCT01529515|528665016|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
146589014|NCT01529515|528665017|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
146589015|NCT01529515|528665018|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
146589016|NCT01529515|528665015|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
146589017|NCT01529515|528665016|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
146589018|NCT01529515|528665017|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
146589019|NCT01529515|528665018|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
146589020|NCT01529515|528665015|FG000|TRANSITION PHASE|Protocol Violation|4|||
146589021|NCT01529515|528665016|FG001|TRANSITION PHASE|Protocol Violation|0|||
146589022|NCT01529515|528665017|FG002|TRANSITION PHASE|Protocol Violation|0|||
146589023|NCT01529515|528665018|FG003|TRANSITION PHASE|Protocol Violation|0|||
146589024|NCT01529515|528665015|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
146589025|NCT01529515|528665016|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
146589026|NCT01529515|528665017|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
146589027|NCT01529515|528665018|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
146589028|NCT01529515|528665015|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
146589029|NCT01529515|528665016|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
146589030|NCT01529515|528665017|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
146589031|NCT01529515|528665018|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
146589032|NCT01529515|528665015|FG000|TRANSITION PHASE|Other|9|||
146589033|NCT01529515|528665016|FG001|TRANSITION PHASE|Other|0|||
146589034|NCT01529515|528665017|FG002|TRANSITION PHASE|Other|0|||
146589035|NCT01529515|528665018|FG003|TRANSITION PHASE|Other|0|||
146589036|NCT01529515|528665015|FG000|MAINTENANCE PHASE|Adverse Event|0|||
146589037|NCT01529515|528665016|FG001|MAINTENANCE PHASE|Adverse Event|10|||
146589038|NCT01529515|528665017|FG002|MAINTENANCE PHASE|Adverse Event|0|||
146589039|NCT01529515|528665018|FG003|MAINTENANCE PHASE|Adverse Event|0|||
146589040|NCT01529515|528665015|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
146589041|NCT01529515|528665016|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
146589042|NCT01529515|528665017|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
146589043|NCT01529515|528665018|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
146589044|NCT01529515|528665015|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
146589045|NCT01529515|528665016|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
146589046|NCT01529515|528665017|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
146589047|NCT01529515|528665018|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
146589048|NCT01529515|528665015|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
146589049|NCT01529515|528665016|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
146589050|NCT01529515|528665017|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
146589051|NCT01529515|528665018|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
146589052|NCT01529515|528665015|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
146589053|NCT01529515|528665016|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
146589054|NCT01529515|528665017|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
146589055|NCT01529515|528665018|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
146589056|NCT01529515|528665015|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
146589057|NCT01529515|528665016|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
146589058|NCT01529515|528665017|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
146589059|NCT01529515|528665018|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
146589060|NCT01529515|528665015|FG000|MAINTENANCE PHASE|Other|0|||
146589061|NCT01529515|528665016|FG001|MAINTENANCE PHASE|Other|10|||
146589062|NCT01529515|528665017|FG002|MAINTENANCE PHASE|Other|0|||
146589063|NCT01529515|528665018|FG003|MAINTENANCE PHASE|Other|0|||
146589064|NCT01529515|528665015|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
146589065|NCT01529515|528665016|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
146589066|NCT01529515|528665017|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
146978335|NCT02266706|530084008|FG005|Overall Study|Withdrawal by Subject|1|||
146978336|NCT02266706|530084009|FG006|Overall Study|Withdrawal by Subject|0|||
146978337|NCT02266706|530084010|FG007|Overall Study|Withdrawal by Subject|0|||
146978338|NCT02266706|530084011|FG008|Overall Study|Withdrawal by Subject|0|||
146589067|NCT01529515|528665018|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
146589068|NCT01529515|528665015|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
146589069|NCT01529515|528665016|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
146589070|NCT01529515|528665017|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
146589071|NCT01529515|528665018|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
146589072|NCT01529515|528665015|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
146589073|NCT01529515|528665016|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
146589074|NCT01529515|528665017|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
146589075|NCT01529515|528665018|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
146589076|NCT01529515|528665015|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
146589077|NCT01529515|528665016|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
146589078|NCT01529515|528665017|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
146589079|NCT01529515|528665018|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
146589080|NCT01529515|528665015|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
146589081|NCT01529515|528665016|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
146589082|NCT01529515|528665017|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
146589083|NCT01529515|528665018|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
146589084|NCT01529515|528665015|FG000|DOUBLE BLIND PHASE|Other|0|||
146978339|NCT02266706|530084003|FG000|Overall Study|Screen failure|0|||
146589085|NCT01529515|528665016|FG001|DOUBLE BLIND PHASE|Other|0|||
146589086|NCT01529515|528665017|FG002|DOUBLE BLIND PHASE|Other|9|||
146589087|NCT01529515|528665018|FG003|DOUBLE BLIND PHASE|Other|2|||
146589088|NCT00523705|528665020|FG000|Overall Study|No time for study.|0|||
146589089|NCT00523705|528665021|FG001|Overall Study|No time for study.|1|||
146589090|NCT00642369|528665022|FG000|Overall Study|Adverse Event|2|||
146589091|NCT00642369|528665023|FG001|Overall Study|Adverse Event|3|||
146589092|NCT00642369|528665022|FG000|Overall Study|Withdrawal by Subject|1|||
146589093|NCT00642369|528665023|FG001|Overall Study|Withdrawal by Subject|0|||
146589094|NCT00642369|528665022|FG000|Overall Study|misdiagnosis|0|||
146589095|NCT00642369|528665023|FG001|Overall Study|misdiagnosis|1|||
146589096|NCT00642369|528665022|FG000|Overall Study|Lack of Efficacy|2|||
146589097|NCT00642369|528665023|FG001|Overall Study|Lack of Efficacy|2|||
146589098|NCT01190475|528665030|FG000|Overall Study|Withdrawal by Subject|0|||
146589099|NCT01190475|528665031|FG001|Overall Study|Withdrawal by Subject|0|||
146589100|NCT01190475|528665032|FG002|Overall Study|Withdrawal by Subject|1|||
146589101|NCT00543803|528665033|FG000|Overall Study|Adverse Event|14|||
146589102|NCT00543803|528665033|FG000|Overall Study|Lack of Efficacy|22|||
146589103|NCT00543803|528665033|FG000|Overall Study|Lost to Follow-up|20|||
146589104|NCT00543803|528665033|FG000|Overall Study|Other|86|||
146589105|NCT01779856|528665034|FG000|Overall Study|Withdrawal by Subject|15|||
146589106|NCT01779856|528665034|FG000|Overall Study|Death|3|||
146589107|NCT01779856|528665034|FG000|Overall Study|Physician Decision|1|||
146589108|NCT01779856|528665034|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
146589109|NCT01779856|528665034|FG000|Overall Study|Delays in scheduling implant|1|||
146589110|NCT01779856|528665034|FG000|Overall Study|Subject ineligible for Implant|2|||
146589111|NCT02680041|528665035|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
146589112|NCT02680041|528665035|FG000|Overall Study|Lost to Follow-up|2|||
146589113|NCT00521599|528665036|FG000|Overall Study|Adverse Event|5|||
146589114|NCT00521599|528665037|FG001|Overall Study|Adverse Event|7|||
146589115|NCT00521599|528665038|FG002|Overall Study|Adverse Event|6|||
146589116|NCT00521599|528665036|FG000|Overall Study|Treatment Failure|8|||
146589117|NCT00521599|528665037|FG001|Overall Study|Treatment Failure|9|||
146589118|NCT00521599|528665038|FG002|Overall Study|Treatment Failure|22|||
146589119|NCT00521599|528665036|FG000|Overall Study|Lost to Follow-up|2|||
146589120|NCT00521599|528665037|FG001|Overall Study|Lost to Follow-up|1|||
146589121|NCT00521599|528665038|FG002|Overall Study|Lost to Follow-up|2|||
146589122|NCT00521599|528665036|FG000|Overall Study|Withdrawal by Subject|3|||
146589123|NCT00521599|528665037|FG001|Overall Study|Withdrawal by Subject|5|||
146589124|NCT00521599|528665038|FG002|Overall Study|Withdrawal by Subject|1|||
146589125|NCT00521599|528665036|FG000|Overall Study|Withdrawal by subject treatment related|3|||
146589126|NCT00521599|528665037|FG001|Overall Study|Withdrawal by subject treatment related|1|||
146589127|NCT00521599|528665038|FG002|Overall Study|Withdrawal by subject treatment related|2|||
146589128|NCT00521599|528665036|FG000|Overall Study|Protocol Violation|2|||
146589129|NCT00521599|528665037|FG001|Overall Study|Protocol Violation|4|||
146589130|NCT00521599|528665038|FG002|Overall Study|Protocol Violation|2|||
146589131|NCT00521599|528665036|FG000|Overall Study|Did not meet protocol eligibility|2|||
146589132|NCT00521599|528665037|FG001|Overall Study|Did not meet protocol eligibility|2|||
146589133|NCT00521599|528665038|FG002|Overall Study|Did not meet protocol eligibility|1|||
146589134|NCT01610713|528665041|FG000|Overall Study|Adverse Event|3|||
146589135|NCT01610713|528665042|FG001|Overall Study|Adverse Event|0|||
146589136|NCT01610713|528665041|FG000|Overall Study|Lack of Efficacy|1|||
146589137|NCT01610713|528665042|FG001|Overall Study|Lack of Efficacy|0|||
146589138|NCT01610713|528665041|FG000|Overall Study|low mood and poor motivation|1|||
146589139|NCT01610713|528665042|FG001|Overall Study|low mood and poor motivation|0|||
146589140|NCT01610713|528665041|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
146589141|NCT01610713|528665042|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
146589142|NCT01610713|528665041|FG000|Overall Study|Lost to Follow-up|0|||
146589143|NCT01610713|528665042|FG001|Overall Study|Lost to Follow-up|1|||
146589144|NCT01774097|528665045|FG000|Overall Study|Withdrawal by Subject|1|||
146589145|NCT01774097|528665046|FG001|Overall Study|Withdrawal by Subject|1|||
146589146|NCT01774097|528665045|FG000|Overall Study|Adverse Event|1|||
146589147|NCT01774097|528665046|FG001|Overall Study|Adverse Event|1|||
146589148|NCT00557310|528665047|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
146589149|NCT00557310|528665047|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
146589150|NCT00557310|528665047|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
146589151|NCT00557310|528665047|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
146589152|NCT00557310|528665047|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
146652661|NCT02545543|528905349|FG001|Overall Study|Lost to Follow-up|25|||
146652662|NCT02545543|528905348|FG000|Overall Study|Physician Decision|3|||
146652663|NCT02545543|528905349|FG001|Overall Study|Physician Decision|0|||
146589153|NCT00557310|528665047|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
146589154|NCT01271712|528665054|FG000|Double Blind Treatment|Death|2|||
146589155|NCT01271712|528665055|FG001|Double Blind Treatment|Death|0|||
146589156|NCT01271712|528665054|FG000|Double Blind Treatment|Lack of Efficacy|1|||
146589157|NCT01271712|528665055|FG001|Double Blind Treatment|Lack of Efficacy|0|||
146652664|NCT02545543|528905348|FG000|Overall Study|Withdrawal by Subject|9|||
146589158|NCT01271712|528665054|FG000|Double Blind Treatment|Adverse Event|9|||
146589159|NCT01271712|528665055|FG001|Double Blind Treatment|Adverse Event|4|||
146589160|NCT01271712|528665054|FG000|Double Blind Treatment|Progressive disease|23|||
146589161|NCT01271712|528665055|FG001|Double Blind Treatment|Progressive disease|3|||
146589162|NCT01271712|528665054|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
146589163|NCT01271712|528665055|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
146589164|NCT01271712|528665054|FG000|Double Blind Treatment|Non compliance with study drug|2|||
146589165|NCT01271712|528665055|FG001|Double Blind Treatment|Non compliance with study drug|0|||
146589166|NCT01271712|528665054|FG000|Double Blind Treatment|receive no study drug|1|||
146589167|NCT01271712|528665055|FG001|Double Blind Treatment|receive no study drug|0|||
146589168|NCT01271712|528665054|FG000|Open Label Treatment|Death|6|||
146589169|NCT01271712|528665055|FG001|Open Label Treatment|Death|5|||
146589170|NCT01271712|528665054|FG000|Open Label Treatment|Withdrawal by Subject|6|||
146589171|NCT01271712|528665055|FG001|Open Label Treatment|Withdrawal by Subject|11|||
146589172|NCT01271712|528665054|FG000|Open Label Treatment|Physician Decision|2|||
146589173|NCT01271712|528665055|FG001|Open Label Treatment|Physician Decision|0|||
146589174|NCT01271712|528665054|FG000|Open Label Treatment|Adverse Event|14|||
146589175|NCT01271712|528665055|FG001|Open Label Treatment|Adverse Event|8|||
146589176|NCT01271712|528665054|FG000|Open Label Treatment|Progressive disease|59|||
146589177|NCT01271712|528665055|FG001|Open Label Treatment|Progressive disease|32|||
146589178|NCT01271712|528665054|FG000|Open Label Treatment|transferred to rollover study|1|||
146589179|NCT01271712|528665055|FG001|Open Label Treatment|transferred to rollover study|0|||
146589180|NCT01271712|528665054|FG000|Open Label Treatment|Non-compliance with study drug|1|||
146589181|NCT01271712|528665055|FG001|Open Label Treatment|Non-compliance with study drug|0|||
146589182|NCT01271712|528665054|FG000|Open Label Treatment|Protocol Violation|0|||
146589183|NCT01271712|528665055|FG001|Open Label Treatment|Protocol Violation|1|||
146589184|NCT01271712|528665054|FG000|Open Label Treatment|Switching to other therapy|2|||
146589185|NCT01271712|528665055|FG001|Open Label Treatment|Switching to other therapy|1|||
146589186|NCT01271712|528665054|FG000|Safety Follow-up|Death|11|||
146589187|NCT01271712|528665055|FG001|Safety Follow-up|Death|7|||
146589188|NCT01271712|528665054|FG000|Safety Follow-up|Withdrawal by Subject|4|||
146589189|NCT01271712|528665055|FG001|Safety Follow-up|Withdrawal by Subject|2|||
146589190|NCT01271712|528665054|FG000|Safety Follow-up|Protocol Violation|1|||
146589191|NCT01271712|528665055|FG001|Safety Follow-up|Protocol Violation|1|||
146589192|NCT01271712|528665054|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
146589193|NCT01271712|528665055|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
146589194|NCT01271712|528665054|FG000|Safety Follow-up|No follow-up|1|||
146589195|NCT01271712|528665055|FG001|Safety Follow-up|No follow-up|1|||
146589196|NCT01271712|528665054|FG000|Safety Follow-up|Progressive disease|1|||
146589197|NCT01271712|528665055|FG001|Safety Follow-up|Progressive disease|0|||
146589198|NCT01271712|528665054|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
146589199|NCT01271712|528665055|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
146589200|NCT03099174|528665057|FG000|Overall Study|Withdrawal by Subject|0|||
146589201|NCT03099174|528665058|FG001|Overall Study|Withdrawal by Subject|0|||
146589202|NCT03099174|528665059|FG002|Overall Study|Withdrawal by Subject|1|||
146589203|NCT03099174|528665060|FG003|Overall Study|Withdrawal by Subject|0|||
146589204|NCT03099174|528665061|FG004|Overall Study|Withdrawal by Subject|2|||
146589205|NCT03099174|528665062|FG005|Overall Study|Withdrawal by Subject|2|||
146589206|NCT03099174|528665063|FG006|Overall Study|Withdrawal by Subject|1|||
146589207|NCT03099174|528665064|FG007|Overall Study|Withdrawal by Subject|4|||
146589208|NCT03099174|528665057|FG000|Overall Study|Adverse Event|0|||
146589209|NCT03099174|528665058|FG001|Overall Study|Adverse Event|1|||
146589210|NCT03099174|528665059|FG002|Overall Study|Adverse Event|1|||
146589211|NCT03099174|528665060|FG003|Overall Study|Adverse Event|2|||
146589212|NCT03099174|528665061|FG004|Overall Study|Adverse Event|5|||
146589213|NCT03099174|528665062|FG005|Overall Study|Adverse Event|3|||
146589214|NCT03099174|528665063|FG006|Overall Study|Adverse Event|6|||
146589215|NCT03099174|528665064|FG007|Overall Study|Adverse Event|4|||
146589216|NCT03099174|528665057|FG000|Overall Study|Other than listed|6|||
146589217|NCT03099174|528665058|FG001|Overall Study|Other than listed|6|||
146589218|NCT03099174|528665059|FG002|Overall Study|Other than listed|5|||
146589219|NCT03099174|528665060|FG003|Overall Study|Other than listed|6|||
146589220|NCT03099174|528665061|FG004|Overall Study|Other than listed|19|||
146589221|NCT03099174|528665062|FG005|Overall Study|Other than listed|10|||
146589222|NCT03099174|528665063|FG006|Overall Study|Other than listed|26|||
146589223|NCT03099174|528665064|FG007|Overall Study|Other than listed|23|||
146589224|NCT04173260|528665065|FG000|Overall Study|Early termination|4|||
146652665|NCT02545543|528905349|FG001|Overall Study|Withdrawal by Subject|8|||
146652666|NCT02545543|528905348|FG000|Overall Study|Noncomplaince|1|||
146589225|NCT02308163|528665066|FG000|Overall Study|Not fulfill eligible criteria|1|||
146589226|NCT02308163|528665067|FG001|Overall Study|Not fulfill eligible criteria|2|||
146589227|NCT02308163|528665068|FG002|Overall Study|Not fulfill eligible criteria|0|||
146589228|NCT02308163|528665069|FG003|Overall Study|Not fulfill eligible criteria|1|||
146589229|NCT02308163|528665070|FG004|Overall Study|Not fulfill eligible criteria|1|||
146652667|NCT02545543|528905349|FG001|Overall Study|Noncomplaince|0|||
146589230|NCT02308163|528665066|FG000|Overall Study|Adverse Event|9|||
146589231|NCT02308163|528665067|FG001|Overall Study|Adverse Event|5|||
146589232|NCT02308163|528665068|FG002|Overall Study|Adverse Event|2|||
146589233|NCT02308163|528665069|FG003|Overall Study|Adverse Event|2|||
146589234|NCT02308163|528665070|FG004|Overall Study|Adverse Event|11|||
146589235|NCT02308163|528665066|FG000|Overall Study|Lack of Efficacy|11|||
146589236|NCT02308163|528665067|FG001|Overall Study|Lack of Efficacy|3|||
146589237|NCT02308163|528665068|FG002|Overall Study|Lack of Efficacy|8|||
146589238|NCT02308163|528665069|FG003|Overall Study|Lack of Efficacy|4|||
146589239|NCT02308163|528665070|FG004|Overall Study|Lack of Efficacy|6|||
146589240|NCT02308163|528665066|FG000|Overall Study|Withdrawal of consent|2|||
146589241|NCT02308163|528665067|FG001|Overall Study|Withdrawal of consent|3|||
146589242|NCT02308163|528665068|FG002|Overall Study|Withdrawal of consent|0|||
146589243|NCT02308163|528665069|FG003|Overall Study|Withdrawal of consent|2|||
146589244|NCT02308163|528665070|FG004|Overall Study|Withdrawal of consent|6|||
146589245|NCT02308163|528665066|FG000|Overall Study|Protocol Violation|3|||
146589246|NCT02308163|528665067|FG001|Overall Study|Protocol Violation|3|||
146589247|NCT02308163|528665068|FG002|Overall Study|Protocol Violation|3|||
146589248|NCT02308163|528665069|FG003|Overall Study|Protocol Violation|2|||
146589249|NCT02308163|528665070|FG004|Overall Study|Protocol Violation|5|||
146589250|NCT02308163|528665066|FG000|Overall Study|Lab data met discontinuation criteria|3|||
146589251|NCT02308163|528665067|FG001|Overall Study|Lab data met discontinuation criteria|0|||
146589252|NCT02308163|528665068|FG002|Overall Study|Lab data met discontinuation criteria|0|||
146589253|NCT02308163|528665069|FG003|Overall Study|Lab data met discontinuation criteria|2|||
146589254|NCT02308163|528665070|FG004|Overall Study|Lab data met discontinuation criteria|0|||
146589255|NCT02308163|528665066|FG000|Overall Study|Miscellaneous|2|||
146589256|NCT02308163|528665067|FG001|Overall Study|Miscellaneous|2|||
146589257|NCT02308163|528665068|FG002|Overall Study|Miscellaneous|1|||
146589258|NCT02308163|528665069|FG003|Overall Study|Miscellaneous|0|||
146589259|NCT02308163|528665070|FG004|Overall Study|Miscellaneous|5|||
146589260|NCT02118766|528665076|FG000|Overall Study|Adverse Event|7|||
146589261|NCT02118766|528665077|FG001|Overall Study|Adverse Event|2|||
146589262|NCT02118766|528665076|FG000|Overall Study|Withdrawal by Subject|3|||
146589263|NCT02118766|528665077|FG001|Overall Study|Withdrawal by Subject|6|||
146589264|NCT02118766|528665076|FG000|Overall Study|Lost to Follow-up|5|||
146589265|NCT02118766|528665077|FG001|Overall Study|Lost to Follow-up|4|||
146589266|NCT02118766|528665076|FG000|Overall Study|Withdrawal by parent/guardian|12|||
146589267|NCT02118766|528665077|FG001|Overall Study|Withdrawal by parent/guardian|18|||
146589268|NCT02118766|528665076|FG000|Overall Study|Other|3|||
146589269|NCT02118766|528665077|FG001|Overall Study|Other|1|||
146589270|NCT03941964|528665078|FG000|Overall Study|Adverse Event|1|||
146589271|NCT03941964|528665079|FG001|Overall Study|Adverse Event|8|||
146589272|NCT03941964|528665078|FG000|Overall Study|Progressive disease|7|||
146589273|NCT03941964|528665079|FG001|Overall Study|Progressive disease|3|||
146589274|NCT03941964|528665078|FG000|Overall Study|Lack of Efficacy|0|||
146589275|NCT03941964|528665079|FG001|Overall Study|Lack of Efficacy|1|||
146589276|NCT03941964|528665078|FG000|Overall Study|Death|3|||
146589277|NCT03941964|528665079|FG001|Overall Study|Death|1|||
146589278|NCT03941964|528665078|FG000|Overall Study|Withdrew consent|1|||
146589279|NCT03941964|528665079|FG001|Overall Study|Withdrew consent|3|||
146589280|NCT03941964|528665078|FG000|Overall Study|Physician Decision|9|||
146589281|NCT03941964|528665079|FG001|Overall Study|Physician Decision|2|||
146589282|NCT03941964|528665078|FG000|Overall Study|Other, not specified|2|||
146589283|NCT03941964|528665079|FG001|Overall Study|Other, not specified|1|||
146589284|NCT00118846|528665082|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
146589285|NCT00118846|528665083|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
146652668|NCT02545543|528905348|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
146652669|NCT02545543|528905349|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
146652670|NCT00622739|528906733|FG000|Overall Study|Physician Decision|1|||
146652671|NCT00622739|528906734|FG001|Overall Study|Physician Decision|0|||
146652672|NCT00622739|528906733|FG000|Overall Study|Adverse Event|1|||
146652673|NCT00622739|528906734|FG001|Overall Study|Adverse Event|2|||
146589286|NCT00118846|528665082|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
146589287|NCT00118846|528665083|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
146589288|NCT00118846|528665082|FG000|Overall Study|Physician Decision|1|||
146589289|NCT00118846|528665083|FG001|Overall Study|Physician Decision|0|||
146589290|NCT00118846|528665082|FG000|Overall Study|Medical condition|2|||
146589291|NCT00118846|528665083|FG001|Overall Study|Medical condition|2|||
146652674|NCT00622739|528906733|FG000|Overall Study|Lack of Efficacy|0|||
146652675|NCT00622739|528906734|FG001|Overall Study|Lack of Efficacy|2|||
146589292|NCT00118846|528665082|FG000|Overall Study|Lost to Follow-up|0|||
146589293|NCT00118846|528665083|FG001|Overall Study|Lost to Follow-up|2|||
146589294|NCT00118846|528665082|FG000|Overall Study|Personal reason|4|||
146589295|NCT00118846|528665083|FG001|Overall Study|Personal reason|5|||
146589296|NCT04669262|528665086|FG000|Overall Study|Withdrawal by Subject|0|||
146589297|NCT04669262|528665087|FG001|Overall Study|Withdrawal by Subject|0|||
146589298|NCT04669262|528665088|FG002|Overall Study|Withdrawal by Subject|0|||
146652676|NCT00622739|528906733|FG000|Overall Study|Withdrawal by Subject|0|||
146652677|NCT00622739|528906734|FG001|Overall Study|Withdrawal by Subject|1|||
146652678|NCT00622739|528906733|FG000|Overall Study|Lost to Follow-up|0|||
146652679|NCT00622739|528906734|FG001|Overall Study|Lost to Follow-up|1|||
146652680|NCT03123185|528906742|FG000|Overall Study|Withdrawal by Subject|0|||
146652681|NCT03123185|528906743|FG001|Overall Study|Withdrawal by Subject|0|||
146652682|NCT03123185|528906744|FG002|Overall Study|Withdrawal by Subject|0|||
146652683|NCT03123185|528906745|FG003|Overall Study|Withdrawal by Subject|0|||
146652684|NCT03123185|528906746|FG004|Overall Study|Withdrawal by Subject|0|||
146589299|NCT04669262|528665089|FG003|Overall Study|Withdrawal by Subject|1|||
146918952|NCT01544595|529864542|FG001|Status at Week 68|Withdrawal by Subject|1|||
146589300|NCT04669262|528665086|FG000|Overall Study|Randomized but Not Treated|0|||
146589301|NCT04669262|528665087|FG001|Overall Study|Randomized but Not Treated|1|||
146589302|NCT04669262|528665088|FG002|Overall Study|Randomized but Not Treated|0|||
146589303|NCT04669262|528665089|FG003|Overall Study|Randomized but Not Treated|0|||
146589304|NCT05463744|528665090|FG000|Treatment Period|Withdrawal by Subject|19|||
146589305|NCT05463744|528665091|FG001|Treatment Period|Withdrawal by Subject|16|||
146589306|NCT05463744|528665090|FG000|Treatment Period|Adverse Event|4|||
146589307|NCT05463744|528665091|FG001|Treatment Period|Adverse Event|4|||
146589308|NCT05463744|528665090|FG000|Treatment Period|Pregnancy|0|||
146589309|NCT05463744|528665091|FG001|Treatment Period|Pregnancy|3|||
146589310|NCT05463744|528665090|FG000|Treatment Period|Lost to Follow-up|1|||
146589311|NCT05463744|528665091|FG001|Treatment Period|Lost to Follow-up|3|||
146589312|NCT05463744|528665090|FG000|Treatment Period|Inadvertent enrollment|2|||
146589313|NCT05463744|528665091|FG001|Treatment Period|Inadvertent enrollment|1|||
146589314|NCT05463744|528665090|FG000|Treatment Period|Death|0|||
146589315|NCT05463744|528665091|FG001|Treatment Period|Death|1|||
146589316|NCT05463744|528665090|FG000|Treatment Period|Non-compliance with Study Drug|1|||
146589317|NCT05463744|528665091|FG001|Treatment Period|Non-compliance with Study Drug|0|||
146589318|NCT05463744|528665090|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
146589319|NCT05463744|528665091|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
146589320|NCT05463744|528665090|FG000|Treatment Period|Physician Decision|0|||
146589321|NCT05463744|528665091|FG001|Treatment Period|Physician Decision|1|||
146589322|NCT05463744|528665090|FG000|Follow-Up Period|Withdrawal by Subject|3|||
146589323|NCT05463744|528665091|FG001|Follow-Up Period|Withdrawal by Subject|1|||
146589324|NCT05463744|528665090|FG000|Follow-Up Period|Lost to Follow-up|1|||
146589325|NCT05463744|528665091|FG001|Follow-Up Period|Lost to Follow-up|1|||
146589326|NCT00068250|528665094|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
146589327|NCT00068250|528665095|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
146589328|NCT00068250|528665096|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
146589329|NCT00068250|528665097|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
146589330|NCT01357161|528665098|FG000|Part 1 (Open Label Run-in)|Death|5|||
146589331|NCT01357161|528665099|FG001|Part 1 (Open Label Run-in)|Death|0|||
146589332|NCT01357161|528665100|FG002|Part 1 (Open Label Run-in)|Death|0|||
146589333|NCT01357161|528665098|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
146589334|NCT01357161|528665099|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
146589335|NCT01357161|528665100|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
146589336|NCT01357161|528665098|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
146589337|NCT01357161|528665099|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
146589338|NCT01357161|528665100|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
146589339|NCT01357161|528665098|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
146589340|NCT01357161|528665099|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
146589341|NCT01357161|528665100|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
146589342|NCT01357161|528665098|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
146589343|NCT01357161|528665099|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
146589344|NCT01357161|528665100|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
146589345|NCT01357161|528665098|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
146589346|NCT01357161|528665099|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
146589347|NCT01357161|528665100|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
146652685|NCT03123185|528906747|FG005|Overall Study|Withdrawal by Subject|0|||
146652686|NCT03123185|528906748|FG006|Overall Study|Withdrawal by Subject|0|||
146652687|NCT03123185|528906749|FG007|Overall Study|Withdrawal by Subject|0|||
146652688|NCT03123185|528906750|FG008|Overall Study|Withdrawal by Subject|0|||
146652689|NCT03123185|528906751|FG009|Overall Study|Withdrawal by Subject|0|||
146652690|NCT03123185|528906752|FG010|Overall Study|Withdrawal by Subject|0|||
146918953|NCT01544595|529864543|FG002|Status at Week 68|Withdrawal by Subject|1|||
146918954|NCT01544595|529864544|FG003|Status at Week 68|Withdrawal by Subject|2|||
146918955|NCT01544595|529864545|FG004|Status at Week 68|Withdrawal by Subject|0|||
146918956|NCT01544595|529864546|FG005|Status at Week 68|Withdrawal by Subject|0|||
146918957|NCT01544595|529864541|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
146918958|NCT01544595|529864542|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
146918959|NCT01544595|529864543|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
146978340|NCT02266706|530084004|FG001|Overall Study|Screen failure|0|||
146978341|NCT02266706|530084005|FG002|Overall Study|Screen failure|0|||
146589348|NCT01357161|528665098|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
146589349|NCT01357161|528665099|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
146589350|NCT01357161|528665100|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
146589351|NCT01357161|528665098|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
146589352|NCT01357161|528665099|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
146589353|NCT01357161|528665100|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
146589354|NCT01357161|528665098|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
146589355|NCT01357161|528665099|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
146589356|NCT01357161|528665100|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
146589357|NCT01357161|528665098|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
146589358|NCT01357161|528665099|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
146589359|NCT01357161|528665100|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
146589360|NCT01357161|528665098|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
146589361|NCT01357161|528665099|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
146589362|NCT01357161|528665100|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
146589363|NCT01824823|528665101|FG000|Overall Study|Lack of Efficacy|1|||
146589364|NCT01824823|528665102|FG001|Overall Study|Lack of Efficacy|1|||
146589365|NCT01824823|528665101|FG000|Overall Study|Off-treatment reason not submitted|1|||
146589366|NCT01824823|528665102|FG001|Overall Study|Off-treatment reason not submitted|0|||
146589367|NCT00098748|528665104|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
146589368|NCT00098748|528665105|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
146589369|NCT00098748|528665106|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
146589370|NCT00098748|528665104|FG000|Received Study Treatment|Death|2|||
146589371|NCT00098748|528665105|FG001|Received Study Treatment|Death|1|||
146589372|NCT00098748|528665106|FG002|Received Study Treatment|Death|2|||
146589373|NCT00098748|528665104|FG000|Received Study Treatment|Adverse Event|1|||
146589374|NCT00098748|528665105|FG001|Received Study Treatment|Adverse Event|2|||
146589375|NCT00098748|528665106|FG002|Received Study Treatment|Adverse Event|5|||
146589376|NCT00098748|528665104|FG000|Received Study Treatment|Lack of Efficacy|40|||
146589377|NCT00098748|528665105|FG001|Received Study Treatment|Lack of Efficacy|27|||
146589378|NCT00098748|528665106|FG002|Received Study Treatment|Lack of Efficacy|27|||
146589379|NCT00098748|528665104|FG000|Received Study Treatment|Other|2|||
146589380|NCT00098748|528665105|FG001|Received Study Treatment|Other|2|||
146589381|NCT00098748|528665106|FG002|Received Study Treatment|Other|6|||
146589382|NCT00098748|528665104|FG000|Received Study Treatment|Subject defaulted|3|||
146589383|NCT00098748|528665105|FG001|Received Study Treatment|Subject defaulted|4|||
146589384|NCT00098748|528665106|FG002|Received Study Treatment|Subject defaulted|4|||
146589385|NCT00098748|528665104|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
146589386|NCT00098748|528665105|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
146589387|NCT00098748|528665106|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
146589388|NCT00098748|528665104|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
146589389|NCT00098748|528665105|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
146589390|NCT00098748|528665106|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
146589391|NCT00098748|528665104|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
146589392|NCT00098748|528665105|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
146589393|NCT00098748|528665106|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
146589394|NCT00098748|528665104|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
146589395|NCT00098748|528665105|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
146589396|NCT00098748|528665106|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
146589397|NCT00098748|528665104|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
146589398|NCT00098748|528665105|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
146589399|NCT00098748|528665106|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
146589400|NCT00433160|528665111|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
146589401|NCT00433160|528665112|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
146589402|NCT00433160|528665111|FG000|52-Week Double-Blind (DB) Period|Death|0|||
146589403|NCT00433160|528665112|FG001|52-Week Double-Blind (DB) Period|Death|0|||
146589404|NCT00433160|528665111|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
146589405|NCT00433160|528665112|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
146589406|NCT00433160|528665111|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
146589407|NCT00433160|528665112|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
146589408|NCT00433160|528665111|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
146589409|NCT00433160|528665112|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
146589410|NCT00433160|528665111|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
146589411|NCT00433160|528665112|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
146589412|NCT00433160|528665111|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
146589413|NCT00433160|528665112|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
146589414|NCT00433160|528665111|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
146589415|NCT00433160|528665112|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
146589416|NCT00433160|528665111|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
146589417|NCT00433160|528665112|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
146589418|NCT00433160|528665111|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
146589419|NCT00433160|528665112|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
146589420|NCT00433160|528665111|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
146589421|NCT00433160|528665112|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
146589422|NCT00433160|528665111|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
146589423|NCT00433160|528665112|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
146589424|NCT00433160|528665111|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
146589425|NCT00433160|528665112|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
146589426|NCT00433160|528665111|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
146589427|NCT00433160|528665112|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
146589428|NCT00433160|528665111|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
146589429|NCT00433160|528665112|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
146589430|NCT00433160|528665111|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
146589431|NCT00433160|528665112|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
146589432|NCT00445939|528666945|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
146589433|NCT00445939|528666946|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
146589434|NCT00445939|528666947|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
146589435|NCT00445939|528666948|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
146589436|NCT00445939|528666945|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
146589437|NCT00445939|528666946|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
146589438|NCT00445939|528666947|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
146589439|NCT00445939|528666948|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
146589440|NCT02576535|528666962|FG000|Overall Study|Withdrawal by Subject|2|||
146589441|NCT01691885|528666964|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
146589442|NCT01691885|528666965|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
146589443|NCT01691885|528666964|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
146589444|NCT01691885|528666965|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
146589445|NCT03555981|528666966|FG000|Overall Study|Lost to Follow-up|0|||
146589446|NCT03555981|528666967|FG001|Overall Study|Lost to Follow-up|2|||
146589447|NCT00354107|528666968|FG000|Overall Study|Adverse Event|2|||
146589448|NCT00354107|528666968|FG000|Overall Study|Physician Decision|2|||
146589449|NCT00354107|528666968|FG000|Overall Study|Withdrawal by Subject|1|||
146589450|NCT04035564|528666969|FG000|Overall Study|Protocol Violation|1|||
146589451|NCT04035564|528666970|FG001|Overall Study|Protocol Violation|2|||
146589452|NCT04035564|528666969|FG000|Overall Study|No laboratory available|2|||
146589453|NCT04035564|528666970|FG001|Overall Study|No laboratory available|2|||
146589454|NCT04035564|528666969|FG000|Overall Study|Guardian declined consent|1|||
146589455|NCT04035564|528666970|FG001|Overall Study|Guardian declined consent|2|||
146589456|NCT00996281|528666975|FG000|Overall Study|Adverse Event|75|||
146589457|NCT00996281|528666976|FG001|Overall Study|Adverse Event|37|||
146589458|NCT00996281|528666975|FG000|Overall Study|Major Protocol Deviation|6|||
146589459|NCT00996281|528666976|FG001|Overall Study|Major Protocol Deviation|7|||
146652691|NCT03123185|528906753|FG011|Overall Study|Withdrawal by Subject|0|||
146652692|NCT03123185|528906754|FG012|Overall Study|Withdrawal by Subject|1|||
146652693|NCT03123185|528906755|FG013|Overall Study|Withdrawal by Subject|0|||
146652694|NCT00718081|528906756|FG000|Overall Study|Adverse Event|0|||
146652695|NCT00718081|528906757|FG001|Overall Study|Adverse Event|1|||
146652696|NCT00718081|528906758|FG002|Overall Study|Adverse Event|0|||
146770948|NCT02139046|529329814|FG003|Overall Study|Lost to Follow-up|18|||
146770949|NCT02139046|529329815|FG004|Overall Study|Lost to Follow-up|13|||
146589460|NCT00996281|528666975|FG000|Overall Study|Lost to Follow-up|14|||
146589461|NCT00996281|528666976|FG001|Overall Study|Lost to Follow-up|16|||
146589462|NCT00996281|528666975|FG000|Overall Study|Withdrawal by Subject|31|||
146589463|NCT00996281|528666976|FG001|Overall Study|Withdrawal by Subject|20|||
146770950|NCT02139046|529329811|FG000|Overall Study|Voluntary Withdrawal|20|||
146770951|NCT02139046|529329812|FG001|Overall Study|Voluntary Withdrawal|8|||
146770952|NCT02139046|529329813|FG002|Overall Study|Voluntary Withdrawal|10|||
146770953|NCT02139046|529329814|FG003|Overall Study|Voluntary Withdrawal|15|||
146770954|NCT02139046|529329815|FG004|Overall Study|Voluntary Withdrawal|16|||
146770955|NCT02139046|529329811|FG000|Overall Study|Lack of Efficacy|0|||
146770956|NCT02139046|529329812|FG001|Overall Study|Lack of Efficacy|1|||
146589464|NCT00996281|528666975|FG000|Overall Study|Lack of Efficacy|0|||
146589465|NCT00996281|528666976|FG001|Overall Study|Lack of Efficacy|2|||
146589466|NCT00996281|528666975|FG000|Overall Study|Other|5|||
146589467|NCT00996281|528666976|FG001|Overall Study|Other|7|||
146589468|NCT03505788|528666979|FG000|Overall Study|Lost to Follow-up|2|||
146652697|NCT00718081|528906756|FG000|Overall Study|Lack of Efficacy|7|||
146652698|NCT00718081|528906757|FG001|Overall Study|Lack of Efficacy|3|||
146652699|NCT00718081|528906758|FG002|Overall Study|Lack of Efficacy|21|||
146589469|NCT03505788|528666980|FG001|Overall Study|Lost to Follow-up|1|||
146770957|NCT02139046|529329813|FG002|Overall Study|Lack of Efficacy|2|||
146770958|NCT02139046|529329814|FG003|Overall Study|Lack of Efficacy|1|||
146770959|NCT02139046|529329815|FG004|Overall Study|Lack of Efficacy|2|||
146770960|NCT02139046|529329811|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
146770961|NCT02139046|529329812|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
146770962|NCT02139046|529329813|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
146770963|NCT02139046|529329814|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
146770964|NCT02139046|529329815|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
146770965|NCT02139046|529329811|FG000|Overall Study|Other Miscellaneous Reasons|10|||
146770966|NCT02139046|529329812|FG001|Overall Study|Other Miscellaneous Reasons|9|||
146770967|NCT02139046|529329813|FG002|Overall Study|Other Miscellaneous Reasons|4|||
146652700|NCT00815516|528906759|FG000|Overall Study|Death|3|||
146652701|NCT00815516|528906760|FG001|Overall Study|Death|1|||
146652702|NCT00815516|528906759|FG000|Overall Study|Physician Decision|1|||
146652703|NCT00815516|528906760|FG001|Overall Study|Physician Decision|0|||
146652704|NCT03468543|528906774|FG000|Overall Study|Protocol stopping rules met|3|||
146652705|NCT00470158|528906775|FG000|Overall Study|Death|0|||
146652706|NCT00470158|528906776|FG001|Overall Study|Death|0|||
146652707|NCT00470158|528906777|FG002|Overall Study|Death|0|||
146652708|NCT00470158|528906778|FG003|Overall Study|Death|0|||
146652709|NCT00470158|528906779|FG004|Overall Study|Death|2|||
146589470|NCT03505788|528666979|FG000|Overall Study|Withdrawal by Subject|1|||
146589471|NCT03505788|528666980|FG001|Overall Study|Withdrawal by Subject|3|||
146589472|NCT03505788|528666979|FG000|Overall Study|Physician Decision|0|||
146589473|NCT03505788|528666980|FG001|Overall Study|Physician Decision|1|||
146589474|NCT03575065|528666981|FG000|Overall Study|Death|31|||
146589475|NCT03575065|528666982|FG001|Overall Study|Death|12|||
146589476|NCT03575065|528666981|FG000|Overall Study|Sponsor's Decision|28|||
146589477|NCT03575065|528666982|FG001|Overall Study|Sponsor's Decision|13|||
146589478|NCT03575065|528666981|FG000|Overall Study|Withdrawal by Subject|2|||
146589479|NCT03575065|528666982|FG001|Overall Study|Withdrawal by Subject|1|||
146589480|NCT03575065|528666981|FG000|Overall Study|Lost to Follow-up|1|||
146589481|NCT03575065|528666982|FG001|Overall Study|Lost to Follow-up|0|||
146589482|NCT00113399|528666987|FG000|Overall Study|Death|1|||
146589483|NCT00113399|528666988|FG001|Overall Study|Death|1|||
146589484|NCT00113399|528666987|FG000|Overall Study|Withdrawal by Subject|1|||
146589485|NCT00113399|528666988|FG001|Overall Study|Withdrawal by Subject|2|||
146589486|NCT00113399|528666987|FG000|Overall Study|Complete Response|0|||
146589487|NCT00113399|528666988|FG001|Overall Study|Complete Response|1|||
146589488|NCT00113399|528666987|FG000|Overall Study|Other|0|||
146589489|NCT00113399|528666988|FG001|Overall Study|Other|1|||
146589490|NCT00396136|528666989|FG000|Overall Study|Death|43|||
146589491|NCT00396136|528666989|FG000|Overall Study|Withdrawal by Subject|59|||
146589492|NCT00396136|528666989|FG000|Overall Study|Lost to Follow-up|15|||
146589493|NCT00396136|528666989|FG000|Overall Study|Study device explanted|8|||
146589494|NCT03447314|528666990|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
146589495|NCT03447314|528666991|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
146589496|NCT03447314|528666992|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
146589497|NCT03447314|528666993|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
146589498|NCT03447314|528666994|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
146589499|NCT03447314|528666995|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
146589500|NCT03447314|528666996|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
146589501|NCT03447314|528666997|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146589502|NCT03447314|528666998|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146589503|NCT03447314|528666999|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146589504|NCT03447314|528667000|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
146589505|NCT03447314|528667001|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
146589506|NCT03447314|528667002|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146589507|NCT03447314|528667003|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146589508|NCT03447314|528667004|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146652710|NCT00470158|528906775|FG000|Overall Study|Lost to Follow-up|7|||
146770968|NCT02139046|529329814|FG003|Overall Study|Other Miscellaneous Reasons|9|||
146770969|NCT02139046|529329815|FG004|Overall Study|Other Miscellaneous Reasons|12|||
146770970|NCT05876949|529329818|FG000|Overall Study|Withdrawal by Subject|1|||
146770971|NCT05876949|529329819|FG001|Overall Study|Withdrawal by Subject|3|||
146589509|NCT03447314|528667005|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146589510|NCT03447314|528667006|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146589511|NCT03447314|528667007|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146589512|NCT03447314|528666990|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
146589513|NCT03447314|528666991|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146589514|NCT03447314|528666992|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
146589515|NCT03447314|528666993|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146652711|NCT00470158|528906776|FG001|Overall Study|Lost to Follow-up|8|||
146652712|NCT00470158|528906777|FG002|Overall Study|Lost to Follow-up|8|||
146652713|NCT00470158|528906778|FG003|Overall Study|Lost to Follow-up|5|||
146770972|NCT05876949|529329818|FG000|Overall Study|Physician Decision|0|||
146770973|NCT05876949|529329819|FG001|Overall Study|Physician Decision|2|||
146652714|NCT00470158|528906779|FG004|Overall Study|Lost to Follow-up|4|||
146652715|NCT00470158|528906775|FG000|Overall Study|Protocol Violation|1|||
146652716|NCT00470158|528906776|FG001|Overall Study|Protocol Violation|0|||
146652717|NCT00470158|528906777|FG002|Overall Study|Protocol Violation|0|||
146652718|NCT00470158|528906778|FG003|Overall Study|Protocol Violation|0|||
146652719|NCT00470158|528906779|FG004|Overall Study|Protocol Violation|0|||
146652720|NCT00880685|528906780|FG000|Memantine 10mg|Lost to Follow-up|2|||
146589516|NCT03447314|528666994|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146589517|NCT03447314|528666995|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
146589518|NCT03447314|528666996|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
146589519|NCT03447314|528666997|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146589520|NCT03447314|528666998|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146589521|NCT03447314|528666999|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146589522|NCT03447314|528667000|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146589523|NCT03447314|528667001|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146652721|NCT00880685|528906780|FG000|Memantine 20mg|Withdrawal by Subject|1|||
146589524|NCT03447314|528667002|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146589525|NCT03447314|528667003|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146589526|NCT03447314|528667004|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146589527|NCT03447314|528667005|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146589528|NCT03447314|528667006|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146589529|NCT03447314|528667007|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146589530|NCT03447314|528666990|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589531|NCT03447314|528666991|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589532|NCT03447314|528666992|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
146589533|NCT03447314|528666993|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589534|NCT03447314|528666994|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589535|NCT03447314|528666995|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589536|NCT03447314|528666996|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589537|NCT03447314|528666997|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589538|NCT03447314|528666998|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589539|NCT03447314|528666999|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589540|NCT03447314|528667000|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589541|NCT03447314|528667001|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589542|NCT03447314|528667002|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589543|NCT03447314|528667003|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589544|NCT03447314|528667004|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589545|NCT03447314|528667005|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589546|NCT03447314|528667006|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589547|NCT03447314|528667007|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146589548|NCT03447314|528666990|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589549|NCT03447314|528666991|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589550|NCT03447314|528666992|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
146589551|NCT03447314|528666993|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589552|NCT03447314|528666994|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589553|NCT03447314|528666995|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589554|NCT03447314|528666996|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589555|NCT03447314|528666997|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589556|NCT03447314|528666998|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589557|NCT03447314|528666999|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589558|NCT03447314|528667000|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589559|NCT03447314|528667001|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589560|NCT03447314|528667002|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589561|NCT03447314|528667003|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589562|NCT03447314|528667004|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589563|NCT03447314|528667005|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589564|NCT03447314|528667006|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589565|NCT03447314|528667007|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146589566|NCT03447314|528666990|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146589567|NCT03447314|528666991|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146652722|NCT01249118|528906781|FG000|First Washout Period|Physician Decision|0|||
146652723|NCT01249118|528906782|FG001|First Washout Period|Physician Decision|1|||
146652724|NCT01249118|528906783|FG002|First Washout Period|Physician Decision|0|||
146652725|NCT04179890|528906784|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
146652726|NCT04179890|528906785|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
146652727|NCT04179890|528906784|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
146770974|NCT05876949|529329818|FG000|Overall Study|Death|0|||
146589568|NCT03447314|528666992|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146589569|NCT03447314|528666993|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146589570|NCT03447314|528666994|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146589571|NCT03447314|528666995|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146589572|NCT03447314|528666996|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146589573|NCT03447314|528666997|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146589574|NCT03447314|528666998|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146589575|NCT03447314|528666999|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146589576|NCT03447314|528667000|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
146589577|NCT03447314|528667001|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146589578|NCT03447314|528667002|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146589579|NCT03447314|528667003|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146589580|NCT03447314|528667004|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146589581|NCT03447314|528667005|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146589582|NCT03447314|528667006|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146589583|NCT03447314|528667007|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146589584|NCT03447314|528666990|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146589585|NCT03447314|528666991|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146589586|NCT03447314|528666992|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146589587|NCT03447314|528666993|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
146589588|NCT03447314|528666994|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146589589|NCT03447314|528666995|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
146589590|NCT03447314|528666996|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146589591|NCT03447314|528666997|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146589592|NCT03447314|528666998|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146589593|NCT03447314|528666999|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146589594|NCT03447314|528667000|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146589595|NCT03447314|528667001|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146589596|NCT03447314|528667002|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146589597|NCT03447314|528667003|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146589598|NCT03447314|528667004|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146652728|NCT04179890|528906785|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
146652729|NCT04179890|528906784|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
146652730|NCT04179890|528906785|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
146652731|NCT04179890|528906784|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
146589599|NCT03447314|528667005|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146589600|NCT03447314|528667006|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146589601|NCT03447314|528667007|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146589602|NCT01703208|528667008|FG000|Overall Study|Death|61|||
146589603|NCT01703208|528667009|FG001|Overall Study|Death|48|||
146589604|NCT01703208|528667008|FG000|Overall Study|Lack of Efficacy|1|||
146589605|NCT01703208|528667009|FG001|Overall Study|Lack of Efficacy|2|||
146589606|NCT01703208|528667008|FG000|Overall Study|Lost to Follow-up|68|||
146589607|NCT01703208|528667009|FG001|Overall Study|Lost to Follow-up|62|||
146589608|NCT01703208|528667008|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146589609|NCT01703208|528667009|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146589610|NCT01703208|528667008|FG000|Overall Study|Excluded Medication|1|||
146589611|NCT01703208|528667009|FG001|Overall Study|Excluded Medication|2|||
146589612|NCT01703208|528667008|FG000|Overall Study|Site Discontinued Study Participation|23|||
146589613|NCT01703208|528667009|FG001|Overall Study|Site Discontinued Study Participation|27|||
146589614|NCT01703208|528667008|FG000|Overall Study|Physician Decision|11|||
146589615|NCT01703208|528667009|FG001|Overall Study|Physician Decision|13|||
146589616|NCT01703208|528667008|FG000|Overall Study|Progressive disease|2|||
146589617|NCT01703208|528667009|FG001|Overall Study|Progressive disease|2|||
146589618|NCT01703208|528667008|FG000|Overall Study|Protocol Violation|1|||
146589619|NCT01703208|528667009|FG001|Overall Study|Protocol Violation|1|||
146589620|NCT01703208|528667008|FG000|Overall Study|Study Terminated by Sponsor|1710|||
146589621|NCT01703208|528667009|FG001|Overall Study|Study Terminated by Sponsor|1716|||
146652732|NCT04179890|528906785|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
146770975|NCT05876949|529329819|FG001|Overall Study|Death|1|||
146770976|NCT02613871|529329826|FG000|Overall Study|Death|2|||
146589622|NCT01703208|528667008|FG000|Overall Study|Withdrawal by Subject|205|||
146589623|NCT01703208|528667009|FG001|Overall Study|Withdrawal by Subject|209|||
146589624|NCT01703208|528667008|FG000|Overall Study|Adverse Event|14|||
146589625|NCT01703208|528667009|FG001|Overall Study|Adverse Event|19|||
146589626|NCT01703208|528667008|FG000|Overall Study|Technical Problems|0|||
146589627|NCT01703208|528667009|FG001|Overall Study|Technical Problems|1|||
146589628|NCT01703208|528667008|FG000|Overall Study|Protocol Deviation|2|||
146589629|NCT01703208|528667009|FG001|Overall Study|Protocol Deviation|0|||
146589630|NCT00252694|528667010|FG000|Overall Study|Withdrawal by Subject|83|||
146589631|NCT00252694|528667011|FG001|Overall Study|Withdrawal by Subject|91|||
146589632|NCT00252694|528667010|FG000|Overall Study|Death|36|||
146589633|NCT00252694|528667011|FG001|Overall Study|Death|34|||
146589634|NCT00252694|528667010|FG000|Overall Study|Mostly Lost to Follow Up|8|||
146589635|NCT00252694|528667011|FG001|Overall Study|Mostly Lost to Follow Up|13|||
146589636|NCT00252694|528667010|FG000|Overall Study|Patient Moving|17|||
146589637|NCT00252694|528667011|FG001|Overall Study|Patient Moving|16|||
146589638|NCT04003207|528667014|FG000|Overall Study|Protocol Violation|1|||
146589639|NCT00443053|528667015|FG000|Overall Study|Adverse Event|2|||
146589640|NCT00443053|528667016|FG001|Overall Study|Adverse Event|1|||
146589641|NCT00443053|528667015|FG000|Overall Study|Withdrawal by Subject|9|||
146589642|NCT00443053|528667016|FG001|Overall Study|Withdrawal by Subject|18|||
146589643|NCT00443053|528667015|FG000|Overall Study|Lost to Follow-up|4|||
146589644|NCT00443053|528667016|FG001|Overall Study|Lost to Follow-up|5|||
146589645|NCT00443053|528667015|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
146589646|NCT00443053|528667016|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
146589647|NCT00443053|528667015|FG000|Overall Study|Noncompliance|2|||
146589648|NCT00443053|528667016|FG001|Overall Study|Noncompliance|1|||
146589649|NCT00443053|528667015|FG000|Overall Study|Other|3|||
146589650|NCT00443053|528667016|FG001|Overall Study|Other|4|||
146589651|NCT00443053|528667015|FG000|Overall Study|Physician Decision|0|||
146589652|NCT00443053|528667016|FG001|Overall Study|Physician Decision|4|||
146589653|NCT00541866|528667017|FG000|Overall Study|Adverse Event|3|||
146589654|NCT00541866|528667018|FG001|Overall Study|Adverse Event|0|||
146589655|NCT00541866|528667019|FG002|Overall Study|Adverse Event|0|||
146589656|NCT00541866|528667020|FG003|Overall Study|Adverse Event|0|||
146589657|NCT00541866|528667021|FG004|Overall Study|Adverse Event|0|||
146589658|NCT00541866|528667017|FG000|Overall Study|Death|1|||
146589659|NCT00541866|528667018|FG001|Overall Study|Death|0|||
146589660|NCT00541866|528667019|FG002|Overall Study|Death|0|||
146589661|NCT00541866|528667020|FG003|Overall Study|Death|0|||
146589662|NCT00541866|528667021|FG004|Overall Study|Death|0|||
146589663|NCT00541866|528667017|FG000|Overall Study|Lack of Efficacy|19|||
146589664|NCT00541866|528667018|FG001|Overall Study|Lack of Efficacy|15|||
146589665|NCT00541866|528667019|FG002|Overall Study|Lack of Efficacy|10|||
146589666|NCT00541866|528667020|FG003|Overall Study|Lack of Efficacy|12|||
146589667|NCT00541866|528667021|FG004|Overall Study|Lack of Efficacy|14|||
146589668|NCT00541866|528667017|FG000|Overall Study|Not Reported or Other|11|||
146589669|NCT00541866|528667018|FG001|Overall Study|Not Reported or Other|3|||
146589670|NCT00541866|528667019|FG002|Overall Study|Not Reported or Other|3|||
146589671|NCT00541866|528667020|FG003|Overall Study|Not Reported or Other|3|||
146589672|NCT00541866|528667021|FG004|Overall Study|Not Reported or Other|1|||
146589673|NCT00541866|528667017|FG000|Overall Study|Physician Decision|0|||
146589674|NCT00541866|528667018|FG001|Overall Study|Physician Decision|0|||
146589675|NCT00541866|528667019|FG002|Overall Study|Physician Decision|2|||
146589676|NCT00541866|528667020|FG003|Overall Study|Physician Decision|1|||
146589677|NCT00541866|528667021|FG004|Overall Study|Physician Decision|0|||
146589678|NCT00522418|528667022|FG000|Overall Study|Local IRB Consent Violation|5|||
146589679|NCT00522418|528667023|FG001|Overall Study|Local IRB Consent Violation|5|||
146589680|NCT00522418|528667022|FG000|Overall Study|Early Study Termination|46|||
146589681|NCT00522418|528667023|FG001|Overall Study|Early Study Termination|47|||
146589682|NCT00522418|528667022|FG000|Overall Study|Noncompliance|2|||
146589683|NCT00522418|528667023|FG001|Overall Study|Noncompliance|2|||
146589684|NCT00522418|528667022|FG000|Overall Study|Reason Not Specified|3|||
146589685|NCT00522418|528667023|FG001|Overall Study|Reason Not Specified|1|||
146589686|NCT00522418|528667022|FG000|Overall Study|Consent Withdraw|1|||
146589687|NCT00522418|528667023|FG001|Overall Study|Consent Withdraw|2|||
146589688|NCT00522418|528667022|FG000|Overall Study|Lack of Efficacy|0|||
146589689|NCT00522418|528667023|FG001|Overall Study|Lack of Efficacy|1|||
146589690|NCT01574157|528667024|FG000|Overall Study|Withdrawal by Subject|4|||
146589691|NCT01574157|528667025|FG001|Overall Study|Withdrawal by Subject|5|||
146589692|NCT01574157|528667024|FG000|Overall Study|Lost to Follow-up|0|||
146589693|NCT01574157|528667025|FG001|Overall Study|Lost to Follow-up|3|||
146589694|NCT00578877|528667028|FG000|Overall Study|Lost to Follow-up|8|||
146589695|NCT00578877|528667029|FG001|Overall Study|Lost to Follow-up|10|||
146589696|NCT00578877|528667028|FG000|Overall Study|early discontinue|61|||
146589697|NCT00578877|528667029|FG001|Overall Study|early discontinue|101|||
146589698|NCT00578877|528667028|FG000|Overall Study|did not provide follow-up data|12|||
146589699|NCT00578877|528667029|FG001|Overall Study|did not provide follow-up data|17|||
146589700|NCT01944098|528667034|FG000|Overall Study|Physician Decision|1|||
146589701|NCT01944098|528667035|FG001|Overall Study|Physician Decision|0|||
146589702|NCT01632241|528667036|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
146589703|NCT01632241|528667037|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
146589704|NCT01632241|528667036|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
146589705|NCT01632241|528667037|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
146589706|NCT01632241|528667036|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
146589707|NCT01632241|528667037|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
146589708|NCT01632241|528667036|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
146589709|NCT01632241|528667037|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
146589710|NCT01632241|528667036|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
146589711|NCT01632241|528667037|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
146589712|NCT01632241|528667036|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
146589713|NCT01632241|528667037|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
146589714|NCT01632241|528667036|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
146589715|NCT01632241|528667037|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
146589716|NCT01632241|528667036|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
146589717|NCT01632241|528667037|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
146589718|NCT01632241|528667036|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
146589719|NCT01632241|528667037|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
146589720|NCT01632241|528667036|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
146589721|NCT01632241|528667037|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
146589722|NCT01632241|528667036|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
146589723|NCT01632241|528667037|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
146589724|NCT01632241|528667036|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
146589725|NCT01632241|528667037|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
146589726|NCT01632241|528667036|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
146589727|NCT01632241|528667037|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
146589728|NCT01632241|528667036|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
146589729|NCT01632241|528667037|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
146589730|NCT01904149|528667039|FG000|Overall Study|Adverse Event|3|||
146589731|NCT01904149|528667040|FG001|Overall Study|Adverse Event|4|||
146589732|NCT01904149|528667041|FG002|Overall Study|Adverse Event|0|||
146589733|NCT01904149|528667042|FG003|Overall Study|Adverse Event|1|||
146589734|NCT01904149|528667043|FG004|Overall Study|Adverse Event|1|||
146589735|NCT01904149|528667044|FG005|Overall Study|Adverse Event|2|||
146589736|NCT01904149|528667039|FG000|Overall Study|Lack of Efficacy|0|||
146589737|NCT01904149|528667040|FG001|Overall Study|Lack of Efficacy|3|||
146589738|NCT01904149|528667041|FG002|Overall Study|Lack of Efficacy|1|||
146589739|NCT01904149|528667042|FG003|Overall Study|Lack of Efficacy|3|||
146589740|NCT01904149|528667043|FG004|Overall Study|Lack of Efficacy|3|||
146589741|NCT01904149|528667044|FG005|Overall Study|Lack of Efficacy|1|||
146589742|NCT01904149|528667039|FG000|Overall Study|Withdrawal by Subject|1|||
146589743|NCT01904149|528667040|FG001|Overall Study|Withdrawal by Subject|3|||
146589744|NCT01904149|528667041|FG002|Overall Study|Withdrawal by Subject|1|||
146589745|NCT01904149|528667042|FG003|Overall Study|Withdrawal by Subject|0|||
146589746|NCT01904149|528667043|FG004|Overall Study|Withdrawal by Subject|1|||
146589747|NCT01904149|528667044|FG005|Overall Study|Withdrawal by Subject|0|||
146589748|NCT01904149|528667039|FG000|Overall Study|Protocol Violation|0|||
146589749|NCT01904149|528667040|FG001|Overall Study|Protocol Violation|1|||
146589750|NCT01904149|528667041|FG002|Overall Study|Protocol Violation|0|||
146589751|NCT01904149|528667042|FG003|Overall Study|Protocol Violation|0|||
146589752|NCT01904149|528667043|FG004|Overall Study|Protocol Violation|0|||
146589753|NCT01904149|528667044|FG005|Overall Study|Protocol Violation|0|||
146589754|NCT01904149|528667039|FG000|Overall Study|non compliance with study drug|1|||
146652733|NCT04179890|528906784|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
146652734|NCT04179890|528906785|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
146770977|NCT02613871|529329826|FG000|Overall Study|Withdrew Consent|1|||
146589755|NCT01904149|528667040|FG001|Overall Study|non compliance with study drug|0|||
146589756|NCT01904149|528667041|FG002|Overall Study|non compliance with study drug|0|||
146589757|NCT01904149|528667042|FG003|Overall Study|non compliance with study drug|0|||
146589758|NCT01904149|528667043|FG004|Overall Study|non compliance with study drug|0|||
146589759|NCT01904149|528667044|FG005|Overall Study|non compliance with study drug|0|||
146589760|NCT00350272|528667045|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
146589761|NCT00350272|528667046|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
146589762|NCT00350272|528667045|FG000|Blinded 12-Week Treatment|Death|1|||
146589763|NCT00350272|528667046|FG001|Blinded 12-Week Treatment|Death|0|||
146589764|NCT00350272|528667045|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
146589765|NCT00350272|528667046|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
146589766|NCT00350272|528667045|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
146589767|NCT00350272|528667046|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
146589768|NCT00350272|528667045|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
146589769|NCT00350272|528667046|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
146589770|NCT00350272|528667045|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
146770978|NCT01786564|529329827|FG000|Overall Study|Lost to Follow-up|47|||
146770979|NCT01786564|529329827|FG000|Overall Study|Ineligible|17|||
146770980|NCT00494442|529329828|FG000|Overall Study|Death|1|||
146770981|NCT00494442|529329829|FG001|Overall Study|Death|1|||
146770982|NCT00494442|529329828|FG000|Overall Study|Lack of Efficacy|16|||
146770983|NCT00494442|529329829|FG001|Overall Study|Lack of Efficacy|10|||
146770984|NCT00494442|529329828|FG000|Overall Study|Adverse Event|0|||
146770985|NCT00494442|529329829|FG001|Overall Study|Adverse Event|2|||
146770986|NCT00494442|529329828|FG000|Overall Study|Physician Decision|0|||
146770987|NCT00494442|529329829|FG001|Overall Study|Physician Decision|1|||
146770988|NCT00494442|529329828|FG000|Overall Study|Non-compliance|0|||
146770989|NCT00494442|529329829|FG001|Overall Study|Non-compliance|1|||
146770990|NCT00494442|529329828|FG000|Overall Study|Intercurrent illness|0|||
146589771|NCT00350272|528667046|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
146589772|NCT00350272|528667045|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
146589773|NCT00350272|528667046|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
146589774|NCT00350272|528667045|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
146589775|NCT00350272|528667046|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
146589776|NCT00350272|528667045|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
146589777|NCT00350272|528667046|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
146589778|NCT00350272|528667045|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
146589779|NCT00350272|528667046|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
146589780|NCT00350272|528667045|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
146589781|NCT00350272|528667046|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
146589782|NCT03349645|528667049|FG000|Overall Study|Sponsor Terminated Study|75|||
146589783|NCT03349645|528667049|FG000|Overall Study|Withdrawal by Subject|4|||
146589784|NCT03349645|528667049|FG000|Overall Study|Protocol Violation|1|||
146589785|NCT03349645|528667049|FG000|Overall Study|Other|2|||
146589786|NCT01939002|528667061|FG000|Overall Study|Adverse Event|13|||
146589787|NCT01939002|528667062|FG001|Overall Study|Adverse Event|13|||
146770991|NCT00494442|529329829|FG001|Overall Study|Intercurrent illness|1|||
146589788|NCT01939002|528667061|FG000|Overall Study|Withdrawal by Subject|5|||
146589789|NCT01939002|528667062|FG001|Overall Study|Withdrawal by Subject|3|||
146589790|NCT01939002|528667061|FG000|Overall Study|Other|1|||
146589791|NCT01939002|528667062|FG001|Overall Study|Other|2|||
146589792|NCT02910401|528667065|FG000|Overall Study|Study closure Study closure|0|||
146589793|NCT02910401|528667066|FG001|Overall Study|Study closure Study closure|0|||
146589794|NCT02910401|528667067|FG002|Overall Study|Study closure Study closure|2|||
146589795|NCT02910401|528667065|FG000|Overall Study|Physician Decision|1|||
146589796|NCT02910401|528667066|FG001|Overall Study|Physician Decision|0|||
146589797|NCT02910401|528667067|FG002|Overall Study|Physician Decision|0|||
146589798|NCT01774253|528667069|FG000|Overall Study|Lack of Efficacy|4|||
146589799|NCT01774253|528667069|FG000|Overall Study|Physician Decision|2|||
146589800|NCT01774253|528667069|FG000|Overall Study|Withdrawal by Subject|2|||
146589801|NCT01774253|528667069|FG000|Overall Study|Death|1|||
146589802|NCT02240368|528667073|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
146589803|NCT02240368|528667074|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
146589804|NCT02240368|528667075|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
146589805|NCT02240368|528667073|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
146589806|NCT02240368|528667074|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
146589807|NCT02240368|528667075|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
146589808|NCT00871117|528667081|FG000|Overall Study|Lost to Follow-up|5|||
146589809|NCT00871117|528667082|FG001|Overall Study|Lost to Follow-up|6|||
146589810|NCT00871117|528667081|FG000|Overall Study|Other|0|||
146589811|NCT00871117|528667082|FG001|Overall Study|Other|4|||
146589812|NCT03222973|528667083|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
146589813|NCT03222973|528667084|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
146589814|NCT03222973|528667085|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
146589815|NCT03222973|528667086|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
146589816|NCT03222973|528667083|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
146589817|NCT03222973|528667084|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
146589818|NCT03222973|528667085|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
146589819|NCT03222973|528667086|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
146589820|NCT03222973|528667083|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
146589821|NCT03222973|528667084|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
146589822|NCT03222973|528667085|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
146589823|NCT03222973|528667086|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
146770992|NCT01241292|529329832|FG000|Overall Study|Administrative Reason by Sponsor|1|||
146770993|NCT01241292|529329833|FG001|Overall Study|Administrative Reason by Sponsor|0|||
146770994|NCT01241292|529329832|FG000|Overall Study|Disease Progression|2|||
146589824|NCT03222973|528667083|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
146589825|NCT03222973|528667084|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
146589826|NCT03222973|528667085|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
146589827|NCT03222973|528667086|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
146589828|NCT03222973|528667083|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
146589829|NCT03222973|528667084|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
146770995|NCT01241292|529329833|FG001|Overall Study|Disease Progression|0|||
146770996|NCT01241292|529329832|FG000|Overall Study|Study Drug Toxicity|0|||
146770997|NCT01241292|529329833|FG001|Overall Study|Study Drug Toxicity|1|||
146770998|NCT01241292|529329832|FG000|Overall Study|Participant Discontinued Treatment|0|||
146770999|NCT01241292|529329833|FG001|Overall Study|Participant Discontinued Treatment|2|||
146771000|NCT03034915|529329836|FG000|Overall Study|Adverse Event|29|||
146771001|NCT03034915|529329837|FG001|Overall Study|Adverse Event|32|||
146771002|NCT03034915|529329838|FG002|Overall Study|Adverse Event|22|||
146771003|NCT03034915|529329836|FG000|Overall Study|Lost to Follow-up|5|||
146771004|NCT03034915|529329837|FG001|Overall Study|Lost to Follow-up|13|||
146771005|NCT03034915|529329838|FG002|Overall Study|Lost to Follow-up|3|||
146771006|NCT03034915|529329836|FG000|Overall Study|Withdrawal by Subject|29|||
146771007|NCT03034915|529329837|FG001|Overall Study|Withdrawal by Subject|46|||
146771008|NCT03034915|529329838|FG002|Overall Study|Withdrawal by Subject|41|||
146771009|NCT03034915|529329836|FG000|Overall Study|Protocol Deviation|2|||
146771010|NCT03034915|529329837|FG001|Overall Study|Protocol Deviation|14|||
146771011|NCT03034915|529329838|FG002|Overall Study|Protocol Deviation|7|||
146771012|NCT03034915|529329836|FG000|Overall Study|Lack of Efficacy|8|||
146771013|NCT03034915|529329837|FG001|Overall Study|Lack of Efficacy|16|||
146771014|NCT03034915|529329838|FG002|Overall Study|Lack of Efficacy|18|||
146771015|NCT03034915|529329836|FG000|Overall Study|Site closed|2|||
146771016|NCT03034915|529329837|FG001|Overall Study|Site closed|2|||
146771017|NCT03034915|529329838|FG002|Overall Study|Site closed|4|||
146771018|NCT03034915|529329836|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
146771019|NCT03034915|529329837|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
146771020|NCT03034915|529329838|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
146771021|NCT03034915|529329836|FG000|Overall Study|Physician Decision|1|||
146771022|NCT03034915|529329837|FG001|Overall Study|Physician Decision|5|||
146771023|NCT03034915|529329838|FG002|Overall Study|Physician Decision|2|||
146771024|NCT03593213|529329839|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
146771025|NCT03593213|529329840|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
146771026|NCT03593213|529329841|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
146771027|NCT03593213|529329842|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
146771028|NCT03593213|529329839|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
146771029|NCT03593213|529329840|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
146771030|NCT03593213|529329841|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
146771031|NCT03593213|529329842|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
146771032|NCT03593213|529329839|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
146771033|NCT03593213|529329840|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
146771034|NCT03593213|529329841|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
146771035|NCT03593213|529329842|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
146771036|NCT03593213|529329839|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
146771037|NCT03593213|529329840|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
146771038|NCT03593213|529329841|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
146771039|NCT03593213|529329842|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
146771040|NCT03593213|529329839|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
146771041|NCT03593213|529329840|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
146771042|NCT03593213|529329841|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
146771043|NCT03593213|529329842|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
146771044|NCT03593213|529329839|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
146771045|NCT03593213|529329840|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
146771046|NCT03593213|529329841|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
146771047|NCT03593213|529329842|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
146771048|NCT03593213|529329839|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
146771049|NCT03593213|529329840|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
146771050|NCT03593213|529329841|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
146771051|NCT03593213|529329842|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
146771052|NCT03593213|529329839|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
146771053|NCT03593213|529329840|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
146771054|NCT03593213|529329841|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
146771055|NCT03593213|529329842|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
146771056|NCT03593213|529329839|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
146771057|NCT03593213|529329840|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
146771058|NCT03593213|529329841|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
146771059|NCT03593213|529329842|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
146978342|NCT02266706|530084006|FG003|Overall Study|Screen failure|0|||
146978343|NCT02266706|530084007|FG004|Overall Study|Screen failure|0|||
146589830|NCT03222973|528667085|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
146589831|NCT03222973|528667086|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
146978344|NCT02266706|530084008|FG005|Overall Study|Screen failure|1|||
146589832|NCT03222973|528667083|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
146589833|NCT03222973|528667084|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
146589834|NCT03222973|528667085|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
146589835|NCT03222973|528667086|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
146589836|NCT03222973|528667083|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
146589837|NCT03222973|528667084|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
146589838|NCT03222973|528667085|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
146589839|NCT03222973|528667086|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
146589840|NCT03222973|528667083|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
146589841|NCT03222973|528667084|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
146589842|NCT03222973|528667085|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
146589843|NCT03222973|528667086|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
146589844|NCT03222973|528667083|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
146589845|NCT03222973|528667084|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
146589846|NCT03222973|528667085|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
146589847|NCT03222973|528667086|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
146589848|NCT03222973|528667083|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
146589849|NCT03222973|528667084|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
146589850|NCT03222973|528667085|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
146589851|NCT03222973|528667086|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
146589852|NCT03222973|528667083|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
146589853|NCT03222973|528667084|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
146589854|NCT03222973|528667085|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
146589855|NCT03222973|528667086|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
146589856|NCT03222973|528667083|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
146589857|NCT03222973|528667084|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
146589858|NCT03222973|528667085|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
146589859|NCT03222973|528667086|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
146589860|NCT02080481|528667087|FG000|Overall Study|Never received a block.|1|||
146589861|NCT02080481|528667088|FG001|Overall Study|Never received a block.|0|||
146589862|NCT01444027|528667091|FG000|Overall Study|Withdrawal by Subject|4|||
146589863|NCT01444027|528667092|FG001|Overall Study|Withdrawal by Subject|10|||
146589864|NCT01444027|528667093|FG002|Overall Study|Withdrawal by Subject|24|||
146589865|NCT01444027|528667091|FG000|Overall Study|Lost to Follow-up|26|||
146589866|NCT01444027|528667092|FG001|Overall Study|Lost to Follow-up|20|||
146589867|NCT01444027|528667093|FG002|Overall Study|Lost to Follow-up|14|||
146589868|NCT00496483|528668681|FG000|Overall Study|Not dosed|9|||
146589869|NCT00496483|528668681|FG000|Overall Study|Adverse Event|2|||
146589870|NCT00496483|528668681|FG000|Overall Study|Lack of Efficacy|1|||
146589871|NCT00428220|528668683|FG000|Overall Study|Participant died|8|||
146589872|NCT00428220|528668683|FG000|Overall Study|Global deterioration of health status|7|||
146589873|NCT00428220|528668683|FG000|Overall Study|Lost to Follow-up|4|||
146589874|NCT00428220|528668683|FG000|Overall Study|Objective progression or relapse|123|||
146589875|NCT00428220|528668683|FG000|Overall Study|Participant refused continued treatment|7|||
146589876|NCT00428220|528668683|FG000|Overall Study|Adverse Event|51|||
146589877|NCT00428220|528668683|FG000|Overall Study|Other|23|||
146589878|NCT00642174|528668690|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
146589879|NCT00642174|528668691|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
146589880|NCT01730339|528668692|FG000|Overall Study|Withdrawal by Subject|3|||
146589881|NCT01730339|528668693|FG001|Overall Study|Withdrawal by Subject|2|||
146589882|NCT01730339|528668692|FG000|Overall Study|Lost to Follow-up|1|||
146589883|NCT01730339|528668693|FG001|Overall Study|Lost to Follow-up|1|||
146589884|NCT01730339|528668692|FG000|Overall Study|Un-specified|1|||
146589885|NCT01730339|528668693|FG001|Overall Study|Un-specified|0|||
146589886|NCT00896363|528668694|FG000|Overall Study|Adverse Event|3|||
146589887|NCT00896363|528668695|FG001|Overall Study|Adverse Event|4|||
146771060|NCT03593213|529329839|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
146589888|NCT00896363|528668696|FG002|Overall Study|Adverse Event|2|||
146589889|NCT00896363|528668694|FG000|Overall Study|Lack of Efficacy|0|||
146589890|NCT00896363|528668695|FG001|Overall Study|Lack of Efficacy|2|||
146589891|NCT00896363|528668696|FG002|Overall Study|Lack of Efficacy|1|||
146589892|NCT00896363|528668694|FG000|Overall Study|Withdrawal by Subject|3|||
146589893|NCT00896363|528668695|FG001|Overall Study|Withdrawal by Subject|5|||
146589894|NCT00896363|528668696|FG002|Overall Study|Withdrawal by Subject|5|||
146589895|NCT01145352|528668701|FG000|Overall Study|Found to have been registered twice|6|||
146589896|NCT01145352|528668701|FG000|Overall Study|Treated before marketing approval|4|||
146589897|NCT01145352|528668701|FG000|Overall Study|Syringe formulation was used|1|||
146589898|NCT03095027|528668702|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
146589899|NCT03095027|528668703|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
146589900|NCT04143217|528668704|FG000|Overall Study|Withdrawal by Subject|42|||
146589901|NCT04143217|528668704|FG000|Overall Study|Adverse Event|29|||
146589902|NCT04143217|528668704|FG000|Overall Study|Lost to Follow-up|29|||
146589903|NCT04143217|528668704|FG000|Overall Study|Lack of Efficacy|15|||
146589904|NCT04143217|528668704|FG000|Overall Study|Physician Decision|1|||
146652735|NCT04179890|528906784|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
146652736|NCT04179890|528906785|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
146652737|NCT04179890|528906784|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
146589905|NCT04143217|528668704|FG000|Overall Study|Non-Compliance With Study Drug|6|||
146589906|NCT04143217|528668704|FG000|Overall Study|Other, Multiple Categories|11|||
146589907|NCT00316693|528668705|FG000|Overall Study|Adverse Event|6|||
146589908|NCT00316693|528668706|FG001|Overall Study|Adverse Event|1|||
146589909|NCT00316693|528668705|FG000|Overall Study|Protocol Violation|1|||
146589910|NCT00316693|528668706|FG001|Overall Study|Protocol Violation|0|||
146589911|NCT00316693|528668705|FG000|Overall Study|Withdrawal by Subject|6|||
146589912|NCT00316693|528668706|FG001|Overall Study|Withdrawal by Subject|6|||
146589913|NCT00316693|528668705|FG000|Overall Study|Lost to Follow-up|26|||
146589914|NCT00316693|528668706|FG001|Overall Study|Lost to Follow-up|34|||
146589915|NCT00316693|528668705|FG000|Overall Study|Other|38|||
146589916|NCT00316693|528668706|FG001|Overall Study|Other|44|||
146589917|NCT02982018|528668707|FG000|Overall Study|Incorrect Lens Dispensed|1|||
146589918|NCT02982018|528668708|FG001|Overall Study|Incorrect Lens Dispensed|0|||
146589919|NCT02982018|528668707|FG000|Overall Study|Protocol Violation|1|||
146589920|NCT02982018|528668708|FG001|Overall Study|Protocol Violation|1|||
146589921|NCT02982018|528668707|FG000|Overall Study|Adverse Event|1|||
146589922|NCT02982018|528668708|FG001|Overall Study|Adverse Event|1|||
146589923|NCT02982018|528668707|FG000|Overall Study|Lens Discomfort|2|||
146589924|NCT02982018|528668708|FG001|Overall Study|Lens Discomfort|0|||
146589925|NCT02982018|528668707|FG000|Overall Study|Withdrawal by Subject|0|||
146589926|NCT02982018|528668708|FG001|Overall Study|Withdrawal by Subject|1|||
146589927|NCT03245736|528668709|FG000|Overall Study|Adverse Event|1|||
146589928|NCT03245736|528668709|FG000|Overall Study|Progressive Disease|4|||
146589929|NCT00132691|528668711|FG000|Overall Study|Lost to Follow-up|5|||
146589930|NCT00132691|528668712|FG001|Overall Study|Lost to Follow-up|8|||
146589931|NCT00132691|528668711|FG000|Overall Study|Missed 2-year visit|4|||
146589932|NCT00132691|528668712|FG001|Overall Study|Missed 2-year visit|4|||
146589933|NCT00132691|528668711|FG000|Overall Study|Death|2|||
146589934|NCT00132691|528668712|FG001|Overall Study|Death|0|||
146589935|NCT02251717|528668713|FG000|Overall Study|Adverse Event|0|||
146589936|NCT02251717|528668714|FG001|Overall Study|Adverse Event|1|||
146589937|NCT02251717|528668713|FG000|Overall Study|Withdrew Consent|1|||
146589938|NCT02251717|528668714|FG001|Overall Study|Withdrew Consent|0|||
146589939|NCT04098367|528668715|FG000|Overall Study|Adverse Event|0|||
146589940|NCT04098367|528668716|FG001|Overall Study|Adverse Event|0|||
146589941|NCT04098367|528668717|FG002|Overall Study|Adverse Event|1|||
146589942|NCT04098367|528668715|FG000|Overall Study|Lost to Follow-up|1|||
146652738|NCT04179890|528906785|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
146978345|NCT02266706|530084009|FG006|Overall Study|Screen failure|1|||
146978346|NCT02266706|530084010|FG007|Overall Study|Screen failure|0|||
146978347|NCT02266706|530084011|FG008|Overall Study|Screen failure|0|||
146978348|NCT02266706|530084003|FG000|Overall Study|Enrollment in another study|0|||
146978349|NCT02266706|530084004|FG001|Overall Study|Enrollment in another study|0|||
146978350|NCT02266706|530084005|FG002|Overall Study|Enrollment in another study|0|||
146978351|NCT02266706|530084006|FG003|Overall Study|Enrollment in another study|1|||
146978352|NCT02266706|530084007|FG004|Overall Study|Enrollment in another study|0|||
146978353|NCT02266706|530084008|FG005|Overall Study|Enrollment in another study|0|||
146978354|NCT02266706|530084009|FG006|Overall Study|Enrollment in another study|0|||
146978355|NCT02266706|530084010|FG007|Overall Study|Enrollment in another study|0|||
146978356|NCT02266706|530084011|FG008|Overall Study|Enrollment in another study|0|||
146978357|NCT01977352|530084012|FG000|Overall Study|Lost to Follow-up|1|||
146978358|NCT01977352|530084013|FG001|Overall Study|Lost to Follow-up|2|||
146978359|NCT00409188|530084014|FG000|Overall Study|Ongoing at data cut-off|383|||
146978360|NCT00409188|530084015|FG001|Overall Study|Ongoing at data cut-off|175|||
146978361|NCT01169649|530084025|FG000|Overall Study|Patient Not Treated|3|||
146978362|NCT00534092|530084026|FG000|Overall Study|Lost to Follow-up|1|||
146589943|NCT04098367|528668716|FG001|Overall Study|Lost to Follow-up|5|||
146652739|NCT04179890|528906784|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
146652740|NCT04179890|528906785|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
146978363|NCT00534092|530084027|FG001|Overall Study|Lost to Follow-up|0|||
146978364|NCT00534092|530084026|FG000|Overall Study|personal reasons/family concerns|1|||
146978365|NCT00534092|530084027|FG001|Overall Study|personal reasons/family concerns|0|||
146978366|NCT02919475|530084028|FG000|Overall Study|Adverse Event|3|||
146978367|NCT02919475|530084029|FG001|Overall Study|Adverse Event|3|||
146589944|NCT04098367|528668717|FG002|Overall Study|Lost to Follow-up|2|||
146978368|NCT02919475|530084030|FG002|Overall Study|Adverse Event|3|||
146589945|NCT04098367|528668715|FG000|Overall Study|Withdrawal by Subject|0|||
146589946|NCT04098367|528668716|FG001|Overall Study|Withdrawal by Subject|0|||
146589947|NCT04098367|528668717|FG002|Overall Study|Withdrawal by Subject|1|||
146589948|NCT04098367|528668715|FG000|Overall Study|Sick . Could not attend visit|1|||
146589949|NCT04098367|528668716|FG001|Overall Study|Sick . Could not attend visit|0|||
146589950|NCT04098367|528668717|FG002|Overall Study|Sick . Could not attend visit|0|||
146589951|NCT00322023|528668724|FG000|Overall Study|various|0|||
146589952|NCT00322023|528668725|FG001|Overall Study|various|2|||
146589953|NCT00322023|528668726|FG002|Overall Study|various|6|||
146589954|NCT03920293|528668727|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
146589955|NCT03920293|528668728|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
146589956|NCT03920293|528668727|FG000|Randomized-Controlled Period|Physician Decision|1|||
146589957|NCT03920293|528668728|FG001|Randomized-Controlled Period|Physician Decision|2|||
146589958|NCT03920293|528668727|FG000|Randomized-Controlled Period|Adverse Event|0|||
146589959|NCT03920293|528668728|FG001|Randomized-Controlled Period|Adverse Event|2|||
146589960|NCT03920293|528668727|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
146589961|NCT03920293|528668728|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
146589962|NCT03920293|528668727|FG000|Randomized-Controlled Period|Death|2|||
146589963|NCT03920293|528668728|FG001|Randomized-Controlled Period|Death|0|||
146589964|NCT03920293|528668727|FG000|Randomized-Controlled Period|Protocol Violation|1|||
146589965|NCT03920293|528668728|FG001|Randomized-Controlled Period|Protocol Violation|0|||
146589966|NCT03920293|528668727|FG000|Randomized-Controlled Period|Noncompliance|1|||
146589967|NCT03920293|528668728|FG001|Randomized-Controlled Period|Noncompliance|0|||
146589968|NCT03920293|528668727|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
146589969|NCT03920293|528668728|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
146589970|NCT03920293|528668727|FG000|Open- Label Extension Period|Death|3|||
146589971|NCT03920293|528668728|FG001|Open- Label Extension Period|Death|3|||
146589972|NCT03920293|528668727|FG000|Open- Label Extension Period|Physician Decision|5|||
146589973|NCT03920293|528668728|FG001|Open- Label Extension Period|Physician Decision|3|||
146589974|NCT03920293|528668727|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
146589975|NCT03920293|528668728|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
146589976|NCT03361189|528668733|FG000|Overall Study|Received heart transplant|1|||
146589977|NCT03361189|528668734|FG001|Overall Study|Received heart transplant|0|||
146589978|NCT03361189|528668733|FG000|Overall Study|Pacemake replacement|0|||
146589979|NCT03361189|528668734|FG001|Overall Study|Pacemake replacement|1|||
146589980|NCT03344549|528668735|FG000|Overall Study|Withdrawal by Subject|3|||
146589981|NCT03344549|528668736|FG001|Overall Study|Withdrawal by Subject|2|||
146589982|NCT03344549|528668735|FG000|Overall Study|Dialysis|2|||
146589983|NCT03344549|528668736|FG001|Overall Study|Dialysis|0|||
146589984|NCT03344549|528668735|FG000|Overall Study|Cancer|1|||
146589985|NCT03344549|528668736|FG001|Overall Study|Cancer|0|||
146589986|NCT03344549|528668735|FG000|Overall Study|Lack of electronic device|1|||
146589987|NCT03344549|528668736|FG001|Overall Study|Lack of electronic device|0|||
146589988|NCT03344549|528668735|FG000|Overall Study|Transportation difficulty|0|||
146589989|NCT03344549|528668736|FG001|Overall Study|Transportation difficulty|13|||
146589990|NCT02323126|528668737|FG000|Overall Study|Patient / guardian decision|0|||
146589991|NCT02323126|528668738|FG001|Overall Study|Patient / guardian decision|1|||
146589992|NCT02323126|528668739|FG002|Overall Study|Patient / guardian decision|2|||
146652741|NCT04179890|528906784|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
146652742|NCT04179890|528906785|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
146652743|NCT00978432|528906787|FG000|Overall Study|Withdrawal by Subject|0|||
146652744|NCT00978432|528906788|FG001|Overall Study|Withdrawal by Subject|0|||
146652745|NCT00978432|528906789|FG002|Overall Study|Withdrawal by Subject|1|||
146652746|NCT00978432|528906787|FG000|Overall Study|Lack of Efficacy|1|||
146652747|NCT00978432|528906788|FG001|Overall Study|Lack of Efficacy|1|||
146652748|NCT00978432|528906789|FG002|Overall Study|Lack of Efficacy|3|||
146652749|NCT00978432|528906787|FG000|Overall Study|Adverse Event|2|||
146652750|NCT00978432|528906788|FG001|Overall Study|Adverse Event|0|||
146652751|NCT00978432|528906789|FG002|Overall Study|Adverse Event|1|||
146652752|NCT02579928|528906790|FG000|Overall Study|Withdrawal by Subject|1|||
146652753|NCT02579928|528906791|FG001|Overall Study|Withdrawal by Subject|0|||
146652754|NCT04300751|528906794|FG000|Overall Study|Withdrawal by Subject|1|||
146652755|NCT04972630|528906799|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
146652756|NCT04972630|528906800|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
146652757|NCT04972630|528906801|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
146652758|NCT05954143|528906802|FG000|Overall Study|Progressive Disease|1|||
146652759|NCT05954143|528906803|FG001|Overall Study|Progressive Disease|0|||
146652760|NCT05954143|528906802|FG000|Overall Study|Physician Decision|1|||
146652761|NCT05954143|528906803|FG001|Overall Study|Physician Decision|0|||
146652762|NCT05954143|528906802|FG000|Overall Study|Study Terminated by Sponsor|2|||
146652763|NCT05954143|528906803|FG001|Overall Study|Study Terminated by Sponsor|4|||
146589993|NCT02323126|528668737|FG000|Overall Study|Progressive disease|14|||
146589994|NCT02323126|528668738|FG001|Overall Study|Progressive disease|8|||
146589995|NCT02323126|528668739|FG002|Overall Study|Progressive disease|14|||
146589996|NCT02323126|528668737|FG000|Overall Study|Physician Decision|0|||
146589997|NCT02323126|528668738|FG001|Overall Study|Physician Decision|1|||
146652764|NCT05954143|528906802|FG000|Overall Study|Death|1|||
146589998|NCT02323126|528668739|FG002|Overall Study|Physician Decision|3|||
146589999|NCT02323126|528668737|FG000|Overall Study|Death|1|||
146590000|NCT02323126|528668738|FG001|Overall Study|Death|1|||
146590001|NCT02323126|528668739|FG002|Overall Study|Death|4|||
146590002|NCT02323126|528668737|FG000|Overall Study|Adverse Event|3|||
146590003|NCT02323126|528668738|FG001|Overall Study|Adverse Event|5|||
146590004|NCT02323126|528668739|FG002|Overall Study|Adverse Event|7|||
146918960|NCT01544595|529864544|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
146918961|NCT01544595|529864545|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
146918962|NCT01544595|529864546|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
146918963|NCT01544595|529864541|FG000|Status at Week 156|Withdrawal by Subject|9|||
146918964|NCT01544595|529864542|FG001|Status at Week 156|Withdrawal by Subject|10|||
146918965|NCT01544595|529864543|FG002|Status at Week 156|Withdrawal by Subject|4|||
146918966|NCT01544595|529864544|FG003|Status at Week 156|Withdrawal by Subject|9|||
146918967|NCT01544595|529864545|FG004|Status at Week 156|Withdrawal by Subject|20|||
146918968|NCT01544595|529864546|FG005|Status at Week 156|Withdrawal by Subject|6|||
146918969|NCT01544595|529864541|FG000|Status at Week 156|Adverse Event|9|||
146918970|NCT01544595|529864542|FG001|Status at Week 156|Adverse Event|11|||
146918971|NCT01544595|529864543|FG002|Status at Week 156|Adverse Event|1|||
146590017|NCT01685801|528668749|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
146590018|NCT01685801|528668750|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
146590019|NCT01685801|528668751|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
146590020|NCT01685801|528668752|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
146590021|NCT01685801|528668749|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
146590022|NCT01685801|528668750|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
146590023|NCT01685801|528668751|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
146590024|NCT01685801|528668752|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
146590025|NCT03350256|528668753|FG000|Overall Study|Inclusion/exclusion violation|4|||
146590026|NCT03350256|528668753|FG000|Overall Study|Recommended for other therapies|2|||
146590027|NCT03350256|528668753|FG000|Overall Study|Protocol Violation|3|||
146590028|NCT03350256|528668753|FG000|Overall Study|Non compliance|2|||
146590029|NCT03350256|528668753|FG000|Overall Study|Denial by insurance|1|||
146590030|NCT03350256|528668753|FG000|Overall Study|Adverse Event|2|||
146590031|NCT03350256|528668753|FG000|Overall Study|Trial failure|12|||
146590032|NCT03350256|528668753|FG000|Overall Study|Did not proceed to permanent implant|3|||
146590033|NCT03350256|528668753|FG000|Overall Study|Withdrawal by Subject|3|||
146590034|NCT03350256|528668753|FG000|Overall Study|Subject moving out of state|1|||
146590035|NCT03350256|528668753|FG000|Overall Study|Lost to Follow-up|1|||
146590036|NCT03350256|528668753|FG000|Overall Study|Lack of Efficacy|2|||
146590037|NCT03960580|528668754|FG000|Overall Study|Adverse Event|2|||
146590038|NCT03960580|528668755|FG001|Overall Study|Adverse Event|1|||
146918972|NCT01544595|529864544|FG003|Status at Week 156|Adverse Event|3|||
146590039|NCT03960580|528668756|FG002|Overall Study|Adverse Event|1|||
146590040|NCT03960580|528668754|FG000|Overall Study|Lost to Follow-up|1|||
146590041|NCT03960580|528668755|FG001|Overall Study|Lost to Follow-up|0|||
146590042|NCT03960580|528668756|FG002|Overall Study|Lost to Follow-up|0|||
146590043|NCT03960580|528668754|FG000|Overall Study|Lack of Efficacy|2|||
146590044|NCT03960580|528668755|FG001|Overall Study|Lack of Efficacy|1|||
146918973|NCT01544595|529864545|FG004|Status at Week 156|Adverse Event|4|||
146918974|NCT01544595|529864546|FG005|Status at Week 156|Adverse Event|2|||
146918975|NCT01544595|529864541|FG000|Status at Week 156|Lost to Follow-up|4|||
146590045|NCT03960580|528668756|FG002|Overall Study|Lack of Efficacy|0|||
146590046|NCT03960580|528668754|FG000|Overall Study|Protocol Violation|0|||
146590047|NCT03960580|528668755|FG001|Overall Study|Protocol Violation|0|||
146590048|NCT03960580|528668756|FG002|Overall Study|Protocol Violation|1|||
146590049|NCT03960580|528668754|FG000|Overall Study|Withdrawal by Subject|1|||
146590050|NCT03960580|528668755|FG001|Overall Study|Withdrawal by Subject|1|||
146590051|NCT03960580|528668756|FG002|Overall Study|Withdrawal by Subject|1|||
146652765|NCT05954143|528906803|FG001|Overall Study|Death|0|||
146652766|NCT05954143|528906802|FG000|Overall Study|Withdrawal by Subject|0|||
146652767|NCT05954143|528906803|FG001|Overall Study|Withdrawal by Subject|1|||
146652768|NCT05954143|528906802|FG000|Overall Study|Other|1|||
146652769|NCT05954143|528906803|FG001|Overall Study|Other|0|||
146652770|NCT06390839|528906804|FG000|Overall Study|Ineligible|2|||
146652771|NCT06390839|528906804|FG000|Overall Study|Never start protocol therapy|3|||
146652772|NCT06390839|528906804|FG000|Overall Study|Adverse Event|1|||
146652773|NCT06390839|528906804|FG000|Overall Study|Alternative therapy|2|||
146652774|NCT06390839|528906804|FG000|Overall Study|Death|3|||
146652775|NCT06390839|528906804|FG000|Overall Study|Disease progression|28|||
146652776|NCT06390839|528906804|FG000|Overall Study|Withdrawal by Subject|2|||
146652777|NCT06390839|528906804|FG000|Overall Study|Complicating disease|1|||
146652778|NCT06390839|528906804|FG000|Overall Study|Noncompliance|1|||
146652779|NCT02720094|528906810|FG000|Overall Study|Ongoing|2210|||
146652780|NCT02720094|528906811|FG001|Overall Study|Ongoing|2203|||
146652781|NCT02720094|528906810|FG000|Overall Study|Scheduled exit visit/end of study|2|||
146918976|NCT01544595|529864542|FG001|Status at Week 156|Lost to Follow-up|4|||
146918977|NCT01544595|529864543|FG002|Status at Week 156|Lost to Follow-up|0|||
146918978|NCT01544595|529864544|FG003|Status at Week 156|Lost to Follow-up|1|||
146590052|NCT03960580|528668754|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
146590053|NCT03960580|528668755|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
146590054|NCT03960580|528668756|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
146590055|NCT00791479|528668764|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
146590056|NCT00791479|528668765|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
146590057|NCT00791479|528668766|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
146590058|NCT00791479|528668767|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
146590059|NCT00791479|528668768|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
146590060|NCT00791479|528668769|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
146590061|NCT00791479|528668764|FG000|Overall Study|Adverse Event|0|||
146590062|NCT00791479|528668765|FG001|Overall Study|Adverse Event|1|||
146590063|NCT00791479|528668766|FG002|Overall Study|Adverse Event|0|||
146590064|NCT00791479|528668767|FG003|Overall Study|Adverse Event|2|||
146590065|NCT00791479|528668768|FG004|Overall Study|Adverse Event|0|||
146590066|NCT00791479|528668769|FG005|Overall Study|Adverse Event|1|||
146590067|NCT00791479|528668764|FG000|Overall Study|Lost to Follow-up|0|||
146590068|NCT00791479|528668765|FG001|Overall Study|Lost to Follow-up|1|||
146652782|NCT02720094|528906811|FG001|Overall Study|Scheduled exit visit/end of study|1|||
146652783|NCT02720094|528906810|FG000|Overall Study|Death|4|||
146652784|NCT02720094|528906811|FG001|Overall Study|Death|7|||
146652785|NCT02720094|528906810|FG000|Overall Study|Withdrawal by Subject|55|||
146652786|NCT02720094|528906811|FG001|Overall Study|Withdrawal by Subject|56|||
146652787|NCT02720094|528906810|FG000|Overall Study|Lost to Follow-up|2|||
146652788|NCT02720094|528906811|FG001|Overall Study|Lost to Follow-up|7|||
146652789|NCT02720094|528906810|FG000|Overall Study|Physician Decision|1|||
146652790|NCT02720094|528906811|FG001|Overall Study|Physician Decision|3|||
146652791|NCT02720094|528906810|FG000|Overall Study|Inappropriate enrollment|1|||
146652792|NCT02720094|528906811|FG001|Overall Study|Inappropriate enrollment|3|||
146652793|NCT02720094|528906810|FG000|Overall Study|Relocation|1|||
146652794|NCT02720094|528906811|FG001|Overall Study|Relocation|1|||
146652795|NCT00732940|528906818|FG000|Overall Study|Withdrawal by Subject|1|||
146652796|NCT00732940|528906819|FG001|Overall Study|Withdrawal by Subject|2|||
146652797|NCT00732940|528906818|FG000|Overall Study|Adverse Event|0|||
146652798|NCT00732940|528906819|FG001|Overall Study|Adverse Event|1|||
146652799|NCT00732940|528906818|FG000|Overall Study|Lost to Follow-up|1|||
146652800|NCT00732940|528906819|FG001|Overall Study|Lost to Follow-up|0|||
146652801|NCT00459979|528906823|FG000|Overall Study|Withdrawal by Subject|1|||
146652802|NCT00459979|528906823|FG000|Overall Study|Protocol Violation|1|||
146652803|NCT00989573|528906824|FG000|Overall Study|Adverse Event|8|||
146652804|NCT00989573|528906825|FG001|Overall Study|Adverse Event|12|||
146652805|NCT00989573|528906826|FG002|Overall Study|Adverse Event|4|||
146652806|NCT00989573|528906824|FG000|Overall Study|Physician Decision|0|||
146652807|NCT00989573|528906825|FG001|Overall Study|Physician Decision|2|||
146652808|NCT00989573|528906826|FG002|Overall Study|Physician Decision|0|||
146652809|NCT00989573|528906824|FG000|Overall Study|Protocol Violation|1|||
146652810|NCT00989573|528906825|FG001|Overall Study|Protocol Violation|1|||
146652811|NCT00989573|528906826|FG002|Overall Study|Protocol Violation|1|||
146652812|NCT00989573|528906824|FG000|Overall Study|Withdrawal by Subject|4|||
146652813|NCT00989573|528906825|FG001|Overall Study|Withdrawal by Subject|7|||
146652814|NCT00989573|528906826|FG002|Overall Study|Withdrawal by Subject|3|||
146652815|NCT05214573|528906829|FG000|Overall Study|Physician Decision|5924|||
146652816|NCT05214573|528906830|FG001|Overall Study|Physician Decision|0|||
146652817|NCT00814801|528906831|FG000|Overall Study|Adverse Event|15|||
146652818|NCT00814801|528906832|FG001|Overall Study|Adverse Event|16|||
146652819|NCT00814801|528906833|FG002|Overall Study|Adverse Event|19|||
146652820|NCT00814801|528906831|FG000|Overall Study|Withdrawal by Subject|9|||
146652821|NCT00814801|528906832|FG001|Overall Study|Withdrawal by Subject|11|||
146652822|NCT00814801|528906833|FG002|Overall Study|Withdrawal by Subject|14|||
146652823|NCT00814801|528906831|FG000|Overall Study|Inappropriate as a subject|1|||
146652824|NCT00814801|528906832|FG001|Overall Study|Inappropriate as a subject|1|||
146652825|NCT00814801|528906833|FG002|Overall Study|Inappropriate as a subject|1|||
146652826|NCT00814801|528906831|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
146652827|NCT00814801|528906832|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
146652828|NCT00814801|528906833|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
146652829|NCT00814801|528906831|FG000|Overall Study|Missing or change of caregiver|6|||
146652830|NCT00814801|528906832|FG001|Overall Study|Missing or change of caregiver|2|||
146652831|NCT00814801|528906833|FG002|Overall Study|Missing or change of caregiver|4|||
146652832|NCT00814801|528906831|FG000|Overall Study|Non-compliance|0|||
146652833|NCT00814801|528906832|FG001|Overall Study|Non-compliance|1|||
146652834|NCT00814801|528906833|FG002|Overall Study|Non-compliance|1|||
146652835|NCT00814801|528906831|FG000|Overall Study|Other|2|||
146918979|NCT01544595|529864545|FG004|Status at Week 156|Lost to Follow-up|4|||
146652836|NCT00814801|528906832|FG001|Overall Study|Other|6|||
146652837|NCT00814801|528906833|FG002|Overall Study|Other|4|||
146652838|NCT02520089|528906836|FG000|Overall Study|Lost to Follow-up|3|||
146652839|NCT02520089|528906837|FG001|Overall Study|Lost to Follow-up|4|||
146771061|NCT03593213|529329840|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
146771062|NCT03593213|529329841|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
146771063|NCT03593213|529329842|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
146771064|NCT03593213|529329839|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
146771065|NCT03593213|529329840|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
146771066|NCT03593213|529329841|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
146771067|NCT03593213|529329842|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
146771068|NCT03593213|529329839|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
146771069|NCT03593213|529329840|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
146771070|NCT03593213|529329841|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
146771071|NCT03593213|529329842|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
146771072|NCT03593213|529329839|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
146771073|NCT03593213|529329840|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
146771074|NCT03593213|529329841|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
146771075|NCT03593213|529329842|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
146771076|NCT03593213|529329839|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
146771077|NCT03593213|529329840|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
146771078|NCT03593213|529329841|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
146771079|NCT03593213|529329842|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
146771080|NCT03593213|529329839|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
146771081|NCT03593213|529329840|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
146771082|NCT03593213|529329841|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
146771083|NCT03593213|529329842|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
146771084|NCT03593213|529329839|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
146771085|NCT03593213|529329840|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
146771086|NCT03593213|529329841|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
146771087|NCT03593213|529329842|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
146771088|NCT03593213|529329839|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
146771089|NCT03593213|529329840|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
146771090|NCT03593213|529329841|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
146771091|NCT03593213|529329842|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
146771092|NCT03593213|529329839|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
146771093|NCT03593213|529329840|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
146771094|NCT03593213|529329841|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
146771095|NCT03593213|529329842|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
146771096|NCT03593213|529329839|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
146771097|NCT03593213|529329840|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
146771098|NCT03593213|529329841|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
146771099|NCT03593213|529329842|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
146771100|NCT01831791|529329843|FG000|Overall Study|Withdrawal by Subject|10|||
146771101|NCT00494780|529329844|FG000|Overall Study|Adverse Event|1|||
146771102|NCT00494780|529329845|FG001|Overall Study|Adverse Event|0|||
146771103|NCT00494780|529329844|FG000|Overall Study|Withdrew before Dosed|0|||
146771104|NCT00494780|529329845|FG001|Overall Study|Withdrew before Dosed|1|||
146771105|NCT00494780|529329844|FG000|Overall Study|Progression of Study Disease|7|||
146771106|NCT00494780|529329845|FG001|Overall Study|Progression of Study Disease|8|||
146771107|NCT00494780|529329844|FG000|Overall Study|New Treatment|2|||
146771108|NCT00494780|529329845|FG001|Overall Study|New Treatment|2|||
146771109|NCT00494780|529329844|FG000|Overall Study|Non-compliance|1|||
146771110|NCT00494780|529329845|FG001|Overall Study|Non-compliance|0|||
146771111|NCT00494780|529329844|FG000|Overall Study|Residual Tumour Mass|0|||
146771112|NCT00494780|529329845|FG001|Overall Study|Residual Tumour Mass|1|||
146771113|NCT00494780|529329844|FG000|Overall Study|Insurance Issues|0|||
146771114|NCT00494780|529329845|FG001|Overall Study|Insurance Issues|1|||
146771115|NCT01190007|529329846|FG000|Overall Study|Withdrawal by Subject|4|||
146771116|NCT01190007|529329846|FG000|Overall Study|Adverse Event|8|||
146771117|NCT01190007|529329846|FG000|Overall Study|Difficulty of visit for complications|1|||
146771118|NCT01190007|529329846|FG000|Overall Study|Participant was arrested|1|||
146771119|NCT01254019|529329847|FG000|Overall Study|Adverse Event|0|||
146771120|NCT01254019|529329848|FG001|Overall Study|Adverse Event|2|||
146771121|NCT01254019|529329847|FG000|Overall Study|Protocol Violation|1|||
146771122|NCT01254019|529329848|FG001|Overall Study|Protocol Violation|0|||
146771123|NCT01254019|529329847|FG000|Overall Study|Withdrawal by Subject|0|||
146771124|NCT01254019|529329848|FG001|Overall Study|Withdrawal by Subject|2|||
146590069|NCT00791479|528668766|FG002|Overall Study|Lost to Follow-up|0|||
146590070|NCT00791479|528668767|FG003|Overall Study|Lost to Follow-up|0|||
146590071|NCT00791479|528668768|FG004|Overall Study|Lost to Follow-up|0|||
146590072|NCT00791479|528668769|FG005|Overall Study|Lost to Follow-up|1|||
146590073|NCT00791479|528668764|FG000|Overall Study|Protocol Violation|2|||
146590074|NCT00791479|528668765|FG001|Overall Study|Protocol Violation|1|||
146590075|NCT00791479|528668766|FG002|Overall Study|Protocol Violation|0|||
146590076|NCT00791479|528668767|FG003|Overall Study|Protocol Violation|1|||
146590077|NCT00791479|528668768|FG004|Overall Study|Protocol Violation|0|||
146590078|NCT00791479|528668769|FG005|Overall Study|Protocol Violation|0|||
146590079|NCT00791479|528668764|FG000|Overall Study|Withdrawal by Subject|0|||
146590080|NCT00791479|528668765|FG001|Overall Study|Withdrawal by Subject|0|||
146590081|NCT00791479|528668766|FG002|Overall Study|Withdrawal by Subject|0|||
146590082|NCT00791479|528668767|FG003|Overall Study|Withdrawal by Subject|1|||
146590083|NCT00791479|528668768|FG004|Overall Study|Withdrawal by Subject|0|||
146590084|NCT00791479|528668769|FG005|Overall Study|Withdrawal by Subject|1|||
146590085|NCT00543296|528668772|FG000|Overall Study|Physician Decision|7|||
146590086|NCT00934947|528668775|FG000|Overall Study|Adverse Event|0|||
146590087|NCT00934947|528668776|FG001|Overall Study|Adverse Event|2|||
146590088|NCT01920568|528668778|FG000|Overall Study|Adverse Event|27|||
146590089|NCT01920568|528668779|FG001|Overall Study|Adverse Event|8|||
146590090|NCT01920568|528668778|FG000|Overall Study|Protocol Violation|5|||
146590091|NCT01920568|528668779|FG001|Overall Study|Protocol Violation|3|||
146590092|NCT01920568|528668778|FG000|Overall Study|Lost to Follow-up|2|||
146590093|NCT01920568|528668779|FG001|Overall Study|Lost to Follow-up|2|||
146590094|NCT01920568|528668778|FG000|Overall Study|Physician Decision|13|||
146590095|NCT01920568|528668779|FG001|Overall Study|Physician Decision|4|||
146590096|NCT01920568|528668778|FG000|Overall Study|Withdrawal by Subject|79|||
146590097|NCT01920568|528668779|FG001|Overall Study|Withdrawal by Subject|55|||
146590098|NCT01920568|528668778|FG000|Overall Study|Death due to disease progression|25|||
146590099|NCT01920568|528668779|FG001|Overall Study|Death due to disease progression|12|||
146590100|NCT03664674|528668783|FG000|Overall Study|Adverse Event|1|||
146590101|NCT03664674|528668784|FG001|Overall Study|Adverse Event|1|||
146590102|NCT03664674|528668783|FG000|Overall Study|Physician Decision|0|||
146590103|NCT03664674|528668784|FG001|Overall Study|Physician Decision|1|||
146590104|NCT03664674|528668783|FG000|Overall Study|Withdrawal by Subject|2|||
146590105|NCT03664674|528668784|FG001|Overall Study|Withdrawal by Subject|0|||
146590106|NCT01342965|528668785|FG000|Overall Study|Death|58|||
146590107|NCT01342965|528668786|FG001|Overall Study|Death|57|||
146590108|NCT01342965|528668785|FG000|Overall Study|Lost to Follow-up|5|||
146590109|NCT01342965|528668786|FG001|Overall Study|Lost to Follow-up|3|||
146590110|NCT01342965|528668785|FG000|Overall Study|Other Reasons- Unspecified|44|||
146590111|NCT01342965|528668786|FG001|Overall Study|Other Reasons- Unspecified|38|||
146590112|NCT01342965|528668785|FG000|Overall Study|Withdrawal by Subject|2|||
146590113|NCT01342965|528668786|FG001|Overall Study|Withdrawal by Subject|9|||
146590114|NCT01170598|528668787|FG000|Overall Study|Withdrawal by Subject|1|||
146590115|NCT01170598|528668787|FG000|Overall Study|Death|3|||
146590116|NCT01170598|528668787|FG000|Overall Study|Lost to Follow-up|1|||
146590117|NCT01170598|528668787|FG000|Overall Study|Refused|1|||
146590118|NCT03022097|528668788|FG000|Overall Study|Adverse Event|3|||
146590119|NCT03022097|528668789|FG001|Overall Study|Adverse Event|4|||
146590120|NCT03022097|528668790|FG002|Overall Study|Adverse Event|1|||
146590121|NCT03022097|528668791|FG003|Overall Study|Adverse Event|3|||
146590122|NCT03022097|528668788|FG000|Overall Study|Progressive Disease|2|||
146590123|NCT03022097|528668789|FG001|Overall Study|Progressive Disease|0|||
146590124|NCT03022097|528668790|FG002|Overall Study|Progressive Disease|5|||
146590125|NCT03022097|528668791|FG003|Overall Study|Progressive Disease|2|||
146590126|NCT03022097|528668788|FG000|Overall Study|Lack of Efficacy|0|||
146590127|NCT03022097|528668789|FG001|Overall Study|Lack of Efficacy|0|||
146590128|NCT03022097|528668790|FG002|Overall Study|Lack of Efficacy|3|||
146590129|NCT03022097|528668791|FG003|Overall Study|Lack of Efficacy|3|||
146590130|NCT03022097|528668788|FG000|Overall Study|Protocol Violation|1|||
146590131|NCT03022097|528668789|FG001|Overall Study|Protocol Violation|0|||
146590132|NCT03022097|528668790|FG002|Overall Study|Protocol Violation|1|||
146590133|NCT03022097|528668791|FG003|Overall Study|Protocol Violation|0|||
146590134|NCT03022097|528668788|FG000|Overall Study|Withdrawal by Subject|11|||
146590135|NCT03022097|528668789|FG001|Overall Study|Withdrawal by Subject|13|||
146590136|NCT03022097|528668790|FG002|Overall Study|Withdrawal by Subject|15|||
146590137|NCT03022097|528668791|FG003|Overall Study|Withdrawal by Subject|21|||
146590138|NCT03022097|528668788|FG000|Overall Study|Lost to Follow-up|0|||
146590139|NCT03022097|528668789|FG001|Overall Study|Lost to Follow-up|0|||
146590140|NCT03022097|528668790|FG002|Overall Study|Lost to Follow-up|1|||
146590141|NCT03022097|528668791|FG003|Overall Study|Lost to Follow-up|1|||
146590142|NCT03022097|528668788|FG000|Overall Study|Other|4|||
146590143|NCT03022097|528668789|FG001|Overall Study|Other|1|||
146590144|NCT03022097|528668790|FG002|Overall Study|Other|6|||
146590145|NCT03022097|528668791|FG003|Overall Study|Other|4|||
146590146|NCT03022097|528668788|FG000|Overall Study|Due to COVID-19 pandemic|0|||
146590147|NCT03022097|528668789|FG001|Overall Study|Due to COVID-19 pandemic|1|||
146652840|NCT02216812|528906840|FG000|Overall Study|Lost to Follow-up|10|||
146590148|NCT03022097|528668790|FG002|Overall Study|Due to COVID-19 pandemic|0|||
146590149|NCT03022097|528668791|FG003|Overall Study|Due to COVID-19 pandemic|0|||
146590150|NCT01451931|528668792|FG000|Overall Study|Lost to Follow-up|17|||
146590151|NCT01451931|528668793|FG001|Overall Study|Lost to Follow-up|36|||
146590152|NCT01451931|528668794|FG002|Overall Study|Lost to Follow-up|21|||
146590153|NCT01451931|528668792|FG000|Overall Study|Withdrawal by Subject|16|||
146590154|NCT01451931|528668793|FG001|Overall Study|Withdrawal by Subject|22|||
146590155|NCT01451931|528668794|FG002|Overall Study|Withdrawal by Subject|22|||
146590156|NCT00855933|528668801|FG000|Overall Study|Withdrawal by Subject|0|||
146590157|NCT00855933|528668802|FG001|Overall Study|Withdrawal by Subject|1|||
146590158|NCT00951080|528668803|FG000|Overall Study|Adverse Event|3|||
146590159|NCT00951080|528668804|FG001|Overall Study|Adverse Event|3|||
146590160|NCT00951080|528668803|FG000|Overall Study|Lost to Follow-up|0|||
146590161|NCT00951080|528668804|FG001|Overall Study|Lost to Follow-up|1|||
146590162|NCT00951080|528668803|FG000|Overall Study|Physician Decision|4|||
146590163|NCT00951080|528668804|FG001|Overall Study|Physician Decision|1|||
146590164|NCT00951080|528668803|FG000|Overall Study|Other|19|||
146590165|NCT00951080|528668804|FG001|Overall Study|Other|22|||
146590166|NCT01960998|528668805|FG000|Overall Study|Lost to Follow-up|3|||
146590167|NCT01960998|528668806|FG001|Overall Study|Lost to Follow-up|7|||
146590168|NCT01960998|528668805|FG000|Overall Study|Death|0|||
146590169|NCT01960998|528668806|FG001|Overall Study|Death|1|||
146590170|NCT01960998|528668805|FG000|Overall Study|Withdrawal by Subject|8|||
146590171|NCT01960998|528668806|FG001|Overall Study|Withdrawal by Subject|2|||
146590172|NCT01960998|528668805|FG000|Overall Study|lost computer access|0|||
146590173|NCT01960998|528668806|FG001|Overall Study|lost computer access|1|||
146590174|NCT00835640|528668807|FG000|Second Intervention|Protocol Violation|1|||
146590175|NCT00835640|528668808|FG001|Second Intervention|Protocol Violation|0|||
146590176|NCT00812006|528668809|FG000|Overall Study|Lost to Follow-up|0|||
146590177|NCT00812006|528668810|FG001|Overall Study|Lost to Follow-up|0|||
146590178|NCT00812006|528668811|FG002|Overall Study|Lost to Follow-up|2|||
146590179|NCT00812006|528668809|FG000|Overall Study|Physician Decision|0|||
146590180|NCT00812006|528668810|FG001|Overall Study|Physician Decision|0|||
146590181|NCT00812006|528668811|FG002|Overall Study|Physician Decision|1|||
146590182|NCT00812006|528668809|FG000|Overall Study|Withdrawal by Subject|2|||
146590183|NCT00812006|528668810|FG001|Overall Study|Withdrawal by Subject|1|||
146590184|NCT00812006|528668811|FG002|Overall Study|Withdrawal by Subject|1|||
146590185|NCT00812006|528668809|FG000|Overall Study|Lack of Qualifying Event|4|||
146590186|NCT00812006|528668810|FG001|Overall Study|Lack of Qualifying Event|2|||
146590187|NCT00812006|528668811|FG002|Overall Study|Lack of Qualifying Event|2|||
146590188|NCT00235391|528668812|FG000|Overall Study|Adverse Event|4|||
146590189|NCT00235391|528668813|FG001|Overall Study|Adverse Event|5|||
146590190|NCT00235391|528668814|FG002|Overall Study|Adverse Event|10|||
146590191|NCT00235391|528668815|FG003|Overall Study|Adverse Event|72|||
146590192|NCT00235391|528668816|FG004|Overall Study|Adverse Event|5|||
146652841|NCT02216812|528906841|FG001|Overall Study|Lost to Follow-up|5|||
146652842|NCT02829944|528906849|FG000|Overall Study|Physician Decision|0|||
146652843|NCT02829944|528906850|FG001|Overall Study|Physician Decision|1|||
146652844|NCT02829944|528906849|FG000|Overall Study|Screen Failure|2|||
146652845|NCT02829944|528906850|FG001|Overall Study|Screen Failure|2|||
146652846|NCT02829944|528906849|FG000|Overall Study|Inadequate Neuraxial Block|1|||
146652847|NCT02829944|528906850|FG001|Overall Study|Inadequate Neuraxial Block|1|||
146652848|NCT02829944|528906849|FG000|Overall Study|Withdrawal by Subject|2|||
146652849|NCT02829944|528906850|FG001|Overall Study|Withdrawal by Subject|1|||
146652850|NCT02829944|528906849|FG000|Overall Study|Catheter Displacement|1|||
146652851|NCT02829944|528906850|FG001|Overall Study|Catheter Displacement|0|||
146652852|NCT02829944|528906849|FG000|Overall Study|Catheter broke|0|||
146652853|NCT02829944|528906850|FG001|Overall Study|Catheter broke|1|||
146652854|NCT02829944|528906849|FG000|Overall Study|Staff unavailable|0|||
146652855|NCT02829944|528906850|FG001|Overall Study|Staff unavailable|1|||
146652856|NCT04675151|528906851|FG000|Overall Study|Protocol Violation|1|||
146652857|NCT04675151|528906852|FG001|Overall Study|Protocol Violation|0|||
146652858|NCT04675151|528906853|FG002|Overall Study|Protocol Violation|0|||
146652859|NCT04675151|528906854|FG003|Overall Study|Protocol Violation|1|||
146652860|NCT04035486|528906855|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
146652861|NCT04035486|528906856|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
146652862|NCT04035486|528906857|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
146652863|NCT04035486|528906858|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
146652864|NCT04035486|528906855|FG000|Overall Study|Death|6|||
146652865|NCT04035486|528906856|FG001|Overall Study|Death|3|||
146590193|NCT00235391|528668817|FG005|Overall Study|Adverse Event|2|||
146652866|NCT04035486|528906857|FG002|Overall Study|Death|70|||
146918980|NCT01544595|529864546|FG005|Status at Week 156|Lost to Follow-up|1|||
146590194|NCT00235391|528668812|FG000|Overall Study|Abnormal laboratory value(s)|3|||
146590195|NCT00235391|528668813|FG001|Overall Study|Abnormal laboratory value(s)|5|||
146590196|NCT00235391|528668814|FG002|Overall Study|Abnormal laboratory value(s)|4|||
146590197|NCT00235391|528668815|FG003|Overall Study|Abnormal laboratory value(s)|27|||
146590198|NCT00235391|528668816|FG004|Overall Study|Abnormal laboratory value(s)|1|||
146590199|NCT00235391|528668817|FG005|Overall Study|Abnormal laboratory value(s)|2|||
146652867|NCT04035486|528906858|FG003|Overall Study|Death|77|||
146590200|NCT00235391|528668812|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146590201|NCT00235391|528668813|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146590202|NCT00235391|528668814|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
146590203|NCT00235391|528668815|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
146590204|NCT00235391|528668816|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
146590205|NCT00235391|528668817|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
146590206|NCT00235391|528668812|FG000|Overall Study|Condition no longer requires treatment|3|||
146590207|NCT00235391|528668813|FG001|Overall Study|Condition no longer requires treatment|0|||
146590208|NCT00235391|528668814|FG002|Overall Study|Condition no longer requires treatment|0|||
146590209|NCT00235391|528668815|FG003|Overall Study|Condition no longer requires treatment|11|||
146590210|NCT00235391|528668816|FG004|Overall Study|Condition no longer requires treatment|1|||
146590211|NCT00235391|528668817|FG005|Overall Study|Condition no longer requires treatment|0|||
146590212|NCT00235391|528668812|FG000|Overall Study|Protocol deviation|0|||
146590213|NCT00235391|528668813|FG001|Overall Study|Protocol deviation|0|||
146590214|NCT00235391|528668814|FG002|Overall Study|Protocol deviation|1|||
146590215|NCT00235391|528668815|FG003|Overall Study|Protocol deviation|11|||
146590216|NCT00235391|528668816|FG004|Overall Study|Protocol deviation|0|||
146590217|NCT00235391|528668817|FG005|Overall Study|Protocol deviation|0|||
146590218|NCT00235391|528668812|FG000|Overall Study|Withdrawal by Subject|2|||
146590219|NCT00235391|528668813|FG001|Overall Study|Withdrawal by Subject|3|||
146590220|NCT00235391|528668814|FG002|Overall Study|Withdrawal by Subject|3|||
146590221|NCT00235391|528668815|FG003|Overall Study|Withdrawal by Subject|61|||
146590222|NCT00235391|528668816|FG004|Overall Study|Withdrawal by Subject|5|||
146590223|NCT00235391|528668817|FG005|Overall Study|Withdrawal by Subject|0|||
146590224|NCT00235391|528668812|FG000|Overall Study|Lost to Follow-up|0|||
146590225|NCT00235391|528668813|FG001|Overall Study|Lost to Follow-up|3|||
146590226|NCT00235391|528668814|FG002|Overall Study|Lost to Follow-up|3|||
146590227|NCT00235391|528668815|FG003|Overall Study|Lost to Follow-up|16|||
146590228|NCT00235391|528668816|FG004|Overall Study|Lost to Follow-up|0|||
146590229|NCT00235391|528668817|FG005|Overall Study|Lost to Follow-up|0|||
146590230|NCT00235391|528668812|FG000|Overall Study|Administrative problems|0|||
146590231|NCT00235391|528668813|FG001|Overall Study|Administrative problems|0|||
146590232|NCT00235391|528668814|FG002|Overall Study|Administrative problems|0|||
146590233|NCT00235391|528668815|FG003|Overall Study|Administrative problems|1|||
146590234|NCT00235391|528668816|FG004|Overall Study|Administrative problems|0|||
146590235|NCT00235391|528668817|FG005|Overall Study|Administrative problems|0|||
146590236|NCT00235391|528668812|FG000|Overall Study|Death|0|||
146590237|NCT00235391|528668813|FG001|Overall Study|Death|0|||
146590238|NCT00235391|528668814|FG002|Overall Study|Death|1|||
146590239|NCT00235391|528668815|FG003|Overall Study|Death|4|||
146590240|NCT00235391|528668816|FG004|Overall Study|Death|0|||
146590241|NCT00235391|528668817|FG005|Overall Study|Death|0|||
146590242|NCT02927925|528668822|FG000|Overall Study|Death|16|||
146590243|NCT02927925|528668822|FG000|Overall Study|Physician Decision|1|||
146590244|NCT02927925|528668822|FG000|Overall Study|Withdrawal by Subject|11|||
146590245|NCT02927925|528668822|FG000|Overall Study|Other|3|||
146590246|NCT02927925|528668822|FG000|Overall Study|Disease progression at clinical cutoff|1|||
146590247|NCT00580034|528668823|FG000|Overall Study|Toxicity|10|||
146590248|NCT00580034|528668824|FG001|Overall Study|Toxicity|0|||
146590249|NCT00916058|528668826|FG000|Phase 1|Screen Failure|0|||
146590250|NCT00916058|528668827|FG001|Phase 1|Screen Failure|0|||
146590251|NCT00916058|528668828|FG002|Phase 1|Screen Failure|0|||
146590252|NCT00916058|528668829|FG003|Phase 1|Screen Failure|0|||
146590253|NCT00916058|528668830|FG004|Phase 1|Screen Failure|0|||
146590254|NCT00916058|528668831|FG005|Phase 1|Screen Failure|1|||
146590255|NCT00916058|528668832|FG006|Phase 1|Screen Failure|0|||
146590256|NCT00916058|528668826|FG000|Phase 2|Screen Failure|0|||
146590257|NCT00916058|528668827|FG001|Phase 2|Screen Failure|0|||
146590258|NCT00916058|528668828|FG002|Phase 2|Screen Failure|0|||
146590259|NCT00916058|528668829|FG003|Phase 2|Screen Failure|0|||
146590260|NCT00916058|528668830|FG004|Phase 2|Screen Failure|0|||
146590261|NCT00916058|528668831|FG005|Phase 2|Screen Failure|0|||
146590262|NCT00916058|528668832|FG006|Phase 2|Screen Failure|3|||
146590263|NCT02439450|528668833|FG000|Overall Study|Adverse Event|4|||
146590264|NCT02439450|528668834|FG001|Overall Study|Adverse Event|1|||
146590265|NCT02439450|528668835|FG002|Overall Study|Adverse Event|0|||
146590266|NCT02439450|528668836|FG003|Overall Study|Adverse Event|0|||
146652868|NCT04035486|528906855|FG000|Overall Study|Screen Failure|0|||
146590267|NCT02439450|528668833|FG000|Overall Study|Withdrawal by Subject|1|||
146590268|NCT02439450|528668834|FG001|Overall Study|Withdrawal by Subject|2|||
146590269|NCT02439450|528668835|FG002|Overall Study|Withdrawal by Subject|0|||
146590270|NCT02439450|528668836|FG003|Overall Study|Withdrawal by Subject|0|||
146590271|NCT02439450|528668833|FG000|Overall Study|Death|3|||
146590272|NCT02439450|528668834|FG001|Overall Study|Death|0|||
146590273|NCT02439450|528668835|FG002|Overall Study|Death|0|||
146590274|NCT02439450|528668836|FG003|Overall Study|Death|1|||
146590275|NCT02439450|528668833|FG000|Overall Study|Progressive Disease|18|||
146590276|NCT02439450|528668834|FG001|Overall Study|Progressive Disease|41|||
146590277|NCT02439450|528668835|FG002|Overall Study|Progressive Disease|2|||
146652869|NCT04035486|528906856|FG001|Overall Study|Screen Failure|0|||
146652870|NCT04035486|528906857|FG002|Overall Study|Screen Failure|1|||
146652871|NCT04035486|528906858|FG003|Overall Study|Screen Failure|1|||
146652872|NCT04035486|528906855|FG000|Overall Study|Withdrawal by Subject|1|||
146652873|NCT04035486|528906856|FG001|Overall Study|Withdrawal by Subject|1|||
146652874|NCT04035486|528906857|FG002|Overall Study|Withdrawal by Subject|11|||
146590278|NCT02439450|528668836|FG003|Overall Study|Progressive Disease|3|||
146590279|NCT01170065|528668837|FG000|Overall Study|Adverse Event|17|||
146590280|NCT01170065|528668838|FG001|Overall Study|Adverse Event|50|||
146590281|NCT01170065|528668839|FG002|Overall Study|Adverse Event|10|||
146590282|NCT01170065|528668837|FG000|Overall Study|Lost to Follow-up|1|||
146590283|NCT01170065|528668838|FG001|Overall Study|Lost to Follow-up|4|||
146590284|NCT01170065|528668839|FG002|Overall Study|Lost to Follow-up|1|||
146590285|NCT01170065|528668837|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
146590286|NCT01170065|528668838|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
146590287|NCT01170065|528668839|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
146590288|NCT01170065|528668837|FG000|Overall Study|Reason other than specified|3|||
146590289|NCT01170065|528668838|FG001|Overall Study|Reason other than specified|8|||
146590290|NCT01170065|528668839|FG002|Overall Study|Reason other than specified|3|||
146590291|NCT01170065|528668837|FG000|Overall Study|Ongoing after planned observation time|5|||
146590292|NCT01170065|528668838|FG001|Overall Study|Ongoing after planned observation time|26|||
146590293|NCT01170065|528668839|FG002|Overall Study|Ongoing after planned observation time|10|||
146590294|NCT00717522|528668842|FG000|Overall Study|Disease Progression|5|||
146590295|NCT00717522|528668842|FG000|Overall Study|Adverse Event|1|||
146590296|NCT00717522|528668842|FG000|Overall Study|Death|1|||
146590297|NCT03551665|528668845|FG000|Overall Study|Lost to Follow-up|11|||
146590298|NCT03551665|528668846|FG001|Overall Study|Lost to Follow-up|2|||
146590299|NCT03333252|528670700|FG000|Overall Study|Adverse Event|10|||
146590300|NCT03333252|528670701|FG001|Overall Study|Adverse Event|6|||
146590301|NCT03333252|528670702|FG002|Overall Study|Adverse Event|5|||
146590302|NCT03333252|528670703|FG003|Overall Study|Adverse Event|2|||
146590303|NCT03333252|528670700|FG000|Overall Study|Death|1|||
146590304|NCT03333252|528670701|FG001|Overall Study|Death|3|||
146590305|NCT03333252|528670702|FG002|Overall Study|Death|0|||
146590306|NCT03333252|528670703|FG003|Overall Study|Death|0|||
146590307|NCT03333252|528670700|FG000|Overall Study|Lack of Efficacy|8|||
146590308|NCT03333252|528670701|FG001|Overall Study|Lack of Efficacy|4|||
146590309|NCT03333252|528670702|FG002|Overall Study|Lack of Efficacy|0|||
146590310|NCT03333252|528670703|FG003|Overall Study|Lack of Efficacy|7|||
146590311|NCT03333252|528670700|FG000|Overall Study|Lost to Follow-up|0|||
146590312|NCT03333252|528670701|FG001|Overall Study|Lost to Follow-up|5|||
146590313|NCT03333252|528670702|FG002|Overall Study|Lost to Follow-up|9|||
146590314|NCT03333252|528670703|FG003|Overall Study|Lost to Follow-up|3|||
146590315|NCT03333252|528670700|FG000|Overall Study|Withdrawal by Subject|14|||
146590316|NCT03333252|528670701|FG001|Overall Study|Withdrawal by Subject|24|||
146590317|NCT03333252|528670702|FG002|Overall Study|Withdrawal by Subject|11|||
146590318|NCT03333252|528670703|FG003|Overall Study|Withdrawal by Subject|17|||
146590319|NCT04049266|528670706|FG000|Overall Study|Adverse Event|16|||
146590320|NCT04049266|528670707|FG001|Overall Study|Adverse Event|9|||
146590321|NCT04049266|528670706|FG000|Overall Study|Non-compliance with study drug|0|||
146590322|NCT04049266|528670707|FG001|Overall Study|Non-compliance with study drug|3|||
146590323|NCT04049266|528670706|FG000|Overall Study|Withdrawal by Subject|6|||
146590324|NCT04049266|528670707|FG001|Overall Study|Withdrawal by Subject|10|||
146590325|NCT04049266|528670706|FG000|Overall Study|Lost to Follow-up|2|||
146590326|NCT04049266|528670707|FG001|Overall Study|Lost to Follow-up|2|||
146590327|NCT04049266|528670706|FG000|Overall Study|Progressive disease|11|||
146590328|NCT04049266|528670707|FG001|Overall Study|Progressive disease|2|||
146590329|NCT04049266|528670706|FG000|Overall Study|Physician Decision|1|||
146590330|NCT04049266|528670707|FG001|Overall Study|Physician Decision|0|||
146652875|NCT04035486|528906858|FG003|Overall Study|Withdrawal by Subject|9|||
146652876|NCT01730937|528906859|FG000|Overall Study|Protocol Violation|5|||
146652877|NCT01730937|528906860|FG001|Overall Study|Protocol Violation|11|||
146652878|NCT03947684|528906861|FG000|Overall Study|Lost to Follow-up|13|||
146652879|NCT03947684|528906862|FG001|Overall Study|Lost to Follow-up|5|||
146590331|NCT04049266|528670706|FG000|Overall Study|Patient moved out of state|1|||
146652880|NCT03947684|528906863|FG002|Overall Study|Lost to Follow-up|1|||
146652881|NCT03947684|528906861|FG000|Overall Study|Withdrawal by Subject|11|||
146652882|NCT03947684|528906862|FG001|Overall Study|Withdrawal by Subject|4|||
146652883|NCT03947684|528906863|FG002|Overall Study|Withdrawal by Subject|0|||
146652884|NCT03947684|528906861|FG000|Overall Study|Physician Decision|1|||
146652885|NCT03947684|528906862|FG001|Overall Study|Physician Decision|0|||
146652886|NCT03947684|528906863|FG002|Overall Study|Physician Decision|0|||
146590332|NCT04049266|528670707|FG001|Overall Study|Patient moved out of state|0|||
146590333|NCT04600076|528670709|FG000|Overall Study|Lost to Follow-up|3|||
146590334|NCT02891681|528670710|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
146652887|NCT03947684|528906861|FG000|Overall Study|Lack of adherence to study protocol|2|||
146652888|NCT03947684|528906862|FG001|Overall Study|Lack of adherence to study protocol|0|||
146652889|NCT03947684|528906863|FG002|Overall Study|Lack of adherence to study protocol|0|||
146590335|NCT02891681|528670711|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
146590336|NCT02891681|528670712|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
146590337|NCT02891681|528670710|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
146590338|NCT02891681|528670711|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
146590339|NCT02891681|528670712|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
146590340|NCT02891681|528670710|FG000|Overall Study|Taken off study after first imaging appointment|1|||
146590341|NCT02891681|528670711|FG001|Overall Study|Taken off study after first imaging appointment|0|||
146590342|NCT02891681|528670712|FG002|Overall Study|Taken off study after first imaging appointment|0|||
146590343|NCT02174523|528670713|FG000|Overall Study|Withdrawal by Subject|1|||
146590344|NCT02174523|528670714|FG001|Overall Study|Withdrawal by Subject|0|||
146590345|NCT02780856|528670721|FG000|Overall Study|Lost to Follow-up|1|||
146590346|NCT03894969|528670725|FG000|Overall Study|Adverse Event|0|||
146590347|NCT03894969|528670726|FG001|Overall Study|Adverse Event|2|||
146590348|NCT03894969|528670727|FG002|Overall Study|Adverse Event|0|||
146590349|NCT03894969|528670728|FG003|Overall Study|Adverse Event|1|||
146590350|NCT03894969|528670729|FG004|Overall Study|Adverse Event|2|||
146590351|NCT03894969|528670725|FG000|Overall Study|Lost to Follow-up|3|||
146590352|NCT03894969|528670726|FG001|Overall Study|Lost to Follow-up|1|||
146590353|NCT03894969|528670727|FG002|Overall Study|Lost to Follow-up|1|||
146590354|NCT03894969|528670728|FG003|Overall Study|Lost to Follow-up|0|||
146590355|NCT03894969|528670729|FG004|Overall Study|Lost to Follow-up|0|||
146590356|NCT03894969|528670725|FG000|Overall Study|Withdrawal by Subject|2|||
146590357|NCT03894969|528670726|FG001|Overall Study|Withdrawal by Subject|1|||
146590358|NCT03894969|528670727|FG002|Overall Study|Withdrawal by Subject|3|||
146590359|NCT03894969|528670728|FG003|Overall Study|Withdrawal by Subject|4|||
146590360|NCT03894969|528670729|FG004|Overall Study|Withdrawal by Subject|8|||
146590361|NCT03894969|528670725|FG000|Overall Study|Other|0|||
146590362|NCT03894969|528670726|FG001|Overall Study|Other|0|||
146590363|NCT03894969|528670727|FG002|Overall Study|Other|0|||
146590364|NCT03894969|528670728|FG003|Overall Study|Other|0|||
146590365|NCT03894969|528670729|FG004|Overall Study|Other|3|||
146590366|NCT03894969|528670725|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
146590367|NCT03894969|528670726|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
146590368|NCT03894969|528670727|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
146590369|NCT03894969|528670728|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
146590370|NCT03894969|528670729|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
146590371|NCT03894969|528670725|FG000|Overall Study|Solicited Adverse Event|0|||
146590372|NCT03894969|528670726|FG001|Overall Study|Solicited Adverse Event|1|||
146590373|NCT03894969|528670727|FG002|Overall Study|Solicited Adverse Event|0|||
146590374|NCT03894969|528670728|FG003|Overall Study|Solicited Adverse Event|0|||
146590375|NCT03894969|528670729|FG004|Overall Study|Solicited Adverse Event|0|||
146590376|NCT00468676|528670730|FG000|Overall Study|Lost to Follow-up|14|||
146590377|NCT00468676|528670731|FG001|Overall Study|Lost to Follow-up|11|||
146590378|NCT00468676|528670730|FG000|Overall Study|Death|2|||
146590379|NCT00468676|528670731|FG001|Overall Study|Death|1|||
146590380|NCT02378298|528670732|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
146590381|NCT02378298|528670733|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
146590382|NCT02378298|528670734|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
146590383|NCT02378298|528670732|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
146590384|NCT02378298|528670733|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
146590385|NCT02378298|528670734|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
146590386|NCT02378298|528670732|FG000|Surveillance (19-68 Weeks)|Death|1|||
146590387|NCT02378298|528670733|FG001|Surveillance (19-68 Weeks)|Death|0|||
146590388|NCT02378298|528670734|FG002|Surveillance (19-68 Weeks)|Death|0|||
146590389|NCT03006458|528670737|FG000|First Intervention|Unsatisfied Vision|0|||
146590390|NCT03006458|528670738|FG001|First Intervention|Unsatisfied Vision|3|||
146590391|NCT01468233|528670739|FG000|Treatment Period 1|Adverse Event|5|||
146590392|NCT01468233|528670740|FG001|Treatment Period 1|Adverse Event|3|||
146590393|NCT01468233|528670741|FG002|Treatment Period 1|Adverse Event|0|||
146590394|NCT01468233|528670742|FG003|Treatment Period 1|Adverse Event|0|||
146590395|NCT01468233|528670743|FG004|Treatment Period 1|Adverse Event|0|||
146590396|NCT01468233|528670744|FG005|Treatment Period 1|Adverse Event|0|||
146590397|NCT01468233|528670739|FG000|Treatment Period 1|Withdrawal by Subject|3|||
146590398|NCT01468233|528670740|FG001|Treatment Period 1|Withdrawal by Subject|4|||
146590399|NCT01468233|528670741|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146590400|NCT01468233|528670742|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146652890|NCT03875235|528906864|FG000|Overall Study|Ongoing study treatment|63|||
146652891|NCT03875235|528906865|FG001|Overall Study|Ongoing study treatment|20|||
146590401|NCT01468233|528670743|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146590402|NCT01468233|528670744|FG005|Treatment Period 1|Withdrawal by Subject|0|||
146590403|NCT01468233|528670739|FG000|Treatment Period 1|Lost to Follow-up|3|||
146590404|NCT01468233|528670740|FG001|Treatment Period 1|Lost to Follow-up|0|||
146590405|NCT01468233|528670741|FG002|Treatment Period 1|Lost to Follow-up|0|||
146590406|NCT01468233|528670742|FG003|Treatment Period 1|Lost to Follow-up|0|||
146590407|NCT01468233|528670743|FG004|Treatment Period 1|Lost to Follow-up|0|||
146590408|NCT01468233|528670744|FG005|Treatment Period 1|Lost to Follow-up|0|||
146590409|NCT01468233|528670739|FG000|Treatment Period 1|Other|1|||
146590410|NCT01468233|528670740|FG001|Treatment Period 1|Other|1|||
146590411|NCT01468233|528670741|FG002|Treatment Period 1|Other|0|||
146590412|NCT01468233|528670742|FG003|Treatment Period 1|Other|0|||
146590413|NCT01468233|528670743|FG004|Treatment Period 1|Other|0|||
146590414|NCT01468233|528670744|FG005|Treatment Period 1|Other|0|||
146590415|NCT01468233|528670739|FG000|Treatment Period 2|Adverse Event|0|||
146590416|NCT01468233|528670740|FG001|Treatment Period 2|Adverse Event|0|||
146590417|NCT01468233|528670741|FG002|Treatment Period 2|Adverse Event|3|||
146590418|NCT01468233|528670742|FG003|Treatment Period 2|Adverse Event|0|||
146590419|NCT01468233|528670743|FG004|Treatment Period 2|Adverse Event|2|||
146590420|NCT01468233|528670744|FG005|Treatment Period 2|Adverse Event|1|||
146590421|NCT01468233|528670739|FG000|Treatment Period 2|Lack of Efficacy|0|||
146590422|NCT01468233|528670740|FG001|Treatment Period 2|Lack of Efficacy|0|||
146590423|NCT01468233|528670741|FG002|Treatment Period 2|Lack of Efficacy|9|||
146590424|NCT01468233|528670742|FG003|Treatment Period 2|Lack of Efficacy|2|||
146590425|NCT01468233|528670743|FG004|Treatment Period 2|Lack of Efficacy|0|||
146590426|NCT01468233|528670744|FG005|Treatment Period 2|Lack of Efficacy|1|||
146590427|NCT01468233|528670739|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146590428|NCT01468233|528670740|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146590429|NCT01468233|528670741|FG002|Treatment Period 2|Withdrawal by Subject|9|||
146590430|NCT01468233|528670742|FG003|Treatment Period 2|Withdrawal by Subject|1|||
146590431|NCT01468233|528670743|FG004|Treatment Period 2|Withdrawal by Subject|1|||
146590432|NCT01468233|528670744|FG005|Treatment Period 2|Withdrawal by Subject|1|||
146590433|NCT01468233|528670739|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
146590434|NCT01468233|528670740|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
146590435|NCT01468233|528670741|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
146590436|NCT01468233|528670742|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
146590437|NCT01468233|528670743|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
146590438|NCT01468233|528670744|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
146590439|NCT01468233|528670739|FG000|Treatment Period 2|Lost to Follow-up|0|||
146590440|NCT01468233|528670740|FG001|Treatment Period 2|Lost to Follow-up|0|||
146590441|NCT01468233|528670741|FG002|Treatment Period 2|Lost to Follow-up|3|||
146590442|NCT01468233|528670742|FG003|Treatment Period 2|Lost to Follow-up|0|||
146590443|NCT01468233|528670743|FG004|Treatment Period 2|Lost to Follow-up|2|||
146590444|NCT01468233|528670744|FG005|Treatment Period 2|Lost to Follow-up|0|||
146590445|NCT01468233|528670739|FG000|Treatment Period 2|Other|0|||
146590446|NCT01468233|528670740|FG001|Treatment Period 2|Other|0|||
146590447|NCT01468233|528670741|FG002|Treatment Period 2|Other|3|||
146590448|NCT01468233|528670742|FG003|Treatment Period 2|Other|0|||
146590449|NCT01468233|528670743|FG004|Treatment Period 2|Other|1|||
146590450|NCT01468233|528670744|FG005|Treatment Period 2|Other|0|||
146590451|NCT00457821|528670748|FG000|Part 2|Withdrawal by Subject|0|||
146590452|NCT00457821|528670749|FG001|Part 2|Withdrawal by Subject|0|||
146590453|NCT00457821|528670750|FG002|Part 2|Withdrawal by Subject|0|||
146590454|NCT00457821|528670751|FG003|Part 2|Withdrawal by Subject|0|||
146590455|NCT00457821|528670752|FG004|Part 2|Withdrawal by Subject|0|||
146590456|NCT00457821|528670753|FG005|Part 2|Withdrawal by Subject|0|||
146590457|NCT00457821|528670754|FG006|Part 2|Withdrawal by Subject|0|||
146590458|NCT00457821|528670755|FG007|Part 2|Withdrawal by Subject|1|||
146590459|NCT02437409|528670758|FG000|Overall Study|Withdrawal by Subject|3|||
146590460|NCT02437409|528670758|FG000|Overall Study|Screening failure|12|||
146590461|NCT03549871|528670771|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
146590462|NCT03549871|528670772|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
146590463|NCT03549871|528670771|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
146590464|NCT03549871|528670772|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
146590465|NCT03549871|528670771|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
146590466|NCT03549871|528670772|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
146590467|NCT03549871|528670771|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
146590468|NCT03549871|528670772|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
146590469|NCT03549871|528670771|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
146590470|NCT03549871|528670772|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
146590471|NCT03549871|528670771|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
146590472|NCT03549871|528670772|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
146590473|NCT03549871|528670771|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
146590474|NCT03549871|528670772|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
146590475|NCT03549871|528670771|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
146652892|NCT03875235|528906864|FG000|Overall Study|Off treatment|77|||
146652893|NCT03875235|528906865|FG001|Overall Study|Off treatment|91|||
146590476|NCT03549871|528670772|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
146590477|NCT03549871|528670771|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
146590478|NCT03549871|528670772|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
146590479|NCT03549871|528670771|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
146590480|NCT03549871|528670772|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
146590481|NCT03549871|528670771|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
146590482|NCT03549871|528670772|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
146590483|NCT01369680|528670773|FG000|Overall Study|Lost to Follow-up|0|||
146590484|NCT01369680|528670774|FG001|Overall Study|Lost to Follow-up|0|||
146590485|NCT01369680|528670775|FG002|Overall Study|Lost to Follow-up|1|||
146590486|NCT01369680|528670776|FG003|Overall Study|Lost to Follow-up|2|||
146590487|NCT00737568|528670783|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
146590488|NCT00737568|528670784|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
146590489|NCT00737568|528670783|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
146590490|NCT00737568|528670784|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
146590491|NCT00737568|528670783|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
146590492|NCT00737568|528670784|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
146590493|NCT00737568|528670783|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
146590494|NCT00737568|528670784|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
146590495|NCT00737568|528670783|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
146590496|NCT00737568|528670784|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
146590497|NCT00737568|528670783|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
146590498|NCT00737568|528670784|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
146590499|NCT00737568|528670783|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
146590500|NCT00737568|528670784|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
146590501|NCT00737568|528670783|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
146590502|NCT00737568|528670784|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
146590503|NCT00737568|528670783|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
146590504|NCT00737568|528670784|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
146590505|NCT01133626|528670785|FG000|Overall Study|Adverse Event|0|||
146590506|NCT01133626|528670786|FG001|Overall Study|Adverse Event|1|||
146590507|NCT01133626|528670787|FG002|Overall Study|Adverse Event|0|||
146590508|NCT01133626|528670785|FG000|Overall Study|Withdrawal by Subject|1|||
146590509|NCT01133626|528670786|FG001|Overall Study|Withdrawal by Subject|2|||
146590510|NCT01133626|528670787|FG002|Overall Study|Withdrawal by Subject|2|||
146590511|NCT01133626|528670785|FG000|Overall Study|Other|0|||
146590512|NCT01133626|528670786|FG001|Overall Study|Other|2|||
146590513|NCT01133626|528670787|FG002|Overall Study|Other|0|||
146590514|NCT00759356|528670788|FG000|Overall Study|Adverse Event|0|||
146590515|NCT00759356|528670789|FG001|Overall Study|Adverse Event|1|||
146590516|NCT00759356|528670788|FG000|Overall Study|Withdrawal by Subject|0|||
146590517|NCT00759356|528670789|FG001|Overall Study|Withdrawal by Subject|2|||
146590518|NCT00759356|528670788|FG000|Overall Study|Subject was unable to return|1|||
146590519|NCT00759356|528670789|FG001|Overall Study|Subject was unable to return|0|||
146590520|NCT02851407|528670790|FG000|Overall Study|Withdrawal by parent/guardian|2|||
146590521|NCT02851407|528670791|FG001|Overall Study|Withdrawal by parent/guardian|7|||
146590522|NCT02851407|528670790|FG000|Overall Study|Protocol deviation|0|||
146590523|NCT02851407|528670791|FG001|Overall Study|Protocol deviation|1|||
146652894|NCT03875235|528906864|FG000|Overall Study|Withdrawal by Subject|3|||
146771125|NCT03061474|529329849|FG000|Overall Study|Adverse Event|2|||
146771126|NCT03061474|529329850|FG001|Overall Study|Adverse Event|0|||
146590524|NCT02851407|528670790|FG000|Overall Study|Transferred to another hospital to continue|1|||
146590525|NCT02851407|528670791|FG001|Overall Study|Transferred to another hospital to continue|0|||
146590526|NCT02851407|528670790|FG000|Overall Study|Other Death|30|||
146590527|NCT02851407|528670791|FG001|Overall Study|Other Death|20|||
146590528|NCT02851407|528670790|FG000|Overall Study|Adverse event, serious fatal|6|||
146590529|NCT02851407|528670791|FG001|Overall Study|Adverse event, serious fatal|8|||
146590530|NCT02851407|528670790|FG000|Overall Study|Consent withdrawn by participant|5|||
146590531|NCT02851407|528670791|FG001|Overall Study|Consent withdrawn by participant|3|||
146590532|NCT02851407|528670790|FG000|Overall Study|Screen failure|2|||
146590533|NCT02851407|528670791|FG001|Overall Study|Screen failure|1|||
146590534|NCT02851407|528670790|FG000|Overall Study|Disease relapse|9|||
146590535|NCT02851407|528670791|FG001|Overall Study|Disease relapse|6|||
146590536|NCT02851407|528670790|FG000|Overall Study|Physician Decision|7|||
146590537|NCT02851407|528670791|FG001|Overall Study|Physician Decision|6|||
146590538|NCT02851407|528670790|FG000|Overall Study|Transferred to hospital closer to home|0|||
146590539|NCT02851407|528670791|FG001|Overall Study|Transferred to hospital closer to home|1|||
146590540|NCT02851407|528670790|FG000|Overall Study|Enrolled in an investigational study|0|||
146590541|NCT02851407|528670791|FG001|Overall Study|Enrolled in an investigational study|1|||
146590542|NCT02851407|528670790|FG000|Overall Study|Early recovery|1|||
146590543|NCT02851407|528670791|FG001|Overall Study|Early recovery|0|||
146590544|NCT02851407|528670790|FG000|Overall Study|Adverse event, non-fatal|7|||
146590545|NCT02851407|528670791|FG001|Overall Study|Adverse event, non-fatal|5|||
146590546|NCT02851407|528670790|FG000|Overall Study|Lost to Follow-up|0|||
146590547|NCT02851407|528670791|FG001|Overall Study|Lost to Follow-up|2|||
146590548|NCT01713283|528670795|FG000|Overall Study|Lack of Efficacy|10|||
146590549|NCT01713283|528670796|FG001|Overall Study|Lack of Efficacy|2|||
146590550|NCT01713283|528670795|FG000|Overall Study|Lost to Follow-up|1|||
146590551|NCT01713283|528670796|FG001|Overall Study|Lost to Follow-up|1|||
146590552|NCT03761394|528670798|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
146590553|NCT03761394|528670799|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
146590554|NCT03761394|528670800|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
146590555|NCT03761394|528670801|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
146590556|NCT03761394|528670798|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
146590557|NCT03761394|528670799|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
146590558|NCT03761394|528670800|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
146590559|NCT03761394|528670801|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
146590560|NCT03761394|528670798|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
146590561|NCT03761394|528670799|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
146590562|NCT03761394|528670800|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
146590563|NCT03761394|528670801|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
146590564|NCT03761394|528670798|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
146590565|NCT03761394|528670799|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
146590566|NCT03761394|528670800|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
146590567|NCT03761394|528670801|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
146590568|NCT01080768|528670802|FG000|Overall Study|Protocol Deviation|2|||
146590569|NCT01080768|528670803|FG001|Overall Study|Protocol Deviation|1|||
146590570|NCT03054350|528670804|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
146590571|NCT03054350|528670805|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
146590572|NCT03054350|528670806|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
146590573|NCT03054350|528670807|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
146590574|NCT03054350|528670808|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
146590575|NCT03054350|528670809|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
146590576|NCT03054350|528670804|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
146590577|NCT03054350|528670805|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
146590578|NCT03054350|528670806|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
146590579|NCT03054350|528670807|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
146590580|NCT03054350|528670808|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
146590581|NCT03054350|528670809|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
146590582|NCT03054350|528670804|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
146590583|NCT03054350|528670805|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
146590584|NCT03054350|528670806|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
146590585|NCT03054350|528670807|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
146590586|NCT03054350|528670808|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
146590587|NCT03054350|528670809|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
146590588|NCT03054350|528670804|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
146590589|NCT03054350|528670805|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
146590590|NCT03054350|528670806|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
146590591|NCT03054350|528670807|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
146590592|NCT03054350|528670808|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
146590593|NCT03054350|528670809|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
146590594|NCT00772369|528670811|FG000|Overall Study|Did not return record release form|1|||
146590595|NCT03510468|528670812|FG000|Overall Study|Lost to Follow-up|1|||
146590596|NCT03510468|528670812|FG000|Overall Study|Adverse Event|5|||
146590597|NCT03510468|528670812|FG000|Overall Study|Physician Decision|1|||
146590598|NCT03510468|528670812|FG000|Overall Study|non-compliant with treatment|2|||
146590599|NCT03510468|528670812|FG000|Overall Study|Missed visit|1|||
146590600|NCT03372460|528670813|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
146590601|NCT03372460|528670814|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
146590602|NCT02499900|528670815|FG000|Core Study Period|Other|1|||
146590603|NCT02499900|528670816|FG001|Core Study Period|Other|4|||
146590604|NCT02499900|528670815|FG000|Core Study Period|Lost to Follow-up|1|||
146590605|NCT02499900|528670816|FG001|Core Study Period|Lost to Follow-up|2|||
146590606|NCT02499900|528670815|FG000|Core Study Period|Per sponsor request|0|||
146590607|NCT02499900|528670816|FG001|Core Study Period|Per sponsor request|1|||
146590608|NCT02499900|528670815|FG000|Core Study Period|Pregnancy|1|||
146590609|NCT02499900|528670816|FG001|Core Study Period|Pregnancy|0|||
146590610|NCT02499900|528670815|FG000|Core Study Period|Protocol Violation|3|||
146771127|NCT03061474|529329849|FG000|Overall Study|Safety Risk|0|||
146590611|NCT02499900|528670816|FG001|Core Study Period|Protocol Violation|0|||
146590612|NCT02499900|528670815|FG000|Core Study Period|Withdrawal by Subject|11|||
146590613|NCT02499900|528670816|FG001|Core Study Period|Withdrawal by Subject|10|||
146590614|NCT02499900|528670815|FG000|Core Study Period|Adverse Event|18|||
146590615|NCT02499900|528670816|FG001|Core Study Period|Adverse Event|14|||
146590616|NCT02499900|528670815|FG000|Core Study Period|Death|0|||
146590617|NCT02499900|528670816|FG001|Core Study Period|Death|1|||
146590618|NCT02499900|528670815|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
146590619|NCT02499900|528670816|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
146590620|NCT02499900|528670815|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
146590621|NCT02499900|528670816|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
146590622|NCT02499900|528670815|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
146590623|NCT02499900|528670816|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
146590624|NCT02499900|528670815|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
146590625|NCT02499900|528670816|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
146590626|NCT02499900|528670815|FG000|Extension Study Period|Adverse Event|2|||
146590627|NCT02499900|528670816|FG001|Extension Study Period|Adverse Event|4|||
146590628|NCT02499900|528670815|FG000|Extension Study Period|Withdrawal by Subject|5|||
146590629|NCT02499900|528670816|FG001|Extension Study Period|Withdrawal by Subject|2|||
146590630|NCT02499900|528670815|FG000|Extension Study Period|Physician Decision|2|||
146590631|NCT02499900|528670816|FG001|Extension Study Period|Physician Decision|5|||
146590632|NCT02499900|528670815|FG000|Extension Study Period|Pregnancy|1|||
146590633|NCT02499900|528670816|FG001|Extension Study Period|Pregnancy|2|||
146590634|NCT02499900|528670815|FG000|Extension Study Period|Lost to Follow-up|2|||
146590635|NCT02499900|528670816|FG001|Extension Study Period|Lost to Follow-up|5|||
146590636|NCT02499900|528670815|FG000|Extension Study Period|Other|0|||
146590637|NCT02499900|528670816|FG001|Extension Study Period|Other|2|||
146590638|NCT01071200|528670839|FG000|Overall Study|Lack of ovarian response|1|||
146590639|NCT01071200|528670840|FG001|Overall Study|Lack of ovarian response|1|||
146590640|NCT01071200|528670839|FG000|Overall Study|No fertilization|4|||
146590641|NCT01071200|528670840|FG001|Overall Study|No fertilization|0|||
146590642|NCT01071200|528670839|FG000|Overall Study|No oocytes retrieved|1|||
146590643|NCT01071200|528670840|FG001|Overall Study|No oocytes retrieved|1|||
146590644|NCT01071200|528670839|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
146590645|NCT01071200|528670840|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
146590646|NCT01071200|528670839|FG000|Overall Study|No viable embryos|0|||
146590647|NCT01071200|528670840|FG001|Overall Study|No viable embryos|1|||
146590648|NCT00919867|528670843|FG000|First Intervention|Withdrawal by Subject|0|||
146590649|NCT00919867|528670844|FG001|First Intervention|Withdrawal by Subject|0|||
146590650|NCT00919867|528670845|FG002|First Intervention|Withdrawal by Subject|1|||
146590651|NCT00919867|528670846|FG003|First Intervention|Withdrawal by Subject|0|||
146590652|NCT00919867|528670847|FG004|First Intervention|Withdrawal by Subject|0|||
146590653|NCT00919867|528670848|FG005|First Intervention|Withdrawal by Subject|0|||
146590654|NCT00919867|528670843|FG000|First Intervention|Physician Decision|0|||
146590655|NCT00919867|528670844|FG001|First Intervention|Physician Decision|0|||
146590656|NCT00919867|528670845|FG002|First Intervention|Physician Decision|0|||
146590657|NCT00919867|528670846|FG003|First Intervention|Physician Decision|0|||
146590658|NCT00919867|528670847|FG004|First Intervention|Physician Decision|0|||
146590659|NCT00919867|528670848|FG005|First Intervention|Physician Decision|1|||
146590660|NCT02323204|528670854|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
146590661|NCT02323204|528670855|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
146590662|NCT02323204|528670856|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
146590663|NCT02323204|528670857|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
146590664|NCT02323204|528670854|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
146978369|NCT02919475|530084031|FG003|Overall Study|Adverse Event|9|||
146978370|NCT02919475|530084032|FG004|Overall Study|Adverse Event|2|||
146978371|NCT02919475|530084028|FG000|Overall Study|Death|0|||
146590665|NCT02323204|528670855|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
146590666|NCT02323204|528670856|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
146590667|NCT02323204|528670857|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
146590668|NCT02323204|528670854|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
146590669|NCT02323204|528670855|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
146590670|NCT02323204|528670856|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
146590671|NCT02323204|528670857|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
146590672|NCT02323204|528670854|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
146590673|NCT02323204|528670855|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
146590674|NCT02323204|528670856|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
146590675|NCT02323204|528670857|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
146590676|NCT02323204|528670854|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
146590677|NCT02323204|528670855|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
146590678|NCT02323204|528670856|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
146978372|NCT02919475|530084029|FG001|Overall Study|Death|1|||
146771128|NCT03061474|529329850|FG001|Overall Study|Safety Risk|1|||
146771129|NCT03061474|529329849|FG000|Overall Study|Participant unwilling or unable to participate|0|||
146590679|NCT02323204|528670857|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
146590680|NCT02323204|528670854|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
146590681|NCT02323204|528670855|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
146590682|NCT02323204|528670856|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
146590683|NCT02323204|528670857|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
146590684|NCT02323204|528670854|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
146590685|NCT02323204|528670855|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
146590686|NCT02323204|528670856|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
146590687|NCT02323204|528670857|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
146590688|NCT02323204|528670854|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
146590689|NCT02323204|528670855|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
146590690|NCT02323204|528670856|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
146590691|NCT02323204|528670857|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
146590692|NCT02323204|528670854|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
146590693|NCT02323204|528670855|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
146590694|NCT02323204|528670856|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
146590695|NCT02323204|528670857|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
146590696|NCT04508751|528670860|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
146590697|NCT04508751|528670861|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
146590698|NCT04508751|528670862|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
146590699|NCT02752958|528670863|FG000|Overall Study|Adverse Event|3|||
146590700|NCT02752958|528670863|FG000|Overall Study|Lost to Follow-up|1|||
146590701|NCT02752958|528670863|FG000|Overall Study|Protocol Violation|1|||
146590702|NCT02752958|528670863|FG000|Overall Study|Withdrawal by Subject|2|||
146590703|NCT02752958|528670863|FG000|Overall Study|Other (Reason not specified)|2|||
146590704|NCT03023826|528670865|FG000|Period 1|Withdrawal by Subject|0|||
146590705|NCT03023826|528670866|FG001|Period 1|Withdrawal by Subject|0|||
146590706|NCT03023826|528670867|FG002|Period 1|Withdrawal by Subject|0|||
146590707|NCT03023826|528670868|FG003|Period 1|Withdrawal by Subject|0|||
146590708|NCT03023826|528670869|FG004|Period 1|Withdrawal by Subject|1|||
146590709|NCT03023826|528670870|FG005|Period 1|Withdrawal by Subject|0|||
146590710|NCT01646645|528670871|FG000|Overall Study|No Treated|1|||
146590711|NCT01646645|528670871|FG000|Overall Study|Inevaluable Donor|29|||
146590712|NCT00072293|528670872|FG000|Overall Study|Lost to Follow-up|1|||
146590713|NCT00072293|528670873|FG001|Overall Study|Lost to Follow-up|1|||
146590714|NCT00072293|528670872|FG000|Overall Study|Withdrawal by Subject|0|||
146590715|NCT00072293|528670873|FG001|Overall Study|Withdrawal by Subject|1|||
146590716|NCT01896271|528670881|FG000|Overall Study|Physician Decision|10|||
146590717|NCT01514240|528672461|FG000|Overall Study|Adverse Event|4|||
146590718|NCT01514240|528672462|FG001|Overall Study|Adverse Event|4|||
146590719|NCT01514240|528672461|FG000|Overall Study|Subject Decision|2|||
146590720|NCT01514240|528672462|FG001|Overall Study|Subject Decision|7|||
146590721|NCT00509093|528672463|FG000|Overall Study|Adverse Event|10|||
146590722|NCT00509093|528672463|FG000|Overall Study|Disease Progression|9|||
146590723|NCT00509093|528672463|FG000|Overall Study|Transformed into MDS|1|||
146590724|NCT00509093|528672463|FG000|Overall Study|Withdrawal by Subject|3|||
146590725|NCT00509093|528672463|FG000|Overall Study|Physician Decision|1|||
146590726|NCT01103063|528672464|FG000|Overall Study|Adverse Event|3|||
146590727|NCT01103063|528672465|FG001|Overall Study|Adverse Event|1|||
146590728|NCT01103063|528672464|FG000|Overall Study|Lost to Follow-up|68|||
146590729|NCT01103063|528672465|FG001|Overall Study|Lost to Follow-up|51|||
146590730|NCT01103063|528672464|FG000|Overall Study|Withdrawal by Subject|60|||
146771130|NCT03061474|529329850|FG001|Overall Study|Participant unwilling or unable to participate|2|||
146771131|NCT03061474|529329849|FG000|Overall Study|Lost to Follow-up|0|||
146771132|NCT03061474|529329850|FG001|Overall Study|Lost to Follow-up|1|||
146771133|NCT00845832|529329853|FG000|Treatment Period|Adverse Event|0|||
146771134|NCT00845832|529329854|FG001|Treatment Period|Adverse Event|2|||
146771135|NCT00845832|529329855|FG002|Treatment Period|Adverse Event|0|||
146771136|NCT00845832|529329853|FG000|Treatment Period|Protocol Violation|1|||
146771137|NCT00845832|529329854|FG001|Treatment Period|Protocol Violation|1|||
146590731|NCT01103063|528672465|FG001|Overall Study|Withdrawal by Subject|15|||
146590732|NCT01103063|528672464|FG000|Overall Study|Other|16|||
146590733|NCT01103063|528672465|FG001|Overall Study|Other|11|||
146590734|NCT01103063|528672464|FG000|Overall Study|Protocol Violation|1|||
146590735|NCT01103063|528672465|FG001|Overall Study|Protocol Violation|0|||
146590736|NCT01103063|528672464|FG000|Overall Study|Study terminated by Sponsor|326|||
146590737|NCT01103063|528672465|FG001|Overall Study|Study terminated by Sponsor|342|||
146590738|NCT01103063|528672464|FG000|Overall Study|Death|3|||
146590739|NCT01103063|528672465|FG001|Overall Study|Death|1|||
146590740|NCT05320393|528672466|FG000|Overall Study|Withdrawal by Subject|1|||
146590741|NCT05320393|528672467|FG001|Overall Study|Withdrawal by Subject|0|||
146771138|NCT00845832|529329855|FG002|Treatment Period|Protocol Violation|0|||
146771139|NCT00845832|529329853|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
146590742|NCT05320393|528672468|FG002|Overall Study|Withdrawal by Subject|2|||
146590743|NCT05320393|528672466|FG000|Overall Study|Lost to Follow-up|1|||
146590744|NCT05320393|528672467|FG001|Overall Study|Lost to Follow-up|2|||
146652895|NCT03875235|528906865|FG001|Overall Study|Withdrawal by Subject|10|||
146652896|NCT03875235|528906864|FG000|Overall Study|Death|198|||
146652897|NCT03875235|528906865|FG001|Overall Study|Death|223|||
146652898|NCT01395784|528906875|FG000|Overall Study|Lost to Follow-up|7|||
146652899|NCT01395784|528906875|FG000|Overall Study|Withdrawal by Subject|3|||
146652900|NCT01395784|528906875|FG000|Overall Study|Physician Decision|5|||
146652901|NCT05772702|528906876|FG000|Overall Study|Adverse Event|1|||
146652902|NCT04268823|528906877|FG000|Overall Study|Adverse Event|1|||
146652903|NCT04268823|528906878|FG001|Overall Study|Adverse Event|0|||
146652904|NCT04268823|528906877|FG000|Overall Study|Participant Decision|1|||
146652905|NCT04268823|528906878|FG001|Overall Study|Participant Decision|0|||
146652906|NCT00884377|528908099|FG000|Overall Study|Withdrawal by Subject|1|||
146652907|NCT00884377|528908100|FG001|Overall Study|Withdrawal by Subject|0|||
146652908|NCT00884377|528908099|FG000|Overall Study|Could not confirm diagnosis|1|||
146652909|NCT00884377|528908100|FG001|Overall Study|Could not confirm diagnosis|0|||
146652910|NCT00884377|528908099|FG000|Overall Study|Physician Decision|0|||
146652911|NCT00884377|528908100|FG001|Overall Study|Physician Decision|1|||
146652912|NCT05247398|528908104|FG000|Overall Study|Withdrawal by Subject|1|||
146652913|NCT04251156|528908105|FG000|Overall Study|Lost to Follow-up|1|||
146652914|NCT04251156|528908106|FG001|Overall Study|Lost to Follow-up|1|||
146652915|NCT04251156|528908105|FG000|Overall Study|Withdrawal by Subject|4|||
146652916|NCT04251156|528908106|FG001|Overall Study|Withdrawal by Subject|4|||
146652917|NCT04214288|528908107|FG000|Overall Study|Ongoing in the study|41|||
146652918|NCT04214288|528908108|FG001|Overall Study|Ongoing in the study|51|||
146652919|NCT04214288|528908109|FG002|Overall Study|Ongoing in the study|12|||
146652920|NCT04214288|528908110|FG003|Overall Study|Ongoing in the study|39|||
146652921|NCT04214288|528908107|FG000|Overall Study|Adverse Event|1|||
146590745|NCT05320393|528672468|FG002|Overall Study|Lost to Follow-up|1|||
146590746|NCT05320393|528672466|FG000|Overall Study|Moved; too much driving|0|||
146590747|NCT05320393|528672467|FG001|Overall Study|Moved; too much driving|0|||
146590748|NCT05320393|528672468|FG002|Overall Study|Moved; too much driving|2|||
146590749|NCT05320393|528672466|FG000|Overall Study|Did not receive treatment|0|||
146590750|NCT05320393|528672467|FG001|Overall Study|Did not receive treatment|0|||
146590751|NCT05320393|528672468|FG002|Overall Study|Did not receive treatment|1|||
146590752|NCT03283098|528672469|FG000|Overall Study|Withdrawal by Subject|0|||
146590753|NCT03283098|528672470|FG001|Overall Study|Withdrawal by Subject|1|||
146590754|NCT00798317|528672471|FG000|Overall Study|Physician Decision|0|||
146590755|NCT00798317|528672472|FG001|Overall Study|Physician Decision|1|||
146590756|NCT00798317|528672471|FG000|Overall Study|Withdrawal by Subject|5|||
146590757|NCT00798317|528672472|FG001|Overall Study|Withdrawal by Subject|4|||
146590758|NCT00798317|528672471|FG000|Overall Study|Lost to Follow-up|2|||
146590759|NCT00798317|528672472|FG001|Overall Study|Lost to Follow-up|2|||
146590760|NCT00798317|528672471|FG000|Overall Study|Adverse Event|2|||
146590761|NCT00798317|528672472|FG001|Overall Study|Adverse Event|0|||
146590762|NCT00798317|528672471|FG000|Overall Study|Death|1|||
146590763|NCT00798317|528672472|FG001|Overall Study|Death|0|||
146590764|NCT01069861|528672474|FG000|Overall Study|Death|1|||
146590765|NCT01069861|528672474|FG000|Overall Study|Adverse Event|1|||
146590766|NCT01069861|528672474|FG000|Overall Study|Did not meet entrance criteria|1|||
146590767|NCT01187446|528672475|FG000|Overall Study|Patient started non-protocol therapy|0|||
146590768|NCT01187446|528672476|FG001|Overall Study|Patient started non-protocol therapy|1|||
146590769|NCT00823212|528672477|FG000|Overall Study|Death|8|||
146590770|NCT00823212|528672478|FG001|Overall Study|Death|10|||
146590771|NCT00823212|528672477|FG000|Overall Study|Withdrawal by Subject|6|||
146590772|NCT00823212|528672478|FG001|Overall Study|Withdrawal by Subject|1|||
146590773|NCT00823212|528672477|FG000|Overall Study|Incarcerated|0|||
146590774|NCT00823212|528672478|FG001|Overall Study|Incarcerated|1|||
146590775|NCT00823212|528672477|FG000|Overall Study|Missed 12-month visit|21|||
146652922|NCT04214288|528908108|FG001|Overall Study|Adverse Event|0|||
146652923|NCT04214288|528908109|FG002|Overall Study|Adverse Event|0|||
146652924|NCT04214288|528908110|FG003|Overall Study|Adverse Event|0|||
146652925|NCT04214288|528908107|FG000|Overall Study|Death|22|||
146590776|NCT00823212|528672478|FG001|Overall Study|Missed 12-month visit|21|||
146652926|NCT04214288|528908108|FG001|Overall Study|Death|13|||
146652927|NCT04214288|528908109|FG002|Overall Study|Death|7|||
146652928|NCT04214288|528908110|FG003|Overall Study|Death|19|||
146590777|NCT00496197|528672479|FG000|Overall Study|Discontinued study due to death|43|||
146590778|NCT00496197|528672479|FG000|Overall Study|Adverse Event|13|||
146590779|NCT00496197|528672479|FG000|Overall Study|Does not meet entrance criteria|5|||
146590780|NCT00496197|528672479|FG000|Overall Study|Insufficient clinical response|3|||
146590781|NCT00496197|528672479|FG000|Overall Study|Insufficient bacteriological response|10|||
146590782|NCT00496197|528672479|FG000|Overall Study|Lost to Follow-up|11|||
146652929|NCT04214288|528908107|FG000|Overall Study|Lost to Follow-up|1|||
146590783|NCT00496197|528672479|FG000|Overall Study|Withdrawal by Subject|11|||
146590784|NCT00496197|528672479|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
146590785|NCT00496197|528672479|FG000|Overall Study|Other|14|||
146590786|NCT00496197|528672479|FG000|Overall Study|Protocol Violation|8|||
146590787|NCT04431713|528672480|FG000|Overall Study|Withdrawal by Subject|2|||
146590788|NCT04431713|528672481|FG001|Overall Study|Withdrawal by Subject|0|||
146590789|NCT04431713|528672480|FG000|Overall Study|Death|2|||
146590790|NCT04431713|528672481|FG001|Overall Study|Death|2|||
146590791|NCT00149994|528672482|FG000|Overall Study|Administrative problems:|1|||
146590792|NCT00149994|528672483|FG001|Overall Study|Administrative problems:|0|||
146590793|NCT00149994|528672482|FG000|Overall Study|Protocol Violation|0|||
146590794|NCT00149994|528672483|FG001|Overall Study|Protocol Violation|1|||
146590795|NCT01344538|528672484|FG000|Overall Study|Adverse Event|1|||
146590796|NCT01344538|528672485|FG001|Overall Study|Adverse Event|1|||
146590797|NCT01344538|528672484|FG000|Overall Study|Lost to Follow-up|1|||
146590798|NCT01344538|528672485|FG001|Overall Study|Lost to Follow-up|0|||
146590799|NCT01655381|528672488|FG000|Overall Study|Investigator Decision|1|||
146590800|NCT01655381|528672488|FG000|Overall Study|Moved to Another City|1|||
146590801|NCT01655381|528672488|FG000|Overall Study|Insufficient Treatment Response|1|||
146590802|NCT02324205|528672489|FG000|Overall Study|Withdrawal by Subject|37|||
146590803|NCT04195438|528672490|FG000|Overall Study|Withdrawal by Subject|1|||
146590804|NCT00613925|528672495|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
146590805|NCT00613925|528672496|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
146590806|NCT03136497|528672497|FG000|Overall Study|Screen Failure|1|||
146590807|NCT03136497|528672498|FG001|Overall Study|Screen Failure|0|||
146590808|NCT03136497|528672499|FG002|Overall Study|Screen Failure|0|||
146590809|NCT00856206|528672501|FG000|Overall Study|Protocol Violation|6|||
146590810|NCT00856206|528672502|FG001|Overall Study|Protocol Violation|18|||
146590811|NCT00856206|528672501|FG000|Overall Study|Adverse Event|10|||
146590812|NCT00856206|528672502|FG001|Overall Study|Adverse Event|46|||
146590813|NCT00856206|528672501|FG000|Overall Study|Lack of Efficacy|1|||
146590814|NCT00856206|528672502|FG001|Overall Study|Lack of Efficacy|2|||
146590815|NCT00856206|528672501|FG000|Overall Study|Withdrawal by Subject|15|||
146590816|NCT00856206|528672502|FG001|Overall Study|Withdrawal by Subject|36|||
146590817|NCT00856206|528672501|FG000|Overall Study|Lost to Follow-up|13|||
146590818|NCT00856206|528672502|FG001|Overall Study|Lost to Follow-up|39|||
146590819|NCT00856206|528672501|FG000|Overall Study|Death|2|||
146590820|NCT00856206|528672502|FG001|Overall Study|Death|2|||
146590821|NCT00856206|528672501|FG000|Overall Study|Decision by the Sponsor|4|||
146590822|NCT00856206|528672502|FG001|Overall Study|Decision by the Sponsor|8|||
146590823|NCT00856206|528672501|FG000|Overall Study|Other than specified above|3|||
146590824|NCT00856206|528672502|FG001|Overall Study|Other than specified above|10|||
146590825|NCT04584346|528672514|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
146590826|NCT04584346|528672515|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
146590827|NCT03640052|528672520|FG000|Overall Study|Lost to Follow-up|0|||
146590828|NCT03640052|528672521|FG001|Overall Study|Lost to Follow-up|1|||
146590829|NCT03640052|528672522|FG002|Overall Study|Lost to Follow-up|0|||
146590830|NCT03640052|528672523|FG003|Overall Study|Lost to Follow-up|0|||
146590831|NCT03640052|528672524|FG004|Overall Study|Lost to Follow-up|0|||
146590832|NCT05479097|528672525|FG000|Overall Study|Withdrawal by Subject|2|||
146590833|NCT01779869|528672528|FG000|Overall Study|Physician Decision|2|||
146590834|NCT00957944|528672531|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
146590835|NCT00957944|528672532|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
146590836|NCT01482169|528672534|FG000|Overall Study|Physician Decision|2|||
146590837|NCT03385265|528672552|FG000|Overall Study|Withdrawal by Subject|5|||
146590838|NCT03385265|528672553|FG001|Overall Study|Withdrawal by Subject|2|||
146590839|NCT03385265|528672554|FG002|Overall Study|Withdrawal by Subject|5|||
146590840|NCT03385265|528672555|FG003|Overall Study|Withdrawal by Subject|2|||
146590841|NCT03220581|528672556|FG000|Overall Study|Withdrawal by Subject|0|||
146590842|NCT03220581|528672557|FG001|Overall Study|Withdrawal by Subject|1|||
146590843|NCT03220581|528672556|FG000|Overall Study|Lost to Follow-up|3|||
146590844|NCT03220581|528672557|FG001|Overall Study|Lost to Follow-up|6|||
146590845|NCT02434354|528672558|FG000|Overall Study|screen fail|3|||
146590846|NCT03730961|528672559|FG000|Overall Study|Adverse Event|0|||
146590847|NCT03730961|528672560|FG001|Overall Study|Adverse Event|1|||
146590848|NCT01920893|528672561|FG000|Overall Study|Adverse Event|5|||
146590849|NCT01920893|528672562|FG001|Overall Study|Adverse Event|2|||
146590850|NCT01920893|528672561|FG000|Overall Study|Lack of Efficacy|2|||
146590851|NCT01920893|528672562|FG001|Overall Study|Lack of Efficacy|0|||
146590852|NCT03576755|528672563|FG000|Overall Study|Withdrawal by Subject|1|||
146590853|NCT03576755|528672564|FG001|Overall Study|Withdrawal by Subject|0|||
146590854|NCT03576755|528672565|FG002|Overall Study|Withdrawal by Subject|0|||
146590855|NCT03576755|528672566|FG003|Overall Study|Withdrawal by Subject|0|||
146590856|NCT01767493|528672567|FG000|Overall Study|screen failures|3|||
146590857|NCT00853125|528672568|FG000|Overall Study|Study participant's donor was CMV +|1|||
146590858|NCT03746600|528672569|FG000|Overall Study|Withdrawal by Subject|3|||
146590859|NCT03746600|528672570|FG001|Overall Study|Withdrawal by Subject|3|||
146590860|NCT03746600|528672569|FG000|Overall Study|dismissed from study|1|||
146590861|NCT03746600|528672570|FG001|Overall Study|dismissed from study|0|||
146590862|NCT03746600|528672569|FG000|Overall Study|Lost to Follow-up|1|||
146978373|NCT02919475|530084030|FG002|Overall Study|Death|0|||
146590863|NCT03746600|528672570|FG001|Overall Study|Lost to Follow-up|0|||
146590864|NCT00884039|528672571|FG000|Overall Study|Withdrawal by Subject|0|||
146590865|NCT00884039|528672572|FG001|Overall Study|Withdrawal by Subject|1|||
146590866|NCT00884039|528672571|FG000|Overall Study|Lack of Efficacy|2|||
146590867|NCT00884039|528672572|FG001|Overall Study|Lack of Efficacy|0|||
146590868|NCT04209114|528672575|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
146590869|NCT04209114|528672576|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
146590870|NCT04209114|528672577|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
146590871|NCT04209114|528672575|FG000|Pre-Treatment Phase|Other reasons|0|||
146590872|NCT04209114|528672576|FG001|Pre-Treatment Phase|Other reasons|0|||
146590873|NCT04209114|528672577|FG002|Pre-Treatment Phase|Other reasons|1|||
146590874|NCT04209114|528672575|FG000|Pre-Treatment Phase|Death|0|||
146590875|NCT04209114|528672576|FG001|Pre-Treatment Phase|Death|0|||
146590876|NCT04209114|528672577|FG002|Pre-Treatment Phase|Death|1|||
146590877|NCT04209114|528672575|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
146590878|NCT04209114|528672576|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
146590879|NCT04209114|528672577|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
146590880|NCT04209114|528672575|FG000|Treatment Phase|Other reasons|5|||
146590881|NCT04209114|528672576|FG001|Treatment Phase|Other reasons|3|||
146590882|NCT04209114|528672577|FG002|Treatment Phase|Other reasons|0|||
146590883|NCT04209114|528672575|FG000|Treatment Phase|Lost to Follow-up|1|||
146590884|NCT04209114|528672576|FG001|Treatment Phase|Lost to Follow-up|0|||
146590885|NCT04209114|528672577|FG002|Treatment Phase|Lost to Follow-up|0|||
146590886|NCT04209114|528672575|FG000|Treatment Phase|Participant withdrew consent|1|||
146590887|NCT04209114|528672576|FG001|Treatment Phase|Participant withdrew consent|0|||
146590888|NCT04209114|528672577|FG002|Treatment Phase|Participant withdrew consent|0|||
146590889|NCT04209114|528672575|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
146590890|NCT04209114|528672576|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
146590891|NCT04209114|528672577|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
146590892|NCT04209114|528672575|FG000|Treatment Phase|Death|4|||
146590893|NCT04209114|528672576|FG001|Treatment Phase|Death|1|||
146590894|NCT04209114|528672577|FG002|Treatment Phase|Death|0|||
146590895|NCT04209114|528672575|FG000|Treatment Phase|Study drug toxicity|4|||
146590896|NCT04209114|528672576|FG001|Treatment Phase|Study drug toxicity|6|||
146590897|NCT04209114|528672577|FG002|Treatment Phase|Study drug toxicity|0|||
146590898|NCT04209114|528672575|FG000|Treatment Phase|Disease progression|6|||
146590899|NCT04209114|528672576|FG001|Treatment Phase|Disease progression|9|||
146590900|NCT04209114|528672577|FG002|Treatment Phase|Disease progression|0|||
146590901|NCT00405964|528672579|FG000|Overall Study|Treatment Failure|17|||
146590902|NCT00405964|528672580|FG001|Overall Study|Treatment Failure|45|||
146590903|NCT00405964|528672579|FG000|Overall Study|Adverse Event|7|||
146590904|NCT00405964|528672580|FG001|Overall Study|Adverse Event|16|||
146590905|NCT00405964|528672579|FG000|Overall Study|Lost to Follow-up|5|||
146590906|NCT00405964|528672580|FG001|Overall Study|Lost to Follow-up|5|||
146590907|NCT00405964|528672579|FG000|Overall Study|Withdrawal by Subject|19|||
146590908|NCT00405964|528672580|FG001|Overall Study|Withdrawal by Subject|23|||
146590909|NCT00405964|528672579|FG000|Overall Study|Protocol Violation|11|||
146590910|NCT00405964|528672580|FG001|Overall Study|Protocol Violation|6|||
146590911|NCT02981407|528672583|FG000|Overall Study|Withdrawal by Subject|2|||
146590912|NCT02981407|528672584|FG001|Overall Study|Withdrawal by Subject|0|||
146590913|NCT01300819|528672587|FG000|Overall Study|Adverse Event|9|||
146590914|NCT01300819|528672588|FG001|Overall Study|Adverse Event|27|||
146590915|NCT01300819|528672587|FG000|Overall Study|Lack of Efficacy|2|||
146590916|NCT01300819|528672588|FG001|Overall Study|Lack of Efficacy|1|||
146978374|NCT02919475|530084031|FG003|Overall Study|Death|0|||
146590917|NCT01300819|528672587|FG000|Overall Study|Withdrawal by Subject|10|||
146590918|NCT01300819|528672588|FG001|Overall Study|Withdrawal by Subject|12|||
146590919|NCT01300819|528672587|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
146590920|NCT01300819|528672588|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
146590921|NCT01300819|528672587|FG000|Overall Study|Refusal to down titrate study drug|0|||
146590922|NCT01300819|528672588|FG001|Overall Study|Refusal to down titrate study drug|1|||
146590923|NCT01300819|528672587|FG000|Overall Study|Administrative reason|0|||
146652930|NCT04214288|528908108|FG001|Overall Study|Lost to Follow-up|2|||
146652931|NCT04214288|528908109|FG002|Overall Study|Lost to Follow-up|1|||
146652932|NCT04214288|528908110|FG003|Overall Study|Lost to Follow-up|0|||
146590924|NCT01300819|528672588|FG001|Overall Study|Administrative reason|1|||
146590925|NCT01300819|528672587|FG000|Overall Study|Safety follow up not done by mistake|0|||
146590926|NCT01300819|528672588|FG001|Overall Study|Safety follow up not done by mistake|1|||
146590927|NCT01300819|528672587|FG000|Overall Study|Follow up call was not done|1|||
146590928|NCT01300819|528672588|FG001|Overall Study|Follow up call was not done|0|||
146590929|NCT02818036|528672594|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
146590930|NCT02818036|528672595|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
146590931|NCT02818036|528672594|FG000|Overall Study|Withdrawal by Subject|1|||
146652933|NCT04214288|528908107|FG000|Overall Study|Other|1|||
146590932|NCT02818036|528672595|FG001|Overall Study|Withdrawal by Subject|0|||
146590933|NCT01319721|528672602|FG000|Overall Study|Lost to Follow-up|1|||
146590934|NCT01319721|528672603|FG001|Overall Study|Lost to Follow-up|6|||
146590935|NCT00468845|528672605|FG000|Overall Study|Adverse Event|9|||
146590936|NCT00468845|528672606|FG001|Overall Study|Adverse Event|14|||
146590937|NCT00468845|528672607|FG002|Overall Study|Adverse Event|11|||
146771140|NCT00845832|529329854|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
146771141|NCT00845832|529329855|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
146771142|NCT00845832|529329853|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
146771143|NCT00845832|529329854|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
146771144|NCT00845832|529329855|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
146771145|NCT01391130|529329856|FG000|Overall Study|Withdrawal by Subject|3|||
146771146|NCT01391130|529329857|FG001|Overall Study|Withdrawal by Subject|2|||
146771147|NCT01391130|529329856|FG000|Overall Study|Physician Decision|2|||
146771148|NCT01391130|529329857|FG001|Overall Study|Physician Decision|3|||
146771149|NCT01391130|529329856|FG000|Overall Study|Did not Receive Drug|1|||
146771150|NCT01391130|529329857|FG001|Overall Study|Did not Receive Drug|1|||
146771151|NCT00189202|529329858|FG000|Overall Study|Physician Decision|5|||
146771152|NCT00668863|529329859|FG000|Overall Study|Objective Progression or Relapse|42|||
146771153|NCT00668863|529329859|FG000|Overall Study|Adverse Event|13|||
146771154|NCT00668863|529329859|FG000|Overall Study|Study Terminated by Sponsor|8|||
146771155|NCT00668863|529329859|FG000|Overall Study|Global Deterioration of Health Status|4|||
146771156|NCT00668863|529329859|FG000|Overall Study|Withdrawal by Subject|1|||
146771157|NCT00668863|529329859|FG000|Overall Study|Surgery|1|||
146771158|NCT00668863|529329859|FG000|Overall Study|Subject's work scheduling problem|1|||
146771159|NCT00668863|529329859|FG000|Overall Study|Physician Decision|1|||
146771160|NCT00869323|529329862|FG000|Maintenance Therapy|concurrent illness|1|||
146771161|NCT01068743|529329865|FG000|Period 3|Adverse Event|0|||
146771162|NCT01068743|529329866|FG001|Period 3|Adverse Event|1|||
146771163|NCT01068743|529329867|FG002|Period 3|Adverse Event|0|||
146771164|NCT01068743|529329868|FG003|Period 3|Adverse Event|0|||
146771165|NCT00638963|529329869|FG000|Overall Study|Withdrawal by Subject|1|||
146771166|NCT00638963|529329870|FG001|Overall Study|Withdrawal by Subject|0|||
146771167|NCT02423291|529329880|FG000|Overall Study|Lack of Efficacy|14|||
146771168|NCT02423291|529329880|FG000|Overall Study|Adverse Event|1|||
146771169|NCT04975308|529329885|FG000|Overall Study|Withdrawal by Subject|6|||
146771170|NCT04975308|529329886|FG001|Overall Study|Withdrawal by Subject|16|||
146771171|NCT04975308|529329887|FG002|Overall Study|Withdrawal by Subject|6|||
146771172|NCT04975308|529329885|FG000|Overall Study|Physician Decision|0|||
146771173|NCT04975308|529329886|FG001|Overall Study|Physician Decision|3|||
146771174|NCT04975308|529329887|FG002|Overall Study|Physician Decision|1|||
146771175|NCT04975308|529329885|FG000|Overall Study|Adverse Event|10|||
146771176|NCT04975308|529329886|FG001|Overall Study|Adverse Event|1|||
146771177|NCT04975308|529329887|FG002|Overall Study|Adverse Event|12|||
146771178|NCT04975308|529329885|FG000|Overall Study|On study treatment (Ongoing)|65|||
146771179|NCT04975308|529329886|FG001|Overall Study|On study treatment (Ongoing)|43|||
146771180|NCT04975308|529329887|FG002|Overall Study|On study treatment (Ongoing)|75|||
146771181|NCT04975308|529329885|FG000|Overall Study|Protocol Deviation|4|||
146771182|NCT04975308|529329886|FG001|Overall Study|Protocol Deviation|3|||
146771183|NCT04975308|529329887|FG002|Overall Study|Protocol Deviation|2|||
146771184|NCT00658996|529329888|FG000|First Intervention|Positive slit lamp finding|1|||
146771185|NCT00658996|529329889|FG001|First Intervention|Positive slit lamp finding|0|||
146771186|NCT00658996|529329888|FG000|First Intervention|Lack of lenses|0|||
146771187|NCT00658996|529329889|FG001|First Intervention|Lack of lenses|1|||
146771188|NCT00658996|529329888|FG000|Crossover Period|Physician Decision|1|||
146771189|NCT00658996|529329889|FG001|Crossover Period|Physician Decision|0|||
146771190|NCT00658996|529329888|FG000|Crossover Period|Ineligible|1|||
146771191|NCT00658996|529329889|FG001|Crossover Period|Ineligible|1|||
146771192|NCT00658996|529329888|FG000|Second Intervention|Developed a stye on upper lid|1|||
146771193|NCT00658996|529329889|FG001|Second Intervention|Developed a stye on upper lid|0|||
146771194|NCT00658996|529329888|FG000|Second Intervention|Positive slit lamp finding|0|||
146771195|NCT00658996|529329889|FG001|Second Intervention|Positive slit lamp finding|1|||
146771196|NCT02994654|529329891|FG000|Overall Study|Lost to Follow-up|1|||
146771197|NCT01810263|529329894|FG000|Overall Study|Lost to Follow-up|8|||
146978375|NCT02919475|530084032|FG004|Overall Study|Death|0|||
146771198|NCT01810263|529329895|FG001|Overall Study|Lost to Follow-up|7|||
146771199|NCT01353963|529329896|FG000|Overall Study|Adverse Event|2|||
146771200|NCT01121549|529329897|FG000|Overall Study|Adverse Event|10|||
146771201|NCT01121549|529329897|FG000|Overall Study|Lack of Efficacy|11|||
146771202|NCT01121549|529329897|FG000|Overall Study|Lost to Follow-up|12|||
146771203|NCT01121549|529329897|FG000|Overall Study|Did not meet entrance criteria|9|||
146771204|NCT01121549|529329897|FG000|Overall Study|Study terminated by sponsor|197|||
146771205|NCT01121549|529329897|FG000|Overall Study|Pregnancy|1|||
146771206|NCT01121549|529329897|FG000|Overall Study|Protocol Violation|33|||
146771207|NCT01121549|529329897|FG000|Overall Study|Withdrawal by Subject|16|||
146590938|NCT00468845|528672605|FG000|Overall Study|Lost to Follow-up|2|||
146771208|NCT01121549|529329897|FG000|Overall Study|Other|58|||
146771209|NCT01662336|529331109|FG000|Overall Study|Adverse Event|1|||
146771210|NCT01662336|529331109|FG000|Overall Study|No longer on LPV/r|30|||
146771211|NCT01662336|529331109|FG000|Overall Study|Other|29|||
146771212|NCT01662336|529331109|FG000|Overall Study|Withdrawal by Subject|6|||
146771213|NCT02189252|529331110|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
146771214|NCT02189252|529331111|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
146771215|NCT02189252|529331112|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
146771216|NCT02189252|529331113|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
146771217|NCT02189252|529331110|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
146771218|NCT02189252|529331111|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
146771219|NCT02189252|529331112|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
146771220|NCT02189252|529331113|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
146771221|NCT00566735|529331114|FG000|Overall Study|Withdrawal by Subject|0|||
146771222|NCT00566735|529331115|FG001|Overall Study|Withdrawal by Subject|1|||
146771223|NCT00566735|529331114|FG000|Overall Study|Refused neuropsychological testing|2|||
146771224|NCT00566735|529331115|FG001|Overall Study|Refused neuropsychological testing|5|||
146771225|NCT00566735|529331114|FG000|Overall Study|Switched into a manic episode|0|||
146771226|NCT00566735|529331115|FG001|Overall Study|Switched into a manic episode|1|||
146771227|NCT04603924|529331116|FG000|Overall Study|Not Dosed|2|||
146771228|NCT04603924|529331117|FG001|Overall Study|Not Dosed|1|||
146771229|NCT04603924|529331116|FG000|Overall Study|Withdrawal by Subject|6|||
146771230|NCT04603924|529331117|FG001|Overall Study|Withdrawal by Subject|6|||
146771231|NCT04603924|529331116|FG000|Overall Study|Adverse Event|2|||
146771232|NCT04603924|529331117|FG001|Overall Study|Adverse Event|2|||
146771233|NCT02731755|529331124|FG000|First Intervention|Withdrawal by Subject|0|||
146771234|NCT02731755|529331125|FG001|First Intervention|Withdrawal by Subject|2|||
146771235|NCT01460446|529331126|FG000|Overall Study|Non-compliance|2|||
146771236|NCT01460446|529331127|FG001|Overall Study|Non-compliance|9|||
146590939|NCT00468845|528672606|FG001|Overall Study|Lost to Follow-up|1|||
146590940|NCT00468845|528672607|FG002|Overall Study|Lost to Follow-up|2|||
146590941|NCT00468845|528672605|FG000|Overall Study|Other|4|||
146590942|NCT00468845|528672606|FG001|Overall Study|Other|9|||
146590943|NCT00468845|528672607|FG002|Overall Study|Other|5|||
146590944|NCT00468845|528672605|FG000|Overall Study|No longer willing to participate|5|||
146590945|NCT00468845|528672606|FG001|Overall Study|No longer willing to participate|6|||
146590946|NCT00468845|528672607|FG002|Overall Study|No longer willing to participate|10|||
146590947|NCT00468845|528672605|FG000|Overall Study|Randomized, not treated|1|||
146590948|NCT00468845|528672606|FG001|Overall Study|Randomized, not treated|4|||
146590949|NCT00468845|528672607|FG002|Overall Study|Randomized, not treated|2|||
146590950|NCT00461305|528672608|FG000|Treatment|Adverse Event|26|||
146590951|NCT00461305|528672609|FG001|Treatment|Adverse Event|3|||
146590952|NCT00461305|528672608|FG000|Treatment|Lost to Follow-up|4|||
146590953|NCT00461305|528672609|FG001|Treatment|Lost to Follow-up|2|||
146590954|NCT00461305|528672608|FG000|Treatment|Protocol Violation|13|||
146590955|NCT00461305|528672609|FG001|Treatment|Protocol Violation|2|||
146590956|NCT00461305|528672608|FG000|Treatment|Withdrawal by Subject|48|||
146590957|NCT00461305|528672609|FG001|Treatment|Withdrawal by Subject|2|||
146590958|NCT00461305|528672608|FG000|Treatment|Never dispensed|5|||
146590959|NCT00461305|528672609|FG001|Treatment|Never dispensed|0|||
146590960|NCT00461305|528672608|FG000|Treatment|Study drug not taken|1|||
146590961|NCT00461305|528672609|FG001|Treatment|Study drug not taken|0|||
146590962|NCT00461305|528672608|FG000|Treatment|Partially missing diary|2|||
146590963|NCT00461305|528672609|FG001|Treatment|Partially missing diary|0|||
146590964|NCT00461305|528672608|FG000|Treatment|Other (missing drug etc)|2|||
146590965|NCT00461305|528672609|FG001|Treatment|Other (missing drug etc)|0|||
146590966|NCT00461305|528672608|FG000|Continued Treatment|Adverse Event|26|||
146590967|NCT00461305|528672609|FG001|Continued Treatment|Adverse Event|0|||
146590968|NCT00461305|528672608|FG000|Continued Treatment|Lost to Follow-up|4|||
146590969|NCT00461305|528672609|FG001|Continued Treatment|Lost to Follow-up|0|||
146590970|NCT00461305|528672608|FG000|Continued Treatment|Protocol Violation|13|||
146590971|NCT00461305|528672609|FG001|Continued Treatment|Protocol Violation|0|||
146590972|NCT00461305|528672608|FG000|Continued Treatment|Withdrawal by Subject|48|||
146590973|NCT00461305|528672609|FG001|Continued Treatment|Withdrawal by Subject|0|||
146590974|NCT00461305|528672608|FG000|Continued Treatment|Partially missing diary|2|||
146590975|NCT00461305|528672609|FG001|Continued Treatment|Partially missing diary|0|||
146590976|NCT00461305|528672608|FG000|Continued Treatment|Other (missing drug etc)|2|||
146590977|NCT00461305|528672609|FG001|Continued Treatment|Other (missing drug etc)|0|||
146590978|NCT00549900|528674780|FG000|Overall Study|Adverse Event|1|||
146771237|NCT01460446|529331126|FG000|Overall Study|Consent Withdrawn|0|||
146771238|NCT01460446|529331127|FG001|Overall Study|Consent Withdrawn|4|||
146771239|NCT01460446|529331126|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
146771240|NCT01460446|529331127|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
146771241|NCT01460446|529331126|FG000|Overall Study|Surgery/Illness|1|||
146771242|NCT01460446|529331127|FG001|Overall Study|Surgery/Illness|1|||
146771243|NCT01460446|529331126|FG000|Overall Study|Pregnancy|1|||
146590979|NCT02210832|528674782|FG000|Overall Study|Pregnancy termination .|3|||
146590980|NCT02210832|528674783|FG001|Overall Study|Pregnancy termination .|4|||
146590981|NCT02210832|528674784|FG002|Overall Study|Pregnancy termination .|1|||
146590982|NCT02210832|528674782|FG000|Overall Study|Lost to Follow-up|26|||
146652934|NCT04214288|528908108|FG001|Overall Study|Other|2|||
146590983|NCT02210832|528674783|FG001|Overall Study|Lost to Follow-up|32|||
146590984|NCT02210832|528674784|FG002|Overall Study|Lost to Follow-up|17|||
146590985|NCT02754141|528674789|FG000|Overall Study|Disease progression|11|||
146590986|NCT02754141|528674790|FG001|Overall Study|Disease progression|7|||
146590987|NCT02754141|528674791|FG002|Overall Study|Disease progression|8|||
146590988|NCT02754141|528674792|FG003|Overall Study|Disease progression|5|||
146590989|NCT02754141|528674793|FG004|Overall Study|Disease progression|7|||
146590990|NCT02754141|528674794|FG005|Overall Study|Disease progression|7|||
146590991|NCT02754141|528674795|FG006|Overall Study|Disease progression|7|||
146590992|NCT02754141|528674796|FG007|Overall Study|Disease progression|6|||
146590993|NCT02754141|528674797|FG008|Overall Study|Disease progression|11|||
146590994|NCT02754141|528674798|FG009|Overall Study|Disease progression|16|||
146590995|NCT02754141|528674799|FG010|Overall Study|Disease progression|18|||
146590996|NCT02754141|528674800|FG011|Overall Study|Disease progression|13|||
146590997|NCT02754141|528674801|FG012|Overall Study|Disease progression|10|||
146590998|NCT02754141|528674802|FG013|Overall Study|Disease progression|12|||
146590999|NCT02754141|528674803|FG014|Overall Study|Disease progression|12|||
146591000|NCT02754141|528674804|FG015|Overall Study|Disease progression|14|||
146591001|NCT02754141|528674805|FG016|Overall Study|Disease progression|0|||
146591002|NCT02754141|528674806|FG017|Overall Study|Disease progression|1|||
146591003|NCT02754141|528674789|FG000|Overall Study|Study drug toxicity|1|||
146591004|NCT02754141|528674790|FG001|Overall Study|Study drug toxicity|1|||
146591005|NCT02754141|528674791|FG002|Overall Study|Study drug toxicity|0|||
146591006|NCT02754141|528674792|FG003|Overall Study|Study drug toxicity|0|||
146591007|NCT02754141|528674793|FG004|Overall Study|Study drug toxicity|0|||
146591008|NCT02754141|528674794|FG005|Overall Study|Study drug toxicity|0|||
146591009|NCT02754141|528674795|FG006|Overall Study|Study drug toxicity|0|||
146591010|NCT02754141|528674796|FG007|Overall Study|Study drug toxicity|0|||
146591011|NCT02754141|528674797|FG008|Overall Study|Study drug toxicity|0|||
146591012|NCT02754141|528674798|FG009|Overall Study|Study drug toxicity|0|||
146591013|NCT02754141|528674799|FG010|Overall Study|Study drug toxicity|2|||
146591014|NCT02754141|528674800|FG011|Overall Study|Study drug toxicity|1|||
146591015|NCT02754141|528674801|FG012|Overall Study|Study drug toxicity|1|||
146591016|NCT02754141|528674802|FG013|Overall Study|Study drug toxicity|0|||
146591017|NCT02754141|528674803|FG014|Overall Study|Study drug toxicity|0|||
146591018|NCT02754141|528674804|FG015|Overall Study|Study drug toxicity|0|||
146591019|NCT02754141|528674805|FG016|Overall Study|Study drug toxicity|0|||
146591020|NCT02754141|528674806|FG017|Overall Study|Study drug toxicity|0|||
146591021|NCT02754141|528674789|FG000|Overall Study|AE unrelated to study drug|1|||
146591022|NCT02754141|528674790|FG001|Overall Study|AE unrelated to study drug|1|||
146591023|NCT02754141|528674791|FG002|Overall Study|AE unrelated to study drug|0|||
146591024|NCT02754141|528674792|FG003|Overall Study|AE unrelated to study drug|1|||
146591025|NCT02754141|528674793|FG004|Overall Study|AE unrelated to study drug|3|||
146591026|NCT02754141|528674794|FG005|Overall Study|AE unrelated to study drug|2|||
146591027|NCT02754141|528674795|FG006|Overall Study|AE unrelated to study drug|1|||
146591028|NCT02754141|528674796|FG007|Overall Study|AE unrelated to study drug|0|||
146591029|NCT02754141|528674797|FG008|Overall Study|AE unrelated to study drug|0|||
146591030|NCT02754141|528674798|FG009|Overall Study|AE unrelated to study drug|0|||
146591031|NCT02754141|528674799|FG010|Overall Study|AE unrelated to study drug|0|||
146591032|NCT02754141|528674800|FG011|Overall Study|AE unrelated to study drug|0|||
146591033|NCT02754141|528674801|FG012|Overall Study|AE unrelated to study drug|0|||
146591034|NCT02754141|528674802|FG013|Overall Study|AE unrelated to study drug|0|||
146591035|NCT02754141|528674803|FG014|Overall Study|AE unrelated to study drug|0|||
146591036|NCT02754141|528674804|FG015|Overall Study|AE unrelated to study drug|0|||
146591037|NCT02754141|528674805|FG016|Overall Study|AE unrelated to study drug|0|||
146591038|NCT02754141|528674806|FG017|Overall Study|AE unrelated to study drug|0|||
146591039|NCT02754141|528674789|FG000|Overall Study|Request to discontinue|0|||
146652935|NCT04214288|528908109|FG002|Overall Study|Other|0|||
146652936|NCT04214288|528908110|FG003|Overall Study|Other|6|||
146652937|NCT04214288|528908107|FG000|Overall Study|Protocol Violation|0|||
146652938|NCT04214288|528908108|FG001|Overall Study|Protocol Violation|1|||
146591040|NCT02754141|528674790|FG001|Overall Study|Request to discontinue|0|||
146591041|NCT02754141|528674791|FG002|Overall Study|Request to discontinue|0|||
146591042|NCT02754141|528674792|FG003|Overall Study|Request to discontinue|0|||
146591043|NCT02754141|528674793|FG004|Overall Study|Request to discontinue|0|||
146591044|NCT02754141|528674794|FG005|Overall Study|Request to discontinue|0|||
146591045|NCT02754141|528674795|FG006|Overall Study|Request to discontinue|0|||
146591046|NCT02754141|528674796|FG007|Overall Study|Request to discontinue|0|||
146591047|NCT02754141|528674797|FG008|Overall Study|Request to discontinue|1|||
146591048|NCT02754141|528674798|FG009|Overall Study|Request to discontinue|0|||
146591049|NCT02754141|528674799|FG010|Overall Study|Request to discontinue|0|||
146591050|NCT02754141|528674800|FG011|Overall Study|Request to discontinue|0|||
146591051|NCT02754141|528674801|FG012|Overall Study|Request to discontinue|0|||
146591052|NCT02754141|528674802|FG013|Overall Study|Request to discontinue|1|||
146591053|NCT02754141|528674803|FG014|Overall Study|Request to discontinue|1|||
146652939|NCT04214288|528908109|FG002|Overall Study|Protocol Violation|0|||
146591054|NCT02754141|528674804|FG015|Overall Study|Request to discontinue|0|||
146591055|NCT02754141|528674805|FG016|Overall Study|Request to discontinue|0|||
146652940|NCT04214288|528908110|FG003|Overall Study|Protocol Violation|0|||
146652941|NCT04214288|528908107|FG000|Overall Study|Withdrawal by Subject|8|||
146652942|NCT04214288|528908108|FG001|Overall Study|Withdrawal by Subject|4|||
146652943|NCT04214288|528908109|FG002|Overall Study|Withdrawal by Subject|0|||
146652944|NCT04214288|528908110|FG003|Overall Study|Withdrawal by Subject|9|||
146918981|NCT01544595|529864541|FG000|Status at Week 156|Non-compliance with study treatement|0|||
146918982|NCT01544595|529864542|FG001|Status at Week 156|Non-compliance with study treatement|1|||
146918983|NCT01544595|529864543|FG002|Status at Week 156|Non-compliance with study treatement|0|||
146918984|NCT01544595|529864544|FG003|Status at Week 156|Non-compliance with study treatement|1|||
146918985|NCT01544595|529864545|FG004|Status at Week 156|Non-compliance with study treatement|0|||
146918986|NCT01544595|529864546|FG005|Status at Week 156|Non-compliance with study treatement|1|||
146918987|NCT01544595|529864541|FG000|Status at Week 156|Physician Decision|0|||
146918988|NCT01544595|529864542|FG001|Status at Week 156|Physician Decision|3|||
146918989|NCT01544595|529864543|FG002|Status at Week 156|Physician Decision|1|||
146918990|NCT01544595|529864544|FG003|Status at Week 156|Physician Decision|0|||
146918991|NCT01544595|529864545|FG004|Status at Week 156|Physician Decision|0|||
146918992|NCT01544595|529864546|FG005|Status at Week 156|Physician Decision|0|||
146918993|NCT01544595|529864541|FG000|Status at Week 156|Pregnancy|2|||
146918994|NCT01544595|529864542|FG001|Status at Week 156|Pregnancy|3|||
146918995|NCT01544595|529864543|FG002|Status at Week 156|Pregnancy|0|||
146918996|NCT01544595|529864544|FG003|Status at Week 156|Pregnancy|0|||
146918997|NCT01544595|529864545|FG004|Status at Week 156|Pregnancy|0|||
146918998|NCT01544595|529864546|FG005|Status at Week 156|Pregnancy|0|||
146918999|NCT01544595|529864541|FG000|Status at Week 156|Protocol Violation|3|||
146919000|NCT01544595|529864542|FG001|Status at Week 156|Protocol Violation|1|||
146919001|NCT01544595|529864543|FG002|Status at Week 156|Protocol Violation|2|||
146919002|NCT01544595|529864544|FG003|Status at Week 156|Protocol Violation|2|||
146919003|NCT01544595|529864545|FG004|Status at Week 156|Protocol Violation|0|||
146591056|NCT02754141|528674806|FG017|Overall Study|Request to discontinue|0|||
146591057|NCT02754141|528674789|FG000|Overall Study|Withdrew consent|0|||
146591058|NCT02754141|528674790|FG001|Overall Study|Withdrew consent|0|||
146591059|NCT02754141|528674791|FG002|Overall Study|Withdrew consent|0|||
146591060|NCT02754141|528674792|FG003|Overall Study|Withdrew consent|0|||
146591061|NCT02754141|528674793|FG004|Overall Study|Withdrew consent|0|||
146591062|NCT02754141|528674794|FG005|Overall Study|Withdrew consent|0|||
146591063|NCT02754141|528674795|FG006|Overall Study|Withdrew consent|0|||
146591064|NCT02754141|528674796|FG007|Overall Study|Withdrew consent|0|||
146591065|NCT02754141|528674797|FG008|Overall Study|Withdrew consent|0|||
146591066|NCT02754141|528674798|FG009|Overall Study|Withdrew consent|1|||
146591067|NCT02754141|528674799|FG010|Overall Study|Withdrew consent|0|||
146591068|NCT02754141|528674800|FG011|Overall Study|Withdrew consent|0|||
146591069|NCT02754141|528674801|FG012|Overall Study|Withdrew consent|0|||
146591070|NCT02754141|528674802|FG013|Overall Study|Withdrew consent|0|||
146591071|NCT02754141|528674803|FG014|Overall Study|Withdrew consent|0|||
146591072|NCT02754141|528674804|FG015|Overall Study|Withdrew consent|0|||
146591073|NCT02754141|528674805|FG016|Overall Study|Withdrew consent|0|||
146591074|NCT02754141|528674806|FG017|Overall Study|Withdrew consent|0|||
146591075|NCT02754141|528674789|FG000|Overall Study|Maximum clinical benefit|0|||
146591076|NCT02754141|528674790|FG001|Overall Study|Maximum clinical benefit|0|||
146919004|NCT01544595|529864546|FG005|Status at Week 156|Protocol Violation|0|||
146919005|NCT01544595|529864541|FG000|Status at Week 156|Technical problems|3|||
146919006|NCT01544595|529864542|FG001|Status at Week 156|Technical problems|1|||
146919007|NCT01544595|529864543|FG002|Status at Week 156|Technical problems|0|||
146919008|NCT01544595|529864544|FG003|Status at Week 156|Technical problems|1|||
146919009|NCT01544595|529864545|FG004|Status at Week 156|Technical problems|0|||
146919010|NCT01544595|529864546|FG005|Status at Week 156|Technical problems|0|||
146919011|NCT01544595|529864541|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
146919012|NCT01544595|529864542|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
146591077|NCT02754141|528674791|FG002|Overall Study|Maximum clinical benefit|0|||
146591078|NCT02754141|528674792|FG003|Overall Study|Maximum clinical benefit|1|||
146591079|NCT02754141|528674793|FG004|Overall Study|Maximum clinical benefit|0|||
146652945|NCT00807027|528908111|FG000|Overall Study|Withdrawal by Subject|13|||
146652946|NCT00807027|528908112|FG001|Overall Study|Withdrawal by Subject|14|||
146652947|NCT00807027|528908111|FG000|Overall Study|Protocol Violation|1|||
146919013|NCT01544595|529864543|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
146919014|NCT01544595|529864544|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
146919015|NCT01544595|529864545|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
146919016|NCT01544595|529864546|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
146919017|NCT01544595|529864541|FG000|Status at Week 156|Lack of Efficacy|1|||
146919018|NCT01544595|529864542|FG001|Status at Week 156|Lack of Efficacy|0|||
146919019|NCT01544595|529864543|FG002|Status at Week 156|Lack of Efficacy|1|||
146919020|NCT01544595|529864544|FG003|Status at Week 156|Lack of Efficacy|4|||
146591080|NCT02754141|528674794|FG005|Overall Study|Maximum clinical benefit|0|||
146591081|NCT02754141|528674795|FG006|Overall Study|Maximum clinical benefit|0|||
146591082|NCT02754141|528674796|FG007|Overall Study|Maximum clinical benefit|0|||
146591083|NCT02754141|528674797|FG008|Overall Study|Maximum clinical benefit|0|||
146591084|NCT02754141|528674798|FG009|Overall Study|Maximum clinical benefit|0|||
146591085|NCT02754141|528674799|FG010|Overall Study|Maximum clinical benefit|0|||
146591086|NCT02754141|528674800|FG011|Overall Study|Maximum clinical benefit|0|||
146591087|NCT02754141|528674801|FG012|Overall Study|Maximum clinical benefit|0|||
146591088|NCT02754141|528674802|FG013|Overall Study|Maximum clinical benefit|0|||
146591089|NCT02754141|528674803|FG014|Overall Study|Maximum clinical benefit|0|||
146591090|NCT02754141|528674804|FG015|Overall Study|Maximum clinical benefit|0|||
146591091|NCT02754141|528674805|FG016|Overall Study|Maximum clinical benefit|0|||
146591092|NCT02754141|528674806|FG017|Overall Study|Maximum clinical benefit|0|||
146591093|NCT02754141|528674789|FG000|Overall Study|No longer meets study criteria|0|||
146591094|NCT02754141|528674790|FG001|Overall Study|No longer meets study criteria|0|||
146591095|NCT02754141|528674791|FG002|Overall Study|No longer meets study criteria|0|||
146591096|NCT02754141|528674792|FG003|Overall Study|No longer meets study criteria|1|||
146591097|NCT02754141|528674793|FG004|Overall Study|No longer meets study criteria|0|||
146591098|NCT02754141|528674794|FG005|Overall Study|No longer meets study criteria|0|||
146591099|NCT02754141|528674795|FG006|Overall Study|No longer meets study criteria|0|||
146591100|NCT02754141|528674796|FG007|Overall Study|No longer meets study criteria|0|||
146591101|NCT02754141|528674797|FG008|Overall Study|No longer meets study criteria|0|||
146591102|NCT02754141|528674798|FG009|Overall Study|No longer meets study criteria|0|||
146591103|NCT02754141|528674799|FG010|Overall Study|No longer meets study criteria|0|||
146591104|NCT02754141|528674800|FG011|Overall Study|No longer meets study criteria|0|||
146591105|NCT02754141|528674801|FG012|Overall Study|No longer meets study criteria|0|||
146591106|NCT02754141|528674802|FG013|Overall Study|No longer meets study criteria|0|||
146591107|NCT02754141|528674803|FG014|Overall Study|No longer meets study criteria|0|||
146591108|NCT02754141|528674804|FG015|Overall Study|No longer meets study criteria|0|||
146591109|NCT02754141|528674805|FG016|Overall Study|No longer meets study criteria|0|||
146591110|NCT02754141|528674806|FG017|Overall Study|No longer meets study criteria|0|||
146591111|NCT02754141|528674789|FG000|Overall Study|Other reasons|0|||
146591112|NCT02754141|528674790|FG001|Overall Study|Other reasons|0|||
146591113|NCT02754141|528674791|FG002|Overall Study|Other reasons|0|||
146591114|NCT02754141|528674792|FG003|Overall Study|Other reasons|0|||
146591115|NCT02754141|528674793|FG004|Overall Study|Other reasons|0|||
146591116|NCT02754141|528674794|FG005|Overall Study|Other reasons|0|||
146591117|NCT02754141|528674795|FG006|Overall Study|Other reasons|0|||
146591118|NCT02754141|528674796|FG007|Overall Study|Other reasons|1|||
146591119|NCT02754141|528674797|FG008|Overall Study|Other reasons|0|||
146591120|NCT02754141|528674798|FG009|Overall Study|Other reasons|0|||
146591121|NCT02754141|528674799|FG010|Overall Study|Other reasons|0|||
146591122|NCT02754141|528674800|FG011|Overall Study|Other reasons|0|||
146591123|NCT02754141|528674801|FG012|Overall Study|Other reasons|2|||
146591124|NCT02754141|528674802|FG013|Overall Study|Other reasons|0|||
146591125|NCT02754141|528674803|FG014|Overall Study|Other reasons|0|||
146591126|NCT02754141|528674804|FG015|Overall Study|Other reasons|0|||
146591127|NCT02754141|528674805|FG016|Overall Study|Other reasons|0|||
146591128|NCT02754141|528674806|FG017|Overall Study|Other reasons|0|||
146591129|NCT02754141|528674789|FG000|Overall Study|Completed treatment as per protocol|0|||
146591130|NCT02754141|528674790|FG001|Overall Study|Completed treatment as per protocol|1|||
146591131|NCT02754141|528674791|FG002|Overall Study|Completed treatment as per protocol|0|||
146591132|NCT02754141|528674792|FG003|Overall Study|Completed treatment as per protocol|0|||
146591133|NCT02754141|528674793|FG004|Overall Study|Completed treatment as per protocol|0|||
146591134|NCT02754141|528674794|FG005|Overall Study|Completed treatment as per protocol|0|||
146591135|NCT02754141|528674795|FG006|Overall Study|Completed treatment as per protocol|0|||
146591136|NCT02754141|528674796|FG007|Overall Study|Completed treatment as per protocol|0|||
146591137|NCT02754141|528674797|FG008|Overall Study|Completed treatment as per protocol|0|||
146591138|NCT02754141|528674798|FG009|Overall Study|Completed treatment as per protocol|0|||
146919021|NCT01544595|529864545|FG004|Status at Week 156|Lack of Efficacy|10|||
146919022|NCT01544595|529864546|FG005|Status at Week 156|Lack of Efficacy|5|||
146919023|NCT00878072|529864549|FG000|Overall Study|Withdrew consent|2|||
146591139|NCT02754141|528674799|FG010|Overall Study|Completed treatment as per protocol|0|||
146591140|NCT02754141|528674800|FG011|Overall Study|Completed treatment as per protocol|0|||
146591141|NCT02754141|528674801|FG012|Overall Study|Completed treatment as per protocol|1|||
146591142|NCT02754141|528674802|FG013|Overall Study|Completed treatment as per protocol|0|||
146591143|NCT02754141|528674803|FG014|Overall Study|Completed treatment as per protocol|0|||
146591144|NCT02754141|528674804|FG015|Overall Study|Completed treatment as per protocol|0|||
146591145|NCT02754141|528674805|FG016|Overall Study|Completed treatment as per protocol|0|||
146591146|NCT02754141|528674806|FG017|Overall Study|Completed treatment as per protocol|0|||
146591147|NCT02754141|528674789|FG000|Overall Study|Not completing monotherapy|0|||
146652948|NCT00807027|528908112|FG001|Overall Study|Protocol Violation|1|||
146652949|NCT00807027|528908111|FG000|Overall Study|Adverse Event|2|||
146919024|NCT02379923|529864555|FG000|Overall Study|Death|5|||
146591148|NCT02754141|528674790|FG001|Overall Study|Not completing monotherapy|0|||
146652950|NCT00807027|528908112|FG001|Overall Study|Adverse Event|2|||
146919025|NCT00872170|529864556|FG000|Overall Study|Adverse Event|1|||
146591149|NCT02754141|528674791|FG002|Overall Study|Not completing monotherapy|0|||
146591150|NCT02754141|528674792|FG003|Overall Study|Not completing monotherapy|0|||
146591151|NCT02754141|528674793|FG004|Overall Study|Not completing monotherapy|0|||
146591152|NCT02754141|528674794|FG005|Overall Study|Not completing monotherapy|0|||
146591153|NCT02754141|528674795|FG006|Overall Study|Not completing monotherapy|0|||
146591154|NCT02754141|528674796|FG007|Overall Study|Not completing monotherapy|0|||
146591155|NCT02754141|528674797|FG008|Overall Study|Not completing monotherapy|0|||
146591156|NCT02754141|528674798|FG009|Overall Study|Not completing monotherapy|0|||
146591157|NCT02754141|528674799|FG010|Overall Study|Not completing monotherapy|0|||
146591158|NCT02754141|528674800|FG011|Overall Study|Not completing monotherapy|0|||
146591159|NCT02754141|528674801|FG012|Overall Study|Not completing monotherapy|0|||
146591160|NCT02754141|528674802|FG013|Overall Study|Not completing monotherapy|1|||
146591161|NCT02754141|528674803|FG014|Overall Study|Not completing monotherapy|0|||
146591162|NCT02754141|528674804|FG015|Overall Study|Not completing monotherapy|0|||
146591163|NCT02754141|528674805|FG016|Overall Study|Not completing monotherapy|0|||
146591164|NCT02754141|528674806|FG017|Overall Study|Not completing monotherapy|0|||
146591165|NCT00794365|528674811|FG000|Overall Study|Lost to Follow-up|38|||
146591166|NCT00794365|528674811|FG000|Overall Study|Other|17|||
146591167|NCT00794365|528674811|FG000|Overall Study|Poor Compliance|11|||
146591168|NCT00794365|528674811|FG000|Overall Study|Adverse Event|10|||
146591169|NCT00794365|528674811|FG000|Overall Study|Lack of Efficacy|3|||
146591170|NCT03538444|528674814|FG000|Overall Study|opioid withdrawal|1|||
146591171|NCT03538444|528674815|FG001|Overall Study|opioid withdrawal|0|||
146591172|NCT00623545|528674818|FG000|Overall Study|Adverse Event|6|||
146591173|NCT00623545|528674818|FG000|Overall Study|Withdrawal by Subject|4|||
146591174|NCT04239222|528674819|FG000|Baseline|Withdrawal by Subject|0|||
146591175|NCT04239222|528674820|FG001|Baseline|Withdrawal by Subject|0|||
146591176|NCT04239222|528674821|FG002|Baseline|Withdrawal by Subject|1|||
146591177|NCT04239222|528674822|FG003|Baseline|Withdrawal by Subject|1|||
146591178|NCT04239222|528674819|FG000|First Foot Assignment|Withdrawal by Subject|0|||
146591179|NCT04239222|528674820|FG001|First Foot Assignment|Withdrawal by Subject|0|||
146591180|NCT04239222|528674821|FG002|First Foot Assignment|Withdrawal by Subject|1|||
146591181|NCT04239222|528674822|FG003|First Foot Assignment|Withdrawal by Subject|0|||
146591182|NCT04239222|528674819|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
146591183|NCT04239222|528674820|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
146591184|NCT04239222|528674821|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
146591185|NCT04239222|528674822|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
146591186|NCT00937404|528674828|FG000|Overall Study|Protocol Violation|1|||
146591187|NCT00937404|528674828|FG000|Overall Study|Withdrawal by Subject|1|||
146591188|NCT00230282|528674833|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
146591189|NCT00230282|528674833|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
146591190|NCT00230282|528674833|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
146591191|NCT00230282|528674833|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
146591192|NCT01691105|528674837|FG000|1 Month Follow-up|Lost to Follow-up|41|||
146591193|NCT01691105|528674838|FG001|1 Month Follow-up|Lost to Follow-up|38|||
146591194|NCT01691105|528674837|FG000|1 Month Follow-up|Death|2|||
146591195|NCT01691105|528674838|FG001|1 Month Follow-up|Death|3|||
146591196|NCT01691105|528674837|FG000|6 Month Follow-up|Lost to Follow-up|39|||
146591197|NCT01691105|528674838|FG001|6 Month Follow-up|Lost to Follow-up|58|||
146591198|NCT01691105|528674837|FG000|6 Month Follow-up|Death|13|||
146591199|NCT01691105|528674838|FG001|6 Month Follow-up|Death|13|||
146591200|NCT01691105|528674837|FG000|12 Month Follow-up|Lost to Follow-up|50|||
146591201|NCT01691105|528674838|FG001|12 Month Follow-up|Lost to Follow-up|71|||
146591202|NCT01691105|528674837|FG000|12 Month Follow-up|Death|22|||
146919026|NCT00872170|529864557|FG001|Overall Study|Adverse Event|0|||
146919027|NCT00601523|529864558|FG000|Overall Study|Adverse Event|42|||
146919028|NCT00601523|529864559|FG001|Overall Study|Adverse Event|14|||
146919029|NCT00601523|529864558|FG000|Overall Study|Lack of Efficacy|3|||
146919030|NCT00601523|529864559|FG001|Overall Study|Lack of Efficacy|0|||
146919031|NCT00601523|529864558|FG000|Overall Study|Protocol Violation|5|||
146591203|NCT01691105|528674838|FG001|12 Month Follow-up|Death|30|||
146591204|NCT01691105|528674837|FG000|12 Month Biochemical Verification|Death|22|||
146591205|NCT01691105|528674838|FG001|12 Month Biochemical Verification|Death|30|||
146591206|NCT01691105|528674837|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
146919032|NCT00601523|529864559|FG001|Overall Study|Protocol Violation|1|||
146591207|NCT01691105|528674838|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
146591208|NCT01691105|528674837|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
146591209|NCT01691105|528674838|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
146919033|NCT00601523|529864558|FG000|Overall Study|Lost to Follow-up|0|||
146919034|NCT00601523|529864559|FG001|Overall Study|Lost to Follow-up|1|||
146591210|NCT00445848|528674839|FG000|Overall Study|Adverse Event|14|||
146591211|NCT00445848|528674839|FG000|Overall Study|Withdrawal by Subject|4|||
146978376|NCT02919475|530084028|FG000|Overall Study|Lost to Follow-up|0|||
146591212|NCT00445848|528674839|FG000|Overall Study|Progression|62|||
146591213|NCT00445848|528674839|FG000|Overall Study|Other-Not protocol specified|5|||
146978377|NCT02919475|530084029|FG001|Overall Study|Lost to Follow-up|0|||
146591214|NCT00790647|528674842|FG000|Overall Study|Adverse Event|1|||
146591215|NCT01777542|528674845|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
146591216|NCT01777542|528674846|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
146591217|NCT04706273|528674850|FG000|Overall Study|Withdrawal by Subject|27|||
146591218|NCT04706273|528674850|FG000|Overall Study|Physician Decision|1|||
146591219|NCT04706273|528674850|FG000|Overall Study|Lost to Follow-up|42|||
146591220|NCT04706273|528674850|FG000|Overall Study|Death|85|||
146591221|NCT04706273|528674850|FG000|Overall Study|Amputation that removes study device|2|||
146591222|NCT04706273|528674850|FG000|Overall Study|Surgical bypass|3|||
146591223|NCT04706273|528674850|FG000|Overall Study|Changing hospital|23|||
146591224|NCT04706273|528674850|FG000|Overall Study|Unable to attend hospital|2|||
146591225|NCT03199053|528674853|FG000|ST Period|Withdrawal by Subject|2|||
146591226|NCT03199053|528674854|FG001|ST Period|Withdrawal by Subject|4|||
146591227|NCT03199053|528674855|FG002|ST Period|Withdrawal by Subject|6|||
146591228|NCT03199053|528674853|FG000|ST Period|Withdrawal by parent/guardian|1|||
146591229|NCT03199053|528674854|FG001|ST Period|Withdrawal by parent/guardian|1|||
146591230|NCT03199053|528674855|FG002|ST Period|Withdrawal by parent/guardian|1|||
146591231|NCT03199053|528674853|FG000|ST Period|Lost to Follow-up|2|||
146591232|NCT03199053|528674854|FG001|ST Period|Lost to Follow-up|0|||
146591233|NCT03199053|528674855|FG002|ST Period|Lost to Follow-up|1|||
146591234|NCT03199053|528674853|FG000|LT Period|Withdrawal by Subject|1|||
146591235|NCT03199053|528674854|FG001|LT Period|Withdrawal by Subject|3|||
146591236|NCT03199053|528674855|FG002|LT Period|Withdrawal by Subject|3|||
146591237|NCT03199053|528674853|FG000|LT Period|Withdrawal by parent/guardian|0|||
146591238|NCT03199053|528674854|FG001|LT Period|Withdrawal by parent/guardian|0|||
146591239|NCT03199053|528674855|FG002|LT Period|Withdrawal by parent/guardian|1|||
146591240|NCT03199053|528674853|FG000|LT Period|Lost to Follow-up|0|||
146591241|NCT03199053|528674854|FG001|LT Period|Lost to Follow-up|1|||
146591242|NCT03199053|528674855|FG002|LT Period|Lost to Follow-up|1|||
146591243|NCT03199053|528674853|FG000|LT Period|Miscellaneous|0|||
146591244|NCT03199053|528674854|FG001|LT Period|Miscellaneous|0|||
146591245|NCT03199053|528674855|FG002|LT Period|Miscellaneous|2|||
146591246|NCT03199053|528674853|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
146591247|NCT03199053|528674854|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
146591248|NCT03199053|528674855|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
146591249|NCT03199053|528674853|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
146652951|NCT03997383|528908113|FG000|Double-blind Treatment Period|Adverse Event|4|||
146652952|NCT03997383|528908114|FG001|Double-blind Treatment Period|Adverse Event|3|||
146652953|NCT03997383|528908113|FG000|Double-blind Treatment Period|Death|4|||
146652954|NCT03997383|528908114|FG001|Double-blind Treatment Period|Death|4|||
146652955|NCT03997383|528908113|FG000|Double-blind Treatment Period|Physician Decision|2|||
146652956|NCT03997383|528908114|FG001|Double-blind Treatment Period|Physician Decision|0|||
146652957|NCT03997383|528908113|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
146652958|NCT03997383|528908114|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
146652959|NCT03997383|528908113|FG000|Open-label Extension Period|Ongoing|148|||
146652960|NCT03997383|528908114|FG001|Open-label Extension Period|Ongoing|151|||
146652961|NCT03997383|528908113|FG000|Open-label Extension Period|Adverse Event|4|||
146652962|NCT03997383|528908114|FG001|Open-label Extension Period|Adverse Event|1|||
146652963|NCT03997383|528908113|FG000|Open-label Extension Period|Death|8|||
146652964|NCT03997383|528908114|FG001|Open-label Extension Period|Death|9|||
146652965|NCT03997383|528908113|FG000|Open-label Extension Period|Physician Decision|1|||
146652966|NCT03997383|528908114|FG001|Open-label Extension Period|Physician Decision|1|||
146591250|NCT03199053|528674854|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
146591251|NCT03199053|528674855|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
146591252|NCT03199053|528674853|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
146591253|NCT03199053|528674854|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
146591254|NCT03199053|528674855|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
146591255|NCT03199053|528674853|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
146591256|NCT03199053|528674854|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
146591257|NCT03199053|528674855|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
146591258|NCT03298984|528674856|FG000|Overall Study|Physician Decision|1|||
146591259|NCT03298984|528674857|FG001|Overall Study|Physician Decision|0|||
146591260|NCT03298984|528674858|FG002|Overall Study|Physician Decision|0|||
146591261|NCT03298984|528674859|FG003|Overall Study|Physician Decision|6|||
146591262|NCT03298984|528674856|FG000|Overall Study|Lack of Efficacy|0|||
146591263|NCT03298984|528674857|FG001|Overall Study|Lack of Efficacy|1|||
146652967|NCT03997383|528908113|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
146652968|NCT03997383|528908114|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
146591264|NCT03298984|528674858|FG002|Overall Study|Lack of Efficacy|1|||
146591265|NCT03298984|528674859|FG003|Overall Study|Lack of Efficacy|4|||
146591266|NCT03298984|528674856|FG000|Overall Study|Relapsed disease (following remission)|0|||
146652969|NCT03997383|528908113|FG000|Open-label Extension Period|Reason Not Specified|2|||
146652970|NCT03997383|528908114|FG001|Open-label Extension Period|Reason Not Specified|0|||
146652971|NCT04798781|528908115|FG000|Overall Study|Withdrawal by Subject|1|||
146591267|NCT03298984|528674857|FG001|Overall Study|Relapsed disease (following remission)|0|||
146591268|NCT03298984|528674858|FG002|Overall Study|Relapsed disease (following remission)|1|||
146591269|NCT03298984|528674859|FG003|Overall Study|Relapsed disease (following remission)|1|||
146591270|NCT03298984|528674856|FG000|Overall Study|Adverse Event|0|||
146591271|NCT03298984|528674857|FG001|Overall Study|Adverse Event|0|||
146591272|NCT03298984|528674858|FG002|Overall Study|Adverse Event|0|||
146591273|NCT03298984|528674859|FG003|Overall Study|Adverse Event|1|||
146591274|NCT03298984|528674856|FG000|Overall Study|Death|0|||
146591275|NCT03298984|528674857|FG001|Overall Study|Death|0|||
146591276|NCT03298984|528674858|FG002|Overall Study|Death|0|||
146591277|NCT03298984|528674859|FG003|Overall Study|Death|2|||
146591278|NCT03298984|528674856|FG000|Overall Study|Insurance Company Decision|0|||
146591279|NCT03298984|528674857|FG001|Overall Study|Insurance Company Decision|0|||
146591280|NCT03298984|528674858|FG002|Overall Study|Insurance Company Decision|0|||
146591281|NCT03298984|528674859|FG003|Overall Study|Insurance Company Decision|1|||
146591282|NCT02403635|528674862|FG000|Overall Study|Not eligible|9|||
146591283|NCT00585221|528674866|FG000|Overall Study|Protocol Violation|8|||
146591284|NCT02585830|528674867|FG000|Overall Study|Withdrawal by Subject|3|||
146591285|NCT02509052|528674868|FG000|Overall Study|Non compliance|0|||
146591286|NCT02509052|528674869|FG001|Overall Study|Non compliance|0|||
146591287|NCT02509052|528674870|FG002|Overall Study|Non compliance|1|||
146591288|NCT03263923|528674871|FG000|Overall Study|Withdrawal by Subject|10|||
146591289|NCT03263923|528674872|FG001|Overall Study|Withdrawal by Subject|8|||
146591290|NCT03263923|528674871|FG000|Overall Study|Lost to Follow-up|15|||
146591291|NCT03263923|528674872|FG001|Overall Study|Lost to Follow-up|13|||
146591292|NCT01323270|528674873|FG000|Overall Study|Withdrawal by Subject|19|||
146591293|NCT01323270|528674874|FG001|Overall Study|Withdrawal by Subject|10|||
146591294|NCT01323270|528674873|FG000|Overall Study|Protocol Violation|9|||
146591295|NCT01323270|528674874|FG001|Overall Study|Protocol Violation|7|||
146591296|NCT01323270|528674873|FG000|Overall Study|Lost to Follow-up|4|||
146591297|NCT01323270|528674874|FG001|Overall Study|Lost to Follow-up|6|||
146591298|NCT01323270|528674873|FG000|Overall Study|Adverse Event|8|||
146591299|NCT01323270|528674874|FG001|Overall Study|Adverse Event|0|||
146591300|NCT01323270|528674873|FG000|Overall Study|Other|0|||
146591301|NCT01323270|528674874|FG001|Overall Study|Other|3|||
146591302|NCT01323270|528674873|FG000|Overall Study|Physician Decision|0|||
146591303|NCT01323270|528674874|FG001|Overall Study|Physician Decision|2|||
146591304|NCT01323270|528674873|FG000|Overall Study|Not eligible|1|||
146591305|NCT01323270|528674874|FG001|Overall Study|Not eligible|1|||
146591306|NCT01323270|528674873|FG000|Overall Study|Death|1|||
146591307|NCT01323270|528674874|FG001|Overall Study|Death|0|||
146591308|NCT01323270|528674873|FG000|Overall Study|Randomized, but not vaccinated|1|||
146591309|NCT01323270|528674874|FG001|Overall Study|Randomized, but not vaccinated|0|||
146591310|NCT00075725|528674876|FG000|Overall Study|Adverse Event|6|||
146591311|NCT00075725|528674877|FG001|Overall Study|Adverse Event|6|||
146591312|NCT00075725|528674878|FG002|Overall Study|Adverse Event|20|||
146591313|NCT00075725|528674879|FG003|Overall Study|Adverse Event|8|||
146591314|NCT00075725|528674880|FG004|Overall Study|Adverse Event|4|||
146591315|NCT00075725|528674881|FG005|Overall Study|Adverse Event|38|||
146591316|NCT00075725|528674882|FG006|Overall Study|Adverse Event|3|||
146591317|NCT00075725|528674883|FG007|Overall Study|Adverse Event|51|||
146591318|NCT00075725|528674884|FG008|Overall Study|Adverse Event|15|||
146591319|NCT00075725|528674885|FG009|Overall Study|Adverse Event|4|||
146591320|NCT00075725|528674886|FG010|Overall Study|Adverse Event|2|||
146591321|NCT00075725|528674887|FG011|Overall Study|Adverse Event|2|||
146591322|NCT00075725|528674876|FG000|Overall Study|Death|3|||
146591323|NCT00075725|528674877|FG001|Overall Study|Death|5|||
146591324|NCT00075725|528674878|FG002|Overall Study|Death|10|||
146591325|NCT00075725|528674879|FG003|Overall Study|Death|2|||
146591326|NCT00075725|528674880|FG004|Overall Study|Death|3|||
146591327|NCT00075725|528674881|FG005|Overall Study|Death|25|||
146591328|NCT00075725|528674882|FG006|Overall Study|Death|4|||
146591329|NCT00075725|528674883|FG007|Overall Study|Death|22|||
146591330|NCT00075725|528674884|FG008|Overall Study|Death|14|||
146591331|NCT00075725|528674885|FG009|Overall Study|Death|4|||
146591332|NCT00075725|528674886|FG010|Overall Study|Death|3|||
146591333|NCT00075725|528674887|FG011|Overall Study|Death|0|||
146591334|NCT00075725|528674876|FG000|Overall Study|Lost to Follow-up|1|||
146591335|NCT00075725|528674877|FG001|Overall Study|Lost to Follow-up|1|||
146591336|NCT00075725|528674878|FG002|Overall Study|Lost to Follow-up|4|||
146591337|NCT00075725|528674879|FG003|Overall Study|Lost to Follow-up|1|||
146591338|NCT00075725|528674880|FG004|Overall Study|Lost to Follow-up|0|||
146591339|NCT00075725|528674881|FG005|Overall Study|Lost to Follow-up|13|||
146591340|NCT00075725|528674882|FG006|Overall Study|Lost to Follow-up|2|||
146591341|NCT00075725|528674883|FG007|Overall Study|Lost to Follow-up|4|||
146591342|NCT00075725|528674884|FG008|Overall Study|Lost to Follow-up|1|||
146591343|NCT00075725|528674885|FG009|Overall Study|Lost to Follow-up|0|||
146591344|NCT00075725|528674886|FG010|Overall Study|Lost to Follow-up|0|||
146591345|NCT00075725|528674887|FG011|Overall Study|Lost to Follow-up|0|||
146591346|NCT00075725|528674876|FG000|Overall Study|Physician Decision|2|||
146591347|NCT00075725|528674877|FG001|Overall Study|Physician Decision|6|||
146591348|NCT00075725|528674878|FG002|Overall Study|Physician Decision|5|||
146591349|NCT00075725|528674879|FG003|Overall Study|Physician Decision|8|||
146591350|NCT00075725|528674880|FG004|Overall Study|Physician Decision|4|||
146591351|NCT00075725|528674881|FG005|Overall Study|Physician Decision|19|||
146591352|NCT00075725|528674882|FG006|Overall Study|Physician Decision|3|||
146591353|NCT00075725|528674883|FG007|Overall Study|Physician Decision|17|||
146591354|NCT00075725|528674884|FG008|Overall Study|Physician Decision|5|||
146591355|NCT00075725|528674885|FG009|Overall Study|Physician Decision|0|||
146591356|NCT00075725|528674886|FG010|Overall Study|Physician Decision|1|||
146591357|NCT00075725|528674887|FG011|Overall Study|Physician Decision|0|||
146591358|NCT00075725|528674876|FG000|Overall Study|Pregnancy|0|||
146591359|NCT00075725|528674877|FG001|Overall Study|Pregnancy|0|||
146591360|NCT00075725|528674878|FG002|Overall Study|Pregnancy|0|||
146591361|NCT00075725|528674879|FG003|Overall Study|Pregnancy|0|||
146591362|NCT00075725|528674880|FG004|Overall Study|Pregnancy|0|||
146591363|NCT00075725|528674881|FG005|Overall Study|Pregnancy|1|||
146591364|NCT00075725|528674882|FG006|Overall Study|Pregnancy|0|||
146591365|NCT00075725|528674883|FG007|Overall Study|Pregnancy|1|||
146591366|NCT00075725|528674884|FG008|Overall Study|Pregnancy|0|||
146591367|NCT00075725|528674885|FG009|Overall Study|Pregnancy|0|||
146591368|NCT00075725|528674886|FG010|Overall Study|Pregnancy|0|||
146591369|NCT00075725|528674887|FG011|Overall Study|Pregnancy|0|||
146591370|NCT00075725|528674876|FG000|Overall Study|Protocol Violation|1|||
146591371|NCT00075725|528674877|FG001|Overall Study|Protocol Violation|1|||
146591372|NCT00075725|528674878|FG002|Overall Study|Protocol Violation|0|||
146591373|NCT00075725|528674879|FG003|Overall Study|Protocol Violation|3|||
146591374|NCT00075725|528674880|FG004|Overall Study|Protocol Violation|3|||
146591375|NCT00075725|528674881|FG005|Overall Study|Protocol Violation|2|||
146591376|NCT00075725|528674882|FG006|Overall Study|Protocol Violation|1|||
146591377|NCT00075725|528674883|FG007|Overall Study|Protocol Violation|2|||
146591378|NCT00075725|528674884|FG008|Overall Study|Protocol Violation|3|||
146591379|NCT00075725|528674885|FG009|Overall Study|Protocol Violation|0|||
146591380|NCT00075725|528674886|FG010|Overall Study|Protocol Violation|0|||
146591381|NCT00075725|528674887|FG011|Overall Study|Protocol Violation|1|||
146591382|NCT00075725|528674876|FG000|Overall Study|Withdrawal by Subject|12|||
146591383|NCT00075725|528674877|FG001|Overall Study|Withdrawal by Subject|3|||
146591384|NCT00075725|528674878|FG002|Overall Study|Withdrawal by Subject|6|||
146591385|NCT00075725|528674879|FG003|Overall Study|Withdrawal by Subject|10|||
146591386|NCT00075725|528674880|FG004|Overall Study|Withdrawal by Subject|6|||
146591387|NCT00075725|528674881|FG005|Overall Study|Withdrawal by Subject|27|||
146591388|NCT00075725|528674882|FG006|Overall Study|Withdrawal by Subject|7|||
146591389|NCT00075725|528674883|FG007|Overall Study|Withdrawal by Subject|31|||
146591390|NCT00075725|528674884|FG008|Overall Study|Withdrawal by Subject|10|||
146591391|NCT00075725|528674885|FG009|Overall Study|Withdrawal by Subject|2|||
146591392|NCT00075725|528674886|FG010|Overall Study|Withdrawal by Subject|0|||
146591393|NCT00075725|528674887|FG011|Overall Study|Withdrawal by Subject|0|||
146591394|NCT00075725|528674876|FG000|Overall Study|Disease Progression, all other reasons|17|||
146591395|NCT00075725|528674877|FG001|Overall Study|Disease Progression, all other reasons|5|||
146591396|NCT00075725|528674878|FG002|Overall Study|Disease Progression, all other reasons|33|||
146591397|NCT00075725|528674879|FG003|Overall Study|Disease Progression, all other reasons|6|||
146591398|NCT00075725|528674880|FG004|Overall Study|Disease Progression, all other reasons|21|||
146591399|NCT00075725|528674881|FG005|Overall Study|Disease Progression, all other reasons|59|||
146591400|NCT00075725|528674882|FG006|Overall Study|Disease Progression, all other reasons|20|||
146591401|NCT00075725|528674883|FG007|Overall Study|Disease Progression, all other reasons|46|||
146591402|NCT00075725|528674884|FG008|Overall Study|Disease Progression, all other reasons|21|||
146591403|NCT00075725|528674885|FG009|Overall Study|Disease Progression, all other reasons|4|||
146591404|NCT00075725|528674886|FG010|Overall Study|Disease Progression, all other reasons|0|||
146591405|NCT00075725|528674887|FG011|Overall Study|Disease Progression, all other reasons|5|||
146591406|NCT00075725|528674876|FG000|Overall Study|Patient off treatment|0|||
146591407|NCT00075725|528674877|FG001|Overall Study|Patient off treatment|0|||
146591408|NCT00075725|528674878|FG002|Overall Study|Patient off treatment|1|||
146591409|NCT00075725|528674879|FG003|Overall Study|Patient off treatment|2|||
146591410|NCT00075725|528674880|FG004|Overall Study|Patient off treatment|1|||
146591411|NCT00075725|528674881|FG005|Overall Study|Patient off treatment|0|||
146591412|NCT00075725|528674882|FG006|Overall Study|Patient off treatment|0|||
146591413|NCT00075725|528674883|FG007|Overall Study|Patient off treatment|2|||
146652972|NCT01129024|528908116|FG000|Overall Study|Physician Decision|5|||
146652973|NCT01129024|528908116|FG000|Overall Study|Study Terminated by Sponsor|8|||
146652974|NCT01129024|528908116|FG000|Overall Study|Withdrawal by Subject|2|||
146591414|NCT00075725|528674884|FG008|Overall Study|Patient off treatment|1|||
146591415|NCT00075725|528674885|FG009|Overall Study|Patient off treatment|0|||
146591416|NCT00075725|528674886|FG010|Overall Study|Patient off treatment|0|||
146591417|NCT00075725|528674887|FG011|Overall Study|Patient off treatment|0|||
146591418|NCT00075725|528674876|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
146652975|NCT01129024|528908116|FG000|Overall Study|Lack of Efficacy|3|||
146591419|NCT00075725|528674877|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
146591420|NCT00075725|528674878|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
146919035|NCT00601523|529864558|FG000|Overall Study|Withdrawal by Subject|18|||
146591421|NCT00075725|528674879|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
146591422|NCT00075725|528674880|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
146591423|NCT00075725|528674881|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
146591424|NCT00075725|528674882|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
146591425|NCT00075725|528674883|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
146591426|NCT00075725|528674884|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
146591427|NCT00075725|528674885|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
146591428|NCT00075725|528674886|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
146591429|NCT00075725|528674887|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
146591430|NCT00075725|528674876|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
146591431|NCT00075725|528674877|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
146591432|NCT00075725|528674878|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
146591433|NCT00075725|528674879|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
146591434|NCT00075725|528674880|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
146591435|NCT00075725|528674881|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
146591436|NCT00075725|528674882|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
146591437|NCT00075725|528674883|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
146591438|NCT00075725|528674884|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
146591439|NCT00075725|528674885|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
146591440|NCT00075725|528674886|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
146591441|NCT00075725|528674887|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
146591442|NCT00075725|528674876|FG000|Overall Study|Pt non compliant with therapy|2|||
146591443|NCT00075725|528674877|FG001|Overall Study|Pt non compliant with therapy|1|||
146591444|NCT00075725|528674878|FG002|Overall Study|Pt non compliant with therapy|1|||
146591445|NCT00075725|528674879|FG003|Overall Study|Pt non compliant with therapy|0|||
146591446|NCT00075725|528674880|FG004|Overall Study|Pt non compliant with therapy|2|||
146652976|NCT01129024|528908116|FG000|Overall Study|Needed a Platelet Transfusion|1|||
146652977|NCT02361580|528908117|FG000|Overall Study|Lost to Follow-up|6|||
146652978|NCT02361580|528908118|FG001|Overall Study|Lost to Follow-up|3|||
146652979|NCT00924781|528908119|FG000|Overall Study|Study terminated by sponsor|12|||
146652980|NCT00924781|528908120|FG001|Overall Study|Study terminated by sponsor|10|||
146652981|NCT00708201|528908121|FG000|Overall Study|Adverse Event|4|||
146652982|NCT00708201|528908122|FG001|Overall Study|Adverse Event|4|||
146652983|NCT00708201|528908121|FG000|Overall Study|Withdrawal by Subject|1|||
146652984|NCT00708201|528908122|FG001|Overall Study|Withdrawal by Subject|1|||
146652985|NCT00708201|528908121|FG000|Overall Study|Lost to Follow-up|2|||
146652986|NCT00708201|528908122|FG001|Overall Study|Lost to Follow-up|0|||
146652987|NCT00708201|528908121|FG000|Overall Study|Protocol Violation|0|||
146652988|NCT00708201|528908122|FG001|Overall Study|Protocol Violation|1|||
146652989|NCT00761748|528908123|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
146652990|NCT00761748|528908124|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
146652991|NCT00761748|528908123|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
146652992|NCT00761748|528908124|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
146652993|NCT01857310|528908125|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
146652994|NCT01857310|528908126|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
146652995|NCT02554279|528908127|FG000|Overall Study|Adverse Event|2|||
146652996|NCT02554279|528908128|FG001|Overall Study|Adverse Event|5|||
146652997|NCT02554279|528908127|FG000|Overall Study|Lost to Follow-up|3|||
146652998|NCT02554279|528908128|FG001|Overall Study|Lost to Follow-up|2|||
146652999|NCT02554279|528908127|FG000|Overall Study|Withdrawal by Subject|6|||
146653000|NCT02554279|528908128|FG001|Overall Study|Withdrawal by Subject|4|||
146653001|NCT02554279|528908127|FG000|Overall Study|Protocol Violation|2|||
146653002|NCT02554279|528908128|FG001|Overall Study|Protocol Violation|1|||
146653003|NCT02554279|528908127|FG000|Overall Study|Other reason|19|||
146653004|NCT02554279|528908128|FG001|Overall Study|Other reason|6|||
146653005|NCT00812487|528908129|FG000|Overall Study|Lost to Follow-up|2|||
146653006|NCT00812487|528908130|FG001|Overall Study|Lost to Follow-up|0|||
146653007|NCT00812487|528908129|FG000|Overall Study|Withdrawal by Subject|3|||
146653008|NCT00812487|528908130|FG001|Overall Study|Withdrawal by Subject|2|||
146653009|NCT00812487|528908129|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
146653010|NCT00812487|528908130|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
146919036|NCT00601523|529864559|FG001|Overall Study|Withdrawal by Subject|9|||
146919037|NCT00601523|529864558|FG000|Overall Study|Other|9|||
146591447|NCT00075725|528674881|FG005|Overall Study|Pt non compliant with therapy|14|||
146591448|NCT00075725|528674882|FG006|Overall Study|Pt non compliant with therapy|2|||
146591449|NCT00075725|528674883|FG007|Overall Study|Pt non compliant with therapy|5|||
146653011|NCT00812487|528908129|FG000|Overall Study|Protocol Violation|0|||
146653012|NCT00812487|528908130|FG001|Overall Study|Protocol Violation|1|||
146653013|NCT00998764|528908131|FG000|Overall Study|Lack of Efficacy|3|||
146653014|NCT00998764|528908132|FG001|Overall Study|Lack of Efficacy|6|||
146919038|NCT00601523|529864559|FG001|Overall Study|Other|1|||
146919039|NCT00804193|529864560|FG000|Overall Study|Lack of baseline fungus|32|||
146919040|NCT00804193|529864561|FG001|Overall Study|Lack of baseline fungus|31|||
146591450|NCT00075725|528674884|FG008|Overall Study|Pt non compliant with therapy|3|||
146591451|NCT00075725|528674885|FG009|Overall Study|Pt non compliant with therapy|0|||
146591452|NCT00075725|528674886|FG010|Overall Study|Pt non compliant with therapy|0|||
146591453|NCT00075725|528674887|FG011|Overall Study|Pt non compliant with therapy|0|||
146591454|NCT00075725|528674876|FG000|Overall Study|Pt age out of range for treatment|0|||
146591455|NCT00075725|528674877|FG001|Overall Study|Pt age out of range for treatment|1|||
146591456|NCT00075725|528674878|FG002|Overall Study|Pt age out of range for treatment|0|||
146591457|NCT00075725|528674879|FG003|Overall Study|Pt age out of range for treatment|0|||
146591458|NCT00075725|528674880|FG004|Overall Study|Pt age out of range for treatment|0|||
146591459|NCT00075725|528674881|FG005|Overall Study|Pt age out of range for treatment|1|||
146591460|NCT00075725|528674882|FG006|Overall Study|Pt age out of range for treatment|0|||
146591461|NCT00075725|528674883|FG007|Overall Study|Pt age out of range for treatment|1|||
146591462|NCT00075725|528674884|FG008|Overall Study|Pt age out of range for treatment|0|||
146591463|NCT00075725|528674885|FG009|Overall Study|Pt age out of range for treatment|0|||
146591464|NCT00075725|528674886|FG010|Overall Study|Pt age out of range for treatment|0|||
146591465|NCT00075725|528674887|FG011|Overall Study|Pt age out of range for treatment|0|||
146591466|NCT00075725|528674876|FG000|Overall Study|Insurance issues|0|||
146591467|NCT00075725|528674877|FG001|Overall Study|Insurance issues|1|||
146591468|NCT00075725|528674878|FG002|Overall Study|Insurance issues|0|||
146591469|NCT00075725|528674879|FG003|Overall Study|Insurance issues|1|||
146591470|NCT00075725|528674880|FG004|Overall Study|Insurance issues|1|||
146591471|NCT00075725|528674881|FG005|Overall Study|Insurance issues|1|||
146591472|NCT00075725|528674882|FG006|Overall Study|Insurance issues|0|||
146591473|NCT00075725|528674883|FG007|Overall Study|Insurance issues|1|||
146591474|NCT00075725|528674884|FG008|Overall Study|Insurance issues|0|||
146591475|NCT00075725|528674885|FG009|Overall Study|Insurance issues|0|||
146591476|NCT00075725|528674886|FG010|Overall Study|Insurance issues|0|||
146591477|NCT00075725|528674887|FG011|Overall Study|Insurance issues|0|||
146591478|NCT00075725|528674876|FG000|Overall Study|MRD positive after extended ind|0|||
146591479|NCT00075725|528674877|FG001|Overall Study|MRD positive after extended ind|1|||
146591480|NCT00075725|528674878|FG002|Overall Study|MRD positive after extended ind|1|||
146591481|NCT00075725|528674879|FG003|Overall Study|MRD positive after extended ind|0|||
146591482|NCT00075725|528674880|FG004|Overall Study|MRD positive after extended ind|1|||
146591483|NCT00075725|528674881|FG005|Overall Study|MRD positive after extended ind|2|||
146591484|NCT00075725|528674882|FG006|Overall Study|MRD positive after extended ind|0|||
146591485|NCT00075725|528674883|FG007|Overall Study|MRD positive after extended ind|1|||
146591486|NCT00075725|528674884|FG008|Overall Study|MRD positive after extended ind|0|||
146591487|NCT00075725|528674885|FG009|Overall Study|MRD positive after extended ind|0|||
146591488|NCT00075725|528674886|FG010|Overall Study|MRD positive after extended ind|0|||
146591489|NCT00075725|528674887|FG011|Overall Study|MRD positive after extended ind|0|||
146591490|NCT00075725|528674876|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
146591491|NCT00075725|528674877|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
146591492|NCT00075725|528674878|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
146591493|NCT00075725|528674879|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
146591494|NCT00075725|528674880|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
146591495|NCT00075725|528674881|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
146591496|NCT00075725|528674882|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
146591497|NCT00075725|528674883|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
146591498|NCT00075725|528674884|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
146591499|NCT00075725|528674885|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
146591500|NCT00075725|528674886|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
146591501|NCT00075725|528674887|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
146591502|NCT00075725|528674876|FG000|Overall Study|Inevaluable|1|||
146591503|NCT00075725|528674877|FG001|Overall Study|Inevaluable|1|||
146591504|NCT00075725|528674878|FG002|Overall Study|Inevaluable|4|||
146591505|NCT00075725|528674879|FG003|Overall Study|Inevaluable|2|||
146591506|NCT00075725|528674880|FG004|Overall Study|Inevaluable|2|||
146591507|NCT00075725|528674881|FG005|Overall Study|Inevaluable|9|||
146591508|NCT00075725|528674882|FG006|Overall Study|Inevaluable|1|||
146591509|NCT00075725|528674883|FG007|Overall Study|Inevaluable|11|||
146591510|NCT00075725|528674884|FG008|Overall Study|Inevaluable|2|||
146591511|NCT00075725|528674885|FG009|Overall Study|Inevaluable|0|||
146591512|NCT00075725|528674886|FG010|Overall Study|Inevaluable|1|||
146591513|NCT00075725|528674887|FG011|Overall Study|Inevaluable|0|||
146591514|NCT00075725|528674876|FG000|Overall Study|Other|4|||
146591515|NCT00075725|528674877|FG001|Overall Study|Other|2|||
146591516|NCT00075725|528674878|FG002|Overall Study|Other|1|||
146591517|NCT00075725|528674879|FG003|Overall Study|Other|1|||
146591518|NCT00075725|528674880|FG004|Overall Study|Other|1|||
146591519|NCT00075725|528674881|FG005|Overall Study|Other|4|||
146591520|NCT00075725|528674882|FG006|Overall Study|Other|2|||
146591521|NCT00075725|528674883|FG007|Overall Study|Other|9|||
146591522|NCT00075725|528674884|FG008|Overall Study|Other|2|||
146591523|NCT00075725|528674885|FG009|Overall Study|Other|1|||
146591524|NCT00075725|528674886|FG010|Overall Study|Other|0|||
146591525|NCT00075725|528674887|FG011|Overall Study|Other|3|||
146771244|NCT01460446|529331127|FG001|Overall Study|Pregnancy|0|||
146771245|NCT01460446|529331126|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
146771246|NCT01460446|529331127|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
146771247|NCT00516321|529331128|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
146771248|NCT00516321|529331129|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
146771249|NCT00516321|529331130|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
146771250|NCT00516321|529331128|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
146771251|NCT00516321|529331129|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
146771252|NCT00516321|529331130|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
146771253|NCT00516321|529331128|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
146771254|NCT00516321|529331129|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
146591526|NCT00075725|528674876|FG000|Overall Study|Pt trying to find a BM donor|0|||
146591527|NCT00075725|528674877|FG001|Overall Study|Pt trying to find a BM donor|1|||
146591528|NCT00075725|528674878|FG002|Overall Study|Pt trying to find a BM donor|0|||
146591529|NCT00075725|528674879|FG003|Overall Study|Pt trying to find a BM donor|0|||
146591530|NCT00075725|528674880|FG004|Overall Study|Pt trying to find a BM donor|0|||
146591531|NCT00075725|528674881|FG005|Overall Study|Pt trying to find a BM donor|0|||
146591532|NCT00075725|528674882|FG006|Overall Study|Pt trying to find a BM donor|0|||
146591533|NCT00075725|528674883|FG007|Overall Study|Pt trying to find a BM donor|0|||
146591534|NCT00075725|528674884|FG008|Overall Study|Pt trying to find a BM donor|0|||
146591535|NCT00075725|528674885|FG009|Overall Study|Pt trying to find a BM donor|0|||
146591536|NCT00075725|528674886|FG010|Overall Study|Pt trying to find a BM donor|0|||
146591537|NCT00075725|528674887|FG011|Overall Study|Pt trying to find a BM donor|0|||
146591538|NCT00075725|528674876|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
146591539|NCT00075725|528674877|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
146591540|NCT00075725|528674878|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
146591541|NCT00075725|528674879|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
146591542|NCT00075725|528674880|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
146591543|NCT00075725|528674881|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
146591544|NCT00075725|528674882|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
146591545|NCT00075725|528674883|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
146591546|NCT00075725|528674884|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
146591547|NCT00075725|528674885|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
146591548|NCT00075725|528674886|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
146591549|NCT00075725|528674887|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
146591550|NCT00075725|528674876|FG000|Overall Study|Unsuccessful institutional transfer|0|||
146591551|NCT00075725|528674877|FG001|Overall Study|Unsuccessful institutional transfer|0|||
146591552|NCT00075725|528674878|FG002|Overall Study|Unsuccessful institutional transfer|2|||
146591553|NCT00075725|528674879|FG003|Overall Study|Unsuccessful institutional transfer|0|||
146591554|NCT00075725|528674880|FG004|Overall Study|Unsuccessful institutional transfer|0|||
146591555|NCT00075725|528674881|FG005|Overall Study|Unsuccessful institutional transfer|0|||
146591556|NCT00075725|528674882|FG006|Overall Study|Unsuccessful institutional transfer|0|||
146591557|NCT00075725|528674883|FG007|Overall Study|Unsuccessful institutional transfer|0|||
146591558|NCT00075725|528674884|FG008|Overall Study|Unsuccessful institutional transfer|0|||
146591559|NCT00075725|528674885|FG009|Overall Study|Unsuccessful institutional transfer|1|||
146591560|NCT00075725|528674886|FG010|Overall Study|Unsuccessful institutional transfer|0|||
146591561|NCT00075725|528674887|FG011|Overall Study|Unsuccessful institutional transfer|0|||
146591562|NCT00075725|528674876|FG000|Overall Study|specimen(s) not submitted|0|||
146591563|NCT00075725|528674877|FG001|Overall Study|specimen(s) not submitted|0|||
146591564|NCT00075725|528674878|FG002|Overall Study|specimen(s) not submitted|2|||
146591565|NCT00075725|528674879|FG003|Overall Study|specimen(s) not submitted|0|||
146591566|NCT00075725|528674880|FG004|Overall Study|specimen(s) not submitted|0|||
146591567|NCT00075725|528674881|FG005|Overall Study|specimen(s) not submitted|0|||
146591568|NCT00075725|528674882|FG006|Overall Study|specimen(s) not submitted|0|||
146591569|NCT00075725|528674883|FG007|Overall Study|specimen(s) not submitted|0|||
146591570|NCT00075725|528674884|FG008|Overall Study|specimen(s) not submitted|0|||
146591571|NCT00075725|528674885|FG009|Overall Study|specimen(s) not submitted|0|||
146591572|NCT00075725|528674886|FG010|Overall Study|specimen(s) not submitted|0|||
146591573|NCT00075725|528674887|FG011|Overall Study|specimen(s) not submitted|0|||
146591574|NCT00075725|528674876|FG000|Overall Study|Pt went to transplant|0|||
146591575|NCT00075725|528674877|FG001|Overall Study|Pt went to transplant|0|||
146591576|NCT00075725|528674878|FG002|Overall Study|Pt went to transplant|0|||
146591577|NCT00075725|528674879|FG003|Overall Study|Pt went to transplant|1|||
146591578|NCT00075725|528674880|FG004|Overall Study|Pt went to transplant|0|||
146771255|NCT00516321|529331130|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
146591579|NCT00075725|528674881|FG005|Overall Study|Pt went to transplant|1|||
146591580|NCT00075725|528674882|FG006|Overall Study|Pt went to transplant|0|||
146591581|NCT00075725|528674883|FG007|Overall Study|Pt went to transplant|0|||
146591582|NCT00075725|528674884|FG008|Overall Study|Pt went to transplant|0|||
146591583|NCT00075725|528674885|FG009|Overall Study|Pt went to transplant|0|||
146591584|NCT00075725|528674886|FG010|Overall Study|Pt went to transplant|0|||
146591585|NCT00075725|528674887|FG011|Overall Study|Pt went to transplant|0|||
146591586|NCT00075725|528674876|FG000|Overall Study|Pt received additional steroids|0|||
146591587|NCT00075725|528674877|FG001|Overall Study|Pt received additional steroids|0|||
146591588|NCT00075725|528674878|FG002|Overall Study|Pt received additional steroids|0|||
146591589|NCT00075725|528674879|FG003|Overall Study|Pt received additional steroids|1|||
146591590|NCT00075725|528674880|FG004|Overall Study|Pt received additional steroids|0|||
146591591|NCT00075725|528674881|FG005|Overall Study|Pt received additional steroids|0|||
146591592|NCT00075725|528674882|FG006|Overall Study|Pt received additional steroids|0|||
146591593|NCT00075725|528674883|FG007|Overall Study|Pt received additional steroids|0|||
146591594|NCT00075725|528674884|FG008|Overall Study|Pt received additional steroids|0|||
146591595|NCT00075725|528674885|FG009|Overall Study|Pt received additional steroids|0|||
146591596|NCT00075725|528674886|FG010|Overall Study|Pt received additional steroids|0|||
146591597|NCT00075725|528674887|FG011|Overall Study|Pt received additional steroids|0|||
146591598|NCT00075725|528674876|FG000|Overall Study|Pt relocated|0|||
146591599|NCT00075725|528674877|FG001|Overall Study|Pt relocated|0|||
146591600|NCT00075725|528674878|FG002|Overall Study|Pt relocated|0|||
146591601|NCT00075725|528674879|FG003|Overall Study|Pt relocated|2|||
146591602|NCT00075725|528674880|FG004|Overall Study|Pt relocated|0|||
146591603|NCT00075725|528674881|FG005|Overall Study|Pt relocated|1|||
146591604|NCT00075725|528674882|FG006|Overall Study|Pt relocated|1|||
146591605|NCT00075725|528674883|FG007|Overall Study|Pt relocated|2|||
146591606|NCT00075725|528674884|FG008|Overall Study|Pt relocated|1|||
146591607|NCT00075725|528674885|FG009|Overall Study|Pt relocated|0|||
146591608|NCT00075725|528674886|FG010|Overall Study|Pt relocated|0|||
146591609|NCT00075725|528674887|FG011|Overall Study|Pt relocated|0|||
146591610|NCT00075725|528674876|FG000|Overall Study|Institution Terminated|0|||
146591611|NCT00075725|528674877|FG001|Overall Study|Institution Terminated|0|||
146591612|NCT00075725|528674878|FG002|Overall Study|Institution Terminated|0|||
146591613|NCT00075725|528674879|FG003|Overall Study|Institution Terminated|0|||
146591614|NCT00075725|528674880|FG004|Overall Study|Institution Terminated|1|||
146591615|NCT00075725|528674881|FG005|Overall Study|Institution Terminated|0|||
146591616|NCT00075725|528674882|FG006|Overall Study|Institution Terminated|0|||
146591617|NCT00075725|528674883|FG007|Overall Study|Institution Terminated|3|||
146591618|NCT00075725|528674884|FG008|Overall Study|Institution Terminated|0|||
146591619|NCT00075725|528674885|FG009|Overall Study|Institution Terminated|0|||
146591620|NCT00075725|528674886|FG010|Overall Study|Institution Terminated|0|||
146591621|NCT00075725|528674887|FG011|Overall Study|Institution Terminated|0|||
146591622|NCT00075725|528674876|FG000|Overall Study|Study Closure|1|||
146591623|NCT00075725|528674877|FG001|Overall Study|Study Closure|0|||
146591624|NCT00075725|528674878|FG002|Overall Study|Study Closure|0|||
146591625|NCT00075725|528674879|FG003|Overall Study|Study Closure|0|||
146591626|NCT00075725|528674880|FG004|Overall Study|Study Closure|1|||
146591627|NCT00075725|528674881|FG005|Overall Study|Study Closure|3|||
146591628|NCT00075725|528674882|FG006|Overall Study|Study Closure|0|||
146591629|NCT00075725|528674883|FG007|Overall Study|Study Closure|1|||
146591630|NCT00075725|528674884|FG008|Overall Study|Study Closure|0|||
146591631|NCT00075725|528674885|FG009|Overall Study|Study Closure|0|||
146591632|NCT00075725|528674886|FG010|Overall Study|Study Closure|0|||
146591633|NCT00075725|528674887|FG011|Overall Study|Study Closure|0|||
146591634|NCT00075725|528674876|FG000|Overall Study|Other complications|0|||
146591635|NCT00075725|528674877|FG001|Overall Study|Other complications|0|||
146591636|NCT00075725|528674878|FG002|Overall Study|Other complications|0|||
146591637|NCT00075725|528674879|FG003|Overall Study|Other complications|0|||
146591638|NCT00075725|528674880|FG004|Overall Study|Other complications|0|||
146591639|NCT00075725|528674881|FG005|Overall Study|Other complications|1|||
146591640|NCT00075725|528674882|FG006|Overall Study|Other complications|0|||
146591641|NCT00075725|528674883|FG007|Overall Study|Other complications|0|||
146591642|NCT00075725|528674884|FG008|Overall Study|Other complications|0|||
146591643|NCT00075725|528674885|FG009|Overall Study|Other complications|0|||
146591644|NCT00075725|528674886|FG010|Overall Study|Other complications|0|||
146591645|NCT00075725|528674887|FG011|Overall Study|Other complications|0|||
146591646|NCT00075725|528674876|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
146771256|NCT00516321|529331128|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
146771257|NCT00516321|529331129|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
146771258|NCT00516321|529331130|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
146591647|NCT00075725|528674877|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
146591648|NCT00075725|528674878|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
146591649|NCT00075725|528674879|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
146591650|NCT00075725|528674880|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
146591651|NCT00075725|528674881|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
146591652|NCT00075725|528674882|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
146591653|NCT00075725|528674883|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
146591654|NCT00075725|528674884|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
146591655|NCT00075725|528674885|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
146591656|NCT00075725|528674886|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
146591657|NCT00075725|528674887|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
146591658|NCT00075725|528674876|FG000|Overall Study|Pt incarcerated|0|||
146591659|NCT00075725|528674877|FG001|Overall Study|Pt incarcerated|0|||
146591660|NCT00075725|528674878|FG002|Overall Study|Pt incarcerated|0|||
146591661|NCT00075725|528674879|FG003|Overall Study|Pt incarcerated|0|||
146591662|NCT00075725|528674880|FG004|Overall Study|Pt incarcerated|0|||
146591663|NCT00075725|528674881|FG005|Overall Study|Pt incarcerated|0|||
146591664|NCT00075725|528674882|FG006|Overall Study|Pt incarcerated|0|||
146591665|NCT00075725|528674883|FG007|Overall Study|Pt incarcerated|1|||
146591666|NCT00075725|528674884|FG008|Overall Study|Pt incarcerated|0|||
146771259|NCT00516321|529331128|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
146771260|NCT00516321|529331129|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
146771261|NCT00516321|529331130|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
146771262|NCT00516321|529331128|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
146771263|NCT00516321|529331129|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
146771264|NCT00516321|529331130|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
146771265|NCT00516321|529331128|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
146591667|NCT00075725|528674885|FG009|Overall Study|Pt incarcerated|0|||
146591668|NCT00075725|528674886|FG010|Overall Study|Pt incarcerated|0|||
146591669|NCT00075725|528674887|FG011|Overall Study|Pt incarcerated|0|||
146591670|NCT03242772|528674888|FG000|Overall Study|Lost to Follow-up|2|||
146591671|NCT03242772|528674889|FG001|Overall Study|Lost to Follow-up|0|||
146591672|NCT03242772|528674888|FG000|Overall Study|Physician Decision|0|||
146591673|NCT03242772|528674889|FG001|Overall Study|Physician Decision|1|||
146591674|NCT03242772|528674888|FG000|Overall Study|Withdrawal by Subject|1|||
146591675|NCT03242772|528674889|FG001|Overall Study|Withdrawal by Subject|0|||
146591676|NCT04065074|528674891|FG000|Overall Study|Adverse Event|1|||
146771266|NCT00516321|529331129|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
146771267|NCT00516321|529331130|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
146771268|NCT00516321|529331128|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
146771269|NCT00516321|529331129|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
146771270|NCT00516321|529331130|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
146771271|NCT00516321|529331128|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
146771272|NCT00516321|529331129|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
146771273|NCT00516321|529331130|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
146771274|NCT00516321|529331128|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
146771275|NCT00516321|529331129|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
146771276|NCT00516321|529331130|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
146771277|NCT00516321|529331128|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
146771278|NCT00516321|529331129|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
146771279|NCT00516321|529331130|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
146771280|NCT01582100|529331139|FG000|Overall Study|Adverse Event|1|||
146771281|NCT01582100|529331139|FG000|Overall Study|Withdrawal by Subject|1|||
146771282|NCT01040689|529331140|FG000|Overall Study|Adverse Event|0|||
146771283|NCT01040689|529331141|FG001|Overall Study|Adverse Event|0|||
146771284|NCT01040689|529331142|FG002|Overall Study|Adverse Event|2|||
146771285|NCT01040689|529331143|FG003|Overall Study|Adverse Event|4|||
146771286|NCT01040689|529331140|FG000|Overall Study|Lack of Efficacy|0|||
146771287|NCT01040689|529331141|FG001|Overall Study|Lack of Efficacy|0|||
146771288|NCT01040689|529331142|FG002|Overall Study|Lack of Efficacy|1|||
146771289|NCT01040689|529331143|FG003|Overall Study|Lack of Efficacy|0|||
146771290|NCT01040689|529331140|FG000|Overall Study|Lost to Follow-up|1|||
146771291|NCT01040689|529331141|FG001|Overall Study|Lost to Follow-up|0|||
146771292|NCT01040689|529331142|FG002|Overall Study|Lost to Follow-up|0|||
146771293|NCT01040689|529331143|FG003|Overall Study|Lost to Follow-up|0|||
146771294|NCT01040689|529331140|FG000|Overall Study|Withdrawal by Subject|2|||
146771295|NCT01040689|529331141|FG001|Overall Study|Withdrawal by Subject|1|||
146771296|NCT01040689|529331142|FG002|Overall Study|Withdrawal by Subject|1|||
146771297|NCT01040689|529331143|FG003|Overall Study|Withdrawal by Subject|0|||
146771298|NCT01040689|529331140|FG000|Overall Study|Other reasons not listed above|0|||
146771299|NCT01040689|529331141|FG001|Overall Study|Other reasons not listed above|1|||
146978378|NCT02919475|530084030|FG002|Overall Study|Lost to Follow-up|0|||
146978379|NCT02919475|530084031|FG003|Overall Study|Lost to Follow-up|1|||
146591677|NCT04065074|528674891|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
146591678|NCT02437305|528674892|FG000|Overall Study|Lost to Follow-up|18|||
146591679|NCT02437305|528674893|FG001|Overall Study|Lost to Follow-up|12|||
146591680|NCT01560637|528674894|FG000|Overall Study|Adverse Event|63|||
146591681|NCT01560637|528674894|FG000|Overall Study|Death|69|||
146591682|NCT01560637|528674894|FG000|Overall Study|Lost to Follow-up|8|||
146591683|NCT01560637|528674894|FG000|Overall Study|Protocol Violation|8|||
146591684|NCT01560637|528674894|FG000|Overall Study|Withdrawal by Subject|24|||
146591685|NCT01560637|528674894|FG000|Overall Study|Progressive Disease|20|||
146591686|NCT01560637|528674894|FG000|Overall Study|Other Reason Not Specified|6|||
146591687|NCT01185964|528674895|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
146591688|NCT01185964|528674896|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
146591689|NCT01185964|528674897|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
146591690|NCT01185964|528674898|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
146591691|NCT01185964|528674895|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
146591692|NCT01185964|528674896|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
146591693|NCT01185964|528674897|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
146591694|NCT01185964|528674898|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
146591695|NCT01185964|528674895|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
146591696|NCT01185964|528674896|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
146591697|NCT01185964|528674897|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
146591698|NCT01185964|528674898|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
146591699|NCT01185964|528674895|FG000|Phase 1b and Phase 2|Adverse Event|1|||
146591700|NCT01185964|528674896|FG001|Phase 1b and Phase 2|Adverse Event|0|||
146591701|NCT01185964|528674897|FG002|Phase 1b and Phase 2|Adverse Event|2|||
146591702|NCT01185964|528674898|FG003|Phase 1b and Phase 2|Adverse Event|0|||
146591703|NCT01185964|528674895|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
146591704|NCT01185964|528674896|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
146591705|NCT01185964|528674897|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
146591706|NCT01185964|528674898|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
146591707|NCT01185964|528674895|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
146591708|NCT01185964|528674896|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
146591709|NCT01185964|528674897|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
146591710|NCT01185964|528674898|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
146591711|NCT01185964|528674895|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
146591712|NCT01185964|528674896|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
146591713|NCT01185964|528674897|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
146591714|NCT01185964|528674898|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
146591715|NCT01185964|528674895|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
146591716|NCT01185964|528674896|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
146591717|NCT01185964|528674897|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
146591718|NCT01185964|528674898|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
146591719|NCT03440918|528674910|FG000|Overall Study|Protocol Violation|0|||
146591720|NCT03440918|528674911|FG001|Overall Study|Protocol Violation|16|||
146591721|NCT01396265|528674912|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
146591722|NCT03444766|528674913|FG000|Overall Study|Other Reasons|2|||
146591723|NCT03444766|528674913|FG000|Overall Study|Participant Withdrew Consent|5|||
146591724|NCT03444766|528674913|FG000|Overall Study|Lost to Follow-up|2|||
146591725|NCT03444766|528674913|FG000|Overall Study|Death|2|||
146591726|NCT03444766|528674913|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
146591727|NCT03444766|528674913|FG000|Overall Study|Disease Progression|49|||
146591728|NCT04346108|528674914|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
146591729|NCT04346108|528674915|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
146591730|NCT04346108|528674916|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
146591731|NCT04346108|528674914|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
146591732|NCT04346108|528674915|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
146591733|NCT04346108|528674916|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
146591734|NCT01081301|528674917|FG000|Overall Study|Bereaved|3|||
146591735|NCT01081301|528674917|FG000|Overall Study|Too busy|5|||
146591736|NCT01081301|528674917|FG000|Overall Study|Patient too ill|2|||
146591737|NCT01081301|528674917|FG000|Overall Study|Lost to Follow-up|4|||
146591738|NCT00724854|528674918|FG000|Overall Study|Lack of Efficacy|187|||
146591739|NCT00724854|528674919|FG001|Overall Study|Lack of Efficacy|13|||
146591740|NCT00724854|528674918|FG000|Overall Study|Lost to Follow-up|87|||
146591741|NCT00724854|528674919|FG001|Overall Study|Lost to Follow-up|10|||
146591742|NCT00724854|528674918|FG000|Overall Study|Adverse Event|62|||
146591743|NCT00724854|528674919|FG001|Overall Study|Adverse Event|4|||
146591744|NCT00724854|528674918|FG000|Overall Study|Other|42|||
146591745|NCT00724854|528674919|FG001|Overall Study|Other|3|||
146591746|NCT00724854|528674918|FG000|Overall Study|Death|11|||
146591747|NCT00724854|528674919|FG001|Overall Study|Death|0|||
146591748|NCT00724854|528674918|FG000|Overall Study|Change of treatment|7|||
146591749|NCT00724854|528674919|FG001|Overall Study|Change of treatment|0|||
146591750|NCT00724854|528674918|FG000|Overall Study|Withdrawal by Subject|5|||
146591751|NCT00724854|528674919|FG001|Overall Study|Withdrawal by Subject|0|||
146591752|NCT00724854|528674918|FG000|Overall Study|Adverse event + lack of efficacy|2|||
146591753|NCT00724854|528674919|FG001|Overall Study|Adverse event + lack of efficacy|1|||
146771300|NCT01040689|529331142|FG002|Overall Study|Other reasons not listed above|0|||
146591754|NCT01095653|528674920|FG000|Overall Study|Lack of Efficacy|3|||
146591755|NCT01095653|528674921|FG001|Overall Study|Lack of Efficacy|0|||
146591756|NCT01095653|528674922|FG002|Overall Study|Lack of Efficacy|0|||
146591757|NCT01095653|528674920|FG000|Overall Study|Adverse Event|1|||
146771301|NCT01040689|529331143|FG003|Overall Study|Other reasons not listed above|0|||
146771302|NCT01185561|529331144|FG000|Overall Study|Lost to Follow-up|0|||
146771303|NCT01185561|529331145|FG001|Overall Study|Lost to Follow-up|4|||
146771304|NCT01185561|529331144|FG000|Overall Study|Withdrawal by Subject|2|||
146771305|NCT01185561|529331145|FG001|Overall Study|Withdrawal by Subject|8|||
146771306|NCT01078116|529331146|FG000|Overall Study|Lost to Follow-up|17|||
146771307|NCT01078116|529331146|FG000|Overall Study|Adverse Event|5|||
146771308|NCT01078116|529331146|FG000|Overall Study|Withdrawal by Subject|8|||
146771309|NCT01078116|529331146|FG000|Overall Study|Lack of effectiveness|15|||
146771310|NCT01078116|529331146|FG000|Overall Study|Case report form not completed|3|||
146771311|NCT02616900|529331147|FG000|Overall Study|Lack of Efficacy|7|||
146771312|NCT02616900|529331147|FG000|Overall Study|Lost to Follow-up|2|||
146771313|NCT02616900|529331147|FG000|Overall Study|Protocol Violation|5|||
146771314|NCT02616900|529331147|FG000|Overall Study|Withdrawal by Subject|3|||
146771315|NCT02616900|529331147|FG000|Overall Study|Incomplete data|6|||
146771316|NCT00979992|529331149|FG000|Overall Study|Ineligible - inadequate pathology|1|||
146771317|NCT00979992|529331149|FG000|Overall Study|Ineligible - wrong cell type|2|||
146771318|NCT00979992|529331149|FG000|Overall Study|Refused - Never Treated|2|||
146771319|NCT03691428|529331150|FG000|Overall Study|Withdrawal by Subject|6|||
146771320|NCT03691428|529331151|FG001|Overall Study|Withdrawal by Subject|8|||
146771321|NCT01460290|529331152|FG000|Overall Study|Adverse Event|3|||
146771322|NCT01460290|529331152|FG000|Overall Study|Elevated liver function|1|||
146771323|NCT02527148|529331153|FG000|Overall Study|Did not receive study intervention|1|||
146771324|NCT02527148|529331154|FG001|Overall Study|Did not receive study intervention|0|||
146771325|NCT00463788|529331165|FG000|Overall Study|Progressive Disease|86|||
146771326|NCT00463788|529331166|FG001|Overall Study|Progressive Disease|42|||
146771327|NCT00463788|529331165|FG000|Overall Study|Adverse Event|6|||
146771328|NCT00463788|529331166|FG001|Overall Study|Adverse Event|2|||
146771329|NCT00463788|529331165|FG000|Overall Study|Withdrawal by Subject|6|||
146771330|NCT00463788|529331166|FG001|Overall Study|Withdrawal by Subject|2|||
146771331|NCT00463788|529331165|FG000|Overall Study|Death|4|||
146771332|NCT00463788|529331166|FG001|Overall Study|Death|3|||
146771333|NCT00463788|529331165|FG000|Overall Study|Symptomatic Deterioration|2|||
146771334|NCT00463788|529331166|FG001|Overall Study|Symptomatic Deterioration|3|||
146771335|NCT00463788|529331165|FG000|Overall Study|Lost to Follow-up|1|||
146919041|NCT00804193|529864562|FG002|Overall Study|Lack of baseline fungus|19|||
146919042|NCT00804193|529864560|FG000|Overall Study|Adverse Event|0|||
146919043|NCT00804193|529864561|FG001|Overall Study|Adverse Event|0|||
146919044|NCT00804193|529864562|FG002|Overall Study|Adverse Event|2|||
146919045|NCT00804193|529864560|FG000|Overall Study|Lack of Efficacy|1|||
146919046|NCT00804193|529864561|FG001|Overall Study|Lack of Efficacy|1|||
146919047|NCT00804193|529864562|FG002|Overall Study|Lack of Efficacy|3|||
146919048|NCT00804193|529864560|FG000|Overall Study|Protocol Violation|0|||
146591758|NCT01095653|528674921|FG001|Overall Study|Adverse Event|4|||
146591759|NCT01095653|528674922|FG002|Overall Study|Adverse Event|4|||
146591760|NCT01095653|528674920|FG000|Overall Study|Lost to Follow-up|1|||
146591761|NCT01095653|528674921|FG001|Overall Study|Lost to Follow-up|0|||
146591762|NCT01095653|528674922|FG002|Overall Study|Lost to Follow-up|4|||
146591763|NCT01095653|528674920|FG000|Overall Study|Withdrawal by Subject|4|||
146591764|NCT01095653|528674921|FG001|Overall Study|Withdrawal by Subject|5|||
146591765|NCT01095653|528674922|FG002|Overall Study|Withdrawal by Subject|3|||
146591766|NCT01095653|528674920|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
146591767|NCT01095653|528674921|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
146591768|NCT01095653|528674922|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
146591769|NCT02046226|528674923|FG000|Overall Study|Lost to Follow-up|7|||
146591770|NCT00171925|528674924|FG000|Overall Study|Adverse Event|10|||
146591771|NCT00171925|528674925|FG001|Overall Study|Adverse Event|6|||
146591772|NCT00171925|528674924|FG000|Overall Study|Protocol Violation|1|||
146591773|NCT00171925|528674925|FG001|Overall Study|Protocol Violation|1|||
146591774|NCT00171925|528674924|FG000|Overall Study|Withdrawal by Subject|6|||
146591775|NCT00171925|528674925|FG001|Overall Study|Withdrawal by Subject|9|||
146591776|NCT00171925|528674924|FG000|Overall Study|Lost to Follow-up|2|||
146919049|NCT00804193|529864561|FG001|Overall Study|Protocol Violation|8|||
146919050|NCT00804193|529864562|FG002|Overall Study|Protocol Violation|2|||
146919051|NCT00804193|529864560|FG000|Overall Study|Lost to Follow-up|3|||
146919052|NCT00804193|529864561|FG001|Overall Study|Lost to Follow-up|3|||
146591777|NCT00171925|528674925|FG001|Overall Study|Lost to Follow-up|2|||
146591778|NCT00171925|528674924|FG000|Overall Study|Administrative problems|10|||
146591779|NCT00171925|528674925|FG001|Overall Study|Administrative problems|11|||
146591780|NCT00171925|528674924|FG000|Overall Study|Death|1|||
146591781|NCT00171925|528674925|FG001|Overall Study|Death|2|||
146771336|NCT00463788|529331166|FG001|Overall Study|Lost to Follow-up|0|||
146771337|NCT00463788|529331165|FG000|Overall Study|Protocol Violation|0|||
146771338|NCT00463788|529331166|FG001|Overall Study|Protocol Violation|1|||
146771339|NCT00463788|529331165|FG000|Overall Study|Other|3|||
146771340|NCT00463788|529331166|FG001|Overall Study|Other|0|||
146771341|NCT00463788|529331165|FG000|Overall Study|Randomized but not treated|1|||
146919053|NCT00804193|529864562|FG002|Overall Study|Lost to Follow-up|4|||
146978380|NCT02919475|530084032|FG004|Overall Study|Lost to Follow-up|0|||
146591782|NCT02182440|528674926|FG000|Overall Study|Adverse Event|0|||
146591783|NCT02182440|528674927|FG001|Overall Study|Adverse Event|1|||
146591784|NCT02182440|528674928|FG002|Overall Study|Adverse Event|0|||
146591785|NCT02182440|528674929|FG003|Overall Study|Adverse Event|0|||
146591786|NCT02182440|528674926|FG000|Overall Study|Death|31|||
146591787|NCT02182440|528674927|FG001|Overall Study|Death|8|||
146591788|NCT02182440|528674928|FG002|Overall Study|Death|5|||
146591789|NCT02182440|528674929|FG003|Overall Study|Death|16|||
146591790|NCT02182440|528674926|FG000|Overall Study|Protocol Violation|0|||
146591791|NCT02182440|528674927|FG001|Overall Study|Protocol Violation|1|||
146591792|NCT02182440|528674928|FG002|Overall Study|Protocol Violation|0|||
146591793|NCT02182440|528674929|FG003|Overall Study|Protocol Violation|0|||
146591794|NCT02182440|528674926|FG000|Overall Study|Physician Decision|1|||
146591795|NCT02182440|528674927|FG001|Overall Study|Physician Decision|0|||
146591796|NCT02182440|528674928|FG002|Overall Study|Physician Decision|0|||
146591797|NCT02182440|528674929|FG003|Overall Study|Physician Decision|0|||
146591798|NCT02182440|528674926|FG000|Overall Study|Withdrawal by Subject|1|||
146591799|NCT02182440|528674927|FG001|Overall Study|Withdrawal by Subject|1|||
146591800|NCT02182440|528674928|FG002|Overall Study|Withdrawal by Subject|3|||
146591801|NCT02182440|528674929|FG003|Overall Study|Withdrawal by Subject|4|||
146591802|NCT02182440|528674926|FG000|Overall Study|different, e.g adm other hospital|12|||
146591803|NCT02182440|528674927|FG001|Overall Study|different, e.g adm other hospital|3|||
146591804|NCT02182440|528674928|FG002|Overall Study|different, e.g adm other hospital|3|||
146591805|NCT02182440|528674929|FG003|Overall Study|different, e.g adm other hospital|10|||
146591806|NCT03754582|528674932|FG000|Treatment Phase|Adverse Event|0|||
146591807|NCT03754582|528674933|FG001|Treatment Phase|Adverse Event|1|||
146591808|NCT03754582|528674934|FG002|Treatment Phase|Adverse Event|0|||
146591809|NCT03754582|528674932|FG000|Follow-up Phase|Other|0|||
146591810|NCT03754582|528674933|FG001|Follow-up Phase|Other|0|||
146591811|NCT03754582|528674934|FG002|Follow-up Phase|Other|1|||
146591812|NCT01799239|528674935|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
146591813|NCT01799239|528674936|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
146591814|NCT01799239|528674935|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
146591815|NCT01799239|528674936|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
146591816|NCT01799239|528674935|FG000|Period 1 (7 Days)|Protocol Violation|0|||
146591817|NCT01799239|528674936|FG001|Period 1 (7 Days)|Protocol Violation|1|||
146591818|NCT01799239|528674935|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
146591819|NCT01799239|528674936|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
146591820|NCT01799239|528674935|FG000|Period 2 (7 Days)|Protocol Violation|1|||
146591821|NCT01799239|528674936|FG001|Period 2 (7 Days)|Protocol Violation|0|||
146591822|NCT01561755|528674937|FG000|Overall Study|Lost to Follow-up|0|||
146591823|NCT01561755|528674938|FG001|Overall Study|Lost to Follow-up|1|||
146591824|NCT01166958|528674939|FG000|Overall Study|Withdrawal by Subject|1|||
146591825|NCT01166958|528674940|FG001|Overall Study|Withdrawal by Subject|0|||
146591826|NCT02680574|528674941|FG000|Overall Study|Death|137|||
146591827|NCT02680574|528674942|FG001|Overall Study|Death|137|||
146591828|NCT02680574|528674941|FG000|Overall Study|Withdrawal by Subject|17|||
146591829|NCT02680574|528674942|FG001|Overall Study|Withdrawal by Subject|9|||
146591830|NCT02680574|528674941|FG000|Overall Study|Lost to Follow-up|4|||
146591831|NCT02680574|528674942|FG001|Overall Study|Lost to Follow-up|6|||
146591832|NCT01286987|528674943|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
146978381|NCT02919475|530084028|FG000|Overall Study|Withdrawal by Subject|2|||
146591833|NCT01286987|528674944|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
146591834|NCT01286987|528674945|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
146591835|NCT01286987|528674946|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
146591836|NCT01286987|528674947|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
146591837|NCT01286987|528674948|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
146591838|NCT01286987|528674949|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
146591839|NCT01286987|528674950|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
146591840|NCT01286987|528674951|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
146591841|NCT01286987|528674952|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
146591842|NCT01286987|528674953|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
146978382|NCT02919475|530084029|FG001|Overall Study|Withdrawal by Subject|3|||
146591843|NCT01286987|528674954|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
146591844|NCT01286987|528674955|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
146591845|NCT01286987|528674956|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
146978383|NCT02919475|530084030|FG002|Overall Study|Withdrawal by Subject|1|||
146978384|NCT02919475|530084031|FG003|Overall Study|Withdrawal by Subject|2|||
146591846|NCT01286987|528674957|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
146591847|NCT01286987|528674943|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
146591848|NCT01286987|528674944|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
146591849|NCT01286987|528674945|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
146591850|NCT01286987|528674946|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
146591851|NCT01286987|528674947|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
146591852|NCT01286987|528674948|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
146591853|NCT01286987|528674949|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
146591854|NCT01286987|528674950|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
146591855|NCT01286987|528674951|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
146591856|NCT01286987|528674952|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
146653015|NCT00998764|528908131|FG000|Overall Study|Adverse Event|17|||
146653016|NCT00998764|528908132|FG001|Overall Study|Adverse Event|12|||
146653017|NCT00998764|528908131|FG000|Overall Study|Withdrawal by Subject|19|||
146653018|NCT00998764|528908132|FG001|Overall Study|Withdrawal by Subject|25|||
146653019|NCT00998764|528908131|FG000|Overall Study|Physician Decision|3|||
146653020|NCT00998764|528908132|FG001|Overall Study|Physician Decision|3|||
146653021|NCT00998764|528908131|FG000|Overall Study|Death|3|||
146653022|NCT00998764|528908132|FG001|Overall Study|Death|1|||
146653023|NCT00998764|528908131|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
146653024|NCT00998764|528908132|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
146653025|NCT00998764|528908131|FG000|Overall Study|Protocol Violation|0|||
146653026|NCT00998764|528908132|FG001|Overall Study|Protocol Violation|1|||
146653027|NCT00998764|528908131|FG000|Overall Study|Failed to Return|1|||
146653028|NCT00998764|528908132|FG001|Overall Study|Failed to Return|1|||
146653029|NCT00998764|528908131|FG000|Overall Study|Lost to Follow-up|1|||
146653030|NCT00998764|528908132|FG001|Overall Study|Lost to Follow-up|1|||
146771342|NCT00463788|529331166|FG001|Overall Study|Randomized but not treated|1|||
146771343|NCT00360698|529331167|FG000|Run-In|Physician Decision|0|||
146591857|NCT01286987|528674953|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
146591858|NCT01286987|528674954|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
146591859|NCT01286987|528674955|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
146591860|NCT01286987|528674956|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
146591861|NCT01286987|528674957|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
146591862|NCT01286987|528674943|FG000|Part 1: Dose Escalation|Physician Decision|0|||
146591863|NCT01286987|528674944|FG001|Part 1: Dose Escalation|Physician Decision|0|||
146591864|NCT01286987|528674945|FG002|Part 1: Dose Escalation|Physician Decision|0|||
146591865|NCT01286987|528674946|FG003|Part 1: Dose Escalation|Physician Decision|0|||
146591866|NCT01286987|528674947|FG004|Part 1: Dose Escalation|Physician Decision|1|||
146591867|NCT01286987|528674948|FG005|Part 1: Dose Escalation|Physician Decision|0|||
146591868|NCT01286987|528674949|FG006|Part 1: Dose Escalation|Physician Decision|0|||
146591869|NCT01286987|528674950|FG007|Part 1: Dose Escalation|Physician Decision|0|||
146591870|NCT01286987|528674951|FG008|Part 1: Dose Escalation|Physician Decision|0|||
146591871|NCT01286987|528674952|FG009|Part 1: Dose Escalation|Physician Decision|0|||
146591872|NCT01286987|528674953|FG010|Part 1: Dose Escalation|Physician Decision|0|||
146591873|NCT01286987|528674954|FG011|Part 1: Dose Escalation|Physician Decision|0|||
146591874|NCT01286987|528674955|FG012|Part 1: Dose Escalation|Physician Decision|0|||
146591875|NCT01286987|528674956|FG013|Part 1: Dose Escalation|Physician Decision|0|||
146591876|NCT01286987|528674957|FG014|Part 1: Dose Escalation|Physician Decision|0|||
146591877|NCT01286987|528674943|FG000|Part 2: Dose Expansion|Death|0|||
146591878|NCT01286987|528674944|FG001|Part 2: Dose Expansion|Death|0|||
146591879|NCT01286987|528674945|FG002|Part 2: Dose Expansion|Death|0|||
146591880|NCT01286987|528674946|FG003|Part 2: Dose Expansion|Death|0|||
146591881|NCT01286987|528674947|FG004|Part 2: Dose Expansion|Death|0|||
146591882|NCT01286987|528674948|FG005|Part 2: Dose Expansion|Death|0|||
146591883|NCT01286987|528674949|FG006|Part 2: Dose Expansion|Death|0|||
146591884|NCT01286987|528674950|FG007|Part 2: Dose Expansion|Death|0|||
146591885|NCT01286987|528674951|FG008|Part 2: Dose Expansion|Death|0|||
146591886|NCT01286987|528674952|FG009|Part 2: Dose Expansion|Death|0|||
146591887|NCT01286987|528674953|FG010|Part 2: Dose Expansion|Death|0|||
146591888|NCT01286987|528674954|FG011|Part 2: Dose Expansion|Death|0|||
146591889|NCT01286987|528674955|FG012|Part 2: Dose Expansion|Death|1|||
146591890|NCT01286987|528674956|FG013|Part 2: Dose Expansion|Death|1|||
146591891|NCT01286987|528674957|FG014|Part 2: Dose Expansion|Death|0|||
146591892|NCT01286987|528674943|FG000|Part 2: Dose Expansion|Physician Decision|0|||
146591893|NCT01286987|528674944|FG001|Part 2: Dose Expansion|Physician Decision|0|||
146591894|NCT01286987|528674945|FG002|Part 2: Dose Expansion|Physician Decision|0|||
146591895|NCT01286987|528674946|FG003|Part 2: Dose Expansion|Physician Decision|0|||
146591896|NCT01286987|528674947|FG004|Part 2: Dose Expansion|Physician Decision|0|||
146591897|NCT01286987|528674948|FG005|Part 2: Dose Expansion|Physician Decision|0|||
146591898|NCT01286987|528674949|FG006|Part 2: Dose Expansion|Physician Decision|0|||
146591899|NCT01286987|528674950|FG007|Part 2: Dose Expansion|Physician Decision|0|||
146591900|NCT01286987|528674951|FG008|Part 2: Dose Expansion|Physician Decision|0|||
146591901|NCT01286987|528674952|FG009|Part 2: Dose Expansion|Physician Decision|0|||
146591902|NCT01286987|528674953|FG010|Part 2: Dose Expansion|Physician Decision|1|||
146653031|NCT00998764|528908131|FG000|Overall Study|Loss of Caregiver|0|||
146653032|NCT00998764|528908132|FG001|Overall Study|Loss of Caregiver|3|||
146653033|NCT00998764|528908131|FG000|Overall Study|Other|4|||
146771344|NCT00360698|529331168|FG001|Run-In|Physician Decision|1|||
146653034|NCT00998764|528908132|FG001|Overall Study|Other|4|||
146771345|NCT00360698|529331167|FG000|Run-In|Withdrawal by Subject|0|||
146591903|NCT01286987|528674954|FG011|Part 2: Dose Expansion|Physician Decision|1|||
146591904|NCT01286987|528674955|FG012|Part 2: Dose Expansion|Physician Decision|0|||
146919054|NCT00804193|529864560|FG000|Overall Study|Withdrawal by Subject|3|||
146919055|NCT00804193|529864561|FG001|Overall Study|Withdrawal by Subject|1|||
146919056|NCT00804193|529864562|FG002|Overall Study|Withdrawal by Subject|2|||
146919057|NCT04072146|529864565|FG000|Overall Study|Adverse Event|0|||
146919058|NCT04072146|529864566|FG001|Overall Study|Adverse Event|1|||
146919059|NCT01617434|529864567|FG000|Overall Study|Adverse Event|12|||
146591905|NCT01286987|528674956|FG013|Part 2: Dose Expansion|Physician Decision|1|||
146591906|NCT01286987|528674957|FG014|Part 2: Dose Expansion|Physician Decision|0|||
146591907|NCT01286987|528674943|FG000|Part 2: Dose Expansion|Other|0|||
146591908|NCT01286987|528674944|FG001|Part 2: Dose Expansion|Other|0|||
146591909|NCT01286987|528674945|FG002|Part 2: Dose Expansion|Other|0|||
146591910|NCT01286987|528674946|FG003|Part 2: Dose Expansion|Other|0|||
146591911|NCT01286987|528674947|FG004|Part 2: Dose Expansion|Other|0|||
146591912|NCT01286987|528674948|FG005|Part 2: Dose Expansion|Other|0|||
146591913|NCT01286987|528674949|FG006|Part 2: Dose Expansion|Other|0|||
146591914|NCT01286987|528674950|FG007|Part 2: Dose Expansion|Other|0|||
146591915|NCT01286987|528674951|FG008|Part 2: Dose Expansion|Other|0|||
146591916|NCT01286987|528674952|FG009|Part 2: Dose Expansion|Other|0|||
146591917|NCT01286987|528674953|FG010|Part 2: Dose Expansion|Other|0|||
146591918|NCT01286987|528674954|FG011|Part 2: Dose Expansion|Other|0|||
146591919|NCT01286987|528674955|FG012|Part 2: Dose Expansion|Other|0|||
146591920|NCT01286987|528674956|FG013|Part 2: Dose Expansion|Other|1|||
146591921|NCT01286987|528674957|FG014|Part 2: Dose Expansion|Other|0|||
146591922|NCT01286987|528674943|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
146591923|NCT01286987|528674944|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
146591924|NCT01286987|528674945|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
146591925|NCT01286987|528674946|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
146591926|NCT01286987|528674947|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
146591927|NCT01286987|528674948|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
146591928|NCT01286987|528674949|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
146591929|NCT01286987|528674950|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
146591930|NCT01286987|528674951|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
146591931|NCT01286987|528674952|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
146591932|NCT01286987|528674953|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
146591933|NCT01286987|528674954|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
146591934|NCT01286987|528674955|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
146591935|NCT01286987|528674956|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
146591936|NCT01286987|528674957|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
146591937|NCT01286987|528674943|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
146591938|NCT01286987|528674944|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
146591939|NCT01286987|528674945|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
146591940|NCT01286987|528674946|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
146591941|NCT01286987|528674947|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
146591942|NCT01286987|528674948|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
146591943|NCT01286987|528674949|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
146591944|NCT01286987|528674950|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
146591945|NCT01286987|528674951|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
146591946|NCT01286987|528674952|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
146653035|NCT00998764|528908131|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
146653036|NCT00998764|528908132|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
146653037|NCT04761627|528908135|FG000|Run-in Period|Death|1|||
146653038|NCT04761627|528908136|FG001|Run-in Period|Death|0|||
146653039|NCT04761627|528908137|FG002|Run-in Period|Death|0|||
146653040|NCT04761627|528908135|FG000|Run-in Period|Required alternative therapy|2|||
146653041|NCT04761627|528908136|FG001|Run-in Period|Required alternative therapy|0|||
146653042|NCT04761627|528908137|FG002|Run-in Period|Required alternative therapy|0|||
146653043|NCT04761627|528908135|FG000|Run-in Period|Lost to Follow-up|2|||
146653044|NCT04761627|528908136|FG001|Run-in Period|Lost to Follow-up|0|||
146653045|NCT04761627|528908137|FG002|Run-in Period|Lost to Follow-up|0|||
146653046|NCT04761627|528908135|FG000|Run-in Period|Protocol Violation|3|||
146653047|NCT04761627|528908136|FG001|Run-in Period|Protocol Violation|0|||
146653048|NCT04761627|528908137|FG002|Run-in Period|Protocol Violation|0|||
146653049|NCT04761627|528908135|FG000|Run-in Period|Abnormal liver function|1|||
146653050|NCT04761627|528908136|FG001|Run-in Period|Abnormal liver function|0|||
146653051|NCT04761627|528908137|FG002|Run-in Period|Abnormal liver function|0|||
146978385|NCT02919475|530084032|FG004|Overall Study|Withdrawal by Subject|2|||
146591947|NCT01286987|528674953|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
146653052|NCT04761627|528908135|FG000|Run-in Period|Adverse Event|6|||
146653053|NCT04761627|528908136|FG001|Run-in Period|Adverse Event|0|||
146653054|NCT04761627|528908137|FG002|Run-in Period|Adverse Event|0|||
146653055|NCT04761627|528908135|FG000|Run-in Period|Withdrawal by Subject|7|||
146919060|NCT01617434|529864568|FG001|Overall Study|Adverse Event|3|||
146919061|NCT01617434|529864567|FG000|Overall Study|Protocol Violation|8|||
146591948|NCT01286987|528674954|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
146591949|NCT01286987|528674955|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
146591950|NCT01286987|528674956|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
146591951|NCT01286987|528674957|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
146591952|NCT01286987|528674943|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146591953|NCT01286987|528674944|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146591954|NCT01286987|528674945|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146591955|NCT01286987|528674946|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146591956|NCT01286987|528674947|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146591957|NCT01286987|528674948|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146591958|NCT01286987|528674949|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146591959|NCT01286987|528674950|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146591960|NCT01286987|528674951|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146591961|NCT01286987|528674952|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146591962|NCT01286987|528674953|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
146591963|NCT01286987|528674954|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146591964|NCT01286987|528674955|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146591965|NCT01286987|528674956|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146591966|NCT01286987|528674957|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146591967|NCT00681564|528674960|FG000|Overall Study|Lost to Follow-up|6|||
146591968|NCT00681564|528674961|FG001|Overall Study|Lost to Follow-up|6|||
146591969|NCT00681564|528674960|FG000|Overall Study|Withdrawal by Subject|0|||
146591970|NCT00681564|528674961|FG001|Overall Study|Withdrawal by Subject|1|||
146591971|NCT00681564|528674960|FG000|Overall Study|Death|0|||
146771346|NCT00360698|529331168|FG001|Run-In|Withdrawal by Subject|2|||
146771347|NCT00360698|529331167|FG000|Run-In|Non compliance with treatment procedure|0|||
146591972|NCT00681564|528674961|FG001|Overall Study|Death|1|||
146591973|NCT02826421|528674964|FG000|Overall Study|Adverse Event|1|||
146591974|NCT02826421|528674965|FG001|Overall Study|Adverse Event|0|||
146591975|NCT02826421|528674966|FG002|Overall Study|Adverse Event|0|||
146591976|NCT02826421|528674967|FG003|Overall Study|Adverse Event|1|||
146591977|NCT02826421|528674964|FG000|Overall Study|Withdrawal by Subject|1|||
146591978|NCT02826421|528674965|FG001|Overall Study|Withdrawal by Subject|3|||
146591979|NCT02826421|528674966|FG002|Overall Study|Withdrawal by Subject|1|||
146591980|NCT02826421|528674967|FG003|Overall Study|Withdrawal by Subject|1|||
146591981|NCT02826421|528674964|FG000|Overall Study|Reason not given|1|||
146591982|NCT02826421|528674965|FG001|Overall Study|Reason not given|0|||
146591983|NCT02826421|528674966|FG002|Overall Study|Reason not given|1|||
146591984|NCT02826421|528674967|FG003|Overall Study|Reason not given|0|||
146591985|NCT02210221|528674972|FG000|Overall Study|Lack of Efficacy|7|||
146591986|NCT02210221|528674972|FG000|Overall Study|Withdrawal by Subject|43|||
146591987|NCT02185014|528674975|FG000|Overall Study|Adverse Event|18|||
146591988|NCT02185014|528674975|FG000|Overall Study|Withdrew Consent|8|||
146591989|NCT02185014|528674975|FG000|Overall Study|Lost to Follow-up|4|||
146591990|NCT02185014|528674975|FG000|Overall Study|Lack of Efficacy|14|||
146591991|NCT02185014|528674975|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
146591992|NCT02185014|528674975|FG000|Overall Study|Subject Noncompliance|1|||
146591993|NCT02185014|528674975|FG000|Overall Study|Other|4|||
146591994|NCT00392808|528674976|FG000|Overall Study|Lost to Follow-up|3|||
146591995|NCT00392808|528674977|FG001|Overall Study|Lost to Follow-up|2|||
146591996|NCT00392808|528674978|FG002|Overall Study|Lost to Follow-up|1|||
146591997|NCT00392808|528674979|FG003|Overall Study|Lost to Follow-up|2|||
146591998|NCT00392808|528674976|FG000|Overall Study|Unable to withdraw blood|3|||
146591999|NCT00392808|528674977|FG001|Overall Study|Unable to withdraw blood|1|||
146592000|NCT00392808|528674978|FG002|Overall Study|Unable to withdraw blood|1|||
146592001|NCT00392808|528674979|FG003|Overall Study|Unable to withdraw blood|2|||
146592002|NCT02649855|528674980|FG000|Overall Study|Refused further treatment|2|||
146592003|NCT02649855|528674981|FG001|Overall Study|Refused further treatment|1|||
146592004|NCT02649855|528674982|FG002|Overall Study|Refused further treatment|1|||
146771348|NCT00360698|529331168|FG001|Run-In|Non compliance with treatment procedure|1|||
146771349|NCT00360698|529331167|FG000|Run-In|Sponsor request|0|||
146771350|NCT00360698|529331168|FG001|Run-In|Sponsor request|2|||
146771351|NCT00360698|529331167|FG000|Run-In|Patient did not meet inclusion criteria|0|||
146771352|NCT00360698|529331168|FG001|Run-In|Patient did not meet inclusion criteria|1|||
146592005|NCT02649855|528674980|FG000|Overall Study|Withdrew consent|0|||
146592006|NCT02649855|528674981|FG001|Overall Study|Withdrew consent|1|||
146592007|NCT02649855|528674982|FG002|Overall Study|Withdrew consent|0|||
146592008|NCT02649855|528674980|FG000|Overall Study|Switched to alternative treatment|0|||
146592009|NCT02649855|528674981|FG001|Overall Study|Switched to alternative treatment|1|||
146592010|NCT02649855|528674982|FG002|Overall Study|Switched to alternative treatment|1|||
146592011|NCT02649855|528674980|FG000|Overall Study|Principal investigator discretion|0|||
146771353|NCT00360698|529331167|FG000|Run-In|Patient personal reasons|0|||
146771354|NCT00360698|529331168|FG001|Run-In|Patient personal reasons|2|||
146771355|NCT00360698|529331167|FG000|Run-In|Need of insulin with meals|0|||
146592012|NCT02649855|528674981|FG001|Overall Study|Principal investigator discretion|1|||
146592013|NCT02649855|528674982|FG002|Overall Study|Principal investigator discretion|1|||
146592014|NCT02649855|528674980|FG000|Overall Study|No treatment, per protocol|1|||
146592015|NCT02649855|528674981|FG001|Overall Study|No treatment, per protocol|0|||
146592016|NCT02649855|528674982|FG002|Overall Study|No treatment, per protocol|0|||
146592017|NCT02649855|528674980|FG000|Overall Study|Initiate new treatment|1|||
146592018|NCT02649855|528674981|FG001|Overall Study|Initiate new treatment|0|||
146592019|NCT02649855|528674982|FG002|Overall Study|Initiate new treatment|0|||
146592020|NCT02653495|528674983|FG000|Overall Study|Lost to Follow-up|2|||
146592021|NCT02653495|528674984|FG001|Overall Study|Lost to Follow-up|0|||
146592022|NCT02653495|528674983|FG000|Overall Study|Screening Failure|10|||
146592023|NCT02653495|528674984|FG001|Overall Study|Screening Failure|0|||
146592024|NCT00953680|528674987|FG000|Period 1|Withdrawal by Subject|0|||
146592025|NCT00953680|528674988|FG001|Period 1|Withdrawal by Subject|1|||
146592026|NCT03966885|528677134|FG000|Overall Study|Death|1|||
146592027|NCT03966885|528677135|FG001|Overall Study|Death|0|||
146592028|NCT03966885|528677134|FG000|Overall Study|Lost to Follow-up|1|||
146592029|NCT03966885|528677135|FG001|Overall Study|Lost to Follow-up|2|||
146592030|NCT03966885|528677134|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
146592031|NCT03966885|528677135|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
146592032|NCT03966885|528677134|FG000|Overall Study|Moved from study area.|0|||
146592033|NCT03966885|528677135|FG001|Overall Study|Moved from study area.|2|||
146592034|NCT03187834|528677136|FG000|Overall Study|Lost to Follow-up|0|||
146592035|NCT03187834|528677137|FG001|Overall Study|Lost to Follow-up|1|||
146592036|NCT03187834|528677138|FG002|Overall Study|Lost to Follow-up|2|||
146592037|NCT03187834|528677139|FG003|Overall Study|Lost to Follow-up|2|||
146592038|NCT03187834|528677136|FG000|Overall Study|Had invalid anthropometric measurements|5|||
146592039|NCT03187834|528677137|FG001|Overall Study|Had invalid anthropometric measurements|3|||
146592040|NCT03187834|528677138|FG002|Overall Study|Had invalid anthropometric measurements|4|||
146592041|NCT03187834|528677139|FG003|Overall Study|Had invalid anthropometric measurements|2|||
146592042|NCT03710876|528677140|FG000|Overall Study|Death|0|||
146592043|NCT03710876|528677141|FG001|Overall Study|Death|2|||
146592044|NCT03710876|528677140|FG000|Overall Study|Withdrawal by Subject|0|||
146592045|NCT03710876|528677141|FG001|Overall Study|Withdrawal by Subject|2|||
146592046|NCT02838901|528677142|FG000|Overall Study|Withdrawal by Subject|1|||
146592047|NCT02838901|528677143|FG001|Overall Study|Withdrawal by Subject|1|||
146592048|NCT02838901|528677142|FG000|Overall Study|Lost to Follow-up|1|||
146592049|NCT02838901|528677143|FG001|Overall Study|Lost to Follow-up|1|||
146592050|NCT01007123|528677144|FG000|Overall Study|Adverse Event|3|||
146592051|NCT01007123|528677145|FG001|Overall Study|Adverse Event|4|||
146592052|NCT01007123|528677146|FG002|Overall Study|Adverse Event|7|||
146592053|NCT01007123|528677147|FG003|Overall Study|Adverse Event|1|||
146592054|NCT01007123|528677144|FG000|Overall Study|Lack of Efficacy|1|||
146592055|NCT01007123|528677145|FG001|Overall Study|Lack of Efficacy|0|||
146592056|NCT01007123|528677146|FG002|Overall Study|Lack of Efficacy|1|||
146592057|NCT01007123|528677147|FG003|Overall Study|Lack of Efficacy|4|||
146592058|NCT01007123|528677144|FG000|Overall Study|Protocol Violation|1|||
146592059|NCT01007123|528677145|FG001|Overall Study|Protocol Violation|1|||
146592060|NCT01007123|528677146|FG002|Overall Study|Protocol Violation|2|||
146592061|NCT01007123|528677147|FG003|Overall Study|Protocol Violation|1|||
146592062|NCT01007123|528677144|FG000|Overall Study|Withdrawal by Subject|1|||
146592063|NCT01007123|528677145|FG001|Overall Study|Withdrawal by Subject|0|||
146592064|NCT01007123|528677146|FG002|Overall Study|Withdrawal by Subject|1|||
146592065|NCT01007123|528677147|FG003|Overall Study|Withdrawal by Subject|0|||
146592066|NCT01007123|528677144|FG000|Overall Study|Lost to Follow-up|0|||
146592067|NCT01007123|528677145|FG001|Overall Study|Lost to Follow-up|1|||
146592068|NCT01007123|528677146|FG002|Overall Study|Lost to Follow-up|0|||
146592069|NCT01007123|528677147|FG003|Overall Study|Lost to Follow-up|0|||
146592070|NCT00320255|528677148|FG000|Overall Study|Lack of Efficacy|1|||
146592071|NCT00320255|528677149|FG001|Overall Study|Lack of Efficacy|0|||
146592072|NCT00320255|528677150|FG002|Overall Study|Lack of Efficacy|0|||
146592073|NCT00320255|528677151|FG003|Overall Study|Lack of Efficacy|0|||
146592074|NCT00320255|528677152|FG004|Overall Study|Lack of Efficacy|0|||
146592075|NCT00320255|528677153|FG005|Overall Study|Lack of Efficacy|0|||
146592076|NCT00320255|528677148|FG000|Overall Study|Adverse Event|5|||
146592077|NCT00320255|528677149|FG001|Overall Study|Adverse Event|2|||
146592078|NCT00320255|528677150|FG002|Overall Study|Adverse Event|3|||
146592079|NCT00320255|528677151|FG003|Overall Study|Adverse Event|2|||
146771356|NCT00360698|529331168|FG001|Run-In|Need of insulin with meals|1|||
146592080|NCT00320255|528677152|FG004|Overall Study|Adverse Event|0|||
146592081|NCT00320255|528677153|FG005|Overall Study|Adverse Event|0|||
146592082|NCT00320255|528677148|FG000|Overall Study|Withdrawal by Subject|1|||
146592083|NCT00320255|528677149|FG001|Overall Study|Withdrawal by Subject|2|||
146592084|NCT00320255|528677150|FG002|Overall Study|Withdrawal by Subject|2|||
146592085|NCT00320255|528677151|FG003|Overall Study|Withdrawal by Subject|4|||
146592086|NCT00320255|528677152|FG004|Overall Study|Withdrawal by Subject|0|||
146592087|NCT00320255|528677153|FG005|Overall Study|Withdrawal by Subject|0|||
146592088|NCT00320255|528677148|FG000|Overall Study|Poor compliance/noncompliance|1|||
146771357|NCT00360698|529331167|FG000|Treatment Period|Non compliance with treatment procedure|1|||
146592089|NCT00320255|528677149|FG001|Overall Study|Poor compliance/noncompliance|1|||
146592090|NCT00320255|528677150|FG002|Overall Study|Poor compliance/noncompliance|0|||
146978386|NCT02919475|530084028|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
146978387|NCT02919475|530084029|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
146978388|NCT02919475|530084030|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
146978389|NCT02919475|530084031|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
146978390|NCT02919475|530084032|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146978391|NCT02323295|530084039|FG000|Overall Study|Adverse Event|0|||
146978392|NCT02323295|530084040|FG001|Overall Study|Adverse Event|1|||
146978393|NCT02323295|530084039|FG000|Overall Study|Withdrawal by Subject|0|||
146592091|NCT00320255|528677151|FG003|Overall Study|Poor compliance/noncompliance|1|||
146592092|NCT00320255|528677152|FG004|Overall Study|Poor compliance/noncompliance|0|||
146592093|NCT00320255|528677153|FG005|Overall Study|Poor compliance/noncompliance|0|||
146592094|NCT00320255|528677148|FG000|Overall Study|No longer meets study criteria|0|||
146592095|NCT00320255|528677149|FG001|Overall Study|No longer meets study criteria|0|||
146592096|NCT00320255|528677150|FG002|Overall Study|No longer meets study criteria|0|||
146592097|NCT00320255|528677151|FG003|Overall Study|No longer meets study criteria|1|||
146592098|NCT00320255|528677152|FG004|Overall Study|No longer meets study criteria|0|||
146592099|NCT00320255|528677153|FG005|Overall Study|No longer meets study criteria|0|||
146592100|NCT00320255|528677148|FG000|Overall Study|Other|3|||
146592101|NCT00320255|528677149|FG001|Overall Study|Other|2|||
146592102|NCT00320255|528677150|FG002|Overall Study|Other|1|||
146592103|NCT00320255|528677151|FG003|Overall Study|Other|0|||
146592104|NCT00320255|528677152|FG004|Overall Study|Other|0|||
146592105|NCT00320255|528677153|FG005|Overall Study|Other|0|||
146592106|NCT03405935|528677160|FG000|Overall Study|Adverse Event|3|||
146592107|NCT03405935|528677160|FG000|Overall Study|Death|2|||
146592108|NCT03405935|528677160|FG000|Overall Study|Withdrawal by Subject|1|||
146592109|NCT03405935|528677160|FG000|Overall Study|Lost to Follow-up|2|||
146592110|NCT04979897|528677161|FG000|Overall Study|Death|1|||
146592111|NCT04979897|528677162|FG001|Overall Study|Death|8|||
146592112|NCT04979897|528677161|FG000|Overall Study|Lost to Follow-up|111|||
146592113|NCT04979897|528677162|FG001|Overall Study|Lost to Follow-up|56|||
146592114|NCT04979897|528677161|FG000|Overall Study|Withdrawal by Subject|7|||
146592115|NCT04979897|528677162|FG001|Overall Study|Withdrawal by Subject|2|||
146592116|NCT02781792|528677166|FG000|Overall Study|Adverse Event|1|||
146592117|NCT02781792|528677167|FG001|Overall Study|Adverse Event|2|||
146592118|NCT02781792|528677166|FG000|Overall Study|Withdrawal by Subject|3|||
146592119|NCT02781792|528677167|FG001|Overall Study|Withdrawal by Subject|1|||
146592120|NCT02781792|528677166|FG000|Overall Study|Lack of Efficacy|1|||
146592121|NCT02781792|528677167|FG001|Overall Study|Lack of Efficacy|1|||
146592122|NCT02781792|528677166|FG000|Overall Study|Hospice|0|||
146592123|NCT02781792|528677167|FG001|Overall Study|Hospice|1|||
146592124|NCT01224821|528677175|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
146592125|NCT01224821|528677175|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
146592126|NCT01224821|528677175|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
146592127|NCT01224821|528677175|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
146592128|NCT01224821|528677175|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
146592129|NCT01224821|528677175|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
146592130|NCT01224821|528677175|FG000|Long-Term Follow-Up|Death|2|||
146592131|NCT01224821|528677175|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
146592132|NCT00683917|528677176|FG000|Overall Study|Study prematurely terminated|10|||
146592133|NCT04422561|528677180|FG000|Overall Study|Lost to Follow-up|25|||
146592134|NCT04422561|528677181|FG001|Overall Study|Lost to Follow-up|11|||
146592135|NCT02685748|528677182|FG000|Overall Study|Withdrawal by Subject|3|||
146592136|NCT02685748|528677183|FG001|Overall Study|Withdrawal by Subject|2|||
146592137|NCT03500172|528677184|FG000|Period 1: Baseline Randomization|Death|0|||
146592138|NCT03500172|528677185|FG001|Period 1: Baseline Randomization|Death|0|||
146592139|NCT03500172|528677186|FG002|Period 1: Baseline Randomization|Death|0|||
146592140|NCT03500172|528677187|FG003|Period 1: Baseline Randomization|Death|0|||
146592141|NCT03500172|528677188|FG004|Period 1: Baseline Randomization|Death|0|||
146592142|NCT03500172|528677189|FG005|Period 1: Baseline Randomization|Death|0|||
146592143|NCT03500172|528677190|FG006|Period 1: Baseline Randomization|Death|0|||
146592144|NCT03500172|528677191|FG007|Period 1: Baseline Randomization|Death|0|||
146592145|NCT03500172|528677192|FG008|Period 1: Baseline Randomization|Death|0|||
146592146|NCT03500172|528677193|FG009|Period 1: Baseline Randomization|Death|2|||
146592147|NCT03500172|528677194|FG010|Period 1: Baseline Randomization|Death|0|||
146592148|NCT03500172|528677184|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
146592149|NCT03500172|528677185|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
146592150|NCT03500172|528677186|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
146592151|NCT03500172|528677187|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
146592152|NCT03500172|528677188|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
146592153|NCT03500172|528677189|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
146592154|NCT03500172|528677190|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
146978394|NCT02323295|530084040|FG001|Overall Study|Withdrawal by Subject|1|||
146653056|NCT04761627|528908136|FG001|Run-in Period|Withdrawal by Subject|0|||
146592155|NCT03500172|528677191|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
146592156|NCT03500172|528677192|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
146592157|NCT03500172|528677193|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
146592158|NCT03500172|528677194|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
146592159|NCT03500172|528677184|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
146592160|NCT03500172|528677185|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
146592161|NCT03500172|528677186|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
146592162|NCT03500172|528677187|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
146592163|NCT03500172|528677188|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
146592164|NCT03500172|528677189|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
146592165|NCT03500172|528677190|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
146592166|NCT03500172|528677191|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
146592167|NCT03500172|528677192|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
146592168|NCT03500172|528677193|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
146592169|NCT03500172|528677194|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
146592170|NCT03500172|528677184|FG000|Period 2: Re-Randomization|Death|0|||
146592171|NCT03500172|528677185|FG001|Period 2: Re-Randomization|Death|0|||
146592172|NCT03500172|528677186|FG002|Period 2: Re-Randomization|Death|0|||
146592173|NCT03500172|528677187|FG003|Period 2: Re-Randomization|Death|4|||
146592174|NCT03500172|528677188|FG004|Period 2: Re-Randomization|Death|2|||
146592175|NCT03500172|528677189|FG005|Period 2: Re-Randomization|Death|0|||
146592176|NCT03500172|528677190|FG006|Period 2: Re-Randomization|Death|5|||
146592177|NCT03500172|528677191|FG007|Period 2: Re-Randomization|Death|2|||
146592178|NCT03500172|528677192|FG008|Period 2: Re-Randomization|Death|0|||
146592179|NCT03500172|528677193|FG009|Period 2: Re-Randomization|Death|0|||
146592180|NCT03500172|528677194|FG010|Period 2: Re-Randomization|Death|0|||
146592181|NCT00090233|528677199|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
146592182|NCT00090233|528677200|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
146592183|NCT00090233|528677199|FG000|Overall Study|Adverse Event|214|||
146592184|NCT00090233|528677200|FG001|Overall Study|Adverse Event|198|||
146592185|NCT00090233|528677199|FG000|Overall Study|Lost to Follow-up|68|||
146592186|NCT00090233|528677200|FG001|Overall Study|Lost to Follow-up|95|||
146592187|NCT00090233|528677199|FG000|Overall Study|Protocol Violation|960|||
146592188|NCT00090233|528677200|FG001|Overall Study|Protocol Violation|1022|||
146592189|NCT00090233|528677199|FG000|Overall Study|Withdrawal by Subject|182|||
146592190|NCT00090233|528677200|FG001|Overall Study|Withdrawal by Subject|211|||
146592191|NCT00090233|528677199|FG000|Overall Study|Moved|203|||
146592192|NCT00090233|528677200|FG001|Overall Study|Moved|189|||
146592193|NCT00090233|528677199|FG000|Overall Study|Other|1211|||
146592194|NCT00090233|528677200|FG001|Overall Study|Other|1160|||
146592195|NCT00090233|528677199|FG000|Overall Study|Data not available at data cut-off point|1552|||
146592196|NCT00090233|528677200|FG001|Overall Study|Data not available at data cut-off point|1563|||
146592197|NCT04863248|528677201|FG000|Overall Study|Sponsor Terminated|4|||
146592198|NCT04863248|528677202|FG001|Overall Study|Sponsor Terminated|1|||
146592199|NCT04863248|528677201|FG000|Overall Study|Death|0|||
146592200|NCT04863248|528677202|FG001|Overall Study|Death|1|||
146592201|NCT04863248|528677201|FG000|Overall Study|Withdrawal by Subject|0|||
146592202|NCT04863248|528677202|FG001|Overall Study|Withdrawal by Subject|1|||
146592203|NCT00027378|528677205|FG000|Overall Study|Physician Decision|0|||
146592204|NCT00027378|528677206|FG001|Overall Study|Physician Decision|3|||
146592205|NCT05605691|528677207|FG000|Overall Study|Lost to Follow-up|1|||
146592206|NCT02279719|528677208|FG000|Overall Study|Patients randomized but never treated|0|||
146592207|NCT02279719|528677209|FG001|Overall Study|Patients randomized but never treated|0|||
146592208|NCT02279719|528677210|FG002|Overall Study|Patients randomized but never treated|0|||
146592209|NCT02279719|528677211|FG003|Overall Study|Patients randomized but never treated|0|||
146592210|NCT02279719|528677212|FG004|Overall Study|Patients randomized but never treated|3|||
146592211|NCT02279719|528677213|FG005|Overall Study|Patients randomized but never treated|0|||
146592212|NCT02279719|528677214|FG006|Overall Study|Patients randomized but never treated|3|||
146592213|NCT03541187|528677215|FG000|Overall Study|Lost to Follow-up|2|||
146592214|NCT03541187|528677216|FG001|Overall Study|Lost to Follow-up|6|||
146592215|NCT03541187|528677215|FG000|Overall Study|Pregnancy|0|||
146592216|NCT03541187|528677216|FG001|Overall Study|Pregnancy|1|||
146592217|NCT03541187|528677215|FG000|Overall Study|Withdrawal by Subject|6|||
146592218|NCT03541187|528677216|FG001|Overall Study|Withdrawal by Subject|2|||
146592219|NCT03541187|528677215|FG000|Overall Study|Moved out of town|1|||
146592220|NCT03541187|528677216|FG001|Overall Study|Moved out of town|0|||
146592221|NCT03541187|528677215|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
146592222|NCT03541187|528677216|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
146592223|NCT03541187|528677215|FG000|Overall Study|Did not meet randomization criteria|1|||
146592224|NCT03541187|528677216|FG001|Overall Study|Did not meet randomization criteria|1|||
146592225|NCT03541187|528677215|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
146592226|NCT03541187|528677216|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
146592227|NCT03541187|528677215|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
146592228|NCT03541187|528677216|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
146592229|NCT02701777|528677217|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
146592230|NCT02701777|528677218|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
146592231|NCT02701777|528677219|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
146592232|NCT02701777|528677220|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
146592233|NCT02701777|528677217|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
146592234|NCT02701777|528677218|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
146592235|NCT02701777|528677219|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
146592236|NCT02701777|528677220|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
146592237|NCT00869050|528677221|FG000|Overall Study|Screen Failure|3|||
146592238|NCT02098369|528677223|FG000|Overall Study|Withdrawal by Subject|1|||
146592239|NCT02098369|528677224|FG001|Overall Study|Withdrawal by Subject|5|||
146592240|NCT02098369|528677225|FG002|Overall Study|Withdrawal by Subject|0|||
146592241|NCT02098369|528677223|FG000|Overall Study|Lost to Follow-up|5|||
146592242|NCT02098369|528677224|FG001|Overall Study|Lost to Follow-up|1|||
146592243|NCT02098369|528677225|FG002|Overall Study|Lost to Follow-up|3|||
146592244|NCT02098369|528677223|FG000|Overall Study|Death|1|||
146592245|NCT02098369|528677224|FG001|Overall Study|Death|1|||
146592246|NCT02098369|528677225|FG002|Overall Study|Death|1|||
146592247|NCT02098369|528677223|FG000|Overall Study|Other|0|||
146592248|NCT02098369|528677224|FG001|Overall Study|Other|2|||
146592249|NCT02098369|528677225|FG002|Overall Study|Other|1|||
146592250|NCT03362931|528677226|FG000|Overall Study|Adverse Event|1|||
146592251|NCT03362931|528677226|FG000|Overall Study|Death|2|||
146592252|NCT02229214|528677230|FG000|Overall Study|Adverse Event|2|||
146592253|NCT02229214|528677231|FG001|Overall Study|Adverse Event|0|||
146592254|NCT02229214|528677230|FG000|Overall Study|Withdrawal by Subject|4|||
146592255|NCT02229214|528677231|FG001|Overall Study|Withdrawal by Subject|0|||
146592256|NCT00246025|528677232|FG000|Overall Study|Adverse Event|7|||
146592257|NCT00246025|528677233|FG001|Overall Study|Adverse Event|9|||
146592258|NCT00246025|528677234|FG002|Overall Study|Adverse Event|9|||
146592259|NCT00246025|528677235|FG003|Overall Study|Adverse Event|10|||
146592260|NCT00246025|528677232|FG000|Overall Study|Withdrawal by Subject|3|||
146592261|NCT00246025|528677233|FG001|Overall Study|Withdrawal by Subject|0|||
146592262|NCT00246025|528677234|FG002|Overall Study|Withdrawal by Subject|1|||
146592263|NCT00246025|528677235|FG003|Overall Study|Withdrawal by Subject|2|||
146592264|NCT00246025|528677232|FG000|Overall Study|unsuitable medical history was found|0|||
146592265|NCT00246025|528677233|FG001|Overall Study|unsuitable medical history was found|0|||
146592266|NCT00246025|528677234|FG002|Overall Study|unsuitable medical history was found|0|||
146592267|NCT00246025|528677235|FG003|Overall Study|unsuitable medical history was found|1|||
146592268|NCT01643850|528677238|FG000|Overall Study|Withdrawal by Subject|0|||
146592269|NCT01643850|528677239|FG001|Overall Study|Withdrawal by Subject|0|||
146592270|NCT01643850|528677240|FG002|Overall Study|Withdrawal by Subject|0|||
146592271|NCT01643850|528677241|FG003|Overall Study|Withdrawal by Subject|0|||
146592272|NCT01643850|528677242|FG004|Overall Study|Withdrawal by Subject|1|||
146592273|NCT01643850|528677243|FG005|Overall Study|Withdrawal by Subject|0|||
146592274|NCT01643850|528677244|FG006|Overall Study|Withdrawal by Subject|0|||
146592275|NCT01643850|528677245|FG007|Overall Study|Withdrawal by Subject|0|||
146592276|NCT01643850|528677246|FG008|Overall Study|Withdrawal by Subject|0|||
146592277|NCT01643850|528677238|FG000|Overall Study|Lost to Follow-up|0|||
146592278|NCT01643850|528677239|FG001|Overall Study|Lost to Follow-up|0|||
146592279|NCT01643850|528677240|FG002|Overall Study|Lost to Follow-up|0|||
146592280|NCT01643850|528677241|FG003|Overall Study|Lost to Follow-up|0|||
146592281|NCT01643850|528677242|FG004|Overall Study|Lost to Follow-up|0|||
146592282|NCT01643850|528677243|FG005|Overall Study|Lost to Follow-up|0|||
146592283|NCT01643850|528677244|FG006|Overall Study|Lost to Follow-up|1|||
146592284|NCT01643850|528677245|FG007|Overall Study|Lost to Follow-up|0|||
146592285|NCT01643850|528677246|FG008|Overall Study|Lost to Follow-up|1|||
146592286|NCT01643850|528677238|FG000|Overall Study|Adverse Event|0|||
146592287|NCT01643850|528677239|FG001|Overall Study|Adverse Event|0|||
146592288|NCT01643850|528677240|FG002|Overall Study|Adverse Event|0|||
146592289|NCT01643850|528677241|FG003|Overall Study|Adverse Event|0|||
146592290|NCT01643850|528677242|FG004|Overall Study|Adverse Event|1|||
146592291|NCT01643850|528677243|FG005|Overall Study|Adverse Event|0|||
146592292|NCT01643850|528677244|FG006|Overall Study|Adverse Event|0|||
146592293|NCT01643850|528677245|FG007|Overall Study|Adverse Event|0|||
146592294|NCT01643850|528677246|FG008|Overall Study|Adverse Event|0|||
146592295|NCT01643850|528677238|FG000|Overall Study|Administrative Problems|0|||
146592296|NCT01643850|528677239|FG001|Overall Study|Administrative Problems|0|||
146653057|NCT04761627|528908137|FG002|Run-in Period|Withdrawal by Subject|0|||
146592297|NCT01643850|528677240|FG002|Overall Study|Administrative Problems|1|||
146592298|NCT01643850|528677241|FG003|Overall Study|Administrative Problems|0|||
146592299|NCT01643850|528677242|FG004|Overall Study|Administrative Problems|1|||
146592300|NCT01643850|528677243|FG005|Overall Study|Administrative Problems|0|||
146592301|NCT01643850|528677244|FG006|Overall Study|Administrative Problems|0|||
146653058|NCT04761627|528908135|FG000|Run-in Period|Did not meet PASI 50|15|||
146592302|NCT01643850|528677245|FG007|Overall Study|Administrative Problems|0|||
146592303|NCT01643850|528677246|FG008|Overall Study|Administrative Problems|0|||
146592304|NCT00931723|528677247|FG000|Overall Study|Withdrawal by Subject|11|||
146592305|NCT00931723|528677248|FG001|Overall Study|Withdrawal by Subject|13|||
146592306|NCT00931723|528677247|FG000|Overall Study|Adverse Event|6|||
146592307|NCT00931723|528677248|FG001|Overall Study|Adverse Event|13|||
146592308|NCT00931723|528677247|FG000|Overall Study|Lithium found in blood|0|||
146592309|NCT00931723|528677248|FG001|Overall Study|Lithium found in blood|1|||
146592310|NCT00931723|528677247|FG000|Overall Study|Condition under investigation worsened|1|||
146592311|NCT00931723|528677248|FG001|Overall Study|Condition under investigation worsened|2|||
146592312|NCT00931723|528677247|FG000|Overall Study|Lost to Follow-up|1|||
146592313|NCT00931723|528677248|FG001|Overall Study|Lost to Follow-up|2|||
146592314|NCT00931723|528677247|FG000|Overall Study|Study-specific discontinuation criteria|1|||
146592315|NCT00931723|528677248|FG001|Overall Study|Study-specific discontinuation criteria|1|||
146592316|NCT00931723|528677247|FG000|Overall Study|Severe non-compliance to protocol|2|||
146592317|NCT00931723|528677248|FG001|Overall Study|Severe non-compliance to protocol|0|||
146592318|NCT00931723|528677247|FG000|Overall Study|Safety reasons|0|||
146592319|NCT00931723|528677248|FG001|Overall Study|Safety reasons|1|||
146592320|NCT00931723|528677247|FG000|Overall Study|Took prohibited concomitant medication|0|||
146592321|NCT00931723|528677248|FG001|Overall Study|Took prohibited concomitant medication|1|||
146592322|NCT00931723|528677247|FG000|Overall Study|Lack or insufficient theraputic response|2|||
146592323|NCT00931723|528677248|FG001|Overall Study|Lack or insufficient theraputic response|5|||
146592324|NCT00931723|528677247|FG000|Overall Study|Sponsor decision|1|||
146592325|NCT00931723|528677248|FG001|Overall Study|Sponsor decision|0|||
146592326|NCT00931723|528677247|FG000|Overall Study|Late hospital discharge|1|||
146592327|NCT00931723|528677248|FG001|Overall Study|Late hospital discharge|0|||
146592328|NCT03300024|528677249|FG000|Overall Study|Physician Decision|4|||
146592329|NCT03300024|528677250|FG001|Overall Study|Physician Decision|6|||
146592330|NCT03305081|528677251|FG000|Overall Study|Lost to Follow-up|10|||
146592331|NCT03305081|528677252|FG001|Overall Study|Lost to Follow-up|15|||
146592332|NCT00570037|528677253|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
146592333|NCT00570037|528677254|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
146592334|NCT00554619|528677255|FG000|Overall Study|Adverse Event|1|||
146592335|NCT00554619|528677255|FG000|Overall Study|Physician Decision|1|||
146592336|NCT00554619|528677255|FG000|Overall Study|Liver Function Test Abnormality|1|||
146592337|NCT01571284|528677256|FG000|Overall Study|Participant's decision|84|||
146592338|NCT01571284|528677256|FG000|Overall Study|Lost to Follow-up|3|||
146592339|NCT01571284|528677256|FG000|Overall Study|Enrolled but not treated|2|||
146592340|NCT01571284|528677256|FG000|Overall Study|Other than specified above|80|||
146592341|NCT04677660|528677257|FG000|Overall Study|Lost to Follow-up|0|||
146592342|NCT04677660|528677258|FG001|Overall Study|Lost to Follow-up|2|||
146592343|NCT04677660|528677257|FG000|Overall Study|Withdrawal by Subject|0|||
146592344|NCT04677660|528677258|FG001|Overall Study|Withdrawal by Subject|1|||
146592345|NCT04677660|528677257|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
146592346|NCT04677660|528677258|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
146592347|NCT01218100|528677259|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
146592348|NCT01218100|528677260|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
146592349|NCT01218100|528677261|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
146592350|NCT01218100|528677262|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
146592351|NCT01218100|528677259|FG000|Overall Study|Adverse Event|4|||
146592352|NCT01218100|528677260|FG001|Overall Study|Adverse Event|6|||
146592353|NCT01218100|528677261|FG002|Overall Study|Adverse Event|6|||
146592354|NCT01218100|528677262|FG003|Overall Study|Adverse Event|7|||
146592355|NCT01218100|528677259|FG000|Overall Study|Lack of Efficacy|9|||
146592356|NCT01218100|528677260|FG001|Overall Study|Lack of Efficacy|6|||
146592357|NCT01218100|528677261|FG002|Overall Study|Lack of Efficacy|5|||
146592358|NCT01218100|528677262|FG003|Overall Study|Lack of Efficacy|12|||
146592359|NCT01218100|528677259|FG000|Overall Study|Protocol Violation|0|||
146592360|NCT01218100|528677260|FG001|Overall Study|Protocol Violation|0|||
146592361|NCT01218100|528677261|FG002|Overall Study|Protocol Violation|1|||
146592362|NCT01218100|528677262|FG003|Overall Study|Protocol Violation|1|||
146592363|NCT01218100|528677259|FG000|Overall Study|Withdrawal by Subject|5|||
146592364|NCT01218100|528677260|FG001|Overall Study|Withdrawal by Subject|2|||
146592365|NCT01218100|528677261|FG002|Overall Study|Withdrawal by Subject|6|||
146592366|NCT01218100|528677262|FG003|Overall Study|Withdrawal by Subject|7|||
146592367|NCT01218100|528677259|FG000|Overall Study|Lost to Follow-up|3|||
146592368|NCT01218100|528677260|FG001|Overall Study|Lost to Follow-up|8|||
146592369|NCT01218100|528677261|FG002|Overall Study|Lost to Follow-up|2|||
146592370|NCT01218100|528677262|FG003|Overall Study|Lost to Follow-up|1|||
146592371|NCT01218100|528677259|FG000|Overall Study|Other Reason|2|||
146592372|NCT01218100|528677260|FG001|Overall Study|Other Reason|2|||
146592373|NCT01218100|528677261|FG002|Overall Study|Other Reason|6|||
146592374|NCT01218100|528677262|FG003|Overall Study|Other Reason|4|||
146592375|NCT01118520|528677265|FG000|Overall Study|AAA repair|9|||
146592376|NCT01118520|528677266|FG001|Overall Study|AAA repair|7|||
146592377|NCT01118520|528677267|FG002|Overall Study|AAA repair|9|||
146919062|NCT01617434|529864568|FG001|Overall Study|Protocol Violation|7|||
146919063|NCT01617434|529864567|FG000|Overall Study|Withdrawal Criteria|12|||
146592378|NCT01118520|528677265|FG000|Overall Study|Adverse Event|3|||
146592379|NCT01118520|528677266|FG001|Overall Study|Adverse Event|3|||
146592380|NCT01118520|528677267|FG002|Overall Study|Adverse Event|3|||
146919064|NCT01617434|529864568|FG001|Overall Study|Withdrawal Criteria|37|||
146919065|NCT01617434|529864567|FG000|Overall Study|Unclassified|3|||
146919066|NCT01617434|529864568|FG001|Overall Study|Unclassified|4|||
146919067|NCT01193348|529864569|FG000|Screening Period|Screen Failure|5|||
146919068|NCT01193348|529864569|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
146919069|NCT01193348|529864569|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
146919070|NCT01193348|529864569|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
146919071|NCT01193348|529864569|FG000|Extension Treatment Period|Physician Decision|1|||
146919072|NCT01193348|529864569|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
146919073|NCT01721408|529864570|FG000|Overall Study|Adverse Event|6|||
146919074|NCT01721408|529864571|FG001|Overall Study|Adverse Event|1|||
146919075|NCT01721408|529864570|FG000|Overall Study|Death|1|||
146919076|NCT01721408|529864571|FG001|Overall Study|Death|0|||
146919077|NCT01721408|529864570|FG000|Overall Study|Insufficient clinical response|15|||
146919078|NCT01721408|529864571|FG001|Overall Study|Insufficient clinical response|6|||
146919079|NCT01721408|529864570|FG000|Overall Study|No longer willing to participate study|9|||
146919080|NCT01721408|529864571|FG001|Overall Study|No longer willing to participate study|10|||
146919081|NCT01721408|529864570|FG000|Overall Study|Protocol Violation|0|||
146919082|NCT01721408|529864571|FG001|Overall Study|Protocol Violation|2|||
146919083|NCT01721408|529864570|FG000|Overall Study|Other|3|||
146919084|NCT01721408|529864571|FG001|Overall Study|Other|3|||
146919085|NCT01721408|529864570|FG000|Overall Study|Lost to Follow-up|1|||
146919086|NCT01721408|529864571|FG001|Overall Study|Lost to Follow-up|2|||
146919087|NCT01721408|529864570|FG000|Overall Study|Does not meet entrance criteria|1|||
146919088|NCT01721408|529864571|FG001|Overall Study|Does not meet entrance criteria|0|||
146919089|NCT02928406|529864572|FG000|Overall Study|Death|780|||
146919090|NCT02928406|529864572|FG000|Overall Study|Progressive disease|3|||
146919091|NCT02928406|529864572|FG000|Overall Study|Lost to Follow-up|49|||
146919092|NCT02928406|529864572|FG000|Overall Study|Non-compliance|2|||
146919093|NCT02928406|529864572|FG000|Overall Study|Withdrawal by Subject|40|||
146592381|NCT01118520|528677265|FG000|Overall Study|Withdrawal by Subject|8|||
146592382|NCT01118520|528677266|FG001|Overall Study|Withdrawal by Subject|13|||
146592383|NCT01118520|528677267|FG002|Overall Study|Withdrawal by Subject|8|||
146592384|NCT01089023|528677270|FG000|Overall Study|Lost to Follow-up|3|||
146592385|NCT01089023|528677270|FG000|Overall Study|Adverse Event|1|||
146592386|NCT01089023|528677270|FG000|Overall Study|Withdrawal by Subject|1|||
146592387|NCT01089023|528677270|FG000|Overall Study|Protocol Violation|1|||
146592388|NCT01089023|528677270|FG000|Overall Study|Lack of Efficacy|1|||
146592389|NCT03883113|528677273|FG000|Overall Study|Physician Decision|4|||
146592390|NCT03883113|528677274|FG001|Overall Study|Physician Decision|2|||
146771358|NCT00360698|529331168|FG001|Treatment Period|Non compliance with treatment procedure|0|||
146771359|NCT00360698|529331167|FG000|Treatment Period|Early termination by error|0|||
146771360|NCT00360698|529331168|FG001|Treatment Period|Early termination by error|1|||
146771361|NCT01692938|529331170|FG000|Overall Study|Protocol Deviation|1|||
146771362|NCT01692938|529331171|FG001|Overall Study|Protocol Deviation|1|||
146592391|NCT03883113|528677273|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
146592392|NCT03883113|528677274|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
146592393|NCT03883113|528677273|FG000|Overall Study|Pregnancy|1|||
146592394|NCT03883113|528677274|FG001|Overall Study|Pregnancy|0|||
146592395|NCT03883113|528677273|FG000|Overall Study|Adverse Event|0|||
146592396|NCT03883113|528677274|FG001|Overall Study|Adverse Event|1|||
146592397|NCT03883113|528677273|FG000|Overall Study|Withdrawal by Subject|1|||
146592398|NCT03883113|528677274|FG001|Overall Study|Withdrawal by Subject|2|||
146592399|NCT03883113|528677273|FG000|Overall Study|Lost to Follow-up|1|||
146592400|NCT03883113|528677274|FG001|Overall Study|Lost to Follow-up|0|||
146592401|NCT04465877|528677275|FG000|Overall Study|Noncompliant with study requirements|0|||
146592402|NCT04465877|528677276|FG001|Overall Study|Noncompliant with study requirements|0|||
146592403|NCT04465877|528677277|FG002|Overall Study|Noncompliant with study requirements|1|||
146592404|NCT04465877|528677278|FG003|Overall Study|Noncompliant with study requirements|0|||
146592405|NCT04962230|528677284|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
146592406|NCT04962230|528677284|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
146919094|NCT02928406|529864572|FG000|Overall Study|Study terminated by sponsor|57|||
146919095|NCT02928406|529864572|FG000|Overall Study|Physician Decision|1|||
146919096|NCT02928406|529864572|FG000|Overall Study|Various reasons|72|||
146919097|NCT01745393|529864574|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
146771363|NCT01692938|529331170|FG000|Overall Study|Study completed prior to site completion|3|||
146919098|NCT01745393|529864575|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
146919099|NCT01745393|529864574|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
146771364|NCT01692938|529331171|FG001|Overall Study|Study completed prior to site completion|3|||
146919100|NCT01745393|529864575|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
146919101|NCT01745393|529864574|FG000|12-month Follow-up|Lost to Follow-up|6|||
146919102|NCT01745393|529864575|FG001|12-month Follow-up|Lost to Follow-up|5|||
146919103|NCT00786838|529864576|FG000|Overall Study|Physician Decision|4|||
146919104|NCT00786838|529864576|FG000|Overall Study|Death|4|||
146919105|NCT00786838|529864576|FG000|Overall Study|Adverse Event|6|||
146919106|NCT00786838|529864576|FG000|Overall Study|Progressive disease|31|||
146919107|NCT00786838|529864576|FG000|Overall Study|Withdrawal by Subject|4|||
146919108|NCT02488759|529864578|FG000|Overall Study|Disease progression|73|||
146919109|NCT02488759|529864579|FG001|Overall Study|Disease progression|111|||
146919110|NCT02488759|529864580|FG002|Overall Study|Disease progression|62|||
146919111|NCT02488759|529864581|FG003|Overall Study|Disease progression|7|||
146919112|NCT02488759|529864582|FG004|Overall Study|Disease progression|4|||
146978395|NCT02323295|530084039|FG000|Overall Study|Patient did not have surgery as planned.|0|||
146978396|NCT02323295|530084040|FG001|Overall Study|Patient did not have surgery as planned.|1|||
146592407|NCT01598753|528677285|FG000|Overall Study|Adverse Event|1|||
146592408|NCT01598753|528677286|FG001|Overall Study|Adverse Event|9|||
146592409|NCT01598753|528677287|FG002|Overall Study|Adverse Event|1|||
146592410|NCT01598753|528677288|FG003|Overall Study|Adverse Event|7|||
146592411|NCT01598753|528677285|FG000|Overall Study|Lost to Follow-up|4|||
146592412|NCT01598753|528677286|FG001|Overall Study|Lost to Follow-up|3|||
146592413|NCT01598753|528677287|FG002|Overall Study|Lost to Follow-up|7|||
146592414|NCT01598753|528677288|FG003|Overall Study|Lost to Follow-up|5|||
146592415|NCT01598753|528677285|FG000|Overall Study|Physician Decision|0|||
146592416|NCT01598753|528677286|FG001|Overall Study|Physician Decision|1|||
146592417|NCT01598753|528677287|FG002|Overall Study|Physician Decision|0|||
146592418|NCT01598753|528677288|FG003|Overall Study|Physician Decision|2|||
146592419|NCT01598753|528677285|FG000|Overall Study|Withdrawal by Subject|7|||
146592420|NCT01598753|528677286|FG001|Overall Study|Withdrawal by Subject|2|||
146592421|NCT01598753|528677287|FG002|Overall Study|Withdrawal by Subject|0|||
146592422|NCT01598753|528677288|FG003|Overall Study|Withdrawal by Subject|1|||
146592423|NCT02275117|528677289|FG000|Overall Study|Adverse Event|0|||
146592424|NCT02275117|528677290|FG001|Overall Study|Adverse Event|0|||
146592425|NCT02275117|528677291|FG002|Overall Study|Adverse Event|0|||
146592426|NCT02275117|528677292|FG003|Overall Study|Adverse Event|0|||
146592427|NCT02275117|528677293|FG004|Overall Study|Adverse Event|1|||
146592428|NCT02275117|528677289|FG000|Overall Study|Lack of Efficacy|6|||
146592429|NCT02275117|528677290|FG001|Overall Study|Lack of Efficacy|7|||
146592430|NCT02275117|528677291|FG002|Overall Study|Lack of Efficacy|5|||
146592431|NCT02275117|528677292|FG003|Overall Study|Lack of Efficacy|2|||
146592432|NCT02275117|528677293|FG004|Overall Study|Lack of Efficacy|10|||
146592433|NCT02275117|528677289|FG000|Overall Study|Lost to Follow-up|11|||
146592434|NCT02275117|528677290|FG001|Overall Study|Lost to Follow-up|16|||
146592435|NCT02275117|528677291|FG002|Overall Study|Lost to Follow-up|15|||
146592436|NCT02275117|528677292|FG003|Overall Study|Lost to Follow-up|16|||
146592437|NCT02275117|528677293|FG004|Overall Study|Lost to Follow-up|8|||
146592438|NCT02275117|528677289|FG000|Overall Study|Physician Decision|0|||
146653059|NCT04761627|528908136|FG001|Run-in Period|Did not meet PASI 50|0|||
146653060|NCT04761627|528908137|FG002|Run-in Period|Did not meet PASI 50|0|||
146653061|NCT04761627|528908135|FG000|Run-in Period|Study site closure|2|||
146653062|NCT04761627|528908136|FG001|Run-in Period|Study site closure|0|||
146653063|NCT04761627|528908137|FG002|Run-in Period|Study site closure|0|||
146653064|NCT04761627|528908135|FG000|Run-in Period|Pregnancy|2|||
146592439|NCT02275117|528677290|FG001|Overall Study|Physician Decision|1|||
146592440|NCT02275117|528677291|FG002|Overall Study|Physician Decision|1|||
146592441|NCT02275117|528677292|FG003|Overall Study|Physician Decision|0|||
146592442|NCT02275117|528677293|FG004|Overall Study|Physician Decision|1|||
146592443|NCT02275117|528677289|FG000|Overall Study|Protocol Violation|1|||
146592444|NCT02275117|528677290|FG001|Overall Study|Protocol Violation|0|||
146592445|NCT02275117|528677291|FG002|Overall Study|Protocol Violation|1|||
146592446|NCT02275117|528677292|FG003|Overall Study|Protocol Violation|1|||
146592447|NCT02275117|528677293|FG004|Overall Study|Protocol Violation|0|||
146592448|NCT02275117|528677289|FG000|Overall Study|Withdrawal by Subject|6|||
146592449|NCT02275117|528677290|FG001|Overall Study|Withdrawal by Subject|4|||
146592450|NCT02275117|528677291|FG002|Overall Study|Withdrawal by Subject|7|||
146592451|NCT02275117|528677292|FG003|Overall Study|Withdrawal by Subject|3|||
146592452|NCT02275117|528677293|FG004|Overall Study|Withdrawal by Subject|3|||
146592453|NCT02275117|528677289|FG000|Overall Study|Terminated by Sponsor|4|||
146592454|NCT02275117|528677290|FG001|Overall Study|Terminated by Sponsor|4|||
146592455|NCT02275117|528677291|FG002|Overall Study|Terminated by Sponsor|4|||
146919113|NCT02488759|529864583|FG005|Overall Study|Disease progression|2|||
146919114|NCT02488759|529864578|FG000|Overall Study|Study drug toxicity|11|||
146919115|NCT02488759|529864579|FG001|Overall Study|Study drug toxicity|33|||
146919116|NCT02488759|529864580|FG002|Overall Study|Study drug toxicity|31|||
146592456|NCT02275117|528677292|FG003|Overall Study|Terminated by Sponsor|6|||
146592457|NCT02275117|528677293|FG004|Overall Study|Terminated by Sponsor|4|||
146592458|NCT02275117|528677289|FG000|Overall Study|Worsening of Study Indication|0|||
146592459|NCT02275117|528677290|FG001|Overall Study|Worsening of Study Indication|1|||
146592460|NCT02275117|528677291|FG002|Overall Study|Worsening of Study Indication|2|||
146592461|NCT02275117|528677292|FG003|Overall Study|Worsening of Study Indication|0|||
146592462|NCT02275117|528677293|FG004|Overall Study|Worsening of Study Indication|0|||
146592463|NCT02275117|528677289|FG000|Overall Study|Study Burden|5|||
146592464|NCT02275117|528677290|FG001|Overall Study|Study Burden|4|||
146592465|NCT02275117|528677291|FG002|Overall Study|Study Burden|7|||
146592466|NCT02275117|528677292|FG003|Overall Study|Study Burden|5|||
146592467|NCT02275117|528677293|FG004|Overall Study|Study Burden|7|||
146592468|NCT02275117|528677289|FG000|Overall Study|Other|1|||
146592469|NCT02275117|528677290|FG001|Overall Study|Other|0|||
146592470|NCT02275117|528677291|FG002|Overall Study|Other|0|||
146592471|NCT02275117|528677292|FG003|Overall Study|Other|0|||
146592472|NCT02275117|528677293|FG004|Overall Study|Other|2|||
146592473|NCT02142283|528677295|FG000|Overall Study|Death|20|||
146592474|NCT02142283|528677296|FG001|Overall Study|Death|18|||
146592475|NCT02142283|528677295|FG000|Overall Study|Withdrawal by Subject|1|||
146592476|NCT02142283|528677296|FG001|Overall Study|Withdrawal by Subject|3|||
146592477|NCT02374814|528677299|FG000|Overall Study|Lost to Follow-up|1|||
146592478|NCT02374814|528677300|FG001|Overall Study|Lost to Follow-up|1|||
146592479|NCT02374814|528677301|FG002|Overall Study|Lost to Follow-up|0|||
146592480|NCT02374814|528677302|FG003|Overall Study|Lost to Follow-up|1|||
146592481|NCT02374814|528677303|FG004|Overall Study|Lost to Follow-up|0|||
146592482|NCT02374814|528677304|FG005|Overall Study|Lost to Follow-up|0|||
146592483|NCT02374814|528677299|FG000|Overall Study|Withdrawal by Subject|0|||
146592484|NCT02374814|528677300|FG001|Overall Study|Withdrawal by Subject|0|||
146592485|NCT02374814|528677301|FG002|Overall Study|Withdrawal by Subject|1|||
146592486|NCT02374814|528677302|FG003|Overall Study|Withdrawal by Subject|1|||
146592487|NCT02374814|528677303|FG004|Overall Study|Withdrawal by Subject|0|||
146592488|NCT02374814|528677304|FG005|Overall Study|Withdrawal by Subject|0|||
146592489|NCT03093974|528677305|FG000|Overall Study|Withdrawal by Subject|32|||
146592490|NCT03093974|528677306|FG001|Overall Study|Withdrawal by Subject|27|||
146592491|NCT03093974|528677305|FG000|Overall Study|Adverse Event|17|||
146592492|NCT03093974|528677306|FG001|Overall Study|Adverse Event|24|||
146592493|NCT03093974|528677305|FG000|Overall Study|Death|0|||
146592494|NCT03093974|528677306|FG001|Overall Study|Death|1|||
146592495|NCT03093974|528677305|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146592496|NCT03093974|528677306|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146592497|NCT03093974|528677305|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
146592498|NCT03093974|528677306|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
146592499|NCT03093974|528677305|FG000|Overall Study|Lost to Follow-up|0|||
146592500|NCT03093974|528677306|FG001|Overall Study|Lost to Follow-up|1|||
146592501|NCT03093974|528677305|FG000|Overall Study|Other|1|||
146592502|NCT03093974|528677306|FG001|Overall Study|Other|2|||
146592503|NCT02141490|528677307|FG000|Overall Study|Screening failures|4|||
146592504|NCT02141490|528677308|FG001|Overall Study|Screening failures|0|||
146592505|NCT02141490|528677309|FG002|Overall Study|Screening failures|0|||
146592506|NCT00033540|528677312|FG000|Overall Study|Adverse Event|14|||
146592507|NCT00033540|528677312|FG000|Overall Study|Death|1|||
146592508|NCT00033540|528677312|FG000|Overall Study|Progression|26|||
146592509|NCT00033540|528677312|FG000|Overall Study|Withdrawal by Subject|6|||
146592510|NCT00033540|528677312|FG000|Overall Study|Other|5|||
146592511|NCT00033540|528677312|FG000|Overall Study|Ineligible|3|||
146592512|NCT00033540|528677312|FG000|Overall Study|Never received treatment|2|||
146592513|NCT01253265|528677315|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
146592514|NCT01253265|528677316|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
146919117|NCT02488759|529864581|FG003|Overall Study|Study drug toxicity|0|||
146919118|NCT02488759|529864582|FG004|Overall Study|Study drug toxicity|0|||
146919119|NCT02488759|529864583|FG005|Overall Study|Study drug toxicity|2|||
146919120|NCT02488759|529864578|FG000|Overall Study|Adverse event unrelated to study drug|9|||
146919121|NCT02488759|529864579|FG001|Overall Study|Adverse event unrelated to study drug|11|||
146919122|NCT02488759|529864580|FG002|Overall Study|Adverse event unrelated to study drug|7|||
146919123|NCT02488759|529864581|FG003|Overall Study|Adverse event unrelated to study drug|0|||
146919124|NCT02488759|529864582|FG004|Overall Study|Adverse event unrelated to study drug|1|||
146592515|NCT01253265|528677317|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
146592516|NCT01253265|528677318|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
146592517|NCT01253265|528677319|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
146592518|NCT01253265|528677315|FG000|Overall Study|Withdrawal by Subject|0|||
146592519|NCT01253265|528677316|FG001|Overall Study|Withdrawal by Subject|0|||
146592520|NCT01253265|528677317|FG002|Overall Study|Withdrawal by Subject|0|||
146919125|NCT02488759|529864583|FG005|Overall Study|Adverse event unrelated to study drug|0|||
146592521|NCT01253265|528677318|FG003|Overall Study|Withdrawal by Subject|0|||
146592522|NCT01253265|528677319|FG004|Overall Study|Withdrawal by Subject|1|||
146592523|NCT00434759|528677322|FG000|Overall Study|Lack of Efficacy|5|||
146592524|NCT00434759|528677323|FG001|Overall Study|Lack of Efficacy|4|||
146592525|NCT00434759|528677322|FG000|Overall Study|Withdrawal by Subject|17|||
146592526|NCT00434759|528677323|FG001|Overall Study|Withdrawal by Subject|1|||
146919126|NCT02488759|529864578|FG000|Overall Study|Participant request to discontinue study treatment|6|||
146771365|NCT02755116|529331172|FG000|Overall Study|surgery converted to open, pt admitted|3|||
146771366|NCT02755116|529331173|FG001|Overall Study|surgery converted to open, pt admitted|1|||
146771367|NCT01510717|529331174|FG000|Overall Study|Adverse Event|1|||
146771368|NCT01510717|529331175|FG001|Overall Study|Adverse Event|2|||
146771369|NCT01510717|529331174|FG000|Overall Study|Death|1|||
146771370|NCT01510717|529331175|FG001|Overall Study|Death|0|||
146771371|NCT01510717|529331174|FG000|Overall Study|Lost to Follow-up|0|||
146771372|NCT01510717|529331175|FG001|Overall Study|Lost to Follow-up|1|||
146592527|NCT00434759|528677322|FG000|Overall Study|family affairs|2|||
146592528|NCT00434759|528677323|FG001|Overall Study|family affairs|0|||
146592529|NCT00495521|528677324|FG000|Overall Study|Physician Decision|0|||
146592530|NCT00495521|528677325|FG001|Overall Study|Physician Decision|1|||
146592531|NCT02410824|528677326|FG000|First Intervention (One Week)|Headache|0|||
146592532|NCT02410824|528677327|FG001|First Intervention (One Week)|Headache|1|||
146592533|NCT02782325|528677328|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
146592534|NCT02782325|528677329|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
146592535|NCT02782325|528677330|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
146592536|NCT02782325|528677328|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
146592537|NCT02782325|528677329|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
146592538|NCT02782325|528677330|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
146592539|NCT01038713|528677331|FG000|Overall Study|Patient to hospice|1|||
146592540|NCT01038713|528677332|FG001|Overall Study|Patient to hospice|1|||
146592541|NCT01038713|528677333|FG002|Overall Study|Patient to hospice|1|||
146592542|NCT01038713|528677331|FG000|Overall Study|Lost to Follow-up|3|||
146592543|NCT01038713|528677332|FG001|Overall Study|Lost to Follow-up|0|||
146592544|NCT01038713|528677333|FG002|Overall Study|Lost to Follow-up|0|||
146592545|NCT01038713|528677331|FG000|Overall Study|Neuroendocrine Tumor|0|||
146592546|NCT01038713|528677332|FG001|Overall Study|Neuroendocrine Tumor|1|||
146592547|NCT01038713|528677333|FG002|Overall Study|Neuroendocrine Tumor|0|||
146592548|NCT01038713|528677331|FG000|Overall Study|died from PEP|0|||
146592549|NCT01038713|528677332|FG001|Overall Study|died from PEP|1|||
146592550|NCT01038713|528677333|FG002|Overall Study|died from PEP|0|||
146592551|NCT01038713|528677331|FG000|Overall Study|Autoimmune Pancreatitis|1|||
146592552|NCT01038713|528677332|FG001|Overall Study|Autoimmune Pancreatitis|0|||
146592553|NCT01038713|528677333|FG002|Overall Study|Autoimmune Pancreatitis|0|||
146592554|NCT03777917|528677334|FG000|Overall Study|Withdrawal by Subject|1|||
146592555|NCT03777917|528677335|FG001|Overall Study|Withdrawal by Subject|0|||
146592556|NCT03777917|528677334|FG000|Overall Study|Physician Decision|1|||
146592557|NCT03777917|528677335|FG001|Overall Study|Physician Decision|0|||
146592558|NCT03777917|528677334|FG000|Overall Study|Lost to Follow-up|6|||
146978397|NCT02370784|530084041|FG000|Overall Study|Patient started prohibited medication|0|||
146592559|NCT03777917|528677335|FG001|Overall Study|Lost to Follow-up|2|||
146592560|NCT03777917|528677334|FG000|Overall Study|Other|1|||
146592561|NCT03777917|528677335|FG001|Overall Study|Other|0|||
146592562|NCT00930969|528677336|FG000|Overall Study|Death|5|||
146592563|NCT00930969|528677336|FG000|Overall Study|Lost to Follow-up|1|||
146592564|NCT00930969|528677336|FG000|Overall Study|Physician Decision|13|||
146592565|NCT00930969|528677336|FG000|Overall Study|Withdrawal by Subject|19|||
146592566|NCT00657150|528677337|FG000|Overall Study|Adverse Event|19|||
146592567|NCT00657150|528677338|FG001|Overall Study|Adverse Event|10|||
146592568|NCT00657150|528677337|FG000|Overall Study|Non-compliant with protocol|5|||
146592569|NCT00657150|528677338|FG001|Overall Study|Non-compliant with protocol|9|||
146592570|NCT00657150|528677337|FG000|Overall Study|Lost to Follow-up|2|||
146592571|NCT00657150|528677338|FG001|Overall Study|Lost to Follow-up|0|||
146592572|NCT00657150|528677337|FG000|Overall Study|Withdrawal by Subject|51|||
146592573|NCT00657150|528677338|FG001|Overall Study|Withdrawal by Subject|36|||
146592574|NCT00657150|528677337|FG000|Overall Study|Other|38|||
146592575|NCT00657150|528677338|FG001|Overall Study|Other|38|||
146592576|NCT00657150|528677337|FG000|Treatment|Adverse Event|60|||
146592577|NCT00657150|528677338|FG001|Treatment|Adverse Event|53|||
146592578|NCT00657150|528677337|FG000|Treatment|Non-compliant with protocol|10|||
146592579|NCT00657150|528677338|FG001|Treatment|Non-compliant with protocol|9|||
146592580|NCT00657150|528677337|FG000|Treatment|Lost to Follow-up|1|||
146592581|NCT00657150|528677338|FG001|Treatment|Lost to Follow-up|0|||
146592582|NCT00657150|528677337|FG000|Treatment|Withdrawal by Subject|23|||
146592583|NCT00657150|528677338|FG001|Treatment|Withdrawal by Subject|20|||
146592584|NCT00657150|528677337|FG000|Treatment|Other|13|||
146592585|NCT00657150|528677338|FG001|Treatment|Other|15|||
146592586|NCT02966795|528677339|FG000|Overall Study|Patient Left the Country|0|||
146592587|NCT02966795|528677340|FG001|Overall Study|Patient Left the Country|1|||
146771373|NCT01510717|529331174|FG000|Overall Study|Withdrawal by Subject|0|||
146771374|NCT01510717|529331175|FG001|Overall Study|Withdrawal by Subject|2|||
146771375|NCT02555215|529331178|FG000|Overall Study|Other|1|||
146771376|NCT02555215|529331178|FG000|Overall Study|Investigator Decision|2|||
146592588|NCT00432744|528677341|FG000|Months 0-6|Withdrawal by Subject|4|||
146592589|NCT00432744|528677342|FG001|Months 0-6|Withdrawal by Subject|4|||
146592590|NCT00432744|528677341|FG000|Months 0-6|Too disabled to score|1|||
146592591|NCT00432744|528677342|FG001|Months 0-6|Too disabled to score|0|||
146592592|NCT00432744|528677341|FG000|Months 7 - 12|Withdrawal by Subject|1|||
146592593|NCT00432744|528677342|FG001|Months 7 - 12|Withdrawal by Subject|0|||
146592594|NCT00432744|528677341|FG000|Months 7 - 12|Too disabled to score|0|||
146592595|NCT00432744|528677342|FG001|Months 7 - 12|Too disabled to score|1|||
146592596|NCT01460719|528679265|FG000|Overall Study|Adverse Event|1|||
146592597|NCT01460719|528679265|FG000|Overall Study|Withdrawal by Subject|1|||
146592598|NCT00350623|528679273|FG000|Overall Study|Lost to Follow-up|8|||
146592599|NCT00350623|528679274|FG001|Overall Study|Lost to Follow-up|3|||
146592600|NCT00350623|528679275|FG002|Overall Study|Lost to Follow-up|4|||
146592601|NCT00350623|528679273|FG000|Overall Study|Withdrawal by Subject|0|||
146592602|NCT00350623|528679274|FG001|Overall Study|Withdrawal by Subject|1|||
146592603|NCT00350623|528679275|FG002|Overall Study|Withdrawal by Subject|1|||
146592604|NCT00350623|528679273|FG000|Overall Study|patient traveling outside the country|0|||
146592605|NCT00350623|528679274|FG001|Overall Study|patient traveling outside the country|0|||
146592606|NCT00350623|528679275|FG002|Overall Study|patient traveling outside the country|1|||
146592607|NCT04126564|528679277|FG000|Overall Study|Withdrawal by Subject|0|||
146592608|NCT04126564|528679278|FG001|Overall Study|Withdrawal by Subject|2|||
146592609|NCT04126564|528679277|FG000|Overall Study|Lost to Follow-up|0|||
146592610|NCT04126564|528679278|FG001|Overall Study|Lost to Follow-up|1|||
146592611|NCT02536300|528679279|FG000|Overall Study|Investigator's Discretion|17|||
146592612|NCT02536300|528679280|FG001|Overall Study|Investigator's Discretion|11|||
146592613|NCT02536300|528679281|FG002|Overall Study|Investigator's Discretion|2|||
146592614|NCT02536300|528679279|FG000|Overall Study|Progressive Disease|11|||
146592615|NCT02536300|528679280|FG001|Overall Study|Progressive Disease|7|||
146592616|NCT02536300|528679281|FG002|Overall Study|Progressive Disease|6|||
146592617|NCT02536300|528679279|FG000|Overall Study|Study Terminated by Sponsor|6|||
146592618|NCT02536300|528679280|FG001|Overall Study|Study Terminated by Sponsor|4|||
146592619|NCT02536300|528679281|FG002|Overall Study|Study Terminated by Sponsor|7|||
146592620|NCT02536300|528679279|FG000|Overall Study|Death|7|||
146592621|NCT02536300|528679280|FG001|Overall Study|Death|0|||
146592622|NCT02536300|528679281|FG002|Overall Study|Death|5|||
146592623|NCT02536300|528679279|FG000|Overall Study|Withdrew Consent|4|||
146592624|NCT02536300|528679280|FG001|Overall Study|Withdrew Consent|2|||
146592625|NCT02536300|528679281|FG002|Overall Study|Withdrew Consent|0|||
146592626|NCT02536300|528679279|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
146592627|NCT02536300|528679280|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
146592628|NCT02536300|528679281|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
146592629|NCT02536300|528679279|FG000|Overall Study|Enrolled but Never Treated|0|||
146592630|NCT02536300|528679280|FG001|Overall Study|Enrolled but Never Treated|0|||
146592631|NCT02536300|528679281|FG002|Overall Study|Enrolled but Never Treated|1|||
146592632|NCT02536300|528679279|FG000|Overall Study|Non-compliance With Study Drug|1|||
146592633|NCT02536300|528679280|FG001|Overall Study|Non-compliance With Study Drug|0|||
146592634|NCT02536300|528679281|FG002|Overall Study|Non-compliance With Study Drug|0|||
146592635|NCT02536300|528679279|FG000|Overall Study|Protocol Violation|0|||
146592636|NCT02536300|528679280|FG001|Overall Study|Protocol Violation|1|||
146592637|NCT02536300|528679281|FG002|Overall Study|Protocol Violation|0|||
146592638|NCT00294645|528679291|FG000|Overall Study|Death|10|||
146592639|NCT00294645|528679292|FG001|Overall Study|Death|18|||
146592640|NCT00294645|528679291|FG000|Overall Study|Lost to Follow-up|1|||
146592641|NCT00294645|528679292|FG001|Overall Study|Lost to Follow-up|10|||
146592642|NCT00294645|528679291|FG000|Overall Study|Withdrawal by Subject|18|||
146592643|NCT00294645|528679292|FG001|Overall Study|Withdrawal by Subject|34|||
146592644|NCT00294645|528679291|FG000|Overall Study|Physician Decision|15|||
146592645|NCT00294645|528679292|FG001|Overall Study|Physician Decision|20|||
146592646|NCT00294645|528679291|FG000|Overall Study|Other|4|||
146592647|NCT00294645|528679292|FG001|Overall Study|Other|10|||
146592648|NCT01238835|528679303|FG000|Overall Study|Death|124|||
146592649|NCT01238835|528679303|FG000|Overall Study|Withdrawal by Subject|9|||
146592650|NCT01238835|528679303|FG000|Overall Study|Lost to Follow-up|1|||
146592651|NCT01238835|528679303|FG000|Overall Study|Site early discontinuation|2|||
146592652|NCT00907803|528679307|FG000|Overall Study|Withdrawal of consent - long commute|1|||
146592653|NCT00907803|528679308|FG001|Overall Study|Withdrawal of consent - long commute|0|||
146592654|NCT00907803|528679309|FG002|Overall Study|Withdrawal of consent - long commute|0|||
146592655|NCT00907803|528679307|FG000|Overall Study|Adverse Event|2|||
146592656|NCT00907803|528679308|FG001|Overall Study|Adverse Event|0|||
146592657|NCT00907803|528679309|FG002|Overall Study|Adverse Event|0|||
146771377|NCT00529789|529331179|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
146592658|NCT00907803|528679307|FG000|Overall Study|Withdrawal by Subject|0|||
146592659|NCT00907803|528679308|FG001|Overall Study|Withdrawal by Subject|1|||
146592660|NCT00907803|528679309|FG002|Overall Study|Withdrawal by Subject|0|||
146592661|NCT00907803|528679307|FG000|Overall Study|Lost to Follow-up|0|||
146592662|NCT00907803|528679308|FG001|Overall Study|Lost to Follow-up|1|||
146592663|NCT00907803|528679309|FG002|Overall Study|Lost to Follow-up|0|||
146592664|NCT00907803|528679307|FG000|Overall Study|Protocol Violation|0|||
146592665|NCT00907803|528679308|FG001|Overall Study|Protocol Violation|1|||
146592666|NCT00907803|528679309|FG002|Overall Study|Protocol Violation|0|||
146919127|NCT02488759|529864579|FG001|Overall Study|Participant request to discontinue study treatment|8|||
146592667|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|Death|1|||
146592668|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|Death|1|||
146592669|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|Death|0|||
146592670|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|Death|0|||
146592671|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|Death|1|||
146592672|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|Death|0|||
146592673|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|Death|0|||
146592674|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|Death|0|||
146592675|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|Death|0|||
146592676|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|Death|0|||
146919128|NCT02488759|529864580|FG002|Overall Study|Participant request to discontinue study treatment|4|||
146919129|NCT02488759|529864581|FG003|Overall Study|Participant request to discontinue study treatment|0|||
146919130|NCT02488759|529864582|FG004|Overall Study|Participant request to discontinue study treatment|0|||
146919131|NCT02488759|529864583|FG005|Overall Study|Participant request to discontinue study treatment|0|||
146592677|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
146919132|NCT02488759|529864578|FG000|Overall Study|Withdrawal by Subject|4|||
146919133|NCT02488759|529864579|FG001|Overall Study|Withdrawal by Subject|0|||
146919134|NCT02488759|529864580|FG002|Overall Study|Withdrawal by Subject|3|||
146919135|NCT02488759|529864581|FG003|Overall Study|Withdrawal by Subject|0|||
146919136|NCT02488759|529864582|FG004|Overall Study|Withdrawal by Subject|0|||
146919137|NCT02488759|529864583|FG005|Overall Study|Withdrawal by Subject|2|||
146919138|NCT02488759|529864578|FG000|Overall Study|Lost to Follow-up|0|||
146919139|NCT02488759|529864579|FG001|Overall Study|Lost to Follow-up|0|||
146919140|NCT02488759|529864580|FG002|Overall Study|Lost to Follow-up|2|||
146919141|NCT02488759|529864581|FG003|Overall Study|Lost to Follow-up|0|||
146919142|NCT02488759|529864582|FG004|Overall Study|Lost to Follow-up|0|||
146919143|NCT02488759|529864583|FG005|Overall Study|Lost to Follow-up|0|||
146919144|NCT02488759|529864578|FG000|Overall Study|Maximum clinical benefit|3|||
146919145|NCT02488759|529864579|FG001|Overall Study|Maximum clinical benefit|0|||
146919146|NCT02488759|529864580|FG002|Overall Study|Maximum clinical benefit|1|||
146919147|NCT02488759|529864581|FG003|Overall Study|Maximum clinical benefit|0|||
146919148|NCT02488759|529864582|FG004|Overall Study|Maximum clinical benefit|0|||
146919149|NCT02488759|529864583|FG005|Overall Study|Maximum clinical benefit|0|||
146919150|NCT02488759|529864578|FG000|Overall Study|Other reasons|7|||
146919151|NCT02488759|529864579|FG001|Overall Study|Other reasons|32|||
146919152|NCT02488759|529864580|FG002|Overall Study|Other reasons|23|||
146919153|NCT02488759|529864581|FG003|Overall Study|Other reasons|1|||
146919154|NCT02488759|529864582|FG004|Overall Study|Other reasons|1|||
146919155|NCT02488759|529864583|FG005|Overall Study|Other reasons|1|||
146919156|NCT00719732|529864584|FG000|Overall Study|Lost to Follow-up|20|||
146919157|NCT00719732|529864584|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
146919158|NCT00719732|529864584|FG000|Overall Study|Illness not associated with device|1|||
146919159|NCT05113953|529866066|FG000|Overall Study|Adverse Event|5|||
146919160|NCT05113953|529866067|FG001|Overall Study|Adverse Event|0|||
146919161|NCT05113953|529866068|FG002|Overall Study|Adverse Event|3|||
146919162|NCT05113953|529866066|FG000|Overall Study|Lost to Follow-up|3|||
146919163|NCT05113953|529866067|FG001|Overall Study|Lost to Follow-up|4|||
146919164|NCT05113953|529866068|FG002|Overall Study|Lost to Follow-up|2|||
146592678|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
146592679|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
146592680|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
146592681|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
146592682|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
146592683|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
146592684|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
146592685|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
146592686|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
146592687|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146592688|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146592689|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146592690|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146592691|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
146919165|NCT05113953|529866066|FG000|Overall Study|Non-compliance with Study Drug|1|||
146919166|NCT05113953|529866067|FG001|Overall Study|Non-compliance with Study Drug|0|||
146919167|NCT05113953|529866068|FG002|Overall Study|Non-compliance with Study Drug|0|||
146592692|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146771378|NCT00529789|529331179|FG000|Study Period II/III|Adverse Event|3|||
146919168|NCT05113953|529866066|FG000|Overall Study|Withdrawal by Subject|2|||
146919169|NCT05113953|529866067|FG001|Overall Study|Withdrawal by Subject|6|||
146919170|NCT05113953|529866068|FG002|Overall Study|Withdrawal by Subject|4|||
146919171|NCT05113953|529866066|FG000|Overall Study|Reason not Specified|2|||
146919172|NCT05113953|529866067|FG001|Overall Study|Reason not Specified|0|||
146919173|NCT05113953|529866068|FG002|Overall Study|Reason not Specified|0|||
146592693|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146592694|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146592695|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146592696|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146592697|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
146592698|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146592699|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146592700|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146592701|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146592702|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146592703|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146592704|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146592705|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146592706|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146592707|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
146592708|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
146592709|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
146592710|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
146592711|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
146592712|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
146592713|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
146592714|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
146592715|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
146592716|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
146592717|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
146592718|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
146592719|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
146592720|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
146592721|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
146592722|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
146592723|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
146592724|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
146592725|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
146592726|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
146592727|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
146592728|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
146592729|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
146592730|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
146592731|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
146592732|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
146592733|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
146592734|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
146592735|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
146592736|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
146592737|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
146592738|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
146592739|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
146592740|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146592741|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
146592742|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146592743|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146592744|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146592745|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146592746|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146592747|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
146592748|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
146592749|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
146592750|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
146592751|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
146592752|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
146592753|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
146592754|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
146592755|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
146592756|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
146592757|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
146592758|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
146592759|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146592760|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
146592761|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
146592762|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146592763|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146592764|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146592765|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146592766|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146592767|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
146592768|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
146592769|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
146592770|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
146592771|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
146592772|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
146592773|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
146592774|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
146592775|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
146592776|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
146592777|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
146592778|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
146592779|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
146592780|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
146592781|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
146592782|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
146592783|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
146592784|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
146592785|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
146592786|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
146592787|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146592788|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146592789|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146592790|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
146592791|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
146592792|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146592793|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146592794|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146592795|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146592796|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146592797|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
146592798|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146592799|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
146592800|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
146592801|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
146592802|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146592803|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146592804|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146653065|NCT04761627|528908136|FG001|Run-in Period|Pregnancy|0|||
146653066|NCT04761627|528908137|FG002|Run-in Period|Pregnancy|0|||
146919174|NCT02626819|529866069|FG000|Overall Study|Lost to Follow-up|3|||
146919175|NCT02626819|529866070|FG001|Overall Study|Lost to Follow-up|2|||
146919176|NCT02626819|529866069|FG000|Overall Study|Withdrawal by Subject|1|||
146919177|NCT02626819|529866070|FG001|Overall Study|Withdrawal by Subject|0|||
146592805|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146592806|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146592807|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
146592808|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
146592809|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
146592810|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
146592811|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
146592812|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
146592813|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
146592814|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
146592815|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
146592816|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
146592817|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592818|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592819|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592820|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592821|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
146592822|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592823|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592824|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592825|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592826|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592827|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
146592828|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
146592829|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
146592830|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
146592831|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
146592832|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
146592833|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
146592834|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
146592835|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
146592836|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
146592837|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
146592838|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
146592839|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
146592840|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
146592841|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
146592842|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
146592843|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
146592844|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
146592845|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
146592846|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
146592847|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
146592848|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
146592849|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
146592850|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
146592851|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
146592852|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
146592853|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
146592854|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
146592855|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
146592856|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
146592857|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|Other|5|||
146592858|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|Other|1|||
146592859|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|Other|0|||
146592860|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|Other|3|||
146592861|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|Other|0|||
146919178|NCT02626819|529866069|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
146919179|NCT02626819|529866070|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
146592862|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|Other|0|||
146592863|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|Other|0|||
146592864|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|Other|0|||
146592865|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|Other|0|||
146592866|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|Other|0|||
146592867|NCT03352557|528679310|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
146592868|NCT03352557|528679311|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
146592869|NCT03352557|528679312|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
146592870|NCT03352557|528679313|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
146592871|NCT03352557|528679314|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
146592872|NCT03352557|528679315|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
146592873|NCT03352557|528679316|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
146592874|NCT03352557|528679317|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
146592875|NCT03352557|528679318|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
146592876|NCT03352557|528679319|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
146592877|NCT03352557|528679310|FG000|LTE Period: Week 80 to Week 173|Death|0|||
146592878|NCT03352557|528679311|FG001|LTE Period: Week 80 to Week 173|Death|0|||
146592879|NCT03352557|528679312|FG002|LTE Period: Week 80 to Week 173|Death|0|||
146592880|NCT03352557|528679313|FG003|LTE Period: Week 80 to Week 173|Death|0|||
146592881|NCT03352557|528679314|FG004|LTE Period: Week 80 to Week 173|Death|0|||
146592882|NCT03352557|528679315|FG005|LTE Period: Week 80 to Week 173|Death|1|||
146592883|NCT03352557|528679316|FG006|LTE Period: Week 80 to Week 173|Death|0|||
146592884|NCT03352557|528679317|FG007|LTE Period: Week 80 to Week 173|Death|1|||
146592885|NCT03352557|528679318|FG008|LTE Period: Week 80 to Week 173|Death|1|||
146592886|NCT03352557|528679319|FG009|LTE Period: Week 80 to Week 173|Death|1|||
146592887|NCT03352557|528679310|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146771379|NCT00529789|529331179|FG000|Study Period II/III|Lack of Efficacy|2|||
146771380|NCT00529789|529331179|FG000|Study Period II/III|Withdrawal by Subject|1|||
146771381|NCT00529789|529331179|FG000|Study Period II/III|Protocol Violation|3|||
146771382|NCT00529789|529331179|FG000|Study Period II/III|Physician Decision|3|||
146771383|NCT00529789|529331179|FG000|Study Period II/III|Lost to Follow-up|3|||
146771384|NCT00529789|529331179|FG000|Study Period IV|Parent/Caregiver Decision|1|||
146771385|NCT00529789|529331179|FG000|Study Period IV|Adverse Event|1|||
146771386|NCT00529789|529331179|FG000|Study Period IV|Lack of Efficacy|1|||
146771387|NCT00529789|529331179|FG000|Study Period IV|Lost to Follow-up|3|||
146771388|NCT01595061|529331180|FG000|Overall Study|Never Treated|3|||
146771389|NCT01595061|529331180|FG000|Overall Study|Inadequate Pathology|1|||
146771390|NCT03194958|529331183|FG000|Overall Study|Death|0|||
146771391|NCT03194958|529331184|FG001|Overall Study|Death|1|||
146771392|NCT03194958|529331185|FG002|Overall Study|Death|1|||
146771393|NCT03194958|529331186|FG003|Overall Study|Death|1|||
146771394|NCT03194958|529331183|FG000|Overall Study|Withdrawal by Subject|24|||
146771395|NCT03194958|529331184|FG001|Overall Study|Withdrawal by Subject|27|||
146771396|NCT03194958|529331185|FG002|Overall Study|Withdrawal by Subject|7|||
146771397|NCT03194958|529331186|FG003|Overall Study|Withdrawal by Subject|22|||
146771398|NCT03194958|529331183|FG000|Overall Study|Lost to Follow-up|168|||
146771399|NCT03194958|529331184|FG001|Overall Study|Lost to Follow-up|196|||
146919180|NCT00502307|529866071|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
146919181|NCT00502307|529866072|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
146919182|NCT00502307|529866073|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
146592888|NCT03352557|528679311|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146592889|NCT03352557|528679312|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146592890|NCT03352557|528679313|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146592891|NCT03352557|528679314|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146592892|NCT03352557|528679315|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
146592893|NCT03352557|528679316|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146592894|NCT03352557|528679317|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146592895|NCT03352557|528679318|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146592896|NCT03352557|528679319|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146592897|NCT03352557|528679310|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146592898|NCT03352557|528679311|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146592899|NCT03352557|528679312|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146771400|NCT03194958|529331185|FG002|Overall Study|Lost to Follow-up|174|||
146771401|NCT03194958|529331186|FG003|Overall Study|Lost to Follow-up|186|||
146771402|NCT00959946|529331188|FG000|Overall Study|Adverse Event|0|||
146771403|NCT00959946|529331189|FG001|Overall Study|Adverse Event|0|||
146771404|NCT00959946|529331190|FG002|Overall Study|Adverse Event|2|||
146771405|NCT00959946|529331191|FG003|Overall Study|Adverse Event|1|||
146771406|NCT00959946|529331192|FG004|Overall Study|Adverse Event|0|||
146771407|NCT00959946|529331193|FG005|Overall Study|Adverse Event|1|||
146771408|NCT00959946|529331194|FG006|Overall Study|Adverse Event|0|||
146771409|NCT00959946|529331195|FG007|Overall Study|Adverse Event|0|||
146771410|NCT00959946|529331188|FG000|Overall Study|Death|0|||
146771411|NCT00959946|529331189|FG001|Overall Study|Death|0|||
146771412|NCT00959946|529331190|FG002|Overall Study|Death|0|||
146919183|NCT00502307|529866071|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
146919184|NCT00502307|529866072|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
146919185|NCT00502307|529866073|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
146919186|NCT00502307|529866071|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
146919187|NCT00502307|529866072|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
146919188|NCT00502307|529866073|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
146919189|NCT00502307|529866071|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
146919190|NCT00502307|529866072|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
146919191|NCT00502307|529866073|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
146919192|NCT00502307|529866071|FG000|Maintenance Period|Progressive disease|80|||
146919193|NCT00502307|529866072|FG001|Maintenance Period|Progressive disease|0|||
146919194|NCT00502307|529866073|FG002|Maintenance Period|Progressive disease|0|||
146919195|NCT00502307|529866071|FG000|Maintenance Period|Discontinued due to other reasons|68|||
146919196|NCT00502307|529866072|FG001|Maintenance Period|Discontinued due to other reasons|0|||
146592900|NCT03352557|528679313|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146592901|NCT03352557|528679314|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146592902|NCT03352557|528679315|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146592903|NCT03352557|528679316|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146592904|NCT03352557|528679317|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146592905|NCT03352557|528679318|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
146592906|NCT03352557|528679319|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146592907|NCT03352557|528679310|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
146592908|NCT03352557|528679311|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
146592909|NCT03352557|528679312|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
146592910|NCT03352557|528679313|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
146592911|NCT03352557|528679314|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
146592912|NCT03352557|528679315|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
146592913|NCT03352557|528679316|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
146592914|NCT03352557|528679317|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
146592915|NCT03352557|528679318|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
146592916|NCT03352557|528679319|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
146592917|NCT03352557|528679310|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146592918|NCT03352557|528679311|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146592919|NCT03352557|528679312|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146592920|NCT03352557|528679313|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146592921|NCT03352557|528679314|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146592922|NCT03352557|528679315|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
146592923|NCT03352557|528679316|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146592924|NCT03352557|528679317|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
146592925|NCT03352557|528679318|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
146592926|NCT03352557|528679319|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
146592927|NCT03352557|528679310|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146592928|NCT03352557|528679311|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146592929|NCT03352557|528679312|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146592930|NCT03352557|528679313|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146592931|NCT03352557|528679314|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146592932|NCT03352557|528679315|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
146592933|NCT03352557|528679316|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146592934|NCT03352557|528679317|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
146653067|NCT04761627|528908135|FG000|Post-randomization Period|Military service|0|||
146653068|NCT04761627|528908136|FG001|Post-randomization Period|Military service|1|||
146919197|NCT00502307|529866073|FG002|Maintenance Period|Discontinued due to other reasons|0|||
146919198|NCT01998581|529866075|FG000|Overall Study|Refused repeat treatment|20|||
146919199|NCT01998581|529866076|FG001|Overall Study|Refused repeat treatment|4|||
146919200|NCT01998581|529866075|FG000|Overall Study|Protocol Violation|1|||
146919201|NCT01998581|529866076|FG001|Overall Study|Protocol Violation|0|||
146919202|NCT01998581|529866075|FG000|Overall Study|Withdrawal by Subject|8|||
146919203|NCT01998581|529866076|FG001|Overall Study|Withdrawal by Subject|1|||
146919204|NCT01998581|529866075|FG000|Overall Study|Lost to Follow-up|12|||
146919205|NCT01998581|529866076|FG001|Overall Study|Lost to Follow-up|4|||
146919206|NCT01998581|529866075|FG000|Overall Study|Adverse Event|1|||
146592935|NCT03352557|528679318|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
146592936|NCT03352557|528679319|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146592937|NCT03352557|528679310|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
146653069|NCT04761627|528908137|FG002|Post-randomization Period|Military service|0|||
146653070|NCT04761627|528908135|FG000|Post-randomization Period|Adverse Event|0|||
146653071|NCT04761627|528908136|FG001|Post-randomization Period|Adverse Event|4|||
146653072|NCT04761627|528908137|FG002|Post-randomization Period|Adverse Event|2|||
146653073|NCT04761627|528908135|FG000|Post-randomization Period|Lost to Follow-up|0|||
146653074|NCT04761627|528908136|FG001|Post-randomization Period|Lost to Follow-up|6|||
146653075|NCT04761627|528908137|FG002|Post-randomization Period|Lost to Follow-up|6|||
146653076|NCT04761627|528908135|FG000|Post-randomization Period|Withdrawal by Subject|0|||
146653077|NCT04761627|528908136|FG001|Post-randomization Period|Withdrawal by Subject|7|||
146653078|NCT04761627|528908137|FG002|Post-randomization Period|Withdrawal by Subject|6|||
146653079|NCT04761627|528908135|FG000|Post-randomization Period|Pregnancy|0|||
146653080|NCT04761627|528908136|FG001|Post-randomization Period|Pregnancy|0|||
146653081|NCT04761627|528908137|FG002|Post-randomization Period|Pregnancy|1|||
146653082|NCT04761627|528908135|FG000|Post-randomization Period|Study site closure|0|||
146653083|NCT04761627|528908136|FG001|Post-randomization Period|Study site closure|0|||
146653084|NCT04761627|528908137|FG002|Post-randomization Period|Study site closure|1|||
146653085|NCT04761627|528908135|FG000|Post-randomization Period|Family planning|0|||
146653086|NCT04761627|528908136|FG001|Post-randomization Period|Family planning|1|||
146653087|NCT04761627|528908137|FG002|Post-randomization Period|Family planning|0|||
146653088|NCT01117792|528908138|FG000|Overall Study|Death|1|||
146653089|NCT01117792|528908138|FG000|Overall Study|Adverse Event|3|||
146653090|NCT05867342|528908139|FG000|Overall Study|Investigator Decision|3|||
146653091|NCT05867342|528908140|FG001|Overall Study|Investigator Decision|3|||
146653092|NCT00723203|528908141|FG000|Overall Study|Withdrawal by Subject|3|||
146653093|NCT00274924|528908145|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
146653094|NCT00274924|528908146|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
146653095|NCT00274924|528908147|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
146653096|NCT00274924|528908145|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
146653097|NCT00274924|528908146|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
146653098|NCT00274924|528908147|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
146653099|NCT00274924|528908145|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
146653100|NCT00274924|528908146|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
146653101|NCT00274924|528908147|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
146653102|NCT00274924|528908145|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
146653103|NCT00274924|528908146|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
146653104|NCT00274924|528908147|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
146653105|NCT00274924|528908145|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
146653106|NCT00274924|528908146|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
146653107|NCT00274924|528908147|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
146653108|NCT00274924|528908145|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
146771413|NCT00959946|529331191|FG003|Overall Study|Death|0|||
146771414|NCT00959946|529331192|FG004|Overall Study|Death|0|||
146771415|NCT00959946|529331193|FG005|Overall Study|Death|1|||
146771416|NCT00959946|529331194|FG006|Overall Study|Death|0|||
146771417|NCT00959946|529331195|FG007|Overall Study|Death|0|||
146771418|NCT00959946|529331188|FG000|Overall Study|Disease Progression|2|||
146771419|NCT00959946|529331189|FG001|Overall Study|Disease Progression|4|||
146592938|NCT03352557|528679311|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
146592939|NCT03352557|528679312|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
146592940|NCT03352557|528679313|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
146592941|NCT03352557|528679314|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
146592942|NCT03352557|528679315|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
146592943|NCT03352557|528679316|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
146592944|NCT03352557|528679317|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
146592945|NCT03352557|528679318|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
146592946|NCT03352557|528679319|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
146592947|NCT03352557|528679310|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146592948|NCT03352557|528679311|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146592949|NCT03352557|528679312|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146592950|NCT03352557|528679313|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146653109|NCT00274924|528908146|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
146653110|NCT00274924|528908147|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
146771420|NCT00959946|529331190|FG002|Overall Study|Disease Progression|2|||
146771421|NCT00959946|529331191|FG003|Overall Study|Disease Progression|4|||
146771422|NCT00959946|529331192|FG004|Overall Study|Disease Progression|4|||
146771423|NCT00959946|529331193|FG005|Overall Study|Disease Progression|6|||
146771424|NCT00959946|529331194|FG006|Overall Study|Disease Progression|2|||
146592951|NCT03352557|528679314|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146592952|NCT03352557|528679315|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146592953|NCT03352557|528679316|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146592954|NCT03352557|528679317|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146592955|NCT03352557|528679318|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
146592956|NCT03352557|528679319|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
146592957|NCT03352557|528679310|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146592958|NCT03352557|528679311|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146592959|NCT03352557|528679312|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146592960|NCT03352557|528679313|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146592961|NCT03352557|528679314|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146592962|NCT03352557|528679315|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146592963|NCT03352557|528679316|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146592964|NCT03352557|528679317|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
146592965|NCT03352557|528679318|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146592966|NCT03352557|528679319|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146592967|NCT03352557|528679310|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146592968|NCT03352557|528679311|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146592969|NCT03352557|528679312|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146592970|NCT03352557|528679313|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146592971|NCT03352557|528679314|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146592972|NCT03352557|528679315|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146592973|NCT03352557|528679316|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146592974|NCT03352557|528679317|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
146592975|NCT03352557|528679318|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146592976|NCT03352557|528679319|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146592977|NCT03352557|528679310|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592978|NCT03352557|528679311|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592979|NCT03352557|528679312|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592980|NCT03352557|528679313|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592981|NCT03352557|528679314|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592982|NCT03352557|528679315|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592983|NCT03352557|528679316|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592984|NCT03352557|528679317|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
146592985|NCT03352557|528679318|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
146592986|NCT03352557|528679319|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146592987|NCT03352557|528679310|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
146592988|NCT03352557|528679311|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
146592989|NCT03352557|528679312|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
146592990|NCT03352557|528679313|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
146592991|NCT03352557|528679314|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
146592992|NCT03352557|528679315|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
146592993|NCT03352557|528679316|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
146592994|NCT03352557|528679317|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
146978398|NCT02370784|530084042|FG001|Overall Study|Patient started prohibited medication|1|||
146978399|NCT00775983|530084044|FG000|Overall Study|Protocol Violation|1|||
146978400|NCT00775983|530084045|FG001|Overall Study|Protocol Violation|2|||
146978401|NCT01059071|530084046|FG000|Overall Study|Lack of Efficacy|1|||
146978402|NCT01059071|530084047|FG001|Overall Study|Lack of Efficacy|4|||
146978403|NCT01059071|530084048|FG002|Overall Study|Lack of Efficacy|2|||
146978404|NCT01059071|530084049|FG003|Overall Study|Lack of Efficacy|3|||
146978405|NCT01059071|530084046|FG000|Overall Study|Withdrawal by Subject|1|||
146978406|NCT01059071|530084047|FG001|Overall Study|Withdrawal by Subject|0|||
146978407|NCT01059071|530084048|FG002|Overall Study|Withdrawal by Subject|0|||
146978408|NCT01059071|530084049|FG003|Overall Study|Withdrawal by Subject|2|||
146978409|NCT01059071|530084046|FG000|Overall Study|Physician Decision|0|||
146978410|NCT01059071|530084047|FG001|Overall Study|Physician Decision|0|||
146978411|NCT01059071|530084048|FG002|Overall Study|Physician Decision|0|||
146592995|NCT03352557|528679318|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
146592996|NCT03352557|528679319|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
146592997|NCT03352557|528679310|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146592998|NCT03352557|528679311|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146592999|NCT03352557|528679312|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146593000|NCT03352557|528679313|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146593001|NCT03352557|528679314|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146593002|NCT03352557|528679315|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146593003|NCT03352557|528679316|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146593004|NCT03352557|528679317|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146593005|NCT03352557|528679318|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146593006|NCT03352557|528679319|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
146593007|NCT03352557|528679310|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
146593008|NCT03352557|528679311|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
146593009|NCT03352557|528679312|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
146593010|NCT03352557|528679313|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
146593011|NCT03352557|528679314|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
146593012|NCT03352557|528679315|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
146593013|NCT03352557|528679316|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
146593014|NCT03352557|528679317|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
146593015|NCT03352557|528679318|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
146593016|NCT03352557|528679319|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
146593017|NCT03352557|528679310|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
146593018|NCT03352557|528679311|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
146593019|NCT03352557|528679312|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
146593020|NCT03352557|528679313|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
146593021|NCT03352557|528679314|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
146593022|NCT03352557|528679315|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
146593023|NCT03352557|528679316|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
146593024|NCT03352557|528679317|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
146593025|NCT03352557|528679318|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
146593026|NCT03352557|528679319|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
146593027|NCT03352557|528679310|FG000|LTE Period: Week 80 to Week 173|Other|0|||
146593028|NCT03352557|528679311|FG001|LTE Period: Week 80 to Week 173|Other|0|||
146593029|NCT03352557|528679312|FG002|LTE Period: Week 80 to Week 173|Other|0|||
146593030|NCT03352557|528679313|FG003|LTE Period: Week 80 to Week 173|Other|0|||
146593031|NCT03352557|528679314|FG004|LTE Period: Week 80 to Week 173|Other|0|||
146593032|NCT03352557|528679315|FG005|LTE Period: Week 80 to Week 173|Other|0|||
146593033|NCT03352557|528679316|FG006|LTE Period: Week 80 to Week 173|Other|0|||
146593034|NCT03352557|528679317|FG007|LTE Period: Week 80 to Week 173|Other|1|||
146593035|NCT03352557|528679318|FG008|LTE Period: Week 80 to Week 173|Other|0|||
146593036|NCT03352557|528679319|FG009|LTE Period: Week 80 to Week 173|Other|0|||
146593037|NCT04612842|528679320|FG000|Overall Study|Lost to Follow-up|20|||
146593038|NCT04612842|528679321|FG001|Overall Study|Lost to Follow-up|11|||
146593039|NCT04612842|528679320|FG000|Overall Study|Withdrawal by Subject|26|||
146593040|NCT04612842|528679321|FG001|Overall Study|Withdrawal by Subject|15|||
146593041|NCT04612842|528679320|FG000|Overall Study|Death|2|||
146593042|NCT04612842|528679321|FG001|Overall Study|Death|2|||
146593043|NCT02419131|528679322|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
146593044|NCT02419131|528679323|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
146593045|NCT02419131|528679324|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
146593046|NCT02419131|528679322|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
146593047|NCT02419131|528679323|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
146593048|NCT02419131|528679324|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
146593049|NCT05426031|528679325|FG000|Overall Study|Circulatory Arrest|3|||
146593050|NCT05426031|528679326|FG001|Overall Study|Circulatory Arrest|2|||
146593051|NCT03060512|528679327|FG000|Overall Study|Adverse Event|4|||
146653111|NCT00274924|528908145|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
146653112|NCT00274924|528908146|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
146653113|NCT00274924|528908147|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
146653114|NCT00274924|528908145|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
146653115|NCT00274924|528908146|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
146593052|NCT03060512|528679328|FG001|Overall Study|Adverse Event|6|||
146593053|NCT03060512|528679327|FG000|Overall Study|Lost to Follow-up|1|||
146593054|NCT03060512|528679328|FG001|Overall Study|Lost to Follow-up|1|||
146593055|NCT03060512|528679327|FG000|Overall Study|Withdrawal by Subject|1|||
146593056|NCT03060512|528679328|FG001|Overall Study|Withdrawal by Subject|0|||
146593057|NCT03060512|528679327|FG000|Overall Study|Non-compliance with study medication|1|||
146593058|NCT03060512|528679328|FG001|Overall Study|Non-compliance with study medication|2|||
146771425|NCT00959946|529331195|FG007|Overall Study|Disease Progression|2|||
146593059|NCT03831880|528679331|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
146593060|NCT03831880|528679332|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
146593061|NCT03831880|528679331|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
146593062|NCT03831880|528679332|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
146593063|NCT03958656|528679335|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
146593064|NCT03958656|528679336|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
146593065|NCT03958656|528679337|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
146593066|NCT03958656|528679338|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
146593067|NCT03958656|528679335|FG000|Overall Study|No longer meets eligibility criteria|0|||
146593068|NCT03958656|528679336|FG001|Overall Study|No longer meets eligibility criteria|0|||
146593069|NCT03958656|528679337|FG002|Overall Study|No longer meets eligibility criteria|1|||
146593070|NCT03958656|528679338|FG003|Overall Study|No longer meets eligibility criteria|0|||
146593071|NCT03958656|528679335|FG000|Overall Study|Started anti-cancer treatment|0|||
146593072|NCT03958656|528679336|FG001|Overall Study|Started anti-cancer treatment|0|||
146593073|NCT03958656|528679337|FG002|Overall Study|Started anti-cancer treatment|1|||
146593074|NCT03958656|528679338|FG003|Overall Study|Started anti-cancer treatment|0|||
146593075|NCT03158012|528679341|FG000|Overall Study|Withdrawal by Subject|0|||
146593076|NCT03158012|528679342|FG001|Overall Study|Withdrawal by Subject|1|||
146653116|NCT00274924|528908147|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
146653117|NCT00274924|528908145|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
146653118|NCT00274924|528908146|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
146653119|NCT00274924|528908147|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
146653120|NCT00274924|528908145|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
146653121|NCT00274924|528908146|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
146653122|NCT00274924|528908147|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
146653123|NCT00274924|528908145|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
146653124|NCT00274924|528908146|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
146653125|NCT00274924|528908147|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
146653126|NCT00274924|528908145|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
146653127|NCT00274924|528908146|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
146653128|NCT00274924|528908147|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
146653129|NCT00274924|528908145|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
146653130|NCT00274924|528908146|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
146653131|NCT00274924|528908147|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
146653132|NCT01055496|528908148|FG000|Overall Study|Withdrawal by Subject|2|||
146653133|NCT01055496|528908149|FG001|Overall Study|Withdrawal by Subject|4|||
146653134|NCT01055496|528908148|FG000|Overall Study|Death|13|||
146653135|NCT01055496|528908149|FG001|Overall Study|Death|23|||
146653136|NCT01055496|528908148|FG000|Overall Study|Lost to Follow-up|0|||
146653137|NCT01055496|528908149|FG001|Overall Study|Lost to Follow-up|2|||
146653138|NCT01055496|528908148|FG000|Overall Study|Other - Unspecified|0|||
146653139|NCT01055496|528908149|FG001|Overall Study|Other - Unspecified|1|||
146653140|NCT00584740|528908150|FG000|Overall Study|Adverse Event|1|||
146653141|NCT00584740|528908151|FG001|Overall Study|Adverse Event|1|||
146653142|NCT00584740|528908150|FG000|Overall Study|Lack of Efficacy|8|||
146653143|NCT00584740|528908151|FG001|Overall Study|Lack of Efficacy|2|||
146653144|NCT00584740|528908150|FG000|Overall Study|Withdrawal by Subject|3|||
146653145|NCT00584740|528908151|FG001|Overall Study|Withdrawal by Subject|2|||
146653146|NCT00584740|528908150|FG000|Overall Study|Lost to Follow-up|0|||
146653147|NCT00584740|528908151|FG001|Overall Study|Lost to Follow-up|1|||
146653148|NCT01673282|528908152|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
146653149|NCT01673282|528908153|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
146653150|NCT01673282|528908152|FG000|Overall Study|Lack of Efficacy|9|||
146653151|NCT01673282|528908153|FG001|Overall Study|Lack of Efficacy|2|||
146653152|NCT01673282|528908152|FG000|Overall Study|Lost to Follow-up|11|||
146653153|NCT01673282|528908153|FG001|Overall Study|Lost to Follow-up|10|||
146653154|NCT01673282|528908152|FG000|Overall Study|Withdrawal by Subject|3|||
146919207|NCT01998581|529866076|FG001|Overall Study|Adverse Event|1|||
146919208|NCT01998581|529866075|FG000|Overall Study|Other reasons|3|||
146919209|NCT01998581|529866076|FG001|Overall Study|Other reasons|2|||
146653155|NCT01673282|528908153|FG001|Overall Study|Withdrawal by Subject|3|||
146653156|NCT01673282|528908152|FG000|Overall Study|Other|1|||
146653157|NCT01673282|528908153|FG001|Overall Study|Other|6|||
146653158|NCT02915874|528908154|FG000|Overall Study|Lost to Follow-up|5|||
146653159|NCT02915874|528908155|FG001|Overall Study|Lost to Follow-up|4|||
146653160|NCT02915874|528908154|FG000|Overall Study|Withdrawal by Subject|1|||
146653161|NCT02915874|528908155|FG001|Overall Study|Withdrawal by Subject|1|||
146653162|NCT02915874|528908154|FG000|Overall Study|Started New Anxiety Medication|0|||
146653163|NCT02915874|528908155|FG001|Overall Study|Started New Anxiety Medication|1|||
146593077|NCT02446418|528679348|FG000|Overall Study|Adverse Event|4|||
146593078|NCT02446418|528679349|FG001|Overall Study|Adverse Event|8|||
146653164|NCT05318183|528908157|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
146593079|NCT02446418|528679348|FG000|Overall Study|Physician Decision|5|||
146593080|NCT02446418|528679349|FG001|Overall Study|Physician Decision|1|||
146593081|NCT02446418|528679348|FG000|Overall Study|Withdrawal by Subject|3|||
146593082|NCT02446418|528679349|FG001|Overall Study|Withdrawal by Subject|3|||
146593083|NCT02446418|528679348|FG000|Overall Study|Lost to Follow-up|2|||
146593084|NCT02446418|528679349|FG001|Overall Study|Lost to Follow-up|2|||
146593085|NCT02446418|528679348|FG000|Overall Study|Protocol Violation|1|||
146593086|NCT02446418|528679349|FG001|Overall Study|Protocol Violation|2|||
146593087|NCT02446418|528679348|FG000|Overall Study|Lack of Efficacy|2|||
146593088|NCT02446418|528679349|FG001|Overall Study|Lack of Efficacy|0|||
146593089|NCT02446418|528679348|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
146593090|NCT02446418|528679349|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
146593091|NCT02014480|528679350|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
146593092|NCT02014480|528679351|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
146593093|NCT02014480|528679352|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
146593094|NCT02014480|528679353|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
146593095|NCT02014480|528679354|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
146593096|NCT02014480|528679355|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
146593097|NCT02014480|528679350|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146593098|NCT02014480|528679351|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
146593099|NCT02014480|528679352|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146593100|NCT02014480|528679353|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
146593101|NCT02014480|528679354|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
146593102|NCT02014480|528679355|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146593103|NCT02014480|528679350|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
146593104|NCT02014480|528679351|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
146593105|NCT02014480|528679352|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
146593106|NCT02014480|528679353|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
146593107|NCT02014480|528679354|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
146593108|NCT02014480|528679355|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
146593109|NCT02014480|528679350|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
146593110|NCT02014480|528679351|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
146593111|NCT02014480|528679352|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
146593112|NCT02014480|528679353|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
146593113|NCT02014480|528679354|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146593114|NCT02014480|528679355|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146593115|NCT02014480|528679350|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
146593116|NCT02014480|528679351|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
146593117|NCT02014480|528679352|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
146593118|NCT02014480|528679353|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
146593119|NCT02014480|528679354|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
146593120|NCT02014480|528679355|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
146593121|NCT02014480|528679350|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
146593122|NCT02014480|528679351|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
146593123|NCT02014480|528679352|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
146593124|NCT02014480|528679353|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
146593125|NCT02014480|528679354|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
146593126|NCT02014480|528679355|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
146593127|NCT02014480|528679350|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146593128|NCT02014480|528679351|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146593129|NCT02014480|528679352|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146593130|NCT02014480|528679353|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146593131|NCT02014480|528679354|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146593132|NCT02014480|528679355|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
146593133|NCT01865812|528679358|FG000|Primary Treatment Phase|Adverse Event|2|||
146593134|NCT01865812|528679359|FG001|Primary Treatment Phase|Adverse Event|0|||
146593135|NCT01865812|528679358|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
146593136|NCT01865812|528679359|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
146593137|NCT01865812|528679358|FG000|Long-term Safety Extension Phase|Pruritus|0|||
146593138|NCT01865812|528679359|FG001|Long-term Safety Extension Phase|Pruritus|3|||
146593139|NCT01865812|528679358|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
146593140|NCT01865812|528679359|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
146593141|NCT01865812|528679358|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
146593142|NCT01865812|528679359|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
146593143|NCT01338610|528679360|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
146593144|NCT01338610|528679361|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
146593145|NCT01338610|528679362|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
146593146|NCT01338610|528679360|FG000|Overall Study|Protocol Violation|1|||
146593147|NCT01338610|528679361|FG001|Overall Study|Protocol Violation|0|||
146593148|NCT01338610|528679362|FG002|Overall Study|Protocol Violation|1|||
146919210|NCT01998581|529866075|FG000|Overall Study|Randomized but withdrew before treatment|1|||
146919211|NCT01998581|529866076|FG001|Overall Study|Randomized but withdrew before treatment|0|||
146919212|NCT04426825|529866082|FG000|Overall Study|Death|17|||
146919213|NCT04426825|529866082|FG000|Overall Study|Lost to Follow-up|1|||
146919214|NCT04426825|529866082|FG000|Overall Study|Study terminated by sponsor|5|||
146919215|NCT01763905|529866090|FG000|Overall Study|Withdrawal by Subject|1|||
146919216|NCT01763905|529866091|FG001|Overall Study|Withdrawal by Subject|1|||
146919217|NCT01763905|529866092|FG002|Overall Study|Withdrawal by Subject|0|||
146919218|NCT01763905|529866093|FG003|Overall Study|Withdrawal by Subject|1|||
146919219|NCT01763905|529866090|FG000|Overall Study|Decision by sponsor|5|||
146919220|NCT01763905|529866091|FG001|Overall Study|Decision by sponsor|0|||
146919221|NCT01763905|529866092|FG002|Overall Study|Decision by sponsor|8|||
146919222|NCT01763905|529866093|FG003|Overall Study|Decision by sponsor|0|||
146919223|NCT01763905|529866090|FG000|Overall Study|Lost to Follow-up|0|||
146919224|NCT01763905|529866091|FG001|Overall Study|Lost to Follow-up|0|||
146919225|NCT01763905|529866092|FG002|Overall Study|Lost to Follow-up|1|||
146919226|NCT01763905|529866093|FG003|Overall Study|Lost to Follow-up|0|||
146919227|NCT04346628|529866094|FG000|Overall Study|Lost to Follow-up|4|||
146919228|NCT04346628|529866095|FG001|Overall Study|Lost to Follow-up|4|||
146919229|NCT04346628|529866094|FG000|Overall Study|Withdrew (had personal reasons)|2|||
146919230|NCT04346628|529866095|FG001|Overall Study|Withdrew (had personal reasons)|5|||
146919231|NCT04346628|529866094|FG000|Overall Study|Withdrew (medication intolerant)|0|||
146919232|NCT04346628|529866095|FG001|Overall Study|Withdrew (medication intolerant)|3|||
146919233|NCT04346628|529866094|FG000|Overall Study|Withdrew (declined intervention)|0|||
146919234|NCT04346628|529866095|FG001|Overall Study|Withdrew (declined intervention)|1|||
146919235|NCT01597557|529866096|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
146593149|NCT01338610|528679360|FG000|Overall Study|Adverse Event|3|||
146593150|NCT01338610|528679361|FG001|Overall Study|Adverse Event|0|||
146593151|NCT01338610|528679362|FG002|Overall Study|Adverse Event|0|||
146593152|NCT02692040|528679363|FG000|Overall Study|Protocol Violation|0|||
146593153|NCT02692040|528679364|FG001|Overall Study|Protocol Violation|0|||
146919236|NCT01597557|529866097|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
146919237|NCT03165721|529866106|FG000|Overall Study|Refused further treatment|3|||
146919238|NCT03165721|529866107|FG001|Overall Study|Refused further treatment|0|||
146919239|NCT03165721|529866108|FG002|Overall Study|Refused further treatment|0|||
146919240|NCT03165721|529866106|FG000|Overall Study|Physician Decision|1|||
146919241|NCT03165721|529866107|FG001|Overall Study|Physician Decision|0|||
146919242|NCT03165721|529866108|FG002|Overall Study|Physician Decision|0|||
146919243|NCT01863849|529866110|FG000|Overall Study|Lost to Follow-up|1|||
146919244|NCT01863849|529866111|FG001|Overall Study|Lost to Follow-up|0|||
146919245|NCT01457118|529866112|FG000|Overall Study|Adverse Event|1|||
146919246|NCT01457118|529866113|FG001|Overall Study|Adverse Event|0|||
146919247|NCT01457118|529866114|FG002|Overall Study|Adverse Event|0|||
146919248|NCT01457118|529866115|FG003|Overall Study|Adverse Event|1|||
146919249|NCT01457118|529866112|FG000|Overall Study|Clinical Progression|0|||
146919250|NCT01457118|529866113|FG001|Overall Study|Clinical Progression|1|||
146919251|NCT01457118|529866114|FG002|Overall Study|Clinical Progression|0|||
146919252|NCT01457118|529866115|FG003|Overall Study|Clinical Progression|1|||
146593154|NCT02692040|528679365|FG002|Overall Study|Protocol Violation|0|||
146919253|NCT01457118|529866112|FG000|Overall Study|Physician Decision|2|||
146919254|NCT01457118|529866113|FG001|Overall Study|Physician Decision|0|||
146919255|NCT01457118|529866114|FG002|Overall Study|Physician Decision|0|||
146919256|NCT01457118|529866115|FG003|Overall Study|Physician Decision|0|||
146978412|NCT01059071|530084049|FG003|Overall Study|Physician Decision|1|||
146978413|NCT04741503|530084052|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
146978414|NCT04741503|530084053|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
146978415|NCT04741503|530084054|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
146978416|NCT04741503|530084052|FG000|Initial Enrollment|Overquotas removed|0|||
146593155|NCT02692040|528679366|FG003|Overall Study|Protocol Violation|0|||
146593156|NCT02692040|528679367|FG004|Overall Study|Protocol Violation|0|||
146593157|NCT02692040|528679368|FG005|Overall Study|Protocol Violation|0|||
146593158|NCT02692040|528679369|FG006|Overall Study|Protocol Violation|0|||
146593159|NCT02692040|528679370|FG007|Overall Study|Protocol Violation|0|||
146593160|NCT02692040|528679371|FG008|Overall Study|Protocol Violation|0|||
146593161|NCT02692040|528679372|FG009|Overall Study|Protocol Violation|0|||
146593162|NCT02692040|528679373|FG010|Overall Study|Protocol Violation|0|||
146593163|NCT02692040|528679374|FG011|Overall Study|Protocol Violation|0|||
146919257|NCT01457118|529866112|FG000|Overall Study|Progressive Disease by RECIST|12|||
146919258|NCT01457118|529866113|FG001|Overall Study|Progressive Disease by RECIST|3|||
146919259|NCT01457118|529866114|FG002|Overall Study|Progressive Disease by RECIST|1|||
146919260|NCT01457118|529866115|FG003|Overall Study|Progressive Disease by RECIST|0|||
146919261|NCT01457118|529866112|FG000|Overall Study|Withdrawal by Subject|5|||
146919262|NCT01457118|529866113|FG001|Overall Study|Withdrawal by Subject|0|||
146919263|NCT01457118|529866114|FG002|Overall Study|Withdrawal by Subject|0|||
146919264|NCT01457118|529866115|FG003|Overall Study|Withdrawal by Subject|0|||
146919265|NCT02324842|529866116|FG000|Overall Study|Lost to Follow-up|1|||
146593164|NCT02692040|528679375|FG012|Overall Study|Protocol Violation|1|||
146593165|NCT02692040|528679376|FG013|Overall Study|Protocol Violation|0|||
146593166|NCT02692040|528679377|FG014|Overall Study|Protocol Violation|0|||
146593167|NCT02692040|528679378|FG015|Overall Study|Protocol Violation|0|||
146593168|NCT02692040|528679379|FG016|Overall Study|Protocol Violation|0|||
146593169|NCT02692040|528679363|FG000|Overall Study|Adverse Event|0|||
146593170|NCT02692040|528679364|FG001|Overall Study|Adverse Event|0|||
146593171|NCT02692040|528679365|FG002|Overall Study|Adverse Event|0|||
146593172|NCT02692040|528679366|FG003|Overall Study|Adverse Event|0|||
146593173|NCT02692040|528679367|FG004|Overall Study|Adverse Event|0|||
146593174|NCT02692040|528679368|FG005|Overall Study|Adverse Event|0|||
146593175|NCT02692040|528679369|FG006|Overall Study|Adverse Event|0|||
146593176|NCT02692040|528679370|FG007|Overall Study|Adverse Event|0|||
146593177|NCT02692040|528679371|FG008|Overall Study|Adverse Event|0|||
146593178|NCT02692040|528679372|FG009|Overall Study|Adverse Event|0|||
146593179|NCT02692040|528679373|FG010|Overall Study|Adverse Event|0|||
146593180|NCT02692040|528679374|FG011|Overall Study|Adverse Event|0|||
146593181|NCT02692040|528679375|FG012|Overall Study|Adverse Event|0|||
146593182|NCT02692040|528679376|FG013|Overall Study|Adverse Event|3|||
146593183|NCT02692040|528679377|FG014|Overall Study|Adverse Event|1|||
146593184|NCT02692040|528679378|FG015|Overall Study|Adverse Event|1|||
146593185|NCT02692040|528679379|FG016|Overall Study|Adverse Event|0|||
146593186|NCT00435162|528679383|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
146593187|NCT00435162|528679384|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
146593188|NCT00435162|528679385|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
146593189|NCT00435162|528679386|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
146593190|NCT00435162|528679387|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
146593191|NCT00435162|528679388|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
146593192|NCT01819129|528679389|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
146593193|NCT01819129|528679390|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
146593194|NCT01819129|528679389|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
146593195|NCT01819129|528679390|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
146593196|NCT01819129|528679389|FG000|Overall Study|Other, Subject moved out of the country|0|||
146593197|NCT01819129|528679390|FG001|Overall Study|Other, Subject moved out of the country|1|||
146593198|NCT01819129|528679389|FG000|Overall Study|Withdrawal by Subject|15|||
146593199|NCT01819129|528679390|FG001|Overall Study|Withdrawal by Subject|15|||
146593200|NCT01819129|528679389|FG000|Overall Study|Lost to Follow-up|5|||
146593201|NCT01819129|528679390|FG001|Overall Study|Lost to Follow-up|2|||
146593202|NCT01819129|528679389|FG000|Overall Study|Lack of Efficacy|0|||
146593203|NCT01819129|528679390|FG001|Overall Study|Lack of Efficacy|1|||
146593204|NCT01819129|528679389|FG000|Overall Study|Adverse Event|1|||
146593205|NCT01819129|528679390|FG001|Overall Study|Adverse Event|4|||
146593206|NCT01819129|528679389|FG000|Overall Study|Death|1|||
146593207|NCT01819129|528679390|FG001|Overall Study|Death|1|||
146593208|NCT01819129|528679389|FG000|Overall Study|Withdrawal Criteria|20|||
146593209|NCT01819129|528679390|FG001|Overall Study|Withdrawal Criteria|15|||
146593210|NCT00054691|528679395|FG000|Overall Study|Unmeasurable Disease|2|||
146593211|NCT00054691|528679395|FG000|Overall Study|Noncompliant|1|||
146593212|NCT02836873|528679402|FG000|Overall Study|Protocol Violation|0|||
146593213|NCT02836873|528679403|FG001|Overall Study|Protocol Violation|1|||
146593214|NCT02836873|528679402|FG000|Overall Study|Adverse Event|1|||
146593215|NCT02836873|528679403|FG001|Overall Study|Adverse Event|4|||
146593216|NCT02836873|528679402|FG000|Overall Study|Withdrawal by Subject|2|||
146593217|NCT02836873|528679403|FG001|Overall Study|Withdrawal by Subject|2|||
146593218|NCT02836873|528679402|FG000|Overall Study|Lost to Follow-up|1|||
146593219|NCT02836873|528679403|FG001|Overall Study|Lost to Follow-up|3|||
146593220|NCT02836873|528679402|FG000|Overall Study|Physician Decision|0|||
146593221|NCT02836873|528679403|FG001|Overall Study|Physician Decision|1|||
146593222|NCT02836873|528679402|FG000|Overall Study|Other|1|||
146593223|NCT02836873|528679403|FG001|Overall Study|Other|0|||
146593224|NCT00694096|528679404|FG000|Overall Study|Withdrawal by Subject|5|||
146593225|NCT02914548|528679410|FG000|Overall Study|Adverse Event|15|||
146593226|NCT02914548|528679411|FG001|Overall Study|Adverse Event|7|||
146593227|NCT02914548|528679412|FG002|Overall Study|Adverse Event|15|||
146593228|NCT02914548|528679410|FG000|Overall Study|Physician Decision|2|||
146593229|NCT02914548|528679411|FG001|Overall Study|Physician Decision|2|||
146593230|NCT02914548|528679412|FG002|Overall Study|Physician Decision|0|||
146593231|NCT02914548|528679410|FG000|Overall Study|Protocol Violation|1|||
146653165|NCT05318183|528908158|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
146653166|NCT05318183|528908157|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
146593232|NCT02914548|528679411|FG001|Overall Study|Protocol Violation|0|||
146593233|NCT02914548|528679412|FG002|Overall Study|Protocol Violation|0|||
146593234|NCT02914548|528679410|FG000|Overall Study|Withdrawal by Subject|3|||
146593235|NCT02914548|528679411|FG001|Overall Study|Withdrawal by Subject|4|||
146593236|NCT02914548|528679412|FG002|Overall Study|Withdrawal by Subject|4|||
146593237|NCT02914548|528679410|FG000|Overall Study|>40% of body surface area|0|||
146593238|NCT02914548|528679411|FG001|Overall Study|>40% of body surface area|1|||
146653167|NCT05318183|528908158|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
146593239|NCT02914548|528679412|FG002|Overall Study|>40% of body surface area|1|||
146593240|NCT00977938|528679422|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
146593241|NCT00977938|528679423|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
146919266|NCT02324842|529866117|FG001|Overall Study|Lost to Follow-up|1|||
146919267|NCT02324842|529866118|FG002|Overall Study|Lost to Follow-up|2|||
146919268|NCT02750800|529866122|FG000|Overall Study|Adverse Event|18|||
146593242|NCT00977938|528679424|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
146593243|NCT00977938|528679425|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
146593244|NCT00977938|528679422|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
146593245|NCT00977938|528679423|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
146593246|NCT00977938|528679424|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
146593247|NCT00977938|528679425|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
146593248|NCT00977938|528679422|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
146593249|NCT00977938|528679423|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
146593250|NCT00977938|528679424|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
146593251|NCT00977938|528679425|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
146593252|NCT00977938|528679422|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
146593253|NCT00977938|528679423|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
146593254|NCT00977938|528679424|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
146593255|NCT00977938|528679425|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
146593256|NCT00977938|528679422|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
146593257|NCT00977938|528679423|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
146593258|NCT00977938|528679424|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
146593259|NCT00977938|528679425|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
146593260|NCT00977938|528679422|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
146593261|NCT00977938|528679423|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
146593262|NCT00977938|528679424|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
146593263|NCT00977938|528679425|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
146593264|NCT02460783|528679431|FG000|Overall Study|Withdrawal by Subject|1|||
146593265|NCT02460783|528679432|FG001|Overall Study|Withdrawal by Subject|3|||
146593266|NCT02460783|528679431|FG000|Overall Study|Lost to Follow-up|1|||
146593267|NCT02460783|528679432|FG001|Overall Study|Lost to Follow-up|1|||
146593268|NCT00747344|528679433|FG000|Controlled Period|Adverse Event|3|||
146593269|NCT00747344|528679434|FG001|Controlled Period|Adverse Event|0|||
146593270|NCT00747344|528679435|FG002|Controlled Period|Adverse Event|0|||
146593271|NCT00747344|528679436|FG003|Controlled Period|Adverse Event|0|||
146593272|NCT00747344|528679433|FG000|Controlled Period|Lack of Efficacy|2|||
146593273|NCT00747344|528679434|FG001|Controlled Period|Lack of Efficacy|1|||
146593274|NCT00747344|528679435|FG002|Controlled Period|Lack of Efficacy|0|||
146593275|NCT00747344|528679436|FG003|Controlled Period|Lack of Efficacy|0|||
146593276|NCT00747344|528679433|FG000|Controlled Period|Other|0|||
146593277|NCT00747344|528679434|FG001|Controlled Period|Other|3|||
146593278|NCT00747344|528679435|FG002|Controlled Period|Other|0|||
146593279|NCT00747344|528679436|FG003|Controlled Period|Other|0|||
146593280|NCT00747344|528679433|FG000|After Controlled Period|Adverse Event|0|||
146593281|NCT00747344|528679434|FG001|After Controlled Period|Adverse Event|0|||
146593282|NCT00747344|528679435|FG002|After Controlled Period|Adverse Event|0|||
146593283|NCT00747344|528679436|FG003|After Controlled Period|Adverse Event|1|||
146593284|NCT01484834|528679437|FG000|Overall Study|Lost to Follow-up|5|||
146593285|NCT01484834|528679438|FG001|Overall Study|Lost to Follow-up|8|||
146593286|NCT01484834|528679439|FG002|Overall Study|Lost to Follow-up|1|||
146593287|NCT01484834|528679440|FG003|Overall Study|Lost to Follow-up|4|||
146593288|NCT01371643|528679445|FG000|Overall Study|Withdrawal by Subject|3|||
146593289|NCT01371643|528679446|FG001|Overall Study|Withdrawal by Subject|0|||
146593290|NCT02214225|528679449|FG000|Overall Study|Lost to Follow-up|46|||
146593291|NCT02214225|528679450|FG001|Overall Study|Lost to Follow-up|18|||
146593292|NCT02214225|528679451|FG002|Overall Study|Lost to Follow-up|18|||
146593293|NCT02214225|528679449|FG000|Overall Study|Withdrawal by Subject|2|||
146593294|NCT02214225|528679450|FG001|Overall Study|Withdrawal by Subject|0|||
146593295|NCT02214225|528679451|FG002|Overall Study|Withdrawal by Subject|2|||
146593296|NCT02214225|528679449|FG000|Overall Study|Death|5|||
146593297|NCT02214225|528679450|FG001|Overall Study|Death|0|||
146593298|NCT02214225|528679451|FG002|Overall Study|Death|1|||
146593299|NCT02214225|528679449|FG000|Overall Study|randomized in error, not vaccinated|2|||
146919269|NCT02750800|529866122|FG000|Overall Study|Lost to Follow-up|12|||
146919270|NCT02750800|529866122|FG000|Overall Study|Investigator decision|53|||
146593300|NCT02214225|528679450|FG001|Overall Study|randomized in error, not vaccinated|1|||
146593301|NCT02214225|528679451|FG002|Overall Study|randomized in error, not vaccinated|1|||
146593302|NCT03987932|528679455|FG000|Overall Study|Lost to Follow-up|2|||
146593303|NCT03987932|528679456|FG001|Overall Study|Lost to Follow-up|1|||
146593304|NCT03987932|528679457|FG002|Overall Study|Lost to Follow-up|1|||
146593305|NCT03987932|528679455|FG000|Overall Study|Non-study related elective surgery|0|||
146593306|NCT03987932|528679456|FG001|Overall Study|Non-study related elective surgery|0|||
146919271|NCT02750800|529866122|FG000|Overall Study|Patient request|12|||
146919272|NCT02750800|529866122|FG000|Overall Study|Other, not specified|3|||
146593307|NCT03987932|528679457|FG002|Overall Study|Non-study related elective surgery|1|||
146593308|NCT01605227|528679458|FG000|Overall Study|Did not receive study treatment|2|||
146593309|NCT01605227|528679459|FG001|Overall Study|Did not receive study treatment|3|||
146593310|NCT01605227|528679458|FG000|Overall Study|Adverse Event|228|||
146593311|NCT01605227|528679459|FG001|Overall Study|Adverse Event|42|||
146593312|NCT01605227|528679458|FG000|Overall Study|Progressive Disease|132|||
146593313|NCT01605227|528679459|FG001|Overall Study|Progressive Disease|128|||
146593314|NCT01605227|528679458|FG000|Overall Study|Clinical Deterioration|227|||
146593315|NCT01605227|528679459|FG001|Overall Study|Clinical Deterioration|133|||
146593316|NCT01605227|528679458|FG000|Overall Study|Lost to Follow-up|1|||
146593317|NCT01605227|528679459|FG001|Overall Study|Lost to Follow-up|0|||
146593318|NCT01605227|528679458|FG000|Overall Study|Protocol Violation|1|||
146593319|NCT01605227|528679459|FG001|Overall Study|Protocol Violation|0|||
146593320|NCT01605227|528679458|FG000|Overall Study|Physician Decision|9|||
146593321|NCT01605227|528679459|FG001|Overall Study|Physician Decision|7|||
146593322|NCT01605227|528679458|FG000|Overall Study|Withdrawal by Subject|18|||
146593323|NCT01605227|528679459|FG001|Overall Study|Withdrawal by Subject|14|||
146593324|NCT01605227|528679458|FG000|Overall Study|Sponsor Decision|2|||
146593325|NCT01605227|528679459|FG001|Overall Study|Sponsor Decision|0|||
146593326|NCT01605227|528679458|FG000|Overall Study|Started New Therapy|1|||
146593327|NCT01605227|528679459|FG001|Overall Study|Started New Therapy|0|||
146593328|NCT01605227|528679458|FG000|Overall Study|Subject Decision|0|||
146593329|NCT01605227|528679459|FG001|Overall Study|Subject Decision|1|||
146593330|NCT01605227|528679458|FG000|Overall Study|Dose Held >6 weeks|0|||
146593331|NCT01605227|528679459|FG001|Overall Study|Dose Held >6 weeks|1|||
146593332|NCT02847858|528679461|FG000|Overall Study|Lost to Follow-up|401|||
146593333|NCT02847858|528679462|FG001|Overall Study|Lost to Follow-up|269|||
146593334|NCT00624819|528679463|FG000|Follow-up Period: Year 4|Parents decision|0|||
146593335|NCT00624819|528679464|FG001|Follow-up Period: Year 4|Parents decision|0|||
146593336|NCT00624819|528679465|FG002|Follow-up Period: Year 4|Parents decision|1|||
146593337|NCT00624819|528679466|FG003|Follow-up Period: Year 4|Parents decision|0|||
146593338|NCT00624819|528679463|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
146593339|NCT00624819|528679464|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
146771426|NCT00959946|529331188|FG000|Overall Study|Withdrawal by Subject|0|||
146771427|NCT00959946|529331189|FG001|Overall Study|Withdrawal by Subject|0|||
146593340|NCT00624819|528679465|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
146593341|NCT00624819|528679466|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
146593342|NCT02387164|528679467|FG000|Overall Study|Lost to Follow-up|2|||
146593343|NCT02387164|528679468|FG001|Overall Study|Lost to Follow-up|0|||
146593344|NCT02387164|528679467|FG000|Overall Study|Diagnosed|1|||
146593345|NCT02387164|528679468|FG001|Overall Study|Diagnosed|2|||
146593346|NCT03271047|528679469|FG000|Phase 1b: Dose Finding Period|Death|8|||
146593347|NCT03271047|528679470|FG001|Phase 1b: Dose Finding Period|Death|8|||
146593348|NCT03271047|528679471|FG002|Phase 1b: Dose Finding Period|Death|0|||
146593349|NCT03271047|528679472|FG003|Phase 1b: Dose Finding Period|Death|0|||
146593350|NCT03271047|528679469|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
146593351|NCT03271047|528679470|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
146593352|NCT03271047|528679471|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
146593353|NCT03271047|528679472|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
146593354|NCT03271047|528679469|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
146593355|NCT03271047|528679470|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
146593356|NCT03271047|528679471|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
146593357|NCT03271047|528679472|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
146593358|NCT03271047|528679469|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
146593359|NCT03271047|528679470|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
146593360|NCT03271047|528679471|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
146593361|NCT03271047|528679472|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
146593362|NCT03271047|528679469|FG000|Randomized Phase 2 Period|Other|0|||
146593363|NCT03271047|528679470|FG001|Randomized Phase 2 Period|Other|0|||
146593364|NCT03271047|528679471|FG002|Randomized Phase 2 Period|Other|0|||
146771428|NCT00959946|529331190|FG002|Overall Study|Withdrawal by Subject|0|||
146593365|NCT03271047|528679472|FG003|Randomized Phase 2 Period|Other|1|||
146593366|NCT03271047|528679469|FG000|Randomized Phase 2 Period|Death|0|||
146593367|NCT03271047|528679470|FG001|Randomized Phase 2 Period|Death|0|||
146593368|NCT03271047|528679471|FG002|Randomized Phase 2 Period|Death|20|||
146593369|NCT03271047|528679472|FG003|Randomized Phase 2 Period|Death|21|||
146593370|NCT03271047|528679469|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
146593371|NCT03271047|528679470|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
146593372|NCT03271047|528679471|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
146593373|NCT03271047|528679472|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
146593374|NCT03271047|528679469|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
146593375|NCT03271047|528679470|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
146593376|NCT03271047|528679471|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
146771429|NCT00959946|529331191|FG003|Overall Study|Withdrawal by Subject|0|||
146771430|NCT00959946|529331192|FG004|Overall Study|Withdrawal by Subject|0|||
146593377|NCT03271047|528679472|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
146593378|NCT03271047|528679469|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
146593379|NCT03271047|528679470|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
146593380|NCT03271047|528679471|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
146593381|NCT03271047|528679472|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
146593382|NCT01416441|528679473|FG000|Overall Study|Lost to Follow-up|5|||
146593383|NCT01416441|528679473|FG000|Overall Study|Adverse Event|6|||
146593384|NCT01416441|528679473|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
146593385|NCT01416441|528679473|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
146593386|NCT01416441|528679473|FG000|Overall Study|Investigator Withdrew Subject|2|||
146593387|NCT01416441|528679473|FG000|Overall Study|Subject Withdrew Consent|12|||
146593388|NCT01416441|528679473|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
146593389|NCT00526110|528679476|FG000|Overall Study|Adverse Event|2|||
146593390|NCT00526110|528679477|FG001|Overall Study|Adverse Event|9|||
146593391|NCT00526110|528679476|FG000|Overall Study|Disease Progression|0|||
146593392|NCT00526110|528679477|FG001|Overall Study|Disease Progression|19|||
146593393|NCT00526110|528679476|FG000|Overall Study|Maximal Response|0|||
146593394|NCT00526110|528679477|FG001|Overall Study|Maximal Response|6|||
146593395|NCT00526110|528679476|FG000|Overall Study|Withdrawal by Subject|0|||
146593396|NCT00526110|528679477|FG001|Overall Study|Withdrawal by Subject|2|||
146593397|NCT00526110|528679476|FG000|Overall Study|Poor Tolerance|0|||
146593398|NCT00526110|528679477|FG001|Overall Study|Poor Tolerance|5|||
146593399|NCT01400243|528679478|FG000|Overall Study|Protocol Violation|8|||
146593400|NCT01400243|528679479|FG001|Overall Study|Protocol Violation|11|||
146593401|NCT02278614|528679482|FG000|Overall Study|Withdrawal by Subject|3|||
146593402|NCT02278614|528679483|FG001|Overall Study|Withdrawal by Subject|5|||
146593403|NCT02278614|528679482|FG000|Overall Study|Adverse Event|1|||
146593404|NCT02278614|528679483|FG001|Overall Study|Adverse Event|0|||
146593405|NCT02278614|528679482|FG000|Overall Study|left eye was not eligible|1|||
146593406|NCT02278614|528679483|FG001|Overall Study|left eye was not eligible|0|||
146593407|NCT03762616|528679485|FG000|Overall Study|Protocol Violation|2|||
146593408|NCT04030247|528682120|FG000|Overall Study|Withdrawal by Subject|4|||
146593409|NCT04030247|528682120|FG000|Overall Study|Lost to Follow-up|13|||
146593410|NCT03559699|528682121|FG000|Overall Study|Withdrawal by Subject|6|||
146593411|NCT03559699|528682121|FG000|Overall Study|Lost to Follow-up|1|||
146593412|NCT00031460|528682122|FG000|Overall Study|Lost to Follow-up|0|||
146593413|NCT00031460|528682123|FG001|Overall Study|Lost to Follow-up|1|||
146593414|NCT00031460|528682122|FG000|Overall Study|Withdrawal by Subject|1|||
146593415|NCT00031460|528682123|FG001|Overall Study|Withdrawal by Subject|1|||
146593416|NCT00031460|528682122|FG000|Overall Study|Non-Compliant|1|||
146593417|NCT00031460|528682123|FG001|Overall Study|Non-Compliant|1|||
146593418|NCT00031460|528682122|FG000|Overall Study|Death|0|||
146593419|NCT00031460|528682123|FG001|Overall Study|Death|1|||
146593420|NCT00031460|528682122|FG000|Overall Study|Reactivation of Disease|5|||
146653168|NCT05318183|528908157|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
146653169|NCT05318183|528908158|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
146653170|NCT05318183|528908157|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
146653171|NCT05318183|528908158|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
146653172|NCT01046825|528908159|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
146653173|NCT01046825|528908160|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
146653174|NCT01046825|528908161|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
146653175|NCT01046825|528908162|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
146653176|NCT01046825|528908163|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
146653177|NCT01046825|528908159|FG000|Overall Study|Physician Decision|0|||
146653178|NCT01046825|528908160|FG001|Overall Study|Physician Decision|1|||
146653179|NCT01046825|528908161|FG002|Overall Study|Physician Decision|2|||
146653180|NCT01046825|528908162|FG003|Overall Study|Physician Decision|0|||
146653181|NCT01046825|528908163|FG004|Overall Study|Physician Decision|0|||
146653182|NCT01046825|528908159|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
146653183|NCT01046825|528908160|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
146653184|NCT01046825|528908161|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
146653185|NCT01046825|528908162|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
146653186|NCT01046825|528908163|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
146653187|NCT01046825|528908159|FG000|Overall Study|Found to be ineligible|0|||
146653188|NCT01046825|528908160|FG001|Overall Study|Found to be ineligible|1|||
146653189|NCT01046825|528908161|FG002|Overall Study|Found to be ineligible|0|||
146653190|NCT01046825|528908162|FG003|Overall Study|Found to be ineligible|0|||
146653191|NCT01046825|528908163|FG004|Overall Study|Found to be ineligible|0|||
146653192|NCT01046825|528908159|FG000|Overall Study|Death|0|||
146653193|NCT01046825|528908160|FG001|Overall Study|Death|0|||
146653194|NCT01046825|528908161|FG002|Overall Study|Death|0|||
146653195|NCT01046825|528908162|FG003|Overall Study|Death|1|||
146653196|NCT01046825|528908163|FG004|Overall Study|Death|0|||
146593421|NCT00031460|528682123|FG001|Overall Study|Reactivation of Disease|9|||
146593422|NCT00031460|528682122|FG000|Overall Study|Disruption of blinded drug supply|2|||
146593423|NCT00031460|528682123|FG001|Overall Study|Disruption of blinded drug supply|0|||
146593424|NCT00031460|528682122|FG000|Overall Study|Confirmed unevaluable|0|||
146593425|NCT00031460|528682123|FG001|Overall Study|Confirmed unevaluable|1|||
146593426|NCT01930890|528682126|FG000|Overall Study|Study Termination|14|||
146593427|NCT01930890|528682127|FG001|Overall Study|Study Termination|28|||
146593428|NCT01930890|528682128|FG002|Overall Study|Study Termination|13|||
146593429|NCT01930890|528682129|FG003|Overall Study|Study Termination|25|||
146593430|NCT01930890|528682126|FG000|Overall Study|Death|0|||
146593431|NCT01930890|528682127|FG001|Overall Study|Death|0|||
146593432|NCT01930890|528682128|FG002|Overall Study|Death|0|||
146593433|NCT01930890|528682129|FG003|Overall Study|Death|1|||
146593434|NCT01930890|528682126|FG000|Overall Study|Investigator Decision|0|||
146593435|NCT01930890|528682127|FG001|Overall Study|Investigator Decision|1|||
146593436|NCT01930890|528682128|FG002|Overall Study|Investigator Decision|0|||
146593437|NCT01930890|528682129|FG003|Overall Study|Investigator Decision|0|||
146593438|NCT01930890|528682126|FG000|Overall Study|Consent Withdrawn|0|||
146593439|NCT01930890|528682127|FG001|Overall Study|Consent Withdrawn|3|||
146593440|NCT01930890|528682128|FG002|Overall Study|Consent Withdrawn|0|||
146593441|NCT01930890|528682129|FG003|Overall Study|Consent Withdrawn|1|||
146593442|NCT01930890|528682126|FG000|Overall Study|Adverse Event|0|||
146593443|NCT01930890|528682127|FG001|Overall Study|Adverse Event|1|||
146593444|NCT01930890|528682128|FG002|Overall Study|Adverse Event|0|||
146593445|NCT01930890|528682129|FG003|Overall Study|Adverse Event|0|||
146593446|NCT01278407|528682130|FG000|Confirmatory Phase|Adverse Event|5|||
146593447|NCT01278407|528682131|FG001|Confirmatory Phase|Adverse Event|10|||
146593448|NCT01278407|528682132|FG002|Confirmatory Phase|Adverse Event|1|||
146593449|NCT01278407|528682133|FG003|Confirmatory Phase|Adverse Event|0|||
146593450|NCT01278407|528682134|FG004|Confirmatory Phase|Adverse Event|0|||
146593451|NCT01278407|528682130|FG000|Confirmatory Phase|Participant's Choice|3|||
146653197|NCT01046825|528908159|FG000|Overall Study|Did not submit biology samples|0|||
146653198|NCT01046825|528908160|FG001|Overall Study|Did not submit biology samples|0|||
146653199|NCT01046825|528908161|FG002|Overall Study|Did not submit biology samples|0|||
146653200|NCT01046825|528908162|FG003|Overall Study|Did not submit biology samples|0|||
146653201|NCT01046825|528908163|FG004|Overall Study|Did not submit biology samples|13|||
146653202|NCT06400251|528908165|FG000|Overall Study|Never Start Protocol Therapy|1|||
146653203|NCT06400251|528908165|FG000|Overall Study|Ineligible|2|||
146653204|NCT06400251|528908165|FG000|Overall Study|Mutation Status Not Confirmed|3|||
146653205|NCT06400251|528908165|FG000|Overall Study|Disease Progression|25|||
146653206|NCT06400251|528908165|FG000|Overall Study|Adverse Event|1|||
146653207|NCT06400251|528908165|FG000|Overall Study|Complicating Disease|1|||
146653208|NCT06400251|528908165|FG000|Overall Study|Physician Decision|2|||
146653209|NCT01150474|528908166|FG000|Overall Study|Withdrawal by Subject|5|||
146653210|NCT01150474|528908167|FG001|Overall Study|Withdrawal by Subject|2|||
146653211|NCT01150474|528908166|FG000|Overall Study|Cancer found|1|||
146653212|NCT01150474|528908167|FG001|Overall Study|Cancer found|0|||
146653213|NCT01150474|528908166|FG000|Overall Study|Multiple Studies|0|||
146653214|NCT01150474|528908167|FG001|Overall Study|Multiple Studies|1|||
146653215|NCT01150474|528908166|FG000|Overall Study|Rectotomy|1|||
146653216|NCT01150474|528908167|FG001|Overall Study|Rectotomy|0|||
146653217|NCT01150474|528908166|FG000|Overall Study|Drug did not arrive in time|1|||
146653218|NCT01150474|528908167|FG001|Overall Study|Drug did not arrive in time|0|||
146653219|NCT01150474|528908166|FG000|Overall Study|Drug not administered|1|||
146653220|NCT01150474|528908167|FG001|Overall Study|Drug not administered|0|||
146653221|NCT01150474|528908166|FG000|Overall Study|Surgery Changed|1|||
146653222|NCT01150474|528908167|FG001|Overall Study|Surgery Changed|0|||
146653223|NCT00219544|528908168|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
146653224|NCT00219544|528908169|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
146653225|NCT00219544|528908168|FG000|Single Blind Treatment Period|Adverse Event|9|||
146653226|NCT00219544|528908169|FG001|Single Blind Treatment Period|Adverse Event|0|||
146653227|NCT00219544|528908168|FG000|Single Blind Treatment Period|Protocol Violation|4|||
146653228|NCT00219544|528908169|FG001|Single Blind Treatment Period|Protocol Violation|0|||
146653229|NCT00219544|528908168|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
146653230|NCT00219544|528908169|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
146653231|NCT00219544|528908168|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
146593452|NCT01278407|528682131|FG001|Confirmatory Phase|Participant's Choice|5|||
146593453|NCT01278407|528682132|FG002|Confirmatory Phase|Participant's Choice|3|||
146593454|NCT01278407|528682133|FG003|Confirmatory Phase|Participant's Choice|0|||
146593455|NCT01278407|528682134|FG004|Confirmatory Phase|Participant's Choice|0|||
146653232|NCT00219544|528908169|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
146653233|NCT00219544|528908168|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
146653234|NCT00219544|528908169|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
146653235|NCT01163032|528908170|FG000|Randomization Phase|Withdrawal by Subject|2|||
146653236|NCT01163032|528908171|FG001|Randomization Phase|Withdrawal by Subject|3|||
146593456|NCT01278407|528682130|FG000|Confirmatory Phase|Other|1|||
146593457|NCT01278407|528682131|FG001|Confirmatory Phase|Other|1|||
146593458|NCT01278407|528682132|FG002|Confirmatory Phase|Other|2|||
146593459|NCT01278407|528682133|FG003|Confirmatory Phase|Other|0|||
146593460|NCT01278407|528682134|FG004|Confirmatory Phase|Other|0|||
146593461|NCT01278407|528682130|FG000|Extension Phase|Adverse Event|0|||
146593462|NCT01278407|528682131|FG001|Extension Phase|Adverse Event|0|||
146593463|NCT01278407|528682132|FG002|Extension Phase|Adverse Event|0|||
146593464|NCT01278407|528682133|FG003|Extension Phase|Adverse Event|7|||
146593465|NCT01278407|528682134|FG004|Extension Phase|Adverse Event|16|||
146593466|NCT01278407|528682130|FG000|Extension Phase|Participant's Choice|0|||
146593467|NCT01278407|528682131|FG001|Extension Phase|Participant's Choice|0|||
146593468|NCT01278407|528682132|FG002|Extension Phase|Participant's Choice|0|||
146593469|NCT01278407|528682133|FG003|Extension Phase|Participant's Choice|4|||
146593470|NCT01278407|528682134|FG004|Extension Phase|Participant's Choice|11|||
146593471|NCT01278407|528682130|FG000|Extension Phase|Other|0|||
146593472|NCT01278407|528682131|FG001|Extension Phase|Other|0|||
146593473|NCT01278407|528682132|FG002|Extension Phase|Other|0|||
146593474|NCT01278407|528682133|FG003|Extension Phase|Other|1|||
146593475|NCT01278407|528682134|FG004|Extension Phase|Other|3|||
146593476|NCT02534935|528682135|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
146593477|NCT02534935|528682136|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
146593478|NCT02534935|528682137|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
146593479|NCT02534935|528682135|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
146593480|NCT02534935|528682136|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
146593481|NCT02534935|528682137|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
146593482|NCT02534935|528682135|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
146593483|NCT02534935|528682136|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
146593484|NCT02534935|528682137|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
146593485|NCT02534935|528682135|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
146593486|NCT02534935|528682136|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
146593487|NCT02534935|528682137|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
146593488|NCT02534935|528682135|FG000|Stage 1: 24 Months|Adverse Event|0|||
146593489|NCT02534935|528682136|FG001|Stage 1: 24 Months|Adverse Event|2|||
146593490|NCT02534935|528682137|FG002|Stage 1: 24 Months|Adverse Event|0|||
146593491|NCT02534935|528682135|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
146593492|NCT02534935|528682136|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
146593493|NCT02534935|528682137|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
146593494|NCT02534935|528682135|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
146593495|NCT02534935|528682136|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
146593496|NCT02534935|528682137|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
146593497|NCT01596335|528682138|FG000|Overall Study|exacerbation of primary disease|5|||
146593498|NCT01596335|528682139|FG001|Overall Study|exacerbation of primary disease|9|||
146593499|NCT01176565|528682142|FG000|Overall Study|Lost to Follow-up|12|||
146593500|NCT01176565|528682143|FG001|Overall Study|Lost to Follow-up|16|||
146593501|NCT01176565|528682142|FG000|Overall Study|Withdrawal by Subject|7|||
146593502|NCT01176565|528682143|FG001|Overall Study|Withdrawal by Subject|1|||
146593503|NCT01176565|528682142|FG000|Overall Study|Not Analyzed (any other reason)|1|||
146593504|NCT01176565|528682143|FG001|Overall Study|Not Analyzed (any other reason)|2|||
146593505|NCT03602885|528682145|FG000|Overall Study|Lost to Follow-up|3|||
146593506|NCT03602885|528682146|FG001|Overall Study|Lost to Follow-up|0|||
146593507|NCT02285114|528682151|FG000|Main Phase|Investigator's Discretion|0|||
146593508|NCT02285114|528682152|FG001|Main Phase|Investigator's Discretion|2|||
146593509|NCT02285114|528682153|FG002|Main Phase|Investigator's Discretion|0|||
146593510|NCT02285114|528682154|FG003|Main Phase|Investigator's Discretion|0|||
146593511|NCT02285114|528682155|FG004|Main Phase|Investigator's Discretion|0|||
146593512|NCT02285114|528682156|FG005|Main Phase|Investigator's Discretion|0|||
146593513|NCT02285114|528682151|FG000|Main Phase|Enrolled but Never Treated|1|||
146593514|NCT02285114|528682152|FG001|Main Phase|Enrolled but Never Treated|0|||
146593515|NCT02285114|528682153|FG002|Main Phase|Enrolled but Never Treated|0|||
146593516|NCT02285114|528682154|FG003|Main Phase|Enrolled but Never Treated|0|||
146593517|NCT02285114|528682155|FG004|Main Phase|Enrolled but Never Treated|0|||
146593518|NCT02285114|528682156|FG005|Main Phase|Enrolled but Never Treated|0|||
146593519|NCT02285114|528682151|FG000|Main Phase|Withdrew Consent|0|||
146593520|NCT02285114|528682152|FG001|Main Phase|Withdrew Consent|0|||
146593521|NCT02285114|528682153|FG002|Main Phase|Withdrew Consent|1|||
146593522|NCT02285114|528682154|FG003|Main Phase|Withdrew Consent|0|||
146593523|NCT02285114|528682155|FG004|Main Phase|Withdrew Consent|0|||
146593524|NCT02285114|528682156|FG005|Main Phase|Withdrew Consent|0|||
146593525|NCT02285114|528682151|FG000|Extension Phase|Investigator's Discretion|0|||
146593526|NCT02285114|528682152|FG001|Extension Phase|Investigator's Discretion|0|||
146593527|NCT02285114|528682153|FG002|Extension Phase|Investigator's Discretion|0|||
146593528|NCT02285114|528682154|FG003|Extension Phase|Investigator's Discretion|14|||
146593529|NCT02285114|528682155|FG004|Extension Phase|Investigator's Discretion|1|||
146593530|NCT02285114|528682156|FG005|Extension Phase|Investigator's Discretion|0|||
146593531|NCT02285114|528682151|FG000|Extension Phase|Lost to Follow-up|0|||
146593532|NCT02285114|528682152|FG001|Extension Phase|Lost to Follow-up|0|||
146593533|NCT02285114|528682153|FG002|Extension Phase|Lost to Follow-up|0|||
146593534|NCT02285114|528682154|FG003|Extension Phase|Lost to Follow-up|1|||
146593535|NCT02285114|528682155|FG004|Extension Phase|Lost to Follow-up|1|||
146593536|NCT02285114|528682156|FG005|Extension Phase|Lost to Follow-up|0|||
146593537|NCT02285114|528682151|FG000|Extension Phase|Non-compliance with Study Drug|0|||
146593538|NCT02285114|528682152|FG001|Extension Phase|Non-compliance with Study Drug|0|||
146593539|NCT02285114|528682153|FG002|Extension Phase|Non-compliance with Study Drug|0|||
146593540|NCT02285114|528682154|FG003|Extension Phase|Non-compliance with Study Drug|2|||
146593541|NCT02285114|528682155|FG004|Extension Phase|Non-compliance with Study Drug|0|||
146593542|NCT02285114|528682156|FG005|Extension Phase|Non-compliance with Study Drug|0|||
146593543|NCT02285114|528682151|FG000|Extension Phase|Pregnancy|0|||
146593544|NCT02285114|528682152|FG001|Extension Phase|Pregnancy|0|||
146593545|NCT02285114|528682153|FG002|Extension Phase|Pregnancy|0|||
146593546|NCT02285114|528682154|FG003|Extension Phase|Pregnancy|1|||
146593547|NCT02285114|528682155|FG004|Extension Phase|Pregnancy|0|||
146593548|NCT02285114|528682156|FG005|Extension Phase|Pregnancy|0|||
146593549|NCT03383783|528682157|FG000|Overall Study|Withdrawal by Subject|2|||
146593550|NCT01156389|528682158|FG000|Overall Study|Elevated liver enzymes|4|||
146593551|NCT01156389|528682159|FG001|Overall Study|Elevated liver enzymes|0|||
146593552|NCT01156389|528682158|FG000|Overall Study|Vomiting|0|||
146593553|NCT01156389|528682159|FG001|Overall Study|Vomiting|1|||
146593554|NCT02233738|528682166|FG000|Overall Study|Lost to Follow-up|5|||
146593555|NCT02233738|528682167|FG001|Overall Study|Lost to Follow-up|12|||
146593556|NCT02233738|528682166|FG000|Overall Study|Death|0|||
146593557|NCT02233738|528682167|FG001|Overall Study|Death|1|||
146593558|NCT02233738|528682166|FG000|Overall Study|Withdrawal by Subject|0|||
146593559|NCT02233738|528682167|FG001|Overall Study|Withdrawal by Subject|1|||
146593560|NCT02233738|528682166|FG000|Overall Study|Did not return after Baseline|3|||
146593561|NCT02233738|528682167|FG001|Overall Study|Did not return after Baseline|2|||
146593562|NCT00096174|528682168|FG000|Overall Study|Lack of Efficacy|9|||
146593563|NCT00096174|528682168|FG000|Overall Study|Adverse Event|15|||
146593564|NCT00096174|528682168|FG000|Overall Study|Death|6|||
146593565|NCT00096174|528682168|FG000|Overall Study|Withdrawal by Subject|15|||
146593566|NCT00096174|528682168|FG000|Overall Study|Not started protocol therapy|3|||
146593567|NCT00096174|528682168|FG000|Overall Study|Ineligible|6|||
146593568|NCT00096174|528682168|FG000|Overall Study|other reason|8|||
146593569|NCT00330928|528682171|FG000|Overall Study|Lost to Follow-up|6|||
146593570|NCT00330928|528682171|FG000|Overall Study|Physician Decision|9|||
146593571|NCT00330928|528682171|FG000|Overall Study|Death|1|||
146593572|NCT00330928|528682171|FG000|Overall Study|IVUS could not be performed.|1|||
146593573|NCT03028480|528682172|FG000|Overall Study|No revisit after the first prescription date|2|||
146593574|NCT03028480|528682172|FG000|Overall Study|Did not use the drug|1|||
146593575|NCT03028480|528682172|FG000|Overall Study|Violation of the enrollment deadline|10|||
146593576|NCT03028480|528682172|FG000|Overall Study|Case report forms were not collected|21|||
146593577|NCT01030874|528682173|FG000|Overall Study|Withdrawal by Subject|1|||
146593578|NCT01030874|528682174|FG001|Overall Study|Withdrawal by Subject|0|||
146593579|NCT01030874|528682173|FG000|Overall Study|Discharged in first 2 weeks|17|||
146593580|NCT01030874|528682174|FG001|Overall Study|Discharged in first 2 weeks|16|||
146593581|NCT03554772|528682177|FG000|Overall Study|Lost to Follow-up|0|||
146593582|NCT03554772|528682178|FG001|Overall Study|Lost to Follow-up|0|||
146593583|NCT03554772|528682179|FG002|Overall Study|Lost to Follow-up|0|||
146593584|NCT03554772|528682180|FG003|Overall Study|Lost to Follow-up|2|||
146593585|NCT01133405|528682184|FG000|Period 1|Withdrawal by Subject|0|||
146653237|NCT01163032|528908172|FG002|Randomization Phase|Withdrawal by Subject|0|||
146653238|NCT01163032|528908170|FG000|Randomization Phase|Adverse Event|3|||
146653239|NCT01163032|528908171|FG001|Randomization Phase|Adverse Event|3|||
146653240|NCT01163032|528908172|FG002|Randomization Phase|Adverse Event|0|||
146653241|NCT01163032|528908170|FG000|Randomization Phase|Protocol Violation|0|||
146593586|NCT01133405|528682185|FG001|Period 1|Withdrawal by Subject|1|||
146593587|NCT01133405|528682186|FG002|Period 1|Withdrawal by Subject|0|||
146593588|NCT01133405|528682187|FG003|Period 1|Withdrawal by Subject|1|||
146593589|NCT01133405|528682188|FG004|Period 1|Withdrawal by Subject|0|||
146593590|NCT01133405|528682189|FG005|Period 1|Withdrawal by Subject|1|||
146593591|NCT01133405|528682190|FG006|Period 1|Withdrawal by Subject|0|||
146593592|NCT01133405|528682191|FG007|Period 1|Withdrawal by Subject|0|||
146593593|NCT01133405|528682192|FG008|Period 1|Withdrawal by Subject|0|||
146593594|NCT01133405|528682193|FG009|Period 1|Withdrawal by Subject|0|||
146653242|NCT01163032|528908171|FG001|Randomization Phase|Protocol Violation|1|||
146653243|NCT01163032|528908172|FG002|Randomization Phase|Protocol Violation|0|||
146593595|NCT01133405|528682184|FG000|Period 1|Physician Decision|0|||
146593596|NCT01133405|528682185|FG001|Period 1|Physician Decision|0|||
146653244|NCT01163032|528908170|FG000|Randomization Phase|Various*|5|||
146919273|NCT03456713|529866125|FG000|Overall Study|Lost to Follow-up|1|||
146593597|NCT01133405|528682186|FG002|Period 1|Physician Decision|0|||
146593598|NCT01133405|528682187|FG003|Period 1|Physician Decision|1|||
146593599|NCT01133405|528682188|FG004|Period 1|Physician Decision|0|||
146593600|NCT01133405|528682189|FG005|Period 1|Physician Decision|0|||
146593601|NCT01133405|528682190|FG006|Period 1|Physician Decision|0|||
146653245|NCT01163032|528908171|FG001|Randomization Phase|Various*|4|||
146978417|NCT04741503|530084053|FG001|Initial Enrollment|Overquotas removed|0|||
146593602|NCT01133405|528682191|FG007|Period 1|Physician Decision|0|||
146593603|NCT01133405|528682192|FG008|Period 1|Physician Decision|0|||
146593604|NCT01133405|528682193|FG009|Period 1|Physician Decision|0|||
146978418|NCT04741503|530084054|FG002|Initial Enrollment|Overquotas removed|186|||
146978419|NCT04741503|530084052|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
146978420|NCT04741503|530084053|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
146978421|NCT04741503|530084054|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
146978422|NCT01663714|530084055|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
146978423|NCT01663714|530084055|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
146978424|NCT01663714|530084055|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
146978425|NCT01663714|530084055|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
146978426|NCT01663714|530084055|FG000|Long-Term Follow-Up|Death|4|||
146978427|NCT01663714|530084055|FG000|Long-Term Follow-Up|Non-compliance|1|||
146978428|NCT02280421|530084058|FG000|Washout (2 Weeks)|Adverse Event|0|||
146978429|NCT02280421|530084059|FG001|Washout (2 Weeks)|Adverse Event|1|||
146978430|NCT02280421|530084058|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
146593605|NCT01133405|528682184|FG000|Period 1|Discontinued after randomization|1|||
146593606|NCT01133405|528682185|FG001|Period 1|Discontinued after randomization|0|||
146593607|NCT01133405|528682186|FG002|Period 1|Discontinued after randomization|0|||
146593608|NCT01133405|528682187|FG003|Period 1|Discontinued after randomization|0|||
146593609|NCT01133405|528682188|FG004|Period 1|Discontinued after randomization|0|||
146593610|NCT01133405|528682189|FG005|Period 1|Discontinued after randomization|0|||
146593611|NCT01133405|528682190|FG006|Period 1|Discontinued after randomization|1|||
146593612|NCT01133405|528682191|FG007|Period 1|Discontinued after randomization|0|||
146593613|NCT01133405|528682192|FG008|Period 1|Discontinued after randomization|0|||
146593614|NCT01133405|528682193|FG009|Period 1|Discontinued after randomization|0|||
146593615|NCT01133405|528682184|FG000|Period 1|Received drug only in period 2|0|||
146593616|NCT01133405|528682185|FG001|Period 1|Received drug only in period 2|1|||
146593617|NCT01133405|528682186|FG002|Period 1|Received drug only in period 2|0|||
146593618|NCT01133405|528682187|FG003|Period 1|Received drug only in period 2|2|||
146593619|NCT01133405|528682188|FG004|Period 1|Received drug only in period 2|0|||
146593620|NCT01133405|528682189|FG005|Period 1|Received drug only in period 2|1|||
146593621|NCT01133405|528682190|FG006|Period 1|Received drug only in period 2|0|||
146593622|NCT01133405|528682191|FG007|Period 1|Received drug only in period 2|0|||
146593623|NCT01133405|528682192|FG008|Period 1|Received drug only in period 2|0|||
146593624|NCT01133405|528682193|FG009|Period 1|Received drug only in period 2|0|||
146653246|NCT01163032|528908172|FG002|Randomization Phase|Various*|0|||
146653247|NCT01163032|528908170|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
146653248|NCT01163032|528908171|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
146653249|NCT01163032|528908172|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
146653250|NCT01163032|528908170|FG000|Open Label Extension Phase|Adverse Event|0|||
146653251|NCT01163032|528908171|FG001|Open Label Extension Phase|Adverse Event|0|||
146653252|NCT01163032|528908172|FG002|Open Label Extension Phase|Adverse Event|3|||
146653253|NCT01163032|528908170|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
146653254|NCT01163032|528908171|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
146653255|NCT01163032|528908172|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
146771431|NCT00959946|529331193|FG005|Overall Study|Withdrawal by Subject|1|||
146771432|NCT00959946|529331194|FG006|Overall Study|Withdrawal by Subject|0|||
146771433|NCT00959946|529331195|FG007|Overall Study|Withdrawal by Subject|0|||
146919274|NCT03456713|529866126|FG001|Overall Study|Lost to Follow-up|0|||
146919275|NCT03456713|529866127|FG002|Overall Study|Lost to Follow-up|0|||
146919276|NCT03456713|529866128|FG003|Overall Study|Lost to Follow-up|0|||
146919277|NCT01263691|529866129|FG000|Overall Study|Lost to Follow-up|1|||
146919278|NCT01263691|529866130|FG001|Overall Study|Lost to Follow-up|0|||
146919279|NCT01263691|529866131|FG002|Overall Study|Lost to Follow-up|1|||
146919280|NCT01263691|529866132|FG003|Overall Study|Lost to Follow-up|1|||
146919281|NCT01263691|529866133|FG004|Overall Study|Lost to Follow-up|0|||
146919282|NCT01263691|529866134|FG005|Overall Study|Lost to Follow-up|0|||
146919283|NCT01263691|529866129|FG000|Overall Study|Withdrawal by Subject|1|||
146919284|NCT01263691|529866130|FG001|Overall Study|Withdrawal by Subject|0|||
146978431|NCT02280421|530084059|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
146593625|NCT01133405|528682184|FG000|Period 1|Received drug only in period 3|0|||
146771434|NCT00356265|529331196|FG000|Overall Study|Withdrawal by Subject|0|||
146593626|NCT01133405|528682185|FG001|Period 1|Received drug only in period 3|1|||
146593627|NCT01133405|528682186|FG002|Period 1|Received drug only in period 3|1|||
146593628|NCT01133405|528682187|FG003|Period 1|Received drug only in period 3|0|||
146593629|NCT01133405|528682188|FG004|Period 1|Received drug only in period 3|0|||
146653256|NCT01163032|528908170|FG000|Open Label Extension Phase|Protocol Violation|0|||
146771435|NCT00356265|529331197|FG001|Overall Study|Withdrawal by Subject|0|||
146919285|NCT01263691|529866131|FG002|Overall Study|Withdrawal by Subject|0|||
146919286|NCT01263691|529866132|FG003|Overall Study|Withdrawal by Subject|0|||
146919287|NCT01263691|529866133|FG004|Overall Study|Withdrawal by Subject|0|||
146919288|NCT01263691|529866134|FG005|Overall Study|Withdrawal by Subject|0|||
146919289|NCT01263691|529866129|FG000|Overall Study|Adverse Event|1|||
146919290|NCT01263691|529866130|FG001|Overall Study|Adverse Event|0|||
146919291|NCT01263691|529866131|FG002|Overall Study|Adverse Event|0|||
146919292|NCT01263691|529866132|FG003|Overall Study|Adverse Event|0|||
146919293|NCT01263691|529866133|FG004|Overall Study|Adverse Event|0|||
146919294|NCT01263691|529866134|FG005|Overall Study|Adverse Event|0|||
146919295|NCT01202227|529866137|FG000|Overall Study|Adverse Event|16|||
146919296|NCT01202227|529866137|FG000|Overall Study|Withdrawal by Subject|2|||
146919297|NCT01202227|529866137|FG000|Overall Study|Lack of Efficacy|1|||
146919298|NCT00643487|529866138|FG000|Overall Study|Technical difficulty|3|||
146919299|NCT00850759|529866141|FG000|Overall Study|Lost to Follow-up|7|||
146919300|NCT00850759|529866142|FG001|Overall Study|Lost to Follow-up|5|||
146919301|NCT00850759|529866143|FG002|Overall Study|Lost to Follow-up|5|||
146919302|NCT00850759|529866144|FG003|Overall Study|Lost to Follow-up|3|||
146919303|NCT03196505|529866145|FG000|Overall Study|Physician Decision|26|||
146919304|NCT03196505|529866146|FG001|Overall Study|Physician Decision|26|||
146919305|NCT01753076|529866147|FG000|Overall Study|Adverse Event|17|||
146919306|NCT01753076|529866148|FG001|Overall Study|Adverse Event|18|||
146919307|NCT01753076|529866147|FG000|Overall Study|Lack of Efficacy|3|||
146593630|NCT01133405|528682189|FG005|Period 1|Received drug only in period 3|0|||
146593631|NCT01133405|528682190|FG006|Period 1|Received drug only in period 3|0|||
146593632|NCT01133405|528682191|FG007|Period 1|Received drug only in period 3|0|||
146593633|NCT01133405|528682192|FG008|Period 1|Received drug only in period 3|0|||
146593634|NCT01133405|528682193|FG009|Period 1|Received drug only in period 3|0|||
146593635|NCT01133405|528682184|FG000|Period 2|Adverse Event|0|||
146593636|NCT01133405|528682185|FG001|Period 2|Adverse Event|0|||
146593637|NCT01133405|528682186|FG002|Period 2|Adverse Event|1|||
146919308|NCT01753076|529866148|FG001|Overall Study|Lack of Efficacy|1|||
146919309|NCT01753076|529866147|FG000|Overall Study|Lost to Follow-up|2|||
146919310|NCT01753076|529866148|FG001|Overall Study|Lost to Follow-up|1|||
146919311|NCT01753076|529866147|FG000|Overall Study|Physician Decision|4|||
146919312|NCT01753076|529866148|FG001|Overall Study|Physician Decision|2|||
146919313|NCT01753076|529866147|FG000|Overall Study|Withdrawal by Subject|14|||
146919314|NCT01753076|529866148|FG001|Overall Study|Withdrawal by Subject|24|||
146919315|NCT01753076|529866147|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
146919316|NCT01753076|529866148|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
146919317|NCT02389816|529866149|FG000|Overall Study|Randomized but Not Treated|1|||
146919318|NCT02389816|529866150|FG001|Overall Study|Randomized but Not Treated|0|||
146919319|NCT02389816|529866151|FG002|Overall Study|Randomized but Not Treated|0|||
146919320|NCT02389816|529866149|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
146919321|NCT02389816|529866150|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
146919322|NCT02389816|529866151|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
146919323|NCT02389816|529866149|FG000|Overall Study|Major Protocol Deviation|1|||
146919324|NCT02389816|529866150|FG001|Overall Study|Major Protocol Deviation|0|||
146593638|NCT01133405|528682187|FG003|Period 2|Adverse Event|0|||
146593639|NCT01133405|528682188|FG004|Period 2|Adverse Event|0|||
146653257|NCT01163032|528908171|FG001|Open Label Extension Phase|Protocol Violation|0|||
146653258|NCT01163032|528908172|FG002|Open Label Extension Phase|Protocol Violation|1|||
146653259|NCT01163032|528908170|FG000|Open Label Extension Phase|Study Termination|0|||
146653260|NCT01163032|528908171|FG001|Open Label Extension Phase|Study Termination|0|||
146653261|NCT01163032|528908172|FG002|Open Label Extension Phase|Study Termination|7|||
146653262|NCT01163032|528908170|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
146653263|NCT01163032|528908171|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
146653264|NCT01163032|528908172|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
146653265|NCT01037088|528908175|FG000|Overall Study|Withdrawal by Subject|3|||
146653266|NCT01958827|528908176|FG000|Overall Study|Adverse Event|3|||
146653267|NCT01958827|528908176|FG000|Overall Study|Lack of Efficacy|6|||
146653268|NCT01958827|528908176|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
146653269|NCT03036800|528908177|FG000|Overall Study|Protocol Violation|1|||
146653270|NCT03036800|528908178|FG001|Overall Study|Protocol Violation|0|||
146653271|NCT03036800|528908177|FG000|Overall Study|Non-compliance|1|||
146653272|NCT03036800|528908178|FG001|Overall Study|Non-compliance|0|||
146653273|NCT03036800|528908177|FG000|Overall Study|Lost to Follow-up|1|||
146919325|NCT02389816|529866151|FG002|Overall Study|Major Protocol Deviation|0|||
146919326|NCT02389816|529866149|FG000|Overall Study|Lost to Follow-up|1|||
146919327|NCT02389816|529866150|FG001|Overall Study|Lost to Follow-up|0|||
146653274|NCT03036800|528908178|FG001|Overall Study|Lost to Follow-up|0|||
146593640|NCT01133405|528682189|FG005|Period 2|Adverse Event|0|||
146593641|NCT01133405|528682190|FG006|Period 2|Adverse Event|0|||
146653275|NCT03036800|528908177|FG000|Overall Study|Death|1|||
146919328|NCT02389816|529866151|FG002|Overall Study|Lost to Follow-up|0|||
146919329|NCT02389816|529866149|FG000|Overall Study|Withdrawal of Consent|6|||
146919330|NCT02389816|529866150|FG001|Overall Study|Withdrawal of Consent|4|||
146919331|NCT02389816|529866151|FG002|Overall Study|Withdrawal of Consent|4|||
146653276|NCT03036800|528908178|FG001|Overall Study|Death|0|||
146593642|NCT01133405|528682191|FG007|Period 2|Adverse Event|0|||
146593643|NCT01133405|528682192|FG008|Period 2|Adverse Event|0|||
146593644|NCT01133405|528682193|FG009|Period 2|Adverse Event|0|||
146593645|NCT01133405|528682184|FG000|Period 2|Withdrawal by Subject|0|||
146593646|NCT01133405|528682185|FG001|Period 2|Withdrawal by Subject|0|||
146593647|NCT01133405|528682186|FG002|Period 2|Withdrawal by Subject|0|||
146593648|NCT01133405|528682187|FG003|Period 2|Withdrawal by Subject|1|||
146593649|NCT01133405|528682188|FG004|Period 2|Withdrawal by Subject|0|||
146593650|NCT01133405|528682189|FG005|Period 2|Withdrawal by Subject|1|||
146593651|NCT01133405|528682190|FG006|Period 2|Withdrawal by Subject|0|||
146593652|NCT01133405|528682191|FG007|Period 2|Withdrawal by Subject|0|||
146593653|NCT01133405|528682192|FG008|Period 2|Withdrawal by Subject|0|||
146593654|NCT01133405|528682193|FG009|Period 2|Withdrawal by Subject|0|||
146593655|NCT01133405|528682184|FG000|Period 2|Entry Criteria Not Met|0|||
146593656|NCT01133405|528682185|FG001|Period 2|Entry Criteria Not Met|1|||
146593657|NCT01133405|528682186|FG002|Period 2|Entry Criteria Not Met|0|||
146593658|NCT01133405|528682187|FG003|Period 2|Entry Criteria Not Met|0|||
146593659|NCT01133405|528682188|FG004|Period 2|Entry Criteria Not Met|0|||
146593660|NCT01133405|528682189|FG005|Period 2|Entry Criteria Not Met|0|||
146593661|NCT01133405|528682190|FG006|Period 2|Entry Criteria Not Met|0|||
146593662|NCT01133405|528682191|FG007|Period 2|Entry Criteria Not Met|0|||
146593663|NCT01133405|528682192|FG008|Period 2|Entry Criteria Not Met|0|||
146593664|NCT01133405|528682193|FG009|Period 2|Entry Criteria Not Met|0|||
146593665|NCT01133405|528682184|FG000|Period 2|Physician Decision|0|||
146593666|NCT01133405|528682185|FG001|Period 2|Physician Decision|0|||
146593667|NCT01133405|528682186|FG002|Period 2|Physician Decision|0|||
146593668|NCT01133405|528682187|FG003|Period 2|Physician Decision|0|||
146593669|NCT01133405|528682188|FG004|Period 2|Physician Decision|0|||
146593670|NCT01133405|528682189|FG005|Period 2|Physician Decision|1|||
146593671|NCT01133405|528682190|FG006|Period 2|Physician Decision|0|||
146593672|NCT01133405|528682191|FG007|Period 2|Physician Decision|0|||
146593673|NCT01133405|528682192|FG008|Period 2|Physician Decision|0|||
146593674|NCT01133405|528682193|FG009|Period 2|Physician Decision|0|||
146593675|NCT00089986|528682196|FG000|Overall Study|Adverse Event|6|||
146919332|NCT02389816|529866149|FG000|Overall Study|Lack of Efficacy|1|||
146919333|NCT02389816|529866150|FG001|Overall Study|Lack of Efficacy|0|||
146919334|NCT02389816|529866151|FG002|Overall Study|Lack of Efficacy|0|||
146919335|NCT02389816|529866149|FG000|Overall Study|Non Compliance with Study Drug|1|||
146919336|NCT02389816|529866150|FG001|Overall Study|Non Compliance with Study Drug|1|||
146919337|NCT02389816|529866151|FG002|Overall Study|Non Compliance with Study Drug|1|||
146919338|NCT02389816|529866149|FG000|Overall Study|Reason not Specified|0|||
146919339|NCT02389816|529866150|FG001|Overall Study|Reason not Specified|2|||
146919340|NCT02389816|529866151|FG002|Overall Study|Reason not Specified|0|||
146919341|NCT01259856|529866158|FG000|Overall Study|Adverse Event|12|||
146919342|NCT01259856|529866159|FG001|Overall Study|Adverse Event|9|||
146919343|NCT01259856|529866158|FG000|Overall Study|Death|0|||
146919344|NCT01259856|529866159|FG001|Overall Study|Death|1|||
146919345|NCT01259856|529866158|FG000|Overall Study|Lack of Efficacy|3|||
146919346|NCT01259856|529866159|FG001|Overall Study|Lack of Efficacy|1|||
146919347|NCT01259856|529866158|FG000|Overall Study|Lost to Follow-up|1|||
146919348|NCT01259856|529866159|FG001|Overall Study|Lost to Follow-up|1|||
146919349|NCT01259856|529866158|FG000|Overall Study|Physician Decision|2|||
146919350|NCT01259856|529866159|FG001|Overall Study|Physician Decision|1|||
146919351|NCT01259856|529866158|FG000|Overall Study|Withdrawal by Subject|9|||
146919352|NCT01259856|529866159|FG001|Overall Study|Withdrawal by Subject|10|||
146919353|NCT01259856|529866158|FG000|Overall Study|Treatment never started|0|||
146919354|NCT01259856|529866159|FG001|Overall Study|Treatment never started|6|||
146919355|NCT01259856|529866158|FG000|Overall Study|Study closure by sponsor|40|||
146919356|NCT01259856|529866159|FG001|Overall Study|Study closure by sponsor|41|||
146919357|NCT01259856|529866158|FG000|Overall Study|Patient developed other disease|0|||
146919358|NCT01259856|529866159|FG001|Overall Study|Patient developed other disease|1|||
146978432|NCT00515073|530084060|FG000|Overall Study|Withdrawal by Subject|1|||
146593676|NCT00089986|528682197|FG001|Overall Study|Adverse Event|9|||
146593677|NCT00089986|528682198|FG002|Overall Study|Adverse Event|6|||
146919359|NCT01259856|529866158|FG000|Overall Study|Transfer to another study|0|||
146919360|NCT01259856|529866159|FG001|Overall Study|Transfer to another study|1|||
146919361|NCT01259856|529866158|FG000|Overall Study|Unknown/missing|2|||
146593678|NCT00089986|528682196|FG000|Overall Study|Lost to Follow-up|3|||
146593679|NCT00089986|528682197|FG001|Overall Study|Lost to Follow-up|1|||
146919362|NCT01259856|529866159|FG001|Overall Study|Unknown/missing|2|||
146919363|NCT00788775|529866160|FG000|Overall Study|Progressive Disease|8|||
146919364|NCT00788775|529866161|FG001|Overall Study|Progressive Disease|6|||
146919365|NCT00788775|529866160|FG000|Overall Study|Withdrawal by Subject|0|||
146919366|NCT00788775|529866161|FG001|Overall Study|Withdrawal by Subject|2|||
146593680|NCT00089986|528682198|FG002|Overall Study|Lost to Follow-up|1|||
146593681|NCT00089986|528682196|FG000|Overall Study|Protocol Violation|0|||
146593682|NCT00089986|528682197|FG001|Overall Study|Protocol Violation|1|||
146593683|NCT00089986|528682198|FG002|Overall Study|Protocol Violation|0|||
146593684|NCT00089986|528682196|FG000|Overall Study|Patient transferred to another hospital|2|||
146593685|NCT00089986|528682197|FG001|Overall Study|Patient transferred to another hospital|1|||
146919367|NCT00788775|529866160|FG000|Overall Study|Patient Non-Compliance|1|||
146919368|NCT00788775|529866161|FG001|Overall Study|Patient Non-Compliance|0|||
146919369|NCT00788775|529866160|FG000|Overall Study|Patient's measurable disease resected.|1|||
146919370|NCT00788775|529866161|FG001|Overall Study|Patient's measurable disease resected.|0|||
146919371|NCT00578864|529866162|FG000|Overall Study|Death|1|||
146919372|NCT00578864|529866163|FG001|Overall Study|Death|0|||
146919373|NCT01217190|529866167|FG000|Second Dosing|Withdrawal by Subject|0|||
146919374|NCT01217190|529866168|FG001|Second Dosing|Withdrawal by Subject|2|||
146919375|NCT01594476|529866169|FG000|Overall Study|Protocol Violation|1|||
146919376|NCT01594476|529866170|FG001|Overall Study|Protocol Violation|3|||
146919377|NCT03116399|529866171|FG000|Overall Study|Death|8|||
146919378|NCT03116399|529866172|FG001|Overall Study|Death|3|||
146919379|NCT03116399|529866171|FG000|Overall Study|Lost to Follow-up|7|||
146919380|NCT03116399|529866172|FG001|Overall Study|Lost to Follow-up|11|||
146919381|NCT03116399|529866171|FG000|Overall Study|Investigator Decision|1|||
146919382|NCT03116399|529866172|FG001|Overall Study|Investigator Decision|1|||
146919383|NCT03116399|529866171|FG000|Overall Study|Withdrawal by Subject|24|||
146919384|NCT03116399|529866172|FG001|Overall Study|Withdrawal by Subject|9|||
146919385|NCT02538666|529866174|FG000|Pre-Treatment|Disease progression|1|||
146919386|NCT02538666|529866175|FG001|Pre-Treatment|Disease progression|0|||
146919387|NCT02538666|529866176|FG002|Pre-Treatment|Disease progression|0|||
146919388|NCT02538666|529866174|FG000|Pre-Treatment|no longer meets study criteria|1|||
146919389|NCT02538666|529866175|FG001|Pre-Treatment|no longer meets study criteria|0|||
146919390|NCT02538666|529866176|FG002|Pre-Treatment|no longer meets study criteria|0|||
146919391|NCT02538666|529866174|FG000|Pre-Treatment|Withdrew Consent|0|||
146919392|NCT02538666|529866175|FG001|Pre-Treatment|Withdrew Consent|1|||
146919393|NCT02538666|529866176|FG002|Pre-Treatment|Withdrew Consent|1|||
146919394|NCT02538666|529866174|FG000|Treatment|Disease progression|270|||
146919395|NCT02538666|529866175|FG001|Treatment|Disease progression|227|||
146919396|NCT02538666|529866176|FG002|Treatment|Disease progression|165|||
146919397|NCT02538666|529866174|FG000|Treatment|Study drug toxicity|1|||
146919398|NCT02538666|529866175|FG001|Treatment|Study drug toxicity|29|||
146919399|NCT02538666|529866176|FG002|Treatment|Study drug toxicity|92|||
146919400|NCT02538666|529866174|FG000|Treatment|Death|0|||
146919401|NCT02538666|529866175|FG001|Treatment|Death|2|||
146919402|NCT02538666|529866176|FG002|Treatment|Death|3|||
146919403|NCT02538666|529866174|FG000|Treatment|Adverse event unrelated to study drug|8|||
146978433|NCT00515073|530084060|FG000|Overall Study|Physician Decision|1|||
146593686|NCT00089986|528682198|FG002|Overall Study|Patient transferred to another hospital|0|||
146593687|NCT00089986|528682196|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
146593688|NCT00089986|528682197|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
146593689|NCT00089986|528682198|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
146593690|NCT00089986|528682196|FG000|Overall Study|Hemohlobin stopping rule|0|||
146593691|NCT00089986|528682197|FG001|Overall Study|Hemohlobin stopping rule|1|||
146593692|NCT00089986|528682198|FG002|Overall Study|Hemohlobin stopping rule|0|||
146593693|NCT00089986|528682196|FG000|Overall Study|Investigator decision to withdrew|0|||
146593694|NCT00089986|528682197|FG001|Overall Study|Investigator decision to withdrew|1|||
146593695|NCT00089986|528682198|FG002|Overall Study|Investigator decision to withdrew|0|||
146593696|NCT00089986|528682196|FG000|Overall Study|Enrollment in another study|0|||
146593697|NCT00089986|528682197|FG001|Overall Study|Enrollment in another study|1|||
146593698|NCT00089986|528682198|FG002|Overall Study|Enrollment in another study|0|||
146593699|NCT00089986|528682196|FG000|Overall Study|Family decision|0|||
146593700|NCT00089986|528682197|FG001|Overall Study|Family decision|1|||
146593701|NCT00089986|528682198|FG002|Overall Study|Family decision|0|||
146593702|NCT00089986|528682196|FG000|Overall Study|Do not resuscitate (DNR)|0|||
146593703|NCT00089986|528682197|FG001|Overall Study|Do not resuscitate (DNR)|0|||
146593704|NCT00089986|528682198|FG002|Overall Study|Do not resuscitate (DNR)|1|||
146593705|NCT00089986|528682196|FG000|Overall Study|Withdrawal by Subject|3|||
146593706|NCT00089986|528682197|FG001|Overall Study|Withdrawal by Subject|6|||
146593707|NCT00089986|528682198|FG002|Overall Study|Withdrawal by Subject|2|||
146593708|NCT03946124|528682199|FG000|Overall Study|Withdrawal by Subject|19|||
146593709|NCT00241631|528682200|FG000|Run in (2 Weeks)|Physician Decision|3|||
146593710|NCT00241631|528682201|FG001|Run in (2 Weeks)|Physician Decision|3|||
146593711|NCT00241631|528682200|FG000|Phase 1 (4 Weeks)|sore throat|1|||
146771436|NCT00356265|529331198|FG002|Overall Study|Withdrawal by Subject|1|||
146919404|NCT02538666|529866175|FG001|Treatment|Adverse event unrelated to study drug|10|||
146919405|NCT02538666|529866176|FG002|Treatment|Adverse event unrelated to study drug|15|||
146919406|NCT02538666|529866174|FG000|Treatment|Participant request to discontinue study treatment|3|||
146919407|NCT02538666|529866175|FG001|Treatment|Participant request to discontinue study treatment|6|||
146919408|NCT02538666|529866176|FG002|Treatment|Participant request to discontinue study treatment|11|||
146593712|NCT00241631|528682201|FG001|Phase 1 (4 Weeks)|sore throat|0|||
146593713|NCT00241631|528682200|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
146593714|NCT00241631|528682201|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
146593715|NCT00241631|528682200|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
146919409|NCT02538666|529866174|FG000|Treatment|Participant withdrew consent|2|||
146653277|NCT03036800|528908177|FG000|Overall Study|Tolerance|5|||
146653278|NCT03036800|528908178|FG001|Overall Study|Tolerance|0|||
146653279|NCT03036800|528908177|FG000|Overall Study|Unknown/no reason given|50|||
146653280|NCT03036800|528908178|FG001|Overall Study|Unknown/no reason given|39|||
146653281|NCT01077154|528908183|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
146653282|NCT01077154|528908184|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
146653283|NCT01077154|528908183|FG000|Overall Study|Withdrawal by Subject|369|||
146653284|NCT01077154|528908184|FG001|Overall Study|Withdrawal by Subject|385|||
146653285|NCT01077154|528908183|FG000|Overall Study|Death|215|||
146653286|NCT01077154|528908184|FG001|Overall Study|Death|214|||
146653287|NCT01077154|528908183|FG000|Overall Study|Lost to Follow-up|43|||
146653288|NCT01077154|528908184|FG001|Overall Study|Lost to Follow-up|35|||
146653289|NCT01077154|528908183|FG000|Overall Study|Noncompliance|22|||
146653290|NCT01077154|528908184|FG001|Overall Study|Noncompliance|20|||
146653291|NCT01077154|528908183|FG000|Overall Study|Disease Progression|18|||
146653292|NCT01077154|528908184|FG001|Overall Study|Disease Progression|20|||
146653293|NCT01077154|528908183|FG000|Overall Study|Ineligibility Determined|10|||
146653294|NCT01077154|528908184|FG001|Overall Study|Ineligibility Determined|14|||
146653295|NCT01077154|528908183|FG000|Overall Study|Other|14|||
146653296|NCT01077154|528908184|FG001|Overall Study|Other|11|||
146653297|NCT01077154|528908183|FG000|Overall Study|Adverse Event|9|||
146653298|NCT01077154|528908184|FG001|Overall Study|Adverse Event|9|||
146653299|NCT01077154|528908183|FG000|Overall Study|Administrative Decision|1|||
146653300|NCT01077154|528908184|FG001|Overall Study|Administrative Decision|6|||
146653301|NCT01077154|528908183|FG000|Overall Study|Protocol Deviation|1|||
146653302|NCT01077154|528908184|FG001|Overall Study|Protocol Deviation|0|||
146653303|NCT02207946|528908185|FG000|Overall Study|Lost to Follow-up|1|||
146653304|NCT02207946|528908186|FG001|Overall Study|Lost to Follow-up|0|||
146653305|NCT02207946|528908185|FG000|Overall Study|Adverse Event|0|||
146653306|NCT02207946|528908186|FG001|Overall Study|Adverse Event|1|||
146653307|NCT03764033|528908190|FG000|Treatment Phase|Withdrawal by Subject|8|||
146653308|NCT03764033|528908191|FG001|Treatment Phase|Withdrawal by Subject|3|||
146653309|NCT03764033|528908190|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
146919410|NCT02538666|529866175|FG001|Treatment|Participant withdrew consent|5|||
146919411|NCT02538666|529866176|FG002|Treatment|Participant withdrew consent|3|||
146919412|NCT02538666|529866174|FG000|Treatment|Lost to Follow-up|0|||
146919413|NCT02538666|529866175|FG001|Treatment|Lost to Follow-up|1|||
146919414|NCT02538666|529866176|FG002|Treatment|Lost to Follow-up|1|||
146919415|NCT02538666|529866174|FG000|Treatment|Maximum clinical benefit|4|||
146919416|NCT02538666|529866175|FG001|Treatment|Maximum clinical benefit|3|||
146919417|NCT02538666|529866176|FG002|Treatment|Maximum clinical benefit|4|||
146919418|NCT02538666|529866174|FG000|Treatment|Poor/non-compliance|0|||
146919419|NCT02538666|529866175|FG001|Treatment|Poor/non-compliance|1|||
146919420|NCT02538666|529866176|FG002|Treatment|Poor/non-compliance|0|||
146919421|NCT02538666|529866174|FG000|Treatment|Participant no longer meets study criteria|0|||
146919422|NCT02538666|529866175|FG001|Treatment|Participant no longer meets study criteria|2|||
146919423|NCT02538666|529866176|FG002|Treatment|Participant no longer meets study criteria|0|||
146919424|NCT02538666|529866174|FG000|Treatment|Administrative reason by sponsor|0|||
146919425|NCT02538666|529866175|FG001|Treatment|Administrative reason by sponsor|0|||
146919426|NCT02538666|529866176|FG002|Treatment|Administrative reason by sponsor|1|||
146919427|NCT02538666|529866174|FG000|Treatment|Other reasons|8|||
146919428|NCT02538666|529866175|FG001|Treatment|Other reasons|15|||
146919429|NCT02538666|529866176|FG002|Treatment|Other reasons|5|||
146919430|NCT02538666|529866174|FG000|Treatment|Not reported|2|||
146919431|NCT02538666|529866175|FG001|Treatment|Not reported|2|||
146919432|NCT02538666|529866176|FG002|Treatment|Not reported|2|||
146919433|NCT03382899|529866177|FG000|Overall Study|Ineligibility Determined|0|||
146919434|NCT03382899|529866178|FG001|Overall Study|Ineligibility Determined|1|||
146919435|NCT03382899|529866177|FG000|Overall Study|Lost to Follow-up|0|||
146919436|NCT03382899|529866178|FG001|Overall Study|Lost to Follow-up|1|||
146919437|NCT03382899|529866177|FG000|Overall Study|Sponsor's decision|31|||
146919438|NCT03382899|529866178|FG001|Overall Study|Sponsor's decision|28|||
146919439|NCT03382899|529866177|FG000|Overall Study|Withdrawal by Subject|0|||
146919440|NCT03382899|529866178|FG001|Overall Study|Withdrawal by Subject|5|||
146919441|NCT01987986|529866179|FG000|Overall Study|Lost to Follow-up|1|||
146919442|NCT01987986|529866180|FG001|Overall Study|Lost to Follow-up|0|||
146919443|NCT01987986|529866181|FG002|Overall Study|Lost to Follow-up|0|||
146653310|NCT03764033|528908191|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
146653311|NCT03764033|528908190|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
146653312|NCT03764033|528908191|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
146653313|NCT01006603|528908194|FG000|Overall Study|Withdrawal by Subject|17|||
146653314|NCT01006603|528908195|FG001|Overall Study|Withdrawal by Subject|19|||
146919444|NCT01987986|529866182|FG003|Overall Study|Lost to Follow-up|0|||
146919445|NCT01987986|529866179|FG000|Overall Study|Adverse Event|1|||
146919446|NCT01987986|529866180|FG001|Overall Study|Adverse Event|0|||
146653315|NCT01006603|528908194|FG000|Overall Study|Lost to Follow-up|0|||
146919447|NCT01987986|529866181|FG002|Overall Study|Adverse Event|2|||
146919448|NCT01987986|529866182|FG003|Overall Study|Adverse Event|0|||
146919449|NCT03259334|529866183|FG000|Overall Study|Adverse Event|3|||
146919450|NCT03259334|529866184|FG001|Overall Study|Adverse Event|8|||
146919451|NCT03259334|529866185|FG002|Overall Study|Adverse Event|5|||
146919452|NCT03259334|529866183|FG000|Overall Study|Withdrawal by Subject|4|||
146919453|NCT03259334|529866184|FG001|Overall Study|Withdrawal by Subject|2|||
146919454|NCT03259334|529866185|FG002|Overall Study|Withdrawal by Subject|4|||
146919455|NCT03259334|529866183|FG000|Overall Study|Physician Decision|1|||
146919456|NCT03259334|529866184|FG001|Overall Study|Physician Decision|0|||
146919457|NCT03259334|529866185|FG002|Overall Study|Physician Decision|0|||
146919458|NCT03259334|529866183|FG000|Overall Study|Lost to Follow-up|0|||
146919459|NCT03259334|529866184|FG001|Overall Study|Lost to Follow-up|2|||
146919460|NCT03259334|529866185|FG002|Overall Study|Lost to Follow-up|1|||
146919461|NCT03259334|529866183|FG000|Overall Study|Protocol Deviation|0|||
146919462|NCT03259334|529866184|FG001|Overall Study|Protocol Deviation|3|||
146919463|NCT03259334|529866185|FG002|Overall Study|Protocol Deviation|2|||
146919464|NCT03259334|529866183|FG000|Overall Study|Lack of Efficacy|2|||
146919465|NCT03259334|529866184|FG001|Overall Study|Lack of Efficacy|0|||
146919466|NCT03259334|529866185|FG002|Overall Study|Lack of Efficacy|1|||
146919467|NCT03259334|529866183|FG000|Overall Study|Randomized but never treated|0|||
146919468|NCT03259334|529866184|FG001|Overall Study|Randomized but never treated|2|||
146919469|NCT03259334|529866185|FG002|Overall Study|Randomized but never treated|0|||
146919470|NCT01187901|529866188|FG000|Overall Study|Protocol Violation|1|||
146919471|NCT01187901|529866189|FG001|Overall Study|Protocol Violation|0|||
146919472|NCT01187901|529866188|FG000|Overall Study|Lost to Follow-up|1|||
146919473|NCT01187901|529866189|FG001|Overall Study|Lost to Follow-up|2|||
146919474|NCT01187901|529866188|FG000|Overall Study|Unrelated Health Reasons|1|||
146919475|NCT01187901|529866189|FG001|Overall Study|Unrelated Health Reasons|2|||
146919476|NCT01187901|529866188|FG000|Overall Study|Suspected Allergic Reaction|1|||
146919477|NCT01187901|529866189|FG001|Overall Study|Suspected Allergic Reaction|1|||
146919478|NCT01187901|529866188|FG000|Overall Study|Adverse Event|3|||
146919479|NCT01187901|529866189|FG001|Overall Study|Adverse Event|0|||
146919480|NCT01187901|529866188|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
146919481|NCT01187901|529866189|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
146919482|NCT01187901|529866188|FG000|Overall Study|Pregnancy|0|||
146919483|NCT01187901|529866189|FG001|Overall Study|Pregnancy|2|||
146978434|NCT02764489|530084061|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
146978435|NCT02764489|530084062|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
146653316|NCT01006603|528908195|FG001|Overall Study|Lost to Follow-up|1|||
146653317|NCT01006603|528908194|FG000|Overall Study|Safety reason|1|||
146653318|NCT01006603|528908195|FG001|Overall Study|Safety reason|1|||
146653319|NCT01006603|528908194|FG000|Overall Study|Protocol Violation|1|||
146653320|NCT01006603|528908195|FG001|Overall Study|Protocol Violation|3|||
146653321|NCT01006603|528908194|FG000|Overall Study|Incorrect enrolment|0|||
146653322|NCT01006603|528908195|FG001|Overall Study|Incorrect enrolment|2|||
146653323|NCT01006603|528908194|FG000|Overall Study|Adverse Event|15|||
146653324|NCT01006603|528908195|FG001|Overall Study|Adverse Event|7|||
146653325|NCT01006603|528908194|FG000|Overall Study|Death|1|||
146653326|NCT01006603|528908195|FG001|Overall Study|Death|1|||
146653327|NCT01006603|528908194|FG000|Overall Study|Study specific discontinuation criteria|33|||
146653328|NCT01006603|528908195|FG001|Overall Study|Study specific discontinuation criteria|34|||
146653329|NCT01006603|528908194|FG000|Overall Study|Other|3|||
146653330|NCT01006603|528908195|FG001|Overall Study|Other|7|||
146653331|NCT02316548|528908597|FG000|Overall Study|Protocol Violation|0|||
146653332|NCT02316548|528908598|FG001|Overall Study|Protocol Violation|1|||
146653333|NCT05171816|528908601|FG000|Overall Study|Death|18|||
146653334|NCT05171816|528908602|FG001|Overall Study|Death|16|||
146653335|NCT02937571|528908603|FG000|Overall Study|Adverse Event|0|||
146653336|NCT02937571|528908604|FG001|Overall Study|Adverse Event|0|||
146653337|NCT02937571|528908605|FG002|Overall Study|Adverse Event|4|||
146653338|NCT02937571|528908603|FG000|Overall Study|Withdrawal by Subject|0|||
146653339|NCT02937571|528908604|FG001|Overall Study|Withdrawal by Subject|0|||
146653340|NCT02937571|528908605|FG002|Overall Study|Withdrawal by Subject|3|||
146653341|NCT04391569|528908606|FG000|Overall Study|Death|15|||
146653342|NCT04391569|528908607|FG001|Overall Study|Death|10|||
146653343|NCT04391569|528908606|FG000|Overall Study|Withdrawal by Subject|1|||
146653344|NCT04391569|528908607|FG001|Overall Study|Withdrawal by Subject|0|||
146771437|NCT00159783|529331207|FG000|Overall Study|Adverse Event|5|||
146919484|NCT04160468|529866190|FG000|Overall Study|Lost to Follow-up|19|||
146919485|NCT04160468|529866191|FG001|Overall Study|Lost to Follow-up|4|||
146919486|NCT04160468|529866190|FG000|Overall Study|Randomized but not dosed|6|||
146919487|NCT04160468|529866191|FG001|Overall Study|Randomized but not dosed|0|||
146919488|NCT04160468|529866190|FG000|Overall Study|Withdrawal by Subject|4|||
146919489|NCT04160468|529866191|FG001|Overall Study|Withdrawal by Subject|1|||
146919490|NCT04160468|529866190|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
146919491|NCT04160468|529866191|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
146653345|NCT04391569|528908606|FG000|Overall Study|Lost to Follow-up|3|||
146919492|NCT04160468|529866190|FG000|Overall Study|Participant incarcerated|1|||
146593716|NCT00241631|528682201|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
146593717|NCT00241631|528682200|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
146593718|NCT00241631|528682201|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
146593719|NCT00413920|528682205|FG000|Overall Study|Adverse Event|9|||
146593720|NCT00413920|528682206|FG001|Overall Study|Adverse Event|11|||
146593721|NCT00413920|528682205|FG000|Overall Study|Lack of Efficacy|11|||
146593722|NCT00413920|528682206|FG001|Overall Study|Lack of Efficacy|9|||
146593723|NCT00413920|528682205|FG000|Overall Study|Death|3|||
146593724|NCT00413920|528682206|FG001|Overall Study|Death|5|||
146593725|NCT00413920|528682205|FG000|Overall Study|Graft Loss|5|||
146593726|NCT00413920|528682206|FG001|Overall Study|Graft Loss|3|||
146593727|NCT02788201|528682207|FG000|Overall Study|Death|1|||
146593728|NCT02788201|528682208|FG001|Overall Study|Death|1|||
146593729|NCT02788201|528682209|FG002|Overall Study|Death|1|||
146593730|NCT02788201|528682210|FG003|Overall Study|Death|1|||
146653346|NCT04391569|528908607|FG001|Overall Study|Lost to Follow-up|2|||
146653347|NCT04391569|528908606|FG000|Overall Study|Lack of Efficacy|0|||
146653348|NCT04391569|528908607|FG001|Overall Study|Lack of Efficacy|1|||
146653349|NCT04391569|528908606|FG000|Overall Study|Participant discharged to hospice facility|0|||
146653350|NCT04391569|528908607|FG001|Overall Study|Participant discharged to hospice facility|1|||
146653351|NCT04391569|528908606|FG000|Overall Study|Participant family decision|1|||
146653352|NCT04391569|528908607|FG001|Overall Study|Participant family decision|0|||
146653353|NCT04391569|528908606|FG000|Overall Study|Participant discharged prematurely|1|||
146653354|NCT04391569|528908607|FG001|Overall Study|Participant discharged prematurely|0|||
146653355|NCT02751931|528908608|FG000|Overall Study|Adverse Event|3|||
146653356|NCT02751931|528908609|FG001|Overall Study|Adverse Event|0|||
146653357|NCT02751931|528908608|FG000|Overall Study|Other: Miscelleneous|10|||
146653358|NCT02751931|528908609|FG001|Overall Study|Other: Miscelleneous|8|||
146653359|NCT05856760|528908610|FG000|Overall Study|Adverse Event|2|||
146653360|NCT05856760|528908610|FG000|Overall Study|Physician Decision|1|||
146653361|NCT05856760|528908610|FG000|Overall Study|Protocol Violation|1|||
146653362|NCT05856760|528908610|FG000|Overall Study|Withdrawal by Subject|3|||
146653363|NCT01892722|528908613|FG000|Overall Study|Protocol deviation|0|||
146653364|NCT01892722|528908614|FG001|Overall Study|Protocol deviation|1|||
146653365|NCT01892722|528908613|FG000|Overall Study|Administrative problems|0|||
146653366|NCT01892722|528908614|FG001|Overall Study|Administrative problems|1|||
146653367|NCT01892722|528908613|FG000|Overall Study|Patient/guardian decision|0|||
146653368|NCT01892722|528908614|FG001|Overall Study|Patient/guardian decision|2|||
146653369|NCT01892722|528908613|FG000|Overall Study|Physician Decision|1|||
146653370|NCT01892722|528908614|FG001|Overall Study|Physician Decision|2|||
146919493|NCT04160468|529866191|FG001|Overall Study|Participant incarcerated|0|||
146919494|NCT01402284|529866192|FG000|Overall Study|Withdrawal consent|2|||
146919495|NCT01402284|529866192|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
146653371|NCT01892722|528908613|FG000|Overall Study|Adverse Event|3|||
146919496|NCT01402284|529866192|FG000|Overall Study|Physician Decision|1|||
146919497|NCT01402284|529866192|FG000|Overall Study|Disease progression on study|10|||
146919498|NCT00540436|529866193|FG000|First 12-Week Treatment Period|Adverse Event|1|||
146919499|NCT00540436|529866193|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
146919500|NCT00540436|529866193|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
146919501|NCT00540436|529866193|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
146919502|NCT00905021|529866198|FG000|Overall Study|Adverse Event|2|||
146919503|NCT05281523|529866199|FG000|Overall Study|Adverse Event|1|||
146919504|NCT05281523|529866200|FG001|Overall Study|Adverse Event|1|||
146919505|NCT05281523|529866199|FG000|Overall Study|Physician Decision|1|||
146919506|NCT05281523|529866200|FG001|Overall Study|Physician Decision|1|||
146919507|NCT05281523|529866199|FG000|Overall Study|Withdrawal by Subject|5|||
146919508|NCT05281523|529866200|FG001|Overall Study|Withdrawal by Subject|15|||
146919509|NCT05281523|529866199|FG000|Overall Study|GCP violations|3|||
146919510|NCT05281523|529866200|FG001|Overall Study|GCP violations|4|||
146919511|NCT04038255|529867828|FG000|Overall Study|Lost to Follow-up|0|||
146919512|NCT04038255|529867829|FG001|Overall Study|Lost to Follow-up|9|||
146919513|NCT04038255|529867830|FG002|Overall Study|Lost to Follow-up|5|||
146919514|NCT04038255|529867828|FG000|Overall Study|Withdrawal by Subject|0|||
146919515|NCT04038255|529867829|FG001|Overall Study|Withdrawal by Subject|0|||
146919516|NCT04038255|529867830|FG002|Overall Study|Withdrawal by Subject|1|||
146919517|NCT05183867|529867831|FG000|Overall Study|Withdrawal by Subject|3|||
146593731|NCT02788201|528682211|FG004|Overall Study|Death|0|||
146653372|NCT01892722|528908614|FG001|Overall Study|Adverse Event|2|||
146653373|NCT01892722|528908613|FG000|Overall Study|Lack of Efficacy|0|||
146919518|NCT05183867|529867832|FG001|Overall Study|Withdrawal by Subject|2|||
146919519|NCT05183867|529867833|FG002|Overall Study|Withdrawal by Subject|0|||
146593732|NCT02788201|528682212|FG005|Overall Study|Death|1|||
146593733|NCT02788201|528682207|FG000|Overall Study|Ineligible|0|||
146593734|NCT02788201|528682208|FG001|Overall Study|Ineligible|0|||
146593735|NCT02788201|528682209|FG002|Overall Study|Ineligible|0|||
146653374|NCT01892722|528908614|FG001|Overall Study|Lack of Efficacy|7|||
146919520|NCT04491877|529867834|FG000|Overall Study|Protocol Deviation|1|||
146919521|NCT04491877|529867835|FG001|Overall Study|Protocol Deviation|0|||
146593736|NCT02788201|528682210|FG003|Overall Study|Ineligible|0|||
146593737|NCT02788201|528682211|FG004|Overall Study|Ineligible|0|||
146593738|NCT02788201|528682212|FG005|Overall Study|Ineligible|1|||
146593739|NCT02788201|528682207|FG000|Overall Study|Withdrawal by Subject|0|||
146593740|NCT02788201|528682208|FG001|Overall Study|Withdrawal by Subject|0|||
146593741|NCT02788201|528682209|FG002|Overall Study|Withdrawal by Subject|0|||
146593742|NCT02788201|528682210|FG003|Overall Study|Withdrawal by Subject|0|||
146593743|NCT02788201|528682211|FG004|Overall Study|Withdrawal by Subject|0|||
146653375|NCT01892722|528908613|FG000|Overall Study|Withdrawal by Subject|3|||
146653376|NCT01892722|528908614|FG001|Overall Study|Withdrawal by Subject|5|||
146653377|NCT05568888|528908615|FG000|Overall Study|Physician Decision|1|||
146653378|NCT05568888|528908616|FG001|Overall Study|Physician Decision|0|||
146653379|NCT05568888|528908615|FG000|Overall Study|Protocol Deviation|2|||
146653380|NCT05568888|528908616|FG001|Overall Study|Protocol Deviation|1|||
146653381|NCT05568888|528908615|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
146919522|NCT04491877|529867836|FG002|Overall Study|Protocol Deviation|2|||
146919523|NCT04491877|529867837|FG003|Overall Study|Protocol Deviation|0|||
146919524|NCT04491877|529867838|FG004|Overall Study|Protocol Deviation|0|||
146919525|NCT04491877|529867839|FG005|Overall Study|Protocol Deviation|0|||
146919526|NCT04491877|529867840|FG006|Overall Study|Protocol Deviation|1|||
146919527|NCT04491877|529867841|FG007|Overall Study|Protocol Deviation|1|||
146919528|NCT04491877|529867842|FG008|Overall Study|Protocol Deviation|0|||
146919529|NCT04491877|529867834|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146919530|NCT04491877|529867835|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146919531|NCT04491877|529867836|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146919532|NCT04491877|529867837|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
146919533|NCT04491877|529867838|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
146919534|NCT04491877|529867839|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
146919535|NCT04491877|529867840|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
146919536|NCT04491877|529867841|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
146919537|NCT04491877|529867842|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
146919538|NCT04491877|529867834|FG000|Overall Study|Lost to Follow-up|0|||
146919539|NCT04491877|529867835|FG001|Overall Study|Lost to Follow-up|2|||
146919540|NCT04491877|529867836|FG002|Overall Study|Lost to Follow-up|0|||
146919541|NCT04491877|529867837|FG003|Overall Study|Lost to Follow-up|0|||
146919542|NCT04491877|529867838|FG004|Overall Study|Lost to Follow-up|0|||
146919543|NCT04491877|529867839|FG005|Overall Study|Lost to Follow-up|0|||
146919544|NCT04491877|529867840|FG006|Overall Study|Lost to Follow-up|2|||
146919545|NCT04491877|529867841|FG007|Overall Study|Lost to Follow-up|1|||
146919546|NCT04491877|529867842|FG008|Overall Study|Lost to Follow-up|1|||
146919547|NCT01096446|529867848|FG000|Overall Study|Death|1|||
146919548|NCT01096446|529867849|FG001|Overall Study|Death|0|||
146919549|NCT01096446|529867848|FG000|Overall Study|Protocol Violation|2|||
146919550|NCT01096446|529867849|FG001|Overall Study|Protocol Violation|0|||
146919551|NCT00418834|529867852|FG000|Overall Study|Adverse Event|16|||
146919552|NCT00418834|529867853|FG001|Overall Study|Adverse Event|9|||
146919553|NCT00418834|529867852|FG000|Overall Study|Lost to Follow-up|0|||
146593744|NCT02788201|528682212|FG005|Overall Study|Withdrawal by Subject|1|||
146593745|NCT01852825|528682213|FG000|Overall Study|Withdrawal by Subject|2|||
146593746|NCT01852825|528682214|FG001|Overall Study|Withdrawal by Subject|0|||
146593747|NCT01852825|528682215|FG002|Overall Study|Withdrawal by Subject|0|||
146593748|NCT03421743|528682220|FG000|Overall Study|Lack of Efficacy|1|||
146593749|NCT03421743|528682221|FG001|Overall Study|Lack of Efficacy|0|||
146593750|NCT03421743|528682220|FG000|Overall Study|Adverse Event|2|||
146593751|NCT03421743|528682221|FG001|Overall Study|Adverse Event|1|||
146593752|NCT03421743|528682220|FG000|Overall Study|Withdrawal by Subject|0|||
146593753|NCT03421743|528682221|FG001|Overall Study|Withdrawal by Subject|1|||
146593754|NCT01457950|528682222|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
146593755|NCT01457950|528682223|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
146919554|NCT00418834|529867853|FG001|Overall Study|Lost to Follow-up|1|||
146593756|NCT01457950|528682224|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
146593757|NCT01457950|528682225|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
146593758|NCT01457950|528682222|FG000|Double-Blind Phase|Protocol Violation|2|||
146593759|NCT01457950|528682223|FG001|Double-Blind Phase|Protocol Violation|1|||
146919555|NCT00418834|529867852|FG000|Overall Study|Protocol Violation|4|||
146919556|NCT00418834|529867853|FG001|Overall Study|Protocol Violation|3|||
146919557|NCT00418834|529867852|FG000|Overall Study|Withdrawal by Subject|3|||
146919558|NCT00418834|529867853|FG001|Overall Study|Withdrawal by Subject|7|||
146919559|NCT01953328|529867854|FG000|Overall Study|Withdrawal by Subject|0|||
146919560|NCT01953328|529867855|FG001|Overall Study|Withdrawal by Subject|0|||
146593760|NCT01457950|528682224|FG002|Double-Blind Phase|Protocol Violation|0|||
146653382|NCT05568888|528908616|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
146653383|NCT05568888|528908615|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
146919561|NCT01953328|529867856|FG002|Overall Study|Withdrawal by Subject|0|||
146919562|NCT01953328|529867857|FG003|Overall Study|Withdrawal by Subject|0|||
146919563|NCT01953328|529867858|FG004|Overall Study|Withdrawal by Subject|1|||
146593761|NCT01457950|528682225|FG003|Double-Blind Phase|Protocol Violation|0|||
146593762|NCT01457950|528682222|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
146593763|NCT01457950|528682223|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
146593764|NCT01457950|528682224|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
146593765|NCT01457950|528682225|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
146593766|NCT01457950|528682222|FG000|Open-Label Phase|Adverse Event|0|||
146593767|NCT01457950|528682223|FG001|Open-Label Phase|Adverse Event|0|||
146593768|NCT01457950|528682224|FG002|Open-Label Phase|Adverse Event|0|||
146593769|NCT01457950|528682225|FG003|Open-Label Phase|Adverse Event|1|||
146593770|NCT01457950|528682222|FG000|Open-Label Phase|Protocol Violation|0|||
146593771|NCT01457950|528682223|FG001|Open-Label Phase|Protocol Violation|0|||
146593772|NCT01457950|528682224|FG002|Open-Label Phase|Protocol Violation|0|||
146593773|NCT01457950|528682225|FG003|Open-Label Phase|Protocol Violation|1|||
146593774|NCT01457950|528682222|FG000|Open-Label Phase|Withdrawal by Subject|0|||
146593775|NCT01457950|528682223|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146593776|NCT01457950|528682224|FG002|Open-Label Phase|Withdrawal by Subject|2|||
146593777|NCT01457950|528682225|FG003|Open-Label Phase|Withdrawal by Subject|0|||
146593778|NCT01765426|528682226|FG000|Overall Study|Lost to Follow-up|0|||
146593779|NCT01765426|528682227|FG001|Overall Study|Lost to Follow-up|1|||
146593780|NCT01765426|528682228|FG002|Overall Study|Lost to Follow-up|0|||
146593781|NCT01765426|528682229|FG003|Overall Study|Lost to Follow-up|0|||
146593782|NCT01166373|528682230|FG000|Overall Study|Lost to Follow-up|3|||
146593783|NCT01166373|528682231|FG001|Overall Study|Lost to Follow-up|2|||
146593784|NCT01166373|528682232|FG002|Overall Study|Lost to Follow-up|2|||
146593785|NCT01166373|528682233|FG003|Overall Study|Lost to Follow-up|2|||
146593786|NCT01166373|528682230|FG000|Overall Study|Withdrawal by Subject|1|||
146593787|NCT01166373|528682231|FG001|Overall Study|Withdrawal by Subject|2|||
146593788|NCT01166373|528682232|FG002|Overall Study|Withdrawal by Subject|2|||
146593789|NCT01166373|528682233|FG003|Overall Study|Withdrawal by Subject|3|||
146593790|NCT01166373|528682230|FG000|Overall Study|Physician Decision|1|||
146593791|NCT01166373|528682231|FG001|Overall Study|Physician Decision|0|||
146593792|NCT01166373|528682232|FG002|Overall Study|Physician Decision|0|||
146593793|NCT01166373|528682233|FG003|Overall Study|Physician Decision|0|||
146593794|NCT01510184|528682234|FG000|Overall Study|Sponsor discretion|28|||
146593795|NCT01510184|528682235|FG001|Overall Study|Sponsor discretion|28|||
146593796|NCT01510184|528682234|FG000|Overall Study|Death|1|||
146593797|NCT01510184|528682235|FG001|Overall Study|Death|2|||
146593798|NCT01510184|528682234|FG000|Overall Study|Withdrawal by Subject|1|||
146593799|NCT01510184|528682235|FG001|Overall Study|Withdrawal by Subject|4|||
146593800|NCT01510184|528682234|FG000|Overall Study|Other|0|||
146593801|NCT01510184|528682235|FG001|Overall Study|Other|1|||
146593802|NCT02310230|528682236|FG000|Overall Study|Physician Decision|1|||
146593803|NCT02310230|528682237|FG001|Overall Study|Physician Decision|3|||
146593804|NCT02310230|528682236|FG000|Overall Study|monitor baseline taken after induction|2|||
146593805|NCT02310230|528682237|FG001|Overall Study|monitor baseline taken after induction|7|||
146593806|NCT02310230|528682236|FG000|Overall Study|Poor signal quality|5|||
146593807|NCT02310230|528682237|FG001|Overall Study|Poor signal quality|8|||
146593808|NCT02310230|528682236|FG000|Overall Study|Case cancelled|1|||
146593809|NCT02310230|528682237|FG001|Overall Study|Case cancelled|0|||
146593810|NCT03593681|528682241|FG000|Overall Study|Inadequate sample collected|12|||
146593811|NCT03593681|528682241|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
146593812|NCT03593681|528682241|FG000|Overall Study|Protocol Violation|3|||
146593813|NCT03593681|528682241|FG000|Overall Study|Withdrawal by Subject|3|||
146593814|NCT03593681|528682241|FG000|Overall Study|Procedure not attempted|3|||
146593815|NCT03593681|528682241|FG000|Overall Study|Adverse Event|2|||
146593816|NCT03593681|528682241|FG000|Overall Study|Physician Decision|1|||
146593817|NCT02078102|528682242|FG000|Overall Study|Adverse Event|1|||
146593818|NCT02078102|528682243|FG001|Overall Study|Adverse Event|0|||
146593819|NCT02078102|528682242|FG000|Overall Study|Withdrawal by Subject|1|||
146593820|NCT02078102|528682243|FG001|Overall Study|Withdrawal by Subject|0|||
146593821|NCT02078102|528682242|FG000|Overall Study|Physician Decision|0|||
146593822|NCT02078102|528682243|FG001|Overall Study|Physician Decision|1|||
146593823|NCT02370641|528682246|FG000|Overall Study|dropped study|4|||
146593824|NCT02370641|528682247|FG001|Overall Study|dropped study|2|||
146593825|NCT05291936|528682251|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
146593826|NCT05291936|528682252|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
146593827|NCT05291936|528682251|FG000|Period 1|Withdrew Consent during study|1|||
146593828|NCT05291936|528682252|FG001|Period 1|Withdrew Consent during study|0|||
146593829|NCT05291936|528682251|FG000|Period 2|Adverse Event|0|||
146593830|NCT05291936|528682252|FG001|Period 2|Adverse Event|1|||
146593831|NCT05291936|528682251|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
146593832|NCT05291936|528682252|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
146653384|NCT05568888|528908616|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
146593833|NCT02436408|528682257|FG000|Overall Study|Death|1|||
146593834|NCT01154283|528682258|FG000|0-6 Weeks|Withdrawal by Subject|7|||
146593835|NCT01154283|528682259|FG001|0-6 Weeks|Withdrawal by Subject|2|||
146593836|NCT01154283|528682258|FG000|0-6 Weeks|Death|0|||
146593837|NCT01154283|528682259|FG001|0-6 Weeks|Death|1|||
146593838|NCT01154283|528682258|FG000|7-12 Weeks|Death|1|||
146653385|NCT05568888|528908615|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
146653386|NCT05568888|528908616|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
146653387|NCT02477696|528908619|FG000|Overall Study|Death|89|||
146653388|NCT02477696|528908620|FG001|Overall Study|Death|106|||
146653389|NCT02477696|528908619|FG000|Overall Study|Lost to Follow-up|7|||
146653390|NCT02477696|528908620|FG001|Overall Study|Lost to Follow-up|5|||
146653391|NCT02477696|528908619|FG000|Overall Study|Withdrawal by Subject|37|||
146653392|NCT02477696|528908620|FG001|Overall Study|Withdrawal by Subject|34|||
146653393|NCT02477696|528908619|FG000|Overall Study|Physician Decision|7|||
146653394|NCT02477696|528908620|FG001|Overall Study|Physician Decision|9|||
146653395|NCT02477696|528908619|FG000|Overall Study|Study terminated by sponsor|103|||
146653396|NCT02477696|528908620|FG001|Overall Study|Study terminated by sponsor|99|||
146771438|NCT00159783|529331208|FG001|Overall Study|Adverse Event|7|||
146771439|NCT00159783|529331209|FG002|Overall Study|Adverse Event|9|||
146919564|NCT01953328|529867859|FG005|Overall Study|Withdrawal by Subject|0|||
146919565|NCT01953328|529867860|FG006|Overall Study|Withdrawal by Subject|0|||
146919566|NCT01953328|529867861|FG007|Overall Study|Withdrawal by Subject|0|||
146919567|NCT01953328|529867854|FG000|Overall Study|Lost to Follow-up|0|||
146919568|NCT01953328|529867855|FG001|Overall Study|Lost to Follow-up|0|||
146919569|NCT01953328|529867856|FG002|Overall Study|Lost to Follow-up|0|||
146919570|NCT01953328|529867857|FG003|Overall Study|Lost to Follow-up|0|||
146919571|NCT01953328|529867858|FG004|Overall Study|Lost to Follow-up|1|||
146919572|NCT01953328|529867859|FG005|Overall Study|Lost to Follow-up|0|||
146919573|NCT01953328|529867860|FG006|Overall Study|Lost to Follow-up|0|||
146919574|NCT01953328|529867861|FG007|Overall Study|Lost to Follow-up|0|||
146919575|NCT00492856|529867865|FG000|Induction|Adverse Event|2|||
146919576|NCT00492856|529867866|FG001|Induction|Adverse Event|0|||
146919577|NCT00492856|529867867|FG002|Induction|Adverse Event|0|||
146919578|NCT00492856|529867868|FG003|Induction|Adverse Event|0|||
146919579|NCT00492856|529867865|FG000|Induction|Withdrawal by Subject|1|||
146919580|NCT00492856|529867866|FG001|Induction|Withdrawal by Subject|0|||
146919581|NCT00492856|529867867|FG002|Induction|Withdrawal by Subject|0|||
146919582|NCT00492856|529867868|FG003|Induction|Withdrawal by Subject|0|||
146919583|NCT00492856|529867865|FG000|Induction|Death|3|||
146919584|NCT00492856|529867866|FG001|Induction|Death|0|||
146919585|NCT00492856|529867867|FG002|Induction|Death|0|||
146919586|NCT00492856|529867868|FG003|Induction|Death|0|||
146919587|NCT00492856|529867865|FG000|Consolidation|Adverse Event|6|||
146919588|NCT00492856|529867866|FG001|Consolidation|Adverse Event|0|||
146919589|NCT00492856|529867867|FG002|Consolidation|Adverse Event|0|||
146919590|NCT00492856|529867868|FG003|Consolidation|Adverse Event|0|||
146919591|NCT00492856|529867865|FG000|Consolidation|Not protocol specified|2|||
146919592|NCT00492856|529867866|FG001|Consolidation|Not protocol specified|0|||
146919593|NCT00492856|529867867|FG002|Consolidation|Not protocol specified|0|||
146919594|NCT00492856|529867868|FG003|Consolidation|Not protocol specified|0|||
146919595|NCT00492856|529867865|FG000|Consolidation|Lost to Follow-up|1|||
146919596|NCT00492856|529867866|FG001|Consolidation|Lost to Follow-up|0|||
146919597|NCT00492856|529867867|FG002|Consolidation|Lost to Follow-up|0|||
146919598|NCT00492856|529867868|FG003|Consolidation|Lost to Follow-up|0|||
146919599|NCT00492856|529867865|FG000|Post-consolidation|Adverse Event|0|||
146919600|NCT00492856|529867866|FG001|Post-consolidation|Adverse Event|4|||
146919601|NCT00492856|529867867|FG002|Post-consolidation|Adverse Event|0|||
146919602|NCT00492856|529867868|FG003|Post-consolidation|Adverse Event|1|||
146919603|NCT00492856|529867865|FG000|Post-consolidation|Withdrawal by Subject|0|||
146653397|NCT02477696|528908619|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
146653398|NCT02477696|528908620|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
146653399|NCT02477696|528908619|FG000|Overall Study|Missing/Unknown|2|||
146653400|NCT02477696|528908620|FG001|Overall Study|Missing/Unknown|0|||
146653401|NCT04153149|528908623|FG000|Double Blind Period|Death|63|||
146653402|NCT04153149|528908624|FG001|Double Blind Period|Death|49|||
146653403|NCT04153149|528908625|FG002|Double Blind Period|Death|0|||
146653404|NCT04153149|528908626|FG003|Double Blind Period|Death|0|||
146653405|NCT04153149|528908623|FG000|Double Blind Period|Withdrawal by Subject|16|||
146771440|NCT00159783|529331207|FG000|Overall Study|Lack of Efficacy|1|||
146771441|NCT00159783|529331208|FG001|Overall Study|Lack of Efficacy|2|||
146919604|NCT00492856|529867866|FG001|Post-consolidation|Withdrawal by Subject|4|||
146919605|NCT00492856|529867867|FG002|Post-consolidation|Withdrawal by Subject|0|||
146919606|NCT00492856|529867868|FG003|Post-consolidation|Withdrawal by Subject|0|||
146919607|NCT00492856|529867865|FG000|Post-consolidation|Death|0|||
146919608|NCT00492856|529867866|FG001|Post-consolidation|Death|1|||
146919609|NCT00492856|529867867|FG002|Post-consolidation|Death|0|||
146919610|NCT00492856|529867868|FG003|Post-consolidation|Death|0|||
146919611|NCT00492856|529867865|FG000|Post-consolidation|Not protocol specified|0|||
146653406|NCT04153149|528908624|FG001|Double Blind Period|Withdrawal by Subject|11|||
146653407|NCT04153149|528908625|FG002|Double Blind Period|Withdrawal by Subject|0|||
146771442|NCT00159783|529331209|FG002|Overall Study|Lack of Efficacy|3|||
146771443|NCT00159783|529331207|FG000|Overall Study|Withdrawal by Subject|7|||
146653408|NCT04153149|528908626|FG003|Double Blind Period|Withdrawal by Subject|0|||
146919612|NCT00492856|529867866|FG001|Post-consolidation|Not protocol specified|1|||
146919613|NCT00492856|529867867|FG002|Post-consolidation|Not protocol specified|0|||
146593839|NCT01154283|528682259|FG001|7-12 Weeks|Death|0|||
146593840|NCT01154283|528682258|FG000|7-12 Weeks|Withdrawal by Subject|0|||
146593841|NCT01154283|528682259|FG001|7-12 Weeks|Withdrawal by Subject|1|||
146593842|NCT00042432|528682260|FG000|Overall Study|Adverse Event|4|||
146593843|NCT00042432|528682261|FG001|Overall Study|Adverse Event|1|||
146593844|NCT00042432|528682260|FG000|Overall Study|Withdrawal by Subject|1|||
146593845|NCT00042432|528682261|FG001|Overall Study|Withdrawal by Subject|3|||
146593846|NCT00042432|528682260|FG000|Overall Study|Death|0|||
146593847|NCT00042432|528682261|FG001|Overall Study|Death|2|||
146593848|NCT00042432|528682260|FG000|Overall Study|Ineligibility determined|1|||
146653409|NCT04153149|528908623|FG000|Double Blind Period|Adverse Event|6|||
146653410|NCT04153149|528908624|FG001|Double Blind Period|Adverse Event|2|||
146653411|NCT04153149|528908625|FG002|Double Blind Period|Adverse Event|0|||
146653412|NCT04153149|528908626|FG003|Double Blind Period|Adverse Event|0|||
146653413|NCT04153149|528908623|FG000|Double Blind Period|Lost to Follow-up|2|||
146653414|NCT04153149|528908624|FG001|Double Blind Period|Lost to Follow-up|1|||
146653415|NCT04153149|528908625|FG002|Double Blind Period|Lost to Follow-up|0|||
146653416|NCT04153149|528908626|FG003|Double Blind Period|Lost to Follow-up|0|||
146653417|NCT04153149|528908623|FG000|Double Blind Period|Withdrawal by guardian|0|||
146653418|NCT04153149|528908624|FG001|Double Blind Period|Withdrawal by guardian|2|||
146653419|NCT04153149|528908625|FG002|Double Blind Period|Withdrawal by guardian|0|||
146653420|NCT04153149|528908626|FG003|Double Blind Period|Withdrawal by guardian|0|||
146653421|NCT04153149|528908623|FG000|Double Blind Period|Reason Not Specified|5|||
146653422|NCT04153149|528908624|FG001|Double Blind Period|Reason Not Specified|4|||
146653423|NCT04153149|528908625|FG002|Double Blind Period|Reason Not Specified|0|||
146653424|NCT04153149|528908626|FG003|Double Blind Period|Reason Not Specified|0|||
146653425|NCT04153149|528908623|FG000|Double Blind Period|Physician Decision|2|||
146653426|NCT04153149|528908624|FG001|Double Blind Period|Physician Decision|0|||
146653427|NCT04153149|528908625|FG002|Double Blind Period|Physician Decision|0|||
146653428|NCT04153149|528908626|FG003|Double Blind Period|Physician Decision|0|||
146653429|NCT04153149|528908623|FG000|Open Label Extension Period|Death|0|||
146653430|NCT04153149|528908624|FG001|Open Label Extension Period|Death|0|||
146653431|NCT04153149|528908625|FG002|Open Label Extension Period|Death|7|||
146653432|NCT04153149|528908626|FG003|Open Label Extension Period|Death|3|||
146653433|NCT04153149|528908623|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
146653434|NCT04153149|528908624|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
146653435|NCT04153149|528908625|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
146653436|NCT04153149|528908626|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
146653437|NCT04153149|528908623|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
146653438|NCT04153149|528908624|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
146653439|NCT04153149|528908625|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
146653440|NCT04153149|528908626|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
146653441|NCT04153149|528908623|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
146653442|NCT04153149|528908624|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
146653443|NCT04153149|528908625|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
146653444|NCT04153149|528908626|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
146653445|NCT02003365|528908988|FG000|Overall Study|Lost to Follow-up|0|||
146653446|NCT02003365|528908989|FG001|Overall Study|Lost to Follow-up|0|||
146653447|NCT02003365|528908990|FG002|Overall Study|Lost to Follow-up|1|||
146653448|NCT00625742|528908991|FG000|Overall Study|Disease Progression|2|||
146653449|NCT00625742|528908991|FG000|Overall Study|Withdrawal by Subject|1|||
146653450|NCT00625742|528908991|FG000|Overall Study|Adverse Event|4|||
146653451|NCT00625742|528908991|FG000|Overall Study|Lost to Follow-up|4|||
146653452|NCT00625742|528908991|FG000|Overall Study|Ineligible|1|||
146653453|NCT00371761|528908992|FG000|Overall Study|Adverse Event|1|||
146653454|NCT00371761|528908993|FG001|Overall Study|Adverse Event|1|||
146653455|NCT00371761|528908992|FG000|Overall Study|Withdrawal by Subject|1|||
146653456|NCT00371761|528908993|FG001|Overall Study|Withdrawal by Subject|3|||
146653457|NCT00371761|528908992|FG000|Overall Study|Investigator Judgment|2|||
146653458|NCT00371761|528908993|FG001|Overall Study|Investigator Judgment|3|||
146653459|NCT00371761|528908992|FG000|Overall Study|Study termination|4|||
146653460|NCT00371761|528908993|FG001|Overall Study|Study termination|3|||
146919614|NCT00492856|529867868|FG003|Post-consolidation|Not protocol specified|0|||
146919615|NCT00492856|529867865|FG000|Post-consolidation|Lost to Follow-up|0|||
146593849|NCT00042432|528682261|FG001|Overall Study|Ineligibility determined|0|||
146653461|NCT03675321|528908995|FG000|Overall Study|Lack of Efficacy|2|||
146653462|NCT03675321|528908996|FG001|Overall Study|Lack of Efficacy|2|||
146653463|NCT03675321|528908995|FG000|Overall Study|Withdrawal by Subject|1|||
146653464|NCT03675321|528908996|FG001|Overall Study|Withdrawal by Subject|3|||
146653465|NCT05040971|528908997|FG000|Overall Study|Withdrawal by Subject|0|||
146593850|NCT00042432|528682260|FG000|Overall Study|Initiation of maintenance dialysis|1|||
146653466|NCT05040971|528908998|FG001|Overall Study|Withdrawal by Subject|2|||
146653467|NCT05040971|528908997|FG000|Overall Study|Lost to Follow-up|8|||
146653468|NCT05040971|528908998|FG001|Overall Study|Lost to Follow-up|3|||
146593851|NCT00042432|528682261|FG001|Overall Study|Initiation of maintenance dialysis|1|||
146593852|NCT00042432|528682260|FG000|Overall Study|Other|2|||
146593853|NCT00042432|528682261|FG001|Overall Study|Other|0|||
146593854|NCT00320372|528682262|FG000|Overall Study|Physician Decision|4|||
146593855|NCT00320372|528682263|FG001|Overall Study|Physician Decision|7|||
146593856|NCT00320372|528682262|FG000|Overall Study|Death|7|||
146593857|NCT00320372|528682263|FG001|Overall Study|Death|8|||
146593858|NCT00320372|528682262|FG000|Overall Study|Withdrawal by Subject|55|||
146593859|NCT00320372|528682263|FG001|Overall Study|Withdrawal by Subject|37|||
146593860|NCT00320372|528682262|FG000|Overall Study|Non-Compliance|40|||
146593861|NCT00320372|528682263|FG001|Overall Study|Non-Compliance|39|||
146593862|NCT00320372|528682262|FG000|Overall Study|Did not Meet (I/E)|3|||
146593863|NCT00320372|528682263|FG001|Overall Study|Did not Meet (I/E)|1|||
146593864|NCT00320372|528682262|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
146593865|NCT00320372|528682263|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
146593866|NCT01853072|528682264|FG000|Overall Study|Adverse event prior to treatment|0|||
146593867|NCT01853072|528682265|FG001|Overall Study|Adverse event prior to treatment|1|||
146593868|NCT01853072|528682264|FG000|Overall Study|Adverse Event|0|||
146593869|NCT01853072|528682265|FG001|Overall Study|Adverse Event|3|||
146919616|NCT00492856|529867866|FG001|Post-consolidation|Lost to Follow-up|2|||
146919617|NCT00492856|529867867|FG002|Post-consolidation|Lost to Follow-up|0|||
146919618|NCT00492856|529867868|FG003|Post-consolidation|Lost to Follow-up|0|||
146919619|NCT00492856|529867865|FG000|Post-consolidation|Observation Arm|0|||
146919620|NCT00492856|529867866|FG001|Post-consolidation|Observation Arm|0|||
146919621|NCT00492856|529867867|FG002|Post-consolidation|Observation Arm|27|||
146919622|NCT00492856|529867868|FG003|Post-consolidation|Observation Arm|0|||
146919623|NCT00748553|529867873|FG000|Overall Study|Adverse Event|0|||
146919624|NCT00748553|529867874|FG001|Overall Study|Adverse Event|1|||
146919625|NCT00748553|529867873|FG000|Overall Study|disease progression|2|||
146919626|NCT00748553|529867874|FG001|Overall Study|disease progression|0|||
146919627|NCT00748553|529867873|FG000|Overall Study|noncompliance|1|||
146919628|NCT00748553|529867874|FG001|Overall Study|noncompliance|0|||
146919629|NCT01251276|529867877|FG000|Overall Study|Protocol Violation|1|||
146919630|NCT01251276|529867878|FG001|Overall Study|Protocol Violation|0|||
146919631|NCT01251276|529867877|FG000|Overall Study|Lost to Follow-up|0|||
146919632|NCT01251276|529867878|FG001|Overall Study|Lost to Follow-up|1|||
146919633|NCT02245568|529867879|FG000|Overall Study|Study terminated by Sponsor|346|||
146919634|NCT02245568|529867879|FG000|Overall Study|Adverse Event|144|||
146919635|NCT02245568|529867879|FG000|Overall Study|Lack of Efficacy|98|||
146919636|NCT02245568|529867879|FG000|Overall Study|Withdrawal by Caregiver|85|||
146919637|NCT02245568|529867879|FG000|Overall Study|Withdrawal by Subject|77|||
146919638|NCT02245568|529867879|FG000|Overall Study|Withdrawal by Legal Representative|31|||
146919639|NCT02245568|529867879|FG000|Overall Study|Missing (Site closure)|16|||
146919640|NCT02245568|529867879|FG000|Overall Study|Physician Decision|14|||
146919641|NCT02245568|529867879|FG000|Overall Study|Non-compliance with study drug|11|||
146919642|NCT02245568|529867879|FG000|Overall Study|Death|9|||
146919643|NCT02245568|529867879|FG000|Overall Study|Blue staining|6|||
146919644|NCT02245568|529867879|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
146919645|NCT02245568|529867879|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
146919646|NCT02245568|529867879|FG000|Overall Study|Lost to Follow-up|5|||
146919647|NCT03628417|529867880|FG000|Overall Study|Death|1|||
146919648|NCT03628417|529867881|FG001|Overall Study|Death|1|||
146919649|NCT05619172|529867885|FG000|Safety Cohort 1|Death|7|||
146919650|NCT05619172|529867886|FG001|Safety Cohort 1|Death|0|||
146919651|NCT05619172|529867885|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
146919652|NCT05619172|529867886|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
146919653|NCT05619172|529867885|FG000|Safety Cohort 2|Death|0|||
146919654|NCT05619172|529867886|FG001|Safety Cohort 2|Death|1|||
146919655|NCT05619172|529867885|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
146919656|NCT05619172|529867886|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
146919657|NCT00769704|529867888|FG000|Overall Study|Lost to Follow-up|3|||
146919658|NCT00769704|529867889|FG001|Overall Study|Lost to Follow-up|2|||
146919659|NCT00769704|529867888|FG000|Overall Study|Death|95|||
146919660|NCT00769704|529867889|FG001|Overall Study|Death|190|||
146919661|NCT00769704|529867888|FG000|Overall Study|Withdrawal by Subject|12|||
146919662|NCT00769704|529867889|FG001|Overall Study|Withdrawal by Subject|5|||
146919663|NCT00769704|529867888|FG000|Overall Study|Other|1|||
146919664|NCT00769704|529867889|FG001|Overall Study|Other|2|||
146919665|NCT00450372|529867890|FG000|Overall Study|Physician Decision|1|||
146919666|NCT05131451|529867891|FG000|Overall Study|Protocol Violation|1|||
146919667|NCT05131451|529867892|FG001|Overall Study|Protocol Violation|0|||
146919668|NCT01856595|529867897|FG000|Overall Study|Withdrawal by Subject|0|||
146593870|NCT01853072|528682264|FG000|Overall Study|Death|1|||
146593871|NCT01853072|528682265|FG001|Overall Study|Death|4|||
146593872|NCT01853072|528682264|FG000|Overall Study|Lost to Follow-up|0|||
146593873|NCT01853072|528682265|FG001|Overall Study|Lost to Follow-up|3|||
146593874|NCT01853072|528682264|FG000|Overall Study|Non-compliance with study drug|0|||
146919669|NCT01856595|529867898|FG001|Overall Study|Withdrawal by Subject|1|||
146919670|NCT01856595|529867899|FG002|Overall Study|Withdrawal by Subject|0|||
146978436|NCT02764489|530084061|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
146978437|NCT02764489|530084062|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
146978438|NCT02764489|530084061|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
146978439|NCT02764489|530084062|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
146978440|NCT02764489|530084061|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
146978441|NCT02764489|530084062|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
146978442|NCT03840811|530084063|FG000|Overall Study|Lost to Follow-up|0|||
146978443|NCT03840811|530084064|FG001|Overall Study|Lost to Follow-up|0|||
146978444|NCT03840811|530084065|FG002|Overall Study|Lost to Follow-up|1|||
146653469|NCT05040971|528908997|FG000|Overall Study|Death|2|||
146653470|NCT05040971|528908998|FG001|Overall Study|Death|0|||
146653471|NCT00773838|528909020|FG000|Overall Study|Adverse Event|29|||
146653472|NCT00773838|528909020|FG000|Overall Study|Lost to Follow-up|1|||
146653473|NCT00773838|528909020|FG000|Overall Study|Physician Decision|8|||
146653474|NCT00773838|528909020|FG000|Overall Study|Progressive Disease|82|||
146653475|NCT00773838|528909020|FG000|Overall Study|Protocol Violation|2|||
146653476|NCT00773838|528909020|FG000|Overall Study|Withdrawal by Subject|21|||
146653477|NCT01589770|528909022|FG000|Overall Study|EGFR <60ml/min|6|||
146653478|NCT01589770|528909023|FG001|Overall Study|EGFR <60ml/min|4|||
146919671|NCT01856595|529867900|FG003|Overall Study|Withdrawal by Subject|0|||
146919672|NCT01856595|529867901|FG004|Overall Study|Withdrawal by Subject|0|||
146919673|NCT01856595|529867902|FG005|Overall Study|Withdrawal by Subject|0|||
146919674|NCT01856595|529867903|FG006|Overall Study|Withdrawal by Subject|1|||
146919675|NCT01856595|529867904|FG007|Overall Study|Withdrawal by Subject|0|||
146919676|NCT01856595|529867905|FG008|Overall Study|Withdrawal by Subject|0|||
146919677|NCT06150573|529867910|FG000|Overall Study|Did not meet study criteria|1|||
146919678|NCT06150573|529867911|FG001|Overall Study|Did not meet study criteria|0|||
146919679|NCT06150573|529867910|FG000|Overall Study|Adverse Event|1|||
146919680|NCT06150573|529867911|FG001|Overall Study|Adverse Event|0|||
146919681|NCT06150573|529867910|FG000|Overall Study|Lost to Follow-up|0|||
146919682|NCT06150573|529867911|FG001|Overall Study|Lost to Follow-up|1|||
146919683|NCT06150573|529867910|FG000|Overall Study|Protocol Violation|0|||
146919684|NCT06150573|529867911|FG001|Overall Study|Protocol Violation|1|||
146919685|NCT06150573|529867910|FG000|Overall Study|Withdrawal by Subject|2|||
146919686|NCT06150573|529867911|FG001|Overall Study|Withdrawal by Subject|0|||
146919687|NCT02284906|529867916|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
146919688|NCT02284906|529867917|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
146919689|NCT02284906|529867918|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
146919690|NCT02284906|529867916|FG000|Overall Study|Major Protocol Deviation|0|||
146919691|NCT02284906|529867917|FG001|Overall Study|Major Protocol Deviation|1|||
146919692|NCT02284906|529867918|FG002|Overall Study|Major Protocol Deviation|0|||
146919693|NCT02284906|529867916|FG000|Overall Study|Voluntary Withdrawal|2|||
146919694|NCT02284906|529867917|FG001|Overall Study|Voluntary Withdrawal|4|||
146919695|NCT02284906|529867918|FG002|Overall Study|Voluntary Withdrawal|5|||
146919696|NCT02284906|529867916|FG000|Overall Study|Study Termination|0|||
146919697|NCT02284906|529867917|FG001|Overall Study|Study Termination|11|||
146919698|NCT02284906|529867918|FG002|Overall Study|Study Termination|14|||
146919699|NCT02284906|529867916|FG000|Overall Study|Reason not Specified|1|||
146919700|NCT02284906|529867917|FG001|Overall Study|Reason not Specified|1|||
146919701|NCT02284906|529867918|FG002|Overall Study|Reason not Specified|0|||
146919702|NCT02575079|529867919|FG000|Overall Study|Death|3|||
146919703|NCT02575079|529867920|FG001|Overall Study|Death|0|||
146919704|NCT02575079|529867919|FG000|Overall Study|Withdrawal by Subject|3|||
146919705|NCT02575079|529867920|FG001|Overall Study|Withdrawal by Subject|0|||
146653479|NCT01589770|528909022|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
146653480|NCT01589770|528909023|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
146653481|NCT02283177|528909026|FG000|Overall Study|Withdrawal by Subject|1|||
146653482|NCT02283177|528909027|FG001|Overall Study|Withdrawal by Subject|1|||
146653483|NCT01101191|528909028|FG000|Period 1|Withdrawal by Subject|1|||
146653484|NCT01101191|528909029|FG001|Period 1|Withdrawal by Subject|0|||
146653485|NCT01101191|528909028|FG000|Period 1|Adverse Event|1|||
146653486|NCT01101191|528909029|FG001|Period 1|Adverse Event|2|||
146919706|NCT01087528|529867921|FG000|Overall Study|Withdrawal by Subject|1|||
146919707|NCT01087528|529867921|FG000|Overall Study|Incomplete CE procedure|6|||
146653487|NCT00811642|528909037|FG000|Overall Study|Adverse Event|3|||
146653488|NCT00811642|528909037|FG000|Overall Study|Protocol Violation|1|||
146919708|NCT05692154|529867924|FG000|Overall Study|Adverse Event|0|||
146919709|NCT05692154|529867925|FG001|Overall Study|Adverse Event|1|||
146919710|NCT04285346|529867930|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
146919711|NCT04285346|529867931|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
146978445|NCT01904383|530084066|FG000|Overall Study|CRF not collected|117|||
146919712|NCT04285346|529867930|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
146919713|NCT04285346|529867931|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
146978446|NCT01904383|530084066|FG000|Overall Study|Reason not listed|147|||
146978447|NCT01904383|530084066|FG000|Overall Study|Lost to Follow-up|674|||
146653489|NCT00811642|528909037|FG000|Overall Study|Death|2|||
146653490|NCT00811642|528909037|FG000|Overall Study|Withdrawal by Subject|7|||
146919714|NCT04285346|529867930|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
146593875|NCT01853072|528682265|FG001|Overall Study|Non-compliance with study drug|1|||
146593876|NCT01853072|528682264|FG000|Overall Study|Physician Decision|1|||
146593877|NCT01853072|528682265|FG001|Overall Study|Physician Decision|1|||
146593878|NCT01853072|528682264|FG000|Overall Study|Withdrawal by Subject|1|||
146593879|NCT01853072|528682265|FG001|Overall Study|Withdrawal by Subject|2|||
146593880|NCT01853072|528682264|FG000|Overall Study|Reason not specified|9|||
146593881|NCT01853072|528682265|FG001|Overall Study|Reason not specified|6|||
146593882|NCT01287221|528682266|FG000|Overall Study|Lack of Perceived Benefit|1|||
146593883|NCT01287221|528682267|FG001|Overall Study|Lack of Perceived Benefit|1|||
146593884|NCT01287221|528682266|FG000|Overall Study|Adverse Event|3|||
146593885|NCT01287221|528682267|FG001|Overall Study|Adverse Event|3|||
146593886|NCT01287221|528682266|FG000|Overall Study|Withdrawal by Subject|0|||
146593887|NCT01287221|528682267|FG001|Overall Study|Withdrawal by Subject|1|||
146593888|NCT02761694|528682279|FG000|Overall Study|Lack of Efficacy|0|||
146593889|NCT02761694|528682280|FG001|Overall Study|Lack of Efficacy|0|||
146593890|NCT02761694|528682281|FG002|Overall Study|Lack of Efficacy|0|||
146593891|NCT02761694|528682282|FG003|Overall Study|Lack of Efficacy|0|||
146593892|NCT02761694|528682283|FG004|Overall Study|Lack of Efficacy|0|||
146593893|NCT02761694|528682284|FG005|Overall Study|Lack of Efficacy|0|||
146593894|NCT02761694|528682285|FG006|Overall Study|Lack of Efficacy|6|||
146593895|NCT02761694|528682286|FG007|Overall Study|Lack of Efficacy|0|||
146593896|NCT02761694|528682287|FG008|Overall Study|Lack of Efficacy|0|||
146593897|NCT02761694|528682288|FG009|Overall Study|Lack of Efficacy|1|||
146593898|NCT02761694|528682289|FG010|Overall Study|Lack of Efficacy|1|||
146593899|NCT02761694|528682290|FG011|Overall Study|Lack of Efficacy|4|||
146593900|NCT02761694|528682279|FG000|Overall Study|Death|0|||
146593901|NCT02761694|528682280|FG001|Overall Study|Death|0|||
146593902|NCT02761694|528682281|FG002|Overall Study|Death|0|||
146593903|NCT02761694|528682282|FG003|Overall Study|Death|0|||
146593904|NCT02761694|528682283|FG004|Overall Study|Death|0|||
146593905|NCT02761694|528682284|FG005|Overall Study|Death|0|||
146593906|NCT02761694|528682285|FG006|Overall Study|Death|2|||
146593907|NCT02761694|528682286|FG007|Overall Study|Death|0|||
146593908|NCT02761694|528682287|FG008|Overall Study|Death|2|||
146593909|NCT02761694|528682288|FG009|Overall Study|Death|2|||
146593910|NCT02761694|528682289|FG010|Overall Study|Death|1|||
146593911|NCT02761694|528682290|FG011|Overall Study|Death|0|||
146593912|NCT02761694|528682279|FG000|Overall Study|Physician Decision|0|||
146593913|NCT02761694|528682280|FG001|Overall Study|Physician Decision|0|||
146593914|NCT02761694|528682281|FG002|Overall Study|Physician Decision|0|||
146593915|NCT02761694|528682282|FG003|Overall Study|Physician Decision|0|||
146593916|NCT02761694|528682283|FG004|Overall Study|Physician Decision|0|||
146593917|NCT02761694|528682284|FG005|Overall Study|Physician Decision|0|||
146593918|NCT02761694|528682285|FG006|Overall Study|Physician Decision|1|||
146593919|NCT02761694|528682286|FG007|Overall Study|Physician Decision|0|||
146593920|NCT02761694|528682287|FG008|Overall Study|Physician Decision|0|||
146593921|NCT02761694|528682288|FG009|Overall Study|Physician Decision|0|||
146593922|NCT02761694|528682289|FG010|Overall Study|Physician Decision|0|||
146593923|NCT02761694|528682290|FG011|Overall Study|Physician Decision|0|||
146593924|NCT02761694|528682279|FG000|Overall Study|Withdrawal by Subject|0|||
146593925|NCT02761694|528682280|FG001|Overall Study|Withdrawal by Subject|0|||
146593926|NCT02761694|528682281|FG002|Overall Study|Withdrawal by Subject|0|||
146593927|NCT02761694|528682282|FG003|Overall Study|Withdrawal by Subject|1|||
146593928|NCT02761694|528682283|FG004|Overall Study|Withdrawal by Subject|0|||
146593929|NCT02761694|528682284|FG005|Overall Study|Withdrawal by Subject|0|||
146593930|NCT02761694|528682285|FG006|Overall Study|Withdrawal by Subject|4|||
146593931|NCT02761694|528682286|FG007|Overall Study|Withdrawal by Subject|0|||
146593932|NCT02761694|528682287|FG008|Overall Study|Withdrawal by Subject|2|||
146593933|NCT02761694|528682288|FG009|Overall Study|Withdrawal by Subject|1|||
146593934|NCT02761694|528682289|FG010|Overall Study|Withdrawal by Subject|0|||
146593935|NCT02761694|528682290|FG011|Overall Study|Withdrawal by Subject|0|||
146593936|NCT02761694|528682279|FG000|Overall Study|Lost to Follow-up|0|||
146919715|NCT04285346|529867931|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
146593937|NCT02761694|528682280|FG001|Overall Study|Lost to Follow-up|0|||
146593938|NCT02761694|528682281|FG002|Overall Study|Lost to Follow-up|0|||
146593939|NCT02761694|528682282|FG003|Overall Study|Lost to Follow-up|0|||
146593940|NCT02761694|528682283|FG004|Overall Study|Lost to Follow-up|0|||
146593941|NCT02761694|528682284|FG005|Overall Study|Lost to Follow-up|0|||
146593942|NCT02761694|528682285|FG006|Overall Study|Lost to Follow-up|1|||
146593943|NCT02761694|528682286|FG007|Overall Study|Lost to Follow-up|0|||
146593944|NCT02761694|528682287|FG008|Overall Study|Lost to Follow-up|0|||
146593945|NCT02761694|528682288|FG009|Overall Study|Lost to Follow-up|0|||
146919716|NCT01975272|529867932|FG000|Overall Study|Excluded after protocol amendment|1|||
146593946|NCT02761694|528682289|FG010|Overall Study|Lost to Follow-up|0|||
146593947|NCT02761694|528682290|FG011|Overall Study|Lost to Follow-up|1|||
146593948|NCT02761694|528682279|FG000|Overall Study|Adverse Event|0|||
146593949|NCT02761694|528682280|FG001|Overall Study|Adverse Event|0|||
146593950|NCT02761694|528682281|FG002|Overall Study|Adverse Event|0|||
146593951|NCT02761694|528682282|FG003|Overall Study|Adverse Event|0|||
146593952|NCT02761694|528682283|FG004|Overall Study|Adverse Event|0|||
146593953|NCT02761694|528682284|FG005|Overall Study|Adverse Event|0|||
146593954|NCT02761694|528682285|FG006|Overall Study|Adverse Event|1|||
146593955|NCT02761694|528682286|FG007|Overall Study|Adverse Event|0|||
146593956|NCT02761694|528682287|FG008|Overall Study|Adverse Event|1|||
146593957|NCT02761694|528682288|FG009|Overall Study|Adverse Event|0|||
146593958|NCT02761694|528682289|FG010|Overall Study|Adverse Event|0|||
146593959|NCT02761694|528682290|FG011|Overall Study|Adverse Event|1|||
146593960|NCT02761694|528682279|FG000|Overall Study|Other|4|||
146593961|NCT02761694|528682280|FG001|Overall Study|Other|4|||
146593962|NCT02761694|528682281|FG002|Overall Study|Other|1|||
146593963|NCT02761694|528682282|FG003|Overall Study|Other|2|||
146593964|NCT02761694|528682283|FG004|Overall Study|Other|3|||
146593965|NCT02761694|528682284|FG005|Overall Study|Other|3|||
146593966|NCT02761694|528682285|FG006|Overall Study|Other|18|||
146593967|NCT02761694|528682286|FG007|Overall Study|Other|8|||
146593968|NCT02761694|528682287|FG008|Overall Study|Other|0|||
146593969|NCT02761694|528682288|FG009|Overall Study|Other|1|||
146593970|NCT02761694|528682289|FG010|Overall Study|Other|1|||
146593971|NCT02761694|528682290|FG011|Overall Study|Other|0|||
146593972|NCT02395055|528682295|FG000|Overall Study|Withdrawal by Subject|7|||
146593973|NCT02395055|528682296|FG001|Overall Study|Withdrawal by Subject|3|||
146593974|NCT00787930|528682297|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
146593975|NCT02513823|528682298|FG000|Overall Study|Lost to Follow-up|4|||
146593976|NCT02513823|528682298|FG000|Overall Study|Physician Decision|1|||
146593977|NCT02743780|528682300|FG000|Part 3 (7 Days)|Adverse Event|0|||
146593978|NCT02743780|528682301|FG001|Part 3 (7 Days)|Adverse Event|0|||
146593979|NCT02743780|528682302|FG002|Part 3 (7 Days)|Adverse Event|1|||
146593980|NCT02743780|528682303|FG003|Part 3 (7 Days)|Adverse Event|0|||
146593981|NCT02743780|528682304|FG004|Part 3 (7 Days)|Adverse Event|0|||
146593982|NCT01294462|528682305|FG000|Overall Study|Lost to Follow-up|1|||
146593983|NCT01294462|528682306|FG001|Overall Study|Lost to Follow-up|0|||
146593984|NCT01294462|528682305|FG000|Overall Study|Withdrawal by Subject|65|||
146593985|NCT01294462|528682306|FG001|Overall Study|Withdrawal by Subject|63|||
146593986|NCT01460407|528682310|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
146593987|NCT01460407|528682311|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
146593988|NCT04070326|528682314|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
146593989|NCT04070326|528682315|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
146593990|NCT02193087|528682320|FG000|Overall Study|Adverse Event|2|||
146593991|NCT02193087|528682321|FG001|Overall Study|Adverse Event|0|||
146593992|NCT02193087|528682322|FG002|Overall Study|Adverse Event|0|||
146593993|NCT02193087|528682323|FG003|Overall Study|Adverse Event|11|||
146593994|NCT02193087|528682320|FG000|Overall Study|Lost to Follow-up|14|||
146593995|NCT02193087|528682321|FG001|Overall Study|Lost to Follow-up|6|||
146593996|NCT02193087|528682322|FG002|Overall Study|Lost to Follow-up|4|||
146593997|NCT02193087|528682323|FG003|Overall Study|Lost to Follow-up|37|||
146593998|NCT02193087|528682320|FG000|Overall Study|Protocol Violation|2|||
146593999|NCT02193087|528682321|FG001|Overall Study|Protocol Violation|0|||
146594000|NCT02193087|528682322|FG002|Overall Study|Protocol Violation|1|||
146594001|NCT02193087|528682323|FG003|Overall Study|Protocol Violation|2|||
146594002|NCT02193087|528682320|FG000|Overall Study|Withdrawal by Subject|10|||
146594003|NCT02193087|528682321|FG001|Overall Study|Withdrawal by Subject|3|||
146594004|NCT02193087|528682322|FG002|Overall Study|Withdrawal by Subject|1|||
146594005|NCT02193087|528682323|FG003|Overall Study|Withdrawal by Subject|19|||
146594006|NCT02193087|528682320|FG000|Overall Study|Other Reason Not Specified|7|||
146594007|NCT02193087|528682321|FG001|Overall Study|Other Reason Not Specified|2|||
146594008|NCT02193087|528682322|FG002|Overall Study|Other Reason Not Specified|1|||
146594009|NCT02193087|528682323|FG003|Overall Study|Other Reason Not Specified|9|||
146594010|NCT02193087|528682320|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
146594011|NCT02193087|528682321|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
146594012|NCT02193087|528682322|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
146594013|NCT02193087|528682323|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
146594014|NCT02279498|528682324|FG000|Overall Study|Adverse Event|3|||
146594015|NCT02279498|528682325|FG001|Overall Study|Adverse Event|0|||
146594016|NCT02279498|528682324|FG000|Overall Study|Lack of Efficacy|4|||
146594017|NCT02279498|528682325|FG001|Overall Study|Lack of Efficacy|0|||
146594018|NCT02279498|528682324|FG000|Overall Study|Lost to Follow-up|0|||
146594019|NCT02279498|528682325|FG001|Overall Study|Lost to Follow-up|1|||
146594020|NCT02279498|528682324|FG000|Overall Study|Withdrawal by Subject|9|||
146594021|NCT02279498|528682325|FG001|Overall Study|Withdrawal by Subject|2|||
146594022|NCT02279498|528682324|FG000|Overall Study|Undefined|2|||
146594023|NCT02279498|528682325|FG001|Overall Study|Undefined|1|||
146594024|NCT00737711|528682326|FG000|Overall Study|Adverse Event|2|||
146594025|NCT00737711|528682326|FG000|Overall Study|Death|8|||
146594026|NCT00737711|528682326|FG000|Overall Study|Failure to return|4|||
146594027|NCT00737711|528682326|FG000|Overall Study|Protocol Violation|1|||
146594028|NCT00737711|528682326|FG000|Overall Study|Withdrawal by Subject|5|||
146594029|NCT00737711|528682326|FG000|Overall Study|Blood transfusion|6|||
146594030|NCT00737711|528682326|FG000|Overall Study|Other|5|||
146978448|NCT01904383|530084066|FG000|Overall Study|Lack of Efficacy|370|||
146594031|NCT00624780|528682327|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
146594032|NCT00624780|528682328|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
146594033|NCT00624780|528682329|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
146594034|NCT00624780|528682330|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
146594035|NCT00624780|528682331|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
146594036|NCT00624780|528682332|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
146594037|NCT00624780|528682327|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
146594038|NCT00624780|528682328|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
146594039|NCT00624780|528682329|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
146594040|NCT00624780|528682330|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
146919717|NCT01975272|529867933|FG001|Overall Study|Excluded after protocol amendment|1|||
146919718|NCT01975272|529867934|FG002|Overall Study|Excluded after protocol amendment|2|||
146919719|NCT00850460|529867936|FG000|Overall Study|Lost to Follow-up|4|||
146919720|NCT00850460|529867937|FG001|Overall Study|Lost to Follow-up|4|||
146919721|NCT05372575|529867940|FG000|Overall Study|Protocol Violation|7|||
146919722|NCT05372575|529867941|FG001|Overall Study|Protocol Violation|16|||
146919723|NCT03196297|529867942|FG000|Main Period|Withdrawal by Subject|4|||
146653491|NCT00811642|528909037|FG000|Overall Study|Cumulative use of antifungal agent|2|||
146653492|NCT01602666|528909038|FG000|Induction Chemotherapy|Death|2|||
146653493|NCT01602666|528909039|FG001|Induction Chemotherapy|Death|1|||
146653494|NCT01602666|528909038|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
146919724|NCT03196297|529867942|FG000|Extension Period|Withdrawal by Subject|1|||
146919725|NCT03196297|529867942|FG000|Extension Period|Lack of Efficacy|2|||
146594041|NCT00624780|528682331|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
146594042|NCT00624780|528682332|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
146594043|NCT00624780|528682327|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
146594044|NCT00624780|528682328|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
146594045|NCT00624780|528682329|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
146594046|NCT00624780|528682330|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
146594047|NCT00624780|528682331|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
146594048|NCT00624780|528682332|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
146594049|NCT00624780|528682327|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
146653495|NCT01602666|528909039|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
146653496|NCT01602666|528909038|FG000|Induction Chemotherapy|Physician Decision|12|||
146653497|NCT01602666|528909039|FG001|Induction Chemotherapy|Physician Decision|5|||
146653498|NCT01602666|528909038|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
146653499|NCT01602666|528909039|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
146653500|NCT01602666|528909038|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
146771444|NCT00159783|529331208|FG001|Overall Study|Withdrawal by Subject|11|||
146771445|NCT00159783|529331209|FG002|Overall Study|Withdrawal by Subject|12|||
146771446|NCT00159783|529331207|FG000|Overall Study|Lost to Follow-up|6|||
146771447|NCT00159783|529331208|FG001|Overall Study|Lost to Follow-up|5|||
146771448|NCT00159783|529331209|FG002|Overall Study|Lost to Follow-up|11|||
146771449|NCT00159783|529331207|FG000|Overall Study|Other|0|||
146771450|NCT00159783|529331208|FG001|Overall Study|Other|2|||
146771451|NCT00159783|529331209|FG002|Overall Study|Other|4|||
146771452|NCT02538107|529331210|FG000|Overall Study|Did not receive any Mircera dose|11|||
146771453|NCT02538107|529331210|FG000|Overall Study|Missing|5|||
146771454|NCT02538107|529331210|FG000|Overall Study|Necessity of dialysis|20|||
146771455|NCT02538107|529331210|FG000|Overall Study|Administration of other ESA|11|||
146771456|NCT02538107|529331210|FG000|Overall Study|No further treatment necessary|18|||
146771457|NCT02538107|529331210|FG000|Overall Study|Withdrawal by Subject|17|||
146771458|NCT02538107|529331210|FG000|Overall Study|Death|4|||
146771459|NCT02538107|529331210|FG000|Overall Study|Administrative reason|5|||
146771460|NCT02538107|529331210|FG000|Overall Study|Adverse Event|4|||
146771461|NCT02538107|529331210|FG000|Overall Study|Surgery|1|||
146771462|NCT02538107|529331210|FG000|Overall Study|Other|7|||
146771463|NCT02538107|529331210|FG000|Overall Study|Not recorded|7|||
146771464|NCT01278394|529331211|FG000|Overall Study|Lost to Follow-up|1|||
146771465|NCT01236560|529331214|FG000|Overall Study|Adverse Event|0|||
146771466|NCT01236560|529331215|FG001|Overall Study|Adverse Event|2|||
146771467|NCT01236560|529331216|FG002|Overall Study|Adverse Event|1|||
146771468|NCT01236560|529331217|FG003|Overall Study|Adverse Event|3|||
146919726|NCT04370028|529867943|FG000|Overall Study|Withdrawal by Subject|695|||
146919727|NCT04370028|529867943|FG000|Overall Study|Protocol Violation|9|||
146653501|NCT01602666|528909039|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
146771469|NCT01236560|529331218|FG004|Overall Study|Adverse Event|0|||
146771470|NCT01236560|529331219|FG005|Overall Study|Adverse Event|0|||
146771471|NCT01236560|529331214|FG000|Overall Study|Death|0|||
146771472|NCT01236560|529331215|FG001|Overall Study|Death|1|||
146771473|NCT01236560|529331216|FG002|Overall Study|Death|0|||
146771474|NCT01236560|529331217|FG003|Overall Study|Death|1|||
146771475|NCT01236560|529331218|FG004|Overall Study|Death|0|||
146919728|NCT04370028|529867943|FG000|Overall Study|Adverse Event|3|||
146919729|NCT04937816|529867945|FG000|Overall Study|Study drug stopped, reason missing|5|||
146594050|NCT00624780|528682328|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
146594051|NCT00624780|528682329|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
146594052|NCT00624780|528682330|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
146594053|NCT00624780|528682331|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
146594054|NCT00624780|528682332|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
146594055|NCT00624780|528682327|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
146594056|NCT00624780|528682328|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
146594057|NCT00624780|528682329|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
146594058|NCT00624780|528682330|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
146594059|NCT00624780|528682331|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
146594060|NCT00624780|528682332|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
146594061|NCT00624780|528682327|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
146594062|NCT00624780|528682328|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
146594063|NCT00624780|528682329|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
146594064|NCT00624780|528682330|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
146594065|NCT00624780|528682331|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
146594066|NCT00624780|528682332|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
146594067|NCT00624780|528682327|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
146594068|NCT00624780|528682328|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
146594069|NCT00624780|528682329|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
146594070|NCT00624780|528682330|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
146594071|NCT00624780|528682331|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
146594072|NCT00624780|528682332|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
146594073|NCT00624780|528682327|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
146594074|NCT00624780|528682328|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
146594075|NCT00624780|528682329|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
146594076|NCT00624780|528682330|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
146594077|NCT00624780|528682331|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
146594078|NCT00624780|528682332|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
146594079|NCT00624780|528682327|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
146594080|NCT00624780|528682328|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
146594081|NCT00624780|528682329|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
146594082|NCT00624780|528682330|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
146594083|NCT00624780|528682331|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
146594084|NCT00624780|528682332|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
146594085|NCT00624780|528682327|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
146594086|NCT00624780|528682328|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
146594087|NCT00624780|528682329|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
146594088|NCT00624780|528682330|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
146594089|NCT00624780|528682331|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
146594090|NCT00624780|528682332|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
146594091|NCT00624780|528682327|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
146594092|NCT00624780|528682328|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
146594093|NCT00624780|528682329|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
146594094|NCT00624780|528682330|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
146594095|NCT00624780|528682331|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
146594096|NCT00624780|528682332|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
146594097|NCT00624780|528682327|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
146594098|NCT00624780|528682328|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
146594099|NCT00624780|528682329|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
146594100|NCT00624780|528682330|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
146594101|NCT00624780|528682331|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
146594102|NCT00624780|528682332|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
146594103|NCT00624780|528682327|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
146594104|NCT00624780|528682328|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
146594105|NCT00624780|528682329|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
146594106|NCT00624780|528682330|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
146594107|NCT00624780|528682331|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
146594108|NCT00624780|528682332|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
146594109|NCT00624780|528682327|FG000|Follow-up (Week 26)|Death|0|||
146594110|NCT00624780|528682328|FG001|Follow-up (Week 26)|Death|0|||
146594111|NCT00624780|528682329|FG002|Follow-up (Week 26)|Death|1|||
146594112|NCT00624780|528682330|FG003|Follow-up (Week 26)|Death|0|||
146594113|NCT00624780|528682331|FG004|Follow-up (Week 26)|Death|0|||
146594114|NCT00624780|528682332|FG005|Follow-up (Week 26)|Death|0|||
146594115|NCT00624780|528682327|FG000|Follow-up (Week 26)|Adverse Event|0|||
146594116|NCT00624780|528682328|FG001|Follow-up (Week 26)|Adverse Event|0|||
146594117|NCT00624780|528682329|FG002|Follow-up (Week 26)|Adverse Event|0|||
146594118|NCT00624780|528682330|FG003|Follow-up (Week 26)|Adverse Event|0|||
146594119|NCT00624780|528682331|FG004|Follow-up (Week 26)|Adverse Event|1|||
146594120|NCT00624780|528682332|FG005|Follow-up (Week 26)|Adverse Event|0|||
146594121|NCT00624780|528682327|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
146594122|NCT00624780|528682328|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
146594123|NCT00624780|528682329|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
146594124|NCT00624780|528682330|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
146594125|NCT00624780|528682331|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
146594126|NCT00624780|528682332|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
146594127|NCT00624780|528682327|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
146594128|NCT00624780|528682328|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
146919730|NCT04937816|529867946|FG001|Overall Study|Study drug stopped, reason missing|3|||
146919731|NCT04937816|529867947|FG002|Overall Study|Study drug stopped, reason missing|4|||
146919732|NCT04937816|529867948|FG003|Overall Study|Study drug stopped, reason missing|6|||
146919733|NCT04937816|529867949|FG004|Overall Study|Study drug stopped, reason missing|1|||
146919734|NCT04937816|529867950|FG005|Overall Study|Study drug stopped, reason missing|0|||
146919735|NCT04937816|529867951|FG006|Overall Study|Study drug stopped, reason missing|0|||
146919736|NCT04937816|529867945|FG000|Overall Study|Other than stated below|173|||
146919737|NCT04937816|529867946|FG001|Overall Study|Other than stated below|143|||
146919738|NCT04937816|529867947|FG002|Overall Study|Other than stated below|125|||
146919739|NCT04937816|529867948|FG003|Overall Study|Other than stated below|44|||
146919740|NCT04937816|529867949|FG004|Overall Study|Other than stated below|45|||
146919741|NCT04937816|529867950|FG005|Overall Study|Other than stated below|28|||
146919742|NCT04937816|529867951|FG006|Overall Study|Other than stated below|31|||
146919743|NCT04937816|529867945|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
146919744|NCT04937816|529867946|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
146919745|NCT04937816|529867947|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
146919746|NCT04937816|529867948|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
146919747|NCT04937816|529867949|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
146919748|NCT04937816|529867950|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
146919749|NCT04937816|529867951|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
146919750|NCT04937816|529867945|FG000|Overall Study|Lost to Follow-up|15|||
146919751|NCT04937816|529867946|FG001|Overall Study|Lost to Follow-up|9|||
146919752|NCT04937816|529867947|FG002|Overall Study|Lost to Follow-up|6|||
146919753|NCT04937816|529867948|FG003|Overall Study|Lost to Follow-up|6|||
146919754|NCT04937816|529867949|FG004|Overall Study|Lost to Follow-up|16|||
146919755|NCT04937816|529867950|FG005|Overall Study|Lost to Follow-up|11|||
146919756|NCT04937816|529867951|FG006|Overall Study|Lost to Follow-up|17|||
146919757|NCT04937816|529867945|FG000|Overall Study|Protocol Violation|15|||
146919758|NCT04937816|529867946|FG001|Overall Study|Protocol Violation|15|||
146919759|NCT04937816|529867947|FG002|Overall Study|Protocol Violation|12|||
146919760|NCT04937816|529867948|FG003|Overall Study|Protocol Violation|30|||
146919761|NCT04937816|529867949|FG004|Overall Study|Protocol Violation|24|||
146919762|NCT04937816|529867950|FG005|Overall Study|Protocol Violation|5|||
146919763|NCT04937816|529867951|FG006|Overall Study|Protocol Violation|5|||
146919764|NCT04937816|529867945|FG000|Overall Study|Adverse Event|303|||
146919765|NCT04937816|529867946|FG001|Overall Study|Adverse Event|267|||
146919766|NCT04937816|529867947|FG002|Overall Study|Adverse Event|273|||
146919767|NCT04937816|529867948|FG003|Overall Study|Adverse Event|553|||
146919768|NCT04937816|529867949|FG004|Overall Study|Adverse Event|575|||
146919769|NCT04937816|529867950|FG005|Overall Study|Adverse Event|343|||
146919770|NCT04937816|529867951|FG006|Overall Study|Adverse Event|337|||
146919771|NCT04937816|529867945|FG000|Overall Study|Not treated|4|||
146919772|NCT04937816|529867946|FG001|Overall Study|Not treated|2|||
146919773|NCT04937816|529867947|FG002|Overall Study|Not treated|2|||
146919774|NCT04937816|529867948|FG003|Overall Study|Not treated|2|||
146919775|NCT04937816|529867949|FG004|Overall Study|Not treated|1|||
146919776|NCT04937816|529867950|FG005|Overall Study|Not treated|4|||
146919777|NCT04937816|529867951|FG006|Overall Study|Not treated|0|||
146919778|NCT01064648|529867952|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
146919779|NCT01064648|529867953|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
146919780|NCT01064648|529867954|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
146919781|NCT01064648|529867955|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
146919782|NCT01064648|529867952|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
146594129|NCT00624780|528682329|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
146594130|NCT00624780|528682330|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
146594131|NCT00624780|528682331|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
146919783|NCT01064648|529867953|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
146919784|NCT01064648|529867954|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
146919785|NCT01064648|529867955|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
146919786|NCT01064648|529867952|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
146919787|NCT01064648|529867953|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
146919788|NCT01064648|529867954|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
146919789|NCT01064648|529867955|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
146919790|NCT01064648|529867952|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
146919791|NCT01064648|529867953|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
146919792|NCT01064648|529867954|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
146919793|NCT01064648|529867955|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
146919794|NCT01064648|529867952|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
146919795|NCT01064648|529867953|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
146919796|NCT01064648|529867954|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
146919797|NCT01064648|529867955|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
146919798|NCT01064648|529867952|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
146919799|NCT01064648|529867953|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
146919800|NCT01064648|529867954|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
146919801|NCT01064648|529867955|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
146919802|NCT01064648|529867952|FG000|Phase II|Adverse Event|0|||
146919803|NCT01064648|529867953|FG001|Phase II|Adverse Event|0|||
146919804|NCT01064648|529867954|FG002|Phase II|Adverse Event|15|||
146919805|NCT01064648|529867955|FG003|Phase II|Adverse Event|8|||
146919806|NCT01064648|529867952|FG000|Phase II|Death|0|||
146919807|NCT01064648|529867953|FG001|Phase II|Death|0|||
146919808|NCT01064648|529867954|FG002|Phase II|Death|4|||
146919809|NCT01064648|529867955|FG003|Phase II|Death|5|||
146919810|NCT01064648|529867952|FG000|Phase II|Withdrawal by Subject|0|||
146919811|NCT01064648|529867953|FG001|Phase II|Withdrawal by Subject|0|||
146919812|NCT01064648|529867954|FG002|Phase II|Withdrawal by Subject|2|||
146919813|NCT01064648|529867955|FG003|Phase II|Withdrawal by Subject|5|||
146919814|NCT01064648|529867952|FG000|Phase II|Progression|0|||
146919815|NCT01064648|529867953|FG001|Phase II|Progression|0|||
146919816|NCT01064648|529867954|FG002|Phase II|Progression|21|||
146919817|NCT01064648|529867955|FG003|Phase II|Progression|27|||
146919818|NCT01064648|529867952|FG000|Phase II|Non-protocol specified|0|||
146919819|NCT01064648|529867953|FG001|Phase II|Non-protocol specified|0|||
146919820|NCT01064648|529867954|FG002|Phase II|Non-protocol specified|5|||
146919821|NCT01064648|529867955|FG003|Phase II|Non-protocol specified|3|||
146919822|NCT01064648|529867952|FG000|Phase II|Under Review|0|||
146919823|NCT01064648|529867953|FG001|Phase II|Under Review|0|||
146919824|NCT01064648|529867954|FG002|Phase II|Under Review|2|||
146919825|NCT01064648|529867955|FG003|Phase II|Under Review|0|||
146919826|NCT05513391|529867956|FG000|Overall Study|Adverse Event|1|||
146919827|NCT05513391|529867957|FG001|Overall Study|Adverse Event|0|||
146919828|NCT05513391|529867956|FG000|Overall Study|Protocol Deviation|0|||
146594132|NCT00624780|528682332|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
146594133|NCT00624780|528682327|FG000|Follow-up (Week 26)|Other|1|||
146594134|NCT00624780|528682328|FG001|Follow-up (Week 26)|Other|1|||
146594135|NCT00624780|528682329|FG002|Follow-up (Week 26)|Other|0|||
146594136|NCT00624780|528682330|FG003|Follow-up (Week 26)|Other|0|||
146594137|NCT00624780|528682331|FG004|Follow-up (Week 26)|Other|0|||
146594138|NCT00624780|528682332|FG005|Follow-up (Week 26)|Other|0|||
146594139|NCT04068519|528682333|FG000|Dose Verification|Death|15|||
146594140|NCT04068519|528682333|FG000|Dose Verification|Withdrawal by Subject|1|||
146594141|NCT04068519|528682333|FG000|Pharmacokinetic Sub-study|Death|35|||
146594142|NCT04068519|528682333|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
146594143|NCT04068519|528682333|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
146594144|NCT04068519|528682333|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
146594145|NCT04068519|528682333|FG000|Indication Expansion|Death|152|||
146594146|NCT04068519|528682333|FG000|Indication Expansion|Withdrawal by Subject|10|||
146594147|NCT04068519|528682333|FG000|Indication Expansion|Lost to Follow-up|7|||
146594148|NCT00969761|528682334|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
146594149|NCT00969761|528682335|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
146594150|NCT00969761|528682336|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
146594151|NCT00969761|528682337|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
146594152|NCT00969761|528682338|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
146594153|NCT00969761|528682339|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
146594154|NCT00969761|528682340|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
146653502|NCT01602666|528909038|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
146919829|NCT05513391|529867957|FG001|Overall Study|Protocol Deviation|1|||
146919830|NCT05513391|529867956|FG000|Overall Study|Withdrawal by Subject|3|||
146653503|NCT01602666|528909039|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
146919831|NCT05513391|529867957|FG001|Overall Study|Withdrawal by Subject|1|||
146919832|NCT05513391|529867956|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
146919833|NCT05513391|529867957|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
146919834|NCT05513391|529867956|FG000|Overall Study|Lost to Follow-up|0|||
146919835|NCT05513391|529867957|FG001|Overall Study|Lost to Follow-up|2|||
146919836|NCT05513053|529867958|FG000|Overall Study|Lost to Follow-up|9|||
146594155|NCT00969761|528682341|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
146594156|NCT00969761|528682342|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
146653504|NCT01602666|528909038|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
146919837|NCT05513053|529867959|FG001|Overall Study|Lost to Follow-up|11|||
146919838|NCT05513053|529867958|FG000|Overall Study|Withdrawal by parent/guardian|2|||
146919839|NCT05513053|529867959|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146919840|NCT05513053|529867958|FG000|Overall Study|Withdrawal by Subject|2|||
146919841|NCT05513053|529867959|FG001|Overall Study|Withdrawal by Subject|9|||
146919842|NCT05513053|529867958|FG000|Overall Study|Protocol Violation|6|||
146919843|NCT05513053|529867959|FG001|Overall Study|Protocol Violation|3|||
146919844|NCT05513053|529867958|FG000|Overall Study|Adverse Event|0|||
146919845|NCT05513053|529867959|FG001|Overall Study|Adverse Event|2|||
146919846|NCT01520324|529868847|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
146919847|NCT01328249|529868848|FG000|Overall Study|Adverse Event|3|||
146919848|NCT01328249|529868849|FG001|Overall Study|Adverse Event|0|||
146919849|NCT01328249|529868848|FG000|Overall Study|Disease progression|1|||
146919850|NCT01328249|529868849|FG001|Overall Study|Disease progression|0|||
146919851|NCT01328249|529868848|FG000|Overall Study|Withdrawal by Subject|1|||
146919852|NCT01328249|529868849|FG001|Overall Study|Withdrawal by Subject|1|||
146919853|NCT01328249|529868848|FG000|Overall Study|Moved before end of treatment visit|1|||
146919854|NCT01328249|529868849|FG001|Overall Study|Moved before end of treatment visit|0|||
146919855|NCT01328249|529868848|FG000|Overall Study|Subject choice|1|||
146919856|NCT01328249|529868849|FG001|Overall Study|Subject choice|1|||
146594157|NCT00969761|528682343|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
146594158|NCT00969761|528682344|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
146594159|NCT00969761|528682345|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
146594160|NCT00969761|528682334|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146594161|NCT00969761|528682335|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146594162|NCT00969761|528682336|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
146594163|NCT00969761|528682337|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146594164|NCT00969761|528682338|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146594165|NCT00969761|528682339|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146594166|NCT00969761|528682340|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146594167|NCT00969761|528682341|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146594168|NCT00969761|528682342|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146594169|NCT00969761|528682343|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146594170|NCT00969761|528682344|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146594171|NCT00969761|528682345|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146594172|NCT00969761|528682334|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146594173|NCT00969761|528682335|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146594174|NCT00969761|528682336|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
146594175|NCT00969761|528682337|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146594176|NCT00969761|528682338|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146594177|NCT00969761|528682339|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146594178|NCT00969761|528682340|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146594179|NCT00969761|528682341|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146594180|NCT00969761|528682342|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146594181|NCT00969761|528682343|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146594182|NCT00969761|528682344|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146594183|NCT00969761|528682345|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146594184|NCT00969761|528682334|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146594185|NCT00969761|528682335|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146594186|NCT00969761|528682336|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146594187|NCT00969761|528682337|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146594188|NCT00969761|528682338|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146594189|NCT00969761|528682339|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146594190|NCT00969761|528682340|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146594191|NCT00969761|528682341|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146594192|NCT00969761|528682342|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
146594193|NCT00969761|528682343|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146594194|NCT00969761|528682344|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146594195|NCT00969761|528682345|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146594196|NCT00969761|528682334|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
146594197|NCT00969761|528682335|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
146653505|NCT01602666|528909039|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
146653506|NCT01602666|528909038|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
146653507|NCT01602666|528909039|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
146653508|NCT01602666|528909038|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
146653509|NCT01602666|528909039|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
146919857|NCT01328249|529868848|FG000|Overall Study|Protocol Violation|0|||
146919858|NCT01328249|529868849|FG001|Overall Study|Protocol Violation|1|||
146919859|NCT00948818|529868850|FG000|Overall Study|Adverse Event|10|||
146594198|NCT00969761|528682336|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
146594199|NCT00969761|528682337|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
146594200|NCT00969761|528682338|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
146594201|NCT00969761|528682339|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
146594202|NCT00969761|528682340|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
146594203|NCT00969761|528682341|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
146594204|NCT00969761|528682342|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
146594205|NCT00969761|528682343|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
146594206|NCT00969761|528682344|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
146594207|NCT00969761|528682345|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
146919860|NCT00948818|529868851|FG001|Overall Study|Adverse Event|32|||
146919861|NCT00948818|529868850|FG000|Overall Study|Protocol Violation|9|||
146919862|NCT00948818|529868851|FG001|Overall Study|Protocol Violation|10|||
146919863|NCT00948818|529868850|FG000|Overall Study|Withdrawal by Subject|25|||
146919864|NCT00948818|529868851|FG001|Overall Study|Withdrawal by Subject|25|||
146919865|NCT00948818|529868850|FG000|Overall Study|Lost to Follow-up|10|||
146919866|NCT00948818|529868851|FG001|Overall Study|Lost to Follow-up|17|||
146919867|NCT00948818|529868850|FG000|Overall Study|Lack of Efficacy|4|||
146919868|NCT00948818|529868851|FG001|Overall Study|Lack of Efficacy|5|||
146919869|NCT00948818|529868850|FG000|Overall Study|Other Reason|4|||
146919870|NCT00948818|529868851|FG001|Overall Study|Other Reason|5|||
146919871|NCT00745368|529868852|FG000|Overall Study|Unable to provide sample|3|||
146919872|NCT02326467|529868853|FG000|Overall Study|Withdrawal by Subject|1|||
146919873|NCT00441441|529868854|FG000|Overall Study|Adverse Event|2|||
146919874|NCT00441441|529868855|FG001|Overall Study|Adverse Event|1|||
146919875|NCT00441441|529868854|FG000|Overall Study|Protocol Violation|4|||
146919876|NCT00441441|529868855|FG001|Overall Study|Protocol Violation|6|||
146919877|NCT00441441|529868854|FG000|Overall Study|Exacerbation of asthma|1|||
146919878|NCT00441441|529868855|FG001|Overall Study|Exacerbation of asthma|2|||
146919879|NCT00441441|529868854|FG000|Overall Study|Withdrawal by Subject|1|||
146919880|NCT00441441|529868855|FG001|Overall Study|Withdrawal by Subject|2|||
146919881|NCT00441441|529868854|FG000|Overall Study|Other|3|||
146919882|NCT00441441|529868855|FG001|Overall Study|Other|3|||
146919883|NCT01051986|529868856|FG000|Overall Study|Death|1|||
146919884|NCT01051986|529868857|FG001|Overall Study|Death|0|||
146919885|NCT01051986|529868856|FG000|Overall Study|Withdrawal by Subject|2|||
146919886|NCT01051986|529868857|FG001|Overall Study|Withdrawal by Subject|1|||
146919887|NCT01051986|529868856|FG000|Overall Study|Protocol Violation|2|||
146919888|NCT01051986|529868857|FG001|Overall Study|Protocol Violation|3|||
146919889|NCT01725152|529868859|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
146919890|NCT01725152|529868860|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
146919891|NCT01725152|529868859|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
146919892|NCT01725152|529868860|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
146919893|NCT01725152|529868859|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
146919894|NCT01725152|529868860|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
146919895|NCT01725152|529868859|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
146919896|NCT01725152|529868860|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
146919897|NCT02044159|529868861|FG000|Overall Study|Consent declined (deferred consent)|2|||
146919898|NCT02044159|529868862|FG001|Overall Study|Consent declined (deferred consent)|4|||
146919899|NCT02044159|529868861|FG000|Overall Study|No longer eligible, drug not given|1|||
146919900|NCT02044159|529868862|FG001|Overall Study|No longer eligible, drug not given|0|||
146919901|NCT02044159|529868861|FG000|Overall Study|Nurse declined to give study drug|1|||
146919902|NCT02044159|529868862|FG001|Overall Study|Nurse declined to give study drug|0|||
146919903|NCT01111539|529868863|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
146919904|NCT01111539|529868864|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
146919905|NCT01111539|529868865|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
146919906|NCT01111539|529868866|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
146919907|NCT01111539|529868867|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
146919908|NCT01111539|529868863|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
146919909|NCT01111539|529868864|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
146919910|NCT01111539|529868865|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
146919911|NCT01111539|529868866|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
146919912|NCT01111539|529868867|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
146919913|NCT01111539|529868863|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
146771476|NCT01236560|529331219|FG005|Overall Study|Death|0|||
146919914|NCT01111539|529868864|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
146919915|NCT01111539|529868865|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
146919916|NCT01111539|529868866|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
146594208|NCT00969761|528682334|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146919917|NCT01111539|529868867|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
146919918|NCT01111539|529868863|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
146919919|NCT01111539|529868864|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
146978449|NCT01904383|530084066|FG000|Overall Study|Improvement|141|||
146594209|NCT00969761|528682335|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146919920|NCT01111539|529868865|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
146919921|NCT01111539|529868866|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
146919922|NCT01111539|529868867|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
146919923|NCT01111539|529868863|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
146919924|NCT01111539|529868864|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
146919925|NCT01111539|529868865|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
146919926|NCT01111539|529868866|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
146919927|NCT01111539|529868867|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
146919928|NCT01111539|529868863|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
146919929|NCT01111539|529868864|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
146919930|NCT01111539|529868865|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
146919931|NCT01111539|529868866|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
146919932|NCT01111539|529868867|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
146919933|NCT01111539|529868863|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
146919934|NCT01111539|529868864|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
146919935|NCT01111539|529868865|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
146919936|NCT01111539|529868866|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
146919937|NCT01111539|529868867|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
146919938|NCT01111539|529868863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
146919939|NCT01111539|529868864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
146919940|NCT01111539|529868865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
146919941|NCT01111539|529868866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
146919942|NCT01111539|529868867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
146919943|NCT01111539|529868863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
146919944|NCT01111539|529868864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
146919945|NCT01111539|529868865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
146919946|NCT01111539|529868866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
146919947|NCT01111539|529868867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
146919948|NCT01111539|529868863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
146919949|NCT01111539|529868864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
146919950|NCT01111539|529868865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
146919951|NCT01111539|529868866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
146919952|NCT01111539|529868867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
146919953|NCT01111539|529868863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
146919954|NCT01111539|529868864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
146919955|NCT01111539|529868865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
146919956|NCT01111539|529868866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
146919957|NCT01111539|529868867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
146919958|NCT01111539|529868863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
146919959|NCT01111539|529868864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
146919960|NCT01111539|529868865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
146919961|NCT01111539|529868866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
146919962|NCT01111539|529868867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
146919963|NCT01111539|529868863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
146919964|NCT01111539|529868864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
146919965|NCT01111539|529868865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
146919966|NCT01111539|529868866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
146919967|NCT01111539|529868867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
146919968|NCT01111539|529868863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
146919969|NCT01111539|529868864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
146919970|NCT01111539|529868865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
146919971|NCT01111539|529868866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
146919972|NCT01111539|529868867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
146919973|NCT01894477|529868868|FG000|Overall Study|Protocol Violation|0|||
146919974|NCT01894477|529868869|FG001|Overall Study|Protocol Violation|1|||
146919975|NCT01894477|529868868|FG000|Overall Study|protocol changed due SC changed to cord|0|||
146919976|NCT01894477|529868869|FG001|Overall Study|protocol changed due SC changed to cord|1|||
146919977|NCT03656926|529868873|FG000|Overall Study|Adverse Event|5|||
146594210|NCT00969761|528682336|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146594211|NCT00969761|528682337|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
146594212|NCT00969761|528682338|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
146594213|NCT00969761|528682339|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146594214|NCT00969761|528682340|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146594215|NCT00969761|528682341|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146653510|NCT01602666|528909038|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
146653511|NCT01602666|528909039|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
146653512|NCT01602666|528909038|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
146653513|NCT01602666|528909039|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
146653514|NCT01163318|528909040|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
146653515|NCT01163318|528909040|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
146653516|NCT01163318|528909040|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
146653517|NCT01163318|528909040|FG000|Overall Study|Participants Without Case Report Form|7|||
146653518|NCT01163318|528909040|FG000|Overall Study|Multiple Reasons Per Participant|224|||
146594216|NCT00969761|528682342|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
146594217|NCT00969761|528682343|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146594218|NCT00969761|528682344|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146594219|NCT00969761|528682345|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146594220|NCT03959982|528684330|FG000|Overall Study|Withdrawal by Subject|1|||
146594221|NCT03959982|528684331|FG001|Overall Study|Withdrawal by Subject|0|||
146594222|NCT03959982|528684330|FG000|Overall Study|Physician Decision|2|||
146594223|NCT03959982|528684331|FG001|Overall Study|Physician Decision|0|||
146594224|NCT03959982|528684330|FG000|Overall Study|Lost to Follow-up|1|||
146594225|NCT03959982|528684331|FG001|Overall Study|Lost to Follow-up|0|||
146594226|NCT00262847|528684332|FG000|Overall Study|Disease Progression|309|||
146594227|NCT00262847|528684333|FG001|Overall Study|Disease Progression|274|||
146653519|NCT00562627|528910615|FG000|Overall Study|Protocol Violation|1|||
146653520|NCT00562627|528910616|FG001|Overall Study|Protocol Violation|1|||
146653521|NCT00562627|528910617|FG002|Overall Study|Protocol Violation|1|||
146771477|NCT01236560|529331214|FG000|Overall Study|Lost to Follow-up|0|||
146771478|NCT01236560|529331215|FG001|Overall Study|Lost to Follow-up|1|||
146771479|NCT01236560|529331216|FG002|Overall Study|Lost to Follow-up|1|||
146771480|NCT01236560|529331217|FG003|Overall Study|Lost to Follow-up|0|||
146771481|NCT01236560|529331218|FG004|Overall Study|Lost to Follow-up|0|||
146771482|NCT01236560|529331219|FG005|Overall Study|Lost to Follow-up|0|||
146771483|NCT01236560|529331214|FG000|Overall Study|Physician Decision|0|||
146771484|NCT01236560|529331215|FG001|Overall Study|Physician Decision|1|||
146771485|NCT01236560|529331216|FG002|Overall Study|Physician Decision|8|||
146771486|NCT01236560|529331217|FG003|Overall Study|Physician Decision|0|||
146771487|NCT01236560|529331218|FG004|Overall Study|Physician Decision|0|||
146771488|NCT01236560|529331219|FG005|Overall Study|Physician Decision|0|||
146771489|NCT01236560|529331214|FG000|Overall Study|Withdrawal by Subject|0|||
146771490|NCT01236560|529331215|FG001|Overall Study|Withdrawal by Subject|0|||
146771491|NCT01236560|529331216|FG002|Overall Study|Withdrawal by Subject|1|||
146771492|NCT01236560|529331217|FG003|Overall Study|Withdrawal by Subject|2|||
146771493|NCT01236560|529331218|FG004|Overall Study|Withdrawal by Subject|0|||
146771494|NCT01236560|529331219|FG005|Overall Study|Withdrawal by Subject|0|||
146771495|NCT01236560|529331214|FG000|Overall Study|Progressive disease|5|||
146771496|NCT01236560|529331215|FG001|Overall Study|Progressive disease|19|||
146771497|NCT01236560|529331216|FG002|Overall Study|Progressive disease|9|||
146771498|NCT01236560|529331217|FG003|Overall Study|Progressive disease|16|||
146771499|NCT01236560|529331218|FG004|Overall Study|Progressive disease|0|||
146771500|NCT01236560|529331219|FG005|Overall Study|Progressive disease|0|||
146771501|NCT02471755|529331220|FG000|Overall Study|Withdrawal by Subject|1|||
146771502|NCT02471755|529331221|FG001|Overall Study|Withdrawal by Subject|0|||
146771503|NCT02471755|529331220|FG000|Overall Study|Lost to Follow-up|0|||
146771504|NCT02471755|529331221|FG001|Overall Study|Lost to Follow-up|1|||
146771505|NCT04740164|529331222|FG000|Overall Study|Lack of Efficacy|4|||
146771506|NCT04740164|529331223|FG001|Overall Study|Lack of Efficacy|0|||
146771507|NCT04740164|529331222|FG000|Overall Study|Physician Decision|3|||
146771508|NCT04740164|529331223|FG001|Overall Study|Physician Decision|3|||
146771509|NCT05323734|529331227|FG000|Overall Study|Adverse Event|5|||
146771510|NCT05323734|529331228|FG001|Overall Study|Adverse Event|2|||
146771511|NCT05323734|529331227|FG000|Overall Study|Physician Decision|1|||
146594228|NCT00262847|528684334|FG002|Overall Study|Disease Progression|195|||
146594229|NCT00262847|528684332|FG000|Overall Study|Patient Refusal|41|||
146594230|NCT00262847|528684333|FG001|Overall Study|Patient Refusal|52|||
146594231|NCT00262847|528684334|FG002|Overall Study|Patient Refusal|47|||
146653522|NCT00997438|528910618|FG000|Overall Study|Blood draw difficulty|2|||
146771512|NCT05323734|529331228|FG001|Overall Study|Physician Decision|0|||
146771513|NCT05323734|529331227|FG000|Overall Study|Lack of Efficacy|1|||
146771514|NCT05323734|529331228|FG001|Overall Study|Lack of Efficacy|2|||
146771515|NCT05323734|529331227|FG000|Overall Study|Withdrawal by Subject|2|||
146771516|NCT05323734|529331228|FG001|Overall Study|Withdrawal by Subject|0|||
146771517|NCT05323734|529331227|FG000|Overall Study|Participant Withdrawn Due|0|||
146771518|NCT05323734|529331228|FG001|Overall Study|Participant Withdrawn Due|1|||
146771519|NCT05061693|529331229|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
146771520|NCT05061693|529331230|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
146771521|NCT05061693|529331231|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
146653523|NCT00997438|528910619|FG001|Overall Study|Blood draw difficulty|0|||
146653524|NCT00997438|528910620|FG002|Overall Study|Blood draw difficulty|1|||
146653525|NCT00997438|528910618|FG000|Overall Study|Withdrawal by Subject|1|||
146653526|NCT00997438|528910619|FG001|Overall Study|Withdrawal by Subject|1|||
146653527|NCT00997438|528910620|FG002|Overall Study|Withdrawal by Subject|0|||
146653528|NCT00997438|528910618|FG000|Overall Study|Exclusion criteria at visit 1|2|||
146653529|NCT00997438|528910619|FG001|Overall Study|Exclusion criteria at visit 1|2|||
146653530|NCT00997438|528910620|FG002|Overall Study|Exclusion criteria at visit 1|3|||
146919978|NCT03656926|529868874|FG001|Overall Study|Adverse Event|4|||
146919979|NCT03656926|529868873|FG000|Overall Study|Withdrawal by Subject|7|||
146919980|NCT03656926|529868874|FG001|Overall Study|Withdrawal by Subject|2|||
146919981|NCT03656926|529868873|FG000|Overall Study|Screen fail after randomization|1|||
146919982|NCT03656926|529868874|FG001|Overall Study|Screen fail after randomization|0|||
146919983|NCT03656926|529868873|FG000|Overall Study|PI decision due to patient condition|1|||
146919984|NCT03656926|529868874|FG001|Overall Study|PI decision due to patient condition|0|||
146919985|NCT03656926|529868873|FG000|Overall Study|Patient unresponsiveness|1|||
146919986|NCT03656926|529868874|FG001|Overall Study|Patient unresponsiveness|0|||
146919987|NCT00069095|529868875|FG000|Primary Treatment Phase|Ongoing|0|||
146919988|NCT00069095|529868876|FG001|Primary Treatment Phase|Ongoing|0|||
146919989|NCT00069095|529868877|FG002|Primary Treatment Phase|Ongoing|5|||
146919990|NCT00069095|529868878|FG003|Primary Treatment Phase|Ongoing|7|||
146919991|NCT00069095|529868879|FG004|Primary Treatment Phase|Ongoing|7|||
146919992|NCT00069095|529868880|FG005|Primary Treatment Phase|Ongoing|4|||
146594232|NCT00262847|528684332|FG000|Overall Study|Adverse Event|74|||
146594233|NCT00262847|528684333|FG001|Overall Study|Adverse Event|88|||
146594234|NCT00262847|528684334|FG002|Overall Study|Adverse Event|108|||
146594235|NCT00262847|528684332|FG000|Overall Study|Death|8|||
146594236|NCT00262847|528684333|FG001|Overall Study|Death|8|||
146594237|NCT00262847|528684334|FG002|Overall Study|Death|11|||
146594238|NCT00262847|528684332|FG000|Overall Study|Concomitant disease|3|||
146594239|NCT00262847|528684333|FG001|Overall Study|Concomitant disease|2|||
146594240|NCT00262847|528684334|FG002|Overall Study|Concomitant disease|4|||
146594241|NCT00262847|528684332|FG000|Overall Study|Other Reasons|79|||
146594242|NCT00262847|528684333|FG001|Overall Study|Other Reasons|88|||
146594243|NCT00262847|528684334|FG002|Overall Study|Other Reasons|27|||
146594244|NCT00262847|528684332|FG000|Overall Study|Did not receive study treatment|4|||
146594245|NCT00262847|528684333|FG001|Overall Study|Did not receive study treatment|1|||
146594246|NCT00262847|528684334|FG002|Overall Study|Did not receive study treatment|4|||
146594247|NCT00758589|528684335|FG000|Overall Study|Adverse Event|3|||
146594248|NCT00758589|528684336|FG001|Overall Study|Adverse Event|2|||
146594249|NCT00758589|528684337|FG002|Overall Study|Adverse Event|5|||
146594250|NCT00758589|528684338|FG003|Overall Study|Adverse Event|4|||
146594251|NCT00758589|528684335|FG000|Overall Study|Withdrawal by Subject|0|||
146594252|NCT00758589|528684336|FG001|Overall Study|Withdrawal by Subject|1|||
146594253|NCT00758589|528684337|FG002|Overall Study|Withdrawal by Subject|1|||
146594254|NCT00758589|528684338|FG003|Overall Study|Withdrawal by Subject|1|||
146594255|NCT00758589|528684335|FG000|Overall Study|Palm stopped to work|0|||
146594256|NCT00758589|528684336|FG001|Overall Study|Palm stopped to work|0|||
146594257|NCT00758589|528684337|FG002|Overall Study|Palm stopped to work|0|||
146594258|NCT00758589|528684338|FG003|Overall Study|Palm stopped to work|1|||
146594259|NCT05013424|528684353|FG000|Overall Study|Lost to Follow-up|1|||
146594260|NCT05013424|528684354|FG001|Overall Study|Lost to Follow-up|1|||
146594261|NCT05013424|528684355|FG002|Overall Study|Lost to Follow-up|1|||
146594262|NCT05013424|528684353|FG000|Overall Study|Withdrawal by Subject|0|||
146594263|NCT05013424|528684354|FG001|Overall Study|Withdrawal by Subject|1|||
146594264|NCT05013424|528684355|FG002|Overall Study|Withdrawal by Subject|0|||
146594265|NCT04411420|528684356|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
146594266|NCT04411420|528684357|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
146594267|NCT04411420|528684356|FG000|Survey Subset|Lost to Follow-up|134|||
146594268|NCT04411420|528684357|FG001|Survey Subset|Lost to Follow-up|120|||
146594269|NCT03899064|528684360|FG000|Overall Study|Lost to Follow-up|1|||
146594270|NCT03899064|528684360|FG000|Overall Study|Protocol Violation|2|||
146594271|NCT03899064|528684360|FG000|Overall Study|Withdrawal by Subject|2|||
146594272|NCT03899064|528684360|FG000|Overall Study|Other|2|||
146594273|NCT00471887|528684366|FG000|Overall Study|Adverse Event|9|||
146594274|NCT05438602|528684367|FG000|Treatment (15 Days)|Adverse Event|2|||
146594275|NCT05438602|528684368|FG001|Treatment (15 Days)|Adverse Event|1|||
146594276|NCT05438602|528684369|FG002|Treatment (15 Days)|Adverse Event|3|||
146594277|NCT05438602|528684367|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
146594278|NCT05438602|528684368|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
146919993|NCT00069095|529868875|FG000|Primary Treatment Phase|Admin/Other|29|||
146919994|NCT00069095|529868876|FG001|Primary Treatment Phase|Admin/Other|38|||
146919995|NCT00069095|529868877|FG002|Primary Treatment Phase|Admin/Other|31|||
146594279|NCT05438602|528684369|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
146594280|NCT05438602|528684367|FG000|Treatment (15 Days)|Other|0|||
146594281|NCT05438602|528684368|FG001|Treatment (15 Days)|Other|0|||
146594282|NCT05438602|528684369|FG002|Treatment (15 Days)|Other|1|||
146594283|NCT05438602|528684367|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
146594284|NCT05438602|528684368|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
146594285|NCT05438602|528684369|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
146594286|NCT05438602|528684367|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
146594287|NCT05438602|528684368|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
146594288|NCT05438602|528684369|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
146594289|NCT05438602|528684367|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
146594290|NCT05438602|528684368|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
146594291|NCT05438602|528684369|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
146594292|NCT05438602|528684367|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
146594293|NCT05438602|528684368|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
146594294|NCT05438602|528684369|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
146594295|NCT05438602|528684367|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
146594296|NCT05438602|528684368|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
146594297|NCT05438602|528684369|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
146594298|NCT05438602|528684367|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
146594299|NCT05438602|528684368|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
146594300|NCT05438602|528684369|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
146594301|NCT05438602|528684367|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
146594302|NCT05438602|528684368|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
146594303|NCT05438602|528684369|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
146594304|NCT02091284|528684370|FG000|Overall Study|Withdrawal by Subject|2|||
146594305|NCT02091284|528684371|FG001|Overall Study|Withdrawal by Subject|1|||
146594306|NCT02091284|528684370|FG000|Overall Study|unreliable data|1|||
146594307|NCT02091284|528684371|FG001|Overall Study|unreliable data|0|||
146594308|NCT04524455|528684376|FG000|Overall Study|Death|3|||
146594309|NCT04524455|528684377|FG001|Overall Study|Death|3|||
146594310|NCT04524455|528684376|FG000|Overall Study|Decision by Sponsor|0|||
146594311|NCT04524455|528684377|FG001|Overall Study|Decision by Sponsor|2|||
146594312|NCT04524455|528684376|FG000|Overall Study|Withdrawal of Consent From Study|1|||
146594313|NCT04524455|528684377|FG001|Overall Study|Withdrawal of Consent From Study|0|||
146594314|NCT04524455|528684376|FG000|Overall Study|Lost to Follow-up|0|||
146594315|NCT04524455|528684377|FG001|Overall Study|Lost to Follow-up|1|||
146594316|NCT00076336|528684380|FG000|Overall Study|Death|13|||
146594317|NCT00076336|528684381|FG001|Overall Study|Death|17|||
146594318|NCT00076336|528684380|FG000|Overall Study|Adverse Event|4|||
146594319|NCT00076336|528684381|FG001|Overall Study|Adverse Event|4|||
146919996|NCT00069095|529868878|FG003|Primary Treatment Phase|Admin/Other|45|||
146919997|NCT00069095|529868879|FG004|Primary Treatment Phase|Admin/Other|48|||
146919998|NCT00069095|529868880|FG005|Primary Treatment Phase|Admin/Other|42|||
146919999|NCT00069095|529868875|FG000|Primary Treatment Phase|Adverse Event|99|||
146920000|NCT00069095|529868876|FG001|Primary Treatment Phase|Adverse Event|92|||
146920001|NCT00069095|529868877|FG002|Primary Treatment Phase|Adverse Event|71|||
146920002|NCT00069095|529868878|FG003|Primary Treatment Phase|Adverse Event|72|||
146920003|NCT00069095|529868879|FG004|Primary Treatment Phase|Adverse Event|109|||
146920004|NCT00069095|529868880|FG005|Primary Treatment Phase|Adverse Event|101|||
146920005|NCT00069095|529868875|FG000|Primary Treatment Phase|Death|14|||
146920006|NCT00069095|529868876|FG001|Primary Treatment Phase|Death|8|||
146920007|NCT00069095|529868877|FG002|Primary Treatment Phase|Death|2|||
146920008|NCT00069095|529868878|FG003|Primary Treatment Phase|Death|5|||
146920009|NCT00069095|529868879|FG004|Primary Treatment Phase|Death|8|||
146920010|NCT00069095|529868880|FG005|Primary Treatment Phase|Death|8|||
146920011|NCT00069095|529868875|FG000|Primary Treatment Phase|Failure to return|5|||
146920012|NCT00069095|529868876|FG001|Primary Treatment Phase|Failure to return|5|||
146920013|NCT00069095|529868877|FG002|Primary Treatment Phase|Failure to return|0|||
146920014|NCT00069095|529868878|FG003|Primary Treatment Phase|Failure to return|0|||
146920015|NCT00069095|529868879|FG004|Primary Treatment Phase|Failure to return|0|||
146920016|NCT00069095|529868880|FG005|Primary Treatment Phase|Failure to return|2|||
146920017|NCT00069095|529868875|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
146920018|NCT00069095|529868876|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
146594320|NCT00076336|528684380|FG000|Overall Study|Lost to Follow-up|4|||
146594321|NCT00076336|528684381|FG001|Overall Study|Lost to Follow-up|4|||
146920019|NCT00069095|529868877|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
146920020|NCT00069095|529868878|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
146920021|NCT00069095|529868879|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
146594322|NCT00076336|528684380|FG000|Overall Study|Non-Compliance|2|||
146594323|NCT00076336|528684381|FG001|Overall Study|Non-Compliance|0|||
146594324|NCT00076336|528684380|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
146594325|NCT00076336|528684381|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
146594326|NCT00076336|528684380|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
146594327|NCT00076336|528684381|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
146653531|NCT04393298|528910621|FG000|Overall Study|Adverse Event|0|||
146920022|NCT00069095|529868880|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
146920023|NCT00069095|529868875|FG000|Primary Treatment Phase|Refused treatment|15|||
146594328|NCT00076336|528684380|FG000|Overall Study|Liver Transplantation|3|||
146594329|NCT00076336|528684381|FG001|Overall Study|Liver Transplantation|3|||
146594330|NCT00076336|528684380|FG000|Overall Study|Virologic Breakthrough|14|||
146920024|NCT00069095|529868876|FG001|Primary Treatment Phase|Refused treatment|26|||
146920025|NCT00069095|529868877|FG002|Primary Treatment Phase|Refused treatment|17|||
146920026|NCT00069095|529868878|FG003|Primary Treatment Phase|Refused treatment|31|||
146920027|NCT00069095|529868879|FG004|Primary Treatment Phase|Refused treatment|24|||
146594331|NCT00076336|528684381|FG001|Overall Study|Virologic Breakthrough|16|||
146594332|NCT00076336|528684380|FG000|Overall Study|Treatment failure|4|||
146594333|NCT00076336|528684381|FG001|Overall Study|Treatment failure|5|||
146594334|NCT00098722|528684385|FG000|Double Blind Phase|Adverse Event|7|||
146594335|NCT00098722|528684386|FG001|Double Blind Phase|Adverse Event|7|||
146594336|NCT00098722|528684387|FG002|Double Blind Phase|Adverse Event|3|||
146594337|NCT00098722|528684388|FG003|Double Blind Phase|Adverse Event|0|||
146594338|NCT00098722|528684389|FG004|Double Blind Phase|Adverse Event|0|||
146594339|NCT00098722|528684390|FG005|Double Blind Phase|Adverse Event|0|||
146594340|NCT00098722|528684391|FG006|Double Blind Phase|Adverse Event|0|||
146594341|NCT00098722|528684385|FG000|Double Blind Phase|Death|2|||
146594342|NCT00098722|528684386|FG001|Double Blind Phase|Death|5|||
146594343|NCT00098722|528684387|FG002|Double Blind Phase|Death|0|||
146594344|NCT00098722|528684388|FG003|Double Blind Phase|Death|0|||
146594345|NCT00098722|528684389|FG004|Double Blind Phase|Death|0|||
146594346|NCT00098722|528684390|FG005|Double Blind Phase|Death|0|||
146594347|NCT00098722|528684391|FG006|Double Blind Phase|Death|0|||
146594348|NCT00098722|528684385|FG000|Double Blind Phase|Lack of Efficacy|21|||
146594349|NCT00098722|528684386|FG001|Double Blind Phase|Lack of Efficacy|23|||
146594350|NCT00098722|528684387|FG002|Double Blind Phase|Lack of Efficacy|15|||
146594351|NCT00098722|528684388|FG003|Double Blind Phase|Lack of Efficacy|0|||
146594352|NCT00098722|528684389|FG004|Double Blind Phase|Lack of Efficacy|0|||
146594353|NCT00098722|528684390|FG005|Double Blind Phase|Lack of Efficacy|0|||
146594354|NCT00098722|528684391|FG006|Double Blind Phase|Lack of Efficacy|0|||
146594355|NCT00098722|528684385|FG000|Double Blind Phase|Participant defaulted|16|||
146594356|NCT00098722|528684386|FG001|Double Blind Phase|Participant defaulted|11|||
146594357|NCT00098722|528684387|FG002|Double Blind Phase|Participant defaulted|9|||
146594358|NCT00098722|528684388|FG003|Double Blind Phase|Participant defaulted|0|||
146594359|NCT00098722|528684389|FG004|Double Blind Phase|Participant defaulted|0|||
146594360|NCT00098722|528684390|FG005|Double Blind Phase|Participant defaulted|0|||
146594361|NCT00098722|528684391|FG006|Double Blind Phase|Participant defaulted|0|||
146594362|NCT00098722|528684385|FG000|Double Blind Phase|Pregnancy|1|||
146594363|NCT00098722|528684386|FG001|Double Blind Phase|Pregnancy|0|||
146594364|NCT00098722|528684387|FG002|Double Blind Phase|Pregnancy|0|||
146594365|NCT00098722|528684388|FG003|Double Blind Phase|Pregnancy|0|||
146594366|NCT00098722|528684389|FG004|Double Blind Phase|Pregnancy|0|||
146594367|NCT00098722|528684390|FG005|Double Blind Phase|Pregnancy|0|||
146594368|NCT00098722|528684391|FG006|Double Blind Phase|Pregnancy|0|||
146594369|NCT00098722|528684385|FG000|Double Blind Phase|Randomized, not treated|4|||
146594370|NCT00098722|528684386|FG001|Double Blind Phase|Randomized, not treated|3|||
146594371|NCT00098722|528684387|FG002|Double Blind Phase|Randomized, not treated|3|||
146594372|NCT00098722|528684388|FG003|Double Blind Phase|Randomized, not treated|0|||
146594373|NCT00098722|528684389|FG004|Double Blind Phase|Randomized, not treated|0|||
146594374|NCT00098722|528684390|FG005|Double Blind Phase|Randomized, not treated|0|||
146594375|NCT00098722|528684391|FG006|Double Blind Phase|Randomized, not treated|0|||
146594376|NCT00098722|528684385|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
146594377|NCT00098722|528684386|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
146594378|NCT00098722|528684387|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
146594379|NCT00098722|528684388|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
146920028|NCT00069095|529868880|FG005|Primary Treatment Phase|Refused treatment|27|||
146920029|NCT00069095|529868875|FG000|Primary Treatment Phase|Withdrew|2|||
146920030|NCT00069095|529868876|FG001|Primary Treatment Phase|Withdrew|3|||
146920031|NCT00069095|529868877|FG002|Primary Treatment Phase|Withdrew|8|||
146594380|NCT00098722|528684389|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
146594381|NCT00098722|528684390|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
146594382|NCT00098722|528684391|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
146594383|NCT00098722|528684385|FG000|Double Blind Phase|Other|7|||
146594384|NCT00098722|528684386|FG001|Double Blind Phase|Other|8|||
146594385|NCT00098722|528684387|FG002|Double Blind Phase|Other|7|||
146594386|NCT00098722|528684388|FG003|Double Blind Phase|Other|0|||
146594387|NCT00098722|528684389|FG004|Double Blind Phase|Other|0|||
146594388|NCT00098722|528684390|FG005|Double Blind Phase|Other|0|||
146594389|NCT00098722|528684391|FG006|Double Blind Phase|Other|0|||
146594390|NCT00098722|528684385|FG000|Open Label Phase|Adverse Event|0|||
146594391|NCT00098722|528684386|FG001|Open Label Phase|Adverse Event|0|||
146594392|NCT00098722|528684387|FG002|Open Label Phase|Adverse Event|0|||
146594393|NCT00098722|528684388|FG003|Open Label Phase|Adverse Event|5|||
146594394|NCT00098722|528684389|FG004|Open Label Phase|Adverse Event|0|||
146594395|NCT00098722|528684390|FG005|Open Label Phase|Adverse Event|0|||
146594396|NCT00098722|528684391|FG006|Open Label Phase|Adverse Event|0|||
146920032|NCT00069095|529868878|FG003|Primary Treatment Phase|Withdrew|2|||
146920033|NCT00069095|529868879|FG004|Primary Treatment Phase|Withdrew|4|||
146920034|NCT00069095|529868880|FG005|Primary Treatment Phase|Withdrew|9|||
146920035|NCT00069095|529868875|FG000|Primary Treatment Phase|Other Violation|0|||
146920036|NCT00069095|529868876|FG001|Primary Treatment Phase|Other Violation|1|||
146920037|NCT00069095|529868877|FG002|Primary Treatment Phase|Other Violation|1|||
146920038|NCT00069095|529868878|FG003|Primary Treatment Phase|Other Violation|1|||
146920039|NCT00069095|529868879|FG004|Primary Treatment Phase|Other Violation|0|||
146920040|NCT00069095|529868880|FG005|Primary Treatment Phase|Other Violation|1|||
146920041|NCT00069095|529868875|FG000|Primary Treatment Phase|Violation criteria|0|||
146920042|NCT00069095|529868876|FG001|Primary Treatment Phase|Violation criteria|2|||
146920043|NCT00069095|529868877|FG002|Primary Treatment Phase|Violation criteria|4|||
146920044|NCT00069095|529868878|FG003|Primary Treatment Phase|Violation criteria|3|||
146920045|NCT00069095|529868879|FG004|Primary Treatment Phase|Violation criteria|1|||
146920046|NCT00069095|529868880|FG005|Primary Treatment Phase|Violation criteria|5|||
146920047|NCT00069095|529868875|FG000|Post-study Treatment Phase|Missing reason|1|||
146920048|NCT00069095|529868876|FG001|Post-study Treatment Phase|Missing reason|3|||
146920049|NCT00069095|529868877|FG002|Post-study Treatment Phase|Missing reason|12|||
146920050|NCT00069095|529868878|FG003|Post-study Treatment Phase|Missing reason|8|||
146920051|NCT00069095|529868879|FG004|Post-study Treatment Phase|Missing reason|18|||
146920052|NCT00069095|529868880|FG005|Post-study Treatment Phase|Missing reason|17|||
146920053|NCT00069095|529868875|FG000|Post-study Treatment Phase|Adverse Event|2|||
146920054|NCT00069095|529868876|FG001|Post-study Treatment Phase|Adverse Event|3|||
146920055|NCT00069095|529868877|FG002|Post-study Treatment Phase|Adverse Event|1|||
146920056|NCT00069095|529868878|FG003|Post-study Treatment Phase|Adverse Event|0|||
146920057|NCT00069095|529868879|FG004|Post-study Treatment Phase|Adverse Event|5|||
146920058|NCT00069095|529868880|FG005|Post-study Treatment Phase|Adverse Event|1|||
146920059|NCT00069095|529868875|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
146594397|NCT00098722|528684385|FG000|Open Label Phase|Death|0|||
146594398|NCT00098722|528684386|FG001|Open Label Phase|Death|0|||
146594399|NCT00098722|528684387|FG002|Open Label Phase|Death|0|||
146594400|NCT00098722|528684388|FG003|Open Label Phase|Death|2|||
146594401|NCT00098722|528684389|FG004|Open Label Phase|Death|0|||
146594402|NCT00098722|528684390|FG005|Open Label Phase|Death|0|||
146594403|NCT00098722|528684391|FG006|Open Label Phase|Death|0|||
146594404|NCT00098722|528684385|FG000|Open Label Phase|Lack of Efficacy|0|||
146594405|NCT00098722|528684386|FG001|Open Label Phase|Lack of Efficacy|0|||
146594406|NCT00098722|528684387|FG002|Open Label Phase|Lack of Efficacy|0|||
146594407|NCT00098722|528684388|FG003|Open Label Phase|Lack of Efficacy|8|||
146594408|NCT00098722|528684389|FG004|Open Label Phase|Lack of Efficacy|0|||
146594409|NCT00098722|528684390|FG005|Open Label Phase|Lack of Efficacy|0|||
146594410|NCT00098722|528684391|FG006|Open Label Phase|Lack of Efficacy|0|||
146594411|NCT00098722|528684385|FG000|Open Label Phase|Pregnancy|0|||
146594412|NCT00098722|528684386|FG001|Open Label Phase|Pregnancy|0|||
146594413|NCT00098722|528684387|FG002|Open Label Phase|Pregnancy|0|||
146594414|NCT00098722|528684388|FG003|Open Label Phase|Pregnancy|1|||
146594415|NCT00098722|528684389|FG004|Open Label Phase|Pregnancy|0|||
146594416|NCT00098722|528684390|FG005|Open Label Phase|Pregnancy|0|||
146594417|NCT00098722|528684391|FG006|Open Label Phase|Pregnancy|0|||
146594418|NCT00098722|528684385|FG000|Open Label Phase|Participant defaulted|0|||
146594419|NCT00098722|528684386|FG001|Open Label Phase|Participant defaulted|0|||
146594420|NCT00098722|528684387|FG002|Open Label Phase|Participant defaulted|0|||
146594421|NCT00098722|528684388|FG003|Open Label Phase|Participant defaulted|18|||
146594422|NCT00098722|528684389|FG004|Open Label Phase|Participant defaulted|0|||
146594423|NCT00098722|528684390|FG005|Open Label Phase|Participant defaulted|0|||
146594424|NCT00098722|528684391|FG006|Open Label Phase|Participant defaulted|0|||
146594425|NCT00098722|528684385|FG000|Open Label Phase|Ongoing at cut-off date|0|||
146594426|NCT00098722|528684386|FG001|Open Label Phase|Ongoing at cut-off date|0|||
146594427|NCT00098722|528684387|FG002|Open Label Phase|Ongoing at cut-off date|0|||
146594428|NCT00098722|528684388|FG003|Open Label Phase|Ongoing at cut-off date|220|||
146594429|NCT00098722|528684389|FG004|Open Label Phase|Ongoing at cut-off date|50|||
146594430|NCT00098722|528684390|FG005|Open Label Phase|Ongoing at cut-off date|0|||
146594431|NCT00098722|528684391|FG006|Open Label Phase|Ongoing at cut-off date|0|||
146594432|NCT00098722|528684385|FG000|Open Label Phase|Other|0|||
146594433|NCT00098722|528684386|FG001|Open Label Phase|Other|0|||
146594434|NCT00098722|528684387|FG002|Open Label Phase|Other|0|||
146594435|NCT00098722|528684388|FG003|Open Label Phase|Other|18|||
146653532|NCT04393298|528910622|FG001|Overall Study|Adverse Event|0|||
146920060|NCT00069095|529868876|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
146920061|NCT00069095|529868877|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
146594436|NCT00098722|528684389|FG004|Open Label Phase|Other|0|||
146594437|NCT00098722|528684390|FG005|Open Label Phase|Other|0|||
146594438|NCT00098722|528684391|FG006|Open Label Phase|Other|0|||
146594439|NCT00098722|528684385|FG000|Observation Phase|Death|0|||
146594440|NCT00098722|528684386|FG001|Observation Phase|Death|0|||
146594441|NCT00098722|528684387|FG002|Observation Phase|Death|0|||
146594442|NCT00098722|528684388|FG003|Observation Phase|Death|0|||
146594443|NCT00098722|528684389|FG004|Observation Phase|Death|0|||
146920062|NCT00069095|529868878|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
146978450|NCT01904383|530084066|FG000|Overall Study|Adverse Event|271|||
146594444|NCT00098722|528684390|FG005|Observation Phase|Death|5|||
146594445|NCT00098722|528684391|FG006|Observation Phase|Death|3|||
146594446|NCT00098722|528684385|FG000|Observation Phase|Lack of Efficacy|0|||
146594447|NCT00098722|528684386|FG001|Observation Phase|Lack of Efficacy|0|||
146594448|NCT00098722|528684387|FG002|Observation Phase|Lack of Efficacy|0|||
146594449|NCT00098722|528684388|FG003|Observation Phase|Lack of Efficacy|0|||
146594450|NCT00098722|528684389|FG004|Observation Phase|Lack of Efficacy|0|||
146594451|NCT00098722|528684390|FG005|Observation Phase|Lack of Efficacy|2|||
146594452|NCT00098722|528684391|FG006|Observation Phase|Lack of Efficacy|0|||
146594453|NCT00098722|528684385|FG000|Observation Phase|Participant defaulted|0|||
146594454|NCT00098722|528684386|FG001|Observation Phase|Participant defaulted|0|||
146594455|NCT00098722|528684387|FG002|Observation Phase|Participant defaulted|0|||
146594456|NCT00098722|528684388|FG003|Observation Phase|Participant defaulted|0|||
146594457|NCT00098722|528684389|FG004|Observation Phase|Participant defaulted|0|||
146594458|NCT00098722|528684390|FG005|Observation Phase|Participant defaulted|17|||
146594459|NCT00098722|528684391|FG006|Observation Phase|Participant defaulted|4|||
146594460|NCT00098722|528684385|FG000|Observation Phase|Other|0|||
146594461|NCT00098722|528684386|FG001|Observation Phase|Other|0|||
146594462|NCT00098722|528684387|FG002|Observation Phase|Other|0|||
146594463|NCT00098722|528684388|FG003|Observation Phase|Other|0|||
146594464|NCT00098722|528684389|FG004|Observation Phase|Other|0|||
146594465|NCT00098722|528684390|FG005|Observation Phase|Other|21|||
146594466|NCT00098722|528684391|FG006|Observation Phase|Other|10|||
146594467|NCT02351349|528684397|FG000|Overall Study|Withdrawal by Subject|2|||
146594468|NCT02351349|528684398|FG001|Overall Study|Withdrawal by Subject|3|||
146594469|NCT01703117|528684399|FG000|Overall Study|Adverse Event|4|||
146594470|NCT01703117|528684400|FG001|Overall Study|Adverse Event|3|||
146594471|NCT01703117|528684399|FG000|Overall Study|Withdrawal by Subject|0|||
146594472|NCT01703117|528684400|FG001|Overall Study|Withdrawal by Subject|1|||
146594473|NCT01340937|528684402|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
146594474|NCT01340937|528684403|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
146594475|NCT01340937|528684404|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
146594476|NCT01340937|528684405|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
146594477|NCT01340937|528684402|FG000|Period 1: Infant Series|Adverse Event|0|||
146594478|NCT01340937|528684403|FG001|Period 1: Infant Series|Adverse Event|1|||
146594479|NCT01340937|528684404|FG002|Period 1: Infant Series|Adverse Event|4|||
146594480|NCT01340937|528684405|FG003|Period 1: Infant Series|Adverse Event|0|||
146594481|NCT01340937|528684402|FG000|Period 1: Infant Series|Death|2|||
146594482|NCT01340937|528684403|FG001|Period 1: Infant Series|Death|0|||
146594483|NCT01340937|528684404|FG002|Period 1: Infant Series|Death|2|||
146594484|NCT01340937|528684405|FG003|Period 1: Infant Series|Death|0|||
146594485|NCT01340937|528684402|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
146594486|NCT01340937|528684403|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
146594487|NCT01340937|528684404|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
146594488|NCT01340937|528684405|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
146594489|NCT01340937|528684402|FG000|Period 1: Infant Series|Physician Decision|2|||
146594490|NCT01340937|528684403|FG001|Period 1: Infant Series|Physician Decision|3|||
146594491|NCT01340937|528684404|FG002|Period 1: Infant Series|Physician Decision|1|||
146594492|NCT01340937|528684405|FG003|Period 1: Infant Series|Physician Decision|0|||
146653533|NCT04393298|528910623|FG002|Overall Study|Adverse Event|0|||
146653534|NCT04393298|528910624|FG003|Overall Study|Adverse Event|0|||
146653535|NCT04393298|528910625|FG004|Overall Study|Adverse Event|1|||
146653536|NCT04393298|528910626|FG005|Overall Study|Adverse Event|0|||
146653537|NCT04393298|528910627|FG006|Overall Study|Adverse Event|0|||
146653538|NCT04393298|528910628|FG007|Overall Study|Adverse Event|0|||
146653539|NCT04393298|528910629|FG008|Overall Study|Adverse Event|2|||
146653540|NCT04393298|528910630|FG009|Overall Study|Adverse Event|0|||
146653541|NCT04393298|528910631|FG010|Overall Study|Adverse Event|0|||
146653542|NCT04393298|528910632|FG011|Overall Study|Adverse Event|0|||
146653543|NCT04393298|528910633|FG012|Overall Study|Adverse Event|1|||
146653544|NCT04393298|528910634|FG013|Overall Study|Adverse Event|1|||
146653545|NCT04393298|528910635|FG014|Overall Study|Adverse Event|0|||
146653546|NCT04393298|528910621|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146653547|NCT04393298|528910622|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146594493|NCT01340937|528684402|FG000|Period 1: Infant Series|Protocol Violation|1|||
146594494|NCT01340937|528684403|FG001|Period 1: Infant Series|Protocol Violation|4|||
146594495|NCT01340937|528684404|FG002|Period 1: Infant Series|Protocol Violation|4|||
146594496|NCT01340937|528684405|FG003|Period 1: Infant Series|Protocol Violation|3|||
146653548|NCT04393298|528910623|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
146653549|NCT04393298|528910624|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146653550|NCT04393298|528910625|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146653551|NCT04393298|528910626|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146594497|NCT01340937|528684402|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
146594498|NCT01340937|528684403|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
146594499|NCT01340937|528684404|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
146920063|NCT00069095|529868879|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
146920064|NCT00069095|529868880|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
146920065|NCT00069095|529868875|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
146920066|NCT00069095|529868876|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
146920067|NCT00069095|529868877|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
146920068|NCT00069095|529868878|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
146920069|NCT00069095|529868879|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
146594500|NCT01340937|528684405|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
146594501|NCT01340937|528684402|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
146594502|NCT01340937|528684403|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
146594503|NCT01340937|528684404|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
146594504|NCT01340937|528684405|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
146594505|NCT01340937|528684402|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
146594506|NCT01340937|528684403|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
146594507|NCT01340937|528684404|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
146594508|NCT01340937|528684405|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
146594509|NCT01340937|528684402|FG000|Period 2: Interim Period|Adverse Event|1|||
146594510|NCT01340937|528684403|FG001|Period 2: Interim Period|Adverse Event|0|||
146594511|NCT01340937|528684404|FG002|Period 2: Interim Period|Adverse Event|1|||
146594512|NCT01340937|528684405|FG003|Period 2: Interim Period|Adverse Event|0|||
146594513|NCT01340937|528684402|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
146594514|NCT01340937|528684403|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
146594515|NCT01340937|528684404|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
146594516|NCT01340937|528684405|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
146594517|NCT01340937|528684402|FG000|Period 2: Interim Period|Physician Decision|0|||
146594518|NCT01340937|528684403|FG001|Period 2: Interim Period|Physician Decision|1|||
146594519|NCT01340937|528684404|FG002|Period 2: Interim Period|Physician Decision|1|||
146594520|NCT01340937|528684405|FG003|Period 2: Interim Period|Physician Decision|0|||
146594521|NCT01340937|528684402|FG000|Period 2: Interim Period|Protocol Violation|5|||
146594522|NCT01340937|528684403|FG001|Period 2: Interim Period|Protocol Violation|3|||
146594523|NCT01340937|528684404|FG002|Period 2: Interim Period|Protocol Violation|6|||
146594524|NCT01340937|528684405|FG003|Period 2: Interim Period|Protocol Violation|3|||
146594525|NCT01340937|528684402|FG000|Period 2: Interim Period|Technical problems|4|||
146594526|NCT01340937|528684403|FG001|Period 2: Interim Period|Technical problems|4|||
146594527|NCT01340937|528684404|FG002|Period 2: Interim Period|Technical problems|6|||
146594528|NCT01340937|528684405|FG003|Period 2: Interim Period|Technical problems|3|||
146594529|NCT01340937|528684402|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
146594530|NCT01340937|528684403|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
146594531|NCT01340937|528684404|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
146594532|NCT01340937|528684405|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
146594533|NCT01340937|528684402|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
146594534|NCT01340937|528684403|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
146594535|NCT01340937|528684404|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
146594536|NCT01340937|528684405|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
146594537|NCT01340937|528684402|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
146594538|NCT01340937|528684403|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
146594539|NCT01340937|528684404|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
146594540|NCT01340937|528684405|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
146594541|NCT01340937|528684402|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
146594542|NCT01340937|528684403|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
146594543|NCT01340937|528684404|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
146594544|NCT01340937|528684405|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
146594545|NCT00440310|528684406|FG000|Overall Study|Lost to Follow-up|4|||
146594546|NCT00440310|528684407|FG001|Overall Study|Lost to Follow-up|5|||
146594547|NCT00440310|528684406|FG000|Overall Study|Protocol Violation|0|||
146594548|NCT00440310|528684407|FG001|Overall Study|Protocol Violation|1|||
146594549|NCT00440310|528684406|FG000|Overall Study|Withdrawal by Subject|15|||
146594550|NCT00440310|528684407|FG001|Overall Study|Withdrawal by Subject|14|||
146594551|NCT00440310|528684406|FG000|Overall Study|No Reply at EOS|7|||
146594552|NCT00440310|528684407|FG001|Overall Study|No Reply at EOS|7|||
146594553|NCT00440310|528684406|FG000|Overall Study|Other|1|||
146653552|NCT04393298|528910627|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146653553|NCT04393298|528910628|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146920070|NCT00069095|529868880|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
146594554|NCT00440310|528684407|FG001|Overall Study|Other|0|||
146594555|NCT00440310|528684406|FG000|Overall Study|Status Unknown|1|||
146594556|NCT00440310|528684407|FG001|Overall Study|Status Unknown|3|||
146594557|NCT02119156|528684408|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
146594558|NCT02119156|528684409|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
146594559|NCT02119156|528684410|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
146594560|NCT02119156|528684408|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
146594561|NCT02119156|528684409|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
146594562|NCT02119156|528684410|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
146594563|NCT02119156|528684408|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
146594564|NCT02119156|528684409|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
146594565|NCT02119156|528684410|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
146594566|NCT02119156|528684408|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
146594567|NCT02119156|528684409|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
146594568|NCT02119156|528684410|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
146594569|NCT02119156|528684408|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
146594570|NCT02119156|528684409|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
146594571|NCT02119156|528684410|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
146594572|NCT02469415|528684411|FG000|Overall Study|Withdrawal by Subject|1|||
146594573|NCT02469415|528684411|FG000|Overall Study|Investigational agent placed on hold|2|||
146771522|NCT05061693|529331232|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146594574|NCT01998893|528684416|FG000|Overall Study|Adverse Event|2|||
146594575|NCT01998893|528684416|FG000|Overall Study|Death|1|||
146594576|NCT01998893|528684416|FG000|Overall Study|Lost to Follow-up|8|||
146594577|NCT01998893|528684416|FG000|Overall Study|Physician Decision|2|||
146594578|NCT01998893|528684416|FG000|Overall Study|Protocol Violation|2|||
146594579|NCT01998893|528684416|FG000|Overall Study|Withdrawal by Subject|1|||
146594580|NCT01998893|528684416|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
146594581|NCT05136898|528684417|FG000|Overall Study|Adverse Event|2|||
146594582|NCT00867087|528684418|FG000|Overall Study|Other|1|||
146594583|NCT00867087|528684418|FG000|Overall Study|Withdrawal by Subject|4|||
146594584|NCT00867087|528684418|FG000|Overall Study|Death|37|||
146594585|NCT02334683|528684427|FG000|First 12 Week Period|Lost to Follow-up|1|||
146594586|NCT02334683|528684428|FG001|First 12 Week Period|Lost to Follow-up|0|||
146594587|NCT02334683|528684427|FG000|Second 12 Week Period|Adverse Event|0|||
146594588|NCT02334683|528684428|FG001|Second 12 Week Period|Adverse Event|1|||
146594589|NCT01891344|528684429|FG000|Overall Study|Ongoing|6|||
146594590|NCT01891344|528684430|FG001|Overall Study|Ongoing|2|||
146594591|NCT01891344|528684431|FG002|Overall Study|Ongoing|0|||
146594592|NCT01891344|528684432|FG003|Overall Study|Ongoing|1|||
146594593|NCT01891344|528684433|FG004|Overall Study|Ongoing|4|||
146594594|NCT01891344|528684434|FG005|Overall Study|Ongoing|1|||
146594595|NCT01891344|528684435|FG006|Overall Study|Ongoing|0|||
146594596|NCT01891344|528684436|FG007|Overall Study|Ongoing|0|||
146594597|NCT02969590|528684437|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
146594598|NCT02969590|528684438|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
146594599|NCT02969590|528684439|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
146594600|NCT01414205|528684440|FG000|Overall Study|Death|5|||
146594601|NCT01414205|528684441|FG001|Overall Study|Death|1|||
146594602|NCT01414205|528684440|FG000|Overall Study|Lost to Follow-up|1|||
146594603|NCT01414205|528684441|FG001|Overall Study|Lost to Follow-up|4|||
146594604|NCT01414205|528684440|FG000|Overall Study|Physician Decision|0|||
146594605|NCT01414205|528684441|FG001|Overall Study|Physician Decision|1|||
146594606|NCT01414205|528684440|FG000|Overall Study|Randomized but not Treated|1|||
146594607|NCT01414205|528684441|FG001|Overall Study|Randomized but not Treated|1|||
146594608|NCT02498067|528684442|FG000|Overall Study|Lost to Follow-up|22|||
146594609|NCT02498067|528684442|FG000|Overall Study|Did not meet inclusion criteria|11|||
146594610|NCT00541099|528684450|FG000|Overall Study|Ineligible|3|||
146594611|NCT00066469|528684451|FG000|Overall Study|Death|3|||
146594612|NCT00066469|528684451|FG000|Overall Study|Lack of Efficacy|9|||
146594613|NCT00066469|528684451|FG000|Overall Study|Lost to Follow-up|1|||
146594614|NCT00066469|528684451|FG000|Overall Study|Physician Decision|1|||
146594615|NCT00066469|528684451|FG000|Overall Study|Withdrawal by Subject|1|||
146594616|NCT00066469|528684451|FG000|Overall Study|ineligible|1|||
146594617|NCT00711802|528684452|FG000|Overall Study|Not treated (no further detail)|2|||
146594618|NCT00711802|528684453|FG001|Overall Study|Not treated (no further detail)|1|||
146594619|NCT00711802|528684454|FG002|Overall Study|Not treated (no further detail)|2|||
146594620|NCT00711802|528684455|FG003|Overall Study|Not treated (no further detail)|0|||
146594621|NCT00711802|528684456|FG004|Overall Study|Not treated (no further detail)|2|||
146594622|NCT00711802|528684457|FG005|Overall Study|Not treated (no further detail)|0|||
146594623|NCT00711802|528684458|FG006|Overall Study|Not treated (no further detail)|0|||
146594624|NCT00711802|528684459|FG007|Overall Study|Not treated (no further detail)|0|||
146594625|NCT00711802|528684452|FG000|Overall Study|Adverse Event|0|||
146594626|NCT00711802|528684453|FG001|Overall Study|Adverse Event|0|||
146594627|NCT00711802|528684454|FG002|Overall Study|Adverse Event|0|||
146920071|NCT00069095|529868875|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
146594628|NCT00711802|528684455|FG003|Overall Study|Adverse Event|0|||
146594629|NCT00711802|528684456|FG004|Overall Study|Adverse Event|1|||
146594630|NCT00711802|528684457|FG005|Overall Study|Adverse Event|1|||
146594631|NCT00711802|528684458|FG006|Overall Study|Adverse Event|0|||
146594632|NCT00711802|528684459|FG007|Overall Study|Adverse Event|0|||
146594633|NCT00711802|528684452|FG000|Overall Study|Microbiological failure|0|||
146594634|NCT00711802|528684453|FG001|Overall Study|Microbiological failure|1|||
146594635|NCT00711802|528684454|FG002|Overall Study|Microbiological failure|0|||
146594636|NCT00711802|528684455|FG003|Overall Study|Microbiological failure|0|||
146594637|NCT00711802|528684456|FG004|Overall Study|Microbiological failure|0|||
146594638|NCT00711802|528684457|FG005|Overall Study|Microbiological failure|1|||
146594639|NCT00711802|528684458|FG006|Overall Study|Microbiological failure|0|||
146594640|NCT00711802|528684459|FG007|Overall Study|Microbiological failure|0|||
146594641|NCT00711802|528684452|FG000|Overall Study|Protocol Violation|0|||
146594642|NCT00711802|528684453|FG001|Overall Study|Protocol Violation|0|||
146594643|NCT00711802|528684454|FG002|Overall Study|Protocol Violation|0|||
146594644|NCT00711802|528684455|FG003|Overall Study|Protocol Violation|1|||
146594645|NCT00711802|528684456|FG004|Overall Study|Protocol Violation|0|||
146594646|NCT00711802|528684457|FG005|Overall Study|Protocol Violation|0|||
146594647|NCT00711802|528684458|FG006|Overall Study|Protocol Violation|0|||
146594648|NCT00711802|528684459|FG007|Overall Study|Protocol Violation|0|||
146594649|NCT00711802|528684452|FG000|Overall Study|Physician Decision|0|||
146594650|NCT00711802|528684453|FG001|Overall Study|Physician Decision|2|||
146594651|NCT00711802|528684454|FG002|Overall Study|Physician Decision|0|||
146594652|NCT00711802|528684455|FG003|Overall Study|Physician Decision|0|||
146594653|NCT00711802|528684456|FG004|Overall Study|Physician Decision|0|||
146594654|NCT00711802|528684457|FG005|Overall Study|Physician Decision|0|||
146594655|NCT00711802|528684458|FG006|Overall Study|Physician Decision|0|||
146594656|NCT00711802|528684459|FG007|Overall Study|Physician Decision|0|||
146594657|NCT00711802|528684452|FG000|Overall Study|Withdrawal by Subject|0|||
146594658|NCT00711802|528684453|FG001|Overall Study|Withdrawal by Subject|1|||
146594659|NCT00711802|528684454|FG002|Overall Study|Withdrawal by Subject|0|||
146594660|NCT00711802|528684455|FG003|Overall Study|Withdrawal by Subject|1|||
146594661|NCT00711802|528684456|FG004|Overall Study|Withdrawal by Subject|0|||
146594662|NCT00711802|528684457|FG005|Overall Study|Withdrawal by Subject|0|||
146594663|NCT00711802|528684458|FG006|Overall Study|Withdrawal by Subject|0|||
146594664|NCT00711802|528684459|FG007|Overall Study|Withdrawal by Subject|0|||
146594665|NCT00711802|528684452|FG000|Overall Study|Lost to Follow-up|0|||
146594666|NCT00711802|528684453|FG001|Overall Study|Lost to Follow-up|0|||
146594667|NCT00711802|528684454|FG002|Overall Study|Lost to Follow-up|3|||
146594668|NCT00711802|528684455|FG003|Overall Study|Lost to Follow-up|1|||
146594669|NCT00711802|528684456|FG004|Overall Study|Lost to Follow-up|10|||
146594670|NCT00711802|528684457|FG005|Overall Study|Lost to Follow-up|6|||
146594671|NCT00711802|528684458|FG006|Overall Study|Lost to Follow-up|4|||
146594672|NCT00711802|528684459|FG007|Overall Study|Lost to Follow-up|2|||
146594673|NCT00711802|528684452|FG000|Overall Study|Reason not reported|0|||
146594674|NCT00711802|528684453|FG001|Overall Study|Reason not reported|1|||
146594675|NCT00711802|528684454|FG002|Overall Study|Reason not reported|1|||
146594676|NCT00711802|528684455|FG003|Overall Study|Reason not reported|0|||
146594677|NCT00711802|528684456|FG004|Overall Study|Reason not reported|1|||
146594678|NCT00711802|528684457|FG005|Overall Study|Reason not reported|0|||
146594679|NCT00711802|528684458|FG006|Overall Study|Reason not reported|1|||
146594680|NCT00711802|528684459|FG007|Overall Study|Reason not reported|0|||
146594681|NCT00581828|528684460|FG000|Overall Study|Protocol Violation|1|||
146594682|NCT02370095|528684461|FG000|Overall Study|Withdrawal by Subject|0|||
146594683|NCT02370095|528684462|FG001|Overall Study|Withdrawal by Subject|1|||
146594684|NCT01667562|528684463|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
146594685|NCT01667562|528684464|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
146594686|NCT01667562|528684463|FG000|Erlotinib Phase|Lost to Follow-up|0|||
146594687|NCT01667562|528684464|FG001|Erlotinib Phase|Lost to Follow-up|1|||
146594688|NCT01667562|528684463|FG000|Erlotinib Phase|Adverse Event|0|||
146594689|NCT01667562|528684464|FG001|Erlotinib Phase|Adverse Event|1|||
146594690|NCT01667562|528684463|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
146594691|NCT01667562|528684464|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
146594692|NCT02130986|528684465|FG000|Overall Study|Withdrawal by Subject|4|||
146594693|NCT02130986|528684466|FG001|Overall Study|Withdrawal by Subject|4|||
146594694|NCT02130986|528684465|FG000|Overall Study|Lost to Follow-up|151|||
146594695|NCT02130986|528684466|FG001|Overall Study|Lost to Follow-up|160|||
146594696|NCT01129882|528684467|FG000|Overall Study|Adverse Event|39|||
146594697|NCT01129882|528684467|FG000|Overall Study|Death|6|||
146594698|NCT01129882|528684467|FG000|Overall Study|Lack of Efficacy|5|||
146594699|NCT01129882|528684467|FG000|Overall Study|Lost to Follow-up|13|||
146594700|NCT01129882|528684467|FG000|Overall Study|Physician Decision|27|||
146594701|NCT01129882|528684467|FG000|Overall Study|Protocol Deviation|3|||
146594702|NCT01129882|528684467|FG000|Overall Study|Withdrawal Criteria Met|19|||
146594703|NCT01129882|528684467|FG000|Overall Study|Trial Termination by Sponsor|6|||
146594704|NCT01129882|528684467|FG000|Overall Study|Withdrawal by Subject|160|||
146594705|NCT02305849|528684468|FG000|Overall Study|Adverse Event|10|||
146594706|NCT02305849|528684469|FG001|Overall Study|Adverse Event|12|||
146594707|NCT02305849|528684470|FG002|Overall Study|Adverse Event|7|||
146594708|NCT02305849|528684471|FG003|Overall Study|Adverse Event|3|||
146594709|NCT02305849|528684468|FG000|Overall Study|Lack of Efficacy|10|||
146594710|NCT02305849|528684469|FG001|Overall Study|Lack of Efficacy|6|||
146594711|NCT02305849|528684470|FG002|Overall Study|Lack of Efficacy|3|||
146594712|NCT02305849|528684471|FG003|Overall Study|Lack of Efficacy|9|||
146594713|NCT02305849|528684468|FG000|Overall Study|Withdrawal by Subject|2|||
146594714|NCT02305849|528684469|FG001|Overall Study|Withdrawal by Subject|2|||
146594715|NCT02305849|528684470|FG002|Overall Study|Withdrawal by Subject|1|||
146594716|NCT02305849|528684471|FG003|Overall Study|Withdrawal by Subject|4|||
146594717|NCT02305849|528684468|FG000|Overall Study|Lost to Follow-up|0|||
146594718|NCT02305849|528684469|FG001|Overall Study|Lost to Follow-up|2|||
146594719|NCT02305849|528684470|FG002|Overall Study|Lost to Follow-up|0|||
146594720|NCT02305849|528684471|FG003|Overall Study|Lost to Follow-up|0|||
146594721|NCT02305849|528684468|FG000|Overall Study|Protocol Violation|3|||
146594722|NCT02305849|528684469|FG001|Overall Study|Protocol Violation|2|||
146594723|NCT02305849|528684470|FG002|Overall Study|Protocol Violation|1|||
146594724|NCT02305849|528684471|FG003|Overall Study|Protocol Violation|1|||
146594725|NCT02305849|528684468|FG000|Overall Study|Lab data met discontinuation criteria|0|||
146594726|NCT02305849|528684469|FG001|Overall Study|Lab data met discontinuation criteria|1|||
146594727|NCT02305849|528684470|FG002|Overall Study|Lab data met discontinuation criteria|2|||
146594728|NCT02305849|528684471|FG003|Overall Study|Lab data met discontinuation criteria|1|||
146594729|NCT02305849|528684468|FG000|Overall Study|Miscellaneous|1|||
146594730|NCT02305849|528684469|FG001|Overall Study|Miscellaneous|2|||
146594731|NCT02305849|528684470|FG002|Overall Study|Miscellaneous|4|||
146594732|NCT02305849|528684471|FG003|Overall Study|Miscellaneous|1|||
146594733|NCT02305849|528684468|FG000|Overall Study|Not fulfill eligibility criteria|1|||
146594734|NCT02305849|528684469|FG001|Overall Study|Not fulfill eligibility criteria|1|||
146594735|NCT02305849|528684470|FG002|Overall Study|Not fulfill eligibility criteria|0|||
146594736|NCT02305849|528684471|FG003|Overall Study|Not fulfill eligibility criteria|0|||
146594737|NCT00355342|528684472|FG000|Overall Study|Adverse Event|13|||
146594738|NCT00355342|528684473|FG001|Overall Study|Adverse Event|15|||
146594739|NCT00355342|528684472|FG000|Overall Study|Lost to Follow-up|4|||
146594740|NCT00355342|528684473|FG001|Overall Study|Lost to Follow-up|2|||
146594741|NCT00355342|528684472|FG000|Overall Study|Withdrawal by Subject|14|||
146594742|NCT00355342|528684473|FG001|Overall Study|Withdrawal by Subject|11|||
146594743|NCT00355342|528684472|FG000|Overall Study|Sponsor terminated study|2|||
146594744|NCT00355342|528684473|FG001|Overall Study|Sponsor terminated study|2|||
146594745|NCT00355342|528684472|FG000|Overall Study|Overcompliant-PI discretion|1|||
146594746|NCT00355342|528684473|FG001|Overall Study|Overcompliant-PI discretion|0|||
146594747|NCT00355342|528684472|FG000|Overall Study|Use of prohibited medication|1|||
146594748|NCT00355342|528684473|FG001|Overall Study|Use of prohibited medication|0|||
146594749|NCT00355342|528684472|FG000|Overall Study|COPD exacerbation|1|||
146594750|NCT00355342|528684473|FG001|Overall Study|COPD exacerbation|1|||
146594751|NCT00355342|528684472|FG000|Overall Study|Dispensed wrong study drug kit|1|||
146594752|NCT00355342|528684473|FG001|Overall Study|Dispensed wrong study drug kit|0|||
146594753|NCT00355342|528684472|FG000|Overall Study|Non-compliance with Dexa scans|1|||
146594754|NCT00355342|528684473|FG001|Overall Study|Non-compliance with Dexa scans|0|||
146594755|NCT00355342|528684472|FG000|Overall Study|Withdrawal by participant and physician|1|||
146594756|NCT00355342|528684473|FG001|Overall Study|Withdrawal by participant and physician|0|||
146594757|NCT00355342|528684472|FG000|Overall Study|Participant relocated|0|||
146594758|NCT00355342|528684473|FG001|Overall Study|Participant relocated|1|||
146594759|NCT00355342|528684472|FG000|Overall Study|Participant discontinued study drug|0|||
146594760|NCT00355342|528684473|FG001|Overall Study|Participant discontinued study drug|1|||
146594761|NCT00355342|528684472|FG000|Overall Study|Study management|0|||
146594762|NCT00355342|528684473|FG001|Overall Study|Study management|1|||
146594763|NCT00355342|528684472|FG000|Overall Study|Protocol Violation|0|||
146653554|NCT04393298|528910629|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146653555|NCT04393298|528910630|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146653556|NCT04393298|528910631|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146653557|NCT04393298|528910632|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146653558|NCT04393298|528910633|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146920072|NCT00069095|529868876|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
146653559|NCT04393298|528910634|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146653560|NCT04393298|528910635|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
146920073|NCT00069095|529868877|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
146920074|NCT00069095|529868878|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
146594764|NCT00355342|528684473|FG001|Overall Study|Protocol Violation|1|||
146594765|NCT00355342|528684472|FG000|Overall Study|Use of protocol excluded medication|0|||
146594766|NCT00355342|528684473|FG001|Overall Study|Use of protocol excluded medication|1|||
146594767|NCT00536874|528684474|FG000|Overall Study|Adverse Event|1|||
146594768|NCT00536874|528684474|FG000|Overall Study|Death|2|||
146594769|NCT00536874|528684474|FG000|Overall Study|Withdrawal by Subject|1|||
146594770|NCT02084238|528684476|FG000|Overall Study|Lost to Follow-up|2|||
146594771|NCT00391391|528684477|FG000|Overall Study|Adverse Event|0|||
146594772|NCT00391391|528684478|FG001|Overall Study|Adverse Event|0|||
146594773|NCT00391391|528684479|FG002|Overall Study|Adverse Event|0|||
146594774|NCT00391391|528684480|FG003|Overall Study|Adverse Event|1|||
146594775|NCT00391391|528684477|FG000|Overall Study|Lost to Follow-up|1|||
146594776|NCT00391391|528684478|FG001|Overall Study|Lost to Follow-up|3|||
146594777|NCT00391391|528684479|FG002|Overall Study|Lost to Follow-up|7|||
146594778|NCT00391391|528684480|FG003|Overall Study|Lost to Follow-up|4|||
146594779|NCT00391391|528684477|FG000|Overall Study|Protocol Violation|2|||
146594780|NCT00391391|528684478|FG001|Overall Study|Protocol Violation|3|||
146594781|NCT00391391|528684479|FG002|Overall Study|Protocol Violation|6|||
146594782|NCT00391391|528684480|FG003|Overall Study|Protocol Violation|7|||
146594783|NCT00391391|528684477|FG000|Overall Study|Withdrawal by Subject|6|||
146594784|NCT00391391|528684478|FG001|Overall Study|Withdrawal by Subject|4|||
146594785|NCT00391391|528684479|FG002|Overall Study|Withdrawal by Subject|10|||
146594786|NCT00391391|528684480|FG003|Overall Study|Withdrawal by Subject|7|||
146594787|NCT04342689|528684484|FG000|Overall Study|Withdrawal by Subject|32|||
146594788|NCT04342689|528684485|FG001|Overall Study|Withdrawal by Subject|33|||
146594789|NCT04342689|528684484|FG000|Overall Study|Lost to Follow-up|10|||
146594790|NCT04342689|528684485|FG001|Overall Study|Lost to Follow-up|12|||
146594791|NCT01367704|528684488|FG000|Overall Study|Lost to Follow-up|47|||
146594792|NCT01367704|528684489|FG001|Overall Study|Lost to Follow-up|161|||
146594793|NCT04096820|528684490|FG000|Overall Study|Did not return for intervention|2|||
146594794|NCT04096820|528684490|FG000|Overall Study|Death|1|||
146594795|NCT00475865|528684491|FG000|Overall Study|Adverse Event|0|||
146594796|NCT00475865|528684492|FG001|Overall Study|Adverse Event|3|||
146594797|NCT00475865|528684493|FG002|Overall Study|Adverse Event|4|||
146594798|NCT00475865|528684491|FG000|Overall Study|Lack of Efficacy|1|||
146594799|NCT00475865|528684492|FG001|Overall Study|Lack of Efficacy|0|||
146594800|NCT00475865|528684493|FG002|Overall Study|Lack of Efficacy|0|||
146594801|NCT00475865|528684491|FG000|Overall Study|Progressive disease|0|||
146594802|NCT00475865|528684492|FG001|Overall Study|Progressive disease|1|||
146594803|NCT00475865|528684493|FG002|Overall Study|Progressive disease|2|||
146594804|NCT00475865|528684491|FG000|Overall Study|Participant did not wish to continue|1|||
146594805|NCT00475865|528684492|FG001|Overall Study|Participant did not wish to continue|0|||
146594806|NCT00475865|528684493|FG002|Overall Study|Participant did not wish to continue|0|||
146594807|NCT00475865|528684491|FG000|Overall Study|Other than above|0|||
146594808|NCT00475865|528684492|FG001|Overall Study|Other than above|1|||
146594809|NCT00475865|528684493|FG002|Overall Study|Other than above|0|||
146594810|NCT01510145|528684494|FG000|Overall Study|Adverse Event|6|||
146653561|NCT04393298|528910621|FG000|Overall Study|Lack of Efficacy|0|||
146653562|NCT04393298|528910622|FG001|Overall Study|Lack of Efficacy|0|||
146653563|NCT04393298|528910623|FG002|Overall Study|Lack of Efficacy|0|||
146653564|NCT04393298|528910624|FG003|Overall Study|Lack of Efficacy|0|||
146653565|NCT04393298|528910625|FG004|Overall Study|Lack of Efficacy|0|||
146653566|NCT04393298|528910626|FG005|Overall Study|Lack of Efficacy|0|||
146653567|NCT04393298|528910627|FG006|Overall Study|Lack of Efficacy|0|||
146653568|NCT04393298|528910628|FG007|Overall Study|Lack of Efficacy|0|||
146653569|NCT04393298|528910629|FG008|Overall Study|Lack of Efficacy|0|||
146653570|NCT04393298|528910630|FG009|Overall Study|Lack of Efficacy|0|||
146653571|NCT04393298|528910631|FG010|Overall Study|Lack of Efficacy|0|||
146653572|NCT04393298|528910632|FG011|Overall Study|Lack of Efficacy|0|||
146653573|NCT04393298|528910633|FG012|Overall Study|Lack of Efficacy|0|||
146653574|NCT04393298|528910634|FG013|Overall Study|Lack of Efficacy|0|||
146653575|NCT04393298|528910635|FG014|Overall Study|Lack of Efficacy|1|||
146653576|NCT04393298|528910621|FG000|Overall Study|Progression|1|||
146653577|NCT04393298|528910622|FG001|Overall Study|Progression|0|||
146653578|NCT04393298|528910623|FG002|Overall Study|Progression|0|||
146653579|NCT04393298|528910624|FG003|Overall Study|Progression|0|||
146653580|NCT04393298|528910625|FG004|Overall Study|Progression|0|||
146653581|NCT04393298|528910626|FG005|Overall Study|Progression|0|||
146653582|NCT04393298|528910627|FG006|Overall Study|Progression|0|||
146653583|NCT04393298|528910628|FG007|Overall Study|Progression|0|||
146653584|NCT04393298|528910629|FG008|Overall Study|Progression|0|||
146653585|NCT04393298|528910630|FG009|Overall Study|Progression|0|||
146653586|NCT04393298|528910631|FG010|Overall Study|Progression|1|||
146653587|NCT04393298|528910632|FG011|Overall Study|Progression|1|||
146653588|NCT04393298|528910633|FG012|Overall Study|Progression|0|||
146653589|NCT04393298|528910634|FG013|Overall Study|Progression|0|||
146653590|NCT04393298|528910635|FG014|Overall Study|Progression|0|||
146653591|NCT04393298|528910621|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
146653592|NCT04393298|528910622|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
146594811|NCT01510145|528684494|FG000|Overall Study|Lost to Follow-up|5|||
146594812|NCT01510145|528684494|FG000|Overall Study|Withdrawal by Subject|6|||
146594813|NCT01510145|528684494|FG000|Overall Study|Relative reported subject withdrew|1|||
146594814|NCT01822535|528684499|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
146594815|NCT01822535|528684500|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
146594816|NCT01822535|528684499|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
146653593|NCT04393298|528910623|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
146653594|NCT04393298|528910624|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
146653595|NCT04393298|528910625|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
146653596|NCT04393298|528910626|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
146653597|NCT04393298|528910627|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
146594817|NCT01822535|528684500|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
146594818|NCT01822535|528684499|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
146594819|NCT01822535|528684500|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
146594820|NCT03582813|528684503|FG000|Overall Study|Lost to Follow-up|18|||
146594821|NCT03582813|528684504|FG001|Overall Study|Lost to Follow-up|21|||
146594822|NCT03582813|528684503|FG000|Overall Study|Withdrawal by Subject|1|||
146594823|NCT03582813|528684504|FG001|Overall Study|Withdrawal by Subject|0|||
146594824|NCT03081858|528685948|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
146594825|NCT03081858|528685949|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
146594826|NCT03081858|528685950|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
146594827|NCT03081858|528685951|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
146594828|NCT00387647|528685956|FG000|Overall Study|Death|18|||
146594829|NCT02032407|528685957|FG000|Overall Study|Lost to Follow-up|2|||
146594830|NCT02032407|528685957|FG000|Overall Study|Pregnancy|1|||
146594831|NCT02032407|528685957|FG000|Overall Study|Other Miscellaneous Reasons|2|||
146594832|NCT01309269|528685958|FG000|Overall Study|Adverse Event|56|||
146594833|NCT01309269|528685958|FG000|Overall Study|Withdrawal by Subject|25|||
146594834|NCT01309269|528685958|FG000|Overall Study|Lack of Acceptance|15|||
146594835|NCT01309269|528685958|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
146594836|NCT01309269|528685958|FG000|Overall Study|Kidney Transplant|25|||
146594837|NCT01309269|528685958|FG000|Overall Study|Administrative Problems|141|||
146594838|NCT01309269|528685958|FG000|Overall Study|Other|256|||
146594839|NCT01309269|528685958|FG000|Overall Study|Other|1|||
146594840|NCT01309269|528685958|FG000|Overall Study|Study Completion Data Not Recorded|95|||
146594841|NCT01309269|528685958|FG000|Overall Study|Enrolled but not Treated|107|||
146594842|NCT01610596|528685977|FG000|Overall Study|Lost to Follow-up|0|||
146594843|NCT01610596|528685978|FG001|Overall Study|Lost to Follow-up|1|||
146594844|NCT01519674|528685979|FG000|Overall Study|Adverse Event|3|||
146594845|NCT01519674|528685980|FG001|Overall Study|Adverse Event|3|||
146594846|NCT01519674|528685981|FG002|Overall Study|Adverse Event|0|||
146594847|NCT01519674|528685979|FG000|Overall Study|Lack of Efficacy|1|||
146594848|NCT01519674|528685980|FG001|Overall Study|Lack of Efficacy|1|||
146594849|NCT01519674|528685981|FG002|Overall Study|Lack of Efficacy|1|||
146594850|NCT01519674|528685979|FG000|Overall Study|Protocol Violation|0|||
146594851|NCT01519674|528685980|FG001|Overall Study|Protocol Violation|3|||
146594852|NCT01519674|528685981|FG002|Overall Study|Protocol Violation|1|||
146594853|NCT01519674|528685979|FG000|Overall Study|Withdrawal Criteria|7|||
146594854|NCT01519674|528685980|FG001|Overall Study|Withdrawal Criteria|2|||
146594855|NCT01519674|528685981|FG002|Overall Study|Withdrawal Criteria|7|||
146594856|NCT01519674|528685979|FG000|Overall Study|Unsclassified|10|||
146594857|NCT01519674|528685980|FG001|Overall Study|Unsclassified|4|||
146594858|NCT01519674|528685981|FG002|Overall Study|Unsclassified|3|||
146594859|NCT04599166|528685988|FG000|Overall Study|Technological failure connecting to study app|80|||
146594860|NCT01974752|528685989|FG000|Overall Study|Death|33|||
146594861|NCT01974752|528685990|FG001|Overall Study|Death|11|||
146594862|NCT01974752|528685989|FG000|Overall Study|Lost to Follow-up|2|||
146594863|NCT01974752|528685990|FG001|Overall Study|Lost to Follow-up|0|||
146594864|NCT01974752|528685989|FG000|Overall Study|Withdrawal by Subject|2|||
146594865|NCT01974752|528685990|FG001|Overall Study|Withdrawal by Subject|3|||
146594866|NCT01974752|528685989|FG000|Overall Study|Other Eligibility Criteria|0|||
146594867|NCT01974752|528685990|FG001|Overall Study|Other Eligibility Criteria|1|||
146594868|NCT02317809|528685991|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
146594869|NCT02317809|528685992|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
146594870|NCT02317809|528685991|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
146594871|NCT02317809|528685992|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
146594872|NCT02435680|528685993|FG000|Overall Study|Physician Decision|3|||
146594873|NCT02435680|528685994|FG001|Overall Study|Physician Decision|0|||
146594874|NCT02435680|528685995|FG002|Overall Study|Physician Decision|0|||
146594875|NCT02435680|528685993|FG000|Overall Study|subject / guardian decision|0|||
146594876|NCT02435680|528685994|FG001|Overall Study|subject / guardian decision|3|||
146594877|NCT02435680|528685995|FG002|Overall Study|subject / guardian decision|2|||
146594878|NCT02435680|528685993|FG000|Overall Study|Adverse Event|8|||
146594879|NCT02435680|528685994|FG001|Overall Study|Adverse Event|3|||
146594880|NCT02435680|528685995|FG002|Overall Study|Adverse Event|2|||
146594881|NCT02435680|528685993|FG000|Overall Study|progressive disease|10|||
146594882|NCT02435680|528685994|FG001|Overall Study|progressive disease|7|||
146594883|NCT02435680|528685995|FG002|Overall Study|progressive disease|11|||
146594884|NCT02435680|528685993|FG000|Overall Study|not treated|0|||
146594885|NCT02435680|528685994|FG001|Overall Study|not treated|0|||
146594886|NCT02435680|528685995|FG002|Overall Study|not treated|1|||
146653598|NCT04393298|528910628|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
146653599|NCT04393298|528910629|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
146653600|NCT04393298|528910630|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
146653601|NCT04393298|528910631|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
146653602|NCT04393298|528910632|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
146978451|NCT01904383|530084066|FG000|Overall Study|No patient visit after entry|54|||
146978452|NCT01625845|530084067|FG000|Overall Study|Adverse Event|1|||
146978453|NCT01625845|530084068|FG001|Overall Study|Adverse Event|2|||
146978454|NCT01625845|530084067|FG000|Overall Study|Lost to Follow-up|2|||
146978455|NCT01625845|530084068|FG001|Overall Study|Lost to Follow-up|1|||
146978456|NCT01625845|530084067|FG000|Overall Study|Withdrawal by Subject|2|||
146978457|NCT01625845|530084068|FG001|Overall Study|Withdrawal by Subject|0|||
146978458|NCT02853929|530084069|FG000|Overall Study|Lost to Follow-up|3|||
146978459|NCT02853929|530084070|FG001|Overall Study|Lost to Follow-up|0|||
146978460|NCT02853929|530084069|FG000|Overall Study|Withdrawal by Subject|1|||
146978461|NCT02853929|530084070|FG001|Overall Study|Withdrawal by Subject|0|||
146978462|NCT02853929|530084069|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
146978463|NCT02853929|530084070|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
146978464|NCT01294592|530084071|FG000|Overall Study|Adverse Event|28|||
146978465|NCT01294592|530084072|FG001|Overall Study|Adverse Event|13|||
146978466|NCT01294592|530084071|FG000|Overall Study|Lack of Efficacy|7|||
146978467|NCT01294592|530084072|FG001|Overall Study|Lack of Efficacy|5|||
146978468|NCT01294592|530084071|FG000|Overall Study|Protocol Violation|1|||
146978469|NCT01294592|530084072|FG001|Overall Study|Protocol Violation|7|||
146978470|NCT01294592|530084071|FG000|Overall Study|Lost to Follow-up|7|||
146978471|NCT01294592|530084072|FG001|Overall Study|Lost to Follow-up|9|||
146978472|NCT01294592|530084071|FG000|Overall Study|Physician Decision|6|||
146978473|NCT01294592|530084072|FG001|Overall Study|Physician Decision|11|||
146978474|NCT01294592|530084071|FG000|Overall Study|Withdrawal by Subject|28|||
146978475|NCT01294592|530084072|FG001|Overall Study|Withdrawal by Subject|28|||
146978476|NCT00693784|530084073|FG000|Overall Study|Lost to Follow-up|2|||
146978477|NCT00693784|530084073|FG000|Overall Study|Withdrawal by Subject|2|||
146594887|NCT00953524|528685996|FG000|Overall Study|Adverse Event|2|||
146594888|NCT00953524|528685997|FG001|Overall Study|Adverse Event|0|||
146594889|NCT00953524|528685998|FG002|Overall Study|Adverse Event|1|||
146594890|NCT00953524|528685999|FG003|Overall Study|Adverse Event|2|||
146594891|NCT00953524|528685996|FG000|Overall Study|Protocol Violation|18|||
146594892|NCT00953524|528685997|FG001|Overall Study|Protocol Violation|10|||
146594893|NCT00953524|528685998|FG002|Overall Study|Protocol Violation|11|||
146594894|NCT00953524|528685999|FG003|Overall Study|Protocol Violation|6|||
146594895|NCT00953524|528685996|FG000|Overall Study|Lost to Follow-up|0|||
146594896|NCT00953524|528685997|FG001|Overall Study|Lost to Follow-up|1|||
146594897|NCT00953524|528685998|FG002|Overall Study|Lost to Follow-up|1|||
146594898|NCT00953524|528685999|FG003|Overall Study|Lost to Follow-up|0|||
146594899|NCT00953524|528685996|FG000|Overall Study|Withdrawal by Subject|2|||
146594900|NCT00953524|528685997|FG001|Overall Study|Withdrawal by Subject|4|||
146594901|NCT00953524|528685998|FG002|Overall Study|Withdrawal by Subject|1|||
146594902|NCT00953524|528685999|FG003|Overall Study|Withdrawal by Subject|0|||
146594903|NCT03784846|528686004|FG000|Pre-COVID Study|Lost to Follow-up|3|||
146594904|NCT03784846|528686005|FG001|Pre-COVID Study|Lost to Follow-up|3|||
146594905|NCT03784846|528686006|FG002|Pre-COVID Study|Lost to Follow-up|2|||
146594906|NCT03784846|528686004|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
146594907|NCT03784846|528686005|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
146594908|NCT03784846|528686006|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
146594909|NCT03784846|528686004|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
146594910|NCT03784846|528686005|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
146594911|NCT03784846|528686006|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
146594912|NCT03784846|528686004|FG000|Post-COVID Study|Lost to Follow-up|3|||
146594913|NCT03784846|528686005|FG001|Post-COVID Study|Lost to Follow-up|5|||
146594914|NCT03784846|528686006|FG002|Post-COVID Study|Lost to Follow-up|1|||
146594915|NCT03784846|528686004|FG000|Post-COVID Study|Withdrawal by Subject|1|||
146594916|NCT03784846|528686005|FG001|Post-COVID Study|Withdrawal by Subject|2|||
146594917|NCT03784846|528686006|FG002|Post-COVID Study|Withdrawal by Subject|0|||
146594918|NCT02231762|528686013|FG000|Combination Phase|Adverse Event|10|||
146594919|NCT02231762|528686014|FG001|Combination Phase|Adverse Event|0|||
146594920|NCT02231762|528686015|FG002|Combination Phase|Adverse Event|0|||
146594921|NCT02231762|528686016|FG003|Combination Phase|Adverse Event|0|||
146594922|NCT02231762|528686013|FG000|Combination Phase|Withdrawal by Subject|2|||
146594923|NCT02231762|528686014|FG001|Combination Phase|Withdrawal by Subject|0|||
146594924|NCT02231762|528686015|FG002|Combination Phase|Withdrawal by Subject|0|||
146594925|NCT02231762|528686016|FG003|Combination Phase|Withdrawal by Subject|0|||
146653603|NCT04393298|528910633|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
146653604|NCT04393298|528910634|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
146653605|NCT04393298|528910635|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
146653606|NCT04393298|528910621|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146653607|NCT04393298|528910622|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
146653608|NCT04393298|528910623|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146978478|NCT00326885|530084077|FG000|Overall Study|Adverse Event|1|||
146594926|NCT02231762|528686013|FG000|Combination Phase|Disease Progression|6|||
146978479|NCT00326885|530084077|FG000|Overall Study|Withdrawal by Subject|3|||
146594927|NCT02231762|528686014|FG001|Combination Phase|Disease Progression|0|||
146594928|NCT02231762|528686015|FG002|Combination Phase|Disease Progression|0|||
146594929|NCT02231762|528686016|FG003|Combination Phase|Disease Progression|0|||
146594930|NCT02231762|528686013|FG000|Combination Phase|Did not meet inclusion criteria|1|||
146594931|NCT02231762|528686014|FG001|Combination Phase|Did not meet inclusion criteria|0|||
146594932|NCT02231762|528686015|FG002|Combination Phase|Did not meet inclusion criteria|0|||
146594933|NCT02231762|528686016|FG003|Combination Phase|Did not meet inclusion criteria|0|||
146594934|NCT02231762|528686013|FG000|Combination Phase|Protocol Violation|1|||
146594935|NCT02231762|528686014|FG001|Combination Phase|Protocol Violation|0|||
146594936|NCT02231762|528686015|FG002|Combination Phase|Protocol Violation|0|||
146594937|NCT02231762|528686016|FG003|Combination Phase|Protocol Violation|0|||
146594938|NCT02231762|528686013|FG000|Maintenance Phase|Disease progression|0|||
146594939|NCT02231762|528686014|FG001|Maintenance Phase|Disease progression|3|||
146594940|NCT02231762|528686015|FG002|Maintenance Phase|Disease progression|4|||
146594941|NCT02231762|528686016|FG003|Maintenance Phase|Disease progression|3|||
146594942|NCT02231762|528686013|FG000|Maintenance Phase|Adverse Event|0|||
146594943|NCT02231762|528686014|FG001|Maintenance Phase|Adverse Event|0|||
146594944|NCT02231762|528686015|FG002|Maintenance Phase|Adverse Event|1|||
146594945|NCT02231762|528686016|FG003|Maintenance Phase|Adverse Event|2|||
146594946|NCT01669421|528686019|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
146594947|NCT01669421|528686019|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
146594948|NCT01149486|528686020|FG000|First Intervention|Adverse Event|0|||
146594949|NCT01149486|528686021|FG001|First Intervention|Adverse Event|1|||
146594950|NCT02961790|528686026|FG000|Overall Study|Canceled|4|||
146594951|NCT02961790|528686027|FG001|Overall Study|Canceled|5|||
146594952|NCT02961790|528686028|FG002|Overall Study|Canceled|1|||
146594953|NCT02961790|528686029|FG003|Overall Study|Canceled|4|||
146594954|NCT02961790|528686026|FG000|Overall Study|without baseline data|4|||
146594955|NCT02961790|528686027|FG001|Overall Study|without baseline data|0|||
146594956|NCT02961790|528686028|FG002|Overall Study|without baseline data|1|||
146594957|NCT02961790|528686029|FG003|Overall Study|without baseline data|0|||
146594958|NCT02961790|528686026|FG000|Overall Study|without post baseline data|7|||
146594959|NCT02961790|528686027|FG001|Overall Study|without post baseline data|6|||
146594960|NCT02961790|528686028|FG002|Overall Study|without post baseline data|4|||
146594961|NCT02961790|528686029|FG003|Overall Study|without post baseline data|1|||
146594962|NCT01135914|528686030|FG000|Overall Study|Withdrawal by Subject|1|||
146594963|NCT01135914|528686031|FG001|Overall Study|Withdrawal by Subject|3|||
146594964|NCT01135914|528686032|FG002|Overall Study|Withdrawal by Subject|6|||
146594965|NCT01135914|528686030|FG000|Overall Study|Lost to Follow-up|1|||
146594966|NCT01135914|528686031|FG001|Overall Study|Lost to Follow-up|0|||
146594967|NCT01135914|528686032|FG002|Overall Study|Lost to Follow-up|1|||
146594968|NCT01135914|528686030|FG000|Overall Study|Protocol Violation|0|||
146594969|NCT01135914|528686031|FG001|Overall Study|Protocol Violation|0|||
146594970|NCT01135914|528686032|FG002|Overall Study|Protocol Violation|3|||
146594971|NCT01135914|528686030|FG000|Overall Study|Lack of Efficacy|2|||
146594972|NCT01135914|528686031|FG001|Overall Study|Lack of Efficacy|1|||
146594973|NCT01135914|528686032|FG002|Overall Study|Lack of Efficacy|10|||
146594974|NCT01135914|528686030|FG000|Overall Study|Adverse Event|0|||
146594975|NCT01135914|528686031|FG001|Overall Study|Adverse Event|1|||
146594976|NCT01135914|528686032|FG002|Overall Study|Adverse Event|2|||
146594977|NCT02594098|528686035|FG000|Overall Study|Lack of Efficacy|17|||
146594978|NCT02594098|528686036|FG001|Overall Study|Lack of Efficacy|6|||
146594979|NCT02594098|528686035|FG000|Overall Study|Withdrawal by Subject|1|||
146594980|NCT02594098|528686036|FG001|Overall Study|Withdrawal by Subject|3|||
146594981|NCT02594098|528686035|FG000|Overall Study|Terminated participation|6|||
146594982|NCT02594098|528686036|FG001|Overall Study|Terminated participation|2|||
146594983|NCT02594098|528686035|FG000|Overall Study|Seek alternative treatment|2|||
146594984|NCT02594098|528686036|FG001|Overall Study|Seek alternative treatment|1|||
146594985|NCT02594098|528686035|FG000|Overall Study|Other|0|||
146594986|NCT02594098|528686036|FG001|Overall Study|Other|1|||
146594987|NCT03906656|528686040|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
146594988|NCT03906656|528686041|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
146594989|NCT03906656|528686040|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
146594990|NCT03906656|528686041|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
146594991|NCT03906656|528686040|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
146594992|NCT03906656|528686041|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
146594993|NCT03906656|528686040|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
146594994|NCT03906656|528686041|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
146594995|NCT03906656|528686040|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
146594996|NCT03906656|528686041|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
146594997|NCT03906656|528686040|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
146594998|NCT03906656|528686041|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
146594999|NCT03906656|528686040|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
146653609|NCT04393298|528910624|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146653610|NCT04393298|528910625|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146595000|NCT03906656|528686041|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
146595001|NCT03906656|528686040|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
146595002|NCT03906656|528686041|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
146595003|NCT03906656|528686040|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
146595004|NCT03906656|528686041|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
146595005|NCT03906656|528686040|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
146595006|NCT03906656|528686041|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
146595007|NCT03906656|528686040|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
146595008|NCT03906656|528686041|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
146595009|NCT03906656|528686040|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
146595010|NCT03906656|528686041|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
146595011|NCT03906656|528686040|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
146595012|NCT03906656|528686041|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
146595013|NCT03906656|528686040|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
146595014|NCT03906656|528686041|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
146595015|NCT03906656|528686040|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
146595016|NCT03906656|528686041|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
146595017|NCT03906656|528686040|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
146595018|NCT03906656|528686041|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
146595019|NCT03906656|528686040|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
146595020|NCT03906656|528686041|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
146595021|NCT03906656|528686040|FG000|Home Use 2 (3 Months)|Death|2|||
146595022|NCT03906656|528686041|FG001|Home Use 2 (3 Months)|Death|0|||
146595023|NCT03906656|528686040|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
146595024|NCT03906656|528686041|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
146595025|NCT03906656|528686040|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
146595026|NCT03906656|528686041|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
146595027|NCT01036529|528686042|FG000|Overall Study|Adverse Event|0|||
146595028|NCT01036529|528686043|FG001|Overall Study|Adverse Event|1|||
146595029|NCT01036529|528686042|FG000|Overall Study|Lost to Follow-up|0|||
146595030|NCT01036529|528686043|FG001|Overall Study|Lost to Follow-up|1|||
146595031|NCT01036529|528686042|FG000|Overall Study|Physician Decision|1|||
146595032|NCT01036529|528686043|FG001|Overall Study|Physician Decision|0|||
146595033|NCT01036529|528686042|FG000|Overall Study|Withdrawal by Subject|1|||
146595034|NCT01036529|528686043|FG001|Overall Study|Withdrawal by Subject|1|||
146595035|NCT01036529|528686042|FG000|Overall Study|Sponsor study termination|11|||
146595036|NCT01036529|528686043|FG001|Overall Study|Sponsor study termination|12|||
146595037|NCT00693472|528686044|FG000|Part 1|Adverse Event|1|||
146595038|NCT00693472|528686045|FG001|Part 1|Adverse Event|1|||
146595039|NCT00693472|528686046|FG002|Part 1|Adverse Event|0|||
146595040|NCT00693472|528686047|FG003|Part 1|Adverse Event|0|||
146595041|NCT00693472|528686044|FG000|Part 1|Lost to Follow-up|0|||
146595042|NCT00693472|528686045|FG001|Part 1|Lost to Follow-up|1|||
146595043|NCT00693472|528686046|FG002|Part 1|Lost to Follow-up|0|||
146595044|NCT00693472|528686047|FG003|Part 1|Lost to Follow-up|0|||
146595045|NCT00693472|528686044|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
146595046|NCT00693472|528686045|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
146595047|NCT00693472|528686046|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
146595048|NCT00693472|528686047|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
146595049|NCT00693472|528686044|FG000|Part 2|Adverse Event|0|||
146595050|NCT00693472|528686045|FG001|Part 2|Adverse Event|0|||
146595051|NCT00693472|528686046|FG002|Part 2|Adverse Event|1|||
146595052|NCT00693472|528686047|FG003|Part 2|Adverse Event|0|||
146595053|NCT00693472|528686044|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
146595054|NCT00693472|528686045|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
146595055|NCT00693472|528686046|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
146595056|NCT00693472|528686047|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
146595057|NCT03412604|528686048|FG000|Overall Study|Withdrawal by Subject|1|||
146595058|NCT00993499|528686055|FG000|Run-in Period (8 Days)|Adverse Event|0|||
146595059|NCT00993499|528686056|FG001|Run-in Period (8 Days)|Adverse Event|1|||
146595060|NCT00993499|528686057|FG002|Run-in Period (8 Days)|Adverse Event|0|||
146595061|NCT00993499|528686058|FG003|Run-in Period (8 Days)|Adverse Event|0|||
146595062|NCT00993499|528686059|FG004|Run-in Period (8 Days)|Adverse Event|0|||
146595063|NCT00993499|528686060|FG005|Run-in Period (8 Days)|Adverse Event|0|||
146595064|NCT00993499|528686055|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
146595065|NCT00993499|528686056|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
146978480|NCT00326885|530084077|FG000|Overall Study|Physician Decision|1|||
146595066|NCT00993499|528686057|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
146595067|NCT00993499|528686058|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
146595068|NCT00993499|528686059|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
146595069|NCT00993499|528686060|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
146595070|NCT00993499|528686055|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
146595071|NCT00993499|528686056|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
146595072|NCT00993499|528686057|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
146595073|NCT00993499|528686058|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
146595074|NCT00993499|528686059|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
146595075|NCT00993499|528686060|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
146595076|NCT00993499|528686055|FG000|Run-in Period (8 Days)|Progressive disease|0|||
146595077|NCT00993499|528686056|FG001|Run-in Period (8 Days)|Progressive disease|1|||
146595078|NCT00993499|528686057|FG002|Run-in Period (8 Days)|Progressive disease|1|||
146595079|NCT00993499|528686058|FG003|Run-in Period (8 Days)|Progressive disease|0|||
146595080|NCT00993499|528686059|FG004|Run-in Period (8 Days)|Progressive disease|0|||
146595081|NCT00993499|528686060|FG005|Run-in Period (8 Days)|Progressive disease|0|||
146595082|NCT00993499|528686055|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
146595083|NCT00993499|528686056|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
146595084|NCT00993499|528686057|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
146595085|NCT00993499|528686058|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
146595086|NCT00993499|528686059|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
146595087|NCT00993499|528686060|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
146595088|NCT00993499|528686055|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
146595089|NCT00993499|528686056|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
146595090|NCT00993499|528686057|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
146595091|NCT00993499|528686058|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
146595092|NCT00993499|528686059|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
146595093|NCT00993499|528686060|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
146595094|NCT00993499|528686055|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
146595095|NCT00993499|528686056|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
146595096|NCT00993499|528686057|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
146595097|NCT00993499|528686058|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
146595098|NCT00993499|528686059|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
146595099|NCT00993499|528686060|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
146595100|NCT00993499|528686055|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
146595101|NCT00993499|528686056|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
146595102|NCT00993499|528686057|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
146595103|NCT00993499|528686058|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
146595104|NCT00993499|528686059|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
146595105|NCT00993499|528686060|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
146595106|NCT00993499|528686055|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
146595107|NCT00993499|528686056|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
146595108|NCT00993499|528686057|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
146595109|NCT00993499|528686058|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
146595110|NCT00993499|528686059|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
146595111|NCT00993499|528686060|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
146595112|NCT00993499|528686055|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
146595113|NCT00993499|528686056|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
146595114|NCT00993499|528686057|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
146595115|NCT00993499|528686058|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
146595116|NCT00993499|528686059|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
146595117|NCT00993499|528686060|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
146595118|NCT00993499|528686055|FG000|Discontinued After Starting Course 3|DLT|1|||
146595119|NCT00993499|528686056|FG001|Discontinued After Starting Course 3|DLT|0|||
146595120|NCT00993499|528686057|FG002|Discontinued After Starting Course 3|DLT|2|||
146595121|NCT00993499|528686058|FG003|Discontinued After Starting Course 3|DLT|1|||
146595122|NCT00993499|528686059|FG004|Discontinued After Starting Course 3|DLT|0|||
146595123|NCT00993499|528686060|FG005|Discontinued After Starting Course 3|DLT|0|||
146595124|NCT00993499|528686055|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
146595125|NCT00993499|528686056|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
146595126|NCT00993499|528686057|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
146595127|NCT00993499|528686058|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
146595128|NCT00993499|528686059|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
146595129|NCT00993499|528686060|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
146595130|NCT01945775|528686061|FG000|Overall Study|Death|214|||
146595131|NCT01945775|528686062|FG001|Overall Study|Death|98|||
146595132|NCT01945775|528686061|FG000|Overall Study|Lost to Follow-up|12|||
146595133|NCT01945775|528686062|FG001|Overall Study|Lost to Follow-up|7|||
146595134|NCT01945775|528686061|FG000|Overall Study|Withdrawal by Subject|11|||
146595135|NCT01945775|528686062|FG001|Overall Study|Withdrawal by Subject|21|||
146595136|NCT01945775|528686061|FG000|Overall Study|Other|50|||
146595137|NCT01945775|528686062|FG001|Overall Study|Other|18|||
146653611|NCT04393298|528910626|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146653612|NCT04393298|528910627|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146653613|NCT04393298|528910628|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146920075|NCT00069095|529868879|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
146920076|NCT00069095|529868880|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
146920077|NCT00069095|529868875|FG000|Post-study Treatment Phase|Participant had complete response|1|||
146920078|NCT00069095|529868876|FG001|Post-study Treatment Phase|Participant had complete response|1|||
146920079|NCT00069095|529868877|FG002|Post-study Treatment Phase|Participant had complete response|0|||
146920080|NCT00069095|529868878|FG003|Post-study Treatment Phase|Participant had complete response|0|||
146595138|NCT02876328|528686063|FG000|Overall Study|Death|2|||
146595139|NCT02876328|528686064|FG001|Overall Study|Death|1|||
146595140|NCT02876328|528686065|FG002|Overall Study|Death|3|||
146595141|NCT02876328|528686066|FG003|Overall Study|Death|0|||
146595142|NCT02876328|528686067|FG004|Overall Study|Death|0|||
146595143|NCT02876328|528686068|FG005|Overall Study|Death|0|||
146595144|NCT02876328|528686069|FG006|Overall Study|Death|1|||
146595145|NCT02876328|528686070|FG007|Overall Study|Death|3|||
146595146|NCT02876328|528686071|FG008|Overall Study|Death|0|||
146595147|NCT02876328|528686072|FG009|Overall Study|Death|1|||
146595148|NCT02876328|528686073|FG010|Overall Study|Death|1|||
146595149|NCT02876328|528686074|FG011|Overall Study|Death|0|||
146595150|NCT02876328|528686075|FG012|Overall Study|Death|0|||
146595151|NCT02876328|528686076|FG013|Overall Study|Death|0|||
146595152|NCT02876328|528686077|FG014|Overall Study|Death|0|||
146595153|NCT02876328|528686078|FG015|Overall Study|Death|0|||
146595154|NCT02876328|528686079|FG016|Overall Study|Death|1|||
146595155|NCT02876328|528686080|FG017|Overall Study|Death|1|||
146595156|NCT02876328|528686081|FG018|Overall Study|Death|0|||
146595157|NCT02876328|528686082|FG019|Overall Study|Death|0|||
146595158|NCT02876328|528686083|FG020|Overall Study|Death|0|||
146595159|NCT02876328|528686084|FG021|Overall Study|Death|1|||
146595160|NCT02876328|528686085|FG022|Overall Study|Death|0|||
146595161|NCT02876328|528686086|FG023|Overall Study|Death|0|||
146595162|NCT02876328|528686063|FG000|Overall Study|Withdrawal by Subject|0|||
146595163|NCT02876328|528686064|FG001|Overall Study|Withdrawal by Subject|2|||
146595164|NCT02876328|528686065|FG002|Overall Study|Withdrawal by Subject|3|||
146595165|NCT02876328|528686066|FG003|Overall Study|Withdrawal by Subject|3|||
146595166|NCT02876328|528686067|FG004|Overall Study|Withdrawal by Subject|0|||
146595167|NCT02876328|528686068|FG005|Overall Study|Withdrawal by Subject|1|||
146595168|NCT02876328|528686069|FG006|Overall Study|Withdrawal by Subject|0|||
146595169|NCT02876328|528686070|FG007|Overall Study|Withdrawal by Subject|1|||
146595170|NCT02876328|528686071|FG008|Overall Study|Withdrawal by Subject|1|||
146595171|NCT02876328|528686072|FG009|Overall Study|Withdrawal by Subject|2|||
146595172|NCT02876328|528686073|FG010|Overall Study|Withdrawal by Subject|0|||
146595173|NCT02876328|528686074|FG011|Overall Study|Withdrawal by Subject|0|||
146595174|NCT02876328|528686075|FG012|Overall Study|Withdrawal by Subject|0|||
146595175|NCT02876328|528686076|FG013|Overall Study|Withdrawal by Subject|0|||
146595176|NCT02876328|528686077|FG014|Overall Study|Withdrawal by Subject|0|||
146595177|NCT02876328|528686078|FG015|Overall Study|Withdrawal by Subject|0|||
146595178|NCT02876328|528686079|FG016|Overall Study|Withdrawal by Subject|1|||
146595179|NCT02876328|528686080|FG017|Overall Study|Withdrawal by Subject|3|||
146595180|NCT02876328|528686081|FG018|Overall Study|Withdrawal by Subject|0|||
146595181|NCT02876328|528686082|FG019|Overall Study|Withdrawal by Subject|0|||
146595182|NCT02876328|528686083|FG020|Overall Study|Withdrawal by Subject|1|||
146595183|NCT02876328|528686084|FG021|Overall Study|Withdrawal by Subject|0|||
146595184|NCT02876328|528686085|FG022|Overall Study|Withdrawal by Subject|0|||
146595185|NCT02876328|528686086|FG023|Overall Study|Withdrawal by Subject|0|||
146595186|NCT02876328|528686063|FG000|Overall Study|Missed 12 Month Visit|15|||
146595187|NCT02876328|528686064|FG001|Overall Study|Missed 12 Month Visit|10|||
146595188|NCT02876328|528686065|FG002|Overall Study|Missed 12 Month Visit|11|||
146595189|NCT02876328|528686066|FG003|Overall Study|Missed 12 Month Visit|6|||
146595190|NCT02876328|528686067|FG004|Overall Study|Missed 12 Month Visit|10|||
146595191|NCT02876328|528686068|FG005|Overall Study|Missed 12 Month Visit|14|||
146920081|NCT00069095|529868879|FG004|Post-study Treatment Phase|Participant had complete response|0|||
146920082|NCT00069095|529868880|FG005|Post-study Treatment Phase|Participant had complete response|0|||
146920083|NCT00069095|529868875|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
146920084|NCT00069095|529868876|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
146595192|NCT02876328|528686069|FG006|Overall Study|Missed 12 Month Visit|3|||
146595193|NCT02876328|528686070|FG007|Overall Study|Missed 12 Month Visit|8|||
146595194|NCT02876328|528686071|FG008|Overall Study|Missed 12 Month Visit|9|||
146920085|NCT00069095|529868877|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
146595195|NCT02876328|528686072|FG009|Overall Study|Missed 12 Month Visit|5|||
146595196|NCT02876328|528686073|FG010|Overall Study|Missed 12 Month Visit|4|||
146595197|NCT02876328|528686074|FG011|Overall Study|Missed 12 Month Visit|1|||
146595198|NCT02876328|528686075|FG012|Overall Study|Missed 12 Month Visit|5|||
146595199|NCT02876328|528686076|FG013|Overall Study|Missed 12 Month Visit|4|||
146595200|NCT02876328|528686077|FG014|Overall Study|Missed 12 Month Visit|4|||
146595201|NCT02876328|528686078|FG015|Overall Study|Missed 12 Month Visit|4|||
146595202|NCT02876328|528686079|FG016|Overall Study|Missed 12 Month Visit|3|||
146595203|NCT02876328|528686080|FG017|Overall Study|Missed 12 Month Visit|6|||
146595204|NCT02876328|528686081|FG018|Overall Study|Missed 12 Month Visit|2|||
146595205|NCT02876328|528686082|FG019|Overall Study|Missed 12 Month Visit|2|||
146595206|NCT02876328|528686083|FG020|Overall Study|Missed 12 Month Visit|11|||
146595207|NCT02876328|528686084|FG021|Overall Study|Missed 12 Month Visit|7|||
146595208|NCT02876328|528686085|FG022|Overall Study|Missed 12 Month Visit|1|||
146595209|NCT02876328|528686086|FG023|Overall Study|Missed 12 Month Visit|0|||
146595210|NCT03464422|528686090|FG000|Overall Study|Lost to Follow-up|2|||
146595211|NCT03464422|528686090|FG000|Overall Study|Withdrawal by Subject|2|||
146595212|NCT00844805|528686094|FG000|Treatment Phase|Adverse Event|5|||
146595213|NCT00844805|528686095|FG001|Treatment Phase|Adverse Event|1|||
146595214|NCT00844805|528686096|FG002|Treatment Phase|Adverse Event|0|||
146595215|NCT00844805|528686097|FG003|Treatment Phase|Adverse Event|0|||
146595216|NCT00844805|528686094|FG000|Treatment Phase|Withdrawal by Subject|3|||
146595217|NCT00844805|528686095|FG001|Treatment Phase|Withdrawal by Subject|4|||
146595218|NCT00844805|528686096|FG002|Treatment Phase|Withdrawal by Subject|0|||
146595219|NCT00844805|528686097|FG003|Treatment Phase|Withdrawal by Subject|0|||
146595220|NCT00844805|528686094|FG000|Treatment Phase|Noncompliance With Protocol|1|||
146595221|NCT00844805|528686095|FG001|Treatment Phase|Noncompliance With Protocol|0|||
146653614|NCT04393298|528910629|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146653615|NCT04393298|528910630|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146653616|NCT04393298|528910631|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146653617|NCT04393298|528910632|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146653618|NCT04393298|528910633|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146653619|NCT04393298|528910634|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146978481|NCT00326885|530084077|FG000|Overall Study|Hospice withdrew consent|2|||
146978482|NCT01703741|530084081|FG000|Overall Study|Withdrawal by Subject|6|||
146653620|NCT04393298|528910635|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146653621|NCT04393298|528910621|FG000|Overall Study|Clinical Progression|0|||
146653622|NCT04393298|528910622|FG001|Overall Study|Clinical Progression|2|||
146653623|NCT04393298|528910623|FG002|Overall Study|Clinical Progression|0|||
146653624|NCT04393298|528910624|FG003|Overall Study|Clinical Progression|0|||
146653625|NCT04393298|528910625|FG004|Overall Study|Clinical Progression|0|||
146920086|NCT00069095|529868878|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
146920087|NCT00069095|529868879|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
146920088|NCT00069095|529868880|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
146920089|NCT00069095|529868875|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
146920090|NCT00069095|529868876|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
146920091|NCT00069095|529868877|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
146920092|NCT00069095|529868878|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
146920093|NCT00069095|529868879|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
146920094|NCT00069095|529868880|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
146920095|NCT00069095|529868875|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
146653626|NCT04393298|528910626|FG005|Overall Study|Clinical Progression|0|||
146653627|NCT04393298|528910627|FG006|Overall Study|Clinical Progression|0|||
146653628|NCT04393298|528910628|FG007|Overall Study|Clinical Progression|0|||
146653629|NCT04393298|528910629|FG008|Overall Study|Clinical Progression|0|||
146653630|NCT04393298|528910630|FG009|Overall Study|Clinical Progression|0|||
146653631|NCT04393298|528910631|FG010|Overall Study|Clinical Progression|0|||
146653632|NCT04393298|528910632|FG011|Overall Study|Clinical Progression|0|||
146653633|NCT04393298|528910633|FG012|Overall Study|Clinical Progression|0|||
146653634|NCT04393298|528910634|FG013|Overall Study|Clinical Progression|0|||
146653635|NCT04393298|528910635|FG014|Overall Study|Clinical Progression|0|||
146920096|NCT00069095|529868876|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
146595222|NCT00844805|528686096|FG002|Treatment Phase|Noncompliance With Protocol|0|||
146595223|NCT00844805|528686097|FG003|Treatment Phase|Noncompliance With Protocol|0|||
146978483|NCT01703741|530084081|FG000|Overall Study|Adverse Event|2|||
146595224|NCT00844805|528686094|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
146595225|NCT00844805|528686095|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
146595226|NCT00844805|528686096|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
146595227|NCT00844805|528686097|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
146595228|NCT00844805|528686094|FG000|Follow-Up Phase|Adverse Event|0|||
146595229|NCT00844805|528686095|FG001|Follow-Up Phase|Adverse Event|0|||
146595230|NCT00844805|528686096|FG002|Follow-Up Phase|Adverse Event|1|||
146653636|NCT04393298|528910621|FG000|Overall Study|Disease Progression|0|||
146653637|NCT04393298|528910622|FG001|Overall Study|Disease Progression|1|||
146653638|NCT04393298|528910623|FG002|Overall Study|Disease Progression|0|||
146653639|NCT04393298|528910624|FG003|Overall Study|Disease Progression|0|||
146595231|NCT00844805|528686097|FG003|Follow-Up Phase|Adverse Event|0|||
146595232|NCT00844805|528686094|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
146595233|NCT00844805|528686095|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
146595234|NCT00844805|528686096|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
146595235|NCT00844805|528686097|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
146595236|NCT00844805|528686094|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
146595237|NCT00844805|528686095|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
146595238|NCT00844805|528686096|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
146595239|NCT00844805|528686097|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
146595240|NCT00844805|528686094|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
146595241|NCT00844805|528686095|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
146595242|NCT00844805|528686096|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
146595243|NCT00844805|528686097|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
146595244|NCT00844805|528686094|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
146595245|NCT00844805|528686095|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
146595246|NCT00844805|528686096|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
146595247|NCT00844805|528686097|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
146595248|NCT04316741|528686098|FG000|Baseline Enrollment|Lost to Follow-up|1|||
146595249|NCT04316741|528686099|FG001|Baseline Enrollment|Lost to Follow-up|1|||
146595250|NCT04316741|528686098|FG000|Immediate Post-Test|Lost to Follow-up|5|||
146595251|NCT04316741|528686099|FG001|Immediate Post-Test|Lost to Follow-up|1|||
146595252|NCT04316741|528686098|FG000|1-month Post-test|Lost to Follow-up|7|||
146595253|NCT04316741|528686099|FG001|1-month Post-test|Lost to Follow-up|2|||
146595254|NCT04316741|528686098|FG000|3-month Follow-up|Lost to Follow-up|10|||
146595255|NCT04316741|528686099|FG001|3-month Follow-up|Lost to Follow-up|2|||
146595256|NCT02726880|528686100|FG000|Overall Study|Withdrawal by Subject|2|||
146595257|NCT02726880|528686101|FG001|Overall Study|Withdrawal by Subject|0|||
146595258|NCT02726880|528686100|FG000|Overall Study|Lost to Follow-up|1|||
146595259|NCT02726880|528686101|FG001|Overall Study|Lost to Follow-up|3|||
146595260|NCT00787202|528686102|FG000|Overall Study|Adverse Event|3|||
146595261|NCT00787202|528686103|FG001|Overall Study|Adverse Event|2|||
146595262|NCT00787202|528686104|FG002|Overall Study|Adverse Event|0|||
146595263|NCT00787202|528686105|FG003|Overall Study|Adverse Event|0|||
146595264|NCT00787202|528686106|FG004|Overall Study|Adverse Event|2|||
146595265|NCT00787202|528686102|FG000|Overall Study|Lack of Efficacy|5|||
146595266|NCT00787202|528686103|FG001|Overall Study|Lack of Efficacy|6|||
146595267|NCT00787202|528686104|FG002|Overall Study|Lack of Efficacy|5|||
146595268|NCT00787202|528686105|FG003|Overall Study|Lack of Efficacy|2|||
146595269|NCT00787202|528686106|FG004|Overall Study|Lack of Efficacy|1|||
146595270|NCT00787202|528686102|FG000|Overall Study|Lost to Follow-up|1|||
146595271|NCT00787202|528686103|FG001|Overall Study|Lost to Follow-up|0|||
146595272|NCT00787202|528686104|FG002|Overall Study|Lost to Follow-up|0|||
146595273|NCT00787202|528686105|FG003|Overall Study|Lost to Follow-up|0|||
146595274|NCT00787202|528686106|FG004|Overall Study|Lost to Follow-up|0|||
146595275|NCT00787202|528686102|FG000|Overall Study|Withdrawal by Subject|2|||
146595276|NCT00787202|528686103|FG001|Overall Study|Withdrawal by Subject|2|||
146595277|NCT00787202|528686104|FG002|Overall Study|Withdrawal by Subject|2|||
146595278|NCT00787202|528686105|FG003|Overall Study|Withdrawal by Subject|0|||
146595279|NCT00787202|528686106|FG004|Overall Study|Withdrawal by Subject|0|||
146595280|NCT00787202|528686102|FG000|Overall Study|Protocol Violation|2|||
146595281|NCT00787202|528686103|FG001|Overall Study|Protocol Violation|1|||
146595282|NCT00787202|528686104|FG002|Overall Study|Protocol Violation|0|||
146595283|NCT00787202|528686105|FG003|Overall Study|Protocol Violation|0|||
146595284|NCT00787202|528686106|FG004|Overall Study|Protocol Violation|1|||
146595285|NCT00787202|528686102|FG000|Overall Study|Randomized, not treated|1|||
146595286|NCT00787202|528686103|FG001|Overall Study|Randomized, not treated|0|||
146595287|NCT00787202|528686104|FG002|Overall Study|Randomized, not treated|0|||
146595288|NCT00787202|528686105|FG003|Overall Study|Randomized, not treated|0|||
146595289|NCT00787202|528686106|FG004|Overall Study|Randomized, not treated|0|||
146595290|NCT01360398|528686107|FG000|Overall Study|Withdrawal by Subject|14|||
146595291|NCT01360398|528686107|FG000|Overall Study|Other|7|||
146595292|NCT01360398|528686107|FG000|Overall Study|Migrated/moved from study area|1|||
146595293|NCT01453946|528686108|FG000|Overall Study|Did not receive drug for the taper phase|1|||
146595294|NCT01453946|528686108|FG000|Overall Study|Protocol Violation|2|||
146653640|NCT04393298|528910625|FG004|Overall Study|Disease Progression|0|||
146595295|NCT01453946|528686108|FG000|Overall Study|Lack of Efficacy|3|||
146595296|NCT01453946|528686108|FG000|Overall Study|Adverse Event|3|||
146595297|NCT00846040|528686109|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
146595298|NCT00846040|528686110|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
146595299|NCT00846040|528686111|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
146595300|NCT00846040|528686109|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
146595301|NCT00846040|528686110|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
146595302|NCT00846040|528686111|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
146595303|NCT03158272|528686115|FG000|Overall Study|Disease progression|3|||
146595304|NCT03158272|528686116|FG001|Overall Study|Disease progression|3|||
146595305|NCT03158272|528686117|FG002|Overall Study|Disease progression|4|||
146595306|NCT03158272|528686118|FG003|Overall Study|Disease progression|6|||
146595307|NCT03158272|528686115|FG000|Overall Study|Death|0|||
146595308|NCT03158272|528686116|FG001|Overall Study|Death|0|||
146595309|NCT03158272|528686117|FG002|Overall Study|Death|1|||
146595310|NCT03158272|528686118|FG003|Overall Study|Death|0|||
146595311|NCT03158272|528686115|FG000|Overall Study|Other reasons|0|||
146595312|NCT03158272|528686116|FG001|Overall Study|Other reasons|0|||
146595313|NCT03158272|528686117|FG002|Overall Study|Other reasons|1|||
146595314|NCT03158272|528686118|FG003|Overall Study|Other reasons|0|||
146595315|NCT03158272|528686115|FG000|Overall Study|Adverse event unrelated to the drug|0|||
146595316|NCT03158272|528686116|FG001|Overall Study|Adverse event unrelated to the drug|1|||
146595317|NCT03158272|528686117|FG002|Overall Study|Adverse event unrelated to the drug|0|||
146595318|NCT03158272|528686118|FG003|Overall Study|Adverse event unrelated to the drug|0|||
146595319|NCT03697993|528686119|FG000|Overall Study|Became Ineligible after Enrollment|1|||
146595320|NCT03697993|528686120|FG001|Overall Study|Became Ineligible after Enrollment|3|||
146595321|NCT03697993|528686119|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
146595322|NCT03697993|528686120|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
146595323|NCT03697993|528686119|FG000|Overall Study|Lost to Follow-up|3|||
146595324|NCT03697993|528686120|FG001|Overall Study|Lost to Follow-up|0|||
146595325|NCT03697993|528686119|FG000|Overall Study|Physician Decision|4|||
146595326|NCT03697993|528686120|FG001|Overall Study|Physician Decision|0|||
146595327|NCT03697993|528686119|FG000|Overall Study|Initial Urine Culture Negative|0|||
146595328|NCT03697993|528686120|FG001|Overall Study|Initial Urine Culture Negative|1|||
146595329|NCT01048866|528686121|FG000|Overall Study|Adverse Event|1|||
146595330|NCT01048866|528686122|FG001|Overall Study|Adverse Event|0|||
146595331|NCT01048866|528686121|FG000|Overall Study|Protocol Violation|1|||
146595332|NCT01048866|528686122|FG001|Overall Study|Protocol Violation|0|||
146595333|NCT01048866|528686121|FG000|Overall Study|Physician Decision|1|||
146595334|NCT01048866|528686122|FG001|Overall Study|Physician Decision|0|||
146595335|NCT01048866|528686121|FG000|Overall Study|Withdrawal by Subject|0|||
146595336|NCT01048866|528686122|FG001|Overall Study|Withdrawal by Subject|2|||
146595337|NCT01048866|528686121|FG000|Overall Study|Lost to Follow-up|0|||
146595338|NCT01048866|528686122|FG001|Overall Study|Lost to Follow-up|2|||
146595339|NCT01048866|528686121|FG000|Overall Study|Other|1|||
146595340|NCT01048866|528686122|FG001|Overall Study|Other|1|||
146595341|NCT02230683|528686123|FG000|Overall Study|Adverse Event|1|||
146653641|NCT04393298|528910626|FG005|Overall Study|Disease Progression|3|||
146653642|NCT04393298|528910627|FG006|Overall Study|Disease Progression|2|||
146653643|NCT04393298|528910628|FG007|Overall Study|Disease Progression|1|||
146653644|NCT04393298|528910629|FG008|Overall Study|Disease Progression|2|||
146653645|NCT04393298|528910630|FG009|Overall Study|Disease Progression|1|||
146653646|NCT04393298|528910631|FG010|Overall Study|Disease Progression|0|||
146653647|NCT04393298|528910632|FG011|Overall Study|Disease Progression|3|||
146653648|NCT04393298|528910633|FG012|Overall Study|Disease Progression|0|||
146653649|NCT04393298|528910634|FG013|Overall Study|Disease Progression|0|||
146653650|NCT04393298|528910635|FG014|Overall Study|Disease Progression|1|||
146653651|NCT04393298|528910621|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146653652|NCT04393298|528910622|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146653653|NCT04393298|528910623|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
146653654|NCT04393298|528910624|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146653655|NCT04393298|528910625|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146653656|NCT04393298|528910626|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146653657|NCT04393298|528910627|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146653658|NCT04393298|528910628|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146653659|NCT04393298|528910629|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146653660|NCT04393298|528910630|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146653661|NCT04393298|528910631|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146653662|NCT04393298|528910632|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146653663|NCT04393298|528910633|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146978484|NCT01703741|530084081|FG000|Overall Study|Physician Decision|2|||
146653664|NCT04393298|528910634|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146653665|NCT04393298|528910635|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146653666|NCT04393298|528910621|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
146653667|NCT04393298|528910622|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
146653668|NCT04393298|528910623|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
146653669|NCT04393298|528910624|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
146653670|NCT04393298|528910625|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
146653671|NCT04393298|528910626|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
146653672|NCT04393298|528910627|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
146653673|NCT04393298|528910628|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
146653674|NCT04393298|528910629|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
146653675|NCT04393298|528910630|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
146595342|NCT00524589|528687568|FG000|Overall Study|Withdrawal by Subject|2|||
146595343|NCT00524589|528687568|FG000|Overall Study|Disease Progression|16|||
146595344|NCT01266317|528687569|FG000|Overall Study|Withdrawal by Subject|2|||
146595345|NCT00490776|528687570|FG000|Overall Study|Withdrawal by Subject|1|||
146595346|NCT00490776|528687570|FG000|Overall Study|Administrative Problems|1|||
146595347|NCT00490776|528687570|FG000|Overall Study|Death|1|||
146595348|NCT00490776|528687570|FG000|Overall Study|New Cancer Therapy|1|||
146595349|NCT00490776|528687570|FG000|Overall Study|Disease Progression|5|||
146595350|NCT00046930|528687571|FG000|Overall Study|Ineligible|12|||
146595351|NCT00046930|528687572|FG001|Overall Study|Ineligible|4|||
146595352|NCT01657760|528687573|FG000|Overall Study|Withdrawal by Subject|0|||
146595353|NCT01657760|528687574|FG001|Overall Study|Withdrawal by Subject|0|||
146595354|NCT01657760|528687575|FG002|Overall Study|Withdrawal by Subject|0|||
146595355|NCT01657760|528687576|FG003|Overall Study|Withdrawal by Subject|1|||
146595356|NCT01657760|528687573|FG000|Overall Study|Physician Decision|1|||
146595357|NCT01657760|528687574|FG001|Overall Study|Physician Decision|1|||
146595358|NCT01657760|528687575|FG002|Overall Study|Physician Decision|1|||
146595359|NCT01657760|528687576|FG003|Overall Study|Physician Decision|2|||
146595360|NCT00799591|528687577|FG000|Overall Study|De-escalation of doses|20|||
146595361|NCT00799591|528687577|FG000|Overall Study|Death|14|||
146595362|NCT00799591|528687577|FG000|Overall Study|Technical failure|12|||
146595363|NCT00799591|528687577|FG000|Overall Study|Resistant germ|11|||
146595364|NCT00799591|528687577|FG000|Overall Study|New infection|4|||
146595365|NCT00799591|528687577|FG000|Overall Study|Resistance germ and technical failure|2|||
146595366|NCT00799591|528687577|FG000|Overall Study|Persistance of fever undetermined origin|1|||
146595367|NCT00799591|528687577|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
146595368|NCT00799591|528687577|FG000|Overall Study|Infectious origin not probable|1|||
146595369|NCT03276052|528687579|FG000|Overall Study|Withdrawal by Subject|5|||
146595370|NCT03276052|528687579|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
146595371|NCT01994863|528687580|FG000|Period 1|Adverse Event|4|||
146595372|NCT01994863|528687581|FG001|Period 1|Adverse Event|0|||
146595373|NCT01994863|528687580|FG000|Period 1|Withdrawal by Subject|1|||
146595374|NCT01994863|528687581|FG001|Period 1|Withdrawal by Subject|0|||
146595375|NCT01994863|528687580|FG000|Period 1|Trial stopped by sponsor|1|||
146595376|NCT01994863|528687581|FG001|Period 1|Trial stopped by sponsor|3|||
146595377|NCT01994863|528687580|FG000|Period 1|Lack of Efficacy|1|||
146653676|NCT04393298|528910631|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
146653677|NCT04393298|528910632|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
146653678|NCT04393298|528910633|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
146653679|NCT04393298|528910634|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
146653680|NCT04393298|528910635|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
146920097|NCT00069095|529868877|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
146920098|NCT00069095|529868878|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
146920099|NCT00069095|529868879|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
146920100|NCT00069095|529868880|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
146920101|NCT00069095|529868875|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
146920102|NCT00069095|529868876|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
146920103|NCT00069095|529868877|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
146595378|NCT01994863|528687581|FG001|Period 1|Lack of Efficacy|0|||
146595379|NCT01994863|528687580|FG000|Period 2|Adverse Event|0|||
146595380|NCT01994863|528687581|FG001|Period 2|Adverse Event|1|||
146653681|NCT04393298|528910621|FG000|Overall Study|Progressive Disease (PD)|0|||
146653682|NCT04393298|528910622|FG001|Overall Study|Progressive Disease (PD)|0|||
146653683|NCT04393298|528910623|FG002|Overall Study|Progressive Disease (PD)|0|||
146653684|NCT04393298|528910624|FG003|Overall Study|Progressive Disease (PD)|3|||
146653685|NCT04393298|528910625|FG004|Overall Study|Progressive Disease (PD)|0|||
146653686|NCT04393298|528910626|FG005|Overall Study|Progressive Disease (PD)|0|||
146653687|NCT04393298|528910627|FG006|Overall Study|Progressive Disease (PD)|0|||
146653688|NCT04393298|528910628|FG007|Overall Study|Progressive Disease (PD)|0|||
146653689|NCT04393298|528910629|FG008|Overall Study|Progressive Disease (PD)|0|||
146653690|NCT04393298|528910630|FG009|Overall Study|Progressive Disease (PD)|0|||
146920104|NCT00069095|529868878|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
146595381|NCT01994863|528687580|FG000|Period 2|Lack of Efficacy|0|||
146595382|NCT01994863|528687581|FG001|Period 2|Lack of Efficacy|2|||
146595383|NCT01994863|528687580|FG000|Period 2|Withdrawal by Subject|1|||
146595384|NCT01994863|528687581|FG001|Period 2|Withdrawal by Subject|1|||
146595385|NCT01062841|528687584|FG000|Overall Study|Indwelling Device Removed|41|||
146653691|NCT04393298|528910631|FG010|Overall Study|Progressive Disease (PD)|0|||
146653692|NCT04393298|528910632|FG011|Overall Study|Progressive Disease (PD)|0|||
146920105|NCT00069095|529868879|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
146978485|NCT01703741|530084081|FG000|Overall Study|Protocol Violation|1|||
146595386|NCT01062841|528687585|FG001|Overall Study|Indwelling Device Removed|48|||
146595387|NCT01062841|528687584|FG000|Overall Study|Death|3|||
146595388|NCT01062841|528687585|FG001|Overall Study|Death|5|||
146595389|NCT01062841|528687584|FG000|Overall Study|Withdrawal by Subject|2|||
146920106|NCT00069095|529868880|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
146920107|NCT00069095|529868875|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
146920108|NCT00069095|529868876|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
146595390|NCT01062841|528687585|FG001|Overall Study|Withdrawal by Subject|0|||
146595391|NCT01062841|528687584|FG000|Overall Study|Withdrawal by Study|3|||
146595392|NCT01062841|528687585|FG001|Overall Study|Withdrawal by Study|0|||
146595393|NCT02046174|528687586|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
146595394|NCT02046174|528687587|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
146595395|NCT03294135|528687592|FG000|Overall Study|Serious Adverse Event|1|||
146595396|NCT03294135|528687593|FG001|Overall Study|Serious Adverse Event|0|||
146595397|NCT03294135|528687594|FG002|Overall Study|Serious Adverse Event|0|||
146595398|NCT03294135|528687592|FG000|Overall Study|Lost to Follow-up|1|||
146595399|NCT03294135|528687593|FG001|Overall Study|Lost to Follow-up|0|||
146595400|NCT03294135|528687594|FG002|Overall Study|Lost to Follow-up|1|||
146595401|NCT03294135|528687592|FG000|Overall Study|Withdrawal by Subject|0|||
146595402|NCT03294135|528687593|FG001|Overall Study|Withdrawal by Subject|0|||
146595403|NCT03294135|528687594|FG002|Overall Study|Withdrawal by Subject|1|||
146595404|NCT03294135|528687592|FG000|Overall Study|Other|2|||
146595405|NCT03294135|528687593|FG001|Overall Study|Other|0|||
146595406|NCT03294135|528687594|FG002|Overall Study|Other|0|||
146595407|NCT00186537|528687595|FG000|Overall Study|Withdrawal by Subject|4|||
146595408|NCT00186537|528687596|FG001|Overall Study|Withdrawal by Subject|0|||
146595409|NCT00186537|528687597|FG002|Overall Study|Withdrawal by Subject|3|||
146595410|NCT00186537|528687595|FG000|Overall Study|ALT > 1.5 x ULN|3|||
146595411|NCT00186537|528687596|FG001|Overall Study|ALT > 1.5 x ULN|0|||
146595412|NCT00186537|528687597|FG002|Overall Study|ALT > 1.5 x ULN|0|||
146595413|NCT02763254|528687598|FG000|Overall Study|Adverse Event|1|||
146595414|NCT01143051|528687601|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
146595415|NCT01143051|528687602|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
146595416|NCT01143051|528687603|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
146595417|NCT01143051|528687604|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
146595418|NCT01143051|528687605|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
146595419|NCT01143051|528687606|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
146595420|NCT01143051|528687601|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
146595421|NCT01143051|528687602|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
146595422|NCT01143051|528687603|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
146595423|NCT01143051|528687604|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
146595424|NCT01143051|528687605|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
146595425|NCT01143051|528687606|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
146595426|NCT00765882|528687607|FG000|Overall Study|Adverse Event|10|||
146595427|NCT00765882|528687608|FG001|Overall Study|Adverse Event|21|||
146595428|NCT00765882|528687609|FG002|Overall Study|Adverse Event|20|||
146595429|NCT00765882|528687607|FG000|Overall Study|Lack of Efficacy|4|||
146595430|NCT00765882|528687608|FG001|Overall Study|Lack of Efficacy|0|||
146595431|NCT00765882|528687609|FG002|Overall Study|Lack of Efficacy|1|||
146595432|NCT00765882|528687607|FG000|Overall Study|Protocol Violation|4|||
146595433|NCT00765882|528687608|FG001|Overall Study|Protocol Violation|3|||
146595434|NCT00765882|528687609|FG002|Overall Study|Protocol Violation|1|||
146595435|NCT00765882|528687607|FG000|Overall Study|Withdrawal by Subject|2|||
146595436|NCT00765882|528687608|FG001|Overall Study|Withdrawal by Subject|6|||
146595437|NCT00765882|528687609|FG002|Overall Study|Withdrawal by Subject|6|||
146595438|NCT00765882|528687607|FG000|Overall Study|Lost to Follow-up|1|||
146595439|NCT00765882|528687608|FG001|Overall Study|Lost to Follow-up|9|||
146595440|NCT00765882|528687609|FG002|Overall Study|Lost to Follow-up|6|||
146595441|NCT00765882|528687607|FG000|Overall Study|Other Reason|3|||
146595442|NCT00765882|528687608|FG001|Overall Study|Other Reason|1|||
146595443|NCT00765882|528687609|FG002|Overall Study|Other Reason|2|||
146595444|NCT03351114|528687613|FG000|Overall Study|Withdrawal by Subject|1|||
146595445|NCT01874275|528687614|FG000|Overall Study|Lost to Follow-up|1|||
146595446|NCT01874275|528687615|FG001|Overall Study|Lost to Follow-up|0|||
146920109|NCT00069095|529868877|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
146920110|NCT00069095|529868878|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
146595447|NCT01665430|528687616|FG000|Overall Study|Adverse Event|1|||
146595448|NCT01665430|528687616|FG000|Overall Study|Withdrawal by Subject|6|||
146595449|NCT01665430|528687616|FG000|Overall Study|Other Unspecified|2|||
146595450|NCT00989235|528687621|FG000|Overall Study|Death|0|||
146595451|NCT00989235|528687622|FG001|Overall Study|Death|1|||
146920111|NCT00069095|529868879|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
146595452|NCT00989235|528687621|FG000|Overall Study|Adverse Event|0|||
146595453|NCT00989235|528687622|FG001|Overall Study|Adverse Event|1|||
146595454|NCT00989235|528687621|FG000|Overall Study|Lack of Efficacy|1|||
146595455|NCT00989235|528687622|FG001|Overall Study|Lack of Efficacy|0|||
146595456|NCT00989235|528687621|FG000|Overall Study|Withdrawal of Consent|1|||
146595457|NCT00989235|528687622|FG001|Overall Study|Withdrawal of Consent|1|||
146595458|NCT00989235|528687621|FG000|Overall Study|Desire to Become Pregnant|1|||
146595459|NCT00989235|528687622|FG001|Overall Study|Desire to Become Pregnant|0|||
146595460|NCT00989235|528687621|FG000|Overall Study|Randomized by Mistake|0|||
146595461|NCT00989235|528687622|FG001|Overall Study|Randomized by Mistake|2|||
146653693|NCT04393298|528910633|FG012|Overall Study|Progressive Disease (PD)|0|||
146653694|NCT04393298|528910634|FG013|Overall Study|Progressive Disease (PD)|0|||
146653695|NCT04393298|528910635|FG014|Overall Study|Progressive Disease (PD)|0|||
146653696|NCT04393298|528910621|FG000|Overall Study|Started a New Cancer Treatment|0|||
146653697|NCT04393298|528910622|FG001|Overall Study|Started a New Cancer Treatment|0|||
146653698|NCT04393298|528910623|FG002|Overall Study|Started a New Cancer Treatment|0|||
146653699|NCT04393298|528910624|FG003|Overall Study|Started a New Cancer Treatment|0|||
146653700|NCT04393298|528910625|FG004|Overall Study|Started a New Cancer Treatment|1|||
146653701|NCT04393298|528910626|FG005|Overall Study|Started a New Cancer Treatment|0|||
146653702|NCT04393298|528910627|FG006|Overall Study|Started a New Cancer Treatment|0|||
146653703|NCT04393298|528910628|FG007|Overall Study|Started a New Cancer Treatment|0|||
146653704|NCT04393298|528910629|FG008|Overall Study|Started a New Cancer Treatment|0|||
146653705|NCT04393298|528910630|FG009|Overall Study|Started a New Cancer Treatment|0|||
146653706|NCT04393298|528910631|FG010|Overall Study|Started a New Cancer Treatment|0|||
146653707|NCT04393298|528910632|FG011|Overall Study|Started a New Cancer Treatment|0|||
146653708|NCT04393298|528910633|FG012|Overall Study|Started a New Cancer Treatment|0|||
146653709|NCT04393298|528910634|FG013|Overall Study|Started a New Cancer Treatment|0|||
146653710|NCT04393298|528910635|FG014|Overall Study|Started a New Cancer Treatment|0|||
146653711|NCT04393298|528910621|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146653712|NCT04393298|528910622|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146653713|NCT04393298|528910623|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146653714|NCT04393298|528910624|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146653715|NCT04393298|528910625|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
146653716|NCT04393298|528910626|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146653717|NCT04393298|528910627|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146653718|NCT04393298|528910628|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146653719|NCT04393298|528910629|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146653720|NCT04393298|528910630|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146595462|NCT00989235|528687621|FG000|Overall Study|Lost to Follow-up|0|||
146595463|NCT00989235|528687622|FG001|Overall Study|Lost to Follow-up|1|||
146595464|NCT03249935|528687623|FG000|Overall Study|Discharged from facility early|36|||
146595465|NCT03249935|528687623|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
146595466|NCT03249935|528687623|FG000|Overall Study|Protocol Violation|5|||
146595467|NCT02813668|528687624|FG000|Overall Study|Death|4|||
146595468|NCT02813668|528687624|FG000|Overall Study|Lost to Follow-up|509|||
146595469|NCT02813668|528687624|FG000|Overall Study|Withdrawal by Subject|148|||
146595470|NCT02813668|528687624|FG000|Overall Study|No longer at worksite|85|||
146595471|NCT02813668|528687624|FG000|Overall Study|Medical reasons not related to the study|4|||
146595472|NCT04662073|528687625|FG000|Overall Study|Withdrawal by Subject|1|||
146595473|NCT04662073|528687626|FG001|Overall Study|Withdrawal by Subject|0|||
146595474|NCT00598078|528687631|FG000|Period 2 (Day 2)|Adverse Event|1|||
146595475|NCT00598078|528687632|FG001|Period 2 (Day 2)|Adverse Event|0|||
146595476|NCT01813721|528687633|FG000|Overall Study|Ineligibility determined|63|||
146595477|NCT01813721|528687633|FG000|Overall Study|Withdrawal by Subject|1|||
146595478|NCT01479595|528687636|FG000|Overall Study|Protocol deviation|0|||
146595479|NCT01479595|528687637|FG001|Overall Study|Protocol deviation|1|||
146595480|NCT01479595|528687636|FG000|Overall Study|Adverse Event|2|||
146595481|NCT01479595|528687637|FG001|Overall Study|Adverse Event|1|||
146595482|NCT00810901|528687638|FG000|Overall Study|Lost to Follow-up|88|||
146595483|NCT00810901|528687639|FG001|Overall Study|Lost to Follow-up|58|||
146595484|NCT02133664|528687640|FG000|Overall Study|Lost to Follow-up|2|||
146595485|NCT02133664|528687641|FG001|Overall Study|Lost to Follow-up|1|||
146595486|NCT02133664|528687640|FG000|Overall Study|Adverse Event|3|||
146595487|NCT02133664|528687641|FG001|Overall Study|Adverse Event|6|||
146595488|NCT03366103|528687644|FG000|Overall Study|Disease Progression|3|||
146595489|NCT03366103|528687645|FG001|Overall Study|Disease Progression|1|||
146595490|NCT03366103|528687646|FG002|Overall Study|Disease Progression|0|||
146595491|NCT03366103|528687644|FG000|Overall Study|Adverse Event|0|||
146653721|NCT04393298|528910631|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146653722|NCT04393298|528910632|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146653723|NCT04393298|528910633|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146653724|NCT04393298|528910634|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146653725|NCT04393298|528910635|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146595492|NCT03366103|528687645|FG001|Overall Study|Adverse Event|1|||
146595493|NCT03366103|528687646|FG002|Overall Study|Adverse Event|0|||
146595494|NCT02120365|528687653|FG000|Overall Study|Withdrawal by Subject|0|||
146595495|NCT02120365|528687654|FG001|Overall Study|Withdrawal by Subject|0|||
146595496|NCT02120365|528687655|FG002|Overall Study|Withdrawal by Subject|2|||
146595497|NCT02120365|528687656|FG003|Overall Study|Withdrawal by Subject|4|||
146595498|NCT02120365|528687657|FG004|Overall Study|Withdrawal by Subject|0|||
146595499|NCT02120365|528687658|FG005|Overall Study|Withdrawal by Subject|2|||
146595500|NCT00343915|528687659|FG000|Primary Study|Withdrawal by Subject|1|||
146595501|NCT00343915|528687660|FG001|Primary Study|Withdrawal by Subject|0|||
146595502|NCT00343915|528687659|FG000|Primary Study|Lost to Follow-up|2|||
146595503|NCT00343915|528687660|FG001|Primary Study|Lost to Follow-up|3|||
146595504|NCT00343915|528687659|FG000|Primary Study|Other|1|||
146595505|NCT00343915|528687660|FG001|Primary Study|Other|0|||
146595506|NCT01719003|528687665|FG000|Overall Study|Non compliant with protocol|1|||
146595507|NCT01719003|528687666|FG001|Overall Study|Non compliant with protocol|1|||
146595508|NCT01719003|528687667|FG002|Overall Study|Non compliant with protocol|0|||
146595509|NCT01719003|528687668|FG003|Overall Study|Non compliant with protocol|1|||
146595510|NCT01719003|528687669|FG004|Overall Study|Non compliant with protocol|2|||
146595511|NCT01719003|528687670|FG005|Overall Study|Non compliant with protocol|1|||
146595512|NCT01719003|528687671|FG006|Overall Study|Non compliant with protocol|2|||
146595513|NCT01719003|528687672|FG007|Overall Study|Non compliant with protocol|3|||
146595514|NCT01719003|528687673|FG008|Overall Study|Non compliant with protocol|0|||
146595515|NCT01719003|528687665|FG000|Overall Study|Adverse Event|6|||
146595516|NCT01719003|528687666|FG001|Overall Study|Adverse Event|5|||
146595517|NCT01719003|528687667|FG002|Overall Study|Adverse Event|4|||
146595518|NCT01719003|528687668|FG003|Overall Study|Adverse Event|3|||
146595519|NCT01719003|528687669|FG004|Overall Study|Adverse Event|4|||
146595520|NCT01719003|528687670|FG005|Overall Study|Adverse Event|3|||
146595521|NCT01719003|528687671|FG006|Overall Study|Adverse Event|6|||
146595522|NCT01719003|528687672|FG007|Overall Study|Adverse Event|5|||
146595523|NCT01719003|528687673|FG008|Overall Study|Adverse Event|0|||
146595524|NCT01719003|528687665|FG000|Overall Study|Lost to Follow-up|0|||
146595525|NCT01719003|528687666|FG001|Overall Study|Lost to Follow-up|6|||
146595526|NCT01719003|528687667|FG002|Overall Study|Lost to Follow-up|7|||
146595527|NCT01719003|528687668|FG003|Overall Study|Lost to Follow-up|2|||
146595528|NCT01719003|528687669|FG004|Overall Study|Lost to Follow-up|3|||
146595529|NCT01719003|528687670|FG005|Overall Study|Lost to Follow-up|4|||
146595530|NCT01719003|528687671|FG006|Overall Study|Lost to Follow-up|3|||
146595531|NCT01719003|528687672|FG007|Overall Study|Lost to Follow-up|2|||
146595532|NCT01719003|528687673|FG008|Overall Study|Lost to Follow-up|2|||
146595533|NCT01719003|528687665|FG000|Overall Study|Refusal to continue, not due to AE|2|||
146595534|NCT01719003|528687666|FG001|Overall Study|Refusal to continue, not due to AE|5|||
146595535|NCT01719003|528687667|FG002|Overall Study|Refusal to continue, not due to AE|4|||
146595536|NCT01719003|528687668|FG003|Overall Study|Refusal to continue, not due to AE|4|||
146595537|NCT01719003|528687669|FG004|Overall Study|Refusal to continue, not due to AE|4|||
146595538|NCT01719003|528687670|FG005|Overall Study|Refusal to continue, not due to AE|3|||
146595539|NCT01719003|528687671|FG006|Overall Study|Refusal to continue, not due to AE|8|||
146595540|NCT01719003|528687672|FG007|Overall Study|Refusal to continue, not due to AE|7|||
146595541|NCT01719003|528687673|FG008|Overall Study|Refusal to continue, not due to AE|1|||
146595542|NCT01719003|528687665|FG000|Overall Study|Reason other than those specified|0|||
146595543|NCT01719003|528687666|FG001|Overall Study|Reason other than those specified|0|||
146595544|NCT01719003|528687667|FG002|Overall Study|Reason other than those specified|2|||
146595545|NCT01719003|528687668|FG003|Overall Study|Reason other than those specified|3|||
146595546|NCT01719003|528687669|FG004|Overall Study|Reason other than those specified|4|||
146595547|NCT01719003|528687670|FG005|Overall Study|Reason other than those specified|1|||
146595548|NCT01719003|528687671|FG006|Overall Study|Reason other than those specified|0|||
146595549|NCT01719003|528687672|FG007|Overall Study|Reason other than those specified|3|||
146595550|NCT01719003|528687673|FG008|Overall Study|Reason other than those specified|1|||
146595551|NCT01719003|528687665|FG000|Overall Study|Lack of Efficacy|0|||
146595552|NCT01719003|528687666|FG001|Overall Study|Lack of Efficacy|0|||
146595553|NCT01719003|528687667|FG002|Overall Study|Lack of Efficacy|0|||
146595554|NCT01719003|528687668|FG003|Overall Study|Lack of Efficacy|0|||
146595555|NCT01719003|528687669|FG004|Overall Study|Lack of Efficacy|0|||
146595556|NCT01719003|528687670|FG005|Overall Study|Lack of Efficacy|0|||
146595557|NCT01719003|528687671|FG006|Overall Study|Lack of Efficacy|1|||
146595558|NCT01719003|528687672|FG007|Overall Study|Lack of Efficacy|0|||
146595559|NCT01719003|528687673|FG008|Overall Study|Lack of Efficacy|0|||
146595560|NCT00882908|528687674|FG000|Overall Study|Adverse Event|0|||
146595561|NCT00882908|528687675|FG001|Overall Study|Adverse Event|0|||
146595562|NCT00882908|528687676|FG002|Overall Study|Adverse Event|1|||
146595563|NCT00882908|528687677|FG003|Overall Study|Adverse Event|0|||
146595564|NCT00882908|528687678|FG004|Overall Study|Adverse Event|1|||
146595565|NCT00882908|528687674|FG000|Overall Study|Lost to Follow-up|3|||
146595566|NCT00882908|528687675|FG001|Overall Study|Lost to Follow-up|5|||
146595567|NCT00882908|528687676|FG002|Overall Study|Lost to Follow-up|3|||
146978486|NCT01703741|530084081|FG000|Overall Study|Lost to Follow-up|3|||
146595568|NCT00882908|528687677|FG003|Overall Study|Lost to Follow-up|1|||
146595569|NCT00882908|528687678|FG004|Overall Study|Lost to Follow-up|2|||
146595570|NCT00882908|528687674|FG000|Overall Study|Protocol Violation|0|||
146595571|NCT00882908|528687675|FG001|Overall Study|Protocol Violation|1|||
146595572|NCT00882908|528687676|FG002|Overall Study|Protocol Violation|0|||
146595573|NCT00882908|528687677|FG003|Overall Study|Protocol Violation|0|||
146595574|NCT00882908|528687678|FG004|Overall Study|Protocol Violation|0|||
146595575|NCT00882908|528687674|FG000|Overall Study|Withdrawal by Subject|0|||
146920112|NCT00069095|529868880|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
146920113|NCT00069095|529868875|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
146920114|NCT00069095|529868876|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
146920115|NCT00069095|529868877|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
146920116|NCT00069095|529868878|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
146920117|NCT00069095|529868879|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
146595576|NCT00882908|528687675|FG001|Overall Study|Withdrawal by Subject|0|||
146595577|NCT00882908|528687676|FG002|Overall Study|Withdrawal by Subject|3|||
146595578|NCT00882908|528687677|FG003|Overall Study|Withdrawal by Subject|5|||
146595579|NCT00882908|528687678|FG004|Overall Study|Withdrawal by Subject|2|||
146595580|NCT00882908|528687674|FG000|Overall Study|Subject reached a virologic endpoint|0|||
146595581|NCT00882908|528687675|FG001|Overall Study|Subject reached a virologic endpoint|0|||
146595582|NCT00882908|528687676|FG002|Overall Study|Subject reached a virologic endpoint|0|||
146595583|NCT00882908|528687677|FG003|Overall Study|Subject reached a virologic endpoint|0|||
146595584|NCT00882908|528687678|FG004|Overall Study|Subject reached a virologic endpoint|1|||
146595585|NCT00882908|528687674|FG000|Overall Study|Study terminated in error|0|||
146595586|NCT00882908|528687675|FG001|Overall Study|Study terminated in error|0|||
146595587|NCT00882908|528687676|FG002|Overall Study|Study terminated in error|0|||
146595588|NCT00882908|528687677|FG003|Overall Study|Study terminated in error|1|||
146595589|NCT00882908|528687678|FG004|Overall Study|Study terminated in error|0|||
146595590|NCT01344629|528687680|FG000|Crossover Period 2|Withdrawal by Subject|0|||
146595591|NCT01344629|528687681|FG001|Crossover Period 2|Withdrawal by Subject|1|||
146595592|NCT05590000|528687685|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
146595593|NCT00762996|528687686|FG000|Period One|Protocol Violation|0|||
146595594|NCT00762996|528687687|FG001|Period One|Protocol Violation|0|||
146595595|NCT00762996|528687688|FG002|Period One|Protocol Violation|1|||
146595596|NCT00762996|528687689|FG003|Period One|Protocol Violation|0|||
146595597|NCT00762996|528687686|FG000|Period One|ineligible|0|||
146595598|NCT00762996|528687687|FG001|Period One|ineligible|0|||
146595599|NCT00762996|528687688|FG002|Period One|ineligible|1|||
146595600|NCT00762996|528687689|FG003|Period One|ineligible|1|||
146595601|NCT00762996|528687686|FG000|Period One|Adverse Event|0|||
146595602|NCT00762996|528687687|FG001|Period One|Adverse Event|0|||
146595603|NCT00762996|528687688|FG002|Period One|Adverse Event|1|||
146595604|NCT00762996|528687689|FG003|Period One|Adverse Event|0|||
146595605|NCT00762996|528687686|FG000|Period One|Withdrawal by Subject|0|||
146595606|NCT00762996|528687687|FG001|Period One|Withdrawal by Subject|0|||
146595607|NCT00762996|528687688|FG002|Period One|Withdrawal by Subject|1|||
146595608|NCT00762996|528687689|FG003|Period One|Withdrawal by Subject|0|||
146595609|NCT02689076|528687692|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
146595610|NCT02689076|528687693|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
146595611|NCT02689076|528687694|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
146595612|NCT02689076|528687692|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
146595613|NCT02689076|528687693|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
146595614|NCT02689076|528687694|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
146595615|NCT02689076|528687692|FG000|Overall Study|Did not have an HIE match|2|||
146595616|NCT02689076|528687693|FG001|Overall Study|Did not have an HIE match|0|||
146595617|NCT02689076|528687694|FG002|Overall Study|Did not have an HIE match|0|||
146595618|NCT02689076|528687692|FG000|Overall Study|Death during non-VA encounter|2|||
146595619|NCT02689076|528687693|FG001|Overall Study|Death during non-VA encounter|5|||
146595620|NCT02689076|528687694|FG002|Overall Study|Death during non-VA encounter|0|||
146595621|NCT02689076|528687692|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
146595622|NCT02689076|528687693|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
146595623|NCT02689076|528687694|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
146595624|NCT02689076|528687692|FG000|Overall Study|Participant no longer active in VA system|1|||
146595625|NCT02689076|528687693|FG001|Overall Study|Participant no longer active in VA system|0|||
146595626|NCT02689076|528687694|FG002|Overall Study|Participant no longer active in VA system|0|||
146595627|NCT02689076|528687692|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
146595628|NCT02689076|528687693|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
146653726|NCT04393298|528910621|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146653727|NCT04393298|528910622|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146653728|NCT04393298|528910623|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146920118|NCT00069095|529868880|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
146595629|NCT02689076|528687694|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
146653729|NCT04393298|528910624|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146595630|NCT04063787|528687700|FG000|Overall Study|Inadequate Doppler data|4|||
146595631|NCT04063787|528687700|FG000|Overall Study|Lost to Follow-up|2|||
146595632|NCT04063787|528687700|FG000|Overall Study|Death|3|||
146595633|NCT01816906|528687701|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
146595634|NCT01816906|528687702|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
146595635|NCT01816906|528687701|FG000|Six Months|Lost to Follow-up|14|||
146595636|NCT01816906|528687702|FG001|Six Months|Lost to Follow-up|16|||
146595637|NCT01816906|528687701|FG000|12 Months|Adverse Event|2|||
146595638|NCT01816906|528687702|FG001|12 Months|Adverse Event|2|||
146595639|NCT01816906|528687701|FG000|12 Months|Death|0|||
146595640|NCT01816906|528687702|FG001|12 Months|Death|2|||
146595641|NCT01816906|528687701|FG000|12 Months|Lost to Follow-up|2|||
146595642|NCT01816906|528687702|FG001|12 Months|Lost to Follow-up|1|||
146595643|NCT01527383|528687703|FG000|Overall Study|Adverse Event|5|||
146595644|NCT01527383|528687704|FG001|Overall Study|Adverse Event|0|||
146595645|NCT01527383|528687703|FG000|Overall Study|Lost to Follow-up|3|||
146595646|NCT01527383|528687704|FG001|Overall Study|Lost to Follow-up|0|||
146595647|NCT01527383|528687703|FG000|Overall Study|Physician Decision|2|||
146595648|NCT01527383|528687704|FG001|Overall Study|Physician Decision|0|||
146595649|NCT01527383|528687703|FG000|Overall Study|Pregnancy|1|||
146595650|NCT01527383|528687704|FG001|Overall Study|Pregnancy|0|||
146595651|NCT01527383|528687703|FG000|Overall Study|Protocol Violation|1|||
146595652|NCT01527383|528687704|FG001|Overall Study|Protocol Violation|0|||
146595653|NCT01527383|528687703|FG000|Overall Study|Screen failure|1|||
146595654|NCT01527383|528687704|FG001|Overall Study|Screen failure|0|||
146595655|NCT01527383|528687703|FG000|Overall Study|Participant moved|0|||
146595656|NCT01527383|528687704|FG001|Overall Study|Participant moved|1|||
146595657|NCT01527383|528687703|FG000|Overall Study|Withdrawal by Subject|2|||
146595658|NCT01527383|528687704|FG001|Overall Study|Withdrawal by Subject|3|||
146595659|NCT00746733|528687705|FG000|Second Intervention|Adverse Event|1|||
146595660|NCT00746733|528687706|FG001|Second Intervention|Adverse Event|0|||
146595661|NCT00746733|528687705|FG000|Third Intervention|Withdrawal by Subject|1|||
146595662|NCT00746733|528687706|FG001|Third Intervention|Withdrawal by Subject|1|||
146595663|NCT02558400|528687710|FG000|Overall Study|Adverse Event|47|||
146595664|NCT02558400|528687711|FG001|Overall Study|Adverse Event|53|||
146595665|NCT02558400|528687712|FG002|Overall Study|Adverse Event|4|||
146595666|NCT02558400|528687710|FG000|Overall Study|Withdrawal by Subject|13|||
146595667|NCT02558400|528687711|FG001|Overall Study|Withdrawal by Subject|9|||
146595668|NCT02558400|528687712|FG002|Overall Study|Withdrawal by Subject|8|||
146595669|NCT02558400|528687710|FG000|Overall Study|Non-Compliant|0|||
146595670|NCT02558400|528687711|FG001|Overall Study|Non-Compliant|1|||
146595671|NCT02558400|528687712|FG002|Overall Study|Non-Compliant|3|||
146595672|NCT02558400|528687710|FG000|Overall Study|Lost to Follow-up|5|||
146595673|NCT02558400|528687711|FG001|Overall Study|Lost to Follow-up|5|||
146595674|NCT02558400|528687712|FG002|Overall Study|Lost to Follow-up|4|||
146595675|NCT02558400|528687710|FG000|Overall Study|Lack of Efficacy|0|||
146595676|NCT02558400|528687711|FG001|Overall Study|Lack of Efficacy|13|||
146595677|NCT02558400|528687712|FG002|Overall Study|Lack of Efficacy|1|||
146595678|NCT02558400|528687710|FG000|Overall Study|Disallowed Concurrent Medication|6|||
146595679|NCT02558400|528687711|FG001|Overall Study|Disallowed Concurrent Medication|7|||
146595680|NCT02558400|528687712|FG002|Overall Study|Disallowed Concurrent Medication|5|||
146595681|NCT02558400|528687710|FG000|Overall Study|Physician Decision|2|||
146595682|NCT02558400|528687711|FG001|Overall Study|Physician Decision|2|||
146595683|NCT02558400|528687712|FG002|Overall Study|Physician Decision|0|||
146595684|NCT02558400|528687710|FG000|Overall Study|Protocol Violation|6|||
146595685|NCT02558400|528687711|FG001|Overall Study|Protocol Violation|3|||
146595686|NCT02558400|528687712|FG002|Overall Study|Protocol Violation|8|||
146595687|NCT02558400|528687710|FG000|Overall Study|Death|0|||
146595688|NCT02558400|528687711|FG001|Overall Study|Death|1|||
146595689|NCT02558400|528687712|FG002|Overall Study|Death|0|||
146595690|NCT02558400|528687710|FG000|Overall Study|Ineligible for the study|0|||
146595691|NCT02558400|528687711|FG001|Overall Study|Ineligible for the study|2|||
146595692|NCT02558400|528687712|FG002|Overall Study|Ineligible for the study|0|||
146595693|NCT00456599|528687713|FG000|Overall Study|Non-compliance|1|||
146653730|NCT04393298|528910625|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146978487|NCT01703741|530084081|FG000|Overall Study|Subject did not want to continue|2|||
146978488|NCT01703741|530084081|FG000|Overall Study|Subject cannot comply with study visits|1|||
146978489|NCT01703741|530084081|FG000|Overall Study|Subject started testosterone injections|1|||
146978490|NCT01717456|530084082|FG000|End of Treatment|Physician Decision|0|||
146595694|NCT00456599|528687713|FG000|Overall Study|Withdrawal by Subject|2|||
146595695|NCT02191605|528689702|FG000|Overall Study|Lost to Follow-up|9|||
146595696|NCT02191605|528689703|FG001|Overall Study|Lost to Follow-up|4|||
146595697|NCT02191605|528689704|FG002|Overall Study|Lost to Follow-up|7|||
146595698|NCT02191605|528689705|FG003|Overall Study|Lost to Follow-up|3|||
146595699|NCT02191605|528689706|FG004|Overall Study|Lost to Follow-up|4|||
146595700|NCT00734071|528689707|FG000|Overall Study|Adverse Event|4|||
146595701|NCT00734071|528689708|FG001|Overall Study|Adverse Event|3|||
146595702|NCT00734071|528689707|FG000|Overall Study|Lack of Efficacy|3|||
146595703|NCT00734071|528689708|FG001|Overall Study|Lack of Efficacy|1|||
146595704|NCT00734071|528689707|FG000|Overall Study|Noncompliance|2|||
146595705|NCT00734071|528689708|FG001|Overall Study|Noncompliance|2|||
146595706|NCT00734071|528689707|FG000|Overall Study|Protocol Deviations|3|||
146595707|NCT00734071|528689708|FG001|Overall Study|Protocol Deviations|4|||
146595708|NCT00734071|528689707|FG000|Overall Study|Voluntary Withdrawal|9|||
146595709|NCT00734071|528689708|FG001|Overall Study|Voluntary Withdrawal|7|||
146595710|NCT00734071|528689707|FG000|Overall Study|Lost to Follow-up|16|||
146595711|NCT00734071|528689708|FG001|Overall Study|Lost to Follow-up|8|||
146595712|NCT00734071|528689707|FG000|Overall Study|Other|1|||
146595713|NCT00734071|528689708|FG001|Overall Study|Other|2|||
146595714|NCT05275582|528689709|FG000|Overall Study|Lost to Follow-up|1|||
146595715|NCT05275582|528689710|FG001|Overall Study|Lost to Follow-up|0|||
146595716|NCT05275582|528689709|FG000|Overall Study|Withdrawal by Subject|0|||
146595717|NCT05275582|528689710|FG001|Overall Study|Withdrawal by Subject|2|||
146595718|NCT05275582|528689709|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
146595719|NCT05275582|528689710|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
146595720|NCT05275582|528689709|FG000|Overall Study|Death|1|||
146595721|NCT05275582|528689710|FG001|Overall Study|Death|0|||
146595722|NCT05275582|528689709|FG000|Overall Study|Protocol Violation|1|||
146595723|NCT05275582|528689710|FG001|Overall Study|Protocol Violation|0|||
146595724|NCT00240110|528689711|FG000|Overall Study|Lost to Follow-up|6|||
146595725|NCT00240110|528689712|FG001|Overall Study|Lost to Follow-up|7|||
146595726|NCT00583791|528689713|FG000|Overall Study|Other|67|||
146595727|NCT00583791|528689713|FG000|Overall Study|Death|6|||
146595728|NCT00203021|528689714|FG000|Overall Study|Death|4|||
146595729|NCT00203021|528689715|FG001|Overall Study|Death|1|||
146595730|NCT00203021|528689714|FG000|Overall Study|Adverse Event|10|||
146595731|NCT00203021|528689715|FG001|Overall Study|Adverse Event|5|||
146595732|NCT00203021|528689714|FG000|Overall Study|Withdrawal by Subject|45|||
146595733|NCT00203021|528689715|FG001|Overall Study|Withdrawal by Subject|48|||
146595734|NCT00203021|528689714|FG000|Overall Study|Lost to Follow-up|9|||
146595735|NCT00203021|528689715|FG001|Overall Study|Lost to Follow-up|7|||
146595736|NCT00203021|528689714|FG000|Overall Study|Other than specified|11|||
146595737|NCT00203021|528689715|FG001|Overall Study|Other than specified|16|||
146595738|NCT02080260|528689717|FG000|Overall Study|Death|18|||
146595739|NCT02080260|528689717|FG000|Overall Study|Withdrawal by Subject|1|||
146595740|NCT03204890|528689722|FG000|Overall Study|Withdrawal by Subject|1|||
146595741|NCT03747120|528689723|FG000|Overall Study|treatment related toxicity|3|||
146595742|NCT03747120|528689724|FG001|Overall Study|treatment related toxicity|0|||
146595743|NCT03747120|528689725|FG002|Overall Study|treatment related toxicity|0|||
146595744|NCT03747120|528689723|FG000|Overall Study|Withdrawal by Subject|0|||
146595745|NCT03747120|528689724|FG001|Overall Study|Withdrawal by Subject|1|||
146595746|NCT03747120|528689725|FG002|Overall Study|Withdrawal by Subject|2|||
146595747|NCT03627065|528689726|FG000|Overall Study|Study Terminated by sponsor|1|||
146595748|NCT03627065|528689726|FG000|Overall Study|Withdrawal by Subject|2|||
146595749|NCT00996801|528689727|FG000|Overall Study|Adverse Event|6|||
146595750|NCT00996801|528689728|FG001|Overall Study|Adverse Event|4|||
146595751|NCT00996801|528689729|FG002|Overall Study|Adverse Event|12|||
146595752|NCT00996801|528689730|FG003|Overall Study|Adverse Event|17|||
146595753|NCT00996801|528689731|FG004|Overall Study|Adverse Event|31|||
146595754|NCT00996801|528689732|FG005|Overall Study|Adverse Event|3|||
146595755|NCT00996801|528689727|FG000|Overall Study|Lack of Efficacy|3|||
146595756|NCT00996801|528689728|FG001|Overall Study|Lack of Efficacy|0|||
146595757|NCT00996801|528689729|FG002|Overall Study|Lack of Efficacy|1|||
146920119|NCT00069095|529868875|FG000|Post-study Treatment Phase|Surgery|0|||
146920120|NCT00069095|529868876|FG001|Post-study Treatment Phase|Surgery|0|||
146595758|NCT00996801|528689730|FG003|Overall Study|Lack of Efficacy|3|||
146595759|NCT00996801|528689731|FG004|Overall Study|Lack of Efficacy|0|||
146595760|NCT00996801|528689732|FG005|Overall Study|Lack of Efficacy|1|||
146595761|NCT00996801|528689727|FG000|Overall Study|Lost to Follow-up|0|||
146595762|NCT00996801|528689728|FG001|Overall Study|Lost to Follow-up|0|||
146595763|NCT00996801|528689729|FG002|Overall Study|Lost to Follow-up|0|||
146920121|NCT00069095|529868877|FG002|Post-study Treatment Phase|Surgery|0|||
146920122|NCT00069095|529868878|FG003|Post-study Treatment Phase|Surgery|1|||
146920123|NCT00069095|529868879|FG004|Post-study Treatment Phase|Surgery|1|||
146920124|NCT00069095|529868880|FG005|Post-study Treatment Phase|Surgery|0|||
146595764|NCT00996801|528689730|FG003|Overall Study|Lost to Follow-up|3|||
146595765|NCT00996801|528689731|FG004|Overall Study|Lost to Follow-up|3|||
146595766|NCT00996801|528689732|FG005|Overall Study|Lost to Follow-up|2|||
146595767|NCT00996801|528689727|FG000|Overall Study|Physician Decision|0|||
146595768|NCT00996801|528689728|FG001|Overall Study|Physician Decision|0|||
146595769|NCT00996801|528689729|FG002|Overall Study|Physician Decision|0|||
146595770|NCT00996801|528689730|FG003|Overall Study|Physician Decision|1|||
146595771|NCT00996801|528689731|FG004|Overall Study|Physician Decision|0|||
146595772|NCT00996801|528689732|FG005|Overall Study|Physician Decision|0|||
146595773|NCT00996801|528689727|FG000|Overall Study|Progressive Disease|0|||
146595774|NCT00996801|528689728|FG001|Overall Study|Progressive Disease|1|||
146595775|NCT00996801|528689729|FG002|Overall Study|Progressive Disease|0|||
146595776|NCT00996801|528689730|FG003|Overall Study|Progressive Disease|0|||
146595777|NCT00996801|528689731|FG004|Overall Study|Progressive Disease|0|||
146595778|NCT00996801|528689732|FG005|Overall Study|Progressive Disease|0|||
146920125|NCT00069095|529868875|FG000|Post-study Treatment Phase|Death|0|||
146595779|NCT00996801|528689727|FG000|Overall Study|Protocol Violation|3|||
146595780|NCT00996801|528689728|FG001|Overall Study|Protocol Violation|4|||
146595781|NCT00996801|528689729|FG002|Overall Study|Protocol Violation|1|||
146595782|NCT00996801|528689730|FG003|Overall Study|Protocol Violation|2|||
146595783|NCT00996801|528689731|FG004|Overall Study|Protocol Violation|3|||
146595784|NCT00996801|528689732|FG005|Overall Study|Protocol Violation|4|||
146595785|NCT00996801|528689727|FG000|Overall Study|Study Terminated by Sponsor|0|||
146595786|NCT00996801|528689728|FG001|Overall Study|Study Terminated by Sponsor|1|||
146595787|NCT00996801|528689729|FG002|Overall Study|Study Terminated by Sponsor|0|||
146595788|NCT00996801|528689730|FG003|Overall Study|Study Terminated by Sponsor|0|||
146595789|NCT00996801|528689731|FG004|Overall Study|Study Terminated by Sponsor|46|||
146595790|NCT00996801|528689732|FG005|Overall Study|Study Terminated by Sponsor|0|||
146595791|NCT00996801|528689727|FG000|Overall Study|Withdrawal by Subject|8|||
146595792|NCT00996801|528689728|FG001|Overall Study|Withdrawal by Subject|6|||
146595793|NCT00996801|528689729|FG002|Overall Study|Withdrawal by Subject|9|||
146595794|NCT00996801|528689730|FG003|Overall Study|Withdrawal by Subject|5|||
146595795|NCT00996801|528689731|FG004|Overall Study|Withdrawal by Subject|5|||
146595796|NCT00996801|528689732|FG005|Overall Study|Withdrawal by Subject|9|||
146595797|NCT01688739|528689733|FG000|Overall Study|Administrative Decision|1|||
146595798|NCT01688739|528689734|FG001|Overall Study|Administrative Decision|0|||
146595799|NCT01688739|528689735|FG002|Overall Study|Administrative Decision|0|||
146595800|NCT01688739|528689736|FG003|Overall Study|Administrative Decision|0|||
146595801|NCT01688739|528689737|FG004|Overall Study|Administrative Decision|0|||
146595802|NCT01688739|528689738|FG005|Overall Study|Administrative Decision|0|||
146595803|NCT01688739|528689739|FG006|Overall Study|Administrative Decision|0|||
146595804|NCT01688739|528689740|FG007|Overall Study|Administrative Decision|0|||
146595805|NCT01688739|528689741|FG008|Overall Study|Administrative Decision|0|||
146595806|NCT01688739|528689742|FG009|Overall Study|Administrative Decision|0|||
146595807|NCT00289198|528689743|FG000|Overall Study|Adverse Event|0|||
146595808|NCT00289198|528689744|FG001|Overall Study|Adverse Event|2|||
146595809|NCT00289198|528689743|FG000|Overall Study|Protocol Violation|2|||
146595810|NCT00289198|528689744|FG001|Overall Study|Protocol Violation|1|||
146595811|NCT00289198|528689743|FG000|Overall Study|Withdrawal by Subject|4|||
146595812|NCT00289198|528689744|FG001|Overall Study|Withdrawal by Subject|1|||
146595813|NCT00289198|528689743|FG000|Overall Study|Lack of Efficacy|2|||
146595814|NCT00289198|528689744|FG001|Overall Study|Lack of Efficacy|0|||
146595815|NCT00289198|528689743|FG000|Overall Study|Other: Low compliance|0|||
146595816|NCT00289198|528689744|FG001|Overall Study|Other: Low compliance|1|||
146595817|NCT00289198|528689743|FG000|Overall Study|Other: Physician's decision|0|||
146595818|NCT00289198|528689744|FG001|Overall Study|Other: Physician's decision|1|||
146595819|NCT00289198|528689743|FG000|Overall Study|Other: Unable to attend on schedule|2|||
146595820|NCT00289198|528689744|FG001|Overall Study|Other: Unable to attend on schedule|1|||
146595821|NCT00289198|528689743|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
146595822|NCT00289198|528689744|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
146595823|NCT00289198|528689743|FG000|Overall Study|Other: Impossible to come on visit|0|||
146595824|NCT00289198|528689744|FG001|Overall Study|Other: Impossible to come on visit|1|||
146595825|NCT03369431|528689745|FG000|Overall Study|Lost to Follow-up|1|||
146595826|NCT03369431|528689746|FG001|Overall Study|Lost to Follow-up|3|||
146595827|NCT03369431|528689745|FG000|Overall Study|Withdrawal by Subject|2|||
146595828|NCT03369431|528689746|FG001|Overall Study|Withdrawal by Subject|3|||
146595829|NCT03369431|528689745|FG000|Overall Study|Protocol Violation|1|||
146595830|NCT03369431|528689746|FG001|Overall Study|Protocol Violation|1|||
146595831|NCT01062061|528689747|FG000|Overall Study|Enrolled more than once|2|||
146595832|NCT01062061|528689747|FG000|Overall Study|Investigated before study start|13|||
146595833|NCT01062061|528689747|FG000|Overall Study|Outside chief indications|10|||
146595834|NCT01062061|528689747|FG000|Overall Study|Failed to meet inclusion criteria|2|||
146595835|NCT01113580|528689752|FG000|Overall Study|Protocol Violation|1|||
146595836|NCT01113580|528689753|FG001|Overall Study|Protocol Violation|0|||
146595837|NCT01145053|528689754|FG000|Overall Study|Adverse Event|22|||
146595838|NCT01145053|528689754|FG000|Overall Study|Lost to Follow-up|28|||
146595839|NCT01145053|528689754|FG000|Overall Study|Withdrawal by Subject|25|||
146595840|NCT01145053|528689754|FG000|Overall Study|Other|18|||
146595841|NCT02088073|528689755|FG000|Acute Phase|Withdrawal by Subject|5|||
146595842|NCT02088073|528689756|FG001|Acute Phase|Withdrawal by Subject|0|||
146595843|NCT02088073|528689757|FG002|Acute Phase|Withdrawal by Subject|0|||
146595844|NCT02088073|528689758|FG003|Acute Phase|Withdrawal by Subject|0|||
146595845|NCT02088073|528689759|FG004|Acute Phase|Withdrawal by Subject|0|||
146595846|NCT02088073|528689755|FG000|Acute Phase|Hyperkalemia|2|||
146595847|NCT02088073|528689756|FG001|Acute Phase|Hyperkalemia|0|||
146595848|NCT02088073|528689757|FG002|Acute Phase|Hyperkalemia|0|||
146595849|NCT02088073|528689758|FG003|Acute Phase|Hyperkalemia|0|||
146595850|NCT02088073|528689759|FG004|Acute Phase|Hyperkalemia|0|||
146595851|NCT02088073|528689755|FG000|Maintanance Phase|Withdrawal by Subject|0|||
146595852|NCT02088073|528689756|FG001|Maintanance Phase|Withdrawal by Subject|2|||
146595853|NCT02088073|528689757|FG002|Maintanance Phase|Withdrawal by Subject|0|||
146595854|NCT02088073|528689758|FG003|Maintanance Phase|Withdrawal by Subject|0|||
146595855|NCT02088073|528689759|FG004|Maintanance Phase|Withdrawal by Subject|0|||
146920126|NCT00069095|529868876|FG001|Post-study Treatment Phase|Death|0|||
146920127|NCT00069095|529868877|FG002|Post-study Treatment Phase|Death|0|||
146920128|NCT00069095|529868878|FG003|Post-study Treatment Phase|Death|0|||
146920129|NCT00069095|529868879|FG004|Post-study Treatment Phase|Death|1|||
146595856|NCT02088073|528689755|FG000|Maintanance Phase|Adverse Event|0|||
146595857|NCT02088073|528689756|FG001|Maintanance Phase|Adverse Event|0|||
146595858|NCT02088073|528689757|FG002|Maintanance Phase|Adverse Event|3|||
146595859|NCT02088073|528689758|FG003|Maintanance Phase|Adverse Event|0|||
146595860|NCT02088073|528689759|FG004|Maintanance Phase|Adverse Event|1|||
146595861|NCT02088073|528689755|FG000|Maintanance Phase|Physician Decision|0|||
146595862|NCT02088073|528689756|FG001|Maintanance Phase|Physician Decision|0|||
146595863|NCT02088073|528689757|FG002|Maintanance Phase|Physician Decision|0|||
146595864|NCT02088073|528689758|FG003|Maintanance Phase|Physician Decision|0|||
146595865|NCT02088073|528689759|FG004|Maintanance Phase|Physician Decision|1|||
146595866|NCT02088073|528689755|FG000|Maintanance Phase|Sponsor's decision|0|||
146595867|NCT02088073|528689756|FG001|Maintanance Phase|Sponsor's decision|2|||
146595868|NCT02088073|528689757|FG002|Maintanance Phase|Sponsor's decision|0|||
146595869|NCT02088073|528689758|FG003|Maintanance Phase|Sponsor's decision|2|||
146595870|NCT02088073|528689759|FG004|Maintanance Phase|Sponsor's decision|1|||
146595871|NCT02088073|528689755|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
146595872|NCT02088073|528689756|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
146595873|NCT02088073|528689757|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
146595874|NCT02088073|528689758|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
146595875|NCT02088073|528689759|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
146595876|NCT02088073|528689755|FG000|Maintanance Phase|Miscellaneous|0|||
146595877|NCT02088073|528689756|FG001|Maintanance Phase|Miscellaneous|2|||
146595878|NCT02088073|528689757|FG002|Maintanance Phase|Miscellaneous|1|||
146595879|NCT02088073|528689758|FG003|Maintanance Phase|Miscellaneous|2|||
146595880|NCT02088073|528689759|FG004|Maintanance Phase|Miscellaneous|1|||
146595881|NCT02088073|528689755|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
146595882|NCT02088073|528689756|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
146595883|NCT02088073|528689757|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
146595884|NCT02088073|528689758|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
146595885|NCT02088073|528689759|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
146595886|NCT02088073|528689755|FG000|Maintanance Phase|Subject compliance|0|||
146595887|NCT02088073|528689756|FG001|Maintanance Phase|Subject compliance|1|||
146595888|NCT02088073|528689757|FG002|Maintanance Phase|Subject compliance|0|||
146595889|NCT02088073|528689758|FG003|Maintanance Phase|Subject compliance|0|||
146595890|NCT02088073|528689759|FG004|Maintanance Phase|Subject compliance|0|||
146595891|NCT03684304|528689760|FG000|Overall Study|Lost to Follow-up|19|||
146595892|NCT03684304|528689761|FG001|Overall Study|Lost to Follow-up|17|||
146595893|NCT01009346|528689762|FG000|Overall Study|Adverse Event|4|||
146595894|NCT02266875|528689767|FG000|Overall Study|Withdrawal by Subject|9|||
146595895|NCT02266875|528689768|FG001|Overall Study|Withdrawal by Subject|0|||
146595896|NCT02266875|528689767|FG000|Overall Study|Lost to Follow-up|2|||
146595897|NCT02266875|528689768|FG001|Overall Study|Lost to Follow-up|0|||
146595898|NCT00849875|528689772|FG000|Overall Study|Death|28|||
146595899|NCT00849875|528689772|FG000|Overall Study|Ongoing (unknown completion status)|11|||
146595900|NCT00849875|528689772|FG000|Overall Study|Others|6|||
146595901|NCT00849875|528689772|FG000|Overall Study|Lost to Follow-up|2|||
146595902|NCT01304329|528689773|FG000|Third Intervention (3 Days)|Adverse Event|0|||
146595903|NCT01304329|528689774|FG001|Third Intervention (3 Days)|Adverse Event|1|||
146595904|NCT01304329|528689775|FG002|Third Intervention (3 Days)|Adverse Event|0|||
146595905|NCT01304329|528689776|FG003|Third Intervention (3 Days)|Adverse Event|0|||
146595906|NCT01304329|528689777|FG004|Third Intervention (3 Days)|Adverse Event|0|||
146595907|NCT01304329|528689778|FG005|Third Intervention (3 Days)|Adverse Event|0|||
146595908|NCT03515941|528689790|FG000|Overall Study|Adverse Event|1|||
146595909|NCT03515941|528689791|FG001|Overall Study|Adverse Event|0|||
146595910|NCT00276094|528689792|FG000|Overall Study|Adverse Event|15|||
146595911|NCT00276094|528689793|FG001|Overall Study|Adverse Event|13|||
146595912|NCT00276094|528689794|FG002|Overall Study|Adverse Event|11|||
146595913|NCT00276094|528689792|FG000|Overall Study|Withdrawal by Subject|14|||
146595914|NCT00276094|528689793|FG001|Overall Study|Withdrawal by Subject|14|||
146595915|NCT00276094|528689794|FG002|Overall Study|Withdrawal by Subject|12|||
146595916|NCT00276094|528689792|FG000|Overall Study|Protocol Violation|16|||
146595917|NCT00276094|528689793|FG001|Overall Study|Protocol Violation|7|||
146595918|NCT00276094|528689794|FG002|Overall Study|Protocol Violation|10|||
146595919|NCT00276094|528689792|FG000|Overall Study|Lost to Follow-up|8|||
146595920|NCT00276094|528689793|FG001|Overall Study|Lost to Follow-up|6|||
146595921|NCT00276094|528689794|FG002|Overall Study|Lost to Follow-up|4|||
146595922|NCT00276094|528689792|FG000|Overall Study|Other-Subject moved out of country|1|||
146595923|NCT00276094|528689793|FG001|Overall Study|Other-Subject moved out of country|0|||
146920130|NCT00069095|529868880|FG005|Post-study Treatment Phase|Death|0|||
146595924|NCT00276094|528689794|FG002|Overall Study|Other-Subject moved out of country|0|||
146595925|NCT00276094|528689792|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
146595926|NCT00276094|528689793|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
146595927|NCT00276094|528689794|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
146595928|NCT00276094|528689792|FG000|Overall Study|Other-Lack of efficacy|1|||
146595929|NCT00276094|528689793|FG001|Overall Study|Other-Lack of efficacy|0|||
146595930|NCT00276094|528689794|FG002|Overall Study|Other-Lack of efficacy|0|||
146595931|NCT00276094|528689792|FG000|Overall Study|Other-Refused follow-up visit|1|||
146595932|NCT00276094|528689793|FG001|Overall Study|Other-Refused follow-up visit|0|||
146595933|NCT00276094|528689794|FG002|Overall Study|Other-Refused follow-up visit|0|||
146595934|NCT00276094|528689792|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
146595935|NCT00276094|528689793|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
146595936|NCT00276094|528689794|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
146595937|NCT00276094|528689792|FG000|Overall Study|Other-Relocation|0|||
146595938|NCT00276094|528689793|FG001|Overall Study|Other-Relocation|1|||
146595939|NCT00276094|528689794|FG002|Overall Study|Other-Relocation|0|||
146595940|NCT00276094|528689792|FG000|Overall Study|Other-Study medication lost|0|||
146595941|NCT00276094|528689793|FG001|Overall Study|Other-Study medication lost|0|||
146595942|NCT00276094|528689794|FG002|Overall Study|Other-Study medication lost|1|||
146595943|NCT02759315|528689795|FG000|Overall Study|Adverse Event|0|||
146595944|NCT02759315|528689796|FG001|Overall Study|Adverse Event|0|||
146595945|NCT02759315|528689797|FG002|Overall Study|Adverse Event|0|||
146595946|NCT02759315|528689798|FG003|Overall Study|Adverse Event|1|||
146595947|NCT02759315|528689799|FG004|Overall Study|Adverse Event|0|||
146595948|NCT02759315|528689795|FG000|Overall Study|Death|0|||
146595949|NCT02759315|528689796|FG001|Overall Study|Death|0|||
146595950|NCT02759315|528689797|FG002|Overall Study|Death|1|||
146595951|NCT02759315|528689798|FG003|Overall Study|Death|0|||
146595952|NCT02759315|528689799|FG004|Overall Study|Death|0|||
146595953|NCT02759315|528689795|FG000|Overall Study|Lost to Follow-up|2|||
146595954|NCT02759315|528689796|FG001|Overall Study|Lost to Follow-up|0|||
146595955|NCT02759315|528689797|FG002|Overall Study|Lost to Follow-up|4|||
146595956|NCT02759315|528689798|FG003|Overall Study|Lost to Follow-up|0|||
146595957|NCT02759315|528689799|FG004|Overall Study|Lost to Follow-up|0|||
146595958|NCT02759315|528689795|FG000|Overall Study|Protocol Violation|0|||
146595959|NCT02759315|528689796|FG001|Overall Study|Protocol Violation|1|||
146595960|NCT02759315|528689797|FG002|Overall Study|Protocol Violation|0|||
146595961|NCT02759315|528689798|FG003|Overall Study|Protocol Violation|0|||
146595962|NCT02759315|528689799|FG004|Overall Study|Protocol Violation|0|||
146595963|NCT02759315|528689795|FG000|Overall Study|Study terminated prior to completion|2|||
146595964|NCT02759315|528689796|FG001|Overall Study|Study terminated prior to completion|0|||
146595965|NCT02759315|528689797|FG002|Overall Study|Study terminated prior to completion|5|||
146595966|NCT02759315|528689798|FG003|Overall Study|Study terminated prior to completion|0|||
146595967|NCT02759315|528689799|FG004|Overall Study|Study terminated prior to completion|1|||
146595968|NCT01406015|528689802|FG000|Overall Study|Withdrawal by Subject|3|||
146595969|NCT01406015|528689803|FG001|Overall Study|Withdrawal by Subject|3|||
146595970|NCT00787137|528689804|FG000|Overall Study|Study Termination|0|||
146595971|NCT00787137|528689805|FG001|Overall Study|Study Termination|0|||
146595972|NCT00787137|528689806|FG002|Overall Study|Study Termination|1|||
146595973|NCT00554099|528689810|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
146595974|NCT00554099|528689811|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
146595975|NCT00554099|528689812|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
146595976|NCT00554099|528689810|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
146595977|NCT00554099|528689811|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
146595978|NCT00554099|528689812|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
146595979|NCT00554099|528689810|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
146595980|NCT00554099|528689811|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146595981|NCT00554099|528689812|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
146595982|NCT00554099|528689810|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
146595983|NCT00554099|528689811|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
146595984|NCT00554099|528689812|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
146595985|NCT00554099|528689810|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
146595986|NCT00554099|528689811|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
146595987|NCT00554099|528689812|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
146595988|NCT00554099|528689810|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
146595989|NCT00554099|528689811|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
146595990|NCT00554099|528689812|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
146595991|NCT00554099|528689810|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
146595992|NCT00554099|528689811|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
146595993|NCT00554099|528689812|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
146595994|NCT00554099|528689810|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
146595995|NCT00554099|528689811|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
146595996|NCT00554099|528689812|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
146595997|NCT00554099|528689810|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
146595998|NCT00554099|528689811|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
146595999|NCT00554099|528689812|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
146596000|NCT02075632|528689816|FG000|Overall Study|Adverse Event|1|||
146596001|NCT02075632|528689817|FG001|Overall Study|Adverse Event|1|||
146596002|NCT02075632|528689816|FG000|Overall Study|Lost to Follow-up|0|||
146596003|NCT02075632|528689817|FG001|Overall Study|Lost to Follow-up|3|||
146596004|NCT02075632|528689816|FG000|Overall Study|Withdrawal by Subject|0|||
146596005|NCT02075632|528689817|FG001|Overall Study|Withdrawal by Subject|1|||
146596006|NCT01628367|528689820|FG000|Overall Study|Adverse Event|1|||
146596007|NCT01628367|528689821|FG001|Overall Study|Adverse Event|0|||
146596008|NCT03353922|528689824|FG000|Overall Study|Withdrawal by Subject|1|||
146596009|NCT03353922|528689825|FG001|Overall Study|Withdrawal by Subject|0|||
146596010|NCT03353922|528689826|FG002|Overall Study|Withdrawal by Subject|1|||
146596011|NCT03353922|528689827|FG003|Overall Study|Withdrawal by Subject|1|||
146596012|NCT03353922|528689828|FG004|Overall Study|Withdrawal by Subject|0|||
146596013|NCT03353922|528689829|FG005|Overall Study|Withdrawal by Subject|0|||
146596014|NCT03353922|528689824|FG000|Overall Study|Adverse Event|0|||
146596015|NCT03353922|528689825|FG001|Overall Study|Adverse Event|1|||
146596016|NCT03353922|528689826|FG002|Overall Study|Adverse Event|0|||
146596017|NCT03353922|528689827|FG003|Overall Study|Adverse Event|0|||
146596018|NCT03353922|528689828|FG004|Overall Study|Adverse Event|0|||
146596019|NCT03353922|528689829|FG005|Overall Study|Adverse Event|0|||
146596020|NCT00740714|528689830|FG000|Overall Study|Withdrawal by Subject|17|||
146920131|NCT00069095|529868875|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
146920132|NCT00069095|529868876|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
146596021|NCT00740714|528689831|FG001|Overall Study|Withdrawal by Subject|19|||
146596022|NCT00740714|528689832|FG002|Overall Study|Withdrawal by Subject|29|||
146596023|NCT03688555|528689833|FG000|Treatment Period|Adverse Event|0|||
146596024|NCT03688555|528689834|FG001|Treatment Period|Adverse Event|0|||
146596025|NCT03688555|528689835|FG002|Treatment Period|Adverse Event|1|||
146596026|NCT00886119|528689840|FG000|Period 1|Did not meet inclusion criteria|1|||
146596027|NCT00886119|528689841|FG001|Period 1|Did not meet inclusion criteria|0|||
146596028|NCT00394901|528689842|FG000|Baseline Phase|Protocol Violation|0|||
146596029|NCT00394901|528689843|FG001|Baseline Phase|Protocol Violation|0|||
146596030|NCT00394901|528689844|FG002|Baseline Phase|Protocol Violation|1|||
146596031|NCT00394901|528689845|FG003|Baseline Phase|Protocol Violation|0|||
146596032|NCT00394901|528689842|FG000|Double-blind Phase|Adverse Event|5|||
146596033|NCT00394901|528689843|FG001|Double-blind Phase|Adverse Event|7|||
146596034|NCT00394901|528689844|FG002|Double-blind Phase|Adverse Event|16|||
146653731|NCT04393298|528910626|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
146653732|NCT04393298|528910627|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146653733|NCT04393298|528910628|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146653734|NCT04393298|528910629|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146653735|NCT04393298|528910630|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146653736|NCT04393298|528910631|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146653737|NCT04393298|528910632|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146653738|NCT04393298|528910633|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146653739|NCT04393298|528910634|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146653740|NCT04393298|528910635|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146653741|NCT04393298|528910621|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146653742|NCT04393298|528910622|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146653743|NCT04393298|528910623|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146653744|NCT04393298|528910624|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146653745|NCT04393298|528910625|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146653746|NCT04393298|528910626|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
146653747|NCT04393298|528910627|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146653748|NCT04393298|528910628|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146653749|NCT04393298|528910629|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146653750|NCT04393298|528910630|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146653751|NCT04393298|528910631|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146653752|NCT04393298|528910632|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146653753|NCT04393298|528910633|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146653754|NCT04393298|528910634|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146653755|NCT04393298|528910635|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
146653756|NCT04393298|528910621|FG000|Overall Study|Death|0|||
146653757|NCT04393298|528910622|FG001|Overall Study|Death|0|||
146653758|NCT04393298|528910623|FG002|Overall Study|Death|0|||
146596035|NCT00394901|528689845|FG003|Double-blind Phase|Adverse Event|20|||
146596036|NCT00394901|528689842|FG000|Double-blind Phase|Lack of Efficacy|6|||
146596037|NCT00394901|528689843|FG001|Double-blind Phase|Lack of Efficacy|4|||
146596038|NCT00394901|528689844|FG002|Double-blind Phase|Lack of Efficacy|1|||
146596039|NCT00394901|528689845|FG003|Double-blind Phase|Lack of Efficacy|3|||
146653759|NCT04393298|528910624|FG003|Overall Study|Death|0|||
146653760|NCT04393298|528910625|FG004|Overall Study|Death|0|||
146653761|NCT04393298|528910626|FG005|Overall Study|Death|1|||
146653762|NCT04393298|528910627|FG006|Overall Study|Death|1|||
146596040|NCT00394901|528689842|FG000|Double-blind Phase|Withdrawal by Subject|2|||
146596041|NCT00394901|528689843|FG001|Double-blind Phase|Withdrawal by Subject|0|||
146596042|NCT00394901|528689844|FG002|Double-blind Phase|Withdrawal by Subject|0|||
146596043|NCT00394901|528689845|FG003|Double-blind Phase|Withdrawal by Subject|0|||
146596044|NCT00394901|528689842|FG000|Double-blind Phase|Lost to Follow-up|0|||
146596045|NCT00394901|528689843|FG001|Double-blind Phase|Lost to Follow-up|0|||
146596046|NCT00394901|528689844|FG002|Double-blind Phase|Lost to Follow-up|0|||
146596047|NCT00394901|528689845|FG003|Double-blind Phase|Lost to Follow-up|1|||
146596048|NCT00394901|528689842|FG000|Double-blind Phase|Protocol Violation|0|||
146596049|NCT00394901|528689843|FG001|Double-blind Phase|Protocol Violation|0|||
146596050|NCT00394901|528689844|FG002|Double-blind Phase|Protocol Violation|0|||
146596051|NCT00394901|528689845|FG003|Double-blind Phase|Protocol Violation|1|||
146596052|NCT00394901|528689842|FG000|Double-blind Phase|Death|1|||
146596053|NCT00394901|528689843|FG001|Double-blind Phase|Death|0|||
146596054|NCT00394901|528689844|FG002|Double-blind Phase|Death|0|||
146596055|NCT00394901|528689845|FG003|Double-blind Phase|Death|0|||
146596056|NCT00394901|528689842|FG000|Double-blind Phase|Subject's Personal Reason|1|||
146596057|NCT00394901|528689843|FG001|Double-blind Phase|Subject's Personal Reason|0|||
146771523|NCT05061693|529331233|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146771524|NCT05061693|529331234|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146596058|NCT00394901|528689844|FG002|Double-blind Phase|Subject's Personal Reason|0|||
146596059|NCT00394901|528689845|FG003|Double-blind Phase|Subject's Personal Reason|1|||
146596060|NCT00394901|528689842|FG000|Double-blind Phase|Lack of Compliance|0|||
146596061|NCT00394901|528689843|FG001|Double-blind Phase|Lack of Compliance|3|||
146596062|NCT00394901|528689844|FG002|Double-blind Phase|Lack of Compliance|0|||
146596063|NCT00394901|528689845|FG003|Double-blind Phase|Lack of Compliance|0|||
146596064|NCT00394901|528689842|FG000|Double-blind Phase|Entry into another study was found|0|||
146596065|NCT00394901|528689843|FG001|Double-blind Phase|Entry into another study was found|0|||
146596066|NCT00394901|528689844|FG002|Double-blind Phase|Entry into another study was found|1|||
146596067|NCT00394901|528689845|FG003|Double-blind Phase|Entry into another study was found|0|||
146596068|NCT00394901|528689842|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
146596069|NCT00394901|528689843|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
146596070|NCT00394901|528689844|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
146596071|NCT00394901|528689845|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
146596072|NCT03002623|528689846|FG000|Overall Study|Lost to Follow-up|1|||
146596073|NCT03002623|528689847|FG001|Overall Study|Lost to Follow-up|0|||
146596074|NCT03002623|528689846|FG000|Overall Study|Physician Decision|1|||
146596075|NCT03002623|528689847|FG001|Overall Study|Physician Decision|1|||
146596076|NCT02256267|528689848|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
146596077|NCT02256267|528689848|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
146596078|NCT01352741|528689850|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
146596079|NCT01352741|528689851|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
146596080|NCT01352741|528689850|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
146596081|NCT01352741|528689851|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
146596082|NCT01352741|528689850|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
146596083|NCT01352741|528689851|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
146596084|NCT01352741|528689850|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
146596085|NCT01352741|528689851|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
146596086|NCT01352741|528689850|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
146596087|NCT01352741|528689851|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
146596088|NCT01352741|528689850|FG000|Open-label Tapentadol Titration Period|Other|4|||
146596089|NCT01352741|528689851|FG001|Open-label Tapentadol Titration Period|Other|0|||
146596090|NCT01352741|528689850|FG000|Double-blind Comparative Period|Protocol Violation|2|||
146596091|NCT01352741|528689851|FG001|Double-blind Comparative Period|Protocol Violation|0|||
146596092|NCT01352741|528689850|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
146596093|NCT01352741|528689851|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
146596094|NCT01352741|528689850|FG000|Double-blind Comparative Period|Adverse Event|16|||
146596095|NCT01352741|528689851|FG001|Double-blind Comparative Period|Adverse Event|17|||
146596096|NCT01352741|528689850|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
146596097|NCT01352741|528689851|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
146596098|NCT01352741|528689850|FG000|Double-blind Comparative Period|Death|0|||
146596099|NCT01352741|528689851|FG001|Double-blind Comparative Period|Death|1|||
146596100|NCT01352741|528689850|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
146596101|NCT01352741|528689851|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
146596102|NCT01352741|528689850|FG000|Double-blind Comparative Period|Other|1|||
146596103|NCT01352741|528689851|FG001|Double-blind Comparative Period|Other|2|||
146596104|NCT01352741|528689850|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
146771525|NCT05061693|529331235|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146596105|NCT01352741|528689851|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
146771526|NCT05061693|529331236|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146596106|NCT01352741|528689850|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
146596107|NCT01352741|528689851|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
146596108|NCT01352741|528689850|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
146596109|NCT01352741|528689851|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
146596110|NCT01352741|528689850|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
146596111|NCT01352741|528689851|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
146596112|NCT00259298|528689853|FG000|Overall Study|Withdrawal by Subject|1|||
146596113|NCT00259298|528689853|FG000|Overall Study|Physician Decision|2|||
146596114|NCT00645528|528689854|FG000|Overall Study|Did not show up for Visit 2|7|||
146596115|NCT03618628|528689858|FG000|Overall Study|Death|1|||
146596116|NCT03618628|528689858|FG000|Overall Study|Lost to Follow-up|1|||
146596117|NCT01969500|528689859|FG000|Overall Study|Death|0|||
146596118|NCT01969500|528689860|FG001|Overall Study|Death|1|||
146596119|NCT01969500|528689859|FG000|Overall Study|extended hospitalization|1|||
146596120|NCT01969500|528689860|FG001|Overall Study|extended hospitalization|1|||
146596121|NCT01741532|528689861|FG000|Overall Study|Adverse Event|4|||
146596122|NCT01741532|528689862|FG001|Overall Study|Adverse Event|0|||
146596123|NCT01741532|528689861|FG000|Overall Study|Withdrawal by Subject|1|||
146596124|NCT01741532|528689862|FG001|Overall Study|Withdrawal by Subject|1|||
146596125|NCT01741532|528689861|FG000|Overall Study|Protocol Violation|0|||
146596126|NCT01741532|528689862|FG001|Overall Study|Protocol Violation|1|||
146596127|NCT01741532|528689861|FG000|Overall Study|Worsening of the disease|3|||
146596128|NCT01741532|528689862|FG001|Overall Study|Worsening of the disease|1|||
146596129|NCT01741532|528689861|FG000|Overall Study|Sponsor decision|1|||
146596130|NCT01741532|528689862|FG001|Overall Study|Sponsor decision|0|||
146596131|NCT01741532|528689861|FG000|Overall Study|Medical event|1|||
146596132|NCT01741532|528689862|FG001|Overall Study|Medical event|0|||
146596133|NCT02463032|528689863|FG000|Overall Study|Lack of Efficacy|61|||
146596134|NCT02463032|528689864|FG001|Overall Study|Lack of Efficacy|50|||
146596135|NCT02463032|528689863|FG000|Overall Study|Death|8|||
146596136|NCT02463032|528689864|FG001|Overall Study|Death|8|||
146596137|NCT02463032|528689863|FG000|Overall Study|Adverse Event|2|||
146596138|NCT02463032|528689864|FG001|Overall Study|Adverse Event|6|||
146596139|NCT00613080|528689865|FG000|Overall Study|Ineligible / no protocol treatment|11|||
146596140|NCT00612508|528689866|FG000|Overall Study|Withdrawal by Subject|3|||
146596141|NCT00612508|528689867|FG001|Overall Study|Withdrawal by Subject|4|||
146596142|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
146596143|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
146596144|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
146596145|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
146596146|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
146596147|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
146596148|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
146596149|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
146596150|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
146596151|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
146653763|NCT04393298|528910628|FG007|Overall Study|Death|0|||
146653764|NCT04393298|528910629|FG008|Overall Study|Death|1|||
146653765|NCT04393298|528910630|FG009|Overall Study|Death|1|||
146653766|NCT04393298|528910631|FG010|Overall Study|Death|0|||
146653767|NCT04393298|528910632|FG011|Overall Study|Death|1|||
146653768|NCT04393298|528910633|FG012|Overall Study|Death|1|||
146653769|NCT04393298|528910634|FG013|Overall Study|Death|0|||
146653770|NCT04393298|528910635|FG014|Overall Study|Death|1|||
146653771|NCT04393298|528910621|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146653772|NCT04393298|528910622|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146653773|NCT04393298|528910623|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146653774|NCT04393298|528910624|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146653775|NCT04393298|528910625|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146653776|NCT04393298|528910626|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
146653777|NCT04393298|528910627|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146653778|NCT04393298|528910628|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146653779|NCT04393298|528910629|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146653780|NCT04393298|528910630|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146653781|NCT04393298|528910631|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146653782|NCT04393298|528910632|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146596152|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
146596153|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
146596154|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
146653783|NCT04393298|528910633|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146653784|NCT04393298|528910634|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146596155|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
146596156|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
146596157|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
146596158|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
146596159|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
146596160|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
146596161|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
146596162|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
146596163|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
146596164|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
146596165|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
146596166|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
146596167|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
146596168|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
146596169|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
146596170|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
146596171|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
146596172|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
146596173|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
146596174|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
146596175|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
146596176|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
146596177|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
146596178|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
146596179|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
146596180|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
146596181|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
146596182|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
146596183|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
146596184|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
146596185|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
146596186|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
146596187|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
146596188|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
146596189|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
146596190|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
146596191|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
146596192|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
146596193|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
146596194|NCT02008357|528689868|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
146596195|NCT02008357|528689869|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
146596196|NCT02008357|528689868|FG000|Open-label Extension Period|Adverse Event|8|||
146596197|NCT02008357|528689869|FG001|Open-label Extension Period|Adverse Event|7|||
146596198|NCT02008357|528689868|FG000|Open-label Extension Period|Death|7|||
146596199|NCT02008357|528689869|FG001|Open-label Extension Period|Death|4|||
146596200|NCT02008357|528689868|FG000|Open-label Extension Period|Lack of Efficacy|9|||
146596201|NCT02008357|528689869|FG001|Open-label Extension Period|Lack of Efficacy|5|||
146596202|NCT02008357|528689868|FG000|Open-label Extension Period|Lost to Follow-up|2|||
146596203|NCT02008357|528689869|FG001|Open-label Extension Period|Lost to Follow-up|2|||
146596204|NCT02008357|528689868|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
146596205|NCT02008357|528689869|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
146596206|NCT02008357|528689868|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
146596207|NCT02008357|528689869|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
146596208|NCT02008357|528689868|FG000|Open-label Extension Period|Safety Risk|2|||
146596209|NCT02008357|528689869|FG001|Open-label Extension Period|Safety Risk|1|||
146596210|NCT02008357|528689868|FG000|Open-label Extension Period|Non-Compliance|0|||
146596211|NCT02008357|528689869|FG001|Open-label Extension Period|Non-Compliance|1|||
146596212|NCT02008357|528689868|FG000|Open-label Extension Period|Investigator Recommendation|0|||
146596213|NCT02008357|528689869|FG001|Open-label Extension Period|Investigator Recommendation|1|||
146596214|NCT02008357|528689868|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
146596215|NCT02008357|528689869|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
146596216|NCT02008357|528689868|FG000|Open-label Extension Period|Coordinating Center Request|2|||
146596217|NCT02008357|528689869|FG001|Open-label Extension Period|Coordinating Center Request|4|||
146596218|NCT02008357|528689868|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
146596219|NCT02008357|528689869|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
146596220|NCT02008357|528689868|FG000|Open-label Extension Period|Study Ended|20|||
146596221|NCT02008357|528689869|FG001|Open-label Extension Period|Study Ended|25|||
146596222|NCT02008357|528689868|FG000|Open-label Extension Period|Personal Reasons|0|||
146596223|NCT02008357|528689869|FG001|Open-label Extension Period|Personal Reasons|1|||
146596224|NCT02008357|528689868|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
146596225|NCT02008357|528689869|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
146596226|NCT02008357|528689868|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
146596227|NCT02008357|528689869|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
146596228|NCT02008357|528689868|FG000|Open-label Extension Period|Other|2|||
146596229|NCT02008357|528689869|FG001|Open-label Extension Period|Other|0|||
146596230|NCT01442064|528689870|FG000|Overall Study|Adverse Event|2|||
146596231|NCT01442064|528689871|FG001|Overall Study|Adverse Event|2|||
146596232|NCT01442064|528689872|FG002|Overall Study|Adverse Event|2|||
146596233|NCT01442064|528689873|FG003|Overall Study|Adverse Event|1|||
146596234|NCT01442064|528689874|FG004|Overall Study|Adverse Event|2|||
146596235|NCT01442064|528689875|FG005|Overall Study|Adverse Event|0|||
146596236|NCT01442064|528689870|FG000|Overall Study|Death|0|||
146596237|NCT01442064|528689871|FG001|Overall Study|Death|1|||
146596238|NCT01442064|528689872|FG002|Overall Study|Death|3|||
146596239|NCT01442064|528689873|FG003|Overall Study|Death|3|||
146596240|NCT01442064|528689874|FG004|Overall Study|Death|1|||
146596241|NCT01442064|528689875|FG005|Overall Study|Death|3|||
146596242|NCT01442064|528689870|FG000|Overall Study|Lost to Follow-up|5|||
146596243|NCT01442064|528689871|FG001|Overall Study|Lost to Follow-up|5|||
146596244|NCT01442064|528689872|FG002|Overall Study|Lost to Follow-up|1|||
146596245|NCT01442064|528689873|FG003|Overall Study|Lost to Follow-up|1|||
146596246|NCT01442064|528689874|FG004|Overall Study|Lost to Follow-up|3|||
146596247|NCT01442064|528689875|FG005|Overall Study|Lost to Follow-up|3|||
146596248|NCT01442064|528689870|FG000|Overall Study|Physician Decision|1|||
146596249|NCT01442064|528689871|FG001|Overall Study|Physician Decision|1|||
146596250|NCT01442064|528689872|FG002|Overall Study|Physician Decision|2|||
146596251|NCT01442064|528689873|FG003|Overall Study|Physician Decision|3|||
146596252|NCT01442064|528689874|FG004|Overall Study|Physician Decision|3|||
146596253|NCT01442064|528689875|FG005|Overall Study|Physician Decision|1|||
146596254|NCT01442064|528689870|FG000|Overall Study|Withdrawal by Subject|6|||
146596255|NCT01442064|528689871|FG001|Overall Study|Withdrawal by Subject|3|||
146596256|NCT01442064|528689872|FG002|Overall Study|Withdrawal by Subject|2|||
146596257|NCT01442064|528689873|FG003|Overall Study|Withdrawal by Subject|2|||
146596258|NCT01442064|528689874|FG004|Overall Study|Withdrawal by Subject|2|||
146596259|NCT01442064|528689875|FG005|Overall Study|Withdrawal by Subject|1|||
146596260|NCT01442064|528689870|FG000|Overall Study|Sponsor decision|82|||
146596261|NCT01442064|528689871|FG001|Overall Study|Sponsor decision|88|||
146596262|NCT01442064|528689872|FG002|Overall Study|Sponsor decision|92|||
146596263|NCT01442064|528689873|FG003|Overall Study|Sponsor decision|88|||
146596264|NCT01442064|528689874|FG004|Overall Study|Sponsor decision|95|||
146596265|NCT01442064|528689875|FG005|Overall Study|Sponsor decision|87|||
146596266|NCT01442064|528689870|FG000|Overall Study|Subject non-compliance|0|||
146596267|NCT01442064|528689871|FG001|Overall Study|Subject non-compliance|0|||
146596268|NCT01442064|528689872|FG002|Overall Study|Subject non-compliance|0|||
146596269|NCT01442064|528689873|FG003|Overall Study|Subject non-compliance|0|||
146596270|NCT01442064|528689874|FG004|Overall Study|Subject non-compliance|0|||
146596271|NCT01442064|528689875|FG005|Overall Study|Subject non-compliance|2|||
146596272|NCT01442064|528689870|FG000|Overall Study|Condition mandated other intervention|1|||
146596273|NCT01442064|528689871|FG001|Overall Study|Condition mandated other intervention|1|||
146596274|NCT01442064|528689872|FG002|Overall Study|Condition mandated other intervention|2|||
146596275|NCT01442064|528689873|FG003|Overall Study|Condition mandated other intervention|0|||
146596276|NCT01442064|528689874|FG004|Overall Study|Condition mandated other intervention|0|||
146596277|NCT01442064|528689875|FG005|Overall Study|Condition mandated other intervention|2|||
146596278|NCT02312219|528689876|FG000|Overall Study|Withdrawal by Subject|1|||
146596279|NCT02312219|528689877|FG001|Overall Study|Withdrawal by Subject|2|||
146596280|NCT02312219|528689876|FG000|Overall Study|could not schedule imaging in time|0|||
146596281|NCT02312219|528689877|FG001|Overall Study|could not schedule imaging in time|2|||
146596282|NCT02312219|528689876|FG000|Overall Study|Other|0|||
146596283|NCT02312219|528689877|FG001|Overall Study|Other|1|||
146596284|NCT02312219|528689876|FG000|Overall Study|Not randomized. Ineligible|0|||
146596285|NCT02312219|528689877|FG001|Overall Study|Not randomized. Ineligible|1|||
146596286|NCT02153346|528689878|FG000|Overall Study|Lost to Follow-up|11|||
146596287|NCT01522404|528689883|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
146596288|NCT01522404|528689884|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
146596289|NCT01522404|528689883|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
146596290|NCT01522404|528689884|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
146596291|NCT01522404|528689883|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
146596292|NCT01522404|528689884|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
146596293|NCT01591863|528689885|FG000|Overall Study|Adverse Event|3|||
146596294|NCT01591863|528689885|FG000|Overall Study|Withdrawal by Subject|1|||
146596295|NCT01591863|528689885|FG000|Overall Study|recurrence|9|||
146596296|NCT01591863|528689885|FG000|Overall Study|Lack of Efficacy|1|||
146596297|NCT02366767|528689888|FG000|Overall Study|left for home after 1 day at camp|1|||
146596298|NCT02366767|528689889|FG001|Overall Study|left for home after 1 day at camp|0|||
146596299|NCT00260065|528689892|FG000|Overall Study|Progressive Disease|22|||
146596300|NCT00260065|528689892|FG000|Overall Study|Adverse Event|17|||
146596301|NCT00260065|528689892|FG000|Overall Study|Death|13|||
146596302|NCT00260065|528689892|FG000|Overall Study|Withdrawal by Subject|13|||
146596303|NCT00260065|528689892|FG000|Overall Study|Physician Decision|19|||
146596304|NCT00260065|528689892|FG000|Overall Study|Not otherwise specified|8|||
146596305|NCT00260065|528689892|FG000|Overall Study|Medication Noncompliance|1|||
146596306|NCT00664326|528691975|FG000|Overall Study|Adverse Event|14|||
146596307|NCT00664326|528691975|FG000|Overall Study|Noncompliance with study medication|3|||
146596308|NCT00664326|528691975|FG000|Overall Study|Withdrawal by Subject|1|||
146596309|NCT00664326|528691975|FG000|Overall Study|Physician Decision|1|||
146596310|NCT00664326|528691975|FG000|Overall Study|Other Reasons|3|||
146596311|NCT00664326|528691975|FG000|Overall Study|Death|2|||
146596312|NCT00664326|528691975|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
146596313|NCT05079477|528691978|FG000|Overall Study|Lost to Follow-up|2|||
146596314|NCT05079477|528691979|FG001|Overall Study|Lost to Follow-up|0|||
146596315|NCT05079477|528691978|FG000|Overall Study|Withdrawal by Subject|1|||
146596316|NCT05079477|528691979|FG001|Overall Study|Withdrawal by Subject|0|||
146596317|NCT05079477|528691978|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
146596318|NCT05079477|528691979|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
146596319|NCT05079477|528691978|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
146596320|NCT05079477|528691979|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
146596321|NCT03769311|528691987|FG000|Overall Study|Withdrawal by Subject|1|||
146653785|NCT04393298|528910635|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146653786|NCT04393298|528910621|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
146653787|NCT04393298|528910622|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
146653788|NCT04393298|528910623|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
146653789|NCT04393298|528910624|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
146653790|NCT04393298|528910625|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
146653791|NCT04393298|528910626|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
146653792|NCT04393298|528910627|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
146653793|NCT04393298|528910628|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
146653794|NCT04393298|528910629|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
146653795|NCT04393298|528910630|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
146653796|NCT04393298|528910631|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
146653797|NCT04393298|528910632|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
146653798|NCT04393298|528910633|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
146653799|NCT04393298|528910634|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
146653800|NCT04393298|528910635|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
146653801|NCT04393298|528910621|FG000|Overall Study|Patient Passed Away|0|||
146653802|NCT04393298|528910622|FG001|Overall Study|Patient Passed Away|0|||
146653803|NCT04393298|528910623|FG002|Overall Study|Patient Passed Away|0|||
146653804|NCT04393298|528910624|FG003|Overall Study|Patient Passed Away|0|||
146653805|NCT04393298|528910625|FG004|Overall Study|Patient Passed Away|0|||
146653806|NCT04393298|528910626|FG005|Overall Study|Patient Passed Away|0|||
146653807|NCT04393298|528910627|FG006|Overall Study|Patient Passed Away|0|||
146653808|NCT04393298|528910628|FG007|Overall Study|Patient Passed Away|1|||
146653809|NCT04393298|528910629|FG008|Overall Study|Patient Passed Away|0|||
146653810|NCT04393298|528910630|FG009|Overall Study|Patient Passed Away|0|||
146653811|NCT04393298|528910631|FG010|Overall Study|Patient Passed Away|0|||
146653812|NCT04393298|528910632|FG011|Overall Study|Patient Passed Away|0|||
146653813|NCT04393298|528910633|FG012|Overall Study|Patient Passed Away|0|||
146653814|NCT04393298|528910634|FG013|Overall Study|Patient Passed Away|0|||
146596322|NCT02853435|528691988|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
146596323|NCT02853435|528691989|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
146596324|NCT02853435|528691990|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
146653815|NCT04393298|528910635|FG014|Overall Study|Patient Passed Away|0|||
146653816|NCT04393298|528910621|FG000|Overall Study|Patient Deceased|0|||
146653817|NCT04393298|528910622|FG001|Overall Study|Patient Deceased|0|||
146653818|NCT04393298|528910623|FG002|Overall Study|Patient Deceased|0|||
146653819|NCT04393298|528910624|FG003|Overall Study|Patient Deceased|0|||
146653820|NCT04393298|528910625|FG004|Overall Study|Patient Deceased|0|||
146771527|NCT05061693|529331237|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146596325|NCT02853435|528691991|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
146596326|NCT02853435|528691992|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
146596327|NCT02853435|528691993|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
146596328|NCT04912895|528692006|FG000|Overall Study|Unable to provide specimen|2|||
146596329|NCT04912895|528692007|FG001|Overall Study|Unable to provide specimen|0|||
146596330|NCT04912895|528692008|FG002|Overall Study|Unable to provide specimen|0|||
146596331|NCT02785458|528692009|FG000|1 Month|Withdrawal by Subject|2|||
146596332|NCT02785458|528692010|FG001|1 Month|Withdrawal by Subject|1|||
146596333|NCT02785458|528692009|FG000|1 Month|Lost to Follow-up|38|||
146596334|NCT02785458|528692010|FG001|1 Month|Lost to Follow-up|31|||
146596335|NCT02785458|528692009|FG000|1 Month|Deemed Ineligible|1|||
146596336|NCT02785458|528692010|FG001|1 Month|Deemed Ineligible|0|||
146596337|NCT02785458|528692009|FG000|1 Month|Completed Evaluation by Baseline|42|||
146596338|NCT02785458|528692010|FG001|1 Month|Completed Evaluation by Baseline|39|||
146920133|NCT00069095|529868877|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
146596339|NCT02785458|528692009|FG000|1 Month|Partial Interview|0|||
146596340|NCT02785458|528692010|FG001|1 Month|Partial Interview|4|||
146596341|NCT02785458|528692009|FG000|3 Months|Withdrawal by Subject|3|||
146596342|NCT02785458|528692010|FG001|3 Months|Withdrawal by Subject|1|||
146596343|NCT02785458|528692009|FG000|3 Months|Lost to Follow-up|25|||
146596344|NCT02785458|528692010|FG001|3 Months|Lost to Follow-up|21|||
146596345|NCT02785458|528692009|FG000|3 Months|Completed Evaluation at 1 Month|100|||
146596346|NCT02785458|528692010|FG001|3 Months|Completed Evaluation at 1 Month|89|||
146596347|NCT01146652|528692011|FG000|Overall Study|Adverse Event|506|||
146596348|NCT01146652|528692012|FG001|Overall Study|Adverse Event|15|||
146596349|NCT01146652|528692011|FG000|Overall Study|Lack of Efficacy|91|||
146596350|NCT01146652|528692012|FG001|Overall Study|Lack of Efficacy|7|||
146596351|NCT01146652|528692011|FG000|Overall Study|Poor compliance to protocol|38|||
146596352|NCT01146652|528692012|FG001|Overall Study|Poor compliance to protocol|1|||
146596353|NCT01146652|528692011|FG000|Overall Study|Other unspecified reasons|314|||
146596354|NCT01146652|528692012|FG001|Overall Study|Other unspecified reasons|22|||
146596355|NCT01146652|528692011|FG000|Overall Study|Enrolled but not treated|2|||
146596356|NCT01146652|528692012|FG001|Overall Study|Enrolled but not treated|0|||
146596357|NCT00520013|528692013|FG000|Overall Study|Withdrawal by Subject|0|||
146596358|NCT00520013|528692014|FG001|Overall Study|Withdrawal by Subject|0|||
146596359|NCT00520013|528692015|FG002|Overall Study|Withdrawal by Subject|1|||
146653821|NCT04393298|528910626|FG005|Overall Study|Patient Deceased|0|||
146653822|NCT04393298|528910627|FG006|Overall Study|Patient Deceased|0|||
146653823|NCT04393298|528910628|FG007|Overall Study|Patient Deceased|1|||
146653824|NCT04393298|528910629|FG008|Overall Study|Patient Deceased|0|||
146653825|NCT04393298|528910630|FG009|Overall Study|Patient Deceased|0|||
146653826|NCT04393298|528910631|FG010|Overall Study|Patient Deceased|0|||
146653827|NCT04393298|528910632|FG011|Overall Study|Patient Deceased|0|||
146653828|NCT04393298|528910633|FG012|Overall Study|Patient Deceased|0|||
146653829|NCT04393298|528910634|FG013|Overall Study|Patient Deceased|0|||
146653830|NCT04393298|528910635|FG014|Overall Study|Patient Deceased|0|||
146653831|NCT04393298|528910621|FG000|Overall Study|Patient Discharged to Hospice|0|||
146653832|NCT04393298|528910622|FG001|Overall Study|Patient Discharged to Hospice|0|||
146653833|NCT04393298|528910623|FG002|Overall Study|Patient Discharged to Hospice|0|||
146653834|NCT04393298|528910624|FG003|Overall Study|Patient Discharged to Hospice|0|||
146653835|NCT04393298|528910625|FG004|Overall Study|Patient Discharged to Hospice|0|||
146653836|NCT04393298|528910626|FG005|Overall Study|Patient Discharged to Hospice|0|||
146653837|NCT04393298|528910627|FG006|Overall Study|Patient Discharged to Hospice|0|||
146653838|NCT04393298|528910628|FG007|Overall Study|Patient Discharged to Hospice|0|||
146653839|NCT04393298|528910629|FG008|Overall Study|Patient Discharged to Hospice|1|||
146653840|NCT04393298|528910630|FG009|Overall Study|Patient Discharged to Hospice|0|||
146653841|NCT04393298|528910631|FG010|Overall Study|Patient Discharged to Hospice|0|||
146920134|NCT00069095|529868878|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
146920135|NCT00069095|529868879|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
146596360|NCT00520013|528692013|FG000|Overall Study|Adverse Event|2|||
146596361|NCT00520013|528692014|FG001|Overall Study|Adverse Event|10|||
146596362|NCT00520013|528692015|FG002|Overall Study|Adverse Event|7|||
146596363|NCT00520013|528692013|FG000|Overall Study|Progressive Disease|7|||
146596364|NCT00520013|528692014|FG001|Overall Study|Progressive Disease|3|||
146653842|NCT04393298|528910632|FG011|Overall Study|Patient Discharged to Hospice|0|||
146653843|NCT04393298|528910633|FG012|Overall Study|Patient Discharged to Hospice|0|||
146653844|NCT04393298|528910634|FG013|Overall Study|Patient Discharged to Hospice|0|||
146653845|NCT04393298|528910635|FG014|Overall Study|Patient Discharged to Hospice|0|||
146653846|NCT04393298|528910621|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146596365|NCT00520013|528692015|FG002|Overall Study|Progressive Disease|0|||
146596366|NCT00520013|528692013|FG000|Overall Study|Clinical Progression|3|||
146596367|NCT00520013|528692014|FG001|Overall Study|Clinical Progression|1|||
146596368|NCT00520013|528692015|FG002|Overall Study|Clinical Progression|0|||
146596369|NCT00520013|528692013|FG000|Overall Study|Death|0|||
146596370|NCT00520013|528692014|FG001|Overall Study|Death|1|||
146771528|NCT05061693|529331238|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146596371|NCT00520013|528692015|FG002|Overall Study|Death|0|||
146596372|NCT00520013|528692013|FG000|Overall Study|Physician Decision|0|||
146596373|NCT00520013|528692014|FG001|Overall Study|Physician Decision|0|||
146596374|NCT00520013|528692015|FG002|Overall Study|Physician Decision|3|||
146596375|NCT02118597|528692016|FG000|Overall Study|Sponsor terminated the study|14|||
146596376|NCT02118597|528692016|FG000|Overall Study|Serious Adverse Event|1|||
146596377|NCT02118597|528692016|FG000|Overall Study|Investigator's decision|1|||
146596378|NCT02590562|528692021|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
146596379|NCT00824005|528692022|FG000|Overall Study|Death|0|||
146596380|NCT00824005|528692023|FG001|Overall Study|Death|1|||
146596381|NCT00824005|528692022|FG000|Overall Study|Lost to Follow-up|0|||
146596382|NCT00824005|528692023|FG001|Overall Study|Lost to Follow-up|1|||
146596383|NCT01866423|528692024|FG000|Overall Study|Lack of Efficacy|3|||
146596384|NCT01866423|528692024|FG000|Overall Study|Sponsor Decision|1|||
146596385|NCT02255565|528692025|FG000|Overall Study|Withdrawal by Subject|0|||
146596386|NCT02255565|528692026|FG001|Overall Study|Withdrawal by Subject|1|||
146596387|NCT02255565|528692027|FG002|Overall Study|Withdrawal by Subject|0|||
146596388|NCT02699450|528692028|FG000|Overall Study|Death|2|||
146596389|NCT02699450|528692029|FG001|Overall Study|Death|1|||
146596390|NCT02699450|528692030|FG002|Overall Study|Death|2|||
146596391|NCT02699450|528692028|FG000|Overall Study|Met Criteria for Study Exit|0|||
146596392|NCT02699450|528692029|FG001|Overall Study|Met Criteria for Study Exit|0|||
146596393|NCT02699450|528692030|FG002|Overall Study|Met Criteria for Study Exit|1|||
146596394|NCT02699450|528692028|FG000|Overall Study|Protocol Violation|4|||
146596395|NCT02699450|528692029|FG001|Overall Study|Protocol Violation|3|||
146596396|NCT02699450|528692030|FG002|Overall Study|Protocol Violation|5|||
146596397|NCT02699450|528692028|FG000|Overall Study|Lost to Follow-up|3|||
146596398|NCT02699450|528692029|FG001|Overall Study|Lost to Follow-up|0|||
146596399|NCT02699450|528692030|FG002|Overall Study|Lost to Follow-up|5|||
146596400|NCT02699450|528692028|FG000|Overall Study|Physician Decision|2|||
146596401|NCT02699450|528692029|FG001|Overall Study|Physician Decision|0|||
146596402|NCT02699450|528692030|FG002|Overall Study|Physician Decision|0|||
146596403|NCT02699450|528692028|FG000|Overall Study|Withdrawal by Subject|3|||
146596404|NCT02699450|528692029|FG001|Overall Study|Withdrawal by Subject|1|||
146596405|NCT02699450|528692030|FG002|Overall Study|Withdrawal by Subject|2|||
146596406|NCT02699450|528692028|FG000|Overall Study|Adverse Event|1|||
146596407|NCT02699450|528692029|FG001|Overall Study|Adverse Event|0|||
146596408|NCT02699450|528692030|FG002|Overall Study|Adverse Event|0|||
146596409|NCT00900146|528692033|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
146653847|NCT04393298|528910622|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146653848|NCT04393298|528910623|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146653849|NCT04393298|528910624|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146653850|NCT04393298|528910625|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146653851|NCT04393298|528910626|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146653852|NCT04393298|528910627|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146653853|NCT04393298|528910628|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146653854|NCT04393298|528910629|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146653855|NCT04393298|528910630|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
146653856|NCT04393298|528910631|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146653857|NCT04393298|528910632|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146653858|NCT04393298|528910633|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146653859|NCT04393298|528910634|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146653860|NCT04393298|528910635|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146653861|NCT04393298|528910621|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
146653862|NCT04393298|528910622|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
146653863|NCT04393298|528910623|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
146653864|NCT04393298|528910624|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
146653865|NCT04393298|528910625|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
146653866|NCT04393298|528910626|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
146653867|NCT04393298|528910627|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
146978491|NCT01717456|530084083|FG001|End of Treatment|Physician Decision|1|||
146978492|NCT01717456|530084082|FG000|End of Treatment|Lost to Follow-up|0|||
146978493|NCT01717456|530084083|FG001|End of Treatment|Lost to Follow-up|1|||
146596410|NCT00900146|528692034|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
146596411|NCT00900146|528692035|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
146596412|NCT00900146|528692036|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
146596413|NCT00900146|528692037|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
146596414|NCT00900146|528692033|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
146596415|NCT00900146|528692034|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
146596416|NCT00900146|528692035|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
146596417|NCT00900146|528692036|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
146596418|NCT00900146|528692037|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
146920136|NCT00069095|529868880|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
146920137|NCT00069095|529868875|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
146920138|NCT00069095|529868876|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
146920139|NCT00069095|529868877|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
146920140|NCT00069095|529868878|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
146920141|NCT00069095|529868879|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
146920142|NCT00069095|529868880|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
146920143|NCT00069095|529868875|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
146920144|NCT00069095|529868876|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
146920145|NCT00069095|529868877|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
146920146|NCT00069095|529868878|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
146920147|NCT00069095|529868879|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
146920148|NCT00069095|529868880|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
146920149|NCT00069095|529868875|FG000|Post-study Treatment Phase|Investigator decision|0|||
146920150|NCT00069095|529868876|FG001|Post-study Treatment Phase|Investigator decision|0|||
146920151|NCT00069095|529868877|FG002|Post-study Treatment Phase|Investigator decision|0|||
146920152|NCT00069095|529868878|FG003|Post-study Treatment Phase|Investigator decision|0|||
146920153|NCT00069095|529868879|FG004|Post-study Treatment Phase|Investigator decision|0|||
146920154|NCT00069095|529868880|FG005|Post-study Treatment Phase|Investigator decision|1|||
146920155|NCT00069095|529868875|FG000|Follow-up Phase|Death|174|||
146920156|NCT00069095|529868876|FG001|Follow-up Phase|Death|206|||
146920157|NCT00069095|529868877|FG002|Follow-up Phase|Death|120|||
146920158|NCT00069095|529868878|FG003|Follow-up Phase|Death|112|||
146920159|NCT00069095|529868879|FG004|Follow-up Phase|Death|92|||
146920160|NCT00069095|529868880|FG005|Follow-up Phase|Death|101|||
146920161|NCT05610176|529868884|FG000|Overall Study|Death|6|||
146920162|NCT01727713|529868896|FG000|Overall Study|Lost to Follow-up|5|||
146920163|NCT01727713|529868896|FG000|Overall Study|Adverse Event|10|||
146920164|NCT01727713|529868896|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
146920165|NCT01727713|529868896|FG000|Overall Study|Withdrawal by Subject|13|||
146920166|NCT01727713|529868896|FG000|Overall Study|Protocol Deviation|2|||
146920167|NCT00532948|529868897|FG000|Overall Study|Protocol Violation|1|||
146920168|NCT00532948|529868898|FG001|Overall Study|Protocol Violation|0|||
146920169|NCT00532948|529868899|FG002|Overall Study|Protocol Violation|0|||
146920170|NCT00532948|529868897|FG000|Overall Study|Death|3|||
146920171|NCT00532948|529868898|FG001|Overall Study|Death|3|||
146920172|NCT00532948|529868899|FG002|Overall Study|Death|4|||
146920173|NCT00532948|529868897|FG000|Overall Study|Violation of selection criteria at entry|0|||
146920174|NCT00532948|529868898|FG001|Overall Study|Violation of selection criteria at entry|1|||
146920175|NCT00532948|529868899|FG002|Overall Study|Violation of selection criteria at entry|0|||
146920176|NCT00532948|529868897|FG000|Overall Study|Failure to return|0|||
146596419|NCT00900146|528692033|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
146596420|NCT00900146|528692034|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
146596421|NCT00900146|528692035|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
146596422|NCT00900146|528692036|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
146596423|NCT00900146|528692037|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
146596424|NCT00900146|528692033|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
146596425|NCT00900146|528692034|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
146596426|NCT00900146|528692035|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
146596427|NCT00900146|528692036|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
146596428|NCT00900146|528692037|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
146596429|NCT00900146|528692033|FG000|Intermediate: Period III|Lost to Follow-up|2|||
146596430|NCT00900146|528692034|FG001|Intermediate: Period III|Lost to Follow-up|0|||
146596431|NCT00900146|528692035|FG002|Intermediate: Period III|Lost to Follow-up|0|||
146596432|NCT00900146|528692036|FG003|Intermediate: Period III|Lost to Follow-up|0|||
146596433|NCT00900146|528692037|FG004|Intermediate: Period III|Lost to Follow-up|1|||
146596434|NCT00900146|528692033|FG000|Intermediate: Period III|Administrative problems|85|||
146920177|NCT00532948|529868898|FG001|Overall Study|Failure to return|1|||
146920178|NCT00532948|529868899|FG002|Overall Study|Failure to return|0|||
146920179|NCT01253044|529868900|FG000|Overall Study|Lost to Follow-up|38|||
146920180|NCT01253044|529868901|FG001|Overall Study|Lost to Follow-up|29|||
146596435|NCT00900146|528692034|FG001|Intermediate: Period III|Administrative problems|92|||
146920181|NCT00987623|529868902|FG000|Overall Study|Lost to Follow-up|2|||
146920182|NCT00987623|529868903|FG001|Overall Study|Lost to Follow-up|1|||
146920183|NCT00987623|529868902|FG000|Overall Study|Time/job conflict|2|||
146920184|NCT00987623|529868903|FG001|Overall Study|Time/job conflict|0|||
146920185|NCT00987623|529868902|FG000|Overall Study|Discomfort|1|||
146920186|NCT00987623|529868903|FG001|Overall Study|Discomfort|0|||
146920187|NCT00987623|529868902|FG000|Overall Study|Biomicroscopy|0|||
146920188|NCT00987623|529868903|FG001|Overall Study|Biomicroscopy|1|||
146596436|NCT00900146|528692035|FG002|Intermediate: Period III|Administrative problems|84|||
146596437|NCT00900146|528692036|FG003|Intermediate: Period III|Administrative problems|90|||
146596438|NCT00900146|528692037|FG004|Intermediate: Period III|Administrative problems|163|||
146596439|NCT00700102|528692038|FG000|Overall Study|Died|394|||
146920189|NCT00987623|529868902|FG000|Overall Study|Influenza|0|||
146920190|NCT00987623|529868903|FG001|Overall Study|Influenza|1|||
146920191|NCT02702193|529868906|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
146596440|NCT00700102|528692039|FG001|Overall Study|Died|385|||
146596441|NCT00700102|528692038|FG000|Overall Study|Lost to Follow-up|8|||
146596442|NCT00700102|528692039|FG001|Overall Study|Lost to Follow-up|10|||
146596443|NCT02525939|528692044|FG000|Overall Study|Lost to Follow-up|27|||
146596444|NCT02525939|528692045|FG001|Overall Study|Lost to Follow-up|24|||
146596445|NCT02525939|528692044|FG000|Overall Study|Physician Decision|0|||
146596446|NCT02525939|528692045|FG001|Overall Study|Physician Decision|1|||
146596447|NCT02525939|528692044|FG000|Overall Study|Withdrawal by Subject|24|||
146596448|NCT02525939|528692045|FG001|Overall Study|Withdrawal by Subject|39|||
146596449|NCT02525939|528692044|FG000|Overall Study|Death|180|||
146596450|NCT02525939|528692045|FG001|Overall Study|Death|179|||
146596451|NCT01635764|528692046|FG000|Overall Study|Adverse Event|46|||
146596452|NCT01635764|528692046|FG000|Overall Study|Lack of Efficacy|76|||
146596453|NCT01635764|528692046|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
146596454|NCT01635764|528692046|FG000|Overall Study|Protocol Deviation|1|||
146596455|NCT01635764|528692046|FG000|Overall Study|Withdrew Consent|67|||
146596456|NCT01635764|528692046|FG000|Overall Study|Lost to Follow-up|53|||
146596457|NCT01635764|528692046|FG000|Overall Study|Other|28|||
146596458|NCT01174004|528692047|FG000|Overall Study|Adverse Event|2|||
146596459|NCT01174004|528692048|FG001|Overall Study|Adverse Event|10|||
146596460|NCT01174004|528692047|FG000|Overall Study|Withdrawal by Subject|2|||
146596461|NCT01174004|528692048|FG001|Overall Study|Withdrawal by Subject|3|||
146596462|NCT01174004|528692047|FG000|Overall Study|At Discretion of Sponsor|2|||
146596463|NCT01174004|528692048|FG001|Overall Study|At Discretion of Sponsor|2|||
146920192|NCT02702193|529868907|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
146920193|NCT02702193|529868906|FG000|4 Month Follow up|Withdrawal by Subject|1|||
146920194|NCT02702193|529868907|FG001|4 Month Follow up|Withdrawal by Subject|0|||
146920195|NCT02702193|529868906|FG000|4 Month Follow up|Lost to Follow-up|17|||
146920196|NCT02702193|529868907|FG001|4 Month Follow up|Lost to Follow-up|18|||
146596464|NCT01174004|528692047|FG000|Overall Study|Protocol Violation|0|||
146596465|NCT01174004|528692048|FG001|Overall Study|Protocol Violation|1|||
146596466|NCT01174004|528692047|FG000|Overall Study|Physician Decision|1|||
146596467|NCT01174004|528692048|FG001|Overall Study|Physician Decision|0|||
146596468|NCT00933244|528692049|FG000|Overall Study|Withdrawal by Subject|5|||
146596469|NCT00933244|528692050|FG001|Overall Study|Withdrawal by Subject|1|||
146596470|NCT00933244|528692051|FG002|Overall Study|Withdrawal by Subject|3|||
146596471|NCT02956850|528692052|FG000|Overall Study|Withdrawal by Subject|0|||
146596472|NCT02956850|528692053|FG001|Overall Study|Withdrawal by Subject|0|||
146596473|NCT02956850|528692054|FG002|Overall Study|Withdrawal by Subject|0|||
146596474|NCT02956850|528692055|FG003|Overall Study|Withdrawal by Subject|0|||
146596475|NCT02956850|528692056|FG004|Overall Study|Withdrawal by Subject|0|||
146596476|NCT02956850|528692057|FG005|Overall Study|Withdrawal by Subject|0|||
146596477|NCT02956850|528692058|FG006|Overall Study|Withdrawal by Subject|0|||
146596478|NCT02956850|528692059|FG007|Overall Study|Withdrawal by Subject|0|||
146596479|NCT02956850|528692060|FG008|Overall Study|Withdrawal by Subject|0|||
146596480|NCT02956850|528692061|FG009|Overall Study|Withdrawal by Subject|0|||
146596481|NCT02956850|528692062|FG010|Overall Study|Withdrawal by Subject|0|||
146596482|NCT02956850|528692063|FG011|Overall Study|Withdrawal by Subject|0|||
146596483|NCT02956850|528692064|FG012|Overall Study|Withdrawal by Subject|0|||
146920197|NCT02702193|529868906|FG000|8 Month Follow up|Withdrawal by Subject|1|||
146596484|NCT02956850|528692065|FG013|Overall Study|Withdrawal by Subject|0|||
146596485|NCT02956850|528692066|FG014|Overall Study|Withdrawal by Subject|0|||
146596486|NCT02956850|528692067|FG015|Overall Study|Withdrawal by Subject|0|||
146596487|NCT02956850|528692068|FG016|Overall Study|Withdrawal by Subject|0|||
146596488|NCT02956850|528692069|FG017|Overall Study|Withdrawal by Subject|1|||
146596489|NCT01920152|528692070|FG000|Overall Study|Withdrawal by Subject|1|||
146920198|NCT02702193|529868907|FG001|8 Month Follow up|Withdrawal by Subject|0|||
146920199|NCT02702193|529868906|FG000|8 Month Follow up|Lost to Follow-up|14|||
146920200|NCT02702193|529868907|FG001|8 Month Follow up|Lost to Follow-up|18|||
146920201|NCT02702193|529868906|FG000|12 Month Follow up|Withdrawal by Subject|1|||
146920202|NCT02702193|529868907|FG001|12 Month Follow up|Withdrawal by Subject|0|||
146596490|NCT01920152|528692071|FG001|Overall Study|Withdrawal by Subject|2|||
146596491|NCT01995552|528692073|FG000|Overall Study|Protocol Violation|1|||
146596492|NCT01995552|528692073|FG000|Overall Study|Lack of Efficacy|15|||
146596493|NCT01995552|528692073|FG000|Overall Study|Death|1|||
146596494|NCT01515475|528692074|FG000|Overall Study|Lost to Follow-up|20|||
146596495|NCT01515475|528692075|FG001|Overall Study|Lost to Follow-up|15|||
146920203|NCT02702193|529868906|FG000|12 Month Follow up|Lost to Follow-up|16|||
146596496|NCT01515475|528692076|FG002|Overall Study|Lost to Follow-up|12|||
146596497|NCT01515475|528692077|FG003|Overall Study|Lost to Follow-up|12|||
146596498|NCT04957758|528692081|FG000|Overall Study|Adverse Event|1|||
146596499|NCT04957758|528692082|FG001|Overall Study|Adverse Event|0|||
146596500|NCT04957758|528692081|FG000|Overall Study|Lost to Follow-up|0|||
146596501|NCT04957758|528692082|FG001|Overall Study|Lost to Follow-up|2|||
146596502|NCT04957758|528692081|FG000|Overall Study|Withdrawal by Subject|4|||
146596503|NCT04957758|528692082|FG001|Overall Study|Withdrawal by Subject|2|||
146596504|NCT04957758|528692081|FG000|Overall Study|Protocol Violation|0|||
146596505|NCT04957758|528692082|FG001|Overall Study|Protocol Violation|1|||
146596506|NCT02360293|528692084|FG000|Overall Study|Lost to Follow-up|73|||
146596507|NCT02360293|528692085|FG001|Overall Study|Lost to Follow-up|95|||
146596508|NCT02360293|528692084|FG000|Overall Study|Withdrawal by Subject|2|||
146596509|NCT02360293|528692085|FG001|Overall Study|Withdrawal by Subject|1|||
146596510|NCT02360293|528692084|FG000|Overall Study|Excluded|1|||
146596511|NCT02360293|528692085|FG001|Overall Study|Excluded|0|||
146596512|NCT02226549|528692086|FG000|Overall Study|Randomized but Never Treated|1|||
146596513|NCT02226549|528692087|FG001|Overall Study|Randomized but Never Treated|0|||
146596514|NCT02226549|528692086|FG000|Overall Study|Lost to Follow-up|0|||
146596515|NCT02226549|528692087|FG001|Overall Study|Lost to Follow-up|1|||
146596516|NCT01269385|528692088|FG000|Overall Study|Adverse Event|1|||
146596517|NCT01269385|528692089|FG001|Overall Study|Adverse Event|1|||
146596518|NCT01269385|528692090|FG002|Overall Study|Adverse Event|0|||
146596519|NCT01269385|528692091|FG003|Overall Study|Adverse Event|0|||
146596520|NCT02741570|528692092|FG000|Pre-Treatment Period|Other reasons|0|||
146596521|NCT02741570|528692093|FG001|Pre-Treatment Period|Other reasons|3|||
146596522|NCT02741570|528692092|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
146596523|NCT02741570|528692093|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
146596524|NCT02741570|528692092|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
146596525|NCT02741570|528692093|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
146596526|NCT02741570|528692092|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
146596527|NCT02741570|528692093|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
146596528|NCT02741570|528692092|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
146596529|NCT02741570|528692093|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
146596530|NCT02741570|528692092|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
146596531|NCT02741570|528692093|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
146596532|NCT02741570|528692092|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
146596533|NCT02741570|528692093|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
146596534|NCT02741570|528692092|FG000|Pre-Treatment Period|Death|0|||
146596535|NCT02741570|528692093|FG001|Pre-Treatment Period|Death|1|||
146596536|NCT02741570|528692092|FG000|Pre-Treatment Period|Disease progression|0|||
146596537|NCT02741570|528692093|FG001|Pre-Treatment Period|Disease progression|1|||
146596538|NCT02741570|528692092|FG000|Treatment Period|Other reasons|47|||
146596539|NCT02741570|528692093|FG001|Treatment Period|Other reasons|12|||
146596540|NCT02741570|528692092|FG000|Treatment Period|Poor/non-compliance|0|||
146596541|NCT02741570|528692093|FG001|Treatment Period|Poor/non-compliance|2|||
146596542|NCT02741570|528692092|FG000|Treatment Period|Maximum clinical benefit|4|||
146596543|NCT02741570|528692093|FG001|Treatment Period|Maximum clinical benefit|6|||
146596544|NCT02741570|528692092|FG000|Treatment Period|Lost to Follow-up|1|||
146596545|NCT02741570|528692093|FG001|Treatment Period|Lost to Follow-up|3|||
146596546|NCT02741570|528692092|FG000|Treatment Period|Participant withdrew consent|9|||
146596547|NCT02741570|528692093|FG001|Treatment Period|Participant withdrew consent|13|||
146596548|NCT02741570|528692092|FG000|Treatment Period|Participant request to discontinue treatment|8|||
146596549|NCT02741570|528692093|FG001|Treatment Period|Participant request to discontinue treatment|23|||
146596550|NCT02741570|528692092|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
146596551|NCT02741570|528692093|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
146596552|NCT02741570|528692092|FG000|Treatment Period|Death|9|||
146596553|NCT02741570|528692093|FG001|Treatment Period|Death|7|||
146596554|NCT02741570|528692092|FG000|Treatment Period|Study drug toxicity|55|||
146596555|NCT02741570|528692093|FG001|Treatment Period|Study drug toxicity|47|||
146596556|NCT02741570|528692092|FG000|Treatment Period|Disease progression|294|||
146596557|NCT02741570|528692093|FG001|Treatment Period|Disease progression|301|||
146771529|NCT05061693|529331239|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146771530|NCT05061693|529331240|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146771531|NCT05061693|529331229|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
146771532|NCT05061693|529331230|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
146771533|NCT05061693|529331231|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
146596558|NCT02741570|528692092|FG000|Treatment Period|Administrative reason by sponsor|0|||
146596559|NCT02741570|528692093|FG001|Treatment Period|Administrative reason by sponsor|1|||
146596560|NCT01498185|528692094|FG000|Overall Study|Adverse Event|0|||
146596561|NCT01498185|528692095|FG001|Overall Study|Adverse Event|0|||
146596562|NCT01498185|528692096|FG002|Overall Study|Adverse Event|0|||
146596563|NCT01498185|528692097|FG003|Overall Study|Adverse Event|1|||
146596564|NCT01498185|528692098|FG004|Overall Study|Adverse Event|0|||
146771534|NCT05061693|529331232|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
146771535|NCT05061693|529331233|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
146771536|NCT05061693|529331234|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
146596565|NCT01498185|528692094|FG000|Overall Study|Withdrawal by Subject|1|||
146596566|NCT01498185|528692095|FG001|Overall Study|Withdrawal by Subject|1|||
146596567|NCT01498185|528692096|FG002|Overall Study|Withdrawal by Subject|0|||
146596568|NCT01498185|528692097|FG003|Overall Study|Withdrawal by Subject|2|||
146596569|NCT01498185|528692098|FG004|Overall Study|Withdrawal by Subject|1|||
146596570|NCT01498185|528692094|FG000|Overall Study|No longer met criteria, etc|0|||
146596571|NCT01498185|528692095|FG001|Overall Study|No longer met criteria, etc|0|||
146596572|NCT01498185|528692096|FG002|Overall Study|No longer met criteria, etc|0|||
146596573|NCT01498185|528692097|FG003|Overall Study|No longer met criteria, etc|0|||
146596574|NCT01498185|528692098|FG004|Overall Study|No longer met criteria, etc|2|||
146596575|NCT00946322|528692099|FG000|Pre-treatment|participant failure to follow up|1|||
146596576|NCT00946322|528692099|FG000|Post-treatment|participant failure to follow up|2|||
146596577|NCT00514020|528692103|FG000|Overall Study|Adverse Event|6|||
146596578|NCT00514020|528692103|FG000|Overall Study|Withdrawal by Subject|3|||
146596579|NCT00514020|528692103|FG000|Overall Study|Physician Decision|1|||
146596580|NCT00514020|528692103|FG000|Overall Study|disease progression|9|||
146596581|NCT00514020|528692103|FG000|Overall Study|other complicating disease|2|||
146596582|NCT00514020|528692103|FG000|Overall Study|patient went to radiation treatment|1|||
146596583|NCT00514020|528692103|FG000|Overall Study|"patients moved to the no tx group"|6|||
146596584|NCT01688921|528692104|FG000|Overall Study|Lost to Follow-up|7|||
146596585|NCT01688921|528692105|FG001|Overall Study|Lost to Follow-up|13|||
146596586|NCT01688921|528692104|FG000|Overall Study|Physician Decision|6|||
146596587|NCT01688921|528692105|FG001|Overall Study|Physician Decision|1|||
146596588|NCT01688921|528692104|FG000|Overall Study|Protocol Violation|0|||
146596589|NCT01688921|528692105|FG001|Overall Study|Protocol Violation|1|||
146596590|NCT01688921|528692104|FG000|Overall Study|informed consent|3|||
146596591|NCT01688921|528692105|FG001|Overall Study|informed consent|0|||
146596592|NCT04384107|528692107|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
146596593|NCT04384107|528692108|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
146596594|NCT04384107|528692107|FG000|Overall Study|Lost to Follow-up|1|||
146596595|NCT04384107|528692108|FG001|Overall Study|Lost to Follow-up|0|||
146596596|NCT00276614|528692109|FG000|Overall Study|Progression of disease under study|3|||
146596597|NCT00459537|528692110|FG000|Overall Study|Adverse Event|1|||
146596598|NCT00459537|528692111|FG001|Overall Study|Adverse Event|6|||
146596599|NCT00459537|528692110|FG000|Overall Study|Lack of Efficacy|10|||
146596600|NCT00459537|528692111|FG001|Overall Study|Lack of Efficacy|11|||
146596601|NCT00459537|528692110|FG000|Overall Study|Withdrawal by Subject|20|||
146596602|NCT00459537|528692111|FG001|Overall Study|Withdrawal by Subject|26|||
146596603|NCT00459537|528692110|FG000|Overall Study|Lost to Follow-up|27|||
146596604|NCT00459537|528692111|FG001|Overall Study|Lost to Follow-up|30|||
146596605|NCT00459537|528692110|FG000|Overall Study|Administrative problems|3|||
146596606|NCT00459537|528692111|FG001|Overall Study|Administrative problems|0|||
146596607|NCT00459537|528692110|FG000|Overall Study|Protocol Violation|4|||
146596608|NCT00459537|528692111|FG001|Overall Study|Protocol Violation|3|||
146596609|NCT00459537|528692110|FG000|Overall Study|Missing|1|||
146596610|NCT00459537|528692111|FG001|Overall Study|Missing|0|||
146596611|NCT03159104|528692112|FG000|Overall Study|Violation of inclusion criteria|1|||
146596612|NCT03159104|528692113|FG001|Overall Study|Violation of inclusion criteria|2|||
146596613|NCT02198235|528692115|FG000|Overall Study|Lost to Follow-up|3|||
146596614|NCT02198235|528692116|FG001|Overall Study|Lost to Follow-up|2|||
146596615|NCT02198235|528692117|FG002|Overall Study|Lost to Follow-up|2|||
146596616|NCT04573881|528692120|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
146596617|NCT01999218|528692121|FG000|Overall Study|Hyperglycemia|18|||
146596618|NCT01999218|528692122|FG001|Overall Study|Hyperglycemia|17|||
146596619|NCT01999218|528692123|FG002|Overall Study|Hyperglycemia|17|||
146596620|NCT01999218|528692121|FG000|Overall Study|Lack of Efficacy|1|||
146596621|NCT01999218|528692122|FG001|Overall Study|Lack of Efficacy|0|||
146596622|NCT01999218|528692123|FG002|Overall Study|Lack of Efficacy|1|||
146596623|NCT01999218|528692121|FG000|Overall Study|Lost to Follow-up|22|||
146596624|NCT01999218|528692122|FG001|Overall Study|Lost to Follow-up|17|||
146596625|NCT01999218|528692123|FG002|Overall Study|Lost to Follow-up|18|||
146596626|NCT01999218|528692121|FG000|Overall Study|Non-Compliance With Study Drug|6|||
146596627|NCT01999218|528692122|FG001|Overall Study|Non-Compliance With Study Drug|4|||
146596628|NCT01999218|528692123|FG002|Overall Study|Non-Compliance With Study Drug|1|||
146596629|NCT01999218|528692121|FG000|Overall Study|Physician Decision|1|||
146596630|NCT01999218|528692122|FG001|Overall Study|Physician Decision|4|||
146596631|NCT01999218|528692123|FG002|Overall Study|Physician Decision|6|||
146596632|NCT01999218|528692121|FG000|Overall Study|Protocol Violation|4|||
146596633|NCT01999218|528692122|FG001|Overall Study|Protocol Violation|5|||
146596634|NCT01999218|528692123|FG002|Overall Study|Protocol Violation|4|||
146596635|NCT01999218|528692121|FG000|Overall Study|Screen failure|0|||
146596636|NCT01999218|528692122|FG001|Overall Study|Screen failure|1|||
146596637|NCT01999218|528692123|FG002|Overall Study|Screen failure|0|||
146596638|NCT01999218|528692121|FG000|Overall Study|Study Terminated By Sponsor|7|||
146596639|NCT01999218|528692122|FG001|Overall Study|Study Terminated By Sponsor|5|||
146596640|NCT01999218|528692123|FG002|Overall Study|Study Terminated By Sponsor|12|||
146596641|NCT01999218|528692121|FG000|Overall Study|Participant moves|2|||
146596642|NCT01999218|528692122|FG001|Overall Study|Participant moves|5|||
146596643|NCT01999218|528692123|FG002|Overall Study|Participant moves|3|||
146596644|NCT01999218|528692121|FG000|Overall Study|Withdrawal by Subject|28|||
146596645|NCT01999218|528692122|FG001|Overall Study|Withdrawal by Subject|29|||
146596646|NCT01999218|528692123|FG002|Overall Study|Withdrawal by Subject|34|||
146596647|NCT01999218|528692121|FG000|Overall Study|Creatinine/eGFR|0|||
146596648|NCT01999218|528692122|FG001|Overall Study|Creatinine/eGFR|0|||
146596649|NCT01999218|528692123|FG002|Overall Study|Creatinine/eGFR|1|||
146596650|NCT01999218|528692121|FG000|Overall Study|Death|7|||
146596651|NCT01999218|528692122|FG001|Overall Study|Death|1|||
146596652|NCT01999218|528692123|FG002|Overall Study|Death|2|||
146596653|NCT01999218|528692121|FG000|Overall Study|Excluded Medication|1|||
146596654|NCT01999218|528692122|FG001|Overall Study|Excluded Medication|1|||
146596655|NCT01999218|528692123|FG002|Overall Study|Excluded Medication|2|||
146596656|NCT01999218|528692121|FG000|Overall Study|Adverse Event|9|||
146596657|NCT01999218|528692122|FG001|Overall Study|Adverse Event|7|||
146596658|NCT01999218|528692123|FG002|Overall Study|Adverse Event|7|||
146596659|NCT01999218|528692121|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
146596660|NCT01999218|528692122|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
146596661|NCT01999218|528692123|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
146596662|NCT00546260|528692124|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
146596663|NCT00546260|528692125|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
146596664|NCT03780959|528692126|FG000|Part 1|Adverse Event|1|||
146596665|NCT03780959|528692127|FG001|Part 1|Adverse Event|0|||
146596666|NCT03780959|528692128|FG002|Part 1|Adverse Event|0|||
146596667|NCT03780959|528692126|FG000|Part 1|Withdrawal by Subject|1|||
146596668|NCT03780959|528692127|FG001|Part 1|Withdrawal by Subject|0|||
146596669|NCT03780959|528692128|FG002|Part 1|Withdrawal by Subject|0|||
146596670|NCT03780959|528692126|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
146596671|NCT03780959|528692127|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
146596672|NCT03780959|528692128|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
146596673|NCT03780959|528692126|FG000|Part 1|Response Status|2|||
146596674|NCT03780959|528692127|FG001|Part 1|Response Status|0|||
146596675|NCT03780959|528692128|FG002|Part 1|Response Status|0|||
146596676|NCT03780959|528692126|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
146596677|NCT03780959|528692127|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
146596678|NCT03780959|528692128|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
146596679|NCT03780959|528692126|FG000|Part 2|Response Status|0|||
146596680|NCT03780959|528692127|FG001|Part 2|Response Status|18|||
146596681|NCT03780959|528692128|FG002|Part 2|Response Status|6|||
146596682|NCT03647267|528693491|FG000|Overall Study|Lost to Follow-up|1|||
146596683|NCT03647267|528693492|FG001|Overall Study|Lost to Follow-up|0|||
146596684|NCT03131596|528693493|FG000|Overall Study|Protocol Violation|3|||
146596685|NCT03131596|528693494|FG001|Overall Study|Protocol Violation|3|||
146596686|NCT03131596|528693493|FG000|Overall Study|Lost to Follow-up|3|||
146596687|NCT03131596|528693494|FG001|Overall Study|Lost to Follow-up|0|||
146596688|NCT03654885|528693495|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
146596689|NCT03654885|528693496|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
146596690|NCT03654885|528693495|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
146596691|NCT03654885|528693496|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
146596692|NCT03654885|528693495|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
146596693|NCT03654885|528693496|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
146596694|NCT03654885|528693495|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
146596695|NCT03654885|528693496|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
146596696|NCT03654885|528693495|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
146596697|NCT03654885|528693496|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
146596698|NCT03654885|528693495|FG000|Overall Study|Adverse Event in Study Eye|3|||
146596699|NCT03654885|528693496|FG001|Overall Study|Adverse Event in Study Eye|0|||
146596700|NCT03654885|528693495|FG000|Overall Study|Consent Withdrawn|1|||
146596701|NCT03654885|528693496|FG001|Overall Study|Consent Withdrawn|0|||
146920204|NCT02702193|529868907|FG001|12 Month Follow up|Lost to Follow-up|18|||
146920205|NCT01201798|529868912|FG000|Overall Study|Adverse Event|2|||
146920206|NCT01201798|529868913|FG001|Overall Study|Adverse Event|0|||
146920207|NCT01201798|529868912|FG000|Overall Study|Lost to Follow-up|3|||
146920208|NCT01201798|529868913|FG001|Overall Study|Lost to Follow-up|5|||
146920209|NCT01201798|529868912|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
146920210|NCT01201798|529868913|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
146596702|NCT03654885|528693495|FG000|Overall Study|Death|3|||
146596703|NCT03654885|528693496|FG001|Overall Study|Death|1|||
146596704|NCT03654885|528693495|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
146596705|NCT03654885|528693496|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
146596706|NCT03654885|528693495|FG000|Overall Study|Lost to Follow-up|3|||
146596707|NCT03654885|528693496|FG001|Overall Study|Lost to Follow-up|3|||
146596708|NCT00004445|528693497|FG000|Overall Study|Physician Decision|2|||
146653868|NCT04393298|528910628|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
146596709|NCT00004445|528693497|FG000|Overall Study|Withdrawal by Subject|1|||
146920211|NCT01201798|529868912|FG000|Overall Study|Noncompliance|1|||
146596710|NCT02753127|528693498|FG000|Overall Study|Lost to Follow-up|13|||
146596711|NCT02753127|528693499|FG001|Overall Study|Lost to Follow-up|11|||
146596712|NCT02753127|528693498|FG000|Overall Study|Withdrawal by Subject|37|||
146596713|NCT02753127|528693499|FG001|Overall Study|Withdrawal by Subject|47|||
146596714|NCT02753127|528693498|FG000|Overall Study|Other|3|||
146596715|NCT02753127|528693499|FG001|Overall Study|Other|8|||
146596716|NCT02753127|528693498|FG000|Overall Study|Hospice|0|||
146596717|NCT02753127|528693499|FG001|Overall Study|Hospice|2|||
146596718|NCT01146288|528693504|FG000|First Intervention(1 Day)|Adverse Event|0|||
146596719|NCT01146288|528693505|FG001|First Intervention(1 Day)|Adverse Event|1|||
146596720|NCT03532932|528693509|FG000|Overall Study|Protocol Deviation|33|||
146596721|NCT03532932|528693510|FG001|Overall Study|Protocol Deviation|31|||
146596722|NCT03532932|528693509|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
146596723|NCT03532932|528693510|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
146596724|NCT03532932|528693509|FG000|Overall Study|Withdrawal by Subject|2|||
146596725|NCT03532932|528693510|FG001|Overall Study|Withdrawal by Subject|0|||
146596726|NCT03532932|528693509|FG000|Overall Study|Lost to Follow-up|15|||
146596727|NCT03532932|528693510|FG001|Overall Study|Lost to Follow-up|9|||
146596728|NCT03532932|528693509|FG000|Overall Study|Adverse Event|4|||
146596729|NCT03532932|528693510|FG001|Overall Study|Adverse Event|3|||
146596730|NCT03532932|528693509|FG000|Overall Study|Death|0|||
146596731|NCT03532932|528693510|FG001|Overall Study|Death|2|||
146596732|NCT03532932|528693509|FG000|Overall Study|Other|11|||
146596733|NCT03532932|528693510|FG001|Overall Study|Other|16|||
146596734|NCT00931801|528693511|FG000|Overall Study|Adverse Event|0|||
146596735|NCT00931801|528693512|FG001|Overall Study|Adverse Event|0|||
146596736|NCT00931801|528693513|FG002|Overall Study|Adverse Event|1|||
146596737|NCT00931801|528693511|FG000|Overall Study|Lost to Follow-up|0|||
146596738|NCT00931801|528693512|FG001|Overall Study|Lost to Follow-up|1|||
146596739|NCT00931801|528693513|FG002|Overall Study|Lost to Follow-up|0|||
146596740|NCT00931801|528693511|FG000|Overall Study|Withdrawal by Subject|1|||
146596741|NCT00931801|528693512|FG001|Overall Study|Withdrawal by Subject|0|||
146596742|NCT00931801|528693513|FG002|Overall Study|Withdrawal by Subject|0|||
146596743|NCT00931801|528693511|FG000|Overall Study|Confirmed Virologic Failure|0|||
146596744|NCT00931801|528693512|FG001|Overall Study|Confirmed Virologic Failure|0|||
146596745|NCT00931801|528693513|FG002|Overall Study|Confirmed Virologic Failure|3|||
146596746|NCT03283150|528693514|FG000|Overall Study|Withdrawal by Subject|6|||
146596747|NCT03283150|528693515|FG001|Overall Study|Withdrawal by Subject|0|||
146596748|NCT03283150|528693516|FG002|Overall Study|Withdrawal by Subject|0|||
146596749|NCT01028716|528693517|FG000|Overall Study|Physician Decision|1|||
146596750|NCT00086502|528693518|FG000|Overall Study|Adverse Event|11|||
146596751|NCT00086502|528693519|FG001|Overall Study|Adverse Event|2|||
146596752|NCT00086502|528693518|FG000|Overall Study|Lack of Efficacy|0|||
146596753|NCT00086502|528693519|FG001|Overall Study|Lack of Efficacy|2|||
146596754|NCT00086502|528693518|FG000|Overall Study|Lost to Follow-up|3|||
146596755|NCT00086502|528693519|FG001|Overall Study|Lost to Follow-up|1|||
146596756|NCT00086502|528693518|FG000|Overall Study|Physician Decision|1|||
146596757|NCT00086502|528693519|FG001|Overall Study|Physician Decision|1|||
146596758|NCT00086502|528693518|FG000|Overall Study|Pregnancy|0|||
146596759|NCT00086502|528693519|FG001|Overall Study|Pregnancy|1|||
146596760|NCT00086502|528693518|FG000|Overall Study|Protocol Violation|3|||
146596761|NCT00086502|528693519|FG001|Overall Study|Protocol Violation|3|||
146596762|NCT00086502|528693518|FG000|Overall Study|Withdrawal by Subject|5|||
146596763|NCT00086502|528693519|FG001|Overall Study|Withdrawal by Subject|6|||
146596764|NCT00086502|528693518|FG000|Overall Study|Patient Moved|1|||
146596765|NCT00086502|528693519|FG001|Overall Study|Patient Moved|1|||
146596766|NCT00086502|528693518|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
146596767|NCT00086502|528693519|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
146596768|NCT00086502|528693518|FG000|Overall Study|Patient Accidentally Unblinded|1|||
146596769|NCT00086502|528693519|FG001|Overall Study|Patient Accidentally Unblinded|0|||
146596770|NCT05545644|528693520|FG000|Overall Study|Lost to Follow-up|4|||
146596771|NCT05545644|528693521|FG001|Overall Study|Lost to Follow-up|3|||
146596772|NCT01842581|528693524|FG000|Overall Study|Adverse Event|6|||
146596773|NCT01842581|528693525|FG001|Overall Study|Adverse Event|4|||
146596774|NCT01842581|528693524|FG000|Overall Study|HE breakthrough|26|||
146596775|NCT01842581|528693525|FG001|Overall Study|HE breakthrough|13|||
146596776|NCT01842581|528693524|FG000|Overall Study|Liver transplant|2|||
146596777|NCT01842581|528693525|FG001|Overall Study|Liver transplant|0|||
146596778|NCT01842581|528693524|FG000|Overall Study|Lost to Follow-up|2|||
146596779|NCT01842581|528693525|FG001|Overall Study|Lost to Follow-up|5|||
146596780|NCT01842581|528693524|FG000|Overall Study|Withdrawal by Subject|5|||
146596781|NCT01842581|528693525|FG001|Overall Study|Withdrawal by Subject|7|||
146596782|NCT01842581|528693524|FG000|Overall Study|Other than specified|3|||
146596783|NCT01842581|528693525|FG001|Overall Study|Other than specified|1|||
146596784|NCT00334282|528693526|FG000|Overall Study|Lost to Follow-up|11|||
146596785|NCT00334282|528693527|FG001|Overall Study|Lost to Follow-up|5|||
146596786|NCT00334282|528693526|FG000|Overall Study|Withdrawal by Subject|17|||
146596787|NCT00334282|528693527|FG001|Overall Study|Withdrawal by Subject|3|||
146596788|NCT00334282|528693526|FG000|Overall Study|Death|194|||
146596789|NCT00334282|528693527|FG001|Overall Study|Death|100|||
146596790|NCT01420627|528693528|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
146596791|NCT00837876|528693529|FG000|Overall Study|Death|2|||
146596792|NCT00837876|528693529|FG000|Overall Study|Adverse Event|7|||
146596793|NCT00837876|528693529|FG000|Overall Study|Physician Decision|1|||
146596794|NCT00837876|528693529|FG000|Overall Study|Withdrawal by Subject|3|||
146596795|NCT00837876|528693529|FG000|Overall Study|disease progression|24|||
146596796|NCT01996592|528693536|FG000|Overall Study|no response to text/no diary entry|32|||
146596797|NCT01996592|528693536|FG000|Overall Study|change in surgical date|4|||
146596798|NCT01996592|528693536|FG000|Overall Study|Withdrawal by Subject|5|||
146596799|NCT01996592|528693536|FG000|Overall Study|change in mode of delivery|4|||
146596800|NCT00870194|528693537|FG000|Overall Study|Adverse Event|10|||
146596801|NCT00870194|528693538|FG001|Overall Study|Adverse Event|5|||
146596802|NCT00870194|528693537|FG000|Overall Study|Lack of Efficacy|0|||
146596803|NCT00870194|528693538|FG001|Overall Study|Lack of Efficacy|1|||
146596804|NCT00870194|528693537|FG000|Overall Study|Lost to Follow-up|2|||
146596805|NCT00870194|528693538|FG001|Overall Study|Lost to Follow-up|0|||
146596806|NCT00870194|528693537|FG000|Overall Study|Physician Decision|3|||
146596807|NCT00870194|528693538|FG001|Overall Study|Physician Decision|1|||
146596808|NCT00870194|528693537|FG000|Overall Study|Protocol Violation|3|||
146596809|NCT00870194|528693538|FG001|Overall Study|Protocol Violation|3|||
146596810|NCT00870194|528693537|FG000|Overall Study|Entry Criteria Not Met|1|||
146596811|NCT00870194|528693538|FG001|Overall Study|Entry Criteria Not Met|2|||
146596812|NCT00870194|528693537|FG000|Overall Study|Subject Decision|7|||
146596813|NCT00870194|528693538|FG001|Overall Study|Subject Decision|2|||
146596814|NCT00707746|528693539|FG000|Treatment Period|Adverse Event|2|||
146596815|NCT00707746|528693540|FG001|Treatment Period|Adverse Event|4|||
146596816|NCT00707746|528693539|FG000|Treatment Period|Ineligibility|0|||
146596817|NCT00707746|528693540|FG001|Treatment Period|Ineligibility|1|||
146596818|NCT01685983|528693541|FG000|Overall Study|Adverse Event|7|||
146596819|NCT01685983|528693541|FG000|Overall Study|Death|1|||
146596820|NCT01685983|528693541|FG000|Overall Study|Withdrawal by Subject|19|||
146596821|NCT01685983|528693541|FG000|Overall Study|Protocol Violation|2|||
146596822|NCT01685983|528693541|FG000|Overall Study|Physician Decision|13|||
146596823|NCT01685983|528693541|FG000|Overall Study|Other|7|||
146596824|NCT01685983|528693541|FG000|Overall Study|Progressive Disease|32|||
146596825|NCT01685983|528693541|FG000|Overall Study|Noncompliance with Study Drug|1|||
146596826|NCT02642965|528693547|FG000|Overall Study|Lack of Efficacy|4|||
146596827|NCT02642965|528693547|FG000|Overall Study|Physician Decision|9|||
146596828|NCT01167907|528693554|FG000|Overall Study|Protocol Violation|1|||
146596829|NCT01167907|528693555|FG001|Overall Study|Protocol Violation|0|||
146596830|NCT01167907|528693554|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
146596831|NCT01167907|528693555|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
146596832|NCT03077698|528693558|FG000|Progestin Monotherapy|Stable Disease|8|||
146596833|NCT03077698|528693559|FG001|Progestin Monotherapy|Stable Disease|0|||
146596834|NCT03077698|528693558|FG000|Progestin Monotherapy|Adverse Event|1|||
146596835|NCT03077698|528693559|FG001|Progestin Monotherapy|Adverse Event|0|||
146596836|NCT03077698|528693558|FG000|Progestin Monotherapy|Death|1|||
146596837|NCT03077698|528693559|FG001|Progestin Monotherapy|Death|0|||
146596838|NCT03077698|528693558|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
146596839|NCT03077698|528693559|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
146596840|NCT03077698|528693558|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
146596841|NCT03077698|528693559|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
146596842|NCT03077698|528693558|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
146653869|NCT04393298|528910629|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
146920212|NCT01201798|529868913|FG001|Overall Study|Noncompliance|0|||
146920213|NCT01201798|529868912|FG000|Overall Study|Protocol Violation|1|||
146920214|NCT01201798|529868913|FG001|Overall Study|Protocol Violation|1|||
146920215|NCT01201798|529868912|FG000|Overall Study|Treatment Failure|1|||
146920216|NCT01201798|529868913|FG001|Overall Study|Treatment Failure|8|||
146920217|NCT03609359|529868920|FG000|Overall Study|Progression of primary disease (PD)|25|||
146920218|NCT03609359|529868920|FG000|Overall Study|Patient's refusal|1|||
146920219|NCT03609359|529868920|FG000|Overall Study|Physician Decision|1|||
146596843|NCT03077698|528693559|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
146596844|NCT03077698|528693558|FG000|Safety Follow Up|Withdrawal by Subject|2|||
146596845|NCT03077698|528693559|FG001|Safety Follow Up|Withdrawal by Subject|1|||
146596846|NCT03077698|528693558|FG000|Safety Follow Up|Transfer of care to hospice|1|||
146596847|NCT03077698|528693559|FG001|Safety Follow Up|Transfer of care to hospice|0|||
146596848|NCT01439074|528693560|FG000|Overall Study|Lost to Follow-up|3|||
146596849|NCT01439074|528693561|FG001|Overall Study|Lost to Follow-up|4|||
146596850|NCT01439074|528693560|FG000|Overall Study|Subject shedding|1|||
146596851|NCT01439074|528693561|FG001|Overall Study|Subject shedding|0|||
146596852|NCT01439074|528693560|FG000|Overall Study|Withdrawal by Subject|1|||
146596853|NCT01439074|528693561|FG001|Overall Study|Withdrawal by Subject|5|||
146596854|NCT01439074|528693560|FG000|Overall Study|Other|4|||
146653870|NCT04393298|528910630|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
146596855|NCT01439074|528693561|FG001|Overall Study|Other|4|||
146596856|NCT01140568|528693562|FG000|Overall Study|disease progression|31|||
146596857|NCT01140568|528693562|FG000|Overall Study|Withdrawal by Subject|1|||
146596858|NCT01140568|528693562|FG000|Overall Study|Screen Fail|4|||
146596859|NCT00815191|528693563|FG000|Overall Study|Protocol Violation|1|||
146596860|NCT00815191|528693564|FG001|Overall Study|Protocol Violation|1|||
146596861|NCT02639338|528693565|FG000|Overall Study|Lost to Follow-up|2|||
146596862|NCT02639338|528693566|FG001|Overall Study|Lost to Follow-up|2|||
146596863|NCT02639338|528693565|FG000|Overall Study|Withdrew Consent|1|||
146596864|NCT02639338|528693566|FG001|Overall Study|Withdrew Consent|2|||
146596865|NCT02639338|528693565|FG000|Overall Study|Death|1|||
146596866|NCT02639338|528693566|FG001|Overall Study|Death|0|||
146596867|NCT02639338|528693565|FG000|Overall Study|Randomized but Not Treated|0|||
146596868|NCT02639338|528693566|FG001|Overall Study|Randomized but Not Treated|1|||
146596869|NCT00493636|528693567|FG000|Overall Study|Withdrawal by Subject|1|||
146596870|NCT00493636|528693568|FG001|Overall Study|Withdrawal by Subject|0|||
146596871|NCT00493636|528693567|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
146596872|NCT00493636|528693568|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
146596873|NCT00493636|528693567|FG000|Overall Study|Mis-randomization|1|||
146596874|NCT00493636|528693568|FG001|Overall Study|Mis-randomization|1|||
146596875|NCT01873729|528693573|FG000|Overall Study|Withdrawal by Subject|1|||
146596876|NCT01066780|528693574|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
146596877|NCT01066780|528693575|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
146596878|NCT03099148|528693577|FG000|Wash-out|scheduling conflict|0|||
146596879|NCT03099148|528693578|FG001|Wash-out|scheduling conflict|1|||
146596880|NCT03099148|528693579|FG002|Wash-out|scheduling conflict|0|||
146596881|NCT03099148|528693580|FG003|Wash-out|scheduling conflict|0|||
146596882|NCT03099148|528693577|FG000|Wash-out|Adverse Event|0|||
146596883|NCT03099148|528693578|FG001|Wash-out|Adverse Event|1|||
146596884|NCT03099148|528693579|FG002|Wash-out|Adverse Event|0|||
146596885|NCT03099148|528693580|FG003|Wash-out|Adverse Event|0|||
146596886|NCT01827332|528693582|FG000|Overall Study|Lost to Follow-up|2|||
146596887|NCT01827332|528693583|FG001|Overall Study|Lost to Follow-up|1|||
146596888|NCT03352453|528693584|FG000|Overall Study|Miscellaneous Reasons|1|||
146596889|NCT03352453|528693585|FG001|Overall Study|Miscellaneous Reasons|2|||
146596890|NCT03352453|528693584|FG000|Overall Study|Lack of Efficacy|1|||
146596891|NCT03352453|528693585|FG001|Overall Study|Lack of Efficacy|0|||
146596892|NCT03352453|528693584|FG000|Overall Study|Withdrawal by Subject|8|||
146596893|NCT03352453|528693585|FG001|Overall Study|Withdrawal by Subject|14|||
146596894|NCT03352453|528693584|FG000|Overall Study|Study Terminated by Sponsor|2|||
146596895|NCT03352453|528693585|FG001|Overall Study|Study Terminated by Sponsor|1|||
146596896|NCT03352453|528693584|FG000|Overall Study|Protocol Deviation|1|||
146596897|NCT03352453|528693585|FG001|Overall Study|Protocol Deviation|0|||
146596898|NCT03352453|528693584|FG000|Overall Study|Lost to Follow-up|7|||
146596899|NCT03352453|528693585|FG001|Overall Study|Lost to Follow-up|6|||
146596900|NCT03352453|528693584|FG000|Overall Study|Adverse Event|2|||
146596901|NCT03352453|528693585|FG001|Overall Study|Adverse Event|9|||
146596902|NCT01241760|528693586|FG000|Overall Study|Adverse Event|1|||
146596903|NCT01241760|528693587|FG001|Overall Study|Adverse Event|0|||
146596904|NCT01241760|528693586|FG000|Overall Study|Lost to Follow-up|18|||
146596905|NCT01241760|528693587|FG001|Overall Study|Lost to Follow-up|22|||
146596906|NCT01241760|528693586|FG000|Overall Study|Withdrawal by Subject|13|||
146596907|NCT01241760|528693587|FG001|Overall Study|Withdrawal by Subject|13|||
146596908|NCT01241760|528693586|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
146596909|NCT01241760|528693587|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
146596910|NCT01241760|528693586|FG000|Overall Study|Other|1|||
146596911|NCT01241760|528693587|FG001|Overall Study|Other|1|||
146596912|NCT02725593|528693588|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
146596913|NCT02725593|528693589|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
146596914|NCT02725593|528693588|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
146596915|NCT02725593|528693589|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
146596916|NCT02725593|528693588|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
146596917|NCT02725593|528693589|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
146596918|NCT02725593|528693588|FG000|Long Term Extension|Withdrawal by Subject|1|||
146596919|NCT02725593|528693589|FG001|Long Term Extension|Withdrawal by Subject|3|||
146771537|NCT05061693|529331235|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
146771538|NCT05061693|529331236|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
146596920|NCT02644356|528693610|FG000|Overall Study|Withdrawal by Subject|2|||
146596921|NCT02210091|528693612|FG000|Overall Study|Physician Decision|0|||
146596922|NCT02210091|528693613|FG001|Overall Study|Physician Decision|1|||
146596923|NCT02210091|528693612|FG000|Overall Study|Withdrawal by Sponsor|0|||
146596924|NCT02210091|528693613|FG001|Overall Study|Withdrawal by Sponsor|1|||
146596925|NCT01711866|528693617|FG000|Overall Study|Noncompliant|3|||
146596926|NCT01711866|528693617|FG000|Overall Study|Withdrawal by Subject|3|||
146596927|NCT01711866|528693617|FG000|Overall Study|Adverse Event|2|||
146596928|NCT01831817|528693618|FG000|Overall Study|Lost to Follow-up|1|||
146596929|NCT01831817|528693619|FG001|Overall Study|Lost to Follow-up|0|||
146596930|NCT01831817|528693620|FG002|Overall Study|Lost to Follow-up|0|||
146596931|NCT01831817|528693621|FG003|Overall Study|Lost to Follow-up|0|||
146596932|NCT01831817|528693618|FG000|Overall Study|Withdrawl of Consent|3|||
146596933|NCT01831817|528693619|FG001|Overall Study|Withdrawl of Consent|0|||
146596934|NCT01831817|528693620|FG002|Overall Study|Withdrawl of Consent|0|||
146596935|NCT01831817|528693621|FG003|Overall Study|Withdrawl of Consent|0|||
146596936|NCT00897390|528693622|FG000|Overall Study|Adverse Event|2|||
146596937|NCT00897390|528693622|FG000|Overall Study|No Longer Met Study Criteria|1|||
146596938|NCT00897390|528693622|FG000|Overall Study|Personal Reasons|1|||
146596939|NCT00897390|528693622|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
146596940|NCT00958217|528693623|FG000|Overall Study|Death|2|||
146596941|NCT00958217|528693624|FG001|Overall Study|Death|1|||
146596942|NCT00958217|528693623|FG000|Overall Study|Withdrawal by Subject|4|||
146596943|NCT00958217|528693624|FG001|Overall Study|Withdrawal by Subject|3|||
146596944|NCT00958217|528693623|FG000|Overall Study|Lost to Follow-up|17|||
146596945|NCT00958217|528693624|FG001|Overall Study|Lost to Follow-up|19|||
146596946|NCT00958217|528693623|FG000|Overall Study|Moved out of area|1|||
146596947|NCT00958217|528693624|FG001|Overall Study|Moved out of area|1|||
146596948|NCT00958217|528693623|FG000|Overall Study|Inpatient hospitalization|0|||
146596949|NCT00958217|528693624|FG001|Overall Study|Inpatient hospitalization|1|||
146596950|NCT00940485|528695644|FG000|Overall Study|HBeAb positive at Baseline|3|||
146596951|NCT00940485|528695645|FG001|Overall Study|HBeAb positive at Baseline|2|||
146596952|NCT00940485|528695644|FG000|Overall Study|Lost to Follow-up|2|||
146596953|NCT00940485|528695645|FG001|Overall Study|Lost to Follow-up|3|||
146596954|NCT00940485|528695644|FG000|Overall Study|Adverse Event|8|||
146596955|NCT00940485|528695645|FG001|Overall Study|Adverse Event|0|||
146596956|NCT00940485|528695644|FG000|Overall Study|Withdrawal by Subject|1|||
146596957|NCT00940485|528695645|FG001|Overall Study|Withdrawal by Subject|1|||
146596958|NCT00940485|528695644|FG000|Overall Study|Others|1|||
146596959|NCT00940485|528695645|FG001|Overall Study|Others|1|||
146596960|NCT06250738|528695648|FG000|Overall Study|Lost to Follow-up|1|||
146978494|NCT01717456|530084082|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
146978495|NCT01717456|530084083|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
146978496|NCT00837577|530084084|FG000|Double-blind Period|Clinical Adverse Event|1|||
146978497|NCT00837577|530084085|FG001|Double-blind Period|Clinical Adverse Event|0|||
146978498|NCT00837577|530084084|FG000|Double-blind Period|Withdrawal by Subject|1|||
146978499|NCT00837577|530084085|FG001|Double-blind Period|Withdrawal by Subject|0|||
146978500|NCT00837577|530084084|FG000|Open-label Period|Clinical Adverse Event|2|||
146978501|NCT00837577|530084085|FG001|Open-label Period|Clinical Adverse Event|2|||
146978502|NCT00837577|530084084|FG000|Open-label Period|Laboratory Adverse Event|0|||
146978503|NCT00837577|530084085|FG001|Open-label Period|Laboratory Adverse Event|1|||
146978504|NCT00837577|530084084|FG000|Open-label Period|Lack of Efficacy|4|||
146978505|NCT00837577|530084085|FG001|Open-label Period|Lack of Efficacy|3|||
146978506|NCT00837577|530084084|FG000|Open-label Period|Withdrawal by Subject|1|||
146653871|NCT04393298|528910631|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
146653872|NCT04393298|528910632|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
146653873|NCT04393298|528910633|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
146596961|NCT02936284|528695649|FG000|Overall Study|Withdrawal by Subject|3|||
146596962|NCT02936284|528695650|FG001|Overall Study|Withdrawal by Subject|1|||
146596963|NCT02936284|528695649|FG000|Overall Study|Lost to Follow-up|7|||
146596964|NCT02936284|528695650|FG001|Overall Study|Lost to Follow-up|8|||
146596965|NCT00293709|528695655|FG000|Overall Study|Other|47|||
146596966|NCT02981524|528695656|FG000|Overall Study|Progressive Disease|14|||
146596967|NCT02981524|528695656|FG000|Overall Study|Death (unrelated)|1|||
146596968|NCT02981524|528695656|FG000|Overall Study|Treatment Related Toxicity|1|||
146596969|NCT02981524|528695656|FG000|Overall Study|Withdrawal by Subject|1|||
146596970|NCT02677844|528695657|FG000|Period 3|Withdrawal by Subject|0|||
146596971|NCT02677844|528695658|FG001|Period 3|Withdrawal by Subject|0|||
146596972|NCT02677844|528695659|FG002|Period 3|Withdrawal by Subject|0|||
146596973|NCT02677844|528695660|FG003|Period 3|Withdrawal by Subject|1|||
146653874|NCT04393298|528910634|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
146653875|NCT04393298|528910635|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
146653876|NCT03754972|528910638|FG000|Overall Study|Protocol Violation|25|||
146596974|NCT02677844|528695661|FG004|Period 3|Withdrawal by Subject|0|||
146596975|NCT02677844|528695662|FG005|Period 3|Withdrawal by Subject|0|||
146653877|NCT01155479|528910639|FG000|Part I|Adverse Event|13|||
146596976|NCT02677844|528695663|FG006|Period 3|Withdrawal by Subject|0|||
146596977|NCT03458702|528695664|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
146596978|NCT03458702|528695665|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
146596979|NCT03458702|528695664|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
146596980|NCT03458702|528695665|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
146596981|NCT01697462|528695666|FG000|Overall Study|Disease Progression|1|||
146653878|NCT01155479|528910640|FG001|Part I|Adverse Event|8|||
146596982|NCT01697462|528695666|FG000|Overall Study|Adverse Event|6|||
146596983|NCT01697462|528695666|FG000|Overall Study|Lost to Follow-up|21|||
146596984|NCT01697462|528695666|FG000|Overall Study|Withdrawal by Subject|12|||
146596985|NCT01697462|528695666|FG000|Overall Study|Investigator Decision|21|||
146596986|NCT01697462|528695666|FG000|Overall Study|Death|1|||
146596987|NCT01697462|528695666|FG000|Overall Study|Other|10|||
146596988|NCT01697462|528695666|FG000|Overall Study|Missing|5|||
146596989|NCT00168103|528695667|FG000|Overall Study|Withdrawal by Subject|1|||
146596990|NCT00168103|528695668|FG001|Overall Study|Withdrawal by Subject|2|||
146596991|NCT00168103|528695669|FG002|Overall Study|Withdrawal by Subject|1|||
146596992|NCT00168103|528695670|FG003|Overall Study|Withdrawal by Subject|0|||
146596993|NCT00168103|528695667|FG000|Overall Study|Lost to Follow-up|1|||
146596994|NCT00168103|528695668|FG001|Overall Study|Lost to Follow-up|3|||
146596995|NCT00168103|528695669|FG002|Overall Study|Lost to Follow-up|0|||
146596996|NCT00168103|528695670|FG003|Overall Study|Lost to Follow-up|0|||
146596997|NCT00545532|528695671|FG000|Overall Study|Withdrawal by Subject|1|||
146596998|NCT00545532|528695672|FG001|Overall Study|Withdrawal by Subject|3|||
146596999|NCT00545532|528695671|FG000|Overall Study|Lost to Follow-up|5|||
146597000|NCT00545532|528695672|FG001|Overall Study|Lost to Follow-up|6|||
146597001|NCT00545532|528695671|FG000|Overall Study|Death|0|||
146597002|NCT00545532|528695672|FG001|Overall Study|Death|1|||
146597003|NCT03630302|528695673|FG000|Surgery|hardware issue prevented LFP recordings|1|||
146597004|NCT03630302|528695673|FG000|3 Month Visit|Adverse Event|2|||
146597005|NCT03630302|528695673|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
146597006|NCT01133275|528695675|FG000|Overall Study|Withdrawal by Subject|1|||
146597007|NCT01133275|528695675|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
146597008|NCT01143896|528695676|FG000|Overall Study|Did not complete Baseline Interview|5|||
146597009|NCT01143896|528695677|FG001|Overall Study|Did not complete Baseline Interview|4|||
146597010|NCT01143896|528695676|FG000|Overall Study|Lost to Follow-up|18|||
146597011|NCT01143896|528695677|FG001|Overall Study|Lost to Follow-up|13|||
146597012|NCT01143896|528695676|FG000|Overall Study|Withdrawal by Subject|13|||
146597013|NCT01143896|528695677|FG001|Overall Study|Withdrawal by Subject|5|||
146920220|NCT03609359|529868920|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
146920221|NCT01912729|529868922|FG000|Overall Study|Withdrawal by Subject|0|||
146920222|NCT01912729|529868923|FG001|Overall Study|Withdrawal by Subject|1|||
146920223|NCT00988559|529868931|FG000|Overall Study|Withdrawal by Subject|1|||
146597014|NCT01143896|528695676|FG000|Overall Study|Death|6|||
146597015|NCT01143896|528695677|FG001|Overall Study|Death|3|||
146597016|NCT01318070|528695678|FG000|Overall Study|Adverse Event|1|||
146597017|NCT01318070|528695679|FG001|Overall Study|Adverse Event|1|||
146597018|NCT01318070|528695680|FG002|Overall Study|Adverse Event|5|||
146597019|NCT01318070|528695678|FG000|Overall Study|Withdrawal by Subject|0|||
146597020|NCT01318070|528695679|FG001|Overall Study|Withdrawal by Subject|1|||
146597021|NCT01318070|528695680|FG002|Overall Study|Withdrawal by Subject|1|||
146597022|NCT01318070|528695678|FG000|Overall Study|Lack of Efficacy|0|||
146597023|NCT01318070|528695679|FG001|Overall Study|Lack of Efficacy|0|||
146597024|NCT01318070|528695680|FG002|Overall Study|Lack of Efficacy|1|||
146597025|NCT01318070|528695678|FG000|Overall Study|Principal Investigator Discretion|1|||
146597026|NCT01318070|528695679|FG001|Overall Study|Principal Investigator Discretion|0|||
146597027|NCT01318070|528695680|FG002|Overall Study|Principal Investigator Discretion|0|||
146597028|NCT04375397|528695683|FG000|Overall Study|Death|1|||
146597029|NCT04375397|528695684|FG001|Overall Study|Death|1|||
146597030|NCT04375397|528695683|FG000|Overall Study|Withdrew consent|2|||
146597031|NCT04375397|528695684|FG001|Overall Study|Withdrew consent|0|||
146597032|NCT04375397|528695683|FG000|Overall Study|Lost to Follow-up|6|||
146597033|NCT04375397|528695684|FG001|Overall Study|Lost to Follow-up|4|||
146597034|NCT04375397|528695683|FG000|Overall Study|Other, not specified|0|||
146597035|NCT04375397|528695684|FG001|Overall Study|Other, not specified|1|||
146597036|NCT00610441|528695686|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
146597037|NCT00610441|528695687|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
146597038|NCT00610441|528695688|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
146597039|NCT00610441|528695689|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
146597040|NCT00610441|528695686|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
146597041|NCT00610441|528695687|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
146597042|NCT00610441|528695688|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
146920224|NCT00988559|529868932|FG001|Overall Study|Withdrawal by Subject|1|||
146920225|NCT00988559|529868933|FG002|Overall Study|Withdrawal by Subject|0|||
146920226|NCT00988559|529868934|FG003|Overall Study|Withdrawal by Subject|1|||
146597043|NCT00610441|528695689|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
146597044|NCT00610441|528695686|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
146597045|NCT00610441|528695687|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
146597046|NCT00610441|528695688|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
146597047|NCT00610441|528695689|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
146597048|NCT00610441|528695686|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
146597049|NCT00610441|528695687|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
146597050|NCT00610441|528695688|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
146597051|NCT00610441|528695689|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
146597052|NCT00610441|528695686|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
146597053|NCT00610441|528695687|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
146653879|NCT01155479|528910641|FG002|Part I|Adverse Event|18|||
146920227|NCT00988559|529868931|FG000|Overall Study|Pregnancy|0|||
146920228|NCT00988559|529868932|FG001|Overall Study|Pregnancy|1|||
146920229|NCT00988559|529868933|FG002|Overall Study|Pregnancy|1|||
146920230|NCT00988559|529868934|FG003|Overall Study|Pregnancy|0|||
146920231|NCT00988559|529868931|FG000|Overall Study|Lost to Follow-up|0|||
146920232|NCT00988559|529868932|FG001|Overall Study|Lost to Follow-up|0|||
146920233|NCT00988559|529868933|FG002|Overall Study|Lost to Follow-up|1|||
146920234|NCT00988559|529868934|FG003|Overall Study|Lost to Follow-up|0|||
146920235|NCT02224846|529868935|FG000|Period 1 (Month 3)|Adverse Event|2|||
146597054|NCT00610441|528695688|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
146597055|NCT00610441|528695689|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
146597056|NCT00610441|528695686|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
146597057|NCT00610441|528695687|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
146597058|NCT00610441|528695688|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
146597059|NCT00610441|528695689|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
146597060|NCT00610441|528695686|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
146597061|NCT00610441|528695687|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
146597062|NCT00610441|528695688|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
146597063|NCT00610441|528695689|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
146597064|NCT00610441|528695686|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
146597065|NCT00610441|528695687|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
146597066|NCT00610441|528695688|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
146597067|NCT00610441|528695689|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
146597068|NCT00610441|528695686|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
146597069|NCT00610441|528695687|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
146597070|NCT00610441|528695688|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
146597071|NCT00610441|528695689|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
146597072|NCT01287195|528695695|FG000|Overall Study|Withdrawal by Subject|2|||
146597073|NCT02068118|528695699|FG000|18-month Comparative Study Period|Death|90|||
146597074|NCT02068118|528695700|FG001|18-month Comparative Study Period|Death|97|||
146597075|NCT02068118|528695699|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
146597076|NCT02068118|528695700|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
146597077|NCT02068118|528695699|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
146597078|NCT02068118|528695700|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
146597079|NCT02068118|528695699|FG000|18-month Comparative Study Period|Heart transplant|9|||
146597080|NCT02068118|528695700|FG001|18-month Comparative Study Period|Heart transplant|15|||
146597081|NCT02068118|528695699|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
146597082|NCT02068118|528695700|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
146597083|NCT02068118|528695699|FG000|18-month Comparative Study Period|Hemiplegia|0|||
146597084|NCT02068118|528695700|FG001|18-month Comparative Study Period|Hemiplegia|1|||
146597085|NCT02068118|528695699|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
146597086|NCT02068118|528695700|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
146597087|NCT02068118|528695699|FG000|18-month Comparative Study Period|Move|0|||
146597088|NCT02068118|528695700|FG001|18-month Comparative Study Period|Move|1|||
146597089|NCT02068118|528695699|FG000|18-month Comparative Study Period|Hearing loss|0|||
146597090|NCT02068118|528695700|FG001|18-month Comparative Study Period|Hearing loss|1|||
146597091|NCT02068118|528695699|FG000|Extension Period|Death|0|||
146597092|NCT02068118|528695700|FG001|Extension Period|Death|2|||
146597093|NCT02068118|528695699|FG000|Extension Period|Withdrawal by Subject|1|||
146597094|NCT02068118|528695700|FG001|Extension Period|Withdrawal by Subject|0|||
146597095|NCT02068118|528695699|FG000|Extension Period|Heart transplant|1|||
146597096|NCT02068118|528695700|FG001|Extension Period|Heart transplant|0|||
146597097|NCT02068118|528695699|FG000|Extension Period|Wrong device use|0|||
146597098|NCT02068118|528695700|FG001|Extension Period|Wrong device use|1|||
146597099|NCT00283868|528695703|FG000|Overall Study|Lost to Follow-up|7|||
146597100|NCT00283868|528695704|FG001|Overall Study|Lost to Follow-up|8|||
146597101|NCT00453973|528695705|FG000|Overall Study|Adverse Event|4|||
146597102|NCT00453973|528695706|FG001|Overall Study|Adverse Event|9|||
146920236|NCT02224846|529868936|FG001|Period 1 (Month 3)|Adverse Event|1|||
146597103|NCT00453973|528695705|FG000|Overall Study|Withdrawal by Subject|7|||
146597104|NCT00453973|528695706|FG001|Overall Study|Withdrawal by Subject|6|||
146597105|NCT00453973|528695705|FG000|Overall Study|PI Decision|0|||
146597106|NCT00453973|528695706|FG001|Overall Study|PI Decision|2|||
146653880|NCT01155479|528910642|FG003|Part I|Adverse Event|7|||
146653881|NCT01155479|528910643|FG004|Part I|Adverse Event|6|||
146653882|NCT01155479|528910639|FG000|Part I|Administrative|2|||
146597107|NCT00453973|528695705|FG000|Overall Study|Relocation|1|||
146653883|NCT01155479|528910640|FG001|Part I|Administrative|2|||
146653884|NCT01155479|528910641|FG002|Part I|Administrative|2|||
146920237|NCT02224846|529868935|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
146597108|NCT00453973|528695706|FG001|Overall Study|Relocation|0|||
146597109|NCT00453973|528695705|FG000|Overall Study|Renal transplant|1|||
146597110|NCT00453973|528695706|FG001|Overall Study|Renal transplant|1|||
146920238|NCT02224846|529868936|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
146920239|NCT02224846|529868935|FG000|Period 1 (Month 3)|Protocol Violation|4|||
146920240|NCT02224846|529868936|FG001|Period 1 (Month 3)|Protocol Violation|8|||
146920241|NCT02224846|529868935|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
146920242|NCT02224846|529868936|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
146920243|NCT02224846|529868935|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
146920244|NCT02224846|529868936|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
146920245|NCT02224846|529868935|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
146920246|NCT02224846|529868936|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
146920247|NCT02224846|529868935|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
146920248|NCT02224846|529868936|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
146920249|NCT02224846|529868935|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
146920250|NCT02224846|529868936|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
146920251|NCT02224846|529868935|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
146920252|NCT02224846|529868936|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
146920253|NCT02224846|529868935|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
146920254|NCT02224846|529868936|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
146920255|NCT02224846|529868935|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
146920256|NCT02224846|529868936|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
146920257|NCT02224846|529868935|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
146920258|NCT02224846|529868936|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
146920259|NCT02224846|529868935|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
146920260|NCT02224846|529868936|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
146920261|NCT02224846|529868935|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
146920262|NCT02224846|529868936|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
146920263|NCT02224846|529868935|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
146920264|NCT02224846|529868936|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
146920265|NCT02224846|529868935|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
146920266|NCT02224846|529868936|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
146920267|NCT02224846|529868935|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
146920268|NCT02224846|529868936|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
146920269|NCT03510663|529868937|FG000|Overall Study|Withdrawal by Subject|0|||
146920270|NCT03510663|529868938|FG001|Overall Study|Withdrawal by Subject|1|||
146920271|NCT03510663|529868939|FG002|Overall Study|Withdrawal by Subject|0|||
146920272|NCT03510663|529868940|FG003|Overall Study|Withdrawal by Subject|0|||
146920273|NCT03510663|529868941|FG004|Overall Study|Withdrawal by Subject|0|||
146920274|NCT03510663|529868942|FG005|Overall Study|Withdrawal by Subject|0|||
146920275|NCT03510663|529868943|FG006|Overall Study|Withdrawal by Subject|0|||
146920276|NCT03510663|529868944|FG007|Overall Study|Withdrawal by Subject|0|||
146920277|NCT04743635|529868953|FG000|Overall Study|Lost to Follow-up|2|||
146920278|NCT04743635|529868954|FG001|Overall Study|Lost to Follow-up|0|||
146920279|NCT01954121|529868955|FG000|Overall Study|Lack of Efficacy|94|||
146920280|NCT01954121|529868956|FG001|Overall Study|Lack of Efficacy|41|||
146920281|NCT01954121|529868955|FG000|Overall Study|Protocol Violation|0|||
146920282|NCT01954121|529868956|FG001|Overall Study|Protocol Violation|2|||
146920283|NCT01954121|529868955|FG000|Overall Study|Lost to Follow-up|5|||
146920284|NCT01954121|529868956|FG001|Overall Study|Lost to Follow-up|6|||
146920285|NCT01954121|529868955|FG000|Overall Study|Withdrawal by Subject|18|||
146920286|NCT01954121|529868956|FG001|Overall Study|Withdrawal by Subject|12|||
146920287|NCT01954121|529868955|FG000|Overall Study|Pregnancy|1|||
146920288|NCT01954121|529868956|FG001|Overall Study|Pregnancy|1|||
146920289|NCT01954121|529868955|FG000|Overall Study|AE, serious fatal|1|||
146920290|NCT01954121|529868956|FG001|Overall Study|AE, serious fatal|0|||
146920291|NCT01954121|529868955|FG000|Overall Study|AE, non-serious non-fatal|5|||
146920292|NCT01954121|529868956|FG001|Overall Study|AE, non-serious non-fatal|22|||
146920293|NCT01954121|529868955|FG000|Overall Study|SAE, non-fatal|1|||
146920294|NCT01954121|529868956|FG001|Overall Study|SAE, non-fatal|4|||
146920295|NCT01954121|529868955|FG000|Overall Study|Non-compliant with study procedures|1|||
146920296|NCT01954121|529868956|FG001|Overall Study|Non-compliant with study procedures|0|||
146920297|NCT01954121|529868955|FG000|Overall Study|Non-compliant patient|1|||
146920298|NCT01954121|529868956|FG001|Overall Study|Non-compliant patient|1|||
146920299|NCT01954121|529868955|FG000|Overall Study|Subject did not follow instructions|0|||
146920300|NCT01954121|529868956|FG001|Overall Study|Subject did not follow instructions|2|||
146920301|NCT01465178|529868958|FG000|Overall Study|Withdrawal by Subject|1|||
146920302|NCT01465178|529868959|FG001|Overall Study|Withdrawal by Subject|0|||
146920303|NCT00436215|529868966|FG000|Overall Study|Refused further treatment|3|||
146920304|NCT00436215|529868966|FG000|Overall Study|Small bowel obstruction|1|||
146920305|NCT00309777|529868967|FG000|Overall Study|Adverse Event|13|||
146920306|NCT00309777|529868968|FG001|Overall Study|Adverse Event|2|||
146920307|NCT00309777|529868969|FG002|Overall Study|Adverse Event|8|||
146920308|NCT00309777|529868970|FG003|Overall Study|Adverse Event|1|||
146920309|NCT00309777|529868967|FG000|Overall Study|Protocol Violation|4|||
146920310|NCT00309777|529868968|FG001|Overall Study|Protocol Violation|1|||
146920311|NCT00309777|529868969|FG002|Overall Study|Protocol Violation|3|||
146920312|NCT00309777|529868970|FG003|Overall Study|Protocol Violation|1|||
146771539|NCT05061693|529331237|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
146771540|NCT05061693|529331238|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
146771541|NCT05061693|529331239|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
146771542|NCT05061693|529331240|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
146771543|NCT05061693|529331229|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
146771544|NCT05061693|529331230|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146771545|NCT05061693|529331231|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146771546|NCT05061693|529331232|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146771547|NCT05061693|529331233|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146771548|NCT05061693|529331234|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146771549|NCT05061693|529331235|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146771550|NCT05061693|529331236|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146771551|NCT05061693|529331237|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146771552|NCT05061693|529331238|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146771553|NCT05061693|529331239|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146771554|NCT05061693|529331240|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146771555|NCT05061693|529331229|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146771556|NCT05061693|529331230|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146771557|NCT05061693|529331231|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
146771558|NCT05061693|529331232|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146771559|NCT05061693|529331233|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146771560|NCT05061693|529331234|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146920313|NCT00309777|529868967|FG000|Overall Study|Withdrawal by Subject|6|||
146920314|NCT00309777|529868968|FG001|Overall Study|Withdrawal by Subject|5|||
146597111|NCT00453973|528695705|FG000|Overall Study|Site closed by sponsor|3|||
146597112|NCT00453973|528695706|FG001|Overall Study|Site closed by sponsor|0|||
146597113|NCT00453973|528695705|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
146597114|NCT00453973|528695706|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
146597115|NCT01219933|528695710|FG000|Overall Study|Adverse Event|8|||
146597116|NCT01219933|528695710|FG000|Overall Study|No LDA reached|5|||
146597117|NCT01219933|528695710|FG000|Overall Study|No LDA maintained|7|||
146597118|NCT01219933|528695710|FG000|Overall Study|Lost to Follow-up|3|||
146597119|NCT01219933|528695710|FG000|Overall Study|GC free|1|||
146597120|NCT01219933|528695710|FG000|Overall Study|Withdrawal by Subject|5|||
146597121|NCT01219933|528695710|FG000|Overall Study|Protocol Violation|8|||
146597122|NCT01219933|528695710|FG000|Overall Study|Lack of Efficacy|1|||
146597123|NCT01443130|528695712|FG000|Overall Study|Lost to Follow-up|44|||
146597124|NCT01443130|528695713|FG001|Overall Study|Lost to Follow-up|42|||
146597125|NCT01443130|528695714|FG002|Overall Study|Lost to Follow-up|50|||
146597126|NCT01443130|528695715|FG003|Overall Study|Lost to Follow-up|23|||
146597127|NCT01443130|528695716|FG004|Overall Study|Lost to Follow-up|25|||
146597128|NCT01443130|528695717|FG005|Overall Study|Lost to Follow-up|21|||
146597129|NCT01443130|528695712|FG000|Overall Study|Death|0|||
146597130|NCT01443130|528695713|FG001|Overall Study|Death|1|||
146597131|NCT01443130|528695714|FG002|Overall Study|Death|0|||
146597132|NCT01443130|528695715|FG003|Overall Study|Death|7|||
146597133|NCT01443130|528695716|FG004|Overall Study|Death|10|||
146597134|NCT01443130|528695717|FG005|Overall Study|Death|8|||
146597135|NCT01443130|528695712|FG000|Overall Study|Adverse Event|2|||
146597136|NCT01443130|528695713|FG001|Overall Study|Adverse Event|1|||
146597137|NCT01443130|528695714|FG002|Overall Study|Adverse Event|1|||
146597138|NCT01443130|528695715|FG003|Overall Study|Adverse Event|0|||
146653885|NCT01155479|528910642|FG003|Part I|Administrative|0|||
146653886|NCT01155479|528910643|FG004|Part I|Administrative|0|||
146653887|NCT01155479|528910639|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
146653888|NCT01155479|528910640|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
146653889|NCT01155479|528910641|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
146653890|NCT01155479|528910642|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
146653891|NCT01155479|528910643|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
146653892|NCT01155479|528910639|FG000|Part I|Withdrawal by Subject|11|||
146653893|NCT01155479|528910640|FG001|Part I|Withdrawal by Subject|13|||
146653894|NCT01155479|528910641|FG002|Part I|Withdrawal by Subject|8|||
146920315|NCT00309777|529868969|FG002|Overall Study|Withdrawal by Subject|7|||
146920316|NCT00309777|529868970|FG003|Overall Study|Withdrawal by Subject|2|||
146920317|NCT00309777|529868967|FG000|Overall Study|Lost to Follow-up|0|||
146597139|NCT01443130|528695716|FG004|Overall Study|Adverse Event|0|||
146597140|NCT01443130|528695717|FG005|Overall Study|Adverse Event|0|||
146653895|NCT01155479|528910642|FG003|Part I|Withdrawal by Subject|8|||
146653896|NCT01155479|528910643|FG004|Part I|Withdrawal by Subject|9|||
146597141|NCT01443130|528695712|FG000|Overall Study|Protocol Violation|2|||
146597142|NCT01443130|528695713|FG001|Overall Study|Protocol Violation|1|||
146597143|NCT01443130|528695714|FG002|Overall Study|Protocol Violation|3|||
146597144|NCT01443130|528695715|FG003|Overall Study|Protocol Violation|2|||
146597145|NCT01443130|528695716|FG004|Overall Study|Protocol Violation|2|||
146597146|NCT01443130|528695717|FG005|Overall Study|Protocol Violation|3|||
146597147|NCT01443130|528695712|FG000|Overall Study|Withdrawal by Subject|15|||
146597148|NCT01443130|528695713|FG001|Overall Study|Withdrawal by Subject|14|||
146597149|NCT01443130|528695714|FG002|Overall Study|Withdrawal by Subject|12|||
146597150|NCT01443130|528695715|FG003|Overall Study|Withdrawal by Subject|7|||
146597151|NCT01443130|528695716|FG004|Overall Study|Withdrawal by Subject|7|||
146597152|NCT01443130|528695717|FG005|Overall Study|Withdrawal by Subject|2|||
146597153|NCT01443130|528695712|FG000|Overall Study|Death of Subject's Infant|5|||
146653897|NCT01155479|528910639|FG000|Part I|Lost to Follow-up|0|||
146653898|NCT01155479|528910640|FG001|Part I|Lost to Follow-up|0|||
146653899|NCT01155479|528910641|FG002|Part I|Lost to Follow-up|1|||
146653900|NCT01155479|528910642|FG003|Part I|Lost to Follow-up|1|||
146653901|NCT01155479|528910643|FG004|Part I|Lost to Follow-up|0|||
146653902|NCT01155479|528910639|FG000|Part I|Treatment Failure|3|||
146653903|NCT01155479|528910640|FG001|Part I|Treatment Failure|0|||
146653904|NCT01155479|528910641|FG002|Part I|Treatment Failure|3|||
146653905|NCT01155479|528910642|FG003|Part I|Treatment Failure|1|||
146653906|NCT01155479|528910643|FG004|Part I|Treatment Failure|2|||
146653907|NCT01155479|528910639|FG000|Part I|Did Not Receive Treatment|4|||
146653908|NCT01155479|528910640|FG001|Part I|Did Not Receive Treatment|2|||
146653909|NCT01155479|528910641|FG002|Part I|Did Not Receive Treatment|2|||
146653910|NCT01155479|528910642|FG003|Part I|Did Not Receive Treatment|6|||
146653911|NCT01155479|528910643|FG004|Part I|Did Not Receive Treatment|1|||
146653912|NCT01155479|528910639|FG000|Part I|Non-Compliance with Protocol|2|||
146653913|NCT01155479|528910640|FG001|Part I|Non-Compliance with Protocol|1|||
146653914|NCT01155479|528910641|FG002|Part I|Non-Compliance with Protocol|3|||
146653915|NCT01155479|528910642|FG003|Part I|Non-Compliance with Protocol|3|||
146653916|NCT01155479|528910643|FG004|Part I|Non-Compliance with Protocol|2|||
146653917|NCT01155479|528910639|FG000|Part II|Adverse Event|7|||
146653918|NCT01155479|528910640|FG001|Part II|Adverse Event|6|||
146653919|NCT01155479|528910641|FG002|Part II|Adverse Event|8|||
146653920|NCT01155479|528910642|FG003|Part II|Adverse Event|3|||
146653921|NCT01155479|528910643|FG004|Part II|Adverse Event|4|||
146653922|NCT01155479|528910639|FG000|Part II|Administrative|43|||
146653923|NCT01155479|528910640|FG001|Part II|Administrative|49|||
146653924|NCT01155479|528910641|FG002|Part II|Administrative|36|||
146653925|NCT01155479|528910642|FG003|Part II|Administrative|38|||
146597154|NCT01443130|528695713|FG001|Overall Study|Death of Subject's Infant|10|||
146597155|NCT01443130|528695714|FG002|Overall Study|Death of Subject's Infant|11|||
146597156|NCT01443130|528695715|FG003|Overall Study|Death of Subject's Infant|0|||
146597157|NCT01443130|528695716|FG004|Overall Study|Death of Subject's Infant|0|||
146597158|NCT01443130|528695717|FG005|Overall Study|Death of Subject's Infant|0|||
146653926|NCT01155479|528910643|FG004|Part II|Administrative|46|||
146653927|NCT01155479|528910639|FG000|Part II|Withdrawal by Subject|8|||
146653928|NCT01155479|528910640|FG001|Part II|Withdrawal by Subject|4|||
146653929|NCT01155479|528910641|FG002|Part II|Withdrawal by Subject|12|||
146653930|NCT01155479|528910642|FG003|Part II|Withdrawal by Subject|7|||
146653931|NCT01155479|528910643|FG004|Part II|Withdrawal by Subject|3|||
146653932|NCT01155479|528910639|FG000|Part II|Lost to Follow-up|1|||
146653933|NCT01155479|528910640|FG001|Part II|Lost to Follow-up|0|||
146653934|NCT01155479|528910641|FG002|Part II|Lost to Follow-up|0|||
146653935|NCT01155479|528910642|FG003|Part II|Lost to Follow-up|0|||
146653936|NCT01155479|528910643|FG004|Part II|Lost to Follow-up|1|||
146653937|NCT01155479|528910639|FG000|Part II|Treatment Failure|0|||
146653938|NCT01155479|528910640|FG001|Part II|Treatment Failure|1|||
146653939|NCT01155479|528910641|FG002|Part II|Treatment Failure|2|||
146653940|NCT01155479|528910642|FG003|Part II|Treatment Failure|0|||
146653941|NCT01155479|528910643|FG004|Part II|Treatment Failure|1|||
146653942|NCT01155479|528910639|FG000|Part II|Non-Compliance with Protocol|0|||
146653943|NCT01155479|528910640|FG001|Part II|Non-Compliance with Protocol|1|||
146653944|NCT01155479|528910641|FG002|Part II|Non-Compliance with Protocol|0|||
146653945|NCT01155479|528910642|FG003|Part II|Non-Compliance with Protocol|2|||
146653946|NCT01155479|528910643|FG004|Part II|Non-Compliance with Protocol|0|||
146653947|NCT02360605|528910644|FG000|Overall Study|Withdrawal by Subject|4|||
146653948|NCT02360605|528910645|FG001|Overall Study|Withdrawal by Subject|9|||
146653949|NCT02360605|528910644|FG000|Overall Study|Lost to Follow-up|7|||
146653950|NCT02360605|528910645|FG001|Overall Study|Lost to Follow-up|8|||
146653951|NCT02360605|528910644|FG000|Overall Study|Death|0|||
146771561|NCT05061693|529331235|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146771562|NCT05061693|529331236|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146653952|NCT02360605|528910645|FG001|Overall Study|Death|1|||
146653953|NCT02497976|528910650|FG000|Overall Study|Withdrawal by Subject|2|||
146653954|NCT02497976|528910651|FG001|Overall Study|Withdrawal by Subject|0|||
146653955|NCT02497976|528910650|FG000|Overall Study|Moved out of area|0|||
146653956|NCT02497976|528910651|FG001|Overall Study|Moved out of area|1|||
146653957|NCT00058539|528910652|FG000|Overall Study|Disease progression|24|||
146653958|NCT00058539|528910652|FG000|Overall Study|Adverse Event|3|||
146653959|NCT00058539|528910652|FG000|Overall Study|Withdrawal by Subject|5|||
146597159|NCT00685373|528695718|FG000|Overall Study|Adverse Event|3|||
146597160|NCT00685373|528695718|FG000|Overall Study|Withdrawal by Subject|5|||
146597161|NCT00685373|528695718|FG000|Overall Study|Lack of Efficacy|3|||
146653960|NCT00058539|528910652|FG000|Overall Study|Physician Decision|9|||
146597162|NCT00685373|528695718|FG000|Overall Study|Condition no longer requires study drug|1|||
146597163|NCT00685373|528695718|FG000|Overall Study|Lost to Follow-up|2|||
146597164|NCT00685373|528695718|FG000|Overall Study|Protocol Violation|1|||
146597165|NCT00582738|528695719|FG000|Overall Study|Administrative Problems|7|||
146597166|NCT00582738|528695720|FG001|Overall Study|Administrative Problems|8|||
146597167|NCT00582738|528695719|FG000|Overall Study|Adverse Event|0|||
146597168|NCT00582738|528695720|FG001|Overall Study|Adverse Event|5|||
146597169|NCT00582738|528695719|FG000|Overall Study|Graft Lost|0|||
146597170|NCT00582738|528695720|FG001|Overall Study|Graft Lost|1|||
146597171|NCT00582738|528695719|FG000|Overall Study|Other|1|||
146597172|NCT00582738|528695720|FG001|Overall Study|Other|0|||
146597173|NCT00582738|528695719|FG000|Overall Study|Protocol Violation|1|||
146597174|NCT00582738|528695720|FG001|Overall Study|Protocol Violation|1|||
146597175|NCT00582738|528695719|FG000|Overall Study|Withdrawal by Subject|0|||
146597176|NCT00582738|528695720|FG001|Overall Study|Withdrawal by Subject|3|||
146597177|NCT02758301|528695721|FG000|Overall Study|Death|12|||
146597178|NCT02758301|528695722|FG001|Overall Study|Death|0|||
146597179|NCT02758301|528695721|FG000|Overall Study|Physician Decision|10|||
146597180|NCT02758301|528695722|FG001|Overall Study|Physician Decision|1|||
146597181|NCT02758301|528695721|FG000|Overall Study|Withdrawal by Subject|5|||
146597182|NCT02758301|528695722|FG001|Overall Study|Withdrawal by Subject|6|||
146597183|NCT02758301|528695721|FG000|Overall Study|Lost to Follow-up|7|||
146597184|NCT02758301|528695722|FG001|Overall Study|Lost to Follow-up|0|||
146597185|NCT02758301|528695721|FG000|Overall Study|Protocol Violation|0|||
146653961|NCT00058539|528910652|FG000|Overall Study|Death|1|||
146653962|NCT01903525|528910655|FG000|Overall Study|Lost to Follow-up|5|||
146920318|NCT00309777|529868968|FG001|Overall Study|Lost to Follow-up|0|||
146653963|NCT01903525|528910656|FG001|Overall Study|Lost to Follow-up|9|||
146653964|NCT01903525|528910655|FG000|Overall Study|Adverse Event|0|||
146920319|NCT00309777|529868969|FG002|Overall Study|Lost to Follow-up|1|||
146920320|NCT00309777|529868970|FG003|Overall Study|Lost to Follow-up|0|||
146920321|NCT00309777|529868967|FG000|Overall Study|Death|0|||
146920322|NCT00309777|529868968|FG001|Overall Study|Death|1|||
146920323|NCT00309777|529868969|FG002|Overall Study|Death|0|||
146920324|NCT00309777|529868970|FG003|Overall Study|Death|0|||
146920325|NCT02330549|529871348|FG000|Overall Study|Adverse Event|1|||
146920326|NCT02330549|529871349|FG001|Overall Study|Adverse Event|0|||
146920327|NCT02330549|529871348|FG000|Overall Study|Subject withdrew consent|2|||
146920328|NCT02330549|529871349|FG001|Overall Study|Subject withdrew consent|1|||
146920329|NCT02330549|529871348|FG000|Overall Study|Failure to meet randomization criteria|1|||
146920330|NCT02330549|529871349|FG001|Overall Study|Failure to meet randomization criteria|0|||
146920331|NCT02364947|529871352|FG000|Overall Study|Withdrawal by Subject|10|||
146920332|NCT02364947|529871353|FG001|Overall Study|Withdrawal by Subject|8|||
146920333|NCT02364947|529871354|FG002|Overall Study|Withdrawal by Subject|9|||
146920334|NCT02364947|529871352|FG000|Overall Study|Adverse Event|45|||
146920335|NCT02364947|529871353|FG001|Overall Study|Adverse Event|33|||
146920336|NCT02364947|529871354|FG002|Overall Study|Adverse Event|11|||
146920337|NCT02364947|529871352|FG000|Overall Study|Protocol Violation|1|||
146920338|NCT02364947|529871353|FG001|Overall Study|Protocol Violation|1|||
146920339|NCT02364947|529871354|FG002|Overall Study|Protocol Violation|1|||
146920340|NCT02364947|529871352|FG000|Overall Study|Physician Decision|3|||
146920341|NCT02364947|529871353|FG001|Overall Study|Physician Decision|2|||
146920342|NCT02364947|529871354|FG002|Overall Study|Physician Decision|5|||
146920343|NCT02364947|529871352|FG000|Overall Study|Death|0|||
146920344|NCT02364947|529871353|FG001|Overall Study|Death|1|||
146920345|NCT02364947|529871354|FG002|Overall Study|Death|0|||
146920346|NCT00423085|529871355|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
146920347|NCT00423085|529871356|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
146920348|NCT00423085|529871357|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
146920349|NCT00423085|529871358|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
146920350|NCT00423085|529871355|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
146920351|NCT00423085|529871356|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
146978507|NCT00837577|530084085|FG001|Open-label Period|Withdrawal by Subject|2|||
146597186|NCT02758301|528695722|FG001|Overall Study|Protocol Violation|1|||
146597187|NCT00364533|528695723|FG000|Overall Study|Adverse Event|8|||
146597188|NCT00364533|528695724|FG001|Overall Study|Adverse Event|7|||
146597189|NCT00364533|528695725|FG002|Overall Study|Adverse Event|15|||
146597190|NCT00364533|528695726|FG003|Overall Study|Adverse Event|5|||
146597191|NCT00364533|528695727|FG004|Overall Study|Adverse Event|2|||
146920352|NCT00423085|529871357|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
146920353|NCT00423085|529871358|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
146920354|NCT00423085|529871355|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
146978508|NCT00837577|530084084|FG000|Open-label Period|Other Reason|1|||
146597192|NCT00364533|528695723|FG000|Overall Study|Withdrawal by Subject|4|||
146597193|NCT00364533|528695724|FG001|Overall Study|Withdrawal by Subject|8|||
146597194|NCT00364533|528695725|FG002|Overall Study|Withdrawal by Subject|6|||
146597195|NCT00364533|528695726|FG003|Overall Study|Withdrawal by Subject|6|||
146653965|NCT01903525|528910656|FG001|Overall Study|Adverse Event|1|||
146597196|NCT00364533|528695727|FG004|Overall Study|Withdrawal by Subject|6|||
146597197|NCT00364533|528695723|FG000|Overall Study|Lack of Efficacy|22|||
146597198|NCT00364533|528695724|FG001|Overall Study|Lack of Efficacy|22|||
146597199|NCT00364533|528695725|FG002|Overall Study|Lack of Efficacy|21|||
146597200|NCT00364533|528695726|FG003|Overall Study|Lack of Efficacy|17|||
146597201|NCT00364533|528695727|FG004|Overall Study|Lack of Efficacy|42|||
146597202|NCT00364533|528695723|FG000|Overall Study|Subject discharged from hospital|4|||
146597203|NCT00364533|528695724|FG001|Overall Study|Subject discharged from hospital|1|||
146597204|NCT00364533|528695725|FG002|Overall Study|Subject discharged from hospital|2|||
146597205|NCT00364533|528695726|FG003|Overall Study|Subject discharged from hospital|3|||
146597206|NCT00364533|528695727|FG004|Overall Study|Subject discharged from hospital|1|||
146597207|NCT00364533|528695723|FG000|Overall Study|Variations in drug compliance|2|||
146597208|NCT00364533|528695724|FG001|Overall Study|Variations in drug compliance|1|||
146597209|NCT00364533|528695725|FG002|Overall Study|Variations in drug compliance|1|||
146597210|NCT00364533|528695726|FG003|Overall Study|Variations in drug compliance|0|||
146597211|NCT00364533|528695727|FG004|Overall Study|Variations in drug compliance|0|||
146597212|NCT00364533|528695723|FG000|Overall Study|Non-compliance|1|||
146597213|NCT00364533|528695724|FG001|Overall Study|Non-compliance|0|||
146597214|NCT00364533|528695725|FG002|Overall Study|Non-compliance|0|||
146597215|NCT00364533|528695726|FG003|Overall Study|Non-compliance|0|||
146597216|NCT00364533|528695727|FG004|Overall Study|Non-compliance|0|||
146597217|NCT00364533|528695723|FG000|Overall Study|Protocol Violation|1|||
146597218|NCT00364533|528695724|FG001|Overall Study|Protocol Violation|1|||
146597219|NCT00364533|528695725|FG002|Overall Study|Protocol Violation|0|||
146597220|NCT00364533|528695726|FG003|Overall Study|Protocol Violation|0|||
146597221|NCT00364533|528695727|FG004|Overall Study|Protocol Violation|0|||
146597222|NCT03461406|528695729|FG000|Overall Study|Death|1|||
146597223|NCT03461406|528695730|FG001|Overall Study|Death|2|||
146597224|NCT03461406|528695729|FG000|Overall Study|Consent Withdrawn by Participant|0|||
146597225|NCT03461406|528695730|FG001|Overall Study|Consent Withdrawn by Participant|1|||
146597226|NCT03461406|528695729|FG000|Overall Study|Screen Failure|3|||
146597227|NCT03461406|528695730|FG001|Overall Study|Screen Failure|1|||
146597228|NCT03461406|528695729|FG000|Overall Study|Reason not Specified|1|||
146597229|NCT03461406|528695730|FG001|Overall Study|Reason not Specified|3|||
146597230|NCT03461406|528695729|FG000|Overall Study|Lost to Follow-up|3|||
146597231|NCT03461406|528695730|FG001|Overall Study|Lost to Follow-up|0|||
146597232|NCT01886690|528695731|FG000|Overall Study|Protocol Violation|0|||
146597233|NCT01886690|528695732|FG001|Overall Study|Protocol Violation|1|||
146597234|NCT01886690|528695731|FG000|Overall Study|Personal Reasons|0|||
146597235|NCT01886690|528695732|FG001|Overall Study|Personal Reasons|1|||
146597236|NCT01011933|528695733|FG000|Overall Study|Wrong cell type|1|||
146597237|NCT01011933|528695733|FG000|Overall Study|Improper pre-protocol Rx|1|||
146597238|NCT01011933|528695733|FG000|Overall Study|Inadequate pathology|1|||
146597239|NCT01011933|528695733|FG000|Overall Study|Never treated|1|||
146597240|NCT02900170|528695736|FG000|Overall Study|Lost to Follow-up|8|||
146597241|NCT01814670|528695740|FG000|Overall Study|Protocol Violation|12|||
146597242|NCT02012686|528695741|FG000|Overall Study|muscle contraction|0|||
146597243|NCT02012686|528695742|FG001|Overall Study|muscle contraction|1|||
146597244|NCT02012686|528695741|FG000|Overall Study|electrocardiography monitoring noise|0|||
146597245|NCT02012686|528695742|FG001|Overall Study|electrocardiography monitoring noise|1|||
146597246|NCT00966719|528695743|FG000|Overall Study|Lost to Follow-up|6|||
146597247|NCT00966719|528695744|FG001|Overall Study|Lost to Follow-up|11|||
146597248|NCT01703065|528695747|FG000|Overall Study|Lack of Efficacy|1|||
146597249|NCT01703065|528695748|FG001|Overall Study|Lack of Efficacy|0|||
146597250|NCT00160199|528695751|FG000|Overall Study|Adverse Event|5|||
146597251|NCT00160199|528695752|FG001|Overall Study|Adverse Event|14|||
146597252|NCT00160199|528695751|FG000|Overall Study|Lack of Efficacy|0|||
146597253|NCT00160199|528695752|FG001|Overall Study|Lack of Efficacy|1|||
146597254|NCT00160199|528695751|FG000|Overall Study|Lost to Follow-up|7|||
146597255|NCT00160199|528695752|FG001|Overall Study|Lost to Follow-up|7|||
146597256|NCT00160199|528695751|FG000|Overall Study|Withdrawal by Subject|4|||
146597257|NCT00160199|528695752|FG001|Overall Study|Withdrawal by Subject|6|||
146597258|NCT00160199|528695751|FG000|Overall Study|Administrative|0|||
146597259|NCT00160199|528695752|FG001|Overall Study|Administrative|1|||
146597260|NCT00160199|528695751|FG000|Overall Study|Protocol Violation|8|||
146597261|NCT00160199|528695752|FG001|Overall Study|Protocol Violation|8|||
146597262|NCT01710527|528695753|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
146597263|NCT01710527|528695754|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
146597264|NCT02124772|528695755|FG000|Overall Study|Lack of Efficacy|2|||
146597265|NCT02124772|528695756|FG001|Overall Study|Lack of Efficacy|0|||
146597266|NCT02124772|528695757|FG002|Overall Study|Lack of Efficacy|0|||
146597267|NCT02124772|528695758|FG003|Overall Study|Lack of Efficacy|1|||
146597268|NCT02124772|528695759|FG004|Overall Study|Lack of Efficacy|2|||
146771563|NCT05061693|529331237|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146597269|NCT02124772|528695760|FG005|Overall Study|Lack of Efficacy|3|||
146597270|NCT02124772|528695761|FG006|Overall Study|Lack of Efficacy|0|||
146597271|NCT02124772|528695762|FG007|Overall Study|Lack of Efficacy|2|||
146597272|NCT02124772|528695763|FG008|Overall Study|Lack of Efficacy|0|||
146771564|NCT05061693|529331238|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146771565|NCT05061693|529331239|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146771566|NCT05061693|529331240|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146771567|NCT05061693|529331229|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
146771568|NCT05061693|529331230|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
146771569|NCT05061693|529331231|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
146771570|NCT05061693|529331232|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
146597273|NCT02124772|528695764|FG009|Overall Study|Lack of Efficacy|1|||
146771571|NCT05061693|529331233|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
146771572|NCT05061693|529331234|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
146771573|NCT05061693|529331235|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
146771574|NCT05061693|529331236|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
146771575|NCT05061693|529331237|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
146597274|NCT02124772|528695765|FG010|Overall Study|Lack of Efficacy|0|||
146597275|NCT02124772|528695766|FG011|Overall Study|Lack of Efficacy|0|||
146597276|NCT02124772|528695767|FG012|Overall Study|Lack of Efficacy|1|||
146597277|NCT02124772|528695755|FG000|Overall Study|Adverse Event|1|||
146597278|NCT02124772|528695756|FG001|Overall Study|Adverse Event|4|||
146597279|NCT02124772|528695757|FG002|Overall Study|Adverse Event|1|||
146597280|NCT02124772|528695758|FG003|Overall Study|Adverse Event|5|||
146597281|NCT02124772|528695759|FG004|Overall Study|Adverse Event|2|||
146597282|NCT02124772|528695760|FG005|Overall Study|Adverse Event|1|||
146597283|NCT02124772|528695761|FG006|Overall Study|Adverse Event|1|||
146597284|NCT02124772|528695762|FG007|Overall Study|Adverse Event|5|||
146597285|NCT02124772|528695763|FG008|Overall Study|Adverse Event|0|||
146597286|NCT02124772|528695764|FG009|Overall Study|Adverse Event|3|||
146597287|NCT02124772|528695765|FG010|Overall Study|Adverse Event|1|||
146597288|NCT02124772|528695766|FG011|Overall Study|Adverse Event|3|||
146771576|NCT05061693|529331238|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
146771577|NCT05061693|529331239|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
146771578|NCT05061693|529331240|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
146771579|NCT05061693|529331229|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
146771580|NCT05061693|529331230|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
146771581|NCT05061693|529331231|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
146771582|NCT05061693|529331232|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
146771583|NCT05061693|529331233|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
146771584|NCT05061693|529331234|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
146771585|NCT05061693|529331235|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
146771586|NCT05061693|529331236|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
146771587|NCT05061693|529331237|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
146771588|NCT05061693|529331238|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
146771589|NCT05061693|529331239|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
146771590|NCT05061693|529331240|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
146920355|NCT00423085|529871356|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
146920356|NCT00423085|529871357|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
146920357|NCT00423085|529871358|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
146920358|NCT00423085|529871355|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
146920359|NCT00423085|529871356|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
146920360|NCT00423085|529871357|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
146597289|NCT02124772|528695767|FG012|Overall Study|Adverse Event|1|||
146597290|NCT02124772|528695755|FG000|Overall Study|Withdrawal consent|0|||
146597291|NCT02124772|528695756|FG001|Overall Study|Withdrawal consent|1|||
146597292|NCT02124772|528695757|FG002|Overall Study|Withdrawal consent|1|||
146597293|NCT02124772|528695758|FG003|Overall Study|Withdrawal consent|1|||
146597294|NCT02124772|528695759|FG004|Overall Study|Withdrawal consent|0|||
146597295|NCT02124772|528695760|FG005|Overall Study|Withdrawal consent|1|||
146597296|NCT02124772|528695761|FG006|Overall Study|Withdrawal consent|1|||
146597297|NCT02124772|528695762|FG007|Overall Study|Withdrawal consent|0|||
146597298|NCT02124772|528695763|FG008|Overall Study|Withdrawal consent|0|||
146597299|NCT02124772|528695764|FG009|Overall Study|Withdrawal consent|1|||
146597300|NCT02124772|528695765|FG010|Overall Study|Withdrawal consent|0|||
146597301|NCT02124772|528695766|FG011|Overall Study|Withdrawal consent|1|||
146771591|NCT05061693|529331229|FG000|24-week Extension Period|Adverse Event|0|||
146771592|NCT05061693|529331230|FG001|24-week Extension Period|Adverse Event|0|||
146597302|NCT02124772|528695767|FG012|Overall Study|Withdrawal consent|0|||
146597303|NCT02124772|528695755|FG000|Overall Study|Investigator discretion|0|||
146597304|NCT02124772|528695756|FG001|Overall Study|Investigator discretion|2|||
146597305|NCT02124772|528695757|FG002|Overall Study|Investigator discretion|2|||
146597306|NCT02124772|528695758|FG003|Overall Study|Investigator discretion|1|||
146597307|NCT02124772|528695759|FG004|Overall Study|Investigator discretion|1|||
146597308|NCT02124772|528695760|FG005|Overall Study|Investigator discretion|0|||
146597309|NCT02124772|528695761|FG006|Overall Study|Investigator discretion|1|||
146597310|NCT02124772|528695762|FG007|Overall Study|Investigator discretion|0|||
146597311|NCT02124772|528695763|FG008|Overall Study|Investigator discretion|0|||
146597312|NCT02124772|528695764|FG009|Overall Study|Investigator discretion|1|||
146597313|NCT02124772|528695765|FG010|Overall Study|Investigator discretion|0|||
146597314|NCT02124772|528695766|FG011|Overall Study|Investigator discretion|1|||
146597315|NCT02124772|528695767|FG012|Overall Study|Investigator discretion|0|||
146597316|NCT02124772|528695755|FG000|Overall Study|Progressive disease|0|||
146597317|NCT02124772|528695756|FG001|Overall Study|Progressive disease|0|||
146597318|NCT02124772|528695757|FG002|Overall Study|Progressive disease|0|||
146597319|NCT02124772|528695758|FG003|Overall Study|Progressive disease|0|||
146597320|NCT02124772|528695759|FG004|Overall Study|Progressive disease|0|||
146597321|NCT02124772|528695760|FG005|Overall Study|Progressive disease|0|||
146597322|NCT02124772|528695761|FG006|Overall Study|Progressive disease|1|||
146597323|NCT02124772|528695762|FG007|Overall Study|Progressive disease|1|||
146597324|NCT02124772|528695763|FG008|Overall Study|Progressive disease|0|||
146597325|NCT02124772|528695764|FG009|Overall Study|Progressive disease|0|||
146597326|NCT02124772|528695765|FG010|Overall Study|Progressive disease|0|||
146597327|NCT02124772|528695766|FG011|Overall Study|Progressive disease|0|||
146597328|NCT02124772|528695767|FG012|Overall Study|Progressive disease|0|||
146597329|NCT02124772|528695755|FG000|Overall Study|Other|0|||
146597330|NCT02124772|528695756|FG001|Overall Study|Other|7|||
146597331|NCT02124772|528695757|FG002|Overall Study|Other|2|||
146597332|NCT02124772|528695758|FG003|Overall Study|Other|5|||
146597333|NCT02124772|528695759|FG004|Overall Study|Other|4|||
146597334|NCT02124772|528695760|FG005|Overall Study|Other|3|||
146597335|NCT02124772|528695761|FG006|Overall Study|Other|4|||
146597336|NCT02124772|528695762|FG007|Overall Study|Other|1|||
146597337|NCT02124772|528695763|FG008|Overall Study|Other|1|||
146597338|NCT02124772|528695764|FG009|Overall Study|Other|1|||
146597339|NCT02124772|528695765|FG010|Overall Study|Other|1|||
146597340|NCT02124772|528695766|FG011|Overall Study|Other|1|||
146597341|NCT02124772|528695767|FG012|Overall Study|Other|0|||
146597342|NCT02827500|528695768|FG000|Overall Study|Death|7|||
146597343|NCT02827500|528695769|FG001|Overall Study|Death|3|||
146597344|NCT02827500|528695768|FG000|Overall Study|Lost to Follow-up|1|||
146597345|NCT02827500|528695769|FG001|Overall Study|Lost to Follow-up|1|||
146597346|NCT02827500|528695768|FG000|Overall Study|Withdrawal by Subject|3|||
146597347|NCT02827500|528695769|FG001|Overall Study|Withdrawal by Subject|1|||
146597348|NCT02827500|528695768|FG000|Overall Study|Missing primary endpoint data|3|||
146597349|NCT02827500|528695769|FG001|Overall Study|Missing primary endpoint data|1|||
146597350|NCT02827500|528695768|FG000|Overall Study|Other|5|||
146597351|NCT02827500|528695769|FG001|Overall Study|Other|1|||
146597352|NCT03089944|528695772|FG000|Overall Study|Lost to Follow-up|8|||
146597353|NCT03089944|528695772|FG000|Overall Study|Withdrew Consent|2|||
146597354|NCT03089944|528695772|FG000|Overall Study|Adverse Event|1|||
146597355|NCT03089944|528695772|FG000|Overall Study|Other|1|||
146597356|NCT01636713|528695773|FG000|Overall Study|Adverse Event|16|||
146597357|NCT01636713|528695774|FG001|Overall Study|Adverse Event|16|||
146597358|NCT01636713|528695775|FG002|Overall Study|Adverse Event|7|||
146653966|NCT03977454|528910657|FG000|Overall Study|immediate postoperative revision|2|||
146653967|NCT03977454|528910658|FG001|Overall Study|immediate postoperative revision|2|||
146653968|NCT01609478|528910663|FG000|Overall Study|Adverse Event|3|||
146653969|NCT01609478|528910664|FG001|Overall Study|Adverse Event|1|||
146653970|NCT01609478|528910665|FG002|Overall Study|Adverse Event|5|||
146653971|NCT01609478|528910663|FG000|Overall Study|Protocol Deviation|0|||
146653972|NCT01609478|528910664|FG001|Overall Study|Protocol Deviation|1|||
146653973|NCT01609478|528910665|FG002|Overall Study|Protocol Deviation|1|||
146653974|NCT01609478|528910663|FG000|Overall Study|Non-Compliance with study treatment|1|||
146597359|NCT01636713|528695773|FG000|Overall Study|Lack of Efficacy|6|||
146597360|NCT01636713|528695774|FG001|Overall Study|Lack of Efficacy|6|||
146597361|NCT01636713|528695775|FG002|Overall Study|Lack of Efficacy|2|||
146597362|NCT01636713|528695773|FG000|Overall Study|Protocol Violation|3|||
146597363|NCT01636713|528695774|FG001|Overall Study|Protocol Violation|0|||
146597364|NCT01636713|528695775|FG002|Overall Study|Protocol Violation|1|||
146597365|NCT01636713|528695773|FG000|Overall Study|Lost to Follow-up|0|||
146597366|NCT01636713|528695774|FG001|Overall Study|Lost to Follow-up|0|||
146597367|NCT01636713|528695775|FG002|Overall Study|Lost to Follow-up|1|||
146597368|NCT01636713|528695773|FG000|Overall Study|Withdrawal by Subject|5|||
146653975|NCT01609478|528910664|FG001|Overall Study|Non-Compliance with study treatment|0|||
146653976|NCT01609478|528910665|FG002|Overall Study|Non-Compliance with study treatment|0|||
146597369|NCT01636713|528695774|FG001|Overall Study|Withdrawal by Subject|4|||
146597370|NCT01636713|528695775|FG002|Overall Study|Withdrawal by Subject|8|||
146597371|NCT01636713|528695773|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
146597372|NCT01636713|528695774|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
146597373|NCT01636713|528695775|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
146597374|NCT03689244|528695776|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
146597375|NCT03689244|528695777|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
146597376|NCT03689244|528695778|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
146597377|NCT03689244|528695779|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
146597378|NCT03689244|528695776|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
146597379|NCT03689244|528695777|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
146597380|NCT03689244|528695778|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
146597381|NCT03689244|528695779|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
146597382|NCT03689244|528695776|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
146597383|NCT03689244|528695777|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
146597384|NCT03689244|528695778|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
146597385|NCT03689244|528695779|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
146597386|NCT03689244|528695776|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
146597387|NCT03689244|528695777|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
146597388|NCT03689244|528695778|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
146597389|NCT03689244|528695779|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
146597390|NCT03689244|528695776|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
146597391|NCT03689244|528695777|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
146597392|NCT03689244|528695778|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
146597393|NCT03689244|528695779|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
146597394|NCT03689244|528695776|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
146597395|NCT03689244|528695777|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
146597396|NCT03689244|528695778|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
146597397|NCT03689244|528695779|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
146597398|NCT03689244|528695776|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
146597399|NCT03689244|528695777|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
146597400|NCT03689244|528695778|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
146597401|NCT03689244|528695779|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
146597402|NCT03689244|528695776|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
146597403|NCT03689244|528695777|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
146597404|NCT03689244|528695778|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
146597405|NCT03689244|528695779|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
146597406|NCT02308488|528695782|FG000|Overall Study|Withdrawal by Subject|2|||
146597407|NCT01541917|528695783|FG000|Overall Study|Lost to Follow-up|2|||
146597408|NCT01541917|528695784|FG001|Overall Study|Lost to Follow-up|2|||
146597409|NCT01541917|528695783|FG000|Overall Study|Withdrawal by Subject|13|||
146597410|NCT01541917|528695784|FG001|Overall Study|Withdrawal by Subject|7|||
146597411|NCT01739803|528695785|FG000|Overall Study|Lost to Follow-up|9|||
146597412|NCT01739803|528695786|FG001|Overall Study|Lost to Follow-up|6|||
146597413|NCT03759041|528695796|FG000|Overall Study|Withdrawal by Subject|4|||
146597414|NCT03759041|528695797|FG001|Overall Study|Withdrawal by Subject|10|||
146597415|NCT03759041|528695798|FG002|Overall Study|Withdrawal by Subject|10|||
146597416|NCT03759041|528695796|FG000|Overall Study|Adverse Event|1|||
146597417|NCT03759041|528695797|FG001|Overall Study|Adverse Event|3|||
146597418|NCT03759041|528695798|FG002|Overall Study|Adverse Event|4|||
146597419|NCT03759041|528695796|FG000|Overall Study|Lack of Efficacy|0|||
146597420|NCT03759041|528695797|FG001|Overall Study|Lack of Efficacy|0|||
146597421|NCT03759041|528695798|FG002|Overall Study|Lack of Efficacy|1|||
146597422|NCT03759041|528695796|FG000|Overall Study|Study Terminated by Sponsor|15|||
146597423|NCT03759041|528695797|FG001|Overall Study|Study Terminated by Sponsor|16|||
146597424|NCT03759041|528695798|FG002|Overall Study|Study Terminated by Sponsor|10|||
146597425|NCT03759041|528695796|FG000|Overall Study|Other reason for discontinuation|0|||
146597426|NCT03759041|528695797|FG001|Overall Study|Other reason for discontinuation|2|||
146597427|NCT03759041|528695798|FG002|Overall Study|Other reason for discontinuation|1|||
146597428|NCT03759041|528695796|FG000|Overall Study|Lost to Follow-up|7|||
146597429|NCT03759041|528695797|FG001|Overall Study|Lost to Follow-up|2|||
146597430|NCT03759041|528695798|FG002|Overall Study|Lost to Follow-up|2|||
146597431|NCT03759041|528695796|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
146597432|NCT03759041|528695797|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
146597433|NCT03759041|528695798|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
146597434|NCT00525824|528695804|FG000|Overall Study|Adverse Event|7|||
146597435|NCT00525824|528695805|FG001|Overall Study|Adverse Event|11|||
146597436|NCT00525824|528695806|FG002|Overall Study|Adverse Event|6|||
146597437|NCT00525824|528695807|FG003|Overall Study|Adverse Event|7|||
146653977|NCT01609478|528910663|FG000|Overall Study|Physician Decision|1|||
146653978|NCT01609478|528910664|FG001|Overall Study|Physician Decision|0|||
146653979|NCT01609478|528910665|FG002|Overall Study|Physician Decision|1|||
146653980|NCT01609478|528910663|FG000|Overall Study|Withdrawal by Subject|2|||
146597438|NCT00525824|528695804|FG000|Overall Study|Withdrawal by Subject|5|||
146597439|NCT00525824|528695805|FG001|Overall Study|Withdrawal by Subject|9|||
146597440|NCT00525824|528695806|FG002|Overall Study|Withdrawal by Subject|3|||
146597441|NCT00525824|528695807|FG003|Overall Study|Withdrawal by Subject|4|||
146597442|NCT00525824|528695804|FG000|Overall Study|Lost to Follow-up|4|||
146597443|NCT00525824|528695805|FG001|Overall Study|Lost to Follow-up|2|||
146597444|NCT00525824|528695806|FG002|Overall Study|Lost to Follow-up|4|||
146597445|NCT00525824|528695807|FG003|Overall Study|Lost to Follow-up|0|||
146597446|NCT00525824|528695804|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
146597447|NCT00525824|528695805|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
146597448|NCT00525824|528695806|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
146597449|NCT00525824|528695807|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
146597450|NCT00525824|528695804|FG000|Overall Study|Severe non-compliance|0|||
146597451|NCT00525824|528695805|FG001|Overall Study|Severe non-compliance|1|||
146597452|NCT00525824|528695806|FG002|Overall Study|Severe non-compliance|1|||
146597453|NCT00525824|528695807|FG003|Overall Study|Severe non-compliance|1|||
146597454|NCT00525824|528695804|FG000|Overall Study|Safety reasons|1|||
146597455|NCT00525824|528695805|FG001|Overall Study|Safety reasons|0|||
146597456|NCT00525824|528695806|FG002|Overall Study|Safety reasons|1|||
146597457|NCT00525824|528695807|FG003|Overall Study|Safety reasons|0|||
146597458|NCT00525824|528695804|FG000|Overall Study|Other|1|||
146597459|NCT00525824|528695805|FG001|Overall Study|Other|3|||
146597460|NCT00525824|528695806|FG002|Overall Study|Other|3|||
146597461|NCT00525824|528695807|FG003|Overall Study|Other|1|||
146597462|NCT01490294|528695812|FG000|Overall Study|Prematurely discontinuation|4|||
146597463|NCT01490294|528695813|FG001|Overall Study|Prematurely discontinuation|0|||
146597464|NCT01490294|528695814|FG002|Overall Study|Prematurely discontinuation|1|||
146597465|NCT01490294|528695815|FG003|Overall Study|Prematurely discontinuation|1|||
146597466|NCT01490294|528695812|FG000|Overall Study|Adverse Event|1|||
146597467|NCT01490294|528695813|FG001|Overall Study|Adverse Event|0|||
146597468|NCT01490294|528695814|FG002|Overall Study|Adverse Event|0|||
146597469|NCT01490294|528695815|FG003|Overall Study|Adverse Event|0|||
146597470|NCT01751776|528695818|FG000|Overall Study|Adverse Event|0|||
146597471|NCT01751776|528695819|FG001|Overall Study|Adverse Event|0|||
146597472|NCT01751776|528695820|FG002|Overall Study|Adverse Event|0|||
146597473|NCT01751776|528695821|FG003|Overall Study|Adverse Event|0|||
146597474|NCT01751776|528695822|FG004|Overall Study|Adverse Event|0|||
146597475|NCT01751776|528695823|FG005|Overall Study|Adverse Event|0|||
146597476|NCT01751776|528695824|FG006|Overall Study|Adverse Event|4|||
146597477|NCT01751776|528695825|FG007|Overall Study|Adverse Event|2|||
146597478|NCT01751776|528695818|FG000|Overall Study|Consent withdrawn|0|||
146597479|NCT01751776|528695819|FG001|Overall Study|Consent withdrawn|0|||
146597480|NCT01751776|528695820|FG002|Overall Study|Consent withdrawn|0|||
146597481|NCT01751776|528695821|FG003|Overall Study|Consent withdrawn|0|||
146597482|NCT01751776|528695822|FG004|Overall Study|Consent withdrawn|0|||
146597483|NCT01751776|528695823|FG005|Overall Study|Consent withdrawn|0|||
146597484|NCT01751776|528695824|FG006|Overall Study|Consent withdrawn|0|||
146597485|NCT01751776|528695825|FG007|Overall Study|Consent withdrawn|1|||
146597486|NCT01751776|528695818|FG000|Overall Study|Other reason not specified above|0|||
146597487|NCT01751776|528695819|FG001|Overall Study|Other reason not specified above|0|||
146597488|NCT01751776|528695820|FG002|Overall Study|Other reason not specified above|0|||
146920361|NCT00423085|529871358|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
146597489|NCT01751776|528695821|FG003|Overall Study|Other reason not specified above|0|||
146597490|NCT01751776|528695822|FG004|Overall Study|Other reason not specified above|0|||
146597491|NCT01751776|528695823|FG005|Overall Study|Other reason not specified above|0|||
146597492|NCT01751776|528695824|FG006|Overall Study|Other reason not specified above|0|||
146597493|NCT01751776|528695825|FG007|Overall Study|Other reason not specified above|1|||
146597494|NCT00160654|528695826|FG000|Overall Study|Adverse Event|14|||
146597495|NCT00160654|528695826|FG000|Overall Study|Lack of Efficacy|4|||
146597496|NCT00160654|528695826|FG000|Overall Study|Lost to Follow-up|2|||
146597497|NCT00160654|528695826|FG000|Overall Study|Intake of expired drug|7|||
146597498|NCT00160654|528695826|FG000|Overall Study|Psychological trauma|1|||
146597499|NCT00160654|528695826|FG000|Overall Study|Sponsor decision|1|||
146597500|NCT00160654|528695826|FG000|Overall Study|Patient met exclusion criteria|1|||
146653981|NCT01609478|528910664|FG001|Overall Study|Withdrawal by Subject|0|||
146920362|NCT00423085|529871355|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
146920363|NCT00423085|529871356|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
146920364|NCT00423085|529871357|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
146597501|NCT00160654|528695826|FG000|Overall Study|Patient decision|1|||
146597502|NCT00160654|528695826|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
146597503|NCT00160654|528695826|FG000|Overall Study|Met exclusion criteria|1|||
146597504|NCT00528996|528697296|FG000|Overall Study|Other reasons than listing|6|||
146597505|NCT00528996|528697297|FG001|Overall Study|Other reasons than listing|7|||
146597506|NCT00528996|528697298|FG002|Overall Study|Other reasons than listing|14|||
146597507|NCT00528996|528697299|FG003|Overall Study|Other reasons than listing|11|||
146920365|NCT00423085|529871358|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
146597508|NCT00528996|528697300|FG004|Overall Study|Other reasons than listing|5|||
146597509|NCT00528996|528697296|FG000|Overall Study|Refused continue medication|16|||
146597510|NCT00528996|528697297|FG001|Overall Study|Refused continue medication|0|||
146597511|NCT00528996|528697298|FG002|Overall Study|Refused continue medication|3|||
146597512|NCT00528996|528697299|FG003|Overall Study|Refused continue medication|3|||
146597513|NCT00528996|528697300|FG004|Overall Study|Refused continue medication|6|||
146597514|NCT00528996|528697296|FG000|Overall Study|Lost to Follow-up|2|||
146597515|NCT00528996|528697297|FG001|Overall Study|Lost to Follow-up|0|||
146597516|NCT00528996|528697298|FG002|Overall Study|Lost to Follow-up|4|||
146597517|NCT00528996|528697299|FG003|Overall Study|Lost to Follow-up|1|||
146597518|NCT00528996|528697300|FG004|Overall Study|Lost to Follow-up|3|||
146597519|NCT00528996|528697296|FG000|Overall Study|Protocol Violation|1|||
146597520|NCT00528996|528697297|FG001|Overall Study|Protocol Violation|2|||
146653982|NCT01609478|528910665|FG002|Overall Study|Withdrawal by Subject|2|||
146597521|NCT00528996|528697298|FG002|Overall Study|Protocol Violation|3|||
146597522|NCT00528996|528697299|FG003|Overall Study|Protocol Violation|3|||
146597523|NCT00528996|528697300|FG004|Overall Study|Protocol Violation|2|||
146597524|NCT00528996|528697296|FG000|Overall Study|Lack of Efficacy|7|||
146597525|NCT00528996|528697297|FG001|Overall Study|Lack of Efficacy|2|||
146597526|NCT00528996|528697298|FG002|Overall Study|Lack of Efficacy|1|||
146597527|NCT00528996|528697299|FG003|Overall Study|Lack of Efficacy|3|||
146653983|NCT02241889|528910670|FG000|Overall Study|device issues|0|||
146653984|NCT02241889|528910671|FG001|Overall Study|device issues|0|||
146653985|NCT02241889|528910672|FG002|Overall Study|device issues|1|||
146653986|NCT02241889|528910673|FG003|Overall Study|device issues|0|||
146653987|NCT02241889|528910674|FG004|Overall Study|device issues|0|||
146653988|NCT02241889|528910675|FG005|Overall Study|device issues|0|||
146653989|NCT02241889|528910670|FG000|Overall Study|Withdrawal by Subject|0|||
146653990|NCT02241889|528910671|FG001|Overall Study|Withdrawal by Subject|0|||
146653991|NCT02241889|528910672|FG002|Overall Study|Withdrawal by Subject|0|||
146653992|NCT02241889|528910673|FG003|Overall Study|Withdrawal by Subject|0|||
146653993|NCT02241889|528910674|FG004|Overall Study|Withdrawal by Subject|0|||
146653994|NCT02241889|528910675|FG005|Overall Study|Withdrawal by Subject|1|||
146653995|NCT01853618|528910676|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
146653996|NCT01853618|528910677|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
146653997|NCT01853618|528910678|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
146653998|NCT01853618|528910679|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
146653999|NCT01853618|528910680|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
146654000|NCT01853618|528910676|FG000|Overall Study|Progressive disease|1|||
146654001|NCT01853618|528910677|FG001|Overall Study|Progressive disease|1|||
146654002|NCT01853618|528910678|FG002|Overall Study|Progressive disease|1|||
146654003|NCT01853618|528910679|FG003|Overall Study|Progressive disease|1|||
146654004|NCT01853618|528910680|FG004|Overall Study|Progressive disease|2|||
146654005|NCT01853618|528910676|FG000|Overall Study|Physician Decision|0|||
146654006|NCT01853618|528910677|FG001|Overall Study|Physician Decision|1|||
146654007|NCT01853618|528910678|FG002|Overall Study|Physician Decision|1|||
146654008|NCT01853618|528910679|FG003|Overall Study|Physician Decision|0|||
146654009|NCT01853618|528910680|FG004|Overall Study|Physician Decision|0|||
146654010|NCT01853618|528910676|FG000|Overall Study|Refused further treatment|0|||
146654011|NCT01853618|528910677|FG001|Overall Study|Refused further treatment|0|||
146654012|NCT01853618|528910678|FG002|Overall Study|Refused further treatment|0|||
146654013|NCT01853618|528910679|FG003|Overall Study|Refused further treatment|0|||
146654014|NCT01853618|528910680|FG004|Overall Study|Refused further treatment|1|||
146654015|NCT01658813|528910681|FG000|Overall Study|Disease progression|3|||
146654016|NCT02398227|528910686|FG000|Overall Study|Lost to Follow-up|21|||
146654017|NCT02398227|528910687|FG001|Overall Study|Lost to Follow-up|12|||
146654018|NCT02398227|528910686|FG000|Overall Study|Withdrawal by Subject|5|||
146654019|NCT02398227|528910687|FG001|Overall Study|Withdrawal by Subject|6|||
146654020|NCT02398227|528910686|FG000|Overall Study|Removed from treatment and dropped out|1|||
146654021|NCT02398227|528910687|FG001|Overall Study|Removed from treatment and dropped out|0|||
146654022|NCT02009384|528910688|FG000|Overall Study|Death|2|||
146654023|NCT00722371|528910689|FG000|Overall Study|Adverse Event|6|||
146654024|NCT00722371|528910690|FG001|Overall Study|Adverse Event|13|||
146654025|NCT00722371|528910691|FG002|Overall Study|Adverse Event|9|||
146654026|NCT00722371|528910692|FG003|Overall Study|Adverse Event|10|||
146654027|NCT00722371|528910693|FG004|Overall Study|Adverse Event|6|||
146654028|NCT00722371|528910694|FG005|Overall Study|Adverse Event|8|||
146654029|NCT00722371|528910695|FG006|Overall Study|Adverse Event|4|||
146654030|NCT00722371|528910689|FG000|Overall Study|Contraindication|0|||
146597528|NCT00528996|528697300|FG004|Overall Study|Lack of Efficacy|3|||
146597529|NCT00528996|528697296|FG000|Overall Study|Adverse Event|32|||
146597530|NCT00528996|528697297|FG001|Overall Study|Adverse Event|13|||
146597531|NCT00528996|528697298|FG002|Overall Study|Adverse Event|18|||
146654031|NCT00722371|528910690|FG001|Overall Study|Contraindication|0|||
146654032|NCT00722371|528910691|FG002|Overall Study|Contraindication|1|||
146654033|NCT00722371|528910692|FG003|Overall Study|Contraindication|0|||
146654034|NCT00722371|528910693|FG004|Overall Study|Contraindication|0|||
146654035|NCT00722371|528910694|FG005|Overall Study|Contraindication|0|||
146654036|NCT00722371|528910695|FG006|Overall Study|Contraindication|0|||
146597532|NCT00528996|528697299|FG003|Overall Study|Adverse Event|29|||
146654037|NCT00722371|528910689|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
146654038|NCT00722371|528910690|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
146597533|NCT00528996|528697300|FG004|Overall Study|Adverse Event|18|||
146597534|NCT02831933|528697302|FG000|Overall Study|Physician Decision|11|||
146654039|NCT00722371|528910691|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
146597535|NCT05065190|528697306|FG000|Overall Study|Other than listed|2|||
146597536|NCT05065190|528697307|FG001|Overall Study|Other than listed|12|||
146597537|NCT05065190|528697306|FG000|Overall Study|Lack of Efficacy|4|||
146597538|NCT05065190|528697307|FG001|Overall Study|Lack of Efficacy|0|||
146597539|NCT05065190|528697306|FG000|Overall Study|Adverse Event|1|||
146597540|NCT05065190|528697307|FG001|Overall Study|Adverse Event|10|||
146597541|NCT04938037|528697308|FG000|Overall Study|Lost to Follow-up|4|||
146597542|NCT04938037|528697309|FG001|Overall Study|Lost to Follow-up|3|||
146597543|NCT03323736|528697312|FG000|Overall Study|Screen Failure|14|||
146597544|NCT03323736|528697313|FG001|Overall Study|Screen Failure|9|||
146597545|NCT03323736|528697314|FG002|Overall Study|Screen Failure|1|||
146597546|NCT03323736|528697312|FG000|Overall Study|Withdrawal Before Treatment|3|||
146597547|NCT03323736|528697313|FG001|Overall Study|Withdrawal Before Treatment|1|||
146597548|NCT03323736|528697314|FG002|Overall Study|Withdrawal Before Treatment|1|||
146654040|NCT00722371|528910692|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
146654041|NCT00722371|528910693|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
146654042|NCT00722371|528910694|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
146654043|NCT00722371|528910695|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
146654044|NCT00722371|528910689|FG000|Overall Study|Excluded medication|0|||
146654045|NCT00722371|528910690|FG001|Overall Study|Excluded medication|1|||
146654046|NCT00722371|528910691|FG002|Overall Study|Excluded medication|1|||
146654047|NCT00722371|528910692|FG003|Overall Study|Excluded medication|0|||
146654048|NCT00722371|528910693|FG004|Overall Study|Excluded medication|0|||
146654049|NCT00722371|528910694|FG005|Overall Study|Excluded medication|0|||
146654050|NCT00722371|528910695|FG006|Overall Study|Excluded medication|1|||
146654051|NCT00722371|528910689|FG000|Overall Study|Hyperglycemia|2|||
146654052|NCT00722371|528910690|FG001|Overall Study|Hyperglycemia|6|||
146654053|NCT00722371|528910691|FG002|Overall Study|Hyperglycemia|4|||
146654054|NCT00722371|528910692|FG003|Overall Study|Hyperglycemia|2|||
146654055|NCT00722371|528910693|FG004|Overall Study|Hyperglycemia|5|||
146654056|NCT00722371|528910694|FG005|Overall Study|Hyperglycemia|1|||
146654057|NCT00722371|528910695|FG006|Overall Study|Hyperglycemia|1|||
146654058|NCT00722371|528910689|FG000|Overall Study|Hypoglycemia|1|||
146654059|NCT00722371|528910690|FG001|Overall Study|Hypoglycemia|0|||
146654060|NCT00722371|528910691|FG002|Overall Study|Hypoglycemia|0|||
146654061|NCT00722371|528910692|FG003|Overall Study|Hypoglycemia|0|||
146654062|NCT00722371|528910693|FG004|Overall Study|Hypoglycemia|0|||
146654063|NCT00722371|528910694|FG005|Overall Study|Hypoglycemia|0|||
146654064|NCT00722371|528910695|FG006|Overall Study|Hypoglycemia|0|||
146654065|NCT00722371|528910689|FG000|Overall Study|Lack of Efficacy|4|||
146654066|NCT00722371|528910690|FG001|Overall Study|Lack of Efficacy|6|||
146654067|NCT00722371|528910691|FG002|Overall Study|Lack of Efficacy|6|||
146654068|NCT00722371|528910692|FG003|Overall Study|Lack of Efficacy|6|||
146654069|NCT00722371|528910693|FG004|Overall Study|Lack of Efficacy|2|||
146654070|NCT00722371|528910694|FG005|Overall Study|Lack of Efficacy|3|||
146654071|NCT00722371|528910695|FG006|Overall Study|Lack of Efficacy|0|||
146654072|NCT00722371|528910689|FG000|Overall Study|Lost to Follow-up|11|||
146654073|NCT00722371|528910690|FG001|Overall Study|Lost to Follow-up|14|||
146654074|NCT00722371|528910691|FG002|Overall Study|Lost to Follow-up|21|||
146654075|NCT00722371|528910692|FG003|Overall Study|Lost to Follow-up|13|||
146654076|NCT00722371|528910693|FG004|Overall Study|Lost to Follow-up|8|||
146654077|NCT00722371|528910694|FG005|Overall Study|Lost to Follow-up|16|||
146654078|NCT00722371|528910695|FG006|Overall Study|Lost to Follow-up|13|||
146654079|NCT00722371|528910689|FG000|Overall Study|Physician Decision|5|||
146654080|NCT00722371|528910690|FG001|Overall Study|Physician Decision|2|||
146654081|NCT00722371|528910691|FG002|Overall Study|Physician Decision|2|||
146654082|NCT00722371|528910692|FG003|Overall Study|Physician Decision|5|||
146654083|NCT00722371|528910693|FG004|Overall Study|Physician Decision|2|||
146654084|NCT00722371|528910694|FG005|Overall Study|Physician Decision|3|||
146654085|NCT00722371|528910695|FG006|Overall Study|Physician Decision|4|||
146654086|NCT00722371|528910689|FG000|Overall Study|Pregnancy|1|||
146597549|NCT03323736|528697312|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
146597550|NCT03323736|528697313|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
146597551|NCT03323736|528697314|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
146597552|NCT05160766|528697316|FG000|Overall Study|Adverse Event|0|||
146597553|NCT05160766|528697317|FG001|Overall Study|Adverse Event|1|||
146597554|NCT05160766|528697318|FG002|Overall Study|Adverse Event|0|||
146597555|NCT05160766|528697319|FG003|Overall Study|Adverse Event|0|||
146597556|NCT05160766|528697316|FG000|Overall Study|COVID-19 infection|0|||
146654087|NCT00722371|528910690|FG001|Overall Study|Pregnancy|1|||
146654088|NCT00722371|528910691|FG002|Overall Study|Pregnancy|0|||
146654089|NCT00722371|528910692|FG003|Overall Study|Pregnancy|0|||
146920366|NCT00423085|529871355|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
146654090|NCT00722371|528910693|FG004|Overall Study|Pregnancy|0|||
146654091|NCT00722371|528910694|FG005|Overall Study|Pregnancy|1|||
146654092|NCT00722371|528910695|FG006|Overall Study|Pregnancy|0|||
146654093|NCT00722371|528910689|FG000|Overall Study|Protocol Violation|6|||
146654094|NCT00722371|528910690|FG001|Overall Study|Protocol Violation|1|||
146654095|NCT00722371|528910691|FG002|Overall Study|Protocol Violation|0|||
146597557|NCT05160766|528697317|FG001|Overall Study|COVID-19 infection|1|||
146597558|NCT05160766|528697318|FG002|Overall Study|COVID-19 infection|0|||
146597559|NCT05160766|528697319|FG003|Overall Study|COVID-19 infection|0|||
146597560|NCT05160766|528697316|FG000|Overall Study|travel time|1|||
146597561|NCT05160766|528697317|FG001|Overall Study|travel time|0|||
146597562|NCT05160766|528697318|FG002|Overall Study|travel time|0|||
146597563|NCT05160766|528697319|FG003|Overall Study|travel time|1|||
146597564|NCT05160766|528697316|FG000|Overall Study|Withdrawal by Subject|3|||
146597565|NCT05160766|528697317|FG001|Overall Study|Withdrawal by Subject|5|||
146597566|NCT05160766|528697318|FG002|Overall Study|Withdrawal by Subject|4|||
146597567|NCT05160766|528697319|FG003|Overall Study|Withdrawal by Subject|2|||
146597568|NCT05160766|528697316|FG000|Overall Study|Death|0|||
146597569|NCT05160766|528697317|FG001|Overall Study|Death|0|||
146597570|NCT05160766|528697318|FG002|Overall Study|Death|2|||
146597571|NCT05160766|528697319|FG003|Overall Study|Death|5|||
146597572|NCT05160766|528697316|FG000|Overall Study|Lost to Follow-up|0|||
146597573|NCT05160766|528697317|FG001|Overall Study|Lost to Follow-up|0|||
146597574|NCT05160766|528697318|FG002|Overall Study|Lost to Follow-up|1|||
146597575|NCT05160766|528697319|FG003|Overall Study|Lost to Follow-up|2|||
146597576|NCT05160766|528697316|FG000|Overall Study|No show|0|||
146597577|NCT05160766|528697317|FG001|Overall Study|No show|0|||
146597578|NCT05160766|528697318|FG002|Overall Study|No show|1|||
146597579|NCT05160766|528697319|FG003|Overall Study|No show|1|||
146597580|NCT05160766|528697316|FG000|Overall Study|Physician Decision|0|||
146597581|NCT05160766|528697317|FG001|Overall Study|Physician Decision|0|||
146597582|NCT05160766|528697318|FG002|Overall Study|Physician Decision|0|||
146597583|NCT05160766|528697319|FG003|Overall Study|Physician Decision|1|||
146597584|NCT05160766|528697316|FG000|Overall Study|Protocol Violation|0|||
146597585|NCT05160766|528697317|FG001|Overall Study|Protocol Violation|0|||
146597586|NCT05160766|528697318|FG002|Overall Study|Protocol Violation|1|||
146597587|NCT05160766|528697319|FG003|Overall Study|Protocol Violation|0|||
146597588|NCT02654236|528697320|FG000|Overall Study|Withdrawal by Subject|0|||
146597589|NCT02654236|528697321|FG001|Overall Study|Withdrawal by Subject|0|||
146597590|NCT02654236|528697322|FG002|Overall Study|Withdrawal by Subject|2|||
146597591|NCT01549873|528697323|FG000|Overall Study|Physician Decision|0|||
146597592|NCT01549873|528697324|FG001|Overall Study|Physician Decision|1|||
146597593|NCT02943915|528697325|FG000|Overall Study|Withdrawal by Subject|2|||
146597594|NCT02943915|528697326|FG001|Overall Study|Withdrawal by Subject|1|||
146597595|NCT02943915|528697327|FG002|Overall Study|Withdrawal by Subject|0|||
146597596|NCT02943915|528697328|FG003|Overall Study|Withdrawal by Subject|0|||
146597597|NCT02943915|528697325|FG000|Overall Study|Lost to Follow-up|3|||
146597598|NCT02943915|528697326|FG001|Overall Study|Lost to Follow-up|1|||
146597599|NCT02943915|528697327|FG002|Overall Study|Lost to Follow-up|0|||
146597600|NCT02943915|528697328|FG003|Overall Study|Lost to Follow-up|0|||
146597601|NCT02943915|528697325|FG000|Overall Study|excluded|0|||
146597602|NCT02943915|528697326|FG001|Overall Study|excluded|1|||
146597603|NCT02943915|528697327|FG002|Overall Study|excluded|0|||
146597604|NCT02943915|528697328|FG003|Overall Study|excluded|0|||
146597605|NCT00701805|528697329|FG000|Overall Study|Withdrawal by Subject|3|||
146597606|NCT00701805|528697330|FG001|Overall Study|Withdrawal by Subject|1|||
146597607|NCT00701805|528697331|FG002|Overall Study|Withdrawal by Subject|4|||
146597608|NCT00701805|528697332|FG003|Overall Study|Withdrawal by Subject|3|||
146597609|NCT00701805|528697329|FG000|Overall Study|Adverse Event|0|||
146597610|NCT00701805|528697330|FG001|Overall Study|Adverse Event|1|||
146597611|NCT00701805|528697331|FG002|Overall Study|Adverse Event|1|||
146597612|NCT00701805|528697332|FG003|Overall Study|Adverse Event|0|||
146597613|NCT00701805|528697329|FG000|Overall Study|Missed 7 consecutive doses|0|||
146597614|NCT00701805|528697330|FG001|Overall Study|Missed 7 consecutive doses|1|||
146597615|NCT00701805|528697331|FG002|Overall Study|Missed 7 consecutive doses|0|||
146597616|NCT00701805|528697332|FG003|Overall Study|Missed 7 consecutive doses|0|||
146597617|NCT00701805|528697329|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
146597618|NCT00701805|528697330|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
146597619|NCT00701805|528697331|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
146597620|NCT00701805|528697332|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
146597621|NCT00701805|528697329|FG000|Overall Study|Physician decision, change of therapy|0|||
146597622|NCT00701805|528697330|FG001|Overall Study|Physician decision, change of therapy|0|||
146597623|NCT00701805|528697331|FG002|Overall Study|Physician decision, change of therapy|0|||
146597624|NCT00701805|528697332|FG003|Overall Study|Physician decision, change of therapy|1|||
146597625|NCT00701805|528697329|FG000|Overall Study|Difficult to travel to dialysis site|0|||
146597626|NCT00701805|528697330|FG001|Overall Study|Difficult to travel to dialysis site|0|||
146597627|NCT00701805|528697331|FG002|Overall Study|Difficult to travel to dialysis site|1|||
146597628|NCT00701805|528697332|FG003|Overall Study|Difficult to travel to dialysis site|0|||
146597629|NCT00701805|528697329|FG000|Overall Study|Resumption criteria were not met|0|||
146597630|NCT00701805|528697330|FG001|Overall Study|Resumption criteria were not met|1|||
146597631|NCT00701805|528697331|FG002|Overall Study|Resumption criteria were not met|0|||
146597632|NCT00701805|528697332|FG003|Overall Study|Resumption criteria were not met|0|||
146597633|NCT02804750|528697338|FG000|Period 1|Adverse Event|0|||
146597634|NCT02804750|528697339|FG001|Period 1|Adverse Event|2|||
146654096|NCT00722371|528910692|FG003|Overall Study|Protocol Violation|1|||
146654097|NCT00722371|528910693|FG004|Overall Study|Protocol Violation|4|||
146654098|NCT00722371|528910694|FG005|Overall Study|Protocol Violation|2|||
146654099|NCT00722371|528910695|FG006|Overall Study|Protocol Violation|1|||
146654100|NCT00722371|528910689|FG000|Overall Study|Withdrawal by Subject|18|||
146654101|NCT00722371|528910690|FG001|Overall Study|Withdrawal by Subject|27|||
146654102|NCT00722371|528910691|FG002|Overall Study|Withdrawal by Subject|19|||
146654103|NCT00722371|528910692|FG003|Overall Study|Withdrawal by Subject|23|||
146597635|NCT02804750|528697338|FG000|Period 1|Withdrawal by Subject|0|||
146597636|NCT02804750|528697339|FG001|Period 1|Withdrawal by Subject|1|||
146597637|NCT02804750|528697338|FG000|Period 2|Adverse Event|1|||
146597638|NCT02804750|528697339|FG001|Period 2|Adverse Event|0|||
146597639|NCT02804750|528697338|FG000|Period 3|Adverse Event|0|||
146597640|NCT02804750|528697339|FG001|Period 3|Adverse Event|2|||
146597641|NCT02804750|528697338|FG000|Period 4|Adverse Event|0|||
146597642|NCT02804750|528697339|FG001|Period 4|Adverse Event|5|||
146597643|NCT02559414|528697340|FG000|Overall Study|Lost to Follow-up|0|||
146597644|NCT02559414|528697341|FG001|Overall Study|Lost to Follow-up|1|||
146597645|NCT02559414|528697342|FG002|Overall Study|Lost to Follow-up|0|||
146597646|NCT02559414|528697340|FG000|Overall Study|Withdrawal by Subject|1|||
146597647|NCT02559414|528697341|FG001|Overall Study|Withdrawal by Subject|0|||
146597648|NCT02559414|528697342|FG002|Overall Study|Withdrawal by Subject|1|||
146597649|NCT02559414|528697340|FG000|Overall Study|Other|0|||
146597650|NCT02559414|528697341|FG001|Overall Study|Other|1|||
146597651|NCT02559414|528697342|FG002|Overall Study|Other|1|||
146597652|NCT04692077|528697349|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
146597653|NCT05149313|528697350|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
146597654|NCT05149313|528697351|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
146597655|NCT05149313|528697352|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
146597656|NCT05149313|528697353|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
146597657|NCT05149313|528697350|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
146597658|NCT05149313|528697351|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
146597659|NCT05149313|528697352|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
146654104|NCT00722371|528910693|FG004|Overall Study|Withdrawal by Subject|19|||
146654105|NCT00722371|528910694|FG005|Overall Study|Withdrawal by Subject|18|||
146654106|NCT00722371|528910695|FG006|Overall Study|Withdrawal by Subject|26|||
146654107|NCT01092832|528910696|FG000|Overall Study|Other|1|||
146654108|NCT01092832|528910697|FG001|Overall Study|Other|0|||
146654109|NCT02674854|528910698|FG000|Overall Study|Adverse Event|17|||
146654110|NCT02674854|528910699|FG001|Overall Study|Adverse Event|15|||
146654111|NCT02674854|528910700|FG002|Overall Study|Adverse Event|5|||
146654112|NCT02674854|528910698|FG000|Overall Study|Withdrawal by Subject|1|||
146654113|NCT02674854|528910699|FG001|Overall Study|Withdrawal by Subject|5|||
146654114|NCT02674854|528910700|FG002|Overall Study|Withdrawal by Subject|4|||
146654115|NCT02674854|528910698|FG000|Overall Study|No-compliant subject|1|||
146654116|NCT02674854|528910699|FG001|Overall Study|No-compliant subject|0|||
146654117|NCT02674854|528910700|FG002|Overall Study|No-compliant subject|1|||
146654118|NCT02674854|528910698|FG000|Overall Study|Lost to Follow-up|1|||
146654119|NCT02674854|528910699|FG001|Overall Study|Lost to Follow-up|0|||
146654120|NCT02674854|528910700|FG002|Overall Study|Lost to Follow-up|2|||
146654121|NCT02674854|528910698|FG000|Overall Study|Lack of Efficacy|0|||
146654122|NCT02674854|528910699|FG001|Overall Study|Lack of Efficacy|3|||
146654123|NCT02674854|528910700|FG002|Overall Study|Lack of Efficacy|0|||
146654124|NCT02674854|528910698|FG000|Overall Study|Disallowed Concurrent Medication|2|||
146654125|NCT02674854|528910699|FG001|Overall Study|Disallowed Concurrent Medication|2|||
146654126|NCT02674854|528910700|FG002|Overall Study|Disallowed Concurrent Medication|0|||
146654127|NCT02674854|528910698|FG000|Overall Study|Protocol Violation|1|||
146654128|NCT02674854|528910699|FG001|Overall Study|Protocol Violation|1|||
146654129|NCT02674854|528910700|FG002|Overall Study|Protocol Violation|2|||
146654130|NCT02674854|528910698|FG000|Overall Study|Death|0|||
146654131|NCT02674854|528910699|FG001|Overall Study|Death|1|||
146654132|NCT02674854|528910700|FG002|Overall Study|Death|0|||
146597660|NCT05149313|528697353|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
146597661|NCT05149313|528697350|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
146597662|NCT05149313|528697351|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
146597663|NCT05149313|528697352|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
146654133|NCT02674854|528910698|FG000|Overall Study|Subject missed V6.2|1|||
146654134|NCT02674854|528910699|FG001|Overall Study|Subject missed V6.2|0|||
146654135|NCT02674854|528910700|FG002|Overall Study|Subject missed V6.2|0|||
146597664|NCT05149313|528697353|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
146597665|NCT05149313|528697350|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
146597666|NCT05149313|528697351|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
146654136|NCT02635646|528910702|FG000|Overall Study|Lost to Follow-up|24|||
146654137|NCT02635646|528910703|FG001|Overall Study|Lost to Follow-up|25|||
146654138|NCT02635646|528910702|FG000|Overall Study|Pregnancy|1|||
146597667|NCT05149313|528697352|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
146597668|NCT05149313|528697353|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
146597669|NCT05149313|528697350|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
146597670|NCT05149313|528697351|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
146597671|NCT05149313|528697352|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
146597672|NCT05149313|528697353|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
146597673|NCT05149313|528697350|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
146597674|NCT05149313|528697351|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
146597675|NCT05149313|528697352|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
146597676|NCT05149313|528697353|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
146597677|NCT05149313|528697350|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
146597678|NCT05149313|528697351|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
146597679|NCT05149313|528697352|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
146597680|NCT05149313|528697353|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
146597681|NCT05149313|528697350|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146597682|NCT05149313|528697351|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146597683|NCT05149313|528697352|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
146597684|NCT05149313|528697353|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
146597685|NCT05149313|528697350|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
146597686|NCT05149313|528697351|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
146597687|NCT05149313|528697352|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
146597688|NCT05149313|528697353|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
146597689|NCT05149313|528697350|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146597690|NCT05149313|528697351|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146597691|NCT05149313|528697352|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
146597692|NCT05149313|528697353|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146597693|NCT05149313|528697350|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
146597694|NCT05149313|528697351|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
146597695|NCT05149313|528697352|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
146597696|NCT05149313|528697353|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
146597697|NCT01867086|528697354|FG000|Overall Study|Disease Progression|1|||
146597698|NCT04271475|528697355|FG000|DB Period: Day 1 up to EODBT|Death|1|||
146597699|NCT04271475|528697356|FG001|DB Period: Day 1 up to EODBT|Death|0|||
146597700|NCT04271475|528697357|FG002|DB Period: Day 1 up to EODBT|Death|0|||
146597701|NCT04271475|528697358|FG003|DB Period: Day 1 up to EODBT|Death|0|||
146597702|NCT04271475|528697355|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
146597703|NCT04271475|528697356|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
146597704|NCT04271475|528697357|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
146597705|NCT04271475|528697358|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
146597706|NCT04271475|528697355|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
146597707|NCT04271475|528697356|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
146597708|NCT04271475|528697357|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
146597709|NCT04271475|528697358|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
146597710|NCT04271475|528697355|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
146597711|NCT04271475|528697356|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
146597712|NCT04271475|528697357|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
146597713|NCT04271475|528697358|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
146597714|NCT04271475|528697355|FG000|DB Period: Day 1 up to EODBT|Other|8|||
146597715|NCT04271475|528697356|FG001|DB Period: Day 1 up to EODBT|Other|5|||
146597716|NCT04271475|528697357|FG002|DB Period: Day 1 up to EODBT|Other|0|||
146597717|NCT04271475|528697358|FG003|DB Period: Day 1 up to EODBT|Other|0|||
146597718|NCT04271475|528697355|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
146597719|NCT04271475|528697356|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
146597720|NCT04271475|528697357|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
146597721|NCT04271475|528697358|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
146597722|NCT04271475|528697355|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
146597723|NCT04271475|528697356|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
146597724|NCT04271475|528697357|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
146597725|NCT04271475|528697358|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
146597726|NCT03681678|528697362|FG000|Overall Study|Lost to Follow-up|20|||
146597727|NCT04619004|528697363|FG000|Overall Study|Death|114|||
146597728|NCT04619004|528697364|FG001|Overall Study|Death|28|||
146597729|NCT04619004|528697363|FG000|Overall Study|Lost to Follow-up|1|||
146597730|NCT04619004|528697364|FG001|Overall Study|Lost to Follow-up|1|||
146597731|NCT04619004|528697363|FG000|Overall Study|Withdrawal by Subject|24|||
146597732|NCT04619004|528697364|FG001|Overall Study|Withdrawal by Subject|7|||
146597733|NCT04619004|528697363|FG000|Overall Study|Other - Not specified|0|||
146654139|NCT02635646|528910703|FG001|Overall Study|Pregnancy|1|||
146654140|NCT00913692|528910704|FG000|Screening (4 Months)|Physician Decision|3|||
146597734|NCT04619004|528697364|FG001|Overall Study|Other - Not specified|1|||
146597735|NCT01114360|528697372|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
146597736|NCT01114360|528697373|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
146597737|NCT03106415|528697374|FG000|Phase 1|Withdrawal by Subject|1|||
146597738|NCT03106415|528697375|FG001|Phase 1|Withdrawal by Subject|0|||
146597739|NCT03106415|528697376|FG002|Phase 1|Withdrawal by Subject|0|||
146597740|NCT03106415|528697374|FG000|Phase 1|Adverse Event|1|||
146597741|NCT03106415|528697375|FG001|Phase 1|Adverse Event|1|||
146597742|NCT03106415|528697376|FG002|Phase 1|Adverse Event|0|||
146597743|NCT03106415|528697374|FG000|Phase 1|Protocol Violation|0|||
146597744|NCT03106415|528697375|FG001|Phase 1|Protocol Violation|1|||
146597745|NCT03106415|528697376|FG002|Phase 1|Protocol Violation|0|||
146597746|NCT01804582|528697377|FG000|Overall Study|Lost to Follow-up|47|||
146597747|NCT01804582|528697378|FG001|Overall Study|Lost to Follow-up|56|||
146597748|NCT01804582|528697377|FG000|Overall Study|Physician Decision|2|||
146597749|NCT01804582|528697378|FG001|Overall Study|Physician Decision|0|||
146597750|NCT00159913|528697381|FG000|Overall Study|Adverse Event|1|||
146597751|NCT00159913|528697382|FG001|Overall Study|Adverse Event|0|||
146597752|NCT00159913|528697383|FG002|Overall Study|Adverse Event|1|||
146597753|NCT00159913|528697384|FG003|Overall Study|Adverse Event|0|||
146597754|NCT00159913|528697381|FG000|Overall Study|Withdrawal by Subject|0|||
146597755|NCT00159913|528697382|FG001|Overall Study|Withdrawal by Subject|0|||
146597756|NCT00159913|528697383|FG002|Overall Study|Withdrawal by Subject|0|||
146597757|NCT00159913|528697384|FG003|Overall Study|Withdrawal by Subject|1|||
146597758|NCT00159913|528697381|FG000|Overall Study|Lost to Follow-up|0|||
146597759|NCT00159913|528697382|FG001|Overall Study|Lost to Follow-up|0|||
146597760|NCT00159913|528697383|FG002|Overall Study|Lost to Follow-up|0|||
146597761|NCT00159913|528697384|FG003|Overall Study|Lost to Follow-up|1|||
146597762|NCT00159913|528697381|FG000|Overall Study|Protocol Violation|1|||
146597763|NCT00159913|528697382|FG001|Overall Study|Protocol Violation|0|||
146597764|NCT00159913|528697383|FG002|Overall Study|Protocol Violation|1|||
146597765|NCT00159913|528697384|FG003|Overall Study|Protocol Violation|0|||
146597766|NCT00385723|528697385|FG000|Overall Study|Lost to Follow-up|1|||
146597767|NCT00385723|528697386|FG001|Overall Study|Lost to Follow-up|1|||
146597768|NCT00385723|528697387|FG002|Overall Study|Lost to Follow-up|0|||
146597769|NCT00385723|528697385|FG000|Overall Study|Withdrawal by Subject|1|||
146597770|NCT00385723|528697386|FG001|Overall Study|Withdrawal by Subject|0|||
146597771|NCT00385723|528697387|FG002|Overall Study|Withdrawal by Subject|2|||
146597772|NCT01390779|528697388|FG000|Overall Study|Physician Decision|1|||
146597773|NCT03455829|528697389|FG000|Overall Study|Death|2|||
146597774|NCT03455829|528697390|FG001|Overall Study|Death|3|||
146597775|NCT03455829|528697391|FG002|Overall Study|Death|2|||
146597776|NCT03455829|528697392|FG003|Overall Study|Death|4|||
146597777|NCT03455829|528697393|FG004|Overall Study|Death|2|||
146597778|NCT03455829|528697389|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
146597779|NCT03455829|528697390|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
146597780|NCT03455829|528697391|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
146597781|NCT03455829|528697392|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
146597782|NCT03455829|528697393|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
146597783|NCT03455829|528697389|FG000|Overall Study|Disease progression|0|||
146597784|NCT03455829|528697390|FG001|Overall Study|Disease progression|0|||
146597785|NCT03455829|528697391|FG002|Overall Study|Disease progression|0|||
146597786|NCT03455829|528697392|FG003|Overall Study|Disease progression|1|||
146597787|NCT03455829|528697393|FG004|Overall Study|Disease progression|1|||
146597788|NCT03689712|528697397|FG000|Overall Study|Adverse Event|1|||
146597789|NCT03689712|528697398|FG001|Overall Study|Adverse Event|0|||
146597790|NCT03689712|528697397|FG000|Overall Study|Death|20|||
146597791|NCT03689712|528697398|FG001|Overall Study|Death|10|||
146654141|NCT00913692|528910704|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
146654142|NCT00913692|528910704|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
146654143|NCT03761797|528910705|FG000|Overall Study|Changing hospital|11|||
146654144|NCT03761797|528910705|FG000|Overall Study|Improvement/remission|6|||
146654145|NCT03761797|528910705|FG000|Overall Study|Withdrawal by Subject|19|||
146654146|NCT03761797|528910705|FG000|Overall Study|Lost to Follow-up|33|||
146654147|NCT03761797|528910705|FG000|Overall Study|Adverse Event|37|||
146654148|NCT03761797|528910705|FG000|Overall Study|Case report form (CRF) not collected|5|||
146654149|NCT03761797|528910705|FG000|Overall Study|No patient visit after entry|13|||
146654150|NCT03761797|528910705|FG000|Overall Study|Switch to other diabetes medication|10|||
146654151|NCT03761797|528910705|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
146978509|NCT00837577|530084085|FG001|Open-label Period|Other Reason|1|||
146597792|NCT03689712|528697397|FG000|Overall Study|Lost to Follow-up|6|||
146597793|NCT03689712|528697398|FG001|Overall Study|Lost to Follow-up|6|||
146597794|NCT03689712|528697397|FG000|Overall Study|Other|1|||
146597795|NCT03689712|528697398|FG001|Overall Study|Other|0|||
146597796|NCT03689712|528697397|FG000|Overall Study|Patient Non-Compliance|0|||
146597797|NCT03689712|528697398|FG001|Overall Study|Patient Non-Compliance|1|||
146597798|NCT03689712|528697397|FG000|Overall Study|Withdrawal by Subject|20|||
146978510|NCT00986154|530084086|FG000|Overall Study|Death|136|||
146978511|NCT00986154|530084087|FG001|Overall Study|Death|127|||
146978512|NCT00986154|530084086|FG000|Overall Study|Lost to Follow-up|7|||
146978513|NCT00986154|530084087|FG001|Overall Study|Lost to Follow-up|4|||
146654152|NCT03761797|528910705|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
146654153|NCT03761797|528910705|FG000|Overall Study|Insufficient effectives|2|||
146654154|NCT03761797|528910705|FG000|Overall Study|Excessive alcohol intake|1|||
146654155|NCT00879879|528910712|FG000|Overall Study|Death|1|||
146654156|NCT00879879|528910712|FG000|Overall Study|Withdrawal by Subject|1|||
146654157|NCT00879879|528910712|FG000|Overall Study|Physician Decision|1|||
146654158|NCT00645788|528910715|FG000|Overall Study|Did not receive study drug|1|||
146654159|NCT00645788|528910716|FG001|Overall Study|Did not receive study drug|1|||
146654160|NCT00645788|528910717|FG002|Overall Study|Did not receive study drug|0|||
146654161|NCT00645788|528910718|FG003|Overall Study|Did not receive study drug|0|||
146654162|NCT00645788|528910715|FG000|Overall Study|Adverse Event|4|||
146654163|NCT00645788|528910716|FG001|Overall Study|Adverse Event|9|||
146654164|NCT00645788|528910717|FG002|Overall Study|Adverse Event|5|||
146654165|NCT00645788|528910718|FG003|Overall Study|Adverse Event|3|||
146654166|NCT00645788|528910715|FG000|Overall Study|Lost to Follow-up|1|||
146654167|NCT00645788|528910716|FG001|Overall Study|Lost to Follow-up|0|||
146654168|NCT00645788|528910717|FG002|Overall Study|Lost to Follow-up|0|||
146654169|NCT00645788|528910718|FG003|Overall Study|Lost to Follow-up|0|||
146654170|NCT00645788|528910715|FG000|Overall Study|Protocol Violation|1|||
146654171|NCT00645788|528910716|FG001|Overall Study|Protocol Violation|0|||
146654172|NCT00645788|528910717|FG002|Overall Study|Protocol Violation|2|||
146654173|NCT00645788|528910718|FG003|Overall Study|Protocol Violation|0|||
146654174|NCT00645788|528910715|FG000|Overall Study|Withdrawal by Subject|0|||
146654175|NCT00645788|528910716|FG001|Overall Study|Withdrawal by Subject|1|||
146654176|NCT00645788|528910717|FG002|Overall Study|Withdrawal by Subject|0|||
146654177|NCT00645788|528910718|FG003|Overall Study|Withdrawal by Subject|2|||
146654178|NCT00645788|528910715|FG000|Overall Study|Pulmonary exacerbation|13|||
146654179|NCT00645788|528910716|FG001|Overall Study|Pulmonary exacerbation|16|||
146654180|NCT00645788|528910717|FG002|Overall Study|Pulmonary exacerbation|11|||
146654181|NCT00645788|528910718|FG003|Overall Study|Pulmonary exacerbation|9|||
146654182|NCT03149848|528910720|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
146654183|NCT03149848|528910720|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
146654184|NCT00400153|528910723|FG000|Overall Study|AE due to study disease worsening|14|||
146654185|NCT00400153|528910724|FG001|Overall Study|AE due to study disease worsening|19|||
146654186|NCT00400153|528910725|FG002|Overall Study|AE due to study disease worsening|20|||
146654187|NCT00400153|528910723|FG000|Overall Study|AE due to other disease worsening|2|||
146978514|NCT00986154|530084086|FG000|Overall Study|Withdrawal by Subject|32|||
146978515|NCT00986154|530084087|FG001|Overall Study|Withdrawal by Subject|33|||
146978516|NCT00986154|530084086|FG000|Overall Study|investigator/subject decide not continue|6|||
146978517|NCT00986154|530084087|FG001|Overall Study|investigator/subject decide not continue|3|||
146654188|NCT00400153|528910724|FG001|Overall Study|AE due to other disease worsening|1|||
146654189|NCT00400153|528910725|FG002|Overall Study|AE due to other disease worsening|0|||
146654190|NCT00400153|528910723|FG000|Overall Study|AE due to other condition|3|||
146654191|NCT00400153|528910724|FG001|Overall Study|AE due to other condition|14|||
146654192|NCT00400153|528910725|FG002|Overall Study|AE due to other condition|15|||
146654193|NCT00400153|528910723|FG000|Overall Study|Protocol Violation|7|||
146654194|NCT00400153|528910724|FG001|Overall Study|Protocol Violation|4|||
146654195|NCT00400153|528910725|FG002|Overall Study|Protocol Violation|9|||
146654196|NCT00400153|528910723|FG000|Overall Study|Lost to Follow-up|2|||
146654197|NCT00400153|528910724|FG001|Overall Study|Lost to Follow-up|1|||
146654198|NCT00400153|528910725|FG002|Overall Study|Lost to Follow-up|4|||
146654199|NCT00400153|528910723|FG000|Overall Study|Withdrawal by Subject|12|||
146654200|NCT00400153|528910724|FG001|Overall Study|Withdrawal by Subject|11|||
146654201|NCT00400153|528910725|FG002|Overall Study|Withdrawal by Subject|10|||
146654202|NCT00400153|528910723|FG000|Overall Study|Other reasons - not mentioned above|8|||
146654203|NCT00400153|528910724|FG001|Overall Study|Other reasons - not mentioned above|5|||
146654204|NCT00400153|528910725|FG002|Overall Study|Other reasons - not mentioned above|3|||
146654205|NCT00327470|528910728|FG000|Overall Study|Randomized, but not treated|0|||
146654206|NCT00327470|528910729|FG001|Overall Study|Randomized, but not treated|2|||
146920367|NCT00423085|529871356|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
146920368|NCT00423085|529871357|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
146920369|NCT00423085|529871358|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
146920370|NCT00423085|529871355|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
146920371|NCT00423085|529871356|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
146920372|NCT00423085|529871357|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
146920373|NCT00423085|529871358|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
146920374|NCT00423085|529871355|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
146920375|NCT00423085|529871356|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
146920376|NCT00423085|529871357|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
146978518|NCT00986154|530084086|FG000|Overall Study|never received study drug|25|||
146978519|NCT00986154|530084087|FG001|Overall Study|never received study drug|27|||
146654207|NCT00327470|528910728|FG000|Overall Study|Adverse Event|9|||
146654208|NCT00327470|528910729|FG001|Overall Study|Adverse Event|14|||
146654209|NCT00327470|528910728|FG000|Overall Study|Lack of Efficacy|7|||
146654210|NCT00327470|528910729|FG001|Overall Study|Lack of Efficacy|19|||
146654211|NCT00327470|528910728|FG000|Overall Study|Other|5|||
146654212|NCT00327470|528910729|FG001|Overall Study|Other|9|||
146654213|NCT00327470|528910728|FG000|Overall Study|Lost to Follow-up|1|||
146654214|NCT00327470|528910729|FG001|Overall Study|Lost to Follow-up|3|||
146654215|NCT00327470|528910728|FG000|Overall Study|Withdrawal by Subject|6|||
146920377|NCT00423085|529871358|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
146920378|NCT00423085|529871355|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
146920379|NCT00423085|529871356|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
146597799|NCT03689712|528697398|FG001|Overall Study|Withdrawal by Subject|4|||
146597800|NCT03689712|528697397|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
146597801|NCT03689712|528697398|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
146597802|NCT03689712|528697397|FG000|Overall Study|Randomized but not Treated|13|||
146597803|NCT03689712|528697398|FG001|Overall Study|Randomized but not Treated|7|||
146597804|NCT03689712|528697397|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
146597805|NCT03689712|528697398|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
146597806|NCT00689793|528697399|FG000|Overall Study|Lost to Follow-up|4|||
146597807|NCT00689793|528697400|FG001|Overall Study|Lost to Follow-up|5|||
146597808|NCT00875056|528697401|FG000|Overall Study|Adverse Event|6|||
146597809|NCT00875056|528697402|FG001|Overall Study|Adverse Event|1|||
146597810|NCT00875056|528697403|FG002|Overall Study|Adverse Event|2|||
146597811|NCT00875056|528697401|FG000|Overall Study|Progressive Disease|14|||
146597812|NCT00875056|528697402|FG001|Overall Study|Progressive Disease|8|||
146597813|NCT00875056|528697403|FG002|Overall Study|Progressive Disease|3|||
146597814|NCT00875056|528697401|FG000|Overall Study|Withdrawal by Subject|3|||
146597815|NCT00875056|528697402|FG001|Overall Study|Withdrawal by Subject|0|||
146597816|NCT00875056|528697403|FG002|Overall Study|Withdrawal by Subject|1|||
146597817|NCT02573246|528697409|FG000|Overall Study|Lost to Follow-up|2|||
146597818|NCT02573246|528697410|FG001|Overall Study|Lost to Follow-up|0|||
146597819|NCT02573246|528697411|FG002|Overall Study|Lost to Follow-up|0|||
146597820|NCT02573246|528697412|FG003|Overall Study|Lost to Follow-up|0|||
146597821|NCT02573246|528697413|FG004|Overall Study|Lost to Follow-up|1|||
146597822|NCT02573246|528697409|FG000|Overall Study|Withdrawal by Subject|0|||
146597823|NCT02573246|528697410|FG001|Overall Study|Withdrawal by Subject|0|||
146597824|NCT02573246|528697411|FG002|Overall Study|Withdrawal by Subject|0|||
146597825|NCT02573246|528697412|FG003|Overall Study|Withdrawal by Subject|0|||
146597826|NCT02573246|528697413|FG004|Overall Study|Withdrawal by Subject|1|||
146597827|NCT02573246|528697409|FG000|Overall Study|Physician Decision|1|||
146597828|NCT02573246|528697410|FG001|Overall Study|Physician Decision|1|||
146597829|NCT02573246|528697411|FG002|Overall Study|Physician Decision|3|||
146597830|NCT02573246|528697412|FG003|Overall Study|Physician Decision|2|||
146597831|NCT02573246|528697413|FG004|Overall Study|Physician Decision|2|||
146597832|NCT01902888|528697414|FG000|Overall Study|Study Terminated|3|||
146597833|NCT03149003|528697415|FG000|Overall Study|Randomized but not treated|0|||
146597834|NCT03149003|528697416|FG001|Overall Study|Randomized but not treated|1|||
146597835|NCT03149003|528697417|FG002|Overall Study|Randomized but not treated|18|||
146597836|NCT00973102|528697423|FG000|Overall Study|Protocol Violation|1|||
146597837|NCT00973102|528697424|FG001|Overall Study|Protocol Violation|0|||
146597838|NCT00973102|528697423|FG000|Overall Study|Prisoner|0|||
146597839|NCT00973102|528697424|FG001|Overall Study|Prisoner|1|||
146597840|NCT01100567|528697425|FG000|Overall Study|Withdrawal by Subject|5|||
146597841|NCT01100567|528697426|FG001|Overall Study|Withdrawal by Subject|8|||
146654216|NCT00327470|528910729|FG001|Overall Study|Withdrawal by Subject|12|||
146920380|NCT00423085|529871357|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
146597842|NCT01100567|528697425|FG000|Overall Study|Early Hospital Discharge|6|||
146597843|NCT01100567|528697426|FG001|Overall Study|Early Hospital Discharge|4|||
146920381|NCT00423085|529871358|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
146920382|NCT00423085|529871355|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
146920383|NCT00423085|529871356|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
146978520|NCT00033631|530084092|FG000|Overall Study|Protocol Violation|14|||
146597844|NCT01100567|528697425|FG000|Overall Study|Lost to Follow-up|1|||
146597845|NCT01100567|528697426|FG001|Overall Study|Lost to Follow-up|2|||
146597846|NCT01100567|528697425|FG000|Overall Study|Physician Decision|0|||
146597847|NCT01100567|528697426|FG001|Overall Study|Physician Decision|1|||
146597848|NCT01100567|528697425|FG000|Overall Study|Deemed ineligible after consent|0|||
146597849|NCT01100567|528697426|FG001|Overall Study|Deemed ineligible after consent|1|||
146597850|NCT02449018|528697427|FG000|Overall Study|Abnormal laboratory value|0|||
146597851|NCT02449018|528697428|FG001|Overall Study|Abnormal laboratory value|1|||
146597852|NCT02449018|528697427|FG000|Overall Study|Administrative problems|1|||
146597853|NCT02449018|528697428|FG001|Overall Study|Administrative problems|0|||
146597854|NCT02449018|528697427|FG000|Overall Study|Adverse Event|5|||
146597855|NCT02449018|528697428|FG001|Overall Study|Adverse Event|1|||
146654217|NCT00327470|528910728|FG000|Overall Study|Death|1|||
146597856|NCT02449018|528697427|FG000|Overall Study|Protocol deviation|4|||
146597857|NCT02449018|528697428|FG001|Overall Study|Protocol deviation|0|||
146597858|NCT02449018|528697427|FG000|Overall Study|Patient decision|2|||
146597859|NCT02449018|528697428|FG001|Overall Study|Patient decision|0|||
146597860|NCT00831701|528697451|FG000|Overall Study|Withdrawal by Subject|2|||
146597861|NCT00831701|528697452|FG001|Overall Study|Withdrawal by Subject|0|||
146597862|NCT00831701|528697451|FG000|Overall Study|Stone expulsion before first medication|2|||
146597863|NCT00831701|528697452|FG001|Overall Study|Stone expulsion before first medication|2|||
146597864|NCT00831701|528697451|FG000|Overall Study|Lost to Follow-up|1|||
146597865|NCT00831701|528697452|FG001|Overall Study|Lost to Follow-up|3|||
146597866|NCT01440881|528697453|FG000|Overall Study|Death|0|||
146597867|NCT01440881|528697454|FG001|Overall Study|Death|1|||
146597868|NCT01977690|528697457|FG000|Overall Study|Withdrawal by Subject|0|||
146597869|NCT01977690|528697458|FG001|Overall Study|Withdrawal by Subject|4|||
146597870|NCT02290938|528697460|FG000|Overall Study|Lost to Follow-up|14|||
146597871|NCT02290938|528697461|FG001|Overall Study|Lost to Follow-up|43|||
146597872|NCT02769962|528698983|FG000|Overall Study|Physician Decision|0|||
146597873|NCT02769962|528698984|FG001|Overall Study|Physician Decision|0|||
146597874|NCT02769962|528698985|FG002|Overall Study|Physician Decision|0|||
146597875|NCT02769962|528698986|FG003|Overall Study|Physician Decision|0|||
146597876|NCT02769962|528698987|FG004|Overall Study|Physician Decision|0|||
146597877|NCT02769962|528698988|FG005|Overall Study|Physician Decision|1|||
146597878|NCT02769962|528698989|FG006|Overall Study|Physician Decision|0|||
146597879|NCT02769962|528698990|FG007|Overall Study|Physician Decision|1|||
146597880|NCT02769962|528698983|FG000|Overall Study|Refused further treatment|0|||
146597881|NCT02769962|528698984|FG001|Overall Study|Refused further treatment|0|||
146597882|NCT02769962|528698985|FG002|Overall Study|Refused further treatment|0|||
146597883|NCT02769962|528698986|FG003|Overall Study|Refused further treatment|0|||
146597884|NCT02769962|528698987|FG004|Overall Study|Refused further treatment|0|||
146597885|NCT02769962|528698988|FG005|Overall Study|Refused further treatment|1|||
146597886|NCT02769962|528698989|FG006|Overall Study|Refused further treatment|1|||
146597887|NCT02769962|528698990|FG007|Overall Study|Refused further treatment|0|||
146597888|NCT03826342|528698994|FG000|Overall Study|Withdrawal by Subject|8|||
146597889|NCT03826342|528698995|FG001|Overall Study|Withdrawal by Subject|1|||
146597890|NCT03826342|528698994|FG000|Overall Study|Lost to Follow-up|7|||
146597891|NCT03826342|528698995|FG001|Overall Study|Lost to Follow-up|7|||
146597892|NCT03826342|528698994|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
146597893|NCT03826342|528698995|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
146597894|NCT02212678|528699002|FG000|Overall Study|Adverse Event|1|||
146597895|NCT02337634|528699003|FG000|Overall Study|Protocol Violation|3|||
146597896|NCT02337634|528699004|FG001|Overall Study|Protocol Violation|1|||
146597897|NCT02337634|528699003|FG000|Overall Study|Lost to Follow-up|1|||
146597898|NCT02337634|528699004|FG001|Overall Study|Lost to Follow-up|0|||
146597899|NCT04068610|528699005|FG000|Overall Study|Death|4|||
146597900|NCT04068610|528699006|FG001|Overall Study|Death|8|||
146597901|NCT04068610|528699007|FG002|Overall Study|Death|13|||
146597902|NCT04068610|528699005|FG000|Overall Study|Lost to Follow-up|0|||
146597903|NCT04068610|528699006|FG001|Overall Study|Lost to Follow-up|2|||
146597904|NCT04068610|528699007|FG002|Overall Study|Lost to Follow-up|0|||
146597905|NCT04068610|528699005|FG000|Overall Study|Withdrawal by Subject|0|||
146597906|NCT04068610|528699006|FG001|Overall Study|Withdrawal by Subject|4|||
146597907|NCT04068610|528699007|FG002|Overall Study|Withdrawal by Subject|2|||
146597908|NCT04068610|528699005|FG000|Overall Study|Other|3|||
146597909|NCT04068610|528699006|FG001|Overall Study|Other|12|||
146597910|NCT04068610|528699007|FG002|Overall Study|Other|11|||
146597911|NCT02046070|528699008|FG000|Overall Study|Progressive Disease|18|||
146597912|NCT02046070|528699009|FG001|Overall Study|Progressive Disease|11|||
146597913|NCT02046070|528699010|FG002|Overall Study|Progressive Disease|40|||
146597914|NCT02046070|528699008|FG000|Overall Study|Adverse Event|8|||
146597915|NCT02046070|528699009|FG001|Overall Study|Adverse Event|10|||
146597916|NCT02046070|528699010|FG002|Overall Study|Adverse Event|17|||
146597917|NCT02046070|528699008|FG000|Overall Study|Withdrawal by Subject|1|||
146597918|NCT02046070|528699009|FG001|Overall Study|Withdrawal by Subject|2|||
146597919|NCT02046070|528699010|FG002|Overall Study|Withdrawal by Subject|6|||
146597920|NCT02046070|528699008|FG000|Overall Study|Study Terminated by Sponsor|1|||
146597921|NCT02046070|528699009|FG001|Overall Study|Study Terminated by Sponsor|1|||
146597922|NCT02046070|528699010|FG002|Overall Study|Study Terminated by Sponsor|1|||
146597923|NCT02046070|528699008|FG000|Overall Study|Reason not Specified|4|||
146597924|NCT02046070|528699009|FG001|Overall Study|Reason not Specified|4|||
146597925|NCT02046070|528699010|FG002|Overall Study|Reason not Specified|6|||
146597926|NCT01818284|528699011|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
146597927|NCT01818284|528699012|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
146597928|NCT01818284|528699011|FG000|Overall Study|Death|0|||
146597929|NCT01818284|528699012|FG001|Overall Study|Death|2|||
146597930|NCT04030962|528699013|FG000|Stage 2|Adverse Event|0|||
146597931|NCT04030962|528699014|FG001|Stage 2|Adverse Event|0|||
146597932|NCT04030962|528699015|FG002|Stage 2|Adverse Event|0|||
146597933|NCT04030962|528699016|FG003|Stage 2|Adverse Event|0|||
146597934|NCT04030962|528699017|FG004|Stage 2|Adverse Event|0|||
146920384|NCT00423085|529871357|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
146920385|NCT00423085|529871358|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
146920386|NCT00423085|529871355|FG000|52-Week Open-Label Extension Phase|Death|0|||
146920387|NCT00423085|529871356|FG001|52-Week Open-Label Extension Phase|Death|0|||
146920388|NCT00423085|529871357|FG002|52-Week Open-Label Extension Phase|Death|0|||
146920389|NCT00423085|529871358|FG003|52-Week Open-Label Extension Phase|Death|2|||
146920390|NCT00853489|529871359|FG000|Overall Study|Lost to Follow-up|5|||
146920391|NCT00853489|529871360|FG001|Overall Study|Lost to Follow-up|2|||
146920392|NCT05525975|529871361|FG000|Overall Study|Surgery cancellation|4|||
146920393|NCT05525975|529871362|FG001|Overall Study|Surgery cancellation|5|||
146597935|NCT04030962|528699018|FG005|Stage 2|Adverse Event|0|||
146597936|NCT04030962|528699019|FG006|Stage 2|Adverse Event|0|||
146597937|NCT04030962|528699020|FG007|Stage 2|Adverse Event|0|||
146597938|NCT04030962|528699021|FG008|Stage 2|Adverse Event|1|||
146597939|NCT04030962|528699022|FG009|Stage 2|Adverse Event|0|||
146597940|NCT04030962|528699023|FG010|Stage 2|Adverse Event|1|||
146597941|NCT04030962|528699024|FG011|Stage 2|Adverse Event|1|||
146597942|NCT04030962|528699025|FG012|Stage 2|Adverse Event|1|||
146597943|NCT04030962|528699013|FG000|Stage 2|Withdrawal by Subject|0|||
146597944|NCT04030962|528699014|FG001|Stage 2|Withdrawal by Subject|0|||
146597945|NCT04030962|528699015|FG002|Stage 2|Withdrawal by Subject|0|||
146597946|NCT04030962|528699016|FG003|Stage 2|Withdrawal by Subject|0|||
146597947|NCT04030962|528699017|FG004|Stage 2|Withdrawal by Subject|0|||
146597948|NCT04030962|528699018|FG005|Stage 2|Withdrawal by Subject|0|||
146597949|NCT04030962|528699019|FG006|Stage 2|Withdrawal by Subject|0|||
146597950|NCT04030962|528699020|FG007|Stage 2|Withdrawal by Subject|0|||
146597951|NCT04030962|528699021|FG008|Stage 2|Withdrawal by Subject|1|||
146597952|NCT04030962|528699022|FG009|Stage 2|Withdrawal by Subject|0|||
146597953|NCT04030962|528699023|FG010|Stage 2|Withdrawal by Subject|0|||
146597954|NCT04030962|528699024|FG011|Stage 2|Withdrawal by Subject|2|||
146597955|NCT04030962|528699025|FG012|Stage 2|Withdrawal by Subject|1|||
146597956|NCT04030962|528699013|FG000|Stage 2|Lost to Follow-up|0|||
146597957|NCT04030962|528699014|FG001|Stage 2|Lost to Follow-up|0|||
146597958|NCT04030962|528699015|FG002|Stage 2|Lost to Follow-up|0|||
146597959|NCT04030962|528699016|FG003|Stage 2|Lost to Follow-up|0|||
146597960|NCT04030962|528699017|FG004|Stage 2|Lost to Follow-up|0|||
146597961|NCT04030962|528699018|FG005|Stage 2|Lost to Follow-up|0|||
146597962|NCT04030962|528699019|FG006|Stage 2|Lost to Follow-up|0|||
146597963|NCT04030962|528699020|FG007|Stage 2|Lost to Follow-up|0|||
146597964|NCT04030962|528699021|FG008|Stage 2|Lost to Follow-up|1|||
146597965|NCT04030962|528699022|FG009|Stage 2|Lost to Follow-up|0|||
146597966|NCT04030962|528699023|FG010|Stage 2|Lost to Follow-up|0|||
146597967|NCT04030962|528699024|FG011|Stage 2|Lost to Follow-up|0|||
146597968|NCT04030962|528699025|FG012|Stage 2|Lost to Follow-up|0|||
146597969|NCT04030962|528699013|FG000|Stage 2|Technical Problems|0|||
146597970|NCT04030962|528699014|FG001|Stage 2|Technical Problems|0|||
146597971|NCT04030962|528699015|FG002|Stage 2|Technical Problems|0|||
146654218|NCT00327470|528910729|FG001|Overall Study|Death|4|||
146654219|NCT04738318|528910730|FG000|Overall Study|Protocol Violation|1|||
146654220|NCT04738318|528910731|FG001|Overall Study|Protocol Violation|0|||
146654221|NCT01226121|528910732|FG000|Overall Study|Lost to Follow-up|2|||
146654222|NCT01226121|528910733|FG001|Overall Study|Lost to Follow-up|0|||
146654223|NCT01226121|528910734|FG002|Overall Study|Lost to Follow-up|1|||
146654224|NCT04231981|528910735|FG000|Overall Study|Adverse Event|1|||
146920394|NCT05525975|529871361|FG000|Overall Study|didn't fill prescription|1|||
146597972|NCT04030962|528699016|FG003|Stage 2|Technical Problems|0|||
146597973|NCT04030962|528699017|FG004|Stage 2|Technical Problems|0|||
146597974|NCT04030962|528699018|FG005|Stage 2|Technical Problems|0|||
146597975|NCT04030962|528699019|FG006|Stage 2|Technical Problems|0|||
146597976|NCT04030962|528699020|FG007|Stage 2|Technical Problems|0|||
146597977|NCT04030962|528699021|FG008|Stage 2|Technical Problems|0|||
146654225|NCT04231981|528910735|FG000|Overall Study|Death|16|||
146654226|NCT04231981|528910735|FG000|Overall Study|Lost to Follow-up|1|||
146654227|NCT02197234|528910736|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
146654228|NCT02197234|528910736|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
146654229|NCT02197234|528910736|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
146978521|NCT00033631|530084093|FG001|Overall Study|Protocol Violation|11|||
146654230|NCT02197234|528910736|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
146597978|NCT04030962|528699022|FG009|Stage 2|Technical Problems|0|||
146597979|NCT04030962|528699023|FG010|Stage 2|Technical Problems|0|||
146597980|NCT04030962|528699024|FG011|Stage 2|Technical Problems|1|||
146597981|NCT04030962|528699025|FG012|Stage 2|Technical Problems|0|||
146597982|NCT05601102|528699029|FG000|Overall Study|Death|1|||
146597983|NCT05601102|528699030|FG001|Overall Study|Death|2|||
146597984|NCT05601102|528699029|FG000|Overall Study|Withdrawal by Subject|1|||
146597985|NCT05601102|528699030|FG001|Overall Study|Withdrawal by Subject|1|||
146597986|NCT05601102|528699029|FG000|Overall Study|Lost to Follow-up|0|||
146597987|NCT05601102|528699030|FG001|Overall Study|Lost to Follow-up|2|||
146597988|NCT05288166|528699031|FG000|Overall Study|Adverse Event|1|||
146920395|NCT05525975|529871362|FG001|Overall Study|didn't fill prescription|0|||
146920396|NCT05525975|529871361|FG000|Overall Study|Withdrawal by Subject|0|||
146597989|NCT05288166|528699032|FG001|Overall Study|Adverse Event|0|||
146597990|NCT05288166|528699031|FG000|Overall Study|Lost to Follow-up|2|||
146597991|NCT05288166|528699032|FG001|Overall Study|Lost to Follow-up|0|||
146597992|NCT05288166|528699031|FG000|Overall Study|Physician Decision|0|||
146597993|NCT05288166|528699032|FG001|Overall Study|Physician Decision|2|||
146597994|NCT05288166|528699031|FG000|Overall Study|Screen Failure|1|||
146597995|NCT05288166|528699032|FG001|Overall Study|Screen Failure|1|||
146597996|NCT05288166|528699031|FG000|Overall Study|Withdrawal by Subject|4|||
146597997|NCT05288166|528699032|FG001|Overall Study|Withdrawal by Subject|2|||
146597998|NCT05288166|528699031|FG000|Overall Study|On Study Treatment|408|||
146597999|NCT05288166|528699032|FG001|Overall Study|On Study Treatment|418|||
146598000|NCT03007745|528699033|FG000|Overall Study|Sleep test negative for OSA|53|||
146598001|NCT03007745|528699034|FG001|Overall Study|Sleep test negative for OSA|49|||
146598002|NCT03007745|528699033|FG000|Overall Study|Physician Decision|6|||
146598003|NCT03007745|528699034|FG001|Overall Study|Physician Decision|9|||
146598004|NCT03007745|528699033|FG000|Overall Study|Withdrawal by Subject|38|||
146598005|NCT03007745|528699034|FG001|Overall Study|Withdrawal by Subject|16|||
146598006|NCT03007745|528699033|FG000|Overall Study|Lost to Follow-up|19|||
146598007|NCT03007745|528699034|FG001|Overall Study|Lost to Follow-up|25|||
146598008|NCT03007745|528699033|FG000|Overall Study|Unable to login to website|17|||
146598009|NCT03007745|528699034|FG001|Overall Study|Unable to login to website|4|||
146598010|NCT04284813|528699035|FG000|Overall Study|Withdrawal by Subject|1|||
146598011|NCT03968159|528699043|FG000|Overall Study|Adverse Event|4|||
146598012|NCT03968159|528699044|FG001|Overall Study|Adverse Event|4|||
146598013|NCT03968159|528699043|FG000|Overall Study|Lost to Follow-up|1|||
146598014|NCT03968159|528699044|FG001|Overall Study|Lost to Follow-up|1|||
146598015|NCT03968159|528699043|FG000|Overall Study|Use of prohibited medication|0|||
146598016|NCT03968159|528699044|FG001|Overall Study|Use of prohibited medication|1|||
146598017|NCT03968159|528699043|FG000|Overall Study|Protocol Violation|2|||
146598018|NCT03968159|528699044|FG001|Overall Study|Protocol Violation|2|||
146598019|NCT03968159|528699043|FG000|Overall Study|Withdrawal by Subject|4|||
146598020|NCT03968159|528699044|FG001|Overall Study|Withdrawal by Subject|6|||
146598021|NCT03968159|528699043|FG000|Overall Study|Lack of Efficacy|0|||
146598022|NCT03968159|528699044|FG001|Overall Study|Lack of Efficacy|1|||
146598023|NCT03968159|528699043|FG000|Overall Study|Not further specified|2|||
146598024|NCT03968159|528699044|FG001|Overall Study|Not further specified|0|||
146598025|NCT00895661|528699052|FG000|Overall Study|Death|1|||
146598026|NCT00895661|528699052|FG000|Overall Study|reason unknown|2|||
146598027|NCT00791557|528699053|FG000|Overall Study|Adverse Event|1|||
146598028|NCT02066129|528699054|FG000|Overall Study|Lost to Follow-up|13|||
146598029|NCT02066129|528699055|FG001|Overall Study|Lost to Follow-up|12|||
146598030|NCT02066129|528699054|FG000|Overall Study|Withdrawal by Subject|7|||
146598031|NCT02066129|528699055|FG001|Overall Study|Withdrawal by Subject|10|||
146598032|NCT02066129|528699054|FG000|Overall Study|Lack of Efficacy|8|||
146598033|NCT02066129|528699055|FG001|Overall Study|Lack of Efficacy|10|||
146598034|NCT02066129|528699054|FG000|Overall Study|Physician Decision|1|||
146598035|NCT02066129|528699055|FG001|Overall Study|Physician Decision|1|||
146598036|NCT02322190|528699056|FG000|Overall Study|Death on study|1|||
146598037|NCT02322190|528699057|FG001|Overall Study|Death on study|0|||
146598038|NCT00357656|528699058|FG000|Overall Study|Other, No surgery performed|0|||
146598039|NCT00357656|528699059|FG001|Overall Study|Other, No surgery performed|3|||
146598040|NCT04941807|528699063|FG000|Overall Study|Lost to Follow-up|1|||
146598041|NCT04941807|528699064|FG001|Overall Study|Lost to Follow-up|1|||
146598042|NCT03553498|528699065|FG000|Overall Study|Missing primary outcome|1|||
146654231|NCT02197234|528910736|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
146654232|NCT02197234|528910736|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
146654233|NCT03473548|528910739|FG000|Overall Study|Did not attempt HST testing|3|||
146654234|NCT03473548|528910740|FG001|Overall Study|Did not attempt HST testing|0|||
146654235|NCT01986933|528910747|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
146598043|NCT03553498|528699066|FG001|Overall Study|Missing primary outcome|2|||
146598044|NCT02713529|528699069|FG000|Overall Study|Withdrawal by Subject|3|||
146598045|NCT02713529|528699070|FG001|Overall Study|Withdrawal by Subject|1|||
146654236|NCT01986933|528910748|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
146654237|NCT01986933|528910749|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
146598046|NCT02713529|528699071|FG002|Overall Study|Withdrawal by Subject|4|||
146598047|NCT02713529|528699072|FG003|Overall Study|Withdrawal by Subject|2|||
146598048|NCT02713529|528699073|FG004|Overall Study|Withdrawal by Subject|0|||
146598049|NCT02713529|528699074|FG005|Overall Study|Withdrawal by Subject|1|||
146598050|NCT02713529|528699075|FG006|Overall Study|Withdrawal by Subject|1|||
146598051|NCT02713529|528699069|FG000|Overall Study|Lost to Follow-up|1|||
146598052|NCT02713529|528699070|FG001|Overall Study|Lost to Follow-up|0|||
146598053|NCT02713529|528699071|FG002|Overall Study|Lost to Follow-up|1|||
146598054|NCT02713529|528699072|FG003|Overall Study|Lost to Follow-up|0|||
146598055|NCT02713529|528699073|FG004|Overall Study|Lost to Follow-up|0|||
146598056|NCT02713529|528699074|FG005|Overall Study|Lost to Follow-up|0|||
146598057|NCT02713529|528699075|FG006|Overall Study|Lost to Follow-up|0|||
146598058|NCT02713529|528699069|FG000|Overall Study|Death|3|||
146598059|NCT02713529|528699070|FG001|Overall Study|Death|3|||
146920397|NCT05525975|529871362|FG001|Overall Study|Withdrawal by Subject|3|||
146920398|NCT01575197|529871363|FG000|Overall Study|Migration out of study area|1|||
146920399|NCT01575197|529871364|FG001|Overall Study|Migration out of study area|5|||
146920400|NCT01575197|529871365|FG002|Overall Study|Migration out of study area|4|||
146920401|NCT01575197|529871363|FG000|Overall Study|SAE|0|||
146920402|NCT01575197|529871364|FG001|Overall Study|SAE|1|||
146920403|NCT01575197|529871365|FG002|Overall Study|SAE|0|||
146920404|NCT01575197|529871363|FG000|Overall Study|Lost to Follow-up|0|||
146920405|NCT01575197|529871364|FG001|Overall Study|Lost to Follow-up|1|||
146920406|NCT01575197|529871365|FG002|Overall Study|Lost to Follow-up|0|||
146920407|NCT01575197|529871363|FG000|Overall Study|Withdrawal by Subject|0|||
146920408|NCT01575197|529871364|FG001|Overall Study|Withdrawal by Subject|1|||
146920409|NCT01575197|529871365|FG002|Overall Study|Withdrawal by Subject|1|||
146920410|NCT01575197|529871363|FG000|Overall Study|Protocol Violation|2|||
146920411|NCT01575197|529871364|FG001|Overall Study|Protocol Violation|1|||
146920412|NCT01575197|529871365|FG002|Overall Study|Protocol Violation|1|||
146920413|NCT00833248|529871369|FG000|Overall Study|Adverse Event|3|||
146920414|NCT00833248|529871370|FG001|Overall Study|Adverse Event|0|||
146920415|NCT00833248|529871369|FG000|Overall Study|Protocol Violation|1|||
146920416|NCT00833248|529871370|FG001|Overall Study|Protocol Violation|2|||
146920417|NCT00833248|529871369|FG000|Overall Study|Withdrawal by Subject|0|||
146920418|NCT00833248|529871370|FG001|Overall Study|Withdrawal by Subject|1|||
146920419|NCT03580382|529871373|FG000|Overall Study|Early Termination of Study|0|||
146920420|NCT03580382|529871374|FG001|Overall Study|Early Termination of Study|3|||
146920421|NCT02808312|529871375|FG000|Overall Study|Enrolled but Never Treated|0|||
146920422|NCT02808312|529871376|FG001|Overall Study|Enrolled but Never Treated|0|||
146920423|NCT02808312|529871377|FG002|Overall Study|Enrolled but Never Treated|1|||
146920424|NCT02808312|529871378|FG003|Overall Study|Enrolled but Never Treated|0|||
146920425|NCT02808312|529871379|FG004|Overall Study|Enrolled but Never Treated|0|||
146920426|NCT01826422|529871380|FG000|Overall Study|Withdrawal by Subject|1|||
146920427|NCT01826422|529871381|FG001|Overall Study|Withdrawal by Subject|3|||
146920428|NCT04009096|529871382|FG000|Overall Study|Withdrawal by Subject|0|||
146920429|NCT04009096|529871383|FG001|Overall Study|Withdrawal by Subject|7|||
146920430|NCT04009096|529871384|FG002|Overall Study|Withdrawal by Subject|0|||
146920431|NCT04009096|529871382|FG000|Overall Study|Physician Decision|0|||
146920432|NCT04009096|529871383|FG001|Overall Study|Physician Decision|1|||
146920433|NCT04009096|529871384|FG002|Overall Study|Physician Decision|0|||
146920434|NCT05151471|529871385|FG000|Overall Study|Adverse Event|21|||
146920435|NCT05151471|529871386|FG001|Overall Study|Adverse Event|16|||
146920436|NCT05151471|529871385|FG000|Overall Study|Death|1|||
146920437|NCT05151471|529871386|FG001|Overall Study|Death|0|||
146920438|NCT05151471|529871385|FG000|Overall Study|Lost to Follow-up|0|||
146920439|NCT05151471|529871386|FG001|Overall Study|Lost to Follow-up|1|||
146920440|NCT05151471|529871385|FG000|Overall Study|Withdrawal by Subject|7|||
146920441|NCT05151471|529871386|FG001|Overall Study|Withdrawal by Subject|9|||
146920442|NCT05151471|529871385|FG000|Overall Study|Study terminated by sponsor|49|||
146920443|NCT05151471|529871386|FG001|Overall Study|Study terminated by sponsor|47|||
146920444|NCT05151471|529871385|FG000|Overall Study|Other|2|||
146920445|NCT05151471|529871386|FG001|Overall Study|Other|1|||
146920446|NCT04263142|529871387|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
146920447|NCT04263142|529871388|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
146920448|NCT04263142|529871389|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
146920449|NCT04263142|529871390|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
146920450|NCT04263142|529871391|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
146920451|NCT04263142|529871387|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
146920452|NCT04263142|529871388|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
146920453|NCT04263142|529871389|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
146920454|NCT04263142|529871390|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
146920455|NCT04263142|529871391|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
146920456|NCT03010423|529871394|FG000|Overall Study|Study termination|8|||
146920457|NCT00520676|529871396|FG000|Overall Study|Death|84|||
146920458|NCT00520676|529871397|FG001|Overall Study|Death|81|||
146920459|NCT00520676|529871396|FG000|Overall Study|Lost to Follow-up|6|||
146920460|NCT00520676|529871397|FG001|Overall Study|Lost to Follow-up|10|||
146920461|NCT00520676|529871396|FG000|Overall Study|Physician Decision|4|||
146654238|NCT01986933|528910750|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
146920462|NCT00520676|529871397|FG001|Overall Study|Physician Decision|1|||
146920463|NCT00520676|529871396|FG000|Overall Study|Withdrawal by Subject|7|||
146920464|NCT00520676|529871397|FG001|Overall Study|Withdrawal by Subject|11|||
146920465|NCT03484923|529871400|FG000|Overall Study|Adverse Event|3|||
146920466|NCT03484923|529871401|FG001|Overall Study|Adverse Event|3|||
146920467|NCT03484923|529871402|FG002|Overall Study|Adverse Event|5|||
146920468|NCT03484923|529871403|FG003|Overall Study|Adverse Event|11|||
146920469|NCT03484923|529871404|FG004|Overall Study|Adverse Event|1|||
146920470|NCT03484923|529871400|FG000|Overall Study|Death|2|||
146920471|NCT03484923|529871401|FG001|Overall Study|Death|2|||
146920472|NCT03484923|529871402|FG002|Overall Study|Death|3|||
146920473|NCT03484923|529871403|FG003|Overall Study|Death|0|||
146920474|NCT03484923|529871404|FG004|Overall Study|Death|1|||
146598060|NCT02713529|528699071|FG002|Overall Study|Death|26|||
146598061|NCT02713529|528699072|FG003|Overall Study|Death|27|||
146598062|NCT02713529|528699073|FG004|Overall Study|Death|3|||
146598063|NCT02713529|528699074|FG005|Overall Study|Death|13|||
146598064|NCT02713529|528699075|FG006|Overall Study|Death|3|||
146598065|NCT01565564|528699079|FG000|Overall Study|Lost to Follow-up|5|||
146598066|NCT01565564|528699080|FG001|Overall Study|Lost to Follow-up|1|||
146598067|NCT03995355|528699081|FG000|Overall Study|Adverse Event|1|||
146598068|NCT03995355|528699082|FG001|Overall Study|Adverse Event|0|||
146598069|NCT03995355|528699081|FG000|Overall Study|Withdrawal by Subject|1|||
146598070|NCT03995355|528699082|FG001|Overall Study|Withdrawal by Subject|0|||
146598071|NCT03995355|528699081|FG000|Overall Study|Scheduling Issues|0|||
146598072|NCT03995355|528699082|FG001|Overall Study|Scheduling Issues|1|||
146598073|NCT00094107|528699083|FG000|Overall Study|Lack of Efficacy|23|||
146598074|NCT00094107|528699083|FG000|Overall Study|Death|5|||
146598075|NCT00094107|528699083|FG000|Overall Study|Adverse Event|3|||
146598076|NCT00094107|528699083|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
146598077|NCT02698371|528699089|FG000|All Participants Flow|Lost to Follow-up|3|||
146598078|NCT02698371|528699089|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
146598079|NCT02698371|528699089|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
146598080|NCT02698371|528699089|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
146598081|NCT02698371|528699089|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
146598082|NCT02698371|528699089|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
146598083|NCT02698371|528699089|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
146598084|NCT02525094|528699090|FG000|Overall Study|Lost to Follow-up|2|||
146598085|NCT02525094|528699091|FG001|Overall Study|Lost to Follow-up|1|||
146598086|NCT02525094|528699090|FG000|Overall Study|Withdrawal by Subject|5|||
146598087|NCT02525094|528699091|FG001|Overall Study|Withdrawal by Subject|6|||
146598088|NCT02525094|528699090|FG000|Overall Study|Not Treated|1|||
146598089|NCT02525094|528699091|FG001|Overall Study|Not Treated|1|||
146598090|NCT00969436|528699093|FG000|Overall Study|Protocol Violation|1|||
146598091|NCT00969436|528699094|FG001|Overall Study|Protocol Violation|3|||
146598092|NCT00969436|528699095|FG002|Overall Study|Protocol Violation|0|||
146598093|NCT00969436|528699093|FG000|Overall Study|Migrated/moved from study area|12|||
146598094|NCT00969436|528699094|FG001|Overall Study|Migrated/moved from study area|10|||
146598095|NCT00969436|528699095|FG002|Overall Study|Migrated/moved from study area|2|||
146598096|NCT00969436|528699093|FG000|Overall Study|Father - serious health problem|0|||
146654239|NCT01986933|528910751|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
146654240|NCT01986933|528910747|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
146654241|NCT01986933|528910748|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
146598097|NCT00969436|528699094|FG001|Overall Study|Father - serious health problem|0|||
146598098|NCT00969436|528699095|FG002|Overall Study|Father - serious health problem|1|||
146598099|NCT00969436|528699093|FG000|Overall Study|Parents personal problem|0|||
146598100|NCT00969436|528699094|FG001|Overall Study|Parents personal problem|0|||
146598101|NCT00969436|528699095|FG002|Overall Study|Parents personal problem|1|||
146598102|NCT00969436|528699093|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
146598103|NCT00969436|528699094|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
146598104|NCT00969436|528699095|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
146654242|NCT01986933|528910749|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
146654243|NCT01986933|528910750|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
146654244|NCT01986933|528910751|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
146654245|NCT01986933|528910747|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
146920475|NCT03484923|529871400|FG000|Overall Study|Physician Decision|6|||
146920476|NCT03484923|529871401|FG001|Overall Study|Physician Decision|7|||
146920477|NCT03484923|529871402|FG002|Overall Study|Physician Decision|6|||
146920478|NCT03484923|529871403|FG003|Overall Study|Physician Decision|3|||
146920479|NCT03484923|529871404|FG004|Overall Study|Physician Decision|2|||
146920480|NCT03484923|529871400|FG000|Overall Study|Progressive disease|33|||
146920481|NCT03484923|529871401|FG001|Overall Study|Progressive disease|28|||
146920482|NCT03484923|529871402|FG002|Overall Study|Progressive disease|26|||
146920483|NCT03484923|529871403|FG003|Overall Study|Progressive disease|30|||
146920484|NCT03484923|529871404|FG004|Overall Study|Progressive disease|16|||
146920485|NCT03484923|529871400|FG000|Overall Study|Subject Decision|1|||
146920486|NCT03484923|529871401|FG001|Overall Study|Subject Decision|3|||
146920487|NCT03484923|529871402|FG002|Overall Study|Subject Decision|3|||
146920488|NCT03484923|529871403|FG003|Overall Study|Subject Decision|0|||
146920489|NCT03484923|529871404|FG004|Overall Study|Subject Decision|1|||
146920490|NCT03439748|529871405|FG000|Overall Study|Withdrawal by Subject|11|||
146920491|NCT03439748|529871406|FG001|Overall Study|Withdrawal by Subject|17|||
146920492|NCT00115349|529871411|FG000|Overall Study|Study closed due to low enrollment.|11|||
146920493|NCT00115349|529871412|FG001|Overall Study|Study closed due to low enrollment.|9|||
146598105|NCT00969436|528699093|FG000|Overall Study|Withdrawal by Subject|3|||
146598106|NCT00969436|528699094|FG001|Overall Study|Withdrawal by Subject|0|||
146920494|NCT03298412|529871413|FG000|Run-in Period|Other, Not Specified|1|||
146920495|NCT03298412|529871413|FG000|Run-in Period|Disease Progression|1|||
146920496|NCT03298412|529871413|FG000|Run-in Period|Ineligibility Determined|1|||
146920497|NCT03298412|529871413|FG000|Run-in Period|Decision by Sponsor|6|||
146920498|NCT04402008|529871416|FG000|Overall Study|Adverse Event|0|||
146920499|NCT04402008|529871417|FG001|Overall Study|Adverse Event|0|||
146920500|NCT04402008|529871418|FG002|Overall Study|Adverse Event|0|||
146920501|NCT04402008|529871419|FG003|Overall Study|Adverse Event|1|||
146920502|NCT04402008|529871420|FG004|Overall Study|Adverse Event|0|||
146920503|NCT04402008|529871421|FG005|Overall Study|Adverse Event|0|||
146920504|NCT04402008|529871422|FG006|Overall Study|Adverse Event|0|||
146598107|NCT00969436|528699095|FG002|Overall Study|Withdrawal by Subject|2|||
146598108|NCT00969436|528699093|FG000|Overall Study|Lost to Follow-up|8|||
146598109|NCT00969436|528699094|FG001|Overall Study|Lost to Follow-up|8|||
146598110|NCT00969436|528699095|FG002|Overall Study|Lost to Follow-up|5|||
146598111|NCT02117349|528699099|FG000|Overall Study|Withdrawal by Subject|1|||
146598112|NCT02117349|528699100|FG001|Overall Study|Withdrawal by Subject|0|||
146598113|NCT02117349|528699099|FG000|Overall Study|Lost to Follow-up|1|||
146598114|NCT02117349|528699100|FG001|Overall Study|Lost to Follow-up|1|||
146598115|NCT02117349|528699099|FG000|Overall Study|Death|1|||
146598116|NCT02117349|528699100|FG001|Overall Study|Death|0|||
146598117|NCT02242981|528699101|FG000|Overall Study|Withdrawal by Subject|1|||
146598118|NCT02535416|528699104|FG000|Overall Study|Family bereavement overseas|1|||
146598119|NCT02535416|528699105|FG001|Overall Study|Family bereavement overseas|0|||
146598120|NCT02535416|528699106|FG002|Overall Study|Family bereavement overseas|0|||
146598121|NCT02535416|528699107|FG003|Overall Study|Family bereavement overseas|0|||
146598122|NCT02535416|528699108|FG004|Overall Study|Family bereavement overseas|0|||
146598123|NCT02535416|528699109|FG005|Overall Study|Family bereavement overseas|0|||
146598124|NCT02535416|528699110|FG006|Overall Study|Family bereavement overseas|0|||
146598125|NCT02535416|528699111|FG007|Overall Study|Family bereavement overseas|0|||
146598126|NCT02535416|528699112|FG008|Overall Study|Family bereavement overseas|0|||
146598127|NCT03474081|528699113|FG000|Overall Study|Adverse Event|6|||
146598128|NCT03474081|528699114|FG001|Overall Study|Adverse Event|3|||
146598129|NCT03474081|528699113|FG000|Overall Study|Lost to Follow-up|2|||
146598130|NCT03474081|528699114|FG001|Overall Study|Lost to Follow-up|1|||
146598131|NCT03474081|528699113|FG000|Overall Study|Physician Decision|3|||
146598132|NCT03474081|528699114|FG001|Overall Study|Physician Decision|2|||
146598133|NCT03474081|528699113|FG000|Overall Study|Withdrawal by Subject|5|||
146598134|NCT03474081|528699114|FG001|Overall Study|Withdrawal by Subject|7|||
146598135|NCT03474081|528699113|FG000|Overall Study|Investigator site closed|1|||
146598136|NCT03474081|528699114|FG001|Overall Study|Investigator site closed|0|||
146598137|NCT02739321|528699119|FG000|Overall Study|Lack of Efficacy|1|||
146598138|NCT02739321|528699120|FG001|Overall Study|Lack of Efficacy|1|||
146598139|NCT02739321|528699119|FG000|Overall Study|Lost to Follow-up|1|||
146598140|NCT02739321|528699120|FG001|Overall Study|Lost to Follow-up|1|||
146598141|NCT02739321|528699119|FG000|Overall Study|Withdrawal by Subject|1|||
146598142|NCT02739321|528699120|FG001|Overall Study|Withdrawal by Subject|2|||
146598143|NCT02440789|528699123|FG000|Overall Study|Withdrawal by Subject|3|||
146598144|NCT02440789|528699123|FG000|Overall Study|Not willing to adhere to reqs|1|||
146598145|NCT03172130|528700114|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
146598146|NCT03172130|528700115|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
146598147|NCT01350115|528700119|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
146598148|NCT01350115|528700120|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
146598149|NCT01350115|528700119|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
146598150|NCT01350115|528700120|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
146598151|NCT01350115|528700119|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
146598152|NCT01350115|528700120|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
146598153|NCT05565937|528700121|FG000|Overall Study|Adverse Event|0|||
146598154|NCT05565937|528700122|FG001|Overall Study|Adverse Event|1|||
146598155|NCT05565937|528700121|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
146598156|NCT05565937|528700122|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
146598157|NCT05565937|528700121|FG000|Overall Study|Lost to Follow-up|2|||
146598158|NCT05565937|528700122|FG001|Overall Study|Lost to Follow-up|0|||
146598159|NCT05565937|528700121|FG000|Overall Study|Pregnancy|0|||
146598160|NCT05565937|528700122|FG001|Overall Study|Pregnancy|2|||
146598161|NCT05565937|528700121|FG000|Overall Study|Anisometropia|0|||
146598162|NCT05565937|528700122|FG001|Overall Study|Anisometropia|1|||
146598163|NCT04544683|528700123|FG000|Overall Study|Lost to Follow-up|2|||
146598164|NCT04544683|528700123|FG000|Overall Study|Underwent cervical spine surgery|6|||
146598165|NCT00151372|528700124|FG000|Overall Study|Death|12|||
146598166|NCT00151372|528700125|FG001|Overall Study|Death|11|||
146598167|NCT00151372|528700124|FG000|Overall Study|Lost to Follow-up|5|||
146598168|NCT00151372|528700125|FG001|Overall Study|Lost to Follow-up|5|||
146598169|NCT00151372|528700124|FG000|Overall Study|Too sick medically to continue|5|||
146598170|NCT00151372|528700125|FG001|Overall Study|Too sick medically to continue|6|||
146598171|NCT00151372|528700124|FG000|Overall Study|Withdrawal by Subject|7|||
146920505|NCT04402008|529871416|FG000|Overall Study|Disease Progression|3|||
146920506|NCT04402008|529871417|FG001|Overall Study|Disease Progression|2|||
146920507|NCT04402008|529871418|FG002|Overall Study|Disease Progression|3|||
146920508|NCT04402008|529871419|FG003|Overall Study|Disease Progression|3|||
146771593|NCT05061693|529331231|FG002|24-week Extension Period|Adverse Event|0|||
146771594|NCT05061693|529331232|FG003|24-week Extension Period|Adverse Event|0|||
146771595|NCT05061693|529331233|FG004|24-week Extension Period|Adverse Event|0|||
146771596|NCT05061693|529331234|FG005|24-week Extension Period|Adverse Event|0|||
146771597|NCT05061693|529331235|FG006|24-week Extension Period|Adverse Event|0|||
146771598|NCT05061693|529331236|FG007|24-week Extension Period|Adverse Event|2|||
146771599|NCT05061693|529331237|FG008|24-week Extension Period|Adverse Event|2|||
146771600|NCT05061693|529331238|FG009|24-week Extension Period|Adverse Event|0|||
146771601|NCT05061693|529331239|FG010|24-week Extension Period|Adverse Event|1|||
146771602|NCT05061693|529331240|FG011|24-week Extension Period|Adverse Event|3|||
146771603|NCT05061693|529331229|FG000|24-week Extension Period|Lack of Efficacy|0|||
146771604|NCT05061693|529331230|FG001|24-week Extension Period|Lack of Efficacy|0|||
146771605|NCT05061693|529331231|FG002|24-week Extension Period|Lack of Efficacy|0|||
146771606|NCT05061693|529331232|FG003|24-week Extension Period|Lack of Efficacy|0|||
146771607|NCT05061693|529331233|FG004|24-week Extension Period|Lack of Efficacy|0|||
146771608|NCT05061693|529331234|FG005|24-week Extension Period|Lack of Efficacy|0|||
146771609|NCT05061693|529331235|FG006|24-week Extension Period|Lack of Efficacy|0|||
146771610|NCT05061693|529331236|FG007|24-week Extension Period|Lack of Efficacy|0|||
146771611|NCT05061693|529331237|FG008|24-week Extension Period|Lack of Efficacy|0|||
146771612|NCT05061693|529331238|FG009|24-week Extension Period|Lack of Efficacy|0|||
146771613|NCT05061693|529331239|FG010|24-week Extension Period|Lack of Efficacy|2|||
146771614|NCT05061693|529331240|FG011|24-week Extension Period|Lack of Efficacy|0|||
146771615|NCT05061693|529331229|FG000|24-week Extension Period|Lost to Follow-up|0|||
146771616|NCT05061693|529331230|FG001|24-week Extension Period|Lost to Follow-up|0|||
146771617|NCT05061693|529331231|FG002|24-week Extension Period|Lost to Follow-up|0|||
146771618|NCT05061693|529331232|FG003|24-week Extension Period|Lost to Follow-up|0|||
146771619|NCT05061693|529331233|FG004|24-week Extension Period|Lost to Follow-up|0|||
146771620|NCT05061693|529331234|FG005|24-week Extension Period|Lost to Follow-up|0|||
146771621|NCT05061693|529331235|FG006|24-week Extension Period|Lost to Follow-up|1|||
146771622|NCT05061693|529331236|FG007|24-week Extension Period|Lost to Follow-up|0|||
146771623|NCT05061693|529331237|FG008|24-week Extension Period|Lost to Follow-up|1|||
146771624|NCT05061693|529331238|FG009|24-week Extension Period|Lost to Follow-up|1|||
146771625|NCT05061693|529331239|FG010|24-week Extension Period|Lost to Follow-up|0|||
146771626|NCT05061693|529331240|FG011|24-week Extension Period|Lost to Follow-up|0|||
146771627|NCT05061693|529331229|FG000|24-week Extension Period|Withdrawal by Subject|0|||
146771628|NCT05061693|529331230|FG001|24-week Extension Period|Withdrawal by Subject|0|||
146771629|NCT05061693|529331231|FG002|24-week Extension Period|Withdrawal by Subject|0|||
146771630|NCT05061693|529331232|FG003|24-week Extension Period|Withdrawal by Subject|0|||
146771631|NCT05061693|529331233|FG004|24-week Extension Period|Withdrawal by Subject|0|||
146771632|NCT05061693|529331234|FG005|24-week Extension Period|Withdrawal by Subject|0|||
146771633|NCT05061693|529331235|FG006|24-week Extension Period|Withdrawal by Subject|0|||
146771634|NCT05061693|529331236|FG007|24-week Extension Period|Withdrawal by Subject|0|||
146771635|NCT05061693|529331237|FG008|24-week Extension Period|Withdrawal by Subject|1|||
146771636|NCT05061693|529331238|FG009|24-week Extension Period|Withdrawal by Subject|2|||
146771637|NCT05061693|529331239|FG010|24-week Extension Period|Withdrawal by Subject|2|||
146771638|NCT05061693|529331240|FG011|24-week Extension Period|Withdrawal by Subject|1|||
146771639|NCT05061693|529331229|FG000|24-week Extension Period|Sponsor Decision|0|||
146771640|NCT05061693|529331230|FG001|24-week Extension Period|Sponsor Decision|0|||
146771641|NCT05061693|529331231|FG002|24-week Extension Period|Sponsor Decision|0|||
146771642|NCT05061693|529331232|FG003|24-week Extension Period|Sponsor Decision|0|||
146771643|NCT05061693|529331233|FG004|24-week Extension Period|Sponsor Decision|0|||
146771644|NCT05061693|529331234|FG005|24-week Extension Period|Sponsor Decision|0|||
146771645|NCT05061693|529331235|FG006|24-week Extension Period|Sponsor Decision|0|||
146771646|NCT05061693|529331236|FG007|24-week Extension Period|Sponsor Decision|1|||
146771647|NCT05061693|529331237|FG008|24-week Extension Period|Sponsor Decision|0|||
146771648|NCT05061693|529331238|FG009|24-week Extension Period|Sponsor Decision|0|||
146771649|NCT05061693|529331239|FG010|24-week Extension Period|Sponsor Decision|0|||
146771650|NCT05061693|529331240|FG011|24-week Extension Period|Sponsor Decision|0|||
146771651|NCT05061693|529331229|FG000|24-week Extension Period|Site Closure|0|||
146771652|NCT05061693|529331230|FG001|24-week Extension Period|Site Closure|0|||
146978522|NCT00033631|530084092|FG000|Overall Study|Withdrawal by Subject|4|||
146978523|NCT00033631|530084093|FG001|Overall Study|Withdrawal by Subject|4|||
146771653|NCT05061693|529331231|FG002|24-week Extension Period|Site Closure|0|||
146771654|NCT05061693|529331232|FG003|24-week Extension Period|Site Closure|0|||
146771655|NCT05061693|529331233|FG004|24-week Extension Period|Site Closure|0|||
146771656|NCT05061693|529331234|FG005|24-week Extension Period|Site Closure|0|||
146771657|NCT05061693|529331235|FG006|24-week Extension Period|Site Closure|0|||
146771658|NCT05061693|529331236|FG007|24-week Extension Period|Site Closure|0|||
146771659|NCT05061693|529331237|FG008|24-week Extension Period|Site Closure|1|||
146771660|NCT05061693|529331238|FG009|24-week Extension Period|Site Closure|0|||
146771661|NCT05061693|529331239|FG010|24-week Extension Period|Site Closure|0|||
146771662|NCT05061693|529331240|FG011|24-week Extension Period|Site Closure|1|||
146771663|NCT01152190|529331241|FG000|Overall Study|Adverse Event|2|||
146598172|NCT00151372|528700125|FG001|Overall Study|Withdrawal by Subject|7|||
146598173|NCT02783170|528700128|FG000|Overall Study|Randomized but not Vaccinated|1|||
146598174|NCT02783170|528700129|FG001|Overall Study|Randomized but not Vaccinated|0|||
146598175|NCT00541346|528700130|FG000|Follow-up|Adverse Event|1|||
146598176|NCT02008773|528700131|FG000|Overall Study|Adverse Event|3|||
146598177|NCT02008773|528700132|FG001|Overall Study|Adverse Event|3|||
146598178|NCT02008773|528700133|FG002|Overall Study|Adverse Event|1|||
146598179|NCT02008773|528700134|FG003|Overall Study|Adverse Event|2|||
146598180|NCT02008773|528700131|FG000|Overall Study|Medication Non-compliance|2|||
146598181|NCT02008773|528700132|FG001|Overall Study|Medication Non-compliance|1|||
146654246|NCT01986933|528910748|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
146654247|NCT01986933|528910749|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
146654248|NCT01986933|528910750|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
146654249|NCT01986933|528910751|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
146654250|NCT01986933|528910747|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
146654251|NCT01986933|528910748|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
146654252|NCT01986933|528910749|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
146654253|NCT01986933|528910750|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
146654254|NCT01986933|528910751|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
146654255|NCT01986933|528910747|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
146654256|NCT01986933|528910748|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
146654257|NCT01986933|528910749|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
146654258|NCT01986933|528910750|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
146654259|NCT01986933|528910751|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
146654260|NCT01986933|528910747|FG000|Active-to-active (Part B)|Adverse Event|0|||
146654261|NCT01986933|528910748|FG001|Active-to-active (Part B)|Adverse Event|2|||
146654262|NCT01986933|528910749|FG002|Active-to-active (Part B)|Adverse Event|0|||
146654263|NCT01986933|528910750|FG003|Active-to-active (Part B)|Adverse Event|1|||
146654264|NCT01986933|528910751|FG004|Active-to-active (Part B)|Adverse Event|3|||
146654265|NCT01986933|528910747|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
146654266|NCT01986933|528910748|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
146654267|NCT01986933|528910749|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
146654268|NCT01986933|528910750|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
146654269|NCT01986933|528910751|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
146654270|NCT01986933|528910747|FG000|Active-to-active (Part B)|Pregnancy|0|||
146654271|NCT01986933|528910748|FG001|Active-to-active (Part B)|Pregnancy|0|||
146654272|NCT01986933|528910749|FG002|Active-to-active (Part B)|Pregnancy|0|||
146654273|NCT01986933|528910750|FG003|Active-to-active (Part B)|Pregnancy|0|||
146654274|NCT01986933|528910751|FG004|Active-to-active (Part B)|Pregnancy|1|||
146654275|NCT01986933|528910747|FG000|Active-to-active (Part B)|Physician Decision|0|||
146654276|NCT01986933|528910748|FG001|Active-to-active (Part B)|Physician Decision|0|||
146654277|NCT01986933|528910749|FG002|Active-to-active (Part B)|Physician Decision|1|||
146654278|NCT01986933|528910750|FG003|Active-to-active (Part B)|Physician Decision|1|||
146654279|NCT01986933|528910751|FG004|Active-to-active (Part B)|Physician Decision|0|||
146654280|NCT01986933|528910747|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
146654281|NCT01986933|528910748|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
146654282|NCT01986933|528910749|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
146654283|NCT01986933|528910750|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
146654284|NCT01986933|528910751|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
146654285|NCT01986933|528910747|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
146654286|NCT01986933|528910748|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
146654287|NCT01986933|528910749|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
146654288|NCT01986933|528910750|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
146654289|NCT01986933|528910751|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
146654290|NCT01986933|528910747|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
146654291|NCT01986933|528910748|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
146654292|NCT01986933|528910749|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
146654293|NCT01986933|528910750|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
146654294|NCT01986933|528910751|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
146654295|NCT01986933|528910747|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
146771664|NCT01152190|529331242|FG001|Overall Study|Adverse Event|4|||
146771665|NCT01152190|529331241|FG000|Overall Study|Death|1|||
146598182|NCT02008773|528700133|FG002|Overall Study|Medication Non-compliance|3|||
146598183|NCT02008773|528700134|FG003|Overall Study|Medication Non-compliance|2|||
146654296|NCT01986933|528910748|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
146654297|NCT01986933|528910749|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
146654298|NCT01986933|528910750|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
146654299|NCT01986933|528910751|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
146598184|NCT02008773|528700131|FG000|Overall Study|Withdrawal by Subject|8|||
146598185|NCT02008773|528700132|FG001|Overall Study|Withdrawal by Subject|4|||
146598186|NCT02008773|528700133|FG002|Overall Study|Withdrawal by Subject|7|||
146920509|NCT04402008|529871420|FG004|Overall Study|Disease Progression|4|||
146920510|NCT04402008|529871421|FG005|Overall Study|Disease Progression|3|||
146598187|NCT02008773|528700134|FG003|Overall Study|Withdrawal by Subject|6|||
146598188|NCT02008773|528700131|FG000|Overall Study|Lost to Follow-up|0|||
146598189|NCT02008773|528700132|FG001|Overall Study|Lost to Follow-up|1|||
146598190|NCT02008773|528700133|FG002|Overall Study|Lost to Follow-up|3|||
146598191|NCT02008773|528700134|FG003|Overall Study|Lost to Follow-up|2|||
146598192|NCT04732949|528700137|FG000|Overall Study|Withdrawal by Subject|23|||
146598193|NCT04732949|528700138|FG001|Overall Study|Withdrawal by Subject|27|||
146598194|NCT04732949|528700137|FG000|Overall Study|Protocol Violation|0|||
146598195|NCT04732949|528700138|FG001|Overall Study|Protocol Violation|1|||
146598196|NCT04732949|528700137|FG000|Overall Study|Non-compliance|0|||
146654300|NCT01986933|528910747|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
146654301|NCT01986933|528910748|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
146654302|NCT01986933|528910749|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
146654303|NCT01986933|528910750|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
146654304|NCT01986933|528910751|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
146654305|NCT01986933|528910747|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
146654306|NCT01986933|528910748|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
146654307|NCT01986933|528910749|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
146654308|NCT01986933|528910750|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
146654309|NCT01986933|528910751|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
146654310|NCT01986933|528910747|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
146654311|NCT01986933|528910748|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
146654312|NCT01986933|528910749|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
146654313|NCT01986933|528910750|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
146654314|NCT01986933|528910751|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
146654315|NCT01986933|528910747|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
146920511|NCT04402008|529871422|FG006|Overall Study|Disease Progression|10|||
146920512|NCT04402008|529871416|FG000|Overall Study|Withdrawal by Subject|0|||
146920513|NCT04402008|529871417|FG001|Overall Study|Withdrawal by Subject|1|||
146920514|NCT04402008|529871418|FG002|Overall Study|Withdrawal by Subject|0|||
146920515|NCT04402008|529871419|FG003|Overall Study|Withdrawal by Subject|0|||
146920516|NCT04402008|529871420|FG004|Overall Study|Withdrawal by Subject|1|||
146920517|NCT04402008|529871421|FG005|Overall Study|Withdrawal by Subject|0|||
146920518|NCT04402008|529871422|FG006|Overall Study|Withdrawal by Subject|0|||
146920519|NCT04402008|529871416|FG000|Overall Study|Sponsor Decision|0|||
146920520|NCT04402008|529871417|FG001|Overall Study|Sponsor Decision|0|||
146920521|NCT04402008|529871418|FG002|Overall Study|Sponsor Decision|0|||
146920522|NCT04402008|529871419|FG003|Overall Study|Sponsor Decision|0|||
146920523|NCT04402008|529871420|FG004|Overall Study|Sponsor Decision|0|||
146920524|NCT04402008|529871421|FG005|Overall Study|Sponsor Decision|0|||
146920525|NCT04402008|529871422|FG006|Overall Study|Sponsor Decision|3|||
146920526|NCT04402008|529871416|FG000|Overall Study|Death|0|||
146920527|NCT04402008|529871417|FG001|Overall Study|Death|0|||
146920528|NCT04402008|529871418|FG002|Overall Study|Death|0|||
146920529|NCT04402008|529871419|FG003|Overall Study|Death|0|||
146920530|NCT04402008|529871420|FG004|Overall Study|Death|1|||
146920531|NCT04402008|529871421|FG005|Overall Study|Death|0|||
146920532|NCT04402008|529871422|FG006|Overall Study|Death|2|||
146920533|NCT04402008|529871416|FG000|Overall Study|Other|0|||
146920534|NCT04402008|529871417|FG001|Overall Study|Other|0|||
146920535|NCT04402008|529871418|FG002|Overall Study|Other|0|||
146920536|NCT04402008|529871419|FG003|Overall Study|Other|0|||
146920537|NCT04402008|529871420|FG004|Overall Study|Other|0|||
146920538|NCT04402008|529871421|FG005|Overall Study|Other|0|||
146920539|NCT04402008|529871422|FG006|Overall Study|Other|5|||
146920540|NCT01028651|529871425|FG000|Overall Study|Death|2|||
146654316|NCT01986933|528910748|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
146920541|NCT01028651|529871425|FG000|Overall Study|Adverse Event|1|||
146920542|NCT01533935|529871426|FG000|Overall Study|Adverse Event|5|||
146920543|NCT01533935|529871427|FG001|Overall Study|Adverse Event|7|||
146978524|NCT00272961|530084096|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
146920544|NCT01533935|529871428|FG002|Overall Study|Adverse Event|1|||
146978525|NCT00272961|530084097|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
146654317|NCT01986933|528910749|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
146654318|NCT01986933|528910750|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
146654319|NCT01986933|528910751|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
146654320|NCT03370276|528910752|FG000|Overall Study|Death|0|||
146654321|NCT03370276|528910753|FG001|Overall Study|Death|2|||
146654322|NCT03370276|528910754|FG002|Overall Study|Death|5|||
146920545|NCT01533935|529871429|FG003|Overall Study|Adverse Event|5|||
146920546|NCT01533935|529871430|FG004|Overall Study|Adverse Event|3|||
146598197|NCT04732949|528700138|FG001|Overall Study|Non-compliance|2|||
146598198|NCT04732949|528700137|FG000|Overall Study|Physician Decision|2|||
146598199|NCT04732949|528700138|FG001|Overall Study|Physician Decision|1|||
146920547|NCT01533935|529871426|FG000|Overall Study|Protocol Violation|0|||
146920548|NCT01533935|529871427|FG001|Overall Study|Protocol Violation|2|||
146598200|NCT04732949|528700137|FG000|Overall Study|Serious adverse event (Fatal)|16|||
146598201|NCT04732949|528700138|FG001|Overall Study|Serious adverse event (Fatal)|18|||
146598202|NCT04732949|528700137|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
146598203|NCT04732949|528700138|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
146598204|NCT04732949|528700137|FG000|Overall Study|Non-serious adverse event|1|||
146598205|NCT04732949|528700138|FG001|Overall Study|Non-serious adverse event|3|||
146598206|NCT04732949|528700137|FG000|Overall Study|Lost to Follow-up|26|||
146598207|NCT04732949|528700138|FG001|Overall Study|Lost to Follow-up|27|||
146598208|NCT04732949|528700137|FG000|Overall Study|Other|6|||
146598209|NCT04732949|528700138|FG001|Overall Study|Other|3|||
146598210|NCT01806064|528700139|FG000|Overall Study|Randomized Not Enrolled|0|||
146598211|NCT01806064|528700140|FG001|Overall Study|Randomized Not Enrolled|0|||
146598212|NCT01806064|528700141|FG002|Overall Study|Randomized Not Enrolled|0|||
146598213|NCT01806064|528700142|FG003|Overall Study|Randomized Not Enrolled|1|||
146598214|NCT01806064|528700143|FG004|Overall Study|Randomized Not Enrolled|2|||
146598215|NCT01286077|528700146|FG000|Overall Study|Adverse Event|2|||
146978526|NCT00272961|530084098|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
146598216|NCT01286077|528700147|FG001|Overall Study|Adverse Event|0|||
146598217|NCT01286077|528700146|FG000|Overall Study|Death|1|||
146598218|NCT01286077|528700147|FG001|Overall Study|Death|0|||
146598219|NCT01286077|528700146|FG000|Overall Study|Protocol Violation|1|||
146598220|NCT01286077|528700147|FG001|Overall Study|Protocol Violation|1|||
146598221|NCT01286077|528700146|FG000|Overall Study|Withdrawal by Subject|0|||
146598222|NCT01286077|528700147|FG001|Overall Study|Withdrawal by Subject|2|||
146598223|NCT01286077|528700146|FG000|Overall Study|Intercurrent illness|1|||
146598224|NCT01286077|528700147|FG001|Overall Study|Intercurrent illness|0|||
146598225|NCT01286077|528700146|FG000|Overall Study|Non-compliance|1|||
146598226|NCT01286077|528700147|FG001|Overall Study|Non-compliance|0|||
146598227|NCT01286077|528700146|FG000|Overall Study|The subject starts with alternative MMY|0|||
146598228|NCT01286077|528700147|FG001|Overall Study|The subject starts with alternative MMY|3|||
146598229|NCT01286077|528700146|FG000|Overall Study|Patient's decision to stop treatment|3|||
146598230|NCT01286077|528700147|FG001|Overall Study|Patient's decision to stop treatment|0|||
146598231|NCT01286077|528700146|FG000|Overall Study|Progression of disease|0|||
146598232|NCT01286077|528700147|FG001|Overall Study|Progression of disease|1|||
146598233|NCT01286077|528700146|FG000|Overall Study|refill medication not received in time|1|||
146598234|NCT01286077|528700147|FG001|Overall Study|refill medication not received in time|0|||
146598235|NCT01282294|528700150|FG000|Overall Study|Lost to Follow-up|14|||
146598236|NCT01282294|528700150|FG000|Overall Study|Screening failure|1|||
146598237|NCT01282294|528700150|FG000|Overall Study|Adverse Event|1|||
146598238|NCT01282294|528700150|FG000|Overall Study|Patient non-compliance|2|||
146598239|NCT01282294|528700150|FG000|Overall Study|Physician Decision|1|||
146598240|NCT02408523|528700151|FG000|Overall Study|Adverse Event|4|||
146598241|NCT02408523|528700152|FG001|Overall Study|Adverse Event|10|||
146598242|NCT02408523|528700151|FG000|Overall Study|Lack of Efficacy|0|||
146598243|NCT02408523|528700152|FG001|Overall Study|Lack of Efficacy|1|||
146598244|NCT02408523|528700151|FG000|Overall Study|Protocol Violation|1|||
146598245|NCT02408523|528700152|FG001|Overall Study|Protocol Violation|2|||
146598246|NCT02408523|528700151|FG000|Overall Study|Lost to Follow-up|2|||
146598247|NCT02408523|528700152|FG001|Overall Study|Lost to Follow-up|3|||
146598248|NCT02408523|528700151|FG000|Overall Study|Withdrawal by Subject|3|||
146598249|NCT02408523|528700152|FG001|Overall Study|Withdrawal by Subject|1|||
146598250|NCT02408523|528700151|FG000|Overall Study|Sponsor request|1|||
146598251|NCT02408523|528700152|FG001|Overall Study|Sponsor request|0|||
146598252|NCT02408523|528700151|FG000|Overall Study|Did not satisfy extension conditions|0|||
146598253|NCT02408523|528700152|FG001|Overall Study|Did not satisfy extension conditions|1|||
146598254|NCT04256512|528700153|FG000|Overall Study|Withdrawal by Subject|1|||
146598255|NCT02797184|528700162|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
146598256|NCT02797184|528700163|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
146598257|NCT03199391|528700168|FG000|Overall Study|Death|1|||
146598258|NCT03199391|528700168|FG000|Overall Study|Lost to Follow-up|3|||
146598259|NCT03199391|528700168|FG000|Overall Study|Adverse Event|2|||
146598260|NCT03199391|528700168|FG000|Overall Study|Withdrawal by Subject|10|||
146598261|NCT03921554|528700175|FG000|Overall Study|Adverse Event|2|||
146598262|NCT03921554|528700175|FG000|Overall Study|Withdrawal by Subject|1|||
146598263|NCT03921554|528700175|FG000|Overall Study|Death|3|||
146598264|NCT00431951|528700176|FG000|Overall Study|Inability to follow study procedures|1|||
146598265|NCT00431951|528700177|FG001|Overall Study|Inability to follow study procedures|0|||
146598266|NCT00431951|528700178|FG002|Overall Study|Inability to follow study procedures|1|||
146598267|NCT00431951|528700179|FG003|Overall Study|Inability to follow study procedures|2|||
146598268|NCT00431951|528700176|FG000|Overall Study|Lost to Follow-up|0|||
146598269|NCT00431951|528700177|FG001|Overall Study|Lost to Follow-up|1|||
146598270|NCT00431951|528700178|FG002|Overall Study|Lost to Follow-up|0|||
146598271|NCT00431951|528700179|FG003|Overall Study|Lost to Follow-up|0|||
146598272|NCT00431951|528700176|FG000|Overall Study|Withdrawal by Subject|0|||
146598273|NCT00431951|528700177|FG001|Overall Study|Withdrawal by Subject|1|||
146920549|NCT01533935|529871428|FG002|Overall Study|Protocol Violation|0|||
146920550|NCT01533935|529871429|FG003|Overall Study|Protocol Violation|0|||
146920551|NCT01533935|529871430|FG004|Overall Study|Protocol Violation|0|||
146920552|NCT01533935|529871426|FG000|Overall Study|Lost to Follow-up|0|||
146598274|NCT00431951|528700178|FG002|Overall Study|Withdrawal by Subject|0|||
146598275|NCT00431951|528700179|FG003|Overall Study|Withdrawal by Subject|0|||
146598276|NCT00431951|528700176|FG000|Overall Study|Adverse Event|0|||
146598277|NCT00431951|528700177|FG001|Overall Study|Adverse Event|0|||
146598278|NCT00431951|528700178|FG002|Overall Study|Adverse Event|1|||
146598279|NCT00431951|528700179|FG003|Overall Study|Adverse Event|0|||
146598280|NCT05824936|528700184|FG000|Overall Study|Lost to Follow-up|1|||
146598281|NCT00096018|528700185|FG000|Overall Study|Became Ineligible (not treated)|0|||
146598282|NCT00096018|528700186|FG001|Overall Study|Became Ineligible (not treated)|3|||
146598283|NCT00096018|528700185|FG000|Overall Study|Miscellaneous (not treated)|0|||
146598284|NCT00096018|528700186|FG001|Overall Study|Miscellaneous (not treated)|2|||
146598285|NCT00096018|528700185|FG000|Overall Study|Adverse Event|0|||
146598286|NCT00096018|528700186|FG001|Overall Study|Adverse Event|5|||
146598287|NCT00096018|528700185|FG000|Overall Study|Death|0|||
146598288|NCT00096018|528700186|FG001|Overall Study|Death|1|||
146598289|NCT00096018|528700185|FG000|Overall Study|Withdrawal by Subject|0|||
146598290|NCT00096018|528700186|FG001|Overall Study|Withdrawal by Subject|2|||
146598291|NCT00096018|528700185|FG000|Overall Study|Miscellaneous|2|||
146598292|NCT00096018|528700186|FG001|Overall Study|Miscellaneous|1|||
146598293|NCT00673881|528700187|FG000|Overall Study|Withdrawal by Subject|1|||
146598294|NCT01299571|528700195|FG000|Overall Study|Protocol Violation|107|||
146598295|NCT00413010|528700196|FG000|Overall Study|Adverse Event|8|||
146598296|NCT00413010|528700197|FG001|Overall Study|Adverse Event|4|||
146598297|NCT00413010|528700196|FG000|Overall Study|Laboratory abnormality|0|||
146598298|NCT00413010|528700197|FG001|Overall Study|Laboratory abnormality|2|||
146598299|NCT00413010|528700196|FG000|Overall Study|Lack of Efficacy|0|||
146598300|NCT00413010|528700197|FG001|Overall Study|Lack of Efficacy|3|||
146598301|NCT00413010|528700196|FG000|Overall Study|Lost to Follow-up|3|||
146598302|NCT00413010|528700197|FG001|Overall Study|Lost to Follow-up|0|||
146598303|NCT00413010|528700196|FG000|Overall Study|Withdrawal by Subject|7|||
146598304|NCT00413010|528700197|FG001|Overall Study|Withdrawal by Subject|2|||
146598305|NCT00413010|528700196|FG000|Overall Study|Due to termination of the study|54|||
146598306|NCT00413010|528700197|FG001|Overall Study|Due to termination of the study|52|||
146598307|NCT00708734|528700198|FG000|Overall Study|scheduling conflict|2|||
146598308|NCT00708734|528700198|FG000|Overall Study|moved|1|||
146598309|NCT00708734|528700198|FG000|Overall Study|leg injury|1|||
146598310|NCT00708734|528700198|FG000|Overall Study|knee replacement|1|||
146598311|NCT00708734|528700198|FG000|Overall Study|vertigo|1|||
146598312|NCT00708734|528700198|FG000|Overall Study|leg fracture|1|||
146598313|NCT01533922|528700199|FG000|Overall Study|Adverse Event|5|||
146598314|NCT01533922|528700200|FG001|Overall Study|Adverse Event|8|||
146598315|NCT01533922|528700201|FG002|Overall Study|Adverse Event|6|||
146598316|NCT01533922|528700202|FG003|Overall Study|Adverse Event|3|||
146598317|NCT01533922|528700203|FG004|Overall Study|Adverse Event|4|||
146598318|NCT01533922|528700199|FG000|Overall Study|Lack of Efficacy|0|||
146920553|NCT01533935|529871427|FG001|Overall Study|Lost to Follow-up|0|||
146920554|NCT01533935|529871428|FG002|Overall Study|Lost to Follow-up|1|||
146598319|NCT01533922|528700200|FG001|Overall Study|Lack of Efficacy|0|||
146598320|NCT01533922|528700201|FG002|Overall Study|Lack of Efficacy|1|||
146598321|NCT01533922|528700202|FG003|Overall Study|Lack of Efficacy|0|||
146598322|NCT01533922|528700203|FG004|Overall Study|Lack of Efficacy|0|||
146598323|NCT01533922|528700199|FG000|Overall Study|Protocol Violation|0|||
146598324|NCT01533922|528700200|FG001|Overall Study|Protocol Violation|3|||
146598325|NCT01533922|528700201|FG002|Overall Study|Protocol Violation|0|||
146598326|NCT01533922|528700202|FG003|Overall Study|Protocol Violation|0|||
146598327|NCT01533922|528700203|FG004|Overall Study|Protocol Violation|1|||
146598328|NCT01533922|528700199|FG000|Overall Study|Withdrawal by Subject|3|||
146598329|NCT01533922|528700200|FG001|Overall Study|Withdrawal by Subject|1|||
146598330|NCT01533922|528700201|FG002|Overall Study|Withdrawal by Subject|2|||
146598331|NCT01533922|528700202|FG003|Overall Study|Withdrawal by Subject|2|||
146654323|NCT04030026|528910755|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
146920555|NCT01533935|529871429|FG003|Overall Study|Lost to Follow-up|0|||
146920556|NCT01533935|529871430|FG004|Overall Study|Lost to Follow-up|0|||
146598332|NCT01533922|528700203|FG004|Overall Study|Withdrawal by Subject|1|||
146598333|NCT01533922|528700199|FG000|Overall Study|Other reason not defined above|2|||
146598334|NCT01533922|528700200|FG001|Overall Study|Other reason not defined above|0|||
146598335|NCT01533922|528700201|FG002|Overall Study|Other reason not defined above|1|||
146598336|NCT01533922|528700202|FG003|Overall Study|Other reason not defined above|0|||
146598337|NCT01533922|528700203|FG004|Overall Study|Other reason not defined above|0|||
146598338|NCT05432167|528700204|FG000|Overall Study|Adverse Event|0|||
146598339|NCT05432167|528700205|FG001|Overall Study|Adverse Event|2|||
146598340|NCT05432167|528700206|FG002|Overall Study|Adverse Event|1|||
146598341|NCT05432167|528700204|FG000|Overall Study|Lost to Follow-up|3|||
146598342|NCT05432167|528700205|FG001|Overall Study|Lost to Follow-up|3|||
146598343|NCT05432167|528700206|FG002|Overall Study|Lost to Follow-up|2|||
146598344|NCT05432167|528700204|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
146598345|NCT05432167|528700205|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
146598346|NCT05432167|528700206|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
146598347|NCT05432167|528700204|FG000|Overall Study|Physician Decision|1|||
146598348|NCT05432167|528700205|FG001|Overall Study|Physician Decision|0|||
146598349|NCT05432167|528700206|FG002|Overall Study|Physician Decision|0|||
146598350|NCT05432167|528700204|FG000|Overall Study|Withdrawal by Subject|7|||
146598351|NCT05432167|528700205|FG001|Overall Study|Withdrawal by Subject|4|||
146598352|NCT05432167|528700206|FG002|Overall Study|Withdrawal by Subject|11|||
146598353|NCT05432167|528700204|FG000|Overall Study|Other|0|||
146598354|NCT05432167|528700205|FG001|Overall Study|Other|0|||
146598355|NCT05432167|528700206|FG002|Overall Study|Other|1|||
146598356|NCT01267175|528700207|FG000|Overall Study|Withdrawal by Subject|1|||
146598357|NCT01267175|528700207|FG000|Overall Study|Lost to Follow-up|1|||
146598358|NCT02006069|528700208|FG000|Overall Study|MPP other programming|239|||
146598359|NCT02006069|528700209|FG001|Overall Study|MPP other programming|0|||
146598360|NCT02006069|528700208|FG000|Overall Study|RV only pacing|0|||
146598361|NCT02006069|528700209|FG001|Overall Study|RV only pacing|3|||
146598362|NCT02690649|528700212|FG000|Overall Study|Withdrawal by Subject|1|||
146598363|NCT02690649|528700213|FG001|Overall Study|Withdrawal by Subject|1|||
146598364|NCT02690649|528700212|FG000|Overall Study|Protocol Violation|0|||
146598365|NCT02690649|528700213|FG001|Overall Study|Protocol Violation|3|||
146598366|NCT02276547|528700214|FG000|Overall Study|Death|2|||
146598367|NCT02276547|528700214|FG000|Overall Study|Explant|2|||
146598368|NCT00530920|528700215|FG000|Overall Study|Randomized but not treated|0|||
146598369|NCT00530920|528700216|FG001|Overall Study|Randomized but not treated|2|||
146598370|NCT00530920|528700217|FG002|Overall Study|Randomized but not treated|0|||
146598371|NCT00530920|528700215|FG000|Overall Study|Adverse Event|0|||
146598372|NCT00530920|528700216|FG001|Overall Study|Adverse Event|0|||
146598373|NCT00530920|528700217|FG002|Overall Study|Adverse Event|3|||
146598374|NCT00530920|528700215|FG000|Overall Study|Withdrawal by Subject|0|||
146598375|NCT00530920|528700216|FG001|Overall Study|Withdrawal by Subject|0|||
146598376|NCT00530920|528700217|FG002|Overall Study|Withdrawal by Subject|1|||
146598377|NCT00316888|528700222|FG000|Overall Study|Adverse Event|4|||
146598378|NCT00316888|528700223|FG001|Overall Study|Adverse Event|5|||
146598379|NCT00316888|528700222|FG000|Overall Study|Withdrawal by Subject|2|||
146598380|NCT00316888|528700223|FG001|Overall Study|Withdrawal by Subject|2|||
146598381|NCT00316888|528700222|FG000|Overall Study|Not start protocol therapy|0|||
146598382|NCT00316888|528700223|FG001|Overall Study|Not start protocol therapy|1|||
146598383|NCT01672866|528700227|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
146598384|NCT01672866|528700228|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
146598385|NCT01672866|528700229|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
146598386|NCT01672866|528700227|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
146598387|NCT01672866|528700228|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
146598388|NCT01672866|528700229|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
146598389|NCT01672866|528700227|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
146598390|NCT01672866|528700228|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
146598391|NCT01672866|528700229|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
146598392|NCT01672866|528700227|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
146598393|NCT01672866|528700228|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
146598394|NCT01672866|528700229|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
146598395|NCT01672866|528700227|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
146654324|NCT04030026|528910756|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
146654325|NCT04030026|528910755|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
146654326|NCT04030026|528910756|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
146654327|NCT04030026|528910755|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
146654328|NCT04030026|528910756|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
146654329|NCT04030026|528910755|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
146654330|NCT04030026|528910756|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
146654331|NCT04030026|528910755|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
146598396|NCT01672866|528700228|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
146598397|NCT01672866|528700229|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
146598398|NCT01672866|528700227|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
146598399|NCT01672866|528700228|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
146598400|NCT01672866|528700229|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
146654332|NCT04030026|528910756|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
146978527|NCT00272961|530084099|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
146598401|NCT01672866|528700227|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
146598402|NCT01672866|528700228|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
146598403|NCT01672866|528700229|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
146598404|NCT01672866|528700227|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
146598405|NCT01672866|528700228|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
146920557|NCT01533935|529871426|FG000|Overall Study|Withdrawal by Subject|0|||
146920558|NCT01533935|529871427|FG001|Overall Study|Withdrawal by Subject|4|||
146920559|NCT01533935|529871428|FG002|Overall Study|Withdrawal by Subject|5|||
146920560|NCT01533935|529871429|FG003|Overall Study|Withdrawal by Subject|2|||
146920561|NCT01533935|529871430|FG004|Overall Study|Withdrawal by Subject|4|||
146920562|NCT01533935|529871426|FG000|Overall Study|Other reason not defined above|1|||
146920563|NCT01533935|529871427|FG001|Overall Study|Other reason not defined above|0|||
146920564|NCT01533935|529871428|FG002|Overall Study|Other reason not defined above|1|||
146920565|NCT01533935|529871429|FG003|Overall Study|Other reason not defined above|0|||
146920566|NCT01533935|529871430|FG004|Overall Study|Other reason not defined above|1|||
146598406|NCT01672866|528700229|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
146920567|NCT05631548|529871431|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
146920568|NCT05631548|529871432|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
146920569|NCT04075266|529871433|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
146920570|NCT04075266|529871434|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
146920571|NCT04075266|529871433|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
146920572|NCT04075266|529871434|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
146920573|NCT05132569|529871435|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
146920574|NCT05132569|529871436|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
146920575|NCT05132569|529871435|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
146920576|NCT05132569|529871436|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
146920577|NCT05132569|529871435|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
146920578|NCT05132569|529871436|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
146920579|NCT01554956|529871437|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
146920580|NCT01554956|529871438|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
146920581|NCT01554956|529871439|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
146920582|NCT01554956|529871437|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
146920583|NCT01554956|529871438|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
146920584|NCT01554956|529871439|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
146920585|NCT01554956|529871437|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
146920586|NCT01554956|529871438|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
146920587|NCT01554956|529871439|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
146920588|NCT00913978|529871440|FG000|Overall Study|Surgeon choice|1|||
146920589|NCT00913978|529871441|FG001|Overall Study|Surgeon choice|3|||
146920590|NCT00210158|529871442|FG000|Overall Study|Protocol Violation|0|||
146920591|NCT00210158|529871443|FG001|Overall Study|Protocol Violation|2|||
146920592|NCT04716933|529871444|FG000|Overall Study|Sponsor Decision|36|||
146920593|NCT04716933|529871445|FG001|Overall Study|Sponsor Decision|33|||
146920594|NCT04716933|529871444|FG000|Overall Study|Death|65|||
146920595|NCT04716933|529871445|FG001|Overall Study|Death|67|||
146920596|NCT01327651|529871446|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
146920597|NCT01327651|529871447|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
146920598|NCT01327651|529871448|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
146920599|NCT01327651|529871449|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
146920600|NCT01327651|529871450|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
146598407|NCT01672866|528700227|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
146598408|NCT01672866|528700228|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
146598409|NCT01672866|528700229|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
146920601|NCT01327651|529871451|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
146978528|NCT00272961|530084100|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
146598410|NCT01672866|528700227|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
146598411|NCT01672866|528700228|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
146598412|NCT01672866|528700229|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
146598413|NCT01672866|528700227|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
146598414|NCT01672866|528700228|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
146598415|NCT01672866|528700229|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
146598416|NCT01672866|528700227|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
146654333|NCT04030026|528910755|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
146654334|NCT04030026|528910756|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
146654335|NCT04030026|528910755|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
146654336|NCT04030026|528910756|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
146598417|NCT01672866|528700228|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
146598418|NCT01672866|528700229|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
146654337|NCT02361346|528910757|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
146654338|NCT02361346|528910758|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
146654339|NCT02361346|528910759|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
146654340|NCT02361346|528910760|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
146598419|NCT01672866|528700227|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
146598420|NCT01672866|528700228|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
146598421|NCT01672866|528700229|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
146598422|NCT02273960|528700230|FG000|Short Term Period|Lost to Follow-up|1|||
146598423|NCT02273960|528700231|FG001|Short Term Period|Lost to Follow-up|0|||
146598424|NCT02273960|528700232|FG002|Short Term Period|Lost to Follow-up|0|||
146598425|NCT02273960|528700233|FG003|Short Term Period|Lost to Follow-up|0|||
146598426|NCT02273960|528700230|FG000|Short Term Period|Lack of Efficacy|0|||
146598427|NCT02273960|528700231|FG001|Short Term Period|Lack of Efficacy|0|||
146598428|NCT02273960|528700232|FG002|Short Term Period|Lack of Efficacy|0|||
146598429|NCT02273960|528700233|FG003|Short Term Period|Lack of Efficacy|1|||
146598430|NCT02273960|528700230|FG000|Short Term Period|ST complete, not entering LTE|4|||
146598431|NCT02273960|528700231|FG001|Short Term Period|ST complete, not entering LTE|6|||
146598432|NCT02273960|528700232|FG002|Short Term Period|ST complete, not entering LTE|4|||
146920602|NCT01327651|529871452|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
146920603|NCT01327651|529871453|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
146920604|NCT01327651|529871454|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
146920605|NCT01327651|529871446|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
146920606|NCT01327651|529871447|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
146920607|NCT01327651|529871448|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
146920608|NCT01327651|529871449|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
146920609|NCT01327651|529871450|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
146920610|NCT01327651|529871451|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
146920611|NCT01327651|529871452|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
146920612|NCT01327651|529871453|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
146920613|NCT01327651|529871454|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
146920614|NCT01327651|529871446|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
146920615|NCT01327651|529871447|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
146920616|NCT01327651|529871448|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
146920617|NCT01327651|529871449|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
146920618|NCT01327651|529871450|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
146920619|NCT01327651|529871451|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
146920620|NCT01327651|529871452|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
146920621|NCT01327651|529871453|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
146920622|NCT01327651|529871454|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
146920623|NCT01327651|529871446|FG000|Post Study Follow-up|Lost to Follow-up|0|||
146920624|NCT01327651|529871447|FG001|Post Study Follow-up|Lost to Follow-up|1|||
146920625|NCT01327651|529871448|FG002|Post Study Follow-up|Lost to Follow-up|1|||
146920626|NCT01327651|529871449|FG003|Post Study Follow-up|Lost to Follow-up|0|||
146920627|NCT01327651|529871450|FG004|Post Study Follow-up|Lost to Follow-up|0|||
146920628|NCT01327651|529871451|FG005|Post Study Follow-up|Lost to Follow-up|0|||
146920629|NCT01327651|529871452|FG006|Post Study Follow-up|Lost to Follow-up|4|||
146920630|NCT01327651|529871453|FG007|Post Study Follow-up|Lost to Follow-up|1|||
146920631|NCT01327651|529871454|FG008|Post Study Follow-up|Lost to Follow-up|2|||
146920632|NCT03249792|529871455|FG000|Arms 1, 2, and 4|Death|1|||
146920633|NCT03249792|529871456|FG001|Arms 1, 2, and 4|Death|1|||
146920634|NCT03249792|529871457|FG002|Arms 1, 2, and 4|Death|0|||
146920635|NCT03249792|529871458|FG003|Arms 1, 2, and 4|Death|2|||
146920636|NCT03249792|529871459|FG004|Arms 1, 2, and 4|Death|3|||
146920637|NCT03249792|529871460|FG005|Arms 1, 2, and 4|Death|2|||
146920638|NCT03249792|529871461|FG006|Arms 1, 2, and 4|Death|2|||
146920639|NCT03249792|529871462|FG007|Arms 1, 2, and 4|Death|4|||
146920640|NCT03249792|529871463|FG008|Arms 1, 2, and 4|Death|2|||
146920641|NCT03249792|529871464|FG009|Arms 1, 2, and 4|Death|1|||
146598433|NCT02273960|528700233|FG003|Short Term Period|ST complete, not entering LTE|5|||
146598434|NCT02273960|528700230|FG000|Long Term Extension|Death|0|||
146598435|NCT02273960|528700231|FG001|Long Term Extension|Death|0|||
146598436|NCT02273960|528700232|FG002|Long Term Extension|Death|0|||
146598437|NCT02273960|528700233|FG003|Long Term Extension|Death|1|||
146598438|NCT01789606|528700234|FG000|Overall Study|Participant not Purchased the Product|0|||
146598439|NCT01789606|528700235|FG001|Overall Study|Participant not Purchased the Product|20|||
146598440|NCT01789606|528700234|FG000|Overall Study|Withdrawal by Subject|0|||
146598441|NCT01789606|528700235|FG001|Overall Study|Withdrawal by Subject|1|||
146598442|NCT01789606|528700234|FG000|Overall Study|Ineligible|6|||
146598443|NCT01789606|528700235|FG001|Overall Study|Ineligible|2|||
146598444|NCT01789606|528700234|FG000|Overall Study|Administrative Reasons|17|||
146598445|NCT01789606|528700235|FG001|Overall Study|Administrative Reasons|6|||
146598446|NCT01789606|528700234|FG000|Overall Study|No Study Medication Taken|0|||
146598447|NCT01789606|528700235|FG001|Overall Study|No Study Medication Taken|1|||
146598448|NCT01789606|528700234|FG000|Overall Study|Protocol Violation|0|||
146598449|NCT01789606|528700235|FG001|Overall Study|Protocol Violation|55|||
146598450|NCT01789606|528700234|FG000|Overall Study|Adverse Event|0|||
146598451|NCT01789606|528700235|FG001|Overall Study|Adverse Event|3|||
146771666|NCT01152190|529331242|FG001|Overall Study|Death|0|||
146771667|NCT01152190|529331241|FG000|Overall Study|Protocol Violation|1|||
146771668|NCT01152190|529331242|FG001|Overall Study|Protocol Violation|1|||
146771669|NCT01152190|529331241|FG000|Overall Study|Withdrawal by Subject|1|||
146771670|NCT01152190|529331242|FG001|Overall Study|Withdrawal by Subject|3|||
146771671|NCT03603717|529331251|FG000|Overall Study|Lost to Follow-up|20|||
146771672|NCT03603717|529331252|FG001|Overall Study|Lost to Follow-up|20|||
146771673|NCT03603717|529331251|FG000|Overall Study|Withdrawal by Subject|16|||
146771674|NCT03603717|529331252|FG001|Overall Study|Withdrawal by Subject|10|||
146771675|NCT05777785|529332558|FG000|Overall Study|Withdrawal by Subject|5|||
146771676|NCT05777785|529332558|FG000|Overall Study|Lost to Follow-up|1|||
146771677|NCT05644444|529332563|FG000|Tolerance Phase|Adverse Event|0|||
146771678|NCT05644444|529332564|FG001|Tolerance Phase|Adverse Event|2|||
146771679|NCT05644444|529332563|FG000|Treatment Phase|Adverse Event|0|||
146771680|NCT05644444|529332564|FG001|Treatment Phase|Adverse Event|2|||
146771681|NCT04817670|529332565|FG000|Overall Study|Withdrawal by Subject|1|||
146771682|NCT04817670|529332566|FG001|Overall Study|Withdrawal by Subject|0|||
146771683|NCT04817670|529332567|FG002|Overall Study|Withdrawal by Subject|0|||
146598452|NCT01789606|528700234|FG000|Overall Study|Lost to Follow-up|0|||
146598453|NCT01789606|528700235|FG001|Overall Study|Lost to Follow-up|14|||
146598454|NCT01789606|528700234|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
146598455|NCT01789606|528700235|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
146598456|NCT01105377|528700236|FG000|Overall Study|Withdrawal by Subject|0|||
146598457|NCT01105377|528700237|FG001|Overall Study|Withdrawal by Subject|1|||
146598458|NCT01825941|528701644|FG000|Overall Study|Lost to Follow-up|4|||
146598459|NCT01825941|528701645|FG001|Overall Study|Lost to Follow-up|1|||
146598460|NCT03495102|528701646|FG000|Overall Study|Adverse Event|5|||
146598461|NCT03495102|528701647|FG001|Overall Study|Adverse Event|7|||
146598462|NCT03495102|528701648|FG002|Overall Study|Adverse Event|10|||
146598463|NCT03495102|528701646|FG000|Overall Study|Death|3|||
146771684|NCT04817670|529332568|FG003|Overall Study|Withdrawal by Subject|0|||
146771685|NCT04817670|529332569|FG004|Overall Study|Withdrawal by Subject|0|||
146598464|NCT03495102|528701647|FG001|Overall Study|Death|4|||
146598465|NCT03495102|528701648|FG002|Overall Study|Death|4|||
146598466|NCT03495102|528701646|FG000|Overall Study|Lost to Follow-up|15|||
146598467|NCT03495102|528701647|FG001|Overall Study|Lost to Follow-up|16|||
146598468|NCT03495102|528701648|FG002|Overall Study|Lost to Follow-up|17|||
146598469|NCT03495102|528701646|FG000|Overall Study|Physician Decision|2|||
146598470|NCT03495102|528701647|FG001|Overall Study|Physician Decision|0|||
146771686|NCT04817670|529332565|FG000|Overall Study|Lost to Follow-up|0|||
146771687|NCT04817670|529332566|FG001|Overall Study|Lost to Follow-up|0|||
146771688|NCT04817670|529332567|FG002|Overall Study|Lost to Follow-up|1|||
146771689|NCT04817670|529332568|FG003|Overall Study|Lost to Follow-up|0|||
146771690|NCT04817670|529332569|FG004|Overall Study|Lost to Follow-up|0|||
146771691|NCT02396316|529332570|FG000|Overall Study|Physician Decision|1|||
146771692|NCT02396316|529332571|FG001|Overall Study|Physician Decision|0|||
146771693|NCT02396316|529332570|FG000|Overall Study|Progressive disease|6|||
146771694|NCT02396316|529332571|FG001|Overall Study|Progressive disease|3|||
146771695|NCT02396316|529332570|FG000|Overall Study|Protocol Violation|0|||
146771696|NCT02396316|529332571|FG001|Overall Study|Protocol Violation|1|||
146771697|NCT02396316|529332570|FG000|Overall Study|Treatment unblinded|0|||
146771698|NCT02396316|529332571|FG001|Overall Study|Treatment unblinded|1|||
146771699|NCT00714714|529332573|FG000|Overall Study|Adverse Event|1|||
146771700|NCT01149369|529332574|FG000|Overall Study|Adverse Event|6|||
146771701|NCT01149369|529332575|FG001|Overall Study|Adverse Event|3|||
146771702|NCT02242487|529332576|FG000|Overall Study|Adverse Event|13|||
146771703|NCT02242487|529332577|FG001|Overall Study|Adverse Event|15|||
146771704|NCT02242487|529332576|FG000|Overall Study|Lack of Efficacy|4|||
146771705|NCT02242487|529332577|FG001|Overall Study|Lack of Efficacy|6|||
146771706|NCT02242487|529332576|FG000|Overall Study|Protocol Violation|2|||
146771707|NCT02242487|529332577|FG001|Overall Study|Protocol Violation|0|||
146771708|NCT02242487|529332576|FG000|Overall Study|Lost to Follow-up|2|||
146598471|NCT03495102|528701648|FG002|Overall Study|Physician Decision|2|||
146598472|NCT03495102|528701646|FG000|Overall Study|Withdrawal by Subject|25|||
146598473|NCT03495102|528701647|FG001|Overall Study|Withdrawal by Subject|36|||
146598474|NCT03495102|528701648|FG002|Overall Study|Withdrawal by Subject|18|||
146771709|NCT02242487|529332577|FG001|Overall Study|Lost to Follow-up|1|||
146771710|NCT02242487|529332576|FG000|Overall Study|Other - Miscellaneous|4|||
146771711|NCT02242487|529332577|FG001|Overall Study|Other - Miscellaneous|6|||
146598475|NCT03495102|528701646|FG000|Overall Study|Protocol Violation|1|||
146598476|NCT03495102|528701647|FG001|Overall Study|Protocol Violation|1|||
146771712|NCT02242487|529332576|FG000|Overall Study|Withdrawal by Subject|37|||
146771713|NCT02242487|529332577|FG001|Overall Study|Withdrawal by Subject|19|||
146771714|NCT03644849|529332580|FG000|Overall Study|Lost to Follow-up|1|||
146771715|NCT03644849|529332581|FG001|Overall Study|Lost to Follow-up|3|||
146771716|NCT00508924|529332582|FG000|Overall Study|Protocol Violation|0|||
146771717|NCT00508924|529332583|FG001|Overall Study|Protocol Violation|0|||
146771718|NCT00508924|529332584|FG002|Overall Study|Protocol Violation|1|||
146771719|NCT00508924|529332585|FG003|Overall Study|Protocol Violation|1|||
146771720|NCT02755805|529332586|FG000|Overall Study|Lost to Follow-up|1|||
146598477|NCT03495102|528701648|FG002|Overall Study|Protocol Violation|0|||
146598478|NCT03495102|528701646|FG000|Overall Study|Site Closure|3|||
146598479|NCT03495102|528701647|FG001|Overall Study|Site Closure|1|||
146598480|NCT03495102|528701648|FG002|Overall Study|Site Closure|2|||
146598481|NCT03495102|528701646|FG000|Overall Study|Non-compliance|1|||
146598482|NCT03495102|528701647|FG001|Overall Study|Non-compliance|0|||
146598483|NCT03495102|528701648|FG002|Overall Study|Non-compliance|0|||
146598484|NCT03495102|528701646|FG000|Overall Study|Participant Duplicated at Another Site|0|||
146598485|NCT03495102|528701647|FG001|Overall Study|Participant Duplicated at Another Site|0|||
146598486|NCT03495102|528701648|FG002|Overall Study|Participant Duplicated at Another Site|1|||
146598487|NCT03495102|528701646|FG000|Overall Study|Primary Care Physician Recommendation|0|||
146598488|NCT03495102|528701647|FG001|Overall Study|Primary Care Physician Recommendation|1|||
146654341|NCT02361346|528910761|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
146654342|NCT02361346|528910762|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
146654343|NCT02361346|528910763|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
146654344|NCT02361346|528910764|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
146654345|NCT02361346|528910765|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
146654346|NCT02361346|528910757|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
146654347|NCT02361346|528910758|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
146654348|NCT02361346|528910759|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
146654349|NCT02361346|528910760|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
146654350|NCT02361346|528910761|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
146654351|NCT02361346|528910762|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
146654352|NCT02361346|528910763|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
146654353|NCT02361346|528910764|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
146654354|NCT02361346|528910765|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
146654355|NCT02361346|528910757|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
146654356|NCT02361346|528910758|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
146654357|NCT02361346|528910759|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
146654358|NCT02361346|528910760|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
146654359|NCT02361346|528910761|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
146654360|NCT02361346|528910762|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
146654361|NCT02361346|528910763|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
146654362|NCT02361346|528910764|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
146654363|NCT02361346|528910765|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
146654364|NCT02361346|528910757|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
146654365|NCT02361346|528910758|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
146654366|NCT02361346|528910759|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
146654367|NCT02361346|528910760|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
146654368|NCT02361346|528910761|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
146654369|NCT02361346|528910762|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
146654370|NCT02361346|528910763|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
146920642|NCT03249792|529871465|FG010|Arms 1, 2, and 4|Death|7|||
146920643|NCT03249792|529871466|FG011|Arms 1, 2, and 4|Death|7|||
146920644|NCT03249792|529871467|FG012|Arms 1, 2, and 4|Death|12|||
146920645|NCT03249792|529871468|FG013|Arms 1, 2, and 4|Death|7|||
146920646|NCT03249792|529871469|FG014|Arms 1, 2, and 4|Death|0|||
146598489|NCT03495102|528701648|FG002|Overall Study|Primary Care Physician Recommendation|0|||
146598490|NCT03495102|528701646|FG000|Overall Study|Relocated to Another Country|0|||
146598491|NCT03495102|528701647|FG001|Overall Study|Relocated to Another Country|1|||
146598492|NCT03495102|528701648|FG002|Overall Study|Relocated to Another Country|0|||
146598493|NCT03495102|528701646|FG000|Overall Study|Participant was in Rehabilitation|1|||
146654371|NCT02361346|528910764|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
146920647|NCT03249792|529871470|FG015|Arms 1, 2, and 4|Death|4|||
146654372|NCT02361346|528910765|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
146654373|NCT02361346|528910757|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
146654374|NCT02361346|528910758|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
146654375|NCT02361346|528910759|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
146920648|NCT03249792|529871471|FG016|Arms 1, 2, and 4|Death|4|||
146920649|NCT03249792|529871472|FG017|Arms 1, 2, and 4|Death|12|||
146920650|NCT03249792|529871473|FG018|Arms 1, 2, and 4|Death|6|||
146920651|NCT03249792|529871474|FG019|Arms 1, 2, and 4|Death|4|||
146920652|NCT03249792|529871475|FG020|Arms 1, 2, and 4|Death|2|||
146598494|NCT03495102|528701647|FG001|Overall Study|Participant was in Rehabilitation|0|||
146598495|NCT03495102|528701648|FG002|Overall Study|Participant was in Rehabilitation|0|||
146598496|NCT01161537|528701649|FG000|Part B|Withdrawal by Subject|2|||
146920653|NCT03249792|529871476|FG021|Arms 1, 2, and 4|Death|3|||
146598497|NCT00358436|528701652|FG000|Overall Study|Adverse Event|29|||
146654376|NCT02361346|528910760|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
146654377|NCT02361346|528910761|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
146920654|NCT03249792|529871477|FG022|Arms 1, 2, and 4|Death|1|||
146920655|NCT03249792|529871478|FG023|Arms 1, 2, and 4|Death|1|||
146920656|NCT03249792|529871479|FG024|Arms 1, 2, and 4|Death|4|||
146920657|NCT03249792|529871480|FG025|Arms 1, 2, and 4|Death|0|||
146920658|NCT03249792|529871481|FG026|Arms 1, 2, and 4|Death|0|||
146920659|NCT03249792|529871482|FG027|Arms 1, 2, and 4|Death|0|||
146920660|NCT03249792|529871483|FG028|Arms 1, 2, and 4|Death|0|||
146920661|NCT03249792|529871484|FG029|Arms 1, 2, and 4|Death|0|||
146920662|NCT03249792|529871485|FG030|Arms 1, 2, and 4|Death|0|||
146920663|NCT03249792|529871486|FG031|Arms 1, 2, and 4|Death|0|||
146920664|NCT03249792|529871487|FG032|Arms 1, 2, and 4|Death|0|||
146920665|NCT03249792|529871455|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920666|NCT03249792|529871456|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920667|NCT03249792|529871457|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
146920668|NCT03249792|529871458|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920669|NCT03249792|529871459|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920670|NCT03249792|529871460|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
146920671|NCT03249792|529871461|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
146920672|NCT03249792|529871462|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920673|NCT03249792|529871463|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
146920674|NCT03249792|529871464|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
146920675|NCT03249792|529871465|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
146920676|NCT03249792|529871466|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
146920677|NCT03249792|529871467|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
146920678|NCT03249792|529871468|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
146920679|NCT03249792|529871469|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920680|NCT03249792|529871470|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920681|NCT03249792|529871471|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
146920682|NCT03249792|529871472|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920683|NCT03249792|529871473|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
146920684|NCT03249792|529871474|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920685|NCT03249792|529871475|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920686|NCT03249792|529871476|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920687|NCT03249792|529871477|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
146920688|NCT03249792|529871478|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
146920689|NCT03249792|529871479|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920690|NCT03249792|529871480|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920691|NCT03249792|529871481|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920692|NCT03249792|529871482|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920693|NCT03249792|529871483|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920694|NCT03249792|529871484|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920695|NCT03249792|529871485|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920696|NCT03249792|529871486|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920697|NCT03249792|529871487|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146920698|NCT03249792|529871455|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
146920699|NCT03249792|529871456|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
146920700|NCT03249792|529871457|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
146920701|NCT03249792|529871458|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
146920702|NCT03249792|529871459|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
146920703|NCT03249792|529871460|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
146920704|NCT03249792|529871461|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
146920705|NCT03249792|529871462|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
146920706|NCT03249792|529871463|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
146920707|NCT03249792|529871464|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
146920708|NCT03249792|529871465|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
146920709|NCT03249792|529871466|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
146920710|NCT03249792|529871467|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
146920711|NCT03249792|529871468|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
146920712|NCT03249792|529871469|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
146920713|NCT03249792|529871470|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
146598498|NCT00358436|528701653|FG001|Overall Study|Adverse Event|13|||
146598499|NCT00358436|528701652|FG000|Overall Study|Lack of Efficacy|34|||
146920714|NCT03249792|529871471|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
146920715|NCT03249792|529871472|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
146920716|NCT03249792|529871473|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
146920717|NCT03249792|529871474|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
146920718|NCT03249792|529871475|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
146920719|NCT03249792|529871476|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
146920720|NCT03249792|529871477|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
146920721|NCT03249792|529871478|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
146920722|NCT03249792|529871479|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
146598500|NCT00358436|528701653|FG001|Overall Study|Lack of Efficacy|36|||
146598501|NCT00358436|528701652|FG000|Overall Study|Lost to Follow-up|11|||
146920723|NCT03249792|529871480|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
146920724|NCT03249792|529871481|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
146920725|NCT03249792|529871482|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
146920726|NCT03249792|529871483|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
146920727|NCT03249792|529871484|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
146920728|NCT03249792|529871485|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
146920729|NCT03249792|529871486|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
146920730|NCT03249792|529871487|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
146920731|NCT03249792|529871455|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
146598502|NCT00358436|528701653|FG001|Overall Study|Lost to Follow-up|6|||
146654378|NCT02361346|528910762|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
146654379|NCT02361346|528910763|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
146654380|NCT02361346|528910764|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
146654381|NCT02361346|528910765|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
146654382|NCT02361346|528910757|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
146654383|NCT02361346|528910758|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
146654384|NCT02361346|528910759|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
146654385|NCT02361346|528910760|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
146654386|NCT02361346|528910761|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
146654387|NCT02361346|528910762|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
146654388|NCT02361346|528910763|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
146654389|NCT02361346|528910764|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
146654390|NCT02361346|528910765|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
146654391|NCT03587727|528910767|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
146654392|NCT03587727|528910767|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
146654393|NCT04102189|528910768|FG000|Overall Study|Withdrawal by Subject|1|||
146654394|NCT04102189|528910769|FG001|Overall Study|Withdrawal by Subject|2|||
146654395|NCT04102189|528910768|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146654396|NCT04102189|528910769|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146654397|NCT04102189|528910768|FG000|Overall Study|Lost to Follow-up|1|||
146654398|NCT04102189|528910769|FG001|Overall Study|Lost to Follow-up|0|||
146654399|NCT03576274|528910770|FG000|Overall Study|Lost to Follow-up|3|||
146654400|NCT03576274|528910771|FG001|Overall Study|Lost to Follow-up|2|||
146654401|NCT03576274|528910772|FG002|Overall Study|Lost to Follow-up|3|||
146654402|NCT03576274|528910773|FG003|Overall Study|Lost to Follow-up|1|||
146654403|NCT03576274|528910774|FG004|Overall Study|Lost to Follow-up|3|||
146654404|NCT03576274|528910770|FG000|Overall Study|Withdrawal by Subject|5|||
146654405|NCT03576274|528910771|FG001|Overall Study|Withdrawal by Subject|3|||
146654406|NCT03576274|528910772|FG002|Overall Study|Withdrawal by Subject|2|||
146654407|NCT03576274|528910773|FG003|Overall Study|Withdrawal by Subject|8|||
146654408|NCT03576274|528910774|FG004|Overall Study|Withdrawal by Subject|6|||
146654409|NCT04078178|528912258|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
146654410|NCT04078178|528912259|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
146598503|NCT00358436|528701652|FG000|Overall Study|Protocol Violation|8|||
146654411|NCT04078178|528912258|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
146654412|NCT04078178|528912259|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
146654413|NCT04078178|528912258|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
146654414|NCT04078178|528912259|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
146598504|NCT00358436|528701653|FG001|Overall Study|Protocol Violation|3|||
146598505|NCT00358436|528701652|FG000|Overall Study|Withdrawal by Subject|40|||
146598506|NCT00358436|528701653|FG001|Overall Study|Withdrawal by Subject|17|||
146598507|NCT00358436|528701652|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
146598508|NCT00358436|528701653|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
146598509|NCT00358436|528701652|FG000|Overall Study|COPD exacerbation|22|||
146598510|NCT00358436|528701653|FG001|Overall Study|COPD exacerbation|10|||
146598511|NCT00358436|528701652|FG000|Overall Study|Other|6|||
146598512|NCT00358436|528701653|FG001|Overall Study|Other|1|||
146598513|NCT03938324|528701655|FG000|Overall Study|Lost to Follow-up|42|||
146598514|NCT03938324|528701656|FG001|Overall Study|Lost to Follow-up|21|||
146598515|NCT03938324|528701655|FG000|Overall Study|Withdrawal by Subject|6|||
146654415|NCT04078178|528912258|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
146654416|NCT04078178|528912259|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
146654417|NCT04078178|528912258|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
146654418|NCT04078178|528912259|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
146654419|NCT02038829|528912260|FG000|Washout Period 1|Death|0|||
146654420|NCT02038829|528912261|FG001|Washout Period 1|Death|0|||
146654421|NCT02038829|528912262|FG002|Washout Period 1|Death|0|||
146654422|NCT02038829|528912263|FG003|Washout Period 1|Death|0|||
146654423|NCT02038829|528912264|FG004|Washout Period 1|Death|1|||
146654424|NCT02038829|528912265|FG005|Washout Period 1|Death|0|||
146654425|NCT02038829|528912266|FG006|Washout Period 1|Death|0|||
146654426|NCT02038829|528912267|FG007|Washout Period 1|Death|0|||
146654427|NCT02038829|528912268|FG008|Washout Period 1|Death|0|||
146654428|NCT02038829|528912269|FG009|Washout Period 1|Death|0|||
146654429|NCT02038829|528912270|FG010|Washout Period 1|Death|0|||
146654430|NCT02038829|528912271|FG011|Washout Period 1|Death|0|||
146654431|NCT02038829|528912260|FG000|Treatment Period 2|Adverse Event|0|||
146654432|NCT02038829|528912261|FG001|Treatment Period 2|Adverse Event|0|||
146654433|NCT02038829|528912262|FG002|Treatment Period 2|Adverse Event|0|||
146654434|NCT02038829|528912263|FG003|Treatment Period 2|Adverse Event|0|||
146598516|NCT03938324|528701656|FG001|Overall Study|Withdrawal by Subject|1|||
146598517|NCT01300351|528701661|FG000|Overall Study|Did not receive treatment|2|||
146598518|NCT01300351|528701662|FG001|Overall Study|Did not receive treatment|0|||
146654435|NCT02038829|528912264|FG004|Treatment Period 2|Adverse Event|0|||
146920732|NCT03249792|529871456|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920733|NCT03249792|529871457|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920734|NCT03249792|529871458|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920735|NCT03249792|529871459|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920736|NCT03249792|529871460|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920737|NCT03249792|529871461|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920738|NCT03249792|529871462|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920739|NCT03249792|529871463|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
146920740|NCT03249792|529871464|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920741|NCT03249792|529871465|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920742|NCT03249792|529871466|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920743|NCT03249792|529871467|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920744|NCT03249792|529871468|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920745|NCT03249792|529871469|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920746|NCT03249792|529871470|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920747|NCT03249792|529871471|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
146920748|NCT03249792|529871472|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
146920749|NCT03249792|529871473|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920750|NCT03249792|529871474|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
146920751|NCT03249792|529871475|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920752|NCT03249792|529871476|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920753|NCT03249792|529871477|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920754|NCT03249792|529871478|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920755|NCT03249792|529871479|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920756|NCT03249792|529871480|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920757|NCT03249792|529871481|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920758|NCT03249792|529871482|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920759|NCT03249792|529871483|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920760|NCT03249792|529871484|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920761|NCT03249792|529871485|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920762|NCT03249792|529871486|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920763|NCT03249792|529871487|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
146920764|NCT03249792|529871455|FG000|Switch Over Period|Withdrawal by Subject|0|||
146920765|NCT03249792|529871456|FG001|Switch Over Period|Withdrawal by Subject|0|||
146920766|NCT03249792|529871457|FG002|Switch Over Period|Withdrawal by Subject|0|||
146920767|NCT03249792|529871458|FG003|Switch Over Period|Withdrawal by Subject|0|||
146920768|NCT03249792|529871459|FG004|Switch Over Period|Withdrawal by Subject|0|||
146920769|NCT03249792|529871460|FG005|Switch Over Period|Withdrawal by Subject|0|||
146920770|NCT03249792|529871461|FG006|Switch Over Period|Withdrawal by Subject|0|||
146978529|NCT00272961|530084096|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
146978530|NCT00272961|530084097|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
146978531|NCT00272961|530084098|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
146598519|NCT01300351|528701661|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
146598520|NCT01300351|528701662|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
146598521|NCT01300351|528701661|FG000|Overall Study|Lost to Follow-up|0|||
146598522|NCT01300351|528701662|FG001|Overall Study|Lost to Follow-up|1|||
146598523|NCT01300351|528701661|FG000|Overall Study|Adverse Event|0|||
146598524|NCT01300351|528701662|FG001|Overall Study|Adverse Event|4|||
146598525|NCT01300351|528701661|FG000|Overall Study|Withdrawal by Subject|7|||
146598526|NCT01300351|528701662|FG001|Overall Study|Withdrawal by Subject|10|||
146598527|NCT02258529|528701666|FG000|Overall Study|Study Terminated by Sponsor|9|||
146598528|NCT02258529|528701666|FG000|Overall Study|Adverse Event|1|||
146598529|NCT00443781|528701667|FG000|Overall Study|Lost to Follow-up|10|||
146598530|NCT00443781|528701667|FG000|Overall Study|Physician Decision|2|||
146598531|NCT00443781|528701667|FG000|Overall Study|Protocol Violation|1|||
146598532|NCT00443781|528701667|FG000|Overall Study|Withdrawal by Subject|6|||
146598533|NCT00443781|528701667|FG000|Overall Study|Unable to comply with study follow up|2|||
146598534|NCT00443781|528701667|FG000|Overall Study|Investigator terminated participation|1|||
146920771|NCT03249792|529871462|FG007|Switch Over Period|Withdrawal by Subject|0|||
146598535|NCT00443781|528701667|FG000|Overall Study|Insurance not covered|2|||
146598536|NCT00443781|528701667|FG000|Overall Study|PD/FAD not done|1|||
146598537|NCT00430937|528701668|FG000|Overall Study|Adverse Event|3|||
146598538|NCT00430937|528701669|FG001|Overall Study|Adverse Event|8|||
146920772|NCT03249792|529871463|FG008|Switch Over Period|Withdrawal by Subject|0|||
146920773|NCT03249792|529871464|FG009|Switch Over Period|Withdrawal by Subject|0|||
146920774|NCT03249792|529871465|FG010|Switch Over Period|Withdrawal by Subject|0|||
146920775|NCT03249792|529871466|FG011|Switch Over Period|Withdrawal by Subject|0|||
146920776|NCT03249792|529871467|FG012|Switch Over Period|Withdrawal by Subject|0|||
146920777|NCT03249792|529871468|FG013|Switch Over Period|Withdrawal by Subject|0|||
146920778|NCT03249792|529871469|FG014|Switch Over Period|Withdrawal by Subject|0|||
146978532|NCT00272961|530084099|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
146598539|NCT00430937|528701668|FG000|Overall Study|Death|0|||
146598540|NCT00430937|528701669|FG001|Overall Study|Death|1|||
146598541|NCT00430937|528701668|FG000|Overall Study|Lost to Follow-up|6|||
146598542|NCT00430937|528701669|FG001|Overall Study|Lost to Follow-up|6|||
146920779|NCT03249792|529871470|FG015|Switch Over Period|Withdrawal by Subject|0|||
146920780|NCT03249792|529871471|FG016|Switch Over Period|Withdrawal by Subject|0|||
146920781|NCT03249792|529871472|FG017|Switch Over Period|Withdrawal by Subject|0|||
146920782|NCT03249792|529871473|FG018|Switch Over Period|Withdrawal by Subject|0|||
146920783|NCT03249792|529871474|FG019|Switch Over Period|Withdrawal by Subject|0|||
146920784|NCT03249792|529871475|FG020|Switch Over Period|Withdrawal by Subject|0|||
146920785|NCT03249792|529871476|FG021|Switch Over Period|Withdrawal by Subject|0|||
146920786|NCT03249792|529871477|FG022|Switch Over Period|Withdrawal by Subject|0|||
146920787|NCT03249792|529871478|FG023|Switch Over Period|Withdrawal by Subject|0|||
146920788|NCT03249792|529871479|FG024|Switch Over Period|Withdrawal by Subject|0|||
146920789|NCT03249792|529871480|FG025|Switch Over Period|Withdrawal by Subject|0|||
146920790|NCT03249792|529871481|FG026|Switch Over Period|Withdrawal by Subject|0|||
146978533|NCT00272961|530084100|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
146978534|NCT00272961|530084096|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
146598543|NCT00430937|528701668|FG000|Overall Study|Withdrawal by Subject|5|||
146598544|NCT00430937|528701669|FG001|Overall Study|Withdrawal by Subject|2|||
146598545|NCT00430937|528701668|FG000|Overall Study|Protocol Violation|3|||
146598546|NCT00430937|528701669|FG001|Overall Study|Protocol Violation|2|||
146598547|NCT00430937|528701668|FG000|Overall Study|Lack of Efficacy|6|||
146598548|NCT00430937|528701669|FG001|Overall Study|Lack of Efficacy|5|||
146598549|NCT00430937|528701668|FG000|Overall Study|Inappropriate enrollment|2|||
146598550|NCT00430937|528701669|FG001|Overall Study|Inappropriate enrollment|1|||
146598551|NCT00430937|528701668|FG000|Overall Study|Administrative reasons|1|||
146598552|NCT00430937|528701669|FG001|Overall Study|Administrative reasons|0|||
146598553|NCT00430937|528701668|FG000|Overall Study|Protocol discontinuation criteria met|1|||
146598554|NCT00430937|528701669|FG001|Overall Study|Protocol discontinuation criteria met|2|||
146598555|NCT00430937|528701668|FG000|Overall Study|Unable to classify|0|||
146598556|NCT00430937|528701669|FG001|Overall Study|Unable to classify|1|||
146598557|NCT02634606|528701670|FG000|Overall Study|unable to obtain the drug at start|13|||
146598558|NCT00353873|528701673|FG000|Overall Study|Protocol Violation|1|||
146598559|NCT00353873|528701674|FG001|Overall Study|Protocol Violation|2|||
146598560|NCT00353873|528701673|FG000|Overall Study|Exacerbation|1|||
146598561|NCT00353873|528701674|FG001|Overall Study|Exacerbation|0|||
146598562|NCT00353873|528701673|FG000|Overall Study|Adverse Event|1|||
146598563|NCT00353873|528701674|FG001|Overall Study|Adverse Event|0|||
146598564|NCT00353873|528701673|FG000|Overall Study|Physician Decision|2|||
146598565|NCT00353873|528701674|FG001|Overall Study|Physician Decision|0|||
146598566|NCT00353873|528701673|FG000|Overall Study|Withdrawal by Subject|1|||
146598567|NCT00353873|528701674|FG001|Overall Study|Withdrawal by Subject|1|||
146598568|NCT03743064|528701675|FG000|Overall Study|Adverse Event|7|||
146598569|NCT03743064|528701676|FG001|Overall Study|Adverse Event|9|||
146598570|NCT03743064|528701675|FG000|Overall Study|Death|25|||
146598571|NCT03743064|528701676|FG001|Overall Study|Death|28|||
146598572|NCT03743064|528701675|FG000|Overall Study|Lost to Follow-up|3|||
146598573|NCT03743064|528701676|FG001|Overall Study|Lost to Follow-up|6|||
146598574|NCT03743064|528701675|FG000|Overall Study|Withdrawal by Subject|28|||
146598575|NCT03743064|528701676|FG001|Overall Study|Withdrawal by Subject|25|||
146598576|NCT03743064|528701675|FG000|Overall Study|Physician Decision|2|||
146598577|NCT03743064|528701676|FG001|Overall Study|Physician Decision|4|||
146598578|NCT03743064|528701675|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
146598579|NCT03743064|528701676|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
146598580|NCT00286221|528701677|FG000|Overall Study|Protocol Violation|2|||
146598581|NCT00286221|528701678|FG001|Overall Study|Protocol Violation|1|||
146598582|NCT00286221|528701679|FG002|Overall Study|Protocol Violation|6|||
146654436|NCT02038829|528912265|FG005|Treatment Period 2|Adverse Event|0|||
146654437|NCT02038829|528912266|FG006|Treatment Period 2|Adverse Event|0|||
146654438|NCT02038829|528912267|FG007|Treatment Period 2|Adverse Event|0|||
146654439|NCT02038829|528912268|FG008|Treatment Period 2|Adverse Event|0|||
146654440|NCT02038829|528912269|FG009|Treatment Period 2|Adverse Event|0|||
146654441|NCT02038829|528912270|FG010|Treatment Period 2|Adverse Event|1|||
146654442|NCT02038829|528912271|FG011|Treatment Period 2|Adverse Event|0|||
146654443|NCT02038829|528912260|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146598583|NCT00286221|528701680|FG003|Overall Study|Protocol Violation|4|||
146598584|NCT00286221|528701677|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
146920791|NCT03249792|529871482|FG027|Switch Over Period|Withdrawal by Subject|0|||
146920792|NCT03249792|529871483|FG028|Switch Over Period|Withdrawal by Subject|0|||
146598585|NCT00286221|528701678|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
146598586|NCT00286221|528701679|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
146598587|NCT00286221|528701680|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
146598588|NCT00286221|528701677|FG000|Overall Study|Inability to trigger PCA|2|||
146598589|NCT00286221|528701678|FG001|Overall Study|Inability to trigger PCA|0|||
146598590|NCT00286221|528701679|FG002|Overall Study|Inability to trigger PCA|0|||
146598591|NCT00286221|528701680|FG003|Overall Study|Inability to trigger PCA|0|||
146598592|NCT00286221|528701677|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
146598593|NCT00286221|528701678|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
146654444|NCT02038829|528912261|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146654445|NCT02038829|528912262|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146654446|NCT02038829|528912263|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146654447|NCT02038829|528912264|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146654448|NCT02038829|528912265|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146654449|NCT02038829|528912266|FG006|Treatment Period 2|Withdrawal by Subject|0|||
146654450|NCT02038829|528912267|FG007|Treatment Period 2|Withdrawal by Subject|0|||
146654451|NCT02038829|528912268|FG008|Treatment Period 2|Withdrawal by Subject|0|||
146654452|NCT02038829|528912269|FG009|Treatment Period 2|Withdrawal by Subject|0|||
146654453|NCT02038829|528912270|FG010|Treatment Period 2|Withdrawal by Subject|0|||
146654454|NCT02038829|528912271|FG011|Treatment Period 2|Withdrawal by Subject|0|||
146654455|NCT02038829|528912260|FG000|Washout Period 2|Adverse Event|0|||
146654456|NCT02038829|528912261|FG001|Washout Period 2|Adverse Event|0|||
146654457|NCT02038829|528912262|FG002|Washout Period 2|Adverse Event|0|||
146654458|NCT02038829|528912263|FG003|Washout Period 2|Adverse Event|0|||
146654459|NCT02038829|528912264|FG004|Washout Period 2|Adverse Event|0|||
146654460|NCT02038829|528912265|FG005|Washout Period 2|Adverse Event|0|||
146654461|NCT02038829|528912266|FG006|Washout Period 2|Adverse Event|0|||
146654462|NCT02038829|528912267|FG007|Washout Period 2|Adverse Event|0|||
146654463|NCT02038829|528912268|FG008|Washout Period 2|Adverse Event|1|||
146654464|NCT02038829|528912269|FG009|Washout Period 2|Adverse Event|0|||
146654465|NCT02038829|528912270|FG010|Washout Period 2|Adverse Event|0|||
146654466|NCT02038829|528912271|FG011|Washout Period 2|Adverse Event|0|||
146654467|NCT02038829|528912260|FG000|Washout Period 2|Withdrawal by Subject|0|||
146654468|NCT02038829|528912261|FG001|Washout Period 2|Withdrawal by Subject|0|||
146654469|NCT02038829|528912262|FG002|Washout Period 2|Withdrawal by Subject|0|||
146654470|NCT02038829|528912263|FG003|Washout Period 2|Withdrawal by Subject|0|||
146654471|NCT02038829|528912264|FG004|Washout Period 2|Withdrawal by Subject|0|||
146598594|NCT00286221|528701679|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
146598595|NCT00286221|528701680|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
146598596|NCT02648217|528701686|FG000|Overall Study|Adverse Event|0|||
146598597|NCT02648217|528701687|FG001|Overall Study|Adverse Event|1|||
146598598|NCT02648217|528701686|FG000|Overall Study|Lost to Follow-up|1|||
146598599|NCT02648217|528701687|FG001|Overall Study|Lost to Follow-up|1|||
146598600|NCT02648217|528701686|FG000|Overall Study|Withdrawal by Subject|4|||
146598601|NCT02648217|528701687|FG001|Overall Study|Withdrawal by Subject|3|||
146598602|NCT02648217|528701686|FG000|Overall Study|Unclassified|5|||
146598603|NCT02648217|528701687|FG001|Overall Study|Unclassified|0|||
146598604|NCT02553538|528701688|FG000|Overall Study|Could Not Reach by Telephone|133|||
146598605|NCT02553538|528701689|FG001|Overall Study|Could Not Reach by Telephone|0|||
146654472|NCT02038829|528912265|FG005|Washout Period 2|Withdrawal by Subject|1|||
146654473|NCT02038829|528912266|FG006|Washout Period 2|Withdrawal by Subject|0|||
146654474|NCT02038829|528912267|FG007|Washout Period 2|Withdrawal by Subject|0|||
146654475|NCT02038829|528912268|FG008|Washout Period 2|Withdrawal by Subject|0|||
146920793|NCT03249792|529871484|FG029|Switch Over Period|Withdrawal by Subject|0|||
146920794|NCT03249792|529871485|FG030|Switch Over Period|Withdrawal by Subject|0|||
146920795|NCT03249792|529871486|FG031|Switch Over Period|Withdrawal by Subject|1|||
146920796|NCT03249792|529871487|FG032|Switch Over Period|Withdrawal by Subject|0|||
146920797|NCT03249792|529871455|FG000|Switch Over Period|Progressive Disease|0|||
146920798|NCT03249792|529871456|FG001|Switch Over Period|Progressive Disease|0|||
146920799|NCT03249792|529871457|FG002|Switch Over Period|Progressive Disease|0|||
146920800|NCT03249792|529871458|FG003|Switch Over Period|Progressive Disease|0|||
146920801|NCT03249792|529871459|FG004|Switch Over Period|Progressive Disease|0|||
146920802|NCT03249792|529871460|FG005|Switch Over Period|Progressive Disease|0|||
146920803|NCT03249792|529871461|FG006|Switch Over Period|Progressive Disease|0|||
146920804|NCT03249792|529871462|FG007|Switch Over Period|Progressive Disease|0|||
146920805|NCT03249792|529871463|FG008|Switch Over Period|Progressive Disease|0|||
146920806|NCT03249792|529871464|FG009|Switch Over Period|Progressive Disease|0|||
146920807|NCT03249792|529871465|FG010|Switch Over Period|Progressive Disease|0|||
146920808|NCT03249792|529871466|FG011|Switch Over Period|Progressive Disease|0|||
146920809|NCT03249792|529871467|FG012|Switch Over Period|Progressive Disease|0|||
146920810|NCT03249792|529871468|FG013|Switch Over Period|Progressive Disease|0|||
146920811|NCT03249792|529871469|FG014|Switch Over Period|Progressive Disease|0|||
146920812|NCT03249792|529871470|FG015|Switch Over Period|Progressive Disease|0|||
146920813|NCT03249792|529871471|FG016|Switch Over Period|Progressive Disease|0|||
146920814|NCT03249792|529871472|FG017|Switch Over Period|Progressive Disease|0|||
146598606|NCT02553538|528701688|FG000|Overall Study|Died or Left Network|54|||
146598607|NCT02553538|528701689|FG001|Overall Study|Died or Left Network|56|||
146654476|NCT02038829|528912269|FG009|Washout Period 2|Withdrawal by Subject|0|||
146654477|NCT02038829|528912270|FG010|Washout Period 2|Withdrawal by Subject|0|||
146654478|NCT02038829|528912271|FG011|Washout Period 2|Withdrawal by Subject|0|||
146654479|NCT02038829|528912260|FG000|Treatment Period 4|Adverse Event|0|||
146654480|NCT02038829|528912261|FG001|Treatment Period 4|Adverse Event|1|||
146654481|NCT02038829|528912262|FG002|Treatment Period 4|Adverse Event|0|||
146654482|NCT02038829|528912263|FG003|Treatment Period 4|Adverse Event|0|||
146654483|NCT02038829|528912264|FG004|Treatment Period 4|Adverse Event|0|||
146654484|NCT02038829|528912265|FG005|Treatment Period 4|Adverse Event|0|||
146654485|NCT02038829|528912266|FG006|Treatment Period 4|Adverse Event|0|||
146598608|NCT00106691|528701690|FG000|Overall Study|Adverse Event|60|||
146598609|NCT00106691|528701691|FG001|Overall Study|Adverse Event|64|||
146598610|NCT00106691|528701690|FG000|Overall Study|Lost to Follow-up|23|||
146598611|NCT00106691|528701691|FG001|Overall Study|Lost to Follow-up|18|||
146598612|NCT00106691|528701690|FG000|Overall Study|Physician Decision|18|||
146598613|NCT00106691|528701691|FG001|Overall Study|Physician Decision|21|||
146598614|NCT00106691|528701690|FG000|Overall Study|Protocol Violation|13|||
146598615|NCT00106691|528701691|FG001|Overall Study|Protocol Violation|18|||
146598616|NCT00106691|528701690|FG000|Overall Study|Withdrawal by Subject|75|||
146598617|NCT00106691|528701691|FG001|Overall Study|Withdrawal by Subject|70|||
146598618|NCT00106691|528701690|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
146598619|NCT00106691|528701691|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
146598620|NCT00106691|528701690|FG000|Overall Study|QTc>480|3|||
146598621|NCT00106691|528701691|FG001|Overall Study|QTc>480|1|||
146598622|NCT00106691|528701690|FG000|Overall Study|mililtary deployment|2|||
146598623|NCT00106691|528701691|FG001|Overall Study|mililtary deployment|0|||
146598624|NCT00106691|528701690|FG000|Overall Study|Study Site Closing/PI Moved|1|||
146598625|NCT00106691|528701691|FG001|Overall Study|Study Site Closing/PI Moved|2|||
146598626|NCT00106691|528701690|FG000|Overall Study|Cardiologist recommendation|1|||
146598627|NCT00106691|528701691|FG001|Overall Study|Cardiologist recommendation|0|||
146598628|NCT00106691|528701690|FG000|Overall Study|Pt. moved to another state|1|||
146598629|NCT00106691|528701691|FG001|Overall Study|Pt. moved to another state|0|||
146598630|NCT00106691|528701690|FG000|Overall Study|Taking exclusionary avodart|1|||
146598631|NCT00106691|528701691|FG001|Overall Study|Taking exclusionary avodart|0|||
146598632|NCT00106691|528701690|FG000|Overall Study|Not able to discontinue plavix|0|||
146598633|NCT00106691|528701691|FG001|Overall Study|Not able to discontinue plavix|1|||
146598634|NCT01754194|528701692|FG000|Overall Study|Lost to Follow-up|39|||
146598635|NCT01754194|528701693|FG001|Overall Study|Lost to Follow-up|14|||
146598636|NCT01754194|528701692|FG000|Overall Study|Withdrawal by Subject|4|||
146598637|NCT01754194|528701693|FG001|Overall Study|Withdrawal by Subject|5|||
146598638|NCT01754194|528701692|FG000|Overall Study|Other|9|||
146598639|NCT01754194|528701693|FG001|Overall Study|Other|8|||
146598640|NCT00907296|528701694|FG000|Overall Study|Ineligibility Determined|1|||
146598641|NCT00907296|528701695|FG001|Overall Study|Ineligibility Determined|0|||
146598642|NCT00907296|528701696|FG002|Overall Study|Ineligibility Determined|0|||
146598643|NCT00907296|528701697|FG003|Overall Study|Ineligibility Determined|1|||
146598644|NCT00907296|528701698|FG004|Overall Study|Ineligibility Determined|0|||
146598645|NCT00907296|528701699|FG005|Overall Study|Ineligibility Determined|0|||
146598646|NCT00907296|528701700|FG006|Overall Study|Ineligibility Determined|0|||
146598647|NCT00907296|528701701|FG007|Overall Study|Ineligibility Determined|1|||
146598648|NCT00907296|528701702|FG008|Overall Study|Ineligibility Determined|0|||
146598649|NCT00907296|528701703|FG009|Overall Study|Ineligibility Determined|0|||
146598650|NCT00907296|528701694|FG000|Overall Study|Protocol Deviation|0|||
146598651|NCT00907296|528701695|FG001|Overall Study|Protocol Deviation|1|||
146598652|NCT00907296|528701696|FG002|Overall Study|Protocol Deviation|0|||
146598653|NCT00907296|528701697|FG003|Overall Study|Protocol Deviation|0|||
146598654|NCT00907296|528701698|FG004|Overall Study|Protocol Deviation|0|||
146598655|NCT00907296|528701699|FG005|Overall Study|Protocol Deviation|0|||
146598656|NCT00907296|528701700|FG006|Overall Study|Protocol Deviation|0|||
146598657|NCT00907296|528701701|FG007|Overall Study|Protocol Deviation|0|||
146598658|NCT00907296|528701702|FG008|Overall Study|Protocol Deviation|0|||
146598659|NCT00907296|528701703|FG009|Overall Study|Protocol Deviation|0|||
146598660|NCT00907296|528701694|FG000|Overall Study|Noncompliance|1|||
146598661|NCT00907296|528701695|FG001|Overall Study|Noncompliance|1|||
146598662|NCT00907296|528701696|FG002|Overall Study|Noncompliance|1|||
146598663|NCT00907296|528701697|FG003|Overall Study|Noncompliance|0|||
146598664|NCT00907296|528701698|FG004|Overall Study|Noncompliance|0|||
146598665|NCT00907296|528701699|FG005|Overall Study|Noncompliance|1|||
146598666|NCT00907296|528701700|FG006|Overall Study|Noncompliance|0|||
146598667|NCT00907296|528701701|FG007|Overall Study|Noncompliance|2|||
146598668|NCT00907296|528701702|FG008|Overall Study|Noncompliance|0|||
146598669|NCT00907296|528701703|FG009|Overall Study|Noncompliance|0|||
146598670|NCT00907296|528701694|FG000|Overall Study|Adverse Event|2|||
146598671|NCT00907296|528701695|FG001|Overall Study|Adverse Event|0|||
146598672|NCT00907296|528701696|FG002|Overall Study|Adverse Event|0|||
146598673|NCT00907296|528701697|FG003|Overall Study|Adverse Event|0|||
146598674|NCT00907296|528701698|FG004|Overall Study|Adverse Event|0|||
146598675|NCT00907296|528701699|FG005|Overall Study|Adverse Event|0|||
146598676|NCT00907296|528701700|FG006|Overall Study|Adverse Event|1|||
146598677|NCT00907296|528701701|FG007|Overall Study|Adverse Event|0|||
146598678|NCT00907296|528701702|FG008|Overall Study|Adverse Event|0|||
146598679|NCT00907296|528701703|FG009|Overall Study|Adverse Event|1|||
146598680|NCT00907296|528701694|FG000|Overall Study|Withdrawal by Subject|7|||
146598681|NCT00907296|528701695|FG001|Overall Study|Withdrawal by Subject|2|||
146598682|NCT00907296|528701696|FG002|Overall Study|Withdrawal by Subject|1|||
146598683|NCT00907296|528701697|FG003|Overall Study|Withdrawal by Subject|1|||
146598684|NCT00907296|528701698|FG004|Overall Study|Withdrawal by Subject|1|||
146598685|NCT00907296|528701699|FG005|Overall Study|Withdrawal by Subject|5|||
146920815|NCT03249792|529871473|FG018|Switch Over Period|Progressive Disease|0|||
146920816|NCT03249792|529871474|FG019|Switch Over Period|Progressive Disease|0|||
146598686|NCT00907296|528701700|FG006|Overall Study|Withdrawal by Subject|3|||
146598687|NCT00907296|528701701|FG007|Overall Study|Withdrawal by Subject|2|||
146598688|NCT00907296|528701702|FG008|Overall Study|Withdrawal by Subject|4|||
146598689|NCT00907296|528701703|FG009|Overall Study|Withdrawal by Subject|2|||
146598690|NCT00907296|528701694|FG000|Overall Study|Lost to Follow-up|9|||
146598691|NCT00907296|528701695|FG001|Overall Study|Lost to Follow-up|1|||
146598692|NCT00907296|528701696|FG002|Overall Study|Lost to Follow-up|0|||
146598693|NCT00907296|528701697|FG003|Overall Study|Lost to Follow-up|2|||
146598694|NCT00907296|528701698|FG004|Overall Study|Lost to Follow-up|0|||
146598695|NCT00907296|528701699|FG005|Overall Study|Lost to Follow-up|3|||
146598696|NCT00907296|528701700|FG006|Overall Study|Lost to Follow-up|2|||
146598697|NCT00907296|528701701|FG007|Overall Study|Lost to Follow-up|2|||
146598698|NCT00907296|528701702|FG008|Overall Study|Lost to Follow-up|0|||
146598699|NCT00907296|528701703|FG009|Overall Study|Lost to Follow-up|4|||
146598700|NCT02392403|528701704|FG000|Overall Study|Adverse Event|1|||
146598701|NCT02392403|528701704|FG000|Overall Study|Death|1|||
146598702|NCT02392403|528701704|FG000|Overall Study|Withdrawal by Subject|1|||
146598703|NCT02776033|528701707|FG000|Overall Study|Withdrawal by Subject|0|||
146598704|NCT02776033|528701708|FG001|Overall Study|Withdrawal by Subject|0|||
146598705|NCT02776033|528701709|FG002|Overall Study|Withdrawal by Subject|2|||
146598706|NCT02776033|528701707|FG000|Overall Study|Physician Decision|2|||
146598707|NCT02776033|528701708|FG001|Overall Study|Physician Decision|0|||
146598708|NCT02776033|528701709|FG002|Overall Study|Physician Decision|0|||
146598709|NCT02776033|528701707|FG000|Overall Study|Lost to Follow-up|1|||
146598710|NCT02776033|528701708|FG001|Overall Study|Lost to Follow-up|0|||
146598711|NCT02776033|528701709|FG002|Overall Study|Lost to Follow-up|0|||
146598712|NCT02776033|528701707|FG000|Overall Study|Adverse Event|1|||
146598713|NCT02776033|528701708|FG001|Overall Study|Adverse Event|2|||
146598714|NCT02776033|528701709|FG002|Overall Study|Adverse Event|0|||
146598715|NCT02616393|528701713|FG000|Overall Study|Death|5|||
146598716|NCT02616393|528701714|FG001|Overall Study|Death|12|||
146598717|NCT02616393|528701715|FG002|Overall Study|Death|1|||
146598718|NCT02616393|528701713|FG000|Overall Study|Termination by Sponsor|4|||
146598719|NCT02616393|528701714|FG001|Overall Study|Termination by Sponsor|5|||
146598720|NCT02616393|528701715|FG002|Overall Study|Termination by Sponsor|2|||
146598721|NCT02616393|528701713|FG000|Overall Study|Other|3|||
146598722|NCT02616393|528701714|FG001|Overall Study|Other|0|||
146598723|NCT02616393|528701715|FG002|Overall Study|Other|0|||
146598724|NCT02616393|528701713|FG000|Overall Study|Withdrawal by Subject|1|||
146598725|NCT02616393|528701714|FG001|Overall Study|Withdrawal by Subject|1|||
146598726|NCT02616393|528701715|FG002|Overall Study|Withdrawal by Subject|0|||
146598727|NCT02616393|528701713|FG000|Overall Study|Lost to Follow-up|0|||
146598728|NCT02616393|528701714|FG001|Overall Study|Lost to Follow-up|2|||
146598729|NCT02616393|528701715|FG002|Overall Study|Lost to Follow-up|0|||
146598730|NCT01302054|528701716|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
146598731|NCT01302054|528701717|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
146598732|NCT01302054|528701718|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
146598733|NCT01302054|528701716|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
146598734|NCT01302054|528701717|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
146598735|NCT01302054|528701718|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
146598736|NCT01302054|528701716|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
146598737|NCT01302054|528701717|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
146598738|NCT01302054|528701718|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
146598739|NCT01302054|528701716|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
146598740|NCT01302054|528701717|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
146598741|NCT01302054|528701718|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
146598742|NCT01302054|528701716|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
146598743|NCT01302054|528701717|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
146598744|NCT01302054|528701718|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
146598745|NCT01302054|528701716|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
146654486|NCT02038829|528912267|FG007|Treatment Period 4|Adverse Event|0|||
146654487|NCT02038829|528912268|FG008|Treatment Period 4|Adverse Event|0|||
146654488|NCT02038829|528912269|FG009|Treatment Period 4|Adverse Event|0|||
146654489|NCT02038829|528912270|FG010|Treatment Period 4|Adverse Event|0|||
146654490|NCT02038829|528912271|FG011|Treatment Period 4|Adverse Event|0|||
146654491|NCT02038829|528912260|FG000|Washout Period 4|Adverse Event|0|||
146654492|NCT02038829|528912261|FG001|Washout Period 4|Adverse Event|0|||
146654493|NCT02038829|528912262|FG002|Washout Period 4|Adverse Event|0|||
146654494|NCT02038829|528912263|FG003|Washout Period 4|Adverse Event|0|||
146654495|NCT02038829|528912264|FG004|Washout Period 4|Adverse Event|0|||
146654496|NCT02038829|528912265|FG005|Washout Period 4|Adverse Event|0|||
146654497|NCT02038829|528912266|FG006|Washout Period 4|Adverse Event|1|||
146654498|NCT02038829|528912267|FG007|Washout Period 4|Adverse Event|0|||
146654499|NCT02038829|528912268|FG008|Washout Period 4|Adverse Event|0|||
146654500|NCT02038829|528912269|FG009|Washout Period 4|Adverse Event|0|||
146598746|NCT01302054|528701717|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
146598747|NCT01302054|528701718|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
146598748|NCT01302054|528701716|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
146598749|NCT01302054|528701717|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
146598750|NCT01302054|528701718|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
146598751|NCT01302054|528701716|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
146598752|NCT01302054|528701717|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
146598753|NCT01302054|528701718|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
146598754|NCT01302054|528701716|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
146598755|NCT01302054|528701717|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
146598756|NCT01302054|528701718|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
146598757|NCT01302054|528701716|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146598758|NCT01302054|528701717|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
146598759|NCT01302054|528701718|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
146598760|NCT01302054|528701716|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
146598761|NCT01302054|528701717|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
146598762|NCT01302054|528701718|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
146598763|NCT01302054|528701716|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
146598764|NCT01302054|528701717|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
146598765|NCT01302054|528701718|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
146598766|NCT01302054|528701716|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
146598767|NCT01302054|528701717|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
146598768|NCT01302054|528701718|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
146598769|NCT01302054|528701716|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
146598770|NCT01302054|528701717|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
146598771|NCT01302054|528701718|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
146598772|NCT01302054|528701716|FG000|Double-Blind Treatment Phase|Other|0|||
146598773|NCT01302054|528701717|FG001|Double-Blind Treatment Phase|Other|4|||
146598774|NCT01302054|528701718|FG002|Double-Blind Treatment Phase|Other|9|||
146598775|NCT00857948|528701719|FG000|Overall Study|Withdrawal by Subject|2|||
146598776|NCT00857948|528701720|FG001|Overall Study|Withdrawal by Subject|0|||
146598777|NCT00857948|528701721|FG002|Overall Study|Withdrawal by Subject|0|||
146598778|NCT00857948|528701722|FG003|Overall Study|Withdrawal by Subject|0|||
146598779|NCT00857948|528701719|FG000|Overall Study|Protocol Violation|1|||
146598780|NCT00857948|528701720|FG001|Overall Study|Protocol Violation|0|||
146598781|NCT00857948|528701721|FG002|Overall Study|Protocol Violation|1|||
146598782|NCT00857948|528701722|FG003|Overall Study|Protocol Violation|0|||
146598783|NCT03757130|528701727|FG000|Overall Study|Lost to Follow-up|0|||
146598784|NCT03757130|528701728|FG001|Overall Study|Lost to Follow-up|0|||
146598785|NCT03757130|528701729|FG002|Overall Study|Lost to Follow-up|0|||
146598786|NCT03757130|528701730|FG003|Overall Study|Lost to Follow-up|1|||
146598787|NCT03757130|528701731|FG004|Overall Study|Lost to Follow-up|0|||
146598788|NCT03757130|528701732|FG005|Overall Study|Lost to Follow-up|0|||
146598789|NCT03757130|528701733|FG006|Overall Study|Lost to Follow-up|0|||
146598790|NCT03757130|528701734|FG007|Overall Study|Lost to Follow-up|1|||
146598791|NCT03757130|528701727|FG000|Overall Study|Withdrawal by Subject|0|||
146598792|NCT03757130|528701728|FG001|Overall Study|Withdrawal by Subject|0|||
146654501|NCT02038829|528912270|FG010|Washout Period 4|Adverse Event|0|||
146654502|NCT02038829|528912271|FG011|Washout Period 4|Adverse Event|0|||
146654503|NCT02038829|528912260|FG000|Treatment Period 6|Adverse Event|0|||
146654504|NCT02038829|528912261|FG001|Treatment Period 6|Adverse Event|0|||
146654505|NCT02038829|528912262|FG002|Treatment Period 6|Adverse Event|1|||
146654506|NCT02038829|528912263|FG003|Treatment Period 6|Adverse Event|0|||
146654507|NCT02038829|528912264|FG004|Treatment Period 6|Adverse Event|0|||
146654508|NCT02038829|528912265|FG005|Treatment Period 6|Adverse Event|0|||
146654509|NCT02038829|528912266|FG006|Treatment Period 6|Adverse Event|0|||
146654510|NCT02038829|528912267|FG007|Treatment Period 6|Adverse Event|0|||
146654511|NCT02038829|528912268|FG008|Treatment Period 6|Adverse Event|0|||
146654512|NCT02038829|528912269|FG009|Treatment Period 6|Adverse Event|0|||
146654513|NCT02038829|528912270|FG010|Treatment Period 6|Adverse Event|0|||
146771721|NCT02755805|529332587|FG001|Overall Study|Lost to Follow-up|2|||
146771722|NCT02755805|529332586|FG000|Overall Study|Refused assessments|1|||
146771723|NCT02755805|529332587|FG001|Overall Study|Refused assessments|0|||
146598793|NCT03757130|528701729|FG002|Overall Study|Withdrawal by Subject|0|||
146598794|NCT03757130|528701730|FG003|Overall Study|Withdrawal by Subject|0|||
146654514|NCT02038829|528912271|FG011|Treatment Period 6|Adverse Event|0|||
146654515|NCT05128929|528912275|FG000|Overall Study|Adverse Event|0|||
146654516|NCT05128929|528912276|FG001|Overall Study|Adverse Event|1|||
146654517|NCT02987660|528912279|FG000|Overall Study|Study terminated by sponsor|10|||
146654518|NCT02987660|528912280|FG001|Overall Study|Study terminated by sponsor|10|||
146654519|NCT05007717|528912281|FG000|Overall Study|Death|3|||
146654520|NCT05007717|528912282|FG001|Overall Study|Death|2|||
146654521|NCT03553836|528912283|FG000|Overall Study|Ongoing in Study|460|||
146654522|NCT03553836|528912284|FG001|Overall Study|Ongoing in Study|459|||
146598795|NCT03757130|528701731|FG004|Overall Study|Withdrawal by Subject|0|||
146598796|NCT03757130|528701732|FG005|Overall Study|Withdrawal by Subject|0|||
146598797|NCT03757130|528701733|FG006|Overall Study|Withdrawal by Subject|1|||
146598798|NCT03757130|528701734|FG007|Overall Study|Withdrawal by Subject|0|||
146598799|NCT01439126|528701737|FG000|Overall Study|Adverse Event|2|||
146598800|NCT01439126|528701738|FG001|Overall Study|Adverse Event|0|||
146598801|NCT01439126|528701737|FG000|Overall Study|Withdrawal by Subject|5|||
146598802|NCT01439126|528701738|FG001|Overall Study|Withdrawal by Subject|21|||
146598803|NCT01439126|528701737|FG000|Overall Study|Protocol Violation|6|||
146598804|NCT01439126|528701738|FG001|Overall Study|Protocol Violation|4|||
146598805|NCT01439126|528701737|FG000|Overall Study|Lost to Follow-up|6|||
146598806|NCT01439126|528701738|FG001|Overall Study|Lost to Follow-up|3|||
146598807|NCT01439126|528701737|FG000|Overall Study|Other-Use of prohibited treatment|0|||
146598808|NCT01439126|528701738|FG001|Overall Study|Other-Use of prohibited treatment|2|||
146598809|NCT01439126|528701737|FG000|Overall Study|Other-Miscellaneous|12|||
146598810|NCT01439126|528701738|FG001|Overall Study|Other-Miscellaneous|12|||
146598811|NCT03242018|528701739|FG000|Overall Study|Adverse Event|7|||
146920817|NCT03249792|529871475|FG020|Switch Over Period|Progressive Disease|0|||
146920818|NCT03249792|529871476|FG021|Switch Over Period|Progressive Disease|0|||
146920819|NCT03249792|529871477|FG022|Switch Over Period|Progressive Disease|0|||
146920820|NCT03249792|529871478|FG023|Switch Over Period|Progressive Disease|0|||
146920821|NCT03249792|529871479|FG024|Switch Over Period|Progressive Disease|0|||
146920822|NCT03249792|529871480|FG025|Switch Over Period|Progressive Disease|0|||
146920823|NCT03249792|529871481|FG026|Switch Over Period|Progressive Disease|1|||
146920824|NCT03249792|529871482|FG027|Switch Over Period|Progressive Disease|0|||
146920825|NCT03249792|529871483|FG028|Switch Over Period|Progressive Disease|1|||
146920826|NCT03249792|529871484|FG029|Switch Over Period|Progressive Disease|2|||
146920827|NCT03249792|529871485|FG030|Switch Over Period|Progressive Disease|1|||
146920828|NCT03249792|529871486|FG031|Switch Over Period|Progressive Disease|0|||
146920829|NCT03249792|529871487|FG032|Switch Over Period|Progressive Disease|1|||
146920830|NCT03249792|529871455|FG000|Switch Over Period|Adverse Event|0|||
146920831|NCT03249792|529871456|FG001|Switch Over Period|Adverse Event|0|||
146920832|NCT03249792|529871457|FG002|Switch Over Period|Adverse Event|0|||
146920833|NCT03249792|529871458|FG003|Switch Over Period|Adverse Event|0|||
146920834|NCT03249792|529871459|FG004|Switch Over Period|Adverse Event|0|||
146920835|NCT03249792|529871460|FG005|Switch Over Period|Adverse Event|0|||
146920836|NCT03249792|529871461|FG006|Switch Over Period|Adverse Event|0|||
146920837|NCT03249792|529871462|FG007|Switch Over Period|Adverse Event|0|||
146920838|NCT03249792|529871463|FG008|Switch Over Period|Adverse Event|0|||
146920839|NCT03249792|529871464|FG009|Switch Over Period|Adverse Event|0|||
146920840|NCT03249792|529871465|FG010|Switch Over Period|Adverse Event|0|||
146920841|NCT03249792|529871466|FG011|Switch Over Period|Adverse Event|0|||
146920842|NCT03249792|529871467|FG012|Switch Over Period|Adverse Event|0|||
146920843|NCT03249792|529871468|FG013|Switch Over Period|Adverse Event|0|||
146920844|NCT03249792|529871469|FG014|Switch Over Period|Adverse Event|0|||
146920845|NCT03249792|529871470|FG015|Switch Over Period|Adverse Event|0|||
146920846|NCT03249792|529871471|FG016|Switch Over Period|Adverse Event|0|||
146920847|NCT03249792|529871472|FG017|Switch Over Period|Adverse Event|0|||
146920848|NCT03249792|529871473|FG018|Switch Over Period|Adverse Event|0|||
146920849|NCT03249792|529871474|FG019|Switch Over Period|Adverse Event|0|||
146920850|NCT03249792|529871475|FG020|Switch Over Period|Adverse Event|0|||
146920851|NCT03249792|529871476|FG021|Switch Over Period|Adverse Event|0|||
146920852|NCT03249792|529871477|FG022|Switch Over Period|Adverse Event|0|||
146920853|NCT03249792|529871478|FG023|Switch Over Period|Adverse Event|0|||
146920854|NCT03249792|529871479|FG024|Switch Over Period|Adverse Event|0|||
146920855|NCT03249792|529871480|FG025|Switch Over Period|Adverse Event|1|||
146920856|NCT03249792|529871481|FG026|Switch Over Period|Adverse Event|0|||
146920857|NCT03249792|529871482|FG027|Switch Over Period|Adverse Event|1|||
146920858|NCT03249792|529871483|FG028|Switch Over Period|Adverse Event|0|||
146920859|NCT03249792|529871484|FG029|Switch Over Period|Adverse Event|0|||
146920860|NCT03249792|529871485|FG030|Switch Over Period|Adverse Event|0|||
146920861|NCT03249792|529871486|FG031|Switch Over Period|Adverse Event|0|||
146920862|NCT03249792|529871487|FG032|Switch Over Period|Adverse Event|0|||
146598812|NCT03242018|528701740|FG001|Overall Study|Adverse Event|7|||
146920863|NCT01842308|529871491|FG000|Overall Study|Withdrawal by Subject|0|||
146920864|NCT01842308|529871492|FG001|Overall Study|Withdrawal by Subject|0|||
146598813|NCT03242018|528701741|FG002|Overall Study|Adverse Event|6|||
146920865|NCT01842308|529871493|FG002|Overall Study|Withdrawal by Subject|0|||
146920866|NCT01842308|529871494|FG003|Overall Study|Withdrawal by Subject|0|||
146920867|NCT01842308|529871495|FG004|Overall Study|Withdrawal by Subject|1|||
146920868|NCT03885726|529871497|FG000|Overall Study|Staffing issues/lost interest|1|||
146920869|NCT03885726|529871497|FG000|Overall Study|Early discharge from hospital|3|||
146598814|NCT03242018|528701739|FG000|Overall Study|Lost to Follow-up|2|||
146771724|NCT02755805|529332586|FG000|Overall Study|Withdrawal by Subject|0|||
146598815|NCT03242018|528701740|FG001|Overall Study|Lost to Follow-up|2|||
146920870|NCT02868216|529871502|FG000|Overall Study|Death|0|||
146920871|NCT02868216|529871503|FG001|Overall Study|Death|1|||
146920872|NCT02868216|529871502|FG000|Overall Study|coronary artery bypass|1|||
146920873|NCT02868216|529871503|FG001|Overall Study|coronary artery bypass|0|||
146920874|NCT02868216|529871502|FG000|Overall Study|Withdrawal by Subject|7|||
146920875|NCT02868216|529871503|FG001|Overall Study|Withdrawal by Subject|5|||
146920876|NCT00610935|529871506|FG000|Overall Study|Lost to Follow-up|0|||
146920877|NCT00610935|529871507|FG001|Overall Study|Lost to Follow-up|1|||
146920878|NCT00610935|529871506|FG000|Overall Study|Withdrawal by Subject|0|||
146920879|NCT00610935|529871507|FG001|Overall Study|Withdrawal by Subject|2|||
146920880|NCT00610935|529871506|FG000|Overall Study|Sponsor Discontinuation|1|||
146920881|NCT00610935|529871507|FG001|Overall Study|Sponsor Discontinuation|0|||
146920882|NCT03345836|529871508|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
146920883|NCT03345836|529871509|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
146920884|NCT03345836|529871510|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
146920885|NCT03345836|529871511|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
146920886|NCT03345836|529871512|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
146920887|NCT03345836|529871513|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
146920888|NCT03345836|529871508|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
146920889|NCT03345836|529871509|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
146920890|NCT03345836|529871510|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
146920891|NCT03345836|529871511|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
146920892|NCT03345836|529871512|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
146920893|NCT03345836|529871513|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
146920894|NCT03345836|529871508|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
146920895|NCT03345836|529871509|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
146920896|NCT03345836|529871510|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
146920897|NCT03345836|529871511|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
146920898|NCT03345836|529871512|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
146920899|NCT03345836|529871513|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
146920900|NCT03345836|529871508|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
146920901|NCT03345836|529871509|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
146920902|NCT03345836|529871510|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
146920903|NCT03345836|529871511|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
146920904|NCT03345836|529871512|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
146920905|NCT03345836|529871513|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
146920906|NCT03345836|529871508|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
146920907|NCT03345836|529871509|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
146920908|NCT03345836|529871510|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
146920909|NCT03345836|529871511|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
146920910|NCT03345836|529871512|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
146920911|NCT03345836|529871513|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
146920912|NCT03345836|529871508|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
146920913|NCT03345836|529871509|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
146920914|NCT03345836|529871510|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
146920915|NCT03345836|529871511|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
146654523|NCT03553836|528912283|FG000|Overall Study|Withdrawal by Subject|9|||
146654524|NCT03553836|528912284|FG001|Overall Study|Withdrawal by Subject|10|||
146654525|NCT03553836|528912283|FG000|Overall Study|Lost to Follow-up|1|||
146654526|NCT03553836|528912284|FG001|Overall Study|Lost to Follow-up|3|||
146654527|NCT03553836|528912283|FG000|Overall Study|Death|17|||
146654528|NCT03553836|528912284|FG001|Overall Study|Death|17|||
146654529|NCT04062123|528912285|FG000|Overall Study|Withdrawal by Subject|0|||
146920916|NCT03345836|529871512|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
146920917|NCT03345836|529871513|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
146920918|NCT03345836|529871508|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
146920919|NCT03345836|529871509|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
146920920|NCT03345836|529871510|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
146920921|NCT03345836|529871511|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
146920922|NCT03345836|529871512|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
146920923|NCT03345836|529871513|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
146920924|NCT03345836|529871508|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
146920925|NCT03345836|529871509|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
146654530|NCT04062123|528912286|FG001|Overall Study|Withdrawal by Subject|1|||
146920926|NCT03345836|529871510|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
146920927|NCT03345836|529871511|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
146920928|NCT03345836|529871512|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
146654531|NCT04062123|528912287|FG002|Overall Study|Withdrawal by Subject|0|||
146654532|NCT04626310|528912291|FG000|Overall Study|4-miss from treatment|6|||
146654533|NCT04626310|528912292|FG001|Overall Study|4-miss from treatment|5|||
146654534|NCT04626310|528912293|FG002|Overall Study|4-miss from treatment|5|||
146598816|NCT03242018|528701741|FG002|Overall Study|Lost to Follow-up|2|||
146598817|NCT03242018|528701739|FG000|Overall Study|At the Participant's Own Request|5|||
146598818|NCT03242018|528701740|FG001|Overall Study|At the Participant's Own Request|1|||
146598819|NCT03242018|528701741|FG002|Overall Study|At the Participant's Own Request|4|||
146598820|NCT03242018|528701739|FG000|Overall Study|Reason Not Specified|3|||
146598821|NCT03242018|528701740|FG001|Overall Study|Reason Not Specified|4|||
146598822|NCT03242018|528701741|FG002|Overall Study|Reason Not Specified|1|||
146598823|NCT03242018|528701739|FG000|Overall Study|Study Terminated by Sponsor|1|||
146598824|NCT03242018|528701740|FG001|Overall Study|Study Terminated by Sponsor|0|||
146598825|NCT03242018|528701741|FG002|Overall Study|Study Terminated by Sponsor|1|||
146598826|NCT00687609|528701742|FG000|Overall Study|Physician Decision|1|||
146598827|NCT00687609|528701742|FG000|Overall Study|Withdrawal by Subject|2|||
146598828|NCT02635347|528701743|FG000|Overall Study|Failed screening|20|||
146920929|NCT03345836|529871513|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
146920930|NCT03345836|529871508|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
146920931|NCT03345836|529871509|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
146920932|NCT03345836|529871510|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
146920933|NCT03345836|529871511|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
146598829|NCT02635347|528701744|FG001|Overall Study|Failed screening|7|||
146598830|NCT01617447|528701745|FG000|Overall Study|Adverse Event|0|||
146598831|NCT01617447|528701746|FG001|Overall Study|Adverse Event|1|||
146598832|NCT01617447|528701745|FG000|Overall Study|Physician Decision|0|||
146598833|NCT01617447|528701746|FG001|Overall Study|Physician Decision|2|||
146598834|NCT00780273|528701747|FG000|Overall Study|Death|1|||
146598835|NCT00780273|528701747|FG000|Overall Study|Lost to Follow-up|1|||
146598836|NCT00121641|528701748|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
146598837|NCT00121641|528701749|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
146598838|NCT00121641|528701750|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
146598839|NCT00121641|528701751|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
146598840|NCT00121641|528701752|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
146598841|NCT00121641|528701748|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
146598842|NCT00121641|528701749|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
146598843|NCT00121641|528701750|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
146598844|NCT00121641|528701751|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
146598845|NCT00121641|528701752|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
146598846|NCT00121641|528701748|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
146598847|NCT00121641|528701749|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
146598848|NCT00121641|528701750|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
146598849|NCT00121641|528701751|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
146598850|NCT00121641|528701752|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
146598851|NCT00121641|528701748|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
146598852|NCT00121641|528701749|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
146598853|NCT00121641|528701750|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
146598854|NCT00121641|528701751|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
146598855|NCT00121641|528701752|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
146598856|NCT00121641|528701748|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
146598857|NCT00121641|528701749|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
146598858|NCT00121641|528701750|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
146598859|NCT00121641|528701751|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
146598860|NCT00121641|528701752|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
146598861|NCT00121641|528701748|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
146598862|NCT00121641|528701749|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
146598863|NCT00121641|528701750|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
146598864|NCT00121641|528701751|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
146598865|NCT00121641|528701752|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
146598866|NCT00121641|528701748|FG000|24-week Short-term Treatment Period|Other Reason|1|||
146598867|NCT00121641|528701749|FG001|24-week Short-term Treatment Period|Other Reason|0|||
146598868|NCT00121641|528701750|FG002|24-week Short-term Treatment Period|Other Reason|0|||
146598869|NCT00121641|528701751|FG003|24-week Short-term Treatment Period|Other Reason|0|||
146598870|NCT00121641|528701752|FG004|24-week Short-term Treatment Period|Other Reason|0|||
146598871|NCT00121641|528701748|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
146598872|NCT00121641|528701749|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
146598873|NCT00121641|528701750|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
146598874|NCT00121641|528701751|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
146598875|NCT00121641|528701752|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
146598876|NCT00121641|528701748|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
146598877|NCT00121641|528701749|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
146920934|NCT03345836|529871512|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
146920935|NCT03345836|529871513|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
146920936|NCT03345836|529871508|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
146920937|NCT03345836|529871509|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
146920938|NCT03345836|529871510|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
146920939|NCT03345836|529871511|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
146920940|NCT03345836|529871512|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
146920941|NCT03345836|529871513|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
146920942|NCT03345836|529871508|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
146920943|NCT03345836|529871509|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
146920944|NCT03345836|529871510|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
146920945|NCT03345836|529871511|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
146920946|NCT03345836|529871512|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
146920947|NCT03345836|529871513|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
146920948|NCT00320385|529871516|FG000|Overall Study|Lost to Follow-up|7|||
146920949|NCT00320385|529871517|FG001|Overall Study|Lost to Follow-up|10|||
146920950|NCT00320385|529871516|FG000|Overall Study|Withdrawal by Subject|6|||
146920951|NCT00320385|529871517|FG001|Overall Study|Withdrawal by Subject|7|||
146920952|NCT00320385|529871516|FG000|Overall Study|Sponsor Terminated Study|2|||
146920953|NCT00320385|529871517|FG001|Overall Study|Sponsor Terminated Study|1|||
146920954|NCT00320385|529871516|FG000|Overall Study|Investigator Decision|0|||
146920955|NCT00320385|529871517|FG001|Overall Study|Investigator Decision|1|||
146920956|NCT00320385|529871516|FG000|Overall Study|Death|1|||
146920957|NCT00320385|529871517|FG001|Overall Study|Death|2|||
146920958|NCT00320385|529871516|FG000|Overall Study|Serious Adverse Event|1|||
146920959|NCT00320385|529871517|FG001|Overall Study|Serious Adverse Event|0|||
146920960|NCT00320385|529871516|FG000|Overall Study|Withdrew Consent|1|||
146598878|NCT00121641|528701750|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
146598879|NCT00121641|528701751|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
146598880|NCT00121641|528701752|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
146598881|NCT00121641|528701748|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
146771725|NCT02755805|529332587|FG001|Overall Study|Withdrawal by Subject|2|||
146771726|NCT02252042|529332589|FG000|Overall Study|Adverse Event|9|||
146771727|NCT02252042|529332590|FG001|Overall Study|Adverse Event|6|||
146771728|NCT02252042|529332589|FG000|Overall Study|Death|209|||
146771729|NCT02252042|529332590|FG001|Overall Study|Death|217|||
146771730|NCT02252042|529332589|FG000|Overall Study|Physician Decision|0|||
146771731|NCT02252042|529332590|FG001|Overall Study|Physician Decision|2|||
146771732|NCT02252042|529332589|FG000|Overall Study|Transferred to Extension Study|7|||
146771733|NCT02252042|529332590|FG001|Overall Study|Transferred to Extension Study|1|||
146598882|NCT00121641|528701749|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
146598883|NCT00121641|528701750|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
146598884|NCT00121641|528701751|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
146598885|NCT00121641|528701752|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
146598886|NCT00121641|528701748|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
146598887|NCT00121641|528701749|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
146598888|NCT00121641|528701750|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
146598889|NCT00121641|528701751|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
146598890|NCT00121641|528701752|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
146771734|NCT02252042|529332589|FG000|Overall Study|Did Not Continue on Extension Study|7|||
146771735|NCT02252042|529332590|FG001|Overall Study|Did Not Continue on Extension Study|2|||
146771736|NCT02252042|529332589|FG000|Overall Study|Withdrawal by Subject|15|||
146920961|NCT00320385|529871517|FG001|Overall Study|Withdrew Consent|0|||
146920962|NCT00320385|529871516|FG000|Overall Study|Adverse Event|0|||
146920963|NCT00320385|529871517|FG001|Overall Study|Adverse Event|1|||
146920964|NCT00748540|529871523|FG000|Overall Study|Physician Decision|1|||
146920965|NCT02775864|529871524|FG000|Overall Study|Data ended end of 2010|1764|||
146920966|NCT02775864|529871525|FG001|Overall Study|Data ended end of 2010|2880|||
146920967|NCT02775864|529871526|FG002|Overall Study|Data ended end of 2010|1140|||
146920968|NCT02775864|529871527|FG003|Overall Study|Data ended end of 2010|1194|||
146598891|NCT00121641|528701748|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
146598892|NCT00121641|528701749|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
146598893|NCT00121641|528701750|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
146598894|NCT00121641|528701751|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
146598895|NCT00121641|528701752|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
146598896|NCT00121641|528701748|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
146598897|NCT00121641|528701749|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
146598898|NCT00121641|528701750|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
146771737|NCT02252042|529332590|FG001|Overall Study|Withdrawal by Subject|20|||
146654535|NCT04626310|528912291|FG000|Overall Study|Withdrawal by Subject|1|||
146598899|NCT00121641|528701751|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
146598900|NCT00121641|528701752|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
146598901|NCT00121641|528701748|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
146598902|NCT00121641|528701749|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
146598903|NCT00121641|528701750|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
146598904|NCT00121641|528701751|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
146598905|NCT00121641|528701752|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
146598906|NCT00121641|528701748|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
146598907|NCT00121641|528701749|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
146598908|NCT00121641|528701750|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
146598909|NCT00121641|528701751|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
146598910|NCT00121641|528701752|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
146598911|NCT00121641|528701748|FG000|48-month Short Term + Long Term Period|Death|0|||
146598912|NCT00121641|528701749|FG001|48-month Short Term + Long Term Period|Death|0|||
146598913|NCT00121641|528701750|FG002|48-month Short Term + Long Term Period|Death|0|||
146598914|NCT00121641|528701751|FG003|48-month Short Term + Long Term Period|Death|1|||
146598915|NCT00121641|528701752|FG004|48-month Short Term + Long Term Period|Death|0|||
146598916|NCT00121641|528701748|FG000|48-month Short Term + Long Term Period|Missing|0|||
146598917|NCT00121641|528701749|FG001|48-month Short Term + Long Term Period|Missing|0|||
146598918|NCT00121641|528701750|FG002|48-month Short Term + Long Term Period|Missing|1|||
146598919|NCT00121641|528701751|FG003|48-month Short Term + Long Term Period|Missing|0|||
146598920|NCT00121641|528701752|FG004|48-month Short Term + Long Term Period|Missing|0|||
146598921|NCT00121641|528701748|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
146598922|NCT00121641|528701749|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
146598923|NCT00121641|528701750|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
146598924|NCT00121641|528701751|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
146598925|NCT00121641|528701752|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
146598926|NCT00619489|528701758|FG000|Overall Study|Adverse Event|0|||
146598927|NCT00619489|528701759|FG001|Overall Study|Adverse Event|7|||
146598928|NCT00619489|528701758|FG000|Overall Study|Withdrawal by Subject|1|||
146598929|NCT00619489|528701759|FG001|Overall Study|Withdrawal by Subject|1|||
146598930|NCT00619489|528701758|FG000|Overall Study|Lack of Efficacy|0|||
146598931|NCT00619489|528701759|FG001|Overall Study|Lack of Efficacy|11|||
146598932|NCT00619489|528701758|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
146598933|NCT00619489|528701759|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
146598934|NCT02356887|528701760|FG000|Overall Study|poor compliance|2|||
146598935|NCT02544373|528701764|FG000|Overall Study|Lost to Follow-up|5|||
146598936|NCT02544373|528701765|FG001|Overall Study|Lost to Follow-up|3|||
146598937|NCT02544373|528701764|FG000|Overall Study|Withdrawal by Subject|8|||
146598938|NCT02544373|528701765|FG001|Overall Study|Withdrawal by Subject|2|||
146598939|NCT02404649|528701766|FG000|Overall Study|Adverse Event|1|||
146598940|NCT02404649|528701767|FG001|Overall Study|Adverse Event|2|||
146598941|NCT00162266|528701771|FG000|Double-Blind Period|Adverse Event|5|||
146654536|NCT04626310|528912292|FG001|Overall Study|Withdrawal by Subject|0|||
146654537|NCT04626310|528912293|FG002|Overall Study|Withdrawal by Subject|3|||
146654538|NCT02278341|528912294|FG000|Overall Study|Randomized but never received study drug|1|||
146654539|NCT02278341|528912295|FG001|Overall Study|Randomized but never received study drug|1|||
146654540|NCT02278341|528912294|FG000|Overall Study|Adverse Event|3|||
146654541|NCT02278341|528912295|FG001|Overall Study|Adverse Event|0|||
146654542|NCT02278341|528912294|FG000|Overall Study|Death|68|||
146654543|NCT02278341|528912295|FG001|Overall Study|Death|56|||
146654544|NCT02278341|528912294|FG000|Overall Study|Withdrawal by Subject|30|||
146654545|NCT02278341|528912295|FG001|Overall Study|Withdrawal by Subject|19|||
146920969|NCT02775864|529871524|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
146920970|NCT02775864|529871525|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
146920971|NCT02775864|529871526|FG002|Overall Study|Medicaid eligibility discontinued|720|||
146920972|NCT02775864|529871527|FG003|Overall Study|Medicaid eligibility discontinued|890|||
146598942|NCT00162266|528701772|FG001|Double-Blind Period|Adverse Event|9|||
146598943|NCT00162266|528701773|FG002|Double-Blind Period|Adverse Event|11|||
146598944|NCT00162266|528701774|FG003|Double-Blind Period|Adverse Event|0|||
146598945|NCT00162266|528701771|FG000|Double-Blind Period|Death|0|||
146598946|NCT00162266|528701772|FG001|Double-Blind Period|Death|1|||
146598947|NCT00162266|528701773|FG002|Double-Blind Period|Death|0|||
146598948|NCT00162266|528701774|FG003|Double-Blind Period|Death|0|||
146598949|NCT00162266|528701771|FG000|Double-Blind Period|Lost to Follow-up|1|||
146598950|NCT00162266|528701772|FG001|Double-Blind Period|Lost to Follow-up|2|||
146598951|NCT00162266|528701773|FG002|Double-Blind Period|Lost to Follow-up|0|||
146654546|NCT02278341|528912294|FG000|Overall Study|Lost to Follow-up|0|||
146654547|NCT02278341|528912295|FG001|Overall Study|Lost to Follow-up|1|||
146654548|NCT02278341|528912294|FG000|Overall Study|Physician Decision|1|||
146654549|NCT02278341|528912295|FG001|Overall Study|Physician Decision|1|||
146654550|NCT02278341|528912294|FG000|Overall Study|Miscellaneous|15|||
146978535|NCT00272961|530084097|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
146598952|NCT00162266|528701774|FG003|Double-Blind Period|Lost to Follow-up|0|||
146598953|NCT00162266|528701771|FG000|Double-Blind Period|Other Reason|1|||
146598954|NCT00162266|528701772|FG001|Double-Blind Period|Other Reason|0|||
146598955|NCT00162266|528701773|FG002|Double-Blind Period|Other Reason|1|||
146598956|NCT00162266|528701774|FG003|Double-Blind Period|Other Reason|0|||
146598957|NCT00162266|528701771|FG000|Double-Blind Period|Lack of Efficacy|13|||
146598958|NCT00162266|528701772|FG001|Double-Blind Period|Lack of Efficacy|17|||
146598959|NCT00162266|528701773|FG002|Double-Blind Period|Lack of Efficacy|30|||
146598960|NCT00162266|528701774|FG003|Double-Blind Period|Lack of Efficacy|0|||
146598961|NCT00162266|528701771|FG000|Double-Blind Period|Withdrawal by Subject|5|||
146598962|NCT00162266|528701772|FG001|Double-Blind Period|Withdrawal by Subject|2|||
146598963|NCT00162266|528701773|FG002|Double-Blind Period|Withdrawal by Subject|6|||
146598964|NCT00162266|528701774|FG003|Double-Blind Period|Withdrawal by Subject|0|||
146598965|NCT00162266|528701771|FG000|Open-Label Period|Death|0|||
146598966|NCT00162266|528701772|FG001|Open-Label Period|Death|0|||
146598967|NCT00162266|528701773|FG002|Open-Label Period|Death|0|||
146598968|NCT00162266|528701774|FG003|Open-Label Period|Death|7|||
146598969|NCT00162266|528701771|FG000|Open-Label Period|Adverse Event|0|||
146598970|NCT00162266|528701772|FG001|Open-Label Period|Adverse Event|0|||
146598971|NCT00162266|528701773|FG002|Open-Label Period|Adverse Event|0|||
146598972|NCT00162266|528701774|FG003|Open-Label Period|Adverse Event|46|||
146598973|NCT00162266|528701771|FG000|Open-Label Period|Lack of Efficacy|0|||
146598974|NCT00162266|528701772|FG001|Open-Label Period|Lack of Efficacy|0|||
146598975|NCT00162266|528701773|FG002|Open-Label Period|Lack of Efficacy|0|||
146598976|NCT00162266|528701774|FG003|Open-Label Period|Lack of Efficacy|26|||
146598977|NCT00162266|528701771|FG000|Open-Label Period|Lost to Follow-up|0|||
146598978|NCT00162266|528701772|FG001|Open-Label Period|Lost to Follow-up|0|||
146598979|NCT00162266|528701773|FG002|Open-Label Period|Lost to Follow-up|0|||
146598980|NCT00162266|528701774|FG003|Open-Label Period|Lost to Follow-up|3|||
146598981|NCT00162266|528701771|FG000|Open-Label Period|Withdrawal by Subject|0|||
146598982|NCT00162266|528701772|FG001|Open-Label Period|Withdrawal by Subject|0|||
146598983|NCT00162266|528701773|FG002|Open-Label Period|Withdrawal by Subject|0|||
146598984|NCT00162266|528701774|FG003|Open-Label Period|Withdrawal by Subject|31|||
146598985|NCT00162266|528701771|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
146598986|NCT00162266|528701772|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
146598987|NCT00162266|528701773|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
146598988|NCT00162266|528701774|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
146598989|NCT00162266|528701771|FG000|Open-Label Period|Other Reasons|0|||
146598990|NCT00162266|528701772|FG001|Open-Label Period|Other Reasons|0|||
146598991|NCT00162266|528701773|FG002|Open-Label Period|Other Reasons|0|||
146598992|NCT00162266|528701774|FG003|Open-Label Period|Other Reasons|15|||
146598993|NCT04208087|528701775|FG000|Overall Study|Adverse Event|1|||
146598994|NCT04208087|528701776|FG001|Overall Study|Adverse Event|0|||
146598995|NCT04208087|528701777|FG002|Overall Study|Adverse Event|0|||
146598996|NCT04208087|528701778|FG003|Overall Study|Adverse Event|0|||
146598997|NCT04208087|528701779|FG004|Overall Study|Adverse Event|0|||
146598998|NCT04208087|528701775|FG000|Overall Study|Withdrawal by Subject|0|||
146598999|NCT04208087|528701776|FG001|Overall Study|Withdrawal by Subject|0|||
146599000|NCT04208087|528701777|FG002|Overall Study|Withdrawal by Subject|1|||
146599001|NCT04208087|528701778|FG003|Overall Study|Withdrawal by Subject|0|||
146599002|NCT04208087|528701779|FG004|Overall Study|Withdrawal by Subject|0|||
146599003|NCT04208087|528701775|FG000|Overall Study|Other|0|||
146599004|NCT04208087|528701776|FG001|Overall Study|Other|0|||
146599005|NCT04208087|528701777|FG002|Overall Study|Other|0|||
146599006|NCT04208087|528701778|FG003|Overall Study|Other|0|||
146599007|NCT04208087|528701779|FG004|Overall Study|Other|1|||
146599008|NCT01839656|528701780|FG000|Overall Study|Withdrawal by Subject|1|||
146599009|NCT01839656|528701781|FG001|Overall Study|Withdrawal by Subject|1|||
146599010|NCT01839656|528701780|FG000|Overall Study|Adverse event, serious fatal|1|||
146599011|NCT01839656|528701781|FG001|Overall Study|Adverse event, serious fatal|4|||
146599012|NCT01839656|528701780|FG000|Overall Study|Early study closure|0|||
146978536|NCT00272961|530084098|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
146599013|NCT01839656|528701781|FG001|Overall Study|Early study closure|11|||
146599014|NCT01839656|528701780|FG000|Overall Study|Adverse Event|1|||
146599015|NCT01839656|528701781|FG001|Overall Study|Adverse Event|0|||
146599016|NCT02621073|528701791|FG000|Overall Study|Lost to Follow-up|0|||
146599017|NCT02621073|528701792|FG001|Overall Study|Lost to Follow-up|1|||
146599018|NCT02621073|528701791|FG000|Overall Study|Physician Decision|3|||
146599019|NCT02621073|528701792|FG001|Overall Study|Physician Decision|2|||
146599020|NCT01595581|528701793|FG000|Overall Study|Withdrawal by Subject|1|||
146599021|NCT01595581|528701794|FG001|Overall Study|Withdrawal by Subject|0|||
146599022|NCT01012323|528701798|FG000|Overall Study|Investigator Judgment|1|||
146599023|NCT00495755|528701799|FG000|Overall Study|Adverse Event|3|||
146599024|NCT01266590|528703339|FG000|Overall Study|Adverse Event|3|||
146599025|NCT01266590|528703339|FG000|Overall Study|Lost to Follow-up|1|||
146599026|NCT01266590|528703339|FG000|Overall Study|Withdrawal by Subject|1|||
146599027|NCT01266590|528703339|FG000|Overall Study|Physician Decision|1|||
146599028|NCT04435600|528703340|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146599029|NCT04435600|528703341|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146599030|NCT04435600|528703342|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
146599031|NCT04435600|528703343|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146599032|NCT04435600|528703344|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146599033|NCT04435600|528703345|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146599034|NCT04435600|528703346|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146599035|NCT04435600|528703347|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146599036|NCT04435600|528703348|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146599037|NCT04435600|528703349|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146599038|NCT04435600|528703340|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146599039|NCT04435600|528703341|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146599040|NCT04435600|528703342|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146599041|NCT04435600|528703343|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146599042|NCT04435600|528703344|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146599043|NCT04435600|528703345|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146599044|NCT04435600|528703346|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146599045|NCT04435600|528703347|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146599046|NCT04435600|528703348|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146599047|NCT04435600|528703349|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
146599048|NCT04435600|528703340|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146599049|NCT04435600|528703341|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146599050|NCT04435600|528703342|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146599051|NCT04435600|528703343|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146599052|NCT04435600|528703344|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146599053|NCT04435600|528703345|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146599054|NCT04435600|528703346|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146599055|NCT04435600|528703347|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146599056|NCT04435600|528703348|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146599057|NCT04435600|528703349|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
146599058|NCT04435600|528703340|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
146599059|NCT04435600|528703341|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
146599060|NCT04435600|528703342|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
146599061|NCT04435600|528703343|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
146599062|NCT04435600|528703344|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
146654551|NCT02278341|528912295|FG001|Overall Study|Miscellaneous|14|||
146654552|NCT04902326|528912296|FG000|Overall Study|Withdrawal by Subject|1|||
146654553|NCT04902326|528912297|FG001|Overall Study|Withdrawal by Subject|3|||
146654554|NCT04902326|528912298|FG002|Overall Study|Withdrawal by Subject|0|||
146654555|NCT04902326|528912299|FG003|Overall Study|Withdrawal by Subject|1|||
146654556|NCT04902326|528912296|FG000|Overall Study|Lost to Follow-up|14|||
146654557|NCT04902326|528912297|FG001|Overall Study|Lost to Follow-up|14|||
146654558|NCT04902326|528912298|FG002|Overall Study|Lost to Follow-up|14|||
146654559|NCT04902326|528912299|FG003|Overall Study|Lost to Follow-up|6|||
146654560|NCT02604017|528912301|FG000|Overall Study|Withdrew Consent|0|||
146654561|NCT02604017|528912302|FG001|Overall Study|Withdrew Consent|2|||
146771738|NCT02593149|529332591|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
146771739|NCT02593149|529332592|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
146920973|NCT02028338|529871529|FG000|Overall Study|Withdrawal by Subject|3|||
146920974|NCT02028338|529871530|FG001|Overall Study|Withdrawal by Subject|1|||
146920975|NCT02028338|529871529|FG000|Overall Study|Unable to contact participant|1|||
146920976|NCT02028338|529871530|FG001|Overall Study|Unable to contact participant|0|||
146920977|NCT01842620|529871533|FG000|Period 1|Withdrawal by Subject|1|||
146920978|NCT01842620|529871534|FG001|Period 1|Withdrawal by Subject|0|||
146920979|NCT00256867|529871535|FG000|Overall Study|Adverse Event|0|||
146920980|NCT00256867|529871536|FG001|Overall Study|Adverse Event|1|||
146920981|NCT00256867|529871537|FG002|Overall Study|Adverse Event|1|||
146920982|NCT00256867|529871538|FG003|Overall Study|Adverse Event|1|||
146920983|NCT00256867|529871539|FG004|Overall Study|Adverse Event|2|||
146920984|NCT00256867|529871540|FG005|Overall Study|Adverse Event|2|||
146920985|NCT00256867|529871541|FG006|Overall Study|Adverse Event|1|||
146920986|NCT00256867|529871542|FG007|Overall Study|Adverse Event|4|||
146654562|NCT02604017|528912301|FG000|Overall Study|Lost to Follow-up|5|||
146654563|NCT02604017|528912302|FG001|Overall Study|Lost to Follow-up|6|||
146978537|NCT00272961|530084099|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
146978538|NCT00272961|530084100|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
146654564|NCT02604017|528912301|FG000|Overall Study|Other|1|||
146920987|NCT00256867|529871535|FG000|Overall Study|Lost to Follow-up|2|||
146920988|NCT00256867|529871536|FG001|Overall Study|Lost to Follow-up|2|||
146920989|NCT00256867|529871537|FG002|Overall Study|Lost to Follow-up|2|||
146920990|NCT00256867|529871538|FG003|Overall Study|Lost to Follow-up|3|||
146920991|NCT00256867|529871539|FG004|Overall Study|Lost to Follow-up|2|||
146599063|NCT04435600|528703345|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
146599064|NCT04435600|528703346|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
146599065|NCT04435600|528703347|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
146599066|NCT04435600|528703348|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
146771740|NCT02593149|529332591|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
146771741|NCT02593149|529332592|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
146771742|NCT04532528|529332593|FG000|Overall Study|Adverse Event|12|||
146771743|NCT04532528|529332594|FG001|Overall Study|Adverse Event|17|||
146771744|NCT04532528|529332593|FG000|Overall Study|Withdrawal of consent|16|||
146771745|NCT04532528|529332594|FG001|Overall Study|Withdrawal of consent|17|||
146771746|NCT04532528|529332593|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
146771747|NCT04532528|529332594|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
146771748|NCT04532528|529332593|FG000|Overall Study|Lost to Follow-up|69|||
146771749|NCT04532528|529332594|FG001|Overall Study|Lost to Follow-up|68|||
146771750|NCT04532528|529332593|FG000|Overall Study|Administrative problems|12|||
146771751|NCT04532528|529332594|FG001|Overall Study|Administrative problems|14|||
146771752|NCT04532528|529332593|FG000|Overall Study|Death|3|||
146771753|NCT04532528|529332594|FG001|Overall Study|Death|3|||
146771754|NCT04532528|529332593|FG000|Overall Study|Other|38|||
146771755|NCT04532528|529332594|FG001|Overall Study|Other|46|||
146771756|NCT02448446|529332597|FG000|Overall Study|Withdrawal by Subject|1|||
146771757|NCT02448446|529332598|FG001|Overall Study|Withdrawal by Subject|0|||
146771758|NCT01254188|529332599|FG000|Overall Study|Disease Progression|6|||
146771759|NCT01254188|529332599|FG000|Overall Study|Protocol Violation|6|||
146771760|NCT01254188|529332599|FG000|Overall Study|Pregnancy|2|||
146771761|NCT01254188|529332599|FG000|Overall Study|Death|4|||
146771762|NCT01254188|529332599|FG000|Overall Study|Lost to Follow-up|5|||
146771763|NCT01254188|529332599|FG000|Overall Study|Withdrawal by Subject|7|||
146771764|NCT01254188|529332599|FG000|Overall Study|Adverse Event|43|||
146771765|NCT01254188|529332599|FG000|Overall Study|per investigator discretion|20|||
146771766|NCT02202499|529332604|FG000|Overall Study|Cancer diagnosis|0|||
146771767|NCT02202499|529332605|FG001|Overall Study|Cancer diagnosis|0|||
146771768|NCT02202499|529332606|FG002|Overall Study|Cancer diagnosis|1|||
146771769|NCT02202499|529332604|FG000|Overall Study|Moved from area|0|||
146771770|NCT02202499|529332605|FG001|Overall Study|Moved from area|0|||
146771771|NCT02202499|529332606|FG002|Overall Study|Moved from area|1|||
146771772|NCT02202499|529332604|FG000|Overall Study|Declined before randomization|1|||
146771773|NCT02202499|529332605|FG001|Overall Study|Declined before randomization|0|||
146771774|NCT02202499|529332606|FG002|Overall Study|Declined before randomization|0|||
146771775|NCT02202499|529332604|FG000|Overall Study|Auto accident|1|||
146771776|NCT02202499|529332605|FG001|Overall Study|Auto accident|0|||
146771777|NCT02202499|529332606|FG002|Overall Study|Auto accident|0|||
146771778|NCT02957136|529332612|FG000|Overall Study|Withdrawal by Subject|2|||
146771779|NCT02957136|529332613|FG001|Overall Study|Withdrawal by Subject|1|||
146771780|NCT00439569|529332616|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
146920992|NCT00256867|529871540|FG005|Overall Study|Lost to Follow-up|0|||
146920993|NCT00256867|529871541|FG006|Overall Study|Lost to Follow-up|1|||
146920994|NCT00256867|529871542|FG007|Overall Study|Lost to Follow-up|2|||
146920995|NCT00256867|529871535|FG000|Overall Study|Protocol Violation|0|||
146920996|NCT00256867|529871536|FG001|Overall Study|Protocol Violation|0|||
146920997|NCT00256867|529871537|FG002|Overall Study|Protocol Violation|0|||
146920998|NCT00256867|529871538|FG003|Overall Study|Protocol Violation|1|||
146920999|NCT00256867|529871539|FG004|Overall Study|Protocol Violation|0|||
146921000|NCT00256867|529871540|FG005|Overall Study|Protocol Violation|1|||
146921001|NCT00256867|529871541|FG006|Overall Study|Protocol Violation|0|||
146921002|NCT00256867|529871542|FG007|Overall Study|Protocol Violation|1|||
146921003|NCT00256867|529871535|FG000|Overall Study|Withdrawal by Subject|0|||
146921004|NCT00256867|529871536|FG001|Overall Study|Withdrawal by Subject|0|||
146921005|NCT00256867|529871537|FG002|Overall Study|Withdrawal by Subject|1|||
146921006|NCT00256867|529871538|FG003|Overall Study|Withdrawal by Subject|1|||
146921007|NCT00256867|529871539|FG004|Overall Study|Withdrawal by Subject|2|||
146921008|NCT00256867|529871540|FG005|Overall Study|Withdrawal by Subject|2|||
146921009|NCT00256867|529871541|FG006|Overall Study|Withdrawal by Subject|3|||
146921010|NCT00256867|529871542|FG007|Overall Study|Withdrawal by Subject|2|||
146921011|NCT00256867|529871535|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
146921012|NCT00256867|529871536|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
146921013|NCT00256867|529871537|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
146599067|NCT04435600|528703349|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
146921014|NCT00256867|529871538|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
146921015|NCT00256867|529871539|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
146921016|NCT00256867|529871540|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
146654565|NCT02604017|528912302|FG001|Overall Study|Other|0|||
146771781|NCT00439569|529332616|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
146771782|NCT00439569|529332616|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
146771783|NCT02200770|529332618|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
146771784|NCT02200770|529332619|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
146921017|NCT00256867|529871541|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
146921018|NCT00256867|529871542|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
146921019|NCT00256867|529871535|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
146921020|NCT00256867|529871536|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
146921021|NCT00256867|529871537|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
146921022|NCT00256867|529871538|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
146921023|NCT00256867|529871539|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
146921024|NCT00256867|529871540|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
146921025|NCT00256867|529871541|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
146921026|NCT00256867|529871542|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
146921027|NCT00256867|529871535|FG000|Overall Study|Investigator's Decision|0|||
146921028|NCT00256867|529871536|FG001|Overall Study|Investigator's Decision|0|||
146921029|NCT00256867|529871537|FG002|Overall Study|Investigator's Decision|0|||
146921030|NCT00256867|529871538|FG003|Overall Study|Investigator's Decision|0|||
146921031|NCT00256867|529871539|FG004|Overall Study|Investigator's Decision|1|||
146654566|NCT01041495|528912303|FG000|Overall Study|Withdrawal by Subject|2|||
146654567|NCT01041495|528912304|FG001|Overall Study|Withdrawal by Subject|5|||
146654568|NCT01041495|528912303|FG000|Overall Study|Adverse Event|2|||
146654569|NCT01041495|528912304|FG001|Overall Study|Adverse Event|1|||
146654570|NCT01041495|528912303|FG000|Overall Study|Lost to Follow-up|0|||
146654571|NCT01041495|528912304|FG001|Overall Study|Lost to Follow-up|1|||
146921032|NCT00256867|529871540|FG005|Overall Study|Investigator's Decision|0|||
146921033|NCT00256867|529871541|FG006|Overall Study|Investigator's Decision|0|||
146921034|NCT00256867|529871542|FG007|Overall Study|Investigator's Decision|0|||
146921035|NCT00256867|529871535|FG000|Overall Study|Non-compliance with study medication|0|||
146921036|NCT00256867|529871536|FG001|Overall Study|Non-compliance with study medication|0|||
146921037|NCT00256867|529871537|FG002|Overall Study|Non-compliance with study medication|0|||
146921038|NCT00256867|529871538|FG003|Overall Study|Non-compliance with study medication|0|||
146921039|NCT00256867|529871539|FG004|Overall Study|Non-compliance with study medication|0|||
146654572|NCT01479985|528912308|FG000|Overall Study|Tablet malfunction, no data saved|1|||
146654573|NCT01479985|528912309|FG001|Overall Study|Tablet malfunction, no data saved|1|||
146654574|NCT01479985|528912308|FG000|Overall Study|No decisional conflict scale responses|0|||
146654575|NCT01479985|528912309|FG001|Overall Study|No decisional conflict scale responses|2|||
146654576|NCT01479985|528912308|FG000|Overall Study|No post-visit survey|5|||
146654577|NCT01479985|528912309|FG001|Overall Study|No post-visit survey|3|||
146654578|NCT01653782|528912310|FG000|Overall Study|Withdrawal by Subject|9|||
146654579|NCT01653782|528912311|FG001|Overall Study|Withdrawal by Subject|15|||
146654580|NCT01653782|528912312|FG002|Overall Study|Withdrawal by Subject|4|||
146654581|NCT01653782|528912310|FG000|Overall Study|Lost to Follow-up|7|||
146654582|NCT01653782|528912311|FG001|Overall Study|Lost to Follow-up|3|||
146654583|NCT01653782|528912312|FG002|Overall Study|Lost to Follow-up|2|||
146654584|NCT01850602|528912318|FG000|Overall Study|Adverse Event|7|||
146654585|NCT01850602|528912319|FG001|Overall Study|Adverse Event|10|||
146654586|NCT01850602|528912318|FG000|Overall Study|Physician Decision|2|||
146654587|NCT01850602|528912319|FG001|Overall Study|Physician Decision|1|||
146654588|NCT01850602|528912318|FG000|Overall Study|Withdrawal by Subject|2|||
146654589|NCT01850602|528912319|FG001|Overall Study|Withdrawal by Subject|4|||
146654590|NCT01850602|528912318|FG000|Overall Study|Decrease in serum calcium|2|||
146654591|NCT01850602|528912319|FG001|Overall Study|Decrease in serum calcium|3|||
146654592|NCT01850602|528912318|FG000|Overall Study|Increase in serum ferritin|1|||
146654593|NCT01850602|528912319|FG001|Overall Study|Increase in serum ferritin|0|||
146654594|NCT00367770|528912320|FG000|Overall Study|Adverse Event|1|||
146654595|NCT00367770|528912320|FG000|Overall Study|Withdrawal by Subject|1|||
146654596|NCT01634178|528912324|FG000|Treatment Period 1|Adverse Event|0|||
146654597|NCT01634178|528912325|FG001|Treatment Period 1|Adverse Event|1|||
146654598|NCT01634178|528912324|FG000|Treatment Period 2|Adverse Event|1|||
146654599|NCT01634178|528912325|FG001|Treatment Period 2|Adverse Event|0|||
146654600|NCT00287079|528912326|FG000|Overall Study|Qualifying relapse|12|||
146654601|NCT00287079|528912327|FG001|Overall Study|Qualifying relapse|1|||
146654602|NCT00287079|528912326|FG000|Overall Study|Non-qualifying relapse|1|||
146654603|NCT00287079|528912327|FG001|Overall Study|Non-qualifying relapse|0|||
146654604|NCT00287079|528912326|FG000|Overall Study|Adverse Event|5|||
146771785|NCT02200770|529332618|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
146921040|NCT00256867|529871540|FG005|Overall Study|Non-compliance with study medication|0|||
146921041|NCT00256867|529871541|FG006|Overall Study|Non-compliance with study medication|0|||
146921042|NCT00256867|529871542|FG007|Overall Study|Non-compliance with study medication|1|||
146654605|NCT00287079|528912327|FG001|Overall Study|Adverse Event|0|||
146654606|NCT00287079|528912326|FG000|Overall Study|Protocol Violation|1|||
146654607|NCT00287079|528912327|FG001|Overall Study|Protocol Violation|0|||
146654608|NCT00287079|528912326|FG000|Overall Study|Other|3|||
146654609|NCT00287079|528912327|FG001|Overall Study|Other|0|||
146654610|NCT01721577|528912328|FG000|Overall Study|Lack of Efficacy|1|||
146654611|NCT01721577|528912329|FG001|Overall Study|Lack of Efficacy|0|||
146654612|NCT01721577|528912328|FG000|Overall Study|Death|1|||
146654613|NCT01721577|528912329|FG001|Overall Study|Death|0|||
146654614|NCT01721577|528912328|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
146654615|NCT01721577|528912329|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
146654616|NCT01721577|528912328|FG000|Overall Study|Adverse Event|0|||
146654617|NCT01721577|528912329|FG001|Overall Study|Adverse Event|2|||
146654618|NCT01282203|528912332|FG000|Overall Study|Adverse Event|1|||
146654619|NCT00740051|528912335|FG000|Overall Study|Lack of Efficacy|2|||
146654620|NCT00740051|528912336|FG001|Overall Study|Lack of Efficacy|5|||
146654621|NCT00740051|528912335|FG000|Overall Study|Adverse Event|1|||
146654622|NCT00740051|528912336|FG001|Overall Study|Adverse Event|4|||
146654623|NCT00740051|528912335|FG000|Overall Study|Protocol Violation|2|||
146654624|NCT00740051|528912336|FG001|Overall Study|Protocol Violation|6|||
146654625|NCT00740051|528912335|FG000|Overall Study|Lost to Follow-up|3|||
146654626|NCT00740051|528912336|FG001|Overall Study|Lost to Follow-up|8|||
146654627|NCT00740051|528912335|FG000|Overall Study|Withdrawal by Subject|6|||
146654628|NCT00740051|528912336|FG001|Overall Study|Withdrawal by Subject|8|||
146654629|NCT00740051|528912335|FG000|Overall Study|Other reason (not specified)|4|||
146654630|NCT00740051|528912336|FG001|Overall Study|Other reason (not specified)|1|||
146654631|NCT00930982|528912337|FG000|Overall Study|Adverse Event|19|||
146654632|NCT00930982|528912338|FG001|Overall Study|Adverse Event|23|||
146654633|NCT00930982|528912337|FG000|Overall Study|Protocol Violation|1|||
146654634|NCT00930982|528912338|FG001|Overall Study|Protocol Violation|5|||
146654635|NCT00930982|528912337|FG000|Overall Study|Withdrawal by Subject|1|||
146654636|NCT00930982|528912338|FG001|Overall Study|Withdrawal by Subject|1|||
146654637|NCT00991952|528912339|FG000|Overall Study|Adverse Event|0|||
146654638|NCT00991952|528912340|FG001|Overall Study|Adverse Event|1|||
146654639|NCT02483533|528912341|FG000|Overall Study|Lack of Efficacy|50|||
146654640|NCT02483533|528912342|FG001|Overall Study|Lack of Efficacy|50|||
146654641|NCT04365257|528912343|FG000|Overall Study|Physician Decision|1|||
146654642|NCT04365257|528912344|FG001|Overall Study|Physician Decision|0|||
146654643|NCT04365257|528912343|FG000|Overall Study|Patient Noncompliance|1|||
146654644|NCT04365257|528912344|FG001|Overall Study|Patient Noncompliance|0|||
146654645|NCT04365257|528912343|FG000|Overall Study|Withdrawal by Subject|0|||
146921043|NCT00256867|529871535|FG000|Overall Study|Participant travelled Overseas|0|||
146921044|NCT00256867|529871536|FG001|Overall Study|Participant travelled Overseas|1|||
146921045|NCT00256867|529871537|FG002|Overall Study|Participant travelled Overseas|0|||
146921046|NCT00256867|529871538|FG003|Overall Study|Participant travelled Overseas|0|||
146921047|NCT00256867|529871539|FG004|Overall Study|Participant travelled Overseas|0|||
146921048|NCT00256867|529871540|FG005|Overall Study|Participant travelled Overseas|0|||
146921049|NCT00256867|529871541|FG006|Overall Study|Participant travelled Overseas|0|||
146921050|NCT00256867|529871542|FG007|Overall Study|Participant travelled Overseas|0|||
146921051|NCT00256867|529871535|FG000|Overall Study|Participant out of assessment window|0|||
146921052|NCT00256867|529871536|FG001|Overall Study|Participant out of assessment window|0|||
146921053|NCT00256867|529871537|FG002|Overall Study|Participant out of assessment window|1|||
146921054|NCT00256867|529871538|FG003|Overall Study|Participant out of assessment window|0|||
146921055|NCT00256867|529871539|FG004|Overall Study|Participant out of assessment window|0|||
146921056|NCT00256867|529871540|FG005|Overall Study|Participant out of assessment window|0|||
146921057|NCT00256867|529871541|FG006|Overall Study|Participant out of assessment window|0|||
146921058|NCT00256867|529871542|FG007|Overall Study|Participant out of assessment window|0|||
146921059|NCT00256867|529871535|FG000|Overall Study|Withdrawal by participant|0|||
146921060|NCT00256867|529871536|FG001|Overall Study|Withdrawal by participant|0|||
146921061|NCT00256867|529871537|FG002|Overall Study|Withdrawal by participant|0|||
146921062|NCT00256867|529871538|FG003|Overall Study|Withdrawal by participant|0|||
146921063|NCT00256867|529871539|FG004|Overall Study|Withdrawal by participant|0|||
146921064|NCT00256867|529871540|FG005|Overall Study|Withdrawal by participant|1|||
146921065|NCT00256867|529871541|FG006|Overall Study|Withdrawal by participant|0|||
146921066|NCT00256867|529871542|FG007|Overall Study|Withdrawal by participant|0|||
146921067|NCT01930799|529871545|FG000|Overall Study|Withdrawal by Subject|3|||
146921068|NCT01930799|529871545|FG000|Overall Study|Lost to Follow-up|5|||
146921069|NCT00875017|529871548|FG000|First Intervention|Withdrawal by Subject|1|||
146654646|NCT04365257|528912344|FG001|Overall Study|Withdrawal by Subject|1|||
146654647|NCT02129777|528912345|FG000|Double-Blind Period|Adverse Event|0|||
146654648|NCT02129777|528912346|FG001|Double-Blind Period|Adverse Event|0|||
146654649|NCT02129777|528912347|FG002|Double-Blind Period|Adverse Event|0|||
146654650|NCT02129777|528912348|FG003|Double-Blind Period|Adverse Event|0|||
146654651|NCT02129777|528912349|FG004|Double-Blind Period|Adverse Event|1|||
146654652|NCT02129777|528912350|FG005|Double-Blind Period|Adverse Event|0|||
146654653|NCT02129777|528912351|FG006|Double-Blind Period|Adverse Event|0|||
146654654|NCT02129777|528912345|FG000|Double-Blind Period|Lost to Follow-up|1|||
146654655|NCT02129777|528912346|FG001|Double-Blind Period|Lost to Follow-up|1|||
146654656|NCT02129777|528912347|FG002|Double-Blind Period|Lost to Follow-up|1|||
146654657|NCT02129777|528912348|FG003|Double-Blind Period|Lost to Follow-up|2|||
146654658|NCT02129777|528912349|FG004|Double-Blind Period|Lost to Follow-up|0|||
146654659|NCT02129777|528912350|FG005|Double-Blind Period|Lost to Follow-up|0|||
146654660|NCT02129777|528912351|FG006|Double-Blind Period|Lost to Follow-up|0|||
146599068|NCT03344172|528703353|FG000|Overall Study|Received <1 dose of treatment|1|||
146599069|NCT03344172|528703354|FG001|Overall Study|Received <1 dose of treatment|0|||
146599070|NCT02066415|528703355|FG000|Overall Study|Decision by Sponsor|5|||
146599071|NCT02066415|528703356|FG001|Overall Study|Decision by Sponsor|4|||
146599072|NCT02066415|528703357|FG002|Overall Study|Decision by Sponsor|2|||
146599073|NCT02066415|528703355|FG000|Overall Study|Withdrawal by Subject|9|||
146599074|NCT02066415|528703356|FG001|Overall Study|Withdrawal by Subject|1|||
146599075|NCT02066415|528703357|FG002|Overall Study|Withdrawal by Subject|4|||
146599076|NCT02066415|528703355|FG000|Overall Study|Lost to Follow-up|7|||
146599077|NCT02066415|528703356|FG001|Overall Study|Lost to Follow-up|2|||
146654661|NCT02129777|528912345|FG000|Double-Blind Period|Withdrawal by Subject|2|||
146654662|NCT02129777|528912346|FG001|Double-Blind Period|Withdrawal by Subject|4|||
146654663|NCT02129777|528912347|FG002|Double-Blind Period|Withdrawal by Subject|3|||
146654664|NCT02129777|528912348|FG003|Double-Blind Period|Withdrawal by Subject|2|||
146654665|NCT02129777|528912349|FG004|Double-Blind Period|Withdrawal by Subject|3|||
146654666|NCT02129777|528912350|FG005|Double-Blind Period|Withdrawal by Subject|0|||
146654667|NCT02129777|528912351|FG006|Double-Blind Period|Withdrawal by Subject|0|||
146654668|NCT02129777|528912345|FG000|Double-Blind Period|Pregnancy|0|||
146771786|NCT02200770|529332619|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
146771787|NCT02200770|529332618|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
146921070|NCT00875017|529871549|FG001|First Intervention|Withdrawal by Subject|0|||
146921071|NCT00875017|529871550|FG002|First Intervention|Withdrawal by Subject|1|||
146921072|NCT00875017|529871551|FG003|First Intervention|Withdrawal by Subject|0|||
146921073|NCT00875017|529871552|FG004|First Intervention|Withdrawal by Subject|0|||
146921074|NCT00875017|529871553|FG005|First Intervention|Withdrawal by Subject|0|||
146921075|NCT00875017|529871548|FG000|First Intervention|Adverse Event|0|||
146921076|NCT00875017|529871549|FG001|First Intervention|Adverse Event|0|||
146921077|NCT00875017|529871550|FG002|First Intervention|Adverse Event|0|||
146921078|NCT00875017|529871551|FG003|First Intervention|Adverse Event|1|||
146921079|NCT00875017|529871552|FG004|First Intervention|Adverse Event|0|||
146921080|NCT00875017|529871553|FG005|First Intervention|Adverse Event|0|||
146921081|NCT00875017|529871548|FG000|First Intervention|Problems collecting rectal effluent|1|||
146921082|NCT00875017|529871549|FG001|First Intervention|Problems collecting rectal effluent|0|||
146921083|NCT00875017|529871550|FG002|First Intervention|Problems collecting rectal effluent|0|||
146921084|NCT00875017|529871551|FG003|First Intervention|Problems collecting rectal effluent|0|||
146921085|NCT00875017|529871552|FG004|First Intervention|Problems collecting rectal effluent|0|||
146921086|NCT00875017|529871553|FG005|First Intervention|Problems collecting rectal effluent|0|||
146921087|NCT00875017|529871548|FG000|First Intervention|Intolerance to nasogastric tube|0|||
146921088|NCT00875017|529871549|FG001|First Intervention|Intolerance to nasogastric tube|0|||
146921089|NCT00875017|529871550|FG002|First Intervention|Intolerance to nasogastric tube|0|||
146921090|NCT00875017|529871551|FG003|First Intervention|Intolerance to nasogastric tube|0|||
146921091|NCT00875017|529871552|FG004|First Intervention|Intolerance to nasogastric tube|1|||
146921092|NCT00875017|529871553|FG005|First Intervention|Intolerance to nasogastric tube|0|||
146921093|NCT00875017|529871548|FG000|Washout|Problem collecting rectal effluent|0|||
146921094|NCT00875017|529871549|FG001|Washout|Problem collecting rectal effluent|0|||
146921095|NCT00875017|529871550|FG002|Washout|Problem collecting rectal effluent|1|||
146921096|NCT00875017|529871551|FG003|Washout|Problem collecting rectal effluent|0|||
146921097|NCT00875017|529871552|FG004|Washout|Problem collecting rectal effluent|0|||
146921098|NCT00875017|529871553|FG005|Washout|Problem collecting rectal effluent|0|||
146921099|NCT00875017|529871548|FG000|Second Intervention|Adverse Event|0|||
146921100|NCT00875017|529871549|FG001|Second Intervention|Adverse Event|0|||
146921101|NCT00875017|529871550|FG002|Second Intervention|Adverse Event|0|||
146921102|NCT00875017|529871551|FG003|Second Intervention|Adverse Event|1|||
146921103|NCT00875017|529871552|FG004|Second Intervention|Adverse Event|0|||
146921104|NCT00875017|529871553|FG005|Second Intervention|Adverse Event|0|||
146921105|NCT00875017|529871548|FG000|Washout|Problems collecting rectal effluent|0|||
146921106|NCT00875017|529871549|FG001|Washout|Problems collecting rectal effluent|1|||
146921107|NCT00875017|529871550|FG002|Washout|Problems collecting rectal effluent|0|||
146921108|NCT00875017|529871551|FG003|Washout|Problems collecting rectal effluent|0|||
146921109|NCT00875017|529871552|FG004|Washout|Problems collecting rectal effluent|0|||
146921110|NCT00875017|529871553|FG005|Washout|Problems collecting rectal effluent|0|||
146921111|NCT00875017|529871548|FG000|Third Intervention|Adverse Event|0|||
146921112|NCT00875017|529871549|FG001|Third Intervention|Adverse Event|1|||
146921113|NCT00875017|529871550|FG002|Third Intervention|Adverse Event|1|||
146921114|NCT00875017|529871551|FG003|Third Intervention|Adverse Event|0|||
146921115|NCT00875017|529871552|FG004|Third Intervention|Adverse Event|0|||
146599078|NCT02066415|528703357|FG002|Overall Study|Lost to Follow-up|2|||
146921116|NCT00875017|529871553|FG005|Third Intervention|Adverse Event|0|||
146921117|NCT00875017|529871548|FG000|Washout|Withdrawal by Subject|0|||
146921118|NCT00875017|529871549|FG001|Washout|Withdrawal by Subject|0|||
146599079|NCT02989805|528703359|FG000|Overall Study|invalid consent|6|||
146599080|NCT02989805|528703360|FG001|Overall Study|invalid consent|4|||
146599081|NCT02771626|528703361|FG000|Overall Study|Adverse Event|1|||
146921119|NCT00875017|529871550|FG002|Washout|Withdrawal by Subject|0|||
146599082|NCT02771626|528703362|FG001|Overall Study|Adverse Event|5|||
146599083|NCT02771626|528703363|FG002|Overall Study|Adverse Event|3|||
146599084|NCT02771626|528703364|FG003|Overall Study|Adverse Event|0|||
146599085|NCT02771626|528703365|FG004|Overall Study|Adverse Event|1|||
146599086|NCT02771626|528703366|FG005|Overall Study|Adverse Event|1|||
146599087|NCT02771626|528703361|FG000|Overall Study|Radiologic Disease Progression|6|||
146599088|NCT02771626|528703362|FG001|Overall Study|Radiologic Disease Progression|13|||
146599089|NCT02771626|528703363|FG002|Overall Study|Radiologic Disease Progression|10|||
146599090|NCT02771626|528703364|FG003|Overall Study|Radiologic Disease Progression|7|||
146599091|NCT02771626|528703365|FG004|Overall Study|Radiologic Disease Progression|28|||
146599092|NCT02771626|528703366|FG005|Overall Study|Radiologic Disease Progression|15|||
146599093|NCT02771626|528703361|FG000|Overall Study|Symptomatic Deterioration|0|||
146599094|NCT02771626|528703362|FG001|Overall Study|Symptomatic Deterioration|4|||
146599095|NCT02771626|528703363|FG002|Overall Study|Symptomatic Deterioration|2|||
146599096|NCT02771626|528703364|FG003|Overall Study|Symptomatic Deterioration|0|||
146599097|NCT02771626|528703365|FG004|Overall Study|Symptomatic Deterioration|5|||
146599098|NCT02771626|528703366|FG005|Overall Study|Symptomatic Deterioration|2|||
146599099|NCT02771626|528703361|FG000|Overall Study|Participant Request|0|||
146599100|NCT02771626|528703362|FG001|Overall Study|Participant Request|1|||
146599101|NCT02771626|528703363|FG002|Overall Study|Participant Request|0|||
146599102|NCT02771626|528703364|FG003|Overall Study|Participant Request|2|||
146599103|NCT02771626|528703365|FG004|Overall Study|Participant Request|0|||
146599104|NCT02771626|528703366|FG005|Overall Study|Participant Request|1|||
146599105|NCT02771626|528703361|FG000|Overall Study|Investigator Decision|0|||
146599106|NCT02771626|528703362|FG001|Overall Study|Investigator Decision|1|||
146599107|NCT02771626|528703363|FG002|Overall Study|Investigator Decision|0|||
146599108|NCT02771626|528703364|FG003|Overall Study|Investigator Decision|0|||
146599109|NCT02771626|528703365|FG004|Overall Study|Investigator Decision|1|||
146599110|NCT02771626|528703366|FG005|Overall Study|Investigator Decision|0|||
146599111|NCT02771626|528703361|FG000|Overall Study|Study Termination by Sponsor|0|||
146599112|NCT02771626|528703362|FG001|Overall Study|Study Termination by Sponsor|2|||
146599113|NCT02771626|528703363|FG002|Overall Study|Study Termination by Sponsor|1|||
146599114|NCT02771626|528703364|FG003|Overall Study|Study Termination by Sponsor|0|||
146599115|NCT02771626|528703365|FG004|Overall Study|Study Termination by Sponsor|1|||
146599116|NCT02771626|528703366|FG005|Overall Study|Study Termination by Sponsor|0|||
146599117|NCT02771626|528703361|FG000|Overall Study|Informed Consent Withdrawn|0|||
146599118|NCT02771626|528703362|FG001|Overall Study|Informed Consent Withdrawn|0|||
146599119|NCT02771626|528703363|FG002|Overall Study|Informed Consent Withdrawn|1|||
146599120|NCT02771626|528703364|FG003|Overall Study|Informed Consent Withdrawn|0|||
146599121|NCT02771626|528703365|FG004|Overall Study|Informed Consent Withdrawn|1|||
146599122|NCT02771626|528703366|FG005|Overall Study|Informed Consent Withdrawn|1|||
146599123|NCT02771626|528703361|FG000|Overall Study|Other, Not Specified|1|||
146599124|NCT02771626|528703362|FG001|Overall Study|Other, Not Specified|0|||
146599125|NCT02771626|528703363|FG002|Overall Study|Other, Not Specified|0|||
146599126|NCT02771626|528703364|FG003|Overall Study|Other, Not Specified|0|||
146599127|NCT02771626|528703365|FG004|Overall Study|Other, Not Specified|0|||
146599128|NCT02771626|528703366|FG005|Overall Study|Other, Not Specified|1|||
146599129|NCT04094584|528703367|FG000|Overall Study|No interest in study|88|||
146599130|NCT04094584|528703367|FG000|Overall Study|Unwilling to undergo screening tests|36|||
146599131|NCT04094584|528703367|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
146599132|NCT04094584|528703367|FG000|Overall Study|Opioid use|7|||
146599133|NCT04094584|528703367|FG000|Overall Study|Need for major surgery in study period|4|||
146599134|NCT04094584|528703367|FG000|Overall Study|eligible but declined enrollment|4|||
146599135|NCT04094584|528703367|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
146599136|NCT04094584|528703367|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
146599137|NCT04094584|528703367|FG000|Overall Study|Lost to Follow-up|3|||
146771788|NCT02200770|529332619|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
146599138|NCT04094584|528703367|FG000|Overall Study|Withdrawal by Subject|2|||
146599139|NCT02713867|528703368|FG000|Randomization|Other Reason|2|||
146599140|NCT02713867|528703369|FG001|Randomization|Other Reason|1|||
146599141|NCT02713867|528703368|FG000|Randomization|Participant Withdrew consent|0|||
146599142|NCT02713867|528703369|FG001|Randomization|Participant Withdrew consent|2|||
146599143|NCT02713867|528703368|FG000|Treatment Period|Other Reasons|22|||
146599144|NCT02713867|528703369|FG001|Treatment Period|Other Reasons|28|||
146771789|NCT02200770|529332618|FG000|Randomized-controlled Period (RCP)|Other|1|||
146771790|NCT02200770|529332619|FG001|Randomized-controlled Period (RCP)|Other|2|||
146599145|NCT02713867|528703368|FG000|Treatment Period|Administrative reason by sponsor|21|||
146599146|NCT02713867|528703369|FG001|Treatment Period|Administrative reason by sponsor|16|||
146599147|NCT02713867|528703368|FG000|Treatment Period|No longer meets study criteria|2|||
146599148|NCT02713867|528703369|FG001|Treatment Period|No longer meets study criteria|1|||
146599149|NCT02713867|528703368|FG000|Treatment Period|Poor/Non Compliance|1|||
146599150|NCT02713867|528703369|FG001|Treatment Period|Poor/Non Compliance|0|||
146599151|NCT02713867|528703368|FG000|Treatment Period|Maximum Clinical Benefit|5|||
146599152|NCT02713867|528703369|FG001|Treatment Period|Maximum Clinical Benefit|6|||
146599153|NCT02713867|528703368|FG000|Treatment Period|Withdrew consent|3|||
146599154|NCT02713867|528703369|FG001|Treatment Period|Withdrew consent|6|||
146599155|NCT02713867|528703368|FG000|Treatment Period|Requested to Discontinue|8|||
146599156|NCT02713867|528703369|FG001|Treatment Period|Requested to Discontinue|8|||
146599157|NCT02713867|528703368|FG000|Treatment Period|AE unrelated to Study Drug|11|||
146599158|NCT02713867|528703369|FG001|Treatment Period|AE unrelated to Study Drug|10|||
146921120|NCT00875017|529871551|FG003|Washout|Withdrawal by Subject|0|||
146921121|NCT00875017|529871552|FG004|Washout|Withdrawal by Subject|1|||
146921122|NCT00875017|529871553|FG005|Washout|Withdrawal by Subject|0|||
146921123|NCT00875017|529871548|FG000|Fourth Intervention|Inability to comply with fasting|0|||
146921124|NCT00875017|529871549|FG001|Fourth Intervention|Inability to comply with fasting|0|||
146921125|NCT00875017|529871550|FG002|Fourth Intervention|Inability to comply with fasting|0|||
146921126|NCT00875017|529871551|FG003|Fourth Intervention|Inability to comply with fasting|0|||
146921127|NCT00875017|529871552|FG004|Fourth Intervention|Inability to comply with fasting|0|||
146921128|NCT00875017|529871553|FG005|Fourth Intervention|Inability to comply with fasting|1|||
146921129|NCT03342469|529871554|FG000|Overall Study|Withdrawal by Subject|0|||
146921130|NCT03342469|529871555|FG001|Overall Study|Withdrawal by Subject|1|||
146921131|NCT03342469|529871556|FG002|Overall Study|Withdrawal by Subject|0|||
146921132|NCT03342469|529871557|FG003|Overall Study|Withdrawal by Subject|0|||
146921133|NCT02689219|529871558|FG000|Overall Study|Death|1|||
146921134|NCT02689219|529871559|FG001|Overall Study|Death|1|||
146921135|NCT02689219|529871558|FG000|Overall Study|Disease Progression|10|||
146921136|NCT02689219|529871559|FG001|Overall Study|Disease Progression|6|||
146921137|NCT01477892|529871560|FG000|Overall Study|Withdrawal by Subject|0|||
146921138|NCT01477892|529871561|FG001|Overall Study|Withdrawal by Subject|2|||
146921139|NCT01921257|529871563|FG000|Overall Study|Adverse Event|1|||
146921140|NCT01921257|529871563|FG000|Overall Study|Protocol Violation|1|||
146921141|NCT01921257|529871563|FG000|Overall Study|Withdrawal by Subject|1|||
146921142|NCT05515601|529871565|FG000|Overall Study|Withdrawal by Subject|1|||
146921143|NCT05515601|529871566|FG001|Overall Study|Withdrawal by Subject|3|||
146921144|NCT05515601|529871567|FG002|Overall Study|Withdrawal by Subject|2|||
146921145|NCT05515601|529871568|FG003|Overall Study|Withdrawal by Subject|1|||
146921146|NCT05515601|529871569|FG004|Overall Study|Withdrawal by Subject|1|||
146921147|NCT05515601|529871570|FG005|Overall Study|Withdrawal by Subject|1|||
146921148|NCT05515601|529871565|FG000|Overall Study|Lost to Follow-up|0|||
146921149|NCT05515601|529871566|FG001|Overall Study|Lost to Follow-up|0|||
146921150|NCT05515601|529871567|FG002|Overall Study|Lost to Follow-up|0|||
146921151|NCT05515601|529871568|FG003|Overall Study|Lost to Follow-up|0|||
146921152|NCT05515601|529871569|FG004|Overall Study|Lost to Follow-up|1|||
146921153|NCT05515601|529871570|FG005|Overall Study|Lost to Follow-up|0|||
146921154|NCT01689207|529871571|FG000|Overall Study|Adverse Event|0|||
146921155|NCT01689207|529871572|FG001|Overall Study|Adverse Event|1|||
146921156|NCT01689207|529871573|FG002|Overall Study|Adverse Event|0|||
146921157|NCT01689207|529871574|FG003|Overall Study|Adverse Event|0|||
146921158|NCT01689207|529871575|FG004|Overall Study|Adverse Event|2|||
146921159|NCT01689207|529871576|FG005|Overall Study|Adverse Event|1|||
146921160|NCT01689207|529871577|FG006|Overall Study|Adverse Event|0|||
146921161|NCT01689207|529871578|FG007|Overall Study|Adverse Event|0|||
146921162|NCT01689207|529871579|FG008|Overall Study|Adverse Event|1|||
146921163|NCT01689207|529871580|FG009|Overall Study|Adverse Event|0|||
146921164|NCT01689207|529871581|FG010|Overall Study|Adverse Event|0|||
146921165|NCT01912768|529871582|FG000|Overall Study|Adverse Event|2|||
146921166|NCT01912768|529871583|FG001|Overall Study|Adverse Event|0|||
146921167|NCT01912768|529871582|FG000|Overall Study|Lost to Follow-up|2|||
146921168|NCT01912768|529871583|FG001|Overall Study|Lost to Follow-up|1|||
146921169|NCT01912768|529871582|FG000|Overall Study|Withdrawal by Subject|5|||
146921170|NCT01912768|529871583|FG001|Overall Study|Withdrawal by Subject|3|||
146921171|NCT01912768|529871582|FG000|Overall Study|Randomized in error|1|||
146921172|NCT01912768|529871583|FG001|Overall Study|Randomized in error|0|||
146921173|NCT00524316|529871584|FG000|Overall Study|Withdrawal by Subject|2|||
146921174|NCT00524316|529871584|FG000|Overall Study|Adverse Event|7|||
146921175|NCT00524316|529871584|FG000|Overall Study|Disease Progression|7|||
147013206|NCT02048813|530210052|FG000|Overall Study|Withdrawal by Subject|7|||
146921176|NCT02426658|529871585|FG000|Overall Study|Withdrawal by Subject|1|||
146921177|NCT02426658|529871585|FG000|Overall Study|Patient expired before treatment|2|||
146921178|NCT01199263|529871588|FG000|Overall Study|Ineligible|0|||
146921179|NCT01199263|529871589|FG001|Overall Study|Ineligible|2|||
146921180|NCT01199263|529871588|FG000|Overall Study|Never Treated|6|||
146921181|NCT01199263|529871589|FG001|Overall Study|Never Treated|0|||
146921182|NCT00488033|529871590|FG000|Overall Study|Withdrawal by Subject|1|||
146921183|NCT00488033|529871591|FG001|Overall Study|Withdrawal by Subject|0|||
146921184|NCT01515306|529871592|FG000|Overall Study|Adverse Event|3|||
146599159|NCT02713867|528703368|FG000|Treatment Period|Death|7|||
146599160|NCT02713867|528703369|FG001|Treatment Period|Death|3|||
146654669|NCT02129777|528912346|FG001|Double-Blind Period|Pregnancy|0|||
146921185|NCT01515306|529871593|FG001|Overall Study|Adverse Event|2|||
146921186|NCT01515306|529871592|FG000|Overall Study|Progressive Disease|19|||
146599161|NCT02713867|528703368|FG000|Treatment Period|Study Drug Toxicity|16|||
146599162|NCT02713867|528703369|FG001|Treatment Period|Study Drug Toxicity|19|||
146599163|NCT02713867|528703368|FG000|Treatment Period|Disease Progression|82|||
146599164|NCT02713867|528703369|FG001|Treatment Period|Disease Progression|83|||
146599165|NCT04135859|528703371|FG000|Overall Study|Withdrawal by Subject|1|||
146599166|NCT04135859|528703372|FG001|Overall Study|Withdrawal by Subject|0|||
146599167|NCT04135859|528703371|FG000|Overall Study|Withdrawal due to screening failure|1|||
146599168|NCT04135859|528703372|FG001|Overall Study|Withdrawal due to screening failure|2|||
146599169|NCT04135859|528703371|FG000|Overall Study|Did not complete stress test|3|||
146599170|NCT04135859|528703372|FG001|Overall Study|Did not complete stress test|3|||
146599171|NCT04135859|528703371|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
146599172|NCT04135859|528703372|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
146599173|NCT03230292|528703373|FG000|Overall Study|Adverse Event|1|||
146599174|NCT03230292|528703373|FG000|Overall Study|Protocol Violation|1|||
146599175|NCT03230292|528703373|FG000|Overall Study|Lost to Follow-up|1|||
146599176|NCT03230292|528703373|FG000|Overall Study|Withdrawal by Subject|3|||
146599177|NCT04047420|528703374|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
146599178|NCT04047420|528703374|FG000|Washout Period|Refused Participation|2|||
146599179|NCT01639755|528703375|FG000|Overall Study|Study Ongoing|15|||
146599180|NCT01639755|528703375|FG000|Overall Study|Patient had device explantation|4|||
146599181|NCT03629912|528703379|FG000|Overall Study|Lost to Follow-up|19|||
146599182|NCT03629912|528703380|FG001|Overall Study|Lost to Follow-up|7|||
146921187|NCT01515306|529871593|FG001|Overall Study|Progressive Disease|9|||
146599183|NCT03629912|528703381|FG002|Overall Study|Lost to Follow-up|5|||
146599184|NCT03629912|528703382|FG003|Overall Study|Lost to Follow-up|1|||
146599185|NCT03629912|528703379|FG000|Overall Study|Withdrawal by Subject|6|||
146599186|NCT03629912|528703380|FG001|Overall Study|Withdrawal by Subject|0|||
146599187|NCT03629912|528703381|FG002|Overall Study|Withdrawal by Subject|1|||
146599188|NCT03629912|528703382|FG003|Overall Study|Withdrawal by Subject|2|||
146599189|NCT03629912|528703379|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
146599190|NCT03629912|528703380|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
146921188|NCT01515306|529871592|FG000|Overall Study|Withdrawal by Subject|1|||
146599191|NCT03629912|528703381|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
146599192|NCT03629912|528703382|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
146599193|NCT03629912|528703379|FG000|Overall Study|Death|1|||
146599194|NCT03629912|528703380|FG001|Overall Study|Death|0|||
146599195|NCT03629912|528703381|FG002|Overall Study|Death|0|||
146599196|NCT03629912|528703382|FG003|Overall Study|Death|0|||
146599197|NCT02365285|528703385|FG000|Overall Study|Physician Decision|0|||
146921189|NCT01515306|529871593|FG001|Overall Study|Withdrawal by Subject|2|||
146921190|NCT01515306|529871592|FG000|Overall Study|Physician Decision|1|||
146921191|NCT01515306|529871593|FG001|Overall Study|Physician Decision|1|||
146921192|NCT03050359|529872920|FG000|Overall Study|Randomized But Not Treated|2|||
146921193|NCT03050359|529872921|FG001|Overall Study|Randomized But Not Treated|0|||
146921194|NCT03050359|529872920|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
146921195|NCT03050359|529872921|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
146921196|NCT03050359|529872920|FG000|Overall Study|Significant Protocol Deviation|2|||
146921197|NCT03050359|529872921|FG001|Overall Study|Significant Protocol Deviation|3|||
146921198|NCT03050359|529872920|FG000|Overall Study|Lost to Follow-up|2|||
146921199|NCT03050359|529872921|FG001|Overall Study|Lost to Follow-up|1|||
146921200|NCT03050359|529872920|FG000|Overall Study|Voluntary Withdrawal|4|||
146921201|NCT03050359|529872921|FG001|Overall Study|Voluntary Withdrawal|6|||
146921202|NCT03050359|529872920|FG000|Overall Study|Pregnancy|1|||
146921203|NCT03050359|529872921|FG001|Overall Study|Pregnancy|0|||
146921204|NCT03050359|529872920|FG000|Overall Study|Reason Not Specified|1|||
146921205|NCT03050359|529872921|FG001|Overall Study|Reason Not Specified|0|||
146921206|NCT02614287|529872924|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
146921207|NCT02614287|529872925|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
146921208|NCT02614287|529872924|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
146921209|NCT02614287|529872925|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
146921210|NCT02614287|529872924|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
146921211|NCT02614287|529872925|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
146921212|NCT02614287|529872924|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
146921213|NCT02614287|529872925|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
146921214|NCT02614287|529872924|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
146599198|NCT02365285|528703386|FG001|Overall Study|Physician Decision|1|||
146599199|NCT02365285|528703387|FG002|Overall Study|Physician Decision|1|||
146599200|NCT02365285|528703388|FG003|Overall Study|Physician Decision|0|||
146599201|NCT02365285|528703385|FG000|Overall Study|Adverse Event|0|||
146599202|NCT02365285|528703386|FG001|Overall Study|Adverse Event|0|||
146599203|NCT02365285|528703387|FG002|Overall Study|Adverse Event|0|||
146599204|NCT02365285|528703388|FG003|Overall Study|Adverse Event|2|||
146599205|NCT03262116|528703389|FG000|Overall Study|Physician Decision|0|||
146599206|NCT03262116|528703390|FG001|Overall Study|Physician Decision|2|||
146599207|NCT03262116|528703391|FG002|Overall Study|Physician Decision|1|||
146599208|NCT03262116|528703392|FG003|Overall Study|Physician Decision|1|||
146599209|NCT03262116|528703393|FG004|Overall Study|Physician Decision|1|||
146599210|NCT03262116|528703394|FG005|Overall Study|Physician Decision|2|||
146599211|NCT02608450|528703396|FG000|Overall Study|Lost to Follow-up|39|||
146599212|NCT02608450|528703397|FG001|Overall Study|Lost to Follow-up|32|||
146599213|NCT02608450|528703396|FG000|Overall Study|Withdrawal by Subject|21|||
146599214|NCT02608450|528703397|FG001|Overall Study|Withdrawal by Subject|15|||
146599215|NCT02608450|528703396|FG000|Overall Study|Adverse Event|3|||
146599216|NCT02608450|528703397|FG001|Overall Study|Adverse Event|6|||
146599217|NCT02608450|528703396|FG000|Overall Study|Withdrawal by parent|2|||
146599218|NCT02608450|528703397|FG001|Overall Study|Withdrawal by parent|3|||
146599219|NCT02608450|528703396|FG000|Overall Study|Lack of Efficacy|0|||
146599220|NCT02608450|528703397|FG001|Overall Study|Lack of Efficacy|3|||
146599221|NCT02608450|528703396|FG000|Overall Study|Noncompliance with study drug|0|||
146599222|NCT02608450|528703397|FG001|Overall Study|Noncompliance with study drug|2|||
146599223|NCT02608450|528703396|FG000|Overall Study|Physician Decision|0|||
146599224|NCT02608450|528703397|FG001|Overall Study|Physician Decision|1|||
146599225|NCT02608450|528703396|FG000|Overall Study|Pregnancy|0|||
146599226|NCT02608450|528703397|FG001|Overall Study|Pregnancy|1|||
146599227|NCT02608450|528703396|FG000|Overall Study|Progressive disease|1|||
146599228|NCT02608450|528703397|FG001|Overall Study|Progressive disease|0|||
146599229|NCT02608450|528703396|FG000|Overall Study|Multiple reasons|0|||
146599230|NCT02608450|528703397|FG001|Overall Study|Multiple reasons|2|||
146599231|NCT00635089|528703400|FG000|Overall Study|Adverse Event|7|||
146921215|NCT02614287|529872925|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
146921216|NCT02614287|529872924|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
146921217|NCT02614287|529872925|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
146921218|NCT02614287|529872924|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
146921219|NCT02614287|529872925|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
146921220|NCT02614287|529872924|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
146921221|NCT02614287|529872925|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
146921222|NCT03364335|529872929|FG000|Overall Study|Adverse Event|3|||
146921223|NCT03364335|529872930|FG001|Overall Study|Adverse Event|4|||
146921224|NCT03364335|529872931|FG002|Overall Study|Adverse Event|1|||
146921225|NCT03364335|529872932|FG003|Overall Study|Adverse Event|2|||
146921226|NCT03364335|529872933|FG004|Overall Study|Adverse Event|0|||
146921227|NCT03364335|529872929|FG000|Overall Study|Lost to Follow-up|7|||
146921228|NCT03364335|529872930|FG001|Overall Study|Lost to Follow-up|7|||
146921229|NCT03364335|529872931|FG002|Overall Study|Lost to Follow-up|10|||
146921230|NCT03364335|529872932|FG003|Overall Study|Lost to Follow-up|11|||
146921231|NCT03364335|529872933|FG004|Overall Study|Lost to Follow-up|11|||
146921232|NCT03725202|529872934|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
146921233|NCT03725202|529872935|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
146921234|NCT03725202|529872936|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
146921235|NCT03725202|529872937|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
146921236|NCT03725202|529872938|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
146921237|NCT03725202|529872939|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
146921238|NCT03725202|529872940|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
146921239|NCT03725202|529872941|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
146921240|NCT03725202|529872934|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
146921241|NCT03725202|529872935|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
146921242|NCT03725202|529872936|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
146921243|NCT03725202|529872937|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
146921244|NCT03725202|529872938|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
146921245|NCT03725202|529872939|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
146921246|NCT03725202|529872940|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
146599232|NCT00635089|528703400|FG000|Overall Study|Lack of Efficacy|28|||
146599233|NCT00635089|528703400|FG000|Overall Study|Protocol Deviation|4|||
146599234|NCT00635089|528703400|FG000|Overall Study|Lost to Follow-up|8|||
146599235|NCT00635089|528703400|FG000|Overall Study|Other|31|||
146599236|NCT01283542|528703404|FG000|Main Phase|Acute or progressive vision loss|1|||
146599237|NCT01283542|528703404|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
146599238|NCT01283542|528703404|FG000|Main Phase|abnormal laboratory values|5|||
146599239|NCT01283542|528703404|FG000|Extension Phase|Physician Decision|1|||
146599240|NCT01283542|528703404|FG000|Extension Phase|Adverse Event|1|||
146771791|NCT02200770|529332618|FG000|Open-label Period (OLP)|Adverse Event|1|||
146921247|NCT03725202|529872941|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
146921248|NCT03725202|529872934|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
146921249|NCT03725202|529872935|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
146921250|NCT03725202|529872936|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
146599241|NCT01283542|528703404|FG000|Extension Phase|Administrative problems|1|||
146599242|NCT02636946|528703405|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
146599243|NCT02636946|528703406|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
146599244|NCT02636946|528703405|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
146921251|NCT03725202|529872937|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
146921252|NCT03725202|529872938|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
146921253|NCT03725202|529872939|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
146921254|NCT03725202|529872940|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
146921255|NCT03725202|529872941|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
146921256|NCT03725202|529872934|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
146921257|NCT03725202|529872935|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
146921258|NCT03725202|529872936|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
146921259|NCT03725202|529872937|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
146921260|NCT03725202|529872938|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
146921261|NCT03725202|529872939|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
146921262|NCT03725202|529872940|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
146921263|NCT03725202|529872941|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
146921264|NCT03725202|529872934|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
146921265|NCT03725202|529872935|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
146921266|NCT03725202|529872936|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
146921267|NCT03725202|529872937|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
146921268|NCT03725202|529872938|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
146921269|NCT03725202|529872939|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
146921270|NCT03725202|529872940|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
146921271|NCT03725202|529872941|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
146921272|NCT03725202|529872934|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
146921273|NCT03725202|529872935|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
146921274|NCT03725202|529872936|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
146921275|NCT03725202|529872937|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
146921276|NCT03725202|529872938|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
146921277|NCT03725202|529872939|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
146921278|NCT03725202|529872940|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
146921279|NCT03725202|529872941|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
146921280|NCT03725202|529872934|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
146921281|NCT03725202|529872935|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
146921282|NCT03725202|529872936|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
146921283|NCT03725202|529872937|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
146921284|NCT03725202|529872938|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
146921285|NCT03725202|529872939|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
146921286|NCT03725202|529872940|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
146921287|NCT03725202|529872941|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
146921288|NCT03725202|529872934|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
146921289|NCT03725202|529872935|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
146921290|NCT03725202|529872936|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
146921291|NCT03725202|529872937|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
146921292|NCT03725202|529872938|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
146921293|NCT03725202|529872939|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
146921294|NCT03725202|529872940|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
146921295|NCT03725202|529872941|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
146921296|NCT03725202|529872934|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
146921297|NCT03725202|529872935|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
146921298|NCT03725202|529872936|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
146921299|NCT03725202|529872937|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
146921300|NCT03725202|529872938|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
146921301|NCT03725202|529872939|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
146921302|NCT03725202|529872940|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
146921303|NCT03725202|529872941|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
146921304|NCT03725202|529872934|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
146921305|NCT03725202|529872935|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
146921306|NCT03725202|529872936|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
146921307|NCT03725202|529872937|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
146921308|NCT03725202|529872938|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
146921309|NCT03725202|529872939|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
146921310|NCT03725202|529872940|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
146921311|NCT03725202|529872941|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
146921312|NCT03725202|529872934|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
146921313|NCT03725202|529872935|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
146921314|NCT03725202|529872936|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
146921315|NCT03725202|529872937|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
146654670|NCT02129777|528912347|FG002|Double-Blind Period|Pregnancy|0|||
146654671|NCT02129777|528912348|FG003|Double-Blind Period|Pregnancy|0|||
146654672|NCT02129777|528912349|FG004|Double-Blind Period|Pregnancy|1|||
146654673|NCT02129777|528912350|FG005|Double-Blind Period|Pregnancy|0|||
146654674|NCT02129777|528912351|FG006|Double-Blind Period|Pregnancy|0|||
146654675|NCT02129777|528912345|FG000|Double-Blind Period|Lack of Efficacy|3|||
146654676|NCT02129777|528912346|FG001|Double-Blind Period|Lack of Efficacy|1|||
146654677|NCT02129777|528912347|FG002|Double-Blind Period|Lack of Efficacy|0|||
146654678|NCT02129777|528912348|FG003|Double-Blind Period|Lack of Efficacy|3|||
146654679|NCT02129777|528912349|FG004|Double-Blind Period|Lack of Efficacy|2|||
146654680|NCT02129777|528912350|FG005|Double-Blind Period|Lack of Efficacy|0|||
146654681|NCT02129777|528912351|FG006|Double-Blind Period|Lack of Efficacy|0|||
146654682|NCT02129777|528912345|FG000|Double-Blind Period|Other|1|||
146654683|NCT02129777|528912346|FG001|Double-Blind Period|Other|2|||
146654684|NCT02129777|528912347|FG002|Double-Blind Period|Other|0|||
146654685|NCT02129777|528912348|FG003|Double-Blind Period|Other|0|||
146654686|NCT02129777|528912349|FG004|Double-Blind Period|Other|0|||
146654687|NCT02129777|528912350|FG005|Double-Blind Period|Other|0|||
146654688|NCT02129777|528912351|FG006|Double-Blind Period|Other|0|||
146654689|NCT02129777|528912345|FG000|Open-Label Period|Lack of Efficacy|0|||
146654690|NCT02129777|528912346|FG001|Open-Label Period|Lack of Efficacy|0|||
146654691|NCT02129777|528912347|FG002|Open-Label Period|Lack of Efficacy|0|||
146654692|NCT02129777|528912348|FG003|Open-Label Period|Lack of Efficacy|0|||
146654693|NCT02129777|528912349|FG004|Open-Label Period|Lack of Efficacy|0|||
146654694|NCT02129777|528912350|FG005|Open-Label Period|Lack of Efficacy|0|||
146654695|NCT02129777|528912351|FG006|Open-Label Period|Lack of Efficacy|5|||
146654696|NCT02129777|528912345|FG000|Open-Label Period|Lost to Follow-up|0|||
146654697|NCT02129777|528912346|FG001|Open-Label Period|Lost to Follow-up|0|||
146654698|NCT02129777|528912347|FG002|Open-Label Period|Lost to Follow-up|0|||
146654699|NCT02129777|528912348|FG003|Open-Label Period|Lost to Follow-up|0|||
146654700|NCT02129777|528912349|FG004|Open-Label Period|Lost to Follow-up|0|||
146654701|NCT02129777|528912350|FG005|Open-Label Period|Lost to Follow-up|1|||
146654702|NCT02129777|528912351|FG006|Open-Label Period|Lost to Follow-up|1|||
146654703|NCT02129777|528912345|FG000|Open-Label Period|Withdrawal by Subject|0|||
146654704|NCT02129777|528912346|FG001|Open-Label Period|Withdrawal by Subject|0|||
146654705|NCT02129777|528912347|FG002|Open-Label Period|Withdrawal by Subject|0|||
146654706|NCT02129777|528912348|FG003|Open-Label Period|Withdrawal by Subject|0|||
146654707|NCT02129777|528912349|FG004|Open-Label Period|Withdrawal by Subject|0|||
146654708|NCT02129777|528912350|FG005|Open-Label Period|Withdrawal by Subject|1|||
146654709|NCT02129777|528912351|FG006|Open-Label Period|Withdrawal by Subject|3|||
146654710|NCT02129777|528912345|FG000|Open-Label Period|Study Termination|0|||
146654711|NCT02129777|528912346|FG001|Open-Label Period|Study Termination|0|||
146654712|NCT02129777|528912347|FG002|Open-Label Period|Study Termination|0|||
146654713|NCT02129777|528912348|FG003|Open-Label Period|Study Termination|0|||
146654714|NCT02129777|528912349|FG004|Open-Label Period|Study Termination|0|||
146654715|NCT02129777|528912350|FG005|Open-Label Period|Study Termination|10|||
146654716|NCT02129777|528912351|FG006|Open-Label Period|Study Termination|39|||
146654717|NCT03116347|528912356|FG000|Overall Study|Withdrawal by Subject|1|||
146654718|NCT03116347|528912357|FG001|Overall Study|Withdrawal by Subject|2|||
146654719|NCT00476047|528912358|FG000|Overall Study|Lost to Follow-up|1|||
146654720|NCT04966741|528912359|FG000|Overall Study|Lost to Follow-up|1|||
146654721|NCT04966741|528912360|FG001|Overall Study|Lost to Follow-up|0|||
146654722|NCT00509262|528912363|FG000|Overall Study|Adverse Event|16|||
146654723|NCT00509262|528912364|FG001|Overall Study|Adverse Event|18|||
146654724|NCT00509262|528912363|FG000|Overall Study|Other|2|||
146654725|NCT00509262|528912364|FG001|Overall Study|Other|2|||
146654726|NCT00509262|528912363|FG000|Overall Study|Lack of Efficacy|1|||
146654727|NCT00509262|528912364|FG001|Overall Study|Lack of Efficacy|0|||
146654728|NCT00509262|528912363|FG000|Overall Study|Lost to Follow-up|1|||
146654729|NCT00509262|528912364|FG001|Overall Study|Lost to Follow-up|6|||
146978539|NCT00272961|530084096|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
146978540|NCT00272961|530084097|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
146654730|NCT00509262|528912363|FG000|Overall Study|Physician Decision|1|||
146654731|NCT00509262|528912364|FG001|Overall Study|Physician Decision|3|||
146654732|NCT00509262|528912363|FG000|Overall Study|Protocol Violation|2|||
146654733|NCT00509262|528912364|FG001|Overall Study|Protocol Violation|2|||
146654734|NCT00509262|528912363|FG000|Overall Study|Withdrawal by Subject|24|||
146654735|NCT00509262|528912364|FG001|Overall Study|Withdrawal by Subject|11|||
146654736|NCT01715129|528912365|FG000|Overall Study|Adverse Event, fatal|1|||
146654737|NCT01715129|528912365|FG000|Overall Study|Lack of Efficacy|3|||
146654738|NCT01715129|528912365|FG000|Overall Study|Protocol Violation|1|||
146654739|NCT01715129|528912365|FG000|Overall Study|Consent Withdrawn|2|||
146654740|NCT01715129|528912365|FG000|Overall Study|Lost to Follow-up|1|||
146654741|NCT01715129|528912365|FG000|Overall Study|Other|1|||
146654742|NCT01146860|528912366|FG000|Overall Study|Withdrawal by Subject|0|||
146654743|NCT01146860|528912367|FG001|Overall Study|Withdrawal by Subject|1|||
146654744|NCT01423604|528912369|FG000|Safety Run-In|Adverse Event|3|||
146654745|NCT01423604|528912370|FG001|Safety Run-In|Adverse Event|0|||
146599245|NCT02636946|528703406|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
146599246|NCT02636946|528703405|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
146599247|NCT02636946|528703406|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
146599248|NCT02636946|528703405|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
146599249|NCT02636946|528703406|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
146599250|NCT02636946|528703405|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
146599251|NCT02636946|528703406|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
146599252|NCT02636946|528703405|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
146599253|NCT02636946|528703406|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
146599254|NCT05059977|528703407|FG000|Overall Study|Withdrawal by Subject|0|||
146599255|NCT05059977|528703408|FG001|Overall Study|Withdrawal by Subject|0|||
146599256|NCT05059977|528703409|FG002|Overall Study|Withdrawal by Subject|1|||
146599257|NCT04405245|528703410|FG000|Overall Study|Adverse Event|0|||
146599258|NCT04405245|528703411|FG001|Overall Study|Adverse Event|1|||
146599259|NCT04405245|528703412|FG002|Overall Study|Adverse Event|0|||
146599260|NCT03443427|528703413|FG000|Overall Study|Adverse Event|2|||
146599261|NCT03443427|528703414|FG001|Overall Study|Adverse Event|3|||
146599262|NCT03443427|528703413|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
146599263|NCT03443427|528703414|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
146599264|NCT03443427|528703413|FG000|Overall Study|Other|4|||
146599265|NCT03443427|528703414|FG001|Overall Study|Other|6|||
146921316|NCT03725202|529872938|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
146921317|NCT03725202|529872939|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
146921318|NCT03725202|529872940|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
146921319|NCT03725202|529872941|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
146921320|NCT03725202|529872934|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
146921321|NCT03725202|529872935|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
146921322|NCT03725202|529872936|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
146921323|NCT03725202|529872937|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
146921324|NCT03725202|529872938|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
146921325|NCT03725202|529872939|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
146921326|NCT03725202|529872940|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
146921327|NCT03725202|529872941|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
146921328|NCT00262080|529872948|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
146921329|NCT00262080|529872949|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
146921330|NCT00262080|529872950|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
146921331|NCT00262080|529872948|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
146921332|NCT00262080|529872949|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
146921333|NCT00262080|529872950|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
146921334|NCT00262080|529872948|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
146921335|NCT00262080|529872949|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
146921336|NCT00262080|529872950|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
146921337|NCT00262080|529872948|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
146921338|NCT00262080|529872949|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
146921339|NCT00262080|529872950|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
146921340|NCT00262080|529872948|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
146921341|NCT00262080|529872949|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
146921342|NCT00262080|529872950|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
146921343|NCT00262080|529872948|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
146921344|NCT00262080|529872949|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
146921345|NCT00262080|529872950|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
146921346|NCT01030458|529872955|FG000|Overall Study|Lost to Follow-up|9|||
146921347|NCT01030458|529872956|FG001|Overall Study|Lost to Follow-up|10|||
146921348|NCT01030458|529872955|FG000|Overall Study|Withdrawal by Subject|2|||
146921349|NCT01030458|529872956|FG001|Overall Study|Withdrawal by Subject|3|||
146921350|NCT01030458|529872955|FG000|Overall Study|Logistical reasons|9|||
146921351|NCT01030458|529872956|FG001|Overall Study|Logistical reasons|5|||
146921352|NCT01030458|529872955|FG000|Overall Study|Moved or changed job|6|||
146921353|NCT01030458|529872956|FG001|Overall Study|Moved or changed job|13|||
146921354|NCT01030458|529872955|FG000|Overall Study|Side effect of medication|1|||
146921355|NCT01030458|529872956|FG001|Overall Study|Side effect of medication|1|||
146921356|NCT02420223|529872957|FG000|Overall Study|Adverse Event|1|||
146921357|NCT02420223|529872958|FG001|Overall Study|Adverse Event|0|||
146921358|NCT02420223|529872957|FG000|Overall Study|Physician Decision|0|||
146921359|NCT02420223|529872958|FG001|Overall Study|Physician Decision|2|||
146921360|NCT01361009|529872959|FG000|Overall Study|Protocol Violation|116|||
146921361|NCT02935634|529872963|FG000|Randomization|Participant withdrew consent|0|||
146921362|NCT02935634|529872964|FG001|Randomization|Participant withdrew consent|1|||
146921363|NCT02935634|529872965|FG002|Randomization|Participant withdrew consent|0|||
146921364|NCT02935634|529872966|FG003|Randomization|Participant withdrew consent|0|||
146921365|NCT02935634|529872967|FG004|Randomization|Participant withdrew consent|0|||
146654746|NCT01423604|528912369|FG000|Safety Run-In|Death|1|||
146654747|NCT01423604|528912370|FG001|Safety Run-In|Death|0|||
146654748|NCT01423604|528912369|FG000|Safety Run-In|Physician Decision|1|||
146654749|NCT01423604|528912370|FG001|Safety Run-In|Physician Decision|0|||
146654750|NCT01423604|528912369|FG000|Safety Run-In|Disease progression|3|||
146654751|NCT01423604|528912370|FG001|Safety Run-In|Disease progression|0|||
146654752|NCT01423604|528912369|FG000|Safety Run-In|Patient decision|1|||
146654753|NCT01423604|528912370|FG001|Safety Run-In|Patient decision|0|||
146654754|NCT01423604|528912369|FG000|Randomized|Adverse Event|4|||
146654755|NCT01423604|528912370|FG001|Randomized|Adverse Event|10|||
146654756|NCT01423604|528912369|FG000|Randomized|Death|1|||
146654757|NCT01423604|528912370|FG001|Randomized|Death|0|||
146654758|NCT01423604|528912369|FG000|Randomized|Physician Decision|16|||
146654759|NCT01423604|528912370|FG001|Randomized|Physician Decision|13|||
146654760|NCT01423604|528912369|FG000|Randomized|Other - unspecified|37|||
146654761|NCT01423604|528912370|FG001|Randomized|Other - unspecified|31|||
146921366|NCT02935634|529872968|FG005|Randomization|Participant withdrew consent|0|||
146921367|NCT02935634|529872963|FG000|Randomization|Death|2|||
146921368|NCT02935634|529872964|FG001|Randomization|Death|1|||
146921369|NCT02935634|529872965|FG002|Randomization|Death|1|||
146921370|NCT02935634|529872966|FG003|Randomization|Death|0|||
146921371|NCT02935634|529872967|FG004|Randomization|Death|0|||
146921372|NCT02935634|529872968|FG005|Randomization|Death|0|||
146921373|NCT02935634|529872963|FG000|Randomization|Other reasons|0|||
146921374|NCT02935634|529872964|FG001|Randomization|Other reasons|2|||
146921375|NCT02935634|529872965|FG002|Randomization|Other reasons|2|||
146921376|NCT02935634|529872966|FG003|Randomization|Other reasons|0|||
146921377|NCT02935634|529872967|FG004|Randomization|Other reasons|0|||
146921378|NCT02935634|529872968|FG005|Randomization|Other reasons|0|||
146921379|NCT02935634|529872963|FG000|Treatment: Track 1|Disease progression|15|||
146921380|NCT02935634|529872964|FG001|Treatment: Track 1|Disease progression|17|||
146921381|NCT02935634|529872965|FG002|Treatment: Track 1|Disease progression|28|||
146921382|NCT02935634|529872966|FG003|Treatment: Track 1|Disease progression|4|||
146921383|NCT02935634|529872967|FG004|Treatment: Track 1|Disease progression|6|||
146921384|NCT02935634|529872968|FG005|Treatment: Track 1|Disease progression|2|||
146921385|NCT02935634|529872963|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
146921386|NCT02935634|529872964|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
146921387|NCT02935634|529872965|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
146921388|NCT02935634|529872966|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
146921389|NCT02935634|529872967|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
146921390|NCT02935634|529872968|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
146921391|NCT02935634|529872963|FG000|Treatment: Track 1|Lost to Follow-up|1|||
146921392|NCT02935634|529872964|FG001|Treatment: Track 1|Lost to Follow-up|0|||
146921393|NCT02935634|529872965|FG002|Treatment: Track 1|Lost to Follow-up|0|||
146921394|NCT02935634|529872966|FG003|Treatment: Track 1|Lost to Follow-up|0|||
146921395|NCT02935634|529872967|FG004|Treatment: Track 1|Lost to Follow-up|0|||
146921396|NCT02935634|529872968|FG005|Treatment: Track 1|Lost to Follow-up|0|||
146921397|NCT02935634|529872963|FG000|Treatment: Track 1|Study drug toxicity|2|||
146921398|NCT02935634|529872964|FG001|Treatment: Track 1|Study drug toxicity|1|||
146921399|NCT02935634|529872965|FG002|Treatment: Track 1|Study drug toxicity|3|||
146921400|NCT02935634|529872966|FG003|Treatment: Track 1|Study drug toxicity|0|||
146921401|NCT02935634|529872967|FG004|Treatment: Track 1|Study drug toxicity|0|||
146921402|NCT02935634|529872968|FG005|Treatment: Track 1|Study drug toxicity|1|||
146921403|NCT02935634|529872963|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
146921404|NCT02935634|529872964|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
146921405|NCT02935634|529872965|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
146921406|NCT02935634|529872966|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
146921407|NCT02935634|529872967|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
146921408|NCT02935634|529872968|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
146921409|NCT02935634|529872963|FG000|Treatment: Track 1|Participant withdrew consent|2|||
146921410|NCT02935634|529872964|FG001|Treatment: Track 1|Participant withdrew consent|0|||
146921411|NCT02935634|529872965|FG002|Treatment: Track 1|Participant withdrew consent|1|||
146978541|NCT00272961|530084098|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
146978542|NCT00272961|530084099|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
146978543|NCT00272961|530084100|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
146654762|NCT01423604|528912369|FG000|Randomized|Patient decision|5|||
146921412|NCT02935634|529872966|FG003|Treatment: Track 1|Participant withdrew consent|0|||
146921413|NCT02935634|529872967|FG004|Treatment: Track 1|Participant withdrew consent|1|||
146921414|NCT02935634|529872968|FG005|Treatment: Track 1|Participant withdrew consent|0|||
146921415|NCT02935634|529872963|FG000|Treatment: Track 1|Other reasons|0|||
146921416|NCT02935634|529872964|FG001|Treatment: Track 1|Other reasons|0|||
146654763|NCT01423604|528912370|FG001|Randomized|Patient decision|9|||
146654764|NCT00378079|528912371|FG000|Overall Study|Lost to Follow-up|6|||
146654765|NCT00378079|528912372|FG001|Overall Study|Lost to Follow-up|1|||
146654766|NCT00378079|528912373|FG002|Overall Study|Lost to Follow-up|0|||
146654767|NCT02581943|528912374|FG000|Overall Study|Death|5|||
146654768|NCT02581943|528912375|FG001|Overall Study|Death|2|||
146654769|NCT02581943|528912374|FG000|Overall Study|Disease Progression|12|||
146654770|NCT02581943|528912375|FG001|Overall Study|Disease Progression|15|||
146654771|NCT02581943|528912374|FG000|Overall Study|Withdrawal by Subject|1|||
146654772|NCT02581943|528912375|FG001|Overall Study|Withdrawal by Subject|2|||
146654773|NCT01233687|528912376|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
146654774|NCT01233687|528912376|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
146654775|NCT01233687|528912376|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
146654776|NCT02290431|528912377|FG000|Overall Study|Adverse Event|20|||
146654777|NCT02290431|528912377|FG000|Overall Study|Progressive disease|4|||
146654778|NCT02290431|528912377|FG000|Overall Study|Study terminated by Sponsor|1|||
146654779|NCT02290431|528912377|FG000|Overall Study|Physician Decision|2|||
146654780|NCT03783702|528912382|FG000|Overall Study|Lost to Follow-up|6|||
146654781|NCT03783702|528912383|FG001|Overall Study|Lost to Follow-up|8|||
146654782|NCT03783702|528912382|FG000|Overall Study|Protocol Violation|1|||
146654783|NCT03783702|528912383|FG001|Overall Study|Protocol Violation|3|||
146654784|NCT02274038|528912384|FG000|Overall Study|Death|1|||
146654785|NCT04473482|528912385|FG000|Overall Study|Death|0|||
146654786|NCT04473482|528912386|FG001|Overall Study|Death|3|||
146654787|NCT04473482|528912385|FG000|Overall Study|Lost to Follow-up|9|||
146654788|NCT04473482|528912386|FG001|Overall Study|Lost to Follow-up|7|||
146654789|NCT04473482|528912385|FG000|Overall Study|Withdrawal by Subject|2|||
146654790|NCT04473482|528912386|FG001|Overall Study|Withdrawal by Subject|1|||
146654791|NCT00745615|528912393|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
146654792|NCT00745615|528912394|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
146654793|NCT00745615|528912395|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
146654794|NCT00745615|528912396|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
146654795|NCT00745615|528912397|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
146654796|NCT00745615|528912398|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
146654797|NCT00745615|528912393|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
146654798|NCT00745615|528912394|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
146654799|NCT00745615|528912395|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
146654800|NCT00745615|528912396|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
146654801|NCT00745615|528912397|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
146654802|NCT00745615|528912398|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
146654803|NCT00745615|528912393|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
146654804|NCT00745615|528912394|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
146654805|NCT00745615|528912395|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
146654806|NCT00745615|528912396|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
146654807|NCT00745615|528912397|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
146654808|NCT00745615|528912398|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
146654809|NCT00745615|528912393|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
146654810|NCT00745615|528912394|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
146654811|NCT00745615|528912395|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
146654812|NCT00745615|528912396|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
146654813|NCT00745615|528912397|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
146654814|NCT00745615|528912398|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
146654815|NCT00745615|528912393|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
146921417|NCT02935634|529872965|FG002|Treatment: Track 1|Other reasons|2|||
146921418|NCT02935634|529872966|FG003|Treatment: Track 1|Other reasons|0|||
146921419|NCT02935634|529872967|FG004|Treatment: Track 1|Other reasons|0|||
146921420|NCT02935634|529872968|FG005|Treatment: Track 1|Other reasons|0|||
146921421|NCT02935634|529872963|FG000|Treatment: Track 2|Disease progression|13|||
146921422|NCT02935634|529872964|FG001|Treatment: Track 2|Disease progression|26|||
146921423|NCT02935634|529872965|FG002|Treatment: Track 2|Disease progression|20|||
146921424|NCT02935634|529872966|FG003|Treatment: Track 2|Disease progression|5|||
146921425|NCT02935634|529872967|FG004|Treatment: Track 2|Disease progression|1|||
146921426|NCT02935634|529872968|FG005|Treatment: Track 2|Disease progression|4|||
146921427|NCT02935634|529872963|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
146921428|NCT02935634|529872964|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
146921429|NCT02935634|529872965|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
146921430|NCT02935634|529872966|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
146921431|NCT02935634|529872967|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
146654816|NCT00745615|528912394|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
146654817|NCT00745615|528912395|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
146654818|NCT00745615|528912396|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
146654819|NCT00745615|528912397|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
146654820|NCT00745615|528912398|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
146654821|NCT00745615|528912393|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
146654822|NCT00745615|528912394|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
146654823|NCT00745615|528912395|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
146921432|NCT02935634|529872968|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
146921433|NCT02935634|529872963|FG000|Treatment: Track 2|Study drug toxicity|7|||
146921434|NCT02935634|529872964|FG001|Treatment: Track 2|Study drug toxicity|3|||
146921435|NCT02935634|529872965|FG002|Treatment: Track 2|Study drug toxicity|0|||
146921436|NCT02935634|529872966|FG003|Treatment: Track 2|Study drug toxicity|0|||
146921437|NCT02935634|529872967|FG004|Treatment: Track 2|Study drug toxicity|0|||
146921438|NCT02935634|529872968|FG005|Treatment: Track 2|Study drug toxicity|0|||
146921439|NCT02935634|529872963|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
146921440|NCT02935634|529872964|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
146921441|NCT02935634|529872965|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
146921442|NCT02935634|529872966|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
146921443|NCT02935634|529872967|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
146921444|NCT02935634|529872968|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
146921445|NCT02935634|529872963|FG000|Treatment: Track 2|Participant withdrew consent|0|||
146921446|NCT02935634|529872964|FG001|Treatment: Track 2|Participant withdrew consent|1|||
146921447|NCT02935634|529872965|FG002|Treatment: Track 2|Participant withdrew consent|1|||
146921448|NCT02935634|529872966|FG003|Treatment: Track 2|Participant withdrew consent|0|||
146921449|NCT02935634|529872967|FG004|Treatment: Track 2|Participant withdrew consent|1|||
146921450|NCT02935634|529872968|FG005|Treatment: Track 2|Participant withdrew consent|0|||
146921451|NCT00995345|529872969|FG000|Overall Study|Withdrawal by Subject|4|||
146921452|NCT00995345|529872970|FG001|Overall Study|Withdrawal by Subject|2|||
146921453|NCT00995345|529872971|FG002|Overall Study|Withdrawal by Subject|1|||
146921454|NCT00995345|529872972|FG003|Overall Study|Withdrawal by Subject|3|||
146921455|NCT00995345|529872973|FG004|Overall Study|Withdrawal by Subject|1|||
146921456|NCT00995345|529872969|FG000|Overall Study|Adverse Event|3|||
146921457|NCT00995345|529872970|FG001|Overall Study|Adverse Event|1|||
146921458|NCT00995345|529872971|FG002|Overall Study|Adverse Event|2|||
146921459|NCT00995345|529872972|FG003|Overall Study|Adverse Event|0|||
146921460|NCT00995345|529872973|FG004|Overall Study|Adverse Event|1|||
146921461|NCT00995345|529872969|FG000|Overall Study|Lost to Follow-up|2|||
146921462|NCT00995345|529872970|FG001|Overall Study|Lost to Follow-up|2|||
146921463|NCT00995345|529872971|FG002|Overall Study|Lost to Follow-up|2|||
146921464|NCT00995345|529872972|FG003|Overall Study|Lost to Follow-up|1|||
146921465|NCT00995345|529872973|FG004|Overall Study|Lost to Follow-up|0|||
146921466|NCT00995345|529872969|FG000|Overall Study|all other reasons combined|2|||
146921467|NCT00995345|529872970|FG001|Overall Study|all other reasons combined|2|||
146921468|NCT00995345|529872971|FG002|Overall Study|all other reasons combined|2|||
146921469|NCT00995345|529872972|FG003|Overall Study|all other reasons combined|1|||
146921470|NCT00995345|529872973|FG004|Overall Study|all other reasons combined|3|||
146921471|NCT02651194|529872974|FG000|Overall Study|Lost to Follow-up|3|||
146921472|NCT02651194|529872974|FG000|Overall Study|Other|2|||
146921473|NCT03521687|529872980|FG000|Overall Study|Adverse Event|4|||
146921474|NCT03521687|529872980|FG000|Overall Study|Physician Decision|1|||
146921475|NCT00830037|529872986|FG000|Overall Study|Withdrawal by Subject|2|||
146921476|NCT00830037|529872987|FG001|Overall Study|Withdrawal by Subject|3|||
146921477|NCT00830037|529872986|FG000|Overall Study|Lost to Follow-up|1|||
146921478|NCT00830037|529872987|FG001|Overall Study|Lost to Follow-up|2|||
146921479|NCT00830037|529872986|FG000|Overall Study|Active when terminated by DSMB|15|||
146921480|NCT00830037|529872987|FG001|Overall Study|Active when terminated by DSMB|14|||
146921481|NCT00740779|529872988|FG000|Overall Study|Adverse Event|4|||
146921482|NCT00740779|529872989|FG001|Overall Study|Adverse Event|6|||
146921483|NCT00740779|529872990|FG002|Overall Study|Adverse Event|3|||
146921484|NCT00740779|529872988|FG000|Overall Study|Protocol Violation|1|||
146921485|NCT00740779|529872989|FG001|Overall Study|Protocol Violation|1|||
146921486|NCT00740779|529872990|FG002|Overall Study|Protocol Violation|1|||
146921487|NCT00740779|529872988|FG000|Overall Study|Lack of Efficacy|0|||
146921488|NCT00740779|529872989|FG001|Overall Study|Lack of Efficacy|0|||
146921489|NCT00740779|529872990|FG002|Overall Study|Lack of Efficacy|2|||
146599266|NCT00576472|528703416|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
146599267|NCT00576472|528703417|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
146599268|NCT00576472|528703418|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
146921490|NCT00740779|529872988|FG000|Overall Study|Withdrawal by Subject|2|||
146921491|NCT00740779|529872989|FG001|Overall Study|Withdrawal by Subject|4|||
146921492|NCT00740779|529872990|FG002|Overall Study|Withdrawal by Subject|2|||
146921493|NCT00740779|529872988|FG000|Overall Study|Lost to Follow-up|2|||
146921494|NCT00740779|529872989|FG001|Overall Study|Lost to Follow-up|3|||
146921495|NCT00740779|529872990|FG002|Overall Study|Lost to Follow-up|5|||
146921496|NCT02399813|529872996|FG000|Overall Study|Progressive Disease-Radiographic|2|||
146978544|NCT00272961|530084096|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
146921497|NCT02399813|529872996|FG000|Overall Study|Death|20|||
146921498|NCT02399813|529872996|FG000|Overall Study|Withdrawal by Subject|3|||
146921499|NCT02399813|529872996|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
146921500|NCT02399813|529872996|FG000|Overall Study|Lost to Follow-up|2|||
146921501|NCT02399813|529872996|FG000|Overall Study|Other than specified|5|||
146921502|NCT03280550|529872997|FG000|Overall Study|Withdrawal by Subject|2|||
146654824|NCT00745615|528912396|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
146654825|NCT00745615|528912397|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
146654826|NCT00745615|528912398|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
146654827|NCT00745615|528912393|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
146654828|NCT00745615|528912394|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
146654829|NCT00745615|528912395|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
146654830|NCT00745615|528912396|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
146654831|NCT00745615|528912397|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
146654832|NCT00745615|528912398|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
146654833|NCT00745615|528912393|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
146921503|NCT03280550|529872998|FG001|Overall Study|Withdrawal by Subject|2|||
146921504|NCT03280550|529872997|FG000|Overall Study|Physician Decision|0|||
146921505|NCT03280550|529872998|FG001|Overall Study|Physician Decision|1|||
146921506|NCT00222729|529873003|FG000|Overall Study|Adverse Event|3|||
146921507|NCT01915849|529873006|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
146921508|NCT01915849|529873007|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
146921509|NCT01915849|529873008|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
146921510|NCT01915849|529873009|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
146921511|NCT01915849|529873006|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
146921512|NCT01915849|529873007|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
146921513|NCT01915849|529873008|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
146921514|NCT01915849|529873009|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
146921515|NCT02761993|529873016|FG000|Overall Study|Adverse Event|0|||
146921516|NCT02761993|529873017|FG001|Overall Study|Adverse Event|2|||
146921517|NCT02761993|529873018|FG002|Overall Study|Adverse Event|0|||
146921518|NCT02761993|529873016|FG000|Overall Study|Lost to Follow-up|1|||
146921519|NCT02761993|529873017|FG001|Overall Study|Lost to Follow-up|3|||
146921520|NCT02761993|529873018|FG002|Overall Study|Lost to Follow-up|2|||
146921521|NCT02761993|529873016|FG000|Overall Study|Withdrawal by Subject|1|||
146921522|NCT02761993|529873017|FG001|Overall Study|Withdrawal by Subject|1|||
146921523|NCT02761993|529873018|FG002|Overall Study|Withdrawal by Subject|2|||
146921524|NCT03591146|529873029|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
146921525|NCT03591146|529873030|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
146921526|NCT03591146|529873031|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
146921527|NCT03591146|529873032|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
146921528|NCT03591146|529873033|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
146921529|NCT03591146|529873029|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
146921530|NCT03591146|529873030|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
146921531|NCT03591146|529873031|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
146921532|NCT03591146|529873032|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
146921533|NCT03591146|529873033|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
146921534|NCT03591146|529873029|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
146921535|NCT03591146|529873030|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
146921536|NCT03591146|529873031|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
146921537|NCT03591146|529873032|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
146921538|NCT03591146|529873033|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
146921539|NCT03591146|529873029|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
146921540|NCT03591146|529873030|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
146921541|NCT03591146|529873031|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
146921542|NCT03591146|529873032|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
146921543|NCT03591146|529873033|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
146921544|NCT04737031|529873036|FG000|Overall Study|Patients who did not have a treatment visit|0|||
146921545|NCT04737031|529873037|FG001|Overall Study|Patients who did not have a treatment visit|31|||
146921546|NCT04737031|529873038|FG002|Overall Study|Patients who did not have a treatment visit|93|||
146921547|NCT04737031|529873039|FG003|Overall Study|Patients who did not have a treatment visit|227|||
146921548|NCT00008138|529873040|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
146654834|NCT00745615|528912394|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
146771792|NCT02200770|529332619|FG001|Open-label Period (OLP)|Adverse Event|2|||
146771793|NCT02200770|529332618|FG000|Open-label Period (OLP)|Death|1|||
146921549|NCT00008138|529873040|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
146921550|NCT00008138|529873040|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
146921551|NCT00008138|529873040|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
146921552|NCT00008138|529873040|FG000|Interval Debulking|Withdrawal by Subject|2|||
146921553|NCT00008138|529873040|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
146978545|NCT00272961|530084097|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
146978546|NCT00272961|530084098|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
146921554|NCT00008138|529873040|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
146921555|NCT00008138|529873040|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
146921556|NCT03453151|529873041|FG000|Overall Study|Withdrawal by Subject|1|||
146921557|NCT03453151|529873041|FG000|Overall Study|Physician Decision|3|||
146599269|NCT00576472|528703419|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
146599270|NCT00576472|528703420|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
146599271|NCT00576472|528703421|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
146599272|NCT00576472|528703422|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
146771794|NCT02200770|529332619|FG001|Open-label Period (OLP)|Death|2|||
146771795|NCT02200770|529332618|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
146771796|NCT02200770|529332619|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
146921558|NCT01204658|529873045|FG000|Primary Phase|Adverse Event|0|||
146599273|NCT00576472|528703423|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
146599274|NCT00576472|528703424|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
146599275|NCT00576472|528703425|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
146599276|NCT00576472|528703426|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
146599277|NCT00576472|528703427|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
146599278|NCT00576472|528703428|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
146599279|NCT00576472|528703429|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
146599280|NCT00576472|528703430|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
146599281|NCT00576472|528703416|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
146599282|NCT00576472|528703417|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
146599283|NCT00576472|528703418|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
146599284|NCT00576472|528703419|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
146599285|NCT00576472|528703420|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
146599286|NCT00576472|528703421|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
146599287|NCT00576472|528703422|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
146599288|NCT00576472|528703423|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
146599289|NCT00576472|528703424|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
146599290|NCT00576472|528703425|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
146599291|NCT00576472|528703426|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
146599292|NCT00576472|528703427|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
146599293|NCT00576472|528703428|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
146599294|NCT00576472|528703429|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
146599295|NCT00576472|528703430|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
146599296|NCT00576472|528703416|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146599297|NCT00576472|528703417|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146599298|NCT00576472|528703418|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146599299|NCT00576472|528703419|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
146599300|NCT00576472|528703420|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146599301|NCT00576472|528703421|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146599302|NCT00576472|528703422|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146599303|NCT00576472|528703423|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146599304|NCT00576472|528703424|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146599305|NCT00576472|528703425|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146599306|NCT00576472|528703426|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146599307|NCT00576472|528703427|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146599308|NCT00576472|528703428|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146599309|NCT00576472|528703429|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146599310|NCT00576472|528703430|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146599311|NCT00576472|528703416|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
146599312|NCT00576472|528703417|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
146599313|NCT00576472|528703418|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
146599314|NCT00576472|528703419|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
146771797|NCT02200770|529332618|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
146771798|NCT02200770|529332619|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
146921559|NCT01204658|529873046|FG001|Primary Phase|Adverse Event|0|||
146921560|NCT01204658|529873047|FG002|Primary Phase|Adverse Event|1|||
146921561|NCT01204658|529873048|FG003|Primary Phase|Adverse Event|0|||
146921562|NCT04973228|529873049|FG000|Overall Study|Adverse Event|2|||
146921563|NCT04973228|529873050|FG001|Overall Study|Adverse Event|3|||
146921564|NCT04973228|529873049|FG000|Overall Study|Lack of Efficacy|1|||
146921565|NCT04973228|529873050|FG001|Overall Study|Lack of Efficacy|3|||
146921566|NCT04973228|529873049|FG000|Overall Study|Lost to Follow-up|12|||
146921567|NCT04973228|529873050|FG001|Overall Study|Lost to Follow-up|4|||
146921568|NCT04973228|529873049|FG000|Overall Study|Withdrawal by Subject|11|||
146921569|NCT04973228|529873050|FG001|Overall Study|Withdrawal by Subject|4|||
146921570|NCT04973228|529873049|FG000|Overall Study|Did not tolerate application|1|||
146921571|NCT04973228|529873050|FG001|Overall Study|Did not tolerate application|0|||
146921572|NCT04973228|529873049|FG000|Overall Study|Wanted to early terminate and use own product|0|||
146921573|NCT04973228|529873050|FG001|Overall Study|Wanted to early terminate and use own product|1|||
146771799|NCT02200770|529332618|FG000|Open-label Period (OLP)|Other|6|||
146921574|NCT04973228|529873049|FG000|Overall Study|Missed visits due to new work schedule|1|||
146599315|NCT00576472|528703420|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
146599316|NCT00576472|528703421|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
146771800|NCT02200770|529332619|FG001|Open-label Period (OLP)|Other|15|||
146771801|NCT01124734|529332620|FG000|Overall Study|Disease progression|13|||
146771802|NCT01124734|529332620|FG000|Overall Study|Adverse Event|1|||
146771803|NCT01124734|529332620|FG000|Overall Study|Withdrawal by Subject|1|||
146771804|NCT01124734|529332620|FG000|Overall Study|Elected for alternative treatment|2|||
146771805|NCT01837966|529332628|FG000|Overall Study|Withdrawal by Subject|2|||
146771806|NCT01837966|529332629|FG001|Overall Study|Withdrawal by Subject|1|||
146771807|NCT01202955|529332630|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
146771808|NCT01202955|529332631|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
146599317|NCT00576472|528703422|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
146599318|NCT00576472|528703423|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
146599319|NCT00576472|528703424|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
146599320|NCT00576472|528703425|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
146599321|NCT00576472|528703426|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
146599322|NCT00576472|528703427|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
146599323|NCT00576472|528703428|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
146599324|NCT00576472|528703429|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
146599325|NCT00576472|528703430|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
146599326|NCT00576472|528703416|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
146599327|NCT00576472|528703417|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
146599328|NCT00576472|528703418|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
146599329|NCT00576472|528703419|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
146771809|NCT02928224|529332634|FG000|Overall Study|Lost to Follow-up|1|||
146771810|NCT02928224|529332635|FG001|Overall Study|Lost to Follow-up|1|||
146771811|NCT02928224|529332636|FG002|Overall Study|Lost to Follow-up|3|||
146771812|NCT02928224|529332637|FG003|Overall Study|Lost to Follow-up|0|||
146771813|NCT02928224|529332634|FG000|Overall Study|Death|30|||
146771814|NCT02928224|529332635|FG001|Overall Study|Death|209|||
146771815|NCT02928224|529332636|FG002|Overall Study|Death|193|||
146771816|NCT02928224|529332637|FG003|Overall Study|Death|198|||
146771817|NCT02928224|529332634|FG000|Overall Study|Withdrawal by Subject|0|||
146771818|NCT02928224|529332635|FG001|Overall Study|Withdrawal by Subject|3|||
146771819|NCT02928224|529332636|FG002|Overall Study|Withdrawal by Subject|7|||
146599330|NCT00576472|528703420|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
146599331|NCT00576472|528703421|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
146599332|NCT00576472|528703422|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
146599333|NCT00576472|528703423|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
146599334|NCT00576472|528703424|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
146599335|NCT00576472|528703425|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
146599336|NCT00576472|528703426|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
146599337|NCT00576472|528703427|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
146599338|NCT00576472|528703428|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
146599339|NCT00576472|528703429|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
146599340|NCT00576472|528703430|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
146599341|NCT00576472|528703416|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
146599342|NCT00576472|528703417|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
146599343|NCT00576472|528703418|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
146599344|NCT00576472|528703419|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
146599345|NCT00576472|528703420|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
146599346|NCT00576472|528703421|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
146599347|NCT00576472|528703422|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
146599348|NCT00576472|528703423|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
146599349|NCT00576472|528703424|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
146599350|NCT00576472|528703425|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
146599351|NCT00576472|528703426|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
146599352|NCT00576472|528703427|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
146599353|NCT00576472|528703428|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
146599354|NCT00576472|528703429|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
146599355|NCT00576472|528703430|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
146599356|NCT00576472|528703416|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
146599357|NCT00576472|528703417|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
146599358|NCT00576472|528703418|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
146599359|NCT00576472|528703419|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
146771820|NCT02928224|529332637|FG003|Overall Study|Withdrawal by Subject|20|||
146771821|NCT02928224|529332634|FG000|Overall Study|Study participation terminated by sponsor|3|||
146771822|NCT02928224|529332635|FG001|Overall Study|Study participation terminated by sponsor|8|||
146978547|NCT00272961|530084099|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
146599360|NCT00576472|528703420|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
146599361|NCT00576472|528703421|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
146599362|NCT00576472|528703422|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
146599363|NCT00576472|528703423|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
146599364|NCT00576472|528703424|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
146599365|NCT00576472|528703425|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
146921575|NCT04973228|529873050|FG001|Overall Study|Missed visits due to new work schedule|0|||
146921576|NCT00091390|529873067|FG000|Overall Study|Protocol Violation|1|||
146921577|NCT00091390|529873067|FG000|Overall Study|No protocol treatment|3|||
146921578|NCT02020031|529874626|FG000|Overall Study|Physician Decision|1|||
146921579|NCT02020031|529874627|FG001|Overall Study|Physician Decision|1|||
146921580|NCT00683475|529874630|FG000|Overall Study|Withdrawal by Subject|1|||
146921581|NCT00683475|529874631|FG001|Overall Study|Withdrawal by Subject|0|||
146921582|NCT00683475|529874630|FG000|Overall Study|Never Treated: Adverse Event|2|||
146921583|NCT00683475|529874631|FG001|Overall Study|Never Treated: Adverse Event|3|||
146921584|NCT00683475|529874630|FG000|Overall Study|Never Treated: Progressive Disease|1|||
146921585|NCT00683475|529874631|FG001|Overall Study|Never Treated: Progressive Disease|0|||
146921586|NCT02669862|529874632|FG000|Overall Study|Lost to Follow-up|0|||
146921587|NCT02669862|529874633|FG001|Overall Study|Lost to Follow-up|2|||
146921588|NCT02669862|529874634|FG002|Overall Study|Lost to Follow-up|1|||
146921589|NCT02669862|529874632|FG000|Overall Study|Withdrawal by Subject|2|||
146921590|NCT02669862|529874633|FG001|Overall Study|Withdrawal by Subject|2|||
146921591|NCT02669862|529874634|FG002|Overall Study|Withdrawal by Subject|3|||
146921592|NCT02669862|529874632|FG000|Overall Study|moved|0|||
146921593|NCT02669862|529874633|FG001|Overall Study|moved|1|||
146921594|NCT02669862|529874634|FG002|Overall Study|moved|0|||
146921595|NCT02669862|529874632|FG000|Overall Study|Protocol Violation|0|||
146921596|NCT02669862|529874633|FG001|Overall Study|Protocol Violation|0|||
146921597|NCT02669862|529874634|FG002|Overall Study|Protocol Violation|1|||
146921598|NCT02429258|529874635|FG000|Overall Study|Withdrawal by Subject|2|||
146921599|NCT02429258|529874636|FG001|Overall Study|Withdrawal by Subject|0|||
146921600|NCT02429258|529874635|FG000|Overall Study|Protocol Violation|0|||
146921601|NCT02429258|529874636|FG001|Overall Study|Protocol Violation|1|||
146921602|NCT01694420|529874637|FG000|Overall Study|Lost to Follow-up|3|||
146599366|NCT00576472|528703426|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
146599367|NCT00576472|528703427|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
146599368|NCT00576472|528703428|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
146599369|NCT00576472|528703429|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
146599370|NCT00576472|528703430|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
146599371|NCT00576472|528703416|FG000|MPH Cross Over Phase|Physician Decision|0|||
146599372|NCT00576472|528703417|FG001|MPH Cross Over Phase|Physician Decision|0|||
146599373|NCT00576472|528703418|FG002|MPH Cross Over Phase|Physician Decision|0|||
146599374|NCT00576472|528703419|FG003|MPH Cross Over Phase|Physician Decision|0|||
146599375|NCT00576472|528703420|FG004|MPH Cross Over Phase|Physician Decision|0|||
146599376|NCT00576472|528703421|FG005|MPH Cross Over Phase|Physician Decision|0|||
146599377|NCT00576472|528703422|FG006|MPH Cross Over Phase|Physician Decision|4|||
146599378|NCT00576472|528703423|FG007|MPH Cross Over Phase|Physician Decision|0|||
146599379|NCT00576472|528703424|FG008|MPH Cross Over Phase|Physician Decision|0|||
146599380|NCT00576472|528703425|FG009|MPH Cross Over Phase|Physician Decision|0|||
146599381|NCT00576472|528703426|FG010|MPH Cross Over Phase|Physician Decision|0|||
146599382|NCT00576472|528703427|FG011|MPH Cross Over Phase|Physician Decision|0|||
146599383|NCT00576472|528703428|FG012|MPH Cross Over Phase|Physician Decision|0|||
146599384|NCT00576472|528703429|FG013|MPH Cross Over Phase|Physician Decision|0|||
146599385|NCT00576472|528703430|FG014|MPH Cross Over Phase|Physician Decision|0|||
146599386|NCT00576472|528703416|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
146599387|NCT00576472|528703417|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
146599388|NCT00576472|528703418|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
146599389|NCT00576472|528703419|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
146599390|NCT00576472|528703420|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
146599391|NCT00576472|528703421|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
146599392|NCT00576472|528703422|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
146654835|NCT00745615|528912395|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
146654836|NCT00745615|528912396|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
146654837|NCT00745615|528912397|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
146654838|NCT00745615|528912398|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
146654839|NCT00745615|528912393|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
146654840|NCT00745615|528912394|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
146921603|NCT03987919|529874639|FG000|Overall Study|Adverse Event|1|||
146921604|NCT03987919|529874640|FG001|Overall Study|Adverse Event|4|||
146921605|NCT03987919|529874641|FG002|Overall Study|Adverse Event|1|||
146921606|NCT03987919|529874642|FG003|Overall Study|Adverse Event|3|||
146921607|NCT03987919|529874639|FG000|Overall Study|Death|4|||
146921608|NCT03987919|529874640|FG001|Overall Study|Death|4|||
146921609|NCT03987919|529874641|FG002|Overall Study|Death|4|||
146599393|NCT00576472|528703423|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
146599394|NCT00576472|528703424|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
146599395|NCT00576472|528703425|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
146599396|NCT00576472|528703426|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
146599397|NCT00576472|528703427|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
146654841|NCT00745615|528912395|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
146654842|NCT00745615|528912396|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
146654843|NCT00745615|528912397|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
146654844|NCT00745615|528912398|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
146654845|NCT00745615|528912393|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
146654846|NCT00745615|528912394|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
146654847|NCT00745615|528912395|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
146654848|NCT00745615|528912396|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
146654849|NCT00745615|528912397|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
146654850|NCT00745615|528912398|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
146654851|NCT00745615|528912393|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
146654852|NCT00745615|528912394|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
146654853|NCT00745615|528912395|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
146654854|NCT00745615|528912396|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
146654855|NCT00745615|528912397|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
146654856|NCT00745615|528912398|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
146654857|NCT00745615|528912393|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
146654858|NCT00745615|528912394|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
146654859|NCT00745615|528912395|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
146654860|NCT00745615|528912396|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
146654861|NCT00745615|528912397|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
146654862|NCT00745615|528912398|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
146654863|NCT00745615|528912393|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
146654864|NCT00745615|528912394|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
146654865|NCT00745615|528912395|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
146654866|NCT00745615|528912396|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
146654867|NCT00745615|528912397|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
146654868|NCT00745615|528912398|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
146654869|NCT00745615|528912393|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
146654870|NCT00745615|528912394|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
146654871|NCT00745615|528912395|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
146654872|NCT00745615|528912396|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
146654873|NCT00745615|528912397|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
146654874|NCT00745615|528912398|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
146654875|NCT00570232|528912399|FG000|Overall Study|Adverse Event|10|||
146654876|NCT00570232|528912399|FG000|Overall Study|discontinued due to medical condition|3|||
146654877|NCT00570232|528912399|FG000|Overall Study|discontinued due to recurrence|8|||
146654878|NCT00570232|528912399|FG000|Overall Study|discontinued due to noncompliance|2|||
146654879|NCT01076075|528912400|FG000|Overall Study|Adverse Event|3|||
146654880|NCT01076075|528912401|FG001|Overall Study|Adverse Event|9|||
146654881|NCT01076075|528912400|FG000|Overall Study|Lack of Efficacy|5|||
146654882|NCT01076075|528912401|FG001|Overall Study|Lack of Efficacy|4|||
146654883|NCT01076075|528912400|FG000|Overall Study|Lost to Follow-up|6|||
146654884|NCT01076075|528912401|FG001|Overall Study|Lost to Follow-up|5|||
146654885|NCT01076075|528912400|FG000|Overall Study|other|19|||
146654886|NCT01076075|528912401|FG001|Overall Study|other|9|||
146654887|NCT01076075|528912400|FG000|Overall Study|Protocol Violation|0|||
146654888|NCT01076075|528912401|FG001|Overall Study|Protocol Violation|1|||
146654889|NCT01076075|528912400|FG000|Overall Study|Withdrawal by Subject|8|||
146654890|NCT01076075|528912401|FG001|Overall Study|Withdrawal by Subject|19|||
146654891|NCT01445886|528912407|FG000|Overall Study|Lost to Follow-up|2|||
146654892|NCT01445886|528912407|FG000|Overall Study|Protocol Violation|3|||
146654893|NCT00586664|528912408|FG000|Overall Study|Withdrawal by Subject|3|||
146654894|NCT00586664|528912409|FG001|Overall Study|Withdrawal by Subject|7|||
146654895|NCT00586664|528912410|FG002|Overall Study|Withdrawal by Subject|1|||
146654896|NCT00586664|528912408|FG000|Overall Study|Exclusion criteria met|2|||
146654897|NCT00586664|528912409|FG001|Overall Study|Exclusion criteria met|0|||
146654898|NCT00586664|528912410|FG002|Overall Study|Exclusion criteria met|0|||
146654899|NCT01585584|528912416|FG000|Overall Study|Lack of Efficacy|1|||
146654900|NCT01585584|528912416|FG000|Overall Study|Withdrawal by Subject|1|||
146654901|NCT01585584|528912416|FG000|Overall Study|Physician Decision|2|||
146654902|NCT00686998|528912417|FG000|Overall Study|Adverse Event|3|||
146654903|NCT00686998|528912418|FG001|Overall Study|Adverse Event|2|||
146654904|NCT00686998|528912419|FG002|Overall Study|Adverse Event|1|||
146654905|NCT00686998|528912417|FG000|Overall Study|Withdrawal by Subject|2|||
146654906|NCT00686998|528912418|FG001|Overall Study|Withdrawal by Subject|1|||
146654907|NCT00686998|528912419|FG002|Overall Study|Withdrawal by Subject|2|||
146654908|NCT00686998|528912417|FG000|Overall Study|Lack of Efficacy|7|||
146654909|NCT00686998|528912418|FG001|Overall Study|Lack of Efficacy|5|||
146654910|NCT00686998|528912419|FG002|Overall Study|Lack of Efficacy|0|||
146654911|NCT00686998|528912417|FG000|Overall Study|Other|0|||
146771823|NCT02928224|529332636|FG002|Overall Study|Study participation terminated by sponsor|12|||
146599398|NCT00576472|528703428|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
146599399|NCT00576472|528703429|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
146599400|NCT00576472|528703430|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
146599401|NCT00576472|528703416|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146599402|NCT00576472|528703417|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146599403|NCT00576472|528703418|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146599404|NCT00576472|528703419|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146599405|NCT00576472|528703420|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146599406|NCT00576472|528703421|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146599407|NCT00576472|528703422|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146654912|NCT00686998|528912418|FG001|Overall Study|Other|0|||
146654913|NCT00686998|528912419|FG002|Overall Study|Other|1|||
146654914|NCT00686998|528912417|FG000|Overall Study|Safety Reasons|1|||
146921610|NCT03987919|529874642|FG003|Overall Study|Death|1|||
146921611|NCT03987919|529874639|FG000|Overall Study|Lost to Follow-up|5|||
146921612|NCT03987919|529874640|FG001|Overall Study|Lost to Follow-up|6|||
146921613|NCT03987919|529874641|FG002|Overall Study|Lost to Follow-up|8|||
146921614|NCT03987919|529874642|FG003|Overall Study|Lost to Follow-up|12|||
146921615|NCT03987919|529874639|FG000|Overall Study|Physician Decision|0|||
146921616|NCT03987919|529874640|FG001|Overall Study|Physician Decision|2|||
146921617|NCT03987919|529874641|FG002|Overall Study|Physician Decision|0|||
146921618|NCT03987919|529874642|FG003|Overall Study|Physician Decision|4|||
146921619|NCT03987919|529874639|FG000|Overall Study|Pregnancy|1|||
146921620|NCT03987919|529874640|FG001|Overall Study|Pregnancy|0|||
146921621|NCT03987919|529874641|FG002|Overall Study|Pregnancy|1|||
146921622|NCT03987919|529874642|FG003|Overall Study|Pregnancy|1|||
146921623|NCT03987919|529874639|FG000|Overall Study|Protocol Violation|0|||
146921624|NCT03987919|529874640|FG001|Overall Study|Protocol Violation|1|||
146921625|NCT03987919|529874641|FG002|Overall Study|Protocol Violation|0|||
146921626|NCT03987919|529874642|FG003|Overall Study|Protocol Violation|0|||
146921627|NCT03987919|529874639|FG000|Overall Study|Site terminated by Sponsor|0|||
146921628|NCT03987919|529874640|FG001|Overall Study|Site terminated by Sponsor|0|||
146921629|NCT03987919|529874641|FG002|Overall Study|Site terminated by Sponsor|0|||
146921630|NCT03987919|529874642|FG003|Overall Study|Site terminated by Sponsor|1|||
146921631|NCT03987919|529874639|FG000|Overall Study|Withdrawal by Subject|7|||
146921632|NCT03987919|529874640|FG001|Overall Study|Withdrawal by Subject|7|||
146921633|NCT03987919|529874641|FG002|Overall Study|Withdrawal by Subject|8|||
146921634|NCT03987919|529874642|FG003|Overall Study|Withdrawal by Subject|4|||
146921635|NCT03987919|529874639|FG000|Overall Study|Other - as reported by the investigator|1|||
146921636|NCT03987919|529874640|FG001|Overall Study|Other - as reported by the investigator|3|||
146921637|NCT03987919|529874641|FG002|Overall Study|Other - as reported by the investigator|2|||
146921638|NCT03987919|529874642|FG003|Overall Study|Other - as reported by the investigator|0|||
146921639|NCT00434512|529874646|FG000|Overall Study|Migrated/moved from study area|0|||
146921640|NCT00434512|529874647|FG001|Overall Study|Migrated/moved from study area|0|||
146921641|NCT00434512|529874648|FG002|Overall Study|Migrated/moved from study area|0|||
146921642|NCT00434512|529874649|FG003|Overall Study|Migrated/moved from study area|1|||
146921643|NCT00434512|529874650|FG004|Overall Study|Migrated/moved from study area|1|||
146921644|NCT00434512|529874651|FG005|Overall Study|Migrated/moved from study area|1|||
146921645|NCT00434512|529874646|FG000|Overall Study|Other|0|||
146921646|NCT00434512|529874647|FG001|Overall Study|Other|1|||
146921647|NCT00434512|529874648|FG002|Overall Study|Other|0|||
146921648|NCT00434512|529874649|FG003|Overall Study|Other|0|||
146921649|NCT00434512|529874650|FG004|Overall Study|Other|0|||
146921650|NCT00434512|529874651|FG005|Overall Study|Other|0|||
146921651|NCT03303092|529874652|FG000|Overall Study|Adverse Event|1|||
146921652|NCT03303092|529874653|FG001|Overall Study|Adverse Event|0|||
146921653|NCT03303092|529874654|FG002|Overall Study|Adverse Event|1|||
146921654|NCT03303092|529874652|FG000|Overall Study|Protocol Violation|1|||
146921655|NCT03303092|529874653|FG001|Overall Study|Protocol Violation|5|||
146921656|NCT03303092|529874654|FG002|Overall Study|Protocol Violation|1|||
146599408|NCT00576472|528703423|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146599409|NCT00576472|528703424|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146599410|NCT00576472|528703425|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146599411|NCT00576472|528703426|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146599412|NCT00576472|528703427|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146654915|NCT00686998|528912418|FG001|Overall Study|Safety Reasons|0|||
146921657|NCT03303092|529874652|FG000|Overall Study|Withdrawal by Subject|1|||
146921658|NCT03303092|529874653|FG001|Overall Study|Withdrawal by Subject|1|||
146921659|NCT03303092|529874654|FG002|Overall Study|Withdrawal by Subject|3|||
146599413|NCT00576472|528703428|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146921660|NCT00411788|529874662|FG000|Overall Study|Protocol Violation|1|||
146921661|NCT00411788|529874662|FG000|Overall Study|Adverse Event|1|||
146921662|NCT00390416|529874664|FG000|Overall Study|Withdrawal by Subject|1|||
146921663|NCT00390416|529874664|FG000|Overall Study|Not treated|3|||
146921664|NCT01592409|529874665|FG000|Overall Study|Withdrawal by Subject|0|||
146654916|NCT00686998|528912419|FG002|Overall Study|Safety Reasons|0|||
146654917|NCT05985980|528912420|FG000|Overall Study|Withdrawal by Subject|1|||
146654918|NCT05985980|528912420|FG000|Overall Study|Withdrawal by Subject|1|||
146654919|NCT05985980|528912420|FG000|Overall Study|Withdrawal by Subject|1|||
146654920|NCT05985980|528912420|FG000|Overall Study|Withdrawal by Subject|1|||
146654921|NCT04854642|528914147|FG000|Overall Study|Adverse Event|1|||
146654922|NCT04854642|528914148|FG001|Overall Study|Adverse Event|2|||
146654923|NCT04854642|528914147|FG000|Overall Study|Withdrawal by Subject|0|||
146654924|NCT04854642|528914148|FG001|Overall Study|Withdrawal by Subject|1|||
146654925|NCT00597701|528914149|FG000|Overall Study|Withdrawal by Subject|5|||
146654926|NCT00597701|528914150|FG001|Overall Study|Withdrawal by Subject|5|||
146654927|NCT00597701|528914149|FG000|Overall Study|Death|0|||
146654928|NCT00597701|528914150|FG001|Overall Study|Death|1|||
146654929|NCT00597701|528914149|FG000|Overall Study|Physician Decision|2|||
146654930|NCT00597701|528914150|FG001|Overall Study|Physician Decision|0|||
146654931|NCT00597701|528914149|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
146654932|NCT00597701|528914150|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
146654933|NCT01107418|528914151|FG000|Overall Study|Disease Progression|45|||
146654934|NCT01107418|528914151|FG000|Overall Study|Adverse Event|3|||
146654935|NCT01107418|528914151|FG000|Overall Study|Withdrawal by Subject|1|||
146654936|NCT01107418|528914151|FG000|Overall Study|Study Closing|1|||
146654937|NCT01107418|528914151|FG000|Overall Study|Started Other Therapy|1|||
146654938|NCT01107418|528914151|FG000|Overall Study|Entered Extension Study|1|||
146654939|NCT01155219|528914155|FG000|Overall Study|Adverse Event|3|||
146654940|NCT01155219|528914156|FG001|Overall Study|Adverse Event|1|||
146654941|NCT01155219|528914155|FG000|Overall Study|non-medical reason|1|||
146654942|NCT01155219|528914156|FG001|Overall Study|non-medical reason|2|||
146654943|NCT01394718|528914160|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
146654944|NCT01394718|528914161|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
146654945|NCT03387150|528914162|FG000|Overall Study|Withdrawal by Subject|3|||
146654946|NCT03387150|528914163|FG001|Overall Study|Withdrawal by Subject|0|||
146654947|NCT03387150|528914164|FG002|Overall Study|Withdrawal by Subject|3|||
146654948|NCT03387150|528914165|FG003|Overall Study|Withdrawal by Subject|4|||
146654949|NCT03387150|528914166|FG004|Overall Study|Withdrawal by Subject|1|||
146654950|NCT03387150|528914167|FG005|Overall Study|Withdrawal by Subject|2|||
146654951|NCT03387150|528914168|FG006|Overall Study|Withdrawal by Subject|0|||
146654952|NCT03387150|528914162|FG000|Overall Study|Lost to Follow-up|3|||
146654953|NCT03387150|528914163|FG001|Overall Study|Lost to Follow-up|2|||
146654954|NCT03387150|528914164|FG002|Overall Study|Lost to Follow-up|2|||
146654955|NCT03387150|528914165|FG003|Overall Study|Lost to Follow-up|3|||
146654956|NCT03387150|528914166|FG004|Overall Study|Lost to Follow-up|3|||
146654957|NCT03387150|528914167|FG005|Overall Study|Lost to Follow-up|3|||
146654958|NCT03387150|528914168|FG006|Overall Study|Lost to Follow-up|0|||
146654959|NCT03387150|528914162|FG000|Overall Study|Participant unable to adhere to visit|0|||
146599414|NCT00576472|528703429|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
146599415|NCT00576472|528703430|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146599416|NCT00576472|528703416|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
146599417|NCT00576472|528703417|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
146599418|NCT00576472|528703418|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
146599419|NCT00576472|528703419|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
146599420|NCT00576472|528703420|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
146599421|NCT00576472|528703421|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
146599422|NCT00576472|528703422|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
146599423|NCT00576472|528703423|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
146599424|NCT00576472|528703424|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
146599425|NCT00576472|528703425|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
146654960|NCT03387150|528914163|FG001|Overall Study|Participant unable to adhere to visit|1|||
146771824|NCT02928224|529332637|FG003|Overall Study|Study participation terminated by sponsor|3|||
146599426|NCT00576472|528703426|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
146654961|NCT03387150|528914164|FG002|Overall Study|Participant unable to adhere to visit|0|||
146654962|NCT03387150|528914165|FG003|Overall Study|Participant unable to adhere to visit|0|||
146654963|NCT03387150|528914166|FG004|Overall Study|Participant unable to adhere to visit|2|||
146654964|NCT03387150|528914167|FG005|Overall Study|Participant unable to adhere to visit|2|||
146654965|NCT03387150|528914168|FG006|Overall Study|Participant unable to adhere to visit|0|||
146654966|NCT04006119|528914169|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
146654967|NCT04006119|528914169|FG000|End of Treatment Veledimex|Adverse Event|2|||
146654968|NCT04006119|528914169|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
146654969|NCT04006119|528914169|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
146771825|NCT02928224|529332634|FG000|Overall Study|Other|3|||
146771826|NCT02928224|529332635|FG001|Overall Study|Other|3|||
146771827|NCT02928224|529332636|FG002|Overall Study|Other|5|||
146771828|NCT02928224|529332637|FG003|Overall Study|Other|0|||
146771829|NCT02115139|529332638|FG000|Overall Study|Protocol Violation|1|||
146771830|NCT02115139|529332638|FG000|Overall Study|treatment discontinuation|6|||
146599427|NCT00576472|528703427|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
146599428|NCT00576472|528703428|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
146599429|NCT00576472|528703429|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
146599430|NCT00576472|528703430|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
146599431|NCT00576472|528703416|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
146599432|NCT00576472|528703417|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
146599433|NCT00576472|528703418|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
146599434|NCT00576472|528703419|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
146599435|NCT00576472|528703420|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
146599436|NCT00576472|528703421|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
146599437|NCT00576472|528703422|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
146599438|NCT00576472|528703423|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
146599439|NCT00576472|528703424|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
146599440|NCT00576472|528703425|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
146599441|NCT00576472|528703426|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
146599442|NCT00576472|528703427|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
146599443|NCT00576472|528703428|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
146599444|NCT00576472|528703429|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
146599445|NCT00576472|528703430|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
146599446|NCT00576472|528703416|FG000|MPH Home Maintenance Phase|Side effects|0|||
146599447|NCT00576472|528703417|FG001|MPH Home Maintenance Phase|Side effects|0|||
146599448|NCT00576472|528703418|FG002|MPH Home Maintenance Phase|Side effects|0|||
146599449|NCT00576472|528703419|FG003|MPH Home Maintenance Phase|Side effects|0|||
146599450|NCT00576472|528703420|FG004|MPH Home Maintenance Phase|Side effects|0|||
146599451|NCT00576472|528703421|FG005|MPH Home Maintenance Phase|Side effects|0|||
146599452|NCT00576472|528703422|FG006|MPH Home Maintenance Phase|Side effects|0|||
146599453|NCT00576472|528703423|FG007|MPH Home Maintenance Phase|Side effects|0|||
146599454|NCT00576472|528703424|FG008|MPH Home Maintenance Phase|Side effects|0|||
146599455|NCT00576472|528703425|FG009|MPH Home Maintenance Phase|Side effects|0|||
146599456|NCT00576472|528703426|FG010|MPH Home Maintenance Phase|Side effects|0|||
146599457|NCT00576472|528703427|FG011|MPH Home Maintenance Phase|Side effects|0|||
146599458|NCT00576472|528703428|FG012|MPH Home Maintenance Phase|Side effects|0|||
146599459|NCT00576472|528703429|FG013|MPH Home Maintenance Phase|Side effects|0|||
146599460|NCT00576472|528703430|FG014|MPH Home Maintenance Phase|Side effects|8|||
146599461|NCT00576472|528703416|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146599462|NCT00576472|528703417|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146599463|NCT00576472|528703418|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146599464|NCT00576472|528703419|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146599465|NCT00576472|528703420|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146599466|NCT00576472|528703421|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146599467|NCT00576472|528703422|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146599468|NCT00576472|528703423|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146599469|NCT00576472|528703424|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146599470|NCT00576472|528703425|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146599471|NCT00576472|528703426|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146599472|NCT00576472|528703427|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146599473|NCT00576472|528703428|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146599474|NCT00576472|528703429|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146599475|NCT00576472|528703430|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
146599476|NCT00576472|528703416|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
146599477|NCT00576472|528703417|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
146599478|NCT00576472|528703418|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
146599479|NCT00576472|528703419|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
146599480|NCT00576472|528703420|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
146599481|NCT00576472|528703421|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
146599482|NCT00576472|528703422|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
146599483|NCT00576472|528703423|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
146654970|NCT04006119|528914169|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
146654971|NCT04006119|528914169|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
146654972|NCT04617795|528914170|FG000|Main Study|Lost to Follow-up|1|||
146654973|NCT04617795|528914171|FG001|Main Study|Lost to Follow-up|0|||
146654974|NCT00472459|528914172|FG000|Overall Study|Adverse Event|13|||
146654975|NCT00472459|528914173|FG001|Overall Study|Adverse Event|13|||
146654976|NCT00472459|528914172|FG000|Overall Study|Withdrawal by Subject|5|||
146599484|NCT00576472|528703424|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
146599485|NCT00576472|528703425|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
146599486|NCT00576472|528703426|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
146654977|NCT00472459|528914173|FG001|Overall Study|Withdrawal by Subject|5|||
146654978|NCT00472459|528914172|FG000|Overall Study|Protocol Violation|3|||
146654979|NCT00472459|528914173|FG001|Overall Study|Protocol Violation|3|||
146654980|NCT00472459|528914172|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
146599487|NCT00576472|528703427|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
146599488|NCT00576472|528703428|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
146599489|NCT00576472|528703429|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
146599490|NCT00576472|528703430|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
146599491|NCT00576472|528703416|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146599492|NCT00576472|528703417|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146599493|NCT00576472|528703418|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146599494|NCT00576472|528703419|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146599495|NCT00576472|528703420|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146599496|NCT00576472|528703421|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146599497|NCT00576472|528703422|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146599498|NCT00576472|528703423|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146599499|NCT00576472|528703424|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146599500|NCT00576472|528703425|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146599501|NCT00576472|528703426|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146599502|NCT00576472|528703427|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146599503|NCT00576472|528703428|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146599504|NCT00576472|528703429|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146599505|NCT00576472|528703430|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
146599506|NCT02576860|528703433|FG000|Overall Study|Adverse Event|6|||
146599507|NCT02576860|528703434|FG001|Overall Study|Adverse Event|6|||
146599508|NCT02576860|528703433|FG000|Overall Study|Lost to Follow-up|5|||
146599509|NCT02576860|528703434|FG001|Overall Study|Lost to Follow-up|7|||
146599510|NCT02576860|528703433|FG000|Overall Study|Physician Decision|0|||
146599511|NCT02576860|528703434|FG001|Overall Study|Physician Decision|1|||
146599512|NCT02576860|528703433|FG000|Overall Study|Protocol Violation|0|||
146599513|NCT02576860|528703434|FG001|Overall Study|Protocol Violation|2|||
146599514|NCT02576860|528703433|FG000|Overall Study|Withdrawal by Subject|13|||
146599515|NCT02576860|528703434|FG001|Overall Study|Withdrawal by Subject|8|||
146599516|NCT02576860|528703433|FG000|Overall Study|Disallowed medication|1|||
146599517|NCT02576860|528703434|FG001|Overall Study|Disallowed medication|0|||
146599518|NCT00477269|528703435|FG000|Core Study|Adverse Event|6|||
146599519|NCT00477269|528703436|FG001|Core Study|Adverse Event|4|||
146599520|NCT00477269|528703437|FG002|Core Study|Adverse Event|0|||
146599521|NCT00477269|528703435|FG000|Core Study|Death|3|||
146654981|NCT00472459|528914173|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
146654982|NCT00472459|528914172|FG000|Overall Study|Lost to Follow-up|1|||
146654983|NCT00472459|528914173|FG001|Overall Study|Lost to Follow-up|1|||
146654984|NCT04850313|528914174|FG000|Overall Study|Withdrawal by Subject|0|||
146921665|NCT01592409|529874666|FG001|Overall Study|Withdrawal by Subject|1|||
146921666|NCT01219959|529874667|FG000|Overall Study|Adverse Event|6|||
146921667|NCT01219959|529874668|FG001|Overall Study|Adverse Event|14|||
146921668|NCT01219959|529874667|FG000|Overall Study|Physician Decision|0|||
146978548|NCT00272961|530084100|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
146978549|NCT00272961|530084096|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
146978550|NCT00272961|530084097|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
146921669|NCT01219959|529874668|FG001|Overall Study|Physician Decision|4|||
146921670|NCT01219959|529874667|FG000|Overall Study|Withdrawal by Subject|0|||
146921671|NCT01219959|529874668|FG001|Overall Study|Withdrawal by Subject|2|||
146921672|NCT01219959|529874667|FG000|Overall Study|Renal Transplantation|0|||
146921673|NCT01219959|529874668|FG001|Overall Study|Renal Transplantation|3|||
146921674|NCT01219959|529874667|FG000|Overall Study|Other|1|||
146921675|NCT01219959|529874668|FG001|Overall Study|Other|0|||
146921676|NCT01728584|529874669|FG000|Overall Study|Adverse Event|1|||
146921677|NCT01728584|529874670|FG001|Overall Study|Adverse Event|0|||
146921678|NCT01728584|529874671|FG002|Overall Study|Adverse Event|0|||
146921679|NCT01728584|529874672|FG003|Overall Study|Adverse Event|0|||
146921680|NCT01728584|529874669|FG000|Overall Study|Physician Decision|4|||
146921681|NCT01728584|529874670|FG001|Overall Study|Physician Decision|0|||
146921682|NCT01728584|529874671|FG002|Overall Study|Physician Decision|1|||
146921683|NCT01728584|529874672|FG003|Overall Study|Physician Decision|0|||
146599522|NCT00477269|528703436|FG001|Core Study|Death|3|||
146599523|NCT00477269|528703437|FG002|Core Study|Death|0|||
146599524|NCT00477269|528703435|FG000|Core Study|Withdrawn Consent|0|||
146599525|NCT00477269|528703436|FG001|Core Study|Withdrawn Consent|1|||
146599526|NCT00477269|528703437|FG002|Core Study|Withdrawn Consent|0|||
146599527|NCT00477269|528703435|FG000|Open Label Extension|Adverse Event|0|||
146599528|NCT00477269|528703436|FG001|Open Label Extension|Adverse Event|0|||
146599529|NCT00477269|528703437|FG002|Open Label Extension|Adverse Event|4|||
146599530|NCT00477269|528703435|FG000|Open Label Extension|Abnormal laboratory values|0|||
146599531|NCT00477269|528703436|FG001|Open Label Extension|Abnormal laboratory values|0|||
146599532|NCT00477269|528703437|FG002|Open Label Extension|Abnormal laboratory values|1|||
146921684|NCT01728584|529874669|FG000|Overall Study|Withdrawal by Subject|1|||
146921685|NCT01728584|529874670|FG001|Overall Study|Withdrawal by Subject|0|||
146654985|NCT04850313|528914175|FG001|Overall Study|Withdrawal by Subject|1|||
146921686|NCT01728584|529874671|FG002|Overall Study|Withdrawal by Subject|0|||
146599533|NCT00477269|528703435|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
146599534|NCT00477269|528703436|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
146599535|NCT00477269|528703437|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
146599536|NCT00477269|528703435|FG000|Open Label Extension|Adminiatrative problems|0|||
146599537|NCT00477269|528703436|FG001|Open Label Extension|Adminiatrative problems|0|||
146599538|NCT00477269|528703437|FG002|Open Label Extension|Adminiatrative problems|2|||
146599539|NCT00477269|528703435|FG000|Open Label Extension|Death|0|||
146599540|NCT00477269|528703436|FG001|Open Label Extension|Death|0|||
146599541|NCT00477269|528703437|FG002|Open Label Extension|Death|4|||
146599542|NCT02391961|528703438|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
146599543|NCT02391961|528703439|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
146599544|NCT02391961|528703438|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
146599545|NCT02391961|528703439|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
146599546|NCT02391961|528703438|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
146599547|NCT02391961|528703439|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
146599548|NCT01792518|528703448|FG000|Overall Study|Adverse Event|3|||
146599549|NCT01792518|528703449|FG001|Overall Study|Adverse Event|4|||
146599550|NCT01792518|528703448|FG000|Overall Study|Protocol Violation|0|||
146599551|NCT01792518|528703449|FG001|Overall Study|Protocol Violation|1|||
146599552|NCT01792518|528703448|FG000|Overall Study|Lost to Follow-up|3|||
146599553|NCT01792518|528703449|FG001|Overall Study|Lost to Follow-up|1|||
146599554|NCT01792518|528703448|FG000|Overall Study|Withdrawal by Subject|2|||
146599555|NCT01792518|528703449|FG001|Overall Study|Withdrawal by Subject|0|||
146599556|NCT01792518|528703448|FG000|Overall Study|Other Reason|0|||
146599557|NCT01792518|528703449|FG001|Overall Study|Other Reason|1|||
146599558|NCT03263780|528703450|FG000|Overall Study|Withdrawal by Subject|3|||
146599559|NCT03263780|528703450|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
146599560|NCT00249613|528703455|FG000|12 Month Follow-up|Death|1|||
146599561|NCT00249613|528703456|FG001|12 Month Follow-up|Death|1|||
146599562|NCT00249613|528703455|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
146599563|NCT00249613|528703456|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
146654986|NCT03269552|528914176|FG000|Overall Study|Adverse Event|2|||
146921687|NCT01728584|529874672|FG003|Overall Study|Withdrawal by Subject|0|||
146921688|NCT01728584|529874669|FG000|Overall Study|Screen failure|1|||
146921689|NCT01728584|529874670|FG001|Overall Study|Screen failure|0|||
146921690|NCT01728584|529874671|FG002|Overall Study|Screen failure|0|||
146921691|NCT01728584|529874672|FG003|Overall Study|Screen failure|0|||
146921692|NCT01728584|529874669|FG000|Overall Study|Other reason (not specified)|1|||
146921693|NCT01728584|529874670|FG001|Overall Study|Other reason (not specified)|0|||
146921694|NCT01728584|529874671|FG002|Overall Study|Other reason (not specified)|0|||
146921695|NCT01728584|529874672|FG003|Overall Study|Other reason (not specified)|1|||
146921696|NCT02345252|529874676|FG000|Double-Blind Phase|Adverse Event|2|||
146921697|NCT02345252|529874677|FG001|Double-Blind Phase|Adverse Event|3|||
146921698|NCT02345252|529874676|FG000|Double-Blind Phase|Death|1|||
146921699|NCT02345252|529874677|FG001|Double-Blind Phase|Death|2|||
146921700|NCT02345252|529874676|FG000|Double-Blind Phase|Lack of Efficacy|1|||
146921701|NCT02345252|529874677|FG001|Double-Blind Phase|Lack of Efficacy|0|||
146921702|NCT02345252|529874676|FG000|Double-Blind Phase|Investigator's Discretion|4|||
146921703|NCT02345252|529874677|FG001|Double-Blind Phase|Investigator's Discretion|6|||
146921704|NCT02345252|529874676|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
146921705|NCT02345252|529874677|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
146921706|NCT02345252|529874676|FG000|Double-Blind Phase|Protocol Violation|2|||
146921707|NCT02345252|529874677|FG001|Double-Blind Phase|Protocol Violation|1|||
146921708|NCT02345252|529874676|FG000|Double-Blind Phase|Withdrew Consent|21|||
146921709|NCT02345252|529874677|FG001|Double-Blind Phase|Withdrew Consent|23|||
146921710|NCT02345252|529874676|FG000|Double-Blind Phase|Lost to Follow-up|8|||
146921711|NCT02345252|529874677|FG001|Double-Blind Phase|Lost to Follow-up|10|||
146921712|NCT02345252|529874676|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
146921713|NCT02345252|529874677|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
146921714|NCT00471536|529874682|FG000|Overall Study|Withdrawal by Subject|1|||
146921715|NCT01980706|529874683|FG000|Overall Study|Withdrawal by Subject|9|||
146921716|NCT01980706|529874684|FG001|Overall Study|Withdrawal by Subject|6|||
146921717|NCT01980706|529874685|FG002|Overall Study|Withdrawal by Subject|2|||
146921718|NCT01980706|529874683|FG000|Overall Study|Adverse Event|1|||
146921719|NCT01980706|529874684|FG001|Overall Study|Adverse Event|2|||
146599564|NCT00249613|528703455|FG000|12 Month Follow-up|Lost to Follow-up|10|||
146599565|NCT00249613|528703456|FG001|12 Month Follow-up|Lost to Follow-up|8|||
146599566|NCT00806442|528703457|FG000|Overall Study|Lost to Follow-up|3|||
146599567|NCT00806442|528703458|FG001|Overall Study|Lost to Follow-up|2|||
146599568|NCT00806442|528703457|FG000|Overall Study|Withdrawal by Subject|1|||
146654987|NCT02186301|528914177|FG000|Overall Study|Progressive Disease|7|||
146654988|NCT02186301|528914178|FG001|Overall Study|Progressive Disease|22|||
146654989|NCT02186301|528914179|FG002|Overall Study|Progressive Disease|27|||
146921720|NCT01980706|529874685|FG002|Overall Study|Adverse Event|5|||
146921721|NCT01980706|529874683|FG000|Overall Study|Lost to Follow-up|3|||
146921722|NCT01980706|529874684|FG001|Overall Study|Lost to Follow-up|4|||
146599569|NCT00806442|528703458|FG001|Overall Study|Withdrawal by Subject|5|||
146599570|NCT00424190|528703473|FG000|Overall Study|Withdrew consent|3|||
146599571|NCT00424190|528703474|FG001|Overall Study|Withdrew consent|4|||
146599572|NCT00424190|528703473|FG000|Overall Study|Death|3|||
146599573|NCT00424190|528703474|FG001|Overall Study|Death|0|||
146599574|NCT00424190|528703473|FG000|Overall Study|Noncompliance|1|||
146599575|NCT00424190|528703474|FG001|Overall Study|Noncompliance|2|||
146599576|NCT00424190|528703473|FG000|Overall Study|Request of sponsor or investigator|0|||
146599577|NCT00424190|528703474|FG001|Overall Study|Request of sponsor or investigator|2|||
146599578|NCT00424190|528703473|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
146599579|NCT00424190|528703474|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
146599580|NCT00424190|528703473|FG000|Overall Study|Other|15|||
146599581|NCT00424190|528703474|FG001|Overall Study|Other|21|||
146599582|NCT00351273|528703475|FG000|Overall Study|Lost to Follow-up|1|||
146599583|NCT00351273|528703476|FG001|Overall Study|Lost to Follow-up|2|||
146599584|NCT00351273|528703477|FG002|Overall Study|Lost to Follow-up|5|||
146599585|NCT02241187|528703478|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
146599586|NCT00199888|528703481|FG000|Overall Study|Lost to Follow-up|1|||
146599587|NCT05219669|528703482|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
146599588|NCT05219669|528703483|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
146599589|NCT05219669|528703484|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
146599590|NCT05219669|528703485|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
146599591|NCT05219669|528703486|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
146599592|NCT05219669|528703487|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
146599593|NCT00330668|528703488|FG000|BID Dosing Period|Adverse Event|1|||
146599594|NCT00330668|528703488|FG000|BID Dosing Period|Lost to Follow-up|7|||
146771831|NCT00468910|529332639|FG000|Overall Study|Lost to Follow-up|2|||
146771832|NCT00468910|529332640|FG001|Overall Study|Lost to Follow-up|1|||
146771833|NCT00468910|529332639|FG000|Overall Study|Withdrawal by Subject|2|||
146771834|NCT00468910|529332640|FG001|Overall Study|Withdrawal by Subject|1|||
146771835|NCT00468910|529332639|FG000|Overall Study|Medical Contraindication|0|||
146771836|NCT00468910|529332640|FG001|Overall Study|Medical Contraindication|1|||
146771837|NCT01909778|529332641|FG000|Overall Study|failed screening|1|||
146771838|NCT00919763|529332642|FG000|Overall Study|Adverse Event|7|||
146771839|NCT00919763|529332643|FG001|Overall Study|Adverse Event|1|||
146771840|NCT00919763|529332642|FG000|Overall Study|Lost to Follow-up|1|||
146771841|NCT00919763|529332643|FG001|Overall Study|Lost to Follow-up|0|||
146771842|NCT00919763|529332642|FG000|Overall Study|Protocol Violation|1|||
146599595|NCT00330668|528703488|FG000|BID Dosing Period|Non-Compliance|5|||
146771843|NCT00919763|529332643|FG001|Overall Study|Protocol Violation|1|||
146771844|NCT00919763|529332642|FG000|Overall Study|Withdrawal by Subject|3|||
146771845|NCT00919763|529332643|FG001|Overall Study|Withdrawal by Subject|1|||
146771846|NCT00919763|529332642|FG000|Overall Study|Non-compliance|0|||
146771847|NCT00919763|529332643|FG001|Overall Study|Non-compliance|1|||
146771848|NCT00433199|529332649|FG000|Double-Blind Period|Adverse Event|0|||
146771849|NCT00433199|529332650|FG001|Double-Blind Period|Adverse Event|25|||
146771850|NCT00433199|529332649|FG000|Double-Blind Period|Lack of Efficacy|0|||
146771851|NCT00433199|529332650|FG001|Double-Blind Period|Lack of Efficacy|2|||
146771852|NCT00433199|529332649|FG000|Double-Blind Period|Lost to Follow-up|2|||
146771853|NCT00433199|529332650|FG001|Double-Blind Period|Lost to Follow-up|5|||
146771854|NCT00433199|529332649|FG000|Double-Blind Period|Withdrawal by Subject|8|||
146771855|NCT00433199|529332650|FG001|Double-Blind Period|Withdrawal by Subject|19|||
146771856|NCT00433199|529332649|FG000|Double-Blind Period|Protocol Violation|1|||
146771857|NCT00433199|529332650|FG001|Double-Blind Period|Protocol Violation|10|||
146771858|NCT00433199|529332649|FG000|Double-Blind Period|Administrative|1|||
146771859|NCT00433199|529332650|FG001|Double-Blind Period|Administrative|5|||
146771860|NCT00433199|529332649|FG000|Open-Label Period|Adverse Event|0|||
146771861|NCT00433199|529332650|FG001|Open-Label Period|Adverse Event|19|||
146771862|NCT00433199|529332649|FG000|Open-Label Period|Lack of Efficacy|0|||
146771863|NCT00433199|529332650|FG001|Open-Label Period|Lack of Efficacy|2|||
146771864|NCT00433199|529332649|FG000|Open-Label Period|Lost to Follow-up|0|||
146921723|NCT01980706|529874685|FG002|Overall Study|Lost to Follow-up|3|||
146921724|NCT01980706|529874683|FG000|Overall Study|miscellaneous|4|||
146921725|NCT01980706|529874684|FG001|Overall Study|miscellaneous|5|||
146921726|NCT01980706|529874685|FG002|Overall Study|miscellaneous|3|||
146599596|NCT00330668|528703488|FG000|BID Dosing Period|Withdrawal by Subject|19|||
146599597|NCT00330668|528703488|FG000|BID Dosing Period|Sponsor's decision|1|||
146599598|NCT00330668|528703488|FG000|BID Dosing Period|Other|3|||
146599599|NCT00330668|528703488|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
146599600|NCT00330668|528703488|FG000|QD Dosing Period|Other|1|||
146599601|NCT00330668|528703488|FG000|QD Dosing Period|Withdrawal by Subject|1|||
146599602|NCT00330668|528703488|FG000|QD Dosing Period|Lost to Follow-up|2|||
146771865|NCT00433199|529332650|FG001|Open-Label Period|Lost to Follow-up|3|||
146771866|NCT00433199|529332649|FG000|Open-Label Period|Withdrawal by Subject|0|||
146771867|NCT00433199|529332650|FG001|Open-Label Period|Withdrawal by Subject|7|||
146771868|NCT00433199|529332649|FG000|Open-Label Period|Protocol Violation|0|||
146771869|NCT00433199|529332650|FG001|Open-Label Period|Protocol Violation|2|||
146921727|NCT02546674|529874688|FG000|Overall Study|Adverse Event|19|||
146921728|NCT02546674|529874688|FG000|Overall Study|Death|1|||
146921729|NCT02546674|529874688|FG000|Overall Study|Lost to Follow-up|1|||
146921730|NCT02546674|529874688|FG000|Overall Study|Physician Decision|13|||
146921731|NCT02546674|529874688|FG000|Overall Study|Pregnancy|1|||
146921732|NCT02546674|529874688|FG000|Overall Study|Progressive Disease|2|||
146921733|NCT02546674|529874688|FG000|Overall Study|Protocol Deviation|2|||
146921734|NCT02546674|529874688|FG000|Overall Study|Subject/Guardian Decision|6|||
146921735|NCT02546674|529874688|FG000|Overall Study|Withdrawal of Informed Consent|3|||
146921736|NCT01864018|529874689|FG000|Overall Study|Ineligible|3|||
146921737|NCT01864018|529874690|FG001|Overall Study|Ineligible|1|||
146921738|NCT04891770|529874691|FG000|Overall Study|Withdrew consent|1|||
146921739|NCT04891770|529874692|FG001|Overall Study|Withdrew consent|3|||
146921740|NCT04891770|529874693|FG002|Overall Study|Withdrew consent|0|||
146921741|NCT04891770|529874691|FG000|Overall Study|Enrolled but never treated|0|||
146921742|NCT04891770|529874692|FG001|Overall Study|Enrolled but never treated|0|||
146921743|NCT04891770|529874693|FG002|Overall Study|Enrolled but never treated|1|||
146921744|NCT04891770|529874691|FG000|Overall Study|Investigator's discretion|0|||
146599603|NCT00558272|528703489|FG000|Overall Study|Adverse Event|10|||
146599604|NCT00558272|528703490|FG001|Overall Study|Adverse Event|0|||
146599605|NCT00558272|528703489|FG000|Overall Study|Death|1|||
146599606|NCT00558272|528703490|FG001|Overall Study|Death|0|||
146599607|NCT00558272|528703489|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
146921745|NCT04891770|529874692|FG001|Overall Study|Investigator's discretion|1|||
146921746|NCT04891770|529874693|FG002|Overall Study|Investigator's discretion|0|||
146921747|NCT05122650|529874694|FG000|Overall Study|Adverse Event|4|||
146921748|NCT05122650|529874695|FG001|Overall Study|Adverse Event|16|||
146921749|NCT05122650|529874696|FG002|Overall Study|Adverse Event|11|||
146921750|NCT05122650|529874697|FG003|Overall Study|Adverse Event|12|||
146921751|NCT05122650|529874694|FG000|Overall Study|Lack of Efficacy|0|||
146921752|NCT05122650|529874695|FG001|Overall Study|Lack of Efficacy|1|||
146921753|NCT05122650|529874696|FG002|Overall Study|Lack of Efficacy|1|||
146599608|NCT00558272|528703490|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
146599609|NCT00558272|528703489|FG000|Overall Study|AZ study team decision|0|||
146599610|NCT00558272|528703490|FG001|Overall Study|AZ study team decision|1|||
146599611|NCT00558272|528703489|FG000|Overall Study|Incorrectly enrolled|1|||
146599612|NCT00558272|528703490|FG001|Overall Study|Incorrectly enrolled|0|||
146599613|NCT00558272|528703489|FG000|Overall Study|Withdrawal by Subject|0|||
146599614|NCT00558272|528703490|FG001|Overall Study|Withdrawal by Subject|1|||
146599615|NCT02920957|528703491|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
146599616|NCT02920957|528703492|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
146599617|NCT02920957|528703491|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
146599618|NCT02920957|528703492|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
146599619|NCT02920957|528703491|FG000|First Intervention : 1 Month|Adverse Event|1|||
146599620|NCT02920957|528703492|FG001|First Intervention : 1 Month|Adverse Event|0|||
146599621|NCT02920957|528703491|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
146599622|NCT02920957|528703492|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
146599623|NCT03442296|528703494|FG000|3 Month Follow-up|Death|3|||
146654990|NCT02186301|528914177|FG000|Overall Study|Adverse Event|5|||
146654991|NCT02186301|528914178|FG001|Overall Study|Adverse Event|5|||
146654992|NCT02186301|528914179|FG002|Overall Study|Adverse Event|5|||
146654993|NCT02186301|528914177|FG000|Overall Study|Death|1|||
146654994|NCT02186301|528914178|FG001|Overall Study|Death|0|||
146654995|NCT02186301|528914179|FG002|Overall Study|Death|0|||
146654996|NCT02186301|528914177|FG000|Overall Study|Withdrawal by Subject|5|||
146654997|NCT02186301|528914178|FG001|Overall Study|Withdrawal by Subject|1|||
146921754|NCT05122650|529874697|FG003|Overall Study|Lack of Efficacy|2|||
146599624|NCT03442296|528703495|FG001|3 Month Follow-up|Death|1|||
146599625|NCT03442296|528703494|FG000|3 Month Follow-up|Lost to Follow-up|1|||
146599626|NCT03442296|528703495|FG001|3 Month Follow-up|Lost to Follow-up|1|||
146599627|NCT03442296|528703494|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
146599628|NCT03442296|528703495|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
146921755|NCT05122650|529874694|FG000|Overall Study|Lost to Follow-up|1|||
146921756|NCT05122650|529874695|FG001|Overall Study|Lost to Follow-up|1|||
146921757|NCT05122650|529874696|FG002|Overall Study|Lost to Follow-up|3|||
146921758|NCT05122650|529874697|FG003|Overall Study|Lost to Follow-up|0|||
146599629|NCT03442296|528703494|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
146599630|NCT03442296|528703495|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
146599631|NCT03442296|528703494|FG000|12 Month Follow-up|Incomplete measurement|1|||
146599632|NCT03442296|528703495|FG001|12 Month Follow-up|Incomplete measurement|1|||
146654998|NCT02186301|528914179|FG002|Overall Study|Withdrawal by Subject|3|||
146654999|NCT02186301|528914177|FG000|Overall Study|Physician Decision|1|||
146655000|NCT02186301|528914178|FG001|Overall Study|Physician Decision|0|||
146921759|NCT05122650|529874694|FG000|Overall Study|Non-compliance with study intervention|0|||
146599633|NCT03684694|528703496|FG000|Phase 1|Withdrawal by Subject|1|||
146599634|NCT03684694|528703497|FG001|Phase 1|Withdrawal by Subject|0|||
146599635|NCT03684694|528703498|FG002|Phase 1|Withdrawal by Subject|0|||
146655001|NCT02186301|528914179|FG002|Overall Study|Physician Decision|1|||
146655002|NCT02186301|528914177|FG000|Overall Study|Study Terminated by Sponsor|1|||
146921760|NCT05122650|529874695|FG001|Overall Study|Non-compliance with study intervention|0|||
146921761|NCT05122650|529874696|FG002|Overall Study|Non-compliance with study intervention|0|||
146921762|NCT05122650|529874697|FG003|Overall Study|Non-compliance with study intervention|2|||
146921763|NCT05122650|529874694|FG000|Overall Study|Protocol Violation|0|||
146921764|NCT05122650|529874695|FG001|Overall Study|Protocol Violation|1|||
146921765|NCT05122650|529874696|FG002|Overall Study|Protocol Violation|0|||
146921766|NCT05122650|529874697|FG003|Overall Study|Protocol Violation|1|||
146921767|NCT05122650|529874694|FG000|Overall Study|Randomized by mistake|0|||
146921768|NCT05122650|529874695|FG001|Overall Study|Randomized by mistake|0|||
146921769|NCT05122650|529874696|FG002|Overall Study|Randomized by mistake|3|||
146921770|NCT05122650|529874697|FG003|Overall Study|Randomized by mistake|2|||
146921771|NCT05122650|529874694|FG000|Overall Study|Sponsor request|0|||
146921772|NCT05122650|529874695|FG001|Overall Study|Sponsor request|1|||
146921773|NCT05122650|529874696|FG002|Overall Study|Sponsor request|1|||
146921774|NCT05122650|529874697|FG003|Overall Study|Sponsor request|2|||
146921775|NCT05122650|529874694|FG000|Overall Study|Withdrawal by Subject|3|||
146921776|NCT05122650|529874695|FG001|Overall Study|Withdrawal by Subject|7|||
146921777|NCT05122650|529874696|FG002|Overall Study|Withdrawal by Subject|4|||
146921778|NCT05122650|529874697|FG003|Overall Study|Withdrawal by Subject|8|||
146921779|NCT05122650|529874694|FG000|Overall Study|Other|5|||
146921780|NCT05122650|529874695|FG001|Overall Study|Other|0|||
146921781|NCT05122650|529874696|FG002|Overall Study|Other|0|||
146921782|NCT05122650|529874697|FG003|Overall Study|Other|0|||
146921783|NCT01401010|529874701|FG000|Overall Study|Could not interpret assay results|1|||
146921784|NCT01401010|529874702|FG001|Overall Study|Could not interpret assay results|0|||
146921785|NCT02203838|529874703|FG000|Overall Study|Lack of Efficacy|7|||
146921786|NCT02203838|529874704|FG001|Overall Study|Lack of Efficacy|0|||
146921787|NCT02203838|529874705|FG002|Overall Study|Lack of Efficacy|1|||
146921788|NCT02203838|529874706|FG003|Overall Study|Lack of Efficacy|1|||
146921789|NCT02203838|529874703|FG000|Overall Study|Adverse Event|46|||
146921790|NCT02203838|529874704|FG001|Overall Study|Adverse Event|6|||
146921791|NCT02203838|529874705|FG002|Overall Study|Adverse Event|3|||
146921792|NCT02203838|529874706|FG003|Overall Study|Adverse Event|2|||
146921793|NCT02203838|529874703|FG000|Overall Study|Lost to Follow-up|39|||
146921794|NCT02203838|529874704|FG001|Overall Study|Lost to Follow-up|3|||
146599636|NCT03684694|528703499|FG003|Phase 1|Withdrawal by Subject|0|||
146599637|NCT03684694|528703500|FG004|Phase 1|Withdrawal by Subject|0|||
146599638|NCT03684694|528703501|FG005|Phase 1|Withdrawal by Subject|0|||
146599639|NCT03684694|528703496|FG000|Phase 1|Investigator/Sponsor Decision|12|||
146599640|NCT03684694|528703497|FG001|Phase 1|Investigator/Sponsor Decision|2|||
146599641|NCT03684694|528703498|FG002|Phase 1|Investigator/Sponsor Decision|1|||
146599642|NCT03684694|528703499|FG003|Phase 1|Investigator/Sponsor Decision|0|||
146599643|NCT03684694|528703500|FG004|Phase 1|Investigator/Sponsor Decision|0|||
146599644|NCT03684694|528703501|FG005|Phase 1|Investigator/Sponsor Decision|0|||
146599645|NCT03684694|528703496|FG000|Phase 1|Death|24|||
146599646|NCT03684694|528703497|FG001|Phase 1|Death|0|||
146599647|NCT03684694|528703498|FG002|Phase 1|Death|3|||
146599648|NCT03684694|528703499|FG003|Phase 1|Death|0|||
146599649|NCT03684694|528703500|FG004|Phase 1|Death|0|||
146599650|NCT03684694|528703501|FG005|Phase 1|Death|0|||
146599651|NCT03684694|528703496|FG000|Phase 1|Lost to Follow-up|0|||
146599652|NCT03684694|528703497|FG001|Phase 1|Lost to Follow-up|0|||
146599653|NCT03684694|528703498|FG002|Phase 1|Lost to Follow-up|1|||
146599654|NCT03684694|528703499|FG003|Phase 1|Lost to Follow-up|0|||
146599655|NCT03684694|528703500|FG004|Phase 1|Lost to Follow-up|0|||
146599656|NCT03684694|528703501|FG005|Phase 1|Lost to Follow-up|0|||
146599657|NCT03684694|528703496|FG000|Phase 1|Miscellaneous|0|||
146599658|NCT03684694|528703497|FG001|Phase 1|Miscellaneous|1|||
146599659|NCT03684694|528703498|FG002|Phase 1|Miscellaneous|0|||
146599660|NCT03684694|528703499|FG003|Phase 1|Miscellaneous|0|||
146599661|NCT03684694|528703500|FG004|Phase 1|Miscellaneous|0|||
146599662|NCT03684694|528703501|FG005|Phase 1|Miscellaneous|0|||
146599663|NCT03684694|528703496|FG000|Phase 2|Withdrawal by Subject|0|||
146599664|NCT03684694|528703497|FG001|Phase 2|Withdrawal by Subject|0|||
146921795|NCT02203838|529874705|FG002|Overall Study|Lost to Follow-up|2|||
146921796|NCT02203838|529874706|FG003|Overall Study|Lost to Follow-up|1|||
146921797|NCT02203838|529874703|FG000|Overall Study|Protocol Violation|7|||
146599665|NCT03684694|528703498|FG002|Phase 2|Withdrawal by Subject|0|||
146921798|NCT02203838|529874704|FG001|Overall Study|Protocol Violation|3|||
146921799|NCT02203838|529874705|FG002|Overall Study|Protocol Violation|0|||
146921800|NCT02203838|529874706|FG003|Overall Study|Protocol Violation|0|||
146599666|NCT03684694|528703499|FG003|Phase 2|Withdrawal by Subject|0|||
146599667|NCT03684694|528703500|FG004|Phase 2|Withdrawal by Subject|0|||
146599668|NCT03684694|528703501|FG005|Phase 2|Withdrawal by Subject|1|||
146599669|NCT03684694|528703496|FG000|Phase 2|Investigator/Sponsor Decision|0|||
146599670|NCT03684694|528703497|FG001|Phase 2|Investigator/Sponsor Decision|0|||
146599671|NCT03684694|528703498|FG002|Phase 2|Investigator/Sponsor Decision|0|||
146599672|NCT03684694|528703499|FG003|Phase 2|Investigator/Sponsor Decision|17|||
146599673|NCT03684694|528703500|FG004|Phase 2|Investigator/Sponsor Decision|16|||
146599674|NCT03684694|528703501|FG005|Phase 2|Investigator/Sponsor Decision|6|||
146599675|NCT03684694|528703496|FG000|Phase 2|Death|0|||
146921801|NCT02203838|529874703|FG000|Overall Study|Withdrawal by Subject|83|||
146921802|NCT02203838|529874704|FG001|Overall Study|Withdrawal by Subject|10|||
146921803|NCT02203838|529874705|FG002|Overall Study|Withdrawal by Subject|8|||
146978551|NCT00272961|530084098|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
146978552|NCT00272961|530084099|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
146978553|NCT00272961|530084100|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
146978554|NCT00272961|530084096|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
146978555|NCT00272961|530084097|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
146978556|NCT00272961|530084098|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
146978557|NCT00272961|530084099|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
146978558|NCT00272961|530084100|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
146978559|NCT00272961|530084096|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
146978560|NCT00272961|530084097|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
146978561|NCT00272961|530084098|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
146978562|NCT00272961|530084099|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
146978563|NCT00272961|530084100|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
146978564|NCT01507831|530084102|FG000|Overall Study|Randomized but not treated|0|||
146978565|NCT01507831|530084103|FG001|Overall Study|Randomized but not treated|3|||
146978566|NCT01507831|530084102|FG000|Overall Study|Adverse Event|48|||
146978567|NCT01507831|530084103|FG001|Overall Study|Adverse Event|113|||
146978568|NCT01507831|530084102|FG000|Overall Study|Death|6|||
146978569|NCT01507831|530084103|FG001|Overall Study|Death|2|||
146978570|NCT01507831|530084102|FG000|Overall Study|Poor compliance to protocol|38|||
146978571|NCT01507831|530084103|FG001|Overall Study|Poor compliance to protocol|60|||
146921804|NCT02203838|529874706|FG003|Overall Study|Withdrawal by Subject|11|||
146921805|NCT02203838|529874703|FG000|Overall Study|Physician Decision|27|||
146921806|NCT02203838|529874704|FG001|Overall Study|Physician Decision|0|||
146921807|NCT02203838|529874705|FG002|Overall Study|Physician Decision|2|||
146921808|NCT02203838|529874706|FG003|Overall Study|Physician Decision|3|||
146921809|NCT02203838|529874703|FG000|Overall Study|Other|1|||
146921810|NCT02203838|529874704|FG001|Overall Study|Other|0|||
146921811|NCT02203838|529874705|FG002|Overall Study|Other|0|||
146921812|NCT02203838|529874706|FG003|Overall Study|Other|0|||
146921813|NCT05091060|529874707|FG000|Overall Study|Lost to Follow-up|1|||
146921814|NCT01798706|529874708|FG000|Overall Study|Adverse Event|15|||
146921815|NCT01798706|529874709|FG001|Overall Study|Adverse Event|10|||
146921816|NCT01798706|529874708|FG000|Overall Study|Lack of Efficacy|0|||
146921817|NCT01798706|529874709|FG001|Overall Study|Lack of Efficacy|2|||
146921818|NCT01798706|529874708|FG000|Overall Study|Poor compliance to protocol|1|||
146921819|NCT01798706|529874709|FG001|Overall Study|Poor compliance to protocol|0|||
146921820|NCT01798706|529874708|FG000|Overall Study|Other than specified above|5|||
146921821|NCT01798706|529874709|FG001|Overall Study|Other than specified above|9|||
146921822|NCT00496873|529874710|FG000|Overall Study|Ineligible|2|||
146921823|NCT00496873|529874710|FG000|Overall Study|Death|2|||
146921824|NCT00496873|529874710|FG000|Overall Study|Withdrawal by Subject|3|||
146921825|NCT03552549|529874713|FG000|Overall Study|Disease progression|25|||
146921826|NCT03552549|529874714|FG001|Overall Study|Disease progression|17|||
146921827|NCT03552549|529874713|FG000|Overall Study|Adverse event in first 12 months|12|||
146921828|NCT03552549|529874714|FG001|Overall Study|Adverse event in first 12 months|8|||
146921829|NCT03552549|529874713|FG000|Overall Study|Withdrawal by Subject|7|||
146921830|NCT03552549|529874714|FG001|Overall Study|Withdrawal by Subject|7|||
146921831|NCT03552549|529874713|FG000|Overall Study|Unknown (no reason provided)|4|||
146921832|NCT03552549|529874714|FG001|Overall Study|Unknown (no reason provided)|2|||
146921833|NCT03552549|529874713|FG000|Overall Study|Not in participant's best interest|2|||
146921834|NCT03552549|529874714|FG001|Overall Study|Not in participant's best interest|1|||
146921835|NCT03552549|529874713|FG000|Overall Study|Did not complete study treatment|2|||
146921836|NCT03552549|529874714|FG001|Overall Study|Did not complete study treatment|3|||
146921837|NCT03552549|529874713|FG000|Overall Study|Did not meet eligibility criteria|1|||
146921838|NCT03552549|529874714|FG001|Overall Study|Did not meet eligibility criteria|0|||
146978572|NCT01507831|530084102|FG000|Overall Study|Physician Decision|0|||
146978573|NCT01507831|530084103|FG001|Overall Study|Physician Decision|4|||
146978574|NCT01507831|530084102|FG000|Overall Study|Participant moved|5|||
146771870|NCT00433199|529332649|FG000|Open-Label Period|Administrative|0|||
146921839|NCT03552549|529874713|FG000|Overall Study|Administrative|0|||
146921840|NCT03552549|529874714|FG001|Overall Study|Administrative|14|||
146921841|NCT02739594|529874715|FG000|Overall Study|Undesired Event|3|||
146921842|NCT02739594|529874716|FG001|Overall Study|Undesired Event|4|||
146978575|NCT01507831|530084103|FG001|Overall Study|Participant moved|19|||
146978576|NCT01507831|530084102|FG000|Overall Study|Consent withdrawn by participant|34|||
146978577|NCT01507831|530084103|FG001|Overall Study|Consent withdrawn by participant|72|||
146978578|NCT01507831|530084102|FG000|Overall Study|Related to study drug administration|5|||
146921843|NCT02739594|529874715|FG000|Overall Study|Violation of Eligibility Criteria|1|||
146921844|NCT02739594|529874716|FG001|Overall Study|Violation of Eligibility Criteria|2|||
146921845|NCT02739594|529874715|FG000|Overall Study|Protocol Violation|5|||
146921846|NCT02739594|529874716|FG001|Overall Study|Protocol Violation|6|||
146921847|NCT02739594|529874715|FG000|Overall Study|Death|4|||
146921848|NCT02739594|529874716|FG001|Overall Study|Death|2|||
146921849|NCT02739594|529874715|FG000|Overall Study|Renal Insufficiency|4|||
146921850|NCT02739594|529874716|FG001|Overall Study|Renal Insufficiency|6|||
146921851|NCT02739594|529874715|FG000|Overall Study|Administrative Reasons|1|||
146921852|NCT02739594|529874716|FG001|Overall Study|Administrative Reasons|3|||
146599676|NCT03684694|528703497|FG001|Phase 2|Death|0|||
146599677|NCT03684694|528703498|FG002|Phase 2|Death|0|||
146599678|NCT03684694|528703499|FG003|Phase 2|Death|28|||
146599679|NCT03684694|528703500|FG004|Phase 2|Death|14|||
146599680|NCT03684694|528703501|FG005|Phase 2|Death|3|||
146599681|NCT03684694|528703496|FG000|Phase 2|Lost to Follow-up|0|||
146921853|NCT02739594|529874715|FG000|Overall Study|Withdrawal by Subject|1|||
146921854|NCT02739594|529874716|FG001|Overall Study|Withdrawal by Subject|1|||
146921855|NCT02739594|529874715|FG000|Overall Study|Lost to Follow-up|0|||
146921856|NCT02739594|529874716|FG001|Overall Study|Lost to Follow-up|1|||
146921857|NCT02739594|529874715|FG000|Overall Study|Elevated Serum Creatinine|0|||
146921858|NCT02739594|529874716|FG001|Overall Study|Elevated Serum Creatinine|1|||
146921859|NCT02739594|529874715|FG000|Overall Study|Other|6|||
146921860|NCT02739594|529874716|FG001|Overall Study|Other|2|||
146921861|NCT00952289|529874721|FG000|All Participants|Death|9|||
146921862|NCT00952289|529874722|FG001|All Participants|Death|9|||
146921863|NCT00952289|529874721|FG000|All Participants|Adverse Event|8|||
146921864|NCT00952289|529874722|FG001|All Participants|Adverse Event|8|||
146921865|NCT00952289|529874721|FG000|All Participants|Disease progression|3|||
146921866|NCT00952289|529874722|FG001|All Participants|Disease progression|12|||
146921867|NCT00952289|529874721|FG000|All Participants|Withdrawal by Subject|1|||
146921868|NCT00952289|529874722|FG001|All Participants|Withdrawal by Subject|10|||
146921869|NCT00952289|529874721|FG000|All Participants|Data lost during site relocation|0|||
146921870|NCT00952289|529874722|FG001|All Participants|Data lost during site relocation|1|||
146921871|NCT00952289|529874721|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
146921872|NCT00952289|529874722|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
146921873|NCT00952289|529874721|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
146921874|NCT00952289|529874722|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
146921875|NCT00952289|529874721|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
146921876|NCT00952289|529874722|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
146921877|NCT00952289|529874721|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
146921878|NCT00952289|529874722|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
146921879|NCT00952289|529874721|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
146921880|NCT00952289|529874722|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
146921881|NCT00777491|529874727|FG000|Overall Study|Protocol Violation|0|||
146921882|NCT00777491|529874728|FG001|Overall Study|Protocol Violation|2|||
146921883|NCT00777491|529874727|FG000|Overall Study|Did not receive any protocol treatment|2|||
146921884|NCT00777491|529874728|FG001|Overall Study|Did not receive any protocol treatment|0|||
146921885|NCT00364845|529874729|FG000|Overall Study|Adverse Event|1|||
146921886|NCT00364845|529874730|FG001|Overall Study|Adverse Event|0|||
146921887|NCT00364845|529874729|FG000|Overall Study|Withdrawal by Subject|2|||
146921888|NCT00364845|529874730|FG001|Overall Study|Withdrawal by Subject|1|||
146921889|NCT00364845|529874729|FG000|Overall Study|Physician Decision|8|||
146921890|NCT00364845|529874730|FG001|Overall Study|Physician Decision|8|||
146921891|NCT00364845|529874729|FG000|Overall Study|Lost to Follow-up|0|||
146921892|NCT00364845|529874730|FG001|Overall Study|Lost to Follow-up|1|||
146921893|NCT00364845|529874729|FG000|Overall Study|Death|0|||
146921894|NCT00364845|529874730|FG001|Overall Study|Death|1|||
146921895|NCT03255291|529874731|FG000|Overall Study|Determined to be ineligible|10|||
146921896|NCT03255291|529874732|FG001|Overall Study|Determined to be ineligible|12|||
146921897|NCT03255291|529874733|FG002|Overall Study|Determined to be ineligible|6|||
146921898|NCT03255291|529874734|FG003|Overall Study|Determined to be ineligible|6|||
146921899|NCT03255291|529874735|FG004|Overall Study|Determined to be ineligible|5|||
146599682|NCT03684694|528703497|FG001|Phase 2|Lost to Follow-up|0|||
146599683|NCT03684694|528703498|FG002|Phase 2|Lost to Follow-up|0|||
146921900|NCT03255291|529874736|FG005|Overall Study|Determined to be ineligible|10|||
146921901|NCT03255291|529874731|FG000|Overall Study|Baseline data collection issues|3|||
146921902|NCT03255291|529874732|FG001|Overall Study|Baseline data collection issues|0|||
146921903|NCT03255291|529874733|FG002|Overall Study|Baseline data collection issues|0|||
146921904|NCT03255291|529874734|FG003|Overall Study|Baseline data collection issues|0|||
146921905|NCT03255291|529874735|FG004|Overall Study|Baseline data collection issues|2|||
146921906|NCT03255291|529874736|FG005|Overall Study|Baseline data collection issues|0|||
146921907|NCT00634244|529874737|FG000|Overall Study|Never started treatment|0|||
146921908|NCT00634244|529874738|FG001|Overall Study|Never started treatment|1|||
146921909|NCT00634244|529874739|FG002|Overall Study|Never started treatment|0|||
146921910|NCT00634244|529874737|FG000|Overall Study|Death|1|||
146921911|NCT00634244|529874738|FG001|Overall Study|Death|6|||
146921912|NCT00634244|529874739|FG002|Overall Study|Death|0|||
146599684|NCT03684694|528703499|FG003|Phase 2|Lost to Follow-up|1|||
146599685|NCT03684694|528703500|FG004|Phase 2|Lost to Follow-up|0|||
146921913|NCT00634244|529874737|FG000|Overall Study|Adverse Event|0|||
146599686|NCT03684694|528703501|FG005|Phase 2|Lost to Follow-up|0|||
146599687|NCT03684694|528703496|FG000|Phase 2|Miscellaneous|0|||
146599688|NCT03684694|528703497|FG001|Phase 2|Miscellaneous|0|||
146599689|NCT03684694|528703498|FG002|Phase 2|Miscellaneous|0|||
146599690|NCT03684694|528703499|FG003|Phase 2|Miscellaneous|3|||
146599691|NCT03684694|528703500|FG004|Phase 2|Miscellaneous|0|||
146599692|NCT03684694|528703501|FG005|Phase 2|Miscellaneous|0|||
146599693|NCT05011513|528705060|FG000|Overall Study|Death|0|||
146771871|NCT00433199|529332650|FG001|Open-Label Period|Administrative|1|||
146921914|NCT00634244|529874738|FG001|Overall Study|Adverse Event|2|||
146921915|NCT00634244|529874739|FG002|Overall Study|Adverse Event|0|||
146921916|NCT00634244|529874737|FG000|Overall Study|Withdrawal by Subject|0|||
146921917|NCT00634244|529874738|FG001|Overall Study|Withdrawal by Subject|1|||
146921918|NCT00634244|529874739|FG002|Overall Study|Withdrawal by Subject|0|||
146921919|NCT00634244|529874737|FG000|Overall Study|Physician Decision|0|||
146921920|NCT00634244|529874738|FG001|Overall Study|Physician Decision|1|||
146921921|NCT00634244|529874739|FG002|Overall Study|Physician Decision|0|||
146921922|NCT00634244|529874737|FG000|Overall Study|Disease progression/relapse|0|||
146921923|NCT00634244|529874738|FG001|Overall Study|Disease progression/relapse|1|||
146921924|NCT00634244|529874739|FG002|Overall Study|Disease progression/relapse|0|||
146921925|NCT00634244|529874737|FG000|Overall Study|Other complicating disease|0|||
146921926|NCT00634244|529874738|FG001|Overall Study|Other complicating disease|1|||
146921927|NCT00634244|529874739|FG002|Overall Study|Other complicating disease|0|||
146921928|NCT04369430|529874747|FG000|Overall Study|Adverse Event|2|||
146921929|NCT04369430|529874748|FG001|Overall Study|Adverse Event|3|||
146921930|NCT04369430|529874747|FG000|Overall Study|Death|1|||
146921931|NCT04369430|529874748|FG001|Overall Study|Death|0|||
146921932|NCT04369430|529874747|FG000|Overall Study|Withdrawal by Subject|4|||
146921933|NCT04369430|529874748|FG001|Overall Study|Withdrawal by Subject|3|||
146921934|NCT04369430|529874747|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
146921935|NCT04369430|529874748|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
146921936|NCT04369430|529874747|FG000|Overall Study|Lost to Follow-up|0|||
146921937|NCT04369430|529874748|FG001|Overall Study|Lost to Follow-up|1|||
146921938|NCT00444626|529874751|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
146921939|NCT00444626|529874751|FG000|Initial Treatment Period|Adverse Event|1|||
146921940|NCT00444626|529874751|FG000|Initial Treatment Period|Lost to Follow-up|9|||
146921941|NCT00142519|529874752|FG000|Overall Study|Not Treated|7|||
146921942|NCT00142519|529874753|FG001|Overall Study|Not Treated|9|||
146921943|NCT00142519|529874752|FG000|Overall Study|Protocol Violation|1|||
146921944|NCT00142519|529874753|FG001|Overall Study|Protocol Violation|0|||
146921945|NCT00142519|529874752|FG000|Overall Study|Withdrawal by Subject|10|||
146921946|NCT00142519|529874753|FG001|Overall Study|Withdrawal by Subject|7|||
146921947|NCT04594239|529874756|FG000|Overall Study|Withdrawal by Subject|3|||
146921948|NCT04594239|529874757|FG001|Overall Study|Withdrawal by Subject|4|||
146921949|NCT04594239|529874758|FG002|Overall Study|Withdrawal by Subject|2|||
146921950|NCT04594239|529874759|FG003|Overall Study|Withdrawal by Subject|4|||
146921951|NCT04594239|529874756|FG000|Overall Study|Lost to Follow-up|8|||
146921952|NCT04594239|529874757|FG001|Overall Study|Lost to Follow-up|5|||
146921953|NCT04594239|529874758|FG002|Overall Study|Lost to Follow-up|4|||
146921954|NCT04594239|529874759|FG003|Overall Study|Lost to Follow-up|6|||
146921955|NCT04594239|529874756|FG000|Overall Study|Subject relocated|0|||
146921956|NCT04594239|529874757|FG001|Overall Study|Subject relocated|0|||
146921957|NCT04594239|529874758|FG002|Overall Study|Subject relocated|0|||
146921958|NCT04594239|529874759|FG003|Overall Study|Subject relocated|1|||
146921959|NCT00406640|529874766|FG000|Acute Phase|Adverse Event|18|||
146921960|NCT00406640|529874767|FG001|Acute Phase|Adverse Event|13|||
146921961|NCT00406640|529874766|FG000|Acute Phase|Failed to Return|5|||
146921962|NCT00406640|529874767|FG001|Acute Phase|Failed to Return|1|||
146921963|NCT00406640|529874766|FG000|Acute Phase|Physician Decision|0|||
146921964|NCT00406640|529874767|FG001|Acute Phase|Physician Decision|1|||
146921965|NCT00406640|529874766|FG000|Acute Phase|Lost to Follow-up|7|||
146921966|NCT00406640|529874767|FG001|Acute Phase|Lost to Follow-up|4|||
146921967|NCT00406640|529874766|FG000|Acute Phase|Protocol deviation|4|||
146921968|NCT00406640|529874767|FG001|Acute Phase|Protocol deviation|10|||
146921969|NCT00406640|529874766|FG000|Acute Phase|Protocol Violation|3|||
146921970|NCT00406640|529874767|FG001|Acute Phase|Protocol Violation|2|||
146921971|NCT00406640|529874766|FG000|Acute Phase|Withdrawal by Subject|11|||
146921972|NCT00406640|529874767|FG001|Acute Phase|Withdrawal by Subject|9|||
146921973|NCT00406640|529874766|FG000|Acute Phase|Lack of Efficacy|3|||
146921974|NCT00406640|529874767|FG001|Acute Phase|Lack of Efficacy|3|||
146921975|NCT00406640|529874766|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
146921976|NCT00406640|529874767|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
146921977|NCT00406640|529874766|FG000|DB Continuation Phase for Responders|Death|1|||
146921978|NCT00406640|529874767|FG001|DB Continuation Phase for Responders|Death|0|||
146978579|NCT01507831|530084103|FG001|Overall Study|Related to study drug administration|14|||
146599694|NCT05011513|528705061|FG001|Overall Study|Death|1|||
146599695|NCT05011513|528705060|FG000|Overall Study|Lost to Follow-up|4|||
146599696|NCT05011513|528705061|FG001|Overall Study|Lost to Follow-up|0|||
146771872|NCT00357097|529332651|FG000|Overall Study|Did not meet inclusion criteria|5|||
146771873|NCT00357097|529332652|FG001|Overall Study|Did not meet inclusion criteria|3|||
146599697|NCT05011513|528705060|FG000|Overall Study|Withdrawal by Subject|18|||
146599698|NCT05011513|528705061|FG001|Overall Study|Withdrawal by Subject|17|||
146599699|NCT05011513|528705060|FG000|Overall Study|Other|4|||
146599700|NCT05011513|528705061|FG001|Overall Study|Other|2|||
146599701|NCT03667690|528705062|FG000|Overall Study|Adverse Event|0|||
146599702|NCT03667690|528705063|FG001|Overall Study|Adverse Event|3|||
146599703|NCT03667690|528705062|FG000|Overall Study|Death|22|||
146599704|NCT03667690|528705063|FG001|Overall Study|Death|21|||
146599705|NCT03667690|528705062|FG000|Overall Study|Lost to Follow-up|4|||
146599706|NCT03667690|528705063|FG001|Overall Study|Lost to Follow-up|5|||
146599707|NCT03667690|528705062|FG000|Overall Study|Withdrawal by Subject|7|||
146599708|NCT03667690|528705063|FG001|Overall Study|Withdrawal by Subject|8|||
146599709|NCT03667690|528705062|FG000|Overall Study|Subject could not return for additional investigational product|1|||
146599710|NCT03667690|528705063|FG001|Overall Study|Subject could not return for additional investigational product|0|||
146599711|NCT03667690|528705062|FG000|Overall Study|Subject discharged to hospice care|2|||
146599712|NCT03667690|528705063|FG001|Overall Study|Subject discharged to hospice care|0|||
146599713|NCT03667690|528705062|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
146599714|NCT03667690|528705063|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
146599715|NCT03667690|528705062|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
146771874|NCT00357097|529332651|FG000|Overall Study|Adverse Event|34|||
146771875|NCT00357097|529332652|FG001|Overall Study|Adverse Event|6|||
146921979|NCT00406640|529874766|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
146921980|NCT00406640|529874767|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
146921981|NCT00406640|529874766|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
146921982|NCT00406640|529874767|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
146921983|NCT00406640|529874766|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
146921984|NCT00406640|529874767|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
146921985|NCT00406640|529874766|FG000|DB Continuation Phase for Responders|non-compliance|7|||
146921986|NCT00406640|529874767|FG001|DB Continuation Phase for Responders|non-compliance|5|||
146921987|NCT00406640|529874766|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
146921988|NCT00406640|529874767|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
146921989|NCT00406640|529874766|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
146921990|NCT00406640|529874767|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
146921991|NCT00406640|529874766|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
146921992|NCT00406640|529874767|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
146921993|NCT00406640|529874766|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
146921994|NCT00406640|529874767|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
146921995|NCT00406640|529874766|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
146921996|NCT00406640|529874767|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
146921997|NCT00406640|529874766|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
146921998|NCT00406640|529874767|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
146921999|NCT00406640|529874766|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
146599716|NCT03667690|528705063|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
146599717|NCT03667690|528705062|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
146599718|NCT03667690|528705063|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
146922000|NCT00406640|529874767|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
146922001|NCT00406640|529874766|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
146922002|NCT00406640|529874767|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
146922003|NCT00406640|529874766|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
146922004|NCT00406640|529874767|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
146922005|NCT00406640|529874766|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
146922006|NCT00406640|529874767|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
146922007|NCT03229759|529874773|FG000|Overall Study|Screen Failure|30|||
146922008|NCT02294318|529876692|FG000|Overall Study|Worsening of drinking|3|||
146922009|NCT02294318|529876693|FG001|Overall Study|Worsening of drinking|0|||
146922010|NCT02294318|529876692|FG000|Overall Study|Not exposed to intervention|0|||
146922011|NCT02294318|529876693|FG001|Overall Study|Not exposed to intervention|2|||
146922012|NCT00762372|529876696|FG000|Overall Study|Adverse Event|1|||
146922013|NCT00762372|529876697|FG001|Overall Study|Adverse Event|0|||
146922014|NCT00762372|529876698|FG002|Overall Study|Adverse Event|0|||
146922015|NCT02670915|529876699|FG000|Overall Study|Withdrawal by Subject|0|||
146922016|NCT02670915|529876700|FG001|Overall Study|Withdrawal by Subject|1|||
146922017|NCT02670915|529876701|FG002|Overall Study|Withdrawal by Subject|4|||
146922018|NCT02670915|529876699|FG000|Overall Study|Withdrawal by parent/guardian|4|||
146771876|NCT00357097|529332651|FG000|Overall Study|Withdrawal by Subject|8|||
146922019|NCT02670915|529876700|FG001|Overall Study|Withdrawal by parent/guardian|4|||
146599719|NCT03667690|528705062|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
146599720|NCT03667690|528705063|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
146599721|NCT03667690|528705062|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
146599722|NCT03667690|528705063|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
146599723|NCT04327024|528705065|FG000|Overall Study|Death|1|||
146599724|NCT04327024|528705066|FG001|Overall Study|Death|2|||
146599725|NCT04327024|528705067|FG002|Overall Study|Death|1|||
146599726|NCT04327024|528705065|FG000|Overall Study|Non-compliance with study drug|0|||
146599727|NCT04327024|528705066|FG001|Overall Study|Non-compliance with study drug|1|||
146655003|NCT02186301|528914178|FG001|Overall Study|Study Terminated by Sponsor|0|||
146655004|NCT02186301|528914179|FG002|Overall Study|Study Terminated by Sponsor|11|||
146655005|NCT02186301|528914177|FG000|Overall Study|Protocol Deviation|0|||
146655006|NCT02186301|528914178|FG001|Overall Study|Protocol Deviation|2|||
146922020|NCT02670915|529876701|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146922021|NCT02670915|529876699|FG000|Overall Study|Unclassified|0|||
146922022|NCT02670915|529876700|FG001|Overall Study|Unclassified|3|||
146922023|NCT02670915|529876701|FG002|Overall Study|Unclassified|0|||
146922024|NCT00495495|529876702|FG000|Overall Study|Protocol Violation|99|||
146922025|NCT02702518|529876703|FG000|Overall Study|Lost to Follow-up|3|||
146922026|NCT02702518|529876704|FG001|Overall Study|Lost to Follow-up|4|||
146922027|NCT01670656|529876705|FG000|Overall Study|Non-compliance with study drug|0|||
146922028|NCT01670656|529876706|FG001|Overall Study|Non-compliance with study drug|0|||
146922029|NCT01670656|529876707|FG002|Overall Study|Non-compliance with study drug|3|||
146922030|NCT01670656|529876708|FG003|Overall Study|Non-compliance with study drug|0|||
146922031|NCT01670656|529876709|FG004|Overall Study|Non-compliance with study drug|1|||
146922032|NCT01670656|529876705|FG000|Overall Study|Pregnancy|0|||
146922033|NCT01670656|529876706|FG001|Overall Study|Pregnancy|0|||
146922034|NCT01670656|529876707|FG002|Overall Study|Pregnancy|0|||
146922035|NCT01670656|529876708|FG003|Overall Study|Pregnancy|0|||
146922036|NCT01670656|529876709|FG004|Overall Study|Pregnancy|1|||
146922037|NCT01670656|529876705|FG000|Overall Study|Withdrawal by Subject|1|||
146922038|NCT01670656|529876706|FG001|Overall Study|Withdrawal by Subject|1|||
146922039|NCT01670656|529876707|FG002|Overall Study|Withdrawal by Subject|0|||
146922040|NCT01670656|529876708|FG003|Overall Study|Withdrawal by Subject|0|||
146922041|NCT01670656|529876709|FG004|Overall Study|Withdrawal by Subject|0|||
146922042|NCT01670656|529876705|FG000|Overall Study|Non-compliance with protocol|0|||
146922043|NCT01670656|529876706|FG001|Overall Study|Non-compliance with protocol|3|||
146922044|NCT01670656|529876707|FG002|Overall Study|Non-compliance with protocol|1|||
146922045|NCT01670656|529876708|FG003|Overall Study|Non-compliance with protocol|1|||
146922046|NCT01670656|529876709|FG004|Overall Study|Non-compliance with protocol|2|||
146922047|NCT01670656|529876705|FG000|Overall Study|Adverse Event|2|||
146599728|NCT04327024|528705067|FG002|Overall Study|Non-compliance with study drug|0|||
146655007|NCT02186301|528914179|FG002|Overall Study|Protocol Deviation|0|||
146655008|NCT02186301|528914177|FG000|Overall Study|Missing|0|||
146655009|NCT02186301|528914178|FG001|Overall Study|Missing|0|||
146655010|NCT02186301|528914179|FG002|Overall Study|Missing|2|||
146655011|NCT02186301|528914177|FG000|Overall Study|Other|0|||
146655012|NCT02186301|528914178|FG001|Overall Study|Other|0|||
146655013|NCT02186301|528914179|FG002|Overall Study|Other|1|||
146655014|NCT03560739|528914181|FG000|Overall Study|Adverse Event|0|||
146655015|NCT03560739|528914182|FG001|Overall Study|Adverse Event|1|||
146655016|NCT03560739|528914183|FG002|Overall Study|Adverse Event|0|||
146655017|NCT03560739|528914184|FG003|Overall Study|Adverse Event|0|||
146655018|NCT01362595|528914185|FG000|Overall Study|Screen failure|10|||
146655019|NCT01362595|528914185|FG000|Overall Study|Withdrawal by Subject|2|||
146655020|NCT00959374|528914186|FG000|Overall Study|Withdrawal by Subject|2|||
146655021|NCT00959374|528914186|FG000|Overall Study|Lost to Follow-up|14|||
146655022|NCT00959374|528914186|FG000|Overall Study|Death|1|||
146655023|NCT00959374|528914186|FG000|Overall Study|Protocol Violation|1|||
146655024|NCT00959374|528914186|FG000|Overall Study|Implant Removed/Not Replaced|4|||
146655025|NCT00959374|528914186|FG000|Overall Study|Physician Decision|1|||
146978580|NCT01507831|530084102|FG000|Overall Study|Last visit outside protocol visit window|51|||
146978581|NCT01507831|530084103|FG001|Overall Study|Last visit outside protocol visit window|143|||
146655026|NCT01741012|528914190|FG000|Overall Study|Lost to Follow-up|1|||
146655027|NCT01741012|528914190|FG000|Overall Study|Withdrawal by Subject|2|||
146655028|NCT00095238|528914191|FG000|Overall Study|Lack of Efficacy|9|||
146655029|NCT00095238|528914192|FG001|Overall Study|Lack of Efficacy|9|||
146655030|NCT00095238|528914191|FG000|Overall Study|Adverse Event|331|||
146655031|NCT00095238|528914192|FG001|Overall Study|Adverse Event|287|||
146655032|NCT00095238|528914191|FG000|Overall Study|Subject Withdrew Consent|208|||
146655033|NCT00095238|528914192|FG001|Overall Study|Subject Withdrew Consent|223|||
146922048|NCT01670656|529876706|FG001|Overall Study|Adverse Event|2|||
146922049|NCT01670656|529876707|FG002|Overall Study|Adverse Event|2|||
146922050|NCT01670656|529876708|FG003|Overall Study|Adverse Event|3|||
146922051|NCT01670656|529876709|FG004|Overall Study|Adverse Event|3|||
146922052|NCT01670656|529876705|FG000|Overall Study|Subject withdrew consent|0|||
146599729|NCT04327024|528705065|FG000|Overall Study|Withdrawal by Subject|1|||
146599730|NCT04327024|528705066|FG001|Overall Study|Withdrawal by Subject|1|||
146599731|NCT04327024|528705067|FG002|Overall Study|Withdrawal by Subject|2|||
146599732|NCT00837759|528705069|FG000|Overall Study|Protocol Violation|3|||
146599733|NCT00837759|528705069|FG000|Overall Study|Lost to Follow-up|1|||
146599734|NCT01073930|528705071|FG000|Overall Study|Withdrawal by Subject|3|||
146599735|NCT01073930|528705072|FG001|Overall Study|Withdrawal by Subject|2|||
146599736|NCT01073930|528705071|FG000|Overall Study|Lost to Follow-up|0|||
146599737|NCT01073930|528705072|FG001|Overall Study|Lost to Follow-up|1|||
146599738|NCT01073930|528705071|FG000|Overall Study|Adverse Event|0|||
146599739|NCT01073930|528705072|FG001|Overall Study|Adverse Event|1|||
146599740|NCT01073930|528705071|FG000|Overall Study|Noncompliance with study drug|0|||
146599741|NCT01073930|528705072|FG001|Overall Study|Noncompliance with study drug|1|||
146599742|NCT01073930|528705071|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
146599743|NCT01073930|528705072|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
146599744|NCT01022424|528705073|FG000|Overall Study|Adverse Event|1|||
146599745|NCT01022424|528705073|FG000|Overall Study|Physician Decision|1|||
146599746|NCT01022424|528705073|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
146599747|NCT00720343|528705074|FG000|Overall Study|Lost to Follow-up|1|||
146599748|NCT00720343|528705075|FG001|Overall Study|Lost to Follow-up|0|||
146599749|NCT00720343|528705074|FG000|Overall Study|Protocol Violation|0|||
146599750|NCT00720343|528705075|FG001|Overall Study|Protocol Violation|2|||
146599751|NCT03459365|528705076|FG000|Overall Study|Withdrawal by Subject|6|||
146599752|NCT03459365|528705076|FG000|Overall Study|Protocol Violation|8|||
146599753|NCT04037254|528705077|FG000|Overall Study|Protocol Violation|1|||
146599754|NCT04037254|528705078|FG001|Overall Study|Protocol Violation|0|||
146599755|NCT04037254|528705079|FG002|Overall Study|Protocol Violation|0|||
146599756|NCT04037254|528705080|FG003|Overall Study|Protocol Violation|0|||
146599757|NCT04037254|528705081|FG004|Overall Study|Protocol Violation|0|||
146599758|NCT04037254|528705077|FG000|Overall Study|Withdrawal by Subject|0|||
146599759|NCT04037254|528705078|FG001|Overall Study|Withdrawal by Subject|0|||
146599760|NCT04037254|528705079|FG002|Overall Study|Withdrawal by Subject|1|||
146599761|NCT04037254|528705080|FG003|Overall Study|Withdrawal by Subject|0|||
146599762|NCT04037254|528705081|FG004|Overall Study|Withdrawal by Subject|0|||
146599763|NCT04037254|528705077|FG000|Overall Study|Delayed or incomplete treatment|0|||
146599764|NCT04037254|528705078|FG001|Overall Study|Delayed or incomplete treatment|2|||
146599765|NCT04037254|528705079|FG002|Overall Study|Delayed or incomplete treatment|1|||
146599766|NCT04037254|528705080|FG003|Overall Study|Delayed or incomplete treatment|0|||
146599767|NCT04037254|528705081|FG004|Overall Study|Delayed or incomplete treatment|0|||
146599768|NCT03320330|528705082|FG000|Overall Study|Lack of Efficacy|5|||
146655034|NCT00095238|528914191|FG000|Overall Study|Death|154|||
146655035|NCT00095238|528914192|FG001|Overall Study|Death|170|||
146655036|NCT00095238|528914191|FG000|Overall Study|Lost to Follow-up|19|||
146655037|NCT00095238|528914192|FG001|Overall Study|Lost to Follow-up|24|||
146655038|NCT00095238|528914191|FG000|Overall Study|Noncompliance|44|||
146655039|NCT00095238|528914192|FG001|Overall Study|Noncompliance|45|||
146922053|NCT01670656|529876706|FG001|Overall Study|Subject withdrew consent|1|||
146922054|NCT01670656|529876707|FG002|Overall Study|Subject withdrew consent|2|||
146922055|NCT01670656|529876708|FG003|Overall Study|Subject withdrew consent|1|||
146922056|NCT01670656|529876709|FG004|Overall Study|Subject withdrew consent|1|||
146922057|NCT01670656|529876705|FG000|Overall Study|Lost to Follow-up|0|||
146922058|NCT01670656|529876706|FG001|Overall Study|Lost to Follow-up|0|||
146922059|NCT01670656|529876707|FG002|Overall Study|Lost to Follow-up|0|||
146922060|NCT01670656|529876708|FG003|Overall Study|Lost to Follow-up|0|||
146922061|NCT01670656|529876709|FG004|Overall Study|Lost to Follow-up|3|||
146922062|NCT01670656|529876705|FG000|Overall Study|Subject moved|0|||
146922063|NCT01670656|529876706|FG001|Overall Study|Subject moved|0|||
146922064|NCT01670656|529876707|FG002|Overall Study|Subject moved|0|||
146922065|NCT01670656|529876708|FG003|Overall Study|Subject moved|1|||
146922066|NCT01670656|529876709|FG004|Overall Study|Subject moved|0|||
146922067|NCT03331666|529876710|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
146922068|NCT03331666|529876711|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
146922069|NCT03544268|529876712|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
146922070|NCT03544268|529876713|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
146922071|NCT04281030|529876721|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
146599769|NCT03320330|528705083|FG001|Overall Study|Lack of Efficacy|5|||
146599770|NCT03320330|528705084|FG002|Overall Study|Lack of Efficacy|14|||
146655040|NCT00095238|528914191|FG000|Overall Study|No longer met study criteria|4|||
146655041|NCT00095238|528914192|FG001|Overall Study|No longer met study criteria|5|||
146922072|NCT04281030|529876722|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
146922073|NCT04281030|529876721|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
146599771|NCT03320330|528705082|FG000|Overall Study|Physician Decision|1|||
146599772|NCT03320330|528705083|FG001|Overall Study|Physician Decision|0|||
146599773|NCT03320330|528705084|FG002|Overall Study|Physician Decision|0|||
146655042|NCT00095238|528914191|FG000|Overall Study|Study terminated by sponsor|0|||
146922074|NCT04281030|529876722|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
146922075|NCT01395368|529876723|FG000|Overall Study|Physician Decision|14|||
146922076|NCT01395368|529876723|FG000|Overall Study|Withdrawal by Subject|2|||
146922077|NCT05142332|529876728|FG000|Overall Study|Withdrawal by Subject|0|||
146922078|NCT05142332|529876729|FG001|Overall Study|Withdrawal by Subject|1|||
146922079|NCT05142332|529876730|FG002|Overall Study|Withdrawal by Subject|2|||
146922080|NCT05142332|529876731|FG003|Overall Study|Withdrawal by Subject|0|||
146922081|NCT05142332|529876732|FG004|Overall Study|Withdrawal by Subject|0|||
146922082|NCT05142332|529876733|FG005|Overall Study|Withdrawal by Subject|2|||
146922083|NCT05142332|529876734|FG006|Overall Study|Withdrawal by Subject|6|||
146922084|NCT05142332|529876728|FG000|Overall Study|Left ED|3|||
146922085|NCT05142332|529876729|FG001|Overall Study|Left ED|0|||
146922086|NCT05142332|529876730|FG002|Overall Study|Left ED|4|||
146922087|NCT05142332|529876731|FG003|Overall Study|Left ED|6|||
146922088|NCT05142332|529876732|FG004|Overall Study|Left ED|1|||
146922089|NCT05142332|529876733|FG005|Overall Study|Left ED|2|||
146599774|NCT02198794|528705085|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
146599775|NCT02198794|528705086|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
146599776|NCT02198794|528705087|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
146599777|NCT02198794|528705088|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
146599778|NCT02198794|528705085|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
146599779|NCT02198794|528705086|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
146599780|NCT02198794|528705087|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
146599781|NCT02198794|528705088|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
146599782|NCT02198794|528705085|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
146599783|NCT02198794|528705086|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
146599784|NCT02198794|528705087|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
146599785|NCT02198794|528705088|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
146599786|NCT02198794|528705085|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
146599787|NCT02198794|528705086|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
146599788|NCT02198794|528705087|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
146599789|NCT02198794|528705088|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
146599790|NCT02198794|528705085|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
146599791|NCT02198794|528705086|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
146599792|NCT02198794|528705087|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
146599793|NCT02198794|528705088|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
146599794|NCT02198794|528705085|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
146599795|NCT02198794|528705086|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
146599796|NCT02198794|528705087|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
146599797|NCT02198794|528705088|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
146599798|NCT02198794|528705085|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
146599799|NCT02198794|528705086|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
146599800|NCT02198794|528705087|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
146599801|NCT02198794|528705088|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
146599802|NCT02198794|528705085|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
146599803|NCT02198794|528705086|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
146599804|NCT02198794|528705087|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
146599805|NCT02198794|528705088|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
146599806|NCT02198794|528705085|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
146599807|NCT02198794|528705086|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
146599808|NCT02198794|528705087|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
146599809|NCT02198794|528705088|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
146599810|NCT02198794|528705085|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
146599811|NCT02198794|528705086|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
146599812|NCT02198794|528705087|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
146599813|NCT02198794|528705088|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
146599814|NCT02198794|528705085|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
146599815|NCT02198794|528705086|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
146599816|NCT02198794|528705087|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
146599817|NCT02198794|528705088|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
146599818|NCT02198794|528705085|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
146599819|NCT02198794|528705086|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
146922090|NCT05142332|529876734|FG006|Overall Study|Left ED|6|||
146599820|NCT02198794|528705087|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
146599821|NCT02198794|528705088|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
146922091|NCT05142332|529876728|FG000|Overall Study|Physician Decision|0|||
146922092|NCT05142332|529876729|FG001|Overall Study|Physician Decision|0|||
146922093|NCT05142332|529876730|FG002|Overall Study|Physician Decision|2|||
146922094|NCT05142332|529876731|FG003|Overall Study|Physician Decision|1|||
146922095|NCT05142332|529876732|FG004|Overall Study|Physician Decision|0|||
146922096|NCT05142332|529876733|FG005|Overall Study|Physician Decision|0|||
146922097|NCT05142332|529876734|FG006|Overall Study|Physician Decision|3|||
146922098|NCT05142332|529876728|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
146922099|NCT05142332|529876729|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
146922100|NCT05142332|529876730|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
146922101|NCT05142332|529876731|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
146922102|NCT05142332|529876732|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
146922103|NCT05142332|529876733|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
146922104|NCT05142332|529876734|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
146922105|NCT01718509|529876735|FG000|Overall Study|Lost to Follow-up|18|||
146922106|NCT01718509|529876736|FG001|Overall Study|Lost to Follow-up|15|||
146922107|NCT01718509|529876735|FG000|Overall Study|Withdrawal by Subject|7|||
146922108|NCT01718509|529876736|FG001|Overall Study|Withdrawal by Subject|13|||
146922109|NCT01718509|529876735|FG000|Overall Study|Adverse Event|5|||
146922110|NCT01718509|529876736|FG001|Overall Study|Adverse Event|7|||
146599822|NCT02198794|528705085|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
146599823|NCT02198794|528705086|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
146599824|NCT02198794|528705087|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
146599825|NCT02198794|528705088|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
146599826|NCT02198794|528705085|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
146599827|NCT02198794|528705086|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
146599828|NCT02198794|528705087|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
146599829|NCT02198794|528705088|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
146599830|NCT02198794|528705085|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
146599831|NCT02198794|528705086|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
146599832|NCT02198794|528705087|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
146599833|NCT02198794|528705088|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
146599834|NCT01918332|528705090|FG000|Overall Study|Adverse Event|0|||
146599835|NCT01918332|528705091|FG001|Overall Study|Adverse Event|0|||
146599836|NCT01918332|528705092|FG002|Overall Study|Adverse Event|0|||
146599837|NCT01918332|528705093|FG003|Overall Study|Adverse Event|1|||
146599838|NCT01918332|528705090|FG000|Overall Study|Withdrawal by Subject|2|||
146599839|NCT01918332|528705091|FG001|Overall Study|Withdrawal by Subject|3|||
146599840|NCT01918332|528705092|FG002|Overall Study|Withdrawal by Subject|2|||
146599841|NCT01918332|528705093|FG003|Overall Study|Withdrawal by Subject|3|||
146599842|NCT01918332|528705090|FG000|Overall Study|Protocol Violation|6|||
146599843|NCT01918332|528705091|FG001|Overall Study|Protocol Violation|2|||
146599844|NCT01918332|528705092|FG002|Overall Study|Protocol Violation|6|||
146599845|NCT01918332|528705093|FG003|Overall Study|Protocol Violation|3|||
146599846|NCT01918332|528705090|FG000|Overall Study|lipid result by central lab did not meet|0|||
146599847|NCT01918332|528705091|FG001|Overall Study|lipid result by central lab did not meet|0|||
146599848|NCT01918332|528705092|FG002|Overall Study|lipid result by central lab did not meet|1|||
146599849|NCT01918332|528705093|FG003|Overall Study|lipid result by central lab did not meet|0|||
146599850|NCT02905006|528705094|FG000|Overall Study|Adverse Event|1|||
146599851|NCT02905006|528705095|FG001|Overall Study|Adverse Event|1|||
146599852|NCT02905006|528705096|FG002|Overall Study|Adverse Event|1|||
146599853|NCT02905006|528705097|FG003|Overall Study|Adverse Event|1|||
146599854|NCT02905006|528705098|FG004|Overall Study|Adverse Event|0|||
146599855|NCT02905006|528705099|FG005|Overall Study|Adverse Event|1|||
146599856|NCT02905006|528705094|FG000|Overall Study|Lack of Efficacy|1|||
146599857|NCT02905006|528705095|FG001|Overall Study|Lack of Efficacy|0|||
146599858|NCT02905006|528705096|FG002|Overall Study|Lack of Efficacy|0|||
146599859|NCT02905006|528705097|FG003|Overall Study|Lack of Efficacy|0|||
146599860|NCT02905006|528705098|FG004|Overall Study|Lack of Efficacy|0|||
146599861|NCT02905006|528705099|FG005|Overall Study|Lack of Efficacy|0|||
146599862|NCT02905006|528705094|FG000|Overall Study|Protocol Violation|2|||
146599863|NCT02905006|528705095|FG001|Overall Study|Protocol Violation|0|||
146599864|NCT02905006|528705096|FG002|Overall Study|Protocol Violation|0|||
146599865|NCT02905006|528705097|FG003|Overall Study|Protocol Violation|0|||
146599866|NCT02905006|528705098|FG004|Overall Study|Protocol Violation|0|||
146599867|NCT02905006|528705099|FG005|Overall Study|Protocol Violation|0|||
146599868|NCT02905006|528705094|FG000|Overall Study|Lost to Follow-up|0|||
146599869|NCT02905006|528705095|FG001|Overall Study|Lost to Follow-up|0|||
146599870|NCT02905006|528705096|FG002|Overall Study|Lost to Follow-up|0|||
146599871|NCT02905006|528705097|FG003|Overall Study|Lost to Follow-up|1|||
146599872|NCT02905006|528705098|FG004|Overall Study|Lost to Follow-up|1|||
146922111|NCT01718509|529876735|FG000|Overall Study|Other|13|||
146922112|NCT01718509|529876736|FG001|Overall Study|Other|11|||
146599873|NCT02905006|528705099|FG005|Overall Study|Lost to Follow-up|0|||
146599874|NCT02905006|528705094|FG000|Overall Study|Withdrawal by Subject|0|||
146922113|NCT01718509|529876735|FG000|Overall Study|Protocol Violation|4|||
146922114|NCT01718509|529876736|FG001|Overall Study|Protocol Violation|2|||
146599875|NCT02905006|528705095|FG001|Overall Study|Withdrawal by Subject|0|||
146599876|NCT02905006|528705096|FG002|Overall Study|Withdrawal by Subject|1|||
146599877|NCT02905006|528705097|FG003|Overall Study|Withdrawal by Subject|1|||
146599878|NCT02905006|528705098|FG004|Overall Study|Withdrawal by Subject|0|||
146599879|NCT02905006|528705099|FG005|Overall Study|Withdrawal by Subject|1|||
146922115|NCT01718509|529876735|FG000|Overall Study|Lack of Efficacy|1|||
146922116|NCT01718509|529876736|FG001|Overall Study|Lack of Efficacy|0|||
146922117|NCT05906732|529876737|FG000|Overall Study|Withdrawal by Subject|1|||
146922118|NCT05906732|529876738|FG001|Overall Study|Withdrawal by Subject|0|||
146922119|NCT05906732|529876739|FG002|Overall Study|Withdrawal by Subject|0|||
146922120|NCT05906732|529876740|FG003|Overall Study|Withdrawal by Subject|0|||
146922121|NCT05906732|529876737|FG000|Overall Study|Physician Decision|2|||
146922122|NCT05906732|529876738|FG001|Overall Study|Physician Decision|4|||
146922123|NCT05906732|529876739|FG002|Overall Study|Physician Decision|0|||
146922124|NCT05906732|529876740|FG003|Overall Study|Physician Decision|0|||
146922125|NCT02052778|529876741|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
146922126|NCT02052778|529876742|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
146922127|NCT02052778|529876743|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
146922128|NCT02052778|529876744|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
146922129|NCT02052778|529876745|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
146922130|NCT02052778|529876746|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
146922131|NCT02052778|529876747|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146922132|NCT02052778|529876748|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
146922133|NCT02052778|529876749|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
146922134|NCT02052778|529876750|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
146922135|NCT02052778|529876751|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
146922136|NCT02052778|529876752|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
146922137|NCT02052778|529876753|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
146922138|NCT02052778|529876754|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
146922139|NCT02052778|529876755|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146922140|NCT02052778|529876756|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146922141|NCT02052778|529876757|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146922142|NCT02052778|529876758|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146922143|NCT02052778|529876759|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146599880|NCT02905006|528705094|FG000|Overall Study|Screening exclusion criteria met|1|||
146599881|NCT02905006|528705095|FG001|Overall Study|Screening exclusion criteria met|0|||
146599882|NCT02905006|528705096|FG002|Overall Study|Screening exclusion criteria met|0|||
146599883|NCT02905006|528705097|FG003|Overall Study|Screening exclusion criteria met|0|||
146599884|NCT02905006|528705098|FG004|Overall Study|Screening exclusion criteria met|0|||
146599885|NCT02905006|528705099|FG005|Overall Study|Screening exclusion criteria met|0|||
146599886|NCT02905006|528705094|FG000|Overall Study|Lab withdrawal criterion met|0|||
146599887|NCT02905006|528705095|FG001|Overall Study|Lab withdrawal criterion met|1|||
146599888|NCT02905006|528705096|FG002|Overall Study|Lab withdrawal criterion met|2|||
146599889|NCT02905006|528705097|FG003|Overall Study|Lab withdrawal criterion met|2|||
146599890|NCT02905006|528705098|FG004|Overall Study|Lab withdrawal criterion met|2|||
146599891|NCT02905006|528705099|FG005|Overall Study|Lab withdrawal criterion met|1|||
146599892|NCT02905006|528705094|FG000|Overall Study|Positive for Tuberculosis|0|||
146599893|NCT02905006|528705095|FG001|Overall Study|Positive for Tuberculosis|1|||
146599894|NCT02905006|528705096|FG002|Overall Study|Positive for Tuberculosis|0|||
146599895|NCT02905006|528705097|FG003|Overall Study|Positive for Tuberculosis|0|||
146599896|NCT02905006|528705098|FG004|Overall Study|Positive for Tuberculosis|0|||
146599897|NCT02905006|528705099|FG005|Overall Study|Positive for Tuberculosis|0|||
146599898|NCT02905006|528705094|FG000|Overall Study|Subject positive for Hep B|0|||
146599899|NCT02905006|528705095|FG001|Overall Study|Subject positive for Hep B|0|||
146599900|NCT02905006|528705096|FG002|Overall Study|Subject positive for Hep B|1|||
146599901|NCT02905006|528705097|FG003|Overall Study|Subject positive for Hep B|0|||
146599902|NCT02905006|528705098|FG004|Overall Study|Subject positive for Hep B|0|||
146599903|NCT02905006|528705099|FG005|Overall Study|Subject positive for Hep B|0|||
146655043|NCT00095238|528914192|FG001|Overall Study|Study terminated by sponsor|1|||
146655044|NCT00095238|528914191|FG000|Overall Study|Missing|1|||
146655045|NCT00095238|528914192|FG001|Overall Study|Missing|0|||
146655046|NCT00095238|528914191|FG000|Overall Study|Other Reasons|87|||
146655047|NCT00095238|528914192|FG001|Overall Study|Other Reasons|88|||
146922144|NCT02052778|529876760|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146922145|NCT02052778|529876761|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146922146|NCT02052778|529876762|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146599904|NCT02905006|528705094|FG000|Overall Study|Patient moved abroad|0|||
146599905|NCT02905006|528705095|FG001|Overall Study|Patient moved abroad|0|||
146599906|NCT02905006|528705096|FG002|Overall Study|Patient moved abroad|0|||
146655048|NCT03505671|528914193|FG000|Overall Study|Withdrawal by Subject|2|||
146599907|NCT02905006|528705097|FG003|Overall Study|Patient moved abroad|1|||
146599908|NCT02905006|528705098|FG004|Overall Study|Patient moved abroad|0|||
146655049|NCT03505671|528914194|FG001|Overall Study|Withdrawal by Subject|1|||
146922147|NCT02052778|529876763|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146922148|NCT02052778|529876741|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
146922149|NCT02052778|529876742|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
146922150|NCT02052778|529876743|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
146922151|NCT02052778|529876744|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
146922152|NCT02052778|529876745|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
146922153|NCT02052778|529876746|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
146922154|NCT02052778|529876747|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
146922155|NCT02052778|529876748|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
146922156|NCT02052778|529876749|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
146922157|NCT02052778|529876750|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146922158|NCT02052778|529876751|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146922159|NCT02052778|529876752|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
146922160|NCT02052778|529876753|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
146922161|NCT02052778|529876754|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
146922162|NCT02052778|529876755|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146922163|NCT02052778|529876756|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146922164|NCT02052778|529876757|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146922165|NCT02052778|529876758|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146922166|NCT02052778|529876759|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146922167|NCT02052778|529876760|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146922168|NCT02052778|529876761|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146922169|NCT02052778|529876762|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146922170|NCT02052778|529876763|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146922171|NCT02052778|529876741|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922172|NCT02052778|529876742|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922173|NCT02052778|529876743|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922174|NCT02052778|529876744|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922175|NCT02052778|529876745|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922176|NCT02052778|529876746|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922177|NCT02052778|529876747|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922178|NCT02052778|529876748|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922179|NCT02052778|529876749|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922180|NCT02052778|529876750|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922181|NCT02052778|529876751|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922182|NCT02052778|529876752|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922183|NCT02052778|529876753|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922184|NCT02052778|529876754|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
146922185|NCT02052778|529876755|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922186|NCT02052778|529876756|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922187|NCT02052778|529876757|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922188|NCT02052778|529876758|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922189|NCT02052778|529876759|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922190|NCT02052778|529876760|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922191|NCT02052778|529876761|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922192|NCT02052778|529876762|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922193|NCT02052778|529876763|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146922194|NCT02052778|529876741|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
146922195|NCT02052778|529876742|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
146922196|NCT02052778|529876743|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
146922197|NCT02052778|529876744|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
146922198|NCT02052778|529876745|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
146922199|NCT02052778|529876746|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
146922200|NCT02052778|529876747|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
146922201|NCT02052778|529876748|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
146978582|NCT01507831|530084102|FG000|Overall Study|Selection criteria finally not met|0|||
146978583|NCT01507831|530084103|FG001|Overall Study|Selection criteria finally not met|1|||
146978584|NCT01507831|530084102|FG000|Overall Study|Site closure|0|||
146978585|NCT01507831|530084103|FG001|Overall Study|Site closure|3|||
146599909|NCT02905006|528705099|FG005|Overall Study|Patient moved abroad|0|||
146599910|NCT02905006|528705094|FG000|Overall Study|Patient randomized by mistake|0|||
146599911|NCT02905006|528705095|FG001|Overall Study|Patient randomized by mistake|0|||
146599912|NCT02905006|528705096|FG002|Overall Study|Patient randomized by mistake|0|||
146599913|NCT02905006|528705097|FG003|Overall Study|Patient randomized by mistake|0|||
146978586|NCT01507831|530084102|FG000|Overall Study|Potential lost to follow-up|3|||
146978587|NCT01507831|530084103|FG001|Overall Study|Potential lost to follow-up|0|||
146978588|NCT01507831|530084102|FG000|Overall Study|Other|3|||
146978589|NCT01507831|530084103|FG001|Overall Study|Other|6|||
146978590|NCT01252238|530084104|FG000|Overall Study|Sponsor terminated study|4|||
146978591|NCT01252238|530084105|FG001|Overall Study|Sponsor terminated study|4|||
146978592|NCT01252238|530084106|FG002|Overall Study|Sponsor terminated study|4|||
146978593|NCT00068237|530084107|FG000|Overall Study|Ineligible|3|||
146978594|NCT00068237|530084107|FG000|Overall Study|No protocol treatment received|2|||
146978595|NCT03276962|530084113|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
146978596|NCT03276962|530084114|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
146978597|NCT03276962|530084115|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
146978598|NCT03276962|530084116|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
146978599|NCT03276962|530084117|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
146978600|NCT03276962|530084113|FG000|Overall Study|Protocol Deviation|2|||
146599914|NCT02905006|528705098|FG004|Overall Study|Patient randomized by mistake|0|||
146599915|NCT02905006|528705099|FG005|Overall Study|Patient randomized by mistake|1|||
146599916|NCT05063539|528705100|FG000|Overall Study|Adverse Event|1|||
146599917|NCT05063539|528705101|FG001|Overall Study|Adverse Event|2|||
146599918|NCT05063539|528705102|FG002|Overall Study|Adverse Event|1|||
146599919|NCT05063539|528705100|FG000|Overall Study|Death|0|||
146599920|NCT05063539|528705101|FG001|Overall Study|Death|1|||
146599921|NCT05063539|528705102|FG002|Overall Study|Death|1|||
146599922|NCT05063539|528705100|FG000|Overall Study|Lost to Follow-up|0|||
146599923|NCT05063539|528705101|FG001|Overall Study|Lost to Follow-up|1|||
146599924|NCT05063539|528705102|FG002|Overall Study|Lost to Follow-up|0|||
146599925|NCT05063539|528705100|FG000|Overall Study|Physician Decision|4|||
146599926|NCT05063539|528705101|FG001|Overall Study|Physician Decision|3|||
146599927|NCT05063539|528705102|FG002|Overall Study|Physician Decision|1|||
146599928|NCT05063539|528705100|FG000|Overall Study|Progressive Disease|0|||
146599929|NCT05063539|528705101|FG001|Overall Study|Progressive Disease|2|||
146599930|NCT05063539|528705102|FG002|Overall Study|Progressive Disease|0|||
146599931|NCT05063539|528705100|FG000|Overall Study|Withdrawal by Subject|17|||
146599932|NCT05063539|528705101|FG001|Overall Study|Withdrawal by Subject|26|||
146599933|NCT05063539|528705102|FG002|Overall Study|Withdrawal by Subject|14|||
146599934|NCT05063539|528705100|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
146599935|NCT05063539|528705101|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
146599936|NCT05063539|528705102|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
146599937|NCT05063539|528705100|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
146599938|NCT05063539|528705101|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
146599939|NCT05063539|528705102|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
146599940|NCT05063539|528705100|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
146978601|NCT03276962|530084114|FG001|Overall Study|Protocol Deviation|0|||
146599941|NCT05063539|528705101|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
146599942|NCT05063539|528705102|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
146599943|NCT05063539|528705100|FG000|Overall Study|Discontinued due to Common Close Design|0|||
146599944|NCT05063539|528705101|FG001|Overall Study|Discontinued due to Common Close Design|1|||
146599945|NCT05063539|528705102|FG002|Overall Study|Discontinued due to Common Close Design|0|||
146599946|NCT05063539|528705100|FG000|Overall Study|Participant not co-operative|0|||
146599947|NCT05063539|528705101|FG001|Overall Study|Participant not co-operative|1|||
146599948|NCT05063539|528705102|FG002|Overall Study|Participant not co-operative|0|||
146599949|NCT05063539|528705100|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
146599950|NCT05063539|528705101|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
146599951|NCT05063539|528705102|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
146599952|NCT05063539|528705100|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
146599953|NCT05063539|528705101|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
146599954|NCT05063539|528705102|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
146599955|NCT02017522|528705103|FG000|Overall Study|Withdrawal by Subject|1|||
146599956|NCT05856227|528705104|FG000|Overall Study|Adverse Event|0|||
146599957|NCT05856227|528705105|FG001|Overall Study|Adverse Event|1|||
146599958|NCT05856227|528705104|FG000|Overall Study|Due to Investigator absence|1|||
146599959|NCT05856227|528705105|FG001|Overall Study|Due to Investigator absence|0|||
146599960|NCT05856227|528705104|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
146599961|NCT05856227|528705105|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
146599962|NCT01751139|528705106|FG000|Overall Study|Other|135|||
146771877|NCT00357097|529332652|FG001|Overall Study|Withdrawal by Subject|7|||
146978602|NCT03276962|530084115|FG002|Overall Study|Protocol Deviation|1|||
146771878|NCT00357097|529332651|FG000|Overall Study|Non-compliance|1|||
146978603|NCT03276962|530084116|FG003|Overall Study|Protocol Deviation|2|||
146978604|NCT03276962|530084117|FG004|Overall Study|Protocol Deviation|1|||
146599963|NCT01751139|528705106|FG000|Overall Study|Sponsor study termination|1609|||
146599964|NCT01751139|528705106|FG000|Overall Study|Lost to Follow-up|240|||
146599965|NCT01751139|528705106|FG000|Overall Study|Withdrawal by Subject|251|||
146599966|NCT01751139|528705106|FG000|Overall Study|Adverse Event|1|||
146599967|NCT01751139|528705106|FG000|Overall Study|Death|31|||
146599968|NCT04736628|528705107|FG000|Overall Study|Not treated|0|||
146599969|NCT04736628|528705108|FG001|Overall Study|Not treated|0|||
146599970|NCT04736628|528705109|FG002|Overall Study|Not treated|0|||
146599971|NCT04736628|528705110|FG003|Overall Study|Not treated|2|||
146599972|NCT04736628|528705107|FG000|Overall Study|Other reason than listed|1|||
146599973|NCT04736628|528705108|FG001|Overall Study|Other reason than listed|2|||
146599974|NCT04736628|528705109|FG002|Overall Study|Other reason than listed|2|||
146599975|NCT04736628|528705110|FG003|Overall Study|Other reason than listed|3|||
146599976|NCT04736628|528705107|FG000|Overall Study|Protocol deviation|0|||
146599977|NCT04736628|528705108|FG001|Overall Study|Protocol deviation|0|||
146599978|NCT04736628|528705109|FG002|Overall Study|Protocol deviation|0|||
146599979|NCT04736628|528705110|FG003|Overall Study|Protocol deviation|1|||
146599980|NCT04736628|528705107|FG000|Overall Study|Burden of study procedures|1|||
146599981|NCT04736628|528705108|FG001|Overall Study|Burden of study procedures|0|||
146599982|NCT04736628|528705109|FG002|Overall Study|Burden of study procedures|0|||
146599983|NCT04736628|528705110|FG003|Overall Study|Burden of study procedures|1|||
146599984|NCT04736628|528705107|FG000|Overall Study|Change of residence|0|||
146599985|NCT04736628|528705108|FG001|Overall Study|Change of residence|1|||
146599986|NCT04736628|528705109|FG002|Overall Study|Change of residence|0|||
146599987|NCT04736628|528705110|FG003|Overall Study|Change of residence|0|||
146599988|NCT04736628|528705107|FG000|Overall Study|Perceived lack of efficacy|1|||
146599989|NCT04736628|528705108|FG001|Overall Study|Perceived lack of efficacy|0|||
146599990|NCT04736628|528705109|FG002|Overall Study|Perceived lack of efficacy|0|||
146599991|NCT04736628|528705110|FG003|Overall Study|Perceived lack of efficacy|1|||
146599992|NCT04736628|528705107|FG000|Overall Study|Adverse Event|3|||
146599993|NCT04736628|528705108|FG001|Overall Study|Adverse Event|2|||
146599994|NCT04736628|528705109|FG002|Overall Study|Adverse Event|4|||
146599995|NCT04736628|528705110|FG003|Overall Study|Adverse Event|3|||
146599996|NCT02428205|528705113|FG000|Overall Study|Lack of Efficacy|1|||
146599997|NCT02428205|528705114|FG001|Overall Study|Lack of Efficacy|0|||
146599998|NCT02428205|528705113|FG000|Overall Study|Lost to Follow-up|1|||
146599999|NCT02428205|528705114|FG001|Overall Study|Lost to Follow-up|1|||
146600000|NCT02428205|528705113|FG000|Overall Study|Worse behavior|0|||
146600001|NCT02428205|528705114|FG001|Overall Study|Worse behavior|1|||
146600002|NCT00527319|528705115|FG000|Overall Study|Withdrawal by Subject|5|||
146600003|NCT00527319|528705116|FG001|Overall Study|Withdrawal by Subject|0|||
146600004|NCT00527319|528705117|FG002|Overall Study|Withdrawal by Subject|1|||
146600005|NCT00527319|528705115|FG000|Overall Study|Lost to Follow-up|1|||
146600006|NCT00527319|528705116|FG001|Overall Study|Lost to Follow-up|0|||
146600007|NCT00527319|528705117|FG002|Overall Study|Lost to Follow-up|0|||
146600008|NCT00527319|528705115|FG000|Overall Study|Death|0|||
146600009|NCT00527319|528705116|FG001|Overall Study|Death|3|||
146600010|NCT00527319|528705117|FG002|Overall Study|Death|1|||
146600011|NCT00527319|528705115|FG000|Overall Study|Intercurrent Medical Illness|0|||
146600012|NCT00527319|528705116|FG001|Overall Study|Intercurrent Medical Illness|1|||
146600013|NCT00527319|528705117|FG002|Overall Study|Intercurrent Medical Illness|3|||
146922202|NCT02052778|529876749|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
146922203|NCT02052778|529876750|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
146922204|NCT02052778|529876751|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
146600014|NCT00527319|528705115|FG000|Overall Study|Adverse Event|0|||
146600015|NCT00527319|528705116|FG001|Overall Study|Adverse Event|0|||
146600016|NCT00527319|528705117|FG002|Overall Study|Adverse Event|1|||
146600017|NCT00680368|528705119|FG000|Overall Study|not supervised, not eligible|15|||
146600018|NCT00483041|528705120|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
146600019|NCT00483041|528705121|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
146600020|NCT03779503|528705122|FG000|First Intervention|Adverse Event|0|||
146600021|NCT03779503|528705123|FG001|First Intervention|Adverse Event|1|||
146600022|NCT03779503|528705122|FG000|First Intervention|Withdrawal by Subject|1|||
146600023|NCT03779503|528705123|FG001|First Intervention|Withdrawal by Subject|0|||
146922205|NCT02052778|529876752|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
146922206|NCT02052778|529876753|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
146600024|NCT00864851|528705124|FG000|Overall Study|Withdrawal by Subject|0|||
146600025|NCT00864851|528705125|FG001|Overall Study|Withdrawal by Subject|1|||
146600026|NCT00864851|528705126|FG002|Overall Study|Withdrawal by Subject|0|||
146600027|NCT00864851|528705124|FG000|Overall Study|Physician Decision|1|||
146600028|NCT00864851|528705125|FG001|Overall Study|Physician Decision|0|||
146600029|NCT00864851|528705126|FG002|Overall Study|Physician Decision|0|||
146600030|NCT00864851|528705124|FG000|Overall Study|Death|1|||
146600031|NCT00864851|528705125|FG001|Overall Study|Death|0|||
146600032|NCT00864851|528705126|FG002|Overall Study|Death|0|||
146600033|NCT00864851|528705124|FG000|Overall Study|Patient uncooperative|1|||
146600034|NCT00864851|528705125|FG001|Overall Study|Patient uncooperative|0|||
146922207|NCT02052778|529876754|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
146922208|NCT02052778|529876755|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
146922209|NCT02052778|529876756|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
146922210|NCT02052778|529876757|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
146922211|NCT02052778|529876758|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
146922212|NCT02052778|529876759|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
146922213|NCT02052778|529876760|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
146922214|NCT02052778|529876761|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
146922215|NCT02052778|529876762|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
146922216|NCT02052778|529876763|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
146922217|NCT02052778|529876741|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922218|NCT02052778|529876742|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922219|NCT02052778|529876743|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146600035|NCT00864851|528705126|FG002|Overall Study|Patient uncooperative|0|||
146600036|NCT03242252|528705128|FG000|Overall Study|At the Participant's own Request|18|||
146600037|NCT03242252|528705129|FG001|Overall Study|At the Participant's own Request|10|||
146600038|NCT03242252|528705130|FG002|Overall Study|At the Participant's own Request|15|||
146600039|NCT03242252|528705128|FG000|Overall Study|Adverse Event|8|||
146600040|NCT03242252|528705129|FG001|Overall Study|Adverse Event|6|||
146600041|NCT03242252|528705130|FG002|Overall Study|Adverse Event|9|||
146600042|NCT03242252|528705128|FG000|Overall Study|Poor Compliance to Protocol|0|||
146600043|NCT03242252|528705129|FG001|Overall Study|Poor Compliance to Protocol|2|||
146600044|NCT03242252|528705130|FG002|Overall Study|Poor Compliance to Protocol|3|||
146600045|NCT03242252|528705128|FG000|Overall Study|Study Terminated by Sponsor|1|||
146600046|NCT03242252|528705129|FG001|Overall Study|Study Terminated by Sponsor|0|||
146600047|NCT03242252|528705130|FG002|Overall Study|Study Terminated by Sponsor|0|||
146600048|NCT03242252|528705128|FG000|Overall Study|Reason not Specified|4|||
146600049|NCT03242252|528705129|FG001|Overall Study|Reason not Specified|4|||
146600050|NCT03242252|528705130|FG002|Overall Study|Reason not Specified|1|||
146600051|NCT03242252|528705128|FG000|Overall Study|Lost to Follow-up|5|||
146600052|NCT03242252|528705129|FG001|Overall Study|Lost to Follow-up|1|||
146600053|NCT03242252|528705130|FG002|Overall Study|Lost to Follow-up|4|||
146600054|NCT01116427|528705131|FG000|Core Phase|Adverse Event|0|||
146600055|NCT01116427|528705132|FG001|Core Phase|Adverse Event|1|||
146600056|NCT01116427|528705131|FG000|Core Phase|Lost to Follow-up|1|||
146600057|NCT01116427|528705132|FG001|Core Phase|Lost to Follow-up|0|||
146600058|NCT01116427|528705131|FG000|Core Phase|Withdrawal by Subject|3|||
146600059|NCT01116427|528705132|FG001|Core Phase|Withdrawal by Subject|0|||
146600060|NCT01116427|528705131|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
146600061|NCT01116427|528705132|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
146600062|NCT01116427|528705131|FG000|Extension Phase|Adverse Event|1|||
146600063|NCT01116427|528705132|FG001|Extension Phase|Adverse Event|1|||
146922220|NCT02052778|529876744|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922221|NCT02052778|529876745|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922222|NCT02052778|529876746|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922223|NCT02052778|529876747|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922224|NCT02052778|529876748|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922225|NCT02052778|529876749|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
146922226|NCT02052778|529876750|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922227|NCT02052778|529876751|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922228|NCT02052778|529876752|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922229|NCT02052778|529876753|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922230|NCT02052778|529876754|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
146600064|NCT01116427|528705131|FG000|Extension Phase|Lost to Follow-up|2|||
146600065|NCT01116427|528705132|FG001|Extension Phase|Lost to Follow-up|0|||
146600066|NCT01116427|528705131|FG000|Extension Phase|Withdrawal by Subject|5|||
146600067|NCT01116427|528705132|FG001|Extension Phase|Withdrawal by Subject|1|||
146600068|NCT01116427|528705131|FG000|Extension Phase|Not using appropriate birth control|1|||
146600069|NCT01116427|528705132|FG001|Extension Phase|Not using appropriate birth control|0|||
146600070|NCT02211313|528705133|FG000|Overall Study|Treatment Failure|5|||
146600071|NCT02211313|528705134|FG001|Overall Study|Treatment Failure|2|||
146600072|NCT02211313|528705133|FG000|Overall Study|No Follow up Questionnaires|1|||
146600073|NCT02211313|528705134|FG001|Overall Study|No Follow up Questionnaires|1|||
146600074|NCT02717130|528705135|FG000|Overall Study|Withdrawal by Subject|1|||
146600075|NCT02717130|528705135|FG000|Overall Study|Adverse Event|1|||
146922231|NCT02052778|529876755|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146600076|NCT02717130|528705135|FG000|Overall Study|Physician Decision|1|||
146600077|NCT02717130|528705135|FG000|Overall Study|Study Closure|4|||
146771879|NCT00357097|529332652|FG001|Overall Study|Non-compliance|2|||
146600078|NCT03344640|528705136|FG000|Overall Study|Adverse Event|1|||
146600079|NCT03344640|528705137|FG001|Overall Study|Adverse Event|0|||
146600080|NCT03344640|528705136|FG000|Overall Study|Physician Decision|1|||
146600081|NCT03344640|528705137|FG001|Overall Study|Physician Decision|1|||
146600082|NCT03344640|528705136|FG000|Overall Study|Withdrawal by Subject|1|||
146600083|NCT03344640|528705137|FG001|Overall Study|Withdrawal by Subject|2|||
146600084|NCT03344640|528705136|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
146600085|NCT03344640|528705137|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
146600086|NCT00657371|528705141|FG000|Overall Study|Poor bowel preparation|15|||
146600087|NCT00657371|528705141|FG000|Overall Study|Unable to intubate the cecum|5|||
146600088|NCT00657371|528705141|FG000|Overall Study|Protocol Violation|2|||
146600089|NCT00657371|528705141|FG000|Overall Study|Device- related reasons|13|||
146600090|NCT00657371|528705141|FG000|Overall Study|Pre-existing medical condition|4|||
146600091|NCT00652899|528705147|FG000|Overall Study|Death|1|||
146600092|NCT00652899|528705147|FG000|Overall Study|Treating physician decision|1|||
146600093|NCT01943552|528705148|FG000|Overall Study|Adverse Event|3|||
146600094|NCT01943552|528705149|FG001|Overall Study|Adverse Event|2|||
146600095|NCT01943552|528705148|FG000|Overall Study|Withdrawal by Subject|6|||
146600096|NCT01943552|528705149|FG001|Overall Study|Withdrawal by Subject|6|||
146600097|NCT01943552|528705148|FG000|Overall Study|Other Reasons|16|||
146600098|NCT01943552|528705149|FG001|Overall Study|Other Reasons|17|||
146600099|NCT01600053|528705150|FG000|Overall Study|Adverse Event|2|||
146600100|NCT01600053|528705150|FG000|Overall Study|trial will not meet the interim endpoint|9|||
146600101|NCT02715726|528705151|FG000|Overall Study|Adverse Event|2|||
146600102|NCT02715726|528705152|FG001|Overall Study|Adverse Event|6|||
146600103|NCT02715726|528705151|FG000|Overall Study|Protocol Violation|1|||
146600104|NCT02715726|528705152|FG001|Overall Study|Protocol Violation|0|||
146600105|NCT02715726|528705151|FG000|Overall Study|Death|2|||
146600106|NCT02715726|528705152|FG001|Overall Study|Death|1|||
146600107|NCT02715726|528705151|FG000|Overall Study|Participant moved|1|||
146600108|NCT02715726|528705152|FG001|Overall Study|Participant moved|3|||
146600109|NCT02715726|528705151|FG000|Overall Study|Other than specified above|11|||
146600110|NCT02715726|528705152|FG001|Overall Study|Other than specified above|15|||
146600111|NCT02715726|528705151|FG000|Overall Study|Randomized but not treated|1|||
146600112|NCT02715726|528705152|FG001|Overall Study|Randomized but not treated|2|||
146600113|NCT02445573|528705153|FG000|Overall Study|Withdrawal by Subject|1|||
146600114|NCT02445573|528705154|FG001|Overall Study|Withdrawal by Subject|1|||
146600115|NCT02445573|528705153|FG000|Overall Study|Lost to Follow-up|0|||
146600116|NCT02445573|528705154|FG001|Overall Study|Lost to Follow-up|1|||
146600117|NCT01565941|528705155|FG000|Overall Study|Withdrawn by parent/guardian|3|||
146600118|NCT01565941|528705156|FG001|Overall Study|Withdrawn by parent/guardian|2|||
146600119|NCT01565941|528705155|FG000|Overall Study|Randomized; did not receive intevention|8|||
146600120|NCT01565941|528705156|FG001|Overall Study|Randomized; did not receive intevention|2|||
146600121|NCT02855944|528705157|FG000|Period 1: Treatment|Ongoing|14|||
146600122|NCT02855944|528705158|FG001|Period 1: Treatment|Ongoing|0|||
146600123|NCT02855944|528705157|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
146600124|NCT02855944|528705158|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
146600125|NCT02855944|528705157|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
146600126|NCT02855944|528705158|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
146600127|NCT02358044|528705161|FG000|Overall Study|Adverse Event|0|||
146600128|NCT02358044|528705162|FG001|Overall Study|Adverse Event|1|||
146600129|NCT02358044|528705161|FG000|Overall Study|Lost to Follow-up|2|||
146600130|NCT02358044|528705162|FG001|Overall Study|Lost to Follow-up|1|||
146600131|NCT02358044|528705161|FG000|Overall Study|Physician Decision|0|||
146600132|NCT02358044|528705162|FG001|Overall Study|Physician Decision|1|||
146600133|NCT02358044|528705161|FG000|Overall Study|Withdrawal by Subject|0|||
146600134|NCT02358044|528705162|FG001|Overall Study|Withdrawal by Subject|4|||
146600135|NCT01455220|528705166|FG000|Overall Study|screen fail|30|||
146600136|NCT00267150|528705167|FG000|Overall Study|Adverse Event|1|||
146600137|NCT04881747|528705169|FG000|Period 2 Washout|Adverse Event|1|||
146600138|NCT04881747|528705170|FG001|Period 2 Washout|Adverse Event|0|||
146600139|NCT04881747|528705171|FG002|Period 2 Washout|Adverse Event|0|||
146600140|NCT04881747|528705172|FG003|Period 2 Washout|Adverse Event|0|||
146655050|NCT03505671|528914193|FG000|Overall Study|Lost to Follow-up|1|||
146655051|NCT03505671|528914194|FG001|Overall Study|Lost to Follow-up|0|||
146655052|NCT00749580|528914197|FG000|Overall Study|Lost to Follow-up|4|||
146655053|NCT00749580|528914198|FG001|Overall Study|Lost to Follow-up|8|||
146655054|NCT00749580|528914197|FG000|Overall Study|Adverse Event|0|||
146655055|NCT00749580|528914198|FG001|Overall Study|Adverse Event|1|||
146655056|NCT03410823|528914199|FG000|Overall Study|Death|1|||
146655057|NCT03410823|528914199|FG000|Overall Study|Withdrawal by Subject|2|||
146655058|NCT03410823|528914199|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
146771880|NCT00357097|529332651|FG000|Overall Study|Lack of Efficacy|2|||
146771881|NCT00357097|529332652|FG001|Overall Study|Lack of Efficacy|8|||
146600141|NCT04881747|528705173|FG004|Period 2 Washout|Adverse Event|1|||
146600142|NCT04881747|528705174|FG005|Period 2 Washout|Adverse Event|0|||
146600143|NCT04881747|528705169|FG000|Period 2 Washout|Withdrawal by Subject|1|||
146600144|NCT04881747|528705170|FG001|Period 2 Washout|Withdrawal by Subject|0|||
146600145|NCT04881747|528705171|FG002|Period 2 Washout|Withdrawal by Subject|0|||
146600146|NCT04881747|528705172|FG003|Period 2 Washout|Withdrawal by Subject|1|||
146655059|NCT06460493|528914203|FG000|Overall Study|Withdrawal by Subject|2|||
146771882|NCT00357097|529332651|FG000|Overall Study|Met Exclusion Criteria|3|||
146600147|NCT04881747|528705173|FG004|Period 2 Washout|Withdrawal by Subject|0|||
146600148|NCT04881747|528705174|FG005|Period 2 Washout|Withdrawal by Subject|0|||
146600149|NCT00521222|528705175|FG000|Overall Study|Lost to Follow-up|0|||
146600150|NCT00521222|528705176|FG001|Overall Study|Lost to Follow-up|0|||
146600151|NCT00521222|528705177|FG002|Overall Study|Lost to Follow-up|1|||
146600152|NCT00521222|528705178|FG003|Overall Study|Lost to Follow-up|1|||
146600153|NCT00521222|528705175|FG000|Overall Study|Withdrawal by Subject|0|||
146600154|NCT00521222|528705176|FG001|Overall Study|Withdrawal by Subject|0|||
146600155|NCT00521222|528705177|FG002|Overall Study|Withdrawal by Subject|2|||
146600156|NCT00521222|528705178|FG003|Overall Study|Withdrawal by Subject|0|||
146600157|NCT00521222|528705175|FG000|Overall Study|Physician Decision|0|||
146600158|NCT00521222|528705176|FG001|Overall Study|Physician Decision|1|||
146600159|NCT00521222|528705177|FG002|Overall Study|Physician Decision|0|||
146600160|NCT00521222|528705178|FG003|Overall Study|Physician Decision|1|||
146600161|NCT01378429|528705180|FG000|Overall Study|Noncompliance with study drug|1|||
146600162|NCT01378429|528705181|FG001|Overall Study|Noncompliance with study drug|0|||
146600163|NCT02265796|528705184|FG000|Overall Study|Death|1|||
146600164|NCT02265796|528705185|FG001|Overall Study|Death|0|||
146600165|NCT02265796|528705184|FG000|Overall Study|started on excluded medication|1|||
146600166|NCT02265796|528705185|FG001|Overall Study|started on excluded medication|0|||
146600167|NCT02265796|528705184|FG000|Overall Study|Withdrawal by Subject|1|||
146600168|NCT02265796|528705185|FG001|Overall Study|Withdrawal by Subject|1|||
146600169|NCT02014584|528705186|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
146600170|NCT02014584|528705187|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
146600171|NCT02014584|528705188|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
146600172|NCT02014584|528705189|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
146600173|NCT02014584|528705190|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
146600174|NCT02014584|528705191|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
146600175|NCT02014584|528705186|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
146600176|NCT02014584|528705187|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
146600177|NCT02014584|528705188|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
146600178|NCT02014584|528705189|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
146600179|NCT02014584|528705190|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
146600180|NCT02014584|528705191|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
146600181|NCT02014584|528705186|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
146600182|NCT02014584|528705187|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
146600183|NCT02014584|528705188|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
146600184|NCT02014584|528705189|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
146600185|NCT02014584|528705190|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
146600186|NCT02014584|528705191|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
146600187|NCT02014584|528705186|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
146600188|NCT02014584|528705187|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
146600189|NCT02014584|528705188|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
146600190|NCT02014584|528705189|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
146600191|NCT02014584|528705190|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
146600192|NCT02014584|528705191|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
146600193|NCT02014584|528705186|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
146600194|NCT02014584|528705187|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
146600195|NCT02014584|528705188|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
146600196|NCT02014584|528705189|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
146600197|NCT02014584|528705190|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
146600198|NCT02014584|528705191|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
146600199|NCT00483002|528705192|FG000|Overall Study|Adverse Event|68|||
146600200|NCT00483002|528705192|FG000|Overall Study|Lack of Efficacy|555|||
146600201|NCT00483002|528705192|FG000|Overall Study|Lost to Follow-up|962|||
146600202|NCT00483002|528705192|FG000|Overall Study|Other|2|||
146600203|NCT00483002|528705192|FG000|Overall Study|Other|967|||
146600204|NCT01597635|528707050|FG000|Part A|Adverse Event|3|||
146600205|NCT01597635|528707051|FG001|Part A|Adverse Event|0|||
146600206|NCT01597635|528707052|FG002|Part A|Adverse Event|0|||
146600207|NCT01597635|528707050|FG000|Part B|Adverse Event|0|||
146600208|NCT01597635|528707051|FG001|Part B|Adverse Event|0|||
146600209|NCT01597635|528707052|FG002|Part B|Adverse Event|1|||
146600210|NCT01597635|528707050|FG000|Part B|Protocol Violation|0|||
146600211|NCT01597635|528707051|FG001|Part B|Protocol Violation|1|||
146600212|NCT01597635|528707052|FG002|Part B|Protocol Violation|0|||
146600213|NCT01597635|528707050|FG000|Part B|Protocol-defined stopping criteria|0|||
146600214|NCT01597635|528707051|FG001|Part B|Protocol-defined stopping criteria|4|||
146600215|NCT01597635|528707052|FG002|Part B|Protocol-defined stopping criteria|3|||
146600216|NCT01597635|528707050|FG000|Part B|Withdrawal by Subject|0|||
146600217|NCT01597635|528707051|FG001|Part B|Withdrawal by Subject|1|||
146600218|NCT01597635|528707052|FG002|Part B|Withdrawal by Subject|0|||
146600219|NCT01192568|528707053|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
146600220|NCT01192568|528707054|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
146600221|NCT01192568|528707055|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
146600222|NCT01192568|528707056|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
146600223|NCT01192568|528707053|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
146600224|NCT01192568|528707054|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
146600225|NCT01192568|528707055|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
146655060|NCT03707184|528914206|FG000|Overall Study|Withdrawal by Subject|2|||
146655061|NCT04704154|528914207|FG000|Overall Study|Adverse Event|3|||
146655062|NCT04704154|528914208|FG001|Overall Study|Adverse Event|2|||
146655063|NCT04704154|528914209|FG002|Overall Study|Adverse Event|4|||
146655064|NCT04704154|528914210|FG003|Overall Study|Adverse Event|2|||
146655065|NCT04704154|528914211|FG004|Overall Study|Adverse Event|3|||
146655066|NCT04704154|528914212|FG005|Overall Study|Adverse Event|0|||
146655067|NCT04704154|528914207|FG000|Overall Study|Death|3|||
146655068|NCT04704154|528914208|FG001|Overall Study|Death|0|||
146655069|NCT04704154|528914209|FG002|Overall Study|Death|0|||
146655070|NCT04704154|528914210|FG003|Overall Study|Death|0|||
146655071|NCT04704154|528914211|FG004|Overall Study|Death|3|||
146655072|NCT04704154|528914212|FG005|Overall Study|Death|0|||
146655073|NCT04704154|528914207|FG000|Overall Study|Physician Decision|1|||
146655074|NCT04704154|528914208|FG001|Overall Study|Physician Decision|0|||
146655075|NCT04704154|528914209|FG002|Overall Study|Physician Decision|1|||
146655076|NCT04704154|528914210|FG003|Overall Study|Physician Decision|0|||
146655077|NCT04704154|528914211|FG004|Overall Study|Physician Decision|2|||
146655078|NCT04704154|528914212|FG005|Overall Study|Physician Decision|0|||
146655079|NCT04704154|528914207|FG000|Overall Study|Participant Decision|1|||
146655080|NCT04704154|528914208|FG001|Overall Study|Participant Decision|1|||
146655081|NCT04704154|528914209|FG002|Overall Study|Participant Decision|0|||
146655082|NCT04704154|528914210|FG003|Overall Study|Participant Decision|0|||
146655083|NCT04704154|528914211|FG004|Overall Study|Participant Decision|0|||
146655084|NCT04704154|528914212|FG005|Overall Study|Participant Decision|0|||
146655085|NCT04704154|528914207|FG000|Overall Study|Progressive Disease|19|||
146655086|NCT04704154|528914208|FG001|Overall Study|Progressive Disease|17|||
146655087|NCT04704154|528914209|FG002|Overall Study|Progressive Disease|20|||
146655088|NCT04704154|528914210|FG003|Overall Study|Progressive Disease|18|||
146655089|NCT04704154|528914211|FG004|Overall Study|Progressive Disease|36|||
146655090|NCT04704154|528914212|FG005|Overall Study|Progressive Disease|30|||
146655091|NCT04704154|528914207|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
146655092|NCT04704154|528914208|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
146655093|NCT04704154|528914209|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
146655094|NCT04704154|528914210|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
146655095|NCT04704154|528914211|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
146655096|NCT04704154|528914212|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
146655097|NCT04704154|528914207|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
146655098|NCT04704154|528914208|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
146655099|NCT04704154|528914209|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
146655100|NCT04704154|528914210|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
146600226|NCT01192568|528707056|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
146655101|NCT04704154|528914211|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
146655102|NCT04704154|528914212|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
146655103|NCT04950608|528914213|FG000|Overall Study|Withdrawal by Subject|2|||
146655104|NCT04950608|528914213|FG000|Overall Study|Physician Decision|3|||
146655105|NCT03220438|528914214|FG000|Overall Study|Lost to Follow-up|0|||
146655106|NCT03220438|528914215|FG001|Overall Study|Lost to Follow-up|0|||
146655107|NCT03220438|528914216|FG002|Overall Study|Lost to Follow-up|1|||
146655108|NCT03220438|528914217|FG003|Overall Study|Lost to Follow-up|0|||
146655109|NCT04565236|528914218|FG000|Overall Study|Patient/Guardian Decision|0|||
146655110|NCT04565236|528914219|FG001|Overall Study|Patient/Guardian Decision|0|||
146655111|NCT04565236|528914220|FG002|Overall Study|Patient/Guardian Decision|1|||
146655112|NCT04565236|528914221|FG003|Overall Study|Patient/Guardian Decision|0|||
146655113|NCT01117051|528914225|FG000|Overall Study|Withdrawal by Subject|5|||
146600227|NCT00652951|528707057|FG000|Booster Phase|Adverse event, non-fatal|0|||
146655114|NCT01117051|528914226|FG001|Overall Study|Withdrawal by Subject|3|||
146655115|NCT01117051|528914225|FG000|Overall Study|Adverse Event|4|||
146655116|NCT01117051|528914226|FG001|Overall Study|Adverse Event|3|||
146655117|NCT01117051|528914225|FG000|Overall Study|Lost to Follow-up|0|||
146655118|NCT01117051|528914226|FG001|Overall Study|Lost to Follow-up|1|||
146600228|NCT00652951|528707058|FG001|Booster Phase|Adverse event, non-fatal|1|||
146600229|NCT00652951|528707059|FG002|Booster Phase|Adverse event, non-fatal|0|||
146655119|NCT01117051|528914225|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
146655120|NCT01117051|528914226|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
146600230|NCT00652951|528707057|FG000|Booster Phase|Other|1|||
146655121|NCT01117051|528914225|FG000|Overall Study|Sponsor's decision|3|||
146655122|NCT01117051|528914226|FG001|Overall Study|Sponsor's decision|1|||
146655123|NCT01117051|528914225|FG000|Overall Study|Surgical procedure|0|||
146655124|NCT01117051|528914226|FG001|Overall Study|Surgical procedure|1|||
146655125|NCT01117051|528914225|FG000|Overall Study|Randomized by mistake|0|||
146655126|NCT01117051|528914226|FG001|Overall Study|Randomized by mistake|1|||
146655127|NCT01117051|528914225|FG000|Overall Study|Convenience issue|1|||
146655128|NCT01117051|528914226|FG001|Overall Study|Convenience issue|0|||
146655129|NCT03584373|528914227|FG000|Overall Study|Lost to Follow-up|7|||
146655130|NCT03584373|528914228|FG001|Overall Study|Lost to Follow-up|8|||
146771883|NCT00357097|529332652|FG001|Overall Study|Met Exclusion Criteria|1|||
146771884|NCT00357097|529332651|FG000|Overall Study|Other|1|||
146771885|NCT00357097|529332652|FG001|Overall Study|Other|1|||
146771886|NCT00357097|529332651|FG000|Overall Study|Increase of RLS Symptoms|0|||
146771887|NCT00357097|529332652|FG001|Overall Study|Increase of RLS Symptoms|1|||
146771888|NCT00732381|529332655|FG000|Overall Study|Adverse Event|1|||
146771889|NCT00732381|529332656|FG001|Overall Study|Adverse Event|0|||
146771890|NCT00732381|529332655|FG000|Overall Study|Treatment Failure|1|||
146771891|NCT00732381|529332656|FG001|Overall Study|Treatment Failure|1|||
146771892|NCT00457691|529332657|FG000|Overall Study|Adverse Event|4|||
146771893|NCT00457691|529332658|FG001|Overall Study|Adverse Event|1|||
146771894|NCT00457691|529332657|FG000|Overall Study|Death|163|||
146771895|NCT00457691|529332658|FG001|Overall Study|Death|148|||
146771896|NCT00457691|529332657|FG000|Overall Study|Protocol Violation|1|||
146771897|NCT00457691|529332658|FG001|Overall Study|Protocol Violation|3|||
146600231|NCT00652951|528707058|FG001|Booster Phase|Other|0|||
146655131|NCT01487577|528914229|FG000|Overall Study|Became ineligible after signing consent|1|||
146655132|NCT03780400|528914230|FG000|Overall Study|Lost to Follow-up|5|||
146655133|NCT03780400|528914230|FG000|Overall Study|Withdrawal by Subject|2|||
146655134|NCT01315236|528914231|FG000|Double-blind Phase|Death|1|||
146655135|NCT01315236|528914232|FG001|Double-blind Phase|Death|0|||
146655136|NCT01315236|528914231|FG000|Double-blind Phase|Adverse Event|1|||
146655137|NCT01315236|528914232|FG001|Double-blind Phase|Adverse Event|0|||
146655138|NCT01315236|528914231|FG000|Double-blind Phase|Withdrawal of Consent|1|||
146655139|NCT01315236|528914232|FG001|Double-blind Phase|Withdrawal of Consent|0|||
146655140|NCT01315236|528914231|FG000|Double-blind Phase|Lost to Follow-up|1|||
146655141|NCT01315236|528914232|FG001|Double-blind Phase|Lost to Follow-up|0|||
146655142|NCT01315236|528914231|FG000|Open-label Phase|Death|1|||
146655143|NCT01315236|528914232|FG001|Open-label Phase|Death|0|||
146655144|NCT01315236|528914231|FG000|Open-label Phase|Adverse Event|0|||
146655145|NCT01315236|528914232|FG001|Open-label Phase|Adverse Event|1|||
146655146|NCT01315236|528914231|FG000|Open-label Phase|Other|0|||
146655147|NCT01315236|528914232|FG001|Open-label Phase|Other|1|||
146655148|NCT01315236|528914231|FG000|12-Month Follow-up Period|Death|0|||
146600232|NCT00652951|528707059|FG002|Booster Phase|Other|0|||
146600233|NCT02593825|528707060|FG000|Intervention|Lost to Follow-up|10|||
146600234|NCT02593825|528707061|FG001|Intervention|Lost to Follow-up|12|||
146600235|NCT02100969|528707062|FG000|Overall Study|Did not pass screening phase|1|||
146600236|NCT06359080|528707063|FG000|Overall Study|Withdrawal by Subject|3|||
146600237|NCT00511134|528707064|FG000|Overall Study|Withdrawal by Subject|0|||
146600238|NCT00511134|528707065|FG001|Overall Study|Withdrawal by Subject|2|||
146600239|NCT01949090|528707066|FG000|Overall Study|Serious Adverse Event|0|||
146600240|NCT01949090|528707067|FG001|Overall Study|Serious Adverse Event|1|||
146600241|NCT01949090|528707068|FG002|Overall Study|Serious Adverse Event|2|||
146600242|NCT01949090|528707069|FG003|Overall Study|Serious Adverse Event|0|||
146600243|NCT01949090|528707070|FG004|Overall Study|Serious Adverse Event|1|||
146600244|NCT01949090|528707066|FG000|Overall Study|Withdrawal by Subject|2|||
146600245|NCT01949090|528707067|FG001|Overall Study|Withdrawal by Subject|0|||
146600246|NCT01949090|528707068|FG002|Overall Study|Withdrawal by Subject|0|||
146600247|NCT01949090|528707069|FG003|Overall Study|Withdrawal by Subject|0|||
146655149|NCT01315236|528914232|FG001|12-Month Follow-up Period|Death|1|||
146655150|NCT01315236|528914231|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
146655151|NCT01315236|528914232|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
146655152|NCT00470184|528914236|FG000|Overall Study|Not Treated(became ineligible)|4|||
146655153|NCT00470184|528914236|FG000|Overall Study|Not treated (other)|1|||
146655154|NCT00470184|528914236|FG000|Overall Study|disease Progression|4|||
146600248|NCT01949090|528707070|FG004|Overall Study|Withdrawal by Subject|1|||
146655155|NCT00470184|528914236|FG000|Overall Study|Adverse Event|3|||
146655156|NCT00470184|528914236|FG000|Overall Study|Withdrawal by Subject|4|||
146655157|NCT00470184|528914236|FG000|Overall Study|other|5|||
146655158|NCT00470184|528914236|FG000|Overall Study|recurrence|1|||
146655159|NCT03282565|528914237|FG000|Overall Study|COVID-19 Research Shutdown|0|||
146655160|NCT03282565|528914238|FG001|Overall Study|COVID-19 Research Shutdown|2|||
146771898|NCT00457691|529332657|FG000|Overall Study|Lost to Follow-up|23|||
146771899|NCT00457691|529332658|FG001|Overall Study|Lost to Follow-up|14|||
146771900|NCT00457691|529332657|FG000|Overall Study|Study terminated by Sponsor|1|||
146771901|NCT00457691|529332658|FG001|Overall Study|Study terminated by Sponsor|1|||
146771902|NCT00457691|529332657|FG000|Overall Study|Subject refused (reason other than AE)|14|||
146922232|NCT02052778|529876756|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922233|NCT02052778|529876757|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922234|NCT02052778|529876758|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922235|NCT02052778|529876759|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922236|NCT02052778|529876760|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922237|NCT02052778|529876761|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922238|NCT02052778|529876762|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922239|NCT02052778|529876763|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146922240|NCT02052778|529876741|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922241|NCT02052778|529876742|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922242|NCT02052778|529876743|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922243|NCT02052778|529876744|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922244|NCT02052778|529876745|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922245|NCT02052778|529876746|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
146922246|NCT02052778|529876747|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922247|NCT02052778|529876748|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922248|NCT02052778|529876749|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922249|NCT02052778|529876750|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922250|NCT02052778|529876751|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922251|NCT02052778|529876752|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922252|NCT02052778|529876753|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
146922253|NCT02052778|529876754|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922254|NCT02052778|529876755|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922255|NCT02052778|529876756|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922256|NCT02052778|529876757|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922257|NCT02052778|529876758|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922258|NCT02052778|529876759|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922259|NCT02052778|529876760|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922260|NCT02052778|529876761|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922261|NCT02052778|529876762|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922262|NCT02052778|529876763|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146922263|NCT02052778|529876741|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146922264|NCT02052778|529876742|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146922265|NCT02052778|529876743|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146922266|NCT02052778|529876744|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146922267|NCT02052778|529876745|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146922268|NCT02052778|529876746|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146922269|NCT02052778|529876747|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146922270|NCT02052778|529876748|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146922271|NCT02052778|529876749|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146922272|NCT02052778|529876750|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146922273|NCT02052778|529876751|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146922274|NCT02052778|529876752|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146922275|NCT02052778|529876753|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146922276|NCT02052778|529876754|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146922277|NCT02052778|529876755|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
146600249|NCT01949090|528707066|FG000|Overall Study|Protocol non-compliance|0|||
146600250|NCT01949090|528707067|FG001|Overall Study|Protocol non-compliance|0|||
146600251|NCT01949090|528707068|FG002|Overall Study|Protocol non-compliance|0|||
146600252|NCT01949090|528707069|FG003|Overall Study|Protocol non-compliance|0|||
146600253|NCT01949090|528707070|FG004|Overall Study|Protocol non-compliance|1|||
146600254|NCT01949090|528707066|FG000|Overall Study|Lost to Follow-up|2|||
146600255|NCT01949090|528707067|FG001|Overall Study|Lost to Follow-up|1|||
146600256|NCT01949090|528707068|FG002|Overall Study|Lost to Follow-up|0|||
146600257|NCT01949090|528707069|FG003|Overall Study|Lost to Follow-up|1|||
146600258|NCT01949090|528707070|FG004|Overall Study|Lost to Follow-up|1|||
146600259|NCT00707954|528707071|FG000|Overall Study|Physician Decision|0|||
146600260|NCT00707954|528707072|FG001|Overall Study|Physician Decision|0|||
146600261|NCT00707954|528707073|FG002|Overall Study|Physician Decision|0|||
146922278|NCT02052778|529876756|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
146978605|NCT03276962|530084113|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
146600262|NCT00707954|528707074|FG003|Overall Study|Physician Decision|0|||
146600263|NCT00707954|528707075|FG004|Overall Study|Physician Decision|1|||
146600264|NCT00599755|528707076|FG000|Overall Study|Adverse Event|11|||
146600265|NCT00599755|528707076|FG000|Overall Study|Withdrawal by Subject|2|||
146600266|NCT00599755|528707076|FG000|Overall Study|Progression of Disease|3|||
146600267|NCT00599755|528707076|FG000|Overall Study|Other Reason|2|||
146600268|NCT00599755|528707076|FG000|Overall Study|No data available|1|||
146600269|NCT01306656|528707077|FG000|Overall Study|Lost to Follow-up|1|||
146600270|NCT01306656|528707078|FG001|Overall Study|Lost to Follow-up|0|||
146600271|NCT00417963|528707082|FG000|Overall Study|Lost to Follow-up|3|||
146600272|NCT00417963|528707082|FG000|Overall Study|Withdrawal by Subject|18|||
146600273|NCT00417963|528707082|FG000|Overall Study|Death|17|||
146600274|NCT00417963|528707082|FG000|Overall Study|Study device could not be deployed|3|||
146600275|NCT00477152|528707085|FG000|Overall Study|Parent withdrew consent|2|||
146600276|NCT00477152|528707085|FG000|Overall Study|Adverse Event|1|||
146600277|NCT01023672|528707086|FG000|Overall Study|Worsening disease|2|||
146600278|NCT01023672|528707086|FG000|Overall Study|Death|1|||
146600279|NCT02504580|528707087|FG000|Overall Study|Other|1|||
146600280|NCT02504580|528707088|FG001|Overall Study|Other|0|||
146600281|NCT02504580|528707089|FG002|Overall Study|Other|0|||
146600282|NCT02504580|528707090|FG003|Overall Study|Other|2|||
146600283|NCT02504580|528707091|FG004|Overall Study|Other|1|||
146600284|NCT02504580|528707092|FG005|Overall Study|Other|1|||
146600285|NCT02504580|528707093|FG006|Overall Study|Other|1|||
146600286|NCT02504580|528707094|FG007|Overall Study|Other|2|||
146600287|NCT02504580|528707095|FG008|Overall Study|Other|0|||
146600288|NCT02504580|528707096|FG009|Overall Study|Other|0|||
146600289|NCT02504580|528707097|FG010|Overall Study|Other|0|||
146600290|NCT02504580|528707098|FG011|Overall Study|Other|2|||
146600291|NCT02504580|528707087|FG000|Overall Study|Subject refusal to continue|0|||
146600292|NCT02504580|528707088|FG001|Overall Study|Subject refusal to continue|1|||
146600293|NCT02504580|528707089|FG002|Overall Study|Subject refusal to continue|0|||
146600294|NCT02504580|528707090|FG003|Overall Study|Subject refusal to continue|0|||
146600295|NCT02504580|528707091|FG004|Overall Study|Subject refusal to continue|0|||
146600296|NCT02504580|528707092|FG005|Overall Study|Subject refusal to continue|0|||
146600297|NCT02504580|528707093|FG006|Overall Study|Subject refusal to continue|0|||
146600298|NCT02504580|528707094|FG007|Overall Study|Subject refusal to continue|0|||
146600299|NCT02504580|528707095|FG008|Overall Study|Subject refusal to continue|0|||
146922279|NCT02052778|529876757|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
146922280|NCT02052778|529876758|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
146922281|NCT02052778|529876759|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
146922282|NCT02052778|529876760|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
146922283|NCT02052778|529876761|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
146922284|NCT02052778|529876762|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
146922285|NCT02052778|529876763|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146922286|NCT02052778|529876741|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146922287|NCT02052778|529876742|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146922288|NCT02052778|529876743|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146922289|NCT02052778|529876744|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146922290|NCT02052778|529876745|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146922291|NCT02052778|529876746|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146922292|NCT02052778|529876747|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146922293|NCT02052778|529876748|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146922294|NCT02052778|529876749|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146922295|NCT02052778|529876750|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146922296|NCT02052778|529876751|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146922297|NCT02052778|529876752|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146922298|NCT02052778|529876753|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146600300|NCT02504580|528707096|FG009|Overall Study|Subject refusal to continue|0|||
146600301|NCT02504580|528707097|FG010|Overall Study|Subject refusal to continue|0|||
146600302|NCT02504580|528707098|FG011|Overall Study|Subject refusal to continue|0|||
146600303|NCT00448747|528707099|FG000|Overall Study|collapsed veins|1|||
146600304|NCT00448747|528707100|FG001|Overall Study|collapsed veins|0|||
146600305|NCT02704689|528707106|FG000|Overall Study|Physician Decision|1|||
146600306|NCT02704689|528707106|FG000|Overall Study|Study device not implanted|2|||
146600307|NCT01646203|528707107|FG000|Overall Study|Adverse Event|2|||
146600308|NCT01646203|528707108|FG001|Overall Study|Adverse Event|0|||
146600309|NCT01646203|528707109|FG002|Overall Study|Adverse Event|1|||
146600310|NCT01646203|528707107|FG000|Overall Study|Withdrawal by Subject|0|||
146600311|NCT01646203|528707108|FG001|Overall Study|Withdrawal by Subject|1|||
146600312|NCT01646203|528707109|FG002|Overall Study|Withdrawal by Subject|0|||
146600313|NCT01646203|528707107|FG000|Overall Study|Physician's Decision|0|||
146600314|NCT01646203|528707108|FG001|Overall Study|Physician's Decision|1|||
146600315|NCT01646203|528707109|FG002|Overall Study|Physician's Decision|0|||
146600316|NCT01100528|528707113|FG000|Overall Study|Death|1|||
146922299|NCT02052778|529876754|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146922300|NCT02052778|529876755|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
146922301|NCT02052778|529876756|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
146922302|NCT02052778|529876757|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146922303|NCT02052778|529876758|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
146922304|NCT02052778|529876759|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
146922305|NCT02052778|529876760|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
146922306|NCT02052778|529876761|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
146922307|NCT02052778|529876762|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
146922308|NCT02052778|529876763|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146922309|NCT02052778|529876741|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922310|NCT02052778|529876742|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922311|NCT02052778|529876743|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922312|NCT02052778|529876744|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922313|NCT02052778|529876745|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922314|NCT02052778|529876746|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922315|NCT02052778|529876747|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922316|NCT02052778|529876748|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922317|NCT02052778|529876749|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922318|NCT02052778|529876750|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922319|NCT02052778|529876751|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922320|NCT02052778|529876752|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922321|NCT02052778|529876753|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922322|NCT02052778|529876754|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922323|NCT02052778|529876755|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
146922324|NCT02052778|529876756|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
146922325|NCT02052778|529876757|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
146922326|NCT02052778|529876758|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922327|NCT02052778|529876759|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
146922328|NCT02052778|529876760|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
146600317|NCT01100528|528707113|FG000|Overall Study|Withdrawal by Subject|2|||
146600318|NCT00551291|528707116|FG000|Overall Study|Physician Decision|1|||
146600319|NCT01177969|528707117|FG000|Overall Study|Protocol Violation|2|||
146600320|NCT01177969|528707118|FG001|Overall Study|Protocol Violation|1|||
146600321|NCT01177969|528707117|FG000|Overall Study|Withdrawal by Subject|1|||
146600322|NCT01177969|528707118|FG001|Overall Study|Withdrawal by Subject|2|||
146600323|NCT01475162|528707122|FG000|Overall Study|Physician Decision|1|||
146600324|NCT01475162|528707122|FG000|Overall Study|Death|10|||
146600325|NCT01475162|528707122|FG000|Overall Study|Study closed for safety|3|||
146600326|NCT00490022|528707123|FG000|Overall Study|Adverse Event|0|||
146600327|NCT00490022|528707124|FG001|Overall Study|Adverse Event|2|||
146600328|NCT00490022|528707123|FG000|Overall Study|Withdrawal by Subject|1|||
146600329|NCT00490022|528707124|FG001|Overall Study|Withdrawal by Subject|0|||
146600330|NCT00490022|528707123|FG000|Overall Study|Subject failed to disclose concommitant|0|||
146600331|NCT00490022|528707124|FG001|Overall Study|Subject failed to disclose concommitant|1|||
146600332|NCT01504204|528707125|FG000|Overall Study|Lost to Follow-up|1|||
146600333|NCT01504204|528707126|FG001|Overall Study|Lost to Follow-up|1|||
146600334|NCT00903331|528707127|FG000|Overall Study|Death|4|||
146600335|NCT00903331|528707128|FG001|Overall Study|Death|8|||
146600336|NCT00903331|528707127|FG000|Overall Study|Withdrawal of consent|1|||
146600337|NCT00903331|528707128|FG001|Overall Study|Withdrawal of consent|8|||
146922329|NCT02052778|529876761|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922330|NCT02052778|529876762|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922331|NCT02052778|529876763|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146922332|NCT02052778|529876741|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146922333|NCT02052778|529876742|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146922334|NCT02052778|529876743|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146922335|NCT02052778|529876744|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146922336|NCT02052778|529876745|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146600338|NCT00903331|528707127|FG000|Overall Study|Lung transplant|0|||
146600339|NCT00903331|528707128|FG001|Overall Study|Lung transplant|2|||
146600340|NCT03426631|528707129|FG000|Overall Study|Lost to Follow-up|0|||
146600341|NCT03426631|528707130|FG001|Overall Study|Lost to Follow-up|1|||
146600342|NCT00654004|528707131|FG000|Overall Study|Lost to Follow-up|1|||
146600343|NCT00654004|528707132|FG001|Overall Study|Lost to Follow-up|0|||
146600344|NCT00444067|528707137|FG000|Overall Study|Lost to Follow-up|0|||
146600345|NCT00444067|528707138|FG001|Overall Study|Lost to Follow-up|1|||
146600346|NCT00710385|528707139|FG000|Overall Study|Did not qualify|1|||
146600347|NCT00710385|528707139|FG000|Overall Study|Withdrawal by Subject|1|||
146600348|NCT00710385|528707139|FG000|Overall Study|Undisclosed back pain|1|||
146600349|NCT00710385|528707139|FG000|Overall Study|Physician Decision|1|||
146600350|NCT00710385|528707139|FG000|Overall Study|Undisclosed excessive methadone use|1|||
146600351|NCT01264770|528707140|FG000|Overall Study|Not reported|0|||
146600352|NCT01264770|528707141|FG001|Overall Study|Not reported|0|||
146600353|NCT01264770|528707142|FG002|Overall Study|Not reported|1|||
146600354|NCT01264770|528707143|FG003|Overall Study|Not reported|0|||
146600355|NCT01264770|528707144|FG004|Overall Study|Not reported|0|||
146600356|NCT01264770|528707145|FG005|Overall Study|Not reported|0|||
146600357|NCT01264770|528707140|FG000|Overall Study|e.g., change in circumstances|8|||
146600358|NCT01264770|528707141|FG001|Overall Study|e.g., change in circumstances|3|||
146600359|NCT01264770|528707142|FG002|Overall Study|e.g., change in circumstances|3|||
146600360|NCT01264770|528707143|FG003|Overall Study|e.g., change in circumstances|3|||
146600361|NCT01264770|528707144|FG004|Overall Study|e.g., change in circumstances|4|||
146600362|NCT01264770|528707145|FG005|Overall Study|e.g., change in circumstances|4|||
146600363|NCT01264770|528707140|FG000|Overall Study|Severe non-compliance to protocol|0|||
146600364|NCT01264770|528707141|FG001|Overall Study|Severe non-compliance to protocol|0|||
146600365|NCT01264770|528707142|FG002|Overall Study|Severe non-compliance to protocol|1|||
146600366|NCT01264770|528707143|FG003|Overall Study|Severe non-compliance to protocol|1|||
146600367|NCT01264770|528707144|FG004|Overall Study|Severe non-compliance to protocol|0|||
146600368|NCT01264770|528707145|FG005|Overall Study|Severe non-compliance to protocol|0|||
146600369|NCT01264770|528707140|FG000|Overall Study|Lack of therapeutic response|1|||
146600370|NCT01264770|528707141|FG001|Overall Study|Lack of therapeutic response|0|||
146600371|NCT01264770|528707142|FG002|Overall Study|Lack of therapeutic response|2|||
146600372|NCT01264770|528707143|FG003|Overall Study|Lack of therapeutic response|1|||
146600373|NCT01264770|528707144|FG004|Overall Study|Lack of therapeutic response|1|||
146600374|NCT01264770|528707145|FG005|Overall Study|Lack of therapeutic response|0|||
146600375|NCT01264770|528707140|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
146600376|NCT01264770|528707141|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
146600377|NCT01264770|528707142|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
146600378|NCT01264770|528707143|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
146600379|NCT01264770|528707144|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
146600380|NCT01264770|528707145|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
146600381|NCT01264770|528707140|FG000|Overall Study|Lost to Follow-up|0|||
146600382|NCT01264770|528707141|FG001|Overall Study|Lost to Follow-up|0|||
146600383|NCT01264770|528707142|FG002|Overall Study|Lost to Follow-up|1|||
146600384|NCT01264770|528707143|FG003|Overall Study|Lost to Follow-up|1|||
146600385|NCT01264770|528707144|FG004|Overall Study|Lost to Follow-up|0|||
146600386|NCT01264770|528707145|FG005|Overall Study|Lost to Follow-up|0|||
146600387|NCT01264770|528707140|FG000|Overall Study|Adverse Event|7|||
146600388|NCT01264770|528707141|FG001|Overall Study|Adverse Event|7|||
146600389|NCT01264770|528707142|FG002|Overall Study|Adverse Event|8|||
146600390|NCT01264770|528707143|FG003|Overall Study|Adverse Event|0|||
146600391|NCT01264770|528707144|FG004|Overall Study|Adverse Event|2|||
146600392|NCT01264770|528707145|FG005|Overall Study|Adverse Event|1|||
146600393|NCT02528357|528707148|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146600394|NCT02528357|528707149|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
146600395|NCT02528357|528707150|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146600396|NCT02528357|528707151|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146600397|NCT02528357|528707152|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146922337|NCT02052778|529876746|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146922338|NCT02052778|529876747|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146922339|NCT02052778|529876748|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146922340|NCT02052778|529876749|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146600398|NCT02528357|528707153|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146600399|NCT02528357|528707154|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146600400|NCT02528357|528707155|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146600401|NCT02528357|528707156|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146922341|NCT02052778|529876750|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146922342|NCT02052778|529876751|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146600402|NCT02528357|528707157|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146600403|NCT02528357|528707158|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146600404|NCT02528357|528707159|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146600405|NCT02528357|528707160|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146600406|NCT02528357|528707161|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146600407|NCT02528357|528707162|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146600408|NCT02528357|528707163|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146600409|NCT02528357|528707164|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146600410|NCT02528357|528707165|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146600411|NCT02528357|528707166|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146600412|NCT02528357|528707148|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146600413|NCT02528357|528707149|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146600414|NCT02528357|528707150|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146600415|NCT02528357|528707151|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
146600416|NCT02528357|528707152|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146600417|NCT02528357|528707153|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
146600418|NCT02528357|528707154|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146600419|NCT02528357|528707155|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
146600420|NCT02528357|528707156|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146600421|NCT02528357|528707157|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146600422|NCT02528357|528707158|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146600423|NCT02528357|528707159|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146600424|NCT02528357|528707160|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146600425|NCT02528357|528707161|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146600426|NCT02528357|528707162|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146600427|NCT02528357|528707163|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146600428|NCT02528357|528707164|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146600429|NCT02528357|528707165|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146600430|NCT02528357|528707166|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146600431|NCT02528357|528707148|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146600432|NCT02528357|528707149|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146600433|NCT02528357|528707150|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
146600434|NCT02528357|528707151|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146600435|NCT02528357|528707152|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
146600436|NCT02528357|528707153|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146600437|NCT02528357|528707154|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
146600438|NCT02528357|528707155|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
146600439|NCT02528357|528707156|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146600440|NCT02528357|528707157|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146600441|NCT02528357|528707158|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146600442|NCT02528357|528707159|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146600443|NCT02528357|528707160|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146600444|NCT02528357|528707161|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146600445|NCT02528357|528707162|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146600446|NCT02528357|528707163|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146600447|NCT02528357|528707164|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146600448|NCT02528357|528707165|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146600449|NCT02528357|528707166|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146600450|NCT02528357|528707148|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600451|NCT02528357|528707149|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600452|NCT02528357|528707150|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600453|NCT02528357|528707151|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600454|NCT02528357|528707152|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
146600455|NCT02528357|528707153|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600456|NCT02528357|528707154|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600457|NCT02528357|528707155|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600458|NCT02528357|528707156|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600459|NCT02528357|528707157|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600460|NCT02528357|528707158|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600461|NCT02528357|528707159|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600462|NCT02528357|528707160|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146771903|NCT00457691|529332658|FG001|Overall Study|Subject refused (reason other than AE)|19|||
146771904|NCT00457691|529332657|FG000|Overall Study|Disease progression, study terminated|180|||
146771905|NCT00457691|529332658|FG001|Overall Study|Disease progression, study terminated|196|||
146771906|NCT01420549|529332659|FG000|Overall Study|Adverse Event|1|||
146771907|NCT01420549|529332660|FG001|Overall Study|Adverse Event|1|||
146771908|NCT01420549|529332659|FG000|Overall Study|Lost to Follow-up|2|||
146600463|NCT02528357|528707161|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600464|NCT02528357|528707162|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600465|NCT02528357|528707163|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600466|NCT02528357|528707164|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600467|NCT02528357|528707165|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600468|NCT02528357|528707166|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600469|NCT02528357|528707148|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600470|NCT02528357|528707149|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600471|NCT02528357|528707150|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600472|NCT02528357|528707151|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600473|NCT02528357|528707152|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600474|NCT02528357|528707153|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600475|NCT02528357|528707154|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600476|NCT02528357|528707155|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600477|NCT02528357|528707156|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600478|NCT02528357|528707157|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600479|NCT02528357|528707158|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600480|NCT02528357|528707159|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600481|NCT02528357|528707160|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600482|NCT02528357|528707161|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
146600483|NCT02528357|528707162|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
146600484|NCT02528357|528707163|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600485|NCT02528357|528707164|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600486|NCT02528357|528707165|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600487|NCT02528357|528707166|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146600488|NCT02528357|528707148|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600489|NCT02528357|528707149|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600490|NCT02528357|528707150|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600491|NCT02528357|528707151|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600492|NCT02528357|528707152|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600493|NCT02528357|528707153|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600494|NCT02528357|528707154|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600495|NCT02528357|528707155|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600496|NCT02528357|528707156|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600497|NCT02528357|528707157|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600498|NCT02528357|528707158|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600499|NCT02528357|528707159|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600500|NCT02528357|528707160|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600501|NCT02528357|528707161|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
146600502|NCT02528357|528707162|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600503|NCT02528357|528707163|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600504|NCT02528357|528707164|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600505|NCT02528357|528707165|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600506|NCT02528357|528707166|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146600507|NCT02528357|528707148|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146600508|NCT02528357|528707149|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146600509|NCT02528357|528707150|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146600510|NCT02528357|528707151|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146600511|NCT02528357|528707152|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146600512|NCT02528357|528707153|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146600513|NCT02528357|528707154|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146600514|NCT02528357|528707155|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146600515|NCT02528357|528707156|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146655161|NCT03282565|528914239|FG002|Overall Study|COVID-19 Research Shutdown|2|||
146655162|NCT02011893|528914240|FG000|Enrollment to Randomization|Adverse Event|2|||
146922343|NCT02052778|529876752|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146922344|NCT02052778|529876753|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146922345|NCT02052778|529876754|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146922346|NCT02052778|529876755|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
146922347|NCT02052778|529876756|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
146600516|NCT02528357|528707157|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146600517|NCT02528357|528707158|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
146600518|NCT02528357|528707159|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146600519|NCT02528357|528707160|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
146600520|NCT02528357|528707161|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
146600521|NCT02528357|528707162|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
146600522|NCT02528357|528707163|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146600523|NCT02528357|528707164|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146600524|NCT02528357|528707165|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146600525|NCT02528357|528707166|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146600526|NCT02528357|528707148|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600527|NCT02528357|528707149|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600528|NCT02528357|528707150|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600529|NCT02528357|528707151|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600530|NCT02528357|528707152|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600531|NCT02528357|528707153|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600532|NCT02528357|528707154|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600533|NCT02528357|528707155|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600534|NCT02528357|528707156|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
146600535|NCT02528357|528707157|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
146600536|NCT02528357|528707158|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600537|NCT02528357|528707159|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
146600538|NCT02528357|528707160|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
146600539|NCT02528357|528707161|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
146600540|NCT02528357|528707162|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
146600541|NCT02528357|528707163|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600542|NCT02528357|528707164|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600543|NCT02528357|528707165|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600544|NCT02528357|528707166|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600545|NCT02528357|528707148|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600546|NCT02528357|528707149|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600547|NCT02528357|528707150|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600548|NCT02528357|528707151|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600549|NCT02528357|528707152|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600550|NCT02528357|528707153|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600551|NCT02528357|528707154|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600552|NCT02528357|528707155|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600553|NCT02528357|528707156|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600554|NCT02528357|528707157|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600555|NCT02528357|528707158|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600556|NCT02528357|528707159|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600557|NCT02528357|528707160|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600558|NCT02528357|528707161|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600559|NCT02528357|528707162|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600560|NCT02528357|528707163|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600561|NCT02528357|528707164|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
146922348|NCT02052778|529876757|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146600562|NCT02528357|528707165|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600563|NCT02528357|528707166|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146600564|NCT02528357|528707148|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600565|NCT02528357|528707149|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600566|NCT02528357|528707150|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146655163|NCT02011893|528914241|FG001|Enrollment to Randomization|Adverse Event|0|||
146922349|NCT02052778|529876758|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146922350|NCT02052778|529876759|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146922351|NCT02052778|529876760|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146600567|NCT02528357|528707151|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600568|NCT02528357|528707152|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600569|NCT02528357|528707153|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600570|NCT02528357|528707154|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600571|NCT02528357|528707155|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600572|NCT02528357|528707156|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600573|NCT02528357|528707157|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600574|NCT02528357|528707158|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600575|NCT02528357|528707159|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600576|NCT02528357|528707160|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600577|NCT02528357|528707161|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600578|NCT02528357|528707162|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600579|NCT02528357|528707163|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146600580|NCT02528357|528707164|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
146600581|NCT02528357|528707165|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
146600582|NCT02528357|528707166|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
146600583|NCT02477553|528707172|FG000|Overall Study|Screening up-to-date|12|||
146600584|NCT02477553|528707173|FG001|Overall Study|Screening up-to-date|13|||
146600585|NCT02477553|528707172|FG000|Overall Study|No MD visit|1|||
146600586|NCT02477553|528707173|FG001|Overall Study|No MD visit|1|||
146600587|NCT02477553|528707172|FG000|Overall Study|Workup consistent w/CRC|1|||
146600588|NCT02477553|528707173|FG001|Overall Study|Workup consistent w/CRC|1|||
146600589|NCT02477553|528707172|FG000|Overall Study|Technical issues with intervention|2|||
146600590|NCT02477553|528707173|FG001|Overall Study|Technical issues with intervention|0|||
146600591|NCT02477553|528707172|FG000|Overall Study|Elevated risk for CRC|2|||
146600592|NCT02477553|528707173|FG001|Overall Study|Elevated risk for CRC|2|||
146600593|NCT02477553|528707172|FG000|Overall Study|MD advised against screening|1|||
146600594|NCT02477553|528707173|FG001|Overall Study|MD advised against screening|3|||
146600595|NCT02477553|528707172|FG000|Overall Study|patient deceased|1|||
146600596|NCT02477553|528707173|FG001|Overall Study|patient deceased|0|||
146600597|NCT02745535|528707179|FG000|Overall Study|Death|1|||
146600598|NCT02745535|528707179|FG000|Overall Study|Adverse Event|3|||
146600599|NCT02745535|528707179|FG000|Overall Study|Lost to Follow-up|2|||
146600600|NCT01291277|528707180|FG000|Overall Study|Death|2|||
146600601|NCT01291277|528707181|FG001|Overall Study|Death|2|||
146600602|NCT01291277|528707180|FG000|Overall Study|Lost to Follow-up|3|||
146600603|NCT01291277|528707181|FG001|Overall Study|Lost to Follow-up|1|||
146600604|NCT00849108|528707185|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
146600605|NCT00849108|528707186|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
146600606|NCT00849108|528707185|FG000|Cohort 2 Efficacy|Adverse Event|0|||
146600607|NCT00849108|528707186|FG001|Cohort 2 Efficacy|Adverse Event|1|||
146600608|NCT00849108|528707185|FG000|Cohort 2 Efficacy|Other|0|||
146600609|NCT00849108|528707186|FG001|Cohort 2 Efficacy|Other|9|||
146600610|NCT02963701|528707187|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
146600611|NCT02963701|528707188|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
146600612|NCT03480009|528707191|FG000|Overall Study|Lost to Follow-up|4|||
146600613|NCT03480009|528707192|FG001|Overall Study|Lost to Follow-up|5|||
146600614|NCT03480009|528707193|FG002|Overall Study|Lost to Follow-up|4|||
146600615|NCT03480009|528707194|FG003|Overall Study|Lost to Follow-up|0|||
146600616|NCT01345682|528707195|FG000|Overall Study|Progressive disease per RECIST|226|||
146600617|NCT01345682|528707196|FG001|Overall Study|Progressive disease per RECIST|93|||
146600618|NCT01345682|528707195|FG000|Overall Study|Worsening of underlying cancer disease|23|||
146600619|NCT01345682|528707196|FG001|Overall Study|Worsening of underlying cancer disease|12|||
146600620|NCT01345682|528707195|FG000|Overall Study|Adverse Event|51|||
146600621|NCT01345682|528707196|FG001|Overall Study|Adverse Event|41|||
146600622|NCT01345682|528707195|FG000|Overall Study|Non-compliance with protocol|0|||
146600623|NCT01345682|528707196|FG001|Overall Study|Non-compliance with protocol|1|||
146600624|NCT01345682|528707195|FG000|Overall Study|Lost to Follow-up|0|||
146600625|NCT01345682|528707196|FG001|Overall Study|Lost to Follow-up|1|||
146600626|NCT01345682|528707195|FG000|Overall Study|Refused to continue trial medication|16|||
146600627|NCT01345682|528707196|FG001|Overall Study|Refused to continue trial medication|9|||
146600628|NCT01345682|528707195|FG000|Overall Study|Not treated|2|||
146600629|NCT01345682|528707196|FG001|Overall Study|Not treated|1|||
146922352|NCT02052778|529876761|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146922353|NCT02052778|529876762|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146922354|NCT02052778|529876763|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146771909|NCT01420549|529332660|FG001|Overall Study|Lost to Follow-up|2|||
146771910|NCT01420549|529332659|FG000|Overall Study|Protocol Violation|0|||
146600630|NCT01345682|528707195|FG000|Overall Study|Reason other than those specified above|4|||
146600631|NCT01345682|528707196|FG001|Overall Study|Reason other than those specified above|3|||
146600632|NCT00637572|528707197|FG000|Overall Study|Adverse Event|1|||
146600633|NCT00637572|528707198|FG001|Overall Study|Adverse Event|2|||
146600634|NCT00637572|528707197|FG000|Overall Study|Death|0|||
146600635|NCT00637572|528707198|FG001|Overall Study|Death|1|||
146600636|NCT00637572|528707197|FG000|Overall Study|Lost to Follow-up|0|||
146600637|NCT00637572|528707198|FG001|Overall Study|Lost to Follow-up|1|||
146600638|NCT00637572|528707197|FG000|Overall Study|Physician Decision|1|||
146600639|NCT00637572|528707198|FG001|Overall Study|Physician Decision|1|||
146600640|NCT00637572|528707197|FG000|Overall Study|Withdrawal by Subject|0|||
146600641|NCT00637572|528707198|FG001|Overall Study|Withdrawal by Subject|2|||
146600642|NCT00637572|528707197|FG000|Overall Study|Illicit Drug Use|1|||
146600643|NCT00637572|528707198|FG001|Overall Study|Illicit Drug Use|0|||
146600644|NCT00896649|528707199|FG000|Overall Study|Physician Decision|1|||
146600645|NCT00896649|528707199|FG000|Overall Study|Pregnancy|1|||
146600646|NCT00896649|528707199|FG000|Overall Study|missing documentation|1|||
146600647|NCT00896649|528707199|FG000|Overall Study|technical difficulties|2|||
146600648|NCT01075984|528707202|FG000|Treatment Phase|Adverse Event|0|||
146600649|NCT01075984|528707203|FG001|Treatment Phase|Adverse Event|1|||
146600650|NCT01075984|528707204|FG002|Treatment Phase|Adverse Event|3|||
146600651|NCT01075984|528707205|FG003|Treatment Phase|Adverse Event|7|||
146600652|NCT01075984|528707206|FG004|Treatment Phase|Adverse Event|35|||
146600653|NCT01075984|528707202|FG000|Treatment Phase|Protocol Violation|0|||
146600654|NCT01075984|528707203|FG001|Treatment Phase|Protocol Violation|0|||
146600655|NCT01075984|528707204|FG002|Treatment Phase|Protocol Violation|1|||
146600656|NCT01075984|528707205|FG003|Treatment Phase|Protocol Violation|0|||
146600657|NCT01075984|528707206|FG004|Treatment Phase|Protocol Violation|3|||
146600658|NCT01075984|528707202|FG000|Treatment Phase|Withdrawal by Subject|0|||
146600659|NCT01075984|528707203|FG001|Treatment Phase|Withdrawal by Subject|0|||
146600660|NCT01075984|528707204|FG002|Treatment Phase|Withdrawal by Subject|2|||
146600661|NCT01075984|528707205|FG003|Treatment Phase|Withdrawal by Subject|0|||
146600662|NCT01075984|528707206|FG004|Treatment Phase|Withdrawal by Subject|15|||
146600663|NCT01075984|528707202|FG000|Treatment Phase|Treatment Failure|0|||
146600664|NCT01075984|528707203|FG001|Treatment Phase|Treatment Failure|0|||
146600665|NCT01075984|528707204|FG002|Treatment Phase|Treatment Failure|1|||
146600666|NCT01075984|528707205|FG003|Treatment Phase|Treatment Failure|0|||
146600667|NCT01075984|528707206|FG004|Treatment Phase|Treatment Failure|5|||
146600668|NCT01075984|528707202|FG000|Treatment Phase|Progression of disease|0|||
146600669|NCT01075984|528707203|FG001|Treatment Phase|Progression of disease|0|||
146600670|NCT01075984|528707204|FG002|Treatment Phase|Progression of disease|0|||
146600671|NCT01075984|528707205|FG003|Treatment Phase|Progression of disease|0|||
146600672|NCT01075984|528707206|FG004|Treatment Phase|Progression of disease|2|||
146600673|NCT01075984|528707202|FG000|Follow-up Phase|Protocol Violation|0|||
146600674|NCT01075984|528707203|FG001|Follow-up Phase|Protocol Violation|0|||
146600675|NCT01075984|528707204|FG002|Follow-up Phase|Protocol Violation|1|||
146600676|NCT01075984|528707205|FG003|Follow-up Phase|Protocol Violation|0|||
146600677|NCT01075984|528707206|FG004|Follow-up Phase|Protocol Violation|3|||
146600678|NCT01075984|528707202|FG000|Follow-up Phase|Adverse Event|0|||
146600679|NCT01075984|528707203|FG001|Follow-up Phase|Adverse Event|0|||
146600680|NCT01075984|528707204|FG002|Follow-up Phase|Adverse Event|0|||
146600681|NCT01075984|528707205|FG003|Follow-up Phase|Adverse Event|2|||
146600682|NCT01075984|528707206|FG004|Follow-up Phase|Adverse Event|27|||
146600683|NCT01075984|528707202|FG000|Follow-up Phase|Administrative|0|||
146600684|NCT01075984|528707203|FG001|Follow-up Phase|Administrative|0|||
146600685|NCT01075984|528707204|FG002|Follow-up Phase|Administrative|0|||
146600686|NCT01075984|528707205|FG003|Follow-up Phase|Administrative|0|||
146600687|NCT01075984|528707206|FG004|Follow-up Phase|Administrative|1|||
146600688|NCT01075984|528707202|FG000|Follow-up Phase|Withdrawal by Subject|0|||
146600689|NCT01075984|528707203|FG001|Follow-up Phase|Withdrawal by Subject|0|||
146600690|NCT01075984|528707204|FG002|Follow-up Phase|Withdrawal by Subject|0|||
146600691|NCT01075984|528707205|FG003|Follow-up Phase|Withdrawal by Subject|0|||
146600692|NCT01075984|528707206|FG004|Follow-up Phase|Withdrawal by Subject|10|||
146600693|NCT01075984|528707202|FG000|Follow-up Phase|Progression of disease|0|||
146600694|NCT01075984|528707203|FG001|Follow-up Phase|Progression of disease|0|||
146600695|NCT01075984|528707204|FG002|Follow-up Phase|Progression of disease|0|||
146771911|NCT01420549|529332660|FG001|Overall Study|Protocol Violation|1|||
146600696|NCT01075984|528707205|FG003|Follow-up Phase|Progression of disease|0|||
146600697|NCT01075984|528707206|FG004|Follow-up Phase|Progression of disease|2|||
146771912|NCT01420549|529332659|FG000|Overall Study|Non-adherence to medication|4|||
146771913|NCT01420549|529332660|FG001|Overall Study|Non-adherence to medication|1|||
146600698|NCT01075984|528707202|FG000|Follow-up Phase|Treatment failure|0|||
146600699|NCT01075984|528707203|FG001|Follow-up Phase|Treatment failure|0|||
146600700|NCT01075984|528707204|FG002|Follow-up Phase|Treatment failure|0|||
146600701|NCT01075984|528707205|FG003|Follow-up Phase|Treatment failure|0|||
146600702|NCT01075984|528707206|FG004|Follow-up Phase|Treatment failure|4|||
146600703|NCT03652675|528707208|FG000|Overall Study|Lost to Follow-up|4|||
146600704|NCT03652675|528707209|FG001|Overall Study|Lost to Follow-up|4|||
146600705|NCT01638559|528707210|FG000|Overall Study|Lost to Follow-up|1|||
146600706|NCT01638559|528707210|FG000|Overall Study|Withdrawal by Subject|1|||
146600707|NCT01638559|528707210|FG000|Overall Study|Subject declined to travel for biopsy|1|||
146600708|NCT01274429|528707221|FG000|Overall Study|Study closed do to lack of funding|5|||
146600709|NCT04046250|528707231|FG000|Overall Study|Death|0|||
146600710|NCT04046250|528707232|FG001|Overall Study|Death|1|||
146600711|NCT04046250|528707231|FG000|Overall Study|Withdrawal by Subject|3|||
146600712|NCT04046250|528707232|FG001|Overall Study|Withdrawal by Subject|3|||
146600713|NCT03268941|528709041|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
146600714|NCT03268941|528709042|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
146600715|NCT03268941|528709043|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
146600716|NCT03268941|528709044|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
146600717|NCT03268941|528709045|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
146600718|NCT03268941|528709046|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
146600719|NCT03268941|528709047|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
146600720|NCT03268941|528709041|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
146600721|NCT03268941|528709042|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
146600722|NCT03268941|528709043|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
146600723|NCT03268941|528709044|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
146600724|NCT03268941|528709045|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
146600725|NCT03268941|528709046|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
146600726|NCT03268941|528709047|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
146600727|NCT03268941|528709041|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
146600728|NCT03268941|528709042|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
146600729|NCT03268941|528709043|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
146600730|NCT03268941|528709044|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
146600731|NCT03268941|528709045|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
146600732|NCT03268941|528709046|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
146600733|NCT03268941|528709047|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
146655164|NCT02011893|528914242|FG002|Enrollment to Randomization|Adverse Event|0|||
146655165|NCT02011893|528914240|FG000|Enrollment to Randomization|Physician Decision|10|||
146655166|NCT02011893|528914241|FG001|Enrollment to Randomization|Physician Decision|0|||
146655167|NCT02011893|528914242|FG002|Enrollment to Randomization|Physician Decision|0|||
146655168|NCT02011893|528914240|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
146655169|NCT02011893|528914241|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
146655170|NCT02011893|528914242|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
146655171|NCT02011893|528914240|FG000|Enrollment to Randomization|Screening Failure|29|||
146655172|NCT02011893|528914241|FG001|Enrollment to Randomization|Screening Failure|0|||
146655173|NCT02011893|528914242|FG002|Enrollment to Randomization|Screening Failure|0|||
146655174|NCT02011893|528914240|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
146655175|NCT02011893|528914241|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
146655176|NCT02011893|528914242|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
146655177|NCT02011893|528914240|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
146655178|NCT02011893|528914241|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
146655179|NCT02011893|528914242|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
146655180|NCT02011893|528914240|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
146655181|NCT02011893|528914241|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
146655182|NCT02011893|528914242|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
146655183|NCT02011893|528914240|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
146655184|NCT02011893|528914241|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
146655185|NCT02011893|528914242|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
146655186|NCT02011893|528914240|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
146655187|NCT02011893|528914241|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
146655188|NCT02011893|528914242|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
146655189|NCT00518973|528914243|FG000|Overall Study|Withdrawal by Subject|3|||
146655190|NCT00518973|528914244|FG001|Overall Study|Withdrawal by Subject|2|||
146655191|NCT03452527|528914245|FG000|Overall Study|Withdrawal by Subject|1|||
146655192|NCT03452527|528914246|FG001|Overall Study|Withdrawal by Subject|1|||
146655193|NCT03452527|528914245|FG000|Overall Study|Study Terminated|2|||
146655194|NCT03452527|528914246|FG001|Overall Study|Study Terminated|3|||
146600734|NCT03268941|528709041|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
146600735|NCT03268941|528709042|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
146655195|NCT00582816|528914247|FG000|Overall Study|Engraftment Failure|3|||
146655196|NCT01565499|528914251|FG000|Overall Study|Physician Decision|1|||
146655197|NCT01565499|528914251|FG000|Overall Study|Adverse Event|5|||
146922355|NCT02052778|529876741|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146655198|NCT01565499|528914251|FG000|Overall Study|Withdrawal by Subject|2|||
146655199|NCT01923168|528914254|FG000|Overall Study|Protocol Violation|1|||
146655200|NCT01923168|528914255|FG001|Overall Study|Protocol Violation|1|||
146655201|NCT01923168|528914256|FG002|Overall Study|Protocol Violation|0|||
146655202|NCT01923168|528914254|FG000|Overall Study|Subject/guardian decision|14|||
146655203|NCT01923168|528914255|FG001|Overall Study|Subject/guardian decision|14|||
146655204|NCT01923168|528914256|FG002|Overall Study|Subject/guardian decision|4|||
146655205|NCT01923168|528914254|FG000|Overall Study|Adverse Event|12|||
146655206|NCT01923168|528914255|FG001|Overall Study|Adverse Event|12|||
146655207|NCT01923168|528914256|FG002|Overall Study|Adverse Event|0|||
146655208|NCT01923168|528914254|FG000|Overall Study|Physician Decision|6|||
146655209|NCT01923168|528914255|FG001|Overall Study|Physician Decision|9|||
146655210|NCT01923168|528914256|FG002|Overall Study|Physician Decision|5|||
146655211|NCT01923168|528914254|FG000|Overall Study|Progressive disease|4|||
146655212|NCT01923168|528914255|FG001|Overall Study|Progressive disease|3|||
146655213|NCT01923168|528914256|FG002|Overall Study|Progressive disease|7|||
146655214|NCT01923168|528914254|FG000|Overall Study|Death|0|||
146655215|NCT01923168|528914255|FG001|Overall Study|Death|0|||
146655216|NCT01923168|528914256|FG002|Overall Study|Death|1|||
146655217|NCT01255787|528914257|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
146655218|NCT01255787|528914258|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
146655219|NCT01255787|528914259|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
146655220|NCT01255787|528914260|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
146655221|NCT01255787|528914257|FG000|Overall Study|Major Protocol Deviation|1|||
146655222|NCT01255787|528914258|FG001|Overall Study|Major Protocol Deviation|1|||
146655223|NCT01255787|528914259|FG002|Overall Study|Major Protocol Deviation|0|||
146655224|NCT01255787|528914260|FG003|Overall Study|Major Protocol Deviation|4|||
146655225|NCT01255787|528914257|FG000|Overall Study|Lost to Follow-up|1|||
146655226|NCT01255787|528914258|FG001|Overall Study|Lost to Follow-up|2|||
146655227|NCT01255787|528914259|FG002|Overall Study|Lost to Follow-up|4|||
146655228|NCT01255787|528914260|FG003|Overall Study|Lost to Follow-up|2|||
146655229|NCT01255787|528914257|FG000|Overall Study|Withdrawal of Consent|3|||
146655230|NCT01255787|528914258|FG001|Overall Study|Withdrawal of Consent|9|||
146655231|NCT01255787|528914259|FG002|Overall Study|Withdrawal of Consent|3|||
146655232|NCT01255787|528914260|FG003|Overall Study|Withdrawal of Consent|4|||
146655233|NCT01255787|528914257|FG000|Overall Study|Pregnancy|0|||
146655234|NCT01255787|528914258|FG001|Overall Study|Pregnancy|0|||
146655235|NCT01255787|528914259|FG002|Overall Study|Pregnancy|0|||
146655236|NCT01255787|528914260|FG003|Overall Study|Pregnancy|1|||
146655237|NCT01255787|528914257|FG000|Overall Study|Lack of Efficacy|2|||
146655238|NCT01255787|528914258|FG001|Overall Study|Lack of Efficacy|2|||
146655239|NCT01255787|528914259|FG002|Overall Study|Lack of Efficacy|2|||
146655240|NCT01255787|528914260|FG003|Overall Study|Lack of Efficacy|2|||
146655241|NCT01255787|528914257|FG000|Overall Study|Noncompliance with Study Drug|3|||
146655242|NCT01255787|528914258|FG001|Overall Study|Noncompliance with Study Drug|1|||
146655243|NCT01255787|528914259|FG002|Overall Study|Noncompliance with Study Drug|0|||
146655244|NCT01255787|528914260|FG003|Overall Study|Noncompliance with Study Drug|0|||
146655245|NCT03170232|528914261|FG000|Overall Study|Adverse Event|0|||
146655246|NCT03170232|528914262|FG001|Overall Study|Adverse Event|1|||
146655247|NCT03170232|528914261|FG000|Overall Study|Protocol Violation|0|||
146655248|NCT03170232|528914262|FG001|Overall Study|Protocol Violation|1|||
146655249|NCT03170232|528914261|FG000|Overall Study|Lack of Efficacy|0|||
146655250|NCT03170232|528914262|FG001|Overall Study|Lack of Efficacy|1|||
146655251|NCT03170232|528914261|FG000|Overall Study|Study closed/terminated|26|||
146655252|NCT03170232|528914262|FG001|Overall Study|Study closed/terminated|23|||
146655253|NCT03170232|528914261|FG000|Overall Study|Lost to Follow-up|1|||
146655254|NCT03170232|528914262|FG001|Overall Study|Lost to Follow-up|0|||
146655255|NCT03170232|528914261|FG000|Overall Study|Withdrawal by Subject|0|||
146655256|NCT03170232|528914262|FG001|Overall Study|Withdrawal by Subject|1|||
146655257|NCT03882008|528914263|FG000|Overall Study|Withdrawal by Subject|1|||
146655258|NCT03882008|528914263|FG000|Overall Study|Lost to Follow-up|1|||
146655259|NCT00768469|528914265|FG000|Overall Study|Adverse Event|0|||
146655260|NCT00768469|528914266|FG001|Overall Study|Adverse Event|2|||
146655261|NCT00768469|528914265|FG000|Overall Study|Disease Progression|3|||
146922356|NCT02052778|529876742|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146922357|NCT02052778|529876743|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146655262|NCT00768469|528914266|FG001|Overall Study|Disease Progression|4|||
146655263|NCT00768469|528914265|FG000|Overall Study|Withdrawal by Subject|0|||
146655264|NCT00768469|528914266|FG001|Overall Study|Withdrawal by Subject|1|||
146655265|NCT01582854|528914269|FG000|Overall Study|Death|8|||
146655266|NCT01582854|528914270|FG001|Overall Study|Death|5|||
146655267|NCT01582854|528914269|FG000|Overall Study|Adverse Event|2|||
146655268|NCT01582854|528914270|FG001|Overall Study|Adverse Event|3|||
146655269|NCT01582854|528914269|FG000|Overall Study|Withdrawal by Participant|8|||
146655270|NCT01582854|528914270|FG001|Overall Study|Withdrawal by Participant|11|||
146655271|NCT01582854|528914269|FG000|Overall Study|Lost to Follow-up|1|||
146655272|NCT01582854|528914270|FG001|Overall Study|Lost to Follow-up|2|||
146655273|NCT01582854|528914269|FG000|Overall Study|Physician Decision|0|||
146922358|NCT02052778|529876744|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146655274|NCT01582854|528914270|FG001|Overall Study|Physician Decision|1|||
146655275|NCT01582854|528914269|FG000|Overall Study|Recurrent Stroke|13|||
146655276|NCT01582854|528914270|FG001|Overall Study|Recurrent Stroke|8|||
146600736|NCT03268941|528709043|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
146600737|NCT03268941|528709044|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
146600738|NCT03268941|528709045|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
146600739|NCT03268941|528709046|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
146600740|NCT03268941|528709047|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
146600741|NCT03268941|528709041|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
146600742|NCT03268941|528709042|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
146600743|NCT03268941|528709043|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
146600744|NCT03268941|528709044|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
146600745|NCT03268941|528709045|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
146600746|NCT03268941|528709046|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
146600747|NCT03268941|528709047|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
146600748|NCT01216683|528709048|FG000|Induction|Never started treatment|0|||
146600749|NCT01216683|528709049|FG001|Induction|Never started treatment|6|||
146600750|NCT01216683|528709050|FG002|Induction|Never started treatment|3|||
146600751|NCT01216683|528709048|FG000|Induction|Lack of Efficacy|4|||
146922359|NCT02052778|529876745|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146922360|NCT02052778|529876746|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146922361|NCT02052778|529876747|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146922362|NCT02052778|529876748|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146600752|NCT01216683|528709049|FG001|Induction|Lack of Efficacy|3|||
146600753|NCT01216683|528709050|FG002|Induction|Lack of Efficacy|7|||
146600754|NCT01216683|528709048|FG000|Induction|Adverse Event|0|||
146600755|NCT01216683|528709049|FG001|Induction|Adverse Event|5|||
146922363|NCT02052778|529876749|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146922364|NCT02052778|529876750|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146922365|NCT02052778|529876751|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146922366|NCT02052778|529876752|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146922367|NCT02052778|529876753|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146922368|NCT02052778|529876754|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146922369|NCT02052778|529876755|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
146978606|NCT03276962|530084114|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
146978607|NCT03276962|530084115|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
146600756|NCT01216683|528709050|FG002|Induction|Adverse Event|5|||
146600757|NCT01216683|528709048|FG000|Induction|Death|0|||
146600758|NCT01216683|528709049|FG001|Induction|Death|0|||
146600759|NCT01216683|528709050|FG002|Induction|Death|2|||
146600760|NCT01216683|528709048|FG000|Induction|Withdrawal by Subject|0|||
146600761|NCT01216683|528709049|FG001|Induction|Withdrawal by Subject|4|||
146600762|NCT01216683|528709050|FG002|Induction|Withdrawal by Subject|2|||
146600763|NCT01216683|528709048|FG000|Induction|Other disease|0|||
146600764|NCT01216683|528709049|FG001|Induction|Other disease|1|||
146600765|NCT01216683|528709050|FG002|Induction|Other disease|2|||
146600766|NCT01216683|528709048|FG000|Continuation|Lack of Efficacy|3|||
146600767|NCT01216683|528709049|FG001|Continuation|Lack of Efficacy|2|||
146600768|NCT01216683|528709050|FG002|Continuation|Lack of Efficacy|7|||
146600769|NCT01216683|528709048|FG000|Continuation|Adverse Event|5|||
146600770|NCT01216683|528709049|FG001|Continuation|Adverse Event|3|||
146600771|NCT01216683|528709050|FG002|Continuation|Adverse Event|16|||
146600772|NCT01216683|528709048|FG000|Continuation|Death|1|||
146600773|NCT01216683|528709049|FG001|Continuation|Death|0|||
146600774|NCT01216683|528709050|FG002|Continuation|Death|2|||
146600775|NCT01216683|528709048|FG000|Continuation|Withdrawal by Subject|4|||
146600776|NCT01216683|528709049|FG001|Continuation|Withdrawal by Subject|5|||
146600777|NCT01216683|528709050|FG002|Continuation|Withdrawal by Subject|9|||
146600778|NCT01216683|528709048|FG000|Continuation|Other diseases|0|||
146600779|NCT01216683|528709049|FG001|Continuation|Other diseases|2|||
146600780|NCT01216683|528709050|FG002|Continuation|Other diseases|1|||
146600781|NCT01216683|528709048|FG000|Continuation|Physician Decision|1|||
146600782|NCT01216683|528709049|FG001|Continuation|Physician Decision|0|||
146600783|NCT01216683|528709050|FG002|Continuation|Physician Decision|1|||
146600784|NCT01216683|528709048|FG000|Continuation|Non-compliance|1|||
146600785|NCT01216683|528709049|FG001|Continuation|Non-compliance|0|||
146600786|NCT01216683|528709050|FG002|Continuation|Non-compliance|1|||
146655277|NCT01582854|528914269|FG000|Overall Study|Disallowed Concomitant Medication|3|||
146600787|NCT01216683|528709048|FG000|Continuation|Insurance change|0|||
146600788|NCT01216683|528709049|FG001|Continuation|Insurance change|1|||
146600789|NCT01216683|528709050|FG002|Continuation|Insurance change|0|||
146600790|NCT01216683|528709048|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
146600791|NCT01216683|528709049|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
146600792|NCT01216683|528709050|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
146600793|NCT01216683|528709048|FG000|Continuation|Not reported|0|||
146600794|NCT01216683|528709049|FG001|Continuation|Not reported|0|||
146600795|NCT01216683|528709050|FG002|Continuation|Not reported|1|||
146771914|NCT03073941|529334325|FG000|Overall Study|Received non-study device intraoperatively|0|||
146771915|NCT03073941|529334326|FG001|Overall Study|Received non-study device intraoperatively|2|||
146771916|NCT03073941|529334325|FG000|Overall Study|Death|1|||
146771917|NCT03073941|529334326|FG001|Overall Study|Death|0|||
146771918|NCT03073941|529334325|FG000|Overall Study|Withdrawal by Subject|1|||
146771919|NCT03073941|529334326|FG001|Overall Study|Withdrawal by Subject|3|||
146771920|NCT03073941|529334325|FG000|Overall Study|Lost to Follow-up|5|||
146771921|NCT03073941|529334326|FG001|Overall Study|Lost to Follow-up|4|||
146771922|NCT03073941|529334325|FG000|Overall Study|Adverse Event|4|||
146771923|NCT03073941|529334326|FG001|Overall Study|Adverse Event|2|||
146771924|NCT03073941|529334325|FG000|Overall Study|Met an exclusion criterion|0|||
146771925|NCT03073941|529334326|FG001|Overall Study|Met an exclusion criterion|1|||
146771932|NCT01188655|529334332|FG000|Overall Study|Lack of Efficacy|1|||
146771933|NCT01188655|529334332|FG000|Overall Study|Lost to Follow-up|1|||
146771934|NCT01188655|529334332|FG000|Overall Study|Other|11|||
146771935|NCT00925899|529334333|FG000|Part 1|Death|1|||
146771936|NCT00925899|529334334|FG001|Part 1|Death|2|||
146771937|NCT00925899|529334333|FG000|Part 1|Withdrawal by Subject|10|||
146771938|NCT00925899|529334334|FG001|Part 1|Withdrawal by Subject|9|||
146771939|NCT00683696|529334335|FG000|Overall Study|Withdrawn due to study closure|337|||
146771940|NCT00683696|529334336|FG001|Overall Study|Withdrawn due to study closure|338|||
146655278|NCT01582854|528914270|FG001|Overall Study|Disallowed Concomitant Medication|2|||
146655279|NCT01582854|528914269|FG000|Overall Study|Carotid or Neurosurgery|0|||
146655280|NCT01582854|528914270|FG001|Overall Study|Carotid or Neurosurgery|1|||
146655281|NCT01582854|528914269|FG000|Overall Study|General Anaesthesia|0|||
146655282|NCT01582854|528914270|FG001|Overall Study|General Anaesthesia|1|||
146655283|NCT01582854|528914269|FG000|Overall Study|Other Miscellaneous Reason|1|||
146655284|NCT01582854|528914270|FG001|Overall Study|Other Miscellaneous Reason|0|||
146655285|NCT02953509|528914271|FG000|Overall Study|Death|1|||
146655286|NCT02953509|528914272|FG001|Overall Study|Death|3|||
146655287|NCT02953509|528914273|FG002|Overall Study|Death|3|||
146655288|NCT02953509|528914274|FG003|Overall Study|Death|4|||
146655289|NCT02953509|528914275|FG004|Overall Study|Death|12|||
146655290|NCT02953509|528914276|FG005|Overall Study|Death|3|||
146655291|NCT02953509|528914277|FG006|Overall Study|Death|25|||
146655292|NCT02953509|528914278|FG007|Overall Study|Death|10|||
146655293|NCT02953509|528914279|FG008|Overall Study|Death|21|||
146771941|NCT00683696|529334335|FG000|Overall Study|Withdrawn prior to study closure|13|||
146771942|NCT00683696|529334336|FG001|Overall Study|Withdrawn prior to study closure|28|||
146771943|NCT00683696|529334335|FG000|Overall Study|Lost to Follow-up|5|||
146771944|NCT00683696|529334336|FG001|Overall Study|Lost to Follow-up|6|||
146771945|NCT00683696|529334335|FG000|Overall Study|Vital status follow-up only|3|||
146771946|NCT00683696|529334336|FG001|Overall Study|Vital status follow-up only|3|||
146771947|NCT00683696|529334335|FG000|Overall Study|Death|46|||
146771948|NCT00683696|529334336|FG001|Overall Study|Death|30|||
146771949|NCT00089544|529334337|FG000|Overall Study|Ineligible|1|||
146771950|NCT00089544|529334338|FG001|Overall Study|Ineligible|0|||
146771951|NCT01823536|529334341|FG000|Overall Study|Lost to Follow-up|1|||
146771952|NCT01823536|529334342|FG001|Overall Study|Lost to Follow-up|0|||
146771953|NCT01823536|529334343|FG002|Overall Study|Lost to Follow-up|0|||
146771954|NCT01823536|529334344|FG003|Overall Study|Lost to Follow-up|1|||
146771955|NCT01823536|529334345|FG004|Overall Study|Lost to Follow-up|1|||
146771956|NCT01823536|529334346|FG005|Overall Study|Lost to Follow-up|0|||
146655294|NCT02953509|528914280|FG009|Overall Study|Death|20|||
146771957|NCT01823536|529334341|FG000|Overall Study|Protocol Violation|0|||
146771958|NCT01823536|529334342|FG001|Overall Study|Protocol Violation|1|||
146771959|NCT01823536|529334343|FG002|Overall Study|Protocol Violation|0|||
146771960|NCT01823536|529334344|FG003|Overall Study|Protocol Violation|0|||
146771961|NCT01823536|529334345|FG004|Overall Study|Protocol Violation|0|||
146771962|NCT01823536|529334346|FG005|Overall Study|Protocol Violation|0|||
146771963|NCT01823536|529334341|FG000|Overall Study|Withdrawal by Subject|1|||
146771964|NCT01823536|529334342|FG001|Overall Study|Withdrawal by Subject|1|||
146771965|NCT01823536|529334343|FG002|Overall Study|Withdrawal by Subject|0|||
146771966|NCT01823536|529334344|FG003|Overall Study|Withdrawal by Subject|0|||
146771967|NCT01823536|529334345|FG004|Overall Study|Withdrawal by Subject|0|||
146922370|NCT02052778|529876756|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
146922371|NCT02052778|529876757|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146655295|NCT02953509|528914271|FG000|Overall Study|Reason Not Specified|0|||
146655296|NCT02953509|528914272|FG001|Overall Study|Reason Not Specified|2|||
146655297|NCT02953509|528914273|FG002|Overall Study|Reason Not Specified|8|||
146655298|NCT02953509|528914274|FG003|Overall Study|Reason Not Specified|2|||
146655299|NCT02953509|528914275|FG004|Overall Study|Reason Not Specified|11|||
146771968|NCT01823536|529334346|FG005|Overall Study|Withdrawal by Subject|0|||
146922372|NCT02052778|529876758|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146922373|NCT02052778|529876759|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146922374|NCT02052778|529876760|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
146922375|NCT02052778|529876761|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146922376|NCT02052778|529876762|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146922377|NCT02052778|529876763|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146922378|NCT02052778|529876741|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
146922379|NCT02052778|529876742|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
146922380|NCT02052778|529876743|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
146922381|NCT02052778|529876744|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
146922382|NCT02052778|529876745|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
146922383|NCT02052778|529876746|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
146922384|NCT02052778|529876747|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
146922385|NCT02052778|529876748|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
146922386|NCT02052778|529876749|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
146922387|NCT02052778|529876750|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
146922388|NCT02052778|529876751|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
146922389|NCT02052778|529876752|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
146922390|NCT02052778|529876753|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
146922391|NCT02052778|529876754|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
146922392|NCT02052778|529876755|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
146922393|NCT02052778|529876756|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
146922394|NCT02052778|529876757|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
146922395|NCT02052778|529876758|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
146922396|NCT02052778|529876759|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
146922397|NCT02052778|529876760|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
146922398|NCT02052778|529876761|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
146922399|NCT02052778|529876762|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
146922400|NCT02052778|529876763|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
146922401|NCT02052778|529876741|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922402|NCT02052778|529876742|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922403|NCT02052778|529876743|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922404|NCT02052778|529876744|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922405|NCT02052778|529876745|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922406|NCT02052778|529876746|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922407|NCT02052778|529876747|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922408|NCT02052778|529876748|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922409|NCT02052778|529876749|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922410|NCT02052778|529876750|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922411|NCT02052778|529876751|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922412|NCT02052778|529876752|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922413|NCT02052778|529876753|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922414|NCT02052778|529876754|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922415|NCT02052778|529876755|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
146922416|NCT02052778|529876756|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
146922417|NCT02052778|529876757|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
146922418|NCT02052778|529876758|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922419|NCT02052778|529876759|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
146922420|NCT02052778|529876760|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922421|NCT02052778|529876761|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922422|NCT02052778|529876762|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922423|NCT02052778|529876763|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146922424|NCT02052778|529876741|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922425|NCT02052778|529876742|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922426|NCT02052778|529876743|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922427|NCT02052778|529876744|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922428|NCT02052778|529876745|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922429|NCT02052778|529876746|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922430|NCT02052778|529876747|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922431|NCT02052778|529876748|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922432|NCT02052778|529876749|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922433|NCT02052778|529876750|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922434|NCT02052778|529876751|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922435|NCT02052778|529876752|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922436|NCT02052778|529876753|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922437|NCT02052778|529876754|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146978608|NCT03276962|530084116|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
146922438|NCT02052778|529876755|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922439|NCT02052778|529876756|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922440|NCT02052778|529876757|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922441|NCT02052778|529876758|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922442|NCT02052778|529876759|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922443|NCT02052778|529876760|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922444|NCT02052778|529876761|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146922445|NCT02052778|529876762|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146600796|NCT01216683|528709048|FG000|Continuation|Never started treatment|0|||
146600797|NCT01216683|528709049|FG001|Continuation|Never started treatment|1|||
146600798|NCT01216683|528709050|FG002|Continuation|Never started treatment|5|||
146600799|NCT01629953|528709051|FG000|Overall Study|Death|3|||
146600800|NCT01629953|528709052|FG001|Overall Study|Death|1|||
146600801|NCT01629953|528709051|FG000|Overall Study|Lost to Follow-up|10|||
146600802|NCT01629953|528709052|FG001|Overall Study|Lost to Follow-up|14|||
146600803|NCT00344500|528709053|FG000|Overall Study|Adverse Event|6|||
146600804|NCT00344500|528709054|FG001|Overall Study|Adverse Event|2|||
146922446|NCT02052778|529876763|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
146922447|NCT02052778|529876741|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922448|NCT02052778|529876742|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922449|NCT02052778|529876743|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922450|NCT02052778|529876744|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922451|NCT02052778|529876745|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922452|NCT02052778|529876746|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922453|NCT02052778|529876747|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922454|NCT02052778|529876748|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922455|NCT02052778|529876749|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922456|NCT02052778|529876750|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922457|NCT02052778|529876751|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146600805|NCT00344500|528709055|FG002|Overall Study|Adverse Event|0|||
146600806|NCT00344500|528709053|FG000|Overall Study|Lost to Follow-up|5|||
146600807|NCT00344500|528709054|FG001|Overall Study|Lost to Follow-up|13|||
146600808|NCT00344500|528709055|FG002|Overall Study|Lost to Follow-up|1|||
146600809|NCT00344500|528709053|FG000|Overall Study|Withdrawal by Subject|7|||
146600810|NCT00344500|528709054|FG001|Overall Study|Withdrawal by Subject|10|||
146600811|NCT00344500|528709055|FG002|Overall Study|Withdrawal by Subject|0|||
146600812|NCT00344500|528709053|FG000|Overall Study|Protocol Violation|4|||
146600813|NCT00344500|528709054|FG001|Overall Study|Protocol Violation|7|||
146600814|NCT00344500|528709055|FG002|Overall Study|Protocol Violation|1|||
146600815|NCT00344500|528709053|FG000|Overall Study|Not Noted|1|||
146600816|NCT00344500|528709054|FG001|Overall Study|Not Noted|3|||
146922458|NCT02052778|529876752|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922459|NCT02052778|529876753|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922460|NCT02052778|529876754|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922461|NCT02052778|529876755|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922462|NCT02052778|529876756|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922463|NCT02052778|529876757|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922464|NCT02052778|529876758|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922465|NCT02052778|529876759|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922466|NCT02052778|529876760|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922467|NCT02052778|529876761|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922468|NCT02052778|529876762|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146922469|NCT02052778|529876763|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
146922470|NCT02052778|529876741|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922471|NCT02052778|529876742|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922472|NCT02052778|529876743|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922473|NCT02052778|529876744|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922474|NCT02052778|529876745|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146600817|NCT00344500|528709055|FG002|Overall Study|Not Noted|0|||
146600818|NCT02252965|528709057|FG000|Overall Study|Adverse Event|9|||
146600819|NCT02252965|528709058|FG001|Overall Study|Adverse Event|14|||
146600820|NCT02252965|528709057|FG000|Overall Study|Lost to Follow-up|16|||
146600821|NCT02252965|528709058|FG001|Overall Study|Lost to Follow-up|8|||
146771969|NCT01823536|529334341|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
146922475|NCT02052778|529876746|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922476|NCT02052778|529876747|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922477|NCT02052778|529876748|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146600822|NCT02252965|528709057|FG000|Overall Study|Protocol Violation|4|||
146600823|NCT02252965|528709058|FG001|Overall Study|Protocol Violation|5|||
146600824|NCT02252965|528709057|FG000|Overall Study|Lack of Efficacy|0|||
146600825|NCT02252965|528709058|FG001|Overall Study|Lack of Efficacy|2|||
146978609|NCT03276962|530084117|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
146978610|NCT03276962|530084113|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
146978611|NCT03276962|530084114|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
146978612|NCT03276962|530084115|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
146978613|NCT03276962|530084116|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
146978614|NCT03276962|530084117|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
146978615|NCT03276962|530084113|FG000|Overall Study|Lost to Follow-up|10|||
146600826|NCT02252965|528709057|FG000|Overall Study|Withdrawal by Subject|7|||
146600827|NCT02252965|528709058|FG001|Overall Study|Withdrawal by Subject|9|||
146600828|NCT02252965|528709057|FG000|Overall Study|Other|4|||
146600829|NCT02252965|528709058|FG001|Overall Study|Other|5|||
146600830|NCT02615691|528709061|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
146600831|NCT02615691|528709061|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
146600832|NCT02615691|528709061|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
146600833|NCT02615691|528709061|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
146600834|NCT04279613|528709063|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
146600835|NCT04279613|528709064|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
146600836|NCT04279613|528709065|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
146600837|NCT04279613|528709066|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
146600838|NCT04279613|528709067|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
146600839|NCT04279613|528709063|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
146600840|NCT04279613|528709064|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
146600841|NCT04279613|528709065|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
146600842|NCT04279613|528709066|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
146600843|NCT04279613|528709067|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
146600844|NCT04279613|528709063|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
146600845|NCT04279613|528709064|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
146600846|NCT04279613|528709065|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
146600847|NCT04279613|528709066|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
146600848|NCT04279613|528709067|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
146600849|NCT04279613|528709063|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
146600850|NCT04279613|528709064|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
146600851|NCT04279613|528709065|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
146600852|NCT04279613|528709066|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
146600853|NCT04279613|528709067|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
146600854|NCT04279613|528709063|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
146600855|NCT04279613|528709064|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
146600856|NCT04279613|528709065|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
146600857|NCT04279613|528709066|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
146600858|NCT04279613|528709067|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
146600859|NCT04051827|528709068|FG000|Overall Study|Death|1|||
146600860|NCT04051827|528709068|FG000|Overall Study|Withdrawal by Subject|4|||
146600861|NCT04051827|528709068|FG000|Overall Study|Progressive disease|16|||
146600862|NCT04051827|528709068|FG000|Overall Study|Physician Decision|1|||
146600863|NCT04051827|528709068|FG000|Overall Study|Other|4|||
146600864|NCT02888743|528709069|FG000|Overall Study|Withdrawal by Subject|1|||
146600865|NCT02888743|528709070|FG001|Overall Study|Withdrawal by Subject|2|||
146600866|NCT02888743|528709071|FG002|Overall Study|Withdrawal by Subject|2|||
146600867|NCT02888743|528709072|FG003|Overall Study|Withdrawal by Subject|0|||
146600868|NCT02888743|528709073|FG004|Overall Study|Withdrawal by Subject|1|||
146600869|NCT02888743|528709069|FG000|Overall Study|Disease progression before treatment|2|||
146600870|NCT02888743|528709070|FG001|Overall Study|Disease progression before treatment|0|||
146600871|NCT02888743|528709071|FG002|Overall Study|Disease progression before treatment|2|||
146600872|NCT02888743|528709072|FG003|Overall Study|Disease progression before treatment|0|||
146600873|NCT02888743|528709073|FG004|Overall Study|Disease progression before treatment|0|||
146600874|NCT02888743|528709069|FG000|Overall Study|Patient ineligible|1|||
146600875|NCT02888743|528709070|FG001|Overall Study|Patient ineligible|2|||
146600876|NCT02888743|528709071|FG002|Overall Study|Patient ineligible|0|||
146600877|NCT02888743|528709072|FG003|Overall Study|Patient ineligible|0|||
146600878|NCT02888743|528709073|FG004|Overall Study|Patient ineligible|0|||
146600879|NCT01424566|528709074|FG000|Single-blind Treatment|Adverse Event|71|||
146600880|NCT01424566|528709075|FG001|Single-blind Treatment|Adverse Event|0|||
146600881|NCT01424566|528709076|FG002|Single-blind Treatment|Adverse Event|0|||
146600882|NCT01424566|528709074|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
146978616|NCT03276962|530084114|FG001|Overall Study|Lost to Follow-up|10|||
146600883|NCT01424566|528709075|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
146600884|NCT01424566|528709076|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
146600885|NCT01424566|528709074|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
146600886|NCT01424566|528709075|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
146600887|NCT01424566|528709076|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
146600888|NCT01424566|528709074|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
146978617|NCT03276962|530084115|FG002|Overall Study|Lost to Follow-up|4|||
146978618|NCT03276962|530084116|FG003|Overall Study|Lost to Follow-up|6|||
146922478|NCT02052778|529876749|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922479|NCT02052778|529876750|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922480|NCT02052778|529876751|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922481|NCT02052778|529876752|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922482|NCT02052778|529876753|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922483|NCT02052778|529876754|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922484|NCT02052778|529876755|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922485|NCT02052778|529876756|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922486|NCT02052778|529876757|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922487|NCT02052778|529876758|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922488|NCT02052778|529876759|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922489|NCT02052778|529876760|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922490|NCT02052778|529876761|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922491|NCT02052778|529876762|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146922492|NCT02052778|529876763|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
146922493|NCT02052778|529876741|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922494|NCT02052778|529876742|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922495|NCT02052778|529876743|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922496|NCT02052778|529876744|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922497|NCT02052778|529876745|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922498|NCT02052778|529876746|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922499|NCT02052778|529876747|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922500|NCT02052778|529876748|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922501|NCT02052778|529876749|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922502|NCT02052778|529876750|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922503|NCT02052778|529876751|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922504|NCT02052778|529876752|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922505|NCT02052778|529876753|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922506|NCT02052778|529876754|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922507|NCT02052778|529876755|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146600889|NCT01424566|528709075|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
146600890|NCT01424566|528709076|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
146600891|NCT01424566|528709074|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
146600892|NCT01424566|528709075|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
146600893|NCT01424566|528709076|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
146600894|NCT01424566|528709074|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
146600895|NCT01424566|528709075|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
146600896|NCT01424566|528709076|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
146600897|NCT01424566|528709074|FG000|Double-blind Treatment|Adverse Event|0|||
146600898|NCT01424566|528709075|FG001|Double-blind Treatment|Adverse Event|21|||
146600899|NCT01424566|528709076|FG002|Double-blind Treatment|Adverse Event|13|||
146600900|NCT01424566|528709074|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
146600901|NCT01424566|528709075|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
146600902|NCT01424566|528709076|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
146600903|NCT01424566|528709074|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
146600904|NCT01424566|528709075|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
146600905|NCT01424566|528709076|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
146600906|NCT01424566|528709074|FG000|Double-blind Treatment|Lack of Efficacy|0|||
146600907|NCT01424566|528709075|FG001|Double-blind Treatment|Lack of Efficacy|1|||
146600908|NCT01424566|528709076|FG002|Double-blind Treatment|Lack of Efficacy|1|||
146600909|NCT01079936|528709081|FG000|Phase I: MTD|First Remission Status|2|||
146600910|NCT01079936|528709082|FG001|Phase I: MTD|First Remission Status|0|||
146600911|NCT01079936|528709083|FG002|Phase I: MTD|First Remission Status|0|||
146600912|NCT01079936|528709084|FG003|Phase I: MTD|First Remission Status|0|||
146600913|NCT01079936|528709085|FG004|Phase I: MTD|First Remission Status|0|||
146600914|NCT01079936|528709081|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
146600915|NCT01079936|528709082|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
146600916|NCT01079936|528709083|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
146600917|NCT01079936|528709084|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
146600918|NCT01079936|528709085|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
146600919|NCT01079936|528709081|FG000|Phase II|Adverse Event|0|||
146600920|NCT01079936|528709082|FG001|Phase II|Adverse Event|0|||
146600921|NCT01079936|528709083|FG002|Phase II|Adverse Event|1|||
146600922|NCT01079936|528709084|FG003|Phase II|Adverse Event|0|||
146600923|NCT01079936|528709085|FG004|Phase II|Adverse Event|0|||
146600924|NCT01079936|528709081|FG000|Phase II|Insurance Issue|0|||
146600925|NCT01079936|528709082|FG001|Phase II|Insurance Issue|0|||
146600926|NCT01079936|528709083|FG002|Phase II|Insurance Issue|0|||
146655300|NCT02953509|528914276|FG005|Overall Study|Reason Not Specified|4|||
146655301|NCT02953509|528914277|FG006|Overall Study|Reason Not Specified|12|||
146655302|NCT02953509|528914278|FG007|Overall Study|Reason Not Specified|2|||
146655303|NCT02953509|528914279|FG008|Overall Study|Reason Not Specified|7|||
146655304|NCT02953509|528914280|FG009|Overall Study|Reason Not Specified|2|||
146655305|NCT02953509|528914271|FG000|Overall Study|Consent Withdrawn|1|||
146922508|NCT02052778|529876756|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922509|NCT02052778|529876757|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922510|NCT02052778|529876758|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922511|NCT02052778|529876759|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922512|NCT02052778|529876760|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922513|NCT02052778|529876761|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922514|NCT02052778|529876762|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146922515|NCT02052778|529876763|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
146922516|NCT02052778|529876741|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922517|NCT02052778|529876742|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922518|NCT02052778|529876743|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922519|NCT02052778|529876744|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922520|NCT02052778|529876745|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922521|NCT02052778|529876746|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922522|NCT02052778|529876747|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922523|NCT02052778|529876748|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922524|NCT02052778|529876749|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922525|NCT02052778|529876750|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922526|NCT02052778|529876751|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922527|NCT02052778|529876752|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922528|NCT02052778|529876753|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922529|NCT02052778|529876754|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922530|NCT02052778|529876755|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922531|NCT02052778|529876756|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922532|NCT02052778|529876757|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922533|NCT02052778|529876758|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922534|NCT02052778|529876759|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922535|NCT02052778|529876760|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922536|NCT02052778|529876761|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922537|NCT02052778|529876762|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146922538|NCT02052778|529876763|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
146922539|NCT02052778|529876741|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
146922540|NCT02052778|529876742|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
146922541|NCT02052778|529876743|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
146922542|NCT02052778|529876744|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
146922543|NCT02052778|529876745|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
146922544|NCT02052778|529876746|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
146922545|NCT02052778|529876747|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
146922546|NCT02052778|529876748|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
146922547|NCT02052778|529876749|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
146922548|NCT02052778|529876750|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
146922549|NCT02052778|529876751|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
146922550|NCT02052778|529876752|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
146922551|NCT02052778|529876753|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
146922552|NCT02052778|529876754|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
146922553|NCT02052778|529876755|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
146922554|NCT02052778|529876756|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
146922555|NCT02052778|529876757|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
146922556|NCT02052778|529876758|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
146922557|NCT02052778|529876759|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
146922558|NCT02052778|529876760|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
146922559|NCT02052778|529876761|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
146922560|NCT02052778|529876762|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
146922561|NCT02052778|529876763|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
146922562|NCT02052778|529876741|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
146922563|NCT02052778|529876742|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
146922564|NCT02052778|529876743|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
146922565|NCT02052778|529876744|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
146922566|NCT02052778|529876745|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
146922567|NCT02052778|529876746|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
146922568|NCT02052778|529876747|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
146922569|NCT02052778|529876748|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
146978619|NCT03276962|530084117|FG004|Overall Study|Lost to Follow-up|10|||
146655306|NCT02953509|528914272|FG001|Overall Study|Consent Withdrawn|1|||
146600927|NCT01079936|528709084|FG003|Phase II|Insurance Issue|0|||
146600928|NCT01079936|528709085|FG004|Phase II|Insurance Issue|1|||
146600929|NCT02335424|528709086|FG000|Overall Study|Withdrawal by Subject|19|||
146600930|NCT02335424|528709086|FG000|Overall Study|Adverse Event|25|||
146600931|NCT02335424|528709086|FG000|Overall Study|Death|273|||
146600932|NCT02335424|528709086|FG000|Overall Study|Lost to Follow-up|3|||
146600933|NCT02335424|528709086|FG000|Overall Study|Physician Decision|13|||
146600934|NCT02335424|528709086|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
146600935|NCT02335424|528709086|FG000|Overall Study|Protocol Violation|1|||
146600936|NCT02335424|528709086|FG000|Overall Study|Screen failure|1|||
146600937|NCT02712424|528709087|FG000|Overall Study|Lost to Follow-up|34|||
146600938|NCT02712424|528709088|FG001|Overall Study|Lost to Follow-up|32|||
146600939|NCT02723175|528709089|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
146600940|NCT02723175|528709090|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
146600941|NCT02723175|528709089|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
146600942|NCT02723175|528709090|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
146655307|NCT02953509|528914273|FG002|Overall Study|Consent Withdrawn|2|||
146655308|NCT02953509|528914274|FG003|Overall Study|Consent Withdrawn|1|||
146655309|NCT02953509|528914275|FG004|Overall Study|Consent Withdrawn|3|||
146655310|NCT02953509|528914276|FG005|Overall Study|Consent Withdrawn|0|||
146655311|NCT02953509|528914277|FG006|Overall Study|Consent Withdrawn|4|||
146655312|NCT02953509|528914278|FG007|Overall Study|Consent Withdrawn|1|||
146655313|NCT02953509|528914279|FG008|Overall Study|Consent Withdrawn|1|||
146655314|NCT02953509|528914280|FG009|Overall Study|Consent Withdrawn|4|||
146655315|NCT02953509|528914271|FG000|Overall Study|Lost to Follow-up|0|||
146655316|NCT02953509|528914272|FG001|Overall Study|Lost to Follow-up|0|||
146655317|NCT02953509|528914273|FG002|Overall Study|Lost to Follow-up|0|||
146655318|NCT02953509|528914274|FG003|Overall Study|Lost to Follow-up|0|||
146655319|NCT02953509|528914275|FG004|Overall Study|Lost to Follow-up|0|||
146655320|NCT02953509|528914276|FG005|Overall Study|Lost to Follow-up|0|||
146655321|NCT02953509|528914277|FG006|Overall Study|Lost to Follow-up|1|||
146655322|NCT02953509|528914278|FG007|Overall Study|Lost to Follow-up|1|||
146655323|NCT02953509|528914279|FG008|Overall Study|Lost to Follow-up|1|||
146655324|NCT02953509|528914280|FG009|Overall Study|Lost to Follow-up|1|||
146655325|NCT02953509|528914271|FG000|Overall Study|Study terminated by sponsor|1|||
146655326|NCT02953509|528914272|FG001|Overall Study|Study terminated by sponsor|0|||
146655327|NCT02953509|528914273|FG002|Overall Study|Study terminated by sponsor|0|||
146655328|NCT02953509|528914274|FG003|Overall Study|Study terminated by sponsor|0|||
146655329|NCT02953509|528914275|FG004|Overall Study|Study terminated by sponsor|0|||
146655330|NCT02953509|528914276|FG005|Overall Study|Study terminated by sponsor|0|||
146655331|NCT02953509|528914277|FG006|Overall Study|Study terminated by sponsor|1|||
146655332|NCT02953509|528914278|FG007|Overall Study|Study terminated by sponsor|0|||
146655333|NCT02953509|528914279|FG008|Overall Study|Study terminated by sponsor|1|||
146655334|NCT02953509|528914280|FG009|Overall Study|Study terminated by sponsor|1|||
146655335|NCT00484185|528914283|FG000|Overall Study|Lost to Follow-up|44|||
146655336|NCT00484185|528914283|FG000|Overall Study|Other|20|||
146655337|NCT00484185|528914283|FG000|Overall Study|Randomized but not treated|5|||
146655338|NCT00484185|528914283|FG000|Overall Study|Death|2|||
146655339|NCT00459056|528914284|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
146655340|NCT00459056|528914285|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
146655341|NCT01222403|528914288|FG000|Overall Study|Inappropriate enrollment|0|||
146600943|NCT04109976|528709091|FG000|Overall Study|Withdrawal by Subject|1|||
146655342|NCT01222403|528914289|FG001|Overall Study|Inappropriate enrollment|2|||
146655343|NCT00725842|528914290|FG000|Overall Study|Lost to Follow-up|19|||
146600944|NCT04109976|528709092|FG001|Overall Study|Withdrawal by Subject|0|||
146600945|NCT01927055|528709097|FG000|Open-label|Adverse Event|6|||
146600946|NCT01927055|528709098|FG001|Open-label|Adverse Event|0|||
146600947|NCT01927055|528709099|FG002|Open-label|Adverse Event|0|||
146600948|NCT01927055|528709097|FG000|Open-label|Withdrawal by Subject|1|||
146655344|NCT00725842|528914290|FG000|Overall Study|Death|1|||
146655345|NCT00725842|528914290|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
146655346|NCT00725842|528914290|FG000|Overall Study|Consent date prior to study start date|5|||
146655347|NCT00725842|528914290|FG000|Overall Study|Inclusion criterion not met|1|||
146922570|NCT02052778|529876749|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
146600949|NCT01927055|528709098|FG001|Open-label|Withdrawal by Subject|0|||
146600950|NCT01927055|528709099|FG002|Open-label|Withdrawal by Subject|0|||
146600951|NCT01927055|528709097|FG000|Open-label|Study Stopped|4|||
146655348|NCT00725842|528914290|FG000|Overall Study|No Visit 1 data|1|||
146655349|NCT02793622|528914294|FG000|Overall Study|Lost to Follow-up|31|||
146655350|NCT02793622|528914295|FG001|Overall Study|Lost to Follow-up|19|||
146655351|NCT02793622|528914294|FG000|Overall Study|Withdrawal by Subject|21|||
146655352|NCT02793622|528914295|FG001|Overall Study|Withdrawal by Subject|17|||
146600952|NCT01927055|528709098|FG001|Open-label|Study Stopped|0|||
146600953|NCT01927055|528709099|FG002|Open-label|Study Stopped|0|||
146600954|NCT01927055|528709097|FG000|Open-label|Supine Hypertension|4|||
146600955|NCT01927055|528709098|FG001|Open-label|Supine Hypertension|0|||
146655353|NCT02793622|528914294|FG000|Overall Study|Adverse Event|0|||
146655354|NCT02793622|528914295|FG001|Overall Study|Adverse Event|1|||
146655355|NCT02793622|528914294|FG000|Overall Study|Protocol Violation|1|||
146978620|NCT03276962|530084113|FG000|Overall Study|Other|0|||
146978621|NCT03276962|530084114|FG001|Overall Study|Other|2|||
146978622|NCT03276962|530084115|FG002|Overall Study|Other|0|||
146978623|NCT03276962|530084116|FG003|Overall Study|Other|2|||
146978624|NCT03276962|530084117|FG004|Overall Study|Other|1|||
146978625|NCT01238211|530084118|FG000|Overall Study|Continues active treatment|31|||
146978626|NCT01238211|530084118|FG000|Overall Study|Adverse Event|7|||
146978627|NCT01238211|530084118|FG000|Overall Study|Death|4|||
146978628|NCT01238211|530084118|FG000|Overall Study|Relapse/Progression|2|||
146978629|NCT01238211|530084118|FG000|Overall Study|Withdrawal by Subject|7|||
146978630|NCT01238211|530084118|FG000|Overall Study|Non-protocol treatment|4|||
146655356|NCT02793622|528914295|FG001|Overall Study|Protocol Violation|5|||
146655357|NCT02068768|528914296|FG000|Overall Study|Lost to Follow-up|5|||
146655358|NCT02068768|528914296|FG000|Overall Study|Early Termination by Sponsor|2|||
146655359|NCT00555425|528914297|FG000|Overall Study|Missed Medication > 1 wk|34|||
146655360|NCT00555425|528914298|FG001|Overall Study|Missed Medication > 1 wk|15|||
146655361|NCT00555425|528914297|FG000|Overall Study|Missed 3 physician management visits|1|||
146655362|NCT00555425|528914298|FG001|Overall Study|Missed 3 physician management visits|0|||
146655363|NCT00555425|528914297|FG000|Overall Study|Met criteria for protective transfer|16|||
146655364|NCT00555425|528914298|FG001|Overall Study|Met criteria for protective transfer|3|||
146655365|NCT00555425|528914297|FG000|Overall Study|Became pregnant and transferred care|0|||
146655366|NCT00555425|528914298|FG001|Overall Study|Became pregnant and transferred care|1|||
146655367|NCT01262352|528914299|FG000|Period 1|Illness after randomization|1|||
146655368|NCT01262352|528914300|FG001|Period 1|Illness after randomization|0|||
146655369|NCT01262352|528914299|FG000|Washout|Adverse Event|1|||
146655370|NCT01262352|528914300|FG001|Washout|Adverse Event|1|||
146655371|NCT01262352|528914299|FG000|Washout|Extended Washout|0|||
146655372|NCT01262352|528914300|FG001|Washout|Extended Washout|1|||
146655373|NCT01185834|528914301|FG000|Overall Study|Lost to Follow-up|2|||
146655374|NCT01185834|528914301|FG000|Overall Study|Discomfort|4|||
146655375|NCT01185834|528914301|FG000|Overall Study|Biomicroscopy|4|||
146655376|NCT01185834|528914301|FG000|Overall Study|Time/Job Conflict|2|||
146655377|NCT01185834|528914301|FG000|Overall Study|Early exit - Site error|2|||
146655378|NCT01683019|528915442|FG000|Overall Study|Withdrawal by Subject|2|||
146655379|NCT01683019|528915443|FG001|Overall Study|Withdrawal by Subject|1|||
146655380|NCT01683019|528915444|FG002|Overall Study|Withdrawal by Subject|4|||
146655381|NCT00543855|528915449|FG000|Overall Study|Adverse Event|3|||
146655382|NCT00543855|528915450|FG001|Overall Study|Adverse Event|1|||
146655383|NCT00543855|528915451|FG002|Overall Study|Adverse Event|3|||
146655384|NCT00543855|528915452|FG003|Overall Study|Adverse Event|4|||
146655385|NCT00543855|528915449|FG000|Overall Study|Lost to Follow-up|0|||
146655386|NCT00543855|528915450|FG001|Overall Study|Lost to Follow-up|0|||
146655387|NCT00543855|528915451|FG002|Overall Study|Lost to Follow-up|1|||
146655388|NCT00543855|528915452|FG003|Overall Study|Lost to Follow-up|0|||
146655389|NCT00543855|528915449|FG000|Overall Study|Withdrawal by Subject|0|||
146655390|NCT00543855|528915450|FG001|Overall Study|Withdrawal by Subject|1|||
146655391|NCT00543855|528915451|FG002|Overall Study|Withdrawal by Subject|2|||
146655392|NCT00543855|528915452|FG003|Overall Study|Withdrawal by Subject|0|||
146655393|NCT00543855|528915449|FG000|Overall Study|Protocol Violation|1|||
146655394|NCT00543855|528915450|FG001|Overall Study|Protocol Violation|0|||
146655395|NCT00543855|528915451|FG002|Overall Study|Protocol Violation|0|||
146978631|NCT01238211|530084118|FG000|Overall Study|Investigator/Patient Decision|3|||
146600956|NCT01927055|528709099|FG002|Open-label|Supine Hypertension|0|||
146600957|NCT01927055|528709097|FG000|Open-label|Difficulty attending study visits|1|||
146600958|NCT01927055|528709098|FG001|Open-label|Difficulty attending study visits|0|||
146600959|NCT01927055|528709099|FG002|Open-label|Difficulty attending study visits|0|||
146600960|NCT01927055|528709097|FG000|Double-Blind|Adverse Event|0|||
146600961|NCT01927055|528709098|FG001|Double-Blind|Adverse Event|1|||
146600962|NCT01927055|528709099|FG002|Double-Blind|Adverse Event|1|||
146600963|NCT01927055|528709097|FG000|Double-Blind|Protocol Violation|0|||
146600964|NCT01927055|528709098|FG001|Double-Blind|Protocol Violation|0|||
146600965|NCT01927055|528709099|FG002|Double-Blind|Protocol Violation|1|||
146600966|NCT01927055|528709097|FG000|Double-Blind|Withdrawal by Subject|0|||
146600967|NCT01927055|528709098|FG001|Double-Blind|Withdrawal by Subject|2|||
146600968|NCT01927055|528709099|FG002|Double-Blind|Withdrawal by Subject|3|||
146600969|NCT01927055|528709097|FG000|Double-Blind|Study Stopped|0|||
146600970|NCT01927055|528709098|FG001|Double-Blind|Study Stopped|7|||
146655396|NCT00543855|528915452|FG003|Overall Study|Protocol Violation|0|||
146978632|NCT01358708|530084119|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
146978633|NCT01358708|530084120|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146600971|NCT01927055|528709099|FG002|Double-Blind|Study Stopped|7|||
146655397|NCT04285580|528915453|FG000|Overall Study|Protocol Violation|0|||
146655398|NCT04285580|528915454|FG001|Overall Study|Protocol Violation|1|||
146655399|NCT02582255|528915455|FG000|Overall Study|Protocol Violation|0|||
146655400|NCT02582255|528915456|FG001|Overall Study|Protocol Violation|3|||
146655401|NCT01709578|528915459|FG000|Overall Study|Rescued and entered in long term safety|63|||
146655402|NCT01709578|528915460|FG001|Overall Study|Rescued and entered in long term safety|25|||
146771970|NCT01823536|529334342|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
146771971|NCT01823536|529334343|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
146771972|NCT01823536|529334344|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
146771973|NCT01823536|529334345|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
146771974|NCT01823536|529334346|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
146771975|NCT01823536|529334341|FG000|Overall Study|Met exclusion criterion No 6|0|||
146771976|NCT01823536|529334342|FG001|Overall Study|Met exclusion criterion No 6|0|||
146771977|NCT01823536|529334343|FG002|Overall Study|Met exclusion criterion No 6|0|||
146771978|NCT01823536|529334344|FG003|Overall Study|Met exclusion criterion No 6|1|||
146771979|NCT01823536|529334345|FG004|Overall Study|Met exclusion criterion No 6|0|||
146771980|NCT01823536|529334346|FG005|Overall Study|Met exclusion criterion No 6|0|||
146771981|NCT01823536|529334341|FG000|Overall Study|Subject moved out of the state|0|||
146771982|NCT01823536|529334342|FG001|Overall Study|Subject moved out of the state|0|||
146771983|NCT01823536|529334343|FG002|Overall Study|Subject moved out of the state|0|||
146771984|NCT01823536|529334344|FG003|Overall Study|Subject moved out of the state|0|||
146771985|NCT01823536|529334345|FG004|Overall Study|Subject moved out of the state|1|||
146771986|NCT01823536|529334346|FG005|Overall Study|Subject moved out of the state|0|||
146771987|NCT03648762|529334347|FG000|Overall Study|Lost to Follow-up|1|||
146771988|NCT03648762|529334348|FG001|Overall Study|Lost to Follow-up|2|||
146771989|NCT03648762|529334349|FG002|Overall Study|Lost to Follow-up|0|||
146771990|NCT03648762|529334347|FG000|Overall Study|Withdrawal by Subject|5|||
146771991|NCT03648762|529334348|FG001|Overall Study|Withdrawal by Subject|2|||
146771992|NCT03648762|529334349|FG002|Overall Study|Withdrawal by Subject|1|||
146771993|NCT01391832|529334352|FG000|Overall Study|Withdrawal by Subject|21|||
146771994|NCT01391832|529334353|FG001|Overall Study|Withdrawal by Subject|22|||
146771995|NCT01391832|529334352|FG000|Overall Study|Lost to Follow-up|0|||
146771996|NCT01391832|529334353|FG001|Overall Study|Lost to Follow-up|1|||
146771997|NCT03345901|529334359|FG000|Overall Study|The study was terminated|18|||
146771998|NCT00722046|529334360|FG000|Overall Study|Adverse Event|0|||
146771999|NCT00722046|529334361|FG001|Overall Study|Adverse Event|1|||
146772000|NCT00722046|529334362|FG002|Overall Study|Adverse Event|2|||
146772001|NCT00722046|529334363|FG003|Overall Study|Adverse Event|1|||
146772002|NCT00722046|529334364|FG004|Overall Study|Adverse Event|2|||
146772003|NCT00722046|529334365|FG005|Overall Study|Adverse Event|1|||
146772004|NCT00722046|529334366|FG006|Overall Study|Adverse Event|0|||
146772005|NCT00722046|529334360|FG000|Overall Study|Death|0|||
146772006|NCT00722046|529334361|FG001|Overall Study|Death|1|||
146772007|NCT00722046|529334362|FG002|Overall Study|Death|0|||
146772008|NCT00722046|529334363|FG003|Overall Study|Death|0|||
146772009|NCT00722046|529334364|FG004|Overall Study|Death|0|||
146772010|NCT00722046|529334365|FG005|Overall Study|Death|0|||
146772011|NCT00722046|529334366|FG006|Overall Study|Death|2|||
146772012|NCT00722046|529334360|FG000|Overall Study|Protocol Violation|1|||
146772013|NCT00722046|529334361|FG001|Overall Study|Protocol Violation|0|||
146772014|NCT00722046|529334362|FG002|Overall Study|Protocol Violation|0|||
146772015|NCT00722046|529334363|FG003|Overall Study|Protocol Violation|0|||
146772016|NCT00722046|529334364|FG004|Overall Study|Protocol Violation|0|||
146772017|NCT00722046|529334365|FG005|Overall Study|Protocol Violation|1|||
146772018|NCT00722046|529334366|FG006|Overall Study|Protocol Violation|0|||
146772019|NCT00722046|529334360|FG000|Overall Study|Withdrawal by Subject|3|||
146772020|NCT00722046|529334361|FG001|Overall Study|Withdrawal by Subject|3|||
146772021|NCT00722046|529334362|FG002|Overall Study|Withdrawal by Subject|4|||
146772022|NCT00722046|529334363|FG003|Overall Study|Withdrawal by Subject|4|||
146772023|NCT00722046|529334364|FG004|Overall Study|Withdrawal by Subject|4|||
146772024|NCT00722046|529334365|FG005|Overall Study|Withdrawal by Subject|7|||
146772025|NCT00722046|529334366|FG006|Overall Study|Withdrawal by Subject|3|||
146772026|NCT00722046|529334360|FG000|Overall Study|Randomized, but not treated|1|||
146772027|NCT00722046|529334361|FG001|Overall Study|Randomized, but not treated|1|||
146772028|NCT00722046|529334362|FG002|Overall Study|Randomized, but not treated|0|||
146772029|NCT00722046|529334363|FG003|Overall Study|Randomized, but not treated|2|||
146772030|NCT00722046|529334364|FG004|Overall Study|Randomized, but not treated|0|||
146772031|NCT00722046|529334365|FG005|Overall Study|Randomized, but not treated|0|||
146772032|NCT00722046|529334366|FG006|Overall Study|Randomized, but not treated|0|||
146772033|NCT00722046|529334360|FG000|Overall Study|Other|0|||
146922571|NCT02052778|529876750|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
146922572|NCT02052778|529876751|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
146922573|NCT02052778|529876752|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
146922574|NCT02052778|529876753|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
146772034|NCT00722046|529334361|FG001|Overall Study|Other|0|||
146772035|NCT00722046|529334362|FG002|Overall Study|Other|1|||
146772036|NCT00722046|529334363|FG003|Overall Study|Other|1|||
146772037|NCT00722046|529334364|FG004|Overall Study|Other|3|||
146772038|NCT00722046|529334365|FG005|Overall Study|Other|2|||
146772039|NCT00722046|529334366|FG006|Overall Study|Other|1|||
146772040|NCT00925587|529334367|FG000|Overall Study|Protocol Specified Criteria|6|||
146772041|NCT00925587|529334368|FG001|Overall Study|Protocol Specified Criteria|6|||
146922575|NCT02052778|529876754|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
146655403|NCT01709578|528915461|FG002|Overall Study|Rescued and entered in long term safety|26|||
146655404|NCT01709578|528915459|FG000|Overall Study|Adverse Event|9|||
146655405|NCT01709578|528915460|FG001|Overall Study|Adverse Event|18|||
146655406|NCT01709578|528915461|FG002|Overall Study|Adverse Event|17|||
146655407|NCT01709578|528915459|FG000|Overall Study|Lack of Efficacy|5|||
146655408|NCT01709578|528915460|FG001|Overall Study|Lack of Efficacy|4|||
146655409|NCT01709578|528915461|FG002|Overall Study|Lack of Efficacy|2|||
146655410|NCT01709578|528915459|FG000|Overall Study|Poor compliance to protocol|1|||
146655411|NCT01709578|528915460|FG001|Overall Study|Poor compliance to protocol|2|||
146655412|NCT01709578|528915461|FG002|Overall Study|Poor compliance to protocol|1|||
146655413|NCT01709578|528915459|FG000|Overall Study|Other, not related to safety or efficacy|2|||
146655414|NCT01709578|528915460|FG001|Overall Study|Other, not related to safety or efficacy|7|||
146655415|NCT01709578|528915461|FG002|Overall Study|Other, not related to safety or efficacy|5|||
146655416|NCT04050371|528915462|FG000|Overall Study|Withdrawal by Subject|1|||
146655417|NCT04050371|528915463|FG001|Overall Study|Withdrawal by Subject|0|||
146655418|NCT01314911|528915465|FG000|Overall Study|Lost to Follow-up|3|||
146655419|NCT01314911|528915466|FG001|Overall Study|Lost to Follow-up|2|||
146655420|NCT01314911|528915465|FG000|Overall Study|Withdrawal by Subject|1|||
146655421|NCT01314911|528915466|FG001|Overall Study|Withdrawal by Subject|3|||
146655422|NCT01314911|528915465|FG000|Overall Study|Received Non-randomized Study Drug|0|||
146655423|NCT01314911|528915466|FG001|Overall Study|Received Non-randomized Study Drug|1|||
146655424|NCT01314911|528915465|FG000|Overall Study|Never Started Treatment|1|||
146655425|NCT01314911|528915466|FG001|Overall Study|Never Started Treatment|0|||
146655426|NCT01547780|528915467|FG000|Baseline PET Scan|Physician Decision|1|||
146655427|NCT01547780|528915468|FG001|Baseline PET Scan|Physician Decision|0|||
146655428|NCT01547780|528915469|FG002|Baseline PET Scan|Physician Decision|1|||
146655429|NCT01547780|528915470|FG003|Baseline PET Scan|Physician Decision|0|||
146655430|NCT01547780|528915467|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
146655431|NCT01547780|528915468|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
146655432|NCT01547780|528915469|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
146655433|NCT01547780|528915470|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
146655434|NCT02448680|528915474|FG000|Overall Study|Physician Decision|1|||
146655435|NCT02448680|528915475|FG001|Overall Study|Physician Decision|1|||
146655436|NCT02448680|528915474|FG000|Overall Study|Withdrawal by Subject|0|||
146655437|NCT02448680|528915475|FG001|Overall Study|Withdrawal by Subject|2|||
146655438|NCT01736657|528915476|FG000|Overall Study|insufficient vascular access|1|||
146655439|NCT00740246|528915490|FG000|Overall Study|Received Blood Transfusion|0|||
146655440|NCT00740246|528915491|FG001|Overall Study|Received Blood Transfusion|1|||
146655441|NCT00740246|528915490|FG000|Overall Study|Adverse Event|1|||
146655442|NCT00740246|528915491|FG001|Overall Study|Adverse Event|2|||
146655443|NCT00740246|528915490|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
146655444|NCT00740246|528915491|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
146655445|NCT00740246|528915490|FG000|Overall Study|Lost to Follow-up|2|||
146655446|NCT00740246|528915491|FG001|Overall Study|Lost to Follow-up|2|||
146655447|NCT00740246|528915490|FG000|Overall Study|Withdrawal by Subject|4|||
146600972|NCT01927055|528709097|FG000|Double-Blind|Supine Hypertension|0|||
146600973|NCT01927055|528709098|FG001|Double-Blind|Supine Hypertension|0|||
146600974|NCT01927055|528709099|FG002|Double-Blind|Supine Hypertension|1|||
146600975|NCT01927055|528709097|FG000|Double-Blind|Extended Vacation|0|||
146600976|NCT01927055|528709098|FG001|Double-Blind|Extended Vacation|1|||
146600977|NCT01927055|528709099|FG002|Double-Blind|Extended Vacation|0|||
146600978|NCT02598128|528709100|FG000|Period A: Days -7 to -1|Adverse Event|1|||
146600979|NCT02598128|528709101|FG001|Period A: Days -7 to -1|Adverse Event|0|||
146600980|NCT02598128|528709102|FG002|Period A: Days -7 to -1|Adverse Event|0|||
146600981|NCT02598128|528709103|FG003|Period A: Days -7 to -1|Adverse Event|0|||
146600982|NCT03134183|528709104|FG000|Overall Study|Withdrawal by Subject|1|||
146600983|NCT03134183|528709105|FG001|Overall Study|Withdrawal by Subject|1|||
146600984|NCT00845065|528709108|FG000|Overall Study|Adverse Event|3|||
146600985|NCT00845065|528709109|FG001|Overall Study|Adverse Event|23|||
146600986|NCT00845065|528709108|FG000|Overall Study|Lack of Efficacy|43|||
146600987|NCT00845065|528709109|FG001|Overall Study|Lack of Efficacy|21|||
146600988|NCT00845065|528709108|FG000|Overall Study|Non-Medical Reasons|1|||
146600989|NCT00845065|528709109|FG001|Overall Study|Non-Medical Reasons|11|||
146600990|NCT02299076|528709110|FG000|Overall Study|Fraudulent Entries|20|||
146600991|NCT02299076|528709111|FG001|Overall Study|Fraudulent Entries|14|||
146600992|NCT01198509|528709112|FG000|Overall Study|Withdrawal by Subject|1|||
146600993|NCT01198509|528709113|FG001|Overall Study|Withdrawal by Subject|0|||
146600994|NCT01198509|528709114|FG002|Overall Study|Withdrawal by Subject|0|||
146600995|NCT01198509|528709115|FG003|Overall Study|Withdrawal by Subject|0|||
146600996|NCT01198509|528709116|FG004|Overall Study|Withdrawal by Subject|0|||
146600997|NCT01198509|528709117|FG005|Overall Study|Withdrawal by Subject|0|||
146655448|NCT00740246|528915491|FG001|Overall Study|Withdrawal by Subject|3|||
146655449|NCT00740246|528915490|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
146655450|NCT00740246|528915491|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
146655451|NCT00740246|528915490|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
146655452|NCT00740246|528915491|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
146655453|NCT00740246|528915490|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
146655454|NCT00740246|528915491|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
146655455|NCT00740246|528915490|FG000|Overall Study|Unable To Comply With Study Visits|2|||
146655456|NCT00740246|528915491|FG001|Overall Study|Unable To Comply With Study Visits|0|||
146655457|NCT00740246|528915490|FG000|Overall Study|Unable to Access Vein|0|||
146655458|NCT00740246|528915491|FG001|Overall Study|Unable to Access Vein|2|||
146655459|NCT00740246|528915490|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
146655460|NCT00740246|528915491|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
146655461|NCT01001299|528915492|FG000|Overall Study|Insufficient Therapeutic Response|20|||
146655462|NCT01001299|528915492|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
146655463|NCT01001299|528915492|FG000|Overall Study|Death|1|||
146655464|NCT01001299|528915492|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
146655465|NCT01001299|528915492|FG000|Overall Study|Withdrew Consent|1|||
146655466|NCT01056380|528915493|FG000|Overall Study|Lost to Follow-up|2|||
146655467|NCT01056380|528915494|FG001|Overall Study|Lost to Follow-up|3|||
146655468|NCT04068896|528915495|FG000|Overall Study|Adverse Event|2|||
146655469|NCT04068896|528915496|FG001|Overall Study|Adverse Event|0|||
146655470|NCT04068896|528915497|FG002|Overall Study|Adverse Event|1|||
146655471|NCT04068896|528915498|FG003|Overall Study|Adverse Event|0|||
146655472|NCT04068896|528915499|FG004|Overall Study|Adverse Event|0|||
146655473|NCT04068896|528915500|FG005|Overall Study|Adverse Event|0|||
146655474|NCT04068896|528915495|FG000|Overall Study|Death|3|||
146655475|NCT04068896|528915496|FG001|Overall Study|Death|1|||
146655476|NCT04068896|528915497|FG002|Overall Study|Death|3|||
146655477|NCT04068896|528915498|FG003|Overall Study|Death|19|||
146655478|NCT04068896|528915499|FG004|Overall Study|Death|17|||
146655479|NCT04068896|528915500|FG005|Overall Study|Death|0|||
146655480|NCT04068896|528915495|FG000|Overall Study|Physician Decision|0|||
146655481|NCT04068896|528915496|FG001|Overall Study|Physician Decision|0|||
146655482|NCT04068896|528915497|FG002|Overall Study|Physician Decision|0|||
146655483|NCT04068896|528915498|FG003|Overall Study|Physician Decision|1|||
146655484|NCT04068896|528915499|FG004|Overall Study|Physician Decision|0|||
146655485|NCT04068896|528915500|FG005|Overall Study|Physician Decision|0|||
146655486|NCT04068896|528915495|FG000|Overall Study|progressive disease|3|||
146655487|NCT04068896|528915496|FG001|Overall Study|progressive disease|5|||
146655488|NCT04068896|528915497|FG002|Overall Study|progressive disease|3|||
146655489|NCT04068896|528915498|FG003|Overall Study|progressive disease|2|||
146655490|NCT04068896|528915499|FG004|Overall Study|progressive disease|1|||
146655491|NCT04068896|528915500|FG005|Overall Study|progressive disease|2|||
146655492|NCT04068896|528915495|FG000|Overall Study|Study terminated by sponsor|0|||
146655493|NCT04068896|528915496|FG001|Overall Study|Study terminated by sponsor|0|||
146655494|NCT04068896|528915497|FG002|Overall Study|Study terminated by sponsor|1|||
146655495|NCT04068896|528915498|FG003|Overall Study|Study terminated by sponsor|2|||
146655496|NCT04068896|528915499|FG004|Overall Study|Study terminated by sponsor|1|||
146655497|NCT04068896|528915500|FG005|Overall Study|Study terminated by sponsor|4|||
146655498|NCT04068896|528915495|FG000|Overall Study|Protocol Violation|0|||
146655499|NCT04068896|528915496|FG001|Overall Study|Protocol Violation|0|||
146655500|NCT04068896|528915497|FG002|Overall Study|Protocol Violation|0|||
146655501|NCT04068896|528915498|FG003|Overall Study|Protocol Violation|1|||
146655502|NCT04068896|528915499|FG004|Overall Study|Protocol Violation|0|||
146772042|NCT00925587|529334367|FG000|Overall Study|Physician Decision|4|||
146772043|NCT00925587|529334368|FG001|Overall Study|Physician Decision|1|||
146922576|NCT02052778|529876755|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
146922577|NCT02052778|529876756|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
146922578|NCT02052778|529876757|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
146655503|NCT04068896|528915500|FG005|Overall Study|Protocol Violation|0|||
146655504|NCT04068896|528915495|FG000|Overall Study|Withdrawal by Subject|0|||
146655505|NCT04068896|528915496|FG001|Overall Study|Withdrawal by Subject|3|||
146922579|NCT02052778|529876758|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
146922580|NCT02052778|529876759|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
146922581|NCT02052778|529876760|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
146922582|NCT02052778|529876761|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
146655506|NCT04068896|528915497|FG002|Overall Study|Withdrawal by Subject|0|||
146655507|NCT04068896|528915498|FG003|Overall Study|Withdrawal by Subject|2|||
146655508|NCT04068896|528915499|FG004|Overall Study|Withdrawal by Subject|1|||
146655509|NCT04068896|528915500|FG005|Overall Study|Withdrawal by Subject|0|||
146655510|NCT04068896|528915495|FG000|Overall Study|Symptomatic deterioration|2|||
146655511|NCT04068896|528915496|FG001|Overall Study|Symptomatic deterioration|0|||
146655512|NCT04068896|528915497|FG002|Overall Study|Symptomatic deterioration|0|||
146655513|NCT04068896|528915498|FG003|Overall Study|Symptomatic deterioration|0|||
146655514|NCT04068896|528915499|FG004|Overall Study|Symptomatic deterioration|0|||
146655515|NCT04068896|528915500|FG005|Overall Study|Symptomatic deterioration|0|||
146655516|NCT02522871|528915501|FG000|Overall Study|Protocol Violation|1|||
146655517|NCT02522871|528915502|FG001|Overall Study|Protocol Violation|4|||
146922583|NCT02052778|529876762|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
146655518|NCT02522871|528915501|FG000|Overall Study|Treated without randomization|1|||
146655519|NCT02522871|528915502|FG001|Overall Study|Treated without randomization|0|||
146655520|NCT02522871|528915501|FG000|Overall Study|Death|9|||
146655521|NCT02522871|528915502|FG001|Overall Study|Death|9|||
146655522|NCT02522871|528915501|FG000|Overall Study|Died in operating room prior to transplant|0|||
146655523|NCT02522871|528915502|FG001|Overall Study|Died in operating room prior to transplant|1|||
146600998|NCT00499746|528709126|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
146600999|NCT00499746|528709126|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
146601000|NCT00499746|528709126|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
146601001|NCT00499746|528709126|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
146601002|NCT02228096|528709127|FG000|Overall Study|Study terminated by Sponsor|24|||
146601003|NCT02228096|528709127|FG000|Overall Study|Lack of Efficacy|18|||
146601004|NCT02228096|528709127|FG000|Overall Study|Death|12|||
146601005|NCT02228096|528709127|FG000|Overall Study|Physician Decision|3|||
146655524|NCT01075191|528915504|FG000|Overall Study|Death|1|||
146655525|NCT01075191|528915504|FG000|Overall Study|Intensification|3|||
146655526|NCT01075191|528915504|FG000|Overall Study|Co-morbidities|1|||
146655527|NCT01075191|528915504|FG000|Overall Study|Adverse Event|4|||
146655528|NCT01075191|528915504|FG000|Overall Study|Noncompliance|3|||
146655529|NCT01075191|528915504|FG000|Overall Study|Therapy Break|3|||
146655530|NCT01075191|528915504|FG000|Overall Study|Patient's Wish|2|||
146655531|NCT01075191|528915504|FG000|Overall Study|Unknown Reasons|1|||
146655532|NCT00718237|528915509|FG000|Overall Study|Adverse Event|1|||
146655533|NCT00718237|528915510|FG001|Overall Study|Adverse Event|3|||
146655534|NCT00718237|528915509|FG000|Overall Study|Lost to Follow-up|2|||
146655535|NCT00718237|528915510|FG001|Overall Study|Lost to Follow-up|2|||
146655536|NCT00718237|528915509|FG000|Overall Study|Physician Decision|1|||
146655537|NCT00718237|528915510|FG001|Overall Study|Physician Decision|0|||
146655538|NCT00718237|528915509|FG000|Overall Study|Withdrawal by Subject|9|||
146655539|NCT00718237|528915510|FG001|Overall Study|Withdrawal by Subject|10|||
146655540|NCT03189381|528915511|FG000|Overall Study|Death|1|||
146655541|NCT03189381|528915512|FG001|Overall Study|Death|0|||
146655542|NCT01975831|528915513|FG000|Overall Study|Adverse Event|1|||
146655543|NCT01975831|528915514|FG001|Overall Study|Adverse Event|2|||
146655544|NCT01975831|528915515|FG002|Overall Study|Adverse Event|2|||
146655545|NCT01975831|528915516|FG003|Overall Study|Adverse Event|0|||
146655546|NCT01975831|528915517|FG004|Overall Study|Adverse Event|1|||
146655547|NCT01975831|528915518|FG005|Overall Study|Adverse Event|1|||
146655548|NCT01975831|528915519|FG006|Overall Study|Adverse Event|3|||
146655549|NCT01975831|528915520|FG007|Overall Study|Adverse Event|4|||
146655550|NCT01975831|528915521|FG008|Overall Study|Adverse Event|1|||
146655551|NCT01975831|528915513|FG000|Overall Study|Death|1|||
146655552|NCT01975831|528915514|FG001|Overall Study|Death|1|||
146655553|NCT01975831|528915515|FG002|Overall Study|Death|0|||
146655554|NCT01975831|528915516|FG003|Overall Study|Death|0|||
146655555|NCT01975831|528915517|FG004|Overall Study|Death|1|||
146655556|NCT01975831|528915518|FG005|Overall Study|Death|0|||
146655557|NCT01975831|528915519|FG006|Overall Study|Death|1|||
146655558|NCT01975831|528915520|FG007|Overall Study|Death|0|||
146655559|NCT01975831|528915521|FG008|Overall Study|Death|0|||
146655560|NCT01975831|528915513|FG000|Overall Study|Progressive Disease|1|||
146655561|NCT01975831|528915514|FG001|Overall Study|Progressive Disease|3|||
146655562|NCT01975831|528915515|FG002|Overall Study|Progressive Disease|2|||
146655563|NCT01975831|528915516|FG003|Overall Study|Progressive Disease|4|||
146655564|NCT01975831|528915517|FG004|Overall Study|Progressive Disease|13|||
146655565|NCT01975831|528915518|FG005|Overall Study|Progressive Disease|9|||
146655566|NCT01975831|528915519|FG006|Overall Study|Progressive Disease|10|||
146655567|NCT01975831|528915520|FG007|Overall Study|Progressive Disease|8|||
146655568|NCT01975831|528915521|FG008|Overall Study|Progressive Disease|10|||
146655569|NCT01975831|528915513|FG000|Overall Study|Withdrawal by Subject|0|||
146655570|NCT01975831|528915514|FG001|Overall Study|Withdrawal by Subject|3|||
146655571|NCT01975831|528915515|FG002|Overall Study|Withdrawal by Subject|0|||
146655572|NCT01975831|528915516|FG003|Overall Study|Withdrawal by Subject|0|||
146655573|NCT01975831|528915517|FG004|Overall Study|Withdrawal by Subject|3|||
146655574|NCT01975831|528915518|FG005|Overall Study|Withdrawal by Subject|1|||
146655575|NCT01975831|528915519|FG006|Overall Study|Withdrawal by Subject|1|||
146655576|NCT01975831|528915520|FG007|Overall Study|Withdrawal by Subject|0|||
146655577|NCT01975831|528915521|FG008|Overall Study|Withdrawal by Subject|0|||
146655578|NCT01975831|528915513|FG000|Overall Study|Physician Decision|0|||
146655579|NCT01975831|528915514|FG001|Overall Study|Physician Decision|0|||
146655580|NCT01975831|528915515|FG002|Overall Study|Physician Decision|0|||
146655581|NCT01975831|528915516|FG003|Overall Study|Physician Decision|0|||
146655582|NCT01975831|528915517|FG004|Overall Study|Physician Decision|0|||
146655583|NCT01975831|528915518|FG005|Overall Study|Physician Decision|1|||
146655584|NCT01975831|528915519|FG006|Overall Study|Physician Decision|0|||
146655585|NCT01975831|528915520|FG007|Overall Study|Physician Decision|1|||
146655586|NCT01975831|528915521|FG008|Overall Study|Physician Decision|0|||
146655587|NCT01975831|528915513|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
146655588|NCT01975831|528915514|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
146601006|NCT02228096|528709127|FG000|Overall Study|Subject/guardian decision|2|||
146601007|NCT02228096|528709127|FG000|Overall Study|New therapy for study indication|1|||
146601008|NCT02228096|528709127|FG000|Overall Study|Enrolled, not infused|11|||
146601009|NCT01969721|528709128|FG000|Overall Study|Adverse Event|3|||
146601010|NCT01969721|528709129|FG001|Overall Study|Adverse Event|8|||
146601011|NCT01969721|528709130|FG002|Overall Study|Adverse Event|3|||
146601012|NCT01969721|528709131|FG003|Overall Study|Adverse Event|2|||
146601013|NCT01969721|528709128|FG000|Overall Study|Lack of Efficacy|0|||
146601014|NCT01969721|528709129|FG001|Overall Study|Lack of Efficacy|0|||
146601015|NCT01969721|528709130|FG002|Overall Study|Lack of Efficacy|1|||
146655589|NCT01975831|528915515|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
146655590|NCT01975831|528915516|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
146655591|NCT01975831|528915517|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
146655592|NCT01975831|528915518|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
146655593|NCT01975831|528915519|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
146655594|NCT01975831|528915520|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
146655595|NCT01975831|528915521|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
146655596|NCT01975831|528915513|FG000|Overall Study|Entered Hospice|0|||
146655597|NCT01975831|528915514|FG001|Overall Study|Entered Hospice|0|||
146655598|NCT01975831|528915515|FG002|Overall Study|Entered Hospice|0|||
146655599|NCT01975831|528915516|FG003|Overall Study|Entered Hospice|0|||
146655600|NCT01975831|528915517|FG004|Overall Study|Entered Hospice|0|||
146655601|NCT01975831|528915518|FG005|Overall Study|Entered Hospice|1|||
146655602|NCT01975831|528915519|FG006|Overall Study|Entered Hospice|0|||
146655603|NCT01975831|528915520|FG007|Overall Study|Entered Hospice|0|||
146655604|NCT01975831|528915521|FG008|Overall Study|Entered Hospice|0|||
146655605|NCT01975831|528915513|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
146655606|NCT01975831|528915514|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
146655607|NCT01975831|528915515|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
146655608|NCT01975831|528915516|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
146655609|NCT01975831|528915517|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
146655610|NCT01975831|528915518|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
146655611|NCT01975831|528915519|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
146655612|NCT01975831|528915520|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
146655613|NCT01975831|528915521|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
146655614|NCT01401959|528915522|FG000|Enrolled|Withdrawal by Subject|1|||
146655615|NCT01401959|528915523|FG001|Enrolled|Withdrawal by Subject|0|||
146655616|NCT01401959|528915524|FG002|Enrolled|Withdrawal by Subject|0|||
146655617|NCT01401959|528915522|FG000|Treated|Disease Progression|2|||
146655618|NCT01401959|528915523|FG001|Treated|Disease Progression|2|||
146655619|NCT01401959|528915524|FG002|Treated|Disease Progression|1|||
146655620|NCT01401959|528915522|FG000|Treated|Adverse Event|4|||
146655621|NCT01401959|528915523|FG001|Treated|Adverse Event|3|||
146655622|NCT01401959|528915524|FG002|Treated|Adverse Event|2|||
146655623|NCT01401959|528915522|FG000|Treated|Withdrawal by Subject|1|||
146655624|NCT01401959|528915523|FG001|Treated|Withdrawal by Subject|2|||
146655625|NCT01401959|528915524|FG002|Treated|Withdrawal by Subject|2|||
146655626|NCT01401959|528915522|FG000|Treated|Protocol Violation|0|||
146655627|NCT01401959|528915523|FG001|Treated|Protocol Violation|1|||
146655628|NCT01401959|528915524|FG002|Treated|Protocol Violation|0|||
146655629|NCT00251004|528915525|FG000|Overall Study|Withdrawal by Subject|23|||
146655630|NCT00251004|528915526|FG001|Overall Study|Withdrawal by Subject|16|||
146655631|NCT00251004|528915527|FG002|Overall Study|Withdrawal by Subject|14|||
146655632|NCT00251004|528915525|FG000|Overall Study|Death|9|||
146655633|NCT00251004|528915526|FG001|Overall Study|Death|10|||
146655634|NCT00251004|528915527|FG002|Overall Study|Death|8|||
146655635|NCT00251004|528915525|FG000|Overall Study|Lost to Follow-up|1|||
146655636|NCT00251004|528915526|FG001|Overall Study|Lost to Follow-up|2|||
146655637|NCT00251004|528915527|FG002|Overall Study|Lost to Follow-up|1|||
146655638|NCT00251004|528915525|FG000|Overall Study|Graft Loss|12|||
146772044|NCT00925587|529334367|FG000|Overall Study|Protocol Violation|6|||
146601016|NCT01969721|528709131|FG003|Overall Study|Lack of Efficacy|0|||
146601017|NCT01969721|528709128|FG000|Overall Study|Non compliant with protocol|1|||
146655639|NCT00251004|528915526|FG001|Overall Study|Graft Loss|13|||
146655640|NCT00251004|528915527|FG002|Overall Study|Graft Loss|8|||
146655641|NCT02694718|528915532|FG000|Overall Study|Death|1|||
146655642|NCT02694718|528915532|FG000|Overall Study|Withdrawal by Subject|1|||
146655643|NCT02925793|528915533|FG000|Overall Study|Adverse Event|3|||
146655644|NCT02925793|528915534|FG001|Overall Study|Adverse Event|3|||
146655645|NCT02925793|528915535|FG002|Overall Study|Adverse Event|6|||
146655646|NCT02925793|528915533|FG000|Overall Study|Withdrawal by Subject|16|||
146601018|NCT01969721|528709129|FG001|Overall Study|Non compliant with protocol|1|||
146655647|NCT02925793|528915534|FG001|Overall Study|Withdrawal by Subject|15|||
146655648|NCT02925793|528915535|FG002|Overall Study|Withdrawal by Subject|13|||
146655649|NCT02925793|528915533|FG000|Overall Study|Investigator Discretion|0|||
146655650|NCT02925793|528915534|FG001|Overall Study|Investigator Discretion|1|||
146601019|NCT01969721|528709130|FG002|Overall Study|Non compliant with protocol|0|||
146655651|NCT02925793|528915535|FG002|Overall Study|Investigator Discretion|1|||
146655652|NCT02925793|528915533|FG000|Overall Study|Lost to Follow-up|2|||
146655653|NCT02925793|528915534|FG001|Overall Study|Lost to Follow-up|3|||
146655654|NCT02925793|528915535|FG002|Overall Study|Lost to Follow-up|1|||
146655655|NCT02925793|528915533|FG000|Overall Study|Lack of Efficacy|2|||
146655656|NCT02925793|528915534|FG001|Overall Study|Lack of Efficacy|6|||
146655657|NCT02925793|528915535|FG002|Overall Study|Lack of Efficacy|4|||
146655658|NCT02925793|528915533|FG000|Overall Study|Other:|2|||
146655659|NCT02925793|528915534|FG001|Overall Study|Other:|1|||
146655660|NCT02925793|528915535|FG002|Overall Study|Other:|3|||
146655661|NCT01244490|528915536|FG000|Overall Study|Lack of Efficacy|14|||
146655662|NCT01244490|528915537|FG001|Overall Study|Lack of Efficacy|5|||
146655663|NCT01244490|528915538|FG002|Overall Study|Lack of Efficacy|5|||
146655664|NCT01244490|528915536|FG000|Overall Study|Withdrawal by Subject|4|||
146655665|NCT01244490|528915537|FG001|Overall Study|Withdrawal by Subject|4|||
146655666|NCT01244490|528915538|FG002|Overall Study|Withdrawal by Subject|9|||
146655667|NCT01244490|528915536|FG000|Overall Study|Adverse Event|1|||
146655668|NCT01244490|528915537|FG001|Overall Study|Adverse Event|9|||
146655669|NCT01244490|528915538|FG002|Overall Study|Adverse Event|5|||
146655670|NCT01244490|528915536|FG000|Overall Study|Lost to Follow-up|0|||
146655671|NCT01244490|528915537|FG001|Overall Study|Lost to Follow-up|6|||
146655672|NCT01244490|528915538|FG002|Overall Study|Lost to Follow-up|3|||
146655673|NCT01244490|528915536|FG000|Overall Study|Other|0|||
146655674|NCT01244490|528915537|FG001|Overall Study|Other|0|||
146655675|NCT01244490|528915538|FG002|Overall Study|Other|1|||
146655676|NCT00393042|528915539|FG000|First Intervention|Withdrawal by Subject|1|||
146655677|NCT00393042|528915540|FG001|First Intervention|Withdrawal by Subject|2|||
146655678|NCT00393042|528915539|FG000|First Intervention|Lost to Follow-up|3|||
146655679|NCT00393042|528915540|FG001|First Intervention|Lost to Follow-up|3|||
146655680|NCT00393042|528915539|FG000|First Intervention|Protocol Violation|1|||
146655681|NCT00393042|528915540|FG001|First Intervention|Protocol Violation|0|||
146655682|NCT00393042|528915539|FG000|First Intervention|Adverse Event|0|||
146655683|NCT00393042|528915540|FG001|First Intervention|Adverse Event|1|||
146655684|NCT00393042|528915539|FG000|Second Intervetion|Adverse Event|0|||
146655685|NCT00393042|528915540|FG001|Second Intervetion|Adverse Event|3|||
146655686|NCT00393042|528915539|FG000|Second Intervetion|Withdrawal by Subject|0|||
146655687|NCT00393042|528915540|FG001|Second Intervetion|Withdrawal by Subject|2|||
146655688|NCT00393042|528915539|FG000|Second Intervetion|Lack of Efficacy|1|||
146655689|NCT00393042|528915540|FG001|Second Intervetion|Lack of Efficacy|0|||
146655690|NCT00393042|528915539|FG000|Second Intervetion|Lost to Follow-up|0|||
146655691|NCT00393042|528915540|FG001|Second Intervetion|Lost to Follow-up|2|||
146655692|NCT00393042|528915539|FG000|Second Intervetion|Protocol Violation|1|||
146655693|NCT00393042|528915540|FG001|Second Intervetion|Protocol Violation|1|||
146655694|NCT03324581|528915546|FG000|Overall Study|Adverse Event|18|||
146601020|NCT01969721|528709131|FG003|Overall Study|Non compliant with protocol|2|||
146601021|NCT01969721|528709128|FG000|Overall Study|Other not defined above|0|||
146601022|NCT01969721|528709129|FG001|Overall Study|Other not defined above|2|||
146601023|NCT01969721|528709130|FG002|Overall Study|Other not defined above|0|||
146601024|NCT01969721|528709131|FG003|Overall Study|Other not defined above|0|||
146601025|NCT01969721|528709128|FG000|Overall Study|Discontinued during washout periods.|0|||
146601026|NCT01969721|528709129|FG001|Overall Study|Discontinued during washout periods.|1|||
146601027|NCT01969721|528709130|FG002|Overall Study|Discontinued during washout periods.|1|||
146601028|NCT01969721|528709131|FG003|Overall Study|Discontinued during washout periods.|2|||
146601029|NCT02383433|528709134|FG000|Overall Study|Disease progression|2|||
146601030|NCT04311463|528709137|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
146601031|NCT04311463|528709138|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
146601032|NCT04311463|528709137|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
146655695|NCT03324581|528915547|FG001|Overall Study|Adverse Event|11|||
146655696|NCT03324581|528915548|FG002|Overall Study|Adverse Event|7|||
146655697|NCT03324581|528915546|FG000|Overall Study|Lack of Efficacy|0|||
146601033|NCT04311463|528709138|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
146601034|NCT04311463|528709137|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
146601035|NCT04311463|528709138|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
146601036|NCT00952614|528709139|FG000|Overall Study|Death|3|||
146655698|NCT03324581|528915547|FG001|Overall Study|Lack of Efficacy|1|||
146655699|NCT03324581|528915548|FG002|Overall Study|Lack of Efficacy|0|||
146655700|NCT03324581|528915546|FG000|Overall Study|Lost to Follow-up|5|||
146655701|NCT03324581|528915547|FG001|Overall Study|Lost to Follow-up|3|||
146655702|NCT03324581|528915548|FG002|Overall Study|Lost to Follow-up|6|||
146655703|NCT03324581|528915546|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
146655704|NCT03324581|528915547|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
146655705|NCT03324581|528915548|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
146655706|NCT03324581|528915546|FG000|Overall Study|Physician Decision|0|||
146655707|NCT03324581|528915547|FG001|Overall Study|Physician Decision|1|||
146655708|NCT03324581|528915548|FG002|Overall Study|Physician Decision|2|||
146601037|NCT00952614|528709139|FG000|Overall Study|Lost to Follow-up|3|||
146601038|NCT00952614|528709139|FG000|Overall Study|other reason|1|||
146601039|NCT04023682|528709141|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
146601040|NCT03180307|528709152|FG000|Overall Study|Lost to Follow-up|2|||
146601041|NCT03180307|528709153|FG001|Overall Study|Lost to Follow-up|0|||
146601042|NCT03180307|528709152|FG000|Overall Study|Death|1|||
146601043|NCT03180307|528709153|FG001|Overall Study|Death|0|||
146655709|NCT03324581|528915546|FG000|Overall Study|Protocol Deviation|8|||
146655710|NCT03324581|528915547|FG001|Overall Study|Protocol Deviation|9|||
146655711|NCT03324581|528915548|FG002|Overall Study|Protocol Deviation|4|||
146655712|NCT03324581|528915546|FG000|Overall Study|Withdrawal by Subject|6|||
146655713|NCT03324581|528915547|FG001|Overall Study|Withdrawal by Subject|8|||
146655714|NCT03324581|528915548|FG002|Overall Study|Withdrawal by Subject|6|||
146655715|NCT03324581|528915546|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
146655716|NCT03324581|528915547|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
146655717|NCT03324581|528915548|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
146655718|NCT00321893|528915550|FG000|Overall Study|Non-Compliance/Refusal|16|||
146655719|NCT00321893|528915551|FG001|Overall Study|Non-Compliance/Refusal|10|||
146655720|NCT00321893|528915550|FG000|Overall Study|Lost to Follow-up|2|||
146655721|NCT00321893|528915551|FG001|Overall Study|Lost to Follow-up|1|||
146655722|NCT00321893|528915550|FG000|Overall Study|Adverse Event|6|||
146655723|NCT00321893|528915551|FG001|Overall Study|Adverse Event|3|||
146655724|NCT03455764|528915552|FG000|Overall Study|Adverse Event|1|||
146655725|NCT03455764|528915553|FG001|Overall Study|Adverse Event|0|||
146655726|NCT03455764|528915554|FG002|Overall Study|Adverse Event|0|||
146655727|NCT03455764|528915555|FG003|Overall Study|Adverse Event|0|||
146655728|NCT03455764|528915556|FG004|Overall Study|Adverse Event|0|||
146655729|NCT03455764|528915552|FG000|Overall Study|Disease Progression|4|||
146655730|NCT03455764|528915553|FG001|Overall Study|Disease Progression|0|||
146655731|NCT03455764|528915554|FG002|Overall Study|Disease Progression|0|||
146655732|NCT03455764|528915555|FG003|Overall Study|Disease Progression|0|||
146655733|NCT03455764|528915556|FG004|Overall Study|Disease Progression|0|||
146655734|NCT03455764|528915552|FG000|Overall Study|On Treatment|1|||
146655735|NCT03455764|528915553|FG001|Overall Study|On Treatment|0|||
146655736|NCT03455764|528915554|FG002|Overall Study|On Treatment|0|||
146655737|NCT03455764|528915555|FG003|Overall Study|On Treatment|0|||
146655738|NCT03455764|528915556|FG004|Overall Study|On Treatment|0|||
146655739|NCT03523000|528915557|FG000|Overall Study|Withdrawal by Subject|3|||
146655740|NCT03523000|528915558|FG001|Overall Study|Withdrawal by Subject|0|||
146655741|NCT03523000|528915557|FG000|Overall Study|Unsuccessful trial|2|||
146655742|NCT03523000|528915558|FG001|Overall Study|Unsuccessful trial|0|||
146655743|NCT00495131|528915559|FG000|Overall Study|Adverse Event|6|||
146655744|NCT00495131|528915560|FG001|Overall Study|Adverse Event|2|||
146655745|NCT00495131|528915559|FG000|Overall Study|Lack of Efficacy|0|||
146655746|NCT00495131|528915560|FG001|Overall Study|Lack of Efficacy|2|||
146655747|NCT00495131|528915559|FG000|Overall Study|Lost to Follow-up|0|||
146655748|NCT00495131|528915560|FG001|Overall Study|Lost to Follow-up|2|||
146655749|NCT00495131|528915559|FG000|Overall Study|Withdrawal by Subject|1|||
146655750|NCT00495131|528915560|FG001|Overall Study|Withdrawal by Subject|0|||
146655751|NCT00727532|528915561|FG000|Overall Study|Adverse Event|1|||
146655752|NCT00727532|528915561|FG000|Overall Study|Withdrawal by Subject|1|||
146655753|NCT00829933|528915562|FG000|Overall Study|Adverse Event|2|||
146655754|NCT00829933|528915563|FG001|Overall Study|Adverse Event|3|||
146655755|NCT00829933|528915564|FG002|Overall Study|Adverse Event|2|||
146655756|NCT00829933|528915565|FG003|Overall Study|Adverse Event|1|||
146655757|NCT00829933|528915562|FG000|Overall Study|Death|0|||
146655758|NCT00829933|528915563|FG001|Overall Study|Death|0|||
146655759|NCT00829933|528915564|FG002|Overall Study|Death|1|||
146655760|NCT00829933|528915565|FG003|Overall Study|Death|1|||
146655761|NCT00829933|528915562|FG000|Overall Study|Lack of Efficacy|0|||
146655762|NCT00829933|528915563|FG001|Overall Study|Lack of Efficacy|1|||
146655763|NCT00829933|528915564|FG002|Overall Study|Lack of Efficacy|0|||
146772045|NCT00925587|529334368|FG001|Overall Study|Protocol Violation|4|||
146772046|NCT00925587|529334367|FG000|Overall Study|Withdrawal by Subject|9|||
146772047|NCT00925587|529334368|FG001|Overall Study|Withdrawal by Subject|6|||
146601044|NCT03180307|528709152|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
146601045|NCT03180307|528709153|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
146601046|NCT01563172|528709154|FG000|Overall Study|Adverse Event|5|||
146655764|NCT00829933|528915565|FG003|Overall Study|Lack of Efficacy|0|||
146655765|NCT00829933|528915562|FG000|Overall Study|Physician Decision|5|||
146655766|NCT00829933|528915563|FG001|Overall Study|Physician Decision|7|||
146655767|NCT00829933|528915564|FG002|Overall Study|Physician Decision|8|||
146655768|NCT00829933|528915565|FG003|Overall Study|Physician Decision|1|||
146655769|NCT00829933|528915562|FG000|Overall Study|Pregnancy|0|||
146655770|NCT00829933|528915563|FG001|Overall Study|Pregnancy|0|||
146655771|NCT00829933|528915564|FG002|Overall Study|Pregnancy|0|||
146655772|NCT00829933|528915565|FG003|Overall Study|Pregnancy|2|||
146655773|NCT00829933|528915562|FG000|Overall Study|Protocol Violation|2|||
146655774|NCT00829933|528915563|FG001|Overall Study|Protocol Violation|1|||
146772048|NCT00925587|529334367|FG000|Overall Study|Death|5|||
146772049|NCT00925587|529334368|FG001|Overall Study|Death|5|||
146772050|NCT00925587|529334367|FG000|Overall Study|Adverse Event|6|||
146772051|NCT00925587|529334368|FG001|Overall Study|Adverse Event|2|||
146772052|NCT00925587|529334367|FG000|Overall Study|Lost to Follow-up|0|||
146772053|NCT00925587|529334368|FG001|Overall Study|Lost to Follow-up|1|||
146772054|NCT01140048|529334378|FG000|Overall Study|Physician Decision|1|||
146772055|NCT01140048|529334378|FG000|Overall Study|Withdrawal by Subject|13|||
146772056|NCT01140048|529334378|FG000|Overall Study|Lost to Follow-up|31|||
146772057|NCT02888080|529334379|FG000|Overall Study|Subject / Guardian decision|1|||
146772058|NCT02888080|529334380|FG001|Overall Study|Subject / Guardian decision|3|||
146772059|NCT02888080|529334379|FG000|Overall Study|New Therapy for study indication|1|||
146772060|NCT02888080|529334380|FG001|Overall Study|New Therapy for study indication|0|||
146772061|NCT02888080|529334379|FG000|Overall Study|Lack of Efficacy|0|||
146772062|NCT02888080|529334380|FG001|Overall Study|Lack of Efficacy|1|||
146772063|NCT02888080|529334379|FG000|Overall Study|Adverse Event|0|||
146772064|NCT02888080|529334380|FG001|Overall Study|Adverse Event|1|||
146772065|NCT00980330|529334381|FG000|Overall Study|Adverse Event|0|||
146772066|NCT00980330|529334382|FG001|Overall Study|Adverse Event|0|||
146772067|NCT00980330|529334383|FG002|Overall Study|Adverse Event|0|||
146772068|NCT00980330|529334384|FG003|Overall Study|Adverse Event|1|||
146772069|NCT00980330|529334385|FG004|Overall Study|Adverse Event|0|||
146772070|NCT00980330|529334386|FG005|Overall Study|Adverse Event|0|||
146772071|NCT00980330|529334387|FG006|Overall Study|Adverse Event|0|||
146772072|NCT00980330|529334381|FG000|Overall Study|Lost to Follow-up|1|||
146772073|NCT00980330|529334382|FG001|Overall Study|Lost to Follow-up|1|||
146772074|NCT00980330|529334383|FG002|Overall Study|Lost to Follow-up|4|||
146772075|NCT00980330|529334384|FG003|Overall Study|Lost to Follow-up|2|||
146772076|NCT00980330|529334385|FG004|Overall Study|Lost to Follow-up|1|||
146772077|NCT00980330|529334386|FG005|Overall Study|Lost to Follow-up|1|||
146772078|NCT00980330|529334387|FG006|Overall Study|Lost to Follow-up|2|||
146772079|NCT00980330|529334381|FG000|Overall Study|Withdrawal by Subject|2|||
146772080|NCT00980330|529334382|FG001|Overall Study|Withdrawal by Subject|4|||
146772081|NCT00980330|529334383|FG002|Overall Study|Withdrawal by Subject|4|||
146772082|NCT00980330|529334384|FG003|Overall Study|Withdrawal by Subject|1|||
146772083|NCT00980330|529334385|FG004|Overall Study|Withdrawal by Subject|3|||
146772084|NCT00980330|529334386|FG005|Overall Study|Withdrawal by Subject|2|||
146772085|NCT00980330|529334387|FG006|Overall Study|Withdrawal by Subject|5|||
146772086|NCT00980330|529334381|FG000|Overall Study|(not specified)|2|||
146772087|NCT00980330|529334382|FG001|Overall Study|(not specified)|0|||
146772088|NCT00980330|529334383|FG002|Overall Study|(not specified)|0|||
146772089|NCT00980330|529334384|FG003|Overall Study|(not specified)|1|||
146772090|NCT00980330|529334385|FG004|Overall Study|(not specified)|1|||
146772091|NCT00980330|529334386|FG005|Overall Study|(not specified)|1|||
146772092|NCT00980330|529334387|FG006|Overall Study|(not specified)|0|||
146772093|NCT00666276|529334390|FG000|Overall Study|Protocol Violation|34|||
146772094|NCT01039688|529334391|FG000|Overall Study|Adverse Event|38|||
146772095|NCT01039688|529334392|FG001|Overall Study|Adverse Event|39|||
146772096|NCT01039688|529334393|FG002|Overall Study|Adverse Event|24|||
146772097|NCT01039688|529334391|FG000|Overall Study|Lack of Efficacy|20|||
146772098|NCT01039688|529334392|FG001|Overall Study|Lack of Efficacy|11|||
146772099|NCT01039688|529334393|FG002|Overall Study|Lack of Efficacy|26|||
146772100|NCT01039688|529334391|FG000|Overall Study|Lost to Follow-up|11|||
146772101|NCT01039688|529334392|FG001|Overall Study|Lost to Follow-up|9|||
146772102|NCT01039688|529334393|FG002|Overall Study|Lost to Follow-up|5|||
146772103|NCT01039688|529334391|FG000|Overall Study|Other|13|||
146772104|NCT01039688|529334392|FG001|Overall Study|Other|25|||
146772105|NCT01039688|529334393|FG002|Overall Study|Other|12|||
146772106|NCT01039688|529334391|FG000|Overall Study|Withdrawal by Subject|23|||
146772107|NCT01039688|529334392|FG001|Overall Study|Withdrawal by Subject|27|||
146772108|NCT01039688|529334393|FG002|Overall Study|Withdrawal by Subject|13|||
146772109|NCT01039688|529334391|FG000|Overall Study|Death|2|||
146772110|NCT01039688|529334392|FG001|Overall Study|Death|0|||
146772111|NCT01039688|529334393|FG002|Overall Study|Death|0|||
146772112|NCT02594735|529334394|FG000|Overall Study|Adverse Event|1|||
146772113|NCT03844269|529334398|FG000|Overall Study|Withdrawal pre-intervention|1|||
146772114|NCT03844269|529334398|FG000|Overall Study|Did not complete the intervention|2|||
146978634|NCT01358708|530084119|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
146772115|NCT00665444|529334399|FG000|Overall Study|Physician Decision|1|||
146772116|NCT00665444|529334399|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
146772117|NCT03520413|529334403|FG000|Overall Study|Lost to Follow-up|1|||
146772118|NCT03520413|529334404|FG001|Overall Study|Lost to Follow-up|1|||
146772119|NCT03520413|529334403|FG000|Overall Study|Withdrawal by Subject|1|||
146772120|NCT03520413|529334404|FG001|Overall Study|Withdrawal by Subject|2|||
146772121|NCT03520413|529334403|FG000|Overall Study|Death|0|||
146772122|NCT03520413|529334404|FG001|Overall Study|Death|1|||
146772123|NCT03520413|529334403|FG000|Overall Study|Physician Decision|3|||
146772124|NCT03520413|529334404|FG001|Overall Study|Physician Decision|3|||
146772125|NCT03520413|529334403|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
146601047|NCT01563172|528709154|FG000|Overall Study|Lost to Follow-up|2|||
146601048|NCT01563172|528709154|FG000|Overall Study|Other (Protocol deviation)|5|||
146601049|NCT01563172|528709154|FG000|Overall Study|Other (Not specified)|1|||
146601050|NCT02986854|528709156|FG000|Overall Study|Withdrawal by Subject|0|||
146601051|NCT02986854|528709157|FG001|Overall Study|Withdrawal by Subject|1|||
146601052|NCT02986854|528709158|FG002|Overall Study|Withdrawal by Subject|1|||
146601053|NCT02986854|528709156|FG000|Overall Study|Lost to Follow-up|3|||
146601054|NCT02986854|528709157|FG001|Overall Study|Lost to Follow-up|11|||
146601055|NCT02986854|528709158|FG002|Overall Study|Lost to Follow-up|2|||
146601056|NCT00718770|528709161|FG000|Overall Study|Adverse Event|1|||
146601057|NCT00718770|528709161|FG000|Overall Study|Lack of Efficacy|1|||
146601058|NCT00718770|528709161|FG000|Overall Study|Lack of Efficacy|1|||
146601059|NCT00718770|528709161|FG000|Overall Study|Adverse Event|1|||
146601060|NCT00718770|528709161|FG000|Overall Study|Lack of Efficacy|1|||
146601061|NCT00718770|528709161|FG000|Overall Study|Adverse Event|1|||
146601062|NCT00718770|528709161|FG000|Overall Study|Lack of Efficacy|1|||
146601063|NCT00718770|528709161|FG000|Overall Study|Adverse Event|1|||
146601064|NCT00772109|528709165|FG000|Overall Study|Serious adverse event|1|||
146601065|NCT00772109|528709166|FG001|Overall Study|Serious adverse event|0|||
146601066|NCT00772109|528709167|FG002|Overall Study|Serious adverse event|1|||
146601067|NCT00772109|528709168|FG003|Overall Study|Serious adverse event|0|||
146601068|NCT00772109|528709165|FG000|Overall Study|Protocol Violation|5|||
146601069|NCT00772109|528709166|FG001|Overall Study|Protocol Violation|8|||
146601070|NCT00772109|528709167|FG002|Overall Study|Protocol Violation|7|||
146601071|NCT00772109|528709168|FG003|Overall Study|Protocol Violation|6|||
146601072|NCT00772109|528709165|FG000|Overall Study|Lost to Follow-up|7|||
146601073|NCT00772109|528709166|FG001|Overall Study|Lost to Follow-up|3|||
146601074|NCT00772109|528709167|FG002|Overall Study|Lost to Follow-up|5|||
146601075|NCT00772109|528709168|FG003|Overall Study|Lost to Follow-up|9|||
146601076|NCT00772109|528709165|FG000|Overall Study|Withdrawal by Subject|8|||
146601077|NCT00772109|528709166|FG001|Overall Study|Withdrawal by Subject|8|||
146601078|NCT00772109|528709167|FG002|Overall Study|Withdrawal by Subject|6|||
146601079|NCT00772109|528709168|FG003|Overall Study|Withdrawal by Subject|16|||
146601080|NCT01624090|528709169|FG000|Overall Study|DLT, taken off therapy|0|||
146601081|NCT01624090|528709170|FG001|Overall Study|DLT, taken off therapy|1|||
146601082|NCT01624090|528709171|FG002|Overall Study|DLT, taken off therapy|0|||
146601083|NCT01624090|528709172|FG003|Overall Study|DLT, taken off therapy|0|||
146601084|NCT01624090|528709169|FG000|Overall Study|Withdrew prior to treatment|0|||
146601085|NCT01624090|528709170|FG001|Overall Study|Withdrew prior to treatment|1|||
146601086|NCT01624090|528709171|FG002|Overall Study|Withdrew prior to treatment|0|||
146601087|NCT01624090|528709172|FG003|Overall Study|Withdrew prior to treatment|0|||
146601088|NCT01624090|528709169|FG000|Overall Study|Died on study|0|||
146601089|NCT01624090|528709170|FG001|Overall Study|Died on study|0|||
146601090|NCT01624090|528709171|FG002|Overall Study|Died on study|2|||
146601091|NCT01624090|528709172|FG003|Overall Study|Died on study|0|||
146601092|NCT01624090|528709169|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
146601093|NCT01624090|528709170|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
146601094|NCT01624090|528709171|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
146601095|NCT01624090|528709172|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
146601096|NCT01624090|528709169|FG000|Overall Study|Dose escalated|0|||
146601097|NCT01624090|528709170|FG001|Overall Study|Dose escalated|0|||
146601098|NCT01624090|528709171|FG002|Overall Study|Dose escalated|3|||
146601099|NCT01624090|528709172|FG003|Overall Study|Dose escalated|0|||
146601100|NCT00752726|528709173|FG000|Overall Study|Lost to Follow-up|2|||
146601101|NCT00752726|528709174|FG001|Overall Study|Lost to Follow-up|1|||
146601102|NCT00752726|528709173|FG000|Overall Study|Adverse Event|3|||
146601103|NCT00752726|528709174|FG001|Overall Study|Adverse Event|0|||
146601104|NCT00752726|528709173|FG000|Overall Study|Withdrawal by Subject|5|||
146601105|NCT00752726|528709174|FG001|Overall Study|Withdrawal by Subject|10|||
146601106|NCT00752726|528709173|FG000|Overall Study|Other Reason|1|||
146601107|NCT00752726|528709174|FG001|Overall Study|Other Reason|2|||
146601108|NCT01403116|528709175|FG000|Overall Study|Adverse Event|7|||
146601109|NCT01403116|528709176|FG001|Overall Study|Adverse Event|4|||
146601110|NCT01403116|528709175|FG000|Overall Study|Lost to Follow-up|7|||
146601111|NCT01403116|528709176|FG001|Overall Study|Lost to Follow-up|5|||
146601112|NCT01403116|528709175|FG000|Overall Study|Withdrawal by Subject|12|||
146601113|NCT01403116|528709176|FG001|Overall Study|Withdrawal by Subject|15|||
146601114|NCT01403116|528709175|FG000|Overall Study|Non-compliance of study drug|3|||
146601115|NCT01403116|528709176|FG001|Overall Study|Non-compliance of study drug|0|||
146601116|NCT01403116|528709175|FG000|Overall Study|Protocol Violation|0|||
146601117|NCT01403116|528709176|FG001|Overall Study|Protocol Violation|1|||
146601118|NCT01403116|528709175|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
146601119|NCT01403116|528709176|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
146601120|NCT01403116|528709175|FG000|Overall Study|Hct >54%|2|||
146601121|NCT01403116|528709176|FG001|Overall Study|Hct >54%|0|||
146601122|NCT01403116|528709175|FG000|Overall Study|unable to keep appointments|0|||
146601123|NCT01403116|528709176|FG001|Overall Study|unable to keep appointments|2|||
146601124|NCT01895309|528709177|FG000|Overall Study|Adverse Event|13|||
146922584|NCT02052778|529876763|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
146601125|NCT01895309|528709178|FG001|Overall Study|Adverse Event|17|||
146601126|NCT01895309|528709177|FG000|Overall Study|Protocol Violation|1|||
146601127|NCT01895309|528709178|FG001|Overall Study|Protocol Violation|0|||
146601128|NCT01895309|528709177|FG000|Overall Study|Lack of Efficacy|1|||
146601129|NCT01895309|528709178|FG001|Overall Study|Lack of Efficacy|3|||
146601130|NCT01895309|528709177|FG000|Overall Study|Lost to Follow-up|1|||
146601131|NCT01895309|528709178|FG001|Overall Study|Lost to Follow-up|3|||
146601132|NCT01895309|528709177|FG000|Overall Study|Physician Decision|15|||
146601133|NCT01895309|528709178|FG001|Overall Study|Physician Decision|10|||
146601134|NCT01895309|528709177|FG000|Overall Study|Withdrawal by Subject|9|||
146601135|NCT01895309|528709178|FG001|Overall Study|Withdrawal by Subject|18|||
146601136|NCT00042666|528709179|FG000|Overall Study|Adverse Event|2|||
146601137|NCT00042666|528709179|FG000|Overall Study|Death|4|||
146601138|NCT00042666|528709179|FG000|Overall Study|Protocol Violation|1|||
146601139|NCT00042666|528709179|FG000|Overall Study|Participant/Physician Perception|1|||
146601140|NCT00042666|528709179|FG000|Overall Study|Progressive Disease|41|||
146601141|NCT00042666|528709179|FG000|Overall Study|Other|1|||
146601142|NCT00042666|528709179|FG000|Overall Study|Other|4|||
146601143|NCT04232215|528709180|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
146601144|NCT04232215|528709181|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
146601145|NCT01555125|528709184|FG000|Induction Period|Lost to Follow-up|0|||
146601146|NCT01555125|528709185|FG001|Induction Period|Lost to Follow-up|2|||
146601147|NCT01555125|528709186|FG002|Induction Period|Lost to Follow-up|0|||
146601148|NCT01555125|528709187|FG003|Induction Period|Lost to Follow-up|0|||
146601149|NCT01555125|528709188|FG004|Induction Period|Lost to Follow-up|0|||
146601150|NCT01555125|528709184|FG000|Induction Period|Adverse Event|0|||
146601151|NCT01555125|528709185|FG001|Induction Period|Adverse Event|1|||
146601152|NCT01555125|528709186|FG002|Induction Period|Adverse Event|0|||
146601153|NCT01555125|528709187|FG003|Induction Period|Adverse Event|0|||
146601154|NCT01555125|528709188|FG004|Induction Period|Adverse Event|1|||
146601155|NCT01555125|528709184|FG000|Induction Period|Subject / guardian decision|0|||
146601156|NCT01555125|528709185|FG001|Induction Period|Subject / guardian decision|0|||
146601157|NCT01555125|528709186|FG002|Induction Period|Subject / guardian decision|0|||
146601158|NCT01555125|528709187|FG003|Induction Period|Subject / guardian decision|0|||
146601159|NCT01555125|528709188|FG004|Induction Period|Subject / guardian decision|2|||
146601160|NCT01555125|528709184|FG000|Induction Period|Death|1|||
146601161|NCT01555125|528709185|FG001|Induction Period|Death|0|||
146601162|NCT01555125|528709186|FG002|Induction Period|Death|0|||
146922585|NCT01409031|529876764|FG000|Overall Study|transferred to other hosp|1|||
146601163|NCT01555125|528709187|FG003|Induction Period|Death|0|||
146601164|NCT01555125|528709188|FG004|Induction Period|Death|0|||
146601165|NCT01555125|528709184|FG000|Maintenance Period|Adverse Event|1|||
146601166|NCT01555125|528709185|FG001|Maintenance Period|Adverse Event|1|||
146601167|NCT01555125|528709186|FG002|Maintenance Period|Adverse Event|0|||
146601168|NCT01555125|528709187|FG003|Maintenance Period|Adverse Event|0|||
146601169|NCT01555125|528709188|FG004|Maintenance Period|Adverse Event|0|||
146601170|NCT01555125|528709184|FG000|Maintenance Period|Subject / guardian decision|1|||
146601171|NCT01555125|528709185|FG001|Maintenance Period|Subject / guardian decision|2|||
146601172|NCT01555125|528709186|FG002|Maintenance Period|Subject / guardian decision|0|||
146601173|NCT01555125|528709187|FG003|Maintenance Period|Subject / guardian decision|0|||
146601174|NCT01555125|528709188|FG004|Maintenance Period|Subject / guardian decision|0|||
146601175|NCT01555125|528709184|FG000|Maintenance Period|Lost to Follow-up|2|||
146601176|NCT01555125|528709185|FG001|Maintenance Period|Lost to Follow-up|0|||
146601177|NCT01555125|528709186|FG002|Maintenance Period|Lost to Follow-up|0|||
146601178|NCT01555125|528709187|FG003|Maintenance Period|Lost to Follow-up|1|||
146601179|NCT01555125|528709188|FG004|Maintenance Period|Lost to Follow-up|0|||
146601180|NCT01555125|528709184|FG000|Maintenance Period|Lack of Efficacy|6|||
146601181|NCT01555125|528709185|FG001|Maintenance Period|Lack of Efficacy|1|||
146601182|NCT01555125|528709186|FG002|Maintenance Period|Lack of Efficacy|3|||
146601183|NCT01555125|528709187|FG003|Maintenance Period|Lack of Efficacy|0|||
146601184|NCT01555125|528709188|FG004|Maintenance Period|Lack of Efficacy|0|||
146601185|NCT01555125|528709184|FG000|Maintenance Period|Physician Decision|0|||
146601186|NCT01555125|528709185|FG001|Maintenance Period|Physician Decision|0|||
146601187|NCT01555125|528709186|FG002|Maintenance Period|Physician Decision|1|||
146601188|NCT01555125|528709187|FG003|Maintenance Period|Physician Decision|0|||
146601189|NCT01555125|528709188|FG004|Maintenance Period|Physician Decision|0|||
146601190|NCT01555125|528709184|FG000|Maintenance Period|Death|0|||
146601191|NCT01555125|528709185|FG001|Maintenance Period|Death|0|||
146601192|NCT01555125|528709186|FG002|Maintenance Period|Death|0|||
146601193|NCT01555125|528709187|FG003|Maintenance Period|Death|1|||
146601194|NCT01555125|528709188|FG004|Maintenance Period|Death|0|||
146601195|NCT01555125|528709184|FG000|Extension|Adverse Event|1|||
146655775|NCT00829933|528915564|FG002|Overall Study|Protocol Violation|0|||
146601196|NCT01555125|528709185|FG001|Extension|Adverse Event|2|||
146601197|NCT01555125|528709186|FG002|Extension|Adverse Event|1|||
146601198|NCT01555125|528709187|FG003|Extension|Adverse Event|1|||
146601199|NCT01555125|528709188|FG004|Extension|Adverse Event|0|||
146772126|NCT03520413|529334404|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
146772127|NCT00101010|529334405|FG000|Overall Study|Physician Decision|1|||
146772128|NCT00346151|529334406|FG000|Overall Study|Withdrawal by Subject|3|||
146601200|NCT01555125|528709184|FG000|Extension|Protocol deviation|1|||
146601201|NCT01555125|528709185|FG001|Extension|Protocol deviation|0|||
146601202|NCT01555125|528709186|FG002|Extension|Protocol deviation|0|||
146601203|NCT01555125|528709187|FG003|Extension|Protocol deviation|0|||
146601204|NCT01555125|528709188|FG004|Extension|Protocol deviation|0|||
146772129|NCT04054635|529334407|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
146772130|NCT04054635|529334408|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
146772131|NCT04054635|529334409|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
146772132|NCT04054635|529334407|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
146772133|NCT04054635|529334408|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
146772134|NCT04054635|529334409|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
146772135|NCT00891930|529334410|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
146772136|NCT00891930|529334410|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
146772137|NCT00891930|529334410|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
146772138|NCT00891930|529334410|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
146772139|NCT00891930|529334410|FG000|Part 2 Panitumumab + AMG479|Death|30|||
146772140|NCT01943916|529334413|FG000|Overall Study|Technically invalid images|10|||
146772141|NCT01943916|529334413|FG000|Overall Study|Enrollment Failure|23|||
146772142|NCT01943916|529334413|FG000|Overall Study|Pilot Phase exclusion|100|||
146772143|NCT01943916|529334413|FG000|Overall Study|Quality Assurance Reader Fail|130|||
146772144|NCT01943916|529334413|FG000|Overall Study|Technical Failure|39|||
146772145|NCT01943916|529334413|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
146772146|NCT01943916|529334413|FG000|Overall Study|No Truth Panel Review|38|||
146772147|NCT01943916|529334413|FG000|Overall Study|Protocol Deviation|1|||
146772148|NCT01576484|529334414|FG000|Overall Study|Adverse Event|1|||
146772149|NCT01576484|529334415|FG001|Overall Study|Adverse Event|1|||
146772150|NCT01576484|529334414|FG000|Overall Study|Protocol Violation|0|||
146772151|NCT01576484|529334415|FG001|Overall Study|Protocol Violation|2|||
146772152|NCT01576484|529334414|FG000|Overall Study|Sponsor Decision|2|||
146772153|NCT01576484|529334415|FG001|Overall Study|Sponsor Decision|8|||
146772154|NCT01576484|529334414|FG000|Overall Study|Withdrawal by Subject|0|||
146772155|NCT01576484|529334415|FG001|Overall Study|Withdrawal by Subject|3|||
146772156|NCT01576484|529334414|FG000|Overall Study|Other|2|||
146772157|NCT01576484|529334415|FG001|Overall Study|Other|5|||
146772158|NCT03823911|529334419|FG000|Overall Study|Lost to Follow-up|1|||
146772159|NCT03823911|529334420|FG001|Overall Study|Lost to Follow-up|5|||
146772160|NCT03823911|529334421|FG002|Overall Study|Lost to Follow-up|2|||
146772161|NCT03823911|529334419|FG000|Overall Study|Did not meet eligibility criteria|13|||
146772162|NCT03823911|529334420|FG001|Overall Study|Did not meet eligibility criteria|7|||
146772163|NCT03823911|529334421|FG002|Overall Study|Did not meet eligibility criteria|4|||
146772164|NCT03823911|529334419|FG000|Overall Study|Death|0|||
146772165|NCT03823911|529334420|FG001|Overall Study|Death|1|||
146772166|NCT03823911|529334421|FG002|Overall Study|Death|0|||
146772167|NCT00958633|529334426|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
146772168|NCT00958633|529334427|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
146772169|NCT00958633|529334428|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
146772170|NCT00958633|529334426|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
146772171|NCT00958633|529334427|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
146772172|NCT00958633|529334428|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
146772173|NCT00958633|529334426|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
146772174|NCT00958633|529334427|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
146772175|NCT00958633|529334428|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
146772176|NCT00958633|529334426|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
146772177|NCT00958633|529334427|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
146772178|NCT00958633|529334428|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
146772179|NCT00958633|529334426|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
146772180|NCT00958633|529334427|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
146772181|NCT00958633|529334428|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
146772182|NCT00958633|529334426|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
146772183|NCT00958633|529334427|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
146772184|NCT00958633|529334428|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
146772185|NCT00958633|529334426|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
146601205|NCT01555125|528709184|FG000|Extension|Lack of Efficacy|7|||
146772186|NCT00958633|529334427|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
146772187|NCT00958633|529334428|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
146772188|NCT00094575|529334432|FG000|Overall Study|Death|146|||
146772189|NCT00094575|529334433|FG001|Overall Study|Death|146|||
146601206|NCT01555125|528709185|FG001|Extension|Lack of Efficacy|6|||
146772190|NCT04305405|529334434|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146772191|NCT04305405|529334435|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146601207|NCT01555125|528709186|FG002|Extension|Lack of Efficacy|3|||
146601208|NCT01555125|528709187|FG003|Extension|Lack of Efficacy|0|||
146601209|NCT01555125|528709188|FG004|Extension|Lack of Efficacy|0|||
146922586|NCT01409031|529876765|FG001|Overall Study|transferred to other hosp|0|||
146922587|NCT01094730|529876768|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
146922588|NCT01094730|529876769|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
146601210|NCT01555125|528709184|FG000|Extension|Lost to Follow-up|2|||
146601211|NCT01555125|528709185|FG001|Extension|Lost to Follow-up|1|||
146601212|NCT01555125|528709186|FG002|Extension|Lost to Follow-up|2|||
146601213|NCT01555125|528709187|FG003|Extension|Lost to Follow-up|0|||
146601214|NCT01555125|528709188|FG004|Extension|Lost to Follow-up|0|||
146655776|NCT00829933|528915565|FG003|Overall Study|Protocol Violation|0|||
146655777|NCT00829933|528915562|FG000|Overall Study|withdrew before treatment started|5|||
146655778|NCT00829933|528915563|FG001|Overall Study|withdrew before treatment started|1|||
146655779|NCT00829933|528915564|FG002|Overall Study|withdrew before treatment started|2|||
146655780|NCT00829933|528915565|FG003|Overall Study|withdrew before treatment started|9|||
146655781|NCT00523367|528915566|FG000|Overall Study|19 screen failures|19|||
146978635|NCT01358708|530084120|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
146655782|NCT00523367|528915566|FG000|Overall Study|4 Withdrawn by PI|4|||
146922589|NCT01094730|529876768|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
146922590|NCT01094730|529876769|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
146922591|NCT01094730|529876768|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
146922592|NCT01094730|529876769|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
146922593|NCT01094730|529876768|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
146922594|NCT01094730|529876769|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
146922595|NCT01094730|529876768|FG000|Period 2 (14 Days)|Protocol Violation|2|||
146922596|NCT01094730|529876769|FG001|Period 2 (14 Days)|Protocol Violation|0|||
146922597|NCT01094730|529876768|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
146922598|NCT01094730|529876769|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
146922599|NCT01094730|529876768|FG000|Period 2 (14 Days)|Adverse Event|0|||
146922600|NCT01094730|529876769|FG001|Period 2 (14 Days)|Adverse Event|1|||
146922601|NCT01094730|529876768|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
146922602|NCT01094730|529876769|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
146922603|NCT02232087|529876770|FG000|Overall Study|Withdrawal by Subject|2|||
146978636|NCT02475980|530084123|FG000|Overall Study|Lost to Follow-up|4|||
146978637|NCT02475980|530084123|FG000|Overall Study|Withdrawal by Subject|1|||
146978638|NCT00990093|530084124|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
146978639|NCT00990093|530084125|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
146978640|NCT00990093|530084124|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
146655783|NCT03150485|528917759|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
146655784|NCT03150485|528917760|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
146655785|NCT03150485|528917761|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
146655786|NCT03150485|528917762|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
146655787|NCT03150485|528917763|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
146655788|NCT03150485|528917764|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
146655789|NCT05828095|528917766|FG000|Overall Study|Lost to Follow-up|1|||
146655790|NCT05828095|528917767|FG001|Overall Study|Lost to Follow-up|0|||
146655791|NCT05828095|528917766|FG000|Overall Study|Reactogenicity symptom|0|||
146655792|NCT05828095|528917767|FG001|Overall Study|Reactogenicity symptom|1|||
146655793|NCT00096954|528917773|FG000|Overall Study|Adverse Event|3|||
146655794|NCT00096954|528917774|FG001|Overall Study|Adverse Event|1|||
146655795|NCT00096954|528917773|FG000|Overall Study|Withdrawal by Subject|9|||
146655796|NCT00096954|528917774|FG001|Overall Study|Withdrawal by Subject|8|||
146655797|NCT00096954|528917773|FG000|Overall Study|Physician Decision|1|||
146655798|NCT00096954|528917774|FG001|Overall Study|Physician Decision|1|||
146655799|NCT00096954|528917773|FG000|Overall Study|Sponsors Decision|1|||
146655800|NCT00096954|528917774|FG001|Overall Study|Sponsors Decision|1|||
146655801|NCT00096954|528917773|FG000|Overall Study|Pregnancy|1|||
146655802|NCT00096954|528917774|FG001|Overall Study|Pregnancy|1|||
146655803|NCT00096954|528917773|FG000|Overall Study|Initiation of immunotherapy|1|||
146655804|NCT00096954|528917774|FG001|Overall Study|Initiation of immunotherapy|0|||
146655805|NCT00096954|528917773|FG000|Overall Study|Non-compliance|0|||
146655806|NCT00096954|528917774|FG001|Overall Study|Non-compliance|3|||
146655807|NCT00096954|528917773|FG000|Overall Study|Lost to Follow-up|8|||
146655808|NCT00096954|528917774|FG001|Overall Study|Lost to Follow-up|5|||
146655809|NCT03442764|528917775|FG000|Overall Study|Adverse Event|1|||
146655810|NCT03442764|528917776|FG001|Overall Study|Adverse Event|0|||
146655811|NCT03442764|528917777|FG002|Overall Study|Adverse Event|0|||
146655812|NCT04478123|528917778|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
146655813|NCT04478123|528917778|FG000|Overall Study|NE|1|||
146601215|NCT01555125|528709184|FG000|Extension|Study terminated by sponsor|32|||
146601216|NCT01555125|528709185|FG001|Extension|Study terminated by sponsor|33|||
146601217|NCT01555125|528709186|FG002|Extension|Study terminated by sponsor|16|||
146601218|NCT01555125|528709187|FG003|Extension|Study terminated by sponsor|20|||
146601219|NCT01555125|528709188|FG004|Extension|Study terminated by sponsor|0|||
146601220|NCT01555125|528709184|FG000|Extension|Subject/guardian decision|1|||
146655814|NCT02395016|528917779|FG000|Overall Study|Adverse Event|4|||
146601221|NCT01555125|528709185|FG001|Extension|Subject/guardian decision|9|||
146601222|NCT01555125|528709186|FG002|Extension|Subject/guardian decision|1|||
146601223|NCT01555125|528709187|FG003|Extension|Subject/guardian decision|0|||
146601224|NCT01555125|528709188|FG004|Extension|Subject/guardian decision|0|||
146601225|NCT01555125|528709184|FG000|Extension|Technical Problems|1|||
146601226|NCT01555125|528709185|FG001|Extension|Technical Problems|0|||
146601227|NCT01555125|528709186|FG002|Extension|Technical Problems|0|||
146601228|NCT01555125|528709187|FG003|Extension|Technical Problems|1|||
146601229|NCT01555125|528709188|FG004|Extension|Technical Problems|0|||
146601230|NCT01555125|528709184|FG000|Follow-Up Period|Lost to Follow-up|1|||
146601231|NCT01555125|528709185|FG001|Follow-Up Period|Lost to Follow-up|0|||
146601232|NCT01555125|528709186|FG002|Follow-Up Period|Lost to Follow-up|0|||
146601233|NCT01555125|528709187|FG003|Follow-Up Period|Lost to Follow-up|0|||
146601234|NCT01555125|528709188|FG004|Follow-Up Period|Lost to Follow-up|0|||
146601235|NCT01555125|528709184|FG000|Follow-Up Period|Subject / guardian decision|3|||
146601236|NCT01555125|528709185|FG001|Follow-Up Period|Subject / guardian decision|1|||
146601237|NCT01555125|528709186|FG002|Follow-Up Period|Subject / guardian decision|1|||
146601238|NCT01555125|528709187|FG003|Follow-Up Period|Subject / guardian decision|1|||
146601239|NCT01555125|528709188|FG004|Follow-Up Period|Subject / guardian decision|0|||
146601240|NCT02651220|528709189|FG000|Overall Study|Adverse Event|1|||
146601241|NCT02651220|528709190|FG001|Overall Study|Adverse Event|5|||
146601242|NCT02651220|528709191|FG002|Overall Study|Adverse Event|1|||
146601243|NCT02651220|528709189|FG000|Overall Study|Lost to Follow-up|8|||
146601244|NCT02651220|528709190|FG001|Overall Study|Lost to Follow-up|14|||
146601245|NCT02651220|528709191|FG002|Overall Study|Lost to Follow-up|14|||
146601246|NCT02651220|528709189|FG000|Overall Study|Non-Compliance with Study Drug|4|||
146601247|NCT02651220|528709190|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146601248|NCT02651220|528709191|FG002|Overall Study|Non-Compliance with Study Drug|1|||
146601249|NCT02651220|528709189|FG000|Overall Study|Pregnancy|1|||
146601250|NCT02651220|528709190|FG001|Overall Study|Pregnancy|0|||
146601251|NCT02651220|528709191|FG002|Overall Study|Pregnancy|1|||
146601252|NCT02651220|528709189|FG000|Overall Study|Protocol Violation|0|||
146601253|NCT02651220|528709190|FG001|Overall Study|Protocol Violation|0|||
146601254|NCT02651220|528709191|FG002|Overall Study|Protocol Violation|1|||
146601255|NCT02651220|528709189|FG000|Overall Study|Withdrawal by Subject|5|||
146601256|NCT02651220|528709190|FG001|Overall Study|Withdrawal by Subject|6|||
146601257|NCT02651220|528709191|FG002|Overall Study|Withdrawal by Subject|8|||
146601258|NCT02651220|528709189|FG000|Overall Study|Miscellaneous|4|||
146601259|NCT02651220|528709190|FG001|Overall Study|Miscellaneous|1|||
146601260|NCT02651220|528709191|FG002|Overall Study|Miscellaneous|2|||
146601261|NCT02651220|528709189|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146601262|NCT02651220|528709190|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146601263|NCT02651220|528709191|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
146601264|NCT04268745|528709192|FG000|Overall Study|Lost to Follow-up|2|||
146601265|NCT04268745|528709193|FG001|Overall Study|Lost to Follow-up|3|||
146601266|NCT04268745|528709192|FG000|Overall Study|Withdrawal by Subject|4|||
146601267|NCT04268745|528709193|FG001|Overall Study|Withdrawal by Subject|2|||
146601268|NCT04268745|528709192|FG000|Overall Study|Death in the family|1|||
146601269|NCT04268745|528709193|FG001|Overall Study|Death in the family|0|||
146601270|NCT00447122|528709195|FG000|Overall Study|worsening medical condition -came off|0|||
146601271|NCT00447122|528709196|FG001|Overall Study|worsening medical condition -came off|1|||
146601272|NCT00447122|528709197|FG002|Overall Study|worsening medical condition -came off|0|||
146601273|NCT00447122|528709198|FG003|Overall Study|worsening medical condition -came off|0|||
146601274|NCT02409342|528709200|FG000|Overall Study|Death|211|||
146601275|NCT02409342|528709201|FG001|Overall Study|Death|201|||
146601276|NCT02409342|528709200|FG000|Overall Study|Withdrawal by Subject|24|||
146601277|NCT02409342|528709201|FG001|Overall Study|Withdrawal by Subject|17|||
146601278|NCT02409342|528709200|FG000|Overall Study|Study Terminated By Sponsor|48|||
146655815|NCT02395016|528917780|FG001|Overall Study|Adverse Event|3|||
146601279|NCT02409342|528709201|FG001|Overall Study|Study Terminated By Sponsor|59|||
146601280|NCT02409342|528709200|FG000|Overall Study|Lost to Follow-up|3|||
146601281|NCT02409342|528709201|FG001|Overall Study|Lost to Follow-up|5|||
146601282|NCT02409342|528709200|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
146601283|NCT02409342|528709201|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
146601284|NCT02409342|528709200|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
146601285|NCT02409342|528709201|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
146601286|NCT02409342|528709200|FG000|Overall Study|Sponsor Decision|1|||
146601287|NCT02409342|528709201|FG001|Overall Study|Sponsor Decision|0|||
146601288|NCT00279812|528709211|FG000|Overall Study|Protocol Violation|1|||
146601289|NCT00279812|528709212|FG001|Overall Study|Protocol Violation|1|||
146601290|NCT00279812|528709213|FG002|Overall Study|Protocol Violation|0|||
146601291|NCT00279812|528709214|FG003|Overall Study|Protocol Violation|0|||
146601292|NCT00279812|528709215|FG004|Overall Study|Protocol Violation|1|||
146601293|NCT00279812|528709216|FG005|Overall Study|Protocol Violation|0|||
146601294|NCT00279812|528709211|FG000|Overall Study|Withdrawal by Subject|0|||
146601295|NCT00279812|528709212|FG001|Overall Study|Withdrawal by Subject|4|||
146922604|NCT02232087|529876771|FG001|Overall Study|Withdrawal by Subject|0|||
146922605|NCT02232087|529876772|FG002|Overall Study|Withdrawal by Subject|0|||
146922606|NCT02232087|529876773|FG003|Overall Study|Withdrawal by Subject|0|||
146922607|NCT02232087|529876774|FG004|Overall Study|Withdrawal by Subject|0|||
146922608|NCT02232087|529876775|FG005|Overall Study|Withdrawal by Subject|1|||
146922609|NCT02232087|529876770|FG000|Overall Study|poor inhalation technique|0|||
146922610|NCT02232087|529876771|FG001|Overall Study|poor inhalation technique|1|||
146922611|NCT02232087|529876772|FG002|Overall Study|poor inhalation technique|0|||
146922612|NCT02232087|529876773|FG003|Overall Study|poor inhalation technique|0|||
146922613|NCT02232087|529876774|FG004|Overall Study|poor inhalation technique|0|||
146922614|NCT02232087|529876775|FG005|Overall Study|poor inhalation technique|2|||
146922615|NCT02232087|529876770|FG000|Overall Study|protocol stop criteria|0|||
146922616|NCT02232087|529876771|FG001|Overall Study|protocol stop criteria|1|||
146922617|NCT02232087|529876772|FG002|Overall Study|protocol stop criteria|0|||
146922618|NCT02232087|529876773|FG003|Overall Study|protocol stop criteria|1|||
146922619|NCT02232087|529876774|FG004|Overall Study|protocol stop criteria|0|||
146601296|NCT00279812|528709213|FG002|Overall Study|Withdrawal by Subject|2|||
146601297|NCT00279812|528709214|FG003|Overall Study|Withdrawal by Subject|0|||
146601298|NCT00279812|528709215|FG004|Overall Study|Withdrawal by Subject|0|||
146601299|NCT00279812|528709216|FG005|Overall Study|Withdrawal by Subject|0|||
146601300|NCT00279812|528709211|FG000|Overall Study|Adverse Event|0|||
146601301|NCT00279812|528709212|FG001|Overall Study|Adverse Event|1|||
146601302|NCT00279812|528709213|FG002|Overall Study|Adverse Event|1|||
146601303|NCT00279812|528709214|FG003|Overall Study|Adverse Event|0|||
146601304|NCT00279812|528709215|FG004|Overall Study|Adverse Event|2|||
146655816|NCT02395016|528917779|FG000|Overall Study|Withdrawal by Subject|9|||
146655817|NCT02395016|528917780|FG001|Overall Study|Withdrawal by Subject|6|||
146655818|NCT02395016|528917779|FG000|Overall Study|Protocol Violation|2|||
146922620|NCT02232087|529876775|FG005|Overall Study|protocol stop criteria|0|||
146922621|NCT02232087|529876770|FG000|Overall Study|Adverse Event|0|||
146922622|NCT02232087|529876771|FG001|Overall Study|Adverse Event|0|||
146922623|NCT02232087|529876772|FG002|Overall Study|Adverse Event|0|||
146922624|NCT02232087|529876773|FG003|Overall Study|Adverse Event|0|||
146922625|NCT02232087|529876774|FG004|Overall Study|Adverse Event|1|||
146922626|NCT02232087|529876775|FG005|Overall Study|Adverse Event|0|||
146922627|NCT01958125|529876776|FG000|Overall Study|Missing diary data|2|||
146922628|NCT01958125|529876777|FG001|Overall Study|Missing diary data|6|||
146922629|NCT01958125|529876776|FG000|Overall Study|No headache attacks|0|||
146922630|NCT01958125|529876777|FG001|Overall Study|No headache attacks|2|||
146922631|NCT04096326|529876778|FG000|Overall Study|Withdrawal by Subject|0|||
146922632|NCT04096326|529876779|FG001|Overall Study|Withdrawal by Subject|0|||
146922633|NCT04096326|529876780|FG002|Overall Study|Withdrawal by Subject|0|||
146922634|NCT04096326|529876781|FG003|Overall Study|Withdrawal by Subject|0|||
146922635|NCT04096326|529876782|FG004|Overall Study|Withdrawal by Subject|0|||
146922636|NCT04096326|529876783|FG005|Overall Study|Withdrawal by Subject|0|||
146922637|NCT04096326|529876784|FG006|Overall Study|Withdrawal by Subject|1|||
146922638|NCT04096326|529876785|FG007|Overall Study|Withdrawal by Subject|0|||
146922639|NCT04096326|529876786|FG008|Overall Study|Withdrawal by Subject|0|||
146922640|NCT04096326|529876787|FG009|Overall Study|Withdrawal by Subject|0|||
146922641|NCT04096326|529876778|FG000|Overall Study|Lost to Follow-up|0|||
146922642|NCT04096326|529876779|FG001|Overall Study|Lost to Follow-up|1|||
146922643|NCT04096326|529876780|FG002|Overall Study|Lost to Follow-up|0|||
146922644|NCT04096326|529876781|FG003|Overall Study|Lost to Follow-up|0|||
146922645|NCT04096326|529876782|FG004|Overall Study|Lost to Follow-up|0|||
146922646|NCT04096326|529876783|FG005|Overall Study|Lost to Follow-up|0|||
146922647|NCT04096326|529876784|FG006|Overall Study|Lost to Follow-up|0|||
146922648|NCT04096326|529876785|FG007|Overall Study|Lost to Follow-up|0|||
146922649|NCT04096326|529876786|FG008|Overall Study|Lost to Follow-up|0|||
146922650|NCT04096326|529876787|FG009|Overall Study|Lost to Follow-up|0|||
146922651|NCT04096326|529876778|FG000|Overall Study|COVID-19-related reasons|0|||
146922652|NCT04096326|529876779|FG001|Overall Study|COVID-19-related reasons|0|||
146922653|NCT04096326|529876780|FG002|Overall Study|COVID-19-related reasons|0|||
146655819|NCT02395016|528917780|FG001|Overall Study|Protocol Violation|3|||
146655820|NCT04444895|528917781|FG000|Overall Study|Adverse Event|2|||
146655821|NCT04444895|528917781|FG000|Overall Study|Lost to Follow-up|2|||
146655822|NCT04444895|528917781|FG000|Overall Study|Withdrawal by Subject|5|||
146655823|NCT00814879|528917782|FG000|By Week 24|Cancer Diagnosis|1|||
146655824|NCT00814879|528917783|FG001|By Week 24|Cancer Diagnosis|0|||
146655825|NCT00814879|528917782|FG000|By Week 24|Incarceration|0|||
146655826|NCT00814879|528917783|FG001|By Week 24|Incarceration|1|||
146655827|NCT00814879|528917782|FG000|By Week 48|Lost to Follow-up|2|||
146655828|NCT00814879|528917783|FG001|By Week 48|Lost to Follow-up|2|||
146655829|NCT00814879|528917782|FG000|By Week 48|Death|0|||
146655830|NCT00814879|528917783|FG001|By Week 48|Death|1|||
146655831|NCT01277042|528917784|FG000|Overall Study|Adverse Event|4|||
146922654|NCT04096326|529876781|FG003|Overall Study|COVID-19-related reasons|0|||
146922655|NCT04096326|529876782|FG004|Overall Study|COVID-19-related reasons|1|||
146601305|NCT00279812|528709216|FG005|Overall Study|Adverse Event|1|||
146601306|NCT05327361|528709217|FG000|Overall Study|Lost to Follow-up|4|||
146922656|NCT04096326|529876783|FG005|Overall Study|COVID-19-related reasons|5|||
146922657|NCT04096326|529876784|FG006|Overall Study|COVID-19-related reasons|0|||
146922658|NCT04096326|529876785|FG007|Overall Study|COVID-19-related reasons|0|||
146601307|NCT01439373|528709218|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
146601308|NCT01439373|528709219|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
146601309|NCT01439373|528709218|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
146601310|NCT01439373|528709219|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
146601311|NCT04576897|528709220|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
146601312|NCT03834220|528709221|FG000|Overall Study|Adverse Event|1|||
146601313|NCT03834220|528709222|FG001|Overall Study|Adverse Event|0|||
146601314|NCT03834220|528709223|FG002|Overall Study|Adverse Event|0|||
146601315|NCT03834220|528709221|FG000|Overall Study|Death|8|||
146601316|NCT03834220|528709222|FG001|Overall Study|Death|1|||
146601317|NCT03834220|528709223|FG002|Overall Study|Death|17|||
146601318|NCT03834220|528709221|FG000|Overall Study|Reason not Specified|9|||
146601319|NCT03834220|528709222|FG001|Overall Study|Reason not Specified|0|||
146601320|NCT03834220|528709223|FG002|Overall Study|Reason not Specified|6|||
146601321|NCT03834220|528709221|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
146601322|NCT03834220|528709222|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
146601323|NCT03834220|528709223|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
146601324|NCT03834220|528709221|FG000|Overall Study|Withdrawal of Consent|2|||
146601325|NCT03834220|528709222|FG001|Overall Study|Withdrawal of Consent|2|||
146601326|NCT03834220|528709223|FG002|Overall Study|Withdrawal of Consent|2|||
146601327|NCT02593318|528709226|FG000|Overall Study|Withdrawal by Subject|1|||
146601328|NCT02593318|528709227|FG001|Overall Study|Withdrawal by Subject|1|||
146601329|NCT01174173|528709229|FG000|Overall Study|drug-drug interaction|1|||
146601330|NCT00527332|528709233|FG000|Overall Study|Protocol Violation|4|||
146601331|NCT00527332|528709234|FG001|Overall Study|Protocol Violation|8|||
146601332|NCT00527332|528709233|FG000|Overall Study|Withdrew consent|5|||
146601333|NCT00527332|528709234|FG001|Overall Study|Withdrew consent|1|||
146601334|NCT02720692|528711388|FG000|Overall Study|Withdrawal by Subject|3|||
146601335|NCT02720692|528711389|FG001|Overall Study|Withdrawal by Subject|0|||
146601336|NCT02720692|528711388|FG000|Overall Study|Physician Decision|1|||
146655832|NCT01277042|528917785|FG001|Overall Study|Adverse Event|3|||
146655833|NCT01277042|528917784|FG000|Overall Study|Lost to Follow-up|2|||
146655834|NCT01277042|528917785|FG001|Overall Study|Lost to Follow-up|2|||
146655835|NCT01277042|528917784|FG000|Overall Study|Withdrawal by Subject|2|||
146655836|NCT01277042|528917785|FG001|Overall Study|Withdrawal by Subject|0|||
146655837|NCT01461057|528917786|FG000|Overall Study|Death|10|||
146655838|NCT01461057|528917787|FG001|Overall Study|Death|9|||
146655839|NCT01461057|528917786|FG000|Overall Study|Withdrawal by Subject|2|||
146655840|NCT01461057|528917787|FG001|Overall Study|Withdrawal by Subject|3|||
146655841|NCT01461057|528917786|FG000|Overall Study|Physician Decision|0|||
146655842|NCT01461057|528917787|FG001|Overall Study|Physician Decision|2|||
146655843|NCT01461057|528917786|FG000|Overall Study|Adverse Event|0|||
146655844|NCT01461057|528917787|FG001|Overall Study|Adverse Event|1|||
146655845|NCT01461057|528917786|FG000|Overall Study|Progression of Disease|1|||
146655846|NCT01461057|528917787|FG001|Overall Study|Progression of Disease|0|||
146655847|NCT01461057|528917786|FG000|Overall Study|Study Terminated by Sponsor|2|||
146655848|NCT01461057|528917787|FG001|Overall Study|Study Terminated by Sponsor|0|||
146655849|NCT03034200|528917788|FG000|Overall Study|Disease progression|8|||
146655850|NCT03034200|528917789|FG001|Overall Study|Disease progression|10|||
146655851|NCT03034200|528917790|FG002|Overall Study|Disease progression|4|||
146655852|NCT03034200|528917788|FG000|Overall Study|Physician Decision|2|||
146655853|NCT03034200|528917789|FG001|Overall Study|Physician Decision|0|||
146655854|NCT03034200|528917790|FG002|Overall Study|Physician Decision|3|||
146655855|NCT03034200|528917788|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
146655856|NCT03034200|528917789|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
146655857|NCT03034200|528917790|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
146655858|NCT03034200|528917788|FG000|Overall Study|Adjuvant Therapy|0|||
146601337|NCT02720692|528711389|FG001|Overall Study|Physician Decision|0|||
146601338|NCT02720692|528711388|FG000|Overall Study|Lost to Follow-up|8|||
146601339|NCT02720692|528711389|FG001|Overall Study|Lost to Follow-up|3|||
146601340|NCT02720692|528711388|FG000|Overall Study|Subject unable to return for visit|1|||
146655859|NCT03034200|528917789|FG001|Overall Study|Adjuvant Therapy|0|||
146655860|NCT03034200|528917790|FG002|Overall Study|Adjuvant Therapy|1|||
146655861|NCT01288976|528917791|FG000|Overall Study|Withdrawal by Subject|58|||
146772192|NCT00206375|529334437|FG000|Overall Study|Lost to Follow-up|1|||
146922659|NCT04096326|529876786|FG008|Overall Study|COVID-19-related reasons|0|||
146601341|NCT02720692|528711389|FG001|Overall Study|Subject unable to return for visit|0|||
146601342|NCT02503501|528711390|FG000|Overall Study|Physician Decision|1|||
146601343|NCT02503501|528711391|FG001|Overall Study|Physician Decision|0|||
146655862|NCT01288976|528917792|FG001|Overall Study|Withdrawal by Subject|12|||
146655863|NCT01288976|528917793|FG002|Overall Study|Withdrawal by Subject|9|||
146655864|NCT01288976|528917791|FG000|Overall Study|Death|98|||
146772193|NCT00206375|529334438|FG001|Overall Study|Lost to Follow-up|0|||
146772194|NCT00206375|529334439|FG002|Overall Study|Lost to Follow-up|0|||
146772195|NCT00206375|529334437|FG000|Overall Study|Withdrawal by Subject|2|||
146772196|NCT00206375|529334438|FG001|Overall Study|Withdrawal by Subject|1|||
146772197|NCT00206375|529334439|FG002|Overall Study|Withdrawal by Subject|3|||
146772198|NCT00206375|529334437|FG000|Overall Study|Study terminated due to lack of funds|0|||
146772199|NCT00206375|529334438|FG001|Overall Study|Study terminated due to lack of funds|1|||
146772200|NCT00206375|529334439|FG002|Overall Study|Study terminated due to lack of funds|1|||
146772201|NCT00837616|529334442|FG000|Overall Study|Withdrawal by Subject|0|||
146772202|NCT00837616|529334443|FG001|Overall Study|Withdrawal by Subject|1|||
146772203|NCT02674750|529334444|FG000|Overall Study|Death|4|||
146772204|NCT02674750|529334445|FG001|Overall Study|Death|5|||
146772205|NCT02674750|529334446|FG002|Overall Study|Death|8|||
146772206|NCT02674750|529334444|FG000|Overall Study|Lost to Follow-up|0|||
146772207|NCT02674750|529334445|FG001|Overall Study|Lost to Follow-up|8|||
146772208|NCT02674750|529334446|FG002|Overall Study|Lost to Follow-up|0|||
146772209|NCT02674750|529334444|FG000|Overall Study|Lack of Efficacy|1|||
146772210|NCT02674750|529334445|FG001|Overall Study|Lack of Efficacy|17|||
146772211|NCT02674750|529334446|FG002|Overall Study|Lack of Efficacy|3|||
146772212|NCT02674750|529334444|FG000|Overall Study|Withdrawal by Subject|0|||
146772213|NCT02674750|529334445|FG001|Overall Study|Withdrawal by Subject|7|||
146772214|NCT02674750|529334446|FG002|Overall Study|Withdrawal by Subject|1|||
146772215|NCT02674750|529334444|FG000|Overall Study|Other|0|||
146772216|NCT02674750|529334445|FG001|Overall Study|Other|8|||
146772217|NCT02674750|529334446|FG002|Overall Study|Other|0|||
146772218|NCT01685606|529334447|FG000|Overall Study|Withdrawal by Subject|1|||
146772219|NCT01787760|529334448|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
146772220|NCT01787760|529334449|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
146772221|NCT01787760|529334450|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
146772222|NCT01787760|529334448|FG000|Overall Study|Decompensated on left exotropia|0|||
146772223|NCT01787760|529334449|FG001|Overall Study|Decompensated on left exotropia|0|||
146772224|NCT01787760|529334450|FG002|Overall Study|Decompensated on left exotropia|1|||
146772225|NCT01787760|529334448|FG000|Overall Study|Dryness|0|||
146772226|NCT01787760|529334449|FG001|Overall Study|Dryness|1|||
146772227|NCT01787760|529334450|FG002|Overall Study|Dryness|0|||
146772228|NCT01787760|529334448|FG000|Overall Study|Relocation|1|||
146772229|NCT01787760|529334449|FG001|Overall Study|Relocation|1|||
146772230|NCT01787760|529334450|FG002|Overall Study|Relocation|0|||
146772231|NCT01787760|529334448|FG000|Overall Study|Lens discomfort|3|||
146772232|NCT01787760|529334449|FG001|Overall Study|Lens discomfort|0|||
146772233|NCT01787760|529334450|FG002|Overall Study|Lens discomfort|0|||
146772234|NCT01787760|529334448|FG000|Overall Study|Lens handling difficulty|1|||
146772235|NCT01787760|529334449|FG001|Overall Study|Lens handling difficulty|2|||
146772236|NCT01787760|529334450|FG002|Overall Study|Lens handling difficulty|0|||
146772237|NCT01787760|529334448|FG000|Overall Study|Protocol Violation|6|||
146772238|NCT01787760|529334449|FG001|Overall Study|Protocol Violation|0|||
146772239|NCT01787760|529334450|FG002|Overall Study|Protocol Violation|1|||
146772240|NCT01787760|529334448|FG000|Overall Study|Withdrawal by Subject|5|||
146772241|NCT01787760|529334449|FG001|Overall Study|Withdrawal by Subject|1|||
146772242|NCT01787760|529334450|FG002|Overall Study|Withdrawal by Subject|2|||
146772243|NCT01787760|529334448|FG000|Overall Study|Lost to Follow-up|1|||
146772244|NCT01787760|529334449|FG001|Overall Study|Lost to Follow-up|0|||
146772245|NCT01787760|529334450|FG002|Overall Study|Lost to Follow-up|1|||
146772246|NCT01787760|529334448|FG000|Overall Study|Stroke|1|||
146772247|NCT01787760|529334449|FG001|Overall Study|Stroke|0|||
146772248|NCT01787760|529334450|FG002|Overall Study|Stroke|0|||
146772249|NCT01787760|529334448|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
146772250|NCT01787760|529334449|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
146772251|NCT01787760|529334450|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
146772252|NCT01787760|529334448|FG000|Overall Study|Unsatisfactory physiological response|2|||
146922660|NCT04096326|529876787|FG009|Overall Study|COVID-19-related reasons|0|||
146772253|NCT01787760|529334449|FG001|Overall Study|Unsatisfactory physiological response|4|||
146772254|NCT01787760|529334450|FG002|Overall Study|Unsatisfactory physiological response|0|||
146772255|NCT01787760|529334448|FG000|Overall Study|Unsatisfactory visual response|1|||
146772256|NCT01787760|529334449|FG001|Overall Study|Unsatisfactory visual response|1|||
146772257|NCT01787760|529334450|FG002|Overall Study|Unsatisfactory visual response|0|||
146922661|NCT02509598|529876788|FG000|Overall Study|Withdrawal by Subject|1|||
146922662|NCT04056455|529876789|FG000|Overall Study|Adverse Event|1|||
146772258|NCT01787760|529334448|FG000|Overall Study|Near vision blur|1|||
146772259|NCT01787760|529334449|FG001|Overall Study|Near vision blur|0|||
146772260|NCT01787760|529334450|FG002|Overall Study|Near vision blur|0|||
146772261|NCT03512756|529334451|FG000|Part 1|Death|23|||
146772262|NCT03512756|529334452|FG001|Part 1|Death|18|||
146772263|NCT03512756|529334453|FG002|Part 1|Death|0|||
146772264|NCT03512756|529334454|FG003|Part 1|Death|0|||
146772265|NCT03512756|529334451|FG000|Part 1|Lost to Follow-up|0|||
146772266|NCT03512756|529334452|FG001|Part 1|Lost to Follow-up|3|||
146772267|NCT03512756|529334453|FG002|Part 1|Lost to Follow-up|0|||
146772268|NCT03512756|529334454|FG003|Part 1|Lost to Follow-up|0|||
146772269|NCT03512756|529334451|FG000|Part 1|Physician Decision|0|||
146772270|NCT03512756|529334452|FG001|Part 1|Physician Decision|1|||
146772271|NCT03512756|529334453|FG002|Part 1|Physician Decision|0|||
146772272|NCT03512756|529334454|FG003|Part 1|Physician Decision|0|||
146772273|NCT03512756|529334451|FG000|Part 1|Withdrawal by Subject|2|||
146772274|NCT03512756|529334452|FG001|Part 1|Withdrawal by Subject|2|||
146772275|NCT03512756|529334453|FG002|Part 1|Withdrawal by Subject|0|||
146772276|NCT03512756|529334454|FG003|Part 1|Withdrawal by Subject|0|||
146772277|NCT03512756|529334451|FG000|Part 2|Death|0|||
146772278|NCT03512756|529334452|FG001|Part 2|Death|0|||
146772279|NCT03512756|529334453|FG002|Part 2|Death|32|||
146772280|NCT03512756|529334454|FG003|Part 2|Death|21|||
146772281|NCT03512756|529334451|FG000|Part 2|Lost to Follow-up|0|||
146772282|NCT03512756|529334452|FG001|Part 2|Lost to Follow-up|0|||
146772283|NCT03512756|529334453|FG002|Part 2|Lost to Follow-up|1|||
146772284|NCT03512756|529334454|FG003|Part 2|Lost to Follow-up|0|||
146772285|NCT03512756|529334451|FG000|Part 2|Physician Decision|0|||
146772286|NCT03512756|529334452|FG001|Part 2|Physician Decision|0|||
146772287|NCT03512756|529334453|FG002|Part 2|Physician Decision|2|||
146772288|NCT03512756|529334454|FG003|Part 2|Physician Decision|4|||
146772289|NCT03512756|529334451|FG000|Part 2|Study Terminated by Sponsor|0|||
146772290|NCT03512756|529334452|FG001|Part 2|Study Terminated by Sponsor|0|||
146772291|NCT03512756|529334453|FG002|Part 2|Study Terminated by Sponsor|2|||
146772292|NCT03512756|529334454|FG003|Part 2|Study Terminated by Sponsor|6|||
146772293|NCT03512756|529334451|FG000|Part 2|Protocol Violation|0|||
146772294|NCT03512756|529334452|FG001|Part 2|Protocol Violation|0|||
146772295|NCT03512756|529334453|FG002|Part 2|Protocol Violation|1|||
146772296|NCT03512756|529334454|FG003|Part 2|Protocol Violation|0|||
146772297|NCT03512756|529334451|FG000|Part 2|Withdrawal by Subject|0|||
146772298|NCT03512756|529334452|FG001|Part 2|Withdrawal by Subject|0|||
146772299|NCT03512756|529334453|FG002|Part 2|Withdrawal by Subject|3|||
146772300|NCT03512756|529334454|FG003|Part 2|Withdrawal by Subject|9|||
146772301|NCT04250883|529335887|FG000|Overall Study|Lost to Follow-up|1|||
146772302|NCT04250883|529335888|FG001|Overall Study|Lost to Follow-up|0|||
146772303|NCT01318382|529335890|FG000|Overall Study|Physician Decision|2|||
146772304|NCT01318382|529335890|FG000|Overall Study|Device Malfunction|10|||
146772305|NCT01318382|529335890|FG000|Overall Study|Protocol Violation|1|||
146772306|NCT01599104|529335891|FG000|Overall Study|Withdrawal by Subject|1|||
146772307|NCT01599104|529335892|FG001|Overall Study|Withdrawal by Subject|1|||
146772308|NCT01599104|529335893|FG002|Overall Study|Withdrawal by Subject|2|||
146772309|NCT01599104|529335891|FG000|Overall Study|Technical Problems|1|||
146772310|NCT01599104|529335892|FG001|Overall Study|Technical Problems|0|||
146772311|NCT01599104|529335893|FG002|Overall Study|Technical Problems|0|||
146772312|NCT01599104|529335891|FG000|Overall Study|Physician Decision|3|||
146772313|NCT01599104|529335892|FG001|Overall Study|Physician Decision|2|||
146772314|NCT01599104|529335893|FG002|Overall Study|Physician Decision|2|||
146772315|NCT01599104|529335891|FG000|Overall Study|Non-compliance with study treatment|0|||
146772316|NCT01599104|529335892|FG001|Overall Study|Non-compliance with study treatment|1|||
146772317|NCT01599104|529335893|FG002|Overall Study|Non-compliance with study treatment|0|||
146772318|NCT01599104|529335891|FG000|Overall Study|Lack of Efficacy|4|||
146772319|NCT01599104|529335892|FG001|Overall Study|Lack of Efficacy|4|||
146772320|NCT01599104|529335893|FG002|Overall Study|Lack of Efficacy|10|||
146772321|NCT01599104|529335891|FG000|Overall Study|Adverse Event|7|||
146772322|NCT01599104|529335892|FG001|Overall Study|Adverse Event|6|||
146772323|NCT01599104|529335893|FG002|Overall Study|Adverse Event|12|||
146772324|NCT02271854|529335898|FG000|Overall Study|Withdrawal by Subject|2|||
146772325|NCT02271854|529335898|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
146772326|NCT02271854|529335898|FG000|Overall Study|Lost to Follow-up|1|||
146772327|NCT01308567|529335899|FG000|Overall Study|Lost to Follow-up|2|||
146772328|NCT01308567|529335900|FG001|Overall Study|Lost to Follow-up|4|||
146772329|NCT01308567|529335901|FG002|Overall Study|Lost to Follow-up|4|||
146772330|NCT01571596|529335904|FG000|Overall Study|Adverse Event|2|||
146772331|NCT01571596|529335905|FG001|Overall Study|Adverse Event|0|||
146772332|NCT01571596|529335906|FG002|Overall Study|Adverse Event|0|||
146772333|NCT01571596|529335904|FG000|Overall Study|Study Terminated by the Sponsor|0|||
146772334|NCT01571596|529335905|FG001|Overall Study|Study Terminated by the Sponsor|1|||
146772335|NCT01571596|529335906|FG002|Overall Study|Study Terminated by the Sponsor|1|||
146772336|NCT00434304|529335909|FG000|Overall Study|Adverse Event|14|||
146772337|NCT00434304|529335909|FG000|Overall Study|Lack of Efficacy|2|||
146772338|NCT00434304|529335909|FG000|Overall Study|Withdrawal by Subject|4|||
146772339|NCT01636687|529335913|FG000|Induction Period|Withdrawal by Subject|1|||
146772340|NCT01636687|529335914|FG001|Induction Period|Withdrawal by Subject|0|||
146772341|NCT01636687|529335915|FG002|Induction Period|Withdrawal by Subject|0|||
146772342|NCT01636687|529335916|FG003|Induction Period|Withdrawal by Subject|0|||
146772343|NCT01636687|529335917|FG004|Induction Period|Withdrawal by Subject|0|||
146772344|NCT01636687|529335913|FG000|Induction Period|Adverse Event|1|||
146772345|NCT01636687|529335914|FG001|Induction Period|Adverse Event|0|||
146772346|NCT01636687|529335915|FG002|Induction Period|Adverse Event|0|||
146772347|NCT01636687|529335916|FG003|Induction Period|Adverse Event|0|||
146772348|NCT01636687|529335917|FG004|Induction Period|Adverse Event|1|||
146601344|NCT02503501|528711390|FG000|Overall Study|Protocol Violation|0|||
146601345|NCT02503501|528711391|FG001|Overall Study|Protocol Violation|1|||
146601346|NCT02503501|528711390|FG000|Overall Study|Withdrawal by Subject|0|||
146601347|NCT02503501|528711391|FG001|Overall Study|Withdrawal by Subject|2|||
146601348|NCT01740401|528711392|FG000|Overall Study|Progression of disease|6|||
146601349|NCT01740401|528711392|FG000|Overall Study|Adverse Event|2|||
146601350|NCT01740401|528711392|FG000|Overall Study|Did not reach primary endpoint|2|||
146601351|NCT03878758|528711393|FG000|Overall Study|Withdrawal by Subject|1|||
146601352|NCT03878758|528711393|FG000|Overall Study|Protocol defined|2|||
146601353|NCT03878758|528711393|FG000|Overall Study|Improper consent documentation|1|||
146601354|NCT00765063|528711394|FG000|Overall Study|Lack of Efficacy|5|||
146601355|NCT00765063|528711394|FG000|Overall Study|Withdrawal by Subject|1|||
146601356|NCT00765063|528711394|FG000|Overall Study|Other|16|||
146601357|NCT00765063|528711394|FG000|Overall Study|Protocol Violation|6|||
146601358|NCT00765063|528711394|FG000|Overall Study|Adverse Event|4|||
146655865|NCT01288976|528917792|FG001|Overall Study|Death|6|||
146655866|NCT01288976|528917793|FG002|Overall Study|Death|4|||
146655867|NCT01288976|528917791|FG000|Overall Study|Data unavailable|22|||
146655868|NCT01288976|528917792|FG001|Overall Study|Data unavailable|9|||
146655869|NCT01288976|528917793|FG002|Overall Study|Data unavailable|7|||
146655870|NCT05523323|528917800|FG000|Overall Study|Death|26|||
146655871|NCT05523323|528917801|FG001|Overall Study|Death|21|||
146655872|NCT05523323|528917800|FG000|Overall Study|Ongoing participants|35|||
146655873|NCT05523323|528917801|FG001|Overall Study|Ongoing participants|30|||
146655874|NCT02469038|528917802|FG000|Overall Study|Physician Decision|4|||
146655875|NCT02469038|528917803|FG001|Overall Study|Physician Decision|5|||
146655876|NCT03435640|528917804|FG000|Overall Study|Withdrawal by Subject|0|||
146655877|NCT03435640|528917805|FG001|Overall Study|Withdrawal by Subject|1|||
146655878|NCT03435640|528917806|FG002|Overall Study|Withdrawal by Subject|0|||
146655879|NCT03435640|528917807|FG003|Overall Study|Withdrawal by Subject|2|||
146655880|NCT03435640|528917808|FG004|Overall Study|Withdrawal by Subject|0|||
146655881|NCT03435640|528917809|FG005|Overall Study|Withdrawal by Subject|0|||
146655882|NCT03435640|528917810|FG006|Overall Study|Withdrawal by Subject|3|||
146655883|NCT03435640|528917811|FG007|Overall Study|Withdrawal by Subject|0|||
146655884|NCT03435640|528917812|FG008|Overall Study|Withdrawal by Subject|0|||
146655885|NCT03435640|528917813|FG009|Overall Study|Withdrawal by Subject|2|||
146655886|NCT03435640|528917814|FG010|Overall Study|Withdrawal by Subject|3|||
146655887|NCT03435640|528917804|FG000|Overall Study|Lost to Follow-up|0|||
146655888|NCT03435640|528917805|FG001|Overall Study|Lost to Follow-up|0|||
146655889|NCT03435640|528917806|FG002|Overall Study|Lost to Follow-up|1|||
146655890|NCT03435640|528917807|FG003|Overall Study|Lost to Follow-up|0|||
146655891|NCT03435640|528917808|FG004|Overall Study|Lost to Follow-up|0|||
146655892|NCT03435640|528917809|FG005|Overall Study|Lost to Follow-up|0|||
146655893|NCT03435640|528917810|FG006|Overall Study|Lost to Follow-up|0|||
146655894|NCT03435640|528917811|FG007|Overall Study|Lost to Follow-up|0|||
146655895|NCT03435640|528917812|FG008|Overall Study|Lost to Follow-up|0|||
146655896|NCT03435640|528917813|FG009|Overall Study|Lost to Follow-up|0|||
146655897|NCT03435640|528917814|FG010|Overall Study|Lost to Follow-up|0|||
146655898|NCT00636987|528917815|FG000|Overall Study|Death|44|||
146655899|NCT00636987|528917815|FG000|Overall Study|Explanted|13|||
146655900|NCT00636987|528917815|FG000|Overall Study|Lost to Follow-up|63|||
146655901|NCT00636987|528917815|FG000|Overall Study|5 year visit window not complete|69|||
146655902|NCT01251146|528917816|FG000|Overall Study|Lost to Follow-up|3|||
146655903|NCT01251146|528917817|FG001|Overall Study|Lost to Follow-up|10|||
146655904|NCT01739400|528917818|FG000|Overall Study|Physician Decision|3|||
146655905|NCT01739400|528917819|FG001|Overall Study|Physician Decision|0|||
146655906|NCT01739400|528917818|FG000|Overall Study|Lost to Follow-up|2|||
146655907|NCT01739400|528917819|FG001|Overall Study|Lost to Follow-up|0|||
146601359|NCT03614325|528711395|FG000|Overall Study|Withdrawal by Subject|0|||
146601360|NCT03614325|528711396|FG001|Overall Study|Withdrawal by Subject|2|||
146601361|NCT03614325|528711395|FG000|Overall Study|Surgery Cancelled|2|||
146655908|NCT01739400|528917818|FG000|Overall Study|Death|5|||
146655909|NCT01739400|528917819|FG001|Overall Study|Death|2|||
146655910|NCT01739400|528917818|FG000|Overall Study|Withdrawal by Subject|7|||
146655911|NCT01739400|528917819|FG001|Overall Study|Withdrawal by Subject|7|||
146655912|NCT03350984|528917820|FG000|Overall Study|Death|1|||
146655913|NCT03350984|528917821|FG001|Overall Study|Death|0|||
146655914|NCT03350984|528917820|FG000|Overall Study|Lost to Follow-up|5|||
146655915|NCT03350984|528917821|FG001|Overall Study|Lost to Follow-up|6|||
146655916|NCT03350984|528917820|FG000|Overall Study|Protocol Violation|1|||
146655917|NCT03350984|528917821|FG001|Overall Study|Protocol Violation|2|||
146655918|NCT03350984|528917820|FG000|Overall Study|Physician Decision|1|||
146601362|NCT03614325|528711396|FG001|Overall Study|Surgery Cancelled|1|||
146601363|NCT03614325|528711395|FG000|Overall Study|Lost to Follow-up|2|||
146601364|NCT03614325|528711396|FG001|Overall Study|Lost to Follow-up|1|||
146601365|NCT03614325|528711395|FG000|Overall Study|Surgery never scheduled|1|||
146601366|NCT03614325|528711396|FG001|Overall Study|Surgery never scheduled|0|||
146655919|NCT03350984|528917821|FG001|Overall Study|Physician Decision|0|||
146655920|NCT01347307|528917822|FG000|Overall Study|Death|0|||
146655921|NCT01347307|528917823|FG001|Overall Study|Death|4|||
146772349|NCT01636687|529335913|FG000|Induction Period|Lack of Efficacy|0|||
146978641|NCT00990093|530084125|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
146978642|NCT00990093|530084124|FG000|Test Period 1 (1-14 Days)|Other|1|||
146978643|NCT00990093|530084125|FG001|Test Period 1 (1-14 Days)|Other|0|||
146601367|NCT00321464|528711397|FG000|Overall Study|Death|169|||
146601368|NCT00321464|528711398|FG001|Overall Study|Death|174|||
146601369|NCT00321464|528711397|FG000|Overall Study|Disease progression|124|||
146601370|NCT00321464|528711398|FG001|Overall Study|Disease progression|124|||
146601371|NCT00321464|528711397|FG000|Overall Study|Withdrawal by Subject|117|||
146601372|NCT00321464|528711398|FG001|Overall Study|Withdrawal by Subject|118|||
146601373|NCT00321464|528711397|FG000|Overall Study|Participant request|57|||
146601374|NCT00321464|528711398|FG001|Overall Study|Participant request|61|||
146601375|NCT00321464|528711397|FG000|Overall Study|Adverse Event|43|||
146601376|NCT00321464|528711398|FG001|Overall Study|Adverse Event|28|||
146601377|NCT00321464|528711397|FG000|Overall Study|Physician Decision|15|||
146601378|NCT00321464|528711398|FG001|Overall Study|Physician Decision|14|||
146601379|NCT00321464|528711397|FG000|Overall Study|Noncompliance|4|||
146655922|NCT01347307|528917822|FG000|Overall Study|Physician Decision|0|||
146655923|NCT01347307|528917823|FG001|Overall Study|Physician Decision|1|||
146655924|NCT00642473|528917824|FG000|Overall Study|Withdrawal by Subject|0|||
146655925|NCT00642473|528917825|FG001|Overall Study|Withdrawal by Subject|5|||
146655926|NCT00642473|528917824|FG000|Overall Study|Progression or death|2|||
146655927|NCT00642473|528917825|FG001|Overall Study|Progression or death|4|||
146655928|NCT00642473|528917824|FG000|Overall Study|Other|2|||
146655929|NCT00642473|528917825|FG001|Overall Study|Other|2|||
146655930|NCT00920829|528917827|FG000|Allocation|No post randomization data|3|||
146655931|NCT00920829|528917828|FG001|Allocation|No post randomization data|1|||
146655932|NCT00920829|528917829|FG002|Allocation|No post randomization data|0|||
146655933|NCT00920829|528917830|FG003|Allocation|No post randomization data|2|||
146655934|NCT00920829|528917827|FG000|Available for Analysis|Withdrawal by Subject|6|||
146655935|NCT00920829|528917828|FG001|Available for Analysis|Withdrawal by Subject|6|||
146655936|NCT00920829|528917829|FG002|Available for Analysis|Withdrawal by Subject|6|||
146655937|NCT00920829|528917830|FG003|Available for Analysis|Withdrawal by Subject|10|||
146655938|NCT00920829|528917827|FG000|Available for Analysis|Required Medical Treatment|0|||
146655939|NCT00920829|528917828|FG001|Available for Analysis|Required Medical Treatment|1|||
146655940|NCT00920829|528917829|FG002|Available for Analysis|Required Medical Treatment|2|||
146655941|NCT00920829|528917830|FG003|Available for Analysis|Required Medical Treatment|0|||
146655942|NCT00920829|528917827|FG000|Available for Analysis|Adverse Event|1|||
146655943|NCT00920829|528917828|FG001|Available for Analysis|Adverse Event|2|||
146655944|NCT00920829|528917829|FG002|Available for Analysis|Adverse Event|1|||
146655945|NCT00920829|528917830|FG003|Available for Analysis|Adverse Event|0|||
146655946|NCT00920829|528917827|FG000|Available for Analysis|Death|1|||
146655947|NCT00920829|528917828|FG001|Available for Analysis|Death|0|||
146655948|NCT00920829|528917829|FG002|Available for Analysis|Death|0|||
146655949|NCT00920829|528917830|FG003|Available for Analysis|Death|0|||
146655950|NCT00920829|528917827|FG000|Available for Analysis|Protocol Violation|0|||
146655951|NCT00920829|528917828|FG001|Available for Analysis|Protocol Violation|0|||
146655952|NCT00920829|528917829|FG002|Available for Analysis|Protocol Violation|1|||
146655953|NCT00920829|528917830|FG003|Available for Analysis|Protocol Violation|0|||
146655954|NCT00920829|528917827|FG000|Available for Analysis|Required more treatment|0|||
146655955|NCT00920829|528917828|FG001|Available for Analysis|Required more treatment|2|||
146655956|NCT00920829|528917829|FG002|Available for Analysis|Required more treatment|0|||
146655957|NCT00920829|528917830|FG003|Available for Analysis|Required more treatment|1|||
146655958|NCT04533880|528917831|FG000|Overall Study|Lost to Follow-up|0|||
146655959|NCT04533880|528917832|FG001|Overall Study|Lost to Follow-up|1|||
146655960|NCT04533880|528917833|FG002|Overall Study|Lost to Follow-up|1|||
146655961|NCT02284178|528917836|FG000|Overall Study|Met exclusion criteria|49|||
146655962|NCT02284178|528917837|FG001|Overall Study|Met exclusion criteria|54|||
146655963|NCT04123665|528917838|FG000|Overall Study|Withdrawal by Subject|7|||
146655964|NCT04123665|528917839|FG001|Overall Study|Withdrawal by Subject|0|||
146655965|NCT04123665|528917838|FG000|Overall Study|Lost to Follow-up|1|||
146655966|NCT04123665|528917839|FG001|Overall Study|Lost to Follow-up|0|||
146655967|NCT01711879|528917846|FG000|Overall Study|Death|1|||
146655968|NCT01711879|528917847|FG001|Overall Study|Death|0|||
146655969|NCT01483690|528917848|FG000|Overall Study|Adverse Event|1|||
146655970|NCT01483690|528917849|FG001|Overall Study|Adverse Event|2|||
146655971|NCT01483690|528917848|FG000|Overall Study|clinical deterioration|1|||
146655972|NCT01483690|528917849|FG001|Overall Study|clinical deterioration|0|||
146655973|NCT01483690|528917848|FG000|Overall Study|Physician Decision|0|||
146655974|NCT01483690|528917849|FG001|Overall Study|Physician Decision|2|||
146655975|NCT01483690|528917848|FG000|Overall Study|exclusionary procedure|0|||
146601380|NCT00321464|528711398|FG001|Overall Study|Noncompliance|10|||
146601381|NCT00321464|528711397|FG000|Overall Study|Lost to Follow-up|7|||
146601382|NCT00321464|528711398|FG001|Overall Study|Lost to Follow-up|8|||
146655976|NCT01483690|528917849|FG001|Overall Study|exclusionary procedure|1|||
146655977|NCT00958789|528917853|FG000|Overall Study|Death|5|||
146655978|NCT00958789|528917853|FG000|Overall Study|Lost to Follow-up|14|||
146772350|NCT01636687|529335914|FG001|Induction Period|Lack of Efficacy|0|||
146601383|NCT00321464|528711397|FG000|Overall Study|Protocol deviation|0|||
146601384|NCT00321464|528711398|FG001|Overall Study|Protocol deviation|2|||
146601385|NCT00321464|528711397|FG000|Overall Study|Ineligibility determined|2|||
146601386|NCT00321464|528711398|FG001|Overall Study|Ineligibility determined|1|||
146601387|NCT00321464|528711397|FG000|Overall Study|Other|21|||
146601388|NCT00321464|528711398|FG001|Overall Study|Other|18|||
146601389|NCT01673620|528711399|FG000|Overall Study|Adverse Event|1|||
146601390|NCT01673620|528711400|FG001|Overall Study|Adverse Event|0|||
146601391|NCT01206582|528711401|FG000|Overall Study|Withdrew prior to study|1|||
146601392|NCT01206582|528711402|FG001|Overall Study|Withdrew prior to study|0|||
146601393|NCT01206582|528711401|FG000|Overall Study|Discontinued intervention before week 8|1|||
146601394|NCT01206582|528711402|FG001|Overall Study|Discontinued intervention before week 8|2|||
146601395|NCT02522325|528711403|FG000|Overall Study|Adverse Event|0|||
146601396|NCT02522325|528711404|FG001|Overall Study|Adverse Event|1|||
146601397|NCT02081599|528711407|FG000|Period 1：Double-blind Period|Adverse Event|3|||
146601398|NCT02081599|528711408|FG001|Period 1：Double-blind Period|Adverse Event|0|||
146601399|NCT02081599|528711407|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
146601400|NCT02081599|528711408|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
146601401|NCT02081599|528711407|FG000|Period 1：Double-blind Period|Physician Decision|1|||
146601402|NCT02081599|528711408|FG001|Period 1：Double-blind Period|Physician Decision|0|||
146601403|NCT02081599|528711407|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
146601404|NCT02081599|528711408|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
146601405|NCT02081599|528711407|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
146601406|NCT02081599|528711408|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
146601407|NCT02081599|528711407|FG000|Period 1：Double-blind Period|stopping criteria|1|||
146601408|NCT02081599|528711408|FG001|Period 1：Double-blind Period|stopping criteria|0|||
146601409|NCT02081599|528711407|FG000|Period 2：Open-label Period|Adverse Event|1|||
146601410|NCT02081599|528711408|FG001|Period 2：Open-label Period|Adverse Event|0|||
146601411|NCT02081599|528711407|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
146601412|NCT02081599|528711408|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
146601413|NCT02081599|528711407|FG000|Period 2：Open-label Period|Physician Decision|1|||
146601414|NCT02081599|528711408|FG001|Period 2：Open-label Period|Physician Decision|0|||
146601415|NCT02081599|528711407|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
146601416|NCT02081599|528711408|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
146601417|NCT00306527|528711414|FG000|Overall Study|Lost to Follow-up|3|||
146601418|NCT00306527|528711415|FG001|Overall Study|Lost to Follow-up|4|||
146601419|NCT00306527|528711416|FG002|Overall Study|Lost to Follow-up|3|||
146601420|NCT00306527|528711417|FG003|Overall Study|Lost to Follow-up|0|||
146601421|NCT00306527|528711414|FG000|Overall Study|Withdrawal by Subject|2|||
146601422|NCT00306527|528711415|FG001|Overall Study|Withdrawal by Subject|3|||
146601423|NCT00306527|528711416|FG002|Overall Study|Withdrawal by Subject|0|||
146601424|NCT00306527|528711417|FG003|Overall Study|Withdrawal by Subject|3|||
146601425|NCT00306527|528711414|FG000|Overall Study|Adverse Event|0|||
146601426|NCT00306527|528711415|FG001|Overall Study|Adverse Event|0|||
146601427|NCT00306527|528711416|FG002|Overall Study|Adverse Event|1|||
146601428|NCT00306527|528711417|FG003|Overall Study|Adverse Event|1|||
146601429|NCT00306527|528711414|FG000|Overall Study|Death|1|||
146601430|NCT00306527|528711415|FG001|Overall Study|Death|0|||
146601431|NCT00306527|528711416|FG002|Overall Study|Death|1|||
146601432|NCT00306527|528711417|FG003|Overall Study|Death|2|||
146601433|NCT00785980|528711418|FG000|7 Day Washout Period|Protocol Violation|3|||
146601434|NCT00528801|528711419|FG000|Overall Study|Withdrawal by Subject|1|||
146601435|NCT00528801|528711420|FG001|Overall Study|Withdrawal by Subject|1|||
146601436|NCT00528801|528711419|FG000|Overall Study|Protocol Violation|11|||
146601437|NCT00528801|528711420|FG001|Overall Study|Protocol Violation|5|||
146601438|NCT00528801|528711419|FG000|Overall Study|Lost to Follow-up|15|||
146601439|NCT00528801|528711420|FG001|Overall Study|Lost to Follow-up|4|||
146601440|NCT00528801|528711419|FG000|Overall Study|Administrative Reasons|0|||
146601441|NCT00528801|528711420|FG001|Overall Study|Administrative Reasons|1|||
146601442|NCT02207491|528711421|FG000|Overall Study|Adverse Event|20|||
146601443|NCT02207491|528711422|FG001|Overall Study|Adverse Event|4|||
146978644|NCT00990093|530084124|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
146601444|NCT02207491|528711421|FG000|Overall Study|Withdrawal by Subject|3|||
146601445|NCT02207491|528711422|FG001|Overall Study|Withdrawal by Subject|2|||
146601446|NCT02207491|528711421|FG000|Overall Study|Non-compliant|0|||
146601447|NCT02207491|528711422|FG001|Overall Study|Non-compliant|1|||
146601448|NCT02207491|528711421|FG000|Overall Study|Lost to Follow-up|0|||
146601449|NCT02207491|528711422|FG001|Overall Study|Lost to Follow-up|1|||
146601450|NCT02207491|528711421|FG000|Overall Study|Lack of Efficacy|3|||
146601451|NCT02207491|528711422|FG001|Overall Study|Lack of Efficacy|0|||
146601452|NCT02207491|528711421|FG000|Overall Study|Physician Decision|2|||
146601453|NCT02207491|528711422|FG001|Overall Study|Physician Decision|0|||
146601454|NCT02207491|528711421|FG000|Overall Study|Protocol Violation|3|||
146601455|NCT02207491|528711422|FG001|Overall Study|Protocol Violation|5|||
146601456|NCT00387725|528711423|FG000|Overall Study|Adverse Event|0|||
146601457|NCT00387725|528711424|FG001|Overall Study|Adverse Event|0|||
146922663|NCT04056455|529876790|FG001|Overall Study|Adverse Event|0|||
146922664|NCT02512068|529876791|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
146601458|NCT00387725|528711425|FG002|Overall Study|Adverse Event|0|||
146601459|NCT00387725|528711426|FG003|Overall Study|Adverse Event|1|||
146601460|NCT00387725|528711423|FG000|Overall Study|Protocol Violation|0|||
146601461|NCT00387725|528711424|FG001|Overall Study|Protocol Violation|1|||
146601462|NCT00387725|528711425|FG002|Overall Study|Protocol Violation|0|||
146601463|NCT00387725|528711426|FG003|Overall Study|Protocol Violation|0|||
146601464|NCT00387725|528711423|FG000|Overall Study|Withdrawal by Subject|1|||
146601465|NCT00387725|528711424|FG001|Overall Study|Withdrawal by Subject|0|||
146601466|NCT00387725|528711425|FG002|Overall Study|Withdrawal by Subject|1|||
146601467|NCT00387725|528711426|FG003|Overall Study|Withdrawal by Subject|0|||
146601468|NCT00387725|528711423|FG000|Overall Study|Parent/legal guardian request|0|||
146601469|NCT00387725|528711424|FG001|Overall Study|Parent/legal guardian request|0|||
146601470|NCT00387725|528711425|FG002|Overall Study|Parent/legal guardian request|1|||
146601471|NCT00387725|528711426|FG003|Overall Study|Parent/legal guardian request|1|||
146601472|NCT02429791|528711428|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
146601473|NCT02429791|528711429|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
146601474|NCT02429791|528711428|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
146601475|NCT02429791|528711429|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
146601476|NCT02429791|528711428|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
146601477|NCT02429791|528711429|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
146601478|NCT02429791|528711428|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
146601479|NCT02429791|528711429|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
146601480|NCT02429791|528711428|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
146601481|NCT02429791|528711429|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
146601482|NCT02429791|528711428|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
146601483|NCT02429791|528711429|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
146601484|NCT02429791|528711428|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
146601485|NCT02429791|528711429|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
146601486|NCT02429791|528711428|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
146601487|NCT02429791|528711429|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
146601488|NCT02429791|528711428|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
146601489|NCT02429791|528711429|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
146601490|NCT02429791|528711428|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
146601491|NCT02429791|528711429|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
146601492|NCT02429791|528711428|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
146601493|NCT02429791|528711429|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
146601494|NCT02429791|528711428|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
146655979|NCT00958789|528917853|FG000|Overall Study|Withdrawal by Subject|17|||
146655980|NCT00958789|528917853|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
146655981|NCT00958789|528917853|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
146655982|NCT00958789|528917853|FG000|Overall Study|Subject terminated|2|||
146655983|NCT00958789|528917853|FG000|Overall Study|Revision|7|||
146655984|NCT02239224|528917861|FG000|Overall Study|Administrative|0|||
146655985|NCT02239224|528917862|FG001|Overall Study|Administrative|0|||
146655986|NCT02239224|528917863|FG002|Overall Study|Administrative|3|||
146655987|NCT02239224|528917864|FG003|Overall Study|Administrative|1|||
146655988|NCT00478881|528917866|FG000|Overall Study|Adverse Event|31|||
146655989|NCT00478881|528917867|FG001|Overall Study|Adverse Event|12|||
146655990|NCT00478881|528917866|FG000|Overall Study|Lack of Efficacy|0|||
146655991|NCT00478881|528917867|FG001|Overall Study|Lack of Efficacy|3|||
146655992|NCT00478881|528917866|FG000|Overall Study|Lost to Follow-up|0|||
146655993|NCT00478881|528917867|FG001|Overall Study|Lost to Follow-up|1|||
146655994|NCT00478881|528917866|FG000|Overall Study|Protocol Violation|2|||
146655995|NCT00478881|528917867|FG001|Overall Study|Protocol Violation|2|||
146655996|NCT00478881|528917866|FG000|Overall Study|Withdrawal by Subject|6|||
146655997|NCT00478881|528917867|FG001|Overall Study|Withdrawal by Subject|2|||
146655998|NCT00478881|528917866|FG000|Overall Study|Non-Compliance with Study Medication|0|||
146655999|NCT00478881|528917867|FG001|Overall Study|Non-Compliance with Study Medication|2|||
146656000|NCT01466179|528917868|FG000|Overall Study|Ongoing in core study|2|||
146656001|NCT01466179|528917868|FG000|Overall Study|Physician Decision|46|||
146656002|NCT01466179|528917868|FG000|Overall Study|Progressive disease|43|||
146656003|NCT01466179|528917868|FG000|Overall Study|Adverse Event|32|||
146656004|NCT01466179|528917868|FG000|Overall Study|Disease relapse|23|||
146656005|NCT01466179|528917868|FG000|Overall Study|Lack of Efficacy|14|||
146656006|NCT01466179|528917868|FG000|Overall Study|Death|7|||
146772351|NCT01636687|529335915|FG002|Induction Period|Lack of Efficacy|0|||
146922665|NCT02512068|529876792|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
146922666|NCT02512068|529876791|FG000|Overall Study|Major Protocol Deviation|1|||
146601495|NCT02429791|528711429|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
146601496|NCT02429791|528711428|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
146922667|NCT02512068|529876792|FG001|Overall Study|Major Protocol Deviation|0|||
146922668|NCT02512068|529876791|FG000|Overall Study|Voluntary Withdrawal|0|||
146922669|NCT02512068|529876792|FG001|Overall Study|Voluntary Withdrawal|1|||
146922670|NCT02512068|529876791|FG000|Overall Study|Lack of Efficacy|0|||
146922671|NCT02512068|529876792|FG001|Overall Study|Lack of Efficacy|1|||
146922672|NCT02512068|529876791|FG000|Overall Study|Reason Not Specified|3|||
146922673|NCT02512068|529876792|FG001|Overall Study|Reason Not Specified|5|||
146922674|NCT01952834|529876796|FG000|Overall Study|Adverse Event|1|||
146922675|NCT04360187|529876799|FG000|Double-Blind Treatment|Adverse Event|9|||
146922676|NCT04360187|529876800|FG001|Double-Blind Treatment|Adverse Event|11|||
146978645|NCT00990093|530084125|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
146978646|NCT00990093|530084124|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
146601497|NCT02429791|528711429|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
146601498|NCT02429791|528711428|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
146601499|NCT02429791|528711429|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
146601500|NCT02429791|528711428|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
146601501|NCT02429791|528711429|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
146601502|NCT02429791|528711428|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
146601503|NCT02429791|528711429|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
146601504|NCT02429791|528711428|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
146601505|NCT02429791|528711429|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
146601506|NCT02429791|528711428|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
146601507|NCT02429791|528711429|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
146601508|NCT04201093|528711430|FG000|Overall Study|Adverse Event|6|||
146601509|NCT04201093|528711431|FG001|Overall Study|Adverse Event|29|||
146601510|NCT04201093|528711432|FG002|Overall Study|Adverse Event|35|||
146601511|NCT04201093|528711430|FG000|Overall Study|Death|2|||
146601512|NCT04201093|528711431|FG001|Overall Study|Death|1|||
146601513|NCT04201093|528711432|FG002|Overall Study|Death|0|||
146601514|NCT04201093|528711430|FG000|Overall Study|Lack of Efficacy|5|||
146601515|NCT04201093|528711431|FG001|Overall Study|Lack of Efficacy|1|||
146601516|NCT04201093|528711432|FG002|Overall Study|Lack of Efficacy|2|||
146601517|NCT04201093|528711430|FG000|Overall Study|Lost to Follow-up|0|||
146601518|NCT04201093|528711431|FG001|Overall Study|Lost to Follow-up|0|||
146601519|NCT04201093|528711432|FG002|Overall Study|Lost to Follow-up|1|||
146601520|NCT04201093|528711430|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
146601521|NCT04201093|528711431|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
146601522|NCT04201093|528711432|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
146656007|NCT01466179|528917868|FG000|Overall Study|Withdrawal by Subject|7|||
146656008|NCT01466179|528917868|FG000|Overall Study|Protocol Violation|2|||
146656009|NCT01466179|528917868|FG000|Overall Study|Other|3|||
146656010|NCT01083173|528917869|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
146656011|NCT01083173|528917870|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
146656012|NCT01083173|528917869|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
146656013|NCT01083173|528917870|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
146656014|NCT01083173|528917869|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
146656015|NCT01083173|528917870|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
146656016|NCT01083173|528917869|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
146656017|NCT01083173|528917870|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
146656018|NCT01083173|528917869|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
146656019|NCT01083173|528917870|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
146656020|NCT01083173|528917869|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
146656021|NCT01083173|528917870|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
146656022|NCT01083173|528917869|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
146656023|NCT01083173|528917870|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
146656024|NCT01083173|528917869|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
146656025|NCT01083173|528917870|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
146656026|NCT01083173|528917869|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
146656027|NCT01083173|528917870|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
146772352|NCT01636687|529335916|FG003|Induction Period|Lack of Efficacy|0|||
146922677|NCT04360187|529876799|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
146601523|NCT04201093|528711430|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
146601524|NCT04201093|528711431|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
146922678|NCT04360187|529876800|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
146922679|NCT04360187|529876799|FG000|Double-Blind Treatment|Physician Decision|1|||
146601525|NCT04201093|528711432|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
146601526|NCT04201093|528711430|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
146601527|NCT04201093|528711431|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
146772353|NCT01636687|529335917|FG004|Induction Period|Lack of Efficacy|1|||
146772354|NCT01636687|529335913|FG000|Induction Period|Physician Decision|1|||
146772355|NCT01636687|529335914|FG001|Induction Period|Physician Decision|0|||
146772356|NCT01636687|529335915|FG002|Induction Period|Physician Decision|0|||
146772357|NCT01636687|529335916|FG003|Induction Period|Physician Decision|0|||
146772358|NCT01636687|529335917|FG004|Induction Period|Physician Decision|0|||
146772359|NCT01636687|529335913|FG000|Maintenance Period|Withdrawal by Subject|2|||
146772360|NCT01636687|529335914|FG001|Maintenance Period|Withdrawal by Subject|0|||
146772361|NCT01636687|529335915|FG002|Maintenance Period|Withdrawal by Subject|2|||
146772362|NCT01636687|529335916|FG003|Maintenance Period|Withdrawal by Subject|0|||
146772363|NCT01636687|529335917|FG004|Maintenance Period|Withdrawal by Subject|0|||
146772364|NCT01636687|529335913|FG000|Maintenance Period|Adverse Event|1|||
146772365|NCT01636687|529335914|FG001|Maintenance Period|Adverse Event|0|||
146922680|NCT04360187|529876800|FG001|Double-Blind Treatment|Physician Decision|0|||
146922681|NCT04360187|529876799|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
146601528|NCT04201093|528711432|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
146601529|NCT04201093|528711430|FG000|Overall Study|Physician Decision|1|||
146601530|NCT04201093|528711431|FG001|Overall Study|Physician Decision|0|||
146601531|NCT04201093|528711432|FG002|Overall Study|Physician Decision|0|||
146601532|NCT04201093|528711430|FG000|Overall Study|Protocol Deviation|1|||
146601533|NCT04201093|528711431|FG001|Overall Study|Protocol Deviation|0|||
146601534|NCT04201093|528711432|FG002|Overall Study|Protocol Deviation|0|||
146601535|NCT04201093|528711430|FG000|Overall Study|Site Terminated by Sponsor|5|||
146601536|NCT04201093|528711431|FG001|Overall Study|Site Terminated by Sponsor|3|||
146601537|NCT04201093|528711432|FG002|Overall Study|Site Terminated by Sponsor|1|||
146601538|NCT04201093|528711430|FG000|Overall Study|Withdrawal by Subject|7|||
146601539|NCT04201093|528711431|FG001|Overall Study|Withdrawal by Subject|8|||
146601540|NCT04201093|528711432|FG002|Overall Study|Withdrawal by Subject|15|||
146601541|NCT04201093|528711430|FG000|Overall Study|Other|0|||
146601542|NCT04201093|528711431|FG001|Overall Study|Other|1|||
146601543|NCT04201093|528711432|FG002|Overall Study|Other|2|||
146601544|NCT00007020|528711433|FG000|Overall Study|Death|16|||
146601545|NCT00007020|528711433|FG000|Overall Study|Lost to Follow-up|13|||
146601546|NCT00007020|528711433|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
146601547|NCT00007020|528711433|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
146601548|NCT00007020|528711433|FG000|Overall Study|Pt cared for by outside physician|4|||
146601549|NCT00007020|528711433|FG000|Overall Study|No evidence of treatment|6|||
146601550|NCT00881504|528711434|FG000|Overall Study|Withdrawal by Subject|1|||
146601551|NCT01276223|528711435|FG000|Overall Study|Adverse Event|7|||
146601552|NCT01276223|528711436|FG001|Overall Study|Adverse Event|4|||
146601553|NCT01276223|528711437|FG002|Overall Study|Adverse Event|1|||
146601554|NCT01276223|528711435|FG000|Overall Study|Lost to Follow-up|0|||
146601555|NCT01276223|528711436|FG001|Overall Study|Lost to Follow-up|0|||
146601556|NCT01276223|528711437|FG002|Overall Study|Lost to Follow-up|1|||
146601557|NCT01276223|528711435|FG000|Overall Study|Other|0|||
146601558|NCT01276223|528711436|FG001|Overall Study|Other|0|||
146601559|NCT01276223|528711437|FG002|Overall Study|Other|1|||
146601560|NCT01276223|528711435|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
146601561|NCT01276223|528711436|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
146601562|NCT01276223|528711437|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
146601563|NCT01276223|528711435|FG000|Overall Study|Protocol Violation|1|||
146601564|NCT01276223|528711436|FG001|Overall Study|Protocol Violation|0|||
146601565|NCT01276223|528711437|FG002|Overall Study|Protocol Violation|0|||
146601566|NCT05011058|528711438|FG000|Overall Study|Sponsor Decision|2|||
146601567|NCT05011058|528711439|FG001|Overall Study|Sponsor Decision|0|||
146601568|NCT05011058|528711440|FG002|Overall Study|Sponsor Decision|14|||
146601569|NCT05011058|528711441|FG003|Overall Study|Sponsor Decision|0|||
146601570|NCT05011058|528711442|FG004|Overall Study|Sponsor Decision|0|||
146601571|NCT05011058|528711443|FG005|Overall Study|Sponsor Decision|1|||
146601572|NCT05011058|528711444|FG006|Overall Study|Sponsor Decision|0|||
146772366|NCT01636687|529335915|FG002|Maintenance Period|Adverse Event|0|||
146922682|NCT04360187|529876800|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
146922683|NCT04360187|529876799|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
146601573|NCT05011058|528711445|FG007|Overall Study|Sponsor Decision|5|||
146601574|NCT02596230|528711446|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
146601575|NCT02596230|528711447|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
146601576|NCT02596230|528711448|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
146601577|NCT02596230|528711449|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
146601578|NCT02596230|528711450|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
146601579|NCT02596230|528711446|FG000|Objective 2, One Year|Lost to Follow-up|0|||
146601580|NCT02596230|528711447|FG001|Objective 2, One Year|Lost to Follow-up|41|||
146601581|NCT02596230|528711448|FG002|Objective 2, One Year|Lost to Follow-up|41|||
146601582|NCT02596230|528711449|FG003|Objective 2, One Year|Lost to Follow-up|32|||
146772367|NCT01636687|529335916|FG003|Maintenance Period|Adverse Event|0|||
146772368|NCT01636687|529335917|FG004|Maintenance Period|Adverse Event|0|||
146772369|NCT01636687|529335913|FG000|Maintenance Period|Lack of Efficacy|4|||
146656028|NCT01083173|528917869|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
146656029|NCT01083173|528917870|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
146656030|NCT01083173|528917869|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
146656031|NCT01083173|528917870|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
146656032|NCT03139604|528917873|FG000|Overall Study|Other|7|||
146656033|NCT03139604|528917874|FG001|Overall Study|Other|3|||
146656034|NCT03139604|528917873|FG000|Overall Study|Withdrawal by Subject|16|||
146656035|NCT03139604|528917874|FG001|Overall Study|Withdrawal by Subject|17|||
146656036|NCT03139604|528917873|FG000|Overall Study|Physician Decision|1|||
146656037|NCT03139604|528917874|FG001|Overall Study|Physician Decision|2|||
146656038|NCT03139604|528917873|FG000|Overall Study|Lost to Follow-up|3|||
146656039|NCT03139604|528917874|FG001|Overall Study|Lost to Follow-up|1|||
146656040|NCT03139604|528917873|FG000|Overall Study|Death|65|||
146656041|NCT03139604|528917874|FG001|Overall Study|Death|67|||
146656042|NCT03139604|528917873|FG000|Overall Study|Study Terminated by Sponsor|122|||
146656043|NCT03139604|528917874|FG001|Overall Study|Study Terminated by Sponsor|127|||
146656044|NCT03139604|528917873|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
146656045|NCT03139604|528917874|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
146656046|NCT00662532|528917878|FG000|Overall Study|Adverse Event|0|||
146656047|NCT00662532|528917879|FG001|Overall Study|Adverse Event|1|||
146656048|NCT00662532|528917878|FG000|Overall Study|Lost to Follow-up|0|||
146656049|NCT00662532|528917879|FG001|Overall Study|Lost to Follow-up|1|||
146656050|NCT00366340|528917880|FG000|Infant Series|Protocol Violation|3|||
146656051|NCT00366340|528917881|FG001|Infant Series|Protocol Violation|4|||
146656052|NCT00366340|528917880|FG000|Infant Series|Withdrawal by Subject|3|||
146656053|NCT00366340|528917881|FG001|Infant Series|Withdrawal by Subject|3|||
146656054|NCT00366340|528917880|FG000|Infant Series|Adverse Event|0|||
146656055|NCT00366340|528917881|FG001|Infant Series|Adverse Event|2|||
146656056|NCT00366340|528917880|FG000|Infant Series|Lost to Follow-up|1|||
146656057|NCT00366340|528917881|FG001|Infant Series|Lost to Follow-up|1|||
146656058|NCT00366340|528917880|FG000|Infant Series|Failure to return|1|||
146656059|NCT00366340|528917881|FG001|Infant Series|Failure to return|0|||
146656060|NCT00366340|528917880|FG000|After the Infant Series|Parent/legal guardian request|1|||
146656061|NCT00366340|528917881|FG001|After the Infant Series|Parent/legal guardian request|1|||
146656062|NCT00366340|528917880|FG000|After the Infant Series|Failed to return|0|||
146772370|NCT01636687|529335914|FG001|Maintenance Period|Lack of Efficacy|1|||
146772371|NCT01636687|529335915|FG002|Maintenance Period|Lack of Efficacy|0|||
146601583|NCT02596230|528711450|FG004|Objective 2, One Year|Lost to Follow-up|46|||
146601584|NCT02596230|528711446|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
146601585|NCT02596230|528711447|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
146601586|NCT02596230|528711448|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
146601587|NCT02596230|528711449|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
146601588|NCT02596230|528711450|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
146601589|NCT02596230|528711446|FG000|Objective 2, One Year|Adverse drug reaction|0|||
146601590|NCT02596230|528711447|FG001|Objective 2, One Year|Adverse drug reaction|1|||
146601591|NCT02596230|528711448|FG002|Objective 2, One Year|Adverse drug reaction|0|||
146601592|NCT02596230|528711449|FG003|Objective 2, One Year|Adverse drug reaction|0|||
146601593|NCT02596230|528711450|FG004|Objective 2, One Year|Adverse drug reaction|0|||
146601594|NCT02596230|528711446|FG000|Objective 2, One Year|Death|0|||
146601595|NCT02596230|528711447|FG001|Objective 2, One Year|Death|12|||
146601596|NCT02596230|528711448|FG002|Objective 2, One Year|Death|41|||
146601597|NCT02596230|528711449|FG003|Objective 2, One Year|Death|21|||
146601598|NCT02596230|528711450|FG004|Objective 2, One Year|Death|30|||
146601599|NCT02596230|528711446|FG000|Objective 2, One Year|Other|0|||
146601600|NCT02596230|528711447|FG001|Objective 2, One Year|Other|3|||
146601601|NCT02596230|528711448|FG002|Objective 2, One Year|Other|2|||
146601602|NCT02596230|528711449|FG003|Objective 2, One Year|Other|0|||
146601603|NCT02596230|528711450|FG004|Objective 2, One Year|Other|0|||
146601604|NCT01571232|528711451|FG000|Overall Study|Lost to Follow-up|0|||
146601605|NCT01571232|528711452|FG001|Overall Study|Lost to Follow-up|1|||
146601606|NCT01571232|528711451|FG000|Overall Study|Withdrawal by Subject|1|||
146601607|NCT01571232|528711452|FG001|Overall Study|Withdrawal by Subject|0|||
146601608|NCT02478164|528711453|FG000|Overall Study|Lack of Efficacy|13|||
146601609|NCT02478164|528711453|FG000|Overall Study|Adverse Event|1|||
146601610|NCT02478164|528711453|FG000|Overall Study|Withdrawal by Subject|1|||
146601611|NCT00802893|528711454|FG000|Overall Study|study terminated|3|||
146656063|NCT00366340|528917881|FG001|After the Infant Series|Failed to return|1|||
146656064|NCT00366340|528917880|FG000|After the Infant Series|Protocol Violation|2|||
146656065|NCT00366340|528917881|FG001|After the Infant Series|Protocol Violation|2|||
146656066|NCT00366340|528917880|FG000|After the Infant Series|Adverse Event|0|||
146656067|NCT00366340|528917881|FG001|After the Infant Series|Adverse Event|1|||
146656068|NCT00366340|528917880|FG000|After the Infant Series|Lost to Follow-up|0|||
146656069|NCT00366340|528917881|FG001|After the Infant Series|Lost to Follow-up|1|||
146601612|NCT00320424|528711455|FG000|Overall Study|Adverse Event|3|||
146656070|NCT00366340|528917880|FG000|Toddler Dose|Failed to return|1|||
146656071|NCT00366340|528917881|FG001|Toddler Dose|Failed to return|0|||
146656072|NCT00366340|528917880|FG000|Toddler Dose|Parent/legal guardian request|0|||
146656073|NCT00366340|528917881|FG001|Toddler Dose|Parent/legal guardian request|1|||
146656074|NCT00442468|528917882|FG000|Overall Study|Adverse Event|4|||
146656075|NCT00442468|528917882|FG000|Overall Study|Withdrawal by Subject|91|||
146656076|NCT00442468|528917882|FG000|Overall Study|Did not complete all study procedures|88|||
146656077|NCT00589784|528917883|FG000|Overall Study|Withdrawal by Subject|0|||
146656078|NCT00589784|528917884|FG001|Overall Study|Withdrawal by Subject|6|||
146656079|NCT00589784|528917883|FG000|Overall Study|Patient inevaluable|1|||
146656080|NCT00589784|528917884|FG001|Overall Study|Patient inevaluable|0|||
146656081|NCT00589784|528917883|FG000|Overall Study|Adverse Event|0|||
146656082|NCT00589784|528917884|FG001|Overall Study|Adverse Event|4|||
146656083|NCT03823378|528917887|FG000|Overall Study|Adverse Event|2|||
146656084|NCT03823378|528917888|FG001|Overall Study|Adverse Event|2|||
146656085|NCT03823378|528917889|FG002|Overall Study|Adverse Event|0|||
146656086|NCT03823378|528917890|FG003|Overall Study|Adverse Event|0|||
146656087|NCT03823378|528917891|FG004|Overall Study|Adverse Event|0|||
146656088|NCT03823378|528917892|FG005|Overall Study|Adverse Event|0|||
146656089|NCT03823378|528917887|FG000|Overall Study|Lost to Follow-up|0|||
146656090|NCT03823378|528917888|FG001|Overall Study|Lost to Follow-up|1|||
146656091|NCT03823378|528917889|FG002|Overall Study|Lost to Follow-up|0|||
146656092|NCT03823378|528917890|FG003|Overall Study|Lost to Follow-up|0|||
146656093|NCT03823378|528917891|FG004|Overall Study|Lost to Follow-up|1|||
146656094|NCT03823378|528917892|FG005|Overall Study|Lost to Follow-up|0|||
146656095|NCT03823378|528917887|FG000|Overall Study|Withdrawal by Subject|0|||
146656096|NCT03823378|528917888|FG001|Overall Study|Withdrawal by Subject|1|||
146656097|NCT03823378|528917889|FG002|Overall Study|Withdrawal by Subject|4|||
146656098|NCT03823378|528917890|FG003|Overall Study|Withdrawal by Subject|2|||
146656099|NCT03823378|528917891|FG004|Overall Study|Withdrawal by Subject|0|||
146656100|NCT03823378|528917892|FG005|Overall Study|Withdrawal by Subject|1|||
146656101|NCT03823378|528917887|FG000|Overall Study|Other, not specified|19|||
146656102|NCT03823378|528917888|FG001|Overall Study|Other, not specified|12|||
146656103|NCT03823378|528917889|FG002|Overall Study|Other, not specified|6|||
146656104|NCT03823378|528917890|FG003|Overall Study|Other, not specified|8|||
146656105|NCT03823378|528917891|FG004|Overall Study|Other, not specified|17|||
146656106|NCT03823378|528917892|FG005|Overall Study|Other, not specified|7|||
146656107|NCT03190369|528917893|FG000|Overall Study|Poor compliance to protocol|0|||
146656108|NCT03190369|528917894|FG001|Overall Study|Poor compliance to protocol|1|||
146656109|NCT03190369|528917893|FG000|Overall Study|Withdraw before treatment|1|||
146656110|NCT03190369|528917894|FG001|Overall Study|Withdraw before treatment|5|||
146656111|NCT03190369|528917893|FG000|Overall Study|Randomized but not treated|0|||
146656112|NCT03190369|528917894|FG001|Overall Study|Randomized but not treated|2|||
146656113|NCT01606254|528917895|FG000|Overall Study|Withdrawal by Subject|1|||
146656114|NCT01606254|528917896|FG001|Overall Study|Withdrawal by Subject|3|||
146656115|NCT01606254|528917897|FG002|Overall Study|Withdrawal by Subject|0|||
146656116|NCT01606254|528917898|FG003|Overall Study|Withdrawal by Subject|2|||
146656117|NCT01606254|528917895|FG000|Overall Study|Adverse Event|1|||
146656118|NCT01606254|528917896|FG001|Overall Study|Adverse Event|1|||
146656119|NCT01606254|528917897|FG002|Overall Study|Adverse Event|0|||
146656120|NCT01606254|528917898|FG003|Overall Study|Adverse Event|1|||
146656121|NCT04543409|528917899|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146656122|NCT04543409|528917900|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146656123|NCT04543409|528917899|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
146656124|NCT04543409|528917900|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
146656125|NCT04543409|528917899|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
146656126|NCT04543409|528917900|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
146656127|NCT04543409|528917899|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
146656128|NCT04543409|528917900|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
146656129|NCT04543409|528917899|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
146656130|NCT04543409|528917900|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
146656131|NCT04543409|528917899|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
146656132|NCT04543409|528917900|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
146656133|NCT04543409|528917899|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
146656134|NCT04543409|528917900|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
146656135|NCT04543409|528917899|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
146656136|NCT04543409|528917900|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
146656137|NCT04543409|528917899|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
146656138|NCT04543409|528917900|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
146656139|NCT04543409|528917899|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
146656140|NCT04543409|528917900|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
146656141|NCT04543409|528917899|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
146601613|NCT00320424|528711455|FG000|Overall Study|Other|3|||
146601614|NCT00231413|528711462|FG000|Overall Study|Non-serious AE|0|||
146601615|NCT00231413|528711463|FG001|Overall Study|Non-serious AE|0|||
146601616|NCT00231413|528711464|FG002|Overall Study|Non-serious AE|1|||
146601617|NCT00231413|528711465|FG003|Overall Study|Non-serious AE|0|||
146601618|NCT00231413|528711466|FG004|Overall Study|Non-serious AE|0|||
146601619|NCT00231413|528711467|FG005|Overall Study|Non-serious AE|0|||
146601620|NCT00231413|528711468|FG006|Overall Study|Non-serious AE|1|||
146601621|NCT00231413|528711462|FG000|Overall Study|Withdrawal by Subject|3|||
146601622|NCT00231413|528711463|FG001|Overall Study|Withdrawal by Subject|1|||
146601623|NCT00231413|528711464|FG002|Overall Study|Withdrawal by Subject|4|||
146601624|NCT00231413|528711465|FG003|Overall Study|Withdrawal by Subject|2|||
146601625|NCT00231413|528711466|FG004|Overall Study|Withdrawal by Subject|2|||
146601626|NCT00231413|528711467|FG005|Overall Study|Withdrawal by Subject|0|||
146601627|NCT00231413|528711468|FG006|Overall Study|Withdrawal by Subject|3|||
146601628|NCT00231413|528711462|FG000|Overall Study|Migrated/moved from study area|0|||
146601629|NCT00231413|528711463|FG001|Overall Study|Migrated/moved from study area|0|||
146601630|NCT00231413|528711464|FG002|Overall Study|Migrated/moved from study area|1|||
146601631|NCT00231413|528711465|FG003|Overall Study|Migrated/moved from study area|0|||
146601632|NCT00231413|528711466|FG004|Overall Study|Migrated/moved from study area|0|||
146601633|NCT00231413|528711467|FG005|Overall Study|Migrated/moved from study area|1|||
146601634|NCT00231413|528711468|FG006|Overall Study|Migrated/moved from study area|0|||
146601635|NCT00231413|528711462|FG000|Overall Study|Lost to Follow-up|4|||
146601636|NCT00231413|528711463|FG001|Overall Study|Lost to Follow-up|4|||
146601637|NCT00231413|528711464|FG002|Overall Study|Lost to Follow-up|1|||
146601638|NCT00231413|528711465|FG003|Overall Study|Lost to Follow-up|1|||
146601639|NCT00231413|528711466|FG004|Overall Study|Lost to Follow-up|1|||
146601640|NCT00231413|528711467|FG005|Overall Study|Lost to Follow-up|4|||
146601641|NCT00231413|528711468|FG006|Overall Study|Lost to Follow-up|0|||
146601642|NCT00231413|528711462|FG000|Overall Study|Pregnancy|1|||
146601643|NCT00231413|528711463|FG001|Overall Study|Pregnancy|0|||
146601644|NCT00231413|528711464|FG002|Overall Study|Pregnancy|0|||
146601645|NCT00231413|528711465|FG003|Overall Study|Pregnancy|0|||
146601646|NCT00231413|528711466|FG004|Overall Study|Pregnancy|0|||
146601647|NCT00231413|528711467|FG005|Overall Study|Pregnancy|0|||
146601648|NCT00231413|528711468|FG006|Overall Study|Pregnancy|0|||
146601649|NCT01659255|528711469|FG000|Overall Study|Adverse Event|0|||
146601650|NCT01659255|528711470|FG001|Overall Study|Adverse Event|0|||
146922684|NCT04360187|529876800|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
146922685|NCT04360187|529876799|FG000|Follow-Up|Lost to Follow-up|1|||
146922686|NCT04360187|529876800|FG001|Follow-Up|Lost to Follow-up|0|||
146601651|NCT01659255|528711471|FG002|Overall Study|Adverse Event|0|||
146601652|NCT01659255|528711472|FG003|Overall Study|Adverse Event|0|||
146601653|NCT01659255|528711473|FG004|Overall Study|Adverse Event|0|||
146601654|NCT01659255|528711474|FG005|Overall Study|Adverse Event|1|||
146601655|NCT01659255|528711475|FG006|Overall Study|Adverse Event|1|||
146601656|NCT01659255|528711476|FG007|Overall Study|Adverse Event|0|||
146601657|NCT01659255|528711477|FG008|Overall Study|Adverse Event|0|||
146601658|NCT01659255|528711478|FG009|Overall Study|Adverse Event|1|||
146601659|NCT01659255|528711479|FG010|Overall Study|Adverse Event|0|||
146601660|NCT01659255|528711480|FG011|Overall Study|Adverse Event|1|||
146601661|NCT01659255|528711481|FG012|Overall Study|Adverse Event|0|||
146601662|NCT01659255|528711482|FG013|Overall Study|Adverse Event|2|||
146601663|NCT01659255|528711483|FG014|Overall Study|Adverse Event|0|||
146601664|NCT01659255|528711484|FG015|Overall Study|Adverse Event|1|||
146601665|NCT01659255|528711485|FG016|Overall Study|Adverse Event|0|||
146601666|NCT01659255|528711469|FG000|Overall Study|Death|0|||
146601667|NCT01659255|528711470|FG001|Overall Study|Death|1|||
146601668|NCT01659255|528711471|FG002|Overall Study|Death|0|||
146601669|NCT01659255|528711472|FG003|Overall Study|Death|0|||
146601670|NCT01659255|528711473|FG004|Overall Study|Death|0|||
146601671|NCT01659255|528711474|FG005|Overall Study|Death|0|||
146601672|NCT01659255|528711475|FG006|Overall Study|Death|0|||
146601673|NCT01659255|528711476|FG007|Overall Study|Death|1|||
146601674|NCT01659255|528711477|FG008|Overall Study|Death|1|||
146601675|NCT01659255|528711478|FG009|Overall Study|Death|0|||
146601676|NCT01659255|528711479|FG010|Overall Study|Death|0|||
146601677|NCT01659255|528711480|FG011|Overall Study|Death|0|||
146601678|NCT01659255|528711481|FG012|Overall Study|Death|1|||
146656142|NCT04543409|528917900|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
146656143|NCT01289782|528917901|FG000|Overall Study|Lost to Follow-up|14|||
146601679|NCT01659255|528711482|FG013|Overall Study|Death|1|||
146601680|NCT01659255|528711483|FG014|Overall Study|Death|2|||
146601681|NCT01659255|528711484|FG015|Overall Study|Death|1|||
146601682|NCT01659255|528711485|FG016|Overall Study|Death|0|||
146601683|NCT01659255|528711469|FG000|Overall Study|Progressive Disease|2|||
146601684|NCT01659255|528711470|FG001|Overall Study|Progressive Disease|0|||
146601685|NCT01659255|528711471|FG002|Overall Study|Progressive Disease|0|||
146601686|NCT01659255|528711472|FG003|Overall Study|Progressive Disease|0|||
146601687|NCT01659255|528711473|FG004|Overall Study|Progressive Disease|0|||
146601688|NCT01659255|528711474|FG005|Overall Study|Progressive Disease|0|||
146772372|NCT01636687|529335916|FG003|Maintenance Period|Lack of Efficacy|0|||
146772373|NCT01636687|529335917|FG004|Maintenance Period|Lack of Efficacy|0|||
146772374|NCT01636687|529335913|FG000|Maintenance Period|Lost to Follow-up|1|||
146772375|NCT01636687|529335914|FG001|Maintenance Period|Lost to Follow-up|1|||
146772376|NCT01636687|529335915|FG002|Maintenance Period|Lost to Follow-up|0|||
146772377|NCT01636687|529335916|FG003|Maintenance Period|Lost to Follow-up|0|||
146772378|NCT01636687|529335917|FG004|Maintenance Period|Lost to Follow-up|1|||
146772379|NCT01636687|529335913|FG000|Maintenance Period|Physician Decision|0|||
146772380|NCT01636687|529335914|FG001|Maintenance Period|Physician Decision|0|||
146772381|NCT01636687|529335915|FG002|Maintenance Period|Physician Decision|0|||
146772382|NCT01636687|529335916|FG003|Maintenance Period|Physician Decision|0|||
146772383|NCT01636687|529335917|FG004|Maintenance Period|Physician Decision|1|||
146772384|NCT01636687|529335913|FG000|Extension Period|technical problems|0|||
146772385|NCT01636687|529335914|FG001|Extension Period|technical problems|1|||
146772386|NCT01636687|529335915|FG002|Extension Period|technical problems|2|||
146656144|NCT01289782|528917902|FG001|Overall Study|Lost to Follow-up|7|||
146656145|NCT01289782|528917901|FG000|Overall Study|Protocol Violation|1|||
146656146|NCT01289782|528917902|FG001|Overall Study|Protocol Violation|1|||
146656147|NCT01289782|528917901|FG000|Overall Study|Withdrawal by Subject|8|||
146656148|NCT01289782|528917902|FG001|Overall Study|Withdrawal by Subject|2|||
146656149|NCT01289782|528917901|FG000|Overall Study|Sponsor's Decision|1|||
146922687|NCT05896761|529876806|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
146656150|NCT01289782|528917902|FG001|Overall Study|Sponsor's Decision|0|||
146656151|NCT01289782|528917901|FG000|Overall Study|Reason not specified|1|||
146656152|NCT01289782|528917902|FG001|Overall Study|Reason not specified|2|||
146656153|NCT02131532|528917903|FG000|Overall Study|Withdrawal by Subject|1|||
146656154|NCT02131532|528917903|FG000|Overall Study|Physician Decision|1|||
146656155|NCT02131532|528917903|FG000|Overall Study|Other health conditions|2|||
146656156|NCT02093026|528917904|FG000|Overall Study|Adverse Event|26|||
146656157|NCT02093026|528917904|FG000|Overall Study|Death|10|||
146656158|NCT02093026|528917904|FG000|Overall Study|Other|157|||
146656159|NCT02195011|528917920|FG000|Overall Study|Adverse Event|4|||
146656160|NCT02195011|528917921|FG001|Overall Study|Adverse Event|0|||
146656161|NCT02195011|528917920|FG000|Overall Study|Progressive Disease|18|||
146656162|NCT02195011|528917921|FG001|Overall Study|Progressive Disease|1|||
146656163|NCT02195011|528917920|FG000|Overall Study|Withdrawal by Subject|3|||
146656164|NCT02195011|528917921|FG001|Overall Study|Withdrawal by Subject|0|||
146656165|NCT00174291|528917925|FG000|Overall Study|Lost to Follow-up|1|||
146656166|NCT00174291|528917926|FG001|Overall Study|Lost to Follow-up|1|||
146656167|NCT00174291|528917925|FG000|Overall Study|Protocol Violation|0|||
146656168|NCT00174291|528917926|FG001|Overall Study|Protocol Violation|2|||
146772387|NCT01636687|529335916|FG003|Extension Period|technical problems|1|||
146772388|NCT01636687|529335917|FG004|Extension Period|technical problems|0|||
146772389|NCT01636687|529335913|FG000|Extension Period|Adverse Event|4|||
146772390|NCT01636687|529335914|FG001|Extension Period|Adverse Event|3|||
146772391|NCT01636687|529335915|FG002|Extension Period|Adverse Event|2|||
146772392|NCT01636687|529335916|FG003|Extension Period|Adverse Event|1|||
146922688|NCT05896761|529876807|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
146922689|NCT05896761|529876806|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
146922690|NCT05896761|529876807|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
146601689|NCT01659255|528711475|FG006|Overall Study|Progressive Disease|0|||
146601690|NCT01659255|528711476|FG007|Overall Study|Progressive Disease|1|||
146601691|NCT01659255|528711477|FG008|Overall Study|Progressive Disease|0|||
146601692|NCT01659255|528711478|FG009|Overall Study|Progressive Disease|2|||
146601693|NCT01659255|528711479|FG010|Overall Study|Progressive Disease|2|||
146601694|NCT01659255|528711480|FG011|Overall Study|Progressive Disease|3|||
146601695|NCT01659255|528711481|FG012|Overall Study|Progressive Disease|5|||
146601696|NCT01659255|528711482|FG013|Overall Study|Progressive Disease|13|||
146601697|NCT01659255|528711483|FG014|Overall Study|Progressive Disease|6|||
146601698|NCT01659255|528711484|FG015|Overall Study|Progressive Disease|2|||
146601699|NCT01659255|528711485|FG016|Overall Study|Progressive Disease|3|||
146601700|NCT01659255|528711469|FG000|Overall Study|Withdrew Consent|0|||
146601701|NCT01659255|528711470|FG001|Overall Study|Withdrew Consent|0|||
146601702|NCT01659255|528711471|FG002|Overall Study|Withdrew Consent|0|||
146772393|NCT01636687|529335917|FG004|Extension Period|Adverse Event|0|||
146601703|NCT01659255|528711472|FG003|Overall Study|Withdrew Consent|0|||
146601704|NCT01659255|528711473|FG004|Overall Study|Withdrew Consent|0|||
146601705|NCT01659255|528711474|FG005|Overall Study|Withdrew Consent|0|||
146656169|NCT00174291|528917925|FG000|Overall Study|Study terminated by sponsor|1|||
146656170|NCT00174291|528917926|FG001|Overall Study|Study terminated by sponsor|0|||
146601706|NCT01659255|528711475|FG006|Overall Study|Withdrew Consent|0|||
146656171|NCT00174291|528917925|FG000|Overall Study|Withdrawal by Subject|3|||
146656172|NCT00174291|528917926|FG001|Overall Study|Withdrawal by Subject|3|||
146656173|NCT00450112|528917927|FG000|Overall Study|Other Treatment Required|5|||
146656174|NCT00450112|528917928|FG001|Overall Study|Other Treatment Required|1|||
146772394|NCT01636687|529335913|FG000|Extension Period|Lack of Efficacy|7|||
146772395|NCT01636687|529335914|FG001|Extension Period|Lack of Efficacy|0|||
146772396|NCT01636687|529335915|FG002|Extension Period|Lack of Efficacy|2|||
146601707|NCT01659255|528711476|FG007|Overall Study|Withdrew Consent|0|||
146601708|NCT01659255|528711477|FG008|Overall Study|Withdrew Consent|0|||
146601709|NCT01659255|528711478|FG009|Overall Study|Withdrew Consent|0|||
146601710|NCT01659255|528711479|FG010|Overall Study|Withdrew Consent|1|||
146601711|NCT01659255|528711480|FG011|Overall Study|Withdrew Consent|0|||
146601712|NCT01659255|528711481|FG012|Overall Study|Withdrew Consent|0|||
146601713|NCT01659255|528711482|FG013|Overall Study|Withdrew Consent|1|||
146601714|NCT01659255|528711483|FG014|Overall Study|Withdrew Consent|0|||
146601715|NCT01659255|528711484|FG015|Overall Study|Withdrew Consent|0|||
146601716|NCT01659255|528711485|FG016|Overall Study|Withdrew Consent|0|||
146601717|NCT01659255|528711469|FG000|Overall Study|Investigator Decision|0|||
146601718|NCT01659255|528711470|FG001|Overall Study|Investigator Decision|0|||
146601719|NCT01659255|528711471|FG002|Overall Study|Investigator Decision|0|||
146601720|NCT01659255|528711472|FG003|Overall Study|Investigator Decision|0|||
146601721|NCT01659255|528711473|FG004|Overall Study|Investigator Decision|0|||
146601722|NCT01659255|528711474|FG005|Overall Study|Investigator Decision|0|||
146601723|NCT01659255|528711475|FG006|Overall Study|Investigator Decision|0|||
146656175|NCT00450112|528917927|FG000|Overall Study|Withdrawal by Subject|4|||
146656176|NCT00450112|528917928|FG001|Overall Study|Withdrawal by Subject|1|||
146656177|NCT00450112|528917927|FG000|Overall Study|Lost to Follow-up|2|||
146656178|NCT00450112|528917928|FG001|Overall Study|Lost to Follow-up|1|||
146656179|NCT00450112|528917927|FG000|Overall Study|Others|2|||
146656180|NCT00450112|528917928|FG001|Overall Study|Others|3|||
146656181|NCT00256282|528917929|FG000|Overall Study|Disease progression, relapse during acti|12|||
146656182|NCT00256282|528917929|FG000|Overall Study|Adverse Event|3|||
146656183|NCT00256282|528917929|FG000|Overall Study|Physician Decision|1|||
146656184|NCT02414139|528917931|FG000|Treatment Period|Adverse Event|11|||
146656185|NCT02414139|528917932|FG001|Treatment Period|Adverse Event|6|||
146656186|NCT02414139|528917933|FG002|Treatment Period|Adverse Event|8|||
146656187|NCT02414139|528917934|FG003|Treatment Period|Adverse Event|5|||
146656188|NCT02414139|528917935|FG004|Treatment Period|Adverse Event|14|||
146656189|NCT02414139|528917936|FG005|Treatment Period|Adverse Event|3|||
146656190|NCT02414139|528917937|FG006|Treatment Period|Adverse Event|6|||
146656191|NCT02414139|528917938|FG007|Treatment Period|Adverse Event|1|||
146656192|NCT02414139|528917939|FG008|Treatment Period|Adverse Event|6|||
146656193|NCT02414139|528917940|FG009|Treatment Period|Adverse Event|8|||
146656194|NCT02414139|528917931|FG000|Treatment Period|Death|0|||
146656195|NCT02414139|528917932|FG001|Treatment Period|Death|0|||
146656196|NCT02414139|528917933|FG002|Treatment Period|Death|1|||
146656197|NCT02414139|528917934|FG003|Treatment Period|Death|1|||
146656198|NCT02414139|528917935|FG004|Treatment Period|Death|0|||
146656199|NCT02414139|528917936|FG005|Treatment Period|Death|0|||
146656200|NCT02414139|528917937|FG006|Treatment Period|Death|0|||
146656201|NCT02414139|528917938|FG007|Treatment Period|Death|0|||
146656202|NCT02414139|528917939|FG008|Treatment Period|Death|0|||
146656203|NCT02414139|528917940|FG009|Treatment Period|Death|1|||
146656204|NCT02414139|528917931|FG000|Treatment Period|Physician Decision|5|||
146656205|NCT02414139|528917932|FG001|Treatment Period|Physician Decision|4|||
146656206|NCT02414139|528917933|FG002|Treatment Period|Physician Decision|6|||
146656207|NCT02414139|528917934|FG003|Treatment Period|Physician Decision|1|||
146656208|NCT02414139|528917935|FG004|Treatment Period|Physician Decision|4|||
146656209|NCT02414139|528917936|FG005|Treatment Period|Physician Decision|0|||
146656210|NCT02414139|528917937|FG006|Treatment Period|Physician Decision|2|||
146656211|NCT02414139|528917938|FG007|Treatment Period|Physician Decision|0|||
146656212|NCT02414139|528917939|FG008|Treatment Period|Physician Decision|1|||
146656213|NCT02414139|528917940|FG009|Treatment Period|Physician Decision|4|||
146656214|NCT02414139|528917931|FG000|Treatment Period|Progressive disease|48|||
146656215|NCT02414139|528917932|FG001|Treatment Period|Progressive disease|31|||
146656216|NCT02414139|528917933|FG002|Treatment Period|Progressive disease|37|||
146656217|NCT02414139|528917934|FG003|Treatment Period|Progressive disease|21|||
146656218|NCT02414139|528917935|FG004|Treatment Period|Progressive disease|43|||
146656219|NCT02414139|528917936|FG005|Treatment Period|Progressive disease|12|||
146656220|NCT02414139|528917937|FG006|Treatment Period|Progressive disease|16|||
146656221|NCT02414139|528917938|FG007|Treatment Period|Progressive disease|2|||
146656222|NCT02414139|528917939|FG008|Treatment Period|Progressive disease|20|||
146601724|NCT01659255|528711476|FG007|Overall Study|Investigator Decision|0|||
146601725|NCT01659255|528711477|FG008|Overall Study|Investigator Decision|0|||
146656223|NCT02414139|528917940|FG009|Treatment Period|Progressive disease|14|||
146656224|NCT02414139|528917931|FG000|Treatment Period|Protocol deviation|0|||
146656225|NCT02414139|528917932|FG001|Treatment Period|Protocol deviation|0|||
146656226|NCT02414139|528917933|FG002|Treatment Period|Protocol deviation|1|||
146656227|NCT02414139|528917934|FG003|Treatment Period|Protocol deviation|0|||
146656228|NCT02414139|528917935|FG004|Treatment Period|Protocol deviation|0|||
146656229|NCT02414139|528917936|FG005|Treatment Period|Protocol deviation|0|||
146656230|NCT02414139|528917937|FG006|Treatment Period|Protocol deviation|0|||
146656231|NCT02414139|528917938|FG007|Treatment Period|Protocol deviation|0|||
146656232|NCT02414139|528917939|FG008|Treatment Period|Protocol deviation|0|||
146656233|NCT02414139|528917940|FG009|Treatment Period|Protocol deviation|0|||
146772397|NCT01636687|529335916|FG003|Extension Period|Lack of Efficacy|1|||
146601726|NCT01659255|528711478|FG009|Overall Study|Investigator Decision|0|||
146601727|NCT01659255|528711479|FG010|Overall Study|Investigator Decision|0|||
146601728|NCT01659255|528711480|FG011|Overall Study|Investigator Decision|0|||
146601729|NCT01659255|528711481|FG012|Overall Study|Investigator Decision|1|||
146601730|NCT01659255|528711482|FG013|Overall Study|Investigator Decision|1|||
146601731|NCT01659255|528711483|FG014|Overall Study|Investigator Decision|0|||
146601732|NCT01659255|528711484|FG015|Overall Study|Investigator Decision|0|||
146601733|NCT01659255|528711485|FG016|Overall Study|Investigator Decision|0|||
146601734|NCT01659255|528711469|FG000|Overall Study|Sponsor's Decision|0|||
146601735|NCT01659255|528711470|FG001|Overall Study|Sponsor's Decision|0|||
146601736|NCT01659255|528711471|FG002|Overall Study|Sponsor's Decision|0|||
146601737|NCT01659255|528711472|FG003|Overall Study|Sponsor's Decision|0|||
146601738|NCT01659255|528711473|FG004|Overall Study|Sponsor's Decision|0|||
146601739|NCT01659255|528711474|FG005|Overall Study|Sponsor's Decision|0|||
146601740|NCT01659255|528711475|FG006|Overall Study|Sponsor's Decision|1|||
146601741|NCT01659255|528711476|FG007|Overall Study|Sponsor's Decision|0|||
146601742|NCT01659255|528711477|FG008|Overall Study|Sponsor's Decision|0|||
146601743|NCT01659255|528711478|FG009|Overall Study|Sponsor's Decision|0|||
146601744|NCT01659255|528711479|FG010|Overall Study|Sponsor's Decision|0|||
146601745|NCT01659255|528711480|FG011|Overall Study|Sponsor's Decision|0|||
146601746|NCT01659255|528711481|FG012|Overall Study|Sponsor's Decision|0|||
146601747|NCT01659255|528711482|FG013|Overall Study|Sponsor's Decision|0|||
146601748|NCT01659255|528711483|FG014|Overall Study|Sponsor's Decision|0|||
146601749|NCT01659255|528711484|FG015|Overall Study|Sponsor's Decision|0|||
146601750|NCT01659255|528711485|FG016|Overall Study|Sponsor's Decision|0|||
146601751|NCT01659255|528711469|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146601752|NCT01659255|528711470|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146601753|NCT01659255|528711471|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146601754|NCT01659255|528711472|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146601755|NCT01659255|528711473|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146601756|NCT01659255|528711474|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146601757|NCT01659255|528711475|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146601758|NCT01659255|528711476|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146601759|NCT01659255|528711477|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146601760|NCT01659255|528711478|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146601761|NCT01659255|528711479|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146601762|NCT01659255|528711480|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146601763|NCT01659255|528711481|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146601764|NCT01659255|528711482|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146601765|NCT01659255|528711483|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146601766|NCT01659255|528711484|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
146601767|NCT01659255|528711485|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146601768|NCT01659255|528711469|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
146601769|NCT01659255|528711470|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
146601770|NCT01659255|528711471|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
146601771|NCT01659255|528711472|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
146601772|NCT01659255|528711473|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
146601773|NCT01659255|528711474|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
146601774|NCT01659255|528711475|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
146601775|NCT01659255|528711476|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
146601776|NCT01659255|528711477|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
146601777|NCT01659255|528711478|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
146601778|NCT01659255|528711479|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
146601779|NCT01659255|528711480|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
146601780|NCT01659255|528711481|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
146601781|NCT01659255|528711482|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
146601782|NCT01659255|528711483|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
146601783|NCT01659255|528711484|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
146601784|NCT01659255|528711485|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
146601785|NCT03316950|528711486|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
146601786|NCT03316950|528711487|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
146601787|NCT03316950|528711488|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
146601788|NCT03316950|528711489|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
146601789|NCT03316950|528711486|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
146601790|NCT03316950|528711487|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
146922691|NCT01318083|529876808|FG000|Overall Study|Adverse Event|4|||
146601791|NCT03316950|528711488|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
146601792|NCT03316950|528711489|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
146922692|NCT01318083|529876809|FG001|Overall Study|Adverse Event|1|||
146656234|NCT02414139|528917931|FG000|Treatment Period|Subject/Guardian decision|5|||
146656235|NCT02414139|528917932|FG001|Treatment Period|Subject/Guardian decision|1|||
146656236|NCT02414139|528917933|FG002|Treatment Period|Subject/Guardian decision|1|||
146656237|NCT02414139|528917934|FG003|Treatment Period|Subject/Guardian decision|2|||
146656238|NCT02414139|528917935|FG004|Treatment Period|Subject/Guardian decision|5|||
146601793|NCT03316950|528711486|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
146601794|NCT03316950|528711487|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
146656239|NCT02414139|528917936|FG005|Treatment Period|Subject/Guardian decision|0|||
146656240|NCT02414139|528917937|FG006|Treatment Period|Subject/Guardian decision|2|||
146656241|NCT02414139|528917938|FG007|Treatment Period|Subject/Guardian decision|0|||
146656242|NCT02414139|528917939|FG008|Treatment Period|Subject/Guardian decision|1|||
146656243|NCT02414139|528917940|FG009|Treatment Period|Subject/Guardian decision|1|||
146656244|NCT02414139|528917931|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
146601795|NCT03316950|528711488|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
146601796|NCT03316950|528711489|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
146601797|NCT02809053|528711490|FG000|Overall Study|Death|0|||
146601798|NCT02809053|528711491|FG001|Overall Study|Death|1|||
146601799|NCT02809053|528711490|FG000|Overall Study|Lost to Follow-up|3|||
146601800|NCT02809053|528711491|FG001|Overall Study|Lost to Follow-up|1|||
146601801|NCT02809053|528711490|FG000|Overall Study|Withdrawal by Subject|2|||
146601802|NCT02809053|528711491|FG001|Overall Study|Withdrawal by Subject|3|||
146601803|NCT02809053|528711490|FG000|Overall Study|Disease Progression|2|||
146601804|NCT02809053|528711491|FG001|Overall Study|Disease Progression|1|||
146601805|NCT02565810|528711494|FG000|Overall Study|Withdrawal by Subject|1|||
146601806|NCT02049138|528711495|FG000|Overall Study|Adverse Event|46|||
146601807|NCT02049138|528711496|FG001|Overall Study|Adverse Event|25|||
146601808|NCT02049138|528711497|FG002|Overall Study|Adverse Event|1|||
146601809|NCT02049138|528711495|FG000|Overall Study|Withdrawal by Subject|57|||
146601810|NCT02049138|528711496|FG001|Overall Study|Withdrawal by Subject|21|||
146601811|NCT02049138|528711497|FG002|Overall Study|Withdrawal by Subject|5|||
146601812|NCT02049138|528711495|FG000|Overall Study|Lost to Follow-up|18|||
146601813|NCT02049138|528711496|FG001|Overall Study|Lost to Follow-up|5|||
146601814|NCT02049138|528711497|FG002|Overall Study|Lost to Follow-up|1|||
146601815|NCT02049138|528711495|FG000|Overall Study|Lack of Efficacy|10|||
146601816|NCT02049138|528711496|FG001|Overall Study|Lack of Efficacy|26|||
146601817|NCT02049138|528711497|FG002|Overall Study|Lack of Efficacy|1|||
146601818|NCT02049138|528711495|FG000|Overall Study|Non-Compliance|15|||
146601819|NCT02049138|528711496|FG001|Overall Study|Non-Compliance|6|||
146601820|NCT02049138|528711497|FG002|Overall Study|Non-Compliance|0|||
146601821|NCT02049138|528711495|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
146601822|NCT02049138|528711496|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
146601823|NCT02049138|528711497|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
146601824|NCT02049138|528711495|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
146601825|NCT02049138|528711496|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
146601826|NCT02049138|528711497|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
146601827|NCT02049138|528711495|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
146601828|NCT02049138|528711496|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
146601829|NCT02049138|528711497|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
146601830|NCT02049138|528711495|FG000|Overall Study|Other|15|||
146601831|NCT02049138|528711496|FG001|Overall Study|Other|13|||
146601832|NCT02049138|528711497|FG002|Overall Study|Other|0|||
146601833|NCT02049138|528711495|FG000|Overall Study|Missing|0|||
146601834|NCT02049138|528711496|FG001|Overall Study|Missing|1|||
146601835|NCT02049138|528711497|FG002|Overall Study|Missing|0|||
146601836|NCT00491608|528711498|FG000|Overall Study|Death|2|||
146601837|NCT00491608|528711498|FG000|Overall Study|Withdrawal by Subject|1|||
146601838|NCT00257660|528711499|FG000|Overall Study|Lack of Efficacy|5|||
146601839|NCT00257660|528711500|FG001|Overall Study|Lack of Efficacy|23|||
146601840|NCT00257660|528711499|FG000|Overall Study|Withdrawal by Subject|2|||
146656245|NCT02414139|528917932|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
146656246|NCT02414139|528917933|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
146656247|NCT02414139|528917934|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
146656248|NCT02414139|528917935|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
146656249|NCT02414139|528917936|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
146772398|NCT01636687|529335917|FG004|Extension Period|Lack of Efficacy|0|||
146601841|NCT00257660|528711500|FG001|Overall Study|Withdrawal by Subject|0|||
146601842|NCT00257660|528711499|FG000|Overall Study|Lost to Follow-up|1|||
146772399|NCT01636687|529335913|FG000|Extension Period|Lost to Follow-up|1|||
146772400|NCT01636687|529335914|FG001|Extension Period|Lost to Follow-up|0|||
146601843|NCT00257660|528711500|FG001|Overall Study|Lost to Follow-up|0|||
146601844|NCT00257660|528711499|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
146601845|NCT00257660|528711500|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
146601846|NCT00257660|528711499|FG000|Overall Study|No longer wanted to do blood draws|1|||
146601847|NCT00257660|528711500|FG001|Overall Study|No longer wanted to do blood draws|0|||
146601848|NCT00413374|528711505|FG000|Overall Study|Ineligible due to screening criteria.|3|||
146601849|NCT00413374|528711506|FG001|Overall Study|Ineligible due to screening criteria.|0|||
146601850|NCT00413374|528711505|FG000|Overall Study|Adverse Event|1|||
146601851|NCT00413374|528711506|FG001|Overall Study|Adverse Event|0|||
146601852|NCT00413374|528711505|FG000|Overall Study|Lost to Follow-up|1|||
146601853|NCT00413374|528711506|FG001|Overall Study|Lost to Follow-up|0|||
146601854|NCT00413374|528711505|FG000|Overall Study|Surgery|1|||
146601855|NCT00413374|528711506|FG001|Overall Study|Surgery|0|||
146601856|NCT00552760|528711507|FG000|Overall Study|Adverse Event|3|||
146601857|NCT00552760|528711508|FG001|Overall Study|Adverse Event|5|||
146601858|NCT00552760|528711507|FG000|Overall Study|Relapsed- Depressed Event|10|||
146601859|NCT00552760|528711508|FG001|Overall Study|Relapsed- Depressed Event|16|||
146601860|NCT00552760|528711507|FG000|Overall Study|Relapse- Manic Event|3|||
146601861|NCT00552760|528711508|FG001|Overall Study|Relapse- Manic Event|3|||
146601862|NCT00552760|528711507|FG000|Overall Study|Relapsed- Mixed Event|3|||
146601863|NCT00552760|528711508|FG001|Overall Study|Relapsed- Mixed Event|5|||
146601864|NCT00552760|528711507|FG000|Overall Study|Protocol Violation|0|||
146601865|NCT00552760|528711508|FG001|Overall Study|Protocol Violation|1|||
146601866|NCT00552760|528711507|FG000|Overall Study|Lost to Follow-up|1|||
146601867|NCT00552760|528711508|FG001|Overall Study|Lost to Follow-up|1|||
146601868|NCT00552760|528711507|FG000|Overall Study|Non-compliance|1|||
146601869|NCT00552760|528711508|FG001|Overall Study|Non-compliance|1|||
146601870|NCT00552760|528711507|FG000|Overall Study|Medical Condition|1|||
146601871|NCT00552760|528711508|FG001|Overall Study|Medical Condition|1|||
146601872|NCT00552760|528711507|FG000|Overall Study|Withdrawal by Subject|3|||
146601873|NCT00552760|528711508|FG001|Overall Study|Withdrawal by Subject|0|||
146601874|NCT00552760|528711507|FG000|Overall Study|Medication Change|1|||
146601875|NCT00552760|528711508|FG001|Overall Study|Medication Change|0|||
146601876|NCT03022981|528711509|FG000|Overall Study|Adverse Event|0|||
146601877|NCT03022981|528711510|FG001|Overall Study|Adverse Event|1|||
146601878|NCT03022981|528711511|FG002|Overall Study|Adverse Event|0|||
146601879|NCT03022981|528711509|FG000|Overall Study|Investigator's Discretion|0|||
146601880|NCT03022981|528711510|FG001|Overall Study|Investigator's Discretion|1|||
146601881|NCT03022981|528711511|FG002|Overall Study|Investigator's Discretion|2|||
146601882|NCT03022981|528711509|FG000|Overall Study|Lost to Follow-up|6|||
146601883|NCT03022981|528711510|FG001|Overall Study|Lost to Follow-up|2|||
146601884|NCT03022981|528711511|FG002|Overall Study|Lost to Follow-up|1|||
146601885|NCT03022981|528711509|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146601886|NCT03022981|528711510|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146601887|NCT03022981|528711511|FG002|Overall Study|Non-Compliance With Study Drug|2|||
146601888|NCT03022981|528711509|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
146601889|NCT03022981|528711510|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
146601890|NCT03022981|528711511|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
146601891|NCT03615066|528711512|FG000|Main Study|Withdrew Consent|0|||
146601892|NCT03615066|528711513|FG001|Main Study|Withdrew Consent|1|||
146601893|NCT03615066|528711514|FG002|Main Study|Withdrew Consent|1|||
146601894|NCT03615066|528711512|FG000|Main Study|Lost to Follow-up|0|||
146601895|NCT03615066|528711513|FG001|Main Study|Lost to Follow-up|0|||
146601896|NCT03615066|528711514|FG002|Main Study|Lost to Follow-up|1|||
146601897|NCT03615066|528711512|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
146601898|NCT03615066|528711513|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
146601899|NCT03615066|528711514|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
146601900|NCT03615066|528711512|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
146601901|NCT03615066|528711513|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
146601902|NCT03615066|528711514|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
146601903|NCT03615066|528711512|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
146601904|NCT03615066|528711513|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
146601905|NCT03615066|528711514|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
146601906|NCT00924404|528711515|FG000|Overall Study|Lost to Follow-up|6|||
146601907|NCT00924404|528711516|FG001|Overall Study|Lost to Follow-up|4|||
146601908|NCT02437084|528711517|FG000|Overall Study|Withdrawal by Subject|2|||
146601909|NCT02437084|528711517|FG000|Overall Study|Physician Decision|1|||
146601910|NCT01571453|528711518|FG000|Overall Study|Adverse Event|14|||
146601911|NCT01571453|528711519|FG001|Overall Study|Adverse Event|32|||
146601912|NCT01571453|528711518|FG000|Overall Study|Lack of Efficacy|8|||
146601913|NCT01571453|528711519|FG001|Overall Study|Lack of Efficacy|3|||
146922693|NCT01318083|529876810|FG002|Overall Study|Adverse Event|2|||
146601914|NCT01571453|528711518|FG000|Overall Study|Non-compliance|2|||
146601915|NCT01571453|528711519|FG001|Overall Study|Non-compliance|4|||
146601916|NCT01571453|528711518|FG000|Overall Study|Protocol Violation|1|||
146601917|NCT01571453|528711519|FG001|Overall Study|Protocol Violation|5|||
146601918|NCT01571453|528711518|FG000|Overall Study|Withdrawal of consent|5|||
146601919|NCT01571453|528711519|FG001|Overall Study|Withdrawal of consent|13|||
146601920|NCT01571453|528711518|FG000|Overall Study|Lost to Follow-up|4|||
146601921|NCT01571453|528711519|FG001|Overall Study|Lost to Follow-up|2|||
146922694|NCT01318083|529876808|FG000|Overall Study|Withdrawal by Subject|1|||
146772401|NCT01636687|529335915|FG002|Extension Period|Lost to Follow-up|1|||
146772402|NCT01636687|529335916|FG003|Extension Period|Lost to Follow-up|0|||
146772403|NCT01636687|529335917|FG004|Extension Period|Lost to Follow-up|0|||
146772404|NCT01636687|529335913|FG000|Extension Period|Physician Decision|1|||
146772405|NCT01636687|529335914|FG001|Extension Period|Physician Decision|0|||
146772406|NCT01636687|529335915|FG002|Extension Period|Physician Decision|0|||
146772407|NCT01636687|529335916|FG003|Extension Period|Physician Decision|1|||
146772408|NCT01636687|529335917|FG004|Extension Period|Physician Decision|0|||
146772409|NCT01636687|529335913|FG000|Extension Period|study terminated by sponsor|33|||
146772410|NCT01636687|529335914|FG001|Extension Period|study terminated by sponsor|50|||
146772411|NCT01636687|529335915|FG002|Extension Period|study terminated by sponsor|17|||
146772412|NCT01636687|529335916|FG003|Extension Period|study terminated by sponsor|23|||
146772413|NCT01636687|529335917|FG004|Extension Period|study terminated by sponsor|0|||
146772414|NCT01636687|529335913|FG000|Extension Period|Withdrawal by Subject|1|||
146772415|NCT01636687|529335914|FG001|Extension Period|Withdrawal by Subject|0|||
146772416|NCT01636687|529335915|FG002|Extension Period|Withdrawal by Subject|1|||
146772417|NCT01636687|529335916|FG003|Extension Period|Withdrawal by Subject|1|||
146772418|NCT01636687|529335917|FG004|Extension Period|Withdrawal by Subject|0|||
146772419|NCT01636687|529335913|FG000|Follow-up Period|Withdrawal by Subject|1|||
146772420|NCT01636687|529335914|FG001|Follow-up Period|Withdrawal by Subject|0|||
146772421|NCT01636687|529335915|FG002|Follow-up Period|Withdrawal by Subject|0|||
146601922|NCT01571453|528711518|FG000|Overall Study|Administrative or other reason(s)|4|||
146601923|NCT01571453|528711519|FG001|Overall Study|Administrative or other reason(s)|3|||
146601924|NCT00129961|528711520|FG000|Overall Study|Adverse Event|1|||
146601925|NCT00129961|528711521|FG001|Overall Study|Adverse Event|0|||
146601926|NCT00129961|528711520|FG000|Overall Study|Death|1|||
146601927|NCT00129961|528711521|FG001|Overall Study|Death|1|||
146601928|NCT00129961|528711520|FG000|Overall Study|Withdrawal by Sponsor|14|||
146601929|NCT00129961|528711521|FG001|Overall Study|Withdrawal by Sponsor|20|||
146601930|NCT00129961|528711520|FG000|Overall Study|Physician Decision|1|||
146601931|NCT00129961|528711521|FG001|Overall Study|Physician Decision|0|||
146601932|NCT00129961|528711520|FG000|Overall Study|Withdrawal by Subject|2|||
146601933|NCT00129961|528711521|FG001|Overall Study|Withdrawal by Subject|1|||
146601934|NCT00129961|528711520|FG000|Overall Study|Missing Record|0|||
146601935|NCT00129961|528711521|FG001|Overall Study|Missing Record|1|||
146601936|NCT01985360|528711522|FG000|Overall Study|Withdrawal by Subject|4|||
146601937|NCT01985360|528711523|FG001|Overall Study|Withdrawal by Subject|0|||
146601938|NCT01985360|528711522|FG000|Overall Study|Lost to Follow-up|5|||
146601939|NCT01985360|528711523|FG001|Overall Study|Lost to Follow-up|3|||
146601940|NCT03691779|528711528|FG000|Part B (24 Weeks)|Adverse Event|0|||
146601941|NCT03691779|528711529|FG001|Part B (24 Weeks)|Adverse Event|1|||
146601942|NCT03691779|528711528|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
146601943|NCT03691779|528711529|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
146601944|NCT03869333|528711534|FG000|Overall Study|Lost to Follow-up|1|||
146601945|NCT03869333|528711535|FG001|Overall Study|Lost to Follow-up|0|||
146601946|NCT03869333|528711536|FG002|Overall Study|Lost to Follow-up|0|||
146601947|NCT03869333|528711537|FG003|Overall Study|Lost to Follow-up|0|||
146601948|NCT03869333|528711534|FG000|Overall Study|Pregnancy|1|||
146601949|NCT03869333|528711535|FG001|Overall Study|Pregnancy|0|||
146601950|NCT03869333|528711536|FG002|Overall Study|Pregnancy|0|||
146601951|NCT03869333|528711537|FG003|Overall Study|Pregnancy|0|||
146601952|NCT03869333|528711534|FG000|Overall Study|Physician Decision|0|||
146601953|NCT03869333|528711535|FG001|Overall Study|Physician Decision|1|||
146601954|NCT03869333|528711536|FG002|Overall Study|Physician Decision|0|||
146601955|NCT03869333|528711537|FG003|Overall Study|Physician Decision|0|||
146601956|NCT01459913|528711538|FG000|Overall Study|Adverse Event|0|||
146601957|NCT01459913|528711539|FG001|Overall Study|Adverse Event|0|||
146601958|NCT01459913|528711540|FG002|Overall Study|Adverse Event|0|||
146601959|NCT01459913|528711541|FG003|Overall Study|Adverse Event|3|||
146601960|NCT01459913|528711538|FG000|Overall Study|Withdrawal by Subject|4|||
146601961|NCT01459913|528711539|FG001|Overall Study|Withdrawal by Subject|0|||
146601962|NCT01459913|528711540|FG002|Overall Study|Withdrawal by Subject|0|||
146601963|NCT01459913|528711541|FG003|Overall Study|Withdrawal by Subject|5|||
146601964|NCT01459913|528711538|FG000|Overall Study|Lost to Follow-up|7|||
146601965|NCT01459913|528711539|FG001|Overall Study|Lost to Follow-up|4|||
146601966|NCT01459913|528711540|FG002|Overall Study|Lost to Follow-up|1|||
146601967|NCT01459913|528711541|FG003|Overall Study|Lost to Follow-up|8|||
146601968|NCT01459913|528711538|FG000|Overall Study|Death|0|||
146601969|NCT01459913|528711539|FG001|Overall Study|Death|0|||
146601970|NCT01459913|528711540|FG002|Overall Study|Death|0|||
146601971|NCT01459913|528711541|FG003|Overall Study|Death|1|||
146601972|NCT01459913|528711538|FG000|Overall Study|Non- Compliance|0|||
146601973|NCT01459913|528711539|FG001|Overall Study|Non- Compliance|0|||
146601974|NCT01459913|528711540|FG002|Overall Study|Non- Compliance|0|||
146601975|NCT01459913|528711541|FG003|Overall Study|Non- Compliance|3|||
146772422|NCT01636687|529335916|FG003|Follow-up Period|Withdrawal by Subject|0|||
146772423|NCT01636687|529335917|FG004|Follow-up Period|Withdrawal by Subject|1|||
146772424|NCT02918279|529335920|FG000|Overall Study|Lost to Follow-up|3|||
146601976|NCT01459913|528711538|FG000|Overall Study|Physician Decision|0|||
146601977|NCT01459913|528711539|FG001|Overall Study|Physician Decision|1|||
146601978|NCT01459913|528711540|FG002|Overall Study|Physician Decision|0|||
146601979|NCT01459913|528711541|FG003|Overall Study|Physician Decision|0|||
146601980|NCT01459913|528711538|FG000|Overall Study|Study Terminated by Sponsor|30|||
146601981|NCT01459913|528711539|FG001|Overall Study|Study Terminated by Sponsor|15|||
146601982|NCT01459913|528711540|FG002|Overall Study|Study Terminated by Sponsor|9|||
146601983|NCT01459913|528711541|FG003|Overall Study|Study Terminated by Sponsor|11|||
146601984|NCT01459913|528711538|FG000|Overall Study|Other|0|||
146601985|NCT01459913|528711539|FG001|Overall Study|Other|0|||
146601986|NCT01459913|528711540|FG002|Overall Study|Other|3|||
146601987|NCT01459913|528711541|FG003|Overall Study|Other|1|||
146601988|NCT01459913|528711538|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
146601989|NCT01459913|528711539|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
146601990|NCT01459913|528711540|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
146601991|NCT01459913|528711541|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
146601992|NCT01064687|528711544|FG000|Overall Study|Adverse Event|9|||
146601993|NCT01064687|528711545|FG001|Overall Study|Adverse Event|4|||
146601994|NCT01064687|528711546|FG002|Overall Study|Adverse Event|10|||
146601995|NCT01064687|528711547|FG003|Overall Study|Adverse Event|3|||
146601996|NCT01064687|528711544|FG000|Overall Study|Death|1|||
146601997|NCT01064687|528711545|FG001|Overall Study|Death|1|||
146601998|NCT01064687|528711546|FG002|Overall Study|Death|0|||
146601999|NCT01064687|528711547|FG003|Overall Study|Death|0|||
146602000|NCT01064687|528711544|FG000|Overall Study|Entry Criteria Not Met|3|||
146602001|NCT01064687|528711545|FG001|Overall Study|Entry Criteria Not Met|0|||
146602002|NCT01064687|528711546|FG002|Overall Study|Entry Criteria Not Met|0|||
146602003|NCT01064687|528711547|FG003|Overall Study|Entry Criteria Not Met|0|||
146602004|NCT01064687|528711544|FG000|Overall Study|Lack of Efficacy|1|||
146602005|NCT01064687|528711545|FG001|Overall Study|Lack of Efficacy|0|||
146602006|NCT01064687|528711546|FG002|Overall Study|Lack of Efficacy|2|||
146602007|NCT01064687|528711547|FG003|Overall Study|Lack of Efficacy|3|||
146602008|NCT01064687|528711544|FG000|Overall Study|Lost to Follow-up|7|||
146602009|NCT01064687|528711545|FG001|Overall Study|Lost to Follow-up|10|||
146602010|NCT01064687|528711546|FG002|Overall Study|Lost to Follow-up|13|||
146602011|NCT01064687|528711547|FG003|Overall Study|Lost to Follow-up|5|||
146602012|NCT01064687|528711544|FG000|Overall Study|Physician Decision|2|||
146602013|NCT01064687|528711545|FG001|Overall Study|Physician Decision|2|||
146602014|NCT01064687|528711546|FG002|Overall Study|Physician Decision|0|||
146602015|NCT01064687|528711547|FG003|Overall Study|Physician Decision|0|||
146602016|NCT01064687|528711544|FG000|Overall Study|Protocol Violation|1|||
146602017|NCT01064687|528711545|FG001|Overall Study|Protocol Violation|1|||
146602018|NCT01064687|528711546|FG002|Overall Study|Protocol Violation|0|||
146602019|NCT01064687|528711547|FG003|Overall Study|Protocol Violation|1|||
146602020|NCT01064687|528711544|FG000|Overall Study|Sponsor Decision|0|||
146602021|NCT01064687|528711545|FG001|Overall Study|Sponsor Decision|0|||
146602022|NCT01064687|528711546|FG002|Overall Study|Sponsor Decision|3|||
146602023|NCT01064687|528711547|FG003|Overall Study|Sponsor Decision|0|||
146602024|NCT01064687|528711544|FG000|Overall Study|Withdrawal by Subject|9|||
146602025|NCT01064687|528711545|FG001|Overall Study|Withdrawal by Subject|7|||
146602026|NCT01064687|528711546|FG002|Overall Study|Withdrawal by Subject|12|||
146602027|NCT01064687|528711547|FG003|Overall Study|Withdrawal by Subject|5|||
146602028|NCT01064687|528711544|FG000|Overall Study|Treatment Noncompliance|1|||
146602029|NCT01064687|528711545|FG001|Overall Study|Treatment Noncompliance|1|||
146602030|NCT01064687|528711546|FG002|Overall Study|Treatment Noncompliance|1|||
146602031|NCT01064687|528711547|FG003|Overall Study|Treatment Noncompliance|0|||
146602032|NCT02966015|528711548|FG000|Inclusion Visit|did not answer questionnaire|8|||
146656250|NCT02414139|528917937|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
146656251|NCT02414139|528917938|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
146656252|NCT02414139|528917939|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
146602033|NCT02966015|528711549|FG001|Inclusion Visit|did not answer questionnaire|3|||
146602034|NCT02039856|528711552|FG000|Overall Study|Death|5|||
146602035|NCT02039856|528711553|FG001|Overall Study|Death|3|||
146602036|NCT02039856|528711552|FG000|Overall Study|Partial survey completion|61|||
146602037|NCT02039856|528711553|FG001|Overall Study|Partial survey completion|26|||
146602038|NCT02039856|528711552|FG000|Overall Study|Lost to Follow-up|388|||
146602039|NCT02039856|528711553|FG001|Overall Study|Lost to Follow-up|206|||
146602040|NCT02039856|528711552|FG000|Overall Study|Withdrawal by Subject|1573|||
146602041|NCT02039856|528711553|FG001|Overall Study|Withdrawal by Subject|618|||
146602042|NCT02540291|528711554|FG000|Overall Study|Death|7|||
146602043|NCT02540291|528711555|FG001|Overall Study|Death|7|||
146602044|NCT02540291|528711556|FG002|Overall Study|Death|5|||
146602045|NCT02540291|528711557|FG003|Overall Study|Death|7|||
146602046|NCT02540291|528711554|FG000|Overall Study|Lost to Follow-up|0|||
146602047|NCT02540291|528711555|FG001|Overall Study|Lost to Follow-up|0|||
146602048|NCT02540291|528711556|FG002|Overall Study|Lost to Follow-up|1|||
146602049|NCT02540291|528711557|FG003|Overall Study|Lost to Follow-up|0|||
146602050|NCT02540291|528711554|FG000|Overall Study|Withdrawal Of Consent|0|||
146602051|NCT02540291|528711555|FG001|Overall Study|Withdrawal Of Consent|1|||
146656253|NCT02414139|528917940|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
146602052|NCT02540291|528711556|FG002|Overall Study|Withdrawal Of Consent|0|||
146602053|NCT02540291|528711557|FG003|Overall Study|Withdrawal Of Consent|0|||
146602054|NCT02540291|528711554|FG000|Overall Study|Study Terminated By Sponsor|1|||
146602055|NCT02540291|528711555|FG001|Overall Study|Study Terminated By Sponsor|0|||
146602056|NCT02540291|528711556|FG002|Overall Study|Study Terminated By Sponsor|0|||
146602057|NCT02540291|528711557|FG003|Overall Study|Study Terminated By Sponsor|0|||
146602058|NCT02540291|528711554|FG000|Overall Study|Other|0|||
146602059|NCT02540291|528711555|FG001|Overall Study|Other|0|||
146602060|NCT02540291|528711556|FG002|Overall Study|Other|1|||
146602061|NCT02540291|528711557|FG003|Overall Study|Other|0|||
146602062|NCT02666105|528711567|FG000|Overall Study|Death|1|||
146602063|NCT02806960|528713534|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
146602064|NCT02806960|528713535|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
146602065|NCT02806960|528713536|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
146602066|NCT02806960|528713537|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
146602067|NCT01769196|528713538|FG000|Overall Study|Adverse Event|24|||
146602068|NCT01769196|528713539|FG001|Overall Study|Adverse Event|20|||
146602069|NCT01769196|528713538|FG000|Overall Study|Death|21|||
146602070|NCT01769196|528713539|FG001|Overall Study|Death|26|||
146602071|NCT01769196|528713538|FG000|Overall Study|Investigator Discretion|7|||
146602072|NCT01769196|528713539|FG001|Overall Study|Investigator Discretion|3|||
146602073|NCT01769196|528713538|FG000|Overall Study|Lack of Efficacy|3|||
146602074|NCT01769196|528713539|FG001|Overall Study|Lack of Efficacy|2|||
146602075|NCT01769196|528713538|FG000|Overall Study|Progressive disease|11|||
146602076|NCT01769196|528713539|FG001|Overall Study|Progressive disease|6|||
146602077|NCT01769196|528713538|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
146602078|NCT01769196|528713539|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
146602079|NCT01769196|528713538|FG000|Overall Study|Protocol Violation|0|||
146602080|NCT01769196|528713539|FG001|Overall Study|Protocol Violation|3|||
146602081|NCT01769196|528713538|FG000|Overall Study|Study terminated by sponsor|160|||
146602082|NCT01769196|528713539|FG001|Overall Study|Study terminated by sponsor|161|||
146602083|NCT01769196|528713538|FG000|Overall Study|Participant never dosed with study drug|1|||
146602084|NCT01769196|528713539|FG001|Overall Study|Participant never dosed with study drug|0|||
146602085|NCT01769196|528713538|FG000|Overall Study|Withdrew consent|36|||
146602086|NCT01769196|528713539|FG001|Overall Study|Withdrew consent|40|||
146602087|NCT00126776|528713540|FG000|Overall Study|follow up complete on all patients|0|||
146602088|NCT00126776|528713541|FG001|Overall Study|follow up complete on all patients|0|||
146602089|NCT01272869|528713553|FG000|Period 2 (14 Days)|Adverse Event|1|||
146602090|NCT01272869|528713554|FG001|Period 2 (14 Days)|Adverse Event|0|||
146602091|NCT00771615|528713555|FG000|Overall Study|Withdrawal by Subject|0|||
146602092|NCT00771615|528713556|FG001|Overall Study|Withdrawal by Subject|1|||
146602093|NCT00771615|528713557|FG002|Overall Study|Withdrawal by Subject|0|||
146602094|NCT00771615|528713558|FG003|Overall Study|Withdrawal by Subject|0|||
146602095|NCT00771615|528713559|FG004|Overall Study|Withdrawal by Subject|0|||
146602096|NCT00771615|528713560|FG005|Overall Study|Withdrawal by Subject|0|||
146602097|NCT00771615|528713561|FG006|Overall Study|Withdrawal by Subject|0|||
146602098|NCT00771615|528713562|FG007|Overall Study|Withdrawal by Subject|1|||
146602099|NCT00771615|528713563|FG008|Overall Study|Withdrawal by Subject|0|||
146602100|NCT00771615|528713555|FG000|Overall Study|Lost to Follow-up|1|||
146602101|NCT00771615|528713556|FG001|Overall Study|Lost to Follow-up|1|||
146602102|NCT00771615|528713557|FG002|Overall Study|Lost to Follow-up|1|||
146602103|NCT00771615|528713558|FG003|Overall Study|Lost to Follow-up|1|||
146602104|NCT00771615|528713559|FG004|Overall Study|Lost to Follow-up|0|||
146602105|NCT00771615|528713560|FG005|Overall Study|Lost to Follow-up|1|||
146602106|NCT00771615|528713561|FG006|Overall Study|Lost to Follow-up|1|||
146602107|NCT00771615|528713562|FG007|Overall Study|Lost to Follow-up|0|||
146602108|NCT00771615|528713563|FG008|Overall Study|Lost to Follow-up|0|||
146602109|NCT02455076|528713564|FG000|Inpatient|Withdrawal by Subject|1|||
146602110|NCT02455076|528713565|FG001|Inpatient|Withdrawal by Subject|0|||
146602111|NCT02455076|528713566|FG002|Inpatient|Withdrawal by Subject|0|||
146602112|NCT02455076|528713567|FG003|Inpatient|Withdrawal by Subject|0|||
146602113|NCT02455076|528713568|FG004|Inpatient|Withdrawal by Subject|0|||
146602114|NCT02455076|528713564|FG000|Inpatient|Discharged <24 h after admission|0|||
146602115|NCT02455076|528713565|FG001|Inpatient|Discharged <24 h after admission|1|||
146602116|NCT02455076|528713566|FG002|Inpatient|Discharged <24 h after admission|0|||
146656254|NCT02414139|528917931|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
146602117|NCT02455076|528713567|FG003|Inpatient|Discharged <24 h after admission|0|||
146602118|NCT02455076|528713568|FG004|Inpatient|Discharged <24 h after admission|0|||
146602119|NCT02455076|528713564|FG000|Inpatient|Adverse Event|3|||
146602120|NCT02455076|528713565|FG001|Inpatient|Adverse Event|0|||
146602121|NCT02455076|528713566|FG002|Inpatient|Adverse Event|0|||
146602122|NCT02455076|528713567|FG003|Inpatient|Adverse Event|0|||
146602123|NCT02455076|528713568|FG004|Inpatient|Adverse Event|0|||
146602124|NCT02455076|528713564|FG000|Outpatient|Adverse Event|0|||
146772425|NCT02918279|529335921|FG001|Overall Study|Lost to Follow-up|6|||
146602125|NCT02455076|528713565|FG001|Outpatient|Adverse Event|0|||
146602126|NCT02455076|528713566|FG002|Outpatient|Adverse Event|0|||
146922695|NCT01318083|529876809|FG001|Overall Study|Withdrawal by Subject|0|||
146602127|NCT02455076|528713567|FG003|Outpatient|Adverse Event|5|||
146602128|NCT02455076|528713568|FG004|Outpatient|Adverse Event|0|||
146602129|NCT02455076|528713564|FG000|Outpatient|Lost to Follow-up|0|||
146602130|NCT02455076|528713565|FG001|Outpatient|Lost to Follow-up|0|||
146602131|NCT02455076|528713566|FG002|Outpatient|Lost to Follow-up|0|||
146602132|NCT02455076|528713567|FG003|Outpatient|Lost to Follow-up|1|||
146602133|NCT02455076|528713568|FG004|Outpatient|Lost to Follow-up|12|||
146602134|NCT00859937|528713569|FG000|Overall Study|Protocol Violation|1|||
146602135|NCT00859937|528713570|FG001|Overall Study|Protocol Violation|0|||
146602136|NCT03908476|528713571|FG000|Overall Study|Death|3|||
146602137|NCT03908476|528713572|FG001|Overall Study|Death|0|||
146602138|NCT03908476|528713571|FG000|Overall Study|Lost to Follow-up|3|||
146602139|NCT03908476|528713572|FG001|Overall Study|Lost to Follow-up|1|||
146602140|NCT03908476|528713571|FG000|Overall Study|Withdrawal by Subject|7|||
146602141|NCT03908476|528713572|FG001|Overall Study|Withdrawal by Subject|1|||
146602142|NCT03908476|528713571|FG000|Overall Study|Physician Decision|2|||
146602143|NCT03908476|528713572|FG001|Overall Study|Physician Decision|0|||
146602144|NCT03908476|528713571|FG000|Overall Study|System Explanted and not Replaced|4|||
146602145|NCT03908476|528713572|FG001|Overall Study|System Explanted and not Replaced|0|||
146602146|NCT03908476|528713571|FG000|Overall Study|Intrathecal Pump|1|||
146656255|NCT02414139|528917932|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146656256|NCT02414139|528917933|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146656257|NCT02414139|528917934|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146656258|NCT02414139|528917935|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
146656259|NCT02414139|528917936|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146656260|NCT02414139|528917937|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146656261|NCT02414139|528917938|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146656262|NCT02414139|528917939|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146656263|NCT02414139|528917940|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146656264|NCT02414139|528917931|FG000|Post-treatment Efficacy Follow-up|Death|0|||
146656265|NCT02414139|528917932|FG001|Post-treatment Efficacy Follow-up|Death|1|||
146656266|NCT02414139|528917933|FG002|Post-treatment Efficacy Follow-up|Death|0|||
146656267|NCT02414139|528917934|FG003|Post-treatment Efficacy Follow-up|Death|0|||
146656268|NCT02414139|528917935|FG004|Post-treatment Efficacy Follow-up|Death|1|||
146656269|NCT02414139|528917936|FG005|Post-treatment Efficacy Follow-up|Death|0|||
146656270|NCT02414139|528917937|FG006|Post-treatment Efficacy Follow-up|Death|0|||
146656271|NCT02414139|528917938|FG007|Post-treatment Efficacy Follow-up|Death|0|||
146656272|NCT02414139|528917939|FG008|Post-treatment Efficacy Follow-up|Death|0|||
146656273|NCT02414139|528917940|FG009|Post-treatment Efficacy Follow-up|Death|1|||
146656274|NCT02414139|528917931|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
146656275|NCT02414139|528917932|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146656276|NCT02414139|528917933|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146656277|NCT02414139|528917934|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146656278|NCT02414139|528917935|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146656279|NCT02414139|528917936|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146656280|NCT02414139|528917937|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146656281|NCT02414139|528917938|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146656282|NCT02414139|528917939|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146656283|NCT02414139|528917940|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146656284|NCT02414139|528917931|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
146656285|NCT02414139|528917932|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
146656286|NCT02414139|528917933|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
146656287|NCT02414139|528917934|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
146656288|NCT02414139|528917935|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
146656289|NCT02414139|528917936|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
146656290|NCT02414139|528917937|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
146656291|NCT02414139|528917938|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
146656292|NCT02414139|528917939|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
146656293|NCT02414139|528917940|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
146656294|NCT02414139|528917931|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
146656295|NCT02414139|528917932|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
146922696|NCT01318083|529876810|FG002|Overall Study|Withdrawal by Subject|2|||
146922697|NCT01318083|529876808|FG000|Overall Study|Lack of Efficacy|0|||
146922698|NCT01318083|529876809|FG001|Overall Study|Lack of Efficacy|0|||
146922699|NCT01318083|529876810|FG002|Overall Study|Lack of Efficacy|1|||
146922700|NCT01318083|529876808|FG000|Overall Study|Treatment Complications|1|||
146602147|NCT03908476|528713572|FG001|Overall Study|Intrathecal Pump|0|||
146602148|NCT03908476|528713571|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
146602149|NCT03908476|528713572|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
146602150|NCT05194267|528713573|FG000|Overall Study|Withdrawal by Subject|2|||
146602151|NCT02868229|528713574|FG000|Overall Study|Adverse Event|1|||
146772426|NCT02918279|529335920|FG000|Overall Study|Withdrawal by Subject|5|||
146772427|NCT02918279|529335921|FG001|Overall Study|Withdrawal by Subject|15|||
146772428|NCT02918279|529335920|FG000|Overall Study|Withdrawal by parent/guardian|2|||
146772429|NCT02918279|529335921|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146772430|NCT02918279|529335920|FG000|Overall Study|Other|3|||
146772431|NCT02918279|529335921|FG001|Overall Study|Other|1|||
146772432|NCT00244855|529335922|FG000|Overall Study|Withdrawal by Subject|0|||
146772433|NCT00244855|529335923|FG001|Overall Study|Withdrawal by Subject|1|||
146772434|NCT00636207|529335924|FG000|Overall Study|Adverse Event|1|||
146772435|NCT00636207|529335925|FG001|Overall Study|Adverse Event|0|||
146772436|NCT00636207|529335926|FG002|Overall Study|Adverse Event|0|||
146772437|NCT00636207|529335927|FG003|Overall Study|Adverse Event|0|||
146772438|NCT00636207|529335928|FG004|Overall Study|Adverse Event|0|||
146772439|NCT00636207|529335929|FG005|Overall Study|Adverse Event|0|||
146772440|NCT00636207|529335930|FG006|Overall Study|Adverse Event|0|||
146772441|NCT00636207|529335924|FG000|Overall Study|Withdrawal by Subject|0|||
146772442|NCT00636207|529335925|FG001|Overall Study|Withdrawal by Subject|1|||
146772443|NCT00636207|529335926|FG002|Overall Study|Withdrawal by Subject|0|||
146772444|NCT00636207|529335927|FG003|Overall Study|Withdrawal by Subject|0|||
146772445|NCT00636207|529335928|FG004|Overall Study|Withdrawal by Subject|1|||
146772446|NCT00636207|529335929|FG005|Overall Study|Withdrawal by Subject|0|||
146772447|NCT00636207|529335930|FG006|Overall Study|Withdrawal by Subject|0|||
146772448|NCT01641198|529335931|FG000|After 12 Months of Function|Lost to Follow-up|3|||
146772449|NCT01641198|529335932|FG001|After 12 Months of Function|Lost to Follow-up|2|||
146772450|NCT01641198|529335933|FG002|After 12 Months of Function|Lost to Follow-up|2|||
146772451|NCT01641198|529335931|FG000|After 12 Months of Function|Protocol Violation|1|||
146772452|NCT01641198|529335932|FG001|After 12 Months of Function|Protocol Violation|0|||
146772453|NCT01641198|529335933|FG002|After 12 Months of Function|Protocol Violation|0|||
146772454|NCT01641198|529335931|FG000|After 12 Months of Function|Adverse Event|0|||
146772455|NCT01641198|529335932|FG001|After 12 Months of Function|Adverse Event|1|||
146772456|NCT01641198|529335933|FG002|After 12 Months of Function|Adverse Event|0|||
146772457|NCT01641198|529335931|FG000|After 24 Months of Function|Lost to Follow-up|4|||
146772458|NCT01641198|529335932|FG001|After 24 Months of Function|Lost to Follow-up|9|||
146772459|NCT01641198|529335933|FG002|After 24 Months of Function|Lost to Follow-up|6|||
146772460|NCT01641198|529335931|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
146772461|NCT01641198|529335932|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
146772462|NCT01641198|529335933|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
146772463|NCT01641198|529335931|FG000|At 15-20 Years of Function|Death|1|||
146772464|NCT01641198|529335932|FG001|At 15-20 Years of Function|Death|0|||
146772465|NCT01641198|529335933|FG002|At 15-20 Years of Function|Death|1|||
146772466|NCT02529995|529335934|FG000|Part A|Ongoing Study at Data Cut-off|14|||
146772467|NCT02529995|529335935|FG001|Part A|Ongoing Study at Data Cut-off|16|||
146772468|NCT02529995|529335934|FG000|Part A|Discontinued Study|1|||
146772469|NCT02529995|529335935|FG001|Part A|Discontinued Study|0|||
146772470|NCT02529995|529335934|FG000|Part B|Ongoing Study at Data Cut-off|0|||
146772471|NCT02529995|529335935|FG001|Part B|Ongoing Study at Data Cut-off|7|||
146772472|NCT02529995|529335934|FG000|Part B|Discontinued Study|6|||
146772473|NCT02529995|529335935|FG001|Part B|Discontinued Study|5|||
146772474|NCT03737240|529335942|FG000|Overall Study|Lost to Follow-up|16|||
146772475|NCT03737240|529335943|FG001|Overall Study|Lost to Follow-up|15|||
146772476|NCT02507752|529335946|FG000|Overall Study|Adverse Event|1|||
146772477|NCT02507752|529335946|FG000|Overall Study|Protocol Violation|6|||
146772478|NCT02507752|529335946|FG000|Overall Study|Lost to Follow-up|7|||
146772479|NCT02507752|529335946|FG000|Overall Study|Infusion reaction at first infusion|1|||
146772480|NCT02507752|529335946|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
146772481|NCT02507752|529335946|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
146772482|NCT01369498|529335951|FG000|Overall Study|Lack of Efficacy|9|||
146772483|NCT01369498|529335952|FG001|Overall Study|Lack of Efficacy|9|||
146772484|NCT01369498|529335953|FG002|Overall Study|Lack of Efficacy|1|||
146772485|NCT01369498|529335954|FG003|Overall Study|Lack of Efficacy|3|||
146772486|NCT01369498|529335951|FG000|Overall Study|Adverse Event|1|||
146772487|NCT01369498|529335952|FG001|Overall Study|Adverse Event|2|||
146772488|NCT01369498|529335953|FG002|Overall Study|Adverse Event|0|||
146772489|NCT01369498|529335954|FG003|Overall Study|Adverse Event|1|||
146772490|NCT01369498|529335951|FG000|Overall Study|Withdrawal of Consent|0|||
146772491|NCT01369498|529335952|FG001|Overall Study|Withdrawal of Consent|1|||
146772492|NCT01369498|529335953|FG002|Overall Study|Withdrawal of Consent|1|||
146772493|NCT01369498|529335954|FG003|Overall Study|Withdrawal of Consent|1|||
146772494|NCT01369498|529335951|FG000|Overall Study|Death|0|||
146772495|NCT01369498|529335952|FG001|Overall Study|Death|0|||
146772496|NCT01369498|529335953|FG002|Overall Study|Death|1|||
146772497|NCT01369498|529335954|FG003|Overall Study|Death|0|||
146772498|NCT01369498|529335951|FG000|Overall Study|Investigator's Discretion|1|||
146772499|NCT01369498|529335952|FG001|Overall Study|Investigator's Discretion|0|||
146772500|NCT01369498|529335953|FG002|Overall Study|Investigator's Discretion|1|||
146772501|NCT01369498|529335954|FG003|Overall Study|Investigator's Discretion|3|||
146772502|NCT01369498|529335951|FG000|Overall Study|Unknown Reason|1|||
146602152|NCT02868229|528713575|FG001|Overall Study|Adverse Event|0|||
146602153|NCT02868229|528713576|FG002|Overall Study|Adverse Event|0|||
146602154|NCT02868229|528713577|FG003|Overall Study|Adverse Event|1|||
146602155|NCT02868229|528713574|FG000|Overall Study|Death|0|||
146602156|NCT02868229|528713575|FG001|Overall Study|Death|0|||
146602157|NCT02868229|528713576|FG002|Overall Study|Death|1|||
146602158|NCT02868229|528713577|FG003|Overall Study|Death|1|||
146602159|NCT02868229|528713574|FG000|Overall Study|Missed dose|0|||
146602160|NCT02868229|528713575|FG001|Overall Study|Missed dose|0|||
146602161|NCT02868229|528713576|FG002|Overall Study|Missed dose|0|||
146602162|NCT02868229|528713577|FG003|Overall Study|Missed dose|3|||
146602163|NCT02540668|528713580|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
146602164|NCT02540668|528713581|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
146602165|NCT03270891|528713582|FG000|Overall Study|Lost to Follow-up|3|||
146602166|NCT03270891|528713583|FG001|Overall Study|Lost to Follow-up|6|||
146602167|NCT03270891|528713584|FG002|Overall Study|Lost to Follow-up|0|||
146602168|NCT03270891|528713582|FG000|Overall Study|Withdrawal by Subject|1|||
146602169|NCT03270891|528713583|FG001|Overall Study|Withdrawal by Subject|0|||
146602170|NCT03270891|528713584|FG002|Overall Study|Withdrawal by Subject|0|||
146602171|NCT03270891|528713582|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
146602172|NCT03270891|528713583|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
146602173|NCT03270891|528713584|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
146602174|NCT05779007|528713585|FG000|Overall Study|not meeting eligibility criteria|3517|||
146602175|NCT05779007|528713586|FG001|Overall Study|not meeting eligibility criteria|2009|||
146602176|NCT05147662|528713589|FG000|Overall Study|Withdrawal by parent/guardian|3|||
146602177|NCT05147662|528713589|FG000|Overall Study|Assigned to treatment but never treated|1|||
146602178|NCT04676867|528713592|FG000|Overall Study|Screen failure|0|||
146602179|NCT04676867|528713593|FG001|Overall Study|Screen failure|0|||
146602180|NCT04676867|528713594|FG002|Overall Study|Screen failure|6|||
146602181|NCT04676867|528713595|FG003|Overall Study|Screen failure|2|||
146602182|NCT04676867|528713592|FG000|Overall Study|Death|0|||
146602183|NCT04676867|528713593|FG001|Overall Study|Death|0|||
146602184|NCT04676867|528713594|FG002|Overall Study|Death|1|||
146602185|NCT04676867|528713595|FG003|Overall Study|Death|0|||
146602186|NCT04676867|528713592|FG000|Overall Study|Withdrawal by Subject|2|||
146602187|NCT04676867|528713593|FG001|Overall Study|Withdrawal by Subject|2|||
146602188|NCT04676867|528713594|FG002|Overall Study|Withdrawal by Subject|4|||
146602189|NCT04676867|528713595|FG003|Overall Study|Withdrawal by Subject|4|||
146602190|NCT04676867|528713592|FG000|Overall Study|Lost to Follow-up|1|||
146602191|NCT04676867|528713593|FG001|Overall Study|Lost to Follow-up|0|||
146602192|NCT04676867|528713594|FG002|Overall Study|Lost to Follow-up|0|||
146602193|NCT04676867|528713595|FG003|Overall Study|Lost to Follow-up|0|||
146602194|NCT00549770|528713596|FG000|Overall Study|Protocol deviation|1|||
146602195|NCT00549770|528713597|FG001|Overall Study|Protocol deviation|1|||
146602196|NCT00549770|528713598|FG002|Overall Study|Protocol deviation|1|||
146602197|NCT00549770|528713599|FG003|Overall Study|Protocol deviation|2|||
146602198|NCT00549770|528713600|FG004|Overall Study|Protocol deviation|2|||
146602199|NCT00549770|528713601|FG005|Overall Study|Protocol deviation|2|||
146602200|NCT00549770|528713602|FG006|Overall Study|Protocol deviation|1|||
146602201|NCT00549770|528713603|FG007|Overall Study|Protocol deviation|2|||
146602202|NCT00549770|528713596|FG000|Overall Study|Administrative problems|0|||
146602203|NCT00549770|528713597|FG001|Overall Study|Administrative problems|1|||
146602204|NCT00549770|528713598|FG002|Overall Study|Administrative problems|0|||
146602205|NCT00549770|528713599|FG003|Overall Study|Administrative problems|0|||
146602206|NCT00549770|528713600|FG004|Overall Study|Administrative problems|0|||
146602207|NCT00549770|528713601|FG005|Overall Study|Administrative problems|0|||
146602208|NCT00549770|528713602|FG006|Overall Study|Administrative problems|0|||
146602209|NCT00549770|528713603|FG007|Overall Study|Administrative problems|1|||
146602210|NCT00549770|528713596|FG000|Overall Study|Lost to Follow-up|0|||
146602211|NCT00549770|528713597|FG001|Overall Study|Lost to Follow-up|0|||
146602212|NCT00549770|528713598|FG002|Overall Study|Lost to Follow-up|2|||
146602213|NCT00549770|528713599|FG003|Overall Study|Lost to Follow-up|2|||
146602214|NCT00549770|528713600|FG004|Overall Study|Lost to Follow-up|3|||
146602215|NCT00549770|528713601|FG005|Overall Study|Lost to Follow-up|2|||
146602216|NCT00549770|528713602|FG006|Overall Study|Lost to Follow-up|0|||
146602217|NCT00549770|528713603|FG007|Overall Study|Lost to Follow-up|0|||
146602218|NCT00549770|528713596|FG000|Overall Study|Withdrawal by Subject|4|||
146602219|NCT00549770|528713597|FG001|Overall Study|Withdrawal by Subject|6|||
146656296|NCT02414139|528917933|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
146656297|NCT02414139|528917934|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
146656298|NCT02414139|528917935|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
146772503|NCT01369498|529335952|FG001|Overall Study|Unknown Reason|0|||
146602220|NCT00549770|528713598|FG002|Overall Study|Withdrawal by Subject|4|||
146602221|NCT00549770|528713599|FG003|Overall Study|Withdrawal by Subject|5|||
146602222|NCT00549770|528713600|FG004|Overall Study|Withdrawal by Subject|6|||
146602223|NCT00549770|528713601|FG005|Overall Study|Withdrawal by Subject|6|||
146602224|NCT00549770|528713602|FG006|Overall Study|Withdrawal by Subject|4|||
146772504|NCT01369498|529335953|FG002|Overall Study|Unknown Reason|11|||
146772505|NCT01369498|529335954|FG003|Overall Study|Unknown Reason|6|||
146772506|NCT01369498|529335951|FG000|Overall Study|Disease Progression|0|||
146772507|NCT01369498|529335952|FG001|Overall Study|Disease Progression|0|||
146772508|NCT01369498|529335953|FG002|Overall Study|Disease Progression|0|||
146772509|NCT01369498|529335954|FG003|Overall Study|Disease Progression|1|||
146772510|NCT00535145|529335961|FG000|Phase I|Adverse Event|3|||
146772511|NCT00535145|529335961|FG000|Phase I|Lost to Follow-up|7|||
146772512|NCT00535145|529335961|FG000|Phase I|Withdrawal by Subject|6|||
146772513|NCT00535145|529335961|FG000|Phase I|(eligibility)|8|||
146772514|NCT00535145|529335961|FG000|Phase I|(protocol violation)|1|||
146772515|NCT00535145|529335961|FG000|Phase I|(PI decision)|1|||
146772516|NCT00535145|529335961|FG000|Phase I|(diagnosis)|3|||
146772517|NCT00535145|529335961|FG000|Phase II|Adverse Event|2|||
146772518|NCT00535145|529335961|FG000|Phase II|Lack of Efficacy|1|||
146772519|NCT00535145|529335961|FG000|Phase II|Lost to Follow-up|5|||
146772520|NCT00535145|529335961|FG000|Phase II|Withdrawal by Subject|5|||
146772521|NCT00535145|529335961|FG000|Phase II|Subject non-compliance|2|||
146772522|NCT01444417|529335962|FG000|Overall Study|Ineligibility Determined|0|||
146772523|NCT01444417|529335963|FG001|Overall Study|Ineligibility Determined|1|||
146772524|NCT01444417|529335962|FG000|Overall Study|Withdrawal by Subject|2|||
146772525|NCT01444417|529335963|FG001|Overall Study|Withdrawal by Subject|0|||
146772526|NCT02214160|529335965|FG000|Overall Study|Withdrawal by Subject|1|||
146772527|NCT02214160|529335966|FG001|Overall Study|Withdrawal by Subject|0|||
146772528|NCT02214160|529335967|FG002|Overall Study|Withdrawal by Subject|6|||
146772529|NCT02214160|529335965|FG000|Overall Study|Death|2|||
146772530|NCT02214160|529335966|FG001|Overall Study|Death|2|||
146772531|NCT02214160|529335967|FG002|Overall Study|Death|1|||
146772532|NCT02214160|529335965|FG000|Overall Study|Subject Non-Compliance|0|||
146772533|NCT02214160|529335966|FG001|Overall Study|Subject Non-Compliance|3|||
146772534|NCT02214160|529335967|FG002|Overall Study|Subject Non-Compliance|1|||
146772535|NCT02214160|529335965|FG000|Overall Study|Adverse Event|0|||
146772536|NCT02214160|529335966|FG001|Overall Study|Adverse Event|1|||
146772537|NCT02214160|529335967|FG002|Overall Study|Adverse Event|1|||
146772538|NCT02214160|529335965|FG000|Overall Study|Sponsor Decision|0|||
146772539|NCT02214160|529335966|FG001|Overall Study|Sponsor Decision|2|||
146772540|NCT02214160|529335967|FG002|Overall Study|Sponsor Decision|0|||
146772541|NCT02214160|529335965|FG000|Overall Study|Protocol Violation|1|||
146772542|NCT02214160|529335966|FG001|Overall Study|Protocol Violation|0|||
146772543|NCT02214160|529335967|FG002|Overall Study|Protocol Violation|0|||
146772544|NCT02214160|529335965|FG000|Overall Study|Physician Decision|0|||
146772545|NCT02214160|529335966|FG001|Overall Study|Physician Decision|0|||
146772546|NCT02214160|529335967|FG002|Overall Study|Physician Decision|1|||
146772547|NCT02423798|529335968|FG000|Overall Study|Withdrawal by Subject|3|||
146772548|NCT01430611|529335972|FG000|Overall Study|Adverse Event|0|||
146772549|NCT01430611|529335973|FG001|Overall Study|Adverse Event|1|||
146772550|NCT01430611|529335972|FG000|Overall Study|Protocol Violation|1|||
146772551|NCT01430611|529335973|FG001|Overall Study|Protocol Violation|0|||
146772552|NCT01430611|529335972|FG000|Overall Study|Lost to Follow-up|1|||
146772553|NCT01430611|529335973|FG001|Overall Study|Lost to Follow-up|0|||
146772554|NCT01430611|529335972|FG000|Overall Study|Withdrawal by Subject|15|||
146772555|NCT01430611|529335973|FG001|Overall Study|Withdrawal by Subject|14|||
146772556|NCT02204982|529335974|FG000|Overall Study|Patient ineligible-medical monitor|1|||
146772557|NCT02204982|529335975|FG001|Overall Study|Patient ineligible-medical monitor|0|||
146772558|NCT02204982|529335974|FG000|Overall Study|Withdrawal by Subject|1|||
146772559|NCT02204982|529335975|FG001|Overall Study|Withdrawal by Subject|0|||
146772560|NCT02204982|529335974|FG000|Overall Study|Adverse Event|1|||
146772561|NCT02204982|529335975|FG001|Overall Study|Adverse Event|0|||
146922701|NCT01318083|529876809|FG001|Overall Study|Treatment Complications|0|||
146922702|NCT01318083|529876810|FG002|Overall Study|Treatment Complications|0|||
146922703|NCT01318083|529876808|FG000|Overall Study|Lack of Study Medication Compliance|0|||
146922704|NCT01318083|529876809|FG001|Overall Study|Lack of Study Medication Compliance|1|||
146922705|NCT01318083|529876810|FG002|Overall Study|Lack of Study Medication Compliance|0|||
146922706|NCT02065869|529876811|FG000|Overall Study|Death|7|||
146922707|NCT02065869|529876811|FG000|Overall Study|Disease relapse|16|||
146922708|NCT02065869|529876811|FG000|Overall Study|Lost to Follow-up|4|||
146772562|NCT02204982|529335974|FG000|Overall Study|Adverse Event and Investigator decision|1|||
146772563|NCT02204982|529335975|FG001|Overall Study|Adverse Event and Investigator decision|0|||
146772564|NCT02204982|529335974|FG000|Overall Study|Physician Decision|0|||
146772565|NCT02204982|529335975|FG001|Overall Study|Physician Decision|2|||
146772566|NCT02204982|529335974|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
146772567|NCT02204982|529335975|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
146772568|NCT02204982|529335974|FG000|Overall Study|Termination of Study bySponsor|0|||
146772569|NCT02204982|529335975|FG001|Overall Study|Termination of Study bySponsor|1|||
146772570|NCT01968226|529335976|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
146772571|NCT00566527|529335977|FG000|Overall Study|Reason not provided|3|||
146772572|NCT00566527|529335978|FG001|Overall Study|Reason not provided|11|||
146772573|NCT00566527|529335979|FG002|Overall Study|Reason not provided|10|||
146772574|NCT00566527|529335977|FG000|Overall Study|Adverse Event|2|||
146772575|NCT00566527|529335978|FG001|Overall Study|Adverse Event|0|||
146772576|NCT00566527|529335979|FG002|Overall Study|Adverse Event|1|||
146772577|NCT00566527|529335977|FG000|Overall Study|Physician Decision|3|||
146772578|NCT00566527|529335978|FG001|Overall Study|Physician Decision|8|||
146772579|NCT00566527|529335979|FG002|Overall Study|Physician Decision|20|||
146772580|NCT00566527|529335977|FG000|Overall Study|Lost to Follow-up|3|||
146772581|NCT00566527|529335978|FG001|Overall Study|Lost to Follow-up|4|||
146772582|NCT00566527|529335979|FG002|Overall Study|Lost to Follow-up|4|||
146772583|NCT00566527|529335977|FG000|Overall Study|Withdrawal by Subject|6|||
146772584|NCT00566527|529335978|FG001|Overall Study|Withdrawal by Subject|43|||
146772585|NCT00566527|529335979|FG002|Overall Study|Withdrawal by Subject|43|||
146772586|NCT00457743|529335980|FG000|Overall Study|Adverse Event|0|||
146772587|NCT00457743|529335981|FG001|Overall Study|Adverse Event|4|||
146772588|NCT00457743|529335982|FG002|Overall Study|Adverse Event|0|||
146772589|NCT00457743|529335980|FG000|Overall Study|Lack of Efficacy|3|||
146772590|NCT00457743|529335981|FG001|Overall Study|Lack of Efficacy|23|||
146772591|NCT00457743|529335982|FG002|Overall Study|Lack of Efficacy|3|||
146772592|NCT02261467|529335983|FG000|Overall Study|Enrolled in Error|1|||
146772593|NCT02261467|529335984|FG001|Overall Study|Enrolled in Error|0|||
146772594|NCT02261467|529335983|FG000|Overall Study|Protocol Violation|0|||
146772595|NCT02261467|529335984|FG001|Overall Study|Protocol Violation|1|||
146772596|NCT02261467|529335983|FG000|Overall Study|Personal Reasons|17|||
146772597|NCT02261467|529335984|FG001|Overall Study|Personal Reasons|22|||
146922709|NCT02065869|529876811|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
146922710|NCT02065869|529876811|FG000|Overall Study|Withdrawal by Subject|1|||
146922711|NCT00527111|529876812|FG000|Overall Study|Adverse Event|14|||
146922712|NCT00527111|529876813|FG001|Overall Study|Adverse Event|13|||
146922713|NCT00527111|529876812|FG000|Overall Study|Death|0|||
146922714|NCT00527111|529876813|FG001|Overall Study|Death|1|||
146922715|NCT00527111|529876812|FG000|Overall Study|Investigator Request|2|||
146922716|NCT00527111|529876813|FG001|Overall Study|Investigator Request|1|||
146772598|NCT02261467|529335983|FG000|Overall Study|Lost to Follow-up|2|||
146772599|NCT02261467|529335984|FG001|Overall Study|Lost to Follow-up|13|||
146772600|NCT02261467|529335983|FG000|Overall Study|Adverse Event|1|||
146772601|NCT02261467|529335984|FG001|Overall Study|Adverse Event|1|||
146772602|NCT00794118|529335987|FG000|Overall Study|Lost to Follow-up|16|||
146772603|NCT00794118|529335987|FG000|Overall Study|Withdrawal by Subject|9|||
146772604|NCT00794118|529335987|FG000|Overall Study|Changed hospital center|2|||
146772605|NCT01597258|529335993|FG000|Overall Study|No Drug Administration|1|||
146772606|NCT01415349|529335994|FG000|Treatment Period 1|Adverse Event|0|||
146772607|NCT01415349|529335995|FG001|Treatment Period 1|Adverse Event|1|||
146772608|NCT01415349|529335994|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146772609|NCT01415349|529335995|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146772610|NCT00933400|529335996|FG000|Overall Study|Withdrawal by Subject|21|||
146772611|NCT00933400|529335997|FG001|Overall Study|Withdrawal by Subject|1|||
146772612|NCT01764464|529335998|FG000|First Intervention|Withdrawal by Subject|1|||
146772613|NCT01764464|529335999|FG001|First Intervention|Withdrawal by Subject|0|||
146772614|NCT01764464|529335998|FG000|First Intervention|Lost to Follow-up|1|||
146772615|NCT01764464|529335999|FG001|First Intervention|Lost to Follow-up|0|||
146772616|NCT01764464|529335998|FG000|First Intervention|Adverse Event|0|||
146772617|NCT01764464|529335999|FG001|First Intervention|Adverse Event|2|||
146772618|NCT01764464|529335998|FG000|First Intervention|did not receive study drug|0|||
146772619|NCT01764464|529335999|FG001|First Intervention|did not receive study drug|1|||
146772620|NCT01764464|529335998|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
146772621|NCT01764464|529335999|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
146772622|NCT02079844|529336000|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
146772623|NCT02079844|529336001|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
146772624|NCT02079844|529336002|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
146772625|NCT02079844|529336000|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
146922717|NCT00527111|529876812|FG000|Overall Study|Patient Request|2|||
146922718|NCT00527111|529876813|FG001|Overall Study|Patient Request|5|||
146922719|NCT00527111|529876812|FG000|Overall Study|Other|2|||
146978647|NCT00990093|530084125|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
146978648|NCT00990093|530084124|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
146978649|NCT00990093|530084125|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
146772626|NCT02079844|529336001|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
146772627|NCT02079844|529336002|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
146772628|NCT00203411|529336007|FG000|Follow-up|Progressive Disease|4|||
146922720|NCT00527111|529876813|FG001|Overall Study|Other|2|||
146922721|NCT02993224|529876814|FG000|Core Phase - Period 1|Adverse Event|4|||
146772629|NCT02531113|529336010|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
146772630|NCT02531113|529336010|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
146772631|NCT02531113|529336010|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
146772632|NCT02531113|529336010|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
146772633|NCT02531113|529336010|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
146772634|NCT02531113|529336010|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
146772635|NCT02531113|529336010|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
146772636|NCT02531113|529336010|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
146772637|NCT00632424|529336011|FG000|Overall Study|Disease Progression|17|||
146772638|NCT00632424|529336011|FG000|Overall Study|Study Drug Toxicity|1|||
146772639|NCT05135000|529336016|FG000|Overall Study|Adverse Event|2|||
146772640|NCT05135000|529336017|FG001|Overall Study|Adverse Event|0|||
146772641|NCT05135000|529336016|FG000|Overall Study|Lost to Follow-up|1|||
146772642|NCT05135000|529336017|FG001|Overall Study|Lost to Follow-up|0|||
146772643|NCT05135000|529336016|FG000|Overall Study|Study Terminated by Sponsor|6|||
146772644|NCT05135000|529336017|FG001|Overall Study|Study Terminated by Sponsor|3|||
146772645|NCT05262738|529338106|FG000|Overall Study|Withdrawal by Subject|1|||
146772646|NCT05262738|529338107|FG001|Overall Study|Withdrawal by Subject|0|||
146772647|NCT02374463|529338110|FG000|Overall Study|Withdrawal by Subject|3|||
146772648|NCT02374463|529338111|FG001|Overall Study|Withdrawal by Subject|3|||
146772649|NCT01424397|529338112|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
146772650|NCT01424397|529338113|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
146772651|NCT01424397|529338114|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
146772652|NCT01424397|529338115|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
146772653|NCT01424397|529338116|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
146772654|NCT01424397|529338117|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
146772655|NCT01424397|529338118|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
146772656|NCT01424397|529338119|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
146772657|NCT01424397|529338120|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
146772658|NCT01424397|529338121|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
146772659|NCT01424397|529338122|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
146772660|NCT01424397|529338123|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
146772661|NCT00774397|529338133|FG000|Overall Study|Adverse Event|1|||
146772662|NCT00774397|529338134|FG001|Overall Study|Adverse Event|3|||
146772663|NCT00774397|529338135|FG002|Overall Study|Adverse Event|16|||
146772664|NCT00774397|529338136|FG003|Overall Study|Adverse Event|8|||
146772665|NCT00774397|529338137|FG004|Overall Study|Adverse Event|8|||
146772666|NCT00774397|529338138|FG005|Overall Study|Adverse Event|3|||
146772667|NCT00774397|529338139|FG006|Overall Study|Adverse Event|16|||
146772668|NCT00774397|529338133|FG000|Overall Study|Lack of Efficacy|11|||
146772669|NCT00774397|529338134|FG001|Overall Study|Lack of Efficacy|4|||
146772670|NCT00774397|529338135|FG002|Overall Study|Lack of Efficacy|5|||
146772671|NCT00774397|529338136|FG003|Overall Study|Lack of Efficacy|3|||
146772672|NCT00774397|529338137|FG004|Overall Study|Lack of Efficacy|27|||
146772673|NCT00774397|529338138|FG005|Overall Study|Lack of Efficacy|15|||
146772674|NCT00774397|529338139|FG006|Overall Study|Lack of Efficacy|9|||
146772675|NCT00774397|529338133|FG000|Overall Study|Protocol Violation|0|||
146772676|NCT00774397|529338134|FG001|Overall Study|Protocol Violation|1|||
146772677|NCT00774397|529338135|FG002|Overall Study|Protocol Violation|3|||
146772678|NCT00774397|529338136|FG003|Overall Study|Protocol Violation|1|||
146772679|NCT00774397|529338137|FG004|Overall Study|Protocol Violation|2|||
146772680|NCT00774397|529338138|FG005|Overall Study|Protocol Violation|1|||
146772681|NCT00774397|529338139|FG006|Overall Study|Protocol Violation|0|||
146922722|NCT02993224|529876814|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
146922723|NCT02993224|529876814|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
146922724|NCT02993224|529876814|FG000|Core Phase- Period 2|Adverse Event|1|||
146922725|NCT02993224|529876814|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
146922726|NCT02993224|529876814|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
146922727|NCT02993224|529876814|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
146922728|NCT02993224|529876814|FG000|Extension Phase|Adverse Event|3|||
146922729|NCT02993224|529876814|FG000|Extension Phase|Withdrawal by Subject|3|||
146922730|NCT02993224|529876814|FG000|Extension Phase|Lost to Follow-up|2|||
146922731|NCT02993224|529876814|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
146922732|NCT03827473|529876816|FG000|Overall Study|Withdrawal by Subject|1|||
146922733|NCT03827473|529876817|FG001|Overall Study|Withdrawal by Subject|0|||
146922734|NCT01423617|529876820|FG000|Overall Study|Lost to Follow-up|0|||
146922735|NCT01423617|529876821|FG001|Overall Study|Lost to Follow-up|1|||
146922736|NCT03855137|529876824|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
146978650|NCT00990093|530084124|FG000|Test Period 2 (15-28 Days)|Other|0|||
146772682|NCT00774397|529338133|FG000|Overall Study|Lost to Follow-up|0|||
146772683|NCT00774397|529338134|FG001|Overall Study|Lost to Follow-up|1|||
146772684|NCT00774397|529338135|FG002|Overall Study|Lost to Follow-up|1|||
146772685|NCT00774397|529338136|FG003|Overall Study|Lost to Follow-up|1|||
146772686|NCT00774397|529338137|FG004|Overall Study|Lost to Follow-up|0|||
146772687|NCT00774397|529338138|FG005|Overall Study|Lost to Follow-up|1|||
146772688|NCT00774397|529338139|FG006|Overall Study|Lost to Follow-up|0|||
146772689|NCT00774397|529338133|FG000|Overall Study|Refused to continue trial medication|1|||
146772690|NCT00774397|529338134|FG001|Overall Study|Refused to continue trial medication|3|||
146772691|NCT00774397|529338135|FG002|Overall Study|Refused to continue trial medication|2|||
146772692|NCT00774397|529338136|FG003|Overall Study|Refused to continue trial medication|2|||
146772693|NCT00774397|529338137|FG004|Overall Study|Refused to continue trial medication|6|||
146602225|NCT00549770|528713603|FG007|Overall Study|Withdrawal by Subject|9|||
146602226|NCT00549770|528713596|FG000|Overall Study|Lack of Efficacy|1|||
146602227|NCT00549770|528713597|FG001|Overall Study|Lack of Efficacy|0|||
146602228|NCT00549770|528713598|FG002|Overall Study|Lack of Efficacy|2|||
146602229|NCT00549770|528713599|FG003|Overall Study|Lack of Efficacy|3|||
146602230|NCT00549770|528713600|FG004|Overall Study|Lack of Efficacy|5|||
146602231|NCT00549770|528713601|FG005|Overall Study|Lack of Efficacy|1|||
146602232|NCT00549770|528713602|FG006|Overall Study|Lack of Efficacy|3|||
146602233|NCT00549770|528713603|FG007|Overall Study|Lack of Efficacy|8|||
146602234|NCT00549770|528713596|FG000|Overall Study|Abnormal test procedure results|0|||
146602235|NCT00549770|528713597|FG001|Overall Study|Abnormal test procedure results|0|||
146602236|NCT00549770|528713598|FG002|Overall Study|Abnormal test procedure results|0|||
146602237|NCT00549770|528713599|FG003|Overall Study|Abnormal test procedure results|2|||
146602238|NCT00549770|528713600|FG004|Overall Study|Abnormal test procedure results|0|||
146602239|NCT00549770|528713601|FG005|Overall Study|Abnormal test procedure results|1|||
146602240|NCT00549770|528713602|FG006|Overall Study|Abnormal test procedure results|1|||
146602241|NCT00549770|528713603|FG007|Overall Study|Abnormal test procedure results|1|||
146602242|NCT00549770|528713596|FG000|Overall Study|Abnormal laboratory values|0|||
146602243|NCT00549770|528713597|FG001|Overall Study|Abnormal laboratory values|0|||
146602244|NCT00549770|528713598|FG002|Overall Study|Abnormal laboratory values|0|||
146602245|NCT00549770|528713599|FG003|Overall Study|Abnormal laboratory values|0|||
146602246|NCT00549770|528713600|FG004|Overall Study|Abnormal laboratory values|0|||
146602247|NCT00549770|528713601|FG005|Overall Study|Abnormal laboratory values|1|||
146602248|NCT00549770|528713602|FG006|Overall Study|Abnormal laboratory values|0|||
146602249|NCT00549770|528713603|FG007|Overall Study|Abnormal laboratory values|0|||
146602250|NCT00549770|528713596|FG000|Overall Study|Adverse Event|1|||
146602251|NCT00549770|528713597|FG001|Overall Study|Adverse Event|3|||
146602252|NCT00549770|528713598|FG002|Overall Study|Adverse Event|1|||
146602253|NCT00549770|528713599|FG003|Overall Study|Adverse Event|2|||
146602254|NCT00549770|528713600|FG004|Overall Study|Adverse Event|1|||
146656299|NCT02414139|528917936|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
146656300|NCT02414139|528917937|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
146602255|NCT00549770|528713601|FG005|Overall Study|Adverse Event|0|||
146602256|NCT00549770|528713602|FG006|Overall Study|Adverse Event|5|||
146602257|NCT00549770|528713603|FG007|Overall Study|Adverse Event|4|||
146602258|NCT02294734|528713604|FG000|Overall Study|Adverse Event|5|||
146602259|NCT02294734|528713605|FG001|Overall Study|Adverse Event|5|||
146602260|NCT02294734|528713604|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
146602261|NCT02294734|528713605|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
146602262|NCT02294734|528713604|FG000|Overall Study|Lost to Follow-up|2|||
146602263|NCT02294734|528713605|FG001|Overall Study|Lost to Follow-up|0|||
146602264|NCT02294734|528713604|FG000|Overall Study|Physician Decision|2|||
146602265|NCT02294734|528713605|FG001|Overall Study|Physician Decision|1|||
146656301|NCT02414139|528917938|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
146656302|NCT02414139|528917939|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
146656303|NCT02414139|528917940|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
146656304|NCT02414139|528917931|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
146656305|NCT02414139|528917932|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
146656306|NCT02414139|528917933|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
146656307|NCT02414139|528917934|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
146656308|NCT02414139|528917935|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
146656309|NCT02414139|528917936|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
146656310|NCT02414139|528917937|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
146656311|NCT02414139|528917938|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
146656312|NCT02414139|528917939|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
146656313|NCT02414139|528917940|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
146656314|NCT02414139|528917931|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
146656315|NCT02414139|528917932|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
146656316|NCT02414139|528917933|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
146656317|NCT02414139|528917934|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
146656318|NCT02414139|528917935|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
146656319|NCT02414139|528917936|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
146656320|NCT02414139|528917937|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
146656321|NCT02414139|528917938|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
146656322|NCT02414139|528917939|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
146656323|NCT02414139|528917940|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
146656324|NCT00591578|528917941|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
146978651|NCT00990093|530084125|FG001|Test Period 2 (15-28 Days)|Other|1|||
146602266|NCT02294734|528713604|FG000|Overall Study|Withdrawal by Subject|4|||
146602267|NCT02294734|528713605|FG001|Overall Study|Withdrawal by Subject|2|||
146602268|NCT00548717|528713606|FG000|Overall Study|Death|5|||
146656325|NCT00591578|528917942|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
146656326|NCT00591578|528917943|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
146656327|NCT00591578|528917941|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
146656328|NCT00591578|528917942|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
146656329|NCT00591578|528917943|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
146656330|NCT00591578|528917941|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
146656331|NCT00591578|528917942|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
146656332|NCT00591578|528917943|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
146656333|NCT00591578|528917941|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
146656334|NCT00591578|528917942|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
146656335|NCT00591578|528917943|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
146656336|NCT00591578|528917941|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
146656337|NCT00591578|528917942|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
146602269|NCT00548717|528713607|FG001|Overall Study|Death|2|||
146602270|NCT00548717|528713606|FG000|Overall Study|Relapse|3|||
146602271|NCT00548717|528713607|FG001|Overall Study|Relapse|0|||
146602272|NCT00548717|528713606|FG000|Overall Study|Alternative treatment for GVHD|1|||
146602273|NCT00548717|528713607|FG001|Overall Study|Alternative treatment for GVHD|0|||
146602274|NCT00908037|528713609|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146602275|NCT00908037|528713610|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146602276|NCT00908037|528713611|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146602277|NCT00908037|528713612|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146602278|NCT00908037|528713613|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
146602279|NCT00908037|528713614|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146602280|NCT00908037|528713615|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
146602281|NCT00908037|528713616|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146602282|NCT00908037|528713617|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
146656338|NCT00591578|528917943|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
146656339|NCT00591578|528917941|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
146656340|NCT00591578|528917942|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
146656341|NCT00591578|528917943|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
146656342|NCT00591578|528917941|FG000|Double-Blind Treatment Phase|Other|4|||
146656343|NCT00591578|528917942|FG001|Double-Blind Treatment Phase|Other|9|||
146656344|NCT00591578|528917943|FG002|Double-Blind Treatment Phase|Other|4|||
146656345|NCT00591578|528917941|FG000|Open-Label Extension Phase|Adverse Event|3|||
146656346|NCT00591578|528917942|FG001|Open-Label Extension Phase|Adverse Event|5|||
146656347|NCT00591578|528917943|FG002|Open-Label Extension Phase|Adverse Event|0|||
146656348|NCT00591578|528917941|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
146656349|NCT00591578|528917942|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
146656350|NCT00591578|528917943|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
146656351|NCT00591578|528917941|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
146656352|NCT00591578|528917942|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
146656353|NCT00591578|528917943|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
146656354|NCT00591578|528917941|FG000|Open-Label Extension Phase|Other|1|||
146656355|NCT00591578|528917942|FG001|Open-Label Extension Phase|Other|0|||
146656356|NCT00591578|528917943|FG002|Open-Label Extension Phase|Other|0|||
146656357|NCT01909453|528917956|FG000|Overall Study|Ongoing|118|||
146656358|NCT01909453|528917957|FG001|Overall Study|Ongoing|103|||
146656359|NCT01909453|528917958|FG002|Overall Study|Ongoing|83|||
146656360|NCT01909453|528917959|FG003|Overall Study|Ongoing|164|||
146656361|NCT01909453|528917960|FG004|Overall Study|Ongoing|50|||
146656362|NCT01909453|528917956|FG000|Overall Study|Death|69|||
146656363|NCT01909453|528917957|FG001|Overall Study|Death|74|||
146656364|NCT01909453|528917958|FG002|Overall Study|Death|88|||
146656365|NCT01909453|528917959|FG003|Overall Study|Death|86|||
146656366|NCT01909453|528917960|FG004|Overall Study|Death|29|||
146656367|NCT01909453|528917956|FG000|Overall Study|Lost to Follow-up|3|||
146656368|NCT01909453|528917957|FG001|Overall Study|Lost to Follow-up|4|||
146656369|NCT01909453|528917958|FG002|Overall Study|Lost to Follow-up|4|||
146772694|NCT00774397|529338138|FG005|Overall Study|Refused to continue trial medication|2|||
146922737|NCT03855137|529876825|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
146602283|NCT00908037|528713618|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146602284|NCT00908037|528713619|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146602285|NCT00908037|528713620|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146602286|NCT00908037|528713609|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146602287|NCT00908037|528713610|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146602288|NCT00908037|528713611|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146602289|NCT00908037|528713612|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146656370|NCT01909453|528917959|FG003|Overall Study|Lost to Follow-up|3|||
146656371|NCT01909453|528917960|FG004|Overall Study|Lost to Follow-up|3|||
146656372|NCT01909453|528917956|FG000|Overall Study|Withdrawal by Subject|2|||
146656373|NCT01909453|528917957|FG001|Overall Study|Withdrawal by Subject|13|||
146656374|NCT01909453|528917958|FG002|Overall Study|Withdrawal by Subject|16|||
146656375|NCT01909453|528917959|FG003|Overall Study|Withdrawal by Subject|5|||
146656376|NCT01909453|528917960|FG004|Overall Study|Withdrawal by Subject|4|||
146656377|NCT00076024|528919563|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
146656378|NCT00076024|528919564|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
146656379|NCT00076024|528919565|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
146656380|NCT00076024|528919566|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
146656381|NCT00076024|528919563|FG000|Phase 1, Lead-in|Adverse Event|1|||
146656382|NCT00076024|528919564|FG001|Phase 1, Lead-in|Adverse Event|0|||
146656383|NCT00076024|528919565|FG002|Phase 1, Lead-in|Adverse Event|0|||
146656384|NCT00076024|528919566|FG003|Phase 1, Lead-in|Adverse Event|0|||
146656385|NCT00076024|528919563|FG000|Phase 1, Lead-in|Clinical progression|1|||
146656386|NCT00076024|528919564|FG001|Phase 1, Lead-in|Clinical progression|0|||
146656387|NCT00076024|528919565|FG002|Phase 1, Lead-in|Clinical progression|0|||
146656388|NCT00076024|528919566|FG003|Phase 1, Lead-in|Clinical progression|0|||
146656389|NCT00076024|528919563|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
146656390|NCT00076024|528919564|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
146656391|NCT00076024|528919565|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
146656392|NCT00076024|528919566|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
146656393|NCT00076024|528919563|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
146656394|NCT00076024|528919564|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
146656395|NCT00076024|528919565|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
146656396|NCT00076024|528919566|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
146656397|NCT00076024|528919563|FG000|Phase 2, Double-blind|Adverse Event|0|||
146656398|NCT00076024|528919564|FG001|Phase 2, Double-blind|Adverse Event|25|||
146656399|NCT00076024|528919565|FG002|Phase 2, Double-blind|Adverse Event|6|||
146656400|NCT00076024|528919566|FG003|Phase 2, Double-blind|Adverse Event|0|||
146656401|NCT00076024|528919563|FG000|Phase 2, Double-blind|Un-specified|0|||
146656402|NCT00076024|528919564|FG001|Phase 2, Double-blind|Un-specified|14|||
146656403|NCT00076024|528919565|FG002|Phase 2, Double-blind|Un-specified|6|||
146656404|NCT00076024|528919566|FG003|Phase 2, Double-blind|Un-specified|0|||
146656405|NCT00076024|528919563|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
146656406|NCT00076024|528919564|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
146656407|NCT00076024|528919565|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
146656408|NCT00076024|528919566|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
146656409|NCT00076024|528919563|FG000|Phase 2, Open-label|Adverse Event|0|||
146656410|NCT00076024|528919564|FG001|Phase 2, Open-label|Adverse Event|0|||
146656411|NCT00076024|528919565|FG002|Phase 2, Open-label|Adverse Event|0|||
146656412|NCT00076024|528919566|FG003|Phase 2, Open-label|Adverse Event|2|||
146656413|NCT00076024|528919563|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
146656414|NCT00076024|528919564|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
146656415|NCT00076024|528919565|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
146656416|NCT00076024|528919566|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
146656417|NCT00076024|528919563|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
146656418|NCT00076024|528919564|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
146656419|NCT00076024|528919565|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
146656420|NCT00076024|528919566|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
146656421|NCT00076024|528919563|FG000|Phase 2, Open-label|Other|0|||
146656422|NCT00076024|528919564|FG001|Phase 2, Open-label|Other|0|||
146656423|NCT00076024|528919565|FG002|Phase 2, Open-label|Other|0|||
146656424|NCT00076024|528919566|FG003|Phase 2, Open-label|Other|2|||
146656425|NCT00301821|528919571|FG000|Overall Study|Ineligible|25|||
146656426|NCT00301821|528919571|FG000|Overall Study|Cancel|1|||
146656427|NCT02294773|528919572|FG000|Overall Study|Withdrawal by Subject|0|||
146656428|NCT02294773|528919573|FG001|Overall Study|Withdrawal by Subject|2|||
146656429|NCT03052764|528919574|FG000|Double-Blind Treatment Period|Adverse Event|2|||
146656430|NCT03052764|528919575|FG001|Double-Blind Treatment Period|Adverse Event|0|||
146656431|NCT03052764|528919574|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
146656432|NCT03052764|528919575|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
146656433|NCT03052764|528919574|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
146656434|NCT03052764|528919575|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
146656435|NCT03052764|528919574|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
146656436|NCT03052764|528919575|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146656437|NCT03052764|528919574|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
146656438|NCT03052764|528919575|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
146656439|NCT03206073|528919576|FG000|Overall Study|Participant Noncompliance|0|||
146656440|NCT03206073|528919577|FG001|Overall Study|Participant Noncompliance|1|||
146656441|NCT03206073|528919578|FG002|Overall Study|Participant Noncompliance|0|||
146656442|NCT03206073|528919579|FG003|Overall Study|Participant Noncompliance|0|||
146656443|NCT03206073|528919576|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
146656444|NCT03206073|528919577|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
146656445|NCT03206073|528919578|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
146656446|NCT03206073|528919579|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
146656447|NCT03206073|528919576|FG000|Overall Study|Death|0|||
146656448|NCT03206073|528919577|FG001|Overall Study|Death|0|||
146656449|NCT03206073|528919578|FG002|Overall Study|Death|1|||
146772695|NCT00774397|529338139|FG006|Overall Study|Refused to continue trial medication|3|||
146772696|NCT00774397|529338133|FG000|Overall Study|Not treated|0|||
146772697|NCT00774397|529338134|FG001|Overall Study|Not treated|0|||
146772698|NCT00774397|529338135|FG002|Overall Study|Not treated|0|||
146772699|NCT00774397|529338136|FG003|Overall Study|Not treated|0|||
146772700|NCT00774397|529338137|FG004|Overall Study|Not treated|1|||
146772701|NCT00774397|529338138|FG005|Overall Study|Not treated|0|||
146772702|NCT00774397|529338139|FG006|Overall Study|Not treated|1|||
146772703|NCT00774397|529338133|FG000|Overall Study|Other than those stated above|1|||
146772704|NCT00774397|529338134|FG001|Overall Study|Other than those stated above|1|||
146772705|NCT00774397|529338135|FG002|Overall Study|Other than those stated above|3|||
146772706|NCT00774397|529338136|FG003|Overall Study|Other than those stated above|2|||
146772707|NCT00774397|529338137|FG004|Overall Study|Other than those stated above|2|||
146772708|NCT00774397|529338138|FG005|Overall Study|Other than those stated above|0|||
146772709|NCT00774397|529338139|FG006|Overall Study|Other than those stated above|1|||
146772710|NCT00858117|529338143|FG000|Treatment on Study|Adverse Event|2|||
146772711|NCT00858117|529338143|FG000|Follow up for 5 Years|Death|4|||
146772712|NCT00858117|529338143|FG000|Follow up for 5 Years|No further data collected for study|9|||
146772713|NCT00077675|529338144|FG000|Overall Study|Adverse Event|1|||
146772714|NCT00077675|529338145|FG001|Overall Study|Adverse Event|2|||
146772715|NCT00077675|529338144|FG000|Overall Study|Lost to Follow-up|6|||
146772716|NCT00077675|529338145|FG001|Overall Study|Lost to Follow-up|3|||
146772717|NCT00077675|529338144|FG000|Overall Study|Withdrawal by Subject|1|||
146772718|NCT00077675|529338145|FG001|Overall Study|Withdrawal by Subject|0|||
146772719|NCT00077675|529338144|FG000|Overall Study|Other|0|||
146772720|NCT00077675|529338145|FG001|Overall Study|Other|1|||
146772721|NCT00077675|529338144|FG000|Overall Study|Never received study treatment|3|||
146772722|NCT00077675|529338145|FG001|Overall Study|Never received study treatment|3|||
146772723|NCT02499159|529338146|FG000|Randomization|Protocol Violation|1|||
146772724|NCT02499159|529338147|FG001|Randomization|Protocol Violation|1|||
146772725|NCT02499159|529338146|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
146772726|NCT02499159|529338147|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
146772727|NCT02499159|529338146|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
146772728|NCT02499159|529338147|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
146602290|NCT00908037|528713613|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
146602291|NCT00908037|528713614|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146602292|NCT00908037|528713615|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146772729|NCT02499159|529338146|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
146772730|NCT02499159|529338147|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
146772731|NCT02499159|529338146|FG000|30-Day Follow-Up Phone Call|Other|1|||
146772732|NCT02499159|529338147|FG001|30-Day Follow-Up Phone Call|Other|0|||
146772733|NCT04425863|529338149|FG000|Overall Study|Death|0|||
146772734|NCT04425863|529338150|FG001|Overall Study|Death|0|||
146772735|NCT04425863|529338151|FG002|Overall Study|Death|1|||
146772736|NCT02601820|529338152|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
146772737|NCT02601820|529338152|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
146772738|NCT02601820|529338152|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
146772739|NCT02601820|529338152|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
146772740|NCT01599793|529338153|FG000|Overall Study|Adverse Event|2|||
146772741|NCT02564744|529338157|FG000|Overall Study|Investigator decision|0|||
146772742|NCT02564744|529338158|FG001|Overall Study|Investigator decision|0|||
146772743|NCT02564744|529338159|FG002|Overall Study|Investigator decision|0|||
146772744|NCT02564744|529338160|FG003|Overall Study|Investigator decision|0|||
146772745|NCT02564744|529338161|FG004|Overall Study|Investigator decision|1|||
146772746|NCT02564744|529338157|FG000|Overall Study|Death|10|||
146772747|NCT02564744|529338158|FG001|Overall Study|Death|5|||
146772748|NCT02564744|529338159|FG002|Overall Study|Death|4|||
146772749|NCT02564744|529338160|FG003|Overall Study|Death|16|||
146922738|NCT03855137|529876826|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
146922739|NCT03855137|529876824|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
146922740|NCT03855137|529876825|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
146602293|NCT00908037|528713616|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146602294|NCT00908037|528713617|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
146772750|NCT02564744|529338161|FG004|Overall Study|Death|16|||
146772751|NCT02564744|529338157|FG000|Overall Study|End of study Page Missing|0|||
146772752|NCT02564744|529338158|FG001|Overall Study|End of study Page Missing|0|||
146772753|NCT02564744|529338159|FG002|Overall Study|End of study Page Missing|3|||
146772754|NCT02564744|529338160|FG003|Overall Study|End of study Page Missing|3|||
146772755|NCT02564744|529338161|FG004|Overall Study|End of study Page Missing|0|||
146772756|NCT02564744|529338157|FG000|Overall Study|Subject Withdrew Consent|1|||
146772757|NCT02564744|529338158|FG001|Overall Study|Subject Withdrew Consent|1|||
146772758|NCT02564744|529338159|FG002|Overall Study|Subject Withdrew Consent|1|||
146772759|NCT02564744|529338160|FG003|Overall Study|Subject Withdrew Consent|0|||
146772760|NCT02564744|529338161|FG004|Overall Study|Subject Withdrew Consent|2|||
146922741|NCT03855137|529876826|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
146922742|NCT03855137|529876824|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
146922743|NCT03855137|529876825|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
146602295|NCT00908037|528713618|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146602296|NCT00908037|528713619|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146602297|NCT00908037|528713620|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146602298|NCT00908037|528713609|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146602299|NCT00908037|528713610|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146602300|NCT00908037|528713611|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146602301|NCT00908037|528713612|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
146602302|NCT00908037|528713613|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146602303|NCT00908037|528713614|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146602304|NCT00908037|528713615|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
146602305|NCT00908037|528713616|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146602306|NCT00908037|528713617|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146602307|NCT00908037|528713618|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146602308|NCT00908037|528713619|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146602309|NCT00908037|528713620|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146602310|NCT00908037|528713609|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146602311|NCT00908037|528713610|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146602312|NCT00908037|528713611|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146602313|NCT00908037|528713612|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146602314|NCT00908037|528713613|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146602315|NCT00908037|528713614|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146602316|NCT00908037|528713615|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146602317|NCT00908037|528713616|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146602318|NCT00908037|528713617|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146602319|NCT00908037|528713618|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146602320|NCT00908037|528713619|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146602321|NCT00908037|528713620|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
146602322|NCT00908037|528713609|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146602323|NCT00908037|528713610|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146602324|NCT00908037|528713611|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146602325|NCT00908037|528713612|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146602326|NCT00908037|528713613|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146602327|NCT00908037|528713614|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146602328|NCT00908037|528713615|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146602329|NCT00908037|528713616|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146602330|NCT00908037|528713617|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146602331|NCT00908037|528713618|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
146602332|NCT00908037|528713619|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146602333|NCT00908037|528713620|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
146602334|NCT00908037|528713609|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146602335|NCT00908037|528713610|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146602336|NCT00908037|528713611|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146602337|NCT00908037|528713612|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146602338|NCT00908037|528713613|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146602339|NCT00908037|528713614|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146602340|NCT00908037|528713615|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146602341|NCT00908037|528713616|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146602342|NCT00908037|528713617|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146602343|NCT00908037|528713618|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
146602344|NCT00908037|528713619|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146602345|NCT00908037|528713620|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146602346|NCT00908037|528713609|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146602347|NCT00908037|528713610|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146602348|NCT00908037|528713611|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146602349|NCT00908037|528713612|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146602350|NCT00908037|528713613|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146602351|NCT00908037|528713614|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146602352|NCT00908037|528713615|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146656450|NCT03206073|528919579|FG003|Overall Study|Death|0|||
146656451|NCT03206073|528919576|FG000|Overall Study|Taken off active treatment|0|||
146656452|NCT03206073|528919577|FG001|Overall Study|Taken off active treatment|0|||
146772761|NCT02564744|529338157|FG000|Overall Study|Lost to Follow-up|0|||
146772762|NCT02564744|529338158|FG001|Overall Study|Lost to Follow-up|1|||
146772763|NCT02564744|529338159|FG002|Overall Study|Lost to Follow-up|0|||
146772764|NCT02564744|529338160|FG003|Overall Study|Lost to Follow-up|0|||
146772765|NCT02564744|529338161|FG004|Overall Study|Lost to Follow-up|1|||
146772766|NCT02564744|529338157|FG000|Overall Study|Reason not specified|1|||
146772767|NCT02564744|529338158|FG001|Overall Study|Reason not specified|0|||
146772768|NCT02564744|529338159|FG002|Overall Study|Reason not specified|0|||
146922744|NCT03855137|529876826|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
146922745|NCT03855137|529876824|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
146602353|NCT00908037|528713616|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146602354|NCT00908037|528713617|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146772769|NCT02564744|529338160|FG003|Overall Study|Reason not specified|0|||
146772770|NCT02564744|529338161|FG004|Overall Study|Reason not specified|0|||
146772771|NCT00277355|529338170|FG000|Overall Study|Withdrawal by Subject|3|||
146772772|NCT00277355|529338171|FG001|Overall Study|Withdrawal by Subject|3|||
146772773|NCT00277355|529338170|FG000|Overall Study|Lost to Follow-up|2|||
146772774|NCT00277355|529338171|FG001|Overall Study|Lost to Follow-up|2|||
146772775|NCT00277355|529338170|FG000|Overall Study|Adverse Event|5|||
146772776|NCT00277355|529338171|FG001|Overall Study|Adverse Event|0|||
146772777|NCT00277355|529338170|FG000|Overall Study|Death|3|||
146772778|NCT00277355|529338171|FG001|Overall Study|Death|0|||
146772779|NCT00277355|529338170|FG000|Overall Study|Physician Decision|1|||
146772780|NCT00277355|529338171|FG001|Overall Study|Physician Decision|0|||
146772781|NCT02765100|529338172|FG000|Overall Study|subject found ineligible after baseline|1|||
146772782|NCT02765100|529338173|FG001|Overall Study|subject found ineligible after baseline|1|||
146772783|NCT02765100|529338172|FG000|Overall Study|Lost to Follow-up|0|||
146772784|NCT02765100|529338173|FG001|Overall Study|Lost to Follow-up|1|||
146772785|NCT02675244|529338183|FG000|Overall Study|Death|9|||
146772786|NCT02675244|529338184|FG001|Overall Study|Death|6|||
146772787|NCT02675244|529338183|FG000|Overall Study|Withdrawal by Subject|3|||
146772788|NCT02675244|529338184|FG001|Overall Study|Withdrawal by Subject|6|||
146772789|NCT02675244|529338183|FG000|Overall Study|Lost to Follow-up|1|||
146772790|NCT02675244|529338184|FG001|Overall Study|Lost to Follow-up|1|||
146772791|NCT02675244|529338183|FG000|Overall Study|Ongoing at 2 Years|190|||
146772792|NCT02675244|529338184|FG001|Overall Study|Ongoing at 2 Years|185|||
146772793|NCT02652442|529338188|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
146772794|NCT01177670|529338190|FG000|Overall Study|Study Terminated|115|||
146772795|NCT01177670|529338190|FG000|Overall Study|Physician Decision|50|||
146772796|NCT01177670|529338190|FG000|Overall Study|Withdrawal by Subject|4|||
146772797|NCT00391898|529338191|FG000|Overall Study|Adverse Event|3|||
146772798|NCT00391898|529338192|FG001|Overall Study|Adverse Event|0|||
146772799|NCT00391898|529338191|FG000|Overall Study|Other|8|||
146772800|NCT00391898|529338192|FG001|Overall Study|Other|10|||
146772801|NCT00309907|529338199|FG000|Overall Study|Death|4|||
146772802|NCT00309907|529338199|FG000|Overall Study|Physician Decision|1|||
146772803|NCT00309907|529338199|FG000|Overall Study|Ineligible|11|||
146772804|NCT00309907|529338199|FG000|Overall Study|Major infectious event|4|||
146772805|NCT00869258|529338200|FG000|Overall Study|Physician Decision|1|||
146772806|NCT01075217|529338204|FG000|Overall Study|Adverse Event|1|||
146772807|NCT01075217|529338205|FG001|Overall Study|Adverse Event|1|||
146772808|NCT01075217|529338204|FG000|Overall Study|Physician Decision|1|||
146772809|NCT01075217|529338205|FG001|Overall Study|Physician Decision|0|||
146772810|NCT00364013|529338208|FG000|Overall Study|Ineligibility determined|4|||
146772811|NCT00364013|529338209|FG001|Overall Study|Ineligibility determined|2|||
146772812|NCT00364013|529338208|FG000|Overall Study|Adverse Event|4|||
146772813|NCT00364013|529338209|FG001|Overall Study|Adverse Event|3|||
146772814|NCT00364013|529338208|FG000|Overall Study|Withdrawal by Subject|13|||
146772815|NCT00364013|529338209|FG001|Overall Study|Withdrawal by Subject|18|||
146602355|NCT00908037|528713618|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146602356|NCT00908037|528713619|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
146602357|NCT00908037|528713620|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146602358|NCT00908037|528713609|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146602359|NCT00908037|528713610|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146602360|NCT00908037|528713611|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146772816|NCT00364013|529338208|FG000|Overall Study|Physician Decision|3|||
146602361|NCT00908037|528713612|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146602362|NCT00908037|528713613|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146602363|NCT00908037|528713614|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146772817|NCT00364013|529338209|FG001|Overall Study|Physician Decision|3|||
146772818|NCT00364013|529338208|FG000|Overall Study|Lost to Follow-up|10|||
146772819|NCT00364013|529338209|FG001|Overall Study|Lost to Follow-up|3|||
146772820|NCT00364013|529338208|FG000|Overall Study|Protocol-specified criteria|6|||
146772821|NCT00364013|529338209|FG001|Overall Study|Protocol-specified criteria|6|||
146772822|NCT00364013|529338208|FG000|Overall Study|Other|41|||
146772823|NCT00364013|529338209|FG001|Overall Study|Other|47|||
146772824|NCT00364013|529338208|FG000|Overall Study|Ongoing|20|||
146602364|NCT00908037|528713615|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146602365|NCT00908037|528713616|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146602366|NCT00908037|528713617|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146602367|NCT00908037|528713618|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
146602368|NCT00908037|528713619|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146602369|NCT00908037|528713620|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146602370|NCT00908037|528713609|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146602371|NCT00908037|528713610|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146602372|NCT00908037|528713611|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146602373|NCT00908037|528713612|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146602374|NCT00908037|528713613|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146602375|NCT00908037|528713614|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146602376|NCT00908037|528713615|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146602377|NCT00908037|528713616|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146602378|NCT00908037|528713617|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146602379|NCT00908037|528713618|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146602380|NCT00908037|528713619|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
146602381|NCT00908037|528713620|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146602382|NCT00025155|528713623|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
146602383|NCT00025155|528713623|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
146602384|NCT05086510|528713624|FG000|Overall Study|Lost to Follow-up|0|||
146602385|NCT05086510|528713625|FG001|Overall Study|Lost to Follow-up|2|||
146602386|NCT05086510|528713624|FG000|Overall Study|Death|0|||
146602387|NCT05086510|528713625|FG001|Overall Study|Death|2|||
146602388|NCT00084487|528713635|FG000|Overall Study|Death|1|||
146602389|NCT01561963|528713636|FG000|Overall Study|Adverse Event|1|||
146602390|NCT04598269|528713637|FG000|Overall Study|Adverse Event|0|||
146602391|NCT04598269|528713638|FG001|Overall Study|Adverse Event|3|||
146602392|NCT04598269|528713637|FG000|Overall Study|Withdrawal by Subject|1|||
146602393|NCT04598269|528713638|FG001|Overall Study|Withdrawal by Subject|4|||
146602394|NCT04598269|528713637|FG000|Overall Study|Lost to Follow-up|1|||
146602395|NCT04598269|528713638|FG001|Overall Study|Lost to Follow-up|0|||
146602396|NCT04598269|528713637|FG000|Overall Study|Not Treated|2|||
146602397|NCT04598269|528713638|FG001|Overall Study|Not Treated|0|||
146602398|NCT03040986|528713639|FG000|Overall Study|Hospice|1|||
146602399|NCT03040986|528713640|FG001|Overall Study|Hospice|0|||
146602400|NCT03040986|528713639|FG000|Overall Study|Adverse Event|2|||
146602401|NCT03040986|528713640|FG001|Overall Study|Adverse Event|1|||
146602402|NCT03040986|528713639|FG000|Overall Study|Disease progression on study|3|||
146602403|NCT03040986|528713640|FG001|Overall Study|Disease progression on study|1|||
146602404|NCT02177838|528713641|FG000|Overall Study|Withdrawal by Subject|1|||
146602405|NCT02177838|528713641|FG000|Overall Study|Physician Decision|1|||
146602406|NCT02177838|528713641|FG000|Overall Study|Death|1|||
146602407|NCT00737633|528713646|FG000|Overall Study|Study terminated by sponsor|44|||
146602408|NCT00737633|528713647|FG001|Overall Study|Study terminated by sponsor|55|||
146602409|NCT00737633|528713646|FG000|Overall Study|Lost to Follow-up|0|||
146602410|NCT00737633|528713647|FG001|Overall Study|Lost to Follow-up|1|||
146602411|NCT00737633|528713646|FG000|Overall Study|protocol non-compliance|0|||
146602412|NCT00737633|528713647|FG001|Overall Study|protocol non-compliance|1|||
146602413|NCT00377364|528713648|FG000|Overall Study|Lost to Follow-up|1|||
146602414|NCT00377364|528713649|FG001|Overall Study|Lost to Follow-up|0|||
146602415|NCT00377364|528713648|FG000|Overall Study|Withdrawal by Subject|1|||
146602416|NCT00377364|528713649|FG001|Overall Study|Withdrawal by Subject|0|||
146602417|NCT02925728|528713650|FG000|Overall Study|Death|3|||
146602418|NCT02925728|528713651|FG001|Overall Study|Death|5|||
146602419|NCT02925728|528713650|FG000|Overall Study|Physician Decision|1|||
146602420|NCT02925728|528713651|FG001|Overall Study|Physician Decision|0|||
146602421|NCT02925728|528713650|FG000|Overall Study|Withdrawal by Subject|1|||
146602422|NCT02925728|528713651|FG001|Overall Study|Withdrawal by Subject|0|||
146602423|NCT03101085|528713652|FG000|Overall Study|Lost to Follow-up|0|||
146602424|NCT03101085|528713653|FG001|Overall Study|Lost to Follow-up|1|||
146602425|NCT00695864|528713657|FG000|Placebo|Withdrawal by Subject|1|||
146602426|NCT00695864|528713657|FG000|Placebo|Physician Decision|4|||
146656453|NCT03206073|528919578|FG002|Overall Study|Taken off active treatment|3|||
146656454|NCT03206073|528919579|FG003|Overall Study|Taken off active treatment|0|||
146656455|NCT03332771|528919580|FG000|Overall Study|Adverse Event|6|||
146656456|NCT03332771|528919581|FG001|Overall Study|Adverse Event|4|||
146602427|NCT01879072|528713658|FG000|Overall Study|Withdrawal by Subject|121|||
146602428|NCT01879072|528713658|FG000|Overall Study|Not Transplanted|30|||
146602429|NCT00626405|528713666|FG000|Overall Study|Deemed Ineligible|1|||
146602430|NCT00626405|528713667|FG001|Overall Study|Deemed Ineligible|0|||
146602431|NCT00626405|528713666|FG000|Overall Study|Withdrawal by Subject|0|||
146602432|NCT00626405|528713667|FG001|Overall Study|Withdrawal by Subject|1|||
146602433|NCT01264419|528713671|FG000|Overall Study|Lost to Follow-up|3|||
146602434|NCT02100475|528715586|FG000|Overall Study|Unclassified|1|||
146602435|NCT02100475|528715587|FG001|Overall Study|Unclassified|2|||
146602436|NCT02100475|528715586|FG000|Overall Study|Withdrawal criteria|1|||
146602437|NCT02100475|528715587|FG001|Overall Study|Withdrawal criteria|0|||
146602438|NCT00527982|528715594|FG000|Overall Study|Physician Decision|1|||
146602439|NCT00527982|528715595|FG001|Overall Study|Physician Decision|0|||
146772825|NCT00364013|529338209|FG001|Overall Study|Ongoing|13|||
146772826|NCT00293293|529338210|FG000|Overall Study|Withdrawal by Subject|1|||
146772827|NCT00293293|529338211|FG001|Overall Study|Withdrawal by Subject|1|||
146772828|NCT00293293|529338210|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
146772829|NCT00293293|529338211|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
146772830|NCT00293293|529338210|FG000|Overall Study|Patient discontinued chemotherapy|0|||
146772831|NCT00293293|529338211|FG001|Overall Study|Patient discontinued chemotherapy|1|||
146772832|NCT02512965|529338214|FG000|Overall Study|Withdrawal by Subject|0|||
146772833|NCT02512965|529338215|FG001|Overall Study|Withdrawal by Subject|4|||
146772834|NCT00835770|529338216|FG000|Overall Study|MS Relapse|17|||
146772835|NCT00835770|529338217|FG001|Overall Study|MS Relapse|23|||
146772836|NCT00835770|529338216|FG000|Overall Study|MS Progression|14|||
146772837|NCT00835770|529338217|FG001|Overall Study|MS Progression|9|||
146772838|NCT00835770|529338216|FG000|Overall Study|Adverse Event|113|||
146772839|NCT00835770|529338217|FG001|Overall Study|Adverse Event|124|||
146772840|NCT00835770|529338216|FG000|Overall Study|Lost to Follow-up|22|||
146772841|NCT00835770|529338217|FG001|Overall Study|Lost to Follow-up|19|||
146772842|NCT00835770|529338216|FG000|Overall Study|Consent Withdrawn|144|||
146772843|NCT00835770|529338217|FG001|Overall Study|Consent Withdrawn|156|||
146772844|NCT00835770|529338216|FG000|Overall Study|Investigator Decision|42|||
146772845|NCT00835770|529338217|FG001|Overall Study|Investigator Decision|42|||
146772846|NCT00835770|529338216|FG000|Overall Study|Participant Non-Compliance|11|||
146772847|NCT00835770|529338217|FG001|Overall Study|Participant Non-Compliance|9|||
146772848|NCT00835770|529338216|FG000|Overall Study|Death|4|||
146772849|NCT00835770|529338217|FG001|Overall Study|Death|6|||
146772850|NCT00835770|529338216|FG000|Overall Study|Other|115|||
146772851|NCT00835770|529338217|FG001|Overall Study|Other|104|||
146772852|NCT00835770|529338216|FG000|Overall Study|Other|2|||
146772853|NCT00835770|529338217|FG001|Overall Study|Other|1|||
146772854|NCT01185782|529338218|FG000|Overall Study|Adverse Event|0|||
146772855|NCT01185782|529338219|FG001|Overall Study|Adverse Event|1|||
146772856|NCT01185782|529338218|FG000|Overall Study|Protocol Violation|1|||
146772857|NCT01185782|529338219|FG001|Overall Study|Protocol Violation|0|||
146772858|NCT01185782|529338218|FG000|Overall Study|Poor Response to Treatment|3|||
146772859|NCT01185782|529338219|FG001|Overall Study|Poor Response to Treatment|1|||
146772860|NCT01185782|529338218|FG000|Overall Study|Other|2|||
146772861|NCT01185782|529338219|FG001|Overall Study|Other|5|||
146772862|NCT01185782|529338218|FG000|Overall Study|Randomized but not treated|0|||
146772863|NCT01185782|529338219|FG001|Overall Study|Randomized but not treated|4|||
146772864|NCT01061151|529338221|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
146772865|NCT01061151|529338222|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
146772866|NCT01061151|529338223|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
146772867|NCT01061151|529338224|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
146772868|NCT01061151|529338221|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
146772869|NCT01061151|529338222|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
146772870|NCT01061151|529338223|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
146772871|NCT01061151|529338224|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
146772872|NCT01061151|529338221|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
146772873|NCT01061151|529338222|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
146772874|NCT01061151|529338223|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
146772875|NCT01061151|529338224|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
146772876|NCT01061151|529338221|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
146772877|NCT01061151|529338222|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
146772878|NCT01061151|529338223|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
146772879|NCT01061151|529338224|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
146772880|NCT01061151|529338221|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
146772881|NCT01061151|529338222|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
146772882|NCT01061151|529338223|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
146772883|NCT01061151|529338224|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
146772884|NCT01061151|529338221|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
146772885|NCT01061151|529338222|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
146772886|NCT01061151|529338223|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
146772887|NCT01061151|529338224|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
146602440|NCT01939366|528715596|FG000|Overall Study|Adverse Event|8|||
146772888|NCT01061151|529338221|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
146656457|NCT03332771|528919582|FG002|Overall Study|Adverse Event|1|||
146656458|NCT03332771|528919583|FG003|Overall Study|Adverse Event|3|||
146656459|NCT03332771|528919580|FG000|Overall Study|Poor Compliance to Protocol|0|||
146656460|NCT03332771|528919581|FG001|Overall Study|Poor Compliance to Protocol|1|||
146656461|NCT03332771|528919582|FG002|Overall Study|Poor Compliance to Protocol|0|||
146656462|NCT03332771|528919583|FG003|Overall Study|Poor Compliance to Protocol|1|||
146656463|NCT03332771|528919580|FG000|Overall Study|Lost to Follow-up|2|||
146656464|NCT03332771|528919581|FG001|Overall Study|Lost to Follow-up|2|||
146656465|NCT03332771|528919582|FG002|Overall Study|Lost to Follow-up|1|||
146656466|NCT03332771|528919583|FG003|Overall Study|Lost to Follow-up|2|||
146656467|NCT03332771|528919580|FG000|Overall Study|At the Participant's own request|20|||
146656468|NCT03332771|528919581|FG001|Overall Study|At the Participant's own request|26|||
146656469|NCT03332771|528919582|FG002|Overall Study|At the Participant's own request|14|||
146656470|NCT03332771|528919583|FG003|Overall Study|At the Participant's own request|23|||
146656471|NCT03332771|528919580|FG000|Overall Study|Reason Not Specified|6|||
146656472|NCT03332771|528919581|FG001|Overall Study|Reason Not Specified|18|||
146656473|NCT03332771|528919582|FG002|Overall Study|Reason Not Specified|16|||
146656474|NCT03332771|528919583|FG003|Overall Study|Reason Not Specified|19|||
146656475|NCT00719264|528919585|FG000|Overall Study|Adverse Event|41|||
146656476|NCT00719264|528919586|FG001|Overall Study|Adverse Event|49|||
146656477|NCT00719264|528919585|FG000|Overall Study|Death|13|||
146656478|NCT00719264|528919586|FG001|Overall Study|Death|10|||
146656479|NCT00719264|528919585|FG000|Overall Study|Administrative Problems|6|||
146656480|NCT00719264|528919586|FG001|Overall Study|Administrative Problems|4|||
146656481|NCT00719264|528919585|FG000|Overall Study|Lost to Follow-up|1|||
146656482|NCT00719264|528919586|FG001|Overall Study|Lost to Follow-up|1|||
146656483|NCT00719264|528919585|FG000|Overall Study|Withdrawal by Subject|12|||
146772889|NCT01061151|529338222|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
146772890|NCT01061151|529338223|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
146772891|NCT01061151|529338224|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
146656484|NCT00719264|528919586|FG001|Overall Study|Withdrawal by Subject|7|||
146656485|NCT00719264|528919585|FG000|Overall Study|Protocol Deviation|1|||
146656486|NCT00719264|528919586|FG001|Overall Study|Protocol Deviation|3|||
146656487|NCT00719264|528919585|FG000|Overall Study|New Cancer Therapy|4|||
146656488|NCT00719264|528919586|FG001|Overall Study|New Cancer Therapy|2|||
146656489|NCT00719264|528919585|FG000|Overall Study|Disease Progression|104|||
146656490|NCT00719264|528919586|FG001|Overall Study|Disease Progression|107|||
146656491|NCT00588952|528919587|FG000|Overall Study|Adverse Event|0|||
146656492|NCT00588952|528919588|FG001|Overall Study|Adverse Event|2|||
146656493|NCT00588952|528919587|FG000|Overall Study|Withdrawal by Subject|3|||
146656494|NCT00588952|528919588|FG001|Overall Study|Withdrawal by Subject|5|||
146772892|NCT01061151|529338221|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
146772893|NCT01061151|529338222|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
146772894|NCT01061151|529338223|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
146772895|NCT01061151|529338224|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
146772896|NCT01061151|529338221|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
146772897|NCT01061151|529338222|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
146772898|NCT01061151|529338223|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
146772899|NCT01061151|529338224|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
146772900|NCT01061151|529338221|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
146772901|NCT01061151|529338222|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
146772902|NCT01061151|529338223|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
146772903|NCT01061151|529338224|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
146772904|NCT01061151|529338221|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
146772905|NCT01061151|529338222|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
146656495|NCT00737464|528919589|FG000|Overall Study|Adverse Event|1|||
146656496|NCT00737464|528919589|FG000|Overall Study|Death|6|||
146656497|NCT00737464|528919589|FG000|Overall Study|Other - Failure to Return|1|||
146656498|NCT00737464|528919589|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
146656499|NCT00737464|528919589|FG000|Overall Study|Other reasons|4|||
146656500|NCT04177355|528919598|FG000|Overall Study|Lost to Follow-up|0|||
146656501|NCT04177355|528919599|FG001|Overall Study|Lost to Follow-up|2|||
146656502|NCT04177355|528919600|FG002|Overall Study|Lost to Follow-up|0|||
146656503|NCT04177355|528919601|FG003|Overall Study|Lost to Follow-up|1|||
146656504|NCT04177355|528919602|FG004|Overall Study|Lost to Follow-up|2|||
146656505|NCT04177355|528919603|FG005|Overall Study|Lost to Follow-up|0|||
146656506|NCT04177355|528919604|FG006|Overall Study|Lost to Follow-up|1|||
146656507|NCT04177355|528919605|FG007|Overall Study|Lost to Follow-up|0|||
146656508|NCT04177355|528919606|FG008|Overall Study|Lost to Follow-up|0|||
146656509|NCT04177355|528919607|FG009|Overall Study|Lost to Follow-up|0|||
146772906|NCT01061151|529338223|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
146772907|NCT01061151|529338224|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
146656510|NCT04177355|528919608|FG010|Overall Study|Lost to Follow-up|0|||
146656511|NCT04177355|528919598|FG000|Overall Study|Withdrawal by Subject|0|||
146922746|NCT03855137|529876825|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
146922747|NCT03855137|529876826|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
146922748|NCT03855137|529876824|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
146922749|NCT03855137|529876825|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
146922750|NCT03855137|529876826|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
146602441|NCT01939366|528715597|FG001|Overall Study|Adverse Event|17|||
146602442|NCT01939366|528715598|FG002|Overall Study|Adverse Event|30|||
146602443|NCT01939366|528715599|FG003|Overall Study|Adverse Event|8|||
146602444|NCT01939366|528715600|FG004|Overall Study|Adverse Event|5|||
146602445|NCT01939366|528715596|FG000|Overall Study|Lack of Efficacy|2|||
146602446|NCT01939366|528715597|FG001|Overall Study|Lack of Efficacy|1|||
146602447|NCT01939366|528715598|FG002|Overall Study|Lack of Efficacy|1|||
146602448|NCT01939366|528715599|FG003|Overall Study|Lack of Efficacy|1|||
146602449|NCT01939366|528715600|FG004|Overall Study|Lack of Efficacy|3|||
146602450|NCT01939366|528715596|FG000|Overall Study|Lost to Follow-up|1|||
146602451|NCT01939366|528715597|FG001|Overall Study|Lost to Follow-up|1|||
146602452|NCT01939366|528715598|FG002|Overall Study|Lost to Follow-up|0|||
146602453|NCT01939366|528715599|FG003|Overall Study|Lost to Follow-up|0|||
146602454|NCT01939366|528715600|FG004|Overall Study|Lost to Follow-up|0|||
146602455|NCT01939366|528715596|FG000|Overall Study|Withdrawal by Subject|1|||
146602456|NCT01939366|528715597|FG001|Overall Study|Withdrawal by Subject|0|||
146602457|NCT01939366|528715598|FG002|Overall Study|Withdrawal by Subject|2|||
146922751|NCT03855137|529876824|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
146922752|NCT03855137|529876825|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
146922753|NCT03855137|529876826|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
146602458|NCT01939366|528715599|FG003|Overall Study|Withdrawal by Subject|2|||
146602459|NCT01939366|528715600|FG004|Overall Study|Withdrawal by Subject|3|||
146602460|NCT01939366|528715596|FG000|Overall Study|Inclusion criteria not met|0|||
146602461|NCT01939366|528715597|FG001|Overall Study|Inclusion criteria not met|1|||
146602462|NCT01939366|528715598|FG002|Overall Study|Inclusion criteria not met|1|||
146602463|NCT01939366|528715599|FG003|Overall Study|Inclusion criteria not met|0|||
146602464|NCT01939366|528715600|FG004|Overall Study|Inclusion criteria not met|1|||
146602465|NCT01939366|528715596|FG000|Overall Study|Other|0|||
146602466|NCT01939366|528715597|FG001|Overall Study|Other|0|||
146602467|NCT01939366|528715598|FG002|Overall Study|Other|2|||
146602468|NCT01939366|528715599|FG003|Overall Study|Other|2|||
146602469|NCT01939366|528715600|FG004|Overall Study|Other|1|||
146602470|NCT01939366|528715596|FG000|Overall Study|Protocol Violation|0|||
146602471|NCT01939366|528715597|FG001|Overall Study|Protocol Violation|0|||
146602472|NCT01939366|528715598|FG002|Overall Study|Protocol Violation|0|||
146602473|NCT01939366|528715599|FG003|Overall Study|Protocol Violation|1|||
146602474|NCT01939366|528715600|FG004|Overall Study|Protocol Violation|0|||
146602475|NCT01939366|528715596|FG000|Overall Study|Sponsor decision|0|||
146602476|NCT01939366|528715597|FG001|Overall Study|Sponsor decision|0|||
146602477|NCT01939366|528715598|FG002|Overall Study|Sponsor decision|0|||
146602478|NCT01939366|528715599|FG003|Overall Study|Sponsor decision|0|||
146602479|NCT01939366|528715600|FG004|Overall Study|Sponsor decision|2|||
146602480|NCT01939366|528715596|FG000|Overall Study|GCP non-compliance at site|2|||
146602481|NCT01939366|528715597|FG001|Overall Study|GCP non-compliance at site|3|||
146602482|NCT01939366|528715598|FG002|Overall Study|GCP non-compliance at site|2|||
146602483|NCT01939366|528715599|FG003|Overall Study|GCP non-compliance at site|3|||
146602484|NCT01939366|528715600|FG004|Overall Study|GCP non-compliance at site|3|||
146602485|NCT04680975|528715605|FG000|Overall Study|Adverse Event|3|||
146602486|NCT04680975|528715605|FG000|Overall Study|Death|1|||
146602487|NCT04680975|528715605|FG000|Overall Study|Progressive Disease|1|||
146602488|NCT04680975|528715605|FG000|Overall Study|Withdrawal by Subject|1|||
146602489|NCT03909152|528715606|FG000|Overall Study|Adverse Event|14|||
146602490|NCT03909152|528715607|FG001|Overall Study|Adverse Event|5|||
146602491|NCT03909152|528715608|FG002|Overall Study|Adverse Event|1|||
146602492|NCT03909152|528715609|FG003|Overall Study|Adverse Event|14|||
146602493|NCT04541628|528715612|FG000|Overall Study|Study Terminated|1|||
146602494|NCT04541628|528715613|FG001|Overall Study|Study Terminated|1|||
146602495|NCT04541628|528715614|FG002|Overall Study|Study Terminated|1|||
146602496|NCT01192412|528715619|FG000|Overall Study|Lost to Follow-up|2|||
146602497|NCT01192412|528715620|FG001|Overall Study|Lost to Follow-up|1|||
146602498|NCT01192412|528715619|FG000|Overall Study|Withdrawal by Subject|2|||
146602499|NCT01192412|528715620|FG001|Overall Study|Withdrawal by Subject|1|||
146602500|NCT00151476|528715621|FG000|FAP Identified Subjects|Protocol Violation|0|||
146602501|NCT00151476|528715622|FG001|FAP Identified Subjects|Protocol Violation|1|||
146602502|NCT00151476|528715621|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
146602503|NCT00151476|528715622|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
146602504|NCT00151476|528715621|FG000|FAP Analyzed Subjects|Other study participation|0|||
146602505|NCT00151476|528715622|FG001|FAP Analyzed Subjects|Other study participation|1|||
146602506|NCT04099511|528715627|FG000|Overall Study|Lost to Follow-up|2|||
146602507|NCT04099511|528715628|FG001|Overall Study|Lost to Follow-up|2|||
146602508|NCT04099511|528715627|FG000|Overall Study|Withdrawal by Subject|8|||
146602509|NCT04099511|528715628|FG001|Overall Study|Withdrawal by Subject|4|||
146602510|NCT06151288|528715630|FG000|Overall Study|Lost to Follow-up|4|||
146602511|NCT06151288|528715631|FG001|Overall Study|Lost to Follow-up|2|||
146602512|NCT06151288|528715632|FG002|Overall Study|Lost to Follow-up|4|||
146602513|NCT06151288|528715633|FG003|Overall Study|Lost to Follow-up|3|||
146602514|NCT06151288|528715630|FG000|Overall Study|Withdrawal by Subject|4|||
146602515|NCT06151288|528715631|FG001|Overall Study|Withdrawal by Subject|5|||
146602516|NCT06151288|528715632|FG002|Overall Study|Withdrawal by Subject|1|||
146602517|NCT06151288|528715633|FG003|Overall Study|Withdrawal by Subject|1|||
146602518|NCT01240200|528715635|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
146602519|NCT01240200|528715636|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
146602520|NCT03194438|528715639|FG000|Overall Study|Withdrawal by Subject|2|||
146602521|NCT02708485|528715640|FG000|Overall Study|Withdrawal by Subject|3|||
146602522|NCT02708485|528715641|FG001|Overall Study|Withdrawal by Subject|2|||
146602523|NCT01554514|528715646|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
146602524|NCT01554514|528715646|FG000|Overall Study|Physician Decision|1|||
146602525|NCT01423916|528715647|FG000|Overall Study|Adverse Event|5|||
146602526|NCT01423916|528715648|FG001|Overall Study|Adverse Event|9|||
146602527|NCT01423916|528715649|FG002|Overall Study|Adverse Event|2|||
146656512|NCT04177355|528919599|FG001|Overall Study|Withdrawal by Subject|0|||
146656513|NCT04177355|528919600|FG002|Overall Study|Withdrawal by Subject|0|||
146656514|NCT04177355|528919601|FG003|Overall Study|Withdrawal by Subject|1|||
146656515|NCT04177355|528919602|FG004|Overall Study|Withdrawal by Subject|1|||
146602528|NCT01423916|528715647|FG000|Overall Study|Met Withdrawal Criteria|1|||
146602529|NCT01423916|528715648|FG001|Overall Study|Met Withdrawal Criteria|1|||
146602530|NCT01423916|528715649|FG002|Overall Study|Met Withdrawal Criteria|1|||
146602531|NCT01423916|528715647|FG000|Overall Study|Physician Decision|1|||
146602532|NCT01423916|528715648|FG001|Overall Study|Physician Decision|0|||
146602533|NCT01423916|528715649|FG002|Overall Study|Physician Decision|1|||
146602534|NCT01423916|528715647|FG000|Overall Study|Withdrawal by Subject|3|||
146602535|NCT01423916|528715648|FG001|Overall Study|Withdrawal by Subject|10|||
146602536|NCT01423916|528715649|FG002|Overall Study|Withdrawal by Subject|3|||
146602537|NCT01423916|528715647|FG000|Overall Study|Protocol Deviation|1|||
146602538|NCT01423916|528715648|FG001|Overall Study|Protocol Deviation|0|||
146602539|NCT01423916|528715649|FG002|Overall Study|Protocol Deviation|0|||
146602540|NCT03157583|528715652|FG000|Overall Study|Other (did not meet study criteria)|1|||
146602541|NCT01581619|528715662|FG000|Overall Study|Withdrawal by Subject|1|||
146602542|NCT01581619|528715662|FG000|Overall Study|Lost to Follow-up|1|||
146602543|NCT00290498|528715663|FG000|Overall Study|Death|2|||
146602544|NCT00290498|528715664|FG001|Overall Study|Death|0|||
146602545|NCT00290498|528715663|FG000|Overall Study|Physician Decision|1|||
146602546|NCT00290498|528715664|FG001|Overall Study|Physician Decision|0|||
146602547|NCT00290498|528715663|FG000|Overall Study|Withdrawal by Subject|1|||
146602548|NCT00290498|528715664|FG001|Overall Study|Withdrawal by Subject|0|||
146602549|NCT00290498|528715663|FG000|Overall Study|Ineligible|3|||
146602550|NCT00290498|528715664|FG001|Overall Study|Ineligible|0|||
146602551|NCT00290498|528715663|FG000|Overall Study|Non-Compliance|1|||
146602552|NCT00290498|528715664|FG001|Overall Study|Non-Compliance|0|||
146656516|NCT04177355|528919603|FG005|Overall Study|Withdrawal by Subject|0|||
146656517|NCT04177355|528919604|FG006|Overall Study|Withdrawal by Subject|0|||
146656518|NCT04177355|528919605|FG007|Overall Study|Withdrawal by Subject|0|||
146656519|NCT04177355|528919606|FG008|Overall Study|Withdrawal by Subject|1|||
146656520|NCT04177355|528919607|FG009|Overall Study|Withdrawal by Subject|0|||
146656521|NCT04177355|528919608|FG010|Overall Study|Withdrawal by Subject|0|||
146656522|NCT03418571|528919612|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
146656523|NCT03418571|528919613|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
146656524|NCT00586326|528919614|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
146656525|NCT00586326|528919614|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
146656526|NCT00586326|528919614|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
146656527|NCT00586326|528919614|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
146656528|NCT00586326|528919614|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
146656529|NCT00586326|528919614|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
146656530|NCT00586326|528919614|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
146656531|NCT00586326|528919614|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
146656532|NCT00586326|528919614|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
146656533|NCT00586326|528919614|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
146602553|NCT02250664|528715667|FG000|Overall Study|Lost to Follow-up|18|||
146602554|NCT02250664|528715668|FG001|Overall Study|Lost to Follow-up|28|||
146602555|NCT02250664|528715669|FG002|Overall Study|Lost to Follow-up|33|||
146602556|NCT02250664|528715667|FG000|Overall Study|Personal Reasons|7|||
146656534|NCT00586326|528919614|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
146602557|NCT02250664|528715668|FG001|Overall Study|Personal Reasons|8|||
146602558|NCT02250664|528715669|FG002|Overall Study|Personal Reasons|14|||
146602559|NCT02250664|528715667|FG000|Overall Study|Adverse Event|6|||
146602560|NCT02250664|528715668|FG001|Overall Study|Adverse Event|3|||
146602561|NCT02250664|528715669|FG002|Overall Study|Adverse Event|8|||
146602562|NCT02250664|528715667|FG000|Overall Study|Incarcerated|2|||
146602563|NCT02250664|528715668|FG001|Overall Study|Incarcerated|1|||
146602564|NCT02250664|528715669|FG002|Overall Study|Incarcerated|2|||
146602565|NCT02250664|528715667|FG000|Overall Study|Withdrawal by Subject|0|||
146602566|NCT02250664|528715668|FG001|Overall Study|Withdrawal by Subject|1|||
146602567|NCT02250664|528715669|FG002|Overall Study|Withdrawal by Subject|2|||
146602568|NCT02250664|528715667|FG000|Overall Study|Death|0|||
146602569|NCT02250664|528715668|FG001|Overall Study|Death|1|||
146602570|NCT02250664|528715669|FG002|Overall Study|Death|1|||
146656535|NCT00586326|528919614|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
146656536|NCT00586326|528919614|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
146656537|NCT00586326|528919614|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
146656538|NCT00586326|528919614|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
146656539|NCT00586326|528919614|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
146656540|NCT00586326|528919614|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
146656541|NCT03595774|528919615|FG000|Overall Study|Adverse Event|1|||
146656542|NCT03595774|528919616|FG001|Overall Study|Adverse Event|0|||
146656543|NCT03595774|528919617|FG002|Overall Study|Adverse Event|1|||
146656544|NCT03595774|528919618|FG003|Overall Study|Adverse Event|0|||
146656545|NCT03595774|528919615|FG000|Overall Study|screen failure|0|||
146656546|NCT03595774|528919616|FG001|Overall Study|screen failure|1|||
146656547|NCT03595774|528919617|FG002|Overall Study|screen failure|0|||
146656548|NCT03595774|528919618|FG003|Overall Study|screen failure|1|||
146656549|NCT03519386|528919619|FG000|Overall Study|Withdrawal by Subject|4|||
146656550|NCT03519386|528919620|FG001|Overall Study|Withdrawal by Subject|1|||
146656551|NCT03519386|528919621|FG002|Overall Study|Withdrawal by Subject|2|||
146656552|NCT03519386|528919619|FG000|Overall Study|Physician Decision|1|||
146656553|NCT03519386|528919620|FG001|Overall Study|Physician Decision|1|||
146656554|NCT03519386|528919621|FG002|Overall Study|Physician Decision|1|||
146656555|NCT03519386|528919619|FG000|Overall Study|Lost to Follow-up|0|||
146656556|NCT03519386|528919620|FG001|Overall Study|Lost to Follow-up|1|||
146656557|NCT03519386|528919621|FG002|Overall Study|Lost to Follow-up|1|||
146656558|NCT03519386|528919619|FG000|Overall Study|Death|1|||
146656559|NCT03519386|528919620|FG001|Overall Study|Death|0|||
146656560|NCT03519386|528919621|FG002|Overall Study|Death|4|||
146656561|NCT03519386|528919619|FG000|Overall Study|Adverse Event|2|||
146656562|NCT03519386|528919620|FG001|Overall Study|Adverse Event|1|||
146656563|NCT03519386|528919621|FG002|Overall Study|Adverse Event|2|||
146656564|NCT03519386|528919619|FG000|Overall Study|Explanted|2|||
146656565|NCT03519386|528919620|FG001|Overall Study|Explanted|1|||
146656566|NCT03519386|528919621|FG002|Overall Study|Explanted|0|||
146656567|NCT03519386|528919619|FG000|Overall Study|Ongoing in study|190|||
146656568|NCT03519386|528919620|FG001|Overall Study|Ongoing in study|192|||
146656569|NCT03519386|528919621|FG002|Overall Study|Ongoing in study|183|||
146656570|NCT03101267|528919623|FG000|Primary Study Period|Withdrawal by Subject|1|||
146656571|NCT03101267|528919624|FG001|Primary Study Period|Withdrawal by Subject|2|||
146656572|NCT03101267|528919625|FG002|Primary Study Period|Withdrawal by Subject|3|||
146656573|NCT03101267|528919623|FG000|Primary Study Period|Miscellaneous|2|||
146656574|NCT03101267|528919624|FG001|Primary Study Period|Miscellaneous|0|||
146656575|NCT03101267|528919625|FG002|Primary Study Period|Miscellaneous|0|||
146656576|NCT00107952|528919626|FG000|Overall Study|Death|75|||
146656577|NCT00107952|528919627|FG001|Overall Study|Death|61|||
146656578|NCT00107952|528919626|FG000|Overall Study|Lost to Follow-up|0|||
146656579|NCT00107952|528919627|FG001|Overall Study|Lost to Follow-up|3|||
146656580|NCT00107952|528919626|FG000|Overall Study|Withdrawal by Subject|9|||
146656581|NCT00107952|528919627|FG001|Overall Study|Withdrawal by Subject|6|||
146656582|NCT00107952|528919626|FG000|Overall Study|Other|2|||
146656583|NCT00107952|528919627|FG001|Overall Study|Other|5|||
146656584|NCT00107952|528919626|FG000|Overall Study|Never received study treatment|9|||
146656585|NCT00107952|528919627|FG001|Overall Study|Never received study treatment|6|||
146656586|NCT03063203|528919635|FG000|Overall Study|Chose alternative therapy|3|||
146656587|NCT03063203|528919635|FG000|Overall Study|Death|2|||
146656588|NCT03063203|528919635|FG000|Overall Study|Disease progression|4|||
146656589|NCT03063203|528919635|FG000|Overall Study|Physician Decision|5|||
146656590|NCT02045303|528919636|FG000|Overall Study|Protocol Violation|2|||
146656591|NCT02045303|528919637|FG001|Overall Study|Protocol Violation|1|||
146656592|NCT02045303|528919638|FG002|Overall Study|Protocol Violation|0|||
146656593|NCT02045303|528919636|FG000|Overall Study|Withdrawal by Subject|0|||
146656594|NCT02045303|528919637|FG001|Overall Study|Withdrawal by Subject|2|||
146656595|NCT02045303|528919638|FG002|Overall Study|Withdrawal by Subject|0|||
146656596|NCT01642407|528919639|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
146656597|NCT01642407|528919639|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
146656598|NCT01642407|528919639|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
146656599|NCT01856023|528919640|FG000|Overall Study|Death|1|||
146656600|NCT01856023|528919641|FG001|Overall Study|Death|2|||
146656601|NCT01856023|528919640|FG000|Overall Study|Adverse Event|2|||
146656602|NCT01856023|528919641|FG001|Overall Study|Adverse Event|1|||
146656603|NCT01856023|528919640|FG000|Overall Study|Lack of Efficacy|5|||
146656604|NCT01856023|528919641|FG001|Overall Study|Lack of Efficacy|5|||
146602571|NCT02250664|528715667|FG000|Overall Study|Physician Decision|1|||
146602572|NCT02250664|528715668|FG001|Overall Study|Physician Decision|3|||
146602573|NCT02250664|528715669|FG002|Overall Study|Physician Decision|1|||
146602574|NCT02250664|528715667|FG000|Overall Study|Protocol Violation|1|||
146602575|NCT02250664|528715668|FG001|Overall Study|Protocol Violation|0|||
146602576|NCT02250664|528715669|FG002|Overall Study|Protocol Violation|1|||
146602577|NCT02250664|528715667|FG000|Overall Study|Reason unknown|1|||
146602578|NCT02250664|528715668|FG001|Overall Study|Reason unknown|0|||
146602579|NCT02250664|528715669|FG002|Overall Study|Reason unknown|0|||
146602580|NCT03847909|528715671|FG000|Overall Study|Withdrawal by Subject|1|||
146602581|NCT03847909|528715672|FG001|Overall Study|Withdrawal by Subject|1|||
146602582|NCT04268173|528715673|FG000|Overall Study|Lost to Follow-up|75|||
146602583|NCT04268173|528715674|FG001|Overall Study|Lost to Follow-up|108|||
146602584|NCT00869401|528715675|FG000|Overall Study|Withdrawal by Subject|0|||
146602585|NCT00869401|528715676|FG001|Overall Study|Withdrawal by Subject|0|||
146602586|NCT00869401|528715677|FG002|Overall Study|Withdrawal by Subject|0|||
146602587|NCT00869401|528715678|FG003|Overall Study|Withdrawal by Subject|5|||
146602588|NCT00869401|528715679|FG004|Overall Study|Withdrawal by Subject|3|||
146602589|NCT00975143|528715680|FG000|Overall Study|Adverse Event|19|||
146602590|NCT00975143|528715681|FG001|Overall Study|Adverse Event|15|||
146602591|NCT00975143|528715680|FG000|Overall Study|Withdrawal by Subject|15|||
146602592|NCT00975143|528715681|FG001|Overall Study|Withdrawal by Subject|15|||
146602593|NCT00975143|528715680|FG000|Overall Study|Lost to Follow-up|20|||
146602594|NCT00975143|528715681|FG001|Overall Study|Lost to Follow-up|16|||
146602595|NCT00975143|528715680|FG000|Overall Study|Non-compliance|5|||
146602596|NCT00975143|528715681|FG001|Overall Study|Non-compliance|8|||
146602597|NCT00975143|528715680|FG000|Overall Study|Physician Decision|1|||
146602598|NCT00975143|528715681|FG001|Overall Study|Physician Decision|2|||
146602599|NCT00975143|528715680|FG000|Overall Study|Details not available|10|||
146602600|NCT00975143|528715681|FG001|Overall Study|Details not available|4|||
146602601|NCT01147900|528715682|FG000|At Year 10|Lost to Follow-up|0|||
146602602|NCT01147900|528715683|FG001|At Year 10|Lost to Follow-up|1|||
146602603|NCT01147900|528715684|FG002|At Year 10|Lost to Follow-up|0|||
146602604|NCT01375608|528715685|FG000|Overall Study|Withdrawal by Subject|2|||
146602605|NCT00581360|528715686|FG000|Overall Study|Withdrawal by Subject|1|||
146602606|NCT03129360|528715687|FG000|Overall Study|Did not meet entry criteria|0|||
146602607|NCT03129360|528715688|FG001|Overall Study|Did not meet entry criteria|2|||
146602608|NCT03129360|528715689|FG002|Overall Study|Did not meet entry criteria|1|||
146602609|NCT03129360|528715687|FG000|Overall Study|Excluded due to motion in scanner|1|||
146602610|NCT03129360|528715688|FG001|Overall Study|Excluded due to motion in scanner|0|||
146602611|NCT03129360|528715689|FG002|Overall Study|Excluded due to motion in scanner|0|||
146602612|NCT00545103|528715690|FG000|Overall Study|Lack of Efficacy|48|||
146602613|NCT00545103|528715691|FG001|Overall Study|Lack of Efficacy|45|||
146602614|NCT00545103|528715692|FG002|Overall Study|Lack of Efficacy|31|||
146602615|NCT00545103|528715693|FG003|Overall Study|Lack of Efficacy|27|||
146602616|NCT00545103|528715690|FG000|Overall Study|Withdrawal by Subject|6|||
146602617|NCT00545103|528715691|FG001|Overall Study|Withdrawal by Subject|10|||
146602618|NCT00545103|528715692|FG002|Overall Study|Withdrawal by Subject|18|||
146602619|NCT00545103|528715693|FG003|Overall Study|Withdrawal by Subject|22|||
146602620|NCT00545103|528715690|FG000|Overall Study|Adverse Event|11|||
146602621|NCT00545103|528715691|FG001|Overall Study|Adverse Event|12|||
146602622|NCT00545103|528715692|FG002|Overall Study|Adverse Event|17|||
146602623|NCT00545103|528715693|FG003|Overall Study|Adverse Event|10|||
146602624|NCT00545103|528715690|FG000|Overall Study|Lost to Follow-up|4|||
146602625|NCT00545103|528715691|FG001|Overall Study|Lost to Follow-up|6|||
146602626|NCT00545103|528715692|FG002|Overall Study|Lost to Follow-up|3|||
146602627|NCT00545103|528715693|FG003|Overall Study|Lost to Follow-up|4|||
146602628|NCT00545103|528715690|FG000|Overall Study|Protocol Violation|1|||
146602629|NCT00545103|528715691|FG001|Overall Study|Protocol Violation|2|||
146602630|NCT00545103|528715692|FG002|Overall Study|Protocol Violation|3|||
146602631|NCT00545103|528715693|FG003|Overall Study|Protocol Violation|0|||
146602632|NCT00545103|528715690|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
146602633|NCT00545103|528715691|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
146602634|NCT00545103|528715692|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
146602635|NCT00545103|528715693|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
146602636|NCT00545103|528715690|FG000|Overall Study|Difficult to open package|0|||
146602637|NCT00545103|528715691|FG001|Overall Study|Difficult to open package|0|||
146602638|NCT00545103|528715692|FG002|Overall Study|Difficult to open package|0|||
146602639|NCT00545103|528715693|FG003|Overall Study|Difficult to open package|1|||
146602640|NCT00545103|528715690|FG000|Overall Study|Investigational product not taken|1|||
146602641|NCT00545103|528715691|FG001|Overall Study|Investigational product not taken|0|||
146602642|NCT00545103|528715692|FG002|Overall Study|Investigational product not taken|0|||
146602643|NCT00545103|528715693|FG003|Overall Study|Investigational product not taken|1|||
146602644|NCT00545103|528715690|FG000|Overall Study|Wish to start a family|0|||
146602645|NCT00545103|528715691|FG001|Overall Study|Wish to start a family|0|||
146602646|NCT00545103|528715692|FG002|Overall Study|Wish to start a family|0|||
146602647|NCT00545103|528715693|FG003|Overall Study|Wish to start a family|1|||
146602648|NCT00545103|528715690|FG000|Overall Study|Diverticulitis crisis|0|||
146602649|NCT00545103|528715691|FG001|Overall Study|Diverticulitis crisis|0|||
146602650|NCT00545103|528715692|FG002|Overall Study|Diverticulitis crisis|0|||
146602651|NCT00545103|528715693|FG003|Overall Study|Diverticulitis crisis|1|||
146602652|NCT00545103|528715690|FG000|Overall Study|Personal reasons|1|||
146602653|NCT00545103|528715691|FG001|Overall Study|Personal reasons|0|||
146602654|NCT00545103|528715692|FG002|Overall Study|Personal reasons|0|||
146602655|NCT00545103|528715693|FG003|Overall Study|Personal reasons|0|||
146602656|NCT00545103|528715690|FG000|Overall Study|Subject's decision|1|||
146602657|NCT00545103|528715691|FG001|Overall Study|Subject's decision|0|||
146602658|NCT00545103|528715692|FG002|Overall Study|Subject's decision|0|||
146602659|NCT00545103|528715693|FG003|Overall Study|Subject's decision|0|||
146602660|NCT00545103|528715690|FG000|Overall Study|Noncompliance|0|||
146602661|NCT00545103|528715691|FG001|Overall Study|Noncompliance|1|||
146602662|NCT00545103|528715692|FG002|Overall Study|Noncompliance|0|||
146602663|NCT00545103|528715693|FG003|Overall Study|Noncompliance|0|||
146602664|NCT00545103|528715690|FG000|Overall Study|Investigator decision|0|||
146602665|NCT00545103|528715691|FG001|Overall Study|Investigator decision|0|||
146602666|NCT00545103|528715692|FG002|Overall Study|Investigator decision|1|||
146602667|NCT00545103|528715693|FG003|Overall Study|Investigator decision|0|||
146602668|NCT00545103|528715690|FG000|Overall Study|Subject moved|0|||
146602669|NCT00545103|528715691|FG001|Overall Study|Subject moved|1|||
146602670|NCT00545103|528715692|FG002|Overall Study|Subject moved|0|||
146602671|NCT00545103|528715693|FG003|Overall Study|Subject moved|0|||
146602672|NCT00545103|528715690|FG000|Overall Study|Use of prohibited medication|0|||
146602673|NCT00545103|528715691|FG001|Overall Study|Use of prohibited medication|0|||
146602674|NCT00545103|528715692|FG002|Overall Study|Use of prohibited medication|1|||
146602675|NCT00545103|528715693|FG003|Overall Study|Use of prohibited medication|0|||
146602676|NCT00545103|528715690|FG000|Overall Study|Does not want to take study drug anymore|1|||
146602677|NCT00545103|528715691|FG001|Overall Study|Does not want to take study drug anymore|0|||
146602678|NCT00545103|528715692|FG002|Overall Study|Does not want to take study drug anymore|1|||
146602679|NCT00545103|528715693|FG003|Overall Study|Does not want to take study drug anymore|0|||
146602680|NCT00545103|528715690|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
146602681|NCT00545103|528715691|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
146602682|NCT00545103|528715692|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
146602683|NCT00545103|528715693|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
146602684|NCT00545103|528715690|FG000|Overall Study|Death|0|||
146602685|NCT00545103|528715691|FG001|Overall Study|Death|1|||
146602686|NCT00545103|528715692|FG002|Overall Study|Death|0|||
146602687|NCT00545103|528715693|FG003|Overall Study|Death|0|||
146602688|NCT01353911|528715694|FG000|Overall Study|Lost to Follow-up|2|||
146602689|NCT01353911|528715695|FG001|Overall Study|Lost to Follow-up|6|||
146602690|NCT01353911|528715696|FG002|Overall Study|Lost to Follow-up|4|||
146602691|NCT01353911|528715697|FG003|Overall Study|Lost to Follow-up|0|||
146602692|NCT01353911|528715698|FG004|Overall Study|Lost to Follow-up|4|||
146602693|NCT01353911|528715699|FG005|Overall Study|Lost to Follow-up|4|||
146602694|NCT01353911|528715700|FG006|Overall Study|Lost to Follow-up|3|||
146602695|NCT01353911|528715701|FG007|Overall Study|Lost to Follow-up|6|||
146602696|NCT01353911|528715694|FG000|Overall Study|Withdrawal by Subject|2|||
146602697|NCT01353911|528715695|FG001|Overall Study|Withdrawal by Subject|3|||
146656605|NCT01856023|528919640|FG000|Overall Study|non compliance, study closure|1|||
146656606|NCT01856023|528919641|FG001|Overall Study|non compliance, study closure|3|||
146656607|NCT01856023|528919640|FG000|Overall Study|Withdrawal by Subject|1|||
146656608|NCT01856023|528919641|FG001|Overall Study|Withdrawal by Subject|1|||
146656609|NCT00829283|528919642|FG000|Overall Study|Lost to Follow-up|7|||
146602698|NCT01353911|528715696|FG002|Overall Study|Withdrawal by Subject|4|||
146602699|NCT01353911|528715697|FG003|Overall Study|Withdrawal by Subject|2|||
146602700|NCT01353911|528715698|FG004|Overall Study|Withdrawal by Subject|2|||
146602701|NCT01353911|528715699|FG005|Overall Study|Withdrawal by Subject|3|||
146602702|NCT01353911|528715700|FG006|Overall Study|Withdrawal by Subject|3|||
146602703|NCT01353911|528715701|FG007|Overall Study|Withdrawal by Subject|9|||
146602704|NCT01353911|528715694|FG000|Overall Study|Status Not Recorded|4|||
146602705|NCT01353911|528715695|FG001|Overall Study|Status Not Recorded|0|||
146602706|NCT01353911|528715696|FG002|Overall Study|Status Not Recorded|1|||
146602707|NCT01353911|528715697|FG003|Overall Study|Status Not Recorded|0|||
146978652|NCT00766506|530085447|FG000|Overall Study|Use rescue medication after 3 hours|3|||
146602708|NCT01353911|528715698|FG004|Overall Study|Status Not Recorded|0|||
146602709|NCT01353911|528715699|FG005|Overall Study|Status Not Recorded|0|||
146602710|NCT01353911|528715700|FG006|Overall Study|Status Not Recorded|0|||
146656610|NCT00829283|528919643|FG001|Overall Study|Lost to Follow-up|25|||
146602711|NCT01353911|528715701|FG007|Overall Study|Status Not Recorded|0|||
146602712|NCT00082381|528715703|FG000|Overall Study|Adverse Event|27|||
146602713|NCT00082381|528715704|FG001|Overall Study|Adverse Event|2|||
146602714|NCT00082381|528715703|FG000|Overall Study|Lost to Follow-up|5|||
146602715|NCT00082381|528715704|FG001|Overall Study|Lost to Follow-up|7|||
146602716|NCT00082381|528715703|FG000|Overall Study|Patient Decision|8|||
146602717|NCT00082381|528715704|FG001|Overall Study|Patient Decision|4|||
146602718|NCT00082381|528715703|FG000|Overall Study|Physician Decision|1|||
146602719|NCT00082381|528715704|FG001|Overall Study|Physician Decision|2|||
146602720|NCT00082381|528715703|FG000|Overall Study|Protocol Violation|10|||
146602721|NCT00082381|528715704|FG001|Overall Study|Protocol Violation|11|||
146602722|NCT00082381|528715703|FG000|Overall Study|Loss of Glucose Control|4|||
146602723|NCT00082381|528715704|FG001|Overall Study|Loss of Glucose Control|0|||
146602724|NCT02925741|528715706|FG000|Overall Study|Withdrawal by Subject|11|||
146602725|NCT02925741|528715707|FG001|Overall Study|Withdrawal by Subject|0|||
146602726|NCT00494507|528715710|FG000|Double-Blind Phase|Adverse Event|2|||
146602727|NCT00494507|528715711|FG001|Double-Blind Phase|Adverse Event|0|||
146602728|NCT00494507|528715712|FG002|Double-Blind Phase|Adverse Event|1|||
146602729|NCT00494507|528715713|FG003|Double-Blind Phase|Adverse Event|0|||
146602730|NCT00494507|528715710|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
146602731|NCT00494507|528715711|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
146602732|NCT00494507|528715712|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
146602733|NCT00494507|528715713|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
146602734|NCT00494507|528715710|FG000|Double-Blind Phase|Subject Non-compliance|0|||
146602735|NCT00494507|528715711|FG001|Double-Blind Phase|Subject Non-compliance|0|||
146602736|NCT00494507|528715712|FG002|Double-Blind Phase|Subject Non-compliance|1|||
146602737|NCT00494507|528715713|FG003|Double-Blind Phase|Subject Non-compliance|0|||
146602738|NCT00494507|528715710|FG000|Double-Blind Phase|Negative DNA test|0|||
146602739|NCT00494507|528715711|FG001|Double-Blind Phase|Negative DNA test|0|||
146602740|NCT00494507|528715712|FG002|Double-Blind Phase|Negative DNA test|0|||
146602741|NCT00494507|528715713|FG003|Double-Blind Phase|Negative DNA test|1|||
146602742|NCT00494507|528715710|FG000|Open-Label Phase|Adverse Event|0|||
146602743|NCT00494507|528715711|FG001|Open-Label Phase|Adverse Event|1|||
146602744|NCT00494507|528715712|FG002|Open-Label Phase|Adverse Event|5|||
146602745|NCT00494507|528715713|FG003|Open-Label Phase|Adverse Event|3|||
146602746|NCT00494507|528715710|FG000|Open-Label Phase|Worsening Disease|0|||
146602747|NCT00494507|528715711|FG001|Open-Label Phase|Worsening Disease|0|||
146602748|NCT00494507|528715712|FG002|Open-Label Phase|Worsening Disease|0|||
146602749|NCT00494507|528715713|FG003|Open-Label Phase|Worsening Disease|2|||
146602750|NCT00295932|528715714|FG000|Overall Study|Not Treated|0|||
146602751|NCT00295932|528715715|FG001|Overall Study|Not Treated|0|||
146602752|NCT00295932|528715716|FG002|Overall Study|Not Treated|0|||
146602753|NCT00295932|528715717|FG003|Overall Study|Not Treated|0|||
146602754|NCT00295932|528715718|FG004|Overall Study|Not Treated|0|||
146602755|NCT00295932|528715719|FG005|Overall Study|Not Treated|0|||
146602756|NCT00295932|528715720|FG006|Overall Study|Not Treated|0|||
146602757|NCT00295932|528715721|FG007|Overall Study|Not Treated|0|||
146602758|NCT00295932|528715722|FG008|Overall Study|Not Treated|0|||
146602759|NCT00295932|528715723|FG009|Overall Study|Not Treated|0|||
146602760|NCT00295932|528715724|FG010|Overall Study|Not Treated|1|||
146602761|NCT00109577|528715725|FG000|Overall Study|Withdrawal by Subject|3|||
146602762|NCT00109577|528715726|FG001|Overall Study|Withdrawal by Subject|3|||
146602763|NCT00587847|528715727|FG000|Overall Study|Lack of Efficacy|5|||
146602764|NCT00587847|528715727|FG000|Overall Study|Adverse Event|2|||
146602765|NCT02613169|528715728|FG000|Overall Study|Withdrawal by Subject|4|||
146602766|NCT02613169|528715729|FG001|Overall Study|Withdrawal by Subject|1|||
146602767|NCT02613169|528715728|FG000|Overall Study|Lost to Follow-up|0|||
146602768|NCT02613169|528715729|FG001|Overall Study|Lost to Follow-up|5|||
146602769|NCT02613169|528715728|FG000|Overall Study|HIV|0|||
146602770|NCT02613169|528715729|FG001|Overall Study|HIV|2|||
146602771|NCT02613169|528715728|FG000|Overall Study|No TB infection endpoint|14|||
146602772|NCT02613169|528715729|FG001|Overall Study|No TB infection endpoint|9|||
146602773|NCT00343382|528715730|FG000|Overall Study|Adverse Event|2|||
146602774|NCT00343382|528715731|FG001|Overall Study|Adverse Event|10|||
146602775|NCT00343382|528715732|FG002|Overall Study|Adverse Event|7|||
146602776|NCT00343382|528715730|FG000|Overall Study|Withdrawal by Subject|1|||
146602777|NCT00343382|528715731|FG001|Overall Study|Withdrawal by Subject|2|||
146602778|NCT00343382|528715732|FG002|Overall Study|Withdrawal by Subject|6|||
146602779|NCT00343382|528715730|FG000|Overall Study|Other Reason Not Specified|1|||
146656611|NCT00424255|528919644|FG000|Overall Study|Death|115|||
146656612|NCT00424255|528919645|FG001|Overall Study|Death|111|||
146656613|NCT00424255|528919644|FG000|Overall Study|Lost to Follow-up|26|||
146922754|NCT03855137|529876824|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
146922755|NCT03855137|529876825|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
146922756|NCT03855137|529876826|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
146602780|NCT00343382|528715731|FG001|Overall Study|Other Reason Not Specified|2|||
146602781|NCT00343382|528715732|FG002|Overall Study|Other Reason Not Specified|4|||
146602782|NCT04032080|528715733|FG000|Overall Study|Death|6|||
146602783|NCT03729245|528715734|FG000|Overall Study|Lost to Follow-up|5|||
146602784|NCT03729245|528715735|FG001|Overall Study|Lost to Follow-up|6|||
146602785|NCT03729245|528715734|FG000|Overall Study|Withdrawal by Subject|16|||
146602786|NCT03729245|528715735|FG001|Overall Study|Withdrawal by Subject|19|||
146602787|NCT03729245|528715734|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
146656614|NCT00424255|528919645|FG001|Overall Study|Lost to Follow-up|20|||
146602788|NCT03729245|528715735|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
146602789|NCT00884832|528715736|FG000|Overall Study|Withdrawal by Subject|0|||
146602790|NCT00884832|528715737|FG001|Overall Study|Withdrawal by Subject|1|||
146602791|NCT02337725|528715738|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
146602792|NCT02337725|528715739|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
146602793|NCT02337725|528715738|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
146602794|NCT02337725|528715739|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
146602795|NCT02337725|528715738|FG000|Overall Study|Major Protocol Deviation|0|||
146602796|NCT02337725|528715739|FG001|Overall Study|Major Protocol Deviation|1|||
146602797|NCT02337725|528715738|FG000|Overall Study|Voluntary Withdrawal|14|||
146602798|NCT02337725|528715739|FG001|Overall Study|Voluntary Withdrawal|3|||
146602799|NCT02337725|528715738|FG000|Overall Study|Lack of Efficacy|4|||
146602800|NCT02337725|528715739|FG001|Overall Study|Lack of Efficacy|0|||
146602801|NCT02096263|528715740|FG000|Overall Study|Adverse Event|1|||
146602802|NCT02096263|528715741|FG001|Overall Study|Adverse Event|0|||
146602803|NCT02096263|528715742|FG002|Overall Study|Adverse Event|1|||
146602804|NCT02096263|528715740|FG000|Overall Study|Lost to Follow-up|14|||
146602805|NCT02096263|528715741|FG001|Overall Study|Lost to Follow-up|18|||
146602806|NCT02096263|528715742|FG002|Overall Study|Lost to Follow-up|15|||
146602807|NCT02096263|528715740|FG000|Overall Study|Other|7|||
146602808|NCT02096263|528715741|FG001|Overall Study|Other|9|||
146602809|NCT02096263|528715742|FG002|Overall Study|Other|6|||
146602810|NCT02096263|528715740|FG000|Overall Study|Sponsor study termination|0|||
146602811|NCT02096263|528715741|FG001|Overall Study|Sponsor study termination|0|||
146602812|NCT02096263|528715742|FG002|Overall Study|Sponsor study termination|1|||
146602813|NCT02096263|528715740|FG000|Overall Study|Protocol Violation|7|||
146602814|NCT02096263|528715741|FG001|Overall Study|Protocol Violation|2|||
146602815|NCT02096263|528715742|FG002|Overall Study|Protocol Violation|8|||
146602816|NCT02096263|528715740|FG000|Overall Study|Withdrawal by Subject|5|||
146602817|NCT02096263|528715741|FG001|Overall Study|Withdrawal by Subject|7|||
146602818|NCT02096263|528715742|FG002|Overall Study|Withdrawal by Subject|8|||
146602819|NCT03322423|528715743|FG000|Period 1|Subject no longer eligible|0|||
146602820|NCT03322423|528715744|FG001|Period 1|Subject no longer eligible|1|||
146602821|NCT03322423|528715743|FG000|Period 1|Withdrawal by Subject|0|||
146602822|NCT03322423|528715744|FG001|Period 1|Withdrawal by Subject|1|||
146602823|NCT03322423|528715743|FG000|Period 1|Incorrect Lens Dispensed|1|||
146602824|NCT03322423|528715744|FG001|Period 1|Incorrect Lens Dispensed|0|||
146602825|NCT03322423|528715743|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
146602826|NCT03322423|528715744|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
146602827|NCT03322423|528715743|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
146602828|NCT03322423|528715744|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
146602829|NCT03322423|528715743|FG000|Period 2|Protocol Violation|1|||
146602830|NCT03322423|528715744|FG001|Period 2|Protocol Violation|0|||
146602831|NCT03322423|528715743|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
146602832|NCT03322423|528715744|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
146602833|NCT04891107|528715745|FG000|Overall Study|Physician Decision|1|||
146602834|NCT04891107|528715745|FG000|Overall Study|Withdrawal by Subject|1|||
146602835|NCT04891107|528715745|FG000|Overall Study|Screen failure after consent|1|||
146602836|NCT00500760|528715752|FG000|Overall Study|Death|32|||
146602837|NCT00500760|528715753|FG001|Overall Study|Death|15|||
146602838|NCT00500760|528715752|FG000|Overall Study|Withdrawal by Subject|5|||
146602839|NCT00500760|528715753|FG001|Overall Study|Withdrawal by Subject|7|||
146602840|NCT00500760|528715752|FG000|Overall Study|Administrative decision|2|||
146602841|NCT00500760|528715753|FG001|Overall Study|Administrative decision|0|||
146602842|NCT00500760|528715752|FG000|Overall Study|Lost to Follow-up|3|||
146602843|NCT00500760|528715753|FG001|Overall Study|Lost to Follow-up|0|||
146602844|NCT00500760|528715752|FG000|Overall Study|Other|1|||
146602845|NCT00500760|528715753|FG001|Overall Study|Other|2|||
146602846|NCT01600092|528715754|FG000|Overall Study|Adverse Event|2|||
146602847|NCT01600092|528715755|FG001|Overall Study|Adverse Event|0|||
146602848|NCT01600092|528715754|FG000|Overall Study|Lost to Follow-up|4|||
146602849|NCT01600092|528715755|FG001|Overall Study|Lost to Follow-up|6|||
146602850|NCT01600092|528715754|FG000|Overall Study|Withdrawal by parent/guardian|8|||
146602851|NCT01600092|528715755|FG001|Overall Study|Withdrawal by parent/guardian|6|||
146602852|NCT01600092|528715754|FG000|Overall Study|Physician Decision|1|||
146602853|NCT01600092|528715755|FG001|Overall Study|Physician Decision|1|||
146656615|NCT00424255|528919644|FG000|Overall Study|Protocol Violation|0|||
146602854|NCT01600092|528715754|FG000|Overall Study|Randomized but not vaccinated|3|||
146602855|NCT01600092|528715755|FG001|Overall Study|Randomized but not vaccinated|3|||
146602856|NCT02914561|528715756|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
146602857|NCT02914561|528715757|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
146602858|NCT02914561|528715758|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
146602859|NCT02914561|528715759|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
146602860|NCT02914561|528715760|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
146656616|NCT00424255|528919645|FG001|Overall Study|Protocol Violation|1|||
146602861|NCT02914561|528715761|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
146602862|NCT02914561|528715762|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
146602863|NCT02914561|528715763|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
146656617|NCT00424255|528919644|FG000|Overall Study|Withdrawal by Subject|34|||
146656618|NCT00424255|528919645|FG001|Overall Study|Withdrawal by Subject|38|||
146656619|NCT00424255|528919644|FG000|Overall Study|Physician Decision|3|||
146656620|NCT00424255|528919645|FG001|Overall Study|Physician Decision|7|||
146656621|NCT00424255|528919644|FG000|Overall Study|Cognitive Disturbance|1|||
146656622|NCT00424255|528919645|FG001|Overall Study|Cognitive Disturbance|0|||
146656623|NCT00424255|528919644|FG000|Overall Study|Non-compliance by Participants|1|||
146656624|NCT00424255|528919645|FG001|Overall Study|Non-compliance by Participants|0|||
146656625|NCT00424255|528919644|FG000|Overall Study|Fatigue|1|||
146656626|NCT00424255|528919645|FG001|Overall Study|Fatigue|0|||
146656627|NCT00424255|528919644|FG000|Overall Study|Disease Progression|0|||
146772908|NCT01061151|529338221|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
146602864|NCT02914561|528715764|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
146602865|NCT02914561|528715765|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
146602866|NCT02914561|528715766|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
146602867|NCT02914561|528715756|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
146602868|NCT02914561|528715757|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
146602869|NCT02914561|528715758|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
146602870|NCT02914561|528715759|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
146602871|NCT02914561|528715760|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
146602872|NCT02914561|528715761|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
146602873|NCT02914561|528715762|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
146602874|NCT02914561|528715763|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
146602875|NCT02914561|528715764|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
146602876|NCT02914561|528715765|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
146602877|NCT02914561|528715766|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
146602878|NCT02914561|528715756|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
146602879|NCT02914561|528715757|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
146602880|NCT02914561|528715758|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
146602881|NCT02914561|528715759|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
146602882|NCT02914561|528715760|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
146602883|NCT02914561|528715761|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
146602884|NCT02914561|528715762|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
146602885|NCT02914561|528715763|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
146602886|NCT02914561|528715764|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
146602887|NCT02914561|528715765|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
146602888|NCT02914561|528715766|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
146602889|NCT02914561|528715756|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
146602890|NCT02914561|528715757|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
146602891|NCT02914561|528715758|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
146602892|NCT02914561|528715759|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
146602893|NCT02914561|528715760|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
146656628|NCT00424255|528919645|FG001|Overall Study|Disease Progression|2|||
146656629|NCT00424255|528919644|FG000|Overall Study|Sponsor Terminated Study|161|||
146656630|NCT00424255|528919645|FG001|Overall Study|Sponsor Terminated Study|167|||
146772909|NCT01061151|529338222|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
146772910|NCT01061151|529338223|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
146772911|NCT01061151|529338224|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
146772912|NCT01061151|529338221|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
146772913|NCT01061151|529338222|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
146772914|NCT01061151|529338223|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
146772915|NCT01061151|529338224|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
146772916|NCT01061151|529338221|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
146772917|NCT01061151|529338222|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
146772918|NCT01061151|529338223|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
146772919|NCT01061151|529338224|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
146772920|NCT01061151|529338221|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
146772921|NCT01061151|529338222|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
146922757|NCT03855137|529876824|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
146922758|NCT03855137|529876825|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
146922759|NCT03855137|529876826|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
146922760|NCT03855137|529876824|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
146602894|NCT02914561|528715761|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
146656631|NCT02431247|528919646|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
146656632|NCT02431247|528919647|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
146656633|NCT02431247|528919648|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
146602895|NCT02914561|528715762|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
146656634|NCT02431247|528919646|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
146602896|NCT02914561|528715763|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
146602897|NCT02914561|528715764|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
146602898|NCT02914561|528715765|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
146602899|NCT02914561|528715766|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
146602900|NCT02914561|528715756|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146602901|NCT02914561|528715757|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146602902|NCT02914561|528715758|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
146602903|NCT02914561|528715759|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146602904|NCT02914561|528715760|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146602905|NCT02914561|528715761|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
146602906|NCT02914561|528715762|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146602907|NCT02914561|528715763|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146602908|NCT02914561|528715764|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146602909|NCT02914561|528715765|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146602910|NCT02914561|528715766|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146602911|NCT02914561|528715756|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
146602912|NCT02914561|528715757|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146602913|NCT02914561|528715758|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146602914|NCT02914561|528715759|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146602915|NCT02914561|528715760|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146602916|NCT02914561|528715761|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146602917|NCT02914561|528715762|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146602918|NCT02914561|528715763|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146602919|NCT02914561|528715764|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146602920|NCT02914561|528715765|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146602921|NCT02914561|528715766|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146602922|NCT02914561|528715756|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146602923|NCT02914561|528715757|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146602924|NCT02914561|528715758|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
146602925|NCT02914561|528715759|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146602926|NCT02914561|528715760|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146656635|NCT02431247|528919647|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
146656636|NCT02431247|528919648|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
146656637|NCT02431247|528919646|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
146656638|NCT02431247|528919647|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
146656639|NCT02431247|528919648|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
146656640|NCT02431247|528919646|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
146656641|NCT02431247|528919647|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
146656642|NCT02431247|528919648|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
146656643|NCT02431247|528919646|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
146656644|NCT02431247|528919647|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
146656645|NCT02431247|528919648|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
146656646|NCT02431247|528919646|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
146656647|NCT02431247|528919647|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
146656648|NCT02431247|528919648|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
146656649|NCT02431247|528919646|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
146656650|NCT02431247|528919647|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
146656651|NCT02431247|528919648|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
146656652|NCT02431247|528919646|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
146656653|NCT02431247|528919647|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
146772922|NCT01061151|529338223|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
146772923|NCT01061151|529338224|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
146772924|NCT03451721|529338227|FG000|Overall Study|Death|1|||
146772925|NCT00960141|529338228|FG000|Overall Study|Adverse Event|4|||
146772926|NCT00960141|529338229|FG001|Overall Study|Adverse Event|8|||
146772927|NCT00960141|529338230|FG002|Overall Study|Adverse Event|2|||
146772928|NCT00960141|529338228|FG000|Overall Study|Lack of Efficacy|3|||
146772929|NCT00960141|529338229|FG001|Overall Study|Lack of Efficacy|4|||
146772930|NCT00960141|529338230|FG002|Overall Study|Lack of Efficacy|2|||
146772931|NCT00960141|529338228|FG000|Overall Study|Lost to Follow-up|1|||
146772932|NCT00960141|529338229|FG001|Overall Study|Lost to Follow-up|0|||
146772933|NCT00960141|529338230|FG002|Overall Study|Lost to Follow-up|0|||
146922761|NCT03855137|529876825|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
146602927|NCT02914561|528715761|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146602928|NCT02914561|528715762|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146602929|NCT02914561|528715763|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146602930|NCT02914561|528715764|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146922762|NCT03855137|529876826|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
146602931|NCT02914561|528715765|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146602932|NCT02914561|528715766|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146602933|NCT02914561|528715756|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
146602934|NCT02914561|528715757|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
146602935|NCT02914561|528715758|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
146602936|NCT02914561|528715759|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
146602937|NCT02914561|528715760|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
146602938|NCT02914561|528715761|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
146602939|NCT02914561|528715762|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
146602940|NCT02914561|528715763|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
146602941|NCT02914561|528715764|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
146602942|NCT02914561|528715765|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
146602943|NCT02914561|528715766|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
146602944|NCT02914561|528715756|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
146602945|NCT02914561|528715757|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
146602946|NCT02914561|528715758|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
146602947|NCT02914561|528715759|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
146602948|NCT02914561|528715760|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
146602949|NCT02914561|528715761|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
146602950|NCT02914561|528715762|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
146602951|NCT02914561|528715763|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
146602952|NCT02914561|528715764|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
146602953|NCT02914561|528715765|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
146602954|NCT02914561|528715766|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
146602955|NCT02914561|528715756|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
146602956|NCT02914561|528715757|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
146602957|NCT02914561|528715758|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
146602958|NCT02914561|528715759|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
146602959|NCT02914561|528715760|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
146602960|NCT02914561|528715761|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
146602961|NCT02914561|528715762|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
146656654|NCT02431247|528919648|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
146656655|NCT02431247|528919646|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
146656656|NCT02431247|528919647|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
146656657|NCT02431247|528919648|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
146656658|NCT02431247|528919646|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
146656659|NCT02431247|528919647|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
146656660|NCT02431247|528919648|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
146656661|NCT02431247|528919646|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
146656662|NCT02431247|528919647|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
146656663|NCT02431247|528919648|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
146656664|NCT02431247|528919646|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
146656665|NCT02431247|528919647|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
146656666|NCT02431247|528919648|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
146656667|NCT02431247|528919646|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
146656668|NCT02431247|528919647|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
146656669|NCT02431247|528919648|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
146656670|NCT02431247|528919646|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
146656671|NCT02431247|528919647|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
146656672|NCT02431247|528919648|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
146656673|NCT00667446|528919649|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
146656674|NCT00667446|528919650|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
146656675|NCT00667446|528919649|FG000|Treatment Period (36 Months)|Other|2|||
146656676|NCT00667446|528919650|FG001|Treatment Period (36 Months)|Other|2|||
146656677|NCT00667446|528919649|FG000|Treatment Period (36 Months)|Personal reasons|2|||
146656678|NCT00667446|528919650|FG001|Treatment Period (36 Months)|Personal reasons|2|||
146656679|NCT00667446|528919649|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
146656680|NCT00667446|528919650|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
146656681|NCT00667446|528919649|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
146656682|NCT00667446|528919650|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
146656683|NCT00667446|528919649|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
146656684|NCT00667446|528919650|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
146656685|NCT00667446|528919649|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
146922763|NCT03855137|529876824|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
146602962|NCT02914561|528715763|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
146602963|NCT02914561|528715764|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
146602964|NCT02914561|528715765|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
146602965|NCT02914561|528715766|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
146602966|NCT02914561|528715756|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
146602967|NCT02914561|528715757|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
146602968|NCT02914561|528715758|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
146602969|NCT02914561|528715759|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
146602970|NCT02914561|528715760|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
146602971|NCT02914561|528715761|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
146602972|NCT02914561|528715762|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
146602973|NCT02914561|528715763|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
146602974|NCT02914561|528715764|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
146602975|NCT02914561|528715765|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
146602976|NCT02914561|528715766|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
146602977|NCT02914561|528715756|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
146602978|NCT02914561|528715757|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
146602979|NCT02914561|528715758|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
146602980|NCT02914561|528715759|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
146602981|NCT02914561|528715760|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
146602982|NCT02914561|528715761|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
146602983|NCT02914561|528715762|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
146602984|NCT02914561|528715763|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
146602985|NCT02914561|528715764|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
146602986|NCT02914561|528715765|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
146602987|NCT02914561|528715766|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
146602988|NCT02914561|528715756|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
146602989|NCT02914561|528715757|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
146602990|NCT02914561|528715758|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
146602991|NCT02914561|528715759|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
146602992|NCT02914561|528715760|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
146602993|NCT02914561|528715761|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
146602994|NCT02914561|528715762|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
146602995|NCT02914561|528715763|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
146602996|NCT02914561|528715764|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
146602997|NCT02914561|528715765|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
146602998|NCT02914561|528715766|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
146602999|NCT02914561|528715756|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146603000|NCT02914561|528715757|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146603001|NCT02914561|528715758|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146603002|NCT02914561|528715759|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146603003|NCT02914561|528715760|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146603004|NCT02914561|528715761|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146656686|NCT00667446|528919650|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
146656687|NCT00667446|528919649|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
146656688|NCT00667446|528919650|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
146656689|NCT00667446|528919649|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
146656690|NCT00667446|528919650|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
146656691|NCT00322153|528919653|FG000|Overall Study|Adverse Event|21|||
146603005|NCT02914561|528715762|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
146656692|NCT00322153|528919654|FG001|Overall Study|Adverse Event|34|||
146656693|NCT00322153|528919653|FG000|Overall Study|Protocol Violation|6|||
146656694|NCT00322153|528919654|FG001|Overall Study|Protocol Violation|14|||
146656695|NCT00322153|528919653|FG000|Overall Study|Withdrawal by Subject|18|||
146656696|NCT00322153|528919654|FG001|Overall Study|Withdrawal by Subject|10|||
146656697|NCT00322153|528919653|FG000|Overall Study|Lack of Efficacy|8|||
146656698|NCT00322153|528919654|FG001|Overall Study|Lack of Efficacy|3|||
146656699|NCT00322153|528919653|FG000|Overall Study|Lost to Follow-up|5|||
146656700|NCT00322153|528919654|FG001|Overall Study|Lost to Follow-up|4|||
146656701|NCT00322153|528919653|FG000|Overall Study|Withdrawn for other reasons|5|||
146656702|NCT00322153|528919654|FG001|Overall Study|Withdrawn for other reasons|4|||
146656703|NCT02632838|528919655|FG000|Overall Study|Withdrawal by Subject|3|||
146656704|NCT02632838|528919656|FG001|Overall Study|Withdrawal by Subject|0|||
146656705|NCT02632838|528919655|FG000|Overall Study|Lost to Follow-up|0|||
146656706|NCT02632838|528919656|FG001|Overall Study|Lost to Follow-up|2|||
146656707|NCT03945175|528919657|FG000|Overall Study|Did not meet inclusion criteria|31|||
146656708|NCT03945175|528919657|FG000|Overall Study|Withdrew consent|2|||
146603006|NCT02914561|528715763|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146603007|NCT02914561|528715764|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
146603008|NCT02914561|528715765|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146603009|NCT02914561|528715766|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146603010|NCT02914561|528715756|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146603011|NCT02914561|528715757|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146603012|NCT02914561|528715758|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146603013|NCT02914561|528715759|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146603014|NCT02914561|528715760|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146603015|NCT02914561|528715761|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146603016|NCT02914561|528715762|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146603017|NCT02914561|528715763|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146603018|NCT02914561|528715764|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
146603019|NCT02914561|528715765|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146603020|NCT02914561|528715766|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146603021|NCT02914561|528715756|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146603022|NCT02914561|528715757|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146603023|NCT02914561|528715758|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146603024|NCT02914561|528715759|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146603025|NCT02914561|528715760|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146603026|NCT02914561|528715761|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146603027|NCT02914561|528715762|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
146603028|NCT02914561|528715763|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146603029|NCT02914561|528715764|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146603030|NCT02914561|528715765|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146603031|NCT02914561|528715766|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146603032|NCT02914561|528715756|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
146603033|NCT02914561|528715757|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
146603034|NCT02914561|528715758|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
146603035|NCT02914561|528715759|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
146603036|NCT02914561|528715760|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
146603037|NCT02914561|528715761|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
146603038|NCT02914561|528715762|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
146603039|NCT02914561|528715763|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
146603040|NCT02914561|528715764|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
146603041|NCT02914561|528715765|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
146603042|NCT02914561|528715766|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
146603043|NCT03332160|528715767|FG000|Overall Study|Withdrawal by Subject|1|||
146603044|NCT03332160|528715768|FG001|Overall Study|Withdrawal by Subject|1|||
146603045|NCT03332160|528715767|FG000|Overall Study|Adverse Event|0|||
146603046|NCT03332160|528715768|FG001|Overall Study|Adverse Event|1|||
146603047|NCT03332160|528715767|FG000|Overall Study|Developed Exclusion Criteria|0|||
146603048|NCT03332160|528715768|FG001|Overall Study|Developed Exclusion Criteria|1|||
146603049|NCT03332160|528715767|FG000|Overall Study|Non-adherence to treatment|0|||
146603050|NCT03332160|528715768|FG001|Overall Study|Non-adherence to treatment|2|||
146603051|NCT03517566|528715774|FG000|Overall Study|Adverse Event|5|||
146603052|NCT03517566|528715775|FG001|Overall Study|Adverse Event|2|||
146603053|NCT03517566|528715776|FG002|Overall Study|Adverse Event|2|||
146603054|NCT03517566|528715777|FG003|Overall Study|Adverse Event|8|||
146603055|NCT03517566|528715778|FG004|Overall Study|Adverse Event|7|||
146603056|NCT03517566|528715774|FG000|Overall Study|Lack of Efficacy|3|||
146603057|NCT03517566|528715775|FG001|Overall Study|Lack of Efficacy|2|||
146603058|NCT03517566|528715776|FG002|Overall Study|Lack of Efficacy|1|||
146603059|NCT03517566|528715777|FG003|Overall Study|Lack of Efficacy|1|||
146603060|NCT03517566|528715778|FG004|Overall Study|Lack of Efficacy|4|||
146603061|NCT03517566|528715774|FG000|Overall Study|Lost to Follow-up|3|||
146603062|NCT03517566|528715775|FG001|Overall Study|Lost to Follow-up|1|||
146603063|NCT03517566|528715776|FG002|Overall Study|Lost to Follow-up|1|||
146603064|NCT03517566|528715777|FG003|Overall Study|Lost to Follow-up|1|||
146603065|NCT03517566|528715778|FG004|Overall Study|Lost to Follow-up|0|||
146603066|NCT03517566|528715774|FG000|Overall Study|Physician Decision|1|||
146603067|NCT03517566|528715775|FG001|Overall Study|Physician Decision|1|||
146603068|NCT03517566|528715776|FG002|Overall Study|Physician Decision|0|||
146656709|NCT03945175|528919657|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
146656710|NCT03945175|528919657|FG000|Overall Study|Early termination during Mydayis treatment|1|||
146603069|NCT03517566|528715777|FG003|Overall Study|Physician Decision|1|||
146603070|NCT03517566|528715778|FG004|Overall Study|Physician Decision|0|||
146603071|NCT03517566|528715774|FG000|Overall Study|Pregnancy|0|||
146603072|NCT03517566|528715775|FG001|Overall Study|Pregnancy|1|||
146603073|NCT03517566|528715776|FG002|Overall Study|Pregnancy|0|||
146603074|NCT03517566|528715777|FG003|Overall Study|Pregnancy|0|||
146603075|NCT03517566|528715778|FG004|Overall Study|Pregnancy|0|||
146603076|NCT03517566|528715774|FG000|Overall Study|Protocol Deviation|0|||
146603077|NCT03517566|528715775|FG001|Overall Study|Protocol Deviation|1|||
146603078|NCT03517566|528715776|FG002|Overall Study|Protocol Deviation|0|||
146603079|NCT03517566|528715777|FG003|Overall Study|Protocol Deviation|1|||
146603080|NCT03517566|528715778|FG004|Overall Study|Protocol Deviation|1|||
146603081|NCT03517566|528715774|FG000|Overall Study|Study terminated by Sponsor|11|||
146603082|NCT03517566|528715775|FG001|Overall Study|Study terminated by Sponsor|5|||
146603083|NCT03517566|528715776|FG002|Overall Study|Study terminated by Sponsor|6|||
146603084|NCT03517566|528715777|FG003|Overall Study|Study terminated by Sponsor|14|||
146603085|NCT03517566|528715778|FG004|Overall Study|Study terminated by Sponsor|12|||
146603086|NCT03517566|528715774|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
146603087|NCT03517566|528715775|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
146603088|NCT03517566|528715776|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
146603089|NCT03517566|528715777|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
146603090|NCT03517566|528715778|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
146603091|NCT01183468|528715779|FG000|Overall Study|Lost to Follow-up|2|||
146603092|NCT01183468|528715780|FG001|Overall Study|Lost to Follow-up|1|||
146603093|NCT01183468|528715781|FG002|Overall Study|Lost to Follow-up|0|||
146603094|NCT01183468|528715782|FG003|Overall Study|Lost to Follow-up|0|||
146603095|NCT01183468|528715779|FG000|Overall Study|Physician Decision|1|||
146603096|NCT01183468|528715780|FG001|Overall Study|Physician Decision|0|||
146603097|NCT01183468|528715781|FG002|Overall Study|Physician Decision|0|||
146603098|NCT01183468|528715782|FG003|Overall Study|Physician Decision|0|||
146603099|NCT01183468|528715779|FG000|Overall Study|Withdrawal by Subject|0|||
146603100|NCT01183468|528715780|FG001|Overall Study|Withdrawal by Subject|1|||
146603101|NCT01183468|528715781|FG002|Overall Study|Withdrawal by Subject|0|||
146603102|NCT01183468|528715782|FG003|Overall Study|Withdrawal by Subject|0|||
146603103|NCT00454649|528715784|FG000|Overall Study|Lack of Efficacy|2|||
146603104|NCT00454649|528715785|FG001|Overall Study|Lack of Efficacy|2|||
146603105|NCT00454649|528715786|FG002|Overall Study|Lack of Efficacy|10|||
146603106|NCT00454649|528715787|FG003|Overall Study|Lack of Efficacy|3|||
146603107|NCT00454649|528715788|FG004|Overall Study|Lack of Efficacy|0|||
146603108|NCT00454649|528715789|FG005|Overall Study|Lack of Efficacy|4|||
146603109|NCT00454649|528715790|FG006|Overall Study|Lack of Efficacy|5|||
146603110|NCT00454649|528715791|FG007|Overall Study|Lack of Efficacy|13|||
146603111|NCT00454649|528715792|FG008|Overall Study|Lack of Efficacy|10|||
146603112|NCT00454649|528715793|FG009|Overall Study|Lack of Efficacy|2|||
146603113|NCT00454649|528715784|FG000|Overall Study|Adverse Event|0|||
146603114|NCT00454649|528715785|FG001|Overall Study|Adverse Event|1|||
146603115|NCT00454649|528715786|FG002|Overall Study|Adverse Event|3|||
146603116|NCT00454649|528715787|FG003|Overall Study|Adverse Event|0|||
146603117|NCT00454649|528715788|FG004|Overall Study|Adverse Event|1|||
146603118|NCT00454649|528715789|FG005|Overall Study|Adverse Event|2|||
146603119|NCT00454649|528715790|FG006|Overall Study|Adverse Event|3|||
146603120|NCT00454649|528715791|FG007|Overall Study|Adverse Event|4|||
146603121|NCT00454649|528715792|FG008|Overall Study|Adverse Event|6|||
146603122|NCT00454649|528715793|FG009|Overall Study|Adverse Event|2|||
146603123|NCT00454649|528715784|FG000|Overall Study|Lost to Follow-up|0|||
146603124|NCT00454649|528715785|FG001|Overall Study|Lost to Follow-up|0|||
146603125|NCT00454649|528715786|FG002|Overall Study|Lost to Follow-up|1|||
146603126|NCT00454649|528715787|FG003|Overall Study|Lost to Follow-up|0|||
146603127|NCT00454649|528715788|FG004|Overall Study|Lost to Follow-up|0|||
146603128|NCT00454649|528715789|FG005|Overall Study|Lost to Follow-up|0|||
146603129|NCT00454649|528715790|FG006|Overall Study|Lost to Follow-up|1|||
146603130|NCT00454649|528715791|FG007|Overall Study|Lost to Follow-up|0|||
146603131|NCT00454649|528715792|FG008|Overall Study|Lost to Follow-up|0|||
146603132|NCT00454649|528715793|FG009|Overall Study|Lost to Follow-up|0|||
146603133|NCT00454649|528715784|FG000|Overall Study|Other|1|||
146603134|NCT00454649|528715785|FG001|Overall Study|Other|1|||
146603135|NCT00454649|528715786|FG002|Overall Study|Other|5|||
146603136|NCT00454649|528715787|FG003|Overall Study|Other|3|||
146603137|NCT00454649|528715788|FG004|Overall Study|Other|0|||
146603138|NCT00454649|528715789|FG005|Overall Study|Other|0|||
146603139|NCT00454649|528715790|FG006|Overall Study|Other|0|||
146656711|NCT00769483|528919662|FG000|Overall Study|Withdrawal by Subject|0|||
146922764|NCT03855137|529876825|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
146922765|NCT03855137|529876826|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
146922766|NCT02435277|529876827|FG000|Overall Study|Adverse Event|1|||
146922767|NCT02435277|529876828|FG001|Overall Study|Adverse Event|1|||
146603140|NCT00454649|528715791|FG007|Overall Study|Other|0|||
146603141|NCT00454649|528715792|FG008|Overall Study|Other|3|||
146603142|NCT00454649|528715793|FG009|Overall Study|Other|1|||
146603143|NCT00454649|528715784|FG000|Overall Study|Withdrawal by Subject|0|||
146603144|NCT00454649|528715785|FG001|Overall Study|Withdrawal by Subject|0|||
146603145|NCT00454649|528715786|FG002|Overall Study|Withdrawal by Subject|0|||
146603146|NCT00454649|528715787|FG003|Overall Study|Withdrawal by Subject|0|||
146603147|NCT00454649|528715788|FG004|Overall Study|Withdrawal by Subject|0|||
146603148|NCT00454649|528715789|FG005|Overall Study|Withdrawal by Subject|1|||
146603149|NCT00454649|528715790|FG006|Overall Study|Withdrawal by Subject|0|||
146603150|NCT00454649|528715791|FG007|Overall Study|Withdrawal by Subject|2|||
146603151|NCT00454649|528715792|FG008|Overall Study|Withdrawal by Subject|1|||
146603152|NCT00454649|528715793|FG009|Overall Study|Withdrawal by Subject|0|||
146603153|NCT00086411|528715796|FG000|Overall Study|Lost to Follow-up|11|||
146603154|NCT00086411|528715797|FG001|Overall Study|Lost to Follow-up|11|||
146603155|NCT00086411|528715798|FG002|Overall Study|Lost to Follow-up|13|||
146603156|NCT00086411|528715799|FG003|Overall Study|Lost to Follow-up|12|||
146603157|NCT01078168|528715802|FG000|Overall Study|Physician Decision|0|||
146603158|NCT01078168|528715803|FG001|Overall Study|Physician Decision|1|||
146603159|NCT03109184|528717336|FG000|Overall Study|Lost to Follow-up|6|||
146603160|NCT03109184|528717337|FG001|Overall Study|Lost to Follow-up|6|||
146603161|NCT03109184|528717336|FG000|Overall Study|Withdrawal by Subject|1|||
146603162|NCT03109184|528717337|FG001|Overall Study|Withdrawal by Subject|1|||
146603163|NCT00602420|528717338|FG000|Overall Study|Death|1|||
146603164|NCT00602420|528717339|FG001|Overall Study|Death|4|||
146603165|NCT00602420|528717338|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
146603166|NCT00602420|528717339|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
146603167|NCT00602420|528717338|FG000|Overall Study|Withdrawal by Subject|18|||
146603168|NCT00602420|528717339|FG001|Overall Study|Withdrawal by Subject|17|||
146603169|NCT00602420|528717338|FG000|Overall Study|Adverse Event|1|||
146603170|NCT00602420|528717339|FG001|Overall Study|Adverse Event|0|||
146603171|NCT02315560|528717343|FG000|Overall Study|noncompliance by subjects|3|||
146603172|NCT01041287|528717344|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
146603173|NCT01041287|528717345|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
146603174|NCT01041287|528717344|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
146603175|NCT01041287|528717345|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
146603176|NCT01209078|528717346|FG000|Overall Study|Adverse Event|5|||
146603177|NCT01209078|528717347|FG001|Overall Study|Adverse Event|0|||
146603178|NCT01209078|528717346|FG000|Overall Study|Lost to Follow-up|4|||
146603179|NCT01209078|528717347|FG001|Overall Study|Lost to Follow-up|0|||
146603180|NCT01209078|528717346|FG000|Overall Study|Physician Decision|5|||
146603181|NCT01209078|528717347|FG001|Overall Study|Physician Decision|2|||
146603182|NCT01209078|528717346|FG000|Overall Study|Withdrawal by Subject|2|||
146603183|NCT01209078|528717347|FG001|Overall Study|Withdrawal by Subject|1|||
146603184|NCT00924508|528717348|FG000|Overall Study|Withdrawal by Subject|3|||
146603185|NCT03464019|528717349|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
146603186|NCT03464019|528717350|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
146603187|NCT03464019|528717351|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
146603188|NCT03464019|528717349|FG000|NODE-301 Part 1|Ablation|0|||
146603189|NCT03464019|528717350|FG001|NODE-301 Part 1|Ablation|0|||
146603190|NCT03464019|528717351|FG002|NODE-301 Part 1|Ablation|16|||
146603191|NCT03464019|528717349|FG000|NODE-301 Part 1|Test Dose Failure|0|||
146603192|NCT03464019|528717350|FG001|NODE-301 Part 1|Test Dose Failure|0|||
146603193|NCT03464019|528717351|FG002|NODE-301 Part 1|Test Dose Failure|8|||
146603194|NCT03464019|528717349|FG000|NODE-301 Part 1|Adverse Event|0|||
146603195|NCT03464019|528717350|FG001|NODE-301 Part 1|Adverse Event|0|||
146603196|NCT03464019|528717351|FG002|NODE-301 Part 1|Adverse Event|5|||
146603197|NCT03464019|528717349|FG000|NODE-301 Part 1|Physician Decision|0|||
146603198|NCT03464019|528717350|FG001|NODE-301 Part 1|Physician Decision|0|||
146603199|NCT03464019|528717351|FG002|NODE-301 Part 1|Physician Decision|4|||
146603200|NCT03464019|528717349|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
146603201|NCT03464019|528717350|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
146603202|NCT03464019|528717351|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
146656712|NCT00769483|528919663|FG001|Overall Study|Withdrawal by Subject|1|||
146656713|NCT00769483|528919664|FG002|Overall Study|Withdrawal by Subject|0|||
146656714|NCT00769483|528919665|FG003|Overall Study|Withdrawal by Subject|0|||
146656715|NCT00769483|528919666|FG004|Overall Study|Withdrawal by Subject|1|||
146656716|NCT00769483|528919667|FG005|Overall Study|Withdrawal by Subject|0|||
146656717|NCT01306877|528919668|FG000|Overall Study|Lost to Follow-up|3|||
146656718|NCT01306877|528919669|FG001|Overall Study|Lost to Follow-up|3|||
146656719|NCT01306877|528919668|FG000|Overall Study|Physician Decision|0|||
146656720|NCT01306877|528919669|FG001|Overall Study|Physician Decision|1|||
146772934|NCT00960141|529338228|FG000|Overall Study|Protocol Violation|1|||
146603203|NCT03464019|528717349|FG000|NODE-301 Part 1|Protocol Violation|0|||
146656721|NCT00006389|528919670|FG000|Overall Study|Adverse Event|1|||
146603204|NCT03464019|528717350|FG001|NODE-301 Part 1|Protocol Violation|0|||
146603205|NCT03464019|528717351|FG002|NODE-301 Part 1|Protocol Violation|2|||
146603206|NCT03464019|528717349|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
146603207|NCT03464019|528717350|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
146772935|NCT00960141|529338229|FG001|Overall Study|Protocol Violation|3|||
146603208|NCT03464019|528717351|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
146603209|NCT03464019|528717349|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
146603210|NCT03464019|528717350|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
146603211|NCT03464019|528717351|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
146603212|NCT03464019|528717349|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
146656722|NCT00999921|528919674|FG000|Overall Study|Lost to Follow-up|10|||
146772936|NCT00960141|529338230|FG002|Overall Study|Protocol Violation|2|||
146603213|NCT03464019|528717350|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
146603214|NCT03464019|528717351|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
146603215|NCT03464019|528717349|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
146603216|NCT03464019|528717350|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
146603217|NCT03464019|528717351|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
146603218|NCT03464019|528717349|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
146603219|NCT03464019|528717350|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
146603220|NCT03464019|528717351|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
146603221|NCT03464019|528717349|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
146603222|NCT03464019|528717350|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
146603223|NCT03464019|528717351|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
146603224|NCT03464019|528717349|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
146603225|NCT03464019|528717350|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
146603226|NCT03464019|528717351|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
146603227|NCT03464019|528717349|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
146603228|NCT03464019|528717350|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
146603229|NCT03464019|528717351|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
146603230|NCT03464019|528717349|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
146603231|NCT03464019|528717350|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
146603232|NCT03464019|528717351|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
146603233|NCT03464019|528717349|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
146603234|NCT03464019|528717350|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
146603235|NCT03464019|528717351|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
146603236|NCT03464019|528717349|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
146603237|NCT03464019|528717350|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
146603238|NCT03464019|528717351|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
146603239|NCT03464019|528717349|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
146603240|NCT03464019|528717350|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
146603241|NCT03464019|528717351|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
146603242|NCT03464019|528717349|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
146603243|NCT03464019|528717350|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
146603244|NCT03464019|528717351|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
146603245|NCT03464019|528717349|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
146603246|NCT03464019|528717350|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
146603247|NCT03464019|528717351|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
146603248|NCT00767806|528717352|FG000|Overall Study|Adverse Event|30|||
146603249|NCT00767806|528717353|FG001|Overall Study|Adverse Event|11|||
146603250|NCT00767806|528717352|FG000|Overall Study|Withdrawal by Subject|8|||
146603251|NCT00767806|528717353|FG001|Overall Study|Withdrawal by Subject|13|||
146603252|NCT00767806|528717352|FG000|Overall Study|Protocol Violation|6|||
146603253|NCT00767806|528717353|FG001|Overall Study|Protocol Violation|5|||
146603254|NCT00767806|528717352|FG000|Overall Study|Lack of Efficacy|1|||
146603255|NCT00767806|528717353|FG001|Overall Study|Lack of Efficacy|9|||
146603256|NCT00767806|528717352|FG000|Overall Study|Physician Decision|4|||
146603257|NCT00767806|528717353|FG001|Overall Study|Physician Decision|3|||
146603258|NCT00767806|528717352|FG000|Overall Study|Lost to Follow-up|1|||
146603259|NCT00767806|528717353|FG001|Overall Study|Lost to Follow-up|4|||
146603260|NCT00767806|528717352|FG000|Overall Study|Entry Criteria Not Met|1|||
146603261|NCT00767806|528717353|FG001|Overall Study|Entry Criteria Not Met|1|||
146603262|NCT00767806|528717352|FG000|Overall Study|Sponsor Decision|0|||
146603263|NCT00767806|528717353|FG001|Overall Study|Sponsor Decision|1|||
146603264|NCT00372697|528717354|FG000|Overall Study|Protocol Violation|1|||
146656723|NCT00999921|528919675|FG001|Overall Study|Lost to Follow-up|19|||
146656724|NCT00772070|528919682|FG000|Overall Study|Lost to Follow-up|0|||
146656725|NCT00772070|528919683|FG001|Overall Study|Lost to Follow-up|8|||
146656726|NCT00772070|528919682|FG000|Overall Study|Withdrawal by Subject|0|||
146656727|NCT00772070|528919683|FG001|Overall Study|Withdrawal by Subject|2|||
146656728|NCT00772070|528919682|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
146656729|NCT00772070|528919683|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
146656730|NCT01309308|528919684|FG000|Overall Study|Lost to Follow-up|6|||
146656731|NCT01309308|528919685|FG001|Overall Study|Lost to Follow-up|4|||
146656732|NCT01307020|528919687|FG000|Overall Study|Lost to Follow-up|0|||
146656733|NCT01307020|528919688|FG001|Overall Study|Lost to Follow-up|0|||
146656734|NCT01307020|528919689|FG002|Overall Study|Lost to Follow-up|1|||
146656735|NCT01307020|528919690|FG003|Overall Study|Lost to Follow-up|1|||
146656736|NCT01307020|528919691|FG004|Overall Study|Lost to Follow-up|0|||
146656737|NCT01307020|528919692|FG005|Overall Study|Lost to Follow-up|0|||
146603265|NCT00372697|528717355|FG001|Overall Study|Protocol Violation|1|||
146603266|NCT01815840|528717356|FG000|Overall Study|Missing|1|||
146603267|NCT01815840|528717357|FG001|Overall Study|Missing|0|||
146603268|NCT01815840|528717356|FG000|Overall Study|Withdrew Consent|31|||
146603269|NCT01815840|528717357|FG001|Overall Study|Withdrew Consent|30|||
146603270|NCT01815840|528717356|FG000|Overall Study|Administrative/Other|1|||
146656738|NCT01307020|528919693|FG006|Overall Study|Lost to Follow-up|1|||
146603271|NCT01815840|528717357|FG001|Overall Study|Administrative/Other|3|||
146603272|NCT01815840|528717356|FG000|Overall Study|Adverse Event|10|||
146603273|NCT01815840|528717357|FG001|Overall Study|Adverse Event|16|||
146603274|NCT01815840|528717356|FG000|Overall Study|Death|2|||
146603275|NCT01815840|528717357|FG001|Overall Study|Death|2|||
146772937|NCT00960141|529338228|FG000|Overall Study|Withdrawal by Subject|1|||
146603276|NCT01815840|528717356|FG000|Overall Study|Disease progression|3|||
146603277|NCT01815840|528717357|FG001|Overall Study|Disease progression|2|||
146603278|NCT01815840|528717356|FG000|Overall Study|Investigators Decision|2|||
146603279|NCT01815840|528717357|FG001|Overall Study|Investigators Decision|3|||
146603280|NCT01815840|528717356|FG000|Overall Study|Lost to Follow-up|3|||
146603281|NCT01815840|528717357|FG001|Overall Study|Lost to Follow-up|6|||
146603282|NCT01815840|528717356|FG000|Overall Study|Refused Treatment|5|||
146603283|NCT01815840|528717357|FG001|Overall Study|Refused Treatment|1|||
146603284|NCT01815840|528717356|FG000|Overall Study|Sponsor Termination Treatment|1|||
146603285|NCT01815840|528717357|FG001|Overall Study|Sponsor Termination Treatment|0|||
146603286|NCT03221842|528717359|FG000|Period 1 (Open-label)|Adverse Event|4|||
146603287|NCT03221842|528717360|FG001|Period 1 (Open-label)|Adverse Event|0|||
146603288|NCT03221842|528717359|FG000|Period 1 (Open-label)|Physician Decision|2|||
146603289|NCT03221842|528717360|FG001|Period 1 (Open-label)|Physician Decision|0|||
146603290|NCT03221842|528717359|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
146603291|NCT03221842|528717360|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
146603292|NCT03221842|528717359|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
146603293|NCT03221842|528717360|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
146603294|NCT03221842|528717359|FG000|Period 1 (Open-label)|Other|2|||
146603295|NCT03221842|528717360|FG001|Period 1 (Open-label)|Other|0|||
146603296|NCT03221842|528717359|FG000|Period 2 (Randomized, Blinded)|Death|0|||
146603297|NCT03221842|528717360|FG001|Period 2 (Randomized, Blinded)|Death|1|||
146603298|NCT03221842|528717359|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
146603299|NCT03221842|528717360|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
146603300|NCT00704288|528717361|FG000|Overall Treatment Period|Adverse Event|11|||
146603301|NCT00704288|528717362|FG001|Overall Treatment Period|Adverse Event|8|||
146603302|NCT00704288|528717363|FG002|Overall Treatment Period|Adverse Event|22|||
146603303|NCT00704288|528717361|FG000|Overall Treatment Period|Death|0|||
146603304|NCT00704288|528717362|FG001|Overall Treatment Period|Death|0|||
146603305|NCT00704288|528717363|FG002|Overall Treatment Period|Death|1|||
146772938|NCT00960141|529338229|FG001|Overall Study|Withdrawal by Subject|2|||
146772939|NCT00960141|529338230|FG002|Overall Study|Withdrawal by Subject|1|||
146772940|NCT00939510|529338231|FG000|Overall Study|Withdrawal by Subject|1|||
146772941|NCT03903822|529338234|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
146772942|NCT03903822|529338235|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
146922768|NCT02435277|529876829|FG002|Overall Study|Adverse Event|0|||
146922769|NCT02435277|529876830|FG003|Overall Study|Adverse Event|0|||
146922770|NCT02435277|529876827|FG000|Overall Study|Withdrawal by Subject|1|||
146603306|NCT00704288|528717361|FG000|Overall Treatment Period|Physician Decision|0|||
146603307|NCT00704288|528717362|FG001|Overall Treatment Period|Physician Decision|2|||
146603308|NCT00704288|528717363|FG002|Overall Treatment Period|Physician Decision|0|||
146603309|NCT00704288|528717361|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
146603310|NCT00704288|528717362|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
146603311|NCT00704288|528717363|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
146603312|NCT00704288|528717361|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
146603313|NCT00704288|528717362|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
146603314|NCT00704288|528717363|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
146603315|NCT00704288|528717361|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
146603316|NCT00704288|528717362|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
146603317|NCT00704288|528717363|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
146603318|NCT00704288|528717361|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
146603319|NCT00704288|528717362|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
146603320|NCT00704288|528717363|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
146603321|NCT00704288|528717361|FG000|Overall Treatment Period|Roll-over to another study|1|||
146603322|NCT00704288|528717362|FG001|Overall Treatment Period|Roll-over to another study|0|||
146603323|NCT00704288|528717363|FG002|Overall Treatment Period|Roll-over to another study|4|||
146603324|NCT00704288|528717361|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
146603325|NCT00704288|528717362|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
146603326|NCT00704288|528717363|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
146603327|NCT00704288|528717361|FG000|Extended Post Treatment Follow Up Period|Death|41|||
146603328|NCT00704288|528717362|FG001|Extended Post Treatment Follow Up Period|Death|50|||
146922771|NCT02435277|529876828|FG001|Overall Study|Withdrawal by Subject|0|||
146603329|NCT00704288|528717363|FG002|Extended Post Treatment Follow Up Period|Death|93|||
146603330|NCT00704288|528717361|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
146656739|NCT01307020|528919694|FG007|Overall Study|Lost to Follow-up|0|||
146656740|NCT01307020|528919695|FG008|Overall Study|Lost to Follow-up|0|||
146656741|NCT01307020|528919696|FG009|Overall Study|Lost to Follow-up|0|||
146656742|NCT01307020|528919687|FG000|Overall Study|Electronic data capture failure|0|||
146656743|NCT01307020|528919688|FG001|Overall Study|Electronic data capture failure|1|||
146656744|NCT01307020|528919689|FG002|Overall Study|Electronic data capture failure|0|||
146656745|NCT01307020|528919690|FG003|Overall Study|Electronic data capture failure|0|||
146656746|NCT01307020|528919691|FG004|Overall Study|Electronic data capture failure|0|||
146656747|NCT01307020|528919692|FG005|Overall Study|Electronic data capture failure|0|||
146603331|NCT00704288|528717362|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
146603332|NCT00704288|528717363|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
146603333|NCT00704288|528717361|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
146603334|NCT00704288|528717362|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
146603335|NCT00704288|528717363|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
146603336|NCT00704288|528717361|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
146603337|NCT00704288|528717362|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
146603338|NCT00704288|528717363|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
146603339|NCT01055314|528717364|FG000|Overall Study|Adverse Event|7|||
146603340|NCT01055314|528717365|FG001|Overall Study|Adverse Event|4|||
146603341|NCT01055314|528717364|FG000|Overall Study|Death|2|||
146603342|NCT01055314|528717365|FG001|Overall Study|Death|1|||
146603343|NCT01055314|528717364|FG000|Overall Study|Lack of Efficacy|11|||
146603344|NCT01055314|528717365|FG001|Overall Study|Lack of Efficacy|19|||
146603345|NCT01055314|528717364|FG000|Overall Study|Physician Decision|10|||
146603346|NCT01055314|528717365|FG001|Overall Study|Physician Decision|5|||
146603347|NCT01055314|528717364|FG000|Overall Study|Withdrawal by Subject|1|||
146603348|NCT01055314|528717365|FG001|Overall Study|Withdrawal by Subject|0|||
146603349|NCT01055314|528717364|FG000|Overall Study|Ineligible|3|||
146603350|NCT01055314|528717365|FG001|Overall Study|Ineligible|5|||
146603351|NCT01055314|528717364|FG000|Overall Study|Refusal of further protocol therapy|10|||
146603352|NCT01055314|528717365|FG001|Overall Study|Refusal of further protocol therapy|4|||
146603353|NCT01055314|528717364|FG000|Overall Study|No treatment|1|||
146603354|NCT01055314|528717365|FG001|Overall Study|No treatment|0|||
146603355|NCT00568126|528717366|FG000|Overall Study|Adverse Event|3|||
146603356|NCT00568126|528717367|FG001|Overall Study|Adverse Event|0|||
146603357|NCT00568126|528717366|FG000|Overall Study|Withdrawal by Subject|2|||
146603358|NCT00568126|528717367|FG001|Overall Study|Withdrawal by Subject|3|||
146603359|NCT00568126|528717366|FG000|Overall Study|Lost to Follow-up|4|||
146603360|NCT00568126|528717367|FG001|Overall Study|Lost to Follow-up|3|||
146603361|NCT00568126|528717366|FG000|Overall Study|Lack of Efficacy|0|||
146603362|NCT00568126|528717367|FG001|Overall Study|Lack of Efficacy|1|||
146603363|NCT00568126|528717366|FG000|Overall Study|Physician Decision|2|||
146603364|NCT00568126|528717367|FG001|Overall Study|Physician Decision|2|||
146603365|NCT04395690|528717368|FG000|Overall Study|Lost to Follow-up|1|||
146603366|NCT04395690|528717369|FG001|Overall Study|Lost to Follow-up|1|||
146603367|NCT04512976|528717370|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
146603368|NCT04512976|528717371|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
146603369|NCT04512976|528717372|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
146603370|NCT04512976|528717373|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
146922772|NCT02435277|529876829|FG002|Overall Study|Withdrawal by Subject|0|||
146922773|NCT02435277|529876830|FG003|Overall Study|Withdrawal by Subject|0|||
146922774|NCT01067508|529876831|FG000|Overall Study|Physician Decision|0|||
146922775|NCT01067508|529876832|FG001|Overall Study|Physician Decision|1|||
146922776|NCT01067508|529876831|FG000|Overall Study|Withdrawal by Subject|0|||
146922777|NCT01067508|529876832|FG001|Overall Study|Withdrawal by Subject|1|||
146922778|NCT02065622|529876835|FG000|Induction Study|Adverse Event|13|||
146922779|NCT02065622|529876836|FG001|Induction Study|Adverse Event|19|||
146922780|NCT02065622|529876837|FG002|Induction Study|Adverse Event|0|||
146922781|NCT02065622|529876838|FG003|Induction Study|Adverse Event|0|||
146922782|NCT02065622|529876839|FG004|Induction Study|Adverse Event|0|||
146603371|NCT04512976|528717374|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
146603372|NCT04512976|528717375|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
146603373|NCT02702414|528717376|FG000|Overall Study|Death|96|||
146603374|NCT02702414|528717377|FG001|Overall Study|Death|42|||
146603375|NCT02702414|528717376|FG000|Overall Study|Lost to Follow-up|0|||
146603376|NCT02702414|528717377|FG001|Overall Study|Lost to Follow-up|1|||
146603377|NCT02702414|528717376|FG000|Overall Study|Withdrawal by Subject|0|||
146656748|NCT01307020|528919693|FG006|Overall Study|Electronic data capture failure|0|||
146656749|NCT01307020|528919694|FG007|Overall Study|Electronic data capture failure|0|||
146656750|NCT01307020|528919695|FG008|Overall Study|Electronic data capture failure|0|||
146656751|NCT01307020|528919696|FG009|Overall Study|Electronic data capture failure|0|||
146922783|NCT02065622|529876835|FG000|Induction Study|Withdrawal by Subject|3|||
146922784|NCT02065622|529876836|FG001|Induction Study|Withdrawal by Subject|5|||
146922785|NCT02065622|529876837|FG002|Induction Study|Withdrawal by Subject|0|||
146922786|NCT02065622|529876838|FG003|Induction Study|Withdrawal by Subject|0|||
146922787|NCT02065622|529876839|FG004|Induction Study|Withdrawal by Subject|0|||
146922788|NCT02065622|529876835|FG000|Induction Study|Lost to Follow-up|1|||
146922789|NCT02065622|529876836|FG001|Induction Study|Lost to Follow-up|0|||
146922790|NCT02065622|529876837|FG002|Induction Study|Lost to Follow-up|0|||
146922791|NCT02065622|529876838|FG003|Induction Study|Lost to Follow-up|0|||
146922792|NCT02065622|529876839|FG004|Induction Study|Lost to Follow-up|0|||
146922793|NCT02065622|529876835|FG000|Induction Study|Lack of Efficacy|22|||
146922794|NCT02065622|529876836|FG001|Induction Study|Lack of Efficacy|27|||
146603378|NCT02702414|528717377|FG001|Overall Study|Withdrawal by Subject|1|||
146603379|NCT02702414|528717376|FG000|Overall Study|Protocol Violation|1|||
146603380|NCT02702414|528717377|FG001|Overall Study|Protocol Violation|0|||
146603381|NCT02702414|528717376|FG000|Overall Study|Sponsor Decision|8|||
146603382|NCT02702414|528717377|FG001|Overall Study|Sponsor Decision|7|||
146603383|NCT03446456|528717378|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
146603384|NCT03446456|528717379|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
146603385|NCT03446456|528717378|FG000|Overall Study|Lost to Follow-up|1|||
146603386|NCT03446456|528717379|FG001|Overall Study|Lost to Follow-up|3|||
146603387|NCT03446456|528717378|FG000|Overall Study|Participant failed the toxicology test|1|||
146603388|NCT03446456|528717379|FG001|Overall Study|Participant failed the toxicology test|0|||
146603389|NCT03446456|528717378|FG000|Overall Study|Break down of the experimental equipment|1|||
146603390|NCT03446456|528717379|FG001|Overall Study|Break down of the experimental equipment|0|||
146603391|NCT04369950|528717380|FG000|Overall Study|Protocol Violation|2|||
146603392|NCT04369950|528717381|FG001|Overall Study|Protocol Violation|2|||
146603393|NCT00989963|528717382|FG000|Overall Study|Adverse Event|1|||
146603394|NCT00989963|528717383|FG001|Overall Study|Adverse Event|1|||
146603395|NCT00989963|528717384|FG002|Overall Study|Adverse Event|1|||
146603396|NCT01529034|528717393|FG000|Overall Study|Discontinued prior to study treatment|14|||
146603397|NCT01529034|528717393|FG000|Overall Study|Site closure|62|||
146603398|NCT01529034|528717393|FG000|Overall Study|Study termination|29|||
146603399|NCT01529034|528717393|FG000|Overall Study|Withdrawal by Subject|25|||
146603400|NCT01529034|528717393|FG000|Overall Study|No treated SCs within protocol window|13|||
146603401|NCT01529034|528717393|FG000|Overall Study|Noncompliance|8|||
146603402|NCT01529034|528717393|FG000|Overall Study|Caregiver no longer available|7|||
146603403|NCT01529034|528717393|FG000|Overall Study|Adverse Event|4|||
146603404|NCT01529034|528717393|FG000|Overall Study|Protocol Violation|4|||
146603405|NCT01529034|528717393|FG000|Overall Study|Lack of Efficacy|4|||
146603406|NCT01529034|528717393|FG000|Overall Study|Investigator no longer available|2|||
146603407|NCT01529034|528717393|FG000|Overall Study|Study drug not available|2|||
146603408|NCT04588389|528717394|FG000|Overall Study|Issues with anesthesia during surgery|2|||
146603409|NCT04588389|528717395|FG001|Overall Study|Issues with anesthesia during surgery|0|||
146603410|NCT04588389|528717396|FG002|Overall Study|Issues with anesthesia during surgery|0|||
146603411|NCT00658814|528717399|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
146603412|NCT00658814|528717400|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
146603413|NCT00658814|528717399|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
146603414|NCT00658814|528717400|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
146603415|NCT00658814|528717399|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
146603416|NCT00658814|528717400|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
146603417|NCT00658814|528717399|FG000|Remission Induction Chemotherapy|Death|1|||
146603418|NCT00658814|528717400|FG001|Remission Induction Chemotherapy|Death|4|||
146603419|NCT00658814|528717399|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
146603420|NCT00658814|528717400|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
146603421|NCT00658814|528717399|FG000|Remission Induction Chemotherapy|Not eligible|1|||
146603422|NCT00658814|528717400|FG001|Remission Induction Chemotherapy|Not eligible|2|||
146603423|NCT00658814|528717399|FG000|Consolidation Therapy|Not protocol specified|0|||
146603424|NCT00658814|528717400|FG001|Consolidation Therapy|Not protocol specified|1|||
146603425|NCT00658814|528717399|FG000|Consolidation Therapy|Not eligible|2|||
146603426|NCT00658814|528717400|FG001|Consolidation Therapy|Not eligible|2|||
146603427|NCT00658814|528717399|FG000|Maintenance Therapy|Adverse Event|1|||
146603428|NCT00658814|528717400|FG001|Maintenance Therapy|Adverse Event|1|||
146603429|NCT00658814|528717399|FG000|Maintenance Therapy|Not protocol specified|1|||
146603430|NCT00658814|528717400|FG001|Maintenance Therapy|Not protocol specified|0|||
146603431|NCT00658814|528717399|FG000|Maintenance Therapy|Not eligible|1|||
146603432|NCT00658814|528717400|FG001|Maintenance Therapy|Not eligible|0|||
146603433|NCT01141478|528717401|FG000|Overall Study|Withdrawal by Subject|1|||
146603434|NCT01141478|528717402|FG001|Overall Study|Withdrawal by Subject|1|||
146603435|NCT01953913|528717407|FG000|Overall Study|Disease Progression|349|||
146603436|NCT01953913|528717407|FG000|Overall Study|Worsening of underlying cancer|22|||
146603437|NCT01953913|528717407|FG000|Overall Study|Adverse Event|20|||
146603438|NCT01953913|528717407|FG000|Overall Study|Protocol Violation|6|||
146603439|NCT01953913|528717407|FG000|Overall Study|Lost to Follow-up|4|||
146922795|NCT02065622|529876837|FG002|Induction Study|Lack of Efficacy|0|||
146922796|NCT02065622|529876838|FG003|Induction Study|Lack of Efficacy|0|||
146922797|NCT02065622|529876839|FG004|Induction Study|Lack of Efficacy|0|||
146603440|NCT01953913|528717407|FG000|Overall Study|Withdrawal by Subject|32|||
146603441|NCT01953913|528717407|FG000|Overall Study|Other than listed|108|||
146603442|NCT01953913|528717407|FG000|Overall Study|Not Treated|1|||
146603443|NCT05026853|528717408|FG000|Overall Study|Cancelled appointment|1|||
146603444|NCT05026853|528717409|FG001|Overall Study|Cancelled appointment|0|||
146603445|NCT05026853|528717408|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
146603446|NCT05026853|528717409|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
146603447|NCT05026853|528717408|FG000|Overall Study|Did not complete 12-week survey|16|||
146603448|NCT05026853|528717409|FG001|Overall Study|Did not complete 12-week survey|16|||
146603449|NCT03836677|528717410|FG000|Period 1|Adverse Event|0|||
146603450|NCT03836677|528717411|FG001|Period 1|Adverse Event|1|||
146603451|NCT03836677|528717410|FG000|Period 2|Severe non-compliance to protocol|1|||
146603452|NCT03836677|528717411|FG001|Period 2|Severe non-compliance to protocol|0|||
146603453|NCT01732913|528717412|FG000|Overall Study|Study Terminated by Sponsor|105|||
146603454|NCT01732913|528717413|FG001|Overall Study|Study Terminated by Sponsor|55|||
146603455|NCT01732913|528717412|FG000|Overall Study|Withdrawal by Subject|27|||
146603456|NCT01732913|528717413|FG001|Overall Study|Withdrawal by Subject|4|||
146603457|NCT01732913|528717412|FG000|Overall Study|Physician Decision|14|||
146603458|NCT01732913|528717413|FG001|Overall Study|Physician Decision|7|||
146603459|NCT01732913|528717412|FG000|Overall Study|Other|7|||
146603460|NCT01732913|528717413|FG001|Overall Study|Other|1|||
146603461|NCT01732913|528717412|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
146603462|NCT01732913|528717413|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
146603463|NCT03233438|528717414|FG000|Overall Study|Lost to Follow-up|4|||
146603464|NCT03233438|528717415|FG001|Overall Study|Lost to Follow-up|9|||
146603465|NCT03233438|528717414|FG000|Overall Study|Withdrawal by Subject|2|||
146603466|NCT03233438|528717415|FG001|Overall Study|Withdrawal by Subject|1|||
146603467|NCT03233438|528717414|FG000|Overall Study|No recording of dalbavancin|0|||
146603468|NCT03233438|528717415|FG001|Overall Study|No recording of dalbavancin|1|||
146603469|NCT03831945|528717416|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
146603470|NCT03831945|528717417|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
146603471|NCT03831945|528717416|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
146603472|NCT03831945|528717417|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
146603473|NCT03831945|528717416|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
146603474|NCT03831945|528717417|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
146603475|NCT03178669|528717418|FG000|Overall Study|Adverse Event|4|||
146603476|NCT03178669|528717419|FG001|Overall Study|Adverse Event|1|||
146603477|NCT03178669|528717420|FG002|Overall Study|Adverse Event|4|||
146603478|NCT03178669|528717421|FG003|Overall Study|Adverse Event|2|||
146603479|NCT03178669|528717422|FG004|Overall Study|Adverse Event|2|||
146603480|NCT03178669|528717418|FG000|Overall Study|Lack of Efficacy|0|||
146603481|NCT03178669|528717419|FG001|Overall Study|Lack of Efficacy|0|||
146603482|NCT03178669|528717420|FG002|Overall Study|Lack of Efficacy|2|||
146603483|NCT03178669|528717421|FG003|Overall Study|Lack of Efficacy|0|||
146603484|NCT03178669|528717422|FG004|Overall Study|Lack of Efficacy|1|||
146603485|NCT03178669|528717418|FG000|Overall Study|Physician Decision|0|||
146603486|NCT03178669|528717419|FG001|Overall Study|Physician Decision|0|||
146603487|NCT03178669|528717420|FG002|Overall Study|Physician Decision|0|||
146603488|NCT03178669|528717421|FG003|Overall Study|Physician Decision|0|||
146603489|NCT03178669|528717422|FG004|Overall Study|Physician Decision|1|||
146603490|NCT03178669|528717418|FG000|Overall Study|Withdrawal by Subject|1|||
146603491|NCT03178669|528717419|FG001|Overall Study|Withdrawal by Subject|0|||
146603492|NCT03178669|528717420|FG002|Overall Study|Withdrawal by Subject|1|||
146603493|NCT03178669|528717421|FG003|Overall Study|Withdrawal by Subject|1|||
146603494|NCT03178669|528717422|FG004|Overall Study|Withdrawal by Subject|0|||
146603495|NCT03178669|528717418|FG000|Overall Study|Lost to Follow-up|0|||
146603496|NCT03178669|528717419|FG001|Overall Study|Lost to Follow-up|0|||
146603497|NCT03178669|528717420|FG002|Overall Study|Lost to Follow-up|0|||
146603498|NCT03178669|528717421|FG003|Overall Study|Lost to Follow-up|1|||
146603499|NCT03178669|528717422|FG004|Overall Study|Lost to Follow-up|0|||
146603500|NCT01300455|528717424|FG000|Washout|Withdrawal by Subject|1|||
146603501|NCT01300455|528717425|FG001|Washout|Withdrawal by Subject|0|||
146603502|NCT02438813|528717429|FG000|Overall Study|Patient Decision|59|||
146603503|NCT02438813|528717429|FG000|Overall Study|Patient Lost to Follow-Up|137|||
146603504|NCT02438813|528717429|FG000|Overall Study|Study Ended by Sponsor|80|||
146603505|NCT02438813|528717429|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
146603506|NCT00694304|528717430|FG000|Overall Study|Adverse Event|42|||
146603507|NCT00694304|528717430|FG000|Overall Study|Lack of Efficacy|35|||
146603508|NCT00694304|528717430|FG000|Overall Study|Non-compliance With Study Product|16|||
146603509|NCT00694304|528717430|FG000|Overall Study|Protocol Violation|6|||
146603510|NCT00694304|528717430|FG000|Overall Study|Withdrawal of Consent|61|||
146603511|NCT00694304|528717430|FG000|Overall Study|Lost to Follow-up|15|||
146603512|NCT00694304|528717430|FG000|Overall Study|Administrative or Other Reasons|32|||
146603513|NCT00576576|528717431|FG000|Overall Study|Lost to Follow-up|6|||
146603514|NCT00576576|528717431|FG000|Overall Study|Protocol Violation|1|||
146603515|NCT03135210|528717432|FG000|Overall Study|Death|0|||
146603516|NCT03135210|528717433|FG001|Overall Study|Death|1|||
146603517|NCT01270256|528717441|FG000|Overall Study|Withdrawal by Subject|1|||
146603518|NCT01270256|528717442|FG001|Overall Study|Withdrawal by Subject|0|||
146603519|NCT02879578|528717443|FG000|Overall Study|Adverse Event|1|||
146603520|NCT02879578|528717444|FG001|Overall Study|Adverse Event|2|||
146603521|NCT02879578|528717445|FG002|Overall Study|Adverse Event|14|||
146603522|NCT02879578|528717443|FG000|Overall Study|Protocol Violation|0|||
146603523|NCT02879578|528717444|FG001|Overall Study|Protocol Violation|1|||
146603524|NCT02879578|528717445|FG002|Overall Study|Protocol Violation|1|||
146603525|NCT02879578|528717443|FG000|Overall Study|Withdrawal by Subject|8|||
146603526|NCT02879578|528717444|FG001|Overall Study|Withdrawal by Subject|6|||
146603527|NCT02879578|528717445|FG002|Overall Study|Withdrawal by Subject|9|||
146603528|NCT02879578|528717443|FG000|Overall Study|Lost to Follow-up|1|||
146603529|NCT02879578|528717444|FG001|Overall Study|Lost to Follow-up|0|||
146603530|NCT02879578|528717445|FG002|Overall Study|Lost to Follow-up|4|||
146603531|NCT02879578|528717443|FG000|Overall Study|Physician Decision|0|||
146603532|NCT02879578|528717444|FG001|Overall Study|Physician Decision|0|||
146603533|NCT02879578|528717445|FG002|Overall Study|Physician Decision|4|||
146603534|NCT04566692|528717446|FG000|Overall Study|Adverse Event|2|||
146603535|NCT04566692|528717447|FG001|Overall Study|Adverse Event|0|||
146603536|NCT04566692|528717446|FG000|Overall Study|Withdrawal by Subject|1|||
146603537|NCT04566692|528717447|FG001|Overall Study|Withdrawal by Subject|1|||
146603538|NCT00671437|528717448|FG000|Overall Study|Progressive disease before C1 week 8|8|||
146603539|NCT00671437|528717448|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
146603540|NCT00671437|528717448|FG000|Overall Study|Adverse Event|3|||
146603541|NCT00671437|528717448|FG000|Overall Study|Ineligible post-hoc|1|||
146603542|NCT05098509|528717449|FG000|Overall Study|Withdrawal by Subject|0|||
146603543|NCT05098509|528717450|FG001|Overall Study|Withdrawal by Subject|0|||
146603544|NCT05098509|528717451|FG002|Overall Study|Withdrawal by Subject|1|||
146603545|NCT05098509|528717452|FG003|Overall Study|Withdrawal by Subject|0|||
146603546|NCT05098509|528717449|FG000|Overall Study|Early study termination|1|||
146603547|NCT05098509|528717450|FG001|Overall Study|Early study termination|1|||
146603548|NCT05098509|528717451|FG002|Overall Study|Early study termination|1|||
146603549|NCT05098509|528717452|FG003|Overall Study|Early study termination|0|||
146603550|NCT04033068|528717453|FG000|Overall Study|Withdrawal by Subject|0|||
146603551|NCT04033068|528717454|FG001|Overall Study|Withdrawal by Subject|0|||
146603552|NCT04033068|528717455|FG002|Overall Study|Withdrawal by Subject|1|||
146603553|NCT04033068|528717456|FG003|Overall Study|Withdrawal by Subject|0|||
146603554|NCT04033068|528717453|FG000|Overall Study|Lost to Follow-up|0|||
146603555|NCT04033068|528717454|FG001|Overall Study|Lost to Follow-up|1|||
146603556|NCT04033068|528717455|FG002|Overall Study|Lost to Follow-up|0|||
146603557|NCT04033068|528717456|FG003|Overall Study|Lost to Follow-up|0|||
146603558|NCT04033068|528717453|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
146603559|NCT04033068|528717454|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
146603560|NCT04033068|528717455|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
146603561|NCT04033068|528717456|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
146603562|NCT02540265|528717460|FG000|Overall Study|Lost to Follow-up|0|||
146603563|NCT02540265|528717461|FG001|Overall Study|Lost to Follow-up|0|||
146603564|NCT02540265|528717462|FG002|Overall Study|Lost to Follow-up|1|||
146603565|NCT01972789|528717463|FG000|Overall Study|Adverse Event|11|||
146603566|NCT01972789|528717464|FG001|Overall Study|Adverse Event|4|||
146603567|NCT01972789|528717463|FG000|Overall Study|Subject withdrew consent|14|||
146603568|NCT01972789|528717464|FG001|Overall Study|Subject withdrew consent|12|||
146603569|NCT01972789|528717463|FG000|Overall Study|Lost to Follow-up|4|||
146603570|NCT01972789|528717464|FG001|Overall Study|Lost to Follow-up|7|||
146603571|NCT01972789|528717463|FG000|Overall Study|Death|7|||
146603572|NCT01972789|528717464|FG001|Overall Study|Death|5|||
146603573|NCT01972789|528717463|FG000|Overall Study|Protocol deviation|1|||
146603574|NCT01972789|528717464|FG001|Overall Study|Protocol deviation|0|||
146603575|NCT01972789|528717463|FG000|Overall Study|Physician Decision|3|||
146603576|NCT01972789|528717464|FG001|Overall Study|Physician Decision|2|||
146603577|NCT01887353|528717477|FG000|Overall Study|Study stopped early|4|||
146603578|NCT01887353|528717478|FG001|Overall Study|Study stopped early|3|||
146603579|NCT00649428|528719512|FG000|Overall Study|Adverse Event|2|||
146603580|NCT00649428|528719513|FG001|Overall Study|Adverse Event|2|||
146603581|NCT00649428|528719512|FG000|Overall Study|Withdrawal by Subject|6|||
146603582|NCT00649428|528719513|FG001|Overall Study|Withdrawal by Subject|6|||
146603583|NCT00649428|528719512|FG000|Overall Study|Lost to Follow-up|1|||
146603584|NCT00649428|528719513|FG001|Overall Study|Lost to Follow-up|3|||
146603585|NCT00649428|528719512|FG000|Overall Study|Insufficient manufacturing yield|5|||
146603586|NCT00649428|528719513|FG001|Overall Study|Insufficient manufacturing yield|1|||
146603587|NCT00649428|528719512|FG000|Overall Study|Protocol Violation|6|||
146603588|NCT00649428|528719513|FG001|Overall Study|Protocol Violation|2|||
146603589|NCT00649428|528719512|FG000|Overall Study|Physician Decision|0|||
146603590|NCT00649428|528719513|FG001|Overall Study|Physician Decision|1|||
146603591|NCT04599465|528719514|FG000|Overall Study|Physician Decision|1|||
146603592|NCT04599465|528719514|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
146603593|NCT00495625|528719517|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
146603594|NCT02702180|528719519|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
146603595|NCT02702180|528719520|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
146603596|NCT02702180|528719521|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146603597|NCT02702180|528719519|FG000|Double-blind Treatment Period|Adverse Event|0|||
146603598|NCT02702180|528719520|FG001|Double-blind Treatment Period|Adverse Event|0|||
146603599|NCT02702180|528719521|FG002|Double-blind Treatment Period|Adverse Event|1|||
146603600|NCT02702180|528719519|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
146603601|NCT02702180|528719520|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
146603602|NCT02702180|528719521|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
146603603|NCT02702180|528719519|FG000|Double-blind Treatment Period|Protocol Violation|0|||
146603604|NCT02702180|528719520|FG001|Double-blind Treatment Period|Protocol Violation|0|||
146603605|NCT02702180|528719521|FG002|Double-blind Treatment Period|Protocol Violation|2|||
146603606|NCT02702180|528719519|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
146603607|NCT02702180|528719520|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
146603608|NCT02702180|528719521|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
146603609|NCT02702180|528719519|FG000|Open-label Treatment Period|Withdrawn in error|0|||
146603610|NCT02702180|528719520|FG001|Open-label Treatment Period|Withdrawn in error|0|||
146603611|NCT02702180|528719521|FG002|Open-label Treatment Period|Withdrawn in error|1|||
146603612|NCT00679172|528719525|FG000|Overall Study|Non-compliance|1|||
146603613|NCT00679172|528719526|FG001|Overall Study|Non-compliance|1|||
146603614|NCT00679172|528719527|FG002|Overall Study|Non-compliance|0|||
146603615|NCT00679172|528719528|FG003|Overall Study|Non-compliance|1|||
146603616|NCT00679172|528719529|FG004|Overall Study|Non-compliance|0|||
146603617|NCT00679172|528719525|FG000|Overall Study|Other not specified|0|||
146603618|NCT00679172|528719526|FG001|Overall Study|Other not specified|0|||
146603619|NCT00679172|528719527|FG002|Overall Study|Other not specified|1|||
146603620|NCT00679172|528719528|FG003|Overall Study|Other not specified|0|||
146603621|NCT00679172|528719529|FG004|Overall Study|Other not specified|0|||
146603622|NCT02241343|528719533|FG000|Overall Study|Adverse Event|1|||
146603623|NCT00753454|528719534|FG000|Overall Study|Adverse Event|4|||
146603624|NCT00753454|528719534|FG000|Overall Study|Lack of Efficacy|1|||
146603625|NCT00753454|528719534|FG000|Overall Study|Lost to Follow-up|3|||
146603626|NCT00753454|528719534|FG000|Overall Study|Withdrawal by Subject|5|||
146603627|NCT00753454|528719534|FG000|Overall Study|Investigator Decision|1|||
146603628|NCT05249569|528719535|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
146603629|NCT03927144|528719536|FG000|Core Phase|Adverse Event|9|||
146603630|NCT03927144|528719537|FG001|Core Phase|Adverse Event|5|||
146603631|NCT03927144|528719536|FG000|Core Phase|Lost to Follow-up|3|||
146603632|NCT03927144|528719537|FG001|Core Phase|Lost to Follow-up|2|||
146603633|NCT03927144|528719536|FG000|Core Phase|New Therapy for Study Indication|0|||
146603634|NCT03927144|528719537|FG001|Core Phase|New Therapy for Study Indication|1|||
146603635|NCT03927144|528719536|FG000|Core Phase|No Longer Clinically Benefiting|4|||
146603636|NCT03927144|528719537|FG001|Core Phase|No Longer Clinically Benefiting|4|||
146603637|NCT03927144|528719536|FG000|Core Phase|Physician Decision|2|||
146603638|NCT03927144|528719537|FG001|Core Phase|Physician Decision|8|||
146603639|NCT03927144|528719536|FG000|Core Phase|Protocol Violation|2|||
146603640|NCT03927144|528719537|FG001|Core Phase|Protocol Violation|2|||
146603641|NCT03927144|528719536|FG000|Core Phase|Withdrawal by Subject|16|||
146603642|NCT03927144|528719537|FG001|Core Phase|Withdrawal by Subject|40|||
146603643|NCT03927144|528719536|FG000|Extension Phase|Adverse Event|2|||
146603644|NCT03927144|528719537|FG001|Extension Phase|Adverse Event|1|||
146656752|NCT02380690|528919697|FG000|Overall Study|Lost to Follow-up|14|||
146656753|NCT02380690|528919698|FG001|Overall Study|Lost to Follow-up|4|||
146656754|NCT02380690|528919697|FG000|Overall Study|Withdrawal by Subject|20|||
146603645|NCT03927144|528719536|FG000|Extension Phase|No longer clinically benefiting|4|||
146603646|NCT03927144|528719537|FG001|Extension Phase|No longer clinically benefiting|5|||
146603647|NCT03927144|528719536|FG000|Extension Phase|Pregnancy|1|||
146603648|NCT03927144|528719537|FG001|Extension Phase|Pregnancy|0|||
146603649|NCT03927144|528719536|FG000|Extension Phase|Protocol Violation|0|||
146603650|NCT03927144|528719537|FG001|Extension Phase|Protocol Violation|1|||
146603651|NCT03927144|528719536|FG000|Extension Phase|Withdrawal by Subject|8|||
146656755|NCT02380690|528919698|FG001|Overall Study|Withdrawal by Subject|8|||
146656756|NCT00266864|528919699|FG000|Overall Study|Lost to Follow-up|4|||
146656757|NCT00266864|528919700|FG001|Overall Study|Lost to Follow-up|1|||
146603652|NCT03927144|528719537|FG001|Extension Phase|Withdrawal by Subject|3|||
146603653|NCT02271945|528719540|FG000|Overall Study|Death|3|||
146603654|NCT02271945|528719541|FG001|Overall Study|Death|3|||
146603655|NCT02271945|528719540|FG000|Overall Study|Withdrawal by Subject|1|||
146656758|NCT00266864|528919699|FG000|Overall Study|Withdrawal by Subject|1|||
146656759|NCT00266864|528919700|FG001|Overall Study|Withdrawal by Subject|1|||
146656760|NCT03687970|528919708|FG000|Overall Study|visit scheduling conflicts|2|||
146656761|NCT03687970|528919709|FG001|Overall Study|visit scheduling conflicts|0|||
146603656|NCT02271945|528719541|FG001|Overall Study|Withdrawal by Subject|1|||
146603657|NCT02271945|528719540|FG000|Overall Study|Other|1|||
146603658|NCT02271945|528719541|FG001|Overall Study|Other|1|||
146603659|NCT01452919|528719542|FG000|Open-Label Treatment|Adverse Event|5|||
146603660|NCT01452919|528719543|FG001|Open-Label Treatment|Adverse Event|0|||
146603661|NCT01452919|528719544|FG002|Open-Label Treatment|Adverse Event|0|||
146603662|NCT01452919|528719542|FG000|Open-Label Treatment|Lost to Follow-up|4|||
146603663|NCT01452919|528719543|FG001|Open-Label Treatment|Lost to Follow-up|0|||
146603664|NCT01452919|528719544|FG002|Open-Label Treatment|Lost to Follow-up|0|||
146603665|NCT01452919|528719542|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
146603666|NCT01452919|528719543|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
146603667|NCT01452919|528719544|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
146603668|NCT01452919|528719542|FG000|Open-Label Treatment|Protocol Violation|4|||
146603669|NCT01452919|528719543|FG001|Open-Label Treatment|Protocol Violation|0|||
146603670|NCT01452919|528719544|FG002|Open-Label Treatment|Protocol Violation|0|||
146603671|NCT01452919|528719542|FG000|Open-Label Treatment|Sponsor Decision|1|||
146603672|NCT01452919|528719543|FG001|Open-Label Treatment|Sponsor Decision|0|||
146603673|NCT01452919|528719544|FG002|Open-Label Treatment|Sponsor Decision|0|||
146603674|NCT01452919|528719542|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
146603675|NCT01452919|528719543|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
146603676|NCT01452919|528719544|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
146603677|NCT01452919|528719542|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
146603678|NCT01452919|528719543|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
146603679|NCT01452919|528719544|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
146603680|NCT01452919|528719542|FG000|Randomization Treatment|Adverse Event|0|||
146603681|NCT01452919|528719543|FG001|Randomization Treatment|Adverse Event|0|||
146603682|NCT01452919|528719544|FG002|Randomization Treatment|Adverse Event|2|||
146603683|NCT01452919|528719542|FG000|Randomization Treatment|Sponsor Decision|0|||
146603684|NCT01452919|528719543|FG001|Randomization Treatment|Sponsor Decision|1|||
146603685|NCT01452919|528719544|FG002|Randomization Treatment|Sponsor Decision|0|||
146603686|NCT01452919|528719542|FG000|Randomization Treatment|Withdrawal by Subject|0|||
146603687|NCT01452919|528719543|FG001|Randomization Treatment|Withdrawal by Subject|1|||
146603688|NCT01452919|528719544|FG002|Randomization Treatment|Withdrawal by Subject|0|||
146603689|NCT01452919|528719542|FG000|Randomization Treatment|Subject is moving or has moved|0|||
146603690|NCT01452919|528719543|FG001|Randomization Treatment|Subject is moving or has moved|1|||
146603691|NCT01452919|528719544|FG002|Randomization Treatment|Subject is moving or has moved|0|||
146603692|NCT00615030|528719546|FG000|Period I|Administrative problem|0|||
146603693|NCT00615030|528719547|FG001|Period I|Administrative problem|0|||
146603694|NCT00615030|528719548|FG002|Period I|Administrative problem|0|||
146603695|NCT00615030|528719549|FG003|Period I|Administrative problem|0|||
146603696|NCT00615030|528719550|FG004|Period I|Administrative problem|1|||
146656762|NCT03119701|528919710|FG000|6-day Dosing|Death|4|||
146656763|NCT03119701|528919711|FG001|6-day Dosing|Death|1|||
146656764|NCT03119701|528919710|FG000|6-day Dosing|Adverse Event|3|||
146656765|NCT03119701|528919711|FG001|6-day Dosing|Adverse Event|0|||
146656766|NCT03119701|528919710|FG000|6-day Dosing|Physician Decision|0|||
146656767|NCT03119701|528919711|FG001|6-day Dosing|Physician Decision|1|||
146656768|NCT03119701|528919710|FG000|6-day Dosing|Withdrawal by Subject|0|||
146656769|NCT03119701|528919711|FG001|6-day Dosing|Withdrawal by Subject|1|||
146656770|NCT03119701|528919710|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
146656771|NCT03119701|528919711|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
146656772|NCT00596362|528919713|FG000|Overall Study|Progressive Disease|1|||
146656773|NCT02793128|528919714|FG000|Overall Study|Death|4|||
146656774|NCT02793128|528919714|FG000|Overall Study|Withdrawal by Subject|2|||
146656775|NCT02793128|528919714|FG000|Overall Study|Physician Decision|1|||
146656776|NCT02793128|528919714|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
146656777|NCT02793128|528919714|FG000|Overall Study|Patient elected nephroureterectomy|1|||
146656778|NCT00356122|528919715|FG000|TREATMENT|Lack of Efficacy|26|||
146656779|NCT00356122|528919715|FG000|TREATMENT|Adverse Event|10|||
146656780|NCT00356122|528919715|FG000|TREATMENT|Subject's request|4|||
146656781|NCT00356122|528919715|FG000|TREATMENT|Other|4|||
146656782|NCT00356122|528919715|FG000|TREATMENT|Did not receive study medication|1|||
146603697|NCT00615030|528719551|FG005|Period I|Administrative problem|0|||
146603698|NCT00615030|528719552|FG006|Period I|Administrative problem|0|||
146603699|NCT00615030|528719553|FG007|Period I|Administrative problem|0|||
146656783|NCT00356122|528919715|FG000|FOLLOW-UP|Death|37|||
146603700|NCT00615030|528719554|FG008|Period I|Administrative problem|0|||
146603701|NCT00615030|528719555|FG009|Period I|Administrative problem|0|||
146603702|NCT00615030|528719556|FG010|Period I|Administrative problem|0|||
146656784|NCT00356122|528919715|FG000|FOLLOW-UP|Lost to Follow-up|2|||
146656785|NCT00356122|528919715|FG000|FOLLOW-UP|Other|2|||
146656786|NCT00491556|528919716|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
146656787|NCT00491556|528919717|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
146656788|NCT00491556|528919716|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
146656789|NCT00491556|528919717|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
146603703|NCT00615030|528719557|FG011|Period I|Administrative problem|0|||
146603704|NCT00615030|528719546|FG000|Period I|Protocol deviation|1|||
146603705|NCT00615030|528719547|FG001|Period I|Protocol deviation|0|||
146656790|NCT00491556|528919716|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
146656791|NCT00491556|528919717|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
146656792|NCT00491556|528919716|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
146656793|NCT00491556|528919717|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
146656794|NCT00491556|528919716|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
146656795|NCT00491556|528919717|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
146656796|NCT00491556|528919716|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
146656797|NCT00491556|528919717|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
146656798|NCT00491556|528919716|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
146656799|NCT00491556|528919717|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
146656800|NCT00491556|528919716|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
146656801|NCT00491556|528919717|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
146656802|NCT00491556|528919716|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
146656803|NCT00491556|528919717|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
146656804|NCT00491556|528919716|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
146656805|NCT00491556|528919717|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
146656806|NCT00491556|528919716|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
146656807|NCT00491556|528919717|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
146656808|NCT00491556|528919716|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
146656809|NCT00491556|528919717|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
146656810|NCT00491556|528919716|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
146656811|NCT00491556|528919717|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
146656812|NCT00491556|528919716|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
146656813|NCT00491556|528919717|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
146656814|NCT00491556|528919716|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
146656815|NCT00491556|528919717|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
146656816|NCT00491556|528919716|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
146656817|NCT00491556|528919717|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
146656818|NCT00491556|528919716|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
146656819|NCT00491556|528919717|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
146656820|NCT00491556|528919716|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
146656821|NCT00491556|528919717|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
146656822|NCT00491556|528919716|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
146656823|NCT00491556|528919717|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
146656824|NCT00491556|528919716|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
146603706|NCT00615030|528719548|FG002|Period I|Protocol deviation|0|||
146603707|NCT00615030|528719549|FG003|Period I|Protocol deviation|0|||
146603708|NCT00615030|528719550|FG004|Period I|Protocol deviation|0|||
146603709|NCT00615030|528719551|FG005|Period I|Protocol deviation|0|||
146603710|NCT00615030|528719552|FG006|Period I|Protocol deviation|0|||
146603711|NCT00615030|528719553|FG007|Period I|Protocol deviation|0|||
146603712|NCT00615030|528719554|FG008|Period I|Protocol deviation|0|||
146603713|NCT00615030|528719555|FG009|Period I|Protocol deviation|0|||
146603714|NCT00615030|528719556|FG010|Period I|Protocol deviation|0|||
146603715|NCT00615030|528719557|FG011|Period I|Protocol deviation|0|||
146603716|NCT00615030|528719546|FG000|Period I|Subject withdrew consent|0|||
146603717|NCT00615030|528719547|FG001|Period I|Subject withdrew consent|0|||
146603718|NCT00615030|528719548|FG002|Period I|Subject withdrew consent|0|||
146603719|NCT00615030|528719549|FG003|Period I|Subject withdrew consent|0|||
146603720|NCT00615030|528719550|FG004|Period I|Subject withdrew consent|0|||
146603721|NCT00615030|528719551|FG005|Period I|Subject withdrew consent|0|||
146603722|NCT00615030|528719552|FG006|Period I|Subject withdrew consent|0|||
146656825|NCT00491556|528919717|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
146603723|NCT00615030|528719553|FG007|Period I|Subject withdrew consent|0|||
146603724|NCT00615030|528719554|FG008|Period I|Subject withdrew consent|1|||
146603725|NCT00615030|528719555|FG009|Period I|Subject withdrew consent|0|||
146603726|NCT00615030|528719556|FG010|Period I|Subject withdrew consent|1|||
146603727|NCT00615030|528719557|FG011|Period I|Subject withdrew consent|1|||
146603728|NCT00615030|528719546|FG000|Period I|Abnormal laboratory value(s)|0|||
146603729|NCT00615030|528719547|FG001|Period I|Abnormal laboratory value(s)|0|||
146603730|NCT00615030|528719548|FG002|Period I|Abnormal laboratory value(s)|0|||
146603731|NCT00615030|528719549|FG003|Period I|Abnormal laboratory value(s)|0|||
146603732|NCT00615030|528719550|FG004|Period I|Abnormal laboratory value(s)|0|||
146603733|NCT00615030|528719551|FG005|Period I|Abnormal laboratory value(s)|1|||
146603734|NCT00615030|528719552|FG006|Period I|Abnormal laboratory value(s)|0|||
146603735|NCT00615030|528719553|FG007|Period I|Abnormal laboratory value(s)|0|||
146603736|NCT00615030|528719554|FG008|Period I|Abnormal laboratory value(s)|0|||
146603737|NCT00615030|528719555|FG009|Period I|Abnormal laboratory value(s)|0|||
146603738|NCT00615030|528719556|FG010|Period I|Abnormal laboratory value(s)|0|||
146603739|NCT00615030|528719557|FG011|Period I|Abnormal laboratory value(s)|0|||
146603740|NCT00615030|528719546|FG000|Period II|Adverse Event|0|||
146603741|NCT00615030|528719547|FG001|Period II|Adverse Event|0|||
146603742|NCT00615030|528719548|FG002|Period II|Adverse Event|1|||
146603743|NCT00615030|528719549|FG003|Period II|Adverse Event|0|||
146603744|NCT00615030|528719550|FG004|Period II|Adverse Event|0|||
146603745|NCT00615030|528719551|FG005|Period II|Adverse Event|0|||
146603746|NCT00615030|528719552|FG006|Period II|Adverse Event|0|||
146603747|NCT00615030|528719553|FG007|Period II|Adverse Event|0|||
146603748|NCT00615030|528719554|FG008|Period II|Adverse Event|1|||
146603749|NCT00615030|528719555|FG009|Period II|Adverse Event|0|||
146603750|NCT00615030|528719556|FG010|Period II|Adverse Event|0|||
146603751|NCT00615030|528719557|FG011|Period II|Adverse Event|0|||
146603752|NCT00615030|528719546|FG000|Period II|Subject withdrew consent|0|||
146603753|NCT00615030|528719547|FG001|Period II|Subject withdrew consent|0|||
146603754|NCT00615030|528719548|FG002|Period II|Subject withdrew consent|0|||
146603755|NCT00615030|528719549|FG003|Period II|Subject withdrew consent|1|||
146603756|NCT00615030|528719550|FG004|Period II|Subject withdrew consent|0|||
146603757|NCT00615030|528719551|FG005|Period II|Subject withdrew consent|0|||
146603758|NCT00615030|528719552|FG006|Period II|Subject withdrew consent|1|||
146603759|NCT00615030|528719553|FG007|Period II|Subject withdrew consent|0|||
146603760|NCT00615030|528719554|FG008|Period II|Subject withdrew consent|0|||
146603761|NCT00615030|528719555|FG009|Period II|Subject withdrew consent|0|||
146603762|NCT00615030|528719556|FG010|Period II|Subject withdrew consent|0|||
146603763|NCT00615030|528719557|FG011|Period II|Subject withdrew consent|0|||
146603764|NCT00615030|528719546|FG000|Period III|Administrative problems|1|||
146603765|NCT00615030|528719547|FG001|Period III|Administrative problems|0|||
146603766|NCT00615030|528719548|FG002|Period III|Administrative problems|0|||
146603767|NCT00615030|528719549|FG003|Period III|Administrative problems|1|||
146603768|NCT00615030|528719550|FG004|Period III|Administrative problems|0|||
146603769|NCT00615030|528719551|FG005|Period III|Administrative problems|0|||
146603770|NCT00615030|528719552|FG006|Period III|Administrative problems|0|||
146603771|NCT00615030|528719553|FG007|Period III|Administrative problems|0|||
146603772|NCT00615030|528719554|FG008|Period III|Administrative problems|0|||
146603773|NCT00615030|528719555|FG009|Period III|Administrative problems|0|||
146603774|NCT00615030|528719556|FG010|Period III|Administrative problems|0|||
146603775|NCT00615030|528719557|FG011|Period III|Administrative problems|0|||
146603776|NCT01359943|528719558|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
146603777|NCT01359943|528719559|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
146603778|NCT01359943|528719560|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
146603779|NCT01359943|528719558|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
146603780|NCT01359943|528719559|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
146603781|NCT01359943|528719560|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
146603782|NCT01359943|528719558|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
146603783|NCT01359943|528719559|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
146603784|NCT01359943|528719560|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
146603785|NCT01359943|528719558|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
146603786|NCT01359943|528719559|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
146603787|NCT01359943|528719560|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
146603788|NCT01359943|528719558|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
146603789|NCT01359943|528719559|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
146603790|NCT01359943|528719560|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
146603791|NCT01359943|528719558|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
146603792|NCT01359943|528719559|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
146603793|NCT01359943|528719560|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
146922798|NCT02065622|529876835|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
146603794|NCT01359943|528719558|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
146603795|NCT01359943|528719559|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
146603796|NCT01359943|528719560|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
146603797|NCT01359943|528719558|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
146603798|NCT01359943|528719559|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
146603799|NCT01359943|528719560|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
146603800|NCT01359943|528719558|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
146603801|NCT01359943|528719559|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
146603802|NCT01359943|528719560|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
146603803|NCT01359943|528719558|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
146603804|NCT01359943|528719559|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
146603805|NCT01359943|528719560|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
146922799|NCT02065622|529876836|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
146922800|NCT02065622|529876837|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
146603806|NCT01359943|528719558|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
146603807|NCT01359943|528719559|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
146922801|NCT02065622|529876838|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
146603808|NCT01359943|528719560|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
146772943|NCT03903822|529338236|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
146603809|NCT01359943|528719558|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
146603810|NCT01359943|528719559|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
146603811|NCT01359943|528719560|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
146603812|NCT01359943|528719558|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
146603813|NCT01359943|528719559|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
146603814|NCT01359943|528719560|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
146603815|NCT01359943|528719558|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
146603816|NCT01359943|528719559|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
146603817|NCT01359943|528719560|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
146603818|NCT01359943|528719558|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
146603819|NCT01359943|528719559|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
146603820|NCT01359943|528719560|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
146603821|NCT03002311|528719565|FG000|Overall Study|Lost to Follow-up|13|||
146603822|NCT03002311|528719566|FG001|Overall Study|Lost to Follow-up|26|||
146603823|NCT03002311|528719565|FG000|Overall Study|Referral provider called to schedule app|3|||
146603824|NCT03002311|528719566|FG001|Overall Study|Referral provider called to schedule app|3|||
146603825|NCT03002311|528719565|FG000|Overall Study|Physician Decision|3|||
146603826|NCT03002311|528719566|FG001|Overall Study|Physician Decision|1|||
146603827|NCT00308074|528719567|FG000|Overall Study|Withdrawal by Subject|1|||
146603828|NCT03722524|528719571|FG000|Overall Study|Protocol Violation|86|||
146603829|NCT03722524|528719571|FG000|Overall Study|Adverse Event|7|||
146603830|NCT03722524|528719571|FG000|Overall Study|Lost to Follow-up|1|||
146603831|NCT03722524|528719571|FG000|Overall Study|Reason is not stated|1|||
146603832|NCT03722524|528719571|FG000|Overall Study|Physician Decision|1|||
146603833|NCT03722524|528719571|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
146603834|NCT02649894|528719572|FG000|Overall Study|Adverse Event|1|||
146603835|NCT02649894|528719573|FG001|Overall Study|Adverse Event|0|||
146603836|NCT02649894|528719572|FG000|Overall Study|Physician Decision|0|||
146603837|NCT02649894|528719573|FG001|Overall Study|Physician Decision|1|||
146603838|NCT02649894|528719572|FG000|Overall Study|Withdrawal by Subject|5|||
146603839|NCT02649894|528719573|FG001|Overall Study|Withdrawal by Subject|2|||
146603840|NCT02649894|528719572|FG000|Overall Study|Lost to Follow-up|2|||
146603841|NCT02649894|528719573|FG001|Overall Study|Lost to Follow-up|1|||
146603842|NCT02649894|528719572|FG000|Overall Study|Death|30|||
146603843|NCT02649894|528719573|FG001|Overall Study|Death|7|||
146603844|NCT02649894|528719572|FG000|Overall Study|Other, not specified|6|||
146603845|NCT02649894|528719573|FG001|Overall Study|Other, not specified|0|||
146603846|NCT00719680|528719574|FG000|Overall Study|Adverse Event|1|||
146603847|NCT00719680|528719574|FG000|Overall Study|Lost to Follow-up|1|||
146772944|NCT03903822|529338237|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
146772945|NCT03903822|529338238|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
146772946|NCT03903822|529338239|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
146772947|NCT03903822|529338240|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
146772948|NCT03903822|529338241|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
146603848|NCT00719680|528719574|FG000|Overall Study|Withdrawal by Subject|3|||
146772949|NCT03903822|529338234|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
146603849|NCT02911142|528719575|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
146603850|NCT02911142|528719575|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
146603851|NCT02911142|528719575|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
146603852|NCT02911142|528719575|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
146603853|NCT01286740|528719576|FG000|Overall Study|Enrolled but not treated|1|||
146603854|NCT01286740|528719576|FG000|Overall Study|Protocol Violation|1|||
146603855|NCT03266172|528719577|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
146603856|NCT03266172|528719578|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
146603857|NCT03266172|528719579|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
146603858|NCT03266172|528719577|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
146772950|NCT03903822|529338235|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
146603859|NCT03266172|528719578|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
146603860|NCT03266172|528719579|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
146603861|NCT03266172|528719577|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
146603862|NCT03266172|528719578|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
146603863|NCT03266172|528719579|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
146603864|NCT03266172|528719577|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
146603865|NCT03266172|528719578|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
146603866|NCT03266172|528719579|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
146772951|NCT03903822|529338236|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
146772952|NCT03903822|529338237|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
146603867|NCT03266172|528719577|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
146772953|NCT03903822|529338238|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
146772954|NCT03903822|529338239|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
146603868|NCT03266172|528719578|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
146603869|NCT03266172|528719579|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
146603870|NCT03266172|528719577|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
146603871|NCT03266172|528719578|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
146603872|NCT03266172|528719579|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
146603873|NCT04856904|528719583|FG000|Overall Study|Physician Decision|1|||
146603874|NCT04856904|528719584|FG001|Overall Study|Physician Decision|1|||
146603875|NCT04856904|528719583|FG000|Overall Study|Withdrawal by Subject|13|||
146603876|NCT04856904|528719584|FG001|Overall Study|Withdrawal by Subject|13|||
146603877|NCT04856904|528719583|FG000|Overall Study|Adverse Event|1|||
146603878|NCT04856904|528719584|FG001|Overall Study|Adverse Event|1|||
146603879|NCT04856904|528719583|FG000|Overall Study|Non-compliance with study drug|1|||
146603880|NCT04856904|528719584|FG001|Overall Study|Non-compliance with study drug|1|||
146603881|NCT04856904|528719583|FG000|Overall Study|Lost to Follow-up|4|||
146603882|NCT04856904|528719584|FG001|Overall Study|Lost to Follow-up|4|||
146603883|NCT04856904|528719583|FG000|Overall Study|Withdrawal by Subject|1|||
146603884|NCT04856904|528719584|FG001|Overall Study|Withdrawal by Subject|1|||
146603885|NCT04856904|528719583|FG000|Overall Study|Protocol Violation|1|||
146603886|NCT04856904|528719584|FG001|Overall Study|Protocol Violation|1|||
146603887|NCT00847015|528719585|FG000|Overall Study|Withdrawal by Subject|1|||
146603888|NCT00847015|528719585|FG000|Overall Study|declined any surgery|1|||
146603889|NCT00847015|528719585|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
146603890|NCT00902174|528719586|FG000|Overall Study|Adverse Event|27|||
146603891|NCT00902174|528719587|FG001|Overall Study|Adverse Event|7|||
146603892|NCT00902174|528719586|FG000|Overall Study|Lack of Efficacy|1|||
146603893|NCT00902174|528719587|FG001|Overall Study|Lack of Efficacy|5|||
146603894|NCT00902174|528719586|FG000|Overall Study|Death|2|||
146603895|NCT00902174|528719587|FG001|Overall Study|Death|2|||
146603896|NCT00902174|528719586|FG000|Overall Study|Withdrawal by Subject|2|||
146603897|NCT00902174|528719587|FG001|Overall Study|Withdrawal by Subject|1|||
146603898|NCT00902174|528719586|FG000|Overall Study|Abnormal labs|1|||
146603899|NCT00902174|528719587|FG001|Overall Study|Abnormal labs|1|||
146603900|NCT00902174|528719586|FG000|Overall Study|Protocol Violation|1|||
146603901|NCT00902174|528719587|FG001|Overall Study|Protocol Violation|1|||
146603902|NCT00902174|528719586|FG000|Overall Study|Administration problem|0|||
146603903|NCT00902174|528719587|FG001|Overall Study|Administration problem|1|||
146603904|NCT00454584|528719588|FG000|Controlled Period|Adverse Event|5|||
146603905|NCT00454584|528719589|FG001|Controlled Period|Adverse Event|2|||
146603906|NCT00454584|528719590|FG002|Controlled Period|Adverse Event|1|||
146603907|NCT00454584|528719591|FG003|Controlled Period|Adverse Event|0|||
146603908|NCT00454584|528719592|FG004|Controlled Period|Adverse Event|0|||
146603909|NCT00454584|528719593|FG005|Controlled Period|Adverse Event|0|||
146603910|NCT00454584|528719588|FG000|Controlled Period|Lost to Follow-up|1|||
146603911|NCT00454584|528719589|FG001|Controlled Period|Lost to Follow-up|2|||
146603912|NCT00454584|528719590|FG002|Controlled Period|Lost to Follow-up|2|||
146603913|NCT00454584|528719591|FG003|Controlled Period|Lost to Follow-up|0|||
146603914|NCT00454584|528719592|FG004|Controlled Period|Lost to Follow-up|0|||
146603915|NCT00454584|528719593|FG005|Controlled Period|Lost to Follow-up|0|||
146603916|NCT00454584|528719588|FG000|Controlled Period|Other|5|||
146603917|NCT00454584|528719589|FG001|Controlled Period|Other|4|||
146603918|NCT00454584|528719590|FG002|Controlled Period|Other|2|||
146603919|NCT00454584|528719591|FG003|Controlled Period|Other|0|||
146603920|NCT00454584|528719592|FG004|Controlled Period|Other|0|||
146603921|NCT00454584|528719593|FG005|Controlled Period|Other|0|||
146603922|NCT00454584|528719588|FG000|After Controlled Period|Adverse Event|0|||
146603923|NCT00454584|528719589|FG001|After Controlled Period|Adverse Event|0|||
146603924|NCT00454584|528719590|FG002|After Controlled Period|Adverse Event|0|||
146603925|NCT00454584|528719591|FG003|After Controlled Period|Adverse Event|9|||
146603926|NCT00454584|528719592|FG004|After Controlled Period|Adverse Event|3|||
146603927|NCT00454584|528719593|FG005|After Controlled Period|Adverse Event|9|||
146603928|NCT00454584|528719588|FG000|After Controlled Period|Lack of Efficacy|0|||
146603929|NCT00454584|528719589|FG001|After Controlled Period|Lack of Efficacy|0|||
146603930|NCT00454584|528719590|FG002|After Controlled Period|Lack of Efficacy|0|||
146603931|NCT00454584|528719591|FG003|After Controlled Period|Lack of Efficacy|1|||
146603932|NCT00454584|528719592|FG004|After Controlled Period|Lack of Efficacy|0|||
146603933|NCT00454584|528719593|FG005|After Controlled Period|Lack of Efficacy|0|||
146603934|NCT00454584|528719588|FG000|After Controlled Period|Lost to Follow-up|0|||
146603935|NCT00454584|528719589|FG001|After Controlled Period|Lost to Follow-up|0|||
146603936|NCT00454584|528719590|FG002|After Controlled Period|Lost to Follow-up|0|||
146603937|NCT00454584|528719591|FG003|After Controlled Period|Lost to Follow-up|2|||
146603938|NCT00454584|528719592|FG004|After Controlled Period|Lost to Follow-up|4|||
146603939|NCT00454584|528719593|FG005|After Controlled Period|Lost to Follow-up|6|||
146603940|NCT00454584|528719588|FG000|After Controlled Period|Other|0|||
146603941|NCT00454584|528719589|FG001|After Controlled Period|Other|0|||
146603942|NCT00454584|528719590|FG002|After Controlled Period|Other|0|||
146603943|NCT00454584|528719591|FG003|After Controlled Period|Other|1|||
146603944|NCT00454584|528719592|FG004|After Controlled Period|Other|0|||
146603945|NCT00454584|528719593|FG005|After Controlled Period|Other|0|||
146603946|NCT00454584|528719588|FG000|After Controlled Period|Other|0|||
146603947|NCT00454584|528719589|FG001|After Controlled Period|Other|0|||
146603948|NCT00454584|528719590|FG002|After Controlled Period|Other|0|||
146603949|NCT00454584|528719591|FG003|After Controlled Period|Other|13|||
146603950|NCT00454584|528719592|FG004|After Controlled Period|Other|5|||
146603951|NCT00454584|528719593|FG005|After Controlled Period|Other|17|||
146603952|NCT01716104|528719594|FG000|Overall Study|Do not meet inclusion criteria|6|||
146603953|NCT01716104|528719595|FG001|Overall Study|Do not meet inclusion criteria|7|||
146603954|NCT02895945|528719596|FG000|Overall Study|Physician Decision|2|||
146603955|NCT02895945|528719597|FG001|Overall Study|Physician Decision|1|||
146603956|NCT03429543|528719602|FG000|Overall Study|Adverse Event|1|||
146603957|NCT03429543|528719603|FG001|Overall Study|Adverse Event|1|||
146603958|NCT03429543|528719604|FG002|Overall Study|Adverse Event|0|||
146603959|NCT03429543|528719605|FG003|Overall Study|Adverse Event|0|||
146603960|NCT03429543|528719606|FG004|Overall Study|Adverse Event|0|||
146603961|NCT03429543|528719607|FG005|Overall Study|Adverse Event|2|||
146603962|NCT03429543|528719608|FG006|Overall Study|Adverse Event|0|||
146603963|NCT03429543|528719602|FG000|Overall Study|Lost to Follow-up|1|||
146603964|NCT03429543|528719603|FG001|Overall Study|Lost to Follow-up|0|||
146603965|NCT03429543|528719604|FG002|Overall Study|Lost to Follow-up|0|||
146603966|NCT03429543|528719605|FG003|Overall Study|Lost to Follow-up|0|||
146603967|NCT03429543|528719606|FG004|Overall Study|Lost to Follow-up|1|||
146603968|NCT03429543|528719607|FG005|Overall Study|Lost to Follow-up|0|||
146603969|NCT03429543|528719608|FG006|Overall Study|Lost to Follow-up|0|||
146603970|NCT03429543|528719602|FG000|Overall Study|Withdrawal by Subject|5|||
146603971|NCT03429543|528719603|FG001|Overall Study|Withdrawal by Subject|0|||
146603972|NCT03429543|528719604|FG002|Overall Study|Withdrawal by Subject|1|||
146603973|NCT03429543|528719605|FG003|Overall Study|Withdrawal by Subject|2|||
146603974|NCT03429543|528719606|FG004|Overall Study|Withdrawal by Subject|6|||
146603975|NCT03429543|528719607|FG005|Overall Study|Withdrawal by Subject|3|||
146603976|NCT03429543|528719608|FG006|Overall Study|Withdrawal by Subject|1|||
146603977|NCT03429543|528719602|FG000|Overall Study|Other reason than listed|0|||
146603978|NCT03429543|528719603|FG001|Overall Study|Other reason than listed|1|||
146603979|NCT03429543|528719604|FG002|Overall Study|Other reason than listed|0|||
146603980|NCT03429543|528719605|FG003|Overall Study|Other reason than listed|0|||
146603981|NCT03429543|528719606|FG004|Overall Study|Other reason than listed|4|||
146603982|NCT03429543|528719607|FG005|Overall Study|Other reason than listed|4|||
146603983|NCT03429543|528719608|FG006|Overall Study|Other reason than listed|0|||
146603984|NCT03429543|528719602|FG000|Overall Study|Not treated|0|||
146603985|NCT03429543|528719603|FG001|Overall Study|Not treated|0|||
146603986|NCT03429543|528719604|FG002|Overall Study|Not treated|0|||
146603987|NCT03429543|528719605|FG003|Overall Study|Not treated|0|||
146603988|NCT03429543|528719606|FG004|Overall Study|Not treated|1|||
146603989|NCT03429543|528719607|FG005|Overall Study|Not treated|0|||
146603990|NCT03429543|528719608|FG006|Overall Study|Not treated|0|||
146603991|NCT01818492|528719609|FG000|Overall Study|Adverse Event|2|||
146603992|NCT01818492|528719609|FG000|Overall Study|Death|3|||
146603993|NCT01818492|528719609|FG000|Overall Study|Withdrawal by Subject|1|||
146603994|NCT01818492|528719609|FG000|Overall Study|Additional therapy when not allowed PP|4|||
146603995|NCT02345330|528719612|FG000|Overall Study|Death|1|||
146603996|NCT02345330|528719612|FG000|Overall Study|Progressive Disease|2|||
146603997|NCT00454181|528719614|FG000|Overall Study|Adverse Event|1|||
146603998|NCT00454181|528719615|FG001|Overall Study|Adverse Event|1|||
146603999|NCT00454181|528719614|FG000|Overall Study|Lost to Follow-up|11|||
146604000|NCT00454181|528719615|FG001|Overall Study|Lost to Follow-up|1|||
146604001|NCT00454181|528719614|FG000|Overall Study|Protocol Violation|1|||
146604002|NCT00454181|528719615|FG001|Overall Study|Protocol Violation|1|||
146604003|NCT00454181|528719614|FG000|Overall Study|Withdrawal by Subject|2|||
146604004|NCT00454181|528719615|FG001|Overall Study|Withdrawal by Subject|0|||
146604005|NCT02976103|528719619|FG000|Overall Study|Withdrawal by Subject|1|||
146604006|NCT02976103|528719620|FG001|Overall Study|Withdrawal by Subject|0|||
146604007|NCT02976103|528719619|FG000|Overall Study|Lost to Follow-up|12|||
146604008|NCT02976103|528719620|FG001|Overall Study|Lost to Follow-up|8|||
146604009|NCT00079677|528719621|FG000|Overall Study|Adverse Event|5|||
146604010|NCT00079677|528719622|FG001|Overall Study|Adverse Event|6|||
146604011|NCT00079677|528719621|FG000|Overall Study|Lack of Efficacy|1|||
146604012|NCT00079677|528719622|FG001|Overall Study|Lack of Efficacy|0|||
146604013|NCT00079677|528719621|FG000|Overall Study|Lost to Follow-up|2|||
146604014|NCT00079677|528719622|FG001|Overall Study|Lost to Follow-up|2|||
146604015|NCT00079677|528719621|FG000|Overall Study|Physician Decision|3|||
146604016|NCT00079677|528719622|FG001|Overall Study|Physician Decision|0|||
146604017|NCT00079677|528719621|FG000|Overall Study|Protocol Violation|2|||
146604018|NCT00079677|528719622|FG001|Overall Study|Protocol Violation|3|||
146604019|NCT00079677|528719621|FG000|Overall Study|Withdrawal by Subject|5|||
146604020|NCT00079677|528719622|FG001|Overall Study|Withdrawal by Subject|3|||
146604021|NCT00079677|528719621|FG000|Overall Study|Miscellaneous|2|||
146604022|NCT00079677|528719622|FG001|Overall Study|Miscellaneous|0|||
146604023|NCT00565136|528719623|FG000|Overall Study|Lost to Follow-up|1|||
146604024|NCT00565136|528719623|FG000|Overall Study|Withdrawal by Subject|1|||
146604025|NCT00565136|528719623|FG000|Overall Study|Protocol Violation|1|||
146604026|NCT00989781|528719629|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
146604027|NCT00989781|528719630|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
146604028|NCT00409344|528719635|FG000|Overall Study|no enrollment|0|||
146604029|NCT00409344|528719636|FG001|Overall Study|no enrollment|0|||
146604030|NCT05096312|528719637|FG000|Overall Study|Lost to Follow-up|2|||
146604031|NCT05096312|528719638|FG001|Overall Study|Lost to Follow-up|4|||
146604032|NCT05096312|528719637|FG000|Overall Study|Adverse Event|1|||
146604033|NCT05096312|528719638|FG001|Overall Study|Adverse Event|0|||
146604034|NCT01805037|528719639|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
146604035|NCT01805037|528719640|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
146604036|NCT01805037|528719639|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
146604037|NCT01805037|528719640|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
146604038|NCT01805037|528719639|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
146604039|NCT01805037|528719640|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
146604040|NCT01805037|528719639|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
146604041|NCT01805037|528719640|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
146604042|NCT01805037|528719639|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
146604043|NCT01805037|528719640|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
146604044|NCT01805037|528719639|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
146604045|NCT01805037|528719640|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
146604046|NCT01805037|528719639|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
146604047|NCT01805037|528719640|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
146604048|NCT01805037|528719639|FG000|Follow Up (up to 3 Years)|Death|0|||
146604049|NCT01805037|528719640|FG001|Follow Up (up to 3 Years)|Death|2|||
146604050|NCT01805037|528719639|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
146604051|NCT01805037|528719640|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
146604052|NCT01805037|528719639|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
146604053|NCT01805037|528719640|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
146604054|NCT03927404|528719641|FG000|Overall Study|Withdrawal by Subject|1|||
146604055|NCT01229449|528719642|FG000|Overall Study|Withdrawal by Subject|0|||
146604056|NCT01229449|528719643|FG001|Overall Study|Withdrawal by Subject|3|||
146604057|NCT01229449|528719644|FG002|Overall Study|Withdrawal by Subject|0|||
146604058|NCT01229449|528719645|FG003|Overall Study|Withdrawal by Subject|1|||
146604059|NCT01229449|528719646|FG004|Overall Study|Withdrawal by Subject|1|||
146604060|NCT01229449|528719642|FG000|Overall Study|Lost to Follow-up|1|||
146604061|NCT01229449|528719643|FG001|Overall Study|Lost to Follow-up|1|||
146604062|NCT01229449|528719644|FG002|Overall Study|Lost to Follow-up|1|||
146604063|NCT01229449|528719645|FG003|Overall Study|Lost to Follow-up|0|||
146604064|NCT01229449|528719646|FG004|Overall Study|Lost to Follow-up|0|||
146604065|NCT01229449|528719642|FG000|Overall Study|Physician Decision|0|||
146604066|NCT01229449|528719643|FG001|Overall Study|Physician Decision|0|||
146604067|NCT01229449|528719644|FG002|Overall Study|Physician Decision|1|||
146604068|NCT01229449|528719645|FG003|Overall Study|Physician Decision|0|||
146604069|NCT01229449|528719646|FG004|Overall Study|Physician Decision|0|||
146604070|NCT03203291|528719649|FG000|Overall Study|Withdrawal by Subject|1|||
146604071|NCT03157037|528719650|FG000|Overall Study|Death|1|||
146604072|NCT02102399|528719651|FG000|Overall Study|Withdrawal by Subject|6|||
146604073|NCT02102399|528719652|FG001|Overall Study|Withdrawal by Subject|4|||
146604074|NCT04349033|528719653|FG000|Overall Study|Lost to Follow-up|3|||
146604075|NCT04349033|528719654|FG001|Overall Study|Lost to Follow-up|1|||
146604076|NCT04349033|528719655|FG002|Overall Study|Lost to Follow-up|1|||
146604077|NCT00324233|528719656|FG000|First Period|unable to insert catheter|1|||
146604078|NCT00324233|528719657|FG001|First Period|unable to insert catheter|0|||
146604079|NCT00324233|528719656|FG000|Second Period|unable to insert catheter|1|||
146604080|NCT00324233|528719657|FG001|Second Period|unable to insert catheter|1|||
146604081|NCT00324233|528719656|FG000|Second Period|Protocol Violation|4|||
146604082|NCT00324233|528719657|FG001|Second Period|Protocol Violation|6|||
146604083|NCT01704456|528719662|FG000|Overall Study|Lost to Follow-up|8|||
146604084|NCT01704456|528719663|FG001|Overall Study|Lost to Follow-up|14|||
146604085|NCT00498355|528719664|FG000|Overall Study|Lost to Follow-up|1|||
146604086|NCT00410605|528719665|FG000|Overall Study|Adverse Event|12|||
146604087|NCT00410605|528719665|FG000|Overall Study|Physician Decision|3|||
146604088|NCT00410605|528719665|FG000|Overall Study|Withdrawal by Subject|5|||
146604089|NCT00410605|528719665|FG000|Overall Study|Started Non-Protocol Therapy|3|||
146604090|NCT00410605|528719665|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
146604091|NCT00410605|528719665|FG000|Overall Study|Transferred to another Institution|1|||
146604092|NCT04583956|528719666|FG000|Overall Study|Death|9|||
146604093|NCT04583956|528719667|FG001|Overall Study|Death|11|||
146604094|NCT04583956|528719666|FG000|Overall Study|Lost to Follow-up|7|||
146656826|NCT00782795|528919718|FG000|Overall Study|Withdrawal by Subject|1|||
146656827|NCT00782795|528919719|FG001|Overall Study|Withdrawal by Subject|2|||
146656828|NCT04480424|528919720|FG000|Overall Study|Withdrawal by Subject|0|||
146922802|NCT02065622|529876839|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
146604095|NCT04583956|528719667|FG001|Overall Study|Lost to Follow-up|9|||
146604096|NCT04583956|528719666|FG000|Overall Study|Protocol Violation|2|||
146604097|NCT04583956|528719667|FG001|Overall Study|Protocol Violation|0|||
146604098|NCT04583956|528719666|FG000|Overall Study|Withdrawal by Subject|0|||
146604099|NCT04583956|528719667|FG001|Overall Study|Withdrawal by Subject|2|||
146604100|NCT04583956|528719666|FG000|Overall Study|Randomized but not dosed|2|||
146604101|NCT04583956|528719667|FG001|Overall Study|Randomized but not dosed|3|||
146604102|NCT04583956|528719666|FG000|Overall Study|Withdrawal of consent before product administration|1|||
146604103|NCT04583956|528719667|FG001|Overall Study|Withdrawal of consent before product administration|0|||
146604104|NCT03908970|528719668|FG000|Overall Study|Adverse Event|7|||
146604105|NCT03908970|528719669|FG001|Overall Study|Adverse Event|21|||
146604106|NCT03908970|528719668|FG000|Overall Study|Physician Decision|1|||
146604107|NCT03908970|528719669|FG001|Overall Study|Physician Decision|4|||
146604108|NCT03908970|528719668|FG000|Overall Study|Withdrawal by Subject|9|||
146604109|NCT03908970|528719669|FG001|Overall Study|Withdrawal by Subject|22|||
146604110|NCT04407234|528719670|FG000|Overall Study|Adverse Event|3|||
146604111|NCT04407234|528719671|FG001|Overall Study|Adverse Event|3|||
146604112|NCT02008227|528721147|FG000|Overall Study|Lost to Follow-up|7|||
146604113|NCT02008227|528721148|FG001|Overall Study|Lost to Follow-up|9|||
146604114|NCT02008227|528721147|FG000|Overall Study|Death|494|||
146604115|NCT02008227|528721148|FG001|Overall Study|Death|485|||
146604116|NCT02008227|528721147|FG000|Overall Study|Withdrawal by Subject|67|||
146604117|NCT02008227|528721148|FG001|Overall Study|Withdrawal by Subject|36|||
146604118|NCT02008227|528721147|FG000|Overall Study|Study Terminated By Sponsor|44|||
146604119|NCT02008227|528721148|FG001|Overall Study|Study Terminated By Sponsor|83|||
146604120|NCT00742417|528721149|FG000|Randomized|Withdrawal by legal representative|0|||
146604121|NCT00742417|528721150|FG001|Randomized|Withdrawal by legal representative|1|||
146604122|NCT00742417|528721149|FG000|Randomized|Withdrawal by Subject|1|||
146604123|NCT00742417|528721150|FG001|Randomized|Withdrawal by Subject|0|||
146604124|NCT00742417|528721149|FG000|Randomized|Physician Decision|1|||
146604125|NCT00742417|528721150|FG001|Randomized|Physician Decision|0|||
146604126|NCT00742417|528721149|FG000|Intensive Period|Withdrawal by Subject|1|||
146604127|NCT00742417|528721150|FG001|Intensive Period|Withdrawal by Subject|1|||
146604128|NCT00742417|528721149|FG000|Intensive Period|Adverse Event|2|||
146604129|NCT00742417|528721150|FG001|Intensive Period|Adverse Event|0|||
146604130|NCT00965575|528721153|FG000|Overall Study|subject unwillingness to swallow study c|1|||
146604131|NCT00965575|528721154|FG001|Overall Study|subject unwillingness to swallow study c|0|||
146604132|NCT02814175|528721157|FG000|Part 1|Adverse Event|2|||
146604133|NCT02814175|528721158|FG001|Part 1|Adverse Event|3|||
146604134|NCT02814175|528721159|FG002|Part 1|Adverse Event|0|||
146604135|NCT02814175|528721160|FG003|Part 1|Adverse Event|0|||
146604136|NCT02814175|528721161|FG004|Part 1|Adverse Event|0|||
146604137|NCT02814175|528721162|FG005|Part 1|Adverse Event|0|||
146604138|NCT02814175|528721157|FG000|Part 1|Withdrawal Consent|8|||
146604139|NCT02814175|528721158|FG001|Part 1|Withdrawal Consent|1|||
146604140|NCT02814175|528721159|FG002|Part 1|Withdrawal Consent|0|||
146604141|NCT02814175|528721160|FG003|Part 1|Withdrawal Consent|0|||
146604142|NCT02814175|528721161|FG004|Part 1|Withdrawal Consent|0|||
146604143|NCT02814175|528721162|FG005|Part 1|Withdrawal Consent|0|||
146604144|NCT02814175|528721157|FG000|Part 1|Lost to Follow-up|1|||
146604145|NCT02814175|528721158|FG001|Part 1|Lost to Follow-up|0|||
146604146|NCT02814175|528721159|FG002|Part 1|Lost to Follow-up|0|||
146604147|NCT02814175|528721160|FG003|Part 1|Lost to Follow-up|0|||
146604148|NCT02814175|528721161|FG004|Part 1|Lost to Follow-up|0|||
146604149|NCT02814175|528721162|FG005|Part 1|Lost to Follow-up|0|||
146604150|NCT02814175|528721157|FG000|Part 1|Lack of Efficacy|1|||
146604151|NCT02814175|528721158|FG001|Part 1|Lack of Efficacy|2|||
146604152|NCT02814175|528721159|FG002|Part 1|Lack of Efficacy|0|||
146604153|NCT02814175|528721160|FG003|Part 1|Lack of Efficacy|0|||
146604154|NCT02814175|528721161|FG004|Part 1|Lack of Efficacy|0|||
146604155|NCT02814175|528721162|FG005|Part 1|Lack of Efficacy|0|||
146604156|NCT02814175|528721157|FG000|Part 2|Adverse Event|0|||
146604157|NCT02814175|528721158|FG001|Part 2|Adverse Event|0|||
146604158|NCT02814175|528721159|FG002|Part 2|Adverse Event|0|||
146604159|NCT02814175|528721160|FG003|Part 2|Adverse Event|1|||
146604160|NCT02814175|528721161|FG004|Part 2|Adverse Event|1|||
146604161|NCT02814175|528721162|FG005|Part 2|Adverse Event|2|||
146604162|NCT02814175|528721157|FG000|Part 2|Withdrawal Consent|0|||
146604163|NCT02814175|528721158|FG001|Part 2|Withdrawal Consent|0|||
146604164|NCT02814175|528721159|FG002|Part 2|Withdrawal Consent|0|||
146772955|NCT03903822|529338240|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
146978653|NCT00766506|530085448|FG001|Overall Study|Use rescue medication after 3 hours|0|||
146978654|NCT00766506|530085447|FG000|Overall Study|Other|2|||
146604165|NCT02814175|528721160|FG003|Part 2|Withdrawal Consent|2|||
146604166|NCT02814175|528721161|FG004|Part 2|Withdrawal Consent|1|||
146604167|NCT02814175|528721162|FG005|Part 2|Withdrawal Consent|1|||
146604168|NCT02814175|528721157|FG000|Part 2|Lost to Follow-up|0|||
146604169|NCT02814175|528721158|FG001|Part 2|Lost to Follow-up|0|||
146604170|NCT02814175|528721159|FG002|Part 2|Lost to Follow-up|0|||
146604171|NCT02814175|528721160|FG003|Part 2|Lost to Follow-up|1|||
146604172|NCT02814175|528721161|FG004|Part 2|Lost to Follow-up|0|||
146604173|NCT02814175|528721162|FG005|Part 2|Lost to Follow-up|0|||
146604174|NCT02814175|528721157|FG000|Part 2|Lack of Efficacy|0|||
146604175|NCT02814175|528721158|FG001|Part 2|Lack of Efficacy|0|||
146604176|NCT02814175|528721159|FG002|Part 2|Lack of Efficacy|0|||
146604177|NCT02814175|528721160|FG003|Part 2|Lack of Efficacy|0|||
146604178|NCT02814175|528721161|FG004|Part 2|Lack of Efficacy|0|||
146604179|NCT02814175|528721162|FG005|Part 2|Lack of Efficacy|3|||
146604180|NCT01912339|528721163|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
146604181|NCT01912339|528721164|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
146604182|NCT01912339|528721165|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
146604183|NCT01912339|528721163|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
146604184|NCT01912339|528721164|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
146604185|NCT01912339|528721165|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
146604186|NCT01912339|528721163|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
146604187|NCT01912339|528721164|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
146604188|NCT01912339|528721165|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
146604189|NCT01912339|528721163|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
146604190|NCT01912339|528721164|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
146604191|NCT01912339|528721165|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
146604192|NCT01912339|528721163|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
146604193|NCT01912339|528721164|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
146604194|NCT01912339|528721165|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
146604195|NCT01912339|528721163|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
146604196|NCT01912339|528721164|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
146604197|NCT01912339|528721165|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
146604198|NCT01912339|528721163|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
146604199|NCT01912339|528721164|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
146604200|NCT01912339|528721165|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
146604201|NCT01912339|528721163|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
146604202|NCT01912339|528721164|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
146604203|NCT01912339|528721165|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
146604204|NCT01912339|528721163|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
146604205|NCT01912339|528721164|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
146604206|NCT01912339|528721165|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
146604207|NCT01912339|528721163|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
146604208|NCT01912339|528721164|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
146604209|NCT01912339|528721165|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
146604210|NCT01912339|528721163|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
146604211|NCT01912339|528721164|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
146604212|NCT01912339|528721165|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
146604213|NCT01912339|528721163|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
146604214|NCT01912339|528721164|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
146604215|NCT01912339|528721165|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
146604216|NCT01912339|528721163|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
146604217|NCT01912339|528721164|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
146604218|NCT01912339|528721165|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
146604219|NCT01754493|528721166|FG000|Overall Study|Adverse Event|1|||
146604220|NCT01754493|528721166|FG000|Overall Study|Lost to Follow-up|3|||
146604221|NCT01754493|528721166|FG000|Overall Study|Withdrawal by Subject|1|||
146604222|NCT01754493|528721166|FG000|Overall Study|Moved out of town|1|||
146604223|NCT01754493|528721166|FG000|Overall Study|Scheduling conflict|1|||
146604224|NCT02489942|528721167|FG000|Overall Study|Request by patient|602|||
146604225|NCT02489942|528721167|FG000|Overall Study|Improvement/remission|157|||
146604226|NCT02489942|528721167|FG000|Overall Study|No change/Progressive disease|263|||
146656829|NCT04480424|528919721|FG001|Overall Study|Withdrawal by Subject|2|||
146656830|NCT04480424|528919720|FG000|Overall Study|Lost to Follow-up|3|||
146656831|NCT04480424|528919721|FG001|Overall Study|Lost to Follow-up|3|||
146656832|NCT04480424|528919720|FG000|Overall Study|Death|14|||
146656833|NCT04480424|528919721|FG001|Overall Study|Death|16|||
146656834|NCT04480424|528919720|FG000|Overall Study|Reason not Specified|5|||
146656835|NCT04480424|528919721|FG001|Overall Study|Reason not Specified|5|||
146656836|NCT03437512|528921608|FG000|Randomized|Withdrawal by Subject|0|||
146656837|NCT03437512|528921609|FG001|Randomized|Withdrawal by Subject|2|||
146656838|NCT03437512|528921608|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
146772956|NCT03903822|529338241|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
146772957|NCT03903822|529338234|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
146604227|NCT02489942|528721167|FG000|Overall Study|Adverse Event|522|||
146604228|NCT02489942|528721167|FG000|Overall Study|Other personal reasons|1218|||
146604229|NCT02489942|528721167|FG000|Overall Study|Lost to Follow-up|456|||
146604230|NCT02489942|528721167|FG000|Overall Study|Not continuously investigated|7|||
146604231|NCT02489942|528721167|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
146656839|NCT03437512|528921609|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
146604232|NCT02489942|528721167|FG000|Overall Study|Multiple registration|1|||
146604233|NCT02489942|528721167|FG000|Overall Study|No patient visit after entry|100|||
146604234|NCT02489942|528721167|FG000|Overall Study|No treatment with Jardiance|2|||
146604235|NCT02489942|528721167|FG000|Overall Study|Patient received Jardiance before registration|1|||
146604236|NCT02489942|528721167|FG000|Overall Study|No CRF collected|86|||
146604237|NCT01272635|528721168|FG000|Overall Study|Lost to Follow-up|31|||
146604238|NCT01272635|528721169|FG001|Overall Study|Lost to Follow-up|20|||
146604239|NCT01272635|528721170|FG002|Overall Study|Lost to Follow-up|31|||
146604240|NCT01272635|528721171|FG003|Overall Study|Lost to Follow-up|23|||
146604241|NCT01543776|528721174|FG000|Overall Study|Withdrawal by Subject|2|||
146604242|NCT01543776|528721175|FG001|Overall Study|Withdrawal by Subject|2|||
146604243|NCT03626545|528721176|FG000|Overall Study|Progressive disease|3|||
146604244|NCT03626545|528721177|FG001|Overall Study|Progressive disease|82|||
146604245|NCT03626545|528721178|FG002|Overall Study|Progressive disease|85|||
146604246|NCT03626545|528721176|FG000|Overall Study|Adverse Event|3|||
146604247|NCT03626545|528721177|FG001|Overall Study|Adverse Event|13|||
146604248|NCT03626545|528721178|FG002|Overall Study|Adverse Event|10|||
146604249|NCT03626545|528721176|FG000|Overall Study|Physician Decision|1|||
146604250|NCT03626545|528721177|FG001|Overall Study|Physician Decision|18|||
146604251|NCT03626545|528721178|FG002|Overall Study|Physician Decision|14|||
146604252|NCT03626545|528721176|FG000|Overall Study|Subject Decision|0|||
146604253|NCT03626545|528721177|FG001|Overall Study|Subject Decision|5|||
146604254|NCT03626545|528721178|FG002|Overall Study|Subject Decision|5|||
146604255|NCT03626545|528721176|FG000|Overall Study|Death|1|||
146604256|NCT03626545|528721177|FG001|Overall Study|Death|1|||
146604257|NCT03626545|528721178|FG002|Overall Study|Death|1|||
146604258|NCT03626545|528721176|FG000|Overall Study|Protocol Deviation|0|||
146604259|NCT03626545|528721177|FG001|Overall Study|Protocol Deviation|1|||
146604260|NCT03626545|528721178|FG002|Overall Study|Protocol Deviation|1|||
146604261|NCT03626545|528721176|FG000|Overall Study|Guardian Decision|0|||
146604262|NCT03626545|528721177|FG001|Overall Study|Guardian Decision|0|||
146604263|NCT03626545|528721178|FG002|Overall Study|Guardian Decision|1|||
146604264|NCT03387020|528721180|FG000|Overall Study|Adverse Event|0|||
146604265|NCT03387020|528721181|FG001|Overall Study|Adverse Event|2|||
146604266|NCT03387020|528721182|FG002|Overall Study|Adverse Event|0|||
146604267|NCT03387020|528721180|FG000|Overall Study|Withdrawal by Subject|2|||
146604268|NCT03387020|528721181|FG001|Overall Study|Withdrawal by Subject|0|||
146604269|NCT03387020|528721182|FG002|Overall Study|Withdrawal by Subject|0|||
146604270|NCT00434642|528721183|FG000|Blinded Treatment Phase|Adverse Event|12|||
146604271|NCT00434642|528721184|FG001|Blinded Treatment Phase|Adverse Event|58|||
146604272|NCT00434642|528721183|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
146604273|NCT00434642|528721184|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
146604274|NCT00434642|528721183|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
146604275|NCT00434642|528721184|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
146604276|NCT00434642|528721183|FG000|Blinded Treatment Phase|Physician Decision|19|||
146604277|NCT00434642|528721184|FG001|Blinded Treatment Phase|Physician Decision|27|||
146604278|NCT00434642|528721183|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
146604279|NCT00434642|528721184|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
146604280|NCT00434642|528721183|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
146604281|NCT00434642|528721184|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
146604282|NCT00434642|528721183|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
146604283|NCT00434642|528721184|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
146604284|NCT00434642|528721183|FG000|Open-label Treatment Phase|Adverse Event|0|||
146604285|NCT00434642|528721184|FG001|Open-label Treatment Phase|Adverse Event|5|||
146604286|NCT00434642|528721183|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
146922803|NCT02065622|529876835|FG000|Induction Study|Subject Noncompliance|1|||
146604287|NCT00434642|528721184|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
146604288|NCT02421588|528721185|FG000|Overall Study|Non-treatment-related AE|8|||
146604289|NCT02421588|528721186|FG001|Overall Study|Non-treatment-related AE|8|||
146604290|NCT02421588|528721185|FG000|Overall Study|Progressive disease|152|||
146604291|NCT02421588|528721186|FG001|Overall Study|Progressive disease|135|||
146604292|NCT02421588|528721185|FG000|Overall Study|Death|11|||
146604293|NCT02421588|528721186|FG001|Overall Study|Death|3|||
146604294|NCT02421588|528721185|FG000|Overall Study|Physician Decision|8|||
146604295|NCT02421588|528721186|FG001|Overall Study|Physician Decision|17|||
146604296|NCT02421588|528721185|FG000|Overall Study|Other reason not specified|3|||
146604297|NCT02421588|528721186|FG001|Overall Study|Other reason not specified|1|||
146604298|NCT02421588|528721185|FG000|Overall Study|Symptomatic deterioration|13|||
146922804|NCT02065622|529876836|FG001|Induction Study|Subject Noncompliance|1|||
146922805|NCT02065622|529876837|FG002|Induction Study|Subject Noncompliance|0|||
146604299|NCT02421588|528721186|FG001|Overall Study|Symptomatic deterioration|19|||
146604300|NCT02421588|528721185|FG000|Overall Study|Treatment-related AE|10|||
146604301|NCT02421588|528721186|FG001|Overall Study|Treatment-related AE|14|||
146604302|NCT02421588|528721185|FG000|Overall Study|Withdrawal by Subject|14|||
146604303|NCT02421588|528721186|FG001|Overall Study|Withdrawal by Subject|16|||
146604304|NCT02421588|528721185|FG000|Overall Study|Not treated|2|||
146604305|NCT02421588|528721186|FG001|Overall Study|Not treated|8|||
146604306|NCT04071158|528721193|FG000|Overall Study|Lost to Follow-up|1|||
146604307|NCT04071158|528721194|FG001|Overall Study|Lost to Follow-up|2|||
146604308|NCT04071158|528721195|FG002|Overall Study|Lost to Follow-up|3|||
146604309|NCT04071158|528721196|FG003|Overall Study|Lost to Follow-up|3|||
146604310|NCT04071158|528721197|FG004|Overall Study|Lost to Follow-up|5|||
146604311|NCT04071158|528721193|FG000|Overall Study|Randomized but not treated|2|||
146604312|NCT04071158|528721194|FG001|Overall Study|Randomized but not treated|2|||
146604313|NCT04071158|528721195|FG002|Overall Study|Randomized but not treated|0|||
146604314|NCT04071158|528721196|FG003|Overall Study|Randomized but not treated|0|||
146604315|NCT04071158|528721197|FG004|Overall Study|Randomized but not treated|0|||
146604316|NCT01178099|528721198|FG000|Overall Study|Physician Decision|0|||
146604317|NCT01178099|528721199|FG001|Overall Study|Physician Decision|1|||
146604318|NCT02473367|528721202|FG000|Wait 1|Withdrawal by Subject|1|||
146604319|NCT02473367|528721202|FG000|Period 4|Lost to Follow-up|1|||
146604320|NCT04816721|528721203|FG000|Overall Study|Withdrawal by Subject|0|||
146604321|NCT04816721|528721204|FG001|Overall Study|Withdrawal by Subject|2|||
146604322|NCT04816721|528721205|FG002|Overall Study|Withdrawal by Subject|0|||
146604323|NCT04816721|528721206|FG003|Overall Study|Withdrawal by Subject|1|||
146604324|NCT04816721|528721207|FG004|Overall Study|Withdrawal by Subject|1|||
146604325|NCT04816721|528721208|FG005|Overall Study|Withdrawal by Subject|0|||
146604326|NCT04816721|528721209|FG006|Overall Study|Withdrawal by Subject|0|||
146604327|NCT04816721|528721210|FG007|Overall Study|Withdrawal by Subject|0|||
146604328|NCT04816721|528721203|FG000|Overall Study|Miscellaneous|0|||
146604329|NCT04816721|528721204|FG001|Overall Study|Miscellaneous|0|||
146604330|NCT04816721|528721205|FG002|Overall Study|Miscellaneous|0|||
146604331|NCT04816721|528721206|FG003|Overall Study|Miscellaneous|0|||
146604332|NCT04816721|528721207|FG004|Overall Study|Miscellaneous|0|||
146604333|NCT04816721|528721208|FG005|Overall Study|Miscellaneous|1|||
146604334|NCT04816721|528721209|FG006|Overall Study|Miscellaneous|0|||
146604335|NCT04816721|528721210|FG007|Overall Study|Miscellaneous|0|||
146604336|NCT04816721|528721203|FG000|Overall Study|Lost to Follow-up|0|||
146604337|NCT04816721|528721204|FG001|Overall Study|Lost to Follow-up|0|||
146604338|NCT04816721|528721205|FG002|Overall Study|Lost to Follow-up|0|||
146604339|NCT04816721|528721206|FG003|Overall Study|Lost to Follow-up|1|||
146604340|NCT04816721|528721207|FG004|Overall Study|Lost to Follow-up|0|||
146604341|NCT04816721|528721208|FG005|Overall Study|Lost to Follow-up|0|||
146604342|NCT04816721|528721209|FG006|Overall Study|Lost to Follow-up|0|||
146604343|NCT04816721|528721210|FG007|Overall Study|Lost to Follow-up|0|||
146604344|NCT02678923|528721225|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
146604345|NCT02678923|528721226|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
146604346|NCT02678923|528721225|FG000|Overall Study|Withdrawal by Subject|3|||
146604347|NCT02678923|528721226|FG001|Overall Study|Withdrawal by Subject|2|||
146604348|NCT02678923|528721225|FG000|Overall Study|Lost to Follow-up|1|||
146604349|NCT02678923|528721226|FG001|Overall Study|Lost to Follow-up|0|||
146604350|NCT02678923|528721225|FG000|Overall Study|Did Not Return for Study Visits|1|||
146604351|NCT02678923|528721226|FG001|Overall Study|Did Not Return for Study Visits|0|||
146604352|NCT00455143|528721227|FG000|Overall Study|Physician Decision|1|||
146604353|NCT00455143|528721227|FG000|Overall Study|Withdrawal by Subject|1|||
146604354|NCT00455143|528721227|FG000|Overall Study|Staff was not avail to follow patient|2|||
146604355|NCT00455143|528721227|FG000|Overall Study|No longer met Inclusion Criteria|1|||
146604356|NCT00455143|528721227|FG000|Overall Study|Surgical time, staff not available|1|||
146604357|NCT05222555|528721230|FG000|Overall Study|Ongoing|2|||
146604358|NCT05222555|528721231|FG001|Overall Study|Ongoing|18|||
146604359|NCT05222555|528721230|FG000|Overall Study|Adverse Event|1|||
146604360|NCT05222555|528721231|FG001|Overall Study|Adverse Event|1|||
146604361|NCT05222555|528721230|FG000|Overall Study|Death|0|||
146604362|NCT05222555|528721231|FG001|Overall Study|Death|6|||
146604363|NCT05222555|528721230|FG000|Overall Study|Withdrawal by Subject|0|||
146604364|NCT05222555|528721231|FG001|Overall Study|Withdrawal by Subject|11|||
146656840|NCT01897714|528921610|FG000|Phase I (Dose Escalation)|Disease progression|3|||
146656841|NCT01897714|528921611|FG001|Phase I (Dose Escalation)|Disease progression|5|||
146604365|NCT00300365|528721232|FG000|Overall Study|Lost to Follow-up|1|||
146604366|NCT00300365|528721233|FG001|Overall Study|Lost to Follow-up|0|||
146604367|NCT00300365|528721232|FG000|Overall Study|Physician Decision|2|||
146604368|NCT00300365|528721233|FG001|Overall Study|Physician Decision|0|||
146604369|NCT00300365|528721232|FG000|Overall Study|Withdrawal by Subject|1|||
146604370|NCT00300365|528721233|FG001|Overall Study|Withdrawal by Subject|0|||
146604371|NCT00300365|528721232|FG000|Overall Study|Adverse Event|0|||
146604372|NCT00300365|528721233|FG001|Overall Study|Adverse Event|2|||
146604373|NCT01374178|528721236|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
146604374|NCT01374178|528721237|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
146604375|NCT01374178|528721236|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
146604376|NCT01374178|528721237|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
146604377|NCT01422824|528721238|FG000|Overall Study|Case record form not evaluated|1|||
146604378|NCT01422824|528721238|FG000|Overall Study|Lost to Follow-up|37|||
146604379|NCT01641822|528721239|FG000|Run-in Phase|Noncompliance with study drug|1|||
146604380|NCT01641822|528721240|FG001|Run-in Phase|Noncompliance with study drug|0|||
146604381|NCT01641822|528721241|FG002|Run-in Phase|Noncompliance with study drug|0|||
146604382|NCT01641822|528721239|FG000|Run-in Phase|Adverse Event|3|||
146604383|NCT01641822|528721240|FG001|Run-in Phase|Adverse Event|0|||
146604384|NCT01641822|528721241|FG002|Run-in Phase|Adverse Event|0|||
146604385|NCT01641822|528721239|FG000|Run-in Phase|Withdrew consent|1|||
146604386|NCT01641822|528721240|FG001|Run-in Phase|Withdrew consent|0|||
146604387|NCT01641822|528721241|FG002|Run-in Phase|Withdrew consent|0|||
146604388|NCT01641822|528721239|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
146604389|NCT01641822|528721240|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
146604390|NCT01641822|528721241|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
146604391|NCT01641822|528721239|FG000|Comparative Phase|Noncompliance with study drug|0|||
146604392|NCT01641822|528721240|FG001|Comparative Phase|Noncompliance with study drug|1|||
146604393|NCT01641822|528721241|FG002|Comparative Phase|Noncompliance with study drug|0|||
146604394|NCT01641822|528721239|FG000|Comparative Phase|Investigator's discretion|0|||
146604395|NCT01641822|528721240|FG001|Comparative Phase|Investigator's discretion|0|||
146604396|NCT01641822|528721241|FG002|Comparative Phase|Investigator's discretion|1|||
146604397|NCT01641822|528721239|FG000|Comparative Phase|Pregnancy|0|||
146604398|NCT01641822|528721240|FG001|Comparative Phase|Pregnancy|0|||
146604399|NCT01641822|528721241|FG002|Comparative Phase|Pregnancy|1|||
146604400|NCT01641822|528721239|FG000|Comparative Phase|Adverse event, serious fatal|0|||
146604401|NCT01641822|528721240|FG001|Comparative Phase|Adverse event, serious fatal|1|||
146604402|NCT01641822|528721241|FG002|Comparative Phase|Adverse event, serious fatal|0|||
146604403|NCT01641822|528721239|FG000|Comparative Phase|Withdrew consent|0|||
146604404|NCT01641822|528721240|FG001|Comparative Phase|Withdrew consent|3|||
146604405|NCT01641822|528721241|FG002|Comparative Phase|Withdrew consent|7|||
146604406|NCT01641822|528721239|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
146604407|NCT01641822|528721240|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
146604408|NCT01641822|528721241|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
146604409|NCT02760810|528721242|FG000|Overall Study|Protocol Violation|1|||
146604410|NCT02421601|528721243|FG000|Overall Study|Adverse Event|4|||
146604411|NCT02421601|528721243|FG000|Overall Study|Lack of Efficacy|5|||
146604412|NCT02421601|528721243|FG000|Overall Study|Physician Decision|1|||
146604413|NCT02421601|528721243|FG000|Overall Study|Withdrawal by Subject|31|||
146604414|NCT02421601|528721243|FG000|Overall Study|Others|41|||
146604415|NCT00470418|528721248|FG000|Overall Study|Withdrawal by Subject|1|||
146604416|NCT00470418|528721249|FG001|Overall Study|Withdrawal by Subject|0|||
146604417|NCT00599638|528721250|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
146604418|NCT00599638|528721251|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
146604419|NCT00599638|528721252|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
146604420|NCT00599638|528721253|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
146604421|NCT00599638|528721250|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
146604422|NCT00599638|528721251|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
146604423|NCT00599638|528721252|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
146604424|NCT00599638|528721253|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
146604425|NCT00599638|528721250|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
146604426|NCT00599638|528721251|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
146604427|NCT00599638|528721252|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
146604428|NCT00599638|528721253|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
146604429|NCT00599638|528721250|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
146604430|NCT00599638|528721251|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
146604431|NCT00599638|528721252|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
146604432|NCT00599638|528721253|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
146604433|NCT00599638|528721250|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
146604434|NCT00599638|528721251|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
146604435|NCT00599638|528721252|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
146604436|NCT00599638|528721253|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
146604437|NCT00599638|528721250|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
146604438|NCT00599638|528721251|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
146604439|NCT00599638|528721252|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
146604440|NCT00599638|528721253|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
146656842|NCT01897714|528921612|FG002|Phase I (Dose Escalation)|Disease progression|1|||
146656843|NCT01897714|528921613|FG003|Phase I (Dose Escalation)|Disease progression|3|||
146604441|NCT00599638|528721250|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
146604442|NCT00599638|528721251|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
146604443|NCT00599638|528721252|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
146604444|NCT00599638|528721253|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
146604445|NCT00599638|528721250|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
146604446|NCT00599638|528721251|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
146604447|NCT00599638|528721252|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
146604448|NCT00599638|528721253|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
146604449|NCT00599638|528721250|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
146604450|NCT00599638|528721251|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
146604451|NCT00599638|528721252|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
146604452|NCT00599638|528721253|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
146604453|NCT03006887|528721254|FG000|Overall Study|Adverse Event|1|||
146604454|NCT00462748|528721255|FG000|Overall Study|Adverse Event|7|||
146604455|NCT00462748|528721256|FG001|Overall Study|Adverse Event|5|||
146604456|NCT00462748|528721257|FG002|Overall Study|Adverse Event|9|||
146604457|NCT00462748|528721255|FG000|Overall Study|Protocol Violation|0|||
146604458|NCT00462748|528721256|FG001|Overall Study|Protocol Violation|2|||
146604459|NCT00462748|528721257|FG002|Overall Study|Protocol Violation|1|||
146604460|NCT00462748|528721255|FG000|Overall Study|Withdrew consent|3|||
146604461|NCT00462748|528721256|FG001|Overall Study|Withdrew consent|3|||
146604462|NCT00462748|528721257|FG002|Overall Study|Withdrew consent|0|||
146604463|NCT00462748|528721255|FG000|Overall Study|Lost to Follow-up|1|||
146604464|NCT00462748|528721256|FG001|Overall Study|Lost to Follow-up|1|||
146604465|NCT00462748|528721257|FG002|Overall Study|Lost to Follow-up|1|||
146604466|NCT00462748|528721255|FG000|Overall Study|Discontinued after 41 days Rx|1|||
146604467|NCT00462748|528721256|FG001|Overall Study|Discontinued after 41 days Rx|0|||
146604468|NCT00462748|528721257|FG002|Overall Study|Discontinued after 41 days Rx|0|||
146604469|NCT01729208|528721258|FG000|Baseline|Physician Decision|5|||
146604470|NCT01729208|528721259|FG001|Baseline|Physician Decision|4|||
146604471|NCT01729208|528721258|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
146604472|NCT01729208|528721259|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
146604473|NCT01729208|528721258|FG000|12 Months Follow-up|Lost to Follow-up|3|||
146604474|NCT01729208|528721259|FG001|12 Months Follow-up|Lost to Follow-up|3|||
146604475|NCT01729208|528721258|FG000|24 Months Follow-up|Lost to Follow-up|3|||
146604476|NCT01729208|528721259|FG001|24 Months Follow-up|Lost to Follow-up|0|||
146604477|NCT01729208|528721258|FG000|36 Months Follow-up|Physician Decision|1|||
146604478|NCT01729208|528721259|FG001|36 Months Follow-up|Physician Decision|0|||
146604479|NCT01729208|528721258|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
146604480|NCT01729208|528721259|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
146604481|NCT02428413|528721260|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
146604482|NCT02428413|528721261|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
146604483|NCT02428413|528721260|FG000|Overall Study|Protocol Violation|1|||
146604484|NCT02428413|528721261|FG001|Overall Study|Protocol Violation|2|||
146604485|NCT02428413|528721260|FG000|Overall Study|Case Cancelled|2|||
146604486|NCT02428413|528721261|FG001|Overall Study|Case Cancelled|0|||
146604487|NCT02428413|528721260|FG000|Overall Study|Missed Cases|1|||
146604488|NCT02428413|528721261|FG001|Overall Study|Missed Cases|2|||
146604489|NCT02428413|528721260|FG000|Overall Study|Nurse Refusal|1|||
146604490|NCT02428413|528721261|FG001|Overall Study|Nurse Refusal|0|||
146604491|NCT03689855|528721264|FG000|Overall Study|Adverse Event|3|||
146604492|NCT03689855|528721264|FG000|Overall Study|Withdrawal by Subject|1|||
146604493|NCT01438177|528721265|FG000|Overall Study|Withdrawal by Subject|1|||
146604494|NCT01438177|528721265|FG000|Overall Study|Initiation of new therapy|1|||
146604495|NCT02772978|528721266|FG000|Overall Study|Withdrawal by Subject|1|||
146604496|NCT02772978|528721267|FG001|Overall Study|Withdrawal by Subject|1|||
146604497|NCT00428844|528721277|FG000|Completed Study Drug Treatment|Adverse Event|2|||
146604498|NCT00428844|528721278|FG001|Completed Study Drug Treatment|Adverse Event|4|||
146604499|NCT00428844|528721279|FG002|Completed Study Drug Treatment|Adverse Event|4|||
146604500|NCT00428844|528721277|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
146604501|NCT00428844|528721278|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
146604502|NCT00428844|528721279|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
146604503|NCT00428844|528721277|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
146604504|NCT00428844|528721278|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
146604505|NCT00428844|528721279|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
146604506|NCT00428844|528721277|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
146604507|NCT00428844|528721278|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
146604508|NCT00428844|528721279|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
146604509|NCT00428844|528721277|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
146604510|NCT00428844|528721278|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
146604511|NCT00428844|528721279|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
146604512|NCT00428844|528721277|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
146604513|NCT00428844|528721278|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
146604514|NCT00428844|528721279|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
146772958|NCT03903822|529338235|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
146604515|NCT00428844|528721277|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
146604516|NCT00428844|528721278|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
146604517|NCT00428844|528721279|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
146604518|NCT00428844|528721277|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
146604519|NCT00428844|528721278|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
146604520|NCT00428844|528721279|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
146604521|NCT00428844|528721277|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
146604522|NCT00428844|528721278|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
146604523|NCT00428844|528721279|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
146604524|NCT00488826|528721280|FG000|Overall Study|Withdrawal by Subject|40|||
146604525|NCT00488826|528721281|FG001|Overall Study|Withdrawal by Subject|35|||
146604526|NCT00488826|528721282|FG002|Overall Study|Withdrawal by Subject|19|||
146604527|NCT00488826|528721280|FG000|Overall Study|Protocol Violation|0|||
146604528|NCT00488826|528721281|FG001|Overall Study|Protocol Violation|0|||
146604529|NCT00488826|528721282|FG002|Overall Study|Protocol Violation|2|||
146604530|NCT00488826|528721280|FG000|Overall Study|Adverse Event|9|||
146604531|NCT00488826|528721281|FG001|Overall Study|Adverse Event|15|||
146604532|NCT00488826|528721282|FG002|Overall Study|Adverse Event|4|||
146604533|NCT00488826|528721280|FG000|Overall Study|Lost to Follow-up|5|||
146604534|NCT00488826|528721281|FG001|Overall Study|Lost to Follow-up|1|||
146604535|NCT00488826|528721282|FG002|Overall Study|Lost to Follow-up|0|||
146604536|NCT00488826|528721280|FG000|Overall Study|Protocol Deviations|2|||
146604537|NCT00488826|528721281|FG001|Overall Study|Protocol Deviations|1|||
146604538|NCT00488826|528721282|FG002|Overall Study|Protocol Deviations|1|||
146604539|NCT04667104|528721289|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
146604540|NCT04667104|528721290|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
146604541|NCT04667104|528721291|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
146604542|NCT03208088|528721293|FG000|Period 2|Withdrawal by Subject|0|||
146604543|NCT03208088|528721294|FG001|Period 2|Withdrawal by Subject|0|||
146604544|NCT03208088|528721295|FG002|Period 2|Withdrawal by Subject|0|||
146604545|NCT03208088|528721296|FG003|Period 2|Withdrawal by Subject|0|||
146604546|NCT03208088|528721297|FG004|Period 2|Withdrawal by Subject|0|||
146604547|NCT03208088|528721298|FG005|Period 2|Withdrawal by Subject|0|||
146604548|NCT03208088|528721299|FG006|Period 2|Withdrawal by Subject|0|||
146604549|NCT03208088|528721300|FG007|Period 2|Withdrawal by Subject|0|||
146604550|NCT03208088|528721301|FG008|Period 2|Withdrawal by Subject|1|||
146604551|NCT03208088|528721302|FG009|Period 2|Withdrawal by Subject|0|||
146604552|NCT03208088|528721293|FG000|Period 3|Unsatisfactory Test Article|0|||
146604553|NCT03208088|528721294|FG001|Period 3|Unsatisfactory Test Article|0|||
146604554|NCT03208088|528721295|FG002|Period 3|Unsatisfactory Test Article|0|||
146604555|NCT03208088|528721296|FG003|Period 3|Unsatisfactory Test Article|1|||
146604556|NCT03208088|528721297|FG004|Period 3|Unsatisfactory Test Article|0|||
146604557|NCT03208088|528721298|FG005|Period 3|Unsatisfactory Test Article|0|||
146604558|NCT03208088|528721299|FG006|Period 3|Unsatisfactory Test Article|0|||
146604559|NCT03208088|528721300|FG007|Period 3|Unsatisfactory Test Article|0|||
146604560|NCT03208088|528721301|FG008|Period 3|Unsatisfactory Test Article|0|||
146604561|NCT03208088|528721302|FG009|Period 3|Unsatisfactory Test Article|0|||
146604562|NCT03208088|528721293|FG000|Period 4|Unsatisfactory Test Article|0|||
146604563|NCT03208088|528721294|FG001|Period 4|Unsatisfactory Test Article|0|||
146604564|NCT03208088|528721295|FG002|Period 4|Unsatisfactory Test Article|0|||
146604565|NCT03208088|528721296|FG003|Period 4|Unsatisfactory Test Article|1|||
146604566|NCT03208088|528721297|FG004|Period 4|Unsatisfactory Test Article|0|||
146604567|NCT03208088|528721298|FG005|Period 4|Unsatisfactory Test Article|0|||
146604568|NCT03208088|528721299|FG006|Period 4|Unsatisfactory Test Article|0|||
146604569|NCT03208088|528721300|FG007|Period 4|Unsatisfactory Test Article|0|||
146604570|NCT03208088|528721301|FG008|Period 4|Unsatisfactory Test Article|0|||
146604571|NCT03208088|528721302|FG009|Period 4|Unsatisfactory Test Article|0|||
146604572|NCT00605345|528721303|FG000|Overall Study|Withdrawal by Subject|1|||
146604573|NCT00605345|528721304|FG001|Overall Study|Withdrawal by Subject|0|||
146604574|NCT00605345|528721303|FG000|Overall Study|Adverse Event|0|||
146604575|NCT00605345|528721304|FG001|Overall Study|Adverse Event|1|||
146604576|NCT00605345|528721303|FG000|Overall Study|Protocol Violation|0|||
146656844|NCT01897714|528921614|FG004|Phase I (Dose Escalation)|Disease progression|0|||
146656845|NCT01897714|528921615|FG005|Phase I (Dose Escalation)|Disease progression|0|||
146656846|NCT01897714|528921610|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
146656847|NCT01897714|528921611|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
146656848|NCT01897714|528921612|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
146656849|NCT01897714|528921613|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
146604577|NCT00605345|528721304|FG001|Overall Study|Protocol Violation|2|||
146656850|NCT01897714|528921614|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
146656851|NCT01897714|528921615|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
146656852|NCT01897714|528921610|FG000|Phase I (Dose Escalation)|Other|0|||
146604578|NCT02126839|528721305|FG000|Overall Study|Adverse Event|0|||
146604579|NCT02126839|528721306|FG001|Overall Study|Adverse Event|1|||
146604580|NCT02126839|528721305|FG000|Overall Study|Withdrawal by Subject|1|||
146604581|NCT02126839|528721306|FG001|Overall Study|Withdrawal by Subject|0|||
146604582|NCT02126839|528721305|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146604583|NCT02126839|528721306|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146604584|NCT02126839|528721305|FG000|Overall Study|Protocol Violation|2|||
146656853|NCT01897714|528921611|FG001|Phase I (Dose Escalation)|Other|1|||
146978655|NCT00766506|530085448|FG001|Overall Study|Other|2|||
146604585|NCT02126839|528721306|FG001|Overall Study|Protocol Violation|3|||
146604586|NCT02126839|528721305|FG000|Overall Study|Sponsor request|0|||
146772959|NCT03903822|529338236|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
146604587|NCT02126839|528721306|FG001|Overall Study|Sponsor request|1|||
146604588|NCT02126839|528721305|FG000|Overall Study|Lost to Follow-up|1|||
146604589|NCT02126839|528721306|FG001|Overall Study|Lost to Follow-up|4|||
146604590|NCT02126839|528721305|FG000|Overall Study|Other|5|||
146604591|NCT02126839|528721306|FG001|Overall Study|Other|5|||
146604592|NCT00422383|528721307|FG000|Overall Study|Adverse Event|5|||
146604593|NCT00422383|528721308|FG001|Overall Study|Adverse Event|3|||
146604594|NCT00422383|528721309|FG002|Overall Study|Adverse Event|1|||
146604595|NCT00422383|528721310|FG003|Overall Study|Adverse Event|1|||
146604596|NCT00422383|528721311|FG004|Overall Study|Adverse Event|0|||
146604597|NCT00422383|528721307|FG000|Overall Study|Lack of Efficacy|4|||
146604598|NCT00422383|528721308|FG001|Overall Study|Lack of Efficacy|4|||
146604599|NCT00422383|528721309|FG002|Overall Study|Lack of Efficacy|2|||
146604600|NCT00422383|528721310|FG003|Overall Study|Lack of Efficacy|1|||
146604601|NCT00422383|528721311|FG004|Overall Study|Lack of Efficacy|1|||
146604602|NCT00422383|528721307|FG000|Overall Study|Lost to Follow-up|0|||
146604603|NCT00422383|528721308|FG001|Overall Study|Lost to Follow-up|1|||
146604604|NCT00422383|528721309|FG002|Overall Study|Lost to Follow-up|0|||
146604605|NCT00422383|528721310|FG003|Overall Study|Lost to Follow-up|0|||
146604606|NCT00422383|528721311|FG004|Overall Study|Lost to Follow-up|1|||
146604607|NCT00422383|528721307|FG000|Overall Study|Protocol Violation|1|||
146604608|NCT00422383|528721308|FG001|Overall Study|Protocol Violation|1|||
146604609|NCT00422383|528721309|FG002|Overall Study|Protocol Violation|1|||
146604610|NCT00422383|528721310|FG003|Overall Study|Protocol Violation|0|||
146604611|NCT00422383|528721311|FG004|Overall Study|Protocol Violation|0|||
146978656|NCT01246986|530085449|FG000|Overall Study|Lost to Follow-up|0|||
146604612|NCT00422383|528721307|FG000|Overall Study|Withdrawal by Subject|5|||
146604613|NCT00422383|528721308|FG001|Overall Study|Withdrawal by Subject|5|||
146604614|NCT00422383|528721309|FG002|Overall Study|Withdrawal by Subject|0|||
146604615|NCT00422383|528721310|FG003|Overall Study|Withdrawal by Subject|0|||
146604616|NCT00422383|528721311|FG004|Overall Study|Withdrawal by Subject|1|||
146604617|NCT00411632|528721312|FG000|Overall Study|Death|1|||
146604618|NCT01108523|528721313|FG000|Overall Study|Protocol Violation|4|||
146604619|NCT00761527|528721316|FG000|Overall Study|Adverse Event|3|||
146604620|NCT00761527|528721316|FG000|Overall Study|Poor Compliance|8|||
146604621|NCT00761527|528721316|FG000|Overall Study|Lost to Follow-up|9|||
146604622|NCT00761527|528721316|FG000|Overall Study|Unknown reason|2|||
146604623|NCT03831100|528723453|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
146604624|NCT03831100|528723454|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
146604625|NCT04566601|528723455|FG000|Overall Study|Other than listed|13|||
146604626|NCT04566601|528723456|FG001|Overall Study|Other than listed|4|||
146604627|NCT04566601|528723457|FG002|Overall Study|Other than listed|2|||
146604628|NCT04566601|528723458|FG003|Overall Study|Other than listed|1|||
146604629|NCT04566601|528723459|FG004|Overall Study|Other than listed|4|||
146604630|NCT04566601|528723455|FG000|Overall Study|Protocol deviation|3|||
146604631|NCT04566601|528723456|FG001|Overall Study|Protocol deviation|0|||
146604632|NCT04566601|528723457|FG002|Overall Study|Protocol deviation|1|||
146604633|NCT04566601|528723458|FG003|Overall Study|Protocol deviation|1|||
146604634|NCT04566601|528723459|FG004|Overall Study|Protocol deviation|1|||
146604635|NCT04566601|528723455|FG000|Overall Study|Technical problems|0|||
146604636|NCT04566601|528723456|FG001|Overall Study|Technical problems|0|||
146604637|NCT04566601|528723457|FG002|Overall Study|Technical problems|1|||
146604638|NCT04566601|528723458|FG003|Overall Study|Technical problems|0|||
146604639|NCT04566601|528723459|FG004|Overall Study|Technical problems|0|||
146604640|NCT04566601|528723455|FG000|Overall Study|No reason available|3|||
146604641|NCT04566601|528723456|FG001|Overall Study|No reason available|2|||
146604642|NCT04566601|528723457|FG002|Overall Study|No reason available|7|||
146604643|NCT04566601|528723458|FG003|Overall Study|No reason available|1|||
146604644|NCT04566601|528723459|FG004|Overall Study|No reason available|5|||
146604645|NCT04566601|528723455|FG000|Overall Study|Burden of study procedures|3|||
146604646|NCT04566601|528723456|FG001|Overall Study|Burden of study procedures|0|||
146604647|NCT04566601|528723457|FG002|Overall Study|Burden of study procedures|0|||
146604648|NCT04566601|528723458|FG003|Overall Study|Burden of study procedures|3|||
146604649|NCT04566601|528723459|FG004|Overall Study|Burden of study procedures|1|||
146604650|NCT04566601|528723455|FG000|Overall Study|Change of residence|2|||
146604651|NCT04566601|528723456|FG001|Overall Study|Change of residence|2|||
146604652|NCT04566601|528723457|FG002|Overall Study|Change of residence|0|||
146604653|NCT04566601|528723458|FG003|Overall Study|Change of residence|1|||
146604654|NCT04566601|528723459|FG004|Overall Study|Change of residence|2|||
146604655|NCT04566601|528723455|FG000|Overall Study|Perceived lack of efficacy|2|||
146604656|NCT04566601|528723456|FG001|Overall Study|Perceived lack of efficacy|0|||
146604657|NCT04566601|528723457|FG002|Overall Study|Perceived lack of efficacy|1|||
146604658|NCT04566601|528723458|FG003|Overall Study|Perceived lack of efficacy|1|||
146604659|NCT04566601|528723459|FG004|Overall Study|Perceived lack of efficacy|2|||
146604660|NCT04566601|528723455|FG000|Overall Study|Adverse Event|7|||
146604661|NCT04566601|528723456|FG001|Overall Study|Adverse Event|4|||
146604662|NCT04566601|528723457|FG002|Overall Study|Adverse Event|6|||
146604663|NCT04566601|528723458|FG003|Overall Study|Adverse Event|5|||
146604664|NCT04566601|528723459|FG004|Overall Study|Adverse Event|12|||
146604665|NCT03047031|528723461|FG000|Overall Study|Other than listed|1|||
146604666|NCT03047031|528723462|FG001|Overall Study|Other than listed|0|||
146604667|NCT03047031|528723463|FG002|Overall Study|Other than listed|0|||
146604668|NCT03047031|528723461|FG000|Overall Study|Lost to Follow-up|4|||
146604669|NCT03047031|528723462|FG001|Overall Study|Lost to Follow-up|0|||
146604670|NCT03047031|528723463|FG002|Overall Study|Lost to Follow-up|0|||
146604671|NCT03047031|528723461|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
146604672|NCT03047031|528723462|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
146604673|NCT03047031|528723463|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
146604674|NCT03047031|528723461|FG000|Overall Study|Adverse Event|1|||
146604675|NCT03047031|528723462|FG001|Overall Study|Adverse Event|0|||
146604676|NCT03047031|528723463|FG002|Overall Study|Adverse Event|0|||
146604677|NCT03047031|528723461|FG000|Overall Study|Withdrawal by Subject|2|||
146604678|NCT03047031|528723462|FG001|Overall Study|Withdrawal by Subject|0|||
146604679|NCT03047031|528723463|FG002|Overall Study|Withdrawal by Subject|0|||
146604680|NCT03047031|528723461|FG000|Overall Study|Change to other medication|2|||
146604681|NCT03047031|528723462|FG001|Overall Study|Change to other medication|0|||
146604682|NCT03047031|528723463|FG002|Overall Study|Change to other medication|0|||
146604683|NCT03047031|528723461|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
146604684|NCT03047031|528723462|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
146604685|NCT03047031|528723463|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
146604686|NCT01450098|528723464|FG000|Period 3|Protocol Violation|0|||
146604687|NCT01450098|528723465|FG001|Period 3|Protocol Violation|1|||
146604688|NCT01450098|528723464|FG000|Period 3|Withdrawal by Subject|0|||
146604689|NCT01450098|528723465|FG001|Period 3|Withdrawal by Subject|2|||
146604690|NCT03229109|528723467|FG000|Overall Study|Withdrawal by Subject|0|||
146604691|NCT03229109|528723468|FG001|Overall Study|Withdrawal by Subject|0|||
146604692|NCT03229109|528723469|FG002|Overall Study|Withdrawal by Subject|0|||
146604693|NCT03229109|528723470|FG003|Overall Study|Withdrawal by Subject|1|||
146604694|NCT04207749|528723471|FG000|Overall Study|Lost to Follow-up|0|||
146604695|NCT04207749|528723472|FG001|Overall Study|Lost to Follow-up|2|||
146604696|NCT04207749|528723471|FG000|Overall Study|Protocol Violation|0|||
146604697|NCT04207749|528723472|FG001|Overall Study|Protocol Violation|1|||
146604698|NCT04207749|528723471|FG000|Overall Study|Withdrawal by Subject|3|||
146604699|NCT04207749|528723472|FG001|Overall Study|Withdrawal by Subject|0|||
146604700|NCT04207749|528723471|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
146604701|NCT04207749|528723472|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
146604702|NCT03416127|528723475|FG000|Overall Study|Withdrawal by Subject|0|||
146604703|NCT03416127|528723476|FG001|Overall Study|Withdrawal by Subject|1|||
146604704|NCT03416127|528723477|FG002|Overall Study|Withdrawal by Subject|1|||
146604705|NCT00567359|528723478|FG000|Overall Study|Withdrawal by Subject|1|||
146604706|NCT02397057|528723479|FG000|Overall Study|Withdrawal by Subject|6|||
146604707|NCT02397057|528723480|FG001|Overall Study|Withdrawal by Subject|7|||
146604708|NCT02397057|528723479|FG000|Overall Study|Lost to Follow-up|4|||
146604709|NCT02397057|528723480|FG001|Overall Study|Lost to Follow-up|3|||
146604710|NCT02397057|528723479|FG000|Overall Study|Death|1|||
146978657|NCT01246986|530085450|FG001|Overall Study|Lost to Follow-up|1|||
146978658|NCT01246986|530085451|FG002|Overall Study|Lost to Follow-up|3|||
146604711|NCT02397057|528723480|FG001|Overall Study|Death|0|||
146604712|NCT02397057|528723479|FG000|Overall Study|Adverse Event|0|||
146604713|NCT02397057|528723480|FG001|Overall Study|Adverse Event|1|||
146604714|NCT02397057|528723479|FG000|Overall Study|Physician Decision|0|||
146604715|NCT02397057|528723480|FG001|Overall Study|Physician Decision|1|||
146604716|NCT02397057|528723479|FG000|Overall Study|Subject did not receive study drug|0|||
146604717|NCT02397057|528723480|FG001|Overall Study|Subject did not receive study drug|1|||
146604718|NCT00793325|528723482|FG000|Overall Study|Protocol Violation|18|||
146604719|NCT00793325|528723482|FG000|Overall Study|Lost to Follow-up|1|||
146604720|NCT01329939|528723487|FG000|Overall Study|Lost to Follow-up|3|||
146604721|NCT01329939|528723488|FG001|Overall Study|Lost to Follow-up|0|||
146604722|NCT01329939|528723489|FG002|Overall Study|Lost to Follow-up|1|||
146604723|NCT01329939|528723490|FG003|Overall Study|Lost to Follow-up|2|||
146604724|NCT01329939|528723487|FG000|Overall Study|Withdrawal by Subject|0|||
146604725|NCT01329939|528723488|FG001|Overall Study|Withdrawal by Subject|1|||
146604726|NCT01329939|528723489|FG002|Overall Study|Withdrawal by Subject|0|||
146604727|NCT01329939|528723490|FG003|Overall Study|Withdrawal by Subject|0|||
146604728|NCT01329939|528723487|FG000|Overall Study|Adverse Event|0|||
146604729|NCT01329939|528723488|FG001|Overall Study|Adverse Event|0|||
146604730|NCT01329939|528723489|FG002|Overall Study|Adverse Event|0|||
146604731|NCT01329939|528723490|FG003|Overall Study|Adverse Event|3|||
146604732|NCT01966445|528723491|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
146604733|NCT01966445|528723492|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
146604734|NCT01966445|528723493|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
146604735|NCT01966445|528723494|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
146978659|NCT01246986|530085452|FG003|Overall Study|Lost to Follow-up|0|||
146604736|NCT01966445|528723495|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
146604737|NCT01966445|528723496|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
146604738|NCT01966445|528723497|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
146604739|NCT01966445|528723491|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
146604740|NCT01966445|528723492|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
146604741|NCT01966445|528723493|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
146604742|NCT01966445|528723494|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
146604743|NCT01966445|528723495|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
146604744|NCT01966445|528723496|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
146604745|NCT01966445|528723497|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
146604746|NCT01966445|528723491|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
146604747|NCT01966445|528723492|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
146604748|NCT01966445|528723493|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
146604749|NCT01966445|528723494|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
146604750|NCT01966445|528723495|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
146604751|NCT01966445|528723496|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
146604752|NCT01966445|528723497|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
146604753|NCT01966445|528723491|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
146604754|NCT01966445|528723492|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
146604755|NCT01966445|528723493|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
146604756|NCT01966445|528723494|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
146604757|NCT01966445|528723495|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
146604758|NCT01966445|528723496|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
146604759|NCT01966445|528723497|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
146604760|NCT01966445|528723491|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
146604761|NCT01966445|528723492|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
146604762|NCT01966445|528723493|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
146604763|NCT01966445|528723494|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
146604764|NCT01966445|528723495|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
146604765|NCT01966445|528723496|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
146604766|NCT01966445|528723497|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
146604767|NCT00117793|528723500|FG000|Overall Study|Withdrawal by Subject|12|||
146604768|NCT01753401|528723501|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
146604769|NCT01753401|528723502|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
146604770|NCT01753401|528723503|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
146604771|NCT01753401|528723504|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
146604772|NCT01753401|528723501|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
146604773|NCT01753401|528723502|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
146604774|NCT01753401|528723503|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
146604775|NCT01753401|528723504|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
146604776|NCT01753401|528723501|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
146604777|NCT01753401|528723502|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
146604778|NCT01753401|528723503|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
146604779|NCT01753401|528723504|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
146604780|NCT01753401|528723501|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
146604781|NCT01753401|528723502|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
146604782|NCT01753401|528723503|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
146604783|NCT01753401|528723504|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
146604784|NCT01753401|528723501|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
146604785|NCT01753401|528723502|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
146604786|NCT01753401|528723503|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
146604787|NCT01753401|528723504|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
146604788|NCT01753401|528723501|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
146604789|NCT01753401|528723502|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
146604790|NCT01753401|528723503|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
146604791|NCT01753401|528723504|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
146604792|NCT01753401|528723501|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
146604793|NCT01753401|528723502|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
146604794|NCT01753401|528723503|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
146604795|NCT01753401|528723504|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
146604796|NCT03688100|528723509|FG000|Overall Study|Lost to Follow-up|21|||
146604797|NCT03688100|528723510|FG001|Overall Study|Lost to Follow-up|15|||
146604798|NCT03688100|528723511|FG002|Overall Study|Lost to Follow-up|15|||
146604799|NCT03688100|528723512|FG003|Overall Study|Lost to Follow-up|18|||
146604800|NCT03688100|528723509|FG000|Overall Study|Withdrawal by Subject|19|||
146604801|NCT03688100|528723510|FG001|Overall Study|Withdrawal by Subject|16|||
146978660|NCT01246986|530085453|FG004|Overall Study|Lost to Follow-up|0|||
146604802|NCT03688100|528723511|FG002|Overall Study|Withdrawal by Subject|0|||
146604803|NCT03688100|528723512|FG003|Overall Study|Withdrawal by Subject|0|||
146604804|NCT03688100|528723509|FG000|Overall Study|Death|36|||
146604805|NCT03688100|528723510|FG001|Overall Study|Death|27|||
146604806|NCT03688100|528723511|FG002|Overall Study|Death|0|||
146604807|NCT03688100|528723512|FG003|Overall Study|Death|0|||
146604808|NCT02453555|528723520|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
146604809|NCT02453555|528723521|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
146604810|NCT02453555|528723522|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
146604811|NCT02453555|528723523|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
146656854|NCT01897714|528921612|FG002|Phase I (Dose Escalation)|Other|0|||
146656855|NCT01897714|528921613|FG003|Phase I (Dose Escalation)|Other|0|||
146656856|NCT01897714|528921614|FG004|Phase I (Dose Escalation)|Other|0|||
146656857|NCT01897714|528921615|FG005|Phase I (Dose Escalation)|Other|0|||
146656858|NCT01897714|528921610|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
146656859|NCT01897714|528921611|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
146656860|NCT01897714|528921612|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
146656861|NCT01897714|528921613|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
146656862|NCT01897714|528921614|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
146656863|NCT01897714|528921615|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
146604812|NCT02453555|528723524|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
146604813|NCT02453555|528723525|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
146604814|NCT02453555|528723520|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
146604815|NCT02453555|528723521|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
146604816|NCT02453555|528723522|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
146604817|NCT02453555|528723523|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
146604818|NCT02453555|528723524|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
146604819|NCT02453555|528723525|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
146604820|NCT02453555|528723520|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
146604821|NCT02453555|528723521|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
146604822|NCT02453555|528723522|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
146604823|NCT02453555|528723523|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
146604824|NCT02453555|528723524|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
146772960|NCT03903822|529338237|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
146772961|NCT03903822|529338238|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
146772962|NCT03903822|529338239|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
146772963|NCT03903822|529338240|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
146772964|NCT03903822|529338241|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
146604825|NCT02453555|528723525|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
146604826|NCT02453555|528723520|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
146604827|NCT02453555|528723521|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
146604828|NCT02453555|528723522|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
146604829|NCT02453555|528723523|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
146604830|NCT02453555|528723524|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
146604831|NCT02453555|528723525|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
146604832|NCT02453555|528723520|FG000|Extension Period|Adverse Event|0|||
146604833|NCT02453555|528723521|FG001|Extension Period|Adverse Event|0|||
146604834|NCT02453555|528723522|FG002|Extension Period|Adverse Event|1|||
146604835|NCT02453555|528723523|FG003|Extension Period|Adverse Event|2|||
146604836|NCT02453555|528723524|FG004|Extension Period|Adverse Event|1|||
146604837|NCT02453555|528723525|FG005|Extension Period|Adverse Event|1|||
146604838|NCT02453555|528723520|FG000|Extension Period|Protocol Violation|0|||
146604839|NCT02453555|528723521|FG001|Extension Period|Protocol Violation|0|||
146604840|NCT02453555|528723522|FG002|Extension Period|Protocol Violation|1|||
146604841|NCT02453555|528723523|FG003|Extension Period|Protocol Violation|0|||
146604842|NCT02453555|528723524|FG004|Extension Period|Protocol Violation|0|||
146604843|NCT02453555|528723525|FG005|Extension Period|Protocol Violation|0|||
146604844|NCT02453555|528723520|FG000|Extension Period|Withdrawal by Subject|0|||
146604845|NCT02453555|528723521|FG001|Extension Period|Withdrawal by Subject|0|||
146656864|NCT01897714|528921610|FG000|Phase II (MTD)|Lost to Follow-up|0|||
146656865|NCT01897714|528921611|FG001|Phase II (MTD)|Lost to Follow-up|0|||
146656866|NCT01897714|528921612|FG002|Phase II (MTD)|Lost to Follow-up|0|||
146604846|NCT02453555|528723522|FG002|Extension Period|Withdrawal by Subject|1|||
146656867|NCT01897714|528921613|FG003|Phase II (MTD)|Lost to Follow-up|0|||
146772965|NCT03903822|529338234|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
146656868|NCT01897714|528921614|FG004|Phase II (MTD)|Lost to Follow-up|1|||
146656869|NCT01897714|528921615|FG005|Phase II (MTD)|Lost to Follow-up|0|||
146656870|NCT01897714|528921610|FG000|Phase II (MTD)|Death|0|||
146604847|NCT02453555|528723523|FG003|Extension Period|Withdrawal by Subject|0|||
146604848|NCT02453555|528723524|FG004|Extension Period|Withdrawal by Subject|0|||
146604849|NCT02453555|528723525|FG005|Extension Period|Withdrawal by Subject|0|||
146604850|NCT02409719|528723530|FG000|Overall Study|Lost to Follow-up|3|||
146604851|NCT02409719|528723531|FG001|Overall Study|Lost to Follow-up|3|||
146604852|NCT02479139|528723532|FG000|Overall Study|Lost to Follow-up|2|||
146604853|NCT02479139|528723533|FG001|Overall Study|Lost to Follow-up|4|||
146604854|NCT02479139|528723534|FG002|Overall Study|Lost to Follow-up|4|||
146604855|NCT02479139|528723535|FG003|Overall Study|Lost to Follow-up|2|||
146604856|NCT02479139|528723536|FG004|Overall Study|Lost to Follow-up|3|||
146604857|NCT02479139|528723537|FG005|Overall Study|Lost to Follow-up|5|||
146604858|NCT02479139|528723532|FG000|Overall Study|Withdrew Consent|5|||
146604859|NCT02479139|528723533|FG001|Overall Study|Withdrew Consent|6|||
146604860|NCT02479139|528723534|FG002|Overall Study|Withdrew Consent|1|||
146604861|NCT02479139|528723535|FG003|Overall Study|Withdrew Consent|4|||
146604862|NCT02479139|528723536|FG004|Overall Study|Withdrew Consent|1|||
146604863|NCT02479139|528723537|FG005|Overall Study|Withdrew Consent|1|||
146604864|NCT02479139|528723532|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
146604865|NCT02479139|528723533|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
146604866|NCT02479139|528723534|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
146604867|NCT02479139|528723535|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
146604868|NCT02479139|528723536|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
146604869|NCT02479139|528723537|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
146604870|NCT02479139|528723532|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146604871|NCT02479139|528723533|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146604872|NCT02479139|528723534|FG002|Overall Study|Other Miscellaneous Reasons|1|||
146604873|NCT02479139|528723535|FG003|Overall Study|Other Miscellaneous Reasons|1|||
146604874|NCT02479139|528723536|FG004|Overall Study|Other Miscellaneous Reasons|1|||
146604875|NCT02479139|528723537|FG005|Overall Study|Other Miscellaneous Reasons|0|||
146604876|NCT00764673|528723538|FG000|Overall Study|Death|1|||
146604877|NCT00764673|528723538|FG000|Overall Study|Lost to Follow-up|3|||
146604878|NCT00764673|528723538|FG000|Overall Study|Withdrawal by Subject|6|||
146604879|NCT00764673|528723538|FG000|Overall Study|Revision of Device|2|||
146604880|NCT01727336|528723541|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
146604881|NCT01727336|528723542|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
146772966|NCT03903822|529338235|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
146772967|NCT03903822|529338236|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
146772968|NCT03903822|529338237|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
146604882|NCT01727336|528723543|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
146604883|NCT01727336|528723544|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
146604884|NCT01727336|528723545|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
146604885|NCT01727336|528723546|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
146604886|NCT01727336|528723541|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
146604887|NCT01727336|528723542|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
146604888|NCT01727336|528723543|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
146604889|NCT01727336|528723544|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
146604890|NCT01727336|528723545|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
146604891|NCT01727336|528723546|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
146604892|NCT01727336|528723541|FG000|Part 2 Blinded|Death|0|||
146604893|NCT01727336|528723542|FG001|Part 2 Blinded|Death|0|||
146604894|NCT01727336|528723543|FG002|Part 2 Blinded|Death|0|||
146604895|NCT01727336|528723544|FG003|Part 2 Blinded|Death|0|||
146604896|NCT01727336|528723545|FG004|Part 2 Blinded|Death|20|||
146604897|NCT01727336|528723546|FG005|Part 2 Blinded|Death|16|||
146604898|NCT01727336|528723541|FG000|Part 2 Blinded|Lack of Efficacy|0|||
146604899|NCT01727336|528723542|FG001|Part 2 Blinded|Lack of Efficacy|0|||
146772969|NCT03903822|529338238|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
146604900|NCT01727336|528723543|FG002|Part 2 Blinded|Lack of Efficacy|0|||
146604901|NCT01727336|528723544|FG003|Part 2 Blinded|Lack of Efficacy|0|||
146604902|NCT01727336|528723545|FG004|Part 2 Blinded|Lack of Efficacy|42|||
146604903|NCT01727336|528723546|FG005|Part 2 Blinded|Lack of Efficacy|44|||
146604904|NCT01727336|528723541|FG000|Part 2 Blinded|Lost to Follow-up|0|||
146604905|NCT01727336|528723542|FG001|Part 2 Blinded|Lost to Follow-up|0|||
146604906|NCT01727336|528723543|FG002|Part 2 Blinded|Lost to Follow-up|0|||
146604907|NCT01727336|528723544|FG003|Part 2 Blinded|Lost to Follow-up|0|||
146604908|NCT01727336|528723545|FG004|Part 2 Blinded|Lost to Follow-up|0|||
146604909|NCT01727336|528723546|FG005|Part 2 Blinded|Lost to Follow-up|1|||
146604910|NCT01727336|528723541|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
146604911|NCT01727336|528723542|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
146772970|NCT03903822|529338239|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
146604912|NCT01727336|528723543|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
146604913|NCT01727336|528723544|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
146604914|NCT01727336|528723545|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
146604915|NCT01727336|528723546|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
146604916|NCT01727336|528723541|FG000|Part 2 Blinded|use of prohibited medications|0|||
146604917|NCT01727336|528723542|FG001|Part 2 Blinded|use of prohibited medications|0|||
146604918|NCT01727336|528723543|FG002|Part 2 Blinded|use of prohibited medications|0|||
146772971|NCT03903822|529338240|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
146772972|NCT03903822|529338241|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
146604919|NCT01727336|528723544|FG003|Part 2 Blinded|use of prohibited medications|0|||
146604920|NCT01727336|528723545|FG004|Part 2 Blinded|use of prohibited medications|1|||
146604921|NCT01727336|528723546|FG005|Part 2 Blinded|use of prohibited medications|3|||
146604922|NCT00619099|528723547|FG000|Overall Study|Progressive Disease|7|||
146604923|NCT00619099|528723548|FG001|Overall Study|Progressive Disease|5|||
146604924|NCT00619099|528723547|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
146604925|NCT00619099|528723548|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
146604926|NCT00619099|528723547|FG000|Overall Study|Adverse Event|4|||
146604927|NCT00619099|528723548|FG001|Overall Study|Adverse Event|3|||
146604928|NCT00619099|528723547|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
146604929|NCT00619099|528723548|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
146604930|NCT00619099|528723547|FG000|Overall Study|Withdrawal by Subject|10|||
146604931|NCT00619099|528723548|FG001|Overall Study|Withdrawal by Subject|2|||
146604932|NCT00619099|528723547|FG000|Overall Study|Physician Decision|9|||
146604933|NCT00619099|528723548|FG001|Overall Study|Physician Decision|6|||
146604934|NCT00885482|528723549|FG000|Overall Study|Pregnancy|1|||
146604935|NCT00885482|528723549|FG000|Overall Study|Lack of Efficacy|1|||
146604936|NCT00885482|528723549|FG000|Overall Study|Death|1|||
146604937|NCT00885482|528723549|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
146604938|NCT00084656|528723550|FG000|Overall Study|Other reasons|0|||
146604939|NCT00084656|528723551|FG001|Overall Study|Other reasons|12|||
146604940|NCT00084656|528723552|FG002|Overall Study|Other reasons|11|||
146604941|NCT00084656|528723550|FG000|Overall Study|Withdrawal by Subject|15|||
146604942|NCT00084656|528723551|FG001|Overall Study|Withdrawal by Subject|4|||
146604943|NCT00084656|528723552|FG002|Overall Study|Withdrawal by Subject|4|||
146604944|NCT00084656|528723550|FG000|Overall Study|Disease relapse|0|||
146604945|NCT00084656|528723551|FG001|Overall Study|Disease relapse|9|||
146604946|NCT00084656|528723552|FG002|Overall Study|Disease relapse|10|||
146604947|NCT00084656|528723550|FG000|Overall Study|Disease progression|9|||
146604948|NCT00084656|528723551|FG001|Overall Study|Disease progression|0|||
146604949|NCT00084656|528723552|FG002|Overall Study|Disease progression|0|||
146604950|NCT00084656|528723550|FG000|Overall Study|Lost to Follow-up|1|||
146604951|NCT00084656|528723551|FG001|Overall Study|Lost to Follow-up|0|||
146604952|NCT00084656|528723552|FG002|Overall Study|Lost to Follow-up|1|||
146604953|NCT01532869|528723553|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
146604954|NCT01532869|528723554|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
146604955|NCT01532869|528723553|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
146604956|NCT01532869|528723554|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
146604957|NCT01532869|528723553|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
146604958|NCT01532869|528723554|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
146604959|NCT01532869|528723553|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
146604960|NCT01532869|528723554|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
146604961|NCT01532869|528723553|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
146604962|NCT01532869|528723554|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
146604963|NCT01532869|528723553|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
146922806|NCT02065622|529876838|FG003|Induction Study|Subject Noncompliance|0|||
146922807|NCT02065622|529876839|FG004|Induction Study|Subject Noncompliance|0|||
146922808|NCT02065622|529876835|FG000|Induction Study|Other, Not Specified|3|||
146922809|NCT02065622|529876836|FG001|Induction Study|Other, Not Specified|2|||
146922810|NCT02065622|529876837|FG002|Induction Study|Other, Not Specified|0|||
146922811|NCT02065622|529876838|FG003|Induction Study|Other, Not Specified|0|||
146922812|NCT02065622|529876839|FG004|Induction Study|Other, Not Specified|0|||
146922813|NCT02065622|529876835|FG000|Maintenance Study|Adverse Event|0|||
146922814|NCT02065622|529876836|FG001|Maintenance Study|Adverse Event|0|||
146922815|NCT02065622|529876837|FG002|Maintenance Study|Adverse Event|25|||
146604964|NCT01532869|528723554|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
146604965|NCT01532869|528723553|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
146604966|NCT01532869|528723554|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
146604967|NCT01532869|528723553|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
146604968|NCT01532869|528723554|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
146604969|NCT01532869|528723553|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
146604970|NCT01532869|528723554|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
146604971|NCT01532869|528723553|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
146604972|NCT01532869|528723554|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
146604973|NCT01532869|528723553|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
146604974|NCT01532869|528723554|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
146604975|NCT01532869|528723553|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
146604976|NCT01532869|528723554|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
146604977|NCT01532869|528723553|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
146604978|NCT01532869|528723554|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
146922816|NCT02065622|529876838|FG003|Maintenance Study|Adverse Event|22|||
146922817|NCT02065622|529876839|FG004|Maintenance Study|Adverse Event|11|||
146922818|NCT02065622|529876835|FG000|Maintenance Study|Withdrawal by Subject|0|||
146922819|NCT02065622|529876836|FG001|Maintenance Study|Withdrawal by Subject|0|||
146922820|NCT02065622|529876837|FG002|Maintenance Study|Withdrawal by Subject|11|||
146922821|NCT02065622|529876838|FG003|Maintenance Study|Withdrawal by Subject|5|||
146922822|NCT02065622|529876839|FG004|Maintenance Study|Withdrawal by Subject|7|||
146922823|NCT02065622|529876835|FG000|Maintenance Study|Lost to Follow-up|0|||
146922824|NCT02065622|529876836|FG001|Maintenance Study|Lost to Follow-up|0|||
146922825|NCT02065622|529876837|FG002|Maintenance Study|Lost to Follow-up|4|||
146922826|NCT02065622|529876838|FG003|Maintenance Study|Lost to Follow-up|1|||
146922827|NCT02065622|529876839|FG004|Maintenance Study|Lost to Follow-up|1|||
146922828|NCT02065622|529876835|FG000|Maintenance Study|Lack of Efficacy|0|||
146922829|NCT02065622|529876836|FG001|Maintenance Study|Lack of Efficacy|0|||
146922830|NCT02065622|529876837|FG002|Maintenance Study|Lack of Efficacy|70|||
146922831|NCT02065622|529876838|FG003|Maintenance Study|Lack of Efficacy|55|||
146922832|NCT02065622|529876839|FG004|Maintenance Study|Lack of Efficacy|19|||
146922833|NCT02065622|529876835|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
146922834|NCT02065622|529876836|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
146922835|NCT02065622|529876837|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
146922836|NCT02065622|529876838|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
146604979|NCT01532869|528723553|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
146604980|NCT01532869|528723554|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
146604981|NCT01532869|528723553|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
146604982|NCT01532869|528723554|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
146604983|NCT01532869|528723553|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
146604984|NCT01532869|528723554|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
146604985|NCT01532869|528723553|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
146604986|NCT01532869|528723554|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
146604987|NCT01026220|528723555|FG000|Induction|Death|1|||
146604988|NCT01026220|528723556|FG001|Induction|Death|0|||
146604989|NCT01026220|528723557|FG002|Induction|Death|0|||
146604990|NCT01026220|528723555|FG000|Induction|Lack of Efficacy|2|||
146604991|NCT01026220|528723556|FG001|Induction|Lack of Efficacy|0|||
146604992|NCT01026220|528723557|FG002|Induction|Lack of Efficacy|0|||
146604993|NCT01026220|528723555|FG000|Induction|Physician Decision|12|||
146604994|NCT01026220|528723556|FG001|Induction|Physician Decision|0|||
146604995|NCT01026220|528723557|FG002|Induction|Physician Decision|0|||
146604996|NCT01026220|528723555|FG000|Induction|Withdrawal by Subject|9|||
146604997|NCT01026220|528723556|FG001|Induction|Withdrawal by Subject|0|||
146604998|NCT01026220|528723557|FG002|Induction|Withdrawal by Subject|0|||
146604999|NCT01026220|528723555|FG000|Induction|Ineligible|1|||
146605000|NCT01026220|528723556|FG001|Induction|Ineligible|0|||
146605001|NCT01026220|528723557|FG002|Induction|Ineligible|0|||
146605002|NCT01026220|528723555|FG000|Consolidation Maintenance|Death|0|||
146605003|NCT01026220|528723556|FG001|Consolidation Maintenance|Death|1|||
146605004|NCT01026220|528723557|FG002|Consolidation Maintenance|Death|0|||
146605005|NCT01026220|528723555|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
146605006|NCT01026220|528723556|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
146605007|NCT01026220|528723557|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
146605008|NCT01026220|528723555|FG000|Consolidation Maintenance|Physician Decision|0|||
146605009|NCT01026220|528723556|FG001|Consolidation Maintenance|Physician Decision|2|||
146605010|NCT01026220|528723557|FG002|Consolidation Maintenance|Physician Decision|7|||
146605011|NCT01026220|528723555|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
146605012|NCT01026220|528723556|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
146605013|NCT01026220|528723557|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
146605014|NCT00778895|528723558|FG000|Active Phase|Adverse Event|3|||
146656871|NCT01897714|528921611|FG001|Phase II (MTD)|Death|0|||
146656872|NCT01897714|528921612|FG002|Phase II (MTD)|Death|0|||
146656873|NCT01897714|528921613|FG003|Phase II (MTD)|Death|0|||
146656874|NCT01897714|528921614|FG004|Phase II (MTD)|Death|25|||
146656875|NCT01897714|528921615|FG005|Phase II (MTD)|Death|10|||
146605015|NCT00778895|528723559|FG001|Active Phase|Adverse Event|1|||
146656876|NCT01897714|528921610|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
146922837|NCT02065622|529876839|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
146922838|NCT02065622|529876835|FG000|Maintenance Study|Subject Non-Compliance|0|||
146922839|NCT02065622|529876836|FG001|Maintenance Study|Subject Non-Compliance|0|||
146605016|NCT00778895|528723560|FG002|Active Phase|Adverse Event|0|||
146605017|NCT00778895|528723558|FG000|Active Phase|Withdrawal by Subject|1|||
146605018|NCT00778895|528723559|FG001|Active Phase|Withdrawal by Subject|4|||
146605019|NCT00778895|528723560|FG002|Active Phase|Withdrawal by Subject|0|||
146605020|NCT00778895|528723558|FG000|Active Phase|Lost to Follow-up|1|||
146605021|NCT00778895|528723559|FG001|Active Phase|Lost to Follow-up|1|||
146605022|NCT00778895|528723560|FG002|Active Phase|Lost to Follow-up|0|||
146605023|NCT00778895|528723558|FG000|Active Phase|Other|2|||
146605024|NCT00778895|528723559|FG001|Active Phase|Other|0|||
146605025|NCT00778895|528723560|FG002|Active Phase|Other|0|||
146656877|NCT01897714|528921611|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
146656878|NCT01897714|528921612|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
146605026|NCT00778895|528723558|FG000|ESFU Phase|Adverse Event|2|||
146605027|NCT00778895|528723559|FG001|ESFU Phase|Adverse Event|1|||
146605028|NCT00778895|528723560|FG002|ESFU Phase|Adverse Event|0|||
146605029|NCT00778895|528723558|FG000|ESFU Phase|Withdrawal by Subject|1|||
146605030|NCT00778895|528723559|FG001|ESFU Phase|Withdrawal by Subject|4|||
146605031|NCT00778895|528723560|FG002|ESFU Phase|Withdrawal by Subject|0|||
146605032|NCT00778895|528723558|FG000|ESFU Phase|Lost to Follow-up|6|||
146605033|NCT00778895|528723559|FG001|ESFU Phase|Lost to Follow-up|7|||
146605034|NCT00778895|528723560|FG002|ESFU Phase|Lost to Follow-up|2|||
146605035|NCT00778895|528723558|FG000|ESFU Phase|Other|2|||
146605036|NCT00778895|528723559|FG001|ESFU Phase|Other|0|||
146605037|NCT00778895|528723560|FG002|ESFU Phase|Other|0|||
146605038|NCT01009086|528723568|FG000|Overall Study|Lack of Efficacy|16|||
146605039|NCT01009086|528723569|FG001|Overall Study|Lack of Efficacy|15|||
146605040|NCT01009086|528723570|FG002|Overall Study|Lack of Efficacy|9|||
146605041|NCT01009086|528723568|FG000|Overall Study|Lost to Follow-up|4|||
146605042|NCT01009086|528723569|FG001|Overall Study|Lost to Follow-up|5|||
146605043|NCT01009086|528723570|FG002|Overall Study|Lost to Follow-up|3|||
146605044|NCT01009086|528723568|FG000|Overall Study|Adverse Event|12|||
146605045|NCT01009086|528723569|FG001|Overall Study|Adverse Event|11|||
146605046|NCT01009086|528723570|FG002|Overall Study|Adverse Event|8|||
146605047|NCT01009086|528723568|FG000|Overall Study|Withdrawal by Subject|9|||
146605048|NCT01009086|528723569|FG001|Overall Study|Withdrawal by Subject|11|||
146605049|NCT01009086|528723570|FG002|Overall Study|Withdrawal by Subject|13|||
146605050|NCT01009086|528723568|FG000|Overall Study|Other|3|||
146605051|NCT01009086|528723569|FG001|Overall Study|Other|5|||
146605052|NCT01009086|528723570|FG002|Overall Study|Other|1|||
146605053|NCT01389323|528723571|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
146605054|NCT01389323|528723571|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
146605055|NCT01389323|528723571|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
146605056|NCT01389323|528723571|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
146605057|NCT01389323|528723571|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
146605058|NCT01389323|528723571|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
146605059|NCT01389323|528723571|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
146605060|NCT01389323|528723571|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
146605061|NCT01389323|528723571|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
146605062|NCT01389323|528723571|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
146605063|NCT01389323|528723571|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
146605064|NCT01147848|528723577|FG000|Run-in Period|Screen Failure|623|||
146605065|NCT01147848|528723578|FG001|Run-in Period|Screen Failure|0|||
146605066|NCT01147848|528723579|FG002|Run-in Period|Screen Failure|0|||
146605067|NCT01147848|528723577|FG000|Run-in Period|Run-in Failure|135|||
146605068|NCT01147848|528723578|FG001|Run-in Period|Run-in Failure|0|||
146605069|NCT01147848|528723579|FG002|Run-in Period|Run-in Failure|0|||
146605070|NCT01147848|528723577|FG000|Randomized Phase|Adverse Event|0|||
146605071|NCT01147848|528723578|FG001|Randomized Phase|Adverse Event|6|||
146656879|NCT01897714|528921613|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
146656880|NCT01897714|528921614|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
146656881|NCT01897714|528921615|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
146656882|NCT01897714|528921610|FG000|Phase II (MTD)|Other|0|||
146656883|NCT01897714|528921611|FG001|Phase II (MTD)|Other|0|||
146656884|NCT01897714|528921612|FG002|Phase II (MTD)|Other|0|||
146656885|NCT01897714|528921613|FG003|Phase II (MTD)|Other|0|||
146656886|NCT01897714|528921614|FG004|Phase II (MTD)|Other|3|||
146656887|NCT01897714|528921615|FG005|Phase II (MTD)|Other|0|||
146656888|NCT01994590|528921616|FG000|Overall Study|Adverse Event|1|||
146656889|NCT01994590|528921616|FG000|Overall Study|Trial Terminated|1|||
146922840|NCT02065622|529876837|FG002|Maintenance Study|Subject Non-Compliance|1|||
146922841|NCT02065622|529876838|FG003|Maintenance Study|Subject Non-Compliance|3|||
146922842|NCT02065622|529876839|FG004|Maintenance Study|Subject Non-Compliance|2|||
146922843|NCT02065622|529876835|FG000|Maintenance Study|Other, Not Specified|0|||
146922844|NCT02065622|529876836|FG001|Maintenance Study|Other, Not Specified|0|||
146922845|NCT02065622|529876837|FG002|Maintenance Study|Other, Not Specified|6|||
146922846|NCT02065622|529876838|FG003|Maintenance Study|Other, Not Specified|14|||
146922847|NCT02065622|529876839|FG004|Maintenance Study|Other, Not Specified|2|||
146922848|NCT02065622|529876835|FG000|Maintenance Study|Unknown Reason|0|||
146605072|NCT01147848|528723579|FG002|Randomized Phase|Adverse Event|8|||
146605073|NCT01147848|528723577|FG000|Randomized Phase|Lack of Efficacy|0|||
146605074|NCT01147848|528723578|FG001|Randomized Phase|Lack of Efficacy|20|||
146605075|NCT01147848|528723579|FG002|Randomized Phase|Lack of Efficacy|11|||
146605076|NCT01147848|528723577|FG000|Randomized Phase|Protocol Violation|0|||
146922849|NCT02065622|529876836|FG001|Maintenance Study|Unknown Reason|0|||
146922850|NCT02065622|529876837|FG002|Maintenance Study|Unknown Reason|0|||
146922851|NCT02065622|529876838|FG003|Maintenance Study|Unknown Reason|1|||
146922852|NCT02065622|529876839|FG004|Maintenance Study|Unknown Reason|0|||
146922853|NCT01687413|529876854|FG000|Overall Study|Withdrawal by Subject|0|||
146922854|NCT01687413|529876855|FG001|Overall Study|Withdrawal by Subject|2|||
146922855|NCT01687413|529876854|FG000|Overall Study|Not eligible|0|||
146605077|NCT01147848|528723578|FG001|Randomized Phase|Protocol Violation|7|||
146605078|NCT01147848|528723579|FG002|Randomized Phase|Protocol Violation|10|||
146605079|NCT01147848|528723577|FG000|Randomized Phase|Lost to Follow-up|0|||
146605080|NCT01147848|528723578|FG001|Randomized Phase|Lost to Follow-up|5|||
146605081|NCT01147848|528723579|FG002|Randomized Phase|Lost to Follow-up|7|||
146605082|NCT01147848|528723577|FG000|Randomized Phase|Physician Decision|0|||
146605083|NCT01147848|528723578|FG001|Randomized Phase|Physician Decision|0|||
146605084|NCT01147848|528723579|FG002|Randomized Phase|Physician Decision|1|||
146605085|NCT01147848|528723577|FG000|Randomized Phase|Withdrawal by Subject|0|||
146605086|NCT01147848|528723578|FG001|Randomized Phase|Withdrawal by Subject|7|||
146605087|NCT01147848|528723579|FG002|Randomized Phase|Withdrawal by Subject|9|||
146605088|NCT03596450|528723592|FG000|Overall Study|Death|9|||
146605089|NCT03596450|528723593|FG001|Overall Study|Death|9|||
146605090|NCT03596450|528723592|FG000|Overall Study|Protocol Violation|18|||
146605091|NCT03596450|528723593|FG001|Overall Study|Protocol Violation|26|||
146605092|NCT03596450|528723592|FG000|Overall Study|Lost to Follow-up|50|||
146605093|NCT03596450|528723593|FG001|Overall Study|Lost to Follow-up|56|||
146605094|NCT03596450|528723592|FG000|Overall Study|Adverse Event|14|||
146605095|NCT03596450|528723593|FG001|Overall Study|Adverse Event|7|||
146605096|NCT03596450|528723592|FG000|Overall Study|Withdrawal by Subject|38|||
146605097|NCT03596450|528723593|FG001|Overall Study|Withdrawal by Subject|36|||
146605098|NCT03596450|528723592|FG000|Overall Study|Accidentally Randomized|2|||
146605099|NCT03596450|528723593|FG001|Overall Study|Accidentally Randomized|0|||
146605100|NCT03596450|528723592|FG000|Overall Study|Other reasons|48|||
146605101|NCT03596450|528723593|FG001|Overall Study|Other reasons|53|||
146605102|NCT03596450|528723592|FG000|Overall Study|Pregnancy|2|||
146605103|NCT03596450|528723593|FG001|Overall Study|Pregnancy|0|||
146605104|NCT04058886|528723594|FG000|Overall Study|Withdrawal by Subject|4|||
146605105|NCT04058886|528723594|FG000|Overall Study|Inadequate deafness interpreter service|1|||
146605106|NCT01069705|528723595|FG000|Overall Study|Adverse Event|1|||
146605107|NCT01069705|528723595|FG000|Overall Study|Withdrawal by Subject|2|||
146605108|NCT03624127|528723596|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
146605109|NCT03624127|528723597|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
146605110|NCT03624127|528723598|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
146605111|NCT03624127|528723596|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
146605112|NCT03624127|528723597|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
146605113|NCT03624127|528723598|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
146605114|NCT03624127|528723596|FG000|Treatment Week 0 - Week 16|Death|0|||
146605115|NCT03624127|528723597|FG001|Treatment Week 0 - Week 16|Death|1|||
146605116|NCT03624127|528723598|FG002|Treatment Week 0 - Week 16|Death|0|||
146605117|NCT03624127|528723596|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
146605118|NCT03624127|528723597|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
146605119|NCT03624127|528723598|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
146605120|NCT03624127|528723596|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
146605121|NCT03624127|528723597|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
146605122|NCT03624127|528723598|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
146605123|NCT03624127|528723596|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
146605124|NCT03624127|528723597|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
146605125|NCT03624127|528723598|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
146605126|NCT03624127|528723596|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
146605127|NCT03624127|528723597|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
146605128|NCT03624127|528723598|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
146605129|NCT03624127|528723596|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
146605130|NCT03624127|528723597|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
146605131|NCT03624127|528723598|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
146605132|NCT03624127|528723596|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
146922856|NCT01687413|529876855|FG001|Overall Study|Not eligible|2|||
146922857|NCT01687413|529876854|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
146922858|NCT01687413|529876855|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
146922859|NCT02678780|529876860|FG000|Overall Study|Adverse Event|11|||
146922860|NCT02678780|529876861|FG001|Overall Study|Adverse Event|14|||
146605133|NCT03624127|528723597|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
146605134|NCT03624127|528723598|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
146605135|NCT03624127|528723596|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
146605136|NCT03624127|528723597|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
146605137|NCT03624127|528723598|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
146605138|NCT03624127|528723596|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
146605139|NCT03624127|528723597|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
146605140|NCT03624127|528723598|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
146605141|NCT03624127|528723596|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
146605142|NCT03624127|528723597|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
146605143|NCT03624127|528723598|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
146922861|NCT02678780|529876860|FG000|Overall Study|Withdrawal by Subject|2|||
146772973|NCT03903822|529338234|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
146772974|NCT03903822|529338235|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
146772975|NCT03903822|529338236|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
146772976|NCT03903822|529338237|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
146772977|NCT03903822|529338238|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
146772978|NCT03903822|529338239|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
146772979|NCT03903822|529338240|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
146772980|NCT03903822|529338241|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
146772981|NCT03903822|529338234|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
146772982|NCT03903822|529338235|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
146772983|NCT03903822|529338236|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
146772984|NCT03903822|529338237|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
146772985|NCT03903822|529338238|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
146772986|NCT03903822|529338239|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
146772987|NCT03903822|529338240|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
146772988|NCT03903822|529338241|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
146772989|NCT03903822|529338234|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
146922862|NCT02678780|529876861|FG001|Overall Study|Withdrawal by Subject|1|||
146605144|NCT03624127|528723596|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
146605145|NCT03624127|528723597|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
146605146|NCT03624127|528723598|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
146605147|NCT03624127|528723596|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
146605148|NCT03624127|528723597|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
146605149|NCT03624127|528723598|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
146605150|NCT03624127|528723596|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
146605151|NCT03624127|528723597|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
146605152|NCT03624127|528723598|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
146605153|NCT03624127|528723596|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
146605154|NCT03624127|528723597|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
146605155|NCT03624127|528723598|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
146605156|NCT03624127|528723596|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
146605157|NCT03624127|528723597|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
146605158|NCT03624127|528723598|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
146605159|NCT03624127|528723596|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
146605160|NCT03624127|528723597|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
146605161|NCT03624127|528723598|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
146605162|NCT03624127|528723596|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
146605163|NCT03624127|528723597|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
146605164|NCT03624127|528723598|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
146605165|NCT03624127|528723596|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
146605166|NCT03624127|528723597|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
146605167|NCT03624127|528723598|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
146605168|NCT03624127|528723596|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
146605169|NCT03624127|528723597|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
146605170|NCT03624127|528723598|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
146605171|NCT00915551|528723599|FG000|Overall Study|Withdrawal by Subject|0|||
146605172|NCT00915551|528723600|FG001|Overall Study|Withdrawal by Subject|1|||
146605173|NCT04390841|528723601|FG000|Overall Study|Withdrawal by Subject|2|||
146605174|NCT02999633|528723602|FG000|Overall Study|Adverse Event|2|||
146605175|NCT02999633|528723602|FG000|Overall Study|Progressive disease|12|||
146605176|NCT01545050|528723603|FG000|Overall Study|Lack of Efficacy|0|||
146605177|NCT01545050|528723604|FG001|Overall Study|Lack of Efficacy|0|||
146605178|NCT01545050|528723605|FG002|Overall Study|Lack of Efficacy|0|||
146605179|NCT01545050|528723606|FG003|Overall Study|Lack of Efficacy|3|||
146605180|NCT01545050|528723607|FG004|Overall Study|Lack of Efficacy|2|||
146605181|NCT01545050|528723603|FG000|Overall Study|Adverse Event|1|||
146605182|NCT01545050|528723604|FG001|Overall Study|Adverse Event|1|||
146605183|NCT01545050|528723605|FG002|Overall Study|Adverse Event|2|||
146605184|NCT01545050|528723606|FG003|Overall Study|Adverse Event|2|||
146772990|NCT03903822|529338235|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
146772991|NCT03903822|529338236|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
146772992|NCT03903822|529338237|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
146772993|NCT03903822|529338238|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
146772994|NCT03903822|529338239|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
146772995|NCT03903822|529338240|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
146605185|NCT01545050|528723607|FG004|Overall Study|Adverse Event|0|||
146605186|NCT01545050|528723603|FG000|Overall Study|Discontinued study treatment|1|||
146772996|NCT03903822|529338241|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
146772997|NCT03903822|529338234|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
146922863|NCT02678780|529876860|FG000|Overall Study|Sponsor discontinuation|7|||
146605187|NCT01545050|528723604|FG001|Overall Study|Discontinued study treatment|0|||
146605188|NCT01545050|528723605|FG002|Overall Study|Discontinued study treatment|0|||
146605189|NCT01545050|528723606|FG003|Overall Study|Discontinued study treatment|0|||
146605190|NCT01545050|528723607|FG004|Overall Study|Discontinued study treatment|0|||
146605191|NCT01545050|528723603|FG000|Overall Study|Withdrawal by Subject|1|||
146605192|NCT01545050|528723604|FG001|Overall Study|Withdrawal by Subject|0|||
146605193|NCT01545050|528723605|FG002|Overall Study|Withdrawal by Subject|0|||
146605194|NCT01545050|528723606|FG003|Overall Study|Withdrawal by Subject|2|||
146605195|NCT01545050|528723607|FG004|Overall Study|Withdrawal by Subject|1|||
146605196|NCT01545050|528723603|FG000|Overall Study|Participant no longer meets study criteria|0|||
146605197|NCT01545050|528723604|FG001|Overall Study|Participant no longer meets study criteria|2|||
146605198|NCT01545050|528723605|FG002|Overall Study|Participant no longer meets study criteria|0|||
146605199|NCT01545050|528723606|FG003|Overall Study|Participant no longer meets study criteria|0|||
146605200|NCT01545050|528723607|FG004|Overall Study|Participant no longer meets study criteria|1|||
146605201|NCT01545050|528723603|FG000|Overall Study|Administrative reason by sponsor|4|||
146605202|NCT01545050|528723604|FG001|Overall Study|Administrative reason by sponsor|2|||
146605203|NCT01545050|528723605|FG002|Overall Study|Administrative reason by sponsor|3|||
146605204|NCT01545050|528723606|FG003|Overall Study|Administrative reason by sponsor|5|||
146605205|NCT01545050|528723607|FG004|Overall Study|Administrative reason by sponsor|5|||
146605206|NCT03262441|528723608|FG000|Overall Study|Withdrawal by Subject|1|||
146605207|NCT02607228|528723609|FG000|Overall Study|Progressive Disease|4|||
146605208|NCT02607228|528723610|FG001|Overall Study|Progressive Disease|3|||
146605209|NCT02607228|528723611|FG002|Overall Study|Progressive Disease|1|||
146605210|NCT02607228|528723612|FG003|Overall Study|Progressive Disease|5|||
146605211|NCT02607228|528723613|FG004|Overall Study|Progressive Disease|4|||
146605212|NCT02607228|528723614|FG005|Overall Study|Progressive Disease|3|||
146605213|NCT02607228|528723615|FG006|Overall Study|Progressive Disease|1|||
146605214|NCT02607228|528723609|FG000|Overall Study|Adverse Event|1|||
146605215|NCT02607228|528723610|FG001|Overall Study|Adverse Event|0|||
146605216|NCT02607228|528723611|FG002|Overall Study|Adverse Event|1|||
146605217|NCT02607228|528723612|FG003|Overall Study|Adverse Event|0|||
146605218|NCT02607228|528723613|FG004|Overall Study|Adverse Event|1|||
146605219|NCT02607228|528723614|FG005|Overall Study|Adverse Event|1|||
146605220|NCT02607228|528723615|FG006|Overall Study|Adverse Event|1|||
146605221|NCT02607228|528723609|FG000|Overall Study|Investigator's Discretion|0|||
146605222|NCT02607228|528723610|FG001|Overall Study|Investigator's Discretion|0|||
146605223|NCT02607228|528723611|FG002|Overall Study|Investigator's Discretion|1|||
146605224|NCT02607228|528723612|FG003|Overall Study|Investigator's Discretion|0|||
146605225|NCT02607228|528723613|FG004|Overall Study|Investigator's Discretion|0|||
146605226|NCT02607228|528723614|FG005|Overall Study|Investigator's Discretion|1|||
146605227|NCT02607228|528723615|FG006|Overall Study|Investigator's Discretion|0|||
146605228|NCT02607228|528723609|FG000|Overall Study|Withdrew Consent|0|||
146605229|NCT02607228|528723610|FG001|Overall Study|Withdrew Consent|1|||
146605230|NCT02607228|528723611|FG002|Overall Study|Withdrew Consent|0|||
146605231|NCT02607228|528723612|FG003|Overall Study|Withdrew Consent|0|||
146605232|NCT02607228|528723613|FG004|Overall Study|Withdrew Consent|0|||
146605233|NCT02607228|528723614|FG005|Overall Study|Withdrew Consent|1|||
146605234|NCT02607228|528723615|FG006|Overall Study|Withdrew Consent|0|||
146605235|NCT02607228|528723609|FG000|Overall Study|Study Terminated by Sponsor|0|||
146605236|NCT02607228|528723610|FG001|Overall Study|Study Terminated by Sponsor|0|||
146605237|NCT02607228|528723611|FG002|Overall Study|Study Terminated by Sponsor|0|||
146605238|NCT02607228|528723612|FG003|Overall Study|Study Terminated by Sponsor|1|||
146605239|NCT02607228|528723613|FG004|Overall Study|Study Terminated by Sponsor|0|||
146605240|NCT02607228|528723614|FG005|Overall Study|Study Terminated by Sponsor|0|||
146922864|NCT02678780|529876861|FG001|Overall Study|Sponsor discontinuation|4|||
146922865|NCT02678780|529876860|FG000|Overall Study|Death|1|||
146922866|NCT02678780|529876861|FG001|Overall Study|Death|1|||
146922867|NCT02678780|529876860|FG000|Overall Study|Other|6|||
146922868|NCT02678780|529876861|FG001|Overall Study|Other|8|||
146922869|NCT00992446|529876863|FG000|Overall Study|Disease Progression|1|||
146922870|NCT00992446|529876863|FG000|Overall Study|Withdrawal by Subject|2|||
146922871|NCT00992446|529876863|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
146922872|NCT00755846|529878671|FG000|Overall Study|Adverse Event|0|||
146605241|NCT02607228|528723615|FG006|Overall Study|Study Terminated by Sponsor|0|||
146605242|NCT03235089|528723622|FG000|Overall Study|Lost to Follow-up|1|||
146605243|NCT03235089|528723623|FG001|Overall Study|Lost to Follow-up|1|||
146605244|NCT03235089|528723622|FG000|Overall Study|Physician Decision|2|||
146605245|NCT03235089|528723623|FG001|Overall Study|Physician Decision|2|||
146605246|NCT01196416|528723629|FG000|Overall Study|Withdrawal by Subject|2|||
146605247|NCT00727558|528723635|FG000|Overall Study|Lens issue|0|||
146605248|NCT00727558|528723636|FG001|Overall Study|Lens issue|1|||
146605249|NCT00727558|528723635|FG000|Overall Study|Adverse Event|0|||
146605250|NCT00727558|528723636|FG001|Overall Study|Adverse Event|1|||
146922873|NCT00755846|529878672|FG001|Overall Study|Adverse Event|0|||
146922874|NCT00755846|529878673|FG002|Overall Study|Adverse Event|0|||
146656920|NCT01801072|528921623|FG000|Overall Study|Lost to Follow-up|17|||
146656921|NCT01801072|528921624|FG001|Overall Study|Lost to Follow-up|14|||
146656922|NCT01801072|528921623|FG000|Overall Study|Physician Decision|2|||
146605251|NCT00727558|528723635|FG000|Overall Study|Subject unable to return for follow-up|1|||
146605252|NCT00727558|528723636|FG001|Overall Study|Subject unable to return for follow-up|1|||
146656923|NCT01801072|528921624|FG001|Overall Study|Physician Decision|3|||
146656924|NCT01801072|528921623|FG000|Overall Study|Withdrawal by Subject|1|||
146656925|NCT01801072|528921624|FG001|Overall Study|Withdrawal by Subject|0|||
146656926|NCT01801072|528921623|FG000|Overall Study|Protocol Violation|2|||
146656927|NCT01801072|528921624|FG001|Overall Study|Protocol Violation|0|||
146656928|NCT01801072|528921623|FG000|Overall Study|Death|7|||
146656929|NCT01801072|528921624|FG001|Overall Study|Death|8|||
146656930|NCT03693170|528921625|FG000|Overall Study|Disease Progression|48|||
146772998|NCT03903822|529338235|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
146772999|NCT03903822|529338236|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
146773000|NCT03903822|529338237|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
146773001|NCT03903822|529338238|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
146773002|NCT03903822|529338239|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
146773003|NCT03903822|529338240|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
146773004|NCT03903822|529338241|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
146773005|NCT03903822|529338234|FG000|Treatment Phase (6 Weeks)|Other|2|||
146773006|NCT03903822|529338235|FG001|Treatment Phase (6 Weeks)|Other|1|||
146773007|NCT03903822|529338236|FG002|Treatment Phase (6 Weeks)|Other|0|||
146773008|NCT03903822|529338237|FG003|Treatment Phase (6 Weeks)|Other|0|||
146773009|NCT03903822|529338238|FG004|Treatment Phase (6 Weeks)|Other|1|||
146773010|NCT03903822|529338239|FG005|Treatment Phase (6 Weeks)|Other|1|||
146605253|NCT00727558|528723635|FG000|Overall Study|Lost to Follow-up|1|||
146773011|NCT03903822|529338240|FG006|Treatment Phase (6 Weeks)|Other|0|||
146773012|NCT03903822|529338241|FG007|Treatment Phase (6 Weeks)|Other|0|||
146773013|NCT03903822|529338234|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
146773014|NCT03903822|529338235|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
146773015|NCT03903822|529338236|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
146773016|NCT03903822|529338237|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
146773017|NCT03903822|529338238|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
146773018|NCT03903822|529338239|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
146773019|NCT03903822|529338240|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
146773020|NCT03903822|529338241|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
146773021|NCT03903822|529338234|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
146773022|NCT03903822|529338235|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
146773023|NCT03903822|529338236|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
146773024|NCT03903822|529338237|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
146773025|NCT03903822|529338238|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
146773026|NCT03903822|529338239|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
146773027|NCT03903822|529338240|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
146773028|NCT03903822|529338241|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
146773029|NCT03903822|529338234|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
146922875|NCT00755846|529878674|FG003|Overall Study|Adverse Event|1|||
146922876|NCT00755846|529878675|FG004|Overall Study|Adverse Event|3|||
146605254|NCT00727558|528723636|FG001|Overall Study|Lost to Follow-up|0|||
146605255|NCT01717326|528723637|FG000|Overall Study|Death|0|||
146605256|NCT01717326|528723638|FG001|Overall Study|Death|0|||
146605257|NCT01717326|528723639|FG002|Overall Study|Death|0|||
146605258|NCT01717326|528723640|FG003|Overall Study|Death|0|||
146605259|NCT01717326|528723641|FG004|Overall Study|Death|0|||
146605260|NCT01717326|528723642|FG005|Overall Study|Death|0|||
146605261|NCT01717326|528723643|FG006|Overall Study|Death|0|||
146605262|NCT01717326|528723644|FG007|Overall Study|Death|0|||
146605263|NCT01717326|528723645|FG008|Overall Study|Death|0|||
146605264|NCT01717326|528723646|FG009|Overall Study|Death|0|||
146605265|NCT01717326|528723647|FG010|Overall Study|Death|1|||
146656931|NCT03693170|528921625|FG000|Overall Study|Adverse Event|16|||
146656932|NCT03693170|528921625|FG000|Overall Study|Physician Decision|6|||
146656933|NCT03693170|528921625|FG000|Overall Study|Protocol Violation|2|||
146656934|NCT03693170|528921625|FG000|Overall Study|Death|1|||
146773030|NCT03903822|529338235|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
146773031|NCT03903822|529338236|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
146773032|NCT03903822|529338237|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
146773033|NCT03903822|529338238|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
146922877|NCT00755846|529878676|FG005|Overall Study|Adverse Event|2|||
146922878|NCT00755846|529878671|FG000|Overall Study|Protocol Violation|1|||
146922879|NCT00755846|529878672|FG001|Overall Study|Protocol Violation|1|||
146605266|NCT01717326|528723648|FG011|Overall Study|Death|0|||
146605267|NCT01717326|528723649|FG012|Overall Study|Death|0|||
146773034|NCT03903822|529338239|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
146773035|NCT03903822|529338240|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
146773036|NCT03903822|529338241|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
146773037|NCT03903822|529338234|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
146922880|NCT00755846|529878673|FG002|Overall Study|Protocol Violation|1|||
146656935|NCT03693170|528921625|FG000|Overall Study|Non compliance with study drug|1|||
146656936|NCT03693170|528921625|FG000|Overall Study|Withdrawal by Subject|1|||
146605268|NCT01717326|528723650|FG013|Overall Study|Death|0|||
146605269|NCT01717326|528723651|FG014|Overall Study|Death|0|||
146773038|NCT03903822|529338235|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
146773039|NCT03903822|529338236|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
146773040|NCT03903822|529338237|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
146773041|NCT03903822|529338238|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
146773042|NCT03903822|529338239|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
146605270|NCT01717326|528723652|FG015|Overall Study|Death|0|||
146605271|NCT01717326|528723653|FG016|Overall Study|Death|0|||
146605272|NCT01717326|528723654|FG017|Overall Study|Death|0|||
146605273|NCT01717326|528723655|FG018|Overall Study|Death|0|||
146605274|NCT01717326|528723656|FG019|Overall Study|Death|0|||
146605275|NCT01717326|528723637|FG000|Overall Study|Lost to Follow-up|3|||
146605276|NCT01717326|528723638|FG001|Overall Study|Lost to Follow-up|0|||
146605277|NCT01717326|528723639|FG002|Overall Study|Lost to Follow-up|0|||
146605278|NCT01717326|528723640|FG003|Overall Study|Lost to Follow-up|2|||
146605279|NCT01717326|528723641|FG004|Overall Study|Lost to Follow-up|1|||
146605280|NCT01717326|528723642|FG005|Overall Study|Lost to Follow-up|0|||
146605281|NCT01717326|528723643|FG006|Overall Study|Lost to Follow-up|1|||
146605282|NCT01717326|528723644|FG007|Overall Study|Lost to Follow-up|0|||
146605283|NCT01717326|528723645|FG008|Overall Study|Lost to Follow-up|0|||
146605284|NCT01717326|528723646|FG009|Overall Study|Lost to Follow-up|0|||
146605285|NCT01717326|528723647|FG010|Overall Study|Lost to Follow-up|1|||
146605286|NCT01717326|528723648|FG011|Overall Study|Lost to Follow-up|0|||
146605287|NCT01717326|528723649|FG012|Overall Study|Lost to Follow-up|0|||
146605288|NCT01717326|528723650|FG013|Overall Study|Lost to Follow-up|0|||
146605289|NCT01717326|528723651|FG014|Overall Study|Lost to Follow-up|0|||
146773043|NCT03903822|529338240|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
146773044|NCT03903822|529338241|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
146773045|NCT03903822|529338234|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
146773046|NCT03903822|529338235|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
146922881|NCT00755846|529878674|FG003|Overall Study|Protocol Violation|1|||
146922882|NCT00755846|529878675|FG004|Overall Study|Protocol Violation|1|||
146922883|NCT00755846|529878676|FG005|Overall Study|Protocol Violation|1|||
146922884|NCT00755846|529878671|FG000|Overall Study|Lost to Follow-up|0|||
146922885|NCT00755846|529878672|FG001|Overall Study|Lost to Follow-up|2|||
146922886|NCT00755846|529878673|FG002|Overall Study|Lost to Follow-up|1|||
146922887|NCT00755846|529878674|FG003|Overall Study|Lost to Follow-up|0|||
146922888|NCT00755846|529878675|FG004|Overall Study|Lost to Follow-up|4|||
146922889|NCT00755846|529878676|FG005|Overall Study|Lost to Follow-up|2|||
146922890|NCT00755846|529878671|FG000|Overall Study|Withdrawal by Subject|2|||
146922891|NCT00755846|529878672|FG001|Overall Study|Withdrawal by Subject|3|||
146922892|NCT00755846|529878673|FG002|Overall Study|Withdrawal by Subject|5|||
146922893|NCT00755846|529878674|FG003|Overall Study|Withdrawal by Subject|2|||
146922894|NCT00755846|529878675|FG004|Overall Study|Withdrawal by Subject|0|||
146922895|NCT00755846|529878676|FG005|Overall Study|Withdrawal by Subject|1|||
146922896|NCT00755846|529878671|FG000|Overall Study|Hyperglycemic Rescue|21|||
146922897|NCT00755846|529878672|FG001|Overall Study|Hyperglycemic Rescue|7|||
146922898|NCT00755846|529878673|FG002|Overall Study|Hyperglycemic Rescue|5|||
146922899|NCT00755846|529878674|FG003|Overall Study|Hyperglycemic Rescue|8|||
146922900|NCT00755846|529878675|FG004|Overall Study|Hyperglycemic Rescue|8|||
146922901|NCT00755846|529878676|FG005|Overall Study|Hyperglycemic Rescue|7|||
146922902|NCT00755846|529878671|FG000|Overall Study|Physician Decision|1|||
146922903|NCT00755846|529878672|FG001|Overall Study|Physician Decision|3|||
146922904|NCT00755846|529878673|FG002|Overall Study|Physician Decision|0|||
146922905|NCT00755846|529878674|FG003|Overall Study|Physician Decision|1|||
146922906|NCT00755846|529878675|FG004|Overall Study|Physician Decision|0|||
146922907|NCT00755846|529878676|FG005|Overall Study|Physician Decision|1|||
146922908|NCT00755846|529878671|FG000|Overall Study|Administrative Error|0|||
146922909|NCT00755846|529878672|FG001|Overall Study|Administrative Error|1|||
146922910|NCT00755846|529878673|FG002|Overall Study|Administrative Error|0|||
146922911|NCT00755846|529878674|FG003|Overall Study|Administrative Error|0|||
146922912|NCT00755846|529878675|FG004|Overall Study|Administrative Error|0|||
146922913|NCT00755846|529878676|FG005|Overall Study|Administrative Error|0|||
146922914|NCT00755846|529878671|FG000|Overall Study|Participant Non-compliance|0|||
146922915|NCT00755846|529878672|FG001|Overall Study|Participant Non-compliance|0|||
146922916|NCT00755846|529878673|FG002|Overall Study|Participant Non-compliance|0|||
146605290|NCT01717326|528723652|FG015|Overall Study|Lost to Follow-up|2|||
146605291|NCT01717326|528723653|FG016|Overall Study|Lost to Follow-up|1|||
146605292|NCT01717326|528723654|FG017|Overall Study|Lost to Follow-up|0|||
146605293|NCT01717326|528723655|FG018|Overall Study|Lost to Follow-up|2|||
146605294|NCT01717326|528723656|FG019|Overall Study|Lost to Follow-up|3|||
146605295|NCT01717326|528723637|FG000|Overall Study|Physician Decision|0|||
146605296|NCT01717326|528723638|FG001|Overall Study|Physician Decision|0|||
146773047|NCT03903822|529338236|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
146922917|NCT00755846|529878674|FG003|Overall Study|Participant Non-compliance|0|||
146922918|NCT00755846|529878675|FG004|Overall Study|Participant Non-compliance|1|||
146605297|NCT01717326|528723639|FG002|Overall Study|Physician Decision|0|||
146922919|NCT00755846|529878676|FG005|Overall Study|Participant Non-compliance|0|||
146605298|NCT01717326|528723640|FG003|Overall Study|Physician Decision|0|||
146605299|NCT01717326|528723641|FG004|Overall Study|Physician Decision|0|||
146605300|NCT01717326|528723642|FG005|Overall Study|Physician Decision|0|||
146605301|NCT01717326|528723643|FG006|Overall Study|Physician Decision|0|||
146605302|NCT01717326|528723644|FG007|Overall Study|Physician Decision|0|||
146605303|NCT01717326|528723645|FG008|Overall Study|Physician Decision|0|||
146605304|NCT01717326|528723646|FG009|Overall Study|Physician Decision|1|||
146605305|NCT01717326|528723647|FG010|Overall Study|Physician Decision|0|||
146605306|NCT01717326|528723648|FG011|Overall Study|Physician Decision|0|||
146605307|NCT01717326|528723649|FG012|Overall Study|Physician Decision|0|||
146605308|NCT01717326|528723650|FG013|Overall Study|Physician Decision|0|||
146605309|NCT01717326|528723651|FG014|Overall Study|Physician Decision|0|||
146605310|NCT01717326|528723652|FG015|Overall Study|Physician Decision|0|||
146605311|NCT01717326|528723653|FG016|Overall Study|Physician Decision|0|||
146605312|NCT01717326|528723654|FG017|Overall Study|Physician Decision|0|||
146605313|NCT01717326|528723655|FG018|Overall Study|Physician Decision|0|||
146605314|NCT01717326|528723656|FG019|Overall Study|Physician Decision|0|||
146605315|NCT01717326|528723637|FG000|Overall Study|Protocol Violation|0|||
146605316|NCT01717326|528723638|FG001|Overall Study|Protocol Violation|0|||
146605317|NCT01717326|528723639|FG002|Overall Study|Protocol Violation|0|||
146605318|NCT01717326|528723640|FG003|Overall Study|Protocol Violation|0|||
146605319|NCT01717326|528723641|FG004|Overall Study|Protocol Violation|1|||
146605320|NCT01717326|528723642|FG005|Overall Study|Protocol Violation|0|||
146605321|NCT01717326|528723643|FG006|Overall Study|Protocol Violation|0|||
146605322|NCT01717326|528723644|FG007|Overall Study|Protocol Violation|0|||
146605323|NCT01717326|528723645|FG008|Overall Study|Protocol Violation|0|||
146605324|NCT01717326|528723646|FG009|Overall Study|Protocol Violation|0|||
146605325|NCT01717326|528723647|FG010|Overall Study|Protocol Violation|0|||
146605326|NCT01717326|528723648|FG011|Overall Study|Protocol Violation|0|||
146605327|NCT01717326|528723649|FG012|Overall Study|Protocol Violation|0|||
146605328|NCT01717326|528723650|FG013|Overall Study|Protocol Violation|0|||
146605329|NCT01717326|528723651|FG014|Overall Study|Protocol Violation|0|||
146656937|NCT00053365|528921626|FG000|Overall Study|Incorrect cell type|1|||
146656938|NCT00053365|528921626|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
146656939|NCT00053365|528921626|FG000|Overall Study|Never treated|4|||
146656940|NCT03183778|528921629|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
146656941|NCT00721123|528921630|FG000|Overall Study|Adverse Event|96|||
146656942|NCT00721123|528921630|FG000|Overall Study|Death|10|||
146656943|NCT00721123|528921630|FG000|Overall Study|Insufficient Therapeutic Response|21|||
146656944|NCT00721123|528921630|FG000|Overall Study|Protocol Violation|1|||
146656945|NCT00721123|528921630|FG000|Overall Study|Refused Treatment|41|||
146656946|NCT00721123|528921630|FG000|Overall Study|Failure to Return|9|||
146656947|NCT00721123|528921630|FG000|Overall Study|Withdrawal by Subject|5|||
146656948|NCT03228420|528921636|FG000|Overall Study|Lost to Follow-up|5|||
146656949|NCT03228420|528921637|FG001|Overall Study|Lost to Follow-up|3|||
146656950|NCT03228420|528921636|FG000|Overall Study|Withdrawal by Subject|10|||
146656951|NCT03228420|528921637|FG001|Overall Study|Withdrawal by Subject|0|||
146656952|NCT03228420|528921636|FG000|Overall Study|Adverse Event|5|||
146656953|NCT03228420|528921637|FG001|Overall Study|Adverse Event|2|||
146656954|NCT03954041|528921640|FG000|Overall Study|Lost to Follow-up|3|||
146656955|NCT03954041|528921641|FG001|Overall Study|Lost to Follow-up|3|||
146656956|NCT03954041|528921642|FG002|Overall Study|Lost to Follow-up|6|||
146656957|NCT03954041|528921640|FG000|Overall Study|Death|4|||
146656958|NCT03954041|528921641|FG001|Overall Study|Death|0|||
146656959|NCT03954041|528921642|FG002|Overall Study|Death|1|||
146656960|NCT03954041|528921640|FG000|Overall Study|Death by neurologic criteria|0|||
146656961|NCT03954041|528921641|FG001|Overall Study|Death by neurologic criteria|0|||
146656962|NCT03954041|528921642|FG002|Overall Study|Death by neurologic criteria|1|||
146656963|NCT03954041|528921640|FG000|Overall Study|Reason not specified|7|||
146656964|NCT03954041|528921641|FG001|Overall Study|Reason not specified|4|||
146656965|NCT03954041|528921642|FG002|Overall Study|Reason not specified|2|||
146656966|NCT03954041|528921640|FG000|Overall Study|Withdrew prior to dosing|4|||
146922920|NCT00818207|529878677|FG000|Overall Study|Adverse Event|6|||
146605330|NCT01717326|528723652|FG015|Overall Study|Protocol Violation|0|||
146605331|NCT01717326|528723653|FG016|Overall Study|Protocol Violation|0|||
146656967|NCT03954041|528921641|FG001|Overall Study|Withdrew prior to dosing|2|||
146656968|NCT03954041|528921642|FG002|Overall Study|Withdrew prior to dosing|0|||
146656969|NCT03868124|528921645|FG000|Overall Study|Withdrawal by Subject|4|||
146656970|NCT03868124|528921646|FG001|Overall Study|Withdrawal by Subject|0|||
146656971|NCT03868124|528921647|FG002|Overall Study|Withdrawal by Subject|1|||
146656972|NCT03868124|528921645|FG000|Overall Study|Physician Decision|1|||
146605332|NCT01717326|528723654|FG017|Overall Study|Protocol Violation|0|||
146605333|NCT01717326|528723655|FG018|Overall Study|Protocol Violation|0|||
146605334|NCT01717326|528723656|FG019|Overall Study|Protocol Violation|0|||
146605335|NCT01717326|528723637|FG000|Overall Study|Withdrawal by Subject|0|||
146605336|NCT01717326|528723638|FG001|Overall Study|Withdrawal by Subject|1|||
146605337|NCT01717326|528723639|FG002|Overall Study|Withdrawal by Subject|0|||
146922921|NCT00818207|529878678|FG001|Overall Study|Adverse Event|0|||
146605338|NCT01717326|528723640|FG003|Overall Study|Withdrawal by Subject|0|||
146605339|NCT01717326|528723641|FG004|Overall Study|Withdrawal by Subject|0|||
146656973|NCT03868124|528921646|FG001|Overall Study|Physician Decision|0|||
146605340|NCT01717326|528723642|FG005|Overall Study|Withdrawal by Subject|0|||
146605341|NCT01717326|528723643|FG006|Overall Study|Withdrawal by Subject|0|||
146605342|NCT01717326|528723644|FG007|Overall Study|Withdrawal by Subject|0|||
146605343|NCT01717326|528723645|FG008|Overall Study|Withdrawal by Subject|0|||
146605344|NCT01717326|528723646|FG009|Overall Study|Withdrawal by Subject|1|||
146605345|NCT01717326|528723647|FG010|Overall Study|Withdrawal by Subject|0|||
146605346|NCT01717326|528723648|FG011|Overall Study|Withdrawal by Subject|0|||
146605347|NCT01717326|528723649|FG012|Overall Study|Withdrawal by Subject|1|||
146605348|NCT01717326|528723650|FG013|Overall Study|Withdrawal by Subject|0|||
146605349|NCT01717326|528723651|FG014|Overall Study|Withdrawal by Subject|0|||
146605350|NCT01717326|528723652|FG015|Overall Study|Withdrawal by Subject|1|||
146605351|NCT01717326|528723653|FG016|Overall Study|Withdrawal by Subject|0|||
146605352|NCT01717326|528723654|FG017|Overall Study|Withdrawal by Subject|0|||
146605353|NCT01717326|528723655|FG018|Overall Study|Withdrawal by Subject|2|||
146605354|NCT01717326|528723656|FG019|Overall Study|Withdrawal by Subject|3|||
146605355|NCT01123707|528723657|FG000|Overall Study|Lost to Follow-up|3|||
146605356|NCT01123707|528723658|FG001|Overall Study|Lost to Follow-up|1|||
146605357|NCT01123707|528723659|FG002|Overall Study|Lost to Follow-up|3|||
146605358|NCT01123707|528723660|FG003|Overall Study|Lost to Follow-up|2|||
146605359|NCT01123707|528723657|FG000|Overall Study|Adverse Event|5|||
146605360|NCT01123707|528723658|FG001|Overall Study|Adverse Event|7|||
146605361|NCT01123707|528723659|FG002|Overall Study|Adverse Event|5|||
146605362|NCT01123707|528723660|FG003|Overall Study|Adverse Event|3|||
146605363|NCT01123707|528723657|FG000|Overall Study|Sponsor Discontinued Study|30|||
146605364|NCT01123707|528723658|FG001|Overall Study|Sponsor Discontinued Study|24|||
146605365|NCT01123707|528723659|FG002|Overall Study|Sponsor Discontinued Study|25|||
146605366|NCT01123707|528723660|FG003|Overall Study|Sponsor Discontinued Study|40|||
146605367|NCT01123707|528723657|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
146605368|NCT01123707|528723658|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
146605369|NCT01123707|528723659|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
146605370|NCT01123707|528723660|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
146605371|NCT01123707|528723657|FG000|Overall Study|Investigator Withdrew Participant|0|||
146605372|NCT01123707|528723658|FG001|Overall Study|Investigator Withdrew Participant|1|||
146605373|NCT01123707|528723659|FG002|Overall Study|Investigator Withdrew Participant|1|||
146605374|NCT01123707|528723660|FG003|Overall Study|Investigator Withdrew Participant|1|||
146605375|NCT01123707|528723657|FG000|Overall Study|Subject Withdrew Consent|4|||
146605376|NCT01123707|528723658|FG001|Overall Study|Subject Withdrew Consent|5|||
146605377|NCT01123707|528723659|FG002|Overall Study|Subject Withdrew Consent|1|||
146605378|NCT01123707|528723660|FG003|Overall Study|Subject Withdrew Consent|2|||
146605379|NCT01123707|528723657|FG000|Overall Study|Lack of Efficacy|1|||
146605380|NCT01123707|528723658|FG001|Overall Study|Lack of Efficacy|2|||
146605381|NCT01123707|528723659|FG002|Overall Study|Lack of Efficacy|1|||
146605382|NCT01123707|528723660|FG003|Overall Study|Lack of Efficacy|0|||
146605383|NCT01123707|528723657|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
146605384|NCT01123707|528723658|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
146605385|NCT01123707|528723659|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
146605386|NCT01123707|528723660|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
146605387|NCT03281304|528723661|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
146605388|NCT03281304|528723662|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
146605389|NCT03281304|528723661|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
146605390|NCT03281304|528723662|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
146605391|NCT03281304|528723661|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
146605392|NCT03281304|528723662|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
146605393|NCT03281304|528723661|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
146605394|NCT03281304|528723662|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
146605395|NCT03281304|528723661|FG000|Treatment Phase (up to 42 Months)|Death|0|||
146605396|NCT03281304|528723662|FG001|Treatment Phase (up to 42 Months)|Death|1|||
146605397|NCT03281304|528723661|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
146605398|NCT03281304|528723662|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
146605399|NCT03281304|528723661|FG000|Treatment Phase (up to 42 Months)|Other|0|||
146605400|NCT03281304|528723662|FG001|Treatment Phase (up to 42 Months)|Other|2|||
146605401|NCT03281304|528723661|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
146605402|NCT03281304|528723662|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
146922922|NCT00818207|529878677|FG000|Overall Study|Lost to Follow-up|160|||
146922923|NCT00818207|529878678|FG001|Overall Study|Lost to Follow-up|146|||
146922924|NCT00818207|529878677|FG000|Overall Study|Multiple reasons|11|||
146922925|NCT00818207|529878678|FG001|Overall Study|Multiple reasons|12|||
146978661|NCT01246986|530085454|FG005|Overall Study|Lost to Follow-up|1|||
146605403|NCT01114438|528723663|FG000|Overall Study|Adverse Event|10|||
146605404|NCT01114438|528723663|FG000|Overall Study|concomitant medication|1|||
146605405|NCT01114438|528723663|FG000|Overall Study|Physician Decision|1|||
146605406|NCT01114438|528723663|FG000|Overall Study|Withdrawal by Subject|2|||
146605407|NCT02577016|528723668|FG000|Overall Study|Adverse Event|2|||
146605408|NCT02577016|528723669|FG001|Overall Study|Adverse Event|1|||
146605409|NCT02577016|528723668|FG000|Overall Study|Physician Decision|0|||
146773048|NCT03903822|529338237|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
146773049|NCT03903822|529338238|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
146773050|NCT03903822|529338239|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
146773051|NCT03903822|529338240|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
146773052|NCT03903822|529338241|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
146773053|NCT03903822|529338234|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
146773054|NCT03903822|529338235|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
146773055|NCT03903822|529338236|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
146922926|NCT00818207|529878677|FG000|Overall Study|Withdrawal by Subject|42|||
146605410|NCT02577016|528723669|FG001|Overall Study|Physician Decision|1|||
146605411|NCT00566254|528723670|FG000|Overall Study|Adverse Event|3|||
146605412|NCT00566254|528723671|FG001|Overall Study|Adverse Event|1|||
146605413|NCT00566254|528723670|FG000|Overall Study|Protocol Violation|1|||
146605414|NCT00566254|528723671|FG001|Overall Study|Protocol Violation|3|||
146605415|NCT00566254|528723670|FG000|Overall Study|Withdrawal by Subject|1|||
146605416|NCT00566254|528723671|FG001|Overall Study|Withdrawal by Subject|2|||
146605417|NCT00566254|528723670|FG000|Overall Study|Lack of Efficacy|5|||
146605418|NCT00566254|528723671|FG001|Overall Study|Lack of Efficacy|6|||
146605419|NCT00566254|528723670|FG000|Overall Study|Other|0|||
146605420|NCT00566254|528723671|FG001|Overall Study|Other|2|||
146605421|NCT00687531|528723672|FG000|Overall Study|Did not meet protocol eligibility|104|||
146605422|NCT00687531|528723672|FG000|Overall Study|Adverse Event|5|||
146605423|NCT00687531|528723672|FG000|Overall Study|Lost to Follow-up|26|||
146605424|NCT02301624|528723673|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
146605425|NCT02301624|528723674|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
146605426|NCT02301624|528723673|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
146605427|NCT02301624|528723674|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
146605428|NCT02301624|528723673|FG000|Open-label Maintenance Phase|Adverse Event|2|||
146605429|NCT02301624|528723674|FG001|Open-label Maintenance Phase|Adverse Event|5|||
146605430|NCT02301624|528723673|FG000|Open-label Maintenance Phase|Physician Decision|3|||
146605431|NCT02301624|528723674|FG001|Open-label Maintenance Phase|Physician Decision|3|||
146605432|NCT02301624|528723673|FG000|Open-label Maintenance Phase|Death|2|||
146605433|NCT02301624|528723674|FG001|Open-label Maintenance Phase|Death|1|||
146605434|NCT02301624|528723673|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
146605435|NCT02301624|528723674|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
146605436|NCT03210961|528725554|FG000|Overall Study|Adverse Event|0|||
146605437|NCT03210961|528725555|FG001|Overall Study|Adverse Event|0|||
146605438|NCT03210961|528725556|FG002|Overall Study|Adverse Event|0|||
146605439|NCT03210961|528725557|FG003|Overall Study|Adverse Event|0|||
146605440|NCT03210961|528725558|FG004|Overall Study|Adverse Event|0|||
146605441|NCT03210961|528725559|FG005|Overall Study|Adverse Event|0|||
146605442|NCT03210961|528725560|FG006|Overall Study|Adverse Event|0|||
146605443|NCT03210961|528725561|FG007|Overall Study|Adverse Event|0|||
146605444|NCT03210961|528725562|FG008|Overall Study|Adverse Event|0|||
146605445|NCT03210961|528725563|FG009|Overall Study|Adverse Event|0|||
146605446|NCT03210961|528725564|FG010|Overall Study|Adverse Event|0|||
146605447|NCT03210961|528725565|FG011|Overall Study|Adverse Event|0|||
146605448|NCT03210961|528725566|FG012|Overall Study|Adverse Event|0|||
146605449|NCT03210961|528725567|FG013|Overall Study|Adverse Event|1|||
146605450|NCT03210961|528725568|FG014|Overall Study|Adverse Event|0|||
146605451|NCT03210961|528725554|FG000|Overall Study|Lost to Follow-up|0|||
146605452|NCT03210961|528725555|FG001|Overall Study|Lost to Follow-up|0|||
146605453|NCT03210961|528725556|FG002|Overall Study|Lost to Follow-up|0|||
146605454|NCT03210961|528725557|FG003|Overall Study|Lost to Follow-up|0|||
146605455|NCT03210961|528725558|FG004|Overall Study|Lost to Follow-up|0|||
146605456|NCT03210961|528725559|FG005|Overall Study|Lost to Follow-up|0|||
146605457|NCT03210961|528725560|FG006|Overall Study|Lost to Follow-up|0|||
146605458|NCT03210961|528725561|FG007|Overall Study|Lost to Follow-up|0|||
146605459|NCT03210961|528725562|FG008|Overall Study|Lost to Follow-up|0|||
146605460|NCT03210961|528725563|FG009|Overall Study|Lost to Follow-up|0|||
146605461|NCT03210961|528725564|FG010|Overall Study|Lost to Follow-up|0|||
146605462|NCT03210961|528725565|FG011|Overall Study|Lost to Follow-up|0|||
146605463|NCT03210961|528725566|FG012|Overall Study|Lost to Follow-up|0|||
146605464|NCT03210961|528725567|FG013|Overall Study|Lost to Follow-up|0|||
146605465|NCT03210961|528725568|FG014|Overall Study|Lost to Follow-up|1|||
146605466|NCT03210961|528725554|FG000|Overall Study|Withdrawal by Subject|0|||
146922927|NCT00818207|529878678|FG001|Overall Study|Withdrawal by Subject|104|||
146605467|NCT03210961|528725555|FG001|Overall Study|Withdrawal by Subject|0|||
146605468|NCT03210961|528725556|FG002|Overall Study|Withdrawal by Subject|0|||
146605469|NCT03210961|528725557|FG003|Overall Study|Withdrawal by Subject|0|||
146605470|NCT03210961|528725558|FG004|Overall Study|Withdrawal by Subject|0|||
146605471|NCT03210961|528725559|FG005|Overall Study|Withdrawal by Subject|0|||
146605472|NCT03210961|528725560|FG006|Overall Study|Withdrawal by Subject|0|||
146605473|NCT03210961|528725561|FG007|Overall Study|Withdrawal by Subject|0|||
146605474|NCT03210961|528725562|FG008|Overall Study|Withdrawal by Subject|0|||
146605475|NCT03210961|528725563|FG009|Overall Study|Withdrawal by Subject|0|||
146605476|NCT03210961|528725564|FG010|Overall Study|Withdrawal by Subject|0|||
146605477|NCT03210961|528725565|FG011|Overall Study|Withdrawal by Subject|0|||
146605478|NCT03210961|528725566|FG012|Overall Study|Withdrawal by Subject|0|||
146605479|NCT03210961|528725567|FG013|Overall Study|Withdrawal by Subject|0|||
146605480|NCT03210961|528725568|FG014|Overall Study|Withdrawal by Subject|1|||
146605481|NCT03210961|528725554|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
146605482|NCT03210961|528725555|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146605483|NCT03210961|528725556|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
146605484|NCT03210961|528725557|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
146605485|NCT03210961|528725558|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
146605486|NCT03210961|528725559|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
146605487|NCT03210961|528725560|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
146605488|NCT03210961|528725561|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
146605489|NCT03210961|528725562|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
146605490|NCT03210961|528725563|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
146605491|NCT03210961|528725564|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
146605492|NCT03210961|528725565|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
146605493|NCT03210961|528725566|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
146605494|NCT03210961|528725567|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
146605495|NCT03210961|528725568|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
146605496|NCT03210961|528725554|FG000|Overall Study|Other|0|||
146605497|NCT03210961|528725555|FG001|Overall Study|Other|0|||
146605498|NCT03210961|528725556|FG002|Overall Study|Other|0|||
146605499|NCT03210961|528725557|FG003|Overall Study|Other|1|||
146605500|NCT03210961|528725558|FG004|Overall Study|Other|0|||
146605501|NCT03210961|528725559|FG005|Overall Study|Other|0|||
146605502|NCT03210961|528725560|FG006|Overall Study|Other|1|||
146605503|NCT03210961|528725561|FG007|Overall Study|Other|0|||
146605504|NCT03210961|528725562|FG008|Overall Study|Other|0|||
146605505|NCT03210961|528725563|FG009|Overall Study|Other|0|||
146605506|NCT03210961|528725564|FG010|Overall Study|Other|1|||
146605507|NCT03210961|528725565|FG011|Overall Study|Other|0|||
146605508|NCT03210961|528725566|FG012|Overall Study|Other|2|||
146605509|NCT03210961|528725567|FG013|Overall Study|Other|2|||
146605510|NCT03210961|528725568|FG014|Overall Study|Other|0|||
146605511|NCT02467582|528725569|FG000|Allocation|Withdrawal by Subject|1|||
146605512|NCT02467582|528725570|FG001|Allocation|Withdrawal by Subject|0|||
146605513|NCT02467582|528725569|FG000|Follow-up|Death|5|||
146605514|NCT02467582|528725570|FG001|Follow-up|Death|4|||
146605515|NCT02467582|528725569|FG000|Follow-up|Lost to Follow-up|6|||
146605516|NCT02467582|528725570|FG001|Follow-up|Lost to Follow-up|5|||
146605517|NCT00703924|528725571|FG000|Overall Study|Withdrawal by Subject|1|||
146605518|NCT00703924|528725572|FG001|Overall Study|Withdrawal by Subject|1|||
146605519|NCT01031979|528725575|FG000|Overall Study|Lost to Follow-up|5|||
146605520|NCT01031979|528725576|FG001|Overall Study|Lost to Follow-up|4|||
146605521|NCT03592368|528725578|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
146605522|NCT03592368|528725579|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
146605523|NCT03592368|528725580|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
146605524|NCT03592368|528725581|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
146605525|NCT03592368|528725578|FG000|Overall Study|Adverse Event|0|||
146605526|NCT03592368|528725579|FG001|Overall Study|Adverse Event|0|||
146605527|NCT03592368|528725580|FG002|Overall Study|Adverse Event|0|||
146605528|NCT03592368|528725581|FG003|Overall Study|Adverse Event|1|||
146605529|NCT03592368|528725578|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
146605530|NCT03592368|528725579|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
146605531|NCT03592368|528725580|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
146605532|NCT03592368|528725581|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
146605533|NCT03354273|528725589|FG000|Overall Study|Adverse Event|5|||
146605534|NCT03354273|528725589|FG000|Overall Study|Screen Failure|21|||
146605535|NCT03354273|528725589|FG000|Overall Study|Withdrawal by Subject|34|||
146605536|NCT03354273|528725589|FG000|Overall Study|Technical Problems|30|||
146605537|NCT03354273|528725589|FG000|Overall Study|Lost to Follow-up|4|||
146922928|NCT00818207|529878677|FG000|Overall Study|Death|3|||
146605538|NCT03354273|528725589|FG000|Overall Study|Investigator Decision|3|||
146605539|NCT03354273|528725589|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
146605540|NCT03354273|528725589|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
146605541|NCT03354273|528725589|FG000|Overall Study|COVID-19 Restrictions|9|||
146605542|NCT03354273|528725589|FG000|Overall Study|Other|5|||
146605543|NCT01971008|528725590|FG000|Overall Study|Protocol Violation|2|||
146605544|NCT01971008|528725591|FG001|Overall Study|Protocol Violation|1|||
146605545|NCT03775512|528725592|FG000|Overall Study|Death|1|||
146605546|NCT03775512|528725593|FG001|Overall Study|Death|1|||
146605547|NCT03775512|528725592|FG000|Overall Study|Withdrawal by Subject|7|||
146605548|NCT03775512|528725593|FG001|Overall Study|Withdrawal by Subject|4|||
146605549|NCT03775512|528725592|FG000|Overall Study|Lost to Follow-up|5|||
146605550|NCT03775512|528725593|FG001|Overall Study|Lost to Follow-up|5|||
146605551|NCT03775512|528725592|FG000|Overall Study|Excluded before Catheter insertion|14|||
146605552|NCT03775512|528725593|FG001|Overall Study|Excluded before Catheter insertion|5|||
146605553|NCT03775512|528725592|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
146605554|NCT03775512|528725593|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
146605555|NCT03775512|528725592|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
146605556|NCT03775512|528725593|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
146605557|NCT00705367|528725596|FG000|Long-term Extension Period|Adverse Event|2|||
146605558|NCT00705367|528725597|FG001|Long-term Extension Period|Adverse Event|0|||
146605559|NCT00705367|528725596|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
146605560|NCT00705367|528725597|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
146605561|NCT00705367|528725596|FG000|Long-term Extension Period|Lack of Efficacy|1|||
146605562|NCT00705367|528725597|FG001|Long-term Extension Period|Lack of Efficacy|0|||
146605563|NCT00705367|528725596|FG000|Long-term Extension Period|No longer met study criteria|1|||
146605564|NCT00705367|528725597|FG001|Long-term Extension Period|No longer met study criteria|0|||
146605565|NCT00705367|528725596|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
146605566|NCT00705367|528725597|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
146605567|NCT01959139|528725601|FG000|Phase II|Disease progression|0|||
146605568|NCT01959139|528725602|FG001|Phase II|Disease progression|0|||
146605569|NCT01959139|528725603|FG002|Phase II|Disease progression|26|||
146605570|NCT01959139|528725604|FG003|Phase II|Disease progression|34|||
146605571|NCT01959139|528725601|FG000|Phase II|Adverse Event|0|||
146605572|NCT01959139|528725602|FG001|Phase II|Adverse Event|0|||
146605573|NCT01959139|528725603|FG002|Phase II|Adverse Event|10|||
146605574|NCT01959139|528725604|FG003|Phase II|Adverse Event|11|||
146605575|NCT01959139|528725601|FG000|Phase II|Patient Refusal|0|||
146605576|NCT01959139|528725602|FG001|Phase II|Patient Refusal|0|||
146605577|NCT01959139|528725603|FG002|Phase II|Patient Refusal|5|||
146605578|NCT01959139|528725604|FG003|Phase II|Patient Refusal|4|||
146605579|NCT01959139|528725601|FG000|Phase II|Death|0|||
146605580|NCT01959139|528725602|FG001|Phase II|Death|0|||
146605581|NCT01959139|528725603|FG002|Phase II|Death|3|||
146605582|NCT01959139|528725604|FG003|Phase II|Death|1|||
146605583|NCT01959139|528725601|FG000|Phase II|Other/Unknown|0|||
146605584|NCT01959139|528725602|FG001|Phase II|Other/Unknown|0|||
146605585|NCT01959139|528725603|FG002|Phase II|Other/Unknown|8|||
146605586|NCT01959139|528725604|FG003|Phase II|Other/Unknown|5|||
146605587|NCT01959139|528725601|FG000|Phase II|On treatment|0|||
146605588|NCT01959139|528725602|FG001|Phase II|On treatment|0|||
146605589|NCT01959139|528725603|FG002|Phase II|On treatment|4|||
146605590|NCT01959139|528725604|FG003|Phase II|On treatment|0|||
146605591|NCT02629822|528725605|FG000|Base Study|Lost to Follow-up|2|||
146605592|NCT02629822|528725605|FG000|Base Study|Non-Compliance With Study Drug|1|||
146605593|NCT02629822|528725605|FG000|Extension Study|Adverse Event|1|||
146605594|NCT02629822|528725605|FG000|Extension Study|Lost to Follow-up|1|||
146605595|NCT03679624|528725606|FG000|Overall Study|Adverse Event|1|||
146605596|NCT03679624|528725607|FG001|Overall Study|Adverse Event|0|||
146605597|NCT00741013|528725608|FG000|Overall Study|Adverse Event|1|||
146605598|NCT00741013|528725609|FG001|Overall Study|Adverse Event|0|||
146605599|NCT00741013|528725610|FG002|Overall Study|Adverse Event|0|||
146605600|NCT00741013|528725608|FG000|Overall Study|Withdrawal by Subject|0|||
146605601|NCT00741013|528725609|FG001|Overall Study|Withdrawal by Subject|0|||
146605602|NCT00741013|528725610|FG002|Overall Study|Withdrawal by Subject|1|||
146605603|NCT00741013|528725608|FG000|Overall Study|Discovered failed screen after enrolled|0|||
146605604|NCT00741013|528725609|FG001|Overall Study|Discovered failed screen after enrolled|2|||
146605605|NCT00741013|528725610|FG002|Overall Study|Discovered failed screen after enrolled|0|||
146605606|NCT00082407|528725611|FG000|Overall Study|Adverse Event|20|||
146605607|NCT00082407|528725612|FG001|Overall Study|Adverse Event|0|||
146605608|NCT00082407|528725611|FG000|Overall Study|Protocol Violation|14|||
146605609|NCT00082407|528725612|FG001|Overall Study|Protocol Violation|12|||
146605610|NCT00082407|528725611|FG000|Overall Study|Patient Decision|13|||
146605611|NCT00082407|528725612|FG001|Overall Study|Patient Decision|6|||
146605612|NCT00082407|528725611|FG000|Overall Study|Physician Decision|5|||
146605613|NCT00082407|528725612|FG001|Overall Study|Physician Decision|3|||
146605614|NCT00082407|528725611|FG000|Overall Study|Loss of Glucose Control|2|||
146605615|NCT00082407|528725612|FG001|Overall Study|Loss of Glucose Control|2|||
146605616|NCT00082407|528725611|FG000|Overall Study|Death|2|||
146605617|NCT00082407|528725612|FG001|Overall Study|Death|1|||
146605618|NCT00082407|528725611|FG000|Overall Study|Lost to Follow-up|0|||
146605619|NCT00082407|528725612|FG001|Overall Study|Lost to Follow-up|3|||
146605620|NCT00858208|528725613|FG000|Overall Study|Adverse Event|3|||
146605621|NCT00858208|528725613|FG000|Overall Study|Lost to Follow-up|26|||
146605622|NCT00858208|528725613|FG000|Overall Study|Participant refused|40|||
146605623|NCT00858208|528725613|FG000|Overall Study|Other|10|||
146605624|NCT02352753|528725614|FG000|6-Month Dosing Period|Decision by sponsor|2|||
146605625|NCT02352753|528725614|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
146605626|NCT02352753|528725614|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
146605627|NCT02352753|528725614|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
146605628|NCT02352753|528725614|FG000|3-Month Dosing Period|Decision by sponsor|14|||
146605629|NCT02352753|528725614|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
146605630|NCT00539305|528725615|FG000|Overall Study|Adverse Event|1|||
146605631|NCT00539305|528725616|FG001|Overall Study|Adverse Event|0|||
146605632|NCT00539305|528725615|FG000|Overall Study|Substance Use|0|||
146605633|NCT00539305|528725616|FG001|Overall Study|Substance Use|1|||
146605634|NCT00539305|528725615|FG000|Overall Study|Withdrawal by Subject|0|||
146605635|NCT00539305|528725616|FG001|Overall Study|Withdrawal by Subject|1|||
146605636|NCT01440816|528725619|FG000|Overall Study|Disease Progression|0|||
146605637|NCT01440816|528725620|FG001|Overall Study|Disease Progression|9|||
146605638|NCT01440816|528725619|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
146605639|NCT01440816|528725620|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
146605640|NCT04302545|528725623|FG000|Overall Study|Lost to Follow-up|3|||
146605641|NCT04302545|528725624|FG001|Overall Study|Lost to Follow-up|4|||
146605642|NCT02516592|528725625|FG000|Overall Study|Patient withdrew consent|5|||
146605643|NCT02516592|528725626|FG001|Overall Study|Patient withdrew consent|2|||
146605644|NCT02516592|528725625|FG000|Overall Study|Protocol deviation|4|||
146605645|NCT02516592|528725626|FG001|Overall Study|Protocol deviation|4|||
146605646|NCT02516592|528725625|FG000|Overall Study|Lost to Follow-up|2|||
146605647|NCT02516592|528725626|FG001|Overall Study|Lost to Follow-up|3|||
146605648|NCT02516592|528725625|FG000|Overall Study|Patient/guardian decision|2|||
146605649|NCT02516592|528725626|FG001|Overall Study|Patient/guardian decision|1|||
146605650|NCT02516592|528725625|FG000|Overall Study|Adverse Event|1|||
146605651|NCT02516592|528725626|FG001|Overall Study|Adverse Event|2|||
146605652|NCT02516592|528725625|FG000|Overall Study|Abnormal test procedure result|1|||
146605653|NCT02516592|528725626|FG001|Overall Study|Abnormal test procedure result|0|||
146605654|NCT02516592|528725625|FG000|Overall Study|Death|1|||
146605655|NCT02516592|528725626|FG001|Overall Study|Death|1|||
146605656|NCT03068754|528725627|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
146605657|NCT03068754|528725628|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
146605658|NCT03068754|528725629|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
146605659|NCT03068754|528725630|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
146605660|NCT03068754|528725627|FG000|Randomized Treatment Period (RTP)|Death|2|||
146605661|NCT03068754|528725628|FG001|Randomized Treatment Period (RTP)|Death|2|||
146605662|NCT03068754|528725629|FG002|Randomized Treatment Period (RTP)|Death|0|||
146605663|NCT03068754|528725630|FG003|Randomized Treatment Period (RTP)|Death|0|||
146605664|NCT03068754|528725627|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
146605665|NCT03068754|528725628|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
146605666|NCT03068754|528725629|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
146605667|NCT03068754|528725630|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
146605668|NCT03068754|528725627|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
146605669|NCT03068754|528725628|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
146605670|NCT03068754|528725629|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
146605671|NCT03068754|528725630|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
146605672|NCT03068754|528725627|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
146605673|NCT03068754|528725628|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
146605674|NCT03068754|528725629|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
146605675|NCT03068754|528725630|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
146656974|NCT03868124|528921647|FG002|Overall Study|Physician Decision|1|||
146656975|NCT03868124|528921645|FG000|Overall Study|Lost to Follow-up|1|||
146656976|NCT03868124|528921646|FG001|Overall Study|Lost to Follow-up|1|||
146656977|NCT03868124|528921647|FG002|Overall Study|Lost to Follow-up|2|||
146656978|NCT03868124|528921645|FG000|Overall Study|Death|1|||
146656979|NCT03868124|528921646|FG001|Overall Study|Death|1|||
146656980|NCT03868124|528921647|FG002|Overall Study|Death|2|||
146656981|NCT03868124|528921645|FG000|Overall Study|Adverse Event|0|||
146656982|NCT03868124|528921646|FG001|Overall Study|Adverse Event|0|||
146656983|NCT03868124|528921647|FG002|Overall Study|Adverse Event|3|||
146656984|NCT03868124|528921645|FG000|Overall Study|Explanted|2|||
146605676|NCT03068754|528725627|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
146656985|NCT03868124|528921646|FG001|Overall Study|Explanted|1|||
146605677|NCT03068754|528725628|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
146605678|NCT03068754|528725629|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
146605679|NCT03068754|528725630|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
146605680|NCT03068754|528725627|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
146605681|NCT03068754|528725628|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
146605682|NCT03068754|528725629|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
146656986|NCT03868124|528921647|FG002|Overall Study|Explanted|0|||
146656987|NCT03868124|528921645|FG000|Overall Study|Ongoing in study|176|||
146656988|NCT03868124|528921646|FG001|Overall Study|Ongoing in study|180|||
146656989|NCT03868124|528921647|FG002|Overall Study|Ongoing in study|183|||
146605683|NCT03068754|528725630|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
146605684|NCT03068754|528725627|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
146605685|NCT03068754|528725628|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
146605686|NCT03068754|528725629|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
146605687|NCT03068754|528725630|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
146605688|NCT03068754|528725627|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
146605689|NCT03068754|528725628|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
146605690|NCT03068754|528725629|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
146605691|NCT03068754|528725630|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
146605692|NCT03068754|528725627|FG000|Open Label Extension Period (OLE)|Death|0|||
146605693|NCT03068754|528725628|FG001|Open Label Extension Period (OLE)|Death|0|||
146605694|NCT03068754|528725629|FG002|Open Label Extension Period (OLE)|Death|0|||
146605695|NCT03068754|528725630|FG003|Open Label Extension Period (OLE)|Death|1|||
146605696|NCT03068754|528725627|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
146605697|NCT03068754|528725628|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
146605698|NCT03068754|528725629|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
146605699|NCT03068754|528725630|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
146605700|NCT03068754|528725627|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
146605701|NCT03068754|528725628|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
146605702|NCT03068754|528725629|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
146605703|NCT03068754|528725630|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
146605704|NCT03068754|528725627|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
146605705|NCT03068754|528725628|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
146605706|NCT03068754|528725629|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
146605707|NCT03068754|528725630|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
146605708|NCT03068754|528725627|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
146605709|NCT03068754|528725628|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
146605710|NCT03068754|528725629|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
146605711|NCT03068754|528725630|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
146605712|NCT01110382|528725631|FG000|Overall Study|Withdrawal by Subject|0|||
146605713|NCT01110382|528725632|FG001|Overall Study|Withdrawal by Subject|1|||
146605714|NCT01110382|528725631|FG000|Overall Study|Protocol Violation|0|||
146605715|NCT01110382|528725632|FG001|Overall Study|Protocol Violation|1|||
146605716|NCT00077649|528725633|FG000|Overall Study|Adverse Event|5|||
146605717|NCT00077649|528725634|FG001|Overall Study|Adverse Event|1|||
146605718|NCT00077649|528725635|FG002|Overall Study|Adverse Event|7|||
146605719|NCT00077649|528725636|FG003|Overall Study|Adverse Event|9|||
146605720|NCT00077649|528725633|FG000|Overall Study|Lack of Efficacy|5|||
146605721|NCT00077649|528725634|FG001|Overall Study|Lack of Efficacy|3|||
146605722|NCT00077649|528725635|FG002|Overall Study|Lack of Efficacy|3|||
146605723|NCT00077649|528725636|FG003|Overall Study|Lack of Efficacy|2|||
146605724|NCT00077649|528725633|FG000|Overall Study|Withdrawal by Subject|0|||
146605725|NCT00077649|528725634|FG001|Overall Study|Withdrawal by Subject|1|||
146605726|NCT00077649|528725635|FG002|Overall Study|Withdrawal by Subject|1|||
146605727|NCT00077649|528725636|FG003|Overall Study|Withdrawal by Subject|2|||
146605728|NCT00077649|528725633|FG000|Overall Study|Lost to Follow-up|2|||
146605729|NCT00077649|528725634|FG001|Overall Study|Lost to Follow-up|2|||
146605730|NCT00077649|528725635|FG002|Overall Study|Lost to Follow-up|3|||
146605731|NCT00077649|528725636|FG003|Overall Study|Lost to Follow-up|2|||
146605732|NCT00077649|528725633|FG000|Overall Study|Abnormality of Laboratory Test|1|||
146605733|NCT00077649|528725634|FG001|Overall Study|Abnormality of Laboratory Test|2|||
146605734|NCT00077649|528725635|FG002|Overall Study|Abnormality of Laboratory Test|1|||
146605735|NCT00077649|528725636|FG003|Overall Study|Abnormality of Laboratory Test|2|||
146605736|NCT00077649|528725633|FG000|Overall Study|Randomized but never dosed|1|||
146605737|NCT00077649|528725634|FG001|Overall Study|Randomized but never dosed|0|||
146605738|NCT00077649|528725635|FG002|Overall Study|Randomized but never dosed|0|||
146605739|NCT00077649|528725636|FG003|Overall Study|Randomized but never dosed|0|||
146605740|NCT00590577|528725639|FG000|Overall Study|Lack of Efficacy|31|||
146605741|NCT00590577|528725640|FG001|Overall Study|Lack of Efficacy|28|||
146605742|NCT00590577|528725641|FG002|Overall Study|Lack of Efficacy|23|||
146605743|NCT00590577|528725642|FG003|Overall Study|Lack of Efficacy|45|||
146605744|NCT00590577|528725639|FG000|Overall Study|Withdrawal by Subject|23|||
146605745|NCT00590577|528725640|FG001|Overall Study|Withdrawal by Subject|28|||
146605746|NCT00590577|528725641|FG002|Overall Study|Withdrawal by Subject|30|||
146605747|NCT00590577|528725642|FG003|Overall Study|Withdrawal by Subject|26|||
146605748|NCT00590577|528725639|FG000|Overall Study|Adverse Event|10|||
146605749|NCT00590577|528725640|FG001|Overall Study|Adverse Event|10|||
146605750|NCT00590577|528725641|FG002|Overall Study|Adverse Event|13|||
146605751|NCT00590577|528725642|FG003|Overall Study|Adverse Event|11|||
146605752|NCT00590577|528725639|FG000|Overall Study|Lost to Follow-up|12|||
146605753|NCT00590577|528725640|FG001|Overall Study|Lost to Follow-up|6|||
146605754|NCT00590577|528725641|FG002|Overall Study|Lost to Follow-up|6|||
146605755|NCT00590577|528725642|FG003|Overall Study|Lost to Follow-up|9|||
146605756|NCT00590577|528725639|FG000|Overall Study|Pregnancy|0|||
146605757|NCT00590577|528725640|FG001|Overall Study|Pregnancy|1|||
146605758|NCT00590577|528725641|FG002|Overall Study|Pregnancy|0|||
146605759|NCT00590577|528725642|FG003|Overall Study|Pregnancy|0|||
146605760|NCT00590577|528725639|FG000|Overall Study|Various reasons|1|||
146605761|NCT00590577|528725640|FG001|Overall Study|Various reasons|3|||
146605762|NCT00590577|528725641|FG002|Overall Study|Various reasons|1|||
146605763|NCT00590577|528725642|FG003|Overall Study|Various reasons|2|||
146605764|NCT01300260|528725643|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
146605765|NCT01300260|528725644|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
146605766|NCT01300260|528725643|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
146605767|NCT01300260|528725644|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
146605768|NCT01300260|528725643|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
146605769|NCT01300260|528725644|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
146605770|NCT00235716|528725654|FG000|Overall Study|Death|26|||
146605771|NCT00235716|528725655|FG001|Overall Study|Death|39|||
146605772|NCT00235716|528725656|FG002|Overall Study|Death|32|||
146605773|NCT00235716|528725657|FG003|Overall Study|Death|31|||
146605774|NCT00235716|528725654|FG000|Overall Study|Withdrawal by Subject|23|||
146605775|NCT00235716|528725655|FG001|Overall Study|Withdrawal by Subject|19|||
146605776|NCT00235716|528725656|FG002|Overall Study|Withdrawal by Subject|17|||
146605777|NCT00235716|528725657|FG003|Overall Study|Withdrawal by Subject|18|||
146605778|NCT00235716|528725654|FG000|Overall Study|Lost to Follow-up|12|||
146605779|NCT00235716|528725655|FG001|Overall Study|Lost to Follow-up|7|||
146605780|NCT00235716|528725656|FG002|Overall Study|Lost to Follow-up|14|||
146605781|NCT00235716|528725657|FG003|Overall Study|Lost to Follow-up|10|||
146605782|NCT00235716|528725654|FG000|Overall Study|Adverse Event|1|||
146605783|NCT00235716|528725655|FG001|Overall Study|Adverse Event|1|||
146605784|NCT00235716|528725656|FG002|Overall Study|Adverse Event|1|||
146605785|NCT00235716|528725657|FG003|Overall Study|Adverse Event|0|||
146605786|NCT00235716|528725654|FG000|Overall Study|Physician Decision|0|||
146605787|NCT00235716|528725655|FG001|Overall Study|Physician Decision|1|||
146605788|NCT00235716|528725656|FG002|Overall Study|Physician Decision|1|||
146605789|NCT00235716|528725657|FG003|Overall Study|Physician Decision|3|||
146605790|NCT03238924|528725658|FG000|Overall Study|Withdrawal by Subject|2|||
146605791|NCT03238924|528725659|FG001|Overall Study|Withdrawal by Subject|2|||
146605792|NCT03576716|528725660|FG000|Overall Study|Withdrawal by Subject|0|||
146605793|NCT03576716|528725661|FG001|Overall Study|Withdrawal by Subject|1|||
146605794|NCT00559988|528725662|FG000|Overall Study|Death|147|||
146605795|NCT00559988|528725663|FG001|Overall Study|Death|140|||
146605796|NCT00559988|528725662|FG000|Overall Study|Withdrawal by Subject|152|||
146605797|NCT00559988|528725663|FG001|Overall Study|Withdrawal by Subject|139|||
146605798|NCT00559988|528725662|FG000|Overall Study|Lost to Follow-up|42|||
146605799|NCT00559988|528725663|FG001|Overall Study|Lost to Follow-up|56|||
146605800|NCT00559988|528725662|FG000|Overall Study|ICD device explanted|10|||
146605801|NCT00559988|528725663|FG001|Overall Study|ICD device explanted|17|||
146605802|NCT02891382|528725664|FG000|Overall Study|Lost to Follow-up|3|||
146605803|NCT02891382|528725665|FG001|Overall Study|Lost to Follow-up|4|||
146605804|NCT02891382|528725666|FG002|Overall Study|Lost to Follow-up|5|||
146605805|NCT02891382|528725667|FG003|Overall Study|Lost to Follow-up|3|||
146605806|NCT02891382|528725668|FG004|Overall Study|Lost to Follow-up|4|||
146605807|NCT01455194|528725669|FG000|Overall Study|Screen Failure|20|||
146605808|NCT01455194|528725670|FG001|Overall Study|Screen Failure|0|||
146605809|NCT01455194|528725671|FG002|Overall Study|Screen Failure|0|||
146605810|NCT01455194|528725672|FG003|Overall Study|Screen Failure|0|||
146605811|NCT01455194|528725669|FG000|Overall Study|Randomisation Failure|90|||
146605812|NCT01455194|528725670|FG001|Overall Study|Randomisation Failure|0|||
146605813|NCT01455194|528725671|FG002|Overall Study|Randomisation Failure|0|||
146605814|NCT01455194|528725672|FG003|Overall Study|Randomisation Failure|0|||
146605815|NCT01455194|528725669|FG000|Overall Study|Deterioration in asthma|12|||
146605816|NCT01455194|528725670|FG001|Overall Study|Deterioration in asthma|6|||
146605817|NCT01455194|528725671|FG002|Overall Study|Deterioration in asthma|14|||
146605818|NCT01455194|528725672|FG003|Overall Study|Deterioration in asthma|9|||
146605819|NCT01455194|528725669|FG000|Overall Study|Adverse Event|1|||
146605820|NCT01455194|528725670|FG001|Overall Study|Adverse Event|1|||
146605821|NCT01455194|528725671|FG002|Overall Study|Adverse Event|1|||
146605822|NCT01455194|528725672|FG003|Overall Study|Adverse Event|3|||
146605823|NCT01455194|528725669|FG000|Overall Study|Withdrawal by Subject|21|||
146605824|NCT01455194|528725670|FG001|Overall Study|Withdrawal by Subject|16|||
146605825|NCT01455194|528725671|FG002|Overall Study|Withdrawal by Subject|12|||
146605826|NCT01455194|528725672|FG003|Overall Study|Withdrawal by Subject|9|||
146605827|NCT01455194|528725669|FG000|Overall Study|Lost to Follow-up|2|||
146605828|NCT01455194|528725670|FG001|Overall Study|Lost to Follow-up|0|||
146605829|NCT01455194|528725671|FG002|Overall Study|Lost to Follow-up|1|||
146605830|NCT01455194|528725672|FG003|Overall Study|Lost to Follow-up|1|||
146605831|NCT01455194|528725669|FG000|Overall Study|Pregnancy|0|||
146605832|NCT01455194|528725670|FG001|Overall Study|Pregnancy|1|||
146605833|NCT01455194|528725671|FG002|Overall Study|Pregnancy|1|||
146656990|NCT03981822|528921648|FG000|Overall Study|Lost to Follow-up|0|||
146656991|NCT03981822|528921649|FG001|Overall Study|Lost to Follow-up|1|||
146656992|NCT03981822|528921650|FG002|Overall Study|Lost to Follow-up|1|||
146656993|NCT03981822|528921651|FG003|Overall Study|Lost to Follow-up|0|||
146605834|NCT01455194|528725672|FG003|Overall Study|Pregnancy|0|||
146605835|NCT01455194|528725669|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
146605836|NCT01455194|528725670|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
146605837|NCT01455194|528725671|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
146605838|NCT01455194|528725672|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
146605839|NCT01455194|528725669|FG000|Overall Study|Miscellaneous|4|||
146605840|NCT01455194|528725670|FG001|Overall Study|Miscellaneous|5|||
146605841|NCT01455194|528725671|FG002|Overall Study|Miscellaneous|1|||
146605842|NCT01455194|528725672|FG003|Overall Study|Miscellaneous|4|||
146605843|NCT02516228|528725673|FG000|Overall Study|Lost to Follow-up|1|||
146605844|NCT02516228|528725673|FG000|Overall Study|Withdrawal by Subject|1|||
146605845|NCT02516228|528725673|FG000|Overall Study|Physician Decision|1|||
146605846|NCT03916484|528725674|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
146605847|NCT03916484|528725675|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
146605848|NCT03916484|528725676|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
146605849|NCT03916484|528725677|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
146605850|NCT03916484|528725674|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
146605851|NCT03916484|528725675|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
146605852|NCT03916484|528725676|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
146605853|NCT03916484|528725677|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
146605854|NCT00788710|528725678|FG000|Overall Study|Adverse Event|1|||
146605855|NCT00788710|528725679|FG001|Overall Study|Adverse Event|3|||
146605856|NCT00788710|528725680|FG002|Overall Study|Adverse Event|4|||
146605857|NCT00788710|528725678|FG000|Overall Study|Lack of Efficacy|0|||
146605858|NCT00788710|528725679|FG001|Overall Study|Lack of Efficacy|0|||
146605859|NCT00788710|528725680|FG002|Overall Study|Lack of Efficacy|1|||
146605860|NCT00788710|528725678|FG000|Overall Study|Lost to Follow-up|0|||
146605861|NCT00788710|528725679|FG001|Overall Study|Lost to Follow-up|1|||
146605862|NCT00788710|528725680|FG002|Overall Study|Lost to Follow-up|0|||
146605863|NCT00788710|528725678|FG000|Overall Study|Physician Decision|2|||
146605864|NCT00788710|528725679|FG001|Overall Study|Physician Decision|1|||
146605865|NCT00788710|528725680|FG002|Overall Study|Physician Decision|0|||
146605866|NCT00788710|528725678|FG000|Overall Study|Protocol Violation|0|||
146605867|NCT00788710|528725679|FG001|Overall Study|Protocol Violation|1|||
146605868|NCT00788710|528725680|FG002|Overall Study|Protocol Violation|1|||
146605869|NCT00788710|528725678|FG000|Overall Study|Withdrawal by Subject|2|||
146605870|NCT00788710|528725679|FG001|Overall Study|Withdrawal by Subject|2|||
146605871|NCT00788710|528725680|FG002|Overall Study|Withdrawal by Subject|0|||
146605872|NCT01990859|528725683|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
146605873|NCT01990859|528725683|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
146605874|NCT02262754|528725684|FG000|Overall Study|Adverse Event|3|||
146605875|NCT02262754|528725685|FG001|Overall Study|Adverse Event|4|||
146605876|NCT02262754|528725686|FG002|Overall Study|Adverse Event|0|||
146605877|NCT02262754|528725684|FG000|Overall Study|Lack of Efficacy|2|||
146605878|NCT02262754|528725685|FG001|Overall Study|Lack of Efficacy|0|||
146656994|NCT03981822|528921652|FG004|Overall Study|Lost to Follow-up|6|||
146656995|NCT03981822|528921653|FG005|Overall Study|Lost to Follow-up|4|||
146605879|NCT02262754|528725686|FG002|Overall Study|Lack of Efficacy|1|||
146605880|NCT02262754|528725684|FG000|Overall Study|Lost to Follow-up|0|||
146605881|NCT02262754|528725685|FG001|Overall Study|Lost to Follow-up|0|||
146605882|NCT02262754|528725686|FG002|Overall Study|Lost to Follow-up|1|||
146605883|NCT02262754|528725684|FG000|Overall Study|No longer meets eligibility criteria|0|||
146605884|NCT02262754|528725685|FG001|Overall Study|No longer meets eligibility criteria|1|||
146605885|NCT02262754|528725686|FG002|Overall Study|No longer meets eligibility criteria|0|||
146605886|NCT02262754|528725684|FG000|Overall Study|Study terminated by sponsor|5|||
146605887|NCT02262754|528725685|FG001|Overall Study|Study terminated by sponsor|4|||
146605888|NCT02262754|528725686|FG002|Overall Study|Study terminated by sponsor|4|||
146605889|NCT02262754|528725684|FG000|Overall Study|Protocol Violation|1|||
146605890|NCT02262754|528725685|FG001|Overall Study|Protocol Violation|0|||
146605891|NCT02262754|528725686|FG002|Overall Study|Protocol Violation|0|||
146605892|NCT02262754|528725684|FG000|Overall Study|Withdrawal by Subject|1|||
146605893|NCT02262754|528725685|FG001|Overall Study|Withdrawal by Subject|0|||
146605894|NCT02262754|528725686|FG002|Overall Study|Withdrawal by Subject|1|||
146605895|NCT02262754|528725684|FG000|Overall Study|Other|4|||
146605896|NCT02262754|528725685|FG001|Overall Study|Other|0|||
146605897|NCT02262754|528725686|FG002|Overall Study|Other|2|||
146656996|NCT03981822|528921654|FG006|Overall Study|Lost to Follow-up|4|||
146605898|NCT04079114|528725689|FG000|Overall Study|Study prematuely terminated.|166|||
146605899|NCT00629798|528725694|FG000|Overall Study|Not Treated|4|||
146605900|NCT02554981|528725695|FG000|Overall Study|Adverse Event|1|||
146605901|NCT02554981|528725695|FG000|Overall Study|Administrative Reasons|1|||
146605902|NCT02554981|528725695|FG000|Overall Study|Other Miscellaneous Reasons|3|||
146656997|NCT03981822|528921655|FG007|Overall Study|Lost to Follow-up|2|||
146605903|NCT02292706|528725698|FG000|Overall Study|Lost to Follow-up|20|||
146605904|NCT02292706|528725699|FG001|Overall Study|Lost to Follow-up|44|||
146605905|NCT02292706|528725700|FG002|Overall Study|Lost to Follow-up|24|||
146605906|NCT02292706|528725701|FG003|Overall Study|Lost to Follow-up|61|||
146605907|NCT02292706|528725702|FG004|Overall Study|Lost to Follow-up|21|||
146605908|NCT02292706|528725703|FG005|Overall Study|Lost to Follow-up|52|||
146605909|NCT02292706|528725704|FG006|Overall Study|Lost to Follow-up|25|||
146605910|NCT02292706|528725705|FG007|Overall Study|Lost to Follow-up|0|||
146605911|NCT02292706|528725698|FG000|Overall Study|Withdrew consent|15|||
146605912|NCT02292706|528725699|FG001|Overall Study|Withdrew consent|56|||
146605913|NCT02292706|528725700|FG002|Overall Study|Withdrew consent|43|||
146605914|NCT02292706|528725701|FG003|Overall Study|Withdrew consent|36|||
146605915|NCT02292706|528725702|FG004|Overall Study|Withdrew consent|13|||
146605916|NCT02292706|528725703|FG005|Overall Study|Withdrew consent|51|||
146605917|NCT02292706|528725704|FG006|Overall Study|Withdrew consent|20|||
146605918|NCT02292706|528725705|FG007|Overall Study|Withdrew consent|0|||
146605919|NCT02292706|528725698|FG000|Overall Study|Death|3|||
146605920|NCT02292706|528725699|FG001|Overall Study|Death|11|||
146605921|NCT02292706|528725700|FG002|Overall Study|Death|16|||
146605922|NCT02292706|528725701|FG003|Overall Study|Death|22|||
146605923|NCT02292706|528725702|FG004|Overall Study|Death|8|||
146605924|NCT02292706|528725703|FG005|Overall Study|Death|17|||
146605925|NCT02292706|528725704|FG006|Overall Study|Death|3|||
146605926|NCT02292706|528725705|FG007|Overall Study|Death|0|||
146605927|NCT02292706|528725698|FG000|Overall Study|Study terminated by sponsor|0|||
146605928|NCT02292706|528725699|FG001|Overall Study|Study terminated by sponsor|9|||
146605929|NCT02292706|528725700|FG002|Overall Study|Study terminated by sponsor|4|||
146605930|NCT02292706|528725701|FG003|Overall Study|Study terminated by sponsor|21|||
146605931|NCT02292706|528725702|FG004|Overall Study|Study terminated by sponsor|11|||
146605932|NCT02292706|528725703|FG005|Overall Study|Study terminated by sponsor|13|||
146605933|NCT02292706|528725704|FG006|Overall Study|Study terminated by sponsor|3|||
146605934|NCT02292706|528725705|FG007|Overall Study|Study terminated by sponsor|0|||
146605935|NCT02292706|528725698|FG000|Overall Study|Investigator's discretion|4|||
146605936|NCT02292706|528725699|FG001|Overall Study|Investigator's discretion|9|||
146605937|NCT02292706|528725700|FG002|Overall Study|Investigator's discretion|7|||
146605938|NCT02292706|528725701|FG003|Overall Study|Investigator's discretion|11|||
146605939|NCT02292706|528725702|FG004|Overall Study|Investigator's discretion|4|||
146605940|NCT02292706|528725703|FG005|Overall Study|Investigator's discretion|10|||
146605941|NCT02292706|528725704|FG006|Overall Study|Investigator's discretion|1|||
146605942|NCT02292706|528725705|FG007|Overall Study|Investigator's discretion|0|||
146605943|NCT02292706|528725698|FG000|Overall Study|Liver transplant|1|||
146605944|NCT02292706|528725699|FG001|Overall Study|Liver transplant|1|||
146605945|NCT02292706|528725700|FG002|Overall Study|Liver transplant|11|||
146605946|NCT02292706|528725701|FG003|Overall Study|Liver transplant|16|||
146605947|NCT02292706|528725702|FG004|Overall Study|Liver transplant|5|||
146605948|NCT02292706|528725703|FG005|Overall Study|Liver transplant|6|||
146605949|NCT02292706|528725704|FG006|Overall Study|Liver transplant|5|||
146605950|NCT02292706|528725705|FG007|Overall Study|Liver transplant|0|||
146605951|NCT02292706|528725698|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
146605952|NCT02292706|528725699|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
146605953|NCT02292706|528725700|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
146605954|NCT02292706|528725701|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
146605955|NCT02292706|528725702|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
146605956|NCT02292706|528725703|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
146605957|NCT02292706|528725704|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
146605958|NCT02292706|528725705|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
146605959|NCT02292706|528725698|FG000|Overall Study|Subject terminated by sponsor|1|||
146605960|NCT02292706|528725699|FG001|Overall Study|Subject terminated by sponsor|0|||
146605961|NCT02292706|528725700|FG002|Overall Study|Subject terminated by sponsor|0|||
146605962|NCT02292706|528725701|FG003|Overall Study|Subject terminated by sponsor|2|||
146605963|NCT02292706|528725702|FG004|Overall Study|Subject terminated by sponsor|1|||
146605964|NCT02292706|528725703|FG005|Overall Study|Subject terminated by sponsor|0|||
146605965|NCT02292706|528725704|FG006|Overall Study|Subject terminated by sponsor|0|||
146605966|NCT02292706|528725705|FG007|Overall Study|Subject terminated by sponsor|0|||
146922929|NCT00818207|529878678|FG001|Overall Study|Death|5|||
146922930|NCT02616185|529878679|FG000|Overall Study|Death|0|||
146922931|NCT02616185|529878680|FG001|Overall Study|Death|0|||
146922932|NCT02616185|529878681|FG002|Overall Study|Death|0|||
146605967|NCT02292706|528725698|FG000|Overall Study|Missing|0|||
146605968|NCT02292706|528725699|FG001|Overall Study|Missing|0|||
146605969|NCT02292706|528725700|FG002|Overall Study|Missing|1|||
146605970|NCT02292706|528725701|FG003|Overall Study|Missing|1|||
146605971|NCT02292706|528725702|FG004|Overall Study|Missing|0|||
146605972|NCT02292706|528725703|FG005|Overall Study|Missing|1|||
146922933|NCT02616185|529878682|FG003|Overall Study|Death|1|||
146922934|NCT02616185|529878683|FG004|Overall Study|Death|2|||
146605973|NCT02292706|528725704|FG006|Overall Study|Missing|0|||
146605974|NCT02292706|528725705|FG007|Overall Study|Missing|0|||
146922935|NCT02616185|529878684|FG005|Overall Study|Death|0|||
146605975|NCT02292706|528725698|FG000|Overall Study|Virologic relapse or reinfection|1|||
146605976|NCT02292706|528725699|FG001|Overall Study|Virologic relapse or reinfection|0|||
146605977|NCT02292706|528725700|FG002|Overall Study|Virologic relapse or reinfection|0|||
146605978|NCT02292706|528725701|FG003|Overall Study|Virologic relapse or reinfection|1|||
146605979|NCT02292706|528725702|FG004|Overall Study|Virologic relapse or reinfection|0|||
146605980|NCT02292706|528725703|FG005|Overall Study|Virologic relapse or reinfection|1|||
146605981|NCT02292706|528725704|FG006|Overall Study|Virologic relapse or reinfection|0|||
146605982|NCT02292706|528725705|FG007|Overall Study|Virologic relapse or reinfection|0|||
146605983|NCT01990612|528725708|FG000|Overall Study|Lost to Follow-up|2|||
146605984|NCT01990612|528725709|FG001|Overall Study|Lost to Follow-up|1|||
146605985|NCT01990612|528725708|FG000|Overall Study|Withdrawal by Subject|5|||
146605986|NCT01990612|528725709|FG001|Overall Study|Withdrawal by Subject|2|||
146605987|NCT02725866|528725710|FG000|Overall Study|Failure to return|6|||
146605988|NCT02725866|528725710|FG000|Overall Study|Withdrew consent|3|||
146605989|NCT02725866|528725710|FG000|Overall Study|Insufficient virological response|1|||
146605990|NCT02725866|528725710|FG000|Overall Study|Other, not specified|4|||
146605991|NCT02188849|528725713|FG000|Overall Study|Lost to Follow-up|3|||
146605992|NCT02188849|528725714|FG001|Overall Study|Lost to Follow-up|8|||
146605993|NCT00812565|528725718|FG000|Overall Study|Did Not Receive Study Medication|1|||
146605994|NCT00812565|528725719|FG001|Overall Study|Did Not Receive Study Medication|1|||
146605995|NCT00812565|528725720|FG002|Overall Study|Did Not Receive Study Medication|0|||
146605996|NCT00812565|528725721|FG003|Overall Study|Did Not Receive Study Medication|0|||
146605997|NCT00812565|528725722|FG004|Overall Study|Did Not Receive Study Medication|0|||
146605998|NCT00812565|528725723|FG005|Overall Study|Did Not Receive Study Medication|0|||
146605999|NCT00812565|528725724|FG006|Overall Study|Did Not Receive Study Medication|0|||
146606000|NCT00812565|528725725|FG007|Overall Study|Did Not Receive Study Medication|0|||
146606001|NCT00812565|528725718|FG000|Overall Study|Adverse Event|0|||
146606002|NCT00812565|528725719|FG001|Overall Study|Adverse Event|0|||
146606003|NCT00812565|528725720|FG002|Overall Study|Adverse Event|0|||
146606004|NCT00812565|528725721|FG003|Overall Study|Adverse Event|2|||
146606005|NCT00812565|528725722|FG004|Overall Study|Adverse Event|0|||
146606006|NCT00812565|528725723|FG005|Overall Study|Adverse Event|0|||
146606007|NCT00812565|528725724|FG006|Overall Study|Adverse Event|0|||
146606008|NCT00812565|528725725|FG007|Overall Study|Adverse Event|1|||
146606009|NCT00812565|528725718|FG000|Overall Study|Did Not Come to Study Visit|1|||
146606010|NCT00812565|528725719|FG001|Overall Study|Did Not Come to Study Visit|0|||
146606011|NCT00812565|528725720|FG002|Overall Study|Did Not Come to Study Visit|0|||
146606012|NCT00812565|528725721|FG003|Overall Study|Did Not Come to Study Visit|0|||
146606013|NCT00812565|528725722|FG004|Overall Study|Did Not Come to Study Visit|0|||
146606014|NCT00812565|528725723|FG005|Overall Study|Did Not Come to Study Visit|0|||
146606015|NCT00812565|528725724|FG006|Overall Study|Did Not Come to Study Visit|0|||
146606016|NCT00812565|528725725|FG007|Overall Study|Did Not Come to Study Visit|0|||
146606017|NCT00812565|528725718|FG000|Overall Study|Withdrawal of Consent|1|||
146606018|NCT00812565|528725719|FG001|Overall Study|Withdrawal of Consent|0|||
146606019|NCT00812565|528725720|FG002|Overall Study|Withdrawal of Consent|0|||
146606020|NCT00812565|528725721|FG003|Overall Study|Withdrawal of Consent|0|||
146606021|NCT00812565|528725722|FG004|Overall Study|Withdrawal of Consent|1|||
146656998|NCT03981822|528921648|FG000|Overall Study|Withdrawal by Subject|0|||
146656999|NCT03981822|528921649|FG001|Overall Study|Withdrawal by Subject|1|||
146606022|NCT00812565|528725723|FG005|Overall Study|Withdrawal of Consent|0|||
146606023|NCT00812565|528725724|FG006|Overall Study|Withdrawal of Consent|0|||
146606024|NCT00812565|528725725|FG007|Overall Study|Withdrawal of Consent|0|||
146606025|NCT00812565|528725718|FG000|Overall Study|Reason Not Specified|0|||
146606026|NCT00812565|528725719|FG001|Overall Study|Reason Not Specified|0|||
146606027|NCT00812565|528725720|FG002|Overall Study|Reason Not Specified|0|||
146606028|NCT00812565|528725721|FG003|Overall Study|Reason Not Specified|0|||
146606029|NCT00812565|528725722|FG004|Overall Study|Reason Not Specified|0|||
146606030|NCT00812565|528725723|FG005|Overall Study|Reason Not Specified|1|||
146657000|NCT03981822|528921650|FG002|Overall Study|Withdrawal by Subject|0|||
146657001|NCT03981822|528921651|FG003|Overall Study|Withdrawal by Subject|0|||
146657002|NCT03981822|528921652|FG004|Overall Study|Withdrawal by Subject|0|||
146657003|NCT03981822|528921653|FG005|Overall Study|Withdrawal by Subject|1|||
146606031|NCT00812565|528725724|FG006|Overall Study|Reason Not Specified|0|||
146657004|NCT03981822|528921654|FG006|Overall Study|Withdrawal by Subject|0|||
146657005|NCT03981822|528921655|FG007|Overall Study|Withdrawal by Subject|2|||
146606032|NCT00812565|528725725|FG007|Overall Study|Reason Not Specified|0|||
146657006|NCT03981822|528921648|FG000|Overall Study|COVID-19 Related|0|||
146606033|NCT01793883|528725726|FG000|Overall Study|Withdrawal by Subject|3|||
146922936|NCT02616185|529878685|FG006|Overall Study|Death|0|||
146606034|NCT01793883|528725727|FG001|Overall Study|Withdrawal by Subject|7|||
146606035|NCT01793883|528725728|FG002|Overall Study|Withdrawal by Subject|3|||
146606036|NCT01793883|528725726|FG000|Overall Study|Subject noncompliance|0|||
146606037|NCT01793883|528725727|FG001|Overall Study|Subject noncompliance|1|||
146606038|NCT01793883|528725728|FG002|Overall Study|Subject noncompliance|1|||
146657007|NCT03981822|528921649|FG001|Overall Study|COVID-19 Related|0|||
146606039|NCT01793883|528725726|FG000|Overall Study|Lost to Follow-up|5|||
146606040|NCT01793883|528725727|FG001|Overall Study|Lost to Follow-up|1|||
146606041|NCT01793883|528725728|FG002|Overall Study|Lost to Follow-up|3|||
146606042|NCT01793883|528725726|FG000|Overall Study|Randomized in error|1|||
146606043|NCT01793883|528725727|FG001|Overall Study|Randomized in error|0|||
146606044|NCT01793883|528725728|FG002|Overall Study|Randomized in error|0|||
146606045|NCT01793883|528725726|FG000|Overall Study|Unable to complete spriometry|1|||
146606046|NCT01793883|528725727|FG001|Overall Study|Unable to complete spriometry|0|||
146606047|NCT01793883|528725728|FG002|Overall Study|Unable to complete spriometry|0|||
146606048|NCT01793883|528725726|FG000|Overall Study|Unable to complete measurements|1|||
146606049|NCT01793883|528725727|FG001|Overall Study|Unable to complete measurements|0|||
146606050|NCT01793883|528725728|FG002|Overall Study|Unable to complete measurements|0|||
146606051|NCT01793883|528725726|FG000|Overall Study|Met exclusion criteria|1|||
146606052|NCT01793883|528725727|FG001|Overall Study|Met exclusion criteria|0|||
146606053|NCT01793883|528725728|FG002|Overall Study|Met exclusion criteria|0|||
146606054|NCT01793883|528725726|FG000|Overall Study|Dosing error|0|||
146606055|NCT01793883|528725727|FG001|Overall Study|Dosing error|1|||
146606056|NCT01793883|528725728|FG002|Overall Study|Dosing error|0|||
146606057|NCT01793883|528725726|FG000|Overall Study|Respiratory distress during spirometry|0|||
146606058|NCT01793883|528725727|FG001|Overall Study|Respiratory distress during spirometry|0|||
146606059|NCT01793883|528725728|FG002|Overall Study|Respiratory distress during spirometry|1|||
146606060|NCT02353728|528725729|FG000|Overall Study|Subject non-compliance|1|||
146606061|NCT00895310|528725730|FG000|Overall Study|Withdrawal by Subject|1|||
146606062|NCT00659230|528725731|FG000|Overall Study|Lost to Follow-up|2|||
146606063|NCT00659230|528725732|FG001|Overall Study|Lost to Follow-up|5|||
146606064|NCT00659230|528725731|FG000|Overall Study|Lost source documentation|5|||
146606065|NCT00659230|528725732|FG001|Overall Study|Lost source documentation|4|||
146606066|NCT00659230|528725731|FG000|Overall Study|Did not return post-randomization|2|||
146606067|NCT00659230|528725732|FG001|Overall Study|Did not return post-randomization|3|||
146606068|NCT00547521|528725733|FG000|Short Term Study (4 Months)|Adverse Event|1|||
146606069|NCT00547521|528725734|FG001|Short Term Study (4 Months)|Adverse Event|0|||
146606070|NCT00547521|528725733|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
146606071|NCT00547521|528725734|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
146606072|NCT00547521|528725733|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
146606073|NCT00547521|528725734|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
146606074|NCT00547521|528725733|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
146606075|NCT00547521|528725734|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
146606076|NCT00547521|528725733|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
146606077|NCT00547521|528725734|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
146606078|NCT00547521|528725733|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
146606079|NCT00547521|528725734|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
146606080|NCT00547521|528725733|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
146606081|NCT00547521|528725734|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
146606082|NCT00547521|528725733|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
146606083|NCT00547521|528725734|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
146606084|NCT00547521|528725733|FG000|Long Term Extension (LTE) Study|Other|0|||
146606085|NCT00547521|528725734|FG001|Long Term Extension (LTE) Study|Other|2|||
146606086|NCT00547521|528725733|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
146606087|NCT00547521|528725734|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
146606088|NCT05066165|528727888|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
146606089|NCT05066165|528727889|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
146922937|NCT02616185|529878686|FG007|Overall Study|Death|2|||
146606090|NCT05066165|528727888|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
146606091|NCT05066165|528727889|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
146606092|NCT02454478|528727893|FG000|Overall Study|Incomplete DLT Evaluation|1|||
146606093|NCT01959841|528727900|FG000|Overall Study|Adverse Event|1|||
146606094|NCT01959841|528727901|FG001|Overall Study|Adverse Event|3|||
146606095|NCT01959841|528727902|FG002|Overall Study|Adverse Event|2|||
146606096|NCT01959841|528727900|FG000|Overall Study|Lack of Efficacy|5|||
146606097|NCT01959841|528727901|FG001|Overall Study|Lack of Efficacy|0|||
146606098|NCT01959841|528727902|FG002|Overall Study|Lack of Efficacy|0|||
146606099|NCT01959841|528727900|FG000|Overall Study|Lost to Follow-up|1|||
146606100|NCT01959841|528727901|FG001|Overall Study|Lost to Follow-up|1|||
146606101|NCT01959841|528727902|FG002|Overall Study|Lost to Follow-up|0|||
146606102|NCT01959841|528727900|FG000|Overall Study|Physician Decision|0|||
146606103|NCT01959841|528727901|FG001|Overall Study|Physician Decision|2|||
146606104|NCT01959841|528727902|FG002|Overall Study|Physician Decision|3|||
146606105|NCT01959841|528727900|FG000|Overall Study|Protocol Violation|16|||
146606106|NCT01959841|528727901|FG001|Overall Study|Protocol Violation|23|||
146606107|NCT01959841|528727902|FG002|Overall Study|Protocol Violation|16|||
146606108|NCT01959841|528727900|FG000|Overall Study|Withdrawal by Subject|7|||
146606109|NCT01959841|528727901|FG001|Overall Study|Withdrawal by Subject|7|||
146606110|NCT01959841|528727902|FG002|Overall Study|Withdrawal by Subject|5|||
146606111|NCT01959841|528727900|FG000|Overall Study|Clinical laboratory value|2|||
146606112|NCT01959841|528727901|FG001|Overall Study|Clinical laboratory value|6|||
146606113|NCT01959841|528727902|FG002|Overall Study|Clinical laboratory value|6|||
146606114|NCT01959841|528727900|FG000|Overall Study|Platelet count below on day1 or 4|11|||
146606115|NCT01959841|528727901|FG001|Overall Study|Platelet count below on day1 or 4|15|||
146606116|NCT01959841|528727902|FG002|Overall Study|Platelet count below on day1 or 4|11|||
146606117|NCT00780416|528727904|FG000|Overall Study|Physician Decision|3|||
146606118|NCT00780416|528727905|FG001|Overall Study|Physician Decision|3|||
146606119|NCT00780416|528727904|FG000|Overall Study|Protocol Violation|1|||
146606120|NCT00780416|528727905|FG001|Overall Study|Protocol Violation|0|||
146606121|NCT00780416|528727904|FG000|Overall Study|Withdrawal by Subject|8|||
146606122|NCT00780416|528727905|FG001|Overall Study|Withdrawal by Subject|6|||
146606123|NCT00666224|528727908|FG000|Double-Blind|Adverse Event|15|||
146606124|NCT00666224|528727909|FG001|Double-Blind|Adverse Event|5|||
146606125|NCT00666224|528727908|FG000|Double-Blind|Lost to Follow-up|2|||
146606126|NCT00666224|528727909|FG001|Double-Blind|Lost to Follow-up|2|||
146606127|NCT00666224|528727908|FG000|Double-Blind|Withdrawal by Subject|18|||
146606128|NCT00666224|528727909|FG001|Double-Blind|Withdrawal by Subject|14|||
146606129|NCT00666224|528727908|FG000|Double-Blind|Physician Decision|0|||
146606130|NCT00666224|528727909|FG001|Double-Blind|Physician Decision|3|||
146606131|NCT00666224|528727908|FG000|Double-Blind|Sponsor decision|1|||
146606132|NCT00666224|528727909|FG001|Double-Blind|Sponsor decision|0|||
146606133|NCT00666224|528727908|FG000|Double-Blind|Pregnancy|3|||
146606134|NCT00666224|528727909|FG001|Double-Blind|Pregnancy|2|||
146606135|NCT00666224|528727908|FG000|Double-Blind|Noncompliance|1|||
146606136|NCT00666224|528727909|FG001|Double-Blind|Noncompliance|0|||
146606137|NCT00666224|528727908|FG000|Double-Blind|Death|1|||
146606138|NCT00666224|528727909|FG001|Double-Blind|Death|0|||
146606139|NCT00666224|528727908|FG000|Double-Blind|Undefined/Unknown|4|||
146606140|NCT00666224|528727909|FG001|Double-Blind|Undefined/Unknown|1|||
146606141|NCT00666224|528727908|FG000|Open-Label|Adverse Event|8|||
146606142|NCT00666224|528727909|FG001|Open-Label|Adverse Event|43|||
146606143|NCT00666224|528727908|FG000|Open-Label|Lost to Follow-up|4|||
146606144|NCT00666224|528727909|FG001|Open-Label|Lost to Follow-up|5|||
146606145|NCT00666224|528727908|FG000|Open-Label|Withdrawal by Subject|12|||
146606146|NCT00666224|528727909|FG001|Open-Label|Withdrawal by Subject|25|||
146606147|NCT00666224|528727908|FG000|Open-Label|Physician Decision|7|||
146606148|NCT00666224|528727909|FG001|Open-Label|Physician Decision|5|||
146606149|NCT00666224|528727908|FG000|Open-Label|Pregnancy|1|||
146606150|NCT00666224|528727909|FG001|Open-Label|Pregnancy|5|||
146606151|NCT00666224|528727908|FG000|Open-Label|Noncompliance|2|||
146606152|NCT00666224|528727909|FG001|Open-Label|Noncompliance|1|||
146606153|NCT00666224|528727908|FG000|Open-Label|Undefined/Unknown|1|||
146606154|NCT00666224|528727909|FG001|Open-Label|Undefined/Unknown|1|||
146606155|NCT03521141|528727919|FG000|Overall Study|Death|1|||
146606156|NCT03521141|528727920|FG001|Overall Study|Death|0|||
146606157|NCT03521141|528727921|FG002|Overall Study|Death|1|||
146606158|NCT00655629|528727929|FG000|Overall Study|Adverse Event|4|||
146606159|NCT00655629|528727930|FG001|Overall Study|Adverse Event|1|||
146606160|NCT00655629|528727929|FG000|Overall Study|Lack of Efficacy|2|||
146606161|NCT00655629|528727930|FG001|Overall Study|Lack of Efficacy|12|||
146606162|NCT00655629|528727929|FG000|Overall Study|Lost to Follow-up|4|||
146606163|NCT00655629|528727930|FG001|Overall Study|Lost to Follow-up|3|||
146606164|NCT00655629|528727929|FG000|Overall Study|Protocol Violation|5|||
146606165|NCT00655629|528727930|FG001|Overall Study|Protocol Violation|3|||
146606166|NCT00655629|528727929|FG000|Overall Study|consent withdrawn|6|||
146606167|NCT00655629|528727930|FG001|Overall Study|consent withdrawn|4|||
146657008|NCT03981822|528921650|FG002|Overall Study|COVID-19 Related|0|||
146657009|NCT03981822|528921651|FG003|Overall Study|COVID-19 Related|0|||
146657010|NCT03981822|528921652|FG004|Overall Study|COVID-19 Related|2|||
146657011|NCT03981822|528921653|FG005|Overall Study|COVID-19 Related|1|||
146657012|NCT03981822|528921654|FG006|Overall Study|COVID-19 Related|2|||
146606168|NCT01610336|528727931|FG000|Overall Study|Progressive Disease|4|||
146606169|NCT01610336|528727932|FG001|Overall Study|Progressive Disease|6|||
146978662|NCT01246986|530085455|FG006|Overall Study|Lost to Follow-up|0|||
146606170|NCT01610336|528727933|FG002|Overall Study|Progressive Disease|6|||
146606171|NCT01610336|528727934|FG003|Overall Study|Progressive Disease|5|||
146606172|NCT01610336|528727935|FG004|Overall Study|Progressive Disease|3|||
146657013|NCT03981822|528921655|FG007|Overall Study|COVID-19 Related|1|||
146606173|NCT01610336|528727936|FG005|Overall Study|Progressive Disease|10|||
146606174|NCT01610336|528727937|FG006|Overall Study|Progressive Disease|1|||
146606175|NCT01610336|528727938|FG007|Overall Study|Progressive Disease|6|||
146606176|NCT01610336|528727939|FG008|Overall Study|Progressive Disease|6|||
146606177|NCT01610336|528727940|FG009|Overall Study|Progressive Disease|40|||
146606178|NCT01610336|528727941|FG010|Overall Study|Progressive Disease|36|||
146606179|NCT01610336|528727931|FG000|Overall Study|Adverse Event|0|||
146657014|NCT02742246|528921656|FG000|Overall Study|Never initiated treatment|5|||
146606180|NCT01610336|528727932|FG001|Overall Study|Adverse Event|0|||
146606181|NCT01610336|528727933|FG002|Overall Study|Adverse Event|0|||
146606182|NCT01610336|528727934|FG003|Overall Study|Adverse Event|1|||
146606183|NCT01610336|528727935|FG004|Overall Study|Adverse Event|1|||
146606184|NCT01610336|528727936|FG005|Overall Study|Adverse Event|1|||
146606185|NCT01610336|528727937|FG006|Overall Study|Adverse Event|0|||
146606186|NCT01610336|528727938|FG007|Overall Study|Adverse Event|0|||
146606187|NCT01610336|528727939|FG008|Overall Study|Adverse Event|2|||
146606188|NCT01610336|528727940|FG009|Overall Study|Adverse Event|8|||
146606189|NCT01610336|528727941|FG010|Overall Study|Adverse Event|6|||
146606190|NCT01610336|528727931|FG000|Overall Study|Subject/Guardian decision|1|||
146606191|NCT01610336|528727932|FG001|Overall Study|Subject/Guardian decision|1|||
146606192|NCT01610336|528727933|FG002|Overall Study|Subject/Guardian decision|0|||
146606193|NCT01610336|528727934|FG003|Overall Study|Subject/Guardian decision|1|||
146606194|NCT01610336|528727935|FG004|Overall Study|Subject/Guardian decision|0|||
146606195|NCT01610336|528727936|FG005|Overall Study|Subject/Guardian decision|0|||
146606196|NCT01610336|528727937|FG006|Overall Study|Subject/Guardian decision|0|||
146606197|NCT01610336|528727938|FG007|Overall Study|Subject/Guardian decision|1|||
146606198|NCT01610336|528727939|FG008|Overall Study|Subject/Guardian decision|0|||
146606199|NCT01610336|528727940|FG009|Overall Study|Subject/Guardian decision|2|||
146606200|NCT01610336|528727941|FG010|Overall Study|Subject/Guardian decision|2|||
146606201|NCT01610336|528727931|FG000|Overall Study|Death|0|||
146606202|NCT01610336|528727932|FG001|Overall Study|Death|0|||
146606203|NCT01610336|528727933|FG002|Overall Study|Death|0|||
146606204|NCT01610336|528727934|FG003|Overall Study|Death|0|||
146606205|NCT01610336|528727935|FG004|Overall Study|Death|0|||
146606206|NCT01610336|528727936|FG005|Overall Study|Death|1|||
146606207|NCT01610336|528727937|FG006|Overall Study|Death|3|||
146606208|NCT01610336|528727938|FG007|Overall Study|Death|0|||
146606209|NCT01610336|528727939|FG008|Overall Study|Death|0|||
146606210|NCT01610336|528727940|FG009|Overall Study|Death|1|||
146606211|NCT01610336|528727941|FG010|Overall Study|Death|2|||
146606212|NCT01610336|528727931|FG000|Overall Study|Non-Compliance with study treatment|0|||
146606213|NCT01610336|528727932|FG001|Overall Study|Non-Compliance with study treatment|0|||
146657015|NCT02742246|528921657|FG001|Overall Study|Never initiated treatment|3|||
146657016|NCT02742246|528921658|FG002|Overall Study|Never initiated treatment|1|||
146657017|NCT02742246|528921656|FG000|Overall Study|dropped out during treatment|7|||
146657018|NCT02742246|528921657|FG001|Overall Study|dropped out during treatment|13|||
146657019|NCT02742246|528921658|FG002|Overall Study|dropped out during treatment|10|||
146657020|NCT02742246|528921656|FG000|Overall Study|Death|1|||
146657021|NCT02742246|528921657|FG001|Overall Study|Death|0|||
146657022|NCT02742246|528921658|FG002|Overall Study|Death|0|||
146657023|NCT03489551|528921659|FG000|Overall Study|Withdrawal by Subject|2|||
146657024|NCT00054717|528921660|FG000|Overall Study|Randomized but not treated|2|||
146657025|NCT00054717|528921661|FG001|Overall Study|Randomized but not treated|8|||
146657026|NCT00054717|528921660|FG000|Overall Study|Adverse Event|70|||
146657027|NCT00054717|528921661|FG001|Overall Study|Adverse Event|22|||
146657028|NCT00054717|528921660|FG000|Overall Study|Protocol Violation|18|||
146657029|NCT00054717|528921661|FG001|Overall Study|Protocol Violation|19|||
146657030|NCT00054717|528921660|FG000|Overall Study|Lost to Follow-up|23|||
146657031|NCT00054717|528921661|FG001|Overall Study|Lost to Follow-up|13|||
146657032|NCT00054717|528921660|FG000|Overall Study|Withdrawal by Subject|32|||
146657033|NCT00054717|528921661|FG001|Overall Study|Withdrawal by Subject|20|||
146657034|NCT00054717|528921660|FG000|Overall Study|Other reason not defined above|117|||
146657035|NCT00054717|528921661|FG001|Overall Study|Other reason not defined above|217|||
146657036|NCT00206076|528921664|FG000|Overall Study|Physician Decision|2|||
146657037|NCT00206076|528921665|FG001|Overall Study|Physician Decision|0|||
146657038|NCT00206076|528921664|FG000|Overall Study|Withdrawal by Subject|1|||
146657039|NCT00206076|528921665|FG001|Overall Study|Withdrawal by Subject|1|||
146657040|NCT00427960|528921667|FG000|Overall Study|Adverse Event|2|||
146657041|NCT00427960|528921668|FG001|Overall Study|Adverse Event|0|||
146657042|NCT00427960|528921667|FG000|Overall Study|Withdrawal by Subject|0|||
146922938|NCT02616185|529878687|FG008|Overall Study|Death|1|||
146922939|NCT02616185|529878679|FG000|Overall Study|Study terminated by sponsor|0|||
146922940|NCT02616185|529878680|FG001|Overall Study|Study terminated by sponsor|0|||
146657043|NCT00427960|528921668|FG001|Overall Study|Withdrawal by Subject|3|||
146657044|NCT00427960|528921667|FG000|Overall Study|Other|0|||
146657045|NCT00427960|528921668|FG001|Overall Study|Other|1|||
146657046|NCT01142128|528921669|FG000|Overall Study|Physician Decision|1|||
146657047|NCT01142128|528921669|FG000|Overall Study|Lost to Follow-up|1|||
146657048|NCT01142128|528921669|FG000|Overall Study|Withdrawal by Subject|2|||
146657049|NCT03355664|528921670|FG000|Overall Study|Adverse Event|1|||
146922941|NCT02616185|529878681|FG002|Overall Study|Study terminated by sponsor|1|||
146606214|NCT01610336|528727933|FG002|Overall Study|Non-Compliance with study treatment|0|||
146606215|NCT01610336|528727934|FG003|Overall Study|Non-Compliance with study treatment|0|||
146606216|NCT01610336|528727935|FG004|Overall Study|Non-Compliance with study treatment|0|||
146606217|NCT01610336|528727936|FG005|Overall Study|Non-Compliance with study treatment|0|||
146606218|NCT01610336|528727937|FG006|Overall Study|Non-Compliance with study treatment|0|||
146606219|NCT01610336|528727938|FG007|Overall Study|Non-Compliance with study treatment|0|||
146606220|NCT01610336|528727939|FG008|Overall Study|Non-Compliance with study treatment|0|||
146606221|NCT01610336|528727940|FG009|Overall Study|Non-Compliance with study treatment|1|||
146657050|NCT03355664|528921671|FG001|Overall Study|Adverse Event|2|||
146773056|NCT03903822|529338237|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
146606222|NCT01610336|528727941|FG010|Overall Study|Non-Compliance with study treatment|0|||
146606223|NCT01610336|528727931|FG000|Overall Study|Physician Decision|0|||
146606224|NCT01610336|528727932|FG001|Overall Study|Physician Decision|0|||
146606225|NCT01610336|528727933|FG002|Overall Study|Physician Decision|0|||
146606226|NCT01610336|528727934|FG003|Overall Study|Physician Decision|0|||
146606227|NCT01610336|528727935|FG004|Overall Study|Physician Decision|0|||
146606228|NCT01610336|528727936|FG005|Overall Study|Physician Decision|0|||
146606229|NCT01610336|528727937|FG006|Overall Study|Physician Decision|1|||
146606230|NCT01610336|528727938|FG007|Overall Study|Physician Decision|0|||
146606231|NCT01610336|528727939|FG008|Overall Study|Physician Decision|0|||
146606232|NCT01610336|528727940|FG009|Overall Study|Physician Decision|0|||
146606233|NCT01610336|528727941|FG010|Overall Study|Physician Decision|0|||
146606234|NCT01610336|528727931|FG000|Overall Study|Protocol Deviation|0|||
146606235|NCT01610336|528727932|FG001|Overall Study|Protocol Deviation|0|||
146606236|NCT01610336|528727933|FG002|Overall Study|Protocol Deviation|0|||
146606237|NCT01610336|528727934|FG003|Overall Study|Protocol Deviation|0|||
146606238|NCT01610336|528727935|FG004|Overall Study|Protocol Deviation|0|||
146606239|NCT01610336|528727936|FG005|Overall Study|Protocol Deviation|0|||
146606240|NCT01610336|528727937|FG006|Overall Study|Protocol Deviation|0|||
146606241|NCT01610336|528727938|FG007|Overall Study|Protocol Deviation|0|||
146606242|NCT01610336|528727939|FG008|Overall Study|Protocol Deviation|0|||
146606243|NCT01610336|528727940|FG009|Overall Study|Protocol Deviation|1|||
146606244|NCT01610336|528727941|FG010|Overall Study|Protocol Deviation|0|||
146606245|NCT01610336|528727931|FG000|Overall Study|Transfer to another trial|0|||
146606246|NCT01610336|528727932|FG001|Overall Study|Transfer to another trial|0|||
146606247|NCT01610336|528727933|FG002|Overall Study|Transfer to another trial|0|||
146606248|NCT01610336|528727934|FG003|Overall Study|Transfer to another trial|0|||
146606249|NCT01610336|528727935|FG004|Overall Study|Transfer to another trial|0|||
146606250|NCT01610336|528727936|FG005|Overall Study|Transfer to another trial|0|||
146606251|NCT01610336|528727937|FG006|Overall Study|Transfer to another trial|0|||
146606252|NCT01610336|528727938|FG007|Overall Study|Transfer to another trial|0|||
146606253|NCT01610336|528727939|FG008|Overall Study|Transfer to another trial|0|||
146606254|NCT01610336|528727940|FG009|Overall Study|Transfer to another trial|0|||
146606255|NCT01610336|528727941|FG010|Overall Study|Transfer to another trial|1|||
146606256|NCT01559675|528727944|FG000|Overall Study|Protocol Violation|1|||
146606257|NCT01559675|528727945|FG001|Overall Study|Protocol Violation|2|||
146606258|NCT01559675|528727944|FG000|Overall Study|2nd operation on same patient excluded|14|||
146606259|NCT01559675|528727945|FG001|Overall Study|2nd operation on same patient excluded|12|||
146606260|NCT00193180|528727948|FG000|Overall Study|Lack of Efficacy|1|||
146606261|NCT00193180|528727948|FG000|Overall Study|Adverse Event|8|||
146606262|NCT00193180|528727948|FG000|Overall Study|Protocol Violation|1|||
146606263|NCT01393639|528727949|FG000|Overall Study|Protocol Violation|0|||
146606264|NCT01393639|528727950|FG001|Overall Study|Protocol Violation|0|||
146606265|NCT01393639|528727951|FG002|Overall Study|Protocol Violation|0|||
146606266|NCT01393639|528727952|FG003|Overall Study|Protocol Violation|1|||
146606267|NCT01393639|528727953|FG004|Overall Study|Protocol Violation|0|||
146606268|NCT01393639|528727954|FG005|Overall Study|Protocol Violation|0|||
146606269|NCT01393639|528727955|FG006|Overall Study|Protocol Violation|0|||
146606270|NCT01393639|528727949|FG000|Overall Study|Other|0|||
146606271|NCT01393639|528727950|FG001|Overall Study|Other|2|||
146606272|NCT01393639|528727951|FG002|Overall Study|Other|0|||
146606273|NCT01393639|528727952|FG003|Overall Study|Other|2|||
146922942|NCT02616185|529878682|FG003|Overall Study|Study terminated by sponsor|0|||
146606274|NCT01393639|528727953|FG004|Overall Study|Other|1|||
146606275|NCT01393639|528727954|FG005|Overall Study|Other|0|||
146606276|NCT01393639|528727955|FG006|Overall Study|Other|1|||
146606277|NCT01393639|528727949|FG000|Overall Study|Withdrawal by Subject|1|||
146606278|NCT01393639|528727950|FG001|Overall Study|Withdrawal by Subject|1|||
146606279|NCT01393639|528727951|FG002|Overall Study|Withdrawal by Subject|0|||
146606280|NCT01393639|528727952|FG003|Overall Study|Withdrawal by Subject|0|||
146606281|NCT01393639|528727953|FG004|Overall Study|Withdrawal by Subject|0|||
146606282|NCT01393639|528727954|FG005|Overall Study|Withdrawal by Subject|0|||
146606283|NCT01393639|528727955|FG006|Overall Study|Withdrawal by Subject|1|||
146606284|NCT01393639|528727949|FG000|Overall Study|Medication error without associated AE|0|||
146606285|NCT01393639|528727950|FG001|Overall Study|Medication error without associated AE|0|||
146606286|NCT01393639|528727951|FG002|Overall Study|Medication error without associated AE|0|||
146606287|NCT01393639|528727952|FG003|Overall Study|Medication error without associated AE|0|||
146606288|NCT01393639|528727953|FG004|Overall Study|Medication error without associated AE|0|||
146606289|NCT01393639|528727954|FG005|Overall Study|Medication error without associated AE|0|||
146606290|NCT01393639|528727955|FG006|Overall Study|Medication error without associated AE|1|||
146606291|NCT01393639|528727949|FG000|Overall Study|Lost to Follow-up|0|||
146606292|NCT01393639|528727950|FG001|Overall Study|Lost to Follow-up|1|||
146606293|NCT01393639|528727951|FG002|Overall Study|Lost to Follow-up|0|||
146606294|NCT01393639|528727952|FG003|Overall Study|Lost to Follow-up|0|||
146606295|NCT01393639|528727953|FG004|Overall Study|Lost to Follow-up|0|||
146922943|NCT02616185|529878683|FG004|Overall Study|Study terminated by sponsor|0|||
146606296|NCT01393639|528727954|FG005|Overall Study|Lost to Follow-up|0|||
146606297|NCT01393639|528727955|FG006|Overall Study|Lost to Follow-up|1|||
146606298|NCT01393639|528727949|FG000|Overall Study|Lack of Efficacy|0|||
146606299|NCT01393639|528727950|FG001|Overall Study|Lack of Efficacy|0|||
146606300|NCT01393639|528727951|FG002|Overall Study|Lack of Efficacy|0|||
146606301|NCT01393639|528727952|FG003|Overall Study|Lack of Efficacy|0|||
146606302|NCT01393639|528727953|FG004|Overall Study|Lack of Efficacy|0|||
146606303|NCT01393639|528727954|FG005|Overall Study|Lack of Efficacy|0|||
146606304|NCT01393639|528727955|FG006|Overall Study|Lack of Efficacy|1|||
146606305|NCT01393639|528727949|FG000|Overall Study|Adverse Event|2|||
146606306|NCT01393639|528727950|FG001|Overall Study|Adverse Event|3|||
146606307|NCT01393639|528727951|FG002|Overall Study|Adverse Event|1|||
146606308|NCT01393639|528727952|FG003|Overall Study|Adverse Event|2|||
146606309|NCT01393639|528727953|FG004|Overall Study|Adverse Event|0|||
146606310|NCT01393639|528727954|FG005|Overall Study|Adverse Event|2|||
146606311|NCT01393639|528727955|FG006|Overall Study|Adverse Event|3|||
146606312|NCT01832155|528727956|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
146606313|NCT01832155|528727957|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
146606314|NCT01832155|528727956|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
146606315|NCT01832155|528727957|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
146606316|NCT01369641|528727958|FG000|Overall Study|Withdrawal by Subject|1|||
146606317|NCT00842543|528727959|FG000|Overall Study|Withdrawal by Subject|2|||
146606318|NCT00842543|528727960|FG001|Overall Study|Withdrawal by Subject|0|||
146606319|NCT00842543|528727961|FG002|Overall Study|Withdrawal by Subject|3|||
146606320|NCT00842543|528727962|FG003|Overall Study|Withdrawal by Subject|4|||
146606321|NCT03100058|528727968|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
146606322|NCT03100058|528727969|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
146606323|NCT03100058|528727970|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
146606324|NCT03100058|528727971|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
146606325|NCT03100058|528727972|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
146606326|NCT03100058|528727973|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
146606327|NCT03100058|528727974|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
146606328|NCT03100058|528727975|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
146606329|NCT03100058|528727976|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
146606330|NCT03100058|528727977|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
146606331|NCT03100058|528727978|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
146606332|NCT03100058|528727979|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
146606333|NCT03100058|528727980|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
146606334|NCT03100058|528727968|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
146606335|NCT03100058|528727969|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
146606336|NCT03100058|528727970|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
146606337|NCT03100058|528727971|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
146606338|NCT03100058|528727972|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
146606339|NCT03100058|528727973|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
146606340|NCT03100058|528727974|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
146606341|NCT03100058|528727975|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
146606342|NCT03100058|528727976|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
146606343|NCT03100058|528727977|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
146606344|NCT03100058|528727978|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
146606345|NCT03100058|528727979|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
146606346|NCT03100058|528727980|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
146606347|NCT03100058|528727968|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146606348|NCT03100058|528727969|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
146606349|NCT03100058|528727970|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
146606350|NCT03100058|528727971|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146606351|NCT03100058|528727972|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146606352|NCT03100058|528727973|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
146606353|NCT03100058|528727974|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
146606354|NCT03100058|528727975|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146657051|NCT03355664|528921670|FG000|Overall Study|Lost to Follow-up|11|||
146657052|NCT03355664|528921671|FG001|Overall Study|Lost to Follow-up|7|||
146657053|NCT03355664|528921670|FG000|Overall Study|Protocol Violation|1|||
146657054|NCT03355664|528921671|FG001|Overall Study|Protocol Violation|2|||
146606355|NCT03100058|528727976|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146606356|NCT03100058|528727977|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146606357|NCT03100058|528727978|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146606358|NCT03100058|528727979|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146606359|NCT03100058|528727980|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146978663|NCT01246986|530085449|FG000|Overall Study|Withdrawal by Subject|3|||
146606360|NCT03100058|528727968|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146606361|NCT03100058|528727969|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
146606362|NCT03100058|528727970|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
146606363|NCT03100058|528727971|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146606364|NCT03100058|528727972|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146606365|NCT03100058|528727973|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146606366|NCT03100058|528727974|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
146606367|NCT03100058|528727975|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146606368|NCT03100058|528727976|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
146606369|NCT03100058|528727977|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146606370|NCT03100058|528727978|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146606371|NCT03100058|528727979|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146606372|NCT03100058|528727980|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146606373|NCT03100058|528727968|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146606374|NCT03100058|528727969|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146606375|NCT03100058|528727970|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146606376|NCT03100058|528727971|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
146606377|NCT03100058|528727972|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146606378|NCT03100058|528727973|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146606379|NCT03100058|528727974|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146606380|NCT03100058|528727975|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
146606381|NCT03100058|528727976|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146606382|NCT03100058|528727977|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146606383|NCT03100058|528727978|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146606384|NCT03100058|528727979|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146606385|NCT03100058|528727980|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146606386|NCT03100058|528727968|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146606387|NCT03100058|528727969|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146606388|NCT03100058|528727970|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146606389|NCT03100058|528727971|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
146606390|NCT03100058|528727972|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146606391|NCT03100058|528727973|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146606392|NCT03100058|528727974|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
146606393|NCT03100058|528727975|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146606394|NCT03100058|528727976|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146606395|NCT03100058|528727977|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146606396|NCT03100058|528727978|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146606397|NCT03100058|528727979|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146606398|NCT03100058|528727980|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146606399|NCT03100058|528727968|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146606400|NCT03100058|528727969|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
146606401|NCT03100058|528727970|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146606402|NCT03100058|528727971|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146606403|NCT03100058|528727972|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146606404|NCT03100058|528727973|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146606405|NCT03100058|528727974|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146606406|NCT03100058|528727975|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146606407|NCT03100058|528727976|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146606408|NCT03100058|528727977|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146606409|NCT03100058|528727978|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146606410|NCT03100058|528727979|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146606411|NCT03100058|528727980|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146606412|NCT03100058|528727968|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
146606413|NCT03100058|528727969|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146606414|NCT03100058|528727970|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146606415|NCT03100058|528727971|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146606416|NCT03100058|528727972|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146606417|NCT03100058|528727973|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146606418|NCT03100058|528727974|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146606419|NCT03100058|528727975|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146606420|NCT03100058|528727976|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146606421|NCT03100058|528727977|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146657055|NCT03355664|528921670|FG000|Overall Study|Withdrawal by Subject|2|||
146657056|NCT03355664|528921671|FG001|Overall Study|Withdrawal by Subject|1|||
146657057|NCT00423670|528921677|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
146922944|NCT02616185|529878684|FG005|Overall Study|Study terminated by sponsor|0|||
146922945|NCT02616185|529878685|FG006|Overall Study|Study terminated by sponsor|5|||
146922946|NCT02616185|529878686|FG007|Overall Study|Study terminated by sponsor|2|||
146922947|NCT02616185|529878687|FG008|Overall Study|Study terminated by sponsor|0|||
146606422|NCT03100058|528727978|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146606423|NCT03100058|528727979|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146606424|NCT03100058|528727980|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146606425|NCT03100058|528727968|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146606426|NCT03100058|528727969|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146606427|NCT03100058|528727970|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146606428|NCT03100058|528727971|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146606429|NCT03100058|528727972|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146606430|NCT03100058|528727973|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146606431|NCT03100058|528727974|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
146606432|NCT03100058|528727975|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146606433|NCT03100058|528727976|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146606434|NCT03100058|528727977|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146606435|NCT03100058|528727978|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146606436|NCT03100058|528727979|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146606437|NCT03100058|528727980|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146606438|NCT03100058|528727968|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146606439|NCT03100058|528727969|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146606440|NCT03100058|528727970|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146606441|NCT03100058|528727971|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146606442|NCT03100058|528727972|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146606443|NCT03100058|528727973|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146606444|NCT03100058|528727974|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146606445|NCT03100058|528727975|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146606446|NCT03100058|528727976|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146606447|NCT03100058|528727977|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146606448|NCT03100058|528727978|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
146606449|NCT03100058|528727979|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
146606450|NCT03100058|528727980|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
146606451|NCT03100058|528727968|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146606452|NCT03100058|528727969|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146606453|NCT03100058|528727970|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146606454|NCT03100058|528727971|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146606455|NCT03100058|528727972|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146606456|NCT03100058|528727973|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146606457|NCT03100058|528727974|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146606458|NCT03100058|528727975|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146606459|NCT03100058|528727976|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146606460|NCT03100058|528727977|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146606461|NCT03100058|528727978|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
146606462|NCT03100058|528727979|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
146606463|NCT03100058|528727980|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146606464|NCT03100058|528727968|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146606465|NCT03100058|528727969|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146606466|NCT03100058|528727970|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146606467|NCT03100058|528727971|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146606468|NCT03100058|528727972|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146606469|NCT03100058|528727973|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146606470|NCT03100058|528727974|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146606471|NCT03100058|528727975|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146606472|NCT03100058|528727976|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146606473|NCT03100058|528727977|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
146773057|NCT03903822|529338238|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
146606474|NCT03100058|528727978|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
146606475|NCT03100058|528727979|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146606476|NCT03100058|528727980|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
146606477|NCT03100058|528727968|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146606478|NCT03100058|528727969|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146606479|NCT03100058|528727970|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146606480|NCT03100058|528727971|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146606481|NCT03100058|528727972|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146606482|NCT03100058|528727973|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146606483|NCT03100058|528727974|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146606484|NCT03100058|528727975|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146606485|NCT03100058|528727976|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146606486|NCT03100058|528727977|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146606487|NCT03100058|528727978|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
146606488|NCT03100058|528727979|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146606489|NCT03100058|528727980|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146606490|NCT03100058|528727968|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146606491|NCT03100058|528727969|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146606492|NCT03100058|528727970|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146606493|NCT03100058|528727971|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146606494|NCT03100058|528727972|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146606495|NCT03100058|528727973|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146606496|NCT03100058|528727974|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146606497|NCT03100058|528727975|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146606498|NCT03100058|528727976|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146606499|NCT03100058|528727977|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146657058|NCT00423670|528921678|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
146657059|NCT00423670|528921679|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
146657060|NCT00423670|528921680|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
146657061|NCT00423670|528921681|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
146657062|NCT00423670|528921682|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
146657063|NCT00423670|528921683|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
146773058|NCT03903822|529338239|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
146773059|NCT03903822|529338240|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
146773060|NCT03903822|529338241|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
146773061|NCT03903822|529338234|FG000|Follow up Phase (4 Weeks)|Other|1|||
146773062|NCT03903822|529338235|FG001|Follow up Phase (4 Weeks)|Other|1|||
146773063|NCT03903822|529338236|FG002|Follow up Phase (4 Weeks)|Other|0|||
146773064|NCT03903822|529338237|FG003|Follow up Phase (4 Weeks)|Other|0|||
146773065|NCT03903822|529338238|FG004|Follow up Phase (4 Weeks)|Other|0|||
146773066|NCT03903822|529338239|FG005|Follow up Phase (4 Weeks)|Other|0|||
146773067|NCT03903822|529338240|FG006|Follow up Phase (4 Weeks)|Other|0|||
146773068|NCT03903822|529338241|FG007|Follow up Phase (4 Weeks)|Other|0|||
146773069|NCT05274217|529338263|FG000|Overall Study|Study terminated.|11|||
146773070|NCT05274217|529338264|FG001|Overall Study|Study terminated.|0|||
146773071|NCT04594759|529338265|FG000|Overall Study|Lost to Follow-up|3|||
146773072|NCT01395758|529338272|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
146773073|NCT01395758|529338273|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
146773074|NCT01395758|529338274|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
146773075|NCT01041417|529338281|FG000|Overall Study|Adverse Event|5|||
146773076|NCT01041417|529338282|FG001|Overall Study|Adverse Event|2|||
146773077|NCT01041417|529338281|FG000|Overall Study|Lost to Follow-up|1|||
146773078|NCT01041417|529338282|FG001|Overall Study|Lost to Follow-up|1|||
146773079|NCT01041417|529338281|FG000|Overall Study|Death|1|||
146773080|NCT01041417|529338282|FG001|Overall Study|Death|0|||
146773081|NCT03473340|529338283|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
146773082|NCT03473340|529338284|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
146773083|NCT03473340|529338283|FG000|Overall Study|Withdrawal by Subject|1|||
146773084|NCT03473340|529338284|FG001|Overall Study|Withdrawal by Subject|0|||
146773085|NCT03473340|529338283|FG000|Overall Study|Lost to Follow-up|1|||
146773086|NCT03473340|529338284|FG001|Overall Study|Lost to Follow-up|2|||
146773087|NCT01212991|529338287|FG000|Double-blind|Lost to Follow-up|8|||
146773088|NCT01212991|529338288|FG001|Double-blind|Lost to Follow-up|4|||
146773089|NCT01212991|529338289|FG002|Double-blind|Lost to Follow-up|0|||
146773090|NCT01212991|529338287|FG000|Double-blind|Death|699|||
146773091|NCT01212991|529338288|FG001|Double-blind|Death|550|||
146773092|NCT01212991|529338289|FG002|Double-blind|Death|0|||
146773093|NCT01212991|529338287|FG000|Double-blind|Withdrawal by Subject|16|||
146773094|NCT01212991|529338288|FG001|Double-blind|Withdrawal by Subject|19|||
146773095|NCT01212991|529338289|FG002|Double-blind|Withdrawal by Subject|0|||
146657064|NCT00423670|528921684|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
146657065|NCT00423670|528921677|FG000|Treatment Period|Adverse Event|8|||
146657066|NCT00423670|528921678|FG001|Treatment Period|Adverse Event|12|||
146657067|NCT00423670|528921679|FG002|Treatment Period|Adverse Event|15|||
146657068|NCT00423670|528921680|FG003|Treatment Period|Adverse Event|20|||
146657069|NCT00423670|528921681|FG004|Treatment Period|Adverse Event|9|||
146657070|NCT00423670|528921682|FG005|Treatment Period|Adverse Event|4|||
146773096|NCT01212991|529338287|FG000|Double-blind|Other|7|||
146773097|NCT01212991|529338288|FG001|Double-blind|Other|0|||
146773098|NCT01212991|529338289|FG002|Double-blind|Other|0|||
146773099|NCT01212991|529338287|FG000|Double-blind|Sponsor decision|142|||
146922948|NCT02616185|529878679|FG000|Overall Study|Participant refused further follow-up|1|||
146922949|NCT02616185|529878680|FG001|Overall Study|Participant refused further follow-up|1|||
146657071|NCT00423670|528921683|FG006|Treatment Period|Adverse Event|7|||
146657072|NCT00423670|528921684|FG007|Treatment Period|Adverse Event|2|||
146773100|NCT01212991|529338288|FG001|Double-blind|Sponsor decision|38|||
146773101|NCT01212991|529338289|FG002|Double-blind|Sponsor decision|0|||
146773102|NCT01212991|529338287|FG000|Open-label|Death|0|||
146773103|NCT01212991|529338288|FG001|Open-label|Death|0|||
146773104|NCT01212991|529338289|FG002|Open-label|Death|166|||
146606500|NCT03100058|528727978|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146606501|NCT03100058|528727979|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146606502|NCT03100058|528727980|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
146606503|NCT03100058|528727968|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146606504|NCT03100058|528727969|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146606505|NCT03100058|528727970|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146606506|NCT03100058|528727971|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146606507|NCT03100058|528727972|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146606508|NCT03100058|528727973|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146606509|NCT03100058|528727974|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146606510|NCT03100058|528727975|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146606511|NCT03100058|528727976|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146606512|NCT03100058|528727977|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
146606513|NCT03100058|528727978|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146606514|NCT03100058|528727979|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146606515|NCT03100058|528727980|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146606516|NCT02718716|528727981|FG000|Overall Study|Lack of Efficacy|1|||
146606517|NCT02718716|528727982|FG001|Overall Study|Lack of Efficacy|0|||
146606518|NCT02718716|528727983|FG002|Overall Study|Lack of Efficacy|0|||
146606519|NCT02718716|528727984|FG003|Overall Study|Lack of Efficacy|0|||
146606520|NCT02718716|528727985|FG004|Overall Study|Lack of Efficacy|0|||
146606521|NCT02942485|528727986|FG000|Overall Study|Lost to Follow-up|1|||
146606522|NCT02942485|528727987|FG001|Overall Study|Lost to Follow-up|0|||
146606523|NCT03194646|528727992|FG000|Overall Study|Adverse Event|24|||
146606524|NCT03194646|528727993|FG001|Overall Study|Adverse Event|25|||
146606525|NCT03194646|528727994|FG002|Overall Study|Adverse Event|14|||
146606526|NCT03194646|528727995|FG003|Overall Study|Adverse Event|17|||
146606527|NCT03194646|528727992|FG000|Overall Study|Lack of Efficacy|4|||
146606528|NCT03194646|528727993|FG001|Overall Study|Lack of Efficacy|2|||
146606529|NCT03194646|528727994|FG002|Overall Study|Lack of Efficacy|2|||
146606530|NCT03194646|528727995|FG003|Overall Study|Lack of Efficacy|12|||
146606531|NCT03194646|528727992|FG000|Overall Study|Lost to Follow-up|30|||
146606532|NCT03194646|528727993|FG001|Overall Study|Lost to Follow-up|22|||
146606533|NCT03194646|528727994|FG002|Overall Study|Lost to Follow-up|12|||
146773105|NCT01212991|529338287|FG000|Open-label|Lost to Follow-up|0|||
146773106|NCT01212991|529338288|FG001|Open-label|Lost to Follow-up|0|||
146773107|NCT01212991|529338289|FG002|Open-label|Lost to Follow-up|5|||
146773108|NCT01212991|529338287|FG000|Open-label|Withdrawal by Subject|0|||
146773109|NCT01212991|529338288|FG001|Open-label|Withdrawal by Subject|0|||
146773110|NCT01212991|529338289|FG002|Open-label|Withdrawal by Subject|7|||
146773111|NCT01212991|529338287|FG000|Open-label|Sponsor decision|0|||
146773112|NCT01212991|529338288|FG001|Open-label|Sponsor decision|0|||
146773113|NCT01212991|529338289|FG002|Open-label|Sponsor decision|53|||
146606534|NCT03194646|528727995|FG003|Overall Study|Lost to Follow-up|35|||
146606535|NCT03194646|528727992|FG000|Overall Study|Non-compliance with study drug|4|||
146657073|NCT00423670|528921677|FG000|Treatment Period|Protocol-defined clinical event|0|||
146657074|NCT00423670|528921678|FG001|Treatment Period|Protocol-defined clinical event|7|||
146657075|NCT00423670|528921679|FG002|Treatment Period|Protocol-defined clinical event|4|||
146657076|NCT00423670|528921680|FG003|Treatment Period|Protocol-defined clinical event|12|||
146657077|NCT00423670|528921681|FG004|Treatment Period|Protocol-defined clinical event|5|||
146657078|NCT00423670|528921682|FG005|Treatment Period|Protocol-defined clinical event|4|||
146657079|NCT00423670|528921683|FG006|Treatment Period|Protocol-defined clinical event|16|||
146657080|NCT00423670|528921684|FG007|Treatment Period|Protocol-defined clinical event|15|||
146657081|NCT00423670|528921677|FG000|Treatment Period|Lost to Follow-up|2|||
146657082|NCT00423670|528921678|FG001|Treatment Period|Lost to Follow-up|1|||
146657083|NCT00423670|528921679|FG002|Treatment Period|Lost to Follow-up|3|||
146657084|NCT00423670|528921680|FG003|Treatment Period|Lost to Follow-up|1|||
146657085|NCT00423670|528921681|FG004|Treatment Period|Lost to Follow-up|6|||
146657086|NCT00423670|528921682|FG005|Treatment Period|Lost to Follow-up|0|||
146657087|NCT00423670|528921683|FG006|Treatment Period|Lost to Follow-up|3|||
146657088|NCT00423670|528921684|FG007|Treatment Period|Lost to Follow-up|1|||
146606536|NCT03194646|528727993|FG001|Overall Study|Non-compliance with study drug|0|||
146657089|NCT00423670|528921677|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
146657090|NCT00423670|528921678|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
146657091|NCT00423670|528921679|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
146773114|NCT01212991|529338287|FG000|Open-label|Other|0|||
146606537|NCT03194646|528727994|FG002|Overall Study|Non-compliance with study drug|1|||
146606538|NCT03194646|528727995|FG003|Overall Study|Non-compliance with study drug|1|||
146606539|NCT03194646|528727992|FG000|Overall Study|Other|89|||
146773115|NCT01212991|529338288|FG001|Open-label|Other|0|||
146773116|NCT01212991|529338289|FG002|Open-label|Other|3|||
146773117|NCT04411056|529339472|FG000|Overall Study|surgery cancelled|1|||
146773118|NCT04411056|529339473|FG001|Overall Study|surgery cancelled|0|||
146773119|NCT04411056|529339472|FG000|Overall Study|Equipment problem during intubation|0|||
146773120|NCT04411056|529339473|FG001|Overall Study|Equipment problem during intubation|1|||
146773121|NCT04623008|529339474|FG000|Baseline to T2|Withdrawal by Subject|4|||
146773122|NCT04623008|529339475|FG001|Baseline to T2|Withdrawal by Subject|2|||
146773123|NCT04623008|529339474|FG000|Baseline to T3|Withdrawal by Subject|4|||
146606540|NCT03194646|528727993|FG001|Overall Study|Other|68|||
146606541|NCT03194646|528727994|FG002|Overall Study|Other|34|||
146606542|NCT03194646|528727995|FG003|Overall Study|Other|31|||
146606543|NCT03194646|528727992|FG000|Overall Study|Physician Decision|7|||
146606544|NCT03194646|528727993|FG001|Overall Study|Physician Decision|9|||
146606545|NCT03194646|528727994|FG002|Overall Study|Physician Decision|5|||
146606546|NCT03194646|528727995|FG003|Overall Study|Physician Decision|4|||
146606547|NCT03194646|528727992|FG000|Overall Study|Pregnancy|4|||
146606548|NCT03194646|528727993|FG001|Overall Study|Pregnancy|5|||
146606549|NCT03194646|528727994|FG002|Overall Study|Pregnancy|1|||
146606550|NCT03194646|528727995|FG003|Overall Study|Pregnancy|2|||
146606551|NCT03194646|528727992|FG000|Overall Study|Protocol Violation|4|||
146606552|NCT03194646|528727993|FG001|Overall Study|Protocol Violation|2|||
146606553|NCT03194646|528727994|FG002|Overall Study|Protocol Violation|1|||
146606554|NCT03194646|528727995|FG003|Overall Study|Protocol Violation|1|||
146606555|NCT03194646|528727992|FG000|Overall Study|Site terminated by sponsor|0|||
146606556|NCT03194646|528727993|FG001|Overall Study|Site terminated by sponsor|0|||
146606557|NCT03194646|528727994|FG002|Overall Study|Site terminated by sponsor|2|||
146606558|NCT03194646|528727995|FG003|Overall Study|Site terminated by sponsor|0|||
146606559|NCT03194646|528727992|FG000|Overall Study|Study terminated by sponsor|62|||
146606560|NCT03194646|528727993|FG001|Overall Study|Study terminated by sponsor|61|||
146606561|NCT03194646|528727994|FG002|Overall Study|Study terminated by sponsor|30|||
146606562|NCT03194646|528727995|FG003|Overall Study|Study terminated by sponsor|34|||
146606563|NCT03194646|528727992|FG000|Overall Study|Withdrawal by Subject|75|||
146606564|NCT03194646|528727993|FG001|Overall Study|Withdrawal by Subject|74|||
146606565|NCT03194646|528727994|FG002|Overall Study|Withdrawal by Subject|36|||
146606566|NCT03194646|528727995|FG003|Overall Study|Withdrawal by Subject|131|||
146606567|NCT03194646|528727992|FG000|Overall Study|Missing|1|||
146606568|NCT03194646|528727993|FG001|Overall Study|Missing|0|||
146606569|NCT03194646|528727994|FG002|Overall Study|Missing|1|||
146606570|NCT03194646|528727995|FG003|Overall Study|Missing|12|||
146606571|NCT02141360|528727996|FG000|Overall Study|Withdrawal by Subject|6|||
146606572|NCT02141360|528727997|FG001|Overall Study|Withdrawal by Subject|0|||
146606573|NCT02141360|528727998|FG002|Overall Study|Withdrawal by Subject|0|||
146606574|NCT02141360|528727996|FG000|Overall Study|Study Terminated before Visit|1|||
146606575|NCT02141360|528727997|FG001|Overall Study|Study Terminated before Visit|0|||
146606576|NCT02141360|528727998|FG002|Overall Study|Study Terminated before Visit|0|||
146606577|NCT00098306|528728000|FG000|Double Blind|Randomized, not treated|9|||
146606578|NCT00098306|528728001|FG001|Double Blind|Randomized, not treated|5|||
146606579|NCT00098306|528728002|FG002|Double Blind|Randomized, not treated|2|||
146606580|NCT00098306|528728003|FG003|Double Blind|Randomized, not treated|0|||
146606581|NCT00098306|528728004|FG004|Double Blind|Randomized, not treated|0|||
146606582|NCT00098306|528728005|FG005|Double Blind|Randomized, not treated|0|||
146606583|NCT00098306|528728006|FG006|Double Blind|Randomized, not treated|0|||
146606584|NCT00098306|528728000|FG000|Double Blind|Ongoing at cut-off date|151|||
146606585|NCT00098306|528728001|FG001|Double Blind|Ongoing at cut-off date|166|||
146606586|NCT00098306|528728002|FG002|Double Blind|Ongoing at cut-off date|72|||
146606587|NCT00098306|528728003|FG003|Double Blind|Ongoing at cut-off date|0|||
146606588|NCT00098306|528728004|FG004|Double Blind|Ongoing at cut-off date|0|||
146606589|NCT00098306|528728005|FG005|Double Blind|Ongoing at cut-off date|0|||
146606590|NCT00098306|528728006|FG006|Double Blind|Ongoing at cut-off date|0|||
146606591|NCT00098306|528728000|FG000|Double Blind|Adverse Event|11|||
146606592|NCT00098306|528728001|FG001|Double Blind|Adverse Event|10|||
146606593|NCT00098306|528728002|FG002|Double Blind|Adverse Event|6|||
146606594|NCT00098306|528728003|FG003|Double Blind|Adverse Event|0|||
146606595|NCT00098306|528728004|FG004|Double Blind|Adverse Event|0|||
146606596|NCT00098306|528728005|FG005|Double Blind|Adverse Event|0|||
146606597|NCT00098306|528728006|FG006|Double Blind|Adverse Event|0|||
146606598|NCT00098306|528728000|FG000|Double Blind|Lack of Efficacy|43|||
146773124|NCT04623008|529339475|FG001|Baseline to T3|Withdrawal by Subject|2|||
146773125|NCT03122886|529339487|FG000|Overall Study|Withdrawal by Subject|1|||
146773126|NCT03122886|529339488|FG001|Overall Study|Withdrawal by Subject|2|||
146606599|NCT00098306|528728001|FG001|Double Blind|Lack of Efficacy|34|||
146606600|NCT00098306|528728002|FG002|Double Blind|Lack of Efficacy|17|||
146606601|NCT00098306|528728003|FG003|Double Blind|Lack of Efficacy|0|||
146606602|NCT00098306|528728004|FG004|Double Blind|Lack of Efficacy|0|||
146606603|NCT00098306|528728005|FG005|Double Blind|Lack of Efficacy|0|||
146606604|NCT00098306|528728006|FG006|Double Blind|Lack of Efficacy|0|||
146606605|NCT00098306|528728000|FG000|Double Blind|Death|1|||
146773127|NCT05985044|529339489|FG000|Overall Study|Death|6|||
146606606|NCT00098306|528728001|FG001|Double Blind|Death|4|||
146606607|NCT00098306|528728002|FG002|Double Blind|Death|1|||
146606608|NCT00098306|528728003|FG003|Double Blind|Death|0|||
146606609|NCT00098306|528728004|FG004|Double Blind|Death|0|||
146606610|NCT00098306|528728005|FG005|Double Blind|Death|0|||
146606611|NCT00098306|528728006|FG006|Double Blind|Death|0|||
146606612|NCT00098306|528728000|FG000|Double Blind|Participant defaulted|19|||
146606613|NCT00098306|528728001|FG001|Double Blind|Participant defaulted|18|||
146606614|NCT00098306|528728002|FG002|Double Blind|Participant defaulted|11|||
146606615|NCT00098306|528728003|FG003|Double Blind|Participant defaulted|0|||
146606616|NCT00098306|528728004|FG004|Double Blind|Participant defaulted|0|||
146606617|NCT00098306|528728005|FG005|Double Blind|Participant defaulted|0|||
146606618|NCT00098306|528728006|FG006|Double Blind|Participant defaulted|0|||
146606619|NCT00098306|528728000|FG000|Double Blind|Un-specified|7|||
146606620|NCT00098306|528728001|FG001|Double Blind|Un-specified|3|||
146606621|NCT00098306|528728002|FG002|Double Blind|Un-specified|11|||
146606622|NCT00098306|528728003|FG003|Double Blind|Un-specified|0|||
146606623|NCT00098306|528728004|FG004|Double Blind|Un-specified|0|||
146606624|NCT00098306|528728005|FG005|Double Blind|Un-specified|0|||
146657092|NCT00423670|528921680|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
146657093|NCT00423670|528921681|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
146657094|NCT00423670|528921682|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
146657095|NCT00423670|528921683|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
146922950|NCT02616185|529878681|FG002|Overall Study|Participant refused further follow-up|2|||
146922951|NCT02616185|529878682|FG003|Overall Study|Participant refused further follow-up|3|||
146922952|NCT02616185|529878683|FG004|Overall Study|Participant refused further follow-up|4|||
146922953|NCT02616185|529878684|FG005|Overall Study|Participant refused further follow-up|0|||
146922954|NCT02616185|529878685|FG006|Overall Study|Participant refused further follow-up|3|||
146922955|NCT02616185|529878686|FG007|Overall Study|Participant refused further follow-up|4|||
146922956|NCT02616185|529878687|FG008|Overall Study|Participant refused further follow-up|3|||
146922957|NCT02616185|529878679|FG000|Overall Study|Not reported|0|||
146922958|NCT02616185|529878680|FG001|Overall Study|Not reported|0|||
146606625|NCT00098306|528728006|FG006|Double Blind|Un-specified|0|||
146606626|NCT00098306|528728000|FG000|Open Label|Lack of Efficacy|0|||
146606627|NCT00098306|528728001|FG001|Open Label|Lack of Efficacy|0|||
146606628|NCT00098306|528728002|FG002|Open Label|Lack of Efficacy|0|||
146657096|NCT00423670|528921684|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
146657097|NCT00423670|528921677|FG000|Treatment Period|Investigator decision|0|||
146657098|NCT00423670|528921678|FG001|Treatment Period|Investigator decision|0|||
146657099|NCT00423670|528921679|FG002|Treatment Period|Investigator decision|0|||
146657100|NCT00423670|528921680|FG003|Treatment Period|Investigator decision|0|||
146657101|NCT00423670|528921681|FG004|Treatment Period|Investigator decision|0|||
146657102|NCT00423670|528921682|FG005|Treatment Period|Investigator decision|0|||
146657103|NCT00423670|528921683|FG006|Treatment Period|Investigator decision|0|||
146657104|NCT00423670|528921684|FG007|Treatment Period|Investigator decision|1|||
146657105|NCT00423670|528921677|FG000|Treatment Period|Non-compliance with protocol|3|||
146657106|NCT00423670|528921678|FG001|Treatment Period|Non-compliance with protocol|1|||
146657107|NCT00423670|528921679|FG002|Treatment Period|Non-compliance with protocol|1|||
146657108|NCT00423670|528921680|FG003|Treatment Period|Non-compliance with protocol|3|||
146657109|NCT00423670|528921681|FG004|Treatment Period|Non-compliance with protocol|2|||
146657110|NCT00423670|528921682|FG005|Treatment Period|Non-compliance with protocol|0|||
146657111|NCT00423670|528921683|FG006|Treatment Period|Non-compliance with protocol|2|||
146657112|NCT00423670|528921684|FG007|Treatment Period|Non-compliance with protocol|2|||
146657113|NCT00423670|528921677|FG000|Follow-up Period|Lost to Follow-up|0|||
146657114|NCT00423670|528921678|FG001|Follow-up Period|Lost to Follow-up|12|||
146657115|NCT00423670|528921679|FG002|Follow-up Period|Lost to Follow-up|8|||
146657116|NCT00423670|528921680|FG003|Follow-up Period|Lost to Follow-up|3|||
146657117|NCT00423670|528921681|FG004|Follow-up Period|Lost to Follow-up|1|||
146657118|NCT00423670|528921682|FG005|Follow-up Period|Lost to Follow-up|0|||
146657119|NCT00423670|528921683|FG006|Follow-up Period|Lost to Follow-up|5|||
146657120|NCT00423670|528921684|FG007|Follow-up Period|Lost to Follow-up|0|||
146657121|NCT00423670|528921677|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
146657122|NCT00423670|528921678|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
146657123|NCT00423670|528921679|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
146657124|NCT00423670|528921680|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
146657125|NCT00423670|528921681|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
146657126|NCT00423670|528921682|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
146657127|NCT00423670|528921683|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
146657128|NCT00423670|528921684|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
146922959|NCT02616185|529878681|FG002|Overall Study|Not reported|0|||
146922960|NCT02616185|529878682|FG003|Overall Study|Not reported|1|||
146922961|NCT02616185|529878683|FG004|Overall Study|Not reported|3|||
146606629|NCT00098306|528728003|FG003|Open Label|Lack of Efficacy|13|||
146606630|NCT00098306|528728004|FG004|Open Label|Lack of Efficacy|0|||
146606631|NCT00098306|528728005|FG005|Open Label|Lack of Efficacy|0|||
146606632|NCT00098306|528728006|FG006|Open Label|Lack of Efficacy|0|||
146606633|NCT00098306|528728000|FG000|Open Label|Adverse Event|0|||
146606634|NCT00098306|528728001|FG001|Open Label|Adverse Event|0|||
146606635|NCT00098306|528728002|FG002|Open Label|Adverse Event|0|||
146606636|NCT00098306|528728003|FG003|Open Label|Adverse Event|2|||
146606637|NCT00098306|528728004|FG004|Open Label|Adverse Event|0|||
146606638|NCT00098306|528728005|FG005|Open Label|Adverse Event|0|||
146606639|NCT00098306|528728006|FG006|Open Label|Adverse Event|0|||
146606640|NCT00098306|528728000|FG000|Open Label|Death|0|||
146606641|NCT00098306|528728001|FG001|Open Label|Death|0|||
146606642|NCT00098306|528728002|FG002|Open Label|Death|0|||
146606643|NCT00098306|528728003|FG003|Open Label|Death|4|||
146606644|NCT00098306|528728004|FG004|Open Label|Death|0|||
146606645|NCT00098306|528728005|FG005|Open Label|Death|0|||
146606646|NCT00098306|528728006|FG006|Open Label|Death|0|||
146606647|NCT00098306|528728000|FG000|Open Label|Participant defaulted|0|||
146606648|NCT00098306|528728001|FG001|Open Label|Participant defaulted|0|||
146606649|NCT00098306|528728002|FG002|Open Label|Participant defaulted|0|||
146606650|NCT00098306|528728003|FG003|Open Label|Participant defaulted|24|||
146606651|NCT00098306|528728004|FG004|Open Label|Participant defaulted|0|||
146606652|NCT00098306|528728005|FG005|Open Label|Participant defaulted|0|||
146606653|NCT00098306|528728006|FG006|Open Label|Participant defaulted|0|||
146606654|NCT00098306|528728000|FG000|Open Label|Un-specified|0|||
146606655|NCT00098306|528728001|FG001|Open Label|Un-specified|0|||
146606656|NCT00098306|528728002|FG002|Open Label|Un-specified|0|||
146606657|NCT00098306|528728003|FG003|Open Label|Un-specified|15|||
146606658|NCT00098306|528728004|FG004|Open Label|Un-specified|0|||
146606659|NCT00098306|528728005|FG005|Open Label|Un-specified|0|||
146606660|NCT00098306|528728006|FG006|Open Label|Un-specified|0|||
146606661|NCT00098306|528728000|FG000|Open Label|Ongoing at cut-off date|0|||
146606662|NCT00098306|528728001|FG001|Open Label|Ongoing at cut-off date|0|||
146606663|NCT00098306|528728002|FG002|Open Label|Ongoing at cut-off date|0|||
146606664|NCT00098306|528728003|FG003|Open Label|Ongoing at cut-off date|269|||
146606665|NCT00098306|528728004|FG004|Open Label|Ongoing at cut-off date|62|||
146606666|NCT00098306|528728005|FG005|Open Label|Ongoing at cut-off date|0|||
146606667|NCT00098306|528728006|FG006|Open Label|Ongoing at cut-off date|0|||
146606668|NCT00098306|528728000|FG000|Observational Phase|Death|0|||
146606669|NCT00098306|528728001|FG001|Observational Phase|Death|0|||
146606670|NCT00098306|528728002|FG002|Observational Phase|Death|0|||
146606671|NCT00098306|528728003|FG003|Observational Phase|Death|0|||
146606672|NCT00098306|528728004|FG004|Observational Phase|Death|0|||
146606673|NCT00098306|528728005|FG005|Observational Phase|Death|5|||
146606674|NCT00098306|528728006|FG006|Observational Phase|Death|4|||
146606675|NCT00098306|528728000|FG000|Observational Phase|Participant defaulted|0|||
146606676|NCT00098306|528728001|FG001|Observational Phase|Participant defaulted|0|||
146606677|NCT00098306|528728002|FG002|Observational Phase|Participant defaulted|0|||
146606678|NCT00098306|528728003|FG003|Observational Phase|Participant defaulted|0|||
146606679|NCT00098306|528728004|FG004|Observational Phase|Participant defaulted|0|||
146606680|NCT00098306|528728005|FG005|Observational Phase|Participant defaulted|34|||
146606681|NCT00098306|528728006|FG006|Observational Phase|Participant defaulted|18|||
146606682|NCT00098306|528728000|FG000|Observational Phase|Un-specified|0|||
146606683|NCT00098306|528728001|FG001|Observational Phase|Un-specified|0|||
146606684|NCT00098306|528728002|FG002|Observational Phase|Un-specified|0|||
146606685|NCT00098306|528728003|FG003|Observational Phase|Un-specified|0|||
146606686|NCT00098306|528728004|FG004|Observational Phase|Un-specified|0|||
146606687|NCT00098306|528728005|FG005|Observational Phase|Un-specified|7|||
146606688|NCT00098306|528728006|FG006|Observational Phase|Un-specified|4|||
146606689|NCT00129467|528728007|FG000|Received Intervention|Death|1|||
146606690|NCT00129467|528728008|FG001|Received Intervention|Death|1|||
146606691|NCT00129467|528728007|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
146606692|NCT00129467|528728008|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
146606693|NCT00129467|528728007|FG000|Received Intervention|Delirium|2|||
146606694|NCT00129467|528728008|FG001|Received Intervention|Delirium|0|||
146606695|NCT00129467|528728007|FG000|Received Intervention|Withdrawal by Subject|1|||
146606696|NCT00129467|528728008|FG001|Received Intervention|Withdrawal by Subject|0|||
146606697|NCT00129467|528728007|FG000|Received Intervention|Nausea|1|||
146606698|NCT00129467|528728008|FG001|Received Intervention|Nausea|0|||
146606699|NCT00129467|528728007|FG000|Received Intervention|Intolerance to citalopram|0|||
146606700|NCT00129467|528728008|FG001|Received Intervention|Intolerance to citalopram|1|||
146606701|NCT00129467|528728007|FG000|Received Intervention|Dizzyness, fatigue|0|||
146606702|NCT00129467|528728008|FG001|Received Intervention|Dizzyness, fatigue|1|||
146606703|NCT00129467|528728007|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
146606704|NCT00129467|528728008|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
146606705|NCT00129467|528728007|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
146606706|NCT00129467|528728008|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
146606707|NCT01331291|528728009|FG000|Overall Study|Lack of Efficacy|2|||
146606708|NCT01331291|528728010|FG001|Overall Study|Lack of Efficacy|8|||
146606709|NCT01331291|528728009|FG000|Overall Study|Death|0|||
146606710|NCT01331291|528728010|FG001|Overall Study|Death|1|||
146606711|NCT01424228|528728011|FG000|Overall Study|Withdrawal by Subject|27|||
146606712|NCT01424228|528728012|FG001|Overall Study|Withdrawal by Subject|11|||
146606713|NCT01424228|528728011|FG000|Overall Study|Adverse Event|10|||
146606714|NCT01424228|528728012|FG001|Overall Study|Adverse Event|14|||
146606715|NCT01424228|528728011|FG000|Overall Study|Sponsor's decision|9|||
146606716|NCT01424228|528728012|FG001|Overall Study|Sponsor's decision|12|||
146606717|NCT01424228|528728011|FG000|Overall Study|Lack of Efficacy|5|||
146606718|NCT01424228|528728012|FG001|Overall Study|Lack of Efficacy|7|||
146606719|NCT01424228|528728011|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
146606720|NCT01424228|528728012|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
146606721|NCT01424228|528728011|FG000|Overall Study|Non-compliance|2|||
146606722|NCT01424228|528728012|FG001|Overall Study|Non-compliance|0|||
146606723|NCT01424228|528728011|FG000|Overall Study|Worsening of symptoms|1|||
146606724|NCT01424228|528728012|FG001|Overall Study|Worsening of symptoms|0|||
146606725|NCT01424228|528728011|FG000|Overall Study|Unplanned journey|0|||
146606726|NCT01424228|528728012|FG001|Overall Study|Unplanned journey|1|||
146606727|NCT00932165|528728013|FG000|Overall Study|Lost to Follow-up|1|||
146606728|NCT00293020|528728016|FG000|Overall Study|Withdrawal by Subject|34|||
146606729|NCT00293020|528728016|FG000|Overall Study|Adverse Event|30|||
146606730|NCT00293020|528728016|FG000|Overall Study|Death|32|||
146606731|NCT00293020|528728016|FG000|Overall Study|Lack of Efficacy|12|||
146606732|NCT00293020|528728016|FG000|Overall Study|Lost to Follow-up|4|||
146606733|NCT00293020|528728016|FG000|Overall Study|Protocol Violation|6|||
146606734|NCT00293020|528728016|FG000|Overall Study|Physician Decision|21|||
146606735|NCT00293020|528728016|FG000|Overall Study|Other Reason|22|||
146606736|NCT00293020|528728016|FG000|Overall Study|No dose taken|1|||
146606737|NCT00666965|528728017|FG000|Overall Study|Adverse Event|0|||
146606738|NCT00666965|528728018|FG001|Overall Study|Adverse Event|2|||
146606739|NCT00666965|528728019|FG002|Overall Study|Adverse Event|1|||
146606740|NCT00666965|528728020|FG003|Overall Study|Adverse Event|9|||
146606741|NCT00666965|528728017|FG000|Overall Study|Lack of Efficacy|1|||
146606742|NCT00666965|528728018|FG001|Overall Study|Lack of Efficacy|1|||
146606743|NCT00666965|528728019|FG002|Overall Study|Lack of Efficacy|0|||
146606744|NCT00666965|528728020|FG003|Overall Study|Lack of Efficacy|0|||
146606745|NCT00666965|528728017|FG000|Overall Study|Protocol Violation|0|||
146606746|NCT00666965|528728018|FG001|Overall Study|Protocol Violation|0|||
146606747|NCT00666965|528728019|FG002|Overall Study|Protocol Violation|0|||
146606748|NCT00666965|528728020|FG003|Overall Study|Protocol Violation|2|||
146606749|NCT00666965|528728017|FG000|Overall Study|Discontinuation criteria|2|||
146606750|NCT00666965|528728018|FG001|Overall Study|Discontinuation criteria|1|||
146606751|NCT00666965|528728019|FG002|Overall Study|Discontinuation criteria|1|||
146606752|NCT00666965|528728020|FG003|Overall Study|Discontinuation criteria|2|||
146606753|NCT00666965|528728017|FG000|Overall Study|Withdrawal by Subject|0|||
146606754|NCT00666965|528728018|FG001|Overall Study|Withdrawal by Subject|0|||
146606755|NCT00666965|528728019|FG002|Overall Study|Withdrawal by Subject|0|||
146606756|NCT00666965|528728020|FG003|Overall Study|Withdrawal by Subject|2|||
146606757|NCT01894022|528728026|FG000|Overall Study|Death|1|||
146606758|NCT01894022|528728027|FG001|Overall Study|Death|0|||
146657129|NCT00423670|528921677|FG000|Follow-up Period|Non-compliance with protocol|2|||
146657130|NCT00423670|528921678|FG001|Follow-up Period|Non-compliance with protocol|0|||
146657131|NCT00423670|528921679|FG002|Follow-up Period|Non-compliance with protocol|1|||
146657132|NCT00423670|528921680|FG003|Follow-up Period|Non-compliance with protocol|1|||
146657133|NCT00423670|528921681|FG004|Follow-up Period|Non-compliance with protocol|0|||
146657134|NCT00423670|528921682|FG005|Follow-up Period|Non-compliance with protocol|0|||
146657135|NCT00423670|528921683|FG006|Follow-up Period|Non-compliance with protocol|3|||
146657136|NCT00423670|528921684|FG007|Follow-up Period|Non-compliance with protocol|2|||
146657137|NCT04163718|528921685|FG000|Overall Study|Study terminated|12|||
146657138|NCT01466595|528921686|FG000|Overall Study|Withdrawal by Subject|0|||
146657139|NCT01466595|528921687|FG001|Overall Study|Withdrawal by Subject|1|||
146657140|NCT02376829|528921690|FG000|Overall Study|Withdrawal by Subject|27|||
146657141|NCT02376829|528921691|FG001|Overall Study|Withdrawal by Subject|44|||
146657142|NCT03631355|528921692|FG000|Overall Study|Lost to Follow-up|1|||
146657143|NCT03631355|528921693|FG001|Overall Study|Lost to Follow-up|2|||
146657144|NCT02810340|528921694|FG000|Overall Study|Withdrawal by Subject|1|||
146657145|NCT02810340|528921695|FG001|Overall Study|Withdrawal by Subject|0|||
146657146|NCT02810340|528921696|FG002|Overall Study|Withdrawal by Subject|0|||
146657147|NCT02810340|528921694|FG000|Overall Study|Incarceration|0|||
146606759|NCT01894022|528728026|FG000|Overall Study|Adverse Event, non-fatal|1|||
146606760|NCT01894022|528728027|FG001|Overall Study|Adverse Event, non-fatal|0|||
146606761|NCT01894022|528728026|FG000|Overall Study|Study Closed/terminated|7|||
146606762|NCT01894022|528728027|FG001|Overall Study|Study Closed/terminated|10|||
146657148|NCT02810340|528921695|FG001|Overall Study|Incarceration|1|||
146657149|NCT02810340|528921696|FG002|Overall Study|Incarceration|0|||
146657150|NCT02810340|528921694|FG000|Overall Study|Lost to Follow-up|0|||
146657151|NCT02810340|528921695|FG001|Overall Study|Lost to Follow-up|0|||
146657152|NCT02810340|528921696|FG002|Overall Study|Lost to Follow-up|1|||
146606763|NCT02249182|528728031|FG000|Treatment Phase|Lost to Follow-up|4|||
146606764|NCT02249182|528728032|FG001|Treatment Phase|Lost to Follow-up|0|||
146606765|NCT02249182|528728033|FG002|Treatment Phase|Lost to Follow-up|0|||
146606766|NCT02249182|528728034|FG003|Treatment Phase|Lost to Follow-up|0|||
146606767|NCT02249182|528728035|FG004|Treatment Phase|Lost to Follow-up|0|||
146606768|NCT05090852|528728040|FG000|Overall Study|Physician Decision|5|||
146606769|NCT00504894|528728041|FG000|Overall Study|fMRI technical problems|1|||
146606770|NCT00504894|528728042|FG001|Overall Study|fMRI technical problems|1|||
146606771|NCT00504894|528728043|FG002|Overall Study|fMRI technical problems|0|||
146606772|NCT00504894|528728041|FG000|Overall Study|Withdrawal by Subject|0|||
146606773|NCT00504894|528728042|FG001|Overall Study|Withdrawal by Subject|1|||
146606774|NCT00504894|528728043|FG002|Overall Study|Withdrawal by Subject|0|||
146606775|NCT00504894|528728041|FG000|Overall Study|Infusion technical problems|0|||
146606776|NCT00504894|528728042|FG001|Overall Study|Infusion technical problems|1|||
146606777|NCT00504894|528728043|FG002|Overall Study|Infusion technical problems|0|||
146606778|NCT00504894|528728041|FG000|Overall Study|poor subject data|2|||
146606779|NCT00504894|528728042|FG001|Overall Study|poor subject data|0|||
146606780|NCT00504894|528728043|FG002|Overall Study|poor subject data|0|||
146606781|NCT00148941|528728044|FG000|Overall Study|Lost to Follow-up|17|||
146606782|NCT00148941|528728045|FG001|Overall Study|Lost to Follow-up|24|||
146606783|NCT00148941|528728046|FG002|Overall Study|Lost to Follow-up|18|||
146606784|NCT00148941|528728047|FG003|Overall Study|Lost to Follow-up|22|||
146606785|NCT00148941|528728044|FG000|Overall Study|Withdrawal by Subject|1|||
146606786|NCT00148941|528728045|FG001|Overall Study|Withdrawal by Subject|0|||
146606787|NCT00148941|528728046|FG002|Overall Study|Withdrawal by Subject|1|||
146606788|NCT00148941|528728047|FG003|Overall Study|Withdrawal by Subject|0|||
146606789|NCT00148941|528728044|FG000|Overall Study|Other|0|||
146606790|NCT00148941|528728045|FG001|Overall Study|Other|0|||
146606791|NCT00148941|528728046|FG002|Overall Study|Other|1|||
146606792|NCT00148941|528728047|FG003|Overall Study|Other|2|||
146606793|NCT03244826|528728048|FG000|Overall Study|Withdrawal by Subject|2|||
146657153|NCT00870233|528921699|FG000|Overall Study|Withdrawal by Subject|18|||
146657154|NCT00870233|528921699|FG000|Overall Study|Did not undergo laparotomy|3|||
146657155|NCT00870233|528921699|FG000|Overall Study|Incompatible internet browser|2|||
146606794|NCT03244826|528728049|FG001|Overall Study|Withdrawal by Subject|0|||
146606795|NCT03244826|528728048|FG000|Overall Study|Transplant delayed or withdrawn|12|||
146606796|NCT03244826|528728049|FG001|Overall Study|Transplant delayed or withdrawn|10|||
146606797|NCT02673684|528728050|FG000|Overall Study|Study not completed d/t loss of funding|9|||
146606798|NCT02673684|528728051|FG001|Overall Study|Study not completed d/t loss of funding|8|||
146606799|NCT04356040|528728054|FG000|Overall Study|Death|2|||
146606800|NCT04356040|528728055|FG001|Overall Study|Death|0|||
146606801|NCT04356040|528728054|FG000|Overall Study|Lost to Follow-up|1|||
146606802|NCT04356040|528728055|FG001|Overall Study|Lost to Follow-up|0|||
146606803|NCT04356040|528728054|FG000|Overall Study|Physician Decision|0|||
146606804|NCT04356040|528728055|FG001|Overall Study|Physician Decision|1|||
146606805|NCT04356040|528728054|FG000|Overall Study|Withdrawal by Subject|13|||
146606806|NCT04356040|528728055|FG001|Overall Study|Withdrawal by Subject|1|||
146606807|NCT04356040|528728054|FG000|Overall Study|Enrollment Pause|10|||
146606808|NCT04356040|528728055|FG001|Overall Study|Enrollment Pause|0|||
146606809|NCT04356040|528728054|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
146606810|NCT04356040|528728055|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
146606811|NCT04356040|528728054|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
146606812|NCT04356040|528728055|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
146606813|NCT04356040|528728054|FG000|Overall Study|PI left institution|3|||
146606814|NCT04356040|528728055|FG001|Overall Study|PI left institution|0|||
146606815|NCT01092663|528728056|FG000|Overall Study|Withdrawal by Subject|3|||
146606816|NCT01092663|528728057|FG001|Overall Study|Withdrawal by Subject|2|||
146606817|NCT01092663|528728056|FG000|Overall Study|Glucose >300mg/dL|1|||
146606818|NCT01092663|528728057|FG001|Overall Study|Glucose >300mg/dL|0|||
146657156|NCT00870233|528921699|FG000|Overall Study|Death|1|||
146657157|NCT01962922|528921709|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
146657158|NCT01962922|528921710|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
146657159|NCT01962922|528921709|FG000|PK Portion Day 7|non-compliance|1|||
146657160|NCT01962922|528921710|FG001|PK Portion Day 7|non-compliance|0|||
146657161|NCT01962922|528921709|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
146657162|NCT01962922|528921710|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
146657163|NCT01962922|528921709|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
146657164|NCT01962922|528921710|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
146657165|NCT00744471|528921711|FG000|Overall Study|Randomized but not treated|1|||
146773128|NCT05985044|529339489|FG000|Overall Study|Lost to Follow-up|4|||
146773129|NCT05985044|529339489|FG000|Overall Study|Incapacitation|3|||
146773130|NCT05985044|529339489|FG000|Overall Study|Withdrawal by Subject|2|||
146606819|NCT01092663|528728056|FG000|Overall Study|High fasting triglyceride|2|||
146606820|NCT01092663|528728057|FG001|Overall Study|High fasting triglyceride|0|||
146606821|NCT01092663|528728056|FG000|Overall Study|Adverse Event|1|||
146606822|NCT01092663|528728057|FG001|Overall Study|Adverse Event|1|||
146606823|NCT01092663|528728056|FG000|Overall Study|Protocol Violation|0|||
146606824|NCT01092663|528728057|FG001|Overall Study|Protocol Violation|1|||
146606825|NCT01008904|528728058|FG000|Overall Study|Lost to Follow-up|1|||
146606826|NCT01008904|528728058|FG000|Overall Study|Adverse Event|2|||
146606827|NCT01008904|528728058|FG000|Overall Study|unexpected unrelated surgery|1|||
146773131|NCT03312907|529339492|FG000|Overall Study|Adverse Event|1|||
146773132|NCT03312907|529339493|FG001|Overall Study|Adverse Event|6|||
146773133|NCT03312907|529339494|FG002|Overall Study|Adverse Event|1|||
146773134|NCT03312907|529339492|FG000|Overall Study|Protocol Violation|2|||
146773135|NCT03312907|529339493|FG001|Overall Study|Protocol Violation|3|||
146773136|NCT03312907|529339494|FG002|Overall Study|Protocol Violation|4|||
146773137|NCT03312907|529339492|FG000|Overall Study|Lost to Follow-up|2|||
146773138|NCT03312907|529339493|FG001|Overall Study|Lost to Follow-up|3|||
146606828|NCT00360568|528728059|FG000|Overall Study|Adverse Event|1|||
146606829|NCT00360568|528728060|FG001|Overall Study|Adverse Event|2|||
146606830|NCT00360568|528728059|FG000|Overall Study|Lack of Efficacy|1|||
146606831|NCT00360568|528728060|FG001|Overall Study|Lack of Efficacy|0|||
146606832|NCT00360568|528728059|FG000|Overall Study|Withdrawal by Subject|0|||
146606833|NCT00360568|528728060|FG001|Overall Study|Withdrawal by Subject|3|||
146606834|NCT01008449|528728061|FG000|Overall Study|Lost to Follow-up|29|||
146606835|NCT01008449|528728062|FG001|Overall Study|Lost to Follow-up|19|||
146606836|NCT01220180|528728063|FG000|Overall Study|Lost to Follow-up|76|||
146606837|NCT01220180|528728063|FG000|Overall Study|Other|72|||
146606838|NCT01220180|528728063|FG000|Overall Study|Adverse Event|35|||
146606839|NCT01220180|528728063|FG000|Overall Study|Lack of Efficacy|22|||
146606840|NCT01220180|528728063|FG000|Overall Study|Death|1|||
146606841|NCT01220180|528728063|FG000|Overall Study|Randomized but not treated|1|||
146606842|NCT01067469|528728064|FG000|Overall Study|Withdrawal by Subject|0|||
146606843|NCT01067469|528728065|FG001|Overall Study|Withdrawal by Subject|1|||
146606844|NCT01067469|528728064|FG000|Overall Study|Disease Progression|0|||
146606845|NCT01067469|528728065|FG001|Overall Study|Disease Progression|1|||
146606846|NCT01364389|528728068|FG000|Overall Study|Withdrawal by Subject|0|||
146606847|NCT01364389|528728069|FG001|Overall Study|Withdrawal by Subject|1|||
146606848|NCT01364389|528728070|FG002|Overall Study|Withdrawal by Subject|0|||
146606849|NCT01364389|528728068|FG000|Overall Study|Protocol deviation|0|||
146606850|NCT01364389|528728069|FG001|Overall Study|Protocol deviation|0|||
146606851|NCT01364389|528728070|FG002|Overall Study|Protocol deviation|1|||
146606852|NCT01364389|528728068|FG000|Overall Study|Administrative problems|1|||
146606853|NCT01364389|528728069|FG001|Overall Study|Administrative problems|0|||
146606854|NCT01364389|528728070|FG002|Overall Study|Administrative problems|0|||
146606855|NCT01364389|528728068|FG000|Overall Study|Adverse Event|1|||
146606856|NCT01364389|528728069|FG001|Overall Study|Adverse Event|0|||
146606857|NCT01364389|528728070|FG002|Overall Study|Adverse Event|0|||
146606858|NCT01534195|528728071|FG000|Overall Study|Withdrawal by Subject|1|||
146606859|NCT01534195|528728072|FG001|Overall Study|Withdrawal by Subject|1|||
146606860|NCT01959243|528728079|FG000|Overall Study|Investigator Decision|3|||
146606861|NCT01959243|528728080|FG001|Overall Study|Investigator Decision|0|||
146606862|NCT01959243|528728079|FG000|Overall Study|Adverse Event|5|||
146606863|NCT01959243|528728080|FG001|Overall Study|Adverse Event|2|||
146606864|NCT01959243|528728079|FG000|Overall Study|Administrative reasons|2|||
146606865|NCT01959243|528728080|FG001|Overall Study|Administrative reasons|1|||
146606866|NCT01959243|528728079|FG000|Overall Study|Lost to Follow-up|3|||
146606867|NCT01959243|528728080|FG001|Overall Study|Lost to Follow-up|1|||
146606868|NCT01345669|528728081|FG000|Overall Study|Primary tumour recurrence|53|||
146606869|NCT01345669|528728082|FG001|Overall Study|Primary tumour recurrence|32|||
146606870|NCT01345669|528728081|FG000|Overall Study|Second primary tumour|4|||
146606871|NCT01345669|528728082|FG001|Overall Study|Second primary tumour|3|||
146657166|NCT00744471|528921712|FG001|Overall Study|Randomized but not treated|1|||
146657167|NCT00744471|528921713|FG002|Overall Study|Randomized but not treated|4|||
146657168|NCT00744471|528921714|FG003|Overall Study|Randomized but not treated|0|||
146657169|NCT00744471|528921711|FG000|Overall Study|Death|0|||
146657170|NCT00744471|528921712|FG001|Overall Study|Death|0|||
146657171|NCT00744471|528921713|FG002|Overall Study|Death|0|||
146657172|NCT00744471|528921714|FG003|Overall Study|Death|1|||
146657173|NCT00744471|528921711|FG000|Overall Study|Adverse Event|6|||
146773139|NCT03312907|529339494|FG002|Overall Study|Lost to Follow-up|2|||
146773140|NCT03312907|529339492|FG000|Overall Study|Physician Decision|3|||
146773141|NCT03312907|529339493|FG001|Overall Study|Physician Decision|4|||
146922962|NCT02616185|529878684|FG005|Overall Study|Not reported|1|||
146606872|NCT01345669|528728081|FG000|Overall Study|Adverse Event|63|||
146657174|NCT00744471|528921712|FG001|Overall Study|Adverse Event|7|||
146657175|NCT00744471|528921713|FG002|Overall Study|Adverse Event|5|||
146657176|NCT00744471|528921714|FG003|Overall Study|Adverse Event|9|||
146773142|NCT03312907|529339494|FG002|Overall Study|Physician Decision|2|||
146773143|NCT03312907|529339492|FG000|Overall Study|Withdrawal by Subject|9|||
146606873|NCT01345669|528728082|FG001|Overall Study|Adverse Event|9|||
146606874|NCT01345669|528728081|FG000|Overall Study|Protocol Violation|3|||
146606875|NCT01345669|528728082|FG001|Overall Study|Protocol Violation|1|||
146922963|NCT02616185|529878685|FG006|Overall Study|Not reported|0|||
146606876|NCT01345669|528728081|FG000|Overall Study|Lost to Follow-up|1|||
146606877|NCT01345669|528728082|FG001|Overall Study|Lost to Follow-up|1|||
146606878|NCT01345669|528728081|FG000|Overall Study|Withdrawal by Subject|52|||
146657177|NCT00744471|528921711|FG000|Overall Study|Withdrawal by Subject|9|||
146773144|NCT03312907|529339493|FG001|Overall Study|Withdrawal by Subject|14|||
146606879|NCT01345669|528728082|FG001|Overall Study|Withdrawal by Subject|13|||
146606880|NCT01345669|528728081|FG000|Overall Study|Other Reasons|111|||
146606881|NCT01345669|528728082|FG001|Overall Study|Other Reasons|60|||
146606882|NCT03343626|528729553|FG000|Overall Study|Lost to Follow-up|4|||
146606883|NCT03343626|528729554|FG001|Overall Study|Lost to Follow-up|3|||
146606884|NCT03343626|528729555|FG002|Overall Study|Lost to Follow-up|2|||
146606885|NCT03343626|528729556|FG003|Overall Study|Lost to Follow-up|5|||
146773145|NCT03312907|529339494|FG002|Overall Study|Withdrawal by Subject|10|||
146773146|NCT02763319|529339498|FG000|Overall Study|Adverse Event|12|||
146773147|NCT02763319|529339499|FG001|Overall Study|Adverse Event|3|||
146773148|NCT02763319|529339498|FG000|Overall Study|Death|123|||
146773149|NCT02763319|529339499|FG001|Overall Study|Death|123|||
146773150|NCT02763319|529339498|FG000|Overall Study|Lost to Follow-up|6|||
146773151|NCT02763319|529339499|FG001|Overall Study|Lost to Follow-up|7|||
146773152|NCT02763319|529339498|FG000|Overall Study|Noncompliance with Study Drug|2|||
146773153|NCT02763319|529339499|FG001|Overall Study|Noncompliance with Study Drug|0|||
146773154|NCT02763319|529339498|FG000|Overall Study|"Captured as Other in Database"|29|||
146773155|NCT02763319|529339499|FG001|Overall Study|"Captured as Other in Database"|34|||
146773156|NCT02763319|529339498|FG000|Overall Study|Physician Decision|1|||
146773157|NCT02763319|529339499|FG001|Overall Study|Physician Decision|7|||
146773158|NCT02763319|529339498|FG000|Overall Study|Progressive Disease|24|||
146773159|NCT02763319|529339499|FG001|Overall Study|Progressive Disease|27|||
146773160|NCT02763319|529339498|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
146773161|NCT02763319|529339499|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
146773162|NCT02763319|529339498|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
146606886|NCT03343626|528729557|FG004|Overall Study|Lost to Follow-up|4|||
146606887|NCT03343626|528729558|FG005|Overall Study|Lost to Follow-up|4|||
146773163|NCT02763319|529339499|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
146606888|NCT03343626|528729559|FG006|Overall Study|Lost to Follow-up|4|||
146606889|NCT03343626|528729560|FG007|Overall Study|Lost to Follow-up|7|||
146606890|NCT03343626|528729553|FG000|Overall Study|Withdrawal of Consent|2|||
146606891|NCT03343626|528729554|FG001|Overall Study|Withdrawal of Consent|1|||
146606892|NCT03343626|528729555|FG002|Overall Study|Withdrawal of Consent|0|||
146606893|NCT03343626|528729556|FG003|Overall Study|Withdrawal of Consent|3|||
146606894|NCT03343626|528729557|FG004|Overall Study|Withdrawal of Consent|3|||
146606895|NCT03343626|528729558|FG005|Overall Study|Withdrawal of Consent|1|||
146606896|NCT03343626|528729559|FG006|Overall Study|Withdrawal of Consent|1|||
146606897|NCT03343626|528729560|FG007|Overall Study|Withdrawal of Consent|2|||
146606898|NCT03343626|528729553|FG000|Overall Study|Reason not Specified|0|||
146606899|NCT03343626|528729554|FG001|Overall Study|Reason not Specified|1|||
146606900|NCT03343626|528729555|FG002|Overall Study|Reason not Specified|0|||
146606901|NCT03343626|528729556|FG003|Overall Study|Reason not Specified|0|||
146606902|NCT03343626|528729557|FG004|Overall Study|Reason not Specified|0|||
146606903|NCT03343626|528729558|FG005|Overall Study|Reason not Specified|0|||
146606904|NCT03343626|528729559|FG006|Overall Study|Reason not Specified|0|||
146606905|NCT03343626|528729560|FG007|Overall Study|Reason not Specified|1|||
146606906|NCT03343626|528729553|FG000|Overall Study|Data Entry Error|0|||
146606907|NCT03343626|528729554|FG001|Overall Study|Data Entry Error|0|||
146606908|NCT03343626|528729555|FG002|Overall Study|Data Entry Error|0|||
146606909|NCT03343626|528729556|FG003|Overall Study|Data Entry Error|0|||
146606910|NCT03343626|528729557|FG004|Overall Study|Data Entry Error|0|||
146606911|NCT03343626|528729558|FG005|Overall Study|Data Entry Error|0|||
146606912|NCT03343626|528729559|FG006|Overall Study|Data Entry Error|0|||
146606913|NCT03343626|528729560|FG007|Overall Study|Data Entry Error|1|||
146606914|NCT01487265|528729564|FG000|Overall Study|Adverse Event|8|||
146606915|NCT01487265|528729564|FG000|Overall Study|Withdrawal by Subject|5|||
146606916|NCT01487265|528729564|FG000|Overall Study|Disease Progression|21|||
146606917|NCT01487265|528729564|FG000|Overall Study|Death|2|||
146606918|NCT01487265|528729564|FG000|Overall Study|Still on Treatment|1|||
146773164|NCT02763319|529339498|FG000|Overall Study|Withdrawal by Subject|26|||
146773165|NCT02763319|529339499|FG001|Overall Study|Withdrawal by Subject|25|||
146773166|NCT03936660|529339501|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
146606919|NCT01618695|528729565|FG000|Core Phase|Adverse Event|4|||
146606920|NCT01618695|528729566|FG001|Core Phase|Adverse Event|5|||
146606921|NCT01618695|528729567|FG002|Core Phase|Adverse Event|15|||
146606922|NCT01618695|528729568|FG003|Core Phase|Adverse Event|20|||
146606923|NCT01618695|528729565|FG000|Core Phase|Lost to Follow-up|0|||
146606924|NCT01618695|528729566|FG001|Core Phase|Lost to Follow-up|0|||
146606925|NCT01618695|528729567|FG002|Core Phase|Lost to Follow-up|1|||
146606926|NCT01618695|528729568|FG003|Core Phase|Lost to Follow-up|0|||
146606927|NCT01618695|528729565|FG000|Core Phase|Withdrawal by Subject|16|||
146606928|NCT01618695|528729566|FG001|Core Phase|Withdrawal by Subject|11|||
146606929|NCT01618695|528729567|FG002|Core Phase|Withdrawal by Subject|9|||
146606930|NCT01618695|528729568|FG003|Core Phase|Withdrawal by Subject|13|||
146606931|NCT01618695|528729565|FG000|Core Phase|Pregnancy|2|||
146606932|NCT01618695|528729566|FG001|Core Phase|Pregnancy|0|||
146773167|NCT03936660|529339502|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
146606933|NCT01618695|528729567|FG002|Core Phase|Pregnancy|0|||
146606934|NCT01618695|528729568|FG003|Core Phase|Pregnancy|0|||
146606935|NCT01618695|528729565|FG000|Core Phase|Lack of Efficacy|1|||
146606936|NCT01618695|528729566|FG001|Core Phase|Lack of Efficacy|2|||
146606937|NCT01618695|528729567|FG002|Core Phase|Lack of Efficacy|1|||
146606938|NCT01618695|528729568|FG003|Core Phase|Lack of Efficacy|1|||
146606939|NCT01618695|528729565|FG000|Core Phase|Other than specified|1|||
146606940|NCT01618695|528729566|FG001|Core Phase|Other than specified|2|||
146606941|NCT01618695|528729567|FG002|Core Phase|Other than specified|2|||
146606942|NCT01618695|528729568|FG003|Core Phase|Other than specified|2|||
146606943|NCT01618695|528729565|FG000|Core Phase|Not treated|1|||
146606944|NCT01618695|528729566|FG001|Core Phase|Not treated|0|||
146606945|NCT01618695|528729567|FG002|Core Phase|Not treated|2|||
146606946|NCT01618695|528729568|FG003|Core Phase|Not treated|0|||
146606947|NCT01618695|528729565|FG000|Extension Phase|Lack of Efficacy|17|||
146606948|NCT01618695|528729566|FG001|Extension Phase|Lack of Efficacy|33|||
146606949|NCT01618695|528729567|FG002|Extension Phase|Lack of Efficacy|26|||
146606950|NCT01618695|528729568|FG003|Extension Phase|Lack of Efficacy|24|||
146606951|NCT01618695|528729565|FG000|Extension Phase|Pregnancy|2|||
146606952|NCT01618695|528729566|FG001|Extension Phase|Pregnancy|0|||
146606953|NCT01618695|528729567|FG002|Extension Phase|Pregnancy|1|||
146606954|NCT01618695|528729568|FG003|Extension Phase|Pregnancy|1|||
146606955|NCT01618695|528729565|FG000|Extension Phase|Withdrawal by Subject|43|||
146606956|NCT01618695|528729566|FG001|Extension Phase|Withdrawal by Subject|48|||
146606957|NCT01618695|528729567|FG002|Extension Phase|Withdrawal by Subject|42|||
146606958|NCT01618695|528729568|FG003|Extension Phase|Withdrawal by Subject|33|||
146606959|NCT01618695|528729565|FG000|Extension Phase|Adverse Event|18|||
146606960|NCT01618695|528729566|FG001|Extension Phase|Adverse Event|16|||
146606961|NCT01618695|528729567|FG002|Extension Phase|Adverse Event|9|||
146606962|NCT01618695|528729568|FG003|Extension Phase|Adverse Event|20|||
146606963|NCT01618695|528729565|FG000|Extension Phase|Lost to Follow-up|2|||
146606964|NCT01618695|528729566|FG001|Extension Phase|Lost to Follow-up|1|||
146606965|NCT01618695|528729567|FG002|Extension Phase|Lost to Follow-up|1|||
146606966|NCT01618695|528729568|FG003|Extension Phase|Lost to Follow-up|1|||
146606967|NCT01618695|528729565|FG000|Extension Phase|Other than specified|13|||
146606968|NCT01618695|528729566|FG001|Extension Phase|Other than specified|18|||
146606969|NCT01618695|528729567|FG002|Extension Phase|Other than specified|13|||
146606970|NCT01618695|528729568|FG003|Extension Phase|Other than specified|18|||
146606971|NCT02291419|528729569|FG000|Overall Study|Early study termination|1|||
146606972|NCT02291419|528729570|FG001|Overall Study|Early study termination|5|||
146606973|NCT01732770|528729575|FG000|Overall Study|Lost to Follow-up|2|||
146606974|NCT01732770|528729576|FG001|Overall Study|Lost to Follow-up|3|||
146606975|NCT01732770|528729575|FG000|Overall Study|Withdrawal by Subject|5|||
146606976|NCT01732770|528729576|FG001|Overall Study|Withdrawal by Subject|3|||
146606977|NCT01732770|528729575|FG000|Overall Study|Decision by Sponsor|2|||
146606978|NCT01732770|528729576|FG001|Overall Study|Decision by Sponsor|2|||
146606979|NCT01732770|528729575|FG000|Overall Study|Death|1|||
146606980|NCT01732770|528729576|FG001|Overall Study|Death|0|||
146606981|NCT03828617|528729582|FG000|Overall Study|Lost to Follow-up|22|||
146606982|NCT03828617|528729583|FG001|Overall Study|Lost to Follow-up|12|||
146606983|NCT03828617|528729584|FG002|Overall Study|Lost to Follow-up|23|||
146606984|NCT03828617|528729585|FG003|Overall Study|Lost to Follow-up|7|||
146606985|NCT03828617|528729582|FG000|Overall Study|No longer met eligibility criteria|0|||
146606986|NCT03828617|528729583|FG001|Overall Study|No longer met eligibility criteria|1|||
146606987|NCT03828617|528729584|FG002|Overall Study|No longer met eligibility criteria|1|||
146606988|NCT03828617|528729585|FG003|Overall Study|No longer met eligibility criteria|3|||
146606989|NCT03828617|528729582|FG000|Overall Study|Protocol Violation|0|||
146606990|NCT03828617|528729583|FG001|Overall Study|Protocol Violation|2|||
146606991|NCT03828617|528729584|FG002|Overall Study|Protocol Violation|0|||
146606992|NCT03828617|528729585|FG003|Overall Study|Protocol Violation|0|||
146606993|NCT03828617|528729582|FG000|Overall Study|Withdrawal by Subject|2|||
146606994|NCT03828617|528729583|FG001|Overall Study|Withdrawal by Subject|0|||
146606995|NCT03828617|528729584|FG002|Overall Study|Withdrawal by Subject|2|||
146606996|NCT03828617|528729585|FG003|Overall Study|Withdrawal by Subject|0|||
146606997|NCT01271725|528729586|FG000|Part A|Progressive disease according to RECIST|8|||
146606998|NCT01271725|528729587|FG001|Part A|Progressive disease according to RECIST|0|||
146606999|NCT01271725|528729586|FG000|Part A|Clinical signs/symptoms of progression|2|||
146607000|NCT01271725|528729587|FG001|Part A|Clinical signs/symptoms of progression|0|||
146607001|NCT01271725|528729586|FG000|Part A|Other Adverse Event|8|||
146607002|NCT01271725|528729587|FG001|Part A|Other Adverse Event|0|||
146607003|NCT01271725|528729586|FG000|Part A|Lost to Follow-up|1|||
146607004|NCT01271725|528729587|FG001|Part A|Lost to Follow-up|0|||
146607005|NCT01271725|528729586|FG000|Part A|Withdrawal by Subject|12|||
146607006|NCT01271725|528729587|FG001|Part A|Withdrawal by Subject|0|||
146607007|NCT01271725|528729586|FG000|Part A|Other than specified|3|||
146607008|NCT01271725|528729587|FG001|Part A|Other than specified|0|||
146607009|NCT01271725|528729586|FG000|Part A|Protocol Violation|1|||
146607010|NCT01271725|528729587|FG001|Part A|Protocol Violation|0|||
146607011|NCT01271725|528729586|FG000|Part B|Other than specified|0|||
146607012|NCT01271725|528729587|FG001|Part B|Other than specified|2|||
146607013|NCT01271725|528729586|FG000|Part B|Clinical signs/symptoms of progression|0|||
146607014|NCT01271725|528729587|FG001|Part B|Clinical signs/symptoms of progression|2|||
146607015|NCT01271725|528729586|FG000|Part B|Other Adverse Event|0|||
146607016|NCT01271725|528729587|FG001|Part B|Other Adverse Event|1|||
146607017|NCT01271725|528729586|FG000|Part B|Protocol Violation|0|||
146607018|NCT01271725|528729587|FG001|Part B|Protocol Violation|1|||
146607019|NCT01271725|528729586|FG000|Part B|Withdrawal by Subject|0|||
146607020|NCT01271725|528729587|FG001|Part B|Withdrawal by Subject|6|||
146607021|NCT02950480|528729590|FG000|Overall Study|Withdrawal by Subject|1|||
146607022|NCT02950480|528729591|FG001|Overall Study|Withdrawal by Subject|0|||
146607023|NCT01835223|528729598|FG000|Overall Study|Adverse Event|1|||
146607024|NCT01835223|528729599|FG001|Overall Study|Adverse Event|0|||
146607025|NCT01835223|528729598|FG000|Overall Study|Withdrawal by Subject|2|||
146607026|NCT01835223|528729599|FG001|Overall Study|Withdrawal by Subject|0|||
146607027|NCT01835223|528729598|FG000|Overall Study|Disease progression|2|||
146607028|NCT01835223|528729599|FG001|Overall Study|Disease progression|1|||
146607029|NCT01835223|528729598|FG000|Overall Study|Became Inelligible|4|||
146607030|NCT01835223|528729599|FG001|Overall Study|Became Inelligible|0|||
146607031|NCT03149055|528729600|FG000|Overall Study|Not treated|4|||
146607032|NCT01279616|528729601|FG000|Overall Study|donor could not be located|5|||
146607033|NCT01279616|528729601|FG000|Overall Study|no signs of sickle cell disease|2|||
146607034|NCT00413036|528729602|FG000|Overall Study|Adverse Event|44|||
146607035|NCT00413036|528729602|FG000|Overall Study|Lack of Efficacy|129|||
146607036|NCT00413036|528729602|FG000|Overall Study|Withdrawal by Subject|7|||
146607037|NCT00413036|528729602|FG000|Overall Study|Death|9|||
146607038|NCT00413036|528729602|FG000|Overall Study|Other|26|||
146607039|NCT00413036|528729602|FG000|Overall Study|Missing|2|||
146607040|NCT00183625|528729603|FG000|Overall Study|Withdrawal by Subject|18|||
146607041|NCT00183625|528729604|FG001|Overall Study|Withdrawal by Subject|18|||
146607042|NCT00183625|528729605|FG002|Overall Study|Withdrawal by Subject|19|||
146607043|NCT00183625|528729606|FG003|Overall Study|Withdrawal by Subject|14|||
146607044|NCT01483183|528729611|FG000|Overall Study|Physician Decision|0|||
146607045|NCT01483183|528729612|FG001|Overall Study|Physician Decision|0|||
146607046|NCT01483183|528729613|FG002|Overall Study|Physician Decision|0|||
146607047|NCT01483183|528729614|FG003|Overall Study|Physician Decision|0|||
146607048|NCT01483183|528729615|FG004|Overall Study|Physician Decision|0|||
146607049|NCT01483183|528729616|FG005|Overall Study|Physician Decision|0|||
146607050|NCT01483183|528729617|FG006|Overall Study|Physician Decision|2|||
146607051|NCT01483183|528729618|FG007|Overall Study|Physician Decision|0|||
146607052|NCT01483183|528729619|FG008|Overall Study|Physician Decision|0|||
146607053|NCT01483183|528729620|FG009|Overall Study|Physician Decision|0|||
146607054|NCT01483183|528729611|FG000|Overall Study|Withdrawal by Subject|0|||
146607055|NCT01483183|528729612|FG001|Overall Study|Withdrawal by Subject|0|||
146607056|NCT01483183|528729613|FG002|Overall Study|Withdrawal by Subject|0|||
146607057|NCT01483183|528729614|FG003|Overall Study|Withdrawal by Subject|0|||
146607058|NCT01483183|528729615|FG004|Overall Study|Withdrawal by Subject|0|||
146607059|NCT01483183|528729616|FG005|Overall Study|Withdrawal by Subject|0|||
146607060|NCT01483183|528729617|FG006|Overall Study|Withdrawal by Subject|0|||
146607061|NCT01483183|528729618|FG007|Overall Study|Withdrawal by Subject|0|||
146607062|NCT01483183|528729619|FG008|Overall Study|Withdrawal by Subject|0|||
146607063|NCT01483183|528729620|FG009|Overall Study|Withdrawal by Subject|1|||
146607064|NCT00239928|528729621|FG000|Overall Study|Lack of Efficacy|1|||
146607065|NCT00239928|528729621|FG000|Overall Study|Adverse Event|4|||
146607066|NCT00239928|528729621|FG000|Overall Study|Not need to continue study|3|||
146607067|NCT00239928|528729621|FG000|Overall Study|Withdrawal by Subject|2|||
146607068|NCT04869358|528729627|FG000|Overall Study|Wish to have children.|1|||
146607069|NCT04869358|528729628|FG001|Overall Study|Wish to have children.|0|||
146607070|NCT04869358|528729629|FG002|Overall Study|Wish to have children.|0|||
146607071|NCT04869358|528729630|FG003|Overall Study|Wish to have children.|0|||
146607072|NCT03550404|528729636|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
146607073|NCT03550404|528729637|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
146607074|NCT03550404|528729638|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
146607075|NCT03550404|528729636|FG000|Phase 2|Vacated position|1|||
146607076|NCT03550404|528729637|FG001|Phase 2|Vacated position|0|||
146607077|NCT03550404|528729638|FG002|Phase 2|Vacated position|0|||
146607078|NCT00820222|528729639|FG000|Overall Study|Lost to Follow-up|10|||
146607079|NCT00820222|528729640|FG001|Overall Study|Lost to Follow-up|9|||
146607080|NCT00820222|528729639|FG000|Overall Study|Withdrawal by Subject|19|||
146607081|NCT00820222|528729640|FG001|Overall Study|Withdrawal by Subject|21|||
146607082|NCT00820222|528729639|FG000|Overall Study|Physician Decision|93|||
146607083|NCT00820222|528729640|FG001|Overall Study|Physician Decision|88|||
146607084|NCT00820222|528729639|FG000|Overall Study|Sponsor Terminated Study|43|||
146607085|NCT00820222|528729640|FG001|Overall Study|Sponsor Terminated Study|65|||
146607086|NCT00820222|528729639|FG000|Overall Study|Unkown|11|||
146607087|NCT00820222|528729640|FG001|Overall Study|Unkown|7|||
146607088|NCT02690714|528729641|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
146607089|NCT02690714|528729641|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
146607090|NCT01361178|528729642|FG000|Overall Study|Death|13|||
146607091|NCT01361178|528729643|FG001|Overall Study|Death|0|||
146607092|NCT05392803|528729650|FG000|Overall Study|Lost to Follow-up|0|||
146607093|NCT05392803|528729651|FG001|Overall Study|Lost to Follow-up|2|||
146607094|NCT01630889|528729661|FG000|Overall Study|Death|2|||
146607095|NCT01630889|528729661|FG000|Overall Study|Withdrawal by Subject|1|||
146607096|NCT01630889|528729661|FG000|Overall Study|Other than Specified|2|||
146607097|NCT01630889|528729661|FG000|Overall Study|Lost to Follow-up|4|||
146607098|NCT01630889|528729661|FG000|Overall Study|Other|1|||
146607099|NCT02974842|528729662|FG000|Overall Study|Withdrawal by Subject|4|||
146607100|NCT02974842|528729662|FG000|Overall Study|Screen failures|4|||
146607101|NCT01068158|528729668|FG000|Overall Study|Withdrawal by Subject|1|||
146607102|NCT01068158|528729669|FG001|Overall Study|Withdrawal by Subject|2|||
146607103|NCT01068158|528729668|FG000|Overall Study|Lost to Follow-up|7|||
146607104|NCT01068158|528729669|FG001|Overall Study|Lost to Follow-up|0|||
146607105|NCT01068158|528729668|FG000|Overall Study|Protocol Violation|0|||
146607106|NCT01068158|528729669|FG001|Overall Study|Protocol Violation|2|||
146607107|NCT01368081|528729676|FG000|Overall Study|Adverse Event|4|||
146607108|NCT01368081|528729677|FG001|Overall Study|Adverse Event|4|||
146607109|NCT01368081|528729678|FG002|Overall Study|Adverse Event|3|||
146607110|NCT01368081|528729679|FG003|Overall Study|Adverse Event|2|||
146607111|NCT01368081|528729680|FG004|Overall Study|Adverse Event|2|||
146607112|NCT01368081|528729681|FG005|Overall Study|Adverse Event|5|||
146607113|NCT01368081|528729682|FG006|Overall Study|Adverse Event|6|||
146607114|NCT01368081|528729683|FG007|Overall Study|Adverse Event|2|||
146607115|NCT01368081|528729684|FG008|Overall Study|Adverse Event|3|||
146607116|NCT01368081|528729685|FG009|Overall Study|Adverse Event|5|||
146607117|NCT01368081|528729686|FG010|Overall Study|Adverse Event|6|||
146607118|NCT01368081|528729687|FG011|Overall Study|Adverse Event|1|||
146607119|NCT01368081|528729688|FG012|Overall Study|Adverse Event|3|||
146607120|NCT01368081|528729676|FG000|Overall Study|Lack of Efficacy|0|||
146607121|NCT01368081|528729677|FG001|Overall Study|Lack of Efficacy|1|||
146607122|NCT01368081|528729678|FG002|Overall Study|Lack of Efficacy|0|||
146607123|NCT01368081|528729679|FG003|Overall Study|Lack of Efficacy|1|||
146607124|NCT01368081|528729680|FG004|Overall Study|Lack of Efficacy|0|||
146607125|NCT01368081|528729681|FG005|Overall Study|Lack of Efficacy|0|||
146607126|NCT01368081|528729682|FG006|Overall Study|Lack of Efficacy|0|||
146607127|NCT01368081|528729683|FG007|Overall Study|Lack of Efficacy|2|||
146607128|NCT01368081|528729684|FG008|Overall Study|Lack of Efficacy|0|||
146607129|NCT01368081|528729685|FG009|Overall Study|Lack of Efficacy|0|||
146607130|NCT01368081|528729686|FG010|Overall Study|Lack of Efficacy|0|||
146607131|NCT01368081|528729687|FG011|Overall Study|Lack of Efficacy|0|||
146607132|NCT01368081|528729688|FG012|Overall Study|Lack of Efficacy|0|||
146607133|NCT01368081|528729676|FG000|Overall Study|Protocol Violation|0|||
146607134|NCT01368081|528729677|FG001|Overall Study|Protocol Violation|0|||
146607135|NCT01368081|528729678|FG002|Overall Study|Protocol Violation|0|||
146607136|NCT01368081|528729679|FG003|Overall Study|Protocol Violation|0|||
146607137|NCT01368081|528729680|FG004|Overall Study|Protocol Violation|0|||
146607138|NCT01368081|528729681|FG005|Overall Study|Protocol Violation|1|||
146607139|NCT01368081|528729682|FG006|Overall Study|Protocol Violation|0|||
146607140|NCT01368081|528729683|FG007|Overall Study|Protocol Violation|1|||
146607141|NCT01368081|528729684|FG008|Overall Study|Protocol Violation|0|||
146607142|NCT01368081|528729685|FG009|Overall Study|Protocol Violation|0|||
146607143|NCT01368081|528729686|FG010|Overall Study|Protocol Violation|0|||
146607144|NCT01368081|528729687|FG011|Overall Study|Protocol Violation|0|||
146607145|NCT01368081|528729688|FG012|Overall Study|Protocol Violation|0|||
146607146|NCT01368081|528729676|FG000|Overall Study|Lost to Follow-up|0|||
146607147|NCT01368081|528729677|FG001|Overall Study|Lost to Follow-up|0|||
146607148|NCT01368081|528729678|FG002|Overall Study|Lost to Follow-up|0|||
146607149|NCT01368081|528729679|FG003|Overall Study|Lost to Follow-up|0|||
146607150|NCT01368081|528729680|FG004|Overall Study|Lost to Follow-up|0|||
146607151|NCT01368081|528729681|FG005|Overall Study|Lost to Follow-up|0|||
146607152|NCT01368081|528729682|FG006|Overall Study|Lost to Follow-up|0|||
146607153|NCT01368081|528729683|FG007|Overall Study|Lost to Follow-up|0|||
146607154|NCT01368081|528729684|FG008|Overall Study|Lost to Follow-up|0|||
146607155|NCT01368081|528729685|FG009|Overall Study|Lost to Follow-up|0|||
146607156|NCT01368081|528729686|FG010|Overall Study|Lost to Follow-up|0|||
146607157|NCT01368081|528729687|FG011|Overall Study|Lost to Follow-up|0|||
146607158|NCT01368081|528729688|FG012|Overall Study|Lost to Follow-up|1|||
146607159|NCT01368081|528729676|FG000|Overall Study|Withdrawal by Subject|4|||
146607160|NCT01368081|528729677|FG001|Overall Study|Withdrawal by Subject|4|||
146607161|NCT01368081|528729678|FG002|Overall Study|Withdrawal by Subject|1|||
146607162|NCT01368081|528729679|FG003|Overall Study|Withdrawal by Subject|1|||
146607163|NCT01368081|528729680|FG004|Overall Study|Withdrawal by Subject|0|||
146607164|NCT01368081|528729681|FG005|Overall Study|Withdrawal by Subject|3|||
146607165|NCT01368081|528729682|FG006|Overall Study|Withdrawal by Subject|4|||
146607166|NCT01368081|528729683|FG007|Overall Study|Withdrawal by Subject|2|||
146607167|NCT01368081|528729684|FG008|Overall Study|Withdrawal by Subject|5|||
146607168|NCT01368081|528729685|FG009|Overall Study|Withdrawal by Subject|4|||
146607169|NCT01368081|528729686|FG010|Overall Study|Withdrawal by Subject|3|||
146657178|NCT00744471|528921712|FG001|Overall Study|Withdrawal by Subject|9|||
146657179|NCT00744471|528921713|FG002|Overall Study|Withdrawal by Subject|15|||
146657180|NCT00744471|528921714|FG003|Overall Study|Withdrawal by Subject|12|||
146657181|NCT00744471|528921711|FG000|Overall Study|Protocol Violation|1|||
146657182|NCT00744471|528921712|FG001|Overall Study|Protocol Violation|4|||
146657183|NCT00744471|528921713|FG002|Overall Study|Protocol Violation|1|||
146657184|NCT00744471|528921714|FG003|Overall Study|Protocol Violation|2|||
146657185|NCT00744471|528921711|FG000|Overall Study|Entered extension study|41|||
146657186|NCT00744471|528921712|FG001|Overall Study|Entered extension study|84|||
146607170|NCT01368081|528729687|FG011|Overall Study|Withdrawal by Subject|2|||
146607171|NCT01368081|528729688|FG012|Overall Study|Withdrawal by Subject|0|||
146607172|NCT01368081|528729676|FG000|Overall Study|Other reason not defined above|2|||
146607173|NCT01368081|528729677|FG001|Overall Study|Other reason not defined above|0|||
146607174|NCT01368081|528729678|FG002|Overall Study|Other reason not defined above|0|||
146607175|NCT01368081|528729679|FG003|Overall Study|Other reason not defined above|1|||
146607176|NCT01368081|528729680|FG004|Overall Study|Other reason not defined above|0|||
146607177|NCT01368081|528729681|FG005|Overall Study|Other reason not defined above|1|||
146607178|NCT01368081|528729682|FG006|Overall Study|Other reason not defined above|2|||
146607179|NCT01368081|528729683|FG007|Overall Study|Other reason not defined above|0|||
146607180|NCT01368081|528729684|FG008|Overall Study|Other reason not defined above|0|||
146607181|NCT01368081|528729685|FG009|Overall Study|Other reason not defined above|1|||
146607182|NCT01368081|528729686|FG010|Overall Study|Other reason not defined above|0|||
146607183|NCT01368081|528729687|FG011|Overall Study|Other reason not defined above|0|||
146607184|NCT01368081|528729688|FG012|Overall Study|Other reason not defined above|3|||
146607185|NCT00238238|528729694|FG000|Overall Study|Withdrawal by Subject|0|||
146607186|NCT00238238|528729695|FG001|Overall Study|Withdrawal by Subject|3|||
146607187|NCT00238238|528729696|FG002|Overall Study|Withdrawal by Subject|0|||
146607188|NCT01007838|528729700|FG000|Overall Study|Withdrawal by Subject|1|||
146607189|NCT01007838|528729701|FG001|Overall Study|Withdrawal by Subject|0|||
146607190|NCT01007838|528729702|FG002|Overall Study|Withdrawal by Subject|0|||
146607191|NCT01007838|528729703|FG003|Overall Study|Withdrawal by Subject|0|||
146607192|NCT01007838|528729700|FG000|Overall Study|Physician Decision|1|||
146607193|NCT01007838|528729701|FG001|Overall Study|Physician Decision|0|||
146607194|NCT01007838|528729702|FG002|Overall Study|Physician Decision|0|||
146607195|NCT01007838|528729703|FG003|Overall Study|Physician Decision|0|||
146607196|NCT01007838|528729700|FG000|Overall Study|Started home haemodialysis|1|||
146607197|NCT01007838|528729701|FG001|Overall Study|Started home haemodialysis|0|||
146607198|NCT01007838|528729702|FG002|Overall Study|Started home haemodialysis|0|||
146607199|NCT01007838|528729703|FG003|Overall Study|Started home haemodialysis|0|||
146607200|NCT02277119|528729704|FG000|Overall Study|Lack of Efficacy|1|||
146607201|NCT02277119|528729705|FG001|Overall Study|Lack of Efficacy|1|||
146607202|NCT02277119|528729706|FG002|Overall Study|Lack of Efficacy|1|||
146607203|NCT02277119|528729704|FG000|Overall Study|Protocol Violation|2|||
146607204|NCT02277119|528729705|FG001|Overall Study|Protocol Violation|3|||
146607205|NCT02277119|528729706|FG002|Overall Study|Protocol Violation|7|||
146607206|NCT04699461|528729707|FG000|Overall Study|Withdrawal by Subject|1|||
146607207|NCT04699461|528729708|FG001|Overall Study|Withdrawal by Subject|0|||
146607208|NCT04699461|528729707|FG000|Overall Study|Study termination by sponsor|2|||
146607209|NCT04699461|528729708|FG001|Overall Study|Study termination by sponsor|1|||
146607210|NCT04699461|528729707|FG000|Overall Study|Death|1|||
146607211|NCT04699461|528729708|FG001|Overall Study|Death|0|||
146607212|NCT04699461|528729707|FG000|Overall Study|Radiographic progression|0|||
146607213|NCT04699461|528729708|FG001|Overall Study|Radiographic progression|1|||
146607214|NCT02478255|528729709|FG000|Overall Study|Physician Decision|6|||
146607215|NCT02478255|528729710|FG001|Overall Study|Physician Decision|0|||
146607216|NCT02478255|528729709|FG000|Overall Study|Withdrawal by Subject|2|||
146607217|NCT02478255|528729710|FG001|Overall Study|Withdrawal by Subject|0|||
146607218|NCT03068767|528729716|FG000|Overall Study|Lost to Follow-up|7|||
146607219|NCT03068767|528729717|FG001|Overall Study|Lost to Follow-up|3|||
146607220|NCT03068767|528729716|FG000|Overall Study|Protocol Violation|3|||
146607221|NCT03068767|528729717|FG001|Overall Study|Protocol Violation|0|||
146607222|NCT01730586|528729718|FG000|Overall Study|Progressive Disease|2|||
146607223|NCT01730586|528729718|FG000|Overall Study|Inadequate Trial|8|||
146607224|NCT01730586|528729718|FG000|Overall Study|Adverse Event|2|||
146607225|NCT01730586|528729718|FG000|Overall Study|Hospice|1|||
146607226|NCT00061633|528729719|FG000|Overall Study|Adverse Event|1|||
146607227|NCT00061633|528729720|FG001|Overall Study|Adverse Event|2|||
146607228|NCT00061633|528729719|FG000|Overall Study|Withdrawal by Subject|2|||
146607229|NCT00061633|528729720|FG001|Overall Study|Withdrawal by Subject|2|||
146607230|NCT00061633|528729719|FG000|Overall Study|Lost to Follow-up|1|||
146607231|NCT00061633|528729720|FG001|Overall Study|Lost to Follow-up|4|||
146607232|NCT00061633|528729719|FG000|Overall Study|Other|1|||
146607233|NCT00061633|528729720|FG001|Overall Study|Other|1|||
146607234|NCT00061633|528729719|FG000|Overall Study|Never received study treatment|0|||
146657187|NCT00744471|528921713|FG002|Overall Study|Entered extension study|100|||
146657188|NCT00744471|528921714|FG003|Overall Study|Entered extension study|91|||
146657189|NCT00744471|528921711|FG000|Overall Study|Other|2|||
146607235|NCT00061633|528729720|FG001|Overall Study|Never received study treatment|2|||
146607236|NCT01431963|528729721|FG000|Overall Study|Adverse Event|18|||
146607237|NCT01431963|528729721|FG000|Overall Study|Lack of Efficacy|7|||
146607238|NCT01431963|528729721|FG000|Overall Study|Protocol Violation|1|||
146607239|NCT01431963|528729721|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
146607240|NCT01431963|528729721|FG000|Overall Study|Physician Decision|4|||
146607241|NCT01431963|528729721|FG000|Overall Study|Withdrawal by Subject|3|||
146607242|NCT01370265|528731478|FG000|First Intervention|Adverse Event|1|||
146607243|NCT01370265|528731479|FG001|First Intervention|Adverse Event|1|||
146607244|NCT02611817|528731480|FG000|Open-label Induction Phase|Reason not Specified|9|||
146607245|NCT02611817|528731481|FG001|Open-label Induction Phase|Reason not Specified|0|||
146607246|NCT02611817|528731482|FG002|Open-label Induction Phase|Reason not Specified|0|||
146607247|NCT02611817|528731480|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
146607248|NCT02611817|528731481|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
146607249|NCT02611817|528731482|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
146607250|NCT02611817|528731480|FG000|Open-label Induction Phase|Pregnancy|1|||
146607251|NCT02611817|528731481|FG001|Open-label Induction Phase|Pregnancy|0|||
146607252|NCT02611817|528731482|FG002|Open-label Induction Phase|Pregnancy|0|||
146607253|NCT02611817|528731480|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
146607254|NCT02611817|528731481|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
146607255|NCT02611817|528731482|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
146607256|NCT02611817|528731480|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
146607257|NCT02611817|528731481|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
146607258|NCT02611817|528731482|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
146657190|NCT00744471|528921712|FG001|Overall Study|Other|3|||
146657191|NCT00744471|528921713|FG002|Overall Study|Other|6|||
146657192|NCT00744471|528921714|FG003|Overall Study|Other|2|||
146657193|NCT00744471|528921711|FG000|Overall Study|Lack of Efficacy|83|||
146657194|NCT00744471|528921712|FG001|Overall Study|Lack of Efficacy|37|||
146657195|NCT00744471|528921713|FG002|Overall Study|Lack of Efficacy|19|||
146657196|NCT00744471|528921714|FG003|Overall Study|Lack of Efficacy|31|||
146657197|NCT00744471|528921711|FG000|Overall Study|Lost to Follow-up|0|||
146657198|NCT00744471|528921712|FG001|Overall Study|Lost to Follow-up|0|||
146657199|NCT00744471|528921713|FG002|Overall Study|Lost to Follow-up|2|||
146657200|NCT00744471|528921714|FG003|Overall Study|Lost to Follow-up|0|||
146657201|NCT03224546|528921715|FG000|Overall Study|Lost to Follow-up|9|||
146657202|NCT03224546|528921716|FG001|Overall Study|Lost to Follow-up|8|||
146657203|NCT03224546|528921717|FG002|Overall Study|Lost to Follow-up|3|||
146657204|NCT03224546|528921715|FG000|Overall Study|Withdrawal by Subject|7|||
146657205|NCT03224546|528921716|FG001|Overall Study|Withdrawal by Subject|14|||
146657206|NCT03224546|528921717|FG002|Overall Study|Withdrawal by Subject|12|||
146657207|NCT04706416|528921718|FG000|Overall Study|Lost to Follow-up|2|||
146657208|NCT04706416|528921719|FG001|Overall Study|Lost to Follow-up|0|||
146657209|NCT00976573|528921727|FG000|Overall Study|Ineligible|0|||
146657210|NCT00976573|528921728|FG001|Overall Study|Ineligible|1|||
146657211|NCT00976573|528921727|FG000|Overall Study|Cancel prior to receiving treatment|4|||
146657212|NCT00976573|528921728|FG001|Overall Study|Cancel prior to receiving treatment|2|||
146657213|NCT02117427|528921729|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
146657214|NCT02117427|528921730|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
146657215|NCT02117427|528921731|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
146657216|NCT02117427|528921729|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
146657217|NCT02117427|528921730|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
146657218|NCT02117427|528921731|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
146657219|NCT02117427|528921729|FG000|Overall Study|Physician Decision|0|||
146657220|NCT02117427|528921730|FG001|Overall Study|Physician Decision|2|||
146657221|NCT02117427|528921731|FG002|Overall Study|Physician Decision|0|||
146657222|NCT02117427|528921729|FG000|Overall Study|No longer meets inclusion criteria|0|||
146657223|NCT02117427|528921730|FG001|Overall Study|No longer meets inclusion criteria|1|||
146657224|NCT02117427|528921731|FG002|Overall Study|No longer meets inclusion criteria|0|||
146657225|NCT02117427|528921729|FG000|Overall Study|Death|0|||
146922964|NCT02616185|529878686|FG007|Overall Study|Not reported|5|||
146607259|NCT02611817|528731480|FG000|Open-label Induction Phase|Protocol Violation|5|||
146607260|NCT02611817|528731481|FG001|Open-label Induction Phase|Protocol Violation|0|||
146607261|NCT02611817|528731482|FG002|Open-label Induction Phase|Protocol Violation|0|||
146607262|NCT02611817|528731480|FG000|Open-label Induction Phase|Adverse Event|16|||
146607263|NCT02611817|528731481|FG001|Open-label Induction Phase|Adverse Event|0|||
146657226|NCT02117427|528921730|FG001|Overall Study|Death|1|||
146657227|NCT02117427|528921731|FG002|Overall Study|Death|0|||
146657228|NCT02730208|528921732|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
146657229|NCT02730208|528921733|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
146657230|NCT00995865|528921734|FG000|Overall Study|Protocol Violation|2|||
146657231|NCT00995865|528921735|FG001|Overall Study|Protocol Violation|0|||
146657232|NCT00995865|528921736|FG002|Overall Study|Protocol Violation|0|||
146922965|NCT02616185|529878687|FG008|Overall Study|Not reported|2|||
146607264|NCT02611817|528731482|FG002|Open-label Induction Phase|Adverse Event|0|||
146657233|NCT00995865|528921734|FG000|Overall Study|Lost to Follow-up|0|||
146657234|NCT00995865|528921735|FG001|Overall Study|Lost to Follow-up|0|||
146607265|NCT02611817|528731480|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
146607266|NCT02611817|528731481|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
146607267|NCT02611817|528731482|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
146607268|NCT02611817|528731480|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
146607269|NCT02611817|528731481|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
146607270|NCT02611817|528731482|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
146607271|NCT02611817|528731480|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
146607272|NCT02611817|528731481|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
146607273|NCT02611817|528731482|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
146607274|NCT02611817|528731480|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
146607275|NCT02611817|528731481|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
146607276|NCT02611817|528731482|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
146607277|NCT02611817|528731480|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
146607278|NCT02611817|528731481|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
146607279|NCT02611817|528731482|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
146607280|NCT02611817|528731480|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
146607281|NCT02611817|528731481|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
146607282|NCT02611817|528731482|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
146607283|NCT02611817|528731480|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
146607284|NCT02611817|528731481|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
146607285|NCT02611817|528731482|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
146607286|NCT03077919|528731483|FG000|Overall Study|Lost to Follow-up|4|||
146607287|NCT03077919|528731484|FG001|Overall Study|Lost to Follow-up|1|||
146607288|NCT00826618|528731485|FG000|Overall Study|Withdrawal by Subject|1|||
146607289|NCT01363661|528731492|FG000|Overall Study|Adverse Event|9|||
146607290|NCT01363661|528731493|FG001|Overall Study|Adverse Event|2|||
146607291|NCT01363661|528731492|FG000|Overall Study|Withdrawal by Subject|1|||
146607292|NCT01363661|528731493|FG001|Overall Study|Withdrawal by Subject|1|||
146607293|NCT01363661|528731492|FG000|Overall Study|Protocol Violation|1|||
146607294|NCT01363661|528731493|FG001|Overall Study|Protocol Violation|0|||
146607295|NCT01363661|528731492|FG000|Overall Study|Lost to Follow-up|3|||
146607296|NCT01363661|528731493|FG001|Overall Study|Lost to Follow-up|1|||
146607297|NCT00303485|528731500|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
146607298|NCT00303485|528731501|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
146657235|NCT00995865|528921736|FG002|Overall Study|Lost to Follow-up|1|||
146657236|NCT00410202|528921738|FG000|On-Treatment|Continuing treatment|69|||
146657237|NCT00410202|528921739|FG001|On-Treatment|Continuing treatment|71|||
146657238|NCT00410202|528921740|FG002|On-Treatment|Continuing treatment|66|||
146657239|NCT00410202|528921738|FG000|On-Treatment|Adverse Event|1|||
146657240|NCT00410202|528921739|FG001|On-Treatment|Adverse Event|3|||
146657241|NCT00410202|528921740|FG002|On-Treatment|Adverse Event|2|||
146657242|NCT00410202|528921738|FG000|On-Treatment|Death|1|||
146657243|NCT00410202|528921739|FG001|On-Treatment|Death|0|||
146657244|NCT00410202|528921740|FG002|On-Treatment|Death|0|||
146657245|NCT00410202|528921738|FG000|On-Treatment|Lost to Follow-up|1|||
146657246|NCT00410202|528921739|FG001|On-Treatment|Lost to Follow-up|0|||
146657247|NCT00410202|528921740|FG002|On-Treatment|Lost to Follow-up|1|||
146657248|NCT00410202|528921738|FG000|On-Treatment|Lack of Efficacy|1|||
146657249|NCT00410202|528921739|FG001|On-Treatment|Lack of Efficacy|4|||
146657250|NCT00410202|528921740|FG002|On-Treatment|Lack of Efficacy|0|||
146657251|NCT00410202|528921738|FG000|On-Treatment|Withdrawal by Subject|2|||
146657252|NCT00410202|528921739|FG001|On-Treatment|Withdrawal by Subject|1|||
146657253|NCT00410202|528921740|FG002|On-Treatment|Withdrawal by Subject|1|||
146657254|NCT00410202|528921738|FG000|On-Treatment|Other Reason|0|||
146657255|NCT00410202|528921739|FG001|On-Treatment|Other Reason|0|||
146657256|NCT00410202|528921740|FG002|On-Treatment|Other Reason|1|||
146657257|NCT00410202|528921738|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
146773168|NCT01875848|529339506|FG000|Overall Study|Withdrawal by Subject|2|||
146773169|NCT01875848|529339507|FG001|Overall Study|Withdrawal by Subject|0|||
146773170|NCT02407249|529339508|FG000|Overall Study|Did not complete 12-month follow-up|13|||
146773171|NCT02407249|529339508|FG000|Overall Study|Not treated|13|||
146773172|NCT00840177|529339509|FG000|Overall Study|Adverse Event|5|||
146607299|NCT00303485|528731500|FG000|Overall Study|Failure to return|0|||
146607300|NCT00303485|528731501|FG001|Overall Study|Failure to return|1|||
146607301|NCT00303485|528731500|FG000|Overall Study|Withdrawal by Subject|1|||
146773173|NCT00840177|529339510|FG001|Overall Study|Adverse Event|1|||
146773174|NCT00840177|529339511|FG002|Overall Study|Adverse Event|1|||
146657258|NCT00410202|528921739|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
146657259|NCT00410202|528921740|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
146657260|NCT00410202|528921738|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
146657261|NCT00410202|528921739|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
146773175|NCT00840177|529339509|FG000|Overall Study|Refusal unrelated to adverse events|1|||
146773176|NCT00840177|529339510|FG001|Overall Study|Refusal unrelated to adverse events|0|||
146607302|NCT00303485|528731501|FG001|Overall Study|Withdrawal by Subject|0|||
146607303|NCT01378325|528731509|FG000|Overall Study|Protocol Violation|0|||
146607304|NCT01378325|528731510|FG001|Overall Study|Protocol Violation|1|||
146607305|NCT01496469|528731513|FG000|Overall Study|Adverse Event|1|||
146607306|NCT01496469|528731514|FG001|Overall Study|Adverse Event|0|||
146607307|NCT01496469|528731513|FG000|Overall Study|Protocol Violation|2|||
146607308|NCT01496469|528731514|FG001|Overall Study|Protocol Violation|0|||
146607309|NCT01496469|528731513|FG000|Overall Study|Lost to Follow-up|1|||
146607310|NCT01496469|528731514|FG001|Overall Study|Lost to Follow-up|1|||
146607311|NCT01496469|528731513|FG000|Overall Study|Withdrawal by Subject|4|||
146607312|NCT01496469|528731514|FG001|Overall Study|Withdrawal by Subject|4|||
146607313|NCT01496469|528731513|FG000|Overall Study|BP exceeds protocol limits|1|||
146607314|NCT01496469|528731514|FG001|Overall Study|BP exceeds protocol limits|2|||
146607315|NCT01496469|528731513|FG000|Overall Study|Other|1|||
146607316|NCT01496469|528731514|FG001|Overall Study|Other|1|||
146607317|NCT00630344|528731516|FG000|Overall Study|Adverse Event|5|||
146607318|NCT00630344|528731516|FG000|Overall Study|Progressive Disease|19|||
146607319|NCT00630344|528731516|FG000|Overall Study|Physician Decision|9|||
146607320|NCT00630344|528731516|FG000|Overall Study|Withdrawal by Subject|1|||
146607321|NCT00630344|528731516|FG000|Overall Study|Intercurrent Illness|1|||
146607322|NCT00630344|528731516|FG000|Overall Study|Other|1|||
146607323|NCT01357551|528731517|FG000|Overall Study|Withdrawal by Subject|6|||
146607324|NCT01357551|528731518|FG001|Overall Study|Withdrawal by Subject|4|||
146607325|NCT01357551|528731517|FG000|Overall Study|Death|0|||
146607326|NCT01357551|528731518|FG001|Overall Study|Death|1|||
146607327|NCT01357551|528731517|FG000|Overall Study|Lost to Follow-up|16|||
146607328|NCT01357551|528731518|FG001|Overall Study|Lost to Follow-up|6|||
146607329|NCT00891228|528731521|FG000|Overall Study|Adverse Event|0|||
146607330|NCT00891228|528731522|FG001|Overall Study|Adverse Event|2|||
146607331|NCT00891228|528731523|FG002|Overall Study|Adverse Event|3|||
146607332|NCT00891228|528731521|FG000|Overall Study|Withdrawal by Subject|2|||
146607333|NCT00891228|528731522|FG001|Overall Study|Withdrawal by Subject|4|||
146607334|NCT00891228|528731523|FG002|Overall Study|Withdrawal by Subject|5|||
146607335|NCT00891228|528731521|FG000|Overall Study|Protocol Violation|3|||
146607336|NCT00891228|528731522|FG001|Overall Study|Protocol Violation|1|||
146607337|NCT00891228|528731523|FG002|Overall Study|Protocol Violation|2|||
146607338|NCT00891228|528731521|FG000|Overall Study|Physician Decision|2|||
146607339|NCT00891228|528731522|FG001|Overall Study|Physician Decision|1|||
146607340|NCT00891228|528731523|FG002|Overall Study|Physician Decision|0|||
146607341|NCT00891228|528731521|FG000|Overall Study|Lost to Follow-up|4|||
146607342|NCT00891228|528731522|FG001|Overall Study|Lost to Follow-up|4|||
146607343|NCT00891228|528731523|FG002|Overall Study|Lost to Follow-up|5|||
146607344|NCT00891228|528731521|FG000|Overall Study|Pregnancy|0|||
146607345|NCT00891228|528731522|FG001|Overall Study|Pregnancy|1|||
146607346|NCT00891228|528731523|FG002|Overall Study|Pregnancy|0|||
146607347|NCT02688985|528731532|FG000|Overall Study|Adverse Event|1|||
146607348|NCT02688985|528731533|FG001|Overall Study|Adverse Event|2|||
146607349|NCT02688985|528731534|FG002|Overall Study|Adverse Event|2|||
146607350|NCT02688985|528731535|FG003|Overall Study|Adverse Event|0|||
146607351|NCT02688985|528731536|FG004|Overall Study|Adverse Event|0|||
146607352|NCT02688985|528731532|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
146607353|NCT02688985|528731533|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
146607354|NCT02688985|528731534|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
146607355|NCT02688985|528731535|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
146607356|NCT02688985|528731536|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
146607357|NCT02688985|528731532|FG000|Overall Study|Death|0|||
146607358|NCT02688985|528731533|FG001|Overall Study|Death|0|||
146607359|NCT02688985|528731534|FG002|Overall Study|Death|0|||
146607360|NCT02688985|528731535|FG003|Overall Study|Death|0|||
146607361|NCT02688985|528731536|FG004|Overall Study|Death|1|||
146607362|NCT02688985|528731532|FG000|Overall Study|Lack of Efficacy|0|||
146607363|NCT02688985|528731533|FG001|Overall Study|Lack of Efficacy|0|||
146607364|NCT02688985|528731534|FG002|Overall Study|Lack of Efficacy|0|||
146607365|NCT02688985|528731535|FG003|Overall Study|Lack of Efficacy|0|||
146922966|NCT03621943|529878688|FG000|First Randomized Intervention|Lost to Follow-up|51|||
146922967|NCT03621943|529878689|FG001|First Randomized Intervention|Lost to Follow-up|54|||
146922968|NCT03621943|529878688|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
146607366|NCT02688985|528731536|FG004|Overall Study|Lack of Efficacy|1|||
146607367|NCT02688985|528731532|FG000|Overall Study|Lost to Follow-up|2|||
146607368|NCT02688985|528731533|FG001|Overall Study|Lost to Follow-up|0|||
146607369|NCT02688985|528731534|FG002|Overall Study|Lost to Follow-up|1|||
146607370|NCT02688985|528731535|FG003|Overall Study|Lost to Follow-up|1|||
146607371|NCT02688985|528731536|FG004|Overall Study|Lost to Follow-up|1|||
146607372|NCT02688985|528731532|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146607373|NCT02688985|528731533|FG001|Overall Study|Non-Compliance With Study Drug|3|||
146607374|NCT02688985|528731534|FG002|Overall Study|Non-Compliance With Study Drug|1|||
146607375|NCT02688985|528731535|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146607376|NCT02688985|528731536|FG004|Overall Study|Non-Compliance With Study Drug|1|||
146607377|NCT02688985|528731532|FG000|Overall Study|Other|3|||
146607378|NCT02688985|528731533|FG001|Overall Study|Other|4|||
146607379|NCT02688985|528731534|FG002|Overall Study|Other|1|||
146607380|NCT02688985|528731535|FG003|Overall Study|Other|0|||
146607381|NCT02688985|528731536|FG004|Overall Study|Other|0|||
146607382|NCT02688985|528731532|FG000|Overall Study|Physician Decision|2|||
146607383|NCT02688985|528731533|FG001|Overall Study|Physician Decision|2|||
146607384|NCT02688985|528731534|FG002|Overall Study|Physician Decision|0|||
146607385|NCT02688985|528731535|FG003|Overall Study|Physician Decision|0|||
146607386|NCT02688985|528731536|FG004|Overall Study|Physician Decision|1|||
146607387|NCT02688985|528731532|FG000|Overall Study|Pregnancy|0|||
146607388|NCT02688985|528731533|FG001|Overall Study|Pregnancy|0|||
146607389|NCT02688985|528731534|FG002|Overall Study|Pregnancy|2|||
146607390|NCT02688985|528731535|FG003|Overall Study|Pregnancy|1|||
146607391|NCT02688985|528731536|FG004|Overall Study|Pregnancy|0|||
146607392|NCT02688985|528731532|FG000|Overall Study|Study Terminated By Sponsor|0|||
146607393|NCT02688985|528731533|FG001|Overall Study|Study Terminated By Sponsor|0|||
146607394|NCT02688985|528731534|FG002|Overall Study|Study Terminated By Sponsor|0|||
146607395|NCT02688985|528731535|FG003|Overall Study|Study Terminated By Sponsor|1|||
146607396|NCT02688985|528731536|FG004|Overall Study|Study Terminated By Sponsor|0|||
146607397|NCT02688985|528731532|FG000|Overall Study|Withdrawal by Subject|2|||
146607398|NCT02688985|528731533|FG001|Overall Study|Withdrawal by Subject|8|||
146607399|NCT02688985|528731534|FG002|Overall Study|Withdrawal by Subject|7|||
146607400|NCT02688985|528731535|FG003|Overall Study|Withdrawal by Subject|1|||
146607401|NCT02688985|528731536|FG004|Overall Study|Withdrawal by Subject|4|||
146607402|NCT01964963|528731539|FG000|Overall Study|Case Report Forms Uncollected|888|||
146607403|NCT01964963|528731539|FG000|Overall Study|Protocol Deviation|50|||
146607404|NCT01964963|528731539|FG000|Overall Study|Data Reliability was not Assured|5|||
146607405|NCT00930553|528731540|FG000|Overall Study|Adverse Event|1|||
146607406|NCT00930553|528731540|FG000|Overall Study|Lack of Efficacy|7|||
146607407|NCT00930553|528731540|FG000|Overall Study|Physician Decision|39|||
146607408|NCT00930553|528731540|FG000|Overall Study|Protocol Violation|1|||
146607409|NCT00930553|528731540|FG000|Overall Study|Pregnancy|1|||
146607410|NCT00930553|528731540|FG000|Overall Study|Withdrawal by Subject|88|||
146607411|NCT00930553|528731540|FG000|Overall Study|Lost to Follow-up|25|||
146607412|NCT00930553|528731540|FG000|Overall Study|Death|9|||
146607413|NCT00930553|528731540|FG000|Overall Study|Study terminated by sponsor|24|||
146607414|NCT00930553|528731540|FG000|Overall Study|Other than specified above|28|||
146607415|NCT01235234|528731541|FG000|Overall Study|Adverse Event|2|||
146607416|NCT01235234|528731542|FG001|Overall Study|Adverse Event|2|||
146607417|NCT01235234|528731543|FG002|Overall Study|Adverse Event|1|||
146607418|NCT01726582|528731544|FG000|Overall Study|Physician Decision|99|||
146607419|NCT01726582|528731544|FG000|Overall Study|Death|85|||
146607420|NCT02630472|528731545|FG000|Overall Study|Physician Decision|10|||
146607421|NCT02630472|528731546|FG001|Overall Study|Physician Decision|0|||
146607422|NCT03704688|528731551|FG000|Overall Study|Adverse Event|0|||
146607423|NCT03704688|528731552|FG001|Overall Study|Adverse Event|0|||
146607424|NCT03704688|528731553|FG002|Overall Study|Adverse Event|0|||
146607425|NCT03704688|528731554|FG003|Overall Study|Adverse Event|4|||
146607426|NCT03704688|528731555|FG004|Overall Study|Adverse Event|1|||
146607427|NCT03704688|528731556|FG005|Overall Study|Adverse Event|0|||
146607428|NCT03704688|528731551|FG000|Overall Study|Disease Progression|0|||
146607429|NCT03704688|528731552|FG001|Overall Study|Disease Progression|0|||
146607430|NCT03704688|528731553|FG002|Overall Study|Disease Progression|0|||
146607431|NCT03704688|528731554|FG003|Overall Study|Disease Progression|3|||
146607432|NCT03704688|528731555|FG004|Overall Study|Disease Progression|1|||
146607433|NCT03704688|528731556|FG005|Overall Study|Disease Progression|0|||
146607434|NCT03704688|528731551|FG000|Overall Study|Death|0|||
146607435|NCT03704688|528731552|FG001|Overall Study|Death|0|||
146607436|NCT03704688|528731553|FG002|Overall Study|Death|0|||
146607437|NCT03704688|528731554|FG003|Overall Study|Death|0|||
146607438|NCT03704688|528731555|FG004|Overall Study|Death|3|||
146607439|NCT03704688|528731556|FG005|Overall Study|Death|0|||
146607440|NCT00787189|528731557|FG000|Overall Study|Lost to Follow-up|2|||
146607441|NCT00787189|528731558|FG001|Overall Study|Lost to Follow-up|2|||
146607442|NCT02462720|528731559|FG000|Part 2|Withdrawal by Subject|1|||
146607443|NCT02462720|528731560|FG001|Part 2|Withdrawal by Subject|0|||
146607444|NCT02462720|528731559|FG000|Part 2|Protocol Violation|0|||
146607445|NCT02462720|528731560|FG001|Part 2|Protocol Violation|1|||
146607446|NCT03250182|528731565|FG000|Overall Study|Withdrawal by Subject|1|||
146607447|NCT01068769|528731566|FG000|Overall Study|Ineligible|1|||
146607448|NCT03671304|528731571|FG000|Overall Study|study terminated|7|||
146607449|NCT00596830|528731572|FG000|Overall Study|Death|258|||
146657262|NCT00410202|528921740|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
146607450|NCT00596830|528731573|FG001|Overall Study|Death|247|||
146607451|NCT00596830|528731572|FG000|Overall Study|Lost to Follow-up|7|||
146607452|NCT00596830|528731573|FG001|Overall Study|Lost to Follow-up|11|||
146607453|NCT00596830|528731572|FG000|Overall Study|Withdrawal by Subject|22|||
146607454|NCT00596830|528731573|FG001|Overall Study|Withdrawal by Subject|12|||
146607455|NCT00596830|528731572|FG000|Overall Study|Study terminated by sponsor|51|||
146607456|NCT00596830|528731573|FG001|Overall Study|Study terminated by sponsor|62|||
146607457|NCT00596830|528731572|FG000|Overall Study|Follow-up was discontinued|1|||
146607458|NCT00596830|528731573|FG001|Overall Study|Follow-up was discontinued|0|||
146607459|NCT00596830|528731572|FG000|Overall Study|Randomized but not treated|3|||
146607460|NCT00596830|528731573|FG001|Overall Study|Randomized but not treated|7|||
146607461|NCT00887926|528731574|FG000|Overall Study|Withdrawal by Subject|0|||
146607462|NCT00887926|528731575|FG001|Overall Study|Withdrawal by Subject|1|||
146607463|NCT00887926|528731576|FG002|Overall Study|Withdrawal by Subject|0|||
146607464|NCT00887926|528731577|FG003|Overall Study|Withdrawal by Subject|0|||
146607465|NCT02097030|528731578|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
146607466|NCT02097030|528731579|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
146607467|NCT02097030|528731578|FG000|First Intervention (3 Days)|Visual Acuity|0|||
146607468|NCT02097030|528731579|FG001|First Intervention (3 Days)|Visual Acuity|1|||
146607469|NCT00774800|528731580|FG000|Intervention 4|Withdrawal by Subject|1|||
146607470|NCT01336023|528731587|FG000|Week 0 to Week 26|Adverse Event|8|||
146607471|NCT01336023|528731588|FG001|Week 0 to Week 26|Adverse Event|10|||
146607472|NCT01336023|528731589|FG002|Week 0 to Week 26|Adverse Event|24|||
146607473|NCT01336023|528731587|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
146607474|NCT01336023|528731588|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
146607475|NCT01336023|528731589|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
146607476|NCT01336023|528731587|FG000|Week 0 to Week 26|Protocol Violation|1|||
146607477|NCT01336023|528731588|FG001|Week 0 to Week 26|Protocol Violation|2|||
146607478|NCT01336023|528731589|FG002|Week 0 to Week 26|Protocol Violation|0|||
146607479|NCT01336023|528731587|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
146607480|NCT01336023|528731588|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
146607481|NCT01336023|528731589|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
146607482|NCT01336023|528731587|FG000|Week 0 to Week 26|Unclassified|5|||
146607483|NCT01336023|528731588|FG001|Week 0 to Week 26|Unclassified|16|||
146607484|NCT01336023|528731589|FG002|Week 0 to Week 26|Unclassified|9|||
146607485|NCT01336023|528731587|FG000|Week 27 to 52|Adverse Event|1|||
146607486|NCT01336023|528731588|FG001|Week 27 to 52|Adverse Event|5|||
146607487|NCT01336023|528731589|FG002|Week 27 to 52|Adverse Event|2|||
146607488|NCT01336023|528731587|FG000|Week 27 to 52|Protocol Violation|0|||
146607489|NCT01336023|528731588|FG001|Week 27 to 52|Protocol Violation|2|||
146607490|NCT01336023|528731589|FG002|Week 27 to 52|Protocol Violation|1|||
146607491|NCT01336023|528731587|FG000|Week 27 to 52|Withdrawal Criteria|14|||
146607492|NCT01336023|528731588|FG001|Week 27 to 52|Withdrawal Criteria|19|||
146607493|NCT01336023|528731589|FG002|Week 27 to 52|Withdrawal Criteria|16|||
146607494|NCT01336023|528731587|FG000|Week 27 to 52|Unclassified|13|||
146607495|NCT01336023|528731588|FG001|Week 27 to 52|Unclassified|18|||
146607496|NCT01336023|528731589|FG002|Week 27 to 52|Unclassified|9|||
146607497|NCT04496453|528731590|FG000|Overall Study|Lost to Follow-up|6|||
146607498|NCT04294147|528731591|FG000|Overall Study|Protocol Violation|2|||
146607499|NCT04294147|528731592|FG001|Overall Study|Protocol Violation|0|||
146607500|NCT02332291|528731593|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
146607501|NCT02332291|528731594|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
146607502|NCT02332291|528731593|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
146607503|NCT02332291|528731594|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
146607504|NCT02332291|528731593|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
146607505|NCT02332291|528731594|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
146607506|NCT02332291|528731593|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
146607507|NCT02332291|528731594|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
146607508|NCT02332291|528731593|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
146607509|NCT02332291|528731594|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
146607510|NCT02332291|528731593|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
146607511|NCT02332291|528731594|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
146607512|NCT03916081|528731597|FG000|Overall Study|Adverse Event|1|||
146607513|NCT03916081|528731598|FG001|Overall Study|Adverse Event|0|||
146607514|NCT03916081|528731599|FG002|Overall Study|Adverse Event|0|||
146607515|NCT03916081|528731597|FG000|Overall Study|Physician Decision|0|||
146607516|NCT03916081|528731598|FG001|Overall Study|Physician Decision|0|||
146607517|NCT03916081|528731599|FG002|Overall Study|Physician Decision|1|||
146607518|NCT03916081|528731597|FG000|Overall Study|Lost to Follow-up|0|||
146607519|NCT03916081|528731598|FG001|Overall Study|Lost to Follow-up|1|||
146607520|NCT03916081|528731599|FG002|Overall Study|Lost to Follow-up|0|||
146607521|NCT03916081|528731597|FG000|Overall Study|Withdrawal by Subject|3|||
146607522|NCT03916081|528731598|FG001|Overall Study|Withdrawal by Subject|0|||
146607523|NCT03916081|528731599|FG002|Overall Study|Withdrawal by Subject|1|||
146607524|NCT03916081|528731597|FG000|Overall Study|Worsening of AD|0|||
146607525|NCT03916081|528731598|FG001|Overall Study|Worsening of AD|0|||
146607526|NCT03916081|528731599|FG002|Overall Study|Worsening of AD|1|||
146607527|NCT01240135|528731600|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
146607528|NCT01240135|528731601|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
146607529|NCT01240135|528731600|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
146607530|NCT01240135|528731601|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
146607531|NCT00699335|528731602|FG000|Overall Study|Combination of multiple reasons|176|||
146607532|NCT00699335|528731602|FG000|Overall Study|Missing data|52|||
146607533|NCT02726022|528731603|FG000|Overall Study|Adverse Event|14|||
146607534|NCT02726022|528731603|FG000|Overall Study|Treatment Failure|8|||
146607535|NCT02726022|528731603|FG000|Overall Study|Poor Compliance|13|||
146607536|NCT02726022|528731603|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
146607537|NCT03688620|528731605|FG000|Overall Study|Other|0|||
146607538|NCT03688620|528731606|FG001|Overall Study|Other|0|||
146607539|NCT03688620|528731607|FG002|Overall Study|Other|1|||
146607540|NCT03688620|528731605|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
146607541|NCT03688620|528731606|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
146607542|NCT03688620|528731607|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
146607543|NCT03688620|528731605|FG000|Overall Study|Lost to Follow-up|16|||
146607544|NCT03688620|528731606|FG001|Overall Study|Lost to Follow-up|0|||
146607545|NCT03688620|528731607|FG002|Overall Study|Lost to Follow-up|1|||
146607546|NCT03688620|528731605|FG000|Overall Study|Withdrawal by Subject|0|||
146607547|NCT03688620|528731606|FG001|Overall Study|Withdrawal by Subject|0|||
146607548|NCT03688620|528731607|FG002|Overall Study|Withdrawal by Subject|6|||
146607549|NCT02828020|528731608|FG000|Treatment Period|Adverse Event|3|||
146607550|NCT02828020|528731609|FG001|Treatment Period|Adverse Event|1|||
146607551|NCT02828020|528731610|FG002|Treatment Period|Adverse Event|1|||
146607552|NCT02828020|528731608|FG000|Treatment Period|Withdrawal of Consent|10|||
146607553|NCT02828020|528731609|FG001|Treatment Period|Withdrawal of Consent|14|||
146607554|NCT02828020|528731610|FG002|Treatment Period|Withdrawal of Consent|9|||
146607555|NCT02828020|528731608|FG000|Treatment Period|Lost to Follow-up|21|||
146607556|NCT02828020|528731609|FG001|Treatment Period|Lost to Follow-up|24|||
146607557|NCT02828020|528731610|FG002|Treatment Period|Lost to Follow-up|18|||
146607558|NCT02828020|528731608|FG000|Treatment Period|Lack of Qualifying Event|44|||
146607559|NCT02828020|528731609|FG001|Treatment Period|Lack of Qualifying Event|53|||
146607560|NCT02828020|528731610|FG002|Treatment Period|Lack of Qualifying Event|43|||
146607561|NCT02828020|528731608|FG000|Treatment Period|Pregnancy|0|||
146607562|NCT02828020|528731609|FG001|Treatment Period|Pregnancy|2|||
146607563|NCT02828020|528731610|FG002|Treatment Period|Pregnancy|0|||
146607564|NCT02828020|528731608|FG000|Treatment Period|Protocol Violation|2|||
146607565|NCT02828020|528731609|FG001|Treatment Period|Protocol Violation|4|||
146607566|NCT02828020|528731610|FG002|Treatment Period|Protocol Violation|7|||
146607567|NCT02828020|528731608|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
146607568|NCT02828020|528731609|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
146607569|NCT02828020|528731610|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
146607570|NCT02828020|528731608|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
146607571|NCT02828020|528731609|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
146607572|NCT02828020|528731610|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
146607573|NCT02828020|528731608|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
146607574|NCT02828020|528731609|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
146607575|NCT02828020|528731610|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
146607576|NCT02828020|528731608|FG000|Safety Follow-up Period|Protocol Violation|0|||
146607577|NCT02828020|528731609|FG001|Safety Follow-up Period|Protocol Violation|2|||
146607578|NCT02828020|528731610|FG002|Safety Follow-up Period|Protocol Violation|1|||
146607579|NCT02828020|528731608|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
146607580|NCT02828020|528731609|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
146607581|NCT02828020|528731610|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
146607582|NCT00416455|528731611|FG000|Overall Study|PET / CT not done|3|||
146607583|NCT00416455|528731612|FG001|Overall Study|PET / CT not done|5|||
146607584|NCT00416455|528731611|FG000|Overall Study|PET / CT poor quality|2|||
146607585|NCT00416455|528731612|FG001|Overall Study|PET / CT poor quality|1|||
146607586|NCT00416455|528731611|FG000|Overall Study|Inadequate pathology|11|||
146607587|NCT00416455|528731612|FG001|Overall Study|Inadequate pathology|2|||
146607588|NCT01183065|528731614|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
146607589|NCT02456857|528731615|FG000|Overall Study|Disease Progression|4|||
146607590|NCT01983774|528731619|FG000|Overall Study|Lung Transplant|0|||
146607591|NCT01983774|528731620|FG001|Overall Study|Lung Transplant|1|||
146607592|NCT01983774|528731619|FG000|Overall Study|Lost to Follow-up|1|||
146607593|NCT01983774|528731620|FG001|Overall Study|Lost to Follow-up|0|||
146607594|NCT01339897|528731621|FG000|Overall Study|Adverse Event|1|||
146607595|NCT01339897|528731622|FG001|Overall Study|Adverse Event|0|||
146607596|NCT01339897|528731623|FG002|Overall Study|Adverse Event|0|||
146607597|NCT01339897|528731624|FG003|Overall Study|Adverse Event|1|||
146607598|NCT03657095|528731627|FG000|Overall Study|Withdrawal by Subject|1|||
146607599|NCT03657095|528731628|FG001|Overall Study|Withdrawal by Subject|1|||
146607600|NCT03657095|528731627|FG000|Overall Study|Adverse Event|0|||
146607601|NCT03657095|528731628|FG001|Overall Study|Adverse Event|3|||
146607602|NCT03657095|528731627|FG000|Overall Study|Study Terminated by Sponsor|58|||
146607603|NCT03657095|528731628|FG001|Overall Study|Study Terminated by Sponsor|49|||
146607604|NCT03043651|528731633|FG000|Overall Study|Death|1|||
146607605|NCT03043651|528731633|FG000|Overall Study|Progressive Disease|2|||
146607606|NCT03043651|528731633|FG000|Overall Study|Adverse Event|2|||
146607607|NCT03043651|528731633|FG000|Overall Study|Withdrawal by Subject|4|||
146607608|NCT03043651|528731633|FG000|Overall Study|Study Terminated by Sponsor|39|||
146607609|NCT02980133|528731634|FG000|Overall Study|Other than specified|1|||
146607610|NCT02980133|528731635|FG001|Overall Study|Other than specified|1|||
146607611|NCT02980133|528731636|FG002|Overall Study|Other than specified|2|||
146607612|NCT02980133|528731637|FG003|Overall Study|Other than specified|2|||
146607613|NCT02980133|528731634|FG000|Overall Study|Lost to Follow-up|0|||
146607614|NCT02980133|528731635|FG001|Overall Study|Lost to Follow-up|0|||
146607615|NCT02980133|528731636|FG002|Overall Study|Lost to Follow-up|1|||
146607616|NCT02980133|528731637|FG003|Overall Study|Lost to Follow-up|3|||
146607617|NCT02980133|528731634|FG000|Overall Study|Protocol Violation|0|||
146607618|NCT02980133|528731635|FG001|Overall Study|Protocol Violation|1|||
146607619|NCT02980133|528731636|FG002|Overall Study|Protocol Violation|0|||
146607620|NCT02980133|528731637|FG003|Overall Study|Protocol Violation|0|||
146607621|NCT02980133|528731634|FG000|Overall Study|Withdrawal by parent/guardian|6|||
146607622|NCT02980133|528731635|FG001|Overall Study|Withdrawal by parent/guardian|3|||
146607623|NCT02980133|528731636|FG002|Overall Study|Withdrawal by parent/guardian|3|||
146607624|NCT02980133|528731637|FG003|Overall Study|Withdrawal by parent/guardian|1|||
146607625|NCT02980133|528731634|FG000|Overall Study|Withdrawal by Subject|0|||
146607626|NCT02980133|528731635|FG001|Overall Study|Withdrawal by Subject|0|||
146607627|NCT02980133|528731636|FG002|Overall Study|Withdrawal by Subject|1|||
146607628|NCT02980133|528731637|FG003|Overall Study|Withdrawal by Subject|0|||
146607629|NCT02596945|528731638|FG000|Overall Study|No documentation of study drug dosing|3|||
146607630|NCT02596945|528731638|FG000|Overall Study|Other|32|||
146607631|NCT02596945|528731638|FG000|Overall Study|Change to hemodialysis|15|||
146607632|NCT02596945|528731638|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
146607633|NCT02596945|528731638|FG000|Overall Study|Withdrawal by Subject|1|||
146607634|NCT02596945|528731638|FG000|Overall Study|Missing|1|||
146607635|NCT03738618|528733638|FG000|Overall Study|Protocol deviation|23|||
146607636|NCT03738618|528733639|FG001|Overall Study|Protocol deviation|0|||
146607637|NCT03738618|528733638|FG000|Overall Study|Adverse Event|4|||
146607638|NCT03738618|528733639|FG001|Overall Study|Adverse Event|0|||
146607639|NCT03738618|528733638|FG000|Overall Study|Lost to Follow-up|2|||
146607640|NCT03738618|528733639|FG001|Overall Study|Lost to Follow-up|0|||
146607641|NCT03738618|528733638|FG000|Overall Study|Randomization failure|1|||
146607642|NCT03738618|528733639|FG001|Overall Study|Randomization failure|0|||
146607643|NCT03738618|528733638|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
146607644|NCT03738618|528733639|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
146607645|NCT03738618|528733638|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
146607646|NCT03738618|528733639|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
146607647|NCT03499314|528733642|FG000|Overall Study|Time Commitment|1|||
146607648|NCT03499314|528733643|FG001|Overall Study|Time Commitment|2|||
146607649|NCT03499314|528733642|FG000|Overall Study|Medical issue unrelated to research study|1|||
146607650|NCT03499314|528733643|FG001|Overall Study|Medical issue unrelated to research study|1|||
146607651|NCT00872599|528733644|FG000|Second Washout Period|Adverse Event|1|||
146607652|NCT00872599|528733645|FG001|Second Washout Period|Adverse Event|1|||
146607653|NCT04794270|528733646|FG000|Period 1|Non Compliance|1|||
146607654|NCT04794270|528733647|FG001|Period 1|Non Compliance|0|||
146607655|NCT04794270|528733646|FG000|Period 1|Adverse Event|1|||
146607656|NCT04794270|528733647|FG001|Period 1|Adverse Event|0|||
146607657|NCT04794270|528733646|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
146607658|NCT04794270|528733647|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
146607659|NCT02510001|528733648|FG000|Overall Study|Early disease progression|0|||
146607660|NCT02510001|528733649|FG001|Overall Study|Early disease progression|0|||
146607661|NCT02510001|528733650|FG002|Overall Study|Early disease progression|0|||
146607662|NCT02510001|528733651|FG003|Overall Study|Early disease progression|1|||
146607663|NCT02510001|528733652|FG004|Overall Study|Early disease progression|1|||
146607664|NCT02510001|528733653|FG005|Overall Study|Early disease progression|1|||
146607665|NCT02510001|528733654|FG006|Overall Study|Early disease progression|0|||
146607666|NCT02510001|528733655|FG007|Overall Study|Early disease progression|0|||
146607667|NCT02510001|528733648|FG000|Overall Study|Adverse Event|0|||
146607668|NCT02510001|528733649|FG001|Overall Study|Adverse Event|0|||
146607669|NCT02510001|528733650|FG002|Overall Study|Adverse Event|0|||
146607670|NCT02510001|528733651|FG003|Overall Study|Adverse Event|1|||
146607671|NCT02510001|528733652|FG004|Overall Study|Adverse Event|2|||
146607672|NCT02510001|528733653|FG005|Overall Study|Adverse Event|1|||
146607673|NCT02510001|528733654|FG006|Overall Study|Adverse Event|2|||
146607674|NCT02510001|528733655|FG007|Overall Study|Adverse Event|5|||
146607675|NCT02510001|528733648|FG000|Overall Study|Physician Decision|0|||
146607676|NCT02510001|528733649|FG001|Overall Study|Physician Decision|0|||
146607677|NCT02510001|528733650|FG002|Overall Study|Physician Decision|0|||
146607678|NCT02510001|528733651|FG003|Overall Study|Physician Decision|0|||
146607679|NCT02510001|528733652|FG004|Overall Study|Physician Decision|1|||
146607680|NCT02510001|528733653|FG005|Overall Study|Physician Decision|0|||
146607681|NCT02510001|528733654|FG006|Overall Study|Physician Decision|0|||
146607682|NCT02510001|528733655|FG007|Overall Study|Physician Decision|0|||
146607683|NCT02510001|528733648|FG000|Overall Study|Withdrawal by Subject|0|||
146607684|NCT02510001|528733649|FG001|Overall Study|Withdrawal by Subject|0|||
146607685|NCT02510001|528733650|FG002|Overall Study|Withdrawal by Subject|0|||
146607686|NCT02510001|528733651|FG003|Overall Study|Withdrawal by Subject|0|||
146607687|NCT02510001|528733652|FG004|Overall Study|Withdrawal by Subject|0|||
146607688|NCT02510001|528733653|FG005|Overall Study|Withdrawal by Subject|0|||
146607689|NCT02510001|528733654|FG006|Overall Study|Withdrawal by Subject|0|||
146607690|NCT02510001|528733655|FG007|Overall Study|Withdrawal by Subject|2|||
146607691|NCT01504841|528733659|FG000|Overall Study|Withdrawal by Subject|1|||
146607692|NCT01504841|528733660|FG001|Overall Study|Withdrawal by Subject|1|||
146607693|NCT01504841|528733661|FG002|Overall Study|Withdrawal by Subject|0|||
146607694|NCT04440813|528733664|FG000|Overall Study|Lost to Follow-up|5|||
146607695|NCT04440813|528733665|FG001|Overall Study|Lost to Follow-up|5|||
146607696|NCT00291018|528733670|FG000|Overall Study|Not Consented or Declined PAS|12|||
146607697|NCT00291018|528733671|FG001|Overall Study|Not Consented or Declined PAS|15|||
146607698|NCT00291018|528733672|FG002|Overall Study|Not Consented or Declined PAS|15|||
146607699|NCT00291018|528733670|FG000|Overall Study|Death|3|||
146607700|NCT00291018|528733671|FG001|Overall Study|Death|3|||
146607701|NCT00291018|528733672|FG002|Overall Study|Death|4|||
146607702|NCT00291018|528733670|FG000|Overall Study|Withdrawal by Subject|2|||
146607703|NCT00291018|528733671|FG001|Overall Study|Withdrawal by Subject|8|||
146607704|NCT00291018|528733672|FG002|Overall Study|Withdrawal by Subject|1|||
146607705|NCT00291018|528733670|FG000|Overall Study|Failures|5|||
146607706|NCT00291018|528733671|FG001|Overall Study|Failures|12|||
146607707|NCT00291018|528733672|FG002|Overall Study|Failures|5|||
146607708|NCT00291018|528733670|FG000|Overall Study|Lost to Follow-up|3|||
146607709|NCT00291018|528733671|FG001|Overall Study|Lost to Follow-up|4|||
146607710|NCT00291018|528733672|FG002|Overall Study|Lost to Follow-up|18|||
146607711|NCT02219334|528733674|FG000|Overall Study|Withdrawal by Subject|1|||
146607712|NCT02219334|528733675|FG001|Overall Study|Withdrawal by Subject|0|||
146607713|NCT02219334|528733674|FG000|Overall Study|Protocol Violation|7|||
146607714|NCT02219334|528733675|FG001|Overall Study|Protocol Violation|3|||
146607715|NCT05362058|528733676|FG000|Treatment Period|Adverse Event|3|||
146607716|NCT05362058|528733677|FG001|Treatment Period|Adverse Event|3|||
146607717|NCT05362058|528733676|FG000|Treatment Period|Assigned treatment by mistake|3|||
146607718|NCT05362058|528733677|FG001|Treatment Period|Assigned treatment by mistake|4|||
146607719|NCT05362058|528733676|FG000|Treatment Period|Death|1|||
146607720|NCT05362058|528733677|FG001|Treatment Period|Death|1|||
146607721|NCT05362058|528733676|FG000|Treatment Period|Lost to Follow-up|6|||
146607722|NCT05362058|528733677|FG001|Treatment Period|Lost to Follow-up|3|||
146607723|NCT05362058|528733676|FG000|Treatment Period|Non-compliance with study drug|0|||
146607724|NCT05362058|528733677|FG001|Treatment Period|Non-compliance with study drug|1|||
146607725|NCT05362058|528733676|FG000|Treatment Period|Physician Decision|1|||
146607726|NCT05362058|528733677|FG001|Treatment Period|Physician Decision|0|||
146607727|NCT05362058|528733676|FG000|Treatment Period|Protocol deviation|1|||
146607728|NCT05362058|528733677|FG001|Treatment Period|Protocol deviation|0|||
146607729|NCT05362058|528733676|FG000|Treatment Period|Withdrawal by Subject|10|||
146607730|NCT05362058|528733677|FG001|Treatment Period|Withdrawal by Subject|11|||
146607731|NCT05362058|528733676|FG000|Follow-Up Period|Death|1|||
146607732|NCT05362058|528733677|FG001|Follow-Up Period|Death|0|||
146607733|NCT05362058|528733676|FG000|Follow-Up Period|Lost to Follow-up|2|||
146607734|NCT05362058|528733677|FG001|Follow-Up Period|Lost to Follow-up|1|||
146607735|NCT05362058|528733676|FG000|Follow-Up Period|Protocol deviation|1|||
146607736|NCT05362058|528733677|FG001|Follow-Up Period|Protocol deviation|1|||
146607737|NCT05362058|528733676|FG000|Follow-Up Period|Withdrawal by Subject|0|||
146607738|NCT05362058|528733677|FG001|Follow-Up Period|Withdrawal by Subject|3|||
146607739|NCT00711971|528733678|FG000|Overall Study|Lost to Follow-up|3|||
146607740|NCT00711971|528733679|FG001|Overall Study|Lost to Follow-up|4|||
146607741|NCT00711971|528733680|FG002|Overall Study|Lost to Follow-up|1|||
146607742|NCT04774926|528733684|FG000|Overall Study|Adverse Event|15|||
146607743|NCT04774926|528733684|FG000|Overall Study|Lost to Follow-up|3|||
146607744|NCT04774926|528733684|FG000|Overall Study|Physician Decision|6|||
146607745|NCT04774926|528733684|FG000|Overall Study|Withdrawal by Subject|3|||
146607746|NCT04774926|528733684|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
146607747|NCT00847886|528733685|FG000|Overall Study|Adverse Event|0|||
146607748|NCT00847886|528733686|FG001|Overall Study|Adverse Event|1|||
146607749|NCT02524158|528733687|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
146607750|NCT02524158|528733688|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
146607751|NCT02524158|528733687|FG000|12-weeks Assessment|Lost to Follow-up|18|||
146607752|NCT02524158|528733688|FG001|12-weeks Assessment|Lost to Follow-up|12|||
146607753|NCT02524158|528733687|FG000|6-month Assessment|Withdrawal by Subject|1|||
146607754|NCT02524158|528733688|FG001|6-month Assessment|Withdrawal by Subject|1|||
146607755|NCT02524158|528733687|FG000|6-month Assessment|Lost to Follow-up|21|||
146607756|NCT02524158|528733688|FG001|6-month Assessment|Lost to Follow-up|20|||
146607757|NCT01973998|528733692|FG000|Overall Study|Death|2|||
146607758|NCT01973998|528733693|FG001|Overall Study|Death|2|||
146607759|NCT00646399|528733694|FG000|Overall Study|Death|63|||
146607760|NCT00646399|528733695|FG001|Overall Study|Death|53|||
146607761|NCT00646399|528733694|FG000|Overall Study|Withdrawal by Subject|9|||
146607762|NCT00646399|528733695|FG001|Overall Study|Withdrawal by Subject|10|||
146607763|NCT00646399|528733694|FG000|Overall Study|Other Reason|11|||
146607764|NCT00646399|528733695|FG001|Overall Study|Other Reason|11|||
146607765|NCT02540993|528733696|FG000|Overall Study|Lost to Follow-up|5|||
146607766|NCT02540993|528733697|FG001|Overall Study|Lost to Follow-up|3|||
146607767|NCT02540993|528733696|FG000|Overall Study|Withdrawal by Subject|4|||
146607768|NCT02540993|528733697|FG001|Overall Study|Withdrawal by Subject|6|||
146607769|NCT02540993|528733696|FG000|Overall Study|GCP violations|33|||
146607770|NCT02540993|528733697|FG001|Overall Study|GCP violations|27|||
146607771|NCT00844558|528733698|FG000|Overall Study|Withdrawal by Subject|9|||
146607772|NCT00844558|528733699|FG001|Overall Study|Withdrawal by Subject|2|||
146607773|NCT00844558|528733698|FG000|Overall Study|Death|1|||
146607774|NCT00844558|528733699|FG001|Overall Study|Death|0|||
146607775|NCT00844558|528733698|FG000|Overall Study|Protocol Violation|1|||
146607776|NCT00844558|528733699|FG001|Overall Study|Protocol Violation|1|||
146607777|NCT00844558|528733698|FG000|Overall Study|Lost to Follow-up|0|||
146607778|NCT00844558|528733699|FG001|Overall Study|Lost to Follow-up|1|||
146607779|NCT00844558|528733698|FG000|Overall Study|Physician Decision|1|||
146607780|NCT00844558|528733699|FG001|Overall Study|Physician Decision|0|||
146607781|NCT00588094|528733700|FG000|Overall Study|Adverse Event|3|||
146607782|NCT00588094|528733700|FG000|Overall Study|Progression of Disease|2|||
146607783|NCT02202538|528733708|FG000|Overall Study|Withdrawal by Subject|5|||
146607784|NCT02202538|528733708|FG000|Overall Study|Did not meet all inclusion criteria|2|||
146607785|NCT02202538|528733708|FG000|Overall Study|Investigator Decision|1|||
146607786|NCT01457846|528733709|FG000|Overall Study|Death before treatment|1|||
146607787|NCT01457846|528733710|FG001|Overall Study|Death before treatment|2|||
146607788|NCT01457846|528733709|FG000|Overall Study|Did not receive treatment|0|||
146607789|NCT01457846|528733710|FG001|Overall Study|Did not receive treatment|1|||
146607790|NCT01457846|528733709|FG000|Overall Study|Death|27|||
146607791|NCT01457846|528733710|FG001|Overall Study|Death|16|||
146607792|NCT01457846|528733709|FG000|Overall Study|Unclassified reason for not completed|11|||
146922969|NCT03621943|529878689|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
146922970|NCT03621943|529878688|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
146607793|NCT01457846|528733710|FG001|Overall Study|Unclassified reason for not completed|10|||
146607794|NCT01457846|528733709|FG000|Overall Study|Withdrawal by Subject|1|||
146607795|NCT01457846|528733710|FG001|Overall Study|Withdrawal by Subject|1|||
146607796|NCT01457846|528733709|FG000|Overall Study|Lost to Follow-up|1|||
146607797|NCT01457846|528733710|FG001|Overall Study|Lost to Follow-up|0|||
146607798|NCT01853878|528733711|FG000|Overall Study|Recurrence|2|||
146607799|NCT01853878|528733712|FG001|Overall Study|Recurrence|0|||
146607800|NCT01853878|528733711|FG000|Overall Study|Adverse Event|2|||
146607801|NCT01853878|528733712|FG001|Overall Study|Adverse Event|0|||
146607802|NCT01853878|528733711|FG000|Overall Study|Withdrawal by Subject|3|||
146607803|NCT01853878|528733712|FG001|Overall Study|Withdrawal by Subject|1|||
146607804|NCT01853878|528733711|FG000|Overall Study|Migrated/moved from the study area|1|||
146607805|NCT01853878|528733712|FG001|Overall Study|Migrated/moved from the study area|0|||
146607806|NCT01853878|528733711|FG000|Overall Study|Other|55|||
146607807|NCT01853878|528733712|FG001|Overall Study|Other|43|||
146607808|NCT01846741|528733713|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
146607809|NCT03997825|528733714|FG000|Overall Study|Death|3|||
146607810|NCT03997825|528733714|FG000|Overall Study|Lost to Follow-up|10|||
146607811|NCT03997825|528733714|FG000|Overall Study|Withdrawal by Subject|3|||
146607812|NCT03997825|528733714|FG000|Overall Study|Refused participation|1|||
146607813|NCT00383162|528733715|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
146607814|NCT00383162|528733716|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
146607815|NCT00383162|528733715|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
146607816|NCT00383162|528733716|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
146607817|NCT00383162|528733715|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
146607818|NCT00383162|528733716|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
146607819|NCT00383162|528733715|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
146607820|NCT00383162|528733716|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
146607821|NCT00383162|528733715|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
146607822|NCT00383162|528733716|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
146607823|NCT00383162|528733715|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
146607824|NCT00383162|528733716|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
146607825|NCT00383162|528733715|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
146607826|NCT00383162|528733716|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
146607827|NCT00383162|528733715|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
146607828|NCT00383162|528733716|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
146607829|NCT00383162|528733715|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
146607830|NCT00383162|528733716|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
146607831|NCT00767819|528733717|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
146607832|NCT00767819|528733718|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
146607833|NCT00767819|528733719|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146607834|NCT00767819|528733717|FG000|Overall Study|Withdrawal by Subject|1|||
146607835|NCT00767819|528733718|FG001|Overall Study|Withdrawal by Subject|1|||
146607836|NCT00767819|528733719|FG002|Overall Study|Withdrawal by Subject|0|||
146607837|NCT00767819|528733717|FG000|Overall Study|Administrative problems|0|||
146607838|NCT00767819|528733718|FG001|Overall Study|Administrative problems|1|||
146607839|NCT00767819|528733719|FG002|Overall Study|Administrative problems|0|||
146607840|NCT00767819|528733717|FG000|Overall Study|Death|2|||
146607841|NCT00767819|528733718|FG001|Overall Study|Death|3|||
146607842|NCT00767819|528733719|FG002|Overall Study|Death|0|||
146607843|NCT00767819|528733717|FG000|Overall Study|Adverse Event|2|||
146607844|NCT00767819|528733718|FG001|Overall Study|Adverse Event|0|||
146607845|NCT00767819|528733719|FG002|Overall Study|Adverse Event|0|||
146607846|NCT00767819|528733717|FG000|Overall Study|Abnormal lab values|1|||
146607847|NCT00767819|528733718|FG001|Overall Study|Abnormal lab values|0|||
146607848|NCT00767819|528733719|FG002|Overall Study|Abnormal lab values|0|||
146657263|NCT00410202|528921738|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
146607849|NCT00767819|528733717|FG000|Overall Study|Lost to Follow-up|1|||
146607850|NCT00767819|528733718|FG001|Overall Study|Lost to Follow-up|0|||
146607851|NCT00767819|528733719|FG002|Overall Study|Lost to Follow-up|0|||
146607852|NCT01153698|528733720|FG000|Overall Study|Adverse Event|12|||
146607853|NCT01153698|528733720|FG000|Overall Study|Lost to Follow-up|4|||
146607854|NCT01153698|528733720|FG000|Overall Study|Withdrawal by Subject|2|||
146607855|NCT01153698|528733720|FG000|Overall Study|Switch to other anticoagulants|4|||
146607856|NCT01153698|528733720|FG000|Overall Study|Other|2|||
146607857|NCT01153698|528733720|FG000|Overall Study|Not treated with Pradaxa|5|||
146607858|NCT00465647|528733726|FG000|Overall Study|Administrative|2|||
146607859|NCT00465647|528733727|FG001|Overall Study|Administrative|2|||
146607860|NCT00465647|528733728|FG002|Overall Study|Administrative|3|||
146607861|NCT00465647|528733729|FG003|Overall Study|Administrative|2|||
146607862|NCT00465647|528733726|FG000|Overall Study|Adverse Event|2|||
146607863|NCT00465647|528733727|FG001|Overall Study|Adverse Event|0|||
146607864|NCT00465647|528733728|FG002|Overall Study|Adverse Event|3|||
146607865|NCT00465647|528733729|FG003|Overall Study|Adverse Event|2|||
146607866|NCT00465647|528733726|FG000|Overall Study|Withdrawal by Subject|1|||
146607867|NCT00465647|528733727|FG001|Overall Study|Withdrawal by Subject|2|||
146607868|NCT00465647|528733728|FG002|Overall Study|Withdrawal by Subject|2|||
146607869|NCT00465647|528733729|FG003|Overall Study|Withdrawal by Subject|7|||
146607870|NCT00465647|528733726|FG000|Overall Study|"The other reasons included loss of IV"|8|||
146607871|NCT00465647|528733727|FG001|Overall Study|"The other reasons included loss of IV"|4|||
146607872|NCT00465647|528733728|FG002|Overall Study|"The other reasons included loss of IV"|3|||
146607873|NCT00465647|528733729|FG003|Overall Study|"The other reasons included loss of IV"|2|||
146607874|NCT01371305|528733734|FG000|Overall Study|Adverse Event|0|||
146607875|NCT01371305|528733735|FG001|Overall Study|Adverse Event|0|||
146607876|NCT01371305|528733736|FG002|Overall Study|Adverse Event|0|||
146607877|NCT01371305|528733737|FG003|Overall Study|Adverse Event|2|||
146607878|NCT01371305|528733738|FG004|Overall Study|Adverse Event|1|||
146607879|NCT01371305|528733739|FG005|Overall Study|Adverse Event|0|||
146607880|NCT01371305|528733734|FG000|Overall Study|Study terminated by sponsor|0|||
146607881|NCT01371305|528733735|FG001|Overall Study|Study terminated by sponsor|0|||
146607882|NCT01371305|528733736|FG002|Overall Study|Study terminated by sponsor|0|||
146607883|NCT01371305|528733737|FG003|Overall Study|Study terminated by sponsor|0|||
146657264|NCT00410202|528921739|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
146657265|NCT00410202|528921740|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
146657266|NCT00144027|528921741|FG000|Overall Study|Lost to Follow-up|1|||
146657267|NCT00144027|528921742|FG001|Overall Study|Lost to Follow-up|3|||
146657268|NCT00144027|528921741|FG000|Overall Study|Withdrawal by Subject|2|||
146657269|NCT00144027|528921742|FG001|Overall Study|Withdrawal by Subject|2|||
146657270|NCT00144027|528921741|FG000|Overall Study|did not complete baseline assessment|0|||
146607884|NCT01371305|528733738|FG004|Overall Study|Study terminated by sponsor|3|||
146607885|NCT01371305|528733739|FG005|Overall Study|Study terminated by sponsor|1|||
146607886|NCT01371305|528733734|FG000|Overall Study|Subject request|0|||
146607887|NCT01371305|528733735|FG001|Overall Study|Subject request|0|||
146657271|NCT00144027|528921742|FG001|Overall Study|did not complete baseline assessment|6|||
146657272|NCT05080660|528921743|FG000|Overall Study|Adverse Event|4|||
146657273|NCT05080660|528921744|FG001|Overall Study|Adverse Event|0|||
146657274|NCT05080660|528921743|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
146657275|NCT05080660|528921744|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
146607888|NCT01371305|528733736|FG002|Overall Study|Subject request|0|||
146607889|NCT01371305|528733737|FG003|Overall Study|Subject request|0|||
146607890|NCT01371305|528733738|FG004|Overall Study|Subject request|0|||
146607891|NCT01371305|528733739|FG005|Overall Study|Subject request|1|||
146607892|NCT04038567|528733740|FG000|Overall Study|Lost to Follow-up|6|||
146607893|NCT04038567|528733741|FG001|Overall Study|Lost to Follow-up|4|||
146607894|NCT04038567|528733742|FG002|Overall Study|Lost to Follow-up|5|||
146607895|NCT04038567|528733743|FG003|Overall Study|Lost to Follow-up|4|||
146607896|NCT04038567|528733744|FG004|Overall Study|Lost to Follow-up|6|||
146607897|NCT04038567|528733745|FG005|Overall Study|Lost to Follow-up|4|||
146607898|NCT04038567|528733746|FG006|Overall Study|Lost to Follow-up|4|||
146978664|NCT01246986|530085450|FG001|Overall Study|Withdrawal by Subject|4|||
146978665|NCT01246986|530085451|FG002|Overall Study|Withdrawal by Subject|3|||
146978666|NCT01246986|530085452|FG003|Overall Study|Withdrawal by Subject|0|||
146978667|NCT01246986|530085453|FG004|Overall Study|Withdrawal by Subject|4|||
146978668|NCT01246986|530085454|FG005|Overall Study|Withdrawal by Subject|0|||
146607899|NCT04038567|528733747|FG007|Overall Study|Lost to Follow-up|1|||
146607900|NCT04038567|528733740|FG000|Overall Study|Withdrawal by Subject|2|||
146607901|NCT04038567|528733741|FG001|Overall Study|Withdrawal by Subject|1|||
146607902|NCT04038567|528733742|FG002|Overall Study|Withdrawal by Subject|1|||
146607903|NCT04038567|528733743|FG003|Overall Study|Withdrawal by Subject|1|||
146607904|NCT04038567|528733744|FG004|Overall Study|Withdrawal by Subject|4|||
146607905|NCT04038567|528733745|FG005|Overall Study|Withdrawal by Subject|1|||
146607906|NCT04038567|528733746|FG006|Overall Study|Withdrawal by Subject|1|||
146607907|NCT04038567|528733747|FG007|Overall Study|Withdrawal by Subject|1|||
146607908|NCT04038567|528733740|FG000|Overall Study|missed survey window|1|||
146607909|NCT04038567|528733741|FG001|Overall Study|missed survey window|2|||
146607910|NCT04038567|528733742|FG002|Overall Study|missed survey window|0|||
146607911|NCT04038567|528733743|FG003|Overall Study|missed survey window|0|||
146607912|NCT04038567|528733744|FG004|Overall Study|missed survey window|1|||
146607913|NCT04038567|528733745|FG005|Overall Study|missed survey window|1|||
146607914|NCT04038567|528733746|FG006|Overall Study|missed survey window|2|||
146607915|NCT04038567|528733747|FG007|Overall Study|missed survey window|2|||
146607916|NCT04038567|528733740|FG000|Overall Study|technical issues|0|||
146607917|NCT04038567|528733741|FG001|Overall Study|technical issues|0|||
146607918|NCT04038567|528733742|FG002|Overall Study|technical issues|0|||
146607919|NCT04038567|528733743|FG003|Overall Study|technical issues|0|||
146607920|NCT04038567|528733744|FG004|Overall Study|technical issues|0|||
146607921|NCT04038567|528733745|FG005|Overall Study|technical issues|0|||
146607922|NCT04038567|528733746|FG006|Overall Study|technical issues|1|||
146607923|NCT04038567|528733747|FG007|Overall Study|technical issues|0|||
146607924|NCT04038567|528733740|FG000|Overall Study|Medical issues (i.e., illness)|0|||
146607925|NCT04038567|528733741|FG001|Overall Study|Medical issues (i.e., illness)|1|||
146607926|NCT04038567|528733742|FG002|Overall Study|Medical issues (i.e., illness)|2|||
146607927|NCT04038567|528733743|FG003|Overall Study|Medical issues (i.e., illness)|1|||
146607928|NCT04038567|528733744|FG004|Overall Study|Medical issues (i.e., illness)|1|||
146607929|NCT04038567|528733745|FG005|Overall Study|Medical issues (i.e., illness)|1|||
146607930|NCT04038567|528733746|FG006|Overall Study|Medical issues (i.e., illness)|0|||
146607931|NCT04038567|528733747|FG007|Overall Study|Medical issues (i.e., illness)|0|||
146607932|NCT04038567|528733740|FG000|Overall Study|Death|0|||
146607933|NCT04038567|528733741|FG001|Overall Study|Death|0|||
146607934|NCT04038567|528733742|FG002|Overall Study|Death|0|||
146607935|NCT04038567|528733743|FG003|Overall Study|Death|1|||
146607936|NCT04038567|528733744|FG004|Overall Study|Death|1|||
146607937|NCT04038567|528733745|FG005|Overall Study|Death|0|||
146607938|NCT04038567|528733746|FG006|Overall Study|Death|0|||
146607939|NCT04038567|528733747|FG007|Overall Study|Death|1|||
146607940|NCT02220712|528733748|FG000|Overall Study|Adverse Event|1|||
146607941|NCT02220712|528733748|FG000|Overall Study|Withdrawal by Subject|2|||
146607942|NCT02220712|528733748|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
146607943|NCT00760838|528733752|FG000|Overall Study|Adverse Event|1|||
146607944|NCT00760838|528733753|FG001|Overall Study|Adverse Event|1|||
146607945|NCT00760838|528733752|FG000|Overall Study|Lack of Efficacy|1|||
146607946|NCT00760838|528733753|FG001|Overall Study|Lack of Efficacy|0|||
146607947|NCT00760838|528733752|FG000|Overall Study|Lost to Follow-up|2|||
146607948|NCT00760838|528733753|FG001|Overall Study|Lost to Follow-up|0|||
146607949|NCT00760838|528733752|FG000|Overall Study|Withdrawal by Subject|1|||
146607950|NCT00760838|528733753|FG001|Overall Study|Withdrawal by Subject|1|||
146607951|NCT01817959|528733754|FG000|Overall Study|Graft loss|1|||
146607952|NCT01817959|528733755|FG001|Overall Study|Graft loss|1|||
146607953|NCT01817959|528733754|FG000|Overall Study|forbidden medication|1|||
146607954|NCT01817959|528733755|FG001|Overall Study|forbidden medication|1|||
146607955|NCT01817959|528733754|FG000|Overall Study|Adverse Event|1|||
146607956|NCT01817959|528733755|FG001|Overall Study|Adverse Event|0|||
146607957|NCT01817959|528733754|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
146607958|NCT01817959|528733755|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
146607959|NCT04356352|528733769|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
146607960|NCT04356352|528733770|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
146607961|NCT04356352|528733771|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
146607962|NCT04356352|528733769|FG000|Overall Study|Protocol Violation|0|||
146607963|NCT04356352|528733770|FG001|Overall Study|Protocol Violation|3|||
146607964|NCT04356352|528733771|FG002|Overall Study|Protocol Violation|1|||
146978669|NCT01246986|530085455|FG006|Overall Study|Withdrawal by Subject|0|||
146978670|NCT02496221|530085456|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
146607965|NCT00781859|528733772|FG000|Overall Study|Adverse Event|2|||
146607966|NCT00781859|528733773|FG001|Overall Study|Adverse Event|2|||
146607967|NCT00781859|528733772|FG000|Overall Study|Withdrawal by Subject|8|||
146607968|NCT00781859|528733773|FG001|Overall Study|Withdrawal by Subject|4|||
146607969|NCT00781859|528733772|FG000|Overall Study|Lost to Follow-up|6|||
146607970|NCT00781859|528733773|FG001|Overall Study|Lost to Follow-up|3|||
146607971|NCT00781859|528733772|FG000|Overall Study|Death|3|||
146607972|NCT00781859|528733773|FG001|Overall Study|Death|0|||
146607973|NCT01138501|528733774|FG000|Overall Study|Protocol Violation|2|||
146607974|NCT01138501|528733774|FG000|Overall Study|Withdrawal by Subject|3|||
146607975|NCT00348309|528733775|FG000|Overall Study|Adverse Event|56|||
146607976|NCT00348309|528733776|FG001|Overall Study|Adverse Event|28|||
146607977|NCT00348309|528733777|FG002|Overall Study|Adverse Event|63|||
146607978|NCT00348309|528733775|FG000|Overall Study|Lost to Follow-up|6|||
146607979|NCT00348309|528733776|FG001|Overall Study|Lost to Follow-up|7|||
146607980|NCT00348309|528733777|FG002|Overall Study|Lost to Follow-up|4|||
146607981|NCT00348309|528733775|FG000|Overall Study|Protocol Violation|7|||
146607982|NCT00348309|528733776|FG001|Overall Study|Protocol Violation|12|||
146607983|NCT00348309|528733777|FG002|Overall Study|Protocol Violation|7|||
146607984|NCT00348309|528733775|FG000|Overall Study|Withdrawal by Subject|33|||
146607985|NCT00348309|528733776|FG001|Overall Study|Withdrawal by Subject|37|||
146607986|NCT00348309|528733777|FG002|Overall Study|Withdrawal by Subject|40|||
146607987|NCT00348309|528733775|FG000|Overall Study|Non-compliance|8|||
146607988|NCT00348309|528733776|FG001|Overall Study|Non-compliance|6|||
146607989|NCT00348309|528733777|FG002|Overall Study|Non-compliance|8|||
146607990|NCT00348309|528733775|FG000|Overall Study|Death of caregiver|1|||
146607991|NCT00348309|528733776|FG001|Overall Study|Death of caregiver|0|||
146607992|NCT00348309|528733777|FG002|Overall Study|Death of caregiver|1|||
146607993|NCT00348309|528733775|FG000|Overall Study|Lack of insight, dementia|1|||
146607994|NCT00348309|528733776|FG001|Overall Study|Lack of insight, dementia|0|||
146607995|NCT00348309|528733777|FG002|Overall Study|Lack of insight, dementia|0|||
146607996|NCT00348309|528733775|FG000|Overall Study|Wrong bottle allocated|1|||
146607997|NCT00348309|528733776|FG001|Overall Study|Wrong bottle allocated|0|||
146607998|NCT00348309|528733777|FG002|Overall Study|Wrong bottle allocated|0|||
146607999|NCT00348309|528733775|FG000|Overall Study|Caregiver sick|1|||
146608000|NCT00348309|528733776|FG001|Overall Study|Caregiver sick|0|||
146608001|NCT00348309|528733777|FG002|Overall Study|Caregiver sick|0|||
146608002|NCT00348309|528733775|FG000|Overall Study|Use of prohibited medication|5|||
146608003|NCT00348309|528733776|FG001|Overall Study|Use of prohibited medication|2|||
146608004|NCT00348309|528733777|FG002|Overall Study|Use of prohibited medication|2|||
146608005|NCT00348309|528733775|FG000|Overall Study|Caregiver withdrawal|3|||
146608006|NCT00348309|528733776|FG001|Overall Study|Caregiver withdrawal|0|||
146657276|NCT05080660|528921743|FG000|Overall Study|Physician Decision|1|||
146657277|NCT05080660|528921744|FG001|Overall Study|Physician Decision|0|||
146657278|NCT05080660|528921743|FG000|Overall Study|Protocol Deviation|2|||
146657279|NCT05080660|528921744|FG001|Overall Study|Protocol Deviation|0|||
146657280|NCT05080660|528921743|FG000|Overall Study|Withdrawal by Subject|5|||
146657281|NCT05080660|528921744|FG001|Overall Study|Withdrawal by Subject|2|||
146657282|NCT00817479|528921745|FG000|Overall Study|Physician Decision|1|||
146657283|NCT00817479|528921746|FG001|Overall Study|Physician Decision|1|||
146657284|NCT00282347|528921752|FG000|Treatment Period|Death|2|||
146657285|NCT00282347|528921753|FG001|Treatment Period|Death|0|||
146657286|NCT00282347|528921752|FG000|Treatment Period|Lost to Follow-up|2|||
146657287|NCT00282347|528921753|FG001|Treatment Period|Lost to Follow-up|5|||
146657288|NCT00282347|528921752|FG000|Treatment Period|Withdrawal by Subject|1|||
146657289|NCT00282347|528921753|FG001|Treatment Period|Withdrawal by Subject|3|||
146657290|NCT00282347|528921752|FG000|Treatment Period|Physician Decision|0|||
146657291|NCT00282347|528921753|FG001|Treatment Period|Physician Decision|1|||
146657292|NCT00282347|528921752|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
146657293|NCT00282347|528921753|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
146657294|NCT00282347|528921752|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
146657295|NCT00282347|528921753|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
146922971|NCT03621943|529878689|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
146922972|NCT03621943|529878688|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
146922973|NCT03621943|529878689|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
146922974|NCT01346371|529878690|FG000|Overall Study|Lost to Follow-up|2|||
146608007|NCT00348309|528733777|FG002|Overall Study|Caregiver withdrawal|7|||
146608008|NCT00348309|528733775|FG000|Overall Study|Unable to complete ET visit|1|||
146608009|NCT00348309|528733776|FG001|Overall Study|Unable to complete ET visit|0|||
146657296|NCT00282347|528921752|FG000|Safety Follow-up Period|Physician Decision|1|||
146657297|NCT00282347|528921753|FG001|Safety Follow-up Period|Physician Decision|1|||
146657298|NCT00282347|528921752|FG000|Safety Follow-up Period|Protocol Deviation|0|||
146608010|NCT00348309|528733777|FG002|Overall Study|Unable to complete ET visit|0|||
146608011|NCT00348309|528733775|FG000|Overall Study|PI closing medical practice|1|||
146608012|NCT00348309|528733776|FG001|Overall Study|PI closing medical practice|0|||
146657299|NCT00282347|528921753|FG001|Safety Follow-up Period|Protocol Deviation|2|||
146922975|NCT01346371|529878691|FG001|Overall Study|Lost to Follow-up|0|||
146608013|NCT00348309|528733777|FG002|Overall Study|PI closing medical practice|0|||
146608014|NCT00348309|528733775|FG000|Overall Study|Principal investigator's decision|1|||
146922976|NCT00111475|529878695|FG000|Overall Study|Lost to Follow-up|0|||
146608015|NCT00348309|528733776|FG001|Overall Study|Principal investigator's decision|0|||
146608016|NCT00348309|528733777|FG002|Overall Study|Principal investigator's decision|0|||
146608017|NCT00348309|528733775|FG000|Overall Study|No disponibility of medication|1|||
146608018|NCT00348309|528733776|FG001|Overall Study|No disponibility of medication|0|||
146608019|NCT00348309|528733777|FG002|Overall Study|No disponibility of medication|0|||
146608020|NCT00348309|528733775|FG000|Overall Study|Worsened neurodegenerative disease|1|||
146608021|NCT00348309|528733776|FG001|Overall Study|Worsened neurodegenerative disease|0|||
146608022|NCT00348309|528733777|FG002|Overall Study|Worsened neurodegenerative disease|0|||
146608023|NCT00348309|528733775|FG000|Overall Study|Cognitive and behaviour worsening|2|||
146608024|NCT00348309|528733776|FG001|Overall Study|Cognitive and behaviour worsening|0|||
146608025|NCT00348309|528733777|FG002|Overall Study|Cognitive and behaviour worsening|0|||
146608026|NCT00348309|528733775|FG000|Overall Study|Worsening of alzheimer|1|||
146608027|NCT00348309|528733776|FG001|Overall Study|Worsening of alzheimer|0|||
146608028|NCT00348309|528733777|FG002|Overall Study|Worsening of alzheimer|1|||
146608029|NCT00348309|528733775|FG000|Overall Study|Did not appear in time for Visit 3|1|||
146608030|NCT00348309|528733776|FG001|Overall Study|Did not appear in time for Visit 3|0|||
146608031|NCT00348309|528733777|FG002|Overall Study|Did not appear in time for Visit 3|0|||
146608032|NCT00348309|528733775|FG000|Overall Study|Participant died|2|||
146608033|NCT00348309|528733776|FG001|Overall Study|Participant died|1|||
146608034|NCT00348309|528733777|FG002|Overall Study|Participant died|1|||
146608035|NCT00348309|528733775|FG000|Overall Study|Decision of sponsor|1|||
146608036|NCT00348309|528733776|FG001|Overall Study|Decision of sponsor|0|||
146608037|NCT00348309|528733777|FG002|Overall Study|Decision of sponsor|0|||
146608038|NCT00348309|528733775|FG000|Overall Study|Ineffectiveness of treatment|0|||
146608039|NCT00348309|528733776|FG001|Overall Study|Ineffectiveness of treatment|1|||
146608040|NCT00348309|528733777|FG002|Overall Study|Ineffectiveness of treatment|0|||
146608041|NCT00348309|528733775|FG000|Overall Study|A foul of exclusion criteria|0|||
146608042|NCT00348309|528733776|FG001|Overall Study|A foul of exclusion criteria|1|||
146608043|NCT00348309|528733777|FG002|Overall Study|A foul of exclusion criteria|0|||
146608044|NCT00348309|528733775|FG000|Overall Study|Participant was hospitalized|0|||
146608045|NCT00348309|528733776|FG001|Overall Study|Participant was hospitalized|1|||
146608046|NCT00348309|528733777|FG002|Overall Study|Participant was hospitalized|0|||
146608047|NCT00348309|528733775|FG000|Overall Study|Sponsor refuseal|0|||
146608048|NCT00348309|528733776|FG001|Overall Study|Sponsor refuseal|1|||
146608049|NCT00348309|528733777|FG002|Overall Study|Sponsor refuseal|1|||
146608050|NCT00348309|528733775|FG000|Overall Study|Forgot often medication|0|||
146608051|NCT00348309|528733776|FG001|Overall Study|Forgot often medication|1|||
146608052|NCT00348309|528733777|FG002|Overall Study|Forgot often medication|0|||
146608053|NCT00348309|528733775|FG000|Overall Study|Medical Monitor decision|0|||
146608054|NCT00348309|528733776|FG001|Overall Study|Medical Monitor decision|0|||
146608055|NCT00348309|528733777|FG002|Overall Study|Medical Monitor decision|1|||
146608056|NCT00348309|528733775|FG000|Overall Study|Increased dose of Aricept|0|||
146608057|NCT00348309|528733776|FG001|Overall Study|Increased dose of Aricept|0|||
146608058|NCT00348309|528733777|FG002|Overall Study|Increased dose of Aricept|1|||
146608059|NCT00348309|528733775|FG000|Overall Study|Site closure|0|||
146608060|NCT00348309|528733776|FG001|Overall Study|Site closure|0|||
146608061|NCT00348309|528733777|FG002|Overall Study|Site closure|1|||
146608062|NCT00348309|528733775|FG000|Overall Study|Adverse event not attended|0|||
146608063|NCT00348309|528733776|FG001|Overall Study|Adverse event not attended|0|||
146608064|NCT00348309|528733777|FG002|Overall Study|Adverse event not attended|1|||
146608065|NCT00348309|528733775|FG000|Overall Study|ECG abnormal|0|||
146608066|NCT00348309|528733776|FG001|Overall Study|ECG abnormal|0|||
146608067|NCT00348309|528733777|FG002|Overall Study|ECG abnormal|2|||
146608068|NCT00348309|528733775|FG000|Overall Study|Cardiologist recommendations|0|||
146608069|NCT00348309|528733776|FG001|Overall Study|Cardiologist recommendations|0|||
146608070|NCT00348309|528733777|FG002|Overall Study|Cardiologist recommendations|1|||
146608071|NCT00348309|528733775|FG000|Overall Study|HCV career|0|||
146608072|NCT00348309|528733776|FG001|Overall Study|HCV career|0|||
146608073|NCT00348309|528733777|FG002|Overall Study|HCV career|1|||
146608074|NCT00622388|528733778|FG000|Overall Study|Disease Progression|47|||
146608075|NCT00622388|528733778|FG000|Overall Study|Adverse Event|6|||
146978671|NCT02496221|530085457|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
146608076|NCT00622388|528733778|FG000|Overall Study|Protocol Violation|3|||
146608077|NCT00622388|528733778|FG000|Overall Study|Participant Refusal|1|||
146608078|NCT00622388|528733778|FG000|Overall Study|Death|3|||
146608079|NCT00622388|528733778|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
146608080|NCT00622388|528733778|FG000|Overall Study|Took Prohibited Medication|2|||
146608081|NCT00622388|528733778|FG000|Overall Study|Withdrew Consent|1|||
146608082|NCT00622388|528733778|FG000|Overall Study|Insurance Expired|1|||
146608083|NCT01894243|528733779|FG000|Overall Study|Adverse Event|0|||
146608084|NCT01894243|528733780|FG001|Overall Study|Adverse Event|1|||
146608085|NCT01894243|528733781|FG002|Overall Study|Adverse Event|2|||
146608086|NCT01894243|528733779|FG000|Overall Study|Death|0|||
146608087|NCT01894243|528733780|FG001|Overall Study|Death|0|||
146608088|NCT01894243|528733781|FG002|Overall Study|Death|3|||
146608089|NCT01894243|528733779|FG000|Overall Study|Lack of Efficacy|3|||
146608090|NCT01894243|528733780|FG001|Overall Study|Lack of Efficacy|3|||
146657300|NCT00282347|528921752|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
146657301|NCT00282347|528921753|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
146657302|NCT00282347|528921752|FG000|B Cell Follow-up Period|Physician Decision|1|||
146657303|NCT00282347|528921753|FG001|B Cell Follow-up Period|Physician Decision|0|||
146657304|NCT00282347|528921752|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
146657305|NCT00282347|528921753|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
146608091|NCT01894243|528733781|FG002|Overall Study|Lack of Efficacy|1|||
146608092|NCT01894243|528733779|FG000|Overall Study|Condition under investigation worsened|8|||
146608093|NCT01894243|528733780|FG001|Overall Study|Condition under investigation worsened|6|||
146608094|NCT01894243|528733781|FG002|Overall Study|Condition under investigation worsened|2|||
146608095|NCT01894243|528733779|FG000|Overall Study|Subject decision|1|||
146608096|NCT01894243|528733780|FG001|Overall Study|Subject decision|0|||
146608097|NCT01894243|528733781|FG002|Overall Study|Subject decision|0|||
146608098|NCT01894243|528733779|FG000|Overall Study|Other|1|||
146608099|NCT01894243|528733780|FG001|Overall Study|Other|0|||
146608100|NCT01894243|528733781|FG002|Overall Study|Other|0|||
146608101|NCT01743040|528733782|FG000|Overall Study|Death|1|||
146608102|NCT01743040|528733782|FG000|Overall Study|Lost to Follow-up|66|||
146608103|NCT01743040|528733782|FG000|Overall Study|Physician Decision|40|||
146608104|NCT01743040|528733782|FG000|Overall Study|Protocol Violation|1|||
146608105|NCT01743040|528733782|FG000|Overall Study|Withdrawal by Subject|121|||
146608106|NCT00828750|528733783|FG000|Overall Study|Lack of Efficacy|3|||
146608107|NCT00828750|528733783|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
146608108|NCT04006392|528733784|FG000|Overall Study|Lost to Follow-up|0|||
146608109|NCT04006392|528733785|FG001|Overall Study|Lost to Follow-up|1|||
146608110|NCT01299116|528733786|FG000|Overall Study|Lost to Follow-up|65|||
146608111|NCT01299116|528733787|FG001|Overall Study|Lost to Follow-up|9|||
146657306|NCT02125604|528921754|FG000|Overall Study|Other|4|||
146657307|NCT02125604|528921754|FG000|Overall Study|Investigator Decision|1|||
146657308|NCT02125604|528921754|FG000|Overall Study|Lost to Follow-up|2|||
146657309|NCT02125604|528921754|FG000|Overall Study|Consent Withdrawn|4|||
146657310|NCT02125604|528921754|FG000|Overall Study|Adverse Event|20|||
146657311|NCT04340063|528921755|FG000|Overall Study|Withdrawal by Subject|1|||
146657312|NCT04340063|528921756|FG001|Overall Study|Withdrawal by Subject|2|||
146657313|NCT04340063|528921755|FG000|Overall Study|Lost to Follow-up|3|||
146657314|NCT04340063|528921756|FG001|Overall Study|Lost to Follow-up|1|||
146657315|NCT04340063|528921755|FG000|Overall Study|Protocol Violation|0|||
146657316|NCT04340063|528921756|FG001|Overall Study|Protocol Violation|1|||
146657317|NCT02418156|528921757|FG000|Overall Study|Lost to Follow-up|12|||
146657318|NCT02418156|528921757|FG000|Overall Study|Death|2|||
146657319|NCT02418156|528921757|FG000|Overall Study|Physician Decision|1|||
146657320|NCT02418156|528921757|FG000|Overall Study|Withdrawal by Subject|1|||
146657321|NCT02418156|528921757|FG000|Overall Study|Subject refused to return|1|||
146657322|NCT00734747|528921761|FG000|SRS Procedure|No staples placed|3|||
146657323|NCT00734747|528921761|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
146657324|NCT03670836|528921765|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
146657325|NCT03670836|528921766|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
146657326|NCT03670836|528921765|FG000|Per Protocol Population (PP)|Physician Decision|9|||
146657327|NCT03670836|528921766|FG001|Per Protocol Population (PP)|Physician Decision|10|||
146657328|NCT03670836|528921765|FG000|Per Protocol Population (PP)|Physician Decision|4|||
146657329|NCT03670836|528921766|FG001|Per Protocol Population (PP)|Physician Decision|6|||
146657330|NCT03670836|528921765|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
146657331|NCT03670836|528921766|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
146657332|NCT03287635|528921767|FG000|Overall Study|Lost to Follow-up|5|||
146657333|NCT03287635|528921767|FG000|Overall Study|Withdrawal by Subject|1|||
146657334|NCT03287635|528921767|FG000|Overall Study|Physician Decision|1|||
146657335|NCT00323869|528921770|FG000|Overall Study|Death|1|||
146657336|NCT01052844|528923061|FG000|Overall Study|Adverse Event|0|||
146657337|NCT01052844|528923062|FG001|Overall Study|Adverse Event|1|||
146657338|NCT01241240|528923063|FG000|Overall Study|Adverse Event|5|||
146657339|NCT01241240|528923064|FG001|Overall Study|Adverse Event|4|||
146657340|NCT01241240|528923063|FG000|Overall Study|Lost to Follow-up|2|||
146657341|NCT01241240|528923064|FG001|Overall Study|Lost to Follow-up|4|||
146657342|NCT01241240|528923063|FG000|Overall Study|Personal Reasons|1|||
146657343|NCT01241240|528923064|FG001|Overall Study|Personal Reasons|1|||
146657344|NCT01439347|528923065|FG000|Overall Study|Death|10|||
146657345|NCT01439347|528923066|FG001|Overall Study|Death|9|||
146657346|NCT01439347|528923065|FG000|Overall Study|Withdrawal by Subject|0|||
146657347|NCT01439347|528923066|FG001|Overall Study|Withdrawal by Subject|1|||
146773177|NCT00840177|529339511|FG002|Overall Study|Refusal unrelated to adverse events|1|||
146608112|NCT01299116|528733788|FG002|Overall Study|Lost to Follow-up|11|||
146608113|NCT01620944|528733789|FG000|Overall Study|Early termination of Study|2|||
146657348|NCT01439347|528923065|FG000|Overall Study|Physician Decision|1|||
146657349|NCT01439347|528923066|FG001|Overall Study|Physician Decision|0|||
146608114|NCT01620944|528733790|FG001|Overall Study|Early termination of Study|1|||
146608115|NCT04378114|528733791|FG000|Overall Study|Withdrawal by Subject|5|||
146608116|NCT00830180|528733792|FG000|Overall Study|Adverse Event|6|||
146608117|NCT00830180|528733792|FG000|Overall Study|Death|11|||
146608118|NCT00830180|528733792|FG000|Overall Study|Insufficient clinical response|1|||
146608119|NCT00830180|528733792|FG000|Overall Study|Withdrawal by Subject|5|||
146608120|NCT00830180|528733792|FG000|Overall Study|Progressive disease|2|||
146608121|NCT00830180|528733792|FG000|Overall Study|Other - Unspecified|1|||
146608122|NCT01832532|528733793|FG000|Overall Study|Withdrawal by Subject|5|||
146608123|NCT01832532|528733794|FG001|Overall Study|Withdrawal by Subject|2|||
146608124|NCT00392990|528733795|FG000|Treatment on Study|Adverse Event|3|||
146608125|NCT00392990|528733796|FG001|Treatment on Study|Adverse Event|1|||
146608126|NCT00392990|528733795|FG000|Follow up for 2 Years|Death|4|||
146608127|NCT00392990|528733796|FG001|Follow up for 2 Years|Death|0|||
146608128|NCT00991406|528733800|FG000|Overall Study|One participant did not respond to FES.|1|||
146608129|NCT03824587|528733801|FG000|Run-in Period|Screen Failure|0|||
146608130|NCT03824587|528733802|FG001|Run-in Period|Screen Failure|275|||
146608131|NCT03824587|528733801|FG000|Treatment Period|Adverse Event|4|||
146608132|NCT03824587|528733802|FG001|Treatment Period|Adverse Event|1|||
146608133|NCT03824587|528733801|FG000|Treatment Period|Withdrawal by Subject|0|||
146608134|NCT03824587|528733802|FG001|Treatment Period|Withdrawal by Subject|1|||
146608135|NCT03824587|528733801|FG000|Treatment Period|Kidney Transplant|1|||
146608136|NCT03824587|528733802|FG001|Treatment Period|Kidney Transplant|1|||
146608137|NCT01300572|528733803|FG000|Overall Study|HAMA + post dosimetry|1|||
146608138|NCT00986362|528733804|FG000|Overall Study|Death|2|||
146773178|NCT00840177|529339509|FG000|Overall Study|Progression/relapse|2|||
146773179|NCT00840177|529339510|FG001|Overall Study|Progression/relapse|0|||
146773180|NCT00840177|529339511|FG002|Overall Study|Progression/relapse|0|||
146773181|NCT00840177|529339509|FG000|Overall Study|Death|4|||
146773182|NCT00840177|529339510|FG001|Overall Study|Death|5|||
146773183|NCT00840177|529339511|FG002|Overall Study|Death|5|||
146773184|NCT00840177|529339509|FG000|Overall Study|not protocol specified|6|||
146773185|NCT00840177|529339510|FG001|Overall Study|not protocol specified|3|||
146773186|NCT00840177|529339511|FG002|Overall Study|not protocol specified|0|||
146773187|NCT00840177|529339509|FG000|Overall Study|Ineligible|0|||
146773188|NCT00840177|529339510|FG001|Overall Study|Ineligible|0|||
146773189|NCT00840177|529339511|FG002|Overall Study|Ineligible|3|||
146773190|NCT00840177|529339509|FG000|Overall Study|Did not start treatment|0|||
146773191|NCT00840177|529339510|FG001|Overall Study|Did not start treatment|0|||
146773192|NCT00840177|529339511|FG002|Overall Study|Did not start treatment|1|||
146773193|NCT01622868|529339512|FG000|Overall Study|Protocol Violation|7|||
146773194|NCT01622868|529339513|FG001|Overall Study|Protocol Violation|0|||
146773195|NCT00542789|529339514|FG000|Overall Study|Adverse Event|18|||
146608139|NCT00986362|528733805|FG001|Overall Study|Death|0|||
146608140|NCT00986362|528733804|FG000|Overall Study|Lost to Follow-up|0|||
146608141|NCT00986362|528733805|FG001|Overall Study|Lost to Follow-up|1|||
146608142|NCT02160145|528733806|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
146608143|NCT02160145|528733807|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
146608144|NCT02160145|528733808|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
146608145|NCT02160145|528733806|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
146608146|NCT02160145|528733807|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
146608147|NCT02160145|528733808|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
146608148|NCT02160145|528733806|FG000|Randomized Double-blind Period|Subject decision|0|||
146608149|NCT02160145|528733807|FG001|Randomized Double-blind Period|Subject decision|21|||
146608150|NCT02160145|528733808|FG002|Randomized Double-blind Period|Subject decision|20|||
146608151|NCT02160145|528733806|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
146608152|NCT02160145|528733807|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
146608153|NCT02160145|528733808|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
146608154|NCT02160145|528733806|FG000|Randomized Double-blind Period|Physician Decision|0|||
146608155|NCT02160145|528733807|FG001|Randomized Double-blind Period|Physician Decision|7|||
146608156|NCT02160145|528733808|FG002|Randomized Double-blind Period|Physician Decision|5|||
146608157|NCT02006979|528733809|FG000|Overall Study|Withdrawal by Subject|1|||
146608158|NCT02006979|528733810|FG001|Overall Study|Withdrawal by Subject|1|||
146608159|NCT02006979|528733809|FG000|Overall Study|Protocol Violation|0|||
146608160|NCT02006979|528733810|FG001|Overall Study|Protocol Violation|1|||
146773196|NCT00542789|529339515|FG001|Overall Study|Adverse Event|17|||
146773197|NCT00542789|529339514|FG000|Overall Study|Withdrawal by Subject|7|||
146773198|NCT00542789|529339515|FG001|Overall Study|Withdrawal by Subject|3|||
146773199|NCT00542789|529339514|FG000|Overall Study|Protocol Violation|8|||
146773200|NCT00542789|529339515|FG001|Overall Study|Protocol Violation|1|||
146773201|NCT00542789|529339514|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
146608161|NCT03170193|528733811|FG000|Overall Study|Withdrawal by Subject|0|||
146608162|NCT03170193|528733812|FG001|Overall Study|Withdrawal by Subject|0|||
146773202|NCT00542789|529339515|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
146608163|NCT03170193|528733813|FG002|Overall Study|Withdrawal by Subject|0|||
146608164|NCT03170193|528733814|FG003|Overall Study|Withdrawal by Subject|1|||
146608165|NCT03170193|528733815|FG004|Overall Study|Withdrawal by Subject|0|||
146608166|NCT03170193|528733816|FG005|Overall Study|Withdrawal by Subject|0|||
146608167|NCT03170193|528733817|FG006|Overall Study|Withdrawal by Subject|0|||
146608168|NCT03170193|528733811|FG000|Overall Study|Lost to Follow-up|1|||
146608169|NCT03170193|528733812|FG001|Overall Study|Lost to Follow-up|1|||
146608170|NCT03170193|528733813|FG002|Overall Study|Lost to Follow-up|0|||
146608171|NCT03170193|528733814|FG003|Overall Study|Lost to Follow-up|0|||
146608172|NCT03170193|528733815|FG004|Overall Study|Lost to Follow-up|0|||
146608173|NCT03170193|528733816|FG005|Overall Study|Lost to Follow-up|0|||
146608174|NCT03170193|528733817|FG006|Overall Study|Lost to Follow-up|0|||
146608175|NCT00375518|528733818|FG000|Overall Study|Withdrawal by Subject|2|||
146608176|NCT00375518|528733819|FG001|Overall Study|Withdrawal by Subject|10|||
146608177|NCT00375518|528733818|FG000|Overall Study|Patient Not Treated|6|||
146608178|NCT00375518|528733819|FG001|Overall Study|Patient Not Treated|6|||
146608179|NCT00375518|528733818|FG000|Overall Study|Death|0|||
146608180|NCT00375518|528733819|FG001|Overall Study|Death|1|||
146608181|NCT03052816|528733822|FG000|Overall Study|Withdrawal by Subject|1|||
146608182|NCT03052816|528733823|FG001|Overall Study|Withdrawal by Subject|0|||
146608183|NCT03052816|528733822|FG000|Overall Study|Desired opioids|2|||
146608184|NCT03052816|528733823|FG001|Overall Study|Desired opioids|0|||
146608185|NCT03755661|528733826|FG000|Overall Study|Lost to Follow-up|1|||
146608186|NCT03755661|528733827|FG001|Overall Study|Lost to Follow-up|0|||
146608187|NCT01016600|528736753|FG000|Overall Study|Did not start treatment|1|||
146608188|NCT01016600|528736754|FG001|Overall Study|Did not start treatment|0|||
146608189|NCT01016600|528736755|FG002|Overall Study|Did not start treatment|0|||
146608190|NCT01016600|528736756|FG003|Overall Study|Did not start treatment|0|||
146608191|NCT00265317|528736762|FG000|Lead-In|Objective progression or relapse|6|||
146608192|NCT00265317|528736763|FG001|Lead-In|Objective progression or relapse|11|||
146608193|NCT00265317|528736764|FG002|Lead-In|Objective progression or relapse|0|||
146608194|NCT00265317|528736765|FG003|Lead-In|Objective progression or relapse|0|||
146608195|NCT00265317|528736762|FG000|Lead-In|Adverse Event|2|||
146608196|NCT00265317|528736763|FG001|Lead-In|Adverse Event|1|||
146608197|NCT00265317|528736764|FG002|Lead-In|Adverse Event|0|||
146608198|NCT00265317|528736765|FG003|Lead-In|Adverse Event|0|||
146608199|NCT00265317|528736762|FG000|Lead-In|Death|3|||
146608200|NCT00265317|528736763|FG001|Lead-In|Death|5|||
146608201|NCT00265317|528736764|FG002|Lead-In|Death|0|||
146608202|NCT00265317|528736765|FG003|Lead-In|Death|0|||
146608203|NCT00265317|528736762|FG000|Lead-In|Withdrawal/other than adverse event|1|||
146608204|NCT00265317|528736763|FG001|Lead-In|Withdrawal/other than adverse event|0|||
146608205|NCT00265317|528736764|FG002|Lead-In|Withdrawal/other than adverse event|0|||
146608206|NCT00265317|528736765|FG003|Lead-In|Withdrawal/other than adverse event|0|||
146608207|NCT00265317|528736762|FG000|Phase 2|Objective progression or relapse|0|||
146608208|NCT00265317|528736763|FG001|Phase 2|Objective progression or relapse|0|||
146608209|NCT00265317|528736764|FG002|Phase 2|Objective progression or relapse|37|||
146608210|NCT00265317|528736765|FG003|Phase 2|Objective progression or relapse|38|||
146608211|NCT00265317|528736762|FG000|Phase 2|Global deterioration of health status|0|||
146608212|NCT00265317|528736763|FG001|Phase 2|Global deterioration of health status|0|||
146608213|NCT00265317|528736764|FG002|Phase 2|Global deterioration of health status|3|||
146608214|NCT00265317|528736765|FG003|Phase 2|Global deterioration of health status|0|||
146608215|NCT00265317|528736762|FG000|Phase 2|Adverse Event|0|||
146608216|NCT00265317|528736763|FG001|Phase 2|Adverse Event|0|||
146608217|NCT00265317|528736764|FG002|Phase 2|Adverse Event|7|||
146608218|NCT00265317|528736765|FG003|Phase 2|Adverse Event|5|||
146608219|NCT00265317|528736762|FG000|Phase 2|Death|0|||
146608220|NCT00265317|528736763|FG001|Phase 2|Death|0|||
146608221|NCT00265317|528736764|FG002|Phase 2|Death|12|||
146608222|NCT00265317|528736765|FG003|Phase 2|Death|15|||
146608223|NCT00265317|528736762|FG000|Phase 2|Protocol Violation|0|||
146608224|NCT00265317|528736763|FG001|Phase 2|Protocol Violation|0|||
146608225|NCT00265317|528736764|FG002|Phase 2|Protocol Violation|1|||
146608226|NCT00265317|528736765|FG003|Phase 2|Protocol Violation|4|||
146608227|NCT00265317|528736762|FG000|Phase 2|Lost to Follow-up|0|||
146608228|NCT00265317|528736763|FG001|Phase 2|Lost to Follow-up|0|||
146608229|NCT00265317|528736764|FG002|Phase 2|Lost to Follow-up|0|||
146608230|NCT00265317|528736765|FG003|Phase 2|Lost to Follow-up|1|||
146608231|NCT00265317|528736762|FG000|Phase 2|Withdrawal/other than adverse event|0|||
146608232|NCT00265317|528736763|FG001|Phase 2|Withdrawal/other than adverse event|0|||
146608233|NCT00265317|528736764|FG002|Phase 2|Withdrawal/other than adverse event|2|||
146608234|NCT00265317|528736765|FG003|Phase 2|Withdrawal/other than adverse event|1|||
146608235|NCT00265317|528736762|FG000|Phase 2|Study terminated by sponsor|0|||
146608236|NCT00265317|528736763|FG001|Phase 2|Study terminated by sponsor|0|||
146608237|NCT00265317|528736764|FG002|Phase 2|Study terminated by sponsor|1|||
146608238|NCT00265317|528736765|FG003|Phase 2|Study terminated by sponsor|0|||
146608239|NCT00265317|528736762|FG000|Phase 2|Other|0|||
146978672|NCT02496221|530085456|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
146608240|NCT00265317|528736763|FG001|Phase 2|Other|0|||
146608241|NCT00265317|528736764|FG002|Phase 2|Other|1|||
146608242|NCT00265317|528736765|FG003|Phase 2|Other|1|||
146608243|NCT00801229|528736766|FG000|Signed Consent|Withdrawal by Subject|2|||
146608244|NCT00801229|528736767|FG001|Signed Consent|Withdrawal by Subject|2|||
146608245|NCT00801229|528736766|FG000|Signed Consent|Found Ineligible|1|||
146608246|NCT00801229|528736767|FG001|Signed Consent|Found Ineligible|1|||
146608247|NCT00801229|528736766|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
146608248|NCT00801229|528736767|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
146608249|NCT00801229|528736766|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
146608250|NCT00801229|528736767|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
146608251|NCT00801229|528736766|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
146608252|NCT00801229|528736767|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
146608253|NCT00801229|528736766|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
146608254|NCT00801229|528736767|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
146608255|NCT00801229|528736766|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
146608256|NCT00801229|528736767|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
146608257|NCT00801229|528736766|FG000|Received Study Drug/Placebo|Adverse Event|1|||
146608258|NCT00801229|528736767|FG001|Received Study Drug/Placebo|Adverse Event|1|||
146608259|NCT03826186|528736768|FG000|Overall Study|Protocol Violation|2|||
146608260|NCT03826186|528736769|FG001|Overall Study|Protocol Violation|0|||
146608261|NCT03826186|528736768|FG000|Overall Study|Withdrawal by Subject|1|||
146608262|NCT03826186|528736769|FG001|Overall Study|Withdrawal by Subject|0|||
146608263|NCT02300259|528736770|FG000|Period 1|Adverse Event|0|||
146608264|NCT02300259|528736771|FG001|Period 1|Adverse Event|0|||
146608265|NCT02300259|528736772|FG002|Period 1|Adverse Event|1|||
146608266|NCT02300259|528736770|FG000|Period 1|Withdrawal by Subject|0|||
146608267|NCT02300259|528736771|FG001|Period 1|Withdrawal by Subject|0|||
146608268|NCT02300259|528736772|FG002|Period 1|Withdrawal by Subject|1|||
146608269|NCT02300259|528736770|FG000|Period 2|Adverse Event|1|||
146608270|NCT02300259|528736771|FG001|Period 2|Adverse Event|0|||
146608271|NCT02300259|528736772|FG002|Period 2|Adverse Event|0|||
146608272|NCT02300259|528736770|FG000|Period 2|Withdrawal by Subject|0|||
146608273|NCT02300259|528736771|FG001|Period 2|Withdrawal by Subject|0|||
146608274|NCT02300259|528736772|FG002|Period 2|Withdrawal by Subject|1|||
146608275|NCT02737475|528736773|FG000|Overall Study|Other reasons|0|||
146608276|NCT02737475|528736774|FG001|Overall Study|Other reasons|0|||
146608277|NCT02737475|528736775|FG002|Overall Study|Other reasons|0|||
146608278|NCT02737475|528736776|FG003|Overall Study|Other reasons|0|||
146608279|NCT02737475|528736777|FG004|Overall Study|Other reasons|1|||
146608280|NCT02737475|528736778|FG005|Overall Study|Other reasons|1|||
146608281|NCT02737475|528736779|FG006|Overall Study|Other reasons|0|||
146608282|NCT02737475|528736780|FG007|Overall Study|Other reasons|0|||
146608283|NCT02737475|528736781|FG008|Overall Study|Other reasons|1|||
146608284|NCT02737475|528736782|FG009|Overall Study|Other reasons|0|||
146608285|NCT02737475|528736783|FG010|Overall Study|Other reasons|1|||
146608286|NCT02737475|528736784|FG011|Overall Study|Other reasons|0|||
146608287|NCT02737475|528736785|FG012|Overall Study|Other reasons|0|||
146608288|NCT02737475|528736786|FG013|Overall Study|Other reasons|0|||
146608289|NCT02737475|528736787|FG014|Overall Study|Other reasons|0|||
146608290|NCT02737475|528736788|FG015|Overall Study|Other reasons|0|||
146608291|NCT02737475|528736789|FG016|Overall Study|Other reasons|0|||
146608292|NCT02737475|528736790|FG017|Overall Study|Other reasons|0|||
146608293|NCT02737475|528736791|FG018|Overall Study|Other reasons|0|||
146608294|NCT02737475|528736792|FG019|Overall Study|Other reasons|0|||
146608295|NCT02737475|528736793|FG020|Overall Study|Other reasons|0|||
146608296|NCT02737475|528736794|FG021|Overall Study|Other reasons|1|||
146608297|NCT02737475|528736795|FG022|Overall Study|Other reasons|0|||
146608298|NCT02737475|528736796|FG023|Overall Study|Other reasons|1|||
146608299|NCT02737475|528736797|FG024|Overall Study|Other reasons|1|||
146608300|NCT02737475|528736798|FG025|Overall Study|Other reasons|1|||
146608301|NCT02737475|528736799|FG026|Overall Study|Other reasons|0|||
146608302|NCT02737475|528736773|FG000|Overall Study|Death|1|||
146608303|NCT02737475|528736774|FG001|Overall Study|Death|0|||
146608304|NCT02737475|528736775|FG002|Overall Study|Death|0|||
146608305|NCT02737475|528736776|FG003|Overall Study|Death|1|||
146657350|NCT01439347|528923065|FG000|Overall Study|Sponsor Terminated Study|2|||
146657351|NCT01439347|528923066|FG001|Overall Study|Sponsor Terminated Study|3|||
146657352|NCT00542451|528923067|FG000|Overall Study|Adverse Event|31|||
146657353|NCT00542451|528923067|FG000|Overall Study|Withdrawal by Subject|30|||
146608306|NCT02737475|528736777|FG004|Overall Study|Death|0|||
146608307|NCT02737475|528736778|FG005|Overall Study|Death|0|||
146608308|NCT02737475|528736779|FG006|Overall Study|Death|0|||
146608309|NCT02737475|528736780|FG007|Overall Study|Death|2|||
146608310|NCT02737475|528736781|FG008|Overall Study|Death|0|||
146608311|NCT02737475|528736782|FG009|Overall Study|Death|0|||
146657354|NCT00542451|528923067|FG000|Overall Study|Physician Decision|4|||
146608312|NCT02737475|528736783|FG010|Overall Study|Death|0|||
146608313|NCT02737475|528736784|FG011|Overall Study|Death|4|||
146657355|NCT00542451|528923067|FG000|Overall Study|Recurrent disease|1|||
146608314|NCT02737475|528736785|FG012|Overall Study|Death|2|||
146608315|NCT02737475|528736786|FG013|Overall Study|Death|2|||
146608316|NCT02737475|528736787|FG014|Overall Study|Death|0|||
146608317|NCT02737475|528736788|FG015|Overall Study|Death|2|||
146608318|NCT02737475|528736789|FG016|Overall Study|Death|2|||
146608319|NCT02737475|528736790|FG017|Overall Study|Death|2|||
146657356|NCT00542451|528923067|FG000|Overall Study|unknown reason|1|||
146657357|NCT00542451|528923067|FG000|Overall Study|Death|2|||
146657358|NCT00542451|528923067|FG000|Overall Study|Lost to Follow-up|10|||
146657359|NCT02788474|528923068|FG000|Double Blind Treatment Period|Not treated|1|||
146657360|NCT02788474|528923069|FG001|Double Blind Treatment Period|Not treated|0|||
146657361|NCT02788474|528923068|FG000|Double Blind Treatment Period|Patient's refusal|3|||
146657362|NCT02788474|528923069|FG001|Double Blind Treatment Period|Patient's refusal|0|||
146657363|NCT02788474|528923068|FG000|Double Blind Treatment Period|Adverse Event|6|||
146657364|NCT02788474|528923069|FG001|Double Blind Treatment Period|Adverse Event|4|||
146608320|NCT02737475|528736791|FG018|Overall Study|Death|1|||
146608321|NCT02737475|528736792|FG019|Overall Study|Death|0|||
146608322|NCT02737475|528736793|FG020|Overall Study|Death|0|||
146608323|NCT02737475|528736794|FG021|Overall Study|Death|0|||
146608324|NCT02737475|528736795|FG022|Overall Study|Death|0|||
146608325|NCT02737475|528736796|FG023|Overall Study|Death|0|||
146608326|NCT02737475|528736797|FG024|Overall Study|Death|0|||
146608327|NCT02737475|528736798|FG025|Overall Study|Death|0|||
146608328|NCT02737475|528736799|FG026|Overall Study|Death|0|||
146608329|NCT02737475|528736773|FG000|Overall Study|Participant withdrew consent|0|||
146608330|NCT02737475|528736774|FG001|Overall Study|Participant withdrew consent|0|||
146608331|NCT02737475|528736775|FG002|Overall Study|Participant withdrew consent|0|||
146608332|NCT02737475|528736776|FG003|Overall Study|Participant withdrew consent|0|||
146608333|NCT02737475|528736777|FG004|Overall Study|Participant withdrew consent|0|||
146608334|NCT02737475|528736778|FG005|Overall Study|Participant withdrew consent|2|||
146608335|NCT02737475|528736779|FG006|Overall Study|Participant withdrew consent|0|||
146608336|NCT02737475|528736780|FG007|Overall Study|Participant withdrew consent|0|||
146608337|NCT02737475|528736781|FG008|Overall Study|Participant withdrew consent|0|||
146608338|NCT02737475|528736782|FG009|Overall Study|Participant withdrew consent|0|||
146608339|NCT02737475|528736783|FG010|Overall Study|Participant withdrew consent|0|||
146608340|NCT02737475|528736784|FG011|Overall Study|Participant withdrew consent|0|||
146608341|NCT02737475|528736785|FG012|Overall Study|Participant withdrew consent|0|||
146608342|NCT02737475|528736786|FG013|Overall Study|Participant withdrew consent|0|||
146608343|NCT02737475|528736787|FG014|Overall Study|Participant withdrew consent|1|||
146608344|NCT02737475|528736788|FG015|Overall Study|Participant withdrew consent|0|||
146608345|NCT02737475|528736789|FG016|Overall Study|Participant withdrew consent|0|||
146608346|NCT02737475|528736790|FG017|Overall Study|Participant withdrew consent|2|||
146608347|NCT02737475|528736791|FG018|Overall Study|Participant withdrew consent|1|||
146608348|NCT02737475|528736792|FG019|Overall Study|Participant withdrew consent|0|||
146608349|NCT02737475|528736793|FG020|Overall Study|Participant withdrew consent|2|||
146608350|NCT02737475|528736794|FG021|Overall Study|Participant withdrew consent|0|||
146608351|NCT02737475|528736795|FG022|Overall Study|Participant withdrew consent|0|||
146608352|NCT02737475|528736796|FG023|Overall Study|Participant withdrew consent|0|||
146608353|NCT02737475|528736797|FG024|Overall Study|Participant withdrew consent|0|||
146608354|NCT02737475|528736798|FG025|Overall Study|Participant withdrew consent|0|||
146608355|NCT02737475|528736799|FG026|Overall Study|Participant withdrew consent|0|||
146608356|NCT02737475|528736773|FG000|Overall Study|Lost to Follow-up|0|||
146608357|NCT02737475|528736774|FG001|Overall Study|Lost to Follow-up|0|||
146608358|NCT02737475|528736775|FG002|Overall Study|Lost to Follow-up|0|||
146608359|NCT02737475|528736776|FG003|Overall Study|Lost to Follow-up|0|||
146608360|NCT02737475|528736777|FG004|Overall Study|Lost to Follow-up|0|||
146608361|NCT02737475|528736778|FG005|Overall Study|Lost to Follow-up|0|||
146608362|NCT02737475|528736779|FG006|Overall Study|Lost to Follow-up|0|||
146608363|NCT02737475|528736780|FG007|Overall Study|Lost to Follow-up|0|||
146608364|NCT02737475|528736781|FG008|Overall Study|Lost to Follow-up|0|||
146657365|NCT02788474|528923068|FG000|Open Label Treatment Period|Adverse Event|29|||
146657366|NCT02788474|528923069|FG001|Open Label Treatment Period|Adverse Event|9|||
146657367|NCT02788474|528923068|FG000|Open Label Treatment Period|Other than reason specified|1|||
146657368|NCT02788474|528923069|FG001|Open Label Treatment Period|Other than reason specified|0|||
146657369|NCT02788474|528923068|FG000|Open Label Treatment Period|Patient's refusal|1|||
146657370|NCT02788474|528923069|FG001|Open Label Treatment Period|Patient's refusal|3|||
146608365|NCT02737475|528736782|FG009|Overall Study|Lost to Follow-up|0|||
146608366|NCT02737475|528736783|FG010|Overall Study|Lost to Follow-up|0|||
146608367|NCT02737475|528736784|FG011|Overall Study|Lost to Follow-up|0|||
146608368|NCT02737475|528736785|FG012|Overall Study|Lost to Follow-up|0|||
146608369|NCT02737475|528736786|FG013|Overall Study|Lost to Follow-up|0|||
146608370|NCT02737475|528736787|FG014|Overall Study|Lost to Follow-up|0|||
146657371|NCT02788474|528923068|FG000|Open Label Treatment Period|Non-compliance|1|||
146608371|NCT02737475|528736788|FG015|Overall Study|Lost to Follow-up|1|||
146608372|NCT02737475|528736789|FG016|Overall Study|Lost to Follow-up|0|||
146608373|NCT02737475|528736790|FG017|Overall Study|Lost to Follow-up|0|||
146608374|NCT02737475|528736791|FG018|Overall Study|Lost to Follow-up|0|||
146657372|NCT02788474|528923069|FG001|Open Label Treatment Period|Non-compliance|0|||
146922977|NCT00111475|529878696|FG001|Overall Study|Lost to Follow-up|0|||
146922978|NCT00111475|529878697|FG002|Overall Study|Lost to Follow-up|0|||
146922979|NCT00111475|529878698|FG003|Overall Study|Lost to Follow-up|0|||
146922980|NCT00111475|529878699|FG004|Overall Study|Lost to Follow-up|0|||
146608375|NCT02737475|528736792|FG019|Overall Study|Lost to Follow-up|0|||
146608376|NCT02737475|528736793|FG020|Overall Study|Lost to Follow-up|0|||
146608377|NCT02737475|528736794|FG021|Overall Study|Lost to Follow-up|0|||
146608378|NCT02737475|528736795|FG022|Overall Study|Lost to Follow-up|0|||
146608379|NCT02737475|528736796|FG023|Overall Study|Lost to Follow-up|0|||
146608380|NCT02737475|528736797|FG024|Overall Study|Lost to Follow-up|0|||
146608381|NCT02737475|528736798|FG025|Overall Study|Lost to Follow-up|0|||
146608382|NCT02737475|528736799|FG026|Overall Study|Lost to Follow-up|0|||
146608383|NCT02737475|528736773|FG000|Overall Study|Disease Progression|0|||
146608384|NCT02737475|528736774|FG001|Overall Study|Disease Progression|0|||
146608385|NCT02737475|528736775|FG002|Overall Study|Disease Progression|0|||
146608386|NCT02737475|528736776|FG003|Overall Study|Disease Progression|0|||
146608387|NCT02737475|528736777|FG004|Overall Study|Disease Progression|0|||
146608388|NCT02737475|528736778|FG005|Overall Study|Disease Progression|0|||
146608389|NCT02737475|528736779|FG006|Overall Study|Disease Progression|0|||
146608390|NCT02737475|528736780|FG007|Overall Study|Disease Progression|0|||
146608391|NCT02737475|528736781|FG008|Overall Study|Disease Progression|0|||
146608392|NCT02737475|528736782|FG009|Overall Study|Disease Progression|0|||
146608393|NCT02737475|528736783|FG010|Overall Study|Disease Progression|0|||
146608394|NCT02737475|528736784|FG011|Overall Study|Disease Progression|0|||
146608395|NCT02737475|528736785|FG012|Overall Study|Disease Progression|0|||
146608396|NCT02737475|528736786|FG013|Overall Study|Disease Progression|0|||
146608397|NCT02737475|528736787|FG014|Overall Study|Disease Progression|0|||
146608398|NCT02737475|528736788|FG015|Overall Study|Disease Progression|0|||
146608399|NCT02737475|528736789|FG016|Overall Study|Disease Progression|0|||
146608400|NCT02737475|528736790|FG017|Overall Study|Disease Progression|0|||
146608401|NCT02737475|528736791|FG018|Overall Study|Disease Progression|0|||
146608402|NCT02737475|528736792|FG019|Overall Study|Disease Progression|0|||
146608403|NCT02737475|528736793|FG020|Overall Study|Disease Progression|0|||
146608404|NCT02737475|528736794|FG021|Overall Study|Disease Progression|0|||
146608405|NCT02737475|528736795|FG022|Overall Study|Disease Progression|0|||
146608406|NCT02737475|528736796|FG023|Overall Study|Disease Progression|0|||
146608407|NCT02737475|528736797|FG024|Overall Study|Disease Progression|0|||
146608408|NCT02737475|528736798|FG025|Overall Study|Disease Progression|0|||
146608409|NCT02737475|528736799|FG026|Overall Study|Disease Progression|1|||
146608410|NCT02255461|528736804|FG000|Overall Study|Adverse Event|0|||
146608411|NCT02255461|528736805|FG001|Overall Study|Adverse Event|1|||
146608412|NCT02255461|528736806|FG002|Overall Study|Adverse Event|0|||
146608413|NCT02255461|528736807|FG003|Overall Study|Adverse Event|0|||
146608414|NCT02255461|528736808|FG004|Overall Study|Adverse Event|1|||
146608415|NCT02255461|528736804|FG000|Overall Study|Withdrawal by Subject|0|||
146608416|NCT02255461|528736805|FG001|Overall Study|Withdrawal by Subject|0|||
146657373|NCT00048061|528923070|FG000|Overall Study|Adverse Event|41|||
146657374|NCT00048061|528923071|FG001|Overall Study|Adverse Event|32|||
146657375|NCT00048061|528923072|FG002|Overall Study|Adverse Event|44|||
146657376|NCT00048061|528923073|FG003|Overall Study|Adverse Event|37|||
146657377|NCT00048061|528923070|FG000|Overall Study|Lost to Follow-up|3|||
146657378|NCT00048061|528923071|FG001|Overall Study|Lost to Follow-up|2|||
146657379|NCT00048061|528923072|FG002|Overall Study|Lost to Follow-up|4|||
146657380|NCT00048061|528923073|FG003|Overall Study|Lost to Follow-up|5|||
146657381|NCT00048061|528923070|FG000|Overall Study|Withdrawal by Subject|20|||
146657382|NCT00048061|528923071|FG001|Overall Study|Withdrawal by Subject|29|||
146657383|NCT00048061|528923072|FG002|Overall Study|Withdrawal by Subject|29|||
146657384|NCT00048061|528923073|FG003|Overall Study|Withdrawal by Subject|32|||
146657385|NCT00048061|528923070|FG000|Overall Study|Did not follow-up|5|||
146657386|NCT00048061|528923071|FG001|Overall Study|Did not follow-up|5|||
146657387|NCT00048061|528923072|FG002|Overall Study|Did not follow-up|4|||
146657388|NCT00048061|528923073|FG003|Overall Study|Did not follow-up|5|||
146657389|NCT00048061|528923070|FG000|Overall Study|Early improvement|6|||
146657390|NCT00048061|528923071|FG001|Overall Study|Early improvement|5|||
146773203|NCT02584829|529339516|FG000|Overall Study|Physician Decision|1|||
146657391|NCT00048061|528923072|FG002|Overall Study|Early improvement|3|||
146773204|NCT02584829|529339517|FG001|Overall Study|Physician Decision|0|||
146657392|NCT00048061|528923073|FG003|Overall Study|Early improvement|0|||
146608417|NCT02255461|528736806|FG002|Overall Study|Withdrawal by Subject|1|||
146608418|NCT02255461|528736807|FG003|Overall Study|Withdrawal by Subject|0|||
146657393|NCT01569464|528923077|FG000|Overall Study|Adverse Event|4|||
146657394|NCT01569464|528923078|FG001|Overall Study|Adverse Event|0|||
146657395|NCT01569464|528923077|FG000|Overall Study|Lack of Efficacy|1|||
146657396|NCT01569464|528923078|FG001|Overall Study|Lack of Efficacy|0|||
146657397|NCT01569464|528923077|FG000|Overall Study|Protocol Violation|1|||
146608419|NCT02255461|528736808|FG004|Overall Study|Withdrawal by Subject|1|||
146608420|NCT02255461|528736804|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
146608421|NCT02255461|528736805|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
146608422|NCT02255461|528736806|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
146608423|NCT02255461|528736807|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
146608424|NCT02255461|528736808|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
146608425|NCT01858740|528736812|FG000|Overall Study|Death|4|||
146608426|NCT03386487|528736813|FG000|Overall Study|Lost to Follow-up|5|||
146608427|NCT03386487|528736814|FG001|Overall Study|Lost to Follow-up|6|||
146608428|NCT03386487|528736813|FG000|Overall Study|Withdrawal by Subject|11|||
146608429|NCT03386487|528736814|FG001|Overall Study|Withdrawal by Subject|7|||
146608430|NCT03386487|528736813|FG000|Overall Study|Physician Decision|11|||
146608431|NCT03386487|528736814|FG001|Overall Study|Physician Decision|8|||
146608432|NCT04207060|528736817|FG000|Overall Study|Lost to Follow-up|2|||
146608433|NCT04207060|528736818|FG001|Overall Study|Lost to Follow-up|0|||
146608434|NCT01067144|528736819|FG000|Treatment|Did not receive allocated intervention|4|||
146608435|NCT01067144|528736820|FG001|Treatment|Did not receive allocated intervention|7|||
146608436|NCT01067144|528736819|FG000|Follow-up|Lost to Follow-up|22|||
146608437|NCT01067144|528736820|FG001|Follow-up|Lost to Follow-up|12|||
146608438|NCT01067144|528736819|FG000|Follow-up|Censored owing to second surgery|19|||
146608439|NCT01067144|528736820|FG001|Follow-up|Censored owing to second surgery|28|||
146922981|NCT00111475|529878700|FG005|Overall Study|Lost to Follow-up|1|||
146922982|NCT00111475|529878701|FG006|Overall Study|Lost to Follow-up|0|||
146922983|NCT00111475|529878702|FG007|Overall Study|Lost to Follow-up|0|||
146608440|NCT01067144|528736819|FG000|Follow-up|Withdrawal by Subject|18|||
146608441|NCT01067144|528736820|FG001|Follow-up|Withdrawal by Subject|14|||
146608442|NCT01067144|528736819|FG000|Follow-up|Surgery cancelled|0|||
146608443|NCT01067144|528736820|FG001|Follow-up|Surgery cancelled|1|||
146608444|NCT01067144|528736819|FG000|Follow-up|Death|0|||
146608445|NCT01067144|528736820|FG001|Follow-up|Death|1|||
146608446|NCT01835158|528736823|FG000|Overall Study|Withdrawal by Subject|1|||
146608447|NCT01835158|528736824|FG001|Overall Study|Withdrawal by Subject|6|||
146608448|NCT00296140|528736825|FG000|Overall Study|Lost to Follow-up|1|||
146608449|NCT00296140|528736826|FG001|Overall Study|Lost to Follow-up|0|||
146608450|NCT00296140|528736825|FG000|Overall Study|Withdrawal by Subject|1|||
146608451|NCT00296140|528736826|FG001|Overall Study|Withdrawal by Subject|0|||
146608452|NCT00296140|528736825|FG000|Overall Study|Discharge to Nursing Home|1|||
146608453|NCT00296140|528736826|FG001|Overall Study|Discharge to Nursing Home|0|||
146608454|NCT01856582|528736827|FG000|Overall Study|Died prior to Boost infusion|1|||
146608455|NCT00880191|528736831|FG000|Overall Study|Refused further treatment|4|||
146608456|NCT00880191|528736832|FG001|Overall Study|Refused further treatment|1|||
146608457|NCT00880191|528736831|FG000|Overall Study|Adverse Event|8|||
146608458|NCT00880191|528736832|FG001|Overall Study|Adverse Event|6|||
146608459|NCT00880191|528736831|FG000|Overall Study|Hospitalization/efficacy|1|||
146608460|NCT00880191|528736832|FG001|Overall Study|Hospitalization/efficacy|1|||
146608461|NCT01919801|528736835|FG000|Overall Study|Withdrawal by Subject|1|||
146608462|NCT01919801|528736836|FG001|Overall Study|Withdrawal by Subject|0|||
146608463|NCT01919801|528736835|FG000|Overall Study|Physician Decision|0|||
146608464|NCT01919801|528736836|FG001|Overall Study|Physician Decision|1|||
146608465|NCT01919801|528736835|FG000|Overall Study|Lost to Follow-up|0|||
146608466|NCT01919801|528736836|FG001|Overall Study|Lost to Follow-up|1|||
146608467|NCT01919801|528736835|FG000|Overall Study|Other|0|||
146608468|NCT01919801|528736836|FG001|Overall Study|Other|1|||
146608469|NCT01843062|528736837|FG000|Overall Study|Protocol Violation|1|||
146608470|NCT01843062|528736838|FG001|Overall Study|Protocol Violation|0|||
146608471|NCT01843062|528736837|FG000|Overall Study|New treatment following progression|2|||
146608472|NCT01843062|528736838|FG001|Overall Study|New treatment following progression|0|||
146608473|NCT01843062|528736837|FG000|Overall Study|Pregnancy|1|||
146608474|NCT01843062|528736838|FG001|Overall Study|Pregnancy|0|||
146608475|NCT01843062|528736837|FG000|Overall Study|Adverse Event|2|||
146608476|NCT01843062|528736838|FG001|Overall Study|Adverse Event|0|||
146608477|NCT01843062|528736837|FG000|Overall Study|Incorrect randomisation|1|||
146608478|NCT01843062|528736838|FG001|Overall Study|Incorrect randomisation|0|||
146608479|NCT01843062|528736837|FG000|Overall Study|Withdrawal by Subject|12|||
146608480|NCT01843062|528736838|FG001|Overall Study|Withdrawal by Subject|3|||
146608481|NCT01843062|528736837|FG000|Overall Study|Death|1|||
146608482|NCT01843062|528736838|FG001|Overall Study|Death|2|||
146922984|NCT00111475|529878703|FG008|Overall Study|Lost to Follow-up|0|||
146922985|NCT00111475|529878704|FG009|Overall Study|Lost to Follow-up|0|||
146608483|NCT01843062|528736837|FG000|Overall Study|Lost to Follow-up|2|||
146608484|NCT01843062|528736838|FG001|Overall Study|Lost to Follow-up|4|||
146608485|NCT01677858|528736839|FG000|Overall Study|Adverse Event|0|||
146608486|NCT01677858|528736840|FG001|Overall Study|Adverse Event|0|||
146608487|NCT01677858|528736841|FG002|Overall Study|Adverse Event|2|||
146608488|NCT01677858|528736842|FG003|Overall Study|Adverse Event|3|||
146608489|NCT01677858|528736843|FG004|Overall Study|Adverse Event|13|||
146657398|NCT01569464|528923078|FG001|Overall Study|Protocol Violation|0|||
146657399|NCT01569464|528923077|FG000|Overall Study|Lost to Follow-up|2|||
146608490|NCT01677858|528736839|FG000|Overall Study|Death|0|||
146608491|NCT01677858|528736840|FG001|Overall Study|Death|0|||
146608492|NCT01677858|528736841|FG002|Overall Study|Death|0|||
146608493|NCT01677858|528736842|FG003|Overall Study|Death|0|||
146657400|NCT01569464|528923078|FG001|Overall Study|Lost to Follow-up|3|||
146608494|NCT01677858|528736843|FG004|Overall Study|Death|1|||
146608495|NCT01677858|528736839|FG000|Overall Study|Physician Decision|1|||
146608496|NCT01677858|528736840|FG001|Overall Study|Physician Decision|0|||
146922986|NCT01026389|529878709|FG000|Overall Study|Withdrawal by Subject|1|||
146922987|NCT01026389|529878710|FG001|Overall Study|Withdrawal by Subject|3|||
146657401|NCT01569464|528923077|FG000|Overall Study|Withdrawal by Subject|1|||
146608497|NCT01677858|528736841|FG002|Overall Study|Physician Decision|2|||
146608498|NCT01677858|528736842|FG003|Overall Study|Physician Decision|0|||
146608499|NCT01677858|528736843|FG004|Overall Study|Physician Decision|12|||
146608500|NCT01677858|528736839|FG000|Overall Study|Progressive Disease|2|||
146608501|NCT01677858|528736840|FG001|Overall Study|Progressive Disease|1|||
146608502|NCT01677858|528736841|FG002|Overall Study|Progressive Disease|9|||
146608503|NCT01677858|528736842|FG003|Overall Study|Progressive Disease|3|||
146608504|NCT01677858|528736843|FG004|Overall Study|Progressive Disease|43|||
146608505|NCT01677858|528736839|FG000|Overall Study|Withdrawal by Subject|0|||
146608506|NCT01677858|528736840|FG001|Overall Study|Withdrawal by Subject|1|||
146608507|NCT01677858|528736841|FG002|Overall Study|Withdrawal by Subject|1|||
146608508|NCT01677858|528736842|FG003|Overall Study|Withdrawal by Subject|0|||
146608509|NCT01677858|528736843|FG004|Overall Study|Withdrawal by Subject|15|||
146608510|NCT01677858|528736839|FG000|Overall Study|Lost to Follow-up|0|||
146608511|NCT01677858|528736840|FG001|Overall Study|Lost to Follow-up|0|||
146608512|NCT01677858|528736841|FG002|Overall Study|Lost to Follow-up|0|||
146608513|NCT01677858|528736842|FG003|Overall Study|Lost to Follow-up|0|||
146608514|NCT01677858|528736843|FG004|Overall Study|Lost to Follow-up|1|||
146608515|NCT01331109|528736844|FG000|Overall Study|Adverse Event|6|||
146608516|NCT01331109|528736844|FG000|Overall Study|Lack of Efficacy|2|||
146608517|NCT01331109|528736844|FG000|Overall Study|Protocol Violation|3|||
146608518|NCT01331109|528736844|FG000|Overall Study|Withdrawal by Subject|7|||
146608519|NCT01331109|528736844|FG000|Overall Study|Lost to Follow-up|1|||
146608520|NCT01331109|528736844|FG000|Overall Study|Study Terminated by Sponsor|38|||
146608521|NCT00988091|528736848|FG000|Double-blind Period|Withdrawal by Subject|15|||
146608522|NCT00988091|528736849|FG001|Double-blind Period|Withdrawal by Subject|13|||
146608523|NCT00988091|528736848|FG000|Double-blind Period|Lost to Follow-up|12|||
146608524|NCT00988091|528736849|FG001|Double-blind Period|Lost to Follow-up|14|||
146608525|NCT00988091|528736848|FG000|Double-blind Period|Other|8|||
146608526|NCT00988091|528736849|FG001|Double-blind Period|Other|8|||
146608527|NCT00988091|528736848|FG000|Double-blind Period|Adverse Event|6|||
146608528|NCT00988091|528736849|FG001|Double-blind Period|Adverse Event|9|||
146608529|NCT00988091|528736848|FG000|Double-blind Period|Use of exclusionary medication|2|||
146608530|NCT00988091|528736849|FG001|Double-blind Period|Use of exclusionary medication|3|||
146608531|NCT00988091|528736848|FG000|Open-label Period|Adverse Event|4|||
146657402|NCT01569464|528923078|FG001|Overall Study|Withdrawal by Subject|1|||
146657403|NCT01569464|528923077|FG000|Overall Study|Other|1|||
146657404|NCT01569464|528923078|FG001|Overall Study|Other|1|||
146657405|NCT04718103|528923079|FG000|Overall Study|Adverse Event|1|||
146657406|NCT04718103|528923080|FG001|Overall Study|Adverse Event|1|||
146657407|NCT04718103|528923079|FG000|Overall Study|Lack of Efficacy|4|||
146657408|NCT04718103|528923080|FG001|Overall Study|Lack of Efficacy|1|||
146657409|NCT04718103|528923079|FG000|Overall Study|Lost to Follow-up|2|||
146657410|NCT04718103|528923080|FG001|Overall Study|Lost to Follow-up|2|||
146657411|NCT04718103|528923079|FG000|Overall Study|Physician Decision|2|||
146657412|NCT04718103|528923080|FG001|Overall Study|Physician Decision|0|||
146657413|NCT04718103|528923079|FG000|Overall Study|Pregnancy|0|||
146657414|NCT04718103|528923080|FG001|Overall Study|Pregnancy|1|||
146657415|NCT04718103|528923079|FG000|Overall Study|Withdrawal by Subject|10|||
146657416|NCT04718103|528923080|FG001|Overall Study|Withdrawal by Subject|6|||
146657417|NCT04718103|528923079|FG000|Overall Study|Randomized, not treated|4|||
146657418|NCT04718103|528923080|FG001|Overall Study|Randomized, not treated|1|||
146657419|NCT04718103|528923079|FG000|Overall Study|GCP violations|7|||
146657420|NCT04718103|528923080|FG001|Overall Study|GCP violations|5|||
146657421|NCT01309893|528923081|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
146657422|NCT01309893|528923082|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
146657423|NCT01309893|528923081|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
146657424|NCT01309893|528923082|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
146657425|NCT01343901|528923084|FG000|Overall Study|Death|85|||
146608532|NCT00988091|528736849|FG001|Open-label Period|Adverse Event|7|||
146608533|NCT00988091|528736848|FG000|Open-label Period|Use of exclusionary medication|1|||
146657426|NCT01343901|528923084|FG000|Overall Study|Physician Decision|4|||
146657427|NCT01343901|528923084|FG000|Overall Study|Lost to Follow-up|12|||
146657428|NCT01343901|528923084|FG000|Overall Study|Management by another medical team|11|||
146657429|NCT01343901|528923084|FG000|Overall Study|Participant decision|1|||
146608534|NCT00988091|528736849|FG001|Open-label Period|Use of exclusionary medication|1|||
146657430|NCT01369485|528923085|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
146773205|NCT02584829|529339516|FG000|Overall Study|Withdrawal by Subject|0|||
146608535|NCT00988091|528736848|FG000|Open-label Period|Protocol Violation|1|||
146608536|NCT00988091|528736849|FG001|Open-label Period|Protocol Violation|1|||
146608537|NCT00988091|528736848|FG000|Open-label Period|Withdrawal by Subject|10|||
146608538|NCT00988091|528736849|FG001|Open-label Period|Withdrawal by Subject|16|||
146608539|NCT00988091|528736848|FG000|Open-label Period|Lost to Follow-up|3|||
146657431|NCT01369485|528923086|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
146657432|NCT01369485|528923085|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
146657433|NCT01369485|528923086|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
146608540|NCT00988091|528736849|FG001|Open-label Period|Lost to Follow-up|5|||
146608541|NCT00988091|528736848|FG000|Open-label Period|Other|2|||
146608542|NCT00988091|528736849|FG001|Open-label Period|Other|3|||
146608543|NCT00773747|528736850|FG000|Overall Study|Lack of Efficacy|112|||
146608544|NCT00773747|528736851|FG001|Overall Study|Lack of Efficacy|144|||
146608545|NCT00773747|528736850|FG000|Overall Study|Physician Decision|26|||
146608546|NCT00773747|528736851|FG001|Overall Study|Physician Decision|18|||
146608547|NCT00773747|528736850|FG000|Overall Study|Lost to Follow-up|0|||
146608548|NCT00773747|528736851|FG001|Overall Study|Lost to Follow-up|1|||
146608549|NCT00773747|528736850|FG000|Overall Study|Protocol Violation|2|||
146608550|NCT00773747|528736851|FG001|Overall Study|Protocol Violation|2|||
146608551|NCT00773747|528736850|FG000|Overall Study|Withdrawal by Subject|89|||
146608552|NCT00773747|528736851|FG001|Overall Study|Withdrawal by Subject|61|||
146608553|NCT00773747|528736850|FG000|Overall Study|Adverse Event|61|||
146608554|NCT00773747|528736851|FG001|Overall Study|Adverse Event|62|||
146608555|NCT00773747|528736850|FG000|Overall Study|Death|5|||
146608556|NCT00773747|528736851|FG001|Overall Study|Death|8|||
146608557|NCT00773747|528736850|FG000|Overall Study|Not Treated|2|||
146608558|NCT00773747|528736851|FG001|Overall Study|Not Treated|0|||
146608559|NCT02669212|528736854|FG000|Overall Study|Lost to Follow-up|1|||
146608560|NCT02669212|528736855|FG001|Overall Study|Lost to Follow-up|0|||
146608561|NCT02669212|528736854|FG000|Overall Study|Medical Condition|3|||
146608562|NCT02669212|528736855|FG001|Overall Study|Medical Condition|4|||
146608563|NCT02669212|528736854|FG000|Overall Study|Withdrawal by Subject|0|||
146608564|NCT02669212|528736855|FG001|Overall Study|Withdrawal by Subject|2|||
146608565|NCT02669212|528736854|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
146608566|NCT02669212|528736855|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
146608567|NCT03549104|528736856|FG000|Overall Study|Withdrawal by Subject|5|||
146608568|NCT03549104|528736857|FG001|Overall Study|Withdrawal by Subject|2|||
146608569|NCT03549104|528736856|FG000|Overall Study|Covid shelter in place|1|||
146608570|NCT03549104|528736857|FG001|Overall Study|Covid shelter in place|2|||
146608571|NCT03078855|528736861|FG000|Overall Study|Lack of Efficacy|62|||
146608572|NCT03078855|528736862|FG001|Overall Study|Lack of Efficacy|31|||
146608573|NCT03078855|528736861|FG000|Overall Study|Death|1|||
146608574|NCT03078855|528736862|FG001|Overall Study|Death|0|||
146608575|NCT03078855|528736861|FG000|Overall Study|Withdrawal by Subject|12|||
146608576|NCT03078855|528736862|FG001|Overall Study|Withdrawal by Subject|6|||
146608577|NCT03078855|528736861|FG000|Overall Study|Physician Decision|3|||
146608578|NCT03078855|528736862|FG001|Overall Study|Physician Decision|2|||
146608579|NCT03078855|528736861|FG000|Overall Study|Second Malignancy|4|||
146608580|NCT03078855|528736862|FG001|Overall Study|Second Malignancy|0|||
146608581|NCT03078855|528736861|FG000|Overall Study|Ineligible|2|||
146608582|NCT03078855|528736862|FG001|Overall Study|Ineligible|0|||
146608583|NCT03078855|528736861|FG000|Overall Study|Withdrew before day 1 treatment|2|||
146608584|NCT03078855|528736862|FG001|Overall Study|Withdrew before day 1 treatment|1|||
146608585|NCT00391027|528736863|FG000|Overall Study|Adverse Event|8|||
146608586|NCT00391027|528736864|FG001|Overall Study|Adverse Event|8|||
146608587|NCT00391027|528736863|FG000|Overall Study|Lack of Efficacy|3|||
146608588|NCT00391027|528736864|FG001|Overall Study|Lack of Efficacy|0|||
146608589|NCT00391027|528736863|FG000|Overall Study|Withdrawal by Subject|10|||
146608590|NCT00391027|528736864|FG001|Overall Study|Withdrawal by Subject|1|||
146608591|NCT00391027|528736863|FG000|Overall Study|Other|4|||
146608592|NCT00391027|528736864|FG001|Overall Study|Other|3|||
146608593|NCT03422536|528736865|FG000|Randomized|Physician Decision|1|||
146608594|NCT03422536|528736866|FG001|Randomized|Physician Decision|1|||
146608595|NCT03422536|528736865|FG000|Allocation - Received Intervention|Disease progression|19|||
146608596|NCT03422536|528736866|FG001|Allocation - Received Intervention|Disease progression|25|||
146608597|NCT03422536|528736865|FG000|Allocation - Received Intervention|Death|1|||
146608598|NCT03422536|528736866|FG001|Allocation - Received Intervention|Death|3|||
146608599|NCT03422536|528736865|FG000|Allocation - Received Intervention|Adverse Event|1|||
146608600|NCT03422536|528736866|FG001|Allocation - Received Intervention|Adverse Event|0|||
146608601|NCT03422536|528736865|FG000|Allocation - Received Intervention|Physician Decision|1|||
146608602|NCT03422536|528736866|FG001|Allocation - Received Intervention|Physician Decision|1|||
146922988|NCT01026389|529878709|FG000|Overall Study|change of treatment, patient moved|4|||
146608603|NCT03422536|528736865|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
146608604|NCT03422536|528736866|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
146608605|NCT03422536|528736865|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
146608606|NCT03422536|528736866|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
146608607|NCT00532298|528736867|FG000|Overall Study|Adverse Event|1|||
146608608|NCT00532298|528736868|FG001|Overall Study|Adverse Event|0|||
146608609|NCT00532298|528736869|FG002|Overall Study|Adverse Event|0|||
146608610|NCT00532298|528736870|FG003|Overall Study|Adverse Event|0|||
146608611|NCT00532298|528736871|FG004|Overall Study|Adverse Event|1|||
146608612|NCT00532298|528736872|FG005|Overall Study|Adverse Event|1|||
146608613|NCT00532298|528736867|FG000|Overall Study|Lost to Follow-up|1|||
146608614|NCT00532298|528736868|FG001|Overall Study|Lost to Follow-up|1|||
146608615|NCT00532298|528736869|FG002|Overall Study|Lost to Follow-up|1|||
146608616|NCT00532298|528736870|FG003|Overall Study|Lost to Follow-up|0|||
146608617|NCT00532298|528736871|FG004|Overall Study|Lost to Follow-up|0|||
146608618|NCT00532298|528736872|FG005|Overall Study|Lost to Follow-up|1|||
146608619|NCT00479856|528736873|FG000|Overall Study|Adverse Event|1|||
146608620|NCT00479856|528736873|FG000|Overall Study|Withdrawal by Subject|1|||
146608621|NCT00479856|528736873|FG000|Overall Study|Physician Decision|1|||
146608622|NCT04164732|528736880|FG000|Treatment run-in Period|Adverse Event|4|||
146608623|NCT04164732|528736881|FG001|Treatment run-in Period|Adverse Event|0|||
146608624|NCT04164732|528736882|FG002|Treatment run-in Period|Adverse Event|0|||
146608625|NCT04164732|528736880|FG000|Treatment run-in Period|Physician Decision|1|||
146608626|NCT04164732|528736881|FG001|Treatment run-in Period|Physician Decision|0|||
146608627|NCT04164732|528736882|FG002|Treatment run-in Period|Physician Decision|0|||
146608628|NCT04164732|528736880|FG000|Treatment run-in Period|Screen Failure|1|||
146608629|NCT04164732|528736881|FG001|Treatment run-in Period|Screen Failure|0|||
146608630|NCT04164732|528736882|FG002|Treatment run-in Period|Screen Failure|0|||
146608631|NCT04164732|528736880|FG000|Randomized Treatment Period|Adverse Event|0|||
146608632|NCT04164732|528736881|FG001|Randomized Treatment Period|Adverse Event|1|||
146608633|NCT04164732|528736882|FG002|Randomized Treatment Period|Adverse Event|0|||
146608634|NCT04164732|528736880|FG000|Randomized Treatment Period|Protocol Deviation|0|||
146608635|NCT04164732|528736881|FG001|Randomized Treatment Period|Protocol Deviation|1|||
146608636|NCT04164732|528736882|FG002|Randomized Treatment Period|Protocol Deviation|1|||
146608637|NCT04164732|528736880|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
146608638|NCT04164732|528736881|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
146608639|NCT04164732|528736882|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
146608640|NCT00661622|528736883|FG000|Overall Study|Protocol Violation|1|||
146608641|NCT00661622|528736884|FG001|Overall Study|Protocol Violation|0|||
146608642|NCT04765202|528736889|FG000|Overall Study|Lost to Follow-up|1|||
146608643|NCT04765202|528736890|FG001|Overall Study|Lost to Follow-up|1|||
146608644|NCT04765202|528736891|FG002|Overall Study|Lost to Follow-up|2|||
146608645|NCT04765202|528736892|FG003|Overall Study|Lost to Follow-up|2|||
146608646|NCT04765202|528736889|FG000|Overall Study|Physician Decision|0|||
146608647|NCT04765202|528736890|FG001|Overall Study|Physician Decision|0|||
146608648|NCT04765202|528736891|FG002|Overall Study|Physician Decision|1|||
146608649|NCT04765202|528736892|FG003|Overall Study|Physician Decision|1|||
146608650|NCT04929249|528736893|FG000|Overall Study|Adverse Event|2|||
146608651|NCT04929249|528736894|FG001|Overall Study|Adverse Event|1|||
146608652|NCT04929249|528736893|FG000|Overall Study|Death|2|||
146608653|NCT04929249|528736894|FG001|Overall Study|Death|1|||
146608654|NCT04929249|528736893|FG000|Overall Study|Lost to Follow-up|3|||
146608655|NCT04929249|528736894|FG001|Overall Study|Lost to Follow-up|11|||
146608656|NCT04929249|528736893|FG000|Overall Study|Technical problems|0|||
146608657|NCT04929249|528736894|FG001|Overall Study|Technical problems|1|||
146608658|NCT04929249|528736893|FG000|Overall Study|Subject decision|6|||
146608659|NCT04929249|528736894|FG001|Overall Study|Subject decision|8|||
146608660|NCT04929249|528736893|FG000|Overall Study|Withdrew consent|0|||
146608661|NCT04929249|528736894|FG001|Overall Study|Withdrew consent|8|||
146608662|NCT01620762|528736895|FG000|Overall Study|Protocol Violation|1|||
146608663|NCT01620762|528736896|FG001|Overall Study|Protocol Violation|1|||
146608664|NCT01620762|528736897|FG002|Overall Study|Protocol Violation|1|||
146608665|NCT01620762|528736895|FG000|Overall Study|Adverse Event|9|||
146608666|NCT01620762|528736896|FG001|Overall Study|Adverse Event|5|||
146608667|NCT01620762|528736897|FG002|Overall Study|Adverse Event|2|||
146608668|NCT01620762|528736895|FG000|Overall Study|Withdrawal by Subject|23|||
146608669|NCT01620762|528736896|FG001|Overall Study|Withdrawal by Subject|26|||
146608670|NCT01620762|528736897|FG002|Overall Study|Withdrawal by Subject|27|||
146608671|NCT01620762|528736895|FG000|Overall Study|Lost to Follow-up|11|||
146608672|NCT01620762|528736896|FG001|Overall Study|Lost to Follow-up|17|||
146608673|NCT01620762|528736897|FG002|Overall Study|Lost to Follow-up|10|||
146608674|NCT01620762|528736895|FG000|Overall Study|Protocol deviation|1|||
146608675|NCT01620762|528736896|FG001|Overall Study|Protocol deviation|1|||
146608676|NCT01620762|528736897|FG002|Overall Study|Protocol deviation|6|||
146608677|NCT01620762|528736895|FG000|Overall Study|Subject deterioration|0|||
146608678|NCT01620762|528736896|FG001|Overall Study|Subject deterioration|1|||
146608679|NCT01620762|528736897|FG002|Overall Study|Subject deterioration|1|||
146608680|NCT01620762|528736895|FG000|Overall Study|Non-specified|3|||
146608681|NCT01620762|528736896|FG001|Overall Study|Non-specified|6|||
146608682|NCT01620762|528736897|FG002|Overall Study|Non-specified|5|||
146608683|NCT01620762|528736895|FG000|Overall Study|Use of prohibted therapies|0|||
146608684|NCT01620762|528736896|FG001|Overall Study|Use of prohibted therapies|1|||
146608685|NCT01620762|528736897|FG002|Overall Study|Use of prohibted therapies|1|||
146608686|NCT00705146|528736898|FG000|Overall Study|Lost to Follow-up|1|||
146608687|NCT00705146|528736899|FG001|Overall Study|Lost to Follow-up|1|||
146608688|NCT00095173|528736900|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
146608689|NCT00095173|528736901|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
146608690|NCT00095173|528736902|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
146608691|NCT00095173|528736903|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
146608692|NCT00095173|528736904|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
146608693|NCT00095173|528736905|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
146608694|NCT00095173|528736900|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
146608695|NCT00095173|528736901|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
146608696|NCT00095173|528736902|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
146608697|NCT00095173|528736903|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
146608698|NCT00095173|528736904|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
146608699|NCT00095173|528736905|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
146608700|NCT00095173|528736900|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
146608701|NCT00095173|528736901|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
146608702|NCT00095173|528736902|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
146608703|NCT00095173|528736903|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
146608704|NCT00095173|528736904|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
146608705|NCT00095173|528736905|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
146608706|NCT00095173|528736900|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
146608707|NCT00095173|528736901|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
146608708|NCT00095173|528736902|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
146608709|NCT00095173|528736903|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
146608710|NCT00095173|528736904|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
146608711|NCT00095173|528736905|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
146608712|NCT00095173|528736900|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
146608713|NCT00095173|528736901|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
146608714|NCT00095173|528736902|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
146608715|NCT00095173|528736903|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
146608716|NCT00095173|528736904|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
146608717|NCT00095173|528736905|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
146608718|NCT00095173|528736900|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
146608719|NCT00095173|528736901|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
146608720|NCT00095173|528736902|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
146608721|NCT00095173|528736903|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
146608722|NCT00095173|528736904|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
146608723|NCT00095173|528736905|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
146608724|NCT00095173|528736900|FG000|Open-Label Extension Phase (Period C)|Death|0|||
146608725|NCT00095173|528736901|FG001|Open-Label Extension Phase (Period C)|Death|0|||
146608726|NCT00095173|528736902|FG002|Open-Label Extension Phase (Period C)|Death|0|||
146608727|NCT00095173|528736903|FG003|Open-Label Extension Phase (Period C)|Death|0|||
146608728|NCT00095173|528736904|FG004|Open-Label Extension Phase (Period C)|Death|0|||
146608729|NCT00095173|528736905|FG005|Open-Label Extension Phase (Period C)|Death|1|||
146608730|NCT00095173|528736900|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
146608731|NCT00095173|528736901|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
146608732|NCT00095173|528736902|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
146608733|NCT00095173|528736903|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
146608734|NCT00095173|528736904|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
146608735|NCT00095173|528736905|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
146608736|NCT00095173|528736900|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
146608737|NCT00095173|528736901|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
146608738|NCT00095173|528736902|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
146608739|NCT00095173|528736903|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
146608740|NCT00095173|528736904|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
146608741|NCT00095173|528736905|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
146608742|NCT00095173|528736900|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
146608743|NCT00095173|528736901|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
146608744|NCT00095173|528736902|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
146608745|NCT00095173|528736903|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
146608746|NCT00095173|528736904|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
146608747|NCT00095173|528736905|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
146608748|NCT00095173|528736900|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
146608749|NCT00095173|528736901|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
146608750|NCT00095173|528736902|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
146608751|NCT00095173|528736903|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
146608752|NCT00095173|528736904|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
146608753|NCT00095173|528736905|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
146657434|NCT01369485|528923085|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
146657435|NCT01369485|528923086|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
146608754|NCT00095173|528736900|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
146657436|NCT01369485|528923085|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
146657437|NCT01369485|528923086|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
146657438|NCT01369485|528923085|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
146608755|NCT00095173|528736901|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
146608756|NCT00095173|528736902|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
146608757|NCT00095173|528736903|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
146608758|NCT00095173|528736904|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
146608759|NCT00095173|528736905|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
146608760|NCT00095173|528736900|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
146608761|NCT00095173|528736901|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
146608762|NCT00095173|528736902|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
146608763|NCT00095173|528736903|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
146608764|NCT00095173|528736904|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
146608765|NCT00095173|528736905|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
146608766|NCT00095173|528736900|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
146608767|NCT00095173|528736901|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
146608768|NCT00095173|528736902|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
146608769|NCT00095173|528736903|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
146608770|NCT00095173|528736904|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
146608771|NCT00095173|528736905|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
146608772|NCT00095173|528736900|FG000|Open-Label Extension Phase (Period C)|Other|0|||
146608773|NCT00095173|528736901|FG001|Open-Label Extension Phase (Period C)|Other|0|||
146608774|NCT00095173|528736902|FG002|Open-Label Extension Phase (Period C)|Other|0|||
146608775|NCT00095173|528736903|FG003|Open-Label Extension Phase (Period C)|Other|4|||
146608776|NCT00095173|528736904|FG004|Open-Label Extension Phase (Period C)|Other|6|||
146608777|NCT00095173|528736905|FG005|Open-Label Extension Phase (Period C)|Other|8|||
146608778|NCT02951429|528736913|FG000|Overall Study|Adverse Event|3|||
146608779|NCT02951429|528736914|FG001|Overall Study|Adverse Event|7|||
146608780|NCT02951429|528736913|FG000|Overall Study|Death|28|||
146608781|NCT02951429|528736914|FG001|Overall Study|Death|36|||
146608782|NCT02951429|528736913|FG000|Overall Study|Lack of Efficacy|0|||
146608783|NCT02951429|528736914|FG001|Overall Study|Lack of Efficacy|1|||
146608784|NCT02951429|528736913|FG000|Overall Study|Lost to Follow-up|0|||
146608785|NCT02951429|528736914|FG001|Overall Study|Lost to Follow-up|1|||
146608786|NCT02951429|528736913|FG000|Overall Study|Lung Transplantation|9|||
146608787|NCT02951429|528736914|FG001|Overall Study|Lung Transplantation|6|||
146608788|NCT02951429|528736913|FG000|Overall Study|Other|1|||
146608789|NCT02951429|528736914|FG001|Overall Study|Other|3|||
146608790|NCT02951429|528736913|FG000|Overall Study|Progressive Disease|1|||
146608791|NCT02951429|528736914|FG001|Overall Study|Progressive Disease|1|||
146608792|NCT02951429|528736913|FG000|Overall Study|Withdrawal by Subject|7|||
146608793|NCT02951429|528736914|FG001|Overall Study|Withdrawal by Subject|11|||
146608794|NCT02951429|528736913|FG000|Overall Study|Participant ongoing in the study|23|||
146608795|NCT02951429|528736914|FG001|Overall Study|Participant ongoing in the study|17|||
146608796|NCT01620528|528736915|FG000|Treatment Period|Did Not Receive Study Drug|0|||
146608797|NCT01620528|528736916|FG001|Treatment Period|Did Not Receive Study Drug|0|||
146608798|NCT01620528|528736917|FG002|Treatment Period|Did Not Receive Study Drug|1|||
146608799|NCT01620528|528736915|FG000|Treatment Period|Withdrawal by Subject|35|||
146608800|NCT01620528|528736916|FG001|Treatment Period|Withdrawal by Subject|21|||
146608801|NCT01620528|528736917|FG002|Treatment Period|Withdrawal by Subject|16|||
146608802|NCT01620528|528736915|FG000|Treatment Period|Adverse Event|17|||
146608803|NCT01620528|528736916|FG001|Treatment Period|Adverse Event|13|||
146608804|NCT01620528|528736917|FG002|Treatment Period|Adverse Event|21|||
146608805|NCT01620528|528736915|FG000|Treatment Period|Lost to Follow-up|16|||
146608806|NCT01620528|528736916|FG001|Treatment Period|Lost to Follow-up|8|||
146608807|NCT01620528|528736917|FG002|Treatment Period|Lost to Follow-up|14|||
146608808|NCT01620528|528736915|FG000|Treatment Period|Other|9|||
146657439|NCT01369485|528923086|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
146657440|NCT01369485|528923085|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
146657441|NCT01369485|528923086|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
146657442|NCT01369485|528923085|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
146657443|NCT01369485|528923086|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
146657444|NCT01369485|528923085|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
146657445|NCT01369485|528923086|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
146657446|NCT01369485|528923085|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
146657447|NCT01369485|528923086|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
146657448|NCT01369485|528923085|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
146608809|NCT01620528|528736916|FG001|Treatment Period|Other|5|||
146608810|NCT01620528|528736917|FG002|Treatment Period|Other|7|||
146608811|NCT01620528|528736915|FG000|Treatment Period|Subject Noncompliant|11|||
146608812|NCT01620528|528736916|FG001|Treatment Period|Subject Noncompliant|2|||
146736240|NCT00279201|529205304|FG003|Intensification Addendum|Sponsor Decision|0|||
146608813|NCT01620528|528736917|FG002|Treatment Period|Subject Noncompliant|2|||
146608814|NCT01620528|528736915|FG000|Treatment Period|Pregnancy|7|||
146608815|NCT01620528|528736916|FG001|Treatment Period|Pregnancy|2|||
146608816|NCT01620528|528736917|FG002|Treatment Period|Pregnancy|2|||
146608817|NCT01620528|528736915|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
146608818|NCT01620528|528736916|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
146608819|NCT01620528|528736917|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
146608820|NCT01620528|528736915|FG000|Treatment Period|Exclusionary Medication Received|0|||
146608821|NCT01620528|528736916|FG001|Treatment Period|Exclusionary Medication Received|1|||
146608822|NCT01620528|528736917|FG002|Treatment Period|Exclusionary Medication Received|0|||
146608823|NCT01620528|528736915|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
146608824|NCT01620528|528736916|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
146608825|NCT01620528|528736917|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
146608826|NCT01620528|528736915|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
146608827|NCT01620528|528736916|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
146608828|NCT01620528|528736917|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
146608829|NCT01620528|528736915|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
146608830|NCT01620528|528736916|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
146608831|NCT01620528|528736917|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
146608832|NCT01620528|528736915|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
146608833|NCT01620528|528736916|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
146608834|NCT01620528|528736917|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
146608835|NCT01620528|528736915|FG000|Post-Treatment Follow-Up Period|Other|6|||
146608836|NCT01620528|528736916|FG001|Post-Treatment Follow-Up Period|Other|4|||
146608837|NCT01620528|528736917|FG002|Post-Treatment Follow-Up Period|Other|2|||
146608838|NCT02161757|528736919|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
146608839|NCT02161757|528736920|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
146608840|NCT02161757|528736921|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
146608841|NCT02161757|528736919|FG000|Treatment Through Study Completion|Adverse Event|1|||
146608842|NCT02161757|528736920|FG001|Treatment Through Study Completion|Adverse Event|1|||
146608843|NCT02161757|528736921|FG002|Treatment Through Study Completion|Adverse Event|0|||
146608844|NCT02161757|528736919|FG000|Treatment Through Study Completion|Protocol Violation|0|||
146608845|NCT02161757|528736920|FG001|Treatment Through Study Completion|Protocol Violation|1|||
146608846|NCT02161757|528736921|FG002|Treatment Through Study Completion|Protocol Violation|2|||
146608847|NCT02161757|528736919|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
146608848|NCT02161757|528736920|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
146608849|NCT02161757|528736921|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
146608850|NCT02161757|528736919|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
146608851|NCT02161757|528736920|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
146608852|NCT02161757|528736921|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
146608853|NCT02161757|528736919|FG000|Treatment Through Study Completion|Other|20|||
146608854|NCT02161757|528736920|FG001|Treatment Through Study Completion|Other|19|||
146608855|NCT02161757|528736921|FG002|Treatment Through Study Completion|Other|12|||
146608856|NCT02161757|528736919|FG000|Treatment Through Study Completion|Death|2|||
146608857|NCT02161757|528736920|FG001|Treatment Through Study Completion|Death|1|||
146608858|NCT02161757|528736921|FG002|Treatment Through Study Completion|Death|1|||
146608859|NCT00391625|528736922|FG000|Month 14|Withdrawal by Subject|1|||
146608860|NCT00391625|528736922|FG000|Month 50|Physician Decision|1|||
146608861|NCT03664765|528736923|FG000|Overall Study|Withdrawal by Subject|4|||
146608862|NCT03664765|528736924|FG001|Overall Study|Withdrawal by Subject|1|||
146608863|NCT03664765|528736923|FG000|Overall Study|Lost to Follow-up|0|||
146608864|NCT03664765|528736924|FG001|Overall Study|Lost to Follow-up|1|||
146608865|NCT01628965|528736933|FG000|Overall Study|Adverse Event|30|||
146608866|NCT01628965|528736933|FG000|Overall Study|Lack of Efficacy|7|||
146608867|NCT01628965|528736933|FG000|Overall Study|Withdrawal by Subject|3|||
146608868|NCT01628965|528736933|FG000|Overall Study|Lost to Follow-up|1|||
146608869|NCT01628965|528736933|FG000|Overall Study|Discontinuation criteria|8|||
146608870|NCT00330681|528736934|FG000|Overall Study|Adverse Event|3|||
146657449|NCT01369485|528923086|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
146657450|NCT00873860|528923087|FG000|Overall Study|Lost to Follow-up|1|||
146657451|NCT00873860|528923088|FG001|Overall Study|Lost to Follow-up|0|||
146657452|NCT00873860|528923089|FG002|Overall Study|Lost to Follow-up|0|||
146608871|NCT00330681|528736935|FG001|Overall Study|Adverse Event|6|||
146608872|NCT00330681|528736934|FG000|Overall Study|Protocol Violation|0|||
146608873|NCT00330681|528736935|FG001|Overall Study|Protocol Violation|1|||
146608874|NCT00330681|528736934|FG000|Overall Study|Withdrawal by Subject|5|||
146608875|NCT00330681|528736935|FG001|Overall Study|Withdrawal by Subject|5|||
146608876|NCT00330681|528736934|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
146608877|NCT00330681|528736935|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
146608878|NCT00847197|528736936|FG000|Overall Study|Adverse Event|21|||
146608879|NCT00847197|528736937|FG001|Overall Study|Adverse Event|3|||
146608880|NCT00847197|528736936|FG000|Overall Study|Protocol Violation|0|||
146657453|NCT00873860|528923090|FG003|Overall Study|Lost to Follow-up|1|||
146657454|NCT00873860|528923087|FG000|Overall Study|Withdrawal by Subject|1|||
146608881|NCT00847197|528736937|FG001|Overall Study|Protocol Violation|1|||
146608882|NCT00847197|528736936|FG000|Overall Study|Withdrawal by Subject|3|||
146608883|NCT00847197|528736937|FG001|Overall Study|Withdrawal by Subject|1|||
146608884|NCT00825812|528736940|FG000|Overall Study|Never entered follow up|0|||
146608885|NCT00825812|528736941|FG001|Overall Study|Never entered follow up|0|||
146608886|NCT00825812|528736942|FG002|Overall Study|Never entered follow up|0|||
146608887|NCT00825812|528736943|FG003|Overall Study|Never entered follow up|1|||
146608888|NCT00825812|528736940|FG000|Overall Study|Adverse Event|0|||
146608889|NCT00825812|528736941|FG001|Overall Study|Adverse Event|0|||
146608890|NCT00825812|528736942|FG002|Overall Study|Adverse Event|0|||
146608891|NCT00825812|528736943|FG003|Overall Study|Adverse Event|1|||
146608892|NCT00825812|528736940|FG000|Overall Study|Subject withdrew consent|0|||
146608893|NCT00825812|528736941|FG001|Overall Study|Subject withdrew consent|0|||
146608894|NCT00825812|528736942|FG002|Overall Study|Subject withdrew consent|3|||
146608895|NCT00825812|528736943|FG003|Overall Study|Subject withdrew consent|2|||
146608896|NCT00825812|528736940|FG000|Overall Study|Non-compliance with protocol|0|||
146608897|NCT00825812|528736941|FG001|Overall Study|Non-compliance with protocol|0|||
146608898|NCT00825812|528736942|FG002|Overall Study|Non-compliance with protocol|0|||
146608899|NCT00825812|528736943|FG003|Overall Study|Non-compliance with protocol|1|||
146608900|NCT00825812|528736940|FG000|Overall Study|Administrative|0|||
146608901|NCT00825812|528736941|FG001|Overall Study|Administrative|1|||
146608902|NCT00825812|528736942|FG002|Overall Study|Administrative|3|||
146608903|NCT00825812|528736943|FG003|Overall Study|Administrative|5|||
146608904|NCT03597061|528736944|FG000|Overall Study|Lost to Follow-up|1|||
146608905|NCT03597061|528736945|FG001|Overall Study|Lost to Follow-up|0|||
146608906|NCT03597061|528736944|FG000|Overall Study|Protocol Violation|0|||
146608907|NCT03597061|528736945|FG001|Overall Study|Protocol Violation|1|||
146608908|NCT00895453|528736946|FG000|Overall Study|Lost to Follow-up|25|||
146608909|NCT00895453|528736947|FG001|Overall Study|Lost to Follow-up|25|||
146608910|NCT00895453|528736948|FG002|Overall Study|Lost to Follow-up|23|||
146608911|NCT04167137|528736950|FG000|Overall Study|Disease progression|1|||
146608912|NCT04167137|528736951|FG001|Overall Study|Disease progression|1|||
146608913|NCT04167137|528736952|FG002|Overall Study|Disease progression|3|||
146608914|NCT04167137|528736953|FG003|Overall Study|Disease progression|3|||
146608915|NCT04167137|528736954|FG004|Overall Study|Disease progression|2|||
146608916|NCT04167137|528736955|FG005|Overall Study|Disease progression|3|||
146608917|NCT04167137|528736956|FG006|Overall Study|Disease progression|2|||
146608918|NCT04167137|528736957|FG007|Overall Study|Disease progression|2|||
146608919|NCT04167137|528736950|FG000|Overall Study|Withdrawal by Subject|1|||
146608920|NCT04167137|528736951|FG001|Overall Study|Withdrawal by Subject|0|||
146608921|NCT04167137|528736952|FG002|Overall Study|Withdrawal by Subject|0|||
146608922|NCT04167137|528736953|FG003|Overall Study|Withdrawal by Subject|1|||
146608923|NCT04167137|528736954|FG004|Overall Study|Withdrawal by Subject|0|||
146608924|NCT04167137|528736955|FG005|Overall Study|Withdrawal by Subject|2|||
146608925|NCT04167137|528736956|FG006|Overall Study|Withdrawal by Subject|1|||
146608926|NCT04167137|528736957|FG007|Overall Study|Withdrawal by Subject|0|||
146608927|NCT04167137|528736950|FG000|Overall Study|Adverse Event|0|||
146657455|NCT00873860|528923088|FG001|Overall Study|Withdrawal by Subject|0|||
146657456|NCT00873860|528923089|FG002|Overall Study|Withdrawal by Subject|2|||
146657457|NCT00873860|528923090|FG003|Overall Study|Withdrawal by Subject|0|||
146657458|NCT00873860|528923087|FG000|Overall Study|Death|1|||
146657459|NCT00873860|528923088|FG001|Overall Study|Death|0|||
146657460|NCT00873860|528923089|FG002|Overall Study|Death|0|||
146657461|NCT00873860|528923090|FG003|Overall Study|Death|0|||
146657462|NCT00873860|528923087|FG000|Overall Study|Other|1|||
146657463|NCT00873860|528923088|FG001|Overall Study|Other|0|||
146657464|NCT00873860|528923089|FG002|Overall Study|Other|1|||
146657465|NCT00873860|528923090|FG003|Overall Study|Other|0|||
146657466|NCT00704808|528923094|FG000|Overall Study|Discontinued prior to starting treatment|14|||
146657467|NCT00704808|528923094|FG000|Overall Study|Death|7|||
146657468|NCT00704808|528923094|FG000|Overall Study|Tumor progression|80|||
146608928|NCT04167137|528736951|FG001|Overall Study|Adverse Event|0|||
146608929|NCT04167137|528736952|FG002|Overall Study|Adverse Event|0|||
146608930|NCT04167137|528736953|FG003|Overall Study|Adverse Event|0|||
146608931|NCT04167137|528736954|FG004|Overall Study|Adverse Event|0|||
146608932|NCT04167137|528736955|FG005|Overall Study|Adverse Event|1|||
146657469|NCT00704808|528923094|FG000|Overall Study|Patient's decision|11|||
146657470|NCT00704808|528923094|FG000|Overall Study|Early therapy discontinuation|16|||
146657471|NCT00704808|528923094|FG000|Overall Study|Adverse Event|1|||
146608933|NCT04167137|528736956|FG006|Overall Study|Adverse Event|0|||
146608934|NCT04167137|528736957|FG007|Overall Study|Adverse Event|1|||
146608935|NCT04167137|528736950|FG000|Overall Study|Physician Decision|0|||
146608936|NCT04167137|528736951|FG001|Overall Study|Physician Decision|0|||
146608937|NCT04167137|528736952|FG002|Overall Study|Physician Decision|0|||
146608938|NCT04167137|528736953|FG003|Overall Study|Physician Decision|1|||
146657472|NCT00704808|528923094|FG000|Overall Study|Lost to Follow-up|1|||
146657473|NCT00704808|528923094|FG000|Overall Study|Treatment change|1|||
146657474|NCT05308290|528923100|FG000|Overall Study|Death|1|||
146657475|NCT05308290|528923101|FG001|Overall Study|Death|0|||
146608939|NCT04167137|528736954|FG004|Overall Study|Physician Decision|0|||
146608940|NCT04167137|528736955|FG005|Overall Study|Physician Decision|0|||
146608941|NCT04167137|528736956|FG006|Overall Study|Physician Decision|1|||
146608942|NCT04167137|528736957|FG007|Overall Study|Physician Decision|0|||
146608943|NCT04167137|528736950|FG000|Overall Study|Death|0|||
146608944|NCT04167137|528736951|FG001|Overall Study|Death|1|||
146608945|NCT04167137|528736952|FG002|Overall Study|Death|0|||
146608946|NCT04167137|528736953|FG003|Overall Study|Death|0|||
146608947|NCT04167137|528736954|FG004|Overall Study|Death|0|||
146608948|NCT04167137|528736955|FG005|Overall Study|Death|0|||
146608949|NCT04167137|528736956|FG006|Overall Study|Death|0|||
146608950|NCT04167137|528736957|FG007|Overall Study|Death|0|||
146608951|NCT04167137|528736950|FG000|Overall Study|Study terminated by Sponsor|0|||
146608952|NCT04167137|528736951|FG001|Overall Study|Study terminated by Sponsor|0|||
146608953|NCT04167137|528736952|FG002|Overall Study|Study terminated by Sponsor|0|||
146608954|NCT04167137|528736953|FG003|Overall Study|Study terminated by Sponsor|0|||
146608955|NCT04167137|528736954|FG004|Overall Study|Study terminated by Sponsor|0|||
146608956|NCT04167137|528736955|FG005|Overall Study|Study terminated by Sponsor|0|||
146608957|NCT04167137|528736956|FG006|Overall Study|Study terminated by Sponsor|0|||
146608958|NCT04167137|528736957|FG007|Overall Study|Study terminated by Sponsor|1|||
146608959|NCT00400569|528736958|FG000|Overall Study|Death|1|||
146608960|NCT02461745|528736962|FG000|Overall Study|Lack of Efficacy|9|||
146608961|NCT02461745|528736963|FG001|Overall Study|Lack of Efficacy|1|||
146608962|NCT02461745|528736962|FG000|Overall Study|Lost to Follow-up|2|||
146608963|NCT02461745|528736963|FG001|Overall Study|Lost to Follow-up|2|||
146608964|NCT02461745|528736962|FG000|Overall Study|Withdrawal by Subject|3|||
146608965|NCT02461745|528736963|FG001|Overall Study|Withdrawal by Subject|1|||
146608966|NCT03848949|528736964|FG000|Overall Study|Lost to Follow-up|5|||
146608967|NCT03848949|528736965|FG001|Overall Study|Lost to Follow-up|7|||
146608968|NCT01865448|528739287|FG000|Overall Study|Adverse Event|1|||
146608969|NCT01865448|528739288|FG001|Overall Study|Adverse Event|1|||
146608970|NCT01865448|528739287|FG000|Overall Study|Pregnancy|0|||
146608971|NCT01865448|528739288|FG001|Overall Study|Pregnancy|1|||
146608972|NCT01865448|528739287|FG000|Overall Study|dropout unrelated to study|1|||
146608973|NCT01865448|528739288|FG001|Overall Study|dropout unrelated to study|1|||
146608974|NCT00931606|528739292|FG000|Overall Study|Death|1|||
146608975|NCT00931606|528739293|FG001|Overall Study|Death|3|||
146608976|NCT00931606|528739294|FG002|Overall Study|Death|2|||
146608977|NCT00931606|528739295|FG003|Overall Study|Death|0|||
146608978|NCT00931606|528739292|FG000|Overall Study|Lost to Follow-up|0|||
146608979|NCT00931606|528739293|FG001|Overall Study|Lost to Follow-up|1|||
146608980|NCT00931606|528739294|FG002|Overall Study|Lost to Follow-up|0|||
146608981|NCT00931606|528739295|FG003|Overall Study|Lost to Follow-up|0|||
146608982|NCT00931606|528739292|FG000|Overall Study|Physician Decision|0|||
146608983|NCT00931606|528739293|FG001|Overall Study|Physician Decision|0|||
146608984|NCT00931606|528739294|FG002|Overall Study|Physician Decision|3|||
146608985|NCT00931606|528739295|FG003|Overall Study|Physician Decision|0|||
146608986|NCT00931606|528739292|FG000|Overall Study|Sponsor Decision|1|||
146608987|NCT00931606|528739293|FG001|Overall Study|Sponsor Decision|4|||
146608988|NCT00931606|528739294|FG002|Overall Study|Sponsor Decision|0|||
146608989|NCT00931606|528739295|FG003|Overall Study|Sponsor Decision|2|||
146608990|NCT00931606|528739292|FG000|Overall Study|Withdrawal by Subject|3|||
146608991|NCT00931606|528739293|FG001|Overall Study|Withdrawal by Subject|1|||
146608992|NCT00931606|528739294|FG002|Overall Study|Withdrawal by Subject|1|||
146608993|NCT00931606|528739295|FG003|Overall Study|Withdrawal by Subject|1|||
146608994|NCT05128578|528739300|FG000|Overall Study|Withdrawal by Subject|9|||
146608995|NCT05128578|528739300|FG000|Overall Study|Lost to Follow-up|5|||
146608996|NCT00871338|528739301|FG000|Prior to Booster|Withdrawal by Subject|1|||
146608997|NCT00871338|528739302|FG001|Prior to Booster|Withdrawal by Subject|3|||
146608998|NCT00871338|528739301|FG000|Prior to Booster|Lost to Follow-up|1|||
146608999|NCT00871338|528739302|FG001|Prior to Booster|Lost to Follow-up|0|||
146609000|NCT02391363|528739303|FG000|Overall Study|Lost to Follow-up|5|||
146609001|NCT02391363|528739304|FG001|Overall Study|Lost to Follow-up|5|||
146609002|NCT02391363|528739303|FG000|Overall Study|Withdrawal by Subject|6|||
146609003|NCT02391363|528739304|FG001|Overall Study|Withdrawal by Subject|3|||
146609004|NCT00799266|528739307|FG000|Overall Study|Adverse Event|0|||
146609005|NCT00799266|528739308|FG001|Overall Study|Adverse Event|1|||
146609006|NCT00799266|528739307|FG000|Overall Study|Subject withdrew consent|3|||
146609007|NCT00799266|528739308|FG001|Overall Study|Subject withdrew consent|0|||
146609008|NCT01702025|528739309|FG000|Overall Study|Equipment failure|1|||
146609009|NCT01702025|528739310|FG001|Overall Study|Equipment failure|0|||
146609010|NCT01702025|528739311|FG002|Overall Study|Equipment failure|0|||
146609011|NCT01702025|528739312|FG003|Overall Study|Equipment failure|0|||
146609012|NCT01702025|528739309|FG000|Overall Study|Adverse Event|1|||
146609013|NCT01702025|528739310|FG001|Overall Study|Adverse Event|1|||
146609014|NCT01702025|528739311|FG002|Overall Study|Adverse Event|1|||
146609015|NCT01702025|528739312|FG003|Overall Study|Adverse Event|0|||
146609016|NCT02679755|528739313|FG000|Overall Study|Death|0|||
146609017|NCT02679755|528739314|FG001|Overall Study|Death|3|||
146609018|NCT02679755|528739313|FG000|Overall Study|Global deterioration of health status|1|||
146609019|NCT02679755|528739314|FG001|Overall Study|Global deterioration of health status|8|||
146609020|NCT02679755|528739313|FG000|Overall Study|Lost to Follow-up|1|||
146609021|NCT02679755|528739314|FG001|Overall Study|Lost to Follow-up|0|||
146609022|NCT02679755|528739313|FG000|Overall Study|Objective progression or relapse|24|||
146609023|NCT02679755|528739314|FG001|Overall Study|Objective progression or relapse|83|||
146609024|NCT02679755|528739313|FG000|Overall Study|Not defined|0|||
146609025|NCT02679755|528739314|FG001|Overall Study|Not defined|2|||
146609026|NCT02679755|528739313|FG000|Overall Study|Withdrawal by participant|6|||
146609027|NCT02679755|528739314|FG001|Overall Study|Withdrawal by participant|3|||
146609028|NCT02679755|528739313|FG000|Overall Study|Adverse Event|1|||
146609029|NCT02679755|528739314|FG001|Overall Study|Adverse Event|4|||
146609030|NCT02679755|528739313|FG000|Overall Study|Adverse events not related to study drug|1|||
146609031|NCT02679755|528739314|FG001|Overall Study|Adverse events not related to study drug|2|||
146609032|NCT01061359|528739315|FG000|Overall Study|Death|32|||
146609033|NCT01061359|528739315|FG000|Overall Study|Lost to Follow-up|1072|||
146609034|NCT01061359|528739315|FG000|Overall Study|Relapse|187|||
146609035|NCT01061359|528739315|FG000|Overall Study|Secondary neoplasm|11|||
146609036|NCT02610777|528739318|FG000|Overall Study|Lost to Follow-up|1|||
146609037|NCT02610777|528739319|FG001|Overall Study|Lost to Follow-up|0|||
146609038|NCT02610777|528739318|FG000|Overall Study|Site Terminated by Sponsor|9|||
146609039|NCT02610777|528739319|FG001|Overall Study|Site Terminated by Sponsor|8|||
146609040|NCT02610777|528739318|FG000|Overall Study|Withdrawal by Subject|2|||
146609041|NCT02610777|528739319|FG001|Overall Study|Withdrawal by Subject|2|||
146609042|NCT02610777|528739318|FG000|Overall Study|Reason not Specified|0|||
146609043|NCT02610777|528739319|FG001|Overall Study|Reason not Specified|1|||
146609044|NCT02610777|528739318|FG000|Overall Study|Death|50|||
146609045|NCT02610777|528739319|FG001|Overall Study|Death|47|||
146773206|NCT02584829|529339517|FG001|Overall Study|Withdrawal by Subject|1|||
146773207|NCT02584829|529339516|FG000|Overall Study|Progressive Disease|0|||
146773208|NCT02584829|529339517|FG001|Overall Study|Progressive Disease|3|||
146773209|NCT02767765|529339519|FG000|Overall Study|Adverse Event|4|||
146773210|NCT02767765|529339519|FG000|Overall Study|Death|1|||
146773211|NCT02767765|529339519|FG000|Overall Study|Insufficient response|1|||
146773212|NCT02767765|529339519|FG000|Overall Study|Lost to Follow-up|2|||
146773213|NCT02767765|529339519|FG000|Overall Study|Investigator decision|1|||
146773214|NCT02767765|529339519|FG000|Overall Study|Non-Compliance|1|||
146773215|NCT02767765|529339519|FG000|Overall Study|Withdrawal by Subject|1|||
146773216|NCT01951170|529339520|FG000|Overall Study|Investigator decision|1|||
146773217|NCT00585052|529339529|FG000|Overall Study|Withdrawal by Subject|1|||
146773218|NCT00446459|529339532|FG000|8 Months|Protocol Violation|12|||
146773219|NCT00446459|529339532|FG000|12 Months|Protocol Violation|4|||
146773220|NCT00446459|529339532|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
146773221|NCT03531840|529339535|FG000|Overall Study|Death on study|3|||
146773222|NCT03531840|529339536|FG001|Overall Study|Death on study|2|||
146773223|NCT03531840|529339537|FG002|Overall Study|Death on study|1|||
146773224|NCT03531840|529339538|FG003|Overall Study|Death on study|2|||
146773225|NCT03531840|529339535|FG000|Overall Study|Death during follow up|2|||
146773226|NCT03531840|529339536|FG001|Overall Study|Death during follow up|3|||
146773227|NCT03531840|529339537|FG002|Overall Study|Death during follow up|4|||
146773228|NCT03531840|529339538|FG003|Overall Study|Death during follow up|1|||
146773229|NCT02092116|529339539|FG000|Overall Study|Withdrawal by Subject|0|||
146773230|NCT02092116|529339540|FG001|Overall Study|Withdrawal by Subject|3|||
146773231|NCT02092116|529339539|FG000|Overall Study|Adverse Event|0|||
146773232|NCT02092116|529339540|FG001|Overall Study|Adverse Event|1|||
146773233|NCT02267824|529339541|FG000|Overall Study|Pregnancy|1|||
146773234|NCT02267824|529339542|FG001|Overall Study|Pregnancy|1|||
146773235|NCT02267824|529339541|FG000|Overall Study|Lost to Follow-up|4|||
146773236|NCT02267824|529339542|FG001|Overall Study|Lost to Follow-up|0|||
146609046|NCT00732875|528739320|FG000|Overall Study|Adverse Event|16|||
146609047|NCT00732875|528739320|FG000|Overall Study|Withdrawal by Subject|6|||
146609048|NCT00732875|528739320|FG000|Overall Study|Lack of Efficacy|13|||
146609049|NCT00660179|528739323|FG000|Overall Study|Death|44|||
146609050|NCT00660179|528739324|FG001|Overall Study|Death|47|||
146609051|NCT00660179|528739325|FG002|Overall Study|Death|34|||
146609052|NCT00660179|528739323|FG000|Overall Study|Withdrawal of consent|4|||
146773237|NCT02267824|529339541|FG000|Overall Study|Protocol Violation|3|||
146609053|NCT00660179|528739324|FG001|Overall Study|Withdrawal of consent|6|||
146609054|NCT00660179|528739325|FG002|Overall Study|Withdrawal of consent|4|||
146773238|NCT02267824|529339542|FG001|Overall Study|Protocol Violation|0|||
146773239|NCT02267824|529339541|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
146773240|NCT02267824|529339542|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
146773241|NCT03074331|529339543|FG000|Overall Study|Enrolled but Not Treated|1|||
146609055|NCT00660179|528739323|FG000|Overall Study|Lost to Follow-up|7|||
146609056|NCT00660179|528739324|FG001|Overall Study|Lost to Follow-up|5|||
146609057|NCT00660179|528739325|FG002|Overall Study|Lost to Follow-up|2|||
146773242|NCT03074331|529339543|FG000|Overall Study|Lost to Follow-up|5|||
146773243|NCT03074331|529339543|FG000|Overall Study|Withdrew Consent|1|||
146773244|NCT03144674|529339546|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
146609058|NCT00660179|528739323|FG000|Overall Study|Administrative reason|0|||
146609059|NCT00660179|528739324|FG001|Overall Study|Administrative reason|0|||
146609060|NCT00660179|528739325|FG002|Overall Study|Administrative reason|1|||
146609061|NCT00660179|528739323|FG000|Overall Study|Incorrect randomization|1|||
146609062|NCT00660179|528739324|FG001|Overall Study|Incorrect randomization|0|||
146609063|NCT00660179|528739325|FG002|Overall Study|Incorrect randomization|0|||
146609064|NCT04171219|528739330|FG000|Overall Study|Adverse Event|1|||
146609065|NCT04171219|528739331|FG001|Overall Study|Adverse Event|0|||
146609066|NCT04171219|528739330|FG000|Overall Study|Death|0|||
146609067|NCT04171219|528739331|FG001|Overall Study|Death|1|||
146609068|NCT04171219|528739330|FG000|Overall Study|Lack of Efficacy|9|||
146609069|NCT04171219|528739331|FG001|Overall Study|Lack of Efficacy|13|||
146609070|NCT04171219|528739330|FG000|Overall Study|Withdrawal by Subject|1|||
146609071|NCT04171219|528739331|FG001|Overall Study|Withdrawal by Subject|2|||
146609072|NCT04171219|528739330|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
146609073|NCT04171219|528739331|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
146609074|NCT04171219|528739330|FG000|Overall Study|Clinical PD/Patient choice|1|||
146609075|NCT04171219|528739331|FG001|Overall Study|Clinical PD/Patient choice|0|||
146609076|NCT04171219|528739330|FG000|Overall Study|Toxicity/ Patient choice|1|||
146609077|NCT04171219|528739331|FG001|Overall Study|Toxicity/ Patient choice|0|||
146609078|NCT02974257|528739334|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
146609079|NCT02974257|528739335|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
146609080|NCT02974257|528739334|FG000|Overall Study|Clinical indication for thiamine|1|||
146609081|NCT02974257|528739335|FG001|Overall Study|Clinical indication for thiamine|0|||
146609082|NCT02974257|528739334|FG000|Overall Study|Already on thiamine|1|||
146609083|NCT02974257|528739335|FG001|Overall Study|Already on thiamine|0|||
146609084|NCT02974257|528739334|FG000|Overall Study|Extubated prior to study drug|0|||
146609085|NCT02974257|528739335|FG001|Overall Study|Extubated prior to study drug|1|||
146609086|NCT02974257|528739334|FG000|Overall Study|Death|0|||
146609087|NCT02974257|528739335|FG001|Overall Study|Death|1|||
146609088|NCT00398567|528739338|FG000|Overall Study|Disease Progression|3|||
146609089|NCT00398567|528739339|FG001|Overall Study|Disease Progression|4|||
146609090|NCT00398567|528739340|FG002|Overall Study|Disease Progression|27|||
146609091|NCT00398567|528739338|FG000|Overall Study|Withdrawal by Subject|1|||
146609092|NCT00398567|528739339|FG001|Overall Study|Withdrawal by Subject|0|||
146609093|NCT00398567|528739340|FG002|Overall Study|Withdrawal by Subject|4|||
146609094|NCT00398567|528739338|FG000|Overall Study|Adverse Event|0|||
146609095|NCT00398567|528739339|FG001|Overall Study|Adverse Event|0|||
146609096|NCT00398567|528739340|FG002|Overall Study|Adverse Event|2|||
146609097|NCT00398567|528739338|FG000|Overall Study|Protocol Violation|0|||
146609098|NCT00398567|528739339|FG001|Overall Study|Protocol Violation|0|||
146609099|NCT00398567|528739340|FG002|Overall Study|Protocol Violation|1|||
146657476|NCT05308290|528923100|FG000|Overall Study|Lost to Follow-up|2|||
146657477|NCT05308290|528923101|FG001|Overall Study|Lost to Follow-up|1|||
146657478|NCT05308290|528923100|FG000|Overall Study|still in study followup|0|||
146657479|NCT05308290|528923101|FG001|Overall Study|still in study followup|1|||
146657480|NCT01017575|528923102|FG000|Overall Study|Lack of Efficacy|0|||
146657481|NCT01017575|528923103|FG001|Overall Study|Lack of Efficacy|1|||
146657482|NCT01017575|528923104|FG002|Overall Study|Lack of Efficacy|0|||
146657483|NCT01017575|528923105|FG003|Overall Study|Lack of Efficacy|1|||
146657484|NCT01017575|528923106|FG004|Overall Study|Lack of Efficacy|1|||
146657485|NCT01017575|528923102|FG000|Overall Study|Adverse Event|0|||
146657486|NCT01017575|528923103|FG001|Overall Study|Adverse Event|1|||
146657487|NCT01017575|528923104|FG002|Overall Study|Adverse Event|0|||
146657488|NCT01017575|528923105|FG003|Overall Study|Adverse Event|0|||
146657489|NCT01017575|528923106|FG004|Overall Study|Adverse Event|2|||
146657490|NCT01017575|528923102|FG000|Overall Study|Withdrawal by Subject|1|||
146657491|NCT01017575|528923103|FG001|Overall Study|Withdrawal by Subject|0|||
146657492|NCT01017575|528923104|FG002|Overall Study|Withdrawal by Subject|0|||
146657493|NCT01017575|528923105|FG003|Overall Study|Withdrawal by Subject|0|||
146609100|NCT04878211|528739347|FG000|Overall Study|Lost to Follow-up|0|||
146609101|NCT04878211|528739348|FG001|Overall Study|Lost to Follow-up|0|||
146609102|NCT04878211|528739349|FG002|Overall Study|Lost to Follow-up|0|||
146609103|NCT04878211|528739350|FG003|Overall Study|Lost to Follow-up|1|||
146609104|NCT04878211|528739351|FG004|Overall Study|Lost to Follow-up|0|||
146609105|NCT04878211|528739352|FG005|Overall Study|Lost to Follow-up|1|||
146609106|NCT04878211|528739347|FG000|Overall Study|Protocol deviation|1|||
146609107|NCT04878211|528739348|FG001|Overall Study|Protocol deviation|0|||
146609108|NCT04878211|528739349|FG002|Overall Study|Protocol deviation|0|||
146609109|NCT04878211|528739350|FG003|Overall Study|Protocol deviation|0|||
146609110|NCT04878211|528739351|FG004|Overall Study|Protocol deviation|0|||
146609111|NCT04878211|528739352|FG005|Overall Study|Protocol deviation|0|||
146657494|NCT01017575|528923106|FG004|Overall Study|Withdrawal by Subject|0|||
146657495|NCT03500679|528923116|FG000|Overall Study|Lost to Follow-up|6|||
146657496|NCT03500679|528923117|FG001|Overall Study|Lost to Follow-up|3|||
146657497|NCT03500679|528923116|FG000|Overall Study|Withdrawal by Subject|3|||
146773245|NCT03144674|529339547|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
146773246|NCT03144674|529339548|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
146773247|NCT03144674|529339549|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
146773248|NCT03144674|529339546|FG000|Overall Study|Death|3|||
146773249|NCT03144674|529339547|FG001|Overall Study|Death|2|||
146773250|NCT03144674|529339548|FG002|Overall Study|Death|6|||
146773251|NCT03144674|529339549|FG003|Overall Study|Death|24|||
146773252|NCT03144674|529339546|FG000|Overall Study|Lost to Follow-up|0|||
146922989|NCT01026389|529878710|FG001|Overall Study|change of treatment, patient moved|2|||
146922990|NCT01995136|529878711|FG000|Overall Study|Change in residence|1|||
146922991|NCT01830543|529878713|FG000|Overall Study|Subject Decision|19|||
146922992|NCT01830543|529878714|FG001|Overall Study|Subject Decision|21|||
146609112|NCT04878211|528739347|FG000|Overall Study|Study terminated by sponsor|0|||
146609113|NCT04878211|528739348|FG001|Overall Study|Study terminated by sponsor|0|||
146609114|NCT04878211|528739349|FG002|Overall Study|Study terminated by sponsor|0|||
146609115|NCT04878211|528739350|FG003|Overall Study|Study terminated by sponsor|0|||
146609116|NCT04878211|528739351|FG004|Overall Study|Study terminated by sponsor|9|||
146609117|NCT04878211|528739352|FG005|Overall Study|Study terminated by sponsor|4|||
146609118|NCT04878211|528739347|FG000|Overall Study|Subject decision|0|||
146609119|NCT04878211|528739348|FG001|Overall Study|Subject decision|0|||
146609120|NCT04878211|528739349|FG002|Overall Study|Subject decision|0|||
146609121|NCT04878211|528739350|FG003|Overall Study|Subject decision|0|||
146609122|NCT04878211|528739351|FG004|Overall Study|Subject decision|1|||
146609123|NCT04878211|528739352|FG005|Overall Study|Subject decision|0|||
146609124|NCT01687101|528739359|FG000|Overall Study|Lost to Follow-up|7|||
146609125|NCT05274269|528739360|FG000|Overall Study|Adverse Event|0|||
146609126|NCT05274269|528739361|FG001|Overall Study|Adverse Event|3|||
146609127|NCT05274269|528739360|FG000|Overall Study|Death|0|||
146922993|NCT01830543|529878715|FG002|Overall Study|Subject Decision|57|||
146922994|NCT01830543|529878713|FG000|Overall Study|Adverse Event|91|||
146609128|NCT05274269|528739361|FG001|Overall Study|Death|1|||
146609129|NCT05274269|528739360|FG000|Overall Study|Other|0|||
146609130|NCT05274269|528739361|FG001|Overall Study|Other|2|||
146609131|NCT05274269|528739360|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
146609132|NCT05274269|528739361|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
146609133|NCT02206035|528739362|FG000|Overall Study|Physician Decision|10|||
146609134|NCT02206035|528739363|FG001|Overall Study|Physician Decision|0|||
146609135|NCT02206035|528739364|FG002|Overall Study|Physician Decision|175|||
146609136|NCT02936843|528739365|FG000|Overall Study|Lost to Follow-up|3|||
146609137|NCT02936843|528739366|FG001|Overall Study|Lost to Follow-up|1|||
146609138|NCT02936843|528739365|FG000|Overall Study|Withdrawal by Subject|1|||
146609139|NCT02936843|528739366|FG001|Overall Study|Withdrawal by Subject|1|||
146609140|NCT03668613|528739367|FG000|Overall Study|Adverse Event|1|||
146609141|NCT03668613|528739368|FG001|Overall Study|Adverse Event|2|||
146609142|NCT03668613|528739367|FG000|Overall Study|Lack of Efficacy|5|||
146609143|NCT03668613|528739368|FG001|Overall Study|Lack of Efficacy|1|||
146609144|NCT03668613|528739367|FG000|Overall Study|Pregnancy|0|||
146609145|NCT03668613|528739368|FG001|Overall Study|Pregnancy|2|||
146609146|NCT03668613|528739367|FG000|Overall Study|Protocol Violation|1|||
146609147|NCT03668613|528739368|FG001|Overall Study|Protocol Violation|0|||
146609148|NCT03668613|528739367|FG000|Overall Study|Physician Decision|1|||
146609149|NCT03668613|528739368|FG001|Overall Study|Physician Decision|0|||
146609150|NCT03668613|528739367|FG000|Overall Study|Withdrawal by Subject|2|||
146609151|NCT03668613|528739368|FG001|Overall Study|Withdrawal by Subject|1|||
146609152|NCT03668613|528739367|FG000|Overall Study|Guardian decision|1|||
146922995|NCT01830543|529878714|FG001|Overall Study|Adverse Event|77|||
146922996|NCT01830543|529878715|FG002|Overall Study|Adverse Event|76|||
146922997|NCT01830543|529878713|FG000|Overall Study|Death|20|||
146609153|NCT03668613|528739368|FG001|Overall Study|Guardian decision|0|||
146609154|NCT00709618|528739371|FG000|Overall Study|Withdrawal by Subject|4|||
146609155|NCT00709618|528739371|FG000|Overall Study|Lost to Follow-up|1|||
146609156|NCT00709618|528739371|FG000|Overall Study|Study Closed/Terminated|25|||
146609157|NCT04042909|528739372|FG000|Overall Study|Withdrawal by Subject|1|||
146609158|NCT04042909|528739373|FG001|Overall Study|Withdrawal by Subject|0|||
146609159|NCT04042909|528739374|FG002|Overall Study|Withdrawal by Subject|0|||
146773253|NCT03144674|529339547|FG001|Overall Study|Lost to Follow-up|1|||
146922998|NCT01830543|529878714|FG001|Overall Study|Death|22|||
146609160|NCT04042909|528739372|FG000|Overall Study|duplicate cases|2|||
146609161|NCT04042909|528739373|FG001|Overall Study|duplicate cases|0|||
146609162|NCT04042909|528739374|FG002|Overall Study|duplicate cases|0|||
146609163|NCT04042909|528739372|FG000|Overall Study|technical problem|0|||
146609164|NCT04042909|528739373|FG001|Overall Study|technical problem|1|||
146609165|NCT04042909|528739374|FG002|Overall Study|technical problem|0|||
146773254|NCT03144674|529339548|FG002|Overall Study|Lost to Follow-up|0|||
146609166|NCT00894361|528739377|FG000|Overall Study|deaths and less than 2 years followup|24|||
146609167|NCT00894361|528739378|FG001|Overall Study|deaths and less than 2 years followup|64|||
146609168|NCT00286494|528739383|FG000|Overall Study|Hyperglycemic rescue|12|||
146922999|NCT01830543|529878715|FG002|Overall Study|Death|22|||
146923000|NCT01830543|529878713|FG000|Overall Study|Protocol Violation|3|||
146923001|NCT01830543|529878714|FG001|Overall Study|Protocol Violation|7|||
146923002|NCT01830543|529878715|FG002|Overall Study|Protocol Violation|7|||
146923003|NCT01830543|529878713|FG000|Overall Study|Physician Decision|11|||
146923004|NCT01830543|529878714|FG001|Overall Study|Physician Decision|5|||
146923005|NCT01830543|529878715|FG002|Overall Study|Physician Decision|12|||
146923006|NCT01830543|529878713|FG000|Overall Study|Withdrawal by consent|3|||
146609169|NCT00286494|528739384|FG001|Overall Study|Hyperglycemic rescue|19|||
146609170|NCT00286494|528739385|FG002|Overall Study|Hyperglycemic rescue|18|||
146609171|NCT00286494|528739383|FG000|Overall Study|Withdrawal by Subject|2|||
146609172|NCT00286494|528739384|FG001|Overall Study|Withdrawal by Subject|10|||
146609173|NCT00286494|528739385|FG002|Overall Study|Withdrawal by Subject|9|||
146609174|NCT00286494|528739383|FG000|Overall Study|Adverse Event|3|||
146609175|NCT00286494|528739384|FG001|Overall Study|Adverse Event|8|||
146609176|NCT00286494|528739385|FG002|Overall Study|Adverse Event|6|||
146609177|NCT00286494|528739383|FG000|Overall Study|Physician Decision|5|||
146609178|NCT00286494|528739384|FG001|Overall Study|Physician Decision|5|||
146609179|NCT00286494|528739385|FG002|Overall Study|Physician Decision|1|||
146609180|NCT00286494|528739383|FG000|Overall Study|Lost to Follow-up|3|||
146609181|NCT00286494|528739384|FG001|Overall Study|Lost to Follow-up|1|||
146609182|NCT00286494|528739385|FG002|Overall Study|Lost to Follow-up|3|||
146609183|NCT00286494|528739383|FG000|Overall Study|Protocol Violation|1|||
146609184|NCT00286494|528739384|FG001|Overall Study|Protocol Violation|1|||
146609185|NCT00286494|528739385|FG002|Overall Study|Protocol Violation|2|||
146609186|NCT04776317|528739386|FG000|Overall Study|Physician Decision|0|||
146609187|NCT04776317|528739387|FG001|Overall Study|Physician Decision|1|||
146609188|NCT04776317|528739388|FG002|Overall Study|Physician Decision|0|||
146609189|NCT04776317|528739389|FG003|Overall Study|Physician Decision|0|||
146609190|NCT04776317|528739390|FG004|Overall Study|Physician Decision|0|||
146609191|NCT04776317|528739391|FG005|Overall Study|Physician Decision|0|||
146609192|NCT04776317|528739392|FG006|Overall Study|Physician Decision|0|||
146609193|NCT04776317|528739393|FG007|Overall Study|Physician Decision|0|||
146609194|NCT04776317|528739394|FG008|Overall Study|Physician Decision|0|||
146609195|NCT04776317|528739395|FG009|Overall Study|Physician Decision|0|||
146609196|NCT04776317|528739396|FG010|Overall Study|Physician Decision|0|||
146609197|NCT04776317|528739397|FG011|Overall Study|Physician Decision|0|||
146609198|NCT04776317|528739398|FG012|Overall Study|Physician Decision|0|||
146609199|NCT04776317|528739399|FG013|Overall Study|Physician Decision|0|||
146609200|NCT04776317|528739400|FG014|Overall Study|Physician Decision|0|||
146609201|NCT04776317|528739386|FG000|Overall Study|Protocol Violation|0|||
146609202|NCT04776317|528739387|FG001|Overall Study|Protocol Violation|0|||
146609203|NCT04776317|528739388|FG002|Overall Study|Protocol Violation|1|||
146609204|NCT04776317|528739389|FG003|Overall Study|Protocol Violation|0|||
146609205|NCT04776317|528739390|FG004|Overall Study|Protocol Violation|0|||
146609206|NCT04776317|528739391|FG005|Overall Study|Protocol Violation|0|||
146609207|NCT04776317|528739392|FG006|Overall Study|Protocol Violation|0|||
146609208|NCT04776317|528739393|FG007|Overall Study|Protocol Violation|0|||
146609209|NCT04776317|528739394|FG008|Overall Study|Protocol Violation|0|||
146609210|NCT04776317|528739395|FG009|Overall Study|Protocol Violation|0|||
146609211|NCT04776317|528739396|FG010|Overall Study|Protocol Violation|0|||
146609212|NCT04776317|528739397|FG011|Overall Study|Protocol Violation|0|||
146609213|NCT04776317|528739398|FG012|Overall Study|Protocol Violation|0|||
146609214|NCT04776317|528739399|FG013|Overall Study|Protocol Violation|0|||
146609215|NCT04776317|528739400|FG014|Overall Study|Protocol Violation|0|||
146609216|NCT04776317|528739386|FG000|Overall Study|Withdrawal by Subject|0|||
146609217|NCT04776317|528739387|FG001|Overall Study|Withdrawal by Subject|0|||
146609218|NCT04776317|528739388|FG002|Overall Study|Withdrawal by Subject|0|||
146609219|NCT04776317|528739389|FG003|Overall Study|Withdrawal by Subject|0|||
146609220|NCT04776317|528739390|FG004|Overall Study|Withdrawal by Subject|1|||
146609221|NCT04776317|528739391|FG005|Overall Study|Withdrawal by Subject|0|||
146609222|NCT04776317|528739392|FG006|Overall Study|Withdrawal by Subject|0|||
146609223|NCT04776317|528739393|FG007|Overall Study|Withdrawal by Subject|0|||
146609224|NCT04776317|528739394|FG008|Overall Study|Withdrawal by Subject|0|||
146609225|NCT04776317|528739395|FG009|Overall Study|Withdrawal by Subject|0|||
146609226|NCT04776317|528739396|FG010|Overall Study|Withdrawal by Subject|0|||
146609227|NCT04776317|528739397|FG011|Overall Study|Withdrawal by Subject|0|||
146609228|NCT04776317|528739398|FG012|Overall Study|Withdrawal by Subject|0|||
146609229|NCT04776317|528739399|FG013|Overall Study|Withdrawal by Subject|0|||
146609230|NCT04776317|528739400|FG014|Overall Study|Withdrawal by Subject|0|||
146609231|NCT05438576|528739401|FG000|Overall Study|Death|1|||
146609232|NCT05438576|528739402|FG001|Overall Study|Death|1|||
146609233|NCT05438576|528739401|FG000|Overall Study|Withdrawal by Subject|4|||
146609234|NCT05438576|528739402|FG001|Overall Study|Withdrawal by Subject|2|||
146609235|NCT05438576|528739401|FG000|Overall Study|Not Eligible|2|||
146609236|NCT05438576|528739402|FG001|Overall Study|Not Eligible|1|||
146609237|NCT05438576|528739401|FG000|Overall Study|Did not complete baseline testing|22|||
146609238|NCT05438576|528739402|FG001|Overall Study|Did not complete baseline testing|4|||
146609239|NCT02881762|528739403|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
146773255|NCT03144674|529339549|FG003|Overall Study|Lost to Follow-up|4|||
146923007|NCT01830543|529878714|FG001|Overall Study|Withdrawal by consent|3|||
146609240|NCT02881762|528739404|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
146609241|NCT01415401|528739411|FG000|Overall Study|Adverse Event|5|||
146609242|NCT01415401|528739411|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
146609243|NCT01415401|528739411|FG000|Overall Study|Terminated by Sponsor|1|||
146609244|NCT00994422|528739412|FG000|Overall Study|Lost to Follow-up|7|||
146609245|NCT00994422|528739413|FG001|Overall Study|Lost to Follow-up|1|||
146609246|NCT04124705|528739414|FG000|Titration Period|Adverse Event|9|||
146609247|NCT04124705|528739415|FG001|Titration Period|Adverse Event|5|||
146609248|NCT04124705|528739414|FG000|Titration Period|Withdrawal by Subject|6|||
146609249|NCT04124705|528739415|FG001|Titration Period|Withdrawal by Subject|3|||
146609250|NCT04124705|528739414|FG000|Titration Period|Lost to Follow-up|0|||
146657498|NCT03500679|528923117|FG001|Overall Study|Withdrawal by Subject|0|||
146657499|NCT00095628|528923118|FG000|Overall Study|Disease progression prior to treatment|1|||
146657500|NCT01484054|528923122|FG000|Period 1|Withdrawal by Subject|0|||
146657501|NCT01484054|528923123|FG001|Period 1|Withdrawal by Subject|1|||
146657502|NCT01539317|528923124|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
146657503|NCT01539317|528923125|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
146657504|NCT01674634|528923127|FG000|Overall Study|Withdrawal by Subject|3|||
146657505|NCT01674634|528923127|FG000|Overall Study|Lost to Follow-up|3|||
146657506|NCT04221230|528923143|FG000|Overall Study|Lost to Follow-up|12|||
146657507|NCT04221230|528923144|FG001|Overall Study|Lost to Follow-up|12|||
146657508|NCT04221230|528923143|FG000|Overall Study|Protocol Violation|2|||
146657509|NCT04221230|528923144|FG001|Overall Study|Protocol Violation|2|||
146657510|NCT04221230|528923143|FG000|Overall Study|Adverse Event|0|||
146657511|NCT04221230|528923144|FG001|Overall Study|Adverse Event|8|||
146657512|NCT04221230|528923143|FG000|Overall Study|Physician Decision|1|||
146657513|NCT04221230|528923144|FG001|Overall Study|Physician Decision|0|||
146657514|NCT04221230|528923143|FG000|Overall Study|Withdrawal by Subject|13|||
146657515|NCT04221230|528923144|FG001|Overall Study|Withdrawal by Subject|11|||
146657516|NCT04221230|528923143|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146657517|NCT04221230|528923144|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146657518|NCT04221230|528923143|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146657519|NCT04221230|528923144|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
146657520|NCT04221230|528923143|FG000|Overall Study|Pregnancy|0|||
146657521|NCT04221230|528923144|FG001|Overall Study|Pregnancy|1|||
146657522|NCT04221230|528923143|FG000|Overall Study|Other|1|||
146657523|NCT04221230|528923144|FG001|Overall Study|Other|2|||
146657524|NCT02021656|528923149|FG000|Overall Study|Adverse Event|1|||
146657525|NCT02021656|528923149|FG000|Overall Study|Lack of Efficacy|2|||
146657526|NCT02021656|528923149|FG000|Overall Study|Lost to Follow-up|1|||
146657527|NCT02021656|528923149|FG000|Overall Study|Withdrew Consent|2|||
146657528|NCT00510952|528923152|FG000|Overall Study|Adverse Event|1|||
146657529|NCT00510952|528923153|FG001|Overall Study|Adverse Event|0|||
146657530|NCT00510952|528923152|FG000|Overall Study|Entry Criteria Not Met|3|||
146657531|NCT00510952|528923153|FG001|Overall Study|Entry Criteria Not Met|1|||
146657532|NCT00510952|528923152|FG000|Overall Study|Lost to Follow-up|5|||
146657533|NCT00510952|528923153|FG001|Overall Study|Lost to Follow-up|3|||
146657534|NCT00510952|528923152|FG000|Overall Study|Physician Decision|1|||
146657535|NCT00510952|528923153|FG001|Overall Study|Physician Decision|1|||
146657536|NCT00510952|528923152|FG000|Overall Study|Protocol Violation|7|||
146657537|NCT00510952|528923153|FG001|Overall Study|Protocol Violation|4|||
146657538|NCT00510952|528923152|FG000|Overall Study|Sponsor Decision|1|||
146657539|NCT00510952|528923153|FG001|Overall Study|Sponsor Decision|0|||
146657540|NCT00510952|528923152|FG000|Overall Study|Withdrawal by Subject|6|||
146657541|NCT00510952|528923153|FG001|Overall Study|Withdrawal by Subject|7|||
146657542|NCT00510952|528923152|FG000|Overall Study|Did Not Receive Study Drug|2|||
146657543|NCT00510952|528923153|FG001|Overall Study|Did Not Receive Study Drug|0|||
146773256|NCT03144674|529339546|FG000|Overall Study|Withdrawal by Participant|0|||
146773257|NCT03144674|529339547|FG001|Overall Study|Withdrawal by Participant|0|||
146773258|NCT03144674|529339548|FG002|Overall Study|Withdrawal by Participant|2|||
146773259|NCT03144674|529339549|FG003|Overall Study|Withdrawal by Participant|6|||
146773260|NCT03144674|529339546|FG000|Overall Study|Discharged from the Trust|0|||
146773261|NCT03144674|529339547|FG001|Overall Study|Discharged from the Trust|0|||
146609251|NCT04124705|528739415|FG001|Titration Period|Lost to Follow-up|1|||
146657544|NCT02359851|528923159|FG000|Overall Study|Death|1|||
146657545|NCT02359851|528923159|FG000|Overall Study|Disease progression|1|||
146657546|NCT00055471|528923160|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
146657547|NCT00055471|528923161|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
146657548|NCT00055471|528923162|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
146657549|NCT00055471|528923160|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
146657550|NCT00055471|528923161|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
146657551|NCT00055471|528923162|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
146773262|NCT03144674|529339548|FG002|Overall Study|Discharged from the Trust|1|||
146609252|NCT04124705|528739414|FG000|Titration Period|Death|1|||
146609253|NCT04124705|528739415|FG001|Titration Period|Death|1|||
146609254|NCT04124705|528739414|FG000|Titration Period|Lack of Efficacy|2|||
146609255|NCT04124705|528739415|FG001|Titration Period|Lack of Efficacy|0|||
146609256|NCT04124705|528739414|FG000|Titration Period|Physician Decision|2|||
146609257|NCT04124705|528739415|FG001|Titration Period|Physician Decision|0|||
146609258|NCT04124705|528739414|FG000|Titration Period|Non-compliance with Study Drug|2|||
146609259|NCT04124705|528739415|FG001|Titration Period|Non-compliance with Study Drug|0|||
146609260|NCT04124705|528739414|FG000|Titration Period|Other|4|||
146609261|NCT04124705|528739415|FG001|Titration Period|Other|9|||
146609262|NCT04124705|528739414|FG000|Stabilization Period|Adverse Event|4|||
146609263|NCT04124705|528739415|FG001|Stabilization Period|Adverse Event|2|||
146609264|NCT04124705|528739414|FG000|Stabilization Period|Withdrawal by Subject|1|||
146609265|NCT04124705|528739415|FG001|Stabilization Period|Withdrawal by Subject|1|||
146609266|NCT04124705|528739414|FG000|Stabilization Period|Lost to Follow-up|0|||
146609267|NCT04124705|528739415|FG001|Stabilization Period|Lost to Follow-up|1|||
146609268|NCT04124705|528739414|FG000|Stabilization Period|Lack of Efficacy|4|||
146609269|NCT04124705|528739415|FG001|Stabilization Period|Lack of Efficacy|2|||
146609270|NCT04124705|528739414|FG000|Stabilization Period|Protocol Deviation|0|||
146609271|NCT04124705|528739415|FG001|Stabilization Period|Protocol Deviation|2|||
146609272|NCT04124705|528739414|FG000|Stabilization Period|Other|2|||
146609273|NCT04124705|528739415|FG001|Stabilization Period|Other|2|||
146609274|NCT01636986|528739420|FG000|Overall Study|Withdrawal by Subject|0|||
146609275|NCT01636986|528739421|FG001|Overall Study|Withdrawal by Subject|1|||
146609276|NCT01636986|528739420|FG000|Overall Study|Corneal Staining|0|||
146609277|NCT01636986|528739421|FG001|Overall Study|Corneal Staining|1|||
146609278|NCT00395850|528739429|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
146609279|NCT00395850|528739430|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
146609280|NCT00395850|528739431|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
146609281|NCT00395850|528739432|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
146609282|NCT00395850|528739429|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
146609283|NCT00395850|528739430|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
146609284|NCT00395850|528739431|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
146609285|NCT00395850|528739432|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
146609286|NCT00395850|528739429|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
146609287|NCT00395850|528739430|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
146609288|NCT00395850|528739431|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
146609289|NCT00395850|528739432|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
146609290|NCT00395850|528739429|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
146609291|NCT00395850|528739430|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
146609292|NCT00395850|528739431|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
146609293|NCT00395850|528739432|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
146609294|NCT00395850|528739429|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
146609295|NCT00395850|528739430|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
146609296|NCT00395850|528739431|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
146609297|NCT00395850|528739432|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
146609298|NCT00395850|528739429|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
146609299|NCT00395850|528739430|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
146609300|NCT00395850|528739431|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
146609301|NCT00395850|528739432|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
146609302|NCT00395850|528739429|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
146609303|NCT00395850|528739430|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
146609304|NCT00395850|528739431|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
146609305|NCT00395850|528739432|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
146609306|NCT01844778|528739439|FG000|Overall Study|Protocol deviation|0|||
146609307|NCT01844778|528739440|FG001|Overall Study|Protocol deviation|1|||
146609308|NCT01844778|528739441|FG002|Overall Study|Protocol deviation|2|||
146609309|NCT01844778|528739439|FG000|Overall Study|Withdrawal by Subject|2|||
146609310|NCT01844778|528739440|FG001|Overall Study|Withdrawal by Subject|0|||
146609311|NCT01844778|528739441|FG002|Overall Study|Withdrawal by Subject|0|||
146609312|NCT01844778|528739439|FG000|Overall Study|Adverse Event|0|||
146609313|NCT01844778|528739440|FG001|Overall Study|Adverse Event|2|||
146609314|NCT01844778|528739441|FG002|Overall Study|Adverse Event|2|||
146609315|NCT01736618|528739444|FG000|Overall Study|Death|294|||
146609316|NCT01736618|528739444|FG000|Overall Study|Lost to Follow-up|193|||
146609317|NCT01736618|528739444|FG000|Overall Study|Withdrawal by Subject|54|||
146609318|NCT01736618|528739444|FG000|Overall Study|Subject unable to be followed at study location|223|||
146609319|NCT01736618|528739444|FG000|Overall Study|Physician Decision|33|||
146657552|NCT00055471|528923160|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
146657553|NCT00055471|528923161|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
146657554|NCT00055471|528923162|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
146657555|NCT01854944|528923163|FG000|Overall Study|Withdrawal by Subject|0|||
146609320|NCT01736618|528739444|FG000|Overall Study|Transplant or removal of target organ|19|||
146609321|NCT01736618|528739444|FG000|Overall Study|Change in indication or condition|78|||
146609322|NCT01736618|528739444|FG000|Overall Study|Study device explant|103|||
146609323|NCT01736618|528739444|FG000|Overall Study|Unable to complete implant|2|||
146609324|NCT00211887|528739447|FG000|Overall Study|Adverse Event|8|||
146609325|NCT00211887|528739448|FG001|Overall Study|Adverse Event|4|||
146609326|NCT00211887|528739449|FG002|Overall Study|Adverse Event|6|||
146609327|NCT00211887|528739447|FG000|Overall Study|Death|1|||
146609328|NCT00211887|528739448|FG001|Overall Study|Death|1|||
146609329|NCT00211887|528739449|FG002|Overall Study|Death|1|||
146609330|NCT00211887|528739447|FG000|Overall Study|Lost to Follow-up|28|||
146609331|NCT00211887|528739448|FG001|Overall Study|Lost to Follow-up|13|||
146609332|NCT00211887|528739449|FG002|Overall Study|Lost to Follow-up|9|||
146609333|NCT00211887|528739447|FG000|Overall Study|Non-medical reason|31|||
146609334|NCT00211887|528739448|FG001|Overall Study|Non-medical reason|14|||
146609335|NCT00211887|528739449|FG002|Overall Study|Non-medical reason|8|||
146609336|NCT00211887|528739447|FG000|Overall Study|Other medical reason|15|||
146609337|NCT00211887|528739448|FG001|Overall Study|Other medical reason|11|||
146609338|NCT00211887|528739449|FG002|Overall Study|Other medical reason|7|||
146609339|NCT00211887|528739447|FG000|Overall Study|Side effects|19|||
146609340|NCT00211887|528739448|FG001|Overall Study|Side effects|13|||
146609341|NCT00211887|528739449|FG002|Overall Study|Side effects|5|||
146609342|NCT00965419|528739450|FG000|Open Label Treatment for Responders|Adverse Event|33|||
146609343|NCT00965419|528739450|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
146609344|NCT00965419|528739450|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
146609345|NCT00965419|528739450|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
146609346|NCT00965419|528739450|FG000|Open Label Treatment for Responders|Physician Decision|6|||
146609347|NCT00965419|528739450|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
146609348|NCT00965419|528739450|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
146609349|NCT00965419|528739450|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
146609350|NCT00965419|528739450|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
146609351|NCT00965419|528739450|FG000|Follow-up Phase|Adverse Event|9|||
146609352|NCT00965419|528739450|FG000|Follow-up Phase|Protocol Violation|4|||
146609353|NCT00965419|528739450|FG000|Follow-up Phase|Withdrawal by Subject|8|||
146609354|NCT00965419|528739450|FG000|Follow-up Phase|Physician Decision|4|||
146609355|NCT00965419|528739450|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
146609356|NCT00965419|528739450|FG000|Follow-up Phase|Lack of Efficacy|28|||
146609357|NCT02475278|528741279|FG000|Overall Study|Lost to Follow-up|1|||
146609358|NCT02475278|528741279|FG000|Overall Study|Reason Not Specified|1|||
146609359|NCT01946152|528741280|FG000|Overall Study|Adverse Event|1|||
146609360|NCT01946152|528741281|FG001|Overall Study|Adverse Event|0|||
146609361|NCT01946152|528741282|FG002|Overall Study|Adverse Event|0|||
146609362|NCT01946152|528741283|FG003|Overall Study|Adverse Event|0|||
146609363|NCT01946152|528741280|FG000|Overall Study|Withdrawal by Subject|0|||
146609364|NCT01946152|528741281|FG001|Overall Study|Withdrawal by Subject|2|||
146609365|NCT01946152|528741282|FG002|Overall Study|Withdrawal by Subject|0|||
146609366|NCT01946152|528741283|FG003|Overall Study|Withdrawal by Subject|0|||
146609367|NCT01946152|528741280|FG000|Overall Study|Progression|0|||
146609368|NCT01946152|528741281|FG001|Overall Study|Progression|1|||
146609369|NCT01946152|528741282|FG002|Overall Study|Progression|4|||
146609370|NCT01946152|528741283|FG003|Overall Study|Progression|7|||
146609371|NCT01946152|528741280|FG000|Overall Study|Physician Decision|0|||
146609372|NCT01946152|528741281|FG001|Overall Study|Physician Decision|0|||
146609373|NCT01946152|528741282|FG002|Overall Study|Physician Decision|1|||
146609374|NCT01946152|528741283|FG003|Overall Study|Physician Decision|0|||
146609375|NCT01946152|528741280|FG000|Overall Study|Second malignancy|0|||
146609376|NCT01946152|528741281|FG001|Overall Study|Second malignancy|0|||
146609377|NCT01946152|528741282|FG002|Overall Study|Second malignancy|1|||
146773263|NCT03144674|529339549|FG003|Overall Study|Discharged from the Trust|0|||
146773264|NCT03144674|529339546|FG000|Overall Study|Exclusion Criteria Met|0|||
146609378|NCT01946152|528741283|FG003|Overall Study|Second malignancy|0|||
146609379|NCT01946152|528741280|FG000|Overall Study|Adverse Event|0|||
146609380|NCT01946152|528741281|FG001|Overall Study|Adverse Event|0|||
146609381|NCT01946152|528741282|FG002|Overall Study|Adverse Event|0|||
146609382|NCT01946152|528741283|FG003|Overall Study|Adverse Event|1|||
146609383|NCT03712787|528741284|FG000|Overall Study|Adverse Event|2|||
146609384|NCT03712787|528741285|FG001|Overall Study|Adverse Event|3|||
146609385|NCT03712787|528741286|FG002|Overall Study|Adverse Event|0|||
146609386|NCT03712787|528741287|FG003|Overall Study|Adverse Event|4|||
146609387|NCT03712787|528741284|FG000|Overall Study|Withdrawal by Subject|4|||
146773265|NCT03144674|529339547|FG001|Overall Study|Exclusion Criteria Met|0|||
146609388|NCT03712787|528741285|FG001|Overall Study|Withdrawal by Subject|14|||
146609389|NCT03712787|528741286|FG002|Overall Study|Withdrawal by Subject|12|||
146609390|NCT03712787|528741287|FG003|Overall Study|Withdrawal by Subject|8|||
146609391|NCT03712787|528741284|FG000|Overall Study|Lost to Follow-up|1|||
146609392|NCT03712787|528741285|FG001|Overall Study|Lost to Follow-up|1|||
146609393|NCT03712787|528741286|FG002|Overall Study|Lost to Follow-up|2|||
146657556|NCT01854944|528923164|FG001|Overall Study|Withdrawal by Subject|0|||
146657557|NCT01854944|528923165|FG002|Overall Study|Withdrawal by Subject|1|||
146657558|NCT02101112|528923166|FG000|Overall Study|Adverse Event|0|||
146657559|NCT02101112|528923167|FG001|Overall Study|Adverse Event|0|||
146657560|NCT02101112|528923168|FG002|Overall Study|Adverse Event|1|||
146657561|NCT02101112|528923169|FG003|Overall Study|Adverse Event|0|||
146657562|NCT02101112|528923170|FG004|Overall Study|Adverse Event|0|||
146657563|NCT02101112|528923171|FG005|Overall Study|Adverse Event|0|||
146657564|NCT02101112|528923166|FG000|Overall Study|Withdrawal by Subject|0|||
146657565|NCT02101112|528923167|FG001|Overall Study|Withdrawal by Subject|0|||
146657566|NCT02101112|528923168|FG002|Overall Study|Withdrawal by Subject|0|||
146657567|NCT02101112|528923169|FG003|Overall Study|Withdrawal by Subject|0|||
146657568|NCT02101112|528923170|FG004|Overall Study|Withdrawal by Subject|1|||
146657569|NCT02101112|528923171|FG005|Overall Study|Withdrawal by Subject|0|||
146657570|NCT02782923|528923174|FG000|Overall Study|Lost to Follow-up|15|||
146657571|NCT00993044|528923175|FG000|Irinotecan 50 mg|Physician Decision|1|||
146657572|NCT05063318|528923178|FG000|Overall Study|Progressive disease|2|||
146657573|NCT05063318|528923179|FG001|Overall Study|Progressive disease|0|||
146657574|NCT05063318|528923180|FG002|Overall Study|Progressive disease|3|||
146657575|NCT05063318|528923178|FG000|Overall Study|Compassionate use|1|||
146657576|NCT05063318|528923179|FG001|Overall Study|Compassionate use|3|||
146657577|NCT05063318|528923180|FG002|Overall Study|Compassionate use|3|||
146657578|NCT05063318|528923178|FG000|Overall Study|Adverse Event|0|||
146657579|NCT05063318|528923179|FG001|Overall Study|Adverse Event|1|||
146657580|NCT05063318|528923180|FG002|Overall Study|Adverse Event|0|||
146657581|NCT05063318|528923178|FG000|Overall Study|Withdrawal by Subject|0|||
146657582|NCT05063318|528923179|FG001|Overall Study|Withdrawal by Subject|1|||
146657583|NCT05063318|528923180|FG002|Overall Study|Withdrawal by Subject|0|||
146657584|NCT03581786|528925169|FG000|Overall Study|Death|67|||
146657585|NCT03581786|528925170|FG001|Overall Study|Death|47|||
146657586|NCT03581786|528925169|FG000|Overall Study|Withdrawal by Subject|2|||
146657587|NCT03581786|528925170|FG001|Overall Study|Withdrawal by Subject|5|||
146657588|NCT03581786|528925169|FG000|Overall Study|Lost to Follow-up|7|||
146657589|NCT03581786|528925170|FG001|Overall Study|Lost to Follow-up|4|||
146657590|NCT03581786|528925169|FG000|Overall Study|reason other than specified above|0|||
146657591|NCT03581786|528925170|FG001|Overall Study|reason other than specified above|1|||
146773266|NCT03144674|529339548|FG002|Overall Study|Exclusion Criteria Met|1|||
146773267|NCT03144674|529339549|FG003|Overall Study|Exclusion Criteria Met|0|||
146773268|NCT03144674|529339546|FG000|Overall Study|Changed Physicians|0|||
146773269|NCT03144674|529339547|FG001|Overall Study|Changed Physicians|0|||
146773270|NCT03144674|529339548|FG002|Overall Study|Changed Physicians|0|||
146773271|NCT03144674|529339549|FG003|Overall Study|Changed Physicians|1|||
146773272|NCT03144674|529339546|FG000|Overall Study|Removed for Safety|0|||
146773273|NCT03144674|529339547|FG001|Overall Study|Removed for Safety|0|||
146773274|NCT03144674|529339548|FG002|Overall Study|Removed for Safety|0|||
146773275|NCT03144674|529339549|FG003|Overall Study|Removed for Safety|1|||
146609394|NCT03712787|528741287|FG003|Overall Study|Lost to Follow-up|1|||
146609395|NCT03712787|528741284|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
146609396|NCT03712787|528741285|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
146609397|NCT03712787|528741286|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
146609398|NCT03712787|528741287|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
146609399|NCT03712787|528741284|FG000|Overall Study|COVID-19 Infection|0|||
146609400|NCT03712787|528741285|FG001|Overall Study|COVID-19 Infection|1|||
146609401|NCT03712787|528741286|FG002|Overall Study|COVID-19 Infection|0|||
146609402|NCT03712787|528741287|FG003|Overall Study|COVID-19 Infection|0|||
146609403|NCT03712787|528741284|FG000|Overall Study|Other, Not Specified|79|||
146773276|NCT03144674|529339546|FG000|Overall Study|Site Closed|0|||
146609404|NCT03712787|528741285|FG001|Overall Study|Other, Not Specified|77|||
146657592|NCT00510874|528925171|FG000|Overall Study|Withdrawal by Subject|1|||
146657593|NCT00510874|528925172|FG001|Overall Study|Withdrawal by Subject|1|||
146657594|NCT00510874|528925173|FG002|Overall Study|Withdrawal by Subject|0|||
146657595|NCT00510874|528925174|FG003|Overall Study|Withdrawal by Subject|0|||
146657596|NCT00510874|528925175|FG004|Overall Study|Withdrawal by Subject|3|||
146773277|NCT03144674|529339547|FG001|Overall Study|Site Closed|0|||
146923008|NCT01830543|529878715|FG002|Overall Study|Withdrawal by consent|3|||
146657597|NCT00510874|528925176|FG005|Overall Study|Withdrawal by Subject|0|||
146923009|NCT01830543|529878713|FG000|Overall Study|Other|12|||
146657598|NCT00510874|528925177|FG006|Overall Study|Withdrawal by Subject|0|||
146657599|NCT00510874|528925171|FG000|Overall Study|Lost to Follow-up|2|||
146773278|NCT03144674|529339548|FG002|Overall Study|Site Closed|0|||
146923010|NCT01830543|529878714|FG001|Overall Study|Other|17|||
146773279|NCT03144674|529339549|FG003|Overall Study|Site Closed|1|||
146609405|NCT03712787|528741286|FG002|Overall Study|Other, Not Specified|74|||
146609406|NCT03712787|528741287|FG003|Overall Study|Other, Not Specified|78|||
146657600|NCT00510874|528925172|FG001|Overall Study|Lost to Follow-up|3|||
146657601|NCT00510874|528925173|FG002|Overall Study|Lost to Follow-up|1|||
146657602|NCT00510874|528925174|FG003|Overall Study|Lost to Follow-up|3|||
146773280|NCT03144674|529339546|FG000|Overall Study|Histological Criteria Not Met|0|||
146923011|NCT01830543|529878715|FG002|Overall Study|Other|37|||
146609407|NCT05111249|528741288|FG000|Overall Study|Lost to Follow-up|0|||
146609408|NCT05111249|528741289|FG001|Overall Study|Lost to Follow-up|2|||
146609409|NCT05111249|528741288|FG000|Overall Study|Physician Decision|0|||
146609410|NCT05111249|528741289|FG001|Overall Study|Physician Decision|1|||
146609411|NCT05111249|528741288|FG000|Overall Study|Participant decision|1|||
146609412|NCT05111249|528741289|FG001|Overall Study|Participant decision|5|||
146609413|NCT03688074|528741292|FG000|Overall Study|Adverse Event|0|||
146609414|NCT03688074|528741293|FG001|Overall Study|Adverse Event|1|||
146609415|NCT03688074|528741292|FG000|Overall Study|Other|1|||
146609416|NCT03688074|528741293|FG001|Overall Study|Other|0|||
146609417|NCT03056339|528741294|FG000|Overall Study|Failed Requirements|0|||
146609418|NCT03056339|528741295|FG001|Overall Study|Failed Requirements|2|||
146609419|NCT03056339|528741296|FG002|Overall Study|Failed Requirements|7|||
146609420|NCT03056339|528741297|FG003|Overall Study|Failed Requirements|1|||
146609421|NCT01363908|528741298|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
146609422|NCT01363908|528741299|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
146609423|NCT01363908|528741298|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
146609424|NCT01363908|528741299|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
146609425|NCT01363908|528741298|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
146609426|NCT01363908|528741299|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
146609427|NCT01363908|528741298|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
146609428|NCT01363908|528741299|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
146609429|NCT02644343|528741300|FG000|Overall Study|Withdrawal by Subject|1|||
146609430|NCT03437577|528741301|FG000|Pre-Randomization|Withdrawal by Subject|0|||
146609431|NCT03437577|528741302|FG001|Pre-Randomization|Withdrawal by Subject|0|||
146609432|NCT03437577|528741303|FG002|Pre-Randomization|Withdrawal by Subject|10|||
146609433|NCT03437577|528741301|FG000|Post-Randomization|Physician Decision|0|||
146609434|NCT03437577|528741302|FG001|Post-Randomization|Physician Decision|2|||
146609435|NCT03437577|528741303|FG002|Post-Randomization|Physician Decision|0|||
146609436|NCT00536471|528741304|FG000|Overall Study|Lost to Follow-up|48|||
146609437|NCT00536471|528741305|FG001|Overall Study|Lost to Follow-up|23|||
146609438|NCT00536471|528741306|FG002|Overall Study|Lost to Follow-up|48|||
146609439|NCT00536471|528741307|FG003|Overall Study|Lost to Follow-up|22|||
146609440|NCT00536471|528741304|FG000|Overall Study|Adverse Event|32|||
146609441|NCT00536471|528741305|FG001|Overall Study|Adverse Event|16|||
146609442|NCT00536471|528741306|FG002|Overall Study|Adverse Event|28|||
146609443|NCT00536471|528741307|FG003|Overall Study|Adverse Event|13|||
146609444|NCT00536471|528741304|FG000|Overall Study|Withdrawal by Subject|40|||
146609445|NCT00536471|528741305|FG001|Overall Study|Withdrawal by Subject|24|||
146609446|NCT00536471|528741306|FG002|Overall Study|Withdrawal by Subject|43|||
146609447|NCT00536471|528741307|FG003|Overall Study|Withdrawal by Subject|21|||
146609448|NCT00536471|528741304|FG000|Overall Study|Lack of Efficacy|17|||
146609449|NCT00536471|528741305|FG001|Overall Study|Lack of Efficacy|18|||
146609450|NCT00536471|528741306|FG002|Overall Study|Lack of Efficacy|11|||
146609451|NCT00536471|528741307|FG003|Overall Study|Lack of Efficacy|9|||
146609452|NCT00536471|528741304|FG000|Overall Study|Protocol Violation|8|||
146609453|NCT00536471|528741305|FG001|Overall Study|Protocol Violation|1|||
146609454|NCT00536471|528741306|FG002|Overall Study|Protocol Violation|2|||
146609455|NCT00536471|528741307|FG003|Overall Study|Protocol Violation|3|||
146609456|NCT00536471|528741304|FG000|Overall Study|Physician Decision|11|||
146609457|NCT00536471|528741305|FG001|Overall Study|Physician Decision|1|||
146609458|NCT00536471|528741306|FG002|Overall Study|Physician Decision|3|||
146609459|NCT00536471|528741307|FG003|Overall Study|Physician Decision|2|||
146609460|NCT00536471|528741304|FG000|Overall Study|Death|0|||
146609461|NCT00536471|528741305|FG001|Overall Study|Death|0|||
146609462|NCT00536471|528741306|FG002|Overall Study|Death|1|||
146609463|NCT00536471|528741307|FG003|Overall Study|Death|2|||
146609464|NCT00536471|528741304|FG000|Overall Study|Sponsor Decision|0|||
146609465|NCT00536471|528741305|FG001|Overall Study|Sponsor Decision|1|||
146609466|NCT00536471|528741306|FG002|Overall Study|Sponsor Decision|3|||
146609467|NCT00536471|528741307|FG003|Overall Study|Sponsor Decision|2|||
146609468|NCT04273893|528741310|FG000|Overall Study|Withdrawal by Subject|0|||
146609469|NCT04273893|528741311|FG001|Overall Study|Withdrawal by Subject|2|||
146609470|NCT04273893|528741310|FG000|Overall Study|Treatment of Disease Progression|0|||
146609471|NCT04273893|528741311|FG001|Overall Study|Treatment of Disease Progression|2|||
146609472|NCT04273893|528741310|FG000|Overall Study|Death|1|||
146609473|NCT04273893|528741311|FG001|Overall Study|Death|2|||
146609474|NCT04273893|528741310|FG000|Overall Study|Lost to Follow-up|0|||
146609475|NCT04273893|528741311|FG001|Overall Study|Lost to Follow-up|2|||
146609476|NCT04273893|528741310|FG000|Overall Study|Physician Decision|1|||
146609477|NCT04273893|528741311|FG001|Overall Study|Physician Decision|0|||
146609478|NCT02783599|528741316|FG000|Overall Study|Progressive disease|23|||
146923012|NCT02695524|529878720|FG000|Overall Study|Lost to Follow-up|3|||
146609479|NCT02783599|528741316|FG000|Overall Study|Surgical Resection|10|||
146609480|NCT02783599|528741316|FG000|Overall Study|Adverse Event|4|||
146609481|NCT02783599|528741316|FG000|Overall Study|Physician Decision|2|||
146609482|NCT02783599|528741316|FG000|Overall Study|Death|1|||
146609483|NCT00856544|528741319|FG000|Overall Study|Randomized but not treated|3|||
146609484|NCT00856544|528741320|FG001|Overall Study|Randomized but not treated|0|||
146609485|NCT00856544|528741321|FG002|Overall Study|Randomized but not treated|0|||
146609486|NCT00856544|528741322|FG003|Overall Study|Randomized but not treated|0|||
146609487|NCT00856544|528741319|FG000|Overall Study|Death|0|||
146609488|NCT00856544|528741320|FG001|Overall Study|Death|2|||
146609489|NCT00856544|528741321|FG002|Overall Study|Death|0|||
146609490|NCT00856544|528741322|FG003|Overall Study|Death|0|||
146609491|NCT00856544|528741319|FG000|Overall Study|Adverse Event|20|||
146609492|NCT00856544|528741320|FG001|Overall Study|Adverse Event|29|||
146609493|NCT00856544|528741321|FG002|Overall Study|Adverse Event|2|||
146609494|NCT00856544|528741322|FG003|Overall Study|Adverse Event|3|||
146609495|NCT00856544|528741319|FG000|Overall Study|Lack of Efficacy|16|||
146609496|NCT00856544|528741320|FG001|Overall Study|Lack of Efficacy|12|||
146609497|NCT00856544|528741321|FG002|Overall Study|Lack of Efficacy|3|||
146609498|NCT00856544|528741322|FG003|Overall Study|Lack of Efficacy|3|||
146609499|NCT00856544|528741319|FG000|Overall Study|Other|9|||
146609500|NCT00856544|528741320|FG001|Overall Study|Other|16|||
146609501|NCT00856544|528741321|FG002|Overall Study|Other|1|||
146609502|NCT00856544|528741322|FG003|Overall Study|Other|6|||
146609503|NCT00856544|528741319|FG000|Overall Study|Lost to Follow-up|1|||
146609504|NCT00856544|528741320|FG001|Overall Study|Lost to Follow-up|2|||
146609505|NCT00856544|528741321|FG002|Overall Study|Lost to Follow-up|2|||
146609506|NCT00856544|528741322|FG003|Overall Study|Lost to Follow-up|0|||
146609507|NCT00856544|528741319|FG000|Overall Study|Withdrawal by Subject|8|||
146609508|NCT00856544|528741320|FG001|Overall Study|Withdrawal by Subject|5|||
146609509|NCT00856544|528741321|FG002|Overall Study|Withdrawal by Subject|0|||
146609510|NCT00856544|528741322|FG003|Overall Study|Withdrawal by Subject|1|||
146609511|NCT01564732|528741323|FG000|Overall Study|Early termination by the study sponsor|6|||
146609512|NCT01564732|528741324|FG001|Overall Study|Early termination by the study sponsor|5|||
146609513|NCT01036321|528741325|FG000|Overall Study|Ineligible after randomization|0|||
146609514|NCT01036321|528741326|FG001|Overall Study|Ineligible after randomization|1|||
146609515|NCT01036321|528741325|FG000|Overall Study|Withdrawal by Subject|3|||
146609516|NCT01036321|528741326|FG001|Overall Study|Withdrawal by Subject|2|||
146609517|NCT01036321|528741325|FG000|Overall Study|Adverse Event|2|||
146609518|NCT01036321|528741326|FG001|Overall Study|Adverse Event|1|||
146609519|NCT00381693|528741327|FG000|Overall Study|Death|1|||
146609520|NCT00381693|528741327|FG000|Overall Study|Adverse Event|4|||
146609521|NCT00381693|528741327|FG000|Overall Study|Patient Choice|1|||
146609522|NCT00381693|528741327|FG000|Overall Study|Progression|2|||
146609523|NCT02003534|528741330|FG000|Overall Study|Lost to Follow-up|47|||
146609524|NCT03920254|528741332|FG000|Overall Study|Adverse Event|1|||
146609525|NCT03920254|528741333|FG001|Overall Study|Adverse Event|0|||
146609526|NCT03920254|528741334|FG002|Overall Study|Adverse Event|0|||
146609527|NCT03920254|528741332|FG000|Overall Study|Physician Decision|0|||
146609528|NCT03920254|528741333|FG001|Overall Study|Physician Decision|1|||
146609529|NCT03920254|528741334|FG002|Overall Study|Physician Decision|2|||
146609530|NCT03920254|528741332|FG000|Overall Study|Study Terminated By Sponsor|12|||
146609531|NCT03920254|528741333|FG001|Overall Study|Study Terminated By Sponsor|17|||
146609532|NCT03920254|528741334|FG002|Overall Study|Study Terminated By Sponsor|12|||
146609533|NCT03920254|528741332|FG000|Overall Study|Withdrawal by Subject|0|||
146609534|NCT03920254|528741333|FG001|Overall Study|Withdrawal by Subject|0|||
146609535|NCT03920254|528741334|FG002|Overall Study|Withdrawal by Subject|1|||
146609536|NCT03040674|528741335|FG000|Overall Study|Lost to Follow-up|225|||
146609537|NCT03040674|528741335|FG000|Overall Study|Death|23|||
146609538|NCT05173012|528741336|FG000|Overall Study|Adverse Event|2|||
146609539|NCT05173012|528741337|FG001|Overall Study|Adverse Event|3|||
146609540|NCT05173012|528741338|FG002|Overall Study|Adverse Event|4|||
146609541|NCT05173012|528741339|FG003|Overall Study|Adverse Event|13|||
146609542|NCT05173012|528741340|FG004|Overall Study|Adverse Event|0|||
146609543|NCT05173012|528741341|FG005|Overall Study|Adverse Event|0|||
146609544|NCT05173012|528741342|FG006|Overall Study|Adverse Event|2|||
146609545|NCT05173012|528741343|FG007|Overall Study|Adverse Event|4|||
146609546|NCT05173012|528741336|FG000|Overall Study|Lost to Follow-up|0|||
146609547|NCT05173012|528741337|FG001|Overall Study|Lost to Follow-up|0|||
146609548|NCT05173012|528741338|FG002|Overall Study|Lost to Follow-up|0|||
146609549|NCT05173012|528741339|FG003|Overall Study|Lost to Follow-up|1|||
146609550|NCT05173012|528741340|FG004|Overall Study|Lost to Follow-up|0|||
146609551|NCT05173012|528741341|FG005|Overall Study|Lost to Follow-up|0|||
146609552|NCT05173012|528741342|FG006|Overall Study|Lost to Follow-up|0|||
146609553|NCT05173012|528741343|FG007|Overall Study|Lost to Follow-up|0|||
146609554|NCT05173012|528741336|FG000|Overall Study|Withdrawal by Subject|1|||
146609555|NCT05173012|528741337|FG001|Overall Study|Withdrawal by Subject|0|||
146609556|NCT05173012|528741338|FG002|Overall Study|Withdrawal by Subject|1|||
146609557|NCT05173012|528741339|FG003|Overall Study|Withdrawal by Subject|3|||
146609558|NCT05173012|528741340|FG004|Overall Study|Withdrawal by Subject|1|||
146609559|NCT05173012|528741341|FG005|Overall Study|Withdrawal by Subject|0|||
146609560|NCT05173012|528741342|FG006|Overall Study|Withdrawal by Subject|1|||
146609561|NCT05173012|528741343|FG007|Overall Study|Withdrawal by Subject|0|||
146609562|NCT05173012|528741336|FG000|Overall Study|Protocol Deviation|0|||
146609563|NCT05173012|528741337|FG001|Overall Study|Protocol Deviation|0|||
146609564|NCT05173012|528741338|FG002|Overall Study|Protocol Deviation|0|||
146657603|NCT00510874|528925175|FG004|Overall Study|Lost to Follow-up|4|||
146657604|NCT00510874|528925176|FG005|Overall Study|Lost to Follow-up|0|||
146657605|NCT00510874|528925177|FG006|Overall Study|Lost to Follow-up|1|||
146657606|NCT00397943|528925183|FG000|Overall Study|Unspecified reasons|12|||
146657607|NCT00397943|528925184|FG001|Overall Study|Unspecified reasons|9|||
146657608|NCT00397943|528925185|FG002|Overall Study|Unspecified reasons|0|||
146657609|NCT00397943|528925186|FG003|Overall Study|Unspecified reasons|0|||
146657610|NCT00397943|528925187|FG004|Overall Study|Unspecified reasons|0|||
146657611|NCT02806973|528925190|FG000|Period 1|Withdrawal by Subject|0|||
146657612|NCT02806973|528925191|FG001|Period 1|Withdrawal by Subject|2|||
146657613|NCT02806973|528925192|FG002|Period 1|Withdrawal by Subject|1|||
146657614|NCT02806973|528925193|FG003|Period 1|Withdrawal by Subject|1|||
146657615|NCT02806973|528925190|FG000|Period 1|Adverse Event|0|||
146657616|NCT02806973|528925191|FG001|Period 1|Adverse Event|0|||
146657617|NCT02806973|528925192|FG002|Period 1|Adverse Event|0|||
146657618|NCT02806973|528925193|FG003|Period 1|Adverse Event|1|||
146657619|NCT02806973|528925190|FG000|Period 3|Withdrawal by Subject|0|||
146657620|NCT02806973|528925191|FG001|Period 3|Withdrawal by Subject|0|||
146657621|NCT02806973|528925192|FG002|Period 3|Withdrawal by Subject|0|||
146657622|NCT02806973|528925193|FG003|Period 3|Withdrawal by Subject|3|||
146657623|NCT02806973|528925190|FG000|Period 3|Adverse Event|0|||
146657624|NCT02806973|528925191|FG001|Period 3|Adverse Event|0|||
146657625|NCT02806973|528925192|FG002|Period 3|Adverse Event|1|||
146657626|NCT02806973|528925193|FG003|Period 3|Adverse Event|0|||
146609565|NCT05173012|528741339|FG003|Overall Study|Protocol Deviation|1|||
146609566|NCT05173012|528741340|FG004|Overall Study|Protocol Deviation|0|||
146609567|NCT05173012|528741341|FG005|Overall Study|Protocol Deviation|0|||
146609568|NCT05173012|528741342|FG006|Overall Study|Protocol Deviation|0|||
146609569|NCT05173012|528741343|FG007|Overall Study|Protocol Deviation|0|||
146609570|NCT05173012|528741336|FG000|Overall Study|Other|0|||
146609571|NCT05173012|528741337|FG001|Overall Study|Other|0|||
146609572|NCT05173012|528741338|FG002|Overall Study|Other|0|||
146609573|NCT05173012|528741339|FG003|Overall Study|Other|2|||
146609574|NCT05173012|528741340|FG004|Overall Study|Other|0|||
146609575|NCT05173012|528741341|FG005|Overall Study|Other|0|||
146609576|NCT05173012|528741342|FG006|Overall Study|Other|0|||
146609577|NCT05173012|528741343|FG007|Overall Study|Other|0|||
146609578|NCT00517361|528741344|FG000|Overall Study|Death|6|||
146609579|NCT00517361|528741344|FG000|Overall Study|The study was terminated|5|||
146609580|NCT03517228|528741348|FG000|Overall Study|Withdrawal by Subject|2|||
146609581|NCT03517228|528741348|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
146609582|NCT03517228|528741348|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
146609583|NCT03517228|528741348|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
146609584|NCT03517228|528741348|FG000|Overall Study|Canceled due to device being updated|1|||
146609585|NCT03517228|528741348|FG000|Overall Study|No V Cares in stock|1|||
146609586|NCT03517228|528741348|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
146609587|NCT03781414|528741353|FG000|Overall Study|Study terminated by sponsor|39|||
146609588|NCT03781414|528741354|FG001|Overall Study|Study terminated by sponsor|34|||
146609589|NCT03781414|528741355|FG002|Overall Study|Study terminated by sponsor|25|||
146609590|NCT03781414|528741353|FG000|Overall Study|Adverse Event|3|||
146609591|NCT03781414|528741354|FG001|Overall Study|Adverse Event|6|||
146609592|NCT03781414|528741355|FG002|Overall Study|Adverse Event|3|||
146609593|NCT03781414|528741353|FG000|Overall Study|Physician Decision|2|||
146609594|NCT03781414|528741354|FG001|Overall Study|Physician Decision|0|||
146609595|NCT03781414|528741355|FG002|Overall Study|Physician Decision|1|||
146609596|NCT03781414|528741353|FG000|Overall Study|Withdrawal by Subject|2|||
146657627|NCT04209426|528925196|FG000|Overall Study|Lost to Follow-up|3|||
146657628|NCT04209426|528925197|FG001|Overall Study|Lost to Follow-up|2|||
146657629|NCT01751802|528925203|FG000|Overall Study|Adverse Event|4|||
146657630|NCT01751802|528925204|FG001|Overall Study|Adverse Event|2|||
146657631|NCT00521001|528925206|FG000|Overall Study|Ineligible|1|||
146657632|NCT02821910|528925207|FG000|Overall Study|Withdrawal by Subject|0|||
146657633|NCT02821910|528925208|FG001|Overall Study|Withdrawal by Subject|0|||
146657634|NCT02821910|528925209|FG002|Overall Study|Withdrawal by Subject|1|||
146609597|NCT03781414|528741354|FG001|Overall Study|Withdrawal by Subject|3|||
146657635|NCT02821910|528925210|FG003|Overall Study|Withdrawal by Subject|0|||
146657636|NCT02821910|528925211|FG004|Overall Study|Withdrawal by Subject|0|||
146657637|NCT02821910|528925212|FG005|Overall Study|Withdrawal by Subject|1|||
146657638|NCT02821910|528925207|FG000|Overall Study|Other than specified|1|||
146657639|NCT02821910|528925208|FG001|Overall Study|Other than specified|0|||
146657640|NCT02821910|528925209|FG002|Overall Study|Other than specified|1|||
146609598|NCT03781414|528741355|FG002|Overall Study|Withdrawal by Subject|3|||
146609599|NCT03781414|528741353|FG000|Overall Study|Death|1|||
146609600|NCT03781414|528741354|FG001|Overall Study|Death|4|||
146609601|NCT03781414|528741355|FG002|Overall Study|Death|0|||
146609602|NCT03781414|528741353|FG000|Overall Study|Lost to Follow-up|1|||
146657641|NCT02821910|528925210|FG003|Overall Study|Other than specified|0|||
146657642|NCT02821910|528925211|FG004|Overall Study|Other than specified|0|||
146657643|NCT02821910|528925212|FG005|Overall Study|Other than specified|0|||
146657644|NCT00900601|528925213|FG000|Overall Study|Physician Decision|1|||
146609603|NCT03781414|528741354|FG001|Overall Study|Lost to Follow-up|1|||
146609604|NCT03781414|528741355|FG002|Overall Study|Lost to Follow-up|0|||
146609605|NCT04752358|528741358|FG000|Overall Study|Death|2|||
146609606|NCT04752358|528741359|FG001|Overall Study|Death|1|||
146609607|NCT00719355|528741360|FG000|Overall Study|Death|0|||
146609608|NCT00719355|528741361|FG001|Overall Study|Death|1|||
146609609|NCT00719355|528741360|FG000|Overall Study|Medical|14|||
146609610|NCT00719355|528741361|FG001|Overall Study|Medical|5|||
146609611|NCT00719355|528741360|FG000|Overall Study|Compliance|4|||
146609612|NCT00719355|528741361|FG001|Overall Study|Compliance|6|||
146609613|NCT00719355|528741360|FG000|Overall Study|Moved|0|||
146609614|NCT00719355|528741361|FG001|Overall Study|Moved|1|||
146609615|NCT01824355|528741362|FG000|Overall Study|Adverse Event|2|||
146609616|NCT01824355|528741362|FG000|Overall Study|unevaluable reference method results per|1|||
146609617|NCT00836186|528741366|FG000|Overall Study|Blood could not be drawn|1|||
146609618|NCT05232864|528741372|FG000|Overall Study|Adverse Event|0|||
146609619|NCT05232864|528741373|FG001|Overall Study|Adverse Event|1|||
146609620|NCT05232864|528741372|FG000|Overall Study|Study terminated by sponsor|16|||
146609621|NCT05232864|528741373|FG001|Overall Study|Study terminated by sponsor|14|||
146609622|NCT02023996|528741374|FG000|Overall Study|Protocol Violation|6|||
146609623|NCT01496846|528741382|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
146609624|NCT01496846|528741383|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
146609625|NCT01496846|528741384|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
146609626|NCT01496846|528741385|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
146609627|NCT01496846|528741386|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
146609628|NCT01496846|528741387|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
146609629|NCT01772576|528741388|FG000|Overall Study|Death|15|||
146609630|NCT01772576|528741388|FG000|Overall Study|Protocol Violation|1|||
146609631|NCT01772576|528741388|FG000|Overall Study|Lost to Follow-up|3|||
146609632|NCT01772576|528741388|FG000|Overall Study|Study device not used|3|||
146609633|NCT01772576|528741388|FG000|Overall Study|Adverse Event|6|||
146609634|NCT01772576|528741388|FG000|Overall Study|Withdrawal by Subject|6|||
146609635|NCT00923845|528741389|FG000|Induction Therapy|Poor performance status|0|||
146609636|NCT00923845|528741390|FG001|Induction Therapy|Poor performance status|2|||
146609637|NCT00379912|528741392|FG000|Overall Study|Lack of Efficacy|1|||
146609638|NCT00379912|528741393|FG001|Overall Study|Lack of Efficacy|0|||
146609639|NCT02578186|528741394|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
146609640|NCT02578186|528741395|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
146609641|NCT02578186|528741394|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
146609642|NCT02578186|528741395|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
146609643|NCT02873338|528741396|FG000|Overall Study|Adverse Event|0|||
146609644|NCT02873338|528741397|FG001|Overall Study|Adverse Event|2|||
146609645|NCT02873338|528741398|FG002|Overall Study|Adverse Event|1|||
146609646|NCT02873338|528741396|FG000|Overall Study|Death|2|||
146609647|NCT02873338|528741397|FG001|Overall Study|Death|1|||
146609648|NCT02873338|528741398|FG002|Overall Study|Death|1|||
146609649|NCT02873338|528741396|FG000|Overall Study|Withdrawal by Subject|2|||
146609650|NCT02873338|528741397|FG001|Overall Study|Withdrawal by Subject|1|||
146609651|NCT02873338|528741398|FG002|Overall Study|Withdrawal by Subject|3|||
146609652|NCT02873338|528741396|FG000|Overall Study|Lack of Efficacy|0|||
146609653|NCT02873338|528741397|FG001|Overall Study|Lack of Efficacy|2|||
146609654|NCT02873338|528741398|FG002|Overall Study|Lack of Efficacy|0|||
146609655|NCT02873338|528741396|FG000|Overall Study|Other or Missing|14|||
146609656|NCT02873338|528741397|FG001|Overall Study|Other or Missing|15|||
146609657|NCT02873338|528741398|FG002|Overall Study|Other or Missing|13|||
146609658|NCT02038075|528741399|FG000|Overall Study|Withdrawal by Subject|3|||
146609659|NCT02038075|528741400|FG001|Overall Study|Withdrawal by Subject|0|||
146609660|NCT04000581|528741401|FG000|Overall Study|Withdrawal by Subject|0|||
146609661|NCT04000581|528741402|FG001|Overall Study|Withdrawal by Subject|1|||
146609662|NCT03477838|528741403|FG000|Overall Study|Lost to Follow-up|14|||
146609663|NCT02519595|528741405|FG000|Overall Study|Protocol Violation|8|||
146609664|NCT02519595|528741406|FG001|Overall Study|Protocol Violation|22|||
146609665|NCT02519595|528741407|FG002|Overall Study|Protocol Violation|16|||
146609666|NCT00850538|528741408|FG000|Overall Study|unable/unwilling to complete MRI|13|||
146609667|NCT00850538|528741408|FG000|Overall Study|specimen missed due to scheduling error|14|||
146609668|NCT00850538|528741408|FG000|Overall Study|specimen unusable|7|||
146609669|NCT00850538|528741408|FG000|Overall Study|Withdrawal by Subject|3|||
146609670|NCT00850538|528741408|FG000|Overall Study|radiology error|2|||
146609671|NCT00850538|528741408|FG000|Overall Study|Protocol Violation|2|||
146609672|NCT03188510|528741411|FG000|Overall Study|Inappropriate behavior with site staff|0|||
146609673|NCT03188510|528741412|FG001|Overall Study|Inappropriate behavior with site staff|1|||
146609674|NCT03188510|528741413|FG002|Overall Study|Inappropriate behavior with site staff|0|||
146609675|NCT01088399|528741420|FG000|Overall Study|Adverse Event|211|||
146609676|NCT01088399|528741421|FG001|Overall Study|Adverse Event|16|||
146609677|NCT01088399|528741422|FG002|Overall Study|Adverse Event|0|||
146657645|NCT01082640|528925214|FG000|Overall Study|Adverse Event|9|||
146609678|NCT01088399|528741420|FG000|Overall Study|Death|204|||
146609679|NCT01088399|528741421|FG001|Overall Study|Death|45|||
146609680|NCT01088399|528741422|FG002|Overall Study|Death|0|||
146609681|NCT01088399|528741420|FG000|Overall Study|Lack of Efficacy|298|||
146609682|NCT01088399|528741421|FG001|Overall Study|Lack of Efficacy|7|||
146609683|NCT01088399|528741422|FG002|Overall Study|Lack of Efficacy|5|||
146609684|NCT01088399|528741420|FG000|Overall Study|Lost to Follow-up|1070|||
146609685|NCT01088399|528741421|FG001|Overall Study|Lost to Follow-up|278|||
146609686|NCT01088399|528741422|FG002|Overall Study|Lost to Follow-up|58|||
146609687|NCT01088399|528741420|FG000|Overall Study|Physician Decision|531|||
146609688|NCT01088399|528741421|FG001|Overall Study|Physician Decision|88|||
146609689|NCT01088399|528741422|FG002|Overall Study|Physician Decision|16|||
146609690|NCT01088399|528741420|FG000|Overall Study|Withdrawal by Subject|544|||
146609691|NCT01088399|528741421|FG001|Overall Study|Withdrawal by Subject|195|||
146609692|NCT01088399|528741422|FG002|Overall Study|Withdrawal by Subject|33|||
146609693|NCT01088399|528741420|FG000|Overall Study|Change to or start of somatropin therapy|234|||
146609694|NCT01088399|528741421|FG001|Overall Study|Change to or start of somatropin therapy|17|||
146609695|NCT01088399|528741422|FG002|Overall Study|Change to or start of somatropin therapy|12|||
146609696|NCT01088399|528741420|FG000|Overall Study|Sponsor decision|1573|||
146609697|NCT01088399|528741421|FG001|Overall Study|Sponsor decision|298|||
146609698|NCT01088399|528741422|FG002|Overall Study|Sponsor decision|7|||
146609699|NCT01088399|528741420|FG000|Overall Study|Protocol Violation|10|||
146609700|NCT01088399|528741421|FG001|Overall Study|Protocol Violation|1|||
146609701|NCT01088399|528741422|FG002|Overall Study|Protocol Violation|0|||
146609702|NCT01088399|528741420|FG000|Overall Study|Enrollment criteria not met|48|||
146609703|NCT01088399|528741421|FG001|Overall Study|Enrollment criteria not met|119|||
146609704|NCT01088399|528741422|FG002|Overall Study|Enrollment criteria not met|70|||
146609705|NCT01088399|528741420|FG000|Overall Study|Study summary visit not completed|2398|||
146609706|NCT01088399|528741421|FG001|Overall Study|Study summary visit not completed|283|||
146609707|NCT01088399|528741422|FG002|Overall Study|Study summary visit not completed|80|||
146609708|NCT01748825|528741426|FG000|Dose Escalation|Refused further treatment|2|||
146609709|NCT01748825|528741427|FG001|Dose Escalation|Refused further treatment|2|||
146609710|NCT01748825|528741428|FG002|Dose Escalation|Refused further treatment|0|||
146609711|NCT01748825|528741429|FG003|Dose Escalation|Refused further treatment|0|||
146609712|NCT01748825|528741430|FG004|Dose Escalation|Refused further treatment|1|||
146609713|NCT01748825|528741431|FG005|Dose Escalation|Refused further treatment|2|||
146609714|NCT01748825|528741432|FG006|Dose Escalation|Refused further treatment|0|||
146609715|NCT01748825|528741433|FG007|Dose Escalation|Refused further treatment|0|||
146609716|NCT01748825|528741434|FG008|Dose Escalation|Refused further treatment|0|||
146609717|NCT01748825|528741435|FG009|Dose Escalation|Refused further treatment|0|||
146609718|NCT01748825|528741426|FG000|Dose Escalation|Switched to alternative treatment|0|||
146609719|NCT01748825|528741427|FG001|Dose Escalation|Switched to alternative treatment|0|||
146609720|NCT01748825|528741428|FG002|Dose Escalation|Switched to alternative treatment|0|||
146609721|NCT01748825|528741429|FG003|Dose Escalation|Switched to alternative treatment|1|||
146609722|NCT01748825|528741430|FG004|Dose Escalation|Switched to alternative treatment|0|||
146609723|NCT01748825|528741431|FG005|Dose Escalation|Switched to alternative treatment|0|||
146609724|NCT01748825|528741432|FG006|Dose Escalation|Switched to alternative treatment|0|||
146609725|NCT01748825|528741433|FG007|Dose Escalation|Switched to alternative treatment|0|||
146609726|NCT01748825|528741434|FG008|Dose Escalation|Switched to alternative treatment|0|||
146609727|NCT01748825|528741435|FG009|Dose Escalation|Switched to alternative treatment|0|||
146609728|NCT01748825|528741426|FG000|Dose Escalation|Adverse Event|0|||
146609729|NCT01748825|528741427|FG001|Dose Escalation|Adverse Event|0|||
146609730|NCT01748825|528741428|FG002|Dose Escalation|Adverse Event|0|||
146609731|NCT01748825|528741429|FG003|Dose Escalation|Adverse Event|0|||
146609732|NCT01748825|528741430|FG004|Dose Escalation|Adverse Event|0|||
146609733|NCT01748825|528741431|FG005|Dose Escalation|Adverse Event|0|||
146609734|NCT01748825|528741432|FG006|Dose Escalation|Adverse Event|1|||
146609735|NCT01748825|528741433|FG007|Dose Escalation|Adverse Event|0|||
146609736|NCT01748825|528741434|FG008|Dose Escalation|Adverse Event|0|||
146609737|NCT01748825|528741435|FG009|Dose Escalation|Adverse Event|0|||
146609738|NCT01748825|528741426|FG000|Dose Expansion|Refused further treatment|0|||
146609739|NCT01748825|528741427|FG001|Dose Expansion|Refused further treatment|0|||
146609740|NCT01748825|528741428|FG002|Dose Expansion|Refused further treatment|0|||
146609741|NCT01748825|528741429|FG003|Dose Expansion|Refused further treatment|0|||
146609742|NCT01748825|528741430|FG004|Dose Expansion|Refused further treatment|0|||
146609743|NCT01748825|528741431|FG005|Dose Expansion|Refused further treatment|0|||
146609744|NCT01748825|528741432|FG006|Dose Expansion|Refused further treatment|0|||
146609745|NCT01748825|528741433|FG007|Dose Expansion|Refused further treatment|0|||
146609746|NCT01748825|528741434|FG008|Dose Expansion|Refused further treatment|1|||
146609747|NCT01748825|528741435|FG009|Dose Expansion|Refused further treatment|1|||
146609748|NCT01748825|528741426|FG000|Dose Expansion|Switched to alternative treatment|0|||
146609749|NCT01748825|528741427|FG001|Dose Expansion|Switched to alternative treatment|0|||
146609750|NCT01748825|528741428|FG002|Dose Expansion|Switched to alternative treatment|0|||
146609751|NCT01748825|528741429|FG003|Dose Expansion|Switched to alternative treatment|0|||
146609752|NCT01748825|528741430|FG004|Dose Expansion|Switched to alternative treatment|0|||
146609753|NCT01748825|528741431|FG005|Dose Expansion|Switched to alternative treatment|0|||
146609754|NCT01748825|528741432|FG006|Dose Expansion|Switched to alternative treatment|0|||
146609755|NCT01748825|528741433|FG007|Dose Expansion|Switched to alternative treatment|0|||
146609756|NCT01748825|528741434|FG008|Dose Expansion|Switched to alternative treatment|0|||
146609757|NCT01748825|528741435|FG009|Dose Expansion|Switched to alternative treatment|1|||
146609758|NCT01748825|528741426|FG000|Dose Expansion|Adverse Event|0|||
146609759|NCT01748825|528741427|FG001|Dose Expansion|Adverse Event|0|||
146609760|NCT01748825|528741428|FG002|Dose Expansion|Adverse Event|0|||
146609761|NCT01748825|528741429|FG003|Dose Expansion|Adverse Event|0|||
146609762|NCT01748825|528741430|FG004|Dose Expansion|Adverse Event|0|||
146609763|NCT01748825|528741431|FG005|Dose Expansion|Adverse Event|0|||
146609764|NCT01748825|528741432|FG006|Dose Expansion|Adverse Event|0|||
146609765|NCT01748825|528741433|FG007|Dose Expansion|Adverse Event|0|||
146609766|NCT01748825|528741434|FG008|Dose Expansion|Adverse Event|0|||
146609767|NCT01748825|528741435|FG009|Dose Expansion|Adverse Event|3|||
146609768|NCT01748825|528741426|FG000|Dose Expansion|Physician Decision|0|||
146609769|NCT01748825|528741427|FG001|Dose Expansion|Physician Decision|0|||
146609770|NCT01748825|528741428|FG002|Dose Expansion|Physician Decision|0|||
146609771|NCT01748825|528741429|FG003|Dose Expansion|Physician Decision|0|||
146609772|NCT01748825|528741430|FG004|Dose Expansion|Physician Decision|0|||
146609773|NCT01748825|528741431|FG005|Dose Expansion|Physician Decision|0|||
146609774|NCT01748825|528741432|FG006|Dose Expansion|Physician Decision|0|||
146609775|NCT01748825|528741433|FG007|Dose Expansion|Physician Decision|0|||
146609776|NCT01748825|528741434|FG008|Dose Expansion|Physician Decision|1|||
146609777|NCT01748825|528741435|FG009|Dose Expansion|Physician Decision|0|||
146609778|NCT02921087|528741436|FG000|Overall Study|Withdrawal by Subject|0|||
146609779|NCT02921087|528741437|FG001|Overall Study|Withdrawal by Subject|1|||
146609780|NCT00852241|528741438|FG000|Overall Study|Physician Decision|18|||
146609781|NCT00619307|528741440|FG000|Overall Study|Adverse Event|0|||
146609782|NCT00619307|528741441|FG001|Overall Study|Adverse Event|1|||
146609783|NCT00619307|528741440|FG000|Overall Study|Lost to Follow-up|0|||
146609784|NCT00619307|528741441|FG001|Overall Study|Lost to Follow-up|1|||
146609785|NCT00619307|528741440|FG000|Overall Study|Protocol Violation|3|||
146609786|NCT00619307|528741441|FG001|Overall Study|Protocol Violation|0|||
146609787|NCT00619307|528741440|FG000|Overall Study|Withdrew consent|1|||
146609788|NCT00619307|528741441|FG001|Overall Study|Withdrew consent|0|||
146609789|NCT00619307|528741440|FG000|Overall Study|Severe migraine|0|||
146609790|NCT00619307|528741441|FG001|Overall Study|Severe migraine|1|||
146609791|NCT00619307|528741440|FG000|Overall Study|MS attack plus steroids|0|||
146609792|NCT00619307|528741441|FG001|Overall Study|MS attack plus steroids|1|||
146609793|NCT00118430|528741444|FG000|Overall Study|Withdrawal by Subject|6|||
146609794|NCT00118430|528741445|FG001|Overall Study|Withdrawal by Subject|2|||
146609795|NCT00118430|528741446|FG002|Overall Study|Withdrawal by Subject|0|||
146609796|NCT00118430|528741444|FG000|Overall Study|Lost to Follow-up|15|||
146609797|NCT00118430|528741445|FG001|Overall Study|Lost to Follow-up|22|||
146609798|NCT00118430|528741446|FG002|Overall Study|Lost to Follow-up|28|||
146609799|NCT02147288|528741447|FG000|Overall Study|post-operative hematoma|1|||
146609800|NCT02147288|528741448|FG001|Overall Study|post-operative hematoma|1|||
146609801|NCT02147288|528741449|FG002|Overall Study|post-operative hematoma|0|||
146609802|NCT02147288|528741450|FG003|Overall Study|post-operative hematoma|0|||
146609803|NCT02147288|528741451|FG004|Overall Study|post-operative hematoma|0|||
146609804|NCT02147288|528741452|FG005|Overall Study|post-operative hematoma|0|||
146609805|NCT02147288|528741453|FG006|Overall Study|post-operative hematoma|0|||
146609806|NCT02147288|528741454|FG007|Overall Study|post-operative hematoma|0|||
146609807|NCT02147288|528741455|FG008|Overall Study|post-operative hematoma|0|||
146609808|NCT02147288|528741456|FG009|Overall Study|post-operative hematoma|0|||
146609809|NCT02147288|528741447|FG000|Overall Study|complications from concurrent hernia rep|0|||
146609810|NCT02147288|528741448|FG001|Overall Study|complications from concurrent hernia rep|1|||
146609811|NCT02147288|528741449|FG002|Overall Study|complications from concurrent hernia rep|0|||
146609812|NCT02147288|528741450|FG003|Overall Study|complications from concurrent hernia rep|0|||
146609813|NCT02147288|528741451|FG004|Overall Study|complications from concurrent hernia rep|0|||
146657646|NCT01082640|528925215|FG001|Overall Study|Adverse Event|5|||
146657647|NCT01082640|528925216|FG002|Overall Study|Adverse Event|3|||
146609814|NCT02147288|528741452|FG005|Overall Study|complications from concurrent hernia rep|0|||
146609815|NCT02147288|528741453|FG006|Overall Study|complications from concurrent hernia rep|0|||
146609816|NCT02147288|528741454|FG007|Overall Study|complications from concurrent hernia rep|0|||
146609817|NCT02147288|528741455|FG008|Overall Study|complications from concurrent hernia rep|0|||
146609818|NCT02147288|528741456|FG009|Overall Study|complications from concurrent hernia rep|0|||
146609819|NCT02069392|528741459|FG000|Overall Study|Withdrawal by Subject|4|||
146609820|NCT02069392|528741460|FG001|Overall Study|Withdrawal by Subject|2|||
146609821|NCT00269633|528741461|FG000|Overall Study|Withdrawal by Subject|1|||
146609822|NCT00269633|528741462|FG001|Overall Study|Withdrawal by Subject|0|||
146609823|NCT04412707|528741463|FG000|Cycle 1|Death|0|||
146609824|NCT04412707|528741464|FG001|Cycle 1|Death|3|||
146609825|NCT04412707|528741463|FG000|Cycle 1|Disease progression|1|||
146609826|NCT04412707|528741464|FG001|Cycle 1|Disease progression|2|||
146609827|NCT04412707|528741463|FG000|Cycle 2|Death|0|||
146609828|NCT04412707|528741464|FG001|Cycle 2|Death|1|||
146609829|NCT04412707|528741463|FG000|Cycle 2|Disease progression|3|||
146609830|NCT04412707|528741464|FG001|Cycle 2|Disease progression|0|||
146609831|NCT04412707|528741463|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
146609832|NCT04412707|528741464|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
146609833|NCT04412707|528741463|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
146609834|NCT04412707|528741464|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
146609835|NCT04412707|528741463|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
146609836|NCT04412707|528741464|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
146609837|NCT04412707|528741463|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
146609838|NCT04412707|528741464|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
146609839|NCT02927938|528741465|FG000|Overall Study|Death|0|||
146609840|NCT02927938|528741466|FG001|Overall Study|Death|1|||
146609841|NCT02927938|528741467|FG002|Overall Study|Death|0|||
146609842|NCT02927938|528741468|FG003|Overall Study|Death|4|||
146609843|NCT02927938|528741465|FG000|Overall Study|Early Study Termination|1|||
146609844|NCT02927938|528741466|FG001|Overall Study|Early Study Termination|5|||
146609845|NCT02927938|528741467|FG002|Overall Study|Early Study Termination|4|||
146609846|NCT02927938|528741468|FG003|Overall Study|Early Study Termination|3|||
146609847|NCT01504412|528743010|FG000|Overall Study|Adverse Event|1|||
146609848|NCT01504412|528743011|FG001|Overall Study|Adverse Event|8|||
146609849|NCT01504412|528743012|FG002|Overall Study|Adverse Event|1|||
146609850|NCT01504412|528743013|FG003|Overall Study|Adverse Event|7|||
146609851|NCT01504412|528743014|FG004|Overall Study|Adverse Event|10|||
146609852|NCT01504412|528743010|FG000|Overall Study|Withdrawal by Subject|2|||
146609853|NCT01504412|528743011|FG001|Overall Study|Withdrawal by Subject|1|||
146609854|NCT01504412|528743012|FG002|Overall Study|Withdrawal by Subject|1|||
146923013|NCT02695524|529878721|FG001|Overall Study|Lost to Follow-up|2|||
146609855|NCT01504412|528743013|FG003|Overall Study|Withdrawal by Subject|5|||
146609856|NCT01504412|528743014|FG004|Overall Study|Withdrawal by Subject|1|||
146609857|NCT01504412|528743010|FG000|Overall Study|Other|2|||
146609858|NCT01504412|528743011|FG001|Overall Study|Other|1|||
146609859|NCT01504412|528743012|FG002|Overall Study|Other|1|||
146609860|NCT01504412|528743013|FG003|Overall Study|Other|6|||
146609861|NCT01504412|528743014|FG004|Overall Study|Other|1|||
146609862|NCT01504412|528743010|FG000|Overall Study|Lost to Follow-up|0|||
146609863|NCT01504412|528743011|FG001|Overall Study|Lost to Follow-up|2|||
146609864|NCT01504412|528743012|FG002|Overall Study|Lost to Follow-up|0|||
146609865|NCT01504412|528743013|FG003|Overall Study|Lost to Follow-up|0|||
146609866|NCT01504412|528743014|FG004|Overall Study|Lost to Follow-up|0|||
146609867|NCT01504412|528743010|FG000|Overall Study|Lack of Efficacy|0|||
146609868|NCT01504412|528743011|FG001|Overall Study|Lack of Efficacy|0|||
146609869|NCT01504412|528743012|FG002|Overall Study|Lack of Efficacy|1|||
146609870|NCT01504412|528743013|FG003|Overall Study|Lack of Efficacy|0|||
146609871|NCT01504412|528743014|FG004|Overall Study|Lack of Efficacy|1|||
146609872|NCT01504412|528743010|FG000|Overall Study|Death|0|||
146609873|NCT01504412|528743011|FG001|Overall Study|Death|0|||
146609874|NCT01504412|528743012|FG002|Overall Study|Death|0|||
146609875|NCT01504412|528743013|FG003|Overall Study|Death|1|||
146609876|NCT01504412|528743014|FG004|Overall Study|Death|0|||
146609877|NCT02598297|528743032|FG000|Overall Study|Study terminated by Sponsor|21|||
146609878|NCT02598297|528743033|FG001|Overall Study|Study terminated by Sponsor|23|||
146609879|NCT02598297|528743032|FG000|Overall Study|Adverse Event|1|||
146609880|NCT02598297|528743033|FG001|Overall Study|Adverse Event|1|||
146609881|NCT02598297|528743032|FG000|Overall Study|Physician Decision|1|||
146609882|NCT02598297|528743033|FG001|Overall Study|Physician Decision|0|||
146609883|NCT02598297|528743032|FG000|Overall Study|Subject/guardian decision|1|||
146657648|NCT01082640|528925214|FG000|Overall Study|Withdrawal by Subject|3|||
146657649|NCT01082640|528925215|FG001|Overall Study|Withdrawal by Subject|3|||
146657650|NCT01082640|528925216|FG002|Overall Study|Withdrawal by Subject|2|||
146657651|NCT01082640|528925214|FG000|Overall Study|Major protocol deviation|3|||
146657652|NCT01082640|528925215|FG001|Overall Study|Major protocol deviation|3|||
146657653|NCT01082640|528925216|FG002|Overall Study|Major protocol deviation|0|||
146657654|NCT01082640|528925214|FG000|Overall Study|Lost to Follow-up|0|||
146773281|NCT03144674|529339547|FG001|Overall Study|Histological Criteria Not Met|0|||
146923014|NCT02695524|529878720|FG000|Overall Study|Death|0|||
146609884|NCT02598297|528743033|FG001|Overall Study|Subject/guardian decision|0|||
146609885|NCT02598297|528743032|FG000|Overall Study|Followed for survival|1|||
146609886|NCT02598297|528743033|FG001|Overall Study|Followed for survival|0|||
146609887|NCT01934010|528743043|FG000|Overall Study|Adverse Event|1|||
146609888|NCT01934010|528743044|FG001|Overall Study|Adverse Event|1|||
146609889|NCT01934010|528743045|FG002|Overall Study|Adverse Event|0|||
146609890|NCT01934010|528743043|FG000|Overall Study|Withdrawal by Subject|15|||
146609891|NCT01934010|528743044|FG001|Overall Study|Withdrawal by Subject|6|||
146609892|NCT01934010|528743045|FG002|Overall Study|Withdrawal by Subject|2|||
146609893|NCT01934010|528743043|FG000|Overall Study|Lost to Follow-up|7|||
146609894|NCT01934010|528743044|FG001|Overall Study|Lost to Follow-up|4|||
146609895|NCT01934010|528743045|FG002|Overall Study|Lost to Follow-up|0|||
146609896|NCT01393821|528743046|FG000|Overall Study|Cancel|1|||
146657655|NCT01082640|528925215|FG001|Overall Study|Lost to Follow-up|3|||
146609897|NCT01393821|528743047|FG001|Overall Study|Cancel|1|||
146609898|NCT01393821|528743046|FG000|Overall Study|not evaluable for primary endpoint|4|||
146609899|NCT01393821|528743047|FG001|Overall Study|not evaluable for primary endpoint|2|||
146609900|NCT00377858|528743058|FG000|Overall Study|Withdrawal by Subject|12|||
146609901|NCT00377858|528743059|FG001|Overall Study|Withdrawal by Subject|11|||
146609902|NCT00377858|528743058|FG000|Overall Study|Lost to Follow-up|6|||
146609903|NCT00377858|528743059|FG001|Overall Study|Lost to Follow-up|1|||
146609904|NCT00377858|528743058|FG000|Overall Study|Physician Decision|5|||
146609905|NCT00377858|528743059|FG001|Overall Study|Physician Decision|5|||
146609906|NCT00377858|528743058|FG000|Overall Study|Protocol Violation|3|||
146609907|NCT00377858|528743059|FG001|Overall Study|Protocol Violation|4|||
146609908|NCT00377858|528743058|FG000|Overall Study|Adverse Event|2|||
146609909|NCT00377858|528743059|FG001|Overall Study|Adverse Event|1|||
146609910|NCT00377858|528743058|FG000|Overall Study|Entry Criteria Not Met|2|||
146609911|NCT00377858|528743059|FG001|Overall Study|Entry Criteria Not Met|0|||
146609912|NCT00377858|528743058|FG000|Overall Study|Sponsor Decision|1|||
146609913|NCT00377858|528743059|FG001|Overall Study|Sponsor Decision|2|||
146609914|NCT00377858|528743058|FG000|Overall Study|Death|0|||
146609915|NCT00377858|528743059|FG001|Overall Study|Death|3|||
146609916|NCT03534141|528743060|FG000|Overall Study|Enrolled in other clinical trial|1|||
146609917|NCT03534141|528743061|FG001|Overall Study|Enrolled in other clinical trial|0|||
146609918|NCT03534141|528743060|FG000|Overall Study|Liver transplant aborted after randomization|0|||
146609919|NCT03534141|528743061|FG001|Overall Study|Liver transplant aborted after randomization|2|||
146609920|NCT03534141|528743060|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
146609921|NCT03534141|528743061|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
146609922|NCT04303572|528743062|FG000|Overall Study|Study closed due to poor enrollment|1|||
146609923|NCT06312592|528743063|FG000|Overall Study|Lost to Follow-up|29|||
146609924|NCT06312592|528743064|FG001|Overall Study|Lost to Follow-up|13|||
146609925|NCT03785405|528743067|FG000|Overall Study|Adverse Event|16|||
146609926|NCT03785405|528743068|FG001|Overall Study|Adverse Event|1|||
146609927|NCT03785405|528743067|FG000|Overall Study|Death|6|||
146609928|NCT03785405|528743068|FG001|Overall Study|Death|4|||
146609929|NCT03785405|528743067|FG000|Overall Study|Guardian decision|4|||
146609930|NCT03785405|528743068|FG001|Overall Study|Guardian decision|1|||
146609931|NCT03785405|528743067|FG000|Overall Study|Lost to Follow-up|1|||
146609932|NCT03785405|528743068|FG001|Overall Study|Lost to Follow-up|0|||
146609933|NCT03785405|528743067|FG000|Overall Study|Physician Decision|8|||
146609934|NCT03785405|528743068|FG001|Overall Study|Physician Decision|5|||
146609935|NCT03785405|528743067|FG000|Overall Study|Participant decision|2|||
146609936|NCT03785405|528743068|FG001|Overall Study|Participant decision|0|||
146609937|NCT03785405|528743067|FG000|Overall Study|Other|1|||
146609938|NCT03785405|528743068|FG001|Overall Study|Other|0|||
146609939|NCT03785405|528743067|FG000|Overall Study|No treatment was received|0|||
146609940|NCT03785405|528743068|FG001|Overall Study|No treatment was received|1|||
146609941|NCT01948063|528743069|FG000|Overall Study|Boston MCI halted research protocol|0|||
146609942|NCT01948063|528743070|FG001|Overall Study|Boston MCI halted research protocol|1|||
146609943|NCT01948063|528743069|FG000|Overall Study|Discovered an enrollment in other study|0|||
146609944|NCT01948063|528743070|FG001|Overall Study|Discovered an enrollment in other study|1|||
146609945|NCT01948063|528743069|FG000|Overall Study|Blood samples were accidentally thawed|1|||
146609946|NCT01948063|528743070|FG001|Overall Study|Blood samples were accidentally thawed|0|||
146609947|NCT00245037|528743073|FG000|Overall Study|Death|17|||
146609948|NCT00203424|528743075|FG000|Treatment Period|Withdrawal by Subject|4|||
146609949|NCT00203424|528743075|FG000|Treatment Period|Adverse Event|5|||
146609950|NCT00203424|528743075|FG000|Treatment Period|progressive disease|2|||
146609951|NCT00203424|528743075|FG000|Follow-up Period|Withdrawal by Subject|1|||
146609952|NCT00203424|528743075|FG000|Follow-up Period|progressive disease|4|||
146609953|NCT00203424|528743075|FG000|Follow-up Period|Lost to Follow-up|1|||
146609954|NCT00555672|528743076|FG000|Overall Study|Death|0|||
146609955|NCT00555672|528743077|FG001|Overall Study|Death|2|||
146657656|NCT01082640|528925216|FG002|Overall Study|Lost to Follow-up|0|||
146657657|NCT01082640|528925214|FG000|Overall Study|Other|2|||
146657658|NCT01082640|528925215|FG001|Overall Study|Other|1|||
146657659|NCT01082640|528925216|FG002|Overall Study|Other|3|||
146657660|NCT01025154|528925221|FG000|Overall Study|Lost to Follow-up|1|||
146609956|NCT00555672|528743076|FG000|Overall Study|Adverse Event|8|||
146609957|NCT00555672|528743077|FG001|Overall Study|Adverse Event|2|||
146609958|NCT00555672|528743076|FG000|Overall Study|Objective progression or relapse|11|||
146609959|NCT00555672|528743077|FG001|Overall Study|Objective progression or relapse|5|||
146609960|NCT00555672|528743076|FG000|Overall Study|Other|3|||
146609961|NCT00555672|528743077|FG001|Overall Study|Other|1|||
146609962|NCT00555672|528743076|FG000|Overall Study|Participant refused|2|||
146609963|NCT00555672|528743077|FG001|Overall Study|Participant refused|0|||
146609964|NCT01053988|528743078|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
146609965|NCT01053988|528743079|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146609966|NCT01053988|528743080|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146657661|NCT01025154|528925221|FG000|Overall Study|Withdrawal by Subject|1|||
146657662|NCT05153473|528925223|FG000|Overall Study|Death|46|||
146773282|NCT03144674|529339548|FG002|Overall Study|Histological Criteria Not Met|0|||
146773283|NCT03144674|529339549|FG003|Overall Study|Histological Criteria Not Met|1|||
146773284|NCT03144674|529339546|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
146773285|NCT03144674|529339547|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
146773286|NCT03144674|529339548|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
146773287|NCT03144674|529339549|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
146773288|NCT03144674|529339546|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
146773289|NCT03144674|529339547|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
146773290|NCT03144674|529339548|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
146773291|NCT03144674|529339549|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
146773292|NCT03942042|529339550|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
146773293|NCT03942042|529339551|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
146773294|NCT03942042|529339550|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
146773295|NCT03942042|529339551|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
146773296|NCT00736853|529339552|FG000|Open-Label Period|Physician Decision|2|||
146773297|NCT00736853|529339553|FG001|Open-Label Period|Physician Decision|0|||
146773298|NCT00736853|529339554|FG002|Open-Label Period|Physician Decision|0|||
146773299|NCT00736853|529339552|FG000|Open-Label Period|Adverse Event|31|||
146773300|NCT00736853|529339553|FG001|Open-Label Period|Adverse Event|0|||
146773301|NCT00736853|529339554|FG002|Open-Label Period|Adverse Event|0|||
146773302|NCT00736853|529339552|FG000|Open-Label Period|Withdrawal by Subject|16|||
146773303|NCT00736853|529339553|FG001|Open-Label Period|Withdrawal by Subject|0|||
146773304|NCT00736853|529339554|FG002|Open-Label Period|Withdrawal by Subject|0|||
146773305|NCT00736853|529339552|FG000|Open-Label Period|Started but not treated|42|||
146773306|NCT00736853|529339553|FG001|Open-Label Period|Started but not treated|0|||
146773307|NCT00736853|529339554|FG002|Open-Label Period|Started but not treated|0|||
146773308|NCT00736853|529339552|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
146773309|NCT00736853|529339553|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
146773310|NCT00736853|529339554|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
146773311|NCT00736853|529339552|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
146773312|NCT00736853|529339553|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
146773313|NCT00736853|529339554|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
146773314|NCT00736853|529339552|FG000|Double-Blind Period|Lack of Efficacy|0|||
146773315|NCT00736853|529339553|FG001|Double-Blind Period|Lack of Efficacy|19|||
146773316|NCT00736853|529339554|FG002|Double-Blind Period|Lack of Efficacy|42|||
146773317|NCT00736853|529339552|FG000|Double-Blind Period|Adverse Event|0|||
146773318|NCT00736853|529339553|FG001|Double-Blind Period|Adverse Event|3|||
146773319|NCT00736853|529339554|FG002|Double-Blind Period|Adverse Event|2|||
146773320|NCT00736853|529339552|FG000|Double-Blind Period|Withdrawal by Subject|0|||
146773321|NCT00736853|529339553|FG001|Double-Blind Period|Withdrawal by Subject|1|||
146773322|NCT00736853|529339554|FG002|Double-Blind Period|Withdrawal by Subject|4|||
146773323|NCT00736853|529339552|FG000|Double-Blind Period|Ineligible to participate the study|0|||
146773324|NCT00736853|529339553|FG001|Double-Blind Period|Ineligible to participate the study|1|||
146773325|NCT00736853|529339554|FG002|Double-Blind Period|Ineligible to participate the study|0|||
146773326|NCT01199705|529339555|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
146609967|NCT01053988|528743081|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146609968|NCT01053988|528743082|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146609969|NCT01053988|528743083|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146609970|NCT01053988|528743078|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
146609971|NCT01053988|528743079|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146609972|NCT01053988|528743080|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146609973|NCT01053988|528743081|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146609974|NCT01053988|528743082|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146609975|NCT01053988|528743083|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146609976|NCT01053988|528743078|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
146609977|NCT01053988|528743079|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146609978|NCT01053988|528743080|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146773327|NCT02918071|529339556|FG000|Overall Study|Withdrawal by Subject|2|||
146773328|NCT02918071|529339556|FG000|Overall Study|Lost to Follow-up|1|||
146773329|NCT01616459|529339557|FG000|Overall Study|Adverse Event|1|||
146923015|NCT02695524|529878721|FG001|Overall Study|Death|1|||
146609979|NCT01053988|528743081|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146609980|NCT01053988|528743082|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146609981|NCT01053988|528743083|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146773330|NCT01616459|529339558|FG001|Overall Study|Adverse Event|1|||
146773331|NCT01616459|529339559|FG002|Overall Study|Adverse Event|2|||
146773332|NCT01616459|529339560|FG003|Overall Study|Adverse Event|0|||
146773333|NCT01616459|529339557|FG000|Overall Study|Lost to Follow-up|1|||
146773334|NCT01616459|529339558|FG001|Overall Study|Lost to Follow-up|11|||
146773335|NCT01616459|529339559|FG002|Overall Study|Lost to Follow-up|3|||
146609982|NCT01053988|528743078|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
146609983|NCT01053988|528743079|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
146609984|NCT01053988|528743080|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
146609985|NCT01053988|528743081|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
146609986|NCT01053988|528743082|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
146609987|NCT01053988|528743083|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
146609988|NCT01053988|528743078|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
146609989|NCT01053988|528743079|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
146609990|NCT01053988|528743080|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
146609991|NCT01053988|528743081|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
146609992|NCT01053988|528743082|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
146609993|NCT01053988|528743083|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
146609994|NCT01053988|528743078|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
146609995|NCT01053988|528743079|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146609996|NCT01053988|528743080|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146609997|NCT01053988|528743081|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146609998|NCT01053988|528743082|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146609999|NCT01053988|528743083|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146610000|NCT01053988|528743078|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
146610001|NCT01053988|528743079|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
146610002|NCT01053988|528743080|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
146610003|NCT01053988|528743081|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
146610004|NCT01053988|528743082|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
146610005|NCT01053988|528743083|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
146610006|NCT01053988|528743078|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146610007|NCT01053988|528743079|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
146610008|NCT01053988|528743080|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
146610009|NCT01053988|528743081|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
146610010|NCT01053988|528743082|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
146610011|NCT01053988|528743083|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146610012|NCT01053988|528743078|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
146610013|NCT01053988|528743079|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
146610014|NCT01053988|528743080|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
146610015|NCT01053988|528743081|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
146610016|NCT01053988|528743082|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
146610017|NCT01053988|528743083|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
146610018|NCT01053988|528743078|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
146610019|NCT01053988|528743079|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
146610020|NCT01053988|528743080|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
146610021|NCT01053988|528743081|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
146610022|NCT01053988|528743082|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
146610023|NCT01053988|528743083|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
146610024|NCT01053988|528743078|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
146610025|NCT01053988|528743079|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
146610026|NCT01053988|528743080|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
146610027|NCT01053988|528743081|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
146610028|NCT01053988|528743082|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
146610029|NCT01053988|528743083|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
146610030|NCT01053988|528743078|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146610031|NCT01053988|528743079|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
146610032|NCT01053988|528743080|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146610033|NCT01053988|528743081|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
146610034|NCT01053988|528743082|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
146610035|NCT01053988|528743083|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
146610036|NCT01053988|528743078|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
146610037|NCT01053988|528743079|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
146610038|NCT01053988|528743080|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
146610039|NCT01053988|528743081|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
146610040|NCT01053988|528743082|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
146610041|NCT01053988|528743083|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
146610042|NCT01053988|528743078|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
146610043|NCT01053988|528743079|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
146657663|NCT05153473|528925223|FG000|Overall Study|Lost to Follow-up|3|||
146610044|NCT01053988|528743080|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
146610045|NCT01053988|528743081|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
146610046|NCT01053988|528743082|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
146610047|NCT01053988|528743083|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
146610048|NCT01922271|528743084|FG000|WASHOUT Period|Withdrawal by Subject|1|||
146610049|NCT01922271|528743085|FG001|WASHOUT Period|Withdrawal by Subject|0|||
146610050|NCT02123823|528743086|FG000|Overall Study|Lack of Efficacy|0|||
146610051|NCT02123823|528743087|FG001|Overall Study|Lack of Efficacy|2|||
146610052|NCT02123823|528743088|FG002|Overall Study|Lack of Efficacy|8|||
146610053|NCT02123823|528743089|FG003|Overall Study|Lack of Efficacy|10|||
146610054|NCT02123823|528743086|FG000|Overall Study|Progressive disease|3|||
146610055|NCT02123823|528743087|FG001|Overall Study|Progressive disease|19|||
146610056|NCT02123823|528743088|FG002|Overall Study|Progressive disease|52|||
146610057|NCT02123823|528743089|FG003|Overall Study|Progressive disease|53|||
146610058|NCT02123823|528743086|FG000|Overall Study|Withdrawal by Subject|0|||
146610059|NCT02123823|528743087|FG001|Overall Study|Withdrawal by Subject|0|||
146610060|NCT02123823|528743088|FG002|Overall Study|Withdrawal by Subject|7|||
146610061|NCT02123823|528743089|FG003|Overall Study|Withdrawal by Subject|2|||
146610062|NCT02123823|528743086|FG000|Overall Study|Adverse Event|0|||
146610063|NCT02123823|528743087|FG001|Overall Study|Adverse Event|0|||
146610064|NCT02123823|528743088|FG002|Overall Study|Adverse Event|3|||
146610065|NCT02123823|528743089|FG003|Overall Study|Adverse Event|5|||
146610066|NCT02106403|528743103|FG000|Follow-Up Visit 3|Other Reason|0|||
146610067|NCT02106403|528743104|FG001|Follow-Up Visit 3|Other Reason|0|||
146610068|NCT02106403|528743105|FG002|Follow-Up Visit 3|Other Reason|0|||
146610069|NCT02106403|528743106|FG003|Follow-Up Visit 3|Other Reason|0|||
146610070|NCT02106403|528743107|FG004|Follow-Up Visit 3|Other Reason|0|||
146610071|NCT02106403|528743108|FG005|Follow-Up Visit 3|Other Reason|1|||
146610072|NCT04698993|528743112|FG000|Overall Study|PCR results not accessible|2|||
146610073|NCT04698993|528743113|FG001|Overall Study|PCR results not accessible|7|||
146610074|NCT04698993|528743112|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
146610075|NCT04698993|528743113|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
146610076|NCT01128946|528743114|FG000|Period I|Protocol Violation|0|||
146610077|NCT01128946|528743115|FG001|Period I|Protocol Violation|1|||
146610078|NCT01128946|528743116|FG002|Period I|Protocol Violation|0|||
146610079|NCT01128946|528743117|FG003|Period I|Protocol Violation|0|||
146610080|NCT01128946|528743114|FG000|Period I|Withdrawal by Subject|0|||
146610081|NCT01128946|528743115|FG001|Period I|Withdrawal by Subject|0|||
146610082|NCT01128946|528743116|FG002|Period I|Withdrawal by Subject|1|||
146610083|NCT01128946|528743117|FG003|Period I|Withdrawal by Subject|1|||
146610084|NCT01128946|528743114|FG000|Period II|Protocol Violation|0|||
146610085|NCT01128946|528743115|FG001|Period II|Protocol Violation|1|||
146610086|NCT01128946|528743116|FG002|Period II|Protocol Violation|0|||
146610087|NCT01128946|528743117|FG003|Period II|Protocol Violation|0|||
146610088|NCT01128946|528743114|FG000|Period II|Withdrawal by Subject|0|||
146610089|NCT01128946|528743115|FG001|Period II|Withdrawal by Subject|0|||
146610090|NCT01128946|528743116|FG002|Period II|Withdrawal by Subject|0|||
146610091|NCT01128946|528743117|FG003|Period II|Withdrawal by Subject|1|||
146610092|NCT01128946|528743114|FG000|Period III|Protocol Violation|1|||
146610093|NCT01128946|528743115|FG001|Period III|Protocol Violation|0|||
146610094|NCT01128946|528743116|FG002|Period III|Protocol Violation|0|||
146773336|NCT01616459|529339560|FG003|Overall Study|Lost to Follow-up|2|||
146773337|NCT01616459|529339557|FG000|Overall Study|Protocol Violation|0|||
146773338|NCT01616459|529339558|FG001|Overall Study|Protocol Violation|0|||
146773339|NCT01616459|529339559|FG002|Overall Study|Protocol Violation|0|||
146773340|NCT01616459|529339560|FG003|Overall Study|Protocol Violation|2|||
146610095|NCT01128946|528743117|FG003|Period III|Protocol Violation|0|||
146773341|NCT01616459|529339557|FG000|Overall Study|Withdrawal by Subject|2|||
146610096|NCT00145574|528743118|FG000|Double Blind|Adverse Event|0|||
146610097|NCT00145574|528743119|FG001|Double Blind|Adverse Event|3|||
146610098|NCT00145574|528743120|FG002|Double Blind|Adverse Event|1|||
146610099|NCT00145574|528743118|FG000|Double Blind|Withdrawal by Subject|1|||
146610100|NCT00145574|528743119|FG001|Double Blind|Withdrawal by Subject|1|||
146610101|NCT00145574|528743120|FG002|Double Blind|Withdrawal by Subject|1|||
146610102|NCT00145574|528743118|FG000|Double Blind|required restricted medicine|0|||
146610103|NCT00145574|528743119|FG001|Double Blind|required restricted medicine|1|||
146610104|NCT00145574|528743120|FG002|Double Blind|required restricted medicine|0|||
146610105|NCT00145574|528743118|FG000|Open Label Long-term Extension|Adverse Event|0|||
146610106|NCT00145574|528743119|FG001|Open Label Long-term Extension|Adverse Event|0|||
146610107|NCT00145574|528743120|FG002|Open Label Long-term Extension|Adverse Event|5|||
146610108|NCT00145574|528743118|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
146610109|NCT00145574|528743119|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
146610110|NCT00145574|528743120|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
146923016|NCT00798655|529878728|FG000|Overall Study|Did not receive at least one dose of pan|2|||
146610111|NCT00145574|528743118|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
146773342|NCT01616459|529339558|FG001|Overall Study|Withdrawal by Subject|4|||
146610112|NCT00145574|528743119|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
146610113|NCT00145574|528743120|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
146610114|NCT00145574|528743118|FG000|Open Label Long-term Extension|required restricted medicine|0|||
146610115|NCT00145574|528743119|FG001|Open Label Long-term Extension|required restricted medicine|0|||
146610116|NCT00145574|528743120|FG002|Open Label Long-term Extension|required restricted medicine|1|||
146610117|NCT00621140|528743121|FG000|Overall Study|Adverse Event|4|||
146610118|NCT00621140|528743122|FG001|Overall Study|Adverse Event|5|||
146610119|NCT00621140|528743121|FG000|Overall Study|Lost to Follow-up|1|||
146610120|NCT00621140|528743122|FG001|Overall Study|Lost to Follow-up|2|||
146610121|NCT00621140|528743121|FG000|Overall Study|Withdrawal by Subject|4|||
146610122|NCT00621140|528743122|FG001|Overall Study|Withdrawal by Subject|6|||
146610123|NCT00621140|528743121|FG000|Overall Study|Other incl. lack of efficacy|6|||
146610124|NCT00621140|528743122|FG001|Overall Study|Other incl. lack of efficacy|5|||
146610125|NCT00527904|528743123|FG000|Overall Study|Adverse Event|45|||
146610126|NCT00527904|528743123|FG000|Overall Study|Withdrawal by Subject|21|||
146610127|NCT00527904|528743123|FG000|Overall Study|Lost to Follow-up|8|||
146610128|NCT00527904|528743123|FG000|Overall Study|misc|22|||
146610129|NCT02669121|528743125|FG000|Overall Study|Adverse Event|4|||
146610130|NCT02669121|528743126|FG001|Overall Study|Adverse Event|5|||
146610131|NCT02669121|528743125|FG000|Overall Study|Lost to Follow-up|15|||
146610132|NCT02669121|528743126|FG001|Overall Study|Lost to Follow-up|27|||
146610133|NCT02669121|528743125|FG000|Overall Study|Withdrawal by Subject|132|||
146610134|NCT02669121|528743126|FG001|Overall Study|Withdrawal by Subject|140|||
146610135|NCT02669121|528743125|FG000|Overall Study|Pregnancy|0|||
146610136|NCT02669121|528743126|FG001|Overall Study|Pregnancy|1|||
146610137|NCT02669121|528743125|FG000|Overall Study|Discharged from US Military Active Service|117|||
146610138|NCT02669121|528743126|FG001|Overall Study|Discharged from US Military Active Service|91|||
146610139|NCT02669121|528743125|FG000|Overall Study|Reason not Specified|22|||
146610140|NCT02669121|528743126|FG001|Overall Study|Reason not Specified|18|||
146610141|NCT02687581|528743127|FG000|Overall Study|Withdrawal by Subject|1|||
146610142|NCT02687581|528743128|FG001|Overall Study|Withdrawal by Subject|0|||
146610143|NCT02687581|528743129|FG002|Overall Study|Withdrawal by Subject|0|||
146610144|NCT02687581|528743130|FG003|Overall Study|Withdrawal by Subject|1|||
146610145|NCT02687581|528743127|FG000|Overall Study|Lost to Follow-up|2|||
146610146|NCT02687581|528743128|FG001|Overall Study|Lost to Follow-up|2|||
146610147|NCT02687581|528743129|FG002|Overall Study|Lost to Follow-up|0|||
146610148|NCT02687581|528743130|FG003|Overall Study|Lost to Follow-up|0|||
146610149|NCT02687581|528743127|FG000|Overall Study|the device is too small for the patient.|1|||
146610150|NCT02687581|528743128|FG001|Overall Study|the device is too small for the patient.|0|||
146610151|NCT02687581|528743129|FG002|Overall Study|the device is too small for the patient.|0|||
146610152|NCT02687581|528743130|FG003|Overall Study|the device is too small for the patient.|0|||
146610153|NCT00835341|528743131|FG000|Overall Study|Lost to Follow-up|3|||
146610154|NCT00835341|528743132|FG001|Overall Study|Lost to Follow-up|12|||
146610155|NCT04405076|528743134|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
146610156|NCT04405076|528743135|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
146610157|NCT04405076|528743136|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
146610158|NCT04405076|528743137|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
146610159|NCT04405076|528743138|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
146610160|NCT04405076|528743139|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
146610161|NCT04405076|528743140|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
146610162|NCT04405076|528743141|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
146610163|NCT04405076|528743142|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
146610164|NCT04405076|528743134|FG000|Part A (Blinded Phase)|Physician Decision|1|||
146610165|NCT04405076|528743135|FG001|Part A (Blinded Phase)|Physician Decision|2|||
146610166|NCT04405076|528743136|FG002|Part A (Blinded Phase)|Physician Decision|0|||
146610167|NCT04405076|528743137|FG003|Part A (Blinded Phase)|Physician Decision|0|||
146610168|NCT04405076|528743138|FG004|Part A (Blinded Phase)|Physician Decision|0|||
146610169|NCT04405076|528743139|FG005|Part A (Blinded Phase)|Physician Decision|0|||
146610170|NCT04405076|528743140|FG006|Part A (Blinded Phase)|Physician Decision|0|||
146610171|NCT04405076|528743141|FG007|Part A (Blinded Phase)|Physician Decision|0|||
146610172|NCT04405076|528743142|FG008|Part A (Blinded Phase)|Physician Decision|0|||
146610173|NCT04405076|528743134|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
146610174|NCT04405076|528743135|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
146610175|NCT04405076|528743136|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
146610176|NCT04405076|528743137|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
146610177|NCT04405076|528743138|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
146773343|NCT01616459|529339559|FG002|Overall Study|Withdrawal by Subject|4|||
146773344|NCT01616459|529339560|FG003|Overall Study|Withdrawal by Subject|4|||
146610178|NCT04405076|528743139|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
146610179|NCT04405076|528743140|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
146610180|NCT04405076|528743141|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
146610181|NCT04405076|528743142|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
146610182|NCT04405076|528743134|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
146610183|NCT04405076|528743135|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
146610184|NCT04405076|528743136|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
146610185|NCT04405076|528743137|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
146610186|NCT04405076|528743138|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
146610187|NCT04405076|528743139|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
146610188|NCT04405076|528743140|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
146610189|NCT04405076|528743141|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
146610190|NCT04405076|528743142|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
146610191|NCT04405076|528743134|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
146610192|NCT04405076|528743135|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
146610193|NCT04405076|528743136|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
146610194|NCT04405076|528743137|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
146610195|NCT04405076|528743138|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
146610196|NCT04405076|528743139|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
146610197|NCT04405076|528743140|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
146610198|NCT04405076|528743141|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
146610199|NCT04405076|528743142|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
146610200|NCT04405076|528743134|FG000|Part A (Blinded Phase)|Other than Specified|0|||
146610201|NCT04405076|528743135|FG001|Part A (Blinded Phase)|Other than Specified|0|||
146610202|NCT04405076|528743136|FG002|Part A (Blinded Phase)|Other than Specified|3|||
146610203|NCT04405076|528743137|FG003|Part A (Blinded Phase)|Other than Specified|0|||
146610204|NCT04405076|528743138|FG004|Part A (Blinded Phase)|Other than Specified|0|||
146610205|NCT04405076|528743139|FG005|Part A (Blinded Phase)|Other than Specified|0|||
146610206|NCT04405076|528743140|FG006|Part A (Blinded Phase)|Other than Specified|0|||
146610207|NCT04405076|528743141|FG007|Part A (Blinded Phase)|Other than Specified|0|||
146610208|NCT04405076|528743142|FG008|Part A (Blinded Phase)|Other than Specified|0|||
146610209|NCT04405076|528743134|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
146610210|NCT04405076|528743135|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
146610211|NCT04405076|528743136|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
146610212|NCT04405076|528743137|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
146610213|NCT04405076|528743138|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
146610214|NCT04405076|528743139|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
146610215|NCT04405076|528743140|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
146610216|NCT04405076|528743141|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
146610217|NCT04405076|528743142|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
146610218|NCT04405076|528743134|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
146610219|NCT04405076|528743135|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
146610220|NCT04405076|528743136|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
146610221|NCT04405076|528743137|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
146610222|NCT04405076|528743138|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
146610223|NCT04405076|528743139|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
146610224|NCT04405076|528743140|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
146610225|NCT04405076|528743141|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
146610226|NCT04405076|528743142|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
146610227|NCT04405076|528743134|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
146610228|NCT04405076|528743135|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
146610229|NCT04405076|528743136|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
146610230|NCT04405076|528743137|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
146610231|NCT04405076|528743138|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
146610232|NCT04405076|528743139|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
146610233|NCT04405076|528743140|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
146610234|NCT04405076|528743141|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
146610235|NCT04405076|528743142|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
146610236|NCT04405076|528743134|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
146610237|NCT04405076|528743135|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
146610238|NCT04405076|528743136|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
146610239|NCT04405076|528743137|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
146610240|NCT04405076|528743138|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
146610241|NCT04405076|528743139|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
146610242|NCT04405076|528743140|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
146610243|NCT04405076|528743141|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
146610244|NCT04405076|528743142|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
146657664|NCT03555435|528925224|FG000|Overall Study|Lost to Follow-up|17|||
146657665|NCT03555435|528925225|FG001|Overall Study|Lost to Follow-up|19|||
146773345|NCT01616459|529339557|FG000|Overall Study|Other reason|0|||
146773346|NCT01616459|529339558|FG001|Overall Study|Other reason|1|||
146773347|NCT01616459|529339559|FG002|Overall Study|Other reason|1|||
146773348|NCT01616459|529339560|FG003|Overall Study|Other reason|0|||
146773349|NCT03394885|529339561|FG000|Overall Study|Adverse Event|4|||
146610245|NCT04405076|528743134|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
146610246|NCT04405076|528743135|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
146610247|NCT04405076|528743136|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
146610248|NCT04405076|528743137|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
146610249|NCT04405076|528743138|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
146610250|NCT04405076|528743139|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
146610251|NCT04405076|528743140|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
146610252|NCT04405076|528743141|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
146610253|NCT04405076|528743142|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
146610254|NCT04310566|528743143|FG000|Period 1|Study Termination due to COVID-19|15|||
146610255|NCT04310566|528743144|FG001|Period 1|Study Termination due to COVID-19|17|||
146610256|NCT04310566|528743143|FG000|Period 1|Protocol Violation|0|||
146610257|NCT04310566|528743144|FG001|Period 1|Protocol Violation|1|||
146610258|NCT04310566|528743143|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
146610259|NCT04310566|528743144|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
146610260|NCT04310566|528743143|FG000|Period 1|Lost to Follow-up|1|||
146610261|NCT04310566|528743144|FG001|Period 1|Lost to Follow-up|0|||
146610262|NCT04310566|528743143|FG000|Period 1|Withdrawal by Subject|0|||
146610263|NCT04310566|528743144|FG001|Period 1|Withdrawal by Subject|1|||
146610264|NCT04310566|528743143|FG000|Period 2|Study Termination|7|||
146610265|NCT04310566|528743144|FG001|Period 2|Study Termination|5|||
146610266|NCT00384332|528743154|FG000|Overall Study|Lost to Follow-up|4|||
146610267|NCT00384332|528743155|FG001|Overall Study|Lost to Follow-up|0|||
146610268|NCT02560012|528743156|FG000|Overall Study|Study Terminated|2|||
146610269|NCT02218008|528743159|FG000|Stage 1 (S1)|Adverse Event|6|||
146610270|NCT02218008|528743160|FG001|Stage 1 (S1)|Adverse Event|5|||
146610271|NCT02218008|528743161|FG002|Stage 1 (S1)|Adverse Event|11|||
146610272|NCT02218008|528743162|FG003|Stage 1 (S1)|Adverse Event|0|||
146610273|NCT02218008|528743163|FG004|Stage 1 (S1)|Adverse Event|0|||
146610274|NCT02218008|528743164|FG005|Stage 1 (S1)|Adverse Event|0|||
146610275|NCT02218008|528743159|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
146610276|NCT02218008|528743160|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
146610277|NCT02218008|528743161|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
146610278|NCT02218008|528743162|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
146610279|NCT02218008|528743163|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
146610280|NCT02218008|528743164|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
146610281|NCT02218008|528743159|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
146610282|NCT02218008|528743160|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
146610283|NCT02218008|528743161|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
146610284|NCT02218008|528743162|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
146610285|NCT02218008|528743163|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
146610286|NCT02218008|528743164|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
146610287|NCT02218008|528743159|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
146610288|NCT02218008|528743160|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
146610289|NCT02218008|528743161|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
146610290|NCT02218008|528743162|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
146610291|NCT02218008|528743163|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
146610292|NCT02218008|528743164|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
146610293|NCT02218008|528743159|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
146610294|NCT02218008|528743160|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
146610295|NCT02218008|528743161|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
146610296|NCT02218008|528743162|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
146610297|NCT02218008|528743163|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
146773350|NCT03394885|529339561|FG000|Overall Study|Lack of Efficacy|1|||
146773351|NCT03394885|529339561|FG000|Overall Study|Physician Decision|1|||
146773352|NCT03394885|529339561|FG000|Overall Study|Withdrawal by Subject|8|||
146773353|NCT03394885|529339561|FG000|Overall Study|Alternative Therapy|1|||
146610298|NCT02218008|528743164|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
146610299|NCT02218008|528743159|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
146610300|NCT02218008|528743160|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
146610301|NCT02218008|528743161|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
146610302|NCT02218008|528743162|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
146610303|NCT02218008|528743163|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
146610304|NCT02218008|528743164|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
146610305|NCT02218008|528743159|FG000|Stage 1 (S1)|Pregnancy|0|||
146610306|NCT02218008|528743160|FG001|Stage 1 (S1)|Pregnancy|0|||
146773354|NCT04980755|529339562|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
146773355|NCT04980755|529339562|FG000|Body Reprogramming Courses|Work commitment|2|||
146610307|NCT02218008|528743161|FG002|Stage 1 (S1)|Pregnancy|1|||
146610308|NCT02218008|528743162|FG003|Stage 1 (S1)|Pregnancy|0|||
146610309|NCT02218008|528743163|FG004|Stage 1 (S1)|Pregnancy|0|||
146610310|NCT02218008|528743164|FG005|Stage 1 (S1)|Pregnancy|0|||
146610311|NCT02218008|528743159|FG000|Stage 1 (S1)|Protocol Violation|0|||
146610312|NCT02218008|528743160|FG001|Stage 1 (S1)|Protocol Violation|0|||
146610313|NCT02218008|528743161|FG002|Stage 1 (S1)|Protocol Violation|1|||
146610314|NCT02218008|528743162|FG003|Stage 1 (S1)|Protocol Violation|0|||
146610315|NCT02218008|528743163|FG004|Stage 1 (S1)|Protocol Violation|0|||
146610316|NCT02218008|528743164|FG005|Stage 1 (S1)|Protocol Violation|0|||
146610317|NCT02218008|528743159|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
146610318|NCT02218008|528743160|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
146610319|NCT02218008|528743161|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
146610320|NCT02218008|528743162|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
146610321|NCT02218008|528743163|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
146610322|NCT02218008|528743164|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
146610323|NCT02218008|528743159|FG000|Stage 2 (S2)|Adverse Event|0|||
146610324|NCT02218008|528743160|FG001|Stage 2 (S2)|Adverse Event|0|||
146610325|NCT02218008|528743161|FG002|Stage 2 (S2)|Adverse Event|0|||
146610326|NCT02218008|528743162|FG003|Stage 2 (S2)|Adverse Event|2|||
146610327|NCT02218008|528743163|FG004|Stage 2 (S2)|Adverse Event|3|||
146610328|NCT02218008|528743164|FG005|Stage 2 (S2)|Adverse Event|3|||
146610329|NCT02218008|528743159|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
146610330|NCT02218008|528743160|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
146610331|NCT02218008|528743161|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
146610332|NCT02218008|528743162|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
146610333|NCT02218008|528743163|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
146610334|NCT02218008|528743164|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
146610335|NCT02218008|528743159|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
146610336|NCT02218008|528743160|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
146610337|NCT02218008|528743161|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
146610338|NCT02218008|528743162|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
146610339|NCT02218008|528743163|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
146610340|NCT02218008|528743164|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
146610341|NCT02218008|528743159|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
146610342|NCT02218008|528743160|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
146610343|NCT02218008|528743161|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
146610344|NCT02218008|528743162|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
146610345|NCT02218008|528743163|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
146610346|NCT02218008|528743164|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
146610347|NCT02218008|528743159|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
146610348|NCT02218008|528743160|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
146610349|NCT02218008|528743161|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
146610350|NCT02218008|528743162|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
146610351|NCT02218008|528743163|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
146610352|NCT02218008|528743164|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
146610353|NCT01278797|528743165|FG000|Period 1|Adverse Event|0|||
146610354|NCT01278797|528743166|FG001|Period 1|Adverse Event|1|||
146610355|NCT01278797|528743165|FG000|Period 1|Protocol Violation|1|||
146610356|NCT01278797|528743166|FG001|Period 1|Protocol Violation|0|||
146610357|NCT00620113|528743170|FG000|Overall Study|Adverse Event|3|||
146610358|NCT00620113|528743171|FG001|Overall Study|Adverse Event|2|||
146610359|NCT00620113|528743172|FG002|Overall Study|Adverse Event|2|||
146610360|NCT00620113|528743173|FG003|Overall Study|Adverse Event|1|||
146610361|NCT00620113|528743170|FG000|Overall Study|Lack of Efficacy|2|||
146610362|NCT00620113|528743171|FG001|Overall Study|Lack of Efficacy|3|||
146610363|NCT00620113|528743172|FG002|Overall Study|Lack of Efficacy|0|||
146610364|NCT00620113|528743173|FG003|Overall Study|Lack of Efficacy|2|||
146610365|NCT00620113|528743170|FG000|Overall Study|Physician Decision|1|||
146610366|NCT00620113|528743171|FG001|Overall Study|Physician Decision|0|||
146610367|NCT00620113|528743172|FG002|Overall Study|Physician Decision|0|||
146610368|NCT00620113|528743173|FG003|Overall Study|Physician Decision|2|||
146610369|NCT00620113|528743170|FG000|Overall Study|Protocol Violation|2|||
146610370|NCT00620113|528743171|FG001|Overall Study|Protocol Violation|1|||
146610371|NCT00620113|528743172|FG002|Overall Study|Protocol Violation|0|||
146610372|NCT00620113|528743173|FG003|Overall Study|Protocol Violation|0|||
146610373|NCT00620113|528743170|FG000|Overall Study|Withdrawal by Subject|5|||
146610374|NCT00620113|528743171|FG001|Overall Study|Withdrawal by Subject|1|||
146610375|NCT00620113|528743172|FG002|Overall Study|Withdrawal by Subject|3|||
146610376|NCT00620113|528743173|FG003|Overall Study|Withdrawal by Subject|5|||
146610377|NCT02476006|528743199|FG000|Overall Study|Death|4|||
146610378|NCT02476006|528743199|FG000|Overall Study|Lack of treatment efficacy|2|||
146610379|NCT02476006|528743199|FG000|Overall Study|Pregnancy|1|||
146610380|NCT02476006|528743199|FG000|Overall Study|Participant did not wish to continue|39|||
146610381|NCT02476006|528743199|FG000|Overall Study|Adverse Event|41|||
146610382|NCT02476006|528743199|FG000|Overall Study|Poor compliance to study protocol|3|||
146610383|NCT02476006|528743199|FG000|Overall Study|Sponsor decision|6|||
146610384|NCT02476006|528743199|FG000|Overall Study|Lost to Follow-up|5|||
146610385|NCT02476006|528743199|FG000|Overall Study|Physician Decision|5|||
146610386|NCT02476006|528743199|FG000|Overall Study|Study ended treatment not available|4|||
146610387|NCT02476006|528743199|FG000|Overall Study|Switched to commercial drug|4|||
146923017|NCT03446651|529878729|FG000|Overall Study|Lost to Follow-up|4|||
146923018|NCT03446651|529878730|FG001|Overall Study|Lost to Follow-up|0|||
146610388|NCT02476006|528743199|FG000|Overall Study|Excluded from study|1|||
146610389|NCT02476006|528743199|FG000|Overall Study|Protocol Violation|1|||
146610390|NCT02476006|528743199|FG000|Overall Study|Enrolled but not treated|4|||
146610391|NCT02813889|528745018|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
146610392|NCT02813889|528745019|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
146610393|NCT04014062|528745021|FG000|Period I: Dosing|Medical Grounds|4|||
146610394|NCT04014062|528745022|FG001|Period I: Dosing|Medical Grounds|5|||
146610395|NCT04014062|528745021|FG000|Period I: Dosing|Withdrawal by Subject|3|||
146610396|NCT04014062|528745022|FG001|Period I: Dosing|Withdrawal by Subject|1|||
146610397|NCT03038126|528745023|FG000|Overall Study|Death|1|||
146610398|NCT03038126|528745024|FG001|Overall Study|Death|1|||
146610399|NCT03038126|528745023|FG000|Overall Study|Withdrawal by Subject|5|||
146610400|NCT03038126|528745024|FG001|Overall Study|Withdrawal by Subject|0|||
146610401|NCT03038126|528745023|FG000|Overall Study|Lost to Follow-up|0|||
146610402|NCT03038126|528745024|FG001|Overall Study|Lost to Follow-up|1|||
146610403|NCT03038126|528745023|FG000|Overall Study|Long Term Hospitalization|2|||
146610404|NCT03038126|528745024|FG001|Overall Study|Long Term Hospitalization|0|||
146610405|NCT03038126|528745023|FG000|Overall Study|Too Ill to Participate|1|||
146610406|NCT03038126|528745024|FG001|Overall Study|Too Ill to Participate|2|||
146610407|NCT02451917|528745025|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
146610408|NCT02451917|528745026|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
146610409|NCT02451917|528745025|FG000|First Intervention (24 Weeks)|Death|0|||
146610410|NCT02451917|528745026|FG001|First Intervention (24 Weeks)|Death|1|||
146657666|NCT03555435|528925226|FG002|Overall Study|Lost to Follow-up|8|||
146657667|NCT01058265|528925229|FG000|Overall Study|Lost to Follow-up|11|||
146657668|NCT01058265|528925230|FG001|Overall Study|Lost to Follow-up|12|||
146657669|NCT02869438|528925231|FG000|Overall Study|Lost to Follow-up|1|||
146657670|NCT02869438|528925232|FG001|Overall Study|Lost to Follow-up|0|||
146657671|NCT02869438|528925231|FG000|Overall Study|Adverse Event|1|||
146657672|NCT02869438|528925232|FG001|Overall Study|Adverse Event|0|||
146657673|NCT02869438|528925231|FG000|Overall Study|Withdrawal by Subject|1|||
146657674|NCT02869438|528925232|FG001|Overall Study|Withdrawal by Subject|2|||
146657675|NCT02964507|528925233|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
146657676|NCT02964507|528925234|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
146657677|NCT02964507|528925235|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
146657678|NCT02964507|528925236|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
146657679|NCT02964507|528925237|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
146657680|NCT02964507|528925238|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
146657681|NCT02964507|528925239|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
146657682|NCT02964507|528925240|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
146657683|NCT02964507|528925233|FG000|Overall Study|Study terminated by Sponsor|9|||
146657684|NCT02964507|528925234|FG001|Overall Study|Study terminated by Sponsor|1|||
146657685|NCT02964507|528925235|FG002|Overall Study|Study terminated by Sponsor|9|||
146657686|NCT02964507|528925236|FG003|Overall Study|Study terminated by Sponsor|3|||
146657687|NCT02964507|528925237|FG004|Overall Study|Study terminated by Sponsor|3|||
146657688|NCT02964507|528925238|FG005|Overall Study|Study terminated by Sponsor|2|||
146657689|NCT02964507|528925239|FG006|Overall Study|Study terminated by Sponsor|0|||
146657690|NCT02964507|528925240|FG007|Overall Study|Study terminated by Sponsor|0|||
146657691|NCT02964507|528925233|FG000|Overall Study|Other|3|||
146657692|NCT02964507|528925234|FG001|Overall Study|Other|0|||
146657693|NCT02964507|528925235|FG002|Overall Study|Other|0|||
146657694|NCT02964507|528925236|FG003|Overall Study|Other|0|||
146657695|NCT02964507|528925237|FG004|Overall Study|Other|1|||
146657696|NCT02964507|528925238|FG005|Overall Study|Other|0|||
146657697|NCT02964507|528925239|FG006|Overall Study|Other|0|||
146657698|NCT02964507|528925240|FG007|Overall Study|Other|0|||
146657699|NCT02964507|528925233|FG000|Overall Study|Death|11|||
146657700|NCT02964507|528925234|FG001|Overall Study|Death|9|||
146657701|NCT02964507|528925235|FG002|Overall Study|Death|12|||
146657702|NCT02964507|528925236|FG003|Overall Study|Death|2|||
146657703|NCT02964507|528925237|FG004|Overall Study|Death|10|||
146657704|NCT02964507|528925238|FG005|Overall Study|Death|5|||
146923019|NCT03446651|529878729|FG000|Overall Study|Open Label Participants|5|||
146923020|NCT03446651|529878730|FG001|Overall Study|Open Label Participants|0|||
146610411|NCT02451917|528745025|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
146657705|NCT02964507|528925239|FG006|Overall Study|Death|0|||
146923021|NCT00343291|529878731|FG000|Overall Study|Adverse Event|13|||
146610412|NCT02451917|528745026|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
146657706|NCT02964507|528925240|FG007|Overall Study|Death|0|||
146657707|NCT02964507|528925233|FG000|Overall Study|Withdrawal by Subject|1|||
146610413|NCT01724866|528745027|FG000|Overall Study|Adverse Event|0|||
146610414|NCT01724866|528745028|FG001|Overall Study|Adverse Event|0|||
146657708|NCT02964507|528925234|FG001|Overall Study|Withdrawal by Subject|0|||
146923022|NCT00343291|529878732|FG001|Overall Study|Adverse Event|13|||
146923023|NCT00343291|529878731|FG000|Overall Study|Death|3|||
146610415|NCT01724866|528745029|FG002|Overall Study|Adverse Event|1|||
146610416|NCT01724866|528745030|FG003|Overall Study|Adverse Event|1|||
146610417|NCT01724866|528745027|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
146610418|NCT01724866|528745028|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
146610419|NCT01724866|528745029|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
146610420|NCT01724866|528745030|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
146610421|NCT01724866|528745027|FG000|Overall Study|Investigator's Discretion|0|||
146610422|NCT01724866|528745028|FG001|Overall Study|Investigator's Discretion|1|||
146610423|NCT01724866|528745029|FG002|Overall Study|Investigator's Discretion|1|||
146610424|NCT01724866|528745030|FG003|Overall Study|Investigator's Discretion|0|||
146610425|NCT01724866|528745027|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
146610426|NCT01724866|528745028|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
146610427|NCT01724866|528745029|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
146610428|NCT01724866|528745030|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
146610429|NCT01724866|528745027|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
146610430|NCT01724866|528745028|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
146610431|NCT01724866|528745029|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
146610432|NCT01724866|528745030|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
146610433|NCT00411671|528745033|FG000|Overall Study|Adverse Event|15|||
146610434|NCT00411671|528745033|FG000|Overall Study|Death|2|||
146610435|NCT00411671|528745033|FG000|Overall Study|Lost to Follow-up|3|||
146610436|NCT01424501|528745034|FG000|Overall Study|Withdrawal by Subject|1|||
146610437|NCT01424501|528745035|FG001|Overall Study|Withdrawal by Subject|0|||
146610438|NCT01424501|528745036|FG002|Overall Study|Withdrawal by Subject|1|||
146610439|NCT01424501|528745037|FG003|Overall Study|Withdrawal by Subject|0|||
146610440|NCT01424501|528745038|FG004|Overall Study|Withdrawal by Subject|0|||
146610441|NCT01424501|528745039|FG005|Overall Study|Withdrawal by Subject|0|||
146610442|NCT01424501|528745034|FG000|Overall Study|Lost to Follow-up|0|||
146610443|NCT01424501|528745035|FG001|Overall Study|Lost to Follow-up|1|||
146610444|NCT01424501|528745036|FG002|Overall Study|Lost to Follow-up|1|||
146610445|NCT01424501|528745037|FG003|Overall Study|Lost to Follow-up|0|||
146610446|NCT01424501|528745038|FG004|Overall Study|Lost to Follow-up|0|||
146610447|NCT01424501|528745039|FG005|Overall Study|Lost to Follow-up|0|||
146610448|NCT01980095|528745040|FG000|Overall Study|Lost to Follow-up|6|||
146610449|NCT01980095|528745041|FG001|Overall Study|Lost to Follow-up|7|||
146610450|NCT01980095|528745040|FG000|Overall Study|Withdrawal by Subject|2|||
146610451|NCT01980095|528745041|FG001|Overall Study|Withdrawal by Subject|3|||
146610452|NCT01980095|528745040|FG000|Overall Study|Poor compliance|5|||
146610453|NCT01980095|528745041|FG001|Overall Study|Poor compliance|0|||
146610454|NCT01980095|528745040|FG000|Overall Study|Safety issue|0|||
146610455|NCT01980095|528745041|FG001|Overall Study|Safety issue|1|||
146610456|NCT01980095|528745040|FG000|Overall Study|Study drug discontinued|1|||
146610457|NCT01980095|528745041|FG001|Overall Study|Study drug discontinued|0|||
146610458|NCT01980095|528745040|FG000|Overall Study|Randomized by mistake|1|||
146610459|NCT01980095|528745041|FG001|Overall Study|Randomized by mistake|0|||
146610460|NCT00546000|528745046|FG000|Overall Study|Adverse Event|1|||
146610461|NCT00546000|528745046|FG000|Overall Study|Lost to Follow-up|1|||
146610462|NCT00546000|528745046|FG000|Overall Study|Baseline HPA Axis Supression|2|||
146610463|NCT01362608|528745053|FG000|Overall Study|Protocol Violation|0|||
146610464|NCT01362608|528745054|FG001|Overall Study|Protocol Violation|1|||
146610465|NCT01362608|528745053|FG000|Overall Study|Lost to Follow-up|3|||
146610466|NCT01362608|528745054|FG001|Overall Study|Lost to Follow-up|1|||
146610467|NCT01362608|528745053|FG000|Overall Study|Withdrawal by Subject|1|||
146610468|NCT01362608|528745054|FG001|Overall Study|Withdrawal by Subject|2|||
146610469|NCT01362608|528745053|FG000|Overall Study|Lack of Efficacy|0|||
146610470|NCT01362608|528745054|FG001|Overall Study|Lack of Efficacy|2|||
146610471|NCT01362608|528745053|FG000|Overall Study|Adverse Event|0|||
146610472|NCT01362608|528745054|FG001|Overall Study|Adverse Event|2|||
146610473|NCT04809285|528745063|FG000|Phase 1|Lost to Follow-up|6|||
146610474|NCT04809285|528745063|FG000|Phase 1|Protocol Violation|2|||
146610475|NCT04809285|528745063|FG000|Phase 1|Physician Decision|3|||
146610476|NCT04809285|528745063|FG000|Phase 1|Withdrawal by Subject|29|||
146610477|NCT04809285|528745063|FG000|Phase 2|Protocol Violation|3|||
146610478|NCT04809285|528745063|FG000|Phase 2|Withdrawal by Subject|4|||
146610479|NCT02837029|528745066|FG000|Screening|Failed to meet screening requirements.|7|||
146610480|NCT02837029|528745067|FG001|Screening|Failed to meet screening requirements.|3|||
146610481|NCT02837029|528745068|FG002|Screening|Failed to meet screening requirements.|0|||
146773356|NCT04980755|529339562|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
146610482|NCT02837029|528745066|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
146610483|NCT02837029|528745067|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
146610484|NCT02837029|528745068|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
146610485|NCT02837029|528745066|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
146610486|NCT02837029|528745067|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
146610487|NCT02837029|528745068|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
146610488|NCT02837029|528745066|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
146610489|NCT02837029|528745067|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
146610490|NCT02837029|528745068|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
146610491|NCT02837029|528745066|FG000|Cycle 2 and Beyond|Adverse Event|1|||
146610492|NCT02837029|528745067|FG001|Cycle 2 and Beyond|Adverse Event|0|||
146610493|NCT02837029|528745068|FG002|Cycle 2 and Beyond|Adverse Event|0|||
146610494|NCT02837029|528745066|FG000|2 Year Follow-up|Death|6|||
146610495|NCT02837029|528745067|FG001|2 Year Follow-up|Death|7|||
146610496|NCT02837029|528745068|FG002|2 Year Follow-up|Death|0|||
146610497|NCT02034877|528745071|FG000|Overall Study|Lost to Follow-up|0|||
146610498|NCT02034877|528745072|FG001|Overall Study|Lost to Follow-up|3|||
146610499|NCT02034877|528745071|FG000|Overall Study|No Longer Willing to Participate|0|||
146610500|NCT02034877|528745072|FG001|Overall Study|No Longer Willing to Participate|3|||
146610501|NCT00394706|528745078|FG000|Overall Study|Withdrawal by Subject|2|||
146610502|NCT00394706|528745079|FG001|Overall Study|Withdrawal by Subject|0|||
146610503|NCT00394706|528745080|FG002|Overall Study|Withdrawal by Subject|1|||
146610504|NCT00394706|528745081|FG003|Overall Study|Withdrawal by Subject|0|||
146610505|NCT00394706|528745082|FG004|Overall Study|Withdrawal by Subject|0|||
146610506|NCT00394706|528745083|FG005|Overall Study|Withdrawal by Subject|2|||
146610507|NCT00394706|528745084|FG006|Overall Study|Withdrawal by Subject|1|||
146610508|NCT00394706|528745085|FG007|Overall Study|Withdrawal by Subject|0|||
146610509|NCT00394706|528745078|FG000|Overall Study|Lost to Follow-up|2|||
146610510|NCT00394706|528745079|FG001|Overall Study|Lost to Follow-up|2|||
146610511|NCT00394706|528745080|FG002|Overall Study|Lost to Follow-up|8|||
146610512|NCT00394706|528745081|FG003|Overall Study|Lost to Follow-up|1|||
146610513|NCT00394706|528745082|FG004|Overall Study|Lost to Follow-up|2|||
146610514|NCT00394706|528745083|FG005|Overall Study|Lost to Follow-up|5|||
146610515|NCT00394706|528745084|FG006|Overall Study|Lost to Follow-up|2|||
146610516|NCT00394706|528745085|FG007|Overall Study|Lost to Follow-up|0|||
146610517|NCT00887549|528745088|FG000|Induction Therapy|Adverse Event|8|||
146610518|NCT00887549|528745088|FG000|Induction Therapy|Physician Decision|1|||
146610519|NCT00887549|528745088|FG000|Induction Therapy|Progressive Disease|13|||
146610520|NCT00887549|528745088|FG000|Induction Therapy|Death due to Study Disease|4|||
146610521|NCT00887549|528745088|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
146610522|NCT00887549|528745088|FG000|Maintenance Therapy|Adverse Event|16|||
146610523|NCT00887549|528745088|FG000|Maintenance Therapy|Physician Decision|1|||
146610524|NCT00887549|528745088|FG000|Maintenance Therapy|Progressive Disease|25|||
146610525|NCT00887549|528745088|FG000|Maintenance Therapy|Death due to adverse event|1|||
146610526|NCT04112303|528745089|FG000|Overall Study|Death|1|||
146610527|NCT00100789|528745090|FG000|Overall Study|Adverse Event|10|||
146610528|NCT00100789|528745090|FG000|Overall Study|Withdrawal by Subject|1|||
146610529|NCT00100789|528745090|FG000|Overall Study|Progression/relapse|42|||
146610530|NCT00100789|528745090|FG000|Overall Study|Death|2|||
146610531|NCT00100789|528745090|FG000|Overall Study|Not protocol specified|5|||
146610532|NCT00100789|528745090|FG000|Overall Study|Ineligible|3|||
146610533|NCT00100789|528745090|FG000|Overall Study|Never received treatment|1|||
146610534|NCT03472950|528745091|FG000|Overall Study|Lost to Follow-up|0|||
146610535|NCT03472950|528745092|FG001|Overall Study|Lost to Follow-up|1|||
146610536|NCT03472950|528745091|FG000|Overall Study|Adverse Event|0|||
146610537|NCT03472950|528745092|FG001|Overall Study|Adverse Event|3|||
146610538|NCT02506192|528745094|FG000|Overall Study|Withdrawal by Subject|1|||
146610539|NCT02506192|528745095|FG001|Overall Study|Withdrawal by Subject|1|||
146610540|NCT01685697|528745096|FG000|Overall Study|Protocol Violation|3|||
146610541|NCT01685697|528745097|FG001|Overall Study|Protocol Violation|3|||
146610542|NCT02703324|528745098|FG000|Period Two|Withdrawal by Subject|0|||
146923024|NCT00343291|529878732|FG001|Overall Study|Death|2|||
146610543|NCT02703324|528745099|FG001|Period Two|Withdrawal by Subject|0|||
146610544|NCT02703324|528745100|FG002|Period Two|Withdrawal by Subject|1|||
146610545|NCT02703324|528745101|FG003|Period Two|Withdrawal by Subject|0|||
146610546|NCT02703324|528745102|FG004|Period Two|Withdrawal by Subject|0|||
146610547|NCT02703324|528745103|FG005|Period Two|Withdrawal by Subject|0|||
146610548|NCT06136897|528745104|FG000|Overall Study|Ineligible|3|||
146610549|NCT06136897|528745104|FG000|Overall Study|Mutation status not confirmed|7|||
146610550|NCT06136897|528745104|FG000|Overall Study|Adverse Event|2|||
146610551|NCT06136897|528745104|FG000|Overall Study|Death|1|||
146610552|NCT06136897|528745104|FG000|Overall Study|Disease progression|18|||
146610553|NCT06136897|528745104|FG000|Overall Study|Other complicating disease|1|||
146610554|NCT06136897|528745104|FG000|Overall Study|Withdrawal by Subject|1|||
146923025|NCT00343291|529878731|FG000|Overall Study|Progressive disease|33|||
146923026|NCT00343291|529878732|FG001|Overall Study|Progressive disease|34|||
146610555|NCT06136897|528745104|FG000|Overall Study|Still on treatment|1|||
146610556|NCT06136897|528745104|FG000|Overall Study|Lost to Follow-up|1|||
146610557|NCT01858766|528745105|FG000|Overall Study|Randomized but Never Treated|0|||
146610558|NCT01858766|528745106|FG001|Overall Study|Randomized but Never Treated|0|||
146610559|NCT01858766|528745107|FG002|Overall Study|Randomized but Never Treated|0|||
146610560|NCT01858766|528745108|FG003|Overall Study|Randomized but Never Treated|0|||
146610561|NCT01858766|528745109|FG004|Overall Study|Randomized but Never Treated|0|||
146610562|NCT01858766|528745110|FG005|Overall Study|Randomized but Never Treated|1|||
146610563|NCT01858766|528745111|FG006|Overall Study|Randomized but Never Treated|0|||
146610564|NCT01858766|528745112|FG007|Overall Study|Randomized but Never Treated|0|||
146610565|NCT01858766|528745113|FG008|Overall Study|Randomized but Never Treated|0|||
146610566|NCT01858766|528745114|FG009|Overall Study|Randomized but Never Treated|0|||
146610567|NCT01858766|528745115|FG010|Overall Study|Randomized but Never Treated|0|||
146610568|NCT01858766|528745116|FG011|Overall Study|Randomized but Never Treated|0|||
146610569|NCT01858766|528745117|FG012|Overall Study|Randomized but Never Treated|0|||
146610570|NCT01858766|528745118|FG013|Overall Study|Randomized but Never Treated|0|||
146610571|NCT01858766|528745119|FG014|Overall Study|Randomized but Never Treated|0|||
146610572|NCT01858766|528745120|FG015|Overall Study|Randomized but Never Treated|0|||
146610573|NCT01858766|528745121|FG016|Overall Study|Randomized but Never Treated|0|||
146610574|NCT01858766|528745122|FG017|Overall Study|Randomized but Never Treated|1|||
146610575|NCT01858766|528745123|FG018|Overall Study|Randomized but Never Treated|0|||
146610576|NCT01858766|528745105|FG000|Overall Study|Death|0|||
146610577|NCT01858766|528745106|FG001|Overall Study|Death|0|||
146610578|NCT01858766|528745107|FG002|Overall Study|Death|1|||
146610579|NCT01858766|528745108|FG003|Overall Study|Death|0|||
146610580|NCT01858766|528745109|FG004|Overall Study|Death|0|||
146610581|NCT01858766|528745110|FG005|Overall Study|Death|0|||
146610582|NCT01858766|528745111|FG006|Overall Study|Death|0|||
146610583|NCT01858766|528745112|FG007|Overall Study|Death|0|||
146610584|NCT01858766|528745113|FG008|Overall Study|Death|0|||
146610585|NCT01858766|528745114|FG009|Overall Study|Death|0|||
146610586|NCT01858766|528745115|FG010|Overall Study|Death|0|||
146610587|NCT01858766|528745116|FG011|Overall Study|Death|0|||
146610588|NCT01858766|528745117|FG012|Overall Study|Death|0|||
146610589|NCT01858766|528745118|FG013|Overall Study|Death|0|||
146610590|NCT01858766|528745119|FG014|Overall Study|Death|0|||
146610591|NCT01858766|528745120|FG015|Overall Study|Death|0|||
146610592|NCT01858766|528745121|FG016|Overall Study|Death|0|||
146610593|NCT01858766|528745122|FG017|Overall Study|Death|0|||
146610594|NCT01858766|528745123|FG018|Overall Study|Death|0|||
146610595|NCT01858766|528745105|FG000|Overall Study|Lack of Efficacy|1|||
146610596|NCT01858766|528745106|FG001|Overall Study|Lack of Efficacy|0|||
146610597|NCT01858766|528745107|FG002|Overall Study|Lack of Efficacy|0|||
146610598|NCT01858766|528745108|FG003|Overall Study|Lack of Efficacy|0|||
146610599|NCT01858766|528745109|FG004|Overall Study|Lack of Efficacy|1|||
146610600|NCT01858766|528745110|FG005|Overall Study|Lack of Efficacy|2|||
146610601|NCT01858766|528745111|FG006|Overall Study|Lack of Efficacy|0|||
146610602|NCT01858766|528745112|FG007|Overall Study|Lack of Efficacy|0|||
146610603|NCT01858766|528745113|FG008|Overall Study|Lack of Efficacy|0|||
146610604|NCT01858766|528745114|FG009|Overall Study|Lack of Efficacy|0|||
146610605|NCT01858766|528745115|FG010|Overall Study|Lack of Efficacy|0|||
146610606|NCT01858766|528745116|FG011|Overall Study|Lack of Efficacy|3|||
146610607|NCT01858766|528745117|FG012|Overall Study|Lack of Efficacy|5|||
146610608|NCT01858766|528745118|FG013|Overall Study|Lack of Efficacy|3|||
146610609|NCT01858766|528745119|FG014|Overall Study|Lack of Efficacy|5|||
146610610|NCT01858766|528745120|FG015|Overall Study|Lack of Efficacy|5|||
146610611|NCT01858766|528745121|FG016|Overall Study|Lack of Efficacy|2|||
146610612|NCT01858766|528745122|FG017|Overall Study|Lack of Efficacy|3|||
146610613|NCT01858766|528745123|FG018|Overall Study|Lack of Efficacy|3|||
146610614|NCT01858766|528745105|FG000|Overall Study|Lost to Follow-up|0|||
146610615|NCT01858766|528745106|FG001|Overall Study|Lost to Follow-up|0|||
146610616|NCT01858766|528745107|FG002|Overall Study|Lost to Follow-up|0|||
146610617|NCT01858766|528745108|FG003|Overall Study|Lost to Follow-up|0|||
146610618|NCT01858766|528745109|FG004|Overall Study|Lost to Follow-up|0|||
146610619|NCT01858766|528745110|FG005|Overall Study|Lost to Follow-up|1|||
146610620|NCT01858766|528745111|FG006|Overall Study|Lost to Follow-up|0|||
146610621|NCT01858766|528745112|FG007|Overall Study|Lost to Follow-up|2|||
146610622|NCT01858766|528745113|FG008|Overall Study|Lost to Follow-up|0|||
146610623|NCT01858766|528745114|FG009|Overall Study|Lost to Follow-up|0|||
146610624|NCT01858766|528745115|FG010|Overall Study|Lost to Follow-up|0|||
146610625|NCT01858766|528745116|FG011|Overall Study|Lost to Follow-up|1|||
146610626|NCT01858766|528745117|FG012|Overall Study|Lost to Follow-up|0|||
146610627|NCT01858766|528745118|FG013|Overall Study|Lost to Follow-up|0|||
146610628|NCT01858766|528745119|FG014|Overall Study|Lost to Follow-up|3|||
146610629|NCT01858766|528745120|FG015|Overall Study|Lost to Follow-up|1|||
146610630|NCT01858766|528745121|FG016|Overall Study|Lost to Follow-up|1|||
146610631|NCT01858766|528745122|FG017|Overall Study|Lost to Follow-up|0|||
146610632|NCT01858766|528745123|FG018|Overall Study|Lost to Follow-up|1|||
146610633|NCT01858766|528745105|FG000|Overall Study|Withdrew Consent|0|||
146610634|NCT01858766|528745106|FG001|Overall Study|Withdrew Consent|0|||
146610635|NCT01858766|528745107|FG002|Overall Study|Withdrew Consent|0|||
146610636|NCT01858766|528745108|FG003|Overall Study|Withdrew Consent|0|||
146610637|NCT01858766|528745109|FG004|Overall Study|Withdrew Consent|0|||
146610638|NCT01858766|528745110|FG005|Overall Study|Withdrew Consent|0|||
146610639|NCT01858766|528745111|FG006|Overall Study|Withdrew Consent|0|||
146610640|NCT01858766|528745112|FG007|Overall Study|Withdrew Consent|0|||
146610641|NCT01858766|528745113|FG008|Overall Study|Withdrew Consent|0|||
146610642|NCT01858766|528745114|FG009|Overall Study|Withdrew Consent|0|||
146610643|NCT01858766|528745115|FG010|Overall Study|Withdrew Consent|0|||
146610644|NCT01858766|528745116|FG011|Overall Study|Withdrew Consent|1|||
146610645|NCT01858766|528745117|FG012|Overall Study|Withdrew Consent|0|||
146610646|NCT01858766|528745118|FG013|Overall Study|Withdrew Consent|0|||
146610647|NCT01858766|528745119|FG014|Overall Study|Withdrew Consent|0|||
146610648|NCT01858766|528745120|FG015|Overall Study|Withdrew Consent|0|||
146610649|NCT01858766|528745121|FG016|Overall Study|Withdrew Consent|0|||
146610650|NCT01858766|528745122|FG017|Overall Study|Withdrew Consent|0|||
146610651|NCT01858766|528745123|FG018|Overall Study|Withdrew Consent|0|||
146610652|NCT00475709|528745130|FG000|Overall Study|Did not meet eligibility criteria|8|||
146610653|NCT00475709|528745130|FG000|Overall Study|Death|41|||
146610654|NCT00475709|528745130|FG000|Overall Study|Device Explant|6|||
146610655|NCT00475709|528745130|FG000|Overall Study|Lost to Follow-up|21|||
146610656|NCT04427072|528745136|FG000|Randomized Treatment Phase|Progressive disease|9|||
146610657|NCT04427072|528745137|FG001|Randomized Treatment Phase|Progressive disease|4|||
146610658|NCT04427072|528745136|FG000|Randomized Treatment Phase|Adverse Event|3|||
146610659|NCT04427072|528745137|FG001|Randomized Treatment Phase|Adverse Event|1|||
146610660|NCT04427072|528745136|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
146610661|NCT04427072|528745137|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
146610662|NCT04427072|528745136|FG000|Randomized Treatment Phase|Death|0|||
146610663|NCT04427072|528745137|FG001|Randomized Treatment Phase|Death|1|||
146610664|NCT04427072|528745136|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
146610665|NCT04427072|528745137|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
146610666|NCT04427072|528745136|FG000|Extension Treatment Phase|Progressive disease|0|||
146610667|NCT04427072|528745137|FG001|Extension Treatment Phase|Progressive disease|5|||
146610668|NCT03400176|528745141|FG000|Dose Escalation|Progressive disease|1|||
146610669|NCT03400176|528745142|FG001|Dose Escalation|Progressive disease|1|||
146610670|NCT03400176|528745143|FG002|Dose Escalation|Progressive disease|0|||
146610671|NCT03400176|528745144|FG003|Dose Escalation|Progressive disease|0|||
146610672|NCT03400176|528745145|FG004|Dose Escalation|Progressive disease|1|||
146610673|NCT03400176|528745141|FG000|Dose Escalation|Patient decision|0|||
146610674|NCT03400176|528745142|FG001|Dose Escalation|Patient decision|0|||
146610675|NCT03400176|528745143|FG002|Dose Escalation|Patient decision|0|||
146610676|NCT03400176|528745144|FG003|Dose Escalation|Patient decision|0|||
146610677|NCT03400176|528745145|FG004|Dose Escalation|Patient decision|1|||
146610678|NCT03400176|528745141|FG000|Dose Expansion|Patient decision|0|||
146610679|NCT03400176|528745142|FG001|Dose Expansion|Patient decision|0|||
146610680|NCT03400176|528745143|FG002|Dose Expansion|Patient decision|0|||
146610681|NCT03400176|528745144|FG003|Dose Expansion|Patient decision|1|||
146610682|NCT03400176|528745145|FG004|Dose Expansion|Patient decision|0|||
146610683|NCT03400176|528745141|FG000|Dose Expansion|Adverse Event|0|||
146610684|NCT03400176|528745142|FG001|Dose Expansion|Adverse Event|0|||
146610685|NCT03400176|528745143|FG002|Dose Expansion|Adverse Event|0|||
146610686|NCT03400176|528745144|FG003|Dose Expansion|Adverse Event|1|||
146610687|NCT03400176|528745145|FG004|Dose Expansion|Adverse Event|0|||
146610688|NCT03400176|528745141|FG000|Dose Expansion|Physician Decision|0|||
146610689|NCT03400176|528745142|FG001|Dose Expansion|Physician Decision|0|||
146610690|NCT03400176|528745143|FG002|Dose Expansion|Physician Decision|0|||
146610691|NCT03400176|528745144|FG003|Dose Expansion|Physician Decision|1|||
146610692|NCT03400176|528745145|FG004|Dose Expansion|Physician Decision|0|||
146610693|NCT03400176|528745141|FG000|Dose Expansion|Progressive disease|0|||
146610694|NCT03400176|528745142|FG001|Dose Expansion|Progressive disease|0|||
146610695|NCT03400176|528745143|FG002|Dose Expansion|Progressive disease|1|||
146610696|NCT03400176|528745144|FG003|Dose Expansion|Progressive disease|1|||
146610697|NCT03400176|528745145|FG004|Dose Expansion|Progressive disease|0|||
146610698|NCT02104947|528745150|FG000|Overall Study|Withdrawal by Subject|10|||
146923027|NCT00343291|529878731|FG000|Overall Study|Withdrawal by Subject|0|||
146610699|NCT02104947|528745151|FG001|Overall Study|Withdrawal by Subject|3|||
146610700|NCT02104947|528745150|FG000|Overall Study|Lost to Follow-up|4|||
146610701|NCT02104947|528745151|FG001|Overall Study|Lost to Follow-up|4|||
146610702|NCT02104947|528745150|FG000|Overall Study|Protocol Violation|6|||
146610703|NCT02104947|528745151|FG001|Overall Study|Protocol Violation|8|||
146610704|NCT02104947|528745150|FG000|Overall Study|Adverse Event|57|||
146610705|NCT02104947|528745151|FG001|Overall Study|Adverse Event|38|||
146610706|NCT02104947|528745150|FG000|Overall Study|Other than stated above|2|||
146610707|NCT02104947|528745151|FG001|Overall Study|Other than stated above|3|||
146610708|NCT01090063|528745152|FG000|Screen|Screen Failed|4|||
146610709|NCT01090063|528745152|FG000|Treatment|Withdrawal by Subject|4|||
146610710|NCT00206440|528745161|FG000|Overall Study|Protocol Violation|1|||
146610711|NCT00206440|528745162|FG001|Overall Study|Protocol Violation|2|||
146610712|NCT00206440|528745161|FG000|Overall Study|Adverse Event|4|||
146610713|NCT00206440|528745162|FG001|Overall Study|Adverse Event|2|||
146610714|NCT00958165|528745163|FG000|Overall Study|Lost to Follow-up|5|||
146610715|NCT00958165|528745163|FG000|Overall Study|Not eligible|9|||
146610716|NCT01371734|528745164|FG000|Overall Study|Other|2|||
146773357|NCT04980755|529339562|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
146773358|NCT00801983|529339565|FG000|Period 1|Lost to Follow-up|2|||
146773359|NCT00801983|529339566|FG001|Period 1|Lost to Follow-up|0|||
146773360|NCT00801983|529339565|FG000|Period 1|Withdrawal by Subject|2|||
146773361|NCT00801983|529339566|FG001|Period 1|Withdrawal by Subject|8|||
146773362|NCT00801983|529339565|FG000|Period 2|Withdrawal by Subject|2|||
146610717|NCT01371734|528745165|FG001|Overall Study|Other|1|||
146610718|NCT01371734|528745166|FG002|Overall Study|Other|2|||
146610719|NCT01371734|528745164|FG000|Overall Study|Withdrawal by Subject|3|||
146610720|NCT01371734|528745165|FG001|Overall Study|Withdrawal by Subject|4|||
146610721|NCT01371734|528745166|FG002|Overall Study|Withdrawal by Subject|9|||
146610722|NCT01371734|528745164|FG000|Overall Study|Lost to Follow-up|5|||
146610723|NCT01371734|528745165|FG001|Overall Study|Lost to Follow-up|3|||
146610724|NCT01371734|528745166|FG002|Overall Study|Lost to Follow-up|1|||
146610725|NCT01371734|528745164|FG000|Overall Study|Protocol Violation|3|||
146610726|NCT01371734|528745165|FG001|Overall Study|Protocol Violation|1|||
146610727|NCT01371734|528745166|FG002|Overall Study|Protocol Violation|2|||
146610728|NCT01371734|528745164|FG000|Overall Study|Adverse Event|8|||
146610729|NCT01371734|528745165|FG001|Overall Study|Adverse Event|8|||
146610730|NCT01371734|528745166|FG002|Overall Study|Adverse Event|3|||
146610731|NCT01371734|528745164|FG000|Overall Study|Lack of Efficacy|2|||
146610732|NCT01371734|528745165|FG001|Overall Study|Lack of Efficacy|2|||
146610733|NCT01371734|528745166|FG002|Overall Study|Lack of Efficacy|0|||
146610734|NCT01298765|528745167|FG000|Titration Period|Adverse Event|26|||
146610735|NCT01298765|528745167|FG000|Titration Period|Death|1|||
146610736|NCT01298765|528745167|FG000|Titration Period|Lack of Efficacy|21|||
146610737|NCT01298765|528745167|FG000|Titration Period|Lost to Follow-up|9|||
146610738|NCT01298765|528745167|FG000|Titration Period|Physician Decision|1|||
146610739|NCT01298765|528745167|FG000|Titration Period|Withdrawal by Subject|10|||
146610740|NCT01298765|528745167|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
146610741|NCT01298765|528745167|FG000|Long-Term Treatment Period|Adverse Event|19|||
146610742|NCT01298765|528745167|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
146610743|NCT01298765|528745167|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
146610744|NCT01298765|528745167|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
146610745|NCT01298765|528745167|FG000|Long-Term Treatment Period|Physician Decision|1|||
146610746|NCT01298765|528745167|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
146657709|NCT02964507|528925235|FG002|Overall Study|Withdrawal by Subject|1|||
146657710|NCT02964507|528925236|FG003|Overall Study|Withdrawal by Subject|1|||
146657711|NCT02964507|528925237|FG004|Overall Study|Withdrawal by Subject|0|||
146657712|NCT02964507|528925238|FG005|Overall Study|Withdrawal by Subject|1|||
146657713|NCT02964507|528925239|FG006|Overall Study|Withdrawal by Subject|0|||
146657714|NCT02964507|528925240|FG007|Overall Study|Withdrawal by Subject|0|||
146657715|NCT02964507|528925233|FG000|Overall Study|Physician Decision|2|||
146657716|NCT02964507|528925234|FG001|Overall Study|Physician Decision|0|||
146657717|NCT02964507|528925235|FG002|Overall Study|Physician Decision|3|||
146657718|NCT02964507|528925236|FG003|Overall Study|Physician Decision|0|||
146657719|NCT02964507|528925237|FG004|Overall Study|Physician Decision|1|||
146657720|NCT02964507|528925238|FG005|Overall Study|Physician Decision|0|||
146657721|NCT02964507|528925239|FG006|Overall Study|Physician Decision|0|||
146657722|NCT02964507|528925240|FG007|Overall Study|Physician Decision|0|||
146657723|NCT04341662|528925241|FG000|Overall Study|Did not have source-verified blood loss data|423|||
146773363|NCT00801983|529339566|FG001|Period 2|Withdrawal by Subject|1|||
146610747|NCT03565237|528745168|FG000|Overall Study|Non-compliance of Investigational Product|1|||
146610748|NCT03565237|528745168|FG000|Overall Study|Physician Decision|1|||
146610749|NCT01140061|528745174|FG000|Part I|Adverse Event|1|||
146610750|NCT01140061|528745175|FG001|Part I|Adverse Event|0|||
146610751|NCT01140061|528745176|FG002|Part I|Adverse Event|0|||
146610752|NCT01140061|528745177|FG003|Part I|Adverse Event|0|||
146610753|NCT01140061|528745178|FG004|Part I|Adverse Event|0|||
146610754|NCT01140061|528745179|FG005|Part I|Adverse Event|0|||
146610755|NCT01140061|528745180|FG006|Part I|Adverse Event|0|||
146610756|NCT01140061|528745181|FG007|Part I|Adverse Event|0|||
146610757|NCT01140061|528745182|FG008|Part I|Adverse Event|0|||
146657724|NCT04341662|528925242|FG001|Overall Study|Did not have source-verified blood loss data|514|||
146848174|NCT01012414|529614029|FG000|Overall Study|Withdrawal by Subject|2|||
146848175|NCT01012414|529614029|FG000|Overall Study|Lost to Follow-up|1|||
146848176|NCT01012414|529614029|FG000|Overall Study|Trial was stopped before completed|7|||
146848177|NCT02601300|529614030|FG000|Induction Phase|Lack of Efficacy|2|||
146848178|NCT02601300|529614030|FG000|Induction Phase|Protocol Violation|1|||
146848179|NCT02601300|529614030|FG000|Extension Phase|Withdrawal by Subject|3|||
146848180|NCT02601300|529614030|FG000|Extension Phase|Adverse Event|4|||
146848181|NCT02601300|529614030|FG000|Extension Phase|Lack of Efficacy|10|||
146848182|NCT01127763|529614031|FG000|Overall Study|Adverse Event|2|||
146848183|NCT01127763|529614031|FG000|Overall Study|Withdrawal by Subject|1|||
146848184|NCT01127763|529614031|FG000|Overall Study|Physician Decision|2|||
146848185|NCT00528931|529614032|FG000|Overall Study|Lost to Follow-up|1|||
146848186|NCT02285153|529614038|FG000|Overall Study|Adverse Event|1|||
146848187|NCT02285153|529614039|FG001|Overall Study|Adverse Event|0|||
146610758|NCT01140061|528745183|FG009|Part I|Adverse Event|0|||
146610759|NCT01140061|528745174|FG000|Extension|Laboratory Adverse Event|0|||
146610760|NCT01140061|528745175|FG001|Extension|Laboratory Adverse Event|0|||
146610761|NCT01140061|528745176|FG002|Extension|Laboratory Adverse Event|0|||
146610762|NCT01140061|528745177|FG003|Extension|Laboratory Adverse Event|0|||
146610763|NCT01140061|528745178|FG004|Extension|Laboratory Adverse Event|0|||
146610764|NCT01140061|528745179|FG005|Extension|Laboratory Adverse Event|0|||
146610765|NCT01140061|528745180|FG006|Extension|Laboratory Adverse Event|0|||
146610766|NCT01140061|528745181|FG007|Extension|Laboratory Adverse Event|0|||
146610767|NCT01140061|528745182|FG008|Extension|Laboratory Adverse Event|0|||
146610768|NCT01140061|528745183|FG009|Extension|Laboratory Adverse Event|1|||
146610769|NCT00428389|528745185|FG000|Core Phase|Adverse Event|6|||
146610770|NCT00428389|528745186|FG001|Core Phase|Adverse Event|4|||
146610771|NCT00428389|528745185|FG000|Core Phase|Lack of Efficacy|2|||
146610772|NCT00428389|528745186|FG001|Core Phase|Lack of Efficacy|0|||
146610773|NCT00428389|528745185|FG000|Core Phase|Abnormal test procedure result(s)|0|||
146610774|NCT00428389|528745186|FG001|Core Phase|Abnormal test procedure result(s)|1|||
146610775|NCT00428389|528745185|FG000|Core Phase|Withdrawal by Subject|3|||
146610776|NCT00428389|528745186|FG001|Core Phase|Withdrawal by Subject|4|||
146610777|NCT00428389|528745185|FG000|Core Phase|Protocol deviation|0|||
146610778|NCT00428389|528745186|FG001|Core Phase|Protocol deviation|2|||
146610779|NCT00428389|528745185|FG000|Extension Phase|Adverse Event|17|||
146610780|NCT00428389|528745186|FG001|Extension Phase|Adverse Event|11|||
146610781|NCT00428389|528745185|FG000|Extension Phase|Lack of Efficacy|4|||
146610782|NCT00428389|528745186|FG001|Extension Phase|Lack of Efficacy|3|||
146610783|NCT00428389|528745185|FG000|Extension Phase|Withdrawal by Subject|6|||
146610784|NCT00428389|528745186|FG001|Extension Phase|Withdrawal by Subject|6|||
146610785|NCT00428389|528745185|FG000|Extension Phase|Lost to Follow-up|0|||
146610786|NCT00428389|528745186|FG001|Extension Phase|Lost to Follow-up|3|||
146610787|NCT00428389|528745185|FG000|Extension Phase|Death|1|||
146610788|NCT00428389|528745186|FG001|Extension Phase|Death|0|||
146610789|NCT00428389|528745185|FG000|Extension Phase|Protocol Violation|3|||
146610790|NCT00428389|528745186|FG001|Extension Phase|Protocol Violation|2|||
146610791|NCT00428389|528745185|FG000|Extension Phase|Administrative problems|1|||
146610792|NCT00428389|528745186|FG001|Extension Phase|Administrative problems|1|||
146610793|NCT00766051|528745187|FG000|Overall Study|Withdrawal by Subject|2|||
146610794|NCT00766051|528745188|FG001|Overall Study|Withdrawal by Subject|0|||
146610795|NCT04384523|528745189|FG000|Overall Study|Lost to Follow-up|0|||
146610796|NCT04384523|528745190|FG001|Overall Study|Lost to Follow-up|0|||
146610797|NCT04384523|528745191|FG002|Overall Study|Lost to Follow-up|0|||
146610798|NCT04384523|528745192|FG003|Overall Study|Lost to Follow-up|0|||
146610799|NCT04384523|528745193|FG004|Overall Study|Lost to Follow-up|0|||
146610800|NCT04384523|528745194|FG005|Overall Study|Lost to Follow-up|1|||
146610801|NCT04384523|528745189|FG000|Overall Study|Protocol Violation|0|||
146610802|NCT04384523|528745190|FG001|Overall Study|Protocol Violation|1|||
146610803|NCT04384523|528745191|FG002|Overall Study|Protocol Violation|0|||
146610804|NCT04384523|528745192|FG003|Overall Study|Protocol Violation|0|||
146610805|NCT04384523|528745193|FG004|Overall Study|Protocol Violation|0|||
146610806|NCT04384523|528745194|FG005|Overall Study|Protocol Violation|0|||
146610807|NCT04384523|528745189|FG000|Overall Study|Withdrawal by Subject|1|||
146657725|NCT02325791|528925243|FG000|Overall Study|Adverse Event|0|||
146657726|NCT02325791|528925244|FG001|Overall Study|Adverse Event|1|||
146657727|NCT02325791|528925245|FG002|Overall Study|Adverse Event|1|||
146657728|NCT02325791|528925246|FG003|Overall Study|Adverse Event|0|||
146657729|NCT02325791|528925243|FG000|Overall Study|Death|0|||
146657730|NCT02325791|528925244|FG001|Overall Study|Death|3|||
146657731|NCT02325791|528925245|FG002|Overall Study|Death|0|||
146657732|NCT02325791|528925246|FG003|Overall Study|Death|1|||
146657733|NCT02325791|528925243|FG000|Overall Study|Lost to Follow-up|0|||
146657734|NCT02325791|528925244|FG001|Overall Study|Lost to Follow-up|15|||
146923028|NCT00343291|529878732|FG001|Overall Study|Withdrawal by Subject|2|||
146923029|NCT00343291|529878731|FG000|Overall Study|Other|8|||
146923030|NCT00343291|529878732|FG001|Overall Study|Other|5|||
146923031|NCT03712345|529878735|FG000|Overall Study|Failure to meet randomization criteria|0|||
146610808|NCT04384523|528745190|FG001|Overall Study|Withdrawal by Subject|0|||
146610809|NCT04384523|528745191|FG002|Overall Study|Withdrawal by Subject|0|||
146610810|NCT04384523|528745192|FG003|Overall Study|Withdrawal by Subject|0|||
146610811|NCT04384523|528745193|FG004|Overall Study|Withdrawal by Subject|0|||
146610812|NCT04384523|528745194|FG005|Overall Study|Withdrawal by Subject|0|||
146610813|NCT03216746|528745195|FG000|Overall Study|Lost to Follow-up|6|||
146610814|NCT03216746|528745196|FG001|Overall Study|Lost to Follow-up|8|||
146657735|NCT02325791|528925245|FG002|Overall Study|Lost to Follow-up|14|||
146657736|NCT02325791|528925246|FG003|Overall Study|Lost to Follow-up|9|||
146610815|NCT03216746|528745197|FG002|Overall Study|Lost to Follow-up|5|||
146610816|NCT03216746|528745198|FG003|Overall Study|Lost to Follow-up|6|||
146610817|NCT00635882|528745199|FG000|Overall Study|Protocol Violation|1|||
146610818|NCT00635882|528745200|FG001|Overall Study|Protocol Violation|0|||
146610819|NCT00635882|528745201|FG002|Overall Study|Protocol Violation|0|||
146657737|NCT02325791|528925243|FG000|Overall Study|Physician Decision|0|||
146773364|NCT04688450|529341038|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
146773365|NCT04688450|529341038|FG000|Overall Study|Withdrawal by Subject|1|||
146773366|NCT02544074|529341039|FG000|Overall Study|Withdrawal by Subject|0|||
146773367|NCT02544074|529341040|FG001|Overall Study|Withdrawal by Subject|1|||
146773368|NCT02544074|529341041|FG002|Overall Study|Withdrawal by Subject|0|||
146773369|NCT02544074|529341042|FG003|Overall Study|Withdrawal by Subject|0|||
146773370|NCT02544074|529341043|FG004|Overall Study|Withdrawal by Subject|0|||
146773371|NCT02544074|529341044|FG005|Overall Study|Withdrawal by Subject|0|||
146773372|NCT02544074|529341045|FG006|Overall Study|Withdrawal by Subject|0|||
146773373|NCT02544074|529341046|FG007|Overall Study|Withdrawal by Subject|0|||
146610820|NCT00635882|528745202|FG003|Overall Study|Protocol Violation|0|||
146610821|NCT00635882|528745203|FG004|Overall Study|Protocol Violation|0|||
146610822|NCT00635882|528745204|FG005|Overall Study|Protocol Violation|0|||
146610823|NCT02305238|528745205|FG000|Overall Study|Death|2|||
146610824|NCT02305238|528745206|FG001|Overall Study|Death|1|||
146610825|NCT02305238|528745207|FG002|Overall Study|Death|0|||
146610826|NCT02305238|528745205|FG000|Overall Study|Progressive disease|4|||
146610827|NCT02305238|528745206|FG001|Overall Study|Progressive disease|4|||
146610828|NCT02305238|528745207|FG002|Overall Study|Progressive disease|0|||
146610829|NCT02305238|528745205|FG000|Overall Study|Logistical difficulties|1|||
146610830|NCT02305238|528745206|FG001|Overall Study|Logistical difficulties|3|||
146610831|NCT02305238|528745207|FG002|Overall Study|Logistical difficulties|0|||
146610832|NCT02305238|528745205|FG000|Overall Study|Protocol Violation|0|||
146610833|NCT02305238|528745206|FG001|Overall Study|Protocol Violation|3|||
146610834|NCT02305238|528745207|FG002|Overall Study|Protocol Violation|0|||
146610835|NCT02305238|528745205|FG000|Overall Study|Physician Decision|2|||
146610836|NCT02305238|528745206|FG001|Overall Study|Physician Decision|1|||
146610837|NCT02305238|528745207|FG002|Overall Study|Physician Decision|0|||
146610838|NCT02305238|528745205|FG000|Overall Study|Adverse Event|4|||
146610839|NCT02305238|528745206|FG001|Overall Study|Adverse Event|2|||
146610840|NCT02305238|528745207|FG002|Overall Study|Adverse Event|0|||
146610841|NCT02305238|528745205|FG000|Overall Study|Withdrawal by Subject|3|||
146610842|NCT02305238|528745206|FG001|Overall Study|Withdrawal by Subject|4|||
146610843|NCT02305238|528745207|FG002|Overall Study|Withdrawal by Subject|0|||
146610844|NCT02305238|528745205|FG000|Overall Study|Randomized failure|0|||
146610845|NCT02305238|528745206|FG001|Overall Study|Randomized failure|0|||
146610846|NCT02305238|528745207|FG002|Overall Study|Randomized failure|8|||
146610847|NCT02305238|528745205|FG000|Overall Study|Required procedure failed|0|||
146610848|NCT02305238|528745206|FG001|Overall Study|Required procedure failed|1|||
146610849|NCT02305238|528745207|FG002|Overall Study|Required procedure failed|0|||
146610850|NCT01711645|528745208|FG000|Overall Study|Withdrawal by Subject|8|||
146610851|NCT01711645|528745208|FG000|Overall Study|Lost to Follow-up|6|||
146610852|NCT01711645|528745208|FG000|Overall Study|Physician Decision|5|||
146610853|NCT00408434|528745209|FG000|Overall Study|Adverse Event|0|||
146610854|NCT00408434|528745210|FG001|Overall Study|Adverse Event|0|||
146610855|NCT00408434|528745211|FG002|Overall Study|Adverse Event|1|||
146610856|NCT00408434|528745212|FG003|Overall Study|Adverse Event|0|||
146610857|NCT00408434|528745213|FG004|Overall Study|Adverse Event|0|||
146610858|NCT00408434|528745214|FG005|Overall Study|Adverse Event|0|||
146610859|NCT00408434|528745215|FG006|Overall Study|Adverse Event|0|||
146610860|NCT00408434|528745209|FG000|Overall Study|Progressive disease|6|||
146610861|NCT00408434|528745210|FG001|Overall Study|Progressive disease|3|||
146610862|NCT00408434|528745211|FG002|Overall Study|Progressive disease|4|||
146610863|NCT00408434|528745212|FG003|Overall Study|Progressive disease|3|||
146610864|NCT00408434|528745213|FG004|Overall Study|Progressive disease|3|||
146610865|NCT00408434|528745214|FG005|Overall Study|Progressive disease|1|||
146610866|NCT00408434|528745215|FG006|Overall Study|Progressive disease|4|||
146773374|NCT02544074|529341047|FG008|Overall Study|Withdrawal by Subject|0|||
146773375|NCT02544074|529341048|FG009|Overall Study|Withdrawal by Subject|0|||
146773376|NCT02544074|529341049|FG010|Overall Study|Withdrawal by Subject|0|||
146773377|NCT02544074|529341050|FG011|Overall Study|Withdrawal by Subject|0|||
146923032|NCT03712345|529878736|FG001|Overall Study|Failure to meet randomization criteria|0|||
146923033|NCT03712345|529878737|FG002|Overall Study|Failure to meet randomization criteria|1|||
146923034|NCT00960934|529878738|FG000|Overall Study|Adverse Event|2|||
146610867|NCT00408434|528745209|FG000|Overall Study|Other|0|||
146923035|NCT00960934|529878739|FG001|Overall Study|Adverse Event|3|||
146610868|NCT00408434|528745210|FG001|Overall Study|Other|0|||
146610869|NCT00408434|528745211|FG002|Overall Study|Other|1|||
146610870|NCT00408434|528745212|FG003|Overall Study|Other|0|||
146610871|NCT00408434|528745213|FG004|Overall Study|Other|2|||
146773378|NCT02544074|529341051|FG012|Overall Study|Withdrawal by Subject|0|||
146773379|NCT02544074|529341052|FG013|Overall Study|Withdrawal by Subject|0|||
146773380|NCT02544074|529341053|FG014|Overall Study|Withdrawal by Subject|0|||
146923036|NCT00960934|529878740|FG002|Overall Study|Adverse Event|3|||
146610872|NCT00408434|528745214|FG005|Overall Study|Other|1|||
146610873|NCT00408434|528745215|FG006|Overall Study|Other|0|||
146610874|NCT00408434|528745209|FG000|Overall Study|Terminated by Investigator|0|||
146610875|NCT00408434|528745210|FG001|Overall Study|Terminated by Investigator|0|||
146610876|NCT00408434|528745211|FG002|Overall Study|Terminated by Investigator|0|||
146610877|NCT00408434|528745212|FG003|Overall Study|Terminated by Investigator|0|||
146610878|NCT00408434|528745213|FG004|Overall Study|Terminated by Investigator|1|||
146610879|NCT00408434|528745214|FG005|Overall Study|Terminated by Investigator|1|||
146610880|NCT00408434|528745215|FG006|Overall Study|Terminated by Investigator|0|||
146610881|NCT00588354|528745216|FG000|Baseline to 2 Weeks|Adverse Event|1|||
146610882|NCT00588354|528745217|FG001|Baseline to 2 Weeks|Adverse Event|0|||
146610883|NCT00588354|528745216|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
146610884|NCT00588354|528745217|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
146610885|NCT00588354|528745216|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
146610886|NCT00588354|528745217|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
146610887|NCT04230213|528745218|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
146610888|NCT04230213|528745219|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
146923037|NCT00960934|529878741|FG003|Overall Study|Adverse Event|2|||
146923038|NCT00960934|529878742|FG004|Overall Study|Adverse Event|4|||
146923039|NCT00960934|529878743|FG005|Overall Study|Adverse Event|3|||
146923040|NCT00960934|529878738|FG000|Overall Study|Lack of Efficacy|1|||
146923041|NCT00960934|529878739|FG001|Overall Study|Lack of Efficacy|0|||
146923042|NCT00960934|529878740|FG002|Overall Study|Lack of Efficacy|0|||
146923043|NCT00960934|529878741|FG003|Overall Study|Lack of Efficacy|0|||
146923044|NCT00960934|529878742|FG004|Overall Study|Lack of Efficacy|0|||
146923045|NCT00960934|529878743|FG005|Overall Study|Lack of Efficacy|0|||
146923046|NCT00960934|529878738|FG000|Overall Study|Lost to Follow-up|0|||
146923047|NCT00960934|529878739|FG001|Overall Study|Lost to Follow-up|1|||
146923048|NCT00960934|529878740|FG002|Overall Study|Lost to Follow-up|0|||
146923049|NCT00960934|529878741|FG003|Overall Study|Lost to Follow-up|0|||
146923050|NCT00960934|529878742|FG004|Overall Study|Lost to Follow-up|0|||
146923051|NCT00960934|529878743|FG005|Overall Study|Lost to Follow-up|0|||
146923052|NCT00960934|529878738|FG000|Overall Study|Other|2|||
146923053|NCT00960934|529878739|FG001|Overall Study|Other|1|||
146923054|NCT00960934|529878740|FG002|Overall Study|Other|5|||
146923055|NCT00960934|529878741|FG003|Overall Study|Other|4|||
146923056|NCT00960934|529878742|FG004|Overall Study|Other|2|||
146923057|NCT00960934|529878743|FG005|Overall Study|Other|2|||
146923058|NCT00960934|529878738|FG000|Overall Study|Physician Decision|0|||
146923059|NCT00960934|529878739|FG001|Overall Study|Physician Decision|1|||
146923060|NCT00960934|529878740|FG002|Overall Study|Physician Decision|0|||
146923061|NCT00960934|529878741|FG003|Overall Study|Physician Decision|0|||
146923062|NCT00960934|529878742|FG004|Overall Study|Physician Decision|0|||
146923063|NCT00960934|529878743|FG005|Overall Study|Physician Decision|0|||
146923064|NCT00960934|529878738|FG000|Overall Study|Progressive Disease|1|||
146923065|NCT00960934|529878739|FG001|Overall Study|Progressive Disease|1|||
146923066|NCT00960934|529878740|FG002|Overall Study|Progressive Disease|0|||
146923067|NCT00960934|529878741|FG003|Overall Study|Progressive Disease|0|||
146923068|NCT00960934|529878742|FG004|Overall Study|Progressive Disease|1|||
146923069|NCT00960934|529878743|FG005|Overall Study|Progressive Disease|1|||
146923070|NCT00960934|529878738|FG000|Overall Study|Protocol Violation|3|||
146923071|NCT00960934|529878739|FG001|Overall Study|Protocol Violation|4|||
146923072|NCT00960934|529878740|FG002|Overall Study|Protocol Violation|0|||
146923073|NCT00960934|529878741|FG003|Overall Study|Protocol Violation|3|||
146923074|NCT00960934|529878742|FG004|Overall Study|Protocol Violation|3|||
146923075|NCT00960934|529878743|FG005|Overall Study|Protocol Violation|2|||
146923076|NCT00960934|529878738|FG000|Overall Study|Withdrawal by Subject|5|||
146923077|NCT00960934|529878739|FG001|Overall Study|Withdrawal by Subject|6|||
146610889|NCT04230213|528745220|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
146610890|NCT04230213|528745218|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
146610891|NCT04230213|528745219|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
146610892|NCT04230213|528745220|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
146610893|NCT04230213|528745218|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
146610894|NCT04230213|528745219|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
146610895|NCT04230213|528745220|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
146610896|NCT04230213|528745218|FG000|TP2: Week 10 to Week 16|Other|0|||
146610897|NCT04230213|528745219|FG001|TP2: Week 10 to Week 16|Other|2|||
146610898|NCT04230213|528745220|FG002|TP2: Week 10 to Week 16|Other|1|||
146610899|NCT04230213|528745218|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
146610900|NCT04230213|528745219|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
146610901|NCT04230213|528745220|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
146923078|NCT00960934|529878740|FG002|Overall Study|Withdrawal by Subject|4|||
146610902|NCT04230213|528745218|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
146923079|NCT00960934|529878741|FG003|Overall Study|Withdrawal by Subject|5|||
146923080|NCT00960934|529878742|FG004|Overall Study|Withdrawal by Subject|5|||
146923081|NCT00960934|529878743|FG005|Overall Study|Withdrawal by Subject|7|||
146923082|NCT00960934|529878738|FG000|Overall Study|Study Terminated by Sponsor|50|||
146923083|NCT00960934|529878739|FG001|Overall Study|Study Terminated by Sponsor|46|||
146923084|NCT00960934|529878740|FG002|Overall Study|Study Terminated by Sponsor|52|||
146923085|NCT00960934|529878741|FG003|Overall Study|Study Terminated by Sponsor|50|||
146923086|NCT00960934|529878742|FG004|Overall Study|Study Terminated by Sponsor|49|||
146923087|NCT00960934|529878743|FG005|Overall Study|Study Terminated by Sponsor|49|||
146923088|NCT00288860|529878746|FG000|Overall Study|Did not complete intake|4|||
146610903|NCT04230213|528745219|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
146610904|NCT04230213|528745220|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
146610905|NCT04230213|528745218|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
146610906|NCT04230213|528745219|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
146610907|NCT04230213|528745220|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
146610908|NCT04230213|528745218|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
146610909|NCT04230213|528745219|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
146610910|NCT04230213|528745220|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
146657738|NCT02325791|528925244|FG001|Overall Study|Physician Decision|1|||
146923089|NCT00288860|529878747|FG001|Overall Study|Did not complete intake|8|||
146923090|NCT00288860|529878746|FG000|Overall Study|Death|4|||
146923091|NCT00288860|529878747|FG001|Overall Study|Death|3|||
146923092|NCT00288860|529878746|FG000|Overall Study|Withdrawal by Subject|20|||
146923093|NCT00288860|529878747|FG001|Overall Study|Withdrawal by Subject|15|||
146923094|NCT00288860|529878746|FG000|Overall Study|Lost to Follow-up|74|||
146923095|NCT00288860|529878747|FG001|Overall Study|Lost to Follow-up|71|||
146923096|NCT02116660|529878748|FG000|Overall Study|Deteriorating renal function|0|||
146923097|NCT02116660|529878749|FG001|Overall Study|Deteriorating renal function|1|||
146923098|NCT02116660|529878748|FG000|Overall Study|Adverse Event|1|||
146923099|NCT02116660|529878749|FG001|Overall Study|Adverse Event|1|||
146923100|NCT02116660|529878748|FG000|Overall Study|Withdrawal by Subject|0|||
146923101|NCT02116660|529878749|FG001|Overall Study|Withdrawal by Subject|2|||
146923102|NCT02116660|529878748|FG000|Overall Study|Organization reason|1|||
146923103|NCT02116660|529878749|FG001|Overall Study|Organization reason|0|||
146923104|NCT01911845|529878758|FG000|Overall Study|Adverse Event|2|||
146923105|NCT01911845|529878758|FG000|Overall Study|Lost to Follow-up|1|||
146923106|NCT01911845|529878758|FG000|Overall Study|Other (not specified)|3|||
146923107|NCT01994226|529878759|FG000|Overall Study|Protocol Violation|13|||
146923108|NCT01994226|529878760|FG001|Overall Study|Protocol Violation|10|||
146923109|NCT01994226|529878759|FG000|Overall Study|Early Cessation of treatment|6|||
146923110|NCT01994226|529878760|FG001|Overall Study|Early Cessation of treatment|11|||
146923111|NCT02488551|529878763|FG000|Overall Study|Lost to Follow-up|4|||
146923112|NCT02488551|529878764|FG001|Overall Study|Lost to Follow-up|7|||
146923113|NCT02488551|529878765|FG002|Overall Study|Lost to Follow-up|0|||
146923114|NCT02488551|529878766|FG003|Overall Study|Lost to Follow-up|0|||
146923115|NCT02488551|529878763|FG000|Overall Study|Military Deployment|1|||
146923116|NCT02488551|529878764|FG001|Overall Study|Military Deployment|1|||
146923117|NCT02488551|529878765|FG002|Overall Study|Military Deployment|0|||
146923118|NCT02488551|529878766|FG003|Overall Study|Military Deployment|0|||
146923119|NCT01188564|529878775|FG000|Double-blind Phase|randomized not treated|1|||
146923120|NCT01188564|529878776|FG001|Double-blind Phase|randomized not treated|0|||
146923121|NCT04171037|529878777|FG000|Overall Study|Lost to Follow-up|1|||
146923122|NCT04171037|529878778|FG001|Overall Study|Lost to Follow-up|0|||
146923123|NCT04171037|529878777|FG000|Overall Study|Physician Decision|3|||
146923124|NCT04171037|529878778|FG001|Overall Study|Physician Decision|3|||
146923125|NCT01934894|529878779|FG000|Overall Study|Adverse Event|1|||
146923126|NCT01934894|529878780|FG001|Overall Study|Adverse Event|2|||
146923127|NCT01934894|529878779|FG000|Overall Study|Death|2|||
146923128|NCT01934894|529878780|FG001|Overall Study|Death|0|||
146923129|NCT01934894|529878779|FG000|Overall Study|Withdrawal by Subject|0|||
146923130|NCT01934894|529878780|FG001|Overall Study|Withdrawal by Subject|1|||
146923131|NCT01934894|529878779|FG000|Overall Study|Progressive Disease|3|||
146923132|NCT01934894|529878780|FG001|Overall Study|Progressive Disease|2|||
146923133|NCT02864940|529878781|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
146923134|NCT02864940|529878782|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
146923135|NCT04804033|529878784|FG000|Period 1: DBT Phase|Adverse Event|1|||
146923136|NCT04804033|529878785|FG001|Period 1: DBT Phase|Adverse Event|5|||
146923137|NCT04804033|529878786|FG002|Period 1: DBT Phase|Adverse Event|3|||
146923138|NCT04804033|529878787|FG003|Period 1: DBT Phase|Adverse Event|4|||
146923139|NCT04804033|529878784|FG000|Period 1: DBT Phase|Death|1|||
146923140|NCT04804033|529878785|FG001|Period 1: DBT Phase|Death|0|||
146923141|NCT04804033|529878786|FG002|Period 1: DBT Phase|Death|0|||
146923142|NCT04804033|529878787|FG003|Period 1: DBT Phase|Death|0|||
146923143|NCT04804033|529878784|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
146923144|NCT04804033|529878785|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
146923145|NCT04804033|529878786|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
146923146|NCT04804033|529878787|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
146923147|NCT04804033|529878784|FG000|Period 1: DBT Phase|Non-compliance|1|||
146923148|NCT04804033|529878785|FG001|Period 1: DBT Phase|Non-compliance|0|||
146923149|NCT04804033|529878786|FG002|Period 1: DBT Phase|Non-compliance|1|||
146610911|NCT04230213|528745218|FG000|TP3: Week 16 to Week 22|Other|0|||
146610912|NCT04230213|528745219|FG001|TP3: Week 16 to Week 22|Other|1|||
146657739|NCT02325791|528925245|FG002|Overall Study|Physician Decision|1|||
146657740|NCT02325791|528925246|FG003|Overall Study|Physician Decision|0|||
146923150|NCT04804033|529878787|FG003|Period 1: DBT Phase|Non-compliance|2|||
146923151|NCT04804033|529878784|FG000|Period 1: DBT Phase|Other|0|||
146923152|NCT04804033|529878785|FG001|Period 1: DBT Phase|Other|1|||
146923153|NCT04804033|529878786|FG002|Period 1: DBT Phase|Other|0|||
146923154|NCT04804033|529878787|FG003|Period 1: DBT Phase|Other|0|||
146923155|NCT04804033|529878784|FG000|Period 1: DBT Phase|Pregnancy|2|||
146923156|NCT04804033|529878785|FG001|Period 1: DBT Phase|Pregnancy|0|||
146923157|NCT04804033|529878786|FG002|Period 1: DBT Phase|Pregnancy|0|||
146923158|NCT04804033|529878787|FG003|Period 1: DBT Phase|Pregnancy|0|||
146923159|NCT04804033|529878784|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
146923160|NCT04804033|529878785|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
146923161|NCT04804033|529878786|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
146923162|NCT04804033|529878787|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
146923163|NCT04804033|529878784|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
146923164|NCT04804033|529878785|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
146923165|NCT04804033|529878786|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
146923166|NCT04804033|529878787|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
146923167|NCT04804033|529878784|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
146923168|NCT04804033|529878785|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
146923169|NCT04804033|529878786|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
146923170|NCT04804033|529878787|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
146923171|NCT04804033|529878784|FG000|Period 2: OLE Phase|Adverse Event|3|||
146923172|NCT04804033|529878785|FG001|Period 2: OLE Phase|Adverse Event|4|||
146923173|NCT04804033|529878786|FG002|Period 2: OLE Phase|Adverse Event|2|||
146610913|NCT04230213|528745220|FG002|TP3: Week 16 to Week 22|Other|3|||
146610914|NCT04230213|528745218|FG000|TP4: Week 22 to Week 32|Other|0|||
146610915|NCT04230213|528745219|FG001|TP4: Week 22 to Week 32|Other|5|||
146610916|NCT04230213|528745220|FG002|TP4: Week 22 to Week 32|Other|5|||
146923174|NCT04804033|529878787|FG003|Period 2: OLE Phase|Adverse Event|0|||
146923175|NCT04804033|529878784|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
146923176|NCT04804033|529878785|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
146610917|NCT04230213|528745218|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
146923177|NCT04804033|529878786|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
146923178|NCT04804033|529878787|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
146923179|NCT04804033|529878784|FG000|Period 2: OLE Phase|Non-compliance|2|||
146923180|NCT04804033|529878785|FG001|Period 2: OLE Phase|Non-compliance|2|||
146923181|NCT04804033|529878786|FG002|Period 2: OLE Phase|Non-compliance|0|||
146923182|NCT04804033|529878787|FG003|Period 2: OLE Phase|Non-compliance|1|||
146923183|NCT04804033|529878784|FG000|Period 2: OLE Phase|Other|0|||
146923184|NCT04804033|529878785|FG001|Period 2: OLE Phase|Other|2|||
146923185|NCT04804033|529878786|FG002|Period 2: OLE Phase|Other|0|||
146923186|NCT04804033|529878787|FG003|Period 2: OLE Phase|Other|0|||
146923187|NCT04804033|529878784|FG000|Period 2: OLE Phase|Physician Decision|1|||
146923188|NCT04804033|529878785|FG001|Period 2: OLE Phase|Physician Decision|1|||
146923189|NCT04804033|529878786|FG002|Period 2: OLE Phase|Physician Decision|0|||
146923190|NCT04804033|529878787|FG003|Period 2: OLE Phase|Physician Decision|0|||
146923191|NCT04804033|529878784|FG000|Period 2: OLE Phase|Pregnancy|0|||
146923192|NCT04804033|529878785|FG001|Period 2: OLE Phase|Pregnancy|0|||
146923193|NCT04804033|529878786|FG002|Period 2: OLE Phase|Pregnancy|2|||
146923194|NCT04804033|529878787|FG003|Period 2: OLE Phase|Pregnancy|0|||
146923195|NCT04804033|529878784|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
146923196|NCT04804033|529878785|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
146923197|NCT04804033|529878786|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
146923198|NCT04804033|529878787|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
146923199|NCT04804033|529878784|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
146923200|NCT04804033|529878785|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
146923201|NCT04804033|529878786|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
146923202|NCT04804033|529878787|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
146923203|NCT04804033|529878784|FG000|Period 2: OLE Phase|Not reported|0|||
146923204|NCT04804033|529878785|FG001|Period 2: OLE Phase|Not reported|2|||
146923205|NCT04804033|529878786|FG002|Period 2: OLE Phase|Not reported|0|||
146923206|NCT04804033|529878787|FG003|Period 2: OLE Phase|Not reported|0|||
146923207|NCT04804033|529878784|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
146923208|NCT04804033|529878785|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
146923209|NCT04804033|529878786|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
146610918|NCT04230213|528745219|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
146610919|NCT04230213|528745220|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
146923210|NCT04804033|529878787|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
146923211|NCT04804033|529878784|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
146923212|NCT04804033|529878785|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
146923213|NCT04804033|529878786|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
146923214|NCT04804033|529878787|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
146923215|NCT04804033|529878784|FG000|Period 3: Follow-up Phase|Other|0|||
146923216|NCT04804033|529878785|FG001|Period 3: Follow-up Phase|Other|1|||
146923217|NCT04804033|529878786|FG002|Period 3: Follow-up Phase|Other|2|||
146923218|NCT04804033|529878787|FG003|Period 3: Follow-up Phase|Other|1|||
146610920|NCT04230213|528745218|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
146610921|NCT04230213|528745219|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
146923219|NCT04804033|529878784|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
146923220|NCT04804033|529878785|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
146923221|NCT04804033|529878786|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
146923222|NCT04804033|529878787|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
146923223|NCT04804033|529878784|FG000|Period 3: Follow-up Phase|Not reported|18|||
146923224|NCT04804033|529878785|FG001|Period 3: Follow-up Phase|Not reported|15|||
146923225|NCT04804033|529878786|FG002|Period 3: Follow-up Phase|Not reported|1|||
146923226|NCT04804033|529878787|FG003|Period 3: Follow-up Phase|Not reported|4|||
146923227|NCT01106625|529878798|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
146923228|NCT01106625|529878799|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
146923229|NCT01106625|529878800|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
146923230|NCT01106625|529878798|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
146923231|NCT01106625|529878799|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
146923232|NCT01106625|529878800|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
146923233|NCT01106625|529878798|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
146923234|NCT01106625|529878799|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
146923235|NCT01106625|529878800|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
146923236|NCT01106625|529878798|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
146923237|NCT01106625|529878799|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
146923238|NCT01106625|529878800|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
146923239|NCT01106625|529878798|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
146923240|NCT01106625|529878799|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
146923241|NCT01106625|529878800|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
146923242|NCT01106625|529878798|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
146923243|NCT01106625|529878799|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
146923244|NCT01106625|529878800|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
146923245|NCT01106625|529878798|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
146923246|NCT01106625|529878799|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
146923247|NCT01106625|529878800|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
146923248|NCT01106625|529878798|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
146923249|NCT01106625|529878799|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
146923250|NCT01106625|529878800|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
146923251|NCT01106625|529878798|FG000|Core Period: Baseline to Week 26|Other|8|||
146923252|NCT01106625|529878799|FG001|Core Period: Baseline to Week 26|Other|7|||
146923253|NCT01106625|529878800|FG002|Core Period: Baseline to Week 26|Other|4|||
146923254|NCT01106625|529878798|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
146610922|NCT04230213|528745220|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
146610923|NCT04230213|528745218|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
146610924|NCT04230213|528745219|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
146610925|NCT04230213|528745220|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
146610926|NCT04230213|528745218|FG000|Follow up: Week 32 to Week 36|Other|0|||
146610927|NCT04230213|528745219|FG001|Follow up: Week 32 to Week 36|Other|1|||
146610928|NCT04230213|528745220|FG002|Follow up: Week 32 to Week 36|Other|1|||
146610929|NCT03058692|528746823|FG000|Overall Study|Lost to Follow-up|2|||
146610930|NCT03058692|528746824|FG001|Overall Study|Lost to Follow-up|1|||
146610931|NCT03058692|528746823|FG000|Overall Study|Withdrawal by Subject|1|||
146610932|NCT03058692|528746824|FG001|Overall Study|Withdrawal by Subject|1|||
146610933|NCT00806988|528746825|FG000|Overall Study|Death|15|||
146610934|NCT00806988|528746826|FG001|Overall Study|Death|16|||
146610935|NCT00806988|528746825|FG000|Overall Study|Withdrawal by Subject|8|||
146610936|NCT00806988|528746826|FG001|Overall Study|Withdrawal by Subject|8|||
146610937|NCT00806988|528746825|FG000|Overall Study|Lost to Follow-up|4|||
146610938|NCT00806988|528746826|FG001|Overall Study|Lost to Follow-up|19|||
146610939|NCT04775953|528746828|FG000|Overall Study|Lost to Follow-up|6|||
146610940|NCT04775953|528746829|FG001|Overall Study|Lost to Follow-up|11|||
146610941|NCT04775953|528746828|FG000|Overall Study|Death|5|||
146610942|NCT04775953|528746829|FG001|Overall Study|Death|4|||
146610943|NCT04775953|528746828|FG000|Overall Study|Withdrawal by Subject|3|||
146610944|NCT04775953|528746829|FG001|Overall Study|Withdrawal by Subject|3|||
146610945|NCT04775953|528746828|FG000|Overall Study|Protocol Violation|2|||
146610946|NCT04775953|528746829|FG001|Overall Study|Protocol Violation|0|||
146610947|NCT04775953|528746828|FG000|Overall Study|Participant non-compliance|0|||
146610948|NCT04775953|528746829|FG001|Overall Study|Participant non-compliance|1|||
146610949|NCT01698814|528746830|FG000|Overall Study|Adverse Event|0|||
146657741|NCT02325791|528925243|FG000|Overall Study|Protocol Violation|0|||
146657742|NCT02325791|528925244|FG001|Overall Study|Protocol Violation|0|||
146610950|NCT01698814|528746831|FG001|Overall Study|Adverse Event|2|||
146610951|NCT01698814|528746830|FG000|Overall Study|Lost to Follow-up|0|||
146610952|NCT01698814|528746831|FG001|Overall Study|Lost to Follow-up|1|||
146610953|NCT01698814|528746830|FG000|Overall Study|Pregnancy|1|||
146610954|NCT01698814|528746831|FG001|Overall Study|Pregnancy|0|||
146657743|NCT02325791|528925245|FG002|Overall Study|Protocol Violation|1|||
146923255|NCT01106625|529878799|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
146923256|NCT01106625|529878800|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
146923257|NCT01106625|529878798|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
146923258|NCT01106625|529878799|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
146923259|NCT01106625|529878800|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
146923260|NCT01106625|529878798|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
146610955|NCT01698814|528746830|FG000|Overall Study|Randomized in error|1|||
146610956|NCT01698814|528746831|FG001|Overall Study|Randomized in error|0|||
146610957|NCT00855959|528746832|FG000|Overall Study|Adverse Event|2|||
146610958|NCT00855959|528746832|FG000|Overall Study|Lost to Follow-up|2|||
146610959|NCT00855959|528746832|FG000|Overall Study|Withdrawal by Subject|3|||
146610960|NCT00855959|528746832|FG000|Overall Study|Pregnancy|1|||
146610961|NCT00855959|528746832|FG000|Overall Study|Incorrect enrolment|1|||
146610962|NCT00368641|528746836|FG000|Overall Study|Adverse Event|2|||
146610963|NCT00368641|528746837|FG001|Overall Study|Adverse Event|1|||
146610964|NCT00368641|528746836|FG000|Overall Study|Death|1|||
146610965|NCT00368641|528746837|FG001|Overall Study|Death|0|||
146610966|NCT00368641|528746836|FG000|Overall Study|Withdrawal by Subject|1|||
146610967|NCT00368641|528746837|FG001|Overall Study|Withdrawal by Subject|0|||
146610968|NCT00368641|528746836|FG000|Overall Study|Sponsor decision to terminate study|2|||
146610969|NCT00368641|528746837|FG001|Overall Study|Sponsor decision to terminate study|5|||
146610970|NCT04737278|528746840|FG000|Overall Study|Lost to Follow-up|1|||
146610971|NCT04737278|528746841|FG001|Overall Study|Lost to Follow-up|1|||
146610972|NCT04737278|528746840|FG000|Overall Study|Withdrawal by Subject|1|||
146610973|NCT04737278|528746841|FG001|Overall Study|Withdrawal by Subject|0|||
146610974|NCT04737278|528746840|FG000|Overall Study|Protocol Violation|1|||
146610975|NCT04737278|528746841|FG001|Overall Study|Protocol Violation|1|||
146610976|NCT04737278|528746840|FG000|Overall Study|failure to complete questionnaire|1|||
146610977|NCT04737278|528746841|FG001|Overall Study|failure to complete questionnaire|1|||
146610978|NCT01128244|528746844|FG000|Overall Study|Adverse Event|1|||
146610979|NCT01128244|528746844|FG000|Overall Study|Scheduling conflict|2|||
146610980|NCT04506502|528746848|FG000|Overall Study|Withdrawal by Subject|1|||
146610981|NCT04506502|528746848|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
146610982|NCT01449006|528746849|FG000|Overall Study|Lost to Follow-up|1|||
146610983|NCT01449006|528746850|FG001|Overall Study|Lost to Follow-up|0|||
146610984|NCT01449006|528746849|FG000|Overall Study|Withdrawal by Subject|1|||
146610985|NCT01449006|528746850|FG001|Overall Study|Withdrawal by Subject|0|||
146610986|NCT01449006|528746849|FG000|Overall Study|Protocol Violation|1|||
146610987|NCT01449006|528746850|FG001|Overall Study|Protocol Violation|0|||
146610988|NCT03526146|528746851|FG000|Overall Study|Lost to Follow-up|5|||
146923261|NCT01106625|529878799|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
146923262|NCT01106625|529878800|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
146923263|NCT01106625|529878798|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
146923264|NCT01106625|529878799|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
146923265|NCT01106625|529878800|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
146923266|NCT01106625|529878798|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
146923267|NCT01106625|529878799|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
146923268|NCT01106625|529878800|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
146923269|NCT01106625|529878798|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
146923270|NCT01106625|529878799|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
146923271|NCT01106625|529878800|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
146923272|NCT01106625|529878798|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
146923273|NCT01106625|529878799|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
146923274|NCT01106625|529878800|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
146923275|NCT01106625|529878798|FG000|Extension Period: Week 26 to Week 52|Other|5|||
146923276|NCT01106625|529878799|FG001|Extension Period: Week 26 to Week 52|Other|5|||
146923277|NCT01106625|529878800|FG002|Extension Period: Week 26 to Week 52|Other|4|||
146923278|NCT02496585|529878801|FG000|Overall Study|Death|3|||
146923279|NCT02496585|529878802|FG001|Overall Study|Death|0|||
146923280|NCT02496585|529878801|FG000|Overall Study|Lost to Follow-up|2|||
146923281|NCT02496585|529878802|FG001|Overall Study|Lost to Follow-up|0|||
146923282|NCT02496585|529878801|FG000|Overall Study|Withdrawal by Subject|1|||
146923283|NCT02496585|529878802|FG001|Overall Study|Withdrawal by Subject|2|||
146923284|NCT02496585|529878801|FG000|Overall Study|Progression of Malignancy|4|||
146610989|NCT03526146|528746851|FG000|Overall Study|Withdrawal by Subject|6|||
146610990|NCT03526146|528746851|FG000|Overall Study|class canceled due to COVID-19|4|||
146610991|NCT02588261|528746852|FG000|Overall Study|Study Terminated by Sponsor|157|||
146610992|NCT02588261|528746853|FG001|Overall Study|Study Terminated by Sponsor|142|||
146610993|NCT02588261|528746852|FG000|Overall Study|Protocol Deviation|1|||
146610994|NCT02588261|528746853|FG001|Overall Study|Protocol Deviation|0|||
146610995|NCT02588261|528746852|FG000|Overall Study|Death|1|||
146610996|NCT02588261|528746853|FG001|Overall Study|Death|2|||
146923285|NCT02496585|529878802|FG001|Overall Study|Progression of Malignancy|1|||
146923286|NCT01100307|529878803|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
146923287|NCT01100307|529878804|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
146923288|NCT01100307|529878803|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
146923289|NCT01100307|529878804|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
146923290|NCT01100307|529878803|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
146923291|NCT01100307|529878804|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
146923292|NCT01100307|529878803|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
146923293|NCT01100307|529878804|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
146923294|NCT01100307|529878803|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
146923295|NCT01100307|529878804|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
146923296|NCT01100307|529878803|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
146923297|NCT01100307|529878804|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
146923298|NCT00997321|529878805|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
146923299|NCT00997321|529878806|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
146923300|NCT01276457|529878809|FG000|Core Study|Adverse Event|6|||
146923301|NCT01276457|529878810|FG001|Core Study|Adverse Event|3|||
146923302|NCT01276457|529878809|FG000|Core Study|Lost to Follow-up|1|||
146923303|NCT01276457|529878810|FG001|Core Study|Lost to Follow-up|2|||
146923304|NCT01276457|529878809|FG000|Core Study|Administrative problems|1|||
146923305|NCT01276457|529878810|FG001|Core Study|Administrative problems|1|||
146923306|NCT01276457|529878809|FG000|Core Study|Death|2|||
146923307|NCT01276457|529878810|FG001|Core Study|Death|2|||
146923308|NCT01276457|529878809|FG000|Core Study|Lack of Efficacy|3|||
146923309|NCT01276457|529878810|FG001|Core Study|Lack of Efficacy|12|||
146923310|NCT01276457|529878809|FG000|Extension Study|Lost to Follow-up|3|||
146923311|NCT01276457|529878810|FG001|Extension Study|Lost to Follow-up|0|||
146923312|NCT01276457|529878809|FG000|Extension Study|Death|0|||
146923313|NCT01276457|529878810|FG001|Extension Study|Death|1|||
146923314|NCT01276457|529878809|FG000|Extension Study|Lack of Efficacy|3|||
146923315|NCT01276457|529878810|FG001|Extension Study|Lack of Efficacy|1|||
146923316|NCT04436822|529878812|FG000|Overall Study|Physician Decision|2|||
146923317|NCT04436822|529878813|FG001|Overall Study|Physician Decision|0|||
146923318|NCT04436822|529878812|FG000|Overall Study|Sponsor request|1|||
146923319|NCT04436822|529878813|FG001|Overall Study|Sponsor request|0|||
146923320|NCT04436822|529878812|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146923321|NCT04436822|529878813|FG001|Overall Study|Withdrawal by parent/guardian|3|||
146923322|NCT04436822|529878812|FG000|Overall Study|Unsuccessful procedure|0|||
146923323|NCT04436822|529878813|FG001|Overall Study|Unsuccessful procedure|1|||
146923324|NCT04436822|529878812|FG000|Overall Study|Withdrawal due to Covid-19|8|||
146923325|NCT04436822|529878813|FG001|Overall Study|Withdrawal due to Covid-19|1|||
146923326|NCT04436822|529878812|FG000|Overall Study|Withdrawal by Subject|1|||
146923327|NCT04436822|529878813|FG001|Overall Study|Withdrawal by Subject|0|||
146923328|NCT04436822|529878812|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
146923329|NCT04436822|529878813|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
146923330|NCT05118386|529878814|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
146923331|NCT05118386|529878815|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
146923332|NCT05118386|529878816|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
146923333|NCT05118386|529878817|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
146923334|NCT05118386|529878818|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
146923335|NCT05118386|529878819|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
146923336|NCT05118386|529878814|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
146923337|NCT05118386|529878815|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
146923338|NCT05118386|529878816|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
146923339|NCT05118386|529878817|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
146923340|NCT05118386|529878818|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
146923341|NCT05118386|529878819|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
146923342|NCT00369668|529878820|FG000|Overall Study|Lack of Efficacy|4|||
146923343|NCT00369668|529878821|FG001|Overall Study|Lack of Efficacy|5|||
146923344|NCT00369668|529878822|FG002|Overall Study|Lack of Efficacy|7|||
146978673|NCT02496221|530085457|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
146978674|NCT02496221|530085456|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
146657744|NCT02325791|528925246|FG003|Overall Study|Protocol Violation|0|||
146657745|NCT02325791|528925243|FG000|Overall Study|Withdrawal by Subject|0|||
146657746|NCT02325791|528925244|FG001|Overall Study|Withdrawal by Subject|5|||
146657747|NCT02325791|528925245|FG002|Overall Study|Withdrawal by Subject|8|||
146923345|NCT00303108|529878823|FG000|Overall Study|Adverse Event|5|||
146923346|NCT00303108|529878824|FG001|Overall Study|Adverse Event|6|||
146923347|NCT00303108|529878825|FG002|Overall Study|Adverse Event|7|||
146978675|NCT02496221|530085457|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
146978676|NCT03262233|530085458|FG000|Overall Study|Withdrawal by Subject|12|||
146978677|NCT03262233|530085459|FG001|Overall Study|Withdrawal by Subject|8|||
146773381|NCT02544074|529341054|FG015|Overall Study|Withdrawal by Subject|0|||
146773382|NCT02544074|529341055|FG016|Overall Study|Withdrawal by Subject|0|||
146773383|NCT02544074|529341056|FG017|Overall Study|Withdrawal by Subject|0|||
146773384|NCT02544074|529341057|FG018|Overall Study|Withdrawal by Subject|0|||
146923348|NCT00303108|529878823|FG000|Overall Study|Patient Request|4|||
146923349|NCT00303108|529878824|FG001|Overall Study|Patient Request|2|||
146923350|NCT00303108|529878825|FG002|Overall Study|Patient Request|8|||
146923351|NCT00303108|529878823|FG000|Overall Study|Failed Entry|1|||
146923352|NCT00303108|529878824|FG001|Overall Study|Failed Entry|0|||
146923353|NCT00303108|529878825|FG002|Overall Study|Failed Entry|1|||
146923354|NCT00303108|529878823|FG000|Overall Study|ineligible|2|||
146923355|NCT00303108|529878824|FG001|Overall Study|ineligible|1|||
146923356|NCT00303108|529878825|FG002|Overall Study|ineligible|0|||
146923357|NCT00894413|529878828|FG000|Overall Study|Physician Decision|0|||
146923358|NCT00894413|529878829|FG001|Overall Study|Physician Decision|2|||
146923359|NCT00894413|529878828|FG000|Overall Study|Adverse Event|0|||
146923360|NCT00894413|529878829|FG001|Overall Study|Adverse Event|2|||
146923361|NCT00894413|529878828|FG000|Overall Study|Withdrawal by Subject|0|||
146923362|NCT00894413|529878829|FG001|Overall Study|Withdrawal by Subject|4|||
146923363|NCT02427477|529878833|FG000|Period 1|Adverse Event|1|||
146923364|NCT02427477|529878834|FG001|Period 1|Adverse Event|0|||
146923365|NCT00471445|529878835|FG000|Overall Study|Withdrawal by Subject|1|||
146923366|NCT00471445|529878836|FG001|Overall Study|Withdrawal by Subject|1|||
146923367|NCT00471445|529878835|FG000|Overall Study|Ineligible|1|||
146923368|NCT00471445|529878836|FG001|Overall Study|Ineligible|0|||
146923369|NCT00471445|529878835|FG000|Overall Study|Protocol Violation|0|||
146923370|NCT00471445|529878836|FG001|Overall Study|Protocol Violation|1|||
146923371|NCT04715230|529878837|FG000|Overall Study|Withdrawal by Subject|1|||
146773385|NCT02544074|529341058|FG019|Overall Study|Withdrawal by Subject|0|||
146773386|NCT02544074|529341059|FG020|Overall Study|Withdrawal by Subject|0|||
146773387|NCT02544074|529341039|FG000|Overall Study|Tablet error|0|||
146773388|NCT02544074|529341040|FG001|Overall Study|Tablet error|0|||
146773389|NCT02544074|529341041|FG002|Overall Study|Tablet error|0|||
146773390|NCT02544074|529341042|FG003|Overall Study|Tablet error|0|||
146773391|NCT02544074|529341043|FG004|Overall Study|Tablet error|0|||
146773392|NCT02544074|529341044|FG005|Overall Study|Tablet error|1|||
146773393|NCT02544074|529341045|FG006|Overall Study|Tablet error|0|||
146773394|NCT02544074|529341046|FG007|Overall Study|Tablet error|0|||
146773395|NCT02544074|529341047|FG008|Overall Study|Tablet error|0|||
146773396|NCT02544074|529341048|FG009|Overall Study|Tablet error|1|||
146773397|NCT02544074|529341049|FG010|Overall Study|Tablet error|0|||
146773398|NCT02544074|529341050|FG011|Overall Study|Tablet error|0|||
146923372|NCT04715230|529878838|FG001|Overall Study|Withdrawal by Subject|0|||
146923373|NCT04715230|529878839|FG002|Overall Study|Withdrawal by Subject|0|||
146923374|NCT04715230|529878837|FG000|Overall Study|Lost to Follow-up|0|||
146773399|NCT02544074|529341051|FG012|Overall Study|Tablet error|0|||
146773400|NCT02544074|529341052|FG013|Overall Study|Tablet error|0|||
146773401|NCT02544074|529341053|FG014|Overall Study|Tablet error|0|||
146773402|NCT02544074|529341054|FG015|Overall Study|Tablet error|0|||
146773403|NCT02544074|529341055|FG016|Overall Study|Tablet error|0|||
146773404|NCT02544074|529341056|FG017|Overall Study|Tablet error|0|||
146773405|NCT02544074|529341057|FG018|Overall Study|Tablet error|0|||
146773406|NCT02544074|529341058|FG019|Overall Study|Tablet error|0|||
146773407|NCT02544074|529341059|FG020|Overall Study|Tablet error|0|||
146773408|NCT03189524|529341061|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
146773409|NCT03189524|529341062|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
146773410|NCT03189524|529341063|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
146773411|NCT03189524|529341061|FG000|Overall Study|Death|2|||
146773412|NCT03189524|529341062|FG001|Overall Study|Death|2|||
146773413|NCT03189524|529341063|FG002|Overall Study|Death|1|||
146773414|NCT03189524|529341061|FG000|Overall Study|Lost to Follow-up|1|||
146923375|NCT04715230|529878838|FG001|Overall Study|Lost to Follow-up|5|||
146923376|NCT04715230|529878839|FG002|Overall Study|Lost to Follow-up|1|||
146923377|NCT01468909|529878847|FG000|Overall Study|Never Treated|2|||
146923378|NCT01468909|529878848|FG001|Overall Study|Never Treated|2|||
146923379|NCT02635737|529878849|FG000|Overall Study|Protocol Violation|1|||
146923380|NCT01552928|529878850|FG000|Period 3|Adverse Event|0|||
146923381|NCT01552928|529878851|FG001|Period 3|Adverse Event|0|||
146923382|NCT01552928|529878852|FG002|Period 3|Adverse Event|1|||
146923383|NCT01552928|529878853|FG003|Period 3|Adverse Event|0|||
146773415|NCT03189524|529341062|FG001|Overall Study|Lost to Follow-up|0|||
146773416|NCT03189524|529341063|FG002|Overall Study|Lost to Follow-up|8|||
146773417|NCT03189524|529341061|FG000|Overall Study|Withdrawal by Subject|1|||
146773418|NCT03189524|529341062|FG001|Overall Study|Withdrawal by Subject|1|||
146773419|NCT03189524|529341063|FG002|Overall Study|Withdrawal by Subject|3|||
146773420|NCT03189524|529341061|FG000|Overall Study|Progressive Disease|0|||
146923384|NCT01511419|529878854|FG000|Dose 2|Physician Decision|1|||
146923385|NCT01511419|529878855|FG001|Dose 2|Physician Decision|0|||
146923386|NCT00937768|529878856|FG000|Overall Study|Refused Further Treatment|3|||
146923387|NCT00937768|529878857|FG001|Overall Study|Refused Further Treatment|2|||
146610997|NCT02588261|528746852|FG000|Overall Study|Withdrawal by Subject|12|||
146610998|NCT02588261|528746853|FG001|Overall Study|Withdrawal by Subject|8|||
146610999|NCT02588261|528746852|FG000|Overall Study|Noncompliance with Study Drug|0|||
146611000|NCT02588261|528746853|FG001|Overall Study|Noncompliance with Study Drug|1|||
146611001|NCT02588261|528746852|FG000|Overall Study|Miscellaneous|5|||
146611002|NCT02588261|528746853|FG001|Overall Study|Miscellaneous|4|||
146611003|NCT02588261|528746852|FG000|Overall Study|Progressive Disease|61|||
146611004|NCT02588261|528746853|FG001|Overall Study|Progressive Disease|82|||
146611005|NCT02588261|528746852|FG000|Overall Study|Adverse Event|29|||
146611006|NCT02588261|528746853|FG001|Overall Study|Adverse Event|24|||
146611007|NCT02588261|528746852|FG000|Overall Study|Lost to Follow-up|1|||
146611008|NCT02588261|528746853|FG001|Overall Study|Lost to Follow-up|0|||
146611009|NCT01746368|528746858|FG000|Overall Study|Lost to Follow-up|2|||
146611010|NCT01746368|528746859|FG001|Overall Study|Lost to Follow-up|0|||
146611011|NCT01746368|528746858|FG000|Overall Study|Withdrawal by Subject|0|||
146611012|NCT01746368|528746859|FG001|Overall Study|Withdrawal by Subject|1|||
146611013|NCT05636852|528746860|FG000|Overall Study|Withdrawal by Subject|1|||
146611014|NCT05636852|528746860|FG000|Overall Study|Other than specified|1|||
146611015|NCT03705559|528746864|FG000|Overall Study|COVID Shut down|1|||
146611016|NCT00195091|528746865|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
146611017|NCT01979952|528746875|FG000|Overall Study|Adverse Event|4|||
146611018|NCT01979952|528746876|FG001|Overall Study|Adverse Event|5|||
146611019|NCT01979952|528746875|FG000|Overall Study|Protocol Violation|1|||
146611020|NCT01979952|528746876|FG001|Overall Study|Protocol Violation|0|||
146611021|NCT01979952|528746875|FG000|Overall Study|Withdrawal by Subject|2|||
146611022|NCT01979952|528746876|FG001|Overall Study|Withdrawal by Subject|1|||
146611023|NCT01979952|528746875|FG000|Overall Study|Other than specified above|1|||
146611024|NCT01979952|528746876|FG001|Overall Study|Other than specified above|0|||
146611025|NCT03364738|528746883|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
146611026|NCT03364738|528746883|FG000|Overall Study|Withdrawal by Subject|1|||
146611027|NCT03364738|528746883|FG000|Overall Study|Adverse Event|1|||
146611028|NCT03245398|528746884|FG000|Overall Study|Travelled to another island|1|||
146611029|NCT03245398|528746885|FG001|Overall Study|Travelled to another island|0|||
146611030|NCT04079816|528746886|FG000|Overall Study|Request of Subject|2|||
146611031|NCT04079816|528746886|FG000|Overall Study|Unable to draw samples|1|||
146611032|NCT04531241|528746887|FG000|Period 1|Withdrawal by Subject|2|||
146611033|NCT04531241|528746888|FG001|Period 1|Withdrawal by Subject|0|||
146611034|NCT04531241|528746887|FG000|Period 1|Dispesed incorrect lens power|1|||
146611035|NCT04531241|528746888|FG001|Period 1|Dispesed incorrect lens power|0|||
146611036|NCT04531241|528746887|FG000|Period 1|Protocol Violation|1|||
146611037|NCT04531241|528746888|FG001|Period 1|Protocol Violation|0|||
146611038|NCT04531241|528746887|FG000|Period 1|No longer eligible|0|||
146611039|NCT04531241|528746888|FG001|Period 1|No longer eligible|1|||
146611040|NCT04531241|528746887|FG000|Period 1|Lens Discomfort|0|||
146611041|NCT04531241|528746888|FG001|Period 1|Lens Discomfort|1|||
146611042|NCT04531241|528746887|FG000|Period 2|Covid-19 Related|1|||
146611043|NCT04531241|528746888|FG001|Period 2|Covid-19 Related|1|||
146611044|NCT02576795|528746889|FG000|Overall Study|Lost to Follow-up|0|||
146611045|NCT02576795|528746890|FG001|Overall Study|Lost to Follow-up|0|||
146611046|NCT02576795|528746891|FG002|Overall Study|Lost to Follow-up|1|||
146611047|NCT02576795|528746892|FG003|Overall Study|Lost to Follow-up|0|||
146611048|NCT01702246|528746893|FG000|Overall Study|Lost to Follow-up|2|||
146611049|NCT01702246|528746893|FG000|Overall Study|Withdrawal by Subject|2|||
146611050|NCT01702246|528746893|FG000|Overall Study|Physician Decision|1|||
146611051|NCT03724890|528746894|FG000|Overall Study|Death|2|||
146611052|NCT03724890|528746895|FG001|Overall Study|Death|6|||
146611053|NCT03724890|528746896|FG002|Overall Study|Death|3|||
146611054|NCT03724890|528746897|FG003|Overall Study|Death|5|||
146611055|NCT03724890|528746898|FG004|Overall Study|Death|2|||
146611056|NCT03724890|528746899|FG005|Overall Study|Death|0|||
146611057|NCT03724890|528746900|FG006|Overall Study|Death|2|||
146611058|NCT03724890|528746901|FG007|Overall Study|Death|3|||
146611059|NCT03724890|528746902|FG008|Overall Study|Death|4|||
146611060|NCT03724890|528746903|FG009|Overall Study|Death|2|||
146611061|NCT03724890|528746904|FG010|Overall Study|Death|2|||
146611062|NCT03724890|528746894|FG000|Overall Study|Lost to Follow-up|0|||
146611063|NCT03724890|528746895|FG001|Overall Study|Lost to Follow-up|3|||
146611064|NCT03724890|528746896|FG002|Overall Study|Lost to Follow-up|0|||
146611065|NCT03724890|528746897|FG003|Overall Study|Lost to Follow-up|1|||
146611066|NCT03724890|528746898|FG004|Overall Study|Lost to Follow-up|2|||
146611067|NCT03724890|528746899|FG005|Overall Study|Lost to Follow-up|2|||
146611068|NCT03724890|528746900|FG006|Overall Study|Lost to Follow-up|1|||
146611069|NCT03724890|528746901|FG007|Overall Study|Lost to Follow-up|0|||
146611070|NCT03724890|528746902|FG008|Overall Study|Lost to Follow-up|2|||
146923388|NCT00937768|529878856|FG000|Overall Study|Disease Progression|1|||
146923389|NCT00937768|529878857|FG001|Overall Study|Disease Progression|1|||
146611071|NCT03724890|528746903|FG009|Overall Study|Lost to Follow-up|0|||
146611072|NCT03724890|528746904|FG010|Overall Study|Lost to Follow-up|0|||
146611073|NCT03724890|528746894|FG000|Overall Study|Withdrawal by Subject|1|||
146657748|NCT02325791|528925246|FG003|Overall Study|Withdrawal by Subject|16|||
146657749|NCT01028378|528925247|FG000|Overall Study|Lost to Follow-up|12|||
146657750|NCT01028378|528925247|FG000|Overall Study|Withdrawal by Subject|1|||
146657751|NCT01028378|528925247|FG000|Overall Study|Adminstrative Reasons|4|||
146657752|NCT01298193|528925248|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
146657753|NCT01298193|528925248|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
146657754|NCT01298193|528925248|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
146657755|NCT01298193|528925248|FG000|Efficacy Phase (Second Cycle)|Death|1|||
146657756|NCT00064298|528925249|FG000|Overall Study|Withdrawal by Subject|2|||
146657757|NCT00064298|528925250|FG001|Overall Study|Withdrawal by Subject|1|||
146657758|NCT00064298|528925249|FG000|Overall Study|Lost to Follow-up|2|||
146657759|NCT00064298|528925250|FG001|Overall Study|Lost to Follow-up|2|||
146657760|NCT00064298|528925249|FG000|Overall Study|Death|0|||
146657761|NCT00064298|528925250|FG001|Overall Study|Death|1|||
146657762|NCT00064298|528925249|FG000|Overall Study|Disease Progression|2|||
146657763|NCT00064298|528925250|FG001|Overall Study|Disease Progression|1|||
146657764|NCT03614975|528925251|FG000|Overall Study|Physician Decision|7|||
146657765|NCT03614975|528925252|FG001|Overall Study|Physician Decision|5|||
146657766|NCT03614975|528925251|FG000|Overall Study|Withdrawal by Subject|2|||
146657767|NCT03614975|528925252|FG001|Overall Study|Withdrawal by Subject|2|||
146657768|NCT03614975|528925251|FG000|Overall Study|Specimens not in lab batch shipment|1|||
146657769|NCT03614975|528925252|FG001|Overall Study|Specimens not in lab batch shipment|1|||
146657770|NCT03475875|528925253|FG000|Period 1|Lost to Follow-up|1|||
146657771|NCT03475875|528925254|FG001|Period 1|Lost to Follow-up|0|||
146657772|NCT03475875|528925253|FG000|Period 1|Adverse Event|2|||
146657773|NCT03475875|528925254|FG001|Period 1|Adverse Event|1|||
146657774|NCT03475875|528925253|FG000|Period 2|Adverse Event|3|||
146657775|NCT03475875|528925254|FG001|Period 2|Adverse Event|0|||
146657776|NCT03475875|528925253|FG000|Period 2|Protocol Violation|0|||
146657777|NCT03475875|528925254|FG001|Period 2|Protocol Violation|1|||
146657778|NCT01390220|528925255|FG000|Test Dose Phase|Adverse Event|17|||
146657779|NCT01390220|528925256|FG001|Test Dose Phase|Adverse Event|0|||
146657780|NCT01390220|528925257|FG002|Test Dose Phase|Adverse Event|0|||
146657781|NCT01390220|528925255|FG000|Test Dose Phase|Withdrawal by Subject|8|||
146657782|NCT01390220|528925256|FG001|Test Dose Phase|Withdrawal by Subject|0|||
146657783|NCT01390220|528925257|FG002|Test Dose Phase|Withdrawal by Subject|0|||
146657784|NCT01390220|528925255|FG000|Test Dose Phase|Lost to Follow-up|2|||
146657785|NCT01390220|528925256|FG001|Test Dose Phase|Lost to Follow-up|0|||
146657786|NCT01390220|528925257|FG002|Test Dose Phase|Lost to Follow-up|0|||
146657787|NCT01390220|528925255|FG000|Test Dose Phase|Protocol Violation|8|||
146657788|NCT01390220|528925256|FG001|Test Dose Phase|Protocol Violation|0|||
146657789|NCT01390220|528925257|FG002|Test Dose Phase|Protocol Violation|0|||
146657790|NCT01390220|528925255|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
146657791|NCT01390220|528925256|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
146657792|NCT01390220|528925257|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
146657793|NCT01390220|528925255|FG000|Test Dose Phase|Study/Site closure|6|||
146657794|NCT01390220|528925256|FG001|Test Dose Phase|Study/Site closure|0|||
146657795|NCT01390220|528925257|FG002|Test Dose Phase|Study/Site closure|0|||
146657796|NCT01390220|528925255|FG000|Test Dose Phase|Caregiver no longer available|5|||
146657797|NCT01390220|528925256|FG001|Test Dose Phase|Caregiver no longer available|0|||
146657798|NCT01390220|528925257|FG002|Test Dose Phase|Caregiver no longer available|0|||
146657799|NCT01390220|528925255|FG000|Test Dose Phase|Noncompliance|2|||
146657800|NCT01390220|528925256|FG001|Test Dose Phase|Noncompliance|0|||
146657801|NCT01390220|528925257|FG002|Test Dose Phase|Noncompliance|0|||
146657802|NCT01390220|528925255|FG000|Test Dose Phase|Logistical|6|||
146657803|NCT01390220|528925256|FG001|Test Dose Phase|Logistical|0|||
146657804|NCT01390220|528925257|FG002|Test Dose Phase|Logistical|0|||
146657805|NCT01390220|528925255|FG000|Comparative Phase|Withdrawal by Subject|0|||
146657806|NCT01390220|528925256|FG001|Comparative Phase|Withdrawal by Subject|1|||
146657807|NCT01390220|528925257|FG002|Comparative Phase|Withdrawal by Subject|0|||
146657808|NCT04025710|528925258|FG000|Overall Study|Death|3|||
146657809|NCT04025710|528925258|FG000|Overall Study|Lost to Follow-up|5|||
146657810|NCT04025710|528925258|FG000|Overall Study|Withdrawal by Subject|1|||
146657811|NCT04025710|528925258|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
146657812|NCT04025710|528925258|FG000|Overall Study|Drop-out according to protocol|34|||
146657813|NCT00245583|528925261|FG000|Overall Study|Lost to Follow-up|1|||
146657814|NCT00245583|528925262|FG001|Overall Study|Lost to Follow-up|5|||
146657815|NCT00245583|528925261|FG000|Overall Study|Adverse Event|2|||
146657816|NCT00245583|528925262|FG001|Overall Study|Adverse Event|1|||
146657817|NCT00245583|528925261|FG000|Overall Study|Lack of Efficacy|1|||
146657818|NCT00245583|528925262|FG001|Overall Study|Lack of Efficacy|0|||
146657819|NCT00245583|528925261|FG000|Overall Study|Withdrawal by Subject|2|||
146657820|NCT00245583|528925262|FG001|Overall Study|Withdrawal by Subject|3|||
146657821|NCT02273739|528925263|FG000|Overall Study|Progression of Disease|3|||
146657822|NCT02273739|528925264|FG001|Overall Study|Progression of Disease|4|||
146657823|NCT02273739|528925265|FG002|Overall Study|Progression of Disease|5|||
146657824|NCT02273739|528925266|FG003|Overall Study|Progression of Disease|2|||
146923390|NCT00937768|529878856|FG000|Overall Study|Alternate Treatment|0|||
146923391|NCT00937768|529878857|FG001|Overall Study|Alternate Treatment|1|||
146923392|NCT00937768|529878856|FG000|Overall Study|No Further Funding|4|||
146923393|NCT00937768|529878857|FG001|Overall Study|No Further Funding|4|||
146923394|NCT00488618|529878859|FG000|Overall Study|Adverse Event|13|||
146923395|NCT00488618|529878860|FG001|Overall Study|Adverse Event|17|||
146923396|NCT00488618|529878859|FG000|Overall Study|Insufficient Therapeutic Response|18|||
146923397|NCT00488618|529878860|FG001|Overall Study|Insufficient Therapeutic Response|11|||
146923398|NCT00488618|529878859|FG000|Overall Study|Protocol Violation|0|||
146923399|NCT00488618|529878860|FG001|Overall Study|Protocol Violation|2|||
146923400|NCT00488618|529878859|FG000|Overall Study|Withdrawal of Consent|15|||
146923401|NCT00488618|529878860|FG001|Overall Study|Withdrawal of Consent|13|||
146923402|NCT00488618|529878859|FG000|Overall Study|Lost to Follow-up|1|||
146923403|NCT00488618|529878860|FG001|Overall Study|Lost to Follow-up|0|||
146923404|NCT00786032|529880857|FG000|Overall Study|Death|4|||
146923405|NCT00786032|529880857|FG000|Overall Study|Withdrawal by Subject|14|||
146923406|NCT00786032|529880857|FG000|Overall Study|Did not complete in the timeframe|6|||
146923407|NCT02922634|529880858|FG000|Overall Study|Withdrawal by Subject|5|||
146923408|NCT02922634|529880858|FG000|Overall Study|Did not have their surgery|5|||
146611074|NCT03724890|528746895|FG001|Overall Study|Withdrawal by Subject|2|||
146611075|NCT03724890|528746896|FG002|Overall Study|Withdrawal by Subject|1|||
146611076|NCT03724890|528746897|FG003|Overall Study|Withdrawal by Subject|0|||
146611077|NCT03724890|528746898|FG004|Overall Study|Withdrawal by Subject|0|||
146611078|NCT03724890|528746899|FG005|Overall Study|Withdrawal by Subject|1|||
146611079|NCT03724890|528746900|FG006|Overall Study|Withdrawal by Subject|0|||
146611080|NCT03724890|528746901|FG007|Overall Study|Withdrawal by Subject|0|||
146923409|NCT02723604|529880859|FG000|Overall Study|ineligible|1|||
146923410|NCT02723604|529880859|FG000|Overall Study|never received treatment|1|||
146923411|NCT01194804|529880860|FG000|Overall Study|Withdrawal by Subject|1|||
146923412|NCT02494778|529880861|FG000|Overall Study|Death|3|||
146923413|NCT02494778|529880861|FG000|Overall Study|Other|173|||
146923414|NCT02494778|529880861|FG000|Overall Study|Lack of Efficacy|4|||
146923415|NCT02494778|529880861|FG000|Overall Study|Adverse Event|18|||
146923416|NCT02494778|529880861|FG000|Overall Study|Withdrawal by Subject|20|||
146923417|NCT02494778|529880861|FG000|Overall Study|Lost to Follow-up|2|||
146923418|NCT02494778|529880861|FG000|Overall Study|Noncompliant with study drug admin.|1|||
146923419|NCT01303380|529880862|FG000|Overall Study|Lack of compliance to study procedures|1|||
146923420|NCT02174861|529880863|FG000|Overall Study|Decision by sponsor|8|||
146923421|NCT02174861|529880863|FG000|Overall Study|Withdrawal by Subject|124|||
146923422|NCT02174861|529880863|FG000|Overall Study|Lost to Follow-up|26|||
146923423|NCT01215734|529880864|FG000|Overall Study|Death|0|||
146923424|NCT01215734|529880865|FG001|Overall Study|Death|1|||
146923425|NCT00315705|529880866|FG000|Phase 1|Refused further treatment|1|||
146923426|NCT00315705|529880866|FG000|Phase 1|Failure to achieve response|8|||
146923427|NCT00315705|529880866|FG000|Phase 1|Disease relapse|4|||
146923428|NCT00315705|529880866|FG000|Phase 1|Scheduled for transplant|9|||
146923429|NCT00315705|529880866|FG000|Phase 1|Death|3|||
146923430|NCT00315705|529880866|FG000|Phase 2|Physician Decision|4|||
146923431|NCT00315705|529880866|FG000|Phase 2|Adverse Event|1|||
146923432|NCT00315705|529880866|FG000|Phase 2|Failure to achieve response|3|||
146923433|NCT00315705|529880866|FG000|Phase 2|Disease relapse|1|||
146923434|NCT00315705|529880866|FG000|Phase 2|Scheduled for transplant|8|||
146923435|NCT00315705|529880866|FG000|Phase 2|Other|1|||
146923436|NCT00315705|529880866|FG000|Phase 2|Death|7|||
146923437|NCT01716533|529880867|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
146923438|NCT01716533|529880868|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
146923439|NCT01716533|529880869|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
146923440|NCT01716533|529880870|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
146923441|NCT01716533|529880867|FG000|Overall Study|Withdrawal by Subject|0|||
146923442|NCT01716533|529880868|FG001|Overall Study|Withdrawal by Subject|0|||
146923443|NCT01716533|529880869|FG002|Overall Study|Withdrawal by Subject|0|||
146923444|NCT01716533|529880870|FG003|Overall Study|Withdrawal by Subject|5|||
146611081|NCT03724890|528746902|FG008|Overall Study|Withdrawal by Subject|2|||
146611082|NCT03724890|528746903|FG009|Overall Study|Withdrawal by Subject|2|||
146611083|NCT03724890|528746904|FG010|Overall Study|Withdrawal by Subject|1|||
146611084|NCT03724890|528746894|FG000|Overall Study|Other|1|||
146611085|NCT03724890|528746895|FG001|Overall Study|Other|0|||
146923445|NCT01716533|529880867|FG000|Overall Study|Death|0|||
146923446|NCT01716533|529880868|FG001|Overall Study|Death|0|||
146923447|NCT01716533|529880869|FG002|Overall Study|Death|0|||
146611086|NCT03724890|528746896|FG002|Overall Study|Other|0|||
146611087|NCT03724890|528746897|FG003|Overall Study|Other|0|||
146611088|NCT03724890|528746898|FG004|Overall Study|Other|0|||
146923448|NCT01716533|529880870|FG003|Overall Study|Death|2|||
146923449|NCT01716533|529880867|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
146923450|NCT01716533|529880868|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
146923451|NCT01716533|529880869|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
146923452|NCT01716533|529880870|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
146611089|NCT03724890|528746899|FG005|Overall Study|Other|0|||
146611090|NCT03724890|528746900|FG006|Overall Study|Other|0|||
146611091|NCT03724890|528746901|FG007|Overall Study|Other|1|||
146611092|NCT03724890|528746902|FG008|Overall Study|Other|1|||
146611093|NCT03724890|528746903|FG009|Overall Study|Other|0|||
146611094|NCT03724890|528746904|FG010|Overall Study|Other|2|||
146611095|NCT01635855|528746915|FG000|Overall Study|Withdrawal by Subject|4|||
146611096|NCT02708355|528746919|FG000|Overall Study|Adverse Event|1|||
146611097|NCT02708355|528746920|FG001|Overall Study|Adverse Event|0|||
146611098|NCT02708355|528746921|FG002|Overall Study|Adverse Event|0|||
146611099|NCT01320202|528746922|FG000|Overall Study|Adverse Event|5|||
146611100|NCT01320202|528746923|FG001|Overall Study|Adverse Event|5|||
146657825|NCT02273739|528925263|FG000|Overall Study|Death|0|||
146657826|NCT02273739|528925264|FG001|Overall Study|Death|0|||
146657827|NCT02273739|528925265|FG002|Overall Study|Death|0|||
146657828|NCT02273739|528925266|FG003|Overall Study|Death|2|||
146657829|NCT02273739|528925263|FG000|Overall Study|Adverse Event|0|||
146657830|NCT02273739|528925264|FG001|Overall Study|Adverse Event|0|||
146657831|NCT02273739|528925265|FG002|Overall Study|Adverse Event|0|||
146657832|NCT02273739|528925266|FG003|Overall Study|Adverse Event|1|||
146657833|NCT02273739|528925263|FG000|Overall Study|Withdrawal by Subject|0|||
146657834|NCT02273739|528925264|FG001|Overall Study|Withdrawal by Subject|0|||
146657835|NCT02273739|528925265|FG002|Overall Study|Withdrawal by Subject|2|||
146657836|NCT02273739|528925266|FG003|Overall Study|Withdrawal by Subject|1|||
146657837|NCT02273739|528925263|FG000|Overall Study|Physician Decision|0|||
146657838|NCT02273739|528925264|FG001|Overall Study|Physician Decision|0|||
146657839|NCT02273739|528925265|FG002|Overall Study|Physician Decision|0|||
146657840|NCT02273739|528925266|FG003|Overall Study|Physician Decision|1|||
146657841|NCT03370289|528925268|FG000|Overall Study|Screen Failure|1|||
146657842|NCT03370289|528925268|FG000|Overall Study|Sample Size Sufficient|4|||
146657843|NCT02764190|528925270|FG000|Overall Study|Lost to Follow-up|17|||
146657844|NCT02764190|528925271|FG001|Overall Study|Lost to Follow-up|13|||
146657845|NCT01484938|528925276|FG000|Overall Study|Adverse Event|2|||
146657846|NCT01484938|528925276|FG000|Overall Study|Lost to Follow-up|1|||
146657847|NCT01484938|528925276|FG000|Overall Study|Noncompliance|1|||
146657848|NCT02140775|528925278|FG000|Overall Study|Withdrawal by Subject|30|||
146657849|NCT02140775|528925279|FG001|Overall Study|Withdrawal by Subject|7|||
146657850|NCT02942576|528925281|FG000|Overall Study|Adverse Event|28|||
146657851|NCT02942576|528925282|FG001|Overall Study|Adverse Event|6|||
146657852|NCT02942576|528925281|FG000|Overall Study|Withdrawal by Subject|7|||
146657853|NCT02942576|528925282|FG001|Overall Study|Withdrawal by Subject|5|||
146657854|NCT02942576|528925281|FG000|Overall Study|Physician Decision|1|||
146657855|NCT02942576|528925282|FG001|Overall Study|Physician Decision|4|||
146657856|NCT02942576|528925281|FG000|Overall Study|Other|10|||
146657857|NCT02942576|528925282|FG001|Overall Study|Other|8|||
146657858|NCT00938964|528925285|FG000|Overall Study|Death|3|||
146657859|NCT00938964|528925286|FG001|Overall Study|Death|3|||
146657860|NCT00938964|528925285|FG000|Overall Study|Lost to Follow-up|2|||
146657861|NCT00938964|528925286|FG001|Overall Study|Lost to Follow-up|3|||
146657862|NCT00938964|528925285|FG000|Overall Study|Withdrawal by Subject|22|||
146657863|NCT00938964|528925286|FG001|Overall Study|Withdrawal by Subject|18|||
146657864|NCT00938964|528925285|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
146657865|NCT00938964|528925286|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
146657866|NCT01858636|528925287|FG000|Overall Study|No Device Deployment Attempted|24|||
146657867|NCT01858636|528925287|FG000|Overall Study|Physician Decision|1|||
146657868|NCT01858636|528925287|FG000|Overall Study|Death|1|||
146657869|NCT01858636|528925287|FG000|Overall Study|Lost to Follow-up|1|||
146657870|NCT01858636|528925287|FG000|Overall Study|Withdrawal by Subject|1|||
146657871|NCT01172275|528925290|FG000|Overall Study|Lost to Follow-up|1|||
146657872|NCT01172275|528925291|FG001|Overall Study|Lost to Follow-up|0|||
146657873|NCT01172275|528925290|FG000|Overall Study|Protocol Violation|1|||
146657874|NCT01172275|528925291|FG001|Overall Study|Protocol Violation|0|||
146657875|NCT01227564|528925296|FG000|Overall Study|No Longer Willing to Participate|4|||
146657876|NCT01227564|528925297|FG001|Overall Study|No Longer Willing to Participate|2|||
146657877|NCT01227564|528925298|FG002|Overall Study|No Longer Willing to Participate|5|||
146657878|NCT01227564|528925296|FG000|Overall Study|Participant moved to another town|0|||
146611101|NCT01320202|528746922|FG000|Overall Study|Death|5|||
146611102|NCT01320202|528746923|FG001|Overall Study|Death|3|||
146611103|NCT01320202|528746922|FG000|Overall Study|Lost to Follow-up|1|||
146611104|NCT01320202|528746923|FG001|Overall Study|Lost to Follow-up|0|||
146611105|NCT01320202|528746922|FG000|Overall Study|Physician Decision|3|||
146611106|NCT01320202|528746923|FG001|Overall Study|Physician Decision|1|||
146611107|NCT01320202|528746922|FG000|Overall Study|Protocol Violation|2|||
146611108|NCT01320202|528746923|FG001|Overall Study|Protocol Violation|1|||
146657879|NCT01227564|528925297|FG001|Overall Study|Participant moved to another town|0|||
146657880|NCT01227564|528925298|FG002|Overall Study|Participant moved to another town|1|||
146657881|NCT04650854|528925311|FG000|Overall Study|Adverse Event|1|||
146657882|NCT04650854|528925312|FG001|Overall Study|Adverse Event|12|||
146657883|NCT04650854|528925313|FG002|Overall Study|Adverse Event|14|||
146657884|NCT04650854|528925311|FG000|Overall Study|Lack of Efficacy|1|||
146923453|NCT00165841|529880877|FG000|Overall Study|Adverse Event|2|||
146923454|NCT00165841|529880878|FG001|Overall Study|Adverse Event|3|||
146923455|NCT00165841|529880877|FG000|Overall Study|Lack of Efficacy|6|||
146923456|NCT00165841|529880878|FG001|Overall Study|Lack of Efficacy|33|||
146923457|NCT00165841|529880877|FG000|Overall Study|Lost to Follow-up|4|||
146923458|NCT00165841|529880878|FG001|Overall Study|Lost to Follow-up|4|||
146923459|NCT00165841|529880877|FG000|Overall Study|Withdrawal by Subject|7|||
146923460|NCT00165841|529880878|FG001|Overall Study|Withdrawal by Subject|8|||
146923461|NCT00165841|529880877|FG000|Overall Study|Physician Decision|1|||
146923462|NCT00165841|529880878|FG001|Overall Study|Physician Decision|0|||
146923463|NCT00165841|529880877|FG000|Overall Study|Protocol Violation|6|||
146923464|NCT00165841|529880878|FG001|Overall Study|Protocol Violation|8|||
146923465|NCT00165841|529880877|FG000|Overall Study|Other|3|||
146923466|NCT00165841|529880878|FG001|Overall Study|Other|5|||
146657885|NCT04650854|528925312|FG001|Overall Study|Lack of Efficacy|3|||
146657886|NCT04650854|528925313|FG002|Overall Study|Lack of Efficacy|6|||
146657887|NCT04650854|528925311|FG000|Overall Study|Lost to Follow-up|1|||
146657888|NCT04650854|528925312|FG001|Overall Study|Lost to Follow-up|1|||
146657889|NCT04650854|528925313|FG002|Overall Study|Lost to Follow-up|0|||
146657890|NCT04650854|528925311|FG000|Overall Study|Withdrawal by Subject|2|||
146657891|NCT04650854|528925312|FG001|Overall Study|Withdrawal by Subject|17|||
146657892|NCT04650854|528925313|FG002|Overall Study|Withdrawal by Subject|9|||
146657893|NCT04650854|528925311|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
146657894|NCT04650854|528925312|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
146657895|NCT04650854|528925313|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
146657896|NCT04650854|528925311|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
146657897|NCT04650854|528925312|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
146657898|NCT04650854|528925313|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
146657899|NCT04650854|528925311|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
146657900|NCT04650854|528925312|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
146657901|NCT04650854|528925313|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
146657902|NCT04650854|528925311|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
146657903|NCT04650854|528925312|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
146657904|NCT04650854|528925313|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
146657905|NCT04650854|528925311|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
146657906|NCT04650854|528925312|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
146657907|NCT04650854|528925313|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
146657908|NCT04650854|528925311|FG000|Overall Study|Use of Rescue Medication|0|||
146657909|NCT04650854|528925312|FG001|Overall Study|Use of Rescue Medication|0|||
146657910|NCT04650854|528925313|FG002|Overall Study|Use of Rescue Medication|1|||
146657911|NCT04650854|528925311|FG000|Overall Study|Last Treatment Per Sponsor|0|||
146657912|NCT04650854|528925312|FG001|Overall Study|Last Treatment Per Sponsor|0|||
146657913|NCT04650854|528925313|FG002|Overall Study|Last Treatment Per Sponsor|2|||
146657914|NCT04650854|528925311|FG000|Overall Study|Rescue Medication|0|||
146657915|NCT04650854|528925312|FG001|Overall Study|Rescue Medication|0|||
146657916|NCT04650854|528925313|FG002|Overall Study|Rescue Medication|1|||
146657917|NCT04650854|528925311|FG000|Overall Study|Participant Want to Start a Family|0|||
146657918|NCT04650854|528925312|FG001|Overall Study|Participant Want to Start a Family|0|||
146657919|NCT04650854|528925313|FG002|Overall Study|Participant Want to Start a Family|1|||
146657920|NCT04650854|528925311|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
146657921|NCT04650854|528925312|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
146657922|NCT04650854|528925313|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
146657923|NCT04650854|528925311|FG000|Overall Study|Participant Screened For MG0020|0|||
146657924|NCT04650854|528925312|FG001|Overall Study|Participant Screened For MG0020|2|||
146657925|NCT04650854|528925313|FG002|Overall Study|Participant Screened For MG0020|3|||
146657926|NCT04650854|528925311|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
146657927|NCT04650854|528925312|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
146657928|NCT04650854|528925313|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
146657929|NCT04650854|528925311|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
146657930|NCT04650854|528925312|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
146657931|NCT04650854|528925313|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
146657932|NCT04650854|528925311|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
146657933|NCT04650854|528925312|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
146657934|NCT04650854|528925313|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
146657935|NCT04650854|528925311|FG000|Overall Study|End Of Study|0|||
146657936|NCT04650854|528925312|FG001|Overall Study|End Of Study|2|||
146657937|NCT04650854|528925313|FG002|Overall Study|End Of Study|1|||
146657938|NCT04650854|528925311|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
146657939|NCT04650854|528925312|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
146923467|NCT00165841|529880877|FG000|Overall Study|Medication Noncompliance|1|||
146923468|NCT00165841|529880878|FG001|Overall Study|Medication Noncompliance|1|||
146923469|NCT02006667|529880881|FG000|Overall Study|Adverse Event|3|||
146611109|NCT01320202|528746922|FG000|Overall Study|Withdrawal by Subject|10|||
146611110|NCT01320202|528746923|FG001|Overall Study|Withdrawal by Subject|3|||
146611111|NCT01320202|528746922|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
146611112|NCT01320202|528746923|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
146611113|NCT01320202|528746922|FG000|Overall Study|kidney transplant|1|||
146611114|NCT01320202|528746923|FG001|Overall Study|kidney transplant|2|||
146611115|NCT01320202|528746922|FG000|Overall Study|blood transfusion|1|||
146611116|NCT01320202|528746923|FG001|Overall Study|blood transfusion|7|||
146611117|NCT01320202|528746922|FG000|Overall Study|moved/changed dialysis|5|||
146657940|NCT04650854|528925313|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
146657941|NCT04650854|528925311|FG000|Overall Study|Participant Received Rescue Medication|0|||
146657942|NCT04650854|528925312|FG001|Overall Study|Participant Received Rescue Medication|1|||
146657943|NCT04650854|528925313|FG002|Overall Study|Participant Received Rescue Medication|0|||
146657944|NCT04650854|528925311|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
146923470|NCT02006667|529880881|FG000|Overall Study|Death|2|||
146923471|NCT02006667|529880881|FG000|Overall Study|Withdrawal by Subject|1|||
146923472|NCT01626352|529880882|FG000|Overall Study|Disease Progression|3|||
146923473|NCT01626352|529880882|FG000|Overall Study|Intercurrent Illness|2|||
146923474|NCT01626352|529880882|FG000|Overall Study|Death|2|||
146923475|NCT01626352|529880882|FG000|Overall Study|Withdrawal by Subject|1|||
146923476|NCT01626352|529880882|FG000|Overall Study|Non-Compliance|1|||
146923477|NCT01626352|529880882|FG000|Overall Study|Never Treated|1|||
146923478|NCT02939937|529880883|FG000|Overall Study|Adverse Event|5|||
146923479|NCT02939937|529880884|FG001|Overall Study|Adverse Event|0|||
146923480|NCT02939937|529880883|FG000|Overall Study|Lost to Follow-up|1|||
146923481|NCT02939937|529880884|FG001|Overall Study|Lost to Follow-up|3|||
146923482|NCT02681055|529880888|FG000|Weeks 5-12|Adverse Event|1|||
146923483|NCT00839423|529880895|FG000|Overall Study|Adverse Event|4|||
146923484|NCT00839423|529880896|FG001|Overall Study|Adverse Event|3|||
146923485|NCT00839423|529880897|FG002|Overall Study|Adverse Event|7|||
146923486|NCT00839423|529880898|FG003|Overall Study|Adverse Event|16|||
146923487|NCT00839423|529880895|FG000|Overall Study|Lack of Efficacy|6|||
146923488|NCT00839423|529880896|FG001|Overall Study|Lack of Efficacy|6|||
146923489|NCT00839423|529880897|FG002|Overall Study|Lack of Efficacy|3|||
146923490|NCT00839423|529880898|FG003|Overall Study|Lack of Efficacy|2|||
146923491|NCT00839423|529880895|FG000|Overall Study|Non-compliance|0|||
146923492|NCT00839423|529880896|FG001|Overall Study|Non-compliance|0|||
146923493|NCT00839423|529880897|FG002|Overall Study|Non-compliance|0|||
146923494|NCT00839423|529880898|FG003|Overall Study|Non-compliance|1|||
146923495|NCT00839423|529880895|FG000|Overall Study|Protocol Violation|0|||
146923496|NCT00839423|529880896|FG001|Overall Study|Protocol Violation|1|||
146923497|NCT00839423|529880897|FG002|Overall Study|Protocol Violation|2|||
146923498|NCT00839423|529880898|FG003|Overall Study|Protocol Violation|0|||
146923499|NCT00839423|529880895|FG000|Overall Study|Withdrawal of consent|4|||
146923500|NCT00839423|529880896|FG001|Overall Study|Withdrawal of consent|0|||
146923501|NCT00839423|529880897|FG002|Overall Study|Withdrawal of consent|4|||
146923502|NCT00839423|529880898|FG003|Overall Study|Withdrawal of consent|1|||
146923503|NCT00839423|529880895|FG000|Overall Study|Lost to Follow-up|1|||
146923504|NCT00839423|529880896|FG001|Overall Study|Lost to Follow-up|0|||
146923505|NCT00839423|529880897|FG002|Overall Study|Lost to Follow-up|1|||
146923506|NCT00839423|529880898|FG003|Overall Study|Lost to Follow-up|0|||
146923507|NCT00839423|529880895|FG000|Overall Study|Administrative or other reasons|3|||
146923508|NCT00839423|529880896|FG001|Overall Study|Administrative or other reasons|0|||
146923509|NCT00839423|529880897|FG002|Overall Study|Administrative or other reasons|1|||
146923510|NCT00839423|529880898|FG003|Overall Study|Administrative or other reasons|0|||
146923511|NCT01071096|529880899|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
146923512|NCT01071096|529880900|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
146923513|NCT02585999|529880901|FG000|Overall Study|Lost to Follow-up|1|||
146923514|NCT02585999|529880901|FG000|Overall Study|Protocol Violation|1|||
146923515|NCT01332019|529880902|FG000|Overall Study|Was Not Dosed|1|||
146923516|NCT01332019|529880903|FG001|Overall Study|Was Not Dosed|0|||
146923517|NCT01332019|529880902|FG000|Overall Study|Other|16|||
146923518|NCT01332019|529880903|FG001|Overall Study|Other|18|||
146923519|NCT01332019|529880902|FG000|Overall Study|Death|2|||
146923520|NCT01332019|529880903|FG001|Overall Study|Death|1|||
146611118|NCT01320202|528746923|FG001|Overall Study|moved/changed dialysis|2|||
146611119|NCT01320202|528746922|FG000|Overall Study|sponsor request|2|||
146611120|NCT01320202|528746923|FG001|Overall Study|sponsor request|0|||
146611121|NCT01320202|528746922|FG000|Overall Study|ineligible|3|||
146923521|NCT01332019|529880902|FG000|Overall Study|Physician Decision|4|||
146923522|NCT01332019|529880903|FG001|Overall Study|Physician Decision|3|||
146923523|NCT01332019|529880902|FG000|Overall Study|Withdrawal by Subject|73|||
146657945|NCT04650854|528925312|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
146923524|NCT01332019|529880903|FG001|Overall Study|Withdrawal by Subject|71|||
146923525|NCT01332019|529880902|FG000|Overall Study|Lost to Follow-up|4|||
146923526|NCT01332019|529880903|FG001|Overall Study|Lost to Follow-up|7|||
146923527|NCT01332019|529880902|FG000|Overall Study|Adverse Event|13|||
146923528|NCT01332019|529880903|FG001|Overall Study|Adverse Event|22|||
146923529|NCT01369849|529880904|FG000|Overall Study|Ineligible prior to treatment|0|||
146923530|NCT01369849|529880905|FG001|Overall Study|Ineligible prior to treatment|0|||
146923531|NCT01369849|529880906|FG002|Overall Study|Ineligible prior to treatment|1|||
146923532|NCT01369849|529880904|FG000|Overall Study|Ineligible after receiving treatment|0|||
146923533|NCT01369849|529880905|FG001|Overall Study|Ineligible after receiving treatment|1|||
146657946|NCT04650854|528925313|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
146657947|NCT04650854|528925311|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
146657948|NCT04650854|528925312|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
146657949|NCT04650854|528925313|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
146657950|NCT04650854|528925311|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
146657951|NCT04650854|528925312|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
146657952|NCT04650854|528925313|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
146657953|NCT04650854|528925311|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
146657954|NCT04650854|528925312|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
146657955|NCT04650854|528925313|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
146657956|NCT04650854|528925311|FG000|Overall Study|Enrollment Cup|0|||
146657957|NCT04650854|528925312|FG001|Overall Study|Enrollment Cup|0|||
146657958|NCT04650854|528925313|FG002|Overall Study|Enrollment Cup|1|||
146657959|NCT02862600|528925314|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
146657960|NCT02862600|528925314|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
146657961|NCT02862600|528925314|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
146657962|NCT02862600|528925314|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
146657963|NCT00194675|528925323|FG000|Overall Study|Lost to Follow-up|1|||
146657964|NCT00194675|528925324|FG001|Overall Study|Lost to Follow-up|1|||
146657965|NCT00194675|528925323|FG000|Overall Study|lack of interest|1|||
146657966|NCT00194675|528925324|FG001|Overall Study|lack of interest|1|||
146657967|NCT00194675|528925323|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
146657968|NCT00194675|528925324|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
146657969|NCT00194675|528925323|FG000|Overall Study|Protocol Violation|1|||
146657970|NCT00194675|528925324|FG001|Overall Study|Protocol Violation|0|||
146657971|NCT00194675|528925323|FG000|Overall Study|Death|1|||
146657972|NCT00194675|528925324|FG001|Overall Study|Death|0|||
146657973|NCT01285960|528925325|FG000|Overall Study|Withdrawal by Subject|2|||
146657974|NCT01285960|528925325|FG000|Overall Study|Lost to Follow-up|2|||
146657975|NCT01285960|528925325|FG000|Overall Study|2 subjects received less 10 sonications|2|||
146657976|NCT00473746|528925326|FG000|Period 1 (Phase 1)|Adverse Event|1|||
146657977|NCT00473746|528925327|FG001|Period 1 (Phase 1)|Adverse Event|0|||
146657978|NCT00473746|528925328|FG002|Period 1 (Phase 1)|Adverse Event|0|||
146657979|NCT00473746|528925329|FG003|Period 1 (Phase 1)|Adverse Event|0|||
146657980|NCT00473746|528925330|FG004|Period 1 (Phase 1)|Adverse Event|0|||
146657981|NCT00473746|528925326|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
146657982|NCT00473746|528925327|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
146657983|NCT00473746|528925328|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
146657984|NCT00473746|528925329|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
146657985|NCT00473746|528925330|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
146657986|NCT00473746|528925326|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
146657987|NCT00473746|528925327|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
146657988|NCT00473746|528925328|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
146657989|NCT00473746|528925329|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
146657990|NCT00473746|528925330|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
146657991|NCT00473746|528925326|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
146657992|NCT00473746|528925327|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
146657993|NCT00473746|528925328|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
146657994|NCT00473746|528925329|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
146657995|NCT00473746|528925330|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
146657996|NCT00473746|528925326|FG000|Period 1 (Phase 1)|Reason not specified|0|||
146657997|NCT00473746|528925327|FG001|Period 1 (Phase 1)|Reason not specified|1|||
146657998|NCT00473746|528925328|FG002|Period 1 (Phase 1)|Reason not specified|0|||
146657999|NCT00473746|528925329|FG003|Period 1 (Phase 1)|Reason not specified|0|||
146658000|NCT00473746|528925330|FG004|Period 1 (Phase 1)|Reason not specified|0|||
146923534|NCT01369849|529880906|FG002|Overall Study|Ineligible after receiving treatment|0|||
146923535|NCT00871377|529880907|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
146658001|NCT00473746|528925326|FG000|Period 2 (Phase 2)|Adverse Event|0|||
146658002|NCT00473746|528925327|FG001|Period 2 (Phase 2)|Adverse Event|0|||
146658003|NCT00473746|528925328|FG002|Period 2 (Phase 2)|Adverse Event|0|||
146658004|NCT00473746|528925329|FG003|Period 2 (Phase 2)|Adverse Event|0|||
146658005|NCT00473746|528925330|FG004|Period 2 (Phase 2)|Adverse Event|3|||
146658006|NCT00473746|528925326|FG000|Period 2 (Phase 2)|Death|0|||
146658007|NCT00473746|528925327|FG001|Period 2 (Phase 2)|Death|0|||
146658008|NCT00473746|528925328|FG002|Period 2 (Phase 2)|Death|0|||
146658009|NCT00473746|528925329|FG003|Period 2 (Phase 2)|Death|0|||
146658010|NCT00473746|528925330|FG004|Period 2 (Phase 2)|Death|1|||
146658011|NCT00473746|528925326|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
146923536|NCT00871377|529880908|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
146923537|NCT00871377|529880909|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
146923538|NCT00871377|529880910|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
146923539|NCT00871377|529880911|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
146923540|NCT00871377|529880912|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
146923541|NCT00871377|529880907|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
146923542|NCT00871377|529880908|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
146923543|NCT00871377|529880909|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
146923544|NCT00871377|529880910|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
146923545|NCT00871377|529880911|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
146923546|NCT00871377|529880912|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
146923547|NCT00871377|529880907|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
146923548|NCT00871377|529880908|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
146923549|NCT00871377|529880909|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
146923550|NCT00871377|529880910|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
146923551|NCT00871377|529880911|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
146923552|NCT00871377|529880912|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
146923553|NCT00871377|529880907|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
146611122|NCT01320202|528746923|FG001|Overall Study|ineligible|0|||
146923554|NCT00871377|529880908|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
146923555|NCT00871377|529880909|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
146923556|NCT00871377|529880910|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
146923557|NCT00871377|529880911|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
146923558|NCT00871377|529880912|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
146923559|NCT00871377|529880907|FG000|Third Intervention (10 Weeks)|Death|0|||
146923560|NCT00871377|529880908|FG001|Third Intervention (10 Weeks)|Death|0|||
146923561|NCT00871377|529880909|FG002|Third Intervention (10 Weeks)|Death|0|||
146923562|NCT00871377|529880910|FG003|Third Intervention (10 Weeks)|Death|1|||
146923563|NCT00871377|529880911|FG004|Third Intervention (10 Weeks)|Death|0|||
146923564|NCT00871377|529880912|FG005|Third Intervention (10 Weeks)|Death|0|||
146923565|NCT00120289|529880913|FG000|Overall Study|Death|96|||
146923566|NCT00120289|529880914|FG001|Overall Study|Death|82|||
146923567|NCT00120289|529880913|FG000|Overall Study|Lost to Follow-up|11|||
146923568|NCT00120289|529880914|FG001|Overall Study|Lost to Follow-up|14|||
146923569|NCT00120289|529880913|FG000|Overall Study|Withdrawal by Subject|14|||
146923570|NCT00120289|529880914|FG001|Overall Study|Withdrawal by Subject|13|||
146923571|NCT02179515|529880920|FG000|Overall Study|switched to alternative treatment|0|||
146923572|NCT02179515|529880921|FG001|Overall Study|switched to alternative treatment|1|||
146923573|NCT02179515|529880922|FG002|Overall Study|switched to alternative treatment|1|||
146923574|NCT02179515|529880920|FG000|Overall Study|Death|0|||
146923575|NCT02179515|529880921|FG001|Overall Study|Death|1|||
146923576|NCT02179515|529880922|FG002|Overall Study|Death|1|||
146923577|NCT02179515|529880920|FG000|Overall Study|refused further treatment|0|||
146923578|NCT02179515|529880921|FG001|Overall Study|refused further treatment|3|||
146923579|NCT02179515|529880922|FG002|Overall Study|refused further treatment|4|||
146923580|NCT02179515|529880920|FG000|Overall Study|Disease progression on study|2|||
146923581|NCT02179515|529880921|FG001|Overall Study|Disease progression on study|11|||
146923582|NCT02179515|529880922|FG002|Overall Study|Disease progression on study|8|||
146923583|NCT00782418|529880923|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
146923584|NCT00782418|529880924|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
146923585|NCT00782418|529880925|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
146923586|NCT00782418|529880926|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
146923587|NCT00782418|529880927|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
146923588|NCT00782418|529880928|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
146923589|NCT00782418|529880929|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
146923590|NCT00782418|529880923|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
146923591|NCT00782418|529880924|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
146923592|NCT00782418|529880925|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
146923593|NCT00782418|529880926|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
146923594|NCT00782418|529880927|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
146923595|NCT00782418|529880928|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
146923596|NCT00782418|529880929|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
146923597|NCT00238303|529880930|FG000|Overall Study|Withdrawal by Subject|11|||
146923598|NCT00238303|529880931|FG001|Overall Study|Withdrawal by Subject|1|||
146923599|NCT00238303|529880932|FG002|Overall Study|Withdrawal by Subject|2|||
146923600|NCT00238303|529880930|FG000|Overall Study|Death|1|||
146923601|NCT00238303|529880931|FG001|Overall Study|Death|0|||
146923602|NCT00238303|529880932|FG002|Overall Study|Death|1|||
146923603|NCT00238303|529880930|FG000|Overall Study|Other Medical Problems|2|||
146611123|NCT01320202|528746922|FG000|Overall Study|regained renal function|1|||
146611124|NCT01320202|528746923|FG001|Overall Study|regained renal function|0|||
146611125|NCT04090242|528746924|FG000|Overall Study|Withdrawal by Subject|1|||
146773421|NCT03189524|529341062|FG001|Overall Study|Progressive Disease|2|||
146923604|NCT00238303|529880931|FG001|Overall Study|Other Medical Problems|0|||
146611126|NCT04090242|528746925|FG001|Overall Study|Withdrawal by Subject|0|||
146611127|NCT02513472|528746926|FG000|Overall Study|Radiological Disease Progression|45|||
146611128|NCT02513472|528746927|FG001|Overall Study|Radiological Disease Progression|57|||
146611129|NCT02513472|528746926|FG000|Overall Study|Clinical Disease Progression|5|||
146611130|NCT02513472|528746927|FG001|Overall Study|Clinical Disease Progression|13|||
146611131|NCT02513472|528746926|FG000|Overall Study|Adverse Event|8|||
146611132|NCT02513472|528746927|FG001|Overall Study|Adverse Event|11|||
146611133|NCT02513472|528746926|FG000|Overall Study|Withdrawal by Subject|0|||
146611134|NCT02513472|528746927|FG001|Overall Study|Withdrawal by Subject|4|||
146611135|NCT02513472|528746926|FG000|Overall Study|Subject Choice|2|||
146923605|NCT00238303|529880932|FG002|Overall Study|Other Medical Problems|2|||
146923606|NCT00238303|529880930|FG000|Overall Study|Poor tolerance of study treatment|1|||
146923607|NCT00238303|529880931|FG001|Overall Study|Poor tolerance of study treatment|0|||
146923608|NCT00238303|529880932|FG002|Overall Study|Poor tolerance of study treatment|1|||
146923609|NCT00238303|529880930|FG000|Overall Study|Adverse Event|0|||
146923610|NCT00238303|529880931|FG001|Overall Study|Adverse Event|1|||
146923611|NCT00238303|529880932|FG002|Overall Study|Adverse Event|3|||
146923612|NCT00848549|529880933|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
146923613|NCT00848549|529880934|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
146923614|NCT00848549|529880933|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
146923615|NCT00848549|529880934|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
146923616|NCT00848549|529880933|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
146923617|NCT00848549|529880934|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
146923618|NCT00848549|529880933|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
146923619|NCT00848549|529880934|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
146923620|NCT00848549|529880933|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
146923621|NCT00848549|529880934|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
146923622|NCT00848549|529880933|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
146923623|NCT00848549|529880934|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
146923624|NCT00848549|529880933|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
146923625|NCT00848549|529880934|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
146923626|NCT00848549|529880933|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
146923627|NCT00848549|529880934|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
146923628|NCT00848549|529880933|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
146923629|NCT00848549|529880934|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
146923630|NCT00848549|529880933|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
146923631|NCT00848549|529880934|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
146923632|NCT00848549|529880933|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
146611136|NCT02513472|528746927|FG001|Overall Study|Subject Choice|7|||
146611137|NCT02513472|528746926|FG000|Overall Study|Treatment Completed as per Protocol|3|||
146611138|NCT02513472|528746927|FG001|Overall Study|Treatment Completed as per Protocol|3|||
146611139|NCT02513472|528746926|FG000|Overall Study|Other|3|||
146611140|NCT02513472|528746927|FG001|Overall Study|Other|6|||
146611141|NCT01019369|528746928|FG000|Overall Study|Lost to Follow-up|10|||
146611142|NCT01019369|528746929|FG001|Overall Study|Lost to Follow-up|6|||
146611143|NCT01019369|528746928|FG000|Overall Study|Withdrawal by Subject|0|||
146611144|NCT01019369|528746929|FG001|Overall Study|Withdrawal by Subject|1|||
146611145|NCT00604695|528746930|FG000|Overall Study|Did not receive first bolus.|0|||
146611146|NCT00604695|528746931|FG001|Overall Study|Did not receive first bolus.|4|||
146611147|NCT03214406|528746932|FG000|Overall Study|did not meet enrollment criteria|9|||
146611148|NCT03214406|528746933|FG001|Overall Study|did not meet enrollment criteria|13|||
146611149|NCT03214406|528746932|FG000|Overall Study|Withdrawal by Subject|1|||
146773422|NCT03189524|529341063|FG002|Overall Study|Progressive Disease|0|||
146773423|NCT01780298|529341065|FG000|Overall Study|Physician Decision|1|||
146611150|NCT03214406|528746933|FG001|Overall Study|Withdrawal by Subject|0|||
146611151|NCT03214406|528746932|FG000|Overall Study|Lost to Follow-up|0|||
146611152|NCT03214406|528746933|FG001|Overall Study|Lost to Follow-up|2|||
146611153|NCT01098305|528746937|FG000|Overall Study|Lost to Follow-up|31|||
146611154|NCT01098305|528746938|FG001|Overall Study|Lost to Follow-up|33|||
146611155|NCT04565951|528746944|FG000|Overall Study|Lost to Follow-up|66|||
146611156|NCT04565951|528746945|FG001|Overall Study|Lost to Follow-up|38|||
146611157|NCT04565951|528746944|FG000|Overall Study|Withdrawal by Subject|14|||
146611158|NCT04565951|528746945|FG001|Overall Study|Withdrawal by Subject|7|||
146611159|NCT04565951|528746944|FG000|Overall Study|Death|0|||
146611160|NCT04565951|528746945|FG001|Overall Study|Death|1|||
146611161|NCT00429169|528746947|FG000|Overall Study|Lost to Follow-up|0|||
146611162|NCT00429169|528746948|FG001|Overall Study|Lost to Follow-up|1|||
146611163|NCT00429169|528746947|FG000|Overall Study|Ineligibility discovered after entry|2|||
146773424|NCT01780298|529341066|FG001|Overall Study|Physician Decision|5|||
146611164|NCT00429169|528746948|FG001|Overall Study|Ineligibility discovered after entry|1|||
146611165|NCT01746173|528746953|FG000|Overall Study|Disease Progression|2|||
146611166|NCT00615017|528748772|FG000|Overall Study|Adverse Event|0|||
146611167|NCT00615017|528748773|FG001|Overall Study|Adverse Event|1|||
146611168|NCT00615017|528748774|FG002|Overall Study|Adverse Event|2|||
146923633|NCT00848549|529880934|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
146923634|NCT00848549|529880933|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
146923635|NCT00848549|529880934|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
146923636|NCT00848549|529880933|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
146923637|NCT00848549|529880934|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
146923638|NCT00848549|529880933|FG000|E2090-E044-314 (Extension Study)|Other|5|||
146923639|NCT00848549|529880934|FG001|E2090-E044-314 (Extension Study)|Other|6|||
146923640|NCT02561299|529880935|FG000|Overall Study|Death|2|||
146923641|NCT02561299|529880936|FG001|Overall Study|Death|4|||
146923642|NCT02561299|529880935|FG000|Overall Study|Lost to Follow-up|1|||
146923643|NCT02561299|529880936|FG001|Overall Study|Lost to Follow-up|0|||
146923644|NCT02561299|529880935|FG000|Overall Study|Withdrawal by Subject|2|||
146923645|NCT02561299|529880936|FG001|Overall Study|Withdrawal by Subject|2|||
146923646|NCT01248130|529880937|FG000|Overall Study|Protocol Violation|1|||
146923647|NCT01248130|529880938|FG001|Overall Study|Protocol Violation|0|||
146923648|NCT01248130|529880937|FG000|Overall Study|Ineligible|1|||
146923649|NCT01248130|529880938|FG001|Overall Study|Ineligible|0|||
146923650|NCT04507867|529880945|FG000|Overall Study|Death|7|||
146923651|NCT04507867|529880946|FG001|Overall Study|Death|1|||
146923652|NCT01860534|529880947|FG000|ROP #1|Needed treatment for ROP|0|||
146923653|NCT01860534|529880948|FG001|ROP #1|Needed treatment for ROP|1|||
146923654|NCT01860534|529880947|FG000|ROP #2|discharged prior to ROP #2|1|||
146923655|NCT01860534|529880948|FG001|ROP #2|discharged prior to ROP #2|0|||
146923656|NCT02175771|529880953|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
146923657|NCT02175771|529880954|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146773425|NCT01780298|529341067|FG002|Overall Study|Physician Decision|1|||
146773426|NCT01780298|529341068|FG003|Overall Study|Physician Decision|1|||
146773427|NCT01780298|529341065|FG000|Overall Study|Subject not matched|1|||
146923658|NCT02175771|529880955|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146923659|NCT02175771|529880956|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146923660|NCT02175771|529880957|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146923661|NCT02175771|529880958|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146923662|NCT02175771|529880959|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146923663|NCT02175771|529880960|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146923664|NCT02175771|529880961|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146923665|NCT02175771|529880953|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
146923666|NCT02175771|529880954|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146923667|NCT02175771|529880955|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146923668|NCT02175771|529880956|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146923669|NCT02175771|529880957|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146923670|NCT02175771|529880958|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146923671|NCT02175771|529880959|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146923672|NCT02175771|529880960|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146923673|NCT02175771|529880961|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146923674|NCT02175771|529880953|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
146923675|NCT02175771|529880954|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146978678|NCT03262233|530085460|FG002|Overall Study|Withdrawal by Subject|21|||
146978679|NCT03262233|530085461|FG003|Overall Study|Withdrawal by Subject|13|||
146611169|NCT00615017|528748775|FG003|Overall Study|Adverse Event|0|||
146611170|NCT00615017|528748776|FG004|Overall Study|Adverse Event|0|||
146611171|NCT00615017|528748777|FG005|Overall Study|Adverse Event|1|||
146611172|NCT00615017|528748772|FG000|Overall Study|Death|0|||
146611173|NCT00615017|528748773|FG001|Overall Study|Death|0|||
146611174|NCT00615017|528748774|FG002|Overall Study|Death|2|||
146611175|NCT00615017|528748775|FG003|Overall Study|Death|0|||
146611176|NCT00615017|528748776|FG004|Overall Study|Death|1|||
146611177|NCT00615017|528748777|FG005|Overall Study|Death|1|||
146611178|NCT00615017|528748772|FG000|Overall Study|Sepsis resolved|0|||
146923676|NCT02175771|529880955|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146923677|NCT02175771|529880956|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146923678|NCT02175771|529880957|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146923679|NCT02175771|529880958|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146923680|NCT02175771|529880959|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146611179|NCT00615017|528748773|FG001|Overall Study|Sepsis resolved|0|||
146611180|NCT00615017|528748774|FG002|Overall Study|Sepsis resolved|1|||
146611181|NCT00615017|528748775|FG003|Overall Study|Sepsis resolved|0|||
146611182|NCT00615017|528748776|FG004|Overall Study|Sepsis resolved|0|||
146978680|NCT03262233|530085458|FG000|Overall Study|Declined due to shock|1|||
146978681|NCT03262233|530085459|FG001|Overall Study|Declined due to shock|2|||
146611183|NCT00615017|528748777|FG005|Overall Study|Sepsis resolved|0|||
146923681|NCT02175771|529880960|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146923682|NCT02175771|529880961|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146923683|NCT02175771|529880953|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
146611184|NCT00615017|528748772|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
146611185|NCT00615017|528748773|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
146923684|NCT02175771|529880954|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
146923685|NCT02175771|529880955|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
146923686|NCT02175771|529880956|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
146923687|NCT02175771|529880957|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
146923688|NCT02175771|529880958|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
146923689|NCT02175771|529880959|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
146923690|NCT02175771|529880960|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
146923691|NCT02175771|529880961|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
146923692|NCT02175771|529880953|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
146923693|NCT02175771|529880954|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146923694|NCT02175771|529880955|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146923695|NCT02175771|529880956|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146923696|NCT02175771|529880957|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146923697|NCT02175771|529880958|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146923698|NCT02175771|529880959|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146611186|NCT00615017|528748774|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
146611187|NCT00615017|528748775|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
146611188|NCT00615017|528748776|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
146611189|NCT00615017|528748777|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
146611190|NCT00615017|528748772|FG000|Overall Study|Physician discontinued drug|0|||
146611191|NCT00615017|528748773|FG001|Overall Study|Physician discontinued drug|0|||
146611192|NCT00615017|528748774|FG002|Overall Study|Physician discontinued drug|0|||
146611193|NCT00615017|528748775|FG003|Overall Study|Physician discontinued drug|0|||
146923699|NCT02175771|529880960|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146923700|NCT02175771|529880961|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146923701|NCT02175771|529880953|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
146923702|NCT02175771|529880954|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146923703|NCT02175771|529880955|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146923704|NCT02175771|529880956|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146923705|NCT02175771|529880957|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146923706|NCT02175771|529880958|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146923707|NCT02175771|529880959|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146923708|NCT02175771|529880960|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146923709|NCT02175771|529880961|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146923710|NCT02175771|529880953|FG000|Run-In Period (Pre-assignment)|Other|8|||
146923711|NCT02175771|529880954|FG001|Run-In Period (Pre-assignment)|Other|0|||
146923712|NCT02175771|529880955|FG002|Run-In Period (Pre-assignment)|Other|0|||
146923713|NCT02175771|529880956|FG003|Run-In Period (Pre-assignment)|Other|0|||
146923714|NCT02175771|529880957|FG004|Run-In Period (Pre-assignment)|Other|0|||
146923715|NCT02175771|529880958|FG005|Run-In Period (Pre-assignment)|Other|0|||
146923716|NCT02175771|529880959|FG006|Run-In Period (Pre-assignment)|Other|0|||
146923717|NCT02175771|529880960|FG007|Run-In Period (Pre-assignment)|Other|0|||
146923718|NCT02175771|529880961|FG008|Run-In Period (Pre-assignment)|Other|0|||
146923719|NCT02175771|529880953|FG000|Treatment Period|Adverse Event|0|||
146923720|NCT02175771|529880954|FG001|Treatment Period|Adverse Event|2|||
146923721|NCT02175771|529880955|FG002|Treatment Period|Adverse Event|1|||
146923722|NCT02175771|529880956|FG003|Treatment Period|Adverse Event|1|||
146923723|NCT02175771|529880957|FG004|Treatment Period|Adverse Event|1|||
146923724|NCT02175771|529880958|FG005|Treatment Period|Adverse Event|3|||
146923725|NCT02175771|529880959|FG006|Treatment Period|Adverse Event|2|||
146611194|NCT00615017|528748776|FG004|Overall Study|Physician discontinued drug|0|||
146611195|NCT00615017|528748777|FG005|Overall Study|Physician discontinued drug|1|||
146611196|NCT03777059|528748778|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
146611197|NCT03777059|528748779|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
146611198|NCT03777059|528748780|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
146611199|NCT03777059|528748781|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
146658012|NCT00473746|528925327|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
146923726|NCT02175771|529880960|FG007|Treatment Period|Adverse Event|0|||
146923727|NCT02175771|529880961|FG008|Treatment Period|Adverse Event|1|||
146611200|NCT03777059|528748778|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
146658013|NCT00473746|528925328|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
146773428|NCT01780298|529341066|FG001|Overall Study|Subject not matched|0|||
146773429|NCT01780298|529341067|FG002|Overall Study|Subject not matched|1|||
146923728|NCT02175771|529880953|FG000|Treatment Period|Withdrawal by Subject|0|||
146923729|NCT02175771|529880954|FG001|Treatment Period|Withdrawal by Subject|9|||
146923730|NCT02175771|529880955|FG002|Treatment Period|Withdrawal by Subject|3|||
146923731|NCT02175771|529880956|FG003|Treatment Period|Withdrawal by Subject|6|||
146611201|NCT03777059|528748779|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
146611202|NCT03777059|528748780|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
146611203|NCT03777059|528748781|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
146611204|NCT03777059|528748778|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
146611205|NCT03777059|528748779|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
146611206|NCT03777059|528748780|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
146611207|NCT03777059|528748781|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
146611208|NCT03777059|528748778|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
146611209|NCT03777059|528748779|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
146773430|NCT01780298|529341068|FG003|Overall Study|Subject not matched|0|||
146773431|NCT01780298|529341065|FG000|Overall Study|Adverse Event|0|||
146773432|NCT01780298|529341066|FG001|Overall Study|Adverse Event|0|||
146773433|NCT01780298|529341067|FG002|Overall Study|Adverse Event|2|||
146773434|NCT01780298|529341068|FG003|Overall Study|Adverse Event|0|||
146773435|NCT03873779|529341069|FG000|Overall Study|Withdrawal by Subject|1|||
146773436|NCT04252586|529341071|FG000|Overall Study|Withdrawal by parent/guardian|3|||
146773437|NCT04252586|529341071|FG000|Overall Study|Adverse Event|1|||
146611210|NCT03777059|528748780|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
146611211|NCT03777059|528748781|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
146611212|NCT03777059|528748778|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
146611213|NCT03777059|528748779|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
146611214|NCT03777059|528748780|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
146611215|NCT03777059|528748781|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
146611216|NCT03777059|528748778|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
146611217|NCT03777059|528748779|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
146611218|NCT03777059|528748780|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
146611219|NCT03777059|528748781|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
146611220|NCT03777059|528748778|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
146611221|NCT03777059|528748779|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
146611222|NCT03777059|528748780|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
146611223|NCT03777059|528748781|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
146611224|NCT03777059|528748778|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
146611225|NCT03777059|528748779|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
146611226|NCT03777059|528748780|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
146611227|NCT03777059|528748781|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
146611228|NCT03777059|528748778|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
146611229|NCT03777059|528748779|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
146611230|NCT03777059|528748780|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
146611231|NCT03777059|528748781|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
146611232|NCT03777059|528748778|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
146611233|NCT03777059|528748779|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
146611234|NCT03777059|528748780|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
146611235|NCT03777059|528748781|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
146611236|NCT03777059|528748778|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
146611237|NCT03777059|528748779|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
146611238|NCT03777059|528748780|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
146611239|NCT03777059|528748781|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
146611240|NCT03350815|528748784|FG000|Period 1|Adverse Event|10|||
146611241|NCT03350815|528748785|FG001|Period 1|Adverse Event|0|||
146611242|NCT03350815|528748786|FG002|Period 1|Adverse Event|0|||
146611243|NCT03350815|528748787|FG003|Period 1|Adverse Event|0|||
146611244|NCT03350815|528748784|FG000|Period 1|Technical problems|1|||
146611245|NCT03350815|528748785|FG001|Period 1|Technical problems|0|||
146611246|NCT03350815|528748786|FG002|Period 1|Technical problems|0|||
146611247|NCT03350815|528748787|FG003|Period 1|Technical problems|0|||
146611248|NCT03350815|528748784|FG000|Period 1|Lost to Follow-up|3|||
146611249|NCT03350815|528748785|FG001|Period 1|Lost to Follow-up|0|||
146611250|NCT03350815|528748786|FG002|Period 1|Lost to Follow-up|0|||
146611251|NCT03350815|528748787|FG003|Period 1|Lost to Follow-up|0|||
146611252|NCT03350815|528748784|FG000|Period 1|Physician Decision|1|||
146611253|NCT03350815|528748785|FG001|Period 1|Physician Decision|0|||
146611254|NCT03350815|528748786|FG002|Period 1|Physician Decision|0|||
146611255|NCT03350815|528748787|FG003|Period 1|Physician Decision|0|||
146611256|NCT03350815|528748784|FG000|Period 1|Withdrawal by Subject|8|||
146611257|NCT03350815|528748785|FG001|Period 1|Withdrawal by Subject|0|||
146611258|NCT03350815|528748786|FG002|Period 1|Withdrawal by Subject|0|||
146611259|NCT03350815|528748787|FG003|Period 1|Withdrawal by Subject|0|||
146611260|NCT03350815|528748784|FG000|Period 1|Lack of Efficacy|15|||
146611261|NCT03350815|528748785|FG001|Period 1|Lack of Efficacy|0|||
146611262|NCT03350815|528748786|FG002|Period 1|Lack of Efficacy|0|||
146611263|NCT03350815|528748787|FG003|Period 1|Lack of Efficacy|0|||
146773438|NCT04252586|529341071|FG000|Overall Study|Death|2|||
146773439|NCT04252586|529341071|FG000|Overall Study|Study terminated by sponsor|4|||
146611264|NCT03350815|528748784|FG000|Period 1|Non-compliance with study treatment|2|||
146611265|NCT03350815|528748785|FG001|Period 1|Non-compliance with study treatment|0|||
146611266|NCT03350815|528748786|FG002|Period 1|Non-compliance with study treatment|0|||
146611267|NCT03350815|528748787|FG003|Period 1|Non-compliance with study treatment|0|||
146611268|NCT03350815|528748784|FG000|Period 1|Protocol Violation|3|||
146611269|NCT03350815|528748785|FG001|Period 1|Protocol Violation|0|||
146611270|NCT03350815|528748786|FG002|Period 1|Protocol Violation|0|||
146611271|NCT03350815|528748787|FG003|Period 1|Protocol Violation|0|||
146611272|NCT03350815|528748784|FG000|Period 2|Adverse Event|0|||
146611273|NCT03350815|528748785|FG001|Period 2|Adverse Event|3|||
146611274|NCT03350815|528748786|FG002|Period 2|Adverse Event|5|||
146611275|NCT03350815|528748787|FG003|Period 2|Adverse Event|0|||
146611276|NCT03350815|528748784|FG000|Period 2|Technical problem|0|||
146611277|NCT03350815|528748785|FG001|Period 2|Technical problem|1|||
146611278|NCT03350815|528748786|FG002|Period 2|Technical problem|0|||
146611279|NCT03350815|528748787|FG003|Period 2|Technical problem|0|||
146611280|NCT03350815|528748784|FG000|Period 2|Lost to Follow-up|0|||
146611281|NCT03350815|528748785|FG001|Period 2|Lost to Follow-up|3|||
146611282|NCT03350815|528748786|FG002|Period 2|Lost to Follow-up|3|||
146611283|NCT03350815|528748787|FG003|Period 2|Lost to Follow-up|0|||
146611284|NCT03350815|528748784|FG000|Period 2|Physician Decision|0|||
146611285|NCT03350815|528748785|FG001|Period 2|Physician Decision|0|||
146611286|NCT03350815|528748786|FG002|Period 2|Physician Decision|1|||
146611287|NCT03350815|528748787|FG003|Period 2|Physician Decision|0|||
146611288|NCT03350815|528748784|FG000|Period 2|Withdrawal by Subject|0|||
146611289|NCT03350815|528748785|FG001|Period 2|Withdrawal by Subject|3|||
146611290|NCT03350815|528748786|FG002|Period 2|Withdrawal by Subject|4|||
146611291|NCT03350815|528748787|FG003|Period 2|Withdrawal by Subject|0|||
146611292|NCT03350815|528748784|FG000|Period 2|Lack of Efficacy|0|||
146611293|NCT03350815|528748785|FG001|Period 2|Lack of Efficacy|6|||
146611294|NCT03350815|528748786|FG002|Period 2|Lack of Efficacy|2|||
146611295|NCT03350815|528748787|FG003|Period 2|Lack of Efficacy|0|||
146611296|NCT03350815|528748784|FG000|Period 2|Protocol Violation|0|||
146611297|NCT03350815|528748785|FG001|Period 2|Protocol Violation|0|||
146611298|NCT03350815|528748786|FG002|Period 2|Protocol Violation|1|||
146611299|NCT03350815|528748787|FG003|Period 2|Protocol Violation|0|||
146611300|NCT03350815|528748784|FG000|Period 2|New therapy for study indication|0|||
146611301|NCT03350815|528748785|FG001|Period 2|New therapy for study indication|0|||
146611302|NCT03350815|528748786|FG002|Period 2|New therapy for study indication|1|||
146611303|NCT03350815|528748787|FG003|Period 2|New therapy for study indication|0|||
146611304|NCT02517541|528748792|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
146773440|NCT04252586|529341071|FG000|Overall Study|Sponsor request|10|||
146611305|NCT02517541|528748792|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
146611306|NCT02517541|528748792|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
146611307|NCT02517541|528748792|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
146611308|NCT02517541|528748792|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
146611309|NCT02517541|528748792|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
146611310|NCT00699608|528748793|FG000|First Intervention|Withdrawal by Subject|0|||
146611311|NCT00699608|528748794|FG001|First Intervention|Withdrawal by Subject|0|||
146611312|NCT00699608|528748795|FG002|First Intervention|Withdrawal by Subject|1|||
146611313|NCT00699608|528748796|FG003|First Intervention|Withdrawal by Subject|0|||
146611314|NCT00699608|528748797|FG004|First Intervention|Withdrawal by Subject|0|||
146611315|NCT00699608|528748798|FG005|First Intervention|Withdrawal by Subject|0|||
146611316|NCT00699608|528748793|FG000|First Intervention|Protocol Violation|0|||
146611317|NCT00699608|528748794|FG001|First Intervention|Protocol Violation|0|||
146611318|NCT00699608|528748795|FG002|First Intervention|Protocol Violation|0|||
146611319|NCT00699608|528748796|FG003|First Intervention|Protocol Violation|0|||
146611320|NCT00699608|528748797|FG004|First Intervention|Protocol Violation|1|||
146611321|NCT00699608|528748798|FG005|First Intervention|Protocol Violation|0|||
146611322|NCT00699608|528748793|FG000|Second Intervention|Adverse Event|0|||
146611323|NCT00699608|528748794|FG001|Second Intervention|Adverse Event|0|||
146611324|NCT00699608|528748795|FG002|Second Intervention|Adverse Event|1|||
146611325|NCT00699608|528748796|FG003|Second Intervention|Adverse Event|0|||
146611326|NCT00699608|528748797|FG004|Second Intervention|Adverse Event|0|||
146611327|NCT00699608|528748798|FG005|Second Intervention|Adverse Event|0|||
146611328|NCT00699608|528748793|FG000|Second Intervention|Withdrawal by Subject|0|||
146611329|NCT00699608|528748794|FG001|Second Intervention|Withdrawal by Subject|0|||
146611330|NCT00699608|528748795|FG002|Second Intervention|Withdrawal by Subject|0|||
146611331|NCT00699608|528748796|FG003|Second Intervention|Withdrawal by Subject|1|||
146611332|NCT00699608|528748797|FG004|Second Intervention|Withdrawal by Subject|0|||
146611333|NCT00699608|528748798|FG005|Second Intervention|Withdrawal by Subject|0|||
146611334|NCT01136408|528748799|FG000|Overall Study|Adverse Event|4|||
146611335|NCT01136408|528748800|FG001|Overall Study|Adverse Event|8|||
146611336|NCT01136408|528748801|FG002|Overall Study|Adverse Event|4|||
146611337|NCT01136408|528748799|FG000|Overall Study|Protocol Violation|1|||
146611338|NCT01136408|528748800|FG001|Overall Study|Protocol Violation|1|||
146611339|NCT01136408|528748801|FG002|Overall Study|Protocol Violation|1|||
146611340|NCT02828436|528748802|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
146611341|NCT02828436|528748803|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
146611342|NCT02828436|528748802|FG000|Period 1|Lost to Follow-up|0|||
146611343|NCT02828436|528748803|FG001|Period 1|Lost to Follow-up|1|||
146611344|NCT02828436|528748802|FG000|Period 2|Withdrawal by Subject|4|||
146611345|NCT02828436|528748803|FG001|Period 2|Withdrawal by Subject|0|||
146611346|NCT02828436|528748802|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
146611347|NCT02828436|528748803|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
146611348|NCT02828436|528748802|FG000|Period 2|Lost to Follow-up|1|||
146611349|NCT02828436|528748803|FG001|Period 2|Lost to Follow-up|0|||
146611350|NCT03078556|528748806|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
146611351|NCT03078556|528748807|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
146611352|NCT03078556|528748808|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
146611353|NCT03078556|528748809|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
146611354|NCT03078556|528748806|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
146611355|NCT03078556|528748807|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
146611356|NCT03078556|528748808|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
146611357|NCT03078556|528748809|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
146611358|NCT03078556|528748806|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
146611359|NCT03078556|528748807|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
146611360|NCT03078556|528748808|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
146611361|NCT03078556|528748809|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
146611362|NCT03078556|528748806|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
146611363|NCT03078556|528748807|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
146611364|NCT03078556|528748808|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
146611365|NCT03078556|528748809|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
146611366|NCT04421482|528748811|FG000|Overall Study|Physician Decision|1|||
146611367|NCT03010319|528748812|FG000|Overall Study|Adverse Event|15|||
146611368|NCT03010319|528748813|FG001|Overall Study|Adverse Event|9|||
146611369|NCT03010319|528748812|FG000|Overall Study|Withdrawal by Subject|1|||
146611370|NCT03010319|528748813|FG001|Overall Study|Withdrawal by Subject|6|||
146611371|NCT03010319|528748812|FG000|Overall Study|Physician Decision|2|||
146611372|NCT03010319|528748813|FG001|Overall Study|Physician Decision|4|||
146611373|NCT03010319|528748812|FG000|Overall Study|Sponsor requested withdrawal|2|||
146611374|NCT03010319|528748813|FG001|Overall Study|Sponsor requested withdrawal|2|||
146611375|NCT03010319|528748812|FG000|Overall Study|Death|1|||
146611376|NCT03010319|528748813|FG001|Overall Study|Death|0|||
146611377|NCT03010319|528748812|FG000|Overall Study|Lost to Follow-up|0|||
146611378|NCT03010319|528748813|FG001|Overall Study|Lost to Follow-up|1|||
146611379|NCT03010319|528748812|FG000|Overall Study|Other Reason|5|||
146611380|NCT03010319|528748813|FG001|Overall Study|Other Reason|7|||
146611381|NCT02128724|528748814|FG000|Overall Study|Death|1|||
146611382|NCT02128724|528748815|FG001|Overall Study|Death|0|||
146611383|NCT02128724|528748816|FG002|Overall Study|Death|0|||
146611384|NCT02128724|528748817|FG003|Overall Study|Death|0|||
146611385|NCT02128724|528748814|FG000|Overall Study|Adverse Event|0|||
146611386|NCT02128724|528748815|FG001|Overall Study|Adverse Event|1|||
146611387|NCT02128724|528748816|FG002|Overall Study|Adverse Event|0|||
146611388|NCT02128724|528748817|FG003|Overall Study|Adverse Event|0|||
146611389|NCT02128724|528748814|FG000|Overall Study|Physician Decision|0|||
146611390|NCT02128724|528748815|FG001|Overall Study|Physician Decision|0|||
146611391|NCT02128724|528748816|FG002|Overall Study|Physician Decision|0|||
146611392|NCT02128724|528748817|FG003|Overall Study|Physician Decision|2|||
146611393|NCT02128724|528748814|FG000|Overall Study|Withdrawal by Subject|0|||
146611394|NCT02128724|528748815|FG001|Overall Study|Withdrawal by Subject|0|||
146611395|NCT02128724|528748816|FG002|Overall Study|Withdrawal by Subject|0|||
146611396|NCT02128724|528748817|FG003|Overall Study|Withdrawal by Subject|1|||
146611397|NCT01442714|528748818|FG000|Overall Study|Death|11|||
146611398|NCT01442714|528748818|FG000|Overall Study|Withdrawal by Subject|1|||
146611399|NCT04306510|528748819|FG000|Overall Study|Voluntarily withdrawal|1|||
146611400|NCT04306510|528748819|FG000|Overall Study|Enrolled but Not Treated|1|||
146848188|NCT01489891|529614043|FG000|Overall Study|Endoscopy failure|1|||
146848189|NCT01489891|529614044|FG001|Overall Study|Endoscopy failure|0|||
146848190|NCT02576587|529614046|FG000|Baseline|Equipment failure|0|||
146848191|NCT02576587|529614047|FG001|Baseline|Equipment failure|1|||
146848192|NCT02576587|529614046|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
146848193|NCT02576587|529614047|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
146848194|NCT02576587|529614046|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
146848195|NCT02576587|529614047|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
146848196|NCT02576587|529614046|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
146848197|NCT02576587|529614047|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
146848198|NCT00844532|529614048|FG000|Overall Study|Death|16|||
146848199|NCT00844532|529614048|FG000|Overall Study|Withdrawal by Subject|16|||
146848200|NCT00844532|529614048|FG000|Overall Study|Lost to Follow-up|7|||
146848201|NCT00948766|529614049|FG000|Core Study|Adverse Event|73|||
146848202|NCT00948766|529614050|FG001|Core Study|Adverse Event|51|||
146848203|NCT00948766|529614049|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
146923732|NCT02175771|529880957|FG004|Treatment Period|Withdrawal by Subject|2|||
146923733|NCT02175771|529880958|FG005|Treatment Period|Withdrawal by Subject|4|||
146923734|NCT02175771|529880959|FG006|Treatment Period|Withdrawal by Subject|2|||
146923735|NCT02175771|529880960|FG007|Treatment Period|Withdrawal by Subject|9|||
146923736|NCT02175771|529880961|FG008|Treatment Period|Withdrawal by Subject|2|||
146923737|NCT02175771|529880953|FG000|Treatment Period|Noncompliance|0|||
146923738|NCT02175771|529880954|FG001|Treatment Period|Noncompliance|1|||
146923739|NCT02175771|529880955|FG002|Treatment Period|Noncompliance|2|||
146923740|NCT02175771|529880956|FG003|Treatment Period|Noncompliance|0|||
146923741|NCT02175771|529880957|FG004|Treatment Period|Noncompliance|0|||
146923742|NCT02175771|529880958|FG005|Treatment Period|Noncompliance|0|||
146923743|NCT02175771|529880959|FG006|Treatment Period|Noncompliance|0|||
146923744|NCT02175771|529880960|FG007|Treatment Period|Noncompliance|0|||
146923745|NCT02175771|529880961|FG008|Treatment Period|Noncompliance|1|||
146923746|NCT02175771|529880953|FG000|Treatment Period|Protocol Violation|0|||
146923747|NCT02175771|529880954|FG001|Treatment Period|Protocol Violation|0|||
146923748|NCT02175771|529880955|FG002|Treatment Period|Protocol Violation|0|||
146923749|NCT02175771|529880956|FG003|Treatment Period|Protocol Violation|0|||
146923750|NCT02175771|529880957|FG004|Treatment Period|Protocol Violation|0|||
146923751|NCT02175771|529880958|FG005|Treatment Period|Protocol Violation|0|||
146923752|NCT02175771|529880959|FG006|Treatment Period|Protocol Violation|0|||
146923753|NCT02175771|529880960|FG007|Treatment Period|Protocol Violation|1|||
146923754|NCT02175771|529880961|FG008|Treatment Period|Protocol Violation|0|||
146923755|NCT02175771|529880953|FG000|Treatment Period|Disease progression|0|||
146923756|NCT02175771|529880954|FG001|Treatment Period|Disease progression|0|||
146923757|NCT02175771|529880955|FG002|Treatment Period|Disease progression|0|||
146923758|NCT02175771|529880956|FG003|Treatment Period|Disease progression|0|||
146923759|NCT02175771|529880957|FG004|Treatment Period|Disease progression|0|||
146923760|NCT02175771|529880958|FG005|Treatment Period|Disease progression|0|||
146923761|NCT02175771|529880959|FG006|Treatment Period|Disease progression|0|||
146923762|NCT02175771|529880960|FG007|Treatment Period|Disease progression|2|||
146611401|NCT04720417|528748820|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
146611402|NCT03329092|528748821|FG000|Overall Study|Other|2|||
146611403|NCT03329092|528748822|FG001|Overall Study|Other|2|||
146611404|NCT03329092|528748821|FG000|Overall Study|Withdrawal by Subject|16|||
146611405|NCT03329092|528748822|FG001|Overall Study|Withdrawal by Subject|3|||
146611406|NCT03329092|528748821|FG000|Overall Study|Physician Decision|1|||
146611407|NCT03329092|528748822|FG001|Overall Study|Physician Decision|0|||
146611408|NCT03329092|528748821|FG000|Overall Study|Death|17|||
146923763|NCT02175771|529880961|FG008|Treatment Period|Disease progression|0|||
146923764|NCT02175771|529880953|FG000|Treatment Period|Lost to Follow-up|0|||
146923765|NCT02175771|529880954|FG001|Treatment Period|Lost to Follow-up|3|||
146923766|NCT02175771|529880955|FG002|Treatment Period|Lost to Follow-up|1|||
146923767|NCT02175771|529880956|FG003|Treatment Period|Lost to Follow-up|3|||
146923768|NCT02175771|529880957|FG004|Treatment Period|Lost to Follow-up|1|||
146923769|NCT02175771|529880958|FG005|Treatment Period|Lost to Follow-up|2|||
146923770|NCT02175771|529880959|FG006|Treatment Period|Lost to Follow-up|1|||
146923771|NCT02175771|529880960|FG007|Treatment Period|Lost to Follow-up|2|||
146923772|NCT02175771|529880961|FG008|Treatment Period|Lost to Follow-up|2|||
146923773|NCT02175771|529880953|FG000|Treatment Period|Lack of Efficacy|0|||
146923774|NCT02175771|529880954|FG001|Treatment Period|Lack of Efficacy|0|||
146923775|NCT02175771|529880955|FG002|Treatment Period|Lack of Efficacy|0|||
146923776|NCT02175771|529880956|FG003|Treatment Period|Lack of Efficacy|0|||
146923777|NCT02175771|529880957|FG004|Treatment Period|Lack of Efficacy|0|||
146923778|NCT02175771|529880958|FG005|Treatment Period|Lack of Efficacy|1|||
146923779|NCT02175771|529880959|FG006|Treatment Period|Lack of Efficacy|0|||
146923780|NCT02175771|529880960|FG007|Treatment Period|Lack of Efficacy|1|||
146923781|NCT02175771|529880961|FG008|Treatment Period|Lack of Efficacy|0|||
146923782|NCT02175771|529880953|FG000|Treatment Period|Other|0|||
146923783|NCT02175771|529880954|FG001|Treatment Period|Other|1|||
146658014|NCT00473746|528925329|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
146658015|NCT00473746|528925330|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
146658016|NCT00473746|528925326|FG000|Period 2 (Phase 2)|Reason not specified|0|||
146658017|NCT00473746|528925327|FG001|Period 2 (Phase 2)|Reason not specified|0|||
146658018|NCT00473746|528925328|FG002|Period 2 (Phase 2)|Reason not specified|0|||
146658019|NCT00473746|528925329|FG003|Period 2 (Phase 2)|Reason not specified|0|||
146923784|NCT02175771|529880955|FG002|Treatment Period|Other|0|||
146923785|NCT02175771|529880956|FG003|Treatment Period|Other|3|||
146923786|NCT02175771|529880957|FG004|Treatment Period|Other|1|||
146923787|NCT02175771|529880958|FG005|Treatment Period|Other|0|||
146923788|NCT02175771|529880959|FG006|Treatment Period|Other|0|||
146923789|NCT02175771|529880960|FG007|Treatment Period|Other|2|||
146923790|NCT02175771|529880961|FG008|Treatment Period|Other|0|||
146923791|NCT01153763|529880964|FG000|Overall Study|Study Closed|16|||
146923792|NCT01153763|529880964|FG000|Overall Study|Lost to Follow-up|1|||
146658020|NCT00473746|528925330|FG004|Period 2 (Phase 2)|Reason not specified|3|||
146611409|NCT03329092|528748822|FG001|Overall Study|Death|11|||
146611410|NCT03329092|528748821|FG000|Overall Study|Adverse Event|3|||
146773441|NCT04252586|529341071|FG000|Overall Study|Did not complete treatment period|1|||
146773442|NCT03740009|529341073|FG000|Overall Study|Physician Decision|9|||
146773443|NCT03740009|529341073|FG000|Overall Study|Lost to Follow-up|1|||
146773444|NCT01236001|529341074|FG000|Overall Study|Adverse Event|5|||
146773445|NCT01236001|529341075|FG001|Overall Study|Adverse Event|14|||
146773446|NCT01236001|529341074|FG000|Overall Study|Lack of Efficacy|6|||
146773447|NCT01236001|529341075|FG001|Overall Study|Lack of Efficacy|6|||
146923793|NCT01153763|529880964|FG000|Overall Study|Physician Decision|2|||
146923794|NCT01153763|529880964|FG000|Overall Study|Withdrawal by Subject|2|||
146923795|NCT01474746|529880967|FG000|Overall Study|Lost to Follow-up|1|||
146923796|NCT01474746|529880968|FG001|Overall Study|Lost to Follow-up|1|||
146923797|NCT01474746|529880967|FG000|Overall Study|Withdrawal by Subject|2|||
146923798|NCT01474746|529880968|FG001|Overall Study|Withdrawal by Subject|1|||
146923799|NCT01606761|529880972|FG000|Prior to Week 24|Lost to Follow-up|0|||
146923800|NCT01606761|529880973|FG001|Prior to Week 24|Lost to Follow-up|3|||
146923801|NCT01606761|529880974|FG002|Prior to Week 24|Lost to Follow-up|2|||
146923802|NCT01606761|529880975|FG003|Prior to Week 24|Lost to Follow-up|0|||
146923803|NCT01606761|529880976|FG004|Prior to Week 24|Lost to Follow-up|0|||
146923804|NCT01606761|529880972|FG000|Prior to Week 24|Withdrawal by Subject|12|||
146923805|NCT01606761|529880973|FG001|Prior to Week 24|Withdrawal by Subject|10|||
146923806|NCT01606761|529880974|FG002|Prior to Week 24|Withdrawal by Subject|9|||
146923807|NCT01606761|529880975|FG003|Prior to Week 24|Withdrawal by Subject|0|||
146923808|NCT01606761|529880976|FG004|Prior to Week 24|Withdrawal by Subject|0|||
146923809|NCT01606761|529880972|FG000|Prior to Week 24|Adverse Event|11|||
146611411|NCT03329092|528748822|FG001|Overall Study|Adverse Event|1|||
146611412|NCT03329092|528748821|FG000|Overall Study|Lost to Follow-up|1|||
146611413|NCT03329092|528748822|FG001|Overall Study|Lost to Follow-up|1|||
146611414|NCT03314987|528748823|FG000|Overall Study|Lost to Follow-up|13|||
146611415|NCT03314987|528748824|FG001|Overall Study|Lost to Follow-up|13|||
146611416|NCT03574779|528748825|FG000|Overall Study|Screening failure|13|||
146611417|NCT03574779|528748826|FG001|Overall Study|Screening failure|83|||
146611418|NCT02751580|528748827|FG000|Overall Study|Lost to Follow-up|4|||
146611419|NCT02751580|528748827|FG000|Overall Study|Death|2|||
146611420|NCT01076036|528748830|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
146611421|NCT02221674|528748831|FG000|Overall Study|Lost to Follow-up|1|||
146611422|NCT02221674|528748832|FG001|Overall Study|Lost to Follow-up|0|||
146923810|NCT01606761|529880973|FG001|Prior to Week 24|Adverse Event|18|||
146923811|NCT01606761|529880974|FG002|Prior to Week 24|Adverse Event|22|||
146773448|NCT01236001|529341074|FG000|Overall Study|Lost to Follow-up|6|||
146773449|NCT01236001|529341075|FG001|Overall Study|Lost to Follow-up|1|||
146773450|NCT01236001|529341074|FG000|Overall Study|Incompliance|1|||
146773451|NCT01236001|529341075|FG001|Overall Study|Incompliance|0|||
146773452|NCT01236001|529341074|FG000|Overall Study|Planned Visit After End of Study|0|||
146773453|NCT01236001|529341075|FG001|Overall Study|Planned Visit After End of Study|1|||
146773454|NCT02988817|529341076|FG000|Overall Study|Withdrawal by Subject|1|||
146773455|NCT02988817|529341077|FG001|Overall Study|Withdrawal by Subject|0|||
146773456|NCT02988817|529341078|FG002|Overall Study|Withdrawal by Subject|0|||
146773457|NCT02988817|529341079|FG003|Overall Study|Withdrawal by Subject|1|||
146773458|NCT02988817|529341080|FG004|Overall Study|Withdrawal by Subject|3|||
146773459|NCT02988817|529341081|FG005|Overall Study|Withdrawal by Subject|1|||
146923812|NCT01606761|529880975|FG003|Prior to Week 24|Adverse Event|0|||
146923813|NCT01606761|529880976|FG004|Prior to Week 24|Adverse Event|0|||
146923814|NCT01606761|529880972|FG000|Prior to Week 24|Lack of Efficacy|15|||
146923815|NCT01606761|529880973|FG001|Prior to Week 24|Lack of Efficacy|14|||
146923816|NCT01606761|529880974|FG002|Prior to Week 24|Lack of Efficacy|8|||
146923817|NCT01606761|529880975|FG003|Prior to Week 24|Lack of Efficacy|0|||
146923818|NCT01606761|529880976|FG004|Prior to Week 24|Lack of Efficacy|0|||
146923819|NCT01606761|529880972|FG000|Prior to Week 24|Physician Decision|0|||
146923820|NCT01606761|529880973|FG001|Prior to Week 24|Physician Decision|3|||
146923821|NCT01606761|529880974|FG002|Prior to Week 24|Physician Decision|1|||
146611423|NCT02221674|528748833|FG002|Overall Study|Lost to Follow-up|0|||
146611424|NCT05292131|528748834|FG000|Overall Study|Lost to Follow-up|1|||
146611425|NCT05292131|528748835|FG001|Overall Study|Lost to Follow-up|1|||
146611426|NCT05292131|528748834|FG000|Overall Study|Withdrawal by Subject|0|||
146773460|NCT02988817|529341082|FG006|Overall Study|Withdrawal by Subject|2|||
146773461|NCT02988817|529341083|FG007|Overall Study|Withdrawal by Subject|1|||
146923822|NCT01606761|529880975|FG003|Prior to Week 24|Physician Decision|0|||
146923823|NCT01606761|529880976|FG004|Prior to Week 24|Physician Decision|0|||
146923824|NCT01606761|529880972|FG000|Prior to Week 24|Other|4|||
146923825|NCT01606761|529880973|FG001|Prior to Week 24|Other|7|||
146923826|NCT01606761|529880974|FG002|Prior to Week 24|Other|5|||
146923827|NCT01606761|529880975|FG003|Prior to Week 24|Other|0|||
146923828|NCT01606761|529880976|FG004|Prior to Week 24|Other|0|||
146923829|NCT01606761|529880972|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
146611427|NCT05292131|528748835|FG001|Overall Study|Withdrawal by Subject|1|||
146611428|NCT02557542|528748837|FG000|Overall Study|Poor recruitment|3|||
146611429|NCT02557542|528748838|FG001|Overall Study|Poor recruitment|0|||
146658021|NCT00667420|528925331|FG000|Overall Study|Adverse Event|2|||
146923830|NCT01606761|529880973|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
146611430|NCT04390880|528748839|FG000|Overall Study|Withdrawal by Subject|1|||
146611431|NCT00465452|528748840|FG000|Overall Study|Adverse Event|1|||
146611432|NCT00172042|528748873|FG000|Overall Study|Adverse Event|27|||
146923831|NCT01606761|529880974|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
146923832|NCT01606761|529880975|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
146923833|NCT01606761|529880976|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
146923834|NCT01606761|529880972|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
146923835|NCT01606761|529880973|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
146923836|NCT01606761|529880974|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
146923837|NCT01606761|529880975|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
146923838|NCT01606761|529880976|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
146923839|NCT01606761|529880972|FG000|Week 24 to Week 52|Adverse Event|0|||
146923840|NCT01606761|529880973|FG001|Week 24 to Week 52|Adverse Event|11|||
146923841|NCT01606761|529880974|FG002|Week 24 to Week 52|Adverse Event|14|||
146923842|NCT01606761|529880975|FG003|Week 24 to Week 52|Adverse Event|3|||
146923843|NCT01606761|529880976|FG004|Week 24 to Week 52|Adverse Event|15|||
146923844|NCT01606761|529880972|FG000|Week 24 to Week 52|Death|0|||
146923845|NCT01606761|529880973|FG001|Week 24 to Week 52|Death|0|||
146923846|NCT01606761|529880974|FG002|Week 24 to Week 52|Death|2|||
146923847|NCT01606761|529880975|FG003|Week 24 to Week 52|Death|1|||
146923848|NCT01606761|529880976|FG004|Week 24 to Week 52|Death|0|||
146923849|NCT01606761|529880972|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
146923850|NCT01606761|529880973|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
146923851|NCT01606761|529880974|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
146923852|NCT01606761|529880975|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
146923853|NCT01606761|529880976|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
146923854|NCT01606761|529880972|FG000|Week 24 to Week 52|Physician Decision|0|||
146923855|NCT01606761|529880973|FG001|Week 24 to Week 52|Physician Decision|1|||
146923856|NCT01606761|529880974|FG002|Week 24 to Week 52|Physician Decision|1|||
146923857|NCT01606761|529880975|FG003|Week 24 to Week 52|Physician Decision|0|||
146923858|NCT01606761|529880976|FG004|Week 24 to Week 52|Physician Decision|0|||
146923859|NCT01606761|529880972|FG000|Week 24 to Week 52|Other|0|||
146923860|NCT01606761|529880973|FG001|Week 24 to Week 52|Other|1|||
146923861|NCT01606761|529880974|FG002|Week 24 to Week 52|Other|5|||
146923862|NCT01606761|529880975|FG003|Week 24 to Week 52|Other|2|||
146923863|NCT01606761|529880976|FG004|Week 24 to Week 52|Other|2|||
146923864|NCT01606761|529880972|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
146923865|NCT01606761|529880973|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
146923866|NCT01606761|529880974|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
146923867|NCT01606761|529880975|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
146923868|NCT01606761|529880976|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
146923869|NCT01606761|529880972|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
146923870|NCT01606761|529880973|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
146923871|NCT01606761|529880974|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
146923872|NCT01606761|529880975|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
146923873|NCT01606761|529880976|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
146923874|NCT01606761|529880972|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
146923875|NCT01606761|529880973|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
146923876|NCT01606761|529880974|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
146923877|NCT01606761|529880975|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
146923878|NCT01606761|529880976|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
146923879|NCT01606761|529880972|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
146923880|NCT01606761|529880973|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
146923881|NCT01606761|529880974|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
146923882|NCT01606761|529880975|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
146923883|NCT01606761|529880976|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
146611433|NCT00172042|528748874|FG001|Overall Study|Adverse Event|13|||
146611434|NCT00172042|528748873|FG000|Overall Study|Abnormal laboratory value(s)|5|||
146773462|NCT02988817|529341084|FG008|Overall Study|Withdrawal by Subject|1|||
146923884|NCT05086289|529880977|FG000|Overall Study|Adverse Event|4|||
146923885|NCT05086289|529880978|FG001|Overall Study|Adverse Event|2|||
146773463|NCT02988817|529341085|FG009|Overall Study|Withdrawal by Subject|1|||
146773464|NCT02988817|529341086|FG010|Overall Study|Withdrawal by Subject|1|||
146923886|NCT05086289|529880977|FG000|Overall Study|Lost to Follow-up|2|||
146923887|NCT05086289|529880978|FG001|Overall Study|Lost to Follow-up|0|||
146923888|NCT05086289|529880977|FG000|Overall Study|Non-compliance with study drug|2|||
146923889|NCT05086289|529880978|FG001|Overall Study|Non-compliance with study drug|1|||
146923890|NCT05086289|529880977|FG000|Overall Study|Physician Decision|2|||
146923891|NCT05086289|529880978|FG001|Overall Study|Physician Decision|0|||
146923892|NCT05086289|529880977|FG000|Overall Study|Withdrawal by Subject|5|||
146611435|NCT00172042|528748874|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146611436|NCT00172042|528748873|FG000|Overall Study|Abnormal test procedure(s)|0|||
146923893|NCT05086289|529880978|FG001|Overall Study|Withdrawal by Subject|2|||
146923894|NCT04544709|529880979|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
146923895|NCT03238235|529880980|FG000|Overall Study|Adverse Event|2|||
146923896|NCT03238235|529880981|FG001|Overall Study|Adverse Event|0|||
146611437|NCT00172042|528748874|FG001|Overall Study|Abnormal test procedure(s)|3|||
146611438|NCT00172042|528748873|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
146923897|NCT03238235|529880980|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
146923898|NCT03238235|529880981|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
146923899|NCT01814800|529880982|FG000|Overall Study|Adverse Event|2|||
146923900|NCT01814800|529880982|FG000|Overall Study|Pregnancy|1|||
146611439|NCT00172042|528748874|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
146611440|NCT00172042|528748873|FG000|Overall Study|Patient no longer requires study drug|10|||
146611441|NCT00172042|528748874|FG001|Overall Study|Patient no longer requires study drug|8|||
146611442|NCT00172042|528748873|FG000|Overall Study|Protocol Violation|8|||
146611443|NCT00172042|528748874|FG001|Overall Study|Protocol Violation|7|||
146611444|NCT00172042|528748873|FG000|Overall Study|Withdrawal by Subject|37|||
146611445|NCT00172042|528748874|FG001|Overall Study|Withdrawal by Subject|25|||
146611446|NCT00172042|528748873|FG000|Overall Study|Lost to Follow-up|3|||
146611447|NCT00172042|528748874|FG001|Overall Study|Lost to Follow-up|5|||
146611448|NCT00172042|528748873|FG000|Overall Study|Administrative problems|13|||
146611449|NCT00172042|528748874|FG001|Overall Study|Administrative problems|10|||
146611450|NCT00172042|528748873|FG000|Overall Study|Death|42|||
146611451|NCT00172042|528748874|FG001|Overall Study|Death|42|||
146611452|NCT01771250|528748875|FG000|Period 1|Met exclusion criteria|1|||
146611453|NCT01771250|528748876|FG001|Period 1|Met exclusion criteria|0|||
146611454|NCT01180296|528748877|FG000|Overall Study|Protocol Violation|1|||
146611455|NCT01180296|528748878|FG001|Overall Study|Protocol Violation|2|||
146611456|NCT00483938|528748879|FG000|Overall Study|Protocol Violation|0|||
146611457|NCT00483938|528748880|FG001|Overall Study|Protocol Violation|0|||
146611458|NCT00483938|528748881|FG002|Overall Study|Protocol Violation|0|||
146611459|NCT00483938|528748882|FG003|Overall Study|Protocol Violation|0|||
146611460|NCT00483938|528748883|FG004|Overall Study|Protocol Violation|0|||
146611461|NCT00483938|528748884|FG005|Overall Study|Protocol Violation|0|||
146611462|NCT00483938|528748885|FG006|Overall Study|Protocol Violation|3|||
146611463|NCT00483938|528748879|FG000|Overall Study|Withdrawal by Subject|1|||
146611464|NCT00483938|528748880|FG001|Overall Study|Withdrawal by Subject|6|||
146611465|NCT00483938|528748881|FG002|Overall Study|Withdrawal by Subject|0|||
146611466|NCT00483938|528748882|FG003|Overall Study|Withdrawal by Subject|0|||
146611467|NCT00483938|528748883|FG004|Overall Study|Withdrawal by Subject|1|||
146611468|NCT00483938|528748884|FG005|Overall Study|Withdrawal by Subject|3|||
146611469|NCT00483938|528748885|FG006|Overall Study|Withdrawal by Subject|2|||
146611470|NCT00483938|528748879|FG000|Overall Study|Lost to Follow-up|1|||
146611471|NCT00483938|528748880|FG001|Overall Study|Lost to Follow-up|2|||
146611472|NCT00483938|528748881|FG002|Overall Study|Lost to Follow-up|0|||
146611473|NCT00483938|528748882|FG003|Overall Study|Lost to Follow-up|2|||
146611474|NCT00483938|528748883|FG004|Overall Study|Lost to Follow-up|1|||
146611475|NCT00483938|528748884|FG005|Overall Study|Lost to Follow-up|1|||
146611476|NCT00483938|528748885|FG006|Overall Study|Lost to Follow-up|3|||
146611477|NCT00483938|528748879|FG000|Overall Study|Death|0|||
146611478|NCT00483938|528748880|FG001|Overall Study|Death|2|||
146611479|NCT00483938|528748881|FG002|Overall Study|Death|0|||
146611480|NCT00483938|528748882|FG003|Overall Study|Death|0|||
146611481|NCT00483938|528748883|FG004|Overall Study|Death|0|||
146611482|NCT00483938|528748884|FG005|Overall Study|Death|0|||
146611483|NCT00483938|528748885|FG006|Overall Study|Death|0|||
146611484|NCT00483938|528748879|FG000|Overall Study|Other|3|||
146923901|NCT01814800|529880982|FG000|Overall Study|Sponsor decision|1|||
146923902|NCT01814800|529880982|FG000|Overall Study|Subject relocation|1|||
146923903|NCT03807739|529880983|FG000|Overall Study|Adverse Event|1|||
146923904|NCT03807739|529880984|FG001|Overall Study|Adverse Event|0|||
146923905|NCT03807739|529880985|FG002|Overall Study|Adverse Event|0|||
146923906|NCT03807739|529880986|FG003|Overall Study|Adverse Event|0|||
146611485|NCT00483938|528748880|FG001|Overall Study|Other|9|||
146773465|NCT02988817|529341087|FG011|Overall Study|Withdrawal by Subject|12|||
146923907|NCT03807739|529880983|FG000|Overall Study|Withdrawal by Subject|1|||
146923908|NCT03807739|529880984|FG001|Overall Study|Withdrawal by Subject|0|||
146923909|NCT03807739|529880985|FG002|Overall Study|Withdrawal by Subject|0|||
146611486|NCT00483938|528748881|FG002|Overall Study|Other|0|||
146611487|NCT00483938|528748882|FG003|Overall Study|Other|4|||
146611488|NCT00483938|528748883|FG004|Overall Study|Other|0|||
146611489|NCT00483938|528748884|FG005|Overall Study|Other|4|||
146611490|NCT00483938|528748885|FG006|Overall Study|Other|32|||
146611491|NCT01371552|528748888|FG000|Part 1, First 3 Days|Inconvenience|0|||
146611492|NCT01371552|528748889|FG001|Part 1, First 3 Days|Inconvenience|0|||
146611493|NCT01371552|528748890|FG002|Part 1, First 3 Days|Inconvenience|1|||
146611494|NCT01371552|528748891|FG003|Part 1, First 3 Days|Inconvenience|0|||
146611495|NCT01371552|528748892|FG004|Part 1, First 3 Days|Inconvenience|0|||
146611496|NCT01371552|528748893|FG005|Part 1, First 3 Days|Inconvenience|0|||
146611497|NCT03364309|528748894|FG000|Induction Period|Adverse Event|4|||
146611498|NCT03364309|528748895|FG001|Induction Period|Adverse Event|0|||
146611499|NCT03364309|528748896|FG002|Induction Period|Adverse Event|1|||
146611500|NCT03364309|528748897|FG003|Induction Period|Adverse Event|0|||
146611501|NCT03364309|528748898|FG004|Induction Period|Adverse Event|0|||
146611502|NCT03364309|528748899|FG005|Induction Period|Adverse Event|0|||
146611503|NCT03364309|528748900|FG006|Induction Period|Adverse Event|0|||
146611504|NCT03364309|528748901|FG007|Induction Period|Adverse Event|0|||
146611505|NCT03364309|528748902|FG008|Induction Period|Adverse Event|0|||
146611506|NCT03364309|528748903|FG009|Induction Period|Adverse Event|0|||
146611507|NCT03364309|528748904|FG010|Induction Period|Adverse Event|0|||
146611508|NCT03364309|528748905|FG011|Induction Period|Adverse Event|0|||
146611509|NCT03364309|528748906|FG012|Induction Period|Adverse Event|0|||
146611510|NCT03364309|528748907|FG013|Induction Period|Adverse Event|0|||
146611511|NCT03364309|528748908|FG014|Induction Period|Adverse Event|0|||
146611512|NCT03364309|528748909|FG015|Induction Period|Adverse Event|0|||
146611513|NCT03364309|528748910|FG016|Induction Period|Adverse Event|0|||
146611514|NCT03364309|528748911|FG017|Induction Period|Adverse Event|0|||
146611515|NCT03364309|528748912|FG018|Induction Period|Adverse Event|0|||
146611516|NCT03364309|528748894|FG000|Induction Period|Withdrawal by Subject|1|||
146611517|NCT03364309|528748895|FG001|Induction Period|Withdrawal by Subject|3|||
146611518|NCT03364309|528748896|FG002|Induction Period|Withdrawal by Subject|0|||
146611519|NCT03364309|528748897|FG003|Induction Period|Withdrawal by Subject|0|||
146611520|NCT03364309|528748898|FG004|Induction Period|Withdrawal by Subject|0|||
146611521|NCT03364309|528748899|FG005|Induction Period|Withdrawal by Subject|0|||
146611522|NCT03364309|528748900|FG006|Induction Period|Withdrawal by Subject|0|||
146658022|NCT00667420|528925331|FG000|Overall Study|Lack of Efficacy|5|||
146658023|NCT00667420|528925331|FG000|Overall Study|Physician Decision|1|||
146658024|NCT00667420|528925331|FG000|Overall Study|Withdrawal by Subject|2|||
146658025|NCT04437368|528925332|FG000|Overall Study|Death|3|||
146658026|NCT04437368|528925333|FG001|Overall Study|Death|0|||
146658027|NCT04437368|528925334|FG002|Overall Study|Death|2|||
146658028|NCT04437368|528925332|FG000|Overall Study|Study terminated by sponsor|16|||
146658029|NCT04437368|528925333|FG001|Overall Study|Study terminated by sponsor|1|||
146658030|NCT04437368|528925334|FG002|Overall Study|Study terminated by sponsor|25|||
146658031|NCT04437368|528925332|FG000|Overall Study|Withdrawal by Subject|4|||
146658032|NCT04437368|528925333|FG001|Overall Study|Withdrawal by Subject|0|||
146658033|NCT04437368|528925334|FG002|Overall Study|Withdrawal by Subject|3|||
146658034|NCT04437368|528925332|FG000|Overall Study|Sponsor instructions|23|||
146658035|NCT04437368|528925333|FG001|Overall Study|Sponsor instructions|0|||
146658036|NCT04437368|528925334|FG002|Overall Study|Sponsor instructions|0|||
146658037|NCT04271280|528925337|FG000|Overall Study|Lost to Follow-up|300|||
146658038|NCT04271280|528925337|FG000|Overall Study|Death|153|||
146658039|NCT04271280|528925337|FG000|Overall Study|Withdrawal of consent by patient|59|||
146658040|NCT04271280|528925337|FG000|Overall Study|Other|51|||
146658041|NCT04271280|528925337|FG000|Overall Study|No end of study information|42|||
146658042|NCT01280955|528925340|FG000|Overall Study|Death|2|||
146658043|NCT01280955|528925340|FG000|Overall Study|Withdrawal by Subject|1|||
146658044|NCT00364130|528925341|FG000|Intervention Period|Lost to Follow-up|4|||
146658045|NCT00364130|528925342|FG001|Intervention Period|Lost to Follow-up|3|||
146658046|NCT00364130|528925341|FG000|Intervention Period|Pregnancy|1|||
146658047|NCT00364130|528925342|FG001|Intervention Period|Pregnancy|0|||
146658048|NCT00364130|528925341|FG000|Intervention Period|Withdrawal by Subject|4|||
146658049|NCT00364130|528925342|FG001|Intervention Period|Withdrawal by Subject|5|||
146658050|NCT00364130|528925341|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
146658051|NCT00364130|528925342|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
146658052|NCT00901927|528925343|FG000|Overall Study|Lack of Efficacy|1|||
146658053|NCT00901927|528925343|FG000|Overall Study|Protocol Violation|3|||
146658054|NCT00901927|528925343|FG000|Overall Study|Withdrawal by Subject|2|||
146658055|NCT00937391|528925349|FG000|Stage 2|Withdrawal by Subject|1|||
146658056|NCT03875118|528927153|FG000|Overall Study|Withdrawal by Subject|4|||
146658057|NCT03875118|528927154|FG001|Overall Study|Withdrawal by Subject|4|||
146658058|NCT02237911|528927155|FG000|Overall Study|Withdrawal by Subject|4|||
146658059|NCT02237911|528927156|FG001|Overall Study|Withdrawal by Subject|7|||
146658060|NCT02237911|528927157|FG002|Overall Study|Withdrawal by Subject|2|||
146658061|NCT02237911|528927155|FG000|Overall Study|Lost to Follow-up|3|||
146658062|NCT02237911|528927156|FG001|Overall Study|Lost to Follow-up|1|||
146773466|NCT02988817|529341088|FG012|Overall Study|Withdrawal by Subject|6|||
146611523|NCT03364309|528748901|FG007|Induction Period|Withdrawal by Subject|0|||
146658063|NCT02237911|528927157|FG002|Overall Study|Lost to Follow-up|1|||
146658064|NCT04521777|528927158|FG000|Overall Study|Death|2|||
146923910|NCT03807739|529880986|FG003|Overall Study|Withdrawal by Subject|0|||
146923911|NCT02371759|529880987|FG000|Overall Study|Protocol Violation|3|||
146923912|NCT02371759|529880988|FG001|Overall Study|Protocol Violation|1|||
146658065|NCT04521777|528927158|FG000|Overall Study|Withdrawal by Subject|2|||
146773467|NCT02988817|529341089|FG013|Overall Study|Withdrawal by Subject|6|||
146923913|NCT02371759|529880989|FG002|Overall Study|Protocol Violation|1|||
146611524|NCT03364309|528748902|FG008|Induction Period|Withdrawal by Subject|0|||
146611525|NCT03364309|528748903|FG009|Induction Period|Withdrawal by Subject|0|||
146611526|NCT03364309|528748904|FG010|Induction Period|Withdrawal by Subject|0|||
146611527|NCT03364309|528748905|FG011|Induction Period|Withdrawal by Subject|0|||
146658066|NCT01143207|528927163|FG000|Overall Study|Lost to Follow-up|2|||
146611528|NCT03364309|528748906|FG012|Induction Period|Withdrawal by Subject|0|||
146611529|NCT03364309|528748907|FG013|Induction Period|Withdrawal by Subject|0|||
146611530|NCT03364309|528748908|FG014|Induction Period|Withdrawal by Subject|0|||
146611531|NCT03364309|528748909|FG015|Induction Period|Withdrawal by Subject|0|||
146611532|NCT03364309|528748910|FG016|Induction Period|Withdrawal by Subject|0|||
146611533|NCT03364309|528748911|FG017|Induction Period|Withdrawal by Subject|0|||
146611534|NCT03364309|528748912|FG018|Induction Period|Withdrawal by Subject|0|||
146611535|NCT03364309|528748894|FG000|Induction Period|Lost to Follow-up|1|||
146611536|NCT03364309|528748895|FG001|Induction Period|Lost to Follow-up|0|||
146611537|NCT03364309|528748896|FG002|Induction Period|Lost to Follow-up|0|||
146611538|NCT03364309|528748897|FG003|Induction Period|Lost to Follow-up|0|||
146611539|NCT03364309|528748898|FG004|Induction Period|Lost to Follow-up|0|||
146611540|NCT03364309|528748899|FG005|Induction Period|Lost to Follow-up|0|||
146611541|NCT03364309|528748900|FG006|Induction Period|Lost to Follow-up|0|||
146611542|NCT03364309|528748901|FG007|Induction Period|Lost to Follow-up|0|||
146611543|NCT03364309|528748902|FG008|Induction Period|Lost to Follow-up|0|||
146611544|NCT03364309|528748903|FG009|Induction Period|Lost to Follow-up|0|||
146611545|NCT03364309|528748904|FG010|Induction Period|Lost to Follow-up|0|||
146611546|NCT03364309|528748905|FG011|Induction Period|Lost to Follow-up|0|||
146611547|NCT03364309|528748906|FG012|Induction Period|Lost to Follow-up|0|||
146611548|NCT03364309|528748907|FG013|Induction Period|Lost to Follow-up|0|||
146611549|NCT03364309|528748908|FG014|Induction Period|Lost to Follow-up|0|||
146611550|NCT03364309|528748909|FG015|Induction Period|Lost to Follow-up|0|||
146611551|NCT03364309|528748910|FG016|Induction Period|Lost to Follow-up|0|||
146611552|NCT03364309|528748911|FG017|Induction Period|Lost to Follow-up|0|||
146658067|NCT01869725|528927164|FG000|Overall Study|ineligible after registration|1|||
146658068|NCT01869725|528927164|FG000|Overall Study|Death|1|||
146923914|NCT02371759|529880990|FG003|Overall Study|Protocol Violation|0|||
146923915|NCT02371759|529880991|FG004|Overall Study|Protocol Violation|3|||
146658069|NCT01869725|528927164|FG000|Overall Study|Lost to Follow-up|2|||
146658070|NCT03416374|528927171|FG000|Between Treatment Period I and II|Other|0|||
146658071|NCT03416374|528927172|FG001|Between Treatment Period I and II|Other|9|||
146658072|NCT03416374|528927171|FG000|Treatment Period II|Lack of Efficacy|3|||
146658073|NCT03416374|528927172|FG001|Treatment Period II|Lack of Efficacy|11|||
146658074|NCT03416374|528927171|FG000|Treatment Period II|Adverse Event|1|||
146658075|NCT03416374|528927172|FG001|Treatment Period II|Adverse Event|4|||
146658076|NCT03416374|528927171|FG000|Treatment Period II|Death|0|||
146658077|NCT03416374|528927172|FG001|Treatment Period II|Death|1|||
146658078|NCT03416374|528927171|FG000|Treatment Period II|Other|0|||
146658079|NCT03416374|528927172|FG001|Treatment Period II|Other|2|||
146658080|NCT03463031|528927175|FG000|Overall Study|Withdrawal by Subject|4|||
146658081|NCT03463031|528927176|FG001|Overall Study|Withdrawal by Subject|2|||
146658082|NCT03463031|528927175|FG000|Overall Study|Investigator/Sponsor Decision|0|||
146658083|NCT03463031|528927176|FG001|Overall Study|Investigator/Sponsor Decision|1|||
146658084|NCT03463031|528927175|FG000|Overall Study|Lost to Follow-up|1|||
146658085|NCT03463031|528927176|FG001|Overall Study|Lost to Follow-up|1|||
146658086|NCT03463031|528927175|FG000|Overall Study|Adverse Event|4|||
146658087|NCT03463031|528927176|FG001|Overall Study|Adverse Event|1|||
146658088|NCT03463031|528927175|FG000|Overall Study|Use of prohibited medication by subject|1|||
146923916|NCT02371759|529880992|FG005|Overall Study|Protocol Violation|1|||
146923917|NCT02371759|529880993|FG006|Overall Study|Protocol Violation|0|||
146923918|NCT02371759|529880994|FG007|Overall Study|Protocol Violation|3|||
146611553|NCT03364309|528748912|FG018|Induction Period|Lost to Follow-up|0|||
146611554|NCT03364309|528748894|FG000|Induction Period|Physician Decision|0|||
146611555|NCT03364309|528748895|FG001|Induction Period|Physician Decision|1|||
146611556|NCT03364309|528748896|FG002|Induction Period|Physician Decision|0|||
146611557|NCT03364309|528748897|FG003|Induction Period|Physician Decision|0|||
146611558|NCT03364309|528748898|FG004|Induction Period|Physician Decision|0|||
146658089|NCT03463031|528927176|FG001|Overall Study|Use of prohibited medication by subject|0|||
146658090|NCT01810432|528927177|FG000|Washout|Protocol Violation|0|||
146658091|NCT01810432|528927178|FG001|Washout|Protocol Violation|1|||
146658092|NCT01810432|528927177|FG000|Washout|Adverse Event|1|||
146658093|NCT01810432|528927178|FG001|Washout|Adverse Event|0|||
146658094|NCT01810432|528927177|FG000|Period 2|Withdrawal by Subject|2|||
146658095|NCT01810432|528927178|FG001|Period 2|Withdrawal by Subject|1|||
146658096|NCT01810432|528927177|FG000|Period 2|Physician Decision|1|||
146658097|NCT01810432|528927178|FG001|Period 2|Physician Decision|0|||
146658098|NCT01810432|528927177|FG000|Period 2|Lost to Follow-up|1|||
146658099|NCT01810432|528927178|FG001|Period 2|Lost to Follow-up|1|||
146658100|NCT00057954|528927179|FG000|Overall Study|Death|1|||
146658101|NCT00057954|528927179|FG000|Overall Study|Disease progression|1|||
146658102|NCT00559754|528927180|FG000|Overall Study|Disease progression|1|||
146923919|NCT02371759|529880987|FG000|Overall Study|Withdrawal by Subject|0|||
146923920|NCT02371759|529880988|FG001|Overall Study|Withdrawal by Subject|0|||
146658103|NCT00559754|528927180|FG000|Overall Study|Adverse Event|5|||
146923921|NCT02371759|529880989|FG002|Overall Study|Withdrawal by Subject|0|||
146611559|NCT03364309|528748899|FG005|Induction Period|Physician Decision|0|||
146658104|NCT00559754|528927180|FG000|Overall Study|Protocol Violation|1|||
146611560|NCT03364309|528748900|FG006|Induction Period|Physician Decision|0|||
146611561|NCT03364309|528748901|FG007|Induction Period|Physician Decision|0|||
146611562|NCT03364309|528748902|FG008|Induction Period|Physician Decision|0|||
146611563|NCT03364309|528748903|FG009|Induction Period|Physician Decision|0|||
146611564|NCT03364309|528748904|FG010|Induction Period|Physician Decision|0|||
146611565|NCT03364309|528748905|FG011|Induction Period|Physician Decision|0|||
146611566|NCT03364309|528748906|FG012|Induction Period|Physician Decision|0|||
146611567|NCT03364309|528748907|FG013|Induction Period|Physician Decision|0|||
146611568|NCT03364309|528748908|FG014|Induction Period|Physician Decision|0|||
146611569|NCT03364309|528748909|FG015|Induction Period|Physician Decision|0|||
146611570|NCT03364309|528748910|FG016|Induction Period|Physician Decision|0|||
146611571|NCT03364309|528748911|FG017|Induction Period|Physician Decision|0|||
146611572|NCT03364309|528748912|FG018|Induction Period|Physician Decision|0|||
146611573|NCT03364309|528748894|FG000|Maintenance Period|Withdrawal by Subject|0|||
146611574|NCT03364309|528748895|FG001|Maintenance Period|Withdrawal by Subject|0|||
146611575|NCT03364309|528748896|FG002|Maintenance Period|Withdrawal by Subject|0|||
146611576|NCT03364309|528748897|FG003|Maintenance Period|Withdrawal by Subject|1|||
146611577|NCT03364309|528748898|FG004|Maintenance Period|Withdrawal by Subject|3|||
146611578|NCT03364309|528748899|FG005|Maintenance Period|Withdrawal by Subject|1|||
146611579|NCT03364309|528748900|FG006|Maintenance Period|Withdrawal by Subject|3|||
146611580|NCT03364309|528748901|FG007|Maintenance Period|Withdrawal by Subject|0|||
146611581|NCT03364309|528748902|FG008|Maintenance Period|Withdrawal by Subject|1|||
146611582|NCT03364309|528748903|FG009|Maintenance Period|Withdrawal by Subject|1|||
146611583|NCT03364309|528748904|FG010|Maintenance Period|Withdrawal by Subject|2|||
146611584|NCT03364309|528748905|FG011|Maintenance Period|Withdrawal by Subject|0|||
146611585|NCT03364309|528748906|FG012|Maintenance Period|Withdrawal by Subject|0|||
146611586|NCT03364309|528748907|FG013|Maintenance Period|Withdrawal by Subject|0|||
146611587|NCT03364309|528748908|FG014|Maintenance Period|Withdrawal by Subject|0|||
146611588|NCT03364309|528748909|FG015|Maintenance Period|Withdrawal by Subject|0|||
146611589|NCT03364309|528748910|FG016|Maintenance Period|Withdrawal by Subject|0|||
146611590|NCT03364309|528748911|FG017|Maintenance Period|Withdrawal by Subject|0|||
146611591|NCT03364309|528748912|FG018|Maintenance Period|Withdrawal by Subject|0|||
146611592|NCT03364309|528748894|FG000|Maintenance Period|Adverse Event|0|||
146611593|NCT03364309|528748895|FG001|Maintenance Period|Adverse Event|0|||
146611594|NCT03364309|528748896|FG002|Maintenance Period|Adverse Event|0|||
146611595|NCT03364309|528748897|FG003|Maintenance Period|Adverse Event|0|||
146611596|NCT03364309|528748898|FG004|Maintenance Period|Adverse Event|2|||
146611597|NCT03364309|528748899|FG005|Maintenance Period|Adverse Event|0|||
146611598|NCT03364309|528748900|FG006|Maintenance Period|Adverse Event|3|||
146611599|NCT03364309|528748901|FG007|Maintenance Period|Adverse Event|0|||
146611600|NCT03364309|528748902|FG008|Maintenance Period|Adverse Event|1|||
146611601|NCT03364309|528748903|FG009|Maintenance Period|Adverse Event|0|||
146611602|NCT03364309|528748904|FG010|Maintenance Period|Adverse Event|2|||
146611603|NCT03364309|528748905|FG011|Maintenance Period|Adverse Event|0|||
146611604|NCT03364309|528748906|FG012|Maintenance Period|Adverse Event|0|||
146611605|NCT03364309|528748907|FG013|Maintenance Period|Adverse Event|0|||
146611606|NCT03364309|528748908|FG014|Maintenance Period|Adverse Event|0|||
146611607|NCT03364309|528748909|FG015|Maintenance Period|Adverse Event|0|||
146611608|NCT03364309|528748910|FG016|Maintenance Period|Adverse Event|0|||
146611609|NCT03364309|528748911|FG017|Maintenance Period|Adverse Event|0|||
146611610|NCT03364309|528748912|FG018|Maintenance Period|Adverse Event|0|||
146611611|NCT03364309|528748894|FG000|Maintenance Period|Relapsed|0|||
146611612|NCT03364309|528748895|FG001|Maintenance Period|Relapsed|0|||
146611613|NCT03364309|528748896|FG002|Maintenance Period|Relapsed|0|||
146611614|NCT03364309|528748897|FG003|Maintenance Period|Relapsed|43|||
146611615|NCT03364309|528748898|FG004|Maintenance Period|Relapsed|7|||
146611616|NCT03364309|528748899|FG005|Maintenance Period|Relapsed|45|||
146611617|NCT03364309|528748900|FG006|Maintenance Period|Relapsed|10|||
146611618|NCT03364309|528748901|FG007|Maintenance Period|Relapsed|2|||
146611619|NCT03364309|528748902|FG008|Maintenance Period|Relapsed|0|||
146611620|NCT03364309|528748903|FG009|Maintenance Period|Relapsed|0|||
146611621|NCT03364309|528748904|FG010|Maintenance Period|Relapsed|0|||
146611622|NCT03364309|528748905|FG011|Maintenance Period|Relapsed|0|||
146611623|NCT03364309|528748906|FG012|Maintenance Period|Relapsed|0|||
146658105|NCT00559754|528927180|FG000|Overall Study|Investigator criteria|2|||
146923922|NCT02371759|529880990|FG003|Overall Study|Withdrawal by Subject|0|||
146923923|NCT02371759|529880991|FG004|Overall Study|Withdrawal by Subject|0|||
146611624|NCT03364309|528748907|FG013|Maintenance Period|Relapsed|0|||
146611625|NCT03364309|528748908|FG014|Maintenance Period|Relapsed|0|||
146611626|NCT03364309|528748909|FG015|Maintenance Period|Relapsed|0|||
146611627|NCT03364309|528748910|FG016|Maintenance Period|Relapsed|0|||
146611628|NCT03364309|528748911|FG017|Maintenance Period|Relapsed|0|||
146611629|NCT03364309|528748912|FG018|Maintenance Period|Relapsed|0|||
146923924|NCT02371759|529880992|FG005|Overall Study|Withdrawal by Subject|0|||
146658106|NCT00559754|528927180|FG000|Overall Study|Withdrawal by Subject|2|||
146611630|NCT03364309|528748894|FG000|Maintenance Period|Lack of Efficacy|0|||
146611631|NCT03364309|528748895|FG001|Maintenance Period|Lack of Efficacy|0|||
146611632|NCT03364309|528748896|FG002|Maintenance Period|Lack of Efficacy|0|||
146611633|NCT03364309|528748897|FG003|Maintenance Period|Lack of Efficacy|0|||
146611634|NCT03364309|528748898|FG004|Maintenance Period|Lack of Efficacy|0|||
146611635|NCT03364309|528748899|FG005|Maintenance Period|Lack of Efficacy|0|||
146611636|NCT03364309|528748900|FG006|Maintenance Period|Lack of Efficacy|0|||
146611637|NCT03364309|528748901|FG007|Maintenance Period|Lack of Efficacy|0|||
146611638|NCT03364309|528748902|FG008|Maintenance Period|Lack of Efficacy|1|||
146611639|NCT03364309|528748903|FG009|Maintenance Period|Lack of Efficacy|3|||
146611640|NCT03364309|528748904|FG010|Maintenance Period|Lack of Efficacy|2|||
146611641|NCT03364309|528748905|FG011|Maintenance Period|Lack of Efficacy|0|||
146611642|NCT03364309|528748906|FG012|Maintenance Period|Lack of Efficacy|0|||
146611643|NCT03364309|528748907|FG013|Maintenance Period|Lack of Efficacy|0|||
146611644|NCT03364309|528748908|FG014|Maintenance Period|Lack of Efficacy|0|||
146611645|NCT03364309|528748909|FG015|Maintenance Period|Lack of Efficacy|0|||
146611646|NCT03364309|528748910|FG016|Maintenance Period|Lack of Efficacy|0|||
146611647|NCT03364309|528748911|FG017|Maintenance Period|Lack of Efficacy|0|||
146611648|NCT03364309|528748912|FG018|Maintenance Period|Lack of Efficacy|0|||
146611649|NCT03364309|528748894|FG000|Maintenance Period|Death|0|||
146611650|NCT03364309|528748895|FG001|Maintenance Period|Death|0|||
146611651|NCT03364309|528748896|FG002|Maintenance Period|Death|0|||
146611652|NCT03364309|528748897|FG003|Maintenance Period|Death|0|||
146611653|NCT03364309|528748898|FG004|Maintenance Period|Death|0|||
146611654|NCT03364309|528748899|FG005|Maintenance Period|Death|0|||
146611655|NCT03364309|528748900|FG006|Maintenance Period|Death|0|||
146611656|NCT03364309|528748901|FG007|Maintenance Period|Death|0|||
146611657|NCT03364309|528748902|FG008|Maintenance Period|Death|1|||
146611658|NCT03364309|528748903|FG009|Maintenance Period|Death|0|||
146611659|NCT03364309|528748904|FG010|Maintenance Period|Death|0|||
146611660|NCT03364309|528748905|FG011|Maintenance Period|Death|0|||
146611661|NCT03364309|528748906|FG012|Maintenance Period|Death|0|||
146611662|NCT03364309|528748907|FG013|Maintenance Period|Death|0|||
146611663|NCT03364309|528748908|FG014|Maintenance Period|Death|0|||
146611664|NCT03364309|528748909|FG015|Maintenance Period|Death|0|||
146611665|NCT03364309|528748910|FG016|Maintenance Period|Death|0|||
146611666|NCT03364309|528748911|FG017|Maintenance Period|Death|0|||
146611667|NCT03364309|528748912|FG018|Maintenance Period|Death|0|||
146611668|NCT03364309|528748894|FG000|Maintenance Period|Lost to Follow-up|0|||
146611669|NCT03364309|528748895|FG001|Maintenance Period|Lost to Follow-up|0|||
146611670|NCT03364309|528748896|FG002|Maintenance Period|Lost to Follow-up|0|||
146611671|NCT03364309|528748897|FG003|Maintenance Period|Lost to Follow-up|0|||
146611672|NCT03364309|528748898|FG004|Maintenance Period|Lost to Follow-up|0|||
146611673|NCT03364309|528748899|FG005|Maintenance Period|Lost to Follow-up|0|||
146611674|NCT03364309|528748900|FG006|Maintenance Period|Lost to Follow-up|0|||
146611675|NCT03364309|528748901|FG007|Maintenance Period|Lost to Follow-up|0|||
146611676|NCT03364309|528748902|FG008|Maintenance Period|Lost to Follow-up|1|||
146658107|NCT01264016|528927181|FG000|Overall Study|Withdrawal by Subject|1|||
146658108|NCT01264016|528927181|FG000|Overall Study|Felt faint at sight of blood|1|||
146658109|NCT01629706|528927182|FG000|Phase 1 PureVision|Screen Failure|4|||
146658110|NCT01629706|528927182|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
146658111|NCT01629706|528927182|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
146658112|NCT01629706|528927182|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
146658113|NCT01629706|528927182|FG000|Phase 2 Habitual|Screen Failure|6|||
146658114|NCT01629706|528927182|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
146658115|NCT01629706|528927182|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
146658116|NCT01629706|528927182|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
146658117|NCT01629706|528927182|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
146658118|NCT02117414|528927183|FG000|Overall Study|Death|5|||
146658119|NCT02117414|528927184|FG001|Overall Study|Death|2|||
146658120|NCT02117414|528927183|FG000|Overall Study|Withdrawal by Subject|10|||
146658121|NCT02117414|528927184|FG001|Overall Study|Withdrawal by Subject|4|||
146658122|NCT02537574|528927185|FG000|Overall Study|Adverse Event|1|||
146658123|NCT02537574|528927186|FG001|Overall Study|Adverse Event|3|||
146978682|NCT03262233|530085460|FG002|Overall Study|Declined due to shock|2|||
146611677|NCT03364309|528748903|FG009|Maintenance Period|Lost to Follow-up|0|||
146611678|NCT03364309|528748904|FG010|Maintenance Period|Lost to Follow-up|0|||
146611679|NCT03364309|528748905|FG011|Maintenance Period|Lost to Follow-up|0|||
146611680|NCT03364309|528748906|FG012|Maintenance Period|Lost to Follow-up|0|||
146611681|NCT03364309|528748907|FG013|Maintenance Period|Lost to Follow-up|0|||
146611682|NCT03364309|528748908|FG014|Maintenance Period|Lost to Follow-up|0|||
146611683|NCT03364309|528748909|FG015|Maintenance Period|Lost to Follow-up|0|||
146611684|NCT03364309|528748910|FG016|Maintenance Period|Lost to Follow-up|0|||
146611685|NCT03364309|528748911|FG017|Maintenance Period|Lost to Follow-up|0|||
146611686|NCT03364309|528748912|FG018|Maintenance Period|Lost to Follow-up|0|||
146611687|NCT03364309|528748894|FG000|Maintenance Period|Miscellaneous|0|||
146611688|NCT03364309|528748895|FG001|Maintenance Period|Miscellaneous|0|||
146611689|NCT03364309|528748896|FG002|Maintenance Period|Miscellaneous|0|||
146611690|NCT03364309|528748897|FG003|Maintenance Period|Miscellaneous|0|||
146611691|NCT03364309|528748898|FG004|Maintenance Period|Miscellaneous|0|||
146611692|NCT03364309|528748899|FG005|Maintenance Period|Miscellaneous|0|||
146923925|NCT02371759|529880993|FG006|Overall Study|Withdrawal by Subject|0|||
146923926|NCT02371759|529880994|FG007|Overall Study|Withdrawal by Subject|1|||
146923927|NCT03201198|529881008|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
146923928|NCT03201198|529881009|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
146923929|NCT03201198|529881008|FG000|Overall Study|Withdrawal by Subject|2|||
146923930|NCT03201198|529881009|FG001|Overall Study|Withdrawal by Subject|3|||
146923931|NCT03213626|529881010|FG000|Overall Study|Adverse Event|1|||
146923932|NCT03213626|529881010|FG000|Overall Study|Progressive Disease|6|||
146923933|NCT01767194|529881011|FG000|Overall Study|Adverse Event|1|||
146923934|NCT01767194|529881012|FG001|Overall Study|Adverse Event|1|||
146923935|NCT01767194|529881011|FG000|Overall Study|Death|0|||
146923936|NCT01767194|529881012|FG001|Overall Study|Death|1|||
146923937|NCT01767194|529881011|FG000|Overall Study|Lack of Efficacy|12|||
146923938|NCT01767194|529881012|FG001|Overall Study|Lack of Efficacy|11|||
146923939|NCT01767194|529881011|FG000|Overall Study|Physician Decision|2|||
146923940|NCT01767194|529881012|FG001|Overall Study|Physician Decision|23|||
146611693|NCT03364309|528748900|FG006|Maintenance Period|Miscellaneous|0|||
146611694|NCT03364309|528748901|FG007|Maintenance Period|Miscellaneous|0|||
146611695|NCT03364309|528748902|FG008|Maintenance Period|Miscellaneous|1|||
146611696|NCT03364309|528748903|FG009|Maintenance Period|Miscellaneous|0|||
146611697|NCT03364309|528748904|FG010|Maintenance Period|Miscellaneous|0|||
146611698|NCT03364309|528748905|FG011|Maintenance Period|Miscellaneous|0|||
146611699|NCT03364309|528748906|FG012|Maintenance Period|Miscellaneous|0|||
146611700|NCT03364309|528748907|FG013|Maintenance Period|Miscellaneous|0|||
146611701|NCT03364309|528748908|FG014|Maintenance Period|Miscellaneous|0|||
146611702|NCT03364309|528748909|FG015|Maintenance Period|Miscellaneous|0|||
146611703|NCT03364309|528748910|FG016|Maintenance Period|Miscellaneous|0|||
146611704|NCT03364309|528748911|FG017|Maintenance Period|Miscellaneous|0|||
146611705|NCT03364309|528748912|FG018|Maintenance Period|Miscellaneous|0|||
146611706|NCT03364309|528748894|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146611707|NCT03364309|528748895|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146611708|NCT03364309|528748896|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146611709|NCT03364309|528748897|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146611710|NCT03364309|528748898|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146611711|NCT03364309|528748899|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146611712|NCT03364309|528748900|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146611713|NCT03364309|528748901|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146611714|NCT03364309|528748902|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146611715|NCT03364309|528748903|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146611716|NCT03364309|528748904|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146611717|NCT03364309|528748905|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146611718|NCT03364309|528748906|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146611719|NCT03364309|528748907|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
146611720|NCT03364309|528748908|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
146611721|NCT03364309|528748909|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
146611722|NCT03364309|528748910|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146611723|NCT03364309|528748911|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146611724|NCT03364309|528748912|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146611725|NCT03364309|528748894|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
146611726|NCT03364309|528748895|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
146611727|NCT03364309|528748896|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
146611728|NCT03364309|528748897|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
146611729|NCT03364309|528748898|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
146611730|NCT03364309|528748899|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
146658124|NCT02537574|528927187|FG002|Overall Study|Adverse Event|2|||
146658125|NCT02537574|528927185|FG000|Overall Study|Lost to Follow-up|40|||
146658126|NCT02537574|528927186|FG001|Overall Study|Lost to Follow-up|51|||
146611731|NCT03364309|528748900|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
146611732|NCT03364309|528748901|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
146611733|NCT03364309|528748902|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
146658127|NCT02537574|528927187|FG002|Overall Study|Lost to Follow-up|55|||
146658128|NCT02537574|528927185|FG000|Overall Study|Noncompliance with study drug|0|||
146658129|NCT02537574|528927186|FG001|Overall Study|Noncompliance with study drug|1|||
146658130|NCT02537574|528927187|FG002|Overall Study|Noncompliance with study drug|1|||
146923941|NCT01767194|529881011|FG000|Overall Study|Withdrawal by Subject|0|||
146923942|NCT01767194|529881012|FG001|Overall Study|Withdrawal by Subject|1|||
146923943|NCT01767194|529881011|FG000|Overall Study|Ineligible|1|||
146923944|NCT01767194|529881012|FG001|Overall Study|Ineligible|1|||
146611734|NCT03364309|528748903|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
146611735|NCT03364309|528748904|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
146658131|NCT02537574|528927185|FG000|Overall Study|Physician Decision|2|||
146923945|NCT01767194|529881011|FG000|Overall Study|Refusal by patient/parent|2|||
146923946|NCT01767194|529881012|FG001|Overall Study|Refusal by patient/parent|4|||
146611736|NCT03364309|528748905|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
146611737|NCT03364309|528748906|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
146611738|NCT03364309|528748907|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
146611739|NCT03364309|528748908|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
146611740|NCT03364309|528748909|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
146611741|NCT03364309|528748910|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
146611742|NCT03364309|528748911|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
146611743|NCT03364309|528748912|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
146611744|NCT03364309|528748894|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
146611745|NCT03364309|528748895|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
146611746|NCT03364309|528748896|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
146611747|NCT03364309|528748897|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
146611748|NCT03364309|528748898|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
146611749|NCT03364309|528748899|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
146611750|NCT03364309|528748900|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
146611751|NCT03364309|528748901|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
146611752|NCT03364309|528748902|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
146611753|NCT03364309|528748903|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
146611754|NCT03364309|528748904|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
146611755|NCT03364309|528748905|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
146611756|NCT03364309|528748906|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
146611757|NCT03364309|528748907|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
146611758|NCT03364309|528748908|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
146611759|NCT03364309|528748909|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
146611760|NCT03364309|528748910|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
146611761|NCT03364309|528748911|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
146611762|NCT03364309|528748912|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
146611763|NCT03364309|528748894|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146611764|NCT03364309|528748895|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146611765|NCT03364309|528748896|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146611766|NCT03364309|528748897|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146611767|NCT03364309|528748898|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146611768|NCT03364309|528748899|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146611769|NCT03364309|528748900|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146611770|NCT03364309|528748901|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146611771|NCT03364309|528748902|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146611772|NCT03364309|528748903|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146611773|NCT03364309|528748904|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146611774|NCT03364309|528748905|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146611775|NCT03364309|528748906|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146611776|NCT03364309|528748907|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146611777|NCT03364309|528748908|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146611778|NCT03364309|528748909|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146611779|NCT03364309|528748910|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
146611780|NCT03364309|528748911|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
146611781|NCT03364309|528748912|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
146611782|NCT03364309|528748894|FG000|Post-Treatment Followup Period|Adverse Event|0|||
146611783|NCT03364309|528748895|FG001|Post-Treatment Followup Period|Adverse Event|0|||
146611784|NCT03364309|528748896|FG002|Post-Treatment Followup Period|Adverse Event|0|||
146611785|NCT03364309|528748897|FG003|Post-Treatment Followup Period|Adverse Event|0|||
146611786|NCT03364309|528748898|FG004|Post-Treatment Followup Period|Adverse Event|0|||
146611787|NCT03364309|528748899|FG005|Post-Treatment Followup Period|Adverse Event|0|||
146611788|NCT03364309|528748900|FG006|Post-Treatment Followup Period|Adverse Event|0|||
146923947|NCT01767194|529881011|FG000|Overall Study|Criteria not met on time for next cycle|0|||
146923948|NCT01767194|529881012|FG001|Overall Study|Criteria not met on time for next cycle|1|||
146923949|NCT00311181|529883098|FG000|Overall Study|Final DFTs were not obtained|96|||
146923950|NCT00506948|529883104|FG000|Overall Study|Death|4|||
146923951|NCT00506948|529883104|FG000|Overall Study|Adverse Event|5|||
146923952|NCT00506948|529883104|FG000|Overall Study|Physician Decision|1|||
146923953|NCT02395653|529883105|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
146923954|NCT02395653|529883105|FG000|Overall Study|Consent Withdrawn at Screening|1|||
146923955|NCT02395653|529883105|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
146611789|NCT03364309|528748901|FG007|Post-Treatment Followup Period|Adverse Event|0|||
146611790|NCT03364309|528748902|FG008|Post-Treatment Followup Period|Adverse Event|0|||
146611791|NCT03364309|528748903|FG009|Post-Treatment Followup Period|Adverse Event|0|||
146611792|NCT03364309|528748904|FG010|Post-Treatment Followup Period|Adverse Event|0|||
146611793|NCT03364309|528748905|FG011|Post-Treatment Followup Period|Adverse Event|0|||
146611794|NCT03364309|528748906|FG012|Post-Treatment Followup Period|Adverse Event|0|||
146611795|NCT03364309|528748907|FG013|Post-Treatment Followup Period|Adverse Event|0|||
146923956|NCT02395653|529883105|FG000|Overall Study|Investigator Decision at Screening|1|||
146923957|NCT02395653|529883105|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
146923958|NCT02395653|529883105|FG000|Overall Study|Withdrawal by Subject|1|||
146923959|NCT02395653|529883105|FG000|Overall Study|Lost to Follow-up|1|||
146923960|NCT00789958|529883108|FG000|Overall Study|Adverse Event|3|||
146923961|NCT00789958|529883108|FG000|Overall Study|Withdrawal by Subject|4|||
146923962|NCT00789958|529883108|FG000|Overall Study|Progression|3|||
146923963|NCT00789958|529883108|FG000|Overall Study|not protocol specified|1|||
146923964|NCT00789958|529883108|FG000|Overall Study|Not eligible/not analyzable|26|||
146923965|NCT02622724|529883111|FG000|Overall Study|Death|51|||
146923966|NCT02622724|529883112|FG001|Overall Study|Death|53|||
146923967|NCT02622724|529883111|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
146923968|NCT02622724|529883112|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
146923969|NCT02622724|529883111|FG000|Overall Study|Early termination of study|38|||
146923970|NCT02622724|529883112|FG001|Overall Study|Early termination of study|43|||
146923971|NCT00296725|529883113|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
146923972|NCT00296725|529883113|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
146923973|NCT00296725|529883113|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
146923974|NCT00487084|529883114|FG000|Overall Study|Did not receive intervention|4|||
146923975|NCT00487084|529883115|FG001|Overall Study|Did not receive intervention|3|||
146923976|NCT00487084|529883116|FG002|Overall Study|Did not receive intervention|5|||
146923977|NCT00254293|529883117|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
146923978|NCT00254293|529883118|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
146923979|NCT00254293|529883119|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
146923980|NCT00254293|529883120|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
146923981|NCT00254293|529883121|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
146923982|NCT00254293|529883122|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
146923983|NCT00254293|529883123|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
146923984|NCT00254293|529883117|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
146923985|NCT00254293|529883118|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
146923986|NCT00254293|529883119|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
146923987|NCT00254293|529883120|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
146923988|NCT00254293|529883121|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
146923989|NCT00254293|529883122|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
146923990|NCT00254293|529883123|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
146923991|NCT00254293|529883117|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
146923992|NCT00254293|529883118|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
146923993|NCT00254293|529883119|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
146923994|NCT00254293|529883120|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
146923995|NCT00254293|529883121|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
146923996|NCT00254293|529883122|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
146923997|NCT00254293|529883123|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
146923998|NCT00254293|529883117|FG000|LTE Open Label Variable SC Dosing|Death|0|||
146923999|NCT00254293|529883118|FG001|LTE Open Label Variable SC Dosing|Death|0|||
146658132|NCT02537574|528927186|FG001|Overall Study|Physician Decision|0|||
146658133|NCT02537574|528927187|FG002|Overall Study|Physician Decision|0|||
146924000|NCT00254293|529883119|FG002|LTE Open Label Variable SC Dosing|Death|1|||
146924001|NCT00254293|529883120|FG003|LTE Open Label Variable SC Dosing|Death|0|||
146924002|NCT00254293|529883121|FG004|LTE Open Label Variable SC Dosing|Death|0|||
146924003|NCT00254293|529883122|FG005|LTE Open Label Variable SC Dosing|Death|0|||
146924004|NCT00254293|529883123|FG006|LTE Open Label Variable SC Dosing|Death|0|||
146924005|NCT00254293|529883117|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
146924006|NCT00254293|529883118|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
146924007|NCT00254293|529883119|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
146924008|NCT00254293|529883120|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
146924009|NCT00254293|529883121|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
146924010|NCT00254293|529883122|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
146924011|NCT00254293|529883123|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
146924012|NCT00254293|529883117|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
146924013|NCT00254293|529883118|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
146924014|NCT00254293|529883119|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
146924015|NCT00254293|529883120|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
146924016|NCT00254293|529883121|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
146924017|NCT00254293|529883122|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
146924018|NCT00254293|529883123|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
146924019|NCT00254293|529883117|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
146924020|NCT00254293|529883118|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
146658134|NCT02537574|528927185|FG000|Overall Study|Protocol Violation|4|||
146658135|NCT02537574|528927186|FG001|Overall Study|Protocol Violation|2|||
146924021|NCT00254293|529883119|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
146924022|NCT00254293|529883120|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
146924023|NCT00254293|529883121|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
146924024|NCT00254293|529883122|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
146924025|NCT00254293|529883123|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
146924026|NCT00254293|529883117|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
146924027|NCT00254293|529883118|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
146924028|NCT00254293|529883119|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
146924029|NCT00254293|529883120|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
146924030|NCT00254293|529883121|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
146924031|NCT00254293|529883122|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
146924032|NCT00254293|529883123|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
146924033|NCT00254293|529883117|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
146924034|NCT00254293|529883118|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
146924035|NCT00254293|529883119|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
146924036|NCT00254293|529883120|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
146924037|NCT00254293|529883121|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
146924038|NCT00254293|529883122|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
146924039|NCT00254293|529883123|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
146924040|NCT00254293|529883117|FG000|LTE Open Label Variable SC Dosing|Other|0|||
146924041|NCT00254293|529883118|FG001|LTE Open Label Variable SC Dosing|Other|0|||
146924042|NCT00254293|529883119|FG002|LTE Open Label Variable SC Dosing|Other|2|||
146924043|NCT00254293|529883120|FG003|LTE Open Label Variable SC Dosing|Other|0|||
146924044|NCT00254293|529883121|FG004|LTE Open Label Variable SC Dosing|Other|0|||
146924045|NCT00254293|529883122|FG005|LTE Open Label Variable SC Dosing|Other|0|||
146924046|NCT00254293|529883123|FG006|LTE Open Label Variable SC Dosing|Other|0|||
146924047|NCT00254293|529883117|FG000|LTE Open Label Fixed Dosing|Death|0|||
146924048|NCT00254293|529883118|FG001|LTE Open Label Fixed Dosing|Death|0|||
146924049|NCT00254293|529883119|FG002|LTE Open Label Fixed Dosing|Death|0|||
146924050|NCT00254293|529883120|FG003|LTE Open Label Fixed Dosing|Death|0|||
146924051|NCT00254293|529883121|FG004|LTE Open Label Fixed Dosing|Death|0|||
146924052|NCT00254293|529883122|FG005|LTE Open Label Fixed Dosing|Death|0|||
146924053|NCT00254293|529883123|FG006|LTE Open Label Fixed Dosing|Death|3|||
146924054|NCT00254293|529883117|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
146924055|NCT00254293|529883118|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
146924056|NCT00254293|529883119|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
146924057|NCT00254293|529883120|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
146924058|NCT00254293|529883121|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
146924059|NCT00254293|529883122|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
146924060|NCT00254293|529883123|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
146924061|NCT00254293|529883117|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
146924062|NCT00254293|529883118|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
146924063|NCT00254293|529883119|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
146924064|NCT00254293|529883120|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
146924065|NCT00254293|529883121|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
146924066|NCT00254293|529883122|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
146924067|NCT00254293|529883123|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
146924068|NCT00254293|529883117|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
146924069|NCT00254293|529883118|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
146924070|NCT00254293|529883119|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
146924071|NCT00254293|529883120|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
146924072|NCT00254293|529883121|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
146924073|NCT00254293|529883122|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
146924074|NCT00254293|529883123|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
146924075|NCT00254293|529883117|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
146924076|NCT00254293|529883118|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
146924077|NCT00254293|529883119|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
146924078|NCT00254293|529883120|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
146924079|NCT00254293|529883121|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
146924080|NCT00254293|529883122|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
146924081|NCT00254293|529883123|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
146924082|NCT00254293|529883117|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
146924083|NCT00254293|529883118|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
146924084|NCT00254293|529883119|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
146658136|NCT02537574|528927187|FG002|Overall Study|Protocol Violation|3|||
146658137|NCT02537574|528927185|FG000|Overall Study|Withdrawal by Subject|37|||
146658138|NCT02537574|528927186|FG001|Overall Study|Withdrawal by Subject|27|||
146658139|NCT02537574|528927187|FG002|Overall Study|Withdrawal by Subject|29|||
146658140|NCT02537574|528927185|FG000|Overall Study|Lack of Efficacy|14|||
146924085|NCT00254293|529883120|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
146924086|NCT00254293|529883121|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
146924087|NCT00254293|529883122|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
146924088|NCT00254293|529883123|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
146924089|NCT00254293|529883117|FG000|LTE Open Label Fixed Dosing|Other|0|||
146924090|NCT00254293|529883118|FG001|LTE Open Label Fixed Dosing|Other|0|||
146924091|NCT00254293|529883119|FG002|LTE Open Label Fixed Dosing|Other|0|||
146924092|NCT00254293|529883120|FG003|LTE Open Label Fixed Dosing|Other|0|||
146924093|NCT00254293|529883121|FG004|LTE Open Label Fixed Dosing|Other|0|||
146924094|NCT00254293|529883122|FG005|LTE Open Label Fixed Dosing|Other|0|||
146924095|NCT00254293|529883123|FG006|LTE Open Label Fixed Dosing|Other|1|||
146924096|NCT01000727|529883129|FG000|Overall Study|Lost to Follow-up|41|||
146924097|NCT01000727|529883130|FG001|Overall Study|Lost to Follow-up|43|||
146924098|NCT01000727|529883129|FG000|Overall Study|Withdrawal by Subject|111|||
146924099|NCT01000727|529883130|FG001|Overall Study|Withdrawal by Subject|109|||
146924100|NCT01000727|529883129|FG000|Overall Study|Study closed/terminated|23|||
146924101|NCT01000727|529883130|FG001|Overall Study|Study closed/terminated|24|||
146924102|NCT03137121|529883131|FG000|Overall Study|Withdrawal by Subject|0|||
146924103|NCT03137121|529883132|FG001|Overall Study|Withdrawal by Subject|1|||
146924104|NCT03196193|529883133|FG000|Overall Study|Adverse Event|1|||
146924105|NCT03196193|529883134|FG001|Overall Study|Adverse Event|0|||
146924106|NCT03196193|529883133|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
146924107|NCT03196193|529883134|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
146924108|NCT02709083|529883140|FG000|Overall Study|Original PI left institution|7|||
146924109|NCT01697267|529883142|FG000|Overall Study|Death|3|||
146924110|NCT01697267|529883143|FG001|Overall Study|Death|1|||
146924111|NCT01697267|529883142|FG000|Overall Study|Withdrawal by Subject|5|||
146924112|NCT01697267|529883143|FG001|Overall Study|Withdrawal by Subject|5|||
146924113|NCT01697267|529883142|FG000|Overall Study|Adverse Event|2|||
146924114|NCT01697267|529883143|FG001|Overall Study|Adverse Event|1|||
146924115|NCT01697267|529883142|FG000|Overall Study|Lost to Follow-up|2|||
146924116|NCT01697267|529883143|FG001|Overall Study|Lost to Follow-up|4|||
146924117|NCT01697267|529883142|FG000|Overall Study|Physician Decision|2|||
146924118|NCT01697267|529883143|FG001|Overall Study|Physician Decision|4|||
146924119|NCT04410198|529883144|FG000|Overall Study|Death|10|||
146924120|NCT04410198|529883144|FG000|Overall Study|Withdrawal by Subject|7|||
146924121|NCT04410198|529883144|FG000|Overall Study|Transferred/Relocation|4|||
146924122|NCT04410198|529883144|FG000|Overall Study|Kidney Transplant|9|||
146924123|NCT04410198|529883144|FG000|Overall Study|Adverse Event|4|||
146924124|NCT04410198|529883144|FG000|Overall Study|Physician Decision|2|||
146924125|NCT04410198|529883144|FG000|Overall Study|Other than specified|1|||
146924126|NCT00882999|529883154|FG000|Overall Study|Adverse Event|0|||
146924127|NCT00882999|529883155|FG001|Overall Study|Adverse Event|0|||
146924128|NCT00882999|529883156|FG002|Overall Study|Adverse Event|0|||
146924129|NCT00882999|529883157|FG003|Overall Study|Adverse Event|0|||
146924130|NCT00882999|529883158|FG004|Overall Study|Adverse Event|1|||
146924131|NCT00882999|529883159|FG005|Overall Study|Adverse Event|0|||
146924132|NCT00882999|529883160|FG006|Overall Study|Adverse Event|0|||
146924133|NCT00882999|529883154|FG000|Overall Study|Death|0|||
146924134|NCT00882999|529883155|FG001|Overall Study|Death|1|||
146924135|NCT00882999|529883156|FG002|Overall Study|Death|0|||
146924136|NCT00882999|529883157|FG003|Overall Study|Death|0|||
146924137|NCT00882999|529883158|FG004|Overall Study|Death|0|||
146924138|NCT00882999|529883159|FG005|Overall Study|Death|0|||
146924139|NCT00882999|529883160|FG006|Overall Study|Death|0|||
146924140|NCT00882999|529883154|FG000|Overall Study|Withdrawal by Subject|7|||
146924141|NCT00882999|529883155|FG001|Overall Study|Withdrawal by Subject|6|||
146924142|NCT00882999|529883156|FG002|Overall Study|Withdrawal by Subject|3|||
146924143|NCT00882999|529883157|FG003|Overall Study|Withdrawal by Subject|3|||
146924144|NCT00882999|529883158|FG004|Overall Study|Withdrawal by Subject|6|||
146924145|NCT00882999|529883159|FG005|Overall Study|Withdrawal by Subject|5|||
146658141|NCT02537574|528927186|FG001|Overall Study|Lack of Efficacy|16|||
146658142|NCT02537574|528927187|FG002|Overall Study|Lack of Efficacy|15|||
146658143|NCT02537574|528927185|FG000|Overall Study|Duplicate Patient|1|||
146658144|NCT02537574|528927186|FG001|Overall Study|Duplicate Patient|0|||
146658145|NCT02537574|528927187|FG002|Overall Study|Duplicate Patient|0|||
146658146|NCT02537574|528927185|FG000|Overall Study|Patient not Stable|0|||
146924146|NCT00882999|529883160|FG006|Overall Study|Withdrawal by Subject|5|||
146658147|NCT02537574|528927186|FG001|Overall Study|Patient not Stable|1|||
146658148|NCT02537574|528927187|FG002|Overall Study|Patient not Stable|0|||
146658149|NCT02537574|528927185|FG000|Overall Study|Incarceration|0|||
146924147|NCT00882999|529883154|FG000|Overall Study|Lost to Follow-up|0|||
146924148|NCT00882999|529883155|FG001|Overall Study|Lost to Follow-up|1|||
146924149|NCT00882999|529883156|FG002|Overall Study|Lost to Follow-up|1|||
146924150|NCT00882999|529883157|FG003|Overall Study|Lost to Follow-up|2|||
146924151|NCT00882999|529883158|FG004|Overall Study|Lost to Follow-up|1|||
146924152|NCT00882999|529883159|FG005|Overall Study|Lost to Follow-up|1|||
146924153|NCT00882999|529883160|FG006|Overall Study|Lost to Follow-up|2|||
146924154|NCT00882999|529883154|FG000|Overall Study|Physician Decision|1|||
146924155|NCT00882999|529883155|FG001|Overall Study|Physician Decision|0|||
146924156|NCT00882999|529883156|FG002|Overall Study|Physician Decision|0|||
146924157|NCT00882999|529883157|FG003|Overall Study|Physician Decision|0|||
146924158|NCT00882999|529883158|FG004|Overall Study|Physician Decision|0|||
146924159|NCT00882999|529883159|FG005|Overall Study|Physician Decision|1|||
146924160|NCT00882999|529883160|FG006|Overall Study|Physician Decision|1|||
146924161|NCT01757405|529883161|FG000|Overall Study|Lost to Follow-up|1|||
146924162|NCT01757405|529883162|FG001|Overall Study|Lost to Follow-up|1|||
146924163|NCT01757405|529883161|FG000|Overall Study|Withdrawal by Subject|0|||
146924164|NCT01757405|529883162|FG001|Overall Study|Withdrawal by Subject|1|||
146924165|NCT00082758|529883164|FG000|Overall Study|Adverse Event|0|||
146924166|NCT00082758|529883165|FG001|Overall Study|Adverse Event|2|||
146924167|NCT00082758|529883166|FG002|Overall Study|Adverse Event|0|||
146924168|NCT00082758|529883164|FG000|Overall Study|Lack of Efficacy|12|||
146924169|NCT00082758|529883165|FG001|Overall Study|Lack of Efficacy|13|||
146924170|NCT00082758|529883166|FG002|Overall Study|Lack of Efficacy|0|||
146924171|NCT00082758|529883164|FG000|Overall Study|Physician Decision|0|||
146924172|NCT00082758|529883165|FG001|Overall Study|Physician Decision|1|||
146924173|NCT00082758|529883166|FG002|Overall Study|Physician Decision|0|||
146924174|NCT00082758|529883164|FG000|Overall Study|Withdrawal by Subject|3|||
146924175|NCT00082758|529883165|FG001|Overall Study|Withdrawal by Subject|0|||
146924176|NCT00082758|529883166|FG002|Overall Study|Withdrawal by Subject|0|||
146924177|NCT00082758|529883164|FG000|Overall Study|Protocol Violation|0|||
146924178|NCT00082758|529883165|FG001|Overall Study|Protocol Violation|1|||
146924179|NCT00082758|529883166|FG002|Overall Study|Protocol Violation|0|||
146924180|NCT00937560|529883168|FG000|Initial Treatment|Death|6|||
146924181|NCT00937560|529883168|FG000|Initial Treatment|Withdraw consent|3|||
146924182|NCT00937560|529883168|FG000|Initial Treatment|Adverse Event|1|||
146924183|NCT00937560|529883168|FG000|Initial Treatment|Lost to Follow-up|1|||
146924184|NCT00937560|529883168|FG000|Initial Treatment|No end of study page|10|||
146611796|NCT03364309|528748908|FG014|Post-Treatment Followup Period|Adverse Event|0|||
146611797|NCT03364309|528748909|FG015|Post-Treatment Followup Period|Adverse Event|0|||
146611798|NCT03364309|528748910|FG016|Post-Treatment Followup Period|Adverse Event|2|||
146611799|NCT03364309|528748911|FG017|Post-Treatment Followup Period|Adverse Event|6|||
146611800|NCT03364309|528748912|FG018|Post-Treatment Followup Period|Adverse Event|1|||
146611801|NCT03364309|528748894|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
146611802|NCT03364309|528748895|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
146611803|NCT03364309|528748896|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
146611804|NCT03364309|528748897|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
146611805|NCT03364309|528748898|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
146611806|NCT03364309|528748899|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
146611807|NCT03364309|528748900|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
146611808|NCT03364309|528748901|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
146611809|NCT03364309|528748902|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
146611810|NCT03364309|528748903|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
146611811|NCT03364309|528748904|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
146611812|NCT03364309|528748905|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
146611813|NCT03364309|528748906|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
146611814|NCT03364309|528748907|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
146611815|NCT03364309|528748908|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
146658150|NCT02537574|528927186|FG001|Overall Study|Incarceration|1|||
146658151|NCT02537574|528927187|FG002|Overall Study|Incarceration|0|||
146658152|NCT02537574|528927185|FG000|Overall Study|Failed Naloxone Challenge|0|||
146658153|NCT02537574|528927186|FG001|Overall Study|Failed Naloxone Challenge|1|||
146924185|NCT00937560|529883168|FG000|Maintenance Treatment|Death|12|||
146924186|NCT00937560|529883168|FG000|Maintenance Treatment|Withdraw consent|5|||
146924187|NCT00937560|529883168|FG000|Maintenance Treatment|According to protocol|1|||
146924188|NCT00501046|529883173|FG000|Overall Study|Adverse Event|21|||
146924189|NCT00501046|529883174|FG001|Overall Study|Adverse Event|25|||
146924190|NCT00501046|529883173|FG000|Overall Study|Death|23|||
146611816|NCT03364309|528748909|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
146611817|NCT03364309|528748910|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
146658154|NCT02537574|528927187|FG002|Overall Study|Failed Naloxone Challenge|0|||
146658155|NCT02537574|528927185|FG000|Overall Study|Transportation Issues|0|||
146658156|NCT02537574|528927186|FG001|Overall Study|Transportation Issues|0|||
146658157|NCT02537574|528927187|FG002|Overall Study|Transportation Issues|1|||
146658158|NCT02537574|528927185|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
146658159|NCT02537574|528927186|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
146658160|NCT02537574|528927187|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
146658161|NCT02537574|528927185|FG000|Overall Study|Noncompliance with Protocol|0|||
146773468|NCT02988817|529341090|FG014|Overall Study|Withdrawal by Subject|4|||
146658162|NCT02537574|528927186|FG001|Overall Study|Noncompliance with Protocol|0|||
146773469|NCT02988817|529341091|FG015|Overall Study|Withdrawal by Subject|5|||
146773470|NCT02988817|529341092|FG016|Overall Study|Withdrawal by Subject|4|||
146924191|NCT00501046|529883174|FG001|Overall Study|Death|30|||
146924192|NCT00501046|529883173|FG000|Overall Study|Lost to Follow-up|14|||
146924193|NCT00501046|529883174|FG001|Overall Study|Lost to Follow-up|13|||
146924194|NCT00501046|529883173|FG000|Overall Study|Physician Decision|7|||
146924195|NCT00501046|529883174|FG001|Overall Study|Physician Decision|2|||
146924196|NCT00501046|529883173|FG000|Overall Study|Pregnancy|0|||
146924197|NCT00501046|529883174|FG001|Overall Study|Pregnancy|3|||
146924198|NCT00501046|529883173|FG000|Overall Study|Protocol Violation|2|||
146924199|NCT00501046|529883174|FG001|Overall Study|Protocol Violation|1|||
146924200|NCT00501046|529883173|FG000|Overall Study|Withdrawal by Subject|84|||
146924201|NCT00501046|529883174|FG001|Overall Study|Withdrawal by Subject|83|||
146924202|NCT00501046|529883173|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
146924203|NCT00501046|529883174|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
146924204|NCT01576016|529883175|FG000|Lead Safety|Death|132|||
146924205|NCT01576016|529883176|FG001|Lead Safety|Death|0|||
146924206|NCT01576016|529883175|FG000|Lead Safety|Withdrawal by Subject|81|||
146924207|NCT01576016|529883176|FG001|Lead Safety|Withdrawal by Subject|0|||
146924208|NCT01576016|529883175|FG000|Lead Safety|System Explanted without Replacement|24|||
146924209|NCT01576016|529883176|FG001|Lead Safety|System Explanted without Replacement|0|||
146924210|NCT01576016|529883175|FG000|Lead Safety|Physician Decision|14|||
146924211|NCT01576016|529883176|FG001|Lead Safety|Physician Decision|0|||
146924212|NCT01576016|529883175|FG000|Lead Safety|Lost to Follow-up|13|||
146924213|NCT01576016|529883176|FG001|Lead Safety|Lost to Follow-up|0|||
146924214|NCT01576016|529883175|FG000|Lead Safety|Unsuccessful implant|2|||
146924215|NCT01576016|529883176|FG001|Lead Safety|Unsuccessful implant|0|||
146924216|NCT01576016|529883175|FG000|Lead Safety|Sponsor request|1|||
146924217|NCT01576016|529883176|FG001|Lead Safety|Sponsor request|0|||
146924218|NCT01576016|529883175|FG000|Lead Safety|Device replaced with CRT-D|1|||
146924219|NCT01576016|529883176|FG001|Lead Safety|Device replaced with CRT-D|0|||
146924220|NCT01576016|529883175|FG000|Lead Safety|Patient on Palliative Care|1|||
146924221|NCT01576016|529883176|FG001|Lead Safety|Patient on Palliative Care|0|||
146924222|NCT01576016|529883175|FG000|Lead Safety|Patient noncompliance|1|||
146924223|NCT01576016|529883176|FG001|Lead Safety|Patient noncompliance|0|||
146924224|NCT01576016|529883175|FG000|Lead Safety|Too far from study site|1|||
146924225|NCT01576016|529883176|FG001|Lead Safety|Too far from study site|0|||
146924226|NCT01576016|529883175|FG000|Lead Safety|System deactivated|1|||
146924227|NCT01576016|529883176|FG001|Lead Safety|System deactivated|0|||
146924228|NCT01576016|529883175|FG000|Lead Safety|Patient no longer followed by study PI|1|||
146924229|NCT01576016|529883176|FG001|Lead Safety|Patient no longer followed by study PI|0|||
146924230|NCT01576016|529883175|FG000|MRI Safety|Withdrawal by Subject|0|||
146924231|NCT01576016|529883176|FG001|MRI Safety|Withdrawal by Subject|10|||
146924232|NCT01576016|529883175|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
146924233|NCT01576016|529883176|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
146924234|NCT01576016|529883175|FG000|MRI Safety|Has not yet completed MRI scan|0|||
146924235|NCT01576016|529883176|FG001|MRI Safety|Has not yet completed MRI scan|56|||
146924236|NCT01576016|529883175|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
146924237|NCT01576016|529883176|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
146924238|NCT03364673|529883178|FG000|Overall Study|Withdrawal by Subject|2|||
146924239|NCT03364673|529883178|FG000|Overall Study|Injury unrelated to study|3|||
146924240|NCT02208024|529883179|FG000|Overall Study|Withdrawal by Subject|1|||
146924241|NCT00779324|529883180|FG000|Overall Study|Lost to Follow-up|2|||
146924242|NCT00779324|529883181|FG001|Overall Study|Lost to Follow-up|1|||
146924243|NCT00779324|529883180|FG000|Overall Study|Withdrawal by Subject|4|||
146924244|NCT00779324|529883181|FG001|Overall Study|Withdrawal by Subject|2|||
146924245|NCT00779324|529883180|FG000|Overall Study|Missed visit|1|||
146924246|NCT00779324|529883181|FG001|Overall Study|Missed visit|1|||
146924247|NCT02207556|529883182|FG000|Overall Study|Physician Decision|1|||
146924248|NCT02207556|529883183|FG001|Overall Study|Physician Decision|0|||
146924249|NCT02207556|529883182|FG000|Overall Study|Withdrawal by Subject|1|||
146924250|NCT02207556|529883183|FG001|Overall Study|Withdrawal by Subject|0|||
146924251|NCT02207556|529883182|FG000|Overall Study|Death|0|||
146924252|NCT02207556|529883183|FG001|Overall Study|Death|5|||
146611818|NCT03364309|528748911|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
146611819|NCT03364309|528748912|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
146611820|NCT03364309|528748894|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
146924253|NCT03558555|529883184|FG000|Overall Study|Lost to Follow-up|2|||
146924254|NCT03558555|529883185|FG001|Overall Study|Lost to Follow-up|1|||
146924255|NCT00194025|529883186|FG000|Overall Study|Adverse Event|1|||
146924256|NCT00194025|529883186|FG000|Overall Study|non-adherence with study medication|4|||
146924257|NCT00543569|529883187|FG000|Overall Study|Death|2|||
146924258|NCT00543569|529883188|FG001|Overall Study|Death|2|||
146924259|NCT00543569|529883189|FG002|Overall Study|Death|3|||
146611821|NCT03364309|528748895|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
146611822|NCT03364309|528748896|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
146924260|NCT00543569|529883190|FG003|Overall Study|Death|1|||
146924261|NCT00543569|529883187|FG000|Overall Study|Lost to Follow-up|0|||
146924262|NCT00543569|529883188|FG001|Overall Study|Lost to Follow-up|0|||
146924263|NCT00543569|529883189|FG002|Overall Study|Lost to Follow-up|1|||
146924264|NCT00543569|529883190|FG003|Overall Study|Lost to Follow-up|1|||
146924265|NCT00543569|529883187|FG000|Overall Study|Miscellaneous Reasons|7|||
146924266|NCT00543569|529883188|FG001|Overall Study|Miscellaneous Reasons|3|||
146611823|NCT03364309|528748897|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
146611824|NCT03364309|528748898|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
146611825|NCT03364309|528748899|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
146611826|NCT03364309|528748900|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
146611827|NCT03364309|528748901|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
146611828|NCT03364309|528748902|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
146611829|NCT03364309|528748903|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
146611830|NCT03364309|528748904|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
146611831|NCT03364309|528748905|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
146611832|NCT03364309|528748906|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
146611833|NCT03364309|528748907|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
146611834|NCT03364309|528748908|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
146611835|NCT03364309|528748909|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
146611836|NCT03364309|528748910|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
146611837|NCT03364309|528748911|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
146611838|NCT03364309|528748912|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
146611839|NCT00615992|528748913|FG000|Overall Study|Protocol Violation|67|||
146611840|NCT02328027|528748914|FG000|Overall Study|Withdrawal by Subject|0|||
146611841|NCT02328027|528748915|FG001|Overall Study|Withdrawal by Subject|1|||
146611842|NCT03319212|528748916|FG000|Overall Study|Discontinued as moving out of local area|0|||
146611843|NCT03319212|528748917|FG001|Overall Study|Discontinued as moving out of local area|1|||
146611844|NCT03319212|528748916|FG000|Overall Study|Adverse Event|2|||
146611845|NCT03319212|528748917|FG001|Overall Study|Adverse Event|2|||
146611846|NCT03319212|528748916|FG000|Overall Study|Withdrawal by Subject|0|||
146611847|NCT03319212|528748917|FG001|Overall Study|Withdrawal by Subject|1|||
146611848|NCT03319212|528748916|FG000|Overall Study|Lost to Follow-up|0|||
146611849|NCT03319212|528748917|FG001|Overall Study|Lost to Follow-up|1|||
146611850|NCT03319212|528748916|FG000|Overall Study|Physician Decision|1|||
146611851|NCT03319212|528748917|FG001|Overall Study|Physician Decision|0|||
146611852|NCT01811186|528748919|FG000|Overall Study|Adverse Event|54|||
146611853|NCT01811186|528748920|FG001|Overall Study|Adverse Event|38|||
146611854|NCT01811186|528748919|FG000|Overall Study|Protocol Violation|5|||
146611855|NCT01811186|528748920|FG001|Overall Study|Protocol Violation|6|||
146611856|NCT01811186|528748919|FG000|Overall Study|Withdrawal by Subject|5|||
146611857|NCT01811186|528748920|FG001|Overall Study|Withdrawal by Subject|10|||
146611858|NCT01811186|528748919|FG000|Overall Study|Lack of Efficacy|3|||
146611859|NCT01811186|528748920|FG001|Overall Study|Lack of Efficacy|6|||
146611860|NCT01811186|528748919|FG000|Overall Study|Lost to Follow-up|4|||
146611861|NCT01811186|528748920|FG001|Overall Study|Lost to Follow-up|2|||
146924267|NCT00543569|529883189|FG002|Overall Study|Miscellaneous Reasons|11|||
146924268|NCT00543569|529883190|FG003|Overall Study|Miscellaneous Reasons|4|||
146924269|NCT00543569|529883187|FG000|Overall Study|Randomized but never received study drug|3|||
146924270|NCT00543569|529883188|FG001|Overall Study|Randomized but never received study drug|3|||
146924271|NCT00543569|529883189|FG002|Overall Study|Randomized but never received study drug|5|||
146924272|NCT00543569|529883190|FG003|Overall Study|Randomized but never received study drug|3|||
146924273|NCT00862849|529883191|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
146924274|NCT00862849|529883192|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
146924275|NCT00862849|529883193|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
146924276|NCT00862849|529883194|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
146924277|NCT00862849|529883195|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
146924278|NCT00862849|529883196|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
146924279|NCT00862849|529883191|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
146924280|NCT00862849|529883192|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
146611862|NCT02465203|528748921|FG000|Overall Study|Protocol Violation|1|||
146611863|NCT02465203|528748922|FG001|Overall Study|Protocol Violation|1|||
146611864|NCT02465203|528748923|FG002|Overall Study|Protocol Violation|1|||
146611865|NCT02465203|528748921|FG000|Overall Study|Study terminated by sponsor|50|||
146611866|NCT02465203|528748922|FG001|Overall Study|Study terminated by sponsor|34|||
146611867|NCT02465203|528748923|FG002|Overall Study|Study terminated by sponsor|11|||
146611868|NCT02465203|528748921|FG000|Overall Study|New therapy for study indication|4|||
146611869|NCT02465203|528748922|FG001|Overall Study|New therapy for study indication|0|||
146658163|NCT02537574|528927187|FG002|Overall Study|Noncompliance with Protocol|1|||
146658164|NCT02663687|528927188|FG000|Overall Study|Adverse Event|1|||
146658165|NCT02663687|528927189|FG001|Overall Study|Adverse Event|0|||
146924281|NCT00862849|529883193|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
146924282|NCT00862849|529883194|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
146924283|NCT00862849|529883195|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
146611870|NCT02465203|528748923|FG002|Overall Study|New therapy for study indication|0|||
146611871|NCT02465203|528748921|FG000|Overall Study|Patient/guardian decision|1|||
146611872|NCT02465203|528748922|FG001|Overall Study|Patient/guardian decision|1|||
146611873|NCT02465203|528748923|FG002|Overall Study|Patient/guardian decision|1|||
146611874|NCT04072887|528748928|FG000|Overall Study|Withdrawal by Subject|3|||
146611875|NCT04072887|528748929|FG001|Overall Study|Withdrawal by Subject|8|||
146924284|NCT00862849|529883196|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
146924285|NCT00617409|529883197|FG000|Overall Study|Withdrawal by Subject|4|||
146924286|NCT00617409|529883198|FG001|Overall Study|Withdrawal by Subject|1|||
146924287|NCT00617409|529883199|FG002|Overall Study|Withdrawal by Subject|2|||
146924288|NCT00617409|529883197|FG000|Overall Study|Adverse Event|0|||
146924289|NCT00617409|529883198|FG001|Overall Study|Adverse Event|2|||
146924290|NCT00617409|529883199|FG002|Overall Study|Adverse Event|3|||
146924291|NCT00617409|529883197|FG000|Overall Study|Disease Progression|8|||
146924292|NCT00617409|529883198|FG001|Overall Study|Disease Progression|8|||
146924293|NCT00617409|529883199|FG002|Overall Study|Disease Progression|18|||
146924294|NCT00617409|529883197|FG000|Overall Study|Death|3|||
146924295|NCT00617409|529883198|FG001|Overall Study|Death|5|||
146924296|NCT00617409|529883199|FG002|Overall Study|Death|4|||
146924297|NCT00617409|529883197|FG000|Overall Study|Alternative Therapy|1|||
146924298|NCT00617409|529883198|FG001|Overall Study|Alternative Therapy|2|||
146924299|NCT00617409|529883199|FG002|Overall Study|Alternative Therapy|0|||
146924300|NCT00668200|529883205|FG000|Overall Study|Withdrawal by Subject|2|||
146924301|NCT00668200|529883205|FG000|Overall Study|Lost to Follow-up|1|||
146924302|NCT01496430|529883206|FG000|Overall Study|Adverse Event|0|||
146924303|NCT01496430|529883207|FG001|Overall Study|Adverse Event|0|||
146924304|NCT01496430|529883208|FG002|Overall Study|Adverse Event|1|||
146924305|NCT01496430|529883206|FG000|Overall Study|Major Protocol Deviation|0|||
146924306|NCT01496430|529883207|FG001|Overall Study|Major Protocol Deviation|0|||
146924307|NCT01496430|529883208|FG002|Overall Study|Major Protocol Deviation|1|||
146611876|NCT04072887|528748930|FG002|Overall Study|Withdrawal by Subject|1|||
146611877|NCT04072887|528748931|FG003|Overall Study|Withdrawal by Subject|3|||
146611878|NCT04072887|528748932|FG004|Overall Study|Withdrawal by Subject|3|||
146611879|NCT04072887|528748933|FG005|Overall Study|Withdrawal by Subject|13|||
146611880|NCT04072887|528748928|FG000|Overall Study|Adverse Event|2|||
146611881|NCT04072887|528748929|FG001|Overall Study|Adverse Event|4|||
146611882|NCT04072887|528748930|FG002|Overall Study|Adverse Event|1|||
146924308|NCT01496430|529883206|FG000|Overall Study|Lost to Follow-up|2|||
146924309|NCT01496430|529883207|FG001|Overall Study|Lost to Follow-up|3|||
146924310|NCT01496430|529883208|FG002|Overall Study|Lost to Follow-up|1|||
146924311|NCT01496430|529883206|FG000|Overall Study|Voluntary Withdrawal|2|||
146924312|NCT01496430|529883207|FG001|Overall Study|Voluntary Withdrawal|1|||
146924313|NCT01496430|529883208|FG002|Overall Study|Voluntary Withdrawal|6|||
146924314|NCT01496430|529883206|FG000|Overall Study|Principal Investigator Discretion|0|||
146611883|NCT04072887|528748931|FG003|Overall Study|Adverse Event|4|||
146611884|NCT04072887|528748932|FG004|Overall Study|Adverse Event|0|||
146611885|NCT04072887|528748933|FG005|Overall Study|Adverse Event|1|||
146611886|NCT04072887|528748928|FG000|Overall Study|Physician Decision|2|||
146611887|NCT04072887|528748929|FG001|Overall Study|Physician Decision|0|||
146611888|NCT04072887|528748930|FG002|Overall Study|Physician Decision|0|||
146611889|NCT04072887|528748931|FG003|Overall Study|Physician Decision|0|||
146611890|NCT04072887|528748932|FG004|Overall Study|Physician Decision|0|||
146611891|NCT04072887|528748933|FG005|Overall Study|Physician Decision|1|||
146611892|NCT04072887|528748928|FG000|Overall Study|Lost to Follow-up|1|||
146611893|NCT04072887|528748929|FG001|Overall Study|Lost to Follow-up|3|||
146611894|NCT04072887|528748930|FG002|Overall Study|Lost to Follow-up|0|||
146611895|NCT04072887|528748931|FG003|Overall Study|Lost to Follow-up|0|||
146611896|NCT04072887|528748932|FG004|Overall Study|Lost to Follow-up|0|||
146611897|NCT04072887|528748933|FG005|Overall Study|Lost to Follow-up|0|||
146611898|NCT04072887|528748928|FG000|Overall Study|Death|0|||
146611899|NCT04072887|528748929|FG001|Overall Study|Death|2|||
146611900|NCT04072887|528748930|FG002|Overall Study|Death|0|||
146611901|NCT04072887|528748931|FG003|Overall Study|Death|2|||
146611902|NCT04072887|528748932|FG004|Overall Study|Death|3|||
146611903|NCT04072887|528748933|FG005|Overall Study|Death|0|||
146611904|NCT00856297|528748934|FG000|Overall Study|Unable to classify|2|||
146611905|NCT00856297|528748935|FG001|Overall Study|Unable to classify|0|||
146611906|NCT00856297|528748936|FG002|Overall Study|Unable to classify|0|||
146611907|NCT00856297|528748937|FG003|Overall Study|Unable to classify|0|||
146611908|NCT00856297|528748938|FG004|Overall Study|Unable to classify|0|||
146611909|NCT02508428|528748945|FG000|Overall Study|Death|32|||
146611910|NCT02508428|528748946|FG001|Overall Study|Death|33|||
146611911|NCT02508428|528748945|FG000|Overall Study|Liner revised|3|||
146611912|NCT02508428|528748946|FG001|Overall Study|Liner revised|19|||
146611913|NCT02508428|528748945|FG000|Overall Study|Incomplete follow-up|17|||
146611914|NCT02508428|528748946|FG001|Overall Study|Incomplete follow-up|15|||
146611915|NCT04371666|528748948|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
146611916|NCT04371666|528748949|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
146611917|NCT04371666|528748948|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
146611918|NCT04371666|528748949|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
146611919|NCT04371666|528748948|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
146611920|NCT04371666|528748949|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
146611921|NCT04371666|528748948|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
146611922|NCT04371666|528748949|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
146924315|NCT01496430|529883207|FG001|Overall Study|Principal Investigator Discretion|1|||
146924316|NCT01496430|529883208|FG002|Overall Study|Principal Investigator Discretion|1|||
146924317|NCT01496430|529883206|FG000|Overall Study|Other|2|||
146924318|NCT01496430|529883207|FG001|Overall Study|Other|0|||
146924319|NCT01496430|529883208|FG002|Overall Study|Other|0|||
146924320|NCT01151579|529883211|FG000|Overall Study|Physician Decision|3|||
146924321|NCT01151579|529883212|FG001|Overall Study|Physician Decision|1|||
146924322|NCT01151579|529883211|FG000|Overall Study|Withdrawal by Subject|3|||
146924323|NCT01151579|529883212|FG001|Overall Study|Withdrawal by Subject|2|||
146924324|NCT01151579|529883211|FG000|Overall Study|Not meet inclusion criteria|6|||
146924325|NCT01151579|529883212|FG001|Overall Study|Not meet inclusion criteria|4|||
146924326|NCT03633227|529883215|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
146924327|NCT03633227|529883216|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
146924328|NCT03633227|529883215|FG000|Double Blind (DB), up to Week 48|Death|2|||
146924329|NCT03633227|529883216|FG001|Double Blind (DB), up to Week 48|Death|1|||
146924330|NCT03633227|529883215|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
146924331|NCT03633227|529883216|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
146924332|NCT03633227|529883215|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
146924333|NCT03633227|529883216|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
146924334|NCT03633227|529883215|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
146924335|NCT03633227|529883216|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
146924336|NCT03633227|529883215|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
146924337|NCT03633227|529883216|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
146924338|NCT03633227|529883215|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
146924339|NCT03633227|529883216|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
146924340|NCT03633227|529883215|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
146924341|NCT03633227|529883216|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
146924342|NCT03633227|529883215|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
146924343|NCT03633227|529883216|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
146924344|NCT03633227|529883215|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
146924345|NCT03633227|529883216|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
146924346|NCT03633227|529883215|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
146924347|NCT03633227|529883216|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
146924348|NCT03633227|529883215|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
146924349|NCT03633227|529883216|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
146611923|NCT04371666|528748948|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
146611924|NCT04371666|528748949|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
146611925|NCT04371666|528748948|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
146611926|NCT04371666|528748949|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
146611927|NCT00534976|528748956|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
146611928|NCT00534976|528748957|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
146611929|NCT00534976|528748956|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
146611930|NCT00534976|528748957|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
146611931|NCT00534976|528748956|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
146611932|NCT00534976|528748957|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
146611933|NCT00861471|528748958|FG000|Overall Study|Withdrawal by Subject|1|||
146611934|NCT00861471|528748958|FG000|Overall Study|Adverse Event|2|||
146611935|NCT00861471|528748958|FG000|Overall Study|Lack of Efficacy|3|||
146611936|NCT00861471|528748958|FG000|Overall Study|treatment for lumbar laminectomy|1|||
146611937|NCT00861471|528748958|FG000|Overall Study|Physician Decision|2|||
146611938|NCT02092025|528748959|FG000|Overall Study|Case Report Forms Uncollected|44|||
146611939|NCT02092025|528748959|FG000|Overall Study|Protocol Deviation|24|||
146611940|NCT00264537|528748960|FG000|Overall Study|Death|0|||
146611941|NCT00264537|528748961|FG001|Overall Study|Death|3|||
146611942|NCT00264537|528748962|FG002|Overall Study|Death|3|||
146611943|NCT00264537|528748963|FG003|Overall Study|Death|2|||
146611944|NCT00264537|528748960|FG000|Overall Study|Lost to Follow-up|3|||
146611945|NCT00264537|528748961|FG001|Overall Study|Lost to Follow-up|4|||
146611946|NCT00264537|528748962|FG002|Overall Study|Lost to Follow-up|7|||
146611947|NCT00264537|528748963|FG003|Overall Study|Lost to Follow-up|6|||
146924350|NCT01766336|529883222|FG000|Overall Study|Adverse Event|11|||
146611948|NCT00264537|528748960|FG000|Overall Study|Adverse Event|21|||
146611949|NCT00264537|528748961|FG001|Overall Study|Adverse Event|32|||
146611950|NCT00264537|528748962|FG002|Overall Study|Adverse Event|24|||
146611951|NCT00264537|528748963|FG003|Overall Study|Adverse Event|34|||
146611952|NCT00264537|528748960|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
146611953|NCT00264537|528748961|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
146611954|NCT00264537|528748962|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
146773471|NCT02988817|529341093|FG017|Overall Study|Withdrawal by Subject|11|||
146924351|NCT01766336|529883223|FG001|Overall Study|Adverse Event|8|||
146924352|NCT01766336|529883222|FG000|Overall Study|Death|4|||
146924353|NCT01766336|529883223|FG001|Overall Study|Death|3|||
146924354|NCT01766336|529883222|FG000|Overall Study|Lost to Follow-up|1|||
146924355|NCT01766336|529883223|FG001|Overall Study|Lost to Follow-up|3|||
146924356|NCT01766336|529883222|FG000|Overall Study|Physician Decision|4|||
146924357|NCT01766336|529883223|FG001|Overall Study|Physician Decision|2|||
146924358|NCT01766336|529883222|FG000|Overall Study|Protocol Violation|0|||
146924359|NCT01766336|529883223|FG001|Overall Study|Protocol Violation|1|||
146924360|NCT01766336|529883222|FG000|Overall Study|Sponsor Decision|52|||
146924361|NCT01766336|529883223|FG001|Overall Study|Sponsor Decision|43|||
146924362|NCT01766336|529883222|FG000|Overall Study|Withdrawal by Subject|18|||
146924363|NCT01766336|529883223|FG001|Overall Study|Withdrawal by Subject|15|||
146924364|NCT02605447|529883225|FG000|Overall Study|Death|66|||
146924365|NCT02605447|529883225|FG000|Overall Study|Physician Decision|1|||
146924366|NCT02605447|529883225|FG000|Overall Study|Lost to Follow-up|24|||
146924367|NCT02605447|529883225|FG000|Overall Study|Withdrawal by Subject|10|||
146924368|NCT02605447|529883225|FG000|Overall Study|Not disclosed|1|||
146924369|NCT01479374|529883226|FG000|Overall Study|Adverse Event|2|||
146924370|NCT01479374|529883227|FG001|Overall Study|Adverse Event|1|||
146924371|NCT01479374|529883228|FG002|Overall Study|Adverse Event|0|||
146924372|NCT01479374|529883226|FG000|Overall Study|Lost to Follow-up|1|||
146924373|NCT01479374|529883227|FG001|Overall Study|Lost to Follow-up|2|||
146924374|NCT01479374|529883228|FG002|Overall Study|Lost to Follow-up|0|||
146924375|NCT01479374|529883226|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
146924376|NCT01479374|529883227|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
146924377|NCT01479374|529883228|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
146924378|NCT01479374|529883226|FG000|Overall Study|Other|0|||
146658166|NCT02663687|528927190|FG002|Overall Study|Adverse Event|0|||
146658167|NCT02663687|528927191|FG003|Overall Study|Adverse Event|0|||
146658168|NCT02663687|528927192|FG004|Overall Study|Adverse Event|0|||
146658169|NCT02663687|528927188|FG000|Overall Study|Other|1|||
146658170|NCT02663687|528927189|FG001|Overall Study|Other|0|||
146658171|NCT02663687|528927190|FG002|Overall Study|Other|1|||
146658172|NCT02663687|528927191|FG003|Overall Study|Other|0|||
146658173|NCT02663687|528927192|FG004|Overall Study|Other|0|||
146658174|NCT01151098|528927193|FG000|Overall Study|Adverse Event|82|||
146658175|NCT01151098|528927193|FG000|Overall Study|Lost to Follow-up|6|||
146658176|NCT01151098|528927193|FG000|Overall Study|Lack of Efficacy|15|||
146658177|NCT01151098|528927193|FG000|Overall Study|Protocol Violation|1|||
146658178|NCT01151098|528927193|FG000|Overall Study|Miscellaneous|13|||
146773472|NCT02988817|529341094|FG018|Overall Study|Withdrawal by Subject|4|||
146773473|NCT02988817|529341095|FG019|Overall Study|Withdrawal by Subject|2|||
146924379|NCT01479374|529883227|FG001|Overall Study|Other|4|||
146924380|NCT01479374|529883228|FG002|Overall Study|Other|5|||
146924381|NCT02045212|529883230|FG000|Overall Study|Adverse Event|0|||
146924382|NCT02045212|529883231|FG001|Overall Study|Adverse Event|1|||
146924383|NCT02045212|529883230|FG000|Overall Study|Withdrawal by Subject|1|||
146924384|NCT02045212|529883231|FG001|Overall Study|Withdrawal by Subject|0|||
146924385|NCT02045212|529883230|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
146924386|NCT02045212|529883231|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
146924387|NCT03135028|529883237|FG000|Overall Study|Death|6|||
146924388|NCT03135028|529883237|FG000|Overall Study|Study Terminated by Sponsor|2|||
146924389|NCT03135028|529883237|FG000|Overall Study|Withdrew Consent|1|||
146924390|NCT02998554|529883238|FG000|Overall Study|Adverse Event|8|||
146924391|NCT02998554|529883239|FG001|Overall Study|Adverse Event|3|||
146924392|NCT02998554|529883238|FG000|Overall Study|Protocol deviation|1|||
146924393|NCT02998554|529883239|FG001|Overall Study|Protocol deviation|0|||
146924394|NCT02998554|529883238|FG000|Overall Study|Withdrawal by Subject|2|||
146773474|NCT02988817|529341076|FG000|Overall Study|Death|0|||
146773475|NCT02988817|529341077|FG001|Overall Study|Death|1|||
146924395|NCT02998554|529883239|FG001|Overall Study|Withdrawal by Subject|6|||
146924396|NCT02998554|529883238|FG000|Overall Study|Lost to Follow-up|0|||
146924397|NCT02998554|529883239|FG001|Overall Study|Lost to Follow-up|1|||
146924398|NCT02998554|529883238|FG000|Overall Study|Lack of Efficacy|0|||
146924399|NCT02998554|529883239|FG001|Overall Study|Lack of Efficacy|1|||
146658179|NCT03343067|528927196|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
146773476|NCT02988817|529341078|FG002|Overall Study|Death|3|||
146773477|NCT02988817|529341079|FG003|Overall Study|Death|1|||
146924400|NCT02112994|529883242|FG000|Overall Study|Progressive Disease|0|||
146924401|NCT02112994|529883243|FG001|Overall Study|Progressive Disease|0|||
146924402|NCT02112994|529883244|FG002|Overall Study|Progressive Disease|1|||
146924403|NCT02112994|529883242|FG000|Overall Study|Pregnancy|0|||
146924404|NCT02112994|529883243|FG001|Overall Study|Pregnancy|1|||
146924405|NCT02112994|529883244|FG002|Overall Study|Pregnancy|1|||
146924406|NCT02112994|529883242|FG000|Overall Study|Liver Transplant|0|||
146978683|NCT03262233|530085461|FG003|Overall Study|Declined due to shock|3|||
146924407|NCT02112994|529883243|FG001|Overall Study|Liver Transplant|1|||
146658180|NCT03343067|528927197|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
146924408|NCT02112994|529883244|FG002|Overall Study|Liver Transplant|0|||
146924409|NCT02112994|529883242|FG000|Overall Study|Withdrawal by Subject|0|||
146924410|NCT02112994|529883243|FG001|Overall Study|Withdrawal by Subject|0|||
146924411|NCT02112994|529883244|FG002|Overall Study|Withdrawal by Subject|1|||
146924412|NCT03675737|529883248|FG000|Overall Study|Death|593|||
146924413|NCT03675737|529883249|FG001|Overall Study|Death|660|||
146924414|NCT03675737|529883248|FG000|Overall Study|Lost to Follow-up|1|||
146924415|NCT03675737|529883249|FG001|Overall Study|Lost to Follow-up|5|||
146924416|NCT03675737|529883248|FG000|Overall Study|Physician Decision|1|||
146924417|NCT03675737|529883249|FG001|Overall Study|Physician Decision|0|||
146924418|NCT03675737|529883248|FG000|Overall Study|Withdrawal by Subject|14|||
146924419|NCT03675737|529883249|FG001|Overall Study|Withdrawal by Subject|12|||
146924420|NCT03675737|529883248|FG000|Overall Study|Ongoing in Study|181|||
146924421|NCT03675737|529883249|FG001|Overall Study|Ongoing in Study|112|||
146924422|NCT02625324|529884686|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
146658181|NCT03343067|528927198|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
146658182|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
146658183|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
146658184|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
146658185|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
146658186|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
146658187|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
146658188|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
146658189|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
146658190|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
146658191|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
146658192|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
146658193|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
146658194|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
146658195|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
146658196|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
146658197|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
146658198|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Program Termination|3|||
146658199|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Program Termination|0|||
146658200|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Program Termination|1|||
146658201|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Program Termination|1|||
146658202|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
146658203|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
146658204|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
146658205|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
146658206|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
146658207|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
146658208|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
146658209|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
146658210|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
146658211|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
146658212|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
146658213|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
146658214|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
146658215|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
146658216|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
146658217|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
146658218|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
146658219|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
146658220|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
146658221|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
146658222|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
146658223|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
146658224|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
146658225|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
146773478|NCT02988817|529341080|FG004|Overall Study|Death|6|||
146658226|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
146658227|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
146658228|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
146658229|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
146658230|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
146658231|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
146773479|NCT02988817|529341081|FG005|Overall Study|Death|10|||
146924423|NCT02625324|529884686|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
146924424|NCT02625324|529884686|FG000|6-Month Follow-up Subject Accountability|Death|5|||
146924425|NCT02625324|529884686|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
146924426|NCT02625324|529884686|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
146924427|NCT02625324|529884686|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
146924428|NCT02625324|529884686|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
146924429|NCT02625324|529884686|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
146924430|NCT02625324|529884686|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
146924431|NCT02625324|529884686|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
146924432|NCT02625324|529884686|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
146924433|NCT02625324|529884686|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
146924434|NCT02625324|529884686|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
146924435|NCT02625324|529884686|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
146924436|NCT02625324|529884686|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
146924437|NCT02625324|529884686|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
146924438|NCT02625324|529884686|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
146924439|NCT02457182|529884687|FG000|Overall Study|Lost to Follow-up|1|||
146924440|NCT02457182|529884688|FG001|Overall Study|Lost to Follow-up|0|||
146924441|NCT00352755|529884689|FG000|Overall Study|Physician Decision|1|||
146924442|NCT00352755|529884689|FG000|Overall Study|Adverse Event|1|||
146924443|NCT02397694|529884690|FG000|Double-Blinded Phase|Adverse Event|1|||
146924444|NCT02397694|529884691|FG001|Double-Blinded Phase|Adverse Event|0|||
146924445|NCT02397694|529884690|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
146924446|NCT02397694|529884691|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
146924447|NCT02397694|529884690|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
146924448|NCT02397694|529884691|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
146924449|NCT02397694|529884690|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
146924450|NCT02397694|529884691|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
146924451|NCT02397694|529884690|FG000|Open Label Extension Phase|Protocol Violation|1|||
146924452|NCT02397694|529884691|FG001|Open Label Extension Phase|Protocol Violation|0|||
146924453|NCT02397694|529884690|FG000|Open Label Extension Phase|Withdrew Consent|3|||
146924454|NCT02397694|529884691|FG001|Open Label Extension Phase|Withdrew Consent|1|||
146924455|NCT02397694|529884690|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
146924456|NCT02397694|529884691|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
146924457|NCT01116687|529884692|FG000|Overall Study|Withdrawal by Subject|4|||
146924458|NCT00424528|529884693|FG000|Overall Study|Adverse Event|2|||
146924459|NCT00424528|529884694|FG001|Overall Study|Adverse Event|1|||
146924460|NCT00424528|529884695|FG002|Overall Study|Adverse Event|2|||
146924461|NCT00424528|529884693|FG000|Overall Study|Protocol Violation|1|||
146924462|NCT00424528|529884694|FG001|Overall Study|Protocol Violation|1|||
146924463|NCT00424528|529884695|FG002|Overall Study|Protocol Violation|0|||
146924464|NCT00424528|529884693|FG000|Overall Study|Lost to Follow-up|0|||
146924465|NCT00424528|529884694|FG001|Overall Study|Lost to Follow-up|1|||
146924466|NCT00424528|529884695|FG002|Overall Study|Lost to Follow-up|0|||
146924467|NCT00424528|529884693|FG000|Overall Study|noncompliance with study requirements|2|||
146924468|NCT00424528|529884694|FG001|Overall Study|noncompliance with study requirements|1|||
146924469|NCT00424528|529884695|FG002|Overall Study|noncompliance with study requirements|2|||
146924470|NCT02115113|529884696|FG000|Participants in Run-in Period|Death|0|||
146924471|NCT02115113|529884697|FG001|Participants in Run-in Period|Death|0|||
146924472|NCT02115113|529884698|FG002|Participants in Run-in Period|Death|1|||
146924473|NCT02115113|529884696|FG000|Participants in Run-in Period|Administrative problems|0|||
146924474|NCT02115113|529884697|FG001|Participants in Run-in Period|Administrative problems|0|||
146924475|NCT02115113|529884698|FG002|Participants in Run-in Period|Administrative problems|1|||
146924476|NCT02115113|529884696|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
146924477|NCT02115113|529884697|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
146924478|NCT02115113|529884698|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
146924479|NCT02115113|529884696|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
146924480|NCT02115113|529884697|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
146924481|NCT02115113|529884698|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
146924482|NCT02115113|529884696|FG000|Participants Randomized|Lost to Follow-up|1|||
146611955|NCT00264537|528748963|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
146611956|NCT00264537|528748960|FG000|Overall Study|Other|21|||
146611957|NCT00264537|528748961|FG001|Overall Study|Other|11|||
146611958|NCT00264537|528748962|FG002|Overall Study|Other|10|||
146611959|NCT00264537|528748963|FG003|Overall Study|Other|11|||
146611960|NCT00264537|528748960|FG000|Overall Study|Not treated|0|||
146611961|NCT00264537|528748961|FG001|Overall Study|Not treated|2|||
146611962|NCT00264537|528748962|FG002|Overall Study|Not treated|1|||
146611963|NCT00264537|528748963|FG003|Overall Study|Not treated|0|||
146611964|NCT02123576|528748964|FG000|Overall Study|Adverse Event|1|||
146611965|NCT02123576|528748965|FG001|Overall Study|Adverse Event|0|||
146611966|NCT00934128|528748966|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
146611967|NCT00934128|528748967|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
146611968|NCT00934128|528748966|FG000|First Intervention (2 Hours)|Adverse Event|4|||
146611969|NCT00934128|528748967|FG001|First Intervention (2 Hours)|Adverse Event|1|||
146611970|NCT00934128|528748966|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
146924483|NCT02115113|529884697|FG001|Participants Randomized|Lost to Follow-up|0|||
146924484|NCT02115113|529884698|FG002|Participants Randomized|Lost to Follow-up|0|||
146924485|NCT02115113|529884696|FG000|Participants Randomized|Death|1|||
146924486|NCT02115113|529884697|FG001|Participants Randomized|Death|0|||
146924487|NCT02115113|529884698|FG002|Participants Randomized|Death|0|||
146924488|NCT00789191|529884700|FG000|Overall Study|Adverse Event|2|||
146924489|NCT00789191|529884701|FG001|Overall Study|Adverse Event|4|||
146924490|NCT00789191|529884700|FG000|Overall Study|Lack of Efficacy|0|||
146924491|NCT00789191|529884701|FG001|Overall Study|Lack of Efficacy|5|||
146924492|NCT00789191|529884700|FG000|Overall Study|Protocol Violation|5|||
146924493|NCT00789191|529884701|FG001|Overall Study|Protocol Violation|3|||
146924494|NCT00789191|529884700|FG000|Overall Study|Withdrawal Criteria|2|||
146924495|NCT00789191|529884701|FG001|Overall Study|Withdrawal Criteria|4|||
146924496|NCT00789191|529884700|FG000|Overall Study|Unclassified|5|||
146924497|NCT00789191|529884701|FG001|Overall Study|Unclassified|3|||
146924498|NCT03497429|529884703|FG000|Overall Study|Progressive disease|3|||
146924499|NCT03497429|529884704|FG001|Overall Study|Progressive disease|4|||
146924500|NCT03497429|529884703|FG000|Overall Study|Adverse Event|0|||
146924501|NCT03497429|529884704|FG001|Overall Study|Adverse Event|2|||
146924502|NCT01009983|529884705|FG000|Overall Study|necessary scans not completed|1|||
146924503|NCT00967226|529884709|FG000|Overall Study|Adverse Event|0|||
146924504|NCT00967226|529884710|FG001|Overall Study|Adverse Event|5|||
146924505|NCT00967226|529884709|FG000|Overall Study|Protocol Violation|2|||
146924506|NCT00967226|529884710|FG001|Overall Study|Protocol Violation|0|||
146924507|NCT00967226|529884709|FG000|Overall Study|Physician Decision|0|||
146924508|NCT00967226|529884710|FG001|Overall Study|Physician Decision|1|||
146924509|NCT05254613|529884711|FG000|Overall Study|Lost to Follow-up|0|||
146924510|NCT05254613|529884712|FG001|Overall Study|Lost to Follow-up|0|||
146924511|NCT05254613|529884713|FG002|Overall Study|Lost to Follow-up|1|||
146924512|NCT02338492|529884714|FG000|Overall Study|Death|32|||
146924513|NCT02338492|529884714|FG000|Overall Study|Adverse Event|3|||
146924514|NCT02338492|529884714|FG000|Overall Study|Lost to Follow-up|4|||
146924515|NCT02338492|529884714|FG000|Overall Study|Reason not captured above|6|||
146924516|NCT00756886|529884718|FG000|Overall Study|Lost to Follow-up|1|||
146924517|NCT00756886|529884719|FG001|Overall Study|Lost to Follow-up|0|||
146924518|NCT00756886|529884718|FG000|Overall Study|Adverse Event|0|||
146924519|NCT00756886|529884719|FG001|Overall Study|Adverse Event|3|||
146924520|NCT00756886|529884718|FG000|Overall Study|Lack of Efficacy|1|||
146924521|NCT00756886|529884719|FG001|Overall Study|Lack of Efficacy|0|||
146924522|NCT00756886|529884718|FG000|Overall Study|Ineligible|9|||
146924523|NCT00756886|529884719|FG001|Overall Study|Ineligible|4|||
146924524|NCT00174785|529884720|FG000|Overall Study|Adverse Event|293|||
146924525|NCT00174785|529884721|FG001|Overall Study|Adverse Event|191|||
146924526|NCT00174785|529884720|FG000|Overall Study|Protocol Violation|14|||
146924527|NCT00174785|529884721|FG001|Overall Study|Protocol Violation|14|||
146924528|NCT00174785|529884720|FG000|Overall Study|Withdrawal by Subject|173|||
146924529|NCT00174785|529884721|FG001|Overall Study|Withdrawal by Subject|175|||
146924530|NCT00174785|529884720|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
146924531|NCT00174785|529884721|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
146924532|NCT00174785|529884720|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
146924533|NCT00174785|529884721|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
146924534|NCT00174785|529884720|FG000|Overall Study|Other prohibited medication|5|||
146924535|NCT00174785|529884721|FG001|Overall Study|Other prohibited medication|3|||
146924536|NCT00174785|529884720|FG000|Overall Study|Family request|6|||
146924537|NCT00174785|529884721|FG001|Overall Study|Family request|8|||
146924538|NCT00174785|529884720|FG000|Overall Study|Not pre-specified/Not coded|56|||
146924539|NCT00174785|529884721|FG001|Overall Study|Not pre-specified/Not coded|70|||
146924540|NCT00310388|529884723|FG000|Primary Reporting Phase|Adverse Event|101|||
146924541|NCT00310388|529884724|FG001|Primary Reporting Phase|Adverse Event|0|||
146924542|NCT00310388|529884723|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
146924543|NCT00310388|529884724|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
146924544|NCT00310388|529884723|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
146924545|NCT00310388|529884724|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
146924546|NCT00310388|529884723|FG000|Primary Reporting Phase|Protocol Violation|10|||
146924547|NCT00310388|529884724|FG001|Primary Reporting Phase|Protocol Violation|0|||
146924548|NCT00310388|529884723|FG000|Primary Reporting Phase|Pregnancy|3|||
146924549|NCT00310388|529884724|FG001|Primary Reporting Phase|Pregnancy|0|||
146924550|NCT00310388|529884723|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
146924551|NCT00310388|529884724|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
146924552|NCT00310388|529884723|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
146924553|NCT00310388|529884724|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
146924554|NCT00310388|529884723|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
146924555|NCT00310388|529884724|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
146924556|NCT00310388|529884723|FG000|Primary Reporting Phase|Physician Decision|2|||
146924557|NCT00310388|529884724|FG001|Primary Reporting Phase|Physician Decision|0|||
146924558|NCT00310388|529884723|FG000|Primary Reporting Phase|Request of the sponsor|19|||
146924559|NCT00310388|529884724|FG001|Primary Reporting Phase|Request of the sponsor|0|||
146924560|NCT00310388|529884723|FG000|Primary Reporting Phase|Failed to return|8|||
146924561|NCT00310388|529884724|FG001|Primary Reporting Phase|Failed to return|0|||
146924562|NCT00310388|529884723|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
146924563|NCT00310388|529884724|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
146924564|NCT00310388|529884723|FG000|Primary Reporting Phase|Participant request|2|||
146924565|NCT00310388|529884724|FG001|Primary Reporting Phase|Participant request|0|||
146924566|NCT00310388|529884723|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
146924567|NCT00310388|529884724|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
146924568|NCT00310388|529884723|FG000|Primary Reporting Phase|Discontinuation of study|1|||
146924569|NCT00310388|529884724|FG001|Primary Reporting Phase|Discontinuation of study|0|||
146924570|NCT00310388|529884723|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
146924571|NCT00310388|529884724|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
146924572|NCT00310388|529884723|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
146924573|NCT00310388|529884724|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
146924574|NCT00310388|529884723|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
146924575|NCT00310388|529884724|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
146924576|NCT00310388|529884723|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
146924577|NCT00310388|529884724|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
146924578|NCT00310388|529884723|FG000|Primary Reporting Phase|Participant passed away|1|||
146924579|NCT00310388|529884724|FG001|Primary Reporting Phase|Participant passed away|0|||
146924580|NCT00310388|529884723|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
146924581|NCT00310388|529884724|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
146924582|NCT00310388|529884723|FG000|Primary Reporting Phase|Missing|1|||
146611971|NCT00934128|528748967|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
146611972|NCT00934128|528748966|FG000|Washout Period (1 Hour)|Patient preference|1|||
146611973|NCT00934128|528748967|FG001|Washout Period (1 Hour)|Patient preference|3|||
146611974|NCT00934128|528748966|FG000|Washout Period (1 Hour)|Pain|1|||
146611975|NCT00934128|528748967|FG001|Washout Period (1 Hour)|Pain|0|||
146611976|NCT00934128|528748966|FG000|Washout Period (1 Hour)|Too tired|1|||
146611977|NCT00934128|528748967|FG001|Washout Period (1 Hour)|Too tired|0|||
146658232|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
146924583|NCT00310388|529884724|FG001|Primary Reporting Phase|Missing|0|||
146924584|NCT00310388|529884723|FG000|Primary Reporting Phase|Other|1|||
146924585|NCT00310388|529884724|FG001|Primary Reporting Phase|Other|0|||
146924586|NCT00310388|529884723|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
146924587|NCT00310388|529884724|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
146924588|NCT00310388|529884723|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
146924589|NCT00310388|529884724|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
146924590|NCT00310388|529884723|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
146924591|NCT00310388|529884724|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
146924592|NCT00310388|529884723|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
146924593|NCT00310388|529884724|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
146924594|NCT02387372|529884731|FG000|Overall Study|Not Treated|1|||
146924595|NCT02387372|529884732|FG001|Overall Study|Not Treated|0|||
146924596|NCT02504268|529884737|FG000|Overall Study|Adverse Event|18|||
146924597|NCT02504268|529884738|FG001|Overall Study|Adverse Event|8|||
146924598|NCT02504268|529884739|FG002|Overall Study|Adverse Event|14|||
146924599|NCT02504268|529884740|FG003|Overall Study|Adverse Event|0|||
146924600|NCT02504268|529884741|FG004|Overall Study|Adverse Event|0|||
146924601|NCT02504268|529884742|FG005|Overall Study|Adverse Event|0|||
146924602|NCT02504268|529884743|FG006|Overall Study|Adverse Event|0|||
146924603|NCT02504268|529884744|FG007|Overall Study|Adverse Event|0|||
146924604|NCT02504268|529884745|FG008|Overall Study|Adverse Event|0|||
146924605|NCT02504268|529884737|FG000|Overall Study|Withdrawal of Consent|11|||
146924606|NCT02504268|529884738|FG001|Overall Study|Withdrawal of Consent|10|||
146924607|NCT02504268|529884739|FG002|Overall Study|Withdrawal of Consent|3|||
146924608|NCT02504268|529884740|FG003|Overall Study|Withdrawal of Consent|0|||
146924609|NCT02504268|529884741|FG004|Overall Study|Withdrawal of Consent|0|||
146924610|NCT02504268|529884742|FG005|Overall Study|Withdrawal of Consent|0|||
146924611|NCT02504268|529884743|FG006|Overall Study|Withdrawal of Consent|0|||
146924612|NCT02504268|529884744|FG007|Overall Study|Withdrawal of Consent|0|||
146924613|NCT02504268|529884745|FG008|Overall Study|Withdrawal of Consent|0|||
146924614|NCT02504268|529884737|FG000|Overall Study|Pregnancy|2|||
146611978|NCT00934128|528748966|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
146611979|NCT00934128|528748967|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
146611980|NCT00934128|528748966|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
146611981|NCT00934128|528748967|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
146611982|NCT03228212|528748968|FG000|Period 1|Adverse Event|1|||
146611983|NCT03228212|528748969|FG001|Period 1|Adverse Event|0|||
146611984|NCT03228212|528748968|FG000|Period 1|no longer meets eligibility criteria|0|||
146924615|NCT02504268|529884738|FG001|Overall Study|Pregnancy|0|||
146924616|NCT02504268|529884739|FG002|Overall Study|Pregnancy|0|||
146924617|NCT02504268|529884740|FG003|Overall Study|Pregnancy|0|||
146924618|NCT02504268|529884741|FG004|Overall Study|Pregnancy|0|||
146924619|NCT02504268|529884742|FG005|Overall Study|Pregnancy|0|||
146924620|NCT02504268|529884743|FG006|Overall Study|Pregnancy|0|||
146924621|NCT02504268|529884744|FG007|Overall Study|Pregnancy|0|||
146924622|NCT02504268|529884745|FG008|Overall Study|Pregnancy|0|||
146924623|NCT02504268|529884737|FG000|Overall Study|Lost to Follow-up|3|||
146924624|NCT02504268|529884738|FG001|Overall Study|Lost to Follow-up|6|||
146924625|NCT02504268|529884739|FG002|Overall Study|Lost to Follow-up|4|||
146924626|NCT02504268|529884740|FG003|Overall Study|Lost to Follow-up|0|||
146924627|NCT02504268|529884741|FG004|Overall Study|Lost to Follow-up|0|||
146924628|NCT02504268|529884742|FG005|Overall Study|Lost to Follow-up|0|||
146924629|NCT02504268|529884743|FG006|Overall Study|Lost to Follow-up|0|||
146924630|NCT02504268|529884744|FG007|Overall Study|Lost to Follow-up|0|||
146658233|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
146658234|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
146658235|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
146658236|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
146658237|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
146658238|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
146658239|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
146658240|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
146658241|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
146658242|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
146658243|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
146924631|NCT02504268|529884745|FG008|Overall Study|Lost to Follow-up|0|||
146924632|NCT02504268|529884737|FG000|Overall Study|Death|1|||
146924633|NCT02504268|529884738|FG001|Overall Study|Death|1|||
146924634|NCT02504268|529884739|FG002|Overall Study|Death|0|||
146924635|NCT02504268|529884740|FG003|Overall Study|Death|0|||
146924636|NCT02504268|529884741|FG004|Overall Study|Death|0|||
146924637|NCT02504268|529884742|FG005|Overall Study|Death|0|||
146924638|NCT02504268|529884743|FG006|Overall Study|Death|0|||
146924639|NCT02504268|529884744|FG007|Overall Study|Death|0|||
146924640|NCT02504268|529884745|FG008|Overall Study|Death|0|||
146924641|NCT02504268|529884737|FG000|Overall Study|Subject Request to Discontinue|11|||
146924642|NCT02504268|529884738|FG001|Overall Study|Subject Request to Discontinue|3|||
146924643|NCT02504268|529884739|FG002|Overall Study|Subject Request to Discontinue|6|||
146924644|NCT02504268|529884740|FG003|Overall Study|Subject Request to Discontinue|0|||
146924645|NCT02504268|529884741|FG004|Overall Study|Subject Request to Discontinue|0|||
146924646|NCT02504268|529884742|FG005|Overall Study|Subject Request to Discontinue|0|||
146924647|NCT02504268|529884743|FG006|Overall Study|Subject Request to Discontinue|0|||
146924648|NCT02504268|529884744|FG007|Overall Study|Subject Request to Discontinue|0|||
146924649|NCT02504268|529884745|FG008|Overall Study|Subject Request to Discontinue|0|||
146924650|NCT02504268|529884737|FG000|Overall Study|No Longer Meets Study Criteria|2|||
146924651|NCT02504268|529884738|FG001|Overall Study|No Longer Meets Study Criteria|3|||
146658244|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
146658245|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
146658246|NCT03739840|528927199|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
146924652|NCT02504268|529884739|FG002|Overall Study|No Longer Meets Study Criteria|0|||
146924653|NCT02504268|529884740|FG003|Overall Study|No Longer Meets Study Criteria|0|||
146924654|NCT02504268|529884741|FG004|Overall Study|No Longer Meets Study Criteria|0|||
146924655|NCT02504268|529884742|FG005|Overall Study|No Longer Meets Study Criteria|0|||
146924656|NCT02504268|529884743|FG006|Overall Study|No Longer Meets Study Criteria|0|||
146924657|NCT02504268|529884744|FG007|Overall Study|No Longer Meets Study Criteria|0|||
146924658|NCT02504268|529884745|FG008|Overall Study|No Longer Meets Study Criteria|0|||
146924659|NCT02504268|529884737|FG000|Overall Study|Lack of Efficacy|11|||
146924660|NCT02504268|529884738|FG001|Overall Study|Lack of Efficacy|35|||
146773480|NCT02988817|529341082|FG006|Overall Study|Death|1|||
146924661|NCT02504268|529884739|FG002|Overall Study|Lack of Efficacy|9|||
146978684|NCT03262233|530085458|FG000|Overall Study|Protocol Violation|5|||
146773481|NCT02988817|529341083|FG007|Overall Study|Death|2|||
146773482|NCT02988817|529341084|FG008|Overall Study|Death|1|||
146773483|NCT02988817|529341085|FG009|Overall Study|Death|5|||
146773484|NCT02988817|529341086|FG010|Overall Study|Death|1|||
146924662|NCT02504268|529884740|FG003|Overall Study|Lack of Efficacy|0|||
146924663|NCT02504268|529884741|FG004|Overall Study|Lack of Efficacy|0|||
146924664|NCT02504268|529884742|FG005|Overall Study|Lack of Efficacy|0|||
146924665|NCT02504268|529884743|FG006|Overall Study|Lack of Efficacy|0|||
146924666|NCT02504268|529884744|FG007|Overall Study|Lack of Efficacy|0|||
146924667|NCT02504268|529884745|FG008|Overall Study|Lack of Efficacy|0|||
146924668|NCT02504268|529884737|FG000|Overall Study|Poor/Non-Compliance|3|||
146924669|NCT02504268|529884738|FG001|Overall Study|Poor/Non-Compliance|2|||
146924670|NCT02504268|529884739|FG002|Overall Study|Poor/Non-Compliance|3|||
146924671|NCT02504268|529884740|FG003|Overall Study|Poor/Non-Compliance|0|||
146924672|NCT02504268|529884741|FG004|Overall Study|Poor/Non-Compliance|0|||
146924673|NCT02504268|529884742|FG005|Overall Study|Poor/Non-Compliance|0|||
146924674|NCT02504268|529884743|FG006|Overall Study|Poor/Non-Compliance|0|||
146924675|NCT02504268|529884744|FG007|Overall Study|Poor/Non-Compliance|0|||
146924676|NCT02504268|529884745|FG008|Overall Study|Poor/Non-Compliance|0|||
146611985|NCT03228212|528748969|FG001|Period 1|no longer meets eligibility criteria|1|||
146611986|NCT03228212|528748968|FG000|Period 2|Lost to Follow-up|1|||
146611987|NCT03228212|528748969|FG001|Period 2|Lost to Follow-up|0|||
146611988|NCT02834247|528748970|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
146611989|NCT02834247|528748971|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
146611990|NCT02834247|528748972|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
146611991|NCT02834247|528748973|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
146611992|NCT02834247|528748970|FG000|Dose Escalation Phase|Death|5|||
146611993|NCT02834247|528748971|FG001|Dose Escalation Phase|Death|6|||
146611994|NCT02834247|528748972|FG002|Dose Escalation Phase|Death|5|||
146611995|NCT02834247|528748973|FG003|Dose Escalation Phase|Death|0|||
146611996|NCT02834247|528748970|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
146611997|NCT02834247|528748971|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
146611998|NCT02834247|528748972|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
146611999|NCT02834247|528748973|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
146612000|NCT02834247|528748970|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
146612001|NCT02834247|528748971|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
146612002|NCT02834247|528748972|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
146612003|NCT02834247|528748973|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
146612004|NCT02834247|528748970|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
146612005|NCT02834247|528748971|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
146612006|NCT02834247|528748972|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
146612007|NCT02834247|528748973|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
146612008|NCT02834247|528748970|FG000|Dose Expansion Phase|Death|0|||
146612009|NCT02834247|528748971|FG001|Dose Expansion Phase|Death|0|||
146612010|NCT02834247|528748972|FG002|Dose Expansion Phase|Death|0|||
146612011|NCT02834247|528748973|FG003|Dose Expansion Phase|Death|8|||
146612012|NCT02834247|528748970|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
146612013|NCT02834247|528748971|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
146612014|NCT02834247|528748972|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
146612015|NCT02834247|528748973|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
146612016|NCT02834247|528748970|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
146612017|NCT02834247|528748971|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
146612018|NCT02834247|528748972|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
146612019|NCT02834247|528748973|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
146612020|NCT01807299|528748974|FG000|Overall Study|Protocol Violation|3|||
146612021|NCT01807299|528748975|FG001|Overall Study|Protocol Violation|1|||
146612022|NCT01807299|528748976|FG002|Overall Study|Protocol Violation|0|||
146612023|NCT01807299|528748977|FG003|Overall Study|Protocol Violation|2|||
146658247|NCT03739840|528927200|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
146658248|NCT03739840|528927201|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
146658249|NCT03739840|528927202|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
146658250|NCT03739840|528927199|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
146658251|NCT03739840|528927200|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
146658252|NCT03739840|528927201|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
146658253|NCT03739840|528927202|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
146658254|NCT03739840|528927199|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
146658255|NCT03739840|528927200|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
146773485|NCT02988817|529341087|FG011|Overall Study|Death|8|||
146612024|NCT04829916|528750424|FG000|Overall Study|Withdrawal by Subject|1|||
146612025|NCT04829916|528750425|FG001|Overall Study|Withdrawal by Subject|0|||
146612026|NCT03781778|528750427|FG000|Overall Study|Withdrawal by Subject|2|||
146612027|NCT03781778|528750428|FG001|Overall Study|Withdrawal by Subject|2|||
146612028|NCT02287467|528750429|FG000|Overall Study|Protocol Violation|12|||
146612029|NCT02287467|528750430|FG001|Overall Study|Protocol Violation|9|||
146612030|NCT04343755|528750438|FG000|Overall Study|Death|11|||
146658256|NCT03739840|528927201|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
146658257|NCT03739840|528927202|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
146924677|NCT02504268|529884737|FG000|Overall Study|Not Disclosed|1|||
146924678|NCT02504268|529884738|FG001|Overall Study|Not Disclosed|0|||
146612031|NCT04343755|528750438|FG000|Overall Study|Screen Failure|1|||
146612032|NCT03755882|528750439|FG000|Period 1|Protocol Violation|1|||
146612033|NCT03755882|528750440|FG001|Period 1|Protocol Violation|0|||
146612034|NCT03755882|528750439|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
146658258|NCT03739840|528927199|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
146924679|NCT02504268|529884739|FG002|Overall Study|Not Disclosed|2|||
146612035|NCT03755882|528750440|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
146612036|NCT02292446|528750441|FG000|Overall Study|Adverse Event|12|||
146612037|NCT02292446|528750441|FG000|Overall Study|Death|1|||
146612038|NCT02292446|528750441|FG000|Overall Study|Disease progression|2|||
146612039|NCT02292446|528750441|FG000|Overall Study|Subject/guardian decision|2|||
146612040|NCT02292446|528750441|FG000|Overall Study|Withdrawal by Subject|3|||
146612041|NCT01290757|528750446|FG000|Overall Study|Adverse Event|1|||
146612042|NCT01290757|528750447|FG001|Overall Study|Adverse Event|0|||
146612043|NCT01290757|528750446|FG000|Overall Study|Protocol Violation|1|||
146612044|NCT01290757|528750447|FG001|Overall Study|Protocol Violation|1|||
146612045|NCT01290757|528750446|FG000|Overall Study|Other|0|||
146612046|NCT01290757|528750447|FG001|Overall Study|Other|1|||
146612047|NCT00570310|528750448|FG000|Overall Study|Adverse Event|1|||
146612048|NCT00570310|528750449|FG001|Overall Study|Adverse Event|2|||
146612049|NCT00570310|528750448|FG000|Overall Study|Lack of Efficacy|1|||
146612050|NCT00570310|528750449|FG001|Overall Study|Lack of Efficacy|4|||
146612051|NCT03329846|528750452|FG000|Overall Study|Disease progression|4|||
146612052|NCT03329846|528750453|FG001|Overall Study|Disease progression|6|||
146612053|NCT03329846|528750452|FG000|Overall Study|Study drug toxicity|1|||
146612054|NCT03329846|528750453|FG001|Overall Study|Study drug toxicity|0|||
146612055|NCT03329846|528750452|FG000|Overall Study|Participant request to discontinue treatment|0|||
146612056|NCT03329846|528750453|FG001|Overall Study|Participant request to discontinue treatment|1|||
146612057|NCT03329846|528750452|FG000|Overall Study|Participant withdrew consent|1|||
146612058|NCT03329846|528750453|FG001|Overall Study|Participant withdrew consent|0|||
146612059|NCT03329846|528750452|FG000|Overall Study|Other reasons|2|||
146612060|NCT03329846|528750453|FG001|Overall Study|Other reasons|2|||
146612061|NCT00108862|528750454|FG000|Overall Study|Death|31|||
146612062|NCT00108862|528750455|FG001|Overall Study|Death|37|||
146612063|NCT00108862|528750454|FG000|Overall Study|Withdrawal by Subject|10|||
146612064|NCT00108862|528750455|FG001|Overall Study|Withdrawal by Subject|6|||
146612065|NCT00108862|528750454|FG000|Overall Study|Lost to Follow-up|27|||
146612066|NCT00108862|528750455|FG001|Overall Study|Lost to Follow-up|19|||
146612067|NCT02021643|528750456|FG000|Overall Study|Enrolled but Never Treated|1|||
146612068|NCT02021643|528750457|FG001|Overall Study|Enrolled but Never Treated|0|||
146612069|NCT02021643|528750458|FG002|Overall Study|Enrolled but Never Treated|0|||
146612070|NCT02021643|528750459|FG003|Overall Study|Enrolled but Never Treated|0|||
146612071|NCT02021643|528750456|FG000|Overall Study|Adverse Event|0|||
146612072|NCT02021643|528750457|FG001|Overall Study|Adverse Event|1|||
146612073|NCT02021643|528750458|FG002|Overall Study|Adverse Event|0|||
146612074|NCT02021643|528750459|FG003|Overall Study|Adverse Event|0|||
146612075|NCT02021643|528750456|FG000|Overall Study|Death|0|||
146612076|NCT02021643|528750457|FG001|Overall Study|Death|1|||
146612077|NCT02021643|528750458|FG002|Overall Study|Death|0|||
146612078|NCT02021643|528750459|FG003|Overall Study|Death|0|||
146612079|NCT02021643|528750456|FG000|Overall Study|Investigator's Discretion|1|||
146612080|NCT02021643|528750457|FG001|Overall Study|Investigator's Discretion|0|||
146612081|NCT02021643|528750458|FG002|Overall Study|Investigator's Discretion|0|||
146612082|NCT02021643|528750459|FG003|Overall Study|Investigator's Discretion|0|||
146612083|NCT02021643|528750456|FG000|Overall Study|Lack of Efficacy|7|||
146612084|NCT02021643|528750457|FG001|Overall Study|Lack of Efficacy|6|||
146612085|NCT02021643|528750458|FG002|Overall Study|Lack of Efficacy|0|||
146612086|NCT02021643|528750459|FG003|Overall Study|Lack of Efficacy|12|||
146612087|NCT02021643|528750456|FG000|Overall Study|Lost to Follow-up|0|||
146612088|NCT02021643|528750457|FG001|Overall Study|Lost to Follow-up|1|||
146612089|NCT02021643|528750458|FG002|Overall Study|Lost to Follow-up|0|||
146612090|NCT02021643|528750459|FG003|Overall Study|Lost to Follow-up|0|||
146612091|NCT02021643|528750456|FG000|Overall Study|Withdrew Consent|0|||
146612092|NCT02021643|528750457|FG001|Overall Study|Withdrew Consent|1|||
146612093|NCT02021643|528750458|FG002|Overall Study|Withdrew Consent|0|||
146612094|NCT02021643|528750459|FG003|Overall Study|Withdrew Consent|0|||
146612095|NCT01345188|528750462|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
146612096|NCT01345188|528750462|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
146612097|NCT06041919|528750465|FG000|Overall Study|Lost to Follow-up|1|||
146612098|NCT06041919|528750466|FG001|Overall Study|Lost to Follow-up|0|||
146612099|NCT06041919|528750467|FG002|Overall Study|Lost to Follow-up|0|||
146612100|NCT06041919|528750468|FG003|Overall Study|Lost to Follow-up|0|||
146612101|NCT06041919|528750469|FG004|Overall Study|Lost to Follow-up|0|||
146612102|NCT06041919|528750465|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
146612103|NCT06041919|528750466|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
146612104|NCT06041919|528750467|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
146612105|NCT06041919|528750468|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
146612106|NCT06041919|528750469|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
146612107|NCT04526145|528750470|FG000|Overall Study|Withdrawal by Subject|5|||
146612108|NCT00577824|528750474|FG000|Overall Study|Adverse Event|6|||
146612109|NCT00577824|528750475|FG001|Overall Study|Adverse Event|18|||
146612110|NCT00577824|528750476|FG002|Overall Study|Adverse Event|1|||
146612111|NCT00577824|528750474|FG000|Overall Study|Patient decision|0|||
146612112|NCT00577824|528750475|FG001|Overall Study|Patient decision|1|||
146612113|NCT00577824|528750476|FG002|Overall Study|Patient decision|1|||
146612114|NCT00577824|528750474|FG000|Overall Study|Protocol Violation|1|||
146612115|NCT00577824|528750475|FG001|Overall Study|Protocol Violation|1|||
146924680|NCT02504268|529884740|FG003|Overall Study|Not Disclosed|0|||
146924681|NCT02504268|529884741|FG004|Overall Study|Not Disclosed|0|||
146924682|NCT02504268|529884742|FG005|Overall Study|Not Disclosed|0|||
146924683|NCT02504268|529884743|FG006|Overall Study|Not Disclosed|0|||
146612116|NCT00577824|528750476|FG002|Overall Study|Protocol Violation|0|||
146612117|NCT01518374|528750477|FG000|Overall Study|Withdrawal by Subject|2|||
146924684|NCT02504268|529884744|FG007|Overall Study|Not Disclosed|0|||
146612118|NCT01518374|528750477|FG000|Overall Study|Protocol Violation|3|||
146612119|NCT01518374|528750477|FG000|Overall Study|Lost to Follow-up|2|||
146612120|NCT04607837|528750483|FG000|Overall Study|Adverse Event|8|||
146612121|NCT04607837|528750484|FG001|Overall Study|Adverse Event|2|||
146612122|NCT04607837|528750483|FG000|Overall Study|Withdrawal by Subject|8|||
146612123|NCT04607837|528750484|FG001|Overall Study|Withdrawal by Subject|7|||
146612124|NCT04607837|528750483|FG000|Overall Study|Physician Decision|2|||
146612125|NCT04607837|528750484|FG001|Overall Study|Physician Decision|0|||
146612126|NCT04607837|528750483|FG000|Overall Study|Lack of Efficacy|2|||
146612127|NCT04607837|528750484|FG001|Overall Study|Lack of Efficacy|0|||
146612128|NCT04607837|528750483|FG000|Overall Study|Participant terminated by sponsor|1|||
146612129|NCT04607837|528750484|FG001|Overall Study|Participant terminated by sponsor|0|||
146612130|NCT04607837|528750483|FG000|Overall Study|Disease worsening|36|||
146612131|NCT04607837|528750484|FG001|Overall Study|Disease worsening|36|||
146612132|NCT04607837|528750483|FG000|Overall Study|Other|1|||
146612133|NCT04607837|528750484|FG001|Overall Study|Other|0|||
146612134|NCT02362464|528750485|FG000|Overall Study|Switched to alternative therapy|1|||
146612135|NCT02362464|528750485|FG000|Overall Study|Refused further treatment|1|||
146612136|NCT02362464|528750485|FG000|Overall Study|Physician Decision|4|||
146612137|NCT04209205|528750490|FG000|Overall Study|Adverse Event|2|||
146612138|NCT04209205|528750491|FG001|Overall Study|Adverse Event|3|||
146612139|NCT04209205|528750490|FG000|Overall Study|Lost to Follow-up|3|||
146612140|NCT04209205|528750491|FG001|Overall Study|Lost to Follow-up|1|||
146612141|NCT04209205|528750490|FG000|Overall Study|Physician Decision|1|||
146612142|NCT04209205|528750491|FG001|Overall Study|Physician Decision|1|||
146612143|NCT04209205|528750490|FG000|Overall Study|Subject decision|10|||
146612144|NCT04209205|528750491|FG001|Overall Study|Subject decision|10|||
146612145|NCT04209205|528750490|FG000|Overall Study|Progressive disease|1|||
146612146|NCT04209205|528750491|FG001|Overall Study|Progressive disease|0|||
146612147|NCT04209205|528750490|FG000|Overall Study|Protocol deviation|0|||
146612148|NCT04209205|528750491|FG001|Overall Study|Protocol deviation|1|||
146612149|NCT04209205|528750490|FG000|Overall Study|New therapy for study indication|1|||
146612150|NCT04209205|528750491|FG001|Overall Study|New therapy for study indication|0|||
146612151|NCT04209205|528750490|FG000|Overall Study|Adverse event - placebo not switched|0|||
146612152|NCT04209205|528750491|FG001|Overall Study|Adverse event - placebo not switched|1|||
146612153|NCT04209205|528750490|FG000|Overall Study|Subject decision - placebo not switched|0|||
146612154|NCT04209205|528750491|FG001|Overall Study|Subject decision - placebo not switched|5|||
146612155|NCT04209205|528750490|FG000|Overall Study|Death - placebo not switched|0|||
146612156|NCT04209205|528750491|FG001|Overall Study|Death - placebo not switched|1|||
146612157|NCT05870865|528750492|FG000|Randomized|Did not receive study treatment|2|||
146612158|NCT05870865|528750493|FG001|Randomized|Did not receive study treatment|4|||
146612159|NCT05870865|528750494|FG002|Randomized|Did not receive study treatment|4|||
146612160|NCT05870865|528750495|FG003|Randomized|Did not receive study treatment|3|||
146612161|NCT05870865|528750492|FG000|Treatment Period|Adverse Event|1|||
146612162|NCT05870865|528750493|FG001|Treatment Period|Adverse Event|1|||
146612163|NCT05870865|528750494|FG002|Treatment Period|Adverse Event|1|||
146612164|NCT05870865|528750495|FG003|Treatment Period|Adverse Event|1|||
146612165|NCT05870865|528750492|FG000|Treatment Period|Lost to Follow-up|0|||
146612166|NCT05870865|528750493|FG001|Treatment Period|Lost to Follow-up|1|||
146612167|NCT05870865|528750494|FG002|Treatment Period|Lost to Follow-up|2|||
146612168|NCT05870865|528750495|FG003|Treatment Period|Lost to Follow-up|0|||
146612169|NCT05870865|528750492|FG000|Treatment Period|Protocol Violation|0|||
146612170|NCT05870865|528750493|FG001|Treatment Period|Protocol Violation|0|||
146612171|NCT05870865|528750494|FG002|Treatment Period|Protocol Violation|0|||
146612172|NCT05870865|528750495|FG003|Treatment Period|Protocol Violation|1|||
146612173|NCT05870865|528750492|FG000|Treatment Period|Withdrawal by Subject|0|||
146612174|NCT05870865|528750493|FG001|Treatment Period|Withdrawal by Subject|1|||
146612175|NCT05870865|528750494|FG002|Treatment Period|Withdrawal by Subject|1|||
146612176|NCT05870865|528750495|FG003|Treatment Period|Withdrawal by Subject|1|||
146612177|NCT03828019|528750500|FG000|Overall Study|Withdrawal by Subject|3|||
146773486|NCT02988817|529341088|FG012|Overall Study|Death|9|||
146924685|NCT02504268|529884745|FG008|Overall Study|Not Disclosed|0|||
146924686|NCT03025217|529884746|FG000|Overall Study|Pregnancy|1|||
146924687|NCT03025217|529884746|FG000|Overall Study|Lost to Follow-up|1|||
146612178|NCT03828019|528750501|FG001|Overall Study|Withdrawal by Subject|8|||
146612179|NCT03828019|528750500|FG000|Overall Study|Lost to Follow-up|1|||
146612180|NCT03828019|528750501|FG001|Overall Study|Lost to Follow-up|6|||
146612181|NCT03828019|528750500|FG000|Overall Study|Incarcerated|1|||
146612182|NCT03828019|528750501|FG001|Overall Study|Incarcerated|0|||
146924688|NCT03025217|529884746|FG000|Overall Study|Not eligible, poor English|2|||
146612183|NCT03828019|528750500|FG000|Overall Study|Adverse Event|0|||
146612184|NCT03828019|528750501|FG001|Overall Study|Adverse Event|1|||
146612185|NCT05715242|528750502|FG000|Overall Study|Lost to Follow-up|0|||
146612186|NCT05715242|528750503|FG001|Overall Study|Lost to Follow-up|0|||
146924689|NCT03198754|529884755|FG000|Overall Study|Withdrawal by Subject|5|||
146924690|NCT03198754|529884756|FG001|Overall Study|Withdrawal by Subject|4|||
146924691|NCT03198754|529884755|FG000|Overall Study|Lost to Follow-up|4|||
146924692|NCT03198754|529884756|FG001|Overall Study|Lost to Follow-up|3|||
146924693|NCT03198754|529884755|FG000|Overall Study|Ineligible|2|||
146924694|NCT03198754|529884756|FG001|Overall Study|Ineligible|1|||
146924695|NCT02108951|529884765|FG000|Overall Study|Lost to Follow-up|1|||
146924696|NCT02108951|529884765|FG000|Overall Study|Patient's/guardian's decision|1|||
146924697|NCT02108951|529884765|FG000|Overall Study|Study Terminated by Sponsor|14|||
146924698|NCT00718666|529884766|FG000|Booster Phase Year 5|No active participation request|0|||
146924699|NCT00718666|529884767|FG001|Booster Phase Year 5|No active participation request|0|||
146924700|NCT00718666|529884768|FG002|Booster Phase Year 5|No active participation request|1|||
146924701|NCT00718666|529884766|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
146924702|NCT00718666|529884767|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
146924703|NCT00718666|529884768|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
146924704|NCT00718666|529884766|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
146924705|NCT00718666|529884767|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
146924706|NCT00718666|529884768|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
146924707|NCT00718666|529884766|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
146924708|NCT00718666|529884767|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
146924709|NCT00718666|529884768|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
146924710|NCT02196038|529884771|FG000|Overall Study|Death|16|||
146924711|NCT02196038|529884772|FG001|Overall Study|Death|21|||
146924712|NCT02196038|529884771|FG000|Overall Study|Withdrawal by Subject|0|||
146924713|NCT02196038|529884772|FG001|Overall Study|Withdrawal by Subject|1|||
146924714|NCT02196038|529884771|FG000|Overall Study|Lost to Follow-up|1|||
146924715|NCT02196038|529884772|FG001|Overall Study|Lost to Follow-up|0|||
146924716|NCT00421343|529884773|FG000|Overall Study|Death|1|||
146924717|NCT00421343|529884773|FG000|Overall Study|Withdrawal by Subject|2|||
146924718|NCT00421343|529884773|FG000|Overall Study|Lost to Follow-up|3|||
146924719|NCT03471767|529884785|FG000|Overall Study|Withdrawal by Subject|3|||
146924720|NCT03471767|529884786|FG001|Overall Study|Withdrawal by Subject|1|||
146924721|NCT03471767|529884785|FG000|Overall Study|Adverse Event|1|||
146924722|NCT03471767|529884786|FG001|Overall Study|Adverse Event|0|||
146924723|NCT03471767|529884785|FG000|Overall Study|Lost to Follow-up|1|||
146924724|NCT03471767|529884786|FG001|Overall Study|Lost to Follow-up|0|||
146924725|NCT03471767|529884785|FG000|Overall Study|PI Withdrawal|1|||
146924726|NCT03471767|529884786|FG001|Overall Study|PI Withdrawal|3|||
146924727|NCT00608530|529884789|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
146924728|NCT00608530|529884790|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
146924729|NCT00608530|529884791|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
146924730|NCT00608530|529884792|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
146924731|NCT00608530|529884789|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
146924732|NCT00608530|529884790|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
146924733|NCT00608530|529884791|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
146924734|NCT00608530|529884792|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
146924735|NCT00608530|529884789|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
146924736|NCT00608530|529884790|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
146924737|NCT00608530|529884791|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
146924738|NCT00608530|529884792|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
146924739|NCT00608530|529884789|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
146924740|NCT00608530|529884790|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
146924741|NCT00608530|529884791|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
146924742|NCT00608530|529884792|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
146924743|NCT00608530|529884789|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
146924744|NCT00608530|529884790|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
146924745|NCT00608530|529884791|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
146924746|NCT00608530|529884792|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
146924747|NCT00608530|529884789|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
146924748|NCT00608530|529884790|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
146924749|NCT00608530|529884791|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
146924750|NCT00608530|529884792|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
146612187|NCT05715242|528750504|FG002|Overall Study|Lost to Follow-up|1|||
146612188|NCT05715242|528750505|FG003|Overall Study|Lost to Follow-up|0|||
146612189|NCT05715242|528750506|FG004|Overall Study|Lost to Follow-up|0|||
146773487|NCT02988817|529341089|FG013|Overall Study|Death|17|||
146924751|NCT01952730|529884793|FG000|Overall Study|FDA shut down core lab used by study|1|||
146924752|NCT01098461|529884794|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
146924753|NCT01098461|529884795|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
146924754|NCT01098461|529884796|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
146924755|NCT01098461|529884797|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
146924756|NCT01098461|529884794|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
146924757|NCT01098461|529884795|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
146924758|NCT01098461|529884796|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
146924759|NCT01098461|529884797|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
146924760|NCT01098461|529884794|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
146924761|NCT01098461|529884795|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
146924762|NCT01098461|529884796|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
146924763|NCT01098461|529884797|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
146924764|NCT01098461|529884794|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
146924765|NCT01098461|529884795|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
146924766|NCT01098461|529884796|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
146924767|NCT01098461|529884797|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
146924768|NCT01098461|529884794|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
146924769|NCT01098461|529884795|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
146924770|NCT01098461|529884796|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
146924771|NCT01098461|529884797|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
146924772|NCT01098461|529884794|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
146924773|NCT01098461|529884795|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
146924774|NCT01098461|529884796|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
146924775|NCT01098461|529884797|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
146924776|NCT01098461|529884794|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
146924777|NCT01098461|529884795|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
146924778|NCT01098461|529884796|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
146924779|NCT01098461|529884797|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
146924780|NCT01514188|529884798|FG000|Overall Study|Adverse Event|3|||
146924781|NCT01514188|529884799|FG001|Overall Study|Adverse Event|5|||
146924782|NCT01514188|529884798|FG000|Overall Study|Withdrawal by Subject|2|||
146924783|NCT01514188|529884799|FG001|Overall Study|Withdrawal by Subject|4|||
146924784|NCT01514188|529884798|FG000|Overall Study|Protocol Violation|2|||
146924785|NCT01514188|529884799|FG001|Overall Study|Protocol Violation|4|||
146924786|NCT01514188|529884798|FG000|Overall Study|Physician Decision|0|||
146924787|NCT01514188|529884799|FG001|Overall Study|Physician Decision|2|||
146924788|NCT01514188|529884798|FG000|Overall Study|Disease Progression|13|||
146924789|NCT01514188|529884799|FG001|Overall Study|Disease Progression|14|||
146924790|NCT01514188|529884798|FG000|Overall Study|Death|1|||
146924791|NCT01514188|529884799|FG001|Overall Study|Death|3|||
146924792|NCT01514188|529884798|FG000|Overall Study|Other|2|||
146924793|NCT01514188|529884799|FG001|Overall Study|Other|1|||
146924794|NCT00515008|529884805|FG000|Overall Study|Lost to Follow-up|1|||
146924795|NCT00515008|529884806|FG001|Overall Study|Lost to Follow-up|0|||
146924796|NCT00515008|529884805|FG000|Overall Study|Declined|0|||
146924797|NCT00515008|529884806|FG001|Overall Study|Declined|3|||
146924798|NCT00515008|529884805|FG000|Overall Study|Left the Boston Area|1|||
146924799|NCT00515008|529884806|FG001|Overall Study|Left the Boston Area|1|||
146924800|NCT00515008|529884805|FG000|Overall Study|Scheduling conflict|1|||
146924801|NCT00515008|529884806|FG001|Overall Study|Scheduling conflict|0|||
146924802|NCT03375112|529884811|FG000|Overall Study|Withdrawal by Subject|3|||
146924803|NCT03375112|529884812|FG001|Overall Study|Withdrawal by Subject|0|||
146924804|NCT00243230|529884814|FG000|Double-Blind Period|Adverse Event|0|||
146924805|NCT00243230|529884815|FG001|Double-Blind Period|Adverse Event|2|||
146924806|NCT00243230|529884816|FG002|Double-Blind Period|Adverse Event|2|||
146924807|NCT00243230|529884817|FG003|Double-Blind Period|Adverse Event|0|||
146924808|NCT00243230|529884814|FG000|Double-Blind Period|Withdrawal by Subject|1|||
146924809|NCT00243230|529884815|FG001|Double-Blind Period|Withdrawal by Subject|0|||
146924810|NCT00243230|529884816|FG002|Double-Blind Period|Withdrawal by Subject|0|||
146924811|NCT00243230|529884817|FG003|Double-Blind Period|Withdrawal by Subject|0|||
146924812|NCT00243230|529884814|FG000|Double-Blind Period|Protocol Violation|0|||
146612190|NCT05715242|528750507|FG005|Overall Study|Lost to Follow-up|1|||
146612191|NCT05715242|528750508|FG006|Overall Study|Lost to Follow-up|0|||
146612192|NCT05715242|528750509|FG007|Overall Study|Lost to Follow-up|0|||
146612193|NCT05715242|528750510|FG008|Overall Study|Lost to Follow-up|0|||
146924813|NCT00243230|529884815|FG001|Double-Blind Period|Protocol Violation|0|||
146924814|NCT00243230|529884816|FG002|Double-Blind Period|Protocol Violation|1|||
146924815|NCT00243230|529884817|FG003|Double-Blind Period|Protocol Violation|0|||
146924816|NCT00243230|529884814|FG000|Double-Blind Period|Randomized but Not Treated|0|||
146924817|NCT00243230|529884815|FG001|Double-Blind Period|Randomized but Not Treated|0|||
146612194|NCT05715242|528750511|FG009|Overall Study|Lost to Follow-up|0|||
146612195|NCT05715242|528750512|FG010|Overall Study|Lost to Follow-up|0|||
146612196|NCT05715242|528750513|FG011|Overall Study|Lost to Follow-up|0|||
146924818|NCT00243230|529884816|FG002|Double-Blind Period|Randomized but Not Treated|2|||
146924819|NCT00243230|529884817|FG003|Double-Blind Period|Randomized but Not Treated|0|||
146924820|NCT00243230|529884814|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
146924821|NCT00243230|529884815|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
146924822|NCT00243230|529884816|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
146924823|NCT00243230|529884817|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
146924824|NCT00243230|529884814|FG000|Open Label Period|Adverse Event|0|||
146924825|NCT00243230|529884815|FG001|Open Label Period|Adverse Event|0|||
146924826|NCT00243230|529884816|FG002|Open Label Period|Adverse Event|0|||
146924827|NCT00243230|529884817|FG003|Open Label Period|Adverse Event|2|||
146924828|NCT00243230|529884814|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
146924829|NCT00243230|529884815|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
146924830|NCT00243230|529884816|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
146924831|NCT00243230|529884817|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
146924832|NCT00243230|529884814|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
146924833|NCT00243230|529884815|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
146924834|NCT00243230|529884816|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
146924835|NCT00243230|529884817|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
146924836|NCT00243230|529884814|FG000|Open Label Period|Lost to Follow-up|0|||
146924837|NCT00243230|529884815|FG001|Open Label Period|Lost to Follow-up|0|||
146924838|NCT00243230|529884816|FG002|Open Label Period|Lost to Follow-up|0|||
146924839|NCT00243230|529884817|FG003|Open Label Period|Lost to Follow-up|2|||
146924840|NCT00243230|529884814|FG000|Open Label Period|Withdrawal by Subject|0|||
146612197|NCT05715242|528750514|FG012|Overall Study|Lost to Follow-up|0|||
146612198|NCT05715242|528750515|FG013|Overall Study|Lost to Follow-up|0|||
146612199|NCT05715242|528750516|FG014|Overall Study|Lost to Follow-up|0|||
146612200|NCT05715242|528750517|FG015|Overall Study|Lost to Follow-up|0|||
146612201|NCT00048347|528750520|FG000|Overall Study|Screen failure|2|||
146612202|NCT00195663|528750521|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
146612203|NCT00195663|528750522|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
146612204|NCT00195663|528750523|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
146612205|NCT00195663|528750521|FG000|2-year Double-blind Treatment Period|Death|0|||
146612206|NCT00195663|528750522|FG001|2-year Double-blind Treatment Period|Death|2|||
146612207|NCT00195663|528750523|FG002|2-year Double-blind Treatment Period|Death|0|||
146612208|NCT00195663|528750521|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
146612209|NCT00195663|528750522|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
146612210|NCT00195663|528750523|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
146612211|NCT00195663|528750521|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
146612212|NCT00195663|528750522|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
146612213|NCT00195663|528750523|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
146612214|NCT00195663|528750521|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
146612215|NCT00195663|528750522|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
146612216|NCT00195663|528750523|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
146612217|NCT00195663|528750521|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
146612218|NCT00195663|528750522|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
146612219|NCT00195663|528750523|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
146612220|NCT00195663|528750521|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
146612221|NCT00195663|528750522|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
146612222|NCT00195663|528750523|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
146612223|NCT00195663|528750521|FG000|2-year Double-blind Treatment Period|Recovery|1|||
146612224|NCT00195663|528750522|FG001|2-year Double-blind Treatment Period|Recovery|0|||
146612225|NCT00195663|528750523|FG002|2-year Double-blind Treatment Period|Recovery|1|||
146612226|NCT00195663|528750521|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
146612227|NCT00195663|528750522|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
146612228|NCT00195663|528750523|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
146612229|NCT00195663|528750521|FG000|Open-Label Extension Period|Adverse Event|21|||
146612230|NCT00195663|528750522|FG001|Open-Label Extension Period|Adverse Event|32|||
146612231|NCT00195663|528750523|FG002|Open-Label Extension Period|Adverse Event|36|||
146612232|NCT00195663|528750521|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
146612233|NCT00195663|528750522|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
146612234|NCT00195663|528750523|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
146612235|NCT00195663|528750521|FG000|Open-Label Extension Period|Recovery|0|||
146612236|NCT00195663|528750522|FG001|Open-Label Extension Period|Recovery|2|||
146612237|NCT00195663|528750523|FG002|Open-Label Extension Period|Recovery|2|||
146612238|NCT00195663|528750521|FG000|Open-Label Extension Period|Protocol Violation|3|||
146612239|NCT00195663|528750522|FG001|Open-Label Extension Period|Protocol Violation|4|||
146773488|NCT02988817|529341090|FG014|Overall Study|Death|18|||
146773489|NCT02988817|529341091|FG015|Overall Study|Death|30|||
146924841|NCT00243230|529884815|FG001|Open Label Period|Withdrawal by Subject|0|||
146924842|NCT00243230|529884816|FG002|Open Label Period|Withdrawal by Subject|0|||
146612240|NCT00195663|528750523|FG002|Open-Label Extension Period|Protocol Violation|4|||
146612241|NCT00195663|528750521|FG000|Open-Label Extension Period|Death|2|||
146612242|NCT00195663|528750522|FG001|Open-Label Extension Period|Death|2|||
146612243|NCT00195663|528750523|FG002|Open-Label Extension Period|Death|2|||
146612244|NCT00195663|528750521|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
146612245|NCT00195663|528750522|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
146612246|NCT00195663|528750523|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
146612247|NCT00195663|528750521|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
146612248|NCT00195663|528750522|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
146612249|NCT00195663|528750523|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
146612250|NCT00195663|528750521|FG000|Open-Label Extension Period|Administrative reasons|11|||
146612251|NCT00195663|528750522|FG001|Open-Label Extension Period|Administrative reasons|11|||
146612252|NCT00195663|528750523|FG002|Open-Label Extension Period|Administrative reasons|13|||
146612253|NCT03182907|528750526|FG000|Overall Study|Death|3|||
146612254|NCT03182907|528750527|FG001|Overall Study|Death|0|||
146612255|NCT03182907|528750526|FG000|Overall Study|Protocol Violation|4|||
146612256|NCT03182907|528750527|FG001|Overall Study|Protocol Violation|0|||
146612257|NCT03182907|528750526|FG000|Overall Study|Lost to Follow-up|1|||
146612258|NCT03182907|528750527|FG001|Overall Study|Lost to Follow-up|0|||
146612259|NCT03182907|528750526|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146612260|NCT03182907|528750527|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
146612261|NCT00166439|528750529|FG000|Overall Study|Ineligible|5|||
146612262|NCT00106353|528750532|FG000|Part 1|Disease progression|3|||
146612263|NCT00106353|528750533|FG001|Part 1|Disease progression|4|||
146612264|NCT00106353|528750534|FG002|Part 1|Disease progression|1|||
146612265|NCT00106353|528750535|FG003|Part 1|Disease progression|3|||
146612266|NCT00106353|528750536|FG004|Part 1|Disease progression|0|||
146612267|NCT00106353|528750537|FG005|Part 1|Disease progression|0|||
146612268|NCT00106353|528750538|FG006|Part 1|Disease progression|0|||
146612269|NCT00106353|528750532|FG000|Part 1|Withdrawal by Subject|0|||
146612270|NCT00106353|528750533|FG001|Part 1|Withdrawal by Subject|0|||
146612271|NCT00106353|528750534|FG002|Part 1|Withdrawal by Subject|1|||
146612272|NCT00106353|528750535|FG003|Part 1|Withdrawal by Subject|2|||
146612273|NCT00106353|528750536|FG004|Part 1|Withdrawal by Subject|0|||
146612274|NCT00106353|528750537|FG005|Part 1|Withdrawal by Subject|0|||
146612275|NCT00106353|528750538|FG006|Part 1|Withdrawal by Subject|0|||
146612276|NCT00106353|528750532|FG000|Part 1|Symptomatic deterioration|0|||
146612277|NCT00106353|528750533|FG001|Part 1|Symptomatic deterioration|0|||
146612278|NCT00106353|528750534|FG002|Part 1|Symptomatic deterioration|1|||
146612279|NCT00106353|528750535|FG003|Part 1|Symptomatic deterioration|0|||
146612280|NCT00106353|528750536|FG004|Part 1|Symptomatic deterioration|0|||
146612281|NCT00106353|528750537|FG005|Part 1|Symptomatic deterioration|0|||
146612282|NCT00106353|528750538|FG006|Part 1|Symptomatic deterioration|0|||
146612283|NCT00106353|528750532|FG000|Part 1|Entered follow-up phase|1|||
146612284|NCT00106353|528750533|FG001|Part 1|Entered follow-up phase|1|||
146612285|NCT00106353|528750534|FG002|Part 1|Entered follow-up phase|0|||
146612286|NCT00106353|528750535|FG003|Part 1|Entered follow-up phase|1|||
146612287|NCT00106353|528750536|FG004|Part 1|Entered follow-up phase|0|||
146612288|NCT00106353|528750537|FG005|Part 1|Entered follow-up phase|0|||
146612289|NCT00106353|528750538|FG006|Part 1|Entered follow-up phase|0|||
146612290|NCT00106353|528750532|FG000|Part 1|Adverse Event|0|||
146612291|NCT00106353|528750533|FG001|Part 1|Adverse Event|0|||
146612292|NCT00106353|528750534|FG002|Part 1|Adverse Event|0|||
146612293|NCT00106353|528750535|FG003|Part 1|Adverse Event|1|||
146612294|NCT00106353|528750536|FG004|Part 1|Adverse Event|0|||
146612295|NCT00106353|528750537|FG005|Part 1|Adverse Event|0|||
146612296|NCT00106353|528750538|FG006|Part 1|Adverse Event|0|||
146612297|NCT00106353|528750532|FG000|Part 2|Disease progression|0|||
146612298|NCT00106353|528750533|FG001|Part 2|Disease progression|0|||
146612299|NCT00106353|528750534|FG002|Part 2|Disease progression|0|||
146612300|NCT00106353|528750535|FG003|Part 2|Disease progression|0|||
146612301|NCT00106353|528750536|FG004|Part 2|Disease progression|8|||
146612302|NCT00106353|528750537|FG005|Part 2|Disease progression|14|||
146612303|NCT00106353|528750538|FG006|Part 2|Disease progression|13|||
146612304|NCT00106353|528750532|FG000|Part 2|Death|0|||
146612305|NCT00106353|528750533|FG001|Part 2|Death|0|||
146773490|NCT02988817|529341092|FG016|Overall Study|Death|17|||
146612306|NCT00106353|528750534|FG002|Part 2|Death|0|||
146612307|NCT00106353|528750535|FG003|Part 2|Death|0|||
146612308|NCT00106353|528750536|FG004|Part 2|Death|3|||
146612309|NCT00106353|528750537|FG005|Part 2|Death|0|||
146612310|NCT00106353|528750538|FG006|Part 2|Death|1|||
146612311|NCT00106353|528750532|FG000|Part 2|Symptomatic deterioration|0|||
146612312|NCT00106353|528750533|FG001|Part 2|Symptomatic deterioration|0|||
146612313|NCT00106353|528750534|FG002|Part 2|Symptomatic deterioration|0|||
146612314|NCT00106353|528750535|FG003|Part 2|Symptomatic deterioration|0|||
146612315|NCT00106353|528750536|FG004|Part 2|Symptomatic deterioration|3|||
146612316|NCT00106353|528750537|FG005|Part 2|Symptomatic deterioration|0|||
146612317|NCT00106353|528750538|FG006|Part 2|Symptomatic deterioration|0|||
146612318|NCT00106353|528750532|FG000|Part 2|Adverse Event|0|||
146612319|NCT00106353|528750533|FG001|Part 2|Adverse Event|0|||
146612320|NCT00106353|528750534|FG002|Part 2|Adverse Event|0|||
146612321|NCT00106353|528750535|FG003|Part 2|Adverse Event|0|||
146612322|NCT00106353|528750536|FG004|Part 2|Adverse Event|0|||
146612323|NCT00106353|528750537|FG005|Part 2|Adverse Event|2|||
146612324|NCT00106353|528750538|FG006|Part 2|Adverse Event|1|||
146612325|NCT00106353|528750532|FG000|Part 2|Other|0|||
146612326|NCT00106353|528750533|FG001|Part 2|Other|0|||
146612327|NCT00106353|528750534|FG002|Part 2|Other|0|||
146612328|NCT00106353|528750535|FG003|Part 2|Other|0|||
146612329|NCT00106353|528750536|FG004|Part 2|Other|1|||
146612330|NCT00106353|528750537|FG005|Part 2|Other|1|||
146612331|NCT00106353|528750538|FG006|Part 2|Other|1|||
146612332|NCT00106353|528750532|FG000|Part 2|Withdrawal by Subject|0|||
146612333|NCT00106353|528750533|FG001|Part 2|Withdrawal by Subject|0|||
146612334|NCT00106353|528750534|FG002|Part 2|Withdrawal by Subject|0|||
146612335|NCT00106353|528750535|FG003|Part 2|Withdrawal by Subject|0|||
146612336|NCT00106353|528750536|FG004|Part 2|Withdrawal by Subject|1|||
146612337|NCT00106353|528750537|FG005|Part 2|Withdrawal by Subject|0|||
146612338|NCT00106353|528750538|FG006|Part 2|Withdrawal by Subject|0|||
146612339|NCT00106353|528750532|FG000|Part 2|Physician Decision|0|||
146612340|NCT00106353|528750533|FG001|Part 2|Physician Decision|0|||
146612341|NCT00106353|528750534|FG002|Part 2|Physician Decision|0|||
146612342|NCT00106353|528750535|FG003|Part 2|Physician Decision|0|||
146612343|NCT00106353|528750536|FG004|Part 2|Physician Decision|0|||
146612344|NCT00106353|528750537|FG005|Part 2|Physician Decision|1|||
146612345|NCT00106353|528750538|FG006|Part 2|Physician Decision|0|||
146612346|NCT03193736|528750539|FG000|Overall Study|Death|2|||
146612347|NCT03193736|528750539|FG000|Overall Study|Withdrawal by Subject|1|||
146612348|NCT03193736|528750539|FG000|Overall Study|Lost to Follow-up|1|||
146612349|NCT03193736|528750539|FG000|Overall Study|implant not received|1|||
146612350|NCT03369236|528750540|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
146612351|NCT03369236|528750541|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
146612352|NCT03369236|528750540|FG000|Open-label Extension Period|Lack of Efficacy|2|||
146612353|NCT03369236|528750541|FG001|Open-label Extension Period|Lack of Efficacy|1|||
146612354|NCT03369236|528750540|FG000|Open-label Extension Period|Adverse Event|0|||
146612355|NCT03369236|528750541|FG001|Open-label Extension Period|Adverse Event|1|||
146612356|NCT03369236|528750540|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
146612357|NCT03369236|528750541|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
146612358|NCT00423449|528750542|FG000|Overall Study|Clinical Adverse Event|1|||
146612359|NCT00423449|528750543|FG001|Overall Study|Clinical Adverse Event|0|||
146612360|NCT00423449|528750544|FG002|Overall Study|Clinical Adverse Event|1|||
146612361|NCT00423449|528750545|FG003|Overall Study|Clinical Adverse Event|8|||
146612362|NCT00423449|528750546|FG004|Overall Study|Clinical Adverse Event|2|||
146612363|NCT00423449|528750542|FG000|Overall Study|Death|1|||
146612364|NCT00423449|528750543|FG001|Overall Study|Death|0|||
146612365|NCT00423449|528750544|FG002|Overall Study|Death|2|||
146612366|NCT00423449|528750545|FG003|Overall Study|Death|1|||
146612367|NCT00423449|528750546|FG004|Overall Study|Death|1|||
146612368|NCT00423449|528750542|FG000|Overall Study|Progressive Disease|1|||
146612369|NCT00423449|528750543|FG001|Overall Study|Progressive Disease|3|||
146612370|NCT00423449|528750544|FG002|Overall Study|Progressive Disease|8|||
146612371|NCT00423449|528750545|FG003|Overall Study|Progressive Disease|11|||
146612372|NCT00423449|528750546|FG004|Overall Study|Progressive Disease|4|||
146612373|NCT00423449|528750542|FG000|Overall Study|Laboratory Adverse Event|0|||
146612374|NCT00423449|528750543|FG001|Overall Study|Laboratory Adverse Event|1|||
146612375|NCT00423449|528750544|FG002|Overall Study|Laboratory Adverse Event|2|||
146612376|NCT00423449|528750545|FG003|Overall Study|Laboratory Adverse Event|0|||
146612377|NCT00423449|528750546|FG004|Overall Study|Laboratory Adverse Event|0|||
146612378|NCT00423449|528750542|FG000|Overall Study|Other|0|||
146612379|NCT00423449|528750543|FG001|Overall Study|Other|0|||
146612380|NCT00423449|528750544|FG002|Overall Study|Other|0|||
146612381|NCT00423449|528750545|FG003|Overall Study|Other|1|||
146612382|NCT00423449|528750546|FG004|Overall Study|Other|0|||
146612383|NCT00423449|528750542|FG000|Overall Study|Protocol Violation|0|||
146612384|NCT00423449|528750543|FG001|Overall Study|Protocol Violation|0|||
146612385|NCT00423449|528750544|FG002|Overall Study|Protocol Violation|2|||
146612386|NCT00423449|528750545|FG003|Overall Study|Protocol Violation|1|||
146612387|NCT00423449|528750546|FG004|Overall Study|Protocol Violation|0|||
146612388|NCT01153724|528750547|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146612389|NCT01153724|528750547|FG000|Treatment Period 2|Adverse Event|1|||
146612390|NCT01153724|528750547|FG000|Treatment Period 2|Other reason not defined above|1|||
146612391|NCT00367835|528750552|FG000|Overall Study|Adverse Event|14|||
146612392|NCT00367835|528750553|FG001|Overall Study|Adverse Event|1|||
146612393|NCT00367835|528750552|FG000|Overall Study|Protocol Violation|1|||
146612394|NCT00367835|528750553|FG001|Overall Study|Protocol Violation|7|||
146612395|NCT00367835|528750552|FG000|Overall Study|Withdrawal by Subject|7|||
146612396|NCT00367835|528750553|FG001|Overall Study|Withdrawal by Subject|6|||
146612397|NCT00367835|528750552|FG000|Overall Study|Lost to Follow-up|1|||
146612398|NCT00367835|528750553|FG001|Overall Study|Lost to Follow-up|4|||
146612399|NCT00367835|528750552|FG000|Overall Study|Lack of Efficacy|3|||
146612400|NCT00367835|528750553|FG001|Overall Study|Lack of Efficacy|12|||
146612401|NCT00367835|528750552|FG000|Overall Study|Subject in juvenile detention center|1|||
146612402|NCT00367835|528750553|FG001|Overall Study|Subject in juvenile detention center|0|||
146612403|NCT00367835|528750552|FG000|Overall Study|refused blood collection|1|||
146612404|NCT00367835|528750553|FG001|Overall Study|refused blood collection|0|||
146612405|NCT00367835|528750552|FG000|Overall Study|Did not respond to calls|1|||
146612406|NCT00367835|528750553|FG001|Overall Study|Did not respond to calls|0|||
146612407|NCT00367835|528750552|FG000|Overall Study|History of lead poisoning|0|||
146612408|NCT00367835|528750553|FG001|Overall Study|History of lead poisoning|1|||
146612409|NCT02697435|528750554|FG000|Overall Study|Withdrawal by Subject|1|||
146612410|NCT02697435|528750555|FG001|Overall Study|Withdrawal by Subject|0|||
146612411|NCT02697435|528750554|FG000|Overall Study|Physician Decision|0|||
146612412|NCT02697435|528750555|FG001|Overall Study|Physician Decision|4|||
146612413|NCT00445770|528750560|FG000|Overall Study|Adverse Event|9|||
146612414|NCT00445770|528750561|FG001|Overall Study|Adverse Event|15|||
146612415|NCT00445770|528750562|FG002|Overall Study|Adverse Event|19|||
146612416|NCT00445770|528750560|FG000|Overall Study|Lack of Efficacy|38|||
146612417|NCT00445770|528750561|FG001|Overall Study|Lack of Efficacy|13|||
146612418|NCT00445770|528750562|FG002|Overall Study|Lack of Efficacy|6|||
146612419|NCT00445770|528750560|FG000|Overall Study|Lost to Follow-up|0|||
146612420|NCT00445770|528750561|FG001|Overall Study|Lost to Follow-up|2|||
146612421|NCT00445770|528750562|FG002|Overall Study|Lost to Follow-up|0|||
146612422|NCT00445770|528750560|FG000|Overall Study|Other|6|||
146612423|NCT00445770|528750561|FG001|Overall Study|Other|5|||
146612424|NCT00445770|528750562|FG002|Overall Study|Other|6|||
146612425|NCT00811174|528750564|FG000|Overall Study|Protocol Violation|2|||
146612426|NCT00811174|528750564|FG000|Overall Study|Sponsors Decision|1|||
146612427|NCT00999544|528752056|FG000|Overall Study|Withdrawal by Subject|1|||
146612428|NCT01392547|528752057|FG000|Overall Study|Adverse Event|2|||
146612429|NCT01392547|528752057|FG000|Overall Study|Non-compliance|2|||
146612430|NCT01392547|528752057|FG000|Overall Study|Withdrawal criteria|3|||
146612431|NCT01392547|528752057|FG000|Overall Study|Unclassified|1|||
146612432|NCT02936635|528752059|FG000|Overall Study|Adverse Event|43|||
146612433|NCT02936635|528752060|FG001|Overall Study|Adverse Event|25|||
146612434|NCT02936635|528752059|FG000|Overall Study|Progressive Disease|10|||
146612435|NCT02936635|528752060|FG001|Overall Study|Progressive Disease|18|||
146612436|NCT02936635|528752059|FG000|Overall Study|Sponsor Discretion|10|||
146658259|NCT03739840|528927200|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
146658260|NCT03739840|528927201|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
146658261|NCT03739840|528927202|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
146658262|NCT03739840|528927199|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
146658263|NCT03739840|528927200|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
146658264|NCT03739840|528927201|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
146658265|NCT03739840|528927202|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
146658266|NCT03739840|528927199|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
146612437|NCT02936635|528752060|FG001|Overall Study|Sponsor Discretion|16|||
146612438|NCT02936635|528752059|FG000|Overall Study|Death|9|||
146612439|NCT02936635|528752060|FG001|Overall Study|Death|15|||
146612440|NCT02936635|528752059|FG000|Overall Study|Withdrawal by Subject|8|||
146658267|NCT03739840|528927200|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
146658268|NCT03739840|528927201|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
146658269|NCT03739840|528927202|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
146658270|NCT03739840|528927199|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
146658271|NCT03739840|528927200|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
146658272|NCT03739840|528927201|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
146658273|NCT03739840|528927202|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
146658274|NCT03739840|528927199|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
146658275|NCT03739840|528927200|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
146658276|NCT03739840|528927201|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
146658277|NCT03739840|528927202|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
146658278|NCT03739840|528927199|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
146658279|NCT03739840|528927200|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
146658280|NCT03739840|528927201|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
146658281|NCT03739840|528927202|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
146773491|NCT02988817|529341093|FG017|Overall Study|Death|38|||
146658282|NCT00116168|528927203|FG000|Overall Study|Lost to Follow-up|6|||
146658283|NCT00116168|528927204|FG001|Overall Study|Lost to Follow-up|5|||
146773492|NCT02988817|529341094|FG018|Overall Study|Death|14|||
146612441|NCT02936635|528752060|FG001|Overall Study|Withdrawal by Subject|15|||
146612442|NCT02936635|528752059|FG000|Overall Study|Physician Decision|2|||
146612443|NCT02936635|528752060|FG001|Overall Study|Physician Decision|9|||
146612444|NCT02936635|528752059|FG000|Overall Study|Lost to Follow-up|1|||
146612445|NCT02936635|528752060|FG001|Overall Study|Lost to Follow-up|2|||
146612446|NCT02936635|528752059|FG000|Overall Study|Protocol Violation|1|||
146612447|NCT02936635|528752060|FG001|Overall Study|Protocol Violation|0|||
146612448|NCT02936635|528752059|FG000|Overall Study|Lack of effect/Entry into other study|31|||
146612449|NCT02936635|528752060|FG001|Overall Study|Lack of effect/Entry into other study|65|||
146612450|NCT02407223|528752061|FG000|Overall Study|Adverse Event|1|||
146612451|NCT02407223|528752062|FG001|Overall Study|Adverse Event|0|||
146612452|NCT02407223|528752063|FG002|Overall Study|Adverse Event|1|||
146612453|NCT02407223|528752061|FG000|Overall Study|Lack of Efficacy|6|||
146612454|NCT02407223|528752062|FG001|Overall Study|Lack of Efficacy|6|||
146612455|NCT02407223|528752063|FG002|Overall Study|Lack of Efficacy|4|||
146612456|NCT02407223|528752061|FG000|Overall Study|Lost to Follow-up|1|||
146612457|NCT02407223|528752062|FG001|Overall Study|Lost to Follow-up|0|||
146612458|NCT02407223|528752063|FG002|Overall Study|Lost to Follow-up|2|||
146612459|NCT02407223|528752061|FG000|Overall Study|Withdrawal by Subject|2|||
146612460|NCT02407223|528752062|FG001|Overall Study|Withdrawal by Subject|4|||
146612461|NCT02407223|528752063|FG002|Overall Study|Withdrawal by Subject|4|||
146612462|NCT02407223|528752061|FG000|Overall Study|Study Terminated by Sponsor|77|||
146612463|NCT02407223|528752062|FG001|Overall Study|Study Terminated by Sponsor|80|||
146612464|NCT02407223|528752063|FG002|Overall Study|Study Terminated by Sponsor|86|||
146924843|NCT00243230|529884817|FG003|Open Label Period|Withdrawal by Subject|2|||
146612465|NCT02407223|528752061|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
146612466|NCT02407223|528752062|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
146612467|NCT02407223|528752063|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
146612468|NCT02407223|528752061|FG000|Overall Study|Other|29|||
146612469|NCT02407223|528752062|FG001|Overall Study|Other|27|||
146612470|NCT02407223|528752063|FG002|Overall Study|Other|25|||
146612471|NCT00447226|528752064|FG000|12-Week Open-label Phase|Adverse Event|0|||
146612472|NCT00447226|528752065|FG001|12-Week Open-label Phase|Adverse Event|3|||
146612473|NCT00447226|528752064|FG000|12-Week Open-label Phase|Protocol Violation|0|||
146612474|NCT00447226|528752065|FG001|12-Week Open-label Phase|Protocol Violation|1|||
146612475|NCT00447226|528752064|FG000|12-Week Open-label Phase|Disease Progression|0|||
146612476|NCT00447226|528752065|FG001|12-Week Open-label Phase|Disease Progression|20|||
146612477|NCT00447226|528752064|FG000|12-Week Open-label Phase|Physician Decision|0|||
146612478|NCT00447226|528752065|FG001|12-Week Open-label Phase|Physician Decision|1|||
146612479|NCT00447226|528752064|FG000|Double-blind Phase|Disease Progression|4|||
146612480|NCT00447226|528752065|FG001|Double-blind Phase|Disease Progression|3|||
146612481|NCT00584012|528752073|FG000|Overall Study|Withdrawal by Subject|1|||
146612482|NCT04404556|528752074|FG000|Intervention|Withdrawal by Subject|15|||
146612483|NCT04404556|528752075|FG001|Intervention|Withdrawal by Subject|3|||
146612484|NCT04404556|528752074|FG000|Intervention|Did not complete all intervention sessions|2|||
146612485|NCT04404556|528752075|FG001|Intervention|Did not complete all intervention sessions|1|||
146612486|NCT04404556|528752074|FG000|Post-Intervention|Missing Data|1|||
146612487|NCT04404556|528752075|FG001|Post-Intervention|Missing Data|2|||
146612488|NCT04404556|528752074|FG000|Follow-up 1|Withdrawal by Subject|5|||
146612489|NCT04404556|528752075|FG001|Follow-up 1|Withdrawal by Subject|1|||
146612490|NCT04404556|528752074|FG000|Follow-up 1|Missing Data|4|||
146612491|NCT04404556|528752075|FG001|Follow-up 1|Missing Data|7|||
146612492|NCT04404556|528752074|FG000|Follow-up 2|Withdrawal by Subject|1|||
146612493|NCT04404556|528752075|FG001|Follow-up 2|Withdrawal by Subject|1|||
146612494|NCT04404556|528752074|FG000|Follow-up 2|Missing Data|6|||
146612495|NCT04404556|528752075|FG001|Follow-up 2|Missing Data|5|||
146612496|NCT00763386|528752077|FG000|Overall Study|Adverse Event|43|||
146612497|NCT00763386|528752078|FG001|Overall Study|Adverse Event|33|||
146612498|NCT00763386|528752077|FG000|Overall Study|Death|1|||
146612499|NCT00763386|528752078|FG001|Overall Study|Death|2|||
146612500|NCT00763386|528752077|FG000|Overall Study|Lost to Follow-up|3|||
146612501|NCT00763386|528752078|FG001|Overall Study|Lost to Follow-up|3|||
146612502|NCT00763386|528752077|FG000|Overall Study|Withdrawal by Subject|0|||
146612503|NCT00763386|528752078|FG001|Overall Study|Withdrawal by Subject|1|||
146612504|NCT00763386|528752077|FG000|Overall Study|CRF missing|0|||
146612505|NCT00763386|528752078|FG001|Overall Study|CRF missing|1|||
146612506|NCT00763386|528752077|FG000|Overall Study|Study Prosthesis Removed|1|||
146612507|NCT00763386|528752078|FG001|Overall Study|Study Prosthesis Removed|0|||
146612508|NCT01402817|528752079|FG000|Overall Study|Withdrawal by Subject|3|||
146612509|NCT01402817|528752079|FG000|Overall Study|Study Suspended by FDA|8|||
146612510|NCT00502671|528752080|FG000|Overall Study|Disease Progression|13|||
146612511|NCT00502671|528752080|FG000|Overall Study|Personal Reasons|22|||
146658284|NCT00116168|528927205|FG002|Overall Study|Lost to Follow-up|0|||
146612512|NCT00502671|528752080|FG000|Overall Study|Lost to Follow-up|7|||
146612513|NCT00502671|528752080|FG000|Overall Study|Protocol Violation|16|||
146612514|NCT00502671|528752080|FG000|Overall Study|Adverse Event|19|||
146612515|NCT00681629|528752081|FG000|Overall Study|Study termination|4|||
146612516|NCT00681629|528752082|FG001|Overall Study|Study termination|2|||
146612517|NCT00681629|528752081|FG000|Overall Study|Adverse Event|1|||
146612518|NCT00681629|528752082|FG001|Overall Study|Adverse Event|0|||
146612519|NCT01173601|528752084|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
146612520|NCT01173601|528752085|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146612521|NCT01173601|528752086|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146612522|NCT01173601|528752087|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146924844|NCT00243230|529884814|FG000|Open Label Period|Protocol Violation|0|||
146924845|NCT00243230|529884815|FG001|Open Label Period|Protocol Violation|0|||
146924846|NCT00243230|529884816|FG002|Open Label Period|Protocol Violation|0|||
146924847|NCT00243230|529884817|FG003|Open Label Period|Protocol Violation|2|||
146924848|NCT00243230|529884814|FG000|Open Label Period|Administrative Reason|0|||
146924849|NCT00243230|529884815|FG001|Open Label Period|Administrative Reason|0|||
146612523|NCT01173601|528752088|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146612524|NCT01173601|528752084|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
146612525|NCT01173601|528752085|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146612526|NCT01173601|528752086|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146612527|NCT01173601|528752087|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146612528|NCT01173601|528752088|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146612529|NCT01173601|528752084|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
146612530|NCT01173601|528752085|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146612531|NCT01173601|528752086|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146612532|NCT01173601|528752087|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146612533|NCT01173601|528752088|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146612534|NCT01173601|528752084|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
146612535|NCT01173601|528752085|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146612536|NCT01173601|528752086|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146612537|NCT01173601|528752087|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146612538|NCT01173601|528752088|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146612539|NCT01173601|528752084|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
146612540|NCT01173601|528752085|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146612541|NCT01173601|528752086|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146612542|NCT01173601|528752087|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146612543|NCT01173601|528752088|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146612544|NCT01173601|528752084|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
146612545|NCT01173601|528752085|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146612546|NCT01173601|528752086|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146612547|NCT01173601|528752087|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146612548|NCT01173601|528752088|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146612549|NCT01173601|528752084|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
146612550|NCT01173601|528752085|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146612551|NCT01173601|528752086|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146612552|NCT01173601|528752087|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146612553|NCT01173601|528752088|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146612554|NCT01173601|528752084|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
146612555|NCT01173601|528752085|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
146612556|NCT01173601|528752086|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
146612557|NCT01173601|528752087|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
146612558|NCT01173601|528752088|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
146612559|NCT01173601|528752084|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
146612560|NCT01173601|528752085|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
146612561|NCT01173601|528752086|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
146612562|NCT01173601|528752087|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
146612563|NCT01173601|528752088|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
146612564|NCT01173601|528752084|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
146612565|NCT01173601|528752085|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
146612566|NCT01173601|528752086|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
146612567|NCT01173601|528752087|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
146612568|NCT01173601|528752088|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
146612569|NCT01173601|528752084|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
146924850|NCT00243230|529884816|FG002|Open Label Period|Administrative Reason|0|||
146924851|NCT00243230|529884817|FG003|Open Label Period|Administrative Reason|63|||
146924852|NCT03599141|529884820|FG000|Overall Study|Lost to Follow-up|3|||
146612570|NCT01173601|528752085|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
146612571|NCT01173601|528752086|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
146612572|NCT01173601|528752087|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
146612573|NCT01173601|528752088|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
146612574|NCT01173601|528752084|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
146612575|NCT01173601|528752085|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
146612576|NCT01173601|528752086|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
146612577|NCT01173601|528752087|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
146924853|NCT03599141|529884821|FG001|Overall Study|Lost to Follow-up|1|||
146924854|NCT03136185|529884822|FG000|Overall Study|Adverse Event|0|||
146612578|NCT01173601|528752088|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
146612579|NCT01173601|528752084|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
146612580|NCT01173601|528752085|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
146612581|NCT01173601|528752086|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
146612582|NCT01173601|528752087|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
146612583|NCT01173601|528752088|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
146612584|NCT01173601|528752084|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
146612585|NCT01173601|528752085|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
146612586|NCT01173601|528752086|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
146612587|NCT01173601|528752087|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
146612588|NCT01173601|528752088|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
146612589|NCT02274792|528752089|FG000|Overall Study|Withdrawal by Subject|13|||
146612590|NCT02274792|528752089|FG000|Overall Study|Lost to Follow-up|8|||
146612591|NCT02274792|528752089|FG000|Overall Study|Protocol Specified Criteria|2|||
146612592|NCT02274792|528752089|FG000|Overall Study|Sponsor Decision|2|||
146612593|NCT01510158|528752090|FG000|Overall Study|Adverse Event|7|||
146612594|NCT01510158|528752091|FG001|Overall Study|Adverse Event|8|||
146612595|NCT01510158|528752092|FG002|Overall Study|Adverse Event|5|||
146612596|NCT01510158|528752090|FG000|Overall Study|Gout flare|1|||
146612597|NCT01510158|528752091|FG001|Overall Study|Gout flare|0|||
146612598|NCT01510158|528752092|FG002|Overall Study|Gout flare|0|||
146612599|NCT01510158|528752090|FG000|Overall Study|Protocol Violation|17|||
146612600|NCT01510158|528752091|FG001|Overall Study|Protocol Violation|16|||
146612601|NCT01510158|528752092|FG002|Overall Study|Protocol Violation|24|||
146612602|NCT01510158|528752090|FG000|Overall Study|Sponsor terminated study.|2|||
146612603|NCT01510158|528752091|FG001|Overall Study|Sponsor terminated study.|0|||
146612604|NCT01510158|528752092|FG002|Overall Study|Sponsor terminated study.|2|||
146612605|NCT01510158|528752090|FG000|Overall Study|Lost to Follow-up|13|||
146612606|NCT01510158|528752091|FG001|Overall Study|Lost to Follow-up|16|||
146612607|NCT01510158|528752092|FG002|Overall Study|Lost to Follow-up|9|||
146612608|NCT01510158|528752090|FG000|Overall Study|Withdrawal by Subject|10|||
146612609|NCT01510158|528752091|FG001|Overall Study|Withdrawal by Subject|13|||
146612610|NCT01510158|528752092|FG002|Overall Study|Withdrawal by Subject|10|||
146612611|NCT01510158|528752090|FG000|Overall Study|Death|1|||
146612612|NCT01510158|528752091|FG001|Overall Study|Death|0|||
146612613|NCT01510158|528752092|FG002|Overall Study|Death|0|||
146612614|NCT05258149|528752093|FG000|Period 1|Protocol Deviation|1|||
146612615|NCT05258149|528752094|FG001|Period 1|Protocol Deviation|0|||
146612616|NCT05258149|528752093|FG000|Period 1|Adverse Event|0|||
146612617|NCT05258149|528752094|FG001|Period 1|Adverse Event|1|||
146612618|NCT05258149|528752093|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
146612619|NCT05258149|528752094|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
146612620|NCT05258149|528752093|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
146612621|NCT05258149|528752094|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
146612622|NCT05258149|528752093|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
146612623|NCT05258149|528752094|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
146612624|NCT00832416|528752101|FG000|Overall Study|Lack of Efficacy|17|||
146612625|NCT00832416|528752102|FG001|Overall Study|Lack of Efficacy|15|||
146612626|NCT00832416|528752103|FG002|Overall Study|Lack of Efficacy|13|||
146612627|NCT00832416|528752104|FG003|Overall Study|Lack of Efficacy|52|||
146612628|NCT00832416|528752101|FG000|Overall Study|Withdrawal by Subject|5|||
146612629|NCT00832416|528752102|FG001|Overall Study|Withdrawal by Subject|7|||
146612630|NCT00832416|528752103|FG002|Overall Study|Withdrawal by Subject|2|||
146612631|NCT00832416|528752104|FG003|Overall Study|Withdrawal by Subject|10|||
146612632|NCT00832416|528752101|FG000|Overall Study|Physician Decision|2|||
146612633|NCT00832416|528752102|FG001|Overall Study|Physician Decision|12|||
146612634|NCT00832416|528752103|FG002|Overall Study|Physician Decision|5|||
146612635|NCT00832416|528752104|FG003|Overall Study|Physician Decision|10|||
146612636|NCT00832416|528752101|FG000|Overall Study|Administrative|0|||
146612637|NCT00832416|528752102|FG001|Overall Study|Administrative|0|||
146612638|NCT00832416|528752103|FG002|Overall Study|Administrative|0|||
146658285|NCT00116168|528927206|FG003|Overall Study|Lost to Follow-up|0|||
146658286|NCT01323946|528927207|FG000|Overall Study|Lost to Follow-up|0|||
146612639|NCT00832416|528752104|FG003|Overall Study|Administrative|1|||
146612640|NCT00832416|528752101|FG000|Overall Study|Adverse Event|21|||
146612641|NCT00832416|528752102|FG001|Overall Study|Adverse Event|19|||
146612642|NCT00832416|528752103|FG002|Overall Study|Adverse Event|41|||
146612643|NCT00832416|528752104|FG003|Overall Study|Adverse Event|10|||
146612644|NCT00832416|528752101|FG000|Overall Study|Death|1|||
146658287|NCT01323946|528927208|FG001|Overall Study|Lost to Follow-up|1|||
146658288|NCT01323946|528927209|FG002|Overall Study|Lost to Follow-up|0|||
146612645|NCT00832416|528752102|FG001|Overall Study|Death|0|||
146612646|NCT00832416|528752103|FG002|Overall Study|Death|0|||
146612647|NCT00832416|528752104|FG003|Overall Study|Death|0|||
146612648|NCT02114606|528752105|FG000|Overall Study|Unable to swallow Cytosponge|6|||
146612649|NCT05786508|528752115|FG000|Overall Study|Withdrawal by Subject|2|||
146612650|NCT05786508|528752116|FG001|Overall Study|Withdrawal by Subject|0|||
146612651|NCT04426318|528752117|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
146612652|NCT04426318|528752118|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
146612653|NCT02152761|528752121|FG000|Epoch: Treatment Epoch|Technical problems|0|||
146612654|NCT02152761|528752122|FG001|Epoch: Treatment Epoch|Technical problems|0|||
146612655|NCT02152761|528752123|FG002|Epoch: Treatment Epoch|Technical problems|0|||
146612656|NCT02152761|528752124|FG003|Epoch: Treatment Epoch|Technical problems|1|||
146612657|NCT02152761|528752121|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
146612658|NCT02152761|528752122|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
146612659|NCT02152761|528752123|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
146612660|NCT02152761|528752124|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
146612661|NCT02152761|528752121|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
146612662|NCT02152761|528752122|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
146612663|NCT02152761|528752123|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
146612664|NCT02152761|528752124|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
146612665|NCT02152761|528752121|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
146612666|NCT02152761|528752122|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
146612667|NCT02152761|528752123|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
146612668|NCT02152761|528752124|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
146612669|NCT02152761|528752121|FG000|Epoch: Treatment Epoch|Death|0|||
146612670|NCT02152761|528752122|FG001|Epoch: Treatment Epoch|Death|3|||
146612671|NCT02152761|528752123|FG002|Epoch: Treatment Epoch|Death|1|||
146612672|NCT02152761|528752124|FG003|Epoch: Treatment Epoch|Death|0|||
146612673|NCT02152761|528752121|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
146612674|NCT02152761|528752122|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
146612675|NCT02152761|528752123|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
146612676|NCT02152761|528752124|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
146612677|NCT02152761|528752121|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
146612678|NCT02152761|528752122|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
146612679|NCT02152761|528752123|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
146612680|NCT02152761|528752124|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
146612681|NCT02152761|528752121|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
146612682|NCT02152761|528752122|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
146612683|NCT02152761|528752123|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
146612684|NCT02152761|528752124|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
146612685|NCT02152761|528752121|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
146612686|NCT02152761|528752122|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
146612687|NCT02152761|528752123|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
146612688|NCT02152761|528752124|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
146612689|NCT02152761|528752121|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
146612690|NCT02152761|528752122|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
146612691|NCT02152761|528752123|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
146612692|NCT02152761|528752124|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
146612693|NCT01957202|528752125|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146612694|NCT01957202|528752126|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
146612695|NCT01957202|528752127|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146612696|NCT01957202|528752128|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146612697|NCT01957202|528752129|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146612698|NCT01957202|528752130|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146612699|NCT01957202|528752131|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146612700|NCT01957202|528752132|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146612701|NCT01957202|528752133|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146612702|NCT01957202|528752134|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146612703|NCT01957202|528752135|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146924855|NCT03136185|529884823|FG001|Overall Study|Adverse Event|1|||
146924856|NCT03136185|529884824|FG002|Overall Study|Adverse Event|3|||
146924857|NCT03136185|529884825|FG003|Overall Study|Adverse Event|1|||
146924858|NCT03136185|529884826|FG004|Overall Study|Adverse Event|2|||
146924859|NCT03136185|529884827|FG005|Overall Study|Adverse Event|2|||
146924860|NCT03136185|529884828|FG006|Overall Study|Adverse Event|5|||
146612704|NCT01957202|528752136|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146612705|NCT01957202|528752137|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146612706|NCT01957202|528752138|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146612707|NCT01957202|528752139|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146612708|NCT01957202|528752140|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146612709|NCT01957202|528752141|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
146612710|NCT01957202|528752142|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146612711|NCT01957202|528752125|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
146658289|NCT01323946|528927207|FG000|Overall Study|Parents refused the last blood draw|1|||
146658290|NCT01323946|528927208|FG001|Overall Study|Parents refused the last blood draw|0|||
146612712|NCT01957202|528752126|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
146612713|NCT01957202|528752127|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
146612714|NCT01957202|528752128|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
146612715|NCT01957202|528752129|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
146612716|NCT01957202|528752130|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
146612717|NCT01957202|528752131|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
146612718|NCT01957202|528752132|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
146612719|NCT01957202|528752133|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
146612720|NCT01957202|528752134|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
146612721|NCT01957202|528752135|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
146612722|NCT01957202|528752136|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
146612723|NCT01957202|528752137|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
146612724|NCT01957202|528752138|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
146612725|NCT01957202|528752139|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
146612726|NCT01957202|528752140|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
146612727|NCT01957202|528752141|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
146612728|NCT01957202|528752142|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
146612729|NCT01456169|528752143|FG000|Overall Study|Adverse Event|1|||
146612730|NCT01456169|528752144|FG001|Overall Study|Adverse Event|2|||
146612731|NCT01456169|528752145|FG002|Overall Study|Adverse Event|7|||
146612732|NCT01456169|528752143|FG000|Overall Study|Major Protocol Deviation|3|||
146612733|NCT01456169|528752144|FG001|Overall Study|Major Protocol Deviation|2|||
146612734|NCT01456169|528752145|FG002|Overall Study|Major Protocol Deviation|3|||
146612735|NCT01456169|528752143|FG000|Overall Study|Voluntary Withdrawal|3|||
146612736|NCT01456169|528752144|FG001|Overall Study|Voluntary Withdrawal|0|||
146612737|NCT01456169|528752145|FG002|Overall Study|Voluntary Withdrawal|2|||
146612738|NCT01456169|528752143|FG000|Overall Study|Lack of Efficacy|2|||
146612739|NCT01456169|528752144|FG001|Overall Study|Lack of Efficacy|0|||
146612740|NCT01456169|528752145|FG002|Overall Study|Lack of Efficacy|0|||
146612741|NCT01456169|528752143|FG000|Overall Study|Other|1|||
146612742|NCT01456169|528752144|FG001|Overall Study|Other|1|||
146612743|NCT01456169|528752145|FG002|Overall Study|Other|0|||
146612744|NCT02652156|528752146|FG000|Overall Study|Physician Decision|1|||
146612745|NCT02652156|528752147|FG001|Overall Study|Physician Decision|0|||
146612746|NCT02652156|528752148|FG002|Overall Study|Physician Decision|0|||
146612747|NCT00496080|528752149|FG000|Overall Study|Lost to Follow-up|9|||
146612748|NCT00496080|528752149|FG000|Overall Study|Surgical re-intervention|7|||
146612749|NCT00496080|528752149|FG000|Overall Study|Withdrawal by Subject|5|||
146612750|NCT00496080|528752149|FG000|Overall Study|Physician Decision|6|||
146612751|NCT00479336|528752154|FG000|Overall Study|Adverse Event|1|||
146612752|NCT00479336|528752155|FG001|Overall Study|Adverse Event|1|||
146612753|NCT00479336|528752156|FG002|Overall Study|Adverse Event|1|||
146612754|NCT00479336|528752157|FG003|Overall Study|Adverse Event|3|||
146612755|NCT00479336|528752154|FG000|Overall Study|Lack of Efficacy|1|||
146612756|NCT00479336|528752155|FG001|Overall Study|Lack of Efficacy|0|||
146612757|NCT00479336|528752156|FG002|Overall Study|Lack of Efficacy|0|||
146612758|NCT00479336|528752157|FG003|Overall Study|Lack of Efficacy|0|||
146612759|NCT00479336|528752154|FG000|Overall Study|Protocol Violation|0|||
146612760|NCT00479336|528752155|FG001|Overall Study|Protocol Violation|1|||
146612761|NCT00479336|528752156|FG002|Overall Study|Protocol Violation|0|||
146612762|NCT00479336|528752157|FG003|Overall Study|Protocol Violation|0|||
146612763|NCT00479336|528752154|FG000|Overall Study|Withdrawal by Subject|1|||
146612764|NCT00479336|528752155|FG001|Overall Study|Withdrawal by Subject|2|||
146612765|NCT00479336|528752156|FG002|Overall Study|Withdrawal by Subject|0|||
146612766|NCT00479336|528752157|FG003|Overall Study|Withdrawal by Subject|0|||
146612767|NCT00479336|528752154|FG000|Overall Study|Physician Decision|0|||
146612768|NCT00479336|528752155|FG001|Overall Study|Physician Decision|1|||
146612769|NCT00479336|528752156|FG002|Overall Study|Physician Decision|0|||
146612770|NCT00479336|528752157|FG003|Overall Study|Physician Decision|2|||
146612771|NCT00479336|528752154|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
146612772|NCT00479336|528752155|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
146612773|NCT00479336|528752156|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
146612774|NCT00479336|528752157|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
146612775|NCT03066193|528752158|FG000|Overall Study|Withdrawal by Subject|1|||
146612776|NCT01397461|528752159|FG000|Overall Study|Withdrawal by Subject|2|||
146612777|NCT01397461|528752160|FG001|Overall Study|Withdrawal by Subject|1|||
146612778|NCT01397461|528752161|FG002|Overall Study|Withdrawal by Subject|0|||
146924861|NCT03136185|529884829|FG007|Overall Study|Adverse Event|1|||
146924862|NCT03136185|529884830|FG008|Overall Study|Adverse Event|1|||
146612779|NCT01397461|528752159|FG000|Overall Study|Lost to Follow-up|0|||
146612780|NCT01397461|528752160|FG001|Overall Study|Lost to Follow-up|2|||
146612781|NCT01397461|528752161|FG002|Overall Study|Lost to Follow-up|1|||
146612782|NCT01397461|528752159|FG000|Overall Study|Lack of Efficacy|0|||
146612783|NCT01397461|528752160|FG001|Overall Study|Lack of Efficacy|3|||
146612784|NCT01397461|528752161|FG002|Overall Study|Lack of Efficacy|0|||
146612785|NCT01397461|528752159|FG000|Overall Study|Not treated|0|||
146612786|NCT01397461|528752160|FG001|Overall Study|Not treated|0|||
146612787|NCT01397461|528752161|FG002|Overall Study|Not treated|1|||
146612788|NCT05729568|528752162|FG000|Overall Study|Still on Study|52|||
146612789|NCT05729568|528752163|FG001|Overall Study|Still on Study|26|||
146612790|NCT05729568|528752162|FG000|Overall Study|Randomized but Never Treated|3|||
146612791|NCT05729568|528752163|FG001|Overall Study|Randomized but Never Treated|0|||
146612792|NCT05729568|528752162|FG000|Overall Study|Adverse Event|0|||
146612793|NCT05729568|528752163|FG001|Overall Study|Adverse Event|1|||
146612794|NCT05729568|528752162|FG000|Overall Study|Investigator's Discretion|1|||
146612795|NCT05729568|528752163|FG001|Overall Study|Investigator's Discretion|0|||
146612796|NCT04181762|528752164|FG000|Overall Study|Adverse Event|1|||
146612797|NCT04181762|528752165|FG001|Overall Study|Adverse Event|3|||
146612798|NCT04181762|528752164|FG000|Overall Study|Lost to Follow-up|1|||
146612799|NCT04181762|528752165|FG001|Overall Study|Lost to Follow-up|1|||
146612800|NCT04181762|528752164|FG000|Overall Study|Physician Decision|1|||
146612801|NCT04181762|528752165|FG001|Overall Study|Physician Decision|3|||
146612802|NCT04181762|528752164|FG000|Overall Study|Pregnancy|0|||
146612803|NCT04181762|528752165|FG001|Overall Study|Pregnancy|1|||
146612804|NCT04181762|528752164|FG000|Overall Study|Lack of Efficacy|2|||
146612805|NCT04181762|528752165|FG001|Overall Study|Lack of Efficacy|2|||
146612806|NCT04181762|528752164|FG000|Overall Study|Study terminated by sponsor|95|||
146612807|NCT04181762|528752165|FG001|Overall Study|Study terminated by sponsor|97|||
146612808|NCT04181762|528752164|FG000|Overall Study|Subject decision|11|||
146612809|NCT04181762|528752165|FG001|Overall Study|Subject decision|4|||
146612810|NCT04181762|528752164|FG000|Overall Study|Death|1|||
146612811|NCT04181762|528752165|FG001|Overall Study|Death|1|||
146612812|NCT04181762|528752164|FG000|Overall Study|Protocol deviation|1|||
146612813|NCT04181762|528752165|FG001|Overall Study|Protocol deviation|0|||
146612814|NCT04181762|528752164|FG000|Overall Study|Withdrawal of informed consent|1|||
146612815|NCT04181762|528752165|FG001|Overall Study|Withdrawal of informed consent|3|||
146612816|NCT01514201|528752175|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
146612817|NCT01514201|528752176|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
146612818|NCT01514201|528752177|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
146612819|NCT01514201|528752178|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
146612820|NCT01514201|528752175|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
146612821|NCT01514201|528752176|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
146612822|NCT01514201|528752177|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
146612823|NCT01514201|528752178|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
146612824|NCT01514201|528752175|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
146612825|NCT01514201|528752176|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
146612826|NCT01514201|528752177|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
146612827|NCT01514201|528752178|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
146612828|NCT01514201|528752175|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
146612829|NCT01514201|528752176|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
146612830|NCT01514201|528752177|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
146612831|NCT01514201|528752178|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
146612832|NCT01514201|528752175|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
146612833|NCT01514201|528752176|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
146612834|NCT01514201|528752177|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
146658291|NCT01323946|528927209|FG002|Overall Study|Parents refused the last blood draw|0|||
146658292|NCT01323946|528927207|FG000|Overall Study|Withdrawal by Subject|2|||
146658293|NCT01323946|528927208|FG001|Overall Study|Withdrawal by Subject|2|||
146658294|NCT01323946|528927209|FG002|Overall Study|Withdrawal by Subject|0|||
146658295|NCT02962765|528927212|FG000|Overall Study|Protocol Violation|9|||
146658296|NCT02962765|528927212|FG000|Overall Study|Withdrawal by Subject|3|||
146658297|NCT02962765|528927212|FG000|Overall Study|Lost to Follow-up|1|||
146658298|NCT02962765|528927212|FG000|Overall Study|Death|1|||
146658299|NCT02962765|528927212|FG000|Overall Study|Limited access to study medication|3|||
146773493|NCT02988817|529341095|FG019|Overall Study|Death|16|||
146773494|NCT02988817|529341076|FG000|Overall Study|Other|0|||
146773495|NCT02988817|529341077|FG001|Overall Study|Other|0|||
146773496|NCT02988817|529341078|FG002|Overall Study|Other|0|||
146773497|NCT02988817|529341079|FG003|Overall Study|Other|1|||
146924863|NCT03136185|529884822|FG000|Overall Study|Death|0|||
146658300|NCT00750880|528927217|FG000|Overall Study|Adverse Event|76|||
146658301|NCT00750880|528927217|FG000|Overall Study|Death|4|||
146658302|NCT00750880|528927217|FG000|Overall Study|Lack of Efficacy|46|||
146658303|NCT00750880|528927217|FG000|Overall Study|Lost to Follow-up|10|||
146924864|NCT03136185|529884823|FG001|Overall Study|Death|0|||
146924865|NCT03136185|529884824|FG002|Overall Study|Death|0|||
146612835|NCT01514201|528752178|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
146612836|NCT01514201|528752175|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
146773498|NCT02988817|529341080|FG004|Overall Study|Other|1|||
146924866|NCT03136185|529884825|FG003|Overall Study|Death|1|||
146658304|NCT00750880|528927217|FG000|Overall Study|Protocol Violation|15|||
146658305|NCT00750880|528927217|FG000|Overall Study|Withdrawal by Subject|33|||
146773499|NCT02988817|529341081|FG005|Overall Study|Other|0|||
146924867|NCT03136185|529884826|FG004|Overall Study|Death|1|||
146773500|NCT02988817|529341082|FG006|Overall Study|Other|0|||
146773501|NCT02988817|529341083|FG007|Overall Study|Other|0|||
146612837|NCT01514201|528752176|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
146612838|NCT01514201|528752177|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
146612839|NCT01514201|528752178|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
146612840|NCT01514201|528752175|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
146612841|NCT01514201|528752176|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
146612842|NCT01514201|528752177|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
146612843|NCT01514201|528752178|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
146612844|NCT01514201|528752175|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
146612845|NCT01514201|528752176|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
146612846|NCT01514201|528752177|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
146612847|NCT01514201|528752178|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
146612848|NCT01514201|528752175|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
146612849|NCT01514201|528752176|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
146612850|NCT01514201|528752177|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
146612851|NCT01514201|528752178|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
146612852|NCT01514201|528752175|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
146612853|NCT01514201|528752176|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
146612854|NCT01514201|528752177|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
146612855|NCT01514201|528752178|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
146612856|NCT01514201|528752175|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
146612857|NCT01514201|528752176|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
146612858|NCT01514201|528752177|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
146612859|NCT01514201|528752178|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
146612860|NCT01514201|528752175|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
146612861|NCT01514201|528752176|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
146612862|NCT01514201|528752177|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
146612863|NCT01514201|528752178|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
146612864|NCT05888181|528752180|FG000|Overall Study|Lost to Follow-up|1|||
146612865|NCT05888181|528752181|FG001|Overall Study|Lost to Follow-up|1|||
146612866|NCT05888181|528752182|FG002|Overall Study|Lost to Follow-up|0|||
146612867|NCT00637416|528752184|FG000|Overall Study|Lost to Follow-up|1|||
146612868|NCT00637416|528752185|FG001|Overall Study|Lost to Follow-up|1|||
146612869|NCT00637416|528752184|FG000|Overall Study|Unable to take study drug|0|||
146612870|NCT00637416|528752185|FG001|Overall Study|Unable to take study drug|1|||
146612871|NCT02534909|528752196|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
146612872|NCT01625000|528752197|FG000|Overall Study|Physician Decision|15|||
146612873|NCT01625000|528752198|FG001|Overall Study|Physician Decision|7|||
146612874|NCT01625000|528752199|FG002|Overall Study|Physician Decision|7|||
146612875|NCT01625000|528752200|FG003|Overall Study|Physician Decision|2|||
146612876|NCT01625000|528752201|FG004|Overall Study|Physician Decision|15|||
146612877|NCT01625000|528752197|FG000|Overall Study|Protocol Violation|3|||
146612878|NCT01625000|528752198|FG001|Overall Study|Protocol Violation|10|||
146612879|NCT01625000|528752199|FG002|Overall Study|Protocol Violation|4|||
146773502|NCT02988817|529341084|FG008|Overall Study|Other|0|||
146773503|NCT02988817|529341085|FG009|Overall Study|Other|0|||
146773504|NCT02988817|529341086|FG010|Overall Study|Other|0|||
146924868|NCT03136185|529884827|FG005|Overall Study|Death|0|||
146924869|NCT03136185|529884828|FG006|Overall Study|Death|1|||
146924870|NCT03136185|529884829|FG007|Overall Study|Death|0|||
146924871|NCT03136185|529884830|FG008|Overall Study|Death|0|||
146924872|NCT03136185|529884822|FG000|Overall Study|Physician Decision|3|||
146924873|NCT03136185|529884823|FG001|Overall Study|Physician Decision|1|||
146924874|NCT03136185|529884824|FG002|Overall Study|Physician Decision|1|||
146924875|NCT03136185|529884825|FG003|Overall Study|Physician Decision|2|||
146924876|NCT03136185|529884826|FG004|Overall Study|Physician Decision|1|||
146924877|NCT03136185|529884827|FG005|Overall Study|Physician Decision|2|||
146924878|NCT03136185|529884828|FG006|Overall Study|Physician Decision|1|||
146924879|NCT03136185|529884829|FG007|Overall Study|Physician Decision|0|||
146924880|NCT03136185|529884830|FG008|Overall Study|Physician Decision|1|||
146924881|NCT03136185|529884822|FG000|Overall Study|Protocol Defined Disease Progression|0|||
146924882|NCT03136185|529884823|FG001|Overall Study|Protocol Defined Disease Progression|0|||
146612880|NCT01625000|528752200|FG003|Overall Study|Protocol Violation|1|||
146612881|NCT01625000|528752201|FG004|Overall Study|Protocol Violation|2|||
146612882|NCT01625000|528752197|FG000|Overall Study|Withdrawal by Subject|19|||
146612883|NCT01625000|528752198|FG001|Overall Study|Withdrawal by Subject|16|||
146612884|NCT01625000|528752199|FG002|Overall Study|Withdrawal by Subject|11|||
146773505|NCT02988817|529341087|FG011|Overall Study|Other|0|||
146773506|NCT02988817|529341088|FG012|Overall Study|Other|0|||
146773507|NCT02988817|529341089|FG013|Overall Study|Other|0|||
146773508|NCT02988817|529341090|FG014|Overall Study|Other|0|||
146924883|NCT03136185|529884824|FG002|Overall Study|Protocol Defined Disease Progression|1|||
146924884|NCT03136185|529884825|FG003|Overall Study|Protocol Defined Disease Progression|0|||
146612885|NCT01625000|528752200|FG003|Overall Study|Withdrawal by Subject|9|||
146612886|NCT01625000|528752201|FG004|Overall Study|Withdrawal by Subject|17|||
146612887|NCT01625000|528752197|FG000|Overall Study|Adverse Event (including Death)|15|||
146612888|NCT01625000|528752198|FG001|Overall Study|Adverse Event (including Death)|19|||
146612889|NCT01625000|528752199|FG002|Overall Study|Adverse Event (including Death)|11|||
146612890|NCT01625000|528752200|FG003|Overall Study|Adverse Event (including Death)|7|||
146612891|NCT01625000|528752201|FG004|Overall Study|Adverse Event (including Death)|21|||
146612892|NCT00566852|528752202|FG000|Overall Study|Protocol Violation|22|||
146612893|NCT00566852|528752203|FG001|Overall Study|Protocol Violation|24|||
146612894|NCT00566852|528752202|FG000|Overall Study|Death|95|||
146612895|NCT00566852|528752203|FG001|Overall Study|Death|78|||
146612896|NCT00566852|528752202|FG000|Overall Study|Withdrawal by Subject|30|||
146612897|NCT00566852|528752203|FG001|Overall Study|Withdrawal by Subject|25|||
146612898|NCT00566852|528752202|FG000|Overall Study|Patient refusal|37|||
146612899|NCT00566852|528752203|FG001|Overall Study|Patient refusal|37|||
146612900|NCT00566852|528752202|FG000|Overall Study|Not tested due to disability|6|||
146612901|NCT00566852|528752203|FG001|Overall Study|Not tested due to disability|12|||
146612902|NCT00566852|528752202|FG000|Overall Study|Missing reason not specified|1|||
146612903|NCT00566852|528752203|FG001|Overall Study|Missing reason not specified|2|||
146612904|NCT00566852|528752202|FG000|Overall Study|Missing reason not reported|16|||
146612905|NCT00566852|528752203|FG001|Overall Study|Missing reason not reported|20|||
146612906|NCT01147055|528752204|FG000|First Intervention Period|Lost to Follow-up|1|||
146612907|NCT01147055|528752205|FG001|First Intervention Period|Lost to Follow-up|0|||
146612908|NCT00132808|528752206|FG000|Stratum I|Adverse Event|2|||
146612909|NCT00132808|528752207|FG001|Stratum I|Adverse Event|1|||
146612910|NCT00132808|528752208|FG002|Stratum I|Adverse Event|0|||
146612911|NCT00132808|528752206|FG000|Stratum I|Lost to Follow-up|3|||
146612912|NCT00132808|528752207|FG001|Stratum I|Lost to Follow-up|4|||
146612913|NCT00132808|528752208|FG002|Stratum I|Lost to Follow-up|1|||
146612914|NCT00132808|528752206|FG000|Stratum I|Withdrawal by Subject|4|||
146612915|NCT00132808|528752207|FG001|Stratum I|Withdrawal by Subject|7|||
146612916|NCT00132808|528752208|FG002|Stratum I|Withdrawal by Subject|3|||
146612917|NCT00132808|528752206|FG000|Stratum I|Abnormal test procedure result (s)|0|||
146612918|NCT00132808|528752207|FG001|Stratum I|Abnormal test procedure result (s)|0|||
146612919|NCT00132808|528752208|FG002|Stratum I|Abnormal test procedure result (s)|1|||
146612920|NCT00132808|528752206|FG000|Stratum II|Adverse Event|1|||
146612921|NCT00132808|528752207|FG001|Stratum II|Adverse Event|2|||
146612922|NCT00132808|528752208|FG002|Stratum II|Adverse Event|1|||
146612923|NCT00132808|528752206|FG000|Stratum II|Death|1|||
146612924|NCT00132808|528752207|FG001|Stratum II|Death|0|||
146612925|NCT00132808|528752208|FG002|Stratum II|Death|0|||
146612926|NCT00132808|528752206|FG000|Stratum II|Lost to Follow-up|2|||
146612927|NCT00132808|528752207|FG001|Stratum II|Lost to Follow-up|2|||
146924885|NCT03136185|529884826|FG004|Overall Study|Protocol Defined Disease Progression|0|||
146924886|NCT03136185|529884827|FG005|Overall Study|Protocol Defined Disease Progression|1|||
146924887|NCT03136185|529884828|FG006|Overall Study|Protocol Defined Disease Progression|0|||
146924888|NCT03136185|529884829|FG007|Overall Study|Protocol Defined Disease Progression|1|||
146924889|NCT03136185|529884830|FG008|Overall Study|Protocol Defined Disease Progression|1|||
146924890|NCT03136185|529884822|FG000|Overall Study|Withdrawal by Subject|1|||
146924891|NCT03136185|529884823|FG001|Overall Study|Withdrawal by Subject|0|||
146924892|NCT03136185|529884824|FG002|Overall Study|Withdrawal by Subject|1|||
146924893|NCT03136185|529884825|FG003|Overall Study|Withdrawal by Subject|1|||
146924894|NCT03136185|529884826|FG004|Overall Study|Withdrawal by Subject|1|||
146924895|NCT03136185|529884827|FG005|Overall Study|Withdrawal by Subject|1|||
146924896|NCT03136185|529884828|FG006|Overall Study|Withdrawal by Subject|2|||
146924897|NCT03136185|529884829|FG007|Overall Study|Withdrawal by Subject|3|||
146924898|NCT03136185|529884830|FG008|Overall Study|Withdrawal by Subject|3|||
146924899|NCT03136185|529884822|FG000|Overall Study|Not Reported|4|||
146924900|NCT03136185|529884823|FG001|Overall Study|Not Reported|1|||
146924901|NCT03136185|529884824|FG002|Overall Study|Not Reported|0|||
146924902|NCT03136185|529884825|FG003|Overall Study|Not Reported|1|||
146612928|NCT00132808|528752208|FG002|Stratum II|Lost to Follow-up|1|||
146612929|NCT00132808|528752206|FG000|Stratum II|Protocol Violation|0|||
146612930|NCT00132808|528752207|FG001|Stratum II|Protocol Violation|2|||
146612931|NCT00132808|528752208|FG002|Stratum II|Protocol Violation|1|||
146612932|NCT00132808|528752206|FG000|Stratum II|Withdrawal by Subject|4|||
146612933|NCT00132808|528752207|FG001|Stratum II|Withdrawal by Subject|9|||
146612934|NCT00132808|528752208|FG002|Stratum II|Withdrawal by Subject|6|||
146612935|NCT04137731|528752211|FG000|Overall Study|Surgery Cancellation|1|||
146612936|NCT04137731|528752212|FG001|Overall Study|Surgery Cancellation|2|||
146612937|NCT04137731|528752211|FG000|Overall Study|Withdrawal by Subject|2|||
146612938|NCT04137731|528752212|FG001|Overall Study|Withdrawal by Subject|0|||
146612939|NCT04137731|528752211|FG000|Overall Study|Protocol Violation|0|||
146612940|NCT04137731|528752212|FG001|Overall Study|Protocol Violation|1|||
146612941|NCT00362648|528752213|FG000|Overall Study|Adverse Event|12|||
146612942|NCT00362648|528752214|FG001|Overall Study|Adverse Event|21|||
146612943|NCT00362648|528752215|FG002|Overall Study|Adverse Event|1|||
146612944|NCT00362648|528752216|FG003|Overall Study|Adverse Event|0|||
146612945|NCT00362648|528752213|FG000|Overall Study|Lost to Follow-up|62|||
146612946|NCT00362648|528752214|FG001|Overall Study|Lost to Follow-up|69|||
146612947|NCT00362648|528752215|FG002|Overall Study|Lost to Follow-up|4|||
146612948|NCT00362648|528752216|FG003|Overall Study|Lost to Follow-up|3|||
146612949|NCT00362648|528752213|FG000|Overall Study|Protocol Violation|4|||
146612950|NCT00362648|528752214|FG001|Overall Study|Protocol Violation|2|||
146612951|NCT00362648|528752215|FG002|Overall Study|Protocol Violation|2|||
146612952|NCT00362648|528752216|FG003|Overall Study|Protocol Violation|2|||
146612953|NCT00362648|528752213|FG000|Overall Study|Withdrawal by Subject|48|||
146612954|NCT00362648|528752214|FG001|Overall Study|Withdrawal by Subject|42|||
146612955|NCT00362648|528752215|FG002|Overall Study|Withdrawal by Subject|2|||
146612956|NCT00362648|528752216|FG003|Overall Study|Withdrawal by Subject|6|||
146612957|NCT02204072|528752217|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
146612958|NCT02204072|528752218|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
146612959|NCT02204072|528752219|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
146612960|NCT02204072|528752220|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
146612961|NCT02204072|528752221|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
146612962|NCT02204072|528752217|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
146612963|NCT02204072|528752218|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
146612964|NCT02204072|528752219|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
146612965|NCT02204072|528752220|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
146612966|NCT02204072|528752221|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
146612967|NCT02204072|528752217|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
146612968|NCT02204072|528752218|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
146612969|NCT02204072|528752219|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
146612970|NCT02204072|528752220|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
146612971|NCT02204072|528752221|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
146612972|NCT02204072|528752217|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
146612973|NCT02204072|528752218|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
146612974|NCT02204072|528752219|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
146612975|NCT02204072|528752220|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
146612976|NCT02204072|528752221|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
146612977|NCT03983304|528752222|FG000|Overall Study|Withdrawal by Subject|5|||
146612978|NCT03983304|528752222|FG000|Overall Study|Lost to Follow-up|2|||
146612979|NCT01587040|528752228|FG000|Overall Study|Protocol Violation|0|||
146612980|NCT01587040|528752229|FG001|Overall Study|Protocol Violation|0|||
146612981|NCT01587040|528752230|FG002|Overall Study|Protocol Violation|1|||
146612982|NCT01587040|528752231|FG003|Overall Study|Protocol Violation|0|||
146612983|NCT01587040|528752228|FG000|Overall Study|Adverse Event|0|||
146612984|NCT01587040|528752229|FG001|Overall Study|Adverse Event|1|||
146612985|NCT01587040|528752230|FG002|Overall Study|Adverse Event|10|||
146612986|NCT01587040|528752231|FG003|Overall Study|Adverse Event|0|||
146612987|NCT01587040|528752228|FG000|Overall Study|Disease progression|12|||
146612988|NCT01587040|528752229|FG001|Overall Study|Disease progression|1|||
146612989|NCT01587040|528752230|FG002|Overall Study|Disease progression|15|||
146612990|NCT01587040|528752231|FG003|Overall Study|Disease progression|3|||
146612991|NCT01587040|528752228|FG000|Overall Study|Other than specified|5|||
146612992|NCT01587040|528752229|FG001|Overall Study|Other than specified|1|||
146612993|NCT01587040|528752230|FG002|Overall Study|Other than specified|11|||
146612994|NCT01587040|528752231|FG003|Overall Study|Other than specified|1|||
146612995|NCT04300309|528752234|FG000|Overall Study|Lost to Follow-up|1|||
146612996|NCT04300309|528752235|FG001|Overall Study|Lost to Follow-up|0|||
146612997|NCT04346654|528752237|FG000|Overall Study|Adverse Event|2|||
146612998|NCT04346654|528752238|FG001|Overall Study|Adverse Event|0|||
146612999|NCT04346654|528752237|FG000|Overall Study|Non-response|1|||
146613000|NCT04346654|528752238|FG001|Overall Study|Non-response|1|||
146613001|NCT04346654|528752237|FG000|Overall Study|Withdrawal by Subject|2|||
146613002|NCT04346654|528752238|FG001|Overall Study|Withdrawal by Subject|0|||
146613003|NCT04346654|528752237|FG000|Overall Study|Lost to Follow-up|0|||
146613004|NCT04346654|528752238|FG001|Overall Study|Lost to Follow-up|1|||
146613005|NCT04346654|528752237|FG000|Overall Study|Pregnancy|0|||
146658306|NCT00750880|528927217|FG000|Overall Study|Physician Decision|20|||
146658307|NCT00750880|528927217|FG000|Overall Study|Administrative|11|||
146658308|NCT02169284|528927218|FG000|Overall Study|Physician Decision|0|||
146658309|NCT02169284|528927219|FG001|Overall Study|Physician Decision|1|||
146924903|NCT03136185|529884826|FG004|Overall Study|Not Reported|0|||
146613006|NCT04346654|528752238|FG001|Overall Study|Pregnancy|1|||
146613007|NCT02343406|528752241|FG000|Overall Study|Progressive disease|72|||
146613008|NCT02343406|528752242|FG001|Overall Study|Progressive disease|70|||
146613009|NCT02343406|528752243|FG002|Overall Study|Progressive disease|43|||
146613010|NCT02343406|528752244|FG003|Overall Study|Progressive disease|15|||
146658310|NCT03583073|528927220|FG000|Overall Study|Lost to Follow-up|8|||
146613011|NCT02343406|528752245|FG004|Overall Study|Progressive disease|5|||
146613012|NCT02343406|528752241|FG000|Overall Study|Adverse Event|6|||
146613013|NCT02343406|528752242|FG001|Overall Study|Adverse Event|8|||
146613014|NCT02343406|528752243|FG002|Overall Study|Adverse Event|6|||
146613015|NCT02343406|528752244|FG003|Overall Study|Adverse Event|3|||
146613016|NCT02343406|528752245|FG004|Overall Study|Adverse Event|0|||
146613017|NCT02343406|528752241|FG000|Overall Study|Withdrawal by Subject|6|||
146613018|NCT02343406|528752242|FG001|Overall Study|Withdrawal by Subject|4|||
146613019|NCT02343406|528752243|FG002|Overall Study|Withdrawal by Subject|8|||
146613020|NCT02343406|528752244|FG003|Overall Study|Withdrawal by Subject|3|||
146613021|NCT02343406|528752245|FG004|Overall Study|Withdrawal by Subject|0|||
146613022|NCT02343406|528752241|FG000|Overall Study|Death|2|||
146613023|NCT02343406|528752242|FG001|Overall Study|Death|1|||
146613024|NCT02343406|528752243|FG002|Overall Study|Death|0|||
146613025|NCT02343406|528752244|FG003|Overall Study|Death|0|||
146613026|NCT02343406|528752245|FG004|Overall Study|Death|0|||
146613027|NCT02343406|528752241|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
146613028|NCT02343406|528752242|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
146613029|NCT02343406|528752243|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
146613030|NCT02343406|528752244|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
146613031|NCT02343406|528752245|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
146613032|NCT02343406|528752241|FG000|Overall Study|Other primary malignancy|0|||
146613033|NCT02343406|528752242|FG001|Overall Study|Other primary malignancy|1|||
146613034|NCT02343406|528752243|FG002|Overall Study|Other primary malignancy|0|||
146613035|NCT02343406|528752244|FG003|Overall Study|Other primary malignancy|0|||
146613036|NCT02343406|528752245|FG004|Overall Study|Other primary malignancy|0|||
146613037|NCT02343406|528752241|FG000|Overall Study|Other, not specified|2|||
146613038|NCT02343406|528752242|FG001|Overall Study|Other, not specified|1|||
146613039|NCT02343406|528752243|FG002|Overall Study|Other, not specified|1|||
146613040|NCT02343406|528752244|FG003|Overall Study|Other, not specified|4|||
146613041|NCT02343406|528752245|FG004|Overall Study|Other, not specified|0|||
146613042|NCT00858637|528752246|FG000|Active Comparison Phase|Adverse Event|14|||
146613043|NCT00858637|528752247|FG001|Active Comparison Phase|Adverse Event|0|||
146613044|NCT00858637|528752248|FG002|Active Comparison Phase|Adverse Event|0|||
146613045|NCT00858637|528752249|FG003|Active Comparison Phase|Adverse Event|9|||
146613046|NCT00858637|528752250|FG004|Active Comparison Phase|Adverse Event|0|||
146613047|NCT00858637|528752251|FG005|Active Comparison Phase|Adverse Event|0|||
146613048|NCT00858637|528752246|FG000|Active Comparison Phase|Death|1|||
146613049|NCT00858637|528752247|FG001|Active Comparison Phase|Death|0|||
146613050|NCT00858637|528752248|FG002|Active Comparison Phase|Death|0|||
146613051|NCT00858637|528752249|FG003|Active Comparison Phase|Death|1|||
146613052|NCT00858637|528752250|FG004|Active Comparison Phase|Death|0|||
146613053|NCT00858637|528752251|FG005|Active Comparison Phase|Death|0|||
146613054|NCT00858637|528752246|FG000|Active Comparison Phase|Physician Decision|1|||
146613055|NCT00858637|528752247|FG001|Active Comparison Phase|Physician Decision|0|||
146613056|NCT00858637|528752248|FG002|Active Comparison Phase|Physician Decision|0|||
146613057|NCT00858637|528752249|FG003|Active Comparison Phase|Physician Decision|1|||
146613058|NCT00858637|528752250|FG004|Active Comparison Phase|Physician Decision|0|||
146613059|NCT00858637|528752251|FG005|Active Comparison Phase|Physician Decision|0|||
146613060|NCT00858637|528752246|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
146613061|NCT00858637|528752247|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
146613062|NCT00858637|528752248|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
146613063|NCT00858637|528752249|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
146613064|NCT00858637|528752250|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
146658311|NCT03583073|528927221|FG001|Overall Study|Lost to Follow-up|12|||
146658312|NCT05323656|528927225|FG000|Overall Study|Still On-Treatment|6|||
146924904|NCT03136185|529884827|FG005|Overall Study|Not Reported|2|||
146924905|NCT03136185|529884828|FG006|Overall Study|Not Reported|1|||
146924906|NCT03136185|529884829|FG007|Overall Study|Not Reported|1|||
146924907|NCT03136185|529884830|FG008|Overall Study|Not Reported|0|||
146924908|NCT03126539|529884838|FG000|Overall Study|Lost to Follow-up|1|||
146924909|NCT03126539|529884839|FG001|Overall Study|Lost to Follow-up|1|||
146924910|NCT03126539|529884840|FG002|Overall Study|Lost to Follow-up|1|||
146924911|NCT03126539|529884841|FG003|Overall Study|Lost to Follow-up|0|||
146924912|NCT03126539|529884842|FG004|Overall Study|Lost to Follow-up|0|||
146613065|NCT00858637|528752251|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
146613066|NCT00858637|528752246|FG000|Active Comparison Phase|Other Reasons|1|||
146613067|NCT00858637|528752247|FG001|Active Comparison Phase|Other Reasons|0|||
146613068|NCT00858637|528752248|FG002|Active Comparison Phase|Other Reasons|0|||
146613069|NCT00858637|528752249|FG003|Active Comparison Phase|Other Reasons|1|||
146613070|NCT00858637|528752250|FG004|Active Comparison Phase|Other Reasons|0|||
146613071|NCT00858637|528752251|FG005|Active Comparison Phase|Other Reasons|0|||
146613072|NCT00858637|528752246|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
146658313|NCT05323656|528927226|FG001|Overall Study|Still On-Treatment|6|||
146924913|NCT01005732|529884845|FG000|Overall Study|Lost to Follow-up|10|||
146924914|NCT01005732|529884845|FG000|Overall Study|Death|1|||
146613073|NCT00858637|528752247|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
146613074|NCT00858637|528752248|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
146613075|NCT00858637|528752249|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
146613076|NCT00858637|528752250|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
146613077|NCT00858637|528752251|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
146613078|NCT00858637|528752246|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
146613079|NCT00858637|528752247|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
146613080|NCT00858637|528752248|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
146613081|NCT00858637|528752249|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
146613082|NCT00858637|528752250|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
146613083|NCT00858637|528752251|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
146613084|NCT01380834|528752252|FG000|Overall Study|Physician Decision|1|||
146613085|NCT01380834|528752253|FG001|Overall Study|Physician Decision|0|||
146613086|NCT04677504|528752254|FG000|Overall Study|Death|51|||
146613087|NCT04677504|528752255|FG001|Overall Study|Death|49|||
146613088|NCT04677504|528752254|FG000|Overall Study|Progressive Disease|1|||
146613089|NCT04677504|528752255|FG001|Overall Study|Progressive Disease|0|||
146613090|NCT04677504|528752254|FG000|Overall Study|Symptomatic Deterioration|1|||
146613091|NCT04677504|528752255|FG001|Overall Study|Symptomatic Deterioration|0|||
146613092|NCT04677504|528752254|FG000|Overall Study|Withdrawal by Subject|2|||
146613093|NCT04677504|528752255|FG001|Overall Study|Withdrawal by Subject|5|||
146613094|NCT04677504|528752254|FG000|Overall Study|Study Terminated By Sponsor|28|||
146613095|NCT04677504|528752255|FG001|Overall Study|Study Terminated By Sponsor|24|||
146613096|NCT04677504|528752254|FG000|Overall Study|Adverse Event|0|||
146613097|NCT04677504|528752255|FG001|Overall Study|Adverse Event|1|||
146613098|NCT02058563|528752258|FG000|Overall Study|Lost to Follow-up|26|||
146613099|NCT02058563|528752259|FG001|Overall Study|Lost to Follow-up|22|||
146613100|NCT02058563|528752258|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
146613101|NCT02058563|528752259|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
146613102|NCT02058563|528752258|FG000|Overall Study|Consent Withdrawal|1|||
146613103|NCT02058563|528752259|FG001|Overall Study|Consent Withdrawal|1|||
146613104|NCT02058563|528752258|FG000|Overall Study|Other (patient incarcerated)|0|||
146613105|NCT02058563|528752259|FG001|Overall Study|Other (patient incarcerated)|1|||
146613106|NCT04039217|528752260|FG000|Overall Study|Lost to Follow-up|1|||
146613107|NCT00167310|528752261|FG000|Overall Study|Protocol Violation|5|||
146613108|NCT00167310|528752262|FG001|Overall Study|Protocol Violation|3|||
146613109|NCT00167310|528752261|FG000|Overall Study|Withdrawal by Subject|3|||
146613110|NCT00167310|528752262|FG001|Overall Study|Withdrawal by Subject|7|||
146613111|NCT03304873|528752263|FG000|Overall Study|Lost to Follow-up|1|||
146613112|NCT03304873|528752264|FG001|Overall Study|Lost to Follow-up|8|||
146613113|NCT01868477|528752266|FG000|Overall Study|Adverse Event|2|||
146613114|NCT01868477|528752267|FG001|Overall Study|Adverse Event|4|||
146613115|NCT01868477|528752266|FG000|Overall Study|Disease progression|1|||
146613116|NCT01868477|528752267|FG001|Overall Study|Disease progression|1|||
146613117|NCT01868477|528752266|FG000|Overall Study|Withdrawal by Subject|1|||
146613118|NCT01868477|528752267|FG001|Overall Study|Withdrawal by Subject|0|||
146613119|NCT00042991|528752268|FG000|Overall Study|Adverse Event|1|||
146613120|NCT00042991|528752269|FG001|Overall Study|Adverse Event|4|||
146613121|NCT00042991|528752270|FG002|Overall Study|Adverse Event|2|||
146658314|NCT05323656|528927225|FG000|Overall Study|Progressive Disease|15|||
146658315|NCT05323656|528927226|FG001|Overall Study|Progressive Disease|14|||
146658316|NCT05323656|528927225|FG000|Overall Study|Adverse Event|2|||
146658317|NCT05323656|528927226|FG001|Overall Study|Adverse Event|3|||
146658318|NCT05323656|528927225|FG000|Overall Study|Death|1|||
146658319|NCT05323656|528927226|FG001|Overall Study|Death|2|||
146658320|NCT05323656|528927225|FG000|Overall Study|Withdrawal by Subject|1|||
146613122|NCT00042991|528752271|FG003|Overall Study|Adverse Event|0|||
146613123|NCT00042991|528752272|FG004|Overall Study|Adverse Event|0|||
146613124|NCT00042991|528752273|FG005|Overall Study|Adverse Event|1|||
146613125|NCT00042991|528752274|FG006|Overall Study|Adverse Event|0|||
146613126|NCT00042991|528752268|FG000|Overall Study|Withdrawal by Subject|0|||
146613127|NCT00042991|528752269|FG001|Overall Study|Withdrawal by Subject|7|||
146613128|NCT00042991|528752270|FG002|Overall Study|Withdrawal by Subject|2|||
146658321|NCT05323656|528927226|FG001|Overall Study|Withdrawal by Subject|0|||
146658322|NCT05323656|528927225|FG000|Overall Study|Clinical disease progression|0|||
146658323|NCT05323656|528927226|FG001|Overall Study|Clinical disease progression|1|||
146658324|NCT05323656|528927225|FG000|Overall Study|Patient and Investigator decision|1|||
146658325|NCT05323656|528927226|FG001|Overall Study|Patient and Investigator decision|0|||
146613129|NCT00042991|528752271|FG003|Overall Study|Withdrawal by Subject|0|||
146613130|NCT00042991|528752272|FG004|Overall Study|Withdrawal by Subject|1|||
146613131|NCT00042991|528752273|FG005|Overall Study|Withdrawal by Subject|0|||
146613132|NCT00042991|528752274|FG006|Overall Study|Withdrawal by Subject|0|||
146613133|NCT00042991|528752268|FG000|Overall Study|Disease Progression|5|||
146613134|NCT00042991|528752269|FG001|Overall Study|Disease Progression|29|||
146613135|NCT00042991|528752270|FG002|Overall Study|Disease Progression|2|||
146613136|NCT00042991|528752271|FG003|Overall Study|Disease Progression|2|||
146658326|NCT05323656|528927225|FG000|Overall Study|Physician Decision|0|||
146613137|NCT00042991|528752272|FG004|Overall Study|Disease Progression|1|||
146613138|NCT00042991|528752273|FG005|Overall Study|Disease Progression|4|||
146613139|NCT00042991|528752274|FG006|Overall Study|Disease Progression|2|||
146613140|NCT00042991|528752268|FG000|Overall Study|Alternative Therapy|0|||
146613141|NCT00042991|528752269|FG001|Overall Study|Alternative Therapy|0|||
146613142|NCT00042991|528752270|FG002|Overall Study|Alternative Therapy|0|||
146613143|NCT00042991|528752271|FG003|Overall Study|Alternative Therapy|0|||
146613144|NCT00042991|528752272|FG004|Overall Study|Alternative Therapy|1|||
146613145|NCT00042991|528752273|FG005|Overall Study|Alternative Therapy|0|||
146613146|NCT00042991|528752274|FG006|Overall Study|Alternative Therapy|0|||
146613147|NCT01574651|528752275|FG000|Overall Study|Lost to Follow-up|2|||
146613148|NCT01574651|528752276|FG001|Overall Study|Lost to Follow-up|4|||
146613149|NCT01574651|528752275|FG000|Overall Study|Administrative problems|0|||
146613150|NCT01574651|528752276|FG001|Overall Study|Administrative problems|1|||
146613151|NCT01574651|528752275|FG000|Overall Study|Death|3|||
146613152|NCT01574651|528752276|FG001|Overall Study|Death|3|||
146613153|NCT01574651|528752275|FG000|Overall Study|Patient's inability to use the device|0|||
146613154|NCT01574651|528752276|FG001|Overall Study|Patient's inability to use the device|1|||
146613155|NCT01574651|528752275|FG000|Overall Study|Adverse Event|36|||
146613156|NCT01574651|528752276|FG001|Overall Study|Adverse Event|27|||
146658327|NCT05323656|528927226|FG001|Overall Study|Physician Decision|1|||
146658328|NCT02495233|528927229|FG000|Overall Study|Miscellaneous|0|||
146658329|NCT02495233|528927230|FG001|Overall Study|Miscellaneous|1|||
146658330|NCT03880461|528927232|FG000|Overall Study|Determined ineligible after enrollment|45|||
146658331|NCT03880461|528927233|FG001|Overall Study|Determined ineligible after enrollment|44|||
146658332|NCT03880461|528927232|FG000|Overall Study|No weight measurement after enrollment|24|||
146658333|NCT03880461|528927233|FG001|Overall Study|No weight measurement after enrollment|17|||
146658334|NCT01115803|528927239|FG000|Overall Study|Withdrawal by Subject|0|||
146658335|NCT01115803|528927240|FG001|Overall Study|Withdrawal by Subject|0|||
146658336|NCT01115803|528927241|FG002|Overall Study|Withdrawal by Subject|0|||
146658337|NCT01115803|528927242|FG003|Overall Study|Withdrawal by Subject|0|||
146658338|NCT01115803|528927243|FG004|Overall Study|Withdrawal by Subject|0|||
146658339|NCT01115803|528927244|FG005|Overall Study|Withdrawal by Subject|0|||
146658340|NCT01115803|528927245|FG006|Overall Study|Withdrawal by Subject|1|||
146658341|NCT01115803|528927239|FG000|Overall Study|Lost to Follow-up|0|||
146658342|NCT01115803|528927240|FG001|Overall Study|Lost to Follow-up|0|||
146658343|NCT01115803|528927241|FG002|Overall Study|Lost to Follow-up|1|||
146658344|NCT01115803|528927242|FG003|Overall Study|Lost to Follow-up|0|||
146658345|NCT01115803|528927243|FG004|Overall Study|Lost to Follow-up|0|||
146658346|NCT01115803|528927244|FG005|Overall Study|Lost to Follow-up|0|||
146658347|NCT01115803|528927245|FG006|Overall Study|Lost to Follow-up|0|||
146658348|NCT01115803|528927239|FG000|Overall Study|Progressive Disease during Cycle1|0|||
146658349|NCT01115803|528927240|FG001|Overall Study|Progressive Disease during Cycle1|0|||
146658350|NCT01115803|528927241|FG002|Overall Study|Progressive Disease during Cycle1|0|||
146658351|NCT01115803|528927242|FG003|Overall Study|Progressive Disease during Cycle1|0|||
146658352|NCT01115803|528927243|FG004|Overall Study|Progressive Disease during Cycle1|0|||
146658353|NCT01115803|528927244|FG005|Overall Study|Progressive Disease during Cycle1|0|||
146658354|NCT01115803|528927245|FG006|Overall Study|Progressive Disease during Cycle1|1|||
146658355|NCT00450385|528927246|FG000|Overall Study|Death|3|||
146658356|NCT00450385|528927246|FG000|Overall Study|Protocol Violation|1|||
146658357|NCT00450385|528927246|FG000|Overall Study|Withdrawal by Subject|2|||
146658358|NCT00450385|528927246|FG000|Overall Study|Lack of Efficacy|2|||
146658359|NCT00450385|528927246|FG000|Overall Study|Adverse Event|1|||
146658360|NCT00450385|528927246|FG000|Overall Study|Physician Decision|1|||
146658361|NCT00450385|528927246|FG000|Overall Study|Other|3|||
146658362|NCT03533686|528927247|FG000|Overall Study|Withdrawal by Subject|1|||
146658363|NCT03533686|528927248|FG001|Overall Study|Withdrawal by Subject|0|||
146658364|NCT03533686|528927249|FG002|Overall Study|Withdrawal by Subject|0|||
146658365|NCT03533686|528927250|FG003|Overall Study|Withdrawal by Subject|3|||
146658366|NCT03533686|528927251|FG004|Overall Study|Withdrawal by Subject|5|||
146658367|NCT03533686|528927252|FG005|Overall Study|Withdrawal by Subject|1|||
146658368|NCT03533686|528927247|FG000|Overall Study|Lost to Follow-up|0|||
146658369|NCT03533686|528927248|FG001|Overall Study|Lost to Follow-up|1|||
146658370|NCT03533686|528927249|FG002|Overall Study|Lost to Follow-up|0|||
146658371|NCT03533686|528927250|FG003|Overall Study|Lost to Follow-up|0|||
146613157|NCT01574651|528752275|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146613158|NCT01574651|528752276|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146658372|NCT03533686|528927251|FG004|Overall Study|Lost to Follow-up|2|||
146613159|NCT01574651|528752275|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146613160|NCT01574651|528752276|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146613161|NCT01574651|528752275|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
146658373|NCT03533686|528927252|FG005|Overall Study|Lost to Follow-up|0|||
146658374|NCT03533686|528927247|FG000|Overall Study|Screen Failure|0|||
146658375|NCT03533686|528927248|FG001|Overall Study|Screen Failure|0|||
146658376|NCT03533686|528927249|FG002|Overall Study|Screen Failure|0|||
146658377|NCT03533686|528927250|FG003|Overall Study|Screen Failure|2|||
146658378|NCT03533686|528927251|FG004|Overall Study|Screen Failure|0|||
146613162|NCT01574651|528752276|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146613163|NCT01574651|528752275|FG000|Overall Study|Protocol Violation|3|||
146613164|NCT01574651|528752276|FG001|Overall Study|Protocol Violation|5|||
146613165|NCT01574651|528752275|FG000|Overall Study|Withdrawal by Subject|9|||
146613166|NCT01574651|528752276|FG001|Overall Study|Withdrawal by Subject|10|||
146613167|NCT01101035|528754164|FG000|Overall Study|Adverse Event|191|||
146613168|NCT01101035|528754165|FG001|Overall Study|Adverse Event|172|||
146613169|NCT01101035|528754164|FG000|Overall Study|Major Protocol Deviation|52|||
146613170|NCT01101035|528754165|FG001|Overall Study|Major Protocol Deviation|46|||
146613171|NCT01101035|528754164|FG000|Overall Study|Lost to Follow-up|226|||
146613172|NCT01101035|528754165|FG001|Overall Study|Lost to Follow-up|223|||
146613173|NCT01101035|528754164|FG000|Overall Study|Voluntary Withdrawal|595|||
146613174|NCT01101035|528754165|FG001|Overall Study|Voluntary Withdrawal|587|||
146613175|NCT01101035|528754164|FG000|Overall Study|Reason not Specified|333|||
146613176|NCT01101035|528754165|FG001|Overall Study|Reason not Specified|363|||
146613177|NCT02871635|528754166|FG000|Overall Study|Primary lack of efficacy|4|||
146613178|NCT02871635|528754167|FG001|Overall Study|Primary lack of efficacy|4|||
146613179|NCT02871635|528754166|FG000|Overall Study|Protocol Violation|3|||
146613180|NCT02871635|528754167|FG001|Overall Study|Protocol Violation|1|||
146613181|NCT02871635|528754166|FG000|Overall Study|Lost to Follow-up|1|||
146613182|NCT02871635|528754167|FG001|Overall Study|Lost to Follow-up|2|||
146613183|NCT02871635|528754166|FG000|Overall Study|Pregnancy|0|||
146613184|NCT02871635|528754167|FG001|Overall Study|Pregnancy|2|||
146613185|NCT02871635|528754166|FG000|Overall Study|Physician Decision|1|||
146613186|NCT02871635|528754167|FG001|Overall Study|Physician Decision|1|||
146613187|NCT02871635|528754166|FG000|Overall Study|Withdrawal by Subject|3|||
146613188|NCT02871635|528754167|FG001|Overall Study|Withdrawal by Subject|4|||
146613189|NCT02871635|528754166|FG000|Overall Study|Adverse Event|4|||
146613190|NCT02871635|528754167|FG001|Overall Study|Adverse Event|4|||
146613191|NCT02871635|528754166|FG000|Overall Study|Secondary lack of efficacy|2|||
146613192|NCT02871635|528754167|FG001|Overall Study|Secondary lack of efficacy|1|||
146613193|NCT00412893|528754170|FG000|Overall Study|Adverse Event|31|||
146613194|NCT00412893|528754171|FG001|Overall Study|Adverse Event|53|||
146613195|NCT00412893|528754170|FG000|Overall Study|Death|17|||
146613196|NCT00412893|528754171|FG001|Overall Study|Death|21|||
146613197|NCT00412893|528754170|FG000|Overall Study|Insufficient Therapeutic Response|39|||
146613198|NCT00412893|528754171|FG001|Overall Study|Insufficient Therapeutic Response|23|||
146613199|NCT00412893|528754170|FG000|Overall Study|Lost to Follow-up|2|||
146613200|NCT00412893|528754171|FG001|Overall Study|Lost to Follow-up|1|||
146613201|NCT00412893|528754170|FG000|Overall Study|Violation of Selection at Entry|17|||
146613202|NCT00412893|528754171|FG001|Overall Study|Violation of Selection at Entry|10|||
146613203|NCT00412893|528754170|FG000|Overall Study|Other Protocol Violation|10|||
146613204|NCT00412893|528754171|FG001|Overall Study|Other Protocol Violation|6|||
146613205|NCT00412893|528754170|FG000|Overall Study|Did Not Cooperate|12|||
146613206|NCT00412893|528754171|FG001|Overall Study|Did Not Cooperate|9|||
146613207|NCT00412893|528754170|FG000|Overall Study|Administrative Reason|12|||
146613208|NCT00412893|528754171|FG001|Overall Study|Administrative Reason|15|||
146613209|NCT00412893|528754170|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
146613210|NCT00412893|528754171|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
146613211|NCT01797263|528754175|FG000|Overall Study|Withdrawal by Subject|21|||
146613212|NCT01797263|528754176|FG001|Overall Study|Withdrawal by Subject|25|||
146613213|NCT01797263|528754175|FG000|Overall Study|Death|1|||
146613214|NCT01797263|528754176|FG001|Overall Study|Death|0|||
146613215|NCT01797263|528754175|FG000|Overall Study|Lost to Follow-up|15|||
146613216|NCT01797263|528754176|FG001|Overall Study|Lost to Follow-up|15|||
146613217|NCT02342223|528754177|FG000|Overall Study|Lost to Follow-up|1|||
146613218|NCT04098809|528754180|FG000|Overall Study|Withdrawal by Subject|1|||
146613219|NCT04098809|528754181|FG001|Overall Study|Withdrawal by Subject|3|||
146613220|NCT04098809|528754180|FG000|Overall Study|Physician Decision|2|||
146613221|NCT04098809|528754181|FG001|Overall Study|Physician Decision|1|||
146613222|NCT01200368|528754182|FG000|Infant Series|Adverse Event|2|||
146613223|NCT01200368|528754183|FG001|Infant Series|Adverse Event|2|||
146613224|NCT01200368|528754184|FG002|Infant Series|Adverse Event|3|||
146613225|NCT01200368|528754182|FG000|Infant Series|Withdrawal by Subject|0|||
146613226|NCT01200368|528754183|FG001|Infant Series|Withdrawal by Subject|2|||
146613227|NCT01200368|528754184|FG002|Infant Series|Withdrawal by Subject|2|||
146613228|NCT01200368|528754182|FG000|Infant Series|Did not meet entrance criteria|0|||
146613229|NCT01200368|528754183|FG001|Infant Series|Did not meet entrance criteria|1|||
146613230|NCT01200368|528754184|FG002|Infant Series|Did not meet entrance criteria|0|||
146613231|NCT01200368|528754182|FG000|Infant Series|Randomized, not vaccinated|0|||
146658379|NCT03533686|528927252|FG005|Overall Study|Screen Failure|0|||
146658380|NCT00136604|528927253|FG000|Overall Study|Lost to Follow-up|1|||
146658381|NCT00136604|528927254|FG001|Overall Study|Lost to Follow-up|0|||
146658382|NCT00136604|528927255|FG002|Overall Study|Lost to Follow-up|0|||
146658383|NCT00136604|528927256|FG003|Overall Study|Lost to Follow-up|0|||
146658384|NCT00136604|528927257|FG004|Overall Study|Lost to Follow-up|1|||
146658385|NCT00136604|528927253|FG000|Overall Study|Migrated/moved from study area|0|||
146613232|NCT01200368|528754183|FG001|Infant Series|Randomized, not vaccinated|1|||
146613233|NCT01200368|528754184|FG002|Infant Series|Randomized, not vaccinated|1|||
146613234|NCT01200368|528754182|FG000|Infant Series|Other|1|||
146613235|NCT01200368|528754183|FG001|Infant Series|Other|0|||
146613236|NCT01200368|528754184|FG002|Infant Series|Other|0|||
146613237|NCT01200368|528754182|FG000|After Infant Series|Adverse Event|6|||
146613238|NCT01200368|528754183|FG001|After Infant Series|Adverse Event|6|||
146613239|NCT01200368|528754184|FG002|After Infant Series|Adverse Event|3|||
146613240|NCT01200368|528754182|FG000|After Infant Series|Withdrawal by Subject|10|||
146613241|NCT01200368|528754183|FG001|After Infant Series|Withdrawal by Subject|8|||
146613242|NCT01200368|528754184|FG002|After Infant Series|Withdrawal by Subject|4|||
146613243|NCT01200368|528754182|FG000|After Infant Series|Lost to Follow-up|1|||
146613244|NCT01200368|528754183|FG001|After Infant Series|Lost to Follow-up|0|||
146613245|NCT01200368|528754184|FG002|After Infant Series|Lost to Follow-up|0|||
146613246|NCT01200368|528754182|FG000|After Infant Series|Other|1|||
146613247|NCT01200368|528754183|FG001|After Infant Series|Other|2|||
146613248|NCT01200368|528754184|FG002|After Infant Series|Other|2|||
146613249|NCT01200368|528754182|FG000|Toddler Dose|Adverse Event|0|||
146613250|NCT01200368|528754183|FG001|Toddler Dose|Adverse Event|3|||
146613251|NCT01200368|528754184|FG002|Toddler Dose|Adverse Event|1|||
146613252|NCT02741596|528754185|FG000|Overall Study|Adverse Event|1|||
146613253|NCT02741596|528754186|FG001|Overall Study|Adverse Event|5|||
146613254|NCT02741596|528754185|FG000|Overall Study|Lost to Follow-up|1|||
146658386|NCT00136604|528927254|FG001|Overall Study|Migrated/moved from study area|1|||
146658387|NCT00136604|528927255|FG002|Overall Study|Migrated/moved from study area|0|||
146658388|NCT00136604|528927256|FG003|Overall Study|Migrated/moved from study area|0|||
146658389|NCT00136604|528927257|FG004|Overall Study|Migrated/moved from study area|0|||
146658390|NCT02017171|528927258|FG000|Overall Study|Death|10|||
146658391|NCT02017171|528927259|FG001|Overall Study|Death|4|||
146658392|NCT02017171|528927258|FG000|Overall Study|Withdrawal by Subject|23|||
146658393|NCT02017171|528927259|FG001|Overall Study|Withdrawal by Subject|17|||
146658394|NCT02017171|528927258|FG000|Overall Study|Lost to Follow-up|21|||
146658395|NCT02017171|528927259|FG001|Overall Study|Lost to Follow-up|20|||
146658396|NCT02017171|528927258|FG000|Overall Study|ESKD|6|||
146658397|NCT02017171|528927259|FG001|Overall Study|ESKD|2|||
146658398|NCT02017171|528927258|FG000|Overall Study|Miscellaneous|2|||
146658399|NCT02017171|528927259|FG001|Overall Study|Miscellaneous|3|||
146658400|NCT01562873|528927260|FG000|Overall Study|Disease Progression per RECIST|10|||
146658401|NCT01562873|528927261|FG001|Overall Study|Disease Progression per RECIST|0|||
146658402|NCT01562873|528927260|FG000|Overall Study|Adverse Event|1|||
146658403|NCT01562873|528927261|FG001|Overall Study|Adverse Event|0|||
146658404|NCT01562873|528927260|FG000|Overall Study|Clinical Disease Progression|9|||
146658405|NCT01562873|528927261|FG001|Overall Study|Clinical Disease Progression|0|||
146658406|NCT01562873|528927260|FG000|Overall Study|Clinical PD and adverse event|1|||
146658407|NCT01562873|528927261|FG001|Overall Study|Clinical PD and adverse event|0|||
146658408|NCT02536833|528927262|FG000|Overall Study|Discontinued Before Treatment|0|||
146658409|NCT02536833|528927263|FG001|Overall Study|Discontinued Before Treatment|0|||
146658410|NCT02536833|528927264|FG002|Overall Study|Discontinued Before Treatment|1|||
146658411|NCT02536833|528927265|FG003|Overall Study|Discontinued Before Treatment|2|||
146658412|NCT02536833|528927262|FG000|Overall Study|Adverse Event|1|||
146658413|NCT02536833|528927263|FG001|Overall Study|Adverse Event|3|||
146658414|NCT02536833|528927264|FG002|Overall Study|Adverse Event|4|||
146658415|NCT02536833|528927265|FG003|Overall Study|Adverse Event|1|||
146658416|NCT02536833|528927262|FG000|Overall Study|Lost to Follow-up|2|||
146658417|NCT02536833|528927263|FG001|Overall Study|Lost to Follow-up|1|||
146658418|NCT02536833|528927264|FG002|Overall Study|Lost to Follow-up|2|||
146658419|NCT02536833|528927265|FG003|Overall Study|Lost to Follow-up|2|||
146658420|NCT02536833|528927262|FG000|Overall Study|Physician Decision|0|||
146658421|NCT02536833|528927263|FG001|Overall Study|Physician Decision|0|||
146658422|NCT02536833|528927264|FG002|Overall Study|Physician Decision|0|||
146658423|NCT02536833|528927265|FG003|Overall Study|Physician Decision|1|||
146658424|NCT02536833|528927262|FG000|Overall Study|Site Terminated by Sponsor|2|||
146613255|NCT02741596|528754186|FG001|Overall Study|Lost to Follow-up|1|||
146613256|NCT02741596|528754185|FG000|Overall Study|Physician Decision|2|||
146613257|NCT02741596|528754186|FG001|Overall Study|Physician Decision|1|||
146613258|NCT02741596|528754185|FG000|Overall Study|Pregnancy|3|||
146613259|NCT02741596|528754186|FG001|Overall Study|Pregnancy|1|||
146613260|NCT02741596|528754185|FG000|Overall Study|Other (Unspecified)|0|||
146613261|NCT02741596|528754186|FG001|Overall Study|Other (Unspecified)|3|||
146658425|NCT02536833|528927263|FG001|Overall Study|Site Terminated by Sponsor|2|||
146658426|NCT02536833|528927264|FG002|Overall Study|Site Terminated by Sponsor|2|||
146658427|NCT02536833|528927265|FG003|Overall Study|Site Terminated by Sponsor|2|||
146658428|NCT02536833|528927262|FG000|Overall Study|Subject Non-Compliance|0|||
146658429|NCT02536833|528927263|FG001|Overall Study|Subject Non-Compliance|1|||
146658430|NCT02536833|528927264|FG002|Overall Study|Subject Non-Compliance|1|||
146613262|NCT02741596|528754185|FG000|Overall Study|Subject withdrawn-Other|17|||
146658431|NCT02536833|528927265|FG003|Overall Study|Subject Non-Compliance|0|||
146658432|NCT02536833|528927262|FG000|Overall Study|Withdrawal by Subject|4|||
146613263|NCT02741596|528754186|FG001|Overall Study|Subject withdrawn-Other|4|||
146613264|NCT02741596|528754185|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
146613265|NCT02741596|528754186|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
146613266|NCT04854551|528754189|FG000|Overall Study|Withdrawal by Subject|1|||
146613267|NCT04854551|528754190|FG001|Overall Study|Withdrawal by Subject|1|||
146613268|NCT02859246|528754191|FG000|Overall Study|Screen fails|3|||
146613269|NCT02859246|528754191|FG000|Overall Study|Adverse Event|1|||
146613270|NCT02859246|528754191|FG000|Overall Study|Withdrawal by Subject|1|||
146613271|NCT05280717|528754192|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
146613272|NCT05280717|528754193|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
146613273|NCT05280717|528754194|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
146613274|NCT05280717|528754195|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
146613275|NCT05280717|528754196|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
146613276|NCT05280717|528754197|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
146613277|NCT05280717|528754198|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
146613278|NCT05280717|528754192|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
146613279|NCT05280717|528754193|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
146658433|NCT02536833|528927263|FG001|Overall Study|Withdrawal by Subject|3|||
146658434|NCT02536833|528927264|FG002|Overall Study|Withdrawal by Subject|5|||
146658435|NCT02536833|528927265|FG003|Overall Study|Withdrawal by Subject|11|||
146658436|NCT02220998|528927266|FG000|Overall Study|Randomized but Never Treated|1|||
146658437|NCT02220998|528927267|FG001|Overall Study|Randomized but Never Treated|2|||
146658438|NCT02220998|528927266|FG000|Overall Study|Death|2|||
146658439|NCT02220998|528927267|FG001|Overall Study|Death|0|||
146658440|NCT02220998|528927266|FG000|Overall Study|Lack of Efficacy|0|||
146658441|NCT02220998|528927267|FG001|Overall Study|Lack of Efficacy|5|||
146658442|NCT02220998|528927266|FG000|Overall Study|Lost to Follow-up|4|||
146658443|NCT02220998|528927267|FG001|Overall Study|Lost to Follow-up|4|||
146658444|NCT02280473|528927269|FG000|Overall Study|Adverse Event|1|||
146658445|NCT02280473|528927270|FG001|Overall Study|Adverse Event|1|||
146658446|NCT02280473|528927269|FG000|Overall Study|Lack of Efficacy|0|||
146658447|NCT02280473|528927270|FG001|Overall Study|Lack of Efficacy|1|||
146658448|NCT02280473|528927269|FG000|Overall Study|Lost to Follow-up|0|||
146658449|NCT02280473|528927270|FG001|Overall Study|Lost to Follow-up|1|||
146658450|NCT04223232|528927275|FG000|Overall Study|Withdrawal by Subject|1|||
146658451|NCT05281601|528927283|FG000|Overall Study|Physician Decision|2|||
146658452|NCT05281601|528927284|FG001|Overall Study|Physician Decision|0|||
146658453|NCT05281601|528927283|FG000|Overall Study|Lost to Follow-up|2|||
146658454|NCT05281601|528927284|FG001|Overall Study|Lost to Follow-up|0|||
146658455|NCT05281601|528927283|FG000|Overall Study|Death|1|||
146658456|NCT05281601|528927284|FG001|Overall Study|Death|0|||
146658457|NCT05281601|528927283|FG000|Overall Study|Withdrawal by parent/guardian|2|||
146658458|NCT05281601|528927284|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146658459|NCT00191646|528927286|FG000|Overall Study|Toxicity|26|||
146658460|NCT00191646|528927287|FG001|Overall Study|Toxicity|37|||
146658461|NCT00191646|528927286|FG000|Overall Study|Disease Progression|5|||
146658462|NCT00191646|528927287|FG001|Overall Study|Disease Progression|6|||
146658463|NCT00191646|528927286|FG000|Overall Study|Physician Decision|20|||
146658464|NCT00191646|528927287|FG001|Overall Study|Physician Decision|11|||
146658465|NCT00191646|528927286|FG000|Overall Study|Withdrawal by Subject|58|||
146658466|NCT00191646|528927287|FG001|Overall Study|Withdrawal by Subject|39|||
146658467|NCT00191646|528927286|FG000|Overall Study|Protocol Violation|5|||
146658468|NCT00191646|528927287|FG001|Overall Study|Protocol Violation|7|||
146658469|NCT00191646|528927286|FG000|Overall Study|Death|6|||
146658470|NCT00191646|528927287|FG001|Overall Study|Death|8|||
146658471|NCT00191646|528927286|FG000|Overall Study|Other|33|||
146658472|NCT00191646|528927287|FG001|Overall Study|Other|34|||
146658473|NCT00191646|528927286|FG000|Overall Study|Missing Data|18|||
146658474|NCT00191646|528927287|FG001|Overall Study|Missing Data|11|||
146658475|NCT03194490|528927289|FG000|Overall Study|Lost to Follow-up|1|||
146658476|NCT03194490|528927290|FG001|Overall Study|Lost to Follow-up|3|||
146658477|NCT03194490|528927289|FG000|Overall Study|participant developed specific neck pain|1|||
146658478|NCT03194490|528927290|FG001|Overall Study|participant developed specific neck pain|0|||
146658479|NCT01505647|528927291|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
146658480|NCT01505647|528927292|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
146658481|NCT01505647|528927291|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
146658482|NCT01505647|528927292|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
146658483|NCT01505647|528927291|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
146658484|NCT01505647|528927292|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
146658485|NCT01505647|528927291|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
146658486|NCT01505647|528927292|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
146658487|NCT01505647|528927291|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
146658488|NCT01505647|528927292|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
146773509|NCT02988817|529341091|FG015|Overall Study|Other|1|||
146658489|NCT01574079|528927293|FG000|Overall Study|Physician Decision|0|||
146658490|NCT01574079|528927294|FG001|Overall Study|Physician Decision|2|||
146613280|NCT05280717|528754194|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
146613281|NCT05280717|528754195|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
146613282|NCT05280717|528754196|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
146613283|NCT05280717|528754197|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
146613284|NCT05280717|528754198|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
146613285|NCT05280717|528754192|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
146613286|NCT05280717|528754193|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
146613287|NCT05280717|528754194|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
146613288|NCT05280717|528754195|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
146613289|NCT05280717|528754196|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
146613290|NCT05280717|528754197|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
146613291|NCT05280717|528754198|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
146613292|NCT05280717|528754192|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
146613293|NCT05280717|528754193|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
146613294|NCT05280717|528754194|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
146613295|NCT05280717|528754195|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
146613296|NCT05280717|528754196|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
146613297|NCT05280717|528754197|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
146613298|NCT05280717|528754198|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
146613299|NCT05280717|528754192|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
146613300|NCT05280717|528754193|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
146613301|NCT05280717|528754194|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
146613302|NCT05280717|528754195|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
146613303|NCT05280717|528754196|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
146613304|NCT05280717|528754197|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
146613305|NCT05280717|528754198|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
146613306|NCT05280717|528754192|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
146613307|NCT05280717|528754193|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
146613308|NCT05280717|528754194|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
146613309|NCT05280717|528754195|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
146613310|NCT05280717|528754196|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
146613311|NCT05280717|528754197|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
146613312|NCT05280717|528754198|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
146613313|NCT00080301|528754199|FG000|Overall Study|Randomized but Never Treated|5|||
146613314|NCT00080301|528754200|FG001|Overall Study|Randomized but Never Treated|10|||
146613315|NCT00080301|528754199|FG000|Overall Study|Still on Treatment as of CSR date|0|||
146613316|NCT00080301|528754200|FG001|Overall Study|Still on Treatment as of CSR date|1|||
146613317|NCT00181766|528754201|FG000|Overall Study|Lost to Follow-up|6|||
146613318|NCT00181766|528754201|FG000|Overall Study|Adverse Event|4|||
146613319|NCT00181766|528754201|FG000|Overall Study|non-compliance|2|||
146613320|NCT00687804|528754202|FG000|Core Study|Adverse Event|5|||
146613321|NCT00687804|528754203|FG001|Core Study|Adverse Event|3|||
146613322|NCT00687804|528754204|FG002|Core Study|Adverse Event|3|||
146613323|NCT00687804|528754202|FG000|Core Study|Abnormal laboratory value(s)|1|||
146613324|NCT00687804|528754203|FG001|Core Study|Abnormal laboratory value(s)|0|||
146613325|NCT00687804|528754204|FG002|Core Study|Abnormal laboratory value(s)|0|||
146613326|NCT00687804|528754202|FG000|Core Study|Lack of Efficacy|1|||
146613327|NCT00687804|528754203|FG001|Core Study|Lack of Efficacy|1|||
146613328|NCT00687804|528754204|FG002|Core Study|Lack of Efficacy|1|||
146613329|NCT00687804|528754202|FG000|Core Study|Withdrawal by Subject|4|||
146613330|NCT00687804|528754203|FG001|Core Study|Withdrawal by Subject|7|||
146613331|NCT00687804|528754204|FG002|Core Study|Withdrawal by Subject|7|||
146613332|NCT00687804|528754202|FG000|Core Study|Lost to Follow-up|0|||
146613333|NCT00687804|528754203|FG001|Core Study|Lost to Follow-up|1|||
146658491|NCT01574079|528927293|FG000|Overall Study|Lost to Follow-up|1|||
146658492|NCT01574079|528927294|FG001|Overall Study|Lost to Follow-up|0|||
146658493|NCT00406718|528927295|FG000|Overall Study|Withdrawal by Subject|2|||
146658494|NCT00406718|528927296|FG001|Overall Study|Withdrawal by Subject|9|||
146658495|NCT00406718|528927297|FG002|Overall Study|Withdrawal by Subject|4|||
146658496|NCT00406718|528927295|FG000|Overall Study|Lost to Follow-up|2|||
146658497|NCT00406718|528927296|FG001|Overall Study|Lost to Follow-up|5|||
146924915|NCT02596711|529884846|FG000|Overall Study|Lost to Follow-up|1|||
146924916|NCT02596711|529884847|FG001|Overall Study|Lost to Follow-up|2|||
146924917|NCT02596711|529884848|FG002|Overall Study|Lost to Follow-up|3|||
146924918|NCT00632463|529884850|FG000|Overall Study|Adverse Event|0|||
146613334|NCT00687804|528754204|FG002|Core Study|Lost to Follow-up|0|||
146613335|NCT00687804|528754202|FG000|Core Study|Death|2|||
146613336|NCT00687804|528754203|FG001|Core Study|Death|2|||
146613337|NCT00687804|528754204|FG002|Core Study|Death|2|||
146613338|NCT00687804|528754202|FG000|Core Study|Protocol Violation|1|||
146613339|NCT00687804|528754203|FG001|Core Study|Protocol Violation|1|||
146613340|NCT00687804|528754204|FG002|Core Study|Protocol Violation|0|||
146613341|NCT00687804|528754202|FG000|Open-Label Extension Study|Adverse Event|2|||
146613342|NCT00687804|528754203|FG001|Open-Label Extension Study|Adverse Event|2|||
146613343|NCT00687804|528754204|FG002|Open-Label Extension Study|Adverse Event|2|||
146613344|NCT00687804|528754202|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
146613345|NCT00687804|528754203|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
146613346|NCT00687804|528754204|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
146613347|NCT00687804|528754202|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
146613348|NCT00687804|528754203|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
146613349|NCT00687804|528754204|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
146613350|NCT00687804|528754202|FG000|Open-Label Extension Study|Administrative problems|1|||
146613351|NCT00687804|528754203|FG001|Open-Label Extension Study|Administrative problems|1|||
146613352|NCT00687804|528754204|FG002|Open-Label Extension Study|Administrative problems|0|||
146613353|NCT00687804|528754202|FG000|Open-Label Extension Study|Death|2|||
146613354|NCT00687804|528754203|FG001|Open-Label Extension Study|Death|3|||
146613355|NCT00687804|528754204|FG002|Open-Label Extension Study|Death|3|||
146613356|NCT00413218|528754205|FG000|Overall Study|Randomized but didn't receive study drug|2|||
146613357|NCT00413218|528754206|FG001|Overall Study|Randomized but didn't receive study drug|8|||
146613358|NCT00413218|528754205|FG000|Overall Study|Death|57|||
146613359|NCT00413218|528754206|FG001|Overall Study|Death|56|||
146658498|NCT00406718|528927297|FG002|Overall Study|Lost to Follow-up|4|||
146658499|NCT03640559|528927298|FG000|Overall Study|Physician Decision|1|||
146658500|NCT03640559|528927299|FG001|Overall Study|Physician Decision|1|||
146658501|NCT03640559|528927298|FG000|Overall Study|Withdrawal by Subject|1|||
146658502|NCT03640559|528927299|FG001|Overall Study|Withdrawal by Subject|0|||
146658503|NCT01436162|528927300|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
146658504|NCT01436162|528927301|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
146658505|NCT01436162|528927302|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
146658506|NCT01436162|528927300|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
146658507|NCT01436162|528927301|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
146658508|NCT01436162|528927302|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
146658509|NCT01436162|528927300|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
146658510|NCT01436162|528927301|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
146613360|NCT00413218|528754205|FG000|Overall Study|Lost to Follow-up|14|||
146613361|NCT00413218|528754206|FG001|Overall Study|Lost to Follow-up|17|||
146613362|NCT00413218|528754205|FG000|Overall Study|Admin|20|||
146613363|NCT00413218|528754206|FG001|Overall Study|Admin|14|||
146613364|NCT00413218|528754205|FG000|Overall Study|Missing|1|||
146613365|NCT00413218|528754206|FG001|Overall Study|Missing|0|||
146613366|NCT00413218|528754205|FG000|Overall Study|Withdrawal by Subject|9|||
146613367|NCT00413218|528754206|FG001|Overall Study|Withdrawal by Subject|1|||
146613368|NCT04034004|528754208|FG000|Overall Study|Withdrawal by Subject|1|||
146613369|NCT04034004|528754209|FG001|Overall Study|Withdrawal by Subject|2|||
146613370|NCT04034004|528754210|FG002|Overall Study|Withdrawal by Subject|2|||
146613371|NCT04034004|528754211|FG003|Overall Study|Withdrawal by Subject|3|||
146613372|NCT04034004|528754208|FG000|Overall Study|could not find vein to administer IV|2|||
146613373|NCT04034004|528754209|FG001|Overall Study|could not find vein to administer IV|1|||
146658511|NCT01436162|528927302|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
146613374|NCT04034004|528754210|FG002|Overall Study|could not find vein to administer IV|0|||
146658512|NCT01436162|528927300|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
146658513|NCT01436162|528927301|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
146658514|NCT01436162|528927302|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
146658515|NCT01436162|528927300|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
146658516|NCT01436162|528927301|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
146658517|NCT01436162|528927302|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
146658518|NCT01436162|528927300|FG000|Single-blind Lead-in Phase|Other|107|||
146658519|NCT01436162|528927301|FG001|Single-blind Lead-in Phase|Other|0|||
146658520|NCT01436162|528927302|FG002|Single-blind Lead-in Phase|Other|0|||
146658521|NCT01436162|528927300|FG000|Randomized Phase|Adverse Event|1|||
146773510|NCT02988817|529341092|FG016|Overall Study|Other|0|||
146658522|NCT01436162|528927301|FG001|Randomized Phase|Adverse Event|5|||
146658523|NCT01436162|528927302|FG002|Randomized Phase|Adverse Event|6|||
146658524|NCT01436162|528927300|FG000|Randomized Phase|Protocol Violation|4|||
146613375|NCT04034004|528754211|FG003|Overall Study|could not find vein to administer IV|0|||
146613376|NCT04034004|528754208|FG000|Overall Study|nurse accidentally unblinded subject|0|||
146613377|NCT04034004|528754209|FG001|Overall Study|nurse accidentally unblinded subject|0|||
146613378|NCT04034004|528754210|FG002|Overall Study|nurse accidentally unblinded subject|0|||
146613379|NCT04034004|528754211|FG003|Overall Study|nurse accidentally unblinded subject|1|||
146613380|NCT04317040|528754212|FG000|Overall Study|Lost to Follow-up|2|||
146613381|NCT04317040|528754213|FG001|Overall Study|Lost to Follow-up|0|||
146613382|NCT04317040|528754212|FG000|Overall Study|Death|16|||
146613383|NCT04317040|528754213|FG001|Overall Study|Death|18|||
146613384|NCT04317040|528754212|FG000|Overall Study|Withdrawal by Subject|0|||
146613385|NCT04317040|528754213|FG001|Overall Study|Withdrawal by Subject|1|||
146613386|NCT04317040|528754212|FG000|Overall Study|Incomplete assessments|0|||
146613387|NCT04317040|528754213|FG001|Overall Study|Incomplete assessments|1|||
146613388|NCT03672292|528754214|FG000|Overall Study|Adverse Event|3|||
146613389|NCT03672292|528754215|FG001|Overall Study|Adverse Event|1|||
146613390|NCT03672292|528754214|FG000|Overall Study|Physician Decision|0|||
146613391|NCT03672292|528754215|FG001|Overall Study|Physician Decision|1|||
146613392|NCT03672292|528754214|FG000|Overall Study|Withdrawal by Subject|1|||
146613393|NCT03672292|528754215|FG001|Overall Study|Withdrawal by Subject|2|||
146613394|NCT02518971|528754216|FG000|Overall Study|Lost to Follow-up|0|||
146613395|NCT02518971|528754217|FG001|Overall Study|Lost to Follow-up|1|||
146613396|NCT02518971|528754216|FG000|Overall Study|Physician Decision|6|||
146613397|NCT02518971|528754217|FG001|Overall Study|Physician Decision|6|||
146613398|NCT02518971|528754216|FG000|Overall Study|Protocol Violation|6|||
146613399|NCT02518971|528754217|FG001|Overall Study|Protocol Violation|4|||
146613400|NCT02518971|528754216|FG000|Overall Study|Withdrawal by Subject|4|||
146613401|NCT02518971|528754217|FG001|Overall Study|Withdrawal by Subject|5|||
146613402|NCT02518971|528754216|FG000|Overall Study|Side effects|1|||
146613403|NCT02518971|528754217|FG001|Overall Study|Side effects|0|||
146613404|NCT02518971|528754216|FG000|Overall Study|medication lost in mail|0|||
146613405|NCT02518971|528754217|FG001|Overall Study|medication lost in mail|1|||
146613406|NCT02518971|528754216|FG000|Overall Study|eligibility criteria no longer met|6|||
146613407|NCT02518971|528754217|FG001|Overall Study|eligibility criteria no longer met|3|||
146613408|NCT03088917|528754218|FG000|Overall Study|In care/cured elsewhere|15|||
146613409|NCT03088917|528754218|FG000|Overall Study|Refuse re-evaluation|13|||
146613410|NCT03088917|528754218|FG000|Overall Study|Contact not established|13|||
146613411|NCT03088917|528754218|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
146613412|NCT03088917|528754218|FG000|Overall Study|Moved outside study region|50|||
146613413|NCT00757237|528754219|FG000|Overall Study|Lost to Follow-up|0|||
146613414|NCT00757237|528754220|FG001|Overall Study|Lost to Follow-up|1|||
146613415|NCT00757237|528754219|FG000|Overall Study|Protocol Violation|0|||
146613416|NCT00757237|528754220|FG001|Overall Study|Protocol Violation|2|||
146613417|NCT00757237|528754219|FG000|Overall Study|Physician Decision|2|||
146613418|NCT00757237|528754220|FG001|Overall Study|Physician Decision|3|||
146613419|NCT00757237|528754219|FG000|Overall Study|Withdrawal by Subject|8|||
146613420|NCT00757237|528754220|FG001|Overall Study|Withdrawal by Subject|12|||
146613421|NCT00757237|528754219|FG000|Overall Study|Safety or Tolerability|3|||
146613422|NCT00757237|528754220|FG001|Overall Study|Safety or Tolerability|5|||
146613423|NCT00757237|528754219|FG000|Overall Study|Other|0|||
146613424|NCT00757237|528754220|FG001|Overall Study|Other|2|||
146613425|NCT05150990|528754227|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
146613426|NCT05150990|528754228|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
146613427|NCT05150990|528754227|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
146613428|NCT05150990|528754228|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
146613429|NCT05150990|528754227|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
146613430|NCT05150990|528754228|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
146613431|NCT05150990|528754227|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
146613432|NCT05150990|528754228|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
146613433|NCT05150990|528754227|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
146613434|NCT05150990|528754228|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
146613435|NCT05150990|528754227|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
146613436|NCT05150990|528754228|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
146613437|NCT05150990|528754227|FG000|Overall Study|Death (unrelated to the intervention)|1|||
146613438|NCT05150990|528754228|FG001|Overall Study|Death (unrelated to the intervention)|2|||
146613439|NCT00779025|528754229|FG000|Overall Study|Withdrawal by Subject|1|||
146613440|NCT02735343|528754250|FG000|Overall Study|screen fail|0|||
146613441|NCT02735343|528754251|FG001|Overall Study|screen fail|2|||
146613442|NCT00310817|528754260|FG000|Overall Study|AE or Death|3|||
146613443|NCT00310817|528754261|FG001|Overall Study|AE or Death|1|||
146613444|NCT00310817|528754262|FG002|Overall Study|AE or Death|0|||
146613445|NCT00310817|528754263|FG003|Overall Study|AE or Death|0|||
146613446|NCT00310817|528754260|FG000|Overall Study|Withdrawal by Subject|1|||
146613447|NCT00310817|528754261|FG001|Overall Study|Withdrawal by Subject|4|||
146613448|NCT00310817|528754262|FG002|Overall Study|Withdrawal by Subject|6|||
146613449|NCT00310817|528754263|FG003|Overall Study|Withdrawal by Subject|7|||
146613450|NCT00310817|528754260|FG000|Overall Study|Lost to Follow-up|2|||
146613451|NCT00310817|528754261|FG001|Overall Study|Lost to Follow-up|1|||
146613452|NCT00310817|528754262|FG002|Overall Study|Lost to Follow-up|0|||
146613453|NCT00310817|528754263|FG003|Overall Study|Lost to Follow-up|0|||
146613454|NCT00310817|528754260|FG000|Overall Study|Inappropriate Enrollment|1|||
146658525|NCT01436162|528927301|FG001|Randomized Phase|Protocol Violation|4|||
146658526|NCT01436162|528927302|FG002|Randomized Phase|Protocol Violation|2|||
146658527|NCT01436162|528927300|FG000|Randomized Phase|Withdrawal by Subject|16|||
146658528|NCT01436162|528927301|FG001|Randomized Phase|Withdrawal by Subject|9|||
146613455|NCT00310817|528754261|FG001|Overall Study|Inappropriate Enrollment|0|||
146613456|NCT00310817|528754262|FG002|Overall Study|Inappropriate Enrollment|1|||
146613457|NCT00310817|528754263|FG003|Overall Study|Inappropriate Enrollment|0|||
146613458|NCT00310817|528754260|FG000|Overall Study|Protocol Violation|1|||
146613459|NCT00310817|528754261|FG001|Overall Study|Protocol Violation|1|||
146613460|NCT00310817|528754262|FG002|Overall Study|Protocol Violation|1|||
146613461|NCT00310817|528754263|FG003|Overall Study|Protocol Violation|1|||
146613462|NCT00310817|528754260|FG000|Overall Study|Unable to classify|3|||
146613463|NCT00310817|528754261|FG001|Overall Study|Unable to classify|1|||
146613464|NCT00310817|528754262|FG002|Overall Study|Unable to classify|0|||
146613465|NCT00310817|528754263|FG003|Overall Study|Unable to classify|0|||
146613466|NCT02915978|528754264|FG000|Overall Study|Adverse Event|2|||
146613467|NCT02915978|528754265|FG001|Overall Study|Adverse Event|1|||
146613468|NCT02915978|528754266|FG002|Overall Study|Adverse Event|0|||
146613469|NCT00548145|528754270|FG000|Overall Study|Death|0|||
146613470|NCT00548145|528754271|FG001|Overall Study|Death|1|||
146613471|NCT00548145|528754270|FG000|Overall Study|Withdrawal by Subject|0|||
146613472|NCT00548145|528754271|FG001|Overall Study|Withdrawal by Subject|2|||
146613473|NCT00548145|528754270|FG000|Overall Study|Physician Decision|1|||
146613474|NCT00548145|528754271|FG001|Overall Study|Physician Decision|1|||
146613475|NCT00874848|528754272|FG000|Overall Study|Adverse Event|13|||
146613476|NCT00874848|528754273|FG001|Overall Study|Adverse Event|2|||
146613477|NCT00874848|528754272|FG000|Overall Study|Progressive neoplastic disease|38|||
146613478|NCT00874848|528754273|FG001|Overall Study|Progressive neoplastic disease|18|||
146613479|NCT00874848|528754272|FG000|Overall Study|Withdrawal by Subject|7|||
146613480|NCT00874848|528754273|FG001|Overall Study|Withdrawal by Subject|4|||
146613481|NCT00874848|528754272|FG000|Overall Study|Noncompliance|1|||
146613482|NCT00874848|528754273|FG001|Overall Study|Noncompliance|1|||
146613483|NCT00874848|528754272|FG000|Overall Study|Failure to comply with protocol|0|||
146613484|NCT00874848|528754273|FG001|Overall Study|Failure to comply with protocol|1|||
146613485|NCT00874848|528754272|FG000|Overall Study|Physician Decision|0|||
146613486|NCT00874848|528754273|FG001|Overall Study|Physician Decision|2|||
146613487|NCT04522141|528754278|FG000|Overall Study|Withdrawal by Subject|1|||
146613488|NCT04522141|528754279|FG001|Overall Study|Withdrawal by Subject|0|||
146613489|NCT03052049|528754280|FG000|Overall Study|Withdrawal by Subject|2|||
146613490|NCT03508609|528754281|FG000|Overall Study|Withdrawal by Subject|1|||
146613491|NCT00999518|528754285|FG000|Overall Study|Adverse Event|1|||
146613492|NCT00999518|528754286|FG001|Overall Study|Adverse Event|6|||
146613493|NCT00999518|528754287|FG002|Overall Study|Adverse Event|3|||
146613494|NCT00999518|528754288|FG003|Overall Study|Adverse Event|1|||
146613495|NCT00999518|528754289|FG004|Overall Study|Adverse Event|2|||
146613496|NCT00999518|528754285|FG000|Overall Study|Lack of Efficacy|2|||
146613497|NCT00999518|528754286|FG001|Overall Study|Lack of Efficacy|0|||
146613498|NCT00999518|528754287|FG002|Overall Study|Lack of Efficacy|0|||
146613499|NCT00999518|528754288|FG003|Overall Study|Lack of Efficacy|2|||
146613500|NCT00999518|528754289|FG004|Overall Study|Lack of Efficacy|2|||
146613501|NCT00999518|528754285|FG000|Overall Study|Lost to Follow-up|0|||
146658529|NCT01436162|528927302|FG002|Randomized Phase|Withdrawal by Subject|8|||
146658530|NCT01436162|528927300|FG000|Randomized Phase|Lost to Follow-up|17|||
146658531|NCT01436162|528927301|FG001|Randomized Phase|Lost to Follow-up|5|||
146658532|NCT01436162|528927302|FG002|Randomized Phase|Lost to Follow-up|4|||
146613502|NCT00999518|528754286|FG001|Overall Study|Lost to Follow-up|0|||
146613503|NCT00999518|528754287|FG002|Overall Study|Lost to Follow-up|0|||
146613504|NCT00999518|528754288|FG003|Overall Study|Lost to Follow-up|4|||
146613505|NCT00999518|528754289|FG004|Overall Study|Lost to Follow-up|1|||
146613506|NCT00999518|528754285|FG000|Overall Study|Did not meet entrance criteria|0|||
146613507|NCT00999518|528754286|FG001|Overall Study|Did not meet entrance criteria|0|||
146613508|NCT00999518|528754287|FG002|Overall Study|Did not meet entrance criteria|0|||
146613509|NCT00999518|528754288|FG003|Overall Study|Did not meet entrance criteria|0|||
146613510|NCT00999518|528754289|FG004|Overall Study|Did not meet entrance criteria|1|||
146613511|NCT00999518|528754285|FG000|Overall Study|Study terminated by sponsor|10|||
146613512|NCT00999518|528754286|FG001|Overall Study|Study terminated by sponsor|6|||
146613513|NCT00999518|528754287|FG002|Overall Study|Study terminated by sponsor|5|||
146658533|NCT01436162|528927300|FG000|Randomized Phase|Lack of Efficacy|0|||
146658534|NCT01436162|528927301|FG001|Randomized Phase|Lack of Efficacy|1|||
146658535|NCT01436162|528927302|FG002|Randomized Phase|Lack of Efficacy|1|||
146924919|NCT00632463|529884851|FG001|Overall Study|Adverse Event|1|||
146613514|NCT00999518|528754288|FG003|Overall Study|Study terminated by sponsor|5|||
146613515|NCT00999518|528754289|FG004|Overall Study|Study terminated by sponsor|9|||
146924920|NCT00632463|529884852|FG002|Overall Study|Adverse Event|0|||
146613516|NCT00999518|528754285|FG000|Overall Study|Pregnancy|0|||
146613517|NCT00999518|528754286|FG001|Overall Study|Pregnancy|0|||
146613518|NCT00999518|528754287|FG002|Overall Study|Pregnancy|1|||
146613519|NCT00999518|528754288|FG003|Overall Study|Pregnancy|0|||
146613520|NCT00999518|528754289|FG004|Overall Study|Pregnancy|0|||
146613521|NCT00999518|528754285|FG000|Overall Study|Protocol Violation|0|||
146613522|NCT00999518|528754286|FG001|Overall Study|Protocol Violation|1|||
146613523|NCT00999518|528754287|FG002|Overall Study|Protocol Violation|0|||
146613524|NCT00999518|528754288|FG003|Overall Study|Protocol Violation|0|||
146613525|NCT00999518|528754289|FG004|Overall Study|Protocol Violation|2|||
146613526|NCT00999518|528754285|FG000|Overall Study|Withdrawal by Subject|5|||
146613527|NCT00999518|528754286|FG001|Overall Study|Withdrawal by Subject|4|||
146613528|NCT00999518|528754287|FG002|Overall Study|Withdrawal by Subject|10|||
146613529|NCT00999518|528754288|FG003|Overall Study|Withdrawal by Subject|6|||
146613530|NCT00999518|528754289|FG004|Overall Study|Withdrawal by Subject|1|||
146613531|NCT00999518|528754285|FG000|Overall Study|Other|5|||
146613532|NCT00999518|528754286|FG001|Overall Study|Other|7|||
146613533|NCT00999518|528754287|FG002|Overall Study|Other|1|||
146613534|NCT00999518|528754288|FG003|Overall Study|Other|4|||
146613535|NCT00999518|528754289|FG004|Overall Study|Other|5|||
146613536|NCT00999518|528754285|FG000|Overall Study|Randomized but not Treated|1|||
146613537|NCT00999518|528754286|FG001|Overall Study|Randomized but not Treated|1|||
146613538|NCT00999518|528754287|FG002|Overall Study|Randomized but not Treated|2|||
146613539|NCT00999518|528754288|FG003|Overall Study|Randomized but not Treated|0|||
146613540|NCT00999518|528754289|FG004|Overall Study|Randomized but not Treated|1|||
146613541|NCT00250276|528754290|FG000|Overall Study|Serious Adverse Event|0|||
146613542|NCT00250276|528754291|FG001|Overall Study|Serious Adverse Event|0|||
146613543|NCT00250276|528754292|FG002|Overall Study|Serious Adverse Event|1|||
146613544|NCT00250276|528754293|FG003|Overall Study|Serious Adverse Event|0|||
146613545|NCT00250276|528754290|FG000|Overall Study|Non-serious Adverse Event|2|||
146613546|NCT00250276|528754291|FG001|Overall Study|Non-serious Adverse Event|0|||
146613547|NCT00250276|528754292|FG002|Overall Study|Non-serious Adverse Event|0|||
146613548|NCT00250276|528754293|FG003|Overall Study|Non-serious Adverse Event|2|||
146613549|NCT00250276|528754290|FG000|Overall Study|Protocol Violation|0|||
146613550|NCT00250276|528754291|FG001|Overall Study|Protocol Violation|1|||
146613551|NCT00250276|528754292|FG002|Overall Study|Protocol Violation|0|||
146613552|NCT00250276|528754293|FG003|Overall Study|Protocol Violation|0|||
146613553|NCT00250276|528754290|FG000|Overall Study|Withdrawal by Subject|1|||
146613554|NCT00250276|528754291|FG001|Overall Study|Withdrawal by Subject|2|||
146613555|NCT00250276|528754292|FG002|Overall Study|Withdrawal by Subject|3|||
146613556|NCT00250276|528754293|FG003|Overall Study|Withdrawal by Subject|2|||
146613557|NCT00250276|528754290|FG000|Overall Study|Migrated/moved from study area|3|||
146613558|NCT00250276|528754291|FG001|Overall Study|Migrated/moved from study area|0|||
146613559|NCT00250276|528754292|FG002|Overall Study|Migrated/moved from study area|2|||
146613560|NCT00250276|528754293|FG003|Overall Study|Migrated/moved from study area|7|||
146613561|NCT00250276|528754290|FG000|Overall Study|Lost to Follow-up|11|||
146613562|NCT00250276|528754291|FG001|Overall Study|Lost to Follow-up|18|||
146613563|NCT00250276|528754292|FG002|Overall Study|Lost to Follow-up|13|||
146613564|NCT00250276|528754293|FG003|Overall Study|Lost to Follow-up|8|||
146613565|NCT01546688|528754294|FG000|Overall Study|Adverse Event|0|||
146613566|NCT01546688|528754295|FG001|Overall Study|Adverse Event|4|||
146613567|NCT01546688|528754294|FG000|Overall Study|Withdrawal by Subject|2|||
146613568|NCT01546688|528754295|FG001|Overall Study|Withdrawal by Subject|1|||
146613569|NCT01546688|528754294|FG000|Overall Study|Lack of Efficacy|1|||
146613570|NCT01546688|528754295|FG001|Overall Study|Lack of Efficacy|0|||
146613571|NCT03543137|528754298|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
146613572|NCT03543137|528754299|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
146613573|NCT03543137|528754298|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
146613574|NCT03543137|528754299|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
146613575|NCT03543137|528754298|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
146613576|NCT03543137|528754299|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
146924921|NCT01683071|529884859|FG000|Part 1|Lack of Efficacy|1|||
146924922|NCT01683071|529884860|FG001|Part 1|Lack of Efficacy|0|||
146924923|NCT01683071|529884861|FG002|Part 1|Lack of Efficacy|0|||
146924924|NCT01683071|529884862|FG003|Part 1|Lack of Efficacy|3|||
146924925|NCT01683071|529884863|FG004|Part 1|Lack of Efficacy|0|||
146924926|NCT01683071|529884864|FG005|Part 1|Lack of Efficacy|0|||
146924927|NCT01683071|529884859|FG000|Part 1|Withdrawal by Subject|1|||
146924928|NCT01683071|529884860|FG001|Part 1|Withdrawal by Subject|2|||
146924929|NCT01683071|529884861|FG002|Part 1|Withdrawal by Subject|2|||
146924930|NCT01683071|529884862|FG003|Part 1|Withdrawal by Subject|1|||
146924931|NCT01683071|529884863|FG004|Part 1|Withdrawal by Subject|0|||
146924932|NCT01683071|529884864|FG005|Part 1|Withdrawal by Subject|0|||
146924933|NCT01683071|529884859|FG000|Part 1|Surgery Cancelled|1|||
146924934|NCT01683071|529884860|FG001|Part 1|Surgery Cancelled|0|||
146924935|NCT01683071|529884861|FG002|Part 1|Surgery Cancelled|0|||
146978685|NCT03262233|530085459|FG001|Overall Study|Protocol Violation|10|||
146924936|NCT01683071|529884862|FG003|Part 1|Surgery Cancelled|0|||
146613577|NCT00782483|528754300|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
146924937|NCT01683071|529884863|FG004|Part 1|Surgery Cancelled|0|||
146924938|NCT01683071|529884864|FG005|Part 1|Surgery Cancelled|0|||
146613578|NCT01052077|528754302|FG000|Phase A|Lost to Follow-up|22|||
146613579|NCT01052077|528754303|FG001|Phase A|Lost to Follow-up|0|||
146613580|NCT01052077|528754304|FG002|Phase A|Lost to Follow-up|0|||
146613581|NCT01052077|528754305|FG003|Phase A|Lost to Follow-up|0|||
146613582|NCT01052077|528754302|FG000|Phase A|Adverse Event|32|||
146613583|NCT01052077|528754303|FG001|Phase A|Adverse Event|0|||
146613584|NCT01052077|528754304|FG002|Phase A|Adverse Event|0|||
146613585|NCT01052077|528754305|FG003|Phase A|Adverse Event|0|||
146613586|NCT01052077|528754302|FG000|Phase A|Met Withdrawal Criteria|26|||
146613587|NCT01052077|528754303|FG001|Phase A|Met Withdrawal Criteria|0|||
146613588|NCT01052077|528754304|FG002|Phase A|Met Withdrawal Criteria|0|||
146613589|NCT01052077|528754305|FG003|Phase A|Met Withdrawal Criteria|0|||
146613590|NCT01052077|528754302|FG000|Phase A|Physician Decision|10|||
146613591|NCT01052077|528754303|FG001|Phase A|Physician Decision|0|||
146613592|NCT01052077|528754304|FG002|Phase A|Physician Decision|0|||
146613593|NCT01052077|528754305|FG003|Phase A|Physician Decision|0|||
146613594|NCT01052077|528754302|FG000|Phase A|Withdrawal by Subject|29|||
146613595|NCT01052077|528754303|FG001|Phase A|Withdrawal by Subject|0|||
146613596|NCT01052077|528754304|FG002|Phase A|Withdrawal by Subject|0|||
146613597|NCT01052077|528754305|FG003|Phase A|Withdrawal by Subject|0|||
146613598|NCT01052077|528754302|FG000|Phase A|Protocol Deviation|27|||
146613599|NCT01052077|528754303|FG001|Phase A|Protocol Deviation|0|||
146613600|NCT01052077|528754304|FG002|Phase A|Protocol Deviation|0|||
146613601|NCT01052077|528754305|FG003|Phase A|Protocol Deviation|0|||
146613602|NCT01052077|528754302|FG000|Phase B|Lost to Follow-up|0|||
146613603|NCT01052077|528754303|FG001|Phase B|Lost to Follow-up|2|||
146613604|NCT01052077|528754304|FG002|Phase B|Lost to Follow-up|3|||
146613605|NCT01052077|528754305|FG003|Phase B|Lost to Follow-up|0|||
146613606|NCT01052077|528754302|FG000|Phase B|Adverse Event|0|||
146613607|NCT01052077|528754303|FG001|Phase B|Adverse Event|9|||
146613608|NCT01052077|528754304|FG002|Phase B|Adverse Event|2|||
146613609|NCT01052077|528754305|FG003|Phase B|Adverse Event|0|||
146613610|NCT01052077|528754302|FG000|Phase B|Met Withdrawal Criteria|0|||
146613611|NCT01052077|528754303|FG001|Phase B|Met Withdrawal Criteria|2|||
146613612|NCT01052077|528754304|FG002|Phase B|Met Withdrawal Criteria|1|||
146613613|NCT01052077|528754305|FG003|Phase B|Met Withdrawal Criteria|0|||
146613614|NCT01052077|528754302|FG000|Phase B|Physician Decision|0|||
146613615|NCT01052077|528754303|FG001|Phase B|Physician Decision|1|||
146613616|NCT01052077|528754304|FG002|Phase B|Physician Decision|1|||
146613617|NCT01052077|528754305|FG003|Phase B|Physician Decision|0|||
146613618|NCT01052077|528754302|FG000|Phase B|Withdrawal by Subject|0|||
146613619|NCT01052077|528754303|FG001|Phase B|Withdrawal by Subject|0|||
146613620|NCT01052077|528754304|FG002|Phase B|Withdrawal by Subject|5|||
146613621|NCT01052077|528754305|FG003|Phase B|Withdrawal by Subject|0|||
146613622|NCT01052077|528754302|FG000|Phase B|Protocol Deviation|0|||
146613623|NCT01052077|528754303|FG001|Phase B|Protocol Deviation|3|||
146613624|NCT01052077|528754304|FG002|Phase B|Protocol Deviation|4|||
146613625|NCT01052077|528754305|FG003|Phase B|Protocol Deviation|0|||
146613626|NCT01052077|528754302|FG000|Phase B|Lack of Efficacy|0|||
146613627|NCT01052077|528754303|FG001|Phase B|Lack of Efficacy|1|||
146613628|NCT01052077|528754304|FG002|Phase B|Lack of Efficacy|0|||
146613629|NCT01052077|528754305|FG003|Phase B|Lack of Efficacy|0|||
146613630|NCT01052077|528754302|FG000|Phase A+|Lost to Follow-up|0|||
146613631|NCT01052077|528754303|FG001|Phase A+|Lost to Follow-up|0|||
146658536|NCT01436162|528927300|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
146658537|NCT01436162|528927301|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
146658538|NCT01436162|528927302|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
146658539|NCT01436162|528927300|FG000|Randomized Phase|Other|2|||
146658540|NCT01436162|528927301|FG001|Randomized Phase|Other|5|||
146613632|NCT01052077|528754304|FG002|Phase A+|Lost to Follow-up|0|||
146613633|NCT01052077|528754305|FG003|Phase A+|Lost to Follow-up|8|||
146613634|NCT01052077|528754302|FG000|Phase A+|Adverse Event|0|||
146613635|NCT01052077|528754303|FG001|Phase A+|Adverse Event|0|||
146613636|NCT01052077|528754304|FG002|Phase A+|Adverse Event|0|||
146924939|NCT01683071|529884859|FG000|Part 1|Did not receive study drug|1|||
146924940|NCT01683071|529884860|FG001|Part 1|Did not receive study drug|0|||
146613637|NCT01052077|528754305|FG003|Phase A+|Adverse Event|4|||
146658541|NCT01436162|528927302|FG002|Randomized Phase|Other|4|||
146658542|NCT01888003|528927303|FG000|Overall Study|Study Terminated|5|||
146658543|NCT01888003|528927304|FG001|Overall Study|Study Terminated|6|||
146658544|NCT01888003|528927305|FG002|Overall Study|Study Terminated|40|||
146658545|NCT04597918|528927306|FG000|Overall Study|Withdrawal by Subject|6|||
146613638|NCT01052077|528754302|FG000|Phase A+|Met Withdrawal Criteria|0|||
146613639|NCT01052077|528754303|FG001|Phase A+|Met Withdrawal Criteria|0|||
146613640|NCT01052077|528754304|FG002|Phase A+|Met Withdrawal Criteria|0|||
146613641|NCT01052077|528754305|FG003|Phase A+|Met Withdrawal Criteria|2|||
146924941|NCT01683071|529884861|FG002|Part 1|Did not receive study drug|0|||
146613642|NCT01052077|528754302|FG000|Phase A+|Withdrawal by Subject|0|||
146613643|NCT01052077|528754303|FG001|Phase A+|Withdrawal by Subject|0|||
146613644|NCT01052077|528754304|FG002|Phase A+|Withdrawal by Subject|0|||
146613645|NCT01052077|528754305|FG003|Phase A+|Withdrawal by Subject|7|||
146613646|NCT01445080|528754306|FG000|Overall Study|Adverse Event|5|||
146613647|NCT01445080|528754307|FG001|Overall Study|Adverse Event|3|||
146613648|NCT01445080|528754308|FG002|Overall Study|Adverse Event|11|||
146613649|NCT01445080|528754309|FG003|Overall Study|Adverse Event|6|||
146613650|NCT01445080|528754310|FG004|Overall Study|Adverse Event|2|||
146613651|NCT01445080|528754311|FG005|Overall Study|Adverse Event|3|||
146613652|NCT01445080|528754312|FG006|Overall Study|Adverse Event|0|||
146613653|NCT01445080|528754313|FG007|Overall Study|Adverse Event|3|||
146613654|NCT01445080|528754314|FG008|Overall Study|Adverse Event|10|||
146613655|NCT01445080|528754306|FG000|Overall Study|Physician Decision|0|||
146613656|NCT01445080|528754307|FG001|Overall Study|Physician Decision|0|||
146613657|NCT01445080|528754308|FG002|Overall Study|Physician Decision|1|||
146613658|NCT01445080|528754309|FG003|Overall Study|Physician Decision|0|||
146613659|NCT01445080|528754310|FG004|Overall Study|Physician Decision|0|||
146613660|NCT01445080|528754311|FG005|Overall Study|Physician Decision|3|||
146613661|NCT01445080|528754312|FG006|Overall Study|Physician Decision|2|||
146613662|NCT01445080|528754313|FG007|Overall Study|Physician Decision|2|||
146613663|NCT01445080|528754314|FG008|Overall Study|Physician Decision|0|||
146613664|NCT01445080|528754306|FG000|Overall Study|Withdrawal by Subject|1|||
146613665|NCT01445080|528754307|FG001|Overall Study|Withdrawal by Subject|0|||
146613666|NCT01445080|528754308|FG002|Overall Study|Withdrawal by Subject|0|||
146613667|NCT01445080|528754309|FG003|Overall Study|Withdrawal by Subject|1|||
146613668|NCT01445080|528754310|FG004|Overall Study|Withdrawal by Subject|0|||
146613669|NCT01445080|528754311|FG005|Overall Study|Withdrawal by Subject|0|||
146613670|NCT01445080|528754312|FG006|Overall Study|Withdrawal by Subject|0|||
146613671|NCT01445080|528754313|FG007|Overall Study|Withdrawal by Subject|0|||
146613672|NCT01445080|528754314|FG008|Overall Study|Withdrawal by Subject|2|||
146613673|NCT01445080|528754306|FG000|Overall Study|Ineligible/Inevaluable|1|||
146613674|NCT01445080|528754307|FG001|Overall Study|Ineligible/Inevaluable|2|||
146613675|NCT01445080|528754308|FG002|Overall Study|Ineligible/Inevaluable|0|||
146613676|NCT01445080|528754309|FG003|Overall Study|Ineligible/Inevaluable|1|||
146613677|NCT01445080|528754310|FG004|Overall Study|Ineligible/Inevaluable|2|||
146613678|NCT01445080|528754311|FG005|Overall Study|Ineligible/Inevaluable|3|||
146613679|NCT01445080|528754312|FG006|Overall Study|Ineligible/Inevaluable|0|||
146613680|NCT01445080|528754313|FG007|Overall Study|Ineligible/Inevaluable|0|||
146613681|NCT01445080|528754314|FG008|Overall Study|Ineligible/Inevaluable|6|||
146613682|NCT03887221|528754315|FG000|Overall Study|Protocol Violation|1|||
146613683|NCT03887221|528754316|FG001|Overall Study|Protocol Violation|0|||
146613684|NCT00947115|528754317|FG000|Overall Study|Missed reporting interval|3|||
146613685|NCT00947115|528754318|FG001|Overall Study|Missed reporting interval|4|||
146613686|NCT00947115|528754319|FG002|Overall Study|Missed reporting interval|2|||
146613687|NCT00947115|528754317|FG000|Overall Study|Physician Decision|0|||
146613688|NCT00947115|528754318|FG001|Overall Study|Physician Decision|2|||
146613689|NCT00947115|528754319|FG002|Overall Study|Physician Decision|0|||
146613690|NCT00947115|528754317|FG000|Overall Study|Death|0|||
146613691|NCT00947115|528754318|FG001|Overall Study|Death|1|||
146613692|NCT00947115|528754319|FG002|Overall Study|Death|1|||
146613693|NCT00947115|528754317|FG000|Overall Study|Migrated from study area|2|||
146613694|NCT00947115|528754318|FG001|Overall Study|Migrated from study area|0|||
146613695|NCT00947115|528754319|FG002|Overall Study|Migrated from study area|0|||
146613696|NCT00947115|528754317|FG000|Overall Study|Withdrawal by Subject|1|||
146613697|NCT00947115|528754318|FG001|Overall Study|Withdrawal by Subject|3|||
146613698|NCT00947115|528754319|FG002|Overall Study|Withdrawal by Subject|4|||
146613699|NCT00947115|528754317|FG000|Overall Study|Lost to Follow-up|11|||
146613700|NCT00947115|528754318|FG001|Overall Study|Lost to Follow-up|12|||
146613701|NCT00947115|528754319|FG002|Overall Study|Lost to Follow-up|8|||
146613702|NCT02487030|528754320|FG000|Overall Study|Lack of Efficacy|2|||
146613703|NCT02487030|528754321|FG001|Overall Study|Lack of Efficacy|4|||
146613704|NCT02487030|528754322|FG002|Overall Study|Lack of Efficacy|1|||
146613705|NCT02487030|528754323|FG003|Overall Study|Lack of Efficacy|0|||
146613706|NCT02487030|528754324|FG004|Overall Study|Lack of Efficacy|1|||
146613707|NCT02487030|528754325|FG005|Overall Study|Lack of Efficacy|0|||
146613708|NCT02487030|528754326|FG006|Overall Study|Lack of Efficacy|0|||
146613709|NCT02487030|528754320|FG000|Overall Study|Lost to Follow-up|0|||
146613710|NCT02487030|528754321|FG001|Overall Study|Lost to Follow-up|0|||
146613711|NCT02487030|528754322|FG002|Overall Study|Lost to Follow-up|1|||
146613712|NCT02487030|528754323|FG003|Overall Study|Lost to Follow-up|1|||
146613713|NCT02487030|528754324|FG004|Overall Study|Lost to Follow-up|0|||
146613714|NCT02487030|528754325|FG005|Overall Study|Lost to Follow-up|1|||
146658546|NCT04597918|528927306|FG000|Overall Study|Lost to Follow-up|3|||
146613715|NCT02487030|528754326|FG006|Overall Study|Lost to Follow-up|0|||
146613716|NCT02487030|528754320|FG000|Overall Study|Adverse Event|0|||
146613717|NCT02487030|528754321|FG001|Overall Study|Adverse Event|0|||
146658547|NCT04597918|528927306|FG000|Overall Study|Death|1|||
146613718|NCT02487030|528754322|FG002|Overall Study|Adverse Event|0|||
146613719|NCT02487030|528754323|FG003|Overall Study|Adverse Event|1|||
146613720|NCT02487030|528754324|FG004|Overall Study|Adverse Event|0|||
146613721|NCT02487030|528754325|FG005|Overall Study|Adverse Event|0|||
146613722|NCT02487030|528754326|FG006|Overall Study|Adverse Event|0|||
146613723|NCT02487030|528754320|FG000|Overall Study|Death|0|||
146613724|NCT02487030|528754321|FG001|Overall Study|Death|0|||
146658548|NCT03172910|528928715|FG000|Overall Study|Adverse Event|0|||
146773511|NCT02988817|529341093|FG017|Overall Study|Other|0|||
146613725|NCT02487030|528754322|FG002|Overall Study|Death|0|||
146613726|NCT02487030|528754323|FG003|Overall Study|Death|0|||
146773512|NCT02988817|529341094|FG018|Overall Study|Other|0|||
146613727|NCT02487030|528754324|FG004|Overall Study|Death|1|||
146613728|NCT02487030|528754325|FG005|Overall Study|Death|0|||
146613729|NCT02487030|528754326|FG006|Overall Study|Death|0|||
146613730|NCT03857542|528754327|FG000|Overall Study|Adverse Event|1|||
146613731|NCT03857542|528754328|FG001|Overall Study|Adverse Event|3|||
146613732|NCT03857542|528754327|FG000|Overall Study|Withdrawal by Subject|2|||
146613733|NCT03857542|528754328|FG001|Overall Study|Withdrawal by Subject|1|||
146613734|NCT03857542|528754327|FG000|Overall Study|Lost to Follow-up|2|||
146613735|NCT03857542|528754328|FG001|Overall Study|Lost to Follow-up|1|||
146613736|NCT03857542|528754327|FG000|Overall Study|Reason not Specified|1|||
146613737|NCT03857542|528754328|FG001|Overall Study|Reason not Specified|0|||
146613738|NCT01594931|528756319|FG000|Overall Study|Adverse Event|3|||
146613739|NCT01594931|528756320|FG001|Overall Study|Adverse Event|1|||
146613740|NCT01594931|528756321|FG002|Overall Study|Adverse Event|1|||
146613741|NCT01594931|528756319|FG000|Overall Study|Withdrawal by Subject|2|||
146613742|NCT01594931|528756320|FG001|Overall Study|Withdrawal by Subject|1|||
146613743|NCT01594931|528756321|FG002|Overall Study|Withdrawal by Subject|1|||
146613744|NCT01594931|528756319|FG000|Overall Study|Lack of Efficacy|7|||
146613745|NCT01594931|528756320|FG001|Overall Study|Lack of Efficacy|2|||
146613746|NCT01594931|528756321|FG002|Overall Study|Lack of Efficacy|2|||
146613747|NCT01594931|528756319|FG000|Overall Study|Lost to Follow-up|4|||
146613748|NCT01594931|528756320|FG001|Overall Study|Lost to Follow-up|3|||
146613749|NCT01594931|528756321|FG002|Overall Study|Lost to Follow-up|3|||
146613750|NCT01594931|528756319|FG000|Overall Study|Protocol Violation|2|||
146613751|NCT01594931|528756320|FG001|Overall Study|Protocol Violation|1|||
146613752|NCT01594931|528756321|FG002|Overall Study|Protocol Violation|0|||
146613753|NCT01594931|528756319|FG000|Overall Study|No defiined|11|||
146613754|NCT01594931|528756320|FG001|Overall Study|No defiined|4|||
146613755|NCT01594931|528756321|FG002|Overall Study|No defiined|7|||
146613756|NCT04864639|528756323|FG000|Overall Study|Death|1|||
146613757|NCT04864639|528756323|FG000|Overall Study|Lost to Follow-up|1|||
146613758|NCT01478971|528756330|FG000|Standard of Care Period|Adverse Event|1|||
146613759|NCT01478971|528756330|FG000|Standard of Care Period|Withdrawal by Subject|3|||
146613760|NCT01478971|528756330|FG000|Standard of Care Period|Death|8|||
146613761|NCT01478971|528756330|FG000|Standard of Care Period|Lost to Follow-up|9|||
146613762|NCT01478971|528756330|FG000|Standard of Care Period|Other|4|||
146613763|NCT01478971|528756330|FG000|Peginesatide Treatment Period|Adverse Event|1|||
146613764|NCT01478971|528756330|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
146613765|NCT01478971|528756330|FG000|Peginesatide Treatment Period|Death|4|||
146613766|NCT01478971|528756330|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
146613767|NCT01478971|528756330|FG000|Peginesatide Treatment Period|Other|4|||
146613768|NCT01525615|528756331|FG000|Overall Study|Adverse Event|11|||
146658549|NCT03172910|528928716|FG001|Overall Study|Adverse Event|0|||
146658550|NCT03172910|528928717|FG002|Overall Study|Adverse Event|0|||
146658551|NCT03172910|528928718|FG003|Overall Study|Adverse Event|0|||
146658552|NCT03172910|528928719|FG004|Overall Study|Adverse Event|1|||
146658553|NCT00451451|528928728|FG000|Overall Study|Adverse Event|11|||
146658554|NCT00451451|528928729|FG001|Overall Study|Adverse Event|21|||
146658555|NCT00451451|528928730|FG002|Overall Study|Adverse Event|26|||
146658556|NCT00451451|528928731|FG003|Overall Study|Adverse Event|10|||
146658557|NCT00451451|528928728|FG000|Overall Study|Lost to Follow-up|11|||
146658558|NCT00451451|528928729|FG001|Overall Study|Lost to Follow-up|9|||
146658559|NCT00451451|528928730|FG002|Overall Study|Lost to Follow-up|8|||
146773513|NCT02988817|529341095|FG019|Overall Study|Other|0|||
146773514|NCT02988817|529341076|FG000|Overall Study|Lost to Follow-up|0|||
146773515|NCT02988817|529341077|FG001|Overall Study|Lost to Follow-up|0|||
146613769|NCT01525615|528756332|FG001|Overall Study|Adverse Event|7|||
146773516|NCT02988817|529341078|FG002|Overall Study|Lost to Follow-up|0|||
146773517|NCT02988817|529341079|FG003|Overall Study|Lost to Follow-up|0|||
146924942|NCT01683071|529884862|FG003|Part 1|Did not receive study drug|1|||
146613770|NCT01525615|528756333|FG002|Overall Study|Adverse Event|5|||
146613771|NCT01525615|528756331|FG000|Overall Study|Lost to Follow-up|1|||
146613772|NCT01525615|528756332|FG001|Overall Study|Lost to Follow-up|0|||
146658560|NCT00451451|528928731|FG003|Overall Study|Lost to Follow-up|11|||
146658561|NCT00451451|528928728|FG000|Overall Study|Consent Withdrawn|14|||
146658562|NCT00451451|528928729|FG001|Overall Study|Consent Withdrawn|9|||
146658563|NCT00451451|528928730|FG002|Overall Study|Consent Withdrawn|17|||
146658564|NCT00451451|528928731|FG003|Overall Study|Consent Withdrawn|17|||
146613773|NCT01525615|528756333|FG002|Overall Study|Lost to Follow-up|0|||
146613774|NCT01525615|528756331|FG000|Overall Study|Withdrawal by Subject|1|||
146613775|NCT01525615|528756332|FG001|Overall Study|Withdrawal by Subject|0|||
146613776|NCT01525615|528756333|FG002|Overall Study|Withdrawal by Subject|0|||
146613777|NCT01525615|528756331|FG000|Overall Study|Other reason not described above|1|||
146613778|NCT01525615|528756332|FG001|Overall Study|Other reason not described above|0|||
146658565|NCT00451451|528928728|FG000|Overall Study|Investigator Decision|6|||
146773518|NCT02988817|529341080|FG004|Overall Study|Lost to Follow-up|0|||
146773519|NCT02988817|529341081|FG005|Overall Study|Lost to Follow-up|0|||
146773520|NCT02988817|529341082|FG006|Overall Study|Lost to Follow-up|0|||
146773521|NCT02988817|529341083|FG007|Overall Study|Lost to Follow-up|0|||
146773522|NCT02988817|529341084|FG008|Overall Study|Lost to Follow-up|1|||
146773523|NCT02988817|529341085|FG009|Overall Study|Lost to Follow-up|0|||
146613779|NCT01525615|528756333|FG002|Overall Study|Other reason not described above|1|||
146613780|NCT04050618|528756334|FG000|First Intervention|Withdrawal by Subject|2|||
146613781|NCT04050618|528756335|FG001|First Intervention|Withdrawal by Subject|0|||
146613782|NCT04050618|528756334|FG000|Second Intervention|Withdrawal by Subject|1|||
146613783|NCT04050618|528756335|FG001|Second Intervention|Withdrawal by Subject|0|||
146613784|NCT02451943|528756345|FG000|Overall Study|Withdrawal by Subject|13|||
146613785|NCT02451943|528756346|FG001|Overall Study|Withdrawal by Subject|16|||
146613786|NCT02451943|528756345|FG000|Overall Study|Lost to Follow-up|3|||
146613787|NCT02451943|528756346|FG001|Overall Study|Lost to Follow-up|4|||
146613788|NCT02451943|528756345|FG000|Overall Study|Sponsor Decision|0|||
146613789|NCT02451943|528756346|FG001|Overall Study|Sponsor Decision|4|||
146613790|NCT00217425|528756349|FG000|Overall Study|Never started treatment|2|||
146613791|NCT00217425|528756349|FG000|Overall Study|Patient ineligible|5|||
146613792|NCT00217425|528756349|FG000|Overall Study|Lack of Efficacy|13|||
146613793|NCT00217425|528756349|FG000|Overall Study|Adverse Event|8|||
146613794|NCT00217425|528756349|FG000|Overall Study|Withdrawal by Subject|4|||
146613795|NCT00217425|528756349|FG000|Overall Study|Other complicating disease|1|||
146613796|NCT00217425|528756349|FG000|Overall Study|Other|4|||
146613797|NCT03951077|528756350|FG000|Overall Study|Adverse Event|1|||
146613798|NCT03951077|528756351|FG001|Overall Study|Adverse Event|0|||
146613799|NCT03951077|528756352|FG002|Overall Study|Adverse Event|0|||
146613800|NCT03951077|528756353|FG003|Overall Study|Adverse Event|0|||
146613801|NCT03951077|528756354|FG004|Overall Study|Adverse Event|0|||
146613802|NCT03951077|528756355|FG005|Overall Study|Adverse Event|0|||
146613803|NCT03951077|528756350|FG000|Overall Study|Withdrawal by Subject|3|||
146613804|NCT03951077|528756351|FG001|Overall Study|Withdrawal by Subject|3|||
146613805|NCT03951077|528756352|FG002|Overall Study|Withdrawal by Subject|0|||
146613806|NCT03951077|528756353|FG003|Overall Study|Withdrawal by Subject|3|||
146613807|NCT03951077|528756354|FG004|Overall Study|Withdrawal by Subject|3|||
146613808|NCT03951077|528756355|FG005|Overall Study|Withdrawal by Subject|2|||
146613809|NCT03951077|528756350|FG000|Overall Study|Lost to Follow-up|1|||
146613810|NCT03951077|528756351|FG001|Overall Study|Lost to Follow-up|1|||
146613811|NCT03951077|528756352|FG002|Overall Study|Lost to Follow-up|2|||
146613812|NCT03951077|528756353|FG003|Overall Study|Lost to Follow-up|3|||
146613813|NCT03951077|528756354|FG004|Overall Study|Lost to Follow-up|2|||
146613814|NCT03951077|528756355|FG005|Overall Study|Lost to Follow-up|3|||
146613815|NCT03951077|528756350|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
146613816|NCT03951077|528756351|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
146613817|NCT03951077|528756352|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
146613818|NCT03951077|528756353|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
146613819|NCT03951077|528756354|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
146613820|NCT03951077|528756355|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
146613821|NCT03951077|528756350|FG000|Overall Study|Other, Not Specified|12|||
146613822|NCT03951077|528756351|FG001|Overall Study|Other, Not Specified|10|||
146613823|NCT03951077|528756352|FG002|Overall Study|Other, Not Specified|10|||
146613824|NCT03951077|528756353|FG003|Overall Study|Other, Not Specified|5|||
146613825|NCT03951077|528756354|FG004|Overall Study|Other, Not Specified|9|||
146613826|NCT03951077|528756355|FG005|Overall Study|Other, Not Specified|6|||
146613827|NCT03951077|528756350|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
146613828|NCT03951077|528756351|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
146613829|NCT03951077|528756352|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
146613830|NCT03951077|528756353|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
146613831|NCT03951077|528756354|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
146613832|NCT03951077|528756355|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
146613833|NCT01473732|528756357|FG000|Overall Study|Adverse Event|1|||
146613834|NCT01473732|528756358|FG001|Overall Study|Adverse Event|0|||
146613835|NCT01473732|528756357|FG000|Overall Study|Death|1|||
146613836|NCT01473732|528756358|FG001|Overall Study|Death|0|||
146613837|NCT01395901|528756359|FG000|Overall Study|Lost to Follow-up|4|||
146613838|NCT01395901|528756360|FG001|Overall Study|Lost to Follow-up|0|||
146613839|NCT01395901|528756359|FG000|Overall Study|Randomized but not received study drug|5|||
146613840|NCT01395901|528756360|FG001|Overall Study|Randomized but not received study drug|4|||
146613841|NCT01395901|528756359|FG000|Overall Study|Adverse Event|0|||
146613842|NCT01395901|528756360|FG001|Overall Study|Adverse Event|1|||
146613843|NCT01395901|528756359|FG000|Overall Study|Withdrawal of consent|1|||
146613844|NCT01395901|528756360|FG001|Overall Study|Withdrawal of consent|0|||
146613845|NCT01217944|528756364|FG000|Overall Study|Protocol Violation|1|||
146613846|NCT01217944|528756365|FG001|Overall Study|Protocol Violation|1|||
146613847|NCT01217944|528756366|FG002|Overall Study|Protocol Violation|0|||
146613848|NCT01217944|528756364|FG000|Overall Study|Lost to Follow-up|3|||
146773524|NCT02988817|529341086|FG010|Overall Study|Lost to Follow-up|1|||
146773525|NCT02988817|529341087|FG011|Overall Study|Lost to Follow-up|1|||
146613849|NCT01217944|528756365|FG001|Overall Study|Lost to Follow-up|1|||
146613850|NCT01217944|528756366|FG002|Overall Study|Lost to Follow-up|0|||
146613851|NCT01217944|528756364|FG000|Overall Study|Withdrawal by Subject|1|||
146613852|NCT01217944|528756365|FG001|Overall Study|Withdrawal by Subject|2|||
146613853|NCT01217944|528756366|FG002|Overall Study|Withdrawal by Subject|0|||
146613854|NCT01217944|528756364|FG000|Overall Study|Lack of Efficacy|1|||
146613855|NCT01217944|528756365|FG001|Overall Study|Lack of Efficacy|0|||
146613856|NCT01217944|528756366|FG002|Overall Study|Lack of Efficacy|0|||
146613857|NCT03579940|528756367|FG000|Period 2|Withdrawal by Subject|0|||
146613858|NCT03579940|528756368|FG001|Period 2|Withdrawal by Subject|0|||
146613859|NCT03579940|528756369|FG002|Period 2|Withdrawal by Subject|1|||
146613860|NCT03579940|528756370|FG003|Period 2|Withdrawal by Subject|0|||
146613861|NCT03579940|528756371|FG004|Period 2|Withdrawal by Subject|0|||
146613862|NCT03579940|528756372|FG005|Period 2|Withdrawal by Subject|0|||
146613863|NCT03579940|528756373|FG006|Period 2|Withdrawal by Subject|0|||
146613864|NCT03579940|528756374|FG007|Period 2|Withdrawal by Subject|0|||
146613865|NCT03579940|528756375|FG008|Period 2|Withdrawal by Subject|0|||
146613866|NCT03579940|528756376|FG009|Period 2|Withdrawal by Subject|0|||
146613867|NCT03579940|528756377|FG010|Period 2|Withdrawal by Subject|0|||
146613868|NCT00671034|528756378|FG000|Overall Study|Adverse Event|5|||
146613869|NCT00671034|528756379|FG001|Overall Study|Adverse Event|7|||
146613870|NCT00671034|528756380|FG002|Overall Study|Adverse Event|1|||
146613871|NCT00671034|528756378|FG000|Overall Study|Death|3|||
146613872|NCT00671034|528756379|FG001|Overall Study|Death|2|||
146613873|NCT00671034|528756380|FG002|Overall Study|Death|1|||
146613874|NCT00671034|528756378|FG000|Overall Study|Physician Decision|12|||
146613875|NCT00671034|528756379|FG001|Overall Study|Physician Decision|4|||
146613876|NCT00671034|528756380|FG002|Overall Study|Physician Decision|5|||
146613877|NCT00671034|528756378|FG000|Overall Study|VHR ALL feature|8|||
146613878|NCT00671034|528756379|FG001|Overall Study|VHR ALL feature|3|||
146613879|NCT00671034|528756380|FG002|Overall Study|VHR ALL feature|5|||
146613880|NCT00671034|528756378|FG000|Overall Study|Refusal|5|||
146613881|NCT00671034|528756379|FG001|Overall Study|Refusal|3|||
146613882|NCT00671034|528756380|FG002|Overall Study|Refusal|5|||
146613883|NCT00671034|528756378|FG000|Overall Study|includes Alternative therapy, etc.|6|||
146613884|NCT00671034|528756379|FG001|Overall Study|includes Alternative therapy, etc.|1|||
146613885|NCT00671034|528756380|FG002|Overall Study|includes Alternative therapy, etc.|7|||
146613886|NCT00853151|528756381|FG000|Overall Study|Adverse Event|1|||
146613887|NCT00853151|528756382|FG001|Overall Study|Adverse Event|4|||
146613888|NCT00853151|528756383|FG002|Overall Study|Adverse Event|2|||
146613889|NCT00853151|528756384|FG003|Overall Study|Adverse Event|0|||
146613890|NCT00853151|528756381|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
146613891|NCT00853151|528756382|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146613892|NCT00853151|528756383|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146613893|NCT00853151|528756384|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146613894|NCT00853151|528756381|FG000|Overall Study|Lost to Follow-up|2|||
146613895|NCT00853151|528756382|FG001|Overall Study|Lost to Follow-up|0|||
146613896|NCT00853151|528756383|FG002|Overall Study|Lost to Follow-up|3|||
146613897|NCT00853151|528756384|FG003|Overall Study|Lost to Follow-up|0|||
146658566|NCT00451451|528928729|FG001|Overall Study|Investigator Decision|2|||
146658567|NCT00451451|528928730|FG002|Overall Study|Investigator Decision|1|||
146658568|NCT00451451|528928731|FG003|Overall Study|Investigator Decision|2|||
146658569|NCT00451451|528928728|FG000|Overall Study|Subject Non-Compliance|8|||
146658570|NCT00451451|528928729|FG001|Overall Study|Subject Non-Compliance|4|||
146658571|NCT00451451|528928730|FG002|Overall Study|Subject Non-Compliance|3|||
146658572|NCT00451451|528928731|FG003|Overall Study|Subject Non-Compliance|3|||
146658573|NCT00451451|528928728|FG000|Overall Study|Death|1|||
146613898|NCT00853151|528756381|FG000|Overall Study|Death|1|||
146613899|NCT00853151|528756382|FG001|Overall Study|Death|0|||
146613900|NCT00853151|528756383|FG002|Overall Study|Death|0|||
146613901|NCT00853151|528756384|FG003|Overall Study|Death|1|||
146658574|NCT00451451|528928729|FG001|Overall Study|Death|0|||
146658575|NCT00451451|528928730|FG002|Overall Study|Death|0|||
146613902|NCT00853151|528756381|FG000|Overall Study|Protocol Violation|0|||
146613903|NCT00853151|528756382|FG001|Overall Study|Protocol Violation|0|||
146613904|NCT00853151|528756383|FG002|Overall Study|Protocol Violation|0|||
146613905|NCT00853151|528756384|FG003|Overall Study|Protocol Violation|1|||
146613906|NCT00853151|528756381|FG000|Overall Study|Withdrawal by Subject|5|||
146613907|NCT00853151|528756382|FG001|Overall Study|Withdrawal by Subject|4|||
146613908|NCT00853151|528756383|FG002|Overall Study|Withdrawal by Subject|2|||
146613909|NCT00853151|528756384|FG003|Overall Study|Withdrawal by Subject|1|||
146613910|NCT00853151|528756381|FG000|Overall Study|Physician Decision|0|||
146613911|NCT00853151|528756382|FG001|Overall Study|Physician Decision|2|||
146613912|NCT00853151|528756383|FG002|Overall Study|Physician Decision|1|||
146613913|NCT00853151|528756384|FG003|Overall Study|Physician Decision|0|||
146658576|NCT00451451|528928731|FG003|Overall Study|Death|1|||
146658577|NCT00451451|528928728|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
146613914|NCT00853151|528756381|FG000|Overall Study|Sponsor Decision|0|||
146658578|NCT00451451|528928729|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
146613915|NCT00853151|528756382|FG001|Overall Study|Sponsor Decision|3|||
146613916|NCT00853151|528756383|FG002|Overall Study|Sponsor Decision|0|||
146613917|NCT00853151|528756384|FG003|Overall Study|Sponsor Decision|0|||
146613918|NCT00713544|528756385|FG000|Overall Study|Adverse Event|5|||
146613919|NCT00713544|528756386|FG001|Overall Study|Adverse Event|3|||
146613920|NCT00713544|528756387|FG002|Overall Study|Adverse Event|7|||
146613921|NCT00713544|528756388|FG003|Overall Study|Adverse Event|7|||
146658579|NCT00451451|528928730|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
146658580|NCT00451451|528928731|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
146658581|NCT00122278|528928732|FG000|Overall Study|Lost to Follow-up|2|||
146658582|NCT00122278|528928733|FG001|Overall Study|Lost to Follow-up|0|||
146658583|NCT01002482|528928734|FG000|Overall Study|Withdrawal by Subject|14|||
146658584|NCT01002482|528928735|FG001|Overall Study|Withdrawal by Subject|21|||
146658585|NCT01002482|528928734|FG000|Overall Study|Included twice|1|||
146658586|NCT01002482|528928735|FG001|Overall Study|Included twice|0|||
146658587|NCT01865084|528928736|FG000|Double Blind Period (DB)|Adverse Event|2|||
146658588|NCT01865084|528928737|FG001|Double Blind Period (DB)|Adverse Event|2|||
146658589|NCT01865084|528928738|FG002|Double Blind Period (DB)|Adverse Event|1|||
146613922|NCT00713544|528756389|FG004|Overall Study|Adverse Event|3|||
146613923|NCT00713544|528756390|FG005|Overall Study|Adverse Event|5|||
146613924|NCT00713544|528756385|FG000|Overall Study|Withdrawal by Subject|2|||
146658590|NCT01865084|528928736|FG000|Double Blind Period (DB)|Protocol Violation|0|||
146658591|NCT01865084|528928737|FG001|Double Blind Period (DB)|Protocol Violation|0|||
146658592|NCT01865084|528928738|FG002|Double Blind Period (DB)|Protocol Violation|1|||
146658593|NCT01865084|528928736|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
146658594|NCT01865084|528928737|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
146658595|NCT01865084|528928738|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
146658596|NCT01865084|528928736|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
146658597|NCT01865084|528928737|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
146658598|NCT01865084|528928738|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
146658599|NCT01865084|528928736|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
146658600|NCT01865084|528928737|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
146658601|NCT01865084|528928738|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
146658602|NCT01865084|528928736|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
146658603|NCT01865084|528928737|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
146658604|NCT01865084|528928738|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
146658605|NCT01865084|528928736|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
146658606|NCT01865084|528928737|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
146658607|NCT01865084|528928738|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
146658608|NCT01865084|528928736|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
146658609|NCT01865084|528928737|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
146658610|NCT01865084|528928738|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
146658611|NCT01865084|528928736|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
146658612|NCT01865084|528928737|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
146658613|NCT01865084|528928738|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
146658614|NCT02247531|528928742|FG000|Overall Study|Adverse Event|3|||
146658615|NCT02247531|528928743|FG001|Overall Study|Adverse Event|4|||
146658616|NCT02247531|528928744|FG002|Overall Study|Adverse Event|9|||
146658617|NCT02247531|528928742|FG000|Overall Study|Death|8|||
146658618|NCT02247531|528928743|FG001|Overall Study|Death|9|||
146658619|NCT02247531|528928744|FG002|Overall Study|Death|5|||
146658620|NCT02247531|528928742|FG000|Overall Study|Lost to Follow-up|1|||
146613925|NCT00713544|528756386|FG001|Overall Study|Withdrawal by Subject|0|||
146658621|NCT02247531|528928743|FG001|Overall Study|Lost to Follow-up|8|||
146658622|NCT02247531|528928744|FG002|Overall Study|Lost to Follow-up|3|||
146658623|NCT02247531|528928742|FG000|Overall Study|Non-compliance|2|||
146658624|NCT02247531|528928743|FG001|Overall Study|Non-compliance|2|||
146658625|NCT02247531|528928744|FG002|Overall Study|Non-compliance|0|||
146658626|NCT02247531|528928742|FG000|Overall Study|Withdrawal by Subject|26|||
146658627|NCT02247531|528928743|FG001|Overall Study|Withdrawal by Subject|31|||
146658628|NCT02247531|528928744|FG002|Overall Study|Withdrawal by Subject|25|||
146658629|NCT02247531|528928742|FG000|Overall Study|Study Terminated by Sponsor|64|||
146658630|NCT02247531|528928743|FG001|Overall Study|Study Terminated by Sponsor|66|||
146658631|NCT02247531|528928744|FG002|Overall Study|Study Terminated by Sponsor|62|||
146658632|NCT02247531|528928742|FG000|Overall Study|Physician Decision|0|||
146658633|NCT02247531|528928743|FG001|Overall Study|Physician Decision|2|||
146658634|NCT02247531|528928744|FG002|Overall Study|Physician Decision|2|||
146613926|NCT00713544|528756387|FG002|Overall Study|Withdrawal by Subject|3|||
146658635|NCT02247531|528928742|FG000|Overall Study|Unspecified Reason|2|||
146658636|NCT02247531|528928743|FG001|Overall Study|Unspecified Reason|3|||
146658637|NCT02247531|528928744|FG002|Overall Study|Unspecified Reason|4|||
146658638|NCT02423109|528928749|FG000|Lens 1|Adverse Event|1|||
146613927|NCT00713544|528756388|FG003|Overall Study|Withdrawal by Subject|2|||
146613928|NCT00713544|528756389|FG004|Overall Study|Withdrawal by Subject|3|||
146658639|NCT02423109|528928750|FG001|Lens 1|Adverse Event|0|||
146613929|NCT00713544|528756390|FG005|Overall Study|Withdrawal by Subject|1|||
146613930|NCT00713544|528756385|FG000|Overall Study|Protocol Violation|0|||
146613931|NCT00713544|528756386|FG001|Overall Study|Protocol Violation|0|||
146613932|NCT00713544|528756387|FG002|Overall Study|Protocol Violation|0|||
146613933|NCT00713544|528756388|FG003|Overall Study|Protocol Violation|0|||
146613934|NCT00713544|528756389|FG004|Overall Study|Protocol Violation|0|||
146613935|NCT00713544|528756390|FG005|Overall Study|Protocol Violation|1|||
146613936|NCT00713544|528756385|FG000|Overall Study|Physician Decision|0|||
146613937|NCT00713544|528756386|FG001|Overall Study|Physician Decision|0|||
146613938|NCT00713544|528756387|FG002|Overall Study|Physician Decision|0|||
146613939|NCT00713544|528756388|FG003|Overall Study|Physician Decision|0|||
146613940|NCT00713544|528756389|FG004|Overall Study|Physician Decision|0|||
146613941|NCT00713544|528756390|FG005|Overall Study|Physician Decision|2|||
146613942|NCT00713544|528756385|FG000|Overall Study|Lack of Efficacy|0|||
146613943|NCT00713544|528756386|FG001|Overall Study|Lack of Efficacy|1|||
146613944|NCT00713544|528756387|FG002|Overall Study|Lack of Efficacy|0|||
146613945|NCT00713544|528756388|FG003|Overall Study|Lack of Efficacy|1|||
146613946|NCT00713544|528756389|FG004|Overall Study|Lack of Efficacy|1|||
146613947|NCT00713544|528756390|FG005|Overall Study|Lack of Efficacy|0|||
146613948|NCT00713544|528756385|FG000|Overall Study|Lost to Follow-up|0|||
146613949|NCT00713544|528756386|FG001|Overall Study|Lost to Follow-up|0|||
146613950|NCT00713544|528756387|FG002|Overall Study|Lost to Follow-up|1|||
146613951|NCT00713544|528756388|FG003|Overall Study|Lost to Follow-up|0|||
146613952|NCT00713544|528756389|FG004|Overall Study|Lost to Follow-up|0|||
146613953|NCT00713544|528756390|FG005|Overall Study|Lost to Follow-up|0|||
146613954|NCT00713544|528756385|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
146613955|NCT00713544|528756386|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
146613956|NCT00713544|528756387|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
146613957|NCT00713544|528756388|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
146613958|NCT00713544|528756389|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
146613959|NCT00713544|528756390|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
146613960|NCT00713544|528756385|FG000|Overall Study|Incorrect enrollment|0|||
146613961|NCT00713544|528756386|FG001|Overall Study|Incorrect enrollment|1|||
146613962|NCT00713544|528756387|FG002|Overall Study|Incorrect enrollment|0|||
146613963|NCT00713544|528756388|FG003|Overall Study|Incorrect enrollment|0|||
146613964|NCT00713544|528756389|FG004|Overall Study|Incorrect enrollment|0|||
146613965|NCT00713544|528756390|FG005|Overall Study|Incorrect enrollment|0|||
146613966|NCT00713544|528756385|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
146613967|NCT00713544|528756386|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
146613968|NCT00713544|528756387|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
146613969|NCT00713544|528756388|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
146613970|NCT00713544|528756389|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
146613971|NCT00713544|528756390|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
146613972|NCT02471014|528756393|FG000|Overall Study|Lost to Follow-up|2|||
146613973|NCT02471014|528756394|FG001|Overall Study|Lost to Follow-up|2|||
146613974|NCT02380287|528756395|FG000|Overall Study|Adverse Event|0|||
146613975|NCT02380287|528756396|FG001|Overall Study|Adverse Event|0|||
146613976|NCT02380287|528756397|FG002|Overall Study|Adverse Event|1|||
146613977|NCT02380287|528756398|FG003|Overall Study|Adverse Event|0|||
146613978|NCT02380287|528756399|FG004|Overall Study|Adverse Event|0|||
146613979|NCT02380287|528756400|FG005|Overall Study|Adverse Event|0|||
146613980|NCT02380287|528756401|FG006|Overall Study|Adverse Event|0|||
146613981|NCT02380287|528756402|FG007|Overall Study|Adverse Event|0|||
146613982|NCT01751984|528756403|FG000|Overall Study|Adverse Event|5|||
146613983|NCT01751984|528756404|FG001|Overall Study|Adverse Event|3|||
146613984|NCT01751984|528756403|FG000|Overall Study|Withdrawal by Subject|0|||
146613985|NCT01751984|528756404|FG001|Overall Study|Withdrawal by Subject|1|||
146613986|NCT01751984|528756403|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
146613987|NCT01751984|528756404|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
146613988|NCT04473963|528756405|FG000|Overall Study|Withdrawal by Subject|1|||
146613989|NCT04473963|528756406|FG001|Overall Study|Withdrawal by Subject|1|||
146613990|NCT04473963|528756407|FG002|Overall Study|Withdrawal by Subject|0|||
146613991|NCT04473963|528756405|FG000|Overall Study|Not inducible in AF|0|||
146613992|NCT04473963|528756406|FG001|Overall Study|Not inducible in AF|0|||
146613993|NCT04473963|528756407|FG002|Overall Study|Not inducible in AF|2|||
146613994|NCT01641601|528756408|FG000|Overall Study|Study discontinued.|3|||
146613995|NCT01641601|528756409|FG001|Overall Study|Study discontinued.|5|||
146613996|NCT00587158|528756410|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
146613997|NCT00587158|528756411|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
146613998|NCT00587158|528756410|FG000|Overall Study|Physician Decision|0|||
146773526|NCT02988817|529341088|FG012|Overall Study|Lost to Follow-up|0|||
146613999|NCT00587158|528756411|FG001|Overall Study|Physician Decision|1|||
146614000|NCT00587158|528756410|FG000|Overall Study|Lost to Follow-up|1|||
146614001|NCT00587158|528756411|FG001|Overall Study|Lost to Follow-up|2|||
146614002|NCT00587158|528756410|FG000|Overall Study|Death|0|||
146614003|NCT00587158|528756411|FG001|Overall Study|Death|1|||
146614004|NCT00587158|528756410|FG000|Overall Study|Subject did not want to take study med|0|||
146614005|NCT00587158|528756411|FG001|Overall Study|Subject did not want to take study med|1|||
146614006|NCT04390243|528756415|FG000|Overall Study|Death|1|||
146614007|NCT04390243|528756415|FG000|Overall Study|Disease Progression|4|||
146614008|NCT04390243|528756415|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
146614009|NCT01196026|528756422|FG000|Overall Study|Withdrawal by Subject|1|||
146614010|NCT01196026|528756423|FG001|Overall Study|Withdrawal by Subject|4|||
146614011|NCT01196026|528756424|FG002|Overall Study|Withdrawal by Subject|0|||
146614012|NCT01196026|528756425|FG003|Overall Study|Withdrawal by Subject|0|||
146614013|NCT01196026|528756426|FG004|Overall Study|Withdrawal by Subject|0|||
146614014|NCT01196026|528756427|FG005|Overall Study|Withdrawal by Subject|0|||
146614015|NCT01196026|528756422|FG000|Overall Study|Lost to Follow-up|0|||
146614016|NCT01196026|528756423|FG001|Overall Study|Lost to Follow-up|3|||
146614017|NCT01196026|528756424|FG002|Overall Study|Lost to Follow-up|0|||
146614018|NCT01196026|528756425|FG003|Overall Study|Lost to Follow-up|0|||
146614019|NCT01196026|528756426|FG004|Overall Study|Lost to Follow-up|1|||
146614020|NCT01196026|528756427|FG005|Overall Study|Lost to Follow-up|0|||
146614021|NCT01196026|528756422|FG000|Overall Study|Other|0|||
146614022|NCT01196026|528756423|FG001|Overall Study|Other|1|||
146614023|NCT01196026|528756424|FG002|Overall Study|Other|0|||
146614024|NCT01196026|528756425|FG003|Overall Study|Other|0|||
146614025|NCT01196026|528756426|FG004|Overall Study|Other|0|||
146614026|NCT01196026|528756427|FG005|Overall Study|Other|0|||
146614027|NCT00799903|528756429|FG000|Overall Study|Investigator Site Closed|25|||
146614028|NCT00799903|528756430|FG001|Overall Study|Investigator Site Closed|23|||
146614029|NCT00799903|528756429|FG000|Overall Study|Withdrawal by Subject|179|||
146614030|NCT00799903|528756430|FG001|Overall Study|Withdrawal by Subject|175|||
146614031|NCT00799903|528756429|FG000|Overall Study|Lost to Follow-up|69|||
146614032|NCT00799903|528756430|FG001|Overall Study|Lost to Follow-up|80|||
146614033|NCT01221350|528756433|FG000|Overall Study|Discontinued intervention (GERD)|1|||
146614034|NCT01221350|528756434|FG001|Overall Study|Discontinued intervention (GERD)|0|||
146614035|NCT01221350|528756433|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
146614036|NCT01221350|528756434|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
146614037|NCT01221350|528756433|FG000|Overall Study|Withdrawal by Subject|4|||
146614038|NCT01221350|528756434|FG001|Overall Study|Withdrawal by Subject|2|||
146614039|NCT02715609|528756438|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
146614040|NCT02715609|528756439|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
146614041|NCT02715609|528756440|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
146614042|NCT02715609|528756438|FG000|Overall Study|Withdrawal by Subject|0|||
146614043|NCT02715609|528756439|FG001|Overall Study|Withdrawal by Subject|0|||
146614044|NCT02715609|528756440|FG002|Overall Study|Withdrawal by Subject|1|||
146614045|NCT05236257|528756443|FG000|Overall Study|Ongoing with study treatment|29|||
146614046|NCT05236257|528756444|FG001|Overall Study|Ongoing with study treatment|1|||
146614047|NCT05236257|528756443|FG000|Overall Study|Discontinued study treatment|22|||
146614048|NCT05236257|528756444|FG001|Overall Study|Discontinued study treatment|41|||
146614049|NCT04752332|528756445|FG000|Overall Study|Adverse Event|3|||
146614050|NCT04752332|528756446|FG001|Overall Study|Adverse Event|1|||
146614051|NCT04752332|528756445|FG000|Overall Study|Disease Relapse|1|||
146614052|NCT04752332|528756446|FG001|Overall Study|Disease Relapse|0|||
146614053|NCT04752332|528756445|FG000|Overall Study|Non-compliance With Study Drug|2|||
146614054|NCT04752332|528756446|FG001|Overall Study|Non-compliance With Study Drug|0|||
146614055|NCT04752332|528756445|FG000|Overall Study|Physician Decision|2|||
146614056|NCT04752332|528756446|FG001|Overall Study|Physician Decision|1|||
146614057|NCT04752332|528756445|FG000|Overall Study|Protocol Violation|1|||
146614058|NCT04752332|528756446|FG001|Overall Study|Protocol Violation|1|||
146614059|NCT04752332|528756445|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
146614060|NCT04752332|528756446|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
146614061|NCT04752332|528756445|FG000|Overall Study|Study Terminated by Sponsor|10|||
146614062|NCT04752332|528756446|FG001|Overall Study|Study Terminated by Sponsor|48|||
146614063|NCT04752332|528756445|FG000|Overall Study|Withdrawal by Subject|11|||
146614064|NCT04752332|528756446|FG001|Overall Study|Withdrawal by Subject|3|||
146614065|NCT00924443|528756449|FG000|Overall Study|Physician Decision|2|||
146614066|NCT00924443|528756449|FG000|Overall Study|Protocol Violation|1|||
146614067|NCT02451124|528756451|FG000|Overall Study|Withdrawal by Subject|1|||
146614068|NCT03301350|528756452|FG000|Overall Study|Withdrawal by Subject|4|||
146614069|NCT03301350|528756452|FG000|Overall Study|Adverse Event|1|||
146614070|NCT03301350|528756452|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
146614071|NCT03301350|528756452|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
146614072|NCT03301350|528756452|FG000|Overall Study|no detail provided|1|||
146614073|NCT01248949|528756453|FG000|Overall Study|Lost to Follow-up|2|||
146614074|NCT01248949|528756454|FG001|Overall Study|Lost to Follow-up|2|||
146614075|NCT01248949|528756455|FG002|Overall Study|Lost to Follow-up|2|||
146614076|NCT01248949|528756456|FG003|Overall Study|Lost to Follow-up|1|||
146614077|NCT01248949|528756457|FG004|Overall Study|Lost to Follow-up|0|||
146614078|NCT01248949|528756453|FG000|Overall Study|Withdrawal by Subject|5|||
146614079|NCT01248949|528756454|FG001|Overall Study|Withdrawal by Subject|3|||
146614080|NCT01248949|528756455|FG002|Overall Study|Withdrawal by Subject|11|||
146614081|NCT01248949|528756456|FG003|Overall Study|Withdrawal by Subject|3|||
146614082|NCT01248949|528756457|FG004|Overall Study|Withdrawal by Subject|1|||
146614083|NCT01248949|528756453|FG000|Overall Study|Death|22|||
146614084|NCT01248949|528756454|FG001|Overall Study|Death|7|||
146614085|NCT01248949|528756455|FG002|Overall Study|Death|21|||
146614086|NCT01248949|528756456|FG003|Overall Study|Death|6|||
146614087|NCT01248949|528756457|FG004|Overall Study|Death|2|||
146614088|NCT01248949|528756453|FG000|Overall Study|Alternative Therapy|1|||
146614089|NCT01248949|528756454|FG001|Overall Study|Alternative Therapy|0|||
146614090|NCT01248949|528756455|FG002|Overall Study|Alternative Therapy|0|||
146614091|NCT01248949|528756456|FG003|Overall Study|Alternative Therapy|0|||
146614092|NCT01248949|528756457|FG004|Overall Study|Alternative Therapy|0|||
146614093|NCT01248949|528756453|FG000|Overall Study|Alternative Therapy.|1|||
146614094|NCT01248949|528756454|FG001|Overall Study|Alternative Therapy.|0|||
146614095|NCT01248949|528756455|FG002|Overall Study|Alternative Therapy.|0|||
146614096|NCT01248949|528756456|FG003|Overall Study|Alternative Therapy.|0|||
146614097|NCT01248949|528756457|FG004|Overall Study|Alternative Therapy.|0|||
146614098|NCT01248949|528756453|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
146614099|NCT01248949|528756454|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
146614100|NCT01248949|528756455|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
146614101|NCT01248949|528756456|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
146614102|NCT01248949|528756457|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
146614103|NCT01248949|528756453|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
146614104|NCT01248949|528756454|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
146614105|NCT01248949|528756455|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
146614106|NCT01248949|528756456|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
146614107|NCT01248949|528756457|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
146614108|NCT01248949|528756453|FG000|Overall Study|Participant Went To Hospice|0|||
146614109|NCT01248949|528756454|FG001|Overall Study|Participant Went To Hospice|0|||
146614110|NCT01248949|528756455|FG002|Overall Study|Participant Went To Hospice|1|||
146614111|NCT01248949|528756456|FG003|Overall Study|Participant Went To Hospice|0|||
146614112|NCT01248949|528756457|FG004|Overall Study|Participant Went To Hospice|0|||
146614113|NCT01248949|528756453|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
146614114|NCT01248949|528756454|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
146614115|NCT01248949|528756455|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
146614116|NCT01248949|528756456|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
146614117|NCT01248949|528756457|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
146614118|NCT01248949|528756453|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
146614119|NCT01248949|528756454|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
146614120|NCT01248949|528756455|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
146614121|NCT01248949|528756456|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
146614122|NCT01248949|528756457|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
146614123|NCT01248949|528756453|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
146614124|NCT01248949|528756454|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
146614125|NCT01248949|528756455|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
146614126|NCT01248949|528756456|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
146614127|NCT01248949|528756457|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
146614128|NCT01248949|528756453|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
146614129|NCT01248949|528756454|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
146614130|NCT01248949|528756455|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
146614131|NCT01248949|528756456|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
146614132|NCT01248949|528756457|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
146614133|NCT00286429|528756458|FG000|Overall Study|Adverse Event|4|||
146614134|NCT00286429|528756459|FG001|Overall Study|Adverse Event|1|||
146614135|NCT00286429|528756460|FG002|Overall Study|Adverse Event|6|||
146614136|NCT00286429|528756458|FG000|Overall Study|Lack of Efficacy|52|||
146614137|NCT00286429|528756459|FG001|Overall Study|Lack of Efficacy|27|||
146614138|NCT00286429|528756460|FG002|Overall Study|Lack of Efficacy|25|||
146614139|NCT00286429|528756458|FG000|Overall Study|Lost to Follow-up|2|||
146614140|NCT00286429|528756459|FG001|Overall Study|Lost to Follow-up|4|||
146614141|NCT00286429|528756460|FG002|Overall Study|Lost to Follow-up|3|||
146614142|NCT00286429|528756458|FG000|Overall Study|Physician Decision|10|||
146614143|NCT00286429|528756459|FG001|Overall Study|Physician Decision|7|||
146614144|NCT00286429|528756460|FG002|Overall Study|Physician Decision|7|||
146614145|NCT00286429|528756458|FG000|Overall Study|Protocol Violation|3|||
146614146|NCT00286429|528756459|FG001|Overall Study|Protocol Violation|5|||
146614147|NCT00286429|528756460|FG002|Overall Study|Protocol Violation|4|||
146614148|NCT00286429|528756458|FG000|Overall Study|Withdrawal by Subject|3|||
146614149|NCT00286429|528756459|FG001|Overall Study|Withdrawal by Subject|2|||
146614150|NCT00286429|528756460|FG002|Overall Study|Withdrawal by Subject|6|||
146614151|NCT00286429|528756458|FG000|Overall Study|Administrative Error|1|||
146614152|NCT00286429|528756459|FG001|Overall Study|Administrative Error|1|||
146614153|NCT00286429|528756460|FG002|Overall Study|Administrative Error|1|||
146614154|NCT00286429|528756458|FG000|Overall Study|Administrative Decision|0|||
146614155|NCT00286429|528756459|FG001|Overall Study|Administrative Decision|1|||
146614156|NCT00286429|528756460|FG002|Overall Study|Administrative Decision|0|||
146614157|NCT01746225|528756463|FG000|Overall Study|Death|1|||
146614158|NCT01746225|528756464|FG001|Overall Study|Death|0|||
146614159|NCT01746225|528756465|FG002|Overall Study|Death|1|||
146614160|NCT01746225|528756463|FG000|Overall Study|Withdrawal by Subject|5|||
146614161|NCT01746225|528756464|FG001|Overall Study|Withdrawal by Subject|15|||
146614162|NCT01746225|528756465|FG002|Overall Study|Withdrawal by Subject|19|||
146614163|NCT01746225|528756463|FG000|Overall Study|Physician Decision|14|||
146614164|NCT01746225|528756464|FG001|Overall Study|Physician Decision|11|||
146614165|NCT01746225|528756465|FG002|Overall Study|Physician Decision|3|||
146614166|NCT01746225|528756463|FG000|Overall Study|Adverse Event|15|||
146614167|NCT01746225|528756464|FG001|Overall Study|Adverse Event|12|||
146614168|NCT01746225|528756465|FG002|Overall Study|Adverse Event|17|||
146614169|NCT01746225|528756463|FG000|Overall Study|Continuing Treatment|5|||
146614170|NCT01746225|528756464|FG001|Overall Study|Continuing Treatment|8|||
146614171|NCT01746225|528756465|FG002|Overall Study|Continuing Treatment|3|||
146614172|NCT03245775|528756468|FG000|Overall Study|Lost to Follow-up|25|||
146614173|NCT03245775|528756469|FG001|Overall Study|Lost to Follow-up|26|||
146614174|NCT03245775|528756470|FG002|Overall Study|Lost to Follow-up|16|||
146614175|NCT03245775|528756471|FG003|Overall Study|Lost to Follow-up|16|||
146614176|NCT02713828|528756474|FG000|Overall Study|Death|2|||
146614177|NCT02713828|528756475|FG001|Overall Study|Death|0|||
146614178|NCT02713828|528756474|FG000|Overall Study|Withdrawal by Subject|1|||
146614179|NCT02713828|528756475|FG001|Overall Study|Withdrawal by Subject|0|||
146614180|NCT02713828|528756474|FG000|Overall Study|study terminated but patient allowed to|2|||
146614181|NCT02713828|528756475|FG001|Overall Study|study terminated but patient allowed to|0|||
146614182|NCT03302247|528756476|FG000|Overall Study|the study has closed prematurely|2|||
146614183|NCT03302247|528756476|FG000|Overall Study|Death|1|||
146614184|NCT03197376|528756477|FG000|Primary and Booster Phase|Adverse Event|0|||
146614185|NCT03197376|528756478|FG001|Primary and Booster Phase|Adverse Event|0|||
146614186|NCT03197376|528756479|FG002|Primary and Booster Phase|Adverse Event|0|||
146614187|NCT03197376|528756480|FG003|Primary and Booster Phase|Adverse Event|1|||
146614188|NCT03197376|528756477|FG000|Primary and Booster Phase|Death|1|||
146614189|NCT03197376|528756478|FG001|Primary and Booster Phase|Death|0|||
146614190|NCT03197376|528756479|FG002|Primary and Booster Phase|Death|0|||
146614191|NCT03197376|528756480|FG003|Primary and Booster Phase|Death|2|||
146614192|NCT03197376|528756477|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
146614193|NCT03197376|528756478|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
146614194|NCT03197376|528756479|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
146614195|NCT03197376|528756480|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
146614196|NCT03197376|528756477|FG000|Primary and Booster Phase|Physician Decision|1|||
146614197|NCT03197376|528756478|FG001|Primary and Booster Phase|Physician Decision|0|||
146614198|NCT03197376|528756479|FG002|Primary and Booster Phase|Physician Decision|1|||
146614199|NCT03197376|528756480|FG003|Primary and Booster Phase|Physician Decision|3|||
146614200|NCT03197376|528756477|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
146614201|NCT03197376|528756478|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
146614202|NCT03197376|528756479|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
146614203|NCT03197376|528756480|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
146614204|NCT03197376|528756477|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
146614205|NCT03197376|528756478|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
146614206|NCT03197376|528756479|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
146614207|NCT03197376|528756480|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
146614208|NCT03197376|528756477|FG000|Primary and Booster Phase|Not vaccine related|1|||
146614209|NCT03197376|528756478|FG001|Primary and Booster Phase|Not vaccine related|2|||
146614210|NCT03197376|528756479|FG002|Primary and Booster Phase|Not vaccine related|0|||
146614211|NCT03197376|528756480|FG003|Primary and Booster Phase|Not vaccine related|6|||
146614212|NCT03197376|528756477|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
146614213|NCT03197376|528756478|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
146614214|NCT03197376|528756479|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
146614215|NCT03197376|528756480|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
146614216|NCT03197376|528756477|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
146614217|NCT03197376|528756478|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
146614218|NCT03197376|528756479|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
146614219|NCT03197376|528756480|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
146614220|NCT03197376|528756477|FG000|Immune Persistence Phase|Not vaccine related|1|||
146614221|NCT03197376|528756478|FG001|Immune Persistence Phase|Not vaccine related|0|||
146614222|NCT03197376|528756479|FG002|Immune Persistence Phase|Not vaccine related|1|||
146773527|NCT02988817|529341089|FG013|Overall Study|Lost to Follow-up|0|||
146614223|NCT03197376|528756480|FG003|Immune Persistence Phase|Not vaccine related|1|||
146614224|NCT01123395|528756482|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
146614225|NCT01123395|528756483|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
146614226|NCT03691571|528756484|FG000|Overall Study|Withdrawal by Subject|9|||
146614227|NCT03691571|528756485|FG001|Overall Study|Withdrawal by Subject|2|||
146614228|NCT03937713|528758016|FG000|Overall Study|Withdrawal by Subject|3|||
146614229|NCT03937713|528758017|FG001|Overall Study|Withdrawal by Subject|6|||
146924943|NCT01683071|529884863|FG004|Part 1|Did not receive study drug|0|||
146614230|NCT03937713|528758016|FG000|Overall Study|Lost to Follow-up|1|||
146614231|NCT03937713|528758017|FG001|Overall Study|Lost to Follow-up|0|||
146614232|NCT00922623|528758023|FG000|Overall Study|Other|4|||
146614233|NCT00922623|528758023|FG000|Overall Study|Lost to Follow-up|1|||
146614234|NCT02420379|528758024|FG000|Overall Study|Withdrawal by Subject|0|||
146614235|NCT02420379|528758025|FG001|Overall Study|Withdrawal by Subject|3|||
146614236|NCT02420379|528758024|FG000|Overall Study|Unable to complete due to schooling|0|||
146614237|NCT02420379|528758025|FG001|Overall Study|Unable to complete due to schooling|1|||
146614238|NCT02420379|528758024|FG000|Overall Study|Transitioned to commercial drug|1|||
146614239|NCT02420379|528758025|FG001|Overall Study|Transitioned to commercial drug|0|||
146614240|NCT00086047|528758026|FG000|Overall Study|Lost to Follow-up|7|||
146614241|NCT00086047|528758027|FG001|Overall Study|Lost to Follow-up|6|||
146614242|NCT00086047|528758026|FG000|Overall Study|Physician Decision|0|||
146614243|NCT00086047|528758027|FG001|Overall Study|Physician Decision|1|||
146614244|NCT00269919|528758033|FG000|Overall Study|Other|26|||
146614245|NCT00269919|528758033|FG000|Overall Study|Started but not treated|1|||
146614246|NCT00786799|528758034|FG000|Overall Study|Lost to Follow-up|1|||
146614247|NCT00786799|528758035|FG001|Overall Study|Lost to Follow-up|1|||
146614248|NCT00950846|528758038|FG000|Overall Study|Death|6|||
146614249|NCT00950846|528758038|FG000|Overall Study|Lost to Follow-up|3|||
146614250|NCT00950846|528758038|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
146614251|NCT01799226|528758041|FG000|Overall Study|Withdrawal by Subject|1|||
146614252|NCT01799226|528758042|FG001|Overall Study|Withdrawal by Subject|0|||
146614253|NCT01799226|528758041|FG000|Overall Study|Disqualified at Day 14|1|||
146614254|NCT01799226|528758042|FG001|Overall Study|Disqualified at Day 14|0|||
146614255|NCT02178995|528758043|FG000|Double Blind|Adverse Event|0|||
146614256|NCT02178995|528758044|FG001|Double Blind|Adverse Event|0|||
146614257|NCT02178995|528758045|FG002|Double Blind|Adverse Event|0|||
146614258|NCT02178995|528758046|FG003|Double Blind|Adverse Event|0|||
146924944|NCT01683071|529884864|FG005|Part 1|Did not receive study drug|0|||
146924945|NCT01683071|529884859|FG000|Part 1|Early termination; met exclusion criteria|0|||
146924946|NCT01683071|529884860|FG001|Part 1|Early termination; met exclusion criteria|2|||
146614259|NCT02178995|528758047|FG004|Double Blind|Adverse Event|0|||
146614260|NCT02178995|528758048|FG005|Double Blind|Adverse Event|1|||
146614261|NCT02178995|528758049|FG006|Double Blind|Adverse Event|0|||
146614262|NCT02178995|528758050|FG007|Double Blind|Adverse Event|1|||
146614263|NCT02178995|528758051|FG008|Double Blind|Adverse Event|1|||
146614264|NCT02178995|528758043|FG000|Double Blind|Lost to Follow-up|0|||
146614265|NCT02178995|528758044|FG001|Double Blind|Lost to Follow-up|1|||
146614266|NCT02178995|528758045|FG002|Double Blind|Lost to Follow-up|0|||
146614267|NCT02178995|528758046|FG003|Double Blind|Lost to Follow-up|0|||
146614268|NCT02178995|528758047|FG004|Double Blind|Lost to Follow-up|0|||
146614269|NCT02178995|528758048|FG005|Double Blind|Lost to Follow-up|0|||
146614270|NCT02178995|528758049|FG006|Double Blind|Lost to Follow-up|0|||
146614271|NCT02178995|528758050|FG007|Double Blind|Lost to Follow-up|1|||
146614272|NCT02178995|528758051|FG008|Double Blind|Lost to Follow-up|0|||
146614273|NCT02178995|528758043|FG000|Open Label|Adverse Event|2|||
146614274|NCT02178995|528758044|FG001|Open Label|Adverse Event|0|||
146614275|NCT02178995|528758045|FG002|Open Label|Adverse Event|0|||
146614276|NCT02178995|528758046|FG003|Open Label|Adverse Event|0|||
146614277|NCT02178995|528758047|FG004|Open Label|Adverse Event|0|||
146614278|NCT02178995|528758048|FG005|Open Label|Adverse Event|0|||
146614279|NCT02178995|528758049|FG006|Open Label|Adverse Event|0|||
146614280|NCT02178995|528758050|FG007|Open Label|Adverse Event|0|||
146614281|NCT02178995|528758051|FG008|Open Label|Adverse Event|0|||
146614282|NCT00981461|528758052|FG000|Overall Study|Lost to Follow-up|5|||
146614283|NCT00981461|528758053|FG001|Overall Study|Lost to Follow-up|2|||
146614284|NCT03361293|528758056|FG000|Overall Study|Lost to Follow-up|0|||
146614285|NCT03361293|528758057|FG001|Overall Study|Lost to Follow-up|2|||
146614286|NCT03361293|528758056|FG000|Overall Study|Withdrawal by Subject|1|||
146614287|NCT03361293|528758057|FG001|Overall Study|Withdrawal by Subject|3|||
146614288|NCT00483405|528758058|FG000|Overall Study|Adverse Event|8|||
146614289|NCT00483405|528758058|FG000|Overall Study|Lack of Efficacy|14|||
146614290|NCT00483405|528758058|FG000|Overall Study|Death|3|||
146614291|NCT00483405|528758058|FG000|Overall Study|Withdrawal by Subject|2|||
146614292|NCT00483405|528758058|FG000|Overall Study|Other complicating disease|1|||
146614293|NCT00571038|528758059|FG000|Overall Study|Lost to Follow-up|1|||
146614294|NCT00571038|528758060|FG001|Overall Study|Lost to Follow-up|4|||
146614295|NCT00571038|528758059|FG000|Overall Study|Death|7|||
146614296|NCT00571038|528758060|FG001|Overall Study|Death|5|||
146614297|NCT00571038|528758059|FG000|Overall Study|Withdrawal by Subject|1|||
146614298|NCT00571038|528758060|FG001|Overall Study|Withdrawal by Subject|3|||
146924947|NCT01683071|529884861|FG002|Part 1|Early termination; met exclusion criteria|1|||
146614299|NCT00571038|528758059|FG000|Overall Study|Moved out of state|2|||
146614300|NCT00571038|528758060|FG001|Overall Study|Moved out of state|2|||
146614301|NCT01426958|528758061|FG000|Overall Study|Adverse Event|2|||
146658640|NCT02428608|528928751|FG000|Overall Study|Pregnancy|2|||
146658641|NCT02428608|528928751|FG000|Overall Study|Lost to Follow-up|37|||
146658642|NCT02428608|528928751|FG000|Overall Study|Withdrawal by Subject|2|||
146658643|NCT02428608|528928751|FG000|Overall Study|scheduling conflicts|15|||
146658644|NCT02428608|528928751|FG000|Overall Study|moved away|10|||
146658645|NCT02428608|528928751|FG000|Overall Study|Death|1|||
146658646|NCT02428608|528928751|FG000|Overall Study|various|16|||
146658647|NCT03468985|528928752|FG000|Overall Study|Adverse Event|0|||
146658648|NCT03468985|528928753|FG001|Overall Study|Adverse Event|2|||
146658649|NCT03468985|528928754|FG002|Overall Study|Adverse Event|0|||
146658650|NCT03468985|528928755|FG003|Overall Study|Adverse Event|0|||
146614302|NCT02631551|528758062|FG000|Overall Study|Adverse Event|1|||
146614303|NCT02631551|528758063|FG001|Overall Study|Adverse Event|2|||
146614304|NCT02631551|528758064|FG002|Overall Study|Adverse Event|4|||
146614305|NCT02631551|528758065|FG003|Overall Study|Adverse Event|0|||
146614306|NCT02631551|528758062|FG000|Overall Study|Lack of Efficacy|0|||
146614307|NCT02631551|528758063|FG001|Overall Study|Lack of Efficacy|0|||
146614308|NCT02631551|528758064|FG002|Overall Study|Lack of Efficacy|1|||
146614309|NCT02631551|528758065|FG003|Overall Study|Lack of Efficacy|0|||
146614310|NCT02631551|528758062|FG000|Overall Study|Lost to Follow-up|1|||
146614311|NCT02631551|528758063|FG001|Overall Study|Lost to Follow-up|2|||
146614312|NCT02631551|528758064|FG002|Overall Study|Lost to Follow-up|0|||
146614313|NCT02631551|528758065|FG003|Overall Study|Lost to Follow-up|3|||
146614314|NCT02631551|528758062|FG000|Overall Study|Withdrawal by Subject|2|||
146614315|NCT02631551|528758063|FG001|Overall Study|Withdrawal by Subject|2|||
146614316|NCT02631551|528758064|FG002|Overall Study|Withdrawal by Subject|0|||
146614317|NCT02631551|528758065|FG003|Overall Study|Withdrawal by Subject|5|||
146614318|NCT02631551|528758062|FG000|Overall Study|Protocol deviation|3|||
146614319|NCT02631551|528758063|FG001|Overall Study|Protocol deviation|6|||
146614320|NCT02631551|528758064|FG002|Overall Study|Protocol deviation|3|||
146614321|NCT02631551|528758065|FG003|Overall Study|Protocol deviation|0|||
146614322|NCT02631551|528758062|FG000|Overall Study|Non-compliance with study procedures|0|||
146658651|NCT03468985|528928752|FG000|Overall Study|Withdrawal by Subject|0|||
146658652|NCT03468985|528928753|FG001|Overall Study|Withdrawal by Subject|0|||
146658653|NCT03468985|528928754|FG002|Overall Study|Withdrawal by Subject|0|||
146658654|NCT03468985|528928755|FG003|Overall Study|Withdrawal by Subject|1|||
146658655|NCT04060862|528928756|FG000|Overall Study|Symptomatic Deterioration|1|||
146658656|NCT04060862|528928756|FG000|Overall Study|Un-specified|6|||
146658657|NCT04060862|528928756|FG000|Overall Study|Progressive disease|12|||
146658658|NCT04060862|528928756|FG000|Overall Study|Physician Decision|1|||
146658659|NCT01068652|528928757|FG000|Overall Study|Adverse Event|4|||
146658660|NCT01068652|528928758|FG001|Overall Study|Adverse Event|0|||
146658661|NCT01068652|528928757|FG000|Overall Study|Lack of Efficacy|0|||
146658662|NCT01068652|528928758|FG001|Overall Study|Lack of Efficacy|2|||
146658663|NCT01068652|528928757|FG000|Overall Study|Lost to Follow-up|2|||
146658664|NCT01068652|528928758|FG001|Overall Study|Lost to Follow-up|1|||
146658665|NCT01068652|528928757|FG000|Overall Study|Protocol Violation|3|||
146658666|NCT01068652|528928758|FG001|Overall Study|Protocol Violation|6|||
146658667|NCT01068652|528928757|FG000|Overall Study|Withdrawal criteria|1|||
146658668|NCT01068652|528928758|FG001|Overall Study|Withdrawal criteria|2|||
146658669|NCT01068652|528928757|FG000|Overall Study|Patient was not eligible|1|||
146658670|NCT01068652|528928758|FG001|Overall Study|Patient was not eligible|0|||
146658671|NCT01068652|528928757|FG000|Overall Study|Unclassified|7|||
146658672|NCT01068652|528928758|FG001|Overall Study|Unclassified|4|||
146658673|NCT00417482|528928763|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
146658674|NCT00417482|528928764|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
146658675|NCT00417482|528928765|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
146658676|NCT00417482|528928763|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
146658677|NCT00417482|528928764|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
146658678|NCT00417482|528928765|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
146658679|NCT00417482|528928763|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
146658680|NCT00417482|528928764|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
146658681|NCT00417482|528928765|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
146614323|NCT02631551|528758063|FG001|Overall Study|Non-compliance with study procedures|0|||
146614324|NCT02631551|528758064|FG002|Overall Study|Non-compliance with study procedures|1|||
146614325|NCT02631551|528758065|FG003|Overall Study|Non-compliance with study procedures|1|||
146614326|NCT02631551|528758062|FG000|Overall Study|Non-compliance with study drug|1|||
146614327|NCT02631551|528758063|FG001|Overall Study|Non-compliance with study drug|0|||
146614328|NCT02631551|528758064|FG002|Overall Study|Non-compliance with study drug|0|||
146614329|NCT02631551|528758065|FG003|Overall Study|Non-compliance with study drug|0|||
146614330|NCT02631551|528758062|FG000|Overall Study|Other, specific reasons not collected|5|||
146658682|NCT00417482|528928763|FG000|Phase B 1st 16 Weeks|Death|1|||
146658683|NCT00417482|528928764|FG001|Phase B 1st 16 Weeks|Death|0|||
146658684|NCT00417482|528928765|FG002|Phase B 1st 16 Weeks|Death|0|||
146658685|NCT00417482|528928763|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
146658686|NCT00417482|528928764|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
146658687|NCT00417482|528928765|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
146614331|NCT02631551|528758063|FG001|Overall Study|Other, specific reasons not collected|7|||
146614332|NCT02631551|528758064|FG002|Overall Study|Other, specific reasons not collected|2|||
146614333|NCT02631551|528758065|FG003|Overall Study|Other, specific reasons not collected|2|||
146614334|NCT02073682|528758070|FG000|Overall Study|Low Creatinine Clearance|1|||
146614335|NCT02073682|528758071|FG001|Overall Study|Low Creatinine Clearance|2|||
146614336|NCT02073682|528758070|FG000|Overall Study|Death|86|||
146614337|NCT02073682|528758071|FG001|Overall Study|Death|100|||
146614338|NCT02073682|528758070|FG000|Overall Study|Cancer Cured|10|||
146614339|NCT02073682|528758071|FG001|Overall Study|Cancer Cured|15|||
146614340|NCT02073682|528758070|FG000|Overall Study|ID: Patient Noncompliance|1|||
146614341|NCT02073682|528758071|FG001|Overall Study|ID: Patient Noncompliance|2|||
146614342|NCT02073682|528758070|FG000|Overall Study|ID: Palliative Treatment Only|10|||
146614343|NCT02073682|528758071|FG001|Overall Study|ID: Palliative Treatment Only|7|||
146614344|NCT02073682|528758070|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
146614345|NCT02073682|528758071|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
146614346|NCT02073682|528758070|FG000|Overall Study|Platelet Count <50,000/mL|1|||
146614347|NCT02073682|528758071|FG001|Overall Study|Platelet Count <50,000/mL|2|||
146614348|NCT02073682|528758070|FG000|Overall Study|Surgery/Medical Procedure|3|||
146614349|NCT02073682|528758071|FG001|Overall Study|Surgery/Medical Procedure|1|||
146614350|NCT02073682|528758070|FG000|Overall Study|Withdrawal by Subject|6|||
146614351|NCT02073682|528758071|FG001|Overall Study|Withdrawal by Subject|8|||
146614352|NCT02073682|528758070|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
146614353|NCT02073682|528758071|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
146614354|NCT02073682|528758070|FG000|Overall Study|Cancer Progression|53|||
146614355|NCT02073682|528758071|FG001|Overall Study|Cancer Progression|33|||
146614356|NCT02073682|528758070|FG000|Overall Study|Protocol Violation|1|||
146614357|NCT02073682|528758071|FG001|Overall Study|Protocol Violation|0|||
146614358|NCT02073682|528758070|FG000|Overall Study|Adverse Event|79|||
146614359|NCT02073682|528758071|FG001|Overall Study|Adverse Event|62|||
146614360|NCT02073682|528758070|FG000|Overall Study|No reason provided|11|||
146614361|NCT02073682|528758071|FG001|Overall Study|No reason provided|9|||
146614362|NCT02073682|528758070|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
146614363|NCT02073682|528758071|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
146614364|NCT02073682|528758070|FG000|Overall Study|Lost to Follow-up|1|||
146614365|NCT02073682|528758071|FG001|Overall Study|Lost to Follow-up|1|||
146614366|NCT02073682|528758070|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
146614367|NCT02073682|528758071|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
146614368|NCT01965704|528758072|FG000|Overall Study|Withdrawal by Subject|2|||
146614369|NCT01965704|528758073|FG001|Overall Study|Withdrawal by Subject|2|||
146614370|NCT01965704|528758074|FG002|Overall Study|Withdrawal by Subject|1|||
146614371|NCT01965704|528758075|FG003|Overall Study|Withdrawal by Subject|1|||
146614372|NCT01965704|528758072|FG000|Overall Study|Delivered at home|1|||
146614373|NCT01965704|528758073|FG001|Overall Study|Delivered at home|1|||
146614374|NCT01965704|528758074|FG002|Overall Study|Delivered at home|0|||
146614375|NCT01965704|528758075|FG003|Overall Study|Delivered at home|0|||
146614376|NCT01965704|528758072|FG000|Overall Study|Experienced complications|0|||
146614377|NCT01965704|528758073|FG001|Overall Study|Experienced complications|0|||
146614378|NCT01965704|528758074|FG002|Overall Study|Experienced complications|2|||
146614379|NCT01965704|528758075|FG003|Overall Study|Experienced complications|2|||
146614380|NCT01965704|528758072|FG000|Overall Study|Adverse Event|0|||
146614381|NCT01965704|528758073|FG001|Overall Study|Adverse Event|0|||
146614382|NCT01965704|528758074|FG002|Overall Study|Adverse Event|1|||
146614383|NCT01965704|528758075|FG003|Overall Study|Adverse Event|1|||
146614384|NCT01965704|528758072|FG000|Overall Study|Did not meet inclusion criteria|0|||
146614385|NCT01965704|528758073|FG001|Overall Study|Did not meet inclusion criteria|0|||
146614386|NCT01965704|528758074|FG002|Overall Study|Did not meet inclusion criteria|1|||
146614387|NCT01965704|528758075|FG003|Overall Study|Did not meet inclusion criteria|1|||
146614388|NCT01843023|528758087|FG000|Overall Study|Death|1|||
146614389|NCT01843023|528758088|FG001|Overall Study|Death|0|||
146614390|NCT01843023|528758087|FG000|Overall Study|Lost to Follow-up|24|||
146614391|NCT01843023|528758088|FG001|Overall Study|Lost to Follow-up|29|||
146614392|NCT01843023|528758087|FG000|Overall Study|Withdrawal by Subject|8|||
146614393|NCT01843023|528758088|FG001|Overall Study|Withdrawal by Subject|6|||
146614394|NCT00466921|528758089|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
146614395|NCT00466921|528758089|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
146614396|NCT00466921|528758089|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
146614397|NCT00466921|528758089|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
146614398|NCT00466921|528758089|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
146614399|NCT00466921|528758089|FG000|Follow up for a Minimum of 1 Year|Death|6|||
146614400|NCT02741635|528758095|FG000|Overall Study|Withdrawal by Subject|1|||
146614401|NCT01427933|528758099|FG000|Overall Study|Withdrawal by Subject|5|||
146614402|NCT01427933|528758100|FG001|Overall Study|Withdrawal by Subject|8|||
146614403|NCT01427933|528758099|FG000|Overall Study|Lost to Follow-up|1|||
146614404|NCT01427933|528758100|FG001|Overall Study|Lost to Follow-up|5|||
146614405|NCT01427933|528758099|FG000|Overall Study|Other|1|||
146614406|NCT01427933|528758100|FG001|Overall Study|Other|0|||
146614407|NCT01427933|528758099|FG000|Overall Study|Investigator's Decision|1|||
146614408|NCT01427933|528758100|FG001|Overall Study|Investigator's Decision|0|||
146614409|NCT01633541|528758101|FG000|Overall Study|Death|1|||
146614410|NCT01633541|528758102|FG001|Overall Study|Death|0|||
146614411|NCT03472326|528758105|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
146614412|NCT03472326|528758106|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
146614413|NCT03472326|528758107|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
146614414|NCT03472326|528758108|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
146614415|NCT03472326|528758105|FG000|Part 2: Combination Therapy|Pregnancy|0|||
146614416|NCT03472326|528758106|FG001|Part 2: Combination Therapy|Pregnancy|0|||
146614417|NCT03472326|528758107|FG002|Part 2: Combination Therapy|Pregnancy|0|||
146614418|NCT03472326|528758108|FG003|Part 2: Combination Therapy|Pregnancy|1|||
146614419|NCT05447663|528758109|FG000|Overall Study|Study terminated by Sponsor|5|||
146614420|NCT05447663|528758109|FG000|Overall Study|Death|2|||
146614421|NCT05447663|528758109|FG000|Overall Study|Withdrawal by Subject|1|||
146614422|NCT01100320|528758112|FG000|Period 1|Withdrawal by Subject|2|||
146614423|NCT01100320|528758113|FG001|Period 1|Withdrawal by Subject|4|||
146614424|NCT01100320|528758112|FG000|Period 1|Positive Drug Screen|1|||
146614425|NCT01100320|528758113|FG001|Period 1|Positive Drug Screen|1|||
146614426|NCT01100320|528758112|FG000|Period 1|Adverse Event|2|||
146614427|NCT01100320|528758113|FG001|Period 1|Adverse Event|2|||
146614428|NCT01100320|528758112|FG000|Period 2|Withdrawal by Subject|1|||
146614429|NCT01100320|528758113|FG001|Period 2|Withdrawal by Subject|1|||
146614430|NCT04669301|528758114|FG000|Overall Study|Lost to Follow-up|0|||
146614431|NCT04669301|528758115|FG001|Overall Study|Lost to Follow-up|1|||
146614432|NCT04669301|528758116|FG002|Overall Study|Lost to Follow-up|0|||
146614433|NCT04669301|528758114|FG000|Overall Study|Withdrawal by Subject|3|||
146614434|NCT04669301|528758115|FG001|Overall Study|Withdrawal by Subject|2|||
146614435|NCT04669301|528758116|FG002|Overall Study|Withdrawal by Subject|0|||
146614436|NCT02863328|528758118|FG000|Overall Study|Lost to Follow-up|4|||
146614437|NCT02863328|528758119|FG001|Overall Study|Lost to Follow-up|10|||
146614438|NCT02863328|528758118|FG000|Overall Study|Withdrawal by Subject|7|||
146614439|NCT02863328|528758119|FG001|Overall Study|Withdrawal by Subject|12|||
146614440|NCT02863328|528758118|FG000|Overall Study|Died|0|||
146614441|NCT02863328|528758119|FG001|Overall Study|Died|1|||
146614442|NCT01870726|528758120|FG000|Overall Study|Withdrawal of informed consent|0|||
146614443|NCT01870726|528758121|FG001|Overall Study|Withdrawal of informed consent|0|||
146614444|NCT01870726|528758122|FG002|Overall Study|Withdrawal of informed consent|0|||
146614445|NCT01870726|528758123|FG003|Overall Study|Withdrawal of informed consent|1|||
146614446|NCT01870726|528758124|FG004|Overall Study|Withdrawal of informed consent|0|||
146614447|NCT01870726|528758125|FG005|Overall Study|Withdrawal of informed consent|0|||
146614448|NCT01870726|528758126|FG006|Overall Study|Withdrawal of informed consent|0|||
146614449|NCT01870726|528758120|FG000|Overall Study|Withdrawal by Subject|0|||
146614450|NCT01870726|528758121|FG001|Overall Study|Withdrawal by Subject|1|||
146614451|NCT01870726|528758122|FG002|Overall Study|Withdrawal by Subject|0|||
146614452|NCT01870726|528758123|FG003|Overall Study|Withdrawal by Subject|0|||
146614453|NCT01870726|528758124|FG004|Overall Study|Withdrawal by Subject|0|||
146614454|NCT01870726|528758125|FG005|Overall Study|Withdrawal by Subject|0|||
146614455|NCT01870726|528758126|FG006|Overall Study|Withdrawal by Subject|0|||
146614456|NCT01870726|528758120|FG000|Overall Study|Adverse Event|0|||
146614457|NCT01870726|528758121|FG001|Overall Study|Adverse Event|0|||
146614458|NCT01870726|528758122|FG002|Overall Study|Adverse Event|0|||
146614459|NCT01870726|528758123|FG003|Overall Study|Adverse Event|0|||
146614460|NCT01870726|528758124|FG004|Overall Study|Adverse Event|1|||
146614461|NCT01870726|528758125|FG005|Overall Study|Adverse Event|1|||
146614462|NCT01870726|528758126|FG006|Overall Study|Adverse Event|0|||
146614463|NCT01870726|528758120|FG000|Overall Study|Progressive disease|5|||
146614464|NCT01870726|528758121|FG001|Overall Study|Progressive disease|5|||
146614465|NCT01870726|528758122|FG002|Overall Study|Progressive disease|4|||
146614466|NCT01870726|528758123|FG003|Overall Study|Progressive disease|5|||
146614467|NCT01870726|528758124|FG004|Overall Study|Progressive disease|6|||
146614468|NCT01870726|528758125|FG005|Overall Study|Progressive disease|4|||
146658688|NCT00417482|528928763|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
146658689|NCT00417482|528928764|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
146614469|NCT01870726|528758126|FG006|Overall Study|Progressive disease|10|||
146614470|NCT00595478|528758127|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
146614471|NCT00595478|528758128|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
146614472|NCT00595478|528758127|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
146614473|NCT00595478|528758128|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
146614474|NCT02978833|528758134|FG000|Overall Study|Study terminated|1|||
146614475|NCT02978833|528758135|FG001|Overall Study|Study terminated|1|||
146614476|NCT00186901|528758137|FG000|Overall Study|Pregnancy|6|||
146614477|NCT00186901|528758138|FG001|Overall Study|Pregnancy|3|||
146614478|NCT00186901|528758139|FG002|Overall Study|Pregnancy|0|||
146614479|NCT00186901|528758137|FG000|Overall Study|Lost to Follow-up|6|||
146658690|NCT00417482|528928765|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
146614480|NCT00186901|528758138|FG001|Overall Study|Lost to Follow-up|3|||
146614481|NCT00186901|528758139|FG002|Overall Study|Lost to Follow-up|0|||
146614482|NCT00186901|528758137|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
146614483|NCT00186901|528758138|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
146614484|NCT00186901|528758139|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
146614485|NCT00186901|528758137|FG000|Overall Study|ALL relapse or second malignancy|1|||
146614486|NCT00186901|528758138|FG001|Overall Study|ALL relapse or second malignancy|2|||
146614487|NCT00186901|528758139|FG002|Overall Study|ALL relapse or second malignancy|0|||
146614488|NCT00186901|528758137|FG000|Overall Study|Withdrawal by Subject|4|||
146614489|NCT00186901|528758138|FG001|Overall Study|Withdrawal by Subject|5|||
146614490|NCT00186901|528758139|FG002|Overall Study|Withdrawal by Subject|0|||
146614491|NCT00186901|528758137|FG000|Overall Study|Open label|3|||
146614492|NCT00186901|528758138|FG001|Overall Study|Open label|2|||
146614493|NCT00186901|528758139|FG002|Overall Study|Open label|0|||
146614494|NCT00186901|528758137|FG000|Overall Study|Limited adherence to study requirements|20|||
146614495|NCT00186901|528758138|FG001|Overall Study|Limited adherence to study requirements|23|||
146614496|NCT00186901|528758139|FG002|Overall Study|Limited adherence to study requirements|0|||
146614497|NCT00186901|528758137|FG000|Overall Study|Bone Mineral Density > 0|0|||
146614498|NCT00186901|528758138|FG001|Overall Study|Bone Mineral Density > 0|0|||
146614499|NCT00186901|528758139|FG002|Overall Study|Bone Mineral Density > 0|149|||
146614500|NCT00555217|528758140|FG000|Overall Study|Withdrawal by Subject|35|||
146614501|NCT00555217|528758141|FG001|Overall Study|Withdrawal by Subject|31|||
146614502|NCT00555217|528758140|FG000|Overall Study|Lost to Follow-up|19|||
146614503|NCT00555217|528758141|FG001|Overall Study|Lost to Follow-up|20|||
146614504|NCT00555217|528758140|FG000|Overall Study|close out sites|21|||
146614505|NCT00555217|528758141|FG001|Overall Study|close out sites|17|||
146614506|NCT02363959|528758147|FG000|Overall Study|Medical instability|1|||
146614507|NCT02363959|528758148|FG001|Overall Study|Medical instability|0|||
146614508|NCT00950248|528758149|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
146614509|NCT00950248|528758150|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
146614510|NCT00950248|528758151|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
146614511|NCT00950248|528758149|FG000|Year 1: Baseline|worsening of symptoms|2|||
146614512|NCT00950248|528758150|FG001|Year 1: Baseline|worsening of symptoms|0|||
146614513|NCT00950248|528758151|FG002|Year 1: Baseline|worsening of symptoms|0|||
146614514|NCT00950248|528758149|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
146614515|NCT00950248|528758150|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
146614516|NCT00950248|528758151|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
146614517|NCT00950248|528758149|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
146614518|NCT00950248|528758150|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
146614519|NCT00950248|528758151|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
146614520|NCT00950248|528758149|FG000|Year 2&3 Treatment Randomization|Death|0|||
146614521|NCT00950248|528758150|FG001|Year 2&3 Treatment Randomization|Death|0|||
146614522|NCT00950248|528758151|FG002|Year 2&3 Treatment Randomization|Death|1|||
146614523|NCT00950248|528758149|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
146614524|NCT00950248|528758150|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
146614525|NCT00950248|528758151|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
146614526|NCT02663622|528758152|FG000|Overall Study|Death|3|||
146614527|NCT02663622|528758153|FG001|Overall Study|Death|1|||
146614528|NCT02663622|528758154|FG002|Overall Study|Death|1|||
146614529|NCT02663622|528758155|FG003|Overall Study|Death|8|||
146614530|NCT02663622|528758152|FG000|Overall Study|Protocol Violation|0|||
146614531|NCT02663622|528758153|FG001|Overall Study|Protocol Violation|0|||
146614532|NCT02663622|528758154|FG002|Overall Study|Protocol Violation|0|||
146614533|NCT02663622|528758155|FG003|Overall Study|Protocol Violation|1|||
146614534|NCT00930930|528758158|FG000|Overall Study|Death|1|||
146614535|NCT00930930|528758159|FG001|Overall Study|Death|0|||
146614536|NCT00930930|528758158|FG000|Overall Study|Physician Decision|1|||
146614537|NCT00930930|528758159|FG001|Overall Study|Physician Decision|0|||
146924948|NCT01683071|529884862|FG003|Part 1|Early termination; met exclusion criteria|0|||
146924949|NCT01683071|529884863|FG004|Part 1|Early termination; met exclusion criteria|0|||
146924950|NCT01683071|529884864|FG005|Part 1|Early termination; met exclusion criteria|0|||
146924951|NCT01683071|529884859|FG000|Part 2|Lack of Efficacy|0|||
146924952|NCT01683071|529884860|FG001|Part 2|Lack of Efficacy|0|||
146614538|NCT00930930|528758158|FG000|Overall Study|Adverse Event|13|||
146924953|NCT01683071|529884861|FG002|Part 2|Lack of Efficacy|0|||
146924954|NCT01683071|529884862|FG003|Part 2|Lack of Efficacy|0|||
146924955|NCT01683071|529884863|FG004|Part 2|Lack of Efficacy|3|||
146614539|NCT00930930|528758159|FG001|Overall Study|Adverse Event|3|||
146614540|NCT00930930|528758158|FG000|Overall Study|Withdrawal by Subject|3|||
146614541|NCT00930930|528758159|FG001|Overall Study|Withdrawal by Subject|1|||
146614542|NCT00930930|528758158|FG000|Overall Study|Disease progression|2|||
146614543|NCT00930930|528758159|FG001|Overall Study|Disease progression|3|||
146614544|NCT00930930|528758158|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
146614545|NCT00930930|528758159|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
146924956|NCT01683071|529884864|FG005|Part 2|Lack of Efficacy|4|||
146614546|NCT00930930|528758158|FG000|Overall Study|patients not compliant|1|||
146924957|NCT01683071|529884859|FG000|Part 2|Lost to Follow-up|0|||
146924958|NCT01683071|529884860|FG001|Part 2|Lost to Follow-up|0|||
146924959|NCT01683071|529884861|FG002|Part 2|Lost to Follow-up|0|||
146614547|NCT00930930|528758159|FG001|Overall Study|patients not compliant|1|||
146614548|NCT04618744|528758160|FG000|Overall Study|Adverse Event|0|||
146614549|NCT04618744|528758161|FG001|Overall Study|Adverse Event|1|||
146614550|NCT04618744|528758160|FG000|Overall Study|Withdrawal by Subject|0|||
146614551|NCT04618744|528758161|FG001|Overall Study|Withdrawal by Subject|1|||
146614552|NCT00900029|528758162|FG000|Overall Study|Lost to Follow-up|0|||
146614553|NCT00900029|528758163|FG001|Overall Study|Lost to Follow-up|2|||
146614554|NCT00900029|528758164|FG002|Overall Study|Lost to Follow-up|1|||
146614555|NCT00900029|528758165|FG003|Overall Study|Lost to Follow-up|4|||
146614556|NCT00900029|528758166|FG004|Overall Study|Lost to Follow-up|4|||
146614557|NCT00900029|528758162|FG000|Overall Study|Withdrawal by Subject|2|||
146614558|NCT00900029|528758163|FG001|Overall Study|Withdrawal by Subject|2|||
146614559|NCT00900029|528758164|FG002|Overall Study|Withdrawal by Subject|1|||
146614560|NCT00900029|528758165|FG003|Overall Study|Withdrawal by Subject|1|||
146614561|NCT00900029|528758166|FG004|Overall Study|Withdrawal by Subject|1|||
146614562|NCT00900029|528758162|FG000|Overall Study|Adverse Event|0|||
146614563|NCT00900029|528758163|FG001|Overall Study|Adverse Event|0|||
146614564|NCT00900029|528758164|FG002|Overall Study|Adverse Event|1|||
146614565|NCT00900029|528758165|FG003|Overall Study|Adverse Event|1|||
146614566|NCT00900029|528758166|FG004|Overall Study|Adverse Event|1|||
146614567|NCT00900029|528758162|FG000|Overall Study|Death|1|||
146614568|NCT00900029|528758163|FG001|Overall Study|Death|0|||
146614569|NCT00900029|528758164|FG002|Overall Study|Death|0|||
146614570|NCT00900029|528758165|FG003|Overall Study|Death|1|||
146614571|NCT00900029|528758166|FG004|Overall Study|Death|0|||
146614572|NCT02709330|528758167|FG000|Overall Study|Death|5|||
146614573|NCT02709330|528758168|FG001|Overall Study|Death|0|||
146614574|NCT02709330|528758167|FG000|Overall Study|Lost to Follow-up|2|||
146614575|NCT02709330|528758168|FG001|Overall Study|Lost to Follow-up|0|||
146614576|NCT02709330|528758167|FG000|Overall Study|Physician Decision|2|||
146614577|NCT02709330|528758168|FG001|Overall Study|Physician Decision|0|||
146614578|NCT02709330|528758167|FG000|Overall Study|Withdrawal by Subject|4|||
146614579|NCT02709330|528758168|FG001|Overall Study|Withdrawal by Subject|0|||
146614580|NCT00511238|528758171|FG000|Overall Study|Adverse Event|13|||
146614581|NCT00511238|528758172|FG001|Overall Study|Adverse Event|33|||
146614582|NCT00511238|528758171|FG000|Overall Study|Withdrawal by Subject|2|||
146614583|NCT00511238|528758172|FG001|Overall Study|Withdrawal by Subject|22|||
146614584|NCT00511238|528758171|FG000|Overall Study|Progressive Disease|23|||
146614585|NCT00511238|528758172|FG001|Overall Study|Progressive Disease|157|||
146614586|NCT00511238|528758171|FG000|Overall Study|various reasons|4|||
146614587|NCT00511238|528758172|FG001|Overall Study|various reasons|14|||
146614588|NCT02587819|528758173|FG000|Overall Study|Adverse Event|1|||
146614589|NCT02587819|528758173|FG000|Overall Study|Lost to Follow-up|1|||
146614590|NCT00859547|528759851|FG000|Overall Study|Lost to Follow-up|1|||
146614591|NCT00859547|528759851|FG000|Overall Study|Parent withdrew consent|1|||
146614592|NCT01410890|528759853|FG000|Overall Study|Withdrawal by Subject|0|||
146614593|NCT01410890|528759854|FG001|Overall Study|Withdrawal by Subject|1|||
146614594|NCT00997035|528759858|FG000|3-week Followup Visit|Lost to Follow-up|9|||
146614595|NCT00997035|528759859|FG001|3-week Followup Visit|Lost to Follow-up|6|||
146614596|NCT00997035|528759858|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
146614597|NCT00997035|528759859|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
146614598|NCT02544503|528759865|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
146614599|NCT02544503|528759866|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
146614600|NCT02544503|528759865|FG000|Overall Study|Lost to Follow-up|9|||
146614601|NCT02544503|528759866|FG001|Overall Study|Lost to Follow-up|0|||
146614602|NCT02544503|528759865|FG000|Overall Study|Withdrawal by Subject|1|||
146614603|NCT02544503|528759866|FG001|Overall Study|Withdrawal by Subject|0|||
146614604|NCT00991939|528759869|FG000|Overall Study|Lost to Follow-up|0|||
146614605|NCT00991939|528759870|FG001|Overall Study|Lost to Follow-up|1|||
146614606|NCT00991939|528759869|FG000|Overall Study|Withdrawal by Subject|1|||
146614607|NCT00991939|528759870|FG001|Overall Study|Withdrawal by Subject|0|||
146614608|NCT00991939|528759869|FG000|Overall Study|Entire study terminated|4|||
146614609|NCT00991939|528759870|FG001|Overall Study|Entire study terminated|1|||
146614610|NCT00714415|528759871|FG000|Overall Study|Lack of Efficacy|1|||
146614611|NCT00714415|528759872|FG001|Overall Study|Lack of Efficacy|0|||
146614612|NCT00714415|528759871|FG000|Overall Study|Death|1|||
146614613|NCT00714415|528759872|FG001|Overall Study|Death|0|||
146614614|NCT01461707|528759875|FG000|Overall Study|Withdrawal by Subject|1|||
146614615|NCT01461707|528759876|FG001|Overall Study|Withdrawal by Subject|0|||
146614616|NCT01450761|528759877|FG000|Randomization|Subject no longer meets study criteria|1|||
146614617|NCT01450761|528759878|FG001|Randomization|Subject no longer meets study criteria|2|||
146614618|NCT01450761|528759877|FG000|Randomization|Withdrawal by Subject|2|||
146614619|NCT01450761|528759878|FG001|Randomization|Withdrawal by Subject|0|||
146614620|NCT01450761|528759877|FG000|Randomization|Disease progression|0|||
146614621|NCT01450761|528759878|FG001|Randomization|Disease progression|2|||
146773528|NCT02988817|529341090|FG014|Overall Study|Lost to Follow-up|1|||
146614622|NCT01450761|528759877|FG000|Randomization|Adverse Event unrelated to study drug|1|||
146614623|NCT01450761|528759878|FG001|Randomization|Adverse Event unrelated to study drug|0|||
146614624|NCT01450761|528759877|FG000|Randomization|Other|0|||
146614625|NCT01450761|528759878|FG001|Randomization|Other|1|||
146614626|NCT01450761|528759877|FG000|Lead-in Chemotherapy|Disease progression|33|||
146614627|NCT01450761|528759878|FG001|Lead-in Chemotherapy|Disease progression|32|||
146614628|NCT01450761|528759877|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
146614629|NCT01450761|528759878|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
146614630|NCT01450761|528759877|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
146614631|NCT01450761|528759878|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
146614632|NCT01450761|528759877|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
146614633|NCT01450761|528759878|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
146614634|NCT01450761|528759877|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
146614635|NCT01450761|528759878|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
146614636|NCT01450761|528759877|FG000|Lead-in Chemotherapy|Death|3|||
146614637|NCT01450761|528759878|FG001|Lead-in Chemotherapy|Death|3|||
146614638|NCT01450761|528759877|FG000|Lead-in Chemotherapy|Other|2|||
146614639|NCT01450761|528759878|FG001|Lead-in Chemotherapy|Other|2|||
146614640|NCT01450761|528759877|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
146614641|NCT01450761|528759878|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
146614642|NCT01450761|528759877|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
146614643|NCT01450761|528759878|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
146614644|NCT01450761|528759877|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
146614645|NCT01450761|528759878|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
146614646|NCT01450761|528759877|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
146614647|NCT01450761|528759878|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
146614648|NCT01450761|528759877|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
146614649|NCT01450761|528759878|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
146614650|NCT01450761|528759877|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
146614651|NCT01450761|528759878|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
146614652|NCT01450761|528759877|FG000|Treatment With Blinded Study Therapy|Death|5|||
146614653|NCT01450761|528759878|FG001|Treatment With Blinded Study Therapy|Death|6|||
146614654|NCT01450761|528759877|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
146614655|NCT01450761|528759878|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
146614656|NCT01450761|528759877|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
146614657|NCT01450761|528759878|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
146614658|NCT01450761|528759877|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
146614659|NCT01450761|528759878|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
146614660|NCT01450761|528759877|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
146614661|NCT01450761|528759878|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
146614662|NCT01450761|528759877|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
146614663|NCT01450761|528759878|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
146614664|NCT01450761|528759877|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
146614665|NCT01450761|528759878|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
146614666|NCT01450761|528759877|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
146614667|NCT01450761|528759878|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
146614668|NCT03801174|528759900|FG000|Overall Study|Withdrawal by Subject|14|||
146924960|NCT01683071|529884862|FG003|Part 2|Lost to Follow-up|0|||
146614669|NCT03801174|528759901|FG001|Overall Study|Withdrawal by Subject|15|||
146614670|NCT03801174|528759900|FG000|Overall Study|Death|1|||
146614671|NCT03801174|528759901|FG001|Overall Study|Death|0|||
146614672|NCT03801174|528759900|FG000|Overall Study|Pregnancy|2|||
146614673|NCT03801174|528759901|FG001|Overall Study|Pregnancy|2|||
146614674|NCT03801174|528759900|FG000|Overall Study|Lost to Follow-up|19|||
146614675|NCT03801174|528759901|FG001|Overall Study|Lost to Follow-up|10|||
146614676|NCT03801174|528759900|FG000|Overall Study|Other|4|||
146614677|NCT03801174|528759901|FG001|Overall Study|Other|3|||
146614678|NCT03801174|528759900|FG000|Overall Study|Lack of Efficacy|4|||
146614679|NCT03801174|528759901|FG001|Overall Study|Lack of Efficacy|0|||
146614680|NCT03801174|528759900|FG000|Overall Study|Unwilling to complete activities|5|||
146614681|NCT03801174|528759901|FG001|Overall Study|Unwilling to complete activities|6|||
146614682|NCT03801174|528759900|FG000|Overall Study|Moved out of area|3|||
146658691|NCT00417482|528928763|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
146658692|NCT00417482|528928764|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
146658693|NCT00417482|528928765|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
146658694|NCT00417482|528928763|FG000|Phase B 2nd 16 Weeks|Death|1|||
146658695|NCT00417482|528928764|FG001|Phase B 2nd 16 Weeks|Death|1|||
146658696|NCT00417482|528928765|FG002|Phase B 2nd 16 Weeks|Death|0|||
146658697|NCT01243671|528928766|FG000|Overall Study|Adverse Event|3|||
146658698|NCT01243671|528928766|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
146924961|NCT01683071|529884863|FG004|Part 2|Lost to Follow-up|2|||
146614683|NCT03801174|528759901|FG001|Overall Study|Moved out of area|0|||
146614684|NCT00855816|528759902|FG000|Overall Study|Withdrawal by Subject|22|||
146614685|NCT00855816|528759903|FG001|Overall Study|Withdrawal by Subject|15|||
146614686|NCT00855816|528759902|FG000|Overall Study|Lost to Follow-up|3|||
146614687|NCT00855816|528759903|FG001|Overall Study|Lost to Follow-up|5|||
146614688|NCT00855816|528759902|FG000|Overall Study|Death|1|||
146614689|NCT00855816|528759903|FG001|Overall Study|Death|0|||
146614690|NCT00855816|528759902|FG000|Overall Study|Became ineligible|0|||
146614691|NCT00855816|528759903|FG001|Overall Study|Became ineligible|1|||
146614692|NCT00337207|528759907|FG000|Overall Study|Withdrawal by Subject|3|||
146614693|NCT01521507|528759908|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
146614694|NCT01521507|528759909|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
146614695|NCT01521507|528759908|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
146614696|NCT01521507|528759909|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
146614697|NCT01521507|528759908|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
146614698|NCT01521507|528759909|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
146614699|NCT01521507|528759908|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
146614700|NCT01521507|528759909|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
146614701|NCT01521507|528759908|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
146614702|NCT01521507|528759909|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
146614703|NCT01521507|528759908|FG000|Stage 2: Observational Design|Physician Decision|1|||
146614704|NCT01521507|528759909|FG001|Stage 2: Observational Design|Physician Decision|0|||
146614705|NCT03573323|528759910|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
146614706|NCT03573323|528759911|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
146614707|NCT03573323|528759910|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
146614708|NCT03573323|528759911|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
146614709|NCT03573323|528759910|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
146614710|NCT03573323|528759911|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
146614711|NCT03573323|528759910|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
146614712|NCT03573323|528759911|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
146614713|NCT03573323|528759910|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
146614714|NCT03573323|528759911|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
146614715|NCT03573323|528759910|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
146614716|NCT03573323|528759911|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
146614717|NCT03573323|528759910|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
146614718|NCT03573323|528759911|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
146614719|NCT03573323|528759910|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
146614720|NCT03573323|528759911|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
146614721|NCT03573323|528759910|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
146614722|NCT03573323|528759911|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
146614723|NCT03573323|528759910|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
146614724|NCT03573323|528759911|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
146614725|NCT03573323|528759910|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
146614726|NCT03573323|528759911|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
146614727|NCT03573323|528759910|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
146614728|NCT03573323|528759911|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
146614729|NCT03573323|528759910|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
146614730|NCT03573323|528759911|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
146614731|NCT03573323|528759910|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
146614732|NCT03573323|528759911|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
146614733|NCT03573323|528759910|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
146614734|NCT03573323|528759911|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
146614735|NCT03573323|528759910|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
146614736|NCT03573323|528759911|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
146614737|NCT03573323|528759910|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
146614738|NCT03573323|528759911|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
146614739|NCT03573323|528759910|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
146614740|NCT03573323|528759911|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
146614741|NCT03573323|528759910|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
146614742|NCT03573323|528759911|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
146658699|NCT01243671|528928766|FG000|Overall Study|Other|1|||
146658700|NCT05342532|528928770|FG000|Overall Study|Adverse Event|5|||
146658701|NCT05342532|528928771|FG001|Overall Study|Adverse Event|20|||
146658702|NCT05342532|528928770|FG000|Overall Study|Lost to Follow-up|10|||
146658703|NCT05342532|528928771|FG001|Overall Study|Lost to Follow-up|15|||
146658704|NCT02675231|528928772|FG000|Overall Study|Withdrawal by Subject|2|||
146924962|NCT01683071|529884864|FG005|Part 2|Lost to Follow-up|0|||
146614743|NCT03188432|528759912|FG000|Overall Study|Death|3|||
146614744|NCT03188432|528759912|FG000|Overall Study|Withdrawal by Subject|15|||
146614745|NCT03188432|528759912|FG000|Overall Study|Did not complete protocol treatment|9|||
146614746|NCT01687296|528759915|FG000|Overall Study|Lack of Efficacy|1|||
146614747|NCT01687296|528759916|FG001|Overall Study|Lack of Efficacy|1|||
146614748|NCT01687296|528759915|FG000|Overall Study|Protocol Violation|0|||
146614749|NCT01687296|528759916|FG001|Overall Study|Protocol Violation|1|||
146614750|NCT01687296|528759915|FG000|Overall Study|Withdrawal by Subject|6|||
146614751|NCT01687296|528759916|FG001|Overall Study|Withdrawal by Subject|3|||
146614752|NCT02336230|528759919|FG000|Overall Study|Adverse Event|1|||
146614753|NCT02336230|528759919|FG000|Overall Study|Withdrawal of consent|1|||
146614754|NCT02336230|528759919|FG000|Overall Study|Death|9|||
146614755|NCT02336230|528759919|FG000|Overall Study|Dose not received due to shipping delay|1|||
146614756|NCT02336230|528759919|FG000|Overall Study|Discontinuation of MSC infusion|1|||
146614757|NCT02524171|528759920|FG000|6-month Follow-up|Lost to Follow-up|53|||
146614758|NCT02524171|528759921|FG001|6-month Follow-up|Lost to Follow-up|45|||
146614759|NCT02524171|528759920|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
146614760|NCT02524171|528759921|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
146614761|NCT01695135|528759922|FG000|Double-blind Treatment Phase|Progressive disease|50|||
146614762|NCT01695135|528759923|FG001|Double-blind Treatment Phase|Progressive disease|110|||
146614763|NCT01695135|528759924|FG002|Double-blind Treatment Phase|Progressive disease|0|||
146614764|NCT01695135|528759925|FG003|Double-blind Treatment Phase|Progressive disease|0|||
146614765|NCT01695135|528759922|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
146614766|NCT01695135|528759923|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
146614767|NCT01695135|528759924|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146614768|NCT01695135|528759925|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146614769|NCT01695135|528759922|FG000|Double-blind Treatment Phase|Adverse Event|7|||
146614770|NCT01695135|528759923|FG001|Double-blind Treatment Phase|Adverse Event|7|||
146614771|NCT01695135|528759924|FG002|Double-blind Treatment Phase|Adverse Event|0|||
146614772|NCT01695135|528759925|FG003|Double-blind Treatment Phase|Adverse Event|0|||
146614773|NCT01695135|528759922|FG000|Double-blind Treatment Phase|Other|1|||
146614774|NCT01695135|528759923|FG001|Double-blind Treatment Phase|Other|3|||
146614775|NCT01695135|528759924|FG002|Double-blind Treatment Phase|Other|0|||
146614776|NCT01695135|528759925|FG003|Double-blind Treatment Phase|Other|0|||
146614777|NCT01695135|528759922|FG000|Double-blind Treatment Phase|Physician Decision|6|||
146614778|NCT01695135|528759923|FG001|Double-blind Treatment Phase|Physician Decision|3|||
146614779|NCT01695135|528759924|FG002|Double-blind Treatment Phase|Physician Decision|0|||
146614780|NCT01695135|528759925|FG003|Double-blind Treatment Phase|Physician Decision|0|||
146614781|NCT01695135|528759922|FG000|Double-blind Treatment Phase|Death|1|||
146614782|NCT01695135|528759923|FG001|Double-blind Treatment Phase|Death|1|||
146614783|NCT01695135|528759924|FG002|Double-blind Treatment Phase|Death|0|||
146614784|NCT01695135|528759925|FG003|Double-blind Treatment Phase|Death|0|||
146614785|NCT01695135|528759922|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
146614786|NCT01695135|528759923|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
146614787|NCT01695135|528759924|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
146614788|NCT01695135|528759925|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
146614789|NCT01695135|528759922|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
146614790|NCT01695135|528759923|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
146614791|NCT01695135|528759924|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
146614792|NCT01695135|528759925|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
146614793|NCT01695135|528759922|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
146614794|NCT01695135|528759923|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
146614795|NCT01695135|528759924|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
146614796|NCT01695135|528759925|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
146614797|NCT01695135|528759922|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
146614798|NCT01695135|528759923|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
146614799|NCT01695135|528759924|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
146614800|NCT01695135|528759925|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
146614801|NCT01695135|528759922|FG000|Open Label Extension Treatment Phase|Other|0|||
146614802|NCT01695135|528759923|FG001|Open Label Extension Treatment Phase|Other|0|||
146614803|NCT01695135|528759924|FG002|Open Label Extension Treatment Phase|Other|4|||
146614804|NCT01695135|528759925|FG003|Open Label Extension Treatment Phase|Other|7|||
146614805|NCT01695135|528759922|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
146614806|NCT01695135|528759923|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
146614807|NCT01695135|528759924|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
146614808|NCT01695135|528759925|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
146614809|NCT01695135|528759922|FG000|Open Label Extension Treatment Phase|Death|0|||
146614810|NCT01695135|528759923|FG001|Open Label Extension Treatment Phase|Death|0|||
146614811|NCT01695135|528759924|FG002|Open Label Extension Treatment Phase|Death|2|||
146614812|NCT01695135|528759925|FG003|Open Label Extension Treatment Phase|Death|7|||
146614813|NCT01695135|528759922|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
146614814|NCT01695135|528759923|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
146614815|NCT01695135|528759924|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
146614816|NCT01695135|528759925|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
146614817|NCT00216671|528759928|FG000|Overall Study|Adverse Event|4|||
146614818|NCT00216671|528759929|FG001|Overall Study|Adverse Event|9|||
146614819|NCT00216671|528759928|FG000|Overall Study|Pregnancy|0|||
146614820|NCT00216671|528759929|FG001|Overall Study|Pregnancy|1|||
146614821|NCT00216671|528759928|FG000|Overall Study|Withdrawal by Subject|4|||
146614822|NCT00216671|528759929|FG001|Overall Study|Withdrawal by Subject|2|||
146614823|NCT00216671|528759928|FG000|Overall Study|Refused Injections|3|||
146614824|NCT00216671|528759929|FG001|Overall Study|Refused Injections|13|||
146614825|NCT00216671|528759928|FG000|Overall Study|No Need to Continue Medication|1|||
146614826|NCT00216671|528759929|FG001|Overall Study|No Need to Continue Medication|1|||
146614827|NCT00216671|528759928|FG000|Overall Study|Insufficient Response|9|||
146614828|NCT00216671|528759929|FG001|Overall Study|Insufficient Response|4|||
146614829|NCT00216671|528759928|FG000|Overall Study|Lost to Follow-up|3|||
146614830|NCT00216671|528759929|FG001|Overall Study|Lost to Follow-up|5|||
146614831|NCT00216671|528759928|FG000|Overall Study|Non compliant|2|||
146614832|NCT00216671|528759929|FG001|Overall Study|Non compliant|2|||
146614833|NCT00216671|528759928|FG000|Overall Study|Ineligible|0|||
146614834|NCT00216671|528759929|FG001|Overall Study|Ineligible|2|||
146614835|NCT00216671|528759928|FG000|Overall Study|Physician Decision|1|||
146614836|NCT00216671|528759929|FG001|Overall Study|Physician Decision|1|||
146614837|NCT00216671|528759928|FG000|Overall Study|Protocol Violation|3|||
146614838|NCT00216671|528759929|FG001|Overall Study|Protocol Violation|5|||
146614839|NCT00216671|528759928|FG000|Overall Study|Relapse|1|||
146614840|NCT00216671|528759929|FG001|Overall Study|Relapse|0|||
146614841|NCT00216671|528759928|FG000|Overall Study|Investigator Illness|0|||
146614842|NCT00216671|528759929|FG001|Overall Study|Investigator Illness|1|||
146614843|NCT00216671|528759928|FG000|Overall Study|Patient Moved|0|||
146614844|NCT00216671|528759929|FG001|Overall Study|Patient Moved|1|||
146614845|NCT00216671|528759928|FG000|Overall Study|Ineligible, no efficacy data|2|||
146614846|NCT00216671|528759929|FG001|Overall Study|Ineligible, no efficacy data|2|||
146614847|NCT00216671|528759928|FG000|Overall Study|Insufficient Response Adverse Event|2|||
146614848|NCT00216671|528759929|FG001|Overall Study|Insufficient Response Adverse Event|1|||
146614849|NCT02714569|528759930|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
146614850|NCT02714569|528759931|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
146614851|NCT02714569|528759932|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
146614852|NCT02714569|528759933|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
146614853|NCT02714569|528759934|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
146614854|NCT02714569|528759935|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
146614855|NCT02714569|528759936|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
146614856|NCT02714569|528759937|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
146614857|NCT02714569|528759938|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
146614858|NCT02714569|528759939|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
146614859|NCT02714569|528759940|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
146614860|NCT02714569|528759930|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146614861|NCT02714569|528759931|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146614862|NCT02714569|528759932|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146614863|NCT02714569|528759933|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
146614864|NCT02714569|528759934|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146614865|NCT02714569|528759935|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146614866|NCT02714569|528759936|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146614867|NCT02714569|528759937|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146614868|NCT02714569|528759938|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146614869|NCT02714569|528759939|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146614870|NCT02714569|528759940|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146614871|NCT02714569|528759930|FG000|Part A Third Intervention|Adverse Event|0|||
146614872|NCT02714569|528759931|FG001|Part A Third Intervention|Adverse Event|0|||
146614873|NCT02714569|528759932|FG002|Part A Third Intervention|Adverse Event|1|||
146614874|NCT02714569|528759933|FG003|Part A Third Intervention|Adverse Event|0|||
146614875|NCT02714569|528759934|FG004|Part A Third Intervention|Adverse Event|0|||
146614876|NCT02714569|528759935|FG005|Part A Third Intervention|Adverse Event|0|||
146614877|NCT02714569|528759936|FG006|Part A Third Intervention|Adverse Event|0|||
146614878|NCT02714569|528759937|FG007|Part A Third Intervention|Adverse Event|0|||
146614879|NCT02714569|528759938|FG008|Part A Third Intervention|Adverse Event|0|||
146614880|NCT02714569|528759939|FG009|Part A Third Intervention|Adverse Event|0|||
146924963|NCT01683071|529884859|FG000|Part 2|Withdrawal by Subject|0|||
146614881|NCT02714569|528759940|FG010|Part A Third Intervention|Adverse Event|0|||
146614882|NCT02714569|528759930|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
146614883|NCT02714569|528759931|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146614884|NCT02714569|528759932|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146614885|NCT02714569|528759933|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146614886|NCT02714569|528759934|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146614887|NCT02714569|528759935|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
146614888|NCT02714569|528759936|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146614889|NCT02714569|528759937|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146614890|NCT02714569|528759938|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146614891|NCT02714569|528759939|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146614892|NCT02714569|528759940|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146614893|NCT02714569|528759930|FG000|Part B (Overall)|Lost to Follow-up|0|||
146614894|NCT02714569|528759931|FG001|Part B (Overall)|Lost to Follow-up|0|||
146614895|NCT02714569|528759932|FG002|Part B (Overall)|Lost to Follow-up|0|||
146614896|NCT02714569|528759933|FG003|Part B (Overall)|Lost to Follow-up|0|||
146614897|NCT02714569|528759934|FG004|Part B (Overall)|Lost to Follow-up|0|||
146614898|NCT02714569|528759935|FG005|Part B (Overall)|Lost to Follow-up|0|||
146614899|NCT02714569|528759936|FG006|Part B (Overall)|Lost to Follow-up|1|||
146614900|NCT02714569|528759937|FG007|Part B (Overall)|Lost to Follow-up|0|||
146614901|NCT02714569|528759938|FG008|Part B (Overall)|Lost to Follow-up|0|||
146614902|NCT02714569|528759939|FG009|Part B (Overall)|Lost to Follow-up|0|||
146614903|NCT02714569|528759940|FG010|Part B (Overall)|Lost to Follow-up|0|||
146614904|NCT02714569|528759930|FG000|Part B (Overall)|Withdrawal by Subject|0|||
146614905|NCT02714569|528759931|FG001|Part B (Overall)|Withdrawal by Subject|0|||
146614906|NCT02714569|528759932|FG002|Part B (Overall)|Withdrawal by Subject|0|||
146614907|NCT02714569|528759933|FG003|Part B (Overall)|Withdrawal by Subject|0|||
146614908|NCT02714569|528759934|FG004|Part B (Overall)|Withdrawal by Subject|0|||
146614909|NCT02714569|528759935|FG005|Part B (Overall)|Withdrawal by Subject|0|||
146614910|NCT02714569|528759936|FG006|Part B (Overall)|Withdrawal by Subject|0|||
146614911|NCT02714569|528759937|FG007|Part B (Overall)|Withdrawal by Subject|1|||
146614912|NCT02714569|528759938|FG008|Part B (Overall)|Withdrawal by Subject|0|||
146614913|NCT02714569|528759939|FG009|Part B (Overall)|Withdrawal by Subject|1|||
146614914|NCT02714569|528759940|FG010|Part B (Overall)|Withdrawal by Subject|0|||
146614915|NCT02714569|528759930|FG000|Part B (Overall)|Adverse Event|0|||
146614916|NCT02714569|528759931|FG001|Part B (Overall)|Adverse Event|0|||
146614917|NCT02714569|528759932|FG002|Part B (Overall)|Adverse Event|0|||
146614918|NCT02714569|528759933|FG003|Part B (Overall)|Adverse Event|0|||
146614919|NCT02714569|528759934|FG004|Part B (Overall)|Adverse Event|0|||
146614920|NCT02714569|528759935|FG005|Part B (Overall)|Adverse Event|0|||
146614921|NCT02714569|528759936|FG006|Part B (Overall)|Adverse Event|0|||
146614922|NCT02714569|528759937|FG007|Part B (Overall)|Adverse Event|0|||
146614923|NCT02714569|528759938|FG008|Part B (Overall)|Adverse Event|0|||
146614924|NCT02714569|528759939|FG009|Part B (Overall)|Adverse Event|1|||
146614925|NCT02714569|528759940|FG010|Part B (Overall)|Adverse Event|0|||
146614926|NCT01684202|528759941|FG000|Dose-escalation Period|Adverse Event|0|||
146614927|NCT01684202|528759942|FG001|Dose-escalation Period|Adverse Event|1|||
146614928|NCT01684202|528759943|FG002|Dose-escalation Period|Adverse Event|0|||
146614929|NCT01684202|528759944|FG003|Dose-escalation Period|Adverse Event|0|||
146614930|NCT01684202|528759941|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
146614931|NCT01684202|528759942|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
146614932|NCT01684202|528759943|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
146614933|NCT01684202|528759944|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
146614934|NCT01684202|528759941|FG000|Maintenance Period|Adverse Event|1|||
146614935|NCT01684202|528759942|FG001|Maintenance Period|Adverse Event|1|||
146614936|NCT01684202|528759943|FG002|Maintenance Period|Adverse Event|1|||
146614937|NCT01684202|528759944|FG003|Maintenance Period|Adverse Event|1|||
146614938|NCT01684202|528759941|FG000|Maintenance Period|Physician Decision|0|||
146614939|NCT01684202|528759942|FG001|Maintenance Period|Physician Decision|1|||
146614940|NCT01684202|528759943|FG002|Maintenance Period|Physician Decision|0|||
146978686|NCT03262233|530085460|FG002|Overall Study|Protocol Violation|2|||
146614941|NCT01684202|528759944|FG003|Maintenance Period|Physician Decision|0|||
146614942|NCT01684202|528759941|FG000|Maintenance Period|Withdrawal by Subject|0|||
146614943|NCT01684202|528759942|FG001|Maintenance Period|Withdrawal by Subject|1|||
146614944|NCT01684202|528759943|FG002|Maintenance Period|Withdrawal by Subject|0|||
146614945|NCT01684202|528759944|FG003|Maintenance Period|Withdrawal by Subject|0|||
146978687|NCT03262233|530085461|FG003|Overall Study|Protocol Violation|13|||
146978688|NCT03262233|530085458|FG000|Overall Study|data collection artifact|0|||
146614946|NCT03305770|528759945|FG000|Overall Study|Physician Decision - prior to dispense|0|||
146614947|NCT03305770|528759946|FG001|Overall Study|Physician Decision - prior to dispense|1|||
146614948|NCT03305770|528759945|FG000|Overall Study|Subject moved|1|||
146614949|NCT03305770|528759946|FG001|Overall Study|Subject moved|0|||
146614950|NCT03539601|528759947|FG000|Overall Study|Withdraw by parent/guardian|1|||
146614951|NCT03539601|528759948|FG001|Overall Study|Withdraw by parent/guardian|0|||
146614952|NCT03539601|528759949|FG002|Overall Study|Withdraw by parent/guardian|1|||
146614953|NCT03539601|528759950|FG003|Overall Study|Withdraw by parent/guardian|0|||
146614954|NCT03539601|528759947|FG000|Overall Study|Adverse Event|0|||
146614955|NCT03539601|528759948|FG001|Overall Study|Adverse Event|2|||
146614956|NCT03539601|528759949|FG002|Overall Study|Adverse Event|0|||
146614957|NCT03539601|528759950|FG003|Overall Study|Adverse Event|0|||
146614958|NCT03539601|528759947|FG000|Overall Study|Lost to Follow-up|2|||
146614959|NCT03539601|528759948|FG001|Overall Study|Lost to Follow-up|4|||
146614960|NCT03539601|528759949|FG002|Overall Study|Lost to Follow-up|5|||
146614961|NCT03539601|528759950|FG003|Overall Study|Lost to Follow-up|0|||
146614962|NCT03539601|528759947|FG000|Overall Study|Withdrawal by Subject|2|||
146614963|NCT03539601|528759948|FG001|Overall Study|Withdrawal by Subject|0|||
146614964|NCT03539601|528759949|FG002|Overall Study|Withdrawal by Subject|0|||
146614965|NCT03539601|528759950|FG003|Overall Study|Withdrawal by Subject|1|||
146614966|NCT03539601|528759947|FG000|Overall Study|Randomized but not treated|1|||
146614967|NCT03539601|528759948|FG001|Overall Study|Randomized but not treated|1|||
146614968|NCT03539601|528759949|FG002|Overall Study|Randomized but not treated|0|||
146614969|NCT03539601|528759950|FG003|Overall Study|Randomized but not treated|0|||
146614970|NCT00226811|528759951|FG000|Overall Study|Death|8|||
146614971|NCT00226811|528759951|FG000|Overall Study|Adverse Event|11|||
146614972|NCT00226811|528759951|FG000|Overall Study|Lack of Efficacy|55|||
146614973|NCT00226811|528759951|FG000|Overall Study|Withdrawal by Subject|2|||
146614974|NCT01010971|528759952|FG000|Overall Study|Adverse Event|2|||
146614975|NCT01010971|528759953|FG001|Overall Study|Adverse Event|4|||
146614976|NCT01010971|528759954|FG002|Overall Study|Adverse Event|3|||
146614977|NCT01010971|528759952|FG000|Overall Study|Withdrawal by Subject|0|||
146614978|NCT01010971|528759953|FG001|Overall Study|Withdrawal by Subject|2|||
146614979|NCT01010971|528759954|FG002|Overall Study|Withdrawal by Subject|5|||
146614980|NCT01010971|528759952|FG000|Overall Study|Lost to Follow-up|0|||
146614981|NCT01010971|528759953|FG001|Overall Study|Lost to Follow-up|2|||
146614982|NCT01010971|528759954|FG002|Overall Study|Lost to Follow-up|3|||
146614983|NCT01010971|528759952|FG000|Overall Study|Other|1|||
146614984|NCT01010971|528759953|FG001|Overall Study|Other|0|||
146658705|NCT02675231|528928773|FG001|Overall Study|Withdrawal by Subject|4|||
146658706|NCT02675231|528928774|FG002|Overall Study|Withdrawal by Subject|2|||
146658707|NCT02675231|528928772|FG000|Overall Study|Lost to Follow-up|3|||
146658708|NCT02675231|528928773|FG001|Overall Study|Lost to Follow-up|4|||
146658709|NCT02675231|528928774|FG002|Overall Study|Lost to Follow-up|3|||
146658710|NCT02652767|528928775|FG000|Overall Study|Death|2|||
146658711|NCT02652767|528928775|FG000|Overall Study|Lost to Follow-up|1|||
146658712|NCT02652767|528928775|FG000|Overall Study|Withdrawal by Subject|1|||
146658713|NCT00887744|528928784|FG000|Overall Study|Adverse Event|3|||
146658714|NCT00887744|528928784|FG000|Overall Study|Death|1|||
146658715|NCT00887744|528928784|FG000|Overall Study|Lost to Follow-up|3|||
146658716|NCT00887744|528928784|FG000|Overall Study|Withdrawal by Subject|18|||
146658717|NCT00887744|528928784|FG000|Overall Study|Various reasons|9|||
146658718|NCT01610271|528928786|FG000|Overall Study|Surgery not complete|0|||
146658719|NCT01610271|528928787|FG001|Overall Study|Surgery not complete|1|||
146658720|NCT01610271|528928786|FG000|Overall Study|Prosthesis not implanted|2|||
146658721|NCT01610271|528928787|FG001|Overall Study|Prosthesis not implanted|3|||
146658722|NCT02961218|528928788|FG000|Overall Study|Lost to Follow-up|0|||
146658723|NCT02961218|528928789|FG001|Overall Study|Lost to Follow-up|2|||
146658724|NCT02961218|528928788|FG000|Overall Study|Physician Decision|0|||
146658725|NCT02961218|528928789|FG001|Overall Study|Physician Decision|2|||
146658726|NCT02961218|528928788|FG000|Overall Study|Subject/Guardian Decision|3|||
146658727|NCT02961218|528928789|FG001|Overall Study|Subject/Guardian Decision|1|||
146658728|NCT01462227|528928790|FG000|Second Assignment|Lost to Follow-up|1|||
146658729|NCT01462227|528928791|FG001|Second Assignment|Lost to Follow-up|0|||
146614985|NCT01010971|528759954|FG002|Overall Study|Other|2|||
146614986|NCT03386721|528759955|FG000|Overall Study|Death|12|||
146614987|NCT03386721|528759956|FG001|Overall Study|Death|21|||
146614988|NCT03386721|528759957|FG002|Overall Study|Death|2|||
146614989|NCT03386721|528759958|FG003|Overall Study|Death|5|||
146614990|NCT03386721|528759959|FG004|Overall Study|Death|1|||
146614991|NCT03386721|528759960|FG005|Overall Study|Death|12|||
146614992|NCT03386721|528759961|FG006|Overall Study|Death|1|||
146614993|NCT03386721|528759962|FG007|Overall Study|Death|1|||
146614994|NCT03386721|528759963|FG008|Overall Study|Death|12|||
146614995|NCT03386721|528759964|FG009|Overall Study|Death|20|||
146614996|NCT03386721|528759965|FG010|Overall Study|Death|21|||
146614997|NCT03386721|528759966|FG011|Overall Study|Death|21|||
146614998|NCT03386721|528759967|FG012|Overall Study|Death|14|||
146614999|NCT03386721|528759968|FG013|Overall Study|Death|2|||
146615000|NCT03386721|528759969|FG014|Overall Study|Death|1|||
146615001|NCT03386721|528759955|FG000|Overall Study|Lost to Follow-up|1|||
146615002|NCT03386721|528759956|FG001|Overall Study|Lost to Follow-up|3|||
146615003|NCT03386721|528759957|FG002|Overall Study|Lost to Follow-up|0|||
146615004|NCT03386721|528759958|FG003|Overall Study|Lost to Follow-up|0|||
146615005|NCT03386721|528759959|FG004|Overall Study|Lost to Follow-up|0|||
146658730|NCT01462227|528928792|FG002|Second Assignment|Lost to Follow-up|0|||
146658731|NCT01462227|528928793|FG003|Second Assignment|Lost to Follow-up|0|||
146658732|NCT01462227|528928790|FG000|Second Assignment|Protocol Violation|0|||
146658733|NCT01462227|528928791|FG001|Second Assignment|Protocol Violation|1|||
146658734|NCT01462227|528928792|FG002|Second Assignment|Protocol Violation|1|||
146658735|NCT01462227|528928793|FG003|Second Assignment|Protocol Violation|0|||
146658736|NCT00591266|528928794|FG000|Overall Study|Adverse Event|2|||
146615006|NCT03386721|528759960|FG005|Overall Study|Lost to Follow-up|2|||
146615007|NCT03386721|528759961|FG006|Overall Study|Lost to Follow-up|1|||
146615008|NCT03386721|528759962|FG007|Overall Study|Lost to Follow-up|0|||
146615009|NCT03386721|528759963|FG008|Overall Study|Lost to Follow-up|1|||
146615010|NCT03386721|528759964|FG009|Overall Study|Lost to Follow-up|2|||
146615011|NCT03386721|528759965|FG010|Overall Study|Lost to Follow-up|1|||
146615012|NCT03386721|528759966|FG011|Overall Study|Lost to Follow-up|0|||
146615013|NCT03386721|528759967|FG012|Overall Study|Lost to Follow-up|0|||
146615014|NCT03386721|528759968|FG013|Overall Study|Lost to Follow-up|0|||
146615015|NCT03386721|528759969|FG014|Overall Study|Lost to Follow-up|0|||
146615016|NCT03386721|528759955|FG000|Overall Study|Reason not specified|3|||
146615017|NCT03386721|528759956|FG001|Overall Study|Reason not specified|0|||
146615018|NCT03386721|528759957|FG002|Overall Study|Reason not specified|0|||
146615019|NCT03386721|528759958|FG003|Overall Study|Reason not specified|0|||
146615020|NCT03386721|528759959|FG004|Overall Study|Reason not specified|0|||
146615021|NCT03386721|528759960|FG005|Overall Study|Reason not specified|3|||
146615022|NCT03386721|528759961|FG006|Overall Study|Reason not specified|1|||
146615023|NCT03386721|528759962|FG007|Overall Study|Reason not specified|0|||
146615024|NCT03386721|528759963|FG008|Overall Study|Reason not specified|0|||
146615025|NCT03386721|528759964|FG009|Overall Study|Reason not specified|1|||
146615026|NCT03386721|528759965|FG010|Overall Study|Reason not specified|2|||
146615027|NCT03386721|528759966|FG011|Overall Study|Reason not specified|6|||
146615028|NCT03386721|528759967|FG012|Overall Study|Reason not specified|1|||
146615029|NCT03386721|528759968|FG013|Overall Study|Reason not specified|0|||
146615030|NCT03386721|528759969|FG014|Overall Study|Reason not specified|0|||
146615031|NCT03386721|528759955|FG000|Overall Study|Progressive Disease|0|||
146615032|NCT03386721|528759956|FG001|Overall Study|Progressive Disease|0|||
146615033|NCT03386721|528759957|FG002|Overall Study|Progressive Disease|1|||
146615034|NCT03386721|528759958|FG003|Overall Study|Progressive Disease|0|||
146615035|NCT03386721|528759959|FG004|Overall Study|Progressive Disease|0|||
146615036|NCT03386721|528759960|FG005|Overall Study|Progressive Disease|1|||
146615037|NCT03386721|528759961|FG006|Overall Study|Progressive Disease|0|||
146615038|NCT03386721|528759962|FG007|Overall Study|Progressive Disease|0|||
146615039|NCT03386721|528759963|FG008|Overall Study|Progressive Disease|2|||
146615040|NCT03386721|528759964|FG009|Overall Study|Progressive Disease|1|||
146615041|NCT03386721|528759965|FG010|Overall Study|Progressive Disease|1|||
146615042|NCT03386721|528759966|FG011|Overall Study|Progressive Disease|0|||
146615043|NCT03386721|528759967|FG012|Overall Study|Progressive Disease|1|||
146615044|NCT03386721|528759968|FG013|Overall Study|Progressive Disease|0|||
146615045|NCT03386721|528759969|FG014|Overall Study|Progressive Disease|0|||
146615046|NCT03386721|528759955|FG000|Overall Study|Site Terminated by Sponsor|5|||
146615047|NCT03386721|528759956|FG001|Overall Study|Site Terminated by Sponsor|5|||
146615048|NCT03386721|528759957|FG002|Overall Study|Site Terminated by Sponsor|0|||
146615049|NCT03386721|528759958|FG003|Overall Study|Site Terminated by Sponsor|0|||
146615050|NCT03386721|528759959|FG004|Overall Study|Site Terminated by Sponsor|1|||
146615051|NCT03386721|528759960|FG005|Overall Study|Site Terminated by Sponsor|3|||
146615052|NCT03386721|528759961|FG006|Overall Study|Site Terminated by Sponsor|0|||
146615053|NCT03386721|528759962|FG007|Overall Study|Site Terminated by Sponsor|1|||
146615054|NCT03386721|528759963|FG008|Overall Study|Site Terminated by Sponsor|4|||
146615055|NCT03386721|528759964|FG009|Overall Study|Site Terminated by Sponsor|5|||
146615056|NCT03386721|528759965|FG010|Overall Study|Site Terminated by Sponsor|3|||
146658737|NCT00591266|528928795|FG001|Overall Study|Adverse Event|2|||
146658738|NCT00591266|528928796|FG002|Overall Study|Adverse Event|3|||
146658739|NCT00591266|528928794|FG000|Overall Study|Lost to Follow-up|0|||
146658740|NCT00591266|528928795|FG001|Overall Study|Lost to Follow-up|1|||
146658741|NCT00591266|528928796|FG002|Overall Study|Lost to Follow-up|0|||
146658742|NCT00591266|528928794|FG000|Overall Study|Protocol Violation|0|||
146658743|NCT00591266|528928795|FG001|Overall Study|Protocol Violation|0|||
146658744|NCT00591266|528928796|FG002|Overall Study|Protocol Violation|1|||
146615057|NCT03386721|528759966|FG011|Overall Study|Site Terminated by Sponsor|11|||
146615058|NCT03386721|528759967|FG012|Overall Study|Site Terminated by Sponsor|6|||
146615059|NCT03386721|528759968|FG013|Overall Study|Site Terminated by Sponsor|0|||
146615060|NCT03386721|528759969|FG014|Overall Study|Site Terminated by Sponsor|0|||
146615061|NCT03386721|528759955|FG000|Overall Study|Symptomatic Deterioration|0|||
146615062|NCT03386721|528759956|FG001|Overall Study|Symptomatic Deterioration|0|||
146658745|NCT00591266|528928794|FG000|Overall Study|Withdrawal by Subject|6|||
146978689|NCT03262233|530085459|FG001|Overall Study|data collection artifact|1|||
146615063|NCT03386721|528759957|FG002|Overall Study|Symptomatic Deterioration|0|||
146615064|NCT03386721|528759958|FG003|Overall Study|Symptomatic Deterioration|0|||
146615065|NCT03386721|528759959|FG004|Overall Study|Symptomatic Deterioration|0|||
146615066|NCT03386721|528759960|FG005|Overall Study|Symptomatic Deterioration|0|||
146615067|NCT03386721|528759961|FG006|Overall Study|Symptomatic Deterioration|0|||
146658746|NCT00591266|528928795|FG001|Overall Study|Withdrawal by Subject|2|||
146658747|NCT00591266|528928796|FG002|Overall Study|Withdrawal by Subject|5|||
146658748|NCT00591266|528928794|FG000|Overall Study|Lack of Efficacy|0|||
146658749|NCT00591266|528928795|FG001|Overall Study|Lack of Efficacy|2|||
146615068|NCT03386721|528759962|FG007|Overall Study|Symptomatic Deterioration|0|||
146615069|NCT03386721|528759963|FG008|Overall Study|Symptomatic Deterioration|1|||
146615070|NCT03386721|528759964|FG009|Overall Study|Symptomatic Deterioration|0|||
146615071|NCT03386721|528759965|FG010|Overall Study|Symptomatic Deterioration|0|||
146615072|NCT03386721|528759966|FG011|Overall Study|Symptomatic Deterioration|1|||
146615073|NCT03386721|528759967|FG012|Overall Study|Symptomatic Deterioration|0|||
146615074|NCT03386721|528759968|FG013|Overall Study|Symptomatic Deterioration|0|||
146615075|NCT03386721|528759969|FG014|Overall Study|Symptomatic Deterioration|0|||
146615076|NCT03386721|528759955|FG000|Overall Study|Withdrawal by Subject|1|||
146615077|NCT03386721|528759956|FG001|Overall Study|Withdrawal by Subject|2|||
146615078|NCT03386721|528759957|FG002|Overall Study|Withdrawal by Subject|0|||
146615079|NCT03386721|528759958|FG003|Overall Study|Withdrawal by Subject|0|||
146615080|NCT03386721|528759959|FG004|Overall Study|Withdrawal by Subject|0|||
146615081|NCT03386721|528759960|FG005|Overall Study|Withdrawal by Subject|0|||
146615082|NCT03386721|528759961|FG006|Overall Study|Withdrawal by Subject|0|||
146615083|NCT03386721|528759962|FG007|Overall Study|Withdrawal by Subject|0|||
146615084|NCT03386721|528759963|FG008|Overall Study|Withdrawal by Subject|2|||
146615085|NCT03386721|528759964|FG009|Overall Study|Withdrawal by Subject|1|||
146615086|NCT03386721|528759965|FG010|Overall Study|Withdrawal by Subject|3|||
146615087|NCT03386721|528759966|FG011|Overall Study|Withdrawal by Subject|2|||
146615088|NCT03386721|528759967|FG012|Overall Study|Withdrawal by Subject|3|||
146615089|NCT03386721|528759968|FG013|Overall Study|Withdrawal by Subject|0|||
146615090|NCT03386721|528759969|FG014|Overall Study|Withdrawal by Subject|0|||
146615091|NCT00700713|528759971|FG000|Overall Study|Protocol Violation|1|||
146615092|NCT00700713|528759972|FG001|Overall Study|Protocol Violation|0|||
146615093|NCT00700713|528759973|FG002|Overall Study|Protocol Violation|1|||
146615094|NCT00700713|528759971|FG000|Overall Study|Withdrawal by Subject|0|||
146615095|NCT00700713|528759972|FG001|Overall Study|Withdrawal by Subject|0|||
146615096|NCT00700713|528759973|FG002|Overall Study|Withdrawal by Subject|1|||
146615097|NCT00550953|528759974|FG000|Overall Study|Adverse Event|4|||
146615098|NCT00550953|528759975|FG001|Overall Study|Adverse Event|3|||
146615099|NCT00550953|528759974|FG000|Overall Study|Not able to visit the site|2|||
146615100|NCT00550953|528759975|FG001|Overall Study|Not able to visit the site|3|||
146615101|NCT03797586|528759976|FG000|Overall Study|Lost to Follow-up|3|||
146615102|NCT03797586|528759977|FG001|Overall Study|Lost to Follow-up|6|||
146615103|NCT03797586|528759976|FG000|Overall Study|Death|1|||
146615104|NCT03797586|528759977|FG001|Overall Study|Death|1|||
146615105|NCT03797586|528759976|FG000|Overall Study|Adverse Event|0|||
146615106|NCT03797586|528759977|FG001|Overall Study|Adverse Event|2|||
146615107|NCT04980612|528759978|FG000|Overall Study|Withdrawal by Subject|7|||
146615108|NCT04980612|528759979|FG001|Overall Study|Withdrawal by Subject|5|||
146615109|NCT01502228|528759982|FG000|Overall Study|Death|1|||
146615110|NCT05730387|528759983|FG000|Overall Study|Stillbirth|0|||
146615111|NCT05730387|528759984|FG001|Overall Study|Stillbirth|262|||
146615112|NCT05730387|528759983|FG000|Overall Study|Died during or after delivery|2|||
146615113|NCT05730387|528759984|FG001|Overall Study|Died during or after delivery|85|||
146615114|NCT05730387|528759983|FG000|Overall Study|Died after being admitted|0|||
146615115|NCT05730387|528759984|FG001|Overall Study|Died after being admitted|44|||
146615116|NCT05730387|528759983|FG000|Overall Study|Lost to Follow-up|69|||
146615117|NCT05730387|528759984|FG001|Overall Study|Lost to Follow-up|77|||
146615118|NCT02728089|528759985|FG000|Overall Study|Physician Decision|2|||
146615119|NCT02728089|528759985|FG000|Overall Study|Withdrawal by Subject|1|||
146615120|NCT01219985|528759986|FG000|Overall Study|Physician Decision|20|||
146615121|NCT00596752|528759987|FG000|Overall Study|Other Reason|44|||
146615122|NCT00596752|528759988|FG001|Overall Study|Other Reason|49|||
146615123|NCT00596752|528759987|FG000|Overall Study|Adverse Event|34|||
146615124|NCT00596752|528759988|FG001|Overall Study|Adverse Event|34|||
146615125|NCT00596752|528759987|FG000|Overall Study|Lost to Follow-up|22|||
146615126|NCT00596752|528759988|FG001|Overall Study|Lost to Follow-up|38|||
146773529|NCT02988817|529341091|FG015|Overall Study|Lost to Follow-up|1|||
146773530|NCT02988817|529341092|FG016|Overall Study|Lost to Follow-up|2|||
146773531|NCT02988817|529341093|FG017|Overall Study|Lost to Follow-up|3|||
146773532|NCT02988817|529341094|FG018|Overall Study|Lost to Follow-up|0|||
146773533|NCT02988817|529341095|FG019|Overall Study|Lost to Follow-up|0|||
146615127|NCT00596752|528759987|FG000|Overall Study|Withdrawal by Subject|12|||
146615128|NCT00596752|528759988|FG001|Overall Study|Withdrawal by Subject|9|||
146773534|NCT02988817|529341076|FG000|Overall Study|Sponsor decision|0|||
146615129|NCT00596752|528759987|FG000|Overall Study|Unsatisfactory Compliance|9|||
146615130|NCT00596752|528759988|FG001|Overall Study|Unsatisfactory Compliance|6|||
146615131|NCT00596752|528759987|FG000|Overall Study|Lack of Efficacy|4|||
146615132|NCT00596752|528759988|FG001|Overall Study|Lack of Efficacy|7|||
146615133|NCT00596752|528759987|FG000|Overall Study|Protocol Violation|1|||
146615134|NCT00596752|528759988|FG001|Overall Study|Protocol Violation|0|||
146773535|NCT02988817|529341077|FG001|Overall Study|Sponsor decision|0|||
146773536|NCT02988817|529341078|FG002|Overall Study|Sponsor decision|0|||
146615135|NCT04797780|528759989|FG000|Overall Study|Lost to Follow-up|1|||
146615136|NCT04797780|528759990|FG001|Overall Study|Lost to Follow-up|1|||
146615137|NCT04797780|528759989|FG000|Overall Study|Withdrawal by Subject|14|||
146615138|NCT04797780|528759990|FG001|Overall Study|Withdrawal by Subject|9|||
146615139|NCT04797780|528759989|FG000|Overall Study|Death|49|||
146615140|NCT04797780|528759990|FG001|Overall Study|Death|20|||
146615141|NCT02940496|528759991|FG000|Overall Study|Adverse Event|1|||
146615142|NCT02940496|528759992|FG001|Overall Study|Adverse Event|0|||
146615143|NCT02940496|528759991|FG000|Overall Study|Death|2|||
146615144|NCT02940496|528759992|FG001|Overall Study|Death|0|||
146615145|NCT02940496|528759991|FG000|Overall Study|Hospice Care|1|||
146615146|NCT02940496|528759992|FG001|Overall Study|Hospice Care|0|||
146615147|NCT02940496|528759991|FG000|Overall Study|No MRE Done|1|||
146615148|NCT02940496|528759992|FG001|Overall Study|No MRE Done|0|||
146615149|NCT02940496|528759991|FG000|Overall Study|MRE Failure|1|||
146615150|NCT02940496|528759992|FG001|Overall Study|MRE Failure|0|||
146615151|NCT02586727|528759993|FG000|Overall Study|Lost to Follow-up|1|||
146615152|NCT02586727|528759994|FG001|Overall Study|Lost to Follow-up|0|||
146615153|NCT04089761|528759999|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
146615154|NCT04089761|528759999|FG000|"Run In Phase"|Lost to Follow-up|1|||
146615155|NCT04089761|528759999|FG000|"Treatment Phase"|No evaluable data|5|||
146615156|NCT04089761|528759999|FG000|"Treatment Phase"|Lost to Follow-up|1|||
146615157|NCT02119663|528760000|FG000|Overall Study|Disease progression|26|||
146615158|NCT02119663|528760001|FG001|Overall Study|Disease progression|27|||
146615159|NCT02119663|528760000|FG000|Overall Study|Adverse Event|5|||
146615160|NCT02119663|528760001|FG001|Overall Study|Adverse Event|5|||
146615161|NCT02119663|528760000|FG000|Overall Study|Death|3|||
146615162|NCT02119663|528760001|FG001|Overall Study|Death|2|||
146615163|NCT02119663|528760000|FG000|Overall Study|Physician Decision|1|||
146615164|NCT02119663|528760001|FG001|Overall Study|Physician Decision|2|||
146615165|NCT02119663|528760000|FG000|Overall Study|Other unspecified|2|||
146615166|NCT02119663|528760001|FG001|Overall Study|Other unspecified|0|||
146615167|NCT02119663|528760000|FG000|Overall Study|Subject decision|0|||
146615168|NCT02119663|528760001|FG001|Overall Study|Subject decision|1|||
146615169|NCT02119663|528760000|FG000|Overall Study|Study Terminated by the Sponsor|3|||
146615170|NCT02119663|528760001|FG001|Overall Study|Study Terminated by the Sponsor|4|||
146615171|NCT00699660|528760002|FG000|Overall Study|Lost to Follow-up|4|||
146615172|NCT00699660|528760003|FG001|Overall Study|Lost to Follow-up|2|||
146615173|NCT00699660|528760002|FG000|Overall Study|missing reports and recording failures|10|||
146615174|NCT00699660|528760003|FG001|Overall Study|missing reports and recording failures|6|||
146615175|NCT00103740|528760008|FG000|Period 1 - Core|Adverse Event|1|||
146615176|NCT00103740|528760009|FG001|Period 1 - Core|Adverse Event|0|||
146615177|NCT00103740|528760008|FG000|Period 1 - Core|Protocol Violation|3|||
146615178|NCT00103740|528760009|FG001|Period 1 - Core|Protocol Violation|2|||
146615179|NCT00103740|528760008|FG000|Period 1 - Core|Patient withdrew consent|3|||
146615180|NCT00103740|528760009|FG001|Period 1 - Core|Patient withdrew consent|2|||
146615181|NCT00103740|528760008|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
146615182|NCT00103740|528760009|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
146615183|NCT00103740|528760008|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
146615184|NCT00103740|528760009|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
146615185|NCT00103740|528760008|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
146615186|NCT00103740|528760009|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
146615187|NCT00103740|528760008|FG000|Period 2 - Extended Observation Period|Death|6|||
146615188|NCT00103740|528760009|FG001|Period 2 - Extended Observation Period|Death|2|||
146615189|NCT00103740|528760008|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
146615190|NCT00103740|528760009|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
146615191|NCT03449758|528761795|FG000|Overall Study|Major protocol deviation|1|||
146615192|NCT03449758|528761795|FG000|Overall Study|Treatment inefficacy|5|||
146615193|NCT03449758|528761795|FG000|Overall Study|Adverse Event|9|||
146615194|NCT03449758|528761795|FG000|Overall Study|Consent withdrawal|1|||
146615195|NCT03449758|528761795|FG000|Overall Study|Other unspecified reason|3|||
146615196|NCT03310723|528761796|FG000|Overall Study|Withdrawal by Subject|0|||
146615197|NCT03310723|528761797|FG001|Overall Study|Withdrawal by Subject|1|||
146615198|NCT03310723|528761796|FG000|Overall Study|Protocol Violation|0|||
146615199|NCT03310723|528761797|FG001|Overall Study|Protocol Violation|2|||
146978690|NCT03262233|530085460|FG002|Overall Study|data collection artifact|0|||
146978691|NCT03262233|530085461|FG003|Overall Study|data collection artifact|0|||
146615200|NCT02098746|528761798|FG000|Overall Study|Changes of Investigator|2|||
146615201|NCT02098746|528761798|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146615202|NCT02098746|528761798|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
146978692|NCT03990389|530085462|FG000|Overall Study|Lost to Follow-up|3|||
146615203|NCT02098746|528761798|FG000|Overall Study|Data Not Available After Treatment|1|||
146615204|NCT00330759|528761799|FG000|Overall Study|Death|316|||
146615205|NCT00330759|528761800|FG001|Overall Study|Death|310|||
146615206|NCT00330759|528761799|FG000|Overall Study|Disease progression|104|||
146615207|NCT00330759|528761800|FG001|Overall Study|Disease progression|126|||
146615208|NCT00330759|528761799|FG000|Overall Study|Withdrawal by Subject|143|||
146615209|NCT00330759|528761800|FG001|Overall Study|Withdrawal by Subject|124|||
146773537|NCT02988817|529341079|FG003|Overall Study|Sponsor decision|0|||
146924964|NCT01683071|529884860|FG001|Part 2|Withdrawal by Subject|0|||
146924965|NCT01683071|529884861|FG002|Part 2|Withdrawal by Subject|0|||
146924966|NCT01683071|529884862|FG003|Part 2|Withdrawal by Subject|0|||
146924967|NCT01683071|529884863|FG004|Part 2|Withdrawal by Subject|3|||
146924968|NCT01683071|529884864|FG005|Part 2|Withdrawal by Subject|3|||
146615210|NCT00330759|528761799|FG000|Overall Study|Adverse Event|48|||
146615211|NCT00330759|528761800|FG001|Overall Study|Adverse Event|36|||
146615212|NCT00330759|528761799|FG000|Overall Study|Participant request|31|||
146615213|NCT00330759|528761800|FG001|Overall Study|Participant request|22|||
146615214|NCT00330759|528761799|FG000|Overall Study|Lost to Follow-up|16|||
146615215|NCT00330759|528761800|FG001|Overall Study|Lost to Follow-up|22|||
146615216|NCT00330759|528761799|FG000|Overall Study|Noncompliance|15|||
146615217|NCT00330759|528761800|FG001|Overall Study|Noncompliance|17|||
146615218|NCT00330759|528761799|FG000|Overall Study|Physician Decision|1|||
146615219|NCT00330759|528761800|FG001|Overall Study|Physician Decision|2|||
146615220|NCT00330759|528761799|FG000|Overall Study|Protocol deviation|0|||
146615221|NCT00330759|528761800|FG001|Overall Study|Protocol deviation|2|||
146615222|NCT00330759|528761799|FG000|Overall Study|Ineligibility determined|2|||
146615223|NCT00330759|528761800|FG001|Overall Study|Ineligibility determined|1|||
146615224|NCT00330759|528761799|FG000|Overall Study|Other|36|||
146615225|NCT00330759|528761800|FG001|Overall Study|Other|44|||
146615226|NCT04070989|528761801|FG000|Overall Study|Death|1|||
146615227|NCT04070989|528761802|FG001|Overall Study|Death|0|||
146615228|NCT04070989|528761803|FG002|Overall Study|Death|0|||
146615229|NCT04070989|528761801|FG000|Overall Study|Study Terminated by Sponsor|7|||
146615230|NCT04070989|528761802|FG001|Overall Study|Study Terminated by Sponsor|8|||
146615231|NCT04070989|528761803|FG002|Overall Study|Study Terminated by Sponsor|23|||
146615232|NCT04070989|528761801|FG000|Overall Study|Withdrawal by Subject|0|||
146615233|NCT04070989|528761802|FG001|Overall Study|Withdrawal by Subject|1|||
146615234|NCT04070989|528761803|FG002|Overall Study|Withdrawal by Subject|0|||
146615235|NCT04070989|528761801|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
146615236|NCT04070989|528761802|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
146615237|NCT04070989|528761803|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
146615238|NCT04070989|528761801|FG000|Overall Study|Other|1|||
146615239|NCT04070989|528761802|FG001|Overall Study|Other|1|||
146615240|NCT04070989|528761803|FG002|Overall Study|Other|0|||
146615241|NCT04685798|528761822|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
146615242|NCT04640311|528761823|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
146615243|NCT04640311|528761824|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615244|NCT04640311|528761825|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615245|NCT04640311|528761826|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615246|NCT04640311|528761827|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615247|NCT04640311|528761828|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615248|NCT04640311|528761829|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615249|NCT04640311|528761830|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615250|NCT04640311|528761831|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615251|NCT04640311|528761832|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615252|NCT04640311|528761833|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615253|NCT04640311|528761834|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615254|NCT04640311|528761835|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146924969|NCT01683071|529884859|FG000|Part 2|Surgery cancelled|0|||
146924970|NCT01683071|529884860|FG001|Part 2|Surgery cancelled|0|||
146924971|NCT01683071|529884861|FG002|Part 2|Surgery cancelled|0|||
146924972|NCT01683071|529884862|FG003|Part 2|Surgery cancelled|0|||
146615255|NCT04640311|528761823|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146615256|NCT04640311|528761824|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
146615257|NCT04640311|528761825|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146615258|NCT04640311|528761826|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146615259|NCT04640311|528761827|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146615260|NCT04640311|528761828|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146615261|NCT04640311|528761829|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146615262|NCT04640311|528761830|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146615263|NCT04640311|528761831|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146615264|NCT04640311|528761832|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146615265|NCT04640311|528761833|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146615266|NCT04640311|528761834|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146615267|NCT04640311|528761835|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146615268|NCT04640311|528761823|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146924973|NCT01683071|529884863|FG004|Part 2|Surgery cancelled|4|||
146924974|NCT01683071|529884864|FG005|Part 2|Surgery cancelled|2|||
146924975|NCT01683071|529884859|FG000|Part 2|Did not receive study drug|0|||
146924976|NCT01683071|529884860|FG001|Part 2|Did not receive study drug|0|||
146924977|NCT01683071|529884861|FG002|Part 2|Did not receive study drug|0|||
146924978|NCT01683071|529884862|FG003|Part 2|Did not receive study drug|0|||
146615269|NCT04640311|528761824|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
146615270|NCT04640311|528761825|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615271|NCT04640311|528761826|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615272|NCT04640311|528761827|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615273|NCT04640311|528761828|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615274|NCT04640311|528761829|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615275|NCT04640311|528761830|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615276|NCT04640311|528761831|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615277|NCT04640311|528761832|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615278|NCT04640311|528761833|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615279|NCT04640311|528761834|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615280|NCT04640311|528761835|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615281|NCT04640311|528761823|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
146615282|NCT04640311|528761824|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
146615283|NCT04640311|528761825|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
146615284|NCT04640311|528761826|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615285|NCT04640311|528761827|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615286|NCT04640311|528761828|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615287|NCT04640311|528761829|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615288|NCT04640311|528761830|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615289|NCT04640311|528761831|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615290|NCT04640311|528761832|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615291|NCT04640311|528761833|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615292|NCT04640311|528761834|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615293|NCT04640311|528761835|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146615294|NCT04640311|528761823|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146615295|NCT04640311|528761824|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146615296|NCT04640311|528761825|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
146615297|NCT04640311|528761826|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146615298|NCT04640311|528761827|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146615299|NCT04640311|528761828|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146615300|NCT04640311|528761829|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146615301|NCT04640311|528761830|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146615302|NCT04640311|528761831|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146615303|NCT04640311|528761832|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146615304|NCT04640311|528761833|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146615305|NCT04640311|528761834|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146615306|NCT04640311|528761835|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146615307|NCT04640311|528761823|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146615308|NCT04640311|528761824|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146615309|NCT04640311|528761825|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146615310|NCT04640311|528761826|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
146615311|NCT04640311|528761827|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146615312|NCT04640311|528761828|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146615313|NCT04640311|528761829|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
146615314|NCT04640311|528761830|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146615315|NCT04640311|528761831|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146615316|NCT04640311|528761832|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146615317|NCT04640311|528761833|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146615318|NCT04640311|528761834|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146615319|NCT04640311|528761835|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146615320|NCT04640311|528761823|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146924979|NCT01683071|529884863|FG004|Part 2|Did not receive study drug|2|||
146924980|NCT01683071|529884864|FG005|Part 2|Did not receive study drug|1|||
146615321|NCT04640311|528761824|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615322|NCT04640311|528761825|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615323|NCT04640311|528761826|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615324|NCT04640311|528761827|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615325|NCT04640311|528761828|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
146615326|NCT04640311|528761829|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615327|NCT04640311|528761830|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615328|NCT04640311|528761831|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
146615329|NCT04640311|528761832|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615330|NCT04640311|528761833|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615331|NCT04640311|528761834|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615332|NCT04640311|528761835|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146615333|NCT04640311|528761823|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146615334|NCT04640311|528761824|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146615335|NCT04640311|528761825|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146615336|NCT04640311|528761826|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146615337|NCT04640311|528761827|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146615338|NCT04640311|528761828|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146615339|NCT04640311|528761829|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
146615340|NCT04640311|528761830|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146615341|NCT04640311|528761831|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146615342|NCT04640311|528761832|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146615343|NCT04640311|528761833|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
146615344|NCT04640311|528761834|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146615345|NCT04640311|528761835|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146615346|NCT04640311|528761823|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146615347|NCT04640311|528761824|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146615348|NCT04640311|528761825|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146615349|NCT04640311|528761826|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146615350|NCT04640311|528761827|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146615351|NCT04640311|528761828|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146615352|NCT04640311|528761829|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146615353|NCT04640311|528761830|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146615354|NCT04640311|528761831|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146615355|NCT04640311|528761832|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146615356|NCT04640311|528761833|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146615357|NCT04640311|528761834|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
146615358|NCT04640311|528761835|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146615359|NCT01388907|528761839|FG000|Overall Study|Adverse Event|2|||
146615360|NCT01388907|528761840|FG001|Overall Study|Adverse Event|0|||
146615361|NCT01910402|528761841|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
146615362|NCT01910402|528761842|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
146615363|NCT01910402|528761843|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
146615364|NCT01910402|528761841|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
146615365|NCT01910402|528761842|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
146615366|NCT01910402|528761843|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
146615367|NCT01910402|528761841|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
146615368|NCT01910402|528761842|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
146615369|NCT01910402|528761843|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
146615370|NCT01910402|528761841|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
146615371|NCT01910402|528761842|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
146615372|NCT01910402|528761843|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
146615373|NCT01910402|528761841|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
146615374|NCT01910402|528761842|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
146615375|NCT01910402|528761843|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
146615376|NCT01910402|528761841|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
146658750|NCT00591266|528928796|FG002|Overall Study|Lack of Efficacy|0|||
146658751|NCT00591266|528928794|FG000|Overall Study|Other|1|||
146658752|NCT00591266|528928795|FG001|Overall Study|Other|4|||
146658753|NCT00591266|528928796|FG002|Overall Study|Other|5|||
146658754|NCT00586846|528928797|FG000|Overall Study|Physician Decision|1|||
146658755|NCT00586846|528928797|FG000|Overall Study|Death|1|||
146658756|NCT00586846|528928797|FG000|Overall Study|Evaluable for Toxicity Only|4|||
146658757|NCT05298306|528928798|FG000|Overall Study|Physician Decision|0|||
146658758|NCT05298306|528928799|FG001|Overall Study|Physician Decision|0|||
146658759|NCT05298306|528928800|FG002|Overall Study|Physician Decision|0|||
146615377|NCT01910402|528761842|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
146615378|NCT01910402|528761843|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
146615379|NCT01910402|528761841|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
146615380|NCT01910402|528761842|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
146615381|NCT01910402|528761843|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
146615382|NCT01910402|528761841|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
146615383|NCT01910402|528761842|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
146615384|NCT01910402|528761843|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
146615385|NCT01910402|528761841|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
146615386|NCT01910402|528761842|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
146615387|NCT01910402|528761843|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
146615388|NCT01910402|528761841|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
146615389|NCT01910402|528761842|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
146615390|NCT01910402|528761843|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
146615391|NCT01910402|528761841|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
146615392|NCT01910402|528761842|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
146615393|NCT01910402|528761843|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
146615394|NCT01910402|528761841|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
146615395|NCT01910402|528761842|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
146615396|NCT01910402|528761843|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
146615397|NCT01910402|528761841|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
146615398|NCT01910402|528761842|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
146615399|NCT01910402|528761843|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
146615400|NCT00824473|528761844|FG000|Overall Study|Adverse Event|4|||
146615401|NCT00824473|528761845|FG001|Overall Study|Adverse Event|5|||
146615402|NCT00824473|528761844|FG000|Overall Study|Lack of Efficacy|2|||
146615403|NCT00824473|528761845|FG001|Overall Study|Lack of Efficacy|2|||
146615404|NCT00824473|528761844|FG000|Overall Study|Protocol Violation|2|||
146615405|NCT00824473|528761845|FG001|Overall Study|Protocol Violation|0|||
146615406|NCT00824473|528761844|FG000|Overall Study|Non-Compliance|4|||
146615407|NCT00824473|528761845|FG001|Overall Study|Non-Compliance|2|||
146615408|NCT00824473|528761844|FG000|Overall Study|Withdrawal by Subject|2|||
146615409|NCT00824473|528761845|FG001|Overall Study|Withdrawal by Subject|3|||
146615410|NCT00824473|528761844|FG000|Overall Study|Other|1|||
146615411|NCT00824473|528761845|FG001|Overall Study|Other|1|||
146615412|NCT01359904|528761846|FG000|Overall Study|Withdrawal by Subject|1|||
146615413|NCT01359904|528761847|FG001|Overall Study|Withdrawal by Subject|0|||
146615414|NCT03594773|528761849|FG000|Overall Study|Withdrawal by Subject|3|||
146615415|NCT03594773|528761850|FG001|Overall Study|Withdrawal by Subject|2|||
146615416|NCT03594773|528761849|FG000|Overall Study|Lost to Follow-up|3|||
146615417|NCT03594773|528761850|FG001|Overall Study|Lost to Follow-up|4|||
146615418|NCT01550757|528761853|FG000|Overall Study|Lost to Follow-up|21|||
146615419|NCT01550757|528761854|FG001|Overall Study|Lost to Follow-up|14|||
146615420|NCT01550757|528761855|FG002|Overall Study|Lost to Follow-up|42|||
146615421|NCT01550757|528761856|FG003|Overall Study|Lost to Follow-up|53|||
146615422|NCT01550757|528761853|FG000|Overall Study|Withdrawal by Subject|2|||
146615423|NCT01550757|528761854|FG001|Overall Study|Withdrawal by Subject|0|||
146615424|NCT01550757|528761855|FG002|Overall Study|Withdrawal by Subject|3|||
146615425|NCT01550757|528761856|FG003|Overall Study|Withdrawal by Subject|1|||
146615426|NCT03191630|528761857|FG000|Overall Study|Lost to Follow-up|7|||
146615427|NCT03191630|528761858|FG001|Overall Study|Lost to Follow-up|7|||
146615428|NCT00193206|528761860|FG000|Preoperative Therapy|Lack of Efficacy|2|||
146615429|NCT00193206|528761860|FG000|Preoperative Therapy|Adverse Event|2|||
146615430|NCT00193206|528761860|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
146615431|NCT00193206|528761860|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
146615432|NCT00193206|528761860|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
146615433|NCT00193206|528761860|FG000|Postoperative Therapy|Physician Decision|3|||
146615434|NCT00193206|528761860|FG000|Postoperative Therapy|Intercurrent Illness|2|||
146615435|NCT00193206|528761860|FG000|Postoperative Therapy|Lack of Efficacy|1|||
146615436|NCT00193206|528761860|FG000|Postoperative Therapy|Protocol Violation|1|||
146615437|NCT00740584|528761867|FG000|Overall Study|Withdrawal by Subject|1|||
146615438|NCT03461146|528761870|FG000|Overall Study|Adverse Event|2|||
146615439|NCT03461146|528761870|FG000|Overall Study|Physician Decision|1|||
146615440|NCT02915263|528761875|FG000|Overall Study|Covid|3|||
146615441|NCT02915263|528761876|FG001|Overall Study|Covid|2|||
146773538|NCT02988817|529341080|FG004|Overall Study|Sponsor decision|0|||
146615442|NCT01479868|528761880|FG000|Overall Study|Adverse Event|1|||
146615443|NCT01479868|528761880|FG000|Overall Study|Lost to Follow-up|4|||
146615444|NCT01479868|528761880|FG000|Overall Study|Protocol Violation|1|||
146615445|NCT01479868|528761880|FG000|Overall Study|Withdrawal by Subject|1|||
146615446|NCT01479868|528761880|FG000|Overall Study|Sponsor's Decision|1|||
146773539|NCT02988817|529341081|FG005|Overall Study|Sponsor decision|0|||
146615447|NCT01479868|528761880|FG000|Overall Study|Initiation of new HCV Therapy|1|||
146615448|NCT01618669|528761881|FG000|Overall Study|Lost to Follow-up|1|||
146615449|NCT01618669|528761882|FG001|Overall Study|Lost to Follow-up|1|||
146615450|NCT01618669|528761881|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
146615451|NCT01618669|528761882|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
146615452|NCT01618669|528761881|FG000|Overall Study|Adverse Event|16|||
146615453|NCT01618669|528761882|FG001|Overall Study|Adverse Event|7|||
146615454|NCT01618669|528761881|FG000|Overall Study|Protocol Violation|5|||
146615455|NCT01618669|528761882|FG001|Overall Study|Protocol Violation|3|||
146615456|NCT01618669|528761881|FG000|Overall Study|Withdrawal by Subject|9|||
146615457|NCT01618669|528761882|FG001|Overall Study|Withdrawal by Subject|9|||
146615458|NCT01618669|528761881|FG000|Overall Study|Miscellaneous Reason|0|||
146615459|NCT01618669|528761882|FG001|Overall Study|Miscellaneous Reason|1|||
146615460|NCT01177007|528761883|FG000|Overall Study|Lost to Follow-up|2|||
146615461|NCT01177007|528761883|FG000|Overall Study|Death|4|||
146615462|NCT01177007|528761883|FG000|Overall Study|Entered hospice care|5|||
146615463|NCT01177007|528761883|FG000|Overall Study|Required additional Y90 treatment|6|||
146615464|NCT01177007|528761883|FG000|Overall Study|Change in treatment modality|21|||
146615465|NCT03259087|528761884|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
146615466|NCT03259087|528761885|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
146615467|NCT03259087|528761886|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
146615468|NCT03259087|528761887|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
146615469|NCT03259087|528761888|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
146615470|NCT03259087|528761884|FG000|Period 2 of Part 2|Adverse Event|0|||
146615471|NCT03259087|528761885|FG001|Period 2 of Part 2|Adverse Event|0|||
146615472|NCT03259087|528761886|FG002|Period 2 of Part 2|Adverse Event|0|||
146615473|NCT03259087|528761887|FG003|Period 2 of Part 2|Adverse Event|0|||
146615474|NCT03259087|528761888|FG004|Period 2 of Part 2|Adverse Event|1|||
146615475|NCT04950465|528761889|FG000|Overall Study|Lost to Follow-up|1|||
146615476|NCT04950465|528761890|FG001|Overall Study|Lost to Follow-up|0|||
146615477|NCT04950465|528761891|FG002|Overall Study|Lost to Follow-up|0|||
146615478|NCT02753946|528761907|FG000|Overall Study|Adverse Event|7|||
146615479|NCT02753946|528761908|FG001|Overall Study|Adverse Event|6|||
146615480|NCT02753946|528761907|FG000|Overall Study|Withdrawal by Subject|6|||
146615481|NCT02753946|528761908|FG001|Overall Study|Withdrawal by Subject|1|||
146615482|NCT02753946|528761907|FG000|Overall Study|Lack of Efficacy|1|||
146615483|NCT02753946|528761908|FG001|Overall Study|Lack of Efficacy|0|||
146615484|NCT02753946|528761907|FG000|Overall Study|Physician Decision|0|||
146615485|NCT02753946|528761908|FG001|Overall Study|Physician Decision|2|||
146615486|NCT01369784|528761909|FG000|Overall Study|Protocol Violation|12|||
146615487|NCT02680665|528761910|FG000|Overall Study|No visit after the first prescription|5|||
146615488|NCT02905266|528761911|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
146615489|NCT02905266|528761912|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
146615490|NCT02905266|528761911|FG000|Treatment Phase Part 1|Disease Progression|6|||
146615491|NCT02905266|528761912|FG001|Treatment Phase Part 1|Disease Progression|7|||
146615492|NCT02905266|528761911|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
146615493|NCT02905266|528761912|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
146615494|NCT02905266|528761911|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
146615495|NCT02905266|528761912|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
146615496|NCT02905266|528761911|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
146615497|NCT02905266|528761912|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
146615498|NCT02905266|528761911|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
146615499|NCT02905266|528761912|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
146615500|NCT02905266|528761911|FG000|Transition From Part 1 to Part 2|Death|0|||
146615501|NCT02905266|528761912|FG001|Transition From Part 1 to Part 2|Death|1|||
146615502|NCT02905266|528761911|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
146615503|NCT02905266|528761912|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
146615504|NCT02905266|528761911|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
146615505|NCT02905266|528761912|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
146615506|NCT02905266|528761911|FG000|Maintenance Phase Part 2|Disease Progression|9|||
146615507|NCT02905266|528761912|FG001|Maintenance Phase Part 2|Disease Progression|2|||
146615508|NCT02905266|528761911|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
146615509|NCT02905266|528761912|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
146615510|NCT02905266|528761911|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
146615511|NCT02905266|528761912|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
146615512|NCT02292719|528761918|FG000|Overall Study|Withdrawal by Subject|0|||
146615513|NCT02292719|528761919|FG001|Overall Study|Withdrawal by Subject|0|||
146615514|NCT02292719|528761920|FG002|Overall Study|Withdrawal by Subject|0|||
146773540|NCT02988817|529341082|FG006|Overall Study|Sponsor decision|0|||
146615515|NCT02292719|528761921|FG003|Overall Study|Withdrawal by Subject|1|||
146615516|NCT02292719|528761922|FG004|Overall Study|Withdrawal by Subject|1|||
146615517|NCT02292719|528761923|FG005|Overall Study|Withdrawal by Subject|0|||
146615518|NCT02292719|528761918|FG000|Overall Study|Subject enrolled in new study.|0|||
146615519|NCT02292719|528761919|FG001|Overall Study|Subject enrolled in new study.|0|||
146615520|NCT02292719|528761920|FG002|Overall Study|Subject enrolled in new study.|1|||
146615521|NCT02292719|528761921|FG003|Overall Study|Subject enrolled in new study.|0|||
146615522|NCT02292719|528761922|FG004|Overall Study|Subject enrolled in new study.|0|||
146615523|NCT02292719|528761923|FG005|Overall Study|Subject enrolled in new study.|0|||
146615524|NCT05973006|528761924|FG000|Overall Study|Early termination|3|||
146615525|NCT05973006|528761925|FG001|Overall Study|Early termination|9|||
146615526|NCT02326597|528761930|FG000|Overall Study|Lost to Follow-up|42|||
146615527|NCT02326597|528761931|FG001|Overall Study|Lost to Follow-up|32|||
146615528|NCT00770601|528761934|FG000|Overall Study|Withdrawal by Subject|1|||
146615529|NCT00428948|528761935|FG000|Overall Study|Lost to Follow-up|15|||
146615530|NCT00428948|528761936|FG001|Overall Study|Lost to Follow-up|8|||
146615531|NCT00428948|528761935|FG000|Overall Study|Adverse Event|148|||
146615532|NCT00428948|528761936|FG001|Overall Study|Adverse Event|24|||
146615533|NCT00428948|528761935|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
146615534|NCT00428948|528761936|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
146615535|NCT00428948|528761935|FG000|Overall Study|Investigator Withdrew Subject|3|||
146615536|NCT00428948|528761936|FG001|Overall Study|Investigator Withdrew Subject|4|||
146615537|NCT00428948|528761935|FG000|Overall Study|Subject Withdrew Consent|50|||
146615538|NCT00428948|528761936|FG001|Overall Study|Subject Withdrew Consent|30|||
146615539|NCT00428948|528761935|FG000|Overall Study|Protocol Deviation|1|||
146615540|NCT00428948|528761936|FG001|Overall Study|Protocol Deviation|1|||
146615541|NCT05907395|528761939|FG000|Period 1|No longer met eligibility criteria|0|||
146615542|NCT05907395|528761940|FG001|Period 1|No longer met eligibility criteria|1|||
146615543|NCT05907395|528761941|FG002|Period 1|No longer met eligibility criteria|0|||
146615544|NCT05907395|528761942|FG003|Period 1|No longer met eligibility criteria|0|||
146615545|NCT05907395|528761943|FG004|Period 1|No longer met eligibility criteria|0|||
146615546|NCT05907395|528761944|FG005|Period 1|No longer met eligibility criteria|1|||
146615547|NCT05907395|528761945|FG006|Period 1|No longer met eligibility criteria|1|||
146615548|NCT05907395|528761946|FG007|Period 1|No longer met eligibility criteria|0|||
146615549|NCT05907395|528761947|FG008|Period 1|No longer met eligibility criteria|0|||
146615550|NCT05907395|528761948|FG009|Period 1|No longer met eligibility criteria|0|||
146615551|NCT05907395|528761949|FG010|Period 1|No longer met eligibility criteria|0|||
146615552|NCT05907395|528761950|FG011|Period 1|No longer met eligibility criteria|0|||
146615553|NCT05907395|528761939|FG000|Period 2|Adverse Event|0|||
146615554|NCT05907395|528761940|FG001|Period 2|Adverse Event|0|||
146615555|NCT05907395|528761941|FG002|Period 2|Adverse Event|0|||
146615556|NCT05907395|528761942|FG003|Period 2|Adverse Event|1|||
146615557|NCT05907395|528761943|FG004|Period 2|Adverse Event|0|||
146615558|NCT05907395|528761944|FG005|Period 2|Adverse Event|0|||
146615559|NCT05907395|528761945|FG006|Period 2|Adverse Event|0|||
146615560|NCT05907395|528761946|FG007|Period 2|Adverse Event|1|||
146615561|NCT05907395|528761947|FG008|Period 2|Adverse Event|0|||
146615562|NCT05907395|528761948|FG009|Period 2|Adverse Event|0|||
146615563|NCT05907395|528761949|FG010|Period 2|Adverse Event|0|||
146615564|NCT05907395|528761950|FG011|Period 2|Adverse Event|0|||
146615565|NCT05907395|528761939|FG000|Period 2|Personal reason|0|||
146615566|NCT05907395|528761940|FG001|Period 2|Personal reason|0|||
146615567|NCT05907395|528761941|FG002|Period 2|Personal reason|0|||
146615568|NCT05907395|528761942|FG003|Period 2|Personal reason|0|||
146615569|NCT05907395|528761943|FG004|Period 2|Personal reason|0|||
146615570|NCT05907395|528761944|FG005|Period 2|Personal reason|0|||
146615571|NCT05907395|528761945|FG006|Period 2|Personal reason|0|||
146615572|NCT05907395|528761946|FG007|Period 2|Personal reason|0|||
146615573|NCT05907395|528761947|FG008|Period 2|Personal reason|0|||
146615574|NCT05907395|528761948|FG009|Period 2|Personal reason|1|||
146615575|NCT05907395|528761949|FG010|Period 2|Personal reason|0|||
146615576|NCT05907395|528761950|FG011|Period 2|Personal reason|0|||
146615577|NCT05907395|528761939|FG000|Period 3|Adverse Event|0|||
146615578|NCT05907395|528761940|FG001|Period 3|Adverse Event|0|||
146615579|NCT05907395|528761941|FG002|Period 3|Adverse Event|0|||
146615580|NCT05907395|528761942|FG003|Period 3|Adverse Event|0|||
146615581|NCT05907395|528761943|FG004|Period 3|Adverse Event|1|||
146615582|NCT05907395|528761944|FG005|Period 3|Adverse Event|0|||
146615583|NCT05907395|528761945|FG006|Period 3|Adverse Event|0|||
146615584|NCT05907395|528761946|FG007|Period 3|Adverse Event|0|||
146615585|NCT05907395|528761947|FG008|Period 3|Adverse Event|0|||
146615586|NCT05907395|528761948|FG009|Period 3|Adverse Event|0|||
146615587|NCT05907395|528761949|FG010|Period 3|Adverse Event|0|||
146615588|NCT05907395|528761950|FG011|Period 3|Adverse Event|0|||
146615589|NCT04544956|528761951|FG000|Overall Study|Withdrawal by Subject|1|||
146615590|NCT01099397|528761952|FG000|Overall Study|Lost to Follow-up|4|||
146615591|NCT01099397|528761952|FG000|Overall Study|Protocol Violation|4|||
146615592|NCT01099397|528761952|FG000|Overall Study|Withdrawal by Subject|5|||
146615593|NCT00003199|528761954|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
146615594|NCT00003199|528761954|FG000|Overall Study|Lack of insurance clearance|2|||
146615595|NCT00003199|528761954|FG000|Overall Study|Screen fail|15|||
146615596|NCT00940498|528761955|FG000|Overall Study|Death|2|||
146615597|NCT00940498|528761956|FG001|Overall Study|Death|0|||
146615598|NCT00940498|528761957|FG002|Overall Study|Death|0|||
146658760|NCT05298306|528928801|FG003|Overall Study|Physician Decision|1|||
146658761|NCT05298306|528928802|FG004|Overall Study|Physician Decision|0|||
146658762|NCT05298306|528928803|FG005|Overall Study|Physician Decision|0|||
146658763|NCT01178073|528928808|FG000|Overall Study|Adverse Event|34|||
146658764|NCT01178073|528928809|FG001|Overall Study|Adverse Event|27|||
146615599|NCT00940498|528761958|FG003|Overall Study|Death|1|||
146615600|NCT00940498|528761959|FG004|Overall Study|Death|5|||
146615601|NCT00940498|528761960|FG005|Overall Study|Death|0|||
146615602|NCT00940498|528761961|FG006|Overall Study|Death|1|||
146615603|NCT00940498|528761962|FG007|Overall Study|Death|0|||
146615604|NCT00940498|528761955|FG000|Overall Study|Lost to Follow-up|1|||
146615605|NCT00940498|528761956|FG001|Overall Study|Lost to Follow-up|1|||
146615606|NCT00940498|528761957|FG002|Overall Study|Lost to Follow-up|2|||
146615607|NCT00940498|528761958|FG003|Overall Study|Lost to Follow-up|0|||
146615608|NCT00940498|528761959|FG004|Overall Study|Lost to Follow-up|1|||
146615609|NCT00940498|528761960|FG005|Overall Study|Lost to Follow-up|0|||
146615610|NCT00940498|528761961|FG006|Overall Study|Lost to Follow-up|0|||
146615611|NCT00940498|528761962|FG007|Overall Study|Lost to Follow-up|1|||
146615612|NCT00940498|528761955|FG000|Overall Study|Disease Progression|0|||
146615613|NCT00940498|528761956|FG001|Overall Study|Disease Progression|0|||
146615614|NCT00940498|528761957|FG002|Overall Study|Disease Progression|1|||
146615615|NCT00940498|528761958|FG003|Overall Study|Disease Progression|1|||
146615616|NCT00940498|528761959|FG004|Overall Study|Disease Progression|0|||
146615617|NCT00940498|528761960|FG005|Overall Study|Disease Progression|1|||
146615618|NCT00940498|528761961|FG006|Overall Study|Disease Progression|0|||
146615619|NCT00940498|528761962|FG007|Overall Study|Disease Progression|0|||
146615620|NCT00940498|528761955|FG000|Overall Study|Physician Decision|0|||
146615621|NCT00940498|528761956|FG001|Overall Study|Physician Decision|0|||
146615622|NCT00940498|528761957|FG002|Overall Study|Physician Decision|0|||
146615623|NCT00940498|528761958|FG003|Overall Study|Physician Decision|0|||
146615624|NCT00940498|528761959|FG004|Overall Study|Physician Decision|2|||
146615625|NCT00940498|528761960|FG005|Overall Study|Physician Decision|0|||
146615626|NCT00940498|528761961|FG006|Overall Study|Physician Decision|0|||
146615627|NCT00940498|528761962|FG007|Overall Study|Physician Decision|0|||
146615628|NCT00940498|528761955|FG000|Overall Study|Not treated due to disease related pain|0|||
146615629|NCT00940498|528761956|FG001|Overall Study|Not treated due to disease related pain|0|||
146615630|NCT00940498|528761957|FG002|Overall Study|Not treated due to disease related pain|0|||
146615631|NCT00940498|528761958|FG003|Overall Study|Not treated due to disease related pain|0|||
146615632|NCT00940498|528761959|FG004|Overall Study|Not treated due to disease related pain|1|||
146615633|NCT00940498|528761960|FG005|Overall Study|Not treated due to disease related pain|0|||
146615634|NCT00940498|528761961|FG006|Overall Study|Not treated due to disease related pain|0|||
146658765|NCT01178073|528928810|FG002|Overall Study|Adverse Event|24|||
146658766|NCT01178073|528928808|FG000|Overall Study|Protocol Violation|1|||
146658767|NCT01178073|528928809|FG001|Overall Study|Protocol Violation|1|||
146658768|NCT01178073|528928810|FG002|Overall Study|Protocol Violation|1|||
146658769|NCT01178073|528928808|FG000|Overall Study|Lost to Follow-up|2|||
146658770|NCT01178073|528928809|FG001|Overall Study|Lost to Follow-up|0|||
146658771|NCT01178073|528928810|FG002|Overall Study|Lost to Follow-up|3|||
146658772|NCT01178073|528928808|FG000|Overall Study|Physician Decision|14|||
146658773|NCT01178073|528928809|FG001|Overall Study|Physician Decision|10|||
146658774|NCT01178073|528928810|FG002|Overall Study|Physician Decision|10|||
146658775|NCT01178073|528928808|FG000|Overall Study|Withdrawal by Subject|10|||
146658776|NCT01178073|528928809|FG001|Overall Study|Withdrawal by Subject|6|||
146658777|NCT01178073|528928810|FG002|Overall Study|Withdrawal by Subject|8|||
146658778|NCT01178073|528928808|FG000|Overall Study|Missing Completion Status|1|||
146658779|NCT01178073|528928809|FG001|Overall Study|Missing Completion Status|0|||
146658780|NCT01178073|528928810|FG002|Overall Study|Missing Completion Status|0|||
146658781|NCT01226043|528928820|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
146773541|NCT02988817|529341083|FG007|Overall Study|Sponsor decision|0|||
146773542|NCT02988817|529341084|FG008|Overall Study|Sponsor decision|0|||
146924981|NCT01683071|529884859|FG000|Part 2|Met exclusion criterion|0|||
146924982|NCT01683071|529884860|FG001|Part 2|Met exclusion criterion|0|||
146615635|NCT00940498|528761962|FG007|Overall Study|Not treated due to disease related pain|0|||
146615636|NCT00650845|528761963|FG000|Overall Study|Withdrawal by Subject|5|||
146615637|NCT00650845|528761964|FG001|Overall Study|Withdrawal by Subject|0|||
146615638|NCT00650845|528761963|FG000|Overall Study|Protocol Violation|0|||
146615639|NCT00650845|528761964|FG001|Overall Study|Protocol Violation|13|||
146615640|NCT03761810|528761965|FG000|Overall Study|Adverse Event|12|||
146615641|NCT03761810|528761966|FG001|Overall Study|Adverse Event|0|||
146615642|NCT03761810|528761965|FG000|Overall Study|Lost to Follow-up|15|||
146615643|NCT03761810|528761966|FG001|Overall Study|Lost to Follow-up|7|||
146658782|NCT01226043|528928821|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
146658783|NCT01226043|528928822|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
146658784|NCT01226043|528928823|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
146658785|NCT01226043|528928820|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
146658786|NCT01226043|528928821|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
146658787|NCT01226043|528928822|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
146924983|NCT01683071|529884861|FG002|Part 2|Met exclusion criterion|0|||
146924984|NCT01683071|529884862|FG003|Part 2|Met exclusion criterion|0|||
146924985|NCT01683071|529884863|FG004|Part 2|Met exclusion criterion|1|||
146924986|NCT01683071|529884864|FG005|Part 2|Met exclusion criterion|1|||
146615644|NCT03761810|528761965|FG000|Overall Study|Pregnancy|1|||
146615645|NCT03761810|528761966|FG001|Overall Study|Pregnancy|0|||
146615646|NCT03761810|528761965|FG000|Overall Study|Withdrawal by Subject|14|||
146615647|NCT03761810|528761966|FG001|Overall Study|Withdrawal by Subject|5|||
146615648|NCT03761810|528761965|FG000|Overall Study|Physician Decision|1|||
146615649|NCT03761810|528761966|FG001|Overall Study|Physician Decision|0|||
146615650|NCT03761810|528761965|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
146615651|NCT03761810|528761966|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146615652|NCT03761810|528761965|FG000|Overall Study|Other Than Specified|1|||
146615653|NCT03761810|528761966|FG001|Overall Study|Other Than Specified|0|||
146615654|NCT03932760|528761969|FG000|Overall Study|Became Ineligible|2|||
146615655|NCT03932760|528761970|FG001|Overall Study|Became Ineligible|5|||
146615656|NCT03932760|528761969|FG000|Overall Study|Withdrawal by Subject|6|||
146615657|NCT03932760|528761970|FG001|Overall Study|Withdrawal by Subject|6|||
146615658|NCT04178720|528761971|FG000|Overall Study|Withdrawal by Subject|2|||
146615659|NCT04178720|528761972|FG001|Overall Study|Withdrawal by Subject|0|||
146615660|NCT04178720|528761971|FG000|Overall Study|Relocation|0|||
146615661|NCT04178720|528761972|FG001|Overall Study|Relocation|1|||
146615662|NCT00869518|528761973|FG000|Overall Study|Lost to Follow-up|1|||
146615663|NCT00869518|528761974|FG001|Overall Study|Lost to Follow-up|1|||
146615664|NCT03922620|528761977|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
146615665|NCT03922620|528761978|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
146615666|NCT00983385|528761979|FG000|Observation Period|Not eligible to be dosed|20|||
146615667|NCT00983385|528761979|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
146615668|NCT01223183|528761981|FG000|Imaging Day 1|Physician Decision|0|||
146615669|NCT01223183|528761982|FG001|Imaging Day 1|Physician Decision|1|||
146615670|NCT01223183|528761981|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
146615671|NCT01223183|528761982|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
146615672|NCT01223183|528761981|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
146615673|NCT01223183|528761982|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
146615674|NCT00163020|528761983|FG000|Overall Study|Lost to Follow-up|0|||
146615675|NCT00163020|528761984|FG001|Overall Study|Lost to Follow-up|2|||
146615676|NCT03772665|528761985|FG000|Overall Study|Protocol Violation|1|||
146615677|NCT03772665|528761986|FG001|Overall Study|Protocol Violation|0|||
146924987|NCT01683071|529884859|FG000|Part 2|Protocol deviation|0|||
146615679|NCT00592904|528765091|FG000|Overall Study|Adverse Event|15|||
146615680|NCT00592904|528765092|FG001|Overall Study|Adverse Event|25|||
146615681|NCT00592904|528765093|FG002|Overall Study|Adverse Event|13|||
146615682|NCT00592904|528765094|FG003|Overall Study|Adverse Event|5|||
146615683|NCT00592904|528765091|FG000|Overall Study|Protocol Violation|1|||
146615684|NCT00592904|528765092|FG001|Overall Study|Protocol Violation|1|||
146615685|NCT00592904|528765093|FG002|Overall Study|Protocol Violation|0|||
146615686|NCT00592904|528765094|FG003|Overall Study|Protocol Violation|1|||
146615687|NCT00592904|528765091|FG000|Overall Study|Withdrawal by Subject|4|||
146615688|NCT00592904|528765092|FG001|Overall Study|Withdrawal by Subject|16|||
146615689|NCT00592904|528765093|FG002|Overall Study|Withdrawal by Subject|1|||
146615690|NCT00592904|528765094|FG003|Overall Study|Withdrawal by Subject|2|||
146615691|NCT00592904|528765091|FG000|Overall Study|Lack of Efficacy|2|||
146615692|NCT00592904|528765092|FG001|Overall Study|Lack of Efficacy|7|||
146615693|NCT00592904|528765093|FG002|Overall Study|Lack of Efficacy|2|||
146615694|NCT00592904|528765094|FG003|Overall Study|Lack of Efficacy|3|||
146615695|NCT00592904|528765091|FG000|Overall Study|Physician Decision|0|||
146615696|NCT00592904|528765092|FG001|Overall Study|Physician Decision|3|||
146615697|NCT00592904|528765093|FG002|Overall Study|Physician Decision|1|||
146615698|NCT00592904|528765094|FG003|Overall Study|Physician Decision|0|||
146615699|NCT00592904|528765091|FG000|Overall Study|Other|3|||
146615700|NCT00592904|528765092|FG001|Overall Study|Other|3|||
146615701|NCT00592904|528765093|FG002|Overall Study|Other|0|||
146615702|NCT00592904|528765094|FG003|Overall Study|Other|0|||
146615703|NCT02640547|528765095|FG000|Overall Study|Failure to Return|1|||
146615704|NCT02640547|528765095|FG000|Overall Study|Withdrawal by Subject|1|||
146615705|NCT02640547|528765095|FG000|Overall Study|Death|6|||
146615706|NCT02640547|528765095|FG000|Overall Study|Miscellaneous|3|||
146615707|NCT02525588|528765096|FG000|Overall Study|Death|3|||
146615708|NCT02525588|528765097|FG001|Overall Study|Death|1|||
146615709|NCT02525588|528765096|FG000|Overall Study|Lost to Follow-up|2|||
146615710|NCT02525588|528765097|FG001|Overall Study|Lost to Follow-up|0|||
146615711|NCT02525588|528765096|FG000|Overall Study|Withdrawal by Subject|1|||
146615712|NCT02525588|528765097|FG001|Overall Study|Withdrawal by Subject|1|||
146615713|NCT02525588|528765096|FG000|Overall Study|Adverse Event|0|||
146615714|NCT02525588|528765097|FG001|Overall Study|Adverse Event|1|||
146615715|NCT03018691|528765098|FG000|Overall Study|Adverse Event|1|||
146615716|NCT03018691|528765099|FG001|Overall Study|Adverse Event|1|||
146924988|NCT01683071|529884860|FG001|Part 2|Protocol deviation|0|||
146924989|NCT01683071|529884861|FG002|Part 2|Protocol deviation|0|||
146615717|NCT03018691|528765100|FG002|Overall Study|Adverse Event|4|||
146615718|NCT03018691|528765098|FG000|Overall Study|Lack of Efficacy|0|||
146615719|NCT03018691|528765099|FG001|Overall Study|Lack of Efficacy|0|||
146615720|NCT03018691|528765100|FG002|Overall Study|Lack of Efficacy|1|||
146658788|NCT01226043|528928823|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
146658789|NCT01226043|528928820|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
146658790|NCT01226043|528928821|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
146658791|NCT01226043|528928822|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
146658792|NCT01226043|528928823|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
146658793|NCT01226043|528928820|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
146658794|NCT01226043|528928821|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
146658795|NCT01226043|528928822|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
146773543|NCT02988817|529341085|FG009|Overall Study|Sponsor decision|0|||
146773544|NCT02988817|529341086|FG010|Overall Study|Sponsor decision|0|||
146773545|NCT02988817|529341087|FG011|Overall Study|Sponsor decision|1|||
146773546|NCT02988817|529341088|FG012|Overall Study|Sponsor decision|1|||
146773547|NCT02988817|529341089|FG013|Overall Study|Sponsor decision|2|||
146773548|NCT02988817|529341090|FG014|Overall Study|Sponsor decision|2|||
146773549|NCT02988817|529341091|FG015|Overall Study|Sponsor decision|6|||
146773550|NCT02988817|529341092|FG016|Overall Study|Sponsor decision|2|||
146773551|NCT02988817|529341093|FG017|Overall Study|Sponsor decision|3|||
146773552|NCT02988817|529341094|FG018|Overall Study|Sponsor decision|2|||
146773553|NCT02988817|529341095|FG019|Overall Study|Sponsor decision|7|||
146773554|NCT02988817|529341076|FG000|Overall Study|Physician Decision|0|||
146773555|NCT02988817|529341077|FG001|Overall Study|Physician Decision|0|||
146773556|NCT02988817|529341078|FG002|Overall Study|Physician Decision|0|||
146773557|NCT02988817|529341079|FG003|Overall Study|Physician Decision|0|||
146773558|NCT02988817|529341080|FG004|Overall Study|Physician Decision|0|||
146773559|NCT02988817|529341081|FG005|Overall Study|Physician Decision|0|||
146773560|NCT02988817|529341082|FG006|Overall Study|Physician Decision|0|||
146773561|NCT02988817|529341083|FG007|Overall Study|Physician Decision|0|||
146773562|NCT02988817|529341084|FG008|Overall Study|Physician Decision|0|||
146773563|NCT02988817|529341085|FG009|Overall Study|Physician Decision|0|||
146773564|NCT02988817|529341086|FG010|Overall Study|Physician Decision|0|||
146773565|NCT02988817|529341087|FG011|Overall Study|Physician Decision|0|||
146773566|NCT02988817|529341088|FG012|Overall Study|Physician Decision|0|||
146773567|NCT02988817|529341089|FG013|Overall Study|Physician Decision|0|||
146773568|NCT02988817|529341090|FG014|Overall Study|Physician Decision|0|||
146773569|NCT02988817|529341091|FG015|Overall Study|Physician Decision|1|||
146773570|NCT02988817|529341092|FG016|Overall Study|Physician Decision|0|||
146615721|NCT03018691|528765098|FG000|Overall Study|Withdrawal by Subject|0|||
146615722|NCT03018691|528765099|FG001|Overall Study|Withdrawal by Subject|0|||
146615723|NCT03018691|528765100|FG002|Overall Study|Withdrawal by Subject|1|||
146615724|NCT03018691|528765098|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146615725|NCT03018691|528765099|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146615726|NCT03018691|528765100|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146615727|NCT03369418|528765102|FG000|Overall Study|Withdrawal by Subject|3|||
146615728|NCT03369418|528765103|FG001|Overall Study|Withdrawal by Subject|3|||
146615729|NCT01485094|528765104|FG000|Overall Study|Adverse Event|1|||
146615730|NCT01485094|528765105|FG001|Overall Study|Adverse Event|1|||
146615731|NCT01485094|528765106|FG002|Overall Study|Adverse Event|1|||
146615732|NCT01485094|528765104|FG000|Overall Study|Lost to Follow-up|1|||
146615733|NCT01485094|528765105|FG001|Overall Study|Lost to Follow-up|0|||
146615734|NCT01485094|528765106|FG002|Overall Study|Lost to Follow-up|0|||
146615735|NCT01485094|528765104|FG000|Overall Study|Withdrawal by Subject|1|||
146615736|NCT01485094|528765105|FG001|Overall Study|Withdrawal by Subject|1|||
146615737|NCT01485094|528765106|FG002|Overall Study|Withdrawal by Subject|0|||
146658796|NCT01226043|528928823|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
146773571|NCT02988817|529341093|FG017|Overall Study|Physician Decision|0|||
146773572|NCT02988817|529341094|FG018|Overall Study|Physician Decision|1|||
146773573|NCT02988817|529341095|FG019|Overall Study|Physician Decision|1|||
146658797|NCT01226043|528928820|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
146773574|NCT05082935|529341102|FG000|Overall Study|Lost to Follow-up|549|||
146773575|NCT05082935|529341103|FG001|Overall Study|Lost to Follow-up|631|||
146773576|NCT05082935|529341102|FG000|Overall Study|Withdrawal by Subject|27|||
146615738|NCT01172535|528765107|FG000|Overall Study|Death|3|||
146615739|NCT01172535|528765107|FG000|Overall Study|Withdrawal by Subject|2|||
146615740|NCT01172535|528765107|FG000|Overall Study|Lost to Follow-up|1|||
146615741|NCT01172535|528765107|FG000|Overall Study|Ineligible at study entry|1|||
146615742|NCT01172535|528765107|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
146615743|NCT02698826|528765113|FG000|Overall Study|Death|13|||
146773577|NCT05082935|529341103|FG001|Overall Study|Withdrawal by Subject|58|||
146773578|NCT04530747|529341108|FG000|Overall Study|Withdrawal by Subject|1|||
146773579|NCT04530747|529341109|FG001|Overall Study|Withdrawal by Subject|0|||
146773580|NCT03292913|529341110|FG000|Overall Study|Death|9|||
146773581|NCT03292913|529341111|FG001|Overall Study|Death|3|||
146615744|NCT02698826|528765113|FG000|Overall Study|Adverse Event|1|||
146924990|NCT01683071|529884862|FG003|Part 2|Protocol deviation|0|||
146924991|NCT01683071|529884863|FG004|Part 2|Protocol deviation|1|||
146924992|NCT01683071|529884864|FG005|Part 2|Protocol deviation|2|||
146924993|NCT01683071|529884859|FG000|Part 2|Withdrawal by investigator decision|0|||
146924994|NCT01683071|529884860|FG001|Part 2|Withdrawal by investigator decision|0|||
146615745|NCT02478463|528765118|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
146615746|NCT02478463|528765118|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
146615747|NCT02478463|528765118|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
146615748|NCT01879683|528765119|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
146615749|NCT01508169|528765120|FG000|Overall Study|Adverse Event|1|||
146615750|NCT01508169|528765121|FG001|Overall Study|Adverse Event|0|||
146615751|NCT01508169|528765120|FG000|Overall Study|Withdrawal by Subject|1|||
146615752|NCT01508169|528765121|FG001|Overall Study|Withdrawal by Subject|0|||
146615753|NCT01508169|528765120|FG000|Overall Study|Lost to Follow-up|1|||
146615754|NCT01508169|528765121|FG001|Overall Study|Lost to Follow-up|2|||
146615755|NCT03600740|528765130|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
146615756|NCT01702558|528765131|FG000|Overall Study|Withdrawal by Subject|0|||
146615757|NCT01702558|528765132|FG001|Overall Study|Withdrawal by Subject|0|||
146615758|NCT01702558|528765133|FG002|Overall Study|Withdrawal by Subject|0|||
146615759|NCT01702558|528765134|FG003|Overall Study|Withdrawal by Subject|12|||
146615760|NCT01702558|528765135|FG004|Overall Study|Withdrawal by Subject|4|||
146615761|NCT01702558|528765131|FG000|Overall Study|Lost to Follow-up|0|||
146615762|NCT01702558|528765132|FG001|Overall Study|Lost to Follow-up|0|||
146615763|NCT01702558|528765133|FG002|Overall Study|Lost to Follow-up|0|||
146615764|NCT01702558|528765134|FG003|Overall Study|Lost to Follow-up|3|||
146615765|NCT01702558|528765135|FG004|Overall Study|Lost to Follow-up|0|||
146615766|NCT01702558|528765131|FG000|Overall Study|Death|4|||
146615767|NCT01702558|528765132|FG001|Overall Study|Death|3|||
146615768|NCT01702558|528765133|FG002|Overall Study|Death|3|||
146615769|NCT01702558|528765134|FG003|Overall Study|Death|16|||
146615770|NCT01702558|528765135|FG004|Overall Study|Death|20|||
146615771|NCT01702558|528765131|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
146615772|NCT01702558|528765132|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
146615773|NCT01702558|528765133|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
146615774|NCT01702558|528765134|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
146615775|NCT01702558|528765135|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
146615776|NCT01702558|528765131|FG000|Overall Study|Study Terminated by Sponsor|0|||
146615777|NCT01702558|528765132|FG001|Overall Study|Study Terminated by Sponsor|1|||
146615778|NCT01702558|528765133|FG002|Overall Study|Study Terminated by Sponsor|0|||
146615779|NCT01702558|528765134|FG003|Overall Study|Study Terminated by Sponsor|0|||
146615780|NCT01702558|528765135|FG004|Overall Study|Study Terminated by Sponsor|1|||
146615781|NCT01702558|528765131|FG000|Overall Study|Other|0|||
146615782|NCT01702558|528765132|FG001|Overall Study|Other|0|||
146615783|NCT01702558|528765133|FG002|Overall Study|Other|0|||
146615784|NCT01702558|528765134|FG003|Overall Study|Other|16|||
146615785|NCT01702558|528765135|FG004|Overall Study|Other|17|||
146615786|NCT02396212|528765138|FG000|Overall Study|Adverse Event|1|||
146615787|NCT02396212|528765138|FG000|Overall Study|Lack of Efficacy|2|||
146615788|NCT01623115|528765139|FG000|Overall Study|Randomized but not treated|0|||
146615789|NCT01623115|528765140|FG001|Overall Study|Randomized but not treated|1|||
146615790|NCT01623115|528765139|FG000|Overall Study|Physician Decision|1|||
146615791|NCT01623115|528765140|FG001|Overall Study|Physician Decision|0|||
146615792|NCT01623115|528765139|FG000|Overall Study|Participants moved|1|||
146615793|NCT01623115|528765140|FG001|Overall Study|Participants moved|5|||
146615794|NCT01623115|528765139|FG000|Overall Study|Adverse Event|10|||
146615795|NCT01623115|528765140|FG001|Overall Study|Adverse Event|13|||
146615796|NCT01623115|528765139|FG000|Overall Study|Poor compliance to protocol|4|||
146615797|NCT01623115|528765140|FG001|Overall Study|Poor compliance to protocol|10|||
146615798|NCT01623115|528765139|FG000|Overall Study|Consent withdrawn by participant|2|||
146615799|NCT01623115|528765140|FG001|Overall Study|Consent withdrawn by participant|6|||
146615800|NCT01623115|528765139|FG000|Overall Study|Related to study drug administration|0|||
146615801|NCT01623115|528765140|FG001|Overall Study|Related to study drug administration|2|||
146773582|NCT03292913|529341110|FG000|Overall Study|Lost to Follow-up|49|||
146773583|NCT03292913|529341111|FG001|Overall Study|Lost to Follow-up|49|||
146924995|NCT01683071|529884861|FG002|Part 2|Withdrawal by investigator decision|0|||
146615802|NCT01623115|528765139|FG000|Overall Study|Last visit outside protocol visit window|14|||
146615803|NCT01623115|528765140|FG001|Overall Study|Last visit outside protocol visit window|26|||
146615804|NCT01623115|528765139|FG000|Overall Study|Site closure|1|||
146615805|NCT01623115|528765140|FG001|Overall Study|Site closure|7|||
146615806|NCT01623115|528765139|FG000|Overall Study|Death|0|||
146615807|NCT01623115|528765140|FG001|Overall Study|Death|4|||
146615808|NCT01623115|528765139|FG000|Overall Study|Other than specified above|0|||
146615809|NCT01623115|528765140|FG001|Overall Study|Other than specified above|3|||
146615810|NCT01338818|528765144|FG000|Overall Study|Adverse Event|8|||
146615811|NCT01338818|528765144|FG000|Overall Study|Lack of Efficacy|5|||
146615812|NCT01338818|528765144|FG000|Overall Study|no longer require study drug|1|||
146615813|NCT01338818|528765144|FG000|Overall Study|Withdrawal by Subject|11|||
146615814|NCT01338818|528765144|FG000|Overall Study|Lost to Follow-up|4|||
146615815|NCT01338818|528765144|FG000|Overall Study|Administrative problems|3|||
146615816|NCT01338818|528765144|FG000|Overall Study|Protocol Deviation|4|||
146615817|NCT01620086|528765145|FG000|Overall Study|Withdrawal by Subject|3|||
146615818|NCT01620086|528765146|FG001|Overall Study|Withdrawal by Subject|3|||
146615819|NCT01620086|528765147|FG002|Overall Study|Withdrawal by Subject|0|||
146615820|NCT01620086|528765145|FG000|Overall Study|failed study criteria|1|||
146615821|NCT01620086|528765146|FG001|Overall Study|failed study criteria|4|||
146615822|NCT01620086|528765147|FG002|Overall Study|failed study criteria|0|||
146615823|NCT01620086|528765145|FG000|Overall Study|Physician Decision|1|||
146615824|NCT01620086|528765146|FG001|Overall Study|Physician Decision|0|||
146615825|NCT01620086|528765147|FG002|Overall Study|Physician Decision|0|||
146615826|NCT05202418|528765153|FG000|Overall Study|Withdrawal by Subject|2|||
146615827|NCT05202418|528765154|FG001|Overall Study|Withdrawal by Subject|1|||
146615828|NCT05202418|528765153|FG000|Overall Study|Lost to Follow-up|1|||
146615829|NCT05202418|528765154|FG001|Overall Study|Lost to Follow-up|1|||
146615830|NCT02562716|528765155|FG000|Overall Study|Adverse Event|7|||
146615831|NCT02562716|528765156|FG001|Overall Study|Adverse Event|14|||
146615832|NCT02562716|528765155|FG000|Overall Study|Withdrawal unrelated to AE|7|||
146615833|NCT02562716|528765156|FG001|Overall Study|Withdrawal unrelated to AE|1|||
146615834|NCT02562716|528765155|FG000|Overall Study|Progression|8|||
146615835|NCT02562716|528765156|FG001|Overall Study|Progression|10|||
146615836|NCT02562716|528765155|FG000|Overall Study|Death|2|||
146615837|NCT02562716|528765156|FG001|Overall Study|Death|1|||
146615838|NCT02562716|528765155|FG000|Overall Study|Not protocol specified|4|||
146615839|NCT02562716|528765156|FG001|Overall Study|Not protocol specified|2|||
146615840|NCT00684996|528765157|FG000|Overall Study|Adverse Event|1|||
146615841|NCT00684996|528765157|FG000|Overall Study|Refusal unrelated to adverse event|1|||
146615842|NCT00684996|528765157|FG000|Overall Study|Progression/relapse|2|||
146615843|NCT00684996|528765157|FG000|Overall Study|Other reasons not protocol specified|1|||
146615844|NCT02519439|528765158|FG000|Overall Study|Study Termination|19|||
146615845|NCT02519439|528765158|FG000|Overall Study|Withdrawal by Subject|1|||
146615846|NCT02519439|528765158|FG000|Overall Study|Adverse Event|1|||
146615847|NCT01078441|528765163|FG000|Overall Study|Withdrawal by Subject|1|||
146615848|NCT02868554|528765164|FG000|Overall Study|Lost to Follow-up|3|||
146615849|NCT02868554|528765165|FG001|Overall Study|Lost to Follow-up|0|||
146615850|NCT02868554|528765166|FG002|Overall Study|Lost to Follow-up|1|||
146615851|NCT04915729|528765167|FG000|Overall Study|Lost to Follow-up|20|||
146615852|NCT04915729|528765168|FG001|Overall Study|Lost to Follow-up|10|||
146615853|NCT04915729|528765167|FG000|Overall Study|Withdrawal by Subject|12|||
146615854|NCT04915729|528765168|FG001|Overall Study|Withdrawal by Subject|5|||
146615855|NCT04915729|528765167|FG000|Overall Study|Death|34|||
146615856|NCT04915729|528765168|FG001|Overall Study|Death|44|||
146615857|NCT04915729|528765167|FG000|Overall Study|not treated|3|||
146615858|NCT04915729|528765168|FG001|Overall Study|not treated|6|||
146615859|NCT04915729|528765167|FG000|Overall Study|Investigator removed subject|1|||
146615860|NCT04915729|528765168|FG001|Overall Study|Investigator removed subject|2|||
146615861|NCT04915729|528765167|FG000|Overall Study|questionnaire result not evaluated|1|||
146615862|NCT04915729|528765168|FG001|Overall Study|questionnaire result not evaluated|0|||
146615863|NCT04915729|528765167|FG000|Overall Study|refuse of hospital visit|1|||
146615864|NCT04915729|528765168|FG001|Overall Study|refuse of hospital visit|3|||
146615865|NCT04915729|528765167|FG000|Overall Study|Subject withdrew|1|||
146615866|NCT04915729|528765168|FG001|Overall Study|Subject withdrew|0|||
146615867|NCT04961541|528765169|FG000|Overall Study|Adverse Event|0|||
146615868|NCT04961541|528765170|FG001|Overall Study|Adverse Event|0|||
146615869|NCT04961541|528765171|FG002|Overall Study|Adverse Event|0|||
146615870|NCT04961541|528765172|FG003|Overall Study|Adverse Event|0|||
146615871|NCT04961541|528765173|FG004|Overall Study|Adverse Event|0|||
146615872|NCT04961541|528765174|FG005|Overall Study|Adverse Event|1|||
146615873|NCT04961541|528765175|FG006|Overall Study|Adverse Event|0|||
146615874|NCT04961541|528765176|FG007|Overall Study|Adverse Event|0|||
146615875|NCT04961541|528765177|FG008|Overall Study|Adverse Event|0|||
146615876|NCT04961541|528765178|FG009|Overall Study|Adverse Event|0|||
146658798|NCT01226043|528928821|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
146615877|NCT04961541|528765179|FG010|Overall Study|Adverse Event|0|||
146615878|NCT04961541|528765180|FG011|Overall Study|Adverse Event|0|||
146615879|NCT04961541|528765181|FG012|Overall Study|Adverse Event|0|||
146615880|NCT04961541|528765182|FG013|Overall Study|Adverse Event|0|||
146615881|NCT04961541|528765169|FG000|Overall Study|Lost to Follow-up|0|||
146615882|NCT04961541|528765170|FG001|Overall Study|Lost to Follow-up|0|||
146615883|NCT04961541|528765171|FG002|Overall Study|Lost to Follow-up|3|||
146615884|NCT04961541|528765172|FG003|Overall Study|Lost to Follow-up|0|||
146615885|NCT04961541|528765173|FG004|Overall Study|Lost to Follow-up|0|||
146615886|NCT04961541|528765174|FG005|Overall Study|Lost to Follow-up|0|||
146615887|NCT04961541|528765175|FG006|Overall Study|Lost to Follow-up|1|||
146615888|NCT04961541|528765176|FG007|Overall Study|Lost to Follow-up|1|||
146615889|NCT04961541|528765177|FG008|Overall Study|Lost to Follow-up|0|||
146615890|NCT04961541|528765178|FG009|Overall Study|Lost to Follow-up|1|||
146615891|NCT04961541|528765179|FG010|Overall Study|Lost to Follow-up|0|||
146658799|NCT01226043|528928822|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
146658800|NCT01226043|528928823|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
146658801|NCT01226043|528928820|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
146658802|NCT01226043|528928821|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
146658803|NCT01226043|528928822|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
146658804|NCT01226043|528928823|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
146658805|NCT01226043|528928820|FG000|6-week Re-randomization Phase|Adverse Event|0|||
146658806|NCT01226043|528928821|FG001|6-week Re-randomization Phase|Adverse Event|0|||
146615892|NCT04961541|528765180|FG011|Overall Study|Lost to Follow-up|0|||
146658807|NCT01226043|528928822|FG002|6-week Re-randomization Phase|Adverse Event|1|||
146615893|NCT04961541|528765181|FG012|Overall Study|Lost to Follow-up|1|||
146615894|NCT04961541|528765182|FG013|Overall Study|Lost to Follow-up|0|||
146615895|NCT04961541|528765169|FG000|Overall Study|Withdrawal by Subject|0|||
146615896|NCT04961541|528765170|FG001|Overall Study|Withdrawal by Subject|0|||
146615897|NCT04961541|528765171|FG002|Overall Study|Withdrawal by Subject|1|||
146615898|NCT04961541|528765172|FG003|Overall Study|Withdrawal by Subject|1|||
146615899|NCT04961541|528765173|FG004|Overall Study|Withdrawal by Subject|0|||
146615900|NCT04961541|528765174|FG005|Overall Study|Withdrawal by Subject|0|||
146615901|NCT04961541|528765175|FG006|Overall Study|Withdrawal by Subject|0|||
146615902|NCT04961541|528765176|FG007|Overall Study|Withdrawal by Subject|0|||
146615903|NCT04961541|528765177|FG008|Overall Study|Withdrawal by Subject|0|||
146615904|NCT04961541|528765178|FG009|Overall Study|Withdrawal by Subject|1|||
146615905|NCT04961541|528765179|FG010|Overall Study|Withdrawal by Subject|0|||
146615906|NCT04961541|528765180|FG011|Overall Study|Withdrawal by Subject|0|||
146615907|NCT04961541|528765181|FG012|Overall Study|Withdrawal by Subject|0|||
146615908|NCT04961541|528765182|FG013|Overall Study|Withdrawal by Subject|0|||
146615909|NCT00191308|528765183|FG000|Overall Study|Adverse Event|1|||
146615910|NCT03710642|528765185|FG000|Overall Study|Adverse Event|5|||
146615911|NCT03710642|528765186|FG001|Overall Study|Adverse Event|1|||
146615912|NCT03710642|528765185|FG000|Overall Study|non-site physician recommendation|1|||
146615913|NCT03710642|528765186|FG001|Overall Study|non-site physician recommendation|0|||
146615914|NCT03710642|528765185|FG000|Overall Study|Participant unwilling or unable to participate|1|||
146615915|NCT03710642|528765186|FG001|Overall Study|Participant unwilling or unable to participate|1|||
146615916|NCT03710642|528765185|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
146615917|NCT03710642|528765186|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
146615918|NCT03710642|528765185|FG000|Overall Study|NA-no code provided|1|||
146615919|NCT03710642|528765186|FG001|Overall Study|NA-no code provided|0|||
146615920|NCT03710642|528765185|FG000|Overall Study|Withdrawal by Subject|1|||
146615921|NCT03710642|528765186|FG001|Overall Study|Withdrawal by Subject|0|||
146615922|NCT01970306|528765187|FG000|Overall Study|Not eligible|3|||
146615923|NCT01970306|528765187|FG000|Overall Study|Not able to be treated|9|||
146615924|NCT03066596|528765188|FG000|Overall Study|Withdrawal by Subject|4|||
146615925|NCT03066596|528765189|FG001|Overall Study|Withdrawal by Subject|2|||
146615926|NCT03066596|528765188|FG000|Overall Study|Lost to Follow-up|14|||
146615927|NCT03066596|528765189|FG001|Overall Study|Lost to Follow-up|10|||
146615928|NCT02864901|528765190|FG000|Overall Study|Withdrawal by Subject|1|||
146615929|NCT02864901|528765191|FG001|Overall Study|Withdrawal by Subject|0|||
146615930|NCT00782717|528765192|FG000|Overall Study|Adverse Event|2|||
146615931|NCT00782717|528765193|FG001|Overall Study|Adverse Event|5|||
146615932|NCT00782717|528765192|FG000|Overall Study|Patient decision unrelated to AE|6|||
146658808|NCT01226043|528928823|FG003|6-week Re-randomization Phase|Adverse Event|1|||
146658809|NCT01226043|528928820|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
146658810|NCT01226043|528928821|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
146658811|NCT01226043|528928822|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
146658812|NCT01226043|528928823|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
146658813|NCT01226043|528928820|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
146658814|NCT01226043|528928821|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
146773584|NCT03292913|529341110|FG000|Overall Study|Withdrawal by Subject|2|||
146773585|NCT03292913|529341111|FG001|Overall Study|Withdrawal by Subject|0|||
146924996|NCT01683071|529884862|FG003|Part 2|Withdrawal by investigator decision|0|||
146978693|NCT03990389|530085463|FG001|Overall Study|Lost to Follow-up|0|||
146658815|NCT01226043|528928822|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
146658816|NCT01226043|528928823|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
146658817|NCT01226043|528928820|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
146658818|NCT01226043|528928821|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
146658819|NCT01226043|528928822|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
146658820|NCT01226043|528928823|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
146615933|NCT00782717|528765193|FG001|Overall Study|Patient decision unrelated to AE|3|||
146615934|NCT00782717|528765192|FG000|Overall Study|Noncompliance|2|||
146615935|NCT00782717|528765193|FG001|Overall Study|Noncompliance|1|||
146615936|NCT00782717|528765192|FG000|Overall Study|Treatment failure|3|||
146615937|NCT00782717|528765193|FG001|Overall Study|Treatment failure|14|||
146615938|NCT00782717|528765192|FG000|Overall Study|Enrollment close prior to surgery|1|||
146615939|NCT00782717|528765193|FG001|Overall Study|Enrollment close prior to surgery|0|||
146615940|NCT00782717|528765192|FG000|Overall Study|Did not meet entrance criteria|1|||
146615941|NCT00782717|528765193|FG001|Overall Study|Did not meet entrance criteria|3|||
146615942|NCT00782717|528765192|FG000|Overall Study|Exited in error|0|||
146615943|NCT00782717|528765193|FG001|Overall Study|Exited in error|2|||
146615944|NCT02446717|528765194|FG000|Overall Study|Adverse Event|0|||
146615945|NCT02446717|528765195|FG001|Overall Study|Adverse Event|0|||
146615946|NCT02446717|528765196|FG002|Overall Study|Adverse Event|1|||
146615947|NCT02446717|528765197|FG003|Overall Study|Adverse Event|0|||
146615948|NCT02446717|528765198|FG004|Overall Study|Adverse Event|0|||
146615949|NCT02446717|528765194|FG000|Overall Study|Lost to Follow-up|0|||
146615950|NCT02446717|528765195|FG001|Overall Study|Lost to Follow-up|1|||
146615951|NCT02446717|528765196|FG002|Overall Study|Lost to Follow-up|1|||
146615952|NCT02446717|528765197|FG003|Overall Study|Lost to Follow-up|0|||
146615953|NCT02446717|528765198|FG004|Overall Study|Lost to Follow-up|1|||
146615954|NCT02446717|528765194|FG000|Overall Study|Withdrew consent|0|||
146924997|NCT01683071|529884863|FG004|Part 2|Withdrawal by investigator decision|1|||
146924998|NCT01683071|529884864|FG005|Part 2|Withdrawal by investigator decision|2|||
146924999|NCT02349789|529885905|FG000|Overall Study|Withdrawal by Subject|2|||
146615955|NCT02446717|528765195|FG001|Overall Study|Withdrew consent|0|||
146615956|NCT02446717|528765196|FG002|Overall Study|Withdrew consent|0|||
146615957|NCT02446717|528765197|FG003|Overall Study|Withdrew consent|1|||
146615958|NCT02446717|528765198|FG004|Overall Study|Withdrew consent|0|||
146615959|NCT05167825|528765201|FG000|Overall Study|Ongoing|3|||
146615960|NCT04739436|528765204|FG000|Overall Study|Lost to Follow-up|21|||
146615961|NCT04739436|528765205|FG001|Overall Study|Lost to Follow-up|23|||
146615962|NCT04739436|528765204|FG000|Overall Study|Withdrawal by Subject|4|||
146615963|NCT04739436|528765205|FG001|Overall Study|Withdrawal by Subject|6|||
146615964|NCT04739436|528765204|FG000|Overall Study|not randomized properly|1|||
146615965|NCT04739436|528765205|FG001|Overall Study|not randomized properly|0|||
146615966|NCT03201419|528765207|FG000|Overall Study|Adverse Event|3|||
146615967|NCT03201419|528765208|FG001|Overall Study|Adverse Event|1|||
146615968|NCT03201419|528765209|FG002|Overall Study|Adverse Event|0|||
146615969|NCT03201419|528765210|FG003|Overall Study|Adverse Event|0|||
146615970|NCT03201419|528765211|FG004|Overall Study|Adverse Event|1|||
146615971|NCT03201419|528765212|FG005|Overall Study|Adverse Event|1|||
146615972|NCT03201419|528765213|FG006|Overall Study|Adverse Event|5|||
146615973|NCT03201419|528765214|FG007|Overall Study|Adverse Event|0|||
146615974|NCT03201419|528765215|FG008|Overall Study|Adverse Event|0|||
146615975|NCT03201419|528765207|FG000|Overall Study|Lost to Follow-up|1|||
146615976|NCT03201419|528765208|FG001|Overall Study|Lost to Follow-up|0|||
146615977|NCT03201419|528765209|FG002|Overall Study|Lost to Follow-up|0|||
146615978|NCT03201419|528765210|FG003|Overall Study|Lost to Follow-up|0|||
146615979|NCT03201419|528765211|FG004|Overall Study|Lost to Follow-up|0|||
146615980|NCT03201419|528765212|FG005|Overall Study|Lost to Follow-up|0|||
146615981|NCT03201419|528765213|FG006|Overall Study|Lost to Follow-up|0|||
146615982|NCT03201419|528765214|FG007|Overall Study|Lost to Follow-up|0|||
146615983|NCT03201419|528765215|FG008|Overall Study|Lost to Follow-up|0|||
146615984|NCT03201419|528765207|FG000|Overall Study|Protocol Deviation|0|||
146658821|NCT01226043|528928820|FG000|6-week Re-randomization Phase|Physician Decision|0|||
146658822|NCT01226043|528928821|FG001|6-week Re-randomization Phase|Physician Decision|0|||
146658823|NCT01226043|528928822|FG002|6-week Re-randomization Phase|Physician Decision|3|||
146658824|NCT01226043|528928823|FG003|6-week Re-randomization Phase|Physician Decision|2|||
146658825|NCT01226043|528928820|FG000|6-week Re-randomization Phase|completed in error|0|||
146658826|NCT01226043|528928821|FG001|6-week Re-randomization Phase|completed in error|0|||
146658827|NCT01226043|528928822|FG002|6-week Re-randomization Phase|completed in error|0|||
146925000|NCT00836277|529885908|FG000|Overall Study|Not evaluable for response|6|||
146925001|NCT00280150|529885909|FG000|Overall Study|Adverse Event|0|||
146615985|NCT03201419|528765208|FG001|Overall Study|Protocol Deviation|0|||
146615986|NCT03201419|528765209|FG002|Overall Study|Protocol Deviation|0|||
146615987|NCT03201419|528765210|FG003|Overall Study|Protocol Deviation|0|||
146615988|NCT03201419|528765211|FG004|Overall Study|Protocol Deviation|0|||
146615989|NCT03201419|528765212|FG005|Overall Study|Protocol Deviation|0|||
146615990|NCT03201419|528765213|FG006|Overall Study|Protocol Deviation|1|||
146615991|NCT03201419|528765214|FG007|Overall Study|Protocol Deviation|0|||
146658828|NCT01226043|528928823|FG003|6-week Re-randomization Phase|completed in error|1|||
146658829|NCT01226043|528928820|FG000|30-week Observational Phase|Adverse Event|0|||
146615992|NCT03201419|528765215|FG008|Overall Study|Protocol Deviation|0|||
146615993|NCT03201419|528765207|FG000|Overall Study|Withdrawal by Subject|4|||
146615994|NCT03201419|528765208|FG001|Overall Study|Withdrawal by Subject|2|||
146615995|NCT03201419|528765209|FG002|Overall Study|Withdrawal by Subject|1|||
146615996|NCT03201419|528765210|FG003|Overall Study|Withdrawal by Subject|0|||
146615997|NCT03201419|528765211|FG004|Overall Study|Withdrawal by Subject|0|||
146658830|NCT01226043|528928821|FG001|30-week Observational Phase|Adverse Event|0|||
146925002|NCT00280150|529885910|FG001|Overall Study|Adverse Event|1|||
146615998|NCT03201419|528765212|FG005|Overall Study|Withdrawal by Subject|0|||
146615999|NCT03201419|528765213|FG006|Overall Study|Withdrawal by Subject|0|||
146616000|NCT03201419|528765214|FG007|Overall Study|Withdrawal by Subject|1|||
146616001|NCT03201419|528765215|FG008|Overall Study|Withdrawal by Subject|2|||
146616002|NCT03201419|528765207|FG000|Overall Study|Other|0|||
146616003|NCT03201419|528765208|FG001|Overall Study|Other|0|||
146616004|NCT03201419|528765209|FG002|Overall Study|Other|1|||
146616005|NCT03201419|528765210|FG003|Overall Study|Other|0|||
146616006|NCT03201419|528765211|FG004|Overall Study|Other|0|||
146616007|NCT03201419|528765212|FG005|Overall Study|Other|0|||
146616008|NCT03201419|528765213|FG006|Overall Study|Other|0|||
146616009|NCT03201419|528765214|FG007|Overall Study|Other|0|||
146616010|NCT03201419|528765215|FG008|Overall Study|Other|0|||
146616011|NCT02701283|528765216|FG000|Overall Study|Death|25|||
146616012|NCT02701283|528765217|FG001|Overall Study|Death|29|||
146616013|NCT02701283|528765218|FG002|Overall Study|Death|19|||
146616014|NCT02701283|528765216|FG000|Overall Study|Lost to Follow-up|3|||
146616015|NCT02701283|528765217|FG001|Overall Study|Lost to Follow-up|8|||
146616016|NCT02701283|528765218|FG002|Overall Study|Lost to Follow-up|1|||
146616017|NCT02701283|528765216|FG000|Overall Study|Withdrawal by Subject|12|||
146616018|NCT02701283|528765217|FG001|Overall Study|Withdrawal by Subject|41|||
146616019|NCT02701283|528765218|FG002|Overall Study|Withdrawal by Subject|1|||
146616020|NCT02701283|528765216|FG000|Overall Study|Missed 2-year visit|22|||
146616021|NCT02701283|528765217|FG001|Overall Study|Missed 2-year visit|27|||
146616022|NCT02701283|528765218|FG002|Overall Study|Missed 2-year visit|0|||
146616023|NCT02701283|528765216|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
146616024|NCT02701283|528765217|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
146616025|NCT02701283|528765218|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
146616026|NCT00892775|528765219|FG000|Overall Study|Protocol Violation|1|||
146616027|NCT00892775|528765220|FG001|Overall Study|Protocol Violation|0|||
146616028|NCT00892775|528765219|FG000|Overall Study|Subject difficulties with blood drawing|1|||
146616029|NCT00892775|528765220|FG001|Overall Study|Subject difficulties with blood drawing|0|||
146616030|NCT00892775|528765219|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
146616031|NCT00892775|528765220|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
146616032|NCT00892775|528765219|FG000|Overall Study|Migrated/ moved from study area|1|||
146616033|NCT00892775|528765220|FG001|Overall Study|Migrated/ moved from study area|0|||
146616034|NCT00892775|528765219|FG000|Overall Study|Withdrawal by Subject|0|||
146616035|NCT00892775|528765220|FG001|Overall Study|Withdrawal by Subject|1|||
146616036|NCT00892775|528765219|FG000|Overall Study|Lost to Follow-up|1|||
146616037|NCT00892775|528765220|FG001|Overall Study|Lost to Follow-up|0|||
146616038|NCT00398320|528765221|FG000|Overall Study|Death|1|||
146616039|NCT00398320|528765221|FG000|Overall Study|Adverse Event|4|||
146616040|NCT00398320|528765221|FG000|Overall Study|Physician Decision|1|||
146616041|NCT00064792|528765222|FG000|Overall Study|Withdrawal by Subject|2|||
146616042|NCT00064792|528765223|FG001|Overall Study|Withdrawal by Subject|0|||
146616043|NCT00064792|528765222|FG000|Overall Study|Adverse Event|3|||
146616044|NCT00064792|528765223|FG001|Overall Study|Adverse Event|0|||
146616045|NCT03160898|528765224|FG000|Overall Study|Adverse Event|4|||
146616046|NCT03160898|528765225|FG001|Overall Study|Adverse Event|8|||
146616047|NCT03160898|528765226|FG002|Overall Study|Adverse Event|7|||
146616048|NCT03160898|528765227|FG003|Overall Study|Adverse Event|10|||
146616049|NCT03160898|528765224|FG000|Overall Study|Death|1|||
146616050|NCT03160898|528765225|FG001|Overall Study|Death|0|||
146616051|NCT03160898|528765226|FG002|Overall Study|Death|0|||
146616052|NCT03160898|528765227|FG003|Overall Study|Death|1|||
146616053|NCT03160898|528765224|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
146616054|NCT03160898|528765225|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
146616055|NCT03160898|528765226|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
146616056|NCT03160898|528765227|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
146616057|NCT03160898|528765224|FG000|Overall Study|Lost to Follow-up|1|||
146616058|NCT03160898|528765225|FG001|Overall Study|Lost to Follow-up|1|||
146616059|NCT03160898|528765226|FG002|Overall Study|Lost to Follow-up|1|||
146616060|NCT03160898|528765227|FG003|Overall Study|Lost to Follow-up|2|||
146616061|NCT03160898|528765224|FG000|Overall Study|Physician Decision|1|||
146616062|NCT03160898|528765225|FG001|Overall Study|Physician Decision|0|||
146616063|NCT03160898|528765226|FG002|Overall Study|Physician Decision|0|||
146616064|NCT03160898|528765227|FG003|Overall Study|Physician Decision|1|||
146616065|NCT03160898|528765224|FG000|Overall Study|Progressive Disease|4|||
146616066|NCT03160898|528765225|FG001|Overall Study|Progressive Disease|1|||
146616067|NCT03160898|528765226|FG002|Overall Study|Progressive Disease|2|||
146616068|NCT03160898|528765227|FG003|Overall Study|Progressive Disease|1|||
146616069|NCT03160898|528765224|FG000|Overall Study|Protocol Violation|1|||
146616070|NCT03160898|528765225|FG001|Overall Study|Protocol Violation|0|||
146925003|NCT00280150|529885911|FG002|Overall Study|Adverse Event|2|||
146616071|NCT03160898|528765226|FG002|Overall Study|Protocol Violation|2|||
146616072|NCT03160898|528765227|FG003|Overall Study|Protocol Violation|0|||
146616073|NCT03160898|528765224|FG000|Overall Study|Sponsor Discretion|2|||
146925004|NCT00280150|529885912|FG003|Overall Study|Adverse Event|3|||
146925005|NCT00280150|529885909|FG000|Overall Study|Lack of Efficacy|0|||
146616074|NCT03160898|528765225|FG001|Overall Study|Sponsor Discretion|0|||
146616075|NCT03160898|528765226|FG002|Overall Study|Sponsor Discretion|0|||
146925006|NCT00280150|529885910|FG001|Overall Study|Lack of Efficacy|0|||
146925007|NCT00280150|529885911|FG002|Overall Study|Lack of Efficacy|0|||
146925008|NCT00280150|529885912|FG003|Overall Study|Lack of Efficacy|3|||
146925009|NCT00280150|529885909|FG000|Overall Study|Physician Decision|0|||
146616076|NCT03160898|528765227|FG003|Overall Study|Sponsor Discretion|0|||
146616077|NCT03160898|528765224|FG000|Overall Study|Withdrawal by Subject|1|||
146616078|NCT03160898|528765225|FG001|Overall Study|Withdrawal by Subject|3|||
146616079|NCT03160898|528765226|FG002|Overall Study|Withdrawal by Subject|2|||
146616080|NCT03160898|528765227|FG003|Overall Study|Withdrawal by Subject|1|||
146616081|NCT03160898|528765224|FG000|Overall Study|Other|2|||
146616082|NCT03160898|528765225|FG001|Overall Study|Other|0|||
146616083|NCT03160898|528765226|FG002|Overall Study|Other|2|||
146616084|NCT03160898|528765227|FG003|Overall Study|Other|2|||
146616085|NCT03405818|528765228|FG000|Overall Study|Withdrawal by Subject|4|||
146616086|NCT03405818|528765228|FG000|Overall Study|Lost to Follow-up|4|||
146616087|NCT00291486|528765231|FG000|Overall Study|Adverse Event|0|||
146616088|NCT00291486|528765232|FG001|Overall Study|Adverse Event|3|||
146616089|NCT00291486|528765233|FG002|Overall Study|Adverse Event|0|||
146616090|NCT00291486|528765234|FG003|Overall Study|Adverse Event|1|||
146616091|NCT00291486|528765235|FG004|Overall Study|Adverse Event|0|||
146616092|NCT00291486|528765231|FG000|Overall Study|Withdrawal by Subject|0|||
146616093|NCT00291486|528765232|FG001|Overall Study|Withdrawal by Subject|0|||
146616094|NCT00291486|528765233|FG002|Overall Study|Withdrawal by Subject|0|||
146616095|NCT00291486|528765234|FG003|Overall Study|Withdrawal by Subject|0|||
146616096|NCT00291486|528765235|FG004|Overall Study|Withdrawal by Subject|1|||
146616097|NCT00291486|528765231|FG000|Overall Study|Disease progression|1|||
146616098|NCT00291486|528765232|FG001|Overall Study|Disease progression|0|||
146616099|NCT00291486|528765233|FG002|Overall Study|Disease progression|1|||
146616100|NCT00291486|528765234|FG003|Overall Study|Disease progression|0|||
146616101|NCT00291486|528765235|FG004|Overall Study|Disease progression|0|||
146616102|NCT01045694|528765238|FG000|Overall Study|Withdrawal by Subject|2|||
146616103|NCT00992459|528765241|FG000|Overall Study|Withdrawal by Subject|0|||
146616104|NCT00992459|528765242|FG001|Overall Study|Withdrawal by Subject|1|||
146616105|NCT00992459|528765241|FG000|Overall Study|Adverse Event|1|||
146616106|NCT00992459|528765242|FG001|Overall Study|Adverse Event|0|||
146616107|NCT01408459|528765243|FG000|Overall Study|Withdrawal by Subject|1|||
146616108|NCT01408459|528765244|FG001|Overall Study|Withdrawal by Subject|1|||
146616109|NCT01657292|528765252|FG000|Overall Study|Adverse Event|6|||
146616110|NCT01657292|528765252|FG000|Overall Study|Withdrawal by Subject|2|||
146616111|NCT01657292|528765252|FG000|Overall Study|Violation of eligibility criteria|1|||
146616112|NCT01657292|528765252|FG000|Overall Study|Change of therapy|1|||
146616113|NCT04725500|528765254|FG000|Screening|Screen Failure|26|||
146616114|NCT04725500|528765254|FG000|Screening|Withdrawal by Subject|1|||
146616115|NCT04725500|528765254|FG000|2 Week Take Home|Screen Fail|5|||
146616116|NCT01633788|528767283|FG000|Overall Study|Adverse Event|1|||
146616117|NCT01633788|528767284|FG001|Overall Study|Adverse Event|3|||
146616118|NCT01633788|528767285|FG002|Overall Study|Adverse Event|3|||
146616119|NCT01633788|528767286|FG003|Overall Study|Adverse Event|3|||
146616120|NCT01633788|528767283|FG000|Overall Study|Lost to Follow-up|2|||
146616121|NCT01633788|528767284|FG001|Overall Study|Lost to Follow-up|2|||
146616122|NCT01633788|528767285|FG002|Overall Study|Lost to Follow-up|2|||
146925010|NCT00280150|529885910|FG001|Overall Study|Physician Decision|0|||
146616123|NCT01633788|528767286|FG003|Overall Study|Lost to Follow-up|0|||
146616124|NCT01633788|528767283|FG000|Overall Study|Personal Reasons|3|||
146616125|NCT01633788|528767284|FG001|Overall Study|Personal Reasons|1|||
146616126|NCT01633788|528767285|FG002|Overall Study|Personal Reasons|1|||
146616127|NCT01633788|528767286|FG003|Overall Study|Personal Reasons|3|||
146616128|NCT01633788|528767283|FG000|Overall Study|Protocol Violation|1|||
146616129|NCT01633788|528767284|FG001|Overall Study|Protocol Violation|0|||
146616130|NCT01633788|528767285|FG002|Overall Study|Protocol Violation|1|||
146616131|NCT01633788|528767286|FG003|Overall Study|Protocol Violation|0|||
146616132|NCT01633788|528767283|FG000|Overall Study|Other Reasons|0|||
146616133|NCT01633788|528767284|FG001|Overall Study|Other Reasons|2|||
146616134|NCT01633788|528767285|FG002|Overall Study|Other Reasons|3|||
146616135|NCT01633788|528767286|FG003|Overall Study|Other Reasons|7|||
146616136|NCT01929226|528767287|FG000|Overall Study|Lost to Follow-up|4|||
146616137|NCT01929226|528767288|FG001|Overall Study|Lost to Follow-up|0|||
146616138|NCT01929226|528767287|FG000|Overall Study|Withdrawal by Subject|1|||
146616139|NCT01929226|528767288|FG001|Overall Study|Withdrawal by Subject|1|||
146616140|NCT03553758|528767289|FG000|Overall Study|Lost to Follow-up|1|||
146616141|NCT01467505|528767292|FG000|Overall Study|Adverse Event|1|||
146616142|NCT01467505|528767293|FG001|Overall Study|Adverse Event|0|||
146616143|NCT01467505|528767292|FG000|Overall Study|Withdrawal by Subject|4|||
146925011|NCT00280150|529885911|FG002|Overall Study|Physician Decision|0|||
146925012|NCT00280150|529885912|FG003|Overall Study|Physician Decision|1|||
146616144|NCT01467505|528767293|FG001|Overall Study|Withdrawal by Subject|0|||
146616145|NCT01467505|528767292|FG000|Overall Study|Study Terminated by Sponsor|28|||
146616146|NCT01467505|528767293|FG001|Overall Study|Study Terminated by Sponsor|3|||
146616147|NCT02807623|528767294|FG000|Overall Study|Lost to Follow-up|23|||
146925013|NCT00280150|529885909|FG000|Overall Study|Protocol Violation|0|||
146616148|NCT02807623|528767295|FG001|Overall Study|Lost to Follow-up|18|||
146616149|NCT02807623|528767296|FG002|Overall Study|Lost to Follow-up|22|||
146616150|NCT02807623|528767294|FG000|Overall Study|Drug intolerance|0|||
146616151|NCT02807623|528767295|FG001|Overall Study|Drug intolerance|1|||
146616152|NCT02807623|528767296|FG002|Overall Study|Drug intolerance|0|||
146616153|NCT02807623|528767294|FG000|Overall Study|incomplete blood draw|0|||
146616154|NCT02807623|528767295|FG001|Overall Study|incomplete blood draw|2|||
146616155|NCT02807623|528767296|FG002|Overall Study|incomplete blood draw|1|||
146616156|NCT03811340|528767297|FG000|Overall Study|subjects did not complete the survey.|90|||
146616157|NCT05104450|528767298|FG000|Overall Study|Death|1|||
146616158|NCT05104450|528767299|FG001|Overall Study|Death|2|||
146616159|NCT05104450|528767298|FG000|Overall Study|Withdrawal by Subject|3|||
146616160|NCT05104450|528767299|FG001|Overall Study|Withdrawal by Subject|1|||
146616161|NCT01380769|528767300|FG000|Overall Study|Withdrawal by Subject|7|||
146616162|NCT01380769|528767301|FG001|Overall Study|Withdrawal by Subject|11|||
146616163|NCT01380769|528767300|FG000|Overall Study|Physician Decision|1|||
146616164|NCT01380769|528767301|FG001|Overall Study|Physician Decision|1|||
146616165|NCT01380769|528767300|FG000|Overall Study|Adverse Event|1|||
146616166|NCT01380769|528767301|FG001|Overall Study|Adverse Event|1|||
146616167|NCT01380769|528767300|FG000|Overall Study|Protocol Violation|0|||
146616168|NCT01380769|528767301|FG001|Overall Study|Protocol Violation|1|||
146616169|NCT01080807|528767303|FG000|Overall Study|Adverse Event|9|||
146616170|NCT01080807|528767304|FG001|Overall Study|Adverse Event|1|||
146616171|NCT01080807|528767303|FG000|Overall Study|Lack of Efficacy|0|||
146616172|NCT01080807|528767304|FG001|Overall Study|Lack of Efficacy|1|||
146616173|NCT01080807|528767303|FG000|Overall Study|Withdrawal by Subject|7|||
146616174|NCT01080807|528767304|FG001|Overall Study|Withdrawal by Subject|2|||
146616175|NCT01080807|528767303|FG000|Overall Study|Protocol Violation|7|||
146616176|NCT01080807|528767304|FG001|Overall Study|Protocol Violation|6|||
146616177|NCT01080807|528767303|FG000|Overall Study|Lost to Follow-up|6|||
146616178|NCT01080807|528767304|FG001|Overall Study|Lost to Follow-up|4|||
146616179|NCT01080807|528767303|FG000|Overall Study|Noncompliance with drug administration|1|||
146616180|NCT01080807|528767304|FG001|Overall Study|Noncompliance with drug administration|1|||
146616181|NCT01080807|528767303|FG000|Overall Study|Noncompliance to study procedures|1|||
146616182|NCT01080807|528767304|FG001|Overall Study|Noncompliance to study procedures|1|||
146616183|NCT01080807|528767303|FG000|Overall Study|Began working day shift|0|||
146616184|NCT01080807|528767304|FG001|Overall Study|Began working day shift|2|||
146616185|NCT01080807|528767303|FG000|Overall Study|Laid off or terminated from job|1|||
146616186|NCT01080807|528767304|FG001|Overall Study|Laid off or terminated from job|2|||
146616187|NCT01080807|528767303|FG000|Overall Study|Stopped working consistent night shifts|0|||
146616188|NCT01080807|528767304|FG001|Overall Study|Stopped working consistent night shifts|1|||
146616189|NCT01080807|528767303|FG000|Overall Study|Work schedule changing|1|||
146616190|NCT01080807|528767304|FG001|Overall Study|Work schedule changing|1|||
146616191|NCT01080807|528767303|FG000|Overall Study|Work schedule and travel|0|||
146616192|NCT01080807|528767304|FG001|Overall Study|Work schedule and travel|1|||
146616193|NCT01080807|528767303|FG000|Overall Study|Switched to first shift|1|||
146616194|NCT01080807|528767304|FG001|Overall Study|Switched to first shift|0|||
146616195|NCT01080807|528767303|FG000|Overall Study|Moved away without notifying center|1|||
146616196|NCT01080807|528767304|FG001|Overall Study|Moved away without notifying center|0|||
146616197|NCT03456076|528767317|FG000|Overall Study|Withdrawal by Subject|5|||
146616198|NCT03456076|528767318|FG001|Overall Study|Withdrawal by Subject|9|||
146616199|NCT03456076|528767317|FG000|Overall Study|Protocol deviation|0|||
146616200|NCT03456076|528767318|FG001|Overall Study|Protocol deviation|1|||
146616201|NCT03456076|528767317|FG000|Overall Study|Lost to Follow-up|0|||
146616202|NCT03456076|528767318|FG001|Overall Study|Lost to Follow-up|1|||
146616203|NCT03456076|528767317|FG000|Overall Study|Death|2|||
146616204|NCT03456076|528767318|FG001|Overall Study|Death|5|||
146658831|NCT01226043|528928822|FG002|30-week Observational Phase|Adverse Event|1|||
146658832|NCT01226043|528928823|FG003|30-week Observational Phase|Adverse Event|1|||
146658833|NCT01226043|528928820|FG000|30-week Observational Phase|Protocol Violation|0|||
146658834|NCT01226043|528928821|FG001|30-week Observational Phase|Protocol Violation|0|||
146658835|NCT01226043|528928822|FG002|30-week Observational Phase|Protocol Violation|0|||
146616205|NCT03456076|528767317|FG000|Overall Study|Study ongoing|123|||
146616206|NCT03456076|528767318|FG001|Overall Study|Study ongoing|111|||
146616207|NCT02045095|528767319|FG000|Overall Study|Other|0|||
146616208|NCT02045095|528767320|FG001|Overall Study|Other|0|||
146616209|NCT02045095|528767321|FG002|Overall Study|Other|1|||
146658836|NCT01226043|528928823|FG003|30-week Observational Phase|Protocol Violation|1|||
146658837|NCT01226043|528928820|FG000|30-week Observational Phase|Lost to Follow-up|0|||
146616210|NCT02045095|528767322|FG003|Overall Study|Other|0|||
146616211|NCT02045095|528767323|FG004|Overall Study|Other|0|||
146616212|NCT02045095|528767324|FG005|Overall Study|Other|2|||
146616213|NCT02045095|528767325|FG006|Overall Study|Other|0|||
146616214|NCT02045095|528767319|FG000|Overall Study|Progressive Disease|3|||
146616215|NCT02045095|528767320|FG001|Overall Study|Progressive Disease|3|||
146616216|NCT02045095|528767321|FG002|Overall Study|Progressive Disease|2|||
146616217|NCT02045095|528767322|FG003|Overall Study|Progressive Disease|4|||
146925014|NCT00280150|529885910|FG001|Overall Study|Protocol Violation|0|||
146925015|NCT00280150|529885911|FG002|Overall Study|Protocol Violation|0|||
146925016|NCT00280150|529885912|FG003|Overall Study|Protocol Violation|1|||
146925017|NCT00280150|529885909|FG000|Overall Study|Withdrawal by Subject|0|||
146925018|NCT00280150|529885910|FG001|Overall Study|Withdrawal by Subject|0|||
146925019|NCT00280150|529885911|FG002|Overall Study|Withdrawal by Subject|0|||
146616218|NCT02045095|528767323|FG004|Overall Study|Progressive Disease|2|||
146616219|NCT02045095|528767324|FG005|Overall Study|Progressive Disease|4|||
146616220|NCT02045095|528767325|FG006|Overall Study|Progressive Disease|1|||
146616221|NCT02045095|528767319|FG000|Overall Study|Withdrawal by Subject|0|||
146616222|NCT02045095|528767320|FG001|Overall Study|Withdrawal by Subject|0|||
146616223|NCT02045095|528767321|FG002|Overall Study|Withdrawal by Subject|0|||
146616224|NCT02045095|528767322|FG003|Overall Study|Withdrawal by Subject|0|||
146616225|NCT02045095|528767323|FG004|Overall Study|Withdrawal by Subject|3|||
146616226|NCT02045095|528767324|FG005|Overall Study|Withdrawal by Subject|0|||
146616227|NCT02045095|528767325|FG006|Overall Study|Withdrawal by Subject|0|||
146616228|NCT02045095|528767319|FG000|Overall Study|Adverse Event|0|||
146616229|NCT02045095|528767320|FG001|Overall Study|Adverse Event|1|||
146616230|NCT02045095|528767321|FG002|Overall Study|Adverse Event|1|||
146616231|NCT02045095|528767322|FG003|Overall Study|Adverse Event|0|||
146616232|NCT02045095|528767323|FG004|Overall Study|Adverse Event|0|||
146616233|NCT02045095|528767324|FG005|Overall Study|Adverse Event|2|||
146616234|NCT02045095|528767325|FG006|Overall Study|Adverse Event|0|||
146616235|NCT01020786|528767329|FG000|Induction Period|Entry Criteria Not Met|2|||
146616236|NCT01020786|528767329|FG000|Induction Period|Adverse Event|10|||
146616237|NCT01020786|528767329|FG000|Induction Period|Progressive Disease|31|||
146658838|NCT01226043|528928821|FG001|30-week Observational Phase|Lost to Follow-up|0|||
146616238|NCT01020786|528767329|FG000|Induction Period|Investigator Decision|3|||
146616239|NCT01020786|528767329|FG000|Induction Period|Withdrawal by Subject|3|||
146616240|NCT01020786|528767329|FG000|Maintenance Period|Adverse Event|8|||
146616241|NCT01020786|528767329|FG000|Maintenance Period|Progressive Disease|43|||
146616242|NCT01020786|528767329|FG000|Maintenance Period|Withdrawal by Subject|8|||
146616243|NCT01020786|528767329|FG000|Maintenance Period|Sponsor Decision|1|||
146616244|NCT01818596|528767330|FG000|Overall Study|Enrolled but Not Treated|4|||
146616245|NCT01818596|528767331|FG001|Overall Study|Enrolled but Not Treated|0|||
146616246|NCT01818596|528767330|FG000|Overall Study|Adverse Event|7|||
146616247|NCT01818596|528767331|FG001|Overall Study|Adverse Event|0|||
146616248|NCT01818596|528767330|FG000|Overall Study|Death|3|||
146616249|NCT01818596|528767331|FG001|Overall Study|Death|0|||
146616250|NCT01818596|528767330|FG000|Overall Study|Investigator's Discretion|4|||
146616251|NCT01818596|528767331|FG001|Overall Study|Investigator's Discretion|0|||
146616252|NCT01818596|528767330|FG000|Overall Study|Protocol Violation|1|||
146616253|NCT01818596|528767331|FG001|Overall Study|Protocol Violation|0|||
146616254|NCT01818596|528767330|FG000|Overall Study|Withdrew Consent|5|||
146616255|NCT01818596|528767331|FG001|Overall Study|Withdrew Consent|0|||
146616256|NCT01818596|528767330|FG000|Overall Study|Lost to Follow-up|7|||
146616257|NCT01818596|528767331|FG001|Overall Study|Lost to Follow-up|0|||
146616258|NCT04435366|528767337|FG000|Year 1 (12 Months)|Adverse Event|3|||
146616259|NCT04435366|528767338|FG001|Year 1 (12 Months)|Adverse Event|0|||
146616260|NCT04435366|528767339|FG002|Year 1 (12 Months)|Adverse Event|2|||
146616261|NCT04435366|528767337|FG000|Year 1 (12 Months)|Death|2|||
146616262|NCT04435366|528767338|FG001|Year 1 (12 Months)|Death|0|||
146616263|NCT04435366|528767339|FG002|Year 1 (12 Months)|Death|1|||
146616264|NCT04435366|528767337|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
146616265|NCT04435366|528767338|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
146616266|NCT04435366|528767339|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
146616267|NCT04435366|528767337|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
146616268|NCT04435366|528767338|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
146658839|NCT01226043|528928822|FG002|30-week Observational Phase|Lost to Follow-up|2|||
146925020|NCT00280150|529885912|FG003|Overall Study|Withdrawal by Subject|1|||
146925021|NCT00280150|529885909|FG000|Overall Study|Did not get consolidation therapy|3|||
146925022|NCT00280150|529885910|FG001|Overall Study|Did not get consolidation therapy|0|||
146925023|NCT00280150|529885911|FG002|Overall Study|Did not get consolidation therapy|3|||
146616269|NCT04435366|528767339|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
146616270|NCT04435366|528767337|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
146616271|NCT04435366|528767338|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
146658840|NCT01226043|528928823|FG003|30-week Observational Phase|Lost to Follow-up|2|||
146925024|NCT00280150|529885912|FG003|Overall Study|Did not get consolidation therapy|0|||
146925025|NCT00280150|529885909|FG000|Overall Study|Declining Performance Status|0|||
146616272|NCT04435366|528767339|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
146616273|NCT04435366|528767337|FG000|Year 1 (12 Months)|Not treated|0|||
146616274|NCT04435366|528767338|FG001|Year 1 (12 Months)|Not treated|0|||
146616275|NCT04435366|528767339|FG002|Year 1 (12 Months)|Not treated|1|||
146616276|NCT04435366|528767337|FG000|Year 2 (12 Months)|Death|1|||
146616277|NCT04435366|528767338|FG001|Year 2 (12 Months)|Death|4|||
146616278|NCT04435366|528767339|FG002|Year 2 (12 Months)|Death|6|||
146616279|NCT04435366|528767337|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
146616280|NCT04435366|528767338|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
146658841|NCT01226043|528928820|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
146658842|NCT01226043|528928821|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
146658843|NCT01226043|528928822|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
146658844|NCT01226043|528928823|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
146658845|NCT01226043|528928820|FG000|30-week Observational Phase|Physician Decision|0|||
146658846|NCT01226043|528928821|FG001|30-week Observational Phase|Physician Decision|0|||
146658847|NCT01226043|528928822|FG002|30-week Observational Phase|Physician Decision|2|||
146658848|NCT01226043|528928823|FG003|30-week Observational Phase|Physician Decision|2|||
146658849|NCT01702571|528928824|FG000|Overall Study|Death|1067|||
146658850|NCT01702571|528928825|FG001|Overall Study|Death|76|||
146658851|NCT01702571|528928824|FG000|Overall Study|Lost to Follow-up|144|||
146658852|NCT01702571|528928825|FG001|Overall Study|Lost to Follow-up|10|||
146658853|NCT01702571|528928824|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
146658854|NCT01702571|528928825|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
146658855|NCT01702571|528928824|FG000|Overall Study|Investigator Decision|5|||
146658856|NCT01702571|528928825|FG001|Overall Study|Investigator Decision|0|||
146658857|NCT01702571|528928824|FG000|Overall Study|Not Classifiable|1|||
146658858|NCT01702571|528928825|FG001|Overall Study|Not Classifiable|0|||
146658859|NCT01702571|528928824|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
146616281|NCT04435366|528767339|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
146616282|NCT04435366|528767337|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
146616283|NCT04435366|528767338|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
146616284|NCT04435366|528767339|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
146616285|NCT04435366|528767337|FG000|Year 2 (12 Months)|Adverse Event|2|||
146616286|NCT04435366|528767338|FG001|Year 2 (12 Months)|Adverse Event|1|||
146616287|NCT04435366|528767339|FG002|Year 2 (12 Months)|Adverse Event|6|||
146616288|NCT00837213|528767341|FG000|Overall Study|Lost to Follow-up|3|||
146616289|NCT00837213|528767342|FG001|Overall Study|Lost to Follow-up|2|||
146616290|NCT00837213|528767341|FG000|Overall Study|Withdrawal by Subject|2|||
146616291|NCT00837213|528767342|FG001|Overall Study|Withdrawal by Subject|2|||
146616292|NCT00837213|528767341|FG000|Overall Study|not stated|1|||
146616293|NCT00837213|528767342|FG001|Overall Study|not stated|1|||
146616294|NCT04497116|528767345|FG000|Overall Study|Lost to Follow-up|1|||
146616295|NCT04497116|528767346|FG001|Overall Study|Lost to Follow-up|0|||
146616296|NCT04497116|528767347|FG002|Overall Study|Lost to Follow-up|0|||
146616297|NCT04497116|528767348|FG003|Overall Study|Lost to Follow-up|0|||
146616298|NCT04497116|528767349|FG004|Overall Study|Lost to Follow-up|0|||
146616299|NCT04497116|528767350|FG005|Overall Study|Lost to Follow-up|0|||
146616300|NCT04497116|528767351|FG006|Overall Study|Lost to Follow-up|0|||
146616301|NCT04497116|528767352|FG007|Overall Study|Lost to Follow-up|3|||
146616302|NCT04497116|528767353|FG008|Overall Study|Lost to Follow-up|3|||
146616303|NCT04497116|528767354|FG009|Overall Study|Lost to Follow-up|0|||
146616304|NCT04497116|528767355|FG010|Overall Study|Lost to Follow-up|0|||
146616305|NCT04497116|528767356|FG011|Overall Study|Lost to Follow-up|0|||
146616306|NCT04497116|528767357|FG012|Overall Study|Lost to Follow-up|0|||
146616307|NCT04497116|528767358|FG013|Overall Study|Lost to Follow-up|0|||
146616308|NCT04497116|528767359|FG014|Overall Study|Lost to Follow-up|0|||
146616309|NCT04497116|528767360|FG015|Overall Study|Lost to Follow-up|0|||
146616310|NCT04497116|528767361|FG016|Overall Study|Lost to Follow-up|0|||
146616311|NCT04497116|528767362|FG017|Overall Study|Lost to Follow-up|0|||
146616312|NCT04497116|528767363|FG018|Overall Study|Lost to Follow-up|0|||
146616313|NCT04497116|528767364|FG019|Overall Study|Lost to Follow-up|0|||
146616314|NCT04497116|528767365|FG020|Overall Study|Lost to Follow-up|0|||
146616315|NCT04497116|528767366|FG021|Overall Study|Lost to Follow-up|0|||
146616316|NCT04497116|528767367|FG022|Overall Study|Lost to Follow-up|1|||
146616317|NCT04497116|528767368|FG023|Overall Study|Lost to Follow-up|0|||
146616318|NCT04497116|528767369|FG024|Overall Study|Lost to Follow-up|0|||
146616319|NCT04497116|528767345|FG000|Overall Study|Sponsor decision to terminate study|0|||
146658860|NCT01702571|528928825|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
146658861|NCT01702571|528928824|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
146658862|NCT01702571|528928825|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
146658863|NCT01702571|528928824|FG000|Overall Study|Progressive Disease|3|||
146658864|NCT01702571|528928825|FG001|Overall Study|Progressive Disease|0|||
146658865|NCT01702571|528928824|FG000|Overall Study|Protocol Violation|2|||
146658866|NCT01702571|528928825|FG001|Overall Study|Protocol Violation|0|||
146658867|NCT01702571|528928824|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
146616320|NCT04497116|528767346|FG001|Overall Study|Sponsor decision to terminate study|0|||
146616321|NCT04497116|528767347|FG002|Overall Study|Sponsor decision to terminate study|0|||
146658868|NCT01702571|528928825|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
146658869|NCT01702571|528928824|FG000|Overall Study|Termination By Sponsor|4|||
146616322|NCT04497116|528767348|FG003|Overall Study|Sponsor decision to terminate study|0|||
146616323|NCT04497116|528767349|FG004|Overall Study|Sponsor decision to terminate study|0|||
146616324|NCT04497116|528767350|FG005|Overall Study|Sponsor decision to terminate study|0|||
146616325|NCT04497116|528767351|FG006|Overall Study|Sponsor decision to terminate study|1|||
146616326|NCT04497116|528767352|FG007|Overall Study|Sponsor decision to terminate study|0|||
146658870|NCT01702571|528928825|FG001|Overall Study|Termination By Sponsor|0|||
146658871|NCT01702571|528928824|FG000|Overall Study|Withdrawal by Subject|177|||
146773586|NCT03292913|529341110|FG000|Overall Study|Clinic closed due to COVID|22|||
146773587|NCT03292913|529341111|FG001|Overall Study|Clinic closed due to COVID|36|||
146773588|NCT02379819|529341112|FG000|Overall Study|Withdrawal by Subject|10|||
146773589|NCT02379819|529341112|FG000|Overall Study|Death|2|||
146616327|NCT04497116|528767353|FG008|Overall Study|Sponsor decision to terminate study|0|||
146616328|NCT04497116|528767354|FG009|Overall Study|Sponsor decision to terminate study|1|||
146616329|NCT04497116|528767355|FG010|Overall Study|Sponsor decision to terminate study|0|||
146616330|NCT04497116|528767356|FG011|Overall Study|Sponsor decision to terminate study|0|||
146616331|NCT04497116|528767357|FG012|Overall Study|Sponsor decision to terminate study|0|||
146616332|NCT04497116|528767358|FG013|Overall Study|Sponsor decision to terminate study|0|||
146616333|NCT04497116|528767359|FG014|Overall Study|Sponsor decision to terminate study|0|||
146616334|NCT04497116|528767360|FG015|Overall Study|Sponsor decision to terminate study|0|||
146616335|NCT04497116|528767361|FG016|Overall Study|Sponsor decision to terminate study|0|||
146616336|NCT04497116|528767362|FG017|Overall Study|Sponsor decision to terminate study|0|||
146616337|NCT04497116|528767363|FG018|Overall Study|Sponsor decision to terminate study|0|||
146616338|NCT04497116|528767364|FG019|Overall Study|Sponsor decision to terminate study|1|||
146616339|NCT04497116|528767365|FG020|Overall Study|Sponsor decision to terminate study|0|||
146616340|NCT04497116|528767366|FG021|Overall Study|Sponsor decision to terminate study|0|||
146616341|NCT04497116|528767367|FG022|Overall Study|Sponsor decision to terminate study|0|||
146616342|NCT04497116|528767368|FG023|Overall Study|Sponsor decision to terminate study|0|||
146616343|NCT04497116|528767369|FG024|Overall Study|Sponsor decision to terminate study|0|||
146616344|NCT04497116|528767345|FG000|Overall Study|Death|4|||
146616345|NCT04497116|528767346|FG001|Overall Study|Death|5|||
146616346|NCT04497116|528767347|FG002|Overall Study|Death|2|||
146616347|NCT04497116|528767348|FG003|Overall Study|Death|2|||
146616348|NCT04497116|528767349|FG004|Overall Study|Death|1|||
146616349|NCT04497116|528767350|FG005|Overall Study|Death|1|||
146616350|NCT04497116|528767351|FG006|Overall Study|Death|3|||
146616351|NCT04497116|528767352|FG007|Overall Study|Death|10|||
146616352|NCT04497116|528767353|FG008|Overall Study|Death|37|||
146616353|NCT04497116|528767354|FG009|Overall Study|Death|17|||
146616354|NCT04497116|528767355|FG010|Overall Study|Death|2|||
146616355|NCT04497116|528767356|FG011|Overall Study|Death|1|||
146616356|NCT04497116|528767357|FG012|Overall Study|Death|1|||
146616357|NCT04497116|528767358|FG013|Overall Study|Death|3|||
146616358|NCT04497116|528767359|FG014|Overall Study|Death|18|||
146616359|NCT04497116|528767360|FG015|Overall Study|Death|3|||
146616360|NCT04497116|528767361|FG016|Overall Study|Death|2|||
146616361|NCT04497116|528767362|FG017|Overall Study|Death|1|||
146616362|NCT04497116|528767363|FG018|Overall Study|Death|4|||
146773590|NCT02379819|529341112|FG000|Overall Study|Lack of Efficacy|1|||
146616363|NCT04497116|528767364|FG019|Overall Study|Death|17|||
146616364|NCT04497116|528767365|FG020|Overall Study|Death|1|||
146616365|NCT04497116|528767366|FG021|Overall Study|Death|0|||
146616366|NCT04497116|528767367|FG022|Overall Study|Death|3|||
146616367|NCT04497116|528767368|FG023|Overall Study|Death|5|||
146616368|NCT04497116|528767369|FG024|Overall Study|Death|4|||
146616369|NCT04497116|528767345|FG000|Overall Study|Withdrawal by Subject|1|||
146616370|NCT04497116|528767346|FG001|Overall Study|Withdrawal by Subject|0|||
146616371|NCT04497116|528767347|FG002|Overall Study|Withdrawal by Subject|1|||
146616372|NCT04497116|528767348|FG003|Overall Study|Withdrawal by Subject|0|||
146616373|NCT04497116|528767349|FG004|Overall Study|Withdrawal by Subject|0|||
146616374|NCT04497116|528767350|FG005|Overall Study|Withdrawal by Subject|0|||
146616375|NCT04497116|528767351|FG006|Overall Study|Withdrawal by Subject|0|||
146616376|NCT04497116|528767352|FG007|Overall Study|Withdrawal by Subject|7|||
146616377|NCT04497116|528767353|FG008|Overall Study|Withdrawal by Subject|14|||
146616378|NCT04497116|528767354|FG009|Overall Study|Withdrawal by Subject|3|||
146616379|NCT04497116|528767355|FG010|Overall Study|Withdrawal by Subject|3|||
146616380|NCT04497116|528767356|FG011|Overall Study|Withdrawal by Subject|0|||
146616381|NCT04497116|528767357|FG012|Overall Study|Withdrawal by Subject|1|||
146616382|NCT04497116|528767358|FG013|Overall Study|Withdrawal by Subject|0|||
146773591|NCT02379819|529341112|FG000|Overall Study|Lost to Follow-up|1|||
146773592|NCT03950622|529341113|FG000|Overall Study|Withdrawal by Subject|1|||
146773593|NCT03950622|529341114|FG001|Overall Study|Withdrawal by Subject|0|||
146616383|NCT04497116|528767359|FG014|Overall Study|Withdrawal by Subject|7|||
146773594|NCT03950622|529341113|FG000|Overall Study|Protocol Deviation|0|||
146616384|NCT04497116|528767360|FG015|Overall Study|Withdrawal by Subject|1|||
146616385|NCT04497116|528767361|FG016|Overall Study|Withdrawal by Subject|3|||
146616386|NCT04497116|528767362|FG017|Overall Study|Withdrawal by Subject|1|||
146616387|NCT04497116|528767363|FG018|Overall Study|Withdrawal by Subject|1|||
146616388|NCT04497116|528767364|FG019|Overall Study|Withdrawal by Subject|5|||
146773595|NCT03950622|529341114|FG001|Overall Study|Protocol Deviation|1|||
146616389|NCT04497116|528767365|FG020|Overall Study|Withdrawal by Subject|2|||
146616390|NCT04497116|528767366|FG021|Overall Study|Withdrawal by Subject|2|||
146616391|NCT04497116|528767367|FG022|Overall Study|Withdrawal by Subject|2|||
146616392|NCT04497116|528767368|FG023|Overall Study|Withdrawal by Subject|4|||
146773596|NCT03950622|529341113|FG000|Overall Study|Physician Decision|1|||
146773597|NCT03950622|529341114|FG001|Overall Study|Physician Decision|0|||
146616393|NCT04497116|528767369|FG024|Overall Study|Withdrawal by Subject|3|||
146616394|NCT04497116|528767345|FG000|Overall Study|Physician Decision|0|||
146616395|NCT04497116|528767346|FG001|Overall Study|Physician Decision|0|||
146616396|NCT04497116|528767347|FG002|Overall Study|Physician Decision|0|||
146616397|NCT04497116|528767348|FG003|Overall Study|Physician Decision|0|||
146616398|NCT04497116|528767349|FG004|Overall Study|Physician Decision|0|||
146616399|NCT04497116|528767350|FG005|Overall Study|Physician Decision|0|||
146616400|NCT04497116|528767351|FG006|Overall Study|Physician Decision|0|||
146616401|NCT04497116|528767352|FG007|Overall Study|Physician Decision|0|||
146616402|NCT04497116|528767353|FG008|Overall Study|Physician Decision|0|||
146616403|NCT04497116|528767354|FG009|Overall Study|Physician Decision|0|||
146616404|NCT04497116|528767355|FG010|Overall Study|Physician Decision|0|||
146616405|NCT04497116|528767356|FG011|Overall Study|Physician Decision|0|||
146616406|NCT04497116|528767357|FG012|Overall Study|Physician Decision|0|||
146616407|NCT04497116|528767358|FG013|Overall Study|Physician Decision|0|||
146616408|NCT04497116|528767359|FG014|Overall Study|Physician Decision|0|||
146616409|NCT04497116|528767360|FG015|Overall Study|Physician Decision|0|||
146616410|NCT04497116|528767361|FG016|Overall Study|Physician Decision|0|||
146616411|NCT04497116|528767362|FG017|Overall Study|Physician Decision|0|||
146616412|NCT04497116|528767363|FG018|Overall Study|Physician Decision|0|||
146616413|NCT04497116|528767364|FG019|Overall Study|Physician Decision|0|||
146616414|NCT04497116|528767365|FG020|Overall Study|Physician Decision|0|||
146616415|NCT04497116|528767366|FG021|Overall Study|Physician Decision|0|||
146616416|NCT04497116|528767367|FG022|Overall Study|Physician Decision|0|||
146616417|NCT04497116|528767368|FG023|Overall Study|Physician Decision|1|||
146616418|NCT04497116|528767369|FG024|Overall Study|Physician Decision|0|||
146616419|NCT04497116|528767345|FG000|Overall Study|Clinical Progression Related|0|||
146616420|NCT04497116|528767346|FG001|Overall Study|Clinical Progression Related|0|||
146616421|NCT04497116|528767347|FG002|Overall Study|Clinical Progression Related|0|||
146616422|NCT04497116|528767348|FG003|Overall Study|Clinical Progression Related|0|||
146616423|NCT04497116|528767349|FG004|Overall Study|Clinical Progression Related|0|||
146616424|NCT04497116|528767350|FG005|Overall Study|Clinical Progression Related|0|||
146616425|NCT04497116|528767351|FG006|Overall Study|Clinical Progression Related|0|||
146616426|NCT04497116|528767352|FG007|Overall Study|Clinical Progression Related|0|||
146616427|NCT04497116|528767353|FG008|Overall Study|Clinical Progression Related|0|||
146616428|NCT04497116|528767354|FG009|Overall Study|Clinical Progression Related|1|||
146616429|NCT04497116|528767355|FG010|Overall Study|Clinical Progression Related|0|||
146616430|NCT04497116|528767356|FG011|Overall Study|Clinical Progression Related|0|||
146616431|NCT04497116|528767357|FG012|Overall Study|Clinical Progression Related|0|||
146616432|NCT04497116|528767358|FG013|Overall Study|Clinical Progression Related|0|||
146616433|NCT04497116|528767359|FG014|Overall Study|Clinical Progression Related|0|||
146616434|NCT04497116|528767360|FG015|Overall Study|Clinical Progression Related|0|||
146616435|NCT04497116|528767361|FG016|Overall Study|Clinical Progression Related|0|||
146616436|NCT04497116|528767362|FG017|Overall Study|Clinical Progression Related|0|||
146616437|NCT04497116|528767363|FG018|Overall Study|Clinical Progression Related|0|||
146616438|NCT04497116|528767364|FG019|Overall Study|Clinical Progression Related|0|||
146616439|NCT04497116|528767365|FG020|Overall Study|Clinical Progression Related|0|||
146616440|NCT04497116|528767366|FG021|Overall Study|Clinical Progression Related|0|||
146616441|NCT04497116|528767367|FG022|Overall Study|Clinical Progression Related|0|||
146616442|NCT04497116|528767368|FG023|Overall Study|Clinical Progression Related|0|||
146616443|NCT04497116|528767369|FG024|Overall Study|Clinical Progression Related|0|||
146616444|NCT01358825|528767373|FG000|Overall Study|Blood sample not drawn|0|||
146616445|NCT01358825|528767374|FG001|Overall Study|Blood sample not drawn|1|||
146616446|NCT04524858|528767377|FG000|Overall Study|Adverse Event|1|||
146616447|NCT00113841|528767381|FG000|Overall Study|Disease progression|0|||
146616448|NCT00113841|528767382|FG001|Overall Study|Disease progression|2|||
146616449|NCT00113841|528767381|FG000|Overall Study|Non-compliant|1|||
146616450|NCT00113841|528767382|FG001|Overall Study|Non-compliant|0|||
146616451|NCT02366195|528767383|FG000|Overall Study|Protocol-specified criteria|3|||
146616452|NCT02366195|528767383|FG000|Overall Study|Withdrawal by Subject|9|||
146773598|NCT03950622|529341113|FG000|Overall Study|Lost to Follow-up|5|||
146773599|NCT03950622|529341114|FG001|Overall Study|Lost to Follow-up|5|||
146773600|NCT03950622|529341113|FG000|Overall Study|Death|1|||
146773601|NCT03950622|529341114|FG001|Overall Study|Death|1|||
146773602|NCT01839331|529341115|FG000|Overall Study|Early Termination|3|||
146773603|NCT01839331|529341116|FG001|Overall Study|Early Termination|0|||
146773604|NCT01839331|529341117|FG002|Overall Study|Early Termination|1|||
146773605|NCT01839331|529341118|FG003|Overall Study|Early Termination|2|||
146773606|NCT01839331|529341115|FG000|Overall Study|Protocol Violation|1|||
146773607|NCT01839331|529341116|FG001|Overall Study|Protocol Violation|6|||
146773608|NCT01839331|529341117|FG002|Overall Study|Protocol Violation|4|||
146773609|NCT01839331|529341118|FG003|Overall Study|Protocol Violation|3|||
146978694|NCT03770000|530085464|FG000|Overall Study|Premature discontinuation due to PD|0|||
146616453|NCT02366195|528767383|FG000|Overall Study|Lost to Follow-up|1|||
146616454|NCT02366195|528767383|FG000|Overall Study|Death|41|||
146616455|NCT01788566|528767384|FG000|Overall Study|Death|4|||
146773610|NCT03752151|529341119|FG000|Overall Study|Withdrawal by Subject|1|||
146616456|NCT01788566|528767384|FG000|Overall Study|Adverse Event|1|||
146616457|NCT01788566|528767384|FG000|Overall Study|Clinical Progressive Disease|3|||
146616458|NCT00580723|528767385|FG000|Overall Study|Did not want to participate in extension|3|||
146616459|NCT00580723|528767385|FG000|Overall Study|Lost to Follow-up|5|||
146616460|NCT00556998|528767386|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
146616461|NCT00556998|528767386|FG000|Voriconazole Intravenous (IV)|Other|4|||
146616462|NCT00556998|528767386|FG000|Voriconazole Oral|Adverse Event|1|||
146616463|NCT00556998|528767386|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
146616464|NCT03030417|528767389|FG000|Dose Expansion|Disease progression before treatment|0|||
146616465|NCT03030417|528767390|FG001|Dose Expansion|Disease progression before treatment|0|||
146616466|NCT03030417|528767391|FG002|Dose Expansion|Disease progression before treatment|0|||
146616467|NCT03030417|528767392|FG003|Dose Expansion|Disease progression before treatment|0|||
146616468|NCT03030417|528767393|FG004|Dose Expansion|Disease progression before treatment|0|||
146616469|NCT03030417|528767394|FG005|Dose Expansion|Disease progression before treatment|0|||
146616470|NCT03030417|528767395|FG006|Dose Expansion|Disease progression before treatment|0|||
146616471|NCT03030417|528767396|FG007|Dose Expansion|Disease progression before treatment|0|||
146616472|NCT03030417|528767397|FG008|Dose Expansion|Disease progression before treatment|0|||
146616473|NCT03030417|528767398|FG009|Dose Expansion|Disease progression before treatment|0|||
146616474|NCT03030417|528767399|FG010|Dose Expansion|Disease progression before treatment|0|||
146616475|NCT03030417|528767400|FG011|Dose Expansion|Disease progression before treatment|0|||
146616476|NCT03030417|528767401|FG012|Dose Expansion|Disease progression before treatment|1|||
146616477|NCT01539759|528767402|FG000|Overall Study|Lost to Follow-up|6|||
146616478|NCT01539759|528767403|FG001|Overall Study|Lost to Follow-up|8|||
146616479|NCT01076959|528767404|FG000|Overall Study|Adverse Event|767|||
146616480|NCT01076959|528767404|FG000|Overall Study|Lack of Efficacy|849|||
146616481|NCT01076959|528767404|FG000|Overall Study|Non-compliance|274|||
146616482|NCT01076959|528767404|FG000|Overall Study|Lost to Follow-up|241|||
146616483|NCT01076959|528767404|FG000|Overall Study|Other|119|||
146616484|NCT01425801|528767405|FG000|Period 1|Withdrawal by Subject|0|||
146616485|NCT01425801|528767406|FG001|Period 1|Withdrawal by Subject|0|||
146616486|NCT01425801|528767407|FG002|Period 1|Withdrawal by Subject|0|||
146616487|NCT01425801|528767408|FG003|Period 1|Withdrawal by Subject|0|||
146616488|NCT01425801|528767409|FG004|Period 1|Withdrawal by Subject|1|||
146616489|NCT01425801|528767410|FG005|Period 1|Withdrawal by Subject|0|||
146616490|NCT01425801|528767405|FG000|Period 2|Withdrawal by Subject|0|||
146616491|NCT01425801|528767406|FG001|Period 2|Withdrawal by Subject|0|||
146616492|NCT01425801|528767407|FG002|Period 2|Withdrawal by Subject|0|||
146616493|NCT01425801|528767408|FG003|Period 2|Withdrawal by Subject|0|||
146616494|NCT01425801|528767409|FG004|Period 2|Withdrawal by Subject|1|||
146616495|NCT01425801|528767410|FG005|Period 2|Withdrawal by Subject|0|||
146616496|NCT01425801|528767405|FG000|Period 3|Stability criteria not fullfilled|0|||
146616497|NCT01425801|528767406|FG001|Period 3|Stability criteria not fullfilled|0|||
146616498|NCT01425801|528767407|FG002|Period 3|Stability criteria not fullfilled|1|||
146616499|NCT01425801|528767408|FG003|Period 3|Stability criteria not fullfilled|0|||
146616500|NCT01425801|528767409|FG004|Period 3|Stability criteria not fullfilled|0|||
146616501|NCT01425801|528767410|FG005|Period 3|Stability criteria not fullfilled|0|||
146616502|NCT01425801|528767405|FG000|Period 4|Not able to maintain visit schedule|0|||
146616503|NCT01425801|528767406|FG001|Period 4|Not able to maintain visit schedule|0|||
146616504|NCT01425801|528767407|FG002|Period 4|Not able to maintain visit schedule|1|||
146616505|NCT01425801|528767408|FG003|Period 4|Not able to maintain visit schedule|0|||
146616506|NCT01425801|528767409|FG004|Period 4|Not able to maintain visit schedule|0|||
146616507|NCT01425801|528767410|FG005|Period 4|Not able to maintain visit schedule|0|||
146616508|NCT02175017|528767411|FG000|Overall Study|Did not receive the investigational product|1|||
146616509|NCT02175017|528767412|FG001|Overall Study|Did not receive the investigational product|2|||
146616510|NCT02175017|528767411|FG000|Overall Study|Withdrawal by Subject|6|||
146616511|NCT02175017|528767412|FG001|Overall Study|Withdrawal by Subject|3|||
146616512|NCT02175017|528767411|FG000|Overall Study|Met an exclusion criteria|0|||
146616513|NCT02175017|528767412|FG001|Overall Study|Met an exclusion criteria|1|||
146616514|NCT02175017|528767411|FG000|Overall Study|Adverse Event|3|||
146616515|NCT02175017|528767412|FG001|Overall Study|Adverse Event|10|||
146616516|NCT02175017|528767411|FG000|Overall Study|Disease progression|20|||
146616517|NCT02175017|528767412|FG001|Overall Study|Disease progression|27|||
146616518|NCT02175017|528767411|FG000|Overall Study|Other than above reasons|3|||
146616519|NCT02175017|528767412|FG001|Overall Study|Other than above reasons|0|||
146616520|NCT02491983|528767413|FG000|Overall Study|Physician Decision|1|||
146658872|NCT01702571|528928825|FG001|Overall Study|Withdrawal by Subject|29|||
146616521|NCT02491983|528767414|FG001|Overall Study|Physician Decision|0|||
146616522|NCT02491983|528767413|FG000|Overall Study|Not meet selection criteria|1|||
146616523|NCT02491983|528767414|FG001|Overall Study|Not meet selection criteria|0|||
146616524|NCT02491983|528767413|FG000|Overall Study|Withdrawal by Subject|0|||
146658873|NCT00910988|528928826|FG000|Overall Study|Lost to Follow-up|2|||
146616525|NCT02491983|528767414|FG001|Overall Study|Withdrawal by Subject|1|||
146616526|NCT02330055|528767415|FG000|Overall Study|technical issues|2|||
146616527|NCT02330055|528767416|FG001|Overall Study|technical issues|0|||
146616528|NCT02330055|528767415|FG000|Overall Study|participant forgot to wear device|5|||
146616529|NCT02330055|528767416|FG001|Overall Study|participant forgot to wear device|5|||
146616530|NCT02330055|528767415|FG000|Overall Study|data for less than 60 minutes|3|||
146616531|NCT02330055|528767416|FG001|Overall Study|data for less than 60 minutes|3|||
146616532|NCT02330055|528767415|FG000|Overall Study|participant did not sleep|0|||
146616533|NCT02330055|528767416|FG001|Overall Study|participant did not sleep|1|||
146616534|NCT02959437|528767417|FG000|Overall Study|Death|33|||
146616535|NCT02959437|528767418|FG001|Overall Study|Death|3|||
146616536|NCT02959437|528767419|FG002|Overall Study|Death|0|||
146616537|NCT02959437|528767420|FG003|Overall Study|Death|0|||
146616538|NCT02959437|528767417|FG000|Overall Study|Lost to Follow-up|3|||
146616539|NCT02959437|528767418|FG001|Overall Study|Lost to Follow-up|1|||
146616540|NCT02959437|528767419|FG002|Overall Study|Lost to Follow-up|0|||
146616541|NCT02959437|528767420|FG003|Overall Study|Lost to Follow-up|0|||
146616542|NCT02959437|528767417|FG000|Overall Study|Withdrawal by Subject|11|||
146616543|NCT02959437|528767418|FG001|Overall Study|Withdrawal by Subject|3|||
146616544|NCT02959437|528767419|FG002|Overall Study|Withdrawal by Subject|0|||
146616545|NCT02959437|528767420|FG003|Overall Study|Withdrawal by Subject|0|||
146616546|NCT02959437|528767417|FG000|Overall Study|Progressive Disease|9|||
146616547|NCT02959437|528767418|FG001|Overall Study|Progressive Disease|1|||
146616548|NCT02959437|528767419|FG002|Overall Study|Progressive Disease|0|||
146616549|NCT02959437|528767420|FG003|Overall Study|Progressive Disease|0|||
146616550|NCT02959437|528767417|FG000|Overall Study|Study Terminated by Sponsor|4|||
146616551|NCT02959437|528767418|FG001|Overall Study|Study Terminated by Sponsor|0|||
146616552|NCT02959437|528767419|FG002|Overall Study|Study Terminated by Sponsor|0|||
146616553|NCT02959437|528767420|FG003|Overall Study|Study Terminated by Sponsor|0|||
146616554|NCT02959437|528767417|FG000|Overall Study|Other Unspecified|2|||
146616555|NCT02959437|528767418|FG001|Overall Study|Other Unspecified|0|||
146616556|NCT02959437|528767419|FG002|Overall Study|Other Unspecified|0|||
146616557|NCT02959437|528767420|FG003|Overall Study|Other Unspecified|0|||
146616558|NCT03622814|528767423|FG000|Overall Study|Lost to Follow-up|8|||
146616559|NCT03622814|528767424|FG001|Overall Study|Lost to Follow-up|14|||
146616560|NCT03269994|528767425|FG000|Overall Study|Withdrawal by Subject|4|||
146616561|NCT03269994|528767426|FG001|Overall Study|Withdrawal by Subject|5|||
146616562|NCT03269994|528767425|FG000|Overall Study|Unresectable at surgery|39|||
146616563|NCT03269994|528767426|FG001|Overall Study|Unresectable at surgery|58|||
146616564|NCT03269994|528767425|FG000|Overall Study|Patient canceled surgery|5|||
146978695|NCT03770000|530085465|FG001|Overall Study|Premature discontinuation due to PD|0|||
146616565|NCT03269994|528767426|FG001|Overall Study|Patient canceled surgery|14|||
146616566|NCT03269994|528767425|FG000|Overall Study|Preoperative progression|14|||
146616567|NCT03269994|528767426|FG001|Overall Study|Preoperative progression|9|||
146616568|NCT03269994|528767425|FG000|Overall Study|Preoperative infection|10|||
146616569|NCT03269994|528767426|FG001|Overall Study|Preoperative infection|4|||
146616570|NCT03269994|528767425|FG000|Overall Study|Kidney insufficiency|1|||
146616571|NCT03269994|528767426|FG001|Overall Study|Kidney insufficiency|0|||
146616572|NCT03269994|528767425|FG000|Overall Study|Drug allergy|0|||
146616573|NCT03269994|528767426|FG001|Overall Study|Drug allergy|2|||
146616574|NCT03269994|528767425|FG000|Overall Study|Operation changed to different resection|9|||
146616575|NCT03269994|528767426|FG001|Overall Study|Operation changed to different resection|0|||
146616576|NCT03269994|528767425|FG000|Overall Study|Preoperative steroid|0|||
146616577|NCT03269994|528767426|FG001|Overall Study|Preoperative steroid|3|||
146616578|NCT03269994|528767425|FG000|Overall Study|Accrual Closed|2|||
146616579|NCT03269994|528767426|FG001|Overall Study|Accrual Closed|0|||
146616580|NCT03269994|528767425|FG000|Overall Study|Operation changed to different resection|0|||
146616581|NCT03269994|528767426|FG001|Overall Study|Operation changed to different resection|10|||
146616582|NCT04417361|528767427|FG000|Overall Study|Withdrawal by Subject|1|||
146616583|NCT04417361|528767428|FG001|Overall Study|Withdrawal by Subject|0|||
146616584|NCT04417361|528767427|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
146616585|NCT04417361|528767428|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
146616586|NCT04707469|528767429|FG000|Overall Study|Site closure|0|||
146616587|NCT04707469|528767430|FG001|Overall Study|Site closure|2|||
146616588|NCT04707469|528767431|FG002|Overall Study|Site closure|0|||
146616589|NCT04707469|528767429|FG000|Overall Study|Physician Decision|2|||
146616590|NCT04707469|528767430|FG001|Overall Study|Physician Decision|2|||
146616591|NCT04707469|528767431|FG002|Overall Study|Physician Decision|2|||
146616592|NCT04707469|528767429|FG000|Overall Study|Death|1|||
146616593|NCT04707469|528767430|FG001|Overall Study|Death|6|||
146616594|NCT04707469|528767431|FG002|Overall Study|Death|2|||
146616595|NCT04707469|528767429|FG000|Overall Study|Lost to Follow-up|9|||
146616596|NCT04707469|528767430|FG001|Overall Study|Lost to Follow-up|19|||
146616597|NCT04707469|528767431|FG002|Overall Study|Lost to Follow-up|14|||
146616598|NCT04707469|528767429|FG000|Overall Study|Withdrawal by Subject|17|||
146616599|NCT04707469|528767430|FG001|Overall Study|Withdrawal by Subject|16|||
146616600|NCT04707469|528767431|FG002|Overall Study|Withdrawal by Subject|12|||
146616601|NCT04661150|528767439|FG000|Overall Study|Ongoing in study|19|||
146616602|NCT04661150|528767440|FG001|Overall Study|Ongoing in study|20|||
146658874|NCT00910988|528928827|FG001|Overall Study|Lost to Follow-up|4|||
146658875|NCT00910988|528928828|FG002|Overall Study|Lost to Follow-up|3|||
146658876|NCT00910988|528928829|FG003|Overall Study|Lost to Follow-up|0|||
146658877|NCT01977937|528928832|FG000|Overall Study|Withdrawal by Subject|2|||
146658878|NCT01977937|528928833|FG001|Overall Study|Withdrawal by Subject|1|||
146658879|NCT01977937|528928832|FG000|Overall Study|Adverse Event|1|||
146658880|NCT01977937|528928833|FG001|Overall Study|Adverse Event|0|||
146658881|NCT01977937|528928832|FG000|Overall Study|Physician Decision|0|||
146658882|NCT01977937|528928833|FG001|Overall Study|Physician Decision|1|||
146658883|NCT03004443|528928837|FG000|Overall Study|Pregnancy|0|||
146658884|NCT03004443|528928838|FG001|Overall Study|Pregnancy|1|||
146658885|NCT00828854|528928839|FG000|Overall Study|Disease Progression|17|||
146658886|NCT00828854|528928839|FG000|Overall Study|Adverse Event|9|||
146658887|NCT00828854|528928839|FG000|Overall Study|Reason not Specified|1|||
146658888|NCT00915356|528928840|FG000|Overall Study|Withdrawal by Subject|1|||
146658889|NCT00915356|528928841|FG001|Overall Study|Withdrawal by Subject|0|||
146658890|NCT00915356|528928842|FG002|Overall Study|Withdrawal by Subject|0|||
146658891|NCT00915356|528928843|FG003|Overall Study|Withdrawal by Subject|0|||
146658892|NCT00915356|528928844|FG004|Overall Study|Withdrawal by Subject|0|||
146658893|NCT03187756|528928852|FG000|Overall Study|Termination of study|4|||
146658894|NCT01931202|528928856|FG000|Overall Study|Withdrawal by Subject|0|||
146658895|NCT01931202|528928857|FG001|Overall Study|Withdrawal by Subject|0|||
146658896|NCT01931202|528928858|FG002|Overall Study|Withdrawal by Subject|2|||
146658897|NCT01931202|528928856|FG000|Overall Study|Lost to Follow-up|0|||
146658898|NCT01931202|528928857|FG001|Overall Study|Lost to Follow-up|5|||
146658899|NCT01931202|528928858|FG002|Overall Study|Lost to Follow-up|2|||
146658900|NCT01876810|528928861|FG000|Overall Study|Physician Decision|0|||
146658901|NCT01876810|528928862|FG001|Overall Study|Physician Decision|1|||
146616603|NCT04661150|528767439|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
146616604|NCT04661150|528767440|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
146616605|NCT04661150|528767439|FG000|Overall Study|Death|2|||
146616606|NCT04661150|528767440|FG001|Overall Study|Death|0|||
146616607|NCT04965688|528767441|FG000|Overall Study|Withdrawal by Subject|2|||
146616608|NCT03868943|528767442|FG000|Overall Study|Adverse Event|1|||
146616609|NCT02777827|528767443|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
146616610|NCT02777827|528767444|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
146616611|NCT02777827|528767445|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
146616612|NCT02777827|528767446|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
146616613|NCT02777827|528767447|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
146616614|NCT02777827|528767448|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
146616615|NCT04551066|528767449|FG000|Overall Study|Death|5|||
146616616|NCT04551066|528767450|FG001|Overall Study|Death|3|||
146616617|NCT04551066|528767449|FG000|Overall Study|Lost to Follow-up|1|||
146616618|NCT04551066|528767450|FG001|Overall Study|Lost to Follow-up|0|||
146616619|NCT04551066|528767449|FG000|Overall Study|Sponsor Decision|104|||
146616620|NCT04551066|528767450|FG001|Overall Study|Sponsor Decision|117|||
146616621|NCT04551066|528767449|FG000|Overall Study|Withdrawal by Subject|8|||
146616622|NCT04551066|528767450|FG001|Overall Study|Withdrawal by Subject|2|||
146616623|NCT04551066|528767449|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
146616624|NCT04551066|528767450|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
146616625|NCT04551066|528767449|FG000|Overall Study|Adverse Event|2|||
146616626|NCT04551066|528767450|FG001|Overall Study|Adverse Event|0|||
146616627|NCT04551066|528767449|FG000|Overall Study|Physician Decision|2|||
146616628|NCT04551066|528767450|FG001|Overall Study|Physician Decision|0|||
146616629|NCT04551066|528767449|FG000|Overall Study|Protocol Violation|1|||
146616630|NCT04551066|528767450|FG001|Overall Study|Protocol Violation|0|||
146616631|NCT04551066|528767449|FG000|Overall Study|Lack of Efficacy|0|||
146616632|NCT04551066|528767450|FG001|Overall Study|Lack of Efficacy|1|||
146616633|NCT04551066|528767449|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
146616634|NCT04551066|528767450|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
146616635|NCT00369577|528767451|FG000|Overall Study|Withdrawal by Subject|0|||
146616636|NCT00369577|528767452|FG001|Overall Study|Withdrawal by Subject|0|||
146658902|NCT05140382|528928863|FG000|Overall Study|Death|3|||
146658903|NCT05140382|528928864|FG001|Overall Study|Death|0|||
146658904|NCT05140382|528928865|FG002|Overall Study|Death|0|||
146658905|NCT05140382|528928863|FG000|Overall Study|Investigator decision|1|||
146658906|NCT05140382|528928864|FG001|Overall Study|Investigator decision|0|||
146658907|NCT05140382|528928865|FG002|Overall Study|Investigator decision|0|||
146658908|NCT05140382|528928863|FG000|Overall Study|Other|4|||
146658909|NCT05140382|528928864|FG001|Overall Study|Other|0|||
146658910|NCT05140382|528928865|FG002|Overall Study|Other|1|||
146658911|NCT05140382|528928863|FG000|Overall Study|Progressive disease|20|||
146658912|NCT05140382|528928864|FG001|Overall Study|Progressive disease|1|||
146658913|NCT05140382|528928865|FG002|Overall Study|Progressive disease|12|||
146616637|NCT00369577|528767453|FG002|Overall Study|Withdrawal by Subject|1|||
146616638|NCT03915470|528767454|FG000|Overall Study|Death|3|||
146658914|NCT05140382|528928863|FG000|Overall Study|Subjective disease progression|2|||
146773611|NCT03752151|529341119|FG000|Overall Study|Protocol Violation|1|||
146773612|NCT04056624|529341120|FG000|Overall Study|Withdrawal by Subject|0|||
146773613|NCT04056624|529341121|FG001|Overall Study|Withdrawal by Subject|0|||
146773614|NCT04056624|529341122|FG002|Overall Study|Withdrawal by Subject|1|||
146773615|NCT04056624|529341120|FG000|Overall Study|Protocol Violation|1|||
146773616|NCT04056624|529341121|FG001|Overall Study|Protocol Violation|2|||
146925026|NCT00280150|529885910|FG001|Overall Study|Declining Performance Status|0|||
146925027|NCT00280150|529885911|FG002|Overall Study|Declining Performance Status|0|||
146925028|NCT00280150|529885912|FG003|Overall Study|Declining Performance Status|1|||
146925029|NCT04031404|529885913|FG000|Baseline|Lost to Follow-up|0|||
146925030|NCT04031404|529885914|FG001|Baseline|Lost to Follow-up|1|||
146616639|NCT03915470|528767455|FG001|Overall Study|Death|1|||
146616640|NCT03915470|528767454|FG000|Overall Study|Adverse Event|1|||
146616641|NCT03915470|528767455|FG001|Overall Study|Adverse Event|0|||
146616642|NCT03915470|528767454|FG000|Overall Study|Physician Decision|1|||
146616643|NCT03915470|528767455|FG001|Overall Study|Physician Decision|0|||
146616644|NCT03915470|528767454|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
146616645|NCT03915470|528767455|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
146616646|NCT00549445|528767461|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
146616647|NCT00549445|528767462|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
146616648|NCT01900652|528767463|FG000|Overall Study|Progressive Disease|1|||
146616649|NCT01900652|528767464|FG001|Overall Study|Progressive Disease|0|||
146616650|NCT01900652|528767463|FG000|Overall Study|Consent withdrawn by subject|1|||
146616651|NCT01900652|528767464|FG001|Overall Study|Consent withdrawn by subject|1|||
146616652|NCT01900652|528767463|FG000|Overall Study|Death|3|||
146616653|NCT01900652|528767464|FG001|Overall Study|Death|0|||
146616654|NCT01900652|528767463|FG000|Overall Study|Adverse Event|2|||
146616655|NCT01900652|528767464|FG001|Overall Study|Adverse Event|1|||
146616656|NCT01900652|528767463|FG000|Overall Study|Physician Decision|1|||
146616657|NCT01900652|528767464|FG001|Overall Study|Physician Decision|1|||
146616658|NCT03566082|528767465|FG000|Overall Study|Death|7|||
146616659|NCT03566082|528767465|FG000|Overall Study|Failures (revision required)|2|||
146616660|NCT03566082|528767465|FG000|Overall Study|Lost to Follow-up|8|||
146616661|NCT01389882|528769013|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
146616662|NCT01389882|528769014|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
146616663|NCT01389882|528769013|FG000|Overall Study|Withdrawal by Subject|0|||
146616664|NCT01389882|528769014|FG001|Overall Study|Withdrawal by Subject|1|||
146616665|NCT01045967|528769015|FG000|Second Intervention|Protocol Violation|0|||
146616666|NCT01045967|528769016|FG001|Second Intervention|Protocol Violation|1|||
146616667|NCT03057496|528769017|FG000|Overall Study|Withdrawal by Subject|8|||
146616668|NCT03057496|528769017|FG000|Overall Study|Lost to Follow-up|5|||
146616669|NCT03057496|528769017|FG000|Overall Study|Did not use device during home trial|3|||
146616670|NCT03057496|528769017|FG000|Overall Study|Device failure|2|||
146616671|NCT00280917|528769021|FG000|Overall Study|Adverse Event|1|||
146616672|NCT00280917|528769022|FG001|Overall Study|Adverse Event|1|||
146616673|NCT00280917|528769023|FG002|Overall Study|Adverse Event|4|||
146616674|NCT00280917|528769024|FG003|Overall Study|Adverse Event|1|||
146616675|NCT00280917|528769021|FG000|Overall Study|Change Therapy|1|||
146616676|NCT00280917|528769022|FG001|Overall Study|Change Therapy|2|||
146616677|NCT00280917|528769023|FG002|Overall Study|Change Therapy|0|||
146616678|NCT00280917|528769024|FG003|Overall Study|Change Therapy|0|||
146616679|NCT00280917|528769021|FG000|Overall Study|Withdrawal by Subject|0|||
146616680|NCT00280917|528769022|FG001|Overall Study|Withdrawal by Subject|2|||
146616681|NCT00280917|528769023|FG002|Overall Study|Withdrawal by Subject|0|||
146616682|NCT00280917|528769024|FG003|Overall Study|Withdrawal by Subject|1|||
146616683|NCT00280917|528769021|FG000|Overall Study|Noncompliance|0|||
146616684|NCT00280917|528769022|FG001|Overall Study|Noncompliance|1|||
146616685|NCT00280917|528769023|FG002|Overall Study|Noncompliance|2|||
146616686|NCT00280917|528769024|FG003|Overall Study|Noncompliance|0|||
146616687|NCT03529110|528769025|FG000|Overall Study|Progressive Disease|66|||
146616688|NCT03529110|528769026|FG001|Overall Study|Progressive Disease|158|||
146616689|NCT03529110|528769025|FG000|Overall Study|Clinical Progression|4|||
146616690|NCT03529110|528769026|FG001|Overall Study|Clinical Progression|12|||
146773617|NCT04056624|529341122|FG002|Overall Study|Protocol Violation|0|||
146925031|NCT04031404|529885913|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
146616691|NCT03529110|528769025|FG000|Overall Study|Adverse Event|35|||
146616692|NCT03529110|528769026|FG001|Overall Study|Adverse Event|17|||
146616693|NCT03529110|528769025|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
146616694|NCT03529110|528769026|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
146616695|NCT03529110|528769025|FG000|Overall Study|Lack of Efficacy|3|||
146616696|NCT03529110|528769026|FG001|Overall Study|Lack of Efficacy|3|||
146616697|NCT03529110|528769025|FG000|Overall Study|Physician Decision|2|||
146616698|NCT03529110|528769026|FG001|Overall Study|Physician Decision|8|||
146616699|NCT03529110|528769025|FG000|Overall Study|Miscellaneous|2|||
146616700|NCT03529110|528769026|FG001|Overall Study|Miscellaneous|5|||
146773618|NCT00350792|529341127|FG000|Overall Study|Adverse Event|11|||
146658915|NCT05140382|528928864|FG001|Overall Study|Subjective disease progression|1|||
146658916|NCT05140382|528928865|FG002|Overall Study|Subjective disease progression|0|||
146658917|NCT05140382|528928863|FG000|Overall Study|Unknown at data cut-off|0|||
146658918|NCT05140382|528928864|FG001|Overall Study|Unknown at data cut-off|0|||
146658919|NCT05140382|528928865|FG002|Overall Study|Unknown at data cut-off|1|||
146658920|NCT05140382|528928863|FG000|Overall Study|Withdrawal by Subject|1|||
146658921|NCT05140382|528928864|FG001|Overall Study|Withdrawal by Subject|0|||
146658922|NCT05140382|528928865|FG002|Overall Study|Withdrawal by Subject|4|||
146658923|NCT05140382|528928863|FG000|Overall Study|Withdrawal of consent|0|||
146658924|NCT05140382|528928864|FG001|Overall Study|Withdrawal of consent|0|||
146658925|NCT05140382|528928865|FG002|Overall Study|Withdrawal of consent|1|||
146925032|NCT04031404|529885914|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
146925033|NCT04031404|529885913|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
146925034|NCT04031404|529885914|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
146616701|NCT01584232|528769027|FG000|Overall Study|Adverse Event|3|||
146616702|NCT01584232|528769028|FG001|Overall Study|Adverse Event|1|||
146616703|NCT01584232|528769027|FG000|Overall Study|Withdrawal by Subject|2|||
146616704|NCT01584232|528769028|FG001|Overall Study|Withdrawal by Subject|1|||
146616705|NCT01584232|528769027|FG000|Overall Study|Physician Decision|2|||
146616706|NCT01584232|528769028|FG001|Overall Study|Physician Decision|1|||
146616707|NCT01584232|528769027|FG000|Overall Study|Lost to Follow-up|1|||
146616708|NCT01584232|528769028|FG001|Overall Study|Lost to Follow-up|0|||
146616709|NCT02723773|528769030|FG000|Overall Study|Adverse Event|934|||
146616710|NCT02723773|528769031|FG001|Overall Study|Adverse Event|3|||
146616711|NCT02723773|528769032|FG002|Overall Study|Adverse Event|1|||
146616712|NCT02723773|528769033|FG003|Overall Study|Adverse Event|9|||
146616713|NCT02723773|528769030|FG000|Overall Study|Protocol Violation|1|||
146616714|NCT02723773|528769031|FG001|Overall Study|Protocol Violation|0|||
146616715|NCT02723773|528769032|FG002|Overall Study|Protocol Violation|0|||
146616716|NCT02723773|528769033|FG003|Overall Study|Protocol Violation|0|||
146616717|NCT02723773|528769030|FG000|Overall Study|Withdrawal by Subject|360|||
146616718|NCT02723773|528769031|FG001|Overall Study|Withdrawal by Subject|5|||
146616719|NCT02723773|528769032|FG002|Overall Study|Withdrawal by Subject|6|||
146616720|NCT02723773|528769033|FG003|Overall Study|Withdrawal by Subject|10|||
146616721|NCT02723773|528769030|FG000|Overall Study|Migrated/moved from study area|37|||
146616722|NCT02723773|528769031|FG001|Overall Study|Migrated/moved from study area|0|||
146616723|NCT02723773|528769032|FG002|Overall Study|Migrated/moved from study area|0|||
146616724|NCT02723773|528769033|FG003|Overall Study|Migrated/moved from study area|1|||
146616725|NCT02723773|528769030|FG000|Overall Study|Lost to Follow-up|198|||
146616726|NCT02723773|528769031|FG001|Overall Study|Lost to Follow-up|0|||
146616727|NCT02723773|528769032|FG002|Overall Study|Lost to Follow-up|0|||
146616728|NCT02723773|528769033|FG003|Overall Study|Lost to Follow-up|0|||
146616729|NCT02723773|528769030|FG000|Overall Study|Other|189|||
146616730|NCT02723773|528769031|FG001|Overall Study|Other|1|||
146616731|NCT02723773|528769032|FG002|Overall Study|Other|2|||
146616732|NCT02723773|528769033|FG003|Overall Study|Other|2|||
146616733|NCT03654690|528769046|FG000|Overall Study|Withdrawal by Subject|1|||
146616734|NCT03654690|528769047|FG001|Overall Study|Withdrawal by Subject|0|||
146616735|NCT03654690|528769048|FG002|Overall Study|Withdrawal by Subject|0|||
146616736|NCT00742183|528769049|FG000|Overall Study|Adverse Event|2|||
146616737|NCT00742183|528769050|FG001|Overall Study|Adverse Event|2|||
146616738|NCT00742183|528769049|FG000|Overall Study|Death|1|||
146616739|NCT00742183|528769050|FG001|Overall Study|Death|0|||
146616740|NCT00742183|528769049|FG000|Overall Study|Physician Decision|0|||
146616741|NCT00742183|528769050|FG001|Overall Study|Physician Decision|2|||
146616742|NCT00742183|528769049|FG000|Overall Study|Lost to Follow-up|4|||
146616743|NCT00742183|528769050|FG001|Overall Study|Lost to Follow-up|4|||
146616744|NCT00742183|528769049|FG000|Overall Study|Required skin-graft|1|||
146658926|NCT01442038|528930462|FG000|Overall Study|Death|35|||
146616745|NCT00742183|528769050|FG001|Overall Study|Required skin-graft|1|||
146616746|NCT00742183|528769049|FG000|Overall Study|Withdrawal by Subject|1|||
146658927|NCT01442038|528930463|FG001|Overall Study|Death|29|||
146658928|NCT01442038|528930462|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
146658929|NCT01442038|528930463|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
146658930|NCT01442038|528930462|FG000|Overall Study|Participant Withdrew Consent|137|||
146658931|NCT01442038|528930463|FG001|Overall Study|Participant Withdrew Consent|102|||
146658932|NCT01442038|528930462|FG000|Overall Study|Lost to Follow-up|37|||
146658933|NCT01442038|528930463|FG001|Overall Study|Lost to Follow-up|51|||
146658934|NCT01442038|528930462|FG000|Overall Study|Adverse Event|26|||
146658935|NCT01442038|528930463|FG001|Overall Study|Adverse Event|15|||
146658936|NCT01442038|528930462|FG000|Overall Study|Protocol Deviation|9|||
146658937|NCT01442038|528930463|FG001|Overall Study|Protocol Deviation|20|||
146658938|NCT01442038|528930462|FG000|Overall Study|Investigator's Discretion|13|||
146658939|NCT01442038|528930463|FG001|Overall Study|Investigator's Discretion|16|||
146658940|NCT01442038|528930462|FG000|Overall Study|Study Terminated By Sponsor|2|||
146658941|NCT01442038|528930463|FG001|Overall Study|Study Terminated By Sponsor|3|||
146658942|NCT00089284|528930464|FG000|Overall Study|Adverse event before starting treatment|0|||
146616747|NCT00742183|528769050|FG001|Overall Study|Withdrawal by Subject|0|||
146616748|NCT00742183|528769049|FG000|Overall Study|Lack of Efficacy|0|||
146616749|NCT00742183|528769050|FG001|Overall Study|Lack of Efficacy|3|||
146616750|NCT03922581|528769054|FG000|Overall Study|Lost to Follow-up|20|||
146616751|NCT03922581|528769055|FG001|Overall Study|Lost to Follow-up|9|||
146616752|NCT03922581|528769054|FG000|Overall Study|Physician Decision|1|||
146616753|NCT03922581|528769055|FG001|Overall Study|Physician Decision|1|||
146616754|NCT03922581|528769054|FG000|Overall Study|Withdrawal by Subject|1|||
146616755|NCT03922581|528769055|FG001|Overall Study|Withdrawal by Subject|0|||
146616756|NCT00764699|528769056|FG000|Overall Study|PI left and study terminated|3|||
146616757|NCT01508312|528769057|FG000|Overall Study|Lost to Follow-up|1|||
146616758|NCT01508312|528769058|FG001|Overall Study|Lost to Follow-up|0|||
146616759|NCT01508312|528769059|FG002|Overall Study|Lost to Follow-up|0|||
146616760|NCT01508312|528769060|FG003|Overall Study|Lost to Follow-up|0|||
146616761|NCT01508312|528769057|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
146616762|NCT01508312|528769058|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
146616763|NCT01508312|528769059|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
146616764|NCT01508312|528769060|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
146616765|NCT01508312|528769057|FG000|Overall Study|Adverse Event|0|||
146616766|NCT01508312|528769058|FG001|Overall Study|Adverse Event|0|||
146616767|NCT01508312|528769059|FG002|Overall Study|Adverse Event|2|||
146616768|NCT01508312|528769060|FG003|Overall Study|Adverse Event|0|||
146616769|NCT01508312|528769057|FG000|Overall Study|Lack of Efficacy|0|||
146616770|NCT01508312|528769058|FG001|Overall Study|Lack of Efficacy|0|||
146616771|NCT01508312|528769059|FG002|Overall Study|Lack of Efficacy|1|||
146616772|NCT01508312|528769060|FG003|Overall Study|Lack of Efficacy|0|||
146616773|NCT01508312|528769057|FG000|Overall Study|Withdrawal by Subject|0|||
146616774|NCT01508312|528769058|FG001|Overall Study|Withdrawal by Subject|0|||
146616775|NCT01508312|528769059|FG002|Overall Study|Withdrawal by Subject|1|||
146616776|NCT01508312|528769060|FG003|Overall Study|Withdrawal by Subject|0|||
146616777|NCT02223715|528769061|FG000|Overall Study|Death|31|||
146616778|NCT02223715|528769061|FG000|Overall Study|Lost to Follow-up|73|||
146616779|NCT02107703|528769065|FG000|Overall Study|Withdrawal by Subject|46|||
146616780|NCT02107703|528769066|FG001|Overall Study|Withdrawal by Subject|21|||
146616781|NCT02107703|528769065|FG000|Overall Study|Lost to Follow-up|20|||
146616782|NCT02107703|528769066|FG001|Overall Study|Lost to Follow-up|9|||
146616783|NCT02107703|528769065|FG000|Overall Study|On study treatment/follow up|48|||
146616784|NCT02107703|528769066|FG001|Overall Study|On study treatment/follow up|5|||
146616785|NCT03906071|528769067|FG000|Overall Study|Death|180|||
146616786|NCT03906071|528769068|FG001|Overall Study|Death|185|||
146616787|NCT03906071|528769067|FG000|Overall Study|Lost to Follow-up|3|||
146616788|NCT03906071|528769068|FG001|Overall Study|Lost to Follow-up|3|||
146616789|NCT03906071|528769067|FG000|Overall Study|Withdrawal by Subject|15|||
146616790|NCT03906071|528769068|FG001|Overall Study|Withdrawal by Subject|27|||
146616791|NCT03906071|528769067|FG000|Overall Study|Other|2|||
146616792|NCT03906071|528769068|FG001|Overall Study|Other|1|||
146616793|NCT00466440|528769069|FG000|Overall Study|Adverse Event|0|||
146616794|NCT00466440|528769070|FG001|Overall Study|Adverse Event|3|||
146616795|NCT00466440|528769071|FG002|Overall Study|Adverse Event|1|||
146616796|NCT00466440|528769069|FG000|Overall Study|Death|1|||
146616797|NCT00466440|528769070|FG001|Overall Study|Death|1|||
146616798|NCT00466440|528769071|FG002|Overall Study|Death|0|||
146616799|NCT00466440|528769069|FG000|Overall Study|Progressive disease|13|||
146616800|NCT00466440|528769070|FG001|Overall Study|Progressive disease|5|||
146616801|NCT00466440|528769071|FG002|Overall Study|Progressive disease|4|||
146616802|NCT00466440|528769069|FG000|Overall Study|Lost to Follow-up|0|||
146616803|NCT00466440|528769070|FG001|Overall Study|Lost to Follow-up|1|||
146616804|NCT00466440|528769071|FG002|Overall Study|Lost to Follow-up|0|||
146616805|NCT00466440|528769069|FG000|Overall Study|Physician Decision|0|||
146616806|NCT00466440|528769070|FG001|Overall Study|Physician Decision|1|||
146616807|NCT00466440|528769071|FG002|Overall Study|Physician Decision|2|||
146616808|NCT00466440|528769069|FG000|Overall Study|Protocol entry criteria not met|0|||
146616809|NCT00466440|528769070|FG001|Overall Study|Protocol entry criteria not met|0|||
146616810|NCT00466440|528769071|FG002|Overall Study|Protocol entry criteria not met|4|||
146616811|NCT00466440|528769069|FG000|Overall Study|Withdrawal by Subject|0|||
146616812|NCT00466440|528769070|FG001|Overall Study|Withdrawal by Subject|1|||
146616813|NCT00466440|528769071|FG002|Overall Study|Withdrawal by Subject|0|||
146616814|NCT00466440|528769069|FG000|Overall Study|Sponsor decision|0|||
146616815|NCT00466440|528769070|FG001|Overall Study|Sponsor decision|0|||
146616816|NCT00466440|528769071|FG002|Overall Study|Sponsor decision|1|||
146616817|NCT03187132|528769072|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
146616818|NCT03187132|528769073|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
146616819|NCT03187132|528769072|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
146616820|NCT03187132|528769073|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
146616821|NCT03187132|528769072|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
146616822|NCT03187132|528769073|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
146658943|NCT00089284|528930465|FG001|Overall Study|Adverse event before starting treatment|0|||
146658944|NCT00089284|528930466|FG002|Overall Study|Adverse event before starting treatment|0|||
146658945|NCT00089284|528930467|FG003|Overall Study|Adverse event before starting treatment|0|||
146658946|NCT00089284|528930468|FG004|Overall Study|Adverse event before starting treatment|0|||
146658947|NCT00089284|528930469|FG005|Overall Study|Adverse event before starting treatment|0|||
146658948|NCT00089284|528930470|FG006|Overall Study|Adverse event before starting treatment|1|||
146658949|NCT01092507|528930472|FG000|Overall Study|Withdrawal by Subject|2|||
146658950|NCT01092507|528930473|FG001|Overall Study|Withdrawal by Subject|0|||
146658951|NCT01251744|528930474|FG000|Overall Study|Lost to Follow-up|1|||
146658952|NCT01251744|528930475|FG001|Overall Study|Lost to Follow-up|0|||
146658953|NCT00214500|528930476|FG000|Treatment Period|Adverse Event|1|||
146658954|NCT00214500|528930476|FG000|Extension Period|Withdrawal by Subject|2|||
146658955|NCT02147184|528930477|FG000|Overall Study|Lost to Follow-up|28|||
146658956|NCT02147184|528930478|FG001|Overall Study|Lost to Follow-up|15|||
146658957|NCT02147184|528930477|FG000|Overall Study|Study Burden|11|||
146658958|NCT02147184|528930478|FG001|Overall Study|Study Burden|7|||
146658959|NCT02147184|528930477|FG000|Overall Study|Pregnancy|6|||
146616823|NCT03187132|528769072|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
146616824|NCT03187132|528769073|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
146616825|NCT03187132|528769072|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
146616826|NCT03187132|528769073|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
146616827|NCT03187132|528769072|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
146616828|NCT03187132|528769073|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
146616829|NCT03187132|528769072|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
146616830|NCT03187132|528769073|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
146616831|NCT03187132|528769072|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
146616832|NCT03187132|528769073|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
146616833|NCT03187132|528769072|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
146616834|NCT03187132|528769073|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
146616835|NCT03187132|528769072|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
146616836|NCT03187132|528769073|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
146616837|NCT03187132|528769072|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
146616838|NCT03187132|528769073|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
146616839|NCT00965081|528769074|FG000|Overall Study|Adverse Event|14|||
146616840|NCT00965081|528769075|FG001|Overall Study|Adverse Event|9|||
146616841|NCT00965081|528769074|FG000|Overall Study|Lack of Efficacy|2|||
146616842|NCT00965081|528769075|FG001|Overall Study|Lack of Efficacy|5|||
146616843|NCT00965081|528769074|FG000|Overall Study|Lost to Follow-up|4|||
146616844|NCT00965081|528769075|FG001|Overall Study|Lost to Follow-up|5|||
146616845|NCT00965081|528769074|FG000|Overall Study|Physician Decision|2|||
146616846|NCT00965081|528769075|FG001|Overall Study|Physician Decision|0|||
146616847|NCT00965081|528769074|FG000|Overall Study|Protocol Violation|2|||
146616848|NCT00965081|528769075|FG001|Overall Study|Protocol Violation|5|||
146616849|NCT00965081|528769074|FG000|Overall Study|Sponsor Decision|1|||
146616850|NCT00965081|528769075|FG001|Overall Study|Sponsor Decision|0|||
146616851|NCT00965081|528769074|FG000|Overall Study|Withdrawal by Subject|4|||
146616852|NCT00965081|528769075|FG001|Overall Study|Withdrawal by Subject|7|||
146616853|NCT00965081|528769074|FG000|Overall Study|Switched to Rescue Arm|5|||
146616854|NCT00965081|528769075|FG001|Overall Study|Switched to Rescue Arm|12|||
146616855|NCT01367834|528769078|FG000|Overall Study|Withdrawal by Subject|2|||
146616856|NCT01367834|528769079|FG001|Overall Study|Withdrawal by Subject|2|||
146616857|NCT01367834|528769078|FG000|Overall Study|Study was ended.|0|||
146616858|NCT01367834|528769079|FG001|Overall Study|Study was ended.|1|||
146616859|NCT00988598|528769080|FG000|Overall Study|Withdrawal by Subject|2|||
146616860|NCT00988598|528769081|FG001|Overall Study|Withdrawal by Subject|0|||
146616861|NCT01141712|528769087|FG000|Overall Study|Disease progression|3|||
146616862|NCT04112810|528769098|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
146616863|NCT05963022|528769099|FG000|Overall Study|Adverse Event|0|||
146616864|NCT05963022|528769100|FG001|Overall Study|Adverse Event|1|||
146658960|NCT02147184|528930478|FG001|Overall Study|Pregnancy|0|||
146658961|NCT02147184|528930477|FG000|Overall Study|Moved out of state|3|||
146658962|NCT02147184|528930478|FG001|Overall Study|Moved out of state|3|||
146616865|NCT05963022|528769101|FG002|Overall Study|Adverse Event|1|||
146616866|NCT05963022|528769102|FG003|Overall Study|Adverse Event|0|||
146616867|NCT05963022|528769099|FG000|Overall Study|Protocol Violation|0|||
146616868|NCT05963022|528769100|FG001|Overall Study|Protocol Violation|3|||
146616869|NCT05963022|528769101|FG002|Overall Study|Protocol Violation|0|||
146616870|NCT05963022|528769102|FG003|Overall Study|Protocol Violation|0|||
146616871|NCT05963022|528769099|FG000|Overall Study|Pregnancy|0|||
146616872|NCT05963022|528769100|FG001|Overall Study|Pregnancy|1|||
146616873|NCT05963022|528769101|FG002|Overall Study|Pregnancy|1|||
146658963|NCT02147184|528930477|FG000|Overall Study|Physician Decision|0|||
146658964|NCT02147184|528930478|FG001|Overall Study|Physician Decision|2|||
146658965|NCT02147184|528930477|FG000|Overall Study|Other|1|||
146658966|NCT02147184|528930478|FG001|Overall Study|Other|0|||
146658967|NCT06400979|528930479|FG000|Overall Study|Lost to Follow-up|29|||
146658968|NCT06400979|528930479|FG000|Overall Study|Withdrawal by Subject|1|||
146658969|NCT00117286|528930482|FG000|Overall Study|Adverse Event|12|||
146658970|NCT00117286|528930483|FG001|Overall Study|Adverse Event|6|||
146658971|NCT00117286|528930482|FG000|Overall Study|Lost to Follow-up|2|||
146658972|NCT00117286|528930483|FG001|Overall Study|Lost to Follow-up|0|||
146658973|NCT00117286|528930482|FG000|Overall Study|Protocol Violation|3|||
146658974|NCT00117286|528930483|FG001|Overall Study|Protocol Violation|3|||
146658975|NCT00117286|528930482|FG000|Overall Study|Withdrawal by Subject|6|||
146658976|NCT00117286|528930483|FG001|Overall Study|Withdrawal by Subject|2|||
146658977|NCT00117286|528930482|FG000|Overall Study|Physician Decision|3|||
146658978|NCT00117286|528930483|FG001|Overall Study|Physician Decision|7|||
146658979|NCT00117286|528930482|FG000|Overall Study|Lack of Efficacy|2|||
146658980|NCT00117286|528930483|FG001|Overall Study|Lack of Efficacy|1|||
146658981|NCT00117286|528930482|FG000|Overall Study|Research site closing|0|||
146658982|NCT00117286|528930483|FG001|Overall Study|Research site closing|2|||
146658983|NCT01272661|528930484|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
146658984|NCT01272661|528930485|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
146658985|NCT01272661|528930486|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
146658986|NCT01367119|528930487|FG000|Overall Study|Adverse Event|1|||
146658987|NCT01367119|528930488|FG001|Overall Study|Adverse Event|0|||
146658988|NCT01367119|528930487|FG000|Overall Study|Withdrawal by Subject|1|||
146658989|NCT01367119|528930488|FG001|Overall Study|Withdrawal by Subject|1|||
146658990|NCT03953183|528930489|FG000|Overall Study|Physician Decision|0|||
146658991|NCT03953183|528930490|FG001|Overall Study|Physician Decision|1|||
146658992|NCT03953183|528930489|FG000|Overall Study|Withdrawal by Subject|0|||
146658993|NCT03953183|528930490|FG001|Overall Study|Withdrawal by Subject|1|||
146658994|NCT02314143|528930493|FG000|Overall Study|Adverse Event|0|||
146658995|NCT02314143|528930494|FG001|Overall Study|Adverse Event|6|||
146658996|NCT02314143|528930495|FG002|Overall Study|Adverse Event|4|||
146658997|NCT02314143|528930493|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
146658998|NCT02314143|528930494|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
146658999|NCT02314143|528930495|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
146659000|NCT02314143|528930493|FG000|Overall Study|Physician Decision|2|||
146659001|NCT02314143|528930494|FG001|Overall Study|Physician Decision|1|||
146659002|NCT02314143|528930495|FG002|Overall Study|Physician Decision|0|||
146659003|NCT02314143|528930493|FG000|Overall Study|Withdrawal by Subject|1|||
146659004|NCT02314143|528930494|FG001|Overall Study|Withdrawal by Subject|0|||
146659005|NCT02314143|528930495|FG002|Overall Study|Withdrawal by Subject|1|||
146659006|NCT00089674|528930497|FG000|Overall Study|Physician Decision|4|||
146659007|NCT00089674|528930498|FG001|Overall Study|Physician Decision|2|||
146659008|NCT00089674|528930497|FG000|Overall Study|Adverse Event|23|||
146659009|NCT00089674|528930498|FG001|Overall Study|Adverse Event|29|||
146659010|NCT00089674|528930497|FG000|Overall Study|Withdrawal by Subject|143|||
146659011|NCT00089674|528930498|FG001|Overall Study|Withdrawal by Subject|127|||
146659012|NCT00089674|528930497|FG000|Overall Study|Death|43|||
146659013|NCT00089674|528930498|FG001|Overall Study|Death|43|||
146659014|NCT00089674|528930497|FG000|Overall Study|Disease progression|21|||
146659015|NCT00089674|528930498|FG001|Overall Study|Disease progression|23|||
146659016|NCT00089674|528930497|FG000|Overall Study|Ineligibility determined|8|||
146659017|NCT00089674|528930498|FG001|Overall Study|Ineligibility determined|10|||
146659018|NCT00089674|528930497|FG000|Overall Study|Lost to Follow-up|21|||
146659019|NCT00089674|528930498|FG001|Overall Study|Lost to Follow-up|17|||
146659020|NCT00089674|528930497|FG000|Overall Study|Noncompliance|7|||
146659021|NCT00089674|528930498|FG001|Overall Study|Noncompliance|3|||
146659022|NCT00089674|528930497|FG000|Overall Study|Other|5|||
146659023|NCT00089674|528930498|FG001|Overall Study|Other|9|||
146659024|NCT00089674|528930497|FG000|Overall Study|Requirement for alternative therapy|14|||
146659025|NCT00089674|528930498|FG001|Overall Study|Requirement for alternative therapy|4|||
146659026|NCT03963401|528930499|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
146659027|NCT03963401|528930500|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
146659028|NCT03963401|528930501|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
146659029|NCT03963401|528930502|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
146659030|NCT03963401|528930503|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
146659031|NCT03963401|528930504|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
146659032|NCT03963401|528930499|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
146659033|NCT03963401|528930500|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
146659034|NCT03963401|528930501|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
146659035|NCT03963401|528930502|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
146659036|NCT03963401|528930503|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
146659037|NCT03963401|528930504|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
146659038|NCT03963401|528930499|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
146659039|NCT03963401|528930500|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
146659040|NCT03963401|528930501|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
146659041|NCT03963401|528930502|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
146659042|NCT03963401|528930503|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
146616874|NCT05963022|528769102|FG003|Overall Study|Pregnancy|1|||
146616875|NCT05963022|528769099|FG000|Overall Study|Withdrawal by Subject|0|||
146616876|NCT05963022|528769100|FG001|Overall Study|Withdrawal by Subject|0|||
146616877|NCT05963022|528769101|FG002|Overall Study|Withdrawal by Subject|2|||
146616878|NCT05963022|528769102|FG003|Overall Study|Withdrawal by Subject|1|||
146616879|NCT05963022|528769099|FG000|Overall Study|Lost to Follow-up|0|||
146616880|NCT05963022|528769100|FG001|Overall Study|Lost to Follow-up|0|||
146616881|NCT05963022|528769101|FG002|Overall Study|Lost to Follow-up|0|||
146616882|NCT05963022|528769102|FG003|Overall Study|Lost to Follow-up|1|||
146616883|NCT05963022|528769099|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
146616884|NCT05963022|528769100|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
146616885|NCT05963022|528769101|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
146616886|NCT05963022|528769102|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
146616887|NCT01012258|528769103|FG000|Overall Study|Death|14|||
146616888|NCT01012258|528769103|FG000|Overall Study|Lost to Follow-up|1|||
146616889|NCT01012258|528769103|FG000|Overall Study|Adverse Event|1|||
146616890|NCT01012258|528769103|FG000|Overall Study|Progressive Disease (PD)|18|||
146616891|NCT01012258|528769103|FG000|Overall Study|Symptomatic Deterioration|1|||
146616892|NCT01012258|528769103|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
146616893|NCT01012258|528769103|FG000|Overall Study|Another Tumor Discovered|1|||
146616894|NCT01012258|528769103|FG000|Overall Study|Ongoing|29|||
146616895|NCT00773513|528769109|FG000|Overall Study|Renal Transplant|254|||
146616896|NCT00773513|528769110|FG001|Overall Study|Renal Transplant|263|||
146616897|NCT00773513|528769109|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
146616898|NCT00773513|528769110|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
146616899|NCT00773513|528769109|FG000|Overall Study|Withdrew Consent|68|||
146616900|NCT00773513|528769110|FG001|Overall Study|Withdrew Consent|69|||
146616901|NCT00773513|528769109|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
146616902|NCT00773513|528769110|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
146616903|NCT00773513|528769109|FG000|Overall Study|Failure to Return|22|||
146616904|NCT00773513|528769110|FG001|Overall Study|Failure to Return|8|||
146616905|NCT00773513|528769109|FG000|Overall Study|Insufficient Therapeutic Response|1|||
146616906|NCT00773513|528769110|FG001|Overall Study|Insufficient Therapeutic Response|18|||
146616907|NCT00773513|528769109|FG000|Overall Study|Reason Not Specified|159|||
146616908|NCT00773513|528769110|FG001|Overall Study|Reason Not Specified|126|||
146616909|NCT00773513|528769109|FG000|Overall Study|Death|531|||
146616910|NCT00773513|528769110|FG001|Overall Study|Death|545|||
146616911|NCT01332994|528769115|FG000|Overall Study|Adverse Event|34|||
146616912|NCT01332994|528769115|FG000|Overall Study|Death|1|||
146616913|NCT01332994|528769115|FG000|Overall Study|Lack of Efficacy|1|||
146616914|NCT01332994|528769115|FG000|Overall Study|Lost to Follow-up|4|||
146616915|NCT01332994|528769115|FG000|Overall Study|Protocol Violation|6|||
146616916|NCT01332994|528769115|FG000|Overall Study|Withdrawal by Subject|15|||
146616917|NCT01332994|528769115|FG000|Overall Study|Administrative Problem|2|||
146616918|NCT01332994|528769115|FG000|Overall Study|Other|8|||
146616919|NCT04170543|528769116|FG000|Overall Study|Death|1|||
146616920|NCT04170543|528769117|FG001|Overall Study|Death|1|||
146616921|NCT04170543|528769118|FG002|Overall Study|Death|1|||
146616922|NCT04170543|528769119|FG003|Overall Study|Death|1|||
146616923|NCT04170543|528769120|FG004|Overall Study|Death|1|||
146616924|NCT04170543|528769116|FG000|Overall Study|Lost to Follow-up|3|||
146616925|NCT04170543|528769117|FG001|Overall Study|Lost to Follow-up|3|||
146616926|NCT04170543|528769118|FG002|Overall Study|Lost to Follow-up|0|||
146616927|NCT04170543|528769119|FG003|Overall Study|Lost to Follow-up|3|||
146616928|NCT04170543|528769120|FG004|Overall Study|Lost to Follow-up|1|||
146616929|NCT04170543|528769116|FG000|Overall Study|Withdrawal by Subject|13|||
146616930|NCT04170543|528769117|FG001|Overall Study|Withdrawal by Subject|6|||
146616931|NCT04170543|528769118|FG002|Overall Study|Withdrawal by Subject|5|||
146616932|NCT04170543|528769119|FG003|Overall Study|Withdrawal by Subject|4|||
146616933|NCT04170543|528769120|FG004|Overall Study|Withdrawal by Subject|9|||
146616934|NCT04170543|528769116|FG000|Overall Study|Not able to transition to phase 2b|8|||
146616935|NCT04170543|528769117|FG001|Overall Study|Not able to transition to phase 2b|0|||
146616936|NCT04170543|528769118|FG002|Overall Study|Not able to transition to phase 2b|10|||
146616937|NCT04170543|528769119|FG003|Overall Study|Not able to transition to phase 2b|0|||
146616938|NCT04170543|528769120|FG004|Overall Study|Not able to transition to phase 2b|6|||
146616939|NCT04170543|528769116|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
146616940|NCT04170543|528769117|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
146616941|NCT04170543|528769118|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
146616942|NCT04170543|528769119|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
146616943|NCT04170543|528769120|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
146616944|NCT04170543|528769116|FG000|Overall Study|Not Treated|0|||
146616945|NCT04170543|528769117|FG001|Overall Study|Not Treated|0|||
146616946|NCT04170543|528769118|FG002|Overall Study|Not Treated|0|||
146616947|NCT04170543|528769119|FG003|Overall Study|Not Treated|0|||
146616948|NCT04170543|528769120|FG004|Overall Study|Not Treated|2|||
146616949|NCT04170543|528769116|FG000|Overall Study|(CRF)|16|||
146659043|NCT03963401|528930504|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
146659044|NCT03963401|528930499|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
146659045|NCT03963401|528930500|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
146659046|NCT03963401|528930501|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
146659047|NCT03963401|528930502|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
146659048|NCT03963401|528930503|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
146659049|NCT03963401|528930504|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
146659050|NCT03963401|528930499|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
146659051|NCT03963401|528930500|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
146659052|NCT03963401|528930501|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
146659053|NCT03963401|528930502|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
146659054|NCT03963401|528930503|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
146659055|NCT03963401|528930504|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
146659056|NCT03963401|528930499|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
146659057|NCT03963401|528930500|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
146659058|NCT03963401|528930501|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
146659059|NCT03963401|528930502|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
146659060|NCT03963401|528930503|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
146659061|NCT03963401|528930504|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
146659062|NCT03963401|528930499|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
146659063|NCT03963401|528930500|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
146659064|NCT03963401|528930501|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
146659065|NCT03963401|528930502|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
146659066|NCT03963401|528930503|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
146659067|NCT03963401|528930504|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
146659068|NCT03963401|528930499|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
146659069|NCT03963401|528930500|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
146659070|NCT03963401|528930501|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
146659071|NCT03963401|528930502|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
146659072|NCT03963401|528930503|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
146659073|NCT03963401|528930504|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
146659074|NCT03963401|528930499|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
146659075|NCT03963401|528930500|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
146659076|NCT03963401|528930501|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
146659077|NCT03963401|528930502|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
146659078|NCT03963401|528930503|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
146659079|NCT03963401|528930504|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
146659080|NCT03963401|528930499|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
146659081|NCT03963401|528930500|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
146659082|NCT03963401|528930501|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
146659083|NCT03963401|528930502|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
146659084|NCT03963401|528930503|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
146659085|NCT03963401|528930504|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
146659086|NCT03963401|528930499|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
146659087|NCT03963401|528930500|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
146659088|NCT03963401|528930501|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
146659089|NCT03963401|528930502|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
146659090|NCT03963401|528930503|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
146659091|NCT03963401|528930504|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
146659092|NCT01982331|528930505|FG000|Received Vaccination 2|Adverse Event|1|||
146659093|NCT01982331|528930506|FG001|Received Vaccination 2|Adverse Event|2|||
146659094|NCT01982331|528930505|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
146659095|NCT01982331|528930506|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
146659096|NCT01982331|528930505|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
146659097|NCT01982331|528930506|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
146659098|NCT01528215|528930507|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
146659099|NCT01528215|528930508|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
146659100|NCT01528215|528930507|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
146659101|NCT01528215|528930508|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
146659102|NCT01528215|528930507|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
146978696|NCT03770000|530085466|FG002|Overall Study|Premature discontinuation due to PD|1|||
146978697|NCT03770000|530085467|FG003|Overall Study|Premature discontinuation due to PD|3|||
146978698|NCT03770000|530085468|FG004|Overall Study|Premature discontinuation due to PD|2|||
146978699|NCT02595528|530085470|FG000|Overall Study|Withdrawal by Subject|1|||
146978700|NCT02595528|530085471|FG001|Overall Study|Withdrawal by Subject|2|||
146659103|NCT01528215|528930508|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
146659104|NCT01528215|528930507|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
146659105|NCT01528215|528930508|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
146659106|NCT03497676|528930514|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
146659107|NCT03497676|528930515|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
146659108|NCT03497676|528930516|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
146659109|NCT03497676|528930517|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
146659110|NCT03497676|528930514|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
146659111|NCT03497676|528930515|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
146659112|NCT03497676|528930516|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
146659113|NCT03497676|528930517|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
146659114|NCT03497676|528930514|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
146659115|NCT03497676|528930515|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
146659116|NCT03497676|528930516|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
146659117|NCT03497676|528930517|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
146659118|NCT03497676|528930514|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
146659119|NCT03497676|528930515|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
146659120|NCT03497676|528930516|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
146659121|NCT03497676|528930517|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
146659122|NCT03497676|528930514|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
146659123|NCT03497676|528930515|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
146659124|NCT03497676|528930516|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
146659125|NCT03497676|528930517|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
146659126|NCT03497676|528930514|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
146659127|NCT03497676|528930515|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
146659128|NCT03497676|528930516|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
146659129|NCT03497676|528930517|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
146659130|NCT03497676|528930514|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
146659131|NCT03497676|528930515|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
146659132|NCT03497676|528930516|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
146659133|NCT03497676|528930517|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
146659134|NCT03497676|528930514|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
146659135|NCT03497676|528930515|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
146659136|NCT03497676|528930516|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
146659137|NCT03497676|528930517|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
146659138|NCT00237185|528930518|FG000|Core|Adverse Event|3|||
146659139|NCT00237185|528930519|FG001|Core|Adverse Event|4|||
146659140|NCT00237185|528930518|FG000|Core|Abnormal laboratory value|0|||
146659141|NCT00237185|528930519|FG001|Core|Abnormal laboratory value|4|||
146659142|NCT00237185|528930518|FG000|Core|Abnormal test procedure results|1|||
146659143|NCT00237185|528930519|FG001|Core|Abnormal test procedure results|0|||
146659144|NCT00237185|528930518|FG000|Core|Lack of Efficacy|30|||
146659145|NCT00237185|528930519|FG001|Core|Lack of Efficacy|23|||
146659146|NCT00237185|528930518|FG000|Core|Protocol Violation|1|||
146659147|NCT00237185|528930519|FG001|Core|Protocol Violation|1|||
146659148|NCT00237185|528930518|FG000|Core|Withdrawal by Subject|4|||
146659149|NCT00237185|528930519|FG001|Core|Withdrawal by Subject|4|||
146659150|NCT00237185|528930518|FG000|Core|Administrative problems|0|||
146925035|NCT04031404|529885913|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
146925036|NCT04031404|529885914|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
146925037|NCT04031404|529885913|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
146659151|NCT00237185|528930519|FG001|Core|Administrative problems|1|||
146659152|NCT00237185|528930518|FG000|Core|Death|4|||
146659153|NCT00237185|528930519|FG001|Core|Death|0|||
146659154|NCT00237185|528930518|FG000|Core|Determined ineligible post randomization|1|||
146659155|NCT00237185|528930519|FG001|Core|Determined ineligible post randomization|0|||
146659156|NCT00237185|528930518|FG000|Extension|Adverse Event|1|||
146659157|NCT00237185|528930519|FG001|Extension|Adverse Event|0|||
146659158|NCT00237185|528930518|FG000|Extension|Abnormal laboratory value|0|||
146659159|NCT00237185|528930519|FG001|Extension|Abnormal laboratory value|1|||
146659160|NCT00237185|528930518|FG000|Extension|Lack of Efficacy|9|||
146659161|NCT00237185|528930519|FG001|Extension|Lack of Efficacy|14|||
146659162|NCT00237185|528930518|FG000|Extension|Condition no longer required study drug|0|||
146659163|NCT00237185|528930519|FG001|Extension|Condition no longer required study drug|1|||
146659164|NCT00237185|528930518|FG000|Extension|Withdrawal by Subject|3|||
146925038|NCT04031404|529885914|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
146925039|NCT00568958|529885916|FG000|Allocation|Withdrawal by Subject|7|||
146925040|NCT00568958|529885917|FG001|Allocation|Withdrawal by Subject|3|||
146925041|NCT00568958|529885916|FG000|Allocation|Physician Decision|2|||
146925042|NCT00568958|529885917|FG001|Allocation|Physician Decision|0|||
146773619|NCT00350792|529341127|FG000|Overall Study|Death from Study Disease|1|||
146773620|NCT00350792|529341127|FG000|Overall Study|Death from Study Drug Toxicity|1|||
146659165|NCT00237185|528930519|FG001|Extension|Withdrawal by Subject|2|||
146659166|NCT00237185|528930518|FG000|Extension|Lost to Follow-up|1|||
146659167|NCT00237185|528930519|FG001|Extension|Lost to Follow-up|0|||
146659168|NCT00237185|528930518|FG000|Extension|Administrative problems|1|||
146659169|NCT00237185|528930519|FG001|Extension|Administrative problems|0|||
146659170|NCT00237185|528930518|FG000|Extension|Death|1|||
146659171|NCT00237185|528930519|FG001|Extension|Death|1|||
146659172|NCT02204007|528930520|FG000|Overall Study|Surgery Canceled|1|||
146659173|NCT02204007|528930521|FG001|Overall Study|Surgery Canceled|1|||
146659174|NCT05211284|528930525|FG000|Overall Study|Study Terminated|3|||
146659175|NCT05211284|528930526|FG001|Overall Study|Study Terminated|1|||
146659176|NCT03911843|528930531|FG000|Overall Study|Adverse Event|2|||
146659177|NCT03911843|528930532|FG001|Overall Study|Adverse Event|0|||
146659178|NCT03911843|528930531|FG000|Overall Study|Protocol Violation|2|||
146773621|NCT00350792|529341127|FG000|Overall Study|Death Not Study Drug Related|2|||
146925043|NCT00568958|529885916|FG000|Follow-Up|Withdrawal by Subject|6|||
146616950|NCT04170543|528769117|FG001|Overall Study|(CRF)|15|||
146616951|NCT04170543|528769118|FG002|Overall Study|(CRF)|12|||
146616952|NCT04170543|528769119|FG003|Overall Study|(CRF)|17|||
146616953|NCT04170543|528769120|FG004|Overall Study|(CRF)|17|||
146616954|NCT04170543|528769116|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
146616955|NCT04170543|528769117|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
146616956|NCT04170543|528769118|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
146616957|NCT04170543|528769119|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
146616958|NCT04170543|528769120|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
146616959|NCT04303559|528769121|FG000|Overall Study|Study closed due to poor enrollment.|1|||
146616960|NCT04378270|528769126|FG000|Overall Study|Lack of Efficacy|1|||
146616961|NCT04378270|528769126|FG000|Overall Study|Withdrawal by Subject|1|||
146616962|NCT04378270|528769126|FG000|Overall Study|Screen Failure|1|||
146616963|NCT04378270|528769126|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
146616964|NCT01327599|528769127|FG000|Overall Study|Adverse Event|1|||
146616965|NCT01327599|528769127|FG000|Overall Study|Could Not Attend Visit|1|||
146616966|NCT01327599|528769127|FG000|Overall Study|Withdrawal of Consent|1|||
146616967|NCT01156714|528769128|FG000|Overall Study|Withdrawal by Subject|9|||
146616968|NCT01156714|528769129|FG001|Overall Study|Withdrawal by Subject|4|||
146616969|NCT01156714|528769130|FG002|Overall Study|Withdrawal by Subject|3|||
146616970|NCT01132313|528769131|FG000|Overall Study|Lack of Efficacy|1|||
146616971|NCT01132313|528769132|FG001|Overall Study|Lack of Efficacy|0|||
146616972|NCT01132313|528769133|FG002|Overall Study|Lack of Efficacy|0|||
146616973|NCT01132313|528769134|FG003|Overall Study|Lack of Efficacy|0|||
146616974|NCT01132313|528769135|FG004|Overall Study|Lack of Efficacy|0|||
146616975|NCT01132313|528769136|FG005|Overall Study|Lack of Efficacy|0|||
146616976|NCT01132313|528769137|FG006|Overall Study|Lack of Efficacy|0|||
146616977|NCT01132313|528769138|FG007|Overall Study|Lack of Efficacy|3|||
146616978|NCT01132313|528769139|FG008|Overall Study|Lack of Efficacy|14|||
146616979|NCT01132313|528769140|FG009|Overall Study|Lack of Efficacy|16|||
146616980|NCT01132313|528769141|FG010|Overall Study|Lack of Efficacy|0|||
146616981|NCT01132313|528769142|FG011|Overall Study|Lack of Efficacy|0|||
146616982|NCT01132313|528769131|FG000|Overall Study|Not treated|2|||
146616983|NCT01132313|528769132|FG001|Overall Study|Not treated|0|||
146616984|NCT01132313|528769133|FG002|Overall Study|Not treated|0|||
146616985|NCT01132313|528769134|FG003|Overall Study|Not treated|0|||
146616986|NCT01132313|528769135|FG004|Overall Study|Not treated|2|||
146616987|NCT01132313|528769136|FG005|Overall Study|Not treated|1|||
146616988|NCT01132313|528769137|FG006|Overall Study|Not treated|3|||
146616989|NCT01132313|528769138|FG007|Overall Study|Not treated|0|||
146616990|NCT01132313|528769139|FG008|Overall Study|Not treated|0|||
146616991|NCT01132313|528769140|FG009|Overall Study|Not treated|0|||
146616992|NCT01132313|528769141|FG010|Overall Study|Not treated|0|||
146616993|NCT01132313|528769142|FG011|Overall Study|Not treated|0|||
146616994|NCT01132313|528769131|FG000|Overall Study|Adverse Event|0|||
146616995|NCT01132313|528769132|FG001|Overall Study|Adverse Event|0|||
146616996|NCT01132313|528769133|FG002|Overall Study|Adverse Event|4|||
146616997|NCT01132313|528769134|FG003|Overall Study|Adverse Event|10|||
146616998|NCT01132313|528769135|FG004|Overall Study|Adverse Event|19|||
146616999|NCT01132313|528769136|FG005|Overall Study|Adverse Event|6|||
146617000|NCT01132313|528769137|FG006|Overall Study|Adverse Event|5|||
146617001|NCT01132313|528769138|FG007|Overall Study|Adverse Event|3|||
146617002|NCT01132313|528769139|FG008|Overall Study|Adverse Event|7|||
146617003|NCT01132313|528769140|FG009|Overall Study|Adverse Event|2|||
146617004|NCT01132313|528769141|FG010|Overall Study|Adverse Event|0|||
146617005|NCT01132313|528769142|FG011|Overall Study|Adverse Event|0|||
146617006|NCT01132313|528769131|FG000|Overall Study|Protocol Violation|0|||
146617007|NCT01132313|528769132|FG001|Overall Study|Protocol Violation|0|||
146617008|NCT01132313|528769133|FG002|Overall Study|Protocol Violation|0|||
146617009|NCT01132313|528769134|FG003|Overall Study|Protocol Violation|1|||
146659179|NCT03911843|528930532|FG001|Overall Study|Protocol Violation|0|||
146659180|NCT03911843|528930531|FG000|Overall Study|Lost to Follow-up|0|||
146659181|NCT03911843|528930532|FG001|Overall Study|Lost to Follow-up|1|||
146925044|NCT00568958|529885917|FG001|Follow-Up|Withdrawal by Subject|6|||
146925045|NCT00568958|529885916|FG000|Follow-Up|Physician Decision|1|||
146659182|NCT02819518|528930533|FG000|Overall Study|Death|9|||
146925046|NCT00568958|529885917|FG001|Follow-Up|Physician Decision|1|||
146925047|NCT00568958|529885916|FG000|Follow-Up|Family Emergency|1|||
146925048|NCT00568958|529885917|FG001|Follow-Up|Family Emergency|0|||
146925049|NCT00568958|529885916|FG000|Follow-Up|Adverse Event|1|||
146925050|NCT00568958|529885917|FG001|Follow-Up|Adverse Event|0|||
146659183|NCT02819518|528930534|FG001|Overall Study|Death|12|||
146659184|NCT02819518|528930535|FG002|Overall Study|Death|9|||
146659185|NCT02819518|528930536|FG003|Overall Study|Death|475|||
146659186|NCT02819518|528930537|FG004|Overall Study|Death|244|||
146659187|NCT02819518|528930533|FG000|Overall Study|Withdrawal by Subject|0|||
146659188|NCT02819518|528930534|FG001|Overall Study|Withdrawal by Subject|0|||
146659189|NCT02819518|528930535|FG002|Overall Study|Withdrawal by Subject|0|||
146659190|NCT02819518|528930536|FG003|Overall Study|Withdrawal by Subject|25|||
146978701|NCT02595528|530085472|FG002|Overall Study|Withdrawal by Subject|1|||
146978702|NCT02595528|530085473|FG003|Overall Study|Withdrawal by Subject|3|||
146978703|NCT02595528|530085470|FG000|Overall Study|Lost to Follow-up|1|||
146978704|NCT02595528|530085471|FG001|Overall Study|Lost to Follow-up|1|||
146978705|NCT02595528|530085472|FG002|Overall Study|Lost to Follow-up|0|||
146978706|NCT02595528|530085473|FG003|Overall Study|Lost to Follow-up|1|||
146978707|NCT00833547|530085474|FG000|Overall Study|Withdrawal by Subject|2|||
146978708|NCT00833547|530085475|FG001|Overall Study|Withdrawal by Subject|2|||
146978709|NCT00566098|530085477|FG000|Collection of MILs|Withdrawal by Subject|1|||
146659191|NCT02819518|528930537|FG004|Overall Study|Withdrawal by Subject|8|||
146659192|NCT02819518|528930533|FG000|Overall Study|Lost to Follow-up|0|||
146659193|NCT02819518|528930534|FG001|Overall Study|Lost to Follow-up|0|||
146659194|NCT02819518|528930535|FG002|Overall Study|Lost to Follow-up|0|||
146659195|NCT02819518|528930536|FG003|Overall Study|Lost to Follow-up|0|||
146659196|NCT02819518|528930537|FG004|Overall Study|Lost to Follow-up|1|||
146659197|NCT02819518|528930533|FG000|Overall Study|Sponsor Decision|1|||
146659198|NCT02819518|528930534|FG001|Overall Study|Sponsor Decision|1|||
146659199|NCT02819518|528930535|FG002|Overall Study|Sponsor Decision|0|||
146659200|NCT02819518|528930536|FG003|Overall Study|Sponsor Decision|34|||
146978710|NCT00566098|530085477|FG000|Collection of MILs|Relapsed|1|||
146978711|NCT00566098|530085477|FG000|Generation of MILs Product|Relapsed|1|||
146978712|NCT00566098|530085477|FG000|Administration of ASCT+MILs|Death|10|||
146978713|NCT00566098|530085477|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
146978714|NCT01690520|530085480|FG000|Overall Study|Death|25|||
146978715|NCT01690520|530085481|FG001|Overall Study|Death|21|||
146978716|NCT01690520|530085480|FG000|Overall Study|Lost to Follow-up|2|||
146978717|NCT01690520|530085481|FG001|Overall Study|Lost to Follow-up|3|||
146978718|NCT01690520|530085480|FG000|Overall Study|Withdrawal by Subject|2|||
146978719|NCT01690520|530085481|FG001|Overall Study|Withdrawal by Subject|0|||
146978720|NCT01690520|530085480|FG000|Overall Study|Relapse|0|||
146659201|NCT02819518|528930537|FG004|Overall Study|Sponsor Decision|17|||
146659202|NCT02819518|528930533|FG000|Overall Study|Transferred to extension study|1|||
146659203|NCT02819518|528930534|FG001|Overall Study|Transferred to extension study|1|||
146659204|NCT02819518|528930535|FG002|Overall Study|Transferred to extension study|1|||
146659205|NCT02819518|528930536|FG003|Overall Study|Transferred to extension study|32|||
146659206|NCT02819518|528930537|FG004|Overall Study|Transferred to extension study|11|||
146659207|NCT00880165|528930538|FG000|Overall Study|Withdrawal by Subject|27|||
146659208|NCT00880165|528930539|FG001|Overall Study|Withdrawal by Subject|23|||
146659209|NCT00880165|528930538|FG000|Overall Study|Not diagnosed with OSA|14|||
146659210|NCT00880165|528930539|FG001|Overall Study|Not diagnosed with OSA|8|||
146659211|NCT00880165|528930538|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
146659212|NCT00880165|528930539|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
146659213|NCT00880165|528930538|FG000|Overall Study|Lost to follow|9|||
146659214|NCT00880165|528930539|FG001|Overall Study|Lost to follow|15|||
146659215|NCT01907100|528930540|FG000|Overall Study|PD based on modified RECIST criteria|31|||
146659216|NCT01907100|528930541|FG001|Overall Study|PD based on modified RECIST criteria|32|||
146659217|NCT01907100|528930542|FG002|Overall Study|PD based on modified RECIST criteria|95|||
146659218|NCT01907100|528930543|FG003|Overall Study|PD based on modified RECIST criteria|92|||
146659219|NCT01907100|528930540|FG000|Overall Study|Withdrawal by Subject|2|||
146659220|NCT01907100|528930541|FG001|Overall Study|Withdrawal by Subject|5|||
146659221|NCT01907100|528930542|FG002|Overall Study|Withdrawal by Subject|10|||
146925051|NCT03583372|529885918|FG000|Overall Study|Withdrawal by Subject|6|||
146925052|NCT03583372|529885919|FG001|Overall Study|Withdrawal by Subject|11|||
146978721|NCT01690520|530085481|FG001|Overall Study|Relapse|1|||
146978722|NCT01690520|530085480|FG000|Overall Study|Other|0|||
146978723|NCT01690520|530085481|FG001|Overall Study|Other|1|||
146659222|NCT01907100|528930543|FG003|Overall Study|Withdrawal by Subject|13|||
146925053|NCT03583372|529885920|FG002|Overall Study|Withdrawal by Subject|7|||
146925054|NCT03583372|529885921|FG003|Overall Study|Withdrawal by Subject|8|||
146978724|NCT01690520|530085480|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
146978725|NCT01690520|530085481|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
146617010|NCT01132313|528769135|FG004|Overall Study|Protocol Violation|0|||
146617011|NCT01132313|528769136|FG005|Overall Study|Protocol Violation|0|||
146617012|NCT01132313|528769137|FG006|Overall Study|Protocol Violation|0|||
146617013|NCT01132313|528769138|FG007|Overall Study|Protocol Violation|0|||
146617014|NCT01132313|528769139|FG008|Overall Study|Protocol Violation|0|||
146617015|NCT01132313|528769140|FG009|Overall Study|Protocol Violation|0|||
146617016|NCT01132313|528769141|FG010|Overall Study|Protocol Violation|0|||
146617017|NCT01132313|528769142|FG011|Overall Study|Protocol Violation|0|||
146617018|NCT01132313|528769131|FG000|Overall Study|Lost to Follow-up|0|||
146617019|NCT01132313|528769132|FG001|Overall Study|Lost to Follow-up|0|||
146617020|NCT01132313|528769133|FG002|Overall Study|Lost to Follow-up|1|||
146617021|NCT01132313|528769134|FG003|Overall Study|Lost to Follow-up|0|||
146617022|NCT01132313|528769135|FG004|Overall Study|Lost to Follow-up|0|||
146617023|NCT01132313|528769136|FG005|Overall Study|Lost to Follow-up|0|||
146617024|NCT01132313|528769137|FG006|Overall Study|Lost to Follow-up|0|||
146617025|NCT01132313|528769138|FG007|Overall Study|Lost to Follow-up|1|||
146617026|NCT01132313|528769139|FG008|Overall Study|Lost to Follow-up|0|||
146617027|NCT01132313|528769140|FG009|Overall Study|Lost to Follow-up|0|||
146617028|NCT01132313|528769141|FG010|Overall Study|Lost to Follow-up|0|||
146617029|NCT01132313|528769142|FG011|Overall Study|Lost to Follow-up|0|||
146617030|NCT01132313|528769131|FG000|Overall Study|Withdrawal by Subject|0|||
146617031|NCT01132313|528769132|FG001|Overall Study|Withdrawal by Subject|0|||
146617032|NCT01132313|528769133|FG002|Overall Study|Withdrawal by Subject|3|||
146617033|NCT01132313|528769134|FG003|Overall Study|Withdrawal by Subject|3|||
146617034|NCT01132313|528769135|FG004|Overall Study|Withdrawal by Subject|6|||
146617035|NCT01132313|528769136|FG005|Overall Study|Withdrawal by Subject|0|||
146617036|NCT01132313|528769137|FG006|Overall Study|Withdrawal by Subject|1|||
146617037|NCT01132313|528769138|FG007|Overall Study|Withdrawal by Subject|0|||
146617038|NCT01132313|528769139|FG008|Overall Study|Withdrawal by Subject|0|||
146617039|NCT01132313|528769140|FG009|Overall Study|Withdrawal by Subject|2|||
146617040|NCT01132313|528769141|FG010|Overall Study|Withdrawal by Subject|0|||
146617041|NCT01132313|528769142|FG011|Overall Study|Withdrawal by Subject|0|||
146617042|NCT01132313|528769131|FG000|Overall Study|Lack of antiviral response|0|||
146617043|NCT01132313|528769132|FG001|Overall Study|Lack of antiviral response|0|||
146617044|NCT01132313|528769133|FG002|Overall Study|Lack of antiviral response|12|||
146617045|NCT01132313|528769134|FG003|Overall Study|Lack of antiviral response|18|||
146617046|NCT01132313|528769135|FG004|Overall Study|Lack of antiviral response|18|||
146617047|NCT01132313|528769136|FG005|Overall Study|Lack of antiviral response|18|||
146617048|NCT01132313|528769137|FG006|Overall Study|Lack of antiviral response|21|||
146617049|NCT01132313|528769138|FG007|Overall Study|Lack of antiviral response|0|||
146617050|NCT01132313|528769139|FG008|Overall Study|Lack of antiviral response|0|||
146617051|NCT01132313|528769140|FG009|Overall Study|Lack of antiviral response|0|||
146617052|NCT01132313|528769141|FG010|Overall Study|Lack of antiviral response|1|||
146617053|NCT01132313|528769142|FG011|Overall Study|Lack of antiviral response|0|||
146617054|NCT01132313|528769131|FG000|Overall Study|Other reason not defined above|0|||
146617055|NCT01132313|528769132|FG001|Overall Study|Other reason not defined above|0|||
146617056|NCT01132313|528769133|FG002|Overall Study|Other reason not defined above|0|||
146617057|NCT01132313|528769134|FG003|Overall Study|Other reason not defined above|0|||
146617058|NCT01132313|528769135|FG004|Overall Study|Other reason not defined above|0|||
146617059|NCT01132313|528769136|FG005|Overall Study|Other reason not defined above|0|||
146617060|NCT01132313|528769137|FG006|Overall Study|Other reason not defined above|0|||
146617061|NCT01132313|528769138|FG007|Overall Study|Other reason not defined above|1|||
146617062|NCT01132313|528769139|FG008|Overall Study|Other reason not defined above|0|||
146617063|NCT01132313|528769140|FG009|Overall Study|Other reason not defined above|0|||
146617064|NCT01132313|528769141|FG010|Overall Study|Other reason not defined above|0|||
146617065|NCT01132313|528769142|FG011|Overall Study|Other reason not defined above|0|||
146617066|NCT04266795|528769146|FG000|Overall Study|Adverse Event|10|||
146617067|NCT04266795|528769147|FG001|Overall Study|Adverse Event|19|||
146617068|NCT04266795|528769146|FG000|Overall Study|Death|7|||
146617069|NCT04266795|528769147|FG001|Overall Study|Death|8|||
146617070|NCT04266795|528769146|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
146617071|NCT04266795|528769147|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
146617072|NCT04266795|528769146|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
146617073|NCT04266795|528769147|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146617074|NCT04266795|528769146|FG000|Overall Study|Progressive Disease|12|||
146617075|NCT04266795|528769147|FG001|Overall Study|Progressive Disease|9|||
146617076|NCT04266795|528769146|FG000|Overall Study|Withdrawal by Patient|5|||
146617077|NCT04266795|528769147|FG001|Overall Study|Withdrawal by Patient|6|||
146617078|NCT04266795|528769146|FG000|Overall Study|Disease Relapse|3|||
146617079|NCT04266795|528769147|FG001|Overall Study|Disease Relapse|6|||
146617080|NCT04266795|528769146|FG000|Overall Study|Reason not Specified|12|||
146617081|NCT04266795|528769147|FG001|Overall Study|Reason not Specified|10|||
146617082|NCT04266795|528769146|FG000|Overall Study|Participants Ongoing on Treatment|25|||
146659223|NCT01907100|528930540|FG000|Overall Study|Protocol Violation|0|||
146659224|NCT01907100|528930541|FG001|Overall Study|Protocol Violation|0|||
146659225|NCT01907100|528930542|FG002|Overall Study|Protocol Violation|1|||
146659226|NCT01907100|528930543|FG003|Overall Study|Protocol Violation|1|||
146659227|NCT01907100|528930540|FG000|Overall Study|Lost to Follow-up|0|||
146659228|NCT01907100|528930541|FG001|Overall Study|Lost to Follow-up|0|||
146659229|NCT01907100|528930542|FG002|Overall Study|Lost to Follow-up|0|||
146659230|NCT01907100|528930543|FG003|Overall Study|Lost to Follow-up|1|||
146659231|NCT01907100|528930540|FG000|Overall Study|Not treated|2|||
146659232|NCT01907100|528930541|FG001|Overall Study|Not treated|0|||
146659233|NCT01907100|528930542|FG002|Overall Study|Not treated|1|||
146659234|NCT01907100|528930543|FG003|Overall Study|Not treated|2|||
146659235|NCT01907100|528930540|FG000|Overall Study|Other than reasons specified|1|||
146659236|NCT01907100|528930541|FG001|Overall Study|Other than reasons specified|0|||
146659237|NCT01907100|528930542|FG002|Overall Study|Other than reasons specified|10|||
146659238|NCT01907100|528930543|FG003|Overall Study|Other than reasons specified|6|||
146659239|NCT01907100|528930540|FG000|Overall Study|Adverse event (AE)|6|||
146659240|NCT01907100|528930541|FG001|Overall Study|Adverse event (AE)|3|||
146659241|NCT01907100|528930542|FG002|Overall Study|Adverse event (AE)|22|||
146659242|NCT01907100|528930543|FG003|Overall Study|Adverse event (AE)|23|||
146659243|NCT01907100|528930540|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
146659244|NCT01907100|528930541|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
146659245|NCT01907100|528930542|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
146659246|NCT01907100|528930543|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
146659247|NCT01758289|528930544|FG000|Overall Study|Premature Study Termination|44|||
146659248|NCT01758289|528930544|FG000|Overall Study|Adverse Event|9|||
146659249|NCT00667602|528930547|FG000|Overall Study|Withdrawal by Subject|4|||
146659250|NCT00667602|528930548|FG001|Overall Study|Withdrawal by Subject|9|||
146659251|NCT00667602|528930549|FG002|Overall Study|Withdrawal by Subject|10|||
146659252|NCT00667602|528930547|FG000|Overall Study|Lost to Follow-up|4|||
146659253|NCT00667602|528930548|FG001|Overall Study|Lost to Follow-up|5|||
146659254|NCT00667602|528930549|FG002|Overall Study|Lost to Follow-up|6|||
146659255|NCT00667602|528930547|FG000|Overall Study|Administrative reason|0|||
146659256|NCT00667602|528930548|FG001|Overall Study|Administrative reason|0|||
146659257|NCT00667602|528930549|FG002|Overall Study|Administrative reason|2|||
146659258|NCT00667602|528930547|FG000|Overall Study|Protocol Violation|0|||
146659259|NCT00667602|528930548|FG001|Overall Study|Protocol Violation|1|||
146659260|NCT00667602|528930549|FG002|Overall Study|Protocol Violation|0|||
146659261|NCT02750943|528930557|FG000|Overall Study|Lost to Follow-up|1|||
146659262|NCT02750943|528930558|FG001|Overall Study|Lost to Follow-up|2|||
146659263|NCT02750943|528930557|FG000|Overall Study|Withdrawal by Subject|5|||
146659264|NCT02750943|528930558|FG001|Overall Study|Withdrawal by Subject|7|||
146659265|NCT00395538|528930559|FG000|Overall Study|Did not re-consent to revised protocol|1|||
146659266|NCT00395538|528930560|FG001|Overall Study|Did not re-consent to revised protocol|10|||
146659267|NCT00395538|528930561|FG002|Overall Study|Did not re-consent to revised protocol|0|||
146659268|NCT00395538|528930559|FG000|Overall Study|FDA partial hold on PTH|0|||
146659269|NCT00395538|528930560|FG001|Overall Study|FDA partial hold on PTH|0|||
146659270|NCT00395538|528930561|FG002|Overall Study|FDA partial hold on PTH|11|||
146659271|NCT00395538|528930559|FG000|Overall Study|Failed screening|0|||
146659272|NCT00395538|528930560|FG001|Overall Study|Failed screening|0|||
146659273|NCT00395538|528930561|FG002|Overall Study|Failed screening|4|||
146659274|NCT00395538|528930559|FG000|Overall Study|Switch to Natpara|0|||
146659275|NCT00395538|528930560|FG001|Overall Study|Switch to Natpara|0|||
146659276|NCT00395538|528930561|FG002|Overall Study|Switch to Natpara|3|||
146659277|NCT00395538|528930559|FG000|Overall Study|Adverse Event|1|||
146659278|NCT00395538|528930560|FG001|Overall Study|Adverse Event|0|||
146659279|NCT00395538|528930561|FG002|Overall Study|Adverse Event|2|||
146659280|NCT00395538|528930559|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
146659281|NCT00395538|528930560|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
146659282|NCT00395538|528930561|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
146659283|NCT00395538|528930559|FG000|Overall Study|Non-compliance with study protocol|0|||
146659284|NCT00395538|528930560|FG001|Overall Study|Non-compliance with study protocol|1|||
146659285|NCT00395538|528930561|FG002|Overall Study|Non-compliance with study protocol|0|||
146659286|NCT00395538|528930559|FG000|Overall Study|PTH resistance|0|||
146659287|NCT00395538|528930560|FG001|Overall Study|PTH resistance|0|||
146659288|NCT00395538|528930561|FG002|Overall Study|PTH resistance|1|||
146659289|NCT00395538|528930559|FG000|Overall Study|Pregnancy|1|||
146659290|NCT00395538|528930560|FG001|Overall Study|Pregnancy|0|||
146659291|NCT00395538|528930561|FG002|Overall Study|Pregnancy|0|||
146659292|NCT00395538|528930559|FG000|Overall Study|Partial recovery of parathyroid function|0|||
146659293|NCT00395538|528930560|FG001|Overall Study|Partial recovery of parathyroid function|0|||
146659294|NCT00395538|528930561|FG002|Overall Study|Partial recovery of parathyroid function|1|||
146659295|NCT00395538|528930559|FG000|Overall Study|Participant elected to discontinue|0|||
146659296|NCT00395538|528930560|FG001|Overall Study|Participant elected to discontinue|0|||
146659297|NCT00395538|528930561|FG002|Overall Study|Participant elected to discontinue|1|||
146659298|NCT01857583|528930562|FG000|Overall Study|Adverse Event|0|||
146617083|NCT04266795|528769147|FG001|Overall Study|Participants Ongoing on Treatment|23|||
146617084|NCT03043872|528769148|FG000|Overall Study|Withdrawal by Subject|6|||
146617085|NCT03043872|528769149|FG001|Overall Study|Withdrawal by Subject|6|||
146617086|NCT03043872|528769150|FG002|Overall Study|Withdrawal by Subject|15|||
146617087|NCT03043872|528769148|FG000|Overall Study|Lost to Follow-up|2|||
146617088|NCT03043872|528769149|FG001|Overall Study|Lost to Follow-up|1|||
146617089|NCT03043872|528769150|FG002|Overall Study|Lost to Follow-up|1|||
146617090|NCT03043872|528769148|FG000|Overall Study|Death|270|||
146617091|NCT03043872|528769149|FG001|Overall Study|Death|269|||
146617092|NCT03043872|528769150|FG002|Overall Study|Death|296|||
146617093|NCT00434109|528769151|FG000|Overall Study|Physician Decision|9|||
146617094|NCT00434109|528769151|FG000|Overall Study|Adverse Event|5|||
146617095|NCT00434109|528769151|FG000|Overall Study|Protocol Violation|1|||
146617096|NCT00434109|528769151|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
146617097|NCT04186871|528769154|FG000|Overall Study|Lack of Efficacy|0|||
146617098|NCT04186871|528769155|FG001|Overall Study|Lack of Efficacy|1|||
146617099|NCT04186871|528769156|FG002|Overall Study|Lack of Efficacy|0|||
146617100|NCT04186871|528769157|FG003|Overall Study|Lack of Efficacy|0|||
146617101|NCT04186871|528769158|FG004|Overall Study|Lack of Efficacy|1|||
146617102|NCT04186871|528769159|FG005|Overall Study|Lack of Efficacy|1|||
146617103|NCT04186871|528769154|FG000|Overall Study|Adverse Event|1|||
146617104|NCT04186871|528769155|FG001|Overall Study|Adverse Event|1|||
146617105|NCT04186871|528769156|FG002|Overall Study|Adverse Event|0|||
146617106|NCT04186871|528769157|FG003|Overall Study|Adverse Event|0|||
146617107|NCT04186871|528769158|FG004|Overall Study|Adverse Event|0|||
146617108|NCT04186871|528769159|FG005|Overall Study|Adverse Event|2|||
146617109|NCT04186871|528769154|FG000|Overall Study|Study terminated by sponsor|1|||
146617110|NCT04186871|528769155|FG001|Overall Study|Study terminated by sponsor|2|||
146617111|NCT04186871|528769156|FG002|Overall Study|Study terminated by sponsor|0|||
146617112|NCT04186871|528769157|FG003|Overall Study|Study terminated by sponsor|1|||
146617113|NCT04186871|528769158|FG004|Overall Study|Study terminated by sponsor|0|||
146617114|NCT04186871|528769159|FG005|Overall Study|Study terminated by sponsor|0|||
146617115|NCT04186871|528769154|FG000|Overall Study|Other reasons|0|||
146617116|NCT04186871|528769155|FG001|Overall Study|Other reasons|0|||
146617117|NCT04186871|528769156|FG002|Overall Study|Other reasons|0|||
146617118|NCT04186871|528769157|FG003|Overall Study|Other reasons|0|||
146617119|NCT04186871|528769158|FG004|Overall Study|Other reasons|0|||
146617120|NCT04186871|528769159|FG005|Overall Study|Other reasons|1|||
146617121|NCT04186871|528769154|FG000|Overall Study|Withdrawal by Subject|0|||
146617122|NCT04186871|528769155|FG001|Overall Study|Withdrawal by Subject|0|||
146617123|NCT04186871|528769156|FG002|Overall Study|Withdrawal by Subject|0|||
146617124|NCT04186871|528769157|FG003|Overall Study|Withdrawal by Subject|0|||
146617125|NCT04186871|528769158|FG004|Overall Study|Withdrawal by Subject|0|||
146617126|NCT04186871|528769159|FG005|Overall Study|Withdrawal by Subject|1|||
146617127|NCT04186871|528769154|FG000|Overall Study|Lost to Follow-up|0|||
146617128|NCT04186871|528769155|FG001|Overall Study|Lost to Follow-up|0|||
146617129|NCT04186871|528769156|FG002|Overall Study|Lost to Follow-up|0|||
146617130|NCT04186871|528769157|FG003|Overall Study|Lost to Follow-up|0|||
146617131|NCT04186871|528769158|FG004|Overall Study|Lost to Follow-up|0|||
146617132|NCT04186871|528769159|FG005|Overall Study|Lost to Follow-up|1|||
146617133|NCT03790917|528769160|FG000|Overall Study|Death|1|||
146617134|NCT00543387|528769170|FG000|Panel 1 + Panel 2|Adverse Event|0|||
146617135|NCT00543387|528769171|FG001|Panel 1 + Panel 2|Adverse Event|1|||
146617136|NCT00543387|528769172|FG002|Panel 1 + Panel 2|Adverse Event|0|||
146617137|NCT00543387|528769173|FG003|Panel 1 + Panel 2|Adverse Event|0|||
146617138|NCT00543387|528769174|FG004|Panel 1 + Panel 2|Adverse Event|0|||
146617139|NCT00543387|528769175|FG005|Panel 1 + Panel 2|Adverse Event|0|||
146617140|NCT00543387|528769176|FG006|Panel 1 + Panel 2|Adverse Event|0|||
146617141|NCT00543387|528769177|FG007|Panel 1 + Panel 2|Adverse Event|1|||
146617142|NCT00543387|528769178|FG008|Panel 1 + Panel 2|Adverse Event|1|||
146617143|NCT00543387|528769179|FG009|Panel 1 + Panel 2|Adverse Event|0|||
146617144|NCT00543387|528769180|FG010|Panel 1 + Panel 2|Adverse Event|0|||
146617145|NCT00543387|528769170|FG000|Panel 1 + Panel 2|Physician Decision|0|||
146617146|NCT00543387|528769171|FG001|Panel 1 + Panel 2|Physician Decision|0|||
146617147|NCT00543387|528769172|FG002|Panel 1 + Panel 2|Physician Decision|1|||
146617148|NCT00543387|528769173|FG003|Panel 1 + Panel 2|Physician Decision|0|||
146617149|NCT00543387|528769174|FG004|Panel 1 + Panel 2|Physician Decision|0|||
146617150|NCT00543387|528769175|FG005|Panel 1 + Panel 2|Physician Decision|0|||
146617151|NCT00543387|528769176|FG006|Panel 1 + Panel 2|Physician Decision|0|||
146617152|NCT00543387|528769177|FG007|Panel 1 + Panel 2|Physician Decision|1|||
146617153|NCT00543387|528769178|FG008|Panel 1 + Panel 2|Physician Decision|0|||
146617154|NCT00543387|528769179|FG009|Panel 1 + Panel 2|Physician Decision|0|||
146617155|NCT00543387|528769180|FG010|Panel 1 + Panel 2|Physician Decision|0|||
146617156|NCT00543387|528769170|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
146617157|NCT00543387|528769171|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
146617158|NCT00543387|528769172|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
146617159|NCT00543387|528769173|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
146925055|NCT03583372|529885918|FG000|Overall Study|Lost to Follow-up|4|||
146659299|NCT01857583|528930563|FG001|Overall Study|Adverse Event|0|||
146659300|NCT01857583|528930564|FG002|Overall Study|Adverse Event|1|||
146659301|NCT01857583|528930565|FG003|Overall Study|Adverse Event|1|||
146659302|NCT01857583|528930562|FG000|Overall Study|Death|0|||
146659303|NCT01857583|528930563|FG001|Overall Study|Death|1|||
146659304|NCT01857583|528930564|FG002|Overall Study|Death|1|||
146659305|NCT01857583|528930565|FG003|Overall Study|Death|0|||
146659306|NCT01857583|528930562|FG000|Overall Study|Physician Decision|0|||
146659307|NCT01857583|528930563|FG001|Overall Study|Physician Decision|0|||
146659308|NCT01857583|528930564|FG002|Overall Study|Physician Decision|0|||
146659309|NCT01857583|528930565|FG003|Overall Study|Physician Decision|1|||
146659310|NCT01857583|528930562|FG000|Overall Study|Withdrawal by Subject|1|||
146659311|NCT01857583|528930563|FG001|Overall Study|Withdrawal by Subject|0|||
146659312|NCT01857583|528930564|FG002|Overall Study|Withdrawal by Subject|1|||
146659313|NCT01857583|528930565|FG003|Overall Study|Withdrawal by Subject|2|||
146659314|NCT02211638|528930566|FG000|Overall Study|Case Report Forms Uncollected|291|||
146659315|NCT02211638|528930566|FG000|Overall Study|Protocol Violation|692|||
146659316|NCT04382755|528930567|FG000|Overall Study|Withdrawal by Subject|1|||
146659317|NCT04382755|528930568|FG001|Overall Study|Withdrawal by Subject|0|||
146659318|NCT04382755|528930567|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
146659319|NCT04382755|528930568|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
146659320|NCT04382755|528930567|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
146659321|NCT04382755|528930568|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
146659322|NCT04041700|528930573|FG000|Overall Study|Pregnancy|1|||
146659323|NCT04041700|528930573|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
146659324|NCT02775903|528930574|FG000|Overall Study|Death|7|||
146659325|NCT02775903|528930575|FG001|Overall Study|Death|11|||
146659326|NCT02775903|528930576|FG002|Overall Study|Death|12|||
146659327|NCT02775903|528930577|FG003|Overall Study|Death|11|||
146659328|NCT02775903|528930574|FG000|Overall Study|Adverse Event|0|||
146659329|NCT02775903|528930575|FG001|Overall Study|Adverse Event|1|||
146659330|NCT02775903|528930576|FG002|Overall Study|Adverse Event|12|||
146659331|NCT02775903|528930577|FG003|Overall Study|Adverse Event|3|||
146659332|NCT02775903|528930574|FG000|Overall Study|Progressive disease|15|||
146659333|NCT02775903|528930575|FG001|Overall Study|Progressive disease|14|||
146659334|NCT02775903|528930576|FG002|Overall Study|Progressive disease|30|||
146659335|NCT02775903|528930577|FG003|Overall Study|Progressive disease|20|||
146659336|NCT02775903|528930574|FG000|Overall Study|Lack of Efficacy|2|||
146659337|NCT02775903|528930575|FG001|Overall Study|Lack of Efficacy|2|||
146659338|NCT02775903|528930576|FG002|Overall Study|Lack of Efficacy|2|||
146659339|NCT02775903|528930577|FG003|Overall Study|Lack of Efficacy|6|||
146659340|NCT02775903|528930574|FG000|Overall Study|Withdrawal by Subject|7|||
146659341|NCT02775903|528930575|FG001|Overall Study|Withdrawal by Subject|5|||
146659342|NCT02775903|528930576|FG002|Overall Study|Withdrawal by Subject|5|||
146659343|NCT02775903|528930577|FG003|Overall Study|Withdrawal by Subject|8|||
146659344|NCT02775903|528930574|FG000|Overall Study|Other reasons|7|||
146659345|NCT02775903|528930575|FG001|Overall Study|Other reasons|8|||
146659346|NCT02775903|528930576|FG002|Overall Study|Other reasons|2|||
146659347|NCT02775903|528930577|FG003|Overall Study|Other reasons|12|||
146659348|NCT00458536|528930580|FG000|Overall Study|Disease progression prior to treatment|7|||
146659349|NCT00458536|528930580|FG000|Overall Study|Unable to make vaccine|3|||
146659350|NCT00458536|528930580|FG000|Overall Study|No measurable disease after surgery|2|||
146659351|NCT00458536|528930580|FG000|Overall Study|Did not have renal cell carcinoma|2|||
146659352|NCT00458536|528930580|FG000|Overall Study|Patient did not have surgery|1|||
146659353|NCT00458536|528930580|FG000|Overall Study|Ineligible due to toxicity|1|||
146659354|NCT00458536|528930580|FG000|Overall Study|Withdrawal by Subject|1|||
146659355|NCT00458536|528930580|FG000|Overall Study|Progressive disease during treatment|2|||
146659356|NCT00285207|528930583|FG000|Overall Study|Lost to Follow-up|3|||
146659357|NCT00285207|528930584|FG001|Overall Study|Lost to Follow-up|2|||
146659358|NCT00285207|528930583|FG000|Overall Study|Withdrawal by Subject|5|||
146659359|NCT00285207|528930584|FG001|Overall Study|Withdrawal by Subject|2|||
146659360|NCT00285207|528930583|FG000|Overall Study|Pregnancy|1|||
146659361|NCT00285207|528930584|FG001|Overall Study|Pregnancy|1|||
146659362|NCT00285207|528930583|FG000|Overall Study|non-compliance|0|||
146659363|NCT00285207|528930584|FG001|Overall Study|non-compliance|1|||
146659364|NCT03552965|528930586|FG000|Overall Study|Death|1|||
146659365|NCT03552965|528930587|FG001|Overall Study|Death|1|||
146659366|NCT03552965|528930586|FG000|Overall Study|Lost to Follow-up|1|||
146659367|NCT03552965|528930587|FG001|Overall Study|Lost to Follow-up|1|||
146659368|NCT03552965|528930586|FG000|Overall Study|Physician Decision|1|||
146659369|NCT03552965|528930587|FG001|Overall Study|Physician Decision|1|||
146659370|NCT03552965|528930586|FG000|Overall Study|Withdrawal by Subject|0|||
146659371|NCT03552965|528930587|FG001|Overall Study|Withdrawal by Subject|2|||
146659372|NCT03552965|528930586|FG000|Overall Study|Continuation not in patient best interest|1|||
146659373|NCT03552965|528930587|FG001|Overall Study|Continuation not in patient best interest|0|||
146659374|NCT03552965|528930586|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
146659375|NCT03552965|528930587|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
146659376|NCT03120624|528930588|FG000|Overall Study|Withdrawal by Subject|0|||
146925056|NCT03583372|529885919|FG001|Overall Study|Lost to Follow-up|6|||
146925057|NCT03583372|529885920|FG002|Overall Study|Lost to Follow-up|3|||
146925058|NCT03583372|529885921|FG003|Overall Study|Lost to Follow-up|2|||
146925059|NCT03583372|529885918|FG000|Overall Study|Adverse Event|1|||
146925060|NCT03583372|529885919|FG001|Overall Study|Adverse Event|3|||
146925061|NCT03583372|529885920|FG002|Overall Study|Adverse Event|4|||
146659377|NCT03120624|528930589|FG001|Overall Study|Withdrawal by Subject|1|||
146659378|NCT03120624|528930590|FG002|Overall Study|Withdrawal by Subject|0|||
146659379|NCT03120624|528930591|FG003|Overall Study|Withdrawal by Subject|0|||
146659380|NCT03120624|528930592|FG004|Overall Study|Withdrawal by Subject|0|||
146659381|NCT03120624|528930593|FG005|Overall Study|Withdrawal by Subject|0|||
146659382|NCT03120624|528930594|FG006|Overall Study|Withdrawal by Subject|0|||
146659383|NCT03120624|528930595|FG007|Overall Study|Withdrawal by Subject|0|||
146659384|NCT04571515|528930596|FG000|Overall Study|Physician Decision|0|||
146659385|NCT04571515|528930597|FG001|Overall Study|Physician Decision|0|||
146659386|NCT04571515|528930598|FG002|Overall Study|Physician Decision|0|||
146659387|NCT04571515|528930599|FG003|Overall Study|Physician Decision|0|||
146659388|NCT04571515|528930600|FG004|Overall Study|Physician Decision|1|||
146659389|NCT04571515|528930596|FG000|Overall Study|Withdrawal by Subject|0|||
146659390|NCT04571515|528930597|FG001|Overall Study|Withdrawal by Subject|0|||
146659391|NCT04571515|528930598|FG002|Overall Study|Withdrawal by Subject|0|||
146659392|NCT04571515|528930599|FG003|Overall Study|Withdrawal by Subject|0|||
146659393|NCT04571515|528930600|FG004|Overall Study|Withdrawal by Subject|1|||
146659394|NCT04571515|528930596|FG000|Overall Study|insufficient pain|1|||
146659395|NCT04571515|528930597|FG001|Overall Study|insufficient pain|0|||
146659396|NCT04571515|528930598|FG002|Overall Study|insufficient pain|0|||
146659397|NCT04571515|528930599|FG003|Overall Study|insufficient pain|0|||
146659398|NCT04571515|528930600|FG004|Overall Study|insufficient pain|1|||
146659399|NCT01659658|528932023|FG000|Overall Study|Withdrawal by Patient|18|||
146659400|NCT01659658|528932024|FG001|Overall Study|Withdrawal by Patient|4|||
146659401|NCT01659658|528932025|FG002|Overall Study|Withdrawal by Patient|2|||
146659402|NCT01659658|528932026|FG003|Overall Study|Withdrawal by Patient|0|||
146659403|NCT01659658|528932027|FG004|Overall Study|Withdrawal by Patient|11|||
146659404|NCT01659658|528932023|FG000|Overall Study|Study Terminated by Sponsor|9|||
146659405|NCT01659658|528932024|FG001|Overall Study|Study Terminated by Sponsor|7|||
146659406|NCT01659658|528932025|FG002|Overall Study|Study Terminated by Sponsor|0|||
146659407|NCT01659658|528932026|FG003|Overall Study|Study Terminated by Sponsor|1|||
146659408|NCT01659658|528932027|FG004|Overall Study|Study Terminated by Sponsor|4|||
146659409|NCT01659658|528932023|FG000|Overall Study|Reason not Specified|61|||
146659410|NCT01659658|528932024|FG001|Overall Study|Reason not Specified|15|||
146659411|NCT01659658|528932025|FG002|Overall Study|Reason not Specified|8|||
146659412|NCT01659658|528932026|FG003|Overall Study|Reason not Specified|1|||
146659413|NCT01659658|528932027|FG004|Overall Study|Reason not Specified|34|||
146659414|NCT01659658|528932023|FG000|Overall Study|Lost to Follow-up|2|||
146659415|NCT01659658|528932024|FG001|Overall Study|Lost to Follow-up|0|||
146659416|NCT01659658|528932025|FG002|Overall Study|Lost to Follow-up|0|||
146659417|NCT01659658|528932026|FG003|Overall Study|Lost to Follow-up|0|||
146659418|NCT01659658|528932027|FG004|Overall Study|Lost to Follow-up|0|||
146659419|NCT01927341|528932029|FG000|Phase 1b|Lost to Follow-up|1|||
146659420|NCT01927341|528932030|FG001|Phase 1b|Lost to Follow-up|0|||
146659421|NCT01927341|528932031|FG002|Phase 1b|Lost to Follow-up|0|||
146659422|NCT01927341|528932032|FG003|Phase 1b|Lost to Follow-up|0|||
146659423|NCT01927341|528932033|FG004|Phase 1b|Lost to Follow-up|0|||
146659424|NCT01927341|528932029|FG000|Phase 1b|Death|2|||
146659425|NCT01927341|528932030|FG001|Phase 1b|Death|0|||
146925062|NCT03583372|529885921|FG003|Overall Study|Adverse Event|4|||
146925063|NCT03583372|529885918|FG000|Overall Study|Physician Decision|0|||
146925064|NCT03583372|529885919|FG001|Overall Study|Physician Decision|1|||
146925065|NCT03583372|529885920|FG002|Overall Study|Physician Decision|1|||
146925066|NCT03583372|529885921|FG003|Overall Study|Physician Decision|1|||
146925067|NCT03583372|529885918|FG000|Overall Study|Lack of Efficacy|0|||
146925068|NCT03583372|529885919|FG001|Overall Study|Lack of Efficacy|1|||
146925069|NCT03583372|529885920|FG002|Overall Study|Lack of Efficacy|0|||
146659426|NCT01927341|528932031|FG002|Phase 1b|Death|0|||
146659427|NCT01927341|528932032|FG003|Phase 1b|Death|0|||
146659428|NCT01927341|528932033|FG004|Phase 1b|Death|0|||
146659429|NCT01927341|528932029|FG000|Phase 1b|Follow-up completed|7|||
146659430|NCT01927341|528932030|FG001|Phase 1b|Follow-up completed|0|||
146659431|NCT01927341|528932031|FG002|Phase 1b|Follow-up completed|0|||
146659432|NCT01927341|528932032|FG003|Phase 1b|Follow-up completed|0|||
146659433|NCT01927341|528932033|FG004|Phase 1b|Follow-up completed|0|||
146659434|NCT01927341|528932029|FG000|Phase 2|Lost to Follow-up|0|||
146659435|NCT01927341|528932030|FG001|Phase 2|Lost to Follow-up|1|||
146659436|NCT01927341|528932031|FG002|Phase 2|Lost to Follow-up|0|||
146659437|NCT01927341|528932032|FG003|Phase 2|Lost to Follow-up|0|||
146659438|NCT01927341|528932033|FG004|Phase 2|Lost to Follow-up|0|||
146773622|NCT00350792|529341127|FG000|Overall Study|Protocol Violation|1|||
146925070|NCT03583372|529885921|FG003|Overall Study|Lack of Efficacy|1|||
146659439|NCT01927341|528932029|FG000|Phase 2|Participant withdrew consent|0|||
146659440|NCT01927341|528932030|FG001|Phase 2|Participant withdrew consent|2|||
146659441|NCT01927341|528932031|FG002|Phase 2|Participant withdrew consent|1|||
146925071|NCT03583372|529885918|FG000|Overall Study|Death|1|||
146925072|NCT03583372|529885919|FG001|Overall Study|Death|0|||
146925073|NCT03583372|529885920|FG002|Overall Study|Death|0|||
146925074|NCT03583372|529885921|FG003|Overall Study|Death|0|||
146659442|NCT01927341|528932032|FG003|Phase 2|Participant withdrew consent|2|||
146659443|NCT01927341|528932033|FG004|Phase 2|Participant withdrew consent|3|||
146659444|NCT01927341|528932029|FG000|Phase 2|Death|0|||
146659445|NCT01927341|528932030|FG001|Phase 2|Death|4|||
146659446|NCT01927341|528932031|FG002|Phase 2|Death|0|||
146659447|NCT01927341|528932032|FG003|Phase 2|Death|3|||
146659448|NCT01927341|528932033|FG004|Phase 2|Death|2|||
146659449|NCT01927341|528932029|FG000|Phase 2|New cancer therapy|0|||
146659450|NCT01927341|528932030|FG001|Phase 2|New cancer therapy|1|||
146659451|NCT01927341|528932031|FG002|Phase 2|New cancer therapy|0|||
146659452|NCT01927341|528932032|FG003|Phase 2|New cancer therapy|4|||
146659453|NCT01927341|528932033|FG004|Phase 2|New cancer therapy|1|||
146659454|NCT01927341|528932029|FG000|Phase 2|Disease progression|0|||
146659455|NCT01927341|528932030|FG001|Phase 2|Disease progression|1|||
146659456|NCT01927341|528932031|FG002|Phase 2|Disease progression|1|||
146659457|NCT01927341|528932032|FG003|Phase 2|Disease progression|1|||
146659458|NCT01927341|528932033|FG004|Phase 2|Disease progression|0|||
146659459|NCT01927341|528932029|FG000|Phase 2|Follow-up completed|0|||
146659460|NCT01927341|528932030|FG001|Phase 2|Follow-up completed|6|||
146659461|NCT01927341|528932031|FG002|Phase 2|Follow-up completed|3|||
146659462|NCT01927341|528932032|FG003|Phase 2|Follow-up completed|5|||
146659463|NCT01927341|528932033|FG004|Phase 2|Follow-up completed|2|||
146659464|NCT01397201|528932034|FG000|Overall Study|Not treated|0|||
146659465|NCT01397201|528932035|FG001|Overall Study|Not treated|0|||
146659466|NCT01397201|528932036|FG002|Overall Study|Not treated|1|||
146659467|NCT01397201|528932037|FG003|Overall Study|Not treated|0|||
146659468|NCT01397201|528932038|FG004|Overall Study|Not treated|0|||
146659469|NCT01397201|528932034|FG000|Overall Study|Not yet defined|3|||
146659470|NCT01397201|528932035|FG001|Overall Study|Not yet defined|6|||
146659471|NCT01397201|528932036|FG002|Overall Study|Not yet defined|5|||
146659472|NCT01397201|528932037|FG003|Overall Study|Not yet defined|5|||
146659473|NCT01397201|528932038|FG004|Overall Study|Not yet defined|4|||
146659474|NCT01397201|528932034|FG000|Overall Study|Adverse Event|2|||
146659475|NCT01397201|528932035|FG001|Overall Study|Adverse Event|0|||
146659476|NCT01397201|528932036|FG002|Overall Study|Adverse Event|0|||
146659477|NCT01397201|528932037|FG003|Overall Study|Adverse Event|0|||
146659478|NCT01397201|528932038|FG004|Overall Study|Adverse Event|0|||
146659479|NCT03956056|528932041|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
146659480|NCT03956056|528932041|FG000|Overall Study|Lack of Efficacy|1|||
146659481|NCT03347188|528932042|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
146659482|NCT03347188|528932043|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
146659483|NCT03347188|528932042|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
146659484|NCT03347188|528932043|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
146659485|NCT03347188|528932042|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
146659486|NCT03347188|528932043|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
146659487|NCT03347188|528932042|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
146659488|NCT03347188|528932043|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
146659489|NCT03347188|528932042|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
146659490|NCT03347188|528932043|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
146925075|NCT03583372|529885918|FG000|Overall Study|Protocol Violation|0|||
146659491|NCT03347188|528932042|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
146659492|NCT03347188|528932043|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
146659493|NCT03347188|528932042|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
146659494|NCT03347188|528932043|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
146659495|NCT03347188|528932042|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
146925076|NCT03583372|529885919|FG001|Overall Study|Protocol Violation|1|||
146659496|NCT03347188|528932043|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
146659497|NCT01298531|528932046|FG000|Overall Study|Lack of Efficacy|0|||
146659498|NCT01298531|528932047|FG001|Overall Study|Lack of Efficacy|1|||
146659499|NCT01298531|528932046|FG000|Overall Study|Lost to Follow-up|2|||
146659500|NCT01298531|528932047|FG001|Overall Study|Lost to Follow-up|0|||
146659501|NCT01298531|528932046|FG000|Overall Study|Protocol Violation|1|||
146659502|NCT01298531|528932047|FG001|Overall Study|Protocol Violation|1|||
146659503|NCT01298531|528932046|FG000|Overall Study|Adverse Event|4|||
146659504|NCT01298531|528932047|FG001|Overall Study|Adverse Event|3|||
146659505|NCT01298531|528932046|FG000|Overall Study|Does not meet entrance criteria|0|||
146659506|NCT01298531|528932047|FG001|Overall Study|Does not meet entrance criteria|1|||
146659507|NCT01298531|528932046|FG000|Overall Study|Other|2|||
146659508|NCT01298531|528932047|FG001|Overall Study|Other|1|||
146925077|NCT03583372|529885920|FG002|Overall Study|Protocol Violation|0|||
146925078|NCT03583372|529885921|FG003|Overall Study|Protocol Violation|0|||
146773623|NCT00350792|529341127|FG000|Overall Study|Withdrawal by Subject|4|||
146773624|NCT00350792|529341127|FG000|Overall Study|Physician Decision|2|||
146925079|NCT03583372|529885918|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
146925080|NCT03583372|529885919|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
146925081|NCT03583372|529885920|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
146925082|NCT03583372|529885921|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
146925083|NCT03583372|529885918|FG000|Overall Study|Did Not Receive Study Drug|0|||
146925084|NCT03583372|529885919|FG001|Overall Study|Did Not Receive Study Drug|1|||
146925085|NCT03583372|529885920|FG002|Overall Study|Did Not Receive Study Drug|0|||
146925086|NCT03583372|529885921|FG003|Overall Study|Did Not Receive Study Drug|0|||
146925087|NCT03583372|529885918|FG000|Overall Study|Captured as Other in the Database|1|||
146925088|NCT03583372|529885919|FG001|Overall Study|Captured as Other in the Database|2|||
146925089|NCT03583372|529885920|FG002|Overall Study|Captured as Other in the Database|4|||
146925090|NCT03583372|529885921|FG003|Overall Study|Captured as Other in the Database|1|||
146617160|NCT00543387|528769174|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
146617161|NCT00543387|528769175|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
146617162|NCT00543387|528769176|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
146617163|NCT00543387|528769177|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
146617164|NCT00543387|528769178|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
146617165|NCT00543387|528769179|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
146617166|NCT00543387|528769180|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
146617167|NCT00543387|528769170|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146617168|NCT00543387|528769171|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146617169|NCT00543387|528769172|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146617170|NCT00543387|528769173|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146617171|NCT00543387|528769174|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146617172|NCT00543387|528769175|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146617173|NCT00543387|528769176|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
146617174|NCT00543387|528769177|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146617175|NCT00543387|528769178|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146617176|NCT00543387|528769179|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146617177|NCT00543387|528769180|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146617178|NCT00543387|528769170|FG000|Crossover Participants|Progressive Disease|0|||
146617179|NCT00543387|528769171|FG001|Crossover Participants|Progressive Disease|0|||
146617180|NCT00543387|528769172|FG002|Crossover Participants|Progressive Disease|0|||
146617181|NCT00543387|528769173|FG003|Crossover Participants|Progressive Disease|0|||
146617182|NCT00543387|528769174|FG004|Crossover Participants|Progressive Disease|0|||
146617183|NCT00543387|528769175|FG005|Crossover Participants|Progressive Disease|0|||
146617184|NCT00543387|528769176|FG006|Crossover Participants|Progressive Disease|0|||
146617185|NCT00543387|528769177|FG007|Crossover Participants|Progressive Disease|0|||
146617186|NCT00543387|528769178|FG008|Crossover Participants|Progressive Disease|0|||
146617187|NCT00543387|528769179|FG009|Crossover Participants|Progressive Disease|1|||
146617188|NCT00543387|528769180|FG010|Crossover Participants|Progressive Disease|2|||
146617189|NCT00543387|528769170|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
146617190|NCT00543387|528769171|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
146617191|NCT00543387|528769172|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
146617192|NCT00543387|528769173|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
146617193|NCT00543387|528769174|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
146617194|NCT00543387|528769175|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
146617195|NCT00543387|528769176|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
146617196|NCT00543387|528769177|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
146617197|NCT00543387|528769178|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
146617198|NCT00543387|528769179|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
146617199|NCT00543387|528769180|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
146617200|NCT01792115|528769184|FG000|Overall Study|Lost to Follow-up|0|||
146617201|NCT01792115|528769185|FG001|Overall Study|Lost to Follow-up|1|||
146617202|NCT01792115|528769186|FG002|Overall Study|Lost to Follow-up|0|||
146617203|NCT03790111|528770802|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
146617204|NCT02796677|528770807|FG000|Overall Study|Adverse Event|11|||
146617205|NCT02796677|528770808|FG001|Overall Study|Adverse Event|22|||
146617206|NCT02796677|528770809|FG002|Overall Study|Adverse Event|14|||
146617207|NCT02796677|528770810|FG003|Overall Study|Adverse Event|14|||
146617208|NCT02796677|528770807|FG000|Overall Study|Protocol Violation|7|||
146617209|NCT02796677|528770808|FG001|Overall Study|Protocol Violation|5|||
146617210|NCT02796677|528770809|FG002|Overall Study|Protocol Violation|4|||
146617211|NCT02796677|528770810|FG003|Overall Study|Protocol Violation|8|||
146617212|NCT02796677|528770807|FG000|Overall Study|Lost to Follow-up|1|||
146617213|NCT02796677|528770808|FG001|Overall Study|Lost to Follow-up|5|||
146617214|NCT02796677|528770809|FG002|Overall Study|Lost to Follow-up|2|||
146617215|NCT02796677|528770810|FG003|Overall Study|Lost to Follow-up|2|||
146617216|NCT02796677|528770807|FG000|Overall Study|Lack of Efficacy|7|||
146617217|NCT02796677|528770808|FG001|Overall Study|Lack of Efficacy|9|||
146925091|NCT02796391|529885922|FG000|Overall Study|Lost to Follow-up|2|||
146659509|NCT03646643|528932048|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
146659510|NCT03646643|528932049|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
146659511|NCT03646643|528932048|FG000|Overall Study|Lost to Follow-up|0|||
146659512|NCT03646643|528932049|FG001|Overall Study|Lost to Follow-up|1|||
146659513|NCT05314478|528932052|FG000|Overall Study|Physician Decision|1|||
146659514|NCT02007512|528932053|FG000|Double Blind Treatment Period|Adverse Event|4|||
146659515|NCT02007512|528932054|FG001|Double Blind Treatment Period|Adverse Event|6|||
146659516|NCT02007512|528932055|FG002|Double Blind Treatment Period|Adverse Event|2|||
146659517|NCT02007512|528932056|FG003|Double Blind Treatment Period|Adverse Event|2|||
146659518|NCT02007512|528932053|FG000|Double Blind Treatment Period|Death|1|||
146659519|NCT02007512|528932054|FG001|Double Blind Treatment Period|Death|0|||
146659520|NCT02007512|528932055|FG002|Double Blind Treatment Period|Death|0|||
146659521|NCT02007512|528932056|FG003|Double Blind Treatment Period|Death|0|||
146659522|NCT02007512|528932053|FG000|Double Blind Treatment Period|Disease progression|51|||
146659523|NCT02007512|528932054|FG001|Double Blind Treatment Period|Disease progression|50|||
146659524|NCT02007512|528932055|FG002|Double Blind Treatment Period|Disease progression|57|||
146659525|NCT02007512|528932056|FG003|Double Blind Treatment Period|Disease progression|52|||
146659526|NCT02007512|528932053|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
146659527|NCT02007512|528932054|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
146659528|NCT02007512|528932055|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
146659529|NCT02007512|528932056|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
146659530|NCT02007512|528932053|FG000|Double Blind Treatment Period|Protocol Violation|1|||
146659531|NCT02007512|528932054|FG001|Double Blind Treatment Period|Protocol Violation|0|||
146659532|NCT02007512|528932055|FG002|Double Blind Treatment Period|Protocol Violation|0|||
146659533|NCT02007512|528932056|FG003|Double Blind Treatment Period|Protocol Violation|1|||
146659534|NCT02007512|528932053|FG000|Double Blind Treatment Period|Other|2|||
146659535|NCT02007512|528932054|FG001|Double Blind Treatment Period|Other|1|||
146659536|NCT02007512|528932055|FG002|Double Blind Treatment Period|Other|1|||
146659537|NCT02007512|528932056|FG003|Double Blind Treatment Period|Other|2|||
146659538|NCT02007512|528932053|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
146659539|NCT02007512|528932054|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
146659540|NCT02007512|528932055|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
146659541|NCT02007512|528932056|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
146659542|NCT02007512|528932053|FG000|Open Label Treatment Period|Adverse Event|1|||
146659543|NCT02007512|528932054|FG001|Open Label Treatment Period|Adverse Event|0|||
146659544|NCT02007512|528932055|FG002|Open Label Treatment Period|Adverse Event|0|||
146659545|NCT02007512|528932056|FG003|Open Label Treatment Period|Adverse Event|0|||
146659546|NCT02007512|528932053|FG000|Open Label Treatment Period|Other|1|||
146659547|NCT02007512|528932054|FG001|Open Label Treatment Period|Other|1|||
146659548|NCT02007512|528932055|FG002|Open Label Treatment Period|Other|0|||
146659549|NCT02007512|528932056|FG003|Open Label Treatment Period|Other|0|||
146659550|NCT02007512|528932053|FG000|Open Label Treatment Period|Disease progression|23|||
146659551|NCT02007512|528932054|FG001|Open Label Treatment Period|Disease progression|11|||
146659552|NCT02007512|528932055|FG002|Open Label Treatment Period|Disease progression|0|||
146659553|NCT02007512|528932056|FG003|Open Label Treatment Period|Disease progression|0|||
146659554|NCT04629508|528932057|FG000|Overall Study|Adverse Event|1|||
146659555|NCT04629508|528932057|FG000|Overall Study|Death|2|||
146659556|NCT04629508|528932057|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
146659557|NCT04073368|528932062|FG000|Overall Study|Adverse Event|2|||
146659558|NCT04073368|528932063|FG001|Overall Study|Adverse Event|0|||
146659559|NCT04073368|528932064|FG002|Overall Study|Adverse Event|1|||
146659560|NCT04073368|528932065|FG003|Overall Study|Adverse Event|1|||
146659561|NCT04073368|528932062|FG000|Overall Study|Withdrawal by Subject|2|||
146659562|NCT04073368|528932063|FG001|Overall Study|Withdrawal by Subject|2|||
146659563|NCT04073368|528932064|FG002|Overall Study|Withdrawal by Subject|1|||
146659564|NCT04073368|528932065|FG003|Overall Study|Withdrawal by Subject|1|||
146659565|NCT04073368|528932062|FG000|Overall Study|Lost to Follow-up|1|||
146659566|NCT04073368|528932063|FG001|Overall Study|Lost to Follow-up|1|||
146659567|NCT04073368|528932064|FG002|Overall Study|Lost to Follow-up|1|||
146659568|NCT04073368|528932065|FG003|Overall Study|Lost to Follow-up|0|||
146773625|NCT00350792|529341127|FG000|Overall Study|Lack of Efficacy|11|||
146773626|NCT01792830|529341131|FG000|Overall Study|Withdrawal by Subject|22|||
146773627|NCT01792830|529341132|FG001|Overall Study|Withdrawal by Subject|0|||
146773628|NCT01792830|529341133|FG002|Overall Study|Withdrawal by Subject|0|||
146659569|NCT04073368|528932062|FG000|Overall Study|Protocol Violation|0|||
146659570|NCT04073368|528932063|FG001|Overall Study|Protocol Violation|1|||
146659571|NCT04073368|528932064|FG002|Overall Study|Protocol Violation|0|||
146659572|NCT04073368|528932065|FG003|Overall Study|Protocol Violation|0|||
146659573|NCT04073368|528932062|FG000|Overall Study|Subject noncompliance|7|||
146659574|NCT04073368|528932063|FG001|Overall Study|Subject noncompliance|4|||
146659575|NCT04073368|528932064|FG002|Overall Study|Subject noncompliance|0|||
146659576|NCT04073368|528932065|FG003|Overall Study|Subject noncompliance|0|||
146659577|NCT00145600|528932066|FG000|Overall Study|Death|1|||
146659578|NCT00145600|528932067|FG001|Overall Study|Death|2|||
146659579|NCT00145600|528932068|FG002|Overall Study|Death|2|||
146659580|NCT00145600|528932069|FG003|Overall Study|Death|6|||
146659581|NCT00145600|528932066|FG000|Overall Study|Ineligible|3|||
146659582|NCT00145600|528932067|FG001|Overall Study|Ineligible|0|||
146659583|NCT00145600|528932068|FG002|Overall Study|Ineligible|1|||
146659584|NCT00145600|528932069|FG003|Overall Study|Ineligible|5|||
146659585|NCT00145600|528932066|FG000|Overall Study|Lost to Follow-up|2|||
146659586|NCT00145600|528932067|FG001|Overall Study|Lost to Follow-up|6|||
146659587|NCT00145600|528932068|FG002|Overall Study|Lost to Follow-up|2|||
146659588|NCT00145600|528932069|FG003|Overall Study|Lost to Follow-up|4|||
146659589|NCT00145600|528932066|FG000|Overall Study|Noncompliance|1|||
146659590|NCT00145600|528932067|FG001|Overall Study|Noncompliance|0|||
146659591|NCT00145600|528932068|FG002|Overall Study|Noncompliance|0|||
146659592|NCT00145600|528932069|FG003|Overall Study|Noncompliance|0|||
146659593|NCT00145600|528932066|FG000|Overall Study|Withdrawal by Subject|1|||
146659594|NCT00145600|528932067|FG001|Overall Study|Withdrawal by Subject|2|||
146659595|NCT00145600|528932068|FG002|Overall Study|Withdrawal by Subject|0|||
146659596|NCT00145600|528932069|FG003|Overall Study|Withdrawal by Subject|1|||
146659597|NCT01229397|528932070|FG000|Overall Study|Withdrawal by Subject|3|||
146659598|NCT01229397|528932071|FG001|Overall Study|Withdrawal by Subject|3|||
146659599|NCT01229397|528932070|FG000|Overall Study|Lost to Follow-up|7|||
146659600|NCT01229397|528932071|FG001|Overall Study|Lost to Follow-up|6|||
146659601|NCT01229397|528932070|FG000|Overall Study|Migrated/moved from study area|1|||
146659602|NCT01229397|528932071|FG001|Overall Study|Migrated/moved from study area|0|||
146659603|NCT00608543|528932072|FG000|Overall Study|Adverse Event|4|||
146659604|NCT04087213|528932077|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
146659605|NCT04087213|528932077|FG000|In-Facility Introduction|Adverse Event|1|||
146659606|NCT04087213|528932077|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
146659607|NCT04087213|528932077|FG000|Assisted Evaluable Period|Personal reasons|3|||
146659608|NCT04087213|528932077|FG000|Transition Period B|Renal Transplantation|1|||
146659609|NCT01134315|528932079|FG000|Overall Study|Adverse Event|1|||
146659610|NCT01134315|528932080|FG001|Overall Study|Adverse Event|2|||
146659611|NCT01134315|528932079|FG000|Overall Study|Other Reason|8|||
146659612|NCT01134315|528932080|FG001|Overall Study|Other Reason|17|||
146659613|NCT02545075|528932083|FG000|Randomization|Lost to Follow-up|0|||
146659614|NCT02545075|528932084|FG001|Randomization|Lost to Follow-up|1|||
146659615|NCT02545075|528932083|FG000|Randomization|Withdrawal by Subject|0|||
146659616|NCT02545075|528932084|FG001|Randomization|Withdrawal by Subject|6|||
146659617|NCT02545075|528932083|FG000|Treatment|Disease progression|71|||
146659618|NCT02545075|528932084|FG001|Treatment|Disease progression|32|||
146659619|NCT02545075|528932083|FG000|Treatment|Participant dicontinued study treatment|7|||
146659620|NCT02545075|528932084|FG001|Treatment|Participant dicontinued study treatment|9|||
146659621|NCT02545075|528932083|FG000|Treatment|Withdrawal by Subject|1|||
146659622|NCT02545075|528932084|FG001|Treatment|Withdrawal by Subject|0|||
146978726|NCT00275028|530085482|FG000|Overall Study|Withdrew consent before treatment began|1|||
146659623|NCT02545075|528932083|FG000|Treatment|Adverse event not related to study drug|1|||
146659624|NCT02545075|528932084|FG001|Treatment|Adverse event not related to study drug|0|||
146659625|NCT02545075|528932083|FG000|Treatment|Death|1|||
146659626|NCT02545075|528932084|FG001|Treatment|Death|0|||
146659627|NCT02545075|528932083|FG000|Treatment|Participant drug toxicity|1|||
146659628|NCT02545075|528932084|FG001|Treatment|Participant drug toxicity|0|||
146659629|NCT02545075|528932083|FG000|Treatment|Completed treatment|40|||
146659630|NCT02545075|528932084|FG001|Treatment|Completed treatment|12|||
146659631|NCT05246397|528932088|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
146659632|NCT00735254|528932089|FG000|Overall Study|Protocol Violation|1|||
146659633|NCT00735254|528932090|FG001|Overall Study|Protocol Violation|1|||
146659634|NCT00735254|528932091|FG002|Overall Study|Protocol Violation|1|||
146659635|NCT00735254|528932092|FG003|Overall Study|Protocol Violation|0|||
146659636|NCT00147251|528932100|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
146659637|NCT00147251|528932101|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
146659638|NCT00751621|528932102|FG000|Overall Study|Adverse Event|1|||
146978727|NCT00275028|530085482|FG000|Overall Study|Withdrawal by Subject|5|||
146978728|NCT00275028|530085482|FG000|Overall Study|Adverse Event|9|||
146659639|NCT00751621|528932102|FG000|Overall Study|Withdrawal by Subject|1|||
146659640|NCT00751621|528932102|FG000|Overall Study|Subject moved to another country|1|||
146659641|NCT00751621|528932102|FG000|Overall Study|Poor adherence to asthma treatment|1|||
146659642|NCT02694523|528932108|FG000|Part A|Adverse Event|7|||
146659643|NCT02694523|528932109|FG001|Part A|Adverse Event|3|||
146659644|NCT02694523|528932110|FG002|Part A|Adverse Event|0|||
146659645|NCT02694523|528932111|FG003|Part A|Adverse Event|0|||
146659646|NCT02694523|528932112|FG004|Part A|Adverse Event|0|||
146659647|NCT02694523|528932113|FG005|Part A|Adverse Event|0|||
146659648|NCT02694523|528932114|FG006|Part A|Adverse Event|0|||
146659649|NCT02694523|528932108|FG000|Part A|Protocol Violation|1|||
146659650|NCT02694523|528932109|FG001|Part A|Protocol Violation|0|||
146659651|NCT02694523|528932110|FG002|Part A|Protocol Violation|0|||
146659652|NCT02694523|528932111|FG003|Part A|Protocol Violation|0|||
146659653|NCT02694523|528932112|FG004|Part A|Protocol Violation|0|||
146659654|NCT02694523|528932113|FG005|Part A|Protocol Violation|0|||
146659655|NCT02694523|528932114|FG006|Part A|Protocol Violation|0|||
146659656|NCT02694523|528932108|FG000|Part A|Lost to Follow-up|1|||
146659657|NCT02694523|528932109|FG001|Part A|Lost to Follow-up|2|||
146659658|NCT02694523|528932110|FG002|Part A|Lost to Follow-up|0|||
146659659|NCT02694523|528932111|FG003|Part A|Lost to Follow-up|0|||
146659660|NCT02694523|528932112|FG004|Part A|Lost to Follow-up|0|||
146659661|NCT02694523|528932113|FG005|Part A|Lost to Follow-up|0|||
146659662|NCT02694523|528932114|FG006|Part A|Lost to Follow-up|0|||
146659663|NCT02694523|528932108|FG000|Part A|Withdrawal by Subject|3|||
146659664|NCT02694523|528932109|FG001|Part A|Withdrawal by Subject|1|||
146659665|NCT02694523|528932110|FG002|Part A|Withdrawal by Subject|0|||
146659666|NCT02694523|528932111|FG003|Part A|Withdrawal by Subject|0|||
146659667|NCT02694523|528932112|FG004|Part A|Withdrawal by Subject|0|||
146659668|NCT02694523|528932113|FG005|Part A|Withdrawal by Subject|0|||
146659669|NCT02694523|528932114|FG006|Part A|Withdrawal by Subject|0|||
146659670|NCT02694523|528932108|FG000|Part A|Other|1|||
146659671|NCT02694523|528932109|FG001|Part A|Other|1|||
146659672|NCT02694523|528932110|FG002|Part A|Other|0|||
146659673|NCT02694523|528932111|FG003|Part A|Other|0|||
146659674|NCT02694523|528932112|FG004|Part A|Other|0|||
146659675|NCT02694523|528932113|FG005|Part A|Other|0|||
146659676|NCT02694523|528932114|FG006|Part A|Other|0|||
146659677|NCT02694523|528932108|FG000|Part B|Adverse Event|0|||
146659678|NCT02694523|528932109|FG001|Part B|Adverse Event|0|||
146659679|NCT02694523|528932110|FG002|Part B|Adverse Event|7|||
146659680|NCT02694523|528932111|FG003|Part B|Adverse Event|1|||
146659681|NCT02694523|528932112|FG004|Part B|Adverse Event|1|||
146659682|NCT02694523|528932113|FG005|Part B|Adverse Event|2|||
146659683|NCT02694523|528932114|FG006|Part B|Adverse Event|0|||
146659684|NCT02694523|528932108|FG000|Part B|Protocol Violation|0|||
146659685|NCT02694523|528932109|FG001|Part B|Protocol Violation|0|||
146659686|NCT02694523|528932110|FG002|Part B|Protocol Violation|1|||
146659687|NCT02694523|528932111|FG003|Part B|Protocol Violation|0|||
146659688|NCT02694523|528932112|FG004|Part B|Protocol Violation|0|||
146659689|NCT02694523|528932113|FG005|Part B|Protocol Violation|0|||
146659690|NCT02694523|528932114|FG006|Part B|Protocol Violation|0|||
146659691|NCT02694523|528932108|FG000|Part B|Lost to Follow-up|0|||
146659692|NCT02694523|528932109|FG001|Part B|Lost to Follow-up|0|||
146659693|NCT02694523|528932110|FG002|Part B|Lost to Follow-up|2|||
146659694|NCT02694523|528932111|FG003|Part B|Lost to Follow-up|3|||
146659695|NCT02694523|528932112|FG004|Part B|Lost to Follow-up|2|||
146659696|NCT02694523|528932113|FG005|Part B|Lost to Follow-up|0|||
146659697|NCT02694523|528932114|FG006|Part B|Lost to Follow-up|1|||
146659698|NCT02694523|528932108|FG000|Part B|Withdrawal by Subject|0|||
146659699|NCT02694523|528932109|FG001|Part B|Withdrawal by Subject|0|||
146659700|NCT02694523|528932110|FG002|Part B|Withdrawal by Subject|9|||
146659701|NCT02694523|528932111|FG003|Part B|Withdrawal by Subject|0|||
146659702|NCT02694523|528932112|FG004|Part B|Withdrawal by Subject|1|||
146659703|NCT02694523|528932113|FG005|Part B|Withdrawal by Subject|3|||
146659704|NCT02694523|528932114|FG006|Part B|Withdrawal by Subject|0|||
146659705|NCT02694523|528932108|FG000|Part B|Other|0|||
146659706|NCT02694523|528932109|FG001|Part B|Other|0|||
146659707|NCT02694523|528932110|FG002|Part B|Other|1|||
146659708|NCT02694523|528932111|FG003|Part B|Other|0|||
146659709|NCT02694523|528932112|FG004|Part B|Other|0|||
146659710|NCT02694523|528932113|FG005|Part B|Other|0|||
146659711|NCT02694523|528932114|FG006|Part B|Other|1|||
146659712|NCT01086423|528932115|FG000|Overall Study|Protocol Violation|0|||
146659713|NCT01086423|528932116|FG001|Overall Study|Protocol Violation|0|||
146659714|NCT01086423|528932117|FG002|Overall Study|Protocol Violation|1|||
146659715|NCT01086423|528932115|FG000|Overall Study|Migrated/moved from study area|2|||
146659716|NCT01086423|528932116|FG001|Overall Study|Migrated/moved from study area|0|||
146925092|NCT02796391|529885923|FG001|Overall Study|Lost to Follow-up|2|||
146925093|NCT02796391|529885924|FG002|Overall Study|Lost to Follow-up|13|||
146925094|NCT02796391|529885925|FG003|Overall Study|Lost to Follow-up|8|||
146659717|NCT01086423|528932117|FG002|Overall Study|Migrated/moved from study area|4|||
146659718|NCT01086423|528932115|FG000|Overall Study|Adverse event, fatal|1|||
146659719|NCT01086423|528932116|FG001|Overall Study|Adverse event, fatal|1|||
146659720|NCT01086423|528932117|FG002|Overall Study|Adverse event, fatal|0|||
146659721|NCT01086423|528932115|FG000|Overall Study|Adverse event, non-fatal|2|||
146659722|NCT01086423|528932116|FG001|Overall Study|Adverse event, non-fatal|1|||
146659723|NCT01086423|528932117|FG002|Overall Study|Adverse event, non-fatal|0|||
146659724|NCT01086423|528932115|FG000|Overall Study|Withdrawal by Subject|5|||
146659725|NCT01086423|528932116|FG001|Overall Study|Withdrawal by Subject|1|||
146659726|NCT01086423|528932117|FG002|Overall Study|Withdrawal by Subject|3|||
146659727|NCT01086423|528932115|FG000|Overall Study|Lost to Follow-up|0|||
146659728|NCT01086423|528932116|FG001|Overall Study|Lost to Follow-up|0|||
146659729|NCT01086423|528932117|FG002|Overall Study|Lost to Follow-up|1|||
146659730|NCT00984568|528932119|FG000|Overall Study|Withdrawal by Subject|1|||
146659731|NCT00984568|528932120|FG001|Overall Study|Withdrawal by Subject|2|||
146659732|NCT00984568|528932119|FG000|Overall Study|Lack of Efficacy|2|||
146659733|NCT00984568|528932120|FG001|Overall Study|Lack of Efficacy|0|||
146659734|NCT00984568|528932119|FG000|Overall Study|Adverse Event|2|||
146659735|NCT00984568|528932120|FG001|Overall Study|Adverse Event|0|||
146925095|NCT02796391|529885926|FG004|Overall Study|Lost to Follow-up|14|||
146925096|NCT02796391|529885927|FG005|Overall Study|Lost to Follow-up|13|||
146925097|NCT02796391|529885922|FG000|Overall Study|COVID|0|||
146925098|NCT02796391|529885923|FG001|Overall Study|COVID|0|||
146925099|NCT02796391|529885924|FG002|Overall Study|COVID|5|||
146925100|NCT02796391|529885925|FG003|Overall Study|COVID|5|||
146925101|NCT02796391|529885926|FG004|Overall Study|COVID|2|||
146659736|NCT00984568|528932119|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
146659737|NCT00984568|528932120|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
146659738|NCT00984568|528932119|FG000|Overall Study|Lost to Follow-up|0|||
146659739|NCT00984568|528932120|FG001|Overall Study|Lost to Follow-up|1|||
146659740|NCT00984568|528932119|FG000|Overall Study|Opportunistic Infection|1|||
146659741|NCT00984568|528932120|FG001|Overall Study|Opportunistic Infection|0|||
146659742|NCT00984568|528932119|FG000|Overall Study|Unknown Reason|1|||
146659743|NCT00984568|528932120|FG001|Overall Study|Unknown Reason|3|||
146659744|NCT04505540|528932121|FG000|Baseline|Protocol Violation|10|||
146659745|NCT04505540|528932121|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
146659746|NCT04505540|528932121|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
146659747|NCT04505540|528932121|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
146659748|NCT04505540|528932121|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
146659749|NCT04505540|528932121|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
146659750|NCT04505540|528932121|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
146659751|NCT04505540|528932121|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
146659752|NCT04505540|528932121|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
146659753|NCT04505540|528932121|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
146659754|NCT04505540|528932121|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
146659755|NCT04505540|528932121|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
146659756|NCT04505540|528932121|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
146659757|NCT02057393|528932124|FG000|Overall Study|Withdrawal by Subject|1|||
146659758|NCT02057393|528932124|FG000|Overall Study|Patient did not meet criteria|1|||
146659759|NCT03180684|528932125|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
146659760|NCT03180684|528932126|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
146659761|NCT03180684|528932125|FG000|Overall Study|Physician Decision|1|||
146659762|NCT03180684|528932126|FG001|Overall Study|Physician Decision|0|||
146659763|NCT03180684|528932125|FG000|Overall Study|Lost to Follow-up|1|||
146659764|NCT03180684|528932126|FG001|Overall Study|Lost to Follow-up|0|||
146659765|NCT03180684|528932125|FG000|Overall Study|Progressive Disease|1|||
146659766|NCT03180684|528932126|FG001|Overall Study|Progressive Disease|0|||
146659767|NCT03091777|528932127|FG000|Overall Study|Pregnancy|2|||
146659768|NCT03091777|528932128|FG001|Overall Study|Pregnancy|1|||
146659769|NCT03091777|528932129|FG002|Overall Study|Pregnancy|0|||
146659770|NCT03091777|528932127|FG000|Overall Study|Adverse Event|2|||
146659771|NCT03091777|528932128|FG001|Overall Study|Adverse Event|1|||
146659772|NCT03091777|528932129|FG002|Overall Study|Adverse Event|4|||
146659773|NCT03091777|528932127|FG000|Overall Study|Withdrawal by Subject|4|||
146659774|NCT03091777|528932128|FG001|Overall Study|Withdrawal by Subject|2|||
146659775|NCT03091777|528932129|FG002|Overall Study|Withdrawal by Subject|6|||
146659776|NCT03091777|528932127|FG000|Overall Study|Protocol Violation|2|||
146659777|NCT03091777|528932128|FG001|Overall Study|Protocol Violation|1|||
146659778|NCT03091777|528932129|FG002|Overall Study|Protocol Violation|1|||
146659779|NCT03091777|528932127|FG000|Overall Study|Lost to Follow-up|12|||
146659780|NCT03091777|528932128|FG001|Overall Study|Lost to Follow-up|14|||
146659781|NCT03091777|528932129|FG002|Overall Study|Lost to Follow-up|7|||
146659782|NCT03091777|528932127|FG000|Overall Study|Lack of Efficacy|0|||
146659783|NCT03091777|528932128|FG001|Overall Study|Lack of Efficacy|0|||
146659784|NCT03091777|528932129|FG002|Overall Study|Lack of Efficacy|5|||
146659785|NCT03091777|528932127|FG000|Overall Study|Noncompliance with study drug|2|||
146773629|NCT01792830|529341134|FG003|Overall Study|Withdrawal by Subject|2|||
146773630|NCT01792830|529341135|FG004|Overall Study|Withdrawal by Subject|1|||
146773631|NCT01792830|529341136|FG005|Overall Study|Withdrawal by Subject|1|||
146773632|NCT01792830|529341137|FG006|Overall Study|Withdrawal by Subject|1|||
146925102|NCT02796391|529885927|FG005|Overall Study|COVID|4|||
146925103|NCT02796391|529885922|FG000|Overall Study|Participant did not like study cigarettes|0|||
146925104|NCT02796391|529885923|FG001|Overall Study|Participant did not like study cigarettes|0|||
146925105|NCT02796391|529885924|FG002|Overall Study|Participant did not like study cigarettes|3|||
146659786|NCT03091777|528932128|FG001|Overall Study|Noncompliance with study drug|3|||
146659787|NCT03091777|528932129|FG002|Overall Study|Noncompliance with study drug|1|||
146659788|NCT03091777|528932127|FG000|Overall Study|Physician Decision|1|||
146659789|NCT03091777|528932128|FG001|Overall Study|Physician Decision|0|||
146659790|NCT03091777|528932129|FG002|Overall Study|Physician Decision|1|||
146659791|NCT03091777|528932127|FG000|Overall Study|Abnormal Laboratory Value|7|||
146659792|NCT03091777|528932128|FG001|Overall Study|Abnormal Laboratory Value|11|||
146659793|NCT03091777|528932129|FG002|Overall Study|Abnormal Laboratory Value|12|||
146925106|NCT02796391|529885925|FG003|Overall Study|Participant did not like study cigarettes|0|||
146925107|NCT02796391|529885926|FG004|Overall Study|Participant did not like study cigarettes|0|||
146925108|NCT02796391|529885927|FG005|Overall Study|Participant did not like study cigarettes|0|||
146925109|NCT02796391|529885922|FG000|Overall Study|Withdrawal by Subject|1|||
146925110|NCT02796391|529885923|FG001|Overall Study|Withdrawal by Subject|1|||
146925111|NCT02796391|529885924|FG002|Overall Study|Withdrawal by Subject|4|||
146925112|NCT02796391|529885925|FG003|Overall Study|Withdrawal by Subject|3|||
146925113|NCT02796391|529885926|FG004|Overall Study|Withdrawal by Subject|4|||
146925114|NCT02796391|529885927|FG005|Overall Study|Withdrawal by Subject|3|||
146617218|NCT02796677|528770809|FG002|Overall Study|Lack of Efficacy|14|||
146617219|NCT02796677|528770810|FG003|Overall Study|Lack of Efficacy|20|||
146617220|NCT02796677|528770807|FG000|Overall Study|Withdrawal by Subject|4|||
146617221|NCT02796677|528770808|FG001|Overall Study|Withdrawal by Subject|14|||
146617222|NCT02796677|528770809|FG002|Overall Study|Withdrawal by Subject|6|||
146617223|NCT02796677|528770810|FG003|Overall Study|Withdrawal by Subject|7|||
146617224|NCT02796677|528770807|FG000|Overall Study|Progressive disease|6|||
146617225|NCT02796677|528770808|FG001|Overall Study|Progressive disease|15|||
146617226|NCT02796677|528770809|FG002|Overall Study|Progressive disease|13|||
146617227|NCT02796677|528770810|FG003|Overall Study|Progressive disease|18|||
146617228|NCT02796677|528770807|FG000|Overall Study|Reason not mentioned|2|||
146617229|NCT02796677|528770808|FG001|Overall Study|Reason not mentioned|3|||
146617230|NCT02796677|528770809|FG002|Overall Study|Reason not mentioned|0|||
146617231|NCT02796677|528770810|FG003|Overall Study|Reason not mentioned|5|||
146617232|NCT03798717|528770811|FG000|Overall Study|Failed Screening|0|||
146617233|NCT03798717|528770812|FG001|Overall Study|Failed Screening|0|||
146617234|NCT03798717|528770813|FG002|Overall Study|Failed Screening|0|||
146617235|NCT03798717|528770814|FG003|Overall Study|Failed Screening|0|||
146617236|NCT03798717|528770815|FG004|Overall Study|Failed Screening|0|||
146617237|NCT03798717|528770816|FG005|Overall Study|Failed Screening|1|||
146617238|NCT03798717|528770811|FG000|Overall Study|Physician Decision|1|||
146617239|NCT03798717|528770812|FG001|Overall Study|Physician Decision|0|||
146617240|NCT03798717|528770813|FG002|Overall Study|Physician Decision|1|||
146617241|NCT03798717|528770814|FG003|Overall Study|Physician Decision|0|||
146617242|NCT03798717|528770815|FG004|Overall Study|Physician Decision|0|||
146617243|NCT03798717|528770816|FG005|Overall Study|Physician Decision|0|||
146617244|NCT03798717|528770811|FG000|Overall Study|Withdrawal by Subject|0|||
146617245|NCT03798717|528770812|FG001|Overall Study|Withdrawal by Subject|0|||
146617246|NCT03798717|528770813|FG002|Overall Study|Withdrawal by Subject|0|||
146617247|NCT03798717|528770814|FG003|Overall Study|Withdrawal by Subject|1|||
146617248|NCT03798717|528770815|FG004|Overall Study|Withdrawal by Subject|0|||
146617249|NCT03798717|528770816|FG005|Overall Study|Withdrawal by Subject|0|||
146617250|NCT03798717|528770811|FG000|Overall Study|Lost to Follow-up|1|||
146617251|NCT03798717|528770812|FG001|Overall Study|Lost to Follow-up|0|||
146617252|NCT03798717|528770813|FG002|Overall Study|Lost to Follow-up|0|||
146617253|NCT03798717|528770814|FG003|Overall Study|Lost to Follow-up|1|||
146617254|NCT03798717|528770815|FG004|Overall Study|Lost to Follow-up|0|||
146617255|NCT03798717|528770816|FG005|Overall Study|Lost to Follow-up|0|||
146617256|NCT03798717|528770811|FG000|Overall Study|Adverse Event|0|||
146617257|NCT03798717|528770812|FG001|Overall Study|Adverse Event|1|||
146617258|NCT03798717|528770813|FG002|Overall Study|Adverse Event|0|||
146617259|NCT03798717|528770814|FG003|Overall Study|Adverse Event|0|||
146617260|NCT03798717|528770815|FG004|Overall Study|Adverse Event|0|||
146617261|NCT03798717|528770816|FG005|Overall Study|Adverse Event|0|||
146617262|NCT03798717|528770811|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
146617263|NCT03798717|528770812|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
146617264|NCT03798717|528770813|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
146617265|NCT03798717|528770814|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
146617266|NCT03798717|528770815|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
146617267|NCT03798717|528770816|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
146617268|NCT04002960|528770818|FG000|Overall Study|Withdrawn prior to Completion|2|||
146617269|NCT00961181|528770819|FG000|Overall Study|Death|2|||
146617270|NCT00961181|528770819|FG000|Overall Study|Withdrawal by Subject|2|||
146617271|NCT00961181|528770819|FG000|Overall Study|Lost to Follow-up|1|||
146617272|NCT03212326|528770820|FG000|Overall Study|Physician Decision|4|||
146617273|NCT01790594|528770830|FG000|Overall Study|Death|1|||
146617274|NCT01790594|528770831|FG001|Overall Study|Death|0|||
146617275|NCT01790594|528770832|FG002|Overall Study|Death|0|||
146617276|NCT01790594|528770830|FG000|Overall Study|Physician Decision|2|||
146617277|NCT01790594|528770831|FG001|Overall Study|Physician Decision|1|||
146617278|NCT01790594|528770832|FG002|Overall Study|Physician Decision|0|||
146617279|NCT01790594|528770830|FG000|Overall Study|Withdrawal by Subject|2|||
146617280|NCT01790594|528770831|FG001|Overall Study|Withdrawal by Subject|0|||
146617281|NCT01790594|528770832|FG002|Overall Study|Withdrawal by Subject|0|||
146617282|NCT01790594|528770830|FG000|Overall Study|Transplant was not done|0|||
146617283|NCT01790594|528770831|FG001|Overall Study|Transplant was not done|0|||
146617284|NCT01790594|528770832|FG002|Overall Study|Transplant was not done|3|||
146617285|NCT01790594|528770830|FG000|Overall Study|Terminated prior to week 76|0|||
146617286|NCT01790594|528770831|FG001|Overall Study|Terminated prior to week 76|2|||
146617287|NCT01790594|528770832|FG002|Overall Study|Terminated prior to week 76|0|||
146773633|NCT01792830|529341138|FG007|Overall Study|Withdrawal by Subject|1|||
146773634|NCT01792830|529341139|FG008|Overall Study|Withdrawal by Subject|7|||
146773635|NCT01792830|529341140|FG009|Overall Study|Withdrawal by Subject|0|||
146773636|NCT01792830|529341141|FG010|Overall Study|Withdrawal by Subject|2|||
146659794|NCT01437878|528932130|FG000|Overall Study|Withdrawal by Subject|1|||
146659795|NCT01437878|528932131|FG001|Overall Study|Withdrawal by Subject|0|||
146659796|NCT01070043|528932133|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
146659797|NCT01070043|528932134|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
146659798|NCT01070043|528932135|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
146659799|NCT01070043|528932133|FG000|Double-Blind Treatment|Adverse Event|0|||
146659800|NCT01070043|528932134|FG001|Double-Blind Treatment|Adverse Event|0|||
146659801|NCT01070043|528932135|FG002|Double-Blind Treatment|Adverse Event|2|||
146659802|NCT01476644|528932139|FG000|Overall Study|Death|5|||
146659803|NCT01476644|528932139|FG000|Overall Study|moved to another state|2|||
146659804|NCT01476644|528932139|FG000|Overall Study|Lost to Follow-up|19|||
146659805|NCT01476644|528932139|FG000|Overall Study|Withdrawal by Subject|13|||
146659806|NCT02393690|528932140|FG000|Overall Study|Ineligible|0|||
146659807|NCT02393690|528932141|FG001|Overall Study|Ineligible|1|||
146659808|NCT03488927|528932142|FG000|Overall Study|Withdrawal by Subject|44|||
146659809|NCT03488927|528932143|FG001|Overall Study|Withdrawal by Subject|118|||
146659810|NCT03488927|528932144|FG002|Overall Study|Withdrawal by Subject|217|||
146659811|NCT00586066|528932145|FG000|Overall Study|Lost to Follow-up|6|||
146659812|NCT00586066|528932146|FG001|Overall Study|Lost to Follow-up|3|||
146659813|NCT00586066|528932145|FG000|Overall Study|Lack of Efficacy|5|||
146659814|NCT00586066|528932146|FG001|Overall Study|Lack of Efficacy|3|||
146659815|NCT00586066|528932145|FG000|Overall Study|Adverse Event|2|||
146659816|NCT00586066|528932146|FG001|Overall Study|Adverse Event|2|||
146659817|NCT00586066|528932145|FG000|Overall Study|Physician Decision|1|||
146659818|NCT00586066|528932146|FG001|Overall Study|Physician Decision|0|||
146659819|NCT00586066|528932145|FG000|Overall Study|Withdrawal of consent|4|||
146659820|NCT00586066|528932146|FG001|Overall Study|Withdrawal of consent|2|||
146659821|NCT02676466|528932147|FG000|Overall Study|Death|0|||
146659822|NCT02676466|528932148|FG001|Overall Study|Death|2|||
146659823|NCT02676466|528932149|FG002|Overall Study|Death|1|||
146659824|NCT02676466|528932150|FG003|Overall Study|Death|0|||
146659825|NCT02676466|528932151|FG004|Overall Study|Death|0|||
146659826|NCT02676466|528932152|FG005|Overall Study|Death|0|||
146659827|NCT02676466|528932153|FG006|Overall Study|Death|0|||
146659828|NCT02676466|528932154|FG007|Overall Study|Death|0|||
146659829|NCT02676466|528932147|FG000|Overall Study|Withdrawal by Subject|4|||
146659830|NCT02676466|528932148|FG001|Overall Study|Withdrawal by Subject|3|||
146659831|NCT02676466|528932149|FG002|Overall Study|Withdrawal by Subject|1|||
146659832|NCT02676466|528932150|FG003|Overall Study|Withdrawal by Subject|0|||
146659833|NCT02676466|528932151|FG004|Overall Study|Withdrawal by Subject|3|||
146659834|NCT02676466|528932152|FG005|Overall Study|Withdrawal by Subject|1|||
146659835|NCT02676466|528932153|FG006|Overall Study|Withdrawal by Subject|1|||
146659836|NCT02676466|528932154|FG007|Overall Study|Withdrawal by Subject|1|||
146659837|NCT02059005|528932155|FG000|Overall Study|Death|1|||
146659838|NCT02059005|528932156|FG001|Overall Study|Death|3|||
146659839|NCT02059005|528932155|FG000|Overall Study|Lost to Follow-up|19|||
146659840|NCT02059005|528932156|FG001|Overall Study|Lost to Follow-up|19|||
146659841|NCT02059005|528932155|FG000|Overall Study|Incarceration|0|||
146659842|NCT02059005|528932156|FG001|Overall Study|Incarceration|1|||
146773637|NCT01792830|529341131|FG000|Overall Study|Death|3|||
146773638|NCT01792830|529341132|FG001|Overall Study|Death|0|||
146659843|NCT02059005|528932155|FG000|Overall Study|Inpatient|0|||
146659844|NCT02059005|528932156|FG001|Overall Study|Inpatient|1|||
146659845|NCT00760084|528932157|FG000|Overall Study|Physician Decision|5|||
146659846|NCT00760084|528932157|FG000|Overall Study|Withdrawal by Subject|2|||
146659847|NCT00760084|528932157|FG000|Overall Study|Progressive Disease|3|||
146925115|NCT02796391|529885922|FG000|Overall Study|Adverse Event|0|||
146925116|NCT02796391|529885923|FG001|Overall Study|Adverse Event|0|||
146925117|NCT02796391|529885924|FG002|Overall Study|Adverse Event|0|||
146659848|NCT01104701|528933731|FG000|Overall Study|Withdrawal by Subject|0|||
146659849|NCT01104701|528933732|FG001|Overall Study|Withdrawal by Subject|1|||
146659850|NCT01104701|528933733|FG002|Overall Study|Withdrawal by Subject|2|||
146659851|NCT01104701|528933734|FG003|Overall Study|Withdrawal by Subject|1|||
146659852|NCT01104701|528933731|FG000|Overall Study|Adverse Event|0|||
146659853|NCT01104701|528933732|FG001|Overall Study|Adverse Event|0|||
146659854|NCT01104701|528933733|FG002|Overall Study|Adverse Event|0|||
146659855|NCT01104701|528933734|FG003|Overall Study|Adverse Event|1|||
146659856|NCT01104701|528933731|FG000|Overall Study|Physician Decision|0|||
146659857|NCT01104701|528933732|FG001|Overall Study|Physician Decision|2|||
146659858|NCT01104701|528933733|FG002|Overall Study|Physician Decision|0|||
146659859|NCT01104701|528933734|FG003|Overall Study|Physician Decision|0|||
146659860|NCT02171065|528933737|FG000|Overall Study|Withdrawal by Subject|1|||
146659861|NCT02171065|528933738|FG001|Overall Study|Withdrawal by Subject|0|||
146659862|NCT02171065|528933739|FG002|Overall Study|Withdrawal by Subject|0|||
146659863|NCT02171065|528933737|FG000|Overall Study|Lost to Follow-up|0|||
146925118|NCT02796391|529885925|FG003|Overall Study|Adverse Event|1|||
146659864|NCT02171065|528933738|FG001|Overall Study|Lost to Follow-up|0|||
146659865|NCT02171065|528933739|FG002|Overall Study|Lost to Follow-up|1|||
146659866|NCT00084838|528933740|FG000|Overall Study|Death|1|||
146659867|NCT00084838|528933740|FG000|Overall Study|Adverse Event|2|||
146659868|NCT00084838|528933740|FG000|Overall Study|Withdrawal by Subject|1|||
146659869|NCT00084838|528933740|FG000|Overall Study|Progressive Disease|4|||
146659870|NCT00084838|528933740|FG000|Overall Study|Pt Non-Compliance|1|||
146659871|NCT00084838|528933740|FG000|Overall Study|Ineligible|4|||
146659872|NCT00518687|528933741|FG000|Overall Study|Adverse Event|201|||
146659873|NCT00518687|528933742|FG001|Overall Study|Adverse Event|177|||
146659874|NCT00518687|528933741|FG000|Overall Study|Lost to Follow-up|144|||
146659875|NCT00518687|528933742|FG001|Overall Study|Lost to Follow-up|155|||
146659876|NCT00518687|528933741|FG000|Overall Study|Physician Decision|42|||
146659877|NCT00518687|528933742|FG001|Overall Study|Physician Decision|48|||
146659878|NCT00518687|528933741|FG000|Overall Study|Progressive disease|2|||
146659879|NCT00518687|528933742|FG001|Overall Study|Progressive disease|2|||
146659880|NCT00518687|528933741|FG000|Overall Study|Protocol Violation|8|||
146659881|NCT00518687|528933742|FG001|Overall Study|Protocol Violation|10|||
146659882|NCT00518687|528933741|FG000|Overall Study|Study terminated by sponsor|930|||
146659883|NCT00518687|528933742|FG001|Overall Study|Study terminated by sponsor|918|||
146659884|NCT00518687|528933741|FG000|Overall Study|Withdrawal by Subject|110|||
146659885|NCT00518687|528933742|FG001|Overall Study|Withdrawal by Subject|110|||
146659886|NCT02598960|528933743|FG000|Treatment Period|Disease Progression|4|||
146659887|NCT02598960|528933744|FG001|Treatment Period|Disease Progression|4|||
146659888|NCT02598960|528933745|FG002|Treatment Period|Disease Progression|4|||
146659889|NCT02598960|528933746|FG003|Treatment Period|Disease Progression|6|||
146659890|NCT02598960|528933747|FG004|Treatment Period|Disease Progression|8|||
146659891|NCT02598960|528933748|FG005|Treatment Period|Disease Progression|2|||
146659892|NCT02598960|528933749|FG006|Treatment Period|Disease Progression|2|||
146659893|NCT02598960|528933750|FG007|Treatment Period|Disease Progression|3|||
146659894|NCT02598960|528933751|FG008|Treatment Period|Disease Progression|7|||
146659895|NCT02598960|528933752|FG009|Treatment Period|Disease Progression|9|||
146659896|NCT02598960|528933753|FG010|Treatment Period|Disease Progression|7|||
146659897|NCT02598960|528933754|FG011|Treatment Period|Disease Progression|143|||
146659898|NCT02598960|528933755|FG012|Treatment Period|Disease Progression|23|||
146773639|NCT01792830|529341133|FG002|Overall Study|Death|0|||
146773640|NCT01792830|529341134|FG003|Overall Study|Death|1|||
146773641|NCT01792830|529341135|FG004|Overall Study|Death|0|||
146659899|NCT02598960|528933743|FG000|Treatment Period|Study drug toxicity|0|||
146659900|NCT02598960|528933744|FG001|Treatment Period|Study drug toxicity|0|||
146659901|NCT02598960|528933745|FG002|Treatment Period|Study drug toxicity|0|||
146659902|NCT02598960|528933746|FG003|Treatment Period|Study drug toxicity|0|||
146659903|NCT02598960|528933747|FG004|Treatment Period|Study drug toxicity|0|||
146659904|NCT02598960|528933748|FG005|Treatment Period|Study drug toxicity|0|||
146659905|NCT02598960|528933749|FG006|Treatment Period|Study drug toxicity|0|||
146659906|NCT02598960|528933750|FG007|Treatment Period|Study drug toxicity|0|||
146659907|NCT02598960|528933751|FG008|Treatment Period|Study drug toxicity|0|||
146659908|NCT02598960|528933752|FG009|Treatment Period|Study drug toxicity|1|||
146659909|NCT02598960|528933753|FG010|Treatment Period|Study drug toxicity|0|||
146659910|NCT02598960|528933754|FG011|Treatment Period|Study drug toxicity|3|||
146659911|NCT02598960|528933755|FG012|Treatment Period|Study drug toxicity|0|||
146659912|NCT02598960|528933743|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
146659913|NCT02598960|528933744|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
146659914|NCT02598960|528933745|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
146659915|NCT02598960|528933746|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
146659916|NCT02598960|528933747|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
146659917|NCT02598960|528933748|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
146659918|NCT02598960|528933749|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
146659919|NCT02598960|528933750|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
146659920|NCT02598960|528933751|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
146773642|NCT01792830|529341136|FG005|Overall Study|Death|0|||
146773643|NCT01792830|529341137|FG006|Overall Study|Death|1|||
146773644|NCT01792830|529341138|FG007|Overall Study|Death|0|||
146659921|NCT02598960|528933752|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
146659922|NCT02598960|528933753|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
146659923|NCT02598960|528933754|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
146659924|NCT02598960|528933755|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
146659925|NCT02598960|528933743|FG000|Treatment Period|participant request to discontinue|0|||
146659926|NCT02598960|528933744|FG001|Treatment Period|participant request to discontinue|1|||
146659927|NCT02598960|528933745|FG002|Treatment Period|participant request to discontinue|0|||
146659928|NCT02598960|528933746|FG003|Treatment Period|participant request to discontinue|0|||
146659929|NCT02598960|528933747|FG004|Treatment Period|participant request to discontinue|1|||
146659930|NCT02598960|528933748|FG005|Treatment Period|participant request to discontinue|0|||
146773645|NCT01792830|529341139|FG008|Overall Study|Death|1|||
146773646|NCT01792830|529341140|FG009|Overall Study|Death|0|||
146659931|NCT02598960|528933749|FG006|Treatment Period|participant request to discontinue|0|||
146659932|NCT02598960|528933750|FG007|Treatment Period|participant request to discontinue|0|||
146659933|NCT02598960|528933751|FG008|Treatment Period|participant request to discontinue|0|||
146659934|NCT02598960|528933752|FG009|Treatment Period|participant request to discontinue|0|||
146659935|NCT02598960|528933753|FG010|Treatment Period|participant request to discontinue|1|||
146659936|NCT02598960|528933754|FG011|Treatment Period|participant request to discontinue|4|||
146659937|NCT02598960|528933755|FG012|Treatment Period|participant request to discontinue|0|||
146659938|NCT02598960|528933743|FG000|Treatment Period|participant withdrew consent|0|||
146659939|NCT02598960|528933744|FG001|Treatment Period|participant withdrew consent|0|||
146659940|NCT02598960|528933745|FG002|Treatment Period|participant withdrew consent|0|||
146659941|NCT02598960|528933746|FG003|Treatment Period|participant withdrew consent|0|||
146659942|NCT02598960|528933747|FG004|Treatment Period|participant withdrew consent|0|||
146659943|NCT02598960|528933748|FG005|Treatment Period|participant withdrew consent|0|||
146659944|NCT02598960|528933749|FG006|Treatment Period|participant withdrew consent|0|||
146659945|NCT02598960|528933750|FG007|Treatment Period|participant withdrew consent|0|||
146659946|NCT02598960|528933751|FG008|Treatment Period|participant withdrew consent|0|||
146659947|NCT02598960|528933752|FG009|Treatment Period|participant withdrew consent|0|||
146659948|NCT02598960|528933753|FG010|Treatment Period|participant withdrew consent|0|||
146659949|NCT02598960|528933754|FG011|Treatment Period|participant withdrew consent|3|||
146659950|NCT02598960|528933755|FG012|Treatment Period|participant withdrew consent|0|||
146659951|NCT02598960|528933743|FG000|Treatment Period|No longer meets study criteria|0|||
146659952|NCT02598960|528933744|FG001|Treatment Period|No longer meets study criteria|0|||
146659953|NCT02598960|528933745|FG002|Treatment Period|No longer meets study criteria|0|||
146659954|NCT02598960|528933746|FG003|Treatment Period|No longer meets study criteria|0|||
146659955|NCT02598960|528933747|FG004|Treatment Period|No longer meets study criteria|0|||
146659956|NCT02598960|528933748|FG005|Treatment Period|No longer meets study criteria|0|||
146659957|NCT02598960|528933749|FG006|Treatment Period|No longer meets study criteria|0|||
146659958|NCT02598960|528933750|FG007|Treatment Period|No longer meets study criteria|0|||
146659959|NCT02598960|528933751|FG008|Treatment Period|No longer meets study criteria|0|||
146659960|NCT02598960|528933752|FG009|Treatment Period|No longer meets study criteria|0|||
146659961|NCT02598960|528933753|FG010|Treatment Period|No longer meets study criteria|0|||
146659962|NCT02598960|528933754|FG011|Treatment Period|No longer meets study criteria|1|||
146659963|NCT02598960|528933755|FG012|Treatment Period|No longer meets study criteria|0|||
146659964|NCT02598960|528933743|FG000|Treatment Period|Other Reasons|0|||
146659965|NCT02598960|528933744|FG001|Treatment Period|Other Reasons|0|||
146659966|NCT02598960|528933745|FG002|Treatment Period|Other Reasons|0|||
146659967|NCT02598960|528933746|FG003|Treatment Period|Other Reasons|0|||
146659968|NCT02598960|528933747|FG004|Treatment Period|Other Reasons|0|||
146659969|NCT02598960|528933748|FG005|Treatment Period|Other Reasons|0|||
146659970|NCT02598960|528933749|FG006|Treatment Period|Other Reasons|0|||
146659971|NCT02598960|528933750|FG007|Treatment Period|Other Reasons|0|||
146659972|NCT02598960|528933751|FG008|Treatment Period|Other Reasons|0|||
146659973|NCT02598960|528933752|FG009|Treatment Period|Other Reasons|0|||
146659974|NCT02598960|528933753|FG010|Treatment Period|Other Reasons|0|||
146659975|NCT02598960|528933754|FG011|Treatment Period|Other Reasons|0|||
146659976|NCT02598960|528933755|FG012|Treatment Period|Other Reasons|1|||
146659977|NCT02598960|528933743|FG000|Participants Entering Follow Up Period|Death|1|||
146659978|NCT02598960|528933744|FG001|Participants Entering Follow Up Period|Death|0|||
146659979|NCT02598960|528933745|FG002|Participants Entering Follow Up Period|Death|0|||
146659980|NCT02598960|528933746|FG003|Participants Entering Follow Up Period|Death|0|||
146659981|NCT02598960|528933747|FG004|Participants Entering Follow Up Period|Death|0|||
146659982|NCT02598960|528933748|FG005|Participants Entering Follow Up Period|Death|0|||
146659983|NCT02598960|528933749|FG006|Participants Entering Follow Up Period|Death|0|||
146659984|NCT02598960|528933750|FG007|Participants Entering Follow Up Period|Death|0|||
146659985|NCT02598960|528933751|FG008|Participants Entering Follow Up Period|Death|0|||
146659986|NCT02598960|528933752|FG009|Participants Entering Follow Up Period|Death|1|||
146659987|NCT02598960|528933753|FG010|Participants Entering Follow Up Period|Death|0|||
146659988|NCT02598960|528933754|FG011|Participants Entering Follow Up Period|Death|11|||
146659989|NCT02598960|528933755|FG012|Participants Entering Follow Up Period|Death|2|||
146659990|NCT02598960|528933743|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
146659991|NCT02598960|528933744|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
146659992|NCT02598960|528933745|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
146659993|NCT02598960|528933746|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
146659994|NCT02598960|528933747|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
146659995|NCT02598960|528933748|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
146659996|NCT02598960|528933749|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
146659997|NCT02598960|528933750|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
146659998|NCT02598960|528933751|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
146978729|NCT00275028|530085482|FG000|Overall Study|Progressive Disease|30|||
146978730|NCT00275028|530085482|FG000|Overall Study|Physician Decision|2|||
146659999|NCT02598960|528933752|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
146660000|NCT02598960|528933753|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
146660001|NCT02598960|528933754|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
146660002|NCT02598960|528933755|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
146660003|NCT02598960|528933743|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
146660004|NCT02598960|528933744|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
146660005|NCT02598960|528933745|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
146660006|NCT02598960|528933746|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
146660007|NCT02598960|528933747|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
146660008|NCT02598960|528933748|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
146660009|NCT02598960|528933749|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
146660010|NCT02598960|528933750|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
146660011|NCT02598960|528933751|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
146660012|NCT02598960|528933752|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
146660013|NCT02598960|528933753|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
146660014|NCT02598960|528933754|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
146660015|NCT02598960|528933755|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
146660016|NCT02598960|528933743|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146660017|NCT02598960|528933744|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146660018|NCT02598960|528933745|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146660019|NCT02598960|528933746|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146660020|NCT02598960|528933747|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146660021|NCT02598960|528933748|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146660022|NCT02598960|528933749|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146660023|NCT02598960|528933750|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146660024|NCT02598960|528933751|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146660025|NCT02598960|528933752|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146660026|NCT02598960|528933753|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146660027|NCT02598960|528933754|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
146660028|NCT02598960|528933755|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146660029|NCT02598960|528933743|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
146660030|NCT02598960|528933744|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
146660031|NCT02598960|528933745|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
146660032|NCT02598960|528933746|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
146660033|NCT02598960|528933747|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
146660034|NCT02598960|528933748|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
146660035|NCT02598960|528933749|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
146660036|NCT02598960|528933750|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
146660037|NCT02598960|528933751|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
146660038|NCT02598960|528933752|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
146660039|NCT02598960|528933753|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
146660040|NCT02598960|528933754|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
146660041|NCT02598960|528933755|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
146660042|NCT01846104|528933756|FG000|Overall Study|Withdrawal by Subject|1|||
146660043|NCT00851630|528933757|FG000|Overall Study|Death|2|||
146660044|NCT00851630|528933758|FG001|Overall Study|Death|1|||
146660045|NCT00851630|528933757|FG000|Overall Study|Clinical failure|0|||
146660046|NCT00851630|528933758|FG001|Overall Study|Clinical failure|1|||
146660047|NCT00398411|528933759|FG000|Overall Study|Death|0|||
146660048|NCT00398411|528933760|FG001|Overall Study|Death|1|||
146660049|NCT01397162|528933761|FG000|Overall Study|Adverse Event|4|||
146660050|NCT01397162|528933762|FG001|Overall Study|Adverse Event|0|||
146660051|NCT01397162|528933763|FG002|Overall Study|Adverse Event|0|||
146660052|NCT01397162|528933764|FG003|Overall Study|Adverse Event|0|||
146660053|NCT01397162|528933765|FG004|Overall Study|Adverse Event|0|||
146660054|NCT01397162|528933761|FG000|Overall Study|Not yet defined|3|||
146660055|NCT01397162|528933762|FG001|Overall Study|Not yet defined|4|||
146660056|NCT01397162|528933763|FG002|Overall Study|Not yet defined|3|||
146660057|NCT01397162|528933764|FG003|Overall Study|Not yet defined|5|||
146660058|NCT01397162|528933765|FG004|Overall Study|Not yet defined|3|||
146660059|NCT00401531|528933768|FG000|Overall Study|Adverse Event|2|||
146660060|NCT00401531|528933769|FG001|Overall Study|Adverse Event|0|||
146660061|NCT00401531|528933768|FG000|Overall Study|Protocol Violation|3|||
146773647|NCT01792830|529341141|FG010|Overall Study|Death|1|||
146925119|NCT02796391|529885926|FG004|Overall Study|Adverse Event|0|||
146925120|NCT02796391|529885927|FG005|Overall Study|Adverse Event|0|||
146925121|NCT02796391|529885922|FG000|Overall Study|Protocol Violation|0|||
146660062|NCT00401531|528933769|FG001|Overall Study|Protocol Violation|7|||
146660063|NCT00401531|528933768|FG000|Overall Study|Lost to Follow-up|1|||
146660064|NCT00401531|528933769|FG001|Overall Study|Lost to Follow-up|1|||
146660065|NCT00401531|528933768|FG000|Overall Study|Withdrawal by Subject|3|||
146660066|NCT00401531|528933769|FG001|Overall Study|Withdrawal by Subject|2|||
146660067|NCT01614600|528933770|FG000|Overall Study|Unacceptable fit|1|||
146660068|NCT01614600|528933770|FG000|Overall Study|Discomfort|1|||
146660069|NCT01614600|528933770|FG000|Overall Study|Unable to remove lens at the end of day|1|||
146660070|NCT01614600|528933770|FG000|Overall Study|Protocol deviation|1|||
146660071|NCT02437513|528933771|FG000|Overall Study|Withdrawal by Subject|2|||
146660072|NCT03403374|528933772|FG000|Overall Study|Lost to Follow-up|1|||
146660073|NCT04879225|528933773|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
146660074|NCT04879225|528933773|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
146660075|NCT00736957|528933776|FG000|Overall Study|Adverse Event|43|||
146660076|NCT00736957|528933776|FG000|Overall Study|Withdrawal by Subject|49|||
146660077|NCT00736957|528933776|FG000|Overall Study|violation of eligibility criteria|2|||
146660078|NCT00736957|528933776|FG000|Overall Study|did not attend hospital appointments|1|||
146660079|NCT00736957|528933776|FG000|Overall Study|not eligible for Treatment Period I|22|||
146660080|NCT00736957|528933776|FG000|Overall Study|Physician Decision|5|||
146660081|NCT01409434|528933777|FG000|Overall Study|Protocol Violation|4|||
146660082|NCT02213042|528933778|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
146660083|NCT02213042|528933779|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
146660084|NCT02213042|528933780|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
146660085|NCT02213042|528933778|FG000|Overall Study|Adverse Event|2|||
146660086|NCT02213042|528933779|FG001|Overall Study|Adverse Event|1|||
146660087|NCT02213042|528933780|FG002|Overall Study|Adverse Event|0|||
146660088|NCT02213042|528933778|FG000|Overall Study|Withdrawal by Subject|0|||
146660089|NCT02213042|528933779|FG001|Overall Study|Withdrawal by Subject|1|||
146660090|NCT02213042|528933780|FG002|Overall Study|Withdrawal by Subject|1|||
146660091|NCT02213042|528933778|FG000|Overall Study|Protocol Violation|1|||
146660092|NCT02213042|528933779|FG001|Overall Study|Protocol Violation|0|||
146660093|NCT02213042|528933780|FG002|Overall Study|Protocol Violation|0|||
146660094|NCT02213042|528933778|FG000|Overall Study|Investigator discretion|0|||
146660095|NCT02213042|528933779|FG001|Overall Study|Investigator discretion|0|||
146660096|NCT02213042|528933780|FG002|Overall Study|Investigator discretion|1|||
146660097|NCT04622735|528933781|FG000|Overall Study|Lost to Follow-up|1|||
146660098|NCT04622735|528933782|FG001|Overall Study|Lost to Follow-up|2|||
146660099|NCT04622735|528933783|FG002|Overall Study|Lost to Follow-up|1|||
146660100|NCT04622735|528933781|FG000|Overall Study|Adverse Event|0|||
146660101|NCT04622735|528933782|FG001|Overall Study|Adverse Event|0|||
146660102|NCT04622735|528933783|FG002|Overall Study|Adverse Event|1|||
146660103|NCT04622735|528933781|FG000|Overall Study|Protocol Violation|1|||
146660104|NCT04622735|528933782|FG001|Overall Study|Protocol Violation|0|||
146660105|NCT04622735|528933783|FG002|Overall Study|Protocol Violation|0|||
146660106|NCT03026088|528933784|FG000|Overall Study|Study termination|20|||
146660107|NCT03960554|528933792|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
146660108|NCT03960554|528933793|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
146660109|NCT00736879|528933794|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
146660110|NCT00736879|528933795|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
146660111|NCT00736879|528933796|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
146660112|NCT00736879|528933797|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
146660113|NCT00736879|528933794|FG000|Double Blind Treatment Period|Adverse Event|0|||
146660114|NCT00736879|528933795|FG001|Double Blind Treatment Period|Adverse Event|1|||
146660115|NCT00736879|528933796|FG002|Double Blind Treatment Period|Adverse Event|1|||
146660116|NCT00736879|528933797|FG003|Double Blind Treatment Period|Adverse Event|0|||
146660117|NCT00736879|528933794|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
146660118|NCT00736879|528933795|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
146660119|NCT00736879|528933796|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
146660120|NCT00736879|528933797|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
146660121|NCT00736879|528933794|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
146660122|NCT00736879|528933795|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
146660123|NCT00736879|528933796|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
146660124|NCT00736879|528933797|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
146660125|NCT00736879|528933794|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
146660126|NCT00736879|528933795|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
146660127|NCT00736879|528933796|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
146660128|NCT00736879|528933797|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
146660129|NCT00736879|528933794|FG000|Double Blind Treatment Period|No longer met criteria|0|||
146660130|NCT00736879|528933795|FG001|Double Blind Treatment Period|No longer met criteria|1|||
146660131|NCT00736879|528933796|FG002|Double Blind Treatment Period|No longer met criteria|0|||
146660132|NCT00736879|528933797|FG003|Double Blind Treatment Period|No longer met criteria|0|||
146660133|NCT00736879|528933794|FG000|Double Blind Treatment Period|non-specified|0|||
146773648|NCT01792830|529341131|FG000|Overall Study|Adverse Event|0|||
146773649|NCT01792830|529341132|FG001|Overall Study|Adverse Event|0|||
146773650|NCT01792830|529341133|FG002|Overall Study|Adverse Event|0|||
146773651|NCT01792830|529341134|FG003|Overall Study|Adverse Event|0|||
146773652|NCT01792830|529341135|FG004|Overall Study|Adverse Event|0|||
146925122|NCT02796391|529885923|FG001|Overall Study|Protocol Violation|0|||
146617288|NCT00404651|528770834|FG000|Overall Study|Serious Adverse Event|0|||
146617289|NCT00404651|528770835|FG001|Overall Study|Serious Adverse Event|0|||
146617290|NCT00404651|528770836|FG002|Overall Study|Serious Adverse Event|2|||
146617291|NCT00404651|528770837|FG003|Overall Study|Serious Adverse Event|0|||
146617292|NCT00404651|528770834|FG000|Overall Study|Protocol Violation|10|||
146617293|NCT00404651|528770835|FG001|Overall Study|Protocol Violation|5|||
146617294|NCT00404651|528770836|FG002|Overall Study|Protocol Violation|14|||
146617295|NCT00404651|528770837|FG003|Overall Study|Protocol Violation|5|||
146617296|NCT00404651|528770834|FG000|Overall Study|Lost to Follow-up|15|||
146617297|NCT00404651|528770835|FG001|Overall Study|Lost to Follow-up|11|||
146617298|NCT00404651|528770836|FG002|Overall Study|Lost to Follow-up|13|||
146617299|NCT00404651|528770837|FG003|Overall Study|Lost to Follow-up|10|||
146617300|NCT00404651|528770834|FG000|Overall Study|Withdrawal by Subject|14|||
146617301|NCT00404651|528770835|FG001|Overall Study|Withdrawal by Subject|12|||
146617302|NCT00404651|528770836|FG002|Overall Study|Withdrawal by Subject|16|||
146617303|NCT00404651|528770837|FG003|Overall Study|Withdrawal by Subject|6|||
146617304|NCT01121146|528770849|FG000|Overall Study|Death|17|||
146617305|NCT01121146|528770850|FG001|Overall Study|Death|15|||
146617306|NCT01121146|528770849|FG000|Overall Study|Adverse Event|2|||
146617307|NCT01121146|528770850|FG001|Overall Study|Adverse Event|11|||
146617308|NCT01121146|528770849|FG000|Overall Study|Lost to Follow-up|7|||
146617309|NCT01121146|528770850|FG001|Overall Study|Lost to Follow-up|16|||
146617310|NCT05030350|528770856|FG000|Overall Study|Adverse Event|13|||
146617311|NCT05030350|528770856|FG000|Overall Study|Lack of Efficacy|8|||
146617312|NCT05030350|528770856|FG000|Overall Study|Lost to Follow-up|35|||
146617313|NCT05030350|528770856|FG000|Overall Study|Pregnancy|2|||
146617314|NCT05030350|528770856|FG000|Overall Study|Protocol Violation|2|||
146617315|NCT05030350|528770856|FG000|Overall Study|Withdrawal by Subject|60|||
146617316|NCT05030350|528770856|FG000|Overall Study|Study terminated by sponsor|349|||
146617317|NCT05030350|528770856|FG000|Overall Study|Positive Drug Screen|4|||
146617318|NCT05030350|528770856|FG000|Overall Study|Other|8|||
146617319|NCT02711137|528770857|FG000|Overall Study|Death|1|||
146617320|NCT02711137|528770858|FG001|Overall Study|Death|4|||
146617321|NCT02711137|528770859|FG002|Overall Study|Death|5|||
146617322|NCT02711137|528770860|FG003|Overall Study|Death|5|||
146617323|NCT02711137|528770861|FG004|Overall Study|Death|3|||
146617324|NCT02711137|528770862|FG005|Overall Study|Death|1|||
146617325|NCT02711137|528770863|FG006|Overall Study|Death|61|||
146617326|NCT02711137|528770864|FG007|Overall Study|Death|3|||
146617327|NCT02711137|528770865|FG008|Overall Study|Death|0|||
146617328|NCT02711137|528770866|FG009|Overall Study|Death|1|||
146617329|NCT02711137|528770867|FG010|Overall Study|Death|1|||
146617330|NCT02711137|528770868|FG011|Overall Study|Death|1|||
146617331|NCT02711137|528770869|FG012|Overall Study|Death|0|||
146617332|NCT02711137|528770870|FG013|Overall Study|Death|0|||
146617333|NCT02711137|528770871|FG014|Overall Study|Death|0|||
146617334|NCT02711137|528770857|FG000|Overall Study|Study Terminated by Sponsor|0|||
146617335|NCT02711137|528770858|FG001|Overall Study|Study Terminated by Sponsor|0|||
146617336|NCT02711137|528770859|FG002|Overall Study|Study Terminated by Sponsor|1|||
146617337|NCT02711137|528770860|FG003|Overall Study|Study Terminated by Sponsor|0|||
146617338|NCT02711137|528770861|FG004|Overall Study|Study Terminated by Sponsor|0|||
146617339|NCT02711137|528770862|FG005|Overall Study|Study Terminated by Sponsor|0|||
146617340|NCT02711137|528770863|FG006|Overall Study|Study Terminated by Sponsor|1|||
146617341|NCT02711137|528770864|FG007|Overall Study|Study Terminated by Sponsor|0|||
146617342|NCT02711137|528770865|FG008|Overall Study|Study Terminated by Sponsor|0|||
146617343|NCT02711137|528770866|FG009|Overall Study|Study Terminated by Sponsor|0|||
146617344|NCT02711137|528770867|FG010|Overall Study|Study Terminated by Sponsor|0|||
146617345|NCT02711137|528770868|FG011|Overall Study|Study Terminated by Sponsor|0|||
146617346|NCT02711137|528770869|FG012|Overall Study|Study Terminated by Sponsor|0|||
146617347|NCT02711137|528770870|FG013|Overall Study|Study Terminated by Sponsor|0|||
146617348|NCT02711137|528770871|FG014|Overall Study|Study Terminated by Sponsor|0|||
146617349|NCT02711137|528770857|FG000|Overall Study|Physician Decision|1|||
146617350|NCT02711137|528770858|FG001|Overall Study|Physician Decision|0|||
146617351|NCT02711137|528770859|FG002|Overall Study|Physician Decision|2|||
146617352|NCT02711137|528770860|FG003|Overall Study|Physician Decision|1|||
146617353|NCT02711137|528770861|FG004|Overall Study|Physician Decision|1|||
146617354|NCT02711137|528770862|FG005|Overall Study|Physician Decision|0|||
146617355|NCT02711137|528770863|FG006|Overall Study|Physician Decision|12|||
146617356|NCT02711137|528770864|FG007|Overall Study|Physician Decision|2|||
146617357|NCT02711137|528770865|FG008|Overall Study|Physician Decision|1|||
146617358|NCT02711137|528770866|FG009|Overall Study|Physician Decision|1|||
146617359|NCT02711137|528770867|FG010|Overall Study|Physician Decision|3|||
146617360|NCT02711137|528770868|FG011|Overall Study|Physician Decision|2|||
146617361|NCT02711137|528770869|FG012|Overall Study|Physician Decision|1|||
146773653|NCT01792830|529341136|FG005|Overall Study|Adverse Event|0|||
146773654|NCT01792830|529341137|FG006|Overall Study|Adverse Event|0|||
146660134|NCT00736879|528933795|FG001|Double Blind Treatment Period|non-specified|1|||
146660135|NCT00736879|528933796|FG002|Double Blind Treatment Period|non-specified|0|||
146660136|NCT00736879|528933797|FG003|Double Blind Treatment Period|non-specified|0|||
146660137|NCT00736879|528933794|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
146660138|NCT00736879|528933795|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
146660139|NCT00736879|528933796|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
146660140|NCT00736879|528933797|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
146660141|NCT00736879|528933794|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
146660142|NCT00736879|528933795|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
146660143|NCT00736879|528933796|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
146660144|NCT00736879|528933797|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
146660145|NCT02360111|528933798|FG000|Overall Study|Death|2|||
146660146|NCT00573248|528933803|FG000|Overall Study|scheduling conflicts|15|||
146660147|NCT00573248|528933804|FG001|Overall Study|scheduling conflicts|11|||
146660148|NCT02791594|528933807|FG000|Overall Study|Physician Decision|2|||
146660149|NCT04950166|528933808|FG000|Overall Study|Withdrawal by Subject|1|||
146660150|NCT05896748|528933809|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
146660151|NCT05896748|528933809|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
146660152|NCT05896748|528933809|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
146660153|NCT05896748|528933809|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
146660154|NCT05896748|528933809|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
146660155|NCT00857415|528933815|FG000|Overall Study|Image acquisition failure|2|||
146660156|NCT00857415|528933816|FG001|Overall Study|Image acquisition failure|0|||
146660157|NCT00857415|528933815|FG000|Overall Study|Invalid image or not imaged|3|||
146660158|NCT00857415|528933816|FG001|Overall Study|Invalid image or not imaged|0|||
146660159|NCT00857415|528933815|FG000|Overall Study|Subject still living at end of study|110|||
146660160|NCT00857415|528933816|FG001|Overall Study|Subject still living at end of study|0|||
146660161|NCT00857415|528933815|FG000|Overall Study|Deceased with no autopsy|2|||
146660162|NCT00857415|528933816|FG001|Overall Study|Deceased with no autopsy|0|||
146660163|NCT04508140|528933819|FG000|Overall Study|Adverse Event|2|||
146660164|NCT04508140|528933820|FG001|Overall Study|Adverse Event|2|||
146660165|NCT04508140|528933819|FG000|Overall Study|Withdrawal by Subject|0|||
146660166|NCT04508140|528933820|FG001|Overall Study|Withdrawal by Subject|2|||
146660167|NCT04508140|528933819|FG000|Overall Study|progressive disease|9|||
146660168|NCT04508140|528933820|FG001|Overall Study|progressive disease|3|||
146660169|NCT01130103|528933821|FG000|Randomized Treatment|Adverse Event|1|||
146660170|NCT01130103|528933822|FG001|Randomized Treatment|Adverse Event|1|||
146660171|NCT01130103|528933821|FG000|Randomized Treatment|Lost to Follow-up|1|||
146660172|NCT01130103|528933822|FG001|Randomized Treatment|Lost to Follow-up|0|||
146660173|NCT01130103|528933821|FG000|Randomized Treatment|Protocol Violation|3|||
146660174|NCT01130103|528933822|FG001|Randomized Treatment|Protocol Violation|2|||
146660175|NCT01130103|528933821|FG000|Randomized Treatment|Withdrawal by Subject|1|||
146660176|NCT01130103|528933822|FG001|Randomized Treatment|Withdrawal by Subject|2|||
146660177|NCT01130103|528933821|FG000|Maintenance Treatment|Lack of Efficacy|0|||
146660178|NCT01130103|528933822|FG001|Maintenance Treatment|Lack of Efficacy|1|||
146660179|NCT01130103|528933821|FG000|Maintenance Treatment|Lost to Follow-up|1|||
146660180|NCT01130103|528933822|FG001|Maintenance Treatment|Lost to Follow-up|1|||
146660181|NCT01130103|528933821|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
146660182|NCT01130103|528933822|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
146660183|NCT01822678|528933825|FG000|Overall Study|Withdrawal by Subject|5|||
146660184|NCT01822678|528933826|FG001|Overall Study|Withdrawal by Subject|4|||
146660185|NCT01822678|528933827|FG002|Overall Study|Withdrawal by Subject|4|||
146660186|NCT01822678|528933825|FG000|Overall Study|Adverse Event|4|||
146660187|NCT01822678|528933826|FG001|Overall Study|Adverse Event|3|||
146660188|NCT01822678|528933827|FG002|Overall Study|Adverse Event|1|||
146660189|NCT01822678|528933825|FG000|Overall Study|Lack of Efficacy|3|||
146660190|NCT01822678|528933826|FG001|Overall Study|Lack of Efficacy|6|||
146660191|NCT01822678|528933827|FG002|Overall Study|Lack of Efficacy|5|||
146660192|NCT01822678|528933825|FG000|Overall Study|Lost to Follow-up|0|||
146660193|NCT01822678|528933826|FG001|Overall Study|Lost to Follow-up|2|||
146660194|NCT01822678|528933827|FG002|Overall Study|Lost to Follow-up|1|||
146660195|NCT04795622|528933833|FG000|Overall Study|Adverse Event|1|||
146660196|NCT04795622|528933834|FG001|Overall Study|Adverse Event|0|||
146660197|NCT04795622|528933833|FG000|Overall Study|Withdrawal by Subject|3|||
146660198|NCT04795622|528933834|FG001|Overall Study|Withdrawal by Subject|3|||
146660199|NCT04795622|528933833|FG000|Overall Study|Protocol Violation|0|||
146660200|NCT04795622|528933834|FG001|Overall Study|Protocol Violation|2|||
146660201|NCT04795622|528933833|FG000|Overall Study|Lost to Follow-up|2|||
146660202|NCT04795622|528933834|FG001|Overall Study|Lost to Follow-up|3|||
146660203|NCT04795622|528933833|FG000|Overall Study|Other|7|||
146660204|NCT04795622|528933834|FG001|Overall Study|Other|8|||
146660205|NCT03309046|528933835|FG000|Overall Study|Withdrawal by Subject|4|||
146660206|NCT03309046|528933836|FG001|Overall Study|Withdrawal by Subject|17|||
146660207|NCT01369615|528933837|FG000|Overall Study|Withdrawal by Subject|0|||
146660208|NCT01369615|528933838|FG001|Overall Study|Withdrawal by Subject|1|||
146660209|NCT01369615|528933837|FG000|Overall Study|Lost to Follow-up|0|||
146660210|NCT01369615|528933838|FG001|Overall Study|Lost to Follow-up|1|||
146660211|NCT04263454|528933839|FG000|Overall Study|Adverse Event|0|||
146660212|NCT04263454|528933840|FG001|Overall Study|Adverse Event|2|||
146660213|NCT04263454|528933839|FG000|Overall Study|Physician Decision|3|||
146660214|NCT04263454|528933840|FG001|Overall Study|Physician Decision|5|||
146660215|NCT04263454|528933839|FG000|Overall Study|Poor Data Quality|0|||
146660216|NCT04263454|528933840|FG001|Overall Study|Poor Data Quality|1|||
146660217|NCT00986479|528933842|FG000|Period 1|Improved mood|1|||
146660218|NCT00986479|528933843|FG001|Period 1|Improved mood|0|||
146660219|NCT00986479|528933842|FG000|Period 1|Administrative reasons|1|||
146660220|NCT00986479|528933843|FG001|Period 1|Administrative reasons|0|||
146660221|NCT01721070|528933844|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
146660222|NCT01090973|528933849|FG000|Overall Study|Disease progression|1|||
146660223|NCT00908011|528933850|FG000|Overall Study|Withdrawal by Subject|2|||
146660224|NCT00908011|528933851|FG001|Overall Study|Withdrawal by Subject|2|||
146660225|NCT00739596|528933852|FG000|Overall Study|Adverse Event|12|||
146660226|NCT00739596|528933853|FG001|Overall Study|Adverse Event|6|||
146660227|NCT00739596|528933852|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
146660228|NCT00739596|528933853|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146660229|NCT00739596|528933852|FG000|Overall Study|Patient Withdrew Consent|8|||
146660230|NCT00739596|528933853|FG001|Overall Study|Patient Withdrew Consent|8|||
146660231|NCT00739596|528933852|FG000|Overall Study|Lost to Follow-up|0|||
146660232|NCT00739596|528933853|FG001|Overall Study|Lost to Follow-up|2|||
146660233|NCT00739596|528933852|FG000|Overall Study|Protocol Deviation|1|||
146660234|NCT00739596|528933853|FG001|Overall Study|Protocol Deviation|1|||
146660235|NCT02567552|528933861|FG000|Overall Study|Adverse Event|0|||
146660236|NCT02567552|528933862|FG001|Overall Study|Adverse Event|1|||
146660237|NCT02301988|528933863|FG000|Overall Study|Withdrawal by Subject|2|||
146660238|NCT02301988|528933864|FG001|Overall Study|Withdrawal by Subject|1|||
146660239|NCT02301988|528933863|FG000|Overall Study|Physician Decision|2|||
146660240|NCT02301988|528933864|FG001|Overall Study|Physician Decision|2|||
146660241|NCT02301988|528933863|FG000|Overall Study|Unknown Reason|1|||
146660242|NCT02301988|528933864|FG001|Overall Study|Unknown Reason|3|||
146660243|NCT02301988|528933863|FG000|Overall Study|Lack of Efficacy|3|||
146660244|NCT02301988|528933864|FG001|Overall Study|Lack of Efficacy|2|||
146660245|NCT02301988|528933863|FG000|Overall Study|Death|1|||
146660246|NCT02301988|528933864|FG001|Overall Study|Death|0|||
146660247|NCT02301988|528933863|FG000|Overall Study|Adverse Event|1|||
146660248|NCT02301988|528933864|FG001|Overall Study|Adverse Event|1|||
146660249|NCT02891161|528933865|FG000|Study Treatment|Disease Progression|2|||
146660250|NCT02891161|528933866|FG001|Study Treatment|Disease Progression|4|||
146660251|NCT02891161|528933865|FG000|Study Treatment|AE/Side Effects/Complications|1|||
146660252|NCT02891161|528933866|FG001|Study Treatment|AE/Side Effects/Complications|5|||
146660253|NCT02891161|528933865|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
146660254|NCT02891161|528933866|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
146660255|NCT02891161|528933865|FG000|Follow up|Death|4|||
146660256|NCT02891161|528933866|FG001|Follow up|Death|8|||
146660257|NCT02891161|528933865|FG000|Follow up|Refused to Follow up|0|||
146660258|NCT02891161|528933866|FG001|Follow up|Refused to Follow up|2|||
146660259|NCT02891161|528933865|FG000|Follow up|Symptomatic deterioration|0|||
146660260|NCT02891161|528933866|FG001|Follow up|Symptomatic deterioration|1|||
146660261|NCT02891161|528933865|FG000|Follow up|Study terminated|0|||
146660262|NCT02891161|528933866|FG001|Follow up|Study terminated|6|||
146660263|NCT01074047|528933873|FG000|Treatment Phase|Adverse Event|89|||
146660264|NCT01074047|528933874|FG001|Treatment Phase|Adverse Event|66|||
146660265|NCT01074047|528933873|FG000|Treatment Phase|Disease Progression|16|||
146660266|NCT01074047|528933874|FG001|Treatment Phase|Disease Progression|21|||
146660267|NCT01074047|528933873|FG000|Treatment Phase|Withdrawal by Subject|27|||
146660268|NCT01074047|528933874|FG001|Treatment Phase|Withdrawal by Subject|48|||
146660269|NCT01074047|528933873|FG000|Treatment Phase|Death|53|||
146660270|NCT01074047|528933874|FG001|Treatment Phase|Death|58|||
146660271|NCT01074047|528933873|FG000|Treatment Phase|Lost to Follow-up|0|||
146660272|NCT01074047|528933874|FG001|Treatment Phase|Lost to Follow-up|1|||
146660273|NCT01074047|528933873|FG000|Treatment Phase|Protocol Violation|0|||
146660274|NCT01074047|528933874|FG001|Treatment Phase|Protocol Violation|1|||
146660275|NCT01074047|528933873|FG000|Treatment Phase|Miscellaneous|32|||
146773655|NCT01792830|529341138|FG007|Overall Study|Adverse Event|0|||
146660276|NCT01074047|528933874|FG001|Treatment Phase|Miscellaneous|39|||
146660277|NCT01074047|528933873|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
146660278|NCT01074047|528933874|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
146660279|NCT01074047|528933873|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
146660280|NCT01074047|528933874|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
146660281|NCT01074047|528933873|FG000|Survival Follow-Up Phase|Death|116|||
146660282|NCT01074047|528933874|FG001|Survival Follow-Up Phase|Death|124|||
146660283|NCT01074047|528933873|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
146660284|NCT01074047|528933874|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
146925123|NCT02796391|529885924|FG002|Overall Study|Protocol Violation|0|||
146925124|NCT02796391|529885925|FG003|Overall Study|Protocol Violation|1|||
146925125|NCT02796391|529885926|FG004|Overall Study|Protocol Violation|0|||
146925126|NCT02796391|529885927|FG005|Overall Study|Protocol Violation|0|||
146925127|NCT00377611|529885928|FG000|Overall Study|Adverse Event|2|||
146925128|NCT00377611|529885929|FG001|Overall Study|Adverse Event|9|||
146925129|NCT00377611|529885928|FG000|Overall Study|Protocol Violation|2|||
146925130|NCT00377611|529885929|FG001|Overall Study|Protocol Violation|0|||
146925131|NCT00377611|529885928|FG000|Overall Study|Withdrawal by Subject|0|||
146925132|NCT00377611|529885929|FG001|Overall Study|Withdrawal by Subject|5|||
146925133|NCT00377611|529885928|FG000|Overall Study|Lost to Follow-up|18|||
146925134|NCT00377611|529885929|FG001|Overall Study|Lost to Follow-up|16|||
146925135|NCT00377611|529885928|FG000|Overall Study|Other|0|||
146925136|NCT00377611|529885929|FG001|Overall Study|Other|3|||
146925137|NCT00831441|529885930|FG000|Randomized|Death|82|||
146925138|NCT00831441|529885931|FG001|Randomized|Death|81|||
146925139|NCT00831441|529885930|FG000|Randomized|Adverse Event|248|||
146925140|NCT00831441|529885931|FG001|Randomized|Adverse Event|321|||
146925141|NCT00831441|529885930|FG000|Randomized|Emergency procedure|2|||
146617362|NCT02711137|528770870|FG013|Overall Study|Physician Decision|1|||
146617363|NCT02711137|528770871|FG014|Overall Study|Physician Decision|2|||
146617364|NCT02711137|528770857|FG000|Overall Study|Other|0|||
146617365|NCT02711137|528770858|FG001|Overall Study|Other|1|||
146617366|NCT02711137|528770859|FG002|Overall Study|Other|0|||
146617367|NCT02711137|528770860|FG003|Overall Study|Other|0|||
146617368|NCT02711137|528770861|FG004|Overall Study|Other|0|||
146617369|NCT02711137|528770862|FG005|Overall Study|Other|0|||
146617370|NCT02711137|528770863|FG006|Overall Study|Other|3|||
146617371|NCT02711137|528770864|FG007|Overall Study|Other|0|||
146617372|NCT02711137|528770865|FG008|Overall Study|Other|0|||
146617373|NCT02711137|528770866|FG009|Overall Study|Other|0|||
146617374|NCT02711137|528770867|FG010|Overall Study|Other|0|||
146617375|NCT02711137|528770868|FG011|Overall Study|Other|0|||
146617376|NCT02711137|528770869|FG012|Overall Study|Other|0|||
146617377|NCT02711137|528770870|FG013|Overall Study|Other|0|||
146617378|NCT02711137|528770871|FG014|Overall Study|Other|1|||
146617379|NCT02711137|528770857|FG000|Overall Study|Withdrawal by Subject|1|||
146617380|NCT02711137|528770858|FG001|Overall Study|Withdrawal by Subject|0|||
146617381|NCT02711137|528770859|FG002|Overall Study|Withdrawal by Subject|0|||
146617382|NCT02711137|528770860|FG003|Overall Study|Withdrawal by Subject|1|||
146617383|NCT02711137|528770861|FG004|Overall Study|Withdrawal by Subject|1|||
146617384|NCT02711137|528770862|FG005|Overall Study|Withdrawal by Subject|0|||
146617385|NCT02711137|528770863|FG006|Overall Study|Withdrawal by Subject|7|||
146617386|NCT02711137|528770864|FG007|Overall Study|Withdrawal by Subject|0|||
146617387|NCT02711137|528770865|FG008|Overall Study|Withdrawal by Subject|0|||
146617388|NCT02711137|528770866|FG009|Overall Study|Withdrawal by Subject|0|||
146617389|NCT02711137|528770867|FG010|Overall Study|Withdrawal by Subject|0|||
146617390|NCT02711137|528770868|FG011|Overall Study|Withdrawal by Subject|0|||
146617391|NCT02711137|528770869|FG012|Overall Study|Withdrawal by Subject|0|||
146617392|NCT02711137|528770870|FG013|Overall Study|Withdrawal by Subject|1|||
146617393|NCT02711137|528770871|FG014|Overall Study|Withdrawal by Subject|0|||
146617394|NCT02711137|528770857|FG000|Overall Study|Lost to Follow-up|1|||
146617395|NCT02711137|528770858|FG001|Overall Study|Lost to Follow-up|0|||
146617396|NCT02711137|528770859|FG002|Overall Study|Lost to Follow-up|0|||
146617397|NCT02711137|528770860|FG003|Overall Study|Lost to Follow-up|0|||
146617398|NCT02711137|528770861|FG004|Overall Study|Lost to Follow-up|0|||
146617399|NCT02711137|528770862|FG005|Overall Study|Lost to Follow-up|0|||
146617400|NCT02711137|528770863|FG006|Overall Study|Lost to Follow-up|2|||
146617401|NCT02711137|528770864|FG007|Overall Study|Lost to Follow-up|0|||
146617402|NCT02711137|528770865|FG008|Overall Study|Lost to Follow-up|0|||
146617403|NCT02711137|528770866|FG009|Overall Study|Lost to Follow-up|0|||
146617404|NCT02711137|528770867|FG010|Overall Study|Lost to Follow-up|0|||
146617405|NCT02711137|528770868|FG011|Overall Study|Lost to Follow-up|0|||
146617406|NCT02711137|528770869|FG012|Overall Study|Lost to Follow-up|0|||
146660285|NCT01074047|528933873|FG000|Extension Phase|Physician Decision|1|||
146660286|NCT01074047|528933874|FG001|Extension Phase|Physician Decision|0|||
146660287|NCT01074047|528933873|FG000|Extension Phase|Adverse Event|5|||
146925142|NCT00831441|529885931|FG001|Randomized|Emergency procedure|2|||
146925143|NCT00831441|529885930|FG000|Randomized|Elective procedure|26|||
146617407|NCT02711137|528770870|FG013|Overall Study|Lost to Follow-up|0|||
146617408|NCT02711137|528770871|FG014|Overall Study|Lost to Follow-up|0|||
146617409|NCT01745367|528770883|FG000|Overall Study|Death|1|||
146617410|NCT01745367|528770884|FG001|Overall Study|Death|0|||
146617411|NCT01745367|528770883|FG000|Overall Study|Withdrawal by Subject|1|||
146617412|NCT01745367|528770884|FG001|Overall Study|Withdrawal by Subject|2|||
146617413|NCT01745367|528770883|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
146617414|NCT01745367|528770884|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
146617415|NCT01745367|528770883|FG000|Overall Study|Other Reasons Unspecified|0|||
146617416|NCT01745367|528770884|FG001|Overall Study|Other Reasons Unspecified|2|||
146617417|NCT00354679|528770885|FG000|Overall Study|Patient Not Treated|1|||
146925144|NCT00831441|529885931|FG001|Randomized|Elective procedure|25|||
146660288|NCT01074047|528933874|FG001|Extension Phase|Adverse Event|0|||
146660289|NCT01074047|528933873|FG000|Extension Phase|Disease Progression|9|||
146660290|NCT01074047|528933874|FG001|Extension Phase|Disease Progression|0|||
146660291|NCT01074047|528933873|FG000|Extension Phase|Withdrawal by Subject|2|||
146660292|NCT01074047|528933874|FG001|Extension Phase|Withdrawal by Subject|0|||
146660293|NCT01074047|528933873|FG000|Extension Phase|Death|5|||
146660294|NCT01074047|528933874|FG001|Extension Phase|Death|0|||
146660295|NCT04669535|528933875|FG000|Overall Study|Death|1|||
146660296|NCT04669535|528933876|FG001|Overall Study|Death|1|||
146660297|NCT04669535|528933877|FG002|Overall Study|Death|0|||
146660298|NCT04669535|528933878|FG003|Overall Study|Death|0|||
146660299|NCT05169567|528933880|FG000|Overall Study|On study treatment|116|||
146660300|NCT05169567|528933881|FG001|Overall Study|On study treatment|128|||
146660301|NCT05169567|528933880|FG000|Overall Study|Lost to Follow-up|1|||
146660302|NCT05169567|528933881|FG001|Overall Study|Lost to Follow-up|0|||
146660303|NCT05169567|528933880|FG000|Overall Study|Withdrawal by Subject|25|||
146660304|NCT05169567|528933881|FG001|Overall Study|Withdrawal by Subject|21|||
146660305|NCT05419908|528933884|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
146660306|NCT05419908|528933885|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
146660307|NCT05419908|528933884|FG000|Overall Study|Serious Adverse Event|0|||
146660308|NCT05419908|528933885|FG001|Overall Study|Serious Adverse Event|2|||
146660309|NCT05419908|528933884|FG000|Overall Study|Withdrawal by Subject|2|||
146660310|NCT05419908|528933885|FG001|Overall Study|Withdrawal by Subject|0|||
146617418|NCT01814527|528770886|FG000|Overall Study|RTP greater than 30 days|6|||
146617419|NCT01814527|528770887|FG001|Overall Study|RTP greater than 30 days|1|||
146617420|NCT03571204|528770888|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
146617421|NCT03571204|528770889|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
146617422|NCT03571204|528770890|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
146617423|NCT03571204|528770888|FG000|Overall Study|Physician Decision|0|||
146617424|NCT03571204|528770889|FG001|Overall Study|Physician Decision|1|||
146617425|NCT03571204|528770890|FG002|Overall Study|Physician Decision|0|||
146617426|NCT03081884|528770892|FG000|Overall Study|deferred prostate cancer treatment|1|||
146617427|NCT03081884|528770892|FG000|Overall Study|metastasis managed with systemic therapy|3|||
146617428|NCT03948334|528770893|FG000|Overall Study|Adverse Event|1|||
146617429|NCT03948334|528770894|FG001|Overall Study|Adverse Event|4|||
146617430|NCT03948334|528770893|FG000|Overall Study|Lack of Efficacy|2|||
146617431|NCT03948334|528770894|FG001|Overall Study|Lack of Efficacy|0|||
146617432|NCT03948334|528770893|FG000|Overall Study|Lost to Follow-up|1|||
146617433|NCT03948334|528770894|FG001|Overall Study|Lost to Follow-up|0|||
146617434|NCT03948334|528770893|FG000|Overall Study|Physician Decision|1|||
146617435|NCT03948334|528770894|FG001|Overall Study|Physician Decision|0|||
146617436|NCT03948334|528770893|FG000|Overall Study|Pregnancy|0|||
146617437|NCT03948334|528770894|FG001|Overall Study|Pregnancy|1|||
146617438|NCT03948334|528770893|FG000|Overall Study|Protocol Deviation|1|||
146617439|NCT03948334|528770894|FG001|Overall Study|Protocol Deviation|0|||
146617440|NCT03948334|528770893|FG000|Overall Study|Study terminated by Sponsor|50|||
146617441|NCT03948334|528770894|FG001|Overall Study|Study terminated by Sponsor|51|||
146617442|NCT03948334|528770893|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
146617443|NCT03948334|528770894|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
146617444|NCT03575403|528770895|FG000|Overall Study|Adverse Event|1|||
146617445|NCT03575403|528770896|FG001|Overall Study|Adverse Event|0|||
146617446|NCT03575403|528770897|FG002|Overall Study|Adverse Event|0|||
146617447|NCT03575403|528770895|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
146617448|NCT03575403|528770896|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
146617449|NCT03575403|528770897|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
146617450|NCT05114473|528770898|FG000|Overall Study|Lost to Follow-up|2|||
146617451|NCT05114473|528770899|FG001|Overall Study|Lost to Follow-up|2|||
146617452|NCT05114473|528770900|FG002|Overall Study|Lost to Follow-up|0|||
146617453|NCT03359174|528770903|FG000|Overall Study|Adverse Event|1|||
146617454|NCT04445662|528770907|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
146617455|NCT04445662|528770908|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
146617456|NCT04445662|528770907|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
146617457|NCT04445662|528770908|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
146617458|NCT04445662|528770907|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
146617459|NCT04445662|528770908|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
146660311|NCT05419908|528933884|FG000|Overall Study|Miscellaneous|1|||
146660312|NCT05419908|528933885|FG001|Overall Study|Miscellaneous|1|||
146660313|NCT05069259|528933889|FG000|Overall Study|Withdrawal by Subject|1|||
146660314|NCT05069259|528933889|FG000|Overall Study|Sponsor decision|1|||
146660315|NCT01828320|528933891|FG000|Overall Study|Lost to Follow-up|1|||
146925145|NCT00831441|529885930|FG000|Randomized|Physician Decision|26|||
146617460|NCT04445662|528770907|FG000|Post-treatment (12-24 weeks)|Death|1|||
146617461|NCT04445662|528770908|FG001|Post-treatment (12-24 weeks)|Death|0|||
146617462|NCT00279916|528770909|FG000|Overall Study|Withdrawal by Subject|4|||
146660316|NCT01828320|528933892|FG001|Overall Study|Lost to Follow-up|3|||
146660317|NCT01828320|528933891|FG000|Overall Study|Withdrawal by Subject|7|||
146660318|NCT01828320|528933892|FG001|Overall Study|Withdrawal by Subject|2|||
146660319|NCT02160782|528935244|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
146660320|NCT02160782|528935245|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
146660321|NCT02160782|528935246|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
146660322|NCT02160782|528935247|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
146660323|NCT02160782|528935248|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
146660324|NCT02160782|528935244|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
146660325|NCT02160782|528935245|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
146660326|NCT02160782|528935246|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
146660327|NCT02160782|528935247|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
146660328|NCT02160782|528935248|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
146660329|NCT02160782|528935244|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
146660330|NCT02160782|528935245|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
146660331|NCT02160782|528935246|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
146660332|NCT02160782|528935247|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
146660333|NCT02160782|528935248|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
146660334|NCT02160782|528935244|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
146660335|NCT02160782|528935245|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
146660336|NCT02160782|528935246|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
146660337|NCT02160782|528935247|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
146660338|NCT02160782|528935248|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
146660339|NCT02160782|528935244|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
146660340|NCT02160782|528935245|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
146660341|NCT02160782|528935246|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
146660342|NCT02160782|528935247|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
146660343|NCT02160782|528935248|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
146660344|NCT02160782|528935244|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
146660345|NCT02160782|528935245|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
146660346|NCT02160782|528935246|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
146660347|NCT02160782|528935247|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
146660348|NCT02160782|528935248|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
146660349|NCT02160782|528935244|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
146660350|NCT02160782|528935245|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
146660351|NCT02160782|528935246|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
146660352|NCT02160782|528935247|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
146660353|NCT02160782|528935248|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
146660354|NCT00891462|528935251|FG000|Overall Study|Withdrawal by Subject|9|||
146660355|NCT00891462|528935252|FG001|Overall Study|Withdrawal by Subject|6|||
146660356|NCT00891462|528935253|FG002|Overall Study|Withdrawal by Subject|7|||
146660357|NCT00891462|528935251|FG000|Overall Study|Adverse Event|7|||
146660358|NCT00891462|528935252|FG001|Overall Study|Adverse Event|8|||
146660359|NCT00891462|528935253|FG002|Overall Study|Adverse Event|7|||
146660360|NCT00891462|528935251|FG000|Overall Study|Lack of Efficacy|10|||
146660361|NCT00891462|528935252|FG001|Overall Study|Lack of Efficacy|5|||
146660362|NCT00891462|528935253|FG002|Overall Study|Lack of Efficacy|1|||
146660363|NCT00891462|528935251|FG000|Overall Study|COPD exacerbation|7|||
146660364|NCT00891462|528935252|FG001|Overall Study|COPD exacerbation|4|||
146660365|NCT00891462|528935253|FG002|Overall Study|COPD exacerbation|1|||
146660366|NCT00891462|528935251|FG000|Overall Study|Other Reason|2|||
146660367|NCT00891462|528935252|FG001|Overall Study|Other Reason|5|||
146660368|NCT00891462|528935253|FG002|Overall Study|Other Reason|3|||
146660369|NCT00891462|528935251|FG000|Overall Study|Protocol Violation|2|||
146660370|NCT00891462|528935252|FG001|Overall Study|Protocol Violation|1|||
146660371|NCT00891462|528935253|FG002|Overall Study|Protocol Violation|3|||
146660372|NCT00891462|528935251|FG000|Overall Study|Inclusion/exclusion criteria|0|||
146660373|NCT00891462|528935252|FG001|Overall Study|Inclusion/exclusion criteria|2|||
146660374|NCT00891462|528935253|FG002|Overall Study|Inclusion/exclusion criteria|2|||
146660375|NCT00891462|528935251|FG000|Overall Study|Lost to Follow-up|0|||
146978731|NCT01847313|530085485|FG000|Overall Study|Death|0|||
146978732|NCT01847313|530085486|FG001|Overall Study|Death|1|||
146978733|NCT01847313|530085485|FG000|Overall Study|Withdrawal by Subject|0|||
146978734|NCT01847313|530085486|FG001|Overall Study|Withdrawal by Subject|1|||
146660376|NCT00891462|528935252|FG001|Overall Study|Lost to Follow-up|2|||
146660377|NCT00891462|528935253|FG002|Overall Study|Lost to Follow-up|0|||
146660378|NCT00423722|528935257|FG000|Overall Study|Death|4|||
146978735|NCT00598559|530085488|FG000|Overall Study|Adverse Event|11|||
146925146|NCT00831441|529885931|FG001|Randomized|Physician Decision|35|||
146925147|NCT00831441|529885930|FG000|Randomized|No longer met criteria|13|||
146925148|NCT00831441|529885931|FG001|Randomized|No longer met criteria|19|||
146925149|NCT00831441|529885930|FG000|Randomized|Withdrawal by Subject|178|||
146925150|NCT00831441|529885931|FG001|Randomized|Withdrawal by Subject|212|||
146925151|NCT00831441|529885930|FG000|Randomized|Lost to Follow-up|26|||
146925152|NCT00831441|529885931|FG001|Randomized|Lost to Follow-up|35|||
146925153|NCT00831441|529885930|FG000|Randomized|Administrative reason by sponsor|2780|||
146925154|NCT00831441|529885931|FG001|Randomized|Administrative reason by sponsor|2671|||
146925155|NCT00831441|529885930|FG000|Randomized|poor/non-compliance|30|||
146925156|NCT00831441|529885931|FG001|Randomized|poor/non-compliance|38|||
146925157|NCT00831441|529885930|FG000|Randomized|non-specified|276|||
146925158|NCT00831441|529885931|FG001|Randomized|non-specified|266|||
146925159|NCT00831441|529885930|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
146925160|NCT00831441|529885931|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
146925161|NCT00831441|529885930|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
146925162|NCT00831441|529885931|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
146925163|NCT00831441|529885930|FG000|Follow Up (30 Days)|Death|63|||
146925164|NCT00831441|529885931|FG001|Follow Up (30 Days)|Death|86|||
146925165|NCT00831441|529885930|FG000|Follow Up (30 Days)|non-specified|16|||
146617463|NCT00279916|528770910|FG001|Overall Study|Withdrawal by Subject|3|||
146617464|NCT00279916|528770909|FG000|Overall Study|Lost to Follow-up|3|||
146617465|NCT00279916|528770910|FG001|Overall Study|Lost to Follow-up|2|||
146617466|NCT00731679|528770914|FG000|Overall Study|Adverse Event|7|||
146617467|NCT00731679|528770915|FG001|Overall Study|Adverse Event|8|||
146617468|NCT00731679|528770914|FG000|Overall Study|Withdrawal by Subject|8|||
146617469|NCT00731679|528770915|FG001|Overall Study|Withdrawal by Subject|8|||
146617470|NCT00731679|528770914|FG000|Overall Study|Lost to Follow-up|7|||
146617471|NCT00731679|528770915|FG001|Overall Study|Lost to Follow-up|8|||
146617472|NCT00731679|528770914|FG000|Overall Study|Noncompliance|0|||
146617473|NCT00731679|528770915|FG001|Overall Study|Noncompliance|1|||
146617474|NCT00731679|528770914|FG000|Overall Study|Pregnancy|0|||
146617475|NCT00731679|528770915|FG001|Overall Study|Pregnancy|1|||
146617476|NCT02488005|528770916|FG000|Overall Study|Lost to Follow-up|2|||
146617477|NCT03384940|528770917|FG000|Overall Study|Progressive disease|36|||
146617478|NCT03384940|528770918|FG001|Overall Study|Progressive disease|11|||
146617479|NCT03384940|528770919|FG002|Overall Study|Progressive disease|13|||
146617480|NCT03384940|528770917|FG000|Overall Study|Clinical progression|4|||
146617481|NCT03384940|528770918|FG001|Overall Study|Clinical progression|0|||
146617482|NCT03384940|528770919|FG002|Overall Study|Clinical progression|3|||
146617483|NCT03384940|528770917|FG000|Overall Study|Adverse Event|7|||
146617484|NCT03384940|528770918|FG001|Overall Study|Adverse Event|1|||
146617485|NCT03384940|528770919|FG002|Overall Study|Adverse Event|1|||
146617486|NCT03384940|528770917|FG000|Overall Study|Withdrawal by Subject|3|||
146617487|NCT03384940|528770918|FG001|Overall Study|Withdrawal by Subject|1|||
146617488|NCT03384940|528770919|FG002|Overall Study|Withdrawal by Subject|0|||
146617489|NCT03384940|528770917|FG000|Overall Study|Physician Decision|1|||
146617490|NCT03384940|528770918|FG001|Overall Study|Physician Decision|1|||
146617491|NCT03384940|528770919|FG002|Overall Study|Physician Decision|0|||
146617492|NCT03384940|528770917|FG000|Overall Study|Death|2|||
146617493|NCT03384940|528770918|FG001|Overall Study|Death|1|||
146617494|NCT03384940|528770919|FG002|Overall Study|Death|0|||
146617495|NCT03384940|528770917|FG000|Overall Study|Other|0|||
146617496|NCT03384940|528770918|FG001|Overall Study|Other|0|||
146617497|NCT03384940|528770919|FG002|Overall Study|Other|1|||
146617498|NCT03089580|528770925|FG000|Overall Study|Lost to Follow-up|2|||
146617499|NCT03087513|528770926|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
146617500|NCT04628780|528770927|FG000|Overall Study|Death|0|||
146617501|NCT04628780|528770928|FG001|Overall Study|Death|1|||
146617502|NCT04628780|528770929|FG002|Overall Study|Death|0|||
146617503|NCT04628780|528770930|FG003|Overall Study|Death|0|||
146617504|NCT04628780|528770931|FG004|Overall Study|Death|1|||
146617505|NCT04628780|528770932|FG005|Overall Study|Death|0|||
146617506|NCT04628780|528770927|FG000|Overall Study|Physician Decision|2|||
146617507|NCT04628780|528770928|FG001|Overall Study|Physician Decision|0|||
146617508|NCT04628780|528770929|FG002|Overall Study|Physician Decision|0|||
146617509|NCT04628780|528770930|FG003|Overall Study|Physician Decision|0|||
146925166|NCT00831441|529885931|FG001|Follow Up (30 Days)|non-specified|26|||
146978736|NCT00598559|530085489|FG001|Overall Study|Adverse Event|7|||
146617510|NCT04628780|528770931|FG004|Overall Study|Physician Decision|2|||
146617511|NCT04628780|528770932|FG005|Overall Study|Physician Decision|0|||
146617512|NCT04628780|528770927|FG000|Overall Study|Progressive disease|2|||
146617513|NCT04628780|528770928|FG001|Overall Study|Progressive disease|2|||
146617514|NCT04628780|528770929|FG002|Overall Study|Progressive disease|2|||
146617515|NCT04628780|528770930|FG003|Overall Study|Progressive disease|3|||
146617516|NCT04628780|528770931|FG004|Overall Study|Progressive disease|9|||
146617517|NCT04628780|528770932|FG005|Overall Study|Progressive disease|4|||
146617518|NCT04628780|528770927|FG000|Overall Study|Withdrawal by Subject|0|||
146617519|NCT04628780|528770928|FG001|Overall Study|Withdrawal by Subject|1|||
146925167|NCT00831441|529885930|FG000|Follow Up (30 Days)|missing end of study status|0|||
146978737|NCT00598559|530085490|FG002|Overall Study|Adverse Event|0|||
146660379|NCT00423722|528935258|FG001|Overall Study|Death|4|||
146660380|NCT00423722|528935257|FG000|Overall Study|Declined to participate|2|||
146660381|NCT00423722|528935258|FG001|Overall Study|Declined to participate|3|||
146660382|NCT00423722|528935257|FG000|Overall Study|Unable to complete questionnaires|4|||
146660383|NCT00423722|528935258|FG001|Overall Study|Unable to complete questionnaires|4|||
146773656|NCT01792830|529341139|FG008|Overall Study|Adverse Event|1|||
146773657|NCT01792830|529341140|FG009|Overall Study|Adverse Event|0|||
146773658|NCT01792830|529341141|FG010|Overall Study|Adverse Event|0|||
146773659|NCT01943799|529341142|FG000|Overall Study|Lost to Follow-up|0|||
146773660|NCT01943799|529341143|FG001|Overall Study|Lost to Follow-up|1|||
146773661|NCT01943799|529341144|FG002|Overall Study|Lost to Follow-up|1|||
146773662|NCT01943799|529341145|FG003|Overall Study|Lost to Follow-up|0|||
146773663|NCT01943799|529341142|FG000|Overall Study|Protocol Violation|1|||
146773664|NCT01943799|529341143|FG001|Overall Study|Protocol Violation|0|||
146773665|NCT01943799|529341144|FG002|Overall Study|Protocol Violation|0|||
146773666|NCT01943799|529341145|FG003|Overall Study|Protocol Violation|0|||
146773667|NCT01943799|529341142|FG000|Overall Study|Withdrawal by Subject|4|||
146773668|NCT01943799|529341143|FG001|Overall Study|Withdrawal by Subject|2|||
146773669|NCT01943799|529341144|FG002|Overall Study|Withdrawal by Subject|1|||
146773670|NCT01943799|529341145|FG003|Overall Study|Withdrawal by Subject|0|||
146773671|NCT03811574|529341148|FG000|Overall Study|Withdrawal by Subject|2|||
146773672|NCT03811574|529341149|FG001|Overall Study|Withdrawal by Subject|4|||
146773673|NCT03811574|529341150|FG002|Overall Study|Withdrawal by Subject|0|||
146773674|NCT01832480|529341151|FG000|Overall Study|Lost to Follow-up|33|||
146773675|NCT01832480|529341152|FG001|Overall Study|Lost to Follow-up|30|||
146773676|NCT01832480|529341151|FG000|Overall Study|Withdrawal by Subject|0|||
146773677|NCT01832480|529341152|FG001|Overall Study|Withdrawal by Subject|2|||
146773678|NCT01832480|529341151|FG000|Overall Study|post randomization ineligible|8|||
146773679|NCT01832480|529341152|FG001|Overall Study|post randomization ineligible|10|||
146773680|NCT05609032|529341158|FG000|Overall Study|Lost to Follow-up|3|||
146773681|NCT05609032|529341159|FG001|Overall Study|Lost to Follow-up|1|||
146773682|NCT05609032|529341158|FG000|Overall Study|Withdrawal by Subject|1|||
146773683|NCT05609032|529341159|FG001|Overall Study|Withdrawal by Subject|0|||
146773684|NCT03764475|529341160|FG000|Overall Study|Adverse Event|11|||
146925168|NCT00831441|529885931|FG001|Follow Up (30 Days)|missing end of study status|1|||
146925169|NCT05674344|529885932|FG000|Overall Study|Screen Fail|21|||
146925170|NCT05674344|529885932|FG000|Overall Study|Incomplete study procedures|3|||
146925171|NCT00111917|529885933|FG000|Overall Study|Withdrawal by Subject|1|||
146925172|NCT00111917|529885934|FG001|Overall Study|Withdrawal by Subject|1|||
146925173|NCT04831515|529885935|FG000|First Intervention|Adverse Event|0|||
146660384|NCT00423722|528935257|FG000|Overall Study|Withdrawal by Subject|4|||
146660385|NCT00423722|528935258|FG001|Overall Study|Withdrawal by Subject|2|||
146660386|NCT00215683|528935259|FG000|Overall Study|Adverse Event|15|||
146660387|NCT00215683|528935260|FG001|Overall Study|Adverse Event|16|||
146660388|NCT00215683|528935261|FG002|Overall Study|Adverse Event|15|||
146660389|NCT00215683|528935259|FG000|Overall Study|Lack of Efficacy|5|||
146660390|NCT00215683|528935260|FG001|Overall Study|Lack of Efficacy|1|||
146660391|NCT00215683|528935261|FG002|Overall Study|Lack of Efficacy|2|||
146660392|NCT00215683|528935259|FG000|Overall Study|Lost to Follow-up|0|||
146660393|NCT00215683|528935260|FG001|Overall Study|Lost to Follow-up|2|||
146660394|NCT00215683|528935261|FG002|Overall Study|Lost to Follow-up|1|||
146660395|NCT00215683|528935259|FG000|Overall Study|Withdrawal by Subject|9|||
146660396|NCT00215683|528935260|FG001|Overall Study|Withdrawal by Subject|4|||
146660397|NCT00215683|528935261|FG002|Overall Study|Withdrawal by Subject|13|||
146925174|NCT04831515|529885936|FG001|First Intervention|Adverse Event|1|||
146925175|NCT01640925|529885937|FG000|Overall Study|Withdrawal by Subject|1|||
146660398|NCT00215683|528935259|FG000|Overall Study|Physician Decision|0|||
146660399|NCT00215683|528935260|FG001|Overall Study|Physician Decision|0|||
146660400|NCT00215683|528935261|FG002|Overall Study|Physician Decision|1|||
146660401|NCT00215683|528935259|FG000|Overall Study|Difficult to attend visits|0|||
146660402|NCT00215683|528935260|FG001|Overall Study|Difficult to attend visits|1|||
146660403|NCT00215683|528935261|FG002|Overall Study|Difficult to attend visits|0|||
146660404|NCT00215683|528935259|FG000|Overall Study|No study drug available|0|||
146660405|NCT00215683|528935260|FG001|Overall Study|No study drug available|1|||
146660406|NCT00215683|528935261|FG002|Overall Study|No study drug available|0|||
146773685|NCT03764475|529341161|FG001|Overall Study|Adverse Event|2|||
146925176|NCT01640925|529885938|FG001|Overall Study|Withdrawal by Subject|0|||
146660407|NCT00215683|528935259|FG000|Overall Study|Intermittent therapy required|0|||
146660408|NCT00215683|528935260|FG001|Overall Study|Intermittent therapy required|1|||
146660409|NCT00215683|528935261|FG002|Overall Study|Intermittent therapy required|0|||
146660410|NCT01083485|528935262|FG000|Overall Study|Adverse Event|0|||
146773686|NCT03764475|529341160|FG000|Overall Study|Lost to Follow-up|24|||
146773687|NCT03764475|529341161|FG001|Overall Study|Lost to Follow-up|10|||
146773688|NCT03764475|529341160|FG000|Overall Study|Withdrawal by Subject|26|||
146773689|NCT03764475|529341161|FG001|Overall Study|Withdrawal by Subject|10|||
146773690|NCT03764475|529341160|FG000|Overall Study|Lack of Efficacy|3|||
146773691|NCT03764475|529341161|FG001|Overall Study|Lack of Efficacy|0|||
146660411|NCT01083485|528935263|FG001|Overall Study|Adverse Event|1|||
146660412|NCT01083485|528935262|FG000|Overall Study|Protocol Violation|1|||
146660413|NCT01083485|528935263|FG001|Overall Study|Protocol Violation|0|||
146660414|NCT01083485|528935262|FG000|Overall Study|Withdrawal by Subject|5|||
146660415|NCT01083485|528935263|FG001|Overall Study|Withdrawal by Subject|2|||
146660416|NCT01083485|528935262|FG000|Overall Study|Other|1|||
146660417|NCT01083485|528935263|FG001|Overall Study|Other|0|||
146660418|NCT04493333|528935264|FG000|Overall Study|Withdrawal by Subject|1|||
146660419|NCT04493333|528935265|FG001|Overall Study|Withdrawal by Subject|1|||
146660420|NCT04493333|528935264|FG000|Overall Study|Ineligible|0|||
146660421|NCT04493333|528935265|FG001|Overall Study|Ineligible|1|||
146660422|NCT04493333|528935264|FG000|Overall Study|Noncompliance|2|||
146660423|NCT04493333|528935265|FG001|Overall Study|Noncompliance|1|||
146660424|NCT00674973|528935268|FG000|Overall Study|Insufficient Therapeutic Response|77|||
146660425|NCT00674973|528935269|FG001|Overall Study|Insufficient Therapeutic Response|72|||
146660426|NCT00674973|528935268|FG000|Overall Study|Refused Treatment|1|||
146660427|NCT00674973|528935269|FG001|Overall Study|Refused Treatment|5|||
146660428|NCT00674973|528935268|FG000|Overall Study|Failure to Return|1|||
146660429|NCT00674973|528935269|FG001|Overall Study|Failure to Return|0|||
146660430|NCT00674973|528935268|FG000|Overall Study|Adverse Event|2|||
146660431|NCT00674973|528935269|FG001|Overall Study|Adverse Event|9|||
146660432|NCT00674973|528935268|FG000|Overall Study|Death|19|||
146660433|NCT00674973|528935269|FG001|Overall Study|Death|15|||
146660434|NCT00674973|528935268|FG000|Overall Study|Protocol Violation|0|||
146660435|NCT00674973|528935269|FG001|Overall Study|Protocol Violation|1|||
146660436|NCT05036369|528935274|FG000|Overall Study|Run In non compliance|1|||
146660437|NCT05036369|528935275|FG001|Overall Study|Run In non compliance|2|||
146660438|NCT05036369|528935274|FG000|Overall Study|Change in eligibility criteria|0|||
146660439|NCT05036369|528935275|FG001|Overall Study|Change in eligibility criteria|1|||
146660440|NCT02095223|528935278|FG000|Overall Study|Withdrawal by Subject|1|||
146660441|NCT02095223|528935279|FG001|Overall Study|Withdrawal by Subject|0|||
146660442|NCT03906461|528935280|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
146660443|NCT03906461|528935280|FG000|Completed 12-month Follow-up|Missed Visit|6|||
146660444|NCT00426231|528935283|FG000|Overall Study|Withdrawal by Subject|9|||
146660445|NCT00426231|528935284|FG001|Overall Study|Withdrawal by Subject|12|||
146660446|NCT01795638|528935285|FG000|Overall Study|Death|0|||
146660447|NCT01795638|528935286|FG001|Overall Study|Death|3|||
146660448|NCT01795638|528935285|FG000|Overall Study|transferred to quaternary hospital|2|||
146660449|NCT01795638|528935286|FG001|Overall Study|transferred to quaternary hospital|3|||
146660450|NCT01795638|528935285|FG000|Overall Study|Protocol Violation|3|||
146660451|NCT01795638|528935286|FG001|Overall Study|Protocol Violation|0|||
146660452|NCT01795638|528935285|FG000|Overall Study|discharged from hospital|7|||
146660453|NCT01795638|528935286|FG001|Overall Study|discharged from hospital|5|||
146660454|NCT01795638|528935285|FG000|Overall Study|Withdrawal by Subject|1|||
146660455|NCT01795638|528935286|FG001|Overall Study|Withdrawal by Subject|0|||
146660456|NCT03061097|528935287|FG000|Overall Study|Withdrawal by Subject|0|||
146660457|NCT03061097|528935288|FG001|Overall Study|Withdrawal by Subject|3|||
146660458|NCT00595465|528935295|FG000|Overall Study|Adverse Event|4|||
146660459|NCT00595465|528935296|FG001|Overall Study|Adverse Event|3|||
146660460|NCT00595465|528935297|FG002|Overall Study|Adverse Event|3|||
146660461|NCT00595465|528935295|FG000|Overall Study|Pregnancy|0|||
146660462|NCT00595465|528935296|FG001|Overall Study|Pregnancy|0|||
146660463|NCT00595465|528935297|FG002|Overall Study|Pregnancy|1|||
146660464|NCT00595465|528935295|FG000|Overall Study|Protocol Violation|2|||
146660465|NCT00595465|528935296|FG001|Overall Study|Protocol Violation|1|||
146773692|NCT03764475|529341160|FG000|Overall Study|COVID-19 Disruption|2|||
146773693|NCT03764475|529341161|FG001|Overall Study|COVID-19 Disruption|0|||
146773694|NCT05510245|529341165|FG000|Overall Study|Withdrawal by Subject|1|||
146773695|NCT05510245|529341166|FG001|Overall Study|Withdrawal by Subject|0|||
146773696|NCT05510245|529341167|FG002|Overall Study|Withdrawal by Subject|0|||
146660466|NCT00595465|528935297|FG002|Overall Study|Protocol Violation|0|||
146660467|NCT00595465|528935295|FG000|Overall Study|Lost to Follow-up|0|||
146773697|NCT01373346|529341173|FG000|Overall Study|Death|1|||
146660468|NCT00595465|528935296|FG001|Overall Study|Lost to Follow-up|0|||
146660469|NCT00595465|528935297|FG002|Overall Study|Lost to Follow-up|2|||
146773698|NCT01198028|529341174|FG000|Overall Study|Adverse Event|5|||
146773699|NCT01198028|529341174|FG000|Overall Study|Death|3|||
146773700|NCT01198028|529341174|FG000|Overall Study|Physician Decision|2|||
146773701|NCT00970359|529341178|FG000|Overall Study|Not Treated|4|||
146925177|NCT01640925|529885937|FG000|Overall Study|Previously enrolled in this trial|13|||
146660470|NCT00595465|528935295|FG000|Overall Study|administrative reason|0|||
146660471|NCT00595465|528935296|FG001|Overall Study|administrative reason|0|||
146660472|NCT00595465|528935297|FG002|Overall Study|administrative reason|1|||
146660473|NCT00107783|528935298|FG000|Overall Study|Adverse Event|0|||
146660474|NCT00107783|528935299|FG001|Overall Study|Adverse Event|2|||
146660475|NCT00107783|528935298|FG000|Overall Study|Death|0|||
146660476|NCT00107783|528935299|FG001|Overall Study|Death|1|||
146660477|NCT00107783|528935298|FG000|Overall Study|Withdrawal by Subject|2|||
146773702|NCT01565148|529341179|FG000|Overall Study|Withdrawal by Subject|1|||
146660478|NCT00107783|528935299|FG001|Overall Study|Withdrawal by Subject|0|||
146660479|NCT00107783|528935298|FG000|Overall Study|Second hip replacement|1|||
146660480|NCT00107783|528935299|FG001|Overall Study|Second hip replacement|1|||
146660481|NCT00422097|528935300|FG000|Dose Level 2|Still on treatment|0|||
146660482|NCT00422097|528935301|FG001|Dose Level 2|Still on treatment|1|||
146660483|NCT00422097|528935302|FG002|Dose Level 2|Still on treatment|0|||
146660484|NCT00422097|528935303|FG003|Dose Level 2|Still on treatment|0|||
146660485|NCT00422097|528935304|FG004|Dose Level 2|Still on treatment|0|||
146660486|NCT00422097|528935305|FG005|Dose Level 2|Still on treatment|0|||
146660487|NCT00422097|528935306|FG006|Dose Level 2|Still on treatment|0|||
146660488|NCT00422097|528935307|FG007|Dose Level 2|Still on treatment|0|||
146660489|NCT02572388|528935308|FG000|Overall Study|Withdrawal by Subject|1|||
146660490|NCT02572388|528935309|FG001|Overall Study|Withdrawal by Subject|1|||
146660491|NCT02572388|528935310|FG002|Overall Study|Withdrawal by Subject|2|||
146660492|NCT02572388|528935311|FG003|Overall Study|Withdrawal by Subject|2|||
146660493|NCT02360995|528935312|FG000|Overall Study|Lost to Follow-up|2|||
146660494|NCT02360995|528935313|FG001|Overall Study|Lost to Follow-up|0|||
146660495|NCT02360995|528935314|FG002|Overall Study|Lost to Follow-up|2|||
146660496|NCT02360995|528935312|FG000|Overall Study|Withdrawal by Subject|0|||
146660497|NCT02360995|528935313|FG001|Overall Study|Withdrawal by Subject|1|||
146660498|NCT02360995|528935314|FG002|Overall Study|Withdrawal by Subject|0|||
146660499|NCT01051466|528935315|FG000|Overall Study|Adverse Event|1|||
146660500|NCT01051466|528935316|FG001|Overall Study|Adverse Event|0|||
146660501|NCT01051466|528935315|FG000|Overall Study|Lost to Follow-up|1|||
146660502|NCT01051466|528935316|FG001|Overall Study|Lost to Follow-up|1|||
146660503|NCT01051466|528935315|FG000|Overall Study|Withdrawal by Subject|5|||
146660504|NCT01051466|528935316|FG001|Overall Study|Withdrawal by Subject|1|||
146660505|NCT01051466|528935315|FG000|Overall Study|Entry Criteria Not Met|0|||
146660506|NCT01051466|528935316|FG001|Overall Study|Entry Criteria Not Met|3|||
146660507|NCT01051466|528935315|FG000|Overall Study|Physician Decision|1|||
146660508|NCT01051466|528935316|FG001|Overall Study|Physician Decision|0|||
146660509|NCT02231918|528935317|FG000|Overall Study|Withdrawal by Subject|0|||
146660510|NCT02231918|528935318|FG001|Overall Study|Withdrawal by Subject|1|||
146660511|NCT02231918|528935319|FG002|Overall Study|Withdrawal by Subject|0|||
146660512|NCT02231918|528935317|FG000|Overall Study|Adverse Event|0|||
146660513|NCT02231918|528935318|FG001|Overall Study|Adverse Event|0|||
146660514|NCT02231918|528935319|FG002|Overall Study|Adverse Event|1|||
146660515|NCT00331864|528935327|FG000|Overall Study|Adverse Event|30|||
146660516|NCT00331864|528935328|FG001|Overall Study|Adverse Event|1|||
146660517|NCT00331864|528935327|FG000|Overall Study|Lack of Efficacy|4|||
146660518|NCT00331864|528935328|FG001|Overall Study|Lack of Efficacy|0|||
146660519|NCT00331864|528935327|FG000|Overall Study|Protocol Violation|3|||
146660520|NCT00331864|528935328|FG001|Overall Study|Protocol Violation|0|||
146660521|NCT00331864|528935327|FG000|Overall Study|Withdrawal by Subject|10|||
146660522|NCT00331864|528935328|FG001|Overall Study|Withdrawal by Subject|0|||
146660523|NCT00331864|528935327|FG000|Overall Study|Lost to Follow-up|4|||
146660524|NCT00331864|528935328|FG001|Overall Study|Lost to Follow-up|3|||
146660525|NCT00331864|528935327|FG000|Overall Study|Administrative Problems|1|||
146660526|NCT00331864|528935328|FG001|Overall Study|Administrative Problems|0|||
146660527|NCT00331864|528935327|FG000|Overall Study|Death|6|||
146660528|NCT00331864|528935328|FG001|Overall Study|Death|0|||
146660529|NCT00137631|528935329|FG000|Overall Study|Lost to Follow-up|37|||
146660530|NCT00137631|528935330|FG001|Overall Study|Lost to Follow-up|41|||
146660531|NCT02611960|528935331|FG000|Overall Study|Adverse Event|7|||
146660532|NCT02611960|528935332|FG001|Overall Study|Adverse Event|8|||
146660533|NCT02611960|528935331|FG000|Overall Study|Death|98|||
146660534|NCT02611960|528935332|FG001|Overall Study|Death|92|||
146660535|NCT02611960|528935331|FG000|Overall Study|Withdrawal by Subject|1|||
146660536|NCT02611960|528935332|FG001|Overall Study|Withdrawal by Subject|5|||
146660537|NCT02611960|528935331|FG000|Overall Study|Sponsor Decision|11|||
146660538|NCT02611960|528935332|FG001|Overall Study|Sponsor Decision|11|||
146660539|NCT02395666|528935333|FG000|Overall Study|Physician Decision|3|||
146660540|NCT02395666|528935334|FG001|Overall Study|Physician Decision|0|||
146660541|NCT02395666|528935333|FG000|Overall Study|Lost to Follow-up|1|||
146660542|NCT02395666|528935334|FG001|Overall Study|Lost to Follow-up|0|||
146660543|NCT02395666|528935333|FG000|Overall Study|Withdrawal by Subject|2|||
146773703|NCT01565148|529341180|FG001|Overall Study|Withdrawal by Subject|1|||
146773704|NCT01565148|529341181|FG002|Overall Study|Withdrawal by Subject|1|||
146660544|NCT02395666|528935334|FG001|Overall Study|Withdrawal by Subject|1|||
146660545|NCT00085709|528935336|FG000|Overall Study|Adverse Event|8|||
146660546|NCT00085709|528935337|FG001|Overall Study|Adverse Event|0|||
146660547|NCT00085709|528935336|FG000|Overall Study|Death|8|||
146660548|NCT00085709|528935337|FG001|Overall Study|Death|2|||
146660549|NCT00085709|528935336|FG000|Overall Study|Refusal unrelated to adverse events|1|||
146660550|NCT00085709|528935337|FG001|Overall Study|Refusal unrelated to adverse events|2|||
146660551|NCT00085709|528935336|FG000|Overall Study|Progression|3|||
146660552|NCT00085709|528935337|FG001|Overall Study|Progression|4|||
146660553|NCT00085709|528935336|FG000|Overall Study|Not protocol specified|12|||
146660554|NCT00085709|528935337|FG001|Overall Study|Not protocol specified|22|||
146660555|NCT00085709|528935336|FG000|Overall Study|Not eligible|19|||
146660556|NCT00085709|528935337|FG001|Overall Study|Not eligible|19|||
146660557|NCT00085709|528935336|FG000|Overall Study|Withdrawal by Subject|2|||
146660558|NCT00085709|528935337|FG001|Overall Study|Withdrawal by Subject|1|||
146660559|NCT00293215|528935338|FG000|Overall Study|Progressive disease|3|||
146660560|NCT00293215|528935339|FG001|Overall Study|Progressive disease|1|||
146660561|NCT00293215|528935338|FG000|Overall Study|Adverse Event|2|||
146660562|NCT00293215|528935339|FG001|Overall Study|Adverse Event|2|||
146660563|NCT04131556|528935340|FG000|Overall Study|Adverse Event|1|||
146660564|NCT04131556|528935340|FG000|Overall Study|Withdrawal by Subject|1|||
146660565|NCT01229371|528935343|FG000|Overall Study|Withdrawal by Subject|0|||
146660566|NCT01229371|528935344|FG001|Overall Study|Withdrawal by Subject|1|||
146660567|NCT01229371|528935345|FG002|Overall Study|Withdrawal by Subject|0|||
146660568|NCT01229371|528935346|FG003|Overall Study|Withdrawal by Subject|0|||
146660569|NCT03611010|528935347|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
146660570|NCT03611010|528935348|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
146660571|NCT03611010|528935349|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
146660572|NCT03611010|528935350|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
146660573|NCT00760214|528935352|FG000|Overall Study|Adverse Event|8|||
146660574|NCT00760214|528935353|FG001|Overall Study|Adverse Event|9|||
146660575|NCT00760214|528935354|FG002|Overall Study|Adverse Event|12|||
146660576|NCT00760214|528935352|FG000|Overall Study|Protocol Violation|3|||
146660577|NCT00760214|528935353|FG001|Overall Study|Protocol Violation|0|||
146660578|NCT00760214|528935354|FG002|Overall Study|Protocol Violation|3|||
146660579|NCT00760214|528935352|FG000|Overall Study|Lost to Follow-up|0|||
146660580|NCT00760214|528935353|FG001|Overall Study|Lost to Follow-up|0|||
146660581|NCT00760214|528935354|FG002|Overall Study|Lost to Follow-up|1|||
146660582|NCT00760214|528935352|FG000|Overall Study|Withdrawal by Subject|12|||
146660583|NCT00760214|528935353|FG001|Overall Study|Withdrawal by Subject|14|||
146660584|NCT00760214|528935354|FG002|Overall Study|Withdrawal by Subject|13|||
146660585|NCT00760214|528935352|FG000|Overall Study|Lack of Efficacy|3|||
146660586|NCT00760214|528935353|FG001|Overall Study|Lack of Efficacy|2|||
146660587|NCT00760214|528935354|FG002|Overall Study|Lack of Efficacy|4|||
146660588|NCT00760214|528935352|FG000|Overall Study|Pregnancy|0|||
146660589|NCT00760214|528935353|FG001|Overall Study|Pregnancy|0|||
146660590|NCT00760214|528935354|FG002|Overall Study|Pregnancy|1|||
146660591|NCT00760214|528935352|FG000|Overall Study|Physician Decision|1|||
146660592|NCT00760214|528935353|FG001|Overall Study|Physician Decision|1|||
146660593|NCT00760214|528935354|FG002|Overall Study|Physician Decision|1|||
146660594|NCT00760214|528935352|FG000|Overall Study|Other|3|||
146660595|NCT00760214|528935353|FG001|Overall Study|Other|4|||
146660596|NCT00760214|528935354|FG002|Overall Study|Other|6|||
146660597|NCT01933217|528935360|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
146660598|NCT01933217|528935361|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
146660599|NCT01933217|528935360|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
146660600|NCT01933217|528935361|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
146660601|NCT03923738|528935364|FG000|Period 1|Adverse Event|1|||
146660602|NCT03923738|528935364|FG000|Period 1|Withdrawal by Subject|1|||
146660603|NCT03583164|528935367|FG000|Overall Study|Death in Main Phase|35|||
146660604|NCT03583164|528935367|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
146660605|NCT03583164|528935367|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
146660606|NCT03583164|528935367|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
146660607|NCT03583164|528935367|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
146660608|NCT03583164|528935367|FG000|Overall Study|Physician decision in Main Phase|1|||
146660609|NCT03583164|528935367|FG000|Overall Study|Physician decision in Extended Phase|2|||
146660610|NCT03583164|528935367|FG000|Overall Study|Death in Extended Phase|13|||
146660611|NCT03583164|528935367|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
146660612|NCT03583164|528935367|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
146660613|NCT03583164|528935367|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
146660614|NCT03583164|528935367|FG000|Overall Study|Treatment failure in Main Phase|2|||
146660615|NCT03583164|528935367|FG000|Overall Study|Treatment failure in Extended Phase|4|||
146660616|NCT03583164|528935367|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
146660617|NCT03583164|528935367|FG000|Overall Study|Other not specified reason in Main Phase|2|||
146660618|NCT01031381|528935368|FG000|Overall Study|Physician Decision|3|||
146660619|NCT01031381|528935368|FG000|Overall Study|Withdrawal by Subject|6|||
146660620|NCT00249288|528935375|FG000|Overall Study|Lost to Follow-up|3|||
146660621|NCT00249288|528935376|FG001|Overall Study|Lost to Follow-up|3|||
146660622|NCT00249288|528935375|FG000|Overall Study|Withdrawal by Subject|2|||
146660623|NCT00249288|528935376|FG001|Overall Study|Withdrawal by Subject|2|||
146660624|NCT03059446|528935377|FG000|Overall Study|Adverse Event|11|||
146660625|NCT03059446|528935377|FG000|Overall Study|Withdrawal of Consent|16|||
146660626|NCT03059446|528935377|FG000|Overall Study|Lost to Follow-up|3|||
146660627|NCT03059446|528935377|FG000|Overall Study|Protocol Violation|1|||
146660628|NCT03059446|528935377|FG000|Overall Study|Study Terminated by Sponsor|131|||
146660629|NCT03059446|528935377|FG000|Overall Study|Reason not Specified|5|||
146660630|NCT00470847|528935378|FG000|Overall Study|Pt still receiving treatment|1|||
146617520|NCT04628780|528770929|FG002|Overall Study|Withdrawal by Subject|2|||
146617521|NCT04628780|528770930|FG003|Overall Study|Withdrawal by Subject|0|||
146617522|NCT04628780|528770931|FG004|Overall Study|Withdrawal by Subject|3|||
146617523|NCT04628780|528770932|FG005|Overall Study|Withdrawal by Subject|1|||
146617524|NCT04628780|528770927|FG000|Overall Study|Global deterioration of health status|0|||
146617525|NCT04628780|528770928|FG001|Overall Study|Global deterioration of health status|0|||
146617526|NCT04628780|528770929|FG002|Overall Study|Global deterioration of health status|0|||
146617527|NCT04628780|528770930|FG003|Overall Study|Global deterioration of health status|0|||
146617528|NCT04628780|528770931|FG004|Overall Study|Global deterioration of health status|1|||
146617529|NCT04628780|528770932|FG005|Overall Study|Global deterioration of health status|1|||
146617530|NCT01987102|528770934|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
146617531|NCT01987102|528770935|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
146617532|NCT01987102|528770934|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
146617533|NCT01987102|528770935|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
146617534|NCT01987102|528770934|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
146617535|NCT01987102|528770935|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
146617536|NCT01987102|528770934|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
146617537|NCT01987102|528770935|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
146617538|NCT01987102|528770934|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
146617539|NCT01987102|528770935|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
146617540|NCT01987102|528770934|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
146617541|NCT01987102|528770935|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
146617542|NCT01288989|528770936|FG000|Overall Study|Death|0|||
146617543|NCT01288989|528770937|FG001|Overall Study|Death|0|||
146617544|NCT01288989|528770938|FG002|Overall Study|Death|0|||
146617545|NCT01288989|528770939|FG003|Overall Study|Death|1|||
146617546|NCT01288989|528770940|FG004|Overall Study|Death|0|||
146617547|NCT01288989|528770936|FG000|Overall Study|Dose limiting toxicity|1|||
146617548|NCT01288989|528770937|FG001|Overall Study|Dose limiting toxicity|0|||
146617549|NCT01288989|528770938|FG002|Overall Study|Dose limiting toxicity|0|||
146617550|NCT01288989|528770939|FG003|Overall Study|Dose limiting toxicity|0|||
146617551|NCT01288989|528770940|FG004|Overall Study|Dose limiting toxicity|0|||
146617552|NCT01288989|528770936|FG000|Overall Study|Adverse Event|0|||
146617553|NCT01288989|528770937|FG001|Overall Study|Adverse Event|0|||
146617554|NCT01288989|528770938|FG002|Overall Study|Adverse Event|0|||
146617555|NCT01288989|528770939|FG003|Overall Study|Adverse Event|0|||
146617556|NCT01288989|528770940|FG004|Overall Study|Adverse Event|2|||
146617557|NCT01288989|528770936|FG000|Overall Study|Physician Decision|0|||
146617558|NCT01288989|528770937|FG001|Overall Study|Physician Decision|0|||
146617559|NCT01288989|528770938|FG002|Overall Study|Physician Decision|0|||
146617560|NCT01288989|528770939|FG003|Overall Study|Physician Decision|0|||
146617561|NCT01288989|528770940|FG004|Overall Study|Physician Decision|1|||
146617562|NCT01288989|528770936|FG000|Overall Study|Withdrawal by Subject|0|||
146617563|NCT01288989|528770937|FG001|Overall Study|Withdrawal by Subject|0|||
146617564|NCT01288989|528770938|FG002|Overall Study|Withdrawal by Subject|0|||
146617565|NCT01288989|528770939|FG003|Overall Study|Withdrawal by Subject|0|||
146617566|NCT01288989|528770940|FG004|Overall Study|Withdrawal by Subject|3|||
146617567|NCT01236521|528770941|FG000|Overall Study|Withdrawal by Subject|12|||
146617568|NCT01236521|528770942|FG001|Overall Study|Withdrawal by Subject|17|||
146617569|NCT01236521|528770941|FG000|Overall Study|Death|2|||
146617570|NCT01236521|528770942|FG001|Overall Study|Death|1|||
146617571|NCT01236521|528770941|FG000|Overall Study|Lost to Follow-up|9|||
146617572|NCT01236521|528770942|FG001|Overall Study|Lost to Follow-up|7|||
146617573|NCT00165672|528770945|FG000|Overall Study|Adverse Event|0|||
146617574|NCT00165672|528770946|FG001|Overall Study|Adverse Event|1|||
146617575|NCT05864586|528770948|FG000|Overall Study|Ineligible|4|||
146617576|NCT05864586|528770949|FG001|Overall Study|Ineligible|12|||
146617577|NCT05864586|528770948|FG000|Overall Study|Pregnancy|0|||
146617578|NCT05864586|528770949|FG001|Overall Study|Pregnancy|1|||
146617579|NCT05864586|528770948|FG000|Overall Study|Withdrawal by Subject|0|||
146617580|NCT05864586|528770949|FG001|Overall Study|Withdrawal by Subject|1|||
146617581|NCT03635424|528770950|FG000|Overall Study|Adverse Event|1|||
146617582|NCT03635424|528770950|FG000|Overall Study|Death|1|||
146617583|NCT03635424|528770950|FG000|Overall Study|Device not implanted|1|||
146617584|NCT05081219|528770951|FG000|Overall Study|Withdrawal by Subject|4|||
146617585|NCT05081219|528770952|FG001|Overall Study|Withdrawal by Subject|0|||
146617586|NCT05081219|528770953|FG002|Overall Study|Withdrawal by Subject|0|||
146617587|NCT05081219|528770954|FG003|Overall Study|Withdrawal by Subject|1|||
146617588|NCT02452424|528770957|FG000|Overall Study|Death|2|||
146617589|NCT02452424|528770958|FG001|Overall Study|Death|2|||
146617590|NCT02452424|528770959|FG002|Overall Study|Death|2|||
146617591|NCT02452424|528770960|FG003|Overall Study|Death|6|||
146617592|NCT02452424|528770961|FG004|Overall Study|Death|2|||
146617593|NCT02452424|528770962|FG005|Overall Study|Death|0|||
146617594|NCT02452424|528770963|FG006|Overall Study|Death|5|||
146617595|NCT02452424|528770964|FG007|Overall Study|Death|1|||
146617596|NCT02452424|528770965|FG008|Overall Study|Death|3|||
146925178|NCT01640925|529885938|FG001|Overall Study|Previously enrolled in this trial|11|||
146925179|NCT02156492|529885939|FG000|Period 1|No Reason Given|0|||
146925180|NCT02156492|529885940|FG001|Period 1|No Reason Given|1|||
146925181|NCT02156492|529885941|FG002|Period 1|No Reason Given|0|||
146925182|NCT02156492|529885939|FG000|Period 3|Adverse Event|0|||
146925183|NCT02156492|529885940|FG001|Period 3|Adverse Event|1|||
146925184|NCT02156492|529885941|FG002|Period 3|Adverse Event|0|||
146925185|NCT00485589|529885959|FG000|Overall Study|Death|2|||
146617597|NCT02452424|528770966|FG009|Overall Study|Death|1|||
146617598|NCT02452424|528770967|FG010|Overall Study|Death|0|||
146617599|NCT02452424|528770957|FG000|Overall Study|Lost to Follow-up|0|||
146617600|NCT02452424|528770958|FG001|Overall Study|Lost to Follow-up|1|||
146617601|NCT02452424|528770959|FG002|Overall Study|Lost to Follow-up|1|||
146617602|NCT02452424|528770960|FG003|Overall Study|Lost to Follow-up|0|||
146617603|NCT02452424|528770961|FG004|Overall Study|Lost to Follow-up|0|||
146617604|NCT02452424|528770962|FG005|Overall Study|Lost to Follow-up|0|||
146617605|NCT02452424|528770963|FG006|Overall Study|Lost to Follow-up|0|||
146617606|NCT02452424|528770964|FG007|Overall Study|Lost to Follow-up|0|||
146617607|NCT02452424|528770965|FG008|Overall Study|Lost to Follow-up|0|||
146617608|NCT02452424|528770966|FG009|Overall Study|Lost to Follow-up|0|||
146617609|NCT02452424|528770967|FG010|Overall Study|Lost to Follow-up|0|||
146617610|NCT02452424|528770957|FG000|Overall Study|Withdrawal by Subject|0|||
146617611|NCT02452424|528770958|FG001|Overall Study|Withdrawal by Subject|0|||
146617612|NCT02452424|528770959|FG002|Overall Study|Withdrawal by Subject|3|||
146617613|NCT02452424|528770960|FG003|Overall Study|Withdrawal by Subject|2|||
146617614|NCT02452424|528770961|FG004|Overall Study|Withdrawal by Subject|0|||
146617615|NCT02452424|528770962|FG005|Overall Study|Withdrawal by Subject|0|||
146617616|NCT02452424|528770963|FG006|Overall Study|Withdrawal by Subject|1|||
146617617|NCT02452424|528770964|FG007|Overall Study|Withdrawal by Subject|0|||
146617618|NCT02452424|528770965|FG008|Overall Study|Withdrawal by Subject|1|||
146617619|NCT02452424|528770966|FG009|Overall Study|Withdrawal by Subject|1|||
146617620|NCT02452424|528770967|FG010|Overall Study|Withdrawal by Subject|0|||
146617621|NCT02452424|528770957|FG000|Overall Study|Other|0|||
146617622|NCT02452424|528770958|FG001|Overall Study|Other|0|||
146617623|NCT02452424|528770959|FG002|Overall Study|Other|1|||
146617624|NCT02452424|528770960|FG003|Overall Study|Other|0|||
146617625|NCT02452424|528770961|FG004|Overall Study|Other|0|||
146617626|NCT02452424|528770962|FG005|Overall Study|Other|1|||
146617627|NCT02452424|528770963|FG006|Overall Study|Other|4|||
146617628|NCT02452424|528770964|FG007|Overall Study|Other|3|||
146617629|NCT02452424|528770965|FG008|Overall Study|Other|0|||
146617630|NCT02452424|528770966|FG009|Overall Study|Other|0|||
146617631|NCT02452424|528770967|FG010|Overall Study|Other|1|||
146617632|NCT02452424|528770957|FG000|Overall Study|Progressive disease (per RECIST)|0|||
146617633|NCT02452424|528770958|FG001|Overall Study|Progressive disease (per RECIST)|0|||
146617634|NCT02452424|528770959|FG002|Overall Study|Progressive disease (per RECIST)|0|||
146617635|NCT02452424|528770960|FG003|Overall Study|Progressive disease (per RECIST)|0|||
146617636|NCT02452424|528770961|FG004|Overall Study|Progressive disease (per RECIST)|0|||
146617637|NCT02452424|528770962|FG005|Overall Study|Progressive disease (per RECIST)|0|||
146617638|NCT02452424|528770963|FG006|Overall Study|Progressive disease (per RECIST)|0|||
146617639|NCT02452424|528770964|FG007|Overall Study|Progressive disease (per RECIST)|0|||
146617640|NCT02452424|528770965|FG008|Overall Study|Progressive disease (per RECIST)|2|||
146617641|NCT02452424|528770966|FG009|Overall Study|Progressive disease (per RECIST)|0|||
146617642|NCT02452424|528770967|FG010|Overall Study|Progressive disease (per RECIST)|0|||
146617643|NCT02452424|528770957|FG000|Overall Study|Adverse Event|0|||
146617644|NCT02452424|528770958|FG001|Overall Study|Adverse Event|0|||
146617645|NCT02452424|528770959|FG002|Overall Study|Adverse Event|0|||
146617646|NCT02452424|528770960|FG003|Overall Study|Adverse Event|0|||
146617647|NCT02452424|528770961|FG004|Overall Study|Adverse Event|0|||
146617648|NCT02452424|528770962|FG005|Overall Study|Adverse Event|0|||
146617649|NCT02452424|528770963|FG006|Overall Study|Adverse Event|0|||
146617650|NCT02452424|528770964|FG007|Overall Study|Adverse Event|0|||
146617651|NCT02452424|528770965|FG008|Overall Study|Adverse Event|0|||
146617652|NCT02452424|528770966|FG009|Overall Study|Adverse Event|0|||
146617653|NCT02452424|528770967|FG010|Overall Study|Adverse Event|1|||
146617654|NCT01463306|528770968|FG000|Overall Study|Adverse Event|6|||
146617655|NCT01463306|528770969|FG001|Overall Study|Adverse Event|9|||
146617656|NCT01463306|528770970|FG002|Overall Study|Adverse Event|3|||
146617657|NCT01463306|528770968|FG000|Overall Study|Death|3|||
146617658|NCT01463306|528770969|FG001|Overall Study|Death|3|||
146617659|NCT01463306|528770970|FG002|Overall Study|Death|0|||
146617660|NCT01463306|528770968|FG000|Overall Study|Lack of Efficacy|22|||
146925186|NCT00485589|529885960|FG001|Overall Study|Death|2|||
146617661|NCT01463306|528770969|FG001|Overall Study|Lack of Efficacy|16|||
146617662|NCT01463306|528770970|FG002|Overall Study|Lack of Efficacy|1|||
146617663|NCT01463306|528770968|FG000|Overall Study|Lost to Follow-up|5|||
146617664|NCT01463306|528770969|FG001|Overall Study|Lost to Follow-up|2|||
146617665|NCT01463306|528770970|FG002|Overall Study|Lost to Follow-up|0|||
146617666|NCT01463306|528770968|FG000|Overall Study|Protocol Violation|4|||
146925187|NCT00485589|529885961|FG002|Overall Study|Death|0|||
146617667|NCT01463306|528770969|FG001|Overall Study|Protocol Violation|0|||
146617668|NCT01463306|528770970|FG002|Overall Study|Protocol Violation|0|||
146660631|NCT02035475|528935385|FG000|Overall Study|Withdrawal by Subject|4|||
146617669|NCT01463306|528770968|FG000|Overall Study|Withdrawal by Subject|19|||
146617670|NCT01463306|528770969|FG001|Overall Study|Withdrawal by Subject|9|||
146617671|NCT01463306|528770970|FG002|Overall Study|Withdrawal by Subject|1|||
146617672|NCT01463306|528770968|FG000|Overall Study|Other|26|||
146617673|NCT01463306|528770969|FG001|Overall Study|Other|13|||
146617674|NCT01463306|528770970|FG002|Overall Study|Other|0|||
146617675|NCT01463306|528770968|FG000|Overall Study|Approval expiry at site|1|||
146617676|NCT01463306|528770969|FG001|Overall Study|Approval expiry at site|0|||
146617677|NCT01463306|528770970|FG002|Overall Study|Approval expiry at site|0|||
146617678|NCT01059318|528770971|FG000|Core Study (26 Week)|Adverse Event|3|||
146617679|NCT01059318|528770971|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
146617680|NCT01059318|528770971|FG000|Extension (36 Week)|Adverse Event|3|||
146617681|NCT02719171|528773055|FG000|Overall Study|Adverse Event|1|||
146617682|NCT02719171|528773056|FG001|Overall Study|Adverse Event|2|||
146617683|NCT02719171|528773057|FG002|Overall Study|Adverse Event|0|||
146617684|NCT02719171|528773058|FG003|Overall Study|Adverse Event|0|||
146617685|NCT02719171|528773059|FG004|Overall Study|Adverse Event|2|||
146617686|NCT02719171|528773055|FG000|Overall Study|Lost to Follow-up|0|||
146617687|NCT02719171|528773056|FG001|Overall Study|Lost to Follow-up|0|||
146617688|NCT02719171|528773057|FG002|Overall Study|Lost to Follow-up|1|||
146617689|NCT02719171|528773058|FG003|Overall Study|Lost to Follow-up|0|||
146617690|NCT02719171|528773059|FG004|Overall Study|Lost to Follow-up|0|||
146617691|NCT02719171|528773055|FG000|Overall Study|Subject Withdrawal|0|||
146617692|NCT02719171|528773056|FG001|Overall Study|Subject Withdrawal|2|||
146617693|NCT02719171|528773057|FG002|Overall Study|Subject Withdrawal|2|||
146617694|NCT02719171|528773058|FG003|Overall Study|Subject Withdrawal|1|||
146617695|NCT02719171|528773059|FG004|Overall Study|Subject Withdrawal|0|||
146617696|NCT02719171|528773055|FG000|Overall Study|Other|0|||
146617697|NCT02719171|528773056|FG001|Overall Study|Other|0|||
146617698|NCT02719171|528773057|FG002|Overall Study|Other|0|||
146617699|NCT02719171|528773058|FG003|Overall Study|Other|1|||
146617700|NCT02719171|528773059|FG004|Overall Study|Other|0|||
146617701|NCT02614729|528773060|FG000|Overall Study|Withdrawal by Subject|1|||
146617702|NCT02614729|528773061|FG001|Overall Study|Withdrawal by Subject|0|||
146617703|NCT00227721|528773062|FG000|Overall Study|On study, but never treated.|1|||
146617704|NCT02539797|528773072|FG000|Overall Study|Lost to Follow-up|0|||
146617705|NCT02539797|528773073|FG001|Overall Study|Lost to Follow-up|1|||
146617706|NCT02539797|528773074|FG002|Overall Study|Lost to Follow-up|0|||
146617707|NCT01777308|528773082|FG000|Overall Study|Withdrawal by Subject|5|||
146617708|NCT01777308|528773083|FG001|Overall Study|Withdrawal by Subject|1|||
146617709|NCT01777308|528773082|FG000|Overall Study|Migrated/moved from study area|1|||
146617710|NCT01777308|528773083|FG001|Overall Study|Migrated/moved from study area|0|||
146617711|NCT01777308|528773082|FG000|Overall Study|Lost to Follow-up|7|||
146617712|NCT01777308|528773083|FG001|Overall Study|Lost to Follow-up|2|||
146617713|NCT01777308|528773082|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
146617714|NCT01777308|528773083|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
146617715|NCT00383786|528773086|FG000|Overall Study|Protocol Violation|2|||
146617716|NCT00383786|528773087|FG001|Overall Study|Protocol Violation|6|||
146617717|NCT00383786|528773086|FG000|Overall Study|Withdrawal by Subject|2|||
146617718|NCT00383786|528773087|FG001|Overall Study|Withdrawal by Subject|5|||
146617719|NCT00383786|528773086|FG000|Overall Study|Physician Decision|0|||
146617720|NCT00383786|528773087|FG001|Overall Study|Physician Decision|1|||
146617721|NCT00985673|528773088|FG000|Overall Study|Lost to Follow-up|6|||
146617722|NCT00985673|528773089|FG001|Overall Study|Lost to Follow-up|7|||
146617723|NCT00985673|528773090|FG002|Overall Study|Lost to Follow-up|6|||
146617724|NCT00985673|528773091|FG003|Overall Study|Lost to Follow-up|10|||
146617725|NCT00985673|528773092|FG004|Overall Study|Lost to Follow-up|5|||
146617726|NCT00985673|528773093|FG005|Overall Study|Lost to Follow-up|3|||
146617727|NCT00985673|528773088|FG000|Overall Study|Withdrawal by Subject|0|||
146617728|NCT00985673|528773089|FG001|Overall Study|Withdrawal by Subject|4|||
146617729|NCT00985673|528773090|FG002|Overall Study|Withdrawal by Subject|5|||
146617730|NCT00985673|528773091|FG003|Overall Study|Withdrawal by Subject|2|||
146617731|NCT00985673|528773092|FG004|Overall Study|Withdrawal by Subject|2|||
146617732|NCT00985673|528773093|FG005|Overall Study|Withdrawal by Subject|3|||
146617733|NCT00985673|528773088|FG000|Overall Study|Other|1|||
146617734|NCT00985673|528773089|FG001|Overall Study|Other|0|||
146617735|NCT00985673|528773090|FG002|Overall Study|Other|1|||
146660632|NCT02035475|528935385|FG000|Overall Study|Physician Decision|1|||
146617736|NCT00985673|528773091|FG003|Overall Study|Other|0|||
146617737|NCT00985673|528773092|FG004|Overall Study|Other|1|||
146617738|NCT00985673|528773093|FG005|Overall Study|Other|0|||
146617739|NCT00531284|528773096|FG000|Overall Study|Progressive Disease|1|||
146617740|NCT00531284|528773097|FG001|Overall Study|Progressive Disease|3|||
146617741|NCT00531284|528773098|FG002|Overall Study|Progressive Disease|5|||
146617742|NCT00531284|528773099|FG003|Overall Study|Progressive Disease|42|||
146617743|NCT00531284|528773100|FG004|Overall Study|Progressive Disease|4|||
146617744|NCT00531284|528773101|FG005|Overall Study|Progressive Disease|4|||
146660633|NCT02035475|528935385|FG000|Overall Study|Equipment Error|1|||
146660634|NCT02047227|528935386|FG000|Overall Study|Adverse Event|2|||
146660635|NCT02047227|528935387|FG001|Overall Study|Adverse Event|4|||
146660636|NCT02047227|528935386|FG000|Overall Study|Lost to Follow-up|0|||
146660637|NCT02047227|528935387|FG001|Overall Study|Lost to Follow-up|3|||
146660638|NCT02047227|528935386|FG000|Overall Study|Protocol Violation|1|||
146660639|NCT02047227|528935387|FG001|Overall Study|Protocol Violation|0|||
146660640|NCT02047227|528935386|FG000|Overall Study|Spontaneous pregnancy|1|||
146660641|NCT02047227|528935387|FG001|Overall Study|Spontaneous pregnancy|0|||
146660642|NCT02047227|528935386|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
146660643|NCT02047227|528935387|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
146660644|NCT02047227|528935386|FG000|Overall Study|No oocytes retrieved|21|||
146660645|NCT02047227|528935387|FG001|Overall Study|No oocytes retrieved|20|||
146660646|NCT02047227|528935386|FG000|Overall Study|No fertilization|61|||
146660647|NCT02047227|528935387|FG001|Overall Study|No fertilization|51|||
146660648|NCT02047227|528935386|FG000|Overall Study|Intention to freeze all embryos|1|||
146660649|NCT02047227|528935387|FG001|Overall Study|Intention to freeze all embryos|0|||
146660650|NCT02047227|528935386|FG000|Overall Study|All embryos discarded|12|||
146660651|NCT02047227|528935387|FG001|Overall Study|All embryos discarded|11|||
146660652|NCT02047227|528935386|FG000|Overall Study|Other|10|||
146660653|NCT02047227|528935387|FG001|Overall Study|Other|9|||
146660654|NCT02766465|528935394|FG000|Overall Study|Withdrawal by Subject|0|||
146660655|NCT02766465|528935395|FG001|Overall Study|Withdrawal by Subject|10|||
146660656|NCT02435069|528935396|FG000|Dose Response - First Intervention|Adverse Event|0|||
146660657|NCT02435069|528935397|FG001|Dose Response - First Intervention|Adverse Event|1|||
146660658|NCT02435069|528935398|FG002|Dose Response - First Intervention|Adverse Event|1|||
146660659|NCT02435069|528935399|FG003|Dose Response - First Intervention|Adverse Event|0|||
146660660|NCT02435069|528935400|FG004|Dose Response - First Intervention|Adverse Event|0|||
146660661|NCT02435069|528935396|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
146660662|NCT02435069|528935397|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
146660663|NCT02435069|528935398|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
146660664|NCT02435069|528935399|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
146660665|NCT02435069|528935400|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
146660666|NCT03112590|528935401|FG000|Overall Study|Adverse Event|0|||
146660667|NCT03112590|528935402|FG001|Overall Study|Adverse Event|1|||
146660668|NCT03112590|528935403|FG002|Overall Study|Adverse Event|0|||
146660669|NCT00843726|528935406|FG000|Overall Study|Death|1|||
146660670|NCT00843726|528935407|FG001|Overall Study|Death|0|||
146660671|NCT00843726|528935406|FG000|Overall Study|Withdrawal by Subject|0|||
146660672|NCT00843726|528935407|FG001|Overall Study|Withdrawal by Subject|1|||
146660673|NCT02520661|528935408|FG000|Overall Study|Lost to Follow-up|7|||
146660674|NCT02520661|528935409|FG001|Overall Study|Lost to Follow-up|3|||
146660675|NCT02520661|528935408|FG000|Overall Study|Admitted from ED|49|||
146660676|NCT02520661|528935409|FG001|Overall Study|Admitted from ED|48|||
146660677|NCT02520661|528935408|FG000|Overall Study|ED greater than 24 hours|29|||
146660678|NCT02520661|528935409|FG001|Overall Study|ED greater than 24 hours|38|||
146660679|NCT02520661|528935408|FG000|Overall Study|other ineligibility|14|||
146660680|NCT02520661|528935409|FG001|Overall Study|other ineligibility|22|||
146660681|NCT02520661|528935408|FG000|Overall Study|Withdrawal by Subject|7|||
146660682|NCT02520661|528935409|FG001|Overall Study|Withdrawal by Subject|16|||
146660683|NCT00171054|528935413|FG000|Overall Study|Protocol Violation|1|||
146660684|NCT00171054|528935414|FG001|Overall Study|Protocol Violation|2|||
146660685|NCT00171054|528935413|FG000|Overall Study|Patient withdrew consent|1|||
146660686|NCT00171054|528935414|FG001|Overall Study|Patient withdrew consent|0|||
146660687|NCT00171054|528935413|FG000|Overall Study|Lost to Follow-up|0|||
146660688|NCT00171054|528935414|FG001|Overall Study|Lost to Follow-up|1|||
146660689|NCT00171054|528935413|FG000|Overall Study|Adverse Event|8|||
146660690|NCT00171054|528935414|FG001|Overall Study|Adverse Event|8|||
146660691|NCT00171054|528935413|FG000|Overall Study|Condition no longer required study drug|0|||
146660692|NCT00171054|528935414|FG001|Overall Study|Condition no longer required study drug|1|||
146660693|NCT05108922|528936830|FG000|Overall Study|Adverse Event|2|||
146660694|NCT05108922|528936831|FG001|Overall Study|Adverse Event|3|||
146660695|NCT05108922|528936830|FG000|Overall Study|Lost to Follow-up|2|||
146660696|NCT05108922|528936831|FG001|Overall Study|Lost to Follow-up|1|||
146660697|NCT05108922|528936830|FG000|Overall Study|Inadvertent enrollment|0|||
146660698|NCT05108922|528936831|FG001|Overall Study|Inadvertent enrollment|1|||
146978738|NCT00598559|530085488|FG000|Overall Study|Withdrawal by Subject|2|||
146660699|NCT05108922|528936830|FG000|Overall Study|Physician Decision|2|||
146660700|NCT05108922|528936831|FG001|Overall Study|Physician Decision|3|||
146978739|NCT00598559|530085489|FG001|Overall Study|Withdrawal by Subject|2|||
146660701|NCT05108922|528936830|FG000|Overall Study|Protocol deviation|1|||
146660702|NCT05108922|528936831|FG001|Overall Study|Protocol deviation|0|||
146660703|NCT05108922|528936830|FG000|Overall Study|Screen failure|1|||
146660704|NCT05108922|528936831|FG001|Overall Study|Screen failure|0|||
146660705|NCT05108922|528936830|FG000|Overall Study|Withdrawal by Subject|11|||
146660706|NCT05108922|528936831|FG001|Overall Study|Withdrawal by Subject|8|||
146660707|NCT02349061|528936836|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
146660708|NCT02349061|528936837|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
146660709|NCT02349061|528936838|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
146660710|NCT02349061|528936836|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
146660711|NCT02349061|528936837|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
146660712|NCT02349061|528936838|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
146660713|NCT02349061|528936836|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
146660714|NCT02349061|528936837|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
146660715|NCT02349061|528936838|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
146660716|NCT02349061|528936836|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
146660717|NCT02349061|528936837|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
146660718|NCT02349061|528936838|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
146660719|NCT02349061|528936836|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
146660720|NCT02349061|528936837|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
146660721|NCT02349061|528936838|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
146660722|NCT02349061|528936836|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
146660723|NCT02349061|528936837|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
146660724|NCT02349061|528936838|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
146660725|NCT02349061|528936836|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
146660726|NCT02349061|528936837|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
146660727|NCT02349061|528936838|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
146660728|NCT02349061|528936836|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
146660729|NCT02349061|528936837|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
146660730|NCT02349061|528936838|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
146660731|NCT02349061|528936836|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
146660732|NCT02349061|528936837|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
146660733|NCT02349061|528936838|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
146660734|NCT02349061|528936836|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
146660735|NCT02349061|528936837|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
146660736|NCT02349061|528936838|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
146660737|NCT02349061|528936836|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
146660738|NCT02349061|528936837|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
146660739|NCT02349061|528936838|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
146660740|NCT02349061|528936836|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
146660741|NCT02349061|528936837|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
146660742|NCT02349061|528936838|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
146660743|NCT02349061|528936836|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
146660744|NCT02349061|528936837|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
146660745|NCT02349061|528936838|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
146660746|NCT01507298|528936839|FG000|Overall Study|Protocol Violation|0|||
146660747|NCT01507298|528936840|FG001|Overall Study|Protocol Violation|6|||
146660748|NCT00810108|528936841|FG000|Overall Study|Withdrawal by Subject|1|||
146660749|NCT00810108|528936842|FG001|Overall Study|Withdrawal by Subject|0|||
146660750|NCT00761579|528936857|FG000|Overall Study|Adverse Event|10|||
146660751|NCT00761579|528936857|FG000|Overall Study|Death|2|||
146660752|NCT00761579|528936857|FG000|Overall Study|Lack of Efficacy|21|||
146660753|NCT00761579|528936857|FG000|Overall Study|Lost to Follow-up|16|||
146660754|NCT00761579|528936857|FG000|Overall Study|Pregnancy|1|||
146660755|NCT00761579|528936857|FG000|Overall Study|Withdrawal by Subject|34|||
146660756|NCT00761579|528936857|FG000|Overall Study|Lack of compliance|2|||
146660757|NCT00761579|528936857|FG000|Overall Study|Protocol deviation|1|||
146660758|NCT00761579|528936857|FG000|Overall Study|Drug overdose|1|||
146660759|NCT00761579|528936857|FG000|Overall Study|Aggravation of depression|1|||
146660760|NCT00761579|528936857|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
146660761|NCT00761579|528936857|FG000|Overall Study|Lost survey form|1|||
146660762|NCT00761579|528936857|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
146660763|NCT00950911|528936858|FG000|Overall Study|Adverse Event|0|||
146660764|NCT00950911|528936859|FG001|Overall Study|Adverse Event|2|||
146660765|NCT00950911|528936858|FG000|Overall Study|Death|4|||
146660766|NCT00950911|528936859|FG001|Overall Study|Death|6|||
146660767|NCT00950911|528936858|FG000|Overall Study|Disease progression|2|||
146660768|NCT00950911|528936859|FG001|Overall Study|Disease progression|2|||
146660769|NCT00950911|528936858|FG000|Overall Study|Consent withdrawn|1|||
146660770|NCT00950911|528936859|FG001|Overall Study|Consent withdrawn|3|||
146660771|NCT00950911|528936858|FG000|Overall Study|Administrative decision|3|||
146660772|NCT00950911|528936859|FG001|Overall Study|Administrative decision|1|||
146660773|NCT00950911|528936858|FG000|Overall Study|Ineligibility determined|1|||
146660774|NCT00950911|528936859|FG001|Overall Study|Ineligibility determined|0|||
146660775|NCT00950911|528936858|FG000|Overall Study|Noncompliance|1|||
146660776|NCT00950911|528936859|FG001|Overall Study|Noncompliance|0|||
146660777|NCT00950911|528936858|FG000|Overall Study|Poor performance status|0|||
146660778|NCT00950911|528936859|FG001|Overall Study|Poor performance status|1|||
146660779|NCT02476422|528936860|FG000|Overall Study|Subject/guardian decision|0|||
146660780|NCT02476422|528936861|FG001|Overall Study|Subject/guardian decision|1|||
146660781|NCT01859143|528936862|FG000|Overall Study|Lost to Follow-up|2|||
146660782|NCT01859143|528936863|FG001|Overall Study|Lost to Follow-up|0|||
146660783|NCT02413372|528936867|FG000|Treatment|Lost to Follow-up|0|||
146660784|NCT02413372|528936868|FG001|Treatment|Lost to Follow-up|2|||
146660785|NCT02413372|528936869|FG002|Treatment|Lost to Follow-up|1|||
146660786|NCT02413372|528936867|FG000|Treatment|Withdrawal by Subject|1|||
146660787|NCT02413372|528936868|FG001|Treatment|Withdrawal by Subject|0|||
146660788|NCT02413372|528936869|FG002|Treatment|Withdrawal by Subject|0|||
146660789|NCT02413372|528936867|FG000|Follow-up|Lost to Follow-up|1|||
146660790|NCT02413372|528936868|FG001|Follow-up|Lost to Follow-up|1|||
146660791|NCT02413372|528936869|FG002|Follow-up|Lost to Follow-up|0|||
146660792|NCT02413372|528936867|FG000|Follow-up|Subject Withdrew Consent|1|||
146660793|NCT02413372|528936868|FG001|Follow-up|Subject Withdrew Consent|0|||
146660794|NCT02413372|528936869|FG002|Follow-up|Subject Withdrew Consent|1|||
146660795|NCT02413372|528936867|FG000|Follow-up|Subject unable to return for visit|0|||
146660796|NCT02413372|528936868|FG001|Follow-up|Subject unable to return for visit|0|||
146660797|NCT02413372|528936869|FG002|Follow-up|Subject unable to return for visit|1|||
146660798|NCT04587271|528936872|FG000|Overall Study|Lost to Follow-up|2|||
146660799|NCT04587271|528936873|FG001|Overall Study|Lost to Follow-up|2|||
146660800|NCT04587271|528936874|FG002|Overall Study|Lost to Follow-up|0|||
146660801|NCT04587271|528936875|FG003|Overall Study|Lost to Follow-up|2|||
146660802|NCT04587271|528936876|FG004|Overall Study|Lost to Follow-up|2|||
146660803|NCT04587271|528936877|FG005|Overall Study|Lost to Follow-up|0|||
146660804|NCT04587271|528936872|FG000|Overall Study|Caregiver brought child to visits|0|||
146660805|NCT04587271|528936873|FG001|Overall Study|Caregiver brought child to visits|0|||
146660806|NCT04587271|528936874|FG002|Overall Study|Caregiver brought child to visits|0|||
146660807|NCT04587271|528936875|FG003|Overall Study|Caregiver brought child to visits|1|||
146660808|NCT04587271|528936876|FG004|Overall Study|Caregiver brought child to visits|0|||
146660809|NCT04587271|528936877|FG005|Overall Study|Caregiver brought child to visits|0|||
146660810|NCT02180165|528936878|FG000|Overall Study|Not Treated|0|||
146660811|NCT02180165|528936879|FG001|Overall Study|Not Treated|0|||
146660812|NCT02180165|528936880|FG002|Overall Study|Not Treated|1|||
146660813|NCT02180165|528936881|FG003|Overall Study|Not Treated|0|||
146660814|NCT02180165|528936878|FG000|Overall Study|Adverse Event|7|||
146660815|NCT02180165|528936879|FG001|Overall Study|Adverse Event|0|||
146660816|NCT02180165|528936880|FG002|Overall Study|Adverse Event|18|||
146660817|NCT02180165|528936881|FG003|Overall Study|Adverse Event|3|||
146660818|NCT02180165|528936878|FG000|Overall Study|Lack of Efficacy|0|||
146660819|NCT02180165|528936879|FG001|Overall Study|Lack of Efficacy|1|||
146660820|NCT02180165|528936880|FG002|Overall Study|Lack of Efficacy|3|||
146660821|NCT02180165|528936881|FG003|Overall Study|Lack of Efficacy|2|||
146660822|NCT02180165|528936878|FG000|Overall Study|Physician Decision|1|||
146660823|NCT02180165|528936879|FG001|Overall Study|Physician Decision|0|||
146660824|NCT02180165|528936880|FG002|Overall Study|Physician Decision|5|||
146660825|NCT02180165|528936881|FG003|Overall Study|Physician Decision|0|||
146660826|NCT02180165|528936878|FG000|Overall Study|Withdrawal by Subject|3|||
146660827|NCT02180165|528936879|FG001|Overall Study|Withdrawal by Subject|0|||
146660828|NCT02180165|528936880|FG002|Overall Study|Withdrawal by Subject|2|||
146660829|NCT02180165|528936881|FG003|Overall Study|Withdrawal by Subject|1|||
146660830|NCT03875768|528936882|FG000|Overall Study|Lost to Follow-up|16|||
146660831|NCT03875768|528936883|FG001|Overall Study|Lost to Follow-up|13|||
146660832|NCT03875768|528936882|FG000|Overall Study|Withdrawal by Subject|10|||
146660833|NCT03875768|528936883|FG001|Overall Study|Withdrawal by Subject|21|||
146660834|NCT03875768|528936882|FG000|Overall Study|Did not complete assessment|21|||
146660835|NCT03875768|528936883|FG001|Overall Study|Did not complete assessment|12|||
146660836|NCT03875768|528936882|FG000|Overall Study|Became ineligible|1|||
146660837|NCT03875768|528936883|FG001|Overall Study|Became ineligible|0|||
146660838|NCT01925274|528936884|FG000|Overall Study|Death|1|||
146660839|NCT01925274|528936885|FG001|Overall Study|Death|0|||
146660840|NCT01925274|528936886|FG002|Overall Study|Death|0|||
146660841|NCT01925274|528936884|FG000|Overall Study|Lost to Follow-up|0|||
146660842|NCT01925274|528936885|FG001|Overall Study|Lost to Follow-up|1|||
146660843|NCT01925274|528936886|FG002|Overall Study|Lost to Follow-up|0|||
146660844|NCT01925274|528936884|FG000|Overall Study|Withdrawal by Subject|1|||
146660845|NCT01925274|528936885|FG001|Overall Study|Withdrawal by Subject|2|||
146660846|NCT01925274|528936886|FG002|Overall Study|Withdrawal by Subject|0|||
146660847|NCT01925274|528936884|FG000|Overall Study|Study terminated by sponsor|4|||
146660848|NCT01925274|528936885|FG001|Overall Study|Study terminated by sponsor|0|||
146660849|NCT01925274|528936886|FG002|Overall Study|Study terminated by sponsor|0|||
146660850|NCT01925274|528936884|FG000|Overall Study|Protocol amendment|1|||
146660851|NCT01925274|528936885|FG001|Overall Study|Protocol amendment|3|||
146925188|NCT00485589|529885959|FG000|Overall Study|Failure to return|6|||
146660852|NCT01925274|528936886|FG002|Overall Study|Protocol amendment|6|||
146660853|NCT04327674|528936887|FG000|Overall Study|Protocol Violation|19|||
146660854|NCT00723398|528936888|FG000|Overall Study|Withdrawal by Subject|2|||
146660855|NCT00723398|528936889|FG001|Overall Study|Withdrawal by Subject|6|||
146660856|NCT00723398|528936890|FG002|Overall Study|Withdrawal by Subject|4|||
146660857|NCT00723398|528936891|FG003|Overall Study|Withdrawal by Subject|4|||
146660858|NCT00723398|528936892|FG004|Overall Study|Withdrawal by Subject|4|||
146660859|NCT00723398|528936888|FG000|Overall Study|Protocol Violation|2|||
146660860|NCT00723398|528936889|FG001|Overall Study|Protocol Violation|1|||
146660861|NCT00723398|528936890|FG002|Overall Study|Protocol Violation|5|||
146660862|NCT00723398|528936891|FG003|Overall Study|Protocol Violation|0|||
146660863|NCT00723398|528936892|FG004|Overall Study|Protocol Violation|0|||
146660864|NCT00723398|528936888|FG000|Overall Study|Physician Decision|2|||
146660865|NCT00723398|528936889|FG001|Overall Study|Physician Decision|2|||
146660866|NCT00723398|528936890|FG002|Overall Study|Physician Decision|5|||
146660867|NCT00723398|528936891|FG003|Overall Study|Physician Decision|0|||
146660868|NCT00723398|528936892|FG004|Overall Study|Physician Decision|1|||
146660869|NCT00723398|528936888|FG000|Overall Study|Adverse Event|0|||
146660870|NCT00723398|528936889|FG001|Overall Study|Adverse Event|5|||
146660871|NCT00723398|528936890|FG002|Overall Study|Adverse Event|3|||
146660872|NCT00723398|528936891|FG003|Overall Study|Adverse Event|1|||
146660873|NCT00723398|528936892|FG004|Overall Study|Adverse Event|4|||
146660874|NCT00723398|528936888|FG000|Overall Study|Lost to Follow-up|0|||
146660875|NCT00723398|528936889|FG001|Overall Study|Lost to Follow-up|1|||
146660876|NCT00723398|528936890|FG002|Overall Study|Lost to Follow-up|0|||
146660877|NCT00723398|528936891|FG003|Overall Study|Lost to Follow-up|0|||
146660878|NCT00723398|528936892|FG004|Overall Study|Lost to Follow-up|0|||
146660879|NCT00267189|528936897|FG000|Overall Study|Patient withdrew consent|1|||
146660880|NCT00267189|528936898|FG001|Overall Study|Patient withdrew consent|1|||
146660881|NCT00267189|528936897|FG000|Overall Study|Death|1|||
146660882|NCT00267189|528936898|FG001|Overall Study|Death|0|||
146660883|NCT00267189|528936897|FG000|Overall Study|Missing|3|||
146660884|NCT00267189|528936898|FG001|Overall Study|Missing|0|||
146660885|NCT04137224|528936900|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
146660886|NCT04137224|528936901|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
146660887|NCT04137224|528936900|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
146660888|NCT04137224|528936901|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
146660889|NCT04137224|528936900|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
146660890|NCT04137224|528936901|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
146660891|NCT01225887|528936902|FG000|Overall Study|Ineligible:required test not done|2|||
146660892|NCT01225887|528936902|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
146660893|NCT01225887|528936902|FG000|Overall Study|Ineligible:inadequate pathology|2|||
146660894|NCT00566501|528936903|FG000|Overall Study|Adverse Event|68|||
146660895|NCT00566501|528936904|FG001|Overall Study|Adverse Event|59|||
146660896|NCT00566501|528936903|FG000|Overall Study|Medication Non-compliance|5|||
146660897|NCT00566501|528936904|FG001|Overall Study|Medication Non-compliance|0|||
146660898|NCT00566501|528936903|FG000|Overall Study|Protocol Violation|2|||
146660899|NCT00566501|528936904|FG001|Overall Study|Protocol Violation|2|||
146660900|NCT00566501|528936903|FG000|Overall Study|Request of Investigator or Sponsor|6|||
146660901|NCT00566501|528936904|FG001|Overall Study|Request of Investigator or Sponsor|7|||
146660902|NCT00566501|528936903|FG000|Overall Study|Withdrawal by Subject|33|||
146660903|NCT00566501|528936904|FG001|Overall Study|Withdrawal by Subject|30|||
146660904|NCT00566501|528936903|FG000|Overall Study|Lack of Efficacy|8|||
146660905|NCT00566501|528936904|FG001|Overall Study|Lack of Efficacy|3|||
146660906|NCT00566501|528936903|FG000|Overall Study|Other|25|||
146660907|NCT00566501|528936904|FG001|Overall Study|Other|21|||
146660908|NCT00925990|528936905|FG000|Overall Study|Adverse Event|1|||
146660909|NCT00925990|528936906|FG001|Overall Study|Adverse Event|3|||
146660910|NCT00925990|528936905|FG000|Overall Study|Withdrawal by Subject|2|||
146660911|NCT00925990|528936906|FG001|Overall Study|Withdrawal by Subject|2|||
146660912|NCT00925990|528936905|FG000|Overall Study|Lost to Follow-up|1|||
146660913|NCT00925990|528936906|FG001|Overall Study|Lost to Follow-up|3|||
146660914|NCT00925990|528936905|FG000|Overall Study|Physician Decision|1|||
146660915|NCT00925990|528936906|FG001|Overall Study|Physician Decision|1|||
146660916|NCT00925990|528936905|FG000|Overall Study|moved out of state, missed medication|0|||
146660917|NCT00925990|528936906|FG001|Overall Study|moved out of state, missed medication|2|||
146660918|NCT01368432|528936911|FG000|Overall Study|Lost to Follow-up|0|||
146660919|NCT01368432|528936912|FG001|Overall Study|Lost to Follow-up|1|||
146660920|NCT01400815|528936925|FG000|Overall Study|Adverse Event|3|||
146660921|NCT01400815|528936926|FG001|Overall Study|Adverse Event|0|||
146660922|NCT01400815|528936925|FG000|Overall Study|Death|0|||
146660923|NCT01400815|528936926|FG001|Overall Study|Death|1|||
146660924|NCT01400815|528936925|FG000|Overall Study|Lost to Follow-up|18|||
146660925|NCT01400815|528936926|FG001|Overall Study|Lost to Follow-up|11|||
146660926|NCT01400815|528936925|FG000|Overall Study|Protocol Violation|0|||
146660927|NCT01400815|528936926|FG001|Overall Study|Protocol Violation|1|||
146773705|NCT01565148|529341182|FG003|Overall Study|Withdrawal by Subject|2|||
146773706|NCT01565148|529341179|FG000|Overall Study|Lost to Follow-up|4|||
146660928|NCT01400815|528936925|FG000|Overall Study|Physician Decision|1|||
146660929|NCT01400815|528936926|FG001|Overall Study|Physician Decision|0|||
146660930|NCT01400815|528936925|FG000|Overall Study|Withdrawal by Subject|15|||
146660931|NCT01400815|528936926|FG001|Overall Study|Withdrawal by Subject|8|||
146660932|NCT01400815|528936925|FG000|Overall Study|Subject in jail|1|||
146660933|NCT01400815|528936926|FG001|Overall Study|Subject in jail|0|||
146660934|NCT01123850|528936927|FG000|Overall Study|Slow enrollment|45|||
146660935|NCT02310321|528936929|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
146660936|NCT02310321|528936930|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
146660937|NCT02310321|528936931|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
146660938|NCT02310321|528936929|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
146660939|NCT02310321|528936930|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
146660940|NCT02310321|528936931|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
146660941|NCT02310321|528936929|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
146660942|NCT02310321|528936930|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
146660943|NCT02310321|528936931|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
146660944|NCT02310321|528936929|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
146660945|NCT02310321|528936930|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
146660946|NCT02310321|528936931|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
146660947|NCT02310321|528936929|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
146660948|NCT02310321|528936930|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
146660949|NCT02310321|528936931|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
146660950|NCT02310321|528936929|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
146660951|NCT02310321|528936930|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
146660952|NCT02310321|528936931|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
146660953|NCT02310321|528936929|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
146660954|NCT02310321|528936930|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
146660955|NCT02310321|528936931|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
146660956|NCT02310321|528936929|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
146660957|NCT02310321|528936930|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
146660958|NCT02310321|528936931|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
146660959|NCT02310321|528936929|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
146660960|NCT02310321|528936930|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
146660961|NCT02310321|528936931|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
146660962|NCT02310321|528936929|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
146660963|NCT02310321|528936930|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
146660964|NCT02310321|528936931|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
146660965|NCT02310321|528936929|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
146660966|NCT02310321|528936930|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
146660967|NCT02310321|528936931|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
146660968|NCT02310321|528936929|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
146660969|NCT02310321|528936930|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
146660970|NCT02310321|528936931|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
146660971|NCT02310321|528936929|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
146660972|NCT02310321|528936930|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
146660973|NCT02310321|528936931|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
146660974|NCT02310321|528936929|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
146660975|NCT02310321|528936930|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
146660976|NCT02310321|528936931|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
146660977|NCT02310321|528936929|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
146660978|NCT02310321|528936930|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
146660979|NCT02310321|528936931|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
146660980|NCT02310321|528936929|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
146660981|NCT02310321|528936930|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
146660982|NCT02310321|528936931|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
146660983|NCT02310321|528936929|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
146660984|NCT02310321|528936930|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
146660985|NCT02310321|528936931|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
146660986|NCT02310321|528936929|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
146660987|NCT02310321|528936930|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
146660988|NCT02310321|528936931|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
146660989|NCT02310321|528936929|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
146660990|NCT02310321|528936930|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
146660991|NCT02310321|528936931|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
146660992|NCT02310321|528936929|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
146660993|NCT02310321|528936930|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
146660994|NCT02310321|528936931|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
146660995|NCT02310321|528936929|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
146660996|NCT02310321|528936930|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
146660997|NCT02310321|528936931|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
146660998|NCT02310321|528936929|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
146660999|NCT02310321|528936930|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
146661000|NCT02310321|528936931|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
146661001|NCT02310321|528936929|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
146661002|NCT02310321|528936930|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
146661003|NCT02310321|528936931|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
146661004|NCT01698905|528936932|FG000|Overall Study|Adverse Event|4|||
146661005|NCT01698905|528936932|FG000|Overall Study|Physician Decision|2|||
146661006|NCT01698905|528936932|FG000|Overall Study|Pregnancy|1|||
146661007|NCT01698905|528936932|FG000|Overall Study|Protocol Violation|1|||
146661008|NCT01698905|528936932|FG000|Overall Study|Subject/guardian decision|2|||
146661009|NCT01698905|528936932|FG000|Overall Study|Death|1|||
146661010|NCT00764504|528936934|FG000|Overall Study|Death|12|||
146661011|NCT00764504|528936935|FG001|Overall Study|Death|6|||
146661012|NCT00764504|528936936|FG002|Overall Study|Death|13|||
146661013|NCT00764504|528936934|FG000|Overall Study|Revision of Device|12|||
146661014|NCT00764504|528936935|FG001|Overall Study|Revision of Device|23|||
146661015|NCT00764504|528936936|FG002|Overall Study|Revision of Device|14|||
146661016|NCT00764504|528936934|FG000|Overall Study|Physician Decision|1|||
146661017|NCT00764504|528936935|FG001|Overall Study|Physician Decision|0|||
146661018|NCT00764504|528936936|FG002|Overall Study|Physician Decision|0|||
146661019|NCT00764504|528936934|FG000|Overall Study|Withdrawal by Subject|1|||
146661020|NCT00764504|528936935|FG001|Overall Study|Withdrawal by Subject|7|||
146661021|NCT00764504|528936936|FG002|Overall Study|Withdrawal by Subject|4|||
146661022|NCT00764504|528936934|FG000|Overall Study|Lost to Follow-up|40|||
146661023|NCT00764504|528936935|FG001|Overall Study|Lost to Follow-up|34|||
146661024|NCT00764504|528936936|FG002|Overall Study|Lost to Follow-up|72|||
146661025|NCT02456103|528936937|FG000|Overall Study|Study Closure|207|||
146661026|NCT02456103|528936937|FG000|Overall Study|Physician Decision|1|||
146661027|NCT02456103|528936937|FG000|Overall Study|Required prohibited medications|5|||
146661028|NCT02456103|528936937|FG000|Overall Study|Protocol Violation|1|||
146661029|NCT02456103|528936937|FG000|Overall Study|Adverse Event|5|||
146661030|NCT02456103|528936937|FG000|Overall Study|Abnormal Laboratory Value|2|||
146661031|NCT02456103|528936937|FG000|Overall Study|Lost to Follow-up|1|||
146661032|NCT02456103|528936937|FG000|Overall Study|Withdrawal by Subject|24|||
146661033|NCT04010539|528936938|FG000|Overall Study|Withdrawal by Subject|4|||
146661034|NCT04010539|528936939|FG001|Overall Study|Withdrawal by Subject|1|||
146661035|NCT04010539|528936938|FG000|Overall Study|Physician Decision|0|||
146661036|NCT04010539|528936939|FG001|Overall Study|Physician Decision|2|||
146661037|NCT04010539|528936938|FG000|Overall Study|Lost to Follow-up|10|||
146661038|NCT04010539|528936939|FG001|Overall Study|Lost to Follow-up|14|||
146661039|NCT04010539|528936938|FG000|Overall Study|Adverse Event|3|||
146661040|NCT04010539|528936939|FG001|Overall Study|Adverse Event|0|||
146661041|NCT04010539|528936938|FG000|Overall Study|Participant Did Not Receive IP|0|||
146661042|NCT04010539|528936939|FG001|Overall Study|Participant Did Not Receive IP|1|||
146661043|NCT04010539|528936938|FG000|Overall Study|Protocol Deviation|0|||
146661044|NCT04010539|528936939|FG001|Overall Study|Protocol Deviation|1|||
146661045|NCT04010539|528936938|FG000|Overall Study|Randomized in Error/ Mistake|2|||
146661046|NCT04010539|528936939|FG001|Overall Study|Randomized in Error/ Mistake|0|||
146661047|NCT04010539|528936938|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
146661048|NCT04010539|528936939|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
146661049|NCT00467610|528936945|FG000|Overall Study|Withdrawal by Subject|1|||
146661050|NCT02001181|528936948|FG000|Overall Study|Adverse Event|0|||
146661051|NCT02001181|528936949|FG001|Overall Study|Adverse Event|2|||
146661052|NCT02001181|528936948|FG000|Overall Study|Lost to Follow-up|1|||
146661053|NCT02001181|528936949|FG001|Overall Study|Lost to Follow-up|0|||
146661054|NCT02001181|528936948|FG000|Overall Study|Withdrawal by Subject|0|||
146661055|NCT02001181|528936949|FG001|Overall Study|Withdrawal by Subject|1|||
146661056|NCT00445978|528936950|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
146925189|NCT00485589|529885960|FG001|Overall Study|Failure to return|5|||
146925190|NCT00485589|529885961|FG002|Overall Study|Failure to return|1|||
146925191|NCT00485589|529885959|FG000|Overall Study|Protocol Violation|1|||
146925192|NCT00485589|529885960|FG001|Overall Study|Protocol Violation|0|||
146661057|NCT00445978|528936950|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
146925193|NCT00485589|529885961|FG002|Overall Study|Protocol Violation|0|||
146925194|NCT00485589|529885959|FG000|Overall Study|Violation of selection criteria at entry|0|||
146661058|NCT00445978|528936950|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
146661059|NCT00445978|528936950|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
146661060|NCT00445978|528936950|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
146661061|NCT00445978|528936950|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
146661062|NCT00445978|528936950|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
146661063|NCT00445978|528936950|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
146661064|NCT00445978|528936950|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
146661065|NCT02898116|528936953|FG000|Overall Study|Adverse Event|1|||
146661066|NCT02898116|528936953|FG000|Overall Study|Progressive disease|1|||
146925195|NCT00485589|529885960|FG001|Overall Study|Violation of selection criteria at entry|3|||
146661067|NCT03635788|528936958|FG000|Step 1|Death|1|||
146661068|NCT03635788|528936959|FG001|Step 1|Death|0|||
146925196|NCT00485589|529885961|FG002|Overall Study|Violation of selection criteria at entry|1|||
146925197|NCT00485589|529885959|FG000|Overall Study|Administrative/Other|1|||
146661069|NCT03635788|528936960|FG002|Step 1|Death|0|||
146661070|NCT03635788|528936958|FG000|Step 1|Lost to Follow-up|31|||
146661071|NCT03635788|528936959|FG001|Step 1|Lost to Follow-up|0|||
146661072|NCT03635788|528936960|FG002|Step 1|Lost to Follow-up|0|||
146661073|NCT03635788|528936958|FG000|Step 1|Pregnancy|1|||
146661074|NCT03635788|528936959|FG001|Step 1|Pregnancy|0|||
146661075|NCT03635788|528936960|FG002|Step 1|Pregnancy|0|||
146661076|NCT03635788|528936958|FG000|Step 1|Protocol Violation|8|||
146661077|NCT03635788|528936959|FG001|Step 1|Protocol Violation|0|||
146661078|NCT03635788|528936960|FG002|Step 1|Protocol Violation|0|||
146661079|NCT03635788|528936958|FG000|Step 1|Withdrawal by Subject|13|||
146661080|NCT03635788|528936959|FG001|Step 1|Withdrawal by Subject|0|||
146661081|NCT03635788|528936960|FG002|Step 1|Withdrawal by Subject|0|||
146661082|NCT03635788|528936958|FG000|Step 1|Other reasons|12|||
146661083|NCT03635788|528936959|FG001|Step 1|Other reasons|0|||
146661084|NCT03635788|528936960|FG002|Step 1|Other reasons|0|||
146661085|NCT03635788|528936958|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
146661086|NCT03635788|528936959|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
146661087|NCT03635788|528936960|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
146661088|NCT03635788|528936958|FG000|Step 2|Lost to Follow-up|0|||
146661089|NCT03635788|528936959|FG001|Step 2|Lost to Follow-up|8|||
146661090|NCT03635788|528936960|FG002|Step 2|Lost to Follow-up|15|||
146661091|NCT03635788|528936958|FG000|Step 2|Withdrawal by Subject|0|||
146661092|NCT03635788|528936959|FG001|Step 2|Withdrawal by Subject|6|||
146661093|NCT03635788|528936960|FG002|Step 2|Withdrawal by Subject|6|||
146661094|NCT03635788|528936958|FG000|Step 2|Death|0|||
146661095|NCT03635788|528936959|FG001|Step 2|Death|2|||
146661096|NCT03635788|528936960|FG002|Step 2|Death|0|||
146661097|NCT03635788|528936958|FG000|Step 2|Incarceration|0|||
146661098|NCT03635788|528936959|FG001|Step 2|Incarceration|2|||
146661099|NCT03635788|528936960|FG002|Step 2|Incarceration|0|||
146661100|NCT03635788|528936958|FG000|Step 2|Non-Compliance With Study Requirements|0|||
146661101|NCT03635788|528936959|FG001|Step 2|Non-Compliance With Study Requirements|1|||
146661102|NCT03635788|528936960|FG002|Step 2|Non-Compliance With Study Requirements|1|||
146661103|NCT03635788|528936958|FG000|Step 2|Confounding Medical Condition|0|||
146661104|NCT03635788|528936959|FG001|Step 2|Confounding Medical Condition|0|||
146661105|NCT03635788|528936960|FG002|Step 2|Confounding Medical Condition|1|||
146661106|NCT03635788|528936958|FG000|Step 2|Out Of State With No Plan To Return|0|||
146661107|NCT03635788|528936959|FG001|Step 2|Out Of State With No Plan To Return|1|||
146661108|NCT03635788|528936960|FG002|Step 2|Out Of State With No Plan To Return|0|||
146661109|NCT03635788|528936958|FG000|Step 2|Switched To Injectables|0|||
146661110|NCT03635788|528936959|FG001|Step 2|Switched To Injectables|0|||
146661111|NCT03635788|528936960|FG002|Step 2|Switched To Injectables|1|||
146661112|NCT03635788|528936958|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
146661113|NCT03635788|528936959|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
146661114|NCT03635788|528936960|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
146661115|NCT01015131|528936961|FG000|Overall Study|Physician Decision|1|||
146661116|NCT01015131|528936961|FG000|Overall Study|Protocol Violation|1|||
146661117|NCT01015131|528936961|FG000|Overall Study|Withdrawal by Subject|2|||
146661118|NCT01015131|528936961|FG000|Overall Study|Other Protocol Specified Criteria|4|||
146661119|NCT05521906|528936967|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
146661120|NCT05521906|528936968|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
146661121|NCT02339285|528938138|FG000|Overall Study|Withdrawal by Subject|0|||
146661122|NCT02339285|528938139|FG001|Overall Study|Withdrawal by Subject|1|||
146661123|NCT02339285|528938140|FG002|Overall Study|Withdrawal by Subject|1|||
146661124|NCT02339285|528938138|FG000|Overall Study|Lost to Follow-up|1|||
146661125|NCT02339285|528938139|FG001|Overall Study|Lost to Follow-up|1|||
146661126|NCT02339285|528938140|FG002|Overall Study|Lost to Follow-up|1|||
146661127|NCT02339285|528938138|FG000|Overall Study|Protocol Deviation|0|||
146661128|NCT02339285|528938139|FG001|Overall Study|Protocol Deviation|1|||
146661129|NCT02339285|528938140|FG002|Overall Study|Protocol Deviation|0|||
146661130|NCT00282412|528938143|FG000|Overall Study|Death|2|||
146661131|NCT01920555|528938146|FG000|Overall Study|Physician Decision|1|||
146661132|NCT01920555|528938147|FG001|Overall Study|Physician Decision|2|||
146661133|NCT01920555|528938148|FG002|Overall Study|Physician Decision|1|||
146661134|NCT01920555|528938149|FG003|Overall Study|Physician Decision|2|||
146925198|NCT00485589|529885960|FG001|Overall Study|Administrative/Other|2|||
146925199|NCT00485589|529885961|FG002|Overall Study|Administrative/Other|1|||
146925200|NCT00485589|529885959|FG000|Overall Study|Insufficient therapeutic response|10|||
146925201|NCT00485589|529885960|FG001|Overall Study|Insufficient therapeutic response|3|||
146925202|NCT00485589|529885961|FG002|Overall Study|Insufficient therapeutic response|1|||
146925203|NCT00485589|529885959|FG000|Overall Study|Refused treatment/did not cooperate|1|||
146661135|NCT01920555|528938150|FG004|Overall Study|Physician Decision|0|||
146661136|NCT01920555|528938146|FG000|Overall Study|Lack of Efficacy|2|||
146661137|NCT01920555|528938147|FG001|Overall Study|Lack of Efficacy|0|||
146661138|NCT01920555|528938148|FG002|Overall Study|Lack of Efficacy|0|||
146773707|NCT01565148|529341180|FG001|Overall Study|Lost to Follow-up|4|||
146773708|NCT01565148|529341181|FG002|Overall Study|Lost to Follow-up|0|||
146773709|NCT01565148|529341182|FG003|Overall Study|Lost to Follow-up|3|||
146773710|NCT01565148|529341179|FG000|Overall Study|Rescue Therapy|8|||
146773711|NCT01565148|529341180|FG001|Overall Study|Rescue Therapy|5|||
146773712|NCT01565148|529341181|FG002|Overall Study|Rescue Therapy|5|||
146773713|NCT01565148|529341182|FG003|Overall Study|Rescue Therapy|8|||
146661139|NCT01920555|528938149|FG003|Overall Study|Lack of Efficacy|0|||
146661140|NCT01920555|528938150|FG004|Overall Study|Lack of Efficacy|0|||
146661141|NCT01920555|528938146|FG000|Overall Study|Travel Difficulties|1|||
146661142|NCT01920555|528938147|FG001|Overall Study|Travel Difficulties|1|||
146661143|NCT01920555|528938148|FG002|Overall Study|Travel Difficulties|0|||
146661144|NCT01920555|528938149|FG003|Overall Study|Travel Difficulties|0|||
146661145|NCT01920555|528938150|FG004|Overall Study|Travel Difficulties|1|||
146661146|NCT01920555|528938146|FG000|Overall Study|Lost to Follow-up|0|||
146661147|NCT01920555|528938147|FG001|Overall Study|Lost to Follow-up|1|||
146661148|NCT01920555|528938148|FG002|Overall Study|Lost to Follow-up|0|||
146661149|NCT01920555|528938149|FG003|Overall Study|Lost to Follow-up|1|||
146661150|NCT01920555|528938150|FG004|Overall Study|Lost to Follow-up|0|||
146661151|NCT03911713|528938151|FG000|Overall Study|Lost to Follow-up|0|||
146661152|NCT03911713|528938152|FG001|Overall Study|Lost to Follow-up|2|||
146661153|NCT03911713|528938153|FG002|Overall Study|Lost to Follow-up|0|||
146661154|NCT03911713|528938154|FG003|Overall Study|Lost to Follow-up|0|||
146661155|NCT03911713|528938155|FG004|Overall Study|Lost to Follow-up|0|||
146661156|NCT03911713|528938151|FG000|Overall Study|Other|0|||
146661157|NCT03911713|528938152|FG001|Overall Study|Other|0|||
146661158|NCT03911713|528938153|FG002|Overall Study|Other|0|||
146661159|NCT03911713|528938154|FG003|Overall Study|Other|1|||
146661160|NCT03911713|528938155|FG004|Overall Study|Other|0|||
146661161|NCT03911713|528938151|FG000|Overall Study|Randomized, Never Dosed|1|||
146661162|NCT03911713|528938152|FG001|Overall Study|Randomized, Never Dosed|0|||
146661163|NCT03911713|528938153|FG002|Overall Study|Randomized, Never Dosed|0|||
146661164|NCT03911713|528938154|FG003|Overall Study|Randomized, Never Dosed|1|||
146661165|NCT03911713|528938155|FG004|Overall Study|Randomized, Never Dosed|0|||
146661166|NCT01845818|528938158|FG000|Overall Study|Withdrawal by Subject|0|||
146661167|NCT01845818|528938159|FG001|Overall Study|Withdrawal by Subject|1|||
146661168|NCT01845818|528938158|FG000|Overall Study|Lost to Follow-up|7|||
146661169|NCT01845818|528938159|FG001|Overall Study|Lost to Follow-up|5|||
146661170|NCT01845818|528938158|FG000|Overall Study|Administrative Reasons|3|||
146661171|NCT01845818|528938159|FG001|Overall Study|Administrative Reasons|1|||
146661172|NCT01845818|528938158|FG000|Overall Study|Serious Adverse Event|1|||
146661173|NCT01845818|528938159|FG001|Overall Study|Serious Adverse Event|1|||
146661174|NCT01845818|528938158|FG000|Overall Study|Other|25|||
146661175|NCT01845818|528938159|FG001|Overall Study|Other|8|||
146661176|NCT01845818|528938158|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
146661177|NCT01845818|528938159|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
146661178|NCT01845818|528938158|FG000|Overall Study|No Follow-Up Data Available|4|||
146661179|NCT01845818|528938159|FG001|Overall Study|No Follow-Up Data Available|1|||
146661180|NCT00195273|528938160|FG000|Overall Study|Adverse Event|9|||
146661181|NCT00195273|528938161|FG001|Overall Study|Adverse Event|9|||
146661182|NCT00195273|528938160|FG000|Overall Study|Protocol deviation|0|||
146661183|NCT00195273|528938161|FG001|Overall Study|Protocol deviation|1|||
146661184|NCT00195273|528938160|FG000|Overall Study|Lack of Efficacy|3|||
146661185|NCT00195273|528938161|FG001|Overall Study|Lack of Efficacy|1|||
146661186|NCT00195273|528938160|FG000|Overall Study|Procedural complications|9|||
146661187|NCT00195273|528938161|FG001|Overall Study|Procedural complications|3|||
146661188|NCT01680965|528938162|FG000|Overall Study|Death|0|||
146661189|NCT01680965|528938163|FG001|Overall Study|Death|0|||
146661190|NCT01680965|528938164|FG002|Overall Study|Death|0|||
146661191|NCT01680965|528938165|FG003|Overall Study|Death|6|||
146661192|NCT02595970|528938166|FG000|Overall Study|Withdrawal by Subject|2|||
146661193|NCT02595970|528938166|FG000|Overall Study|Physician Decision|2|||
146661194|NCT02595970|528938166|FG000|Overall Study|Protocol Violation|4|||
146661195|NCT02595970|528938166|FG000|Overall Study|Adverse Event|5|||
146661196|NCT02595970|528938166|FG000|Overall Study|Lack of Efficacy|7|||
146661197|NCT02570074|528938167|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
146661198|NCT02570074|528938168|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
146661199|NCT02923427|528938169|FG000|Overall Study|convert to laparatomy|2|||
146661200|NCT02923427|528938170|FG001|Overall Study|convert to laparatomy|2|||
146661201|NCT02923427|528938169|FG000|Overall Study|destaturation|1|||
146661202|NCT02923427|528938170|FG001|Overall Study|destaturation|0|||
146661203|NCT02923427|528938169|FG000|Overall Study|can not replace LMA|1|||
146773714|NCT01565148|529341179|FG000|Overall Study|Death|0|||
146661204|NCT02923427|528938170|FG001|Overall Study|can not replace LMA|0|||
146661205|NCT01325623|528938171|FG000|Overall Study|Withdrawal by Subject|3|||
146661206|NCT01539642|528938176|FG000|Overall Study|Lack of Efficacy|20|||
146661207|NCT01539642|528938177|FG001|Overall Study|Lack of Efficacy|18|||
146661208|NCT01539642|528938176|FG000|Overall Study|Patient ready for early discharge|8|||
146661209|NCT01539642|528938177|FG001|Overall Study|Patient ready for early discharge|7|||
146661210|NCT01539642|528938176|FG000|Overall Study|Adverse Event|6|||
146661211|NCT01539642|528938177|FG001|Overall Study|Adverse Event|4|||
146661212|NCT01539642|528938176|FG000|Overall Study|Withdrawal by Subject|2|||
146661213|NCT01539642|528938177|FG001|Overall Study|Withdrawal by Subject|2|||
146661214|NCT00598702|528938178|FG000|Overall Study|Other|0|||
146661215|NCT00598702|528938179|FG001|Overall Study|Other|2|||
146661216|NCT00598702|528938180|FG002|Overall Study|Other|0|||
146661217|NCT00598702|528938181|FG003|Overall Study|Other|0|||
146661218|NCT00598702|528938182|FG004|Overall Study|Other|0|||
146661219|NCT00598702|528938183|FG005|Overall Study|Other|1|||
146661220|NCT00598702|528938184|FG006|Overall Study|Other|0|||
146661221|NCT00598702|528938185|FG007|Overall Study|Other|0|||
146661222|NCT00598702|528938178|FG000|Overall Study|Early discharge from hospital|0|||
146661223|NCT00598702|528938179|FG001|Overall Study|Early discharge from hospital|0|||
146661224|NCT00598702|528938180|FG002|Overall Study|Early discharge from hospital|2|||
146661225|NCT00598702|528938181|FG003|Overall Study|Early discharge from hospital|5|||
146661226|NCT00598702|528938182|FG004|Overall Study|Early discharge from hospital|0|||
146661227|NCT00598702|528938183|FG005|Overall Study|Early discharge from hospital|10|||
146661228|NCT00598702|528938184|FG006|Overall Study|Early discharge from hospital|1|||
146661229|NCT00598702|528938185|FG007|Overall Study|Early discharge from hospital|0|||
146661230|NCT00598702|528938178|FG000|Overall Study|Adverse Event|0|||
146661231|NCT00598702|528938179|FG001|Overall Study|Adverse Event|0|||
146661232|NCT00598702|528938180|FG002|Overall Study|Adverse Event|0|||
146661233|NCT00598702|528938181|FG003|Overall Study|Adverse Event|1|||
146661234|NCT00598702|528938182|FG004|Overall Study|Adverse Event|0|||
146661235|NCT00598702|528938183|FG005|Overall Study|Adverse Event|0|||
146661236|NCT00598702|528938184|FG006|Overall Study|Adverse Event|0|||
146661237|NCT00598702|528938185|FG007|Overall Study|Adverse Event|0|||
146661238|NCT00598702|528938178|FG000|Overall Study|Withdrawal by Subject|0|||
146661239|NCT00598702|528938179|FG001|Overall Study|Withdrawal by Subject|0|||
146661240|NCT00598702|528938180|FG002|Overall Study|Withdrawal by Subject|0|||
146661241|NCT00598702|528938181|FG003|Overall Study|Withdrawal by Subject|1|||
146661242|NCT00598702|528938182|FG004|Overall Study|Withdrawal by Subject|1|||
146661243|NCT00598702|528938183|FG005|Overall Study|Withdrawal by Subject|0|||
146661244|NCT00598702|528938184|FG006|Overall Study|Withdrawal by Subject|0|||
146661245|NCT00598702|528938185|FG007|Overall Study|Withdrawal by Subject|0|||
146661246|NCT00598702|528938178|FG000|Overall Study|Physician Decision|0|||
146661247|NCT00598702|528938179|FG001|Overall Study|Physician Decision|0|||
146661248|NCT00598702|528938180|FG002|Overall Study|Physician Decision|0|||
146661249|NCT00598702|528938181|FG003|Overall Study|Physician Decision|0|||
146661250|NCT00598702|528938182|FG004|Overall Study|Physician Decision|1|||
146661251|NCT00598702|528938183|FG005|Overall Study|Physician Decision|0|||
146661252|NCT00598702|528938184|FG006|Overall Study|Physician Decision|0|||
146661253|NCT00598702|528938185|FG007|Overall Study|Physician Decision|0|||
146661254|NCT00598702|528938178|FG000|Overall Study|Dose limiting toxicity|0|||
146661255|NCT00598702|528938179|FG001|Overall Study|Dose limiting toxicity|0|||
146661256|NCT00598702|528938180|FG002|Overall Study|Dose limiting toxicity|0|||
146661257|NCT00598702|528938181|FG003|Overall Study|Dose limiting toxicity|1|||
146661258|NCT00598702|528938182|FG004|Overall Study|Dose limiting toxicity|1|||
146661259|NCT00598702|528938183|FG005|Overall Study|Dose limiting toxicity|1|||
146661260|NCT00598702|528938184|FG006|Overall Study|Dose limiting toxicity|0|||
146661261|NCT00598702|528938185|FG007|Overall Study|Dose limiting toxicity|0|||
146661262|NCT02063880|528938186|FG000|Overall Study|Death|21|||
146661263|NCT02063880|528938187|FG001|Overall Study|Death|18|||
146661264|NCT02063880|528938186|FG000|Overall Study|Lost to Follow-up|7|||
146661265|NCT02063880|528938187|FG001|Overall Study|Lost to Follow-up|7|||
146661266|NCT02063880|528938186|FG000|Overall Study|Ineligible|0|||
146661267|NCT02063880|528938187|FG001|Overall Study|Ineligible|2|||
146661268|NCT02600351|528938188|FG000|Overall Study|Lack of Efficacy|3|||
146661269|NCT02600351|528938189|FG001|Overall Study|Lack of Efficacy|0|||
146661270|NCT02600351|528938190|FG002|Overall Study|Lack of Efficacy|5|||
146773715|NCT01565148|529341180|FG001|Overall Study|Death|0|||
146773716|NCT01565148|529341181|FG002|Overall Study|Death|1|||
146661271|NCT02600351|528938191|FG003|Overall Study|Lack of Efficacy|2|||
146661272|NCT02600351|528938188|FG000|Overall Study|Lost to Follow-up|1|||
146661273|NCT02600351|528938189|FG001|Overall Study|Lost to Follow-up|0|||
146925204|NCT00485589|529885960|FG001|Overall Study|Refused treatment/did not cooperate|0|||
146661274|NCT02600351|528938190|FG002|Overall Study|Lost to Follow-up|0|||
146661275|NCT02600351|528938191|FG003|Overall Study|Lost to Follow-up|0|||
146661276|NCT02600351|528938188|FG000|Overall Study|Randomized but Not Treated|1|||
146661277|NCT02600351|528938189|FG001|Overall Study|Randomized but Not Treated|0|||
146661278|NCT02600351|528938190|FG002|Overall Study|Randomized but Not Treated|1|||
146661279|NCT02600351|528938191|FG003|Overall Study|Randomized but Not Treated|3|||
146661280|NCT02106910|528938194|FG000|Overall Study|Lost to Follow-up|1|||
146661281|NCT02106910|528938195|FG001|Overall Study|Lost to Follow-up|1|||
146661282|NCT00567593|528938196|FG000|Overall Study|Adverse Event|1|||
146661283|NCT00567593|528938196|FG000|Overall Study|Physician Decision|1|||
146661284|NCT00700570|528938197|FG000|Overall Study|Adverse Event|2|||
146661285|NCT00700570|528938198|FG001|Overall Study|Adverse Event|6|||
146661286|NCT00700570|528938197|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
146661287|NCT00700570|528938198|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
146661288|NCT00700570|528938197|FG000|Overall Study|Disease Progression|8|||
146661289|NCT00700570|528938198|FG001|Overall Study|Disease Progression|11|||
146661290|NCT00700570|528938197|FG000|Overall Study|Withdrawal by Subject|1|||
146661291|NCT00700570|528938198|FG001|Overall Study|Withdrawal by Subject|6|||
146661292|NCT02556203|528938199|FG000|Overall Study|Withdrawal by Subject|21|||
146661293|NCT02556203|528938200|FG001|Overall Study|Withdrawal by Subject|21|||
146661294|NCT02556203|528938199|FG000|Overall Study|Lost to Follow-up|5|||
146661295|NCT02556203|528938200|FG001|Overall Study|Lost to Follow-up|5|||
146661296|NCT02556203|528938199|FG000|Overall Study|Adverse Event|1|||
146661297|NCT02556203|528938200|FG001|Overall Study|Adverse Event|0|||
146661298|NCT02943460|528938206|FG000|Blinded Study Phase|Adverse Event|3|||
146661299|NCT02943460|528938207|FG001|Blinded Study Phase|Adverse Event|0|||
146661300|NCT02943460|528938208|FG002|Blinded Study Phase|Adverse Event|0|||
146661301|NCT02943460|528938206|FG000|Blinded Study Phase|Withdrew Consent|0|||
146661302|NCT02943460|528938207|FG001|Blinded Study Phase|Withdrew Consent|1|||
146661303|NCT02943460|528938208|FG002|Blinded Study Phase|Withdrew Consent|0|||
146661304|NCT02943460|528938206|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
146661305|NCT02943460|528938207|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
146661306|NCT02943460|528938208|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
146661307|NCT02943460|528938206|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
146661308|NCT02943460|528938207|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
146661309|NCT02943460|528938208|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
146661310|NCT02943460|528938206|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
146661311|NCT02943460|528938207|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
146661312|NCT02943460|528938208|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
146661313|NCT01134731|528938215|FG000|Overall Study|Adverse Event|3|||
146661314|NCT01134731|528938216|FG001|Overall Study|Adverse Event|2|||
146661315|NCT01134731|528938217|FG002|Overall Study|Adverse Event|1|||
146661316|NCT01134731|528938215|FG000|Overall Study|Physician Decision|2|||
146661317|NCT01134731|528938216|FG001|Overall Study|Physician Decision|2|||
146773717|NCT01565148|529341182|FG003|Overall Study|Death|0|||
146661318|NCT01134731|528938217|FG002|Overall Study|Physician Decision|2|||
146661319|NCT01134731|528938215|FG000|Overall Study|Lack of Efficacy|0|||
146661320|NCT01134731|528938216|FG001|Overall Study|Lack of Efficacy|0|||
146661321|NCT01134731|528938217|FG002|Overall Study|Lack of Efficacy|1|||
146661322|NCT01134731|528938215|FG000|Overall Study|Withdrawal by Subject|3|||
146661323|NCT01134731|528938216|FG001|Overall Study|Withdrawal by Subject|3|||
146661324|NCT01134731|528938217|FG002|Overall Study|Withdrawal by Subject|1|||
146661325|NCT01134731|528938215|FG000|Overall Study|Lost to Follow-up|5|||
146661326|NCT01134731|528938216|FG001|Overall Study|Lost to Follow-up|4|||
146661327|NCT01134731|528938217|FG002|Overall Study|Lost to Follow-up|3|||
146661328|NCT01669928|528938218|FG000|First Intervention|Withdrawal by Subject|3|||
146661329|NCT01669928|528938219|FG001|First Intervention|Withdrawal by Subject|5|||
146661330|NCT00437320|528938222|FG000|Overall Study|Participant request|2|||
146661331|NCT00437320|528938223|FG001|Overall Study|Participant request|1|||
146661332|NCT00437320|528938224|FG002|Overall Study|Participant request|4|||
146661333|NCT00381381|528938228|FG000|Overall Study|Adverse Event|3|||
146661334|NCT00381381|528938228|FG000|Overall Study|Lost to Follow-up|52|||
146661335|NCT00381381|528938228|FG000|Overall Study|Withdrawal by Subject|9|||
146661336|NCT00568685|528938231|FG000|Overall Study|Adverse Event|2|||
146661337|NCT00568685|528938232|FG001|Overall Study|Adverse Event|3|||
146661338|NCT00568685|528938233|FG002|Overall Study|Adverse Event|3|||
146661339|NCT00568685|528938231|FG000|Overall Study|Withdrawal by Subject|7|||
146661340|NCT00568685|528938232|FG001|Overall Study|Withdrawal by Subject|2|||
146661341|NCT00568685|528938233|FG002|Overall Study|Withdrawal by Subject|2|||
146661342|NCT00568685|528938231|FG000|Overall Study|Protocol Violation|1|||
146661343|NCT00568685|528938232|FG001|Overall Study|Protocol Violation|0|||
146661344|NCT00568685|528938233|FG002|Overall Study|Protocol Violation|0|||
146661345|NCT01638819|528938235|FG000|Overall Study|Lost to Follow-up|1|||
146661346|NCT01638819|528938236|FG001|Overall Study|Lost to Follow-up|0|||
146661347|NCT00471146|528938239|FG000|Overall Study|Adverse Event|32|||
146661348|NCT00471146|528938240|FG001|Overall Study|Adverse Event|33|||
146661349|NCT00471146|528938239|FG000|Overall Study|Withdrawal by Subject|14|||
146661350|NCT00471146|528938240|FG001|Overall Study|Withdrawal by Subject|11|||
146661351|NCT00471146|528938239|FG000|Overall Study|Death|11|||
146661352|NCT00471146|528938240|FG001|Overall Study|Death|12|||
146661353|NCT00471146|528938239|FG000|Overall Study|Lost to Follow-up|4|||
146661354|NCT00471146|528938240|FG001|Overall Study|Lost to Follow-up|2|||
146661355|NCT00471146|528938239|FG000|Overall Study|Protocol Violation|2|||
146661356|NCT00471146|528938240|FG001|Overall Study|Protocol Violation|2|||
146661357|NCT00471146|528938239|FG000|Overall Study|Objective progression or relapse|84|||
146661358|NCT00471146|528938240|FG001|Overall Study|Objective progression or relapse|87|||
146661359|NCT00471146|528938239|FG000|Overall Study|Global deterioration of health status|12|||
146661360|NCT00471146|528938240|FG001|Overall Study|Global deterioration of health status|14|||
146661361|NCT00471146|528938239|FG000|Overall Study|Randomized but not treated|9|||
146925205|NCT00485589|529885961|FG002|Overall Study|Refused treatment/did not cooperate|2|||
146925206|NCT00485589|529885959|FG000|Overall Study|Withdrawal by Subject|3|||
146925207|NCT00485589|529885960|FG001|Overall Study|Withdrawal by Subject|2|||
146925208|NCT00485589|529885961|FG002|Overall Study|Withdrawal by Subject|2|||
146925209|NCT00485589|529885959|FG000|Overall Study|Adverse Event|3|||
146925210|NCT00485589|529885960|FG001|Overall Study|Adverse Event|3|||
146925211|NCT00485589|529885961|FG002|Overall Study|Adverse Event|10|||
146925212|NCT04348656|529885962|FG000|Overall Study|Withdrawal by Subject|2|||
146661362|NCT00471146|528938240|FG001|Overall Study|Randomized but not treated|8|||
146661363|NCT00471146|528938239|FG000|Overall Study|Other|4|||
146661364|NCT00471146|528938240|FG001|Overall Study|Other|5|||
146661365|NCT03538431|528938241|FG000|Overall Study|Physician Decision|0|||
146661366|NCT03538431|528938242|FG001|Overall Study|Physician Decision|1|||
146661367|NCT03538431|528938241|FG000|Overall Study|Withdrawal by Subject|1|||
146661368|NCT03538431|528938242|FG001|Overall Study|Withdrawal by Subject|0|||
146661369|NCT01231347|528938245|FG000|Overall Study|Full Consent withdrawn|19|||
146661370|NCT01231347|528938246|FG001|Overall Study|Full Consent withdrawn|19|||
146661371|NCT01231347|528938247|FG002|Overall Study|Full Consent withdrawn|11|||
146661372|NCT01231347|528938245|FG000|Overall Study|Lost to Follow-up|4|||
146661373|NCT01231347|528938246|FG001|Overall Study|Lost to Follow-up|2|||
146661374|NCT01231347|528938247|FG002|Overall Study|Lost to Follow-up|2|||
146661375|NCT01231347|528938245|FG000|Overall Study|Death|202|||
146661376|NCT01231347|528938246|FG001|Overall Study|Death|210|||
146661377|NCT01231347|528938247|FG002|Overall Study|Death|101|||
146661378|NCT01231347|528938245|FG000|Overall Study|other event|7|||
146661379|NCT01231347|528938246|FG001|Overall Study|other event|9|||
146661380|NCT01231347|528938247|FG002|Overall Study|other event|3|||
146661381|NCT01460368|528938248|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
146661382|NCT01460368|528938249|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
146661383|NCT01460368|528938250|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
146661384|NCT01460368|528938251|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
146661385|NCT01460368|528938252|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
146661386|NCT01460368|528938253|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
146661387|NCT01460368|528938254|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
146661388|NCT01460368|528938248|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
146661389|NCT01460368|528938249|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
146661390|NCT01460368|528938250|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
146661391|NCT01460368|528938251|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
146661392|NCT01460368|528938252|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
146661393|NCT01460368|528938253|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
146661394|NCT01460368|528938254|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
146661395|NCT01460368|528938248|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
146661396|NCT01460368|528938249|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
146661397|NCT01460368|528938250|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
146661398|NCT01460368|528938251|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
146661399|NCT01460368|528938252|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
146661400|NCT01460368|528938253|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
146661401|NCT01460368|528938254|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
146661402|NCT01460368|528938248|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
146661403|NCT01460368|528938249|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
146661404|NCT01460368|528938250|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
146661405|NCT01460368|528938251|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
146661406|NCT01460368|528938252|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
146661407|NCT01460368|528938253|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
146661408|NCT01460368|528938254|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
146661409|NCT01460368|528938248|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
146661410|NCT01460368|528938249|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
146661411|NCT01460368|528938250|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
146661412|NCT01460368|528938251|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
146661413|NCT01460368|528938252|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
146661414|NCT01460368|528938253|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
146661415|NCT01460368|528938254|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
146661416|NCT02322021|528938255|FG000|Core Phase|Adverse Event|1|||
146661417|NCT02322021|528938256|FG001|Core Phase|Adverse Event|3|||
146661418|NCT02322021|528938257|FG002|Core Phase|Adverse Event|4|||
146661419|NCT02322021|528938258|FG003|Core Phase|Adverse Event|2|||
146661420|NCT02322021|528938259|FG004|Core Phase|Adverse Event|0|||
146661421|NCT02322021|528938255|FG000|Core Phase|Participant Choice|4|||
146661422|NCT02322021|528938256|FG001|Core Phase|Participant Choice|5|||
146925213|NCT04348656|529885963|FG001|Overall Study|Withdrawal by Subject|0|||
146925214|NCT04348656|529885962|FG000|Overall Study|Lost to Follow-up|11|||
146925215|NCT04348656|529885963|FG001|Overall Study|Lost to Follow-up|6|||
146661423|NCT02322021|528938257|FG002|Core Phase|Participant Choice|4|||
146661424|NCT02322021|528938258|FG003|Core Phase|Participant Choice|2|||
146661425|NCT02322021|528938259|FG004|Core Phase|Participant Choice|0|||
146661426|NCT02322021|528938255|FG000|Core Phase|Lost to Follow-up|0|||
146661427|NCT02322021|528938256|FG001|Core Phase|Lost to Follow-up|0|||
146661428|NCT02322021|528938257|FG002|Core Phase|Lost to Follow-up|0|||
146661429|NCT02322021|528938258|FG003|Core Phase|Lost to Follow-up|1|||
146661430|NCT02322021|528938259|FG004|Core Phase|Lost to Follow-up|0|||
146661431|NCT02322021|528938255|FG000|Core Phase|Other|0|||
146661432|NCT02322021|528938256|FG001|Core Phase|Other|0|||
146661433|NCT02322021|528938257|FG002|Core Phase|Other|1|||
146661434|NCT02322021|528938258|FG003|Core Phase|Other|0|||
146661435|NCT02322021|528938259|FG004|Core Phase|Other|0|||
146661436|NCT02322021|528938255|FG000|Extension Phase|Adverse Event|0|||
146661437|NCT02322021|528938256|FG001|Extension Phase|Adverse Event|0|||
146661438|NCT02322021|528938257|FG002|Extension Phase|Adverse Event|0|||
146661439|NCT02322021|528938258|FG003|Extension Phase|Adverse Event|0|||
146661440|NCT02322021|528938259|FG004|Extension Phase|Adverse Event|3|||
146661441|NCT02322021|528938255|FG000|Extension Phase|Participant Choice|0|||
146661442|NCT02322021|528938256|FG001|Extension Phase|Participant Choice|0|||
146661443|NCT02322021|528938257|FG002|Extension Phase|Participant Choice|0|||
146661444|NCT02322021|528938258|FG003|Extension Phase|Participant Choice|0|||
146661445|NCT02322021|528938259|FG004|Extension Phase|Participant Choice|6|||
146661446|NCT02322021|528938255|FG000|Extension Phase|Other|0|||
146925216|NCT01944969|529885964|FG000|Overall Study|Adverse Event|1|||
146925217|NCT01944969|529885964|FG000|Overall Study|Lack of Efficacy|1|||
146925218|NCT01944969|529885964|FG000|Overall Study|Non-compliance with IMP|1|||
146661447|NCT02322021|528938256|FG001|Extension Phase|Other|0|||
146661448|NCT02322021|528938257|FG002|Extension Phase|Other|0|||
146661449|NCT02322021|528938258|FG003|Extension Phase|Other|0|||
146661450|NCT02322021|528938259|FG004|Extension Phase|Other|3|||
146661451|NCT02322021|528938255|FG000|Extension Phase|Lost to Follow-up|0|||
146661452|NCT02322021|528938256|FG001|Extension Phase|Lost to Follow-up|0|||
146661453|NCT02322021|528938257|FG002|Extension Phase|Lost to Follow-up|0|||
146661454|NCT02322021|528938258|FG003|Extension Phase|Lost to Follow-up|0|||
146661455|NCT02322021|528938259|FG004|Extension Phase|Lost to Follow-up|1|||
146661456|NCT02322021|528938255|FG000|Extension Phase|Study terminated by sponsor|0|||
146661457|NCT02322021|528938256|FG001|Extension Phase|Study terminated by sponsor|0|||
146661458|NCT02322021|528938257|FG002|Extension Phase|Study terminated by sponsor|0|||
146661459|NCT02322021|528938258|FG003|Extension Phase|Study terminated by sponsor|0|||
146661460|NCT02322021|528938259|FG004|Extension Phase|Study terminated by sponsor|28|||
146661461|NCT03643159|528938260|FG000|Overall Study|Adverse Event|1|||
146661462|NCT03643159|528938260|FG000|Overall Study|Withdrawal by Subject|1|||
146661463|NCT03438383|528938261|FG000|Overall Study|Protocol Violation|9|||
146661464|NCT03438383|528938262|FG001|Overall Study|Protocol Violation|3|||
146661465|NCT01528033|528938263|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
146661466|NCT01528033|528938264|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
146661467|NCT01528033|528938263|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
146661468|NCT01528033|528938264|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
146661469|NCT01528033|528938263|FG000|Primary Endpoint Assessment ITT|Death|2|||
146661470|NCT01528033|528938264|FG001|Primary Endpoint Assessment ITT|Death|2|||
146661471|NCT01528033|528938263|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
146661472|NCT01528033|528938264|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
146661473|NCT01528033|528938263|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
146661474|NCT01528033|528938264|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
146661475|NCT01528033|528938263|FG000|Follow Up|No data available|46|||
146661476|NCT01528033|528938264|FG001|Follow Up|No data available|44|||
146661477|NCT02030938|528938267|FG000|Overall Study|Lost to Follow-up|4|||
146925219|NCT01944969|529885964|FG000|Overall Study|Administrative or other reasons|23|||
146661478|NCT02030938|528938267|FG000|Overall Study|Withdrawal by Subject|1|||
146661479|NCT03148275|528938272|FG000|Overall Study|Death|6|||
146661480|NCT03148275|528938272|FG000|Overall Study|Adverse Event|3|||
146661481|NCT03148275|528938272|FG000|Overall Study|Liver transplant|2|||
146661482|NCT03148275|528938272|FG000|Overall Study|Patient decision|5|||
146661483|NCT03148275|528938272|FG000|Overall Study|transition to commercial drug|1|||
146661484|NCT03148275|528938272|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
146661485|NCT05098938|528938273|FG000|Overall Study|Adverse Event|4|||
146661486|NCT05098938|528938274|FG001|Overall Study|Adverse Event|3|||
146661487|NCT05098938|528938273|FG000|Overall Study|inclusion/exclusion criteria change|11|||
146661488|NCT05098938|528938274|FG001|Overall Study|inclusion/exclusion criteria change|5|||
146661489|NCT05098938|528938273|FG000|Overall Study|lack of compliance|26|||
146661490|NCT05098938|528938274|FG001|Overall Study|lack of compliance|19|||
146661491|NCT05098938|528938273|FG000|Overall Study|Lost to Follow-up|37|||
146925220|NCT03072719|529885965|FG000|Overall Study|Adverse Event|1|||
146661492|NCT05098938|528938274|FG001|Overall Study|Lost to Follow-up|40|||
146661493|NCT05098938|528938273|FG000|Overall Study|Lost in treatment period|17|||
146661494|NCT05098938|528938274|FG001|Overall Study|Lost in treatment period|13|||
146661495|NCT05098938|528938273|FG000|Overall Study|Met an exclusion criterion|0|||
146661496|NCT05098938|528938274|FG001|Overall Study|Met an exclusion criterion|3|||
146661497|NCT05098938|528938273|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
146661498|NCT05098938|528938274|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
146661499|NCT05098938|528938273|FG000|Overall Study|Physician Decision|25|||
146661500|NCT05098938|528938274|FG001|Overall Study|Physician Decision|32|||
146661501|NCT05098938|528938273|FG000|Overall Study|Run in failure in treatment phase|1|||
146661502|NCT05098938|528938274|FG001|Overall Study|Run in failure in treatment phase|1|||
146661503|NCT05098938|528938273|FG000|Overall Study|Withdrawal by Subject|0|||
146661504|NCT05098938|528938274|FG001|Overall Study|Withdrawal by Subject|3|||
146661505|NCT05098938|528938273|FG000|Overall Study|Run-in Failure in early study|505|||
146661506|NCT05098938|528938274|FG001|Overall Study|Run-in Failure in early study|514|||
146661507|NCT05098938|528938273|FG000|Overall Study|IMP delivery missed|1|||
146661508|NCT05098938|528938274|FG001|Overall Study|IMP delivery missed|5|||
146661509|NCT05098938|528938273|FG000|Overall Study|6 months visit was missed|2|||
146661510|NCT05098938|528938274|FG001|Overall Study|6 months visit was missed|0|||
146661511|NCT05098938|528938273|FG000|Overall Study|fit for use was not completed within window|3|||
146661512|NCT05098938|528938274|FG001|Overall Study|fit for use was not completed within window|0|||
146661513|NCT05098938|528938273|FG000|Overall Study|V2 visit was not completed within window|0|||
146661514|NCT05098938|528938274|FG001|Overall Study|V2 visit was not completed within window|1|||
146661515|NCT05098938|528938273|FG000|Overall Study|exclusionary medication use|1|||
146661516|NCT05098938|528938274|FG001|Overall Study|exclusionary medication use|2|||
146661517|NCT05098938|528938273|FG000|Overall Study|change in medication|1|||
146661518|NCT05098938|528938274|FG001|Overall Study|change in medication|0|||
146661519|NCT05098938|528938273|FG000|Overall Study|treatment failure|2|||
146661520|NCT05098938|528938274|FG001|Overall Study|treatment failure|1|||
146661521|NCT03803683|528938275|FG000|Overall Study|Lost to Follow-up|41|||
146661522|NCT03803683|528938276|FG001|Overall Study|Lost to Follow-up|18|||
146661523|NCT03803683|528938277|FG002|Overall Study|Lost to Follow-up|12|||
146661524|NCT03803683|528938275|FG000|Overall Study|Withdrawal by Subject|9|||
146661525|NCT03803683|528938276|FG001|Overall Study|Withdrawal by Subject|1|||
146661526|NCT03803683|528938277|FG002|Overall Study|Withdrawal by Subject|4|||
146661527|NCT00492050|528938278|FG000|Overall Study|Adverse Event|1|||
146661528|NCT00492050|528938278|FG000|Overall Study|Lack of Efficacy|1|||
146661529|NCT00492050|528938278|FG000|Overall Study|Withdrawal by Subject|3|||
146661530|NCT00492050|528938278|FG000|Overall Study|Unable to collect SCT|2|||
146661531|NCT00492050|528938278|FG000|Overall Study|Progressive Disease|2|||
146661532|NCT00537238|528939942|FG000|Overall Study|Death|1|||
146661533|NCT00537238|528939943|FG001|Overall Study|Death|2|||
146925221|NCT03072719|529885966|FG001|Overall Study|Adverse Event|1|||
146925222|NCT01260467|529885970|FG000|Overall Study|Withdrawal by Subject|2|||
146925223|NCT00436566|529885975|FG000|Overall Study|Withdrawal by Subject|2|||
146925224|NCT00436566|529885975|FG000|Overall Study|Protocol Violation|1|||
146925225|NCT03888391|529885978|FG000|Overall Study|Lost to Follow-up|15|||
146925226|NCT01954251|529885979|FG000|Overall Study|Adverse Event|5|||
146925227|NCT01954251|529885980|FG001|Overall Study|Adverse Event|7|||
146925228|NCT01954251|529885979|FG000|Overall Study|Lost to Follow-up|6|||
146978740|NCT00598559|530085490|FG002|Overall Study|Withdrawal by Subject|0|||
146661534|NCT00537238|528939942|FG000|Overall Study|Adverse Event|31|||
146661535|NCT00537238|528939943|FG001|Overall Study|Adverse Event|22|||
146661536|NCT00537238|528939942|FG000|Overall Study|Lack of Efficacy|20|||
146661537|NCT00537238|528939943|FG001|Overall Study|Lack of Efficacy|21|||
146661538|NCT00537238|528939942|FG000|Overall Study|Lost to Follow-up|12|||
146661539|NCT00537238|528939943|FG001|Overall Study|Lost to Follow-up|8|||
146661540|NCT00537238|528939942|FG000|Overall Study|Withdrawal by Subject|51|||
146661541|NCT00537238|528939943|FG001|Overall Study|Withdrawal by Subject|47|||
146661542|NCT00537238|528939942|FG000|Overall Study|Protocol Violation|15|||
146661543|NCT00537238|528939943|FG001|Overall Study|Protocol Violation|19|||
146661544|NCT00537238|528939942|FG000|Overall Study|Does not meet entrance criteria|0|||
146661545|NCT00537238|528939943|FG001|Overall Study|Does not meet entrance criteria|2|||
146661546|NCT00537238|528939942|FG000|Overall Study|Other|44|||
146661547|NCT00537238|528939943|FG001|Overall Study|Other|52|||
146661548|NCT01193660|528939946|FG000|Overall Study|Withdrawal by Subject|2|||
146661549|NCT01193660|528939947|FG001|Overall Study|Withdrawal by Subject|3|||
146661550|NCT01193660|528939948|FG002|Overall Study|Withdrawal by Subject|1|||
146661551|NCT01193660|528939946|FG000|Overall Study|Death|1|||
146661552|NCT01193660|528939947|FG001|Overall Study|Death|0|||
146661553|NCT01193660|528939948|FG002|Overall Study|Death|0|||
146661554|NCT01193660|528939946|FG000|Overall Study|Physician Decision|1|||
146661555|NCT01193660|528939947|FG001|Overall Study|Physician Decision|0|||
146925229|NCT01954251|529885980|FG001|Overall Study|Lost to Follow-up|6|||
146925230|NCT01954251|529885979|FG000|Overall Study|Withdrawal by Subject|2|||
146661556|NCT01193660|528939948|FG002|Overall Study|Physician Decision|1|||
146661557|NCT02367131|528939949|FG000|Overall Study|Adverse Event|64|||
146661558|NCT02367131|528939949|FG000|Overall Study|No visit since the first visit|3|||
146661559|NCT02367131|528939949|FG000|Overall Study|Request by patient|53|||
146661560|NCT02367131|528939949|FG000|Overall Study|Improvement/remission|2|||
146661561|NCT02367131|528939949|FG000|Overall Study|No change/progressive disease|78|||
146661562|NCT02367131|528939949|FG000|Overall Study|Other than stated above|20|||
146661563|NCT02367131|528939949|FG000|Overall Study|Not treated|2|||
146661564|NCT05061966|528939950|FG000|Overall Study|Lost to Follow-up|13|||
146661565|NCT05061966|528939951|FG001|Overall Study|Lost to Follow-up|13|||
146661566|NCT01675427|528939956|FG000|Overall Study|Withdrawal by Subject|7|||
146661567|NCT01675427|528939956|FG000|Overall Study|Participant Refused Sample Collection|18|||
146661568|NCT01675427|528939956|FG000|Overall Study|Sample not Collected by Mistake|2|||
146661569|NCT01675427|528939956|FG000|Overall Study|Lost to Follow-up|5|||
146661570|NCT01675427|528939956|FG000|Overall Study|Other|2|||
146661571|NCT00611533|528939957|FG000|First Intervention (6 Weeks)|Never started study|0|||
146661572|NCT00611533|528939958|FG001|First Intervention (6 Weeks)|Never started study|1|||
146661573|NCT00611533|528939957|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
146661574|NCT00611533|528939958|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
146661575|NCT00611533|528939957|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
146661576|NCT00611533|528939958|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
146661577|NCT01461980|528939962|FG000|Overall Study|Other|9|||
146661578|NCT01461980|528939963|FG001|Overall Study|Other|8|||
146661579|NCT01461980|528939964|FG002|Overall Study|Other|6|||
146661580|NCT01461980|528939962|FG000|Overall Study|Medication error|7|||
146661581|NCT01461980|528939963|FG001|Overall Study|Medication error|5|||
146661582|NCT01461980|528939964|FG002|Overall Study|Medication error|6|||
146661583|NCT01461980|528939962|FG000|Overall Study|Adverse Event|12|||
146661584|NCT01461980|528939963|FG001|Overall Study|Adverse Event|5|||
146661585|NCT01461980|528939964|FG002|Overall Study|Adverse Event|6|||
146661586|NCT01461980|528939962|FG000|Overall Study|Protocol Violation|12|||
146661587|NCT01461980|528939963|FG001|Overall Study|Protocol Violation|19|||
146661588|NCT01461980|528939964|FG002|Overall Study|Protocol Violation|16|||
146661589|NCT01461980|528939962|FG000|Overall Study|No longer meets eligibility criteria|18|||
146661590|NCT01461980|528939963|FG001|Overall Study|No longer meets eligibility criteria|9|||
146661591|NCT01461980|528939964|FG002|Overall Study|No longer meets eligibility criteria|19|||
146661592|NCT01461980|528939962|FG000|Overall Study|Lost to Follow-up|52|||
146661593|NCT01461980|528939963|FG001|Overall Study|Lost to Follow-up|53|||
146661594|NCT01461980|528939964|FG002|Overall Study|Lost to Follow-up|51|||
146661595|NCT01461980|528939962|FG000|Overall Study|No longer willing to participate|52|||
146661596|NCT01461980|528939963|FG001|Overall Study|No longer willing to participate|38|||
146661597|NCT01461980|528939964|FG002|Overall Study|No longer willing to participate|54|||
146661598|NCT01461980|528939962|FG000|Overall Study|Randomized but not vaccinated|4|||
146661599|NCT01461980|528939963|FG001|Overall Study|Randomized but not vaccinated|8|||
146661600|NCT01461980|528939964|FG002|Overall Study|Randomized but not vaccinated|7|||
146661601|NCT04171765|528939965|FG000|Overall Study|Adverse Event|2|||
146661602|NCT04171765|528939966|FG001|Overall Study|Adverse Event|0|||
146661603|NCT04171765|528939967|FG002|Overall Study|Adverse Event|1|||
146661604|NCT04171765|528939968|FG003|Overall Study|Adverse Event|0|||
146661605|NCT04171765|528939965|FG000|Overall Study|Lost to Follow-up|0|||
146661606|NCT04171765|528939966|FG001|Overall Study|Lost to Follow-up|2|||
146661607|NCT04171765|528939967|FG002|Overall Study|Lost to Follow-up|2|||
146661608|NCT04171765|528939968|FG003|Overall Study|Lost to Follow-up|2|||
146661609|NCT04171765|528939965|FG000|Overall Study|Week 58 visit missed|0|||
146661610|NCT04171765|528939966|FG001|Overall Study|Week 58 visit missed|0|||
146661611|NCT04171765|528939967|FG002|Overall Study|Week 58 visit missed|1|||
146661612|NCT04171765|528939968|FG003|Overall Study|Week 58 visit missed|0|||
146661613|NCT04171765|528939965|FG000|Overall Study|Study terminated by sponsor|2|||
146661614|NCT04171765|528939966|FG001|Overall Study|Study terminated by sponsor|0|||
146661615|NCT04171765|528939967|FG002|Overall Study|Study terminated by sponsor|0|||
146661616|NCT04171765|528939968|FG003|Overall Study|Study terminated by sponsor|0|||
146661617|NCT04171765|528939965|FG000|Overall Study|Withdrawal by Subject|1|||
146661618|NCT04171765|528939966|FG001|Overall Study|Withdrawal by Subject|0|||
146661619|NCT04171765|528939967|FG002|Overall Study|Withdrawal by Subject|0|||
146661620|NCT04171765|528939968|FG003|Overall Study|Withdrawal by Subject|3|||
146661621|NCT00122109|528939969|FG000|Overall Study|Did not meet criteria|6|||
146661622|NCT00122109|528939970|FG001|Overall Study|Did not meet criteria|7|||
146661623|NCT00100178|528939971|FG000|Overall Study|Lost to Follow-up|0|||
146661624|NCT00100178|528939972|FG001|Overall Study|Lost to Follow-up|6|||
146661625|NCT00100178|528939973|FG002|Overall Study|Lost to Follow-up|5|||
146661626|NCT00100178|528939971|FG000|Overall Study|Adverse Event|2|||
146661627|NCT00100178|528939972|FG001|Overall Study|Adverse Event|2|||
146661628|NCT00100178|528939973|FG002|Overall Study|Adverse Event|1|||
146661629|NCT00100178|528939971|FG000|Overall Study|Withdrawal by Subject|1|||
146661630|NCT00100178|528939972|FG001|Overall Study|Withdrawal by Subject|1|||
146661631|NCT00100178|528939973|FG002|Overall Study|Withdrawal by Subject|1|||
146661632|NCT00100178|528939971|FG000|Overall Study|Physician Decision|6|||
146661633|NCT00100178|528939972|FG001|Overall Study|Physician Decision|1|||
146661634|NCT00100178|528939973|FG002|Overall Study|Physician Decision|3|||
146661635|NCT00631696|528939976|FG000|Overall Study|Entered, not randomized to treatment|1|||
146661636|NCT00631696|528939977|FG001|Overall Study|Entered, not randomized to treatment|1|||
146661637|NCT00631696|528939976|FG000|Overall Study|Discontinued after database release date|1|||
146661638|NCT00631696|528939977|FG001|Overall Study|Discontinued after database release date|0|||
146661639|NCT00631696|528939976|FG000|Overall Study|Follow up after database release date|1|||
146661640|NCT00631696|528939977|FG001|Overall Study|Follow up after database release date|0|||
146661641|NCT00631696|528939976|FG000|Overall Study|Lost to Follow-up|7|||
146661642|NCT00631696|528939977|FG001|Overall Study|Lost to Follow-up|10|||
146661643|NCT00631696|528939976|FG000|Overall Study|Withdrawal by Subject|2|||
146661644|NCT00631696|528939977|FG001|Overall Study|Withdrawal by Subject|9|||
146661645|NCT00631696|528939976|FG000|Overall Study|Other|8|||
146661646|NCT00631696|528939977|FG001|Overall Study|Other|8|||
146661647|NCT00631696|528939976|FG000|Overall Study|Protocol Violation|9|||
146661648|NCT00631696|528939977|FG001|Overall Study|Protocol Violation|9|||
146661649|NCT00631696|528939976|FG000|Overall Study|Study terminated by sponsor|3|||
146661650|NCT00631696|528939977|FG001|Overall Study|Study terminated by sponsor|3|||
146661651|NCT00631696|528939976|FG000|Overall Study|Adverse Event|5|||
146661652|NCT00631696|528939977|FG001|Overall Study|Adverse Event|0|||
146661653|NCT01439568|528939979|FG000|Overall Study|Lost to Follow-up|1|||
146661654|NCT01439568|528939980|FG001|Overall Study|Lost to Follow-up|0|||
146661655|NCT01439568|528939979|FG000|Overall Study|Withdrawal by Subject|2|||
146661656|NCT01439568|528939980|FG001|Overall Study|Withdrawal by Subject|2|||
146661657|NCT01578330|528939981|FG000|Overall Study|Adverse Event|2|||
146661658|NCT01578330|528939981|FG000|Overall Study|Protocol Violation|5|||
146661659|NCT01199731|528939984|FG000|Overall Study|Adverse Event|0|||
146661660|NCT01199731|528939985|FG001|Overall Study|Adverse Event|1|||
146661661|NCT01199731|528939986|FG002|Overall Study|Adverse Event|0|||
146661662|NCT01199731|528939984|FG000|Overall Study|Study closed/terminated|7|||
146661663|NCT01199731|528939985|FG001|Overall Study|Study closed/terminated|9|||
146661664|NCT01199731|528939986|FG002|Overall Study|Study closed/terminated|7|||
146661665|NCT01199731|528939984|FG000|Overall Study|Lost to Follow-up|0|||
146661666|NCT01199731|528939985|FG001|Overall Study|Lost to Follow-up|0|||
146661667|NCT01199731|528939986|FG002|Overall Study|Lost to Follow-up|2|||
146661668|NCT01199731|528939984|FG000|Overall Study|Physician Decision|0|||
146661669|NCT01199731|528939985|FG001|Overall Study|Physician Decision|1|||
146661670|NCT01199731|528939986|FG002|Overall Study|Physician Decision|1|||
146661671|NCT01199731|528939984|FG000|Overall Study|Withdrawal by Subject|2|||
146661672|NCT01199731|528939985|FG001|Overall Study|Withdrawal by Subject|0|||
146661673|NCT01199731|528939986|FG002|Overall Study|Withdrawal by Subject|0|||
146661674|NCT01465191|528939987|FG000|Overall Study|Protocol Violation|6|||
146661675|NCT01465191|528939988|FG001|Overall Study|Protocol Violation|3|||
146661676|NCT01465191|528939989|FG002|Overall Study|Protocol Violation|3|||
146661677|NCT01465191|528939987|FG000|Overall Study|Lost to Follow-up|3|||
146661678|NCT01465191|528939988|FG001|Overall Study|Lost to Follow-up|6|||
146661679|NCT01465191|528939989|FG002|Overall Study|Lost to Follow-up|4|||
146661680|NCT02448810|528939990|FG000|Overall Study|Adverse Event|0|||
146661681|NCT02448810|528939991|FG001|Overall Study|Adverse Event|0|||
146661682|NCT02448810|528939992|FG002|Overall Study|Adverse Event|1|||
146661683|NCT02448810|528939993|FG003|Overall Study|Adverse Event|0|||
146661684|NCT02448810|528939994|FG004|Overall Study|Adverse Event|0|||
146661685|NCT02448810|528939995|FG005|Overall Study|Adverse Event|0|||
146661686|NCT02448810|528939996|FG006|Overall Study|Adverse Event|0|||
146661687|NCT02448810|528939997|FG007|Overall Study|Adverse Event|0|||
146661688|NCT02448810|528939990|FG000|Overall Study|Withdrawal by Subject|0|||
146661689|NCT02448810|528939991|FG001|Overall Study|Withdrawal by Subject|0|||
146661690|NCT02448810|528939992|FG002|Overall Study|Withdrawal by Subject|1|||
146661691|NCT02448810|528939993|FG003|Overall Study|Withdrawal by Subject|0|||
146661692|NCT02448810|528939994|FG004|Overall Study|Withdrawal by Subject|3|||
146661693|NCT02448810|528939995|FG005|Overall Study|Withdrawal by Subject|5|||
146661694|NCT02448810|528939996|FG006|Overall Study|Withdrawal by Subject|0|||
146661695|NCT02448810|528939997|FG007|Overall Study|Withdrawal by Subject|2|||
146661696|NCT02448810|528939990|FG000|Overall Study|Other (study terminated by sponsor)|0|||
146661697|NCT02448810|528939991|FG001|Overall Study|Other (study terminated by sponsor)|0|||
146661698|NCT02448810|528939992|FG002|Overall Study|Other (study terminated by sponsor)|0|||
146661699|NCT02448810|528939993|FG003|Overall Study|Other (study terminated by sponsor)|0|||
146661700|NCT02448810|528939994|FG004|Overall Study|Other (study terminated by sponsor)|4|||
146661701|NCT02448810|528939995|FG005|Overall Study|Other (study terminated by sponsor)|2|||
146661702|NCT02448810|528939996|FG006|Overall Study|Other (study terminated by sponsor)|2|||
146661703|NCT02448810|528939997|FG007|Overall Study|Other (study terminated by sponsor)|1|||
146661704|NCT02448810|528939990|FG000|Overall Study|Death|1|||
146661705|NCT02448810|528939991|FG001|Overall Study|Death|0|||
146661706|NCT02448810|528939992|FG002|Overall Study|Death|1|||
146661707|NCT02448810|528939993|FG003|Overall Study|Death|0|||
146661708|NCT02448810|528939994|FG004|Overall Study|Death|1|||
146661709|NCT02448810|528939995|FG005|Overall Study|Death|0|||
146661710|NCT02448810|528939996|FG006|Overall Study|Death|0|||
146661711|NCT02448810|528939997|FG007|Overall Study|Death|0|||
146661712|NCT02448810|528939990|FG000|Overall Study|Other (Progressive disease)|2|||
146661713|NCT02448810|528939991|FG001|Overall Study|Other (Progressive disease)|2|||
146661714|NCT02448810|528939992|FG002|Overall Study|Other (Progressive disease)|0|||
146661715|NCT02448810|528939993|FG003|Overall Study|Other (Progressive disease)|3|||
146661716|NCT02448810|528939994|FG004|Overall Study|Other (Progressive disease)|23|||
146661717|NCT02448810|528939995|FG005|Overall Study|Other (Progressive disease)|9|||
146661718|NCT02448810|528939996|FG006|Overall Study|Other (Progressive disease)|14|||
146661719|NCT02448810|528939997|FG007|Overall Study|Other (Progressive disease)|5|||
146661720|NCT02448810|528939990|FG000|Overall Study|Lost to Follow-up|0|||
146661721|NCT02448810|528939991|FG001|Overall Study|Lost to Follow-up|1|||
146661722|NCT02448810|528939992|FG002|Overall Study|Lost to Follow-up|0|||
146661723|NCT02448810|528939993|FG003|Overall Study|Lost to Follow-up|0|||
146661724|NCT02448810|528939994|FG004|Overall Study|Lost to Follow-up|0|||
146661725|NCT02448810|528939995|FG005|Overall Study|Lost to Follow-up|0|||
146661726|NCT02448810|528939996|FG006|Overall Study|Lost to Follow-up|0|||
146661727|NCT02448810|528939997|FG007|Overall Study|Lost to Follow-up|0|||
146661728|NCT02448810|528939990|FG000|Overall Study|Other (unspecified)|0|||
146661729|NCT02448810|528939991|FG001|Overall Study|Other (unspecified)|0|||
146661730|NCT02448810|528939992|FG002|Overall Study|Other (unspecified)|0|||
146661731|NCT02448810|528939993|FG003|Overall Study|Other (unspecified)|0|||
146661732|NCT02448810|528939994|FG004|Overall Study|Other (unspecified)|0|||
146661733|NCT02448810|528939995|FG005|Overall Study|Other (unspecified)|0|||
146661734|NCT02448810|528939996|FG006|Overall Study|Other (unspecified)|2|||
146661735|NCT02448810|528939997|FG007|Overall Study|Other (unspecified)|0|||
146661736|NCT01916967|528939998|FG000|Overall Study|Adverse Event|0|||
146661737|NCT01916967|528939999|FG001|Overall Study|Adverse Event|0|||
146661738|NCT01916967|528940000|FG002|Overall Study|Adverse Event|2|||
146661739|NCT01916967|528939998|FG000|Overall Study|Lack of Efficacy|0|||
146661740|NCT01916967|528939999|FG001|Overall Study|Lack of Efficacy|0|||
146661741|NCT01916967|528940000|FG002|Overall Study|Lack of Efficacy|6|||
146661742|NCT01916967|528939998|FG000|Overall Study|Physician Decision|0|||
146661743|NCT01916967|528939999|FG001|Overall Study|Physician Decision|0|||
146661744|NCT01916967|528940000|FG002|Overall Study|Physician Decision|1|||
146661745|NCT01916967|528939998|FG000|Overall Study|Protocol Violation|0|||
146661746|NCT01916967|528939999|FG001|Overall Study|Protocol Violation|1|||
146661747|NCT01916967|528940000|FG002|Overall Study|Protocol Violation|0|||
146661748|NCT00620464|528940001|FG000|Overall Study|Adverse Event|15|||
146661749|NCT00620464|528940002|FG001|Overall Study|Adverse Event|17|||
146661750|NCT00620464|528940001|FG000|Overall Study|Lost to Follow-up|1|||
146661751|NCT00620464|528940002|FG001|Overall Study|Lost to Follow-up|1|||
146661752|NCT00620464|528940001|FG000|Overall Study|Planning Pregnancy|1|||
146661753|NCT00620464|528940002|FG001|Overall Study|Planning Pregnancy|4|||
146661754|NCT00620464|528940001|FG000|Overall Study|Personal|2|||
146661755|NCT00620464|528940002|FG001|Overall Study|Personal|2|||
146661756|NCT00620464|528940001|FG000|Overall Study|Used prohibited medication|1|||
146661757|NCT00620464|528940002|FG001|Overall Study|Used prohibited medication|0|||
146661758|NCT05394350|528940003|FG000|Overall Study|Death|2|||
146661759|NCT05394350|528940004|FG001|Overall Study|Death|2|||
146661760|NCT05394350|528940005|FG002|Overall Study|Death|4|||
146661761|NCT05394350|528940006|FG003|Overall Study|Death|0|||
146661762|NCT05394350|528940007|FG004|Overall Study|Death|1|||
146661763|NCT05394350|528940008|FG005|Overall Study|Death|0|||
146661764|NCT05394350|528940003|FG000|Overall Study|Study terminated by sponsor|1|||
146661765|NCT05394350|528940004|FG001|Overall Study|Study terminated by sponsor|1|||
146661766|NCT05394350|528940005|FG002|Overall Study|Study terminated by sponsor|7|||
146661767|NCT05394350|528940006|FG003|Overall Study|Study terminated by sponsor|3|||
146661768|NCT05394350|528940007|FG004|Overall Study|Study terminated by sponsor|2|||
146661769|NCT05394350|528940008|FG005|Overall Study|Study terminated by sponsor|4|||
146661770|NCT01336569|528940011|FG000|Overall Study|Lost to Follow-up|4|||
146661771|NCT03911154|528940012|FG000|Overall Study|Withdrawal by Subject|1|||
146661772|NCT00406354|528940013|FG000|All Randomized Patients|Protocol Violation|0|||
146661773|NCT00406354|528940014|FG001|All Randomized Patients|Protocol Violation|0|||
146661774|NCT00406354|528940015|FG002|All Randomized Patients|Protocol Violation|1|||
146661775|NCT00406354|528940013|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
146661776|NCT00406354|528940014|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
146661777|NCT00406354|528940015|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
146661778|NCT00406354|528940013|FG000|All Randomized and Treated Patients|Adverse Event|6|||
146661779|NCT00406354|528940014|FG001|All Randomized and Treated Patients|Adverse Event|2|||
146661780|NCT00406354|528940015|FG002|All Randomized and Treated Patients|Adverse Event|1|||
146661781|NCT00406354|528940013|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
146661782|NCT00406354|528940014|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
146661783|NCT00406354|528940015|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
146661784|NCT00406354|528940013|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
146661785|NCT00406354|528940014|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
146661786|NCT00406354|528940015|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
146661787|NCT00406354|528940013|FG000|All Randomized and Treated Patients|Physician Decision|0|||
146661788|NCT00406354|528940014|FG001|All Randomized and Treated Patients|Physician Decision|0|||
146661789|NCT00406354|528940015|FG002|All Randomized and Treated Patients|Physician Decision|1|||
146661790|NCT01385371|528940028|FG000|Overall Study|Adverse Event|54|||
146661791|NCT01385371|528940029|FG001|Overall Study|Adverse Event|19|||
146925231|NCT01954251|529885980|FG001|Overall Study|Withdrawal by Subject|6|||
146661792|NCT01385371|528940028|FG000|Overall Study|Lost to Follow-up|16|||
146661793|NCT01385371|528940029|FG001|Overall Study|Lost to Follow-up|16|||
146661794|NCT01385371|528940028|FG000|Overall Study|Withdrawal by Subject|52|||
146661795|NCT01385371|528940029|FG001|Overall Study|Withdrawal by Subject|39|||
146661796|NCT01385371|528940028|FG000|Overall Study|Protocol Violation|25|||
146661797|NCT01385371|528940029|FG001|Overall Study|Protocol Violation|21|||
146661798|NCT01385371|528940028|FG000|Overall Study|Administrative|2|||
146661799|NCT01385371|528940029|FG001|Overall Study|Administrative|2|||
146661800|NCT00292318|528940035|FG000|Overall Study|Study terminated by officials|2|||
146661801|NCT00292318|528940036|FG001|Overall Study|Study terminated by officials|1|||
146661802|NCT02027376|528940037|FG000|Overall Study|Death|1|||
146661803|NCT02027376|528940038|FG001|Overall Study|Death|0|||
146661804|NCT02027376|528940039|FG002|Overall Study|Death|0|||
146661805|NCT01278160|528940043|FG000|Overall Study|Adverse Event|1|||
146661806|NCT01278160|528940044|FG001|Overall Study|Adverse Event|1|||
146661807|NCT01278160|528940043|FG000|Overall Study|Lost to Follow-up|0|||
146661808|NCT01278160|528940044|FG001|Overall Study|Lost to Follow-up|1|||
146661809|NCT01278160|528940043|FG000|Overall Study|Withdrawal by Subject|3|||
146661810|NCT01278160|528940044|FG001|Overall Study|Withdrawal by Subject|2|||
146661811|NCT01278160|528940043|FG000|Overall Study|Unclassified|1|||
146661812|NCT01278160|528940044|FG001|Overall Study|Unclassified|2|||
146661813|NCT00304239|528940047|FG000|Overall Study|Protocol Deviations/Violations|15|||
146661814|NCT00304239|528940048|FG001|Overall Study|Protocol Deviations/Violations|0|||
146661815|NCT00304239|528940047|FG000|Overall Study|Adverse Event|2|||
146661816|NCT00304239|528940048|FG001|Overall Study|Adverse Event|0|||
146661817|NCT02979197|528940049|FG000|Overall Study|Adverse Event|4|||
146661818|NCT02979197|528940050|FG001|Overall Study|Adverse Event|2|||
146661819|NCT02979197|528940051|FG002|Overall Study|Adverse Event|0|||
146661820|NCT02979197|528940049|FG000|Overall Study|Protocol Violation|0|||
146661821|NCT02979197|528940050|FG001|Overall Study|Protocol Violation|1|||
146661822|NCT02979197|528940051|FG002|Overall Study|Protocol Violation|0|||
146661823|NCT02979197|528940049|FG000|Overall Study|Subject unable to commit to study dates|0|||
146661824|NCT02979197|528940050|FG001|Overall Study|Subject unable to commit to study dates|1|||
146661825|NCT02979197|528940051|FG002|Overall Study|Subject unable to commit to study dates|0|||
146661826|NCT01631812|528940052|FG000|Overall Study|Adverse Event|25|||
146661827|NCT01631812|528940052|FG000|Overall Study|Lack of Efficacy|5|||
146661828|NCT01631812|528940052|FG000|Overall Study|Withdrawal by Subject|4|||
146661829|NCT01631812|528940052|FG000|Overall Study|Physician Decision|3|||
146661830|NCT02436681|528940053|FG000|Overall Study|Lost to Follow-up|10|||
146661831|NCT02436681|528940053|FG000|Overall Study|Withdrawal by Subject|2|||
146661832|NCT02436681|528940053|FG000|Overall Study|Death|2|||
146661833|NCT01414608|528940054|FG000|Overall Study|Ineligible|5|||
146661834|NCT01414608|528940055|FG001|Overall Study|Ineligible|2|||
146661835|NCT05156073|528940056|FG000|Overall Study|Patient canceled appointment with PCP|1|||
146661836|NCT00973349|528940057|FG000|Overall Study|Adverse Event|0|||
146661837|NCT00973349|528940058|FG001|Overall Study|Adverse Event|0|||
146661838|NCT00973349|528940059|FG002|Overall Study|Adverse Event|0|||
146661839|NCT00973349|528940060|FG003|Overall Study|Adverse Event|0|||
146661840|NCT00973349|528940061|FG004|Overall Study|Adverse Event|1|||
146661841|NCT00973349|528940062|FG005|Overall Study|Adverse Event|0|||
146661842|NCT00973349|528940063|FG006|Overall Study|Adverse Event|0|||
146661843|NCT00973349|528940064|FG007|Overall Study|Adverse Event|0|||
146661844|NCT00973349|528940065|FG008|Overall Study|Adverse Event|1|||
146661845|NCT00973349|528940066|FG009|Overall Study|Adverse Event|0|||
146661846|NCT00973349|528940067|FG010|Overall Study|Adverse Event|0|||
146661847|NCT00973349|528940068|FG011|Overall Study|Adverse Event|0|||
146661848|NCT00973349|528940069|FG012|Overall Study|Adverse Event|0|||
146661849|NCT00973349|528940070|FG013|Overall Study|Adverse Event|0|||
146661850|NCT00973349|528940071|FG014|Overall Study|Adverse Event|1|||
146661851|NCT00973349|528940072|FG015|Overall Study|Adverse Event|0|||
146661852|NCT00973349|528940057|FG000|Overall Study|Withdrawal by Subject|1|||
146661853|NCT00973349|528940058|FG001|Overall Study|Withdrawal by Subject|2|||
146661854|NCT00973349|528940059|FG002|Overall Study|Withdrawal by Subject|2|||
146661855|NCT00973349|528940060|FG003|Overall Study|Withdrawal by Subject|3|||
146661856|NCT00973349|528940061|FG004|Overall Study|Withdrawal by Subject|2|||
146661857|NCT00973349|528940062|FG005|Overall Study|Withdrawal by Subject|0|||
146661858|NCT00973349|528940063|FG006|Overall Study|Withdrawal by Subject|2|||
146661859|NCT00973349|528940064|FG007|Overall Study|Withdrawal by Subject|2|||
146661860|NCT00973349|528940065|FG008|Overall Study|Withdrawal by Subject|0|||
146661861|NCT00973349|528940066|FG009|Overall Study|Withdrawal by Subject|2|||
146661862|NCT00973349|528940067|FG010|Overall Study|Withdrawal by Subject|0|||
146925232|NCT00502320|529885981|FG000|Overall Study|Lost to Follow-up|1|||
146661863|NCT00973349|528940068|FG011|Overall Study|Withdrawal by Subject|1|||
146661864|NCT00973349|528940069|FG012|Overall Study|Withdrawal by Subject|0|||
146661865|NCT00973349|528940070|FG013|Overall Study|Withdrawal by Subject|0|||
146925233|NCT00502320|529885982|FG001|Overall Study|Lost to Follow-up|1|||
146661866|NCT00973349|528940071|FG014|Overall Study|Withdrawal by Subject|0|||
146925234|NCT00502320|529885981|FG000|Overall Study|Withdrew Consent|1|||
146925235|NCT00502320|529885982|FG001|Overall Study|Withdrew Consent|0|||
146661867|NCT00973349|528940072|FG015|Overall Study|Withdrawal by Subject|0|||
146661868|NCT00973349|528940057|FG000|Overall Study|Lost to Follow-up|3|||
146661869|NCT00973349|528940058|FG001|Overall Study|Lost to Follow-up|1|||
146661870|NCT00973349|528940059|FG002|Overall Study|Lost to Follow-up|2|||
146661871|NCT00973349|528940060|FG003|Overall Study|Lost to Follow-up|2|||
146661872|NCT00973349|528940061|FG004|Overall Study|Lost to Follow-up|1|||
146661873|NCT00973349|528940062|FG005|Overall Study|Lost to Follow-up|3|||
146661874|NCT00973349|528940063|FG006|Overall Study|Lost to Follow-up|0|||
146661875|NCT00973349|528940064|FG007|Overall Study|Lost to Follow-up|1|||
146661876|NCT00973349|528940065|FG008|Overall Study|Lost to Follow-up|2|||
146661877|NCT00973349|528940066|FG009|Overall Study|Lost to Follow-up|1|||
146661878|NCT00973349|528940067|FG010|Overall Study|Lost to Follow-up|0|||
146661879|NCT00973349|528940068|FG011|Overall Study|Lost to Follow-up|1|||
146661880|NCT00973349|528940069|FG012|Overall Study|Lost to Follow-up|0|||
146661881|NCT00973349|528940070|FG013|Overall Study|Lost to Follow-up|0|||
146661882|NCT00973349|528940071|FG014|Overall Study|Lost to Follow-up|0|||
146661883|NCT00973349|528940072|FG015|Overall Study|Lost to Follow-up|1|||
146661884|NCT00973349|528940057|FG000|Overall Study|Inappropriate enrolment|0|||
146661885|NCT00973349|528940058|FG001|Overall Study|Inappropriate enrolment|0|||
146661886|NCT00973349|528940059|FG002|Overall Study|Inappropriate enrolment|1|||
146661887|NCT00973349|528940060|FG003|Overall Study|Inappropriate enrolment|0|||
146661888|NCT00973349|528940061|FG004|Overall Study|Inappropriate enrolment|0|||
146661889|NCT00973349|528940062|FG005|Overall Study|Inappropriate enrolment|0|||
146661890|NCT00973349|528940063|FG006|Overall Study|Inappropriate enrolment|0|||
146661891|NCT00973349|528940064|FG007|Overall Study|Inappropriate enrolment|0|||
146661892|NCT00973349|528940065|FG008|Overall Study|Inappropriate enrolment|0|||
146661893|NCT00973349|528940066|FG009|Overall Study|Inappropriate enrolment|2|||
146661894|NCT00973349|528940067|FG010|Overall Study|Inappropriate enrolment|0|||
146661895|NCT00973349|528940068|FG011|Overall Study|Inappropriate enrolment|0|||
146661896|NCT00973349|528940069|FG012|Overall Study|Inappropriate enrolment|1|||
146661897|NCT00973349|528940070|FG013|Overall Study|Inappropriate enrolment|0|||
146661898|NCT00973349|528940071|FG014|Overall Study|Inappropriate enrolment|1|||
146661899|NCT00973349|528940072|FG015|Overall Study|Inappropriate enrolment|1|||
146661900|NCT00973349|528940057|FG000|Overall Study|Protocol Violation|0|||
146661901|NCT00973349|528940058|FG001|Overall Study|Protocol Violation|0|||
146661902|NCT00973349|528940059|FG002|Overall Study|Protocol Violation|0|||
146661903|NCT00973349|528940060|FG003|Overall Study|Protocol Violation|0|||
146661904|NCT00973349|528940061|FG004|Overall Study|Protocol Violation|0|||
146661905|NCT00973349|528940062|FG005|Overall Study|Protocol Violation|0|||
146661906|NCT00973349|528940063|FG006|Overall Study|Protocol Violation|0|||
146661907|NCT00973349|528940064|FG007|Overall Study|Protocol Violation|0|||
146661908|NCT00973349|528940065|FG008|Overall Study|Protocol Violation|1|||
146661909|NCT00973349|528940066|FG009|Overall Study|Protocol Violation|0|||
146661910|NCT00973349|528940067|FG010|Overall Study|Protocol Violation|0|||
146661911|NCT00973349|528940068|FG011|Overall Study|Protocol Violation|0|||
146661912|NCT00973349|528940069|FG012|Overall Study|Protocol Violation|0|||
146661913|NCT00973349|528940070|FG013|Overall Study|Protocol Violation|0|||
146661914|NCT00973349|528940071|FG014|Overall Study|Protocol Violation|0|||
146661915|NCT00973349|528940072|FG015|Overall Study|Protocol Violation|0|||
146661916|NCT00973349|528940057|FG000|Overall Study|Unable to classify|0|||
146661917|NCT00973349|528940058|FG001|Overall Study|Unable to classify|0|||
146661918|NCT00973349|528940059|FG002|Overall Study|Unable to classify|0|||
146661919|NCT00973349|528940060|FG003|Overall Study|Unable to classify|0|||
146661920|NCT00973349|528940061|FG004|Overall Study|Unable to classify|1|||
146661921|NCT00973349|528940062|FG005|Overall Study|Unable to classify|1|||
146661922|NCT00973349|528940063|FG006|Overall Study|Unable to classify|0|||
146661923|NCT00973349|528940064|FG007|Overall Study|Unable to classify|0|||
146661924|NCT00973349|528940065|FG008|Overall Study|Unable to classify|0|||
146661925|NCT00973349|528940066|FG009|Overall Study|Unable to classify|1|||
146661926|NCT00973349|528940067|FG010|Overall Study|Unable to classify|0|||
146661927|NCT00973349|528940068|FG011|Overall Study|Unable to classify|0|||
146661928|NCT00973349|528940069|FG012|Overall Study|Unable to classify|0|||
146661929|NCT00973349|528940070|FG013|Overall Study|Unable to classify|0|||
146661930|NCT00973349|528940071|FG014|Overall Study|Unable to classify|0|||
146661931|NCT00973349|528940072|FG015|Overall Study|Unable to classify|0|||
146661932|NCT05597020|528940076|FG000|Washout|Forbidden medication|2|||
146661933|NCT05597020|528940077|FG001|Washout|Forbidden medication|0|||
146661934|NCT05597020|528940076|FG000|Treatment Period II|Advice from primary care physician|1|||
146661935|NCT05597020|528940077|FG001|Treatment Period II|Advice from primary care physician|0|||
146661936|NCT05597020|528940076|FG000|Treatment Period II|Subject lost investigational product|1|||
146661937|NCT05597020|528940077|FG001|Treatment Period II|Subject lost investigational product|0|||
146661938|NCT05597020|528940076|FG000|Treatment Period II|Private reasons|0|||
146661939|NCT05597020|528940077|FG001|Treatment Period II|Private reasons|1|||
146661940|NCT05430022|528940078|FG000|Overall Study|Withdrawal by Subject|4|||
146661941|NCT05430022|528940079|FG001|Overall Study|Withdrawal by Subject|4|||
146661942|NCT02718300|528940082|FG000|Overall Study|Death|4|||
146661943|NCT02718300|528940083|FG001|Overall Study|Death|5|||
146925236|NCT00502320|529885981|FG000|Overall Study|No longer met criteria|1|||
146925237|NCT00502320|529885982|FG001|Overall Study|No longer met criteria|0|||
146617745|NCT00531284|528773102|FG006|Overall Study|Progressive Disease|3|||
146617746|NCT00531284|528773103|FG007|Overall Study|Progressive Disease|8|||
146617747|NCT00531284|528773104|FG008|Overall Study|Progressive Disease|6|||
146617748|NCT00531284|528773105|FG009|Overall Study|Progressive Disease|3|||
146617749|NCT00531284|528773106|FG010|Overall Study|Progressive Disease|3|||
146617750|NCT00531284|528773107|FG011|Overall Study|Progressive Disease|14|||
146617751|NCT00531284|528773108|FG012|Overall Study|Progressive Disease|2|||
146617752|NCT00531284|528773109|FG013|Overall Study|Progressive Disease|1|||
146617753|NCT00531284|528773110|FG014|Overall Study|Progressive Disease|2|||
146617754|NCT00531284|528773111|FG015|Overall Study|Progressive Disease|11|||
146617755|NCT00531284|528773112|FG016|Overall Study|Progressive Disease|5|||
146617756|NCT00531284|528773096|FG000|Overall Study|Adverse Event|0|||
146617757|NCT00531284|528773097|FG001|Overall Study|Adverse Event|1|||
146617758|NCT00531284|528773098|FG002|Overall Study|Adverse Event|1|||
146617759|NCT00531284|528773099|FG003|Overall Study|Adverse Event|7|||
146617760|NCT00531284|528773100|FG004|Overall Study|Adverse Event|0|||
146617761|NCT00531284|528773101|FG005|Overall Study|Adverse Event|2|||
146617762|NCT00531284|528773102|FG006|Overall Study|Adverse Event|3|||
146617763|NCT00531284|528773103|FG007|Overall Study|Adverse Event|2|||
146617764|NCT00531284|528773104|FG008|Overall Study|Adverse Event|3|||
146617765|NCT00531284|528773105|FG009|Overall Study|Adverse Event|0|||
146617766|NCT00531284|528773106|FG010|Overall Study|Adverse Event|0|||
146617767|NCT00531284|528773107|FG011|Overall Study|Adverse Event|5|||
146617768|NCT00531284|528773108|FG012|Overall Study|Adverse Event|0|||
146617769|NCT00531284|528773109|FG013|Overall Study|Adverse Event|1|||
146617770|NCT00531284|528773110|FG014|Overall Study|Adverse Event|1|||
146617771|NCT00531284|528773111|FG015|Overall Study|Adverse Event|0|||
146617772|NCT00531284|528773112|FG016|Overall Study|Adverse Event|2|||
146617773|NCT00531284|528773096|FG000|Overall Study|Withdrawal by Subject|1|||
146617774|NCT00531284|528773097|FG001|Overall Study|Withdrawal by Subject|0|||
146617775|NCT00531284|528773098|FG002|Overall Study|Withdrawal by Subject|0|||
146617776|NCT00531284|528773099|FG003|Overall Study|Withdrawal by Subject|4|||
146617777|NCT00531284|528773100|FG004|Overall Study|Withdrawal by Subject|0|||
146617778|NCT00531284|528773101|FG005|Overall Study|Withdrawal by Subject|0|||
146617779|NCT00531284|528773102|FG006|Overall Study|Withdrawal by Subject|0|||
146617780|NCT00531284|528773103|FG007|Overall Study|Withdrawal by Subject|0|||
146617781|NCT00531284|528773104|FG008|Overall Study|Withdrawal by Subject|0|||
146617782|NCT00531284|528773105|FG009|Overall Study|Withdrawal by Subject|0|||
146617783|NCT00531284|528773106|FG010|Overall Study|Withdrawal by Subject|0|||
146617784|NCT00531284|528773107|FG011|Overall Study|Withdrawal by Subject|3|||
146617785|NCT00531284|528773108|FG012|Overall Study|Withdrawal by Subject|0|||
146617786|NCT00531284|528773109|FG013|Overall Study|Withdrawal by Subject|1|||
146617787|NCT00531284|528773110|FG014|Overall Study|Withdrawal by Subject|0|||
146617788|NCT00531284|528773111|FG015|Overall Study|Withdrawal by Subject|1|||
146617789|NCT00531284|528773112|FG016|Overall Study|Withdrawal by Subject|1|||
146617790|NCT00531284|528773096|FG000|Overall Study|Other|1|||
146617791|NCT00531284|528773097|FG001|Overall Study|Other|0|||
146617792|NCT00531284|528773098|FG002|Overall Study|Other|0|||
146617793|NCT00531284|528773099|FG003|Overall Study|Other|10|||
146617794|NCT00531284|528773100|FG004|Overall Study|Other|2|||
146617795|NCT00531284|528773101|FG005|Overall Study|Other|1|||
146617796|NCT00531284|528773102|FG006|Overall Study|Other|0|||
146617797|NCT00531284|528773103|FG007|Overall Study|Other|0|||
146617798|NCT00531284|528773104|FG008|Overall Study|Other|2|||
146617799|NCT00531284|528773105|FG009|Overall Study|Other|1|||
146617800|NCT00531284|528773106|FG010|Overall Study|Other|0|||
146617801|NCT00531284|528773107|FG011|Overall Study|Other|2|||
146617802|NCT00531284|528773108|FG012|Overall Study|Other|0|||
146617803|NCT00531284|528773109|FG013|Overall Study|Other|0|||
146617804|NCT00531284|528773110|FG014|Overall Study|Other|1|||
146617805|NCT00531284|528773111|FG015|Overall Study|Other|0|||
146617806|NCT00531284|528773112|FG016|Overall Study|Other|0|||
146617807|NCT02219464|528773114|FG000|Overall Study|Withdrawal by Subject|1|||
146617808|NCT02219464|528773115|FG001|Overall Study|Withdrawal by Subject|0|||
146617809|NCT02219464|528773114|FG000|Overall Study|case cancelled|1|||
146617810|NCT02219464|528773115|FG001|Overall Study|case cancelled|0|||
146617811|NCT02219464|528773114|FG000|Overall Study|catheter malfunction|1|||
146617812|NCT02219464|528773115|FG001|Overall Study|catheter malfunction|0|||
146617813|NCT00984256|528773116|FG000|Overall Study|Withdrawal by Subject|0|||
146925238|NCT00502320|529885981|FG000|Overall Study|Screen Failure|0|||
146617814|NCT00984256|528773117|FG001|Overall Study|Withdrawal by Subject|1|||
146617815|NCT03493945|528773120|FG000|Phase I Dose Escalation|Ineligible|0|||
146617816|NCT03493945|528773121|FG001|Phase I Dose Escalation|Ineligible|0|||
146617817|NCT03493945|528773122|FG002|Phase I Dose Escalation|Ineligible|1|||
146617818|NCT03493945|528773123|FG003|Phase I Dose Escalation|Ineligible|0|||
146617819|NCT03493945|528773124|FG004|Phase I Dose Escalation|Ineligible|0|||
146617820|NCT03493945|528773125|FG005|Phase I Dose Escalation|Ineligible|0|||
146617821|NCT03493945|528773126|FG006|Phase I Dose Escalation|Ineligible|0|||
146661944|NCT02718300|528940084|FG002|Overall Study|Death|17|||
146661945|NCT02718300|528940082|FG000|Overall Study|Lost to Follow-up|1|||
146661946|NCT02718300|528940083|FG001|Overall Study|Lost to Follow-up|0|||
146661947|NCT02718300|528940084|FG002|Overall Study|Lost to Follow-up|2|||
146661948|NCT02718300|528940082|FG000|Overall Study|Physician Decision|1|||
146661949|NCT02718300|528940083|FG001|Overall Study|Physician Decision|0|||
146661950|NCT02718300|528940084|FG002|Overall Study|Physician Decision|2|||
146661951|NCT02718300|528940082|FG000|Overall Study|Study Terminated by Sponsor|6|||
146661952|NCT02718300|528940083|FG001|Overall Study|Study Terminated by Sponsor|3|||
146661953|NCT02718300|528940084|FG002|Overall Study|Study Terminated by Sponsor|4|||
146661954|NCT02718300|528940082|FG000|Overall Study|Withdrawal by Subject|0|||
146661955|NCT02718300|528940083|FG001|Overall Study|Withdrawal by Subject|4|||
146661956|NCT02718300|528940084|FG002|Overall Study|Withdrawal by Subject|3|||
146661957|NCT02718300|528940082|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
146661958|NCT02718300|528940083|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
146661959|NCT02718300|528940084|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
146661960|NCT02452697|528940085|FG000|Overall Study|Physician Decision|4|||
146661961|NCT02452697|528940086|FG001|Overall Study|Physician Decision|4|||
146661962|NCT02452697|528940087|FG002|Overall Study|Physician Decision|3|||
146661963|NCT02452697|528940088|FG003|Overall Study|Physician Decision|2|||
146661964|NCT02452697|528940085|FG000|Overall Study|Withdrawal by Subject|1|||
146661965|NCT02452697|528940086|FG001|Overall Study|Withdrawal by Subject|0|||
146661966|NCT02452697|528940087|FG002|Overall Study|Withdrawal by Subject|0|||
146661967|NCT02452697|528940088|FG003|Overall Study|Withdrawal by Subject|0|||
146661968|NCT02452697|528940085|FG000|Overall Study|still in follow-up|2|||
146661969|NCT02452697|528940086|FG001|Overall Study|still in follow-up|2|||
146661970|NCT02452697|528940087|FG002|Overall Study|still in follow-up|1|||
146661971|NCT02452697|528940088|FG003|Overall Study|still in follow-up|3|||
146661972|NCT00560885|528940091|FG000|Overall Study|Death|7|||
146661973|NCT00560885|528940091|FG000|Overall Study|Withdrawal by Subject|1|||
146661974|NCT02887859|528940092|FG000|Overall Study|Ongoing|6|||
146661975|NCT02887859|528940092|FG000|Overall Study|Adverse Event|7|||
146661976|NCT02887859|528940092|FG000|Overall Study|Death|1|||
146661977|NCT02887859|528940092|FG000|Overall Study|Physician Decision|1|||
146661978|NCT00257608|528942610|FG000|Chemotherapy Phase|Adverse Event|138|||
146661979|NCT00257608|528942611|FG001|Chemotherapy Phase|Adverse Event|0|||
146661980|NCT00257608|528942612|FG002|Chemotherapy Phase|Adverse Event|0|||
146661981|NCT00257608|528942610|FG000|Chemotherapy Phase|Disease progression|139|||
146661982|NCT00257608|528942611|FG001|Chemotherapy Phase|Disease progression|0|||
146661983|NCT00257608|528942612|FG002|Chemotherapy Phase|Disease progression|0|||
146661984|NCT00257608|528942610|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
146661985|NCT00257608|528942611|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
146661986|NCT00257608|528942612|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
146661987|NCT00257608|528942610|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
146661988|NCT00257608|528942611|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
146661989|NCT00257608|528942612|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
146661990|NCT00257608|528942610|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
146661991|NCT00257608|528942611|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
146661992|NCT00257608|528942612|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
146661993|NCT00257608|528942610|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
146661994|NCT00257608|528942611|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
146661995|NCT00257608|528942612|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
146661996|NCT00257608|528942610|FG000|Chemotherapy Phase|Physician Decision|28|||
146661997|NCT00257608|528942611|FG001|Chemotherapy Phase|Physician Decision|0|||
146661998|NCT00257608|528942612|FG002|Chemotherapy Phase|Physician Decision|0|||
146661999|NCT00257608|528942610|FG000|Post Chemotherapy Phase|Adverse Event|0|||
146662000|NCT00257608|528942611|FG001|Post Chemotherapy Phase|Adverse Event|34|||
146662001|NCT00257608|528942612|FG002|Post Chemotherapy Phase|Adverse Event|38|||
146662002|NCT00257608|528942610|FG000|Post Chemotherapy Phase|Disease progression|0|||
146662003|NCT00257608|528942611|FG001|Post Chemotherapy Phase|Disease progression|204|||
146662004|NCT00257608|528942612|FG002|Post Chemotherapy Phase|Disease progression|168|||
146662005|NCT00257608|528942610|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
146662006|NCT00257608|528942611|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
146925239|NCT00502320|529885982|FG001|Overall Study|Screen Failure|1|||
146925240|NCT00502320|529885981|FG000|Overall Study|Adverse Event|3|||
146662007|NCT00257608|528942612|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
146662008|NCT00257608|528942610|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
146662009|NCT00257608|528942611|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
146662010|NCT00257608|528942612|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
146662011|NCT00257608|528942610|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
146662012|NCT00257608|528942611|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
146662013|NCT00257608|528942612|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
146925241|NCT00502320|529885982|FG001|Overall Study|Adverse Event|5|||
146662014|NCT00257608|528942610|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
146662015|NCT00257608|528942611|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
146662016|NCT00257608|528942612|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
146662017|NCT00257608|528942610|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
146662018|NCT00257608|528942611|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
146662019|NCT00257608|528942612|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
146662020|NCT00257608|528942610|FG000|Post Chemotherapy Phase|Physician Decision|0|||
146662021|NCT00257608|528942611|FG001|Post Chemotherapy Phase|Physician Decision|8|||
146662022|NCT00257608|528942612|FG002|Post Chemotherapy Phase|Physician Decision|11|||
146662023|NCT00257608|528942610|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
146662024|NCT00257608|528942611|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
146662025|NCT00257608|528942612|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
146662026|NCT00257608|528942610|FG000|Post Chemotherapy Phase|Not treated|0|||
146662027|NCT00257608|528942611|FG001|Post Chemotherapy Phase|Not treated|4|||
146662028|NCT00257608|528942612|FG002|Post Chemotherapy Phase|Not treated|7|||
146662029|NCT00866788|528942613|FG000|Overall Study|Adverse Event|0|||
146662030|NCT00866788|528942614|FG001|Overall Study|Adverse Event|2|||
146662031|NCT00866788|528942615|FG002|Overall Study|Adverse Event|0|||
146662032|NCT00866788|528942616|FG003|Overall Study|Adverse Event|1|||
146662033|NCT00866788|528942613|FG000|Overall Study|Lost to Follow-up|1|||
146662034|NCT00866788|528942614|FG001|Overall Study|Lost to Follow-up|1|||
146662035|NCT00866788|528942615|FG002|Overall Study|Lost to Follow-up|0|||
146662036|NCT00866788|528942616|FG003|Overall Study|Lost to Follow-up|2|||
146662037|NCT00866788|528942613|FG000|Overall Study|Withdrawal by Subject|2|||
146662038|NCT00866788|528942614|FG001|Overall Study|Withdrawal by Subject|1|||
146662039|NCT00866788|528942615|FG002|Overall Study|Withdrawal by Subject|0|||
146662040|NCT00866788|528942616|FG003|Overall Study|Withdrawal by Subject|1|||
146662041|NCT00866788|528942613|FG000|Overall Study|Pregnancy|0|||
146662042|NCT00866788|528942614|FG001|Overall Study|Pregnancy|1|||
146662043|NCT00866788|528942615|FG002|Overall Study|Pregnancy|0|||
146662044|NCT00866788|528942616|FG003|Overall Study|Pregnancy|0|||
146662045|NCT00866788|528942613|FG000|Overall Study|Disease progression|3|||
146662046|NCT00866788|528942614|FG001|Overall Study|Disease progression|1|||
146662047|NCT00866788|528942615|FG002|Overall Study|Disease progression|1|||
146662048|NCT00866788|528942616|FG003|Overall Study|Disease progression|0|||
146662049|NCT00866788|528942613|FG000|Overall Study|Physician Decision|0|||
146662050|NCT00866788|528942614|FG001|Overall Study|Physician Decision|0|||
146662051|NCT00866788|528942615|FG002|Overall Study|Physician Decision|1|||
146662052|NCT00866788|528942616|FG003|Overall Study|Physician Decision|1|||
146662053|NCT01854658|528942617|FG000|Overall Study|Protocol Violation|6|||
146662054|NCT01854658|528942618|FG001|Overall Study|Protocol Violation|2|||
146662055|NCT01854658|528942619|FG002|Overall Study|Protocol Violation|2|||
146662056|NCT01854658|528942620|FG003|Overall Study|Protocol Violation|1|||
146662057|NCT01854658|528942617|FG000|Overall Study|Physician Decision|7|||
146662058|NCT01854658|528942618|FG001|Overall Study|Physician Decision|5|||
146662059|NCT01854658|528942619|FG002|Overall Study|Physician Decision|2|||
146662060|NCT01854658|528942620|FG003|Overall Study|Physician Decision|4|||
146662061|NCT01854658|528942617|FG000|Overall Study|Lost to Follow-up|8|||
146662062|NCT01854658|528942618|FG001|Overall Study|Lost to Follow-up|9|||
146662063|NCT01854658|528942619|FG002|Overall Study|Lost to Follow-up|8|||
146662064|NCT01854658|528942620|FG003|Overall Study|Lost to Follow-up|4|||
146662065|NCT01854658|528942617|FG000|Overall Study|Withdrawal by Subject|28|||
146662066|NCT01854658|528942618|FG001|Overall Study|Withdrawal by Subject|21|||
146662067|NCT01854658|528942619|FG002|Overall Study|Withdrawal by Subject|29|||
146662068|NCT01854658|528942620|FG003|Overall Study|Withdrawal by Subject|15|||
146662069|NCT01854658|528942617|FG000|Overall Study|Protocol-specified criteria|15|||
146662070|NCT01854658|528942618|FG001|Overall Study|Protocol-specified criteria|15|||
146662071|NCT01854658|528942619|FG002|Overall Study|Protocol-specified criteria|10|||
146662072|NCT01854658|528942620|FG003|Overall Study|Protocol-specified criteria|7|||
146662073|NCT01854658|528942617|FG000|Overall Study|Lack of Efficacy|3|||
146662074|NCT01854658|528942618|FG001|Overall Study|Lack of Efficacy|8|||
146662075|NCT01854658|528942619|FG002|Overall Study|Lack of Efficacy|4|||
146662076|NCT01854658|528942620|FG003|Overall Study|Lack of Efficacy|7|||
146662077|NCT01854658|528942617|FG000|Overall Study|Adverse Event|21|||
146662078|NCT01854658|528942618|FG001|Overall Study|Adverse Event|14|||
146662079|NCT01854658|528942619|FG002|Overall Study|Adverse Event|23|||
146662080|NCT01854658|528942620|FG003|Overall Study|Adverse Event|19|||
146662081|NCT01854658|528942617|FG000|Overall Study|Administrative reasons|5|||
146662082|NCT01854658|528942618|FG001|Overall Study|Administrative reasons|1|||
146662083|NCT01854658|528942619|FG002|Overall Study|Administrative reasons|2|||
146662084|NCT01854658|528942620|FG003|Overall Study|Administrative reasons|2|||
146662085|NCT01973569|528942626|FG000|Overall Study|Adverse Event|9|||
146662086|NCT01973569|528942627|FG001|Overall Study|Adverse Event|2|||
146662087|NCT01973569|528942628|FG002|Overall Study|Adverse Event|4|||
146925242|NCT02124707|529885989|FG000|Overall Study|Adverse Event|5|||
146662088|NCT01973569|528942626|FG000|Overall Study|Protocol Violation|2|||
146662089|NCT01973569|528942627|FG001|Overall Study|Protocol Violation|1|||
146925243|NCT02124707|529885989|FG000|Overall Study|Physician Decision|1|||
146662090|NCT01973569|528942628|FG002|Overall Study|Protocol Violation|3|||
146662091|NCT01973569|528942626|FG000|Overall Study|Withdrawal by Subject|7|||
146662092|NCT01973569|528942627|FG001|Overall Study|Withdrawal by Subject|5|||
146662093|NCT01973569|528942628|FG002|Overall Study|Withdrawal by Subject|2|||
146662094|NCT01973569|528942626|FG000|Overall Study|Invasive dental treatment|3|||
146662095|NCT01973569|528942627|FG001|Overall Study|Invasive dental treatment|5|||
146662096|NCT01973569|528942628|FG002|Overall Study|Invasive dental treatment|6|||
146662097|NCT01973569|528942626|FG000|Overall Study|Prohibited concomitant d|1|||
146662098|NCT01973569|528942627|FG001|Overall Study|Prohibited concomitant d|5|||
146662099|NCT01973569|528942628|FG002|Overall Study|Prohibited concomitant d|0|||
146662100|NCT01973569|528942626|FG000|Overall Study|Disease progression|0|||
146662101|NCT01973569|528942627|FG001|Overall Study|Disease progression|3|||
146662102|NCT01973569|528942628|FG002|Overall Study|Disease progression|0|||
146662103|NCT01973569|528942626|FG000|Overall Study|Other|1|||
146662104|NCT01973569|528942627|FG001|Overall Study|Other|1|||
146662105|NCT01973569|528942628|FG002|Overall Study|Other|0|||
146662106|NCT01973569|528942626|FG000|Overall Study|Did not receive study drug|6|||
146662107|NCT01973569|528942627|FG001|Overall Study|Did not receive study drug|3|||
146662108|NCT01973569|528942628|FG002|Overall Study|Did not receive study drug|3|||
146662109|NCT03793556|528942629|FG000|Overall Study|Withdrawal by Subject|12|||
146662110|NCT03793556|528942630|FG001|Overall Study|Withdrawal by Subject|1|||
146662111|NCT03793556|528942629|FG000|Overall Study|Lost to Follow-up|1|||
146662112|NCT03793556|528942630|FG001|Overall Study|Lost to Follow-up|1|||
146662113|NCT04416633|528942633|FG000|Overall Study|Death|1|||
146662114|NCT04416633|528942633|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
146662115|NCT04416633|528942633|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
146662116|NCT04416633|528942633|FG000|Overall Study|Adverse Event|6|||
146662117|NCT04416633|528942633|FG000|Overall Study|Withdrawal by Subject|6|||
146662118|NCT00785928|528942634|FG000|Treatment Phase|Adverse Event|1|||
146662119|NCT00785928|528942635|FG001|Treatment Phase|Adverse Event|1|||
146662120|NCT00785928|528942636|FG002|Treatment Phase|Adverse Event|2|||
146662121|NCT00785928|528942637|FG003|Treatment Phase|Adverse Event|0|||
146662122|NCT00785928|528942638|FG004|Treatment Phase|Adverse Event|0|||
146662123|NCT00785928|528942639|FG005|Treatment Phase|Adverse Event|0|||
146662124|NCT00785928|528942640|FG006|Treatment Phase|Adverse Event|2|||
146662125|NCT00785928|528942634|FG000|Treatment Phase|Inadequate Response|0|||
146662126|NCT00785928|528942635|FG001|Treatment Phase|Inadequate Response|1|||
146662127|NCT00785928|528942636|FG002|Treatment Phase|Inadequate Response|0|||
146662128|NCT00785928|528942637|FG003|Treatment Phase|Inadequate Response|0|||
146662129|NCT00785928|528942638|FG004|Treatment Phase|Inadequate Response|0|||
146662130|NCT00785928|528942639|FG005|Treatment Phase|Inadequate Response|0|||
146662131|NCT00785928|528942640|FG006|Treatment Phase|Inadequate Response|0|||
146662132|NCT00785928|528942634|FG000|Treatment Phase|Lack of Efficacy|0|||
146662133|NCT00785928|528942635|FG001|Treatment Phase|Lack of Efficacy|1|||
146662134|NCT00785928|528942636|FG002|Treatment Phase|Lack of Efficacy|1|||
146662135|NCT00785928|528942637|FG003|Treatment Phase|Lack of Efficacy|0|||
146662136|NCT00785928|528942638|FG004|Treatment Phase|Lack of Efficacy|0|||
146662137|NCT00785928|528942639|FG005|Treatment Phase|Lack of Efficacy|0|||
146662138|NCT00785928|528942640|FG006|Treatment Phase|Lack of Efficacy|0|||
146662139|NCT00785928|528942634|FG000|Treatment Phase|Physician Decision|0|||
146662140|NCT00785928|528942635|FG001|Treatment Phase|Physician Decision|0|||
146662141|NCT00785928|528942636|FG002|Treatment Phase|Physician Decision|0|||
146662142|NCT00785928|528942637|FG003|Treatment Phase|Physician Decision|0|||
146662143|NCT00785928|528942638|FG004|Treatment Phase|Physician Decision|1|||
146662144|NCT00785928|528942639|FG005|Treatment Phase|Physician Decision|0|||
146662145|NCT00785928|528942640|FG006|Treatment Phase|Physician Decision|0|||
146662146|NCT00785928|528942634|FG000|Treatment Phase|Sponsor Decision|1|||
146662147|NCT00785928|528942635|FG001|Treatment Phase|Sponsor Decision|0|||
146662148|NCT00785928|528942636|FG002|Treatment Phase|Sponsor Decision|0|||
146662149|NCT00785928|528942637|FG003|Treatment Phase|Sponsor Decision|0|||
146662150|NCT00785928|528942638|FG004|Treatment Phase|Sponsor Decision|0|||
146662151|NCT00785928|528942639|FG005|Treatment Phase|Sponsor Decision|0|||
146662152|NCT00785928|528942640|FG006|Treatment Phase|Sponsor Decision|1|||
146662153|NCT00785928|528942634|FG000|Treatment Phase|Withdrawal by Subject|1|||
146662154|NCT00785928|528942635|FG001|Treatment Phase|Withdrawal by Subject|2|||
146662155|NCT00785928|528942636|FG002|Treatment Phase|Withdrawal by Subject|0|||
146662156|NCT00785928|528942637|FG003|Treatment Phase|Withdrawal by Subject|0|||
146662157|NCT00785928|528942638|FG004|Treatment Phase|Withdrawal by Subject|1|||
146662158|NCT00785928|528942639|FG005|Treatment Phase|Withdrawal by Subject|0|||
146662159|NCT00785928|528942640|FG006|Treatment Phase|Withdrawal by Subject|0|||
146662160|NCT05021081|528942647|FG000|Phase 2|Subject enrolled in error|1|||
146662161|NCT05021081|528942648|FG001|Phase 2|Subject enrolled in error|1|||
146662162|NCT05021081|528942649|FG002|Phase 2|Subject enrolled in error|0|||
146662163|NCT00809354|528942655|FG000|Overall Study|Adverse Event|32|||
146662164|NCT00809354|528942656|FG001|Overall Study|Adverse Event|45|||
146662165|NCT00809354|528942657|FG002|Overall Study|Adverse Event|37|||
146662166|NCT00809354|528942658|FG003|Overall Study|Adverse Event|53|||
146662167|NCT00809354|528942659|FG004|Overall Study|Adverse Event|26|||
146925244|NCT02124707|529885989|FG000|Overall Study|Death|1|||
146925245|NCT00781599|529885990|FG000|Overall Study|Lost to Follow-up|7|||
146925246|NCT00781599|529885991|FG001|Overall Study|Lost to Follow-up|4|||
146925247|NCT01088438|529885997|FG000|Overall Study|Withdrawal by Subject|11|||
146662168|NCT00809354|528942660|FG005|Overall Study|Adverse Event|33|||
146662169|NCT00809354|528942661|FG006|Overall Study|Adverse Event|44|||
146662170|NCT00809354|528942662|FG007|Overall Study|Adverse Event|40|||
146662171|NCT00809354|528942663|FG008|Overall Study|Adverse Event|46|||
146662172|NCT00809354|528942664|FG009|Overall Study|Adverse Event|26|||
146662173|NCT00809354|528942655|FG000|Overall Study|Lack of Efficacy|23|||
146662174|NCT00809354|528942656|FG001|Overall Study|Lack of Efficacy|23|||
146662175|NCT00809354|528942657|FG002|Overall Study|Lack of Efficacy|22|||
146662176|NCT00809354|528942658|FG003|Overall Study|Lack of Efficacy|15|||
146662177|NCT00809354|528942659|FG004|Overall Study|Lack of Efficacy|40|||
146662178|NCT00809354|528942660|FG005|Overall Study|Lack of Efficacy|19|||
146662179|NCT00809354|528942661|FG006|Overall Study|Lack of Efficacy|21|||
146662180|NCT00809354|528942662|FG007|Overall Study|Lack of Efficacy|15|||
146662181|NCT00809354|528942663|FG008|Overall Study|Lack of Efficacy|18|||
146662182|NCT00809354|528942664|FG009|Overall Study|Lack of Efficacy|38|||
146662183|NCT00809354|528942655|FG000|Overall Study|Lost to Follow-up|10|||
146662184|NCT00809354|528942656|FG001|Overall Study|Lost to Follow-up|11|||
146662185|NCT00809354|528942657|FG002|Overall Study|Lost to Follow-up|8|||
146662186|NCT00809354|528942658|FG003|Overall Study|Lost to Follow-up|13|||
146662187|NCT00809354|528942659|FG004|Overall Study|Lost to Follow-up|6|||
146662188|NCT00809354|528942660|FG005|Overall Study|Lost to Follow-up|2|||
146662189|NCT00809354|528942661|FG006|Overall Study|Lost to Follow-up|0|||
146662190|NCT00809354|528942662|FG007|Overall Study|Lost to Follow-up|5|||
146662191|NCT00809354|528942663|FG008|Overall Study|Lost to Follow-up|4|||
146662192|NCT00809354|528942664|FG009|Overall Study|Lost to Follow-up|0|||
146662193|NCT00809354|528942655|FG000|Overall Study|Protocol Violation|7|||
146662194|NCT00809354|528942656|FG001|Overall Study|Protocol Violation|14|||
146662195|NCT00809354|528942657|FG002|Overall Study|Protocol Violation|14|||
146662196|NCT00809354|528942658|FG003|Overall Study|Protocol Violation|12|||
146662197|NCT00809354|528942659|FG004|Overall Study|Protocol Violation|14|||
146662198|NCT00809354|528942660|FG005|Overall Study|Protocol Violation|6|||
146662199|NCT00809354|528942661|FG006|Overall Study|Protocol Violation|4|||
146662200|NCT00809354|528942662|FG007|Overall Study|Protocol Violation|6|||
146662201|NCT00809354|528942663|FG008|Overall Study|Protocol Violation|9|||
146662202|NCT00809354|528942664|FG009|Overall Study|Protocol Violation|3|||
146662203|NCT00809354|528942655|FG000|Overall Study|Withdrawal by Subject|32|||
146662204|NCT00809354|528942656|FG001|Overall Study|Withdrawal by Subject|27|||
146662205|NCT00809354|528942657|FG002|Overall Study|Withdrawal by Subject|31|||
146662206|NCT00809354|528942658|FG003|Overall Study|Withdrawal by Subject|33|||
146662207|NCT00809354|528942659|FG004|Overall Study|Withdrawal by Subject|34|||
146662208|NCT00809354|528942660|FG005|Overall Study|Withdrawal by Subject|29|||
146662209|NCT00809354|528942661|FG006|Overall Study|Withdrawal by Subject|27|||
146662210|NCT00809354|528942662|FG007|Overall Study|Withdrawal by Subject|19|||
146662211|NCT00809354|528942663|FG008|Overall Study|Withdrawal by Subject|18|||
146662212|NCT00809354|528942664|FG009|Overall Study|Withdrawal by Subject|20|||
146662213|NCT00809354|528942655|FG000|Overall Study|Other|10|||
146662214|NCT00809354|528942656|FG001|Overall Study|Other|2|||
146662215|NCT00809354|528942657|FG002|Overall Study|Other|7|||
146662216|NCT00809354|528942658|FG003|Overall Study|Other|10|||
146662217|NCT00809354|528942659|FG004|Overall Study|Other|5|||
146662218|NCT00809354|528942660|FG005|Overall Study|Other|3|||
146662219|NCT00809354|528942661|FG006|Overall Study|Other|2|||
146662220|NCT00809354|528942662|FG007|Overall Study|Other|3|||
146662221|NCT00809354|528942663|FG008|Overall Study|Other|4|||
146662222|NCT00809354|528942664|FG009|Overall Study|Other|3|||
146662223|NCT00809354|528942655|FG000|Overall Study|Study terminated by sponsor|138|||
146662224|NCT00809354|528942656|FG001|Overall Study|Study terminated by sponsor|134|||
146662225|NCT00809354|528942657|FG002|Overall Study|Study terminated by sponsor|129|||
146662226|NCT00809354|528942658|FG003|Overall Study|Study terminated by sponsor|120|||
146662227|NCT00809354|528942659|FG004|Overall Study|Study terminated by sponsor|126|||
146662228|NCT00809354|528942660|FG005|Overall Study|Study terminated by sponsor|133|||
146662229|NCT00809354|528942661|FG006|Overall Study|Study terminated by sponsor|124|||
146662230|NCT00809354|528942662|FG007|Overall Study|Study terminated by sponsor|148|||
146662231|NCT00809354|528942663|FG008|Overall Study|Study terminated by sponsor|127|||
146662232|NCT00809354|528942664|FG009|Overall Study|Study terminated by sponsor|135|||
146662233|NCT00809354|528942655|FG000|Overall Study|Withdrawn due to pregnancy|0|||
146662234|NCT00809354|528942656|FG001|Overall Study|Withdrawn due to pregnancy|1|||
146662235|NCT00809354|528942657|FG002|Overall Study|Withdrawn due to pregnancy|0|||
146662236|NCT00809354|528942658|FG003|Overall Study|Withdrawn due to pregnancy|0|||
146662237|NCT00809354|528942659|FG004|Overall Study|Withdrawn due to pregnancy|0|||
146662238|NCT00809354|528942660|FG005|Overall Study|Withdrawn due to pregnancy|0|||
146662239|NCT00809354|528942661|FG006|Overall Study|Withdrawn due to pregnancy|0|||
146662240|NCT00809354|528942662|FG007|Overall Study|Withdrawn due to pregnancy|0|||
146662241|NCT00809354|528942663|FG008|Overall Study|Withdrawn due to pregnancy|0|||
146662242|NCT00809354|528942664|FG009|Overall Study|Withdrawn due to pregnancy|0|||
146925248|NCT01088438|529885998|FG001|Overall Study|Withdrawal by Subject|6|||
146662243|NCT00809354|528942655|FG000|Overall Study|Randomized but not Treated|3|||
146662244|NCT00809354|528942656|FG001|Overall Study|Randomized but not Treated|1|||
146662245|NCT00809354|528942657|FG002|Overall Study|Randomized but not Treated|6|||
146662246|NCT00809354|528942658|FG003|Overall Study|Randomized but not Treated|0|||
146662247|NCT00809354|528942659|FG004|Overall Study|Randomized but not Treated|5|||
146662248|NCT00809354|528942660|FG005|Overall Study|Randomized but not Treated|0|||
146662249|NCT00809354|528942661|FG006|Overall Study|Randomized but not Treated|1|||
146662250|NCT00809354|528942662|FG007|Overall Study|Randomized but not Treated|1|||
146662251|NCT00809354|528942663|FG008|Overall Study|Randomized but not Treated|2|||
146662252|NCT00809354|528942664|FG009|Overall Study|Randomized but not Treated|1|||
146662253|NCT00809354|528942655|FG000|Overall Study|Death|0|||
146662254|NCT00809354|528942656|FG001|Overall Study|Death|0|||
146662255|NCT00809354|528942657|FG002|Overall Study|Death|0|||
146662256|NCT00809354|528942658|FG003|Overall Study|Death|0|||
146662257|NCT00809354|528942659|FG004|Overall Study|Death|0|||
146662258|NCT00809354|528942660|FG005|Overall Study|Death|0|||
146662259|NCT00809354|528942661|FG006|Overall Study|Death|0|||
146662260|NCT00809354|528942662|FG007|Overall Study|Death|1|||
146662261|NCT00809354|528942663|FG008|Overall Study|Death|0|||
146662262|NCT00809354|528942664|FG009|Overall Study|Death|0|||
146662263|NCT02477839|528942667|FG000|Overall Study|Adverse Event|0|||
146662264|NCT02477839|528942668|FG001|Overall Study|Adverse Event|1|||
146662265|NCT02477839|528942667|FG000|Overall Study|Protocol Violation|0|||
146662266|NCT02477839|528942668|FG001|Overall Study|Protocol Violation|2|||
146662267|NCT02477839|528942667|FG000|Overall Study|Withdrawal by Subject|3|||
146662268|NCT02477839|528942668|FG001|Overall Study|Withdrawal by Subject|3|||
146662269|NCT02477839|528942667|FG000|Overall Study|Participant had PGS during V6|0|||
146662270|NCT02477839|528942668|FG001|Overall Study|Participant had PGS during V6|1|||
146662271|NCT02477839|528942667|FG000|Overall Study|Parents decided to stop medication|0|||
146662272|NCT02477839|528942668|FG001|Overall Study|Parents decided to stop medication|1|||
146662273|NCT02477839|528942667|FG000|Overall Study|Lack of tolerability|0|||
146662274|NCT02477839|528942668|FG001|Overall Study|Lack of tolerability|1|||
146662275|NCT02477839|528942667|FG000|Overall Study|Exclusion criterion|0|||
146662276|NCT02477839|528942668|FG001|Overall Study|Exclusion criterion|1|||
146662277|NCT02607930|528942671|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
146662278|NCT02607930|528942672|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
146662279|NCT02607930|528942673|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
146662280|NCT02607930|528942674|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
146662281|NCT02607930|528942671|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
146662282|NCT02607930|528942672|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
146662283|NCT02607930|528942673|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
146662284|NCT02607930|528942674|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
146662285|NCT02607930|528942671|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
146662286|NCT02607930|528942672|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
146662287|NCT02607930|528942673|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
146662288|NCT02607930|528942674|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
146662289|NCT02607930|528942671|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
146662290|NCT02607930|528942672|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
146662291|NCT02607930|528942673|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
146662292|NCT02607930|528942674|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
146662293|NCT02607930|528942671|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
146662294|NCT02607930|528942672|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
146662295|NCT02607930|528942673|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
146662296|NCT02607930|528942674|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
146662297|NCT02607930|528942671|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
146662298|NCT02607930|528942672|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
146662299|NCT02607930|528942673|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
146662300|NCT02607930|528942674|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
146662301|NCT02607930|528942671|FG000|Double-Blinded Treatment Phase|Death|2|||
146662302|NCT02607930|528942672|FG001|Double-Blinded Treatment Phase|Death|1|||
146925249|NCT01088438|529885997|FG000|Overall Study|Lost to Follow-up|18|||
146925250|NCT01088438|529885998|FG001|Overall Study|Lost to Follow-up|30|||
146662303|NCT02607930|528942673|FG002|Double-Blinded Treatment Phase|Death|0|||
146662304|NCT02607930|528942674|FG003|Double-Blinded Treatment Phase|Death|0|||
146662305|NCT02607930|528942671|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
146662306|NCT02607930|528942672|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
146662307|NCT02607930|528942673|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
146662308|NCT02607930|528942674|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
146662309|NCT02607930|528942671|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
146662310|NCT02607930|528942672|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
146662311|NCT02607930|528942673|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
146662312|NCT02607930|528942674|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
146925251|NCT01363713|529885999|FG000|Overall Study|Adverse Event|1|||
146662313|NCT02607930|528942671|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
146662314|NCT02607930|528942672|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
146662315|NCT02607930|528942673|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
146662316|NCT02607930|528942674|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
146662317|NCT02607930|528942671|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
146662318|NCT02607930|528942672|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
146662319|NCT02607930|528942673|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
146662320|NCT02607930|528942674|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
146662321|NCT02607930|528942671|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
146662322|NCT02607930|528942672|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
146662323|NCT02607930|528942673|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
146662324|NCT02607930|528942674|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
146662325|NCT02607930|528942671|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
146662326|NCT02607930|528942672|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
146662327|NCT02607930|528942673|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
146662328|NCT02607930|528942674|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
146662329|NCT02607930|528942671|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
146662330|NCT02607930|528942672|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
146662331|NCT02607930|528942673|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
146662332|NCT02607930|528942674|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
146662333|NCT02607930|528942671|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
146662334|NCT02607930|528942672|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
146662335|NCT02607930|528942673|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
146662336|NCT02607930|528942674|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
146662337|NCT02607930|528942671|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
146662338|NCT02607930|528942672|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
146662339|NCT02607930|528942673|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
146662340|NCT02607930|528942674|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
146662341|NCT01050543|528942675|FG000|Overall Study|Withdrawal by Subject|0|||
146662342|NCT01050543|528942676|FG001|Overall Study|Withdrawal by Subject|2|||
146662343|NCT01050543|528942675|FG000|Overall Study|Protocol Violation|0|||
146662344|NCT01050543|528942676|FG001|Overall Study|Protocol Violation|1|||
146662345|NCT01050543|528942675|FG000|Overall Study|Administrative|4|||
146662346|NCT01050543|528942676|FG001|Overall Study|Administrative|1|||
146662347|NCT03053271|528942679|FG000|Overall Study|Did not meet randomization criteria|3|||
146662348|NCT03053271|528942679|FG000|Overall Study|Withdrawal by Subject|1|||
146662349|NCT00570765|528942680|FG000|DB Phase|Withdrawal by Subject|1|||
146662350|NCT00570765|528942681|FG001|DB Phase|Withdrawal by Subject|0|||
146662351|NCT00570765|528942682|FG002|DB Phase|Withdrawal by Subject|0|||
146662352|NCT00570765|528942683|FG003|DB Phase|Withdrawal by Subject|0|||
146662353|NCT00570765|528942680|FG000|DB Phase|Protocol Violation|0|||
146662354|NCT00570765|528942681|FG001|DB Phase|Protocol Violation|1|||
146662355|NCT00570765|528942682|FG002|DB Phase|Protocol Violation|0|||
146662356|NCT00570765|528942683|FG003|DB Phase|Protocol Violation|0|||
146662357|NCT00570765|528942680|FG000|DB Phase|Adverse Event|3|||
146662358|NCT00570765|528942681|FG001|DB Phase|Adverse Event|6|||
146662359|NCT00570765|528942682|FG002|DB Phase|Adverse Event|0|||
146662360|NCT00570765|528942683|FG003|DB Phase|Adverse Event|0|||
146662361|NCT00570765|528942680|FG000|DB Phase|Did Not Receive Study Drug|0|||
146662362|NCT00570765|528942681|FG001|DB Phase|Did Not Receive Study Drug|0|||
146662363|NCT00570765|528942682|FG002|DB Phase|Did Not Receive Study Drug|1|||
146662364|NCT00570765|528942683|FG003|DB Phase|Did Not Receive Study Drug|0|||
146662365|NCT00570765|528942680|FG000|LTSE Phase|Withdrawal by Subject|0|||
146662366|NCT00570765|528942681|FG001|LTSE Phase|Withdrawal by Subject|0|||
146662367|NCT00570765|528942682|FG002|LTSE Phase|Withdrawal by Subject|0|||
146662368|NCT00570765|528942683|FG003|LTSE Phase|Withdrawal by Subject|1|||
146662369|NCT00570765|528942680|FG000|LTSE Phase|Adverse Event|0|||
146662370|NCT00570765|528942681|FG001|LTSE Phase|Adverse Event|0|||
146662371|NCT00570765|528942682|FG002|LTSE Phase|Adverse Event|0|||
146662372|NCT00570765|528942683|FG003|LTSE Phase|Adverse Event|7|||
146662373|NCT00570765|528942680|FG000|LTSE Phase|Physician Decision|0|||
146662374|NCT00570765|528942681|FG001|LTSE Phase|Physician Decision|0|||
146662375|NCT00570765|528942682|FG002|LTSE Phase|Physician Decision|0|||
146662376|NCT00570765|528942683|FG003|LTSE Phase|Physician Decision|4|||
146662377|NCT02517866|528942684|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
146662378|NCT02517866|528942685|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
146662379|NCT02517866|528942686|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
146662380|NCT02517866|528942684|FG000|Overall Study|Significant Protocol Deviation|4|||
146662381|NCT02517866|528942685|FG001|Overall Study|Significant Protocol Deviation|1|||
146662382|NCT02517866|528942686|FG002|Overall Study|Significant Protocol Deviation|0|||
146662383|NCT02517866|528942684|FG000|Overall Study|Lost to Follow-up|1|||
146662384|NCT02517866|528942685|FG001|Overall Study|Lost to Follow-up|0|||
146662385|NCT02517866|528942686|FG002|Overall Study|Lost to Follow-up|0|||
146662386|NCT02517866|528942684|FG000|Overall Study|Voluntary Withdrawal|2|||
146662387|NCT02517866|528942685|FG001|Overall Study|Voluntary Withdrawal|2|||
146662388|NCT02517866|528942686|FG002|Overall Study|Voluntary Withdrawal|0|||
146662389|NCT02517866|528942684|FG000|Overall Study|Investigator Decision|2|||
146662390|NCT02517866|528942685|FG001|Overall Study|Investigator Decision|1|||
146662391|NCT02517866|528942686|FG002|Overall Study|Investigator Decision|0|||
146662392|NCT02517866|528942684|FG000|Overall Study|Reason not specified|2|||
146662393|NCT02517866|528942685|FG001|Overall Study|Reason not specified|0|||
146662394|NCT02517866|528942686|FG002|Overall Study|Reason not specified|0|||
146662395|NCT03114488|528942688|FG000|Time Period 2|Withdrawal by Subject|1|||
146662396|NCT03114488|528942689|FG001|Time Period 2|Withdrawal by Subject|3|||
146662397|NCT03711266|528942691|FG000|Overall Study|Lost to Follow-up|10|||
146662398|NCT01954342|528942692|FG000|Overall Study|Missing data from 13-16week study visit|0|||
146662399|NCT01954342|528942693|FG001|Overall Study|Missing data from 13-16week study visit|0|||
146662400|NCT01954342|528942694|FG002|Overall Study|Missing data from 13-16week study visit|0|||
146662401|NCT01954342|528942695|FG003|Overall Study|Missing data from 13-16week study visit|1|||
146662402|NCT01954342|528942692|FG000|Overall Study|Miscarriage|0|||
146662403|NCT01954342|528942693|FG001|Overall Study|Miscarriage|0|||
146662404|NCT01954342|528942694|FG002|Overall Study|Miscarriage|0|||
146662405|NCT01954342|528942695|FG003|Overall Study|Miscarriage|3|||
146662406|NCT01954342|528942692|FG000|Overall Study|Lost to Follow-up|0|||
146662407|NCT01954342|528942693|FG001|Overall Study|Lost to Follow-up|0|||
146662408|NCT01954342|528942694|FG002|Overall Study|Lost to Follow-up|0|||
146662409|NCT01954342|528942695|FG003|Overall Study|Lost to Follow-up|5|||
146662410|NCT01954342|528942692|FG000|Overall Study|Preterm delivery|0|||
146662411|NCT01954342|528942693|FG001|Overall Study|Preterm delivery|0|||
146662412|NCT01954342|528942694|FG002|Overall Study|Preterm delivery|0|||
146662413|NCT01954342|528942695|FG003|Overall Study|Preterm delivery|3|||
146662414|NCT01954342|528942692|FG000|Overall Study|Pre-eclampsia|0|||
146662415|NCT01954342|528942693|FG001|Overall Study|Pre-eclampsia|0|||
146662416|NCT01954342|528942694|FG002|Overall Study|Pre-eclampsia|0|||
146662417|NCT01954342|528942695|FG003|Overall Study|Pre-eclampsia|4|||
146662418|NCT01954342|528942692|FG000|Overall Study|Unreliable Data|0|||
146662419|NCT01954342|528942693|FG001|Overall Study|Unreliable Data|0|||
146662420|NCT01954342|528942694|FG002|Overall Study|Unreliable Data|0|||
146662421|NCT01954342|528942695|FG003|Overall Study|Unreliable Data|2|||
146662422|NCT01646073|528942696|FG000|Period A (12 Weeks)|Adverse Event|0|||
146662423|NCT01646073|528942697|FG001|Period A (12 Weeks)|Adverse Event|2|||
146662424|NCT01646073|528942696|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
146662425|NCT01646073|528942697|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
146662426|NCT01646073|528942696|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
146662427|NCT01646073|528942697|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
146662428|NCT01646073|528942696|FG000|Period A (12 Weeks)|Protocol Violation|0|||
146662429|NCT01646073|528942697|FG001|Period A (12 Weeks)|Protocol Violation|1|||
146662430|NCT01646073|528942696|FG000|Period A (12 Weeks)|Other|0|||
146662431|NCT01646073|528942697|FG001|Period A (12 Weeks)|Other|1|||
146662432|NCT01646073|528942696|FG000|Period B (12 Weeks)|Adverse Event|0|||
146662433|NCT01646073|528942697|FG001|Period B (12 Weeks)|Adverse Event|7|||
146662434|NCT01646073|528942696|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
146662435|NCT01646073|528942697|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
146662436|NCT01646073|528942696|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
146662437|NCT01646073|528942697|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
146662438|NCT05095454|528942700|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
146662439|NCT05095454|528942701|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
146662440|NCT00057876|528942702|FG000|Overall Study|Adverse Event|8|||
146662441|NCT00057876|528942703|FG001|Overall Study|Adverse Event|8|||
146662442|NCT00057876|528942702|FG000|Overall Study|Death|2|||
146662443|NCT00057876|528942703|FG001|Overall Study|Death|1|||
146662444|NCT00057876|528942702|FG000|Overall Study|Withdrawal by Subject|5|||
146662445|NCT00057876|528942703|FG001|Overall Study|Withdrawal by Subject|6|||
146662446|NCT00057876|528942702|FG000|Overall Study|Lack of Efficacy|10|||
146662447|NCT00057876|528942703|FG001|Overall Study|Lack of Efficacy|8|||
146662448|NCT00057876|528942702|FG000|Overall Study|Ineligible|1|||
146662449|NCT00057876|528942703|FG001|Overall Study|Ineligible|2|||
146662450|NCT00057876|528942702|FG000|Overall Study|other reason|2|||
146662451|NCT00057876|528942703|FG001|Overall Study|other reason|2|||
146662452|NCT00057876|528942702|FG000|Overall Study|other complicating disease|1|||
146662453|NCT00057876|528942703|FG001|Overall Study|other complicating disease|0|||
146662454|NCT00679055|528942704|FG000|Overall Study|Adverse Event|0|||
146662455|NCT00679055|528942705|FG001|Overall Study|Adverse Event|1|||
146662456|NCT00679055|528942704|FG000|Overall Study|Other|0|||
146662457|NCT00679055|528942705|FG001|Overall Study|Other|3|||
146662458|NCT00679055|528942704|FG000|Overall Study|Study Terminated|2|||
146662459|NCT00679055|528942705|FG001|Overall Study|Study Terminated|1|||
146662460|NCT02758171|528942706|FG000|Wash-out|Withdrawal by Subject|1|||
146662461|NCT02758171|528942707|FG001|Wash-out|Withdrawal by Subject|0|||
146662462|NCT02758171|528942706|FG000|Wash-out|Other reason|1|||
146662463|NCT02758171|528942707|FG001|Wash-out|Other reason|0|||
146662464|NCT00853073|528942708|FG000|Overall Study|Withdrawal by Subject|3|||
146925252|NCT01363713|529885999|FG000|Overall Study|Protocol Violation|3|||
146662465|NCT00853073|528942709|FG001|Overall Study|Withdrawal by Subject|2|||
146662466|NCT01999114|528942710|FG000|Overall Study|Adverse Event|8|||
146662467|NCT01999114|528942711|FG001|Overall Study|Adverse Event|7|||
146662468|NCT01999114|528942712|FG002|Overall Study|Adverse Event|2|||
146662469|NCT01999114|528942713|FG003|Overall Study|Adverse Event|2|||
146662470|NCT01999114|528942714|FG004|Overall Study|Adverse Event|1|||
146662471|NCT01999114|528942710|FG000|Overall Study|Withdrawal by Subject|0|||
146662472|NCT01999114|528942711|FG001|Overall Study|Withdrawal by Subject|0|||
146662473|NCT01999114|528942712|FG002|Overall Study|Withdrawal by Subject|1|||
146662474|NCT01999114|528942713|FG003|Overall Study|Withdrawal by Subject|0|||
146662475|NCT01999114|528942714|FG004|Overall Study|Withdrawal by Subject|1|||
146662476|NCT01999114|528942710|FG000|Overall Study|Lost to Follow-up|0|||
146662477|NCT01999114|528942711|FG001|Overall Study|Lost to Follow-up|0|||
146662478|NCT01999114|528942712|FG002|Overall Study|Lost to Follow-up|1|||
146662479|NCT01999114|528942713|FG003|Overall Study|Lost to Follow-up|0|||
146662480|NCT01999114|528942714|FG004|Overall Study|Lost to Follow-up|0|||
146662481|NCT01999114|528942710|FG000|Overall Study|Administrative|0|||
146662482|NCT01999114|528942711|FG001|Overall Study|Administrative|0|||
146662483|NCT01999114|528942712|FG002|Overall Study|Administrative|1|||
146662484|NCT01999114|528942713|FG003|Overall Study|Administrative|1|||
146662485|NCT01999114|528942714|FG004|Overall Study|Administrative|2|||
146662486|NCT00943124|528942718|FG000|Period 1|Withdrawal by Subject|1|||
146662487|NCT00943124|528942719|FG001|Period 1|Withdrawal by Subject|1|||
146662488|NCT00943124|528942718|FG000|Period 1|Did Not Follow Study Procedures|1|||
146662489|NCT00943124|528942719|FG001|Period 1|Did Not Follow Study Procedures|0|||
146662490|NCT00943124|528942718|FG000|Period 1|Personal Reasons|0|||
146662491|NCT00943124|528942719|FG001|Period 1|Personal Reasons|1|||
146662492|NCT02992132|528942720|FG000|Overall Study|Adverse Event|4|||
146662493|NCT02992132|528942721|FG001|Overall Study|Adverse Event|1|||
146662494|NCT02992132|528942722|FG002|Overall Study|Adverse Event|3|||
146662495|NCT02992132|528942720|FG000|Overall Study|Lack of Efficacy|2|||
146662496|NCT02992132|528942721|FG001|Overall Study|Lack of Efficacy|0|||
146662497|NCT02992132|528942722|FG002|Overall Study|Lack of Efficacy|0|||
146662498|NCT02992132|528942720|FG000|Overall Study|Non-compliance with study drug|2|||
146662499|NCT02992132|528942721|FG001|Overall Study|Non-compliance with study drug|0|||
146662500|NCT02992132|528942722|FG002|Overall Study|Non-compliance with study drug|0|||
146662501|NCT02992132|528942720|FG000|Overall Study|Progressive disease|1|||
146662502|NCT02992132|528942721|FG001|Overall Study|Progressive disease|0|||
146662503|NCT02992132|528942722|FG002|Overall Study|Progressive disease|0|||
146662504|NCT02992132|528942720|FG000|Overall Study|Protocol Violation|2|||
146662505|NCT02992132|528942721|FG001|Overall Study|Protocol Violation|2|||
146662506|NCT02992132|528942722|FG002|Overall Study|Protocol Violation|0|||
146662507|NCT02992132|528942720|FG000|Overall Study|Caregiver withdrew consent|2|||
146662508|NCT02992132|528942721|FG001|Overall Study|Caregiver withdrew consent|3|||
146662509|NCT02992132|528942722|FG002|Overall Study|Caregiver withdrew consent|2|||
146662510|NCT02992132|528942720|FG000|Overall Study|Withdrawal by Subject|0|||
146662511|NCT02992132|528942721|FG001|Overall Study|Withdrawal by Subject|2|||
146662512|NCT02992132|528942722|FG002|Overall Study|Withdrawal by Subject|1|||
146662513|NCT02992132|528942720|FG000|Overall Study|Physician Decision|0|||
146662514|NCT02992132|528942721|FG001|Overall Study|Physician Decision|0|||
146662515|NCT02992132|528942722|FG002|Overall Study|Physician Decision|1|||
146662516|NCT01104155|528942735|FG000|Overall Study|Adverse Event|15|||
146662517|NCT01104155|528942736|FG001|Overall Study|Adverse Event|8|||
146662518|NCT01104155|528942735|FG000|Overall Study|Participant choice|6|||
146662519|NCT01104155|528942736|FG001|Overall Study|Participant choice|5|||
146662520|NCT01104155|528942735|FG000|Overall Study|Withdrawal of consent|1|||
146662521|NCT01104155|528942736|FG001|Overall Study|Withdrawal of consent|1|||
146662522|NCT01104155|528942735|FG000|Overall Study|Other|3|||
146662523|NCT01104155|528942736|FG001|Overall Study|Other|4|||
146662524|NCT02787551|528942742|FG000|Core Period: 26 Weeks|Adverse Event|10|||
146662525|NCT02787551|528942743|FG001|Core Period: 26 Weeks|Adverse Event|0|||
146662526|NCT02787551|528942742|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
146662527|NCT02787551|528942743|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
146662528|NCT02787551|528942742|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
146662529|NCT02787551|528942743|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
146662530|NCT02787551|528942742|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
146662531|NCT02787551|528942743|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
146662532|NCT02787551|528942742|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
146662533|NCT02787551|528942743|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
146662534|NCT02787551|528942742|FG000|Core Period: 26 Weeks|Other than specified|3|||
146662535|NCT02787551|528942743|FG001|Core Period: 26 Weeks|Other than specified|1|||
146662536|NCT02787551|528942742|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
146662537|NCT02787551|528942743|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
146662538|NCT02787551|528942742|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
146662539|NCT02787551|528942743|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
146773718|NCT01565148|529341179|FG000|Overall Study|Physician Decision|2|||
146662540|NCT02787551|528942742|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
146662541|NCT02787551|528942743|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
146662542|NCT03799211|528942744|FG000|Overall Study|Lost to Follow-up|2|||
146662543|NCT03799211|528942745|FG001|Overall Study|Lost to Follow-up|13|||
146662544|NCT03799211|528942744|FG000|Overall Study|Withdrawal by Subject|2|||
146662545|NCT03799211|528942745|FG001|Overall Study|Withdrawal by Subject|0|||
146662546|NCT00764491|528942746|FG000|Overall Study|Lost to Follow-up|35|||
146662547|NCT00764491|528942747|FG001|Overall Study|Lost to Follow-up|17|||
146662548|NCT00923936|528942748|FG000|Overall Study|progressive disease on study|2|||
146662549|NCT00923936|528942749|FG001|Overall Study|progressive disease on study|1|||
146662550|NCT00923936|528942748|FG000|Overall Study|Adverse Event|2|||
146662551|NCT00923936|528942749|FG001|Overall Study|Adverse Event|1|||
146662552|NCT00923936|528942748|FG000|Overall Study|Lost to follow up|2|||
146662553|NCT00923936|528942749|FG001|Overall Study|Lost to follow up|0|||
146662554|NCT00923936|528942748|FG000|Overall Study|Continuing in follow up period|2|||
146662555|NCT00923936|528942749|FG001|Overall Study|Continuing in follow up period|1|||
146662556|NCT02038452|528942751|FG000|Overall Study|Withdrawal by Subject|7|||
146662557|NCT02038452|528942752|FG001|Overall Study|Withdrawal by Subject|9|||
146662558|NCT02038452|528942751|FG000|Overall Study|Lost to Follow-up|31|||
146662559|NCT02038452|528942752|FG001|Overall Study|Lost to Follow-up|28|||
146662560|NCT03139279|528942753|FG000|Overall Study|Physician Decision|2|||
146662561|NCT03139279|528942754|FG001|Overall Study|Physician Decision|0|||
146662562|NCT03139279|528942753|FG000|Overall Study|Protocol Violation|5|||
146662563|NCT03139279|528942754|FG001|Overall Study|Protocol Violation|4|||
146662564|NCT03139279|528942753|FG000|Overall Study|Withdrawal by Subject|0|||
146662565|NCT03139279|528942754|FG001|Overall Study|Withdrawal by Subject|2|||
146662566|NCT02337738|528942755|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
146662567|NCT02337738|528942756|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
146662568|NCT02337738|528942757|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
146662569|NCT02337738|528942755|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
146662570|NCT02337738|528942756|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
146662571|NCT02337738|528942757|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
146662572|NCT02337738|528942755|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
146662573|NCT02337738|528942756|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
146662574|NCT02337738|528942757|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
146662575|NCT02337738|528942755|FG000|Overall Study|Voluntary Withdrawal|10|||
146662576|NCT02337738|528942756|FG001|Overall Study|Voluntary Withdrawal|5|||
146662577|NCT02337738|528942757|FG002|Overall Study|Voluntary Withdrawal|2|||
146662578|NCT02337738|528942755|FG000|Overall Study|Lack of Efficacy|2|||
146662579|NCT02337738|528942756|FG001|Overall Study|Lack of Efficacy|4|||
146662580|NCT02337738|528942757|FG002|Overall Study|Lack of Efficacy|0|||
146662581|NCT02337738|528942755|FG000|Overall Study|Investigator's Judgment|1|||
146662582|NCT02337738|528942756|FG001|Overall Study|Investigator's Judgment|1|||
146662583|NCT02337738|528942757|FG002|Overall Study|Investigator's Judgment|3|||
146662584|NCT01565642|528942758|FG000|Overall Study|Withdrawal by Subject|2|||
146662585|NCT01565642|528942759|FG001|Overall Study|Withdrawal by Subject|1|||
146662586|NCT01934972|528942760|FG000|Overall Study|Withdrawal by Subject|9|||
146662587|NCT01934972|528942761|FG001|Overall Study|Withdrawal by Subject|6|||
146662588|NCT03954132|528942763|FG000|Overall Study|Adverse Event|2|||
146662589|NCT03954132|528942764|FG001|Overall Study|Adverse Event|0|||
146662590|NCT03954132|528942763|FG000|Overall Study|Patient's wish|5|||
146662591|NCT03954132|528942764|FG001|Overall Study|Patient's wish|0|||
146662592|NCT03954132|528942763|FG000|Overall Study|Lost to Follow-up|10|||
146662593|NCT03954132|528942764|FG001|Overall Study|Lost to Follow-up|0|||
146662594|NCT03954132|528942763|FG000|Overall Study|Screening failure|0|||
146662595|NCT03954132|528942764|FG001|Overall Study|Screening failure|1|||
146662596|NCT03954132|528942763|FG000|Overall Study|No registration after Visit 1|5|||
146662597|NCT03954132|528942764|FG001|Overall Study|No registration after Visit 1|2|||
146662598|NCT03954132|528942763|FG000|Overall Study|Other reason than listed|2|||
146662599|NCT03954132|528942764|FG001|Overall Study|Other reason than listed|2|||
146662600|NCT03954132|528942763|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
146662601|NCT03954132|528942764|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
146662602|NCT03954132|528942763|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
146662603|NCT03954132|528942764|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
146662604|NCT00932737|528942767|FG000|Overall Study|Not treated in second episode|1|||
146662605|NCT00932737|528942768|FG001|Overall Study|Not treated in second episode|0|||
146662606|NCT00932737|528942767|FG000|Overall Study|Adverse Event|0|||
146662607|NCT00932737|528942768|FG001|Overall Study|Adverse Event|1|||
146662608|NCT02906332|528942771|FG000|Overall Study|Withdrawal by Subject|1|||
146662609|NCT02949700|528942772|FG000|Phase I|Withdrawal by Subject|1|||
146662610|NCT02949700|528942773|FG001|Phase I|Withdrawal by Subject|1|||
146662611|NCT02949700|528942774|FG002|Phase I|Withdrawal by Subject|0|||
146662612|NCT02949700|528942775|FG003|Phase I|Withdrawal by Subject|0|||
146662613|NCT02949700|528942772|FG000|Phase I|Protocol Violation|1|||
146662614|NCT02949700|528942773|FG001|Phase I|Protocol Violation|0|||
146662615|NCT02949700|528942774|FG002|Phase I|Protocol Violation|0|||
146662616|NCT02949700|528942775|FG003|Phase I|Protocol Violation|0|||
146662617|NCT02949700|528942772|FG000|Phase II|Withdrawal by Subject|0|||
146662618|NCT02949700|528942773|FG001|Phase II|Withdrawal by Subject|0|||
146662619|NCT02949700|528942774|FG002|Phase II|Withdrawal by Subject|0|||
146662620|NCT02949700|528942775|FG003|Phase II|Withdrawal by Subject|2|||
146662621|NCT02949700|528942772|FG000|Phase II|Protocol Violation|0|||
146662622|NCT02949700|528942773|FG001|Phase II|Protocol Violation|0|||
146662623|NCT02949700|528942774|FG002|Phase II|Protocol Violation|1|||
146662624|NCT02949700|528942775|FG003|Phase II|Protocol Violation|3|||
146662625|NCT01554397|528942779|FG000|Overall Study|Withdrawal by Subject|1|||
146662626|NCT01554397|528942780|FG001|Overall Study|Withdrawal by Subject|0|||
146662627|NCT01554397|528942779|FG000|Overall Study|Ineligible|7|||
146662628|NCT01554397|528942780|FG001|Overall Study|Ineligible|0|||
146662629|NCT01896050|528944642|FG000|Overall Study|Adverse Event|37|||
146662630|NCT01896050|528944643|FG001|Overall Study|Adverse Event|2|||
146662631|NCT01896050|528944642|FG000|Overall Study|Death|1|||
146662632|NCT01896050|528944643|FG001|Overall Study|Death|0|||
146662633|NCT03693300|528944644|FG000|Overall Study|Withdrawal by Subject|6|||
146662634|NCT03693300|528944645|FG001|Overall Study|Withdrawal by Subject|0|||
146662635|NCT03693300|528944644|FG000|Overall Study|Death|50|||
146662636|NCT03693300|528944645|FG001|Overall Study|Death|2|||
146662637|NCT03693300|528944644|FG000|Overall Study|Lost to Follow-up|2|||
146662638|NCT03693300|528944645|FG001|Overall Study|Lost to Follow-up|0|||
146662639|NCT02206048|528944646|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
146662640|NCT00697073|528944647|FG000|Overall Study|Withdrawal by Subject|2|||
146662641|NCT00697073|528944647|FG000|Overall Study|Pregnancy|1|||
146662642|NCT00697073|528944647|FG000|Overall Study|non compliance and other|6|||
146662643|NCT03265665|528944648|FG000|24-week Data Collection|Withdrawal by Subject|2|||
146662644|NCT03265665|528944649|FG001|24-week Data Collection|Withdrawal by Subject|2|||
146662645|NCT03265665|528944648|FG000|24-week Data Collection|Lost to Follow-up|4|||
146662646|NCT03265665|528944649|FG001|24-week Data Collection|Lost to Follow-up|5|||
146662647|NCT03265665|528944648|FG000|36-week Data Collection|Lost to Follow-up|6|||
146662648|NCT03265665|528944649|FG001|36-week Data Collection|Lost to Follow-up|8|||
146662649|NCT01858376|528944650|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
146662650|NCT00108433|528944654|FG000|Overall Study|Lack of Efficacy|1|||
146662651|NCT00108433|528944655|FG001|Overall Study|Lack of Efficacy|2|||
146662652|NCT00108433|528944654|FG000|Overall Study|Death|3|||
146662653|NCT00108433|528944655|FG001|Overall Study|Death|0|||
146662654|NCT00108433|528944654|FG000|Overall Study|Adverse Event|3|||
146662655|NCT00108433|528944655|FG001|Overall Study|Adverse Event|1|||
146662656|NCT00108433|528944654|FG000|Overall Study|Other|14|||
146662657|NCT00108433|528944655|FG001|Overall Study|Other|14|||
146662658|NCT02203071|528944656|FG000|Overall Study|Lost to Follow-up|3|||
146662659|NCT02203071|528944657|FG001|Overall Study|Lost to Follow-up|1|||
146662660|NCT01886716|528944658|FG000|Week 1|Lost to Follow-up|0|||
146662661|NCT01886716|528944659|FG001|Week 1|Lost to Follow-up|0|||
146662662|NCT01886716|528944660|FG002|Week 1|Lost to Follow-up|2|||
146662663|NCT01886716|528944661|FG003|Week 1|Lost to Follow-up|2|||
146662664|NCT01886716|528944658|FG000|Week 2|Lost to Follow-up|3|||
146662665|NCT01886716|528944659|FG001|Week 2|Lost to Follow-up|2|||
146662666|NCT01886716|528944660|FG002|Week 2|Lost to Follow-up|1|||
146662667|NCT01886716|528944661|FG003|Week 2|Lost to Follow-up|3|||
146662668|NCT01886716|528944658|FG000|Week 3|Lost to Follow-up|1|||
146662669|NCT01886716|528944659|FG001|Week 3|Lost to Follow-up|1|||
146662670|NCT01886716|528944660|FG002|Week 3|Lost to Follow-up|0|||
146662671|NCT01886716|528944661|FG003|Week 3|Lost to Follow-up|1|||
146662672|NCT03894046|528944664|FG000|Overall Study|Protocol Violation|1|||
146662673|NCT03894046|528944665|FG001|Overall Study|Protocol Violation|0|||
146662674|NCT03894046|528944666|FG002|Overall Study|Protocol Violation|0|||
146662675|NCT03894046|528944664|FG000|Overall Study|Adverse Event|0|||
146662676|NCT03894046|528944665|FG001|Overall Study|Adverse Event|1|||
146662677|NCT03894046|528944666|FG002|Overall Study|Adverse Event|0|||
146662678|NCT03894046|528944664|FG000|Overall Study|Withdrawal by Subject|2|||
146662679|NCT03894046|528944665|FG001|Overall Study|Withdrawal by Subject|3|||
146662680|NCT03894046|528944666|FG002|Overall Study|Withdrawal by Subject|1|||
146662681|NCT03894046|528944664|FG000|Overall Study|Death|15|||
146662682|NCT03894046|528944665|FG001|Overall Study|Death|21|||
146662683|NCT03894046|528944666|FG002|Overall Study|Death|4|||
146662684|NCT03894046|528944664|FG000|Overall Study|No growth of ABC|2|||
146662685|NCT03894046|528944665|FG001|Overall Study|No growth of ABC|1|||
146662686|NCT03894046|528944666|FG002|Overall Study|No growth of ABC|0|||
146662687|NCT03894046|528944664|FG000|Overall Study|Physician Decision|1|||
146662688|NCT03894046|528944665|FG001|Overall Study|Physician Decision|1|||
146662689|NCT03894046|528944666|FG002|Overall Study|Physician Decision|1|||
146662690|NCT03894046|528944664|FG000|Overall Study|Prohibited concomitant medication|1|||
146662691|NCT03894046|528944665|FG001|Overall Study|Prohibited concomitant medication|0|||
146662692|NCT03894046|528944666|FG002|Overall Study|Prohibited concomitant medication|0|||
146662693|NCT03894046|528944664|FG000|Overall Study|Transferred to other arm/group|1|||
146773719|NCT01565148|529341180|FG001|Overall Study|Physician Decision|5|||
146925253|NCT01363713|529885999|FG000|Overall Study|Withdrawal by Subject|2|||
146925254|NCT01199055|529886000|FG000|Overall Study|Death|0|||
146925255|NCT01199055|529886001|FG001|Overall Study|Death|1|||
146662694|NCT03894046|528944665|FG001|Overall Study|Transferred to other arm/group|1|||
146662695|NCT03894046|528944666|FG002|Overall Study|Transferred to other arm/group|0|||
146662696|NCT04806503|528944673|FG000|Overall Study|Lost to Follow-up|0|||
146662697|NCT04806503|528944674|FG001|Overall Study|Lost to Follow-up|0|||
146662698|NCT04806503|528944675|FG002|Overall Study|Lost to Follow-up|1|||
146662699|NCT04806503|528944676|FG003|Overall Study|Lost to Follow-up|0|||
146662700|NCT04806503|528944677|FG004|Overall Study|Lost to Follow-up|0|||
146662701|NCT04806503|528944673|FG000|Overall Study|Withdrawal by Subject|1|||
146662702|NCT04806503|528944674|FG001|Overall Study|Withdrawal by Subject|0|||
146662703|NCT04806503|528944675|FG002|Overall Study|Withdrawal by Subject|1|||
146662704|NCT04806503|528944676|FG003|Overall Study|Withdrawal by Subject|1|||
146662705|NCT04806503|528944677|FG004|Overall Study|Withdrawal by Subject|1|||
146662706|NCT04806503|528944673|FG000|Overall Study|Adverse Event|1|||
146662707|NCT04806503|528944674|FG001|Overall Study|Adverse Event|1|||
146662708|NCT04806503|528944675|FG002|Overall Study|Adverse Event|0|||
146662709|NCT04806503|528944676|FG003|Overall Study|Adverse Event|1|||
146662710|NCT04806503|528944677|FG004|Overall Study|Adverse Event|0|||
146662711|NCT03589469|528944678|FG000|Overall Study|Withdrawal by Subject|8|||
146662712|NCT03589469|528944678|FG000|Overall Study|Physician Decision|20|||
146662713|NCT03589469|528944678|FG000|Overall Study|Death|97|||
146662714|NCT03589469|528944678|FG000|Overall Study|Lost to Follow-up|8|||
146662715|NCT03589469|528944678|FG000|Overall Study|Miscellaneous|1|||
146662716|NCT02202837|528944681|FG000|Overall Study|Enbrel treatment discontinued|36|||
146662717|NCT02202837|528944682|FG001|Overall Study|Enbrel treatment discontinued|4|||
146662718|NCT02202837|528944681|FG000|Overall Study|Other|10|||
146662719|NCT02202837|528944682|FG001|Overall Study|Other|0|||
146662720|NCT02202837|528944681|FG000|Overall Study|Lost to Follow-up|7|||
146662721|NCT02202837|528944682|FG001|Overall Study|Lost to Follow-up|1|||
146662722|NCT02486302|528944683|FG000|Overall Study|Discontinued prematurely|410|||
146662723|NCT02486302|528944683|FG000|Overall Study|Documentation not completed|255|||
146662724|NCT02486302|528944683|FG000|Overall Study|Excluded due to legal reasons|8|||
146662725|NCT02486302|528944683|FG000|Overall Study|Not treated|3|||
146662726|NCT01871142|528944684|FG000|Overall Study|Adverse Event|1|||
146662727|NCT00734474|528944688|FG000|Overall Study|Entry Criteria Not Met|0|||
146662728|NCT00734474|528944689|FG001|Overall Study|Entry Criteria Not Met|0|||
146662729|NCT00734474|528944690|FG002|Overall Study|Entry Criteria Not Met|5|||
146662730|NCT00734474|528944691|FG003|Overall Study|Entry Criteria Not Met|0|||
146662731|NCT00734474|528944692|FG004|Overall Study|Entry Criteria Not Met|3|||
146662732|NCT00734474|528944693|FG005|Overall Study|Entry Criteria Not Met|1|||
146662733|NCT00734474|528944694|FG006|Overall Study|Entry Criteria Not Met|0|||
146662734|NCT00734474|528944695|FG007|Overall Study|Entry Criteria Not Met|1|||
146662735|NCT00734474|528944696|FG008|Overall Study|Entry Criteria Not Met|1|||
146662736|NCT00734474|528944688|FG000|Overall Study|Lost to Follow-up|1|||
146662737|NCT00734474|528944689|FG001|Overall Study|Lost to Follow-up|0|||
146662738|NCT00734474|528944690|FG002|Overall Study|Lost to Follow-up|13|||
146662739|NCT00734474|528944691|FG003|Overall Study|Lost to Follow-up|0|||
146662740|NCT00734474|528944692|FG004|Overall Study|Lost to Follow-up|11|||
146662741|NCT00734474|528944693|FG005|Overall Study|Lost to Follow-up|1|||
146662742|NCT00734474|528944694|FG006|Overall Study|Lost to Follow-up|0|||
146662743|NCT00734474|528944695|FG007|Overall Study|Lost to Follow-up|9|||
146662744|NCT00734474|528944696|FG008|Overall Study|Lost to Follow-up|4|||
146662745|NCT00734474|528944688|FG000|Overall Study|Withdrawal by Subject|2|||
146662746|NCT00734474|528944689|FG001|Overall Study|Withdrawal by Subject|1|||
146662747|NCT00734474|528944690|FG002|Overall Study|Withdrawal by Subject|18|||
146662748|NCT00734474|528944691|FG003|Overall Study|Withdrawal by Subject|0|||
146662749|NCT00734474|528944692|FG004|Overall Study|Withdrawal by Subject|24|||
146662750|NCT00734474|528944693|FG005|Overall Study|Withdrawal by Subject|2|||
146662751|NCT00734474|528944694|FG006|Overall Study|Withdrawal by Subject|0|||
146662752|NCT00734474|528944695|FG007|Overall Study|Withdrawal by Subject|36|||
146662753|NCT00734474|528944696|FG008|Overall Study|Withdrawal by Subject|21|||
146662754|NCT00734474|528944688|FG000|Overall Study|Physician Decision|0|||
146662755|NCT00734474|528944689|FG001|Overall Study|Physician Decision|0|||
146662756|NCT00734474|528944690|FG002|Overall Study|Physician Decision|4|||
146662757|NCT00734474|528944691|FG003|Overall Study|Physician Decision|1|||
146662758|NCT00734474|528944692|FG004|Overall Study|Physician Decision|11|||
146662759|NCT00734474|528944693|FG005|Overall Study|Physician Decision|0|||
146662760|NCT00734474|528944694|FG006|Overall Study|Physician Decision|0|||
146662761|NCT00734474|528944695|FG007|Overall Study|Physician Decision|9|||
146662762|NCT00734474|528944696|FG008|Overall Study|Physician Decision|9|||
146662763|NCT00734474|528944688|FG000|Overall Study|Adverse Event|4|||
146662764|NCT00734474|528944689|FG001|Overall Study|Adverse Event|4|||
146662765|NCT00734474|528944690|FG002|Overall Study|Adverse Event|63|||
146662766|NCT00734474|528944691|FG003|Overall Study|Adverse Event|1|||
146662767|NCT00734474|528944692|FG004|Overall Study|Adverse Event|64|||
146662768|NCT00734474|528944693|FG005|Overall Study|Adverse Event|0|||
146925256|NCT01199055|529886002|FG002|Overall Study|Death|0|||
146925257|NCT01199055|529886000|FG000|Overall Study|Physician Decision|0|||
146925258|NCT01199055|529886001|FG001|Overall Study|Physician Decision|1|||
146925259|NCT01199055|529886002|FG002|Overall Study|Physician Decision|1|||
146925260|NCT01199055|529886000|FG000|Overall Study|Progressive disease|2|||
146925261|NCT01199055|529886001|FG001|Overall Study|Progressive disease|1|||
146662769|NCT00734474|528944694|FG006|Overall Study|Adverse Event|1|||
146662770|NCT00734474|528944695|FG007|Overall Study|Adverse Event|65|||
146662771|NCT00734474|528944696|FG008|Overall Study|Adverse Event|39|||
146662772|NCT00734474|528944688|FG000|Overall Study|Protocol Violation|0|||
146662773|NCT00734474|528944689|FG001|Overall Study|Protocol Violation|0|||
146662774|NCT00734474|528944690|FG002|Overall Study|Protocol Violation|4|||
146662775|NCT00734474|528944691|FG003|Overall Study|Protocol Violation|0|||
146662776|NCT00734474|528944692|FG004|Overall Study|Protocol Violation|3|||
146662777|NCT00734474|528944693|FG005|Overall Study|Protocol Violation|0|||
146662778|NCT00734474|528944694|FG006|Overall Study|Protocol Violation|0|||
146662779|NCT00734474|528944695|FG007|Overall Study|Protocol Violation|3|||
146662780|NCT00734474|528944696|FG008|Overall Study|Protocol Violation|1|||
146662781|NCT00734474|528944688|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
146662782|NCT00734474|528944689|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
146662783|NCT00734474|528944690|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
146662784|NCT00734474|528944691|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
146662785|NCT00734474|528944692|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
146662786|NCT00734474|528944693|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
146662787|NCT00734474|528944694|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
146662788|NCT00734474|528944695|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
146662789|NCT00734474|528944696|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
146662790|NCT00734474|528944688|FG000|Overall Study|Sponsor Decision|0|||
146662791|NCT00734474|528944689|FG001|Overall Study|Sponsor Decision|0|||
146662792|NCT00734474|528944690|FG002|Overall Study|Sponsor Decision|0|||
146662793|NCT00734474|528944691|FG003|Overall Study|Sponsor Decision|0|||
146662794|NCT00734474|528944692|FG004|Overall Study|Sponsor Decision|2|||
146662795|NCT00734474|528944693|FG005|Overall Study|Sponsor Decision|0|||
146662796|NCT00734474|528944694|FG006|Overall Study|Sponsor Decision|0|||
146662797|NCT00734474|528944695|FG007|Overall Study|Sponsor Decision|0|||
146662798|NCT00734474|528944696|FG008|Overall Study|Sponsor Decision|0|||
146662799|NCT00734474|528944688|FG000|Overall Study|Death|0|||
146662800|NCT00734474|528944689|FG001|Overall Study|Death|0|||
146662801|NCT00734474|528944690|FG002|Overall Study|Death|1|||
146662802|NCT00734474|528944691|FG003|Overall Study|Death|0|||
146662803|NCT00734474|528944692|FG004|Overall Study|Death|0|||
146662804|NCT00734474|528944693|FG005|Overall Study|Death|0|||
146662805|NCT00734474|528944694|FG006|Overall Study|Death|0|||
146662806|NCT00734474|528944695|FG007|Overall Study|Death|2|||
146662807|NCT00734474|528944696|FG008|Overall Study|Death|1|||
146662808|NCT00734474|528944688|FG000|Overall Study|Lack of Efficacy|0|||
146662809|NCT00734474|528944689|FG001|Overall Study|Lack of Efficacy|0|||
146662810|NCT00734474|528944690|FG002|Overall Study|Lack of Efficacy|4|||
146662811|NCT00734474|528944691|FG003|Overall Study|Lack of Efficacy|0|||
146662812|NCT00734474|528944692|FG004|Overall Study|Lack of Efficacy|0|||
146662813|NCT00734474|528944693|FG005|Overall Study|Lack of Efficacy|0|||
146662814|NCT00734474|528944694|FG006|Overall Study|Lack of Efficacy|0|||
146662815|NCT00734474|528944695|FG007|Overall Study|Lack of Efficacy|4|||
146662816|NCT00734474|528944696|FG008|Overall Study|Lack of Efficacy|6|||
146662817|NCT00231842|528944705|FG000|Overall Study|Withdrawal by Subject|3|||
146662818|NCT00231842|528944705|FG000|Overall Study|Did not complete the last 3 cycle|8|||
146662819|NCT00639678|528944706|FG000|Overall Study|Withdrawal by Subject|3|||
146662820|NCT00639678|528944707|FG001|Overall Study|Withdrawal by Subject|0|||
146662821|NCT00639678|528944708|FG002|Overall Study|Withdrawal by Subject|4|||
146662822|NCT00639678|528944709|FG003|Overall Study|Withdrawal by Subject|0|||
146662823|NCT00639678|528944706|FG000|Overall Study|Lost to Follow-up|1|||
146662824|NCT00639678|528944707|FG001|Overall Study|Lost to Follow-up|0|||
146662825|NCT00639678|528944708|FG002|Overall Study|Lost to Follow-up|6|||
146662826|NCT00639678|528944709|FG003|Overall Study|Lost to Follow-up|0|||
146662827|NCT00639678|528944706|FG000|Overall Study|Adverse Event|0|||
146662828|NCT00639678|528944707|FG001|Overall Study|Adverse Event|1|||
146662829|NCT00639678|528944708|FG002|Overall Study|Adverse Event|0|||
146925262|NCT01199055|529886002|FG002|Overall Study|Progressive disease|2|||
146925263|NCT01199055|529886000|FG000|Overall Study|Withdrawal by Subject|0|||
146925264|NCT01199055|529886001|FG001|Overall Study|Withdrawal by Subject|0|||
146662830|NCT00639678|528944709|FG003|Overall Study|Adverse Event|0|||
146662831|NCT00639678|528944706|FG000|Overall Study|Lack of Compliance|0|||
146662832|NCT00639678|528944707|FG001|Overall Study|Lack of Compliance|0|||
146662833|NCT00639678|528944708|FG002|Overall Study|Lack of Compliance|1|||
146662834|NCT00639678|528944709|FG003|Overall Study|Lack of Compliance|0|||
146662835|NCT02436304|528944710|FG000|Overall Study|Lost to Follow-up|0|||
146662836|NCT02436304|528944711|FG001|Overall Study|Lost to Follow-up|1|||
146662837|NCT02436304|528944712|FG002|Overall Study|Lost to Follow-up|0|||
146662838|NCT02436304|528944710|FG000|Overall Study|Withdrawal by Subject|0|||
146662839|NCT02436304|528944711|FG001|Overall Study|Withdrawal by Subject|1|||
146662840|NCT02436304|528944712|FG002|Overall Study|Withdrawal by Subject|0|||
146662841|NCT02436304|528944710|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
146662842|NCT02436304|528944711|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
146662843|NCT02436304|528944712|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
146662844|NCT00369122|528944723|FG000|Overall Study|Ineligible|10|||
146662845|NCT00369122|528944723|FG000|Overall Study|No protocol treatment|1|||
146662846|NCT02651467|528944724|FG000|Overall Study|Withdrawal by Subject|0|||
146662847|NCT02651467|528944725|FG001|Overall Study|Withdrawal by Subject|0|||
146662848|NCT02651467|528944726|FG002|Overall Study|Withdrawal by Subject|2|||
146662849|NCT02651467|528944724|FG000|Overall Study|Other (Not specified)|1|||
146662850|NCT02651467|528944725|FG001|Overall Study|Other (Not specified)|0|||
146662851|NCT02651467|528944726|FG002|Overall Study|Other (Not specified)|2|||
146662852|NCT00408629|528944727|FG000|Overall Study|Adverse Event|13|||
146662853|NCT00408629|528944728|FG001|Overall Study|Adverse Event|27|||
146662854|NCT00408629|528944727|FG000|Overall Study|Withdrawal by Subject|8|||
146662855|NCT00408629|528944728|FG001|Overall Study|Withdrawal by Subject|4|||
146662856|NCT00408629|528944727|FG000|Overall Study|Lost to Follow-up|1|||
146662857|NCT00408629|528944728|FG001|Overall Study|Lost to Follow-up|1|||
146662858|NCT00408629|528944727|FG000|Overall Study|Lack of Efficacy|63|||
146662859|NCT00408629|528944728|FG001|Overall Study|Lack of Efficacy|73|||
146662860|NCT00408629|528944727|FG000|Overall Study|Protocol Violation|1|||
146662861|NCT00408629|528944728|FG001|Overall Study|Protocol Violation|5|||
146662862|NCT00408629|528944727|FG000|Overall Study|Miscellaneous|11|||
146662863|NCT00408629|528944728|FG001|Overall Study|Miscellaneous|15|||
146662864|NCT00191906|528944729|FG000|Study Period II|Adverse Event|0|||
146662865|NCT00191906|528944730|FG001|Study Period II|Adverse Event|1|||
146662866|NCT00191906|528944731|FG002|Study Period II|Adverse Event|0|||
146662867|NCT00191906|528944732|FG003|Study Period II|Adverse Event|0|||
146662868|NCT00191906|528944729|FG000|Study Period II|Withdrawal by Subject|0|||
146662869|NCT00191906|528944730|FG001|Study Period II|Withdrawal by Subject|3|||
146662870|NCT00191906|528944731|FG002|Study Period II|Withdrawal by Subject|0|||
146662871|NCT00191906|528944732|FG003|Study Period II|Withdrawal by Subject|0|||
146662872|NCT00191906|528944729|FG000|Study Period II|Parent/Caregiver Decision|0|||
146662873|NCT00191906|528944730|FG001|Study Period II|Parent/Caregiver Decision|1|||
146662874|NCT00191906|528944731|FG002|Study Period II|Parent/Caregiver Decision|0|||
146662875|NCT00191906|528944732|FG003|Study Period II|Parent/Caregiver Decision|0|||
146662876|NCT00191906|528944729|FG000|Study Period II|Entry Criteria Exclusion|0|||
146662877|NCT00191906|528944730|FG001|Study Period II|Entry Criteria Exclusion|0|||
146662878|NCT00191906|528944731|FG002|Study Period II|Entry Criteria Exclusion|1|||
146662879|NCT00191906|528944732|FG003|Study Period II|Entry Criteria Exclusion|0|||
146662880|NCT00191906|528944729|FG000|Study Period III|Adverse Event|1|||
146662881|NCT00191906|528944730|FG001|Study Period III|Adverse Event|0|||
146662882|NCT00191906|528944731|FG002|Study Period III|Adverse Event|0|||
146662883|NCT00191906|528944732|FG003|Study Period III|Adverse Event|0|||
146662884|NCT00191906|528944729|FG000|Study Period III|Lost to Follow-up|0|||
146662885|NCT00191906|528944730|FG001|Study Period III|Lost to Follow-up|1|||
146662886|NCT00191906|528944731|FG002|Study Period III|Lost to Follow-up|0|||
146662887|NCT00191906|528944732|FG003|Study Period III|Lost to Follow-up|0|||
146662888|NCT00191906|528944729|FG000|Study Period III|Parent/Caregiver Decision|1|||
146662889|NCT00191906|528944730|FG001|Study Period III|Parent/Caregiver Decision|0|||
146662890|NCT00191906|528944731|FG002|Study Period III|Parent/Caregiver Decision|0|||
146662891|NCT00191906|528944732|FG003|Study Period III|Parent/Caregiver Decision|0|||
146662892|NCT00191906|528944729|FG000|Study Period III|Lack of Efficacy|3|||
146662893|NCT00191906|528944730|FG001|Study Period III|Lack of Efficacy|3|||
146662894|NCT00191906|528944731|FG002|Study Period III|Lack of Efficacy|0|||
146662895|NCT00191906|528944732|FG003|Study Period III|Lack of Efficacy|0|||
146662896|NCT00573937|528944733|FG000|Overall Study|Study Terminated|0|||
146662897|NCT00573937|528944734|FG001|Overall Study|Study Terminated|1|||
146662898|NCT00333801|528944735|FG000|Overall Study|Moved to another state|5|||
146662899|NCT00333801|528944736|FG001|Overall Study|Moved to another state|3|||
146662900|NCT00333801|528944735|FG000|Overall Study|Lost to Follow-up|2|||
146662901|NCT00333801|528944736|FG001|Overall Study|Lost to Follow-up|0|||
146662902|NCT00333801|528944735|FG000|Overall Study|Incarcerated|1|||
146662903|NCT00333801|528944736|FG001|Overall Study|Incarcerated|2|||
146662904|NCT00333801|528944735|FG000|Overall Study|Withdrawal by Subject|0|||
146662905|NCT00333801|528944736|FG001|Overall Study|Withdrawal by Subject|1|||
146662906|NCT03633617|528944737|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
146662907|NCT03633617|528944738|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
146662908|NCT03633617|528944739|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146662909|NCT03633617|528944740|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146662910|NCT03633617|528944741|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146662911|NCT03633617|528944742|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146662912|NCT03633617|528944743|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146773720|NCT01565148|529341181|FG002|Overall Study|Physician Decision|0|||
146662913|NCT03633617|528944744|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146662914|NCT03633617|528944745|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146662915|NCT03633617|528944746|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146662916|NCT03633617|528944747|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146662917|NCT03633617|528944737|FG000|Part A|Unconfirmed early termination visit|1|||
146662918|NCT03633617|528944738|FG001|Part A|Unconfirmed early termination visit|0|||
146662919|NCT03633617|528944739|FG002|Part A|Unconfirmed early termination visit|0|||
146662920|NCT03633617|528944740|FG003|Part A|Unconfirmed early termination visit|0|||
146662921|NCT03633617|528944741|FG004|Part A|Unconfirmed early termination visit|0|||
146662922|NCT03633617|528944742|FG005|Part A|Unconfirmed early termination visit|0|||
146662923|NCT03633617|528944743|FG006|Part A|Unconfirmed early termination visit|0|||
146662924|NCT03633617|528944744|FG007|Part A|Unconfirmed early termination visit|0|||
146662925|NCT03633617|528944745|FG008|Part A|Unconfirmed early termination visit|0|||
146662926|NCT03633617|528944746|FG009|Part A|Unconfirmed early termination visit|0|||
146662927|NCT03633617|528944747|FG010|Part A|Unconfirmed early termination visit|0|||
146662928|NCT03633617|528944737|FG000|Part A|Adverse Event|0|||
146662929|NCT03633617|528944738|FG001|Part A|Adverse Event|1|||
146662930|NCT03633617|528944739|FG002|Part A|Adverse Event|0|||
146662931|NCT03633617|528944740|FG003|Part A|Adverse Event|0|||
146662932|NCT03633617|528944741|FG004|Part A|Adverse Event|0|||
146662933|NCT03633617|528944742|FG005|Part A|Adverse Event|0|||
146662934|NCT03633617|528944743|FG006|Part A|Adverse Event|0|||
146662935|NCT03633617|528944744|FG007|Part A|Adverse Event|0|||
146662936|NCT03633617|528944745|FG008|Part A|Adverse Event|0|||
146662937|NCT03633617|528944746|FG009|Part A|Adverse Event|0|||
146662938|NCT03633617|528944747|FG010|Part A|Adverse Event|0|||
146662939|NCT03633617|528944737|FG000|Part A|Pregnancy|1|||
146662940|NCT03633617|528944738|FG001|Part A|Pregnancy|0|||
146662941|NCT03633617|528944739|FG002|Part A|Pregnancy|0|||
146662942|NCT03633617|528944740|FG003|Part A|Pregnancy|0|||
146662943|NCT03633617|528944741|FG004|Part A|Pregnancy|0|||
146662944|NCT03633617|528944742|FG005|Part A|Pregnancy|0|||
146662945|NCT03633617|528944743|FG006|Part A|Pregnancy|0|||
146662946|NCT03633617|528944744|FG007|Part A|Pregnancy|0|||
146662947|NCT03633617|528944745|FG008|Part A|Pregnancy|0|||
146662948|NCT03633617|528944746|FG009|Part A|Pregnancy|0|||
146662949|NCT03633617|528944747|FG010|Part A|Pregnancy|0|||
146662950|NCT03633617|528944737|FG000|Part A|Withdrawal by Subject|0|||
146662951|NCT03633617|528944738|FG001|Part A|Withdrawal by Subject|1|||
146662952|NCT03633617|528944739|FG002|Part A|Withdrawal by Subject|0|||
146662953|NCT03633617|528944740|FG003|Part A|Withdrawal by Subject|0|||
146662954|NCT03633617|528944741|FG004|Part A|Withdrawal by Subject|0|||
146662955|NCT03633617|528944742|FG005|Part A|Withdrawal by Subject|0|||
146662956|NCT03633617|528944743|FG006|Part A|Withdrawal by Subject|0|||
146662957|NCT03633617|528944744|FG007|Part A|Withdrawal by Subject|0|||
146662958|NCT03633617|528944745|FG008|Part A|Withdrawal by Subject|0|||
146662959|NCT03633617|528944746|FG009|Part A|Withdrawal by Subject|0|||
146662960|NCT03633617|528944747|FG010|Part A|Withdrawal by Subject|0|||
146662961|NCT03633617|528944737|FG000|Part B|Adverse Event|0|||
146662962|NCT03633617|528944738|FG001|Part B|Adverse Event|0|||
146662963|NCT03633617|528944739|FG002|Part B|Adverse Event|2|||
146662964|NCT03633617|528944740|FG003|Part B|Adverse Event|2|||
146662965|NCT03633617|528944741|FG004|Part B|Adverse Event|1|||
146662966|NCT03633617|528944742|FG005|Part B|Adverse Event|0|||
146662967|NCT03633617|528944743|FG006|Part B|Adverse Event|0|||
146662968|NCT03633617|528944744|FG007|Part B|Adverse Event|0|||
146662969|NCT03633617|528944745|FG008|Part B|Adverse Event|0|||
146662970|NCT03633617|528944746|FG009|Part B|Adverse Event|0|||
146662971|NCT03633617|528944747|FG010|Part B|Adverse Event|0|||
146773721|NCT01565148|529341182|FG003|Overall Study|Physician Decision|0|||
146662972|NCT03633617|528944737|FG000|Part B|Withdrawal by Subject|0|||
146662973|NCT03633617|528944738|FG001|Part B|Withdrawal by Subject|0|||
146773722|NCT01170962|529341184|FG000|Treatment Period|Lack of Efficacy|96|||
146662974|NCT03633617|528944739|FG002|Part B|Withdrawal by Subject|1|||
146662975|NCT03633617|528944740|FG003|Part B|Withdrawal by Subject|0|||
146773723|NCT01170962|529341185|FG001|Treatment Period|Lack of Efficacy|91|||
146662976|NCT03633617|528944741|FG004|Part B|Withdrawal by Subject|2|||
146662977|NCT03633617|528944742|FG005|Part B|Withdrawal by Subject|0|||
146662978|NCT03633617|528944743|FG006|Part B|Withdrawal by Subject|0|||
146662979|NCT03633617|528944744|FG007|Part B|Withdrawal by Subject|0|||
146662980|NCT03633617|528944745|FG008|Part B|Withdrawal by Subject|0|||
146662981|NCT03633617|528944746|FG009|Part B|Withdrawal by Subject|0|||
146662982|NCT03633617|528944747|FG010|Part B|Withdrawal by Subject|0|||
146662983|NCT03633617|528944737|FG000|Part B|Lost to Follow-up|0|||
146662984|NCT03633617|528944738|FG001|Part B|Lost to Follow-up|0|||
146662985|NCT03633617|528944739|FG002|Part B|Lost to Follow-up|0|||
146662986|NCT03633617|528944740|FG003|Part B|Lost to Follow-up|0|||
146662987|NCT03633617|528944741|FG004|Part B|Lost to Follow-up|1|||
146662988|NCT03633617|528944742|FG005|Part B|Lost to Follow-up|0|||
146662989|NCT03633617|528944743|FG006|Part B|Lost to Follow-up|0|||
146662990|NCT03633617|528944744|FG007|Part B|Lost to Follow-up|0|||
146662991|NCT03633617|528944745|FG008|Part B|Lost to Follow-up|0|||
146662992|NCT03633617|528944746|FG009|Part B|Lost to Follow-up|0|||
146662993|NCT03633617|528944747|FG010|Part B|Lost to Follow-up|0|||
146662994|NCT03633617|528944737|FG000|Part B|Physician Decision|0|||
146662995|NCT03633617|528944738|FG001|Part B|Physician Decision|0|||
146662996|NCT03633617|528944739|FG002|Part B|Physician Decision|0|||
146662997|NCT03633617|528944740|FG003|Part B|Physician Decision|0|||
146662998|NCT03633617|528944741|FG004|Part B|Physician Decision|1|||
146662999|NCT03633617|528944742|FG005|Part B|Physician Decision|0|||
146663000|NCT03633617|528944743|FG006|Part B|Physician Decision|0|||
146663001|NCT03633617|528944744|FG007|Part B|Physician Decision|0|||
146663002|NCT03633617|528944745|FG008|Part B|Physician Decision|0|||
146663003|NCT03633617|528944746|FG009|Part B|Physician Decision|0|||
146663004|NCT03633617|528944747|FG010|Part B|Physician Decision|0|||
146663005|NCT03633617|528944737|FG000|Part B|COVID-19 Restrictions|0|||
146663006|NCT03633617|528944738|FG001|Part B|COVID-19 Restrictions|0|||
146663007|NCT03633617|528944739|FG002|Part B|COVID-19 Restrictions|1|||
146663008|NCT03633617|528944740|FG003|Part B|COVID-19 Restrictions|0|||
146663009|NCT03633617|528944741|FG004|Part B|COVID-19 Restrictions|0|||
146663010|NCT03633617|528944742|FG005|Part B|COVID-19 Restrictions|0|||
146663011|NCT03633617|528944743|FG006|Part B|COVID-19 Restrictions|0|||
146663012|NCT03633617|528944744|FG007|Part B|COVID-19 Restrictions|0|||
146663013|NCT03633617|528944745|FG008|Part B|COVID-19 Restrictions|0|||
146663014|NCT03633617|528944746|FG009|Part B|COVID-19 Restrictions|0|||
146663015|NCT03633617|528944747|FG010|Part B|COVID-19 Restrictions|0|||
146663016|NCT03633617|528944737|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146663017|NCT03633617|528944738|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146663018|NCT03633617|528944739|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
146663019|NCT03633617|528944740|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146663020|NCT03633617|528944741|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146663021|NCT03633617|528944742|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146663022|NCT03633617|528944743|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146663023|NCT03633617|528944744|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146663024|NCT03633617|528944745|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146663025|NCT03633617|528944746|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146663026|NCT03633617|528944747|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146663027|NCT03633617|528944737|FG000|Part C (& Follow-up)|Adverse Event|0|||
146663028|NCT03633617|528944738|FG001|Part C (& Follow-up)|Adverse Event|0|||
146663029|NCT03633617|528944739|FG002|Part C (& Follow-up)|Adverse Event|0|||
146663030|NCT03633617|528944740|FG003|Part C (& Follow-up)|Adverse Event|0|||
146663031|NCT03633617|528944741|FG004|Part C (& Follow-up)|Adverse Event|0|||
146663032|NCT03633617|528944742|FG005|Part C (& Follow-up)|Adverse Event|1|||
146663033|NCT03633617|528944743|FG006|Part C (& Follow-up)|Adverse Event|0|||
146663034|NCT03633617|528944744|FG007|Part C (& Follow-up)|Adverse Event|1|||
146663035|NCT03633617|528944745|FG008|Part C (& Follow-up)|Adverse Event|0|||
146663036|NCT03633617|528944746|FG009|Part C (& Follow-up)|Adverse Event|0|||
146663037|NCT03633617|528944747|FG010|Part C (& Follow-up)|Adverse Event|0|||
146663038|NCT03633617|528944737|FG000|Part C (& Follow-up)|Pregnancy|0|||
146663039|NCT03633617|528944738|FG001|Part C (& Follow-up)|Pregnancy|0|||
146663040|NCT03633617|528944739|FG002|Part C (& Follow-up)|Pregnancy|0|||
146663041|NCT03633617|528944740|FG003|Part C (& Follow-up)|Pregnancy|0|||
146663042|NCT03633617|528944741|FG004|Part C (& Follow-up)|Pregnancy|0|||
146663043|NCT03633617|528944742|FG005|Part C (& Follow-up)|Pregnancy|0|||
146663044|NCT03633617|528944743|FG006|Part C (& Follow-up)|Pregnancy|0|||
146663045|NCT03633617|528944744|FG007|Part C (& Follow-up)|Pregnancy|0|||
146663046|NCT03633617|528944745|FG008|Part C (& Follow-up)|Pregnancy|0|||
146663047|NCT03633617|528944746|FG009|Part C (& Follow-up)|Pregnancy|1|||
146663048|NCT03633617|528944747|FG010|Part C (& Follow-up)|Pregnancy|0|||
146663049|NCT03633617|528944737|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
146663050|NCT03633617|528944738|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
146663051|NCT03633617|528944739|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
146663052|NCT03633617|528944740|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
146663053|NCT03633617|528944741|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
146663054|NCT03633617|528944742|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
146663055|NCT03633617|528944743|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
146663056|NCT03633617|528944744|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
146663057|NCT03633617|528944745|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
146663058|NCT03633617|528944746|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
146663059|NCT03633617|528944747|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
146663060|NCT03633617|528944737|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
146663061|NCT03633617|528944738|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
146663062|NCT03633617|528944739|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
146663063|NCT03633617|528944740|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
146663064|NCT03633617|528944741|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
146663065|NCT03633617|528944742|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
146663066|NCT03633617|528944743|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
146663067|NCT03633617|528944744|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
146663068|NCT03633617|528944745|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
146663069|NCT03633617|528944746|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
146663070|NCT03633617|528944747|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
146663071|NCT03633617|528944737|FG000|Part C (& Follow-up)|Physician Decision|0|||
146663072|NCT03633617|528944738|FG001|Part C (& Follow-up)|Physician Decision|0|||
146663073|NCT03633617|528944739|FG002|Part C (& Follow-up)|Physician Decision|0|||
146663074|NCT03633617|528944740|FG003|Part C (& Follow-up)|Physician Decision|0|||
146663075|NCT03633617|528944741|FG004|Part C (& Follow-up)|Physician Decision|0|||
146663076|NCT03633617|528944742|FG005|Part C (& Follow-up)|Physician Decision|0|||
146663077|NCT03633617|528944743|FG006|Part C (& Follow-up)|Physician Decision|0|||
146663078|NCT03633617|528944744|FG007|Part C (& Follow-up)|Physician Decision|1|||
146663079|NCT03633617|528944745|FG008|Part C (& Follow-up)|Physician Decision|0|||
146663080|NCT03633617|528944746|FG009|Part C (& Follow-up)|Physician Decision|0|||
146663081|NCT03633617|528944747|FG010|Part C (& Follow-up)|Physician Decision|1|||
146663082|NCT03633617|528944737|FG000|Part C (& Follow-up)|COVID-19 related|0|||
146663083|NCT03633617|528944738|FG001|Part C (& Follow-up)|COVID-19 related|0|||
146663084|NCT03633617|528944739|FG002|Part C (& Follow-up)|COVID-19 related|0|||
146663085|NCT03633617|528944740|FG003|Part C (& Follow-up)|COVID-19 related|0|||
146663086|NCT03633617|528944741|FG004|Part C (& Follow-up)|COVID-19 related|0|||
146663087|NCT03633617|528944742|FG005|Part C (& Follow-up)|COVID-19 related|1|||
146663088|NCT03633617|528944743|FG006|Part C (& Follow-up)|COVID-19 related|0|||
146663089|NCT03633617|528944744|FG007|Part C (& Follow-up)|COVID-19 related|0|||
146663090|NCT03633617|528944745|FG008|Part C (& Follow-up)|COVID-19 related|0|||
146663091|NCT03633617|528944746|FG009|Part C (& Follow-up)|COVID-19 related|0|||
146663092|NCT03633617|528944747|FG010|Part C (& Follow-up)|COVID-19 related|0|||
146663093|NCT03633617|528944737|FG000|Part C (& Follow-up)|Protocol Violation|0|||
146663094|NCT03633617|528944738|FG001|Part C (& Follow-up)|Protocol Violation|0|||
146663095|NCT03633617|528944739|FG002|Part C (& Follow-up)|Protocol Violation|0|||
146663096|NCT03633617|528944740|FG003|Part C (& Follow-up)|Protocol Violation|0|||
146663097|NCT03633617|528944741|FG004|Part C (& Follow-up)|Protocol Violation|0|||
146663098|NCT03633617|528944742|FG005|Part C (& Follow-up)|Protocol Violation|0|||
146663099|NCT03633617|528944743|FG006|Part C (& Follow-up)|Protocol Violation|0|||
146663100|NCT03633617|528944744|FG007|Part C (& Follow-up)|Protocol Violation|0|||
146663101|NCT03633617|528944745|FG008|Part C (& Follow-up)|Protocol Violation|0|||
146663102|NCT03633617|528944746|FG009|Part C (& Follow-up)|Protocol Violation|3|||
146663103|NCT03633617|528944747|FG010|Part C (& Follow-up)|Protocol Violation|1|||
146663104|NCT03633617|528944737|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
146663105|NCT03633617|528944738|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
146663106|NCT03633617|528944739|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
146663107|NCT03633617|528944740|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
146663108|NCT03633617|528944741|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
146663109|NCT03633617|528944742|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
146663110|NCT03633617|528944743|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
146663111|NCT03633617|528944744|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
146663112|NCT03633617|528944745|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
146663113|NCT03633617|528944746|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
146663114|NCT03633617|528944747|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
146663115|NCT01890746|528944748|FG000|Overall Study|Death|39|||
146663116|NCT01890746|528944749|FG001|Overall Study|Death|30|||
146663117|NCT01890746|528944748|FG000|Overall Study|Adverse Event|1|||
146663118|NCT01890746|528944749|FG001|Overall Study|Adverse Event|0|||
146663119|NCT01890746|528944748|FG000|Overall Study|Lost to Follow-up|4|||
146663120|NCT01890746|528944749|FG001|Overall Study|Lost to Follow-up|1|||
146663121|NCT01890746|528944748|FG000|Overall Study|Physician Decision|3|||
146663122|NCT01890746|528944749|FG001|Overall Study|Physician Decision|2|||
146663123|NCT01890746|528944748|FG000|Overall Study|Withdrawal by Subject|5|||
146663124|NCT01890746|528944749|FG001|Overall Study|Withdrawal by Subject|8|||
146663125|NCT00777205|528944752|FG000|Overall Study|Lost to Follow-up|25|||
146663126|NCT00777205|528944753|FG001|Overall Study|Lost to Follow-up|9|||
146663127|NCT00777205|528944752|FG000|Overall Study|Withdrawal by Subject|6|||
146663128|NCT00777205|528944753|FG001|Overall Study|Withdrawal by Subject|4|||
146663129|NCT00777205|528944752|FG000|Overall Study|Death|0|||
146663130|NCT00777205|528944753|FG001|Overall Study|Death|2|||
146663131|NCT00777205|528944752|FG000|Overall Study|Protocol Violation|0|||
146663132|NCT00777205|528944753|FG001|Overall Study|Protocol Violation|56|||
146663133|NCT03257371|528944754|FG000|Overall Study|Lost to Follow-up|1|||
146663134|NCT03198078|528944758|FG000|Overall Study|Adverse Event|0|||
146663135|NCT03198078|528944759|FG001|Overall Study|Adverse Event|1|||
146663136|NCT03198078|528944760|FG002|Overall Study|Adverse Event|2|||
146663137|NCT03198078|528944758|FG000|Overall Study|Lack of Efficacy|0|||
146925265|NCT01199055|529886002|FG002|Overall Study|Withdrawal by Subject|1|||
146663138|NCT03198078|528944759|FG001|Overall Study|Lack of Efficacy|0|||
146663139|NCT03198078|528944760|FG002|Overall Study|Lack of Efficacy|3|||
146663140|NCT03198078|528944758|FG000|Overall Study|Lost to Follow-up|1|||
146663141|NCT03198078|528944759|FG001|Overall Study|Lost to Follow-up|0|||
146663142|NCT03198078|528944760|FG002|Overall Study|Lost to Follow-up|0|||
146663143|NCT03198078|528944758|FG000|Overall Study|Pregnancy|0|||
146925266|NCT00511342|529886003|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
146925267|NCT00511342|529886004|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
146663144|NCT03198078|528944759|FG001|Overall Study|Pregnancy|1|||
146663145|NCT03198078|528944760|FG002|Overall Study|Pregnancy|0|||
146663146|NCT03198078|528944758|FG000|Overall Study|Withdrawal by Subject|1|||
146663147|NCT03198078|528944759|FG001|Overall Study|Withdrawal by Subject|0|||
146663148|NCT03198078|528944760|FG002|Overall Study|Withdrawal by Subject|2|||
146663149|NCT03198078|528944758|FG000|Overall Study|Withdrawal by Caregiver|1|||
146663150|NCT03198078|528944759|FG001|Overall Study|Withdrawal by Caregiver|3|||
146663151|NCT03198078|528944760|FG002|Overall Study|Withdrawal by Caregiver|5|||
146663152|NCT01676727|528944761|FG000|Overall Study|Death|18|||
146663153|NCT01676727|528944761|FG000|Overall Study|Withdrawal by Subject|6|||
146663154|NCT01676727|528944761|FG000|Overall Study|Screening failure|5|||
146663155|NCT01676727|528944761|FG000|Overall Study|Not willing to attend 1-year visit|2|||
146663156|NCT01676727|528944761|FG000|Overall Study|Valve explanted|1|||
146663157|NCT00580970|528944762|FG000|Pre-treatment|Non-compliance|1|||
146663158|NCT00580970|528944762|FG000|Treatment (Lovastatin)|Non-compliance|6|||
146663159|NCT00580970|528944762|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
146663160|NCT00580970|528944762|FG000|Treatment (Lovastatin)|Physician Decision|4|||
146663161|NCT00580970|528944762|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
146663162|NCT00580970|528944762|FG000|Treatment (Lovastatin)|Death|1|||
146663163|NCT03161093|528944765|FG000|Overall Study|Protocol Violation|11|||
146663164|NCT03161093|528944766|FG001|Overall Study|Protocol Violation|14|||
146663165|NCT03161093|528944767|FG002|Overall Study|Protocol Violation|6|||
146663166|NCT03161093|528944768|FG003|Overall Study|Protocol Violation|13|||
146663167|NCT03161093|528944769|FG004|Overall Study|Protocol Violation|1|||
146663168|NCT03161093|528944770|FG005|Overall Study|Protocol Violation|0|||
146663169|NCT03161093|528944765|FG000|Overall Study|Adverse Event|5|||
146663170|NCT03161093|528944766|FG001|Overall Study|Adverse Event|21|||
146663171|NCT03161093|528944767|FG002|Overall Study|Adverse Event|16|||
146663172|NCT03161093|528944768|FG003|Overall Study|Adverse Event|35|||
146663173|NCT03161093|528944769|FG004|Overall Study|Adverse Event|2|||
146663174|NCT03161093|528944770|FG005|Overall Study|Adverse Event|1|||
146663175|NCT03161093|528944765|FG000|Overall Study|Lack of Efficacy|9|||
146663176|NCT03161093|528944766|FG001|Overall Study|Lack of Efficacy|13|||
146663177|NCT03161093|528944767|FG002|Overall Study|Lack of Efficacy|9|||
146663178|NCT03161093|528944768|FG003|Overall Study|Lack of Efficacy|24|||
146663179|NCT03161093|528944769|FG004|Overall Study|Lack of Efficacy|4|||
146663180|NCT03161093|528944770|FG005|Overall Study|Lack of Efficacy|1|||
146663181|NCT03161093|528944765|FG000|Overall Study|Physician Decision|0|||
146663182|NCT03161093|528944766|FG001|Overall Study|Physician Decision|1|||
146663183|NCT03161093|528944767|FG002|Overall Study|Physician Decision|0|||
146663184|NCT03161093|528944768|FG003|Overall Study|Physician Decision|2|||
146663185|NCT03161093|528944769|FG004|Overall Study|Physician Decision|17|||
146663186|NCT03161093|528944770|FG005|Overall Study|Physician Decision|15|||
146663187|NCT03161093|528944765|FG000|Overall Study|Withdrawal by Subject|24|||
146663188|NCT03161093|528944766|FG001|Overall Study|Withdrawal by Subject|73|||
146663189|NCT03161093|528944767|FG002|Overall Study|Withdrawal by Subject|44|||
146663190|NCT03161093|528944768|FG003|Overall Study|Withdrawal by Subject|97|||
146663191|NCT03161093|528944769|FG004|Overall Study|Withdrawal by Subject|11|||
146663192|NCT03161093|528944770|FG005|Overall Study|Withdrawal by Subject|10|||
146663193|NCT03161093|528944765|FG000|Overall Study|Lost to Follow-up|3|||
146663194|NCT03161093|528944766|FG001|Overall Study|Lost to Follow-up|12|||
146925268|NCT00511342|529886003|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
146925269|NCT00511342|529886004|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
146925270|NCT00511342|529886003|FG000|Overall Study|Pregnancy|0|||
146925271|NCT00511342|529886004|FG001|Overall Study|Pregnancy|1|||
146925272|NCT00511342|529886003|FG000|Overall Study|Pregnancy wish|0|||
146663195|NCT03161093|528944767|FG002|Overall Study|Lost to Follow-up|4|||
146663196|NCT03161093|528944768|FG003|Overall Study|Lost to Follow-up|7|||
146663197|NCT03161093|528944769|FG004|Overall Study|Lost to Follow-up|8|||
146663198|NCT03161093|528944770|FG005|Overall Study|Lost to Follow-up|13|||
146663199|NCT03161093|528944765|FG000|Overall Study|Death|3|||
146925273|NCT00511342|529886004|FG001|Overall Study|Pregnancy wish|1|||
146663200|NCT03161093|528944766|FG001|Overall Study|Death|9|||
146663201|NCT03161093|528944767|FG002|Overall Study|Death|7|||
146663202|NCT03161093|528944768|FG003|Overall Study|Death|9|||
146663203|NCT03161093|528944769|FG004|Overall Study|Death|0|||
146663204|NCT03161093|528944770|FG005|Overall Study|Death|0|||
146925274|NCT00511342|529886003|FG000|Overall Study|Lost to Follow-up|1|||
146663205|NCT03161093|528944765|FG000|Overall Study|Unknown - Not reported|0|||
146663206|NCT03161093|528944766|FG001|Overall Study|Unknown - Not reported|1|||
146663207|NCT03161093|528944767|FG002|Overall Study|Unknown - Not reported|0|||
146663208|NCT03161093|528944768|FG003|Overall Study|Unknown - Not reported|0|||
146663209|NCT03161093|528944769|FG004|Overall Study|Unknown - Not reported|0|||
146925275|NCT00511342|529886004|FG001|Overall Study|Lost to Follow-up|5|||
146663210|NCT03161093|528944770|FG005|Overall Study|Unknown - Not reported|1|||
146663211|NCT01031706|528944771|FG000|Overall Study|Adverse Event|1|||
146663212|NCT01031706|528944772|FG001|Overall Study|Adverse Event|0|||
146663213|NCT01031706|528944771|FG000|Overall Study|Withdrawal by Subject|1|||
146663214|NCT01031706|528944772|FG001|Overall Study|Withdrawal by Subject|1|||
146663215|NCT02124161|528944773|FG000|Overall Study|Other unspecified|0|||
146663216|NCT02124161|528944774|FG001|Overall Study|Other unspecified|1|||
146663217|NCT02124161|528944773|FG000|Overall Study|Death|1|||
146663218|NCT02124161|528944774|FG001|Overall Study|Death|0|||
146663219|NCT02124161|528944773|FG000|Overall Study|Protocol Violation|2|||
146663220|NCT02124161|528944774|FG001|Overall Study|Protocol Violation|1|||
146663221|NCT02124161|528944773|FG000|Overall Study|Withdrawal by Subject|1|||
146663222|NCT02124161|528944774|FG001|Overall Study|Withdrawal by Subject|2|||
146663223|NCT02124161|528944773|FG000|Overall Study|Adverse Event|2|||
146663224|NCT02124161|528944774|FG001|Overall Study|Adverse Event|0|||
146663225|NCT02124161|528944773|FG000|Overall Study|Does not meet entrance criteria|2|||
146663226|NCT02124161|528944774|FG001|Overall Study|Does not meet entrance criteria|3|||
146663227|NCT02124161|528944773|FG000|Overall Study|No longer meets eligibility criteria|5|||
146663228|NCT02124161|528944774|FG001|Overall Study|No longer meets eligibility criteria|4|||
146663229|NCT02124161|528944773|FG000|Overall Study|Lost to Follow-up|3|||
146663230|NCT02124161|528944774|FG001|Overall Study|Lost to Follow-up|4|||
146663231|NCT01393301|528944775|FG000|Overall Study|Lost to Follow-up|5|||
146663232|NCT01393301|528944776|FG001|Overall Study|Lost to Follow-up|3|||
146663233|NCT01393301|528944775|FG000|Overall Study|Withdrawal by Subject|2|||
146663234|NCT01393301|528944776|FG001|Overall Study|Withdrawal by Subject|0|||
146663235|NCT01393301|528944775|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
146663236|NCT01393301|528944776|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
146663237|NCT03342963|528944777|FG000|Overall Study|Adverse Event|1|||
146663238|NCT03342963|528944778|FG001|Overall Study|Adverse Event|2|||
146663239|NCT03342963|528944779|FG002|Overall Study|Adverse Event|0|||
146925276|NCT00511342|529886003|FG000|Overall Study|Other Reason|2|||
146925277|NCT00511342|529886004|FG001|Overall Study|Other Reason|2|||
146925278|NCT02432040|529886005|FG000|Overall Study|Lack of Efficacy|3|||
146663240|NCT03342963|528944780|FG003|Overall Study|Adverse Event|0|||
146663241|NCT03342963|528944777|FG000|Overall Study|Withdrawal by Subject|1|||
146663242|NCT03342963|528944778|FG001|Overall Study|Withdrawal by Subject|0|||
146663243|NCT03342963|528944779|FG002|Overall Study|Withdrawal by Subject|0|||
146663244|NCT03342963|528944780|FG003|Overall Study|Withdrawal by Subject|0|||
146663245|NCT01008150|528944781|FG000|Overall Study|did not receive study drug|1|||
146663246|NCT01008150|528944782|FG001|Overall Study|did not receive study drug|1|||
146663247|NCT01008150|528944783|FG002|Overall Study|did not receive study drug|1|||
146663248|NCT01008150|528944784|FG003|Overall Study|did not receive study drug|0|||
146663249|NCT01309165|528944785|FG000|Overall Study|Lost to Follow-up|4|||
146663250|NCT01309165|528944786|FG001|Overall Study|Lost to Follow-up|3|||
146663251|NCT01309165|528944785|FG000|Overall Study|Return to work|1|||
146663252|NCT01309165|528944786|FG001|Overall Study|Return to work|2|||
146663253|NCT01309165|528944785|FG000|Overall Study|Left country|0|||
146663254|NCT01309165|528944786|FG001|Overall Study|Left country|1|||
146925279|NCT02432040|529886006|FG001|Overall Study|Lack of Efficacy|0|||
146925280|NCT02432040|529886005|FG000|Overall Study|Lost to Follow-up|4|||
146663255|NCT01309165|528944785|FG000|Overall Study|No transportation|0|||
146663256|NCT01309165|528944786|FG001|Overall Study|No transportation|1|||
146663257|NCT01309165|528944785|FG000|Overall Study|Admitted to hospital for second stroke|1|||
146925281|NCT02432040|529886006|FG001|Overall Study|Lost to Follow-up|5|||
146925282|NCT02432040|529886005|FG000|Overall Study|Physician Decision|1|||
146925283|NCT02432040|529886006|FG001|Overall Study|Physician Decision|1|||
146925284|NCT01019486|529886008|FG000|Overall Study|Withdrawal by Subject|1|||
146925285|NCT01019486|529886009|FG001|Overall Study|Withdrawal by Subject|1|||
146925286|NCT01019486|529886010|FG002|Overall Study|Withdrawal by Subject|1|||
146925287|NCT05373706|529886011|FG000|Overall Study|Lost to Follow-up|2|||
146925288|NCT05373706|529886012|FG001|Overall Study|Lost to Follow-up|2|||
146925289|NCT02402218|529886015|FG000|Overall Study|Did not pickup study medication|12|||
146663258|NCT01309165|528944786|FG001|Overall Study|Admitted to hospital for second stroke|0|||
146663259|NCT01497275|528944788|FG000|Overall Study|Death|1|||
146663260|NCT01497275|528944788|FG000|Overall Study|Adverse Event|1|||
146663261|NCT01626495|528944793|FG000|Overall Study|Adverse Event|3|||
146663262|NCT01626495|528944793|FG000|Overall Study|Disease progression|27|||
146663263|NCT01626495|528944793|FG000|Overall Study|Withdrawal by Subject|1|||
146925290|NCT02402218|529886016|FG001|Overall Study|Did not pickup study medication|9|||
146925291|NCT02402218|529886017|FG002|Overall Study|Did not pickup study medication|13|||
146925292|NCT02402218|529886015|FG000|Overall Study|Lack of Efficacy|0|||
146663264|NCT01626495|528944793|FG000|Overall Study|Administrative problem|1|||
146663265|NCT01626495|528944793|FG000|Overall Study|Death|2|||
146663266|NCT01626495|528944793|FG000|Overall Study|Physician Decision|1|||
146663267|NCT01626495|528944793|FG000|Overall Study|New cancer therapy|16|||
146773724|NCT01170962|529341186|FG002|Treatment Period|Lack of Efficacy|7|||
146925293|NCT02402218|529886016|FG001|Overall Study|Lack of Efficacy|1|||
146925294|NCT02402218|529886017|FG002|Overall Study|Lack of Efficacy|1|||
146663268|NCT01626495|528944793|FG000|Overall Study|Manufacturing failure|1|||
146663269|NCT02925923|528946092|FG000|Overall Study|blood samples hemolyzed|0|||
146663270|NCT02925923|528946093|FG001|Overall Study|blood samples hemolyzed|2|||
146663271|NCT00428792|528946094|FG000|Overall Study|Lack of Efficacy|1|||
146663272|NCT00428792|528946095|FG001|Overall Study|Lack of Efficacy|3|||
146663273|NCT00428792|528946094|FG000|Overall Study|Lost to Follow-up|0|||
146663274|NCT00428792|528946095|FG001|Overall Study|Lost to Follow-up|1|||
146663275|NCT04612790|528946101|FG000|DB Period (Up to 36 Weeks)|Death|1|||
146663276|NCT04612790|528946102|FG001|DB Period (Up to 36 Weeks)|Death|1|||
146663277|NCT04612790|528946103|FG002|DB Period (Up to 36 Weeks)|Death|0|||
146663278|NCT04612790|528946104|FG003|DB Period (Up to 36 Weeks)|Death|0|||
146663279|NCT04612790|528946101|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
146663280|NCT04612790|528946102|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
146663281|NCT04612790|528946103|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
146663282|NCT04612790|528946104|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
146663283|NCT04612790|528946101|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
146663284|NCT04612790|528946102|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
146663285|NCT04612790|528946103|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
146663286|NCT04612790|528946104|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
146663287|NCT04612790|528946101|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
146663288|NCT04612790|528946102|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
146663289|NCT04612790|528946103|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
146663290|NCT04612790|528946104|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
146663291|NCT04612790|528946101|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
146663292|NCT04612790|528946102|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
146663293|NCT04612790|528946103|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
146663294|NCT04612790|528946104|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
146663295|NCT04612790|528946101|FG000|DB Period (Up to 36 Weeks)|Other|1|||
146663296|NCT04612790|528946102|FG001|DB Period (Up to 36 Weeks)|Other|0|||
146663297|NCT04612790|528946103|FG002|DB Period (Up to 36 Weeks)|Other|0|||
146663298|NCT04612790|528946104|FG003|DB Period (Up to 36 Weeks)|Other|0|||
146663299|NCT04612790|528946101|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
146663300|NCT04612790|528946102|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
146663301|NCT04612790|528946103|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
146663302|NCT04612790|528946104|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
146663303|NCT04612790|528946101|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
146663304|NCT04612790|528946102|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
146663305|NCT04612790|528946103|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
146663306|NCT04612790|528946104|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
146663307|NCT04612790|528946101|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
146663308|NCT04612790|528946102|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
146663309|NCT04612790|528946103|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
146663310|NCT04612790|528946104|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
146663311|NCT04612790|528946101|FG000|OLE Period (Up to 1 Year)|Other|0|||
146663312|NCT04612790|528946102|FG001|OLE Period (Up to 1 Year)|Other|0|||
146663313|NCT04612790|528946103|FG002|OLE Period (Up to 1 Year)|Other|0|||
146663314|NCT04612790|528946104|FG003|OLE Period (Up to 1 Year)|Other|1|||
146663315|NCT03387683|528946105|FG000|Overall Study|In receipt of disallowed medication|1|||
146663316|NCT03387683|528946106|FG001|Overall Study|In receipt of disallowed medication|0|||
146663317|NCT03387683|528946105|FG000|Overall Study|Did not receive treatment|1|||
146663318|NCT03387683|528946106|FG001|Overall Study|Did not receive treatment|0|||
146663319|NCT00722423|528946107|FG000|Overall Study|Protocol Violation|0|||
146663320|NCT00722423|528946108|FG001|Overall Study|Protocol Violation|1|||
146663321|NCT01950169|528946109|FG000|Overall Study|Withdrawal by Subject|2|||
146663322|NCT01950169|528946110|FG001|Overall Study|Withdrawal by Subject|8|||
146925295|NCT02402218|529886015|FG000|Overall Study|Death|1|||
146925296|NCT02402218|529886016|FG001|Overall Study|Death|0|||
146925297|NCT02402218|529886017|FG002|Overall Study|Death|0|||
146925298|NCT02402218|529886015|FG000|Overall Study|Reinfection|0|||
146925299|NCT02402218|529886016|FG001|Overall Study|Reinfection|0|||
146925300|NCT02402218|529886017|FG002|Overall Study|Reinfection|1|||
146925301|NCT02402218|529886015|FG000|Overall Study|Adverse Event|0|||
146663323|NCT01950169|528946111|FG002|Overall Study|Withdrawal by Subject|1|||
146663324|NCT01950169|528946109|FG000|Overall Study|Death|1|||
146663325|NCT01950169|528946110|FG001|Overall Study|Death|0|||
146925302|NCT02402218|529886016|FG001|Overall Study|Adverse Event|2|||
146663326|NCT01950169|528946111|FG002|Overall Study|Death|0|||
146663327|NCT01938573|528946113|FG000|Overall Study|Lack of Efficacy|1|||
146663328|NCT01938573|528946114|FG001|Overall Study|Lack of Efficacy|0|||
146663329|NCT01938573|528946113|FG000|Overall Study|Operation at other hospital|1|||
146663330|NCT01938573|528946114|FG001|Overall Study|Operation at other hospital|0|||
146663331|NCT00737438|528946119|FG000|Overall Study|Withdrawal by Subject|2|||
146663332|NCT00737438|528946119|FG000|Overall Study|Patient ineligible|1|||
146925303|NCT02402218|529886017|FG002|Overall Study|Adverse Event|1|||
146925304|NCT02402218|529886015|FG000|Overall Study|Withdrawal by Subject|1|||
146663333|NCT02410551|528946120|FG000|Overall Study|Adverse Event|1|||
146663334|NCT02410551|528946120|FG000|Overall Study|Withdrawal by Subject|1|||
146663335|NCT02410551|528946120|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
146663336|NCT01739309|528946121|FG000|Overall Study|Adverse Event|1|||
146663337|NCT01739309|528946121|FG000|Overall Study|Withdrawal by Subject|1|||
146663338|NCT05085730|528946124|FG000|Overall Study|Withdrawal by Subject|4|||
146663339|NCT05085730|528946124|FG000|Overall Study|Physician Decision|1|||
146663340|NCT05447897|528946125|FG000|Overall Study|Did not participate in survey|2|||
146663341|NCT04553679|528946126|FG000|Overall Study|Withdrawal by Subject|2|||
146663342|NCT04553679|528946127|FG001|Overall Study|Withdrawal by Subject|0|||
146663343|NCT04553679|528946126|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
146663344|NCT04553679|528946127|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
146663345|NCT01649804|528946128|FG000|Overall Study|Administrative/Other|8|||
146663346|NCT03719586|528946129|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
146663347|NCT03719586|528946130|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
146663348|NCT03719586|528946131|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
146663349|NCT03719586|528946132|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
146663350|NCT00178633|528946133|FG000|Overall Study|Lost to Follow-up|6|||
146663351|NCT03845543|528946134|FG000|Overall Study|Death|25|||
146663352|NCT03845543|528946134|FG000|Overall Study|Withdrawal by Subject|2|||
146663353|NCT03845543|528946134|FG000|Overall Study|Lost to Follow-up|12|||
146663354|NCT03845543|528946134|FG000|Overall Study|Adverse Event|17|||
146663355|NCT02028871|528946143|FG000|Overall Study|Positive urine drug screen|1|||
146663356|NCT02028871|528946144|FG001|Overall Study|Positive urine drug screen|1|||
146663357|NCT02028871|528946143|FG000|Overall Study|Withdrawal by Subject|1|||
146663358|NCT02028871|528946144|FG001|Overall Study|Withdrawal by Subject|2|||
146663359|NCT02028871|528946143|FG000|Overall Study|IV placement difficulty|1|||
146663360|NCT02028871|528946144|FG001|Overall Study|IV placement difficulty|0|||
146663361|NCT02028871|528946143|FG000|Overall Study|Current Illness|1|||
146663362|NCT02028871|528946144|FG001|Overall Study|Current Illness|0|||
146663363|NCT02633501|528946147|FG000|Overall Study|Adverse Event|0|||
146663364|NCT02633501|528946148|FG001|Overall Study|Adverse Event|0|||
146663365|NCT02633501|528946149|FG002|Overall Study|Adverse Event|1|||
146663366|NCT02633501|528946150|FG003|Overall Study|Adverse Event|0|||
146663367|NCT02633501|528946151|FG004|Overall Study|Adverse Event|1|||
146663368|NCT02633501|528946152|FG005|Overall Study|Adverse Event|1|||
146663369|NCT02633501|528946147|FG000|Overall Study|Withdrawal by Subject|2|||
146663370|NCT02633501|528946148|FG001|Overall Study|Withdrawal by Subject|1|||
146663371|NCT02633501|528946149|FG002|Overall Study|Withdrawal by Subject|2|||
146663372|NCT02633501|528946150|FG003|Overall Study|Withdrawal by Subject|2|||
146663373|NCT02633501|528946151|FG004|Overall Study|Withdrawal by Subject|1|||
146663374|NCT02633501|528946152|FG005|Overall Study|Withdrawal by Subject|3|||
146663375|NCT02633501|528946147|FG000|Overall Study|Various other reasons|0|||
146663376|NCT02633501|528946148|FG001|Overall Study|Various other reasons|2|||
146663377|NCT02633501|528946149|FG002|Overall Study|Various other reasons|4|||
146663378|NCT02633501|528946150|FG003|Overall Study|Various other reasons|1|||
146663379|NCT02633501|528946151|FG004|Overall Study|Various other reasons|7|||
146663380|NCT02633501|528946152|FG005|Overall Study|Various other reasons|11|||
146663381|NCT02633501|528946147|FG000|Overall Study|Lost to Follow-up|0|||
146663382|NCT02633501|528946148|FG001|Overall Study|Lost to Follow-up|0|||
146663383|NCT02633501|528946149|FG002|Overall Study|Lost to Follow-up|0|||
146663384|NCT02633501|528946150|FG003|Overall Study|Lost to Follow-up|1|||
146663385|NCT02633501|528946151|FG004|Overall Study|Lost to Follow-up|2|||
146663386|NCT02633501|528946152|FG005|Overall Study|Lost to Follow-up|0|||
146663387|NCT01912963|528946153|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
146663388|NCT01912963|528946154|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
146663389|NCT01912963|528946155|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
146663390|NCT01912963|528946153|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
146663391|NCT01912963|528946154|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
146663392|NCT01912963|528946155|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
146663393|NCT01912963|528946153|FG000|Overall Study|Adverse Event|0|||
146663394|NCT01912963|528946154|FG001|Overall Study|Adverse Event|1|||
146663395|NCT01912963|528946155|FG002|Overall Study|Adverse Event|1|||
146663396|NCT01912963|528946153|FG000|Overall Study|Withdrawal by Subject|0|||
146663397|NCT01912963|528946154|FG001|Overall Study|Withdrawal by Subject|1|||
146663398|NCT01912963|528946155|FG002|Overall Study|Withdrawal by Subject|0|||
146663399|NCT01912963|528946153|FG000|Overall Study|Sought treatment locally|0|||
146663400|NCT01912963|528946154|FG001|Overall Study|Sought treatment locally|1|||
146663401|NCT01912963|528946155|FG002|Overall Study|Sought treatment locally|0|||
146663402|NCT01147172|528946166|FG000|Overall Study|Withdrawal by Subject|2|||
146663403|NCT01147172|528946166|FG000|Overall Study|Lost to Follow-up|2|||
146663404|NCT01069627|528946167|FG000|Overall Study|Disease progression|7|||
146663405|NCT01069627|528946167|FG000|Overall Study|Adverse Event|12|||
146663406|NCT01069627|528946167|FG000|Overall Study|Protocol Violation|1|||
146663407|NCT02963935|528946172|FG000|Overall Study|Adverse Event|12|||
146663408|NCT02963935|528946173|FG001|Overall Study|Adverse Event|6|||
146663409|NCT02963935|528946172|FG000|Overall Study|Protocol Violation|2|||
146663410|NCT02963935|528946173|FG001|Overall Study|Protocol Violation|1|||
146663411|NCT02963935|528946172|FG000|Overall Study|Lack of Efficacy|0|||
146663412|NCT02963935|528946173|FG001|Overall Study|Lack of Efficacy|2|||
146663413|NCT02963935|528946172|FG000|Overall Study|Lost to Follow-up|1|||
146663414|NCT02963935|528946173|FG001|Overall Study|Lost to Follow-up|6|||
146663415|NCT02963935|528946172|FG000|Overall Study|Unclassified|13|||
146663416|NCT02963935|528946173|FG001|Overall Study|Unclassified|22|||
146663417|NCT00464269|528946174|FG000|Overall Study|Lack of Efficacy|1|||
146663418|NCT00464269|528946175|FG001|Overall Study|Lack of Efficacy|0|||
146663419|NCT00464269|528946176|FG002|Overall Study|Lack of Efficacy|0|||
146663420|NCT00464269|528946177|FG003|Overall Study|Lack of Efficacy|0|||
146663421|NCT00464269|528946174|FG000|Overall Study|Lost to Follow-up|0|||
146663422|NCT00464269|528946175|FG001|Overall Study|Lost to Follow-up|4|||
146663423|NCT00464269|528946176|FG002|Overall Study|Lost to Follow-up|0|||
146663424|NCT00464269|528946177|FG003|Overall Study|Lost to Follow-up|1|||
146663425|NCT00464269|528946174|FG000|Overall Study|Withdrawal by Subject|0|||
146663426|NCT00464269|528946175|FG001|Overall Study|Withdrawal by Subject|2|||
146663427|NCT00464269|528946176|FG002|Overall Study|Withdrawal by Subject|1|||
146663428|NCT00464269|528946177|FG003|Overall Study|Withdrawal by Subject|1|||
146663429|NCT00464269|528946174|FG000|Overall Study|Other reason|3|||
146663430|NCT00464269|528946175|FG001|Overall Study|Other reason|3|||
146663431|NCT00464269|528946176|FG002|Overall Study|Other reason|1|||
146663432|NCT00464269|528946177|FG003|Overall Study|Other reason|1|||
146663433|NCT00464269|528946174|FG000|Overall Study|AE, serious fatal|0|||
146663434|NCT00464269|528946175|FG001|Overall Study|AE, serious fatal|0|||
146663435|NCT00464269|528946176|FG002|Overall Study|AE, serious fatal|1|||
146663436|NCT00464269|528946177|FG003|Overall Study|AE, serious fatal|1|||
146663437|NCT00464269|528946174|FG000|Overall Study|SAE, non-fatal|0|||
146663438|NCT00464269|528946175|FG001|Overall Study|SAE, non-fatal|0|||
146663439|NCT00464269|528946176|FG002|Overall Study|SAE, non-fatal|0|||
146663440|NCT00464269|528946177|FG003|Overall Study|SAE, non-fatal|1|||
146663441|NCT00464269|528946174|FG000|Overall Study|AE, non-serious non-fatal|2|||
146663442|NCT00464269|528946175|FG001|Overall Study|AE, non-serious non-fatal|8|||
146663443|NCT00464269|528946176|FG002|Overall Study|AE, non-serious non-fatal|3|||
146663444|NCT00464269|528946177|FG003|Overall Study|AE, non-serious non-fatal|4|||
146663445|NCT00464269|528946174|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
146663446|NCT00464269|528946175|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
146663447|NCT00464269|528946176|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
146663448|NCT00464269|528946177|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
146663449|NCT00747461|528946178|FG000|Overall Study|study terminated by sponsor|5|||
146663450|NCT02149875|528946179|FG000|Overall Study|Lost to Follow-up|3|||
146663451|NCT02149875|528946180|FG001|Overall Study|Lost to Follow-up|4|||
146663452|NCT02149875|528946181|FG002|Overall Study|Lost to Follow-up|5|||
146663453|NCT02149875|528946179|FG000|Overall Study|Withdrawal by Subject|3|||
146663454|NCT02149875|528946180|FG001|Overall Study|Withdrawal by Subject|2|||
146663455|NCT02149875|528946181|FG002|Overall Study|Withdrawal by Subject|2|||
146663456|NCT02149875|528946179|FG000|Overall Study|Physician Decision|1|||
146663457|NCT02149875|528946180|FG001|Overall Study|Physician Decision|2|||
146663458|NCT02149875|528946181|FG002|Overall Study|Physician Decision|2|||
146663459|NCT00299182|528946183|FG000|Overall Study|Withdrawal by Subject|0|||
146663460|NCT00299182|528946184|FG001|Overall Study|Withdrawal by Subject|0|||
146663461|NCT00299182|528946185|FG002|Overall Study|Withdrawal by Subject|1|||
146663462|NCT00299182|528946186|FG003|Overall Study|Withdrawal by Subject|0|||
146663463|NCT00299182|528946187|FG004|Overall Study|Withdrawal by Subject|1|||
146663464|NCT00299182|528946188|FG005|Overall Study|Withdrawal by Subject|2|||
146663465|NCT00299182|528946189|FG006|Overall Study|Withdrawal by Subject|0|||
146663466|NCT00299182|528946183|FG000|Overall Study|Chemotherapy Changed|0|||
146663467|NCT00299182|528946184|FG001|Overall Study|Chemotherapy Changed|0|||
146663468|NCT00299182|528946185|FG002|Overall Study|Chemotherapy Changed|1|||
146663469|NCT00299182|528946186|FG003|Overall Study|Chemotherapy Changed|0|||
146663470|NCT00299182|528946187|FG004|Overall Study|Chemotherapy Changed|1|||
146663471|NCT00299182|528946188|FG005|Overall Study|Chemotherapy Changed|0|||
146663472|NCT00299182|528946189|FG006|Overall Study|Chemotherapy Changed|1|||
146663473|NCT00299182|528946183|FG000|Overall Study|Adverse Event|0|||
146663474|NCT00299182|528946184|FG001|Overall Study|Adverse Event|0|||
146663475|NCT00299182|528946185|FG002|Overall Study|Adverse Event|0|||
146663476|NCT00299182|528946186|FG003|Overall Study|Adverse Event|0|||
146663477|NCT00299182|528946187|FG004|Overall Study|Adverse Event|0|||
146663478|NCT00299182|528946188|FG005|Overall Study|Adverse Event|1|||
146663479|NCT00299182|528946189|FG006|Overall Study|Adverse Event|0|||
146663480|NCT00299182|528946183|FG000|Overall Study|Not Eligible|0|||
146663481|NCT00299182|528946184|FG001|Overall Study|Not Eligible|0|||
146663482|NCT00299182|528946185|FG002|Overall Study|Not Eligible|0|||
146663483|NCT00299182|528946186|FG003|Overall Study|Not Eligible|0|||
146925305|NCT02402218|529886016|FG001|Overall Study|Withdrawal by Subject|1|||
146925306|NCT02402218|529886017|FG002|Overall Study|Withdrawal by Subject|1|||
146925307|NCT03011840|529886018|FG000|Overall Study|Not received PIL in post PIL phase|0|||
146925308|NCT03011840|529886019|FG001|Overall Study|Not received PIL in post PIL phase|21|||
146925309|NCT03738566|529886020|FG000|Initial Study Phase|Withdrawal by Subject|1|||
146925310|NCT03738566|529886021|FG001|Initial Study Phase|Withdrawal by Subject|1|||
146925311|NCT03738566|529886022|FG002|Initial Study Phase|Withdrawal by Subject|2|||
146663484|NCT00299182|528946187|FG004|Overall Study|Not Eligible|1|||
146663485|NCT00299182|528946188|FG005|Overall Study|Not Eligible|0|||
146663486|NCT00299182|528946189|FG006|Overall Study|Not Eligible|0|||
146663487|NCT00771316|528946195|FG000|Overall Study|Adverse Event|0|||
146663488|NCT00771316|528946196|FG001|Overall Study|Adverse Event|1|||
146663489|NCT00771316|528946195|FG000|Overall Study|Patient withdrew consent|1|||
146663490|NCT00771316|528946196|FG001|Overall Study|Patient withdrew consent|0|||
146663491|NCT00771316|528946195|FG000|Overall Study|Discontinued due to early termination|1|||
146663492|NCT00771316|528946196|FG001|Overall Study|Discontinued due to early termination|0|||
146663493|NCT02955797|528946197|FG000|Overall Study|Protocol Violation|1|||
146663494|NCT02955797|528946198|FG001|Overall Study|Protocol Violation|0|||
146663495|NCT02955797|528946199|FG002|Overall Study|Protocol Violation|0|||
146663496|NCT02955797|528946200|FG003|Overall Study|Protocol Violation|1|||
146663497|NCT02955797|528946197|FG000|Overall Study|Withdrawal by Subject|2|||
146663498|NCT02955797|528946198|FG001|Overall Study|Withdrawal by Subject|2|||
146663499|NCT02955797|528946199|FG002|Overall Study|Withdrawal by Subject|0|||
146663500|NCT02955797|528946200|FG003|Overall Study|Withdrawal by Subject|1|||
146663501|NCT02955797|528946197|FG000|Overall Study|Lost to Follow-up|0|||
146663502|NCT02955797|528946198|FG001|Overall Study|Lost to Follow-up|1|||
146663503|NCT02955797|528946199|FG002|Overall Study|Lost to Follow-up|0|||
146663504|NCT02955797|528946200|FG003|Overall Study|Lost to Follow-up|0|||
146663505|NCT03131453|528946201|FG000|Overall Study|Study terminated by Sponsor|424|||
146663506|NCT03131453|528946202|FG001|Overall Study|Study terminated by Sponsor|222|||
146663507|NCT03131453|528946203|FG002|Overall Study|Study terminated by Sponsor|438|||
146663508|NCT03131453|528946201|FG000|Overall Study|Withdrawal by Subject|18|||
146663509|NCT03131453|528946202|FG001|Overall Study|Withdrawal by Subject|7|||
146663510|NCT03131453|528946203|FG002|Overall Study|Withdrawal by Subject|13|||
146663511|NCT03131453|528946201|FG000|Overall Study|Adverse Event|10|||
146663512|NCT03131453|528946202|FG001|Overall Study|Adverse Event|3|||
146663513|NCT03131453|528946203|FG002|Overall Study|Adverse Event|3|||
146663514|NCT03131453|528946201|FG000|Overall Study|Lost to Follow-up|1|||
146663515|NCT03131453|528946202|FG001|Overall Study|Lost to Follow-up|0|||
146663516|NCT03131453|528946203|FG002|Overall Study|Lost to Follow-up|1|||
146663517|NCT03131453|528946201|FG000|Overall Study|Physician Decision|1|||
146663518|NCT03131453|528946202|FG001|Overall Study|Physician Decision|0|||
146663519|NCT03131453|528946203|FG002|Overall Study|Physician Decision|1|||
146663520|NCT03131453|528946201|FG000|Overall Study|Non-compliance with study treatment|1|||
146663521|NCT03131453|528946202|FG001|Overall Study|Non-compliance with study treatment|0|||
146663522|NCT03131453|528946203|FG002|Overall Study|Non-compliance with study treatment|0|||
146663523|NCT03131453|528946201|FG000|Overall Study|Technical problems|1|||
146663524|NCT03131453|528946202|FG001|Overall Study|Technical problems|0|||
146663525|NCT03131453|528946203|FG002|Overall Study|Technical problems|0|||
146663526|NCT03131453|528946201|FG000|Overall Study|Protocol deviation|0|||
146663527|NCT03131453|528946202|FG001|Overall Study|Protocol deviation|1|||
146663528|NCT03131453|528946203|FG002|Overall Study|Protocol deviation|0|||
146663529|NCT02081183|528946204|FG000|Overall Study|Lost to Follow-up|0|||
146663530|NCT02081183|528946205|FG001|Overall Study|Lost to Follow-up|1|||
146663531|NCT02081183|528946204|FG000|Overall Study|Protocol Violation|1|||
146663532|NCT02081183|528946205|FG001|Overall Study|Protocol Violation|0|||
146663533|NCT02081183|528946204|FG000|Overall Study|Other|3|||
146663534|NCT02081183|528946205|FG001|Overall Study|Other|3|||
146663535|NCT04176705|528946206|FG000|Overall Study|Withdrawal by Subject|4|||
146663536|NCT04176705|528946207|FG001|Overall Study|Withdrawal by Subject|4|||
146663537|NCT04176705|528946206|FG000|Overall Study|Death|1|||
146663538|NCT04176705|528946207|FG001|Overall Study|Death|1|||
146663539|NCT04176705|528946206|FG000|Overall Study|Lost to Follow-up|3|||
146663540|NCT04176705|528946207|FG001|Overall Study|Lost to Follow-up|3|||
146663541|NCT02024555|528946208|FG000|Overall Study|Lost to Follow-up|1|||
146663542|NCT02024555|528946209|FG001|Overall Study|Lost to Follow-up|1|||
146663543|NCT02024555|528946208|FG000|Overall Study|Withdrawal by Subject|5|||
146663544|NCT02024555|528946209|FG001|Overall Study|Withdrawal by Subject|1|||
146663545|NCT03805646|528946222|FG000|Overall Study|Death|40|||
146663546|NCT03805646|528946223|FG001|Overall Study|Death|49|||
146663547|NCT03805646|528946222|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
146663548|NCT03805646|528946223|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
146925312|NCT03738566|529886023|FG003|Initial Study Phase|Withdrawal by Subject|0|||
146925313|NCT03738566|529886020|FG000|Initial Study Phase|Death|0|||
146925314|NCT03738566|529886021|FG001|Initial Study Phase|Death|1|||
146663549|NCT01863953|528947747|FG000|Overall Study|Adverse Event|0|||
146663550|NCT01863953|528947748|FG001|Overall Study|Adverse Event|0|||
146663551|NCT01863953|528947749|FG002|Overall Study|Adverse Event|1|||
146925315|NCT03738566|529886022|FG002|Initial Study Phase|Death|0|||
146925316|NCT03738566|529886023|FG003|Initial Study Phase|Death|0|||
146925317|NCT03738566|529886020|FG000|Initial Study Phase|Treatment failure|5|||
146925318|NCT03738566|529886021|FG001|Initial Study Phase|Treatment failure|0|||
146925319|NCT03738566|529886022|FG002|Initial Study Phase|Treatment failure|0|||
146925320|NCT03738566|529886023|FG003|Initial Study Phase|Treatment failure|0|||
146925321|NCT03738566|529886020|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
146925322|NCT03738566|529886021|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
146925323|NCT03738566|529886022|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
146925324|NCT03738566|529886023|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
146925325|NCT00946530|529886024|FG000|Overall Study|Withdrawal by Subject|0|||
146925326|NCT00946530|529886025|FG001|Overall Study|Withdrawal by Subject|3|||
146663552|NCT01824342|528947757|FG000|Overall Study|Withdrawal by Subject|0|||
146663553|NCT01824342|528947758|FG001|Overall Study|Withdrawal by Subject|3|||
146663554|NCT01824342|528947757|FG000|Overall Study|Adverse Event|1|||
146663555|NCT01824342|528947758|FG001|Overall Study|Adverse Event|1|||
146663556|NCT01824342|528947757|FG000|Overall Study|Disease Progression|1|||
146663557|NCT01824342|528947758|FG001|Overall Study|Disease Progression|1|||
146663558|NCT01824342|528947757|FG000|Overall Study|Physician Decision|5|||
146663559|NCT01824342|528947758|FG001|Overall Study|Physician Decision|0|||
146663560|NCT01824342|528947757|FG000|Overall Study|Death|2|||
146663561|NCT01824342|528947758|FG001|Overall Study|Death|0|||
146663562|NCT04195906|528947761|FG000|Part 1|Adverse Event|3|||
146663563|NCT04195906|528947762|FG001|Part 1|Adverse Event|7|||
146663564|NCT04195906|528947761|FG000|Part 1|Withdrawal by Subject|0|||
146663565|NCT04195906|528947762|FG001|Part 1|Withdrawal by Subject|1|||
146663566|NCT04195906|528947761|FG000|Part 2|Adverse Event|1|||
146663567|NCT04195906|528947762|FG001|Part 2|Adverse Event|1|||
146663568|NCT04195906|528947761|FG000|Part 2|Withdrawal by Subject|0|||
146663569|NCT04195906|528947762|FG001|Part 2|Withdrawal by Subject|3|||
146663570|NCT04195906|528947761|FG000|Part 2|Other|1|||
146663571|NCT04195906|528947762|FG001|Part 2|Other|3|||
146663572|NCT00385762|528947769|FG000|Overall Study|Adverse Event|1|||
146663573|NCT00385762|528947769|FG000|Overall Study|Lost to Follow-up|1|||
146663574|NCT02104752|528947770|FG000|Overall Study|Withdrawal by Subject|1|||
146663575|NCT02104752|528947771|FG001|Overall Study|Withdrawal by Subject|0|||
146663576|NCT02104752|528947770|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
146663577|NCT02104752|528947771|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
146663578|NCT02899299|528947772|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
146663579|NCT02899299|528947773|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
146663580|NCT02899299|528947772|FG000|Pre-treatment|Participant withdrew consent|1|||
146663581|NCT02899299|528947773|FG001|Pre-treatment|Participant withdrew consent|11|||
146663582|NCT02899299|528947772|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
146663583|NCT02899299|528947773|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
146663584|NCT02899299|528947772|FG000|Pre-treatment|Not reported|0|||
146663585|NCT02899299|528947773|FG001|Pre-treatment|Not reported|1|||
146663586|NCT02899299|528947772|FG000|Treatment|Disease Progression|182|||
146663587|NCT02899299|528947773|FG001|Treatment|Disease Progression|43|||
146925327|NCT00946530|529886026|FG002|Overall Study|Withdrawal by Subject|0|||
146663588|NCT02899299|528947772|FG000|Treatment|Study Drug Toxicity|60|||
146663589|NCT02899299|528947773|FG001|Treatment|Study Drug Toxicity|24|||
146663590|NCT02899299|528947772|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
146663591|NCT02899299|528947773|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
146663592|NCT02899299|528947772|FG000|Treatment|Participant request to discontinue Study treatment|4|||
146663593|NCT02899299|528947773|FG001|Treatment|Participant request to discontinue Study treatment|10|||
146663594|NCT02899299|528947772|FG000|Treatment|Participant withdrew consent|6|||
146663595|NCT02899299|528947773|FG001|Treatment|Participant withdrew consent|3|||
146663596|NCT02899299|528947772|FG000|Treatment|Lost to Follow-up|0|||
146663597|NCT02899299|528947773|FG001|Treatment|Lost to Follow-up|2|||
146663598|NCT02899299|528947772|FG000|Treatment|Maximum Clinical Benefit|11|||
146663599|NCT02899299|528947773|FG001|Treatment|Maximum Clinical Benefit|2|||
146663600|NCT02899299|528947772|FG000|Treatment|Poor/Non-compliance|1|||
146663601|NCT02899299|528947773|FG001|Treatment|Poor/Non-compliance|0|||
146663602|NCT02899299|528947772|FG000|Treatment|Participant no longer meets Study criteria|4|||
146663603|NCT02899299|528947773|FG001|Treatment|Participant no longer meets Study criteria|0|||
146663604|NCT02899299|528947772|FG000|Treatment|Administrative reason by Sponsor|2|||
146663605|NCT02899299|528947773|FG001|Treatment|Administrative reason by Sponsor|0|||
146663606|NCT02899299|528947772|FG000|Treatment|Other reasons|12|||
146663607|NCT02899299|528947773|FG001|Treatment|Other reasons|2|||
146663608|NCT02899299|528947772|FG000|Treatment|Not reported|7|||
146663609|NCT02899299|528947773|FG001|Treatment|Not reported|0|||
146663610|NCT00313300|528947774|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
146663611|NCT00313300|528947775|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
146663612|NCT00313300|528947776|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
146663613|NCT00313300|528947777|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
146663614|NCT00313300|528947778|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
146663615|NCT00313300|528947774|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
146663616|NCT00313300|528947775|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
146663617|NCT00313300|528947776|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
146663618|NCT00313300|528947777|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
146663619|NCT00313300|528947778|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
146663620|NCT00313300|528947774|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
146663621|NCT00313300|528947775|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
146663622|NCT00313300|528947776|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
146663623|NCT00313300|528947777|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
146663624|NCT00313300|528947778|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
146663625|NCT00313300|528947774|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
146663626|NCT00313300|528947775|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
146663627|NCT00313300|528947776|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
146663628|NCT00313300|528947777|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
146663629|NCT00313300|528947778|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
146663630|NCT00313300|528947774|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
146663631|NCT00313300|528947775|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
146663632|NCT00313300|528947776|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
146663633|NCT00313300|528947777|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
146663634|NCT00313300|528947778|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
146663635|NCT00313300|528947774|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
146663636|NCT00313300|528947775|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
146663637|NCT00313300|528947776|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
146663638|NCT00313300|528947777|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
146663639|NCT00313300|528947778|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
146663640|NCT00313300|528947774|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
146663641|NCT00313300|528947775|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
146663642|NCT00313300|528947776|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
146663643|NCT00313300|528947777|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
146663644|NCT00313300|528947778|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
146663645|NCT00313300|528947774|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
146663646|NCT00313300|528947775|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
146663647|NCT00313300|528947776|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
146663648|NCT00313300|528947777|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
146663649|NCT00313300|528947778|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
146663650|NCT00313300|528947774|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
146663651|NCT00313300|528947775|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
146663652|NCT00313300|528947776|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
146663653|NCT00313300|528947777|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
146663654|NCT00313300|528947778|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
146663655|NCT00313300|528947774|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
146663656|NCT00313300|528947775|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
146663657|NCT00313300|528947776|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
146663658|NCT00313300|528947777|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
146663659|NCT00313300|528947778|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
146663660|NCT00313300|528947774|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
146663661|NCT00313300|528947775|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
146663662|NCT00313300|528947776|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
146663663|NCT00313300|528947777|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
146663664|NCT00313300|528947778|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
146663665|NCT00313300|528947774|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
146663666|NCT00313300|528947775|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
146663667|NCT00313300|528947776|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
146663668|NCT00313300|528947777|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
146663669|NCT00313300|528947778|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
146663670|NCT00313300|528947774|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
146663671|NCT00313300|528947775|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
146663672|NCT00313300|528947776|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
146663673|NCT00313300|528947777|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
146663674|NCT00313300|528947778|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
146663675|NCT00313300|528947774|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
146663676|NCT00313300|528947775|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
146663677|NCT00313300|528947776|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
146663678|NCT00313300|528947777|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
146663679|NCT00313300|528947778|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
146663680|NCT00313300|528947774|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
146925328|NCT00946530|529886027|FG003|Overall Study|Withdrawal by Subject|3|||
146663681|NCT00313300|528947775|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
146925329|NCT00946530|529886024|FG000|Overall Study|Physician Decision|1|||
146925330|NCT00946530|529886025|FG001|Overall Study|Physician Decision|1|||
146925331|NCT00946530|529886026|FG002|Overall Study|Physician Decision|1|||
146663682|NCT00313300|528947776|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
146663683|NCT00313300|528947777|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
146663684|NCT00313300|528947778|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
146663685|NCT00313300|528947774|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
146663686|NCT00313300|528947775|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
146663687|NCT00313300|528947776|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
146663688|NCT00313300|528947777|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
146663689|NCT00313300|528947778|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
146663690|NCT00313300|528947774|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
146663691|NCT00313300|528947775|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
146663692|NCT00313300|528947776|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
146663693|NCT00313300|528947777|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
146663694|NCT00313300|528947778|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
146663695|NCT00313300|528947774|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
146663696|NCT00313300|528947775|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
146663697|NCT00313300|528947776|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
146663698|NCT00313300|528947777|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
146663699|NCT00313300|528947778|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
146663700|NCT00313300|528947774|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
146663701|NCT00313300|528947775|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
146663702|NCT00313300|528947776|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
146663703|NCT00313300|528947777|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
146663704|NCT00313300|528947778|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
146663705|NCT00313300|528947774|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
146663706|NCT00313300|528947775|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
146663707|NCT00313300|528947776|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
146663708|NCT00313300|528947777|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
146663709|NCT00313300|528947778|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
146663710|NCT00313300|528947774|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
146663711|NCT00313300|528947775|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
146663712|NCT00313300|528947776|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
146663713|NCT00313300|528947777|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
146663714|NCT00313300|528947778|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
146663715|NCT02336373|528947779|FG000|Overall Study|Protocol closed early|4|||
146663716|NCT02336373|528947779|FG000|Overall Study|Physician Decision|14|||
146663717|NCT00850343|528947780|FG000|Overall Study|Withdrawal by Subject|11|||
146663718|NCT00850343|528947781|FG001|Overall Study|Withdrawal by Subject|0|||
146663719|NCT00850343|528947782|FG002|Overall Study|Withdrawal by Subject|3|||
146663720|NCT00850343|528947783|FG003|Overall Study|Withdrawal by Subject|2|||
146663721|NCT00850343|528947780|FG000|Overall Study|Adverse Event|15|||
146663722|NCT00850343|528947781|FG001|Overall Study|Adverse Event|2|||
146663723|NCT00850343|528947782|FG002|Overall Study|Adverse Event|6|||
146663724|NCT00850343|528947783|FG003|Overall Study|Adverse Event|6|||
146663725|NCT00850343|528947780|FG000|Overall Study|Pregnancy|0|||
146663726|NCT00850343|528947781|FG001|Overall Study|Pregnancy|0|||
146663727|NCT00850343|528947782|FG002|Overall Study|Pregnancy|0|||
146663728|NCT00850343|528947783|FG003|Overall Study|Pregnancy|1|||
146663729|NCT00850343|528947780|FG000|Overall Study|Lack of Efficacy|17|||
146663730|NCT00850343|528947781|FG001|Overall Study|Lack of Efficacy|0|||
146663731|NCT00850343|528947782|FG002|Overall Study|Lack of Efficacy|3|||
146663732|NCT00850343|528947783|FG003|Overall Study|Lack of Efficacy|2|||
146663733|NCT00850343|528947780|FG000|Overall Study|Non-compliance with Study Procedures|1|||
146663734|NCT00850343|528947781|FG001|Overall Study|Non-compliance with Study Procedures|0|||
146663735|NCT00850343|528947782|FG002|Overall Study|Non-compliance with Study Procedures|1|||
146663736|NCT00850343|528947783|FG003|Overall Study|Non-compliance with Study Procedures|1|||
146663737|NCT00850343|528947780|FG000|Overall Study|Physician Decision|2|||
146663738|NCT00850343|528947781|FG001|Overall Study|Physician Decision|1|||
146663739|NCT00850343|528947782|FG002|Overall Study|Physician Decision|1|||
146663740|NCT00850343|528947783|FG003|Overall Study|Physician Decision|1|||
146663741|NCT00371826|528947784|FG000|Core Phase (12 Months)|Adverse Event|15|||
146663742|NCT00371826|528947785|FG001|Core Phase (12 Months)|Adverse Event|4|||
146925332|NCT00946530|529886027|FG003|Overall Study|Physician Decision|1|||
146663743|NCT00371826|528947786|FG002|Core Phase (12 Months)|Adverse Event|9|||
146663744|NCT00371826|528947784|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
146663745|NCT00371826|528947785|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
146925333|NCT03105700|529886028|FG000|Overall Study|screen fail|3|||
146663746|NCT00371826|528947786|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
146663747|NCT00371826|528947784|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
146663748|NCT00371826|528947785|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
146663749|NCT00371826|528947786|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
146663750|NCT00371826|528947784|FG000|Core Phase (12 Months)|Protocol Violation|1|||
146663751|NCT00371826|528947785|FG001|Core Phase (12 Months)|Protocol Violation|0|||
146663752|NCT00371826|528947786|FG002|Core Phase (12 Months)|Protocol Violation|1|||
146663753|NCT00371826|528947784|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
146663754|NCT00371826|528947785|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
146663755|NCT00371826|528947786|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
146663756|NCT00371826|528947784|FG000|Core Phase (12 Months)|Administrative problems|1|||
146663757|NCT00371826|528947785|FG001|Core Phase (12 Months)|Administrative problems|0|||
146663758|NCT00371826|528947786|FG002|Core Phase (12 Months)|Administrative problems|8|||
146663759|NCT00371826|528947784|FG000|Core Phase (12 Months)|Graft Loss|0|||
146663760|NCT00371826|528947785|FG001|Core Phase (12 Months)|Graft Loss|1|||
146663761|NCT00371826|528947786|FG002|Core Phase (12 Months)|Graft Loss|0|||
146663762|NCT00371826|528947784|FG000|Extension Phase (24 Months)|Adverse Event|4|||
146663763|NCT00371826|528947785|FG001|Extension Phase (24 Months)|Adverse Event|5|||
146663764|NCT00371826|528947786|FG002|Extension Phase (24 Months)|Adverse Event|0|||
146663765|NCT00371826|528947784|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
146663766|NCT00371826|528947785|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
146663767|NCT00371826|528947786|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
146663768|NCT00371826|528947784|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
146663769|NCT00371826|528947785|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
146663770|NCT00371826|528947786|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
146663771|NCT00371826|528947784|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
146663772|NCT00371826|528947785|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
146663773|NCT00371826|528947786|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
146663774|NCT00371826|528947784|FG000|Extension Phase (24 Months)|Administrative problems|0|||
146663775|NCT00371826|528947785|FG001|Extension Phase (24 Months)|Administrative problems|0|||
146663776|NCT00371826|528947786|FG002|Extension Phase (24 Months)|Administrative problems|2|||
146663777|NCT02497612|528947787|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
146663778|NCT02497612|528947788|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
146663779|NCT02497612|528947789|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
146663780|NCT02497612|528947790|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
146663781|NCT02497612|528947787|FG000|Overall Study|Participant's request|2|||
146663782|NCT02497612|528947788|FG001|Overall Study|Participant's request|3|||
146663783|NCT02497612|528947789|FG002|Overall Study|Participant's request|4|||
146663784|NCT02497612|528947790|FG003|Overall Study|Participant's request|1|||
146663785|NCT02497612|528947787|FG000|Overall Study|Investigator's judgement|1|||
146663786|NCT02497612|528947788|FG001|Overall Study|Investigator's judgement|0|||
146663787|NCT02497612|528947789|FG002|Overall Study|Investigator's judgement|0|||
146663788|NCT02497612|528947790|FG003|Overall Study|Investigator's judgement|2|||
146663789|NCT02497612|528947787|FG000|Overall Study|Adverse Event|3|||
146663790|NCT02497612|528947788|FG001|Overall Study|Adverse Event|1|||
146663791|NCT02497612|528947789|FG002|Overall Study|Adverse Event|4|||
146663792|NCT02497612|528947790|FG003|Overall Study|Adverse Event|1|||
146663793|NCT02497612|528947787|FG000|Overall Study|Lost to Follow-up|1|||
146663794|NCT02497612|528947788|FG001|Overall Study|Lost to Follow-up|1|||
146663795|NCT02497612|528947789|FG002|Overall Study|Lost to Follow-up|0|||
146663796|NCT02497612|528947790|FG003|Overall Study|Lost to Follow-up|1|||
146663797|NCT02497612|528947787|FG000|Overall Study|Other unspecified|1|||
146663798|NCT02497612|528947788|FG001|Overall Study|Other unspecified|1|||
146663799|NCT02497612|528947789|FG002|Overall Study|Other unspecified|2|||
146663800|NCT02497612|528947790|FG003|Overall Study|Other unspecified|0|||
146663801|NCT02497612|528947787|FG000|Overall Study|Not eligible|1|||
146663802|NCT02497612|528947788|FG001|Overall Study|Not eligible|0|||
146663803|NCT02497612|528947789|FG002|Overall Study|Not eligible|0|||
146663804|NCT02497612|528947790|FG003|Overall Study|Not eligible|1|||
146663805|NCT00629772|528947793|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
146663806|NCT00629772|528947794|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
146663807|NCT00629772|528947793|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
146663808|NCT00629772|528947794|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
146663809|NCT03840174|528947795|FG000|Overall Study|Withdrawal by Subject|1|||
146663810|NCT03840174|528947796|FG001|Overall Study|Withdrawal by Subject|0|||
146663811|NCT03840174|528947797|FG002|Overall Study|Withdrawal by Subject|0|||
146663812|NCT03840174|528947798|FG003|Overall Study|Withdrawal by Subject|0|||
146663813|NCT01495975|528947799|FG000|Overall Study|Lost to Follow-up|1|||
146663814|NCT01495975|528947800|FG001|Overall Study|Lost to Follow-up|0|||
146663815|NCT01453725|528947801|FG000|Overall Study|Adverse Event|3|||
146663816|NCT01453725|528947802|FG001|Overall Study|Adverse Event|3|||
146663817|NCT01453725|528947801|FG000|Overall Study|Lost to Follow-up|4|||
146663818|NCT01453725|528947802|FG001|Overall Study|Lost to Follow-up|0|||
146925334|NCT03105700|529886028|FG000|Overall Study|Lost to Follow-up|4|||
146663819|NCT01453725|528947801|FG000|Overall Study|Non-compliance With Protocol|1|||
146663820|NCT01453725|528947802|FG001|Overall Study|Non-compliance With Protocol|2|||
146663821|NCT01453725|528947801|FG000|Overall Study|Protocol Violation|1|||
146663822|NCT01453725|528947802|FG001|Overall Study|Protocol Violation|0|||
146663823|NCT01453725|528947801|FG000|Overall Study|Withdrawal by Subject|2|||
146663824|NCT01453725|528947802|FG001|Overall Study|Withdrawal by Subject|3|||
146663825|NCT01453725|528947801|FG000|Overall Study|Pregnancy Wish|0|||
146663826|NCT01453725|528947802|FG001|Overall Study|Pregnancy Wish|2|||
146663827|NCT01453725|528947801|FG000|Overall Study|Pregnancy|1|||
146663828|NCT01453725|528947802|FG001|Overall Study|Pregnancy|0|||
146663829|NCT01453725|528947801|FG000|Overall Study|Physician Decision|1|||
146663830|NCT01453725|528947802|FG001|Overall Study|Physician Decision|1|||
146663831|NCT03605212|528947804|FG000|Treatment Period|Adverse Event|1|||
146663832|NCT03605212|528947805|FG001|Treatment Period|Adverse Event|0|||
146663833|NCT03605212|528947806|FG002|Treatment Period|Adverse Event|0|||
146663834|NCT03605212|528947807|FG003|Treatment Period|Adverse Event|0|||
146663835|NCT03605212|528947808|FG004|Treatment Period|Adverse Event|0|||
146663836|NCT03605212|528947804|FG000|Treatment Period|Physician Decision|0|||
146663837|NCT03605212|528947805|FG001|Treatment Period|Physician Decision|0|||
146663838|NCT03605212|528947806|FG002|Treatment Period|Physician Decision|0|||
146663839|NCT03605212|528947807|FG003|Treatment Period|Physician Decision|0|||
146663840|NCT03605212|528947808|FG004|Treatment Period|Physician Decision|1|||
146663841|NCT01254292|528947809|FG000|Comparative Phase|Adverse Event|25|||
146663842|NCT01254292|528947810|FG001|Comparative Phase|Adverse Event|25|||
146663843|NCT01254292|528947809|FG000|Comparative Phase|Lost to Follow-up|3|||
146663844|NCT01254292|528947810|FG001|Comparative Phase|Lost to Follow-up|21|||
146663845|NCT01254292|528947809|FG000|Comparative Phase|Pregnancy|2|||
146663846|NCT01254292|528947810|FG001|Comparative Phase|Pregnancy|6|||
146663847|NCT01254292|528947809|FG000|Comparative Phase|Withdrawal by Subject|20|||
146663848|NCT01254292|528947810|FG001|Comparative Phase|Withdrawal by Subject|21|||
146663849|NCT01254292|528947809|FG000|Comparative Phase|Protocol Violation|1|||
146663850|NCT01254292|528947810|FG001|Comparative Phase|Protocol Violation|2|||
146663851|NCT01254292|528947809|FG000|Comparative Phase|Wish for pregnancy|4|||
146663852|NCT01254292|528947810|FG001|Comparative Phase|Wish for pregnancy|6|||
146663853|NCT01254292|528947809|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
146663854|NCT01254292|528947810|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
146663855|NCT01254292|528947809|FG000|LCS12 Extension Phase|Adverse Event|9|||
146663856|NCT01254292|528947810|FG001|LCS12 Extension Phase|Adverse Event|0|||
146663857|NCT01254292|528947809|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
146663858|NCT01254292|528947810|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
146663859|NCT01254292|528947809|FG000|LCS12 Extension Phase|Other unknown|4|||
146663860|NCT01254292|528947810|FG001|LCS12 Extension Phase|Other unknown|0|||
146663861|NCT01254292|528947809|FG000|LCS12 Extension Phase|Pregnancy|2|||
146663862|NCT01254292|528947810|FG001|LCS12 Extension Phase|Pregnancy|0|||
146663863|NCT01254292|528947809|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
146663864|NCT01254292|528947810|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
146663865|NCT01484132|528947811|FG000|Overall Study|Lost to Follow-up|8|||
146663866|NCT01484132|528947811|FG000|Overall Study|Difficulty with time commitment|2|||
146663867|NCT01484132|528947811|FG000|Overall Study|Ineligible|1|||
146663868|NCT01484132|528947811|FG000|Overall Study|No pre-treatment urine sample collected|1|||
146663869|NCT01484132|528947811|FG000|Overall Study|No post-treatment urine sample collected|10|||
146663870|NCT01697358|528947817|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
146663871|NCT01697358|528947818|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
146663872|NCT01697358|528947817|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
146663873|NCT01697358|528947818|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
146663874|NCT01697358|528947817|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
146663875|NCT01697358|528947818|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
146663876|NCT01697358|528947817|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
146663877|NCT01697358|528947818|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
146663878|NCT01697358|528947817|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
146663879|NCT01697358|528947818|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
146663880|NCT01697358|528947817|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
146663881|NCT01697358|528947818|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
146663882|NCT01697358|528947817|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
146663883|NCT01697358|528947818|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
146663884|NCT01697358|528947817|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
146663885|NCT01697358|528947818|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
146663886|NCT01697358|528947817|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
146663887|NCT01697358|528947818|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
146663888|NCT01697358|528947817|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
146663889|NCT01697358|528947818|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
146925335|NCT02768194|529886029|FG000|Period 1|Adverse Event|0|||
146925336|NCT02768194|529886030|FG001|Period 1|Adverse Event|0|||
146925337|NCT02768194|529886031|FG002|Period 1|Adverse Event|0|||
146925338|NCT02768194|529886032|FG003|Period 1|Adverse Event|1|||
146925339|NCT02768194|529886033|FG004|Period 1|Adverse Event|0|||
146925340|NCT02768194|529886034|FG005|Period 1|Adverse Event|0|||
146925341|NCT02768194|529886029|FG000|Period 2|Other (Reason not specified)|1|||
146925342|NCT02768194|529886030|FG001|Period 2|Other (Reason not specified)|0|||
146925343|NCT02768194|529886031|FG002|Period 2|Other (Reason not specified)|0|||
146663890|NCT05055128|528947819|FG000|Overall Study|Adverse Event|0|||
146663891|NCT05055128|528947820|FG001|Overall Study|Adverse Event|0|||
146663892|NCT05055128|528947821|FG002|Overall Study|Adverse Event|0|||
146663893|NCT05055128|528947822|FG003|Overall Study|Adverse Event|1|||
146663894|NCT05055128|528947823|FG004|Overall Study|Adverse Event|1|||
146663895|NCT05055128|528947819|FG000|Overall Study|Protocol Violation|0|||
146663896|NCT05055128|528947820|FG001|Overall Study|Protocol Violation|0|||
146663897|NCT05055128|528947821|FG002|Overall Study|Protocol Violation|0|||
146663898|NCT05055128|528947822|FG003|Overall Study|Protocol Violation|1|||
146663899|NCT05055128|528947823|FG004|Overall Study|Protocol Violation|0|||
146663900|NCT05055128|528947819|FG000|Overall Study|Withdrawal by Subject|5|||
146663901|NCT05055128|528947820|FG001|Overall Study|Withdrawal by Subject|2|||
146663902|NCT05055128|528947821|FG002|Overall Study|Withdrawal by Subject|2|||
146663903|NCT05055128|528947822|FG003|Overall Study|Withdrawal by Subject|4|||
146663904|NCT05055128|528947823|FG004|Overall Study|Withdrawal by Subject|2|||
146663905|NCT05055128|528947819|FG000|Overall Study|Randomized By Mistake|0|||
146663906|NCT05055128|528947820|FG001|Overall Study|Randomized By Mistake|1|||
146663907|NCT05055128|528947821|FG002|Overall Study|Randomized By Mistake|0|||
146663908|NCT05055128|528947822|FG003|Overall Study|Randomized By Mistake|0|||
146663909|NCT05055128|528947823|FG004|Overall Study|Randomized By Mistake|0|||
146663910|NCT05055128|528947819|FG000|Overall Study|Other|1|||
146663911|NCT05055128|528947820|FG001|Overall Study|Other|0|||
146663912|NCT05055128|528947821|FG002|Overall Study|Other|0|||
146663913|NCT05055128|528947822|FG003|Overall Study|Other|0|||
146663914|NCT05055128|528947823|FG004|Overall Study|Other|0|||
146663915|NCT00936611|528947830|FG000|Overall Study|Progressive Disease|3|||
146663916|NCT00936611|528947830|FG000|Overall Study|New Systemic Therapy|22|||
146663917|NCT00936611|528947830|FG000|Overall Study|Lost to Follow-up|1|||
146663918|NCT00936611|528947830|FG000|Overall Study|Withdrawal by Subject|2|||
146663919|NCT00936611|528947830|FG000|Overall Study|Still on Follow-up|1|||
146663920|NCT00936611|528947830|FG000|Overall Study|Still on Active Therapy|7|||
146663921|NCT00936611|528947830|FG000|Overall Study|Ineligible for Study Drug|3|||
146663922|NCT01822496|528947834|FG000|Overall Study|Protocol Violation|2|||
146663923|NCT01822496|528947835|FG001|Overall Study|Protocol Violation|2|||
146663924|NCT01822496|528947836|FG002|Overall Study|Protocol Violation|0|||
146663925|NCT01822496|528947837|FG003|Overall Study|Protocol Violation|1|||
146663926|NCT01822496|528947834|FG000|Overall Study|Withdrawal by Subject|0|||
146663927|NCT01822496|528947835|FG001|Overall Study|Withdrawal by Subject|0|||
146663928|NCT01822496|528947836|FG002|Overall Study|Withdrawal by Subject|0|||
146663929|NCT01822496|528947837|FG003|Overall Study|Withdrawal by Subject|3|||
146663930|NCT03841448|528947840|FG000|Double-blind Treatment (DBT) Period|Death|1|||
146663931|NCT03841448|528947841|FG001|Double-blind Treatment (DBT) Period|Death|1|||
146663932|NCT03841448|528947842|FG002|Double-blind Treatment (DBT) Period|Death|0|||
146663933|NCT03841448|528947843|FG003|Double-blind Treatment (DBT) Period|Death|0|||
146663934|NCT03841448|528947840|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
146663935|NCT03841448|528947841|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
146663936|NCT03841448|528947842|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
146663937|NCT03841448|528947843|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
146663938|NCT03841448|528947840|FG000|Open-Label Extension (OLE) Period|Death|0|||
146663939|NCT03841448|528947841|FG001|Open-Label Extension (OLE) Period|Death|0|||
146925344|NCT02768194|529886032|FG003|Period 2|Other (Reason not specified)|0|||
146925345|NCT02768194|529886033|FG004|Period 2|Other (Reason not specified)|0|||
146925346|NCT02768194|529886034|FG005|Period 2|Other (Reason not specified)|0|||
146925347|NCT02768194|529886029|FG000|Period 3|Other (Reason not specified)|0|||
146663940|NCT03841448|528947842|FG002|Open-Label Extension (OLE) Period|Death|0|||
146663941|NCT03841448|528947843|FG003|Open-Label Extension (OLE) Period|Death|1|||
146663942|NCT03841448|528947840|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
146663943|NCT03841448|528947841|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
146663944|NCT03841448|528947842|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
146925348|NCT02768194|529886030|FG001|Period 3|Other (Reason not specified)|1|||
146925349|NCT02768194|529886031|FG002|Period 3|Other (Reason not specified)|0|||
146663945|NCT03841448|528947843|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
146663946|NCT03841448|528947840|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
146663947|NCT03841448|528947841|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
146663948|NCT03841448|528947842|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
146663949|NCT03841448|528947843|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
146663950|NCT03841448|528947840|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
146925350|NCT02768194|529886032|FG003|Period 3|Other (Reason not specified)|0|||
146663951|NCT03841448|528947841|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
146663952|NCT03841448|528947842|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
146663953|NCT03841448|528947843|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
146663954|NCT00543543|528947844|FG000|Base Study|Adverse Event|1|||
146663955|NCT00543543|528947845|FG001|Base Study|Adverse Event|11|||
146663956|NCT00543543|528947846|FG002|Base Study|Adverse Event|0|||
146663957|NCT00543543|528947847|FG003|Base Study|Adverse Event|5|||
146663958|NCT00543543|528947844|FG000|Base Study|Lost to Follow-up|12|||
146663959|NCT00543543|528947845|FG001|Base Study|Lost to Follow-up|749|||
146663960|NCT00543543|528947846|FG002|Base Study|Lost to Follow-up|9|||
146663961|NCT00543543|528947847|FG003|Base Study|Lost to Follow-up|701|||
146663962|NCT00543543|528947844|FG000|Base Study|Physician Decision|0|||
146663963|NCT00543543|528947845|FG001|Base Study|Physician Decision|4|||
146663964|NCT00543543|528947846|FG002|Base Study|Physician Decision|0|||
146663965|NCT00543543|528947847|FG003|Base Study|Physician Decision|7|||
146663966|NCT00543543|528947844|FG000|Base Study|Protocol Violation|0|||
146663967|NCT00543543|528947845|FG001|Base Study|Protocol Violation|6|||
146663968|NCT00543543|528947846|FG002|Base Study|Protocol Violation|0|||
146663969|NCT00543543|528947847|FG003|Base Study|Protocol Violation|6|||
146663970|NCT00543543|528947844|FG000|Base Study|Withdrawal by Subject|7|||
146663971|NCT00543543|528947845|FG001|Base Study|Withdrawal by Subject|482|||
146663972|NCT00543543|528947846|FG002|Base Study|Withdrawal by Subject|5|||
146663973|NCT00543543|528947847|FG003|Base Study|Withdrawal by Subject|503|||
146663974|NCT00543543|528947844|FG000|Extension Study|Adverse Event|0|||
146663975|NCT00543543|528947845|FG001|Extension Study|Adverse Event|0|||
146663976|NCT00543543|528947846|FG002|Extension Study|Adverse Event|0|||
146663977|NCT00543543|528947847|FG003|Extension Study|Adverse Event|5|||
146663978|NCT00543543|528947844|FG000|Extension Study|Lost to Follow-up|0|||
146663979|NCT00543543|528947845|FG001|Extension Study|Lost to Follow-up|0|||
146663980|NCT00543543|528947846|FG002|Extension Study|Lost to Follow-up|0|||
146663981|NCT00543543|528947847|FG003|Extension Study|Lost to Follow-up|77|||
146663982|NCT00543543|528947844|FG000|Extension Study|Physician Decision|0|||
146663983|NCT00543543|528947845|FG001|Extension Study|Physician Decision|0|||
146663984|NCT00543543|528947846|FG002|Extension Study|Physician Decision|0|||
146663985|NCT00543543|528947847|FG003|Extension Study|Physician Decision|7|||
146663986|NCT00543543|528947844|FG000|Extension Study|Pregnancy|0|||
146663987|NCT00543543|528947845|FG001|Extension Study|Pregnancy|0|||
146663988|NCT00543543|528947846|FG002|Extension Study|Pregnancy|0|||
146663989|NCT00543543|528947847|FG003|Extension Study|Pregnancy|6|||
146663990|NCT00543543|528947844|FG000|Extension Study|Protocol Violation|0|||
146663991|NCT00543543|528947845|FG001|Extension Study|Protocol Violation|0|||
146663992|NCT00543543|528947846|FG002|Extension Study|Protocol Violation|0|||
146663993|NCT00543543|528947847|FG003|Extension Study|Protocol Violation|11|||
146663994|NCT00543543|528947844|FG000|Extension Study|Withdrawal by Subject|0|||
146663995|NCT00543543|528947845|FG001|Extension Study|Withdrawal by Subject|0|||
146663996|NCT00543543|528947846|FG002|Extension Study|Withdrawal by Subject|0|||
146663997|NCT00543543|528947847|FG003|Extension Study|Withdrawal by Subject|120|||
146663998|NCT04308304|528947848|FG000|Overall Study|Withdrawal by Subject|4|||
146663999|NCT04308304|528947849|FG001|Overall Study|Withdrawal by Subject|0|||
146664000|NCT04308304|528947848|FG000|Overall Study|Protocol Violation|1|||
146664001|NCT04308304|528947849|FG001|Overall Study|Protocol Violation|0|||
146664002|NCT00945555|528947850|FG000|Overall Study|Referred to another hospital|5|||
146664003|NCT00945555|528947850|FG000|Overall Study|Worsening condition, intensive care unit|1|||
146664004|NCT00945555|528947850|FG000|Overall Study|Withdrawal by Subject|2|||
146664005|NCT00945555|528947850|FG000|Overall Study|Participant continued treatment at home|1|||
146664006|NCT00945555|528947850|FG000|Overall Study|Death|18|||
146664007|NCT00945555|528947850|FG000|Overall Study|Other|1|||
146664008|NCT04502979|528947852|FG000|Overall Study|Lost to Follow-up|1|||
146664009|NCT04502979|528947853|FG001|Overall Study|Lost to Follow-up|3|||
146664010|NCT04502979|528947852|FG000|Overall Study|Withdrawal by Subject|2|||
146925351|NCT02768194|529886033|FG004|Period 3|Other (Reason not specified)|0|||
146925352|NCT02768194|529886034|FG005|Period 3|Other (Reason not specified)|0|||
146925353|NCT03095521|529886035|FG000|Overall Study|Withdrawal by Subject|0|||
146925354|NCT03095521|529886036|FG001|Overall Study|Withdrawal by Subject|1|||
146664011|NCT04502979|528947853|FG001|Overall Study|Withdrawal by Subject|1|||
146664012|NCT00165984|528947858|FG000|Overall Study|Death|15|||
146664013|NCT03945266|528947859|FG000|Overall Study|Withdrawal by Subject|1|||
146664014|NCT03945266|528947860|FG001|Overall Study|Withdrawal by Subject|0|||
146664015|NCT03945266|528947859|FG000|Overall Study|Miscarriage|0|||
146664016|NCT03945266|528947860|FG001|Overall Study|Miscarriage|2|||
146664017|NCT03945266|528947859|FG000|Overall Study|Lost to Follow-up|1|||
146664018|NCT03945266|528947860|FG001|Overall Study|Lost to Follow-up|0|||
146664019|NCT01686828|528947861|FG000|Overall Study|Physician Decision|1|||
146664020|NCT01686828|528947862|FG001|Overall Study|Physician Decision|0|||
146664021|NCT01686828|528947863|FG002|Overall Study|Physician Decision|0|||
146664022|NCT01686828|528947864|FG003|Overall Study|Physician Decision|0|||
146664023|NCT01686828|528947861|FG000|Overall Study|New Job|0|||
146664024|NCT01686828|528947862|FG001|Overall Study|New Job|1|||
146664025|NCT01686828|528947863|FG002|Overall Study|New Job|0|||
146664026|NCT01686828|528947864|FG003|Overall Study|New Job|0|||
146664027|NCT01686828|528947861|FG000|Overall Study|Weight Loss|0|||
146664028|NCT01686828|528947862|FG001|Overall Study|Weight Loss|0|||
146664029|NCT01686828|528947863|FG002|Overall Study|Weight Loss|1|||
146664030|NCT01686828|528947864|FG003|Overall Study|Weight Loss|0|||
146664031|NCT01736124|528947867|FG000|Post-intervention Assessment|Death|2|||
146664032|NCT01736124|528947868|FG001|Post-intervention Assessment|Death|2|||
146664033|NCT01736124|528947867|FG000|Post-intervention Assessment|lost computer access|1|||
146664034|NCT01736124|528947868|FG001|Post-intervention Assessment|lost computer access|1|||
146664035|NCT01736124|528947867|FG000|Post-intervention Assessment|Moved away|3|||
146664036|NCT01736124|528947868|FG001|Post-intervention Assessment|Moved away|1|||
146664037|NCT01736124|528947867|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
146664038|NCT01736124|528947868|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
146664039|NCT01736124|528947867|FG000|Post-intervention Assessment|Illness|3|||
146664040|NCT01736124|528947868|FG001|Post-intervention Assessment|Illness|2|||
146664041|NCT01736124|528947867|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
146664042|NCT01736124|528947868|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
146664043|NCT01736124|528947867|FG000|Post-intervention Assessment|Temporarily away|3|||
146664044|NCT01736124|528947868|FG001|Post-intervention Assessment|Temporarily away|1|||
146664045|NCT01736124|528947867|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
146664046|NCT01736124|528947868|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
146664047|NCT01736124|528947867|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
146664048|NCT01736124|528947868|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
146664049|NCT01736124|528947867|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
146664050|NCT01736124|528947868|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
146664051|NCT01736124|528947867|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
146664052|NCT01736124|528947868|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
146664053|NCT01736124|528947867|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
146664054|NCT01736124|528947868|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
146664055|NCT01736124|528947867|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
146664056|NCT01736124|528947868|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
146664057|NCT01736124|528947867|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
146664058|NCT01736124|528947868|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
146664059|NCT01736124|528947867|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
146664060|NCT01736124|528947868|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
146664061|NCT01736124|528947867|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
146664062|NCT01736124|528947868|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
146664063|NCT02734433|528947879|FG000|Overall Study|Disease progression|1|||
146664064|NCT02734433|528947880|FG001|Overall Study|Disease progression|5|||
146664065|NCT02734433|528947879|FG000|Overall Study|Clinical progression|0|||
146664066|NCT02734433|528947880|FG001|Overall Study|Clinical progression|1|||
146664067|NCT02734433|528947879|FG000|Overall Study|Withdrawal by Subject|1|||
146664068|NCT02734433|528947880|FG001|Overall Study|Withdrawal by Subject|2|||
146664069|NCT02628769|528947881|FG000|First Intervention|Adverse Event|1|||
146664070|NCT02628769|528947882|FG001|First Intervention|Adverse Event|0|||
146664071|NCT02628769|528947881|FG000|First Intervention|Withdrawal by Subject|0|||
146664072|NCT02628769|528947882|FG001|First Intervention|Withdrawal by Subject|1|||
146664073|NCT02628769|528947881|FG000|Second Intervention|Adverse Event|2|||
146925355|NCT03095521|529886035|FG000|Overall Study|Lost to Follow-up|0|||
146925356|NCT03095521|529886036|FG001|Overall Study|Lost to Follow-up|1|||
146925357|NCT01536119|529886037|FG000|Overall Study|Lost to Follow-up|17|||
146925358|NCT01536119|529886038|FG001|Overall Study|Lost to Follow-up|14|||
146925359|NCT03521193|529886039|FG000|Overall Study|Withdrawal by Subject|8|||
146925360|NCT03521193|529886040|FG001|Overall Study|Withdrawal by Subject|0|||
146925361|NCT03521193|529886039|FG000|Overall Study|non compliant to ASA treatment|8|||
146925362|NCT03521193|529886040|FG001|Overall Study|non compliant to ASA treatment|0|||
146925363|NCT01810042|529886041|FG000|Overall Study|Lost to Follow-up|10|||
146925364|NCT01454401|529886042|FG000|Overall Study|Death|1|||
146925365|NCT01454401|529886042|FG000|Overall Study|hospitalised|1|||
146925366|NCT01454401|529886042|FG000|Overall Study|osteomyelitis|2|||
146925367|NCT01454401|529886042|FG000|Overall Study|non-adherence|1|||
146925368|NCT00605722|529888220|FG000|Overall Study|Adverse Event|6|||
146925369|NCT00605722|529888220|FG000|Overall Study|Insufficient therapeutic response|44|||
146925370|NCT00605722|529888220|FG000|Overall Study|Failure to return|1|||
146925371|NCT00356863|529888226|FG000|Overall Study|Death|16|||
146925372|NCT00356863|529888227|FG001|Overall Study|Death|32|||
146925373|NCT00356863|529888226|FG000|Overall Study|Lost to Follow-up|76|||
146925374|NCT00356863|529888227|FG001|Overall Study|Lost to Follow-up|43|||
146925375|NCT00333619|529888230|FG000|Overall Study|Death|12|||
146664074|NCT02628769|528947882|FG001|Second Intervention|Adverse Event|0|||
146664075|NCT02628769|528947881|FG000|Second Intervention|Physician Decision|0|||
146664076|NCT02628769|528947882|FG001|Second Intervention|Physician Decision|1|||
146664077|NCT05274165|528947887|FG000|Overall Study|Withdrawal by Subject|3|||
146773725|NCT01170962|529341184|FG000|Treatment Period|Adverse Event|11|||
146925376|NCT00333619|529888231|FG001|Overall Study|Death|6|||
146925377|NCT00333619|529888230|FG000|Overall Study|Withdrawal by Subject|6|||
146664078|NCT05274165|528947888|FG001|Overall Study|Withdrawal by Subject|3|||
146664079|NCT01066000|528947891|FG000|Overall Study|Protocol Violation|4|||
146664080|NCT01066000|528947891|FG000|Overall Study|Death|3|||
146664081|NCT01066000|528947891|FG000|Overall Study|Withdrawal by Subject|1|||
146664082|NCT01066000|528947891|FG000|Overall Study|Adverse Event|1|||
146664083|NCT03507400|528947892|FG000|Overall Study|discontinued|5|||
146664084|NCT03507400|528947893|FG001|Overall Study|discontinued|1|||
146664085|NCT03507400|528947892|FG000|Overall Study|Lost to Follow-up|8|||
146664086|NCT03507400|528947893|FG001|Overall Study|Lost to Follow-up|6|||
146664087|NCT03507400|528947892|FG000|Overall Study|Protocol Violation|0|||
146664088|NCT03507400|528947893|FG001|Overall Study|Protocol Violation|1|||
146664089|NCT03673046|528949387|FG000|Overall Study|Adverse Event|1|||
146664090|NCT03673046|528949388|FG001|Overall Study|Adverse Event|1|||
146664091|NCT03673046|528949387|FG000|Overall Study|Withdrawal by Subject|8|||
146664092|NCT03673046|528949388|FG001|Overall Study|Withdrawal by Subject|2|||
146664093|NCT03817879|528949389|FG000|Overall Study|Drop out|5|||
146664094|NCT03817879|528949390|FG001|Overall Study|Drop out|12|||
146664095|NCT03817879|528949389|FG000|Overall Study|Withdrawal by Subject|0|||
146664096|NCT03817879|528949390|FG001|Overall Study|Withdrawal by Subject|1|||
146664097|NCT00392015|528949393|FG000|Overall Study|Lost to Follow-up|2|||
146664098|NCT00392015|528949394|FG001|Overall Study|Lost to Follow-up|0|||
146664099|NCT00392015|528949395|FG002|Overall Study|Lost to Follow-up|2|||
146664100|NCT00392015|528949396|FG003|Overall Study|Lost to Follow-up|1|||
146664101|NCT00392015|528949397|FG004|Overall Study|Lost to Follow-up|1|||
146664102|NCT00392015|528949398|FG005|Overall Study|Lost to Follow-up|0|||
146664103|NCT00392015|528949393|FG000|Overall Study|Withdrawal by Subject|0|||
146664104|NCT00392015|528949394|FG001|Overall Study|Withdrawal by Subject|0|||
146664105|NCT00392015|528949395|FG002|Overall Study|Withdrawal by Subject|2|||
146664106|NCT00392015|528949396|FG003|Overall Study|Withdrawal by Subject|0|||
146664107|NCT00392015|528949397|FG004|Overall Study|Withdrawal by Subject|0|||
146664108|NCT00392015|528949398|FG005|Overall Study|Withdrawal by Subject|0|||
146664109|NCT00392015|528949393|FG000|Overall Study|Adverse Event|0|||
146664110|NCT00392015|528949394|FG001|Overall Study|Adverse Event|0|||
146664111|NCT00392015|528949395|FG002|Overall Study|Adverse Event|0|||
146664112|NCT00392015|528949396|FG003|Overall Study|Adverse Event|0|||
146664113|NCT00392015|528949397|FG004|Overall Study|Adverse Event|1|||
146664114|NCT00392015|528949398|FG005|Overall Study|Adverse Event|0|||
146664115|NCT00392015|528949393|FG000|Overall Study|Previous trial recipient|0|||
146664116|NCT00392015|528949394|FG001|Overall Study|Previous trial recipient|0|||
146664117|NCT00392015|528949395|FG002|Overall Study|Previous trial recipient|0|||
146664118|NCT00392015|528949396|FG003|Overall Study|Previous trial recipient|0|||
146664119|NCT00392015|528949397|FG004|Overall Study|Previous trial recipient|1|||
146664120|NCT00392015|528949398|FG005|Overall Study|Previous trial recipient|0|||
146664121|NCT00717093|528949400|FG000|Overall Study|Adverse Event|19|||
146664122|NCT00717093|528949401|FG001|Overall Study|Adverse Event|9|||
146664123|NCT00717093|528949400|FG000|Overall Study|Lack of Efficacy|3|||
146664124|NCT00717093|528949401|FG001|Overall Study|Lack of Efficacy|13|||
146664125|NCT00717093|528949400|FG000|Overall Study|Lost to Follow-up|9|||
146664126|NCT00717093|528949401|FG001|Overall Study|Lost to Follow-up|6|||
146664127|NCT00717093|528949400|FG000|Overall Study|Withdrawal by Subject|12|||
146664128|NCT00717093|528949401|FG001|Overall Study|Withdrawal by Subject|19|||
146664129|NCT00717093|528949400|FG000|Overall Study|Other|0|||
146664130|NCT00717093|528949401|FG001|Overall Study|Other|1|||
146664131|NCT00717093|528949400|FG000|Overall Study|Randomized but not treated|1|||
146664132|NCT00717093|528949401|FG001|Overall Study|Randomized but not treated|0|||
146664133|NCT01543698|528949406|FG000|Phase 1b|Disease progression|2|||
146664134|NCT01543698|528949407|FG001|Phase 1b|Disease progression|4|||
146664135|NCT01543698|528949408|FG002|Phase 1b|Disease progression|3|||
146664136|NCT01543698|528949409|FG003|Phase 1b|Disease progression|2|||
146664137|NCT01543698|528949410|FG004|Phase 1b|Disease progression|10|||
146664138|NCT01543698|528949411|FG005|Phase 1b|Disease progression|6|||
146664139|NCT01543698|528949412|FG006|Phase 1b|Disease progression|5|||
146664140|NCT01543698|528949413|FG007|Phase 1b|Disease progression|3|||
146664141|NCT01543698|528949414|FG008|Phase 1b|Disease progression|4|||
146664142|NCT01543698|528949415|FG009|Phase 1b|Disease progression|5|||
146925378|NCT00333619|529888231|FG001|Overall Study|Withdrawal by Subject|1|||
146664143|NCT01543698|528949416|FG010|Phase 1b|Disease progression|1|||
146664144|NCT01543698|528949417|FG011|Phase 1b|Disease progression|0|||
146664145|NCT01543698|528949418|FG012|Phase 1b|Disease progression|0|||
146664146|NCT01543698|528949419|FG013|Phase 1b|Disease progression|0|||
146664147|NCT01543698|528949420|FG014|Phase 1b|Disease progression|0|||
146664148|NCT01543698|528949406|FG000|Phase 1b|Death|0|||
146664149|NCT01543698|528949407|FG001|Phase 1b|Death|0|||
146664150|NCT01543698|528949408|FG002|Phase 1b|Death|1|||
146664151|NCT01543698|528949409|FG003|Phase 1b|Death|1|||
146664152|NCT01543698|528949410|FG004|Phase 1b|Death|0|||
146664153|NCT01543698|528949411|FG005|Phase 1b|Death|0|||
146664154|NCT01543698|528949412|FG006|Phase 1b|Death|0|||
146664155|NCT01543698|528949413|FG007|Phase 1b|Death|0|||
146664156|NCT01543698|528949414|FG008|Phase 1b|Death|0|||
146664157|NCT01543698|528949415|FG009|Phase 1b|Death|0|||
146664158|NCT01543698|528949416|FG010|Phase 1b|Death|1|||
146664159|NCT01543698|528949417|FG011|Phase 1b|Death|0|||
146664160|NCT01543698|528949418|FG012|Phase 1b|Death|0|||
146664161|NCT01543698|528949419|FG013|Phase 1b|Death|0|||
146664162|NCT01543698|528949420|FG014|Phase 1b|Death|0|||
146664163|NCT01543698|528949406|FG000|Phase 1b|Withdrawal by Subject|0|||
146664164|NCT01543698|528949407|FG001|Phase 1b|Withdrawal by Subject|1|||
146664165|NCT01543698|528949408|FG002|Phase 1b|Withdrawal by Subject|0|||
146664166|NCT01543698|528949409|FG003|Phase 1b|Withdrawal by Subject|1|||
146664167|NCT01543698|528949410|FG004|Phase 1b|Withdrawal by Subject|0|||
146664168|NCT01543698|528949411|FG005|Phase 1b|Withdrawal by Subject|0|||
146664169|NCT01543698|528949412|FG006|Phase 1b|Withdrawal by Subject|1|||
146664170|NCT01543698|528949413|FG007|Phase 1b|Withdrawal by Subject|0|||
146664171|NCT01543698|528949414|FG008|Phase 1b|Withdrawal by Subject|0|||
146664172|NCT01543698|528949415|FG009|Phase 1b|Withdrawal by Subject|0|||
146664173|NCT01543698|528949416|FG010|Phase 1b|Withdrawal by Subject|0|||
146664174|NCT01543698|528949417|FG011|Phase 1b|Withdrawal by Subject|0|||
146664175|NCT01543698|528949418|FG012|Phase 1b|Withdrawal by Subject|0|||
146664176|NCT01543698|528949419|FG013|Phase 1b|Withdrawal by Subject|0|||
146664177|NCT01543698|528949420|FG014|Phase 1b|Withdrawal by Subject|0|||
146664178|NCT01543698|528949406|FG000|Phase 1b|Adverse Event|1|||
146664179|NCT01543698|528949407|FG001|Phase 1b|Adverse Event|0|||
146664180|NCT01543698|528949408|FG002|Phase 1b|Adverse Event|0|||
146664181|NCT01543698|528949409|FG003|Phase 1b|Adverse Event|1|||
146664182|NCT01543698|528949410|FG004|Phase 1b|Adverse Event|2|||
146664183|NCT01543698|528949411|FG005|Phase 1b|Adverse Event|2|||
146664184|NCT01543698|528949412|FG006|Phase 1b|Adverse Event|0|||
146664185|NCT01543698|528949413|FG007|Phase 1b|Adverse Event|0|||
146664186|NCT01543698|528949414|FG008|Phase 1b|Adverse Event|1|||
146664187|NCT01543698|528949415|FG009|Phase 1b|Adverse Event|1|||
146664188|NCT01543698|528949416|FG010|Phase 1b|Adverse Event|2|||
146664189|NCT01543698|528949417|FG011|Phase 1b|Adverse Event|0|||
146664190|NCT01543698|528949418|FG012|Phase 1b|Adverse Event|0|||
146664191|NCT01543698|528949419|FG013|Phase 1b|Adverse Event|0|||
146664192|NCT01543698|528949420|FG014|Phase 1b|Adverse Event|0|||
146664193|NCT01543698|528949406|FG000|Phase 1b|Administrative problems|1|||
146664194|NCT01543698|528949407|FG001|Phase 1b|Administrative problems|0|||
146664195|NCT01543698|528949408|FG002|Phase 1b|Administrative problems|0|||
146664196|NCT01543698|528949409|FG003|Phase 1b|Administrative problems|0|||
146664197|NCT01543698|528949410|FG004|Phase 1b|Administrative problems|1|||
146664198|NCT01543698|528949411|FG005|Phase 1b|Administrative problems|0|||
146664199|NCT01543698|528949412|FG006|Phase 1b|Administrative problems|0|||
146664200|NCT01543698|528949413|FG007|Phase 1b|Administrative problems|1|||
146664201|NCT01543698|528949414|FG008|Phase 1b|Administrative problems|0|||
146664202|NCT01543698|528949415|FG009|Phase 1b|Administrative problems|0|||
146664203|NCT01543698|528949416|FG010|Phase 1b|Administrative problems|2|||
146664204|NCT01543698|528949417|FG011|Phase 1b|Administrative problems|0|||
146664205|NCT01543698|528949418|FG012|Phase 1b|Administrative problems|0|||
146664206|NCT01543698|528949419|FG013|Phase 1b|Administrative problems|0|||
146664207|NCT01543698|528949420|FG014|Phase 1b|Administrative problems|0|||
146664208|NCT01543698|528949406|FG000|Phase 1b|Protocol Violation|2|||
146664209|NCT01543698|528949407|FG001|Phase 1b|Protocol Violation|0|||
146664210|NCT01543698|528949408|FG002|Phase 1b|Protocol Violation|0|||
146664211|NCT01543698|528949409|FG003|Phase 1b|Protocol Violation|0|||
146664212|NCT01543698|528949410|FG004|Phase 1b|Protocol Violation|0|||
146664213|NCT01543698|528949411|FG005|Phase 1b|Protocol Violation|0|||
146664214|NCT01543698|528949412|FG006|Phase 1b|Protocol Violation|0|||
146664215|NCT01543698|528949413|FG007|Phase 1b|Protocol Violation|0|||
146664216|NCT01543698|528949414|FG008|Phase 1b|Protocol Violation|0|||
146664217|NCT01543698|528949415|FG009|Phase 1b|Protocol Violation|0|||
146664218|NCT01543698|528949416|FG010|Phase 1b|Protocol Violation|0|||
146664219|NCT01543698|528949417|FG011|Phase 1b|Protocol Violation|0|||
146664220|NCT01543698|528949418|FG012|Phase 1b|Protocol Violation|0|||
146664221|NCT01543698|528949419|FG013|Phase 1b|Protocol Violation|0|||
146664222|NCT01543698|528949420|FG014|Phase 1b|Protocol Violation|0|||
146664223|NCT01543698|528949406|FG000|Phase 2|Protocol Violation|0|||
146664224|NCT01543698|528949407|FG001|Phase 2|Protocol Violation|0|||
146664225|NCT01543698|528949408|FG002|Phase 2|Protocol Violation|0|||
146664226|NCT01543698|528949409|FG003|Phase 2|Protocol Violation|0|||
146664227|NCT01543698|528949410|FG004|Phase 2|Protocol Violation|0|||
146664228|NCT01543698|528949411|FG005|Phase 2|Protocol Violation|0|||
146664229|NCT01543698|528949412|FG006|Phase 2|Protocol Violation|0|||
146664230|NCT01543698|528949413|FG007|Phase 2|Protocol Violation|0|||
146664231|NCT01543698|528949414|FG008|Phase 2|Protocol Violation|0|||
146664232|NCT01543698|528949415|FG009|Phase 2|Protocol Violation|0|||
146664233|NCT01543698|528949416|FG010|Phase 2|Protocol Violation|0|||
146664234|NCT01543698|528949417|FG011|Phase 2|Protocol Violation|0|||
146664235|NCT01543698|528949418|FG012|Phase 2|Protocol Violation|1|||
146664236|NCT01543698|528949419|FG013|Phase 2|Protocol Violation|0|||
146664237|NCT01543698|528949420|FG014|Phase 2|Protocol Violation|0|||
146664238|NCT01543698|528949406|FG000|Phase 2|Disease progression|0|||
146664239|NCT01543698|528949407|FG001|Phase 2|Disease progression|0|||
146664240|NCT01543698|528949408|FG002|Phase 2|Disease progression|0|||
146664241|NCT01543698|528949409|FG003|Phase 2|Disease progression|0|||
146664242|NCT01543698|528949410|FG004|Phase 2|Disease progression|0|||
146664243|NCT01543698|528949411|FG005|Phase 2|Disease progression|0|||
146664244|NCT01543698|528949412|FG006|Phase 2|Disease progression|0|||
146664245|NCT01543698|528949413|FG007|Phase 2|Disease progression|0|||
146664246|NCT01543698|528949414|FG008|Phase 2|Disease progression|0|||
146664247|NCT01543698|528949415|FG009|Phase 2|Disease progression|0|||
146664248|NCT01543698|528949416|FG010|Phase 2|Disease progression|0|||
146664249|NCT01543698|528949417|FG011|Phase 2|Disease progression|10|||
146664250|NCT01543698|528949418|FG012|Phase 2|Disease progression|21|||
146664251|NCT01543698|528949419|FG013|Phase 2|Disease progression|30|||
146664252|NCT01543698|528949420|FG014|Phase 2|Disease progression|25|||
146664253|NCT01543698|528949406|FG000|Phase 2|Death|0|||
146664254|NCT01543698|528949407|FG001|Phase 2|Death|0|||
146664255|NCT01543698|528949408|FG002|Phase 2|Death|0|||
146664256|NCT01543698|528949409|FG003|Phase 2|Death|0|||
146664257|NCT01543698|528949410|FG004|Phase 2|Death|0|||
146664258|NCT01543698|528949411|FG005|Phase 2|Death|0|||
146664259|NCT01543698|528949412|FG006|Phase 2|Death|0|||
146664260|NCT01543698|528949413|FG007|Phase 2|Death|0|||
146664261|NCT01543698|528949414|FG008|Phase 2|Death|0|||
146664262|NCT01543698|528949415|FG009|Phase 2|Death|0|||
146664263|NCT01543698|528949416|FG010|Phase 2|Death|0|||
146664264|NCT01543698|528949417|FG011|Phase 2|Death|0|||
146664265|NCT01543698|528949418|FG012|Phase 2|Death|1|||
146664266|NCT01543698|528949419|FG013|Phase 2|Death|1|||
146664267|NCT01543698|528949420|FG014|Phase 2|Death|1|||
146664268|NCT01543698|528949406|FG000|Phase 2|Administrative problems|0|||
146664269|NCT01543698|528949407|FG001|Phase 2|Administrative problems|0|||
146664270|NCT01543698|528949408|FG002|Phase 2|Administrative problems|0|||
146664271|NCT01543698|528949409|FG003|Phase 2|Administrative problems|0|||
146664272|NCT01543698|528949410|FG004|Phase 2|Administrative problems|0|||
146664273|NCT01543698|528949411|FG005|Phase 2|Administrative problems|0|||
146664274|NCT01543698|528949412|FG006|Phase 2|Administrative problems|0|||
146664275|NCT01543698|528949413|FG007|Phase 2|Administrative problems|0|||
146664276|NCT01543698|528949414|FG008|Phase 2|Administrative problems|0|||
146664277|NCT01543698|528949415|FG009|Phase 2|Administrative problems|0|||
146664278|NCT01543698|528949416|FG010|Phase 2|Administrative problems|0|||
146664279|NCT01543698|528949417|FG011|Phase 2|Administrative problems|0|||
146664280|NCT01543698|528949418|FG012|Phase 2|Administrative problems|0|||
146664281|NCT01543698|528949419|FG013|Phase 2|Administrative problems|3|||
146664282|NCT01543698|528949420|FG014|Phase 2|Administrative problems|1|||
146664283|NCT01543698|528949406|FG000|Phase 2|Withdrawal by Subject|0|||
146664284|NCT01543698|528949407|FG001|Phase 2|Withdrawal by Subject|0|||
146664285|NCT01543698|528949408|FG002|Phase 2|Withdrawal by Subject|0|||
146664286|NCT01543698|528949409|FG003|Phase 2|Withdrawal by Subject|0|||
146664287|NCT01543698|528949410|FG004|Phase 2|Withdrawal by Subject|0|||
146664288|NCT01543698|528949411|FG005|Phase 2|Withdrawal by Subject|0|||
146664289|NCT01543698|528949412|FG006|Phase 2|Withdrawal by Subject|0|||
146664290|NCT01543698|528949413|FG007|Phase 2|Withdrawal by Subject|0|||
146664291|NCT01543698|528949414|FG008|Phase 2|Withdrawal by Subject|0|||
146664292|NCT01543698|528949415|FG009|Phase 2|Withdrawal by Subject|0|||
146664293|NCT01543698|528949416|FG010|Phase 2|Withdrawal by Subject|0|||
146664294|NCT01543698|528949417|FG011|Phase 2|Withdrawal by Subject|0|||
146664295|NCT01543698|528949418|FG012|Phase 2|Withdrawal by Subject|0|||
146664296|NCT01543698|528949419|FG013|Phase 2|Withdrawal by Subject|3|||
146664297|NCT01543698|528949420|FG014|Phase 2|Withdrawal by Subject|1|||
146664298|NCT01543698|528949406|FG000|Phase 2|Adverse Event|0|||
146664299|NCT01543698|528949407|FG001|Phase 2|Adverse Event|0|||
146664300|NCT01543698|528949408|FG002|Phase 2|Adverse Event|0|||
146664301|NCT01543698|528949409|FG003|Phase 2|Adverse Event|0|||
146664302|NCT01543698|528949410|FG004|Phase 2|Adverse Event|0|||
146664303|NCT01543698|528949411|FG005|Phase 2|Adverse Event|0|||
146664304|NCT01543698|528949412|FG006|Phase 2|Adverse Event|0|||
146664305|NCT01543698|528949413|FG007|Phase 2|Adverse Event|0|||
146664306|NCT01543698|528949414|FG008|Phase 2|Adverse Event|0|||
146664307|NCT01543698|528949415|FG009|Phase 2|Adverse Event|0|||
146664308|NCT01543698|528949416|FG010|Phase 2|Adverse Event|0|||
146664309|NCT01543698|528949417|FG011|Phase 2|Adverse Event|1|||
146664310|NCT01543698|528949418|FG012|Phase 2|Adverse Event|3|||
146664311|NCT01543698|528949419|FG013|Phase 2|Adverse Event|5|||
146664312|NCT01543698|528949420|FG014|Phase 2|Adverse Event|14|||
146664313|NCT00217620|528949421|FG000|Overall Study|Adverse Event|2|||
146664314|NCT00217620|528949421|FG000|Overall Study|Progression|31|||
146664315|NCT00217620|528949421|FG000|Overall Study|Not Protocol Specified|4|||
146664316|NCT00217620|528949421|FG000|Overall Study|Ineligible|13|||
146664317|NCT00217620|528949421|FG000|Overall Study|Never received treatment|1|||
146664318|NCT02742441|528949429|FG000|Overall Study|Lost to Follow-up|4|||
146664319|NCT02742441|528949430|FG001|Overall Study|Lost to Follow-up|4|||
146664320|NCT02742441|528949429|FG000|Overall Study|Withdrawal by Subject|2|||
146664321|NCT02742441|528949430|FG001|Overall Study|Withdrawal by Subject|2|||
146664322|NCT02742441|528949429|FG000|Overall Study|Adverse Event|0|||
146664323|NCT02742441|528949430|FG001|Overall Study|Adverse Event|2|||
146664324|NCT02008318|528949436|FG000|Overall Study|Adverse Event|4|||
146664325|NCT02008318|528949437|FG001|Overall Study|Adverse Event|0|||
146664326|NCT02008318|528949436|FG000|Overall Study|Physician Decision|2|||
146664327|NCT02008318|528949437|FG001|Overall Study|Physician Decision|0|||
146664328|NCT02008318|528949436|FG000|Overall Study|Progressive Disease|2|||
146664329|NCT02008318|528949437|FG001|Overall Study|Progressive Disease|0|||
146664330|NCT02008318|528949436|FG000|Overall Study|Protocol Violation|1|||
146664331|NCT02008318|528949437|FG001|Overall Study|Protocol Violation|1|||
146664332|NCT02008318|528949436|FG000|Overall Study|Withdrawal by Subject|3|||
146664333|NCT02008318|528949437|FG001|Overall Study|Withdrawal by Subject|0|||
146664334|NCT02281773|528949439|FG000|Overall Study|Adverse Event|6|||
146664335|NCT02281773|528949440|FG001|Overall Study|Adverse Event|1|||
146664336|NCT02281773|528949441|FG002|Overall Study|Adverse Event|4|||
146664337|NCT02281773|528949442|FG003|Overall Study|Adverse Event|8|||
146664338|NCT02281773|528949443|FG004|Overall Study|Adverse Event|9|||
146664339|NCT02281773|528949439|FG000|Overall Study|Protocol Violation|1|||
146664340|NCT02281773|528949440|FG001|Overall Study|Protocol Violation|0|||
146664341|NCT02281773|528949441|FG002|Overall Study|Protocol Violation|0|||
146664342|NCT02281773|528949442|FG003|Overall Study|Protocol Violation|2|||
146664343|NCT02281773|528949443|FG004|Overall Study|Protocol Violation|2|||
146664344|NCT02281773|528949439|FG000|Overall Study|Lost to Follow-up|2|||
146664345|NCT02281773|528949440|FG001|Overall Study|Lost to Follow-up|2|||
146664346|NCT02281773|528949441|FG002|Overall Study|Lost to Follow-up|6|||
146664347|NCT02281773|528949442|FG003|Overall Study|Lost to Follow-up|2|||
146664348|NCT02281773|528949443|FG004|Overall Study|Lost to Follow-up|10|||
146664349|NCT02281773|528949439|FG000|Overall Study|Withdrawal by Subject|2|||
146664350|NCT02281773|528949440|FG001|Overall Study|Withdrawal by Subject|8|||
146664351|NCT02281773|528949441|FG002|Overall Study|Withdrawal by Subject|6|||
146664352|NCT02281773|528949442|FG003|Overall Study|Withdrawal by Subject|6|||
146664353|NCT02281773|528949443|FG004|Overall Study|Withdrawal by Subject|8|||
146664354|NCT02281773|528949439|FG000|Overall Study|Other Reason|0|||
146664355|NCT02281773|528949440|FG001|Overall Study|Other Reason|4|||
146664356|NCT02281773|528949441|FG002|Overall Study|Other Reason|2|||
146664357|NCT02281773|528949442|FG003|Overall Study|Other Reason|3|||
146664358|NCT02281773|528949443|FG004|Overall Study|Other Reason|1|||
146664359|NCT02422303|528949444|FG000|Overall Study|Lost to Follow-up|1|||
146664360|NCT02422303|528949445|FG001|Overall Study|Lost to Follow-up|1|||
146664361|NCT01364649|528949450|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
146664362|NCT01364649|528949451|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
146664363|NCT01364649|528949450|FG000|Overall Study|Lack of Efficacy|6|||
146664364|NCT01364649|528949451|FG001|Overall Study|Lack of Efficacy|0|||
146664365|NCT01364649|528949450|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
146664366|NCT01364649|528949451|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
146664367|NCT01364649|528949450|FG000|Overall Study|Protocol Deviations|4|||
146664368|NCT01364649|528949451|FG001|Overall Study|Protocol Deviations|8|||
146664369|NCT01364649|528949450|FG000|Overall Study|Withdrawal of Consent|9|||
146664370|NCT01364649|528949451|FG001|Overall Study|Withdrawal of Consent|7|||
146664371|NCT01364649|528949450|FG000|Overall Study|Lost to Follow-up|12|||
146664372|NCT01364649|528949451|FG001|Overall Study|Lost to Follow-up|13|||
146664373|NCT01364649|528949450|FG000|Overall Study|Other|4|||
146664374|NCT01364649|528949451|FG001|Overall Study|Other|1|||
146664375|NCT00902668|528949452|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
146664376|NCT00004635|528949453|FG000|Period One|refused|2|||
146664377|NCT00004635|528949454|FG001|Period One|refused|1|||
146664378|NCT00004635|528949453|FG000|Period One|Withdrawal by Subject|1|||
146664379|NCT00004635|528949454|FG001|Period One|Withdrawal by Subject|1|||
146664380|NCT00004635|528949453|FG000|Period One|Protocol Violation|1|||
146664381|NCT00004635|528949454|FG001|Period One|Protocol Violation|0|||
146925379|NCT00333619|529888230|FG000|Overall Study|Lost to Follow-up|3|||
146925380|NCT00333619|529888231|FG001|Overall Study|Lost to Follow-up|3|||
146925381|NCT02871401|529888240|FG000|Overall Study|Adverse Event|1|||
146925382|NCT02871401|529888241|FG001|Overall Study|Adverse Event|0|||
146925383|NCT01120379|529888242|FG000|One Year Timepoint|Withdrawal by Subject|41|||
146664382|NCT00004635|528949453|FG000|Period One|PSA did not go <5 ng/mL|1|||
146664383|NCT00004635|528949454|FG001|Period One|PSA did not go <5 ng/mL|0|||
146664384|NCT00004635|528949453|FG000|Period One|second malignancy|1|||
146664385|NCT00004635|528949454|FG001|Period One|second malignancy|0|||
146925384|NCT01120379|529888242|FG000|One Year Timepoint|Lost to Follow-up|115|||
146664386|NCT00004635|528949453|FG000|Period One|progressed|0|||
146664387|NCT00004635|528949454|FG001|Period One|progressed|2|||
146925385|NCT01120379|529888242|FG000|One Year Timepoint|Death|108|||
146664388|NCT00004635|528949453|FG000|Period One|health problem|0|||
146664389|NCT00004635|528949454|FG001|Period One|health problem|1|||
146664390|NCT00004635|528949453|FG000|Period One|discrepancy in data entry|0|||
146664391|NCT00004635|528949454|FG001|Period One|discrepancy in data entry|1|||
146664392|NCT00004635|528949453|FG000|Period Two|progression|2|||
146664393|NCT00004635|528949454|FG001|Period Two|progression|3|||
146664394|NCT00004635|528949453|FG000|Period Two|Adverse Event|1|||
146925386|NCT01120379|529888242|FG000|One Year Timepoint|Physician Decision|9|||
146664395|NCT00004635|528949454|FG001|Period Two|Adverse Event|0|||
146664396|NCT00004635|528949453|FG000|Period Two|refused|0|||
146664397|NCT00004635|528949454|FG001|Period Two|refused|2|||
146664398|NCT00004635|528949453|FG000|Period Two|health problem|1|||
146664399|NCT00004635|528949454|FG001|Period Two|health problem|1|||
146664400|NCT00004635|528949453|FG000|Period Two|travel issues|0|||
146664401|NCT00004635|528949454|FG001|Period Two|travel issues|1|||
146664402|NCT00004635|528949453|FG000|Period Two|secondary malignancy|1|||
146664403|NCT00004635|528949454|FG001|Period Two|secondary malignancy|1|||
146664404|NCT00004635|528949453|FG000|Period Two|Lost to Follow-up|1|||
146664405|NCT00004635|528949454|FG001|Period Two|Lost to Follow-up|0|||
146664406|NCT00004635|528949453|FG000|Period Two|discrepancy in data entry|0|||
146664407|NCT00004635|528949454|FG001|Period Two|discrepancy in data entry|1|||
146664408|NCT01788046|528949455|FG000|Overall Study|Withdrawal by Subject|12|||
146664409|NCT01788046|528949456|FG001|Overall Study|Withdrawal by Subject|12|||
146664410|NCT01788046|528949455|FG000|Overall Study|Lost to Follow-up|12|||
146664411|NCT01788046|528949456|FG001|Overall Study|Lost to Follow-up|19|||
146664412|NCT01788046|528949455|FG000|Overall Study|Death|7|||
146664413|NCT01788046|528949456|FG001|Overall Study|Death|5|||
146664414|NCT01788046|528949455|FG000|Overall Study|Protocol Specified Criteria|25|||
146664415|NCT01788046|528949456|FG001|Overall Study|Protocol Specified Criteria|1|||
146664416|NCT01797731|528949457|FG000|Overall Study|Didn't have proper radiographs required|3|||
146664417|NCT01797731|528949458|FG001|Overall Study|Didn't have proper radiographs required|3|||
146664418|NCT00808483|528949461|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
146664419|NCT00808483|528949462|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
146664420|NCT00808483|528949461|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
146664421|NCT00808483|528949462|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
146664422|NCT00808483|528949461|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
146664423|NCT00808483|528949462|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
146664424|NCT02038881|528949463|FG000|Overall Study|Withdrawal by Subject|0|||
146664425|NCT02038881|528949464|FG001|Overall Study|Withdrawal by Subject|0|||
146664426|NCT02038881|528949465|FG002|Overall Study|Withdrawal by Subject|1|||
146664427|NCT02038881|528949463|FG000|Overall Study|Lost to Follow-up|2|||
146664428|NCT02038881|528949464|FG001|Overall Study|Lost to Follow-up|0|||
146664429|NCT02038881|528949465|FG002|Overall Study|Lost to Follow-up|0|||
146664430|NCT02038881|528949463|FG000|Overall Study|incarcerated|1|||
146664431|NCT02038881|528949464|FG001|Overall Study|incarcerated|0|||
146664432|NCT02038881|528949465|FG002|Overall Study|incarcerated|0|||
146664433|NCT00333840|528949466|FG000|First-line Treatment Period|Adverse Event|38|||
146664434|NCT00333840|528949467|FG001|First-line Treatment Period|Adverse Event|37|||
146664435|NCT00333840|528949468|FG002|First-line Treatment Period|Adverse Event|0|||
146664436|NCT00333840|528949469|FG003|First-line Treatment Period|Adverse Event|0|||
146664437|NCT00333840|528949466|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
146664438|NCT00333840|528949467|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
146664439|NCT00333840|528949468|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
146664440|NCT00333840|528949469|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
146664441|NCT00333840|528949466|FG000|First-line Treatment Period|Abnormal procedure|2|||
146664442|NCT00333840|528949467|FG001|First-line Treatment Period|Abnormal procedure|0|||
146664443|NCT00333840|528949468|FG002|First-line Treatment Period|Abnormal procedure|0|||
146664444|NCT00333840|528949469|FG003|First-line Treatment Period|Abnormal procedure|0|||
146664445|NCT00333840|528949466|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
146664446|NCT00333840|528949467|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
146664447|NCT00333840|528949468|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
146664448|NCT00333840|528949469|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
146664449|NCT00333840|528949466|FG000|First-line Treatment Period|No longer required study drug|21|||
146664450|NCT00333840|528949467|FG001|First-line Treatment Period|No longer required study drug|8|||
146664451|NCT00333840|528949468|FG002|First-line Treatment Period|No longer required study drug|0|||
146664452|NCT00333840|528949469|FG003|First-line Treatment Period|No longer required study drug|0|||
146664453|NCT00333840|528949466|FG000|First-line Treatment Period|Protocol Violation|17|||
146664454|NCT00333840|528949467|FG001|First-line Treatment Period|Protocol Violation|17|||
146664455|NCT00333840|528949468|FG002|First-line Treatment Period|Protocol Violation|0|||
146664456|NCT00333840|528949469|FG003|First-line Treatment Period|Protocol Violation|0|||
146664457|NCT00333840|528949466|FG000|First-line Treatment Period|Subject withdrew consent|57|||
146664458|NCT00333840|528949467|FG001|First-line Treatment Period|Subject withdrew consent|77|||
146664459|NCT00333840|528949468|FG002|First-line Treatment Period|Subject withdrew consent|0|||
146925387|NCT01120379|529888242|FG000|One Year Timepoint|Any other reason for early termination|5|||
146664460|NCT00333840|528949469|FG003|First-line Treatment Period|Subject withdrew consent|0|||
146664461|NCT00333840|528949466|FG000|First-line Treatment Period|Lost to Follow-up|15|||
146664462|NCT00333840|528949467|FG001|First-line Treatment Period|Lost to Follow-up|6|||
146664463|NCT00333840|528949468|FG002|First-line Treatment Period|Lost to Follow-up|0|||
146664464|NCT00333840|528949469|FG003|First-line Treatment Period|Lost to Follow-up|0|||
146664465|NCT00333840|528949466|FG000|First-line Treatment Period|Administrative problems|12|||
146664466|NCT00333840|528949467|FG001|First-line Treatment Period|Administrative problems|6|||
146664467|NCT00333840|528949468|FG002|First-line Treatment Period|Administrative problems|0|||
146664468|NCT00333840|528949469|FG003|First-line Treatment Period|Administrative problems|0|||
146664469|NCT00333840|528949466|FG000|First-line Treatment Period|Death|19|||
146664470|NCT00333840|528949467|FG001|First-line Treatment Period|Death|2|||
146664471|NCT00333840|528949468|FG002|First-line Treatment Period|Death|0|||
146664472|NCT00333840|528949469|FG003|First-line Treatment Period|Death|0|||
146664473|NCT00333840|528949466|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
146664474|NCT00333840|528949467|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
146664475|NCT00333840|528949468|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
146664476|NCT00333840|528949469|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
146664477|NCT00333840|528949466|FG000|Second-line Treatment Period|Adverse Event|0|||
146664478|NCT00333840|528949467|FG001|Second-line Treatment Period|Adverse Event|0|||
146664479|NCT00333840|528949468|FG002|Second-line Treatment Period|Adverse Event|3|||
146664480|NCT00333840|528949469|FG003|Second-line Treatment Period|Adverse Event|34|||
146664481|NCT00333840|528949466|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
146664482|NCT00333840|528949467|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
146664483|NCT00333840|528949468|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
146664484|NCT00333840|528949469|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
146664485|NCT00333840|528949466|FG000|Second-line Treatment Period|Abnormal procedure|0|||
146664486|NCT00333840|528949467|FG001|Second-line Treatment Period|Abnormal procedure|0|||
146664487|NCT00333840|528949468|FG002|Second-line Treatment Period|Abnormal procedure|0|||
146664488|NCT00333840|528949469|FG003|Second-line Treatment Period|Abnormal procedure|1|||
146664489|NCT00333840|528949466|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
146664490|NCT00333840|528949467|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
146664491|NCT00333840|528949468|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
146664492|NCT00333840|528949469|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
146664493|NCT00333840|528949466|FG000|Second-line Treatment Period|No longer required study drug|0|||
146664494|NCT00333840|528949467|FG001|Second-line Treatment Period|No longer required study drug|0|||
146664495|NCT00333840|528949468|FG002|Second-line Treatment Period|No longer required study drug|1|||
146664496|NCT00333840|528949469|FG003|Second-line Treatment Period|No longer required study drug|14|||
146664497|NCT00333840|528949466|FG000|Second-line Treatment Period|Protocol Violation|0|||
146664498|NCT00333840|528949467|FG001|Second-line Treatment Period|Protocol Violation|0|||
146664499|NCT00333840|528949468|FG002|Second-line Treatment Period|Protocol Violation|1|||
146664500|NCT00333840|528949469|FG003|Second-line Treatment Period|Protocol Violation|10|||
146664501|NCT00333840|528949466|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
146664502|NCT00333840|528949467|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
146664503|NCT00333840|528949468|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
146664504|NCT00333840|528949469|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
146664505|NCT00333840|528949466|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
146664506|NCT00333840|528949467|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
146664507|NCT00333840|528949468|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
146664508|NCT00333840|528949469|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
146664509|NCT00333840|528949466|FG000|Second-line Treatment Period|Administrative problems|0|||
146664510|NCT00333840|528949467|FG001|Second-line Treatment Period|Administrative problems|0|||
146664511|NCT00333840|528949468|FG002|Second-line Treatment Period|Administrative problems|0|||
146664512|NCT00333840|528949469|FG003|Second-line Treatment Period|Administrative problems|7|||
146664513|NCT00333840|528949466|FG000|Second-line Treatment Period|Death|0|||
146664514|NCT00333840|528949467|FG001|Second-line Treatment Period|Death|0|||
146664515|NCT00333840|528949468|FG002|Second-line Treatment Period|Death|0|||
146664516|NCT00333840|528949469|FG003|Second-line Treatment Period|Death|9|||
146664517|NCT03945214|528949470|FG000|Overall Study|Lost to Follow-up|3|||
146664518|NCT03945214|528949471|FG001|Overall Study|Lost to Follow-up|4|||
146664519|NCT03945214|528949472|FG002|Overall Study|Lost to Follow-up|7|||
146664520|NCT03945214|528949473|FG003|Overall Study|Lost to Follow-up|4|||
146664521|NCT01436396|528949484|FG000|Overall Study|Protocol Violation|7|||
146664522|NCT01436396|528949485|FG001|Overall Study|Protocol Violation|5|||
146664523|NCT01436396|528949484|FG000|Overall Study|Adverse Event|1|||
146664524|NCT01436396|528949485|FG001|Overall Study|Adverse Event|2|||
146664525|NCT01436396|528949484|FG000|Overall Study|Withdrawal by Subject|19|||
146664526|NCT01436396|528949485|FG001|Overall Study|Withdrawal by Subject|29|||
146664527|NCT01436396|528949484|FG000|Overall Study|Serious adverse event|2|||
146664528|NCT01436396|528949485|FG001|Overall Study|Serious adverse event|3|||
146664529|NCT01436396|528949484|FG000|Overall Study|Lost to Follow-up|3|||
146664530|NCT01436396|528949485|FG001|Overall Study|Lost to Follow-up|3|||
146664531|NCT00875979|528949486|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
146664532|NCT00875979|528949487|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
146664533|NCT00875979|528949486|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
146664534|NCT00875979|528949487|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
146925388|NCT01120379|529888242|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
146925389|NCT01120379|529888242|FG000|Two Year Timepoint|Lost to Follow-up|87|||
146925390|NCT01120379|529888242|FG000|Two Year Timepoint|Death|123|||
146925391|NCT01120379|529888242|FG000|Two Year Timepoint|Physician Decision|12|||
146664535|NCT00875979|528949486|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
146664536|NCT00875979|528949487|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
146664537|NCT00875979|528949486|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
146664538|NCT00875979|528949487|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
146664539|NCT00875979|528949486|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
146664540|NCT00875979|528949487|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
146664541|NCT00875979|528949486|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
146664542|NCT00875979|528949487|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
146664543|NCT00875979|528949486|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
146664544|NCT00875979|528949487|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
146664545|NCT00875979|528949486|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
146664546|NCT00875979|528949487|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
146664547|NCT00875979|528949486|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
146664548|NCT00875979|528949487|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
146664549|NCT02083081|528949489|FG000|Overall Study|Lost to Follow-up|31|||
146664550|NCT02083081|528949490|FG001|Overall Study|Lost to Follow-up|9|||
146664551|NCT02905149|528949491|FG000|Overall Study|Lost to Follow-up|2|||
146664552|NCT02905149|528949492|FG001|Overall Study|Lost to Follow-up|0|||
146664553|NCT03277690|528949493|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
146664554|NCT03277690|528949494|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
146664555|NCT03277690|528949493|FG000|Dose Titration and Maintenance|Physician Decision|1|||
146664556|NCT03277690|528949494|FG001|Dose Titration and Maintenance|Physician Decision|0|||
146664557|NCT03277690|528949493|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
146664558|NCT03277690|528949494|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
146664559|NCT03277690|528949493|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
146664560|NCT03277690|528949494|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
146664561|NCT03277690|528949493|FG000|Dose Titration and Maintenance|Adverse Event|15|||
146664562|NCT03277690|528949494|FG001|Dose Titration and Maintenance|Adverse Event|0|||
146664563|NCT03277690|528949493|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
146664564|NCT03277690|528949494|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
146664565|NCT03277690|528949493|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
146664566|NCT03277690|528949494|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
146664567|NCT00747812|528949495|FG000|Overall Study|Research Site Staff Relocation|5|||
146664568|NCT00747812|528949496|FG001|Overall Study|Research Site Staff Relocation|3|||
146664569|NCT04209348|528949497|FG000|Overall Study|Lost to Follow-up|1|||
146664570|NCT04209348|528949498|FG001|Overall Study|Lost to Follow-up|0|||
146664571|NCT02927262|528949499|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
146664572|NCT02927262|528949500|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
146664573|NCT02927262|528949499|FG000|Treatment Period (Up to 744 Days)|Death|1|||
146664574|NCT02927262|528949500|FG001|Treatment Period (Up to 744 Days)|Death|0|||
146664575|NCT02927262|528949499|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
146664576|NCT02927262|528949500|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
146664577|NCT02927262|528949499|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
146664578|NCT02927262|528949500|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
146664579|NCT02927262|528949499|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
146664580|NCT02927262|528949500|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
146664581|NCT02927262|528949499|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
146664582|NCT02927262|528949500|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
146664583|NCT02927262|528949499|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
146664584|NCT02927262|528949500|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
146664585|NCT02927262|528949499|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
146664586|NCT02927262|528949500|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
146664587|NCT02927262|528949499|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
146664588|NCT02927262|528949500|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
146664589|NCT02927262|528949499|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
146664590|NCT02927262|528949500|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
146664591|NCT02927262|528949499|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
146664592|NCT02927262|528949500|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
146664593|NCT02927262|528949499|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
146664594|NCT02927262|528949500|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
146664595|NCT02927262|528949499|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
146773726|NCT01170962|529341185|FG001|Treatment Period|Adverse Event|12|||
146925392|NCT01120379|529888242|FG000|Two Year Timepoint|Any other reason for early termination|4|||
146925393|NCT01120379|529888242|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
146925394|NCT01120379|529888242|FG000|Three Year Timepoint|Lost to Follow-up|43|||
146664596|NCT02927262|528949500|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
146664597|NCT02927262|528949499|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
146664598|NCT02927262|528949500|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
146664599|NCT02927262|528949499|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
146664600|NCT02927262|528949500|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
146664601|NCT02927262|528949499|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
146664602|NCT02927262|528949500|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
146664603|NCT04043728|528949501|FG000|Overall Study|Lost to Follow-up|1|||
146664604|NCT04043728|528949502|FG001|Overall Study|Lost to Follow-up|2|||
146664605|NCT04043728|528949503|FG002|Overall Study|Lost to Follow-up|0|||
146664606|NCT00072176|528949504|FG000|Overall Study|Withdrawal by Subject|1|||
146978741|NCT00598559|530085488|FG000|Overall Study|Protocol Non-compliance|1|||
146978742|NCT00598559|530085489|FG001|Overall Study|Protocol Non-compliance|0|||
146978743|NCT00598559|530085490|FG002|Overall Study|Protocol Non-compliance|0|||
146978744|NCT00598559|530085488|FG000|Overall Study|Early discharge from hospital|9|||
146978745|NCT00598559|530085489|FG001|Overall Study|Early discharge from hospital|12|||
146664607|NCT00072176|528949505|FG001|Overall Study|Withdrawal by Subject|0|||
146664608|NCT00072176|528949504|FG000|Overall Study|Protocol Violation|0|||
146664609|NCT00072176|528949505|FG001|Overall Study|Protocol Violation|1|||
146664610|NCT02423772|528949507|FG000|Overall Study|Lost to Follow-up|3|||
146664611|NCT02423772|528949508|FG001|Overall Study|Lost to Follow-up|3|||
146664612|NCT02423772|528949507|FG000|Overall Study|Did not begin intervention|2|||
146664613|NCT02423772|528949508|FG001|Overall Study|Did not begin intervention|5|||
146664614|NCT03698331|528949509|FG000|Overall Study|Adverse Event|2|||
146664615|NCT03698331|528949510|FG001|Overall Study|Adverse Event|3|||
146664616|NCT03698331|528949509|FG000|Overall Study|Withdrawal by Subject|1|||
146664617|NCT03698331|528949510|FG001|Overall Study|Withdrawal by Subject|1|||
146664618|NCT03698331|528949509|FG000|Overall Study|Lost to Follow-up|0|||
146664619|NCT03698331|528949510|FG001|Overall Study|Lost to Follow-up|2|||
146664620|NCT03698331|528949509|FG000|Overall Study|Non-compliance with study drug|1|||
146664621|NCT03698331|528949510|FG001|Overall Study|Non-compliance with study drug|0|||
146664622|NCT01467583|528949512|FG000|Overall Study|Death|1|||
146664623|NCT01467583|528949513|FG001|Overall Study|Death|1|||
146664624|NCT01467583|528949514|FG002|Overall Study|Death|0|||
146664625|NCT01467583|528949512|FG000|Overall Study|Withdrawal by Subject|1|||
146664626|NCT01467583|528949513|FG001|Overall Study|Withdrawal by Subject|0|||
146664627|NCT01467583|528949514|FG002|Overall Study|Withdrawal by Subject|0|||
146664628|NCT01467583|528949512|FG000|Overall Study|Protocol Violation|0|||
146664629|NCT01467583|528949513|FG001|Overall Study|Protocol Violation|0|||
146664630|NCT01467583|528949514|FG002|Overall Study|Protocol Violation|2|||
146664631|NCT02130024|528949515|FG000|Overall Study|Adverse Event|10|||
146664632|NCT02130024|528949516|FG001|Overall Study|Adverse Event|11|||
146664633|NCT02130024|528949515|FG000|Overall Study|Death|2|||
146664634|NCT02130024|528949516|FG001|Overall Study|Death|2|||
146664635|NCT02130024|528949515|FG000|Overall Study|Lost to Follow-up|1|||
146664636|NCT02130024|528949516|FG001|Overall Study|Lost to Follow-up|1|||
146664637|NCT02130024|528949515|FG000|Overall Study|Physician Decision|1|||
146664638|NCT02130024|528949516|FG001|Overall Study|Physician Decision|3|||
146664639|NCT02130024|528949515|FG000|Overall Study|Protocol Deviation|4|||
146664640|NCT02130024|528949516|FG001|Overall Study|Protocol Deviation|0|||
146664641|NCT02130024|528949515|FG000|Overall Study|Site Administration Problems|1|||
146664642|NCT02130024|528949516|FG001|Overall Study|Site Administration Problems|0|||
146664643|NCT02130024|528949515|FG000|Overall Study|Subject Withdrew Consent|6|||
146664644|NCT02130024|528949516|FG001|Overall Study|Subject Withdrew Consent|14|||
146664645|NCT04916769|528949522|FG000|Period 1|Physician Decision|0|||
146664646|NCT04916769|528949523|FG001|Period 1|Physician Decision|0|||
146664647|NCT04916769|528949524|FG002|Period 1|Physician Decision|0|||
146664648|NCT04916769|528949525|FG003|Period 1|Physician Decision|0|||
146664649|NCT04916769|528949526|FG004|Period 1|Physician Decision|0|||
146664650|NCT04916769|528949527|FG005|Period 1|Physician Decision|1|||
146664651|NCT04916769|528949522|FG000|Period 2|Physician Decision|0|||
146664652|NCT04916769|528949523|FG001|Period 2|Physician Decision|1|||
146664653|NCT04916769|528949524|FG002|Period 2|Physician Decision|0|||
146664654|NCT04916769|528949525|FG003|Period 2|Physician Decision|0|||
146664655|NCT04916769|528949526|FG004|Period 2|Physician Decision|0|||
146664656|NCT04916769|528949527|FG005|Period 2|Physician Decision|0|||
146664657|NCT05736224|528949528|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
146664658|NCT04526509|528949529|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
146664659|NCT04526509|528949530|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
146664660|NCT04526509|528949531|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
146664661|NCT04526509|528949532|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
146664662|NCT04526509|528949533|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
146664663|NCT04526509|528949534|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
146664664|NCT04526509|528949535|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
146664665|NCT04526509|528949529|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
146664666|NCT04526509|528949530|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
146664667|NCT04526509|528949531|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
146664668|NCT04526509|528949532|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
146664669|NCT04526509|528949533|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
146664670|NCT04526509|528949534|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
146664671|NCT04526509|528949535|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
146664672|NCT04526509|528949529|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
146664673|NCT04526509|528949530|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
146664674|NCT04526509|528949531|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
146664675|NCT04526509|528949532|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
146664676|NCT04526509|528949533|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
146664677|NCT04526509|528949534|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
146664678|NCT04526509|528949535|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
146664679|NCT04526509|528949529|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
146664680|NCT04526509|528949530|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
146664681|NCT04526509|528949531|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
146664682|NCT04526509|528949532|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
146664683|NCT04526509|528949533|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
146664684|NCT04526509|528949534|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
146664685|NCT04526509|528949535|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
146664686|NCT04526509|528949529|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
146664687|NCT04526509|528949530|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
146664688|NCT04526509|528949531|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
146664689|NCT04526509|528949532|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
146664690|NCT04526509|528949533|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
146664691|NCT04526509|528949534|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
146664692|NCT04526509|528949535|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
146664693|NCT04526509|528949529|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
146664694|NCT04526509|528949530|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
146664695|NCT04526509|528949531|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
146664696|NCT04526509|528949532|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
146664697|NCT04526509|528949533|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
146664698|NCT04526509|528949534|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
146664699|NCT04526509|528949535|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
146664700|NCT04526509|528949529|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
146664701|NCT04526509|528949530|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
146664702|NCT04526509|528949531|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
146664703|NCT04526509|528949532|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
146664704|NCT04526509|528949533|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
146664705|NCT04526509|528949534|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
146664706|NCT04526509|528949535|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
146664707|NCT04526509|528949529|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
146664708|NCT04526509|528949530|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
146664709|NCT04526509|528949531|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
146664710|NCT04526509|528949532|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
146664711|NCT04526509|528949533|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
146664712|NCT04526509|528949534|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
146664713|NCT04526509|528949535|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
146664714|NCT04526509|528949529|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
146664715|NCT04526509|528949530|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
146664716|NCT04526509|528949531|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
146664717|NCT04526509|528949532|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
146664718|NCT04526509|528949533|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
146664719|NCT04526509|528949534|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
146664720|NCT04526509|528949535|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
146664721|NCT04526509|528949529|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
146664722|NCT04526509|528949530|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
146664723|NCT04526509|528949531|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
146664724|NCT04526509|528949532|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
146664725|NCT04526509|528949533|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
146664726|NCT04526509|528949534|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
146664727|NCT04526509|528949535|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
146664728|NCT04526509|528949529|FG000|Enrolled|Study Terminated by Sponsor|0|||
146664729|NCT04526509|528949530|FG001|Enrolled|Study Terminated by Sponsor|0|||
146664730|NCT04526509|528949531|FG002|Enrolled|Study Terminated by Sponsor|0|||
146664731|NCT04526509|528949532|FG003|Enrolled|Study Terminated by Sponsor|0|||
146664732|NCT04526509|528949533|FG004|Enrolled|Study Terminated by Sponsor|0|||
146664733|NCT04526509|528949534|FG005|Enrolled|Study Terminated by Sponsor|0|||
146664734|NCT04526509|528949535|FG006|Enrolled|Study Terminated by Sponsor|1|||
146664735|NCT04526509|528949529|FG000|Enrolled|Death prior to lymphodepletion|0|||
146664736|NCT04526509|528949530|FG001|Enrolled|Death prior to lymphodepletion|0|||
146664737|NCT04526509|528949531|FG002|Enrolled|Death prior to lymphodepletion|0|||
146664738|NCT04526509|528949532|FG003|Enrolled|Death prior to lymphodepletion|1|||
146664739|NCT04526509|528949533|FG004|Enrolled|Death prior to lymphodepletion|0|||
146664740|NCT04526509|528949534|FG005|Enrolled|Death prior to lymphodepletion|0|||
146664741|NCT04526509|528949535|FG006|Enrolled|Death prior to lymphodepletion|0|||
146664742|NCT04526509|528949529|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
146664743|NCT04526509|528949530|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
146664744|NCT04526509|528949531|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
146664745|NCT04526509|528949532|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
146664746|NCT04526509|528949533|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
146664747|NCT04526509|528949534|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
146664748|NCT04526509|528949535|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
146664749|NCT04526509|528949529|FG000|Enrolled|Physician Decision|0|||
146664750|NCT04526509|528949530|FG001|Enrolled|Physician Decision|1|||
146664751|NCT04526509|528949531|FG002|Enrolled|Physician Decision|0|||
146664752|NCT04526509|528949532|FG003|Enrolled|Physician Decision|0|||
146664753|NCT04526509|528949533|FG004|Enrolled|Physician Decision|0|||
146664754|NCT04526509|528949534|FG005|Enrolled|Physician Decision|0|||
146664755|NCT04526509|528949535|FG006|Enrolled|Physician Decision|0|||
146664756|NCT02719327|528949538|FG000|Overall Study|Withdrawal by Subject|11|||
146664757|NCT02719327|528949539|FG001|Overall Study|Withdrawal by Subject|8|||
146664758|NCT04340193|528949540|FG000|Overall Study|Other reason|0|||
146664759|NCT04340193|528949541|FG001|Overall Study|Other reason|0|||
146664760|NCT04340193|528949542|FG002|Overall Study|Other reason|1|||
146925395|NCT01120379|529888242|FG000|Three Year Timepoint|Death|120|||
146925396|NCT01120379|529888242|FG000|Three Year Timepoint|Physician Decision|9|||
146925397|NCT01120379|529888242|FG000|Three Year Timepoint|Any other reason for early termination|17|||
146925398|NCT01120379|529888242|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
146925399|NCT01120379|529888242|FG000|Four Year Timepoint|Lost to Follow-up|10|||
146925400|NCT01120379|529888242|FG000|Four Year Timepoint|Death|131|||
146925401|NCT01120379|529888242|FG000|Four Year Timepoint|Physician Decision|5|||
146925402|NCT01120379|529888242|FG000|Four Year Timepoint|Any other reason for early termination|217|||
146925403|NCT01354353|529888245|FG000|Overall Study|Adverse Event|1|||
146925404|NCT01354353|529888246|FG001|Overall Study|Adverse Event|0|||
146664761|NCT04340193|528949540|FG000|Overall Study|Disease recurrence|0|||
146664762|NCT04340193|528949541|FG001|Overall Study|Disease recurrence|1|||
146664763|NCT04340193|528949542|FG002|Overall Study|Disease recurrence|0|||
146664764|NCT04340193|528949540|FG000|Overall Study|Study drug toxicity|1|||
146664765|NCT04340193|528949541|FG001|Overall Study|Study drug toxicity|0|||
146664766|NCT04340193|528949542|FG002|Overall Study|Study drug toxicity|0|||
146664767|NCT04340193|528949540|FG000|Overall Study|Disease progression|1|||
146664768|NCT04340193|528949541|FG001|Overall Study|Disease progression|2|||
146664769|NCT04340193|528949542|FG002|Overall Study|Disease progression|3|||
146664770|NCT04340193|528949540|FG000|Overall Study|Administrative reasons by sponsor|0|||
146664771|NCT04340193|528949541|FG001|Overall Study|Administrative reasons by sponsor|1|||
146664772|NCT04340193|528949542|FG002|Overall Study|Administrative reasons by sponsor|0|||
146664773|NCT04340193|528949540|FG000|Overall Study|Adverse Event|1|||
146664774|NCT04340193|528949541|FG001|Overall Study|Adverse Event|1|||
146664775|NCT04340193|528949542|FG002|Overall Study|Adverse Event|0|||
146664776|NCT03350620|528949543|FG000|Stage 2|Adverse Event|0|||
146664777|NCT03350620|528949544|FG001|Stage 2|Adverse Event|1|||
146664778|NCT03350620|528949545|FG002|Stage 2|Adverse Event|1|||
146664779|NCT03350620|528949543|FG000|Stage 2|Lack of Efficacy|0|||
146664780|NCT03350620|528949544|FG001|Stage 2|Lack of Efficacy|2|||
146664781|NCT03350620|528949545|FG002|Stage 2|Lack of Efficacy|0|||
146664782|NCT03350620|528949543|FG000|Stage 2|Lost to Follow-up|1|||
146664783|NCT03350620|528949544|FG001|Stage 2|Lost to Follow-up|2|||
146664784|NCT03350620|528949545|FG002|Stage 2|Lost to Follow-up|2|||
146664785|NCT03350620|528949543|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
146664786|NCT03350620|528949544|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
146664787|NCT03350620|528949545|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
146664788|NCT01386008|528949548|FG000|Overall Study|exited w/o incident /study discontinued|17|||
146664789|NCT01386008|528949548|FG000|Overall Study|Adverse Event|3|||
146664790|NCT03001882|528949549|FG000|Overall Study|Death|1|||
146664791|NCT03001882|528949550|FG001|Overall Study|Death|0|||
146664792|NCT03001882|528949551|FG002|Overall Study|Death|0|||
146664793|NCT03001882|528949552|FG003|Overall Study|Death|3|||
146664794|NCT03001882|528949549|FG000|Overall Study|Participant withdrew consent|0|||
146664795|NCT03001882|528949550|FG001|Overall Study|Participant withdrew consent|1|||
146664796|NCT03001882|528949551|FG002|Overall Study|Participant withdrew consent|0|||
146664797|NCT03001882|528949552|FG003|Overall Study|Participant withdrew consent|5|||
146664798|NCT03001882|528949549|FG000|Overall Study|Other reasons|1|||
146664799|NCT03001882|528949550|FG001|Overall Study|Other reasons|2|||
146664800|NCT03001882|528949551|FG002|Overall Study|Other reasons|0|||
146664801|NCT03001882|528949552|FG003|Overall Study|Other reasons|5|||
146664802|NCT03001882|528949549|FG000|Overall Study|Administrative reason by sponsor|0|||
146664803|NCT03001882|528949550|FG001|Overall Study|Administrative reason by sponsor|0|||
146664804|NCT03001882|528949551|FG002|Overall Study|Administrative reason by sponsor|0|||
146664805|NCT03001882|528949552|FG003|Overall Study|Administrative reason by sponsor|1|||
146664806|NCT03001882|528949549|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
146664807|NCT03001882|528949550|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
146664808|NCT03001882|528949551|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
146664809|NCT03001882|528949552|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
146664810|NCT03001882|528949549|FG000|Overall Study|Not reported|0|||
146664811|NCT03001882|528949550|FG001|Overall Study|Not reported|0|||
146664812|NCT03001882|528949551|FG002|Overall Study|Not reported|0|||
146664813|NCT03001882|528949552|FG003|Overall Study|Not reported|6|||
146664814|NCT03001882|528949549|FG000|Overall Study|Maximum clinical benefit|2|||
146664815|NCT03001882|528949550|FG001|Overall Study|Maximum clinical benefit|3|||
146664816|NCT03001882|528949551|FG002|Overall Study|Maximum clinical benefit|0|||
146664817|NCT03001882|528949552|FG003|Overall Study|Maximum clinical benefit|10|||
146664818|NCT03001882|528949549|FG000|Overall Study|AE unrelated to study drug|3|||
146664819|NCT03001882|528949550|FG001|Overall Study|AE unrelated to study drug|3|||
146664820|NCT03001882|528949551|FG002|Overall Study|AE unrelated to study drug|0|||
146664821|NCT03001882|528949552|FG003|Overall Study|AE unrelated to study drug|11|||
146664822|NCT03001882|528949549|FG000|Overall Study|Study Drug Toxicity|8|||
146664823|NCT03001882|528949550|FG001|Overall Study|Study Drug Toxicity|5|||
146664824|NCT03001882|528949551|FG002|Overall Study|Study Drug Toxicity|0|||
146664825|NCT03001882|528949552|FG003|Overall Study|Study Drug Toxicity|37|||
146664826|NCT03001882|528949549|FG000|Overall Study|Disease progression|16|||
146664827|NCT03001882|528949550|FG001|Overall Study|Disease progression|14|||
146664828|NCT03001882|528949551|FG002|Overall Study|Disease progression|1|||
146664829|NCT03001882|528949552|FG003|Overall Study|Disease progression|90|||
146664830|NCT00566111|528949553|FG000|Overall Study|Adverse Event|0|||
146664831|NCT00566111|528949554|FG001|Overall Study|Adverse Event|2|||
146664832|NCT04449861|528949555|FG000|Overall Study|Withdrawal by Subject|4|||
146664833|NCT04449861|528949555|FG000|Overall Study|Lost to Follow-up|5|||
146664834|NCT04449861|528949555|FG000|Overall Study|Death|112|||
146664835|NCT05268055|528949556|FG000|Overall Study|Lost to Follow-up|68|||
146664836|NCT05268055|528949557|FG001|Overall Study|Lost to Follow-up|68|||
146664837|NCT05268055|528949556|FG000|Overall Study|Withdrawal by Subject|12|||
146664838|NCT05268055|528949557|FG001|Overall Study|Withdrawal by Subject|8|||
146664839|NCT01555983|528949558|FG000|Overall Study|Withdrawal by Subject|1|||
146664840|NCT01555983|528949559|FG001|Overall Study|Withdrawal by Subject|0|||
146664841|NCT01555983|528949560|FG002|Overall Study|Withdrawal by Subject|0|||
146664842|NCT01555983|528949561|FG003|Overall Study|Withdrawal by Subject|0|||
146664843|NCT01555983|528949562|FG004|Overall Study|Withdrawal by Subject|1|||
146664844|NCT01555983|528949563|FG005|Overall Study|Withdrawal by Subject|1|||
146664845|NCT05439941|528951505|FG000|Overall Study|Lack of Efficacy|8|||
146664846|NCT05439941|528951506|FG001|Overall Study|Lack of Efficacy|5|||
146664847|NCT05439941|528951507|FG002|Overall Study|Lack of Efficacy|3|||
146664848|NCT05439941|528951505|FG000|Overall Study|Treatment Failure|0|||
146664849|NCT05439941|528951506|FG001|Overall Study|Treatment Failure|1|||
146664850|NCT05439941|528951507|FG002|Overall Study|Treatment Failure|0|||
146664851|NCT05439941|528951505|FG000|Overall Study|Adverse Event|1|||
146664852|NCT05439941|528951506|FG001|Overall Study|Adverse Event|3|||
146664853|NCT05439941|528951507|FG002|Overall Study|Adverse Event|0|||
146664854|NCT05439941|528951505|FG000|Overall Study|Adverse Event - Parent Study|1|||
146664855|NCT05439941|528951506|FG001|Overall Study|Adverse Event - Parent Study|0|||
146664856|NCT05439941|528951507|FG002|Overall Study|Adverse Event - Parent Study|0|||
146664857|NCT05439941|528951505|FG000|Overall Study|Pregnancy|1|||
146664858|NCT05439941|528951506|FG001|Overall Study|Pregnancy|0|||
146664859|NCT05439941|528951507|FG002|Overall Study|Pregnancy|0|||
146664860|NCT05439941|528951505|FG000|Overall Study|Withdrawal by Subject|9|||
146664861|NCT05439941|528951506|FG001|Overall Study|Withdrawal by Subject|6|||
146664862|NCT05439941|528951507|FG002|Overall Study|Withdrawal by Subject|10|||
146664863|NCT05439941|528951505|FG000|Overall Study|Non-Compliance|1|||
146664864|NCT05439941|528951506|FG001|Overall Study|Non-Compliance|1|||
146664865|NCT05439941|528951507|FG002|Overall Study|Non-Compliance|1|||
146664866|NCT05439941|528951505|FG000|Overall Study|Lost to Follow-up|2|||
146664867|NCT05439941|528951506|FG001|Overall Study|Lost to Follow-up|2|||
146664868|NCT05439941|528951507|FG002|Overall Study|Lost to Follow-up|0|||
146664869|NCT05439941|528951505|FG000|Overall Study|Physician Decision|1|||
146664870|NCT05439941|528951506|FG001|Overall Study|Physician Decision|0|||
146664871|NCT05439941|528951507|FG002|Overall Study|Physician Decision|0|||
146664872|NCT05439941|528951505|FG000|Overall Study|Trial Termination by Sponsor|78|||
146664873|NCT05439941|528951506|FG001|Overall Study|Trial Termination by Sponsor|83|||
146664874|NCT05439941|528951507|FG002|Overall Study|Trial Termination by Sponsor|65|||
146664875|NCT05439941|528951505|FG000|Overall Study|Other than Reasons Listed|2|||
146664876|NCT05439941|528951506|FG001|Overall Study|Other than Reasons Listed|1|||
146664877|NCT05439941|528951507|FG002|Overall Study|Other than Reasons Listed|0|||
146664878|NCT00573183|528951508|FG000|Overall Study|Lost to Follow-up|52|||
146664879|NCT00573183|528951509|FG001|Overall Study|Lost to Follow-up|50|||
146664880|NCT00573183|528951508|FG000|Overall Study|Withdrawal by Subject|8|||
146664881|NCT00573183|528951509|FG001|Overall Study|Withdrawal by Subject|2|||
146664882|NCT00573183|528951508|FG000|Overall Study|Death|0|||
146664883|NCT00573183|528951509|FG001|Overall Study|Death|1|||
146664884|NCT00573183|528951508|FG000|Overall Study|Adverse Event|2|||
146664885|NCT00573183|528951509|FG001|Overall Study|Adverse Event|0|||
146664886|NCT00573183|528951508|FG000|Overall Study|Incarceration|5|||
146664887|NCT00573183|528951509|FG001|Overall Study|Incarceration|8|||
146664888|NCT00573183|528951508|FG000|Overall Study|Other|5|||
146664889|NCT00573183|528951509|FG001|Overall Study|Other|2|||
146664890|NCT01926015|528951511|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146664891|NCT01926015|528951512|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146664892|NCT01926015|528951511|FG000|Overall Study|Randomized not treated|2|||
146664893|NCT01926015|528951512|FG001|Overall Study|Randomized not treated|0|||
146664894|NCT01914757|528951513|FG000|Overall Study|Severe non-compliance to protocol|3|||
146664895|NCT01914757|528951514|FG001|Overall Study|Severe non-compliance to protocol|1|||
146664896|NCT01914757|528951515|FG002|Overall Study|Severe non-compliance to protocol|2|||
146664897|NCT01914757|528951513|FG000|Overall Study|Lost to Follow-up|5|||
146664898|NCT01914757|528951514|FG001|Overall Study|Lost to Follow-up|8|||
146664899|NCT01914757|528951515|FG002|Overall Study|Lost to Follow-up|6|||
146664900|NCT01914757|528951513|FG000|Overall Study|Withdrawal by Subject|15|||
146664901|NCT01914757|528951514|FG001|Overall Study|Withdrawal by Subject|27|||
146664902|NCT01914757|528951515|FG002|Overall Study|Withdrawal by Subject|19|||
146664903|NCT01914757|528951513|FG000|Overall Study|Death|2|||
146664904|NCT01914757|528951514|FG001|Overall Study|Death|2|||
146664905|NCT01914757|528951515|FG002|Overall Study|Death|1|||
146664906|NCT01914757|528951513|FG000|Overall Study|Adverse Event|4|||
146664907|NCT01914757|528951514|FG001|Overall Study|Adverse Event|3|||
146664908|NCT01914757|528951515|FG002|Overall Study|Adverse Event|4|||
146664909|NCT01914757|528951513|FG000|Overall Study|Study specific withdrawal criteria|0|||
146664910|NCT01914757|528951514|FG001|Overall Study|Study specific withdrawal criteria|1|||
146664911|NCT01914757|528951515|FG002|Overall Study|Study specific withdrawal criteria|0|||
146664912|NCT01914757|528951513|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
146664913|NCT01914757|528951514|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146664914|NCT01914757|528951515|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
146664915|NCT01914757|528951513|FG000|Overall Study|Other reasons|5|||
146664916|NCT01914757|528951514|FG001|Overall Study|Other reasons|9|||
146664917|NCT01914757|528951515|FG002|Overall Study|Other reasons|4|||
146664918|NCT00615108|528951516|FG000|Overall Study|Adverse Event|122|||
146664919|NCT00615108|528951516|FG000|Overall Study|Other|370|||
146664920|NCT00615108|528951516|FG000|Overall Study|Lost to Follow-up|15|||
146664921|NCT01147640|528951517|FG000|Overall Study|Adverse Event|2|||
146664922|NCT01147640|528951518|FG001|Overall Study|Adverse Event|0|||
146664923|NCT01147640|528951517|FG000|Overall Study|Physician Decision|1|||
146664924|NCT01147640|528951518|FG001|Overall Study|Physician Decision|0|||
146664925|NCT01147640|528951517|FG000|Overall Study|Withdrawal by Subject|1|||
146664926|NCT01147640|528951518|FG001|Overall Study|Withdrawal by Subject|0|||
146664927|NCT01147640|528951517|FG000|Overall Study|Lost to Follow-up|0|||
146664928|NCT01147640|528951518|FG001|Overall Study|Lost to Follow-up|1|||
146664929|NCT01147640|528951517|FG000|Overall Study|Didn't meet eligibility criteria|1|||
146664930|NCT01147640|528951518|FG001|Overall Study|Didn't meet eligibility criteria|0|||
146664931|NCT01856907|528951521|FG000|Overall Study|Pregnancy|0|||
146664932|NCT01856907|528951522|FG001|Overall Study|Pregnancy|1|||
146664933|NCT01856907|528951523|FG002|Overall Study|Pregnancy|0|||
146664934|NCT01856907|528951521|FG000|Overall Study|Pregnancy|0|||
146664935|NCT01856907|528951522|FG001|Overall Study|Pregnancy|1|||
146664936|NCT01856907|528951523|FG002|Overall Study|Pregnancy|0|||
146664937|NCT01856907|528951521|FG000|Overall Study|Withdrawal by Subject|0|||
146664938|NCT01856907|528951522|FG001|Overall Study|Withdrawal by Subject|1|||
146664939|NCT01856907|528951523|FG002|Overall Study|Withdrawal by Subject|0|||
146664940|NCT00091442|528951525|FG000|Overall Study|Progressive Disease|220|||
146664941|NCT00091442|528951526|FG001|Overall Study|Progressive Disease|189|||
146664942|NCT00091442|528951525|FG000|Overall Study|Physician Decision|61|||
146664943|NCT00091442|528951526|FG001|Overall Study|Physician Decision|58|||
146664944|NCT00091442|528951525|FG000|Overall Study|Withdrawal by Subject|38|||
146664945|NCT00091442|528951526|FG001|Overall Study|Withdrawal by Subject|46|||
146664946|NCT00091442|528951525|FG000|Overall Study|Adverse Event|29|||
146664947|NCT00091442|528951526|FG001|Overall Study|Adverse Event|48|||
146664948|NCT00091442|528951525|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
146664949|NCT00091442|528951526|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
146664950|NCT00091442|528951525|FG000|Overall Study|Death|9|||
146664951|NCT00091442|528951526|FG001|Overall Study|Death|7|||
146664952|NCT00091442|528951525|FG000|Overall Study|Lost to Follow-up|1|||
146664953|NCT00091442|528951526|FG001|Overall Study|Lost to Follow-up|3|||
146664954|NCT00091442|528951525|FG000|Overall Study|Other|2|||
146664955|NCT00091442|528951526|FG001|Overall Study|Other|6|||
146664956|NCT00917501|528951527|FG000|Overall Study|Lost to Follow-up|4|||
146664957|NCT00917501|528951528|FG001|Overall Study|Lost to Follow-up|1|||
146664958|NCT00917501|528951527|FG000|Overall Study|Withdrawal by Subject|3|||
146664959|NCT00917501|528951528|FG001|Overall Study|Withdrawal by Subject|1|||
146664960|NCT00917501|528951527|FG000|Overall Study|Lack of Efficacy|1|||
146664961|NCT00917501|528951528|FG001|Overall Study|Lack of Efficacy|2|||
146664962|NCT00917501|528951527|FG000|Overall Study|trouble swollowing capsules|0|||
146664963|NCT00917501|528951528|FG001|Overall Study|trouble swollowing capsules|1|||
146664964|NCT00986830|528951537|FG000|Overall Study|Death|1|||
146664965|NCT00986830|528951537|FG000|Overall Study|Lost to Follow-up|1|||
146664966|NCT00986830|528951537|FG000|Overall Study|Lack of Efficacy|1|||
146664967|NCT00986830|528951537|FG000|Overall Study|Unable to access sinus with device|5|||
146664968|NCT00216476|528951538|FG000|Overall Study|Withdrawal by Subject|59|||
146664969|NCT00216476|528951539|FG001|Overall Study|Withdrawal by Subject|72|||
146664970|NCT00216476|528951540|FG002|Overall Study|Withdrawal by Subject|9|||
146664971|NCT00216476|528951538|FG000|Overall Study|Lost to Follow-up|10|||
146664972|NCT00216476|528951539|FG001|Overall Study|Lost to Follow-up|9|||
146664973|NCT00216476|528951540|FG002|Overall Study|Lost to Follow-up|1|||
146664974|NCT00216476|528951538|FG000|Overall Study|Adverse Event|6|||
146664975|NCT00216476|528951539|FG001|Overall Study|Adverse Event|10|||
146664976|NCT00216476|528951540|FG002|Overall Study|Adverse Event|1|||
146664977|NCT00216476|528951538|FG000|Overall Study|Lack of Efficacy|4|||
146664978|NCT00216476|528951539|FG001|Overall Study|Lack of Efficacy|3|||
146664979|NCT00216476|528951540|FG002|Overall Study|Lack of Efficacy|0|||
146664980|NCT00216476|528951538|FG000|Overall Study|Death|2|||
146664981|NCT00216476|528951539|FG001|Overall Study|Death|0|||
146664982|NCT00216476|528951540|FG002|Overall Study|Death|0|||
146664983|NCT00216476|528951538|FG000|Overall Study|Pregnancy|0|||
146664984|NCT00216476|528951539|FG001|Overall Study|Pregnancy|1|||
146664985|NCT00216476|528951540|FG002|Overall Study|Pregnancy|1|||
146664986|NCT00216476|528951538|FG000|Overall Study|Other|0|||
146664987|NCT00216476|528951539|FG001|Overall Study|Other|0|||
146664988|NCT00216476|528951540|FG002|Overall Study|Other|1|||
146664989|NCT00216476|528951538|FG000|Overall Study|Refuses Injection|11|||
146664990|NCT00216476|528951539|FG001|Overall Study|Refuses Injection|0|||
146664991|NCT00216476|528951540|FG002|Overall Study|Refuses Injection|0|||
146664992|NCT00216476|528951538|FG000|Overall Study|No Further Need for Treatment|3|||
146664993|NCT00216476|528951539|FG001|Overall Study|No Further Need for Treatment|4|||
146664994|NCT00216476|528951540|FG002|Overall Study|No Further Need for Treatment|1|||
146664995|NCT00216476|528951538|FG000|Overall Study|Non-compliance|0|||
146664996|NCT00216476|528951539|FG001|Overall Study|Non-compliance|4|||
146664997|NCT00216476|528951540|FG002|Overall Study|Non-compliance|1|||
146664998|NCT00216476|528951538|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
146664999|NCT00216476|528951539|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
146665000|NCT00216476|528951540|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
146665001|NCT00216476|528951538|FG000|Overall Study|Administrative Reasons|1|||
146665002|NCT00216476|528951539|FG001|Overall Study|Administrative Reasons|1|||
146665003|NCT00216476|528951540|FG002|Overall Study|Administrative Reasons|0|||
146665004|NCT00216476|528951538|FG000|Overall Study|Protocol Deviation|5|||
146665005|NCT00216476|528951539|FG001|Overall Study|Protocol Deviation|1|||
146665006|NCT00216476|528951540|FG002|Overall Study|Protocol Deviation|0|||
146665007|NCT00216476|528951538|FG000|Overall Study|Patient Moved|2|||
146665008|NCT00216476|528951539|FG001|Overall Study|Patient Moved|2|||
146665009|NCT00216476|528951540|FG002|Overall Study|Patient Moved|0|||
146665010|NCT02191137|528951541|FG000|Treatment|Death|4|||
146665011|NCT02191137|528951541|FG000|Treatment|Withdrawal by Subject|3|||
146665012|NCT02191137|528951541|FG000|Treatment|Adverse Event|2|||
146665013|NCT02191137|528951541|FG000|Treatment|Other|1|||
146665014|NCT02191137|528951541|FG000|Follow-up|Lost to Follow-up|2|||
146665015|NCT02191137|528951541|FG000|Follow-up|Ongoing/unknown|2|||
146665016|NCT02191137|528951541|FG000|Follow-up|Adverse Event|1|||
146665017|NCT01332331|528951542|FG000|Overall Study|Lost to Follow-up|0|||
146665018|NCT01332331|528951543|FG001|Overall Study|Lost to Follow-up|1|||
146665019|NCT01332331|528951542|FG000|Overall Study|Adverse Event|1|||
146665020|NCT01332331|528951543|FG001|Overall Study|Adverse Event|1|||
146665021|NCT01332331|528951542|FG000|Overall Study|Physician Decision|1|||
146665022|NCT01332331|528951543|FG001|Overall Study|Physician Decision|0|||
146665023|NCT01904058|528951545|FG000|Overall Study|Adverse Event|2|||
146665024|NCT01904058|528951546|FG001|Overall Study|Adverse Event|0|||
146665025|NCT01904058|528951547|FG002|Overall Study|Adverse Event|0|||
146665026|NCT01904058|528951548|FG003|Overall Study|Adverse Event|0|||
146665027|NCT01904058|528951545|FG000|Overall Study|Withdrawal by Subject|1|||
146665028|NCT01904058|528951546|FG001|Overall Study|Withdrawal by Subject|0|||
146665029|NCT01904058|528951547|FG002|Overall Study|Withdrawal by Subject|1|||
146665030|NCT01904058|528951548|FG003|Overall Study|Withdrawal by Subject|0|||
146665031|NCT01904058|528951545|FG000|Overall Study|Pregnancy|0|||
146665032|NCT01904058|528951546|FG001|Overall Study|Pregnancy|0|||
146665033|NCT01904058|528951547|FG002|Overall Study|Pregnancy|0|||
146665034|NCT01904058|528951548|FG003|Overall Study|Pregnancy|1|||
146665035|NCT03096483|528951549|FG000|Overall Study|Withdrawal by site|1|||
146665036|NCT04810481|528951551|FG000|Overall Study|Disqualified data sets|10|||
146665037|NCT04810481|528951552|FG001|Overall Study|Disqualified data sets|28|||
146665038|NCT00369707|528951555|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
146665039|NCT00369707|528951555|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
146665040|NCT00369707|528951555|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
146665041|NCT00369707|528951555|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
146665042|NCT00369707|528951555|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
146665043|NCT00369707|528951555|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
146665044|NCT00369707|528951555|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
146665045|NCT00369707|528951555|FG000|Follow up for 2 Years After Treatment|Death|1|||
146665046|NCT00369707|528951555|FG000|Follow up for 2 Years After Treatment|Other|2|||
146665047|NCT00285818|528951560|FG000|Overall Study|Withdrawal by Subject|3|||
146665048|NCT00285818|528951561|FG001|Overall Study|Withdrawal by Subject|2|||
146665049|NCT00285818|528951560|FG000|Overall Study|Lost to Follow-up|1|||
146665050|NCT00285818|528951561|FG001|Overall Study|Lost to Follow-up|0|||
146665051|NCT04041375|528951565|FG000|Intervention Phase|Withdrawal by Subject|2|||
146665052|NCT04041375|528951566|FG001|Intervention Phase|Withdrawal by Subject|2|||
146665053|NCT04041375|528951565|FG000|Follow-up Phase|Death|2|||
146773727|NCT01170962|529341186|FG002|Treatment Period|Adverse Event|3|||
146773728|NCT01170962|529341184|FG000|Treatment Period|Withdrawal by Subject|2|||
146925405|NCT01354353|529888247|FG002|Overall Study|Adverse Event|0|||
146925406|NCT01354353|529888248|FG003|Overall Study|Adverse Event|4|||
146665054|NCT04041375|528951566|FG001|Follow-up Phase|Death|0|||
146665055|NCT04041375|528951565|FG000|Follow-up Phase|Lost to Follow-up|2|||
146665056|NCT04041375|528951566|FG001|Follow-up Phase|Lost to Follow-up|1|||
146665057|NCT04041375|528951565|FG000|Follow-up Phase|Too ill|3|||
146665058|NCT04041375|528951566|FG001|Follow-up Phase|Too ill|0|||
146665059|NCT04674644|528951572|FG000|Overall Study|with missing data|37|||
146665060|NCT01230710|528951575|FG000|Overall Study|Disease Progression|41|||
146665061|NCT01230710|528951575|FG000|Overall Study|Lost to Follow-up|3|||
146665062|NCT01230710|528951575|FG000|Overall Study|Death|4|||
146665063|NCT01230710|528951575|FG000|Overall Study|Withdrawal of Consent|1|||
146665064|NCT01708161|528951576|FG000|Overall Study|Adverse Event|1|||
146665065|NCT01708161|528951577|FG001|Overall Study|Adverse Event|3|||
146665066|NCT01708161|528951578|FG002|Overall Study|Adverse Event|4|||
146665067|NCT01708161|528951579|FG003|Overall Study|Adverse Event|2|||
146665068|NCT01708161|528951580|FG004|Overall Study|Adverse Event|3|||
146925407|NCT01354353|529888249|FG004|Overall Study|Adverse Event|0|||
146665069|NCT01708161|528951581|FG005|Overall Study|Adverse Event|0|||
146665070|NCT01708161|528951576|FG000|Overall Study|Death|0|||
146665071|NCT01708161|528951577|FG001|Overall Study|Death|0|||
146665072|NCT01708161|528951578|FG002|Overall Study|Death|0|||
146665073|NCT01708161|528951579|FG003|Overall Study|Death|1|||
146665074|NCT01708161|528951580|FG004|Overall Study|Death|0|||
146665075|NCT01708161|528951581|FG005|Overall Study|Death|1|||
146665076|NCT01708161|528951576|FG000|Overall Study|Withdrawal by Subject|0|||
146665077|NCT01708161|528951577|FG001|Overall Study|Withdrawal by Subject|1|||
146665078|NCT01708161|528951578|FG002|Overall Study|Withdrawal by Subject|1|||
146665079|NCT01708161|528951579|FG003|Overall Study|Withdrawal by Subject|0|||
146665080|NCT01708161|528951580|FG004|Overall Study|Withdrawal by Subject|0|||
146665081|NCT01708161|528951581|FG005|Overall Study|Withdrawal by Subject|0|||
146665082|NCT01708161|528951576|FG000|Overall Study|Administrative problems|0|||
146665083|NCT01708161|528951577|FG001|Overall Study|Administrative problems|1|||
146665084|NCT01708161|528951578|FG002|Overall Study|Administrative problems|0|||
146665085|NCT01708161|528951579|FG003|Overall Study|Administrative problems|0|||
146665086|NCT01708161|528951580|FG004|Overall Study|Administrative problems|0|||
146665087|NCT01708161|528951581|FG005|Overall Study|Administrative problems|0|||
146665088|NCT01708161|528951576|FG000|Overall Study|Disease progression|3|||
146665089|NCT01708161|528951577|FG001|Overall Study|Disease progression|5|||
146665090|NCT01708161|528951578|FG002|Overall Study|Disease progression|5|||
146665091|NCT01708161|528951579|FG003|Overall Study|Disease progression|13|||
146665092|NCT01708161|528951580|FG004|Overall Study|Disease progression|3|||
146665093|NCT01708161|528951581|FG005|Overall Study|Disease progression|0|||
146665094|NCT01268150|528951584|FG000|Treatment Phase|Progression of disease|18|||
146665095|NCT01268150|528951584|FG000|Treatment Phase|Adverse Event|3|||
146665096|NCT01268150|528951584|FG000|Treatment Phase|Withdrawal by Subject|3|||
146665097|NCT01268150|528951584|FG000|Treatment Phase|Other|4|||
146665098|NCT01268150|528951584|FG000|Extension Phase|Adverse Event|3|||
146665099|NCT01268150|528951584|FG000|Extension Phase|Disease progression|18|||
146665100|NCT01268150|528951584|FG000|Extension Phase|Other|6|||
146665101|NCT00395733|528951585|FG000|Period 2|Withdrawal by Subject|1|||
146665102|NCT00395733|528951586|FG001|Period 2|Withdrawal by Subject|2|||
146665103|NCT00395733|528951585|FG000|Period 2|Protocol Violation|0|||
146665104|NCT00395733|528951586|FG001|Period 2|Protocol Violation|1|||
146665105|NCT00395733|528951585|FG000|Period 2|Adverse Event|0|||
146665106|NCT00395733|528951586|FG001|Period 2|Adverse Event|2|||
146665107|NCT00395733|528951585|FG000|Period 2|Technical problems|1|||
146665108|NCT00395733|528951586|FG001|Period 2|Technical problems|0|||
146665109|NCT03725852|528951587|FG000|Overall Study|Death|1|||
146665110|NCT03725852|528951588|FG001|Overall Study|Death|0|||
146665111|NCT03725852|528951587|FG000|Overall Study|Withdrawal by Subject|1|||
146665112|NCT03725852|528951588|FG001|Overall Study|Withdrawal by Subject|0|||
146665113|NCT03725852|528951587|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
146665114|NCT03725852|528951588|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
146665115|NCT01986140|528951590|FG000|Overall Study|Withdrawal by Subject|31|||
146665116|NCT01986140|528951591|FG001|Overall Study|Withdrawal by Subject|25|||
146665117|NCT01986140|528951590|FG000|Overall Study|alternative treatment|1|||
146665118|NCT01986140|528951591|FG001|Overall Study|alternative treatment|1|||
146665119|NCT01986140|528951590|FG000|Overall Study|found not eligible|3|||
146665120|NCT01986140|528951591|FG001|Overall Study|found not eligible|0|||
146665121|NCT01986140|528951590|FG000|Overall Study|Adverse Event|0|||
146665122|NCT01986140|528951591|FG001|Overall Study|Adverse Event|1|||
146665123|NCT01986140|528951590|FG000|Overall Study|progression disease|0|||
146665124|NCT01986140|528951591|FG001|Overall Study|progression disease|1|||
146665125|NCT02808650|528951592|FG000|Overall Study|Death|0|||
146665126|NCT02808650|528951593|FG001|Overall Study|Death|0|||
146665127|NCT02808650|528951594|FG002|Overall Study|Death|0|||
146665128|NCT02808650|528951595|FG003|Overall Study|Death|0|||
146665129|NCT02808650|528951596|FG004|Overall Study|Death|1|||
146665130|NCT02808650|528951592|FG000|Overall Study|Lack of Efficacy|5|||
146665131|NCT02808650|528951593|FG001|Overall Study|Lack of Efficacy|5|||
146665132|NCT02808650|528951594|FG002|Overall Study|Lack of Efficacy|6|||
146665133|NCT02808650|528951595|FG003|Overall Study|Lack of Efficacy|5|||
146665134|NCT02808650|528951596|FG004|Overall Study|Lack of Efficacy|4|||
146665135|NCT02808650|528951592|FG000|Overall Study|Physician Decision|1|||
146665136|NCT02808650|528951593|FG001|Overall Study|Physician Decision|1|||
146665137|NCT02808650|528951594|FG002|Overall Study|Physician Decision|0|||
146665138|NCT02808650|528951595|FG003|Overall Study|Physician Decision|0|||
146665139|NCT02808650|528951596|FG004|Overall Study|Physician Decision|0|||
146665140|NCT02808650|528951592|FG000|Overall Study|Withdrawal by Subject|0|||
146665141|NCT02808650|528951593|FG001|Overall Study|Withdrawal by Subject|0|||
146665142|NCT02808650|528951594|FG002|Overall Study|Withdrawal by Subject|0|||
146665143|NCT02808650|528951595|FG003|Overall Study|Withdrawal by Subject|1|||
146665144|NCT02808650|528951596|FG004|Overall Study|Withdrawal by Subject|1|||
146665145|NCT02853344|528951601|FG000|Overall Study|Lost to Follow-up|1|||
146665146|NCT02853344|528951602|FG001|Overall Study|Lost to Follow-up|1|||
146665147|NCT02853344|528951601|FG000|Overall Study|Withdrawal by Subject|2|||
146665148|NCT02853344|528951602|FG001|Overall Study|Withdrawal by Subject|4|||
146665149|NCT02853344|528951601|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
146665150|NCT02853344|528951602|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
146665151|NCT02853344|528951601|FG000|Overall Study|Death|70|||
146665152|NCT02853344|528951602|FG001|Overall Study|Death|112|||
146665153|NCT02913612|528951603|FG000|Overall Study|Lost to Follow-up|6|||
146665154|NCT02913612|528951604|FG001|Overall Study|Lost to Follow-up|5|||
146665155|NCT02913612|528951605|FG002|Overall Study|Lost to Follow-up|2|||
146665156|NCT02913612|528951606|FG003|Overall Study|Lost to Follow-up|0|||
146665157|NCT02913612|528951603|FG000|Overall Study|Physician Decision|1|||
146665158|NCT02913612|528951604|FG001|Overall Study|Physician Decision|4|||
146665159|NCT02913612|528951605|FG002|Overall Study|Physician Decision|1|||
146665160|NCT02913612|528951606|FG003|Overall Study|Physician Decision|0|||
146665161|NCT02913612|528951603|FG000|Overall Study|Withdrawal by Subject|2|||
146665162|NCT02913612|528951604|FG001|Overall Study|Withdrawal by Subject|4|||
146665163|NCT02913612|528951605|FG002|Overall Study|Withdrawal by Subject|0|||
146665164|NCT02913612|528951606|FG003|Overall Study|Withdrawal by Subject|0|||
146665165|NCT02913612|528951603|FG000|Overall Study|Hemangioma resolved|1|||
146665166|NCT02913612|528951604|FG001|Overall Study|Hemangioma resolved|0|||
146665167|NCT02913612|528951605|FG002|Overall Study|Hemangioma resolved|0|||
146665168|NCT02913612|528951606|FG003|Overall Study|Hemangioma resolved|0|||
146665169|NCT02913612|528951603|FG000|Overall Study|Local IRB decision|1|||
146665170|NCT02913612|528951604|FG001|Overall Study|Local IRB decision|0|||
146665171|NCT02913612|528951605|FG002|Overall Study|Local IRB decision|0|||
146665172|NCT02913612|528951606|FG003|Overall Study|Local IRB decision|0|||
146665173|NCT02913612|528951603|FG000|Overall Study|Study drug non-compliance|1|||
146665174|NCT02913612|528951604|FG001|Overall Study|Study drug non-compliance|1|||
146665175|NCT02913612|528951605|FG002|Overall Study|Study drug non-compliance|0|||
146665176|NCT02913612|528951606|FG003|Overall Study|Study drug non-compliance|0|||
146665177|NCT02913612|528951603|FG000|Overall Study|Insurance issues|0|||
146665178|NCT02913612|528951604|FG001|Overall Study|Insurance issues|1|||
146665179|NCT02913612|528951605|FG002|Overall Study|Insurance issues|0|||
146665180|NCT02913612|528951606|FG003|Overall Study|Insurance issues|0|||
146665181|NCT02913612|528951603|FG000|Overall Study|Needed to treat second hemangioma|0|||
146665182|NCT02913612|528951604|FG001|Overall Study|Needed to treat second hemangioma|1|||
146665183|NCT02913612|528951605|FG002|Overall Study|Needed to treat second hemangioma|0|||
146665184|NCT02913612|528951606|FG003|Overall Study|Needed to treat second hemangioma|0|||
146665185|NCT02913612|528951603|FG000|Overall Study|Study completion criteria not met|0|||
146665186|NCT02913612|528951604|FG001|Overall Study|Study completion criteria not met|1|||
146665187|NCT02913612|528951605|FG002|Overall Study|Study completion criteria not met|0|||
146665188|NCT02913612|528951606|FG003|Overall Study|Study completion criteria not met|0|||
146665189|NCT02913612|528951603|FG000|Overall Study|Ineligible|0|||
146665190|NCT02913612|528951604|FG001|Overall Study|Ineligible|1|||
146665191|NCT02913612|528951605|FG002|Overall Study|Ineligible|0|||
146665192|NCT02913612|528951606|FG003|Overall Study|Ineligible|0|||
146665193|NCT01898208|528951612|FG000|Overall Study|Positive blood culture|17|||
146665194|NCT01898208|528951613|FG001|Overall Study|Positive blood culture|23|||
146665195|NCT01898208|528951614|FG002|Overall Study|Positive blood culture|15|||
146925408|NCT01354353|529888250|FG005|Overall Study|Adverse Event|5|||
146925409|NCT01354353|529888245|FG000|Overall Study|Entry Criteria Not Met|0|||
146925410|NCT01354353|529888246|FG001|Overall Study|Entry Criteria Not Met|0|||
146925411|NCT01354353|529888247|FG002|Overall Study|Entry Criteria Not Met|0|||
146925412|NCT01354353|529888248|FG003|Overall Study|Entry Criteria Not Met|1|||
146925413|NCT01354353|529888249|FG004|Overall Study|Entry Criteria Not Met|1|||
146925414|NCT01354353|529888250|FG005|Overall Study|Entry Criteria Not Met|0|||
146925415|NCT01354353|529888245|FG000|Overall Study|Physician Decision|0|||
146925416|NCT01354353|529888246|FG001|Overall Study|Physician Decision|1|||
146925417|NCT01354353|529888247|FG002|Overall Study|Physician Decision|1|||
146925418|NCT01354353|529888248|FG003|Overall Study|Physician Decision|0|||
146925419|NCT01354353|529888249|FG004|Overall Study|Physician Decision|0|||
146925420|NCT01354353|529888250|FG005|Overall Study|Physician Decision|0|||
146925421|NCT01354353|529888245|FG000|Overall Study|Withdrawal by Subject|2|||
146925422|NCT01354353|529888246|FG001|Overall Study|Withdrawal by Subject|0|||
146665196|NCT01898208|528951612|FG000|Overall Study|Death/comfort care within 24 hours|10|||
146665197|NCT01898208|528951613|FG001|Overall Study|Death/comfort care within 24 hours|9|||
146925423|NCT01354353|529888247|FG002|Overall Study|Withdrawal by Subject|1|||
146925424|NCT01354353|529888248|FG003|Overall Study|Withdrawal by Subject|0|||
146925425|NCT01354353|529888249|FG004|Overall Study|Withdrawal by Subject|0|||
146925426|NCT01354353|529888250|FG005|Overall Study|Withdrawal by Subject|1|||
146665198|NCT01898208|528951614|FG002|Overall Study|Death/comfort care within 24 hours|8|||
146665199|NCT01898208|528951612|FG000|Overall Study|Negative Gram Stain|6|||
146665200|NCT01898208|528951613|FG001|Overall Study|Negative Gram Stain|9|||
146665201|NCT01898208|528951614|FG002|Overall Study|Negative Gram Stain|6|||
146665202|NCT01898208|528951612|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
146665203|NCT01898208|528951613|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
146665204|NCT01898208|528951614|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
146665205|NCT01898208|528951612|FG000|Overall Study|System/Technical Error|1|||
146925427|NCT01104584|529888251|FG000|Overall Study|Study drug never administered|21|||
146665206|NCT01898208|528951613|FG001|Overall Study|System/Technical Error|2|||
146665207|NCT01898208|528951614|FG002|Overall Study|System/Technical Error|3|||
146665208|NCT01898208|528951612|FG000|Overall Study|Lost to Follow-up|3|||
146665209|NCT01898208|528951613|FG001|Overall Study|Lost to Follow-up|1|||
146665210|NCT01898208|528951614|FG002|Overall Study|Lost to Follow-up|1|||
146665211|NCT02711345|528951616|FG000|Overall Study|Adverse Event|0|||
146665212|NCT02711345|528951617|FG001|Overall Study|Adverse Event|0|||
146665213|NCT02711345|528951618|FG002|Overall Study|Adverse Event|0|||
146665214|NCT02711345|528951619|FG003|Overall Study|Adverse Event|1|||
146665215|NCT02711345|528951620|FG004|Overall Study|Adverse Event|1|||
146665216|NCT02711345|528951621|FG005|Overall Study|Adverse Event|2|||
146665217|NCT02711345|528951622|FG006|Overall Study|Adverse Event|1|||
146665218|NCT02711345|528951623|FG007|Overall Study|Adverse Event|0|||
146665219|NCT02711345|528951624|FG008|Overall Study|Adverse Event|0|||
146665220|NCT02711345|528951625|FG009|Overall Study|Adverse Event|2|||
146665221|NCT02711345|528951616|FG000|Overall Study|Physician Decision|0|||
146665222|NCT02711345|528951617|FG001|Overall Study|Physician Decision|0|||
146665223|NCT02711345|528951618|FG002|Overall Study|Physician Decision|1|||
146665224|NCT02711345|528951619|FG003|Overall Study|Physician Decision|0|||
146665225|NCT02711345|528951620|FG004|Overall Study|Physician Decision|0|||
146665226|NCT02711345|528951621|FG005|Overall Study|Physician Decision|0|||
146665227|NCT02711345|528951622|FG006|Overall Study|Physician Decision|0|||
146665228|NCT02711345|528951623|FG007|Overall Study|Physician Decision|0|||
146665229|NCT02711345|528951624|FG008|Overall Study|Physician Decision|1|||
146665230|NCT02711345|528951625|FG009|Overall Study|Physician Decision|0|||
146665231|NCT02711345|528951616|FG000|Overall Study|Progressive disease|1|||
146665232|NCT02711345|528951617|FG001|Overall Study|Progressive disease|3|||
146665233|NCT02711345|528951618|FG002|Overall Study|Progressive disease|5|||
146665234|NCT02711345|528951619|FG003|Overall Study|Progressive disease|3|||
146665235|NCT02711345|528951620|FG004|Overall Study|Progressive disease|7|||
146665236|NCT02711345|528951621|FG005|Overall Study|Progressive disease|2|||
146665237|NCT02711345|528951622|FG006|Overall Study|Progressive disease|8|||
146665238|NCT02711345|528951623|FG007|Overall Study|Progressive disease|4|||
146665239|NCT02711345|528951624|FG008|Overall Study|Progressive disease|5|||
146665240|NCT02711345|528951625|FG009|Overall Study|Progressive disease|6|||
146665241|NCT02711345|528951616|FG000|Overall Study|Subject/guardian decision|0|||
146665242|NCT02711345|528951617|FG001|Overall Study|Subject/guardian decision|0|||
146665243|NCT02711345|528951618|FG002|Overall Study|Subject/guardian decision|0|||
146665244|NCT02711345|528951619|FG003|Overall Study|Subject/guardian decision|0|||
146665245|NCT02711345|528951620|FG004|Overall Study|Subject/guardian decision|0|||
146665246|NCT02711345|528951621|FG005|Overall Study|Subject/guardian decision|2|||
146665247|NCT02711345|528951622|FG006|Overall Study|Subject/guardian decision|3|||
146665248|NCT02711345|528951623|FG007|Overall Study|Subject/guardian decision|1|||
146665249|NCT02711345|528951624|FG008|Overall Study|Subject/guardian decision|0|||
146665250|NCT02711345|528951625|FG009|Overall Study|Subject/guardian decision|4|||
146665251|NCT02711345|528951616|FG000|Overall Study|Death|1|||
146665252|NCT02711345|528951617|FG001|Overall Study|Death|0|||
146978746|NCT00598559|530085490|FG002|Overall Study|Early discharge from hospital|3|||
146978747|NCT00598559|530085488|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
146978748|NCT00598559|530085489|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
146665253|NCT02711345|528951618|FG002|Overall Study|Death|0|||
146665254|NCT02711345|528951619|FG003|Overall Study|Death|0|||
146665255|NCT02711345|528951620|FG004|Overall Study|Death|0|||
146665256|NCT02711345|528951621|FG005|Overall Study|Death|0|||
146665257|NCT02711345|528951622|FG006|Overall Study|Death|0|||
146665258|NCT02711345|528951623|FG007|Overall Study|Death|1|||
146665259|NCT02711345|528951624|FG008|Overall Study|Death|0|||
146665260|NCT02711345|528951625|FG009|Overall Study|Death|0|||
146665261|NCT00961649|528951626|FG000|Overall Study|Adverse Event|4|||
146665262|NCT00961649|528951627|FG001|Overall Study|Adverse Event|0|||
146665263|NCT00961649|528951628|FG002|Overall Study|Adverse Event|0|||
146665264|NCT00961649|528951629|FG003|Overall Study|Adverse Event|2|||
146665265|NCT00961649|528951626|FG000|Overall Study|Inadequate control of IOP|0|||
146665266|NCT00961649|528951627|FG001|Overall Study|Inadequate control of IOP|0|||
146665267|NCT00961649|528951628|FG002|Overall Study|Inadequate control of IOP|0|||
146665268|NCT00961649|528951629|FG003|Overall Study|Inadequate control of IOP|1|||
146665269|NCT00961649|528951626|FG000|Overall Study|Patient has travel plans during holidays|0|||
146665270|NCT00961649|528951627|FG001|Overall Study|Patient has travel plans during holidays|0|||
146665271|NCT00961649|528951628|FG002|Overall Study|Patient has travel plans during holidays|1|||
146665272|NCT00961649|528951629|FG003|Overall Study|Patient has travel plans during holidays|0|||
146665273|NCT00961649|528951626|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
146665274|NCT00961649|528951627|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
146665275|NCT00961649|528951628|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
146665276|NCT00961649|528951629|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
146665277|NCT00961649|528951626|FG000|Overall Study|Study terminated by sponsor|4|||
146665278|NCT00961649|528951627|FG001|Overall Study|Study terminated by sponsor|4|||
146665279|NCT00961649|528951628|FG002|Overall Study|Study terminated by sponsor|4|||
146665280|NCT00961649|528951629|FG003|Overall Study|Study terminated by sponsor|1|||
146665281|NCT01011738|528951631|FG000|Overall Study|Death|12|||
146665282|NCT01011738|528951632|FG001|Overall Study|Death|3|||
146665283|NCT01011738|528951633|FG002|Overall Study|Death|0|||
146665284|NCT01011738|528951631|FG000|Overall Study|Unknown reasons|312|||
146665285|NCT01011738|528951632|FG001|Overall Study|Unknown reasons|291|||
146665286|NCT01011738|528951633|FG002|Overall Study|Unknown reasons|17|||
146665287|NCT03896165|528951636|FG000|Overall Study|Withdrawal by Subject|2|||
146665288|NCT02919696|528951637|FG000|Overall Study|Adverse Event|1|||
146665289|NCT02919696|528951638|FG001|Overall Study|Adverse Event|2|||
146665290|NCT02919696|528951637|FG000|Overall Study|Withdrawal by Subject|2|||
146665291|NCT02919696|528951638|FG001|Overall Study|Withdrawal by Subject|1|||
146665292|NCT02919696|528951637|FG000|Overall Study|Sponsor Decision|1|||
146665293|NCT02919696|528951638|FG001|Overall Study|Sponsor Decision|1|||
146665294|NCT02919696|528951637|FG000|Overall Study|Never Treated|0|||
146665295|NCT02919696|528951638|FG001|Overall Study|Never Treated|1|||
146665296|NCT03181893|528951639|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146665297|NCT03181893|528951640|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
146665298|NCT03181893|528951641|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146665299|NCT03181893|528951642|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146665300|NCT03181893|528951643|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146665301|NCT03181893|528951644|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146665302|NCT03181893|528951645|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146665303|NCT03181893|528951646|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146665304|NCT03181893|528951647|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146665305|NCT03181893|528951648|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146665306|NCT03181893|528951649|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146665307|NCT03181893|528951639|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
146665308|NCT03181893|528951640|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
146665309|NCT03181893|528951641|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146665310|NCT03181893|528951642|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146665311|NCT03181893|528951643|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146665312|NCT03181893|528951644|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146665313|NCT03181893|528951645|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146665314|NCT03181893|528951646|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146665315|NCT03181893|528951647|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146665316|NCT03181893|528951648|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146665317|NCT03181893|528951649|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146665318|NCT03181893|528951639|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146665319|NCT03181893|528951640|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146665320|NCT03181893|528951641|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146665321|NCT03181893|528951642|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146665322|NCT03181893|528951643|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146665323|NCT03181893|528951644|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146665324|NCT03181893|528951645|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146665325|NCT03181893|528951646|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
146665326|NCT03181893|528951647|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
146665327|NCT03181893|528951648|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146665328|NCT03181893|528951649|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146665329|NCT03181893|528951639|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146665330|NCT03181893|528951640|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146665331|NCT03181893|528951641|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146665332|NCT03181893|528951642|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146665333|NCT03181893|528951643|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146665334|NCT03181893|528951644|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146665335|NCT03181893|528951645|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146665336|NCT03181893|528951646|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146665337|NCT03181893|528951647|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146665338|NCT03181893|528951648|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
146665339|NCT03181893|528951649|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146665340|NCT03181893|528951639|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146665341|NCT03181893|528951640|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146665342|NCT03181893|528951641|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146925428|NCT01104584|529888251|FG000|Overall Study|Study prematurely discontinued|2|||
146665343|NCT03181893|528951642|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146665344|NCT03181893|528951643|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146925429|NCT04017442|529888252|FG000|Overall Study|Withdrawal by Subject|0|||
146925430|NCT04017442|529888253|FG001|Overall Study|Withdrawal by Subject|3|||
146925431|NCT04017442|529888252|FG000|Overall Study|Lost to Follow-up|21|||
146925432|NCT04017442|529888253|FG001|Overall Study|Lost to Follow-up|19|||
146925433|NCT02586233|529888254|FG000|Overall Study|Randomized but did not receive treatment|0|||
146665345|NCT03181893|528951644|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146665346|NCT03181893|528951645|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146665347|NCT03181893|528951646|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146665348|NCT03181893|528951647|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146665349|NCT03181893|528951648|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146665350|NCT03181893|528951649|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
146665351|NCT04128371|528951652|FG000|Overall Study|Lack of Efficacy|1|||
146665352|NCT00968864|528951656|FG000|Overall Study|Protocol exception/ not evaluable|1|||
146665353|NCT01346969|528951657|FG000|Overall Study|Withdrawal by Subject|0|||
146665354|NCT01346969|528951658|FG001|Overall Study|Withdrawal by Subject|0|||
146665355|NCT01346969|528951659|FG002|Overall Study|Withdrawal by Subject|1|||
146665356|NCT01346969|528951660|FG003|Overall Study|Withdrawal by Subject|0|||
146665357|NCT01346969|528951657|FG000|Overall Study|Lost to Follow-up|1|||
146665358|NCT01346969|528951658|FG001|Overall Study|Lost to Follow-up|0|||
146665359|NCT01346969|528951659|FG002|Overall Study|Lost to Follow-up|2|||
146665360|NCT01346969|528951660|FG003|Overall Study|Lost to Follow-up|0|||
146665361|NCT01346969|528951657|FG000|Overall Study|Physician Decision|0|||
146665362|NCT01346969|528951658|FG001|Overall Study|Physician Decision|0|||
146665363|NCT01346969|528951659|FG002|Overall Study|Physician Decision|0|||
146773729|NCT01170962|529341185|FG001|Treatment Period|Withdrawal by Subject|1|||
146773730|NCT01170962|529341186|FG002|Treatment Period|Withdrawal by Subject|0|||
146773731|NCT01170962|529341184|FG000|Treatment Period|Lost to Follow-up|1|||
146773732|NCT01170962|529341185|FG001|Treatment Period|Lost to Follow-up|1|||
146665364|NCT01346969|528951660|FG003|Overall Study|Physician Decision|1|||
146665365|NCT01346969|528951657|FG000|Overall Study|Randomized but not treated|1|||
146665366|NCT01346969|528951658|FG001|Overall Study|Randomized but not treated|0|||
146665367|NCT01346969|528951659|FG002|Overall Study|Randomized but not treated|0|||
146665368|NCT01346969|528951660|FG003|Overall Study|Randomized but not treated|0|||
146665369|NCT04815031|528951665|FG000|Overall Study|No adverse event information (missing information)|33|||
146665370|NCT00586625|528951666|FG000|Overall Study|Adverse Event|6|||
146665371|NCT00586625|528951667|FG001|Overall Study|Adverse Event|6|||
146665372|NCT00586625|528951666|FG000|Overall Study|Protocol Violation|3|||
146665373|NCT00586625|528951667|FG001|Overall Study|Protocol Violation|0|||
146665374|NCT00586625|528951666|FG000|Overall Study|Withdrawal by Subject|32|||
146665375|NCT00586625|528951667|FG001|Overall Study|Withdrawal by Subject|10|||
146665376|NCT00586625|528951666|FG000|Overall Study|Subject non-compliance|0|||
146665377|NCT00586625|528951667|FG001|Overall Study|Subject non-compliance|1|||
146665378|NCT00586625|528951666|FG000|Overall Study|Subject unable to return for visit|2|||
146665379|NCT00586625|528951667|FG001|Overall Study|Subject unable to return for visit|0|||
146665380|NCT04032652|528951668|FG000|Overall Study|The study was terminated and the PI has|1|||
146665381|NCT04032652|528951669|FG001|Overall Study|The study was terminated and the PI has|1|||
146665382|NCT01558739|528951670|FG000|Overall Study|Adverse Event|7|||
146665383|NCT01558739|528951670|FG000|Overall Study|Withdrawal by Subject|2|||
146665384|NCT01558739|528951670|FG000|Overall Study|Death|3|||
146665385|NCT01558739|528951670|FG000|Overall Study|Disease Progression|4|||
146665386|NCT01558739|528951670|FG000|Overall Study|Protocol Violation|1|||
146665387|NCT01193842|528951672|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
146665388|NCT01193842|528951673|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
146665389|NCT01193842|528951674|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
146665390|NCT01193842|528951675|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
146665391|NCT01193842|528951676|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
146665392|NCT01193842|528951672|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
146665393|NCT01193842|528951673|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
146665394|NCT01193842|528951674|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
146665395|NCT01193842|528951675|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
146665396|NCT01193842|528951676|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
146773733|NCT01170962|529341186|FG002|Treatment Period|Lost to Follow-up|1|||
146773734|NCT01170962|529341184|FG000|Treatment Period|Participant no longer meets criteria|0|||
146773735|NCT01170962|529341185|FG001|Treatment Period|Participant no longer meets criteria|1|||
146773736|NCT01170962|529341186|FG002|Treatment Period|Participant no longer meets criteria|0|||
146773737|NCT01170962|529341184|FG000|Treatment Period|Request to discontinue treatment|7|||
146773738|NCT01170962|529341185|FG001|Treatment Period|Request to discontinue treatment|3|||
146773739|NCT01170962|529341186|FG002|Treatment Period|Request to discontinue treatment|1|||
146665397|NCT01193842|528951672|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
146773740|NCT01170962|529341184|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
146773741|NCT01170962|529341185|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
146773742|NCT01170962|529341186|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
146773743|NCT01170962|529341184|FG000|Follow up Period|Withdrawal by Subject|14|||
146665398|NCT01193842|528951673|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
146665399|NCT01193842|528951674|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
146665400|NCT01193842|528951675|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
146665401|NCT01193842|528951676|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
146665402|NCT01193842|528951672|FG000|Phase II: Randomized Groups|Death|0|||
146665403|NCT01193842|528951673|FG001|Phase II: Randomized Groups|Death|0|||
146665404|NCT01193842|528951674|FG002|Phase II: Randomized Groups|Death|0|||
146665405|NCT01193842|528951675|FG003|Phase II: Randomized Groups|Death|1|||
146665406|NCT01193842|528951676|FG004|Phase II: Randomized Groups|Death|1|||
146665407|NCT01193842|528951672|FG000|Phase II: Randomized Groups|Adverse Event|0|||
146665408|NCT01193842|528951673|FG001|Phase II: Randomized Groups|Adverse Event|0|||
146665409|NCT01193842|528951674|FG002|Phase II: Randomized Groups|Adverse Event|0|||
146665410|NCT01193842|528951675|FG003|Phase II: Randomized Groups|Adverse Event|5|||
146665411|NCT01193842|528951676|FG004|Phase II: Randomized Groups|Adverse Event|3|||
146665412|NCT01193842|528951672|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
146665413|NCT01193842|528951673|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
146665414|NCT01193842|528951674|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
146665415|NCT01193842|528951675|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
146665416|NCT01193842|528951676|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
146665417|NCT01193842|528951672|FG000|Phase II: Randomized Groups|Ineligible|0|||
146665418|NCT01193842|528951673|FG001|Phase II: Randomized Groups|Ineligible|0|||
146665419|NCT01193842|528951674|FG002|Phase II: Randomized Groups|Ineligible|0|||
146665420|NCT01193842|528951675|FG003|Phase II: Randomized Groups|Ineligible|0|||
146665421|NCT01193842|528951676|FG004|Phase II: Randomized Groups|Ineligible|1|||
146665422|NCT01193842|528951672|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
146665423|NCT01193842|528951673|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
146665424|NCT01193842|528951674|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
146665425|NCT01193842|528951675|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
146665426|NCT01193842|528951676|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
146665427|NCT02484690|528951678|FG000|Overall Study|Adverse Event|1|||
146665428|NCT02484690|528951679|FG001|Overall Study|Adverse Event|3|||
146665429|NCT02484690|528951680|FG002|Overall Study|Adverse Event|0|||
146665430|NCT02484690|528951681|FG003|Overall Study|Adverse Event|0|||
146665431|NCT02484690|528951682|FG004|Overall Study|Adverse Event|5|||
146665432|NCT02484690|528951678|FG000|Overall Study|Death|0|||
146665433|NCT02484690|528951679|FG001|Overall Study|Death|0|||
146665434|NCT02484690|528951680|FG002|Overall Study|Death|0|||
146665435|NCT02484690|528951681|FG003|Overall Study|Death|0|||
146665436|NCT02484690|528951682|FG004|Overall Study|Death|1|||
146665437|NCT02484690|528951678|FG000|Overall Study|Withdrawal by Subject|1|||
146665438|NCT02484690|528951679|FG001|Overall Study|Withdrawal by Subject|3|||
146665439|NCT02484690|528951680|FG002|Overall Study|Withdrawal by Subject|1|||
146665440|NCT02484690|528951681|FG003|Overall Study|Withdrawal by Subject|2|||
146665441|NCT02484690|528951682|FG004|Overall Study|Withdrawal by Subject|0|||
146665442|NCT02484690|528951678|FG000|Overall Study|Physician Decision|2|||
146665443|NCT02484690|528951679|FG001|Overall Study|Physician Decision|0|||
146665444|NCT02484690|528951680|FG002|Overall Study|Physician Decision|1|||
146665445|NCT02484690|528951681|FG003|Overall Study|Physician Decision|0|||
146665446|NCT02484690|528951682|FG004|Overall Study|Physician Decision|0|||
146665447|NCT02484690|528951678|FG000|Overall Study|Lost to Follow-up|0|||
146665448|NCT02484690|528951679|FG001|Overall Study|Lost to Follow-up|0|||
146665449|NCT02484690|528951680|FG002|Overall Study|Lost to Follow-up|1|||
146665450|NCT02484690|528951681|FG003|Overall Study|Lost to Follow-up|0|||
146665451|NCT02484690|528951682|FG004|Overall Study|Lost to Follow-up|0|||
146665452|NCT03672643|528951683|FG000|Overall Study|Adverse Event|3|||
146665453|NCT03672643|528951683|FG000|Overall Study|Death|2|||
146665454|NCT03672643|528951683|FG000|Overall Study|Withdrawal by Subject|1|||
146665455|NCT03672643|528951683|FG000|Overall Study|Progressive disease|11|||
146665456|NCT03672643|528951683|FG000|Overall Study|Global deterioration of health status|1|||
146665457|NCT03672643|528951683|FG000|Overall Study|Refused further treatment|7|||
146665458|NCT03672643|528951683|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
146665459|NCT01067976|528951684|FG000|Overall Study|Study drug never administered|20|||
146665460|NCT01067976|528951684|FG000|Overall Study|Study prematurely discontinued|2|||
146665461|NCT00589290|528951685|FG000|Overall Study|Withdrawal by Subject|1|||
146665462|NCT00976677|528951686|FG000|Overall Study|Adverse Event|1|||
146665463|NCT00976677|528951687|FG001|Overall Study|Adverse Event|0|||
146665464|NCT00976677|528951686|FG000|Overall Study|Withdrawal by Subject|0|||
146665465|NCT00976677|528951687|FG001|Overall Study|Withdrawal by Subject|2|||
146665466|NCT00976677|528951686|FG000|Overall Study|Disease progression|1|||
146665467|NCT00976677|528951687|FG001|Overall Study|Disease progression|1|||
146665468|NCT00976677|528951686|FG000|Overall Study|Trial unblinded|2|||
146665469|NCT00976677|528951687|FG001|Overall Study|Trial unblinded|2|||
146665470|NCT00976677|528951686|FG000|Overall Study|Unknown/Missing|1|||
146665471|NCT00976677|528951687|FG001|Overall Study|Unknown/Missing|0|||
146665472|NCT02468232|528953014|FG000|Core Part of Study|Adverse Event|0|||
146665473|NCT02468232|528953015|FG001|Core Part of Study|Adverse Event|1|||
146665474|NCT02468232|528953016|FG002|Core Part of Study|Adverse Event|0|||
146665475|NCT02468232|528953017|FG003|Core Part of Study|Adverse Event|0|||
146665476|NCT02468232|528953014|FG000|Core Part of Study|Death|20|||
146665477|NCT02468232|528953015|FG001|Core Part of Study|Death|17|||
146665478|NCT02468232|528953016|FG002|Core Part of Study|Death|0|||
146665479|NCT02468232|528953017|FG003|Core Part of Study|Death|0|||
146665480|NCT02468232|528953014|FG000|Core Part of Study|Technical Problems|1|||
146665481|NCT02468232|528953015|FG001|Core Part of Study|Technical Problems|1|||
146665482|NCT02468232|528953016|FG002|Core Part of Study|Technical Problems|0|||
146665483|NCT02468232|528953017|FG003|Core Part of Study|Technical Problems|0|||
146665484|NCT02468232|528953014|FG000|OLE Part of Study|Adverse Event|0|||
146665485|NCT02468232|528953015|FG001|OLE Part of Study|Adverse Event|0|||
146665486|NCT02468232|528953016|FG002|OLE Part of Study|Adverse Event|4|||
146665487|NCT02468232|528953017|FG003|OLE Part of Study|Adverse Event|5|||
146665488|NCT02468232|528953014|FG000|OLE Part of Study|Death|0|||
146665489|NCT02468232|528953015|FG001|OLE Part of Study|Death|0|||
146665490|NCT02468232|528953016|FG002|OLE Part of Study|Death|4|||
146665491|NCT02468232|528953017|FG003|OLE Part of Study|Death|2|||
146665492|NCT02468232|528953014|FG000|OLE Part of Study|Physician Decision|0|||
146665493|NCT02468232|528953015|FG001|OLE Part of Study|Physician Decision|0|||
146665494|NCT02468232|528953016|FG002|OLE Part of Study|Physician Decision|4|||
146665495|NCT02468232|528953017|FG003|OLE Part of Study|Physician Decision|0|||
146665496|NCT02468232|528953014|FG000|OLE Part of Study|Subject/Guardian decision|0|||
146665497|NCT02468232|528953015|FG001|OLE Part of Study|Subject/Guardian decision|0|||
146665498|NCT02468232|528953016|FG002|OLE Part of Study|Subject/Guardian decision|2|||
146665499|NCT02468232|528953017|FG003|OLE Part of Study|Subject/Guardian decision|5|||
146665500|NCT02024529|528953020|FG000|Overall Study|Withdrawal by Subject|11|||
146665501|NCT02024529|528953021|FG001|Overall Study|Withdrawal by Subject|21|||
146665502|NCT02024529|528953020|FG000|Overall Study|Lost to Follow-up|2|||
146665503|NCT02024529|528953021|FG001|Overall Study|Lost to Follow-up|4|||
146665504|NCT00354614|528953022|FG000|Overall Study|Lack of Efficacy|28|||
146665505|NCT03650556|528953023|FG000|Overall Study|Death|2|||
146665506|NCT03650556|528953023|FG000|Overall Study|Withdrawal by Subject|20|||
146665507|NCT03650556|528953023|FG000|Overall Study|Physician Decision|2|||
146665508|NCT03650556|528953023|FG000|Overall Study|Lost to Follow-up|8|||
146665509|NCT03650556|528953023|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
146665510|NCT03650556|528953023|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
146665511|NCT01426438|528953026|FG000|Overall Study|Lost to Follow-up|1|||
146665512|NCT01426438|528953027|FG001|Overall Study|Lost to Follow-up|3|||
146665513|NCT01426438|528953026|FG000|Overall Study|Off study Treatment|9|||
146665514|NCT01426438|528953027|FG001|Overall Study|Off study Treatment|3|||
146665515|NCT01426438|528953026|FG000|Overall Study|Poor scan quality|3|||
146665516|NCT01426438|528953027|FG001|Overall Study|Poor scan quality|2|||
146665517|NCT01426438|528953026|FG000|Overall Study|Missed Scan|2|||
146665518|NCT01426438|528953027|FG001|Overall Study|Missed Scan|2|||
146665519|NCT02122458|528953028|FG000|Overall Study|Withdrawal by Subject|0|||
146665520|NCT02122458|528953029|FG001|Overall Study|Withdrawal by Subject|0|||
146665521|NCT02122458|528953030|FG002|Overall Study|Withdrawal by Subject|0|||
146665522|NCT02122458|528953031|FG003|Overall Study|Withdrawal by Subject|4|||
146665523|NCT02122458|528953032|FG004|Overall Study|Withdrawal by Subject|4|||
146665524|NCT02122458|528953033|FG005|Overall Study|Withdrawal by Subject|4|||
146665525|NCT02122458|528953034|FG006|Overall Study|Withdrawal by Subject|0|||
146665526|NCT02122458|528953028|FG000|Overall Study|Lost to Follow-up|1|||
146665527|NCT02122458|528953029|FG001|Overall Study|Lost to Follow-up|3|||
146665528|NCT02122458|528953030|FG002|Overall Study|Lost to Follow-up|0|||
146665529|NCT02122458|528953031|FG003|Overall Study|Lost to Follow-up|7|||
146665530|NCT02122458|528953032|FG004|Overall Study|Lost to Follow-up|5|||
146665531|NCT02122458|528953033|FG005|Overall Study|Lost to Follow-up|15|||
146665532|NCT02122458|528953034|FG006|Overall Study|Lost to Follow-up|1|||
146665533|NCT02122458|528953028|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
146665534|NCT02122458|528953029|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
146665535|NCT02122458|528953030|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
146665536|NCT02122458|528953031|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
146665537|NCT02122458|528953032|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
146665538|NCT02122458|528953033|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
146665539|NCT02122458|528953034|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
146665540|NCT02122458|528953028|FG000|Overall Study|Adverse Event|1|||
146665541|NCT02122458|528953029|FG001|Overall Study|Adverse Event|0|||
146665542|NCT02122458|528953030|FG002|Overall Study|Adverse Event|0|||
146665543|NCT02122458|528953031|FG003|Overall Study|Adverse Event|0|||
146665544|NCT02122458|528953032|FG004|Overall Study|Adverse Event|0|||
146665545|NCT02122458|528953033|FG005|Overall Study|Adverse Event|0|||
146665546|NCT02122458|528953034|FG006|Overall Study|Adverse Event|0|||
146665547|NCT02122458|528953028|FG000|Overall Study|Experimental Error|0|||
146665548|NCT02122458|528953029|FG001|Overall Study|Experimental Error|0|||
146665549|NCT02122458|528953030|FG002|Overall Study|Experimental Error|0|||
146665550|NCT02122458|528953031|FG003|Overall Study|Experimental Error|0|||
146665551|NCT02122458|528953032|FG004|Overall Study|Experimental Error|3|||
146665552|NCT02122458|528953033|FG005|Overall Study|Experimental Error|0|||
146665553|NCT02122458|528953034|FG006|Overall Study|Experimental Error|0|||
146665554|NCT02122458|528953028|FG000|Overall Study|Deployed or Moved|0|||
146665555|NCT02122458|528953029|FG001|Overall Study|Deployed or Moved|0|||
146665556|NCT02122458|528953030|FG002|Overall Study|Deployed or Moved|0|||
146665557|NCT02122458|528953031|FG003|Overall Study|Deployed or Moved|0|||
146665558|NCT02122458|528953032|FG004|Overall Study|Deployed or Moved|1|||
146665559|NCT02122458|528953033|FG005|Overall Study|Deployed or Moved|0|||
146665560|NCT02122458|528953034|FG006|Overall Study|Deployed or Moved|0|||
146665561|NCT02122458|528953028|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
146665562|NCT02122458|528953029|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
146665563|NCT02122458|528953030|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
146665564|NCT02122458|528953031|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
146665565|NCT02122458|528953032|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
146665566|NCT02122458|528953033|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
146665567|NCT02122458|528953034|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
146665568|NCT02122458|528953028|FG000|Overall Study|Noncompliance|0|||
146665569|NCT02122458|528953029|FG001|Overall Study|Noncompliance|1|||
146665570|NCT02122458|528953030|FG002|Overall Study|Noncompliance|0|||
146665571|NCT02122458|528953031|FG003|Overall Study|Noncompliance|0|||
146665572|NCT02122458|528953032|FG004|Overall Study|Noncompliance|0|||
146665573|NCT02122458|528953033|FG005|Overall Study|Noncompliance|0|||
146665574|NCT02122458|528953034|FG006|Overall Study|Noncompliance|0|||
146665575|NCT02833350|528953035|FG000|Overall Study|Adverse Event|0|||
146665576|NCT02833350|528953036|FG001|Overall Study|Adverse Event|3|||
146665577|NCT02833350|528953037|FG002|Overall Study|Adverse Event|4|||
146665578|NCT02833350|528953038|FG003|Overall Study|Adverse Event|4|||
146665579|NCT02833350|528953039|FG004|Overall Study|Adverse Event|1|||
146665580|NCT02833350|528953040|FG005|Overall Study|Adverse Event|0|||
146665581|NCT02833350|528953041|FG006|Overall Study|Adverse Event|1|||
146665582|NCT02833350|528953035|FG000|Overall Study|Death|0|||
146665583|NCT02833350|528953036|FG001|Overall Study|Death|0|||
146665584|NCT02833350|528953037|FG002|Overall Study|Death|1|||
146665585|NCT02833350|528953038|FG003|Overall Study|Death|0|||
146665586|NCT02833350|528953039|FG004|Overall Study|Death|0|||
146665587|NCT02833350|528953040|FG005|Overall Study|Death|0|||
146665588|NCT02833350|528953041|FG006|Overall Study|Death|0|||
146665589|NCT02833350|528953035|FG000|Overall Study|Lack of Efficacy|0|||
146665590|NCT02833350|528953036|FG001|Overall Study|Lack of Efficacy|2|||
146665591|NCT02833350|528953037|FG002|Overall Study|Lack of Efficacy|1|||
146665592|NCT02833350|528953038|FG003|Overall Study|Lack of Efficacy|4|||
146665593|NCT02833350|528953039|FG004|Overall Study|Lack of Efficacy|0|||
146665594|NCT02833350|528953040|FG005|Overall Study|Lack of Efficacy|1|||
146665595|NCT02833350|528953041|FG006|Overall Study|Lack of Efficacy|1|||
146665596|NCT02833350|528953035|FG000|Overall Study|Lost to Follow-up|0|||
146665597|NCT02833350|528953036|FG001|Overall Study|Lost to Follow-up|1|||
146665598|NCT02833350|528953037|FG002|Overall Study|Lost to Follow-up|0|||
146665599|NCT02833350|528953038|FG003|Overall Study|Lost to Follow-up|0|||
146665600|NCT02833350|528953039|FG004|Overall Study|Lost to Follow-up|0|||
146665601|NCT02833350|528953040|FG005|Overall Study|Lost to Follow-up|0|||
146665602|NCT02833350|528953041|FG006|Overall Study|Lost to Follow-up|1|||
146665603|NCT02833350|528953035|FG000|Overall Study|Withdrawal by Subject|3|||
146665604|NCT02833350|528953036|FG001|Overall Study|Withdrawal by Subject|3|||
146665605|NCT02833350|528953037|FG002|Overall Study|Withdrawal by Subject|2|||
146665606|NCT02833350|528953038|FG003|Overall Study|Withdrawal by Subject|0|||
146665607|NCT02833350|528953039|FG004|Overall Study|Withdrawal by Subject|2|||
146665608|NCT02833350|528953040|FG005|Overall Study|Withdrawal by Subject|0|||
146665609|NCT02833350|528953041|FG006|Overall Study|Withdrawal by Subject|2|||
146665610|NCT01500031|528953044|FG000|Overall Study|Death|1|||
146665611|NCT01500031|528953044|FG000|Overall Study|Withdrawal by Subject|4|||
146665612|NCT01604408|528953050|FG000|Treatment Period 1|Protocol Violation|0|||
146665613|NCT01604408|528953051|FG001|Treatment Period 1|Protocol Violation|1|||
146665614|NCT01604408|528953050|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146665615|NCT01604408|528953051|FG001|Treatment Period 2|Withdrawal by Subject|1|||
146665616|NCT01604408|528953050|FG000|Treatment Period 2|Protocol Violation|1|||
146665617|NCT01604408|528953051|FG001|Treatment Period 2|Protocol Violation|0|||
146665618|NCT01604408|528953050|FG000|Treatment Period 2|Adverse Event|0|||
146665619|NCT01604408|528953051|FG001|Treatment Period 2|Adverse Event|1|||
146665620|NCT01604408|528953050|FG000|Treatment Period 3|Protocol Violation|1|||
146665621|NCT01604408|528953051|FG001|Treatment Period 3|Protocol Violation|1|||
146665622|NCT01604408|528953050|FG000|Treatment Period 3|Adverse Event|0|||
146665623|NCT01604408|528953051|FG001|Treatment Period 3|Adverse Event|3|||
146665624|NCT01604408|528953050|FG000|Treatment Period 3|Withdrawal by Subject|3|||
146665625|NCT01604408|528953051|FG001|Treatment Period 3|Withdrawal by Subject|1|||
146773744|NCT01170962|529341185|FG001|Follow up Period|Withdrawal by Subject|10|||
146665626|NCT01604408|528953050|FG000|Treatment Period 3|Sponsor Decision|1|||
146665627|NCT01604408|528953051|FG001|Treatment Period 3|Sponsor Decision|0|||
146665628|NCT01604408|528953050|FG000|Treatment Period 4|Death|1|||
146665629|NCT01604408|528953051|FG001|Treatment Period 4|Death|0|||
146665630|NCT01604408|528953050|FG000|Treatment Period 4|Withdrawal by Subject|2|||
146665631|NCT01604408|528953051|FG001|Treatment Period 4|Withdrawal by Subject|1|||
146925434|NCT02586233|529888255|FG001|Overall Study|Randomized but did not receive treatment|1|||
146665632|NCT01604408|528953050|FG000|Treatment Period 4|Adverse Event|0|||
146665633|NCT01604408|528953051|FG001|Treatment Period 4|Adverse Event|1|||
146665634|NCT01604408|528953050|FG000|Treatment Period 5|Adverse Event|4|||
146665635|NCT01604408|528953051|FG001|Treatment Period 5|Adverse Event|0|||
146665636|NCT01604408|528953050|FG000|Treatment Period 6|Lost to Follow-up|0|||
146665637|NCT01604408|528953051|FG001|Treatment Period 6|Lost to Follow-up|1|||
146665638|NCT01604408|528953050|FG000|Treatment Period 6|Adverse Event|2|||
146665639|NCT01604408|528953051|FG001|Treatment Period 6|Adverse Event|0|||
146665640|NCT01604408|528953050|FG000|Treatment Period 6|Sponsor decision|0|||
146665641|NCT01604408|528953051|FG001|Treatment Period 6|Sponsor decision|1|||
146665642|NCT01604408|528953050|FG000|Observation Period|Adverse Event|1|||
146665643|NCT01604408|528953051|FG001|Observation Period|Adverse Event|1|||
146665644|NCT01604408|528953050|FG000|Observation Period|Withdrawal by Subject|0|||
146665645|NCT01604408|528953051|FG001|Observation Period|Withdrawal by Subject|2|||
146665646|NCT00538291|528953057|FG000|Overall Study|Adverse Event|2|||
146665647|NCT00538291|528953057|FG000|Overall Study|Withdrawal by Subject|1|||
146665648|NCT00694707|528953058|FG000|Overall Study|Did Not Receive Treatment|0|||
146665649|NCT00694707|528953059|FG001|Overall Study|Did Not Receive Treatment|0|||
146665650|NCT00694707|528953060|FG002|Overall Study|Did Not Receive Treatment|1|||
146665651|NCT00694707|528953061|FG003|Overall Study|Did Not Receive Treatment|1|||
146665652|NCT00694707|528953062|FG004|Overall Study|Did Not Receive Treatment|1|||
146665653|NCT00694707|528953058|FG000|Overall Study|Adverse Event|22|||
146665654|NCT00694707|528953059|FG001|Overall Study|Adverse Event|14|||
146665655|NCT00694707|528953060|FG002|Overall Study|Adverse Event|8|||
146665656|NCT00694707|528953061|FG003|Overall Study|Adverse Event|12|||
146665657|NCT00694707|528953062|FG004|Overall Study|Adverse Event|13|||
146925435|NCT02586233|529888256|FG002|Overall Study|Randomized but did not receive treatment|0|||
146925436|NCT02586233|529888257|FG003|Overall Study|Randomized but did not receive treatment|0|||
146925437|NCT02586233|529888258|FG004|Overall Study|Randomized but did not receive treatment|0|||
146925438|NCT02586233|529888259|FG005|Overall Study|Randomized but did not receive treatment|2|||
146925439|NCT02586233|529888260|FG006|Overall Study|Randomized but did not receive treatment|2|||
146925440|NCT02586233|529888254|FG000|Overall Study|Death|0|||
146925441|NCT02586233|529888255|FG001|Overall Study|Death|1|||
146925442|NCT02586233|529888256|FG002|Overall Study|Death|0|||
146925443|NCT02586233|529888257|FG003|Overall Study|Death|0|||
146665658|NCT00694707|528953058|FG000|Overall Study|Insufficient Therapeutic Response|33|||
146665659|NCT00694707|528953059|FG001|Overall Study|Insufficient Therapeutic Response|18|||
146665660|NCT00694707|528953060|FG002|Overall Study|Insufficient Therapeutic Response|17|||
146665661|NCT00694707|528953061|FG003|Overall Study|Insufficient Therapeutic Response|15|||
146925444|NCT02586233|529888258|FG004|Overall Study|Death|2|||
146925445|NCT02586233|529888259|FG005|Overall Study|Death|0|||
146925446|NCT02586233|529888260|FG006|Overall Study|Death|0|||
146925447|NCT03421964|529888266|FG000|Overall Study|Lost to Follow-up|11|||
146925448|NCT03421964|529888267|FG001|Overall Study|Lost to Follow-up|21|||
146925449|NCT03421964|529888266|FG000|Overall Study|Withdrawal by Subject|9|||
146925450|NCT03421964|529888267|FG001|Overall Study|Withdrawal by Subject|3|||
146665662|NCT00694707|528953062|FG004|Overall Study|Insufficient Therapeutic Response|10|||
146665663|NCT00694707|528953058|FG000|Overall Study|Protocol Violation|1|||
146665664|NCT00694707|528953059|FG001|Overall Study|Protocol Violation|2|||
146665665|NCT00694707|528953060|FG002|Overall Study|Protocol Violation|1|||
146665666|NCT00694707|528953061|FG003|Overall Study|Protocol Violation|3|||
146665667|NCT00694707|528953062|FG004|Overall Study|Protocol Violation|1|||
146665668|NCT00694707|528953058|FG000|Overall Study|Withdrawal of Consent|14|||
146665669|NCT00694707|528953059|FG001|Overall Study|Withdrawal of Consent|18|||
146665670|NCT00694707|528953060|FG002|Overall Study|Withdrawal of Consent|22|||
146665671|NCT00694707|528953061|FG003|Overall Study|Withdrawal of Consent|16|||
146665672|NCT00694707|528953062|FG004|Overall Study|Withdrawal of Consent|15|||
146665673|NCT00694707|528953058|FG000|Overall Study|Lost to Follow-up|0|||
146925451|NCT03421964|529888266|FG000|Overall Study|Incarcerated|1|||
146925452|NCT03421964|529888267|FG001|Overall Study|Incarcerated|0|||
146665674|NCT00694707|528953059|FG001|Overall Study|Lost to Follow-up|1|||
146665675|NCT00694707|528953060|FG002|Overall Study|Lost to Follow-up|2|||
146665676|NCT00694707|528953061|FG003|Overall Study|Lost to Follow-up|0|||
146665677|NCT00694707|528953062|FG004|Overall Study|Lost to Follow-up|0|||
146665678|NCT00694707|528953058|FG000|Overall Study|Jeopardizing Parole Status|1|||
146665679|NCT00694707|528953059|FG001|Overall Study|Jeopardizing Parole Status|0|||
146665680|NCT00694707|528953060|FG002|Overall Study|Jeopardizing Parole Status|0|||
146665681|NCT00694707|528953061|FG003|Overall Study|Jeopardizing Parole Status|0|||
146665682|NCT00694707|528953062|FG004|Overall Study|Jeopardizing Parole Status|0|||
146665683|NCT00694707|528953058|FG000|Overall Study|Death in the Family|1|||
146925453|NCT03421964|529888266|FG000|Overall Study|Inpt Treatment Facility|1|||
146925454|NCT03421964|529888267|FG001|Overall Study|Inpt Treatment Facility|1|||
146925455|NCT03421964|529888266|FG000|Overall Study|Virtual Platform Issues|1|||
146925456|NCT03421964|529888267|FG001|Overall Study|Virtual Platform Issues|1|||
146665684|NCT00694707|528953059|FG001|Overall Study|Death in the Family|0|||
146665685|NCT00694707|528953060|FG002|Overall Study|Death in the Family|0|||
146773745|NCT01170962|529341186|FG002|Follow up Period|Withdrawal by Subject|2|||
146773746|NCT01170962|529341184|FG000|Follow up Period|Lost to Follow-up|13|||
146773747|NCT01170962|529341185|FG001|Follow up Period|Lost to Follow-up|8|||
146773748|NCT01170962|529341186|FG002|Follow up Period|Lost to Follow-up|1|||
146773749|NCT01170962|529341184|FG000|Follow up Period|Death|2|||
146773750|NCT01170962|529341185|FG001|Follow up Period|Death|2|||
146773751|NCT01170962|529341186|FG002|Follow up Period|Death|0|||
146773752|NCT01170962|529341184|FG000|Follow up Period|Others|10|||
146773753|NCT01170962|529341185|FG001|Follow up Period|Others|7|||
146773754|NCT01170962|529341186|FG002|Follow up Period|Others|3|||
146773755|NCT02581215|529343437|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
146773756|NCT02581215|529343438|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
146773757|NCT02581215|529343437|FG000|Overall Study|Eligibility Criteria Not Met|0|||
146773758|NCT02581215|529343438|FG001|Overall Study|Eligibility Criteria Not Met|1|||
146773759|NCT02566902|529343447|FG000|Overall Study|Protocol Violation|2|||
146773760|NCT02566902|529343448|FG001|Overall Study|Protocol Violation|1|||
146773761|NCT04425629|529343453|FG000|Overall Study|Adverse Event|0|||
146773762|NCT04425629|529343454|FG001|Overall Study|Adverse Event|0|||
146773763|NCT04425629|529343455|FG002|Overall Study|Adverse Event|0|||
146773764|NCT04425629|529343456|FG003|Overall Study|Adverse Event|0|||
146773765|NCT04425629|529343457|FG004|Overall Study|Adverse Event|1|||
146773766|NCT04425629|529343458|FG005|Overall Study|Adverse Event|0|||
146773767|NCT04425629|529343459|FG006|Overall Study|Adverse Event|0|||
146773768|NCT04425629|529343460|FG007|Overall Study|Adverse Event|0|||
146773769|NCT04425629|529343461|FG008|Overall Study|Adverse Event|0|||
146773770|NCT04425629|529343462|FG009|Overall Study|Adverse Event|3|||
146773771|NCT04425629|529343463|FG010|Overall Study|Adverse Event|2|||
146773772|NCT04425629|529343464|FG011|Overall Study|Adverse Event|1|||
146773773|NCT04425629|529343465|FG012|Overall Study|Adverse Event|1|||
146773774|NCT04425629|529343466|FG013|Overall Study|Adverse Event|0|||
146773775|NCT04425629|529343467|FG014|Overall Study|Adverse Event|0|||
146773776|NCT04425629|529343468|FG015|Overall Study|Adverse Event|0|||
146773777|NCT04425629|529343469|FG016|Overall Study|Adverse Event|0|||
146773778|NCT04425629|529343470|FG017|Overall Study|Adverse Event|0|||
146773779|NCT04425629|529343471|FG018|Overall Study|Adverse Event|0|||
146773780|NCT04425629|529343453|FG000|Overall Study|Lost to Follow-up|1|||
146773781|NCT04425629|529343454|FG001|Overall Study|Lost to Follow-up|3|||
146773782|NCT04425629|529343455|FG002|Overall Study|Lost to Follow-up|1|||
146773783|NCT04425629|529343456|FG003|Overall Study|Lost to Follow-up|7|||
146773784|NCT04425629|529343457|FG004|Overall Study|Lost to Follow-up|1|||
146773785|NCT04425629|529343458|FG005|Overall Study|Lost to Follow-up|2|||
146773786|NCT04425629|529343459|FG006|Overall Study|Lost to Follow-up|1|||
146773787|NCT04425629|529343460|FG007|Overall Study|Lost to Follow-up|0|||
146665686|NCT00694707|528953061|FG003|Overall Study|Death in the Family|0|||
146665687|NCT00694707|528953062|FG004|Overall Study|Death in the Family|0|||
146665688|NCT00694707|528953058|FG000|Overall Study|Arrest by Police|0|||
146665689|NCT00694707|528953059|FG001|Overall Study|Arrest by Police|1|||
146665690|NCT00694707|528953060|FG002|Overall Study|Arrest by Police|0|||
146665691|NCT00694707|528953061|FG003|Overall Study|Arrest by Police|0|||
146665692|NCT00694707|528953062|FG004|Overall Study|Arrest by Police|0|||
146665693|NCT00694707|528953058|FG000|Overall Study|Administrative Reasons|0|||
146665694|NCT00694707|528953059|FG001|Overall Study|Administrative Reasons|1|||
146665695|NCT00694707|528953060|FG002|Overall Study|Administrative Reasons|0|||
146665696|NCT00694707|528953061|FG003|Overall Study|Administrative Reasons|2|||
146665697|NCT00694707|528953062|FG004|Overall Study|Administrative Reasons|0|||
146665698|NCT00694707|528953058|FG000|Overall Study|Notification of Past Head Injury|0|||
146665699|NCT00694707|528953059|FG001|Overall Study|Notification of Past Head Injury|0|||
146665700|NCT00694707|528953060|FG002|Overall Study|Notification of Past Head Injury|0|||
146665701|NCT00694707|528953061|FG003|Overall Study|Notification of Past Head Injury|1|||
146665702|NCT00694707|528953062|FG004|Overall Study|Notification of Past Head Injury|0|||
146665703|NCT02046733|528953076|FG000|Overall Study|never initiated 'treatment visits'|6|||
146665704|NCT02046733|528953077|FG001|Overall Study|never initiated 'treatment visits'|0|||
146773788|NCT04425629|529343461|FG008|Overall Study|Lost to Follow-up|1|||
146773789|NCT04425629|529343462|FG009|Overall Study|Lost to Follow-up|64|||
146773790|NCT04425629|529343463|FG010|Overall Study|Lost to Follow-up|70|||
146773791|NCT04425629|529343464|FG011|Overall Study|Lost to Follow-up|98|||
146773792|NCT04425629|529343465|FG012|Overall Study|Lost to Follow-up|30|||
146773793|NCT04425629|529343466|FG013|Overall Study|Lost to Follow-up|0|||
146773794|NCT04425629|529343467|FG014|Overall Study|Lost to Follow-up|5|||
146773795|NCT04425629|529343468|FG015|Overall Study|Lost to Follow-up|4|||
146773796|NCT04425629|529343469|FG016|Overall Study|Lost to Follow-up|0|||
146773797|NCT04425629|529343470|FG017|Overall Study|Lost to Follow-up|3|||
146773798|NCT04425629|529343471|FG018|Overall Study|Lost to Follow-up|1|||
146773799|NCT04425629|529343453|FG000|Overall Study|Subject Decision|0|||
146665705|NCT01756053|528953078|FG000|Period 1 (10 Days)|Protocol Violation|1|||
146665706|NCT01756053|528953079|FG001|Period 1 (10 Days)|Protocol Violation|1|||
146665707|NCT01756053|528953078|FG000|Period 2 (10 Days)|Protocol Violation|0|||
146773800|NCT04425629|529343454|FG001|Overall Study|Subject Decision|2|||
146773801|NCT04425629|529343455|FG002|Overall Study|Subject Decision|1|||
146665708|NCT01756053|528953079|FG001|Period 2 (10 Days)|Protocol Violation|2|||
146665709|NCT02019277|528953080|FG000|Overall Study|Withdrawal by Subject|3|||
146665710|NCT02019277|528953080|FG000|Overall Study|Death|7|||
146665711|NCT02019277|528953080|FG000|Overall Study|Did no Cooperate|1|||
146665712|NCT02019277|528953080|FG000|Overall Study|Adverse Event|1|||
146665713|NCT01672736|528953084|FG000|Overall Study|Available drug expired on 31 May 16|3|||
146665714|NCT04251273|528953085|FG000|Overall Study|Lost to Follow-up|331|||
146665715|NCT04251273|528953086|FG001|Overall Study|Lost to Follow-up|290|||
146665716|NCT00810693|528953087|FG000|Treatment Period|Adverse Event|8|||
146665717|NCT00810693|528953088|FG001|Treatment Period|Adverse Event|1|||
146665718|NCT00810693|528953089|FG002|Treatment Period|Adverse Event|7|||
146665719|NCT00810693|528953087|FG000|Treatment Period|Death|0|||
146665720|NCT00810693|528953088|FG001|Treatment Period|Death|1|||
146773802|NCT04425629|529343456|FG003|Overall Study|Subject Decision|3|||
146773803|NCT04425629|529343457|FG004|Overall Study|Subject Decision|6|||
146773804|NCT04425629|529343458|FG005|Overall Study|Subject Decision|6|||
146773805|NCT04425629|529343459|FG006|Overall Study|Subject Decision|3|||
146773806|NCT04425629|529343460|FG007|Overall Study|Subject Decision|3|||
146665721|NCT00810693|528953089|FG002|Treatment Period|Death|2|||
146665722|NCT00810693|528953087|FG000|Treatment Period|Lack of Efficacy|0|||
146665723|NCT00810693|528953088|FG001|Treatment Period|Lack of Efficacy|0|||
146665724|NCT00810693|528953089|FG002|Treatment Period|Lack of Efficacy|1|||
146773807|NCT04425629|529343461|FG008|Overall Study|Subject Decision|1|||
146773808|NCT04425629|529343462|FG009|Overall Study|Subject Decision|70|||
146773809|NCT04425629|529343463|FG010|Overall Study|Subject Decision|95|||
146773810|NCT04425629|529343464|FG011|Overall Study|Subject Decision|124|||
146773811|NCT04425629|529343465|FG012|Overall Study|Subject Decision|25|||
146773812|NCT04425629|529343466|FG013|Overall Study|Subject Decision|0|||
146773813|NCT04425629|529343467|FG014|Overall Study|Subject Decision|1|||
146773814|NCT04425629|529343468|FG015|Overall Study|Subject Decision|4|||
146773815|NCT04425629|529343469|FG016|Overall Study|Subject Decision|1|||
146773816|NCT04425629|529343470|FG017|Overall Study|Subject Decision|0|||
146773817|NCT04425629|529343471|FG018|Overall Study|Subject Decision|2|||
146773818|NCT04425629|529343453|FG000|Overall Study|Death|0|||
146773819|NCT04425629|529343454|FG001|Overall Study|Death|0|||
146773820|NCT04425629|529343455|FG002|Overall Study|Death|0|||
146773821|NCT04425629|529343456|FG003|Overall Study|Death|0|||
146773822|NCT04425629|529343457|FG004|Overall Study|Death|0|||
146773823|NCT04425629|529343458|FG005|Overall Study|Death|0|||
146773824|NCT04425629|529343459|FG006|Overall Study|Death|0|||
146773825|NCT04425629|529343460|FG007|Overall Study|Death|0|||
146773826|NCT04425629|529343461|FG008|Overall Study|Death|0|||
146773827|NCT04425629|529343462|FG009|Overall Study|Death|11|||
146773828|NCT04425629|529343463|FG010|Overall Study|Death|2|||
146773829|NCT04425629|529343464|FG011|Overall Study|Death|4|||
146773830|NCT04425629|529343465|FG012|Overall Study|Death|0|||
146773831|NCT04425629|529343466|FG013|Overall Study|Death|0|||
146773832|NCT04425629|529343467|FG014|Overall Study|Death|0|||
146773833|NCT04425629|529343468|FG015|Overall Study|Death|0|||
146665725|NCT00810693|528953087|FG000|Treatment Period|Lost to Follow-up|1|||
146665726|NCT00810693|528953088|FG001|Treatment Period|Lost to Follow-up|0|||
146665727|NCT00810693|528953089|FG002|Treatment Period|Lost to Follow-up|0|||
146665728|NCT00810693|528953087|FG000|Treatment Period|Non-compliance|1|||
146665729|NCT00810693|528953088|FG001|Treatment Period|Non-compliance|0|||
146665730|NCT00810693|528953089|FG002|Treatment Period|Non-compliance|0|||
146665731|NCT00810693|528953087|FG000|Treatment Period|Protocol Violation|1|||
146665732|NCT00810693|528953088|FG001|Treatment Period|Protocol Violation|2|||
146665733|NCT00810693|528953089|FG002|Treatment Period|Protocol Violation|2|||
146665734|NCT00810693|528953087|FG000|Treatment Period|Withdrawal by Subject|6|||
146665735|NCT00810693|528953088|FG001|Treatment Period|Withdrawal by Subject|2|||
146773834|NCT04425629|529343469|FG016|Overall Study|Death|0|||
146773835|NCT04425629|529343470|FG017|Overall Study|Death|0|||
146773836|NCT04425629|529343471|FG018|Overall Study|Death|0|||
146773837|NCT04425629|529343453|FG000|Overall Study|Sponsor Request|0|||
146773838|NCT04425629|529343454|FG001|Overall Study|Sponsor Request|0|||
146773839|NCT04425629|529343455|FG002|Overall Study|Sponsor Request|0|||
146773840|NCT04425629|529343456|FG003|Overall Study|Sponsor Request|2|||
146773841|NCT04425629|529343457|FG004|Overall Study|Sponsor Request|2|||
146773842|NCT04425629|529343458|FG005|Overall Study|Sponsor Request|2|||
146773843|NCT04425629|529343459|FG006|Overall Study|Sponsor Request|1|||
146773844|NCT04425629|529343460|FG007|Overall Study|Sponsor Request|0|||
146773845|NCT04425629|529343461|FG008|Overall Study|Sponsor Request|0|||
146773846|NCT04425629|529343462|FG009|Overall Study|Sponsor Request|9|||
146773847|NCT04425629|529343463|FG010|Overall Study|Sponsor Request|9|||
146773848|NCT04425629|529343464|FG011|Overall Study|Sponsor Request|10|||
146665736|NCT00810693|528953089|FG002|Treatment Period|Withdrawal by Subject|3|||
146665737|NCT00810693|528953087|FG000|Treatment Period|Not treated|0|||
146665738|NCT00810693|528953088|FG001|Treatment Period|Not treated|1|||
146665739|NCT00810693|528953089|FG002|Treatment Period|Not treated|1|||
146773849|NCT04425629|529343465|FG012|Overall Study|Sponsor Request|8|||
146773850|NCT04425629|529343466|FG013|Overall Study|Sponsor Request|0|||
146773851|NCT04425629|529343467|FG014|Overall Study|Sponsor Request|0|||
146665740|NCT00810693|528953087|FG000|Follow-up Period (FUP)|Adverse Event|3|||
146665741|NCT00810693|528953088|FG001|Follow-up Period (FUP)|Adverse Event|1|||
146665742|NCT00810693|528953089|FG002|Follow-up Period (FUP)|Adverse Event|1|||
146665743|NCT00810693|528953087|FG000|Follow-up Period (FUP)|Death|2|||
146665744|NCT00810693|528953088|FG001|Follow-up Period (FUP)|Death|0|||
146665745|NCT00810693|528953089|FG002|Follow-up Period (FUP)|Death|1|||
146665746|NCT00810693|528953087|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
146665747|NCT00810693|528953088|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
146665748|NCT00810693|528953089|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
146665749|NCT00810693|528953087|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
146665750|NCT00810693|528953088|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
146665751|NCT00810693|528953089|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
146665752|NCT00810693|528953087|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
146665753|NCT00810693|528953088|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
146665754|NCT00810693|528953089|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
146665755|NCT00331422|528953094|FG000|Overall Study|Did not receive entire study regimen|5|||
146665756|NCT02345226|528953095|FG000|Double-Blind Phase|Adverse Event|5|||
146665757|NCT02345226|528953096|FG001|Double-Blind Phase|Adverse Event|6|||
146665758|NCT02345226|528953095|FG000|Double-Blind Phase|Death|3|||
146665759|NCT02345226|528953096|FG001|Double-Blind Phase|Death|0|||
146665760|NCT02345226|528953095|FG000|Double-Blind Phase|Pregnancy|0|||
146665761|NCT02345226|528953096|FG001|Double-Blind Phase|Pregnancy|1|||
146665762|NCT02345226|528953095|FG000|Double-Blind Phase|Lack of Efficacy|1|||
146665763|NCT02345226|528953096|FG001|Double-Blind Phase|Lack of Efficacy|0|||
146665764|NCT02345226|528953095|FG000|Double-Blind Phase|Investigator's Discretion|4|||
146665765|NCT02345226|528953096|FG001|Double-Blind Phase|Investigator's Discretion|3|||
146665766|NCT02345226|528953095|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
146665767|NCT02345226|528953096|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
146665768|NCT02345226|528953095|FG000|Double-Blind Phase|Withdrew Consent|41|||
146665769|NCT02345226|528953096|FG001|Double-Blind Phase|Withdrew Consent|39|||
146665770|NCT02345226|528953095|FG000|Double-Blind Phase|Lost to Follow-up|12|||
146665771|NCT02345226|528953096|FG001|Double-Blind Phase|Lost to Follow-up|16|||
146665772|NCT02345226|528953095|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
146665773|NCT02345226|528953096|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
146665774|NCT02345226|528953095|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
146665775|NCT02345226|528953096|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
146665776|NCT01710046|528953099|FG000|Overall Study|Lost to Follow-up|1|||
146665777|NCT01710046|528953100|FG001|Overall Study|Lost to Follow-up|0|||
146665778|NCT02282358|528953107|FG000|Overall Study|Nonevaluable|1|||
146665779|NCT04357782|528953108|FG000|Overall Study|Discharged from hospital|1|||
146665780|NCT04357782|528953109|FG001|Overall Study|Discharged from hospital|0|||
146665781|NCT04357782|528953108|FG000|Overall Study|Death|0|||
146665782|NCT04357782|528953109|FG001|Overall Study|Death|2|||
146665783|NCT01033851|528953110|FG000|Overall Study|Withdrawal by Subject|3|||
146665784|NCT01033851|528953111|FG001|Overall Study|Withdrawal by Subject|7|||
146665785|NCT02349542|528953112|FG000|Overall Study|Withdrawal by Subject|5|||
146665786|NCT01163266|528953113|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
146665787|NCT01163266|528953114|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
146665788|NCT01163266|528953115|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
146665789|NCT01163266|528953113|FG000|Overall Study|Lack of Efficacy|1|||
146665790|NCT01163266|528953114|FG001|Overall Study|Lack of Efficacy|3|||
146665791|NCT01163266|528953115|FG002|Overall Study|Lack of Efficacy|1|||
146665792|NCT01163266|528953113|FG000|Overall Study|Noncompliance with Study Drug|0|||
146665793|NCT01163266|528953114|FG001|Overall Study|Noncompliance with Study Drug|2|||
146665794|NCT01163266|528953115|FG002|Overall Study|Noncompliance with Study Drug|0|||
146665795|NCT01163266|528953113|FG000|Overall Study|Protocol Deviations|2|||
146665796|NCT01163266|528953114|FG001|Overall Study|Protocol Deviations|2|||
146665797|NCT01163266|528953115|FG002|Overall Study|Protocol Deviations|5|||
146665798|NCT01163266|528953113|FG000|Overall Study|Withdrawal of Consent|5|||
146665799|NCT01163266|528953114|FG001|Overall Study|Withdrawal of Consent|7|||
146665800|NCT01163266|528953115|FG002|Overall Study|Withdrawal of Consent|3|||
146665801|NCT01163266|528953113|FG000|Overall Study|Lost to Follow-up|7|||
146665802|NCT01163266|528953114|FG001|Overall Study|Lost to Follow-up|7|||
146665803|NCT01163266|528953115|FG002|Overall Study|Lost to Follow-up|10|||
146665804|NCT01163266|528953113|FG000|Overall Study|Other|1|||
146665805|NCT01163266|528953114|FG001|Overall Study|Other|1|||
146665806|NCT01163266|528953115|FG002|Overall Study|Other|2|||
146665807|NCT02158975|528953116|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
146665808|NCT02840721|528953117|FG000|Treatment Period|Adverse Event|1|||
146665809|NCT02840721|528953117|FG000|Follow-Up|Lack of Efficacy|1|||
146665810|NCT02840721|528953117|FG000|Follow-Up|Withdrawal by Subject|4|||
146665811|NCT02840721|528953117|FG000|Follow-Up|Withdrawal of Consent|2|||
146665812|NCT03666624|528953119|FG000|Overall Study|participant grieving over recent death of parent|1|||
146665813|NCT03666624|528953120|FG001|Overall Study|participant grieving over recent death of parent|0|||
146665814|NCT02959983|528953123|FG000|Overall Study|Protocol Violation|0|||
146978749|NCT00598559|530085490|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
146665815|NCT02959983|528953124|FG001|Overall Study|Protocol Violation|1|||
146665816|NCT02959983|528953123|FG000|Overall Study|Lack of Efficacy|0|||
146665817|NCT02959983|528953124|FG001|Overall Study|Lack of Efficacy|1|||
146665818|NCT02959983|528953123|FG000|Overall Study|Lost to Follow-up|12|||
146665819|NCT02959983|528953124|FG001|Overall Study|Lost to Follow-up|9|||
146665820|NCT02959983|528953123|FG000|Overall Study|Other|1|||
146665821|NCT02959983|528953124|FG001|Overall Study|Other|1|||
146665822|NCT02959983|528953123|FG000|Overall Study|Physician Decision|1|||
146665823|NCT02959983|528953124|FG001|Overall Study|Physician Decision|0|||
146665824|NCT02959983|528953123|FG000|Overall Study|Adverse Event|5|||
146665825|NCT02959983|528953124|FG001|Overall Study|Adverse Event|1|||
146665826|NCT02959983|528953123|FG000|Overall Study|Withdrawal by Subject|7|||
146665827|NCT02959983|528953124|FG001|Overall Study|Withdrawal by Subject|12|||
146665828|NCT01254630|528953125|FG000|Overall Study|Adverse Event|36|||
146665829|NCT01254630|528953126|FG001|Overall Study|Adverse Event|15|||
146665830|NCT01254630|528953127|FG002|Overall Study|Adverse Event|40|||
146665831|NCT01254630|528953128|FG003|Overall Study|Adverse Event|8|||
146665832|NCT01254630|528953125|FG000|Overall Study|Death|461|||
146665833|NCT01254630|528953126|FG001|Overall Study|Death|151|||
146665834|NCT01254630|528953127|FG002|Overall Study|Death|478|||
146665835|NCT01254630|528953128|FG003|Overall Study|Death|139|||
146665836|NCT01254630|528953125|FG000|Overall Study|Lost to Follow-up|80|||
146665837|NCT01254630|528953126|FG001|Overall Study|Lost to Follow-up|26|||
146665838|NCT01254630|528953127|FG002|Overall Study|Lost to Follow-up|89|||
146665839|NCT01254630|528953128|FG003|Overall Study|Lost to Follow-up|32|||
146665840|NCT01254630|528953125|FG000|Overall Study|Physician Decision|24|||
146665841|NCT01254630|528953126|FG001|Overall Study|Physician Decision|8|||
146665842|NCT01254630|528953127|FG002|Overall Study|Physician Decision|16|||
146665843|NCT01254630|528953128|FG003|Overall Study|Physician Decision|7|||
146665844|NCT01254630|528953125|FG000|Overall Study|Withdrawal by Subject|201|||
146665845|NCT01254630|528953126|FG001|Overall Study|Withdrawal by Subject|94|||
146665846|NCT01254630|528953127|FG002|Overall Study|Withdrawal by Subject|188|||
146665847|NCT01254630|528953128|FG003|Overall Study|Withdrawal by Subject|89|||
146665848|NCT01254630|528953125|FG000|Overall Study|Study terminated by sponsor|0|||
146665849|NCT01254630|528953126|FG001|Overall Study|Study terminated by sponsor|994|||
146665850|NCT01254630|528953127|FG002|Overall Study|Study terminated by sponsor|0|||
146665851|NCT01254630|528953128|FG003|Overall Study|Study terminated by sponsor|1010|||
146665852|NCT01254630|528953125|FG000|Overall Study|Status not recorded|0|||
146665853|NCT01254630|528953126|FG001|Overall Study|Status not recorded|0|||
146665854|NCT01254630|528953127|FG002|Overall Study|Status not recorded|1|||
146665855|NCT01254630|528953128|FG003|Overall Study|Status not recorded|0|||
146665856|NCT00484094|528953129|FG000|Overall Study|Discontinued|39|||
146665857|NCT00484094|528953129|FG000|Overall Study|Other|3|||
146665858|NCT01826604|528954827|FG000|Overall Study|Lost to Follow-up|8|||
146665859|NCT01826604|528954828|FG001|Overall Study|Lost to Follow-up|9|||
146665860|NCT01303861|528954842|FG000|Overall Study|Lost to Follow-up|34|||
146665861|NCT01303861|528954843|FG001|Overall Study|Lost to Follow-up|14|||
146665862|NCT01303861|528954844|FG002|Overall Study|Lost to Follow-up|27|||
146665863|NCT01303861|528954845|FG003|Overall Study|Lost to Follow-up|31|||
146665864|NCT01303861|528954842|FG000|Overall Study|Lack of Efficacy|3|||
146665865|NCT01303861|528954843|FG001|Overall Study|Lack of Efficacy|2|||
146665866|NCT01303861|528954844|FG002|Overall Study|Lack of Efficacy|1|||
146665867|NCT01303861|528954845|FG003|Overall Study|Lack of Efficacy|0|||
146665868|NCT01303861|528954842|FG000|Overall Study|Withdrawal by Subject|16|||
146925457|NCT02938585|529888268|FG000|Overall Study|Withdrawal by parent or guardian|0|||
146925458|NCT02938585|529888269|FG001|Overall Study|Withdrawal by parent or guardian|1|||
146925459|NCT02938585|529888270|FG002|Overall Study|Withdrawal by parent or guardian|0|||
146665869|NCT01303861|528954843|FG001|Overall Study|Withdrawal by Subject|8|||
146665870|NCT01303861|528954844|FG002|Overall Study|Withdrawal by Subject|8|||
146665871|NCT01303861|528954845|FG003|Overall Study|Withdrawal by Subject|23|||
146665872|NCT01303861|528954842|FG000|Overall Study|Adverse Event|4|||
146665873|NCT01303861|528954843|FG001|Overall Study|Adverse Event|1|||
146665874|NCT01303861|528954844|FG002|Overall Study|Adverse Event|0|||
146925460|NCT02938585|529888271|FG003|Overall Study|Withdrawal by parent or guardian|0|||
146665875|NCT01303861|528954845|FG003|Overall Study|Adverse Event|5|||
146665876|NCT01303861|528954842|FG000|Overall Study|Pregnancy|1|||
146665877|NCT01303861|528954843|FG001|Overall Study|Pregnancy|0|||
146665878|NCT01303861|528954844|FG002|Overall Study|Pregnancy|0|||
146665879|NCT01303861|528954845|FG003|Overall Study|Pregnancy|0|||
146665880|NCT03270644|528954849|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
146665881|NCT03270644|528954849|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
146665882|NCT01868503|528954850|FG000|Overall Study|Withdrawal by Subject|1|||
146665883|NCT01868503|528954850|FG000|Overall Study|Protocol Violation|1|||
146665884|NCT02476201|528954855|FG000|Overall Study|Unable to program MPP|9|||
146665885|NCT02476201|528954855|FG000|Overall Study|Study echo not performed|5|||
146665886|NCT02476201|528954855|FG000|Overall Study|Adverse Event|4|||
146665887|NCT02476201|528954855|FG000|Overall Study|Death|2|||
146665888|NCT02476201|528954855|FG000|Overall Study|Lost to Follow-up|2|||
146665889|NCT02476201|528954855|FG000|Overall Study|MPP programmed to OFF|2|||
146665890|NCT02476201|528954855|FG000|Overall Study|Withdrawal by Subject|1|||
146665891|NCT02476201|528954855|FG000|Overall Study|Unsuccessful implant|1|||
146665892|NCT02642029|528954856|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
146665893|NCT02642029|528954857|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
146665894|NCT02642029|528954858|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
146665895|NCT02642029|528954859|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
146665896|NCT02642029|528954860|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
146665897|NCT02642029|528954861|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
146665898|NCT02642029|528954856|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
146665899|NCT02642029|528954857|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
146665900|NCT02642029|528954858|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
146665901|NCT02642029|528954859|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
146665902|NCT02642029|528954860|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
146665903|NCT02642029|528954861|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
146665904|NCT02642029|528954856|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
146925461|NCT02938585|529888268|FG000|Overall Study|Withdrawal by Subject|0|||
146925462|NCT02938585|529888269|FG001|Overall Study|Withdrawal by Subject|0|||
146925463|NCT02938585|529888270|FG002|Overall Study|Withdrawal by Subject|0|||
146925464|NCT02938585|529888271|FG003|Overall Study|Withdrawal by Subject|5|||
146925465|NCT02106455|529888272|FG000|Overall Study|Case Report Form Uncollected|6|||
146925466|NCT02106455|529888272|FG000|Overall Study|Protocol Deviation|2|||
146925467|NCT03654755|529888273|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
146925468|NCT03654755|529888274|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
146925469|NCT03654755|529888275|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
146925470|NCT03654755|529888273|FG000|Overall Study|Withdrawal by Subject|2|||
146925471|NCT03654755|529888274|FG001|Overall Study|Withdrawal by Subject|4|||
146925472|NCT03654755|529888275|FG002|Overall Study|Withdrawal by Subject|8|||
146925473|NCT03654755|529888273|FG000|Overall Study|Lost to Follow-up|1|||
146925474|NCT03654755|529888274|FG001|Overall Study|Lost to Follow-up|3|||
146925475|NCT03654755|529888275|FG002|Overall Study|Lost to Follow-up|7|||
146925476|NCT03654755|529888273|FG000|Overall Study|Physician Decision|0|||
146665905|NCT02642029|528954857|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
146665906|NCT02642029|528954858|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
146665907|NCT02642029|528954859|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
146665908|NCT02642029|528954860|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
146665909|NCT02642029|528954861|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
146665910|NCT02642029|528954856|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
146665911|NCT02642029|528954857|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
146665912|NCT02642029|528954858|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
146665913|NCT02642029|528954859|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
146665914|NCT02642029|528954860|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
146665915|NCT02642029|528954861|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
146665916|NCT02642029|528954856|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
146665917|NCT02642029|528954857|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
146665918|NCT02642029|528954858|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
146665919|NCT02642029|528954859|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
146665920|NCT02642029|528954860|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
146665921|NCT02642029|528954861|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
146665922|NCT02642029|528954856|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
146665923|NCT02642029|528954857|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
146665924|NCT02642029|528954858|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
146665925|NCT02642029|528954859|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
146665926|NCT02642029|528954860|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
146665927|NCT02642029|528954861|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
146665928|NCT00691301|528954862|FG000|Overall Study|Adverse Event|10|||
146773852|NCT04425629|529343468|FG015|Overall Study|Sponsor Request|1|||
146925477|NCT03654755|529888274|FG001|Overall Study|Physician Decision|1|||
146925478|NCT03654755|529888275|FG002|Overall Study|Physician Decision|0|||
146925479|NCT03654755|529888273|FG000|Overall Study|Adverse Event|0|||
146925480|NCT03654755|529888274|FG001|Overall Study|Adverse Event|0|||
146925481|NCT03654755|529888275|FG002|Overall Study|Adverse Event|4|||
146925482|NCT03654755|529888273|FG000|Overall Study|Lack of Efficacy|0|||
146925483|NCT03654755|529888274|FG001|Overall Study|Lack of Efficacy|0|||
146925484|NCT03654755|529888275|FG002|Overall Study|Lack of Efficacy|1|||
146925485|NCT00678587|529888280|FG000|Overall Study|Adverse Event|3|||
146978750|NCT02762565|530085491|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
146665929|NCT00691301|528954862|FG000|Overall Study|Death|2|||
146665930|NCT00691301|528954862|FG000|Overall Study|Lack of Efficacy|32|||
146665931|NCT00691301|528954862|FG000|Overall Study|Withdrawal by Subject|4|||
146925486|NCT00678587|529888281|FG001|Overall Study|Adverse Event|3|||
146925487|NCT00678587|529888280|FG000|Overall Study|Lack of Efficacy|1|||
146665932|NCT00691301|528954862|FG000|Overall Study|Concurrent illness|2|||
146665933|NCT00691301|528954862|FG000|Overall Study|other reason|3|||
146665934|NCT00691301|528954862|FG000|Overall Study|Did not initiate study treatment|1|||
146665935|NCT01823146|528954864|FG000|Overall Study|Withdrawal by Subject|0|||
146665936|NCT01823146|528954865|FG001|Overall Study|Withdrawal by Subject|1|||
146665937|NCT01823146|528954864|FG000|Overall Study|Lost to Follow-up|2|||
146665938|NCT01823146|528954865|FG001|Overall Study|Lost to Follow-up|1|||
146665939|NCT00463580|528954866|FG000|Overall Study|Lost to Follow-up|1|||
146665940|NCT00463580|528954867|FG001|Overall Study|Lost to Follow-up|0|||
146665941|NCT00463580|528954866|FG000|Overall Study|Schedule conflict|2|||
146665942|NCT00463580|528954867|FG001|Overall Study|Schedule conflict|0|||
146665943|NCT00463580|528954866|FG000|Overall Study|Medical/psychiatric complications|0|||
146665944|NCT00463580|528954867|FG001|Overall Study|Medical/psychiatric complications|2|||
146665945|NCT03917459|528954868|FG000|Overall Study|Adverse Event|1|||
146665946|NCT03917459|528954869|FG001|Overall Study|Adverse Event|0|||
146665947|NCT03917459|528954868|FG000|Overall Study|Withdrawal by Subject|0|||
146665948|NCT03917459|528954869|FG001|Overall Study|Withdrawal by Subject|1|||
146665949|NCT00736944|528954870|FG000|Induction|Death|1|||
146665950|NCT00736944|528954870|FG000|Definitive Treatment|Physician Decision|1|||
146665951|NCT00676338|528954871|FG000|Overall Study|Adverse Event|6|||
146665952|NCT00676338|528954872|FG001|Overall Study|Adverse Event|6|||
146665953|NCT00676338|528954873|FG002|Overall Study|Adverse Event|5|||
146665954|NCT00676338|528954874|FG003|Overall Study|Adverse Event|1|||
146665955|NCT00676338|528954871|FG000|Overall Study|Lost to Follow-up|4|||
146665956|NCT00676338|528954872|FG001|Overall Study|Lost to Follow-up|1|||
146665957|NCT00676338|528954873|FG002|Overall Study|Lost to Follow-up|3|||
146665958|NCT00676338|528954874|FG003|Overall Study|Lost to Follow-up|4|||
146665959|NCT00676338|528954871|FG000|Overall Study|Physician Decision|3|||
146665960|NCT00676338|528954872|FG001|Overall Study|Physician Decision|3|||
146665961|NCT00676338|528954873|FG002|Overall Study|Physician Decision|2|||
146665962|NCT00676338|528954874|FG003|Overall Study|Physician Decision|3|||
146665963|NCT00676338|528954871|FG000|Overall Study|Protocol Violation|5|||
146665964|NCT00676338|528954872|FG001|Overall Study|Protocol Violation|9|||
146665965|NCT00676338|528954873|FG002|Overall Study|Protocol Violation|2|||
146665966|NCT00676338|528954874|FG003|Overall Study|Protocol Violation|5|||
146665967|NCT00676338|528954871|FG000|Overall Study|Withdrawal by Subject|17|||
146665968|NCT00676338|528954872|FG001|Overall Study|Withdrawal by Subject|9|||
146665969|NCT00676338|528954873|FG002|Overall Study|Withdrawal by Subject|12|||
146665970|NCT00676338|528954874|FG003|Overall Study|Withdrawal by Subject|6|||
146665971|NCT00676338|528954871|FG000|Overall Study|Entry Criteria Not Met|0|||
146665972|NCT00676338|528954872|FG001|Overall Study|Entry Criteria Not Met|2|||
146665973|NCT00676338|528954873|FG002|Overall Study|Entry Criteria Not Met|1|||
146665974|NCT00676338|528954874|FG003|Overall Study|Entry Criteria Not Met|1|||
146665975|NCT00676338|528954871|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
146665976|NCT00676338|528954872|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
146665977|NCT00676338|528954873|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
146665978|NCT00676338|528954874|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
146665979|NCT00412542|528954875|FG000|Overall Study|Withdrawal by Subject|0|||
146665980|NCT00412542|528954876|FG001|Overall Study|Withdrawal by Subject|2|||
146665981|NCT00412542|528954875|FG000|Overall Study|Not Eligible|0|||
146665982|NCT00412542|528954876|FG001|Overall Study|Not Eligible|1|||
146665983|NCT00075218|528954877|FG000|Double-Blind Treatment|Adverse Event|23|||
146665984|NCT00075218|528954878|FG001|Double-Blind Treatment|Adverse Event|4|||
146665985|NCT00075218|528954879|FG002|Double-Blind Treatment|Adverse Event|0|||
146665986|NCT00075218|528954877|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
146665987|NCT00075218|528954878|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
146665988|NCT00075218|528954879|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
146665989|NCT00075218|528954877|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
146665990|NCT00075218|528954878|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
146665991|NCT00075218|528954879|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
146665992|NCT00075218|528954877|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
146665993|NCT00075218|528954878|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
146665994|NCT00075218|528954879|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
146665995|NCT00075218|528954877|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
146665996|NCT00075218|528954878|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
146665997|NCT00075218|528954879|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
146665998|NCT00075218|528954877|FG000|Double-Blind Treatment|No study medication taken|2|||
146665999|NCT00075218|528954878|FG001|Double-Blind Treatment|No study medication taken|0|||
146666000|NCT00075218|528954879|FG002|Double-Blind Treatment|No study medication taken|0|||
146666001|NCT00075218|528954877|FG000|Open-Label Treatment|Lack of Efficacy|0|||
146666002|NCT00075218|528954878|FG001|Open-Label Treatment|Lack of Efficacy|0|||
146666003|NCT00075218|528954879|FG002|Open-Label Treatment|Lack of Efficacy|174|||
146666004|NCT00075218|528954877|FG000|Open-Label Treatment|Adverse Event|0|||
146666005|NCT00075218|528954878|FG001|Open-Label Treatment|Adverse Event|0|||
146666006|NCT00075218|528954879|FG002|Open-Label Treatment|Adverse Event|51|||
146666007|NCT00075218|528954877|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
146666008|NCT00075218|528954878|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
146666009|NCT00075218|528954879|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
146666010|NCT00075218|528954877|FG000|Open-Label Treatment|Decision of Sponsor|0|||
146666011|NCT00075218|528954878|FG001|Open-Label Treatment|Decision of Sponsor|0|||
146666012|NCT00075218|528954879|FG002|Open-Label Treatment|Decision of Sponsor|8|||
146925488|NCT00678587|529888281|FG001|Overall Study|Lack of Efficacy|0|||
146925489|NCT00678587|529888280|FG000|Overall Study|Protocol Violation|2|||
146925490|NCT00678587|529888281|FG001|Overall Study|Protocol Violation|1|||
146925491|NCT00678587|529888280|FG000|Overall Study|Study Closed/Terminated|1|||
146925492|NCT00678587|529888281|FG001|Overall Study|Study Closed/Terminated|0|||
146925493|NCT00678587|529888280|FG000|Overall Study|Lost to Follow-up|3|||
146925494|NCT00678587|529888281|FG001|Overall Study|Lost to Follow-up|5|||
146666013|NCT00075218|528954877|FG000|Open-Label Treatment|Protocol Violation|0|||
146666014|NCT00075218|528954878|FG001|Open-Label Treatment|Protocol Violation|0|||
146666015|NCT00075218|528954879|FG002|Open-Label Treatment|Protocol Violation|1|||
146925495|NCT00678587|529888280|FG000|Overall Study|Investigator Discretion|2|||
146666016|NCT00075218|528954877|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
146666017|NCT00075218|528954878|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
146666018|NCT00075218|528954879|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
146666019|NCT03643575|528954882|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
146666020|NCT03643575|528954883|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
146666021|NCT03643575|528954884|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
146666022|NCT03643575|528954885|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
146666023|NCT03643575|528954886|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
146666024|NCT03643575|528954887|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
146666025|NCT03643575|528954882|FG000|Washout: 7 Days|Adverse Event|1|||
146666026|NCT03643575|528954883|FG001|Washout: 7 Days|Adverse Event|0|||
146666027|NCT03643575|528954884|FG002|Washout: 7 Days|Adverse Event|0|||
146666028|NCT03643575|528954885|FG003|Washout: 7 Days|Adverse Event|0|||
146666029|NCT03643575|528954886|FG004|Washout: 7 Days|Adverse Event|0|||
146666030|NCT03643575|528954887|FG005|Washout: 7 Days|Adverse Event|0|||
146666031|NCT03643575|528954882|FG000|Washout: 7 Days|Non compliance check in|0|||
146666032|NCT03643575|528954883|FG001|Washout: 7 Days|Non compliance check in|1|||
146666033|NCT03643575|528954884|FG002|Washout: 7 Days|Non compliance check in|0|||
146666034|NCT03643575|528954885|FG003|Washout: 7 Days|Non compliance check in|0|||
146666035|NCT03643575|528954886|FG004|Washout: 7 Days|Non compliance check in|0|||
146666036|NCT03643575|528954887|FG005|Washout: 7 Days|Non compliance check in|0|||
146666037|NCT01189604|528954888|FG000|Overall Study|Impossible to visit|0|||
146666038|NCT01189604|528954889|FG001|Overall Study|Impossible to visit|0|||
146666039|NCT01189604|528954890|FG002|Overall Study|Impossible to visit|0|||
146978751|NCT03549130|530085492|FG000|Overall Study|Adverse Event|0|||
146978752|NCT03549130|530085493|FG001|Overall Study|Adverse Event|1|||
146978753|NCT03549130|530085492|FG000|Overall Study|Lost to Follow-up|0|||
146978754|NCT03549130|530085493|FG001|Overall Study|Lost to Follow-up|1|||
146978755|NCT01113710|530085494|FG000|Overall Study|Adverse Event|64|||
146978756|NCT01113710|530085494|FG000|Overall Study|Lack of Efficacy|41|||
146666040|NCT01189604|528954891|FG003|Overall Study|Impossible to visit|0|||
146666041|NCT01189604|528954892|FG004|Overall Study|Impossible to visit|0|||
146666042|NCT01189604|528954893|FG005|Overall Study|Impossible to visit|1|||
146666043|NCT01189604|528954894|FG006|Overall Study|Impossible to visit|0|||
146666044|NCT01189604|528954888|FG000|Overall Study|Adverse Event|0|||
146666045|NCT01189604|528954889|FG001|Overall Study|Adverse Event|1|||
146666046|NCT01189604|528954890|FG002|Overall Study|Adverse Event|0|||
146666047|NCT01189604|528954891|FG003|Overall Study|Adverse Event|0|||
146666048|NCT01189604|528954892|FG004|Overall Study|Adverse Event|2|||
146666049|NCT01189604|528954893|FG005|Overall Study|Adverse Event|0|||
146666050|NCT01189604|528954894|FG006|Overall Study|Adverse Event|1|||
146925496|NCT00678587|529888281|FG001|Overall Study|Investigator Discretion|6|||
146925497|NCT00678587|529888280|FG000|Overall Study|Withdrew Consent|8|||
146925498|NCT00678587|529888281|FG001|Overall Study|Withdrew Consent|3|||
146925499|NCT03806179|529888282|FG000|Overall Study|Progressive disease|0|||
146666051|NCT01189604|528954888|FG000|Overall Study|Withdrawal by Subject|1|||
146666052|NCT01189604|528954889|FG001|Overall Study|Withdrawal by Subject|0|||
146666053|NCT01189604|528954890|FG002|Overall Study|Withdrawal by Subject|0|||
146666054|NCT01189604|528954891|FG003|Overall Study|Withdrawal by Subject|0|||
146666055|NCT01189604|528954892|FG004|Overall Study|Withdrawal by Subject|0|||
146666056|NCT01189604|528954893|FG005|Overall Study|Withdrawal by Subject|0|||
146666057|NCT01189604|528954894|FG006|Overall Study|Withdrawal by Subject|0|||
146666058|NCT03626168|528954895|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
146666059|NCT03626168|528954896|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
146736241|NCT00279201|529205305|FG004|Intensification Addendum|Sponsor Decision|1|||
146925500|NCT03806179|529888283|FG001|Overall Study|Progressive disease|2|||
146925501|NCT00077610|529888286|FG000|Overall Study|Adverse Event|9|||
146925502|NCT00077610|529888287|FG001|Overall Study|Adverse Event|7|||
146925503|NCT00077610|529888288|FG002|Overall Study|Adverse Event|1|||
146978757|NCT01113710|530085494|FG000|Overall Study|No Information Available|40|||
146978758|NCT01113710|530085494|FG000|Overall Study|Withdrawal by Subject|28|||
146666060|NCT03626168|528954895|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
146666061|NCT03626168|528954896|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
146666062|NCT03626168|528954895|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
146666063|NCT03626168|528954896|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
146666064|NCT02357979|528954897|FG000|Overall Study|Lost to Follow-up|5|||
146666065|NCT02357979|528954898|FG001|Overall Study|Lost to Follow-up|5|||
146666066|NCT05047770|528954899|FG000|Overall Study|Withdrawal by Subject|15|||
146666067|NCT05047770|528954900|FG001|Overall Study|Withdrawal by Subject|10|||
146666068|NCT05047770|528954901|FG002|Overall Study|Withdrawal by Subject|6|||
146666069|NCT05047770|528954902|FG003|Overall Study|Withdrawal by Subject|12|||
146666070|NCT05047770|528954899|FG000|Overall Study|Lost to Follow-up|7|||
146666071|NCT05047770|528954900|FG001|Overall Study|Lost to Follow-up|5|||
146666072|NCT05047770|528954901|FG002|Overall Study|Lost to Follow-up|12|||
146666073|NCT05047770|528954902|FG003|Overall Study|Lost to Follow-up|13|||
146666074|NCT05047770|528954899|FG000|Overall Study|Other|1|||
146666075|NCT05047770|528954900|FG001|Overall Study|Other|0|||
146666076|NCT05047770|528954901|FG002|Overall Study|Other|1|||
146666077|NCT05047770|528954902|FG003|Overall Study|Other|0|||
146666078|NCT01772160|528954904|FG000|Overall Study|Death|3|||
146666079|NCT01772160|528954904|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
146666080|NCT01772160|528954904|FG000|Overall Study|Consent withdrawal|3|||
146666081|NCT01772160|528954904|FG000|Overall Study|Migrated / moved from the study area|4|||
146666082|NCT01772160|528954904|FG000|Overall Study|Lost to Follow-up|30|||
146666083|NCT01772160|528954904|FG000|Overall Study|Other|5|||
146666084|NCT01696695|528954905|FG000|Overall Study|Disease progression|373|||
146666085|NCT01696695|528954905|FG000|Overall Study|Death|29|||
146666086|NCT01696695|528954905|FG000|Overall Study|Adverse Event|74|||
146666087|NCT01696695|528954905|FG000|Overall Study|Withdrawal by Subject|92|||
146666088|NCT01696695|528954905|FG000|Overall Study|Lost to Follow-up|48|||
146666089|NCT01696695|528954905|FG000|Overall Study|Other|74|||
146666090|NCT01696695|528954905|FG000|Overall Study|Major Protocol Violation|192|||
146666091|NCT02404220|528954908|FG000|Overall Study|Adverse Event|0|||
146666092|NCT02404220|528954909|FG001|Overall Study|Adverse Event|0|||
146666093|NCT02404220|528954910|FG002|Overall Study|Adverse Event|1|||
146666094|NCT02404220|528954911|FG003|Overall Study|Adverse Event|0|||
146666095|NCT02404220|528954908|FG000|Overall Study|Death|5|||
146666096|NCT02404220|528954909|FG001|Overall Study|Death|5|||
146666097|NCT02404220|528954910|FG002|Overall Study|Death|3|||
146666098|NCT02404220|528954911|FG003|Overall Study|Death|8|||
146666099|NCT02404220|528954908|FG000|Overall Study|Progressive Disease|0|||
146666100|NCT02404220|528954909|FG001|Overall Study|Progressive Disease|0|||
146666101|NCT02404220|528954910|FG002|Overall Study|Progressive Disease|1|||
146666102|NCT02404220|528954911|FG003|Overall Study|Progressive Disease|1|||
146666103|NCT02404220|528954908|FG000|Overall Study|Study Terminated by Sponsor|0|||
146666104|NCT02404220|528954909|FG001|Overall Study|Study Terminated by Sponsor|0|||
146666105|NCT02404220|528954910|FG002|Overall Study|Study Terminated by Sponsor|2|||
146666106|NCT02404220|528954911|FG003|Overall Study|Study Terminated by Sponsor|1|||
146666107|NCT02404220|528954908|FG000|Overall Study|Withdrawal by Subject|0|||
146666108|NCT02404220|528954909|FG001|Overall Study|Withdrawal by Subject|1|||
146666109|NCT02404220|528954910|FG002|Overall Study|Withdrawal by Subject|0|||
146666110|NCT02404220|528954911|FG003|Overall Study|Withdrawal by Subject|0|||
146666111|NCT02404220|528954908|FG000|Overall Study|Enrolled but Never Treated|0|||
146666112|NCT02404220|528954909|FG001|Overall Study|Enrolled but Never Treated|2|||
146666113|NCT02404220|528954910|FG002|Overall Study|Enrolled but Never Treated|0|||
146666114|NCT02404220|528954911|FG003|Overall Study|Enrolled but Never Treated|0|||
146666115|NCT03469934|528954914|FG000|Overall Study|Withdrawal by Subject|0|||
146666116|NCT03469934|528954915|FG001|Overall Study|Withdrawal by Subject|1|||
146666117|NCT00669396|528954917|FG000|Overall Study|Lost to Follow-up|10|||
146666118|NCT00669396|528954918|FG001|Overall Study|Lost to Follow-up|12|||
146666119|NCT01262573|528954919|FG000|Overall Study|Withdrawal by Subject|0|||
146666120|NCT01262573|528954920|FG001|Overall Study|Withdrawal by Subject|1|||
146773853|NCT04425629|529343469|FG016|Overall Study|Sponsor Request|0|||
146925504|NCT00077610|529888286|FG000|Overall Study|Lost to Follow-up|0|||
146925505|NCT00077610|529888287|FG001|Overall Study|Lost to Follow-up|1|||
146925506|NCT00077610|529888288|FG002|Overall Study|Lost to Follow-up|2|||
146666121|NCT04402060|528954921|FG000|Overall Study|Death|1|||
146666122|NCT04402060|528954922|FG001|Overall Study|Death|12|||
146666123|NCT04402060|528954923|FG002|Overall Study|Death|7|||
146925507|NCT00077610|529888286|FG000|Overall Study|Withdrawal by Subject|4|||
146666124|NCT04402060|528954921|FG000|Overall Study|Adverse Event|0|||
146666125|NCT04402060|528954922|FG001|Overall Study|Adverse Event|0|||
146666126|NCT04402060|528954923|FG002|Overall Study|Adverse Event|1|||
146666127|NCT04402060|528954921|FG000|Overall Study|Withdrawal by Subject|0|||
146666128|NCT04402060|528954922|FG001|Overall Study|Withdrawal by Subject|1|||
146666129|NCT04402060|528954923|FG002|Overall Study|Withdrawal by Subject|2|||
146666130|NCT04402060|528954921|FG000|Overall Study|Sponsor Request|0|||
146925508|NCT00077610|529888287|FG001|Overall Study|Withdrawal by Subject|10|||
146925509|NCT00077610|529888288|FG002|Overall Study|Withdrawal by Subject|6|||
146925510|NCT00077610|529888286|FG000|Overall Study|Death|17|||
146925511|NCT00077610|529888287|FG001|Overall Study|Death|13|||
146925512|NCT00077610|529888288|FG002|Overall Study|Death|13|||
146666131|NCT04402060|528954922|FG001|Overall Study|Sponsor Request|2|||
146666132|NCT04402060|528954923|FG002|Overall Study|Sponsor Request|0|||
146666133|NCT04402060|528954921|FG000|Overall Study|Physician Decision|0|||
146666134|NCT04402060|528954922|FG001|Overall Study|Physician Decision|0|||
146666135|NCT04402060|528954923|FG002|Overall Study|Physician Decision|1|||
146666136|NCT04402060|528954921|FG000|Overall Study|Other|0|||
146666137|NCT04402060|528954922|FG001|Overall Study|Other|1|||
146666138|NCT04402060|528954923|FG002|Overall Study|Other|0|||
146666139|NCT02507973|528954924|FG000|Overall Study|Adverse Event|1|||
146666140|NCT03386474|528954927|FG000|Overall Study|Death|1|||
146666141|NCT03386474|528954928|FG001|Overall Study|Death|0|||
146666142|NCT03386474|528954927|FG000|Overall Study|Adverse Event|0|||
146666143|NCT03386474|528954928|FG001|Overall Study|Adverse Event|1|||
146666144|NCT02155881|528954929|FG000|Overall Study|Withdrawal by Subject|0|||
146666145|NCT02155881|528954930|FG001|Overall Study|Withdrawal by Subject|2|||
146666146|NCT02155881|528954929|FG000|Overall Study|Inappropriately randomized|2|||
146666147|NCT02155881|528954930|FG001|Overall Study|Inappropriately randomized|2|||
146666148|NCT01786148|528954931|FG000|Overall Study|Lost to Follow-up|21|||
146666149|NCT01786148|528954932|FG001|Overall Study|Lost to Follow-up|13|||
146666150|NCT01786148|528954931|FG000|Overall Study|Death|0|||
146666151|NCT01786148|528954932|FG001|Overall Study|Death|1|||
146666152|NCT01786148|528954931|FG000|Overall Study|Withdrawal by Subject|0|||
146666153|NCT01786148|528954932|FG001|Overall Study|Withdrawal by Subject|7|||
146666154|NCT01786148|528954931|FG000|Overall Study|Incarceration|1|||
146666155|NCT01786148|528954932|FG001|Overall Study|Incarceration|1|||
146666156|NCT03780543|528954933|FG000|Overall Study|Adverse Event|1|||
146666157|NCT03780543|528954934|FG001|Overall Study|Adverse Event|0|||
146666158|NCT03780543|528954935|FG002|Overall Study|Adverse Event|2|||
146666159|NCT03780543|528954933|FG000|Overall Study|Lost to Follow-up|2|||
146666160|NCT03780543|528954934|FG001|Overall Study|Lost to Follow-up|0|||
146666161|NCT03780543|528954935|FG002|Overall Study|Lost to Follow-up|1|||
146666162|NCT03780543|528954933|FG000|Overall Study|Study terminated by Sponsor|8|||
146666163|NCT03780543|528954934|FG001|Overall Study|Study terminated by Sponsor|7|||
146666164|NCT03780543|528954935|FG002|Overall Study|Study terminated by Sponsor|13|||
146666165|NCT03780543|528954933|FG000|Overall Study|Withdrawal by Subject|1|||
146666166|NCT03780543|528954934|FG001|Overall Study|Withdrawal by Subject|8|||
146666167|NCT03780543|528954935|FG002|Overall Study|Withdrawal by Subject|1|||
146666168|NCT03780543|528954933|FG000|Overall Study|Noncompliance with study drug|1|||
146666169|NCT03780543|528954934|FG001|Overall Study|Noncompliance with study drug|0|||
146666170|NCT03780543|528954935|FG002|Overall Study|Noncompliance with study drug|0|||
146666171|NCT00066729|528954936|FG000|Overall Study|Lost to Follow-up|1|||
146666172|NCT00066729|528954936|FG000|Overall Study|Disease progression|1|||
146666173|NCT02215096|528954937|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
146666174|NCT02215096|528954938|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
146666175|NCT02215096|528954939|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
146666176|NCT02215096|528954940|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
146666177|NCT02215096|528954941|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
146666178|NCT02215096|528954937|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
146666179|NCT02215096|528954938|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
146666180|NCT02215096|528954939|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
146666181|NCT02215096|528954940|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
146666182|NCT02215096|528954941|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
146666183|NCT02215096|528954937|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
146666184|NCT02215096|528954938|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
146666185|NCT02215096|528954939|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
146666186|NCT02215096|528954940|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
146666187|NCT02215096|528954941|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
146666188|NCT02215096|528954937|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
146925513|NCT00077610|529888286|FG000|Overall Study|Renal transplant|12|||
146925514|NCT00077610|529888287|FG001|Overall Study|Renal transplant|15|||
146666189|NCT02215096|528954938|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
146666190|NCT02215096|528954939|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
146666191|NCT02215096|528954940|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
146666192|NCT02215096|528954941|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
146925515|NCT00077610|529888288|FG002|Overall Study|Renal transplant|11|||
146666193|NCT02586064|528954942|FG000|Overall Study|Other Obligations|6|||
146666194|NCT02586064|528954943|FG001|Overall Study|Other Obligations|6|||
146666195|NCT02586064|528954942|FG000|Overall Study|Other|3|||
146666196|NCT02586064|528954943|FG001|Overall Study|Other|7|||
146925516|NCT00077610|529888286|FG000|Overall Study|Withdrew from dialysis care|5|||
146925517|NCT00077610|529888287|FG001|Overall Study|Withdrew from dialysis care|0|||
146925518|NCT00077610|529888288|FG002|Overall Study|Withdrew from dialysis care|3|||
146666197|NCT02586064|528954942|FG000|Overall Study|Never Started|3|||
146666198|NCT02586064|528954943|FG001|Overall Study|Never Started|3|||
146666199|NCT02586064|528954942|FG000|Overall Study|Lost Interest|1|||
146666200|NCT02586064|528954943|FG001|Overall Study|Lost Interest|4|||
146666201|NCT02586064|528954942|FG000|Overall Study|Miscellaneous Life Issues|0|||
146666202|NCT02586064|528954943|FG001|Overall Study|Miscellaneous Life Issues|5|||
146666203|NCT02586064|528954942|FG000|Overall Study|Infrequent Attendance|2|||
146666204|NCT02586064|528954943|FG001|Overall Study|Infrequent Attendance|1|||
146666205|NCT02586064|528954942|FG000|Overall Study|Timed Out|2|||
146666206|NCT02586064|528954943|FG001|Overall Study|Timed Out|0|||
146666207|NCT02586064|528954942|FG000|Overall Study|AUD relapse|0|||
146666208|NCT02586064|528954943|FG001|Overall Study|AUD relapse|2|||
146666209|NCT02586064|528954942|FG000|Overall Study|Legal Issue|1|||
146666210|NCT02586064|528954943|FG001|Overall Study|Legal Issue|0|||
146666211|NCT01967173|528954944|FG000|Overall Study|Lost to Follow-up|5|||
146666212|NCT01967173|528954945|FG001|Overall Study|Lost to Follow-up|3|||
146666213|NCT01967173|528954946|FG002|Overall Study|Lost to Follow-up|2|||
146666214|NCT01967173|528954947|FG003|Overall Study|Lost to Follow-up|4|||
146666215|NCT01967173|528954948|FG004|Overall Study|Lost to Follow-up|8|||
146666216|NCT01967173|528954949|FG005|Overall Study|Lost to Follow-up|12|||
146666217|NCT01967173|528954950|FG006|Overall Study|Lost to Follow-up|6|||
146666218|NCT01967173|528954951|FG007|Overall Study|Lost to Follow-up|8|||
146666219|NCT01967173|528954944|FG000|Overall Study|Physician Decision|2|||
146666220|NCT01967173|528954945|FG001|Overall Study|Physician Decision|0|||
146666221|NCT01967173|528954946|FG002|Overall Study|Physician Decision|2|||
146666222|NCT01967173|528954947|FG003|Overall Study|Physician Decision|1|||
146666223|NCT01967173|528954948|FG004|Overall Study|Physician Decision|1|||
146666224|NCT01967173|528954949|FG005|Overall Study|Physician Decision|1|||
146666225|NCT01967173|528954950|FG006|Overall Study|Physician Decision|1|||
146666226|NCT01967173|528954951|FG007|Overall Study|Physician Decision|0|||
146666227|NCT01967173|528954944|FG000|Overall Study|Lack of Efficacy|2|||
146666228|NCT01967173|528954945|FG001|Overall Study|Lack of Efficacy|0|||
146666229|NCT01967173|528954946|FG002|Overall Study|Lack of Efficacy|2|||
146925519|NCT00077610|529888286|FG000|Overall Study|Insufficient Therapeutic Response|1|||
146666230|NCT01967173|528954947|FG003|Overall Study|Lack of Efficacy|2|||
146666231|NCT01967173|528954948|FG004|Overall Study|Lack of Efficacy|0|||
146666232|NCT01967173|528954949|FG005|Overall Study|Lack of Efficacy|1|||
146666233|NCT01967173|528954950|FG006|Overall Study|Lack of Efficacy|0|||
146666234|NCT01967173|528954951|FG007|Overall Study|Lack of Efficacy|2|||
146666235|NCT01967173|528954944|FG000|Overall Study|Pregnancy|0|||
146666236|NCT01967173|528954945|FG001|Overall Study|Pregnancy|0|||
146666237|NCT01967173|528954946|FG002|Overall Study|Pregnancy|0|||
146666238|NCT01967173|528954947|FG003|Overall Study|Pregnancy|0|||
146666239|NCT01967173|528954948|FG004|Overall Study|Pregnancy|0|||
146666240|NCT01967173|528954949|FG005|Overall Study|Pregnancy|0|||
146666241|NCT01967173|528954950|FG006|Overall Study|Pregnancy|1|||
146666242|NCT01967173|528954951|FG007|Overall Study|Pregnancy|1|||
146666243|NCT01967173|528954944|FG000|Overall Study|Adverse Event|0|||
146666244|NCT01967173|528954945|FG001|Overall Study|Adverse Event|0|||
146666245|NCT01967173|528954946|FG002|Overall Study|Adverse Event|0|||
146666246|NCT01967173|528954947|FG003|Overall Study|Adverse Event|0|||
146666247|NCT01967173|528954948|FG004|Overall Study|Adverse Event|0|||
146666248|NCT01967173|528954949|FG005|Overall Study|Adverse Event|0|||
146666249|NCT01967173|528954950|FG006|Overall Study|Adverse Event|0|||
146666250|NCT01967173|528954951|FG007|Overall Study|Adverse Event|1|||
146666251|NCT01967173|528954944|FG000|Overall Study|Withdrawal by Subject|15|||
146666252|NCT01967173|528954945|FG001|Overall Study|Withdrawal by Subject|14|||
146666253|NCT01967173|528954946|FG002|Overall Study|Withdrawal by Subject|10|||
146666254|NCT01967173|528954947|FG003|Overall Study|Withdrawal by Subject|7|||
146666255|NCT01967173|528954948|FG004|Overall Study|Withdrawal by Subject|8|||
146978759|NCT01113710|530085494|FG000|Overall Study|Lost to Follow-up|20|||
146666256|NCT01967173|528954949|FG005|Overall Study|Withdrawal by Subject|9|||
146666257|NCT01967173|528954950|FG006|Overall Study|Withdrawal by Subject|10|||
146666258|NCT01967173|528954951|FG007|Overall Study|Withdrawal by Subject|12|||
146666259|NCT03540030|528954955|FG000|Overall Study|Withdrawal by Subject|2|||
146666260|NCT03540030|528954956|FG001|Overall Study|Withdrawal by Subject|1|||
146666261|NCT03540030|528954955|FG000|Overall Study|screen fail|7|||
146666262|NCT03540030|528954956|FG001|Overall Study|screen fail|1|||
146666263|NCT03540030|528954955|FG000|Overall Study|never had surgery after signing consent|9|||
146666264|NCT03540030|528954956|FG001|Overall Study|never had surgery after signing consent|1|||
146666265|NCT03021304|528954957|FG000|Overall Study|Lack of Efficacy|1|||
146666266|NCT00397215|528954963|FG000|Month 0 (Day 0)|Adverse Event|0|||
146666267|NCT00397215|528954964|FG001|Month 0 (Day 0)|Adverse Event|1|||
146666268|NCT00397215|528954965|FG002|Month 0 (Day 0)|Adverse Event|0|||
146666269|NCT00397215|528954966|FG003|Month 0 (Day 0)|Adverse Event|0|||
146666270|NCT00397215|528954963|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
146666271|NCT00397215|528954964|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
146666272|NCT00397215|528954965|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
146666273|NCT00397215|528954966|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
146666274|NCT00397215|528954963|FG000|Month 0 (Day 0)|Other|4|||
146666275|NCT00397215|528954964|FG001|Month 0 (Day 0)|Other|1|||
146666276|NCT00397215|528954965|FG002|Month 0 (Day 0)|Other|3|||
146666277|NCT00397215|528954966|FG003|Month 0 (Day 0)|Other|3|||
146666278|NCT00397215|528954963|FG000|Month 6 (Day 180)|Adverse Event|0|||
146666279|NCT00397215|528954964|FG001|Month 6 (Day 180)|Adverse Event|3|||
146666280|NCT00397215|528954965|FG002|Month 6 (Day 180)|Adverse Event|2|||
146666281|NCT00397215|528954966|FG003|Month 6 (Day 180)|Adverse Event|0|||
146666282|NCT00397215|528954963|FG000|Month 6 (Day 180)|Other|2|||
146666283|NCT00397215|528954964|FG001|Month 6 (Day 180)|Other|0|||
146666284|NCT00397215|528954965|FG002|Month 6 (Day 180)|Other|3|||
146666285|NCT00397215|528954966|FG003|Month 6 (Day 180)|Other|0|||
146666286|NCT01361568|528954967|FG000|Overall Study|Adverse Event|0|||
146666287|NCT01361568|528954968|FG001|Overall Study|Adverse Event|0|||
146666288|NCT01361568|528954969|FG002|Overall Study|Adverse Event|0|||
146666289|NCT01361568|528954970|FG003|Overall Study|Adverse Event|0|||
146666290|NCT01361568|528954971|FG004|Overall Study|Adverse Event|1|||
146666291|NCT01361568|528954972|FG005|Overall Study|Adverse Event|0|||
146666292|NCT01361568|528954967|FG000|Overall Study|Physician Decision|0|||
146666293|NCT01361568|528954968|FG001|Overall Study|Physician Decision|0|||
146666294|NCT01361568|528954969|FG002|Overall Study|Physician Decision|0|||
146666295|NCT01361568|528954970|FG003|Overall Study|Physician Decision|0|||
146666296|NCT01361568|528954971|FG004|Overall Study|Physician Decision|0|||
146666297|NCT01361568|528954972|FG005|Overall Study|Physician Decision|1|||
146666298|NCT01361568|528954967|FG000|Overall Study|Withdrawal by Subject|2|||
146666299|NCT01361568|528954968|FG001|Overall Study|Withdrawal by Subject|1|||
146666300|NCT01361568|528954969|FG002|Overall Study|Withdrawal by Subject|0|||
146666301|NCT01361568|528954970|FG003|Overall Study|Withdrawal by Subject|0|||
146666302|NCT01361568|528954971|FG004|Overall Study|Withdrawal by Subject|0|||
146666303|NCT01361568|528954972|FG005|Overall Study|Withdrawal by Subject|1|||
146666304|NCT02020577|528954977|FG000|Overall Study|Progressive disease|3|||
146666305|NCT02020577|528954978|FG001|Overall Study|Progressive disease|38|||
146666306|NCT02020577|528954977|FG000|Overall Study|Other AE or clinical progression|0|||
146666307|NCT02020577|528954978|FG001|Overall Study|Other AE or clinical progression|15|||
146666308|NCT02020577|528954977|FG000|Overall Study|Withdrawal by Subject|0|||
146666309|NCT02020577|528954978|FG001|Overall Study|Withdrawal by Subject|1|||
146666310|NCT02020577|528954977|FG000|Overall Study|Other than stated above|0|||
146666311|NCT02020577|528954978|FG001|Overall Study|Other than stated above|1|||
146666312|NCT02728596|528954979|FG000|Overall Study|Refusal unrelated to adverse event|3|||
146666313|NCT02728596|528954980|FG001|Overall Study|Refusal unrelated to adverse event|6|||
146666314|NCT02728596|528954981|FG002|Overall Study|Refusal unrelated to adverse event|7|||
146666315|NCT02728596|528954982|FG003|Overall Study|Refusal unrelated to adverse event|7|||
146666316|NCT02728596|528954979|FG000|Overall Study|Death|44|||
146666317|NCT02728596|528954980|FG001|Overall Study|Death|42|||
146666318|NCT02728596|528954981|FG002|Overall Study|Death|123|||
146666319|NCT02728596|528954982|FG003|Overall Study|Death|68|||
146666320|NCT03439657|528954983|FG000|Overall Study|Adverse Event|2|||
146666321|NCT03439657|528954984|FG001|Overall Study|Adverse Event|3|||
146666322|NCT03439657|528954983|FG000|Overall Study|Lost to Follow-up|1|||
146666323|NCT03439657|528954984|FG001|Overall Study|Lost to Follow-up|0|||
146666324|NCT03439657|528954983|FG000|Overall Study|Protocol Violation|1|||
146666325|NCT03439657|528954984|FG001|Overall Study|Protocol Violation|1|||
146666326|NCT03439657|528954983|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
146666327|NCT03439657|528954984|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
146666328|NCT00370071|528954986|FG000|Overall Study|Withdrawal by Subject|2|||
146666329|NCT03553927|528954989|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
146666330|NCT03553927|528954990|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
146666331|NCT03553927|528954989|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
146666332|NCT03553927|528954990|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
146666333|NCT02612129|528954992|FG000|Single Dose Treatment Period|Screening Failure|1|||
146666334|NCT02612129|528954993|FG001|Single Dose Treatment Period|Screening Failure|0|||
146666335|NCT02612129|528954994|FG002|Single Dose Treatment Period|Screening Failure|0|||
146666336|NCT02612129|528954992|FG000|Continuous Treatment Period|Early Escape|0|||
146666337|NCT02612129|528954993|FG001|Continuous Treatment Period|Early Escape|2|||
146666338|NCT02612129|528954994|FG002|Continuous Treatment Period|Early Escape|0|||
146666339|NCT02612129|528954992|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
146666340|NCT02612129|528954993|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
146666341|NCT02612129|528954994|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
146666342|NCT02612129|528954992|FG000|Continuous Treatment Period|Safety Reasons|0|||
146666343|NCT02612129|528954993|FG001|Continuous Treatment Period|Safety Reasons|3|||
146666344|NCT02612129|528954994|FG002|Continuous Treatment Period|Safety Reasons|0|||
146666345|NCT02612129|528954992|FG000|Continuous Treatment Period|Death|0|||
146666346|NCT02612129|528954993|FG001|Continuous Treatment Period|Death|1|||
146666347|NCT02612129|528954994|FG002|Continuous Treatment Period|Death|0|||
146666348|NCT02612129|528954992|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
146736242|NCT00279201|529205306|FG005|Intensification Addendum|Sponsor Decision|1|||
146666349|NCT02612129|528954993|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
146666350|NCT02612129|528954994|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
146666351|NCT02557295|528954995|FG000|Overall Study|Withdrawal by Subject|9|||
146666352|NCT02557295|528954996|FG001|Overall Study|Withdrawal by Subject|2|||
146666353|NCT02557295|528954997|FG002|Overall Study|Withdrawal by Subject|4|||
146666354|NCT02557295|528954998|FG003|Overall Study|Withdrawal by Subject|0|||
146666355|NCT02557295|528954999|FG004|Overall Study|Withdrawal by Subject|0|||
146666356|NCT02557295|528955000|FG005|Overall Study|Withdrawal by Subject|0|||
146666357|NCT02557295|528955001|FG006|Overall Study|Withdrawal by Subject|15|||
146666358|NCT02557295|528955002|FG007|Overall Study|Withdrawal by Subject|1|||
146666359|NCT02557295|528955003|FG008|Overall Study|Withdrawal by Subject|3|||
146666360|NCT02557295|528954995|FG000|Overall Study|Disease Progression|0|||
146666361|NCT02557295|528954996|FG001|Overall Study|Disease Progression|0|||
146666362|NCT02557295|528954997|FG002|Overall Study|Disease Progression|0|||
146666363|NCT02557295|528954998|FG003|Overall Study|Disease Progression|0|||
146666364|NCT02557295|528954999|FG004|Overall Study|Disease Progression|0|||
146666365|NCT02557295|528955000|FG005|Overall Study|Disease Progression|0|||
146666366|NCT02557295|528955001|FG006|Overall Study|Disease Progression|1|||
146666367|NCT02557295|528955002|FG007|Overall Study|Disease Progression|0|||
146666368|NCT02557295|528955003|FG008|Overall Study|Disease Progression|0|||
146666369|NCT02557295|528954995|FG000|Overall Study|Lack of Efficacy|24|||
146666370|NCT02557295|528954996|FG001|Overall Study|Lack of Efficacy|1|||
146666371|NCT02557295|528954997|FG002|Overall Study|Lack of Efficacy|3|||
146666372|NCT02557295|528954998|FG003|Overall Study|Lack of Efficacy|0|||
146666373|NCT02557295|528954999|FG004|Overall Study|Lack of Efficacy|0|||
146666374|NCT02557295|528955000|FG005|Overall Study|Lack of Efficacy|0|||
146666375|NCT02557295|528955001|FG006|Overall Study|Lack of Efficacy|12|||
146666376|NCT02557295|528955002|FG007|Overall Study|Lack of Efficacy|1|||
146666377|NCT02557295|528955003|FG008|Overall Study|Lack of Efficacy|0|||
146666378|NCT02557295|528954995|FG000|Overall Study|Adverse Event|16|||
146666379|NCT02557295|528954996|FG001|Overall Study|Adverse Event|2|||
146666380|NCT02557295|528954997|FG002|Overall Study|Adverse Event|3|||
146666381|NCT02557295|528954998|FG003|Overall Study|Adverse Event|0|||
146666382|NCT02557295|528954999|FG004|Overall Study|Adverse Event|0|||
146666383|NCT02557295|528955000|FG005|Overall Study|Adverse Event|0|||
146666384|NCT02557295|528955001|FG006|Overall Study|Adverse Event|2|||
146666385|NCT02557295|528955002|FG007|Overall Study|Adverse Event|1|||
146666386|NCT02557295|528955003|FG008|Overall Study|Adverse Event|1|||
146666387|NCT02557295|528954995|FG000|Overall Study|Lost to Follow-up|4|||
146666388|NCT02557295|528954996|FG001|Overall Study|Lost to Follow-up|0|||
146666389|NCT02557295|528954997|FG002|Overall Study|Lost to Follow-up|0|||
146666390|NCT02557295|528954998|FG003|Overall Study|Lost to Follow-up|0|||
146666391|NCT02557295|528954999|FG004|Overall Study|Lost to Follow-up|0|||
146666392|NCT02557295|528955000|FG005|Overall Study|Lost to Follow-up|0|||
146666393|NCT02557295|528955001|FG006|Overall Study|Lost to Follow-up|9|||
146666394|NCT02557295|528955002|FG007|Overall Study|Lost to Follow-up|0|||
146666395|NCT02557295|528955003|FG008|Overall Study|Lost to Follow-up|0|||
146666396|NCT02557295|528954995|FG000|Overall Study|Study Close|54|||
146666397|NCT02557295|528954996|FG001|Overall Study|Study Close|3|||
146666398|NCT02557295|528954997|FG002|Overall Study|Study Close|5|||
146666399|NCT02557295|528954998|FG003|Overall Study|Study Close|3|||
146666400|NCT02557295|528954999|FG004|Overall Study|Study Close|0|||
146666401|NCT02557295|528955000|FG005|Overall Study|Study Close|0|||
146666402|NCT02557295|528955001|FG006|Overall Study|Study Close|37|||
146666403|NCT02557295|528955002|FG007|Overall Study|Study Close|3|||
146666404|NCT02557295|528955003|FG008|Overall Study|Study Close|19|||
146666405|NCT02557295|528954995|FG000|Overall Study|except for study close|4|||
146666406|NCT02557295|528954996|FG001|Overall Study|except for study close|0|||
146666407|NCT02557295|528954997|FG002|Overall Study|except for study close|0|||
146666408|NCT02557295|528954998|FG003|Overall Study|except for study close|0|||
146925520|NCT00077610|529888287|FG001|Overall Study|Insufficient Therapeutic Response|0|||
146666409|NCT02557295|528954999|FG004|Overall Study|except for study close|0|||
146666410|NCT02557295|528955000|FG005|Overall Study|except for study close|0|||
146666411|NCT02557295|528955001|FG006|Overall Study|except for study close|5|||
146666412|NCT02557295|528955002|FG007|Overall Study|except for study close|1|||
146666413|NCT02557295|528955003|FG008|Overall Study|except for study close|0|||
146666414|NCT03487549|528955004|FG000|Overall Study|Protocol Violation|0|||
146666415|NCT03487549|528955005|FG001|Overall Study|Protocol Violation|1|||
146666416|NCT03487549|528955004|FG000|Overall Study|Lost to Follow-up|2|||
146666417|NCT03487549|528955005|FG001|Overall Study|Lost to Follow-up|1|||
146666418|NCT03487549|528955004|FG000|Overall Study|Withdrawal by Subject|2|||
146666419|NCT03487549|528955005|FG001|Overall Study|Withdrawal by Subject|0|||
146666420|NCT01313858|528956792|FG000|Overall Study|Premature Treatment Termination|251|||
146666421|NCT01313858|528956793|FG001|Overall Study|Premature Treatment Termination|219|||
146666422|NCT01313858|528956794|FG002|Overall Study|Premature Treatment Termination|191|||
146666423|NCT01313858|528956792|FG000|Overall Study|Lost to Follow-up|35|||
146666424|NCT01313858|528956793|FG001|Overall Study|Lost to Follow-up|51|||
146666425|NCT01313858|528956794|FG002|Overall Study|Lost to Follow-up|47|||
146666426|NCT03689530|528956799|FG000|Overall Study|Withdrawal by Subject|53|||
146666427|NCT03689530|528956800|FG001|Overall Study|Withdrawal by Subject|16|||
146666428|NCT01392443|528956801|FG000|Overall Study|Disease progression|30|||
146666429|NCT01392443|528956801|FG000|Overall Study|Adverse Event|24|||
146666430|NCT01392443|528956801|FG000|Overall Study|Death|7|||
146666431|NCT01392443|528956801|FG000|Overall Study|Withdrawal by Subject|5|||
146666432|NCT01392443|528956801|FG000|Overall Study|Lost to Follow-up|1|||
146666433|NCT01392443|528956801|FG000|Overall Study|Protocol Violation|1|||
146666434|NCT01546207|528956814|FG000|Overall Study|Death|1|||
146666435|NCT01626456|528956815|FG000|Overall Study|Withdrawal by Subject|21|||
146666436|NCT01626456|528956816|FG001|Overall Study|Withdrawal by Subject|46|||
146666437|NCT01626456|528956815|FG000|Overall Study|Adverse Event|2|||
146666438|NCT01626456|528956816|FG001|Overall Study|Adverse Event|27|||
146666439|NCT01626456|528956815|FG000|Overall Study|Lost to Follow-up|2|||
146666440|NCT01626456|528956816|FG001|Overall Study|Lost to Follow-up|27|||
146666441|NCT01626456|528956815|FG000|Overall Study|Lack of Efficacy|6|||
146666442|NCT01626456|528956816|FG001|Overall Study|Lack of Efficacy|7|||
146666443|NCT01626456|528956815|FG000|Overall Study|Physician Decision|1|||
146666444|NCT01626456|528956816|FG001|Overall Study|Physician Decision|4|||
146666445|NCT01626456|528956815|FG000|Overall Study|Protocol Violation|1|||
146666446|NCT01626456|528956816|FG001|Overall Study|Protocol Violation|1|||
146666447|NCT01626456|528956815|FG000|Overall Study|Site Closure|2|||
146666448|NCT01626456|528956816|FG001|Overall Study|Site Closure|3|||
146666449|NCT01626456|528956815|FG000|Overall Study|Incarceration|0|||
146666450|NCT01626456|528956816|FG001|Overall Study|Incarceration|2|||
146666451|NCT01816074|528956817|FG000|Phase 1|Time commitment issues|0|||
146666452|NCT01816074|528956818|FG001|Phase 1|Time commitment issues|0|||
146666453|NCT01816074|528956819|FG002|Phase 1|Time commitment issues|1|||
146666454|NCT01816074|528956820|FG003|Phase 1|Time commitment issues|0|||
146666455|NCT01816074|528956817|FG000|Phase 2|Time commitment Issues|0|||
146666456|NCT01816074|528956818|FG001|Phase 2|Time commitment Issues|2|||
146666457|NCT01816074|528956819|FG002|Phase 2|Time commitment Issues|0|||
146666458|NCT01816074|528956820|FG003|Phase 2|Time commitment Issues|0|||
146666459|NCT01816074|528956817|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
146666460|NCT01816074|528956818|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
146666461|NCT01816074|528956819|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
146666462|NCT01816074|528956820|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
146666463|NCT01816074|528956817|FG000|Phase 2|Physician Decision|0|||
146666464|NCT01816074|528956818|FG001|Phase 2|Physician Decision|0|||
146666465|NCT01816074|528956819|FG002|Phase 2|Physician Decision|0|||
146666466|NCT01816074|528956820|FG003|Phase 2|Physician Decision|1|||
146666467|NCT01816074|528956817|FG000|Phase 2|Withdrawal by Subject|1|||
146666468|NCT01816074|528956818|FG001|Phase 2|Withdrawal by Subject|0|||
146666469|NCT01816074|528956819|FG002|Phase 2|Withdrawal by Subject|0|||
146666470|NCT01816074|528956820|FG003|Phase 2|Withdrawal by Subject|0|||
146666471|NCT00131508|528956826|FG000|Overall Study|Disease progression|0|||
146666472|NCT00131508|528956827|FG001|Overall Study|Disease progression|2|||
146666473|NCT00131508|528956826|FG000|Overall Study|Non-Compliance|2|||
146666474|NCT00131508|528956827|FG001|Overall Study|Non-Compliance|4|||
146666475|NCT00131508|528956826|FG000|Overall Study|Withdrawal by Subject|1|||
146666476|NCT00131508|528956827|FG001|Overall Study|Withdrawal by Subject|2|||
146666477|NCT01330030|528956828|FG000|Overall Study|Lost to Follow-up|16|||
146666478|NCT01330030|528956829|FG001|Overall Study|Lost to Follow-up|17|||
146666479|NCT00845858|528956830|FG000|Overall Study|Withdrawal by Subject|5|||
146666480|NCT00845858|528956831|FG001|Overall Study|Withdrawal by Subject|1|||
146666481|NCT00845858|528956832|FG002|Overall Study|Withdrawal by Subject|1|||
146666482|NCT00845858|528956830|FG000|Overall Study|Adverse Event|3|||
146666483|NCT00845858|528956831|FG001|Overall Study|Adverse Event|8|||
146666484|NCT00845858|528956832|FG002|Overall Study|Adverse Event|4|||
146666485|NCT00845858|528956830|FG000|Overall Study|Protocol Violation|0|||
146666486|NCT00845858|528956831|FG001|Overall Study|Protocol Violation|0|||
146666487|NCT00845858|528956832|FG002|Overall Study|Protocol Violation|1|||
146666488|NCT00845858|528956830|FG000|Overall Study|not eligible|0|||
146666489|NCT00845858|528956831|FG001|Overall Study|not eligible|3|||
146666490|NCT00845858|528956832|FG002|Overall Study|not eligible|2|||
146666491|NCT02980783|528956833|FG000|Overall Study|Lost to Follow-up|1|||
146666492|NCT00850070|528956834|FG000|Overall Study|Lack of Efficacy|1|||
146666493|NCT00850070|528956835|FG001|Overall Study|Lack of Efficacy|1|||
146666494|NCT00850070|528956834|FG000|Overall Study|Adverse Event|2|||
146666495|NCT00850070|528956835|FG001|Overall Study|Adverse Event|0|||
146666496|NCT03758443|528956836|FG000|Induction Period|Adverse Event|2|||
146666497|NCT03758443|528956837|FG001|Induction Period|Adverse Event|4|||
146666498|NCT03758443|528956838|FG002|Induction Period|Adverse Event|2|||
146666499|NCT03758443|528956839|FG003|Induction Period|Adverse Event|3|||
146666500|NCT03758443|528956836|FG000|Induction Period|Physician Decision|1|||
146666501|NCT03758443|528956837|FG001|Induction Period|Physician Decision|1|||
146666502|NCT03758443|528956838|FG002|Induction Period|Physician Decision|3|||
146666503|NCT03758443|528956839|FG003|Induction Period|Physician Decision|0|||
146666504|NCT03758443|528956836|FG000|Induction Period|Protocol Violation|0|||
146773854|NCT04425629|529343470|FG017|Overall Study|Sponsor Request|0|||
146666505|NCT03758443|528956837|FG001|Induction Period|Protocol Violation|0|||
146666506|NCT03758443|528956838|FG002|Induction Period|Protocol Violation|0|||
146666507|NCT03758443|528956839|FG003|Induction Period|Protocol Violation|1|||
146666508|NCT03758443|528956836|FG000|Induction Period|Withdrawal by Subject|3|||
146666509|NCT03758443|528956837|FG001|Induction Period|Withdrawal by Subject|2|||
146666510|NCT03758443|528956838|FG002|Induction Period|Withdrawal by Subject|2|||
146666511|NCT03758443|528956839|FG003|Induction Period|Withdrawal by Subject|4|||
146666512|NCT03758443|528956836|FG000|Extended Induction Period|Adverse Event|1|||
146666513|NCT03758443|528956837|FG001|Extended Induction Period|Adverse Event|1|||
146666514|NCT03758443|528956838|FG002|Extended Induction Period|Adverse Event|0|||
146666515|NCT03758443|528956839|FG003|Extended Induction Period|Adverse Event|1|||
146666516|NCT03758443|528956836|FG000|Extended Induction Period|Lost to Follow-up|1|||
146666517|NCT03758443|528956837|FG001|Extended Induction Period|Lost to Follow-up|0|||
146666518|NCT03758443|528956838|FG002|Extended Induction Period|Lost to Follow-up|0|||
146666519|NCT03758443|528956839|FG003|Extended Induction Period|Lost to Follow-up|0|||
146666520|NCT03758443|528956836|FG000|Extended Induction Period|Physician Decision|2|||
146666521|NCT03758443|528956837|FG001|Extended Induction Period|Physician Decision|1|||
146666522|NCT03758443|528956838|FG002|Extended Induction Period|Physician Decision|2|||
146666523|NCT03758443|528956839|FG003|Extended Induction Period|Physician Decision|2|||
146666524|NCT03758443|528956836|FG000|Extended Induction Period|Protocol Violation|0|||
146666525|NCT03758443|528956837|FG001|Extended Induction Period|Protocol Violation|0|||
146666526|NCT03758443|528956838|FG002|Extended Induction Period|Protocol Violation|0|||
146666527|NCT03758443|528956839|FG003|Extended Induction Period|Protocol Violation|1|||
146666528|NCT03758443|528956836|FG000|Extended Induction Period|Withdrawal by Subject|8|||
146666529|NCT03758443|528956837|FG001|Extended Induction Period|Withdrawal by Subject|1|||
146666530|NCT03758443|528956838|FG002|Extended Induction Period|Withdrawal by Subject|7|||
146666531|NCT03758443|528956839|FG003|Extended Induction Period|Withdrawal by Subject|3|||
146666532|NCT03758443|528956836|FG000|Extended Induction Period|Miscellaneous|1|||
146666533|NCT03758443|528956837|FG001|Extended Induction Period|Miscellaneous|0|||
146666534|NCT03758443|528956838|FG002|Extended Induction Period|Miscellaneous|0|||
146666535|NCT03758443|528956839|FG003|Extended Induction Period|Miscellaneous|0|||
146666536|NCT03758443|528956836|FG000|Maintenance Period|Adverse Event|1|||
146666537|NCT03758443|528956837|FG001|Maintenance Period|Adverse Event|2|||
146666538|NCT03758443|528956838|FG002|Maintenance Period|Adverse Event|0|||
146666539|NCT03758443|528956839|FG003|Maintenance Period|Adverse Event|0|||
146666540|NCT03758443|528956836|FG000|Maintenance Period|Lost to Follow-up|0|||
146666541|NCT03758443|528956837|FG001|Maintenance Period|Lost to Follow-up|0|||
146666542|NCT03758443|528956838|FG002|Maintenance Period|Lost to Follow-up|0|||
146666543|NCT03758443|528956839|FG003|Maintenance Period|Lost to Follow-up|1|||
146666544|NCT03758443|528956836|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
146666545|NCT03758443|528956837|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
146666546|NCT03758443|528956838|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
146666547|NCT03758443|528956839|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
146666548|NCT03758443|528956836|FG000|Maintenance Period|Protocol Violation|0|||
146666549|NCT03758443|528956837|FG001|Maintenance Period|Protocol Violation|1|||
146666550|NCT03758443|528956838|FG002|Maintenance Period|Protocol Violation|0|||
146666551|NCT03758443|528956839|FG003|Maintenance Period|Protocol Violation|0|||
146666552|NCT03758443|528956836|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
146666553|NCT03758443|528956837|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
146666554|NCT03758443|528956838|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
146666555|NCT03758443|528956839|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
146666556|NCT03758443|528956836|FG000|Maintenance Period|Withdrawal by Subject|1|||
146666557|NCT03758443|528956837|FG001|Maintenance Period|Withdrawal by Subject|0|||
146666558|NCT03758443|528956838|FG002|Maintenance Period|Withdrawal by Subject|1|||
146666559|NCT03758443|528956839|FG003|Maintenance Period|Withdrawal by Subject|1|||
146666560|NCT03758443|528956836|FG000|Maintenance Period|Miscellaneous|0|||
146666561|NCT03758443|528956837|FG001|Maintenance Period|Miscellaneous|0|||
146666562|NCT03758443|528956838|FG002|Maintenance Period|Miscellaneous|1|||
146666563|NCT03758443|528956839|FG003|Maintenance Period|Miscellaneous|0|||
146666564|NCT01522248|528956842|FG000|Overall Study|Lost to Follow-up|1|||
146666565|NCT01522248|528956843|FG001|Overall Study|Lost to Follow-up|0|||
146666566|NCT00696800|528956848|FG000|Overall Study|Adverse Event|16|||
146666567|NCT00696800|528956849|FG001|Overall Study|Adverse Event|3|||
146666568|NCT00696800|528956848|FG000|Overall Study|Insufficient compliance with medication|2|||
146666569|NCT00696800|528956849|FG001|Overall Study|Insufficient compliance with medication|1|||
146666570|NCT00696800|528956848|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
146666571|NCT00696800|528956849|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
146666572|NCT00696800|528956848|FG000|Overall Study|Insufficient ovarian response|4|||
146666573|NCT00696800|528956849|FG001|Overall Study|Insufficient ovarian response|1|||
146666574|NCT00696800|528956848|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
146666575|NCT00696800|528956849|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
146666576|NCT00696800|528956848|FG000|Overall Study|Too high ovarian response|6|||
146666577|NCT00696800|528956849|FG001|Overall Study|Too high ovarian response|1|||
146666578|NCT00696800|528956848|FG000|Overall Study|No/too few/bad quality oocytes|4|||
146666579|NCT00696800|528956849|FG001|Overall Study|No/too few/bad quality oocytes|3|||
146666580|NCT00696800|528956848|FG000|Overall Study|No/abnormal fertilization|11|||
146666581|NCT00696800|528956849|FG001|Overall Study|No/abnormal fertilization|13|||
146666582|NCT00696800|528956848|FG000|Overall Study|No/too few/bad quality embryos|24|||
146666583|NCT00696800|528956849|FG001|Overall Study|No/too few/bad quality embryos|18|||
146666584|NCT00696800|528956848|FG000|Overall Study|Other Reasons|5|||
146666585|NCT00696800|528956849|FG001|Overall Study|Other Reasons|3|||
146666586|NCT00696800|528956848|FG000|Overall Study|Not treated|1|||
146666587|NCT00696800|528956849|FG001|Overall Study|Not treated|2|||
146666588|NCT05224141|528956852|FG000|Overall Study|Ongoing|75|||
146666589|NCT05224141|528956853|FG001|Overall Study|Ongoing|88|||
146666590|NCT05224141|528956852|FG000|Overall Study|Withdrawal by Subject|2|||
146666591|NCT05224141|528956853|FG001|Overall Study|Withdrawal by Subject|4|||
146666592|NCT05224141|528956852|FG000|Overall Study|Death|153|||
146666593|NCT05224141|528956853|FG001|Overall Study|Death|138|||
146666594|NCT00199875|528956865|FG000|Overall Study|Withdrawal by Subject|0|||
146666595|NCT00199875|528956866|FG001|Overall Study|Withdrawal by Subject|0|||
146666596|NCT00199875|528956867|FG002|Overall Study|Withdrawal by Subject|0|||
146666597|NCT00199875|528956868|FG003|Overall Study|Withdrawal by Subject|0|||
146666598|NCT00199875|528956869|FG004|Overall Study|Withdrawal by Subject|1|||
146666599|NCT01024231|528956874|FG000|Overall Study|Other Reasons|1|||
146666600|NCT01024231|528956875|FG001|Overall Study|Other Reasons|2|||
146666601|NCT01024231|528956876|FG002|Overall Study|Other Reasons|0|||
146666602|NCT01024231|528956877|FG003|Overall Study|Other Reasons|0|||
146666603|NCT01024231|528956878|FG004|Overall Study|Other Reasons|2|||
146666604|NCT01024231|528956879|FG005|Overall Study|Other Reasons|0|||
146666605|NCT01024231|528956880|FG006|Overall Study|Other Reasons|1|||
146666606|NCT01024231|528956874|FG000|Overall Study|Maximum Clinical Benefit|1|||
146666607|NCT01024231|528956875|FG001|Overall Study|Maximum Clinical Benefit|2|||
146666608|NCT01024231|528956876|FG002|Overall Study|Maximum Clinical Benefit|0|||
146666609|NCT01024231|528956877|FG003|Overall Study|Maximum Clinical Benefit|1|||
146666610|NCT01024231|528956878|FG004|Overall Study|Maximum Clinical Benefit|1|||
146666611|NCT01024231|528956879|FG005|Overall Study|Maximum Clinical Benefit|0|||
146666612|NCT01024231|528956880|FG006|Overall Study|Maximum Clinical Benefit|0|||
146666613|NCT01024231|528956874|FG000|Overall Study|Disease Progression|3|||
146666614|NCT01024231|528956875|FG001|Overall Study|Disease Progression|1|||
146666615|NCT01024231|528956876|FG002|Overall Study|Disease Progression|3|||
146666616|NCT01024231|528956877|FG003|Overall Study|Disease Progression|0|||
146666617|NCT01024231|528956878|FG004|Overall Study|Disease Progression|4|||
146666618|NCT01024231|528956879|FG005|Overall Study|Disease Progression|11|||
146666619|NCT01024231|528956880|FG006|Overall Study|Disease Progression|6|||
146666620|NCT01024231|528956874|FG000|Overall Study|AE unrelated to Study Drug|0|||
146666621|NCT01024231|528956875|FG001|Overall Study|AE unrelated to Study Drug|1|||
146666622|NCT01024231|528956876|FG002|Overall Study|AE unrelated to Study Drug|0|||
146666623|NCT01024231|528956877|FG003|Overall Study|AE unrelated to Study Drug|0|||
146666624|NCT01024231|528956878|FG004|Overall Study|AE unrelated to Study Drug|0|||
146666625|NCT01024231|528956879|FG005|Overall Study|AE unrelated to Study Drug|0|||
146666626|NCT01024231|528956880|FG006|Overall Study|AE unrelated to Study Drug|0|||
146666627|NCT01024231|528956874|FG000|Overall Study|No longer meets criteria|0|||
146666628|NCT01024231|528956875|FG001|Overall Study|No longer meets criteria|0|||
146666629|NCT01024231|528956876|FG002|Overall Study|No longer meets criteria|0|||
146666630|NCT01024231|528956877|FG003|Overall Study|No longer meets criteria|0|||
146666631|NCT01024231|528956878|FG004|Overall Study|No longer meets criteria|1|||
146666632|NCT01024231|528956879|FG005|Overall Study|No longer meets criteria|0|||
146666633|NCT01024231|528956880|FG006|Overall Study|No longer meets criteria|1|||
146666634|NCT01024231|528956874|FG000|Overall Study|Study Drug Toxicity|1|||
146666635|NCT01024231|528956875|FG001|Overall Study|Study Drug Toxicity|6|||
146666636|NCT01024231|528956876|FG002|Overall Study|Study Drug Toxicity|6|||
146666637|NCT01024231|528956877|FG003|Overall Study|Study Drug Toxicity|4|||
146666638|NCT01024231|528956878|FG004|Overall Study|Study Drug Toxicity|2|||
146666639|NCT01024231|528956879|FG005|Overall Study|Study Drug Toxicity|0|||
146666640|NCT01024231|528956880|FG006|Overall Study|Study Drug Toxicity|7|||
146666641|NCT01024231|528956874|FG000|Overall Study|Death|6|||
146666642|NCT01024231|528956875|FG001|Overall Study|Death|2|||
146666643|NCT01024231|528956876|FG002|Overall Study|Death|1|||
146773855|NCT04425629|529343471|FG018|Overall Study|Sponsor Request|0|||
146773856|NCT04425629|529343453|FG000|Overall Study|Physician Decision|0|||
146666644|NCT01024231|528956877|FG003|Overall Study|Death|0|||
146666645|NCT01024231|528956878|FG004|Overall Study|Death|4|||
146666646|NCT01024231|528956879|FG005|Overall Study|Death|3|||
146666647|NCT01024231|528956880|FG006|Overall Study|Death|5|||
146666648|NCT01024231|528956874|FG000|Overall Study|Lost to Follow-up|0|||
146666649|NCT01024231|528956875|FG001|Overall Study|Lost to Follow-up|0|||
146666650|NCT01024231|528956876|FG002|Overall Study|Lost to Follow-up|0|||
146666651|NCT01024231|528956877|FG003|Overall Study|Lost to Follow-up|0|||
146666652|NCT01024231|528956878|FG004|Overall Study|Lost to Follow-up|0|||
146666653|NCT01024231|528956879|FG005|Overall Study|Lost to Follow-up|0|||
146666654|NCT01024231|528956880|FG006|Overall Study|Lost to Follow-up|1|||
146666655|NCT01024231|528956874|FG000|Overall Study|Withdrew Consent|0|||
146666656|NCT01024231|528956875|FG001|Overall Study|Withdrew Consent|1|||
146666657|NCT01024231|528956876|FG002|Overall Study|Withdrew Consent|0|||
146666658|NCT01024231|528956877|FG003|Overall Study|Withdrew Consent|0|||
146666659|NCT01024231|528956878|FG004|Overall Study|Withdrew Consent|0|||
146666660|NCT01024231|528956879|FG005|Overall Study|Withdrew Consent|0|||
146666661|NCT01024231|528956880|FG006|Overall Study|Withdrew Consent|0|||
146666662|NCT01024231|528956874|FG000|Overall Study|Continuing on Treatment|0|||
146666663|NCT01024231|528956875|FG001|Overall Study|Continuing on Treatment|0|||
146666664|NCT01024231|528956876|FG002|Overall Study|Continuing on Treatment|0|||
146666665|NCT01024231|528956877|FG003|Overall Study|Continuing on Treatment|0|||
146666666|NCT01024231|528956878|FG004|Overall Study|Continuing on Treatment|3|||
146666667|NCT01024231|528956879|FG005|Overall Study|Continuing on Treatment|2|||
146666668|NCT01024231|528956880|FG006|Overall Study|Continuing on Treatment|0|||
146666669|NCT01691898|528956881|FG000|Overall Study|Death|34|||
146666670|NCT01691898|528956882|FG001|Overall Study|Death|32|||
146666671|NCT01691898|528956883|FG002|Overall Study|Death|6|||
146666672|NCT01691898|528956884|FG003|Overall Study|Death|3|||
146666673|NCT01691898|528956885|FG004|Overall Study|Death|8|||
146666674|NCT01691898|528956886|FG005|Overall Study|Death|31|||
146666675|NCT01691898|528956881|FG000|Overall Study|Adverse Event|0|||
146666676|NCT01691898|528956882|FG001|Overall Study|Adverse Event|1|||
146666677|NCT01691898|528956883|FG002|Overall Study|Adverse Event|0|||
146666678|NCT01691898|528956884|FG003|Overall Study|Adverse Event|1|||
146666679|NCT01691898|528956885|FG004|Overall Study|Adverse Event|1|||
146666680|NCT01691898|528956886|FG005|Overall Study|Adverse Event|0|||
146666681|NCT01691898|528956881|FG000|Overall Study|Progression of Disease|1|||
146666682|NCT01691898|528956882|FG001|Overall Study|Progression of Disease|2|||
146666683|NCT01691898|528956883|FG002|Overall Study|Progression of Disease|1|||
146666684|NCT01691898|528956884|FG003|Overall Study|Progression of Disease|0|||
146666685|NCT01691898|528956885|FG004|Overall Study|Progression of Disease|0|||
146666686|NCT01691898|528956886|FG005|Overall Study|Progression of Disease|1|||
146666687|NCT01691898|528956881|FG000|Overall Study|Lost to Follow-up|3|||
146666688|NCT01691898|528956882|FG001|Overall Study|Lost to Follow-up|1|||
146666689|NCT01691898|528956883|FG002|Overall Study|Lost to Follow-up|0|||
146666690|NCT01691898|528956884|FG003|Overall Study|Lost to Follow-up|0|||
146666691|NCT01691898|528956885|FG004|Overall Study|Lost to Follow-up|1|||
146666692|NCT01691898|528956886|FG005|Overall Study|Lost to Follow-up|0|||
146666693|NCT01691898|528956881|FG000|Overall Study|Withdrawal by Subject|9|||
146666694|NCT01691898|528956882|FG001|Overall Study|Withdrawal by Subject|8|||
146666695|NCT01691898|528956883|FG002|Overall Study|Withdrawal by Subject|2|||
146666696|NCT01691898|528956884|FG003|Overall Study|Withdrawal by Subject|1|||
146666697|NCT01691898|528956885|FG004|Overall Study|Withdrawal by Subject|3|||
146666698|NCT01691898|528956886|FG005|Overall Study|Withdrawal by Subject|3|||
146666699|NCT01691898|528956881|FG000|Overall Study|Non-Compliance|0|||
146666700|NCT01691898|528956882|FG001|Overall Study|Non-Compliance|0|||
146666701|NCT01691898|528956883|FG002|Overall Study|Non-Compliance|0|||
146666702|NCT01691898|528956884|FG003|Overall Study|Non-Compliance|0|||
146666703|NCT01691898|528956885|FG004|Overall Study|Non-Compliance|1|||
146666704|NCT01691898|528956886|FG005|Overall Study|Non-Compliance|0|||
146666705|NCT01013350|528956887|FG000|Overall Study|Lost to Follow-up|15|||
146666706|NCT01013350|528956888|FG001|Overall Study|Lost to Follow-up|95|||
146666707|NCT01013350|528956887|FG000|Overall Study|Adverse Event|0|||
146666708|NCT01013350|528956888|FG001|Overall Study|Adverse Event|1|||
146666709|NCT01013350|528956887|FG000|Overall Study|Physician Decision|4|||
146666710|NCT01013350|528956888|FG001|Overall Study|Physician Decision|20|||
146666711|NCT01013350|528956887|FG000|Overall Study|Withdrawal by Subject|15|||
146666712|NCT01013350|528956888|FG001|Overall Study|Withdrawal by Subject|38|||
146666713|NCT01013350|528956887|FG000|Overall Study|Death|3|||
146666714|NCT01013350|528956888|FG001|Overall Study|Death|5|||
146666715|NCT01013350|528956887|FG000|Overall Study|Participant entered interventional study|0|||
146773857|NCT04425629|529343454|FG001|Overall Study|Physician Decision|0|||
146925521|NCT00077610|529888288|FG002|Overall Study|Insufficient Therapeutic Response|0|||
146925522|NCT00077610|529888286|FG000|Overall Study|Multiple blood transfusions|0|||
146925523|NCT00077610|529888287|FG001|Overall Study|Multiple blood transfusions|0|||
146925524|NCT00077610|529888288|FG002|Overall Study|Multiple blood transfusions|1|||
146666716|NCT01013350|528956888|FG001|Overall Study|Participant entered interventional study|8|||
146666717|NCT01013350|528956887|FG000|Overall Study|Other|1|||
146666718|NCT01013350|528956888|FG001|Overall Study|Other|25|||
146666719|NCT04738734|528956889|FG000|Overall Study|Withdrawal by Subject|2|||
146666720|NCT04738734|528956890|FG001|Overall Study|Withdrawal by Subject|4|||
146666721|NCT04738734|528956889|FG000|Overall Study|Lost to Follow-up|5|||
146666722|NCT04738734|528956890|FG001|Overall Study|Lost to Follow-up|2|||
146666723|NCT04738734|528956889|FG000|Overall Study|Physician Decision|0|||
146666724|NCT04738734|528956890|FG001|Overall Study|Physician Decision|1|||
146666725|NCT04738734|528956889|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
146666726|NCT04738734|528956890|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
146666727|NCT02639546|528956891|FG000|Overall Study|Death|2|||
146666728|NCT02639546|528956892|FG001|Overall Study|Death|2|||
146666729|NCT02639546|528956893|FG002|Overall Study|Death|1|||
146666730|NCT02639546|528956894|FG003|Overall Study|Death|2|||
146666731|NCT02639546|528956895|FG004|Overall Study|Death|2|||
146666732|NCT02639546|528956896|FG005|Overall Study|Death|2|||
146666733|NCT02639546|528956897|FG006|Overall Study|Death|0|||
146666734|NCT02639546|528956898|FG007|Overall Study|Death|0|||
146666735|NCT02639546|528956891|FG000|Overall Study|Lost to Follow-up|0|||
146666736|NCT02639546|528956892|FG001|Overall Study|Lost to Follow-up|0|||
146666737|NCT02639546|528956893|FG002|Overall Study|Lost to Follow-up|1|||
146666738|NCT02639546|528956894|FG003|Overall Study|Lost to Follow-up|0|||
146666739|NCT02639546|528956895|FG004|Overall Study|Lost to Follow-up|1|||
146666740|NCT02639546|528956896|FG005|Overall Study|Lost to Follow-up|1|||
146666741|NCT02639546|528956897|FG006|Overall Study|Lost to Follow-up|0|||
146666742|NCT02639546|528956898|FG007|Overall Study|Lost to Follow-up|1|||
146666743|NCT02639546|528956891|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
146666744|NCT02639546|528956892|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
146666745|NCT02639546|528956893|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
146666746|NCT02639546|528956894|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
146666747|NCT02639546|528956895|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
146666748|NCT02639546|528956896|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
146666749|NCT02639546|528956897|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
146666750|NCT02639546|528956898|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
146666751|NCT02639546|528956891|FG000|Overall Study|Study Terminated By Sponsor|0|||
146666752|NCT02639546|528956892|FG001|Overall Study|Study Terminated By Sponsor|2|||
146666753|NCT02639546|528956893|FG002|Overall Study|Study Terminated By Sponsor|3|||
146666754|NCT02639546|528956894|FG003|Overall Study|Study Terminated By Sponsor|4|||
146666755|NCT02639546|528956895|FG004|Overall Study|Study Terminated By Sponsor|4|||
146666756|NCT02639546|528956896|FG005|Overall Study|Study Terminated By Sponsor|3|||
146666757|NCT02639546|528956897|FG006|Overall Study|Study Terminated By Sponsor|3|||
146666758|NCT02639546|528956898|FG007|Overall Study|Study Terminated By Sponsor|9|||
146666759|NCT02639546|528956891|FG000|Overall Study|Withdrawal by Subject|2|||
146666760|NCT02639546|528956892|FG001|Overall Study|Withdrawal by Subject|2|||
146666761|NCT02639546|528956893|FG002|Overall Study|Withdrawal by Subject|1|||
146666762|NCT02639546|528956894|FG003|Overall Study|Withdrawal by Subject|0|||
146666763|NCT02639546|528956895|FG004|Overall Study|Withdrawal by Subject|0|||
146666764|NCT02639546|528956896|FG005|Overall Study|Withdrawal by Subject|1|||
146666765|NCT02639546|528956897|FG006|Overall Study|Withdrawal by Subject|2|||
146666766|NCT02639546|528956898|FG007|Overall Study|Withdrawal by Subject|1|||
146666767|NCT02478372|528956899|FG000|Overall Study|Protocol Violation|12|||
146666768|NCT02478372|528956900|FG001|Overall Study|Protocol Violation|8|||
146666769|NCT02478372|528956899|FG000|Overall Study|Lost to Follow-up|1|||
146666770|NCT02478372|528956900|FG001|Overall Study|Lost to Follow-up|4|||
146666771|NCT02478372|528956899|FG000|Overall Study|Death|0|||
146666772|NCT02478372|528956900|FG001|Overall Study|Death|2|||
146666773|NCT03212690|528956903|FG000|Overall Study|Protocol Violation|1|||
146666774|NCT01297920|528956904|FG000|Overall Study|Adverse Event|42|||
146666775|NCT01297920|528956905|FG001|Overall Study|Adverse Event|10|||
146666776|NCT01297920|528956906|FG002|Overall Study|Adverse Event|38|||
146666777|NCT01297920|528956904|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
146666778|NCT01297920|528956905|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
146666779|NCT01297920|528956906|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
146666780|NCT01297920|528956904|FG000|Overall Study|Noncompliance|1|||
146666781|NCT01297920|528956905|FG001|Overall Study|Noncompliance|0|||
146666782|NCT01297920|528956906|FG002|Overall Study|Noncompliance|0|||
146666783|NCT01297920|528956904|FG000|Overall Study|Protocol Violation|1|||
146666784|NCT01297920|528956905|FG001|Overall Study|Protocol Violation|3|||
146666785|NCT01297920|528956906|FG002|Overall Study|Protocol Violation|0|||
146666786|NCT01297920|528956904|FG000|Overall Study|Inadequate Control of IOP|7|||
146666787|NCT01297920|528956905|FG001|Overall Study|Inadequate Control of IOP|9|||
146666788|NCT01297920|528956906|FG002|Overall Study|Inadequate Control of IOP|17|||
146666789|NCT01297920|528956904|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
146666790|NCT01297920|528956905|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
146666791|NCT01297920|528956906|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
146666792|NCT00474760|528956908|FG000|Overall Study|Death|0|||
146666793|NCT00474760|528956909|FG001|Overall Study|Death|0|||
146666794|NCT00474760|528956910|FG002|Overall Study|Death|0|||
146666795|NCT00474760|528956911|FG003|Overall Study|Death|0|||
146666796|NCT00474760|528956912|FG004|Overall Study|Death|2|||
146666797|NCT00474760|528956913|FG005|Overall Study|Death|0|||
146666798|NCT00474760|528956914|FG006|Overall Study|Death|0|||
146666799|NCT00474760|528956908|FG000|Overall Study|Adverse Event|0|||
146666800|NCT00474760|528956909|FG001|Overall Study|Adverse Event|0|||
146666801|NCT00474760|528956910|FG002|Overall Study|Adverse Event|0|||
146666802|NCT00474760|528956911|FG003|Overall Study|Adverse Event|0|||
146666803|NCT00474760|528956912|FG004|Overall Study|Adverse Event|1|||
146666804|NCT00474760|528956913|FG005|Overall Study|Adverse Event|7|||
146666805|NCT00474760|528956914|FG006|Overall Study|Adverse Event|0|||
146666806|NCT00474760|528956908|FG000|Overall Study|Laboratory abnormality|0|||
146666807|NCT00474760|528956909|FG001|Overall Study|Laboratory abnormality|0|||
146666808|NCT00474760|528956910|FG002|Overall Study|Laboratory abnormality|0|||
146666809|NCT00474760|528956911|FG003|Overall Study|Laboratory abnormality|0|||
146666810|NCT00474760|528956912|FG004|Overall Study|Laboratory abnormality|0|||
146666811|NCT00474760|528956913|FG005|Overall Study|Laboratory abnormality|1|||
146666812|NCT00474760|528956914|FG006|Overall Study|Laboratory abnormality|0|||
146666813|NCT00474760|528956908|FG000|Overall Study|Withdrawal by Subject|0|||
146666814|NCT00474760|528956909|FG001|Overall Study|Withdrawal by Subject|0|||
146666815|NCT00474760|528956910|FG002|Overall Study|Withdrawal by Subject|0|||
146666816|NCT00474760|528956911|FG003|Overall Study|Withdrawal by Subject|1|||
146666817|NCT00474760|528956912|FG004|Overall Study|Withdrawal by Subject|0|||
146666818|NCT00474760|528956913|FG005|Overall Study|Withdrawal by Subject|1|||
146666819|NCT00474760|528956914|FG006|Overall Study|Withdrawal by Subject|1|||
146666820|NCT00474760|528956908|FG000|Overall Study|Other|0|||
146666821|NCT00474760|528956909|FG001|Overall Study|Other|1|||
146666822|NCT00474760|528956910|FG002|Overall Study|Other|0|||
146666823|NCT00474760|528956911|FG003|Overall Study|Other|0|||
146666824|NCT00474760|528956912|FG004|Overall Study|Other|1|||
146666825|NCT00474760|528956913|FG005|Overall Study|Other|0|||
146666826|NCT00474760|528956914|FG006|Overall Study|Other|0|||
146666827|NCT00474760|528956908|FG000|Overall Study|Progressive disease|3|||
146666828|NCT00474760|528956909|FG001|Overall Study|Progressive disease|2|||
146666829|NCT00474760|528956910|FG002|Overall Study|Progressive disease|3|||
146666830|NCT00474760|528956911|FG003|Overall Study|Progressive disease|2|||
146666831|NCT00474760|528956912|FG004|Overall Study|Progressive disease|8|||
146666832|NCT00474760|528956913|FG005|Overall Study|Progressive disease|20|||
146666833|NCT00474760|528956914|FG006|Overall Study|Progressive disease|7|||
146666834|NCT00474760|528956908|FG000|Overall Study|Terminated by sponsor|0|||
146666835|NCT00474760|528956909|FG001|Overall Study|Terminated by sponsor|0|||
146666836|NCT00474760|528956910|FG002|Overall Study|Terminated by sponsor|0|||
146666837|NCT00474760|528956911|FG003|Overall Study|Terminated by sponsor|0|||
146666838|NCT00474760|528956912|FG004|Overall Study|Terminated by sponsor|0|||
146666839|NCT00474760|528956913|FG005|Overall Study|Terminated by sponsor|0|||
146666840|NCT00474760|528956914|FG006|Overall Study|Terminated by sponsor|2|||
146666841|NCT01927627|528956915|FG000|Overall Study|Adverse Event|3|||
146666842|NCT01927627|528956915|FG000|Overall Study|Lack of Efficacy|1|||
146666843|NCT01927627|528956915|FG000|Overall Study|Financial Concerns|1|||
146666844|NCT00910273|528956916|FG000|Overall Study|Lack of Efficacy|6|||
146666845|NCT00910273|528956917|FG001|Overall Study|Lack of Efficacy|9|||
146666846|NCT00910273|528956916|FG000|Overall Study|Adverse Event|1|||
146666847|NCT00910273|528956917|FG001|Overall Study|Adverse Event|1|||
146666848|NCT00910273|528956916|FG000|Overall Study|Withdrawal by Subject|1|||
146666849|NCT00910273|528956917|FG001|Overall Study|Withdrawal by Subject|0|||
146666850|NCT00910273|528956916|FG000|Overall Study|Discontinuation of study by sponsor|8|||
146666851|NCT00910273|528956917|FG001|Overall Study|Discontinuation of study by sponsor|2|||
146666852|NCT00910273|528956916|FG000|Overall Study|Protocol Violation|1|||
146666853|NCT00910273|528956917|FG001|Overall Study|Protocol Violation|0|||
146666854|NCT00910273|528956916|FG000|Overall Study|Lost to Follow-up|1|||
146666855|NCT00910273|528956917|FG001|Overall Study|Lost to Follow-up|1|||
146666856|NCT04122534|528956918|FG000|Overall Study|Lost to Follow-up|4|||
146666857|NCT02128932|528956922|FG000|Overall Study|Withdrawal by Subject|11|||
146666858|NCT02128932|528956923|FG001|Overall Study|Withdrawal by Subject|7|||
146666859|NCT02128932|528956924|FG002|Overall Study|Withdrawal by Subject|8|||
146666860|NCT02128932|528956922|FG000|Overall Study|Death|2|||
146666861|NCT02128932|528956923|FG001|Overall Study|Death|0|||
146666862|NCT02128932|528956924|FG002|Overall Study|Death|2|||
146666863|NCT02128932|528956922|FG000|Overall Study|Lost to Follow-up|2|||
146666864|NCT02128932|528956923|FG001|Overall Study|Lost to Follow-up|1|||
146773858|NCT04425629|529343455|FG002|Overall Study|Physician Decision|0|||
146773859|NCT04425629|529343456|FG003|Overall Study|Physician Decision|0|||
146773860|NCT04425629|529343457|FG004|Overall Study|Physician Decision|0|||
146925525|NCT00077610|529888286|FG000|Overall Study|Principal Investigator's decision|1|||
146666865|NCT02128932|528956924|FG002|Overall Study|Lost to Follow-up|1|||
146666866|NCT02128932|528956922|FG000|Overall Study|No reason for withdrawal|12|||
146666867|NCT02128932|528956923|FG001|Overall Study|No reason for withdrawal|11|||
146666868|NCT02128932|528956924|FG002|Overall Study|No reason for withdrawal|7|||
146666869|NCT03113916|528956925|FG000|Overall Study|Withdrawal by Subject|9|||
146666870|NCT03113916|528956926|FG001|Overall Study|Withdrawal by Subject|7|||
146666871|NCT03113916|528956925|FG000|Overall Study|Pregnancy|1|||
146666872|NCT03113916|528956926|FG001|Overall Study|Pregnancy|3|||
146773861|NCT04425629|529343458|FG005|Overall Study|Physician Decision|0|||
146925526|NCT00077610|529888287|FG001|Overall Study|Principal Investigator's decision|0|||
146666873|NCT03113916|528956925|FG000|Overall Study|Lost to Follow-up|1|||
146666874|NCT03113916|528956926|FG001|Overall Study|Lost to Follow-up|2|||
146666875|NCT02663908|528956927|FG000|Overall Study|Withdrawal by Subject|8|||
146666876|NCT02663908|528956928|FG001|Overall Study|Withdrawal by Subject|5|||
146666877|NCT02663908|528956927|FG000|Overall Study|Lost to Follow-up|1|||
146666878|NCT02663908|528956928|FG001|Overall Study|Lost to Follow-up|5|||
146666879|NCT02663908|528956927|FG000|Overall Study|Adverse Event|13|||
146666880|NCT02663908|528956928|FG001|Overall Study|Adverse Event|11|||
146666881|NCT02663908|528956927|FG000|Overall Study|Protocol Violation|1|||
146666882|NCT02663908|528956928|FG001|Overall Study|Protocol Violation|2|||
146666883|NCT02663908|528956927|FG000|Overall Study|Lack of therapeutic response|2|||
146666884|NCT02663908|528956928|FG001|Overall Study|Lack of therapeutic response|0|||
146666885|NCT02663908|528956927|FG000|Overall Study|COVID-19|1|||
146666886|NCT02663908|528956928|FG001|Overall Study|COVID-19|0|||
146666887|NCT02663908|528956927|FG000|Overall Study|Site closed|1|||
146666888|NCT02663908|528956928|FG001|Overall Study|Site closed|0|||
146666889|NCT02663908|528956927|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
146666890|NCT02663908|528956928|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
146666891|NCT02663908|528956927|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
146666892|NCT02663908|528956928|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
146666893|NCT02663908|528956927|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
146666894|NCT02663908|528956928|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
146666895|NCT02663908|528956927|FG000|Overall Study|Death|1|||
146666896|NCT02663908|528956928|FG001|Overall Study|Death|0|||
146666897|NCT02663908|528956927|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
146666898|NCT02663908|528956928|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
146666899|NCT02663908|528956927|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
146666900|NCT02663908|528956928|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
146666901|NCT00761631|528956929|FG000|Overall Study|Parent/legal guardian request|8|||
146666902|NCT00761631|528956930|FG001|Overall Study|Parent/legal guardian request|3|||
146666903|NCT00761631|528956931|FG002|Overall Study|Parent/legal guardian request|8|||
146666904|NCT00761631|528956932|FG003|Overall Study|Parent/legal guardian request|0|||
146666905|NCT00761631|528956933|FG004|Overall Study|Parent/legal guardian request|5|||
146666906|NCT00761631|528956934|FG005|Overall Study|Parent/legal guardian request|0|||
146666907|NCT00761631|528956929|FG000|Overall Study|Lost to Follow-up|2|||
146666908|NCT00761631|528956930|FG001|Overall Study|Lost to Follow-up|4|||
146666909|NCT00761631|528956931|FG002|Overall Study|Lost to Follow-up|7|||
146666910|NCT00761631|528956932|FG003|Overall Study|Lost to Follow-up|1|||
146666911|NCT00761631|528956933|FG004|Overall Study|Lost to Follow-up|6|||
146666912|NCT00761631|528956934|FG005|Overall Study|Lost to Follow-up|1|||
146666913|NCT00761631|528956929|FG000|Overall Study|Protocol Violation|2|||
146666914|NCT00761631|528956930|FG001|Overall Study|Protocol Violation|0|||
146666915|NCT00761631|528956931|FG002|Overall Study|Protocol Violation|0|||
146666916|NCT00761631|528956932|FG003|Overall Study|Protocol Violation|1|||
146666917|NCT00761631|528956933|FG004|Overall Study|Protocol Violation|5|||
146666918|NCT00761631|528956934|FG005|Overall Study|Protocol Violation|1|||
146666919|NCT00761631|528956929|FG000|Overall Study|Randomized, not treated|1|||
146666920|NCT00761631|528956930|FG001|Overall Study|Randomized, not treated|0|||
146666921|NCT00761631|528956931|FG002|Overall Study|Randomized, not treated|0|||
146666922|NCT00761631|528956932|FG003|Overall Study|Randomized, not treated|0|||
146666923|NCT00761631|528956933|FG004|Overall Study|Randomized, not treated|0|||
146666924|NCT00761631|528956934|FG005|Overall Study|Randomized, not treated|0|||
146666925|NCT00761631|528956929|FG000|Overall Study|Failed to return|1|||
146666926|NCT00761631|528956930|FG001|Overall Study|Failed to return|0|||
146666927|NCT00761631|528956931|FG002|Overall Study|Failed to return|1|||
146666928|NCT00761631|528956932|FG003|Overall Study|Failed to return|1|||
146666929|NCT00761631|528956933|FG004|Overall Study|Failed to return|5|||
146666930|NCT00761631|528956934|FG005|Overall Study|Failed to return|2|||
146666931|NCT00761631|528956929|FG000|Overall Study|Physician Decision|1|||
146666932|NCT00761631|528956930|FG001|Overall Study|Physician Decision|0|||
146666933|NCT00761631|528956931|FG002|Overall Study|Physician Decision|0|||
146666934|NCT00761631|528956932|FG003|Overall Study|Physician Decision|0|||
146666935|NCT00761631|528956933|FG004|Overall Study|Physician Decision|0|||
146666936|NCT00761631|528956934|FG005|Overall Study|Physician Decision|0|||
146666937|NCT00761631|528956929|FG000|Overall Study|Other|0|||
146666938|NCT00761631|528956930|FG001|Overall Study|Other|0|||
146666939|NCT00761631|528956931|FG002|Overall Study|Other|0|||
146666940|NCT00761631|528956932|FG003|Overall Study|Other|0|||
146666941|NCT00761631|528956933|FG004|Overall Study|Other|1|||
146666942|NCT00761631|528956934|FG005|Overall Study|Other|1|||
146666943|NCT01999868|528956935|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
146666944|NCT01999868|528956936|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
146666945|NCT01999868|528956937|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
146666946|NCT01999868|528956935|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
146666947|NCT01999868|528956936|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
146666948|NCT01999868|528956937|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
146666949|NCT01999868|528956935|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
146666950|NCT01999868|528956936|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
146666951|NCT01999868|528956937|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
146666952|NCT01999868|528956935|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
146666953|NCT01999868|528956936|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
146666954|NCT01999868|528956937|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
146666955|NCT01999868|528956935|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
146666956|NCT01999868|528956936|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
146666957|NCT01999868|528956937|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
146666958|NCT01999868|528956935|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
146666959|NCT01999868|528956936|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
146666960|NCT01999868|528956937|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
146666961|NCT01999868|528956935|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
146666962|NCT01999868|528956936|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
146666963|NCT01999868|528956937|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
146666964|NCT01999868|528956935|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
146666965|NCT01999868|528956936|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
146666966|NCT01999868|528956937|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
146666967|NCT01999868|528956935|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
146666968|NCT01999868|528956936|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
146666969|NCT01999868|528956937|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
146666970|NCT01999868|528956935|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
146666971|NCT01999868|528956936|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
146666972|NCT01999868|528956937|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
146666973|NCT01999868|528956935|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
146666974|NCT01999868|528956936|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
146666975|NCT01999868|528956937|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
146666976|NCT01999868|528956935|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
146666977|NCT01999868|528956936|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
146666978|NCT01999868|528956937|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
146666979|NCT01999868|528956935|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
146666980|NCT01999868|528956936|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
146666981|NCT01999868|528956937|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
146666982|NCT01999868|528956935|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
146666983|NCT01999868|528956936|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
146666984|NCT01999868|528956937|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
146666985|NCT01999868|528956935|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
146666986|NCT01999868|528956936|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
146666987|NCT01999868|528956937|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
146666988|NCT00289016|528956942|FG000|Overall Study|Disease Progression|29|||
146666989|NCT00289016|528956942|FG000|Overall Study|Death|2|||
146666990|NCT00289016|528956942|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
146666991|NCT00289016|528956942|FG000|Overall Study|Withdrawal by Subject|2|||
146666992|NCT00289016|528956942|FG000|Overall Study|Adverse Event|1|||
146666993|NCT00289016|528956942|FG000|Overall Study|Other|1|||
146666994|NCT00319501|528956943|FG000|Double-blind Period|Withdrawal by Subject|0|||
146666995|NCT00319501|528956944|FG001|Double-blind Period|Withdrawal by Subject|3|||
146925527|NCT00077610|529888288|FG002|Overall Study|Principal Investigator's decision|1|||
146666996|NCT00319501|528956943|FG000|Double-blind Period|Sponsor Request|1|||
146666997|NCT00319501|528956944|FG001|Double-blind Period|Sponsor Request|0|||
146666998|NCT00319501|528956943|FG000|Double-blind Period|Did not receive treatment|42|||
146666999|NCT00319501|528956944|FG001|Double-blind Period|Did not receive treatment|29|||
146667000|NCT00319501|528956943|FG000|Open-label Period|Adverse Event|5|||
146667001|NCT00319501|528956944|FG001|Open-label Period|Adverse Event|0|||
146667002|NCT00319501|528956943|FG000|Open-label Period|Protocol Violation|6|||
146667003|NCT00319501|528956944|FG001|Open-label Period|Protocol Violation|0|||
146667004|NCT00319501|528956943|FG000|Open-label Period|Withdrawal by Subject|38|||
146667005|NCT00319501|528956944|FG001|Open-label Period|Withdrawal by Subject|0|||
146667006|NCT00319501|528956943|FG000|Open-label Period|Principal Investigator decision|6|||
146667007|NCT00319501|528956944|FG001|Open-label Period|Principal Investigator decision|0|||
146667008|NCT00319501|528956943|FG000|Open-label Period|Sponsor request|12|||
146667009|NCT00319501|528956944|FG001|Open-label Period|Sponsor request|0|||
146667010|NCT00319501|528956943|FG000|Open-label Period|Lost to Follow-up|5|||
146667011|NCT00319501|528956944|FG001|Open-label Period|Lost to Follow-up|0|||
146667012|NCT00319501|528956943|FG000|Open-label Period|Did not receive treatment|33|||
146667013|NCT00319501|528956944|FG001|Open-label Period|Did not receive treatment|0|||
146925528|NCT00077610|529888286|FG000|Overall Study|Worsening of health condition|1|||
146925529|NCT00077610|529888287|FG001|Overall Study|Worsening of health condition|1|||
146925530|NCT00077610|529888288|FG002|Overall Study|Worsening of health condition|0|||
146667014|NCT00319501|528956943|FG000|Open-label Period|Other|11|||
146667015|NCT00319501|528956944|FG001|Open-label Period|Other|0|||
146925531|NCT00077610|529888286|FG000|Overall Study|Given Epogen in hospital|1|||
146667016|NCT00319501|528956943|FG000|Open-label Extension Period|Adverse Event|2|||
146667017|NCT00319501|528956944|FG001|Open-label Extension Period|Adverse Event|0|||
146667018|NCT00319501|528956943|FG000|Open-label Extension Period|Did not receive treatment|18|||
146667019|NCT00319501|528956944|FG001|Open-label Extension Period|Did not receive treatment|0|||
146667020|NCT00319501|528956943|FG000|Open-label Extension Period|Other|1|||
146667021|NCT00319501|528956944|FG001|Open-label Extension Period|Other|0|||
146667022|NCT00319501|528956943|FG000|Open-label Extension Period|Principal investigator decision|2|||
146667023|NCT00319501|528956944|FG001|Open-label Extension Period|Principal investigator decision|0|||
146667024|NCT00319501|528956943|FG000|Open-label Extension Period|Sponsor request|26|||
146667025|NCT00319501|528956944|FG001|Open-label Extension Period|Sponsor request|0|||
146667026|NCT00319501|528956943|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
146667027|NCT00319501|528956944|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
146667028|NCT00667875|528956946|FG000|Overall Study|Adverse Event|0|||
146667029|NCT00667875|528956947|FG001|Overall Study|Adverse Event|2|||
146667030|NCT00667875|528956948|FG002|Overall Study|Adverse Event|6|||
146667031|NCT00667875|528956946|FG000|Overall Study|Withdrawal by Subject|10|||
146667032|NCT00667875|528956947|FG001|Overall Study|Withdrawal by Subject|9|||
146667033|NCT00667875|528956948|FG002|Overall Study|Withdrawal by Subject|7|||
146667034|NCT00450255|528956949|FG000|Overall Study|Prior RFA ablation of liver|1|||
146667035|NCT00142298|528956950|FG000|Overall Study|Adverse Event|10|||
146667036|NCT00142298|528956951|FG001|Overall Study|Adverse Event|10|||
146667037|NCT00142298|528956952|FG002|Overall Study|Adverse Event|1|||
146667038|NCT00142298|528956953|FG003|Overall Study|Adverse Event|5|||
146667039|NCT00142298|528956954|FG004|Overall Study|Adverse Event|2|||
146667040|NCT00142298|528956955|FG005|Overall Study|Adverse Event|2|||
146667041|NCT00142298|528956956|FG006|Overall Study|Adverse Event|0|||
146667042|NCT00142298|528956957|FG007|Overall Study|Adverse Event|0|||
146667043|NCT00142298|528956958|FG008|Overall Study|Adverse Event|0|||
146667044|NCT00142298|528956959|FG009|Overall Study|Adverse Event|0|||
146667045|NCT00142298|528956950|FG000|Overall Study|Clinical disease progression|1|||
146667046|NCT00142298|528956951|FG001|Overall Study|Clinical disease progression|0|||
146667047|NCT00142298|528956952|FG002|Overall Study|Clinical disease progression|0|||
146667048|NCT00142298|528956953|FG003|Overall Study|Clinical disease progression|0|||
146667049|NCT00142298|528956954|FG004|Overall Study|Clinical disease progression|0|||
146667050|NCT00142298|528956955|FG005|Overall Study|Clinical disease progression|0|||
146667051|NCT00142298|528956956|FG006|Overall Study|Clinical disease progression|0|||
146667052|NCT00142298|528956957|FG007|Overall Study|Clinical disease progression|0|||
146667053|NCT00142298|528956958|FG008|Overall Study|Clinical disease progression|0|||
146667054|NCT00142298|528956959|FG009|Overall Study|Clinical disease progression|0|||
146667055|NCT00142298|528956950|FG000|Overall Study|Death|1|||
146667056|NCT00142298|528956951|FG001|Overall Study|Death|1|||
146667057|NCT00142298|528956952|FG002|Overall Study|Death|1|||
146667058|NCT00142298|528956953|FG003|Overall Study|Death|0|||
146667059|NCT00142298|528956954|FG004|Overall Study|Death|0|||
146667060|NCT00142298|528956955|FG005|Overall Study|Death|6|||
146667061|NCT00142298|528956956|FG006|Overall Study|Death|0|||
146667062|NCT00142298|528956957|FG007|Overall Study|Death|0|||
146667063|NCT00142298|528956958|FG008|Overall Study|Death|0|||
146667064|NCT00142298|528956959|FG009|Overall Study|Death|0|||
146667065|NCT00142298|528956950|FG000|Overall Study|Lack of Efficacy|44|||
146667066|NCT00142298|528956951|FG001|Overall Study|Lack of Efficacy|62|||
146667067|NCT00142298|528956952|FG002|Overall Study|Lack of Efficacy|9|||
146667068|NCT00142298|528956953|FG003|Overall Study|Lack of Efficacy|12|||
146667069|NCT00142298|528956954|FG004|Overall Study|Lack of Efficacy|1|||
146667070|NCT00142298|528956955|FG005|Overall Study|Lack of Efficacy|0|||
146667071|NCT00142298|528956956|FG006|Overall Study|Lack of Efficacy|0|||
146667072|NCT00142298|528956957|FG007|Overall Study|Lack of Efficacy|1|||
146667073|NCT00142298|528956958|FG008|Overall Study|Lack of Efficacy|0|||
146667074|NCT00142298|528956959|FG009|Overall Study|Lack of Efficacy|0|||
146667075|NCT00142298|528956950|FG000|Overall Study|Non-compliance|15|||
146667076|NCT00142298|528956951|FG001|Overall Study|Non-compliance|13|||
146667077|NCT00142298|528956952|FG002|Overall Study|Non-compliance|0|||
146667078|NCT00142298|528956953|FG003|Overall Study|Non-compliance|6|||
146667079|NCT00142298|528956954|FG004|Overall Study|Non-compliance|1|||
146667080|NCT00142298|528956955|FG005|Overall Study|Non-compliance|0|||
146667081|NCT00142298|528956956|FG006|Overall Study|Non-compliance|0|||
146667082|NCT00142298|528956957|FG007|Overall Study|Non-compliance|3|||
146667083|NCT00142298|528956958|FG008|Overall Study|Non-compliance|3|||
146667084|NCT00142298|528956959|FG009|Overall Study|Non-compliance|0|||
146667085|NCT00142298|528956950|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
146667086|NCT00142298|528956951|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
146667087|NCT00142298|528956952|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
146667088|NCT00142298|528956953|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
146667089|NCT00142298|528956954|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
146667090|NCT00142298|528956955|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
146667091|NCT00142298|528956956|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
146925532|NCT00077610|529888287|FG001|Overall Study|Given Epogen in hospital|0|||
146925533|NCT00077610|529888288|FG002|Overall Study|Given Epogen in hospital|0|||
146925534|NCT00077610|529888286|FG000|Overall Study|Transferred to other unit|0|||
146925535|NCT00077610|529888287|FG001|Overall Study|Transferred to other unit|0|||
146925536|NCT00077610|529888288|FG002|Overall Study|Transferred to other unit|1|||
146667092|NCT00142298|528956957|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
146667093|NCT00142298|528956958|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
146667094|NCT00142298|528956959|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
146667095|NCT00142298|528956950|FG000|Overall Study|Pregnancy|4|||
146667096|NCT00142298|528956951|FG001|Overall Study|Pregnancy|4|||
146667097|NCT00142298|528956952|FG002|Overall Study|Pregnancy|2|||
146667098|NCT00142298|528956953|FG003|Overall Study|Pregnancy|3|||
146667099|NCT00142298|528956954|FG004|Overall Study|Pregnancy|0|||
146667100|NCT00142298|528956955|FG005|Overall Study|Pregnancy|0|||
146667101|NCT00142298|528956956|FG006|Overall Study|Pregnancy|0|||
146667102|NCT00142298|528956957|FG007|Overall Study|Pregnancy|0|||
146667103|NCT00142298|528956958|FG008|Overall Study|Pregnancy|1|||
146667104|NCT00142298|528956959|FG009|Overall Study|Pregnancy|0|||
146667105|NCT00142298|528956950|FG000|Overall Study|Virologic breakthrough|19|||
146667106|NCT00142298|528956951|FG001|Overall Study|Virologic breakthrough|23|||
146667107|NCT00142298|528956952|FG002|Overall Study|Virologic breakthrough|9|||
146667108|NCT00142298|528956953|FG003|Overall Study|Virologic breakthrough|7|||
146667109|NCT00142298|528956954|FG004|Overall Study|Virologic breakthrough|2|||
146667110|NCT00142298|528956955|FG005|Overall Study|Virologic breakthrough|3|||
146667111|NCT00142298|528956956|FG006|Overall Study|Virologic breakthrough|3|||
146667112|NCT00142298|528956957|FG007|Overall Study|Virologic breakthrough|0|||
146667113|NCT00142298|528956958|FG008|Overall Study|Virologic breakthrough|0|||
146667114|NCT00142298|528956959|FG009|Overall Study|Virologic breakthrough|0|||
146667115|NCT00142298|528956950|FG000|Overall Study|Other- not specified|0|||
146667116|NCT00142298|528956951|FG001|Overall Study|Other- not specified|3|||
146667117|NCT00142298|528956952|FG002|Overall Study|Other- not specified|0|||
146667118|NCT00142298|528956953|FG003|Overall Study|Other- not specified|1|||
146667119|NCT00142298|528956954|FG004|Overall Study|Other- not specified|0|||
146667120|NCT00142298|528956955|FG005|Overall Study|Other- not specified|0|||
146667121|NCT00142298|528956956|FG006|Overall Study|Other- not specified|0|||
146667122|NCT00142298|528956957|FG007|Overall Study|Other- not specified|0|||
146667123|NCT00142298|528956958|FG008|Overall Study|Other- not specified|0|||
146667124|NCT00142298|528956959|FG009|Overall Study|Other- not specified|0|||
146667125|NCT00142298|528956950|FG000|Overall Study|Lost to Follow-up|0|||
146667126|NCT00142298|528956951|FG001|Overall Study|Lost to Follow-up|0|||
146667127|NCT00142298|528956952|FG002|Overall Study|Lost to Follow-up|0|||
146667128|NCT00142298|528956953|FG003|Overall Study|Lost to Follow-up|0|||
146667129|NCT00142298|528956954|FG004|Overall Study|Lost to Follow-up|0|||
146667130|NCT00142298|528956955|FG005|Overall Study|Lost to Follow-up|0|||
146667131|NCT00142298|528956956|FG006|Overall Study|Lost to Follow-up|2|||
146667132|NCT00142298|528956957|FG007|Overall Study|Lost to Follow-up|0|||
146667133|NCT00142298|528956958|FG008|Overall Study|Lost to Follow-up|0|||
146667134|NCT00142298|528956959|FG009|Overall Study|Lost to Follow-up|0|||
146667135|NCT00142298|528956950|FG000|Overall Study|Treatment Failure|0|||
146667136|NCT00142298|528956951|FG001|Overall Study|Treatment Failure|0|||
146667137|NCT00142298|528956952|FG002|Overall Study|Treatment Failure|0|||
146667138|NCT00142298|528956953|FG003|Overall Study|Treatment Failure|0|||
146667139|NCT00142298|528956954|FG004|Overall Study|Treatment Failure|0|||
146667140|NCT00142298|528956955|FG005|Overall Study|Treatment Failure|2|||
146925537|NCT00077610|529888286|FG000|Overall Study|Transferred to nursing home|0|||
146925538|NCT00077610|529888287|FG001|Overall Study|Transferred to nursing home|0|||
146925539|NCT00077610|529888288|FG002|Overall Study|Transferred to nursing home|1|||
146925540|NCT00077610|529888286|FG000|Overall Study|Transfer to satellite unit|1|||
146925541|NCT00077610|529888287|FG001|Overall Study|Transfer to satellite unit|0|||
146925542|NCT00077610|529888288|FG002|Overall Study|Transfer to satellite unit|0|||
146925543|NCT00077610|529888286|FG000|Overall Study|Transfer to other center for surgery|1|||
146925544|NCT00077610|529888287|FG001|Overall Study|Transfer to other center for surgery|0|||
146925545|NCT00077610|529888288|FG002|Overall Study|Transfer to other center for surgery|0|||
146925546|NCT00077610|529888286|FG000|Overall Study|Change in dialysis modality|1|||
146667141|NCT00142298|528956956|FG006|Overall Study|Treatment Failure|2|||
146667142|NCT00142298|528956957|FG007|Overall Study|Treatment Failure|0|||
146667143|NCT00142298|528956958|FG008|Overall Study|Treatment Failure|0|||
146667144|NCT00142298|528956959|FG009|Overall Study|Treatment Failure|0|||
146667145|NCT01759511|528956960|FG000|Overall Study|Adverse Event|4|||
146667146|NCT01759511|528956960|FG000|Overall Study|Death|2|||
146925547|NCT00077610|529888287|FG001|Overall Study|Change in dialysis modality|0|||
146667147|NCT01759511|528956960|FG000|Overall Study|Lack of Efficacy|2|||
146667148|NCT01759511|528956960|FG000|Overall Study|Physician Decision|1|||
146667149|NCT01759511|528956960|FG000|Overall Study|Progressive Disease|5|||
146667150|NCT01759511|528956960|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
146667151|NCT01759511|528956960|FG000|Overall Study|Study Terminated by Sponsor|13|||
146667152|NCT01759511|528956960|FG000|Overall Study|Withdrawal by Subject|3|||
146667153|NCT02569671|528956961|FG000|Overall Study|Lost to Follow-up|2|||
146667154|NCT02569671|528956962|FG001|Overall Study|Lost to Follow-up|1|||
146667155|NCT02569671|528956961|FG000|Overall Study|Withdrawal by Subject|1|||
146667156|NCT02569671|528956962|FG001|Overall Study|Withdrawal by Subject|3|||
146667157|NCT01757535|528956963|FG000|Overall Study|Disease Relapse|151|||
146667158|NCT01757535|528956964|FG001|Overall Study|Disease Relapse|181|||
146667159|NCT01757535|528956963|FG000|Overall Study|Other Reasons|28|||
146667160|NCT01757535|528956964|FG001|Overall Study|Other Reasons|27|||
146667161|NCT01757535|528956963|FG000|Overall Study|Adverse Event|31|||
146667162|NCT01757535|528956964|FG001|Overall Study|Adverse Event|11|||
146667163|NCT01757535|528956963|FG000|Overall Study|Withdrew Consent|19|||
146667164|NCT01757535|528956964|FG001|Overall Study|Withdrew Consent|13|||
146667165|NCT01757535|528956963|FG000|Overall Study|Physician Decision|7|||
146667166|NCT01757535|528956964|FG001|Overall Study|Physician Decision|0|||
146667167|NCT01757535|528956963|FG000|Overall Study|Death|2|||
146667168|NCT01757535|528956964|FG001|Overall Study|Death|2|||
146667169|NCT06238362|528956965|FG000|Overall Study|Insufficient total sleep time|1|||
146667170|NCT06238362|528956966|FG001|Overall Study|Insufficient total sleep time|0|||
146667171|NCT06238362|528956965|FG000|Overall Study|Inadequate signal quality|1|||
146667172|NCT06238362|528956966|FG001|Overall Study|Inadequate signal quality|0|||
146667173|NCT01977794|528958256|FG000|Overall Study|Adverse Event|2|||
146667174|NCT01977794|528958257|FG001|Overall Study|Adverse Event|2|||
146667175|NCT01977794|528958256|FG000|Overall Study|Lost to Follow-up|2|||
146667176|NCT01977794|528958257|FG001|Overall Study|Lost to Follow-up|1|||
146667177|NCT01977794|528958256|FG000|Overall Study|Protocol Violation|1|||
146667178|NCT01977794|528958257|FG001|Overall Study|Protocol Violation|0|||
146667179|NCT01977794|528958256|FG000|Overall Study|Death|1|||
146667180|NCT01977794|528958257|FG001|Overall Study|Death|1|||
146667181|NCT01977794|528958256|FG000|Overall Study|Withdrew consent|2|||
146667182|NCT01977794|528958257|FG001|Overall Study|Withdrew consent|1|||
146667183|NCT01977794|528958256|FG000|Overall Study|Other|0|||
146667184|NCT01977794|528958257|FG001|Overall Study|Other|1|||
146667185|NCT00246753|528958262|FG000|Overall Study|Withdrawal by Subject|2|||
146667186|NCT00246753|528958262|FG000|Overall Study|Physician Decision|2|||
146667187|NCT00246753|528958262|FG000|Overall Study|Adverse Event|2|||
146667188|NCT00246753|528958262|FG000|Overall Study|Unacceptable toxicity|2|||
146667189|NCT03019185|528958265|FG000|Overall Study|Lost to Follow-up|3|||
146667190|NCT03019185|528958266|FG001|Overall Study|Lost to Follow-up|0|||
146667191|NCT03019185|528958267|FG002|Overall Study|Lost to Follow-up|2|||
146667192|NCT03019185|528958265|FG000|Overall Study|Withdrawal by Subject|1|||
146667193|NCT03019185|528958266|FG001|Overall Study|Withdrawal by Subject|1|||
146667194|NCT03019185|528958267|FG002|Overall Study|Withdrawal by Subject|0|||
146667195|NCT03019185|528958265|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
146667196|NCT03019185|528958266|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
146667197|NCT03019185|528958267|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
146667198|NCT03019185|528958265|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
146667199|NCT03019185|528958266|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
146667200|NCT03019185|528958267|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
146667201|NCT00617851|528958268|FG000|Overall Study|Death|0|||
146667202|NCT00617851|528958269|FG001|Overall Study|Death|0|||
146667203|NCT00617851|528958270|FG002|Overall Study|Death|0|||
146667204|NCT00617851|528958271|FG003|Overall Study|Death|1|||
146667205|NCT00617851|528958268|FG000|Overall Study|Withdrawal by Subject|14|||
146667206|NCT00617851|528958269|FG001|Overall Study|Withdrawal by Subject|7|||
146667207|NCT00617851|528958270|FG002|Overall Study|Withdrawal by Subject|12|||
146667208|NCT00617851|528958271|FG003|Overall Study|Withdrawal by Subject|4|||
146667209|NCT00617851|528958268|FG000|Overall Study|Lost to Follow-up|27|||
146667210|NCT00617851|528958269|FG001|Overall Study|Lost to Follow-up|29|||
146667211|NCT00617851|528958270|FG002|Overall Study|Lost to Follow-up|31|||
146667212|NCT00617851|528958271|FG003|Overall Study|Lost to Follow-up|19|||
146667213|NCT00617851|528958268|FG000|Overall Study|Inappropriate Enrollment|5|||
146667214|NCT00617851|528958269|FG001|Overall Study|Inappropriate Enrollment|4|||
146667215|NCT00617851|528958270|FG002|Overall Study|Inappropriate Enrollment|1|||
146667216|NCT00617851|528958271|FG003|Overall Study|Inappropriate Enrollment|1|||
146667217|NCT00617851|528958268|FG000|Overall Study|Unable to classify|1|||
146667218|NCT00617851|528958269|FG001|Overall Study|Unable to classify|0|||
146667219|NCT00617851|528958270|FG002|Overall Study|Unable to classify|1|||
146667220|NCT00617851|528958271|FG003|Overall Study|Unable to classify|0|||
146667221|NCT01601132|528958275|FG000|Overall Study|Patient withdrew consent|1|||
146667222|NCT01601132|528958275|FG000|Overall Study|Protocol deviation|1|||
146667223|NCT02110238|528958276|FG000|12 Week Pivotal Phase|Adverse Event|3|||
146667224|NCT02110238|528958277|FG001|12 Week Pivotal Phase|Adverse Event|0|||
146667225|NCT02110238|528958276|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
146667226|NCT02110238|528958277|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
146667227|NCT02110238|528958276|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
146667228|NCT02110238|528958277|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
146667229|NCT02110238|528958276|FG000|12 Week Pivotal Phase|Physician Decision|0|||
146667230|NCT02110238|528958277|FG001|12 Week Pivotal Phase|Physician Decision|2|||
146667231|NCT02110238|528958276|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
146667232|NCT02110238|528958277|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
146667233|NCT02110238|528958276|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
146667234|NCT02110238|528958277|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
146667235|NCT02110238|528958276|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
146667236|NCT02110238|528958277|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
146667237|NCT02110238|528958276|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
146667238|NCT02110238|528958277|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
146667239|NCT02110238|528958276|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
146667240|NCT02110238|528958277|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
146667241|NCT02110238|528958276|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
146667242|NCT02110238|528958277|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
146667243|NCT02110238|528958276|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
146667244|NCT02110238|528958277|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
146667245|NCT03228433|528958284|FG000|Overall Study|Lost to Follow-up|1|||
146667246|NCT03228433|528958285|FG001|Overall Study|Lost to Follow-up|0|||
146667247|NCT03228433|528958286|FG002|Overall Study|Lost to Follow-up|0|||
146667248|NCT03228433|528958287|FG003|Overall Study|Lost to Follow-up|0|||
146667249|NCT03228433|528958288|FG004|Overall Study|Lost to Follow-up|0|||
146667250|NCT03228433|528958289|FG005|Overall Study|Lost to Follow-up|0|||
146667251|NCT03228433|528958284|FG000|Overall Study|Positive alcohol test|0|||
146667252|NCT03228433|528958285|FG001|Overall Study|Positive alcohol test|0|||
146667253|NCT03228433|528958286|FG002|Overall Study|Positive alcohol test|0|||
146667254|NCT03228433|528958287|FG003|Overall Study|Positive alcohol test|1|||
146667255|NCT03228433|528958288|FG004|Overall Study|Positive alcohol test|0|||
146667256|NCT03228433|528958289|FG005|Overall Study|Positive alcohol test|0|||
146667257|NCT01365052|528958299|FG000|Overall Study|Adverse Event|4|||
146667258|NCT01365052|528958300|FG001|Overall Study|Adverse Event|4|||
146667259|NCT02435147|528958309|FG000|Overall Study|non-evaluable DXA scan|11|||
146667260|NCT02939079|528958310|FG000|Overall Study|Adverse Event|2|||
146667261|NCT02939079|528958311|FG001|Overall Study|Adverse Event|1|||
146667262|NCT02939079|528958310|FG000|Overall Study|Lost to Follow-up|0|||
146667263|NCT02939079|528958311|FG001|Overall Study|Lost to Follow-up|2|||
146667264|NCT02939079|528958310|FG000|Overall Study|Protocol Violation|1|||
146667265|NCT02939079|528958311|FG001|Overall Study|Protocol Violation|0|||
146667266|NCT02939079|528958310|FG000|Overall Study|Withdrawal by Subject|0|||
146667267|NCT02939079|528958311|FG001|Overall Study|Withdrawal by Subject|1|||
146667268|NCT02939079|528958310|FG000|Overall Study|relapse during the study|1|||
146667269|NCT02939079|528958311|FG001|Overall Study|relapse during the study|1|||
146667270|NCT04093414|528958312|FG000|3 Month Follow up|Physician Decision|0|||
146667271|NCT04093414|528958313|FG001|3 Month Follow up|Physician Decision|1|||
146667272|NCT04093414|528958312|FG000|6month Follow up|Physician Decision|1|||
146667273|NCT04093414|528958313|FG001|6month Follow up|Physician Decision|3|||
146667274|NCT04889222|528958314|FG000|Overall Study|Did not meet eligibility criteria|8|||
146667275|NCT04889222|528958314|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
146667276|NCT04889222|528958314|FG000|Overall Study|Did not proceed due to time constraints|5|||
146667277|NCT00116428|528958315|FG000|Overall Study|Withdrawal by Subject|2|||
146667278|NCT00116428|528958316|FG001|Overall Study|Withdrawal by Subject|5|||
146667279|NCT00116428|528958315|FG000|Overall Study|Did not meet inclusion criteria|1|||
146667280|NCT00116428|528958316|FG001|Overall Study|Did not meet inclusion criteria|0|||
146667281|NCT00113087|528958317|FG000|Overall Study|Death or Transplant|14|||
146667282|NCT00113087|528958318|FG001|Overall Study|Death or Transplant|16|||
146667283|NCT00113087|528958317|FG000|Overall Study|Family or MD withdrew subject|10|||
146667284|NCT00113087|528958318|FG001|Overall Study|Family or MD withdrew subject|5|||
146667285|NCT03452228|528958319|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
146667286|NCT03452228|528958320|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
146667287|NCT03452228|528958321|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
146667288|NCT03452228|528958319|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
146667289|NCT03452228|528958320|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
146667290|NCT03452228|528958321|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146667291|NCT03452228|528958319|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
146667292|NCT03452228|528958320|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
146667293|NCT03452228|528958321|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
146667294|NCT03452228|528958319|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146667295|NCT03452228|528958320|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146667296|NCT03452228|528958321|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
146667297|NCT00386607|528958322|FG000|Core|Adverse Event|40|||
146667298|NCT00386607|528958323|FG001|Core|Adverse Event|0|||
146667299|NCT00386607|528958322|FG000|Core|Abnormal laboratory value(s)|3|||
146667300|NCT00386607|528958323|FG001|Core|Abnormal laboratory value(s)|0|||
146667301|NCT00386607|528958322|FG000|Core|Unsatisfactory therapeutic effect|23|||
146667302|NCT00386607|528958323|FG001|Core|Unsatisfactory therapeutic effect|0|||
146667303|NCT00386607|528958322|FG000|Core|Condition no longer requires study drug|4|||
146667304|NCT00386607|528958323|FG001|Core|Condition no longer requires study drug|0|||
146667305|NCT00386607|528958322|FG000|Core|Patient withdrew consent|15|||
146667306|NCT00386607|528958323|FG001|Core|Patient withdrew consent|0|||
146667307|NCT00386607|528958322|FG000|Core|Lost to Follow-up|23|||
146667308|NCT00386607|528958323|FG001|Core|Lost to Follow-up|0|||
146667309|NCT00386607|528958322|FG000|Core|Administrative problems|1|||
146667310|NCT00386607|528958323|FG001|Core|Administrative problems|0|||
146667311|NCT00386607|528958322|FG000|Core|Protocol Deviation|6|||
146667312|NCT00386607|528958323|FG001|Core|Protocol Deviation|0|||
146667313|NCT00386607|528958322|FG000|Extension|Adverse Event|0|||
146667314|NCT00386607|528958323|FG001|Extension|Adverse Event|6|||
146667315|NCT00386607|528958322|FG000|Extension|Abnormal laboratory value(s)|0|||
146667316|NCT00386607|528958323|FG001|Extension|Abnormal laboratory value(s)|1|||
146667317|NCT00386607|528958322|FG000|Extension|Administrative problems|0|||
146667318|NCT00386607|528958323|FG001|Extension|Administrative problems|1|||
146667319|NCT00386607|528958322|FG000|Extension|Lost to Follow-up|0|||
146667320|NCT00386607|528958323|FG001|Extension|Lost to Follow-up|3|||
146667321|NCT00386607|528958322|FG000|Extension|Patient withdrew consent|0|||
146667322|NCT00386607|528958323|FG001|Extension|Patient withdrew consent|5|||
146667323|NCT00386607|528958322|FG000|Extension|Unsatisfactory therapeutic effect|0|||
146667324|NCT00386607|528958323|FG001|Extension|Unsatisfactory therapeutic effect|1|||
146667325|NCT00338104|528958326|FG000|Overall Study|Protocol Violation|2|||
146667326|NCT00338104|528958327|FG001|Overall Study|Protocol Violation|1|||
146667327|NCT00338104|528958328|FG002|Overall Study|Protocol Violation|3|||
146667328|NCT00633750|528958330|FG000|Overall Study|Adverse Event|2|||
146667329|NCT00633750|528958330|FG000|Overall Study|Withdrawal by Subject|3|||
146667330|NCT02362269|528958333|FG000|Overall Study|Moved|1|||
146667331|NCT02362269|528958334|FG001|Overall Study|Moved|0|||
146667332|NCT02362269|528958333|FG000|Overall Study|Lost to Follow-up|0|||
146667333|NCT02362269|528958334|FG001|Overall Study|Lost to Follow-up|6|||
146667334|NCT03000569|528958335|FG000|Overall Study|Withdrawal by Subject|1|||
146667335|NCT03000569|528958336|FG001|Overall Study|Withdrawal by Subject|0|||
146667336|NCT02298023|528958337|FG000|Overall Study|Withdrawal by Subject|1|||
146667337|NCT02298023|528958338|FG001|Overall Study|Withdrawal by Subject|0|||
146667338|NCT02298023|528958339|FG002|Overall Study|Withdrawal by Subject|0|||
146667339|NCT00423514|528958344|FG000|Overall Study|Ineligible|1|||
146667340|NCT00423514|528958345|FG001|Overall Study|Ineligible|0|||
146667341|NCT04729621|528958346|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
146667342|NCT04729621|528958347|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
146667343|NCT04729621|528958348|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
146667344|NCT04729621|528958349|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
146667345|NCT04729621|528958350|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
146667346|NCT04729621|528958346|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
146667347|NCT04729621|528958347|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
146667348|NCT04729621|528958348|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
146667349|NCT04729621|528958349|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
146667350|NCT04729621|528958350|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
146667351|NCT04729621|528958346|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
146667352|NCT04729621|528958347|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
146667353|NCT04729621|528958348|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
146667354|NCT04729621|528958349|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
146667355|NCT04729621|528958350|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
146667356|NCT04729621|528958346|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
146667357|NCT04729621|528958347|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
146667358|NCT04729621|528958348|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
146667359|NCT04729621|528958349|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
146667360|NCT04729621|528958350|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
146667361|NCT04729621|528958346|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
146667362|NCT04729621|528958347|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
146667363|NCT04729621|528958348|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
146667364|NCT04729621|528958349|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
146667365|NCT04729621|528958350|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
146667366|NCT04729621|528958346|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
146667367|NCT04729621|528958347|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
146667368|NCT04729621|528958348|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
146667369|NCT04729621|528958349|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
146667370|NCT04729621|528958350|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
146667371|NCT03308786|528958351|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
146667372|NCT02004522|528958352|FG000|Overall Study|Adverse Event|55|||
146667373|NCT02004522|528958353|FG001|Overall Study|Adverse Event|6|||
146667374|NCT02004522|528958352|FG000|Overall Study|Withdrawal by Subject|13|||
146667375|NCT02004522|528958353|FG001|Overall Study|Withdrawal by Subject|7|||
146667376|NCT02004522|528958352|FG000|Overall Study|Death|12|||
146667377|NCT02004522|528958353|FG001|Overall Study|Death|3|||
146667378|NCT02004522|528958352|FG000|Overall Study|Physician Decision|3|||
146667379|NCT02004522|528958353|FG001|Overall Study|Physician Decision|4|||
146667380|NCT02004522|528958352|FG000|Overall Study|Protocol Violation|1|||
146667381|NCT02004522|528958353|FG001|Overall Study|Protocol Violation|0|||
146667382|NCT02004522|528958352|FG000|Overall Study|Other is reason listed by PI|4|||
146667383|NCT02004522|528958353|FG001|Overall Study|Other is reason listed by PI|1|||
146667384|NCT02004522|528958352|FG000|Overall Study|Never Dosed|2|||
146667385|NCT02004522|528958353|FG001|Overall Study|Never Dosed|4|||
146667386|NCT02004522|528958352|FG000|Overall Study|Disease Progression|35|||
146667387|NCT02004522|528958353|FG001|Overall Study|Disease Progression|31|||
146667388|NCT02004522|528958352|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
146667389|NCT02004522|528958353|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
146667390|NCT01787331|528958354|FG000|Overall Study|Physician Decision|1|||
146667391|NCT01787331|528958354|FG000|Overall Study|Withdrawal by Subject|1|||
146667392|NCT01441180|528958356|FG000|Overall Study|Lost to Follow-up|1|||
146667393|NCT01441180|528958357|FG001|Overall Study|Lost to Follow-up|1|||
146667394|NCT01441180|528958358|FG002|Overall Study|Lost to Follow-up|1|||
146667395|NCT01441180|528958356|FG000|Overall Study|Discontinued|0|||
146667396|NCT01441180|528958357|FG001|Overall Study|Discontinued|0|||
146667397|NCT01441180|528958358|FG002|Overall Study|Discontinued|2|||
146667398|NCT01402011|528958359|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
146667399|NCT01402011|528958360|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
146667400|NCT01402011|528958361|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
146667401|NCT01402011|528958359|FG000|Active Treatment Period|Withdrawal by Subject|1|||
146667402|NCT01402011|528958360|FG001|Active Treatment Period|Withdrawal by Subject|3|||
146667403|NCT01402011|528958361|FG002|Active Treatment Period|Withdrawal by Subject|0|||
146667404|NCT01402011|528958359|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
146667405|NCT01402011|528958360|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
146667406|NCT01402011|528958361|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
146667407|NCT03360747|528958362|FG000|Overall Study|Voluntary Withdrawal|1|||
146667408|NCT00531934|528960075|FG000|Overall Study|Adverse Event|4|||
146667409|NCT00531934|528960076|FG001|Overall Study|Adverse Event|8|||
146667410|NCT00531934|528960075|FG000|Overall Study|Progression|52|||
146667411|NCT00531934|528960076|FG001|Overall Study|Progression|42|||
146667412|NCT00531934|528960075|FG000|Overall Study|Death|7|||
146667413|NCT00531934|528960076|FG001|Overall Study|Death|10|||
146667414|NCT00531934|528960075|FG000|Overall Study|Withdrawal by Subject|1|||
146667415|NCT00531934|528960076|FG001|Overall Study|Withdrawal by Subject|1|||
146667416|NCT00531934|528960075|FG000|Overall Study|Other|2|||
146667417|NCT00531934|528960076|FG001|Overall Study|Other|2|||
146667418|NCT00150709|528960078|FG000|Overall Study|Protocol Violation|7|||
146667419|NCT00150709|528960079|FG001|Overall Study|Protocol Violation|8|||
146667420|NCT00150709|528960080|FG002|Overall Study|Protocol Violation|3|||
146667421|NCT00150709|528960081|FG003|Overall Study|Protocol Violation|1|||
146667422|NCT00150709|528960078|FG000|Overall Study|Adverse Event|8|||
146667423|NCT00150709|528960079|FG001|Overall Study|Adverse Event|2|||
146667424|NCT00150709|528960080|FG002|Overall Study|Adverse Event|2|||
146667425|NCT00150709|528960081|FG003|Overall Study|Adverse Event|3|||
146667426|NCT00150709|528960078|FG000|Overall Study|Lack of Efficacy|6|||
146667427|NCT00150709|528960079|FG001|Overall Study|Lack of Efficacy|11|||
146667428|NCT00150709|528960080|FG002|Overall Study|Lack of Efficacy|9|||
146667429|NCT00150709|528960081|FG003|Overall Study|Lack of Efficacy|0|||
146667430|NCT00150709|528960078|FG000|Overall Study|Withdrawal by Subject|7|||
146667431|NCT00150709|528960079|FG001|Overall Study|Withdrawal by Subject|10|||
146667432|NCT00150709|528960080|FG002|Overall Study|Withdrawal by Subject|5|||
146667433|NCT00150709|528960081|FG003|Overall Study|Withdrawal by Subject|0|||
146667434|NCT00150709|528960078|FG000|Overall Study|Lost to Follow-up|3|||
146667435|NCT00150709|528960079|FG001|Overall Study|Lost to Follow-up|2|||
146667436|NCT00150709|528960080|FG002|Overall Study|Lost to Follow-up|0|||
146667437|NCT00150709|528960081|FG003|Overall Study|Lost to Follow-up|0|||
146667438|NCT00150709|528960078|FG000|Overall Study|Sponsor decision|0|||
146667439|NCT00150709|528960079|FG001|Overall Study|Sponsor decision|0|||
146667440|NCT00150709|528960080|FG002|Overall Study|Sponsor decision|0|||
146667441|NCT00150709|528960081|FG003|Overall Study|Sponsor decision|1|||
146667442|NCT00150709|528960078|FG000|Overall Study|Site/Investigator discontinued the study|5|||
146667443|NCT00150709|528960079|FG001|Overall Study|Site/Investigator discontinued the study|5|||
146667444|NCT00150709|528960080|FG002|Overall Study|Site/Investigator discontinued the study|2|||
146667445|NCT00150709|528960081|FG003|Overall Study|Site/Investigator discontinued the study|0|||
146667446|NCT00150709|528960078|FG000|Overall Study|Decision of parent(s)|1|||
146667447|NCT00150709|528960079|FG001|Overall Study|Decision of parent(s)|2|||
146667448|NCT00150709|528960080|FG002|Overall Study|Decision of parent(s)|0|||
146667449|NCT00150709|528960081|FG003|Overall Study|Decision of parent(s)|0|||
146667450|NCT00150709|528960078|FG000|Overall Study|Decision of parent(s) and investigator|3|||
146667451|NCT00150709|528960079|FG001|Overall Study|Decision of parent(s) and investigator|0|||
146667452|NCT00150709|528960080|FG002|Overall Study|Decision of parent(s) and investigator|0|||
146667453|NCT00150709|528960081|FG003|Overall Study|Decision of parent(s) and investigator|0|||
146667454|NCT00150709|528960078|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
146667455|NCT00150709|528960079|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
146667456|NCT00150709|528960080|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
146667457|NCT00150709|528960081|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
146667458|NCT00150709|528960078|FG000|Overall Study|Investigator decision|1|||
146667459|NCT00150709|528960079|FG001|Overall Study|Investigator decision|0|||
146667460|NCT00150709|528960080|FG002|Overall Study|Investigator decision|0|||
146667461|NCT00150709|528960081|FG003|Overall Study|Investigator decision|1|||
146667462|NCT00150709|528960078|FG000|Overall Study|Subject relocated|2|||
146667463|NCT00150709|528960079|FG001|Overall Study|Subject relocated|2|||
146667464|NCT00150709|528960080|FG002|Overall Study|Subject relocated|1|||
146667465|NCT00150709|528960081|FG003|Overall Study|Subject relocated|0|||
146667466|NCT00150709|528960078|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
146667467|NCT00150709|528960079|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
146667468|NCT00150709|528960080|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
146667469|NCT00150709|528960081|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
146667470|NCT00150709|528960078|FG000|Overall Study|Convenience|0|||
146667471|NCT00150709|528960079|FG001|Overall Study|Convenience|1|||
146667472|NCT00150709|528960080|FG002|Overall Study|Convenience|0|||
146667473|NCT00150709|528960081|FG003|Overall Study|Convenience|0|||
146667474|NCT00150709|528960078|FG000|Overall Study|Subject entered new drug study|0|||
146667475|NCT00150709|528960079|FG001|Overall Study|Subject entered new drug study|1|||
146667476|NCT00150709|528960080|FG002|Overall Study|Subject entered new drug study|0|||
146667477|NCT00150709|528960081|FG003|Overall Study|Subject entered new drug study|0|||
146667478|NCT00150709|528960078|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
146667479|NCT00150709|528960079|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
146667480|NCT00150709|528960080|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
146667481|NCT00150709|528960081|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
146667482|NCT00150709|528960078|FG000|Overall Study|Lack of ease of swallowing|0|||
146667483|NCT00150709|528960079|FG001|Overall Study|Lack of ease of swallowing|1|||
146667484|NCT00150709|528960080|FG002|Overall Study|Lack of ease of swallowing|0|||
146667485|NCT00150709|528960081|FG003|Overall Study|Lack of ease of swallowing|0|||
146667486|NCT04092582|528960082|FG000|Overall Study|Death|1|||
146667487|NCT04092582|528960083|FG001|Overall Study|Death|1|||
146667488|NCT04092582|528960082|FG000|Overall Study|Withdrawal by Subject|4|||
146667489|NCT04092582|528960083|FG001|Overall Study|Withdrawal by Subject|1|||
146667490|NCT04092582|528960082|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
146667491|NCT04092582|528960083|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
146667492|NCT02280304|528960084|FG000|Overall Study|Lost to Follow-up|7|||
146667493|NCT02280304|528960085|FG001|Overall Study|Lost to Follow-up|8|||
146667494|NCT01644565|528960086|FG000|Overall Study|Undisclosed Medical History|1|||
146667495|NCT01644565|528960087|FG001|Overall Study|Undisclosed Medical History|0|||
146667496|NCT01644565|528960088|FG002|Overall Study|Undisclosed Medical History|0|||
146667497|NCT01644565|528960089|FG003|Overall Study|Undisclosed Medical History|0|||
146667498|NCT01644565|528960090|FG004|Overall Study|Undisclosed Medical History|0|||
146667499|NCT01644565|528960091|FG005|Overall Study|Undisclosed Medical History|0|||
146667500|NCT01644565|528960092|FG006|Overall Study|Undisclosed Medical History|0|||
146667501|NCT01644565|528960093|FG007|Overall Study|Undisclosed Medical History|0|||
146773862|NCT04425629|529343459|FG006|Overall Study|Physician Decision|0|||
146667502|NCT01644565|528960094|FG008|Overall Study|Undisclosed Medical History|0|||
146667503|NCT01644565|528960086|FG000|Overall Study|Lost to Follow-up|0|||
146667504|NCT01644565|528960087|FG001|Overall Study|Lost to Follow-up|0|||
146667505|NCT01644565|528960088|FG002|Overall Study|Lost to Follow-up|0|||
146773863|NCT04425629|529343460|FG007|Overall Study|Physician Decision|0|||
146667506|NCT01644565|528960089|FG003|Overall Study|Lost to Follow-up|1|||
146667507|NCT01644565|528960090|FG004|Overall Study|Lost to Follow-up|0|||
146667508|NCT01644565|528960091|FG005|Overall Study|Lost to Follow-up|0|||
146667509|NCT01644565|528960092|FG006|Overall Study|Lost to Follow-up|0|||
146667510|NCT01644565|528960093|FG007|Overall Study|Lost to Follow-up|2|||
146667511|NCT01644565|528960094|FG008|Overall Study|Lost to Follow-up|0|||
146667512|NCT01644565|528960086|FG000|Overall Study|Family emergency|0|||
146667513|NCT01644565|528960087|FG001|Overall Study|Family emergency|0|||
146667514|NCT01644565|528960088|FG002|Overall Study|Family emergency|0|||
146667515|NCT01644565|528960089|FG003|Overall Study|Family emergency|0|||
146667516|NCT01644565|528960090|FG004|Overall Study|Family emergency|1|||
146667517|NCT01644565|528960091|FG005|Overall Study|Family emergency|0|||
146667518|NCT01644565|528960092|FG006|Overall Study|Family emergency|0|||
146667519|NCT01644565|528960093|FG007|Overall Study|Family emergency|0|||
146667520|NCT01644565|528960094|FG008|Overall Study|Family emergency|0|||
146667521|NCT01644565|528960086|FG000|Overall Study|Relocation|0|||
146667522|NCT01644565|528960087|FG001|Overall Study|Relocation|0|||
146667523|NCT01644565|528960088|FG002|Overall Study|Relocation|0|||
146667524|NCT01644565|528960089|FG003|Overall Study|Relocation|0|||
146667525|NCT01644565|528960090|FG004|Overall Study|Relocation|0|||
146667526|NCT01644565|528960091|FG005|Overall Study|Relocation|0|||
146667527|NCT01644565|528960092|FG006|Overall Study|Relocation|0|||
146667528|NCT01644565|528960093|FG007|Overall Study|Relocation|0|||
146667529|NCT01644565|528960094|FG008|Overall Study|Relocation|1|||
146667530|NCT00533897|528960095|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
146667531|NCT00533897|528960096|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
146667532|NCT00533897|528960097|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
146667533|NCT00533897|528960098|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
146667534|NCT00533897|528960099|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
146667535|NCT00533897|528960100|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
146667536|NCT00533897|528960101|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
146667537|NCT00533897|528960102|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
146667538|NCT00533897|528960095|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
146667539|NCT00533897|528960096|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
146667540|NCT00533897|528960097|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
146667541|NCT00533897|528960098|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
146667542|NCT00533897|528960099|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
146667543|NCT00533897|528960100|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
146667544|NCT00533897|528960101|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
146667545|NCT00533897|528960102|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
146667546|NCT00533897|528960095|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
146667547|NCT00533897|528960096|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
146667548|NCT00533897|528960097|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
146667549|NCT00533897|528960098|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
146667550|NCT00533897|528960099|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
146667551|NCT00533897|528960100|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
146667552|NCT00533897|528960101|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
146667553|NCT00533897|528960102|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
146667554|NCT00533897|528960095|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
146667555|NCT00533897|528960096|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
146667556|NCT00533897|528960097|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
146667557|NCT00533897|528960098|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
146667558|NCT00533897|528960099|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
146667559|NCT00533897|528960100|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
146667560|NCT00533897|528960101|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
146667561|NCT00533897|528960102|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
146667562|NCT00533897|528960095|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
146667563|NCT00533897|528960096|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
146667564|NCT00533897|528960097|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
146667565|NCT00533897|528960098|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
146667566|NCT00533897|528960099|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
146667567|NCT00533897|528960100|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
146667568|NCT00533897|528960101|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
146667569|NCT00533897|528960102|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
146667570|NCT00533897|528960095|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
146667571|NCT00533897|528960096|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
146667572|NCT00533897|528960097|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
146667573|NCT00533897|528960098|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
146667574|NCT00533897|528960099|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
146667575|NCT00533897|528960100|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
146667576|NCT00533897|528960101|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
146667577|NCT00533897|528960102|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
146667578|NCT00533897|528960095|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
146667579|NCT00533897|528960096|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
146667580|NCT00533897|528960097|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
146667581|NCT00533897|528960098|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
146667582|NCT00533897|528960099|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
146667583|NCT00533897|528960100|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
146667584|NCT00533897|528960101|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
146667585|NCT00533897|528960102|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
146667586|NCT00533897|528960095|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
146667587|NCT00533897|528960096|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
146667588|NCT00533897|528960097|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
146667589|NCT00533897|528960098|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
146667590|NCT00533897|528960099|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
146667591|NCT00533897|528960100|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
146667592|NCT00533897|528960101|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
146667593|NCT00533897|528960102|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
146667594|NCT00533897|528960095|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
146667595|NCT00533897|528960096|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
146667596|NCT00533897|528960097|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
146667597|NCT00533897|528960098|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
146667598|NCT00533897|528960099|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
146667599|NCT00533897|528960100|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
146667600|NCT00533897|528960101|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
146667601|NCT00533897|528960102|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
146667602|NCT00533897|528960095|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
146667603|NCT00533897|528960096|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
146667604|NCT00533897|528960097|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
146667605|NCT00533897|528960098|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
146667606|NCT00533897|528960099|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
146667607|NCT00533897|528960100|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
146667608|NCT00533897|528960101|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
146667609|NCT00533897|528960102|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
146667610|NCT00533897|528960095|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
146667611|NCT00533897|528960096|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
146667612|NCT00533897|528960097|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
146667613|NCT00533897|528960098|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
146667614|NCT00533897|528960099|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
146667615|NCT00533897|528960100|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
146667616|NCT00533897|528960101|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
146667617|NCT00533897|528960102|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
146667618|NCT00533897|528960095|FG000|Long Term Extension (LTE)|Death|0|||
146667619|NCT00533897|528960096|FG001|Long Term Extension (LTE)|Death|0|||
146667620|NCT00533897|528960097|FG002|Long Term Extension (LTE)|Death|0|||
146667621|NCT00533897|528960098|FG003|Long Term Extension (LTE)|Death|0|||
146667622|NCT00533897|528960099|FG004|Long Term Extension (LTE)|Death|0|||
146667623|NCT00533897|528960100|FG005|Long Term Extension (LTE)|Death|0|||
146667624|NCT00533897|528960101|FG006|Long Term Extension (LTE)|Death|1|||
146667625|NCT00533897|528960102|FG007|Long Term Extension (LTE)|Death|3|||
146667626|NCT00533897|528960095|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
146667627|NCT00533897|528960096|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
146667628|NCT00533897|528960097|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
146667629|NCT00533897|528960098|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
146667630|NCT00533897|528960099|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
146667631|NCT00533897|528960100|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
146667632|NCT00533897|528960101|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
146667633|NCT00533897|528960102|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
146667634|NCT00533897|528960095|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
146667635|NCT00533897|528960096|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
146667636|NCT00533897|528960097|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
146667637|NCT00533897|528960098|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
146667638|NCT00533897|528960099|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
146667639|NCT00533897|528960100|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
146667640|NCT00533897|528960101|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
146667641|NCT00533897|528960102|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
146667642|NCT00533897|528960095|FG000|Long Term Extension (LTE)|Adverse Event|0|||
146667643|NCT00533897|528960096|FG001|Long Term Extension (LTE)|Adverse Event|0|||
146667644|NCT00533897|528960097|FG002|Long Term Extension (LTE)|Adverse Event|0|||
146667645|NCT00533897|528960098|FG003|Long Term Extension (LTE)|Adverse Event|0|||
146667646|NCT00533897|528960099|FG004|Long Term Extension (LTE)|Adverse Event|0|||
146667647|NCT00533897|528960100|FG005|Long Term Extension (LTE)|Adverse Event|0|||
146667648|NCT00533897|528960101|FG006|Long Term Extension (LTE)|Adverse Event|2|||
146667649|NCT00533897|528960102|FG007|Long Term Extension (LTE)|Adverse Event|5|||
146667650|NCT00533897|528960095|FG000|Long Term Extension (LTE)|Pregnancy|0|||
146667651|NCT00533897|528960096|FG001|Long Term Extension (LTE)|Pregnancy|0|||
146667652|NCT00533897|528960097|FG002|Long Term Extension (LTE)|Pregnancy|0|||
146667653|NCT00533897|528960098|FG003|Long Term Extension (LTE)|Pregnancy|0|||
146667654|NCT00533897|528960099|FG004|Long Term Extension (LTE)|Pregnancy|0|||
146667655|NCT00533897|528960100|FG005|Long Term Extension (LTE)|Pregnancy|0|||
146667656|NCT00533897|528960101|FG006|Long Term Extension (LTE)|Pregnancy|0|||
146667657|NCT00533897|528960102|FG007|Long Term Extension (LTE)|Pregnancy|2|||
146667658|NCT00533897|528960095|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
146667659|NCT00533897|528960096|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
146667660|NCT00533897|528960097|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
146667661|NCT00533897|528960098|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
146667662|NCT00533897|528960099|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
146773864|NCT04425629|529343461|FG008|Overall Study|Physician Decision|0|||
146925548|NCT00077610|529888288|FG002|Overall Study|Change in dialysis modality|0|||
146925549|NCT00077610|529888286|FG000|Overall Study|Relocation|0|||
146925550|NCT00077610|529888287|FG001|Overall Study|Relocation|8|||
146925551|NCT00077610|529888288|FG002|Overall Study|Relocation|5|||
146925552|NCT00077610|529888286|FG000|Overall Study|Financial issues|0|||
146925553|NCT00077610|529888287|FG001|Overall Study|Financial issues|1|||
146925554|NCT00077610|529888288|FG002|Overall Study|Financial issues|0|||
146925555|NCT00077610|529888286|FG000|Overall Study|Sponsors decision to withdraw|0|||
146925556|NCT00077610|529888287|FG001|Overall Study|Sponsors decision to withdraw|0|||
146925557|NCT00077610|529888288|FG002|Overall Study|Sponsors decision to withdraw|1|||
146925558|NCT01357915|529888292|FG000|Overall Study|Lost to Follow-up|3|||
146925559|NCT01357915|529888293|FG001|Overall Study|Lost to Follow-up|0|||
146667663|NCT00533897|528960100|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
146667664|NCT00533897|528960101|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
146667665|NCT00533897|528960102|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
146667666|NCT00533897|528960095|FG000|Long Term Extension (LTE)|Other|0|||
146667667|NCT00533897|528960096|FG001|Long Term Extension (LTE)|Other|0|||
146667668|NCT00533897|528960097|FG002|Long Term Extension (LTE)|Other|0|||
146667669|NCT00533897|528960098|FG003|Long Term Extension (LTE)|Other|0|||
146667670|NCT00533897|528960099|FG004|Long Term Extension (LTE)|Other|0|||
146667671|NCT00533897|528960100|FG005|Long Term Extension (LTE)|Other|0|||
146667672|NCT00533897|528960101|FG006|Long Term Extension (LTE)|Other|1|||
146667673|NCT00533897|528960102|FG007|Long Term Extension (LTE)|Other|6|||
146667674|NCT00713323|528960105|FG000|Overall Study|Adverse Event|75|||
146667675|NCT00713323|528960105|FG000|Overall Study|Withdrawal by Subject|15|||
146667676|NCT00713323|528960105|FG000|Overall Study|Lost to Follow-up|11|||
146667677|NCT00713323|528960105|FG000|Overall Study|Lack of Efficacy|36|||
146667678|NCT00713323|528960105|FG000|Overall Study|Low creatine clearance at screening|1|||
146667679|NCT00713323|528960105|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
146667680|NCT00713323|528960105|FG000|Overall Study|Surgery cured allodynic pain|1|||
146667681|NCT00713323|528960105|FG000|Overall Study|Pain free|1|||
146667682|NCT00713323|528960105|FG000|Overall Study|Non-compliance|1|||
146667683|NCT00713323|528960105|FG000|Overall Study|Pain resolved|1|||
146667684|NCT00713323|528960105|FG000|Overall Study|Subject travelling to USA|1|||
146667685|NCT00713323|528960105|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
146667686|NCT00713323|528960105|FG000|Overall Study|Treatment that may interact with Sativex|1|||
146667687|NCT00506662|528960106|FG000|Overall Study|Adverse Event|0|||
146667688|NCT00506662|528960107|FG001|Overall Study|Adverse Event|2|||
146667689|NCT00506662|528960106|FG000|Overall Study|Lack of Efficacy|1|||
146667690|NCT00506662|528960107|FG001|Overall Study|Lack of Efficacy|0|||
146667691|NCT00506662|528960106|FG000|Overall Study|Protocol Violation|2|||
146667692|NCT00506662|528960107|FG001|Overall Study|Protocol Violation|4|||
146667693|NCT00506662|528960106|FG000|Overall Study|Trial terminated|10|||
146667694|NCT00506662|528960107|FG001|Overall Study|Trial terminated|16|||
146667695|NCT00506662|528960106|FG000|Overall Study|Not recorded|4|||
146667696|NCT00506662|528960107|FG001|Overall Study|Not recorded|6|||
146667697|NCT04015336|528960108|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
146667698|NCT00491075|528960109|FG000|Overall Study|Withdrawal by Subject|1|||
146667699|NCT00491075|528960109|FG000|Overall Study|Physician Decision|1|||
146667700|NCT01603355|528960110|FG000|Overall Study|Lack of Efficacy|2|||
146667701|NCT02764333|528960113|FG000|Overall Study|Ineligible|1|||
146667702|NCT03355365|528960114|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
146667703|NCT03355365|528960115|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
146667704|NCT03355365|528960114|FG000|Year 1, First Intervention|Protocol Violation|1|||
146667705|NCT03355365|528960115|FG001|Year 1, First Intervention|Protocol Violation|0|||
146667706|NCT03355365|528960114|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
146667707|NCT03355365|528960115|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
146667708|NCT03355365|528960114|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
146667709|NCT03355365|528960115|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
146667710|NCT03355365|528960114|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
146667711|NCT03355365|528960115|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
146667712|NCT03355365|528960114|FG000|Year 2, Crossover Intervention|severe COVID|0|||
146667713|NCT03355365|528960115|FG001|Year 2, Crossover Intervention|severe COVID|1|||
146667714|NCT03355365|528960114|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
146667715|NCT03355365|528960115|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
146667716|NCT04622306|528960116|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
146667717|NCT04622306|528960117|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
146667718|NCT04622306|528960118|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
146667719|NCT04622306|528960119|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
146667720|NCT04622306|528960120|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
146667721|NCT04622306|528960121|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
146667722|NCT04622306|528960116|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
146925560|NCT00305253|529888294|FG000|Overall Study|Withdrawal by Subject|0|||
146667723|NCT04622306|528960117|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
146667724|NCT04622306|528960118|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
146667725|NCT04622306|528960119|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
146667726|NCT04622306|528960120|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
146667727|NCT04622306|528960121|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
146667728|NCT01200524|528960122|FG000|Overall Study|Withdrawal by Subject|1|||
146667729|NCT01200524|528960123|FG001|Overall Study|Withdrawal by Subject|1|||
146667730|NCT01200524|528960124|FG002|Overall Study|Withdrawal by Subject|3|||
146667731|NCT01200524|528960122|FG000|Overall Study|Adverse Event|1|||
146667732|NCT01200524|528960123|FG001|Overall Study|Adverse Event|0|||
146667733|NCT01200524|528960124|FG002|Overall Study|Adverse Event|0|||
146667734|NCT01200524|528960122|FG000|Overall Study|Non availability of study nurse|0|||
146667735|NCT01200524|528960123|FG001|Overall Study|Non availability of study nurse|0|||
146667736|NCT01200524|528960124|FG002|Overall Study|Non availability of study nurse|1|||
146667737|NCT00491764|528960126|FG000|Overall Study|Adverse Event|1|||
146667738|NCT00491764|528960127|FG001|Overall Study|Adverse Event|2|||
146667739|NCT00491764|528960128|FG002|Overall Study|Adverse Event|4|||
146667740|NCT00491764|528960129|FG003|Overall Study|Adverse Event|4|||
146667741|NCT00491764|528960130|FG004|Overall Study|Adverse Event|0|||
146667742|NCT00491764|528960131|FG005|Overall Study|Adverse Event|1|||
146667743|NCT00491764|528960126|FG000|Overall Study|Lost to Follow-up|0|||
146667744|NCT00491764|528960127|FG001|Overall Study|Lost to Follow-up|1|||
146667745|NCT00491764|528960128|FG002|Overall Study|Lost to Follow-up|0|||
146667746|NCT00491764|528960129|FG003|Overall Study|Lost to Follow-up|1|||
146667747|NCT00491764|528960130|FG004|Overall Study|Lost to Follow-up|0|||
146667748|NCT00491764|528960131|FG005|Overall Study|Lost to Follow-up|3|||
146667749|NCT00491764|528960126|FG000|Overall Study|Withdrawal by Subject|2|||
146667750|NCT00491764|528960127|FG001|Overall Study|Withdrawal by Subject|3|||
146667751|NCT00491764|528960128|FG002|Overall Study|Withdrawal by Subject|1|||
146667752|NCT00491764|528960129|FG003|Overall Study|Withdrawal by Subject|2|||
146667753|NCT00491764|528960130|FG004|Overall Study|Withdrawal by Subject|2|||
146667754|NCT00491764|528960131|FG005|Overall Study|Withdrawal by Subject|4|||
146667755|NCT00491764|528960126|FG000|Overall Study|Non Compliance with the Protocol|1|||
146667756|NCT00491764|528960127|FG001|Overall Study|Non Compliance with the Protocol|0|||
146667757|NCT00491764|528960128|FG002|Overall Study|Non Compliance with the Protocol|0|||
146667758|NCT00491764|528960129|FG003|Overall Study|Non Compliance with the Protocol|0|||
146667759|NCT00491764|528960130|FG004|Overall Study|Non Compliance with the Protocol|0|||
146667760|NCT00491764|528960131|FG005|Overall Study|Non Compliance with the Protocol|0|||
146667761|NCT00491764|528960126|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
146667762|NCT00491764|528960127|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
146667763|NCT00491764|528960128|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
146667764|NCT00491764|528960129|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
146667765|NCT00491764|528960130|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
146667766|NCT00491764|528960131|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
146667767|NCT00491764|528960126|FG000|Overall Study|Administrative|1|||
146667768|NCT00491764|528960127|FG001|Overall Study|Administrative|0|||
146667769|NCT00491764|528960128|FG002|Overall Study|Administrative|2|||
146667770|NCT00491764|528960129|FG003|Overall Study|Administrative|1|||
146667771|NCT00491764|528960130|FG004|Overall Study|Administrative|0|||
146667772|NCT00491764|528960131|FG005|Overall Study|Administrative|0|||
146667773|NCT00697788|528960132|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
146667774|NCT00697788|528960133|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
146667775|NCT00697788|528960134|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
146667776|NCT00697788|528960135|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
146667777|NCT00697788|528960136|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
146667778|NCT00697788|528960137|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
146667779|NCT00697788|528960138|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
146667780|NCT00697788|528960139|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
146667781|NCT00697788|528960132|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
146667782|NCT00697788|528960133|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
146667783|NCT00697788|528960134|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
146667784|NCT00697788|528960135|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
146667785|NCT00697788|528960136|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
146667786|NCT00697788|528960137|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
146667787|NCT00697788|528960138|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
146667788|NCT00697788|528960139|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
146667789|NCT00074984|528960140|FG000|Overall Study|Death|1|||
146667790|NCT00074984|528960141|FG001|Overall Study|Death|2|||
146667791|NCT00074984|528960140|FG000|Overall Study|Withdrawal by Subject|2|||
146667792|NCT00074984|528960141|FG001|Overall Study|Withdrawal by Subject|3|||
146667793|NCT00074984|528960140|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
146667794|NCT00074984|528960141|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
146667795|NCT03080454|528960142|FG000|Baseline|Adverse Event|2|||
146667796|NCT03080454|528960142|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
146667797|NCT03080454|528960142|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
146667798|NCT02202980|528960143|FG000|Overall Study|Lack of Efficacy|1|||
146667799|NCT02202980|528960144|FG001|Overall Study|Lack of Efficacy|0|||
146667800|NCT02202980|528960145|FG002|Overall Study|Lack of Efficacy|7|||
146667801|NCT02202980|528960146|FG003|Overall Study|Lack of Efficacy|0|||
146667802|NCT02202980|528960147|FG004|Overall Study|Lack of Efficacy|3|||
146667803|NCT02202980|528960148|FG005|Overall Study|Lack of Efficacy|1|||
146667804|NCT02202980|528960149|FG006|Overall Study|Lack of Efficacy|11|||
146667805|NCT02202980|528960150|FG007|Overall Study|Lack of Efficacy|2|||
146667806|NCT02202980|528960151|FG008|Overall Study|Lack of Efficacy|2|||
146667807|NCT02202980|528960152|FG009|Overall Study|Lack of Efficacy|0|||
146667808|NCT02202980|528960153|FG010|Overall Study|Lack of Efficacy|0|||
146667809|NCT02202980|528960154|FG011|Overall Study|Lack of Efficacy|3|||
146667810|NCT02202980|528960155|FG012|Overall Study|Lack of Efficacy|10|||
146667811|NCT02202980|528960156|FG013|Overall Study|Lack of Efficacy|0|||
146667812|NCT02202980|528960143|FG000|Overall Study|Protocol Violation|0|||
146667813|NCT02202980|528960144|FG001|Overall Study|Protocol Violation|0|||
146667814|NCT02202980|528960145|FG002|Overall Study|Protocol Violation|0|||
146667815|NCT02202980|528960146|FG003|Overall Study|Protocol Violation|3|||
146667816|NCT02202980|528960147|FG004|Overall Study|Protocol Violation|3|||
146667817|NCT02202980|528960148|FG005|Overall Study|Protocol Violation|0|||
146667818|NCT02202980|528960149|FG006|Overall Study|Protocol Violation|0|||
146667819|NCT02202980|528960150|FG007|Overall Study|Protocol Violation|0|||
146667820|NCT02202980|528960151|FG008|Overall Study|Protocol Violation|0|||
146667821|NCT02202980|528960152|FG009|Overall Study|Protocol Violation|0|||
146667822|NCT02202980|528960153|FG010|Overall Study|Protocol Violation|0|||
146667823|NCT02202980|528960154|FG011|Overall Study|Protocol Violation|0|||
146667824|NCT02202980|528960155|FG012|Overall Study|Protocol Violation|0|||
146667825|NCT02202980|528960156|FG013|Overall Study|Protocol Violation|0|||
146773865|NCT04425629|529343462|FG009|Overall Study|Physician Decision|4|||
146667826|NCT02202980|528960143|FG000|Overall Study|Lost to Follow-up|0|||
146667827|NCT02202980|528960144|FG001|Overall Study|Lost to Follow-up|1|||
146667828|NCT02202980|528960145|FG002|Overall Study|Lost to Follow-up|1|||
146667829|NCT02202980|528960146|FG003|Overall Study|Lost to Follow-up|1|||
146667830|NCT02202980|528960147|FG004|Overall Study|Lost to Follow-up|0|||
146667831|NCT02202980|528960148|FG005|Overall Study|Lost to Follow-up|0|||
146667832|NCT02202980|528960149|FG006|Overall Study|Lost to Follow-up|0|||
146667833|NCT02202980|528960150|FG007|Overall Study|Lost to Follow-up|1|||
146667834|NCT02202980|528960151|FG008|Overall Study|Lost to Follow-up|1|||
146667835|NCT02202980|528960152|FG009|Overall Study|Lost to Follow-up|0|||
146667836|NCT02202980|528960153|FG010|Overall Study|Lost to Follow-up|0|||
146667837|NCT02202980|528960154|FG011|Overall Study|Lost to Follow-up|0|||
146667838|NCT02202980|528960155|FG012|Overall Study|Lost to Follow-up|1|||
146667839|NCT02202980|528960156|FG013|Overall Study|Lost to Follow-up|0|||
146667840|NCT02202980|528960143|FG000|Overall Study|Withdrew Consent|0|||
146667841|NCT02202980|528960144|FG001|Overall Study|Withdrew Consent|1|||
146667842|NCT02202980|528960145|FG002|Overall Study|Withdrew Consent|2|||
146667843|NCT02202980|528960146|FG003|Overall Study|Withdrew Consent|0|||
146667844|NCT02202980|528960147|FG004|Overall Study|Withdrew Consent|0|||
146667845|NCT02202980|528960148|FG005|Overall Study|Withdrew Consent|0|||
146667846|NCT02202980|528960149|FG006|Overall Study|Withdrew Consent|0|||
146667847|NCT02202980|528960150|FG007|Overall Study|Withdrew Consent|0|||
146773866|NCT04425629|529343463|FG010|Overall Study|Physician Decision|3|||
146773867|NCT04425629|529343464|FG011|Overall Study|Physician Decision|5|||
146773868|NCT04425629|529343465|FG012|Overall Study|Physician Decision|1|||
146773869|NCT04425629|529343466|FG013|Overall Study|Physician Decision|0|||
146773870|NCT04425629|529343467|FG014|Overall Study|Physician Decision|0|||
146773871|NCT04425629|529343468|FG015|Overall Study|Physician Decision|1|||
146773872|NCT04425629|529343469|FG016|Overall Study|Physician Decision|0|||
146773873|NCT04425629|529343470|FG017|Overall Study|Physician Decision|0|||
146667848|NCT02202980|528960151|FG008|Overall Study|Withdrew Consent|1|||
146667849|NCT02202980|528960152|FG009|Overall Study|Withdrew Consent|0|||
146667850|NCT02202980|528960153|FG010|Overall Study|Withdrew Consent|0|||
146773874|NCT04425629|529343471|FG018|Overall Study|Physician Decision|0|||
146667851|NCT02202980|528960154|FG011|Overall Study|Withdrew Consent|0|||
146667852|NCT02202980|528960155|FG012|Overall Study|Withdrew Consent|0|||
146667853|NCT02202980|528960156|FG013|Overall Study|Withdrew Consent|0|||
146667854|NCT04138810|528960160|FG000|Overall Study|Withdrawal by Subject|0|||
146667855|NCT04138810|528960161|FG001|Overall Study|Withdrawal by Subject|1|||
146667856|NCT04138810|528960160|FG000|Overall Study|Subject cancelled surgery|1|||
146667857|NCT04138810|528960161|FG001|Overall Study|Subject cancelled surgery|0|||
146667858|NCT00591344|528960162|FG000|Overall Study|Transportation issues|1|||
146667859|NCT00591344|528960163|FG001|Overall Study|Transportation issues|0|||
146667860|NCT00591344|528960162|FG000|Overall Study|Moved out of state|1|||
146667861|NCT00591344|528960163|FG001|Overall Study|Moved out of state|0|||
146667862|NCT00591344|528960162|FG000|Overall Study|Medical complications|1|||
146667863|NCT00591344|528960163|FG001|Overall Study|Medical complications|3|||
146773875|NCT04425629|529343453|FG000|Overall Study|Lack of Efficacy|0|||
146667864|NCT00591344|528960162|FG000|Overall Study|Underwent DBS|2|||
146667865|NCT00591344|528960163|FG001|Overall Study|Underwent DBS|2|||
146667866|NCT00591344|528960162|FG000|Overall Study|Death|0|||
146667867|NCT00591344|528960163|FG001|Overall Study|Death|1|||
146667868|NCT00591344|528960162|FG000|Overall Study|Lost to Follow-up|0|||
146667869|NCT00591344|528960163|FG001|Overall Study|Lost to Follow-up|1|||
146667870|NCT00591344|528960162|FG000|Overall Study|Did not want to come off medication|0|||
146667871|NCT00591344|528960163|FG001|Overall Study|Did not want to come off medication|1|||
146667872|NCT01058655|528960168|FG000|Overall Study|Withdrawal by Subject|1|||
146667873|NCT01058655|528960169|FG001|Overall Study|Withdrawal by Subject|0|||
146667874|NCT01058655|528960170|FG002|Overall Study|Withdrawal by Subject|3|||
146667875|NCT01058655|528960171|FG003|Overall Study|Withdrawal by Subject|4|||
146667876|NCT01058655|528960168|FG000|Overall Study|Prolonged Treatment Delay|0|||
146667877|NCT01058655|528960169|FG001|Overall Study|Prolonged Treatment Delay|0|||
146667878|NCT01058655|528960170|FG002|Overall Study|Prolonged Treatment Delay|0|||
146667879|NCT01058655|528960171|FG003|Overall Study|Prolonged Treatment Delay|2|||
146667880|NCT01058655|528960168|FG000|Overall Study|Symptomatic Deterioration|0|||
146667881|NCT01058655|528960169|FG001|Overall Study|Symptomatic Deterioration|0|||
146667882|NCT01058655|528960170|FG002|Overall Study|Symptomatic Deterioration|0|||
146667883|NCT01058655|528960171|FG003|Overall Study|Symptomatic Deterioration|1|||
146667884|NCT01058655|528960168|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
146667885|NCT01058655|528960169|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
146667886|NCT01058655|528960170|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
146667887|NCT01058655|528960171|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
146667888|NCT01058655|528960168|FG000|Overall Study|Death|0|||
146667889|NCT01058655|528960169|FG001|Overall Study|Death|1|||
146667890|NCT01058655|528960170|FG002|Overall Study|Death|1|||
146667891|NCT01058655|528960171|FG003|Overall Study|Death|0|||
146667892|NCT01058655|528960168|FG000|Overall Study|Disease Progression|1|||
146667893|NCT01058655|528960169|FG001|Overall Study|Disease Progression|2|||
146667894|NCT01058655|528960170|FG002|Overall Study|Disease Progression|4|||
146667895|NCT01058655|528960171|FG003|Overall Study|Disease Progression|24|||
146667896|NCT01058655|528960168|FG000|Overall Study|Other|0|||
146667897|NCT01058655|528960169|FG001|Overall Study|Other|0|||
146667898|NCT01058655|528960170|FG002|Overall Study|Other|0|||
146667899|NCT01058655|528960171|FG003|Overall Study|Other|4|||
146667900|NCT00619177|528960174|FG000|Overall Study|Adverse Event|18|||
146667901|NCT00619177|528960174|FG000|Overall Study|Lost to Follow-up|2|||
146667902|NCT00619177|528960174|FG000|Overall Study|Lack of Efficacy|1|||
146667903|NCT00619177|528960174|FG000|Overall Study|Missing termination information|481|||
146667904|NCT00619177|528960174|FG000|Overall Study|Not specified reasons|6|||
146667905|NCT01180647|528960175|FG000|Overall Study|Lost to Follow-up|5|||
146667906|NCT01180647|528960176|FG001|Overall Study|Lost to Follow-up|6|||
146667907|NCT03800173|528960188|FG000|Overall Study|Lost to Follow-up|0|||
146667908|NCT03800173|528960189|FG001|Overall Study|Lost to Follow-up|0|||
146667909|NCT03800173|528960190|FG002|Overall Study|Lost to Follow-up|0|||
146667910|NCT03800173|528960191|FG003|Overall Study|Lost to Follow-up|0|||
146667911|NCT03800173|528960192|FG004|Overall Study|Lost to Follow-up|1|||
146667912|NCT01903031|528960207|FG000|Overall Study|Not Able to Attend Clinic|1|||
146667913|NCT01903031|528960208|FG001|Overall Study|Not Able to Attend Clinic|1|||
146667914|NCT01903031|528960209|FG002|Overall Study|Not Able to Attend Clinic|0|||
146667915|NCT01903031|528960207|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
146667916|NCT01903031|528960208|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
146667917|NCT01903031|528960209|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
146667918|NCT01903031|528960207|FG000|Overall Study|Adverse Event|0|||
146667919|NCT01903031|528960208|FG001|Overall Study|Adverse Event|1|||
146667920|NCT01903031|528960209|FG002|Overall Study|Adverse Event|0|||
146667921|NCT01903031|528960207|FG000|Overall Study|Withdrawal by Subject|0|||
146667922|NCT01903031|528960208|FG001|Overall Study|Withdrawal by Subject|1|||
146667923|NCT01903031|528960209|FG002|Overall Study|Withdrawal by Subject|1|||
146667924|NCT01903031|528960207|FG000|Overall Study|Protocol Violation|0|||
146667925|NCT01903031|528960208|FG001|Overall Study|Protocol Violation|0|||
146667926|NCT01903031|528960209|FG002|Overall Study|Protocol Violation|2|||
146667927|NCT01903031|528960207|FG000|Overall Study|Lost to Follow-up|0|||
146667928|NCT01903031|528960208|FG001|Overall Study|Lost to Follow-up|0|||
146667929|NCT01903031|528960209|FG002|Overall Study|Lost to Follow-up|1|||
146667930|NCT01903031|528960207|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
146667931|NCT01903031|528960208|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
146667932|NCT01903031|528960209|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
146667933|NCT01811225|528960210|FG000|Treatment Period 1|Adverse Event|2|||
146667934|NCT01811225|528960211|FG001|Treatment Period 1|Adverse Event|3|||
146667935|NCT01811225|528960210|FG000|Treatment Period 1|Lost to Follow-up|12|||
146667936|NCT01811225|528960211|FG001|Treatment Period 1|Lost to Follow-up|8|||
146667937|NCT01811225|528960210|FG000|Treatment Period 1|transporation|1|||
146667938|NCT01811225|528960211|FG001|Treatment Period 1|transporation|0|||
146667939|NCT01811225|528960210|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
146667940|NCT01811225|528960211|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
146667941|NCT01811225|528960210|FG000|Treatment Period 2|Lost to Follow-up|1|||
146667942|NCT01811225|528960211|FG001|Treatment Period 2|Lost to Follow-up|2|||
146667943|NCT01811225|528960210|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
146667944|NCT01811225|528960211|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
146773876|NCT04425629|529343454|FG001|Overall Study|Lack of Efficacy|0|||
146773877|NCT04425629|529343455|FG002|Overall Study|Lack of Efficacy|0|||
146773878|NCT04425629|529343456|FG003|Overall Study|Lack of Efficacy|0|||
146773879|NCT04425629|529343457|FG004|Overall Study|Lack of Efficacy|0|||
146773880|NCT04425629|529343458|FG005|Overall Study|Lack of Efficacy|0|||
146667945|NCT00287365|528960212|FG000|Overall Study|sample not acquired|13|||
146667946|NCT01187433|528960217|FG000|Overall Study|Protocol Violation|6|||
146667947|NCT01187433|528960218|FG001|Overall Study|Protocol Violation|2|||
146667948|NCT01187433|528960217|FG000|Overall Study|Withdrawal by Subject|5|||
146667949|NCT01187433|528960218|FG001|Overall Study|Withdrawal by Subject|2|||
146667950|NCT00302107|528960219|FG000|Overall Study|Lost to Follow-up|6|||
146667951|NCT00302107|528960220|FG001|Overall Study|Lost to Follow-up|5|||
146667952|NCT00302107|528960219|FG000|Overall Study|Protocol Violation|1|||
146667953|NCT00302107|528960220|FG001|Overall Study|Protocol Violation|0|||
146667954|NCT00302107|528960219|FG000|Overall Study|Relocation|0|||
146667955|NCT00302107|528960220|FG001|Overall Study|Relocation|1|||
146667956|NCT00302107|528960219|FG000|Overall Study|Withdrawal by Subject|0|||
146667957|NCT00302107|528960220|FG001|Overall Study|Withdrawal by Subject|3|||
146667958|NCT00302107|528960219|FG000|Overall Study|Adverse Event|1|||
146667959|NCT00302107|528960220|FG001|Overall Study|Adverse Event|0|||
146667960|NCT00437983|528960221|FG000|Overall Study|Adverse Event|6|||
146667961|NCT00437983|528960222|FG001|Overall Study|Adverse Event|6|||
146667962|NCT00437983|528960221|FG000|Overall Study|Protocol Violation|2|||
146667963|NCT00437983|528960222|FG001|Overall Study|Protocol Violation|1|||
146667964|NCT00437983|528960221|FG000|Overall Study|Withdrawal by Subject|5|||
146667965|NCT00437983|528960222|FG001|Overall Study|Withdrawal by Subject|6|||
146667966|NCT01790932|528960223|FG000|Overall Study|Disease Progression|41|||
146667967|NCT01790932|528960223|FG000|Overall Study|Adverse Event|7|||
146667968|NCT01790932|528960223|FG000|Overall Study|Physician Decision|1|||
146667969|NCT01790932|528960223|FG000|Overall Study|Withdrawal by Subject|1|||
146667970|NCT04223973|528960226|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
146667971|NCT04223973|528960227|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
146667972|NCT04223973|528960226|FG000|Overall Study|Adverse Event|4|||
146667973|NCT04223973|528960227|FG001|Overall Study|Adverse Event|0|||
146667974|NCT04223973|528960226|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
146667975|NCT04223973|528960227|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
146667976|NCT04223973|528960226|FG000|Overall Study|Physician Decision|1|||
146667977|NCT04223973|528960227|FG001|Overall Study|Physician Decision|1|||
146667978|NCT04223973|528960226|FG000|Overall Study|Withdrawal by Subject|0|||
146667979|NCT04223973|528960227|FG001|Overall Study|Withdrawal by Subject|1|||
146667980|NCT00594659|528960235|FG000|Overall Study|Lost to Follow-up|13|||
146667981|NCT00594659|528960236|FG001|Overall Study|Lost to Follow-up|9|||
146667982|NCT00594659|528960237|FG002|Overall Study|Lost to Follow-up|7|||
146667983|NCT00300274|528960238|FG000|Overall Study|Withdrawal by Subject|12|||
146667984|NCT00300274|528960239|FG001|Overall Study|Withdrawal by Subject|3|||
146667985|NCT00300274|528960240|FG002|Overall Study|Withdrawal by Subject|14|||
146667986|NCT00300274|528960238|FG000|Overall Study|Lost to Follow-up|3|||
146667987|NCT00300274|528960239|FG001|Overall Study|Lost to Follow-up|4|||
146667988|NCT00300274|528960240|FG002|Overall Study|Lost to Follow-up|5|||
146667989|NCT00300274|528960238|FG000|Overall Study|Death|31|||
146667990|NCT00300274|528960239|FG001|Overall Study|Death|20|||
146667991|NCT00300274|528960240|FG002|Overall Study|Death|25|||
146667992|NCT00300274|528960238|FG000|Overall Study|Re-transplant|0|||
146667993|NCT00300274|528960239|FG001|Overall Study|Re-transplant|0|||
146667994|NCT00300274|528960240|FG002|Overall Study|Re-transplant|1|||
146667995|NCT00242216|528960241|FG000|Overall Study|Lost to Follow-up|12|||
146667996|NCT00242216|528960242|FG001|Overall Study|Lost to Follow-up|17|||
146667997|NCT00242216|528960241|FG000|Overall Study|Death|4|||
146667998|NCT00242216|528960242|FG001|Overall Study|Death|2|||
146667999|NCT00242216|528960241|FG000|Overall Study|Lack of Efficacy|1|||
146773881|NCT04425629|529343459|FG006|Overall Study|Lack of Efficacy|0|||
146925561|NCT00305253|529888295|FG001|Overall Study|Withdrawal by Subject|1|||
146668000|NCT00242216|528960242|FG001|Overall Study|Lack of Efficacy|2|||
146668001|NCT00242216|528960241|FG000|Overall Study|no medicaiton dispensed|1|||
146668002|NCT00242216|528960242|FG001|Overall Study|no medicaiton dispensed|1|||
146668003|NCT00678080|528960244|FG000|Overall Study|Physician Decision|2|||
146668004|NCT00678080|528960245|FG001|Overall Study|Physician Decision|0|||
146668005|NCT00678080|528960244|FG000|Overall Study|Lost to Follow-up|1|||
146668006|NCT00678080|528960245|FG001|Overall Study|Lost to Follow-up|0|||
146668007|NCT00678080|528960244|FG000|Overall Study|Withdrawal by Subject|0|||
146668008|NCT00678080|528960245|FG001|Overall Study|Withdrawal by Subject|1|||
146668009|NCT04439201|528960255|FG000|Overall Study|Ineligible|2|||
146668010|NCT04439201|528960255|FG000|Overall Study|Never start protocol therapy|1|||
146668011|NCT04439201|528960255|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
146925562|NCT02662985|529888297|FG000|Treatment Period 1|Adverse Event|0|||
146925563|NCT02662985|529888298|FG001|Treatment Period 1|Adverse Event|2|||
146925564|NCT02662985|529888297|FG000|Treatment Period 1|Protocol Violation|0|||
146925565|NCT02662985|529888298|FG001|Treatment Period 1|Protocol Violation|1|||
146668012|NCT04439201|528960255|FG000|Overall Study|Mutation status not confirmed|4|||
146668013|NCT04439201|528960255|FG000|Overall Study|Adverse Event|1|||
146668014|NCT04439201|528960255|FG000|Overall Study|Death|7|||
146668015|NCT04439201|528960255|FG000|Overall Study|Withdrawal by Subject|2|||
146668016|NCT04439201|528960255|FG000|Overall Study|Disease progression|20|||
146668017|NCT04439201|528960255|FG000|Overall Study|Alternative therapy|1|||
146668018|NCT04439201|528960255|FG000|Overall Study|Physician Decision|1|||
146668019|NCT03320057|528961922|FG000|Overall Study|Lost to Follow-up|4|||
146668020|NCT03320057|528961923|FG001|Overall Study|Lost to Follow-up|17|||
146668021|NCT03320057|528961922|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
146668022|NCT03320057|528961923|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
146668023|NCT02323113|528961924|FG000|Overall Study|Adverse Event|3|||
146668024|NCT02323113|528961925|FG001|Overall Study|Adverse Event|3|||
146668025|NCT02323113|528961926|FG002|Overall Study|Adverse Event|2|||
146668026|NCT02323113|528961927|FG003|Overall Study|Adverse Event|5|||
146668027|NCT02323113|528961928|FG004|Overall Study|Adverse Event|8|||
146668028|NCT02323113|528961929|FG005|Overall Study|Adverse Event|3|||
146668029|NCT02323113|528961930|FG006|Overall Study|Adverse Event|6|||
146668030|NCT02323113|528961931|FG007|Overall Study|Adverse Event|0|||
146668031|NCT02323113|528961924|FG000|Overall Study|Progressive Disease|0|||
146668032|NCT02323113|528961925|FG001|Overall Study|Progressive Disease|1|||
146668033|NCT02323113|528961926|FG002|Overall Study|Progressive Disease|1|||
146668034|NCT02323113|528961927|FG003|Overall Study|Progressive Disease|0|||
146668035|NCT02323113|528961928|FG004|Overall Study|Progressive Disease|0|||
146668036|NCT02323113|528961929|FG005|Overall Study|Progressive Disease|3|||
146668037|NCT02323113|528961930|FG006|Overall Study|Progressive Disease|0|||
146668038|NCT02323113|528961931|FG007|Overall Study|Progressive Disease|0|||
146668039|NCT02323113|528961924|FG000|Overall Study|Symptomatic Deterioration|0|||
146668040|NCT02323113|528961925|FG001|Overall Study|Symptomatic Deterioration|0|||
146668041|NCT02323113|528961926|FG002|Overall Study|Symptomatic Deterioration|1|||
146668042|NCT02323113|528961927|FG003|Overall Study|Symptomatic Deterioration|0|||
146668043|NCT02323113|528961928|FG004|Overall Study|Symptomatic Deterioration|1|||
146668044|NCT02323113|528961929|FG005|Overall Study|Symptomatic Deterioration|0|||
146668045|NCT02323113|528961930|FG006|Overall Study|Symptomatic Deterioration|0|||
146668046|NCT02323113|528961931|FG007|Overall Study|Symptomatic Deterioration|0|||
146668047|NCT02323113|528961924|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
146668048|NCT02323113|528961925|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
146668049|NCT02323113|528961926|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
146668050|NCT02323113|528961927|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
146668051|NCT02323113|528961928|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
146668052|NCT02323113|528961929|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
146668053|NCT02323113|528961930|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
146668054|NCT02323113|528961931|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
146668055|NCT02323113|528961924|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
146668056|NCT02323113|528961925|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
146668057|NCT02323113|528961926|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
146668058|NCT02323113|528961927|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
146668059|NCT02323113|528961928|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
146668060|NCT02323113|528961929|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
146668061|NCT02323113|528961930|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
146668062|NCT02323113|528961931|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
146668063|NCT00403234|528961932|FG000|Overall Study|Withdrawal by Subject|0|||
146668064|NCT00403234|528961933|FG001|Overall Study|Withdrawal by Subject|1|||
146668065|NCT00403234|528961934|FG002|Overall Study|Withdrawal by Subject|0|||
146668066|NCT00403234|528961935|FG003|Overall Study|Withdrawal by Subject|0|||
146925566|NCT02662985|529888297|FG000|Treatment Period 1|Physician Decision|1|||
146668067|NCT00403234|528961932|FG000|Overall Study|Adverse Event|1|||
146668068|NCT00403234|528961933|FG001|Overall Study|Adverse Event|0|||
146668069|NCT00403234|528961934|FG002|Overall Study|Adverse Event|1|||
146668070|NCT00403234|528961935|FG003|Overall Study|Adverse Event|0|||
146668071|NCT00316719|528961936|FG000|Overall Study|Adverse Event|0|||
146668072|NCT00316719|528961937|FG001|Overall Study|Adverse Event|6|||
146668073|NCT00316719|528961936|FG000|Overall Study|Consent withdrawn|2|||
146668074|NCT00316719|528961937|FG001|Overall Study|Consent withdrawn|0|||
146668075|NCT02468674|528961940|FG000|Overall Study|Adverse Event|0|||
146668076|NCT02468674|528961941|FG001|Overall Study|Adverse Event|0|||
146668077|NCT02468674|528961942|FG002|Overall Study|Adverse Event|0|||
146668078|NCT02468674|528961943|FG003|Overall Study|Adverse Event|1|||
146668079|NCT02468674|528961944|FG004|Overall Study|Adverse Event|0|||
146668080|NCT02468674|528961945|FG005|Overall Study|Adverse Event|1|||
146668081|NCT02468674|528961946|FG006|Overall Study|Adverse Event|0|||
146668082|NCT02468674|528961947|FG007|Overall Study|Adverse Event|0|||
146668083|NCT02468674|528961948|FG008|Overall Study|Adverse Event|0|||
146668084|NCT02468674|528961940|FG000|Overall Study|Lost to Follow-up|1|||
146668085|NCT02468674|528961941|FG001|Overall Study|Lost to Follow-up|0|||
146668086|NCT02468674|528961942|FG002|Overall Study|Lost to Follow-up|0|||
146668087|NCT02468674|528961943|FG003|Overall Study|Lost to Follow-up|0|||
146668088|NCT02468674|528961944|FG004|Overall Study|Lost to Follow-up|0|||
146668089|NCT02468674|528961945|FG005|Overall Study|Lost to Follow-up|0|||
146668090|NCT02468674|528961946|FG006|Overall Study|Lost to Follow-up|0|||
146668091|NCT02468674|528961947|FG007|Overall Study|Lost to Follow-up|1|||
146668092|NCT02468674|528961948|FG008|Overall Study|Lost to Follow-up|1|||
146668093|NCT02468674|528961940|FG000|Overall Study|Physician Decision|0|||
146668094|NCT02468674|528961941|FG001|Overall Study|Physician Decision|0|||
146668095|NCT02468674|528961942|FG002|Overall Study|Physician Decision|0|||
146668096|NCT02468674|528961943|FG003|Overall Study|Physician Decision|0|||
146668097|NCT02468674|528961944|FG004|Overall Study|Physician Decision|0|||
146668098|NCT02468674|528961945|FG005|Overall Study|Physician Decision|0|||
146668099|NCT02468674|528961946|FG006|Overall Study|Physician Decision|1|||
146668100|NCT02468674|528961947|FG007|Overall Study|Physician Decision|0|||
146668101|NCT02468674|528961948|FG008|Overall Study|Physician Decision|0|||
146668102|NCT02468674|528961940|FG000|Overall Study|Patient/Guardian Decision|0|||
146668103|NCT02468674|528961941|FG001|Overall Study|Patient/Guardian Decision|0|||
146668104|NCT02468674|528961942|FG002|Overall Study|Patient/Guardian Decision|0|||
146668105|NCT02468674|528961943|FG003|Overall Study|Patient/Guardian Decision|0|||
146668106|NCT02468674|528961944|FG004|Overall Study|Patient/Guardian Decision|1|||
146668107|NCT02468674|528961945|FG005|Overall Study|Patient/Guardian Decision|0|||
146668108|NCT02468674|528961946|FG006|Overall Study|Patient/Guardian Decision|0|||
146668109|NCT02468674|528961947|FG007|Overall Study|Patient/Guardian Decision|2|||
146668110|NCT02468674|528961948|FG008|Overall Study|Patient/Guardian Decision|1|||
146668111|NCT02468674|528961940|FG000|Overall Study|Protocol Deviation|0|||
146668112|NCT02468674|528961941|FG001|Overall Study|Protocol Deviation|0|||
146668113|NCT02468674|528961942|FG002|Overall Study|Protocol Deviation|0|||
146668114|NCT02468674|528961943|FG003|Overall Study|Protocol Deviation|0|||
146668115|NCT02468674|528961944|FG004|Overall Study|Protocol Deviation|0|||
146668116|NCT02468674|528961945|FG005|Overall Study|Protocol Deviation|0|||
146668117|NCT02468674|528961946|FG006|Overall Study|Protocol Deviation|0|||
146668118|NCT02468674|528961947|FG007|Overall Study|Protocol Deviation|1|||
146668119|NCT02468674|528961948|FG008|Overall Study|Protocol Deviation|1|||
146668120|NCT03281577|528961950|FG000|Overall Study|Adverse Event|0|||
146668121|NCT03281577|528961951|FG001|Overall Study|Adverse Event|0|||
146668122|NCT03281577|528961952|FG002|Overall Study|Adverse Event|0|||
146668123|NCT03281577|528961953|FG003|Overall Study|Adverse Event|1|||
146668124|NCT03281577|528961950|FG000|Overall Study|Withdrawal by Subject|1|||
146668125|NCT03281577|528961951|FG001|Overall Study|Withdrawal by Subject|0|||
146668126|NCT03281577|528961952|FG002|Overall Study|Withdrawal by Subject|0|||
146668127|NCT03281577|528961953|FG003|Overall Study|Withdrawal by Subject|0|||
146668128|NCT01550289|528961954|FG000|Overall Study|Protocol Violation|1|||
146668129|NCT01550289|528961955|FG001|Overall Study|Protocol Violation|0|||
146668130|NCT01550289|528961954|FG000|Overall Study|Lost to Follow-up|1|||
146668131|NCT01550289|528961955|FG001|Overall Study|Lost to Follow-up|1|||
146668132|NCT01550289|528961954|FG000|Overall Study|Withdrawal by Subject|11|||
146668133|NCT01550289|528961955|FG001|Overall Study|Withdrawal by Subject|3|||
146773882|NCT04425629|529343460|FG007|Overall Study|Lack of Efficacy|0|||
146773883|NCT04425629|529343461|FG008|Overall Study|Lack of Efficacy|0|||
146773884|NCT04425629|529343462|FG009|Overall Study|Lack of Efficacy|0|||
146773885|NCT04425629|529343463|FG010|Overall Study|Lack of Efficacy|1|||
146773886|NCT04425629|529343464|FG011|Overall Study|Lack of Efficacy|0|||
146773887|NCT04425629|529343465|FG012|Overall Study|Lack of Efficacy|0|||
146668134|NCT02975336|528961956|FG000|DBPC (52 Weeks)|Adverse Event|16|||
146668135|NCT02975336|528961957|FG001|DBPC (52 Weeks)|Adverse Event|17|||
146668136|NCT02975336|528961958|FG002|DBPC (52 Weeks)|Adverse Event|13|||
146668137|NCT02975336|528961959|FG003|DBPC (52 Weeks)|Adverse Event|18|||
146668138|NCT02975336|528961960|FG004|DBPC (52 Weeks)|Adverse Event|0|||
146668139|NCT02975336|528961961|FG005|DBPC (52 Weeks)|Adverse Event|0|||
146668140|NCT02975336|528961962|FG006|DBPC (52 Weeks)|Adverse Event|0|||
146668141|NCT02975336|528961963|FG007|DBPC (52 Weeks)|Adverse Event|0|||
146668142|NCT02975336|528961956|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
146668143|NCT02975336|528961957|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
146668144|NCT02975336|528961958|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
146668145|NCT02975336|528961959|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
146668146|NCT02975336|528961960|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
146668147|NCT02975336|528961961|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
146668148|NCT02975336|528961962|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
146668149|NCT02975336|528961963|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
146668150|NCT02975336|528961956|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
146668151|NCT02975336|528961957|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
146668152|NCT02975336|528961958|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
146668153|NCT02975336|528961959|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
146668154|NCT02975336|528961960|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
146668155|NCT02975336|528961961|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
146668156|NCT02975336|528961962|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
146668157|NCT02975336|528961963|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
146668158|NCT02975336|528961956|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
146668159|NCT02975336|528961957|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
146668160|NCT02975336|528961958|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
146668161|NCT02975336|528961959|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
146668162|NCT02975336|528961960|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
146668163|NCT02975336|528961961|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
146668164|NCT02975336|528961962|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
146668165|NCT02975336|528961963|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
146668166|NCT02975336|528961956|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
146668167|NCT02975336|528961957|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
146668168|NCT02975336|528961958|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
146668169|NCT02975336|528961959|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
146668170|NCT02975336|528961960|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
146668171|NCT02975336|528961961|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
146668172|NCT02975336|528961962|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
146668173|NCT02975336|528961963|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
146668174|NCT02975336|528961956|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
146668175|NCT02975336|528961957|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
146668176|NCT02975336|528961958|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
146668177|NCT02975336|528961959|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
146668178|NCT02975336|528961960|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
146668179|NCT02975336|528961961|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
146668180|NCT02975336|528961962|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
146668181|NCT02975336|528961963|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
146668182|NCT02975336|528961956|FG000|LTE (104 Weeks)|Adverse Event|0|||
146668183|NCT02975336|528961957|FG001|LTE (104 Weeks)|Adverse Event|0|||
146668184|NCT02975336|528961958|FG002|LTE (104 Weeks)|Adverse Event|0|||
146668185|NCT02975336|528961959|FG003|LTE (104 Weeks)|Adverse Event|0|||
146668186|NCT02975336|528961960|FG004|LTE (104 Weeks)|Adverse Event|7|||
146668187|NCT02975336|528961961|FG005|LTE (104 Weeks)|Adverse Event|4|||
146668188|NCT02975336|528961962|FG006|LTE (104 Weeks)|Adverse Event|2|||
146668189|NCT02975336|528961963|FG007|LTE (104 Weeks)|Adverse Event|0|||
146668190|NCT02975336|528961956|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
146668191|NCT02975336|528961957|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
146668192|NCT02975336|528961958|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
146668193|NCT02975336|528961959|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
146668194|NCT02975336|528961960|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
146668195|NCT02975336|528961961|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
146668196|NCT02975336|528961962|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
146668197|NCT02975336|528961963|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
146668198|NCT02975336|528961956|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
146668199|NCT02975336|528961957|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
146668200|NCT02975336|528961958|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
146668201|NCT02975336|528961959|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
146668202|NCT02975336|528961960|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
146668203|NCT02975336|528961961|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
146668204|NCT02975336|528961962|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
146668205|NCT02975336|528961963|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
146668206|NCT02975336|528961956|FG000|LTE (104 Weeks)|Other|0|||
146668207|NCT02975336|528961957|FG001|LTE (104 Weeks)|Other|0|||
146668208|NCT02975336|528961958|FG002|LTE (104 Weeks)|Other|0|||
146668209|NCT02975336|528961959|FG003|LTE (104 Weeks)|Other|0|||
146668210|NCT02975336|528961960|FG004|LTE (104 Weeks)|Other|55|||
146668211|NCT02975336|528961961|FG005|LTE (104 Weeks)|Other|63|||
146668212|NCT02975336|528961962|FG006|LTE (104 Weeks)|Other|76|||
146668213|NCT02975336|528961963|FG007|LTE (104 Weeks)|Other|72|||
146668214|NCT01897454|528961964|FG000|Overall Study|Withdrawal by Subject|1|||
146668215|NCT05154578|528961966|FG000|Overall Study|Withdrawal by Subject|2|||
146668216|NCT05154578|528961967|FG001|Overall Study|Withdrawal by Subject|3|||
146668217|NCT05154578|528961968|FG002|Overall Study|Withdrawal by Subject|2|||
146668218|NCT05154578|528961969|FG003|Overall Study|Withdrawal by Subject|4|||
146668219|NCT05154578|528961970|FG004|Overall Study|Withdrawal by Subject|0|||
146668220|NCT05154578|528961966|FG000|Overall Study|Lost to Follow-up|0|||
146668221|NCT05154578|528961967|FG001|Overall Study|Lost to Follow-up|1|||
146668222|NCT05154578|528961968|FG002|Overall Study|Lost to Follow-up|0|||
146668223|NCT05154578|528961969|FG003|Overall Study|Lost to Follow-up|3|||
146668224|NCT05154578|528961970|FG004|Overall Study|Lost to Follow-up|0|||
146668225|NCT05154578|528961966|FG000|Overall Study|Adverse Event|0|||
146668226|NCT05154578|528961967|FG001|Overall Study|Adverse Event|0|||
146668227|NCT05154578|528961968|FG002|Overall Study|Adverse Event|0|||
146668228|NCT05154578|528961969|FG003|Overall Study|Adverse Event|1|||
146668229|NCT05154578|528961970|FG004|Overall Study|Adverse Event|0|||
146668230|NCT05154578|528961966|FG000|Overall Study|Relocated to another province|0|||
146668231|NCT05154578|528961967|FG001|Overall Study|Relocated to another province|0|||
146668232|NCT05154578|528961968|FG002|Overall Study|Relocated to another province|1|||
146668233|NCT05154578|528961969|FG003|Overall Study|Relocated to another province|0|||
146668234|NCT05154578|528961970|FG004|Overall Study|Relocated to another province|1|||
146668235|NCT05154578|528961966|FG000|Overall Study|Baby loss|0|||
146668236|NCT05154578|528961967|FG001|Overall Study|Baby loss|1|||
146668237|NCT05154578|528961968|FG002|Overall Study|Baby loss|0|||
146668238|NCT05154578|528961969|FG003|Overall Study|Baby loss|0|||
146668239|NCT05154578|528961970|FG004|Overall Study|Baby loss|0|||
146668240|NCT00894166|528961978|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
146668241|NCT00894166|528961979|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
146668242|NCT00894166|528961980|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
146668243|NCT00894166|528961981|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
146668244|NCT00894166|528961982|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
146668245|NCT00894166|528961983|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
146668246|NCT00894166|528961984|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
146668247|NCT00894166|528961985|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
146668248|NCT00894166|528961978|FG000|Overall Study|Death|0|||
146668249|NCT00894166|528961979|FG001|Overall Study|Death|0|||
146668250|NCT00894166|528961980|FG002|Overall Study|Death|0|||
146668251|NCT00894166|528961981|FG003|Overall Study|Death|1|||
146668252|NCT00894166|528961982|FG004|Overall Study|Death|0|||
146668253|NCT00894166|528961983|FG005|Overall Study|Death|0|||
146668254|NCT00894166|528961984|FG006|Overall Study|Death|0|||
146668255|NCT00894166|528961985|FG007|Overall Study|Death|0|||
146668256|NCT05350410|528961986|FG000|Overall Study|Withdrawal by Subject|1|||
146668257|NCT00142935|528961990|FG000|Overall Study|Other reason|1|||
146668258|NCT00142935|528961991|FG001|Overall Study|Other reason|1|||
146668259|NCT00142935|528961992|FG002|Overall Study|Other reason|1|||
146668260|NCT00142935|528961990|FG000|Overall Study|Lost to Follow-up|2|||
146668261|NCT00142935|528961991|FG001|Overall Study|Lost to Follow-up|5|||
146668262|NCT00142935|528961992|FG002|Overall Study|Lost to Follow-up|5|||
146668263|NCT00142935|528961990|FG000|Overall Study|Death|0|||
146668264|NCT00142935|528961991|FG001|Overall Study|Death|2|||
146668265|NCT00142935|528961992|FG002|Overall Study|Death|1|||
146668266|NCT01180985|528961993|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
146668267|NCT01180985|528961994|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
146668268|NCT00705289|528961995|FG000|Overall Study|Subject or treating physician's choice|131|||
146668269|NCT04289623|528961999|FG000|Wave 1 Emails|Email was not delivered|268|||
146668270|NCT04289623|528962000|FG001|Wave 1 Emails|Email was not delivered|257|||
146668271|NCT04289623|528962001|FG002|Wave 1 Emails|Email was not delivered|0|||
146668272|NCT04289623|528962002|FG003|Wave 1 Emails|Email was not delivered|0|||
146668273|NCT04289623|528962003|FG004|Wave 1 Emails|Email was not delivered|0|||
146668274|NCT04289623|528962004|FG005|Wave 1 Emails|Email was not delivered|0|||
146668275|NCT01952145|528962005|FG000|Overall Study|Protocol Violation|2|||
146668276|NCT01952145|528962006|FG001|Overall Study|Protocol Violation|1|||
146668277|NCT01952145|528962005|FG000|Overall Study|Death|0|||
146668278|NCT01952145|528962006|FG001|Overall Study|Death|1|||
146668279|NCT01952145|528962005|FG000|Overall Study|Adverse Event|9|||
146668280|NCT01952145|528962006|FG001|Overall Study|Adverse Event|0|||
146668281|NCT01952145|528962005|FG000|Overall Study|Withdrawal Criteria|16|||
146668282|NCT01952145|528962006|FG001|Overall Study|Withdrawal Criteria|11|||
146668283|NCT01952145|528962005|FG000|Overall Study|Unclassified|1|||
146668284|NCT01952145|528962006|FG001|Overall Study|Unclassified|1|||
146668285|NCT04515394|528962011|FG000|Overall Study|Participant did not receive treatment|1|||
146668286|NCT00413244|528962012|FG000|Overall Study|Withdrawal by Subject|10|||
146668287|NCT00413244|528962013|FG001|Overall Study|Withdrawal by Subject|1|||
146668288|NCT01609231|528962015|FG000|Overall Study|Adverse Event|1|||
146668289|NCT01609231|528962016|FG001|Overall Study|Adverse Event|3|||
146668290|NCT01609231|528962015|FG000|Overall Study|Physician Decision|1|||
146773888|NCT04425629|529343466|FG013|Overall Study|Lack of Efficacy|0|||
146668291|NCT01609231|528962016|FG001|Overall Study|Physician Decision|0|||
146668292|NCT01609231|528962015|FG000|Overall Study|Withdrawal by Subject|1|||
146668293|NCT01609231|528962016|FG001|Overall Study|Withdrawal by Subject|0|||
146668294|NCT02761733|528962018|FG000|Overall Study|Death|3|||
146668295|NCT02761733|528962019|FG001|Overall Study|Death|5|||
146668296|NCT02761733|528962020|FG002|Overall Study|Death|1|||
146668297|NCT02761733|528962021|FG003|Overall Study|Death|1|||
146668298|NCT02761733|528962018|FG000|Overall Study|Lost to Follow-up|6|||
146773889|NCT04425629|529343467|FG014|Overall Study|Lack of Efficacy|0|||
146668299|NCT02761733|528962019|FG001|Overall Study|Lost to Follow-up|7|||
146668300|NCT02761733|528962020|FG002|Overall Study|Lost to Follow-up|0|||
146668301|NCT02761733|528962021|FG003|Overall Study|Lost to Follow-up|3|||
146668302|NCT02761733|528962018|FG000|Overall Study|Physician Decision|4|||
146668303|NCT02761733|528962019|FG001|Overall Study|Physician Decision|0|||
146668304|NCT02761733|528962020|FG002|Overall Study|Physician Decision|0|||
146668305|NCT02761733|528962021|FG003|Overall Study|Physician Decision|0|||
146668306|NCT02761733|528962018|FG000|Overall Study|Withdrawal by Subject|2|||
146668307|NCT02761733|528962019|FG001|Overall Study|Withdrawal by Subject|0|||
146668308|NCT02761733|528962020|FG002|Overall Study|Withdrawal by Subject|0|||
146668309|NCT02761733|528962021|FG003|Overall Study|Withdrawal by Subject|0|||
146668310|NCT02761733|528962018|FG000|Overall Study|Discharged from Study Site|10|||
146668311|NCT02761733|528962019|FG001|Overall Study|Discharged from Study Site|9|||
146668312|NCT02761733|528962020|FG002|Overall Study|Discharged from Study Site|25|||
146668313|NCT02761733|528962021|FG003|Overall Study|Discharged from Study Site|11|||
146668314|NCT02761733|528962018|FG000|Overall Study|Cognitive Impairment|5|||
146668315|NCT02761733|528962019|FG001|Overall Study|Cognitive Impairment|0|||
146668316|NCT02761733|528962020|FG002|Overall Study|Cognitive Impairment|1|||
146668317|NCT02761733|528962021|FG003|Overall Study|Cognitive Impairment|0|||
146668318|NCT02713204|528962022|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
146668319|NCT02713204|528962023|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
146668320|NCT02713204|528962024|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
146668321|NCT02713204|528962025|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
146668322|NCT02713204|528962026|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
146668323|NCT02713204|528962027|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
146668324|NCT02713204|528962028|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
146668325|NCT02713204|528962029|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
146668326|NCT02713204|528962022|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146668327|NCT02713204|528962023|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146668328|NCT02713204|528962024|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
146668329|NCT02713204|528962025|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146668330|NCT02713204|528962026|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146668331|NCT02713204|528962027|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146668332|NCT02713204|528962028|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146668333|NCT02713204|528962029|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146668334|NCT02713204|528962022|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146668335|NCT02713204|528962023|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
146668336|NCT02713204|528962024|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146668337|NCT02713204|528962025|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146668338|NCT02713204|528962026|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146668339|NCT02713204|528962027|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146668340|NCT02713204|528962028|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146668341|NCT02713204|528962029|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146668342|NCT02713204|528962022|FG000|From Week 12 up to Week 36|Adverse Event|1|||
146668343|NCT02713204|528962023|FG001|From Week 12 up to Week 36|Adverse Event|0|||
146668344|NCT02713204|528962024|FG002|From Week 12 up to Week 36|Adverse Event|0|||
146668345|NCT02713204|528962025|FG003|From Week 12 up to Week 36|Adverse Event|1|||
146668346|NCT02713204|528962026|FG004|From Week 12 up to Week 36|Adverse Event|1|||
146668347|NCT02713204|528962027|FG005|From Week 12 up to Week 36|Adverse Event|0|||
146668348|NCT02713204|528962028|FG006|From Week 12 up to Week 36|Adverse Event|2|||
146668349|NCT02713204|528962029|FG007|From Week 12 up to Week 36|Adverse Event|1|||
146668350|NCT02713204|528962022|FG000|From Week 12 up to Week 36|Death|0|||
146668351|NCT02713204|528962023|FG001|From Week 12 up to Week 36|Death|0|||
146668352|NCT02713204|528962024|FG002|From Week 12 up to Week 36|Death|0|||
146668353|NCT02713204|528962025|FG003|From Week 12 up to Week 36|Death|1|||
146668354|NCT02713204|528962026|FG004|From Week 12 up to Week 36|Death|0|||
146668355|NCT02713204|528962027|FG005|From Week 12 up to Week 36|Death|1|||
146668356|NCT02713204|528962028|FG006|From Week 12 up to Week 36|Death|0|||
146668357|NCT02713204|528962029|FG007|From Week 12 up to Week 36|Death|3|||
146668358|NCT02713204|528962022|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
146668359|NCT02713204|528962023|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
146668360|NCT02713204|528962024|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
146668361|NCT02713204|528962025|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
146668362|NCT02713204|528962026|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
146668363|NCT02713204|528962027|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
146668364|NCT02713204|528962028|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
146668365|NCT02713204|528962029|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
146668366|NCT02713204|528962022|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
146668367|NCT02713204|528962023|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
146668368|NCT02713204|528962024|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
146925567|NCT02662985|529888298|FG001|Treatment Period 1|Physician Decision|0|||
146925568|NCT02662985|529888297|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146668369|NCT02713204|528962025|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
146668370|NCT02713204|528962026|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
146668371|NCT02713204|528962027|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
146668372|NCT02713204|528962028|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
146668373|NCT02713204|528962029|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
146668374|NCT00569270|528962033|FG000|Period: First Intervention|Protocol Violation|0|||
146668375|NCT00569270|528962034|FG001|Period: First Intervention|Protocol Violation|1|||
146925569|NCT02662985|529888298|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146925570|NCT02662985|529888297|FG000|Treatment Period 2|Lack of Efficacy|0|||
146925571|NCT02662985|529888298|FG001|Treatment Period 2|Lack of Efficacy|1|||
146925572|NCT02662985|529888297|FG000|Treatment Period 2|Lost to Follow-up|1|||
146925573|NCT02662985|529888298|FG001|Treatment Period 2|Lost to Follow-up|0|||
146925574|NCT02662985|529888297|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
146925575|NCT02662985|529888298|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
146925576|NCT02662985|529888297|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
146925577|NCT02662985|529888298|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
146925578|NCT02662985|529888297|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
146925579|NCT02662985|529888298|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
146925580|NCT02662985|529888297|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
146925581|NCT02662985|529888298|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
146925582|NCT02662985|529888297|FG000|Treatment Period 3 (Extension Period)|Death|0|||
146925583|NCT02662985|529888298|FG001|Treatment Period 3 (Extension Period)|Death|1|||
146925584|NCT03442829|529888299|FG000|Overall Study|Scheduling clash|3|||
146668376|NCT00447005|528962035|FG000|Overall Study|Adverse Event|1|||
146668377|NCT00447005|528962035|FG000|Overall Study|Lack of Efficacy|11|||
146668378|NCT00492531|528962036|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
146668379|NCT00492531|528962037|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
146668380|NCT03685123|528962041|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
146668381|NCT03685123|528962042|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
146668382|NCT03685123|528962043|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
146668383|NCT03685123|528962041|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
146668384|NCT03685123|528962042|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
146668385|NCT03685123|528962043|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
146668386|NCT03685123|528962041|FG000|Weight Loss Phase|Lost to Follow-up|1|||
146668387|NCT03685123|528962042|FG001|Weight Loss Phase|Lost to Follow-up|0|||
146668388|NCT03685123|528962043|FG002|Weight Loss Phase|Lost to Follow-up|0|||
146668389|NCT03685123|528962041|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
146668390|NCT03685123|528962042|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
146668391|NCT03685123|528962043|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
146668392|NCT03685123|528962041|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
146668393|NCT03685123|528962042|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
146668394|NCT03685123|528962043|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
146668395|NCT03685123|528962041|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
146668396|NCT03685123|528962042|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
146668397|NCT03685123|528962043|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
146668398|NCT00400764|528962045|FG000|Phase Ib|Adverse Event|1|||
146668399|NCT00400764|528962046|FG001|Phase Ib|Adverse Event|0|||
146668400|NCT00400764|528962047|FG002|Phase Ib|Adverse Event|0|||
146668401|NCT00400764|528962048|FG003|Phase Ib|Adverse Event|0|||
146668402|NCT00400764|528962049|FG004|Phase Ib|Adverse Event|0|||
146668403|NCT00400764|528962045|FG000|Phase Ib|Death|1|||
146668404|NCT00400764|528962046|FG001|Phase Ib|Death|0|||
146668405|NCT00400764|528962047|FG002|Phase Ib|Death|0|||
146668406|NCT00400764|528962048|FG003|Phase Ib|Death|0|||
146668407|NCT00400764|528962049|FG004|Phase Ib|Death|0|||
146668408|NCT00400764|528962045|FG000|Phase Ib|Disease Progression|4|||
146668409|NCT00400764|528962046|FG001|Phase Ib|Disease Progression|4|||
146668410|NCT00400764|528962047|FG002|Phase Ib|Disease Progression|0|||
146668411|NCT00400764|528962048|FG003|Phase Ib|Disease Progression|0|||
146668412|NCT00400764|528962049|FG004|Phase Ib|Disease Progression|0|||
146668413|NCT00400764|528962045|FG000|Phase II|Death|0|||
146668414|NCT00400764|528962046|FG001|Phase II|Death|0|||
146668415|NCT00400764|528962047|FG002|Phase II|Death|1|||
146668416|NCT00400764|528962048|FG003|Phase II|Death|2|||
146668417|NCT00400764|528962049|FG004|Phase II|Death|0|||
146668418|NCT00400764|528962045|FG000|Phase II|Lost to Follow-up|0|||
146668419|NCT00400764|528962046|FG001|Phase II|Lost to Follow-up|0|||
146668420|NCT00400764|528962047|FG002|Phase II|Lost to Follow-up|1|||
146668421|NCT00400764|528962048|FG003|Phase II|Lost to Follow-up|0|||
146668422|NCT00400764|528962049|FG004|Phase II|Lost to Follow-up|0|||
146668423|NCT00400764|528962045|FG000|Phase II|Physician Decision|0|||
146668424|NCT00400764|528962046|FG001|Phase II|Physician Decision|0|||
146925585|NCT03442829|529888300|FG001|Overall Study|Scheduling clash|1|||
146925586|NCT03442829|529888299|FG000|Overall Study|Illness unrelated to study|1|||
146668425|NCT00400764|528962047|FG002|Phase II|Physician Decision|1|||
146668426|NCT00400764|528962048|FG003|Phase II|Physician Decision|1|||
146668427|NCT00400764|528962049|FG004|Phase II|Physician Decision|0|||
146668428|NCT00400764|528962045|FG000|Phase II|Sponsor's decision to terminate|0|||
146668429|NCT00400764|528962046|FG001|Phase II|Sponsor's decision to terminate|0|||
146668430|NCT00400764|528962047|FG002|Phase II|Sponsor's decision to terminate|18|||
146668431|NCT00400764|528962048|FG003|Phase II|Sponsor's decision to terminate|22|||
146668432|NCT00400764|528962049|FG004|Phase II|Sponsor's decision to terminate|11|||
146668433|NCT00400764|528962045|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
146668434|NCT00400764|528962046|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
146668435|NCT00400764|528962047|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
146668436|NCT00400764|528962048|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
146668437|NCT00400764|528962049|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
146668438|NCT00400764|528962045|FG000|Phase II|Withdrawal by Subject|0|||
146668439|NCT00400764|528962046|FG001|Phase II|Withdrawal by Subject|0|||
146668440|NCT00400764|528962047|FG002|Phase II|Withdrawal by Subject|1|||
146668441|NCT00400764|528962048|FG003|Phase II|Withdrawal by Subject|1|||
146668442|NCT00400764|528962049|FG004|Phase II|Withdrawal by Subject|0|||
146668443|NCT01758523|528962053|FG000|Overall Study|Adverse Event|2|||
146668444|NCT01758523|528962054|FG001|Overall Study|Adverse Event|1|||
146668445|NCT01758523|528962053|FG000|Overall Study|Lack of Efficacy|4|||
146668446|NCT01758523|528962054|FG001|Overall Study|Lack of Efficacy|2|||
146668447|NCT01758523|528962053|FG000|Overall Study|Lost to Follow-up|3|||
146668448|NCT01758523|528962054|FG001|Overall Study|Lost to Follow-up|4|||
146668449|NCT01758523|528962053|FG000|Overall Study|Withdrawal by Subject|12|||
146668450|NCT01758523|528962054|FG001|Overall Study|Withdrawal by Subject|7|||
146668451|NCT00621959|528962055|FG000|Overall Study|Adverse Event|4|||
146668452|NCT00621959|528962056|FG001|Overall Study|Adverse Event|2|||
146668453|NCT00621959|528962055|FG000|Overall Study|Lack of Efficacy|1|||
146668454|NCT00621959|528962056|FG001|Overall Study|Lack of Efficacy|1|||
146668455|NCT00621959|528962055|FG000|Overall Study|Lost to Follow-up|0|||
146668456|NCT00621959|528962056|FG001|Overall Study|Lost to Follow-up|2|||
146668457|NCT00621959|528962055|FG000|Overall Study|Withdrawal by Subject|1|||
146668458|NCT00621959|528962056|FG001|Overall Study|Withdrawal by Subject|1|||
146668459|NCT00621959|528962055|FG000|Overall Study|Other|1|||
146668460|NCT00621959|528962056|FG001|Overall Study|Other|3|||
146668461|NCT00722800|528962057|FG000|Overall Study|Withdrawal by Subject|1|||
146668462|NCT00722800|528962058|FG001|Overall Study|Withdrawal by Subject|0|||
146668463|NCT00722800|528962057|FG000|Overall Study|Physician Decision|1|||
146668464|NCT00722800|528962058|FG001|Overall Study|Physician Decision|0|||
146668465|NCT02130297|528962063|FG000|Overall Study|Lost to Follow-up|4|||
146668466|NCT01387789|528962064|FG000|Overall Study|Adverse Event|5|||
146668467|NCT01387789|528962064|FG000|Overall Study|Lack of Efficacy|2|||
146668468|NCT01387789|528962064|FG000|Overall Study|Lost to Follow-up|1|||
146668469|NCT02187744|528962065|FG000|Study|Participant refused further follow-up|1|||
146668470|NCT02187744|528962066|FG001|Study|Participant refused further follow-up|0|||
146668471|NCT02187744|528962065|FG000|Study|Other|2|||
146668472|NCT02187744|528962066|FG001|Study|Other|1|||
146668473|NCT02187744|528962065|FG000|Study|Lost to Follow-up|0|||
146668474|NCT02187744|528962066|FG001|Study|Lost to Follow-up|2|||
146668475|NCT02187744|528962065|FG000|Study|Related adverse event, not serious|0|||
146668476|NCT02187744|528962066|FG001|Study|Related adverse event, not serious|2|||
146668477|NCT02187744|528962065|FG000|Study|Death|1|||
146668478|NCT02187744|528962066|FG001|Study|Death|0|||
146668479|NCT02187744|528962065|FG000|Study|Related adverse event, serious non-fatal|0|||
146668480|NCT02187744|528962066|FG001|Study|Related adverse event, serious non-fatal|1|||
146668481|NCT02187744|528962065|FG000|Treatment|Death|1|||
146668482|NCT02187744|528962066|FG001|Treatment|Death|0|||
146668483|NCT02187744|528962065|FG000|Treatment|Related adverse event, serious non-fatal|0|||
146668484|NCT02187744|528962066|FG001|Treatment|Related adverse event, serious non-fatal|1|||
146668485|NCT02187744|528962065|FG000|Treatment|Related adverse event, not serious|0|||
146668486|NCT02187744|528962066|FG001|Treatment|Related adverse event, not serious|2|||
146668487|NCT02187744|528962065|FG000|Treatment|Lost to Follow-up|0|||
146668488|NCT02187744|528962066|FG001|Treatment|Lost to Follow-up|1|||
146668489|NCT02187744|528962065|FG000|Treatment|Other|2|||
146668490|NCT02187744|528962066|FG001|Treatment|Other|0|||
146668491|NCT02187744|528962065|FG000|Treatment|Participant refused continued treatment|1|||
146668492|NCT02187744|528962066|FG001|Treatment|Participant refused continued treatment|1|||
146668493|NCT00508755|528962071|FG000|Overall Study|Withdrawal by Subject|1|||
146668494|NCT00945893|528962072|FG000|Overall Study|Lost to Follow-up|2|||
146668495|NCT00945893|528962073|FG001|Overall Study|Lost to Follow-up|8|||
146668496|NCT00945893|528962072|FG000|Overall Study|Withdrawal of consent|1|||
146668497|NCT00945893|528962073|FG001|Overall Study|Withdrawal of consent|2|||
146668498|NCT03113071|528962074|FG000|Overall Study|Withdrawal by Subject|1|||
146668499|NCT03113071|528962075|FG001|Overall Study|Withdrawal by Subject|0|||
146668500|NCT01602120|528962076|FG000|Overall Study|Adverse Event|3|||
146668501|NCT01602120|528962077|FG001|Overall Study|Adverse Event|6|||
146668502|NCT01602120|528962078|FG002|Overall Study|Adverse Event|0|||
146668503|NCT01602120|528962079|FG003|Overall Study|Adverse Event|2|||
146668504|NCT01602120|528962076|FG000|Overall Study|Death|0|||
146668505|NCT01602120|528962077|FG001|Overall Study|Death|4|||
146668506|NCT01602120|528962078|FG002|Overall Study|Death|0|||
146668507|NCT01602120|528962079|FG003|Overall Study|Death|0|||
146668508|NCT01602120|528962076|FG000|Overall Study|Lost to Follow-up|0|||
146668509|NCT01602120|528962077|FG001|Overall Study|Lost to Follow-up|1|||
146668510|NCT01602120|528962078|FG002|Overall Study|Lost to Follow-up|0|||
146668511|NCT01602120|528962079|FG003|Overall Study|Lost to Follow-up|1|||
146668512|NCT01602120|528962076|FG000|Overall Study|Protocol Violation|1|||
146668513|NCT01602120|528962077|FG001|Overall Study|Protocol Violation|1|||
146668514|NCT01602120|528962078|FG002|Overall Study|Protocol Violation|0|||
146668515|NCT01602120|528962079|FG003|Overall Study|Protocol Violation|0|||
146668516|NCT01602120|528962076|FG000|Overall Study|Non-compliance|0|||
146668517|NCT01602120|528962077|FG001|Overall Study|Non-compliance|3|||
146668518|NCT01602120|528962078|FG002|Overall Study|Non-compliance|0|||
146668519|NCT01602120|528962079|FG003|Overall Study|Non-compliance|1|||
146668520|NCT01602120|528962076|FG000|Overall Study|Withdrawal by Subject|8|||
146668521|NCT01602120|528962077|FG001|Overall Study|Withdrawal by Subject|17|||
146668522|NCT01602120|528962078|FG002|Overall Study|Withdrawal by Subject|0|||
146668523|NCT01602120|528962079|FG003|Overall Study|Withdrawal by Subject|3|||
146668524|NCT01602120|528962076|FG000|Overall Study|Study Terminated by Sponsor|12|||
146668525|NCT01602120|528962077|FG001|Overall Study|Study Terminated by Sponsor|24|||
146668526|NCT01602120|528962078|FG002|Overall Study|Study Terminated by Sponsor|17|||
146668527|NCT01602120|528962079|FG003|Overall Study|Study Terminated by Sponsor|44|||
146668528|NCT01602120|528962076|FG000|Overall Study|Physician Decision|2|||
146668529|NCT01602120|528962077|FG001|Overall Study|Physician Decision|3|||
146668530|NCT01602120|528962078|FG002|Overall Study|Physician Decision|0|||
146668531|NCT01602120|528962079|FG003|Overall Study|Physician Decision|0|||
146668532|NCT01602120|528962076|FG000|Overall Study|Unspecified Reason|3|||
146668533|NCT01602120|528962077|FG001|Overall Study|Unspecified Reason|1|||
146668534|NCT01602120|528962078|FG002|Overall Study|Unspecified Reason|0|||
146668535|NCT01602120|528962079|FG003|Overall Study|Unspecified Reason|2|||
146668536|NCT03298867|528962089|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
146668537|NCT03298867|528962090|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
146668538|NCT03298867|528962089|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
146668539|NCT03298867|528962090|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
146668540|NCT03298867|528962089|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
146668541|NCT03298867|528962090|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
146668542|NCT03298867|528962089|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
146668543|NCT03298867|528962090|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
146668544|NCT03298867|528962089|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
146668545|NCT03298867|528962090|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
146668546|NCT03298867|528962089|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
146668547|NCT03298867|528962090|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
146668548|NCT03298867|528962089|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
146668549|NCT03298867|528962090|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
146668550|NCT03298867|528962089|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
146668551|NCT03298867|528962090|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
146668552|NCT03298867|528962089|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
146668553|NCT03298867|528962090|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
146668554|NCT05136690|528962091|FG000|Period 1|Withdrawal by Subject|0|||
146668555|NCT05136690|528962092|FG001|Period 1|Withdrawal by Subject|1|||
146668556|NCT05136690|528962091|FG000|Period 2|Lost to Follow-up|0|||
146668557|NCT05136690|528962092|FG001|Period 2|Lost to Follow-up|3|||
146668558|NCT05136690|528962091|FG000|Period 2|Withdrawal by Subject|0|||
146668559|NCT05136690|528962092|FG001|Period 2|Withdrawal by Subject|1|||
146668560|NCT03730012|528962093|FG000|Overall Study|Adverse Event|0|||
146668561|NCT03730012|528962094|FG001|Overall Study|Adverse Event|1|||
146668562|NCT03730012|528962093|FG000|Overall Study|Lack of Efficacy|1|||
146668563|NCT03730012|528962094|FG001|Overall Study|Lack of Efficacy|5|||
146668564|NCT03730012|528962093|FG000|Overall Study|Withdrawal by Subject|0|||
146668565|NCT03730012|528962094|FG001|Overall Study|Withdrawal by Subject|1|||
146668566|NCT03730012|528962093|FG000|Overall Study|Miscellaneous|2|||
146668567|NCT03730012|528962094|FG001|Overall Study|Miscellaneous|1|||
146668568|NCT01030536|528963792|FG000|Overall Study|Withdrawal by Subject|0|||
146668569|NCT01030536|528963793|FG001|Overall Study|Withdrawal by Subject|0|||
146668570|NCT01030536|528963794|FG002|Overall Study|Withdrawal by Subject|1|||
146668571|NCT01030536|528963795|FG003|Overall Study|Withdrawal by Subject|0|||
146668572|NCT01030536|528963796|FG004|Overall Study|Withdrawal by Subject|0|||
146668573|NCT01030536|528963792|FG000|Overall Study|undefined|1|||
146668574|NCT01030536|528963793|FG001|Overall Study|undefined|0|||
146668575|NCT01030536|528963794|FG002|Overall Study|undefined|1|||
146668576|NCT01030536|528963795|FG003|Overall Study|undefined|1|||
146668577|NCT01030536|528963796|FG004|Overall Study|undefined|0|||
146668578|NCT01030536|528963792|FG000|Overall Study|Adverse Event|0|||
146668579|NCT01030536|528963793|FG001|Overall Study|Adverse Event|3|||
146668580|NCT01030536|528963794|FG002|Overall Study|Adverse Event|1|||
146668581|NCT01030536|528963795|FG003|Overall Study|Adverse Event|0|||
146668582|NCT01030536|528963796|FG004|Overall Study|Adverse Event|1|||
146668583|NCT01030536|528963792|FG000|Overall Study|Progressive disease|6|||
146668584|NCT01030536|528963793|FG001|Overall Study|Progressive disease|2|||
146668585|NCT01030536|528963794|FG002|Overall Study|Progressive disease|3|||
146668586|NCT01030536|528963795|FG003|Overall Study|Progressive disease|2|||
146668587|NCT01030536|528963796|FG004|Overall Study|Progressive disease|0|||
146668588|NCT01030536|528963792|FG000|Overall Study|Death|0|||
146668589|NCT01030536|528963793|FG001|Overall Study|Death|1|||
146668590|NCT01030536|528963794|FG002|Overall Study|Death|0|||
146668591|NCT01030536|528963795|FG003|Overall Study|Death|0|||
146668592|NCT01030536|528963796|FG004|Overall Study|Death|0|||
146668593|NCT00129272|528963797|FG000|Overall Study|Lost to Follow-up|12|||
146668594|NCT00129272|528963798|FG001|Overall Study|Lost to Follow-up|11|||
146668595|NCT00129272|528963797|FG000|Overall Study|Withdrawal by Subject|5|||
146668596|NCT00129272|528963798|FG001|Overall Study|Withdrawal by Subject|11|||
146668597|NCT02601027|528963799|FG000|Registration to Surgery|Withdrawal by Subject|20|||
146668598|NCT02601027|528963800|FG001|Registration to Surgery|Withdrawal by Subject|10|||
146668599|NCT01419626|528963801|FG000|Overall Study|Protocol Violation|3|||
146668600|NCT01419626|528963802|FG001|Overall Study|Protocol Violation|2|||
146668601|NCT01419626|528963803|FG002|Overall Study|Protocol Violation|2|||
146668602|NCT01419626|528963801|FG000|Overall Study|Withdrawal by Subject|1|||
146668603|NCT01419626|528963802|FG001|Overall Study|Withdrawal by Subject|0|||
146668604|NCT01419626|528963803|FG002|Overall Study|Withdrawal by Subject|0|||
146668605|NCT01419626|528963801|FG000|Overall Study|Lost to Follow-up|0|||
146668606|NCT01419626|528963802|FG001|Overall Study|Lost to Follow-up|1|||
146668607|NCT01419626|528963803|FG002|Overall Study|Lost to Follow-up|1|||
146668608|NCT01146912|528963804|FG000|Overall Study|Already received influenza vaccination|817|||
146668609|NCT01146912|528963805|FG001|Overall Study|Already received influenza vaccination|822|||
146668610|NCT01146912|528963806|FG002|Overall Study|Already received influenza vaccination|13|||
146668611|NCT01146912|528963807|FG003|Overall Study|Already received influenza vaccination|15|||
146668612|NCT01146912|528963808|FG004|Overall Study|Already received influenza vaccination|41|||
146668613|NCT01146912|528963809|FG005|Overall Study|Already received influenza vaccination|61|||
146668614|NCT01146912|528963810|FG006|Overall Study|Already received influenza vaccination|56|||
146668615|NCT01146912|528963811|FG007|Overall Study|Already received influenza vaccination|0|||
146668616|NCT01146912|528963804|FG000|Overall Study|< 14 weeks gestational age|0|||
146668617|NCT01146912|528963805|FG001|Overall Study|< 14 weeks gestational age|0|||
146668618|NCT01146912|528963806|FG002|Overall Study|< 14 weeks gestational age|3|||
146668619|NCT01146912|528963807|FG003|Overall Study|< 14 weeks gestational age|2|||
146668620|NCT01146912|528963808|FG004|Overall Study|< 14 weeks gestational age|0|||
146668621|NCT01146912|528963809|FG005|Overall Study|< 14 weeks gestational age|0|||
146668622|NCT01146912|528963810|FG006|Overall Study|< 14 weeks gestational age|0|||
146668623|NCT01146912|528963811|FG007|Overall Study|< 14 weeks gestational age|0|||
146668624|NCT01146912|528963804|FG000|Overall Study|Duplicate patient|0|||
146668625|NCT01146912|528963805|FG001|Overall Study|Duplicate patient|0|||
146668626|NCT01146912|528963806|FG002|Overall Study|Duplicate patient|1|||
146668627|NCT01146912|528963807|FG003|Overall Study|Duplicate patient|0|||
146668628|NCT01146912|528963808|FG004|Overall Study|Duplicate patient|0|||
146668629|NCT01146912|528963809|FG005|Overall Study|Duplicate patient|0|||
146668630|NCT01146912|528963810|FG006|Overall Study|Duplicate patient|0|||
146668631|NCT01146912|528963811|FG007|Overall Study|Duplicate patient|0|||
146668632|NCT02248701|528963814|FG000|Overall Study|Withdrawal by Subject|2|||
146668633|NCT02248701|528963815|FG001|Overall Study|Withdrawal by Subject|1|||
146668634|NCT02248701|528963814|FG000|Overall Study|Physician Decision|0|||
146668635|NCT02248701|528963815|FG001|Overall Study|Physician Decision|1|||
146668636|NCT02248701|528963814|FG000|Overall Study|Adverse Event|1|||
146668637|NCT02248701|528963815|FG001|Overall Study|Adverse Event|0|||
146668638|NCT02248701|528963814|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
146668639|NCT02248701|528963815|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
146668640|NCT01145625|528963816|FG000|Overall Study|Lost to Follow-up|8|||
146668641|NCT01145625|528963817|FG001|Overall Study|Lost to Follow-up|9|||
146668642|NCT01145625|528963816|FG000|Overall Study|Adverse Event|6|||
146668643|NCT01145625|528963817|FG001|Overall Study|Adverse Event|4|||
146668644|NCT01145625|528963816|FG000|Overall Study|Protocol Violation|3|||
146668645|NCT01145625|528963817|FG001|Overall Study|Protocol Violation|1|||
146668646|NCT01145625|528963816|FG000|Overall Study|Withdrawal by Subject|7|||
146668647|NCT01145625|528963817|FG001|Overall Study|Withdrawal by Subject|16|||
146668648|NCT01145625|528963816|FG000|Overall Study|Pregnancy|0|||
146668649|NCT01145625|528963817|FG001|Overall Study|Pregnancy|1|||
146668650|NCT00885846|528963818|FG000|Overall Study|Withdrawal by Subject|2|||
146668651|NCT00885846|528963819|FG001|Overall Study|Withdrawal by Subject|5|||
146668652|NCT00885846|528963820|FG002|Overall Study|Withdrawal by Subject|2|||
146668653|NCT01540838|528963822|FG000|Overall Study|Open nasogastric tube|9|||
146668654|NCT01540838|528963823|FG001|Overall Study|Open nasogastric tube|7|||
146668655|NCT01540838|528963822|FG000|Overall Study|Treatment doses missing|8|||
146668656|NCT01540838|528963823|FG001|Overall Study|Treatment doses missing|12|||
146668657|NCT01540838|528963822|FG000|Overall Study|Additional antibiotic treatment|1|||
146668658|NCT01540838|528963823|FG001|Overall Study|Additional antibiotic treatment|2|||
146668659|NCT01540838|528963822|FG000|Overall Study|Died before treatment initiation|1|||
146668660|NCT01540838|528963823|FG001|Overall Study|Died before treatment initiation|1|||
146668661|NCT01540838|528963822|FG000|Overall Study|Not BM. Other treatment|3|||
146668662|NCT01540838|528963823|FG001|Overall Study|Not BM. Other treatment|1|||
146668663|NCT02130570|528963824|FG000|Overall Study|Death|3|||
146668664|NCT02130570|528963825|FG001|Overall Study|Death|5|||
146668665|NCT02130570|528963824|FG000|Overall Study|Withdrawal by Subject|6|||
146668666|NCT02130570|528963825|FG001|Overall Study|Withdrawal by Subject|3|||
146668667|NCT02130570|528963824|FG000|Overall Study|Part of practice that discontinued study|0|||
146668668|NCT02130570|528963825|FG001|Overall Study|Part of practice that discontinued study|5|||
146668669|NCT00493025|528963828|FG000|Overall Study|Physician Decision|19|||
146668670|NCT03863197|528963829|FG000|Overall Study|Lost to Follow-up|2|||
146668671|NCT03863197|528963830|FG001|Overall Study|Lost to Follow-up|3|||
146668672|NCT03863197|528963829|FG000|Overall Study|Withdrawal by Subject|4|||
146668673|NCT03863197|528963830|FG001|Overall Study|Withdrawal by Subject|0|||
146668674|NCT03863197|528963829|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
146668675|NCT03863197|528963830|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
146668676|NCT01065597|528963831|FG000|Overall Study|Adverse Event|1|||
146668677|NCT01622231|528963832|FG000|Overall Study|Physician Decision|1|||
146668678|NCT01622231|528963832|FG000|Overall Study|Withdrawal by Subject|1|||
146668679|NCT04545554|528963840|FG000|Overall Study|Withdrawal by Subject|0|||
146668680|NCT04545554|528963841|FG001|Overall Study|Withdrawal by Subject|0|||
146668681|NCT04545554|528963842|FG002|Overall Study|Withdrawal by Subject|0|||
146668682|NCT04545554|528963843|FG003|Overall Study|Withdrawal by Subject|1|||
146668683|NCT04545554|528963844|FG004|Overall Study|Withdrawal by Subject|0|||
146668684|NCT04545554|528963845|FG005|Overall Study|Withdrawal by Subject|0|||
146668685|NCT01032174|528963846|FG000|Overall Study|Adverse Event|0|||
146668686|NCT01032174|528963847|FG001|Overall Study|Adverse Event|1|||
146668687|NCT00494299|528963848|FG000|Overall Study|Adverse Event|93|||
146668688|NCT00494299|528963849|FG001|Overall Study|Adverse Event|13|||
146668689|NCT00494299|528963848|FG000|Overall Study|Lost to Follow-up|1|||
146668690|NCT00494299|528963849|FG001|Overall Study|Lost to Follow-up|0|||
146668691|NCT00494299|528963848|FG000|Overall Study|Physician Decision|0|||
146668692|NCT00494299|528963849|FG001|Overall Study|Physician Decision|2|||
146668693|NCT00494299|528963848|FG000|Overall Study|Protocol Violation|1|||
146668694|NCT00494299|528963849|FG001|Overall Study|Protocol Violation|2|||
146668695|NCT00494299|528963848|FG000|Overall Study|Withdrawal by Subject|8|||
146668696|NCT00494299|528963849|FG001|Overall Study|Withdrawal by Subject|3|||
146668697|NCT00494299|528963848|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
146668698|NCT00494299|528963849|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
146668699|NCT00494299|528963848|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
146668700|NCT00494299|528963849|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
146668701|NCT00494299|528963848|FG000|Overall Study|Site Closed by Sponsor|6|||
146668702|NCT00494299|528963849|FG001|Overall Study|Site Closed by Sponsor|0|||
146668703|NCT00494299|528963848|FG000|Overall Study|Protocol Driven Decision Point|11|||
146668704|NCT00494299|528963849|FG001|Overall Study|Protocol Driven Decision Point|22|||
146668705|NCT01986907|528963852|FG000|Overall Study|Adverse Event|11|||
146668706|NCT01986907|528963852|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
146668707|NCT01986907|528963852|FG000|Overall Study|Protocol Violation|4|||
146668708|NCT01986907|528963852|FG000|Overall Study|Withdrawal by Subject|76|||
146668709|NCT01986907|528963852|FG000|Overall Study|Lost to Follow-up|38|||
146668710|NCT01986907|528963852|FG000|Overall Study|Death|9|||
146668711|NCT00467857|528963855|FG000|Overall Study|Adverse Event|1|||
146668712|NCT00467857|528963856|FG001|Overall Study|Adverse Event|0|||
146668713|NCT00467857|528963855|FG000|Overall Study|Withdrew consent|2|||
146668714|NCT00467857|528963856|FG001|Overall Study|Withdrew consent|0|||
146668715|NCT00467857|528963855|FG000|Overall Study|Death|0|||
146668716|NCT00467857|528963856|FG001|Overall Study|Death|1|||
146668717|NCT00467857|528963855|FG000|Overall Study|Discharged from court service|0|||
146668718|NCT00467857|528963856|FG001|Overall Study|Discharged from court service|1|||
146668719|NCT00467857|528963855|FG000|Overall Study|Emergency care required|0|||
146668720|NCT00467857|528963856|FG001|Overall Study|Emergency care required|1|||
146668721|NCT00467857|528963855|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
146668722|NCT00467857|528963856|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
146978760|NCT01113710|530085494|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
146978761|NCT01113710|530085494|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
146978762|NCT01113710|530085494|FG000|Overall Study|Lack of Patient's Compliance|8|||
146978763|NCT01113710|530085494|FG000|Overall Study|Other|7|||
146668723|NCT00467857|528963855|FG000|Overall Study|Discontinuation reason missing|0|||
146668724|NCT00467857|528963856|FG001|Overall Study|Discontinuation reason missing|3|||
146668725|NCT03576495|528963858|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
146668726|NCT03576495|528963859|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
146668727|NCT02635776|528963860|FG000|Overall Study|Physician Decision|1|||
146668728|NCT02635776|528963861|FG001|Overall Study|Physician Decision|0|||
146668729|NCT02635776|528963860|FG000|Overall Study|Adverse Event|51|||
146668730|NCT02635776|528963861|FG001|Overall Study|Adverse Event|3|||
146668731|NCT02635776|528963860|FG000|Overall Study|Withdrawal by Subject|41|||
146978764|NCT01113710|530085494|FG000|Overall Study|Adverse Event/Other|5|||
146668732|NCT02635776|528963861|FG001|Overall Study|Withdrawal by Subject|7|||
146668733|NCT02635776|528963860|FG000|Overall Study|Lost to Follow-up|4|||
146668734|NCT02635776|528963861|FG001|Overall Study|Lost to Follow-up|0|||
146668735|NCT02635776|528963860|FG000|Overall Study|Other reasons|5|||
146668736|NCT02635776|528963861|FG001|Overall Study|Other reasons|1|||
146668737|NCT00788073|528963863|FG000|STX209 Then Placebo|Adverse Event|1|||
146668738|NCT00788073|528963864|FG001|STX209 Then Placebo|Adverse Event|0|||
146668739|NCT00788073|528963863|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
146668740|NCT00788073|528963864|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
146668741|NCT00788073|528963863|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
146668742|NCT00788073|528963864|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
146668743|NCT00788073|528963863|FG000|STX209 Then Placebo|unable to return due to travel|0|||
146668744|NCT00788073|528963864|FG001|STX209 Then Placebo|unable to return due to travel|1|||
146668745|NCT00788073|528963863|FG000|Placebo Then STX209|Adverse Event|2|||
146668746|NCT00788073|528963864|FG001|Placebo Then STX209|Adverse Event|0|||
146668747|NCT00788073|528963863|FG000|Placebo Then STX209|Protocol Violation|0|||
146668748|NCT00788073|528963864|FG001|Placebo Then STX209|Protocol Violation|1|||
146668749|NCT03608254|528963865|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
146668750|NCT03608254|528963865|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
146668751|NCT03208127|528963866|FG000|Overall Study|Death|1|||
146668752|NCT00660673|528963867|FG000|Overall Study|Adverse Event|84|||
146668753|NCT00660673|528963867|FG000|Overall Study|Lack of Efficacy|7|||
146668754|NCT00660673|528963867|FG000|Overall Study|Withdrawal by Subject|22|||
146668755|NCT00660673|528963867|FG000|Overall Study|Administrative|2|||
146668756|NCT00660673|528963867|FG000|Overall Study|Protocol Violation|2|||
146668757|NCT00516074|528963868|FG000|Overall Study|Adverse Event|0|||
146668758|NCT00516074|528963869|FG001|Overall Study|Adverse Event|1|||
146668759|NCT00516074|528963868|FG000|Overall Study|Subject Decision|4|||
146668760|NCT00516074|528963869|FG001|Overall Study|Subject Decision|2|||
146668761|NCT00516074|528963868|FG000|Overall Study|Loss of Glucose Control|2|||
146668762|NCT00516074|528963869|FG001|Overall Study|Loss of Glucose Control|0|||
146668763|NCT05213481|528963871|FG000|Overall Study|Adverse Event|3|||
146668764|NCT05213481|528963871|FG000|Overall Study|Lost to Follow-up|1|||
146668765|NCT03822182|528963875|FG000|Overall Study|Protocol Violation|0|||
146668766|NCT03822182|528963876|FG001|Overall Study|Protocol Violation|1|||
146668767|NCT03822182|528963877|FG002|Overall Study|Protocol Violation|1|||
146668768|NCT01612858|528963879|FG000|Overall Study|Withdrawal by Subject|5|||
146668769|NCT01612858|528963880|FG001|Overall Study|Withdrawal by Subject|1|||
146668770|NCT01484275|528963881|FG000|Overall Study|Study terminated by sponsor|28|||
146668771|NCT01484275|528963882|FG001|Overall Study|Study terminated by sponsor|32|||
146668772|NCT01484275|528963881|FG000|Overall Study|Other|10|||
146668773|NCT01484275|528963882|FG001|Overall Study|Other|0|||
146668774|NCT01484275|528963881|FG000|Overall Study|Death|3|||
146668775|NCT01484275|528963882|FG001|Overall Study|Death|4|||
146668776|NCT01484275|528963881|FG000|Overall Study|Withdrawal by Subject|1|||
146668777|NCT01484275|528963882|FG001|Overall Study|Withdrawal by Subject|5|||
146668778|NCT01484275|528963881|FG000|Overall Study|Lost to Follow-up|1|||
146668779|NCT01484275|528963882|FG001|Overall Study|Lost to Follow-up|1|||
146668780|NCT00657358|528963885|FG000|Overall Study|Lack of Efficacy|6|||
146668781|NCT01893203|528963890|FG000|Overall Study|Withdrawal by Subject|1|||
146668782|NCT02925117|528963894|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
146668783|NCT02925117|528963895|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
146668784|NCT02925117|528963896|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
146925587|NCT03442829|529888300|FG001|Overall Study|Illness unrelated to study|1|||
146925588|NCT01486784|529888301|FG000|Overall Study|Withdrawal by Subject|0|||
146925589|NCT01486784|529888302|FG001|Overall Study|Withdrawal by Subject|0|||
146925590|NCT01486784|529888303|FG002|Overall Study|Withdrawal by Subject|1|||
146925591|NCT01486784|529888304|FG003|Overall Study|Withdrawal by Subject|0|||
146925592|NCT01486784|529888305|FG004|Overall Study|Withdrawal by Subject|1|||
146925593|NCT01486784|529888306|FG005|Overall Study|Withdrawal by Subject|2|||
146925594|NCT01486784|529888301|FG000|Overall Study|Subject did not meet entry criteria|0|||
146925595|NCT01486784|529888302|FG001|Overall Study|Subject did not meet entry criteria|0|||
146925596|NCT01486784|529888303|FG002|Overall Study|Subject did not meet entry criteria|0|||
146925597|NCT01486784|529888304|FG003|Overall Study|Subject did not meet entry criteria|0|||
146668785|NCT02925117|528963897|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
146668786|NCT02925117|528963898|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
146668787|NCT02925117|528963899|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
146668788|NCT02925117|528963900|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
146668789|NCT02925117|528963901|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
146668790|NCT02925117|528963902|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
146668791|NCT02925117|528963903|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
146668792|NCT02925117|528963904|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
146668793|NCT02925117|528963905|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
146925598|NCT01486784|529888305|FG004|Overall Study|Subject did not meet entry criteria|1|||
146925599|NCT01486784|529888306|FG005|Overall Study|Subject did not meet entry criteria|0|||
146668794|NCT02925117|528963894|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
146668795|NCT02925117|528963895|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
146668796|NCT02925117|528963896|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
146668797|NCT02925117|528963897|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146668798|NCT02925117|528963898|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146668799|NCT02925117|528963899|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146668800|NCT02925117|528963900|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146668801|NCT02925117|528963901|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146668802|NCT02925117|528963902|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146668803|NCT02925117|528963903|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146668804|NCT02925117|528963904|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146668805|NCT02925117|528963905|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146668806|NCT02925117|528963894|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
146668807|NCT02925117|528963895|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
146668808|NCT02925117|528963896|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146668809|NCT02925117|528963897|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146668810|NCT02925117|528963898|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146668811|NCT02925117|528963899|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146668812|NCT02925117|528963900|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146668813|NCT02925117|528963901|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146668814|NCT02925117|528963902|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146668815|NCT02925117|528963903|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146668816|NCT02925117|528963904|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146668817|NCT02925117|528963905|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146668818|NCT02925117|528963894|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
146668819|NCT02925117|528963895|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
146668820|NCT02925117|528963896|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
146668821|NCT02925117|528963897|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
146668822|NCT02925117|528963898|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
146668823|NCT02925117|528963899|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
146668824|NCT02925117|528963900|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
146668825|NCT02925117|528963901|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
146668826|NCT02925117|528963902|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
146668827|NCT02925117|528963903|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
146668828|NCT02925117|528963904|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
146668829|NCT02925117|528963905|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
146668830|NCT02925117|528963894|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146668831|NCT02925117|528963895|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146668832|NCT02925117|528963896|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146668833|NCT02925117|528963897|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146668834|NCT02925117|528963898|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146668835|NCT02925117|528963899|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
146668836|NCT02925117|528963900|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146668837|NCT02925117|528963901|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146668838|NCT02925117|528963902|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146668839|NCT02925117|528963903|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146668840|NCT02925117|528963904|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
146668841|NCT02925117|528963905|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
146668842|NCT02925117|528963894|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
146668843|NCT02925117|528963895|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
146668844|NCT02925117|528963896|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
146668845|NCT02925117|528963897|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
146668846|NCT02925117|528963898|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
146668847|NCT02925117|528963899|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
146668848|NCT02925117|528963900|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
146668849|NCT02925117|528963901|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
146668850|NCT02925117|528963902|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
146668851|NCT02925117|528963903|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
146668852|NCT02925117|528963904|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
146668853|NCT02925117|528963905|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
146668854|NCT02925117|528963894|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
146668855|NCT02925117|528963895|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
146668856|NCT02925117|528963896|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
146668857|NCT02925117|528963897|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
146668858|NCT02925117|528963898|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
146668859|NCT02925117|528963899|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
146668860|NCT02925117|528963900|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
146668861|NCT02925117|528963901|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
146668862|NCT02925117|528963902|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
146668863|NCT02925117|528963903|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
146668864|NCT02925117|528963904|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
146668865|NCT02925117|528963905|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
146668866|NCT02925117|528963894|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
146668867|NCT02925117|528963895|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
146668868|NCT02925117|528963896|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
146668869|NCT02925117|528963897|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
146668870|NCT02925117|528963898|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
146668871|NCT02925117|528963899|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
146668872|NCT02925117|528963900|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
146668873|NCT02925117|528963901|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
146668874|NCT02925117|528963902|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
146668875|NCT02925117|528963903|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
146668876|NCT02925117|528963904|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
146668877|NCT02925117|528963905|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
146668878|NCT01449539|528963907|FG000|Overall Study|Withdrawal by Subject|3|||
146668879|NCT01449539|528963907|FG000|Overall Study|Toxicity not study related|1|||
146668880|NCT00347360|528963908|FG000|Overall Study|Adverse Event|1|||
146668881|NCT00347360|528963909|FG001|Overall Study|Adverse Event|2|||
146668882|NCT00347360|528963910|FG002|Overall Study|Adverse Event|0|||
146668883|NCT00347360|528963911|FG003|Overall Study|Adverse Event|4|||
146668884|NCT00347360|528963912|FG004|Overall Study|Adverse Event|1|||
146668885|NCT00347360|528963913|FG005|Overall Study|Adverse Event|2|||
146668886|NCT00347360|528963914|FG006|Overall Study|Adverse Event|2|||
146668887|NCT00347360|528963915|FG007|Overall Study|Adverse Event|0|||
146668888|NCT00347360|528963916|FG008|Overall Study|Adverse Event|2|||
146668889|NCT00347360|528963917|FG009|Overall Study|Adverse Event|3|||
146668890|NCT00347360|528963918|FG010|Overall Study|Adverse Event|3|||
146668891|NCT00347360|528963919|FG011|Overall Study|Adverse Event|1|||
146668892|NCT00347360|528963920|FG012|Overall Study|Adverse Event|3|||
146668893|NCT00347360|528963921|FG013|Overall Study|Adverse Event|2|||
146668894|NCT00347360|528963922|FG014|Overall Study|Adverse Event|2|||
146668895|NCT00347360|528963908|FG000|Overall Study|Lost to Follow-up|0|||
146668896|NCT00347360|528963909|FG001|Overall Study|Lost to Follow-up|0|||
146668897|NCT00347360|528963910|FG002|Overall Study|Lost to Follow-up|0|||
146668898|NCT00347360|528963911|FG003|Overall Study|Lost to Follow-up|2|||
146668899|NCT00347360|528963912|FG004|Overall Study|Lost to Follow-up|1|||
146668900|NCT00347360|528963913|FG005|Overall Study|Lost to Follow-up|1|||
146668901|NCT00347360|528963914|FG006|Overall Study|Lost to Follow-up|0|||
146668902|NCT00347360|528963915|FG007|Overall Study|Lost to Follow-up|1|||
146668903|NCT00347360|528963916|FG008|Overall Study|Lost to Follow-up|1|||
146668904|NCT00347360|528963917|FG009|Overall Study|Lost to Follow-up|2|||
146668905|NCT00347360|528963918|FG010|Overall Study|Lost to Follow-up|0|||
146668906|NCT00347360|528963919|FG011|Overall Study|Lost to Follow-up|0|||
146668907|NCT00347360|528963920|FG012|Overall Study|Lost to Follow-up|1|||
146668908|NCT00347360|528963921|FG013|Overall Study|Lost to Follow-up|0|||
146668909|NCT00347360|528963922|FG014|Overall Study|Lost to Follow-up|0|||
146668910|NCT00347360|528963908|FG000|Overall Study|Protocol Violation|2|||
146668911|NCT00347360|528963909|FG001|Overall Study|Protocol Violation|3|||
146668912|NCT00347360|528963910|FG002|Overall Study|Protocol Violation|1|||
146668913|NCT00347360|528963911|FG003|Overall Study|Protocol Violation|2|||
146668914|NCT00347360|528963912|FG004|Overall Study|Protocol Violation|1|||
146668915|NCT00347360|528963913|FG005|Overall Study|Protocol Violation|2|||
146668916|NCT00347360|528963914|FG006|Overall Study|Protocol Violation|0|||
146668917|NCT00347360|528963915|FG007|Overall Study|Protocol Violation|0|||
146668918|NCT00347360|528963916|FG008|Overall Study|Protocol Violation|1|||
146668919|NCT00347360|528963917|FG009|Overall Study|Protocol Violation|2|||
146668920|NCT00347360|528963918|FG010|Overall Study|Protocol Violation|0|||
146668921|NCT00347360|528963919|FG011|Overall Study|Protocol Violation|0|||
146668922|NCT00347360|528963920|FG012|Overall Study|Protocol Violation|0|||
146668923|NCT00347360|528963921|FG013|Overall Study|Protocol Violation|1|||
146668924|NCT00347360|528963922|FG014|Overall Study|Protocol Violation|0|||
146668925|NCT00347360|528963908|FG000|Overall Study|Withdrawal by Subject|0|||
146668926|NCT00347360|528963909|FG001|Overall Study|Withdrawal by Subject|1|||
146668927|NCT00347360|528963910|FG002|Overall Study|Withdrawal by Subject|2|||
146668928|NCT00347360|528963911|FG003|Overall Study|Withdrawal by Subject|4|||
146668929|NCT00347360|528963912|FG004|Overall Study|Withdrawal by Subject|1|||
146668930|NCT00347360|528963913|FG005|Overall Study|Withdrawal by Subject|2|||
146668931|NCT00347360|528963914|FG006|Overall Study|Withdrawal by Subject|1|||
146668932|NCT00347360|528963915|FG007|Overall Study|Withdrawal by Subject|1|||
146668933|NCT00347360|528963916|FG008|Overall Study|Withdrawal by Subject|1|||
146668934|NCT00347360|528963917|FG009|Overall Study|Withdrawal by Subject|1|||
146668935|NCT00347360|528963918|FG010|Overall Study|Withdrawal by Subject|0|||
146668936|NCT00347360|528963919|FG011|Overall Study|Withdrawal by Subject|3|||
146668937|NCT00347360|528963920|FG012|Overall Study|Withdrawal by Subject|4|||
146668938|NCT00347360|528963921|FG013|Overall Study|Withdrawal by Subject|2|||
146668939|NCT00347360|528963922|FG014|Overall Study|Withdrawal by Subject|1|||
146668940|NCT00347360|528963908|FG000|Overall Study|Lack of Efficacy|1|||
146668941|NCT00347360|528963909|FG001|Overall Study|Lack of Efficacy|1|||
146668942|NCT00347360|528963910|FG002|Overall Study|Lack of Efficacy|3|||
146668943|NCT00347360|528963911|FG003|Overall Study|Lack of Efficacy|1|||
146668944|NCT00347360|528963912|FG004|Overall Study|Lack of Efficacy|0|||
146668945|NCT00347360|528963913|FG005|Overall Study|Lack of Efficacy|1|||
146668946|NCT00347360|528963914|FG006|Overall Study|Lack of Efficacy|0|||
146668947|NCT00347360|528963915|FG007|Overall Study|Lack of Efficacy|1|||
146668948|NCT00347360|528963916|FG008|Overall Study|Lack of Efficacy|1|||
146668949|NCT00347360|528963917|FG009|Overall Study|Lack of Efficacy|0|||
146668950|NCT00347360|528963918|FG010|Overall Study|Lack of Efficacy|0|||
146668951|NCT00347360|528963919|FG011|Overall Study|Lack of Efficacy|0|||
146668952|NCT00347360|528963920|FG012|Overall Study|Lack of Efficacy|0|||
146668953|NCT00347360|528963921|FG013|Overall Study|Lack of Efficacy|0|||
146668954|NCT00347360|528963922|FG014|Overall Study|Lack of Efficacy|0|||
146668955|NCT00347360|528963908|FG000|Overall Study|Reason not listed/blank|1|||
146668956|NCT00347360|528963909|FG001|Overall Study|Reason not listed/blank|0|||
146668957|NCT00347360|528963910|FG002|Overall Study|Reason not listed/blank|0|||
146668958|NCT00347360|528963911|FG003|Overall Study|Reason not listed/blank|0|||
146668959|NCT00347360|528963912|FG004|Overall Study|Reason not listed/blank|0|||
146668960|NCT00347360|528963913|FG005|Overall Study|Reason not listed/blank|0|||
146668961|NCT00347360|528963914|FG006|Overall Study|Reason not listed/blank|1|||
146668962|NCT00347360|528963915|FG007|Overall Study|Reason not listed/blank|0|||
146668963|NCT00347360|528963916|FG008|Overall Study|Reason not listed/blank|0|||
146668964|NCT00347360|528963917|FG009|Overall Study|Reason not listed/blank|0|||
146668965|NCT00347360|528963918|FG010|Overall Study|Reason not listed/blank|0|||
146668966|NCT00347360|528963919|FG011|Overall Study|Reason not listed/blank|0|||
146668967|NCT00347360|528963920|FG012|Overall Study|Reason not listed/blank|0|||
146668968|NCT00347360|528963921|FG013|Overall Study|Reason not listed/blank|1|||
146668969|NCT00347360|528963922|FG014|Overall Study|Reason not listed/blank|0|||
146668970|NCT00347360|528963908|FG000|Overall Study|Per sponsors instruction|0|||
146668971|NCT00347360|528963909|FG001|Overall Study|Per sponsors instruction|1|||
146668972|NCT00347360|528963910|FG002|Overall Study|Per sponsors instruction|0|||
146668973|NCT00347360|528963911|FG003|Overall Study|Per sponsors instruction|0|||
146668974|NCT00347360|528963912|FG004|Overall Study|Per sponsors instruction|0|||
146668975|NCT00347360|528963913|FG005|Overall Study|Per sponsors instruction|0|||
146668976|NCT00347360|528963914|FG006|Overall Study|Per sponsors instruction|0|||
146668977|NCT00347360|528963915|FG007|Overall Study|Per sponsors instruction|0|||
146668978|NCT00347360|528963916|FG008|Overall Study|Per sponsors instruction|0|||
146668979|NCT00347360|528963917|FG009|Overall Study|Per sponsors instruction|0|||
146668980|NCT00347360|528963918|FG010|Overall Study|Per sponsors instruction|0|||
146668981|NCT00347360|528963919|FG011|Overall Study|Per sponsors instruction|0|||
146668982|NCT00347360|528963920|FG012|Overall Study|Per sponsors instruction|0|||
146668983|NCT00347360|528963921|FG013|Overall Study|Per sponsors instruction|0|||
146668984|NCT00347360|528963922|FG014|Overall Study|Per sponsors instruction|0|||
146668985|NCT00347360|528963908|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
146668986|NCT00347360|528963909|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
146668987|NCT00347360|528963910|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
146668988|NCT00347360|528963911|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
146668989|NCT00347360|528963912|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
146668990|NCT00347360|528963913|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
146668991|NCT00347360|528963914|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
146668992|NCT00347360|528963915|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
146668993|NCT00347360|528963916|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
146668994|NCT00347360|528963917|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
146668995|NCT00347360|528963918|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
146668996|NCT00347360|528963919|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
146668997|NCT00347360|528963920|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
146668998|NCT00347360|528963921|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
146668999|NCT00347360|528963922|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
146669000|NCT00347360|528963908|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
146669001|NCT00347360|528963909|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
146669002|NCT00347360|528963910|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
146669003|NCT00347360|528963911|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
146669004|NCT00347360|528963912|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
146669005|NCT00347360|528963913|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
146669006|NCT00347360|528963914|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
146669007|NCT00347360|528963915|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
146669008|NCT00347360|528963916|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
146669009|NCT00347360|528963917|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
146669010|NCT00347360|528963918|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
146669011|NCT00347360|528963919|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
146669012|NCT00347360|528963920|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
146669013|NCT00347360|528963921|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
146669014|NCT00347360|528963922|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
146669015|NCT00347360|528963908|FG000|Overall Study|Abnormal lab values|0|||
146669016|NCT00347360|528963909|FG001|Overall Study|Abnormal lab values|0|||
146669017|NCT00347360|528963910|FG002|Overall Study|Abnormal lab values|0|||
146669018|NCT00347360|528963911|FG003|Overall Study|Abnormal lab values|0|||
146925600|NCT01486784|529888301|FG000|Overall Study|Death|0|||
146925601|NCT01486784|529888302|FG001|Overall Study|Death|0|||
146669019|NCT00347360|528963912|FG004|Overall Study|Abnormal lab values|0|||
146669020|NCT00347360|528963913|FG005|Overall Study|Abnormal lab values|0|||
146669021|NCT00347360|528963914|FG006|Overall Study|Abnormal lab values|1|||
146669022|NCT00347360|528963915|FG007|Overall Study|Abnormal lab values|0|||
146669023|NCT00347360|528963916|FG008|Overall Study|Abnormal lab values|0|||
146669024|NCT00347360|528963917|FG009|Overall Study|Abnormal lab values|0|||
146669025|NCT00347360|528963918|FG010|Overall Study|Abnormal lab values|0|||
146669026|NCT00347360|528963919|FG011|Overall Study|Abnormal lab values|0|||
146669027|NCT00347360|528963920|FG012|Overall Study|Abnormal lab values|0|||
146669028|NCT00347360|528963921|FG013|Overall Study|Abnormal lab values|0|||
146669029|NCT00347360|528963922|FG014|Overall Study|Abnormal lab values|0|||
146669030|NCT00347360|528963908|FG000|Overall Study|PI recommended early withdrawal|0|||
146669031|NCT00347360|528963909|FG001|Overall Study|PI recommended early withdrawal|0|||
146669032|NCT00347360|528963910|FG002|Overall Study|PI recommended early withdrawal|0|||
146669033|NCT00347360|528963911|FG003|Overall Study|PI recommended early withdrawal|0|||
146669034|NCT00347360|528963912|FG004|Overall Study|PI recommended early withdrawal|0|||
146669035|NCT00347360|528963913|FG005|Overall Study|PI recommended early withdrawal|0|||
146669036|NCT00347360|528963914|FG006|Overall Study|PI recommended early withdrawal|0|||
146669037|NCT00347360|528963915|FG007|Overall Study|PI recommended early withdrawal|0|||
146669038|NCT00347360|528963916|FG008|Overall Study|PI recommended early withdrawal|0|||
146669039|NCT00347360|528963917|FG009|Overall Study|PI recommended early withdrawal|1|||
146669040|NCT00347360|528963918|FG010|Overall Study|PI recommended early withdrawal|0|||
146669041|NCT00347360|528963919|FG011|Overall Study|PI recommended early withdrawal|0|||
146669042|NCT00347360|528963920|FG012|Overall Study|PI recommended early withdrawal|0|||
146669043|NCT00347360|528963921|FG013|Overall Study|PI recommended early withdrawal|0|||
146669044|NCT00347360|528963922|FG014|Overall Study|PI recommended early withdrawal|0|||
146669045|NCT00347360|528963908|FG000|Overall Study|Did not meet criteria before ABPM|0|||
146669046|NCT00347360|528963909|FG001|Overall Study|Did not meet criteria before ABPM|0|||
146669047|NCT00347360|528963910|FG002|Overall Study|Did not meet criteria before ABPM|0|||
146669048|NCT00347360|528963911|FG003|Overall Study|Did not meet criteria before ABPM|0|||
146669049|NCT00347360|528963912|FG004|Overall Study|Did not meet criteria before ABPM|0|||
146669050|NCT00347360|528963913|FG005|Overall Study|Did not meet criteria before ABPM|0|||
146669051|NCT00347360|528963914|FG006|Overall Study|Did not meet criteria before ABPM|0|||
146925602|NCT01486784|529888303|FG002|Overall Study|Death|0|||
146925603|NCT01486784|529888304|FG003|Overall Study|Death|0|||
146925604|NCT01486784|529888305|FG004|Overall Study|Death|0|||
146925605|NCT01486784|529888306|FG005|Overall Study|Death|1|||
146925606|NCT02841787|529888307|FG000|Overall Study|Lost to Follow-up|1|||
146669052|NCT00347360|528963915|FG007|Overall Study|Did not meet criteria before ABPM|0|||
146669053|NCT00347360|528963916|FG008|Overall Study|Did not meet criteria before ABPM|0|||
146669054|NCT00347360|528963917|FG009|Overall Study|Did not meet criteria before ABPM|0|||
146669055|NCT00347360|528963918|FG010|Overall Study|Did not meet criteria before ABPM|1|||
146669056|NCT00347360|528963919|FG011|Overall Study|Did not meet criteria before ABPM|0|||
146669057|NCT00347360|528963920|FG012|Overall Study|Did not meet criteria before ABPM|0|||
146669058|NCT00347360|528963921|FG013|Overall Study|Did not meet criteria before ABPM|0|||
146669059|NCT00347360|528963922|FG014|Overall Study|Did not meet criteria before ABPM|0|||
146669060|NCT00347360|528963908|FG000|Overall Study|Randomized in error|0|||
146669061|NCT00347360|528963909|FG001|Overall Study|Randomized in error|0|||
146669062|NCT00347360|528963910|FG002|Overall Study|Randomized in error|0|||
146669063|NCT00347360|528963911|FG003|Overall Study|Randomized in error|0|||
146669064|NCT00347360|528963912|FG004|Overall Study|Randomized in error|0|||
146669065|NCT00347360|528963913|FG005|Overall Study|Randomized in error|0|||
146669066|NCT00347360|528963914|FG006|Overall Study|Randomized in error|0|||
146669067|NCT00347360|528963915|FG007|Overall Study|Randomized in error|0|||
146669068|NCT00347360|528963916|FG008|Overall Study|Randomized in error|0|||
146669069|NCT00347360|528963917|FG009|Overall Study|Randomized in error|0|||
146669070|NCT00347360|528963918|FG010|Overall Study|Randomized in error|0|||
146669071|NCT00347360|528963919|FG011|Overall Study|Randomized in error|1|||
146669072|NCT00347360|528963920|FG012|Overall Study|Randomized in error|0|||
146669073|NCT00347360|528963921|FG013|Overall Study|Randomized in error|0|||
146669074|NCT00347360|528963922|FG014|Overall Study|Randomized in error|0|||
146669075|NCT00347360|528963908|FG000|Overall Study|Failed inclusion criteria #4|0|||
146669076|NCT00347360|528963909|FG001|Overall Study|Failed inclusion criteria #4|0|||
146669077|NCT00347360|528963910|FG002|Overall Study|Failed inclusion criteria #4|0|||
146925607|NCT02841787|529888308|FG001|Overall Study|Lost to Follow-up|0|||
146925608|NCT02841787|529888309|FG002|Overall Study|Lost to Follow-up|0|||
146669078|NCT00347360|528963911|FG003|Overall Study|Failed inclusion criteria #4|0|||
146669079|NCT00347360|528963912|FG004|Overall Study|Failed inclusion criteria #4|0|||
146669080|NCT00347360|528963913|FG005|Overall Study|Failed inclusion criteria #4|0|||
146669081|NCT00347360|528963914|FG006|Overall Study|Failed inclusion criteria #4|0|||
146669082|NCT00347360|528963915|FG007|Overall Study|Failed inclusion criteria #4|0|||
146925609|NCT02841787|529888307|FG000|Overall Study|Symptoms dropped below threshold|1|||
146925610|NCT02841787|529888308|FG001|Overall Study|Symptoms dropped below threshold|0|||
146925611|NCT02841787|529888309|FG002|Overall Study|Symptoms dropped below threshold|0|||
146925612|NCT02841787|529888307|FG000|Overall Study|Withdrawal by Subject|1|||
146669083|NCT00347360|528963916|FG008|Overall Study|Failed inclusion criteria #4|0|||
146669084|NCT00347360|528963917|FG009|Overall Study|Failed inclusion criteria #4|0|||
146669085|NCT00347360|528963918|FG010|Overall Study|Failed inclusion criteria #4|0|||
146669086|NCT00347360|528963919|FG011|Overall Study|Failed inclusion criteria #4|1|||
146669087|NCT00347360|528963920|FG012|Overall Study|Failed inclusion criteria #4|0|||
146669088|NCT00347360|528963921|FG013|Overall Study|Failed inclusion criteria #4|0|||
146669089|NCT00347360|528963922|FG014|Overall Study|Failed inclusion criteria #4|0|||
146669090|NCT00347360|528963908|FG000|Overall Study|Prolonged duration between visits|0|||
146669091|NCT00347360|528963909|FG001|Overall Study|Prolonged duration between visits|0|||
146669092|NCT00347360|528963910|FG002|Overall Study|Prolonged duration between visits|0|||
146669093|NCT00347360|528963911|FG003|Overall Study|Prolonged duration between visits|0|||
146669094|NCT00347360|528963912|FG004|Overall Study|Prolonged duration between visits|0|||
146669095|NCT00347360|528963913|FG005|Overall Study|Prolonged duration between visits|0|||
146669096|NCT00347360|528963914|FG006|Overall Study|Prolonged duration between visits|0|||
146669097|NCT00347360|528963915|FG007|Overall Study|Prolonged duration between visits|0|||
146669098|NCT00347360|528963916|FG008|Overall Study|Prolonged duration between visits|0|||
146669099|NCT00347360|528963917|FG009|Overall Study|Prolonged duration between visits|0|||
146669100|NCT00347360|528963918|FG010|Overall Study|Prolonged duration between visits|0|||
146669101|NCT00347360|528963919|FG011|Overall Study|Prolonged duration between visits|0|||
146669102|NCT00347360|528963920|FG012|Overall Study|Prolonged duration between visits|1|||
146669103|NCT00347360|528963921|FG013|Overall Study|Prolonged duration between visits|0|||
146669104|NCT00347360|528963922|FG014|Overall Study|Prolonged duration between visits|0|||
146669105|NCT00347360|528963908|FG000|Overall Study|Subject left town, ran out of study drug|0|||
146669106|NCT00347360|528963909|FG001|Overall Study|Subject left town, ran out of study drug|0|||
146669107|NCT00347360|528963910|FG002|Overall Study|Subject left town, ran out of study drug|0|||
146669108|NCT00347360|528963911|FG003|Overall Study|Subject left town, ran out of study drug|0|||
146669109|NCT00347360|528963912|FG004|Overall Study|Subject left town, ran out of study drug|0|||
146669110|NCT00347360|528963913|FG005|Overall Study|Subject left town, ran out of study drug|0|||
146669111|NCT00347360|528963914|FG006|Overall Study|Subject left town, ran out of study drug|0|||
146669112|NCT00347360|528963915|FG007|Overall Study|Subject left town, ran out of study drug|0|||
146669113|NCT00347360|528963916|FG008|Overall Study|Subject left town, ran out of study drug|0|||
146669114|NCT00347360|528963917|FG009|Overall Study|Subject left town, ran out of study drug|0|||
146669115|NCT00347360|528963918|FG010|Overall Study|Subject left town, ran out of study drug|0|||
146669116|NCT00347360|528963919|FG011|Overall Study|Subject left town, ran out of study drug|0|||
146669117|NCT00347360|528963920|FG012|Overall Study|Subject left town, ran out of study drug|0|||
146669118|NCT00347360|528963921|FG013|Overall Study|Subject left town, ran out of study drug|1|||
146669119|NCT00347360|528963922|FG014|Overall Study|Subject left town, ran out of study drug|0|||
146669120|NCT00347360|528963908|FG000|Overall Study|Subject refuse to sign updated consent|0|||
146669121|NCT00347360|528963909|FG001|Overall Study|Subject refuse to sign updated consent|0|||
146669122|NCT00347360|528963910|FG002|Overall Study|Subject refuse to sign updated consent|0|||
146669123|NCT00347360|528963911|FG003|Overall Study|Subject refuse to sign updated consent|0|||
146669124|NCT00347360|528963912|FG004|Overall Study|Subject refuse to sign updated consent|0|||
146669125|NCT00347360|528963913|FG005|Overall Study|Subject refuse to sign updated consent|0|||
146669126|NCT00347360|528963914|FG006|Overall Study|Subject refuse to sign updated consent|0|||
146669127|NCT00347360|528963915|FG007|Overall Study|Subject refuse to sign updated consent|0|||
146669128|NCT00347360|528963916|FG008|Overall Study|Subject refuse to sign updated consent|0|||
146669129|NCT00347360|528963917|FG009|Overall Study|Subject refuse to sign updated consent|0|||
146669130|NCT00347360|528963918|FG010|Overall Study|Subject refuse to sign updated consent|0|||
146669131|NCT00347360|528963919|FG011|Overall Study|Subject refuse to sign updated consent|0|||
146669132|NCT00347360|528963920|FG012|Overall Study|Subject refuse to sign updated consent|0|||
146669133|NCT00347360|528963921|FG013|Overall Study|Subject refuse to sign updated consent|0|||
146669134|NCT00347360|528963922|FG014|Overall Study|Subject refuse to sign updated consent|1|||
146669135|NCT00347360|528963908|FG000|Overall Study|Visits conflicted with new job|0|||
146669136|NCT00347360|528963909|FG001|Overall Study|Visits conflicted with new job|0|||
146669137|NCT00347360|528963910|FG002|Overall Study|Visits conflicted with new job|0|||
146669138|NCT00347360|528963911|FG003|Overall Study|Visits conflicted with new job|0|||
146669139|NCT00347360|528963912|FG004|Overall Study|Visits conflicted with new job|0|||
146669140|NCT00347360|528963913|FG005|Overall Study|Visits conflicted with new job|0|||
146669141|NCT00347360|528963914|FG006|Overall Study|Visits conflicted with new job|1|||
146669142|NCT00347360|528963915|FG007|Overall Study|Visits conflicted with new job|0|||
146669143|NCT00347360|528963916|FG008|Overall Study|Visits conflicted with new job|0|||
146669144|NCT00347360|528963917|FG009|Overall Study|Visits conflicted with new job|0|||
146669145|NCT00347360|528963918|FG010|Overall Study|Visits conflicted with new job|0|||
146669146|NCT00347360|528963919|FG011|Overall Study|Visits conflicted with new job|0|||
146669147|NCT00347360|528963920|FG012|Overall Study|Visits conflicted with new job|0|||
146669148|NCT00347360|528963921|FG013|Overall Study|Visits conflicted with new job|0|||
146669149|NCT00347360|528963922|FG014|Overall Study|Visits conflicted with new job|0|||
146669150|NCT00913380|528963925|FG000|Clinical Outcomes|Lost to Follow-up|6|||
146669151|NCT00913380|528963926|FG001|Clinical Outcomes|Lost to Follow-up|6|||
146669152|NCT01788228|528963931|FG000|Overall Study|Migrated/moved from study area|1|||
146669153|NCT01788228|528963932|FG001|Overall Study|Migrated/moved from study area|0|||
146669154|NCT01972568|528963933|FG000|Overall Study|Other events|3|||
146669155|NCT01972568|528963934|FG001|Overall Study|Other events|0|||
146669156|NCT01972568|528963935|FG002|Overall Study|Other events|0|||
146669157|NCT01972568|528963933|FG000|Overall Study|Lack of Efficacy|0|||
146669158|NCT01972568|528963934|FG001|Overall Study|Lack of Efficacy|1|||
146669159|NCT01972568|528963935|FG002|Overall Study|Lack of Efficacy|2|||
146669160|NCT01972568|528963933|FG000|Overall Study|Protocol Violation|1|||
146669161|NCT01972568|528963934|FG001|Overall Study|Protocol Violation|2|||
146669162|NCT01972568|528963935|FG002|Overall Study|Protocol Violation|2|||
146669163|NCT01972568|528963933|FG000|Overall Study|Withdrawal by Subject|6|||
146669164|NCT01972568|528963934|FG001|Overall Study|Withdrawal by Subject|3|||
146669165|NCT01972568|528963935|FG002|Overall Study|Withdrawal by Subject|7|||
146669166|NCT01972568|528963933|FG000|Overall Study|Lost to Follow-up|1|||
146669167|NCT01972568|528963934|FG001|Overall Study|Lost to Follow-up|0|||
146669168|NCT01972568|528963935|FG002|Overall Study|Lost to Follow-up|0|||
146669169|NCT01972568|528963933|FG000|Overall Study|Adverse Event|5|||
146669170|NCT01972568|528963934|FG001|Overall Study|Adverse Event|6|||
146669171|NCT01972568|528963935|FG002|Overall Study|Adverse Event|5|||
146669172|NCT00957580|528963936|FG000|Overall Study|Ongoing at data cut-off|0|||
146669173|NCT00957580|528963937|FG001|Overall Study|Ongoing at data cut-off|1|||
146669174|NCT00957580|528963938|FG002|Overall Study|Ongoing at data cut-off|0|||
146669175|NCT00957580|528963936|FG000|Overall Study|Enrolled but not treated|0|||
146669176|NCT00957580|528963937|FG001|Overall Study|Enrolled but not treated|1|||
146669177|NCT00957580|528963938|FG002|Overall Study|Enrolled but not treated|0|||
146669178|NCT02699593|528963941|FG000|Period 1|Unsatisfactory Visual Response|0|||
146669179|NCT02699593|528963942|FG001|Period 1|Unsatisfactory Visual Response|1|||
146669180|NCT02699593|528963941|FG000|Period 1|Torn Contact Len|4|||
146669181|NCT02699593|528963942|FG001|Period 1|Torn Contact Len|3|||
146669182|NCT02699593|528963941|FG000|Period 1|Protocol Violation|0|||
146669183|NCT02699593|528963942|FG001|Period 1|Protocol Violation|1|||
146669184|NCT02699593|528963941|FG000|Period 1|Withdrawal by Subject|0|||
146669185|NCT02699593|528963942|FG001|Period 1|Withdrawal by Subject|1|||
146669186|NCT02699593|528963941|FG000|Period 1|Adverse Event|1|||
146669187|NCT02699593|528963942|FG001|Period 1|Adverse Event|1|||
146669188|NCT02699593|528963941|FG000|Period 2|Adverse Event|1|||
146669189|NCT02699593|528963942|FG001|Period 2|Adverse Event|1|||
146669190|NCT02699593|528963941|FG000|Period 2|Lost Contact Lens|0|||
146669191|NCT02699593|528963942|FG001|Period 2|Lost Contact Lens|1|||
146669192|NCT02699593|528963941|FG000|Period 2|Torn Contact Lens|1|||
146669193|NCT02699593|528963942|FG001|Period 2|Torn Contact Lens|0|||
146669194|NCT01696071|528963955|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
146669195|NCT01696071|528963956|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
146669196|NCT02764697|528963957|FG000|Overall Study|Lack of Efficacy|3|||
146669197|NCT01995825|528965609|FG000|Overall Study|Withdrawal by Subject|1|||
146669198|NCT01995825|528965610|FG001|Overall Study|Withdrawal by Subject|0|||
146669199|NCT01798004|528965611|FG000|Overall Study|Death|2|||
146669200|NCT01798004|528965611|FG000|Overall Study|Lack of Efficacy|8|||
146669201|NCT01798004|528965611|FG000|Overall Study|Physician Decision|25|||
146669202|NCT01798004|528965611|FG000|Overall Study|Withdrawal by Subject|4|||
146669203|NCT01798004|528965611|FG000|Overall Study|Ineligible|4|||
146669204|NCT01798004|528965611|FG000|Overall Study|Patient/parent refusal|7|||
146669205|NCT01798004|528965611|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
146669206|NCT01798004|528965611|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
146669207|NCT04680052|528965612|FG000|Overall Study|Ongoing|244|||
146669208|NCT04680052|528965613|FG001|Overall Study|Ongoing|229|||
146669209|NCT04680052|528965614|FG002|Overall Study|Ongoing|39|||
146669210|NCT04680052|528965615|FG003|Overall Study|Ongoing|46|||
146669211|NCT04680052|528965612|FG000|Overall Study|Death|15|||
146669212|NCT04680052|528965613|FG001|Overall Study|Death|22|||
146669213|NCT04680052|528965614|FG002|Overall Study|Death|7|||
146669214|NCT04680052|528965615|FG003|Overall Study|Death|1|||
146669215|NCT04680052|528965612|FG000|Overall Study|Lost to Follow-up|3|||
146669216|NCT04680052|528965613|FG001|Overall Study|Lost to Follow-up|2|||
146669217|NCT04680052|528965614|FG002|Overall Study|Lost to Follow-up|0|||
146669218|NCT04680052|528965615|FG003|Overall Study|Lost to Follow-up|1|||
146669219|NCT04680052|528965612|FG000|Overall Study|Withdrawal by Subject|11|||
146669220|NCT04680052|528965613|FG001|Overall Study|Withdrawal by Subject|19|||
146669221|NCT04680052|528965614|FG002|Overall Study|Withdrawal by Subject|7|||
146669222|NCT04680052|528965615|FG003|Overall Study|Withdrawal by Subject|5|||
146669223|NCT04680052|528965612|FG000|Overall Study|Missing|0|||
146669224|NCT04680052|528965613|FG001|Overall Study|Missing|1|||
146669225|NCT04680052|528965614|FG002|Overall Study|Missing|0|||
146669226|NCT04680052|528965615|FG003|Overall Study|Missing|0|||
146669227|NCT04680052|528965612|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
146669228|NCT04680052|528965613|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
146669229|NCT04680052|528965614|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
146669230|NCT04680052|528965615|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
146669231|NCT04680052|528965612|FG000|Overall Study|Physician Decision|0|||
146669232|NCT04680052|528965613|FG001|Overall Study|Physician Decision|1|||
146669233|NCT04680052|528965614|FG002|Overall Study|Physician Decision|0|||
146669234|NCT04680052|528965615|FG003|Overall Study|Physician Decision|0|||
146669235|NCT06956170|528965616|FG000|Overall Study|Death|2|||
146669236|NCT06956170|528965617|FG001|Overall Study|Death|1|||
146669237|NCT06956170|528965616|FG000|Overall Study|Withdrawal by Subject|1|||
146669238|NCT06956170|528965617|FG001|Overall Study|Withdrawal by Subject|0|||
146669239|NCT06956170|528965616|FG000|Overall Study|Ongoing|7|||
146669240|NCT06956170|528965617|FG001|Overall Study|Ongoing|10|||
146669241|NCT00825682|528965618|FG000|Overall Study|personal reasons/ inconvenience|13|||
146669242|NCT00825682|528965619|FG001|Overall Study|personal reasons/ inconvenience|5|||
146669243|NCT00094172|528965622|FG000|Overall Study|Adverse Event|0|||
146669244|NCT00094172|528965623|FG001|Overall Study|Adverse Event|1|||
146669245|NCT00094172|528965622|FG000|Overall Study|Lost to Follow-up|2|||
146669246|NCT00094172|528965623|FG001|Overall Study|Lost to Follow-up|0|||
146669247|NCT00094172|528965622|FG000|Overall Study|Protocol Violation|0|||
146669248|NCT00094172|528965623|FG001|Overall Study|Protocol Violation|1|||
146669249|NCT00094172|528965622|FG000|Overall Study|Withdrawal by Subject|10|||
146669250|NCT00094172|528965623|FG001|Overall Study|Withdrawal by Subject|5|||
146669251|NCT00094172|528965622|FG000|Overall Study|Primary endpoint met.|1|||
146669252|NCT00094172|528965623|FG001|Overall Study|Primary endpoint met.|0|||
146669253|NCT00094172|528965622|FG000|Overall Study|Started other MS therapy due to disease|1|||
146669254|NCT00094172|528965623|FG001|Overall Study|Started other MS therapy due to disease|0|||
146669255|NCT02478632|528965635|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
146669256|NCT02478632|528965636|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
146669257|NCT02478632|528965635|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
146669258|NCT02478632|528965636|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
146669259|NCT02478632|528965635|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
146669260|NCT02478632|528965636|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
146669261|NCT00002651|528965637|FG000|Induction|Adverse Event|44|||
146669262|NCT00002651|528965638|FG001|Induction|Adverse Event|0|||
146669263|NCT00002651|528965639|FG002|Induction|Adverse Event|0|||
146669264|NCT00002651|528965637|FG000|Induction|Refusal unrelated to adverse event|50|||
146669265|NCT00002651|528965638|FG001|Induction|Refusal unrelated to adverse event|0|||
146669266|NCT00002651|528965639|FG002|Induction|Refusal unrelated to adverse event|0|||
146669267|NCT00002651|528965637|FG000|Induction|Progression/relapse|274|||
146669268|NCT00002651|528965638|FG001|Induction|Progression/relapse|0|||
146669269|NCT00002651|528965639|FG002|Induction|Progression/relapse|0|||
146669270|NCT00002651|528965637|FG000|Induction|Death|62|||
146669271|NCT00002651|528965638|FG001|Induction|Death|0|||
146669272|NCT00002651|528965639|FG002|Induction|Death|0|||
146669273|NCT00002651|528965637|FG000|Induction|Other|823|||
146669274|NCT00002651|528965638|FG001|Induction|Other|0|||
146669275|NCT00002651|528965639|FG002|Induction|Other|0|||
146669276|NCT00002651|528965637|FG000|Induction|not eligible|90|||
146669277|NCT00002651|528965638|FG001|Induction|not eligible|0|||
146669278|NCT00002651|528965639|FG002|Induction|not eligible|0|||
146669279|NCT00002651|528965637|FG000|Consolidation and Randomization|Adverse Event|0|||
146669280|NCT00002651|528965638|FG001|Consolidation and Randomization|Adverse Event|36|||
146669281|NCT00002651|528965639|FG002|Consolidation and Randomization|Adverse Event|14|||
146669282|NCT00002651|528965637|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
146669283|NCT00002651|528965638|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
146669284|NCT00002651|528965639|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
146669285|NCT00002651|528965637|FG000|Consolidation and Randomization|Progression/relapse|0|||
146669286|NCT00002651|528965638|FG001|Consolidation and Randomization|Progression/relapse|295|||
146669287|NCT00002651|528965639|FG002|Consolidation and Randomization|Progression/relapse|298|||
146669288|NCT00002651|528965637|FG000|Consolidation and Randomization|Death|0|||
146669289|NCT00002651|528965638|FG001|Consolidation and Randomization|Death|38|||
146669290|NCT00002651|528965639|FG002|Consolidation and Randomization|Death|48|||
146669291|NCT00002651|528965637|FG000|Consolidation and Randomization|Other|0|||
146669292|NCT00002651|528965638|FG001|Consolidation and Randomization|Other|314|||
146669293|NCT00002651|528965639|FG002|Consolidation and Randomization|Other|313|||
146669294|NCT00002651|528965637|FG000|Consolidation and Randomization|not eligible|0|||
146669295|NCT00002651|528965638|FG001|Consolidation and Randomization|not eligible|102|||
146669296|NCT00002651|528965639|FG002|Consolidation and Randomization|not eligible|112|||
146669297|NCT03750955|528965640|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
146669298|NCT03750955|528965641|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
146669299|NCT03750955|528965640|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
146669300|NCT03750955|528965641|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
146669301|NCT01705730|528965642|FG000|Overall Study|Lack of Efficacy|1|||
146669302|NCT01705730|528965642|FG000|Overall Study|Adverse Event|3|||
146978765|NCT01113710|530085494|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
146669303|NCT01705730|528965642|FG000|Overall Study|Lost to Follow-up|1|||
146669304|NCT01705730|528965642|FG000|Overall Study|Reason not Specified|4|||
146669305|NCT01773733|528965643|FG000|Overall Study|Adverse Event|3286|||
146669306|NCT01773733|528965644|FG001|Overall Study|Adverse Event|540|||
146669307|NCT01773733|528965643|FG000|Overall Study|Pregnancy|28|||
146669308|NCT01773733|528965644|FG001|Overall Study|Pregnancy|0|||
146669309|NCT01773733|528965643|FG000|Overall Study|Other different categories of not compl|55415|||
146669310|NCT01773733|528965644|FG001|Overall Study|Other different categories of not compl|7781|||
146669311|NCT00880542|528965649|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
146669312|NCT00880542|528965649|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
146669313|NCT00880542|528965649|FG000|REP: Surgical Resection|progressive disease|1|||
146669314|NCT00762385|528965650|FG000|First Intervention|Lens Issue|1|||
146669315|NCT00762385|528965651|FG001|First Intervention|Lens Issue|1|||
146669316|NCT00762385|528965650|FG000|First Intervention|Lost to Follow-up|0|||
146669317|NCT00762385|528965651|FG001|First Intervention|Lost to Follow-up|2|||
146669318|NCT00762385|528965650|FG000|First Intervention|Ineligible|1|||
146669319|NCT00762385|528965651|FG001|First Intervention|Ineligible|0|||
146669320|NCT00762385|528965650|FG000|First Intervention|Protocol Violation|0|||
146669321|NCT00762385|528965651|FG001|First Intervention|Protocol Violation|1|||
146669322|NCT00762385|528965650|FG000|Second Intervention|Protocol Violation|3|||
146669323|NCT00762385|528965651|FG001|Second Intervention|Protocol Violation|3|||
146669324|NCT01781975|528965652|FG000|Overall Study|Death|1|||
146669325|NCT01781975|528965653|FG001|Overall Study|Death|0|||
146669326|NCT01781975|528965652|FG000|Overall Study|Withdrawal by Subject|1|||
146669327|NCT01781975|528965653|FG001|Overall Study|Withdrawal by Subject|1|||
146669328|NCT02329080|528965654|FG000|Overall Study|Adverse Event|1|||
146669329|NCT02329080|528965654|FG000|Overall Study|Death|4|||
146669330|NCT02329080|528965654|FG000|Overall Study|Lack of Efficacy|22|||
146669331|NCT02329080|528965654|FG000|Overall Study|Lost to Follow-up|1|||
146669332|NCT02329080|528965654|FG000|Overall Study|Physician Decision|2|||
146669333|NCT02329080|528965654|FG000|Overall Study|Partial response|4|||
146669334|NCT02329080|528965654|FG000|Overall Study|Complete response|4|||
146669335|NCT04545060|528965655|FG000|Overall Study|Adverse Event|0|||
146669336|NCT04545060|528965656|FG001|Overall Study|Adverse Event|1|||
146669337|NCT04545060|528965655|FG000|Overall Study|Death|0|||
146669338|NCT04545060|528965656|FG001|Overall Study|Death|5|||
146669339|NCT04545060|528965655|FG000|Overall Study|Lost to Follow-up|10|||
146669340|NCT04545060|528965656|FG001|Overall Study|Lost to Follow-up|13|||
146669341|NCT04545060|528965655|FG000|Overall Study|Physician Decision|3|||
146669342|NCT04545060|528965656|FG001|Overall Study|Physician Decision|0|||
146669343|NCT04545060|528965655|FG000|Overall Study|Withdrawal by Subject|17|||
146669344|NCT04545060|528965656|FG001|Overall Study|Withdrawal by Subject|22|||
146669345|NCT00973674|528965657|FG000|Overall Study|Protocol Violation|2|||
146669346|NCT00973674|528965658|FG001|Overall Study|Protocol Violation|0|||
146669347|NCT00071396|528965661|FG000|Overall Study|Withdrawal by Subject|1|||
146669348|NCT00071396|528965661|FG000|Overall Study|Physician Decision|2|||
146669349|NCT03082261|528965662|FG000|Overall Study|Death|4|||
146669350|NCT03082261|528965662|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
146669351|NCT03082261|528965662|FG000|Overall Study|Insurance denial|1|||
146669352|NCT03082261|528965662|FG000|Overall Study|Peripheral lead added|1|||
146669353|NCT03082261|528965662|FG000|Overall Study|Withdrawal by Subject|40|||
146669354|NCT03082261|528965662|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
146669355|NCT03082261|528965662|FG000|Overall Study|Subject implanted with device other than study device|1|||
146669356|NCT03082261|528965662|FG000|Overall Study|Lost to Follow-up|14|||
146669357|NCT03082261|528965662|FG000|Overall Study|Subject moved to a different state|1|||
146669358|NCT03082261|528965662|FG000|Overall Study|Subject non-compliance|2|||
146669359|NCT03082261|528965662|FG000|Overall Study|Subject participation terminated by investigator|9|||
146925613|NCT02841787|529888308|FG001|Overall Study|Withdrawal by Subject|4|||
146925614|NCT02841787|529888309|FG002|Overall Study|Withdrawal by Subject|0|||
146925615|NCT03491553|529888310|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
146925616|NCT03491553|529888311|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
146925617|NCT03491553|529888312|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
146925618|NCT03491553|529888313|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
146669360|NCT03082261|528965662|FG000|Overall Study|Subject participation terminated by sponsor|4|||
146669361|NCT03082261|528965662|FG000|Overall Study|System explant|19|||
146669362|NCT03082261|528965662|FG000|Overall Study|Unable to place lead(s)|2|||
146669363|NCT03082261|528965662|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
146669364|NCT00839852|528965663|FG000|Overall Study|Adverse Event|10|||
146669365|NCT00839852|528965663|FG000|Overall Study|Insufficient Therapeutic Response|3|||
146669366|NCT00839852|528965663|FG000|Overall Study|Protocol Violation|9|||
146669367|NCT00839852|528965663|FG000|Overall Study|Withdrawal of Consent|16|||
146669368|NCT00839852|528965663|FG000|Overall Study|Lost to Follow-up|7|||
146669369|NCT00839852|528965663|FG000|Overall Study|Lack of Compliance While in Jail|1|||
146925619|NCT03491553|529888314|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
146925620|NCT03491553|529888315|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
146669370|NCT00839852|528965663|FG000|Overall Study|Pregnancy|1|||
146669371|NCT01281137|528965668|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
146669372|NCT01281137|528965669|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
146669373|NCT01281137|528965668|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
146669374|NCT01281137|528965669|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
146669375|NCT01281137|528965668|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
146669376|NCT01281137|528965669|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
146669377|NCT01281137|528965668|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
146669378|NCT01281137|528965669|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
146669379|NCT01281137|528965668|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
146669380|NCT01281137|528965669|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
146669381|NCT01313312|528965673|FG000|Overall Study|Adverse Event|5|||
146669382|NCT01313312|528965673|FG000|Overall Study|Withdrawal by Subject|18|||
146669383|NCT01313312|528965673|FG000|Overall Study|Lack of Efficacy|3|||
146669384|NCT01313312|528965673|FG000|Overall Study|Investigator Decision|1|||
146669385|NCT01313312|528965673|FG000|Overall Study|Observational Phase|1|||
146669386|NCT01313312|528965673|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
146669387|NCT01313312|528965673|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
146669388|NCT04295772|528965674|FG000|Overall Study|Protocol Violation|1|||
146669389|NCT04295772|528965675|FG001|Overall Study|Protocol Violation|0|||
146669390|NCT04295772|528965674|FG000|Overall Study|Ongoing for safety monitoring|14|||
146669391|NCT04295772|528965675|FG001|Overall Study|Ongoing for safety monitoring|1|||
146669392|NCT04295772|528965674|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
146669393|NCT04295772|528965675|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
146669394|NCT02846324|528965676|FG000|Overall Study|Other|1|||
146669395|NCT02846324|528965677|FG001|Overall Study|Other|0|||
146669396|NCT02846324|528965678|FG002|Overall Study|Other|0|||
146669397|NCT02846324|528965679|FG003|Overall Study|Other|0|||
146669398|NCT02846324|528965676|FG000|Overall Study|Withdrawal by Subject|1|||
146669399|NCT02846324|528965677|FG001|Overall Study|Withdrawal by Subject|0|||
146669400|NCT02846324|528965678|FG002|Overall Study|Withdrawal by Subject|4|||
146669401|NCT02846324|528965679|FG003|Overall Study|Withdrawal by Subject|0|||
146669402|NCT01206166|528965687|FG000|Overall Study|No evaluable data|2|||
146669403|NCT01206166|528965688|FG001|Overall Study|No evaluable data|3|||
146669404|NCT00932126|528965689|FG000|Overall Study|Adverse Event|0|||
146669405|NCT00932126|528965690|FG001|Overall Study|Adverse Event|0|||
146669406|NCT00932126|528965691|FG002|Overall Study|Adverse Event|0|||
146669407|NCT00932126|528965692|FG003|Overall Study|Adverse Event|0|||
146669408|NCT00932126|528965693|FG004|Overall Study|Adverse Event|0|||
146669409|NCT00932126|528965694|FG005|Overall Study|Adverse Event|0|||
146669410|NCT00932126|528965695|FG006|Overall Study|Adverse Event|1|||
146669411|NCT00932126|528965696|FG007|Overall Study|Adverse Event|2|||
146669412|NCT00932126|528965689|FG000|Overall Study|Protocol Violation|0|||
146669413|NCT00932126|528965690|FG001|Overall Study|Protocol Violation|0|||
146669414|NCT00932126|528965691|FG002|Overall Study|Protocol Violation|0|||
146669415|NCT00932126|528965692|FG003|Overall Study|Protocol Violation|0|||
146669416|NCT00932126|528965693|FG004|Overall Study|Protocol Violation|1|||
146669417|NCT00932126|528965694|FG005|Overall Study|Protocol Violation|0|||
146669418|NCT00932126|528965695|FG006|Overall Study|Protocol Violation|0|||
146669419|NCT00932126|528965696|FG007|Overall Study|Protocol Violation|0|||
146669420|NCT00932126|528965689|FG000|Overall Study|Withdrawal by Subject|0|||
146669421|NCT00932126|528965690|FG001|Overall Study|Withdrawal by Subject|0|||
146669422|NCT00932126|528965691|FG002|Overall Study|Withdrawal by Subject|1|||
146669423|NCT00932126|528965692|FG003|Overall Study|Withdrawal by Subject|0|||
146669424|NCT00932126|528965693|FG004|Overall Study|Withdrawal by Subject|0|||
146669425|NCT00932126|528965694|FG005|Overall Study|Withdrawal by Subject|0|||
146669426|NCT00932126|528965695|FG006|Overall Study|Withdrawal by Subject|0|||
146669427|NCT00932126|528965696|FG007|Overall Study|Withdrawal by Subject|1|||
146669428|NCT00932126|528965689|FG000|Overall Study|Objective progression or relapse|3|||
146669429|NCT00932126|528965690|FG001|Overall Study|Objective progression or relapse|3|||
146669430|NCT00932126|528965691|FG002|Overall Study|Objective progression or relapse|2|||
146669431|NCT00932126|528965692|FG003|Overall Study|Objective progression or relapse|3|||
146669432|NCT00932126|528965693|FG004|Overall Study|Objective progression or relapse|3|||
146669433|NCT00932126|528965694|FG005|Overall Study|Objective progression or relapse|3|||
146669434|NCT00932126|528965695|FG006|Overall Study|Objective progression or relapse|3|||
146669435|NCT00932126|528965696|FG007|Overall Study|Objective progression or relapse|5|||
146669436|NCT00932126|528965689|FG000|Overall Study|Other|0|||
146669437|NCT00932126|528965690|FG001|Overall Study|Other|0|||
146669438|NCT00932126|528965691|FG002|Overall Study|Other|0|||
146669439|NCT00932126|528965692|FG003|Overall Study|Other|0|||
146925621|NCT03491553|529888310|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
146925622|NCT03491553|529888311|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
146925623|NCT03491553|529888312|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
146925624|NCT03491553|529888313|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
146925625|NCT03491553|529888314|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
146925626|NCT03491553|529888315|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
146925627|NCT03029650|529888318|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
146925628|NCT03029650|529888319|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
146925629|NCT03029650|529888318|FG000|Washout (1 Week)|Physician Decision|0|||
146669440|NCT00932126|528965693|FG004|Overall Study|Other|1|||
146669441|NCT00932126|528965694|FG005|Overall Study|Other|0|||
146669442|NCT00932126|528965695|FG006|Overall Study|Other|1|||
146669443|NCT00932126|528965696|FG007|Overall Study|Other|2|||
146669444|NCT02716805|528965697|FG000|Overall Study|Progressive disease|2|||
146669445|NCT02716805|528965698|FG001|Overall Study|Progressive disease|0|||
146669446|NCT02716805|528965699|FG002|Overall Study|Progressive disease|0|||
146669447|NCT02716805|528965700|FG003|Overall Study|Progressive disease|0|||
146669448|NCT00066365|528965701|FG000|Overall Study|Adverse Event|1|||
146669449|NCT00066365|528965702|FG001|Overall Study|Adverse Event|0|||
146669450|NCT00066365|528965701|FG000|Overall Study|Lack of Efficacy|15|||
146669451|NCT00066365|528965702|FG001|Overall Study|Lack of Efficacy|12|||
146669452|NCT00066365|528965701|FG000|Overall Study|Physician Decision|1|||
146669453|NCT00066365|528965702|FG001|Overall Study|Physician Decision|0|||
146669454|NCT00066365|528965701|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
146669455|NCT00066365|528965702|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
146669456|NCT00066365|528965701|FG000|Overall Study|Ineligible|4|||
146669457|NCT00066365|528965702|FG001|Overall Study|Ineligible|2|||
146669458|NCT04203797|528965705|FG000|Overall Study|Adverse Event|1|||
146669459|NCT04203797|528965706|FG001|Overall Study|Adverse Event|0|||
146669460|NCT04203797|528965705|FG000|Overall Study|Did not complete End of Study follow-up|1|||
146669461|NCT04203797|528965706|FG001|Overall Study|Did not complete End of Study follow-up|0|||
146669462|NCT00579098|528965708|FG000|Overall Study|Lost to Follow-up|2|||
146669463|NCT00579098|528965709|FG001|Overall Study|Lost to Follow-up|0|||
146669464|NCT00579098|528965708|FG000|Overall Study|Adverse Event|2|||
146669465|NCT00579098|528965709|FG001|Overall Study|Adverse Event|3|||
146669466|NCT00579098|528965708|FG000|Overall Study|Withdrawal by Subject|2|||
146669467|NCT00579098|528965709|FG001|Overall Study|Withdrawal by Subject|3|||
146669468|NCT00579098|528965708|FG000|Overall Study|AF returned after ablation|3|||
146669469|NCT00579098|528965709|FG001|Overall Study|AF returned after ablation|2|||
146669470|NCT01254331|528965710|FG000|Initial Phase|Adverse Event|3|||
146669471|NCT01254331|528965710|FG000|Initial Phase|Withdrawal by Subject|1|||
146669472|NCT01254331|528965710|FG000|Initial Phase|Pregnancy|1|||
146669473|NCT01254331|528965710|FG000|Extension Phase|Lack of Efficacy|1|||
146669474|NCT01254331|528965710|FG000|Extension Phase|Lost to Follow-up|3|||
146669475|NCT00810355|528965716|FG000|Overall Study|Lost to Follow-up|13|||
146669476|NCT00810355|528965717|FG001|Overall Study|Lost to Follow-up|17|||
146669477|NCT00810355|528965718|FG002|Overall Study|Lost to Follow-up|11|||
146669478|NCT00810355|528965716|FG000|Overall Study|Withdrawal by Subject|1|||
146669479|NCT00810355|528965717|FG001|Overall Study|Withdrawal by Subject|0|||
146669480|NCT00810355|528965718|FG002|Overall Study|Withdrawal by Subject|0|||
146669481|NCT00003487|528965719|FG000|Overall Study|Not evaluable|2|||
146669482|NCT04154930|528965722|FG000|Overall Study|Withdrawal by Subject|15|||
146669483|NCT04154930|528965723|FG001|Overall Study|Withdrawal by Subject|6|||
146669484|NCT04154930|528965722|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
146925630|NCT03029650|529888319|FG001|Washout (1 Week)|Physician Decision|1|||
146669485|NCT04154930|528965723|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
146669486|NCT04154930|528965722|FG000|Overall Study|Lost to Follow-up|14|||
146669487|NCT04154930|528965723|FG001|Overall Study|Lost to Follow-up|6|||
146669488|NCT04154930|528965722|FG000|Overall Study|Other|6|||
146669489|NCT04154930|528965723|FG001|Overall Study|Other|0|||
146669490|NCT02628938|528965724|FG000|Overall Study|Did not attend the follow up recall|2|||
146669491|NCT02628938|528965725|FG001|Overall Study|Did not attend the follow up recall|2|||
146669492|NCT02628938|528965726|FG002|Overall Study|Did not attend the follow up recall|1|||
146669493|NCT02628938|528965724|FG000|Overall Study|Failure to comply with the instructions|3|||
146669494|NCT02628938|528965725|FG001|Overall Study|Failure to comply with the instructions|0|||
146669495|NCT02628938|528965726|FG002|Overall Study|Failure to comply with the instructions|3|||
146669496|NCT02058693|528965727|FG000|Phase 1|Withdrawal by Subject|3|||
146669497|NCT02058693|528965728|FG001|Phase 1|Withdrawal by Subject|2|||
146669498|NCT02058693|528965727|FG000|Phase 1|Adverse Event|0|||
146669499|NCT02058693|528965728|FG001|Phase 1|Adverse Event|1|||
146669500|NCT02058693|528965727|FG000|Phase 1|Lack of Efficacy|1|||
146669501|NCT02058693|528965728|FG001|Phase 1|Lack of Efficacy|0|||
146669502|NCT02058693|528965727|FG000|Phase 1|Physician Decision|1|||
146925631|NCT01875367|529888320|FG000|Overall Study|Not complete at least 2 questionaries|4|||
146925632|NCT01875367|529888321|FG001|Overall Study|Not complete at least 2 questionaries|2|||
146669503|NCT02058693|528965728|FG001|Phase 1|Physician Decision|1|||
146669504|NCT02058693|528965727|FG000|Phase 2|Withdrawal by Subject|0|||
146669505|NCT02058693|528965728|FG001|Phase 2|Withdrawal by Subject|2|||
146669506|NCT00241358|528965729|FG000|Overall Study|Determined to be not ineligible|0|||
146669507|NCT00241358|528965730|FG001|Overall Study|Determined to be not ineligible|1|||
146669508|NCT00241358|528965731|FG002|Overall Study|Determined to be not ineligible|1|||
146669509|NCT00843856|528965732|FG000|Overall Study|Lost to Follow-up|1|||
146669510|NCT00843856|528965733|FG001|Overall Study|Lost to Follow-up|2|||
146669511|NCT03855228|528965734|FG000|Overall Study|Adverse Event|2|||
146669512|NCT03855228|528965735|FG001|Overall Study|Adverse Event|4|||
146669513|NCT03855228|528965736|FG002|Overall Study|Adverse Event|4|||
146669514|NCT03855228|528965737|FG003|Overall Study|Adverse Event|8|||
146925633|NCT01875367|529888320|FG000|Overall Study|Not receive study treatment|1|||
146669515|NCT03855228|528965734|FG000|Overall Study|Treatment Failure|1|||
146669516|NCT03855228|528965735|FG001|Overall Study|Treatment Failure|2|||
146669517|NCT03855228|528965736|FG002|Overall Study|Treatment Failure|1|||
146669518|NCT03855228|528965737|FG003|Overall Study|Treatment Failure|8|||
146669519|NCT03855228|528965734|FG000|Overall Study|Lost to Follow-up|0|||
146669520|NCT03855228|528965735|FG001|Overall Study|Lost to Follow-up|0|||
146669521|NCT03855228|528965736|FG002|Overall Study|Lost to Follow-up|0|||
146669522|NCT03855228|528965737|FG003|Overall Study|Lost to Follow-up|1|||
146669523|NCT03855228|528965734|FG000|Overall Study|Protocol Violation|0|||
146669524|NCT03855228|528965735|FG001|Overall Study|Protocol Violation|1|||
146669525|NCT03855228|528965736|FG002|Overall Study|Protocol Violation|2|||
146669526|NCT03855228|528965737|FG003|Overall Study|Protocol Violation|1|||
146669527|NCT03855228|528965734|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
146669528|NCT03855228|528965735|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
146669529|NCT03855228|528965736|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
146669530|NCT03855228|528965737|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
146669531|NCT00590135|528965738|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
146669532|NCT00806351|528965756|FG000|Overall Study|Death|5|||
146669533|NCT00806351|528965757|FG001|Overall Study|Death|4|||
146669534|NCT02059408|528965758|FG000|Overall Study|Did not get tested|0|||
146669535|NCT02059408|528965759|FG001|Overall Study|Did not get tested|330|||
146669536|NCT02059408|528965760|FG002|Overall Study|Did not get tested|358|||
146669537|NCT01681472|528965764|FG000|Overall Study|Adverse Event|0|||
146669538|NCT01681472|528965765|FG001|Overall Study|Adverse Event|1|||
146669539|NCT01681472|528965766|FG002|Overall Study|Adverse Event|0|||
146669540|NCT01681472|528965767|FG003|Overall Study|Adverse Event|0|||
146669541|NCT01999179|528965768|FG000|Overall Study|Adverse Event|1|||
146669542|NCT01999179|528965768|FG000|Overall Study|Lost to Follow-up|1|||
146669543|NCT01999179|528965768|FG000|Overall Study|Change in Therapy|3|||
146669544|NCT01999179|528965768|FG000|Overall Study|New catheter|2|||
146669545|NCT01752985|528965769|FG000|Treatment Period|Subject request to discontinue treatment|1|||
146669546|NCT01752985|528965770|FG001|Treatment Period|Subject request to discontinue treatment|0|||
146669547|NCT01752985|528965771|FG002|Treatment Period|Subject request to discontinue treatment|1|||
146669548|NCT01752985|528965769|FG000|Treatment Period|Subject no longer meets study criteria|0|||
146669549|NCT01752985|528965770|FG001|Treatment Period|Subject no longer meets study criteria|1|||
146669550|NCT01752985|528965771|FG002|Treatment Period|Subject no longer meets study criteria|1|||
146669551|NCT01752985|528965769|FG000|Treatment Period|Adverse Event|2|||
146669552|NCT01752985|528965770|FG001|Treatment Period|Adverse Event|1|||
146669553|NCT01752985|528965771|FG002|Treatment Period|Adverse Event|2|||
146669554|NCT01752985|528965769|FG000|Treatment Period|Withdrawal by Subject|1|||
146669555|NCT01752985|528965770|FG001|Treatment Period|Withdrawal by Subject|1|||
146669556|NCT01752985|528965771|FG002|Treatment Period|Withdrawal by Subject|0|||
146669557|NCT01752985|528965769|FG000|Treatment Period|Lost to Follow-up|0|||
146669558|NCT01752985|528965770|FG001|Treatment Period|Lost to Follow-up|0|||
146669559|NCT01752985|528965771|FG002|Treatment Period|Lost to Follow-up|1|||
146669560|NCT05147428|528965772|FG000|Overall Study|Removed prior to mailing|289|||
146669561|NCT05147428|528965773|FG001|Overall Study|Removed prior to mailing|306|||
146669562|NCT05147428|528965774|FG002|Overall Study|Removed prior to mailing|270|||
146669563|NCT05147428|528965772|FG000|Overall Study|Died or disenrolled during blackout period|239|||
146669564|NCT05147428|528965773|FG001|Overall Study|Died or disenrolled during blackout period|278|||
146925634|NCT01875367|529888321|FG001|Overall Study|Not receive study treatment|0|||
146925635|NCT02237157|529888322|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
146925636|NCT02237157|529888323|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
146925637|NCT02237157|529888324|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
146669565|NCT05147428|528965774|FG002|Overall Study|Died or disenrolled during blackout period|273|||
146925638|NCT02237157|529888325|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
146925639|NCT02237157|529888322|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
146669566|NCT01367002|528967582|FG000|Overall Study|Withdrawal by Subject|1|||
146669567|NCT01367002|528967583|FG001|Overall Study|Withdrawal by Subject|0|||
146669568|NCT01367002|528967582|FG000|Overall Study|Physician Decision|0|||
146669569|NCT01367002|528967583|FG001|Overall Study|Physician Decision|2|||
146669570|NCT01516437|528967584|FG000|Overall Study|Reason not specified|0|||
146669571|NCT01516437|528967585|FG001|Overall Study|Reason not specified|0|||
146669572|NCT01516437|528967586|FG002|Overall Study|Reason not specified|1|||
146925640|NCT02237157|529888323|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
146669573|NCT01516437|528967587|FG003|Overall Study|Reason not specified|1|||
146669574|NCT01385566|528967591|FG000|Overall Study|Lost to Follow-up|1|||
146925641|NCT02237157|529888324|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
146925642|NCT02237157|529888325|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
146925643|NCT03628508|529888326|FG000|Overall Study|Lost to Follow-up|1|||
146925644|NCT01996748|529888327|FG000|Overall Study|Personal reason|1|||
146925645|NCT01996748|529888328|FG001|Overall Study|Personal reason|0|||
146925646|NCT01996748|529888327|FG000|Overall Study|Physician Decision|2|||
146925647|NCT01996748|529888328|FG001|Overall Study|Physician Decision|0|||
146925648|NCT01996748|529888327|FG000|Overall Study|Adverse Event|1|||
146925649|NCT01996748|529888328|FG001|Overall Study|Adverse Event|4|||
146669575|NCT01385566|528967592|FG001|Overall Study|Lost to Follow-up|0|||
146669576|NCT01385566|528967593|FG002|Overall Study|Lost to Follow-up|0|||
146669577|NCT01385566|528967594|FG003|Overall Study|Lost to Follow-up|0|||
146669578|NCT01385566|528967595|FG004|Overall Study|Lost to Follow-up|0|||
146669579|NCT01385566|528967596|FG005|Overall Study|Lost to Follow-up|0|||
146669580|NCT01385566|528967591|FG000|Overall Study|Withdrawal by Subject|0|||
146669581|NCT01385566|528967592|FG001|Overall Study|Withdrawal by Subject|0|||
146669582|NCT01385566|528967593|FG002|Overall Study|Withdrawal by Subject|0|||
146669583|NCT01385566|528967594|FG003|Overall Study|Withdrawal by Subject|1|||
146669584|NCT01385566|528967595|FG004|Overall Study|Withdrawal by Subject|0|||
146669585|NCT01385566|528967596|FG005|Overall Study|Withdrawal by Subject|0|||
146669586|NCT00560105|528967603|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
146669587|NCT00560105|528967604|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
146669588|NCT02400333|528967605|FG000|Overall Study|Withdrawal by Subject|0|||
146669589|NCT02400333|528967606|FG001|Overall Study|Withdrawal by Subject|1|||
146669590|NCT02400333|528967607|FG002|Overall Study|Withdrawal by Subject|0|||
146669591|NCT02400333|528967608|FG003|Overall Study|Withdrawal by Subject|1|||
146669592|NCT02400333|528967605|FG000|Overall Study|Protocol Violation|1|||
146669593|NCT02400333|528967606|FG001|Overall Study|Protocol Violation|0|||
146669594|NCT02400333|528967607|FG002|Overall Study|Protocol Violation|2|||
146669595|NCT02400333|528967608|FG003|Overall Study|Protocol Violation|1|||
146669596|NCT00289133|528967616|FG000|Overall Study|Non-study device implanted|12|||
146669597|NCT00289133|528967617|FG001|Overall Study|Non-study device implanted|0|||
146669598|NCT00289133|528967616|FG000|Overall Study|Protocol Violation|32|||
146669599|NCT00289133|528967617|FG001|Overall Study|Protocol Violation|38|||
146669600|NCT00289133|528967616|FG000|Overall Study|Withdrawal by Subject|9|||
146669601|NCT00289133|528967617|FG001|Overall Study|Withdrawal by Subject|10|||
146669602|NCT00289133|528967616|FG000|Overall Study|Death|5|||
146669603|NCT00289133|528967617|FG001|Overall Study|Death|10|||
146669604|NCT00289133|528967616|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
146669605|NCT00289133|528967617|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
146669606|NCT00289133|528967616|FG000|Overall Study|Physician Decision|41|||
146669607|NCT00289133|528967617|FG001|Overall Study|Physician Decision|45|||
146669608|NCT00289133|528967616|FG000|Overall Study|Revision|8|||
146669609|NCT00289133|528967617|FG001|Overall Study|Revision|6|||
146669610|NCT00289133|528967616|FG000|Overall Study|Lost to Follow-up|92|||
146669611|NCT00289133|528967617|FG001|Overall Study|Lost to Follow-up|115|||
146669612|NCT00541931|528967618|FG000|Overall Study|Adverse Event|1|||
146669613|NCT00541931|528967619|FG001|Overall Study|Adverse Event|0|||
146669614|NCT00541931|528967618|FG000|Overall Study|Lost to Follow-up|3|||
146669615|NCT00541931|528967619|FG001|Overall Study|Lost to Follow-up|3|||
146669616|NCT00541931|528967618|FG000|Overall Study|Withdrawal by Subject|1|||
146669617|NCT00541931|528967619|FG001|Overall Study|Withdrawal by Subject|0|||
146669618|NCT00541931|528967618|FG000|Overall Study|Transportation Issue|0|||
146669619|NCT00541931|528967619|FG001|Overall Study|Transportation Issue|1|||
146669620|NCT01947582|528967620|FG000|Overall Study|Withdrawal by Subject|1|||
146669621|NCT00064337|528967621|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
146669622|NCT00064337|528967621|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
146669623|NCT00064337|528967621|FG000|PBSCC or Induction/PBSCC|Progression|3|||
146669624|NCT00064337|528967621|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
146669625|NCT00064337|528967621|FG000|PBSCC or Induction/PBSCC|Death|2|||
146669626|NCT00064337|528967621|FG000|Transplant|Adverse Event|9|||
146669627|NCT00064337|528967621|FG000|Transplant|Not protocol-specified|5|||
146669628|NCT00064337|528967621|FG000|Transplant|Death|3|||
146669629|NCT00064337|528967621|FG000|Transplant|Patient Refusal|2|||
146669630|NCT00064337|528967621|FG000|Transplant|Progression|2|||
146669631|NCT00064337|528967621|FG000|Maintenance|Adverse Event|3|||
146669632|NCT00064337|528967621|FG000|Maintenance|Progression|2|||
146669633|NCT00064337|528967621|FG000|Maintenance|On treatment at time of analysis|2|||
146669634|NCT00064337|528967621|FG000|Maintenance|Not protocol-specified|2|||
146669635|NCT00064337|528967621|FG000|Maintenance|Death|1|||
146925650|NCT01996748|529888327|FG000|Overall Study|Withdrawal by Subject|0|||
146669636|NCT00612040|528967622|FG000|Overall Study|Adverse Event|0|||
146669637|NCT00612040|528967623|FG001|Overall Study|Adverse Event|2|||
146669638|NCT00612040|528967624|FG002|Overall Study|Adverse Event|1|||
146669639|NCT00612040|528967622|FG000|Overall Study|Protocol Violation|1|||
146669640|NCT00612040|528967623|FG001|Overall Study|Protocol Violation|2|||
146669641|NCT00612040|528967624|FG002|Overall Study|Protocol Violation|1|||
146669642|NCT00612040|528967622|FG000|Overall Study|Lack of Efficacy|2|||
146669643|NCT00612040|528967623|FG001|Overall Study|Lack of Efficacy|1|||
146669644|NCT00612040|528967624|FG002|Overall Study|Lack of Efficacy|0|||
146669645|NCT00612040|528967622|FG000|Overall Study|Unclassified|2|||
146669646|NCT00612040|528967623|FG001|Overall Study|Unclassified|2|||
146669647|NCT00612040|528967624|FG002|Overall Study|Unclassified|5|||
146669648|NCT00827502|528967627|FG000|Overall Study|randomized but not treated|11|||
146669649|NCT00827502|528967627|FG000|Overall Study|Adverse Event|1|||
146669650|NCT00827502|528967627|FG000|Overall Study|Lost to Follow-up|4|||
146669651|NCT00827502|528967627|FG000|Overall Study|Withdrawal by Subject|5|||
146669652|NCT01397890|528967632|FG000|Overall Study|Withdrawal by Subject|7|||
146669653|NCT01397890|528967633|FG001|Overall Study|Withdrawal by Subject|11|||
146669654|NCT01397890|528967632|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
146669655|NCT01397890|528967633|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
146669656|NCT01397890|528967632|FG000|Overall Study|Death|2|||
146669657|NCT01397890|528967633|FG001|Overall Study|Death|3|||
146669658|NCT01397890|528967632|FG000|Overall Study|Lost to Follow-up|1|||
146669659|NCT01397890|528967633|FG001|Overall Study|Lost to Follow-up|4|||
146669660|NCT01397890|528967632|FG000|Overall Study|Condition under Investigation Worsened|1|||
146669661|NCT01397890|528967633|FG001|Overall Study|Condition under Investigation Worsened|3|||
146669662|NCT01397890|528967632|FG000|Overall Study|Adverse Event|1|||
146669663|NCT01397890|528967633|FG001|Overall Study|Adverse Event|2|||
146669664|NCT01397890|528967632|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
146669665|NCT01397890|528967633|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
146669666|NCT01397890|528967632|FG000|Overall Study|Others|2|||
146669667|NCT01397890|528967633|FG001|Overall Study|Others|1|||
146669668|NCT02924571|528967634|FG000|Overall Study|Lost to Follow-up|1|||
146669669|NCT02924571|528967635|FG001|Overall Study|Lost to Follow-up|1|||
146669670|NCT02924571|528967636|FG002|Overall Study|Lost to Follow-up|0|||
146669671|NCT00434954|528967640|FG000|Overall Study|Adverse Event|17|||
146669672|NCT00434954|528967641|FG001|Overall Study|Adverse Event|2|||
146669673|NCT00434954|528967640|FG000|Overall Study|Entry criteria not met|14|||
146669674|NCT00434954|528967641|FG001|Overall Study|Entry criteria not met|16|||
146669675|NCT00434954|528967640|FG000|Overall Study|Lost to Follow-up|0|||
146669676|NCT00434954|528967641|FG001|Overall Study|Lost to Follow-up|1|||
146669677|NCT00434954|528967640|FG000|Overall Study|Physician Decision|6|||
146669678|NCT00434954|528967641|FG001|Overall Study|Physician Decision|3|||
146669679|NCT00434954|528967640|FG000|Overall Study|Protocol Violation|36|||
146669680|NCT00434954|528967641|FG001|Overall Study|Protocol Violation|27|||
146669681|NCT00434954|528967640|FG000|Overall Study|Sponsor decision|1|||
146669682|NCT00434954|528967641|FG001|Overall Study|Sponsor decision|0|||
146669683|NCT00434954|528967640|FG000|Overall Study|Subject decision|8|||
146669684|NCT00434954|528967641|FG001|Overall Study|Subject decision|22|||
146669685|NCT03417219|528967650|FG000|Overall Study|Lost to Follow-up|0|||
146669686|NCT03417219|528967651|FG001|Overall Study|Lost to Follow-up|3|||
146669687|NCT03345914|528967652|FG000|Overall Study|Transition to another study at week 16|80|||
146669688|NCT03345914|528967653|FG001|Overall Study|Transition to another study at week 16|86|||
146669689|NCT03345914|528967654|FG002|Overall Study|Transition to another study at week 16|78|||
146669690|NCT03345914|528967652|FG000|Overall Study|Transition to OLE during follow-up|37|||
146669691|NCT03345914|528967653|FG001|Overall Study|Transition to OLE during follow-up|33|||
146669692|NCT03345914|528967654|FG002|Overall Study|Transition to OLE during follow-up|39|||
146669693|NCT03345914|528967652|FG000|Overall Study|Physician Decision|0|||
146669694|NCT03345914|528967653|FG001|Overall Study|Physician Decision|1|||
146669695|NCT03345914|528967654|FG002|Overall Study|Physician Decision|1|||
146773890|NCT04425629|529343468|FG015|Overall Study|Lack of Efficacy|0|||
146925651|NCT01996748|529888328|FG001|Overall Study|Withdrawal by Subject|1|||
146925652|NCT01996748|529888327|FG000|Overall Study|Lost to Follow-up|4|||
146669696|NCT03345914|528967652|FG000|Overall Study|Withdrawal by Subject|5|||
146669697|NCT03345914|528967653|FG001|Overall Study|Withdrawal by Subject|1|||
146669698|NCT03345914|528967654|FG002|Overall Study|Withdrawal by Subject|2|||
146669699|NCT03345914|528967652|FG000|Overall Study|Other|1|||
146669700|NCT03345914|528967653|FG001|Overall Study|Other|1|||
146669701|NCT03345914|528967654|FG002|Overall Study|Other|1|||
146669702|NCT03345914|528967652|FG000|Overall Study|Ongoing|0|||
146669703|NCT03345914|528967653|FG001|Overall Study|Ongoing|0|||
146669704|NCT03345914|528967654|FG002|Overall Study|Ongoing|1|||
146669705|NCT02609828|528967655|FG000|Overall Study|Adverse Event|8|||
146669706|NCT02609828|528967656|FG001|Overall Study|Adverse Event|1|||
146669707|NCT02609828|528967657|FG002|Overall Study|Adverse Event|0|||
146669708|NCT02609828|528967658|FG003|Overall Study|Adverse Event|6|||
146669709|NCT02609828|528967655|FG000|Overall Study|Death|15|||
146669710|NCT02609828|528967656|FG001|Overall Study|Death|1|||
146669711|NCT02609828|528967657|FG002|Overall Study|Death|1|||
146669712|NCT02609828|528967658|FG003|Overall Study|Death|19|||
146669713|NCT02609828|528967655|FG000|Overall Study|Insufficient clinical response|2|||
146925653|NCT01996748|529888328|FG001|Overall Study|Lost to Follow-up|1|||
146669714|NCT02609828|528967656|FG001|Overall Study|Insufficient clinical response|1|||
146669715|NCT02609828|528967657|FG002|Overall Study|Insufficient clinical response|0|||
146669716|NCT02609828|528967658|FG003|Overall Study|Insufficient clinical response|0|||
146669717|NCT02609828|528967655|FG000|Overall Study|Lost to Follow-up|0|||
146669718|NCT02609828|528967656|FG001|Overall Study|Lost to Follow-up|0|||
146669719|NCT02609828|528967657|FG002|Overall Study|Lost to Follow-up|0|||
146669720|NCT02609828|528967658|FG003|Overall Study|Lost to Follow-up|1|||
146669721|NCT02609828|528967655|FG000|Overall Study|Protocol Violation|2|||
146669722|NCT02609828|528967656|FG001|Overall Study|Protocol Violation|0|||
146669723|NCT02609828|528967657|FG002|Overall Study|Protocol Violation|0|||
146669724|NCT02609828|528967658|FG003|Overall Study|Protocol Violation|1|||
146669725|NCT02609828|528967655|FG000|Overall Study|Withdrawal by Subject|12|||
146669726|NCT02609828|528967656|FG001|Overall Study|Withdrawal by Subject|1|||
146669727|NCT02609828|528967657|FG002|Overall Study|Withdrawal by Subject|0|||
146669728|NCT02609828|528967658|FG003|Overall Study|Withdrawal by Subject|10|||
146669729|NCT02609828|528967655|FG000|Overall Study|Other|3|||
146669730|NCT02609828|528967656|FG001|Overall Study|Other|0|||
146669731|NCT02609828|528967657|FG002|Overall Study|Other|0|||
146669732|NCT02609828|528967658|FG003|Overall Study|Other|6|||
146669733|NCT02609828|528967655|FG000|Overall Study|Randomized but not treated|1|||
146669734|NCT02609828|528967656|FG001|Overall Study|Randomized but not treated|0|||
146669735|NCT02609828|528967657|FG002|Overall Study|Randomized but not treated|0|||
146669736|NCT02609828|528967658|FG003|Overall Study|Randomized but not treated|0|||
146669737|NCT00319553|528967659|FG000|Overall Study|Protocol Violation|1|||
146669738|NCT00319553|528967660|FG001|Overall Study|Protocol Violation|2|||
146669739|NCT00319553|528967659|FG000|Overall Study|Lost to Follow-up|2|||
146669740|NCT00319553|528967660|FG001|Overall Study|Lost to Follow-up|1|||
146669741|NCT00319553|528967659|FG000|Overall Study|Withdrawal by Subject|1|||
146669742|NCT00319553|528967660|FG001|Overall Study|Withdrawal by Subject|1|||
146669743|NCT01896102|528967661|FG000|Overall Study|Death|1|||
146669744|NCT01896102|528967661|FG000|Overall Study|Participant to receive allogenic transplant|2|||
146669745|NCT00753766|528967662|FG000|Overall Study|Physician Decision|1|||
146669746|NCT00753766|528967663|FG001|Overall Study|Physician Decision|0|||
146669747|NCT02805972|528967668|FG000|Washout Period|Lost to Follow-up|3|||
146669748|NCT02805972|528967669|FG001|Washout Period|Lost to Follow-up|0|||
146669749|NCT00939640|528967678|FG000|Overall Study|Physician Decision|1|||
146669750|NCT00239590|528967679|FG000|Randomized|Lost to Follow-up|0|||
146669751|NCT00239590|528967680|FG001|Randomized|Lost to Follow-up|1|||
146669752|NCT00239590|528967679|FG000|Randomized|Withdrawal by Subject|0|||
146669753|NCT00239590|528967680|FG001|Randomized|Withdrawal by Subject|1|||
146669754|NCT00239590|528967679|FG000|Completed Study Protocol|Adverse Event|1|||
146669755|NCT00239590|528967680|FG001|Completed Study Protocol|Adverse Event|1|||
146669756|NCT00239590|528967679|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
146669757|NCT00239590|528967680|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
146669758|NCT02121522|528967682|FG000|Overall Study|Adverse Event|1|||
146669759|NCT00892047|528967688|FG000|Overall Study|Adverse Event|2|||
146669760|NCT00892047|528967689|FG001|Overall Study|Adverse Event|2|||
146669761|NCT00892047|528967688|FG000|Overall Study|subject burden|2|||
146669762|NCT00892047|528967689|FG001|Overall Study|subject burden|3|||
146669763|NCT00892047|528967688|FG000|Overall Study|Lack of Efficacy|0|||
146669764|NCT00892047|528967689|FG001|Overall Study|Lack of Efficacy|2|||
146669765|NCT05306977|528967690|FG000|Overall Study|Withdrawal by Subject|1|||
146669766|NCT00306189|528967691|FG000|Overall Study|Physician Decision|0|||
146669767|NCT00306189|528967692|FG001|Overall Study|Physician Decision|0|||
146669768|NCT00306189|528967693|FG002|Overall Study|Physician Decision|0|||
146669769|NCT00306189|528967694|FG003|Overall Study|Physician Decision|1|||
146669770|NCT00306189|528967691|FG000|Overall Study|Adverse Event|3|||
146669771|NCT00306189|528967692|FG001|Overall Study|Adverse Event|3|||
146669772|NCT00306189|528967693|FG002|Overall Study|Adverse Event|2|||
146669773|NCT00306189|528967694|FG003|Overall Study|Adverse Event|2|||
146669774|NCT00306189|528967691|FG000|Overall Study|Withdrawal by Subject|4|||
146669775|NCT00306189|528967692|FG001|Overall Study|Withdrawal by Subject|2|||
146669776|NCT00306189|528967693|FG002|Overall Study|Withdrawal by Subject|8|||
146669777|NCT00306189|528967694|FG003|Overall Study|Withdrawal by Subject|1|||
146669778|NCT00306189|528967691|FG000|Overall Study|Ineligibility determined|1|||
146669779|NCT00306189|528967692|FG001|Overall Study|Ineligibility determined|1|||
146669780|NCT00306189|528967693|FG002|Overall Study|Ineligibility determined|1|||
146669781|NCT00306189|528967694|FG003|Overall Study|Ineligibility determined|1|||
146669782|NCT00306189|528967691|FG000|Overall Study|Other|1|||
146669783|NCT00306189|528967692|FG001|Overall Study|Other|0|||
146669784|NCT00306189|528967693|FG002|Overall Study|Other|0|||
146669785|NCT00306189|528967694|FG003|Overall Study|Other|0|||
146669786|NCT02993757|528967695|FG000|Overall Study|Non compliance with the protocol|155|||
146669787|NCT02993757|528967696|FG001|Overall Study|Non compliance with the protocol|170|||
146669788|NCT02993757|528967695|FG000|Overall Study|Lost to Follow-up|1|||
146669789|NCT02993757|528967696|FG001|Overall Study|Lost to Follow-up|0|||
146669790|NCT02993757|528967695|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
146669791|NCT02993757|528967696|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
146669792|NCT00190671|528967697|FG000|Overall Study|Satisfactory Response|4|||
146669793|NCT00190671|528967698|FG001|Overall Study|Satisfactory Response|7|||
146669794|NCT00190671|528967697|FG000|Overall Study|Lack of Efficacy|19|||
146669795|NCT00190671|528967698|FG001|Overall Study|Lack of Efficacy|24|||
146669796|NCT00190671|528967697|FG000|Overall Study|Death from Study Disease|1|||
146669797|NCT00190671|528967698|FG001|Overall Study|Death from Study Disease|1|||
146669798|NCT00190671|528967697|FG000|Overall Study|Adverse Event|3|||
146669799|NCT00190671|528967698|FG001|Overall Study|Adverse Event|2|||
146669800|NCT00190671|528967697|FG000|Overall Study|Clinical Relapse|0|||
146669801|NCT00190671|528967698|FG001|Overall Study|Clinical Relapse|1|||
146669802|NCT00190671|528967697|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
146669803|NCT00190671|528967698|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
146669804|NCT00190671|528967697|FG000|Overall Study|Death from Other Causes|0|||
146669805|NCT00190671|528967698|FG001|Overall Study|Death from Other Causes|2|||
146669806|NCT00190671|528967697|FG000|Overall Study|Protocol Violation|0|||
146669807|NCT00190671|528967698|FG001|Overall Study|Protocol Violation|1|||
146669808|NCT00190671|528967697|FG000|Overall Study|Withdrawal by Subject|0|||
146669809|NCT00190671|528967698|FG001|Overall Study|Withdrawal by Subject|2|||
146669810|NCT04502433|528967699|FG000|Overall Study|Death|2|||
146669811|NCT04502433|528967700|FG001|Overall Study|Death|4|||
146669812|NCT04502433|528967699|FG000|Overall Study|Lost to Follow-up|1|||
146669813|NCT04502433|528967700|FG001|Overall Study|Lost to Follow-up|0|||
146669814|NCT04502433|528967699|FG000|Overall Study|Physician Decision|0|||
146669815|NCT04502433|528967700|FG001|Overall Study|Physician Decision|1|||
146669816|NCT00672646|528967703|FG000|Overall Study|Lost to Follow-up|0|||
146669817|NCT00672646|528967704|FG001|Overall Study|Lost to Follow-up|1|||
146669818|NCT00672646|528967705|FG002|Overall Study|Lost to Follow-up|2|||
146669819|NCT00672646|528967703|FG000|Overall Study|Withdrawal by Subject|0|||
146669820|NCT00672646|528967704|FG001|Overall Study|Withdrawal by Subject|0|||
146669821|NCT00672646|528967705|FG002|Overall Study|Withdrawal by Subject|1|||
146669822|NCT00289783|528967706|FG000|Primary Phase|Adverse Event|10|||
146669823|NCT00289783|528967707|FG001|Primary Phase|Adverse Event|1|||
146669824|NCT00289783|528967706|FG000|Primary Phase|Protocol Violation|27|||
146669825|NCT00289783|528967707|FG001|Primary Phase|Protocol Violation|6|||
146669826|NCT00289783|528967706|FG000|Primary Phase|Withdrawal by Subject|93|||
146669827|NCT00289783|528967707|FG001|Primary Phase|Withdrawal by Subject|40|||
146669828|NCT00289783|528967706|FG000|Primary Phase|Lost to Follow-up|60|||
146669829|NCT00289783|528967707|FG001|Primary Phase|Lost to Follow-up|14|||
146669830|NCT00289783|528967706|FG000|Primary Phase|Migration from the study area|26|||
146669831|NCT00289783|528967707|FG001|Primary Phase|Migration from the study area|10|||
146669832|NCT00289783|528967706|FG000|Primary Phase|Other|32|||
146669833|NCT00289783|528967707|FG001|Primary Phase|Other|12|||
146669834|NCT00289783|528967706|FG000|Fourth Dose Phase|Adverse Event|1|||
146669835|NCT00289783|528967707|FG001|Fourth Dose Phase|Adverse Event|0|||
146669836|NCT00289783|528967706|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
146669837|NCT00289783|528967707|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
146669838|NCT00289783|528967706|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
146669839|NCT00289783|528967707|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
146669840|NCT00289783|528967706|FG000|Fourth Dose Phase|Migration from the study area|1|||
146669841|NCT00289783|528967707|FG001|Fourth Dose Phase|Migration from the study area|1|||
146669842|NCT00289783|528967706|FG000|Fourth Dose Phase|Other|22|||
146669843|NCT00289783|528967707|FG001|Fourth Dose Phase|Other|10|||
146669844|NCT00660699|528967708|FG000|Overall Study|Withdrawal by Subject|2|||
146669845|NCT06934993|528967711|FG000|Overall Study|Withdrawal by Subject|29|||
146669846|NCT06934993|528967711|FG000|Overall Study|elevated postoperative creatinine level|11|||
146669847|NCT06934993|528967711|FG000|Overall Study|Death|3|||
146669848|NCT03128047|528967712|FG000|Overall Study|Withdrawal by Subject|1|||
146669849|NCT01687998|528969003|FG000|Overall Study|Withdrawal by Subject|49|||
146669850|NCT01687998|528969004|FG001|Overall Study|Withdrawal by Subject|51|||
146669851|NCT01687998|528969003|FG000|Overall Study|Known to be Alive at Study End|54|||
146669852|NCT01687998|528969004|FG001|Overall Study|Known to be Alive at Study End|62|||
146669853|NCT01687998|528969003|FG000|Overall Study|Lost to Follow-up|9|||
146669854|NCT01687998|528969004|FG001|Overall Study|Lost to Follow-up|7|||
146669855|NCT00443261|528969005|FG000|Overall Study|Death|1|||
146669856|NCT01663532|528969006|FG000|Overall Study|Lost to Follow-up|9|||
146669857|NCT01663532|528969007|FG001|Overall Study|Lost to Follow-up|10|||
146669858|NCT01663532|528969006|FG000|Overall Study|Adverse Event|7|||
146669859|NCT01663532|528969007|FG001|Overall Study|Adverse Event|13|||
146669860|NCT01663532|528969006|FG000|Overall Study|Met Withdrawal Criteria|7|||
146669861|NCT01663532|528969007|FG001|Overall Study|Met Withdrawal Criteria|6|||
146669862|NCT01663532|528969006|FG000|Overall Study|Physician Decision|1|||
146669863|NCT01663532|528969007|FG001|Overall Study|Physician Decision|1|||
146669864|NCT01663532|528969006|FG000|Overall Study|Withdrawal by Subject|35|||
146669865|NCT01663532|528969007|FG001|Overall Study|Withdrawal by Subject|17|||
146669866|NCT01663532|528969006|FG000|Overall Study|Lack of Efficacy|15|||
146669867|NCT01663532|528969007|FG001|Overall Study|Lack of Efficacy|60|||
146669868|NCT03539081|528969010|FG000|Overall Study|Withdrawal by Subject|2|||
146669869|NCT03539081|528969011|FG001|Overall Study|Withdrawal by Subject|3|||
146669870|NCT03539081|528969012|FG002|Overall Study|Withdrawal by Subject|0|||
146736243|NCT00279201|529205301|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
146669871|NCT03539081|528969010|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
146669872|NCT03539081|528969011|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
146669873|NCT03539081|528969012|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
146669874|NCT02025621|528969013|FG000|Overall Study|Withdrawal by Subject|1|||
146669875|NCT02025621|528969014|FG001|Overall Study|Withdrawal by Subject|0|||
146669876|NCT02025621|528969013|FG000|Overall Study|Death|0|||
146669877|NCT02025621|528969014|FG001|Overall Study|Death|1|||
146669878|NCT02025621|528969013|FG000|Overall Study|No longer eligible|10|||
146669879|NCT02025621|528969014|FG001|Overall Study|No longer eligible|15|||
146669880|NCT02025621|528969013|FG000|Overall Study|Surgery initiated before infusion|3|||
146669881|NCT02025621|528969014|FG001|Overall Study|Surgery initiated before infusion|3|||
146669882|NCT00739674|528969015|FG000|Overall Study|Screening failures|19|||
146669883|NCT00739674|528969016|FG001|Overall Study|Screening failures|17|||
146669884|NCT00739674|528969015|FG000|Overall Study|Site 212 removal|19|||
146669885|NCT00739674|528969016|FG001|Overall Study|Site 212 removal|13|||
146669886|NCT00739674|528969015|FG000|Overall Study|No follow-up data|33|||
146669887|NCT00739674|528969016|FG001|Overall Study|No follow-up data|18|||
146669888|NCT00739674|528969015|FG000|Overall Study|Dietician consultation >30 days|1|||
146669889|NCT00739674|528969016|FG001|Overall Study|Dietician consultation >30 days|9|||
146669890|NCT00739674|528969015|FG000|Overall Study|Adverse Event|22|||
146669891|NCT00739674|528969016|FG001|Overall Study|Adverse Event|13|||
146669892|NCT00739674|528969015|FG000|Overall Study|Death|1|||
146669893|NCT00739674|528969016|FG001|Overall Study|Death|0|||
146669894|NCT00739674|528969015|FG000|Overall Study|Lack of Efficacy|1|||
146669895|NCT00739674|528969016|FG001|Overall Study|Lack of Efficacy|0|||
146669896|NCT00739674|528969015|FG000|Overall Study|Lost to Follow-up|52|||
146669897|NCT00739674|528969016|FG001|Overall Study|Lost to Follow-up|30|||
146669898|NCT00739674|528969015|FG000|Overall Study|Protocol Violation|5|||
146669899|NCT00739674|528969016|FG001|Overall Study|Protocol Violation|5|||
146669900|NCT00739674|528969015|FG000|Overall Study|Withdrawal by Subject|9|||
146669901|NCT00739674|528969016|FG001|Overall Study|Withdrawal by Subject|9|||
146669902|NCT00739674|528969015|FG000|Overall Study|Reason missing|2|||
146669903|NCT00739674|528969016|FG001|Overall Study|Reason missing|0|||
146669904|NCT00739674|528969015|FG000|Overall Study|Clinic closed|6|||
146669905|NCT00739674|528969016|FG001|Overall Study|Clinic closed|4|||
146669906|NCT00739674|528969015|FG000|Overall Study|Patient moved|3|||
146669907|NCT00739674|528969016|FG001|Overall Study|Patient moved|2|||
146669908|NCT00739674|528969015|FG000|Overall Study|Non compliant|4|||
146669909|NCT00739674|528969016|FG001|Overall Study|Non compliant|0|||
146669910|NCT00739674|528969015|FG000|Overall Study|Unable to attend visit|3|||
146669911|NCT00739674|528969016|FG001|Overall Study|Unable to attend visit|1|||
146669912|NCT00739674|528969015|FG000|Overall Study|Home monitoring off meds|1|||
146669913|NCT00739674|528969016|FG001|Overall Study|Home monitoring off meds|0|||
146669914|NCT00739674|528969015|FG000|Overall Study|Erectile dysfunction|0|||
146669915|NCT00739674|528969016|FG001|Overall Study|Erectile dysfunction|1|||
146669916|NCT04805541|528969018|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
146669917|NCT00283400|528969021|FG000|Overall Study|Withdrawal by Subject|1|||
146669918|NCT00283400|528969022|FG001|Overall Study|Withdrawal by Subject|1|||
146669919|NCT00283400|528969023|FG002|Overall Study|Withdrawal by Subject|0|||
146669920|NCT00283400|528969024|FG003|Overall Study|Withdrawal by Subject|0|||
146669921|NCT00283400|528969021|FG000|Overall Study|Death|1|||
146669922|NCT00283400|528969022|FG001|Overall Study|Death|0|||
146669923|NCT00283400|528969023|FG002|Overall Study|Death|1|||
146669924|NCT00283400|528969024|FG003|Overall Study|Death|0|||
146669925|NCT02195583|528969029|FG000|Overall Study|Lost to Follow-up|1|||
146669926|NCT02195583|528969029|FG000|Overall Study|Withdrawal by Subject|4|||
146669927|NCT02195583|528969029|FG000|Overall Study|Adverse Event|2|||
146669928|NCT02195583|528969029|FG000|Overall Study|Other Reason|2|||
146669929|NCT01560403|528969030|FG000|Overall Study|Lost to Follow-up|0|||
146669930|NCT01560403|528969031|FG001|Overall Study|Lost to Follow-up|1|||
146669931|NCT00354744|528969032|FG000|Overall Study|Adverse Event|2|||
146669932|NCT00354744|528969032|FG000|Overall Study|Death|2|||
146669933|NCT00354744|528969032|FG000|Overall Study|Lack of Efficacy|11|||
146669934|NCT00354744|528969032|FG000|Overall Study|Lost to Follow-up|2|||
146669935|NCT00354744|528969032|FG000|Overall Study|Physician Decision|11|||
146773891|NCT04425629|529343469|FG016|Overall Study|Lack of Efficacy|0|||
146773892|NCT04425629|529343470|FG017|Overall Study|Lack of Efficacy|0|||
146925654|NCT00586924|529888334|FG000|Overall Study|Adverse event/serious adverse event|0|||
146669936|NCT00354744|528969032|FG000|Overall Study|Withdrawal by Subject|14|||
146669937|NCT00983437|528969033|FG000|Overall Study|Adverse Event|9|||
146669938|NCT00983437|528969033|FG000|Overall Study|Lack of Efficacy|1|||
146669939|NCT00983437|528969033|FG000|Overall Study|Withdrawal by Subject|8|||
146669940|NCT00983437|528969033|FG000|Overall Study|Noncompliance to Study Procedures|1|||
146773893|NCT04425629|529343471|FG018|Overall Study|Lack of Efficacy|0|||
146925655|NCT00586924|529888335|FG001|Overall Study|Adverse event/serious adverse event|0|||
146669941|NCT00983437|528969033|FG000|Overall Study|Lost to Follow-up|2|||
146669942|NCT00983437|528969033|FG000|Overall Study|Other Reason|26|||
146925656|NCT00586924|529888336|FG002|Overall Study|Adverse event/serious adverse event|0|||
146925657|NCT00586924|529888337|FG003|Overall Study|Adverse event/serious adverse event|1|||
146925658|NCT00586924|529888338|FG004|Overall Study|Adverse event/serious adverse event|0|||
146925659|NCT00586924|529888339|FG005|Overall Study|Adverse event/serious adverse event|2|||
146925660|NCT00586924|529888334|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
146925661|NCT00586924|529888335|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
146669943|NCT01020981|528969034|FG000|Overall Study|Did not return mailed survey|74|||
146669944|NCT01020981|528969035|FG001|Overall Study|Did not return mailed survey|58|||
146925662|NCT00586924|529888336|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
146925663|NCT00586924|529888337|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
146925664|NCT00586924|529888338|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
146669945|NCT01020981|528969034|FG000|Overall Study|Survey returned undeliverable|8|||
146669946|NCT01020981|528969035|FG001|Overall Study|Survey returned undeliverable|32|||
146669947|NCT01020981|528969034|FG000|Overall Study|Participant declined to complete survey|2|||
146669948|NCT01020981|528969035|FG001|Overall Study|Participant declined to complete survey|0|||
146669949|NCT03372096|528969041|FG000|Overall Study|Study Closed|8|||
146669950|NCT00040365|528969042|FG000|Overall Study|Death|1|||
146669951|NCT00040365|528969042|FG000|Overall Study|Progressive disease|7|||
146669952|NCT00040365|528969042|FG000|Overall Study|Lost to Follow-up|3|||
146669953|NCT00680017|528969043|FG000|Overall Study|Adverse Event|13|||
146669954|NCT00680017|528969044|FG001|Overall Study|Adverse Event|7|||
146669955|NCT00680017|528969043|FG000|Overall Study|Withdrawal by Subject|2|||
146669956|NCT00680017|528969044|FG001|Overall Study|Withdrawal by Subject|5|||
146669957|NCT00680017|528969043|FG000|Overall Study|Lost to Follow-up|2|||
146669958|NCT00680017|528969044|FG001|Overall Study|Lost to Follow-up|0|||
146669959|NCT02555683|528969048|FG000|Overall Study|Physician Decision|1|||
146669960|NCT02555683|528969049|FG001|Overall Study|Physician Decision|0|||
146669961|NCT02555683|528969050|FG002|Overall Study|Physician Decision|2|||
146669962|NCT02555683|528969048|FG000|Overall Study|Lost to Follow-up|2|||
146669963|NCT02555683|528969049|FG001|Overall Study|Lost to Follow-up|1|||
146669964|NCT02555683|528969050|FG002|Overall Study|Lost to Follow-up|2|||
146669965|NCT02555683|528969048|FG000|Overall Study|Technical Problems|1|||
146669966|NCT02555683|528969049|FG001|Overall Study|Technical Problems|1|||
146669967|NCT02555683|528969050|FG002|Overall Study|Technical Problems|0|||
146669968|NCT02555683|528969048|FG000|Overall Study|Protocol deviation|0|||
146669969|NCT02555683|528969049|FG001|Overall Study|Protocol deviation|1|||
146669970|NCT02555683|528969050|FG002|Overall Study|Protocol deviation|0|||
146669971|NCT02555683|528969048|FG000|Overall Study|Lack of Efficacy|2|||
146669972|NCT02555683|528969049|FG001|Overall Study|Lack of Efficacy|0|||
146669973|NCT02555683|528969050|FG002|Overall Study|Lack of Efficacy|0|||
146669974|NCT02555683|528969048|FG000|Overall Study|Death|0|||
146669975|NCT02555683|528969049|FG001|Overall Study|Death|1|||
146669976|NCT02555683|528969050|FG002|Overall Study|Death|2|||
146669977|NCT02555683|528969048|FG000|Overall Study|Adverse Event|1|||
146669978|NCT02555683|528969049|FG001|Overall Study|Adverse Event|0|||
146669979|NCT02555683|528969050|FG002|Overall Study|Adverse Event|1|||
146669980|NCT02555683|528969048|FG000|Overall Study|Subject/guardian decision|12|||
146669981|NCT02555683|528969049|FG001|Overall Study|Subject/guardian decision|12|||
146669982|NCT02555683|528969050|FG002|Overall Study|Subject/guardian decision|22|||
146669983|NCT02555683|528969048|FG000|Overall Study|Death post Treatment/safety period|0|||
146669984|NCT02555683|528969049|FG001|Overall Study|Death post Treatment/safety period|1|||
146669985|NCT02555683|528969050|FG002|Overall Study|Death post Treatment/safety period|0|||
146669986|NCT01153347|528969051|FG000|Overall Study|Withdrawal by Subject|7|||
146669987|NCT01153347|528969052|FG001|Overall Study|Withdrawal by Subject|7|||
146669988|NCT01153347|528969053|FG002|Overall Study|Withdrawal by Subject|7|||
146669989|NCT01153347|528969054|FG003|Overall Study|Withdrawal by Subject|7|||
146669990|NCT01153347|528969051|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146669991|NCT01153347|528969052|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146669992|NCT01153347|528969053|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
146669993|NCT01153347|528969054|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
146669994|NCT01153347|528969051|FG000|Overall Study|Adverse Event|3|||
146669995|NCT01153347|528969052|FG001|Overall Study|Adverse Event|9|||
146669996|NCT01153347|528969053|FG002|Overall Study|Adverse Event|21|||
146669997|NCT01153347|528969054|FG003|Overall Study|Adverse Event|7|||
146669998|NCT01153347|528969051|FG000|Overall Study|Severe non-compliance to protocol|6|||
146669999|NCT01153347|528969052|FG001|Overall Study|Severe non-compliance to protocol|7|||
146670000|NCT01153347|528969053|FG002|Overall Study|Severe non-compliance to protocol|4|||
146670001|NCT01153347|528969054|FG003|Overall Study|Severe non-compliance to protocol|3|||
146670002|NCT01153347|528969051|FG000|Overall Study|Condition under investigation worsened|1|||
146670003|NCT01153347|528969052|FG001|Overall Study|Condition under investigation worsened|1|||
146670004|NCT01153347|528969053|FG002|Overall Study|Condition under investigation worsened|0|||
146670005|NCT01153347|528969054|FG003|Overall Study|Condition under investigation worsened|0|||
146670006|NCT01153347|528969051|FG000|Overall Study|Lack of Efficacy|2|||
146670007|NCT01153347|528969052|FG001|Overall Study|Lack of Efficacy|2|||
146670008|NCT01153347|528969053|FG002|Overall Study|Lack of Efficacy|0|||
146925665|NCT00586924|529888339|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
146925666|NCT00586924|529888334|FG000|Overall Study|Disease progression|0|||
146925667|NCT00586924|529888335|FG001|Overall Study|Disease progression|0|||
146925668|NCT00586924|529888336|FG002|Overall Study|Disease progression|0|||
146925669|NCT00586924|529888337|FG003|Overall Study|Disease progression|1|||
146925670|NCT00586924|529888338|FG004|Overall Study|Disease progression|1|||
146925671|NCT00586924|529888339|FG005|Overall Study|Disease progression|0|||
146925672|NCT00586924|529888334|FG000|Overall Study|Development of neutralizing antibodies|2|||
146925673|NCT00586924|529888335|FG001|Overall Study|Development of neutralizing antibodies|2|||
146925674|NCT00586924|529888336|FG002|Overall Study|Development of neutralizing antibodies|2|||
146925675|NCT00586924|529888337|FG003|Overall Study|Development of neutralizing antibodies|0|||
146925676|NCT00586924|529888338|FG004|Overall Study|Development of neutralizing antibodies|0|||
146925677|NCT00586924|529888339|FG005|Overall Study|Development of neutralizing antibodies|22|||
146925678|NCT00586924|529888334|FG000|Overall Study|Complete response|0|||
146925679|NCT00586924|529888335|FG001|Overall Study|Complete response|1|||
146925680|NCT00586924|529888336|FG002|Overall Study|Complete response|0|||
146925681|NCT00586924|529888337|FG003|Overall Study|Complete response|0|||
146670009|NCT01153347|528969054|FG003|Overall Study|Lack of Efficacy|4|||
146670010|NCT01153347|528969051|FG000|Overall Study|Study-specific withdrawal criteria|4|||
146670011|NCT01153347|528969052|FG001|Overall Study|Study-specific withdrawal criteria|3|||
146670012|NCT01153347|528969053|FG002|Overall Study|Study-specific withdrawal criteria|1|||
146670013|NCT01153347|528969054|FG003|Overall Study|Study-specific withdrawal criteria|2|||
146670014|NCT01153347|528969051|FG000|Overall Study|Lost to Follow-up|4|||
146670015|NCT01153347|528969052|FG001|Overall Study|Lost to Follow-up|9|||
146670016|NCT01153347|528969053|FG002|Overall Study|Lost to Follow-up|11|||
146670017|NCT01153347|528969054|FG003|Overall Study|Lost to Follow-up|8|||
146670018|NCT01153347|528969051|FG000|Overall Study|Other|5|||
146670019|NCT01153347|528969052|FG001|Overall Study|Other|5|||
146670020|NCT01153347|528969053|FG002|Overall Study|Other|4|||
146670021|NCT01153347|528969054|FG003|Overall Study|Other|0|||
146670022|NCT01153347|528969051|FG000|Overall Study|Death|1|||
146670023|NCT01153347|528969052|FG001|Overall Study|Death|0|||
146670024|NCT01153347|528969053|FG002|Overall Study|Death|0|||
146670025|NCT01153347|528969054|FG003|Overall Study|Death|0|||
146670026|NCT05096221|528969055|FG000|Part 2|Physician Decision|0|||
146670027|NCT05096221|528969056|FG001|Part 2|Physician Decision|1|||
146670028|NCT04678661|528969059|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
146670029|NCT04678661|528969060|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
146670030|NCT04678661|528969059|FG000|Overall Study|Protocol Violation|2|||
146670031|NCT04678661|528969060|FG001|Overall Study|Protocol Violation|0|||
146670032|NCT04678661|528969059|FG000|Overall Study|Withdrawal by Subject|1|||
146670033|NCT04678661|528969060|FG001|Overall Study|Withdrawal by Subject|0|||
146670034|NCT04678661|528969059|FG000|Overall Study|Lost to Follow-up|2|||
146670035|NCT04678661|528969060|FG001|Overall Study|Lost to Follow-up|0|||
146670036|NCT04678661|528969059|FG000|Overall Study|Death|2|||
146670037|NCT04678661|528969060|FG001|Overall Study|Death|0|||
146670038|NCT01086033|528969061|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
146670039|NCT01086033|528969061|FG000|Overall Study|Lost to Follow-up|86|||
146670040|NCT01086033|528969061|FG000|Overall Study|Adverse Event|42|||
146670041|NCT01086033|528969061|FG000|Overall Study|Withdrawal by Subject|41|||
146670042|NCT01086033|528969061|FG000|Overall Study|Other|14|||
146670043|NCT01086033|528969061|FG000|Overall Study|Other|13|||
146670044|NCT01086033|528969061|FG000|Overall Study|AE and Withdrew Consent|5|||
146670045|NCT01086033|528969061|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
146670046|NCT01086033|528969061|FG000|Overall Study|Withdrew consent and Other Reason|4|||
146670047|NCT01086033|528969061|FG000|Overall Study|AE and Lack of Efficacy|4|||
146670048|NCT01086033|528969061|FG000|Overall Study|Death|1|||
146670049|NCT01086033|528969061|FG000|Overall Study|AE and Lost to Follow-up|1|||
146670050|NCT01086033|528969061|FG000|Overall Study|AE and Other Reason|1|||
146670051|NCT01086033|528969061|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
146670052|NCT03094169|528969062|FG000|Overall Study|Lack of Efficacy|0|||
146670053|NCT03094169|528969063|FG001|Overall Study|Lack of Efficacy|0|||
146670054|NCT03094169|528969064|FG002|Overall Study|Lack of Efficacy|0|||
146670055|NCT03094169|528969065|FG003|Overall Study|Lack of Efficacy|0|||
146670056|NCT03094169|528969066|FG004|Overall Study|Lack of Efficacy|0|||
146670057|NCT03094169|528969067|FG005|Overall Study|Lack of Efficacy|0|||
146670058|NCT03094169|528969068|FG006|Overall Study|Lack of Efficacy|0|||
146773894|NCT00610649|529343472|FG000|Overall Study|Adverse Event|1|||
146925682|NCT00586924|529888338|FG004|Overall Study|Complete response|2|||
146925683|NCT00586924|529888339|FG005|Overall Study|Complete response|2|||
146925684|NCT00586924|529888334|FG000|Overall Study|Other|1|||
146670059|NCT03094169|528969069|FG007|Overall Study|Lack of Efficacy|21|||
146670060|NCT03094169|528969062|FG000|Overall Study|Adverse Event|0|||
146670061|NCT03094169|528969063|FG001|Overall Study|Adverse Event|0|||
146670062|NCT03094169|528969064|FG002|Overall Study|Adverse Event|0|||
146670063|NCT03094169|528969065|FG003|Overall Study|Adverse Event|0|||
146670064|NCT03094169|528969066|FG004|Overall Study|Adverse Event|0|||
146670065|NCT03094169|528969067|FG005|Overall Study|Adverse Event|0|||
146670066|NCT03094169|528969068|FG006|Overall Study|Adverse Event|0|||
146670067|NCT03094169|528969069|FG007|Overall Study|Adverse Event|2|||
146670068|NCT03094169|528969062|FG000|Overall Study|Withdrawal by Subject|0|||
146670069|NCT03094169|528969063|FG001|Overall Study|Withdrawal by Subject|0|||
146670070|NCT03094169|528969064|FG002|Overall Study|Withdrawal by Subject|0|||
146670071|NCT03094169|528969065|FG003|Overall Study|Withdrawal by Subject|0|||
146925685|NCT00586924|529888335|FG001|Overall Study|Other|0|||
146925686|NCT00586924|529888336|FG002|Overall Study|Other|1|||
146925687|NCT00586924|529888337|FG003|Overall Study|Other|1|||
146925688|NCT00586924|529888338|FG004|Overall Study|Other|1|||
146670072|NCT03094169|528969066|FG004|Overall Study|Withdrawal by Subject|0|||
146670073|NCT03094169|528969067|FG005|Overall Study|Withdrawal by Subject|0|||
146670074|NCT03094169|528969068|FG006|Overall Study|Withdrawal by Subject|1|||
146670075|NCT03094169|528969069|FG007|Overall Study|Withdrawal by Subject|1|||
146670076|NCT03094169|528969062|FG000|Overall Study|Trial Termination|0|||
146670077|NCT03094169|528969063|FG001|Overall Study|Trial Termination|0|||
146670078|NCT03094169|528969064|FG002|Overall Study|Trial Termination|0|||
146670079|NCT03094169|528969065|FG003|Overall Study|Trial Termination|0|||
146670080|NCT03094169|528969066|FG004|Overall Study|Trial Termination|0|||
146670081|NCT03094169|528969067|FG005|Overall Study|Trial Termination|0|||
146670082|NCT03094169|528969068|FG006|Overall Study|Trial Termination|0|||
146670083|NCT03094169|528969069|FG007|Overall Study|Trial Termination|1|||
146670084|NCT04645953|528969070|FG000|Overall Study|Lost to Follow-up|2|||
146670085|NCT04645953|528969071|FG001|Overall Study|Lost to Follow-up|1|||
146670086|NCT04645953|528969072|FG002|Overall Study|Lost to Follow-up|1|||
146670087|NCT04645953|528969070|FG000|Overall Study|Withdrawal by Subject|0|||
146670088|NCT04645953|528969071|FG001|Overall Study|Withdrawal by Subject|1|||
146670089|NCT04645953|528969072|FG002|Overall Study|Withdrawal by Subject|0|||
146670090|NCT04645953|528969070|FG000|Overall Study|Physician Decision|0|||
146670091|NCT04645953|528969071|FG001|Overall Study|Physician Decision|1|||
146670092|NCT04645953|528969072|FG002|Overall Study|Physician Decision|0|||
146670093|NCT04645953|528969070|FG000|Overall Study|Discontinued Prior to Dosing|0|||
146670094|NCT04645953|528969071|FG001|Overall Study|Discontinued Prior to Dosing|0|||
146670095|NCT04645953|528969072|FG002|Overall Study|Discontinued Prior to Dosing|2|||
146670096|NCT00864721|528969073|FG000|Overall Study|Patient request|11|||
146670097|NCT00864721|528969073|FG000|Overall Study|Hospitalized|1|||
146670098|NCT00864721|528969073|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
146670099|NCT00864721|528969073|FG000|Overall Study|Adverse Event|21|||
146670100|NCT02763462|528969076|FG000|Overall Study|Protocol Violation|6|||
146670101|NCT00261807|528969077|FG000|Overall Study|Lost to Follow-up|2|||
146670102|NCT00261807|528969077|FG000|Overall Study|Adverse Event|2|||
146670103|NCT00261807|528969077|FG000|Overall Study|Death|1|||
146670104|NCT00261807|528969077|FG000|Overall Study|Protocol Violation|2|||
146670105|NCT00762229|528969078|FG000|Overall Study|Lost to Follow-up|1|||
146670106|NCT00762229|528969079|FG001|Overall Study|Lost to Follow-up|1|||
146670107|NCT00762229|528969078|FG000|Overall Study|did not recveive intervention|0|||
146670108|NCT00762229|528969079|FG001|Overall Study|did not recveive intervention|1|||
146670109|NCT01751178|528969082|FG000|Overall Study|Adverse Event|2|||
146670110|NCT01751178|528969083|FG001|Overall Study|Adverse Event|0|||
146670111|NCT01751178|528969084|FG002|Overall Study|Adverse Event|0|||
146670112|NCT01751178|528969082|FG000|Overall Study|Other Reason (unknown)|1|||
146670113|NCT01751178|528969083|FG001|Overall Study|Other Reason (unknown)|0|||
146670114|NCT01751178|528969084|FG002|Overall Study|Other Reason (unknown)|2|||
146670115|NCT02747875|528969088|FG000|Overall Study|Physician Decision|1|||
146670116|NCT02747875|528969089|FG001|Overall Study|Physician Decision|0|||
146670117|NCT02747875|528969088|FG000|Overall Study|Adverse Event|0|||
146670118|NCT02747875|528969089|FG001|Overall Study|Adverse Event|1|||
146670119|NCT04891978|528969093|FG000|Baseline|Protocol Violation|2|||
146670120|NCT04891978|528969094|FG001|Baseline|Protocol Violation|1|||
146670121|NCT04891978|528969095|FG002|Baseline|Protocol Violation|0|||
146670122|NCT04891978|528969093|FG000|Baseline|Missing AIRQ|1|||
146670123|NCT04891978|528969094|FG001|Baseline|Missing AIRQ|0|||
146670124|NCT04891978|528969095|FG002|Baseline|Missing AIRQ|0|||
146670125|NCT04891978|528969093|FG000|Baseline|Did not attend a baseline visit|0|||
146670126|NCT04891978|528969094|FG001|Baseline|Did not attend a baseline visit|0|||
146670127|NCT04891978|528969095|FG002|Baseline|Did not attend a baseline visit|9|||
146773895|NCT00610649|529343473|FG001|Overall Study|Adverse Event|0|||
146925689|NCT00586924|529888339|FG005|Overall Study|Other|6|||
146925690|NCT04570657|529888342|FG000|Overall Study|Adverse Event|0|||
146670128|NCT01776840|528969096|FG000|Overall Study|Lost to Follow-up|12|||
146670129|NCT01776840|528969097|FG001|Overall Study|Lost to Follow-up|7|||
146670130|NCT01776840|528969096|FG000|Overall Study|Withdrawal by Subject|32|||
146670131|NCT01776840|528969097|FG001|Overall Study|Withdrawal by Subject|48|||
146670132|NCT01776840|528969096|FG000|Overall Study|Sponsor decision|89|||
146670133|NCT01776840|528969097|FG001|Overall Study|Sponsor decision|87|||
146670134|NCT03641339|528969098|FG000|Overall Study|Physician Decision|1|||
146925691|NCT04570657|529888343|FG001|Overall Study|Adverse Event|0|||
146925692|NCT04570657|529888344|FG002|Overall Study|Adverse Event|1|||
146670135|NCT03641339|528969099|FG001|Overall Study|Physician Decision|0|||
146670136|NCT03641339|528969100|FG002|Overall Study|Physician Decision|0|||
146670137|NCT03641339|528969101|FG003|Overall Study|Physician Decision|0|||
146670138|NCT03641339|528969102|FG004|Overall Study|Physician Decision|0|||
146670139|NCT03641339|528969103|FG005|Overall Study|Physician Decision|0|||
146670140|NCT03641339|528969098|FG000|Overall Study|Withdrawal by Subject|0|||
146670141|NCT03641339|528969099|FG001|Overall Study|Withdrawal by Subject|2|||
146670142|NCT03641339|528969100|FG002|Overall Study|Withdrawal by Subject|0|||
146670143|NCT03641339|528969101|FG003|Overall Study|Withdrawal by Subject|2|||
146670144|NCT03641339|528969102|FG004|Overall Study|Withdrawal by Subject|0|||
146670145|NCT03641339|528969103|FG005|Overall Study|Withdrawal by Subject|1|||
146670146|NCT02589405|528969106|FG000|Overall Study|Adverse Event|3|||
146670147|NCT02589405|528969106|FG000|Overall Study|Withdrawal by Subject|1|||
146670148|NCT00446251|528969110|FG000|Overall Study|On-study Transplants|2|||
146670149|NCT00446251|528969110|FG000|Overall Study|Rituximab Infusion Reaction|2|||
146670150|NCT00446251|528969110|FG000|Overall Study|Lost to Follow-up|1|||
146670151|NCT02264639|528969115|FG000|Overall Study|Death (after completing single-dose phase)|1|||
146670152|NCT02264639|528969116|FG001|Overall Study|Death (after completing single-dose phase)|0|||
146670153|NCT02264639|528969117|FG002|Overall Study|Death (after completing single-dose phase)|0|||
146670154|NCT02264639|528969118|FG003|Overall Study|Death (after completing single-dose phase)|0|||
146670155|NCT02264639|528969119|FG004|Overall Study|Death (after completing single-dose phase)|0|||
146670156|NCT02264639|528969115|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
146670157|NCT02264639|528969116|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
146670158|NCT02264639|528969117|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
146670159|NCT02264639|528969118|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
146670160|NCT02264639|528969119|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
146670161|NCT02264639|528969115|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
146670162|NCT02264639|528969116|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
146670163|NCT02264639|528969117|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
146670164|NCT02264639|528969118|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
146670165|NCT02264639|528969119|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
146670166|NCT02264639|528969115|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
146670167|NCT02264639|528969116|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
146670168|NCT02264639|528969117|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
146670169|NCT02264639|528969118|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
146670170|NCT02264639|528969119|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
146670171|NCT02693119|528969127|FG000|Open-Label Period|Withdrawal by Subject|0|||
146670172|NCT02693119|528969128|FG001|Open-Label Period|Withdrawal by Subject|1|||
146670173|NCT02319837|528969129|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
146670174|NCT02319837|528969130|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
146670175|NCT02319837|528969131|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
146670176|NCT02319837|528969129|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
146670177|NCT02319837|528969130|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
146670178|NCT02319837|528969131|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
146670179|NCT02319837|528969129|FG000|Study Treatment Phase|Adverse Event|73|||
146670180|NCT02319837|528969130|FG001|Study Treatment Phase|Adverse Event|36|||
146670181|NCT02319837|528969131|FG002|Study Treatment Phase|Adverse Event|63|||
146670182|NCT02319837|528969129|FG000|Study Treatment Phase|Development of castration resistance|0|||
146670183|NCT02319837|528969130|FG001|Study Treatment Phase|Development of castration resistance|2|||
146670184|NCT02319837|528969131|FG002|Study Treatment Phase|Development of castration resistance|0|||
146670185|NCT02319837|528969129|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
146670186|NCT02319837|528969130|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
146670187|NCT02319837|528969131|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
146670188|NCT02319837|528969129|FG000|Study Treatment Phase|Protocol Violation|2|||
146925693|NCT04570657|529888342|FG000|Overall Study|Lost to Follow-up|0|||
146925694|NCT04570657|529888343|FG001|Overall Study|Lost to Follow-up|0|||
146670189|NCT02319837|528969130|FG001|Study Treatment Phase|Protocol Violation|2|||
146670190|NCT02319837|528969131|FG002|Study Treatment Phase|Protocol Violation|1|||
146670191|NCT02319837|528969129|FG000|Study Treatment Phase|Lost to Follow-up|0|||
146670192|NCT02319837|528969130|FG001|Study Treatment Phase|Lost to Follow-up|1|||
146670193|NCT02319837|528969131|FG002|Study Treatment Phase|Lost to Follow-up|0|||
146670194|NCT02319837|528969129|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
146670195|NCT02319837|528969130|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
146670196|NCT02319837|528969131|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
146670197|NCT02319837|528969129|FG000|Study Treatment Phase|Other|0|||
146670198|NCT02319837|528969130|FG001|Study Treatment Phase|Other|1|||
146925695|NCT04570657|529888344|FG002|Overall Study|Lost to Follow-up|1|||
146925696|NCT04570657|529888342|FG000|Overall Study|Physician Decision|0|||
146925697|NCT04570657|529888343|FG001|Overall Study|Physician Decision|1|||
146925698|NCT04570657|529888344|FG002|Overall Study|Physician Decision|0|||
146925699|NCT04570657|529888342|FG000|Overall Study|Withdrawal by Subject|1|||
146925700|NCT04570657|529888343|FG001|Overall Study|Withdrawal by Subject|2|||
146925701|NCT04570657|529888344|FG002|Overall Study|Withdrawal by Subject|2|||
146925702|NCT01079962|529888345|FG000|Overall Study|Adverse Event|2|||
146925703|NCT01079962|529888346|FG001|Overall Study|Adverse Event|2|||
146925704|NCT01079962|529888345|FG000|Overall Study|Withdrawal by Subject|5|||
146925705|NCT01079962|529888346|FG001|Overall Study|Withdrawal by Subject|7|||
146925706|NCT01079962|529888345|FG000|Overall Study|Protocol Violation|2|||
146925707|NCT01079962|529888346|FG001|Overall Study|Protocol Violation|2|||
146925708|NCT01079962|529888345|FG000|Overall Study|No blood pressure (BP) control|3|||
146925709|NCT01079962|529888346|FG001|Overall Study|No blood pressure (BP) control|0|||
146925710|NCT01079962|529888345|FG000|Overall Study|Inclusion/exclusion criteria|1|||
146925711|NCT01079962|529888346|FG001|Overall Study|Inclusion/exclusion criteria|3|||
146925712|NCT01079962|529888345|FG000|Overall Study|Participant not returning for next visit|1|||
146925713|NCT01079962|529888346|FG001|Overall Study|Participant not returning for next visit|0|||
146925714|NCT01079962|529888345|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
146925715|NCT01079962|529888346|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
146925716|NCT01331239|529888347|FG000|Part II: Core Study|Adverse Event|0|||
146925717|NCT01331239|529888348|FG001|Part II: Core Study|Adverse Event|3|||
146925718|NCT01331239|529888349|FG002|Part II: Core Study|Adverse Event|0|||
146925719|NCT01331239|529888347|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
146925720|NCT01331239|529888348|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
146925721|NCT01331239|529888349|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
146925722|NCT01331239|529888347|FG000|Part II: Core Study|Withdrawal by Subject|0|||
146925723|NCT01331239|529888348|FG001|Part II: Core Study|Withdrawal by Subject|2|||
146925724|NCT01331239|529888349|FG002|Part II: Core Study|Withdrawal by Subject|0|||
146925725|NCT01331239|529888347|FG000|Part II: Core Study|Administrative problems|0|||
146925726|NCT01331239|529888348|FG001|Part II: Core Study|Administrative problems|1|||
146925727|NCT01331239|529888349|FG002|Part II: Core Study|Administrative problems|0|||
146925728|NCT01072539|529888350|FG000|Overall Study|Treated prior to the Site Initiation|1|||
146925729|NCT01072539|529888350|FG000|Overall Study|Protocol Violation|2|||
146925730|NCT01008995|529888352|FG000|Controlled Period|Adverse Event|1|||
146925731|NCT01008995|529888353|FG001|Controlled Period|Adverse Event|2|||
146925732|NCT01008995|529888354|FG002|Controlled Period|Adverse Event|0|||
146670199|NCT02319837|528969131|FG002|Study Treatment Phase|Other|0|||
146670200|NCT02319837|528969129|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
146670201|NCT02319837|528969130|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
146670202|NCT02319837|528969131|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
146670203|NCT02319837|528969129|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
146670204|NCT02319837|528969130|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
146670205|NCT02319837|528969131|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
146670206|NCT02319837|528969129|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
146670207|NCT02319837|528969130|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
146670208|NCT02319837|528969131|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
146670209|NCT02319837|528969129|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
146670210|NCT02319837|528969130|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
146670211|NCT02319837|528969131|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
146670212|NCT02319837|528969129|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
146670213|NCT02319837|528969130|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
146670214|NCT02319837|528969131|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
146670215|NCT02319837|528969129|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
146670216|NCT02319837|528969130|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
146670217|NCT02319837|528969131|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
146670218|NCT02319837|528969129|FG000|Long-Term Follow-Up Phase|Death|33|||
146670219|NCT02319837|528969130|FG001|Long-Term Follow-Up Phase|Death|54|||
146670220|NCT02319837|528969131|FG002|Long-Term Follow-Up Phase|Death|42|||
146670221|NCT01453361|528969142|FG000|Overall Study|Disease Progression|6|||
146670222|NCT01453361|528969142|FG000|Overall Study|Screen-Failures|10|||
146670223|NCT02165215|528970879|FG000|Induction Phase|Adverse Event|1|||
146670224|NCT02165215|528970880|FG001|Induction Phase|Adverse Event|0|||
146670225|NCT02165215|528970881|FG002|Induction Phase|Adverse Event|0|||
146670226|NCT02165215|528970879|FG000|Induction Phase|Withdrawal by Subject|10|||
146670227|NCT02165215|528970880|FG001|Induction Phase|Withdrawal by Subject|0|||
146925733|NCT01008995|529888355|FG003|Controlled Period|Adverse Event|0|||
146925734|NCT01008995|529888352|FG000|Controlled Period|Other|2|||
146670228|NCT02165215|528970881|FG002|Induction Phase|Withdrawal by Subject|0|||
146925735|NCT01008995|529888353|FG001|Controlled Period|Other|1|||
146925736|NCT01008995|529888354|FG002|Controlled Period|Other|0|||
146925737|NCT01008995|529888355|FG003|Controlled Period|Other|0|||
146925738|NCT01008995|529888352|FG000|After Controlled Period|Adverse Event|0|||
146925739|NCT01008995|529888353|FG001|After Controlled Period|Adverse Event|0|||
146670229|NCT02165215|528970879|FG000|Induction Phase|Protocol Violation|1|||
146670230|NCT02165215|528970880|FG001|Induction Phase|Protocol Violation|0|||
146670231|NCT02165215|528970881|FG002|Induction Phase|Protocol Violation|0|||
146670232|NCT02165215|528970879|FG000|Induction Phase|Physician Decision|1|||
146670233|NCT02165215|528970880|FG001|Induction Phase|Physician Decision|0|||
146670234|NCT02165215|528970881|FG002|Induction Phase|Physician Decision|0|||
146670235|NCT02165215|528970879|FG000|Induction Phase|Lack of Efficacy|2|||
146670236|NCT02165215|528970880|FG001|Induction Phase|Lack of Efficacy|0|||
146670237|NCT02165215|528970881|FG002|Induction Phase|Lack of Efficacy|0|||
146670238|NCT02165215|528970879|FG000|Induction Phase|Non-Compliance|2|||
146670239|NCT02165215|528970880|FG001|Induction Phase|Non-Compliance|0|||
146670240|NCT02165215|528970881|FG002|Induction Phase|Non-Compliance|0|||
146670241|NCT02165215|528970879|FG000|Induction Phase|Lost to Follow-up|6|||
146670242|NCT02165215|528970880|FG001|Induction Phase|Lost to Follow-up|0|||
146670243|NCT02165215|528970881|FG002|Induction Phase|Lost to Follow-up|0|||
146670244|NCT02165215|528970879|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146670245|NCT02165215|528970880|FG001|Maintenance Phase|Withdrawal by Subject|7|||
146670246|NCT02165215|528970881|FG002|Maintenance Phase|Withdrawal by Subject|3|||
146670247|NCT02165215|528970879|FG000|Maintenance Phase|Multiple reasons|0|||
146670248|NCT02165215|528970880|FG001|Maintenance Phase|Multiple reasons|2|||
146670249|NCT02165215|528970881|FG002|Maintenance Phase|Multiple reasons|1|||
146670250|NCT02165215|528970879|FG000|Maintenance Phase|Lost to Follow-up|0|||
146670251|NCT02165215|528970880|FG001|Maintenance Phase|Lost to Follow-up|2|||
146670252|NCT02165215|528970881|FG002|Maintenance Phase|Lost to Follow-up|0|||
146670253|NCT02165215|528970879|FG000|Maintenance Phase|Adverse Event|0|||
146670254|NCT02165215|528970880|FG001|Maintenance Phase|Adverse Event|1|||
146670255|NCT02165215|528970881|FG002|Maintenance Phase|Adverse Event|1|||
146670256|NCT05074667|528970882|FG000|Overall Study|Death|1|||
146670257|NCT05074667|528970882|FG000|Overall Study|Withdrawal by Subject|4|||
146670258|NCT05074667|528970882|FG000|Overall Study|Lost to Follow-up|10|||
146670259|NCT02279420|528970883|FG000|Overall Study|Lost to Follow-up|23|||
146670260|NCT03535844|528970886|FG000|Overall Study|Withdrawal by Subject|0|||
146670261|NCT03535844|528970887|FG001|Overall Study|Withdrawal by Subject|1|||
146670262|NCT00297830|528970888|FG000|6 Month Visit|Death|1|||
146670263|NCT00297830|528970889|FG001|6 Month Visit|Death|0|||
146670264|NCT00297830|528970890|FG002|6 Month Visit|Death|2|||
146670265|NCT00297830|528970888|FG000|6 Month Visit|Withdrawal by Subject|2|||
146670266|NCT00297830|528970889|FG001|6 Month Visit|Withdrawal by Subject|1|||
146670267|NCT00297830|528970890|FG002|6 Month Visit|Withdrawal by Subject|1|||
146670268|NCT00297830|528970888|FG000|6 Month Visit|Adverse Event|0|||
146670269|NCT00297830|528970889|FG001|6 Month Visit|Adverse Event|1|||
146670270|NCT00297830|528970890|FG002|6 Month Visit|Adverse Event|0|||
146670271|NCT00297830|528970888|FG000|12 Month Visit|Lost to Follow-up|1|||
146670272|NCT00297830|528970889|FG001|12 Month Visit|Lost to Follow-up|0|||
146925740|NCT01008995|529888354|FG002|After Controlled Period|Adverse Event|1|||
146925741|NCT01008995|529888355|FG003|After Controlled Period|Adverse Event|1|||
146925742|NCT01008995|529888352|FG000|After Controlled Period|Other|0|||
146925743|NCT01008995|529888353|FG001|After Controlled Period|Other|0|||
146670273|NCT00297830|528970890|FG002|12 Month Visit|Lost to Follow-up|0|||
146670274|NCT00297830|528970888|FG000|12 Month Visit|Adverse Event|0|||
146670275|NCT00297830|528970889|FG001|12 Month Visit|Adverse Event|3|||
146670276|NCT00297830|528970890|FG002|12 Month Visit|Adverse Event|0|||
146670277|NCT00297830|528970888|FG000|12 Month Visit|Withdrawal by Subject|0|||
146670278|NCT00297830|528970889|FG001|12 Month Visit|Withdrawal by Subject|3|||
146670279|NCT00297830|528970890|FG002|12 Month Visit|Withdrawal by Subject|0|||
146670280|NCT02835820|528970891|FG000|Overall Study|Baseline Screen Failure|0|||
146670281|NCT02835820|528970892|FG001|Overall Study|Baseline Screen Failure|3|||
146670282|NCT01847274|528970898|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
146670283|NCT01847274|528970899|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
146670284|NCT01847274|528970900|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
146670285|NCT01847274|528970901|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
146773896|NCT00610649|529343474|FG002|Overall Study|Adverse Event|0|||
146773897|NCT00610649|529343475|FG003|Overall Study|Adverse Event|0|||
146925744|NCT01008995|529888354|FG002|After Controlled Period|Other|1|||
146670286|NCT01847274|528970902|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
146670287|NCT01847274|528970903|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
146670288|NCT01847274|528970904|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
146670289|NCT01847274|528970905|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
146925745|NCT01008995|529888355|FG003|After Controlled Period|Other|0|||
146925746|NCT00115804|529888356|FG000|Overall Study|Adverse Event|2|||
146670290|NCT01847274|528970906|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
146670291|NCT01847274|528970907|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
146670292|NCT01847274|528970908|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
146670293|NCT01847274|528970898|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
146670294|NCT01847274|528970899|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
146670295|NCT01847274|528970900|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
146670296|NCT01847274|528970901|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
146670297|NCT01847274|528970902|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
146670298|NCT01847274|528970903|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
146670299|NCT01847274|528970904|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
146670300|NCT01847274|528970905|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
146670301|NCT01847274|528970906|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
146670302|NCT01847274|528970907|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
146670303|NCT01847274|528970908|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
146670304|NCT01847274|528970898|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
146670305|NCT01847274|528970899|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
146670306|NCT01847274|528970900|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
146670307|NCT01847274|528970901|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
146670308|NCT01847274|528970902|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
146670309|NCT01847274|528970903|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
146670310|NCT01847274|528970904|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
146670311|NCT01847274|528970905|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
146670312|NCT01847274|528970906|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
146670313|NCT01847274|528970907|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
146670314|NCT01847274|528970908|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
146670315|NCT01847274|528970898|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146670316|NCT01847274|528970899|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146670317|NCT01847274|528970900|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146670318|NCT01847274|528970901|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
146670319|NCT01847274|528970902|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146670320|NCT01847274|528970903|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146670321|NCT01847274|528970904|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146670322|NCT01847274|528970905|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146670323|NCT01847274|528970906|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146670324|NCT01847274|528970907|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146670325|NCT01847274|528970908|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146670326|NCT01847274|528970898|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
146670327|NCT01847274|528970899|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
146670328|NCT01847274|528970900|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
146670329|NCT01847274|528970901|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
146670330|NCT01847274|528970902|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
146670331|NCT01847274|528970903|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
146670332|NCT01847274|528970904|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
146670333|NCT01847274|528970905|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
146670334|NCT01847274|528970906|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
146670335|NCT01847274|528970907|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
146670336|NCT01847274|528970908|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
146670337|NCT01847274|528970898|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
146670338|NCT01847274|528970899|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
146670339|NCT01847274|528970900|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
146670340|NCT01847274|528970901|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
146670341|NCT01847274|528970902|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
146670342|NCT01847274|528970903|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
146670343|NCT01847274|528970904|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
146670344|NCT01847274|528970905|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
146670345|NCT01847274|528970906|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
146670346|NCT01847274|528970907|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
146670347|NCT01847274|528970908|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
146670348|NCT01847274|528970898|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
146670349|NCT01847274|528970899|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
146670350|NCT01847274|528970900|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
146670351|NCT01847274|528970901|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
146925747|NCT00621855|529888359|FG000|Overall Study|Adverse Event|32|||
146925748|NCT00621855|529888360|FG001|Overall Study|Adverse Event|31|||
146925749|NCT00621855|529888361|FG002|Overall Study|Adverse Event|48|||
146925750|NCT00621855|529888362|FG003|Overall Study|Adverse Event|34|||
146670352|NCT01847274|528970902|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
146670353|NCT01847274|528970903|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
146670354|NCT01847274|528970904|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
146670355|NCT01847274|528970905|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
146670356|NCT01847274|528970906|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
146670357|NCT01847274|528970907|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
146670358|NCT01847274|528970908|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
146670359|NCT01847274|528970898|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146670360|NCT01847274|528970899|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146670361|NCT01847274|528970900|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146670362|NCT01847274|528970901|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146670363|NCT01847274|528970902|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146670364|NCT01847274|528970903|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
146670365|NCT01847274|528970904|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146670366|NCT01847274|528970905|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146670367|NCT01847274|528970906|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146670368|NCT01847274|528970907|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146670369|NCT01847274|528970908|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146670370|NCT01847274|528970898|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146670371|NCT01847274|528970899|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146670372|NCT01847274|528970900|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146670373|NCT01847274|528970901|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146670374|NCT01847274|528970902|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
146670375|NCT01847274|528970903|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146670376|NCT01847274|528970904|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146670377|NCT01847274|528970905|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146670378|NCT01847274|528970906|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146670379|NCT01847274|528970907|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146670380|NCT01847274|528970908|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146670381|NCT01847274|528970898|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146670382|NCT01847274|528970899|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146670383|NCT01847274|528970900|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146670384|NCT01847274|528970901|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146670385|NCT01847274|528970902|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146670386|NCT01847274|528970903|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146670387|NCT01847274|528970904|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
146670388|NCT01847274|528970905|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146670389|NCT01847274|528970906|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146670390|NCT01847274|528970907|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146670391|NCT01847274|528970908|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146670392|NCT01847274|528970898|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146670393|NCT01847274|528970899|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146670394|NCT01847274|528970900|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146670395|NCT01847274|528970901|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146670396|NCT01847274|528970902|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146670397|NCT01847274|528970903|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146670398|NCT01847274|528970904|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
146670399|NCT01847274|528970905|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146670400|NCT01847274|528970906|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146670401|NCT01847274|528970907|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146670402|NCT01847274|528970908|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146670403|NCT01847274|528970898|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146670404|NCT01847274|528970899|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146670405|NCT01847274|528970900|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146670406|NCT01847274|528970901|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146670407|NCT01847274|528970902|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146670408|NCT01847274|528970903|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146670409|NCT01847274|528970904|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
146670410|NCT01847274|528970905|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146670411|NCT01847274|528970906|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146925751|NCT00621855|529888363|FG004|Overall Study|Adverse Event|31|||
146925752|NCT00621855|529888359|FG000|Overall Study|Lost to Follow-up|0|||
146925753|NCT00621855|529888360|FG001|Overall Study|Lost to Follow-up|1|||
146670412|NCT01847274|528970907|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146670413|NCT01847274|528970908|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146670414|NCT01847274|528970898|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
146670415|NCT01847274|528970899|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
146670416|NCT01847274|528970900|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
146670417|NCT01847274|528970901|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
146670418|NCT01847274|528970902|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
146670419|NCT01847274|528970903|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
146670420|NCT01847274|528970904|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
146670421|NCT01847274|528970905|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
146670422|NCT01847274|528970906|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
146670423|NCT01847274|528970907|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
146670424|NCT01847274|528970908|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
146670425|NCT01847274|528970898|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146670426|NCT01847274|528970899|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146670427|NCT01847274|528970900|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146670428|NCT01847274|528970901|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146670429|NCT01847274|528970902|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146670430|NCT01847274|528970903|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146670431|NCT01847274|528970904|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146670432|NCT01847274|528970905|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
146670433|NCT01847274|528970906|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146670434|NCT01847274|528970907|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
146670435|NCT01847274|528970908|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146670436|NCT01847274|528970898|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
146670437|NCT01847274|528970899|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
146670438|NCT01847274|528970900|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
146670439|NCT01847274|528970901|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
146670440|NCT01847274|528970902|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
146670441|NCT01847274|528970903|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
146670442|NCT01847274|528970904|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
146670443|NCT01847274|528970905|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
146670444|NCT01847274|528970906|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
146670445|NCT01847274|528970907|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
146670446|NCT01847274|528970908|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
146670447|NCT01847274|528970898|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146670448|NCT01847274|528970899|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146670449|NCT01847274|528970900|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146670450|NCT01847274|528970901|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146670451|NCT01847274|528970902|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146670452|NCT01847274|528970903|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146670453|NCT01847274|528970904|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146670454|NCT01847274|528970905|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146670455|NCT01847274|528970906|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146670456|NCT01847274|528970907|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
146670457|NCT01847274|528970908|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146670458|NCT01921387|528970909|FG000|Overall Study|Adverse Event|1|||
146670459|NCT03741062|528970910|FG000|Overall Study|Protocol Violation|1|||
146670460|NCT03741062|528970911|FG001|Overall Study|Protocol Violation|0|||
146773898|NCT00610649|529343476|FG004|Overall Study|Adverse Event|0|||
146773899|NCT00610649|529343477|FG005|Overall Study|Adverse Event|0|||
146773900|NCT00610649|529343478|FG006|Overall Study|Adverse Event|0|||
146773901|NCT00610649|529343479|FG007|Overall Study|Adverse Event|0|||
146773902|NCT00610649|529343480|FG008|Overall Study|Adverse Event|0|||
146925754|NCT00621855|529888361|FG002|Overall Study|Lost to Follow-up|3|||
146925755|NCT00621855|529888362|FG003|Overall Study|Lost to Follow-up|4|||
146925756|NCT00621855|529888363|FG004|Overall Study|Lost to Follow-up|1|||
146925757|NCT00621855|529888359|FG000|Overall Study|Protocol Violation|16|||
146925758|NCT00621855|529888360|FG001|Overall Study|Protocol Violation|8|||
146925759|NCT00621855|529888361|FG002|Overall Study|Protocol Violation|6|||
146925760|NCT00621855|529888362|FG003|Overall Study|Protocol Violation|7|||
146925761|NCT00621855|529888363|FG004|Overall Study|Protocol Violation|8|||
146925762|NCT00621855|529888359|FG000|Overall Study|Withdrawal by Subject|16|||
146925763|NCT00621855|529888360|FG001|Overall Study|Withdrawal by Subject|11|||
146925764|NCT00621855|529888361|FG002|Overall Study|Withdrawal by Subject|13|||
146670461|NCT01706146|528970914|FG000|Overall Study|Withdrawal by Subject|1|||
146670462|NCT01706146|528970914|FG000|Overall Study|Adverse Event|3|||
146670463|NCT01706146|528970914|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
146670464|NCT00675948|528970916|FG000|Overall Study|Adverse Event|23|||
146670465|NCT00675948|528970917|FG001|Overall Study|Adverse Event|1|||
146670466|NCT00675948|528970916|FG000|Overall Study|Lack of Efficacy|3|||
146670467|NCT00675948|528970917|FG001|Overall Study|Lack of Efficacy|0|||
146670468|NCT00675948|528970916|FG000|Overall Study|Withdrawal by Subject|7|||
146670469|NCT00675948|528970917|FG001|Overall Study|Withdrawal by Subject|0|||
146670470|NCT00675948|528970916|FG000|Overall Study|Lost to Follow-up|2|||
146670471|NCT00675948|528970917|FG001|Overall Study|Lost to Follow-up|0|||
146670472|NCT00675948|528970916|FG000|Overall Study|Protocol Violation|1|||
146670473|NCT00675948|528970917|FG001|Overall Study|Protocol Violation|0|||
146670474|NCT00675948|528970916|FG000|Overall Study|Pain under control|1|||
146670475|NCT00675948|528970917|FG001|Overall Study|Pain under control|0|||
146670476|NCT00675948|528970916|FG000|Overall Study|Sponsor decision|0|||
146670477|NCT00675948|528970917|FG001|Overall Study|Sponsor decision|1|||
146670478|NCT00675948|528970916|FG000|Overall Study|Patient died|1|||
146670479|NCT00675948|528970917|FG001|Overall Study|Patient died|0|||
146670480|NCT00675948|528970916|FG000|Overall Study|Patient unable to comply with diaries|1|||
146670481|NCT00675948|528970917|FG001|Overall Study|Patient unable to comply with diaries|0|||
146773903|NCT00610649|529343481|FG009|Overall Study|Adverse Event|0|||
146773904|NCT00610649|529343482|FG010|Overall Study|Adverse Event|1|||
146773905|NCT00610649|529343472|FG000|Overall Study|Family Emergency|0|||
146773906|NCT00610649|529343473|FG001|Overall Study|Family Emergency|1|||
146773907|NCT00610649|529343474|FG002|Overall Study|Family Emergency|0|||
146773908|NCT00610649|529343475|FG003|Overall Study|Family Emergency|0|||
146773909|NCT00610649|529343476|FG004|Overall Study|Family Emergency|0|||
146773910|NCT00610649|529343477|FG005|Overall Study|Family Emergency|0|||
146773911|NCT00610649|529343478|FG006|Overall Study|Family Emergency|0|||
146773912|NCT00610649|529343479|FG007|Overall Study|Family Emergency|0|||
146773913|NCT00610649|529343480|FG008|Overall Study|Family Emergency|0|||
146773914|NCT00610649|529343481|FG009|Overall Study|Family Emergency|0|||
146773915|NCT00610649|529343482|FG010|Overall Study|Family Emergency|0|||
146773916|NCT00610649|529343472|FG000|Overall Study|Withdrawal by Subject|0|||
146773917|NCT00610649|529343473|FG001|Overall Study|Withdrawal by Subject|0|||
146773918|NCT00610649|529343474|FG002|Overall Study|Withdrawal by Subject|0|||
146773919|NCT00610649|529343475|FG003|Overall Study|Withdrawal by Subject|0|||
146773920|NCT00610649|529343476|FG004|Overall Study|Withdrawal by Subject|0|||
146773921|NCT00610649|529343477|FG005|Overall Study|Withdrawal by Subject|0|||
146773922|NCT00610649|529343478|FG006|Overall Study|Withdrawal by Subject|0|||
146773923|NCT00610649|529343479|FG007|Overall Study|Withdrawal by Subject|0|||
146773924|NCT00610649|529343480|FG008|Overall Study|Withdrawal by Subject|0|||
146773925|NCT00610649|529343481|FG009|Overall Study|Withdrawal by Subject|1|||
146773926|NCT00610649|529343482|FG010|Overall Study|Withdrawal by Subject|0|||
146773927|NCT00232180|529343483|FG000|Double-blind (DB) Phase|Death|186|||
146773928|NCT00232180|529343484|FG001|Double-blind (DB) Phase|Death|222|||
146773929|NCT00232180|529343485|FG002|Double-blind (DB) Phase|Death|0|||
146773930|NCT00232180|529343483|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
146773931|NCT00232180|529343484|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
146773932|NCT00232180|529343485|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
146773933|NCT00232180|529343483|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
146773934|NCT00232180|529343484|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
146773935|NCT00232180|529343485|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
146773936|NCT00232180|529343483|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
146773937|NCT00232180|529343484|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
146773938|NCT00232180|529343485|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
146773939|NCT00232180|529343483|FG000|Double-blind (DB) Phase|Adverse Event|83|||
146773940|NCT00232180|529343484|FG001|Double-blind (DB) Phase|Adverse Event|100|||
146773941|NCT00232180|529343485|FG002|Double-blind (DB) Phase|Adverse Event|0|||
146773942|NCT00232180|529343483|FG000|Double-blind (DB) Phase|Other|70|||
146773943|NCT00232180|529343484|FG001|Double-blind (DB) Phase|Other|75|||
146773944|NCT00232180|529343485|FG002|Double-blind (DB) Phase|Other|0|||
146773945|NCT00232180|529343483|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
146670482|NCT00675948|528970916|FG000|Overall Study|Patient feels unable to take medication|0|||
146670483|NCT00675948|528970917|FG001|Overall Study|Patient feels unable to take medication|1|||
146670484|NCT02527161|528970918|FG000|Overall Study|Failed MRI|52|||
146670485|NCT02527161|528970918|FG000|Overall Study|Withdrawal by Subject|19|||
146773946|NCT00232180|529343484|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
146773947|NCT00232180|529343485|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
146773948|NCT00232180|529343483|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
146773949|NCT00232180|529343484|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
146773950|NCT00232180|529343485|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
146670486|NCT02527161|528970918|FG000|Overall Study|Delay in or unfit for surgery|16|||
146670487|NCT02527161|528970918|FG000|Overall Study|MRI contraindication|6|||
146773951|NCT00232180|529343483|FG000|Open Label Phase|Death|0|||
146670488|NCT02527161|528970918|FG000|Overall Study|Consent violation|4|||
146670489|NCT02527161|528970918|FG000|Overall Study|Only Recruited to Part A|27|||
146670490|NCT02527161|528970918|FG000|Overall Study|Physician Decision|1|||
146670491|NCT02527161|528970918|FG000|Overall Study|Adverse Event|1|||
146670492|NCT02527161|528970918|FG000|Overall Study|Lost to Follow-up|6|||
146670493|NCT02100514|528970919|FG000|Treatment Period|Adverse Event|0|||
146670494|NCT02100514|528970920|FG001|Treatment Period|Adverse Event|5|||
146670495|NCT02100514|528970921|FG002|Treatment Period|Adverse Event|0|||
146670496|NCT02100514|528970922|FG003|Treatment Period|Adverse Event|0|||
146670497|NCT02100514|528970923|FG004|Treatment Period|Adverse Event|0|||
146670498|NCT02100514|528970919|FG000|Treatment Period|Death|2|||
146670499|NCT02100514|528970920|FG001|Treatment Period|Death|2|||
146670500|NCT02100514|528970921|FG002|Treatment Period|Death|0|||
146670501|NCT02100514|528970922|FG003|Treatment Period|Death|0|||
146670502|NCT02100514|528970923|FG004|Treatment Period|Death|0|||
146670503|NCT02100514|528970919|FG000|Treatment Period|Lost to Follow-up|5|||
146670504|NCT02100514|528970920|FG001|Treatment Period|Lost to Follow-up|17|||
146670505|NCT02100514|528970921|FG002|Treatment Period|Lost to Follow-up|0|||
146670506|NCT02100514|528970922|FG003|Treatment Period|Lost to Follow-up|0|||
146670507|NCT02100514|528970923|FG004|Treatment Period|Lost to Follow-up|0|||
146670508|NCT02100514|528970919|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
146670509|NCT02100514|528970920|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
146670510|NCT02100514|528970921|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
146670511|NCT02100514|528970922|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
146670512|NCT02100514|528970923|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
146670513|NCT02100514|528970919|FG000|Treatment Period|Protocol Violation|1|||
146670514|NCT02100514|528970920|FG001|Treatment Period|Protocol Violation|1|||
146670515|NCT02100514|528970921|FG002|Treatment Period|Protocol Violation|0|||
146670516|NCT02100514|528970922|FG003|Treatment Period|Protocol Violation|0|||
146670517|NCT02100514|528970923|FG004|Treatment Period|Protocol Violation|0|||
146670518|NCT02100514|528970919|FG000|Treatment Period|Withdrawal by Subject|12|||
146670519|NCT02100514|528970920|FG001|Treatment Period|Withdrawal by Subject|37|||
146670520|NCT02100514|528970921|FG002|Treatment Period|Withdrawal by Subject|0|||
146670521|NCT02100514|528970922|FG003|Treatment Period|Withdrawal by Subject|0|||
146670522|NCT02100514|528970923|FG004|Treatment Period|Withdrawal by Subject|0|||
146670523|NCT02100514|528970919|FG000|Treatment Period|Other|9|||
146670524|NCT02100514|528970920|FG001|Treatment Period|Other|11|||
146670525|NCT02100514|528970921|FG002|Treatment Period|Other|0|||
146670526|NCT02100514|528970922|FG003|Treatment Period|Other|0|||
146670527|NCT02100514|528970923|FG004|Treatment Period|Other|0|||
146670528|NCT02100514|528970919|FG000|Extension Period|Withdrew consent|0|||
146670529|NCT02100514|528970920|FG001|Extension Period|Withdrew consent|0|||
146670530|NCT02100514|528970921|FG002|Extension Period|Withdrew consent|2|||
146670531|NCT02100514|528970922|FG003|Extension Period|Withdrew consent|0|||
146670532|NCT02100514|528970923|FG004|Extension Period|Withdrew consent|0|||
146670533|NCT01786668|528970933|FG000|Overall Study|Adverse Event|0|||
146670534|NCT01786668|528970934|FG001|Overall Study|Adverse Event|1|||
146670535|NCT01786668|528970935|FG002|Overall Study|Adverse Event|1|||
146670536|NCT01786668|528970936|FG003|Overall Study|Adverse Event|2|||
146670537|NCT01786668|528970933|FG000|Overall Study|Withdrawal by Subject|0|||
146670538|NCT01786668|528970934|FG001|Overall Study|Withdrawal by Subject|0|||
146670539|NCT01786668|528970935|FG002|Overall Study|Withdrawal by Subject|3|||
146670540|NCT01786668|528970936|FG003|Overall Study|Withdrawal by Subject|1|||
146670541|NCT01786668|528970933|FG000|Overall Study|Pregnancy|0|||
146670542|NCT01786668|528970934|FG001|Overall Study|Pregnancy|0|||
146670543|NCT01786668|528970935|FG002|Overall Study|Pregnancy|0|||
146670544|NCT01786668|528970936|FG003|Overall Study|Pregnancy|1|||
146670545|NCT01786668|528970933|FG000|Overall Study|Lost to Follow-up|1|||
146670546|NCT01786668|528970934|FG001|Overall Study|Lost to Follow-up|0|||
146670547|NCT01786668|528970935|FG002|Overall Study|Lost to Follow-up|1|||
146670548|NCT01786668|528970936|FG003|Overall Study|Lost to Follow-up|0|||
146978766|NCT01113710|530085494|FG000|Overall Study|Lack of Efficacy/Other|4|||
146670549|NCT03570697|528970937|FG000|Overall Study|Lost to Follow-up|0|||
146670550|NCT03570697|528970938|FG001|Overall Study|Lost to Follow-up|1|||
146670551|NCT03570697|528970937|FG000|Overall Study|Death|2|||
146978767|NCT01113710|530085494|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
146670552|NCT03570697|528970938|FG001|Overall Study|Death|0|||
146670553|NCT03570697|528970937|FG000|Overall Study|Withdrawal by Subject|4|||
146670554|NCT03570697|528970938|FG001|Overall Study|Withdrawal by Subject|2|||
146670555|NCT03173313|528970940|FG000|Overall Study|Lost to Follow-up|2|||
146670556|NCT03173313|528970941|FG001|Overall Study|Lost to Follow-up|3|||
146670557|NCT03173313|528970940|FG000|Overall Study|Withdrawal by Subject|0|||
146670558|NCT03173313|528970941|FG001|Overall Study|Withdrawal by Subject|1|||
146670559|NCT03173313|528970940|FG000|Overall Study|Death|5|||
146670560|NCT03173313|528970941|FG001|Overall Study|Death|0|||
146670561|NCT03173313|528970940|FG000|Overall Study|Physician Decision|1|||
146670562|NCT03173313|528970941|FG001|Overall Study|Physician Decision|0|||
146670563|NCT03173313|528970940|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
146670564|NCT03173313|528970941|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
146670565|NCT03173313|528970940|FG000|Overall Study|Bone Fracture|1|||
146670566|NCT03173313|528970941|FG001|Overall Study|Bone Fracture|0|||
146925765|NCT00621855|529888362|FG003|Overall Study|Withdrawal by Subject|13|||
146925766|NCT00621855|529888363|FG004|Overall Study|Withdrawal by Subject|9|||
146925767|NCT00621855|529888359|FG000|Overall Study|Other|9|||
146925768|NCT00621855|529888360|FG001|Overall Study|Other|7|||
146925769|NCT00621855|529888361|FG002|Overall Study|Other|6|||
146925770|NCT00621855|529888362|FG003|Overall Study|Other|5|||
146670567|NCT01876420|528970942|FG000|Overall Study|Missed 30 day visit|1|||
146670568|NCT05338216|528970945|FG000|Overall Study|Withdrawal by Subject|1|||
146670569|NCT05338216|528970946|FG001|Overall Study|Withdrawal by Subject|1|||
146670570|NCT04457336|528970947|FG000|Period 2: Part A|Withdrawal by Subject|0|||
146670571|NCT04457336|528970948|FG001|Period 2: Part A|Withdrawal by Subject|1|||
146670572|NCT04457336|528970949|FG002|Period 2: Part A|Withdrawal by Subject|1|||
146670573|NCT04457336|528970950|FG003|Period 2: Part A|Withdrawal by Subject|1|||
146670574|NCT04457336|528970951|FG004|Period 2: Part A|Withdrawal by Subject|0|||
146670575|NCT04457336|528970952|FG005|Period 2: Part A|Withdrawal by Subject|0|||
146670576|NCT04457336|528970953|FG006|Period 2: Part A|Withdrawal by Subject|0|||
146670577|NCT04457336|528970954|FG007|Period 2: Part A|Withdrawal by Subject|0|||
146670578|NCT04457336|528970947|FG000|Period 2: Part A|Adverse Event|0|||
146670579|NCT04457336|528970948|FG001|Period 2: Part A|Adverse Event|0|||
146670580|NCT04457336|528970949|FG002|Period 2: Part A|Adverse Event|1|||
146670581|NCT04457336|528970950|FG003|Period 2: Part A|Adverse Event|1|||
146670582|NCT04457336|528970951|FG004|Period 2: Part A|Adverse Event|0|||
146670583|NCT04457336|528970952|FG005|Period 2: Part A|Adverse Event|0|||
146670584|NCT04457336|528970953|FG006|Period 2: Part A|Adverse Event|0|||
146670585|NCT04457336|528970954|FG007|Period 2: Part A|Adverse Event|0|||
146670586|NCT04457336|528970947|FG000|Period 2: Part A|Study Terminated|0|||
146670587|NCT04457336|528970948|FG001|Period 2: Part A|Study Terminated|0|||
146670588|NCT04457336|528970949|FG002|Period 2: Part A|Study Terminated|1|||
146670589|NCT04457336|528970950|FG003|Period 2: Part A|Study Terminated|0|||
146670590|NCT04457336|528970951|FG004|Period 2: Part A|Study Terminated|0|||
146670591|NCT04457336|528970952|FG005|Period 2: Part A|Study Terminated|0|||
146670592|NCT04457336|528970953|FG006|Period 2: Part A|Study Terminated|0|||
146773952|NCT00232180|529343484|FG001|Open Label Phase|Death|0|||
146773953|NCT00232180|529343485|FG002|Open Label Phase|Death|48|||
146773954|NCT00232180|529343483|FG000|Open Label Phase|Lost to Follow-up|0|||
146773955|NCT00232180|529343484|FG001|Open Label Phase|Lost to Follow-up|0|||
146773956|NCT00232180|529343485|FG002|Open Label Phase|Lost to Follow-up|5|||
146773957|NCT00232180|529343483|FG000|Open Label Phase|Protocol Violation|0|||
146773958|NCT00232180|529343484|FG001|Open Label Phase|Protocol Violation|0|||
146773959|NCT00232180|529343485|FG002|Open Label Phase|Protocol Violation|3|||
146773960|NCT00232180|529343483|FG000|Open Label Phase|Study terminated by sponsor|0|||
146773961|NCT00232180|529343484|FG001|Open Label Phase|Study terminated by sponsor|0|||
146773962|NCT00232180|529343485|FG002|Open Label Phase|Study terminated by sponsor|3|||
146773963|NCT00232180|529343483|FG000|Open Label Phase|Withdrawal by Subject|0|||
146773964|NCT00232180|529343484|FG001|Open Label Phase|Withdrawal by Subject|0|||
146773965|NCT00232180|529343485|FG002|Open Label Phase|Withdrawal by Subject|37|||
146773966|NCT00232180|529343483|FG000|Open Label Phase|Other|0|||
146773967|NCT00232180|529343484|FG001|Open Label Phase|Other|0|||
146773968|NCT00232180|529343485|FG002|Open Label Phase|Other|16|||
146773969|NCT00232180|529343483|FG000|Open Label Phase|Adverse Event|0|||
146773970|NCT00232180|529343484|FG001|Open Label Phase|Adverse Event|0|||
146773971|NCT00232180|529343485|FG002|Open Label Phase|Adverse Event|25|||
146773972|NCT00232180|529343483|FG000|Open Label Phase|Laboratory abnormality|0|||
146773973|NCT00232180|529343484|FG001|Open Label Phase|Laboratory abnormality|0|||
146773974|NCT00232180|529343485|FG002|Open Label Phase|Laboratory abnormality|10|||
146773975|NCT00232180|529343483|FG000|Open Label Phase|Randomized but not treated|0|||
146773976|NCT00232180|529343484|FG001|Open Label Phase|Randomized but not treated|0|||
146773977|NCT00232180|529343485|FG002|Open Label Phase|Randomized but not treated|1|||
146773978|NCT02748317|529343486|FG000|Overall Study|Withdrawal by Subject|14|||
146773979|NCT02748317|529343486|FG000|Overall Study|Lost to Follow-up|8|||
146773980|NCT02748317|529343486|FG000|Overall Study|Death|1|||
146773981|NCT00414544|529343487|FG000|Overall Study|Lost to Follow-up|14|||
146925771|NCT00621855|529888363|FG004|Overall Study|Other|4|||
146773982|NCT04259450|529343488|FG000|Overall Study|Adverse event/ Toxicity|0|||
146925772|NCT00621855|529888359|FG000|Overall Study|Patients did not receive study drug|3|||
146925773|NCT00621855|529888360|FG001|Overall Study|Patients did not receive study drug|3|||
146670593|NCT04457336|528970954|FG007|Period 2: Part A|Study Terminated|0|||
146670594|NCT04457336|528970947|FG000|Period 2: Part A|Protocol Violation|0|||
146670595|NCT04457336|528970948|FG001|Period 2: Part A|Protocol Violation|1|||
146670596|NCT04457336|528970949|FG002|Period 2: Part A|Protocol Violation|0|||
146670597|NCT04457336|528970950|FG003|Period 2: Part A|Protocol Violation|0|||
146670598|NCT04457336|528970951|FG004|Period 2: Part A|Protocol Violation|0|||
146773983|NCT04259450|529343489|FG001|Overall Study|Adverse event/ Toxicity|3|||
146773984|NCT04259450|529343490|FG002|Overall Study|Adverse event/ Toxicity|0|||
146773985|NCT04259450|529343491|FG003|Overall Study|Adverse event/ Toxicity|1|||
146773986|NCT04259450|529343492|FG004|Overall Study|Adverse event/ Toxicity|0|||
146670599|NCT04457336|528970952|FG005|Period 2: Part A|Protocol Violation|0|||
146670600|NCT04457336|528970953|FG006|Period 2: Part A|Protocol Violation|0|||
146670601|NCT04457336|528970954|FG007|Period 2: Part A|Protocol Violation|0|||
146670602|NCT04457336|528970947|FG000|Period 2: Part A|Lost to Follow-up|0|||
146670603|NCT04457336|528970948|FG001|Period 2: Part A|Lost to Follow-up|1|||
146670604|NCT04457336|528970949|FG002|Period 2: Part A|Lost to Follow-up|0|||
146670605|NCT04457336|528970950|FG003|Period 2: Part A|Lost to Follow-up|0|||
146670606|NCT04457336|528970951|FG004|Period 2: Part A|Lost to Follow-up|0|||
146670607|NCT04457336|528970952|FG005|Period 2: Part A|Lost to Follow-up|0|||
146670608|NCT04457336|528970953|FG006|Period 2: Part A|Lost to Follow-up|0|||
146670609|NCT04457336|528970954|FG007|Period 2: Part A|Lost to Follow-up|0|||
146670610|NCT04457336|528970947|FG000|Period 2: Part A|Other|0|||
146670611|NCT04457336|528970948|FG001|Period 2: Part A|Other|1|||
146670612|NCT04457336|528970949|FG002|Period 2: Part A|Other|0|||
146670613|NCT04457336|528970950|FG003|Period 2: Part A|Other|0|||
146670614|NCT04457336|528970951|FG004|Period 2: Part A|Other|0|||
146670615|NCT04457336|528970952|FG005|Period 2: Part A|Other|0|||
146670616|NCT04457336|528970953|FG006|Period 2: Part A|Other|0|||
146670617|NCT04457336|528970954|FG007|Period 2: Part A|Other|0|||
146670618|NCT04457336|528970947|FG000|Period 2: Part A|Physician Decision|0|||
146670619|NCT04457336|528970948|FG001|Period 2: Part A|Physician Decision|0|||
146670620|NCT04457336|528970949|FG002|Period 2: Part A|Physician Decision|0|||
146670621|NCT04457336|528970950|FG003|Period 2: Part A|Physician Decision|1|||
146670622|NCT04457336|528970951|FG004|Period 2: Part A|Physician Decision|0|||
146670623|NCT04457336|528970952|FG005|Period 2: Part A|Physician Decision|0|||
146670624|NCT04457336|528970953|FG006|Period 2: Part A|Physician Decision|0|||
146670625|NCT04457336|528970954|FG007|Period 2: Part A|Physician Decision|0|||
146670626|NCT04457336|528970947|FG000|Period 3: Part B|Study Terminated|0|||
146670627|NCT04457336|528970948|FG001|Period 3: Part B|Study Terminated|0|||
146670628|NCT04457336|528970949|FG002|Period 3: Part B|Study Terminated|0|||
146670629|NCT04457336|528970950|FG003|Period 3: Part B|Study Terminated|0|||
146670630|NCT04457336|528970951|FG004|Period 3: Part B|Study Terminated|1|||
146670631|NCT04457336|528970952|FG005|Period 3: Part B|Study Terminated|10|||
146670632|NCT04457336|528970953|FG006|Period 3: Part B|Study Terminated|13|||
146670633|NCT04457336|528970954|FG007|Period 3: Part B|Study Terminated|0|||
146670634|NCT04457336|528970947|FG000|Period 3: Part B|Withdrawal by Subject|0|||
146670635|NCT04457336|528970948|FG001|Period 3: Part B|Withdrawal by Subject|0|||
146670636|NCT04457336|528970949|FG002|Period 3: Part B|Withdrawal by Subject|0|||
146670637|NCT04457336|528970950|FG003|Period 3: Part B|Withdrawal by Subject|0|||
146670638|NCT04457336|528970951|FG004|Period 3: Part B|Withdrawal by Subject|0|||
146670639|NCT04457336|528970952|FG005|Period 3: Part B|Withdrawal by Subject|1|||
146670640|NCT04457336|528970953|FG006|Period 3: Part B|Withdrawal by Subject|2|||
146670641|NCT04457336|528970954|FG007|Period 3: Part B|Withdrawal by Subject|0|||
146670642|NCT04457336|528970947|FG000|Period 4: Part C|Study Terminated|0|||
146670643|NCT04457336|528970948|FG001|Period 4: Part C|Study Terminated|0|||
146670644|NCT04457336|528970949|FG002|Period 4: Part C|Study Terminated|0|||
146670645|NCT04457336|528970950|FG003|Period 4: Part C|Study Terminated|0|||
146670646|NCT04457336|528970951|FG004|Period 4: Part C|Study Terminated|0|||
146670647|NCT04457336|528970952|FG005|Period 4: Part C|Study Terminated|0|||
146670648|NCT04457336|528970953|FG006|Period 4: Part C|Study Terminated|0|||
146670649|NCT04457336|528970954|FG007|Period 4: Part C|Study Terminated|30|||
146670650|NCT04457336|528970947|FG000|Period 4: Part C|Adverse Event|0|||
146670651|NCT04457336|528970948|FG001|Period 4: Part C|Adverse Event|0|||
146670652|NCT04457336|528970949|FG002|Period 4: Part C|Adverse Event|0|||
146670653|NCT04457336|528970950|FG003|Period 4: Part C|Adverse Event|0|||
146670654|NCT04457336|528970951|FG004|Period 4: Part C|Adverse Event|0|||
146670655|NCT04457336|528970952|FG005|Period 4: Part C|Adverse Event|0|||
146670656|NCT04457336|528970953|FG006|Period 4: Part C|Adverse Event|0|||
146670657|NCT04457336|528970954|FG007|Period 4: Part C|Adverse Event|2|||
146670658|NCT04457336|528970947|FG000|Period 4: Part C|Site Terminated|0|||
146670659|NCT04457336|528970948|FG001|Period 4: Part C|Site Terminated|0|||
146670660|NCT04457336|528970949|FG002|Period 4: Part C|Site Terminated|0|||
146670661|NCT04457336|528970950|FG003|Period 4: Part C|Site Terminated|0|||
146670662|NCT04457336|528970951|FG004|Period 4: Part C|Site Terminated|0|||
146670663|NCT04457336|528970952|FG005|Period 4: Part C|Site Terminated|0|||
146670664|NCT04457336|528970953|FG006|Period 4: Part C|Site Terminated|0|||
146670665|NCT04457336|528970954|FG007|Period 4: Part C|Site Terminated|1|||
146670666|NCT04457336|528970947|FG000|Period 4: Part C|Other|0|||
146670667|NCT04457336|528970948|FG001|Period 4: Part C|Other|0|||
146670668|NCT04457336|528970949|FG002|Period 4: Part C|Other|0|||
146670669|NCT04457336|528970950|FG003|Period 4: Part C|Other|0|||
146670670|NCT04457336|528970951|FG004|Period 4: Part C|Other|0|||
146670671|NCT04457336|528970952|FG005|Period 4: Part C|Other|0|||
146670672|NCT04457336|528970953|FG006|Period 4: Part C|Other|0|||
146670673|NCT04457336|528970954|FG007|Period 4: Part C|Other|2|||
146670674|NCT04457336|528970947|FG000|Period 4: Part C|Withdrawal by Subject|0|||
146670675|NCT04457336|528970948|FG001|Period 4: Part C|Withdrawal by Subject|0|||
146670676|NCT04457336|528970949|FG002|Period 4: Part C|Withdrawal by Subject|0|||
146670677|NCT04457336|528970950|FG003|Period 4: Part C|Withdrawal by Subject|0|||
146670678|NCT04457336|528970951|FG004|Period 4: Part C|Withdrawal by Subject|0|||
146670679|NCT04457336|528970952|FG005|Period 4: Part C|Withdrawal by Subject|0|||
146670680|NCT04457336|528970953|FG006|Period 4: Part C|Withdrawal by Subject|0|||
146670681|NCT04457336|528970954|FG007|Period 4: Part C|Withdrawal by Subject|3|||
146670682|NCT03330288|528970961|FG000|Overall Study|Other reason|1|||
146670683|NCT03330288|528970962|FG001|Overall Study|Other reason|1|||
146670684|NCT03330288|528970961|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
146670685|NCT03330288|528970962|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
146670686|NCT03330288|528970961|FG000|Overall Study|Adverse Event|1|||
146670687|NCT03330288|528970962|FG001|Overall Study|Adverse Event|0|||
146670688|NCT03330288|528970961|FG000|Overall Study|Withdrawal by Subject|1|||
146670689|NCT03330288|528970962|FG001|Overall Study|Withdrawal by Subject|0|||
146670690|NCT03330288|528970961|FG000|Overall Study|Lost to Follow-up|26|||
146670691|NCT03330288|528970962|FG001|Overall Study|Lost to Follow-up|7|||
146670692|NCT01042678|528970963|FG000|Overall Study|Physician Decision|1|||
146670693|NCT01042678|528970964|FG001|Overall Study|Physician Decision|0|||
146670694|NCT01042678|528970965|FG002|Overall Study|Physician Decision|0|||
146670695|NCT01042678|528970966|FG003|Overall Study|Physician Decision|0|||
146670696|NCT01042678|528970967|FG004|Overall Study|Physician Decision|0|||
146670697|NCT01042678|528970968|FG005|Overall Study|Physician Decision|0|||
146670698|NCT01416272|528970969|FG000|Overall Study|Unacceptable distance visual acuity|2|||
146670699|NCT01416272|528970969|FG000|Overall Study|Lost to Follow-up|1|||
146670700|NCT01416272|528970969|FG000|Overall Study|Study related complaints|1|||
146670701|NCT01719783|528970972|FG000|Dose 2|Physician Decision|1|||
146670702|NCT01719783|528970973|FG001|Dose 2|Physician Decision|0|||
146670703|NCT01350492|528970974|FG000|Intervention|Lost to Follow-up|2|||
146670704|NCT01350492|528970975|FG001|Intervention|Lost to Follow-up|5|||
146670705|NCT01350492|528970974|FG000|Intervention|Withdrawal by Subject|3|||
146670706|NCT01350492|528970975|FG001|Intervention|Withdrawal by Subject|1|||
146670707|NCT01350492|528970974|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
146670708|NCT01350492|528970975|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
146670709|NCT01350492|528970974|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
146670710|NCT01350492|528970975|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
146670711|NCT00205881|528970976|FG000|Overall Study|Withdrawal by Subject|16|||
146670712|NCT00702689|528970977|FG000|Overall Study|Withdrawal by Subject|4|||
146925774|NCT00621855|529888361|FG002|Overall Study|Patients did not receive study drug|5|||
146670713|NCT00702689|528970977|FG000|Overall Study|Recurrent malignancy|1|||
146670714|NCT00702689|528970977|FG000|Overall Study|Adverse Event|1|||
146670715|NCT00369824|528970979|FG000|Overall Study|Adverse Event|0|||
146670716|NCT00369824|528970980|FG001|Overall Study|Adverse Event|2|||
146670717|NCT00369824|528970981|FG002|Overall Study|Adverse Event|0|||
146670718|NCT00369824|528970982|FG003|Overall Study|Adverse Event|0|||
146670719|NCT00369824|528970983|FG004|Overall Study|Adverse Event|1|||
146670720|NCT00369824|528970984|FG005|Overall Study|Adverse Event|0|||
146670721|NCT00369824|528970979|FG000|Overall Study|Protocol Violation|0|||
146670722|NCT00369824|528970980|FG001|Overall Study|Protocol Violation|1|||
146670723|NCT00369824|528970981|FG002|Overall Study|Protocol Violation|0|||
146670724|NCT00369824|528970982|FG003|Overall Study|Protocol Violation|1|||
146670725|NCT00369824|528970983|FG004|Overall Study|Protocol Violation|1|||
146670726|NCT00369824|528970984|FG005|Overall Study|Protocol Violation|0|||
146670727|NCT00369824|528970979|FG000|Overall Study|Withdrawal by Subject|9|||
146670728|NCT00369824|528970980|FG001|Overall Study|Withdrawal by Subject|5|||
146670729|NCT00369824|528970981|FG002|Overall Study|Withdrawal by Subject|5|||
146670730|NCT00369824|528970982|FG003|Overall Study|Withdrawal by Subject|4|||
146670731|NCT00369824|528970983|FG004|Overall Study|Withdrawal by Subject|6|||
146670732|NCT00369824|528970984|FG005|Overall Study|Withdrawal by Subject|2|||
146670733|NCT00369824|528970979|FG000|Overall Study|Lost to Follow-up|6|||
146670734|NCT00369824|528970980|FG001|Overall Study|Lost to Follow-up|11|||
146670735|NCT00369824|528970981|FG002|Overall Study|Lost to Follow-up|7|||
146670736|NCT00369824|528970982|FG003|Overall Study|Lost to Follow-up|8|||
146670737|NCT00369824|528970983|FG004|Overall Study|Lost to Follow-up|9|||
146670738|NCT00369824|528970984|FG005|Overall Study|Lost to Follow-up|6|||
146670739|NCT00369824|528970979|FG000|Overall Study|Other|0|||
146670740|NCT00369824|528970980|FG001|Overall Study|Other|0|||
146670741|NCT00369824|528970981|FG002|Overall Study|Other|0|||
146670742|NCT00369824|528970982|FG003|Overall Study|Other|2|||
146670743|NCT00369824|528970983|FG004|Overall Study|Other|1|||
146670744|NCT00369824|528970984|FG005|Overall Study|Other|3|||
146670745|NCT01443078|528970985|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
146670746|NCT01443078|528970985|FG000|Overall Study|Withdrawal by Subject|1|||
146670747|NCT01443078|528970985|FG000|Overall Study|Patient had brain mets|1|||
146670748|NCT02217878|528970986|FG000|Overall Study|required morphine due to chest pain|1|||
146670749|NCT02217878|528970987|FG001|Overall Study|required morphine due to chest pain|2|||
146670750|NCT02217878|528970986|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
146670751|NCT02217878|528970987|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
146670752|NCT00415168|528970988|FG000|Overall Study|Death|26|||
146670753|NCT00415168|528970988|FG000|Overall Study|Lost to Follow-up|3|||
146670754|NCT00415168|528970988|FG000|Overall Study|Physician Decision|13|||
146670755|NCT00415168|528970988|FG000|Overall Study|Sponsor Decision|4|||
146670756|NCT00415168|528970988|FG000|Overall Study|Withdrawal by Subject|6|||
146670757|NCT02106975|528970991|FG000|Overall Study|Death|25|||
146670758|NCT02106975|528970992|FG001|Overall Study|Death|39|||
146670759|NCT01611155|528970993|FG000|Overall Study|Adverse Event|1|||
146670760|NCT01611155|528970994|FG001|Overall Study|Adverse Event|1|||
146925775|NCT00621855|529888362|FG003|Overall Study|Patients did not receive study drug|4|||
146925776|NCT00621855|529888363|FG004|Overall Study|Patients did not receive study drug|2|||
146925777|NCT03731364|529888364|FG000|Overall Study|Adverse Event|0|||
146925778|NCT03731364|529888365|FG001|Overall Study|Adverse Event|0|||
146925779|NCT03731364|529888366|FG002|Overall Study|Adverse Event|1|||
146925780|NCT03731364|529888367|FG003|Overall Study|Adverse Event|2|||
146670761|NCT01611155|528970993|FG000|Overall Study|Refused further treatment|6|||
146670762|NCT01611155|528970994|FG001|Overall Study|Refused further treatment|4|||
146670763|NCT01611155|528970993|FG000|Overall Study|Disease progression|1|||
146670764|NCT01611155|528970994|FG001|Overall Study|Disease progression|0|||
146670765|NCT01611155|528970993|FG000|Overall Study|Withdrawal by Subject|1|||
146670766|NCT01611155|528970994|FG001|Overall Study|Withdrawal by Subject|0|||
146670767|NCT01611155|528970993|FG000|Overall Study|Alternative treatment|0|||
146670768|NCT01611155|528970994|FG001|Overall Study|Alternative treatment|1|||
146670769|NCT01611155|528970993|FG000|Overall Study|Ineligible patient|0|||
146670770|NCT01611155|528970994|FG001|Overall Study|Ineligible patient|1|||
146670771|NCT00087607|528970996|FG000|Overall Study|Adverse Event|14|||
146670772|NCT00087607|528970997|FG001|Overall Study|Adverse Event|24|||
146670773|NCT00087607|528970996|FG000|Overall Study|Death|0|||
146670774|NCT00087607|528970997|FG001|Overall Study|Death|1|||
146670775|NCT00087607|528970996|FG000|Overall Study|Insufficient Therapeutic Response|53|||
146670776|NCT00087607|528970997|FG001|Overall Study|Insufficient Therapeutic Response|42|||
146670777|NCT00087607|528970996|FG000|Overall Study|Failure to return|21|||
146670778|NCT00087607|528970997|FG001|Overall Study|Failure to return|17|||
146670779|NCT00087607|528970996|FG000|Overall Study|Withdrew Consent|12|||
146670780|NCT00087607|528970997|FG001|Overall Study|Withdrew Consent|16|||
146670781|NCT00087607|528970996|FG000|Overall Study|Administrative|12|||
146670782|NCT00087607|528970997|FG001|Overall Study|Administrative|12|||
146670783|NCT00087607|528970996|FG000|Overall Study|Refused Treatment|5|||
146670784|NCT00087607|528970997|FG001|Overall Study|Refused Treatment|7|||
146670785|NCT00087607|528970996|FG000|Overall Study|Other Protocol Violation|5|||
146670786|NCT00087607|528970997|FG001|Overall Study|Other Protocol Violation|2|||
146670787|NCT00087607|528970996|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
146670788|NCT00087607|528970997|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
146670789|NCT02015754|528970998|FG000|Overall Study|Disease progression|5|||
146670790|NCT02015754|528970998|FG000|Overall Study|Change in treatment modality|5|||
146670791|NCT02015754|528970998|FG000|Overall Study|Lost to Follow-up|1|||
146670792|NCT02369016|528970999|FG000|Overall Study|AE associated with clinical disease progression|2|||
146670793|NCT02369016|528971000|FG001|Overall Study|AE associated with clinical disease progression|1|||
146670794|NCT02369016|528970999|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
146670795|NCT02369016|528971000|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
146773987|NCT04259450|529343493|FG005|Overall Study|Adverse event/ Toxicity|0|||
146773988|NCT04259450|529343494|FG006|Overall Study|Adverse event/ Toxicity|0|||
146773989|NCT04259450|529343495|FG007|Overall Study|Adverse event/ Toxicity|1|||
146773990|NCT04259450|529343496|FG008|Overall Study|Adverse event/ Toxicity|0|||
146773991|NCT04259450|529343497|FG009|Overall Study|Adverse event/ Toxicity|3|||
146773992|NCT04259450|529343488|FG000|Overall Study|Disease progression|2|||
146773993|NCT04259450|529343489|FG001|Overall Study|Disease progression|3|||
146773994|NCT04259450|529343490|FG002|Overall Study|Disease progression|4|||
146773995|NCT04259450|529343491|FG003|Overall Study|Disease progression|4|||
146773996|NCT04259450|529343492|FG004|Overall Study|Disease progression|6|||
146773997|NCT04259450|529343493|FG005|Overall Study|Disease progression|6|||
146773998|NCT04259450|529343494|FG006|Overall Study|Disease progression|6|||
146773999|NCT04259450|529343495|FG007|Overall Study|Disease progression|15|||
146774000|NCT04259450|529343496|FG008|Overall Study|Disease progression|6|||
146774001|NCT04259450|529343497|FG009|Overall Study|Disease progression|18|||
146925781|NCT03731364|529888368|FG004|Overall Study|Adverse Event|1|||
146925782|NCT02953782|529888369|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
146925783|NCT02953782|529888370|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
146925784|NCT02953782|529888371|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
146670796|NCT02369016|528970999|FG000|Overall Study|Progressive disease - clinical progression|1|||
146670797|NCT02369016|528971000|FG001|Overall Study|Progressive disease - clinical progression|4|||
146670798|NCT02369016|528970999|FG000|Overall Study|withdrawal by patient|4|||
146670799|NCT02369016|528971000|FG001|Overall Study|withdrawal by patient|0|||
146925785|NCT02953782|529888372|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
146925786|NCT02953782|529888373|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
146774002|NCT04259450|529343488|FG000|Overall Study|Death|0|||
146774003|NCT04259450|529343489|FG001|Overall Study|Death|0|||
146774004|NCT04259450|529343490|FG002|Overall Study|Death|0|||
146774005|NCT04259450|529343491|FG003|Overall Study|Death|0|||
146774006|NCT04259450|529343492|FG004|Overall Study|Death|0|||
146670800|NCT02369016|528970999|FG000|Overall Study|Progressive disease - radiological progression|6|||
146670801|NCT02369016|528971000|FG001|Overall Study|Progressive disease - radiological progression|2|||
146670802|NCT02229383|528971001|FG000|Overall Study|Adverse Event|7|||
146670803|NCT02229383|528971002|FG001|Overall Study|Adverse Event|4|||
146670804|NCT02229383|528971001|FG000|Overall Study|Death|0|||
146670805|NCT02229383|528971002|FG001|Overall Study|Death|1|||
146670806|NCT02229383|528971001|FG000|Overall Study|Lost to Follow-up|5|||
146670807|NCT02229383|528971002|FG001|Overall Study|Lost to Follow-up|3|||
146670808|NCT02229383|528971001|FG000|Overall Study|Withdrawal by Subject|4|||
146670809|NCT02229383|528971002|FG001|Overall Study|Withdrawal by Subject|6|||
146670810|NCT02229383|528971001|FG000|Overall Study|Did not receive treatment|1|||
146670811|NCT02229383|528971002|FG001|Overall Study|Did not receive treatment|0|||
146670812|NCT02229383|528971001|FG000|Overall Study|Other|3|||
146670813|NCT02229383|528971002|FG001|Overall Study|Other|8|||
146670814|NCT05248867|528971007|FG000|Double-blind Period|Lost to Follow-up|0|||
146670815|NCT05248867|528971008|FG001|Double-blind Period|Lost to Follow-up|3|||
146670816|NCT05248867|528971009|FG002|Double-blind Period|Lost to Follow-up|0|||
146670817|NCT05248867|528971010|FG003|Double-blind Period|Lost to Follow-up|0|||
146670818|NCT05248867|528971011|FG004|Double-blind Period|Lost to Follow-up|0|||
146670819|NCT05248867|528971012|FG005|Double-blind Period|Lost to Follow-up|0|||
146670820|NCT05248867|528971007|FG000|Double-blind Period|Withdrawal by Subject|5|||
146670821|NCT05248867|528971008|FG001|Double-blind Period|Withdrawal by Subject|14|||
146670822|NCT05248867|528971009|FG002|Double-blind Period|Withdrawal by Subject|0|||
146670823|NCT05248867|528971010|FG003|Double-blind Period|Withdrawal by Subject|0|||
146670824|NCT05248867|528971011|FG004|Double-blind Period|Withdrawal by Subject|0|||
146670825|NCT05248867|528971012|FG005|Double-blind Period|Withdrawal by Subject|0|||
146670826|NCT05248867|528971007|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
146670827|NCT05248867|528971008|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
146670828|NCT05248867|528971009|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
146670829|NCT05248867|528971010|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
146670830|NCT05248867|528971011|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
146670831|NCT05248867|528971012|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
146670832|NCT05248867|528971007|FG000|Double-blind Period|Other, not specified|3|||
146670833|NCT05248867|528971008|FG001|Double-blind Period|Other, not specified|8|||
146670834|NCT05248867|528971009|FG002|Double-blind Period|Other, not specified|0|||
146670835|NCT05248867|528971010|FG003|Double-blind Period|Other, not specified|0|||
146670836|NCT05248867|528971011|FG004|Double-blind Period|Other, not specified|0|||
146670837|NCT05248867|528971012|FG005|Double-blind Period|Other, not specified|0|||
146670838|NCT05248867|528971007|FG000|Open-label Period|Withdrawal by Subject|0|||
146670839|NCT05248867|528971008|FG001|Open-label Period|Withdrawal by Subject|0|||
146670840|NCT05248867|528971009|FG002|Open-label Period|Withdrawal by Subject|3|||
146670841|NCT05248867|528971010|FG003|Open-label Period|Withdrawal by Subject|1|||
146670842|NCT05248867|528971011|FG004|Open-label Period|Withdrawal by Subject|7|||
146670843|NCT05248867|528971012|FG005|Open-label Period|Withdrawal by Subject|9|||
146670844|NCT05248867|528971007|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
146670845|NCT05248867|528971008|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
146670846|NCT05248867|528971009|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
146670847|NCT05248867|528971010|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
146670848|NCT05248867|528971011|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
146670849|NCT05248867|528971012|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
146670850|NCT05248867|528971007|FG000|Open-label Period|Lost to Follow-up|0|||
146670851|NCT05248867|528971008|FG001|Open-label Period|Lost to Follow-up|0|||
146670852|NCT05248867|528971009|FG002|Open-label Period|Lost to Follow-up|0|||
146670853|NCT05248867|528971010|FG003|Open-label Period|Lost to Follow-up|0|||
146670854|NCT05248867|528971011|FG004|Open-label Period|Lost to Follow-up|5|||
146670855|NCT05248867|528971012|FG005|Open-label Period|Lost to Follow-up|2|||
146670856|NCT05248867|528971007|FG000|Open-label Period|COVID-19 Infection|0|||
146670857|NCT05248867|528971008|FG001|Open-label Period|COVID-19 Infection|0|||
146670858|NCT05248867|528971009|FG002|Open-label Period|COVID-19 Infection|0|||
146670859|NCT05248867|528971010|FG003|Open-label Period|COVID-19 Infection|0|||
146670860|NCT05248867|528971011|FG004|Open-label Period|COVID-19 Infection|1|||
146670861|NCT05248867|528971012|FG005|Open-label Period|COVID-19 Infection|0|||
146670862|NCT05248867|528971007|FG000|Open-label Period|Other, not specified|0|||
146670863|NCT05248867|528971008|FG001|Open-label Period|Other, not specified|0|||
146670864|NCT05248867|528971009|FG002|Open-label Period|Other, not specified|0|||
146670865|NCT05248867|528971010|FG003|Open-label Period|Other, not specified|0|||
146670866|NCT05248867|528971011|FG004|Open-label Period|Other, not specified|4|||
146670867|NCT05248867|528971012|FG005|Open-label Period|Other, not specified|0|||
146670868|NCT01064310|528971013|FG000|Period 1|Adverse Event|7|||
146670869|NCT01064310|528971014|FG001|Period 1|Adverse Event|10|||
146670870|NCT01064310|528971015|FG002|Period 1|Adverse Event|0|||
146670871|NCT01064310|528971013|FG000|Period 1|Physician Decision|1|||
146670872|NCT01064310|528971014|FG001|Period 1|Physician Decision|0|||
146670873|NCT01064310|528971015|FG002|Period 1|Physician Decision|0|||
146670874|NCT01064310|528971013|FG000|Period 1|Withdrawal by Subject|2|||
146670875|NCT01064310|528971014|FG001|Period 1|Withdrawal by Subject|2|||
146670876|NCT01064310|528971015|FG002|Period 1|Withdrawal by Subject|0|||
146670877|NCT01064310|528971013|FG000|Period 1|Lack of Efficacy|3|||
146670878|NCT01064310|528971014|FG001|Period 1|Lack of Efficacy|5|||
146670879|NCT01064310|528971015|FG002|Period 1|Lack of Efficacy|0|||
146670880|NCT01064310|528971013|FG000|Period 1|Entered Open-label Period|1|||
146670881|NCT01064310|528971014|FG001|Period 1|Entered Open-label Period|1|||
146670882|NCT01064310|528971015|FG002|Period 1|Entered Open-label Period|0|||
146670883|NCT01064310|528971013|FG000|Period 2|Adverse Event|2|||
146670884|NCT01064310|528971014|FG001|Period 2|Adverse Event|1|||
146670885|NCT01064310|528971015|FG002|Period 2|Adverse Event|0|||
146670886|NCT01064310|528971013|FG000|Period 2|Physician Decision|0|||
146670887|NCT01064310|528971014|FG001|Period 2|Physician Decision|1|||
146670888|NCT01064310|528971015|FG002|Period 2|Physician Decision|0|||
146670889|NCT01064310|528971013|FG000|Period 2|Entered Open-label Period|1|||
146670890|NCT01064310|528971014|FG001|Period 2|Entered Open-label Period|0|||
146670891|NCT01064310|528971015|FG002|Period 2|Entered Open-label Period|0|||
146670892|NCT01064310|528971013|FG000|Period 2|Lack of Efficacy|1|||
146670893|NCT01064310|528971014|FG001|Period 2|Lack of Efficacy|4|||
146670894|NCT01064310|528971015|FG002|Period 2|Lack of Efficacy|0|||
146670895|NCT01064310|528971013|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
146670896|NCT01064310|528971014|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
146670897|NCT01064310|528971015|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
146670898|NCT01064310|528971013|FG000|Open Label Pazopinib|Adverse Event|0|||
146670899|NCT01064310|528971014|FG001|Open Label Pazopinib|Adverse Event|0|||
146670900|NCT01064310|528971015|FG002|Open Label Pazopinib|Adverse Event|12|||
146670901|NCT01064310|528971013|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
146670902|NCT01064310|528971014|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
146670903|NCT01064310|528971015|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
146670904|NCT01064310|528971013|FG000|Open Label Pazopinib|Physician Decision|0|||
146774007|NCT04259450|529343493|FG005|Overall Study|Death|0|||
146774008|NCT04259450|529343494|FG006|Overall Study|Death|0|||
146774009|NCT04259450|529343495|FG007|Overall Study|Death|1|||
146774010|NCT04259450|529343496|FG008|Overall Study|Death|1|||
146774011|NCT04259450|529343497|FG009|Overall Study|Death|0|||
146774012|NCT04259450|529343488|FG000|Overall Study|Withdrawal by Subject|0|||
146774013|NCT04259450|529343489|FG001|Overall Study|Withdrawal by Subject|0|||
146774014|NCT04259450|529343490|FG002|Overall Study|Withdrawal by Subject|0|||
146978768|NCT01113710|530085494|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
146774015|NCT04259450|529343491|FG003|Overall Study|Withdrawal by Subject|0|||
146774016|NCT04259450|529343492|FG004|Overall Study|Withdrawal by Subject|0|||
146774017|NCT04259450|529343493|FG005|Overall Study|Withdrawal by Subject|0|||
146774018|NCT04259450|529343494|FG006|Overall Study|Withdrawal by Subject|0|||
146774019|NCT04259450|529343495|FG007|Overall Study|Withdrawal by Subject|1|||
146774020|NCT04259450|529343496|FG008|Overall Study|Withdrawal by Subject|0|||
146774021|NCT04259450|529343497|FG009|Overall Study|Withdrawal by Subject|0|||
146774022|NCT04259450|529343488|FG000|Overall Study|Other than listed|0|||
146774023|NCT04259450|529343489|FG001|Overall Study|Other than listed|0|||
146774024|NCT04259450|529343490|FG002|Overall Study|Other than listed|0|||
146774025|NCT04259450|529343491|FG003|Overall Study|Other than listed|0|||
146774026|NCT04259450|529343492|FG004|Overall Study|Other than listed|0|||
146774027|NCT04259450|529343493|FG005|Overall Study|Other than listed|0|||
146774028|NCT04259450|529343494|FG006|Overall Study|Other than listed|0|||
146774029|NCT04259450|529343495|FG007|Overall Study|Other than listed|1|||
146774030|NCT04259450|529343496|FG008|Overall Study|Other than listed|1|||
146774031|NCT04259450|529343497|FG009|Overall Study|Other than listed|2|||
146774032|NCT03452189|529343498|FG000|First Intervention (3 Months)|Adverse Event|1|||
146774033|NCT03452189|529343499|FG001|First Intervention (3 Months)|Adverse Event|0|||
146774034|NCT03452189|529343498|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
146774035|NCT03452189|529343499|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
146774036|NCT00332241|529343500|FG000|Overall Study|Lack of Efficacy|6|||
146774037|NCT00332241|529343501|FG001|Overall Study|Lack of Efficacy|1|||
146774038|NCT00332241|529343500|FG000|Overall Study|Adverse Event|3|||
146670905|NCT01064310|528971014|FG001|Open Label Pazopinib|Physician Decision|0|||
146670906|NCT01064310|528971015|FG002|Open Label Pazopinib|Physician Decision|20|||
146670907|NCT02639065|528971016|FG000|Study Treatment|Disease Progression|13|||
146670908|NCT02639065|528971016|FG000|Study Treatment|Adverse Event|9|||
146670909|NCT02639065|528971016|FG000|Study Treatment|Withdrawal by Subject|1|||
146670910|NCT02639065|528971016|FG000|Follow up|Subject refused to follow up|1|||
146670911|NCT02639065|528971016|FG000|Follow up|Symptomatic Deterioration|2|||
146774039|NCT00332241|529343501|FG001|Overall Study|Adverse Event|5|||
146774040|NCT00332241|529343500|FG000|Overall Study|Withdrawal by Subject|2|||
146774041|NCT00332241|529343501|FG001|Overall Study|Withdrawal by Subject|1|||
146774042|NCT00332241|529343500|FG000|Overall Study|Lost to Follow-up|4|||
146774043|NCT00332241|529343501|FG001|Overall Study|Lost to Follow-up|1|||
146774044|NCT02724592|529343508|FG000|Overall Study|Lost to Follow-up|4|||
146774045|NCT02724592|529343509|FG001|Overall Study|Lost to Follow-up|1|||
146670912|NCT02639065|528971016|FG000|Follow up|Death|2|||
146670913|NCT02639065|528971016|FG000|Follow up|Study Terminated|1|||
146670914|NCT02639065|528971016|FG000|Follow up|Disease Progression|3|||
146670915|NCT00873015|528971020|FG000|Overall Study|Withdrawal by Subject|0|||
146670916|NCT00873015|528971021|FG001|Overall Study|Withdrawal by Subject|1|||
146670917|NCT00873015|528971022|FG002|Overall Study|Withdrawal by Subject|0|||
146670918|NCT00873015|528971023|FG003|Overall Study|Withdrawal by Subject|0|||
146670919|NCT03128411|528971024|FG000|Treatment Phase|Adverse Event|21|||
146670920|NCT03128411|528971024|FG000|Treatment Phase|Physician Decision|1|||
146670921|NCT03128411|528971024|FG000|Treatment Phase|Other|2|||
146670922|NCT03128411|528971024|FG000|Long Term Follow-up Phase|Death|2|||
146670923|NCT00345839|528971025|FG000|Overall Study|Withdrawal by Subject|91|||
146670924|NCT00345839|528971026|FG001|Overall Study|Withdrawal by Subject|98|||
146670925|NCT00345839|528971025|FG000|Overall Study|Lost to Follow-up|58|||
146670926|NCT00345839|528971026|FG001|Overall Study|Lost to Follow-up|61|||
146670927|NCT00967668|528972617|FG000|Overall Study|Withdrawal by Subject|13|||
146670928|NCT00967668|528972618|FG001|Overall Study|Withdrawal by Subject|8|||
146670929|NCT00967668|528972619|FG002|Overall Study|Withdrawal by Subject|8|||
146670930|NCT00967668|528972617|FG000|Overall Study|Death|0|||
146670931|NCT00967668|528972618|FG001|Overall Study|Death|2|||
146670932|NCT00967668|528972619|FG002|Overall Study|Death|4|||
146670933|NCT00967668|528972617|FG000|Overall Study|Removed due to behavior|1|||
146670934|NCT00967668|528972618|FG001|Overall Study|Removed due to behavior|1|||
146670935|NCT00967668|528972619|FG002|Overall Study|Removed due to behavior|2|||
146670936|NCT00967668|528972617|FG000|Overall Study|Refused Year 2|11|||
146670937|NCT00967668|528972618|FG001|Overall Study|Refused Year 2|6|||
146670938|NCT00967668|528972619|FG002|Overall Study|Refused Year 2|4|||
146670939|NCT00967668|528972617|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
146670940|NCT00967668|528972618|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
146670941|NCT00967668|528972619|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
146670942|NCT00967668|528972617|FG000|Overall Study|Lost to Follow-up|15|||
146670943|NCT00967668|528972618|FG001|Overall Study|Lost to Follow-up|9|||
146670944|NCT00967668|528972619|FG002|Overall Study|Lost to Follow-up|16|||
146670945|NCT00967668|528972617|FG000|Overall Study|Refused 12-mo assessment|3|||
146670946|NCT00967668|528972618|FG001|Overall Study|Refused 12-mo assessment|1|||
146670947|NCT00967668|528972619|FG002|Overall Study|Refused 12-mo assessment|9|||
146670948|NCT00967668|528972617|FG000|Overall Study|Pregnancy|1|||
146670949|NCT00967668|528972618|FG001|Overall Study|Pregnancy|0|||
146670950|NCT00967668|528972619|FG002|Overall Study|Pregnancy|0|||
146670951|NCT01594281|528972623|FG000|Interventional Core Phase|Protocol Deviation|1|||
146670952|NCT01594281|528972624|FG001|Interventional Core Phase|Protocol Deviation|0|||
146670953|NCT01594281|528972625|FG002|Interventional Core Phase|Protocol Deviation|0|||
146670954|NCT01594281|528972623|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
146670955|NCT01594281|528972624|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
146670956|NCT01594281|528972625|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
146670957|NCT01594281|528972623|FG000|Interventional Core Phase|Death|1|||
146670958|NCT01594281|528972624|FG001|Interventional Core Phase|Death|1|||
146670959|NCT01594281|528972625|FG002|Interventional Core Phase|Death|2|||
146670960|NCT01594281|528972623|FG000|Interventional Core Phase|Lost to Follow-up|1|||
146670961|NCT01594281|528972624|FG001|Interventional Core Phase|Lost to Follow-up|4|||
146670962|NCT01594281|528972625|FG002|Interventional Core Phase|Lost to Follow-up|1|||
146670963|NCT01594281|528972623|FG000|Interventional Core Phase|Adverse Event|4|||
146670964|NCT01594281|528972624|FG001|Interventional Core Phase|Adverse Event|4|||
146670965|NCT01594281|528972625|FG002|Interventional Core Phase|Adverse Event|4|||
146670966|NCT01594281|528972623|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
146670967|NCT01594281|528972624|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
146670968|NCT01594281|528972625|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
146670969|NCT01594281|528972623|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
146670970|NCT01594281|528972624|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
146670971|NCT01594281|528972625|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
146670972|NCT01594281|528972623|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
146670973|NCT01594281|528972624|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
146670974|NCT01594281|528972625|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
146670975|NCT01871532|528972626|FG000|Overall Study|Withdrawal by Subject|1|||
146670976|NCT01871532|528972627|FG001|Overall Study|Withdrawal by Subject|2|||
146670977|NCT02550106|528972629|FG000|Overall Study|Adverse Event|1|||
146670978|NCT02550106|528972629|FG000|Overall Study|Lack of Efficacy|3|||
146670979|NCT02550106|528972629|FG000|Overall Study|Protocol Violation|6|||
146670980|NCT02550106|528972629|FG000|Overall Study|Withdrawal by Subject|2|||
146670981|NCT01709513|528972630|FG000|Overall Study|Randomized but not treated|0|||
146670982|NCT01709513|528972631|FG001|Overall Study|Randomized but not treated|1|||
146670983|NCT01709513|528972632|FG002|Overall Study|Randomized but not treated|0|||
146670984|NCT01709513|528972630|FG000|Overall Study|Adverse Event|16|||
146670985|NCT01709513|528972631|FG001|Overall Study|Adverse Event|31|||
146670986|NCT01709513|528972632|FG002|Overall Study|Adverse Event|23|||
146925787|NCT02953782|529888374|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
146925788|NCT02953782|529888375|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
146925789|NCT02953782|529888376|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
146925790|NCT02953782|529888369|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
146925791|NCT02953782|529888370|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
146670987|NCT01709513|528972630|FG000|Overall Study|Poor compliance to protocol|2|||
146670988|NCT01709513|528972631|FG001|Overall Study|Poor compliance to protocol|0|||
146670989|NCT01709513|528972632|FG002|Overall Study|Poor compliance to protocol|0|||
146670990|NCT01709513|528972630|FG000|Overall Study|Other|3|||
146670991|NCT01709513|528972631|FG001|Overall Study|Other|11|||
146670992|NCT01709513|528972632|FG002|Overall Study|Other|7|||
146670993|NCT01034631|528972633|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
146670994|NCT01034631|528972634|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
146670995|NCT01034631|528972635|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
146670996|NCT01034631|528972633|FG000|Phase II|Not Evaluable per protocol|0|||
146670997|NCT01034631|528972634|FG001|Phase II|Not Evaluable per protocol|0|||
146670998|NCT01034631|528972635|FG002|Phase II|Not Evaluable per protocol|2|||
146670999|NCT01034631|528972633|FG000|Phase II|Determined Ineligible per protocol|0|||
146671000|NCT01034631|528972634|FG001|Phase II|Determined Ineligible per protocol|1|||
146671001|NCT01034631|528972635|FG002|Phase II|Determined Ineligible per protocol|0|||
146671002|NCT01193530|528972638|FG000|Overall Study|Withdrawal by Subject|2|||
146671003|NCT01193530|528972639|FG001|Overall Study|Withdrawal by Subject|2|||
146671004|NCT01193530|528972638|FG000|Overall Study|Began Contraindicated Therapy|1|||
146671005|NCT01193530|528972639|FG001|Overall Study|Began Contraindicated Therapy|0|||
146671006|NCT01193530|528972638|FG000|Overall Study|Lost Light Box|0|||
146671007|NCT01193530|528972639|FG001|Overall Study|Lost Light Box|1|||
146671008|NCT01193530|528972638|FG000|Overall Study|Returned home - out of state|0|||
146671009|NCT01193530|528972639|FG001|Overall Study|Returned home - out of state|1|||
146671010|NCT01193530|528972638|FG000|Overall Study|Non-Compliance|0|||
146671011|NCT01193530|528972639|FG001|Overall Study|Non-Compliance|1|||
146671012|NCT04218695|528972640|FG000|Overall Study|Adverse Event|1|||
146671013|NCT04218695|528972641|FG001|Overall Study|Adverse Event|0|||
146671014|NCT01890473|528972642|FG000|Overall Study|Lost to Follow-up|1|||
146671015|NCT01890473|528972643|FG001|Overall Study|Lost to Follow-up|0|||
146671016|NCT01890473|528972642|FG000|Overall Study|Poor/non-compliance|1|||
146671017|NCT01890473|528972643|FG001|Overall Study|Poor/non-compliance|0|||
146671018|NCT03166735|528972644|FG000|Overall Study|Not Treated|1|||
146671019|NCT03166735|528972645|FG001|Overall Study|Not Treated|0|||
146671020|NCT03166735|528972646|FG002|Overall Study|Not Treated|0|||
146671021|NCT03166735|528972647|FG003|Overall Study|Not Treated|0|||
146671022|NCT03166735|528972648|FG004|Overall Study|Not Treated|0|||
146671023|NCT03166735|528972644|FG000|Overall Study|follow-up not completed as planned|0|||
146671024|NCT03166735|528972645|FG001|Overall Study|follow-up not completed as planned|1|||
146671025|NCT03166735|528972646|FG002|Overall Study|follow-up not completed as planned|1|||
146671026|NCT03166735|528972647|FG003|Overall Study|follow-up not completed as planned|0|||
146671027|NCT03166735|528972648|FG004|Overall Study|follow-up not completed as planned|1|||
146671028|NCT03166735|528972644|FG000|Overall Study|Withdrawal by Subject|0|||
146671029|NCT03166735|528972645|FG001|Overall Study|Withdrawal by Subject|0|||
146671030|NCT03166735|528972646|FG002|Overall Study|Withdrawal by Subject|1|||
146671031|NCT03166735|528972647|FG003|Overall Study|Withdrawal by Subject|1|||
146671032|NCT03166735|528972648|FG004|Overall Study|Withdrawal by Subject|2|||
146671033|NCT03166735|528972644|FG000|Overall Study|Lost to Follow-up|0|||
146671034|NCT03166735|528972645|FG001|Overall Study|Lost to Follow-up|2|||
146671035|NCT03166735|528972646|FG002|Overall Study|Lost to Follow-up|1|||
146671036|NCT03166735|528972647|FG003|Overall Study|Lost to Follow-up|0|||
146671037|NCT03166735|528972648|FG004|Overall Study|Lost to Follow-up|1|||
146671038|NCT04019288|528972649|FG000|Overall Study|Death|1|||
146671039|NCT04019288|528972650|FG001|Overall Study|Death|0|||
146671040|NCT04019288|528972651|FG002|Overall Study|Death|0|||
146671041|NCT01543958|528972652|FG000|Overall Study|Loss to follow-up|3|||
146671042|NCT01543958|528972652|FG000|Overall Study|ART initiation|1|||
146671043|NCT01945281|528972653|FG000|Overall Study|Adverse Event|1|||
146671044|NCT01945281|528972654|FG001|Overall Study|Adverse Event|0|||
146671045|NCT01945281|528972653|FG000|Overall Study|Death|3|||
146671046|NCT01945281|528972654|FG001|Overall Study|Death|3|||
146671047|NCT01945281|528972653|FG000|Overall Study|Physician Decision|1|||
146671048|NCT01945281|528972654|FG001|Overall Study|Physician Decision|1|||
146671049|NCT01945281|528972653|FG000|Overall Study|Technical Problems|1|||
146671050|NCT01945281|528972654|FG001|Overall Study|Technical Problems|0|||
146671051|NCT00934089|528972655|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
146671052|NCT00934089|528972656|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
146671053|NCT00934089|528972655|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
146671054|NCT00934089|528972656|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
146671055|NCT00799383|528972660|FG000|Overall Study|Protocol Violation|1|||
146671056|NCT00799383|528972661|FG001|Overall Study|Protocol Violation|1|||
146671057|NCT00799383|528972660|FG000|Overall Study|Adverse Event|0|||
146671058|NCT00799383|528972661|FG001|Overall Study|Adverse Event|1|||
146671059|NCT00799383|528972660|FG000|Overall Study|Lost to Follow-up|1|||
146671060|NCT00799383|528972661|FG001|Overall Study|Lost to Follow-up|2|||
146671061|NCT00799383|528972660|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
146671062|NCT00799383|528972661|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
146671063|NCT00799383|528972660|FG000|Overall Study|Withdrawal by Subject|0|||
146671064|NCT00799383|528972661|FG001|Overall Study|Withdrawal by Subject|1|||
146671065|NCT00926328|528972662|FG000|Overall Study|Lost to Follow-up|12|||
146671066|NCT00926328|528972663|FG001|Overall Study|Lost to Follow-up|14|||
146671067|NCT00726986|528972664|FG000|Induction Phase|Adverse Event|4|||
146671068|NCT00726986|528972664|FG000|Induction Phase|Withdrawal by Subject|2|||
146671069|NCT00726986|528972664|FG000|Induction Phase|Death|2|||
146671070|NCT00726986|528972664|FG000|Induction Phase|Lack of Efficacy|5|||
146671071|NCT00726986|528972664|FG000|Induction Phase|Secondary Disease|2|||
146671072|NCT00726986|528972664|FG000|Maintenance Phase|Adverse Event|1|||
146671073|NCT00726986|528972664|FG000|Maintenance Phase|Lack of Efficacy|2|||
146671074|NCT01434667|528972672|FG000|Overall Study|Lost to Follow-up|5|||
146671075|NCT01434667|528972673|FG001|Overall Study|Lost to Follow-up|10|||
146671076|NCT01877265|528972676|FG000|Treatment Period 1|Sponsor Decision|0|||
146671077|NCT01877265|528972677|FG001|Treatment Period 1|Sponsor Decision|0|||
146671078|NCT01877265|528972678|FG002|Treatment Period 1|Sponsor Decision|1|||
146671079|NCT01877265|528972679|FG003|Treatment Period 1|Sponsor Decision|0|||
146671080|NCT01877265|528972680|FG004|Treatment Period 1|Sponsor Decision|0|||
146671081|NCT01877265|528972681|FG005|Treatment Period 1|Sponsor Decision|0|||
146671082|NCT01877265|528972676|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
146671083|NCT01877265|528972677|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
146671084|NCT01877265|528972678|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
146671085|NCT01877265|528972679|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
146671086|NCT01877265|528972680|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
146671087|NCT01877265|528972681|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
146671088|NCT01877265|528972676|FG000|Treatment Period 3|Lost to Follow-up|1|||
146671089|NCT01877265|528972677|FG001|Treatment Period 3|Lost to Follow-up|0|||
146671090|NCT01877265|528972678|FG002|Treatment Period 3|Lost to Follow-up|0|||
146671091|NCT01877265|528972679|FG003|Treatment Period 3|Lost to Follow-up|0|||
146671092|NCT01877265|528972680|FG004|Treatment Period 3|Lost to Follow-up|0|||
146671093|NCT01877265|528972681|FG005|Treatment Period 3|Lost to Follow-up|0|||
146671094|NCT04401423|528972684|FG000|Overall Study|Withdrawal by Subject|3|||
146671095|NCT04401423|528972685|FG001|Overall Study|Withdrawal by Subject|1|||
146671096|NCT04401423|528972684|FG000|Overall Study|Physician Decision|2|||
146671097|NCT04401423|528972685|FG001|Overall Study|Physician Decision|1|||
146671098|NCT00003473|528972686|FG000|Overall Study|Three patients were not evaluable.|3|||
146671099|NCT02193867|528972687|FG000|Overall Study|Death|2|||
146671100|NCT02193867|528972687|FG000|Overall Study|Sponsor Study Termination|2|||
146671101|NCT01867424|528972688|FG000|Overall Study|Patient noncompliance|2|||
146671102|NCT01867424|528972689|FG001|Overall Study|Patient noncompliance|1|||
146671103|NCT04613375|528972690|FG000|Overall Study|Death|198|||
146671104|NCT04613375|528972690|FG000|Overall Study|Withdrawal by Subject|3|||
146671105|NCT02582983|528972691|FG000|Overall Study|Death|3|||
146671106|NCT02582983|528972691|FG000|Overall Study|Withdrawal by Subject|2|||
146671107|NCT02582983|528972691|FG000|Overall Study|Adverse Event|1|||
146671108|NCT05209360|528972692|FG000|Overall Study|Withdrawal by Subject|0|||
146671109|NCT05209360|528972693|FG001|Overall Study|Withdrawal by Subject|0|||
146671110|NCT05209360|528972694|FG002|Overall Study|Withdrawal by Subject|1|||
146671111|NCT05209360|528972695|FG003|Overall Study|Withdrawal by Subject|0|||
146671112|NCT05209360|528972696|FG004|Overall Study|Withdrawal by Subject|0|||
146671113|NCT05209360|528972697|FG005|Overall Study|Withdrawal by Subject|0|||
146671114|NCT02021331|528972700|FG000|Overall Study|Adverse Event|0|||
146671115|NCT02021331|528972701|FG001|Overall Study|Adverse Event|2|||
146671116|NCT01081678|528972704|FG000|Overall Study|Ineligibility Determined|0|||
146671117|NCT01081678|528972705|FG001|Overall Study|Ineligibility Determined|0|||
146671118|NCT01081678|528972706|FG002|Overall Study|Ineligibility Determined|1|||
146671119|NCT01081678|528972707|FG003|Overall Study|Ineligibility Determined|1|||
146671120|NCT01081678|528972704|FG000|Overall Study|Noncompliance|3|||
146671121|NCT01081678|528972705|FG001|Overall Study|Noncompliance|4|||
146671122|NCT01081678|528972706|FG002|Overall Study|Noncompliance|5|||
146671123|NCT01081678|528972707|FG003|Overall Study|Noncompliance|2|||
146671124|NCT01081678|528972704|FG000|Overall Study|Adverse Event|2|||
146671125|NCT01081678|528972705|FG001|Overall Study|Adverse Event|1|||
146671126|NCT01081678|528972706|FG002|Overall Study|Adverse Event|2|||
146671127|NCT01081678|528972707|FG003|Overall Study|Adverse Event|2|||
146671128|NCT01081678|528972704|FG000|Overall Study|Withdrawal by Subject|15|||
146671129|NCT01081678|528972705|FG001|Overall Study|Withdrawal by Subject|7|||
146671130|NCT01081678|528972706|FG002|Overall Study|Withdrawal by Subject|17|||
146671131|NCT01081678|528972707|FG003|Overall Study|Withdrawal by Subject|14|||
146671132|NCT01081678|528972704|FG000|Overall Study|Administrative Decision|1|||
146671133|NCT01081678|528972705|FG001|Overall Study|Administrative Decision|0|||
146671134|NCT01081678|528972706|FG002|Overall Study|Administrative Decision|0|||
146671135|NCT01081678|528972707|FG003|Overall Study|Administrative Decision|1|||
146671136|NCT01081678|528972704|FG000|Overall Study|Lost to Follow-up|4|||
146671137|NCT01081678|528972705|FG001|Overall Study|Lost to Follow-up|1|||
146671138|NCT01081678|528972706|FG002|Overall Study|Lost to Follow-up|4|||
146671139|NCT01081678|528972707|FG003|Overall Study|Lost to Follow-up|3|||
146671140|NCT01081678|528972704|FG000|Overall Study|Death|2|||
146671141|NCT01081678|528972705|FG001|Overall Study|Death|2|||
146671142|NCT01081678|528972706|FG002|Overall Study|Death|2|||
146671143|NCT01081678|528972707|FG003|Overall Study|Death|6|||
146671144|NCT01081678|528972704|FG000|Overall Study|Other|0|||
146671145|NCT01081678|528972705|FG001|Overall Study|Other|1|||
146671146|NCT01081678|528972706|FG002|Overall Study|Other|0|||
146671147|NCT01081678|528972707|FG003|Overall Study|Other|0|||
146671148|NCT01619423|528972710|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
146671149|NCT01619423|528972711|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
146671150|NCT01619423|528972712|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
146671151|NCT01619423|528972713|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
146671152|NCT01281865|528972714|FG000|Overall Study|Adverse Event|1|||
146671153|NCT01281865|528972715|FG001|Overall Study|Adverse Event|1|||
146671154|NCT01281865|528972714|FG000|Overall Study|Withdrawal by Subject|1|||
146671155|NCT01281865|528972715|FG001|Overall Study|Withdrawal by Subject|0|||
146671156|NCT01281865|528972714|FG000|Overall Study|Lack of Efficacy|1|||
146671157|NCT01281865|528972715|FG001|Overall Study|Lack of Efficacy|0|||
146671158|NCT03478657|528972716|FG000|Overall Study|Withdrawal by Subject|0|||
146671159|NCT03478657|528972717|FG001|Overall Study|Withdrawal by Subject|1|||
146671160|NCT03948581|528972718|FG000|Overall Study|Lost to Follow-up|0|||
146671161|NCT03948581|528972719|FG001|Overall Study|Lost to Follow-up|1|||
146671162|NCT03068455|528972720|FG000|Pre-treatment Period|Disease progression|0|||
146671163|NCT03068455|528972721|FG001|Pre-treatment Period|Disease progression|1|||
146671164|NCT03068455|528972720|FG000|Pre-treatment Period|Participant withdrew consent|1|||
146671165|NCT03068455|528972721|FG001|Pre-treatment Period|Participant withdrew consent|1|||
146671166|NCT03068455|528972720|FG000|Pre-treatment Period|Poor/non-compliance|0|||
146671167|NCT03068455|528972721|FG001|Pre-treatment Period|Poor/non-compliance|1|||
146671168|NCT03068455|528972720|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
146671169|NCT03068455|528972721|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
146671170|NCT03068455|528972720|FG000|Pre-treatment Period|Not reported|2|||
146671171|NCT03068455|528972721|FG001|Pre-treatment Period|Not reported|1|||
146671172|NCT03068455|528972720|FG000|Treatment Period|Disease progression|166|||
146671173|NCT03068455|528972721|FG001|Treatment Period|Disease progression|208|||
146671174|NCT03068455|528972720|FG000|Treatment Period|Study drug toxicity|317|||
146671175|NCT03068455|528972721|FG001|Treatment Period|Study drug toxicity|104|||
146671176|NCT03068455|528972720|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
146671177|NCT03068455|528972721|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
146671178|NCT03068455|528972720|FG000|Treatment Period|Participant request to stop therapy|33|||
146671179|NCT03068455|528972721|FG001|Treatment Period|Participant request to stop therapy|20|||
146671180|NCT03068455|528972720|FG000|Treatment Period|Participant withdrew consent|5|||
146671181|NCT03068455|528972721|FG001|Treatment Period|Participant withdrew consent|10|||
146671182|NCT03068455|528972720|FG000|Treatment Period|Poor/non-compliance|3|||
146671183|NCT03068455|528972721|FG001|Treatment Period|Poor/non-compliance|0|||
146671184|NCT03068455|528972720|FG000|Treatment Period|Participant no longer meets study criteria|1|||
146671185|NCT03068455|528972721|FG001|Treatment Period|Participant no longer meets study criteria|3|||
146671186|NCT03068455|528972720|FG000|Treatment Period|Other reasons|12|||
146671187|NCT03068455|528972721|FG001|Treatment Period|Other reasons|4|||
146671188|NCT00005044|528972731|FG000|Overall Study|Protocol Violation|37|||
146671189|NCT00005044|528972732|FG001|Overall Study|Protocol Violation|46|||
146671190|NCT00005044|528972731|FG000|Overall Study|Withdrawal by Subject|1|||
146671191|NCT00005044|528972732|FG001|Overall Study|Withdrawal by Subject|5|||
146671192|NCT00005044|528972731|FG000|Overall Study|No protocol treatment|0|||
146671193|NCT00005044|528972732|FG001|Overall Study|No protocol treatment|1|||
146671194|NCT00181155|528972733|FG000|Overall Study|Physician Decision|1|||
146925792|NCT02953782|529888371|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
146925793|NCT02953782|529888372|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
146671195|NCT00181155|528972734|FG001|Overall Study|Physician Decision|0|||
146671196|NCT00181155|528972733|FG000|Overall Study|Withdrawal by Subject|1|||
146671197|NCT00181155|528972734|FG001|Overall Study|Withdrawal by Subject|0|||
146671198|NCT02572401|528972735|FG000|Overall Study|Lost to Follow-up|5|||
146925794|NCT02953782|529888373|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
146925795|NCT02953782|529888374|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
146925796|NCT02953782|529888375|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
146671199|NCT02572401|528972736|FG001|Overall Study|Lost to Follow-up|8|||
146671200|NCT02572401|528972737|FG002|Overall Study|Lost to Follow-up|9|||
146671201|NCT02572401|528972738|FG003|Overall Study|Lost to Follow-up|9|||
146671202|NCT02572401|528972735|FG000|Overall Study|Death|0|||
146671203|NCT02572401|528972736|FG001|Overall Study|Death|0|||
146671204|NCT02572401|528972737|FG002|Overall Study|Death|0|||
146671205|NCT02572401|528972738|FG003|Overall Study|Death|1|||
146671206|NCT01548287|528972739|FG000|Screening|No reason provided|0|||
146671207|NCT01548287|528972740|FG001|Screening|No reason provided|0|||
146671208|NCT01548287|528972741|FG002|Screening|No reason provided|0|||
146671209|NCT01548287|528972742|FG003|Screening|No reason provided|0|||
146671210|NCT01548287|528972743|FG004|Screening|No reason provided|9|||
146671211|NCT01548287|528972739|FG000|Screening|Did not meet eligibility criteria|0|||
146671212|NCT01548287|528972740|FG001|Screening|Did not meet eligibility criteria|0|||
146671213|NCT01548287|528972741|FG002|Screening|Did not meet eligibility criteria|0|||
146671214|NCT01548287|528972742|FG003|Screening|Did not meet eligibility criteria|0|||
146671215|NCT01548287|528972743|FG004|Screening|Did not meet eligibility criteria|74|||
146671216|NCT01548287|528972739|FG000|Randomized Period|Did not meet inclusion criteria|0|||
146671217|NCT01548287|528972740|FG001|Randomized Period|Did not meet inclusion criteria|0|||
146671218|NCT01548287|528972741|FG002|Randomized Period|Did not meet inclusion criteria|2|||
146671219|NCT01548287|528972742|FG003|Randomized Period|Did not meet inclusion criteria|0|||
146671220|NCT01548287|528972743|FG004|Randomized Period|Did not meet inclusion criteria|0|||
146671221|NCT01548287|528972739|FG000|Randomized Period|Adverse Event|0|||
146671222|NCT01548287|528972740|FG001|Randomized Period|Adverse Event|2|||
146671223|NCT01548287|528972741|FG002|Randomized Period|Adverse Event|5|||
146671224|NCT01548287|528972742|FG003|Randomized Period|Adverse Event|0|||
146671225|NCT01548287|528972743|FG004|Randomized Period|Adverse Event|0|||
146671226|NCT02762578|528972748|FG000|Overall Study|Adverse Event|1|||
146671227|NCT02762578|528972749|FG001|Overall Study|Adverse Event|6|||
146671228|NCT02762578|528972748|FG000|Overall Study|Protocol Violation|4|||
146671229|NCT02762578|528972749|FG001|Overall Study|Protocol Violation|2|||
146671230|NCT02762578|528972748|FG000|Overall Study|Withdrawal by Subject|4|||
146671231|NCT02762578|528972749|FG001|Overall Study|Withdrawal by Subject|2|||
146671232|NCT02762578|528972748|FG000|Overall Study|Unclassified|6|||
146671233|NCT02762578|528972749|FG001|Overall Study|Unclassified|0|||
146671234|NCT00259610|528972750|FG000|Overall Study|Withdrawal by Subject|33|||
146671235|NCT00259610|528972751|FG001|Overall Study|Withdrawal by Subject|25|||
146671236|NCT00259610|528972752|FG002|Overall Study|Withdrawal by Subject|29|||
146774046|NCT04723394|529343512|FG000|Overall Study|Adverse Event|0|||
146774047|NCT04723394|529343513|FG001|Overall Study|Adverse Event|3|||
146774048|NCT04723394|529343512|FG000|Overall Study|Death|8|||
146774049|NCT04723394|529343513|FG001|Overall Study|Death|8|||
146925797|NCT02953782|529888376|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
146925798|NCT02953782|529888369|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
146925799|NCT02953782|529888370|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
146925800|NCT02953782|529888371|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
146925801|NCT02953782|529888372|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
146925802|NCT02953782|529888373|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
146925803|NCT02953782|529888374|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
146925804|NCT02953782|529888375|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
146925805|NCT02953782|529888376|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
146925806|NCT02953782|529888369|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
146925807|NCT02953782|529888370|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
146925808|NCT02953782|529888371|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
146925809|NCT02953782|529888372|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
146925810|NCT02953782|529888373|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
146925811|NCT02953782|529888374|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
146925812|NCT02953782|529888375|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
146925813|NCT02953782|529888376|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
146925814|NCT02953782|529888369|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
146925815|NCT02953782|529888370|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
146925816|NCT02953782|529888371|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
146925817|NCT02953782|529888372|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
146925818|NCT02953782|529888373|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
146925819|NCT02953782|529888374|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
146925820|NCT02953782|529888375|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
146925821|NCT02953782|529888376|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
146925822|NCT02953782|529888369|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
146925823|NCT02953782|529888370|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
146925824|NCT02953782|529888371|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
146671237|NCT00259610|528972753|FG003|Overall Study|Withdrawal by Subject|19|||
146671238|NCT00259610|528972750|FG000|Overall Study|Lost to Follow-up|19|||
146671239|NCT00259610|528972751|FG001|Overall Study|Lost to Follow-up|8|||
146671240|NCT00259610|528972752|FG002|Overall Study|Lost to Follow-up|18|||
146774050|NCT04723394|529343512|FG000|Overall Study|Lost to Follow-up|20|||
146671241|NCT00259610|528972753|FG003|Overall Study|Lost to Follow-up|15|||
146671242|NCT00259610|528972750|FG000|Overall Study|Physician Decision|6|||
146671243|NCT00259610|528972751|FG001|Overall Study|Physician Decision|4|||
146671244|NCT00259610|528972752|FG002|Overall Study|Physician Decision|7|||
146671245|NCT00259610|528972753|FG003|Overall Study|Physician Decision|2|||
146671246|NCT00259610|528972750|FG000|Overall Study|Death|1|||
146671247|NCT00259610|528972751|FG001|Overall Study|Death|1|||
146671248|NCT00259610|528972752|FG002|Overall Study|Death|2|||
146671249|NCT00259610|528972753|FG003|Overall Study|Death|0|||
146671250|NCT00259610|528972750|FG000|Overall Study|non medical reason|6|||
146671251|NCT00259610|528972751|FG001|Overall Study|non medical reason|2|||
146671252|NCT00259610|528972752|FG002|Overall Study|non medical reason|10|||
146671253|NCT00259610|528972753|FG003|Overall Study|non medical reason|3|||
146671254|NCT00259610|528972750|FG000|Overall Study|Adverse Event|3|||
146671255|NCT00259610|528972751|FG001|Overall Study|Adverse Event|4|||
146671256|NCT00259610|528972752|FG002|Overall Study|Adverse Event|5|||
146671257|NCT00259610|528972753|FG003|Overall Study|Adverse Event|2|||
146671258|NCT00259610|528972750|FG000|Overall Study|Serious Adverse Event|8|||
146671259|NCT00259610|528972751|FG001|Overall Study|Serious Adverse Event|2|||
146671260|NCT00259610|528972752|FG002|Overall Study|Serious Adverse Event|2|||
146671261|NCT00259610|528972753|FG003|Overall Study|Serious Adverse Event|2|||
146671262|NCT01768286|528972756|FG000|Overall Study|Randomized But Not Treated|0|||
146671263|NCT01768286|528972757|FG001|Overall Study|Randomized But Not Treated|0|||
146671264|NCT01768286|528972758|FG002|Overall Study|Randomized But Not Treated|1|||
146925825|NCT02953782|529888372|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
146925826|NCT02953782|529888373|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
146925827|NCT02953782|529888374|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
146925828|NCT02953782|529888375|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
146925829|NCT02953782|529888376|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
146925830|NCT02953782|529888369|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
146671265|NCT01768286|528972759|FG003|Overall Study|Randomized But Not Treated|0|||
146671266|NCT01768286|528972756|FG000|Overall Study|Lack of Efficacy|7|||
146671267|NCT01768286|528972757|FG001|Overall Study|Lack of Efficacy|4|||
146671268|NCT01768286|528972758|FG002|Overall Study|Lack of Efficacy|0|||
146671269|NCT01768286|528972759|FG003|Overall Study|Lack of Efficacy|1|||
146671270|NCT01768286|528972756|FG000|Overall Study|Withdrew Consent|0|||
146671271|NCT01768286|528972757|FG001|Overall Study|Withdrew Consent|0|||
146671272|NCT01768286|528972758|FG002|Overall Study|Withdrew Consent|1|||
146671273|NCT01768286|528972759|FG003|Overall Study|Withdrew Consent|0|||
146671274|NCT02083965|528972760|FG000|Treatment Period|Other|1|||
146671275|NCT02083965|528972761|FG001|Treatment Period|Other|0|||
146671276|NCT01201785|528972763|FG000|Overall Study|Lost to Follow-up|16|||
146671277|NCT02151110|528972764|FG000|Overall Study|Withdrawal by Subject|0|||
146671278|NCT02151110|528972765|FG001|Overall Study|Withdrawal by Subject|0|||
146671279|NCT02151110|528972766|FG002|Overall Study|Withdrawal by Subject|0|||
146671280|NCT02151110|528972767|FG003|Overall Study|Withdrawal by Subject|0|||
146671281|NCT02151110|528972768|FG004|Overall Study|Withdrawal by Subject|0|||
146671282|NCT02151110|528972769|FG005|Overall Study|Withdrawal by Subject|0|||
146671283|NCT02151110|528972770|FG006|Overall Study|Withdrawal by Subject|0|||
146671284|NCT02151110|528972771|FG007|Overall Study|Withdrawal by Subject|1|||
146671285|NCT02151110|528972764|FG000|Overall Study|Lost to Follow-up|0|||
146671286|NCT02151110|528972765|FG001|Overall Study|Lost to Follow-up|0|||
146671287|NCT02151110|528972766|FG002|Overall Study|Lost to Follow-up|0|||
146671288|NCT02151110|528972767|FG003|Overall Study|Lost to Follow-up|0|||
146671289|NCT02151110|528972768|FG004|Overall Study|Lost to Follow-up|0|||
146671290|NCT02151110|528972769|FG005|Overall Study|Lost to Follow-up|0|||
146671291|NCT02151110|528972770|FG006|Overall Study|Lost to Follow-up|0|||
146671292|NCT02151110|528972771|FG007|Overall Study|Lost to Follow-up|2|||
146671293|NCT00939770|528972772|FG000|Overall Study|Adverse Event|1|||
146671294|NCT00939770|528972773|FG001|Overall Study|Adverse Event|1|||
146671295|NCT00939770|528972774|FG002|Overall Study|Adverse Event|0|||
146671296|NCT00939770|528972775|FG003|Overall Study|Adverse Event|0|||
146671297|NCT00939770|528972776|FG004|Overall Study|Adverse Event|6|||
146671298|NCT00939770|528972777|FG005|Overall Study|Adverse Event|2|||
146671299|NCT00939770|528972778|FG006|Overall Study|Adverse Event|1|||
146774051|NCT04723394|529343513|FG001|Overall Study|Lost to Follow-up|17|||
146925831|NCT02953782|529888370|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
146671300|NCT00939770|528972779|FG007|Overall Study|Adverse Event|1|||
146671301|NCT00939770|528972772|FG000|Overall Study|Lack of Efficacy|4|||
146671302|NCT00939770|528972773|FG001|Overall Study|Lack of Efficacy|6|||
146671303|NCT00939770|528972774|FG002|Overall Study|Lack of Efficacy|13|||
146671304|NCT00939770|528972775|FG003|Overall Study|Lack of Efficacy|9|||
146671305|NCT00939770|528972776|FG004|Overall Study|Lack of Efficacy|16|||
146671306|NCT00939770|528972777|FG005|Overall Study|Lack of Efficacy|8|||
146671307|NCT00939770|528972778|FG006|Overall Study|Lack of Efficacy|11|||
146671308|NCT00939770|528972779|FG007|Overall Study|Lack of Efficacy|1|||
146671309|NCT00939770|528972772|FG000|Overall Study|Lost to Follow-up|0|||
146774052|NCT04723394|529343512|FG000|Overall Study|Physician Decision|1|||
146671310|NCT00939770|528972773|FG001|Overall Study|Lost to Follow-up|0|||
146671311|NCT00939770|528972774|FG002|Overall Study|Lost to Follow-up|0|||
146671312|NCT00939770|528972775|FG003|Overall Study|Lost to Follow-up|0|||
146671313|NCT00939770|528972776|FG004|Overall Study|Lost to Follow-up|1|||
146671314|NCT00939770|528972777|FG005|Overall Study|Lost to Follow-up|0|||
146671315|NCT00939770|528972778|FG006|Overall Study|Lost to Follow-up|0|||
146671316|NCT00939770|528972779|FG007|Overall Study|Lost to Follow-up|0|||
146671317|NCT00939770|528972772|FG000|Overall Study|Physician Decision|0|||
146671318|NCT00939770|528972773|FG001|Overall Study|Physician Decision|0|||
146671319|NCT00939770|528972774|FG002|Overall Study|Physician Decision|2|||
146925832|NCT02953782|529888371|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
146671320|NCT00939770|528972775|FG003|Overall Study|Physician Decision|0|||
146671321|NCT00939770|528972776|FG004|Overall Study|Physician Decision|7|||
146671322|NCT00939770|528972777|FG005|Overall Study|Physician Decision|1|||
146671323|NCT00939770|528972778|FG006|Overall Study|Physician Decision|0|||
146671324|NCT00939770|528972779|FG007|Overall Study|Physician Decision|6|||
146671325|NCT00939770|528972772|FG000|Overall Study|Protocol Violation|0|||
146671326|NCT00939770|528972773|FG001|Overall Study|Protocol Violation|0|||
146671327|NCT00939770|528972774|FG002|Overall Study|Protocol Violation|0|||
146671328|NCT00939770|528972775|FG003|Overall Study|Protocol Violation|0|||
146671329|NCT00939770|528972776|FG004|Overall Study|Protocol Violation|1|||
146671330|NCT00939770|528972777|FG005|Overall Study|Protocol Violation|0|||
146671331|NCT00939770|528972778|FG006|Overall Study|Protocol Violation|0|||
146671332|NCT00939770|528972779|FG007|Overall Study|Protocol Violation|0|||
146671333|NCT00939770|528972772|FG000|Overall Study|Withdrawal by Subject|0|||
146671334|NCT00939770|528972773|FG001|Overall Study|Withdrawal by Subject|1|||
146671335|NCT00939770|528972774|FG002|Overall Study|Withdrawal by Subject|5|||
146671336|NCT00939770|528972775|FG003|Overall Study|Withdrawal by Subject|2|||
146671337|NCT00939770|528972776|FG004|Overall Study|Withdrawal by Subject|6|||
146671338|NCT00939770|528972777|FG005|Overall Study|Withdrawal by Subject|0|||
146671339|NCT00939770|528972778|FG006|Overall Study|Withdrawal by Subject|2|||
146671340|NCT00939770|528972779|FG007|Overall Study|Withdrawal by Subject|2|||
146671341|NCT01146665|528972780|FG000|Overall Study|Withdrawal by Subject|10|||
146671342|NCT01146665|528972781|FG001|Overall Study|Withdrawal by Subject|16|||
146671343|NCT04560998|528972782|FG000|Overall Study|Withdrawal by Subject|18|||
146671344|NCT04560998|528972783|FG001|Overall Study|Withdrawal by Subject|12|||
146671345|NCT04560998|528972782|FG000|Overall Study|Lost to Follow-up|8|||
146671346|NCT04560998|528972783|FG001|Overall Study|Lost to Follow-up|5|||
146671347|NCT04560998|528972782|FG000|Overall Study|Physician Decision|4|||
146671348|NCT04560998|528972783|FG001|Overall Study|Physician Decision|0|||
146671349|NCT03749447|528974177|FG000|Overall Study|Adverse Event|11|||
146671350|NCT03749447|528974178|FG001|Overall Study|Adverse Event|3|||
146671351|NCT03749447|528974177|FG000|Overall Study|Death|1|||
146671352|NCT03749447|528974178|FG001|Overall Study|Death|1|||
146671353|NCT03749447|528974177|FG000|Overall Study|Lost to Follow-up|2|||
146671354|NCT03749447|528974178|FG001|Overall Study|Lost to Follow-up|2|||
146671355|NCT03749447|528974177|FG000|Overall Study|Reason Not Specified|0|||
146671356|NCT03749447|528974178|FG001|Overall Study|Reason Not Specified|3|||
146671357|NCT03749447|528974177|FG000|Overall Study|Physician Decision|4|||
146671358|NCT03749447|528974178|FG001|Overall Study|Physician Decision|3|||
146671359|NCT03749447|528974177|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
146671360|NCT03749447|528974178|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
146925833|NCT02953782|529888372|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
146925834|NCT02953782|529888373|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
146925835|NCT02953782|529888374|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
146925836|NCT02953782|529888375|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
146925837|NCT02953782|529888376|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
146925838|NCT02953782|529888369|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
146925839|NCT02953782|529888370|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
146925840|NCT02953782|529888371|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
146978769|NCT01113710|530085494|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
146671361|NCT03749447|528974177|FG000|Overall Study|Study Terminated By Sponsor|112|||
146671362|NCT03749447|528974178|FG001|Overall Study|Study Terminated By Sponsor|105|||
146671363|NCT03749447|528974177|FG000|Overall Study|Withdrawal by Subject|12|||
146671364|NCT03749447|528974178|FG001|Overall Study|Withdrawal by Subject|6|||
146671365|NCT03749447|528974177|FG000|Overall Study|Non-compliance With Study Drug|0|||
146671366|NCT03749447|528974178|FG001|Overall Study|Non-compliance With Study Drug|1|||
146671367|NCT01218113|528974179|FG000|Overall Study|Withdrawal by Subject|1|||
146671368|NCT01218113|528974180|FG001|Overall Study|Withdrawal by Subject|0|||
146671369|NCT01218113|528974181|FG002|Overall Study|Withdrawal by Subject|1|||
146671370|NCT01218113|528974179|FG000|Overall Study|Lost to Follow-up|4|||
146671371|NCT01218113|528974180|FG001|Overall Study|Lost to Follow-up|1|||
146671372|NCT01218113|528974181|FG002|Overall Study|Lost to Follow-up|4|||
146671373|NCT01218113|528974179|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
146671374|NCT01218113|528974180|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
146925841|NCT02953782|529888372|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
146925842|NCT02953782|529888373|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
146925843|NCT02953782|529888374|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
146925844|NCT02953782|529888375|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
146925845|NCT02953782|529888376|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
146925846|NCT01934192|529888379|FG000|Overall Study|Protocol Violation|0|||
146925847|NCT01934192|529888380|FG001|Overall Study|Protocol Violation|0|||
146925848|NCT01934192|529888381|FG002|Overall Study|Protocol Violation|0|||
146925849|NCT01934192|529888382|FG003|Overall Study|Protocol Violation|1|||
146925850|NCT01934192|529888379|FG000|Overall Study|Other: reached stopping criteria|6|||
146925851|NCT01934192|529888380|FG001|Overall Study|Other: reached stopping criteria|5|||
146925852|NCT01934192|529888381|FG002|Overall Study|Other: reached stopping criteria|1|||
146925853|NCT01934192|529888382|FG003|Overall Study|Other: reached stopping criteria|0|||
146925854|NCT01934192|529888379|FG000|Overall Study|Physician Decision|3|||
146925855|NCT01934192|529888380|FG001|Overall Study|Physician Decision|2|||
146925856|NCT01934192|529888381|FG002|Overall Study|Physician Decision|0|||
146925857|NCT01934192|529888382|FG003|Overall Study|Physician Decision|0|||
146925858|NCT01737840|529888383|FG000|Overall Study|Diagnosed with an other pathology|2|||
146671375|NCT01218113|528974181|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
146671376|NCT00115739|528974182|FG000|Overall Study|Lost to Follow-up|3|||
146671377|NCT00259649|528974183|FG000|Overall Study|Lost to Follow-up|7|||
146671378|NCT00259649|528974183|FG000|Overall Study|irregular menses|3|||
146671379|NCT00745823|528974186|FG000|Overall Study|Adverse Event|5|||
146671380|NCT00745823|528974187|FG001|Overall Study|Adverse Event|3|||
146671381|NCT00745823|528974186|FG000|Overall Study|Lack of Efficacy|20|||
146671382|NCT00745823|528974187|FG001|Overall Study|Lack of Efficacy|6|||
146671383|NCT00745823|528974186|FG000|Overall Study|Lost to Follow-up|10|||
146671384|NCT00745823|528974187|FG001|Overall Study|Lost to Follow-up|11|||
146671385|NCT00745823|528974186|FG000|Overall Study|Physician Decision|10|||
146671386|NCT00745823|528974187|FG001|Overall Study|Physician Decision|5|||
146671387|NCT00745823|528974186|FG000|Overall Study|Pregnancy|0|||
146671388|NCT00745823|528974187|FG001|Overall Study|Pregnancy|4|||
146671389|NCT00745823|528974186|FG000|Overall Study|Withdrawal by Subject|14|||
146671390|NCT00745823|528974187|FG001|Overall Study|Withdrawal by Subject|8|||
146671391|NCT00745823|528974186|FG000|Overall Study|Study Terminated by Sponsor|326|||
146671392|NCT00745823|528974187|FG001|Overall Study|Study Terminated by Sponsor|349|||
146671393|NCT01433991|528974197|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
146671394|NCT01433991|528974198|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
146671395|NCT01433991|528974199|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
146671396|NCT01433991|528974200|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
146671397|NCT01433991|528974197|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
146671398|NCT01433991|528974198|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
146671399|NCT01433991|528974199|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
146671400|NCT01433991|528974200|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
146671401|NCT01433991|528974197|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
146671402|NCT01433991|528974198|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
146671403|NCT01433991|528974199|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
146671404|NCT01433991|528974200|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
146925859|NCT01737840|529888384|FG001|Overall Study|Diagnosed with an other pathology|2|||
146925860|NCT02357849|529888387|FG000|Overall Study|Withdrawal by Subject|2|||
146925861|NCT02357849|529888388|FG001|Overall Study|Withdrawal by Subject|3|||
146925862|NCT01982773|529888389|FG000|Overall Study|Withdrawal by Subject|1|||
146925863|NCT01982773|529888390|FG001|Overall Study|Withdrawal by Subject|3|||
146925864|NCT01982773|529888389|FG000|Overall Study|Lost to Follow-up|7|||
146925865|NCT01982773|529888390|FG001|Overall Study|Lost to Follow-up|1|||
146925866|NCT01029886|529888391|FG000|Overall Study|Adverse Event|12|||
146925867|NCT01029886|529888392|FG001|Overall Study|Adverse Event|25|||
146925868|NCT01029886|529888391|FG000|Overall Study|Lost to Follow-up|1|||
146925869|NCT01029886|529888392|FG001|Overall Study|Lost to Follow-up|0|||
146925870|NCT01029886|529888391|FG000|Overall Study|Physician Decision|2|||
146671405|NCT01433991|528974197|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
146671406|NCT01433991|528974198|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
146671407|NCT01433991|528974199|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
146671408|NCT01433991|528974200|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
146671409|NCT01433991|528974197|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
146671410|NCT01433991|528974198|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
146671411|NCT01433991|528974199|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
146671412|NCT01433991|528974200|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
146925871|NCT01029886|529888392|FG001|Overall Study|Physician Decision|6|||
146925872|NCT01029886|529888391|FG000|Overall Study|Protocol Violation|17|||
146925873|NCT01029886|529888392|FG001|Overall Study|Protocol Violation|5|||
146925874|NCT01029886|529888391|FG000|Overall Study|Withdrawal by Subject|8|||
146925875|NCT01029886|529888392|FG001|Overall Study|Withdrawal by Subject|18|||
146925876|NCT01029886|529888391|FG000|Overall Study|Entry Criteria Not Met|13|||
146925877|NCT01029886|529888392|FG001|Overall Study|Entry Criteria Not Met|5|||
146925878|NCT01029886|529888391|FG000|Overall Study|Sponsor Decision|1|||
146925879|NCT01029886|529888392|FG001|Overall Study|Sponsor Decision|0|||
146925880|NCT01029886|529888391|FG000|Overall Study|Loss Glucose Control|7|||
146925881|NCT01029886|529888392|FG001|Overall Study|Loss Glucose Control|1|||
146925882|NCT01778127|529888397|FG000|Overall Study|Lost to Follow-up|5|||
146925883|NCT01778127|529888398|FG001|Overall Study|Lost to Follow-up|1|||
146925884|NCT01778127|529888399|FG002|Overall Study|Lost to Follow-up|2|||
146925885|NCT01778127|529888397|FG000|Overall Study|Withdrawal by Subject|3|||
146925886|NCT01778127|529888398|FG001|Overall Study|Withdrawal by Subject|1|||
146925887|NCT01778127|529888399|FG002|Overall Study|Withdrawal by Subject|4|||
146925888|NCT02720016|529888400|FG000|Overall Study|Separation of couple|6|||
146925889|NCT02720016|529888401|FG001|Overall Study|Separation of couple|8|||
146925890|NCT02720016|529888402|FG002|Overall Study|Separation of couple|2|||
146671413|NCT01433991|528974197|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
146671414|NCT01433991|528974198|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
146671415|NCT01433991|528974199|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
146671416|NCT01433991|528974200|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
146671417|NCT01433991|528974197|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
146671418|NCT01433991|528974198|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
146671419|NCT01433991|528974199|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
146671420|NCT01433991|528974200|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
146671421|NCT00787891|528974203|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
146671422|NCT00787891|528974204|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
146671423|NCT00787891|528974203|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
146671424|NCT00787891|528974204|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
146671425|NCT00787891|528974203|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
146671426|NCT00787891|528974204|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
146671427|NCT00787891|528974203|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
146671428|NCT00787891|528974204|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
146671429|NCT00787891|528974203|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
146671430|NCT00787891|528974204|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
146671431|NCT00787891|528974203|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
146671432|NCT00787891|528974204|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
146671433|NCT00787891|528974203|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
146671434|NCT00787891|528974204|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
146671435|NCT00787891|528974203|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
146671436|NCT00787891|528974204|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
146671437|NCT00787891|528974203|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
146671438|NCT00787891|528974204|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
146671439|NCT00787891|528974203|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
146671440|NCT00787891|528974204|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
146671441|NCT01673867|528974207|FG000|Randomization|Adverse event unrelated to study drug|1|||
146671442|NCT01673867|528974208|FG001|Randomization|Adverse event unrelated to study drug|0|||
146671443|NCT01673867|528974207|FG000|Randomization|Participant request to discontinue study treatment|0|||
146671444|NCT01673867|528974208|FG001|Randomization|Participant request to discontinue study treatment|4|||
146671445|NCT01673867|528974207|FG000|Randomization|Withdrawal by participant|0|||
146671446|NCT01673867|528974208|FG001|Randomization|Withdrawal by participant|12|||
146671447|NCT01673867|528974207|FG000|Randomization|Lost to Follow-up|0|||
146671448|NCT01673867|528974208|FG001|Randomization|Lost to Follow-up|1|||
146671449|NCT01673867|528974207|FG000|Randomization|Participant no longer meets study criteria|4|||
146671450|NCT01673867|528974208|FG001|Randomization|Participant no longer meets study criteria|5|||
146671451|NCT01673867|528974207|FG000|Treatment|Disease Progression|208|||
146671452|NCT01673867|528974208|FG001|Treatment|Disease Progression|178|||
146671453|NCT01673867|528974207|FG000|Treatment|Study Drug Toxicity|23|||
146671454|NCT01673867|528974208|FG001|Treatment|Study Drug Toxicity|43|||
146671455|NCT01673867|528974207|FG000|Treatment|Death|2|||
146671456|NCT01673867|528974208|FG001|Treatment|Death|3|||
146671457|NCT01673867|528974207|FG000|Treatment|Adverse event unrelated to study drug|23|||
146671458|NCT01673867|528974208|FG001|Treatment|Adverse event unrelated to study drug|10|||
146671459|NCT01673867|528974207|FG000|Treatment|Participant request to discontinue study treatment|7|||
146671460|NCT01673867|528974208|FG001|Treatment|Participant request to discontinue study treatment|17|||
146925891|NCT02720016|529888400|FG000|Overall Study|Withdrawal by Subject|6|||
146925892|NCT02720016|529888401|FG001|Overall Study|Withdrawal by Subject|6|||
146978770|NCT01113710|530085494|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
146671461|NCT01673867|528974207|FG000|Treatment|Withdrawal by participant|5|||
146671462|NCT01673867|528974208|FG001|Treatment|Withdrawal by participant|5|||
146671463|NCT01673867|528974207|FG000|Treatment|Maximum clinical benefit|1|||
146671464|NCT01673867|528974208|FG001|Treatment|Maximum clinical benefit|10|||
146671465|NCT01673867|528974207|FG000|Treatment|Participant no longer meets study criteria|2|||
146671466|NCT01673867|528974208|FG001|Treatment|Participant no longer meets study criteria|0|||
146671467|NCT01673867|528974207|FG000|Treatment|Administrative reason by sponsor|3|||
146671468|NCT01673867|528974208|FG001|Treatment|Administrative reason by sponsor|0|||
146671469|NCT01673867|528974207|FG000|Treatment|Other reason|11|||
146671470|NCT01673867|528974208|FG001|Treatment|Other reason|2|||
146671471|NCT03486223|528974216|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
146671472|NCT03486223|528974217|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
146671473|NCT01819831|528974220|FG000|Overall Study|Withdrawal by Subject|1|||
146671474|NCT01513343|528974221|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
146671475|NCT01513343|528974222|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
146671476|NCT01513343|528974221|FG000|Post Data Collection|Dropped/withdrew from study|7|||
146671477|NCT01513343|528974222|FG001|Post Data Collection|Dropped/withdrew from study|1|||
146671478|NCT01513343|528974221|FG000|Post Data Collection|Lost to Follow-up|10|||
146671479|NCT01513343|528974222|FG001|Post Data Collection|Lost to Follow-up|23|||
146671480|NCT01513343|528974221|FG000|6-month Follow-up|Lost to Follow-up|28|||
146671481|NCT01513343|528974222|FG001|6-month Follow-up|Lost to Follow-up|17|||
146671482|NCT01513343|528974221|FG000|12-month Follow-up|Lost to Follow-up|10|||
146671483|NCT01513343|528974222|FG001|12-month Follow-up|Lost to Follow-up|3|||
146671484|NCT00724932|528974240|FG000|Overall Study|Lost to Follow-up|1|||
146671485|NCT00724932|528974241|FG001|Overall Study|Lost to Follow-up|0|||
146671486|NCT00724932|528974240|FG000|Overall Study|Not treated|4|||
146671487|NCT00724932|528974241|FG001|Overall Study|Not treated|3|||
146671488|NCT03758066|528974243|FG000|Overall Study|Lost to Follow-up|14|||
146671489|NCT02590003|528974244|FG000|Overall Study|Death|1|||
146671490|NCT02590003|528974245|FG001|Overall Study|Death|2|||
146671491|NCT03733470|528974246|FG000|Overall Study|PI Decision|1|||
146671492|NCT03733470|528974247|FG001|Overall Study|PI Decision|1|||
146671493|NCT01849783|528974250|FG000|Overall Study|Adverse Event|5|||
146671494|NCT01849783|528974250|FG000|Overall Study|Death|2|||
146671495|NCT01849783|528974250|FG000|Overall Study|Physician Decision|1|||
146671496|NCT01849783|528974250|FG000|Overall Study|Withdrawal by Subject|1|||
146671497|NCT01849783|528974250|FG000|Overall Study|Unable to comply|2|||
146671498|NCT01849783|528974250|FG000|Overall Study|Disease progression|11|||
146671499|NCT04203498|528974255|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
146671500|NCT04203498|528974256|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
146671501|NCT04203498|528974255|FG000|Overall Study|Withdrawal of patient consent|7|||
146671502|NCT04203498|528974256|FG001|Overall Study|Withdrawal of patient consent|2|||
146671503|NCT04203498|528974255|FG000|Overall Study|Adverse Event|4|||
146671504|NCT04203498|528974256|FG001|Overall Study|Adverse Event|1|||
146671505|NCT04203498|528974255|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
146671506|NCT04203498|528974256|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
146671507|NCT04203498|528974255|FG000|Overall Study|Did not receive IMP|2|||
146671508|NCT04203498|528974256|FG001|Overall Study|Did not receive IMP|0|||
146671509|NCT03988088|528974262|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
146671510|NCT03988088|528974263|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
146671511|NCT03988088|528974264|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
146671512|NCT03988088|528974265|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
146671513|NCT03988088|528974262|FG000|Open-Label Addendum|Lost to Follow-up|0|||
146671514|NCT03988088|528974263|FG001|Open-Label Addendum|Lost to Follow-up|0|||
146671515|NCT03988088|528974264|FG002|Open-Label Addendum|Lost to Follow-up|1|||
146671516|NCT03988088|528974265|FG003|Open-Label Addendum|Lost to Follow-up|0|||
146671517|NCT03546062|528974266|FG000|Overall Study|Adverse Event|6|||
146671518|NCT03546062|528974267|FG001|Overall Study|Adverse Event|5|||
146671519|NCT03546062|528974268|FG002|Overall Study|Adverse Event|8|||
146671520|NCT00781274|528974269|FG000|Overall Study|Withdrawal by Subject|2|||
146774053|NCT04723394|529343513|FG001|Overall Study|Physician Decision|0|||
146774054|NCT04723394|529343512|FG000|Overall Study|Withdrawal by Subject|20|||
146925893|NCT02720016|529888402|FG002|Overall Study|Withdrawal by Subject|4|||
146671521|NCT01090492|528974270|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
146671522|NCT01090492|528974271|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
146774055|NCT04723394|529343513|FG001|Overall Study|Withdrawal by Subject|34|||
146774056|NCT04723394|529343512|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
146925894|NCT02720016|529888400|FG000|Overall Study|Scheduling issues|2|||
146671523|NCT01090492|528974272|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
146671524|NCT01090492|528974273|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
146774057|NCT04723394|529343513|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
146671525|NCT01090492|528974274|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
146671526|NCT01090492|528974275|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
146671527|NCT01090492|528974276|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
146671528|NCT01090492|528974277|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
146925895|NCT02720016|529888401|FG001|Overall Study|Scheduling issues|4|||
146925896|NCT02720016|529888402|FG002|Overall Study|Scheduling issues|7|||
146925897|NCT02720016|529888400|FG000|Overall Study|Childcare|2|||
146925898|NCT02720016|529888401|FG001|Overall Study|Childcare|0|||
146925899|NCT02720016|529888402|FG002|Overall Study|Childcare|2|||
146925900|NCT02720016|529888400|FG000|Overall Study|Withdrawal by PI|2|||
146925901|NCT02720016|529888401|FG001|Overall Study|Withdrawal by PI|2|||
146925902|NCT02720016|529888402|FG002|Overall Study|Withdrawal by PI|0|||
146925903|NCT02720016|529888400|FG000|Overall Study|Moved away|2|||
146925904|NCT02720016|529888401|FG001|Overall Study|Moved away|0|||
146925905|NCT02720016|529888402|FG002|Overall Study|Moved away|0|||
146925906|NCT02720016|529888400|FG000|Overall Study|Not Primary Health Concern|0|||
146925907|NCT02720016|529888401|FG001|Overall Study|Not Primary Health Concern|0|||
146925908|NCT02720016|529888402|FG002|Overall Study|Not Primary Health Concern|2|||
146925909|NCT02720016|529888400|FG000|Overall Study|Transportation issues|0|||
146925910|NCT02720016|529888401|FG001|Overall Study|Transportation issues|0|||
146925911|NCT02720016|529888402|FG002|Overall Study|Transportation issues|1|||
146925912|NCT02720016|529888400|FG000|Overall Study|Other|0|||
146774058|NCT00371787|529343514|FG000|Overall Study|Withdrawal by Subject|3|||
146774059|NCT00371787|529343515|FG001|Overall Study|Withdrawal by Subject|1|||
146925913|NCT02720016|529888401|FG001|Overall Study|Other|0|||
146925914|NCT02720016|529888402|FG002|Overall Study|Other|2|||
146925915|NCT00751114|529888405|FG000|Overall Study|Adverse Event|2|||
146671529|NCT01090492|528974270|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
146671530|NCT01090492|528974271|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
146671531|NCT01090492|528974272|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
146671532|NCT01090492|528974273|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
146671533|NCT01090492|528974274|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
146671534|NCT01090492|528974275|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
146671535|NCT01090492|528974276|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
146671536|NCT01090492|528974277|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
146671537|NCT01090492|528974270|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146671538|NCT01090492|528974271|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146671539|NCT01090492|528974272|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
146671540|NCT01090492|528974273|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146671541|NCT01090492|528974274|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146671542|NCT01090492|528974275|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146671543|NCT01090492|528974276|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146671544|NCT01090492|528974277|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146671545|NCT01090492|528974270|FG000|First Intervention Period (4 Weeks)|Other|0|||
146671546|NCT01090492|528974271|FG001|First Intervention Period (4 Weeks)|Other|0|||
146671547|NCT01090492|528974272|FG002|First Intervention Period (4 Weeks)|Other|1|||
146671548|NCT01090492|528974273|FG003|First Intervention Period (4 Weeks)|Other|1|||
146671549|NCT01090492|528974274|FG004|First Intervention Period (4 Weeks)|Other|2|||
146671550|NCT01090492|528974275|FG005|First Intervention Period (4 Weeks)|Other|0|||
146671551|NCT01090492|528974276|FG006|First Intervention Period (4 Weeks)|Other|0|||
146671552|NCT01090492|528974277|FG007|First Intervention Period (4 Weeks)|Other|0|||
146671553|NCT01090492|528974270|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
146671554|NCT01090492|528974271|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
146671555|NCT01090492|528974272|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
146671556|NCT01090492|528974273|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
146671557|NCT01090492|528974274|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
146671558|NCT01090492|528974275|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
146671559|NCT01090492|528974276|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
146671560|NCT01090492|528974277|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
146671561|NCT01090492|528974270|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
146671562|NCT01090492|528974271|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
146671563|NCT01090492|528974272|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
146671564|NCT01090492|528974273|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
146671565|NCT01090492|528974274|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
146671566|NCT01090492|528974275|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
146671567|NCT01090492|528974276|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
146671568|NCT01090492|528974277|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
146671569|NCT01090492|528974270|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
146671570|NCT01090492|528974271|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
146925916|NCT00751114|529888406|FG001|Overall Study|Adverse Event|4|||
146925917|NCT00751114|529888405|FG000|Overall Study|Protocol Violation|8|||
146925918|NCT00751114|529888406|FG001|Overall Study|Protocol Violation|9|||
146925919|NCT00751114|529888405|FG000|Overall Study|Withdrawal by Subject|9|||
146925920|NCT00751114|529888406|FG001|Overall Study|Withdrawal by Subject|4|||
146925921|NCT00751114|529888405|FG000|Overall Study|Lost to Follow-up|4|||
146925922|NCT00751114|529888406|FG001|Overall Study|Lost to Follow-up|7|||
146925923|NCT00751114|529888405|FG000|Overall Study|Lack of Efficacy|0|||
146925924|NCT00751114|529888406|FG001|Overall Study|Lack of Efficacy|7|||
146925925|NCT00751114|529888405|FG000|Overall Study|Not Treated|13|||
146925926|NCT00751114|529888406|FG001|Overall Study|Not Treated|1|||
146925927|NCT00751114|529888405|FG000|Overall Study|Out of country for 2 months|1|||
146925928|NCT00751114|529888406|FG001|Overall Study|Out of country for 2 months|0|||
146925929|NCT00751114|529888405|FG000|Overall Study|Move to another city|1|||
146925930|NCT00751114|529888406|FG001|Overall Study|Move to another city|0|||
146925931|NCT05319080|529888407|FG000|Overall Study|Withdrawal by Subject|2|||
146925932|NCT05319080|529888407|FG000|Overall Study|Physician Decision|4|||
146925933|NCT02358369|529888408|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
146925934|NCT02358369|529888409|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
146925935|NCT02358369|529888410|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
146925936|NCT02358369|529888411|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
146925937|NCT02358369|529888412|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
146925938|NCT02358369|529888408|FG000|Treatment Period A/B|Adverse Event|0|||
146925939|NCT02358369|529888409|FG001|Treatment Period A/B|Adverse Event|0|||
146925940|NCT02358369|529888410|FG002|Treatment Period A/B|Adverse Event|1|||
146925941|NCT02358369|529888411|FG003|Treatment Period A/B|Adverse Event|2|||
146925942|NCT02358369|529888412|FG004|Treatment Period A/B|Adverse Event|0|||
146925943|NCT02358369|529888408|FG000|Treatment Period A/B|Death|0|||
146925944|NCT02358369|529888409|FG001|Treatment Period A/B|Death|0|||
146925945|NCT02358369|529888410|FG002|Treatment Period A/B|Death|1|||
146925946|NCT02358369|529888411|FG003|Treatment Period A/B|Death|0|||
146925947|NCT02358369|529888412|FG004|Treatment Period A/B|Death|0|||
146925948|NCT02358369|529888408|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
146925949|NCT02358369|529888409|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
146925950|NCT02358369|529888410|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
146925951|NCT02358369|529888411|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
146671571|NCT01090492|528974272|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
146671572|NCT01090492|528974273|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
146671573|NCT01090492|528974274|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
146671574|NCT01090492|528974275|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
146671575|NCT01090492|528974276|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
146671576|NCT01090492|528974277|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
146671577|NCT01090492|528974270|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
146671578|NCT01090492|528974271|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
146671579|NCT01090492|528974272|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
146671580|NCT01090492|528974273|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
146671581|NCT01090492|528974274|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
146671582|NCT01090492|528974275|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
146671583|NCT01090492|528974276|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
146671584|NCT01090492|528974277|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
146671585|NCT01090492|528974270|FG000|Second Intervention Period (4 Weeks)|Other|0|||
146671586|NCT01090492|528974271|FG001|Second Intervention Period (4 Weeks)|Other|1|||
146671587|NCT01090492|528974272|FG002|Second Intervention Period (4 Weeks)|Other|1|||
146671588|NCT01090492|528974273|FG003|Second Intervention Period (4 Weeks)|Other|0|||
146671589|NCT01090492|528974274|FG004|Second Intervention Period (4 Weeks)|Other|0|||
146671590|NCT01090492|528974275|FG005|Second Intervention Period (4 Weeks)|Other|0|||
146671591|NCT01090492|528974276|FG006|Second Intervention Period (4 Weeks)|Other|0|||
146671592|NCT01090492|528974277|FG007|Second Intervention Period (4 Weeks)|Other|0|||
146671593|NCT01090492|528974270|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
146671594|NCT01090492|528974271|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
146671595|NCT01090492|528974272|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
146671596|NCT01090492|528974273|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
146671597|NCT01090492|528974274|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
146671598|NCT01090492|528974275|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
146671599|NCT01090492|528974276|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
146671600|NCT01090492|528974277|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
146671601|NCT01090492|528974270|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146671602|NCT01090492|528974271|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146671603|NCT01090492|528974272|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146671604|NCT01090492|528974273|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146671605|NCT01090492|528974274|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146671606|NCT01090492|528974275|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146671607|NCT01090492|528974276|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
146925952|NCT02358369|529888412|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
146925953|NCT02358369|529888408|FG000|Treatment Period C|Adverse Event|0|||
146925954|NCT02358369|529888409|FG001|Treatment Period C|Adverse Event|0|||
146925955|NCT02358369|529888410|FG002|Treatment Period C|Adverse Event|0|||
146925956|NCT02358369|529888411|FG003|Treatment Period C|Adverse Event|0|||
146925957|NCT02358369|529888412|FG004|Treatment Period C|Adverse Event|7|||
146925958|NCT00448916|529888413|FG000|Overall Study|Adverse Event|2|||
146925959|NCT00448916|529888414|FG001|Overall Study|Adverse Event|2|||
146925960|NCT00448916|529888415|FG002|Overall Study|Adverse Event|3|||
146925961|NCT00448916|529888416|FG003|Overall Study|Adverse Event|2|||
146671608|NCT01090492|528974277|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146671609|NCT00868608|528974278|FG000|Overall Study|Withdrawal by Subject|3|||
146671610|NCT00868608|528974279|FG001|Overall Study|Withdrawal by Subject|1|||
146671611|NCT00868608|528974280|FG002|Overall Study|Withdrawal by Subject|0|||
146671612|NCT00868608|528974278|FG000|Overall Study|Lost to Follow-up|3|||
146671613|NCT00868608|528974279|FG001|Overall Study|Lost to Follow-up|0|||
146671614|NCT00868608|528974280|FG002|Overall Study|Lost to Follow-up|1|||
146671615|NCT00868608|528974278|FG000|Overall Study|Death|16|||
146671616|NCT00868608|528974279|FG001|Overall Study|Death|2|||
146671617|NCT00868608|528974280|FG002|Overall Study|Death|4|||
146671618|NCT00868608|528974278|FG000|Overall Study|Other - Unspecified|1|||
146671619|NCT00868608|528974279|FG001|Overall Study|Other - Unspecified|0|||
146671620|NCT00868608|528974280|FG002|Overall Study|Other - Unspecified|0|||
146671621|NCT02935842|528974281|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
146671622|NCT02935842|528974282|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
146671623|NCT02935842|528974283|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
146671624|NCT02935842|528974284|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
146671625|NCT02935842|528974281|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
146671626|NCT02935842|528974282|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
146671627|NCT02935842|528974283|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
146671628|NCT02935842|528974284|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
146671629|NCT02935842|528974281|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
146671630|NCT02935842|528974282|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
146671631|NCT02935842|528974283|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
146671632|NCT02935842|528974284|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
146671633|NCT02935842|528974281|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
146671634|NCT02935842|528974282|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
146671635|NCT02935842|528974283|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
146671636|NCT02935842|528974284|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
146671637|NCT02935842|528974281|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
146978771|NCT01113710|530085494|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
146978772|NCT01113710|530085494|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
146978773|NCT01113710|530085494|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
146978774|NCT01113710|530085494|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
146978775|NCT01113710|530085494|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
146978776|NCT01113710|530085494|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
146925962|NCT00448916|529888413|FG000|Overall Study|Lack of Efficacy|1|||
146925963|NCT00448916|529888414|FG001|Overall Study|Lack of Efficacy|0|||
146978777|NCT01113710|530085494|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
146671638|NCT02935842|528974282|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
146671639|NCT02935842|528974283|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
146671640|NCT02935842|528974284|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
146671641|NCT00911547|528974285|FG000|Overall Study|Adverse Event|8|||
146671642|NCT00911547|528974286|FG001|Overall Study|Adverse Event|27|||
146671643|NCT00911547|528974287|FG002|Overall Study|Adverse Event|11|||
146671644|NCT00911547|528974288|FG003|Overall Study|Adverse Event|6|||
146671645|NCT00911547|528974285|FG000|Overall Study|Lost to Follow-up|0|||
146671646|NCT00911547|528974286|FG001|Overall Study|Lost to Follow-up|0|||
146671647|NCT00911547|528974287|FG002|Overall Study|Lost to Follow-up|2|||
146671648|NCT00911547|528974288|FG003|Overall Study|Lost to Follow-up|1|||
146671649|NCT00911547|528974285|FG000|Overall Study|Protocol Violation|0|||
146671650|NCT00911547|528974286|FG001|Overall Study|Protocol Violation|5|||
146671651|NCT00911547|528974287|FG002|Overall Study|Protocol Violation|5|||
146671652|NCT00911547|528974288|FG003|Overall Study|Protocol Violation|1|||
146671653|NCT00911547|528974285|FG000|Overall Study|Withdrawal by Subject|3|||
146671654|NCT00911547|528974286|FG001|Overall Study|Withdrawal by Subject|10|||
146671655|NCT00911547|528974287|FG002|Overall Study|Withdrawal by Subject|4|||
146671656|NCT00911547|528974288|FG003|Overall Study|Withdrawal by Subject|8|||
146671657|NCT03344796|528974289|FG000|Overall Study|Lost to Follow-up|0|||
146671658|NCT03344796|528974290|FG001|Overall Study|Lost to Follow-up|0|||
146671659|NCT03344796|528974291|FG002|Overall Study|Lost to Follow-up|0|||
146671660|NCT03344796|528974292|FG003|Overall Study|Lost to Follow-up|0|||
146978778|NCT01113710|530085494|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
146978779|NCT01113710|530085494|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
146671661|NCT03344796|528974293|FG004|Overall Study|Lost to Follow-up|0|||
146671662|NCT03344796|528974294|FG005|Overall Study|Lost to Follow-up|2|||
146671663|NCT00001880|528974303|FG000|Overall Study|Death|14|||
146671664|NCT00481078|528974304|FG000|Overall Study|Progression of disease|11|||
146671665|NCT00481078|528974305|FG001|Overall Study|Progression of disease|11|||
146671666|NCT00481078|528974304|FG000|Overall Study|Adverse Event|15|||
146671667|NCT00481078|528974305|FG001|Overall Study|Adverse Event|3|||
146671668|NCT00481078|528974304|FG000|Overall Study|Death|5|||
146671669|NCT00481078|528974305|FG001|Overall Study|Death|3|||
146671670|NCT00481078|528974304|FG000|Overall Study|Intercurrent illness|1|||
146671671|NCT00481078|528974305|FG001|Overall Study|Intercurrent illness|0|||
146671672|NCT00481078|528974304|FG000|Overall Study|Withdrawal by Subject|7|||
146671673|NCT00481078|528974305|FG001|Overall Study|Withdrawal by Subject|1|||
146671674|NCT00481078|528974304|FG000|Overall Study|Information not available|1|||
146671675|NCT00481078|528974305|FG001|Overall Study|Information not available|0|||
146671676|NCT00481078|528974304|FG000|Overall Study|Received other treatment|2|||
146671677|NCT00481078|528974305|FG001|Overall Study|Received other treatment|1|||
146671678|NCT00481078|528974304|FG000|Overall Study|Brain metastasis|0|||
146671679|NCT00481078|528974305|FG001|Overall Study|Brain metastasis|1|||
146671680|NCT05695209|528974310|FG000|3-months|Withdrawal by Subject|2|||
146671681|NCT05695209|528974311|FG001|3-months|Withdrawal by Subject|0|||
146671682|NCT05695209|528974310|FG000|3-months|Unable to contact for 3-month data collection|0|||
146671683|NCT05695209|528974311|FG001|3-months|Unable to contact for 3-month data collection|1|||
146671684|NCT05695209|528974310|FG000|6-months|Lost to Follow-up|1|||
146671685|NCT05695209|528974311|FG001|6-months|Lost to Follow-up|1|||
146925964|NCT00448916|529888415|FG002|Overall Study|Lack of Efficacy|2|||
146671686|NCT05372419|528974312|FG000|Overall Study|Protocol Deviation|1|||
146671687|NCT05372419|528974312|FG000|Overall Study|Withdrawal by Subject|5|||
146671688|NCT05372419|528974312|FG000|Overall Study|Lost to Follow-up|7|||
146671689|NCT04362072|528974315|FG000|Treatment|Adverse Event|1|||
146671690|NCT04362072|528974315|FG000|Treatment|Death|9|||
146671691|NCT04362072|528974315|FG000|Treatment|Physician Decision|2|||
146671692|NCT04362072|528974315|FG000|Treatment|Progressive disease|27|||
146671693|NCT04362072|528974315|FG000|Treatment|Withdrawal by Subject|4|||
146671694|NCT04362072|528974315|FG000|Treatment|Global deterioration of health status|1|||
146671695|NCT04362072|528974315|FG000|Treatment|Switched to commercial Lorlatinib|13|||
146671696|NCT04362072|528974315|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
146671697|NCT04362072|528974315|FG000|Treatment|Other|3|||
146671698|NCT04362072|528974315|FG000|Follow up|Death|2|||
146671699|NCT04362072|528974315|FG000|Follow up|Other|2|||
146671700|NCT04731363|528974316|FG000|Overall Study|Could not obtain samples|0|||
146671701|NCT04731363|528974317|FG001|Overall Study|Could not obtain samples|1|||
146671702|NCT04731363|528974318|FG002|Overall Study|Could not obtain samples|0|||
146671703|NCT04731363|528974319|FG003|Overall Study|Could not obtain samples|0|||
146671704|NCT04731363|528974316|FG000|Overall Study|Physician Decision|0|||
146671705|NCT04731363|528974317|FG001|Overall Study|Physician Decision|1|||
146671706|NCT04731363|528974318|FG002|Overall Study|Physician Decision|0|||
146671707|NCT04731363|528974319|FG003|Overall Study|Physician Decision|0|||
146671708|NCT00290888|528975906|FG000|Overall Study|Physician Decision|3|||
146671709|NCT00290888|528975907|FG001|Overall Study|Physician Decision|1|||
146671710|NCT02034110|528975912|FG000|Overall Study|Physician Decision|0|||
146671711|NCT02034110|528975913|FG001|Overall Study|Physician Decision|0|||
146671712|NCT02034110|528975914|FG002|Overall Study|Physician Decision|0|||
146671713|NCT02034110|528975915|FG003|Overall Study|Physician Decision|0|||
146671714|NCT02034110|528975916|FG004|Overall Study|Physician Decision|2|||
146671715|NCT02034110|528975917|FG005|Overall Study|Physician Decision|0|||
146671716|NCT02034110|528975918|FG006|Overall Study|Physician Decision|1|||
146671717|NCT02034110|528975919|FG007|Overall Study|Physician Decision|0|||
146671718|NCT02034110|528975912|FG000|Overall Study|Lost to Follow-up|1|||
146671719|NCT02034110|528975913|FG001|Overall Study|Lost to Follow-up|0|||
146671720|NCT02034110|528975914|FG002|Overall Study|Lost to Follow-up|0|||
146671721|NCT02034110|528975915|FG003|Overall Study|Lost to Follow-up|0|||
146671722|NCT02034110|528975916|FG004|Overall Study|Lost to Follow-up|1|||
146671723|NCT02034110|528975917|FG005|Overall Study|Lost to Follow-up|0|||
146671724|NCT02034110|528975918|FG006|Overall Study|Lost to Follow-up|1|||
146671725|NCT02034110|528975919|FG007|Overall Study|Lost to Follow-up|0|||
146671726|NCT02034110|528975912|FG000|Overall Study|Withdrawal by Subject|5|||
146671727|NCT02034110|528975913|FG001|Overall Study|Withdrawal by Subject|7|||
146671728|NCT02034110|528975914|FG002|Overall Study|Withdrawal by Subject|0|||
146671729|NCT02034110|528975915|FG003|Overall Study|Withdrawal by Subject|3|||
146671730|NCT02034110|528975916|FG004|Overall Study|Withdrawal by Subject|7|||
146671731|NCT02034110|528975917|FG005|Overall Study|Withdrawal by Subject|0|||
146671732|NCT02034110|528975918|FG006|Overall Study|Withdrawal by Subject|3|||
146671733|NCT02034110|528975919|FG007|Overall Study|Withdrawal by Subject|1|||
146671734|NCT02034110|528975912|FG000|Overall Study|Study closed by sponsor|6|||
146671735|NCT02034110|528975913|FG001|Overall Study|Study closed by sponsor|2|||
146671736|NCT02034110|528975914|FG002|Overall Study|Study closed by sponsor|0|||
146671737|NCT02034110|528975915|FG003|Overall Study|Study closed by sponsor|6|||
146671738|NCT02034110|528975916|FG004|Overall Study|Study closed by sponsor|7|||
146671739|NCT02034110|528975917|FG005|Overall Study|Study closed by sponsor|0|||
146671740|NCT02034110|528975918|FG006|Overall Study|Study closed by sponsor|42|||
146671741|NCT02034110|528975919|FG007|Overall Study|Study closed by sponsor|0|||
146925965|NCT00448916|529888416|FG003|Overall Study|Lack of Efficacy|1|||
146671742|NCT02587234|528975920|FG000|Overall Study|Withdrawal by Subject|1|||
146671743|NCT02587234|528975921|FG001|Overall Study|Withdrawal by Subject|1|||
146671744|NCT02587234|528975920|FG000|Overall Study|Lost to Follow-up|0|||
146671745|NCT02587234|528975921|FG001|Overall Study|Lost to Follow-up|2|||
146671746|NCT00590720|528975922|FG000|Overall Study|Lost to Follow-up|1|||
146671747|NCT00590720|528975923|FG001|Overall Study|Lost to Follow-up|0|||
146671748|NCT00590720|528975922|FG000|Overall Study|Withdrawal by Subject|0|||
146671749|NCT00590720|528975923|FG001|Overall Study|Withdrawal by Subject|1|||
146671750|NCT01001377|528975925|FG000|Overall Study|Ineligibility determined|2|||
146671751|NCT01001377|528975926|FG001|Overall Study|Ineligibility determined|0|||
146671752|NCT01001377|528975925|FG000|Overall Study|Withdrawal by Subject|19|||
146671753|NCT01001377|528975926|FG001|Overall Study|Withdrawal by Subject|20|||
146671754|NCT01001377|528975925|FG000|Overall Study|Lost to Follow-up|14|||
146671755|NCT01001377|528975926|FG001|Overall Study|Lost to Follow-up|17|||
146671756|NCT01001377|528975925|FG000|Overall Study|Death|391|||
146671757|NCT01001377|528975926|FG001|Overall Study|Death|384|||
146671758|NCT03039283|528975930|FG000|Overall Study|Protocol Violation|2|||
146671759|NCT02732119|528975931|FG000|Phase I|Adverse Event|1|||
146671760|NCT02732119|528975932|FG001|Phase I|Adverse Event|3|||
146671761|NCT02732119|528975933|FG002|Phase I|Adverse Event|1|||
146671762|NCT02732119|528975934|FG003|Phase I|Adverse Event|0|||
146671763|NCT02732119|528975935|FG004|Phase I|Adverse Event|0|||
146671764|NCT02732119|528975931|FG000|Phase I|Progressive disease|7|||
146671765|NCT02732119|528975932|FG001|Phase I|Progressive disease|3|||
146671766|NCT02732119|528975933|FG002|Phase I|Progressive disease|2|||
146671767|NCT02732119|528975934|FG003|Phase I|Progressive disease|0|||
146671768|NCT02732119|528975935|FG004|Phase I|Progressive disease|0|||
146671769|NCT02732119|528975931|FG000|Phase I|Protocol deviation|0|||
146925966|NCT00448916|529888413|FG000|Overall Study|Withdrawal by Subject|3|||
146925967|NCT00448916|529888414|FG001|Overall Study|Withdrawal by Subject|3|||
146925968|NCT00448916|529888415|FG002|Overall Study|Withdrawal by Subject|1|||
146671770|NCT02732119|528975932|FG001|Phase I|Protocol deviation|1|||
146671771|NCT02732119|528975933|FG002|Phase I|Protocol deviation|0|||
146671772|NCT02732119|528975934|FG003|Phase I|Protocol deviation|0|||
146671773|NCT02732119|528975935|FG004|Phase I|Protocol deviation|0|||
146671774|NCT02732119|528975931|FG000|Phase I|Physician Decision|0|||
146671775|NCT02732119|528975932|FG001|Phase I|Physician Decision|3|||
146671776|NCT02732119|528975933|FG002|Phase I|Physician Decision|4|||
146671777|NCT02732119|528975934|FG003|Phase I|Physician Decision|0|||
146671778|NCT02732119|528975935|FG004|Phase I|Physician Decision|0|||
146671779|NCT02732119|528975931|FG000|Phase II|Adverse Event|0|||
146671780|NCT02732119|528975932|FG001|Phase II|Adverse Event|0|||
146671781|NCT02732119|528975933|FG002|Phase II|Adverse Event|0|||
146671782|NCT02732119|528975934|FG003|Phase II|Adverse Event|3|||
146671783|NCT02732119|528975935|FG004|Phase II|Adverse Event|3|||
146671784|NCT02732119|528975931|FG000|Phase II|Death|0|||
146671785|NCT02732119|528975932|FG001|Phase II|Death|0|||
146671786|NCT02732119|528975933|FG002|Phase II|Death|0|||
146671787|NCT02732119|528975934|FG003|Phase II|Death|1|||
146671788|NCT02732119|528975935|FG004|Phase II|Death|0|||
146671789|NCT02732119|528975931|FG000|Phase II|Progressive dissease|0|||
146671790|NCT02732119|528975932|FG001|Phase II|Progressive dissease|0|||
146671791|NCT02732119|528975933|FG002|Phase II|Progressive dissease|0|||
146671792|NCT02732119|528975934|FG003|Phase II|Progressive dissease|30|||
146671793|NCT02732119|528975935|FG004|Phase II|Progressive dissease|23|||
146671794|NCT02732119|528975931|FG000|Phase II|Study terminated by sponsor|0|||
146671795|NCT02732119|528975932|FG001|Phase II|Study terminated by sponsor|0|||
146671796|NCT02732119|528975933|FG002|Phase II|Study terminated by sponsor|0|||
146671797|NCT02732119|528975934|FG003|Phase II|Study terminated by sponsor|2|||
146671798|NCT02732119|528975935|FG004|Phase II|Study terminated by sponsor|2|||
146671799|NCT02732119|528975931|FG000|Phase II|Other|0|||
146671800|NCT02732119|528975932|FG001|Phase II|Other|0|||
146671801|NCT02732119|528975933|FG002|Phase II|Other|0|||
146925969|NCT00448916|529888416|FG003|Overall Study|Withdrawal by Subject|1|||
146925970|NCT00448916|529888413|FG000|Overall Study|Other|1|||
146671802|NCT02732119|528975934|FG003|Phase II|Other|2|||
146671803|NCT02732119|528975935|FG004|Phase II|Other|0|||
146671804|NCT02732119|528975931|FG000|Phase II|Physician Decision|0|||
146671805|NCT02732119|528975932|FG001|Phase II|Physician Decision|0|||
146671806|NCT02732119|528975933|FG002|Phase II|Physician Decision|0|||
146671807|NCT02732119|528975934|FG003|Phase II|Physician Decision|8|||
146671808|NCT02732119|528975935|FG004|Phase II|Physician Decision|5|||
146671809|NCT00964860|528975936|FG000|Overall Study|Withdrawal by Subject|0|||
146671810|NCT00964860|528975937|FG001|Overall Study|Withdrawal by Subject|1|||
146925971|NCT00448916|529888414|FG001|Overall Study|Other|0|||
146925972|NCT00448916|529888415|FG002|Overall Study|Other|0|||
146671811|NCT00867568|528975938|FG000|Overall Study|Lack of Efficacy|10|||
146671812|NCT00867568|528975938|FG000|Overall Study|Adverse Event|4|||
146671813|NCT00867568|528975938|FG000|Overall Study|Withdrawal by Subject|1|||
146671814|NCT01056653|528975939|FG000|Overall Study|Lost to Follow-up|0|||
146671815|NCT01056653|528975940|FG001|Overall Study|Lost to Follow-up|0|||
146671816|NCT01056653|528975941|FG002|Overall Study|Lost to Follow-up|2|||
146671817|NCT03639935|528975942|FG000|Overall Study|Death|3|||
146671818|NCT03639935|528975942|FG000|Overall Study|Adverse Event|1|||
146671819|NCT03727230|528975944|FG000|Overall Study|Lost to Follow-up|12|||
146671820|NCT04377620|528975946|FG000|Overall Study|Death|42|||
146671821|NCT04377620|528975947|FG001|Overall Study|Death|48|||
146671822|NCT04377620|528975948|FG002|Overall Study|Death|36|||
146671823|NCT04377620|528975946|FG000|Overall Study|Withdrawal by Subject|0|||
146671824|NCT04377620|528975947|FG001|Overall Study|Withdrawal by Subject|2|||
146671825|NCT04377620|528975948|FG002|Overall Study|Withdrawal by Subject|0|||
146671826|NCT02059395|528975949|FG000|Overall Study|Lost to Follow-up|2|||
146671827|NCT02059395|528975950|FG001|Overall Study|Lost to Follow-up|4|||
146671828|NCT00134082|528975951|FG000|Overall Study|Adverse Event|2|||
146671829|NCT00134082|528975951|FG000|Overall Study|Death|1|||
146671830|NCT01606007|528975952|FG000|Overall Study|Reason 'Other' in the protocol|0|||
146671831|NCT01606007|528975953|FG001|Overall Study|Reason 'Other' in the protocol|1|||
146671832|NCT01606007|528975954|FG002|Overall Study|Reason 'Other' in the protocol|1|||
146671833|NCT01606007|528975952|FG000|Overall Study|Pregnancy|0|||
146671834|NCT01606007|528975953|FG001|Overall Study|Pregnancy|1|||
146671835|NCT01606007|528975954|FG002|Overall Study|Pregnancy|1|||
146671836|NCT01606007|528975952|FG000|Overall Study|Withdrawal by Subject|8|||
146671837|NCT01606007|528975953|FG001|Overall Study|Withdrawal by Subject|6|||
146671838|NCT01606007|528975954|FG002|Overall Study|Withdrawal by Subject|1|||
146671839|NCT01606007|528975952|FG000|Overall Study|Adverse Event|0|||
146671840|NCT01606007|528975953|FG001|Overall Study|Adverse Event|1|||
146671841|NCT01606007|528975954|FG002|Overall Study|Adverse Event|1|||
146671842|NCT01606007|528975952|FG000|Overall Study|discontinue study treatment|0|||
146671843|NCT01606007|528975953|FG001|Overall Study|discontinue study treatment|2|||
146671844|NCT01606007|528975954|FG002|Overall Study|discontinue study treatment|1|||
146671845|NCT01606007|528975952|FG000|Overall Study|Lost to Follow-up|6|||
146671846|NCT01606007|528975953|FG001|Overall Study|Lost to Follow-up|8|||
146671847|NCT01606007|528975954|FG002|Overall Study|Lost to Follow-up|5|||
146671848|NCT01606007|528975952|FG000|Overall Study|Poor/Non-compliance|1|||
146671849|NCT01606007|528975953|FG001|Overall Study|Poor/Non-compliance|0|||
146671850|NCT01606007|528975954|FG002|Overall Study|Poor/Non-compliance|0|||
146671851|NCT03095612|528975966|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
146671852|NCT03095612|528975967|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
146671853|NCT03095612|528975968|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
146671854|NCT03095612|528975969|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
146671855|NCT03095612|528975970|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
146671856|NCT03095612|528975971|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
146671857|NCT03095612|528975972|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
146671858|NCT04447794|528975973|FG000|Overall Study|Lost to Follow-up|2|||
146671859|NCT04447794|528975974|FG001|Overall Study|Lost to Follow-up|3|||
146671860|NCT04447794|528975975|FG002|Overall Study|Lost to Follow-up|8|||
146671861|NCT04447794|528975973|FG000|Overall Study|Withdrawal by Subject|1|||
146671862|NCT04447794|528975974|FG001|Overall Study|Withdrawal by Subject|1|||
146671863|NCT04447794|528975975|FG002|Overall Study|Withdrawal by Subject|0|||
146671864|NCT01235689|528975976|FG000|Overall Study|Adverse Event|12|||
146671865|NCT01235689|528975977|FG001|Overall Study|Adverse Event|16|||
146671866|NCT01235689|528975976|FG000|Overall Study|Lack of Efficacy|12|||
146671867|NCT01235689|528975977|FG001|Overall Study|Lack of Efficacy|5|||
146671868|NCT01235689|528975976|FG000|Overall Study|Withdrawal by Subject|3|||
146671869|NCT01235689|528975977|FG001|Overall Study|Withdrawal by Subject|4|||
146671870|NCT01235689|528975976|FG000|Overall Study|Lost to Follow-up|1|||
146671871|NCT01235689|528975977|FG001|Overall Study|Lost to Follow-up|2|||
146671872|NCT01235689|528975976|FG000|Overall Study|Miscellaneous|1|||
146671873|NCT01235689|528975977|FG001|Overall Study|Miscellaneous|5|||
146671874|NCT01390649|528975978|FG000|Overall Study|Physician Decision|1|||
146671875|NCT00389597|528975979|FG000|Overall Study|Lost to Follow-up|8|||
146671876|NCT00389597|528975980|FG001|Overall Study|Lost to Follow-up|6|||
146671877|NCT00389597|528975981|FG002|Overall Study|Lost to Follow-up|4|||
146671878|NCT00389597|528975982|FG003|Overall Study|Lost to Follow-up|6|||
146671879|NCT00334958|528975983|FG000|Overall Study|Medication Noncompliance|0|||
146671880|NCT00334958|528975984|FG001|Overall Study|Medication Noncompliance|3|||
146671881|NCT00334958|528975983|FG000|Overall Study|Protocol Violation|2|||
146671882|NCT00334958|528975984|FG001|Overall Study|Protocol Violation|2|||
146671883|NCT00334958|528975983|FG000|Overall Study|Request of the investigator or sponsor|0|||
146671884|NCT00334958|528975984|FG001|Overall Study|Request of the investigator or sponsor|1|||
146671885|NCT00334958|528975983|FG000|Overall Study|Withdrawal by Subject|7|||
146671886|NCT00334958|528975984|FG001|Overall Study|Withdrawal by Subject|4|||
146671887|NCT00334958|528975983|FG000|Overall Study|Adverse Event|27|||
146671888|NCT00334958|528975984|FG001|Overall Study|Adverse Event|12|||
146671889|NCT00334958|528975983|FG000|Overall Study|Other|1|||
146671890|NCT00334958|528975984|FG001|Overall Study|Other|2|||
146671891|NCT04431453|528975985|FG000|Overall Study|Withdrew Consent|0|||
146671892|NCT04431453|528975986|FG001|Overall Study|Withdrew Consent|1|||
146925973|NCT00448916|529888416|FG003|Overall Study|Other|0|||
146925974|NCT00448916|529888413|FG000|Overall Study|Lost to Follow-up|0|||
146925975|NCT00448916|529888414|FG001|Overall Study|Lost to Follow-up|1|||
146925976|NCT00448916|529888415|FG002|Overall Study|Lost to Follow-up|0|||
146925977|NCT00448916|529888416|FG003|Overall Study|Lost to Follow-up|1|||
146925978|NCT00448916|529888413|FG000|Overall Study|Protocol Violation|0|||
146925979|NCT00448916|529888414|FG001|Overall Study|Protocol Violation|0|||
146925980|NCT00448916|529888415|FG002|Overall Study|Protocol Violation|0|||
146925981|NCT00448916|529888416|FG003|Overall Study|Protocol Violation|1|||
146925982|NCT03655717|529888417|FG000|Overall Study|Withdrawal by Subject|4|||
146925983|NCT03655717|529888418|FG001|Overall Study|Withdrawal by Subject|8|||
146671893|NCT04431453|528975987|FG002|Overall Study|Withdrew Consent|0|||
146671894|NCT04431453|528975988|FG003|Overall Study|Withdrew Consent|2|||
146671895|NCT04431453|528975989|FG004|Overall Study|Withdrew Consent|0|||
146671896|NCT04431453|528975990|FG005|Overall Study|Withdrew Consent|0|||
146671897|NCT04431453|528975991|FG006|Overall Study|Withdrew Consent|0|||
146671898|NCT04431453|528975992|FG007|Overall Study|Withdrew Consent|0|||
146671899|NCT04431453|528975985|FG000|Overall Study|Death|1|||
146671900|NCT04431453|528975986|FG001|Overall Study|Death|0|||
146671901|NCT04431453|528975987|FG002|Overall Study|Death|0|||
146671902|NCT04431453|528975988|FG003|Overall Study|Death|0|||
146671903|NCT04431453|528975989|FG004|Overall Study|Death|0|||
146671904|NCT04431453|528975990|FG005|Overall Study|Death|0|||
146925984|NCT03655717|529888419|FG002|Overall Study|Withdrawal by Subject|1|||
146925985|NCT03655717|529888420|FG003|Overall Study|Withdrawal by Subject|0|||
146671905|NCT04431453|528975991|FG006|Overall Study|Death|0|||
146671906|NCT04431453|528975992|FG007|Overall Study|Death|1|||
146671907|NCT04431453|528975985|FG000|Overall Study|Lost to Follow-up|0|||
146671908|NCT04431453|528975986|FG001|Overall Study|Lost to Follow-up|0|||
146671909|NCT04431453|528975987|FG002|Overall Study|Lost to Follow-up|1|||
146671910|NCT04431453|528975988|FG003|Overall Study|Lost to Follow-up|1|||
146671911|NCT04431453|528975989|FG004|Overall Study|Lost to Follow-up|0|||
146671912|NCT04431453|528975990|FG005|Overall Study|Lost to Follow-up|0|||
146671913|NCT04431453|528975991|FG006|Overall Study|Lost to Follow-up|0|||
146671914|NCT04431453|528975992|FG007|Overall Study|Lost to Follow-up|0|||
146671915|NCT04431453|528975985|FG000|Overall Study|Enrolled but Never Treated|0|||
146671916|NCT04431453|528975986|FG001|Overall Study|Enrolled but Never Treated|0|||
146671917|NCT04431453|528975987|FG002|Overall Study|Enrolled but Never Treated|0|||
146671918|NCT04431453|528975988|FG003|Overall Study|Enrolled but Never Treated|0|||
146671919|NCT04431453|528975989|FG004|Overall Study|Enrolled but Never Treated|1|||
146671920|NCT04431453|528975990|FG005|Overall Study|Enrolled but Never Treated|0|||
146671921|NCT04431453|528975991|FG006|Overall Study|Enrolled but Never Treated|0|||
146671922|NCT04431453|528975992|FG007|Overall Study|Enrolled but Never Treated|0|||
146671923|NCT00622401|528975993|FG000|Overall Study|Disease progression prior to treatment|3|||
146671924|NCT00622401|528975994|FG001|Overall Study|Disease progression prior to treatment|2|||
146671925|NCT00622401|528975995|FG002|Overall Study|Disease progression prior to treatment|0|||
146671926|NCT02021773|528976002|FG000|Overall Study|Adverse Event|1|||
146671927|NCT02021773|528976003|FG001|Overall Study|Adverse Event|4|||
146671928|NCT02021773|528976004|FG002|Overall Study|Adverse Event|3|||
146671929|NCT02021773|528976002|FG000|Overall Study|Lack of Efficacy|2|||
146671930|NCT02021773|528976003|FG001|Overall Study|Lack of Efficacy|2|||
146671931|NCT02021773|528976004|FG002|Overall Study|Lack of Efficacy|2|||
146671932|NCT02021773|528976002|FG000|Overall Study|Protocol Violation|2|||
146671933|NCT02021773|528976003|FG001|Overall Study|Protocol Violation|3|||
146671934|NCT02021773|528976004|FG002|Overall Study|Protocol Violation|1|||
146671935|NCT02021773|528976002|FG000|Overall Study|Withdrawal by Subject|3|||
146671936|NCT02021773|528976003|FG001|Overall Study|Withdrawal by Subject|4|||
146925986|NCT03655717|529888421|FG004|Overall Study|Withdrawal by Subject|0|||
146671937|NCT02021773|528976004|FG002|Overall Study|Withdrawal by Subject|5|||
146671938|NCT02021773|528976002|FG000|Overall Study|Lost to Follow-up|1|||
146671939|NCT02021773|528976003|FG001|Overall Study|Lost to Follow-up|3|||
146671940|NCT02021773|528976004|FG002|Overall Study|Lost to Follow-up|0|||
146671941|NCT02021773|528976002|FG000|Overall Study|Reason not specified|3|||
146671942|NCT02021773|528976003|FG001|Overall Study|Reason not specified|0|||
146671943|NCT02021773|528976004|FG002|Overall Study|Reason not specified|0|||
146671944|NCT00282984|528976005|FG000|Overall Study|Death|2|||
146671945|NCT00282984|528976006|FG001|Overall Study|Death|5|||
146671946|NCT00282984|528976005|FG000|Overall Study|Adverse Event|8|||
146671947|NCT00282984|528976006|FG001|Overall Study|Adverse Event|5|||
146671948|NCT00282984|528976005|FG000|Overall Study|Lack of Efficacy|0|||
146671949|NCT00282984|528976006|FG001|Overall Study|Lack of Efficacy|2|||
146925987|NCT03655717|529888422|FG005|Overall Study|Withdrawal by Subject|1|||
146671950|NCT00282984|528976005|FG000|Overall Study|Lost to Follow-up|14|||
146671951|NCT00282984|528976006|FG001|Overall Study|Lost to Follow-up|10|||
146671952|NCT00282984|528976005|FG000|Overall Study|Withdrawal by Participant|22|||
146671953|NCT00282984|528976006|FG001|Overall Study|Withdrawal by Participant|34|||
146925988|NCT03655717|529888423|FG006|Overall Study|Withdrawal by Subject|3|||
146671954|NCT00282984|528976005|FG000|Overall Study|Participant stopped study medication|2|||
146774060|NCT01972724|529343516|FG000|Double-Blind|Rescue Criteria Met|1|||
146671955|NCT00282984|528976006|FG001|Overall Study|Participant stopped study medication|2|||
146671956|NCT00282984|528976005|FG000|Overall Study|Participant only allowed phone follow-up|0|||
146671957|NCT00282984|528976006|FG001|Overall Study|Participant only allowed phone follow-up|1|||
146671958|NCT00282984|528976005|FG000|Overall Study|Participant used antipsychosis meds|0|||
146671959|NCT00282984|528976006|FG001|Overall Study|Participant used antipsychosis meds|1|||
146671960|NCT00282984|528976005|FG000|Overall Study|lack of motivation|1|||
146671961|NCT00282984|528976006|FG001|Overall Study|lack of motivation|0|||
146774061|NCT01972724|529343517|FG001|Double-Blind|Rescue Criteria Met|0|||
146671962|NCT00282984|528976005|FG000|Overall Study|in prison|0|||
146671963|NCT00282984|528976006|FG001|Overall Study|in prison|1|||
146671964|NCT00282984|528976005|FG000|Overall Study|Protocol Violation|2|||
146671965|NCT00282984|528976006|FG001|Overall Study|Protocol Violation|0|||
146671966|NCT00191269|528976007|FG000|Overall Study|Protocol Violation|0|||
146671967|NCT00191269|528976008|FG001|Overall Study|Protocol Violation|2|||
146671968|NCT00191269|528976007|FG000|Overall Study|Adverse Event|1|||
146671969|NCT00191269|528976008|FG001|Overall Study|Adverse Event|4|||
146671970|NCT00191269|528976007|FG000|Overall Study|Progression of Disease|4|||
146671971|NCT00191269|528976008|FG001|Overall Study|Progression of Disease|42|||
146671972|NCT00191269|528976007|FG000|Overall Study|Lack of Efficacy|1|||
146671973|NCT00191269|528976008|FG001|Overall Study|Lack of Efficacy|5|||
146671974|NCT00191269|528976007|FG000|Overall Study|Withdrawal by Subject|0|||
146671975|NCT00191269|528976008|FG001|Overall Study|Withdrawal by Subject|1|||
146671976|NCT00191269|528976007|FG000|Overall Study|Pathologic Aggrevation|0|||
146671977|NCT00191269|528976008|FG001|Overall Study|Pathologic Aggrevation|1|||
146671978|NCT00191269|528976007|FG000|Overall Study|Physician Decision|0|||
146671979|NCT00191269|528976008|FG001|Overall Study|Physician Decision|3|||
146671980|NCT00915278|528976014|FG000|Overall Study|Death|1|||
146671981|NCT00915278|528976015|FG001|Overall Study|Death|0|||
146671982|NCT00915278|528976016|FG002|Overall Study|Death|0|||
146671983|NCT00915278|528976017|FG003|Overall Study|Death|0|||
146671984|NCT00915278|528976018|FG004|Overall Study|Death|0|||
146671985|NCT00915278|528976019|FG005|Overall Study|Death|0|||
146671986|NCT00915278|528976014|FG000|Overall Study|Lost to Follow-up|0|||
146671987|NCT00915278|528976015|FG001|Overall Study|Lost to Follow-up|1|||
146671988|NCT00915278|528976016|FG002|Overall Study|Lost to Follow-up|0|||
146671989|NCT00915278|528976017|FG003|Overall Study|Lost to Follow-up|0|||
146671990|NCT00915278|528976018|FG004|Overall Study|Lost to Follow-up|0|||
146671991|NCT00915278|528976019|FG005|Overall Study|Lost to Follow-up|0|||
146671992|NCT00915278|528976014|FG000|Overall Study|Withdrawal by Subject|0|||
146671993|NCT00915278|528976015|FG001|Overall Study|Withdrawal by Subject|1|||
146671994|NCT00915278|528976016|FG002|Overall Study|Withdrawal by Subject|0|||
146671995|NCT00915278|528976017|FG003|Overall Study|Withdrawal by Subject|0|||
146671996|NCT00915278|528976018|FG004|Overall Study|Withdrawal by Subject|1|||
146671997|NCT00915278|528976019|FG005|Overall Study|Withdrawal by Subject|4|||
146671998|NCT00915278|528976014|FG000|Overall Study|Adverse Event|4|||
146671999|NCT00915278|528976015|FG001|Overall Study|Adverse Event|1|||
146672000|NCT00915278|528976016|FG002|Overall Study|Adverse Event|0|||
146672001|NCT00915278|528976017|FG003|Overall Study|Adverse Event|0|||
146672002|NCT00915278|528976018|FG004|Overall Study|Adverse Event|0|||
146672003|NCT00915278|528976019|FG005|Overall Study|Adverse Event|0|||
146672004|NCT00915278|528976014|FG000|Overall Study|Progressive disease/clinical progression|0|||
146672005|NCT00915278|528976015|FG001|Overall Study|Progressive disease/clinical progression|0|||
146672006|NCT00915278|528976016|FG002|Overall Study|Progressive disease/clinical progression|0|||
146672007|NCT00915278|528976017|FG003|Overall Study|Progressive disease/clinical progression|3|||
146672008|NCT00915278|528976018|FG004|Overall Study|Progressive disease/clinical progression|1|||
146672009|NCT00915278|528976019|FG005|Overall Study|Progressive disease/clinical progression|2|||
146672010|NCT00915278|528976014|FG000|Overall Study|Infusion related AEs|0|||
146672011|NCT00915278|528976015|FG001|Overall Study|Infusion related AEs|0|||
146672012|NCT00915278|528976016|FG002|Overall Study|Infusion related AEs|0|||
146672013|NCT00915278|528976017|FG003|Overall Study|Infusion related AEs|0|||
146672014|NCT00915278|528976018|FG004|Overall Study|Infusion related AEs|0|||
146672015|NCT00915278|528976019|FG005|Overall Study|Infusion related AEs|2|||
146672016|NCT00915278|528976014|FG000|Overall Study|Admission to hospice|0|||
146672017|NCT00915278|528976015|FG001|Overall Study|Admission to hospice|0|||
146672018|NCT00915278|528976016|FG002|Overall Study|Admission to hospice|1|||
146672019|NCT00915278|528976017|FG003|Overall Study|Admission to hospice|0|||
146672020|NCT00915278|528976018|FG004|Overall Study|Admission to hospice|0|||
146672021|NCT00915278|528976019|FG005|Overall Study|Admission to hospice|0|||
146672022|NCT00674362|528976024|FG000|Double Blind|Adverse Event|6|||
146672023|NCT00674362|528976025|FG001|Double Blind|Adverse Event|6|||
146672024|NCT00674362|528976024|FG000|Double Blind|Lack of Efficacy|2|||
146672025|NCT00674362|528976025|FG001|Double Blind|Lack of Efficacy|6|||
146672026|NCT00674362|528976024|FG000|Double Blind|Loss of efficacy|0|||
146672027|NCT00674362|528976025|FG001|Double Blind|Loss of efficacy|1|||
146774062|NCT01972724|529343518|FG002|Double-Blind|Rescue Criteria Met|0|||
146774063|NCT01972724|529343516|FG000|Double-Blind|Adverse Event|1|||
146672028|NCT00674362|528976024|FG000|Double Blind|Withdrawal by Subject|4|||
146672029|NCT00674362|528976025|FG001|Double Blind|Withdrawal by Subject|3|||
146672030|NCT00674362|528976024|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
146672031|NCT00674362|528976025|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
146672032|NCT00674362|528976024|FG000|Double Blind|Other: Surgery|0|||
146672033|NCT00674362|528976025|FG001|Double Blind|Other: Surgery|1|||
146672034|NCT00674362|528976024|FG000|Open Label|Adverse Event|1|||
146672035|NCT00674362|528976025|FG001|Open Label|Adverse Event|0|||
146672036|NCT00674362|528976024|FG000|Open Label|Other: Subject moved to extension study|1|||
146672037|NCT00674362|528976025|FG001|Open Label|Other: Subject moved to extension study|0|||
146672038|NCT01201850|528976028|FG000|Overall Study|Tumor progression|4|||
146672039|NCT00816595|528976029|FG000|Overall Study|Withdrawal by Subject|2|||
146672040|NCT00816595|528976030|FG001|Overall Study|Withdrawal by Subject|0|||
146672041|NCT00453063|528976031|FG000|Overall Study|Adverse Event|1|||
146672042|NCT00453063|528976032|FG001|Overall Study|Adverse Event|2|||
146672043|NCT00453063|528976031|FG000|Overall Study|Withdrawal by Subject|1|||
146672044|NCT00453063|528976032|FG001|Overall Study|Withdrawal by Subject|1|||
146672045|NCT00453063|528976031|FG000|Overall Study|Protocol Violation|1|||
146672046|NCT00453063|528976032|FG001|Overall Study|Protocol Violation|0|||
146672047|NCT00365508|528976035|FG000|Overall Study|Lost to Follow-up|139|||
146672048|NCT00365508|528976036|FG001|Overall Study|Lost to Follow-up|154|||
146672049|NCT02538029|528976038|FG000|Overall Study|unable to complete cognitive assessments|1|||
146672050|NCT02538029|528976039|FG001|Overall Study|unable to complete cognitive assessments|0|||
146672051|NCT02538029|528976040|FG002|Overall Study|unable to complete cognitive assessments|1|||
146672052|NCT00566995|528976042|FG000|Overall Study|Toxicity|4|||
146672053|NCT00566995|528976042|FG000|Overall Study|Withdrew consent|3|||
146672054|NCT00404235|528976043|FG000|Overall Study|Withdrawal by Subject|1|||
146672055|NCT00404235|528976044|FG001|Overall Study|Withdrawal by Subject|2|||
146672056|NCT01558271|528976045|FG000|Overall Study|Adverse Event|6|||
146672057|NCT01558271|528976046|FG001|Overall Study|Adverse Event|3|||
146672058|NCT01558271|528976047|FG002|Overall Study|Adverse Event|4|||
146672059|NCT01558271|528976045|FG000|Overall Study|Lost to Follow-up|1|||
146672060|NCT01558271|528976046|FG001|Overall Study|Lost to Follow-up|0|||
146672061|NCT01558271|528976047|FG002|Overall Study|Lost to Follow-up|0|||
146672062|NCT01558271|528976045|FG000|Overall Study|Protocol Violation|1|||
146672063|NCT01558271|528976046|FG001|Overall Study|Protocol Violation|0|||
146672064|NCT01558271|528976047|FG002|Overall Study|Protocol Violation|0|||
146672065|NCT01558271|528976045|FG000|Overall Study|Withdrawal by Subject|10|||
146672066|NCT01558271|528976046|FG001|Overall Study|Withdrawal by Subject|6|||
146672067|NCT01558271|528976047|FG002|Overall Study|Withdrawal by Subject|12|||
146672068|NCT01558271|528976045|FG000|Overall Study|Physician Decision|0|||
146672069|NCT01558271|528976046|FG001|Overall Study|Physician Decision|2|||
146672070|NCT01558271|528976047|FG002|Overall Study|Physician Decision|1|||
146672071|NCT00228384|528976048|FG000|Overall Study|Death|9|||
146672072|NCT00228384|528976049|FG001|Overall Study|Death|3|||
146672073|NCT00228384|528976048|FG000|Overall Study|Lost to Follow-up|6|||
146672074|NCT00228384|528976049|FG001|Overall Study|Lost to Follow-up|10|||
146672075|NCT00228384|528976048|FG000|Overall Study|Surgical Intervention (bypass)|5|||
146672076|NCT00228384|528976049|FG001|Overall Study|Surgical Intervention (bypass)|5|||
146672077|NCT00228384|528976048|FG000|Overall Study|Withdrawal by Subject|9|||
146672078|NCT00228384|528976049|FG001|Overall Study|Withdrawal by Subject|10|||
146672079|NCT00228384|528976048|FG000|Overall Study|Physician Decision|0|||
146672080|NCT00228384|528976049|FG001|Overall Study|Physician Decision|1|||
146672081|NCT00873912|528976050|FG000|Overall Study|Withdrawal by Subject|1|||
146672082|NCT00873912|528976051|FG001|Overall Study|Withdrawal by Subject|0|||
146672083|NCT00873912|528976050|FG000|Overall Study|Lost to Follow-up|2|||
146672084|NCT00873912|528976051|FG001|Overall Study|Lost to Follow-up|0|||
146672085|NCT01980940|528976055|FG000|Overall Study|Protocol Violation|0|||
146672086|NCT01980940|528976056|FG001|Overall Study|Protocol Violation|0|||
146672087|NCT01980940|528976057|FG002|Overall Study|Protocol Violation|0|||
146672088|NCT01980940|528976058|FG003|Overall Study|Protocol Violation|0|||
146672089|NCT01980940|528976059|FG004|Overall Study|Protocol Violation|0|||
146672090|NCT01980940|528976060|FG005|Overall Study|Protocol Violation|2|||
146672091|NCT01980940|528976061|FG006|Overall Study|Protocol Violation|0|||
146672092|NCT01980940|528976062|FG007|Overall Study|Protocol Violation|0|||
146978780|NCT01078623|530085496|FG000|Treatment Period 1|Adverse Event|1|||
146672093|NCT05358444|528976066|FG000|Overall Study|Withdrawal by Subject|0|||
146672094|NCT05358444|528976067|FG001|Overall Study|Withdrawal by Subject|1|||
146672095|NCT05358444|528976066|FG000|Overall Study|Lost to Follow-up|0|||
146672096|NCT05358444|528976067|FG001|Overall Study|Lost to Follow-up|3|||
146672097|NCT00709761|528978041|FG000|Overall Study|Withdrawal by Subject|8|||
146672098|NCT00709761|528978041|FG000|Overall Study|study closed/terminated|17|||
146672099|NCT00709761|528978041|FG000|Overall Study|Lost to Follow-up|2|||
146672100|NCT02955602|528978042|FG000|Overall Study|Adverse Event|0|||
146672101|NCT02955602|528978043|FG001|Overall Study|Adverse Event|3|||
146672102|NCT02955602|528978044|FG002|Overall Study|Adverse Event|0|||
146672103|NCT02955602|528978042|FG000|Overall Study|Withdrawal of informed consent|1|||
146672104|NCT02955602|528978043|FG001|Overall Study|Withdrawal of informed consent|3|||
146672105|NCT02955602|528978044|FG002|Overall Study|Withdrawal of informed consent|2|||
146672106|NCT02955602|528978042|FG000|Overall Study|Lost to Follow-up|0|||
146672107|NCT02955602|528978043|FG001|Overall Study|Lost to Follow-up|0|||
146672108|NCT02955602|528978044|FG002|Overall Study|Lost to Follow-up|1|||
146672109|NCT02955602|528978042|FG000|Overall Study|Other|0|||
146672110|NCT02955602|528978043|FG001|Overall Study|Other|1|||
146672111|NCT02955602|528978044|FG002|Overall Study|Other|3|||
146672112|NCT02501473|528978047|FG000|Overall Study|Study Terminated|2|||
146925989|NCT03655717|529888424|FG007|Overall Study|Withdrawal by Subject|1|||
146925990|NCT03655717|529888425|FG008|Overall Study|Withdrawal by Subject|2|||
146925991|NCT03655717|529888426|FG009|Overall Study|Withdrawal by Subject|0|||
146672113|NCT02501473|528978048|FG001|Overall Study|Study Terminated|3|||
146672114|NCT02501473|528978049|FG002|Overall Study|Study Terminated|7|||
146672115|NCT02501473|528978050|FG003|Overall Study|Study Terminated|9|||
146672116|NCT02501473|528978051|FG004|Overall Study|Study Terminated|2|||
146672117|NCT02501473|528978052|FG005|Overall Study|Study Terminated|10|||
146672118|NCT02501473|528978053|FG006|Overall Study|Study Terminated|1|||
146672119|NCT02501473|528978054|FG007|Overall Study|Study Terminated|0|||
146672120|NCT02501473|528978047|FG000|Overall Study|Withdrawal by Subject|0|||
146672121|NCT02501473|528978048|FG001|Overall Study|Withdrawal by Subject|0|||
146672122|NCT02501473|528978049|FG002|Overall Study|Withdrawal by Subject|3|||
146672123|NCT02501473|528978050|FG003|Overall Study|Withdrawal by Subject|3|||
146672124|NCT02501473|528978051|FG004|Overall Study|Withdrawal by Subject|2|||
146672125|NCT02501473|528978052|FG005|Overall Study|Withdrawal by Subject|2|||
146672126|NCT02501473|528978053|FG006|Overall Study|Withdrawal by Subject|0|||
146672127|NCT02501473|528978054|FG007|Overall Study|Withdrawal by Subject|0|||
146672128|NCT02501473|528978047|FG000|Overall Study|Death|0|||
146672129|NCT02501473|528978048|FG001|Overall Study|Death|0|||
146672130|NCT02501473|528978049|FG002|Overall Study|Death|1|||
146672131|NCT02501473|528978050|FG003|Overall Study|Death|1|||
146672132|NCT02501473|528978051|FG004|Overall Study|Death|0|||
146672133|NCT02501473|528978052|FG005|Overall Study|Death|1|||
146672134|NCT02501473|528978053|FG006|Overall Study|Death|0|||
146672135|NCT02501473|528978054|FG007|Overall Study|Death|0|||
146672136|NCT02501473|528978047|FG000|Overall Study|Lost to Follow-up|1|||
146672137|NCT02501473|528978048|FG001|Overall Study|Lost to Follow-up|0|||
146672138|NCT02501473|528978049|FG002|Overall Study|Lost to Follow-up|1|||
146672139|NCT02501473|528978050|FG003|Overall Study|Lost to Follow-up|0|||
146672140|NCT02501473|528978051|FG004|Overall Study|Lost to Follow-up|0|||
146672141|NCT02501473|528978052|FG005|Overall Study|Lost to Follow-up|1|||
146672142|NCT02501473|528978053|FG006|Overall Study|Lost to Follow-up|0|||
146672143|NCT02501473|528978054|FG007|Overall Study|Lost to Follow-up|0|||
146672144|NCT02501473|528978047|FG000|Overall Study|Reason not specified|0|||
146672145|NCT02501473|528978048|FG001|Overall Study|Reason not specified|0|||
146672146|NCT02501473|528978049|FG002|Overall Study|Reason not specified|1|||
146672147|NCT02501473|528978050|FG003|Overall Study|Reason not specified|1|||
146672148|NCT02501473|528978051|FG004|Overall Study|Reason not specified|0|||
146672149|NCT02501473|528978052|FG005|Overall Study|Reason not specified|0|||
146672150|NCT02501473|528978053|FG006|Overall Study|Reason not specified|0|||
146672151|NCT02501473|528978054|FG007|Overall Study|Reason not specified|0|||
146672152|NCT01581931|528978055|FG000|Washout|Adverse Event|0|||
146672153|NCT01581931|528978056|FG001|Washout|Adverse Event|1|||
146672154|NCT04160195|528978061|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
146672155|NCT04160195|528978062|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
146672156|NCT03068130|528978067|FG000|Overall Study|Adverse Event|19|||
146672157|NCT03068130|528978067|FG000|Overall Study|Death|14|||
146672158|NCT03068130|528978067|FG000|Overall Study|Lost to Follow-up|4|||
146672159|NCT03068130|528978067|FG000|Overall Study|Withdrawal by Subject|26|||
146672160|NCT03068130|528978067|FG000|Overall Study|Administrative Reasons|3|||
146672161|NCT03068130|528978067|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
146672162|NCT03068130|528978067|FG000|Overall Study|Study terminated by sponsor|194|||
146672163|NCT05275400|528978070|FG000|Treatment Period|Adverse Event|7|||
146672164|NCT05275400|528978071|FG001|Treatment Period|Adverse Event|1|||
146672165|NCT05275400|528978070|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
146672166|NCT05275400|528978071|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
146672167|NCT05275400|528978070|FG000|Treatment Period|Death|5|||
146672168|NCT05275400|528978071|FG001|Treatment Period|Death|2|||
146672169|NCT05275400|528978070|FG000|Treatment Period|Protocol Violation|1|||
146672170|NCT05275400|528978071|FG001|Treatment Period|Protocol Violation|0|||
146672171|NCT05275400|528978070|FG000|Treatment Period|Physician Decision|5|||
146672172|NCT05275400|528978071|FG001|Treatment Period|Physician Decision|4|||
146672173|NCT05275400|528978070|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
146672174|NCT05275400|528978071|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
146672175|NCT05275400|528978070|FG000|Treatment Period|Withdrawal by Subject|30|||
146925992|NCT03655717|529888427|FG010|Overall Study|Withdrawal by Subject|0|||
146672176|NCT05275400|528978071|FG001|Treatment Period|Withdrawal by Subject|12|||
146672177|NCT05275400|528978070|FG000|Treatment Period|Lost to Follow-up|1|||
146672178|NCT05275400|528978071|FG001|Treatment Period|Lost to Follow-up|5|||
146672179|NCT05275400|528978070|FG000|Treatment Period|Lack of Efficacy|1|||
146672180|NCT05275400|528978071|FG001|Treatment Period|Lack of Efficacy|0|||
146672181|NCT05275400|528978070|FG000|Treatment Period|Sponsor Decision|1|||
146672182|NCT05275400|528978071|FG001|Treatment Period|Sponsor Decision|0|||
146672183|NCT05275400|528978070|FG000|Follow-Up Period|Death|2|||
146672184|NCT05275400|528978071|FG001|Follow-Up Period|Death|0|||
146672185|NCT05275400|528978070|FG000|Follow-Up Period|Protocol Violation|1|||
146672186|NCT05275400|528978071|FG001|Follow-Up Period|Protocol Violation|0|||
146672187|NCT05275400|528978070|FG000|Follow-Up Period|Withdrawal by Subject|3|||
146672188|NCT05275400|528978071|FG001|Follow-Up Period|Withdrawal by Subject|0|||
146672189|NCT02585960|528978072|FG000|PK/Safety Assessment Period|Physician Decision|0|||
146672190|NCT02585960|528978073|FG001|PK/Safety Assessment Period|Physician Decision|1|||
146672191|NCT02585960|528978074|FG002|PK/Safety Assessment Period|Physician Decision|0|||
146672192|NCT02585960|528978072|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
146672193|NCT02585960|528978073|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
146672194|NCT02585960|528978074|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
146672195|NCT02585960|528978072|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
146672196|NCT02585960|528978073|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
146672197|NCT02585960|528978074|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
146672198|NCT02585960|528978072|FG000|PK/Safety Assessment Period|Other|4|||
146672199|NCT02585960|528978073|FG001|PK/Safety Assessment Period|Other|4|||
146672200|NCT02585960|528978074|FG002|PK/Safety Assessment Period|Other|0|||
146672201|NCT02585960|528978072|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
146672202|NCT02585960|528978073|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
146672203|NCT02585960|528978074|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
146672204|NCT02585960|528978072|FG000|PK/Safety Assessment Period|Screen Failure|0|||
146672205|NCT02585960|528978073|FG001|PK/Safety Assessment Period|Screen Failure|0|||
146672206|NCT02585960|528978074|FG002|PK/Safety Assessment Period|Screen Failure|1|||
146672207|NCT02585960|528978072|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
146672208|NCT02585960|528978073|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
146672209|NCT02585960|528978074|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
146672210|NCT02585960|528978072|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
146672211|NCT02585960|528978073|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
146672212|NCT02585960|528978074|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
146672213|NCT06333613|528978075|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
146672214|NCT04930965|528978078|FG000|Overall Study|Lost to Follow-up|7|||
146672215|NCT04930965|528978079|FG001|Overall Study|Lost to Follow-up|5|||
146672216|NCT05587296|528978080|FG000|Overall Study|Adverse Event|15|||
146672217|NCT05587296|528978081|FG001|Overall Study|Adverse Event|7|||
146672218|NCT05587296|528978080|FG000|Overall Study|Lack of Efficacy|2|||
146672219|NCT05587296|528978081|FG001|Overall Study|Lack of Efficacy|0|||
146672220|NCT05587296|528978080|FG000|Overall Study|Lost to Follow-up|1|||
146672221|NCT05587296|528978081|FG001|Overall Study|Lost to Follow-up|0|||
146672222|NCT05587296|528978080|FG000|Overall Study|Withdrawal by Subject|14|||
146672223|NCT05587296|528978081|FG001|Overall Study|Withdrawal by Subject|4|||
146672224|NCT05587296|528978080|FG000|Overall Study|miscellaneous|3|||
146672225|NCT05587296|528978081|FG001|Overall Study|miscellaneous|6|||
146672226|NCT05587296|528978080|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
146672227|NCT05587296|528978081|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
146672228|NCT02849678|528978082|FG000|Overall Study|Protocol Violation|3|||
146672229|NCT02849678|528978083|FG001|Overall Study|Protocol Violation|6|||
146672230|NCT00444912|528978086|FG000|Overall Study|Death|1|||
146672231|NCT00444912|528978087|FG001|Overall Study|Death|2|||
146672232|NCT00444912|528978086|FG000|Overall Study|Lost to Follow-up|1|||
146672233|NCT00444912|528978087|FG001|Overall Study|Lost to Follow-up|0|||
146672234|NCT00444912|528978086|FG000|Overall Study|Participant Failed Mobilization|1|||
146672235|NCT00444912|528978087|FG001|Overall Study|Participant Failed Mobilization|0|||
146672236|NCT02499783|528978088|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
146672237|NCT02499783|528978089|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
146672238|NCT02499783|528978090|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
146672239|NCT02499783|528978088|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
146672240|NCT02499783|528978089|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
146672241|NCT02499783|528978090|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
146672242|NCT02499783|528978088|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
146672243|NCT02499783|528978089|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
146672244|NCT02499783|528978090|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
146672245|NCT02499783|528978088|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
146672246|NCT02499783|528978089|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
146672247|NCT02499783|528978090|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
146672248|NCT02499783|528978088|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
146672249|NCT02499783|528978089|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
146672250|NCT02499783|528978090|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
146672251|NCT02499783|528978088|FG000|DB Period: Weeks 0-8|Other|1|||
146672252|NCT02499783|528978089|FG001|DB Period: Weeks 0-8|Other|1|||
146672253|NCT02499783|528978090|FG002|DB Period: Weeks 0-8|Other|0|||
146672254|NCT02499783|528978088|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
146672255|NCT02499783|528978089|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
146672256|NCT02499783|528978090|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
146672257|NCT02499783|528978088|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
146672258|NCT02499783|528978089|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
146672259|NCT02499783|528978090|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
146672260|NCT02499783|528978088|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
146672261|NCT02499783|528978089|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
146672262|NCT02499783|528978090|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
146672263|NCT02499783|528978088|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
146672264|NCT02499783|528978089|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
146672265|NCT02499783|528978090|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
146672266|NCT02228460|528978091|FG000|Overall Study|Adverse Event|1|||
146672267|NCT02228460|528978091|FG000|Overall Study|Lost to Follow-up|1|||
146672268|NCT01243892|528978092|FG000|Overall Study|Did not meet eligibility criteria|2|||
146672269|NCT01243892|528978093|FG001|Overall Study|Did not meet eligibility criteria|0|||
146672270|NCT00329238|528978094|FG000|Overall Study|Adverse Event|147|||
146672271|NCT00329238|528978095|FG001|Overall Study|Adverse Event|129|||
146672272|NCT00329238|528978094|FG000|Overall Study|Protocol Violation|23|||
146672273|NCT00329238|528978095|FG001|Overall Study|Protocol Violation|34|||
146672274|NCT00329238|528978094|FG000|Overall Study|Lost to Follow-up|2|||
146672275|NCT00329238|528978095|FG001|Overall Study|Lost to Follow-up|6|||
146672276|NCT00329238|528978094|FG000|Overall Study|Withdrawal by Subject|64|||
146672277|NCT00329238|528978095|FG001|Overall Study|Withdrawal by Subject|58|||
146672278|NCT00329238|528978094|FG000|Overall Study|Other reason (not specified)|40|||
146672279|NCT00329238|528978095|FG001|Overall Study|Other reason (not specified)|54|||
146672280|NCT00801632|528978096|FG000|Overall Study|Re-transplant|1|||
146672281|NCT05379231|528978097|FG000|Home Visit|Withdrawal by Subject|2|||
146672282|NCT05379231|528978097|FG000|In-lab Visit|Withdrawal by Subject|2|||
146672283|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
146672284|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
146672285|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
146672286|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
146672287|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
146672288|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
146672289|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
146672290|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
146672291|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
146672292|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
146672293|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
146672294|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
146672295|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
146672296|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
146672297|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
146672298|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
146672299|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
146672300|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
146672301|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
146672302|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
146672303|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
146672304|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
146672305|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
146672306|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
146672307|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
146672308|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
146672309|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
146774064|NCT01972724|529343517|FG001|Double-Blind|Adverse Event|0|||
146774065|NCT01972724|529343518|FG002|Double-Blind|Adverse Event|0|||
146774066|NCT01972724|529343516|FG000|Double-Blind|Withdrawal of Consent|2|||
146774067|NCT01972724|529343517|FG001|Double-Blind|Withdrawal of Consent|1|||
146774068|NCT01972724|529343518|FG002|Double-Blind|Withdrawal of Consent|0|||
146774069|NCT01972724|529343516|FG000|Double-Blind|Significant Protocol Deviation|5|||
146774070|NCT01972724|529343517|FG001|Double-Blind|Significant Protocol Deviation|8|||
146774071|NCT01972724|529343518|FG002|Double-Blind|Significant Protocol Deviation|0|||
146774072|NCT01972724|529343516|FG000|Open-Label|Withdrew Consent|0|||
146774073|NCT01972724|529343517|FG001|Open-Label|Withdrew Consent|0|||
146672310|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
146672311|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
146672312|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
146925993|NCT03655717|529888428|FG011|Overall Study|Withdrawal by Subject|1|||
146925994|NCT03655717|529888429|FG012|Overall Study|Withdrawal by Subject|0|||
146925995|NCT03655717|529888430|FG013|Overall Study|Withdrawal by Subject|3|||
146925996|NCT03655717|529888431|FG014|Overall Study|Withdrawal by Subject|0|||
146925997|NCT03655717|529888432|FG015|Overall Study|Withdrawal by Subject|1|||
146925998|NCT03655717|529888433|FG016|Overall Study|Withdrawal by Subject|0|||
146925999|NCT03655717|529888434|FG017|Overall Study|Withdrawal by Subject|0|||
146926000|NCT03655717|529888435|FG018|Overall Study|Withdrawal by Subject|1|||
146926001|NCT03655717|529888436|FG019|Overall Study|Withdrawal by Subject|0|||
146926002|NCT03655717|529888437|FG020|Overall Study|Withdrawal by Subject|0|||
146926003|NCT03655717|529888438|FG021|Overall Study|Withdrawal by Subject|1|||
146926004|NCT03655717|529888439|FG022|Overall Study|Withdrawal by Subject|2|||
146926005|NCT03655717|529888440|FG023|Overall Study|Withdrawal by Subject|1|||
146926006|NCT03655717|529888441|FG024|Overall Study|Withdrawal by Subject|1|||
146926007|NCT03655717|529888442|FG025|Overall Study|Withdrawal by Subject|0|||
146926008|NCT03655717|529888417|FG000|Overall Study|Physician Decision|3|||
146926009|NCT03655717|529888418|FG001|Overall Study|Physician Decision|3|||
146926010|NCT03655717|529888419|FG002|Overall Study|Physician Decision|0|||
146926011|NCT03655717|529888420|FG003|Overall Study|Physician Decision|0|||
146926012|NCT03655717|529888421|FG004|Overall Study|Physician Decision|0|||
146926013|NCT03655717|529888422|FG005|Overall Study|Physician Decision|0|||
146926014|NCT03655717|529888423|FG006|Overall Study|Physician Decision|0|||
146926015|NCT03655717|529888424|FG007|Overall Study|Physician Decision|0|||
146926016|NCT03655717|529888425|FG008|Overall Study|Physician Decision|0|||
146926017|NCT03655717|529888426|FG009|Overall Study|Physician Decision|1|||
146926018|NCT03655717|529888427|FG010|Overall Study|Physician Decision|0|||
146926019|NCT03655717|529888428|FG011|Overall Study|Physician Decision|0|||
146926020|NCT03655717|529888429|FG012|Overall Study|Physician Decision|0|||
146926021|NCT03655717|529888430|FG013|Overall Study|Physician Decision|0|||
146926022|NCT03655717|529888431|FG014|Overall Study|Physician Decision|0|||
146926023|NCT03655717|529888432|FG015|Overall Study|Physician Decision|0|||
146926024|NCT03655717|529888433|FG016|Overall Study|Physician Decision|0|||
146926025|NCT03655717|529888434|FG017|Overall Study|Physician Decision|0|||
146926026|NCT03655717|529888435|FG018|Overall Study|Physician Decision|0|||
146926027|NCT03655717|529888436|FG019|Overall Study|Physician Decision|1|||
146926028|NCT03655717|529888437|FG020|Overall Study|Physician Decision|0|||
146672313|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
146672314|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
146672315|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
146672316|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
146672317|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
146672318|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
146672319|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
146672320|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
146672321|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
146672322|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
146672323|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
146672324|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
146672325|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
146672326|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
146672327|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
146672328|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
146672329|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
146672330|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
146672331|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
146672332|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
146672333|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
146672334|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
146672335|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
146672336|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
146672337|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
146672338|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
146672339|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
146672340|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
146926029|NCT03655717|529888438|FG021|Overall Study|Physician Decision|0|||
146926030|NCT03655717|529888439|FG022|Overall Study|Physician Decision|0|||
146926031|NCT03655717|529888440|FG023|Overall Study|Physician Decision|1|||
146926032|NCT03655717|529888441|FG024|Overall Study|Physician Decision|0|||
146926033|NCT03655717|529888442|FG025|Overall Study|Physician Decision|0|||
146926034|NCT03655717|529888417|FG000|Overall Study|Lost to Follow-up|3|||
146926035|NCT03655717|529888418|FG001|Overall Study|Lost to Follow-up|1|||
146926036|NCT03655717|529888419|FG002|Overall Study|Lost to Follow-up|0|||
146672341|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
146672342|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
146672343|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
146672344|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
146672345|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
146672346|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
146672347|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
146672348|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
146672349|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
146672350|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
146672351|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
146672352|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
146672353|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Change of location|0|||
146672354|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Change of location|0|||
146672355|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Change of location|0|||
146672356|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Change of location|1|||
146672357|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Change of location|0|||
146672358|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
146672359|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
146672360|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
146672361|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
146672362|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
146672363|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
146672364|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
146672365|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
146672366|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
146672367|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
146672368|NCT00730405|528978104|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
146672369|NCT00730405|528978105|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
146672370|NCT00730405|528978106|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
146672371|NCT00730405|528978107|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
146672372|NCT00730405|528978108|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
146672373|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
146672374|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
146672375|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
146672376|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
146672377|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
146672378|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
146672379|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
146672380|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
146672381|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
146672382|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
146672383|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
146672384|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
146672385|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
146672386|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
146672387|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
146672388|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Death|0|||
146672389|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Death|1|||
146672390|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Death|0|||
146672391|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Death|1|||
146672392|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Death|0|||
146672393|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Change of location|1|||
146672394|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Change of location|1|||
146672395|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Change of location|0|||
146672396|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Change of location|1|||
146672397|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Change of location|0|||
146672398|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
146672399|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
146672400|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
146672401|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
146672402|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
146672403|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
146672404|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
146672405|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
146672406|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
146672407|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
146672408|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
146672409|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
146672410|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
146672411|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
146672412|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
146672413|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
146672414|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
146672415|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
146672416|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
146672417|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
146672418|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
146672419|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
146672420|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
146672421|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
146672422|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
146672423|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
146672424|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
146672425|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
146672426|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
146672427|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
146672428|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
146672429|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
146672430|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
146672431|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
146672432|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
146672433|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
146672434|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
146672435|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
146672436|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
146672437|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
146672438|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
146672439|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
146672440|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
146672441|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
146672442|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
146672443|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
146672444|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
146672445|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
146672446|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
146672447|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
146672448|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Missing|0|||
146672449|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Missing|0|||
146672450|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Missing|2|||
146672451|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Missing|0|||
146672452|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Missing|0|||
146672453|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
146672454|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
146672455|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
146672456|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
146672457|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
146672458|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
146672459|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
146672460|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
146672461|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
146672462|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
146672463|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
146672464|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
146672465|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
146672466|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
146672467|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
146672468|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
146672469|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
146926037|NCT03655717|529888420|FG003|Overall Study|Lost to Follow-up|1|||
146926038|NCT03655717|529888421|FG004|Overall Study|Lost to Follow-up|0|||
146926039|NCT03655717|529888422|FG005|Overall Study|Lost to Follow-up|1|||
146926040|NCT03655717|529888423|FG006|Overall Study|Lost to Follow-up|0|||
146926041|NCT03655717|529888424|FG007|Overall Study|Lost to Follow-up|0|||
146926042|NCT03655717|529888425|FG008|Overall Study|Lost to Follow-up|0|||
146926043|NCT03655717|529888426|FG009|Overall Study|Lost to Follow-up|0|||
146926044|NCT03655717|529888427|FG010|Overall Study|Lost to Follow-up|0|||
146926045|NCT03655717|529888428|FG011|Overall Study|Lost to Follow-up|1|||
146926046|NCT03655717|529888429|FG012|Overall Study|Lost to Follow-up|0|||
146926047|NCT03655717|529888430|FG013|Overall Study|Lost to Follow-up|0|||
146926048|NCT03655717|529888431|FG014|Overall Study|Lost to Follow-up|0|||
146926049|NCT03655717|529888432|FG015|Overall Study|Lost to Follow-up|0|||
146926050|NCT03655717|529888433|FG016|Overall Study|Lost to Follow-up|0|||
146672470|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
146672471|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
146672472|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
146672473|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
146672474|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
146672475|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
146672476|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
146672477|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
146672478|NCT00730405|528978104|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
146672479|NCT00730405|528978105|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
146672480|NCT00730405|528978106|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
146672481|NCT00730405|528978107|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
146672482|NCT00730405|528978108|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
146672483|NCT01496807|528978112|FG000|Overall Study|Progressive Disease|21|||
146672484|NCT01496807|528978112|FG000|Overall Study|Participant preference/toxicity|8|||
146672485|NCT01496807|528978112|FG000|Overall Study|Change in diagnosis|1|||
146672486|NCT00923156|528978118|FG000|Overall Study|Adverse Event|0|||
146672487|NCT00923156|528978119|FG001|Overall Study|Adverse Event|2|||
146672488|NCT00923156|528978120|FG002|Overall Study|Adverse Event|1|||
146672489|NCT00923156|528978118|FG000|Overall Study|Abnormal laboratory values|0|||
146672490|NCT00923156|528978119|FG001|Overall Study|Abnormal laboratory values|0|||
146672491|NCT00923156|528978120|FG002|Overall Study|Abnormal laboratory values|1|||
146672492|NCT00923156|528978118|FG000|Overall Study|Withdrawal by Subject|0|||
146672493|NCT00923156|528978119|FG001|Overall Study|Withdrawal by Subject|1|||
146672494|NCT00923156|528978120|FG002|Overall Study|Withdrawal by Subject|0|||
146672495|NCT00923156|528978118|FG000|Overall Study|Death|0|||
146672496|NCT00923156|528978119|FG001|Overall Study|Death|1|||
146672497|NCT00923156|528978120|FG002|Overall Study|Death|0|||
146672498|NCT00923156|528978118|FG000|Overall Study|Lack of Efficacy|0|||
146672499|NCT00923156|528978119|FG001|Overall Study|Lack of Efficacy|0|||
146672500|NCT00923156|528978120|FG002|Overall Study|Lack of Efficacy|1|||
146672501|NCT03137537|528978121|FG000|Overall Study|Adverse Event|0|||
146672502|NCT03137537|528978122|FG001|Overall Study|Adverse Event|1|||
146672503|NCT04066023|528978123|FG000|Overall Study|Adverse Event|0|||
146672504|NCT04066023|528978124|FG001|Overall Study|Adverse Event|0|||
146672505|NCT04066023|528978125|FG002|Overall Study|Adverse Event|1|||
146672506|NCT04066023|528978123|FG000|Overall Study|Sponsor decision|3|||
146672507|NCT04066023|528978124|FG001|Overall Study|Sponsor decision|6|||
146672508|NCT04066023|528978125|FG002|Overall Study|Sponsor decision|2|||
146672509|NCT04066023|528978123|FG000|Overall Study|Physician Decision|0|||
146672510|NCT04066023|528978124|FG001|Overall Study|Physician Decision|0|||
146672511|NCT04066023|528978125|FG002|Overall Study|Physician Decision|1|||
146672512|NCT04066023|528978123|FG000|Overall Study|Lost to Follow-up|0|||
146672513|NCT04066023|528978124|FG001|Overall Study|Lost to Follow-up|1|||
146672514|NCT04066023|528978125|FG002|Overall Study|Lost to Follow-up|1|||
146672515|NCT04066023|528978123|FG000|Overall Study|Noncompliance|0|||
146672516|NCT04066023|528978124|FG001|Overall Study|Noncompliance|1|||
146672517|NCT04066023|528978125|FG002|Overall Study|Noncompliance|1|||
146926051|NCT03655717|529888434|FG017|Overall Study|Lost to Follow-up|0|||
146978781|NCT01078623|530085497|FG001|Treatment Period 1|Adverse Event|1|||
146978782|NCT01078623|530085498|FG002|Treatment Period 1|Adverse Event|1|||
146672518|NCT01552694|528978126|FG000|Overall Study|Lost to Follow-up|0|||
146672519|NCT01552694|528978127|FG001|Overall Study|Lost to Follow-up|1|||
146672520|NCT01552694|528978126|FG000|Overall Study|Protocol Violation|0|||
146672521|NCT01552694|528978127|FG001|Overall Study|Protocol Violation|1|||
146672522|NCT04665856|528978128|FG000|Overall Study|Site Terminated by Sponsor|1|||
146672523|NCT04665856|528978129|FG001|Overall Study|Site Terminated by Sponsor|0|||
146672524|NCT04665856|528978128|FG000|Overall Study|Withdrawal by Subject|2|||
146672525|NCT04665856|528978129|FG001|Overall Study|Withdrawal by Subject|0|||
146672526|NCT04665856|528978128|FG000|Overall Study|Lost to Follow-up|3|||
146926052|NCT03655717|529888435|FG018|Overall Study|Lost to Follow-up|0|||
146926053|NCT03655717|529888436|FG019|Overall Study|Lost to Follow-up|0|||
146978783|NCT01078623|530085499|FG003|Treatment Period 1|Adverse Event|0|||
146926054|NCT03655717|529888437|FG020|Overall Study|Lost to Follow-up|0|||
146926055|NCT03655717|529888438|FG021|Overall Study|Lost to Follow-up|0|||
146926056|NCT03655717|529888439|FG022|Overall Study|Lost to Follow-up|0|||
146926057|NCT03655717|529888440|FG023|Overall Study|Lost to Follow-up|0|||
146672527|NCT04665856|528978129|FG001|Overall Study|Lost to Follow-up|2|||
146672528|NCT04665856|528978128|FG000|Overall Study|Death|39|||
146672529|NCT04665856|528978129|FG001|Overall Study|Death|44|||
146672530|NCT04665856|528978128|FG000|Overall Study|Ongoing in study|17|||
146672531|NCT04665856|528978129|FG001|Overall Study|Ongoing in study|15|||
146672532|NCT00191139|528978130|FG000|Overall Study|Adverse Event|2|||
146672533|NCT00191139|528978131|FG001|Overall Study|Adverse Event|6|||
146672534|NCT00191139|528978130|FG000|Overall Study|Death|2|||
146672535|NCT00191139|528978131|FG001|Overall Study|Death|0|||
146672536|NCT00191139|528978130|FG000|Overall Study|Withdrawal by Subject|0|||
146672537|NCT00191139|528978131|FG001|Overall Study|Withdrawal by Subject|3|||
146672538|NCT00191139|528978130|FG000|Overall Study|Disease Progression|0|||
146672539|NCT00191139|528978131|FG001|Overall Study|Disease Progression|1|||
146672540|NCT00191139|528978130|FG000|Overall Study|Other|1|||
146672541|NCT00191139|528978131|FG001|Overall Study|Other|2|||
146672542|NCT03386448|528978133|FG000|Overall Study|Adverse Event|0|||
146672543|NCT03386448|528978134|FG001|Overall Study|Adverse Event|2|||
146672544|NCT03338010|528978137|FG000|Overall Study|Withdrawal by Subject|14|||
146672545|NCT03338010|528978138|FG001|Overall Study|Withdrawal by Subject|8|||
146672546|NCT03338010|528978137|FG000|Overall Study|Lost to Follow-up|4|||
146672547|NCT03338010|528978138|FG001|Overall Study|Lost to Follow-up|2|||
146672548|NCT03338010|528978137|FG000|Overall Study|Adverse Event|3|||
146672549|NCT03338010|528978138|FG001|Overall Study|Adverse Event|2|||
146672550|NCT03338010|528978137|FG000|Overall Study|Physician Decision|2|||
146672551|NCT03338010|528978138|FG001|Overall Study|Physician Decision|2|||
146672552|NCT03338010|528978137|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146672553|NCT03338010|528978138|FG001|Overall Study|Non-Compliance with Study Drug|3|||
146672554|NCT03338010|528978137|FG000|Overall Study|Protocol Violation|0|||
146672555|NCT03338010|528978138|FG001|Overall Study|Protocol Violation|1|||
146672556|NCT02465515|528978139|FG000|Overall Study|Investigator site closed|4|||
146672557|NCT02465515|528978140|FG001|Overall Study|Investigator site closed|5|||
146672558|NCT02465515|528978139|FG000|Overall Study|Withdrawal by Subject|74|||
146672559|NCT02465515|528978140|FG001|Overall Study|Withdrawal by Subject|43|||
146672560|NCT02465515|528978139|FG000|Overall Study|Physician Decision|8|||
146672561|NCT02465515|528978140|FG001|Overall Study|Physician Decision|12|||
146672562|NCT02465515|528978139|FG000|Overall Study|Lost to Follow-up|68|||
146672563|NCT02465515|528978140|FG001|Overall Study|Lost to Follow-up|51|||
146672564|NCT02564796|528978141|FG000|Overall Study|Physician Decision|2|||
146672565|NCT02564796|528978142|FG001|Overall Study|Physician Decision|2|||
146672566|NCT00293033|528978143|FG000|Open-label Titration Period|Adverse Event|10|||
146672567|NCT00293033|528978143|FG000|Open-label Titration Period|Death|3|||
146672568|NCT00293033|528978143|FG000|Open-label Titration Period|Lack of Efficacy|5|||
146672569|NCT00293033|528978143|FG000|Open-label Titration Period|Protocol Violation|2|||
146672570|NCT00293033|528978143|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
146672571|NCT00293033|528978143|FG000|Open-label Titration Period|Noncompliance and other|27|||
146672572|NCT00293033|528978143|FG000|Double-blind Treatment Period|Adverse Event|3|||
146672573|NCT00293033|528978143|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
146672574|NCT00293033|528978143|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
146672575|NCT00293033|528978143|FG000|Double-blind Treatment Period|Noncompliance|4|||
146672576|NCT03583697|528978144|FG000|Overall Study|Withdrawal by Subject|0|||
146672577|NCT03583697|528978145|FG001|Overall Study|Withdrawal by Subject|0|||
146672578|NCT03583697|528978146|FG002|Overall Study|Withdrawal by Subject|1|||
146672579|NCT03583697|528978144|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
146672580|NCT03583697|528978145|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
146672581|NCT03583697|528978146|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
146672582|NCT00114530|528978147|FG000|Overall Study|Death|3|||
146774074|NCT01972724|529343518|FG002|Open-Label|Withdrew Consent|3|||
146926058|NCT03655717|529888441|FG024|Overall Study|Lost to Follow-up|0|||
146926059|NCT03655717|529888442|FG025|Overall Study|Lost to Follow-up|0|||
146926060|NCT03162055|529890678|FG000|Overall Study|Adverse Event|6|||
146926061|NCT03162055|529890679|FG001|Overall Study|Adverse Event|5|||
146926062|NCT03162055|529890678|FG000|Overall Study|Death|3|||
146672583|NCT00114530|528978148|FG001|Overall Study|Death|11|||
146672584|NCT00114530|528978147|FG000|Overall Study|Lost to Follow-up|1|||
146672585|NCT00114530|528978148|FG001|Overall Study|Lost to Follow-up|1|||
146672586|NCT00114530|528978147|FG000|Overall Study|Physician Decision|1|||
146672587|NCT00114530|528978148|FG001|Overall Study|Physician Decision|1|||
146672588|NCT00114530|528978147|FG000|Overall Study|Withdrawal by Subject|2|||
146672589|NCT00114530|528978148|FG001|Overall Study|Withdrawal by Subject|6|||
146774075|NCT01972724|529343516|FG000|Open-Label|Significant Protocol Deviation|0|||
146926063|NCT03162055|529890679|FG001|Overall Study|Death|3|||
146926064|NCT03162055|529890678|FG000|Overall Study|Lost to Follow-up|0|||
146672590|NCT00114530|528978147|FG000|Overall Study|Breast Cancer|1|||
146926065|NCT03162055|529890679|FG001|Overall Study|Lost to Follow-up|1|||
146774076|NCT01972724|529343517|FG001|Open-Label|Significant Protocol Deviation|0|||
146672591|NCT00114530|528978148|FG001|Overall Study|Breast Cancer|0|||
146672592|NCT00114530|528978147|FG000|Overall Study|Subject decision after endpoint failure|0|||
146672593|NCT00114530|528978148|FG001|Overall Study|Subject decision after endpoint failure|1|||
146672594|NCT00114530|528978147|FG000|Overall Study|Ineligible|1|||
146672595|NCT00114530|528978148|FG001|Overall Study|Ineligible|0|||
146672596|NCT03724032|528978150|FG000|Overall Study|Physician Decision|1|||
146672597|NCT03724032|528978151|FG001|Overall Study|Physician Decision|0|||
146672598|NCT03724032|528978152|FG002|Overall Study|Physician Decision|0|||
146672599|NCT03724032|528978150|FG000|Overall Study|Protocol Violation|2|||
146672600|NCT03724032|528978151|FG001|Overall Study|Protocol Violation|2|||
146672601|NCT03724032|528978152|FG002|Overall Study|Protocol Violation|1|||
146672602|NCT00751933|528978153|FG000|Overall Study|Withdrawal by Subject|0|||
146672603|NCT00751933|528978154|FG001|Overall Study|Withdrawal by Subject|1|||
146672604|NCT00751933|528978155|FG002|Overall Study|Withdrawal by Subject|0|||
146672605|NCT00751933|528978156|FG003|Overall Study|Withdrawal by Subject|0|||
146672606|NCT00751933|528978153|FG000|Overall Study|Physician Decision|0|||
146672607|NCT00751933|528978154|FG001|Overall Study|Physician Decision|0|||
146672608|NCT00751933|528978155|FG002|Overall Study|Physician Decision|1|||
146672609|NCT00751933|528978156|FG003|Overall Study|Physician Decision|1|||
146672610|NCT01817530|528978158|FG000|Overall Study|Exclusionary Medication Received|0|||
146672611|NCT01817530|528978159|FG001|Overall Study|Exclusionary Medication Received|0|||
146672612|NCT01817530|528978160|FG002|Overall Study|Exclusionary Medication Received|0|||
146672613|NCT01817530|528978161|FG003|Overall Study|Exclusionary Medication Received|0|||
146672614|NCT01817530|528978162|FG004|Overall Study|Exclusionary Medication Received|1|||
146672615|NCT01817530|528978163|FG005|Overall Study|Exclusionary Medication Received|0|||
146672616|NCT01817530|528978164|FG006|Overall Study|Exclusionary Medication Received|0|||
146672617|NCT01817530|528978165|FG007|Overall Study|Exclusionary Medication Received|0|||
146672618|NCT01817530|528978158|FG000|Overall Study|Adverse Event|6|||
146672619|NCT01817530|528978159|FG001|Overall Study|Adverse Event|3|||
146672620|NCT01817530|528978160|FG002|Overall Study|Adverse Event|2|||
146672621|NCT01817530|528978161|FG003|Overall Study|Adverse Event|5|||
146672622|NCT01817530|528978162|FG004|Overall Study|Adverse Event|0|||
146672623|NCT01817530|528978163|FG005|Overall Study|Adverse Event|10|||
146672624|NCT01817530|528978164|FG006|Overall Study|Adverse Event|5|||
146672625|NCT01817530|528978165|FG007|Overall Study|Adverse Event|8|||
146672626|NCT01817530|528978158|FG000|Overall Study|Subject Noncompliant|3|||
146672627|NCT01817530|528978159|FG001|Overall Study|Subject Noncompliant|1|||
146672628|NCT01817530|528978160|FG002|Overall Study|Subject Noncompliant|0|||
146672629|NCT01817530|528978161|FG003|Overall Study|Subject Noncompliant|4|||
146672630|NCT01817530|528978162|FG004|Overall Study|Subject Noncompliant|0|||
146672631|NCT01817530|528978163|FG005|Overall Study|Subject Noncompliant|1|||
146672632|NCT01817530|528978164|FG006|Overall Study|Subject Noncompliant|1|||
146672633|NCT01817530|528978165|FG007|Overall Study|Subject Noncompliant|1|||
146672634|NCT01817530|528978158|FG000|Overall Study|Lack of Efficacy|1|||
146672635|NCT01817530|528978159|FG001|Overall Study|Lack of Efficacy|0|||
146672636|NCT01817530|528978160|FG002|Overall Study|Lack of Efficacy|0|||
146672637|NCT01817530|528978161|FG003|Overall Study|Lack of Efficacy|0|||
146672638|NCT01817530|528978162|FG004|Overall Study|Lack of Efficacy|0|||
146672639|NCT01817530|528978163|FG005|Overall Study|Lack of Efficacy|1|||
146672640|NCT01817530|528978164|FG006|Overall Study|Lack of Efficacy|0|||
146672641|NCT01817530|528978165|FG007|Overall Study|Lack of Efficacy|1|||
146672642|NCT01817530|528978158|FG000|Overall Study|Pregnancy|0|||
146672643|NCT01817530|528978159|FG001|Overall Study|Pregnancy|0|||
146672644|NCT01817530|528978160|FG002|Overall Study|Pregnancy|0|||
146672645|NCT01817530|528978161|FG003|Overall Study|Pregnancy|0|||
146672646|NCT01817530|528978162|FG004|Overall Study|Pregnancy|0|||
146672647|NCT01817530|528978163|FG005|Overall Study|Pregnancy|1|||
146672648|NCT01817530|528978164|FG006|Overall Study|Pregnancy|0|||
146672649|NCT01817530|528978165|FG007|Overall Study|Pregnancy|0|||
146672650|NCT01817530|528978158|FG000|Overall Study|Other|0|||
146672651|NCT01817530|528978159|FG001|Overall Study|Other|1|||
146672652|NCT01817530|528978160|FG002|Overall Study|Other|0|||
146774077|NCT01972724|529343518|FG002|Open-Label|Significant Protocol Deviation|2|||
146672653|NCT01817530|528978161|FG003|Overall Study|Other|0|||
146672654|NCT01817530|528978162|FG004|Overall Study|Other|1|||
146672655|NCT01817530|528978163|FG005|Overall Study|Other|0|||
146672656|NCT01817530|528978164|FG006|Overall Study|Other|5|||
146672657|NCT01817530|528978165|FG007|Overall Study|Other|0|||
146672658|NCT01817530|528978158|FG000|Overall Study|Surgery or Invasive Intervention|1|||
146672659|NCT01817530|528978159|FG001|Overall Study|Surgery or Invasive Intervention|0|||
146672660|NCT01817530|528978160|FG002|Overall Study|Surgery or Invasive Intervention|0|||
146672661|NCT01817530|528978161|FG003|Overall Study|Surgery or Invasive Intervention|0|||
146774078|NCT00106080|529343526|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
146672662|NCT01817530|528978162|FG004|Overall Study|Surgery or Invasive Intervention|1|||
146672663|NCT01817530|528978163|FG005|Overall Study|Surgery or Invasive Intervention|1|||
146672664|NCT01817530|528978164|FG006|Overall Study|Surgery or Invasive Intervention|1|||
146672665|NCT01817530|528978165|FG007|Overall Study|Surgery or Invasive Intervention|0|||
146672666|NCT01817530|528978158|FG000|Overall Study|Consent Withdrawn by Subject|3|||
146672667|NCT01817530|528978159|FG001|Overall Study|Consent Withdrawn by Subject|4|||
146672668|NCT01817530|528978160|FG002|Overall Study|Consent Withdrawn by Subject|7|||
146672669|NCT01817530|528978161|FG003|Overall Study|Consent Withdrawn by Subject|3|||
146672670|NCT01817530|528978162|FG004|Overall Study|Consent Withdrawn by Subject|5|||
146672671|NCT01817530|528978163|FG005|Overall Study|Consent Withdrawn by Subject|3|||
146672672|NCT01817530|528978164|FG006|Overall Study|Consent Withdrawn by Subject|3|||
146672673|NCT01817530|528978165|FG007|Overall Study|Consent Withdrawn by Subject|10|||
146672674|NCT01817530|528978158|FG000|Overall Study|Lost to Follow-up|1|||
146672675|NCT01817530|528978159|FG001|Overall Study|Lost to Follow-up|4|||
146672676|NCT01817530|528978160|FG002|Overall Study|Lost to Follow-up|2|||
146672677|NCT01817530|528978161|FG003|Overall Study|Lost to Follow-up|1|||
146672678|NCT01817530|528978162|FG004|Overall Study|Lost to Follow-up|3|||
146672679|NCT01817530|528978163|FG005|Overall Study|Lost to Follow-up|2|||
146672680|NCT01817530|528978164|FG006|Overall Study|Lost to Follow-up|8|||
146672681|NCT01817530|528978165|FG007|Overall Study|Lost to Follow-up|4|||
146672682|NCT03846804|528978166|FG000|Overall Study|Refused blood draw|1|||
146672683|NCT03846804|528978166|FG000|Overall Study|Protocol Violation|1|||
146672684|NCT00679432|528978167|FG000|Overall Study|Adverse Event|5|||
146672685|NCT00679432|528978168|FG001|Overall Study|Adverse Event|6|||
146672686|NCT00679432|528978169|FG002|Overall Study|Adverse Event|10|||
146672687|NCT00679432|528978170|FG003|Overall Study|Adverse Event|7|||
146672688|NCT00679432|528978167|FG000|Overall Study|Protocol Violation|1|||
146672689|NCT00679432|528978168|FG001|Overall Study|Protocol Violation|1|||
146672690|NCT00679432|528978169|FG002|Overall Study|Protocol Violation|2|||
146672691|NCT00679432|528978170|FG003|Overall Study|Protocol Violation|1|||
146672692|NCT00679432|528978167|FG000|Overall Study|Withdrawal by Subject|8|||
146672693|NCT00679432|528978168|FG001|Overall Study|Withdrawal by Subject|11|||
146672694|NCT00679432|528978169|FG002|Overall Study|Withdrawal by Subject|10|||
146672695|NCT00679432|528978170|FG003|Overall Study|Withdrawal by Subject|9|||
146672696|NCT00679432|528978167|FG000|Overall Study|Lost to Follow-up|1|||
146672697|NCT00679432|528978168|FG001|Overall Study|Lost to Follow-up|5|||
146672698|NCT00679432|528978169|FG002|Overall Study|Lost to Follow-up|4|||
146672699|NCT00679432|528978170|FG003|Overall Study|Lost to Follow-up|2|||
146672700|NCT00679432|528978167|FG000|Overall Study|Physician Decision|3|||
146672701|NCT00679432|528978168|FG001|Overall Study|Physician Decision|2|||
146672702|NCT00679432|528978169|FG002|Overall Study|Physician Decision|2|||
146672703|NCT00679432|528978170|FG003|Overall Study|Physician Decision|2|||
146672704|NCT00679432|528978167|FG000|Overall Study|Sponsor decision|1|||
146672705|NCT00679432|528978168|FG001|Overall Study|Sponsor decision|0|||
146672706|NCT00679432|528978169|FG002|Overall Study|Sponsor decision|0|||
146672707|NCT00679432|528978170|FG003|Overall Study|Sponsor decision|0|||
146672708|NCT00679432|528978167|FG000|Overall Study|Lack of Efficacy|13|||
146672709|NCT00679432|528978168|FG001|Overall Study|Lack of Efficacy|9|||
146672710|NCT00679432|528978169|FG002|Overall Study|Lack of Efficacy|14|||
146672711|NCT00679432|528978170|FG003|Overall Study|Lack of Efficacy|8|||
146672712|NCT00679432|528978167|FG000|Overall Study|Infectious colitis, normal histology|5|||
146672713|NCT00679432|528978168|FG001|Overall Study|Infectious colitis, normal histology|4|||
146672714|NCT00679432|528978169|FG002|Overall Study|Infectious colitis, normal histology|8|||
146672715|NCT00679432|528978170|FG003|Overall Study|Infectious colitis, normal histology|3|||
146672716|NCT00679432|528978167|FG000|Overall Study|Randomization error, return to prior Rx|0|||
146672717|NCT00679432|528978168|FG001|Overall Study|Randomization error, return to prior Rx|0|||
146672718|NCT00679432|528978169|FG002|Overall Study|Randomization error, return to prior Rx|3|||
146672719|NCT00679432|528978170|FG003|Overall Study|Randomization error, return to prior Rx|0|||
146672720|NCT00824720|528978171|FG000|Overall Study|failed plug insertion|3|||
146672721|NCT00824720|528978172|FG001|Overall Study|failed plug insertion|1|||
146672722|NCT00824720|528978173|FG002|Overall Study|failed plug insertion|0|||
146672723|NCT00824720|528978171|FG000|Overall Study|Protocol Violation|0|||
146672724|NCT00824720|528978172|FG001|Overall Study|Protocol Violation|0|||
146672725|NCT00824720|528978173|FG002|Overall Study|Protocol Violation|1|||
146672726|NCT02339584|528978174|FG000|Overall Study|Adverse Event|11|||
146672727|NCT02339584|528978175|FG001|Overall Study|Adverse Event|7|||
146672728|NCT02339584|528978174|FG000|Overall Study|Lack of Efficacy|0|||
146672729|NCT02339584|528978175|FG001|Overall Study|Lack of Efficacy|1|||
146672730|NCT02339584|528978174|FG000|Overall Study|Physician Decision|1|||
146672731|NCT02339584|528978175|FG001|Overall Study|Physician Decision|2|||
146672732|NCT02339584|528978174|FG000|Overall Study|Protocol Violation|1|||
146672733|NCT02339584|528978175|FG001|Overall Study|Protocol Violation|1|||
146672734|NCT02339584|528978174|FG000|Overall Study|Withdrawal by Subject|2|||
146672735|NCT02339584|528978175|FG001|Overall Study|Withdrawal by Subject|4|||
146672736|NCT00743483|528978176|FG000|Baseline Period|Physician Decision|1|||
146672737|NCT00743483|528978176|FG000|Treatment Period|Adverse Event|1|||
146672738|NCT01084083|528978177|FG000|Overall Study|Adverse Event|5|||
146672739|NCT01084083|528978177|FG000|Overall Study|Death|1|||
146672740|NCT01084083|528978177|FG000|Overall Study|Withdrawal by Subject|2|||
146672741|NCT01084083|528978177|FG000|Overall Study|Complicating disease|1|||
146672742|NCT01084083|528978177|FG000|Overall Study|Other|2|||
146672743|NCT01084083|528978177|FG000|Overall Study|Never started assigned therapy|1|||
146672744|NCT01273597|528978178|FG000|Overall Study|Adverse Event|5|||
146672745|NCT01273597|528978178|FG000|Overall Study|Underwent Kidney Transplantation|2|||
146672746|NCT01273597|528978178|FG000|Overall Study|Reason Not Reported|1|||
146672747|NCT01466153|528978181|FG000|Overall Study|Disease Progression|2|||
146672748|NCT01466153|528978182|FG001|Overall Study|Disease Progression|2|||
146672749|NCT01466153|528978183|FG002|Overall Study|Disease Progression|0|||
146672750|NCT01466153|528978181|FG000|Overall Study|Adverse Event|14|||
146672751|NCT01466153|528978182|FG001|Overall Study|Adverse Event|13|||
146672752|NCT01466153|528978183|FG002|Overall Study|Adverse Event|17|||
146672753|NCT01466153|528978181|FG000|Overall Study|Withdrawal of Consent|2|||
146672754|NCT01466153|528978182|FG001|Overall Study|Withdrawal of Consent|0|||
146672755|NCT01466153|528978183|FG002|Overall Study|Withdrawal of Consent|0|||
146672756|NCT01466153|528978181|FG000|Overall Study|Investigator Discretion|3|||
146672757|NCT01466153|528978182|FG001|Overall Study|Investigator Discretion|2|||
146672758|NCT01466153|528978183|FG002|Overall Study|Investigator Discretion|2|||
146672759|NCT01466153|528978181|FG000|Overall Study|Randomized-Not Treated|2|||
146672760|NCT01466153|528978182|FG001|Overall Study|Randomized-Not Treated|3|||
146672761|NCT01466153|528978183|FG002|Overall Study|Randomized-Not Treated|4|||
146672762|NCT01466153|528978181|FG000|Overall Study|Other-Unspecified|6|||
146672763|NCT01466153|528978182|FG001|Overall Study|Other-Unspecified|4|||
146672764|NCT01466153|528978183|FG002|Overall Study|Other-Unspecified|2|||
146672765|NCT01785069|528978187|FG000|Overall Study|Implanted with nonstudy device|1|||
146672766|NCT01785069|528978188|FG001|Overall Study|Implanted with nonstudy device|2|||
146672767|NCT01785069|528978189|FG002|Overall Study|Implanted with nonstudy device|1|||
146672768|NCT01785069|528978190|FG003|Overall Study|Implanted with nonstudy device|0|||
146672769|NCT01785069|528978187|FG000|Overall Study|Death|0|||
146672770|NCT01785069|528978188|FG001|Overall Study|Death|0|||
146672771|NCT01785069|528978189|FG002|Overall Study|Death|2|||
146672772|NCT01785069|528978190|FG003|Overall Study|Death|0|||
146672773|NCT01785069|528978187|FG000|Overall Study|Subject choice|2|||
146672774|NCT01785069|528978188|FG001|Overall Study|Subject choice|2|||
146672775|NCT01785069|528978189|FG002|Overall Study|Subject choice|0|||
146672776|NCT01785069|528978190|FG003|Overall Study|Subject choice|1|||
146672777|NCT01785069|528978187|FG000|Overall Study|Lost to Follow-up|1|||
146672778|NCT01785069|528978188|FG001|Overall Study|Lost to Follow-up|2|||
146672779|NCT01785069|528978189|FG002|Overall Study|Lost to Follow-up|4|||
146672780|NCT01785069|528978190|FG003|Overall Study|Lost to Follow-up|1|||
146672781|NCT01785069|528978187|FG000|Overall Study|Reason not Specified|1|||
146672782|NCT01785069|528978188|FG001|Overall Study|Reason not Specified|2|||
146672783|NCT01785069|528978189|FG002|Overall Study|Reason not Specified|1|||
146672784|NCT01785069|528978190|FG003|Overall Study|Reason not Specified|4|||
146672785|NCT01785069|528978187|FG000|Overall Study|Not evaluable|7|||
146672786|NCT01785069|528978188|FG001|Overall Study|Not evaluable|4|||
146672787|NCT01785069|528978189|FG002|Overall Study|Not evaluable|5|||
146672788|NCT01785069|528978190|FG003|Overall Study|Not evaluable|8|||
146672789|NCT01088997|528978193|FG000|Overall Study|Physician Decision|1|||
146672790|NCT01088997|528978194|FG001|Overall Study|Physician Decision|1|||
146672791|NCT01088997|528978193|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
146672792|NCT01088997|528978194|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
146672793|NCT01088997|528978193|FG000|Overall Study|Excluded prior to receiving drug|1|||
146672794|NCT01088997|528978194|FG001|Overall Study|Excluded prior to receiving drug|1|||
146672795|NCT05570500|528978199|FG000|Overall Study|Lost to Follow-up|7|||
146672796|NCT05570500|528978200|FG001|Overall Study|Lost to Follow-up|5|||
146672797|NCT04997304|528978201|FG000|Overall Study|Lost to Follow-up|11|||
146672798|NCT04997304|528978201|FG000|Overall Study|Death|1|||
146672799|NCT04997304|528978201|FG000|Overall Study|Withdrawal by Subject|14|||
146672800|NCT00688753|528980340|FG000|Overall Study|Disease progression|55|||
146672801|NCT00688753|528980340|FG000|Overall Study|Missing|1|||
146672802|NCT00688753|528980340|FG000|Overall Study|Death|9|||
146672803|NCT00688753|528980340|FG000|Overall Study|Withdrawal by Subject|3|||
146774079|NCT00106080|529343527|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
146672804|NCT00688753|528980340|FG000|Overall Study|Adverse Event|20|||
146672805|NCT00688753|528980340|FG000|Overall Study|Protocol Violation|1|||
146672806|NCT00688753|528980340|FG000|Overall Study|Lost to Follow-up|3|||
146672807|NCT05996718|528980341|FG000|Overall Study|Lost to Follow-up|3|||
146774080|NCT00978042|529343529|FG000|Initial Treatment Period|Treated in Error|0|||
146774081|NCT00978042|529343530|FG001|Initial Treatment Period|Treated in Error|3|||
146774082|NCT00978042|529343529|FG000|Initial Treatment Period|Ineligibility|1|||
146774083|NCT00978042|529343530|FG001|Initial Treatment Period|Ineligibility|0|||
146774084|NCT00978042|529343529|FG000|Initial Treatment Period|Lost to Follow-up|21|||
146774085|NCT00978042|529343530|FG001|Initial Treatment Period|Lost to Follow-up|3|||
146774086|NCT00978042|529343529|FG000|Initial Treatment Period|Adverse Event|2|||
146774087|NCT00978042|529343530|FG001|Initial Treatment Period|Adverse Event|0|||
146774088|NCT00978042|529343529|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
146774089|NCT00978042|529343530|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
146774090|NCT00978042|529343529|FG000|Initial Treatment Period|Consent withdrawn|22|||
146672820|NCT01713686|528980344|FG000|Overall Study|Lost to Follow-up|9|||
146672821|NCT01713686|528980344|FG000|Overall Study|Withdrawal by Subject|6|||
146672822|NCT03187197|528980348|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
146672823|NCT03187197|528980349|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
146672824|NCT03187197|528980350|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
146672825|NCT03187197|528980348|FG000|Overall Study|Withdrawal by Subject|8|||
146672826|NCT03187197|528980349|FG001|Overall Study|Withdrawal by Subject|63|||
146672827|NCT03187197|528980350|FG002|Overall Study|Withdrawal by Subject|4|||
146672828|NCT03187197|528980348|FG000|Overall Study|Lost to Follow-up|1|||
146672829|NCT03187197|528980349|FG001|Overall Study|Lost to Follow-up|60|||
146672830|NCT03187197|528980350|FG002|Overall Study|Lost to Follow-up|7|||
146672831|NCT03187197|528980348|FG000|Overall Study|Adverse Event|6|||
146672832|NCT03187197|528980349|FG001|Overall Study|Adverse Event|29|||
146672833|NCT03187197|528980350|FG002|Overall Study|Adverse Event|0|||
146672834|NCT03187197|528980348|FG000|Overall Study|Death|0|||
146672835|NCT03187197|528980349|FG001|Overall Study|Death|11|||
146672836|NCT03187197|528980350|FG002|Overall Study|Death|0|||
146672837|NCT03187197|528980348|FG000|Overall Study|Administrative problem|1|||
146672838|NCT03187197|528980349|FG001|Overall Study|Administrative problem|1|||
146672839|NCT03187197|528980350|FG002|Overall Study|Administrative problem|0|||
146672840|NCT03187197|528980348|FG000|Overall Study|Reason not listed|2|||
146672841|NCT03187197|528980349|FG001|Overall Study|Reason not listed|54|||
146672842|NCT03187197|528980350|FG002|Overall Study|Reason not listed|1|||
146672843|NCT03187197|528980348|FG000|Overall Study|Missing|1|||
146672844|NCT03187197|528980349|FG001|Overall Study|Missing|32|||
146672845|NCT03187197|528980350|FG002|Overall Study|Missing|3|||
146672846|NCT03187197|528980348|FG000|Overall Study|Status missing|2|||
146672847|NCT03187197|528980349|FG001|Overall Study|Status missing|33|||
146672848|NCT03187197|528980350|FG002|Overall Study|Status missing|3|||
146672849|NCT03187197|528980348|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
146672850|NCT03187197|528980349|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
146672851|NCT03187197|528980350|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
146672852|NCT02385045|528980351|FG000|Overall Study|Endoscopy could not be completed|4|||
146672853|NCT02200211|528980354|FG000|Overall Study|Lost to Follow-up|7|||
146672854|NCT02200211|528980355|FG001|Overall Study|Lost to Follow-up|7|||
146672855|NCT02200211|528980356|FG002|Overall Study|Lost to Follow-up|1|||
146672856|NCT02200211|528980357|FG003|Overall Study|Lost to Follow-up|2|||
146672857|NCT02200211|528980354|FG000|Overall Study|Withdrawal by Subject|1|||
146672858|NCT02200211|528980355|FG001|Overall Study|Withdrawal by Subject|0|||
146672859|NCT02200211|528980356|FG002|Overall Study|Withdrawal by Subject|0|||
146672860|NCT02200211|528980357|FG003|Overall Study|Withdrawal by Subject|0|||
146672861|NCT00381485|528980358|FG000|Open-Label Run-In Period|Adverse Event|9|||
146672862|NCT00381485|528980359|FG001|Open-Label Run-In Period|Adverse Event|0|||
146672863|NCT00381485|528980360|FG002|Open-Label Run-In Period|Adverse Event|0|||
146672864|NCT00381485|528980361|FG003|Open-Label Run-In Period|Adverse Event|0|||
146672865|NCT00381485|528980358|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
146672866|NCT00381485|528980359|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
146672867|NCT00381485|528980360|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
146672868|NCT00381485|528980361|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
146672869|NCT00381485|528980358|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
146672870|NCT00381485|528980359|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
146672871|NCT00381485|528980360|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
146672872|NCT00381485|528980361|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
146672873|NCT00381485|528980358|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
146672874|NCT00381485|528980359|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
146672875|NCT00381485|528980360|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
146672876|NCT00381485|528980361|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
146926066|NCT03162055|529890678|FG000|Overall Study|Study-specific withdrawal criteria|22|||
146926067|NCT03162055|529890679|FG001|Overall Study|Study-specific withdrawal criteria|14|||
146926068|NCT03162055|529890678|FG000|Overall Study|Withdrawal by Subject|17|||
146926069|NCT03162055|529890679|FG001|Overall Study|Withdrawal by Subject|2|||
146926070|NCT03162055|529890678|FG000|Overall Study|Did not receive treatment|2|||
146926071|NCT03162055|529890679|FG001|Overall Study|Did not receive treatment|0|||
146926072|NCT03162055|529890678|FG000|Overall Study|Incorrect randomization|4|||
146672877|NCT00381485|528980358|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
146672878|NCT00381485|528980359|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
146672879|NCT00381485|528980360|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
146672880|NCT00381485|528980361|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
146926073|NCT03162055|529890679|FG001|Overall Study|Incorrect randomization|3|||
146672881|NCT00381485|528980358|FG000|Open-Label Run-In Period|Treatment failure|1|||
146672882|NCT00381485|528980359|FG001|Open-Label Run-In Period|Treatment failure|0|||
146672883|NCT00381485|528980360|FG002|Open-Label Run-In Period|Treatment failure|0|||
146672884|NCT00381485|528980361|FG003|Open-Label Run-In Period|Treatment failure|0|||
146926074|NCT03162055|529890678|FG000|Overall Study|Other|8|||
146672885|NCT00381485|528980358|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146672886|NCT00381485|528980359|FG001|Double-Blind Treatment Period|Adverse Event|2|||
146672887|NCT00381485|528980360|FG002|Double-Blind Treatment Period|Adverse Event|2|||
146672888|NCT00381485|528980361|FG003|Double-Blind Treatment Period|Adverse Event|5|||
146672889|NCT00381485|528980358|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
146672890|NCT00381485|528980359|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
146672891|NCT00381485|528980360|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
146672892|NCT00381485|528980361|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
146672893|NCT00381485|528980358|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146672894|NCT00381485|528980359|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
146672895|NCT00381485|528980360|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
146672896|NCT00381485|528980361|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
146672897|NCT00381485|528980358|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
146672898|NCT00381485|528980359|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
146672899|NCT00381485|528980360|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
146672900|NCT00381485|528980361|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
146672901|NCT00381485|528980358|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
146672902|NCT00381485|528980359|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
146672903|NCT00381485|528980360|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
146672904|NCT00381485|528980361|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
146672905|NCT00381485|528980358|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
146672906|NCT00381485|528980359|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
146672907|NCT00381485|528980360|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
146672908|NCT00381485|528980361|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
146672909|NCT00381485|528980358|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
146672910|NCT00381485|528980359|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
146672911|NCT00381485|528980360|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
146672912|NCT00381485|528980361|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
146672913|NCT00381485|528980358|FG000|Double-Blind Treatment Period|Administrative|0|||
146672914|NCT00381485|528980359|FG001|Double-Blind Treatment Period|Administrative|1|||
146672915|NCT00381485|528980360|FG002|Double-Blind Treatment Period|Administrative|0|||
146672916|NCT00381485|528980361|FG003|Double-Blind Treatment Period|Administrative|1|||
146672917|NCT01235351|528980362|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
146672918|NCT01235351|528980363|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
146672919|NCT01918774|528980364|FG000|Overall Study|Lost prior to first CBTw session|4|||
146672920|NCT01918774|528980364|FG000|Overall Study|Lost to Follow-up|1|||
146672921|NCT01606800|528980365|FG000|Overall Study|Adverse Event|3|||
146672922|NCT01606800|528980366|FG001|Overall Study|Adverse Event|1|||
146672923|NCT01606800|528980365|FG000|Overall Study|Participant withdrew consent|0|||
146672924|NCT01606800|528980366|FG001|Overall Study|Participant withdrew consent|1|||
146672925|NCT01606800|528980365|FG000|Overall Study|Missing completion status|2|||
146672926|NCT01606800|528980366|FG001|Overall Study|Missing completion status|0|||
146672927|NCT00126191|528980367|FG000|Overall Study|Physician Decision|0|||
146672928|NCT00126191|528980368|FG001|Overall Study|Physician Decision|1|||
146672929|NCT00126191|528980367|FG000|Overall Study|Death|0|||
146672930|NCT00126191|528980368|FG001|Overall Study|Death|1|||
146672931|NCT03000439|528980371|FG000|Open Label Part 1|Adverse Event|6|||
146672932|NCT03000439|528980372|FG001|Open Label Part 1|Adverse Event|0|||
146672933|NCT03000439|528980373|FG002|Open Label Part 1|Adverse Event|0|||
146672934|NCT03000439|528980374|FG003|Open Label Part 1|Adverse Event|0|||
146672935|NCT03000439|528980371|FG000|Open Label Part 1|Other|2|||
146672936|NCT03000439|528980372|FG001|Open Label Part 1|Other|0|||
146672937|NCT03000439|528980373|FG002|Open Label Part 1|Other|0|||
146672938|NCT03000439|528980374|FG003|Open Label Part 1|Other|0|||
146672939|NCT03000439|528980371|FG000|Open Label Part 1|Insufficient clinical response|16|||
146672940|NCT03000439|528980372|FG001|Open Label Part 1|Insufficient clinical response|0|||
146672941|NCT03000439|528980373|FG002|Open Label Part 1|Insufficient clinical response|0|||
146672942|NCT03000439|528980374|FG003|Open Label Part 1|Insufficient clinical response|0|||
146672943|NCT03000439|528980371|FG000|Open Label Part 2|Other|0|||
146672944|NCT03000439|528980372|FG001|Open Label Part 2|Other|5|||
146672945|NCT03000439|528980373|FG002|Open Label Part 2|Other|0|||
146672946|NCT03000439|528980374|FG003|Open Label Part 2|Other|0|||
146926075|NCT03162055|529890679|FG001|Overall Study|Other|15|||
146672947|NCT03000439|528980371|FG000|Open Label Part 2|Insufficient clinical response|0|||
146672948|NCT03000439|528980372|FG001|Open Label Part 2|Insufficient clinical response|12|||
146672949|NCT03000439|528980373|FG002|Open Label Part 2|Insufficient clinical response|0|||
146672950|NCT03000439|528980374|FG003|Open Label Part 2|Insufficient clinical response|0|||
146672951|NCT03000439|528980371|FG000|Double Blind Phase|Adverse Event|0|||
146672952|NCT03000439|528980372|FG001|Double Blind Phase|Adverse Event|0|||
146672953|NCT03000439|528980373|FG002|Double Blind Phase|Adverse Event|2|||
146774091|NCT00978042|529343530|FG001|Initial Treatment Period|Consent withdrawn|9|||
146672954|NCT03000439|528980374|FG003|Double Blind Phase|Adverse Event|1|||
146672955|NCT03000439|528980371|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
146672956|NCT03000439|528980372|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
146672957|NCT03000439|528980373|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
146672958|NCT03000439|528980374|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
146672959|NCT03000439|528980371|FG000|Double Blind Phase|Other|0|||
146672960|NCT03000439|528980372|FG001|Double Blind Phase|Other|0|||
146672961|NCT03000439|528980373|FG002|Double Blind Phase|Other|10|||
146672962|NCT03000439|528980374|FG003|Double Blind Phase|Other|11|||
146672963|NCT03000439|528980371|FG000|Double Blind Phase|Insufficient clinical response|0|||
146672964|NCT03000439|528980372|FG001|Double Blind Phase|Insufficient clinical response|0|||
146774092|NCT00978042|529343529|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
146774093|NCT00978042|529343530|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
146774094|NCT00529516|529343531|FG000|Overall Study|Adverse Event|2|||
146774095|NCT00529516|529343532|FG001|Overall Study|Adverse Event|1|||
146774096|NCT00529516|529343533|FG002|Overall Study|Adverse Event|0|||
146774097|NCT00529516|529343531|FG000|Overall Study|Withdrawal by Subject|1|||
146774098|NCT00529516|529343532|FG001|Overall Study|Withdrawal by Subject|1|||
146774099|NCT00529516|529343533|FG002|Overall Study|Withdrawal by Subject|0|||
146774100|NCT00529516|529343531|FG000|Overall Study|Lost to Follow-up|0|||
146774101|NCT00529516|529343532|FG001|Overall Study|Lost to Follow-up|0|||
146774102|NCT00529516|529343533|FG002|Overall Study|Lost to Follow-up|1|||
146774103|NCT00703820|529343534|FG000|Overall Study|Adverse Event|12|||
146774104|NCT00703820|529343535|FG001|Overall Study|Adverse Event|17|||
146774105|NCT00703820|529343534|FG000|Overall Study|Death|5|||
146774106|NCT00703820|529343535|FG001|Overall Study|Death|0|||
146774107|NCT00703820|529343534|FG000|Overall Study|Lack of Efficacy|11|||
146774108|NCT00703820|529343535|FG001|Overall Study|Lack of Efficacy|11|||
146774109|NCT00703820|529343534|FG000|Overall Study|Received non-protocol therapy|1|||
146774110|NCT00703820|529343535|FG001|Overall Study|Received non-protocol therapy|0|||
146774111|NCT00703820|529343534|FG000|Overall Study|Physician Decision|4|||
146774112|NCT00703820|529343535|FG001|Overall Study|Physician Decision|5|||
146774113|NCT00703820|529343534|FG000|Overall Study|Withdrawal by Subject|2|||
146774114|NCT00703820|529343535|FG001|Overall Study|Withdrawal by Subject|1|||
146774115|NCT00761605|529343536|FG000|Overall Study|Adverse Event|26|||
146774116|NCT00761605|529343536|FG000|Overall Study|Death|2|||
146774117|NCT00761605|529343536|FG000|Overall Study|Lack of Efficacy|26|||
146774118|NCT00761605|529343536|FG000|Overall Study|Lost to Follow-up|29|||
146774119|NCT00761605|529343536|FG000|Overall Study|Withdrawal by Subject|37|||
146774120|NCT00761605|529343536|FG000|Overall Study|Other|21|||
146774121|NCT01985334|529343539|FG000|Overall Study|Administrative problems|1|||
146774122|NCT01985334|529343540|FG001|Overall Study|Administrative problems|1|||
146774123|NCT01985334|529343541|FG002|Overall Study|Administrative problems|0|||
146774124|NCT01985334|529343542|FG003|Overall Study|Administrative problems|2|||
146774125|NCT01985334|529343543|FG004|Overall Study|Administrative problems|0|||
146774126|NCT01985334|529343544|FG005|Overall Study|Administrative problems|1|||
146774127|NCT01985334|529343545|FG006|Overall Study|Administrative problems|1|||
146774128|NCT01985334|529343546|FG007|Overall Study|Administrative problems|3|||
146774129|NCT01985334|529343539|FG000|Overall Study|Death|1|||
146774130|NCT01985334|529343540|FG001|Overall Study|Death|0|||
146774131|NCT01985334|529343541|FG002|Overall Study|Death|0|||
146774132|NCT01985334|529343542|FG003|Overall Study|Death|3|||
146774133|NCT01985334|529343543|FG004|Overall Study|Death|0|||
146774134|NCT01985334|529343544|FG005|Overall Study|Death|0|||
146774135|NCT01985334|529343545|FG006|Overall Study|Death|1|||
146774136|NCT01985334|529343546|FG007|Overall Study|Death|2|||
146774137|NCT01985334|529343539|FG000|Overall Study|Worsening of disease|0|||
146774138|NCT01985334|529343540|FG001|Overall Study|Worsening of disease|0|||
146774139|NCT01985334|529343541|FG002|Overall Study|Worsening of disease|0|||
146774140|NCT01985334|529343542|FG003|Overall Study|Worsening of disease|1|||
146774141|NCT01985334|529343543|FG004|Overall Study|Worsening of disease|0|||
146774142|NCT01985334|529343544|FG005|Overall Study|Worsening of disease|3|||
146774143|NCT01985334|529343545|FG006|Overall Study|Worsening of disease|0|||
146774144|NCT01985334|529343546|FG007|Overall Study|Worsening of disease|1|||
146672965|NCT03000439|528980373|FG002|Double Blind Phase|Insufficient clinical response|0|||
146672966|NCT03000439|528980374|FG003|Double Blind Phase|Insufficient clinical response|2|||
146672967|NCT02370160|528980377|FG000|Overall Study|Death|3|||
146672968|NCT02370160|528980378|FG001|Overall Study|Death|4|||
146774145|NCT01985334|529343539|FG000|Overall Study|Other|2|||
146774146|NCT01985334|529343540|FG001|Overall Study|Other|9|||
146774147|NCT01985334|529343541|FG002|Overall Study|Other|7|||
146774148|NCT01985334|529343542|FG003|Overall Study|Other|17|||
146774149|NCT01985334|529343543|FG004|Overall Study|Other|4|||
146774150|NCT01985334|529343544|FG005|Overall Study|Other|8|||
146774151|NCT01985334|529343545|FG006|Overall Study|Other|4|||
146672969|NCT02370160|528980379|FG002|Overall Study|Death|1|||
146672970|NCT03478930|528980385|FG000|Overall Study|Adverse Event|0|||
146774152|NCT01985334|529343546|FG007|Overall Study|Other|7|||
146774153|NCT01985334|529343539|FG000|Overall Study|Protocol deviation|6|||
146774154|NCT01985334|529343540|FG001|Overall Study|Protocol deviation|31|||
146672971|NCT03478930|528980386|FG001|Overall Study|Adverse Event|1|||
146672972|NCT03478930|528980385|FG000|Overall Study|Lack of Efficacy|3|||
146672973|NCT03478930|528980386|FG001|Overall Study|Lack of Efficacy|3|||
146672974|NCT03478930|528980385|FG000|Overall Study|Withdrawal by Subject|6|||
146672975|NCT03478930|528980386|FG001|Overall Study|Withdrawal by Subject|5|||
146672976|NCT04189081|528980387|FG000|Overall Study|Lost to Follow-up|1|||
146672977|NCT04189081|528980388|FG001|Overall Study|Lost to Follow-up|0|||
146672978|NCT04189081|528980389|FG002|Overall Study|Lost to Follow-up|0|||
146672979|NCT04189081|528980387|FG000|Overall Study|Withdrawal by Subject|0|||
146672980|NCT04189081|528980388|FG001|Overall Study|Withdrawal by Subject|0|||
146672981|NCT04189081|528980389|FG002|Overall Study|Withdrawal by Subject|1|||
146672982|NCT00044083|528980390|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
146672983|NCT00044083|528980391|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
146672984|NCT00044083|528980390|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
146672985|NCT00044083|528980391|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
146672986|NCT00044083|528980390|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
146672987|NCT00044083|528980391|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
146672988|NCT00044083|528980390|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
146672989|NCT00044083|528980391|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
146672990|NCT00044083|528980390|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
146672991|NCT00044083|528980391|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
146672992|NCT00044083|528980390|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
146672993|NCT00044083|528980391|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
146672994|NCT00044083|528980390|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
146672995|NCT00044083|528980391|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
146672996|NCT00044083|528980390|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
146672997|NCT00044083|528980391|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
146672998|NCT00044083|528980390|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
146672999|NCT00044083|528980391|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
146673000|NCT00044083|528980390|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
146673001|NCT00044083|528980391|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
146673002|NCT00288054|528980392|FG000|Overall Study|Protocol Violation|2|||
146673003|NCT00288054|528980392|FG000|Overall Study|Lack of Efficacy|16|||
146673004|NCT00288054|528980392|FG000|Overall Study|Adverse Event|3|||
146673005|NCT00288054|528980392|FG000|Overall Study|Withdrawal by Subject|1|||
146673006|NCT00288054|528980392|FG000|Overall Study|Not protocol specified|2|||
146673007|NCT00289991|528980393|FG000|Overall Study|Death|35|||
146673008|NCT00289991|528980394|FG001|Overall Study|Death|38|||
146673009|NCT00289991|528980393|FG000|Overall Study|Adverse Event|15|||
146673010|NCT00289991|528980394|FG001|Overall Study|Adverse Event|13|||
146673011|NCT00289991|528980393|FG000|Overall Study|Failure of prophylaxis|1|||
146673012|NCT00289991|528980394|FG001|Overall Study|Failure of prophylaxis|1|||
146673013|NCT00289991|528980393|FG000|Overall Study|Fungal breakthrough infection|0|||
146673014|NCT00289991|528980394|FG001|Overall Study|Fungal breakthrough infection|1|||
146673015|NCT00289991|528980393|FG000|Overall Study|Lost to Follow-up|0|||
146673016|NCT00289991|528980394|FG001|Overall Study|Lost to Follow-up|1|||
146673017|NCT00289991|528980393|FG000|Overall Study|Withdrawal by Subject|2|||
146673018|NCT00289991|528980394|FG001|Overall Study|Withdrawal by Subject|12|||
146673019|NCT00289991|528980393|FG000|Overall Study|Other|5|||
146673020|NCT00289991|528980394|FG001|Overall Study|Other|14|||
146673021|NCT00851747|528980414|FG000|Overall Study|Physician Decision|6|||
146673022|NCT00851747|528980415|FG001|Overall Study|Physician Decision|6|||
146673023|NCT00851747|528980416|FG002|Overall Study|Physician Decision|6|||
146673024|NCT02340975|528980417|FG000|Overall Study|Death|6|||
146673025|NCT02340975|528980418|FG001|Overall Study|Death|23|||
146673026|NCT02340975|528980419|FG002|Overall Study|Death|21|||
146673027|NCT02340975|528980420|FG003|Overall Study|Death|7|||
146673028|NCT02340975|528980421|FG004|Overall Study|Death|21|||
146673029|NCT02340975|528980422|FG005|Overall Study|Death|13|||
146673030|NCT02340975|528980417|FG000|Overall Study|Lost to Follow-up|0|||
146673031|NCT02340975|528980418|FG001|Overall Study|Lost to Follow-up|0|||
146673032|NCT02340975|528980419|FG002|Overall Study|Lost to Follow-up|0|||
146673033|NCT02340975|528980420|FG003|Overall Study|Lost to Follow-up|0|||
146673034|NCT02340975|528980421|FG004|Overall Study|Lost to Follow-up|2|||
146673035|NCT02340975|528980422|FG005|Overall Study|Lost to Follow-up|0|||
146673036|NCT02340975|528980417|FG000|Overall Study|Withdrawal by Subject|0|||
146673037|NCT02340975|528980418|FG001|Overall Study|Withdrawal by Subject|0|||
146673038|NCT02340975|528980419|FG002|Overall Study|Withdrawal by Subject|3|||
146673039|NCT02340975|528980420|FG003|Overall Study|Withdrawal by Subject|3|||
146673040|NCT02340975|528980421|FG004|Overall Study|Withdrawal by Subject|2|||
146673041|NCT02340975|528980422|FG005|Overall Study|Withdrawal by Subject|0|||
146673042|NCT02340975|528980417|FG000|Overall Study|Other|0|||
146673043|NCT02340975|528980418|FG001|Overall Study|Other|4|||
146673044|NCT02340975|528980419|FG002|Overall Study|Other|0|||
146673045|NCT02340975|528980420|FG003|Overall Study|Other|2|||
146673046|NCT02340975|528980421|FG004|Overall Study|Other|0|||
146926076|NCT01993615|529890680|FG000|Overall Study|Death|1|||
146926077|NCT01993615|529890681|FG001|Overall Study|Death|0|||
146926078|NCT02370498|529890690|FG000|Overall Study|Adverse Event|10|||
146673047|NCT02340975|528980422|FG005|Overall Study|Other|6|||
146673048|NCT01007812|528980425|FG000|Period 1, One Week|Lost to Follow-up|0|||
146673049|NCT01007812|528980426|FG001|Period 1, One Week|Lost to Follow-up|1|||
146673050|NCT01007812|528980425|FG000|Period 1, One Week|Discomfort|1|||
146673051|NCT01007812|528980426|FG001|Period 1, One Week|Discomfort|0|||
146673052|NCT01091974|528980429|FG000|Overall Study|Did not start intervention|3|||
146673053|NCT01091974|528980430|FG001|Overall Study|Did not start intervention|1|||
146673054|NCT01091974|528980431|FG002|Overall Study|Did not start intervention|3|||
146673055|NCT01091974|528980432|FG003|Overall Study|Did not start intervention|1|||
146673056|NCT01091974|528980429|FG000|Overall Study|resumed sleep medication|0|||
146673057|NCT01091974|528980430|FG001|Overall Study|resumed sleep medication|0|||
146673058|NCT01091974|528980431|FG002|Overall Study|resumed sleep medication|1|||
146673059|NCT01091974|528980432|FG003|Overall Study|resumed sleep medication|2|||
146673060|NCT01091974|528980429|FG000|Overall Study|Withdrawal by Subject|1|||
146673061|NCT01091974|528980430|FG001|Overall Study|Withdrawal by Subject|3|||
146673062|NCT01091974|528980431|FG002|Overall Study|Withdrawal by Subject|2|||
146673063|NCT01091974|528980432|FG003|Overall Study|Withdrawal by Subject|2|||
146673064|NCT01091974|528980429|FG000|Overall Study|side-effects|1|||
146673065|NCT01091974|528980430|FG001|Overall Study|side-effects|1|||
146673066|NCT01091974|528980431|FG002|Overall Study|side-effects|0|||
146673067|NCT01091974|528980432|FG003|Overall Study|side-effects|2|||
146673068|NCT01866293|528980437|FG000|Overall Study|Adverse Event|2|||
146673069|NCT03066804|528980438|FG000|Overall Study|Physician Decision|0|||
146673070|NCT03066804|528980439|FG001|Overall Study|Physician Decision|4|||
146673071|NCT03066804|528980438|FG000|Overall Study|Death|23|||
146673072|NCT03066804|528980439|FG001|Overall Study|Death|17|||
146673073|NCT03066804|528980438|FG000|Overall Study|Withdrawal by Subject|19|||
146673074|NCT03066804|528980439|FG001|Overall Study|Withdrawal by Subject|25|||
146673075|NCT03066804|528980438|FG000|Overall Study|Lost to Follow-up|2|||
146673076|NCT03066804|528980439|FG001|Overall Study|Lost to Follow-up|0|||
146673077|NCT03066804|528980438|FG000|Overall Study|Adverse Event|2|||
146673078|NCT03066804|528980439|FG001|Overall Study|Adverse Event|3|||
146673079|NCT03066804|528980438|FG000|Overall Study|Technical problems|5|||
146673080|NCT03066804|528980439|FG001|Overall Study|Technical problems|1|||
146673081|NCT00555971|528980441|FG000|Overall Study|Adverse Event|1|||
146673082|NCT00555971|528980442|FG001|Overall Study|Adverse Event|1|||
146673083|NCT03982368|528980443|FG000|Overall Study|Adverse Event|6|||
146673084|NCT03982368|528980444|FG001|Overall Study|Adverse Event|4|||
146673085|NCT03982368|528980445|FG002|Overall Study|Adverse Event|3|||
146673086|NCT03982368|528980443|FG000|Overall Study|Lost to Follow-up|2|||
146673087|NCT03982368|528980444|FG001|Overall Study|Lost to Follow-up|1|||
146673088|NCT03982368|528980445|FG002|Overall Study|Lost to Follow-up|0|||
146673089|NCT03982368|528980443|FG000|Overall Study|Withdrawal by Subject|1|||
146673090|NCT03982368|528980444|FG001|Overall Study|Withdrawal by Subject|2|||
146673091|NCT03982368|528980445|FG002|Overall Study|Withdrawal by Subject|0|||
146673092|NCT03982368|528980443|FG000|Overall Study|unknow|4|||
146673093|NCT03982368|528980444|FG001|Overall Study|unknow|0|||
146673094|NCT03982368|528980445|FG002|Overall Study|unknow|2|||
146673095|NCT00518284|528980446|FG000|Overall Study|Adverse Event|0|||
146673096|NCT00518284|528980447|FG001|Overall Study|Adverse Event|1|||
146673097|NCT00518284|528980448|FG002|Overall Study|Adverse Event|0|||
146673098|NCT00518284|528980449|FG003|Overall Study|Adverse Event|0|||
146673099|NCT00518284|528980446|FG000|Overall Study|Study Termination|0|||
146673100|NCT00518284|528980447|FG001|Overall Study|Study Termination|2|||
146673101|NCT00518284|528980448|FG002|Overall Study|Study Termination|1|||
146673102|NCT00518284|528980449|FG003|Overall Study|Study Termination|2|||
146673103|NCT03768414|528980450|FG000|Overall Study|Adverse Event or side effects|72|||
146673104|NCT03768414|528980451|FG001|Overall Study|Adverse Event or side effects|28|||
146673105|NCT03768414|528980450|FG000|Overall Study|Refusal unrelated to adverse event|33|||
146673106|NCT03768414|528980451|FG001|Overall Study|Refusal unrelated to adverse event|33|||
146673107|NCT03768414|528980450|FG000|Overall Study|Progression/relapse|132|||
146673108|NCT03768414|528980451|FG001|Overall Study|Progression/relapse|60|||
146673109|NCT03768414|528980450|FG000|Overall Study|Death|9|||
146673110|NCT03768414|528980451|FG001|Overall Study|Death|6|||
146673111|NCT03768414|528980450|FG000|Overall Study|Other - not protocol specified|45|||
146774155|NCT01985334|529343541|FG002|Overall Study|Protocol deviation|25|||
146774156|NCT01985334|529343542|FG003|Overall Study|Protocol deviation|84|||
146774157|NCT01985334|529343543|FG004|Overall Study|Protocol deviation|17|||
146673112|NCT03768414|528980451|FG001|Overall Study|Other - not protocol specified|18|||
146673113|NCT03768414|528980450|FG000|Overall Study|Reason under review|3|||
146673114|NCT03768414|528980451|FG001|Overall Study|Reason under review|2|||
146673115|NCT02571777|528980453|FG000|Overall Study|Subject/guardian decision|34|||
146673116|NCT02571777|528980454|FG001|Overall Study|Subject/guardian decision|26|||
146774158|NCT01985334|529343544|FG005|Overall Study|Protocol deviation|47|||
146673117|NCT02571777|528980455|FG002|Overall Study|Subject/guardian decision|26|||
146673118|NCT02571777|528980456|FG003|Overall Study|Subject/guardian decision|25|||
146774159|NCT01985334|529343545|FG006|Overall Study|Protocol deviation|15|||
146774160|NCT01985334|529343546|FG007|Overall Study|Protocol deviation|42|||
146774161|NCT01985334|529343539|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
146774162|NCT01985334|529343540|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
146926079|NCT02370498|529890691|FG001|Overall Study|Adverse Event|8|||
146673119|NCT02571777|528980457|FG004|Overall Study|Subject/guardian decision|27|||
146673120|NCT02571777|528980453|FG000|Overall Study|Protocol Deviation|2|||
146673121|NCT02571777|528980454|FG001|Overall Study|Protocol Deviation|3|||
146673122|NCT02571777|528980455|FG002|Overall Study|Protocol Deviation|4|||
146673123|NCT02571777|528980456|FG003|Overall Study|Protocol Deviation|8|||
146673124|NCT02571777|528980457|FG004|Overall Study|Protocol Deviation|4|||
146673125|NCT02571777|528980453|FG000|Overall Study|Death|1|||
146673126|NCT02571777|528980454|FG001|Overall Study|Death|1|||
146673127|NCT02571777|528980455|FG002|Overall Study|Death|4|||
146673128|NCT02571777|528980456|FG003|Overall Study|Death|0|||
146673129|NCT02571777|528980457|FG004|Overall Study|Death|0|||
146673130|NCT02571777|528980453|FG000|Overall Study|Lost to Follow-up|1|||
146673131|NCT02571777|528980454|FG001|Overall Study|Lost to Follow-up|1|||
146673132|NCT02571777|528980455|FG002|Overall Study|Lost to Follow-up|2|||
146673133|NCT02571777|528980456|FG003|Overall Study|Lost to Follow-up|0|||
146673134|NCT02571777|528980457|FG004|Overall Study|Lost to Follow-up|1|||
146673135|NCT02571777|528980453|FG000|Overall Study|Physician Decision|1|||
146673136|NCT02571777|528980454|FG001|Overall Study|Physician Decision|7|||
146673137|NCT02571777|528980455|FG002|Overall Study|Physician Decision|5|||
146673138|NCT02571777|528980456|FG003|Overall Study|Physician Decision|2|||
146673139|NCT02571777|528980457|FG004|Overall Study|Physician Decision|4|||
146673140|NCT02571777|528980453|FG000|Overall Study|Pregnancy|0|||
146673141|NCT02571777|528980454|FG001|Overall Study|Pregnancy|0|||
146673142|NCT02571777|528980455|FG002|Overall Study|Pregnancy|0|||
146673143|NCT02571777|528980456|FG003|Overall Study|Pregnancy|2|||
146673144|NCT02571777|528980457|FG004|Overall Study|Pregnancy|0|||
146673145|NCT03706079|528980458|FG000|Predecessor Study|Death|0|||
146673146|NCT03706079|528980459|FG001|Predecessor Study|Death|2|||
146673147|NCT03706079|528980460|FG002|Predecessor Study|Death|0|||
146673148|NCT03706079|528980461|FG003|Predecessor Study|Death|1|||
146673149|NCT03706079|528980462|FG004|Predecessor Study|Death|0|||
146673150|NCT03706079|528980463|FG005|Predecessor Study|Death|0|||
146673151|NCT03706079|528980458|FG000|Predecessor Study|Lost to Follow-up|5|||
146673152|NCT03706079|528980459|FG001|Predecessor Study|Lost to Follow-up|2|||
146673153|NCT03706079|528980460|FG002|Predecessor Study|Lost to Follow-up|0|||
146673154|NCT03706079|528980461|FG003|Predecessor Study|Lost to Follow-up|0|||
146673155|NCT03706079|528980462|FG004|Predecessor Study|Lost to Follow-up|1|||
146673156|NCT03706079|528980463|FG005|Predecessor Study|Lost to Follow-up|0|||
146673157|NCT03706079|528980458|FG000|Predecessor Study|Withdrawal by Subject|8|||
146673158|NCT03706079|528980459|FG001|Predecessor Study|Withdrawal by Subject|15|||
146673159|NCT03706079|528980460|FG002|Predecessor Study|Withdrawal by Subject|0|||
146673160|NCT03706079|528980461|FG003|Predecessor Study|Withdrawal by Subject|5|||
146673161|NCT03706079|528980462|FG004|Predecessor Study|Withdrawal by Subject|2|||
146673162|NCT03706079|528980463|FG005|Predecessor Study|Withdrawal by Subject|0|||
146673163|NCT03706079|528980458|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
146673164|NCT03706079|528980459|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
146673165|NCT03706079|528980460|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
146673166|NCT03706079|528980461|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
146673167|NCT03706079|528980462|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
146673168|NCT03706079|528980463|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
146673169|NCT03706079|528980458|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
146673170|NCT03706079|528980459|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
146673171|NCT03706079|528980460|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
146673172|NCT03706079|528980461|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
146673173|NCT03706079|528980462|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
146673174|NCT03706079|528980463|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
146673175|NCT03706079|528980458|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
146673176|NCT03706079|528980459|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
146673177|NCT03706079|528980460|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
146673178|NCT03706079|528980461|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
146673179|NCT03706079|528980462|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
146673180|NCT03706079|528980463|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
146673181|NCT03706079|528980458|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
146774163|NCT01985334|529343541|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
146774164|NCT01985334|529343542|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
146926080|NCT02370498|529890690|FG000|Overall Study|Death|263|||
146673182|NCT03706079|528980459|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
146673183|NCT03706079|528980460|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
146673184|NCT03706079|528980461|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
146673185|NCT03706079|528980462|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
146673186|NCT03706079|528980463|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
146673187|NCT03706079|528980458|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
146673188|NCT03706079|528980459|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
146673189|NCT03706079|528980460|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
146673190|NCT03706079|528980461|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
146673191|NCT03706079|528980462|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
146673192|NCT03706079|528980463|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
146673193|NCT03706079|528980458|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
146673194|NCT03706079|528980459|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
146673195|NCT03706079|528980460|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
146673196|NCT03706079|528980461|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
146673197|NCT03706079|528980462|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
146673198|NCT03706079|528980463|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
146673199|NCT03706079|528980458|FG000|Long Term Extension (DESTINATION)|Death|8|||
146673200|NCT03706079|528980459|FG001|Long Term Extension (DESTINATION)|Death|2|||
146673201|NCT03706079|528980460|FG002|Long Term Extension (DESTINATION)|Death|2|||
146673202|NCT03706079|528980461|FG003|Long Term Extension (DESTINATION)|Death|1|||
146673203|NCT03706079|528980462|FG004|Long Term Extension (DESTINATION)|Death|0|||
146673204|NCT03706079|528980463|FG005|Long Term Extension (DESTINATION)|Death|0|||
146673205|NCT00963937|528980466|FG000|Overall Study|Protocol Violation|1|||
146673206|NCT00963937|528980467|FG001|Overall Study|Protocol Violation|1|||
146673207|NCT00963937|528980468|FG002|Overall Study|Protocol Violation|0|||
146673208|NCT00963937|528980466|FG000|Overall Study|Physician Decision|18|||
146673209|NCT00963937|528980467|FG001|Overall Study|Physician Decision|10|||
146673210|NCT00963937|528980468|FG002|Overall Study|Physician Decision|4|||
146673211|NCT02197520|528980469|FG000|Period 1|Withdrawal by Subject|1|||
146673212|NCT02197520|528980470|FG001|Period 1|Withdrawal by Subject|0|||
146673213|NCT02197520|528980469|FG000|Period 2|Adverse Event|0|||
146673214|NCT02197520|528980470|FG001|Period 2|Adverse Event|2|||
146673215|NCT02197520|528980469|FG000|Period 2|Withdrawal by Subject|1|||
146673216|NCT02197520|528980470|FG001|Period 2|Withdrawal by Subject|0|||
146673217|NCT00913497|528980471|FG000|Overall Study|Adverse Event|1|||
146673218|NCT00913497|528980471|FG000|Overall Study|Withdrawal by Subject|2|||
146673219|NCT03385564|528980472|FG000|Overall Study|Adverse Event|0|||
146673220|NCT03385564|528980473|FG001|Overall Study|Adverse Event|0|||
146673221|NCT03385564|528980474|FG002|Overall Study|Adverse Event|3|||
146673222|NCT03385564|528980475|FG003|Overall Study|Adverse Event|3|||
146673223|NCT03385564|528980472|FG000|Overall Study|Other than listed|0|||
146673224|NCT03385564|528980473|FG001|Overall Study|Other than listed|0|||
146673225|NCT03385564|528980474|FG002|Overall Study|Other than listed|0|||
146673226|NCT03385564|528980475|FG003|Overall Study|Other than listed|5|||
146673227|NCT03385564|528980472|FG000|Overall Study|Withdrawal by Subject|0|||
146673228|NCT03385564|528980473|FG001|Overall Study|Withdrawal by Subject|1|||
146673229|NCT03385564|528980474|FG002|Overall Study|Withdrawal by Subject|1|||
146673230|NCT03385564|528980475|FG003|Overall Study|Withdrawal by Subject|0|||
146673231|NCT03385564|528980472|FG000|Overall Study|Lack of Efficacy|0|||
146673232|NCT03385564|528980473|FG001|Overall Study|Lack of Efficacy|0|||
146673233|NCT03385564|528980474|FG002|Overall Study|Lack of Efficacy|0|||
146673234|NCT03385564|528980475|FG003|Overall Study|Lack of Efficacy|1|||
146673235|NCT03385564|528980472|FG000|Overall Study|Death|0|||
146673236|NCT03385564|528980473|FG001|Overall Study|Death|0|||
146673237|NCT03385564|528980474|FG002|Overall Study|Death|1|||
146673238|NCT03385564|528980475|FG003|Overall Study|Death|0|||
146673239|NCT03087643|528980480|FG000|Overall Study|Withdrawal by Subject|2|||
146673240|NCT03087643|528980481|FG001|Overall Study|Withdrawal by Subject|4|||
146673241|NCT03087643|528980480|FG000|Overall Study|Death|2|||
146673242|NCT03087643|528980481|FG001|Overall Study|Death|2|||
146673243|NCT01546883|528980487|FG000|Overall Study|Withdrawal by Subject|3|||
146673244|NCT01546883|528980487|FG000|Overall Study|Adverse Event|4|||
146673245|NCT01546883|528980487|FG000|Overall Study|Lost to Follow-up|2|||
146673246|NCT01546883|528980487|FG000|Overall Study|early closure of study|2|||
146673247|NCT01546883|528980487|FG000|Overall Study|other unrelated illness|1|||
146673248|NCT02256631|528980490|FG000|Overall Study|Lost to Follow-up|1|||
146673249|NCT02256631|528980491|FG001|Overall Study|Lost to Follow-up|1|||
146926081|NCT02370498|529890691|FG001|Overall Study|Death|265|||
146673250|NCT02256631|528980492|FG002|Overall Study|Lost to Follow-up|0|||
146673251|NCT02256631|528980493|FG003|Overall Study|Lost to Follow-up|2|||
146673252|NCT02256631|528980494|FG004|Overall Study|Lost to Follow-up|0|||
146673253|NCT02256631|528980495|FG005|Overall Study|Lost to Follow-up|4|||
146673254|NCT02256631|528980496|FG006|Overall Study|Lost to Follow-up|1|||
146673255|NCT02256631|528980490|FG000|Overall Study|Withdrawal by Subject|0|||
146673256|NCT02256631|528980491|FG001|Overall Study|Withdrawal by Subject|0|||
146673257|NCT02256631|528980492|FG002|Overall Study|Withdrawal by Subject|0|||
146673258|NCT02256631|528980493|FG003|Overall Study|Withdrawal by Subject|1|||
146673259|NCT02256631|528980494|FG004|Overall Study|Withdrawal by Subject|1|||
146673260|NCT02256631|528980495|FG005|Overall Study|Withdrawal by Subject|0|||
146673261|NCT02256631|528980496|FG006|Overall Study|Withdrawal by Subject|1|||
146673262|NCT02256631|528980490|FG000|Overall Study|Unable to get to clinic|0|||
146673263|NCT02256631|528980491|FG001|Overall Study|Unable to get to clinic|2|||
146673264|NCT02256631|528980492|FG002|Overall Study|Unable to get to clinic|0|||
146673265|NCT02256631|528980493|FG003|Overall Study|Unable to get to clinic|1|||
146673266|NCT02256631|528980494|FG004|Overall Study|Unable to get to clinic|0|||
146673267|NCT02256631|528980495|FG005|Overall Study|Unable to get to clinic|1|||
146673268|NCT02256631|528980496|FG006|Overall Study|Unable to get to clinic|2|||
146673269|NCT01427972|528980497|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146673270|NCT01427972|528980498|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146673271|NCT01427972|528980499|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146673272|NCT01427972|528980500|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146673273|NCT01427972|528980501|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146673274|NCT01427972|528980502|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146673275|NCT01427972|528980503|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146673276|NCT01427972|528980504|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
146673277|NCT01427972|528980505|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146673278|NCT01427972|528980506|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146673279|NCT01427972|528980507|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146673280|NCT01427972|528980508|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146673281|NCT01427972|528980497|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146673282|NCT01427972|528980498|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146673283|NCT01427972|528980499|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146673284|NCT01427972|528980500|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146673285|NCT01427972|528980501|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146673286|NCT01427972|528980502|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
146673287|NCT01427972|528980503|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146673288|NCT01427972|528980504|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146673289|NCT01427972|528980505|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146673290|NCT01427972|528980506|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146673291|NCT01427972|528980507|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146673292|NCT01427972|528980508|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146673293|NCT01427972|528980497|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146673294|NCT01427972|528980498|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
146673295|NCT01427972|528980499|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146673296|NCT01427972|528980500|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146673297|NCT01427972|528980501|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146673298|NCT01427972|528980502|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146673299|NCT01427972|528980503|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146673300|NCT01427972|528980504|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146673301|NCT01427972|528980505|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146673302|NCT01427972|528980506|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146673303|NCT01427972|528980507|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146673304|NCT01427972|528980508|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146673305|NCT00530946|528980510|FG000|Overall Study|Adverse Event|1|||
146673306|NCT00530946|528980511|FG001|Overall Study|Adverse Event|2|||
146673307|NCT00530946|528980512|FG002|Overall Study|Adverse Event|1|||
146673308|NCT00530946|528980513|FG003|Overall Study|Adverse Event|1|||
146673309|NCT00530946|528980510|FG000|Overall Study|Protocol Violation|0|||
146673310|NCT00530946|528980511|FG001|Overall Study|Protocol Violation|0|||
146673311|NCT00530946|528980512|FG002|Overall Study|Protocol Violation|0|||
146673312|NCT00530946|528980513|FG003|Overall Study|Protocol Violation|1|||
146673313|NCT00530946|528980510|FG000|Overall Study|Noncompliance|1|||
146673314|NCT00530946|528980511|FG001|Overall Study|Noncompliance|0|||
146673315|NCT00530946|528980512|FG002|Overall Study|Noncompliance|0|||
146673316|NCT00530946|528980513|FG003|Overall Study|Noncompliance|0|||
146673317|NCT01534962|528980514|FG000|Overall Study|Randomized but did not start treatment|2|||
146673318|NCT01534962|528980515|FG001|Overall Study|Randomized but did not start treatment|0|||
146673319|NCT01534962|528980516|FG002|Overall Study|Randomized but did not start treatment|0|||
146673320|NCT01534962|528980517|FG003|Overall Study|Randomized but did not start treatment|1|||
146673321|NCT01534962|528980514|FG000|Overall Study|Discontinued at AF recurrence|35|||
146673322|NCT01534962|528980515|FG001|Overall Study|Discontinued at AF recurrence|26|||
146673323|NCT01534962|528980516|FG002|Overall Study|Discontinued at AF recurrence|24|||
146673324|NCT01534962|528980517|FG003|Overall Study|Discontinued at AF recurrence|31|||
146673325|NCT02243696|528980518|FG000|Overall Study|Death|282|||
146673326|NCT02243696|528980518|FG000|Overall Study|Withdrawal by Subject|79|||
146673327|NCT02243696|528980518|FG000|Overall Study|Lost to Follow-up|57|||
146673328|NCT02243696|528980518|FG000|Overall Study|Subject No Longer has Study System|42|||
146673329|NCT02243696|528980518|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
146673330|NCT02243696|528980518|FG000|Overall Study|Study Terminated for EP PASSION|961|||
146673331|NCT00622284|528980519|FG000|Overall Study|Lack of Efficacy|45|||
146673332|NCT00622284|528980520|FG001|Overall Study|Lack of Efficacy|15|||
146673333|NCT00622284|528980519|FG000|Overall Study|Adverse Event|61|||
146926082|NCT02370498|529890690|FG000|Overall Study|Protocol Violation|1|||
146926083|NCT02370498|529890691|FG001|Overall Study|Protocol Violation|2|||
146926084|NCT02370498|529890690|FG000|Overall Study|Withdrawal by Subject|7|||
146926085|NCT02370498|529890691|FG001|Overall Study|Withdrawal by Subject|12|||
146926086|NCT02370498|529890690|FG000|Overall Study|Sponsor's decision|15|||
146926087|NCT02370498|529890691|FG001|Overall Study|Sponsor's decision|9|||
146926088|NCT03225716|529890695|FG000|Overall Study|Withdrawal by Subject|2|||
146926089|NCT03225716|529890696|FG001|Overall Study|Withdrawal by Subject|2|||
146926090|NCT03225716|529890697|FG002|Overall Study|Withdrawal by Subject|0|||
146926091|NCT03225716|529890695|FG000|Overall Study|Lack of Efficacy|1|||
146926092|NCT03225716|529890696|FG001|Overall Study|Lack of Efficacy|0|||
146926093|NCT03225716|529890697|FG002|Overall Study|Lack of Efficacy|0|||
146926094|NCT03225716|529890695|FG000|Overall Study|Adverse Event|2|||
146926095|NCT03225716|529890696|FG001|Overall Study|Adverse Event|0|||
146926096|NCT03225716|529890697|FG002|Overall Study|Adverse Event|1|||
146926097|NCT03225716|529890695|FG000|Overall Study|Study early termination by Sponsor|0|||
146926098|NCT03225716|529890696|FG001|Overall Study|Study early termination by Sponsor|0|||
146926099|NCT03225716|529890697|FG002|Overall Study|Study early termination by Sponsor|2|||
146926100|NCT00848250|529890698|FG000|Overall Study|surgery was completed without cardiopulm|0|||
146926101|NCT00848250|529890699|FG001|Overall Study|surgery was completed without cardiopulm|1|||
146926102|NCT00213980|529890707|FG000|Overall Study|Withdrawal by Subject|3|||
146926103|NCT00213980|529890708|FG001|Overall Study|Withdrawal by Subject|1|||
146926104|NCT00213980|529890707|FG000|Overall Study|Adverse Event|1|||
146926105|NCT00213980|529890708|FG001|Overall Study|Adverse Event|1|||
146926106|NCT00213980|529890707|FG000|Overall Study|Disease progression|0|||
146926107|NCT00213980|529890708|FG001|Overall Study|Disease progression|2|||
146926108|NCT00213980|529890707|FG000|Overall Study|Developed ovarian cancer|1|||
146673334|NCT00622284|528980520|FG001|Overall Study|Adverse Event|90|||
146673335|NCT00622284|528980519|FG000|Overall Study|Protocol Violation|12|||
146673336|NCT00622284|528980520|FG001|Overall Study|Protocol Violation|5|||
146673337|NCT00622284|528980519|FG000|Overall Study|Lost to Follow-up|11|||
146673338|NCT00622284|528980520|FG001|Overall Study|Lost to Follow-up|13|||
146673339|NCT00622284|528980519|FG000|Overall Study|Withdrawal by Subject|27|||
146673340|NCT00622284|528980520|FG001|Overall Study|Withdrawal by Subject|24|||
146673341|NCT00622284|528980519|FG000|Overall Study|Other reason (not specified)|33|||
146673342|NCT00622284|528980520|FG001|Overall Study|Other reason (not specified)|24|||
146673343|NCT00457301|528980521|FG000|Overall Study|Withdrawal by Subject|3|||
146673344|NCT00457301|528980522|FG001|Overall Study|Withdrawal by Subject|3|||
146673345|NCT00457301|528980521|FG000|Overall Study|Censored out of the study|15|||
146673346|NCT00457301|528980522|FG001|Overall Study|Censored out of the study|14|||
146673347|NCT00457301|528980521|FG000|Overall Study|Death|5|||
146673348|NCT00457301|528980522|FG001|Overall Study|Death|7|||
146673349|NCT05399641|528980531|FG000|Overall Study|Adverse Event|0|||
146673350|NCT05399641|528980532|FG001|Overall Study|Adverse Event|1|||
146673351|NCT05399641|528980533|FG002|Overall Study|Adverse Event|1|||
146673352|NCT05399641|528980531|FG000|Overall Study|Lost to Follow-up|1|||
146673353|NCT05399641|528980532|FG001|Overall Study|Lost to Follow-up|2|||
146673354|NCT05399641|528980533|FG002|Overall Study|Lost to Follow-up|2|||
146673355|NCT05399641|528980531|FG000|Overall Study|Physician Decision|1|||
146673356|NCT05399641|528980532|FG001|Overall Study|Physician Decision|3|||
146673357|NCT05399641|528980533|FG002|Overall Study|Physician Decision|3|||
146673358|NCT05399641|528980531|FG000|Overall Study|Withdrawal by Subject|4|||
146673359|NCT05399641|528980532|FG001|Overall Study|Withdrawal by Subject|11|||
146673360|NCT05399641|528980533|FG002|Overall Study|Withdrawal by Subject|7|||
146673361|NCT05399641|528980531|FG000|Overall Study|Reason not defined|3|||
146926109|NCT00213980|529890708|FG001|Overall Study|Developed ovarian cancer|0|||
146926110|NCT00213980|529890707|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
146926111|NCT00213980|529890708|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
146926112|NCT03607838|529890709|FG000|Overall Study|Lack of Efficacy|14|||
146926113|NCT03607838|529890710|FG001|Overall Study|Lack of Efficacy|20|||
146926114|NCT03607838|529890709|FG000|Overall Study|Withdrawal by Subject|13|||
146926115|NCT03607838|529890710|FG001|Overall Study|Withdrawal by Subject|8|||
146926116|NCT03607838|529890709|FG000|Overall Study|Lost to Follow-up|6|||
146926117|NCT03607838|529890710|FG001|Overall Study|Lost to Follow-up|11|||
146673362|NCT05399641|528980532|FG001|Overall Study|Reason not defined|5|||
146673363|NCT05399641|528980533|FG002|Overall Study|Reason not defined|6|||
146673364|NCT03408483|528980534|FG000|Overall Study|Physician Decision|3|||
146673365|NCT03408483|528980535|FG001|Overall Study|Physician Decision|3|||
146673366|NCT03408483|528980534|FG000|Overall Study|Lost to Follow-up|3|||
146673367|NCT03408483|528980535|FG001|Overall Study|Lost to Follow-up|0|||
146673368|NCT02094677|528980536|FG000|Overall Study|Screening|3|||
146926118|NCT03607838|529890709|FG000|Overall Study|Adverse Event|2|||
146926119|NCT03607838|529890710|FG001|Overall Study|Adverse Event|2|||
146926120|NCT03607838|529890709|FG000|Overall Study|Physician Decision|2|||
146673369|NCT02094677|528980537|FG001|Overall Study|Screening|1|||
146673370|NCT00478231|528980538|FG000|Overall Study|Death|7|||
146673371|NCT00478231|528980538|FG000|Overall Study|Lack of Efficacy|47|||
146673372|NCT00478231|528980538|FG000|Overall Study|Lost to Follow-up|7|||
146673373|NCT00478231|528980538|FG000|Overall Study|Withdrawal by Subject|6|||
146673374|NCT00478231|528980538|FG000|Overall Study|Other|9|||
146673375|NCT00478231|528980538|FG000|Overall Study|Adverse Event|5|||
146673376|NCT00478231|528980538|FG000|Overall Study|Randomized, not treated|3|||
146673377|NCT01300650|528980539|FG000|Overall Study|Adverse Event|1|||
146673378|NCT01702961|528980540|FG000|Overall Study|Additional treatment|3|||
146673379|NCT01702961|528980540|FG000|Overall Study|Progressive disease|5|||
146673380|NCT01702961|528980540|FG000|Overall Study|Relapse|20|||
146673381|NCT01702961|528980540|FG000|Overall Study|Death|6|||
146673382|NCT01702961|528980540|FG000|Overall Study|Lost to Follow-up|2|||
146673383|NCT01702961|528980540|FG000|Overall Study|Ongoing|11|||
146673384|NCT02610725|528980543|FG000|Overall Study|Lost to Follow-up|197|||
146673385|NCT02610725|528980543|FG000|Overall Study|self-reported contraindication|9|||
146673386|NCT04094883|528980544|FG000|Overall Study|Withdrawal by Subject|1|||
146673387|NCT02302807|528980547|FG000|Overall Study|Withdrawal by Subject|28|||
146673388|NCT02302807|528980548|FG001|Overall Study|Withdrawal by Subject|11|||
146673389|NCT02302807|528980547|FG000|Overall Study|Lost to Follow-up|4|||
146673390|NCT02302807|528980548|FG001|Overall Study|Lost to Follow-up|6|||
146673391|NCT02302807|528980547|FG000|Overall Study|Death|397|||
146673392|NCT02302807|528980548|FG001|Overall Study|Death|385|||
146673393|NCT02302807|528980547|FG000|Overall Study|Study Terminated By Sponsor|35|||
146673394|NCT02302807|528980548|FG001|Overall Study|Study Terminated By Sponsor|64|||
146673395|NCT02302807|528980547|FG000|Overall Study|Physician Decision|0|||
146673396|NCT02302807|528980548|FG001|Overall Study|Physician Decision|1|||
146673397|NCT01133522|528980552|FG000|Overall Study|Withdrawal by Subject|0|||
146673398|NCT01133522|528980553|FG001|Overall Study|Withdrawal by Subject|1|||
146673399|NCT01133522|528980554|FG002|Overall Study|Withdrawal by Subject|0|||
146673400|NCT01133522|528980555|FG003|Overall Study|Withdrawal by Subject|1|||
146673401|NCT01133522|528980556|FG004|Overall Study|Withdrawal by Subject|0|||
146673402|NCT01133522|528980557|FG005|Overall Study|Withdrawal by Subject|0|||
146673403|NCT01133522|528980558|FG006|Overall Study|Withdrawal by Subject|0|||
146673404|NCT01133522|528980559|FG007|Overall Study|Withdrawal by Subject|0|||
146673405|NCT01133522|528980560|FG008|Overall Study|Withdrawal by Subject|0|||
146673406|NCT01133522|528980561|FG009|Overall Study|Withdrawal by Subject|0|||
146673407|NCT01133522|528980552|FG000|Overall Study|Physician Decision|0|||
146673408|NCT01133522|528980553|FG001|Overall Study|Physician Decision|0|||
146673409|NCT01133522|528980554|FG002|Overall Study|Physician Decision|0|||
146673410|NCT01133522|528980555|FG003|Overall Study|Physician Decision|0|||
146673411|NCT01133522|528980556|FG004|Overall Study|Physician Decision|1|||
146673412|NCT01133522|528980557|FG005|Overall Study|Physician Decision|0|||
146673413|NCT01133522|528980558|FG006|Overall Study|Physician Decision|0|||
146673414|NCT01133522|528980559|FG007|Overall Study|Physician Decision|0|||
146673415|NCT01133522|528980560|FG008|Overall Study|Physician Decision|0|||
146673416|NCT01133522|528980561|FG009|Overall Study|Physician Decision|0|||
146673417|NCT00717197|528982702|FG000|Overall Study|Unable to purchase study drug|5|||
146673418|NCT00717197|528982702|FG000|Overall Study|Tumor Progression|1|||
146673419|NCT00717197|528982702|FG000|Overall Study|Physician Decision|1|||
146673420|NCT00982137|528982703|FG000|Overall Study|Lost to Follow-up|0|||
146673421|NCT00982137|528982704|FG001|Overall Study|Lost to Follow-up|0|||
146673422|NCT00982137|528982705|FG002|Overall Study|Lost to Follow-up|0|||
146673423|NCT00982137|528982706|FG003|Overall Study|Lost to Follow-up|1|||
146673424|NCT00982137|528982703|FG000|Overall Study|Withdrawal by Subject|0|||
146673425|NCT00982137|528982704|FG001|Overall Study|Withdrawal by Subject|1|||
146673426|NCT00982137|528982705|FG002|Overall Study|Withdrawal by Subject|0|||
146673427|NCT00982137|528982706|FG003|Overall Study|Withdrawal by Subject|0|||
146673428|NCT01648101|528982709|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
146673429|NCT01648101|528982710|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
146673430|NCT01648101|528982711|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
146774165|NCT01985334|529343543|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
146673431|NCT01648101|528982709|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
146673432|NCT01648101|528982710|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
146673433|NCT01648101|528982711|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
146673434|NCT01648101|528982709|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
146673435|NCT01648101|528982710|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
146774166|NCT01985334|529343544|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
146774167|NCT01985334|529343545|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
146673436|NCT01648101|528982711|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
146673437|NCT01648101|528982709|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
146673438|NCT01648101|528982710|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
146673439|NCT01648101|528982711|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
146673440|NCT01648101|528982709|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
146673441|NCT01648101|528982710|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
146673442|NCT01648101|528982711|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
146673443|NCT01648101|528982709|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
146673444|NCT01648101|528982710|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
146673445|NCT01648101|528982711|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
146673446|NCT01648101|528982709|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
146673447|NCT01648101|528982710|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
146673448|NCT01648101|528982711|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
146673449|NCT01648101|528982709|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
146673450|NCT01648101|528982710|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
146673451|NCT01648101|528982711|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
146673452|NCT01648101|528982709|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
146673453|NCT01648101|528982710|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
146673454|NCT01648101|528982711|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
146673455|NCT01648101|528982709|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
146673456|NCT01648101|528982710|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
146673457|NCT01648101|528982711|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
146673458|NCT01648101|528982709|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
146673459|NCT01648101|528982710|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
146673460|NCT01648101|528982711|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
146673461|NCT02469298|528982727|FG000|Overall Study|Protocol Violation|0|||
146673462|NCT02469298|528982728|FG001|Overall Study|Protocol Violation|1|||
146673463|NCT02469298|528982729|FG002|Overall Study|Protocol Violation|1|||
146673464|NCT02469298|528982730|FG003|Overall Study|Protocol Violation|0|||
146673465|NCT02469298|528982727|FG000|Overall Study|Lost to Follow-up|1|||
146673466|NCT02469298|528982728|FG001|Overall Study|Lost to Follow-up|0|||
146673467|NCT02469298|528982729|FG002|Overall Study|Lost to Follow-up|1|||
146673468|NCT02469298|528982730|FG003|Overall Study|Lost to Follow-up|0|||
146673469|NCT02469298|528982727|FG000|Overall Study|Physician Decision|0|||
146673470|NCT02469298|528982728|FG001|Overall Study|Physician Decision|0|||
146673471|NCT02469298|528982729|FG002|Overall Study|Physician Decision|0|||
146673472|NCT02469298|528982730|FG003|Overall Study|Physician Decision|1|||
146673473|NCT02469298|528982727|FG000|Overall Study|Withdrawal by Subject|0|||
146673474|NCT02469298|528982728|FG001|Overall Study|Withdrawal by Subject|0|||
146673475|NCT02469298|528982729|FG002|Overall Study|Withdrawal by Subject|0|||
146673476|NCT02469298|528982730|FG003|Overall Study|Withdrawal by Subject|1|||
146673477|NCT00307294|528982731|FG000|Overall Study|Withdrawal by Subject|1|||
146673478|NCT03311724|528982734|FG000|Overall Study|Physician Decision|0|||
146673479|NCT03311724|528982735|FG001|Overall Study|Physician Decision|0|||
146673480|NCT03311724|528982736|FG002|Overall Study|Physician Decision|0|||
146673481|NCT03311724|528982737|FG003|Overall Study|Physician Decision|1|||
146673482|NCT03311724|528982734|FG000|Overall Study|Protocol Violation|1|||
146673483|NCT03311724|528982735|FG001|Overall Study|Protocol Violation|0|||
146673484|NCT03311724|528982736|FG002|Overall Study|Protocol Violation|1|||
146673485|NCT03311724|528982737|FG003|Overall Study|Protocol Violation|0|||
146673486|NCT03311724|528982734|FG000|Overall Study|Withdrawal by Subject|1|||
146673487|NCT03311724|528982735|FG001|Overall Study|Withdrawal by Subject|1|||
146673488|NCT03311724|528982736|FG002|Overall Study|Withdrawal by Subject|0|||
146673489|NCT03311724|528982737|FG003|Overall Study|Withdrawal by Subject|0|||
146673490|NCT03311724|528982734|FG000|Overall Study|Lost to Follow-up|1|||
146673491|NCT03311724|528982735|FG001|Overall Study|Lost to Follow-up|0|||
146673492|NCT03311724|528982736|FG002|Overall Study|Lost to Follow-up|0|||
146673493|NCT03311724|528982737|FG003|Overall Study|Lost to Follow-up|0|||
146673494|NCT03311724|528982734|FG000|Overall Study|Sponsor Decision|0|||
146673495|NCT03311724|528982735|FG001|Overall Study|Sponsor Decision|0|||
146673496|NCT03311724|528982736|FG002|Overall Study|Sponsor Decision|1|||
146673497|NCT03311724|528982737|FG003|Overall Study|Sponsor Decision|0|||
146673498|NCT02980601|528982744|FG000|Overall Study|Lost to Follow-up|2|||
146673499|NCT02980601|528982745|FG001|Overall Study|Lost to Follow-up|2|||
146673500|NCT02980601|528982744|FG000|Overall Study|Death|0|||
146673501|NCT02980601|528982745|FG001|Overall Study|Death|1|||
146673502|NCT02980601|528982744|FG000|Overall Study|Graft loss|1|||
146673503|NCT02980601|528982745|FG001|Overall Study|Graft loss|0|||
146673504|NCT02980601|528982744|FG000|Overall Study|Failed to sign consent|2|||
146673505|NCT02980601|528982745|FG001|Overall Study|Failed to sign consent|0|||
146673506|NCT01575769|528982746|FG000|Overall Study|Adverse Event|1|||
146673507|NCT01575769|528982746|FG000|Overall Study|Study terminated by sponsor|40|||
146673508|NCT01473836|528982747|FG000|Overall Study|Adverse Event|4|||
146774168|NCT01985334|529343546|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
146673509|NCT01473836|528982747|FG000|Overall Study|Lack of Efficacy|1|||
146673510|NCT01473836|528982747|FG000|Overall Study|Does not meet entrance criteria|1|||
146673511|NCT02954237|528982753|FG000|Overall Study|Withdrawal by Subject|25|||
146673512|NCT02954237|528982753|FG000|Overall Study|Missed visit|16|||
146774169|NCT01985334|529343539|FG000|Overall Study|Subject withdrawal of consent|3|||
146673513|NCT02954237|528982753|FG000|Overall Study|Death|2|||
146673514|NCT00599924|528982755|FG000|Overall Study|Lack of Efficacy|3|||
146673515|NCT00599924|528982756|FG001|Overall Study|Lack of Efficacy|5|||
146673516|NCT00599924|528982757|FG002|Overall Study|Lack of Efficacy|1|||
146673517|NCT00599924|528982758|FG003|Overall Study|Lack of Efficacy|2|||
146673518|NCT00599924|528982759|FG004|Overall Study|Lack of Efficacy|3|||
146673519|NCT00599924|528982760|FG005|Overall Study|Lack of Efficacy|2|||
146673520|NCT00599924|528982761|FG006|Overall Study|Lack of Efficacy|0|||
146673521|NCT00599924|528982755|FG000|Overall Study|Adverse Event|0|||
146673522|NCT00599924|528982756|FG001|Overall Study|Adverse Event|0|||
146673523|NCT00599924|528982757|FG002|Overall Study|Adverse Event|0|||
146673524|NCT00599924|528982758|FG003|Overall Study|Adverse Event|2|||
146673525|NCT00599924|528982759|FG004|Overall Study|Adverse Event|0|||
146673526|NCT00599924|528982760|FG005|Overall Study|Adverse Event|0|||
146673527|NCT00599924|528982761|FG006|Overall Study|Adverse Event|2|||
146673528|NCT00599924|528982755|FG000|Overall Study|Death|0|||
146673529|NCT00599924|528982756|FG001|Overall Study|Death|0|||
146673530|NCT00599924|528982757|FG002|Overall Study|Death|0|||
146673531|NCT00599924|528982758|FG003|Overall Study|Death|2|||
146673532|NCT00599924|528982759|FG004|Overall Study|Death|0|||
146673533|NCT00599924|528982760|FG005|Overall Study|Death|2|||
146673534|NCT00599924|528982761|FG006|Overall Study|Death|1|||
146673535|NCT00599924|528982755|FG000|Overall Study|Protocol Violation|0|||
146673536|NCT00599924|528982756|FG001|Overall Study|Protocol Violation|0|||
146673537|NCT00599924|528982757|FG002|Overall Study|Protocol Violation|0|||
146673538|NCT00599924|528982758|FG003|Overall Study|Protocol Violation|1|||
146673539|NCT00599924|528982759|FG004|Overall Study|Protocol Violation|0|||
146673540|NCT00599924|528982760|FG005|Overall Study|Protocol Violation|0|||
146673541|NCT00599924|528982761|FG006|Overall Study|Protocol Violation|0|||
146673542|NCT00599924|528982755|FG000|Overall Study|Withdrawal by Subject|0|||
146673543|NCT00599924|528982756|FG001|Overall Study|Withdrawal by Subject|0|||
146673544|NCT00599924|528982757|FG002|Overall Study|Withdrawal by Subject|1|||
146673545|NCT00599924|528982758|FG003|Overall Study|Withdrawal by Subject|0|||
146673546|NCT00599924|528982759|FG004|Overall Study|Withdrawal by Subject|1|||
146673547|NCT00599924|528982760|FG005|Overall Study|Withdrawal by Subject|0|||
146673548|NCT00599924|528982761|FG006|Overall Study|Withdrawal by Subject|0|||
146673549|NCT00599924|528982755|FG000|Overall Study|Other|0|||
146673550|NCT00599924|528982756|FG001|Overall Study|Other|0|||
146673551|NCT00599924|528982757|FG002|Overall Study|Other|0|||
146673552|NCT00599924|528982758|FG003|Overall Study|Other|1|||
146673553|NCT00599924|528982759|FG004|Overall Study|Other|2|||
146673554|NCT00599924|528982760|FG005|Overall Study|Other|0|||
146673555|NCT00599924|528982761|FG006|Overall Study|Other|2|||
146673556|NCT01806298|528982762|FG000|Overall Study|Adverse Event|3|||
146673557|NCT01806298|528982762|FG000|Overall Study|Protocol Non-compliance|1|||
146673558|NCT01806298|528982762|FG000|Overall Study|Withdrawal by Subject|1|||
146673559|NCT01806298|528982762|FG000|Overall Study|Other|5|||
146673560|NCT00980057|528982767|FG000|Overall Study|Death|13|||
146673561|NCT00980057|528982768|FG001|Overall Study|Death|3|||
146673562|NCT00980057|528982767|FG000|Overall Study|Adverse Event|0|||
146673563|NCT00980057|528982768|FG001|Overall Study|Adverse Event|1|||
146673564|NCT00980057|528982767|FG000|Overall Study|Physician Decision|4|||
146673565|NCT00980057|528982768|FG001|Overall Study|Physician Decision|0|||
146673566|NCT00980057|528982767|FG000|Overall Study|Lost to Follow-up|1|||
146673567|NCT00980057|528982768|FG001|Overall Study|Lost to Follow-up|0|||
146673568|NCT00980057|528982767|FG000|Overall Study|Withdrawal by Subject|1|||
146673569|NCT00980057|528982768|FG001|Overall Study|Withdrawal by Subject|1|||
146673570|NCT04980040|528982769|FG000|Overall Study|Violated the Inclusion Criteria|260|||
146673571|NCT04980040|528982769|FG000|Overall Study|Violated the Administration & Dosage|225|||
146673572|NCT04980040|528982769|FG000|Overall Study|Lost to Safety-Follow-up|4|||
146673573|NCT04980040|528982769|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
146673574|NCT00691015|528982773|FG000|Overall Study|Refused further treatment|1|||
146673575|NCT00592384|528982778|FG000|Overall Study|Withdrawal by Subject|5|||
146673576|NCT00592384|528982779|FG001|Overall Study|Withdrawal by Subject|6|||
146673577|NCT03600818|528982780|FG000|Overall Study|Adverse Event|4|||
146673578|NCT03600818|528982781|FG001|Overall Study|Adverse Event|7|||
146673579|NCT03600818|528982780|FG000|Overall Study|Lack of Efficacy|9|||
146673580|NCT03600818|528982781|FG001|Overall Study|Lack of Efficacy|4|||
146673581|NCT03600818|528982780|FG000|Overall Study|Withdrawal by Subject|4|||
146673582|NCT03600818|528982781|FG001|Overall Study|Withdrawal by Subject|3|||
146673583|NCT03600818|528982780|FG000|Overall Study|Other-unspecified|5|||
146673584|NCT03600818|528982781|FG001|Overall Study|Other-unspecified|3|||
146673585|NCT03600818|528982780|FG000|Overall Study|Randomized and not treated|0|||
146673586|NCT03600818|528982781|FG001|Overall Study|Randomized and not treated|1|||
146673587|NCT01488370|528982782|FG000|Overall Study|Protocol Violation|0|||
146673588|NCT01488370|528982783|FG001|Overall Study|Protocol Violation|1|||
146673589|NCT01488370|528982784|FG002|Overall Study|Protocol Violation|1|||
146673590|NCT01471171|528982785|FG000|Treatment Period 1|Adverse Event|4|||
146673591|NCT01471171|528982786|FG001|Treatment Period 1|Adverse Event|1|||
146673592|NCT01471171|528982785|FG000|Treatment Period 2|Adverse Event|1|||
146673593|NCT01471171|528982786|FG001|Treatment Period 2|Adverse Event|0|||
146673594|NCT00553644|528982789|FG000|Overall Study|Adverse Event|17|||
146673595|NCT00553644|528982789|FG000|Overall Study|Withdrawal by Subject|4|||
146673596|NCT00553644|528982789|FG000|Overall Study|Physician Decision|1|||
146673597|NCT00553644|528982789|FG000|Overall Study|Alternative therapy|6|||
146673598|NCT00705484|528982790|FG000|Overall Study|Adverse Event|28|||
146673599|NCT00705484|528982791|FG001|Overall Study|Adverse Event|27|||
146673600|NCT00705484|528982790|FG000|Overall Study|Lost to Follow-up|169|||
146673601|NCT00705484|528982791|FG001|Overall Study|Lost to Follow-up|250|||
146673602|NCT00705484|528982790|FG000|Overall Study|Withdrawal by Subject|96|||
146673603|NCT00705484|528982791|FG001|Overall Study|Withdrawal by Subject|72|||
146673604|NCT00705484|528982790|FG000|Overall Study|Administrative|89|||
146673605|NCT00705484|528982791|FG001|Overall Study|Administrative|59|||
146673606|NCT00119106|528982792|FG000|Overall Study|HIV infected at baseline|179|||
146673607|NCT00119106|528982793|FG001|Overall Study|HIV infected at baseline|178|||
146673608|NCT01010061|528982794|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
146673609|NCT01010061|528982795|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
146673610|NCT01010061|528982794|FG000|Overall Study|Disease Progression|2|||
146673611|NCT01010061|528982795|FG001|Overall Study|Disease Progression|8|||
146673612|NCT01010061|528982794|FG000|Overall Study|Withdrew Consent|5|||
146673613|NCT01010061|528982795|FG001|Overall Study|Withdrew Consent|1|||
146673614|NCT01010061|528982794|FG000|Overall Study|Death|3|||
146673615|NCT01010061|528982795|FG001|Overall Study|Death|6|||
146673616|NCT01010061|528982794|FG000|Overall Study|Administrative/Other|0|||
146673617|NCT01010061|528982795|FG001|Overall Study|Administrative/Other|1|||
146673618|NCT01010061|528982794|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
146926121|NCT03607838|529890710|FG001|Overall Study|Physician Decision|0|||
146926122|NCT03607838|529890709|FG000|Overall Study|Failure to meet randomization criteria|1|||
146926123|NCT03607838|529890710|FG001|Overall Study|Failure to meet randomization criteria|2|||
146926124|NCT03607838|529890709|FG000|Overall Study|Pregnancy|1|||
146926125|NCT03607838|529890710|FG001|Overall Study|Pregnancy|0|||
146926126|NCT03607838|529890709|FG000|Overall Study|Protocol Violation|1|||
146926127|NCT03607838|529890710|FG001|Overall Study|Protocol Violation|0|||
146926128|NCT03607838|529890709|FG000|Overall Study|Due to work|1|||
146926129|NCT03607838|529890710|FG001|Overall Study|Due to work|0|||
146926130|NCT03607838|529890709|FG000|Overall Study|Litigation|0|||
146926131|NCT03607838|529890710|FG001|Overall Study|Litigation|1|||
146926132|NCT03607838|529890709|FG000|Overall Study|Temperature excursion for study drug|0|||
146926133|NCT03607838|529890710|FG001|Overall Study|Temperature excursion for study drug|1|||
146926134|NCT03607838|529890709|FG000|Overall Study|Change of mind|0|||
146926135|NCT03607838|529890710|FG001|Overall Study|Change of mind|1|||
146926136|NCT02411201|529890711|FG000|Overall Study|Adverse Event|2|||
146926137|NCT02411201|529890711|FG000|Overall Study|Withdrawal by Subject|2|||
146926138|NCT02411201|529890711|FG000|Overall Study|Age group completed|2|||
146926139|NCT00798694|529890712|FG000|Overall Study|Lost to Follow-up|1|||
146926140|NCT00798694|529890713|FG001|Overall Study|Lost to Follow-up|1|||
146926141|NCT00798694|529890712|FG000|Overall Study|Physician Decision|1|||
146926142|NCT00798694|529890713|FG001|Overall Study|Physician Decision|0|||
146926143|NCT01774344|529890715|FG000|Overall Study|Withdrawal by Subject|3|||
146926144|NCT01774344|529890716|FG001|Overall Study|Withdrawal by Subject|10|||
146926145|NCT01774344|529890715|FG000|Overall Study|Protocol Violation|0|||
146926146|NCT01774344|529890716|FG001|Overall Study|Protocol Violation|1|||
146926147|NCT01774344|529890715|FG000|Overall Study|Lost to Follow-up|4|||
146926148|NCT01774344|529890716|FG001|Overall Study|Lost to Follow-up|10|||
146926149|NCT01774344|529890715|FG000|Overall Study|End of survival follow-up not available|2|||
146926150|NCT01774344|529890716|FG001|Overall Study|End of survival follow-up not available|2|||
146926151|NCT01774344|529890715|FG000|Overall Study|Data collection finished|4|||
146926152|NCT01774344|529890716|FG001|Overall Study|Data collection finished|14|||
146926153|NCT01774344|529890715|FG000|Overall Study|Other|0|||
146926154|NCT01774344|529890716|FG001|Overall Study|Other|1|||
146926155|NCT01774344|529890715|FG000|Overall Study|Did not enter Survival Follow up|49|||
146926156|NCT01774344|529890716|FG001|Overall Study|Did not enter Survival Follow up|83|||
146926157|NCT03364608|529890725|FG000|Overall Study|Withdrawal by Subject|4|||
146926158|NCT03364608|529890725|FG000|Overall Study|Protocol Violation|2|||
146926159|NCT03364608|529890725|FG000|Overall Study|Lost to Follow-up|2|||
146926160|NCT00423735|529890728|FG000|Overall Study|Ineligible / No protocol treatment|8|||
146926161|NCT00423735|529890729|FG001|Overall Study|Ineligible / No protocol treatment|6|||
146926162|NCT00423735|529890730|FG002|Overall Study|Ineligible / No protocol treatment|0|||
146926163|NCT02951988|529890731|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
146926164|NCT02951988|529890732|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
146926165|NCT02951988|529890733|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
146926166|NCT02951988|529890734|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
146926167|NCT02951988|529890731|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
146926168|NCT02951988|529890732|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
146926169|NCT02951988|529890733|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
146926170|NCT02951988|529890734|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
146926171|NCT02951988|529890731|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
146926172|NCT02951988|529890732|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
146926173|NCT02951988|529890733|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
146926174|NCT02951988|529890734|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
146673619|NCT01010061|528982795|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
146673620|NCT01010061|528982794|FG000|Overall Study|Insufficient Therapeutic Response|1|||
146673621|NCT01010061|528982795|FG001|Overall Study|Insufficient Therapeutic Response|5|||
146673622|NCT01010061|528982794|FG000|Overall Study|Violation of Selection Criteria|0|||
146673623|NCT01010061|528982795|FG001|Overall Study|Violation of Selection Criteria|1|||
146673624|NCT01010061|528982794|FG000|Overall Study|Did Not Receive Treatment|2|||
146673625|NCT01010061|528982795|FG001|Overall Study|Did Not Receive Treatment|2|||
146673626|NCT03470441|528982799|FG000|Overall Study|Death|0|||
146673627|NCT03470441|528982800|FG001|Overall Study|Death|1|||
146673628|NCT03470441|528982801|FG002|Overall Study|Death|1|||
146673629|NCT03470441|528982802|FG003|Overall Study|Death|0|||
146673630|NCT03470441|528982799|FG000|Overall Study|Adverse Event|0|||
146673631|NCT03470441|528982800|FG001|Overall Study|Adverse Event|0|||
146673632|NCT03470441|528982801|FG002|Overall Study|Adverse Event|0|||
146673633|NCT03470441|528982802|FG003|Overall Study|Adverse Event|1|||
146673634|NCT03470441|528982799|FG000|Overall Study|Withdrawal by Subject|1|||
146673635|NCT03470441|528982800|FG001|Overall Study|Withdrawal by Subject|4|||
146673636|NCT03470441|528982801|FG002|Overall Study|Withdrawal by Subject|1|||
146673637|NCT03470441|528982802|FG003|Overall Study|Withdrawal by Subject|3|||
146673638|NCT01203098|528982805|FG000|Overall Study|Adverse Event|3|||
146673639|NCT01203098|528982806|FG001|Overall Study|Adverse Event|1|||
146673640|NCT01203098|528982807|FG002|Overall Study|Adverse Event|7|||
146673641|NCT01203098|528982805|FG000|Overall Study|Lost to Follow-up|0|||
146673642|NCT01203098|528982806|FG001|Overall Study|Lost to Follow-up|0|||
146673643|NCT01203098|528982807|FG002|Overall Study|Lost to Follow-up|1|||
146673644|NCT01203098|528982805|FG000|Overall Study|Physician Decision|2|||
146673645|NCT01203098|528982806|FG001|Overall Study|Physician Decision|2|||
146673646|NCT01203098|528982807|FG002|Overall Study|Physician Decision|0|||
146673647|NCT01203098|528982805|FG000|Overall Study|Withdrawal by Subject|1|||
146673648|NCT01203098|528982806|FG001|Overall Study|Withdrawal by Subject|1|||
146673649|NCT01203098|528982807|FG002|Overall Study|Withdrawal by Subject|3|||
146673650|NCT03851705|528982812|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
146673651|NCT03851705|528982813|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
146673652|NCT03851705|528982814|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
146673653|NCT03851705|528982815|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
146673654|NCT03851705|528982812|FG000|Part 1: Double-Blind Period|Other reason|1|||
146673655|NCT03851705|528982813|FG001|Part 1: Double-Blind Period|Other reason|0|||
146673656|NCT03851705|528982814|FG002|Part 1: Double-Blind Period|Other reason|0|||
146673657|NCT03851705|528982815|FG003|Part 1: Double-Blind Period|Other reason|0|||
146673658|NCT03851705|528982812|FG000|Part 2: Open-Label Period|Other reason|0|||
146673659|NCT03851705|528982813|FG001|Part 2: Open-Label Period|Other reason|0|||
146673660|NCT03851705|528982814|FG002|Part 2: Open-Label Period|Other reason|0|||
146673661|NCT03851705|528982815|FG003|Part 2: Open-Label Period|Other reason|1|||
146673662|NCT03851705|528982812|FG000|Part 2: Open-Label Period|Death|0|||
146673663|NCT03851705|528982813|FG001|Part 2: Open-Label Period|Death|0|||
146673664|NCT03851705|528982814|FG002|Part 2: Open-Label Period|Death|3|||
146673665|NCT03851705|528982815|FG003|Part 2: Open-Label Period|Death|0|||
146673666|NCT03851705|528982812|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
146673667|NCT03851705|528982813|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
146673668|NCT03851705|528982814|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
146673669|NCT03851705|528982815|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
146673670|NCT00621582|528982819|FG000|Overall Study|Adverse Event|7|||
146673671|NCT00621582|528982819|FG000|Overall Study|Protocol Violation|57|||
146673672|NCT00621582|528982819|FG000|Overall Study|Lost to Follow-up|24|||
146673673|NCT00621582|528982819|FG000|Overall Study|issues not identified by investigators|18|||
146673674|NCT01387932|528982821|FG000|Randomized and Treated|Physician Decision|3|||
146673675|NCT01387932|528982822|FG001|Randomized and Treated|Physician Decision|2|||
146673676|NCT01387932|528982821|FG000|Randomized and Treated|Withdrawal by Subject|4|||
146673677|NCT01387932|528982822|FG001|Randomized and Treated|Withdrawal by Subject|2|||
146673678|NCT01387932|528982821|FG000|Survival Follow-up|Liver Transplant|24|||
146673679|NCT01387932|528982822|FG001|Survival Follow-up|Liver Transplant|28|||
146673680|NCT01387932|528982821|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
146673681|NCT01387932|528982822|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
146673682|NCT01387932|528982821|FG000|Survival Follow-up|Withdrawal by Subject|2|||
146673683|NCT01387932|528982822|FG001|Survival Follow-up|Withdrawal by Subject|4|||
146673684|NCT01387932|528982821|FG000|Survival Follow-up|Lost to Follow-up|6|||
146673685|NCT01387932|528982822|FG001|Survival Follow-up|Lost to Follow-up|5|||
146673686|NCT02591290|528982823|FG000|Overall Study|Withdrawal by Subject|2|||
146673687|NCT02571075|528982824|FG000|Overall Study|Lost to Follow-up|20|||
146673688|NCT02571075|528982825|FG001|Overall Study|Lost to Follow-up|24|||
146673689|NCT01306942|528982831|FG000|Phase I|Adverse Event|2|||
146673690|NCT01306942|528982832|FG001|Phase I|Adverse Event|2|||
146673691|NCT01306942|528982833|FG002|Phase I|Adverse Event|0|||
146673692|NCT01306942|528982834|FG003|Phase I|Adverse Event|0|||
146673693|NCT01306942|528982831|FG000|Phase I|Physician Decision|3|||
146673694|NCT01306942|528982832|FG001|Phase I|Physician Decision|1|||
146673695|NCT01306942|528982833|FG002|Phase I|Physician Decision|0|||
146673696|NCT01306942|528982834|FG003|Phase I|Physician Decision|0|||
146673697|NCT01306942|528982831|FG000|Phase II|Adverse Event|0|||
146673698|NCT01306942|528982832|FG001|Phase II|Adverse Event|0|||
146673699|NCT01306942|528982833|FG002|Phase II|Adverse Event|0|||
146673700|NCT01306942|528982834|FG003|Phase II|Adverse Event|6|||
146673701|NCT01306942|528982831|FG000|Phase II|Physician Decision|2|||
146673702|NCT01306942|528982832|FG001|Phase II|Physician Decision|0|||
146673703|NCT01306942|528982833|FG002|Phase II|Physician Decision|0|||
146673704|NCT01306942|528982834|FG003|Phase II|Physician Decision|5|||
146673705|NCT01306942|528982831|FG000|Phase II|Withdrawal by Subject|0|||
146673706|NCT01306942|528982832|FG001|Phase II|Withdrawal by Subject|0|||
146673707|NCT01306942|528982833|FG002|Phase II|Withdrawal by Subject|0|||
146673708|NCT01306942|528982834|FG003|Phase II|Withdrawal by Subject|2|||
146673709|NCT01306942|528982831|FG000|Phase II|Death|0|||
146673710|NCT01306942|528982832|FG001|Phase II|Death|0|||
146673711|NCT01306942|528982833|FG002|Phase II|Death|0|||
146673712|NCT01306942|528982834|FG003|Phase II|Death|1|||
146673713|NCT01306942|528982831|FG000|Phase II|Not finished treatment|0|||
146673714|NCT01306942|528982832|FG001|Phase II|Not finished treatment|0|||
146673715|NCT01306942|528982833|FG002|Phase II|Not finished treatment|0|||
146673716|NCT01306942|528982834|FG003|Phase II|Not finished treatment|1|||
146673717|NCT01306942|528982831|FG000|Phase II|Protocol Violation|0|||
146673718|NCT01306942|528982832|FG001|Phase II|Protocol Violation|0|||
146673719|NCT01306942|528982833|FG002|Phase II|Protocol Violation|0|||
146673720|NCT01306942|528982834|FG003|Phase II|Protocol Violation|1|||
146673721|NCT03190915|528982841|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
146673722|NCT03190915|528982841|FG000|Overall Study|Progressive Disease|3|||
146673723|NCT04545385|528982842|FG000|Overall Study|Withdrawal by Subject|2|||
146673724|NCT04545385|528982843|FG001|Overall Study|Withdrawal by Subject|0|||
146673725|NCT04545385|528982842|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
146673726|NCT04545385|528982843|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
146673727|NCT04545385|528982842|FG000|Overall Study|Study termination|10|||
146673728|NCT04545385|528982843|FG001|Overall Study|Study termination|10|||
146673729|NCT04545385|528982842|FG000|Overall Study|Sponsor decision|2|||
146673730|NCT04545385|528982843|FG001|Overall Study|Sponsor decision|2|||
146673731|NCT04545385|528982842|FG000|Overall Study|Other than specified|1|||
146673732|NCT04545385|528982843|FG001|Overall Study|Other than specified|0|||
146673733|NCT01128842|528982844|FG000|Overall Study|Adverse Event|1|||
146673734|NCT01128842|528982844|FG000|Overall Study|Disease Progression|6|||
146673735|NCT04528732|528982845|FG000|Overall Study|Death|1|||
146673736|NCT04528732|528982846|FG001|Overall Study|Death|0|||
146673737|NCT04528732|528982847|FG002|Overall Study|Death|1|||
146673738|NCT04528732|528982845|FG000|Overall Study|Lost to Follow-up|0|||
146673739|NCT04528732|528982846|FG001|Overall Study|Lost to Follow-up|1|||
146673740|NCT04528732|528982847|FG002|Overall Study|Lost to Follow-up|2|||
146673741|NCT00668707|528982848|FG000|Overall Study|Cancer Recurrence|58|||
146673742|NCT00668707|528982849|FG001|Overall Study|Cancer Recurrence|58|||
146673743|NCT00668707|528982848|FG000|Overall Study|Withdrawal by Subject|117|||
146673744|NCT00668707|528982849|FG001|Overall Study|Withdrawal by Subject|100|||
146673745|NCT00668707|528982848|FG000|Overall Study|Lost to Follow-up|3|||
146673746|NCT00668707|528982849|FG001|Overall Study|Lost to Follow-up|6|||
146673747|NCT00668707|528982848|FG000|Overall Study|Protocol Violation|10|||
146673748|NCT00668707|528982849|FG001|Overall Study|Protocol Violation|12|||
146673749|NCT00668707|528982848|FG000|Overall Study|Death|11|||
146673750|NCT00668707|528982849|FG001|Overall Study|Death|4|||
146673751|NCT02605824|528982850|FG000|Overall Study|Physician Decision|1|||
146673752|NCT02605824|528982851|FG001|Overall Study|Physician Decision|0|||
146673753|NCT00826943|528982852|FG000|Overall Study|Withdrawal by Subject|0|||
146673754|NCT00826943|528982853|FG001|Overall Study|Withdrawal by Subject|0|||
146673755|NCT00826943|528982854|FG002|Overall Study|Withdrawal by Subject|0|||
146673756|NCT00826943|528982855|FG003|Overall Study|Withdrawal by Subject|0|||
146673757|NCT00826943|528982856|FG004|Overall Study|Withdrawal by Subject|1|||
146978784|NCT01078623|530085500|FG004|Treatment Period 1|Adverse Event|0|||
146978785|NCT01078623|530085501|FG005|Treatment Period 1|Adverse Event|0|||
146673758|NCT00826943|528982857|FG005|Overall Study|Withdrawal by Subject|0|||
146673759|NCT01382212|528982858|FG000|Overall Study|Kidney transplant|1|||
146673760|NCT01382212|528982858|FG000|Overall Study|Withdrew consent|1|||
146673761|NCT01095731|528982859|FG000|Overall Study|Protocol Violation|1|||
146673762|NCT01095731|528982860|FG001|Overall Study|Protocol Violation|1|||
146673763|NCT01095731|528982859|FG000|Overall Study|Withdrawal by Subject|0|||
146673764|NCT01095731|528982860|FG001|Overall Study|Withdrawal by Subject|1|||
146673765|NCT01446289|528982861|FG000|Overall Study|Withdrawal by Subject|1|||
146673766|NCT01446289|528982862|FG001|Overall Study|Withdrawal by Subject|0|||
146673767|NCT01446289|528982863|FG002|Overall Study|Withdrawal by Subject|1|||
146673768|NCT01446289|528982864|FG003|Overall Study|Withdrawal by Subject|0|||
146673769|NCT03329573|528982865|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
146673770|NCT03329573|528982866|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
146673771|NCT03329573|528982867|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
146978786|NCT01078623|530085502|FG006|Treatment Period 1|Adverse Event|1|||
146673772|NCT03329573|528982868|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
146673773|NCT03329573|528982865|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
146673774|NCT03329573|528982866|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
146673775|NCT03329573|528982867|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146673776|NCT03329573|528982868|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146673777|NCT03329573|528982865|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
146673778|NCT03329573|528982866|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
146673779|NCT03329573|528982867|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
146673780|NCT03329573|528982868|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
146673781|NCT03329573|528982865|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
146673782|NCT03329573|528982866|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
146673783|NCT03329573|528982867|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
146673784|NCT03329573|528982868|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
146673785|NCT02777333|528982871|FG000|Overall Study|Withdrawal by Subject|0|||
146673786|NCT02777333|528982872|FG001|Overall Study|Withdrawal by Subject|1|||
146673787|NCT02777333|528982871|FG000|Overall Study|Lost to Follow-up|0|||
146673788|NCT02777333|528982872|FG001|Overall Study|Lost to Follow-up|1|||
146673789|NCT00837811|528982873|FG000|Overall Study|Adverse Event|4|||
146673790|NCT00837811|528982874|FG001|Overall Study|Adverse Event|6|||
146673791|NCT00837811|528982875|FG002|Overall Study|Adverse Event|0|||
146673792|NCT00837811|528982873|FG000|Overall Study|Death|1|||
146673793|NCT00837811|528982874|FG001|Overall Study|Death|1|||
146673794|NCT00837811|528982875|FG002|Overall Study|Death|0|||
146673795|NCT00837811|528982873|FG000|Overall Study|Lack of Efficacy|0|||
146673796|NCT00837811|528982874|FG001|Overall Study|Lack of Efficacy|11|||
146673797|NCT00837811|528982875|FG002|Overall Study|Lack of Efficacy|0|||
146673798|NCT00837811|528982873|FG000|Overall Study|Lost to Follow-up|1|||
146673799|NCT00837811|528982874|FG001|Overall Study|Lost to Follow-up|3|||
146673800|NCT00837811|528982875|FG002|Overall Study|Lost to Follow-up|0|||
146673801|NCT00837811|528982873|FG000|Overall Study|Physician Decision|0|||
146673802|NCT00837811|528982874|FG001|Overall Study|Physician Decision|2|||
146673803|NCT00837811|528982875|FG002|Overall Study|Physician Decision|1|||
146673804|NCT00837811|528982873|FG000|Overall Study|Withdrawal by Subject|1|||
146673805|NCT00837811|528982874|FG001|Overall Study|Withdrawal by Subject|9|||
146673806|NCT00837811|528982875|FG002|Overall Study|Withdrawal by Subject|0|||
146673807|NCT00837811|528982873|FG000|Overall Study|Sponsor Decision|0|||
146673808|NCT00837811|528982874|FG001|Overall Study|Sponsor Decision|2|||
146673809|NCT00837811|528982875|FG002|Overall Study|Sponsor Decision|0|||
146673810|NCT03307967|528982876|FG000|Overall Study|Lost to Follow-up|4|||
146673811|NCT02578316|528982877|FG000|Extension Phase|Progression of disease|6|||
146673812|NCT05243641|528982881|FG000|Overall Study|Adverse Event|3|||
146673813|NCT05243641|528982882|FG001|Overall Study|Adverse Event|0|||
146673814|NCT05243641|528982883|FG002|Overall Study|Adverse Event|0|||
146673815|NCT05243641|528982884|FG003|Overall Study|Adverse Event|1|||
146673816|NCT05243641|528982885|FG004|Overall Study|Adverse Event|0|||
146673817|NCT05243641|528982886|FG005|Overall Study|Adverse Event|0|||
146673818|NCT05243641|528982881|FG000|Overall Study|Disease progression|4|||
146673819|NCT05243641|528982882|FG001|Overall Study|Disease progression|0|||
146673820|NCT05243641|528982883|FG002|Overall Study|Disease progression|0|||
146673821|NCT05243641|528982884|FG003|Overall Study|Disease progression|2|||
146673822|NCT05243641|528982885|FG004|Overall Study|Disease progression|0|||
146673823|NCT05243641|528982886|FG005|Overall Study|Disease progression|0|||
146673824|NCT03268954|528982888|FG000|Overall Study|Withdrawal by Subject|27|||
146673825|NCT03268954|528982889|FG001|Overall Study|Withdrawal by Subject|17|||
146673826|NCT03268954|528982888|FG000|Overall Study|Lost to Follow-up|2|||
146673827|NCT03268954|528982889|FG001|Overall Study|Lost to Follow-up|3|||
146673828|NCT03268954|528982888|FG000|Overall Study|Reason Not Specified|3|||
146673829|NCT03268954|528982889|FG001|Overall Study|Reason Not Specified|8|||
146673830|NCT03820986|528982892|FG000|Overall Study|Death|201|||
146673831|NCT03820986|528982893|FG001|Overall Study|Death|175|||
146673832|NCT03820986|528982892|FG000|Overall Study|Lost to Follow-up|1|||
146673833|NCT03820986|528982893|FG001|Overall Study|Lost to Follow-up|1|||
146673834|NCT03820986|528982892|FG000|Overall Study|Physician Decision|1|||
146673835|NCT03820986|528982893|FG001|Overall Study|Physician Decision|0|||
146673836|NCT03820986|528982892|FG000|Overall Study|Sponsor Decision|122|||
146673837|NCT03820986|528982893|FG001|Overall Study|Sponsor Decision|160|||
146673838|NCT03820986|528982892|FG000|Overall Study|Withdrawal by Subject|9|||
146673839|NCT03820986|528982893|FG001|Overall Study|Withdrawal by Subject|4|||
146673840|NCT02993146|528982894|FG000|Overall Study|Withdrawal by Subject|0|||
146673841|NCT02993146|528982895|FG001|Overall Study|Withdrawal by Subject|0|||
146673842|NCT02993146|528982896|FG002|Overall Study|Withdrawal by Subject|1|||
146673843|NCT02993146|528982897|FG003|Overall Study|Withdrawal by Subject|1|||
146673844|NCT03192462|528984655|FG000|Overall Study|Death|13|||
146673845|NCT03192462|528984656|FG001|Overall Study|Death|11|||
146673846|NCT03192462|528984657|FG002|Overall Study|Death|10|||
146673847|NCT03192462|528984655|FG000|Overall Study|Lost to Follow-up|0|||
146673848|NCT03192462|528984656|FG001|Overall Study|Lost to Follow-up|1|||
146673849|NCT03192462|528984657|FG002|Overall Study|Lost to Follow-up|0|||
146673850|NCT04840615|528984658|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
146673851|NCT04840615|528984659|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
146673852|NCT04840615|528984660|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
146673853|NCT01898806|528984663|FG000|Overall Study|Withdrawal by Subject|2|||
146673854|NCT01898806|528984663|FG000|Overall Study|Physician Decision|1|||
146673855|NCT03003390|528984664|FG000|Overall Study|Physician Decision|2|||
146673856|NCT03003390|528984665|FG001|Overall Study|Physician Decision|0|||
146673857|NCT03003390|528984664|FG000|Overall Study|Parent refused intervention|2|||
146673858|NCT03003390|528984665|FG001|Overall Study|Parent refused intervention|0|||
146673859|NCT03156543|528984669|FG000|Overall Study|Withdrawal by Subject|1|||
146673860|NCT03156543|528984670|FG001|Overall Study|Withdrawal by Subject|0|||
146673861|NCT03364023|528984671|FG000|Overall Study|Lost to Follow-up|3|||
146673862|NCT03364023|528984671|FG000|Overall Study|Death|14|||
146673863|NCT00674700|528984676|FG000|Year 1|Adverse Event|17|||
146673864|NCT00674700|528984677|FG001|Year 1|Adverse Event|20|||
146673865|NCT00674700|528984678|FG002|Year 1|Adverse Event|5|||
146673866|NCT00674700|528984676|FG000|Year 1|Withdrawal by Subject|7|||
146673867|NCT00674700|528984677|FG001|Year 1|Withdrawal by Subject|7|||
146673868|NCT00674700|528984678|FG002|Year 1|Withdrawal by Subject|6|||
146673869|NCT00674700|528984676|FG000|Year 1|Any other reason not above-mentioned|7|||
146673870|NCT00674700|528984677|FG001|Year 1|Any other reason not above-mentioned|7|||
146673871|NCT00674700|528984678|FG002|Year 1|Any other reason not above-mentioned|6|||
146673872|NCT00674700|528984676|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
146673873|NCT00674700|528984677|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
146673874|NCT00674700|528984678|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
146673875|NCT00674700|528984676|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
146673876|NCT00674700|528984677|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
146673877|NCT00674700|528984678|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
146673878|NCT00674700|528984676|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
146673879|NCT00674700|528984677|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
146673880|NCT00674700|528984678|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
146673881|NCT00395304|528984679|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146673882|NCT00395304|528984680|FG001|Treatment Period 1|Withdrawal by Subject|3|||
146673883|NCT00395304|528984681|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146673884|NCT00395304|528984682|FG003|Treatment Period 1|Withdrawal by Subject|2|||
146673885|NCT00395304|528984683|FG004|Treatment Period 1|Withdrawal by Subject|1|||
146673886|NCT00395304|528984684|FG005|Treatment Period 1|Withdrawal by Subject|1|||
146673887|NCT00395304|528984679|FG000|Treatment Period 1|Lost to Follow-up|1|||
146673888|NCT00395304|528984680|FG001|Treatment Period 1|Lost to Follow-up|0|||
146673889|NCT00395304|528984681|FG002|Treatment Period 1|Lost to Follow-up|0|||
146673890|NCT00395304|528984682|FG003|Treatment Period 1|Lost to Follow-up|1|||
146673891|NCT00395304|528984683|FG004|Treatment Period 1|Lost to Follow-up|0|||
146673892|NCT00395304|528984684|FG005|Treatment Period 1|Lost to Follow-up|1|||
146673893|NCT00395304|528984679|FG000|Treatment Period 1|Physician Decision|0|||
146673894|NCT00395304|528984680|FG001|Treatment Period 1|Physician Decision|1|||
146673895|NCT00395304|528984681|FG002|Treatment Period 1|Physician Decision|0|||
146673896|NCT00395304|528984682|FG003|Treatment Period 1|Physician Decision|0|||
146673897|NCT00395304|528984683|FG004|Treatment Period 1|Physician Decision|0|||
146673898|NCT00395304|528984684|FG005|Treatment Period 1|Physician Decision|0|||
146673899|NCT00395304|528984679|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146673900|NCT00395304|528984680|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146673901|NCT00395304|528984681|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146673902|NCT00395304|528984682|FG003|Treatment Period 2|Withdrawal by Subject|1|||
146673903|NCT00395304|528984683|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146673904|NCT00395304|528984684|FG005|Treatment Period 2|Withdrawal by Subject|2|||
146673905|NCT00395304|528984679|FG000|Treatment Period 2|Lost to Follow-up|0|||
146673906|NCT00395304|528984680|FG001|Treatment Period 2|Lost to Follow-up|3|||
146673907|NCT00395304|528984681|FG002|Treatment Period 2|Lost to Follow-up|0|||
146673908|NCT00395304|528984682|FG003|Treatment Period 2|Lost to Follow-up|0|||
146673909|NCT00395304|528984683|FG004|Treatment Period 2|Lost to Follow-up|0|||
146774170|NCT01985334|529343540|FG001|Overall Study|Subject withdrawal of consent|6|||
146673910|NCT00395304|528984684|FG005|Treatment Period 2|Lost to Follow-up|0|||
146673911|NCT00395304|528984679|FG000|Treatment Period 2|Physician Decision|0|||
146673912|NCT00395304|528984680|FG001|Treatment Period 2|Physician Decision|0|||
146774171|NCT01985334|529343541|FG002|Overall Study|Subject withdrawal of consent|2|||
146673913|NCT00395304|528984681|FG002|Treatment Period 2|Physician Decision|1|||
146673914|NCT00395304|528984682|FG003|Treatment Period 2|Physician Decision|0|||
146673915|NCT00395304|528984683|FG004|Treatment Period 2|Physician Decision|0|||
146673916|NCT00395304|528984684|FG005|Treatment Period 2|Physician Decision|0|||
146673917|NCT00395304|528984679|FG000|Treatment Period 2|Other|0|||
146673918|NCT00395304|528984680|FG001|Treatment Period 2|Other|1|||
146673919|NCT00395304|528984681|FG002|Treatment Period 2|Other|0|||
146926175|NCT02951988|529890731|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
146673920|NCT00395304|528984682|FG003|Treatment Period 2|Other|0|||
146673921|NCT00395304|528984683|FG004|Treatment Period 2|Other|0|||
146673922|NCT00395304|528984684|FG005|Treatment Period 2|Other|0|||
146673923|NCT00395304|528984679|FG000|Treatment Period 3|Withdrawal by Subject|0|||
146673924|NCT00395304|528984680|FG001|Treatment Period 3|Withdrawal by Subject|0|||
146673925|NCT00395304|528984681|FG002|Treatment Period 3|Withdrawal by Subject|0|||
146673926|NCT00395304|528984682|FG003|Treatment Period 3|Withdrawal by Subject|1|||
146673927|NCT00395304|528984683|FG004|Treatment Period 3|Withdrawal by Subject|0|||
146673928|NCT00395304|528984684|FG005|Treatment Period 3|Withdrawal by Subject|1|||
146673929|NCT00395304|528984679|FG000|Treatment Period 3|Lost to Follow-up|1|||
146673930|NCT00395304|528984680|FG001|Treatment Period 3|Lost to Follow-up|1|||
146673931|NCT00395304|528984681|FG002|Treatment Period 3|Lost to Follow-up|0|||
146673932|NCT00395304|528984682|FG003|Treatment Period 3|Lost to Follow-up|0|||
146673933|NCT00395304|528984683|FG004|Treatment Period 3|Lost to Follow-up|0|||
146673934|NCT00395304|528984684|FG005|Treatment Period 3|Lost to Follow-up|0|||
146673935|NCT00395304|528984679|FG000|Treatment Period 3|Physician Decision|0|||
146673936|NCT00395304|528984680|FG001|Treatment Period 3|Physician Decision|1|||
146673937|NCT00395304|528984681|FG002|Treatment Period 3|Physician Decision|0|||
146673938|NCT00395304|528984682|FG003|Treatment Period 3|Physician Decision|0|||
146673939|NCT00395304|528984683|FG004|Treatment Period 3|Physician Decision|0|||
146673940|NCT00395304|528984684|FG005|Treatment Period 3|Physician Decision|0|||
146673941|NCT00395304|528984679|FG000|Treatment Period 3|Other|0|||
146673942|NCT00395304|528984680|FG001|Treatment Period 3|Other|0|||
146673943|NCT00395304|528984681|FG002|Treatment Period 3|Other|0|||
146673944|NCT00395304|528984682|FG003|Treatment Period 3|Other|1|||
146673945|NCT00395304|528984683|FG004|Treatment Period 3|Other|0|||
146673946|NCT00395304|528984684|FG005|Treatment Period 3|Other|0|||
146673947|NCT01389817|528984691|FG000|Overall Study|Physician Decision|1|||
146673948|NCT01389817|528984692|FG001|Overall Study|Physician Decision|0|||
146673949|NCT01389817|528984691|FG000|Overall Study|Lost to Follow-up|1|||
146673950|NCT01389817|528984692|FG001|Overall Study|Lost to Follow-up|0|||
146673951|NCT01389817|528984691|FG000|Overall Study|Withdrawal by Subject|2|||
146673952|NCT01389817|528984692|FG001|Overall Study|Withdrawal by Subject|0|||
146673953|NCT01749137|528984693|FG000|Overall Study|Adverse Event|4|||
146673954|NCT01749137|528984694|FG001|Overall Study|Adverse Event|4|||
146673955|NCT01749137|528984693|FG000|Overall Study|Lost to Follow-up|2|||
146673956|NCT01749137|528984694|FG001|Overall Study|Lost to Follow-up|3|||
146673957|NCT01749137|528984693|FG000|Overall Study|Physician Decision|1|||
146673958|NCT01749137|528984694|FG001|Overall Study|Physician Decision|0|||
146673959|NCT01749137|528984693|FG000|Overall Study|Withdrawal by Subject|8|||
146673960|NCT01749137|528984694|FG001|Overall Study|Withdrawal by Subject|4|||
146673961|NCT02871297|528984702|FG000|Overall Study|Adverse Event|34|||
146673962|NCT02871297|528984702|FG000|Overall Study|Lack of Efficacy|10|||
146673963|NCT02871297|528984702|FG000|Overall Study|Non-compliance with study drug|15|||
146673964|NCT02871297|528984702|FG000|Overall Study|Protocol Violation|3|||
146673965|NCT02871297|528984702|FG000|Overall Study|Withdrawal by Subject|20|||
146673966|NCT02871297|528984702|FG000|Overall Study|Lost to Follow-up|13|||
146673967|NCT02871297|528984702|FG000|Overall Study|Rolled over to 13546A|2|||
146673968|NCT02871297|528984702|FG000|Overall Study|Other than specified|39|||
146673969|NCT02966028|528984703|FG000|Overall Study|Adverse Event|7|||
146673970|NCT02966028|528984704|FG001|Overall Study|Adverse Event|13|||
146673971|NCT02966028|528984705|FG002|Overall Study|Adverse Event|10|||
146673972|NCT02966028|528984703|FG000|Overall Study|Physician Decision|1|||
146673973|NCT02966028|528984704|FG001|Overall Study|Physician Decision|0|||
146673974|NCT02966028|528984705|FG002|Overall Study|Physician Decision|2|||
146673975|NCT02966028|528984703|FG000|Overall Study|Withdrawal by Subject|7|||
146673976|NCT02966028|528984704|FG001|Overall Study|Withdrawal by Subject|5|||
146673977|NCT02966028|528984705|FG002|Overall Study|Withdrawal by Subject|5|||
146673978|NCT02966028|528984703|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
146673979|NCT02966028|528984704|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
146673980|NCT02966028|528984705|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
146673981|NCT00621985|528984706|FG000|Dexamethasone Admission|Adverse Event|1|||
146673982|NCT01408485|528984707|FG000|Overall Study|Withdrawal by Subject|21|||
146673983|NCT01397084|528984708|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
146673984|NCT01397084|528984708|FG000|Overall Study|Protocol Violation|2|||
146673985|NCT01397084|528984708|FG000|Overall Study|Adverse Event|2|||
146673986|NCT01397084|528984708|FG000|Overall Study|Withdrawal by Subject|1|||
146673987|NCT01397084|528984708|FG000|Overall Study|Lost to Follow-up|1|||
146673988|NCT01397084|528984708|FG000|Overall Study|Used other proton pump inhibitor|1|||
146673989|NCT00573469|528984709|FG000|Overall Study|Adverse Event|1|||
146673990|NCT00573469|528984710|FG001|Overall Study|Adverse Event|1|||
146673991|NCT00573469|528984711|FG002|Overall Study|Adverse Event|1|||
146673992|NCT00573469|528984709|FG000|Overall Study|Withdrawal by Subject|0|||
146673993|NCT00573469|528984710|FG001|Overall Study|Withdrawal by Subject|2|||
146673994|NCT00573469|528984711|FG002|Overall Study|Withdrawal by Subject|0|||
146673995|NCT00573469|528984709|FG000|Overall Study|Other|5|||
146673996|NCT00573469|528984710|FG001|Overall Study|Other|1|||
146673997|NCT00573469|528984711|FG002|Overall Study|Other|3|||
146978787|NCT01078623|530085503|FG007|Treatment Period 1|Adverse Event|0|||
146978788|NCT01078623|530085504|FG008|Treatment Period 1|Adverse Event|1|||
146978789|NCT01078623|530085505|FG009|Treatment Period 1|Adverse Event|1|||
146978790|NCT01078623|530085506|FG010|Treatment Period 1|Adverse Event|0|||
146978791|NCT01078623|530085507|FG011|Treatment Period 1|Adverse Event|0|||
146978792|NCT01078623|530085508|FG012|Treatment Period 1|Adverse Event|0|||
146978793|NCT01078623|530085509|FG013|Treatment Period 1|Adverse Event|0|||
146978794|NCT01078623|530085510|FG014|Treatment Period 1|Adverse Event|0|||
146978795|NCT01078623|530085511|FG015|Treatment Period 1|Adverse Event|0|||
146978796|NCT01078623|530085512|FG016|Treatment Period 1|Adverse Event|0|||
146978797|NCT01078623|530085513|FG017|Treatment Period 1|Adverse Event|0|||
146978798|NCT01078623|530085514|FG018|Treatment Period 1|Adverse Event|0|||
146978799|NCT01078623|530085515|FG019|Treatment Period 1|Adverse Event|0|||
146978800|NCT01078623|530085496|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146978801|NCT01078623|530085497|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146978802|NCT01078623|530085498|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146978803|NCT01078623|530085499|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146978804|NCT01078623|530085500|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146978805|NCT01078623|530085501|FG005|Treatment Period 1|Withdrawal by Subject|0|||
146978806|NCT01078623|530085502|FG006|Treatment Period 1|Withdrawal by Subject|0|||
146978807|NCT01078623|530085503|FG007|Treatment Period 1|Withdrawal by Subject|1|||
146978808|NCT01078623|530085504|FG008|Treatment Period 1|Withdrawal by Subject|0|||
146978809|NCT01078623|530085505|FG009|Treatment Period 1|Withdrawal by Subject|0|||
146978810|NCT01078623|530085506|FG010|Treatment Period 1|Withdrawal by Subject|1|||
146978811|NCT01078623|530085507|FG011|Treatment Period 1|Withdrawal by Subject|0|||
146978812|NCT01078623|530085508|FG012|Treatment Period 1|Withdrawal by Subject|0|||
146978813|NCT01078623|530085509|FG013|Treatment Period 1|Withdrawal by Subject|0|||
146978814|NCT01078623|530085510|FG014|Treatment Period 1|Withdrawal by Subject|0|||
146978815|NCT01078623|530085511|FG015|Treatment Period 1|Withdrawal by Subject|0|||
146978816|NCT01078623|530085512|FG016|Treatment Period 1|Withdrawal by Subject|0|||
146978817|NCT01078623|530085513|FG017|Treatment Period 1|Withdrawal by Subject|0|||
146978818|NCT01078623|530085514|FG018|Treatment Period 1|Withdrawal by Subject|0|||
146978819|NCT01078623|530085515|FG019|Treatment Period 1|Withdrawal by Subject|0|||
146978820|NCT01078623|530085496|FG000|Treatment Period 1|Protocol Violation|0|||
146978821|NCT01078623|530085497|FG001|Treatment Period 1|Protocol Violation|0|||
146978822|NCT01078623|530085498|FG002|Treatment Period 1|Protocol Violation|0|||
146978823|NCT01078623|530085499|FG003|Treatment Period 1|Protocol Violation|0|||
146978824|NCT01078623|530085500|FG004|Treatment Period 1|Protocol Violation|0|||
146978825|NCT01078623|530085501|FG005|Treatment Period 1|Protocol Violation|1|||
146978826|NCT01078623|530085502|FG006|Treatment Period 1|Protocol Violation|0|||
146978827|NCT01078623|530085503|FG007|Treatment Period 1|Protocol Violation|0|||
146978828|NCT01078623|530085504|FG008|Treatment Period 1|Protocol Violation|0|||
146673998|NCT01751867|528984713|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
146673999|NCT01751867|528984714|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
146674000|NCT01751867|528984713|FG000|Overall Study|Diease Progression|4|||
146674001|NCT01751867|528984714|FG001|Overall Study|Diease Progression|18|||
146674002|NCT01751867|528984713|FG000|Overall Study|Adverse Event|8|||
146674003|NCT01751867|528984714|FG001|Overall Study|Adverse Event|15|||
146674004|NCT01751867|528984713|FG000|Overall Study|Poor Compliance|0|||
146674005|NCT01751867|528984714|FG001|Overall Study|Poor Compliance|5|||
146674006|NCT01751867|528984713|FG000|Overall Study|Withdrawal by Subject|3|||
146674007|NCT01751867|528984714|FG001|Overall Study|Withdrawal by Subject|1|||
146674008|NCT01751867|528984713|FG000|Overall Study|Physician Decision|4|||
146674009|NCT01751867|528984714|FG001|Overall Study|Physician Decision|7|||
146674010|NCT01751867|528984713|FG000|Overall Study|Protocol Violation|0|||
146674011|NCT01751867|528984714|FG001|Overall Study|Protocol Violation|2|||
146674012|NCT01751867|528984713|FG000|Overall Study|Death|0|||
146674013|NCT01751867|528984714|FG001|Overall Study|Death|5|||
146674014|NCT01751867|528984713|FG000|Overall Study|Other|11|||
146674015|NCT01751867|528984714|FG001|Overall Study|Other|37|||
146674016|NCT01751867|528984713|FG000|Overall Study|Randomized but not treated.|2|||
146674017|NCT01751867|528984714|FG001|Overall Study|Randomized but not treated.|1|||
146674018|NCT04932096|528984715|FG000|Overall Study|Withdrawal by Subject|1|||
146674019|NCT04932096|528984716|FG001|Overall Study|Withdrawal by Subject|1|||
146674020|NCT04932096|528984715|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
146674021|NCT04932096|528984716|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
146674022|NCT01508650|528984717|FG000|Overall Study|Lost to Follow-up|0|||
146674023|NCT01508650|528984718|FG001|Overall Study|Lost to Follow-up|3|||
146674024|NCT02064894|528984719|FG000|Overall Study|Withdrawal by Subject|43|||
146674025|NCT02064894|528984720|FG001|Overall Study|Withdrawal by Subject|102|||
146674026|NCT02064894|528984721|FG002|Overall Study|Withdrawal by Subject|115|||
146674027|NCT01396148|528984722|FG000|Overall Study|Patient Decision|1|||
146674028|NCT00160693|528984727|FG000|Overall Study|Adverse Event|97|||
146674029|NCT00160693|528984727|FG000|Overall Study|Lack of Efficacy|30|||
146674030|NCT00160693|528984727|FG000|Overall Study|Protocol Violation|24|||
146978829|NCT01078623|530085505|FG009|Treatment Period 1|Protocol Violation|0|||
146978830|NCT01078623|530085506|FG010|Treatment Period 1|Protocol Violation|0|||
146674031|NCT00160693|528984727|FG000|Overall Study|Lost to Follow-up|15|||
146674032|NCT00160693|528984727|FG000|Overall Study|Withdrawal by Subject|54|||
146674033|NCT00160693|528984727|FG000|Overall Study|Study terminated by sponsor|15|||
146674034|NCT01976338|528984728|FG000|Overall Study|Physician Decision|0|||
146674035|NCT01976338|528984729|FG001|Overall Study|Physician Decision|1|||
146674036|NCT01976338|528984728|FG000|Overall Study|Lost to Follow-up|3|||
146674037|NCT01976338|528984729|FG001|Overall Study|Lost to Follow-up|0|||
146674038|NCT01976338|528984728|FG000|Overall Study|Withdrawal by Subject|5|||
146674039|NCT01976338|528984729|FG001|Overall Study|Withdrawal by Subject|2|||
146674040|NCT01976338|528984728|FG000|Overall Study|Adverse Event|5|||
146674041|NCT01976338|528984729|FG001|Overall Study|Adverse Event|1|||
146674042|NCT02853604|528984730|FG000|Overall Study|Withdrawal by Subject|12|||
146674043|NCT02853604|528984731|FG001|Overall Study|Withdrawal by Subject|35|||
146674044|NCT02853604|528984730|FG000|Overall Study|Lost to Follow-up|4|||
146674045|NCT02853604|528984731|FG001|Overall Study|Lost to Follow-up|8|||
146674046|NCT02853604|528984730|FG000|Overall Study|Death|1|||
146674047|NCT02853604|528984731|FG001|Overall Study|Death|5|||
146674048|NCT02853604|528984730|FG000|Overall Study|Miscellaneous|11|||
146674049|NCT02853604|528984731|FG001|Overall Study|Miscellaneous|2|||
146674050|NCT02853604|528984730|FG000|Overall Study|Progressive Disease|0|||
146674051|NCT02853604|528984731|FG001|Overall Study|Progressive Disease|2|||
146674052|NCT03766581|528984732|FG000|Randomization|Other reasons|2|||
146774172|NCT01985334|529343542|FG003|Overall Study|Subject withdrawal of consent|28|||
146774173|NCT01985334|529343543|FG004|Overall Study|Subject withdrawal of consent|4|||
146774174|NCT01985334|529343544|FG005|Overall Study|Subject withdrawal of consent|19|||
146674053|NCT03766581|528984733|FG001|Randomization|Other reasons|1|||
146674054|NCT03766581|528984734|FG002|Randomization|Other reasons|0|||
146674055|NCT03766581|528984735|FG003|Randomization|Other reasons|1|||
146674056|NCT03766581|528984736|FG004|Randomization|Other reasons|0|||
146674057|NCT03766581|528984737|FG005|Randomization|Other reasons|0|||
146674058|NCT03766581|528984738|FG006|Randomization|Other reasons|0|||
146674059|NCT03766581|528984739|FG007|Randomization|Other reasons|0|||
146674060|NCT03766581|528984732|FG000|Randomization|Participant no longer meets study criteria|5|||
146774175|NCT01985334|529343545|FG006|Overall Study|Subject withdrawal of consent|0|||
146774176|NCT01985334|529343546|FG007|Overall Study|Subject withdrawal of consent|20|||
146774177|NCT01985334|529343539|FG000|Overall Study|Adverse Event|0|||
146774178|NCT01985334|529343540|FG001|Overall Study|Adverse Event|8|||
146774179|NCT01985334|529343541|FG002|Overall Study|Adverse Event|2|||
146774180|NCT01985334|529343542|FG003|Overall Study|Adverse Event|26|||
146774181|NCT01985334|529343543|FG004|Overall Study|Adverse Event|3|||
146774182|NCT01985334|529343544|FG005|Overall Study|Adverse Event|18|||
146774183|NCT01985334|529343545|FG006|Overall Study|Adverse Event|3|||
146774184|NCT01985334|529343546|FG007|Overall Study|Adverse Event|15|||
146774185|NCT01985334|529343539|FG000|Overall Study|Other|4|||
146774186|NCT01985334|529343540|FG001|Overall Study|Other|2|||
146774187|NCT01985334|529343541|FG002|Overall Study|Other|3|||
146774188|NCT01985334|529343542|FG003|Overall Study|Other|10|||
146774189|NCT01985334|529343543|FG004|Overall Study|Other|1|||
146774190|NCT01985334|529343544|FG005|Overall Study|Other|6|||
146774191|NCT01985334|529343545|FG006|Overall Study|Other|2|||
146774192|NCT01985334|529343546|FG007|Overall Study|Other|2|||
146774193|NCT01985334|529343539|FG000|Overall Study|Medication non-compliance|0|||
146774194|NCT01985334|529343540|FG001|Overall Study|Medication non-compliance|4|||
146774195|NCT01985334|529343541|FG002|Overall Study|Medication non-compliance|1|||
146774196|NCT01985334|529343542|FG003|Overall Study|Medication non-compliance|6|||
146774197|NCT01985334|529343543|FG004|Overall Study|Medication non-compliance|2|||
146774198|NCT01985334|529343544|FG005|Overall Study|Medication non-compliance|3|||
146774199|NCT01985334|529343545|FG006|Overall Study|Medication non-compliance|1|||
146774200|NCT01985334|529343546|FG007|Overall Study|Medication non-compliance|3|||
146774201|NCT01985334|529343539|FG000|Overall Study|Use of prohibited treatment|1|||
146774202|NCT01985334|529343540|FG001|Overall Study|Use of prohibited treatment|4|||
146774203|NCT01985334|529343541|FG002|Overall Study|Use of prohibited treatment|1|||
146774204|NCT01985334|529343542|FG003|Overall Study|Use of prohibited treatment|2|||
146774205|NCT01985334|529343543|FG004|Overall Study|Use of prohibited treatment|1|||
146774206|NCT01985334|529343544|FG005|Overall Study|Use of prohibited treatment|6|||
146774207|NCT01985334|529343545|FG006|Overall Study|Use of prohibited treatment|2|||
146774208|NCT01985334|529343546|FG007|Overall Study|Use of prohibited treatment|0|||
146774209|NCT01985334|529343539|FG000|Overall Study|Investigator decision|0|||
146774210|NCT01985334|529343540|FG001|Overall Study|Investigator decision|3|||
146774211|NCT01985334|529343541|FG002|Overall Study|Investigator decision|0|||
146774212|NCT01985334|529343542|FG003|Overall Study|Investigator decision|7|||
146774213|NCT01985334|529343543|FG004|Overall Study|Investigator decision|1|||
146774214|NCT01985334|529343544|FG005|Overall Study|Investigator decision|1|||
146774215|NCT01985334|529343545|FG006|Overall Study|Investigator decision|0|||
146774216|NCT01985334|529343546|FG007|Overall Study|Investigator decision|4|||
146674061|NCT03766581|528984733|FG001|Randomization|Participant no longer meets study criteria|3|||
146674062|NCT03766581|528984734|FG002|Randomization|Participant no longer meets study criteria|4|||
146774217|NCT01985334|529343539|FG000|Overall Study|Lost to Follow-up|0|||
146926176|NCT02951988|529890732|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
146926177|NCT02951988|529890733|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
146926178|NCT02951988|529890734|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
146926179|NCT02951988|529890731|FG000|Open-Label Treatment Period|Protocol Violation|22|||
146926180|NCT02951988|529890732|FG001|Open-Label Treatment Period|Protocol Violation|0|||
146926181|NCT02951988|529890733|FG002|Open-Label Treatment Period|Protocol Violation|0|||
146926182|NCT02951988|529890734|FG003|Open-Label Treatment Period|Protocol Violation|0|||
146926183|NCT02951988|529890731|FG000|Open-Label Treatment Period|Pregnancy|2|||
146926184|NCT02951988|529890732|FG001|Open-Label Treatment Period|Pregnancy|0|||
146926185|NCT02951988|529890733|FG002|Open-Label Treatment Period|Pregnancy|0|||
146926186|NCT02951988|529890734|FG003|Open-Label Treatment Period|Pregnancy|0|||
146926187|NCT02951988|529890731|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
146926188|NCT02951988|529890732|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
146926189|NCT02951988|529890733|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
146926190|NCT02951988|529890734|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
146926191|NCT02951988|529890731|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
146926192|NCT02951988|529890732|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
146926193|NCT02951988|529890733|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
146926194|NCT02951988|529890734|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
146926195|NCT02951988|529890731|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
146926196|NCT02951988|529890732|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
146774218|NCT01985334|529343540|FG001|Overall Study|Lost to Follow-up|2|||
146774219|NCT01985334|529343541|FG002|Overall Study|Lost to Follow-up|0|||
146774220|NCT01985334|529343542|FG003|Overall Study|Lost to Follow-up|3|||
146774221|NCT01985334|529343543|FG004|Overall Study|Lost to Follow-up|1|||
146774222|NCT01985334|529343544|FG005|Overall Study|Lost to Follow-up|4|||
146774223|NCT01985334|529343545|FG006|Overall Study|Lost to Follow-up|0|||
146774224|NCT01985334|529343546|FG007|Overall Study|Lost to Follow-up|3|||
146774225|NCT01546753|529343547|FG000|Overall Study|anxiety|1|||
146774226|NCT01546753|529343548|FG001|Overall Study|anxiety|1|||
146774227|NCT01546753|529343547|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
146774228|NCT01546753|529343548|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
146774229|NCT03036813|529343549|FG000|Overall Study|Adverse Event|6|||
146774230|NCT03036813|529343550|FG001|Overall Study|Adverse Event|11|||
146774231|NCT03036813|529343551|FG002|Overall Study|Adverse Event|6|||
146774232|NCT03036813|529343549|FG000|Overall Study|Withdrawal by Subject|12|||
146774233|NCT03036813|529343550|FG001|Overall Study|Withdrawal by Subject|6|||
146774234|NCT03036813|529343551|FG002|Overall Study|Withdrawal by Subject|10|||
146774235|NCT03036813|529343549|FG000|Overall Study|Lost to Follow-up|1|||
146774236|NCT03036813|529343550|FG001|Overall Study|Lost to Follow-up|1|||
146774237|NCT03036813|529343551|FG002|Overall Study|Lost to Follow-up|0|||
146774238|NCT03036813|529343549|FG000|Overall Study|Physician Decision|2|||
146774239|NCT03036813|529343550|FG001|Overall Study|Physician Decision|1|||
146774240|NCT03036813|529343551|FG002|Overall Study|Physician Decision|1|||
146774241|NCT03036813|529343549|FG000|Overall Study|Non-Compliance|1|||
146774242|NCT03036813|529343550|FG001|Overall Study|Non-Compliance|5|||
146774243|NCT03036813|529343551|FG002|Overall Study|Non-Compliance|3|||
146774244|NCT03036813|529343549|FG000|Overall Study|Pregnancy|0|||
146774245|NCT03036813|529343550|FG001|Overall Study|Pregnancy|0|||
146774246|NCT03036813|529343551|FG002|Overall Study|Pregnancy|1|||
146774247|NCT03036813|529343549|FG000|Overall Study|Other|0|||
146774248|NCT03036813|529343550|FG001|Overall Study|Other|3|||
146774249|NCT03036813|529343551|FG002|Overall Study|Other|5|||
146774250|NCT01102231|529343552|FG000|Overall Study|Protocol Violation|3|||
146774251|NCT01102231|529343552|FG000|Overall Study|Lack of Efficacy|2|||
146774252|NCT01102231|529343552|FG000|Overall Study|Death|2|||
146774253|NCT01102231|529343552|FG000|Overall Study|Adverse Event|3|||
146774254|NCT01102231|529343552|FG000|Overall Study|Withdrawal by Subject|1|||
146774255|NCT01102231|529343552|FG000|Overall Study|Did not received the treatment|4|||
146774256|NCT00546754|529343553|FG000|Overall Study|Serious Adverse Event|1|||
146774257|NCT00546754|529343554|FG001|Overall Study|Serious Adverse Event|1|||
146774258|NCT00546754|529343553|FG000|Overall Study|Adverse Event|11|||
146774259|NCT00546754|529343554|FG001|Overall Study|Adverse Event|16|||
146774260|NCT00546754|529343553|FG000|Overall Study|Lack of Efficacy|1|||
146774261|NCT00546754|529343554|FG001|Overall Study|Lack of Efficacy|1|||
146774262|NCT00546754|529343553|FG000|Overall Study|Lost to Follow-up|9|||
146774263|NCT00546754|529343554|FG001|Overall Study|Lost to Follow-up|15|||
146774264|NCT00546754|529343553|FG000|Overall Study|Protocol Violation|3|||
146774265|NCT00546754|529343554|FG001|Overall Study|Protocol Violation|0|||
146774266|NCT00546754|529343553|FG000|Overall Study|Withdrawal by Subject|6|||
146774267|NCT00546754|529343554|FG001|Overall Study|Withdrawal by Subject|7|||
146774268|NCT00546754|529343553|FG000|Overall Study|Dyspnea|1|||
146774269|NCT00546754|529343554|FG001|Overall Study|Dyspnea|0|||
146774270|NCT00546754|529343553|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
146774271|NCT00546754|529343554|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
146774272|NCT00546754|529343553|FG000|Overall Study|Hip Replacement|1|||
146774273|NCT00546754|529343554|FG001|Overall Study|Hip Replacement|0|||
146674063|NCT03766581|528984735|FG003|Randomization|Participant no longer meets study criteria|0|||
146674064|NCT03766581|528984736|FG004|Randomization|Participant no longer meets study criteria|2|||
146674065|NCT03766581|528984737|FG005|Randomization|Participant no longer meets study criteria|3|||
146674066|NCT03766581|528984738|FG006|Randomization|Participant no longer meets study criteria|0|||
146674067|NCT03766581|528984739|FG007|Randomization|Participant no longer meets study criteria|1|||
146674068|NCT03766581|528984732|FG000|Randomization|Participant request to discontinue study treatment|1|||
146674069|NCT03766581|528984733|FG001|Randomization|Participant request to discontinue study treatment|0|||
146674070|NCT03766581|528984734|FG002|Randomization|Participant request to discontinue study treatment|0|||
146674071|NCT03766581|528984735|FG003|Randomization|Participant request to discontinue study treatment|0|||
146674072|NCT03766581|528984736|FG004|Randomization|Participant request to discontinue study treatment|1|||
146674073|NCT03766581|528984737|FG005|Randomization|Participant request to discontinue study treatment|2|||
146674074|NCT03766581|528984738|FG006|Randomization|Participant request to discontinue study treatment|0|||
146674075|NCT03766581|528984739|FG007|Randomization|Participant request to discontinue study treatment|0|||
146674076|NCT03766581|528984732|FG000|Randomization|Participant withdrew consent|1|||
146674077|NCT03766581|528984733|FG001|Randomization|Participant withdrew consent|0|||
146674078|NCT03766581|528984734|FG002|Randomization|Participant withdrew consent|1|||
146674079|NCT03766581|528984735|FG003|Randomization|Participant withdrew consent|2|||
146674080|NCT03766581|528984736|FG004|Randomization|Participant withdrew consent|1|||
146674081|NCT03766581|528984737|FG005|Randomization|Participant withdrew consent|1|||
146674082|NCT03766581|528984738|FG006|Randomization|Participant withdrew consent|0|||
146674083|NCT03766581|528984739|FG007|Randomization|Participant withdrew consent|0|||
146674084|NCT03766581|528984732|FG000|Treatment|Adverse Event|82|||
146674085|NCT03766581|528984733|FG001|Treatment|Adverse Event|44|||
146674086|NCT03766581|528984734|FG002|Treatment|Adverse Event|47|||
146674087|NCT03766581|528984735|FG003|Treatment|Adverse Event|46|||
146674088|NCT03766581|528984736|FG004|Treatment|Adverse Event|50|||
146674089|NCT03766581|528984737|FG005|Treatment|Adverse Event|77|||
146674090|NCT03766581|528984738|FG006|Treatment|Adverse Event|5|||
146674091|NCT03766581|528984739|FG007|Treatment|Adverse Event|2|||
146674092|NCT03766581|528984732|FG000|Treatment|Participant request to discontinue treatment|34|||
146674093|NCT03766581|528984733|FG001|Treatment|Participant request to discontinue treatment|6|||
146674094|NCT03766581|528984734|FG002|Treatment|Participant request to discontinue treatment|10|||
146674095|NCT03766581|528984735|FG003|Treatment|Participant request to discontinue treatment|10|||
146674096|NCT03766581|528984736|FG004|Treatment|Participant request to discontinue treatment|14|||
146674097|NCT03766581|528984737|FG005|Treatment|Participant request to discontinue treatment|15|||
146674098|NCT03766581|528984738|FG006|Treatment|Participant request to discontinue treatment|0|||
146674099|NCT03766581|528984739|FG007|Treatment|Participant request to discontinue treatment|1|||
146674100|NCT03766581|528984732|FG000|Treatment|Participant withdrew consent|11|||
146674101|NCT03766581|528984733|FG001|Treatment|Participant withdrew consent|4|||
146674102|NCT03766581|528984734|FG002|Treatment|Participant withdrew consent|5|||
146674103|NCT03766581|528984735|FG003|Treatment|Participant withdrew consent|5|||
146674104|NCT03766581|528984736|FG004|Treatment|Participant withdrew consent|4|||
146674105|NCT03766581|528984737|FG005|Treatment|Participant withdrew consent|4|||
146674106|NCT03766581|528984738|FG006|Treatment|Participant withdrew consent|0|||
146674107|NCT03766581|528984739|FG007|Treatment|Participant withdrew consent|0|||
146674108|NCT03766581|528984732|FG000|Treatment|Death|1|||
146674109|NCT03766581|528984733|FG001|Treatment|Death|0|||
146674110|NCT03766581|528984734|FG002|Treatment|Death|0|||
146674111|NCT03766581|528984735|FG003|Treatment|Death|0|||
146674112|NCT03766581|528984736|FG004|Treatment|Death|0|||
146674113|NCT03766581|528984737|FG005|Treatment|Death|0|||
146674114|NCT03766581|528984738|FG006|Treatment|Death|0|||
146674115|NCT03766581|528984739|FG007|Treatment|Death|0|||
146674116|NCT03766581|528984732|FG000|Treatment|Lost to Follow-up|1|||
146674117|NCT03766581|528984733|FG001|Treatment|Lost to Follow-up|0|||
146674118|NCT03766581|528984734|FG002|Treatment|Lost to Follow-up|0|||
146674119|NCT03766581|528984735|FG003|Treatment|Lost to Follow-up|1|||
146674120|NCT03766581|528984736|FG004|Treatment|Lost to Follow-up|0|||
146674121|NCT03766581|528984737|FG005|Treatment|Lost to Follow-up|0|||
146674122|NCT03766581|528984738|FG006|Treatment|Lost to Follow-up|0|||
146674123|NCT03766581|528984739|FG007|Treatment|Lost to Follow-up|0|||
146674124|NCT03766581|528984732|FG000|Treatment|Poor/Non compliance|2|||
146674125|NCT03766581|528984733|FG001|Treatment|Poor/Non compliance|2|||
146674126|NCT03766581|528984734|FG002|Treatment|Poor/Non compliance|1|||
146674127|NCT03766581|528984735|FG003|Treatment|Poor/Non compliance|1|||
146674128|NCT03766581|528984736|FG004|Treatment|Poor/Non compliance|1|||
146674129|NCT03766581|528984737|FG005|Treatment|Poor/Non compliance|1|||
146674130|NCT03766581|528984738|FG006|Treatment|Poor/Non compliance|0|||
146674131|NCT03766581|528984739|FG007|Treatment|Poor/Non compliance|0|||
146674132|NCT03766581|528984732|FG000|Treatment|Participant no longer meets study criteria|9|||
146674133|NCT03766581|528984733|FG001|Treatment|Participant no longer meets study criteria|1|||
146674134|NCT03766581|528984734|FG002|Treatment|Participant no longer meets study criteria|5|||
146674135|NCT03766581|528984735|FG003|Treatment|Participant no longer meets study criteria|4|||
146674136|NCT03766581|528984736|FG004|Treatment|Participant no longer meets study criteria|4|||
146674137|NCT03766581|528984737|FG005|Treatment|Participant no longer meets study criteria|4|||
146674138|NCT03766581|528984738|FG006|Treatment|Participant no longer meets study criteria|2|||
146674139|NCT03766581|528984739|FG007|Treatment|Participant no longer meets study criteria|0|||
146674140|NCT03766581|528984732|FG000|Treatment|Other reasons|13|||
146674141|NCT03766581|528984733|FG001|Treatment|Other reasons|8|||
146674142|NCT03766581|528984734|FG002|Treatment|Other reasons|3|||
146674143|NCT03766581|528984735|FG003|Treatment|Other reasons|7|||
146674144|NCT03766581|528984736|FG004|Treatment|Other reasons|3|||
146674145|NCT03766581|528984737|FG005|Treatment|Other reasons|3|||
146674146|NCT03766581|528984738|FG006|Treatment|Other reasons|0|||
146674147|NCT03766581|528984739|FG007|Treatment|Other reasons|0|||
146674148|NCT03716024|528984740|FG000|Overall Study|Randomized, not Treated|7|||
146674149|NCT03716024|528984741|FG001|Overall Study|Randomized, not Treated|8|||
146674150|NCT03716024|528984740|FG000|Overall Study|Adverse Event|1|||
146674151|NCT03716024|528984741|FG001|Overall Study|Adverse Event|2|||
146674152|NCT03716024|528984740|FG000|Overall Study|Treatment Failure|1|||
146674153|NCT03716024|528984741|FG001|Overall Study|Treatment Failure|0|||
146674154|NCT03716024|528984740|FG000|Overall Study|Lost to Follow-up|2|||
146674155|NCT03716024|528984741|FG001|Overall Study|Lost to Follow-up|6|||
146674156|NCT03716024|528984740|FG000|Overall Study|Withdrawal by Subject|0|||
146674157|NCT03716024|528984741|FG001|Overall Study|Withdrawal by Subject|1|||
146674158|NCT03716024|528984740|FG000|Overall Study|Missing Reason|0|||
146674159|NCT03716024|528984741|FG001|Overall Study|Missing Reason|1|||
146674160|NCT04343261|528984742|FG000|Overall Study|Adverse Event|1|||
146674161|NCT04343261|528984742|FG000|Overall Study|received inadequate amount of antibodies|7|||
146674162|NCT04182763|528984749|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
146674163|NCT04182763|528984750|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
146674164|NCT04182763|528984751|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
146674165|NCT04182763|528984752|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
146674166|NCT04182763|528984753|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
146674167|NCT04182763|528984749|FG000|Double-Blind Period, initial 6 months|Death|0|||
146674168|NCT04182763|528984750|FG001|Double-Blind Period, initial 6 months|Death|1|||
146674169|NCT04182763|528984751|FG002|Double-Blind Period, initial 6 months|Death|0|||
146674170|NCT04182763|528984752|FG003|Double-Blind Period, initial 6 months|Death|0|||
146674171|NCT04182763|528984753|FG004|Double-Blind Period, initial 6 months|Death|0|||
146674172|NCT04182763|528984749|FG000|Open-Label Period, subsequent 18 months|Death|3|||
146674173|NCT04182763|528984750|FG001|Open-Label Period, subsequent 18 months|Death|2|||
146674174|NCT04182763|528984751|FG002|Open-Label Period, subsequent 18 months|Death|2|||
146674175|NCT04182763|528984752|FG003|Open-Label Period, subsequent 18 months|Death|0|||
146674176|NCT04182763|528984753|FG004|Open-Label Period, subsequent 18 months|Death|1|||
146674177|NCT04182763|528984749|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
146674178|NCT04182763|528984750|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
146674179|NCT04182763|528984751|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
146674180|NCT04182763|528984752|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
146674181|NCT04182763|528984753|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
146674182|NCT04182763|528984749|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
146674183|NCT04182763|528984750|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
146674184|NCT04182763|528984751|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
146674185|NCT04182763|528984752|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
146674186|NCT04182763|528984753|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
146674187|NCT05988619|528984755|FG000|Overall Study|Lost to Follow-up|1|||
146674188|NCT05988619|528984756|FG001|Overall Study|Lost to Follow-up|4|||
146674189|NCT05988619|528984755|FG000|Overall Study|Withdrawal by Subject|2|||
146674190|NCT05988619|528984756|FG001|Overall Study|Withdrawal by Subject|9|||
146674191|NCT03616600|528984759|FG000|Overall Study|Withdrawal by Subject|1|||
146674192|NCT03616600|528984760|FG001|Overall Study|Withdrawal by Subject|0|||
146674193|NCT00587054|528984761|FG000|Overall Study|Patient not treated|9|||
146674194|NCT03984994|528984762|FG000|Overall Study|Withdrawal by Subject|2|||
146674195|NCT03984994|528984763|FG001|Overall Study|Withdrawal by Subject|1|||
146674196|NCT03010176|528984765|FG000|Overall Study|Death|21|||
146674197|NCT03010176|528984766|FG001|Overall Study|Death|35|||
146674198|NCT03010176|528984767|FG002|Overall Study|Death|19|||
146674199|NCT03010176|528984768|FG003|Overall Study|Death|19|||
146674200|NCT03010176|528984769|FG004|Overall Study|Death|14|||
146674201|NCT03010176|528984770|FG005|Overall Study|Death|0|||
146674202|NCT03010176|528984765|FG000|Overall Study|Lost to Follow-up|0|||
146674203|NCT03010176|528984766|FG001|Overall Study|Lost to Follow-up|0|||
146674204|NCT03010176|528984767|FG002|Overall Study|Lost to Follow-up|0|||
146674205|NCT03010176|528984768|FG003|Overall Study|Lost to Follow-up|0|||
146674206|NCT03010176|528984769|FG004|Overall Study|Lost to Follow-up|1|||
146774274|NCT00546754|529343553|FG000|Overall Study|Suicide|1|||
146774275|NCT00546754|529343554|FG001|Overall Study|Suicide|0|||
146674207|NCT03010176|528984770|FG005|Overall Study|Lost to Follow-up|0|||
146674208|NCT03010176|528984765|FG000|Overall Study|Physician Decision|0|||
146674209|NCT03010176|528984766|FG001|Overall Study|Physician Decision|4|||
146674210|NCT03010176|528984767|FG002|Overall Study|Physician Decision|0|||
146674211|NCT03010176|528984768|FG003|Overall Study|Physician Decision|1|||
146674212|NCT03010176|528984769|FG004|Overall Study|Physician Decision|0|||
146674213|NCT03010176|528984770|FG005|Overall Study|Physician Decision|0|||
146674214|NCT03010176|528984765|FG000|Overall Study|Sponsor Decision|0|||
146674215|NCT03010176|528984766|FG001|Overall Study|Sponsor Decision|4|||
146674216|NCT03010176|528984767|FG002|Overall Study|Sponsor Decision|4|||
146674217|NCT03010176|528984768|FG003|Overall Study|Sponsor Decision|1|||
146674218|NCT03010176|528984769|FG004|Overall Study|Sponsor Decision|6|||
146674219|NCT03010176|528984770|FG005|Overall Study|Sponsor Decision|0|||
146674220|NCT03010176|528984765|FG000|Overall Study|Withdrawal by Subject|11|||
146674221|NCT03010176|528984766|FG001|Overall Study|Withdrawal by Subject|9|||
146674222|NCT03010176|528984767|FG002|Overall Study|Withdrawal by Subject|3|||
146674223|NCT03010176|528984768|FG003|Overall Study|Withdrawal by Subject|0|||
146674224|NCT03010176|528984769|FG004|Overall Study|Withdrawal by Subject|4|||
146674225|NCT03010176|528984770|FG005|Overall Study|Withdrawal by Subject|0|||
146674226|NCT00726232|528984773|FG000|Initial Phase (Dose-finding)|Death|0|||
146674227|NCT00726232|528984774|FG001|Initial Phase (Dose-finding)|Death|0|||
146674228|NCT00726232|528984775|FG002|Initial Phase (Dose-finding)|Death|0|||
146674229|NCT00726232|528984776|FG003|Initial Phase (Dose-finding)|Death|0|||
146674230|NCT00726232|528984777|FG004|Initial Phase (Dose-finding)|Death|1|||
146674231|NCT00726232|528984778|FG005|Initial Phase (Dose-finding)|Death|0|||
146674232|NCT00726232|528984779|FG006|Initial Phase (Dose-finding)|Death|0|||
146674233|NCT00726232|528984780|FG007|Initial Phase (Dose-finding)|Death|0|||
146674234|NCT00726232|528984773|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
146674235|NCT00726232|528984774|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
146674236|NCT00726232|528984775|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
146674237|NCT00726232|528984776|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
146674238|NCT00726232|528984777|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
146674239|NCT00726232|528984778|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
146674240|NCT00726232|528984779|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
146674241|NCT00726232|528984780|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
146674242|NCT00726232|528984773|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
146674243|NCT00726232|528984774|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
146674244|NCT00726232|528984775|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
146674245|NCT00726232|528984776|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
146674246|NCT00726232|528984777|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
146674247|NCT00726232|528984778|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
146674248|NCT00726232|528984779|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
146674249|NCT00726232|528984780|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
146674250|NCT00726232|528984773|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
146674251|NCT00726232|528984774|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
146674252|NCT00726232|528984775|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
146674253|NCT00726232|528984776|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
146674254|NCT00726232|528984777|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
146674255|NCT00726232|528984778|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
146674256|NCT00726232|528984779|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
146674257|NCT00726232|528984780|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
146674258|NCT00726232|528984773|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
146674259|NCT00726232|528984774|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
146674260|NCT00726232|528984775|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
146674261|NCT00726232|528984776|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
146674262|NCT00726232|528984777|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
146674263|NCT00726232|528984778|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
146674264|NCT00726232|528984779|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
146674265|NCT00726232|528984780|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
146674266|NCT00726232|528984773|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
146674267|NCT00726232|528984774|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
146674268|NCT00726232|528984775|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
146674269|NCT00726232|528984776|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
146674270|NCT00726232|528984777|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
146674271|NCT00726232|528984778|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
146774276|NCT00546754|529343553|FG000|Overall Study|Missing Cooperation|1|||
146926197|NCT02951988|529890733|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
146674272|NCT00726232|528984779|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
146674273|NCT00726232|528984780|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
146926198|NCT02951988|529890734|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
146674274|NCT00726232|528984773|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
146674275|NCT00726232|528984774|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
146674276|NCT00726232|528984775|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
146674277|NCT00726232|528984776|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
146674278|NCT00726232|528984777|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
146674279|NCT00726232|528984778|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
146674280|NCT00726232|528984779|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
146674281|NCT00726232|528984780|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
146674282|NCT00726232|528984773|FG000|Expansion Phase|Death|0|||
146674283|NCT00726232|528984774|FG001|Expansion Phase|Death|0|||
146674284|NCT00726232|528984775|FG002|Expansion Phase|Death|0|||
146674285|NCT00726232|528984776|FG003|Expansion Phase|Death|0|||
146674286|NCT00726232|528984777|FG004|Expansion Phase|Death|0|||
146674287|NCT00726232|528984778|FG005|Expansion Phase|Death|0|||
146674288|NCT00726232|528984779|FG006|Expansion Phase|Death|0|||
146674289|NCT00726232|528984780|FG007|Expansion Phase|Death|1|||
146674290|NCT00726232|528984773|FG000|Expansion Phase|Adverse Event|0|||
146674291|NCT00726232|528984774|FG001|Expansion Phase|Adverse Event|0|||
146674292|NCT00726232|528984775|FG002|Expansion Phase|Adverse Event|0|||
146674293|NCT00726232|528984776|FG003|Expansion Phase|Adverse Event|0|||
146674294|NCT00726232|528984777|FG004|Expansion Phase|Adverse Event|0|||
146674295|NCT00726232|528984778|FG005|Expansion Phase|Adverse Event|0|||
146674296|NCT00726232|528984779|FG006|Expansion Phase|Adverse Event|6|||
146674297|NCT00726232|528984780|FG007|Expansion Phase|Adverse Event|11|||
146674298|NCT00726232|528984773|FG000|Expansion Phase|Withdrawal by Subject|0|||
146674299|NCT00726232|528984774|FG001|Expansion Phase|Withdrawal by Subject|0|||
146674300|NCT00726232|528984775|FG002|Expansion Phase|Withdrawal by Subject|0|||
146674301|NCT00726232|528984776|FG003|Expansion Phase|Withdrawal by Subject|0|||
146674302|NCT00726232|528984777|FG004|Expansion Phase|Withdrawal by Subject|0|||
146674303|NCT00726232|528984778|FG005|Expansion Phase|Withdrawal by Subject|0|||
146674304|NCT00726232|528984779|FG006|Expansion Phase|Withdrawal by Subject|2|||
146674305|NCT00726232|528984780|FG007|Expansion Phase|Withdrawal by Subject|3|||
146674306|NCT00726232|528984773|FG000|Expansion Phase|Disease progression|0|||
146674307|NCT00726232|528984774|FG001|Expansion Phase|Disease progression|0|||
146674308|NCT00726232|528984775|FG002|Expansion Phase|Disease progression|0|||
146674309|NCT00726232|528984776|FG003|Expansion Phase|Disease progression|0|||
146674310|NCT00726232|528984777|FG004|Expansion Phase|Disease progression|0|||
146674311|NCT00726232|528984778|FG005|Expansion Phase|Disease progression|0|||
146674312|NCT00726232|528984779|FG006|Expansion Phase|Disease progression|4|||
146674313|NCT00726232|528984780|FG007|Expansion Phase|Disease progression|0|||
146674314|NCT00726232|528984773|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
146674315|NCT00726232|528984774|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
146674316|NCT00726232|528984775|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
146674317|NCT00726232|528984776|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
146674318|NCT00726232|528984777|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
146674319|NCT00726232|528984778|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
146674320|NCT00726232|528984779|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
146674321|NCT00726232|528984780|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
146674322|NCT00726232|528984773|FG000|Expansion Phase|Per Investigator: lack of response|0|||
146674323|NCT00726232|528984774|FG001|Expansion Phase|Per Investigator: lack of response|0|||
146674324|NCT00726232|528984775|FG002|Expansion Phase|Per Investigator: lack of response|0|||
146674325|NCT00726232|528984776|FG003|Expansion Phase|Per Investigator: lack of response|0|||
146674326|NCT00726232|528984777|FG004|Expansion Phase|Per Investigator: lack of response|0|||
146674327|NCT00726232|528984778|FG005|Expansion Phase|Per Investigator: lack of response|0|||
146674328|NCT00726232|528984779|FG006|Expansion Phase|Per Investigator: lack of response|1|||
146674329|NCT00726232|528984780|FG007|Expansion Phase|Per Investigator: lack of response|7|||
146674330|NCT00726232|528984773|FG000|Expansion Phase|Unspecified reason|0|||
146674331|NCT00726232|528984774|FG001|Expansion Phase|Unspecified reason|0|||
146774277|NCT00546754|529343554|FG001|Overall Study|Missing Cooperation|0|||
146774278|NCT00546754|529343553|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
146774279|NCT00546754|529343554|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
146926199|NCT02951988|529890731|FG000|Open-Label Treatment Period|Adverse Event|45|||
146674332|NCT00726232|528984775|FG002|Expansion Phase|Unspecified reason|0|||
146674333|NCT00726232|528984776|FG003|Expansion Phase|Unspecified reason|0|||
146674334|NCT00726232|528984777|FG004|Expansion Phase|Unspecified reason|0|||
146674335|NCT00726232|528984778|FG005|Expansion Phase|Unspecified reason|0|||
146674336|NCT00726232|528984779|FG006|Expansion Phase|Unspecified reason|1|||
146674337|NCT00726232|528984780|FG007|Expansion Phase|Unspecified reason|0|||
146674338|NCT01651039|528984786|FG000|Overall Study|Non-evaluables|5|||
146674339|NCT01651039|528984786|FG000|Overall Study|Physician Decision|2|||
146674340|NCT01651039|528984786|FG000|Overall Study|Withdrawal by Subject|1|||
146674341|NCT01651039|528984786|FG000|Overall Study|Progressive Disease|22|||
146774280|NCT00546754|529343553|FG000|Overall Study|Patient's Decision|0|||
146926200|NCT02951988|529890732|FG001|Open-Label Treatment Period|Adverse Event|0|||
146978831|NCT01078623|530085507|FG011|Treatment Period 1|Protocol Violation|0|||
146978832|NCT01078623|530085508|FG012|Treatment Period 1|Protocol Violation|0|||
146978833|NCT01078623|530085509|FG013|Treatment Period 1|Protocol Violation|0|||
146978834|NCT01078623|530085510|FG014|Treatment Period 1|Protocol Violation|0|||
146978835|NCT01078623|530085511|FG015|Treatment Period 1|Protocol Violation|0|||
146978836|NCT01078623|530085512|FG016|Treatment Period 1|Protocol Violation|0|||
146978837|NCT01078623|530085513|FG017|Treatment Period 1|Protocol Violation|0|||
146978838|NCT01078623|530085514|FG018|Treatment Period 1|Protocol Violation|0|||
146978839|NCT01078623|530085515|FG019|Treatment Period 1|Protocol Violation|0|||
146978840|NCT01078623|530085496|FG000|Treatment Period 2|Adverse Event|0|||
146978841|NCT01078623|530085497|FG001|Treatment Period 2|Adverse Event|0|||
146978842|NCT01078623|530085498|FG002|Treatment Period 2|Adverse Event|0|||
146978843|NCT01078623|530085499|FG003|Treatment Period 2|Adverse Event|0|||
146978844|NCT01078623|530085500|FG004|Treatment Period 2|Adverse Event|0|||
146978845|NCT01078623|530085501|FG005|Treatment Period 2|Adverse Event|0|||
146978846|NCT01078623|530085502|FG006|Treatment Period 2|Adverse Event|1|||
146978847|NCT01078623|530085503|FG007|Treatment Period 2|Adverse Event|0|||
146978848|NCT01078623|530085504|FG008|Treatment Period 2|Adverse Event|0|||
146978849|NCT01078623|530085505|FG009|Treatment Period 2|Adverse Event|0|||
146978850|NCT01078623|530085506|FG010|Treatment Period 2|Adverse Event|0|||
146978851|NCT01078623|530085507|FG011|Treatment Period 2|Adverse Event|0|||
146978852|NCT01078623|530085508|FG012|Treatment Period 2|Adverse Event|0|||
146978853|NCT01078623|530085509|FG013|Treatment Period 2|Adverse Event|0|||
146978854|NCT01078623|530085510|FG014|Treatment Period 2|Adverse Event|0|||
146978855|NCT01078623|530085511|FG015|Treatment Period 2|Adverse Event|0|||
146978856|NCT01078623|530085512|FG016|Treatment Period 2|Adverse Event|0|||
146978857|NCT01078623|530085513|FG017|Treatment Period 2|Adverse Event|0|||
146978858|NCT01078623|530085514|FG018|Treatment Period 2|Adverse Event|1|||
146978859|NCT01078623|530085515|FG019|Treatment Period 2|Adverse Event|0|||
146978860|NCT01078623|530085496|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146978861|NCT01078623|530085497|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146978862|NCT01078623|530085498|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146978863|NCT01078623|530085499|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146978864|NCT01078623|530085500|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146978865|NCT01078623|530085501|FG005|Treatment Period 2|Withdrawal by Subject|1|||
146978866|NCT01078623|530085502|FG006|Treatment Period 2|Withdrawal by Subject|0|||
146978867|NCT01078623|530085503|FG007|Treatment Period 2|Withdrawal by Subject|0|||
146978868|NCT01078623|530085504|FG008|Treatment Period 2|Withdrawal by Subject|0|||
146978869|NCT01078623|530085505|FG009|Treatment Period 2|Withdrawal by Subject|0|||
146978870|NCT01078623|530085506|FG010|Treatment Period 2|Withdrawal by Subject|0|||
146978871|NCT01078623|530085507|FG011|Treatment Period 2|Withdrawal by Subject|0|||
146978872|NCT01078623|530085508|FG012|Treatment Period 2|Withdrawal by Subject|0|||
146978873|NCT01078623|530085509|FG013|Treatment Period 2|Withdrawal by Subject|0|||
146978874|NCT01078623|530085510|FG014|Treatment Period 2|Withdrawal by Subject|0|||
146978875|NCT01078623|530085511|FG015|Treatment Period 2|Withdrawal by Subject|0|||
146978876|NCT01078623|530085512|FG016|Treatment Period 2|Withdrawal by Subject|0|||
146978877|NCT01078623|530085513|FG017|Treatment Period 2|Withdrawal by Subject|0|||
146978878|NCT01078623|530085514|FG018|Treatment Period 2|Withdrawal by Subject|0|||
146978879|NCT01078623|530085515|FG019|Treatment Period 2|Withdrawal by Subject|0|||
146978880|NCT01078623|530085496|FG000|Treatment Period 3|Adverse Event|0|||
146978881|NCT01078623|530085497|FG001|Treatment Period 3|Adverse Event|0|||
146978882|NCT01078623|530085498|FG002|Treatment Period 3|Adverse Event|0|||
146978883|NCT01078623|530085499|FG003|Treatment Period 3|Adverse Event|0|||
146978884|NCT01078623|530085500|FG004|Treatment Period 3|Adverse Event|1|||
146978885|NCT01078623|530085501|FG005|Treatment Period 3|Adverse Event|0|||
146978886|NCT01078623|530085502|FG006|Treatment Period 3|Adverse Event|0|||
146978887|NCT01078623|530085503|FG007|Treatment Period 3|Adverse Event|0|||
146978888|NCT01078623|530085504|FG008|Treatment Period 3|Adverse Event|0|||
146674342|NCT05393895|528984789|FG000|Overall Study|Adverse Event|2|||
146978889|NCT01078623|530085505|FG009|Treatment Period 3|Adverse Event|0|||
146978890|NCT01078623|530085506|FG010|Treatment Period 3|Adverse Event|0|||
146978891|NCT01078623|530085507|FG011|Treatment Period 3|Adverse Event|0|||
146978892|NCT01078623|530085508|FG012|Treatment Period 3|Adverse Event|0|||
146978893|NCT01078623|530085509|FG013|Treatment Period 3|Adverse Event|1|||
146978894|NCT01078623|530085510|FG014|Treatment Period 3|Adverse Event|0|||
146978895|NCT01078623|530085511|FG015|Treatment Period 3|Adverse Event|0|||
146674343|NCT05393895|528984790|FG001|Overall Study|Adverse Event|3|||
146674344|NCT05393895|528984789|FG000|Overall Study|Lost to Follow-up|4|||
146978896|NCT01078623|530085512|FG016|Treatment Period 3|Adverse Event|0|||
146978897|NCT01078623|530085513|FG017|Treatment Period 3|Adverse Event|0|||
146978898|NCT01078623|530085514|FG018|Treatment Period 3|Adverse Event|0|||
146978899|NCT01078623|530085515|FG019|Treatment Period 3|Adverse Event|0|||
146978900|NCT01078623|530085496|FG000|Treatment Period 4|Adverse Event|0|||
146978901|NCT01078623|530085497|FG001|Treatment Period 4|Adverse Event|0|||
146978902|NCT01078623|530085498|FG002|Treatment Period 4|Adverse Event|1|||
146978903|NCT01078623|530085499|FG003|Treatment Period 4|Adverse Event|0|||
146978904|NCT01078623|530085500|FG004|Treatment Period 4|Adverse Event|0|||
146978905|NCT01078623|530085501|FG005|Treatment Period 4|Adverse Event|0|||
146674345|NCT05393895|528984790|FG001|Overall Study|Lost to Follow-up|3|||
146674346|NCT05393895|528984789|FG000|Overall Study|Protocol Violation|1|||
146674347|NCT05393895|528984790|FG001|Overall Study|Protocol Violation|0|||
146674348|NCT05393895|528984789|FG000|Overall Study|Withdrawal by Subject|1|||
146674349|NCT05393895|528984790|FG001|Overall Study|Withdrawal by Subject|4|||
146674350|NCT00968513|528984791|FG000|Overall Study|Death|4|||
146674351|NCT00968513|528984792|FG001|Overall Study|Death|10|||
146674352|NCT00968513|528984793|FG002|Overall Study|Death|15|||
146674353|NCT02002091|528984798|FG000|Screening|Lost to Follow-up|10|||
146674354|NCT02002091|528984799|FG001|Screening|Lost to Follow-up|12|||
146674355|NCT02002091|528984798|FG000|Screening|Death|3|||
146674356|NCT02002091|528984799|FG001|Screening|Death|2|||
146674357|NCT02083783|528984808|FG000|Overall Study|Withdrawal by Subject|1|||
146674358|NCT02083783|528984809|FG001|Overall Study|Withdrawal by Subject|0|||
146674359|NCT04967443|528984810|FG000|Open Label Treatment|Death|1|||
146674360|NCT04967443|528984811|FG001|Open Label Treatment|Death|0|||
146674361|NCT04967443|528984812|FG002|Open Label Treatment|Death|0|||
146674362|NCT04967443|528984813|FG003|Open Label Treatment|Death|0|||
146674363|NCT04967443|528984814|FG004|Open Label Treatment|Death|0|||
146674364|NCT04967443|528984815|FG005|Open Label Treatment|Death|0|||
146674365|NCT04967443|528984816|FG006|Open Label Treatment|Death|0|||
146674366|NCT04967443|528984817|FG007|Open Label Treatment|Death|0|||
146674367|NCT04967443|528984810|FG000|Open Label Treatment|Lost to Follow-up|0|||
146674368|NCT04967443|528984811|FG001|Open Label Treatment|Lost to Follow-up|0|||
146674369|NCT04967443|528984812|FG002|Open Label Treatment|Lost to Follow-up|1|||
146674370|NCT04967443|528984813|FG003|Open Label Treatment|Lost to Follow-up|0|||
146674371|NCT04967443|528984814|FG004|Open Label Treatment|Lost to Follow-up|0|||
146674372|NCT04967443|528984815|FG005|Open Label Treatment|Lost to Follow-up|0|||
146674373|NCT04967443|528984816|FG006|Open Label Treatment|Lost to Follow-up|0|||
146674374|NCT04967443|528984817|FG007|Open Label Treatment|Lost to Follow-up|0|||
146674375|NCT04967443|528984810|FG000|Open Label Treatment|Withdrawal by Subject|0|||
146674376|NCT04967443|528984811|FG001|Open Label Treatment|Withdrawal by Subject|1|||
146674377|NCT04967443|528984812|FG002|Open Label Treatment|Withdrawal by Subject|0|||
146674378|NCT04967443|528984813|FG003|Open Label Treatment|Withdrawal by Subject|1|||
146674379|NCT04967443|528984814|FG004|Open Label Treatment|Withdrawal by Subject|0|||
146674380|NCT04967443|528984815|FG005|Open Label Treatment|Withdrawal by Subject|1|||
146674381|NCT04967443|528984816|FG006|Open Label Treatment|Withdrawal by Subject|2|||
146674382|NCT04967443|528984817|FG007|Open Label Treatment|Withdrawal by Subject|3|||
146674383|NCT04967443|528984810|FG000|Follow-Up|Death|1|||
146674384|NCT04967443|528984811|FG001|Follow-Up|Death|0|||
146674385|NCT04967443|528984812|FG002|Follow-Up|Death|0|||
146674386|NCT04967443|528984813|FG003|Follow-Up|Death|0|||
146674387|NCT04967443|528984814|FG004|Follow-Up|Death|0|||
146674388|NCT04967443|528984815|FG005|Follow-Up|Death|0|||
146674389|NCT04967443|528984816|FG006|Follow-Up|Death|0|||
146674390|NCT04967443|528984817|FG007|Follow-Up|Death|0|||
146674391|NCT04967443|528984810|FG000|Follow-Up|Lost to Follow-up|0|||
146674392|NCT04967443|528984811|FG001|Follow-Up|Lost to Follow-up|0|||
146674393|NCT04967443|528984812|FG002|Follow-Up|Lost to Follow-up|1|||
146674394|NCT04967443|528984813|FG003|Follow-Up|Lost to Follow-up|1|||
146674395|NCT04967443|528984814|FG004|Follow-Up|Lost to Follow-up|0|||
146674396|NCT04967443|528984815|FG005|Follow-Up|Lost to Follow-up|0|||
146674397|NCT04967443|528984816|FG006|Follow-Up|Lost to Follow-up|0|||
146674398|NCT04967443|528984817|FG007|Follow-Up|Lost to Follow-up|0|||
146674399|NCT04967443|528984810|FG000|Follow-Up|Withdrawal by Subject|0|||
146674400|NCT04967443|528984811|FG001|Follow-Up|Withdrawal by Subject|1|||
146674401|NCT04967443|528984812|FG002|Follow-Up|Withdrawal by Subject|0|||
146674402|NCT04967443|528984813|FG003|Follow-Up|Withdrawal by Subject|1|||
146674403|NCT04967443|528984814|FG004|Follow-Up|Withdrawal by Subject|0|||
146674404|NCT04967443|528984815|FG005|Follow-Up|Withdrawal by Subject|1|||
146674405|NCT04967443|528984816|FG006|Follow-Up|Withdrawal by Subject|2|||
146674406|NCT04967443|528984817|FG007|Follow-Up|Withdrawal by Subject|3|||
146674407|NCT01654536|528984818|FG000|Overall Study|Lost to Follow-up|5|||
146674408|NCT01654536|528984819|FG001|Overall Study|Lost to Follow-up|5|||
146674409|NCT01654536|528984818|FG000|Overall Study|Physician Decision|12|||
146674410|NCT01654536|528984819|FG001|Overall Study|Physician Decision|8|||
146674411|NCT01654536|528984818|FG000|Overall Study|Withdrawal by Subject|27|||
146674412|NCT01654536|528984819|FG001|Overall Study|Withdrawal by Subject|25|||
146674413|NCT03943147|528984820|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
146674414|NCT03943147|528984821|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
146674415|NCT03943147|528984820|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
146674416|NCT03943147|528984821|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
146674417|NCT03943147|528984820|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
146674418|NCT03943147|528984821|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
146674419|NCT03943147|528984820|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
146674420|NCT03943147|528984821|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
146674421|NCT03943147|528984820|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
146674422|NCT03943147|528984821|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
146674423|NCT03943147|528984820|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
146674424|NCT03943147|528984821|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
146674425|NCT00629707|528984822|FG000|Overall Study|Withdrawal by Subject|0|||
146674426|NCT00629707|528984823|FG001|Overall Study|Withdrawal by Subject|1|||
146674427|NCT00629707|528984822|FG000|Overall Study|Physician Decision|0|||
146674428|NCT00629707|528984823|FG001|Overall Study|Physician Decision|1|||
146674429|NCT00968201|528984827|FG000|Base Study - (Period II)|Adverse Event|8|||
146674430|NCT00968201|528984828|FG001|Base Study - (Period II)|Adverse Event|0|||
146674431|NCT00968201|528984829|FG002|Base Study - (Period II)|Adverse Event|16|||
146674432|NCT00968201|528984827|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
146674433|NCT00968201|528984828|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
146674434|NCT00968201|528984829|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
146674435|NCT00968201|528984827|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
146674436|NCT00968201|528984828|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
146674437|NCT00968201|528984829|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
146674438|NCT00968201|528984827|FG000|Base Study - (Period II)|Protocol Violation|12|||
146674439|NCT00968201|528984828|FG001|Base Study - (Period II)|Protocol Violation|0|||
146674440|NCT00968201|528984829|FG002|Base Study - (Period II)|Protocol Violation|12|||
146674441|NCT00968201|528984827|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
146674442|NCT00968201|528984828|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
146674443|NCT00968201|528984829|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
146674444|NCT00968201|528984827|FG000|Base Study - (Period II)|Site Error|0|||
146674445|NCT00968201|528984828|FG001|Base Study - (Period II)|Site Error|0|||
146674446|NCT00968201|528984829|FG002|Base Study - (Period II)|Site Error|1|||
146674447|NCT00968201|528984827|FG000|Extension Study - (Period III)|Adverse Event|0|||
146674448|NCT00968201|528984828|FG001|Extension Study - (Period III)|Adverse Event|5|||
146674449|NCT00968201|528984829|FG002|Extension Study - (Period III)|Adverse Event|22|||
146674450|NCT00968201|528984827|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
146674451|NCT00968201|528984828|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
146674452|NCT00968201|528984829|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
146674453|NCT00968201|528984827|FG000|Extension Study - (Period III)|Protocol Violation|0|||
146674454|NCT00968201|528984828|FG001|Extension Study - (Period III)|Protocol Violation|17|||
146674455|NCT00968201|528984829|FG002|Extension Study - (Period III)|Protocol Violation|14|||
146674456|NCT00968201|528984827|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
146674457|NCT00968201|528984828|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
146674458|NCT00968201|528984829|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
146674459|NCT00968201|528984827|FG000|Extension Study - (Period III)|Patient Relocated|0|||
146674460|NCT00968201|528984828|FG001|Extension Study - (Period III)|Patient Relocated|1|||
146674461|NCT00968201|528984829|FG002|Extension Study - (Period III)|Patient Relocated|1|||
146674462|NCT00968201|528984827|FG000|Extension Study - (Period III)|Noncompliance|0|||
146674463|NCT00968201|528984828|FG001|Extension Study - (Period III)|Noncompliance|0|||
146674464|NCT00968201|528984829|FG002|Extension Study - (Period III)|Noncompliance|3|||
146674465|NCT00968201|528984827|FG000|Extension Study - (Period III)|Other|0|||
146674466|NCT00968201|528984828|FG001|Extension Study - (Period III)|Other|0|||
146674467|NCT00968201|528984829|FG002|Extension Study - (Period III)|Other|2|||
146674468|NCT00968201|528984827|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
146674469|NCT00968201|528984828|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
146674470|NCT00968201|528984829|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
146674471|NCT02619175|528984831|FG000|Overall Study|Withdrawal by Subject|1|||
146674472|NCT02619175|528984832|FG001|Overall Study|Withdrawal by Subject|0|||
146674473|NCT02619175|528984831|FG000|Overall Study|foot pain|1|||
146674474|NCT02619175|528984832|FG001|Overall Study|foot pain|0|||
146674475|NCT02657369|528984833|FG000|Overall Study|Death|27|||
146674476|NCT02657369|528984833|FG000|Overall Study|Study terminated by sponsor|7|||
146674477|NCT00361569|528984834|FG000|Overall Study|Protocol Violation|3|||
146674478|NCT00361569|528984835|FG001|Overall Study|Protocol Violation|2|||
146674479|NCT00361569|528984836|FG002|Overall Study|Protocol Violation|4|||
146926201|NCT02951988|529890733|FG002|Open-Label Treatment Period|Adverse Event|0|||
146926202|NCT02951988|529890734|FG003|Open-Label Treatment Period|Adverse Event|0|||
146926203|NCT02951988|529890731|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
146674480|NCT00361569|528984837|FG003|Overall Study|Protocol Violation|2|||
146674481|NCT00361569|528984834|FG000|Overall Study|Withdrawal by Subject|2|||
146674482|NCT00361569|528984835|FG001|Overall Study|Withdrawal by Subject|1|||
146674483|NCT00361569|528984836|FG002|Overall Study|Withdrawal by Subject|9|||
146926204|NCT02951988|529890732|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
146926205|NCT02951988|529890733|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
146674484|NCT00361569|528984837|FG003|Overall Study|Withdrawal by Subject|14|||
146674485|NCT00361569|528984834|FG000|Overall Study|Adverse Event|3|||
146674486|NCT00361569|528984835|FG001|Overall Study|Adverse Event|5|||
146674487|NCT00361569|528984836|FG002|Overall Study|Adverse Event|2|||
146674488|NCT00361569|528984837|FG003|Overall Study|Adverse Event|2|||
146774281|NCT00546754|529343554|FG001|Overall Study|Patient's Decision|1|||
146674489|NCT00361569|528984834|FG000|Overall Study|Lost to Follow-up|2|||
146674490|NCT00361569|528984835|FG001|Overall Study|Lost to Follow-up|3|||
146674491|NCT00361569|528984836|FG002|Overall Study|Lost to Follow-up|3|||
146674492|NCT00361569|528984837|FG003|Overall Study|Lost to Follow-up|2|||
146674493|NCT00361569|528984834|FG000|Overall Study|Not specified by investigator|2|||
146674494|NCT00361569|528984835|FG001|Overall Study|Not specified by investigator|0|||
146674495|NCT00361569|528984836|FG002|Overall Study|Not specified by investigator|0|||
146674496|NCT00361569|528984837|FG003|Overall Study|Not specified by investigator|1|||
146674497|NCT04698187|528984840|FG000|Overall Study|Withdrawal by Subject|7|||
146674498|NCT04698187|528984840|FG000|Overall Study|Death|21|||
146674499|NCT04698187|528984840|FG000|Overall Study|Sponsor Decision|15|||
146674500|NCT04698187|528984840|FG000|Overall Study|In-transit Disease|1|||
146674501|NCT02513394|528984841|FG000|Overall Study|Withdrawal by Subject|11|||
146674502|NCT02513394|528984842|FG001|Overall Study|Withdrawal by Subject|23|||
146674503|NCT02513394|528984841|FG000|Overall Study|Ineligible|1|||
146674504|NCT02513394|528984842|FG001|Overall Study|Ineligible|0|||
146674505|NCT00612690|528986781|FG000|Overall Study|Lost to Follow-up|72|||
146674506|NCT00612690|528986782|FG001|Overall Study|Lost to Follow-up|98|||
146674507|NCT00612690|528986781|FG000|Overall Study|Withdrawal by Subject|32|||
146674508|NCT00612690|528986782|FG001|Overall Study|Withdrawal by Subject|20|||
146674509|NCT00612690|528986781|FG000|Overall Study|Withdrawal by Site|11|||
146674510|NCT00612690|528986782|FG001|Overall Study|Withdrawal by Site|0|||
146674511|NCT04487730|528986783|FG000|Overall Study|Withdrawal by Subject|3|||
146674512|NCT04487730|528986784|FG001|Overall Study|Withdrawal by Subject|1|||
146674513|NCT04487730|528986783|FG000|Overall Study|Lost to Follow-up|0|||
146674514|NCT04487730|528986784|FG001|Overall Study|Lost to Follow-up|1|||
146674515|NCT04487730|528986783|FG000|Overall Study|Physician Decision|0|||
146674516|NCT04487730|528986784|FG001|Overall Study|Physician Decision|1|||
146674517|NCT03797014|528986788|FG000|Overall Study|Withdrawal by Subject|1|||
146674518|NCT03797014|528986788|FG000|Overall Study|Lost to Follow-up|1|||
146674519|NCT03797014|528986788|FG000|Overall Study|Protocol Violation|1|||
146674520|NCT01970397|528986789|FG000|Overall Study|Adverse Event|0|||
146674521|NCT01970397|528986790|FG001|Overall Study|Adverse Event|1|||
146674522|NCT01970397|528986789|FG000|Overall Study|Lost to Follow-up|0|||
146674523|NCT01970397|528986790|FG001|Overall Study|Lost to Follow-up|1|||
146674524|NCT01970397|528986789|FG000|Overall Study|Personal Reasons|1|||
146674525|NCT01970397|528986790|FG001|Overall Study|Personal Reasons|2|||
146674526|NCT01970397|528986789|FG000|Overall Study|Protocol Violation|1|||
146674527|NCT01970397|528986790|FG001|Overall Study|Protocol Violation|1|||
146674528|NCT03305575|528986793|FG000|Overall Study|Physician Decision|1|||
146674529|NCT03305575|528986794|FG001|Overall Study|Physician Decision|0|||
146674530|NCT00105469|528986795|FG000|Overall Study|Adverse Event|9|||
146674531|NCT00105469|528986796|FG001|Overall Study|Adverse Event|8|||
146674532|NCT00105469|528986795|FG000|Overall Study|Protocol Violation|4|||
146674533|NCT00105469|528986796|FG001|Overall Study|Protocol Violation|0|||
146674534|NCT00105469|528986795|FG000|Overall Study|Withdrawal by Subject|2|||
146674535|NCT00105469|528986796|FG001|Overall Study|Withdrawal by Subject|3|||
146674536|NCT00105469|528986795|FG000|Overall Study|Lost to Follow-up|1|||
146674537|NCT00105469|528986796|FG001|Overall Study|Lost to Follow-up|0|||
146674538|NCT00105469|528986795|FG000|Overall Study|Lack of Efficacy|2|||
146674539|NCT00105469|528986796|FG001|Overall Study|Lack of Efficacy|0|||
146674540|NCT00105469|528986795|FG000|Overall Study|Other Reason|4|||
146674541|NCT00105469|528986796|FG001|Overall Study|Other Reason|0|||
146674542|NCT04115839|528986801|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
146674543|NCT04115839|528986802|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
146674544|NCT04115839|528986803|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
146674545|NCT04115839|528986804|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
146674546|NCT04115839|528986805|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
146674547|NCT04115839|528986806|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
146674548|NCT04115839|528986807|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
146674549|NCT04115839|528986801|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
146674550|NCT04115839|528986802|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
146674551|NCT04115839|528986803|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
146674552|NCT04115839|528986804|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
146674553|NCT04115839|528986805|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
146674554|NCT04115839|528986806|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
146674555|NCT04115839|528986807|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
146978906|NCT01078623|530085502|FG006|Treatment Period 4|Adverse Event|0|||
146674556|NCT04115839|528986801|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
146674557|NCT04115839|528986802|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
146674558|NCT04115839|528986803|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
146674559|NCT04115839|528986804|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
146674560|NCT04115839|528986805|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
146674561|NCT04115839|528986806|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
146674562|NCT04115839|528986807|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
146674563|NCT04115839|528986801|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
146674564|NCT04115839|528986802|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
146674565|NCT04115839|528986803|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
146674566|NCT04115839|528986804|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
146674567|NCT04115839|528986805|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
146674568|NCT04115839|528986806|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
146674569|NCT04115839|528986807|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
146674570|NCT04115839|528986801|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
146674571|NCT04115839|528986802|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
146674572|NCT04115839|528986803|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
146674573|NCT04115839|528986804|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
146674574|NCT04115839|528986805|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
146674575|NCT04115839|528986806|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
146674576|NCT04115839|528986807|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
146674577|NCT04115839|528986801|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
146674578|NCT04115839|528986802|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
146674579|NCT04115839|528986803|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
146674580|NCT04115839|528986804|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
146674581|NCT04115839|528986805|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
146674582|NCT04115839|528986806|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
146674583|NCT04115839|528986807|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
146674584|NCT03808545|528986808|FG000|Overall Study|Withdrawal by Subject|1|||
146674585|NCT03808545|528986809|FG001|Overall Study|Withdrawal by Subject|1|||
146674586|NCT01338792|528986810|FG000|Overall Study|Adverse Event|2|||
146674587|NCT01338792|528986810|FG000|Overall Study|Death|1|||
146674588|NCT01338792|528986810|FG000|Overall Study|Withdrawal by Subject|1|||
146674589|NCT00618072|528986811|FG000|Overall Study|Lost to Follow-up|2|||
146674590|NCT00618072|528986812|FG001|Overall Study|Lost to Follow-up|0|||
146674591|NCT00618072|528986813|FG002|Overall Study|Lost to Follow-up|3|||
146926206|NCT02951988|529890734|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
146926207|NCT02951988|529890731|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
146926208|NCT02951988|529890732|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
146926209|NCT02951988|529890733|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
146926210|NCT02951988|529890734|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
146674592|NCT00618072|528986811|FG000|Overall Study|Physician Decision|0|||
146674593|NCT00618072|528986812|FG001|Overall Study|Physician Decision|1|||
146674594|NCT00618072|528986813|FG002|Overall Study|Physician Decision|1|||
146674595|NCT00684593|528986815|FG000|Overall Study|Adverse Event|0|||
146926211|NCT02951988|529890731|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
146926212|NCT02951988|529890732|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
146926213|NCT02951988|529890733|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
146926214|NCT02951988|529890734|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
146926215|NCT02951988|529890731|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
146926216|NCT02951988|529890732|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
146926217|NCT02951988|529890733|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
146926218|NCT02951988|529890734|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
146926219|NCT02951988|529890731|FG000|Double-Blind Treatment Period|Pregnancy|0|||
146926220|NCT02951988|529890732|FG001|Double-Blind Treatment Period|Pregnancy|1|||
146926221|NCT02951988|529890733|FG002|Double-Blind Treatment Period|Pregnancy|1|||
146926222|NCT02951988|529890734|FG003|Double-Blind Treatment Period|Pregnancy|0|||
146926223|NCT02951988|529890731|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146926224|NCT02951988|529890732|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
146926225|NCT02951988|529890733|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
146926226|NCT02951988|529890734|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
146926227|NCT02951988|529890731|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146926228|NCT02951988|529890732|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
146926229|NCT02951988|529890733|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
146926230|NCT02951988|529890734|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
146926231|NCT02951988|529890731|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146926232|NCT02951988|529890732|FG001|Double-Blind Treatment Period|Adverse Event|8|||
146926233|NCT02951988|529890733|FG002|Double-Blind Treatment Period|Adverse Event|3|||
146926234|NCT02951988|529890734|FG003|Double-Blind Treatment Period|Adverse Event|6|||
146926235|NCT02951988|529890731|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
146926236|NCT02951988|529890732|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
146926237|NCT02951988|529890733|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
146926238|NCT02951988|529890734|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
146926239|NCT05836818|529890735|FG000|Overall Study|Physician Decision|1|||
146926240|NCT05836818|529890736|FG001|Overall Study|Physician Decision|1|||
146926241|NCT05836818|529890737|FG002|Overall Study|Physician Decision|0|||
146926242|NCT05836818|529890735|FG000|Overall Study|Withdrawal by Subject|0|||
146926243|NCT05836818|529890736|FG001|Overall Study|Withdrawal by Subject|0|||
146674596|NCT00684593|528986816|FG001|Overall Study|Adverse Event|2|||
146674597|NCT00617773|528986817|FG000|Overall Study|Physician Decision|1|||
146674598|NCT00617773|528986817|FG000|Overall Study|Lack of compliance with the protocol|1|||
146674599|NCT00617773|528986817|FG000|Overall Study|Withdrawal by Subject|1|||
146674600|NCT00617773|528986817|FG000|Overall Study|Death|1|||
146674601|NCT00617773|528986817|FG000|Overall Study|Progressive disease|19|||
146674602|NCT00617773|528986817|FG000|Overall Study|Protocol Violation|1|||
146674603|NCT03130257|528986818|FG000|Overall Study|Withdrawal by Subject|1|||
146674604|NCT03130257|528986819|FG001|Overall Study|Withdrawal by Subject|0|||
146674605|NCT03130257|528986820|FG002|Overall Study|Withdrawal by Subject|2|||
146674606|NCT05526716|528986824|FG000|Overall Study|Death|1|||
146674607|NCT05526716|528986825|FG001|Overall Study|Death|2|||
146674608|NCT05526716|528986824|FG000|Overall Study|Lost to Follow-up|17|||
146674609|NCT05526716|528986825|FG001|Overall Study|Lost to Follow-up|15|||
146674610|NCT05526716|528986824|FG000|Overall Study|Physician Decision|0|||
146674611|NCT05526716|528986825|FG001|Overall Study|Physician Decision|1|||
146674612|NCT05526716|528986824|FG000|Overall Study|Randomized by mistake without study treatment|0|||
146674613|NCT05526716|528986825|FG001|Overall Study|Randomized by mistake without study treatment|1|||
146674614|NCT05526716|528986824|FG000|Overall Study|Withdrawal by Subject|12|||
146674615|NCT05526716|528986825|FG001|Overall Study|Withdrawal by Subject|12|||
146674616|NCT05526716|528986824|FG000|Overall Study|Not reported|0|||
146674617|NCT05526716|528986825|FG001|Overall Study|Not reported|2|||
146674618|NCT03095066|528986832|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
146674619|NCT03095066|528986833|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
146674620|NCT03095066|528986834|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
146674621|NCT03095066|528986835|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
146674622|NCT03095066|528986836|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
146674623|NCT03095066|528986837|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
146674624|NCT03095066|528986838|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
146674625|NCT03095066|528986839|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
146674626|NCT03095066|528986832|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
146674627|NCT03095066|528986833|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
146674628|NCT03095066|528986834|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
146674629|NCT03095066|528986835|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
146674630|NCT03095066|528986836|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
146674631|NCT03095066|528986837|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
146674632|NCT03095066|528986838|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
146674633|NCT03095066|528986839|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
146674634|NCT03095066|528986832|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
146674635|NCT03095066|528986833|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
146674636|NCT03095066|528986834|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
146674637|NCT03095066|528986835|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
146674638|NCT03095066|528986836|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
146674639|NCT03095066|528986837|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
146674640|NCT03095066|528986838|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
146674641|NCT03095066|528986839|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
146674642|NCT03095066|528986832|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
146674643|NCT03095066|528986833|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
146674644|NCT03095066|528986834|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
146674645|NCT03095066|528986835|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
146674646|NCT03095066|528986836|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
146674647|NCT03095066|528986837|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
146674648|NCT03095066|528986838|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
146674649|NCT03095066|528986839|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
146674650|NCT03095066|528986832|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
146674651|NCT03095066|528986833|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
146674652|NCT03095066|528986834|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
146674653|NCT03095066|528986835|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
146674654|NCT03095066|528986836|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
146674655|NCT03095066|528986837|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
146674656|NCT03095066|528986838|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
146926244|NCT05836818|529890737|FG002|Overall Study|Withdrawal by Subject|1|||
146926245|NCT05836818|529890735|FG000|Overall Study|Later found to be previously vaccinated|0|||
146926246|NCT05836818|529890736|FG001|Overall Study|Later found to be previously vaccinated|1|||
146674657|NCT03095066|528986839|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
146674658|NCT03095066|528986832|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
146674659|NCT03095066|528986833|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
146674660|NCT03095066|528986834|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
146674661|NCT03095066|528986835|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
146674662|NCT03095066|528986836|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
146674663|NCT03095066|528986837|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
146674664|NCT03095066|528986838|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
146674665|NCT03095066|528986839|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
146674666|NCT03095066|528986832|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
146674667|NCT03095066|528986833|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
146674668|NCT03095066|528986834|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
146674669|NCT03095066|528986835|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
146674670|NCT03095066|528986836|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
146674671|NCT03095066|528986837|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
146674672|NCT03095066|528986838|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
146674673|NCT03095066|528986839|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
146674674|NCT03095066|528986832|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
146674675|NCT03095066|528986833|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
146674676|NCT03095066|528986834|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
146674677|NCT03095066|528986835|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
146674678|NCT03095066|528986836|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
146674679|NCT03095066|528986837|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
146674680|NCT03095066|528986838|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
146674681|NCT03095066|528986839|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
146674682|NCT03095066|528986832|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
146674683|NCT03095066|528986833|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
146674684|NCT03095066|528986834|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
146674685|NCT03095066|528986835|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
146674686|NCT03095066|528986836|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
146674687|NCT03095066|528986837|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
146674688|NCT03095066|528986838|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
146674689|NCT03095066|528986839|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
146674690|NCT03095066|528986832|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
146674691|NCT03095066|528986833|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
146674692|NCT03095066|528986834|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
146674693|NCT03095066|528986835|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
146674694|NCT03095066|528986836|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
146674695|NCT03095066|528986837|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
146674696|NCT03095066|528986838|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
146674697|NCT03095066|528986839|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
146674698|NCT03095066|528986832|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
146674699|NCT03095066|528986833|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
146674700|NCT03095066|528986834|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
146674701|NCT03095066|528986835|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
146674702|NCT03095066|528986836|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
146674703|NCT03095066|528986837|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
146674704|NCT03095066|528986838|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
146674705|NCT03095066|528986839|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
146674706|NCT03095066|528986832|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
146674707|NCT03095066|528986833|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
146674708|NCT03095066|528986834|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
146674709|NCT03095066|528986835|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
146674710|NCT03095066|528986836|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
146674711|NCT03095066|528986837|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
146674712|NCT03095066|528986838|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
146674713|NCT03095066|528986839|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
146674714|NCT03095066|528986832|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
146926247|NCT05836818|529890737|FG002|Overall Study|Later found to be previously vaccinated|3|||
146926248|NCT05836818|529890735|FG000|Overall Study|Pregnancy|0|||
146926249|NCT05836818|529890736|FG001|Overall Study|Pregnancy|1|||
146926250|NCT05836818|529890737|FG002|Overall Study|Pregnancy|0|||
146926251|NCT05836818|529890735|FG000|Overall Study|Allergic to vaccines|0|||
146926252|NCT05836818|529890736|FG001|Overall Study|Allergic to vaccines|1|||
146926253|NCT05836818|529890737|FG002|Overall Study|Allergic to vaccines|0|||
146926254|NCT01165021|529890738|FG000|Overall Study|Death|1|||
146926255|NCT02491073|529890739|FG000|Overall Study|screen failure|1|||
146926256|NCT02491073|529890740|FG001|Overall Study|screen failure|0|||
146926257|NCT03977727|529890741|FG000|Second Treatment|Lost to Follow-up|0|||
146926258|NCT03977727|529890742|FG001|Second Treatment|Lost to Follow-up|3|||
146926259|NCT01419665|529890743|FG000|Combination Treatment|Adverse Event|7|||
146926260|NCT01419665|529890744|FG001|Combination Treatment|Adverse Event|10|||
146674715|NCT03095066|528986833|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
146674716|NCT03095066|528986834|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
146674717|NCT03095066|528986835|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
146674718|NCT03095066|528986836|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
146674719|NCT03095066|528986837|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
146674720|NCT03095066|528986838|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
146674721|NCT03095066|528986839|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
146674722|NCT03095066|528986832|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
146674723|NCT03095066|528986833|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
146674724|NCT03095066|528986834|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
146674725|NCT03095066|528986835|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
146674726|NCT03095066|528986836|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
146674727|NCT03095066|528986837|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
146674728|NCT03095066|528986838|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
146674729|NCT03095066|528986839|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
146674730|NCT03095066|528986832|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
146674731|NCT03095066|528986833|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
146674732|NCT03095066|528986834|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
146674733|NCT03095066|528986835|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
146674734|NCT03095066|528986836|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
146617822|NCT03493945|528773120|FG000|Phase I Dose Escalation|New therapy|0|||
146617823|NCT03493945|528773121|FG001|Phase I Dose Escalation|New therapy|1|||
146617824|NCT03493945|528773122|FG002|Phase I Dose Escalation|New therapy|0|||
146617825|NCT03493945|528773123|FG003|Phase I Dose Escalation|New therapy|0|||
146617826|NCT03493945|528773124|FG004|Phase I Dose Escalation|New therapy|0|||
146617827|NCT03493945|528773125|FG005|Phase I Dose Escalation|New therapy|0|||
146617828|NCT03493945|528773126|FG006|Phase I Dose Escalation|New therapy|0|||
146617829|NCT03493945|528773120|FG000|Phase II Dose Expansion|Refused further treatment|0|||
146674735|NCT03095066|528986837|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
146674736|NCT03095066|528986838|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
146674737|NCT03095066|528986839|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
146674738|NCT03095066|528986832|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
146674739|NCT03095066|528986833|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
146674740|NCT03095066|528986834|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
146674741|NCT03095066|528986835|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
146674742|NCT03095066|528986836|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
146674743|NCT03095066|528986837|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
146674744|NCT03095066|528986838|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
146674745|NCT03095066|528986839|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
146674746|NCT03095066|528986832|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
146674747|NCT03095066|528986833|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
146674748|NCT03095066|528986834|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
146674749|NCT03095066|528986835|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
146674750|NCT03095066|528986836|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
146674751|NCT03095066|528986837|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
146674752|NCT03095066|528986838|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
146674753|NCT03095066|528986839|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
146674754|NCT03095066|528986832|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
146674755|NCT03095066|528986833|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
146674756|NCT03095066|528986834|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
146674757|NCT03095066|528986835|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
146674758|NCT03095066|528986836|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
146674759|NCT03095066|528986837|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
146674760|NCT03095066|528986838|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
146674761|NCT03095066|528986839|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
146674762|NCT03095066|528986832|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
146674763|NCT03095066|528986833|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
146674764|NCT03095066|528986834|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
146674765|NCT03095066|528986835|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
146674766|NCT03095066|528986836|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
146674767|NCT03095066|528986837|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
146674768|NCT03095066|528986838|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
146674769|NCT03095066|528986839|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
146674770|NCT03095066|528986832|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
146674771|NCT03095066|528986833|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
146674772|NCT03095066|528986834|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
146674773|NCT03095066|528986835|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
146674774|NCT03095066|528986836|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
146674775|NCT03095066|528986837|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
146674776|NCT03095066|528986838|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
146674777|NCT03095066|528986839|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
146674778|NCT02170298|528986845|FG000|Overall Study|Withdrawal by Subject|0|||
146674779|NCT02170298|528986846|FG001|Overall Study|Withdrawal by Subject|1|||
146674780|NCT02170298|528986845|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
146674781|NCT02170298|528986846|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
146674782|NCT00777608|528986847|FG000|Overall Study|Lost to Follow-up|1|||
146674783|NCT00777608|528986848|FG001|Overall Study|Lost to Follow-up|1|||
146674784|NCT00777608|528986847|FG000|Overall Study|Withdrawal by Subject|1|||
146674785|NCT00777608|528986848|FG001|Overall Study|Withdrawal by Subject|3|||
146926261|NCT01419665|529890743|FG000|Combination Treatment|Physician Decision|5|||
146926262|NCT01419665|529890744|FG001|Combination Treatment|Physician Decision|8|||
146926263|NCT01419665|529890743|FG000|Combination Treatment|Protocol Violation|6|||
146926264|NCT01419665|529890744|FG001|Combination Treatment|Protocol Violation|2|||
146926265|NCT01419665|529890743|FG000|Combination Treatment|disease progression|10|||
146926266|NCT01419665|529890744|FG001|Combination Treatment|disease progression|9|||
146926267|NCT01419665|529890743|FG000|Combination Treatment|Death|5|||
146926268|NCT01419665|529890744|FG001|Combination Treatment|Death|7|||
146926269|NCT01419665|529890743|FG000|Combination Treatment|administrative problems|0|||
146926270|NCT01419665|529890744|FG001|Combination Treatment|administrative problems|1|||
146674786|NCT00777608|528986847|FG000|Overall Study|Protocol Violation|1|||
146674787|NCT00777608|528986848|FG001|Overall Study|Protocol Violation|0|||
146674788|NCT00777608|528986847|FG000|Overall Study|Investigator Decision|1|||
146674789|NCT00777608|528986848|FG001|Overall Study|Investigator Decision|2|||
146674790|NCT04213079|528986849|FG000|Overall Study|Lost to Follow-up|0|||
146674791|NCT04213079|528986850|FG001|Overall Study|Lost to Follow-up|2|||
146674792|NCT00520936|528986852|FG000|Overall Study|Physician Decision|0|||
146674793|NCT00520936|528986853|FG001|Overall Study|Physician Decision|2|||
146674794|NCT00520936|528986854|FG002|Overall Study|Physician Decision|1|||
146674795|NCT00520936|528986855|FG003|Overall Study|Physician Decision|0|||
146674796|NCT00520936|528986856|FG004|Overall Study|Physician Decision|0|||
146674797|NCT00520936|528986857|FG005|Overall Study|Physician Decision|0|||
146674798|NCT00520936|528986858|FG006|Overall Study|Physician Decision|0|||
146674799|NCT00520936|528986859|FG007|Overall Study|Physician Decision|0|||
146674800|NCT00520936|528986852|FG000|Overall Study|Withdrawal by Subject|0|||
146674801|NCT00520936|528986853|FG001|Overall Study|Withdrawal by Subject|0|||
146674802|NCT00520936|528986854|FG002|Overall Study|Withdrawal by Subject|0|||
146674803|NCT00520936|528986855|FG003|Overall Study|Withdrawal by Subject|0|||
146674804|NCT00520936|528986856|FG004|Overall Study|Withdrawal by Subject|0|||
146674805|NCT00520936|528986857|FG005|Overall Study|Withdrawal by Subject|0|||
146674806|NCT00520936|528986858|FG006|Overall Study|Withdrawal by Subject|0|||
146674807|NCT00520936|528986859|FG007|Overall Study|Withdrawal by Subject|1|||
146674808|NCT00520936|528986852|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
146674809|NCT00520936|528986853|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
146674810|NCT00520936|528986854|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
146674811|NCT00520936|528986855|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
146674812|NCT00520936|528986856|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
146674813|NCT00520936|528986857|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
146674814|NCT00520936|528986858|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
146674815|NCT00520936|528986859|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
146674816|NCT00520936|528986852|FG000|Overall Study|Death|0|||
146674817|NCT00520936|528986853|FG001|Overall Study|Death|0|||
146674818|NCT00520936|528986854|FG002|Overall Study|Death|0|||
146674819|NCT00520936|528986855|FG003|Overall Study|Death|0|||
146674820|NCT00520936|528986856|FG004|Overall Study|Death|0|||
146674821|NCT00520936|528986857|FG005|Overall Study|Death|0|||
146674822|NCT00520936|528986858|FG006|Overall Study|Death|1|||
146674823|NCT00520936|528986859|FG007|Overall Study|Death|0|||
146674824|NCT00520936|528986852|FG000|Overall Study|Protocol Violation|0|||
146674825|NCT00520936|528986853|FG001|Overall Study|Protocol Violation|1|||
146674826|NCT00520936|528986854|FG002|Overall Study|Protocol Violation|1|||
146674827|NCT00520936|528986855|FG003|Overall Study|Protocol Violation|0|||
146674828|NCT00520936|528986856|FG004|Overall Study|Protocol Violation|1|||
146674829|NCT00520936|528986857|FG005|Overall Study|Protocol Violation|0|||
146674830|NCT00520936|528986858|FG006|Overall Study|Protocol Violation|1|||
146674831|NCT00520936|528986859|FG007|Overall Study|Protocol Violation|0|||
146926271|NCT01419665|529890743|FG000|Combination Treatment|Withdrawal by Subject|5|||
146926272|NCT01419665|529890744|FG001|Combination Treatment|Withdrawal by Subject|4|||
146926273|NCT01419665|529890743|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
146774282|NCT00546754|529343553|FG000|Overall Study|Missing|14|||
146926274|NCT01419665|529890744|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
146674832|NCT04220866|528986864|FG000|Overall Study|Death|4|||
146674833|NCT04220866|528986865|FG001|Overall Study|Death|5|||
146674834|NCT04220866|528986864|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
146674835|NCT04220866|528986865|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
146674836|NCT04220866|528986864|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
146774283|NCT00546754|529343554|FG001|Overall Study|Missing|7|||
146674837|NCT04220866|528986865|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
146674838|NCT04220866|528986864|FG000|Overall Study|Withdrawal by Subject|0|||
146674839|NCT04220866|528986865|FG001|Overall Study|Withdrawal by Subject|1|||
146674840|NCT03858309|528986866|FG000|Overall Study|Withdrawal by Subject|2|||
146674841|NCT03858309|528986867|FG001|Overall Study|Withdrawal by Subject|3|||
146674842|NCT03897465|528986871|FG000|Overall Study|Lost to Follow-up|2|||
146674843|NCT03897465|528986872|FG001|Overall Study|Lost to Follow-up|1|||
146674844|NCT03897465|528986871|FG000|Overall Study|Adverse Event|2|||
146674845|NCT03897465|528986872|FG001|Overall Study|Adverse Event|0|||
146674846|NCT03897465|528986871|FG000|Overall Study|complete healing by V2|1|||
146674847|NCT03897465|528986872|FG001|Overall Study|complete healing by V2|0|||
146674848|NCT03897465|528986871|FG000|Overall Study|occurence of exclusion criterion|1|||
146674849|NCT03897465|528986872|FG001|Overall Study|occurence of exclusion criterion|1|||
146674850|NCT03897465|528986871|FG000|Overall Study|Other|1|||
146674851|NCT03897465|528986872|FG001|Overall Study|Other|0|||
146674852|NCT02197247|528986875|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
146674853|NCT02197247|528986875|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
146674854|NCT02197247|528986875|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
146674855|NCT02197247|528986875|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
146674856|NCT02197247|528986875|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
146674857|NCT02197247|528986875|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
146674858|NCT02197247|528986875|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
146674859|NCT02197247|528986875|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
146674860|NCT00601458|528986879|FG000|Overall Study|Dosing Error|1|||
146674861|NCT00601458|528986880|FG001|Overall Study|Dosing Error|0|||
146674862|NCT00601458|528986881|FG002|Overall Study|Dosing Error|0|||
146674863|NCT00601458|528986879|FG000|Overall Study|Incomplete Data|0|||
146674864|NCT00601458|528986880|FG001|Overall Study|Incomplete Data|2|||
146674865|NCT00601458|528986881|FG002|Overall Study|Incomplete Data|0|||
146674866|NCT00601458|528986879|FG000|Overall Study|Protocol Violation|3|||
146674867|NCT00601458|528986880|FG001|Overall Study|Protocol Violation|2|||
146674868|NCT00601458|528986881|FG002|Overall Study|Protocol Violation|1|||
146674869|NCT00601458|528986879|FG000|Overall Study|Early Termination|0|||
146674870|NCT00601458|528986880|FG001|Overall Study|Early Termination|1|||
146674871|NCT00601458|528986881|FG002|Overall Study|Early Termination|1|||
146674872|NCT00370032|528986882|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
146674873|NCT00370032|528986883|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
146674874|NCT00370032|528986882|FG000|Washout Period|Withdrawal by Subject|0|||
146674875|NCT00370032|528986883|FG001|Washout Period|Withdrawal by Subject|1|||
146674876|NCT00370032|528986882|FG000|Washout Period|Lost to Follow-up|0|||
146674877|NCT00370032|528986883|FG001|Washout Period|Lost to Follow-up|1|||
146674878|NCT00370032|528986882|FG000|Washout Period|Adverse Event|1|||
146674879|NCT00370032|528986883|FG001|Washout Period|Adverse Event|0|||
146674880|NCT00370032|528986882|FG000|Follow-up Period|Withdrawal by Subject|1|||
146674881|NCT00370032|528986883|FG001|Follow-up Period|Withdrawal by Subject|0|||
146674882|NCT05683249|528986884|FG000|Overall Study|Adverse Event|3|||
146674883|NCT05683249|528986885|FG001|Overall Study|Adverse Event|1|||
146674884|NCT05683249|528986884|FG000|Overall Study|Lack of Efficacy|0|||
146774284|NCT00311363|529343557|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
146774285|NCT00311363|529343558|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
146774286|NCT00311363|529343559|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
146774287|NCT00311363|529343557|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
146774288|NCT00311363|529343558|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
146774289|NCT00311363|529343559|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
146774290|NCT00311363|529343557|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
146926275|NCT01419665|529890743|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
146674885|NCT05683249|528986885|FG001|Overall Study|Lack of Efficacy|2|||
146674886|NCT05683249|528986884|FG000|Overall Study|Lost to Follow-up|6|||
146674887|NCT05683249|528986885|FG001|Overall Study|Lost to Follow-up|5|||
146674888|NCT05683249|528986884|FG000|Overall Study|Non-compliance with Study Drug|2|||
146674889|NCT05683249|528986885|FG001|Overall Study|Non-compliance with Study Drug|0|||
146674890|NCT05683249|528986884|FG000|Overall Study|Protocol Violation|6|||
146674891|NCT05683249|528986885|FG001|Overall Study|Protocol Violation|3|||
146674892|NCT05683249|528986884|FG000|Overall Study|Withdrawal by Subject|9|||
146674893|NCT05683249|528986885|FG001|Overall Study|Withdrawal by Subject|8|||
146674894|NCT05683249|528986884|FG000|Overall Study|Other|0|||
146674895|NCT05683249|528986885|FG001|Overall Study|Other|2|||
146674896|NCT05469178|528986886|FG000|Overall Study|Death|1|||
146674897|NCT05469178|528986887|FG001|Overall Study|Death|1|||
146674898|NCT05469178|528986888|FG002|Overall Study|Death|3|||
146674899|NCT05469178|528986889|FG003|Overall Study|Death|6|||
146674900|NCT05469178|528986886|FG000|Overall Study|Lack of Efficacy|2|||
146674901|NCT05469178|528986887|FG001|Overall Study|Lack of Efficacy|2|||
146674902|NCT05469178|528986888|FG002|Overall Study|Lack of Efficacy|1|||
146674903|NCT05469178|528986889|FG003|Overall Study|Lack of Efficacy|10|||
146674904|NCT01328431|528986890|FG000|Baseline|Protocol Violation|0|||
146674905|NCT01328431|528986891|FG001|Baseline|Protocol Violation|2|||
146674906|NCT01328431|528986890|FG000|1 Month (1M)|Lost to Follow-up|55|||
146674907|NCT01328431|528986891|FG001|1 Month (1M)|Lost to Follow-up|58|||
146674908|NCT01328431|528986890|FG000|3 Month (3M)|Death|2|||
146674909|NCT01328431|528986891|FG001|3 Month (3M)|Death|2|||
146674910|NCT01328431|528986890|FG000|3 Month (3M)|Lost to Follow-up|75|||
146674911|NCT01328431|528986891|FG001|3 Month (3M)|Lost to Follow-up|70|||
146674912|NCT01328431|528986890|FG000|12 Month (12M)|Death|2|||
146674913|NCT01328431|528986891|FG001|12 Month (12M)|Death|6|||
146674914|NCT01328431|528986890|FG000|12 Month (12M)|Lost to Follow-up|82|||
146674915|NCT01328431|528986891|FG001|12 Month (12M)|Lost to Follow-up|91|||
146674916|NCT03617185|528986896|FG000|Baseline|Lost to Follow-up|0|||
146674917|NCT03617185|528986897|FG001|Baseline|Lost to Follow-up|2|||
146674918|NCT03617185|528986898|FG002|Baseline|Lost to Follow-up|1|||
146674919|NCT03617185|528986899|FG003|Baseline|Lost to Follow-up|1|||
146674920|NCT03617185|528986896|FG000|Baseline|Withdrawal by Subject|0|||
146674921|NCT03617185|528986897|FG001|Baseline|Withdrawal by Subject|1|||
146674922|NCT03617185|528986898|FG002|Baseline|Withdrawal by Subject|0|||
146674923|NCT03617185|528986899|FG003|Baseline|Withdrawal by Subject|1|||
146674924|NCT03617185|528986896|FG000|Baseline|Driving Distance/Travel|0|||
146674925|NCT03617185|528986897|FG001|Baseline|Driving Distance/Travel|0|||
146674926|NCT03617185|528986898|FG002|Baseline|Driving Distance/Travel|2|||
146674927|NCT03617185|528986899|FG003|Baseline|Driving Distance/Travel|0|||
146674928|NCT03617185|528986896|FG000|Baseline|Family Obligations|0|||
146674929|NCT03617185|528986897|FG001|Baseline|Family Obligations|0|||
146674930|NCT03617185|528986898|FG002|Baseline|Family Obligations|0|||
146674931|NCT03617185|528986899|FG003|Baseline|Family Obligations|1|||
146674932|NCT03617185|528986896|FG000|3 Months|Lost to Follow-up|4|||
146674933|NCT03617185|528986897|FG001|3 Months|Lost to Follow-up|1|||
146674934|NCT03617185|528986898|FG002|3 Months|Lost to Follow-up|0|||
146674935|NCT03617185|528986899|FG003|3 Months|Lost to Follow-up|2|||
146674936|NCT03617185|528986896|FG000|3 Months|Withdrawal by Subject|1|||
146674937|NCT03617185|528986897|FG001|3 Months|Withdrawal by Subject|3|||
146674938|NCT03617185|528986898|FG002|3 Months|Withdrawal by Subject|0|||
146674939|NCT03617185|528986899|FG003|3 Months|Withdrawal by Subject|0|||
146674940|NCT03617185|528986896|FG000|3 Months|Driving Distance/Travel|1|||
146674941|NCT03617185|528986897|FG001|3 Months|Driving Distance/Travel|0|||
146674942|NCT03617185|528986898|FG002|3 Months|Driving Distance/Travel|0|||
146674943|NCT03617185|528986899|FG003|3 Months|Driving Distance/Travel|0|||
146674944|NCT03617185|528986896|FG000|3 Months|Family Obligations|0|||
146674945|NCT03617185|528986897|FG001|3 Months|Family Obligations|0|||
146674946|NCT03617185|528986898|FG002|3 Months|Family Obligations|0|||
146674947|NCT03617185|528986899|FG003|3 Months|Family Obligations|1|||
146674948|NCT03617185|528986896|FG000|12 Months|Lost to Follow-up|3|||
146674949|NCT03617185|528986897|FG001|12 Months|Lost to Follow-up|1|||
146674950|NCT03617185|528986898|FG002|12 Months|Lost to Follow-up|3|||
146674951|NCT03617185|528986899|FG003|12 Months|Lost to Follow-up|0|||
146674952|NCT03617185|528986896|FG000|12 Months|Withdrawal by Subject|0|||
146674953|NCT03617185|528986897|FG001|12 Months|Withdrawal by Subject|0|||
146674954|NCT03617185|528986898|FG002|12 Months|Withdrawal by Subject|0|||
146674955|NCT03617185|528986899|FG003|12 Months|Withdrawal by Subject|1|||
146674956|NCT03617185|528986896|FG000|12 Months|Driving Distance/Travel|0|||
146674957|NCT03617185|528986897|FG001|12 Months|Driving Distance/Travel|0|||
146674958|NCT03617185|528986898|FG002|12 Months|Driving Distance/Travel|1|||
146674959|NCT03617185|528986899|FG003|12 Months|Driving Distance/Travel|0|||
146674960|NCT01964430|528986900|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
146674961|NCT01964430|528986901|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
146674962|NCT01964430|528986900|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
146674963|NCT01964430|528986901|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
146674964|NCT01964430|528986900|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
146674965|NCT01964430|528986901|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
146674966|NCT01964430|528986900|FG000|Treatment Period|Adverse Event|71|||
146674967|NCT01964430|528986901|FG001|Treatment Period|Adverse Event|37|||
146674968|NCT01964430|528986900|FG000|Treatment Period|Withdrawal by Subject|36|||
146674969|NCT01964430|528986901|FG001|Treatment Period|Withdrawal by Subject|27|||
146674970|NCT01964430|528986900|FG000|Treatment Period|Death|1|||
146674971|NCT01964430|528986901|FG001|Treatment Period|Death|3|||
146674972|NCT01964430|528986900|FG000|Treatment Period|Protocol Deviation|0|||
146674973|NCT01964430|528986901|FG001|Treatment Period|Protocol Deviation|1|||
146674974|NCT01964430|528986900|FG000|Treatment Period|Physician Decision|5|||
146674975|NCT01964430|528986901|FG001|Treatment Period|Physician Decision|4|||
146674976|NCT01964430|528986900|FG000|Treatment Period|Disease Relapse|28|||
146674977|NCT01964430|528986901|FG001|Treatment Period|Disease Relapse|38|||
146674978|NCT01964430|528986900|FG000|Treatment Period|Other reasons|1|||
146674979|NCT01964430|528986901|FG001|Treatment Period|Other reasons|3|||
146674980|NCT03310021|528986906|FG000|Overall Study|Withdrawal by Subject|0|||
146674981|NCT03310021|528986907|FG001|Overall Study|Withdrawal by Subject|0|||
146674982|NCT03310021|528986908|FG002|Overall Study|Withdrawal by Subject|0|||
146674983|NCT03310021|528986909|FG003|Overall Study|Withdrawal by Subject|0|||
146674984|NCT03310021|528986910|FG004|Overall Study|Withdrawal by Subject|0|||
146674985|NCT03310021|528986911|FG005|Overall Study|Withdrawal by Subject|0|||
146674986|NCT03310021|528986912|FG006|Overall Study|Withdrawal by Subject|1|||
146674987|NCT03310021|528986913|FG007|Overall Study|Withdrawal by Subject|0|||
146674988|NCT03310021|528986914|FG008|Overall Study|Withdrawal by Subject|0|||
146674989|NCT03310021|528986915|FG009|Overall Study|Withdrawal by Subject|0|||
146674990|NCT03310021|528986916|FG010|Overall Study|Withdrawal by Subject|0|||
146674991|NCT03310021|528986917|FG011|Overall Study|Withdrawal by Subject|0|||
146674992|NCT03310021|528986918|FG012|Overall Study|Withdrawal by Subject|0|||
146674993|NCT03310021|528986919|FG013|Overall Study|Withdrawal by Subject|0|||
146674994|NCT03310021|528986920|FG014|Overall Study|Withdrawal by Subject|0|||
146674995|NCT03310021|528986921|FG015|Overall Study|Withdrawal by Subject|0|||
146674996|NCT03310021|528986922|FG016|Overall Study|Withdrawal by Subject|0|||
146674997|NCT03310021|528986923|FG017|Overall Study|Withdrawal by Subject|0|||
146926276|NCT01419665|529890744|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
146926277|NCT01419665|529890743|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
146926278|NCT01419665|529890744|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
146926279|NCT01419665|529890743|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
146926280|NCT01419665|529890744|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
146926281|NCT01419665|529890743|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
146926282|NCT01419665|529890744|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
146926283|NCT01419665|529890743|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
146926284|NCT01419665|529890744|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
146926285|NCT01419665|529890743|FG000|Maintenance Treatment and/or Follow up|Death|1|||
146926286|NCT01419665|529890744|FG001|Maintenance Treatment and/or Follow up|Death|2|||
146926287|NCT01419665|529890743|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
146926288|NCT01419665|529890744|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
146926289|NCT01419665|529890743|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
146926290|NCT01419665|529890744|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
146926291|NCT01419665|529890743|FG000|Open Label Phase|Death|1|||
146926292|NCT01419665|529890744|FG001|Open Label Phase|Death|0|||
146926293|NCT01419665|529890743|FG000|Open Label Phase|disease progression|0|||
146926294|NCT01419665|529890744|FG001|Open Label Phase|disease progression|1|||
146926295|NCT01655823|529890746|FG000|Overall Study|Lost to Follow-up|0|||
146926296|NCT01655823|529890747|FG001|Overall Study|Lost to Follow-up|1|||
146926297|NCT01655823|529890748|FG002|Overall Study|Lost to Follow-up|0|||
146926298|NCT01655823|529890749|FG003|Overall Study|Lost to Follow-up|0|||
146674998|NCT03310021|528986924|FG018|Overall Study|Withdrawal by Subject|0|||
146674999|NCT03310021|528986925|FG019|Overall Study|Withdrawal by Subject|0|||
146675000|NCT03310021|528986906|FG000|Overall Study|Lost to Follow-up|0|||
146675001|NCT03310021|528986907|FG001|Overall Study|Lost to Follow-up|0|||
146675002|NCT03310021|528986908|FG002|Overall Study|Lost to Follow-up|0|||
146675003|NCT03310021|528986909|FG003|Overall Study|Lost to Follow-up|0|||
146675004|NCT03310021|528986910|FG004|Overall Study|Lost to Follow-up|0|||
146675005|NCT03310021|528986911|FG005|Overall Study|Lost to Follow-up|0|||
146675006|NCT03310021|528986912|FG006|Overall Study|Lost to Follow-up|0|||
146675007|NCT03310021|528986913|FG007|Overall Study|Lost to Follow-up|0|||
146675008|NCT03310021|528986914|FG008|Overall Study|Lost to Follow-up|0|||
146675009|NCT03310021|528986915|FG009|Overall Study|Lost to Follow-up|0|||
146675010|NCT03310021|528986916|FG010|Overall Study|Lost to Follow-up|1|||
146675011|NCT03310021|528986917|FG011|Overall Study|Lost to Follow-up|0|||
146675012|NCT03310021|528986918|FG012|Overall Study|Lost to Follow-up|0|||
146675013|NCT03310021|528986919|FG013|Overall Study|Lost to Follow-up|0|||
146675014|NCT03310021|528986920|FG014|Overall Study|Lost to Follow-up|0|||
146675015|NCT03310021|528986921|FG015|Overall Study|Lost to Follow-up|0|||
146675016|NCT03310021|528986922|FG016|Overall Study|Lost to Follow-up|0|||
146675017|NCT03310021|528986923|FG017|Overall Study|Lost to Follow-up|0|||
146926299|NCT01655823|529890750|FG004|Overall Study|Lost to Follow-up|1|||
146926300|NCT01655823|529890746|FG000|Overall Study|Withdrawal by Subject|0|||
146926301|NCT01655823|529890747|FG001|Overall Study|Withdrawal by Subject|1|||
146675018|NCT03310021|528986924|FG018|Overall Study|Lost to Follow-up|0|||
146675019|NCT03310021|528986925|FG019|Overall Study|Lost to Follow-up|0|||
146926302|NCT01655823|529890748|FG002|Overall Study|Withdrawal by Subject|0|||
146926303|NCT01655823|529890749|FG003|Overall Study|Withdrawal by Subject|1|||
146675020|NCT00702923|528986928|FG000|Overall Study|Adverse Event|1|||
146926304|NCT01655823|529890750|FG004|Overall Study|Withdrawal by Subject|0|||
146926305|NCT01627067|529890751|FG000|Overall Study|Screen Failure|1|||
146675021|NCT02405780|528986936|FG000|Period I|Adverse Event|8|||
146675022|NCT02405780|528986937|FG001|Period I|Adverse Event|0|||
146675023|NCT02405780|528986938|FG002|Period I|Adverse Event|3|||
146675024|NCT02405780|528986939|FG003|Period I|Adverse Event|7|||
146675025|NCT02405780|528986936|FG000|Period I|Medical reasons|1|||
146675026|NCT02405780|528986937|FG001|Period I|Medical reasons|1|||
146675027|NCT02405780|528986938|FG002|Period I|Medical reasons|0|||
146675028|NCT02405780|528986939|FG003|Period I|Medical reasons|1|||
146675029|NCT02405780|528986936|FG000|Period I|Screening Failure|1|||
146675030|NCT02405780|528986937|FG001|Period I|Screening Failure|0|||
146675031|NCT02405780|528986938|FG002|Period I|Screening Failure|1|||
146675032|NCT02405780|528986939|FG003|Period I|Screening Failure|0|||
146675033|NCT02405780|528986936|FG000|Period I|Withdrawal by Subject|9|||
146675034|NCT02405780|528986937|FG001|Period I|Withdrawal by Subject|1|||
146675035|NCT02405780|528986938|FG002|Period I|Withdrawal by Subject|3|||
146675036|NCT02405780|528986939|FG003|Period I|Withdrawal by Subject|4|||
146675037|NCT02405780|528986936|FG000|Period I|Non-compliance with study procedures|8|||
146675038|NCT02405780|528986937|FG001|Period I|Non-compliance with study procedures|6|||
146675039|NCT02405780|528986938|FG002|Period I|Non-compliance with study procedures|8|||
146675040|NCT02405780|528986939|FG003|Period I|Non-compliance with study procedures|11|||
146675041|NCT02405780|528986936|FG000|Period II|Adverse Event|3|||
146675042|NCT02405780|528986937|FG001|Period II|Adverse Event|5|||
146675043|NCT02405780|528986938|FG002|Period II|Adverse Event|4|||
146675044|NCT02405780|528986939|FG003|Period II|Adverse Event|11|||
146675045|NCT02405780|528986936|FG000|Period II|Medical reason|0|||
146675046|NCT02405780|528986937|FG001|Period II|Medical reason|1|||
146675047|NCT02405780|528986938|FG002|Period II|Medical reason|0|||
146675048|NCT02405780|528986939|FG003|Period II|Medical reason|0|||
146675049|NCT02405780|528986936|FG000|Period II|Pregnancy|0|||
146675050|NCT02405780|528986937|FG001|Period II|Pregnancy|0|||
146675051|NCT02405780|528986938|FG002|Period II|Pregnancy|1|||
146675052|NCT02405780|528986939|FG003|Period II|Pregnancy|0|||
146675053|NCT02405780|528986936|FG000|Period II|Withdrawal by Subject|7|||
146675054|NCT02405780|528986937|FG001|Period II|Withdrawal by Subject|4|||
146675055|NCT02405780|528986938|FG002|Period II|Withdrawal by Subject|0|||
146675056|NCT02405780|528986939|FG003|Period II|Withdrawal by Subject|3|||
146675057|NCT02405780|528986936|FG000|Period II|Non-compliance with study procedures|5|||
146675058|NCT02405780|528986937|FG001|Period II|Non-compliance with study procedures|2|||
146675059|NCT02405780|528986938|FG002|Period II|Non-compliance with study procedures|7|||
146675060|NCT02405780|528986939|FG003|Period II|Non-compliance with study procedures|4|||
146675061|NCT04502693|528986940|FG000|Overall Study|Adverse Event|7|||
146675062|NCT04502693|528986941|FG001|Overall Study|Adverse Event|6|||
146675063|NCT04502693|528986942|FG002|Overall Study|Adverse Event|11|||
146675064|NCT04502693|528986943|FG003|Overall Study|Adverse Event|1|||
146675065|NCT04502693|528986940|FG000|Overall Study|Lost to Follow-up|32|||
146675066|NCT04502693|528986941|FG001|Overall Study|Lost to Follow-up|36|||
146675067|NCT04502693|528986942|FG002|Overall Study|Lost to Follow-up|69|||
146675068|NCT04502693|528986943|FG003|Overall Study|Lost to Follow-up|4|||
146675069|NCT04502693|528986940|FG000|Overall Study|Protocol Violation|8|||
146675070|NCT04502693|528986941|FG001|Overall Study|Protocol Violation|8|||
146675071|NCT04502693|528986942|FG002|Overall Study|Protocol Violation|16|||
146675072|NCT04502693|528986943|FG003|Overall Study|Protocol Violation|1|||
146675073|NCT04502693|528986940|FG000|Overall Study|Withdrawal by Subject|46|||
146675074|NCT04502693|528986941|FG001|Overall Study|Withdrawal by Subject|38|||
146675075|NCT04502693|528986942|FG002|Overall Study|Withdrawal by Subject|54|||
146675076|NCT04502693|528986943|FG003|Overall Study|Withdrawal by Subject|7|||
146675077|NCT04502693|528986940|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
146675078|NCT04502693|528986941|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
146675079|NCT04502693|528986942|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
146675080|NCT04502693|528986943|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146675081|NCT04502693|528986940|FG000|Overall Study|Other|1|||
146675082|NCT04502693|528986941|FG001|Overall Study|Other|0|||
146675083|NCT04502693|528986942|FG002|Overall Study|Other|1|||
146675084|NCT04502693|528986943|FG003|Overall Study|Other|1|||
146675085|NCT00602797|528986948|FG000|Overall Study|Adverse Event|1|||
146675086|NCT03736447|528986951|FG000|Overall Study|Adverse Event|5|||
146675087|NCT03736447|528986952|FG001|Overall Study|Adverse Event|1|||
146675088|NCT03736447|528986951|FG000|Overall Study|Withdrawal by Subject|5|||
146675089|NCT03736447|528986952|FG001|Overall Study|Withdrawal by Subject|1|||
146926306|NCT03352414|529890755|FG000|Overall Study|Ineligible by operative criteria|12|||
146675090|NCT03736447|528986951|FG000|Overall Study|Lost to Follow-up|1|||
146675091|NCT03736447|528986952|FG001|Overall Study|Lost to Follow-up|0|||
146675092|NCT03736447|528986951|FG000|Overall Study|Physician Decision|1|||
146675093|NCT03736447|528986952|FG001|Overall Study|Physician Decision|0|||
146675094|NCT03736447|528986951|FG000|Overall Study|Continued commitment to study treatment|3|||
146675095|NCT03736447|528986952|FG001|Overall Study|Continued commitment to study treatment|0|||
146675096|NCT03736447|528986951|FG000|Overall Study|Taste aversion to study product|0|||
146675097|NCT03736447|528986952|FG001|Overall Study|Taste aversion to study product|1|||
146675098|NCT02784431|528986953|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
146926307|NCT03352414|529890756|FG001|Overall Study|Ineligible by operative criteria|10|||
146675099|NCT02784431|528986953|FG000|Overall Study|Early Study Termination|19|||
146675100|NCT04875195|528986954|FG000|Overall Study|Death|9|||
146675101|NCT04875195|528986955|FG001|Overall Study|Death|3|||
146675102|NCT04875195|528986954|FG000|Overall Study|Withdrawal by Subject|2|||
146675103|NCT04875195|528986955|FG001|Overall Study|Withdrawal by Subject|1|||
146926308|NCT02632110|529890757|FG000|Overall Study|Withdrawal by Subject|1|||
146926309|NCT02632110|529890758|FG001|Overall Study|Withdrawal by Subject|1|||
146926310|NCT02632110|529890759|FG002|Overall Study|Withdrawal by Subject|0|||
146926311|NCT02632110|529890760|FG003|Overall Study|Withdrawal by Subject|0|||
146926312|NCT02632110|529890761|FG004|Overall Study|Withdrawal by Subject|1|||
146926313|NCT02632110|529890762|FG005|Overall Study|Withdrawal by Subject|1|||
146926314|NCT02632110|529890763|FG006|Overall Study|Withdrawal by Subject|3|||
146926315|NCT02632110|529890764|FG007|Overall Study|Withdrawal by Subject|3|||
146926316|NCT02632110|529890765|FG008|Overall Study|Withdrawal by Subject|1|||
146926317|NCT02632110|529890766|FG009|Overall Study|Withdrawal by Subject|1|||
146926318|NCT00516269|529890767|FG000|Overall Study|Adverse Event|2|||
146926319|NCT00516269|529890768|FG001|Overall Study|Adverse Event|1|||
146926320|NCT00516269|529890767|FG000|Overall Study|Lost to Follow-up|0|||
146926321|NCT00516269|529890768|FG001|Overall Study|Lost to Follow-up|1|||
146926322|NCT00516269|529890767|FG000|Overall Study|Protocol Violation|0|||
146926323|NCT00516269|529890768|FG001|Overall Study|Protocol Violation|1|||
146926324|NCT00926796|529890769|FG000|Overall Study|Did not receive randomized treatment|4|||
146926325|NCT00926796|529890770|FG001|Overall Study|Did not receive randomized treatment|7|||
146926326|NCT00926796|529890769|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
146926327|NCT00926796|529890770|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
146926328|NCT00926796|529890769|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
146926329|NCT00926796|529890770|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
146926330|NCT00926796|529890769|FG000|Overall Study|Adverse Event|7|||
146926331|NCT00926796|529890770|FG001|Overall Study|Adverse Event|14|||
146675104|NCT04875195|528986954|FG000|Overall Study|Ongoing in study|49|||
146675105|NCT04875195|528986955|FG001|Overall Study|Ongoing in study|2|||
146675106|NCT00074152|528986956|FG000|Overall Study|Death|21|||
146675107|NCT00074152|528986957|FG001|Overall Study|Death|9|||
146675108|NCT00074152|528986956|FG000|Overall Study|Lack of Efficacy|34|||
146675109|NCT00074152|528986957|FG001|Overall Study|Lack of Efficacy|24|||
146675110|NCT01594762|528986961|FG000|Overall Study|Withdrawal by Subject|1|||
146675111|NCT01594762|528986962|FG001|Overall Study|Withdrawal by Subject|0|||
146675112|NCT01594762|528986961|FG000|Overall Study|Lost to Follow-up|10|||
146675113|NCT01594762|528986962|FG001|Overall Study|Lost to Follow-up|10|||
146675114|NCT00382252|528986963|FG000|Overall Study|Death|4|||
146675115|NCT00382252|528986963|FG000|Overall Study|Protocol Violation|8|||
146675116|NCT00382252|528986963|FG000|Overall Study|Not treated by RFA|1|||
146675117|NCT03338998|528986964|FG000|Treatment Period|Withdrawal by Subject|1|||
146675118|NCT03338998|528986965|FG001|Treatment Period|Withdrawal by Subject|1|||
146675119|NCT03338998|528986964|FG000|Treatment Period|Adverse Event|0|||
146675120|NCT03338998|528986965|FG001|Treatment Period|Adverse Event|2|||
146675121|NCT03338998|528986964|FG000|Treatment Period|Protocol deviation|1|||
146675122|NCT03338998|528986965|FG001|Treatment Period|Protocol deviation|0|||
146675123|NCT03338998|528986964|FG000|Treatment Period|Physician Decision|2|||
146675124|NCT03338998|528986965|FG001|Treatment Period|Physician Decision|0|||
146675125|NCT03338998|528986964|FG000|Treatment Period|Subject failed swallow test|4|||
146926332|NCT00926796|529890769|FG000|Overall Study|Lost to Follow-up|22|||
146926333|NCT00926796|529890770|FG001|Overall Study|Lost to Follow-up|13|||
146926334|NCT00926796|529890769|FG000|Overall Study|Protocol Violation|15|||
146926335|NCT00926796|529890770|FG001|Overall Study|Protocol Violation|11|||
146926336|NCT00926796|529890769|FG000|Overall Study|Withdrawal by Subject|1|||
146675126|NCT03338998|528986965|FG001|Treatment Period|Subject failed swallow test|0|||
146675127|NCT03338998|528986964|FG000|Safety Follow-Up Period|Adverse Event|0|||
146675128|NCT03338998|528986965|FG001|Safety Follow-Up Period|Adverse Event|1|||
146675129|NCT03338998|528986964|FG000|Safety Follow-Up Period|Protocol deviation|1|||
146675130|NCT03338998|528986965|FG001|Safety Follow-Up Period|Protocol deviation|0|||
146675131|NCT03338998|528986964|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
146675132|NCT03338998|528986965|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
146675133|NCT02612727|528986966|FG000|Overall Study|Parent request|4|||
146675134|NCT02612727|528986967|FG001|Overall Study|Parent request|1|||
146675135|NCT02612727|528986966|FG000|Overall Study|Needed treatment incompatible with PT|1|||
146675136|NCT02612727|528986967|FG001|Overall Study|Needed treatment incompatible with PT|1|||
146675137|NCT02612727|528986966|FG000|Overall Study|Direct hyperbilirubinemia|0|||
146675138|NCT02612727|528986967|FG001|Overall Study|Direct hyperbilirubinemia|2|||
146926337|NCT00926796|529890770|FG001|Overall Study|Withdrawal by Subject|0|||
146926338|NCT01341652|529890771|FG000|Overall Study|Incorrect Random Assignment|0|||
146926339|NCT01341652|529890772|FG001|Overall Study|Incorrect Random Assignment|1|||
146926340|NCT01341652|529890771|FG000|Overall Study|ineligible; presence metastatic disease|0|||
146926341|NCT01341652|529890772|FG001|Overall Study|ineligible; presence metastatic disease|1|||
146926342|NCT00403559|529890776|FG000|Overall Study|Adverse Event|0|||
146926343|NCT00403559|529890777|FG001|Overall Study|Adverse Event|1|||
146926344|NCT00403559|529890776|FG000|Overall Study|Lost to Follow-up|3|||
146926345|NCT00403559|529890777|FG001|Overall Study|Lost to Follow-up|3|||
146675149|NCT04524689|528986970|FG000|Overall Study|Withdrawal by Subject|1|||
146675150|NCT04524689|528986971|FG001|Overall Study|Withdrawal by Subject|1|||
146675151|NCT04524689|528986972|FG002|Overall Study|Withdrawal by Subject|0|||
146926346|NCT00403559|529890776|FG000|Overall Study|Withdrawal by Subject|1|||
146926347|NCT00403559|529890777|FG001|Overall Study|Withdrawal by Subject|0|||
146675152|NCT04524689|528986973|FG003|Overall Study|Withdrawal by Subject|0|||
146675153|NCT04524689|528986974|FG004|Overall Study|Withdrawal by Subject|2|||
146675154|NCT04524689|528986975|FG005|Overall Study|Withdrawal by Subject|0|||
146675155|NCT04524689|528986970|FG000|Overall Study|Study terminated by Sponsor|6|||
146675156|NCT04524689|528986971|FG001|Overall Study|Study terminated by Sponsor|0|||
146675157|NCT04524689|528986972|FG002|Overall Study|Study terminated by Sponsor|1|||
146675158|NCT04524689|528986973|FG003|Overall Study|Study terminated by Sponsor|0|||
146675159|NCT04524689|528986974|FG004|Overall Study|Study terminated by Sponsor|4|||
146675160|NCT04524689|528986975|FG005|Overall Study|Study terminated by Sponsor|0|||
146675161|NCT04524689|528986970|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
146675162|NCT04524689|528986971|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
146675163|NCT04524689|528986972|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
146675164|NCT04524689|528986973|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
146675165|NCT04524689|528986974|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
146675166|NCT04524689|528986975|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
146675167|NCT04292743|528986976|FG000|Overall Study|Physician Decision|1|||
146675168|NCT04292743|528986977|FG001|Overall Study|Physician Decision|3|||
146675169|NCT04292743|528986978|FG002|Overall Study|Physician Decision|0|||
146675170|NCT04292743|528986979|FG003|Overall Study|Physician Decision|0|||
146675171|NCT04292743|528986976|FG000|Overall Study|Withdrawal by Subject|0|||
146675172|NCT04292743|528986977|FG001|Overall Study|Withdrawal by Subject|5|||
146675173|NCT04292743|528986978|FG002|Overall Study|Withdrawal by Subject|0|||
146675174|NCT04292743|528986979|FG003|Overall Study|Withdrawal by Subject|0|||
146675175|NCT04292743|528986976|FG000|Overall Study|Death|0|||
146675176|NCT04292743|528986977|FG001|Overall Study|Death|1|||
146675177|NCT04292743|528986978|FG002|Overall Study|Death|0|||
146675178|NCT04292743|528986979|FG003|Overall Study|Death|0|||
146675179|NCT04292743|528986976|FG000|Overall Study|Progression of Disease|2|||
146675180|NCT04292743|528986977|FG001|Overall Study|Progression of Disease|5|||
146675181|NCT04292743|528986978|FG002|Overall Study|Progression of Disease|0|||
146675182|NCT04292743|528986979|FG003|Overall Study|Progression of Disease|0|||
146675183|NCT04292743|528986976|FG000|Overall Study|No Treatment per protocol|0|||
146675184|NCT04292743|528986977|FG001|Overall Study|No Treatment per protocol|2|||
146675185|NCT04292743|528986978|FG002|Overall Study|No Treatment per protocol|0|||
146675186|NCT04292743|528986979|FG003|Overall Study|No Treatment per protocol|0|||
146675187|NCT05766423|528986980|FG000|Overall Study|Withdrawal by Subject|1|||
146675188|NCT05766423|528986981|FG001|Overall Study|Withdrawal by Subject|0|||
146675189|NCT05766423|528986980|FG000|Overall Study|Consented, not scheduled|3|||
146675190|NCT05766423|528986981|FG001|Overall Study|Consented, not scheduled|5|||
146675191|NCT01664533|528988782|FG000|Overall Study|Death|42|||
146675192|NCT01664533|528988782|FG000|Overall Study|Lost to Follow-up|3|||
146675193|NCT01664533|528988782|FG000|Overall Study|Study termination|9|||
146675194|NCT01664533|528988782|FG000|Overall Study|Protocol Violation|3|||
146675195|NCT00844831|528988784|FG000|Overall Study|Withdrawal by Subject|4|||
146675196|NCT00844831|528988784|FG000|Overall Study|Adverse Event|1|||
146675197|NCT00844831|528988784|FG000|Overall Study|Physician Decision|1|||
146675198|NCT05255068|528988785|FG000|Overall Study|Lost to Follow-up|0|||
146675199|NCT05255068|528988786|FG001|Overall Study|Lost to Follow-up|1|||
146675200|NCT00540514|528988788|FG000|Overall Study|Still on treatment|3|||
146675201|NCT00540514|528988789|FG001|Overall Study|Still on treatment|0|||
146675202|NCT00540514|528988788|FG000|Overall Study|Unacceptable Toxicity|61|||
146675203|NCT00540514|528988789|FG001|Overall Study|Unacceptable Toxicity|62|||
146675204|NCT00540514|528988788|FG000|Overall Study|Adverse Event|20|||
146675205|NCT00540514|528988789|FG001|Overall Study|Adverse Event|24|||
146675206|NCT00540514|528988788|FG000|Overall Study|Physician Decision|86|||
146675207|NCT00540514|528988789|FG001|Overall Study|Physician Decision|99|||
146675208|NCT00540514|528988788|FG000|Overall Study|Protocol Deviation|3|||
146675209|NCT00540514|528988789|FG001|Overall Study|Protocol Deviation|4|||
146675210|NCT00540514|528988788|FG000|Overall Study|Lost to Follow-up|1|||
146675211|NCT00540514|528988789|FG001|Overall Study|Lost to Follow-up|1|||
146675212|NCT00540514|528988788|FG000|Overall Study|Withdrawal by Subject|65|||
146675213|NCT00540514|528988789|FG001|Overall Study|Withdrawal by Subject|67|||
146675214|NCT00540514|528988788|FG000|Overall Study|Excluded prior to treatment|7|||
146675215|NCT00540514|528988789|FG001|Overall Study|Excluded prior to treatment|7|||
146675216|NCT00540514|528988788|FG000|Overall Study|Paclitaxel not available|0|||
146675217|NCT00540514|528988789|FG001|Overall Study|Paclitaxel not available|2|||
146675218|NCT00907777|528988790|FG000|Overall Study|Withdrawal by Subject|0|||
146675219|NCT00907777|528988791|FG001|Overall Study|Withdrawal by Subject|1|||
146675220|NCT03291808|528988792|FG000|Overall Study|Lost to Follow-up|6|||
146675221|NCT03291808|528988792|FG000|Overall Study|Research burden|4|||
146675222|NCT02674529|528988793|FG000|Overall Study|Lost to Follow-up|1|||
146675223|NCT02674529|528988794|FG001|Overall Study|Lost to Follow-up|2|||
146675224|NCT02674529|528988793|FG000|Overall Study|Withdrawal by Subject|2|||
146675225|NCT02674529|528988794|FG001|Overall Study|Withdrawal by Subject|1|||
146675226|NCT02674529|528988793|FG000|Overall Study|Physician Decision|0|||
146675227|NCT02674529|528988794|FG001|Overall Study|Physician Decision|1|||
146675228|NCT02674529|528988793|FG000|Overall Study|Protocol Violation|0|||
146675229|NCT02674529|528988794|FG001|Overall Study|Protocol Violation|1|||
146675230|NCT02891850|528988795|FG000|Overall Study|Adverse Event|3|||
146675231|NCT02891850|528988796|FG001|Overall Study|Adverse Event|0|||
146675232|NCT02891850|528988795|FG000|Overall Study|Death|0|||
146675233|NCT02891850|528988796|FG001|Overall Study|Death|4|||
146675234|NCT02891850|528988795|FG000|Overall Study|Physician Decision|1|||
146675235|NCT02891850|528988796|FG001|Overall Study|Physician Decision|0|||
146675236|NCT02891850|528988795|FG000|Overall Study|Pregnancy|1|||
146675237|NCT02891850|528988796|FG001|Overall Study|Pregnancy|0|||
146675238|NCT02891850|528988795|FG000|Overall Study|Withdrawal by Subject|2|||
146675239|NCT02891850|528988796|FG001|Overall Study|Withdrawal by Subject|3|||
146675240|NCT00790023|528988805|FG000|Overall Study|Adverse Event|2|||
146675241|NCT00790023|528988806|FG001|Overall Study|Adverse Event|1|||
146675242|NCT00790023|528988807|FG002|Overall Study|Adverse Event|4|||
146675243|NCT00790023|528988805|FG000|Overall Study|Protocol Violation|2|||
146675244|NCT00790023|528988806|FG001|Overall Study|Protocol Violation|4|||
146675245|NCT00790023|528988807|FG002|Overall Study|Protocol Violation|2|||
146675246|NCT00790023|528988805|FG000|Overall Study|Withdrawal by Subject|2|||
146675247|NCT00790023|528988806|FG001|Overall Study|Withdrawal by Subject|0|||
146675248|NCT00790023|528988807|FG002|Overall Study|Withdrawal by Subject|6|||
146675249|NCT00790023|528988805|FG000|Overall Study|Lost to Follow-up|0|||
146675250|NCT00790023|528988806|FG001|Overall Study|Lost to Follow-up|0|||
146675251|NCT00790023|528988807|FG002|Overall Study|Lost to Follow-up|1|||
146675252|NCT00790023|528988805|FG000|Overall Study|Other|5|||
146675253|NCT00790023|528988806|FG001|Overall Study|Other|5|||
146675254|NCT00790023|528988807|FG002|Overall Study|Other|8|||
146675255|NCT02468414|528988808|FG000|Overall Study|Early Study Termination by Sponsor|1|||
146675256|NCT02468414|528988809|FG001|Overall Study|Early Study Termination by Sponsor|0|||
146675257|NCT02468414|528988808|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
146675258|NCT02468414|528988809|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
146675259|NCT02468414|528988808|FG000|Overall Study|Screen Failure|1|||
146675260|NCT02468414|528988809|FG001|Overall Study|Screen Failure|0|||
146675261|NCT02151591|528988810|FG000|Overall Study|Lost to Follow-up|6|||
146675262|NCT02151591|528988811|FG001|Overall Study|Lost to Follow-up|3|||
146675263|NCT03555591|528988814|FG000|Overall Study|Protocol Violation|77|||
146675264|NCT03633695|528988815|FG000|Overall Study|Lost to Follow-up|4|||
146675265|NCT03633695|528988816|FG001|Overall Study|Lost to Follow-up|5|||
146675266|NCT03633695|528988815|FG000|Overall Study|Discontinued|8|||
146675267|NCT03633695|528988816|FG001|Overall Study|Discontinued|4|||
146675268|NCT01438957|528988826|FG000|Overall Study|Physician Decision|1|||
146675269|NCT01438957|528988827|FG001|Overall Study|Physician Decision|1|||
146675270|NCT01438957|528988828|FG002|Overall Study|Physician Decision|0|||
146675271|NCT01438957|528988829|FG003|Overall Study|Physician Decision|1|||
146675272|NCT01438957|528988830|FG004|Overall Study|Physician Decision|0|||
146675273|NCT00407797|528988831|FG000|Overall Study|Lost to Follow-up|2|||
146675274|NCT00407797|528988831|FG000|Overall Study|Adverse Event|6|||
146675275|NCT00407797|528988831|FG000|Overall Study|Other|7|||
146675276|NCT00407797|528988831|FG000|Overall Study|Withdrawal by Subject|3|||
146675277|NCT01812174|528988832|FG000|Overall Study|Death|1|||
146675278|NCT01812174|528988833|FG001|Overall Study|Death|0|||
146675279|NCT01812174|528988832|FG000|Overall Study|Protocol Violation|2|||
146675280|NCT01812174|528988833|FG001|Overall Study|Protocol Violation|0|||
146675281|NCT00518986|528988837|FG000|Overall Study|Adverse Event|12|||
146675282|NCT00518986|528988838|FG001|Overall Study|Adverse Event|7|||
146675283|NCT00518986|528988837|FG000|Overall Study|Lack of Efficacy|0|||
146675284|NCT00518986|528988838|FG001|Overall Study|Lack of Efficacy|2|||
146675285|NCT00518986|528988837|FG000|Overall Study|Lost to Follow-up|3|||
146675286|NCT00518986|528988838|FG001|Overall Study|Lost to Follow-up|2|||
146675287|NCT00518986|528988837|FG000|Overall Study|Physician Decision|0|||
146675288|NCT00518986|528988838|FG001|Overall Study|Physician Decision|3|||
146675289|NCT00518986|528988837|FG000|Overall Study|Protocol Violation|5|||
146675290|NCT00518986|528988838|FG001|Overall Study|Protocol Violation|7|||
146675291|NCT00518986|528988837|FG000|Overall Study|Withdrawal by Subject|4|||
146675292|NCT00518986|528988838|FG001|Overall Study|Withdrawal by Subject|4|||
146675293|NCT00518986|528988837|FG000|Overall Study|Non-Specific|2|||
146675294|NCT00518986|528988838|FG001|Overall Study|Non-Specific|1|||
146675295|NCT02801396|528988840|FG000|Period 1|Withdrawal by Subject|0|||
146675296|NCT02801396|528988841|FG001|Period 1|Withdrawal by Subject|0|||
146675297|NCT02801396|528988842|FG002|Period 1|Withdrawal by Subject|0|||
146675298|NCT02801396|528988843|FG003|Period 1|Withdrawal by Subject|0|||
146675299|NCT02801396|528988844|FG004|Period 1|Withdrawal by Subject|1|||
146675300|NCT02801396|528988845|FG005|Period 1|Withdrawal by Subject|0|||
146675301|NCT03322631|528988855|FG000|Overall Study|Withdrawal by Subject|0|||
146675302|NCT03322631|528988856|FG001|Overall Study|Withdrawal by Subject|1|||
146675303|NCT03322631|528988857|FG002|Overall Study|Withdrawal by Subject|0|||
146675304|NCT03322631|528988858|FG003|Overall Study|Withdrawal by Subject|0|||
146675305|NCT03322631|528988855|FG000|Overall Study|Adverse Event|0|||
146675306|NCT03322631|528988856|FG001|Overall Study|Adverse Event|0|||
146774291|NCT00311363|529343558|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
146774292|NCT00311363|529343559|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
146926348|NCT04105244|529890778|FG000|Overall Study|Withdrawal by Subject|10|||
146926349|NCT04105244|529890779|FG001|Overall Study|Withdrawal by Subject|12|||
146926350|NCT04105244|529890778|FG000|Overall Study|Lost to Follow-up|20|||
146926351|NCT04105244|529890779|FG001|Overall Study|Lost to Follow-up|15|||
146926352|NCT04105244|529890778|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
146675307|NCT03322631|528988857|FG002|Overall Study|Adverse Event|1|||
146675308|NCT03322631|528988858|FG003|Overall Study|Adverse Event|0|||
146675309|NCT02378961|528988860|FG000|Overall Study|Lack of Efficacy|4|||
146675310|NCT02378961|528988861|FG001|Overall Study|Lack of Efficacy|2|||
146675311|NCT02378961|528988862|FG002|Overall Study|Lack of Efficacy|0|||
146675312|NCT02378961|528988863|FG003|Overall Study|Lack of Efficacy|1|||
146675313|NCT02378961|528988860|FG000|Overall Study|Death|0|||
146675314|NCT02378961|528988861|FG001|Overall Study|Death|0|||
146675315|NCT02378961|528988862|FG002|Overall Study|Death|1|||
146675316|NCT02378961|528988863|FG003|Overall Study|Death|0|||
146675317|NCT02412618|528988864|FG000|Overall Study|Withdrawal by Subject|1|||
146675318|NCT02412618|528988865|FG001|Overall Study|Withdrawal by Subject|1|||
146675319|NCT02412618|528988864|FG000|Overall Study|Expulsion|1|||
146675320|NCT02412618|528988865|FG001|Overall Study|Expulsion|1|||
146675321|NCT01253408|528988866|FG000|Overall Study|Adverse Event|0|||
146675322|NCT01253408|528988867|FG001|Overall Study|Adverse Event|1|||
146675323|NCT01253408|528988868|FG002|Overall Study|Adverse Event|0|||
146675324|NCT00393029|528988872|FG000|Overall Study|Not treated|0|||
146675325|NCT00393029|528988873|FG001|Overall Study|Not treated|1|||
146675326|NCT03715530|528988874|FG000|Overall Study|Lost to Follow-up|3|||
146675327|NCT03715530|528988875|FG001|Overall Study|Lost to Follow-up|1|||
146675328|NCT03715530|528988876|FG002|Overall Study|Lost to Follow-up|2|||
146675329|NCT00039130|528988878|FG000|Overall Study|Adverse Event|11|||
146675330|NCT00039130|528988878|FG000|Overall Study|Death|9|||
146675331|NCT00039130|528988878|FG000|Overall Study|Withdrawal by Subject|3|||
146675332|NCT00039130|528988878|FG000|Overall Study|Progression|2|||
146675333|NCT00039130|528988878|FG000|Overall Study|Subsequent treatment|2|||
146675334|NCT00039130|528988878|FG000|Overall Study|Physician Decision|3|||
146675335|NCT03288129|528988879|FG000|Overall Study|Adverse Event|10|||
146675336|NCT03288129|528988879|FG000|Overall Study|Lost to Follow-up|3|||
146675337|NCT03288129|528988879|FG000|Overall Study|Withdrawal by Subject|3|||
146675338|NCT03288129|528988879|FG000|Overall Study|Withdrawal of consent/assent|1|||
146675339|NCT03288129|528988879|FG000|Overall Study|Other|5|||
146675340|NCT01744197|528988885|FG000|Overall Study|Received 1 patch|2|||
146675341|NCT01744197|528988886|FG001|Overall Study|Received 1 patch|1|||
146675342|NCT01744197|528988885|FG000|Overall Study|No patch received|2|||
146675343|NCT01744197|528988886|FG001|Overall Study|No patch received|2|||
146675344|NCT01949506|528988887|FG000|Overall Study|Physician Decision|1|||
146675345|NCT02915016|528988888|FG000|Overall Study|Lost to Follow-up|4|||
146675346|NCT02915016|528988889|FG001|Overall Study|Lost to Follow-up|2|||
146675347|NCT02915016|528988890|FG002|Overall Study|Lost to Follow-up|5|||
146675348|NCT02915016|528988891|FG003|Overall Study|Lost to Follow-up|3|||
146675349|NCT02915016|528988892|FG004|Overall Study|Lost to Follow-up|5|||
146675350|NCT02915016|528988893|FG005|Overall Study|Lost to Follow-up|2|||
146675351|NCT02915016|528988894|FG006|Overall Study|Lost to Follow-up|8|||
146675352|NCT02915016|528988895|FG007|Overall Study|Lost to Follow-up|2|||
146675353|NCT02915016|528988888|FG000|Overall Study|Physician Decision|0|||
146675354|NCT02915016|528988889|FG001|Overall Study|Physician Decision|0|||
146675355|NCT02915016|528988890|FG002|Overall Study|Physician Decision|1|||
146675356|NCT02915016|528988891|FG003|Overall Study|Physician Decision|0|||
146675357|NCT02915016|528988892|FG004|Overall Study|Physician Decision|0|||
146675358|NCT02915016|528988893|FG005|Overall Study|Physician Decision|1|||
146926353|NCT04105244|529890779|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
146926354|NCT04105244|529890778|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
146978907|NCT01078623|530085503|FG007|Treatment Period 4|Adverse Event|0|||
146675359|NCT02915016|528988894|FG006|Overall Study|Physician Decision|2|||
146675360|NCT02915016|528988895|FG007|Overall Study|Physician Decision|0|||
146675361|NCT02915016|528988888|FG000|Overall Study|Withdrawal by Subject|2|||
146675362|NCT02915016|528988889|FG001|Overall Study|Withdrawal by Subject|0|||
146675363|NCT02915016|528988890|FG002|Overall Study|Withdrawal by Subject|1|||
146675364|NCT02915016|528988891|FG003|Overall Study|Withdrawal by Subject|0|||
146675365|NCT02915016|528988892|FG004|Overall Study|Withdrawal by Subject|1|||
146675366|NCT02915016|528988893|FG005|Overall Study|Withdrawal by Subject|3|||
146675367|NCT02915016|528988894|FG006|Overall Study|Withdrawal by Subject|1|||
146675368|NCT02915016|528988895|FG007|Overall Study|Withdrawal by Subject|1|||
146675369|NCT02915016|528988888|FG000|Overall Study|Elected not to continue|0|||
146675370|NCT02915016|528988889|FG001|Overall Study|Elected not to continue|0|||
146675371|NCT02915016|528988890|FG002|Overall Study|Elected not to continue|0|||
146675372|NCT02915016|528988891|FG003|Overall Study|Elected not to continue|1|||
146675373|NCT02915016|528988892|FG004|Overall Study|Elected not to continue|0|||
146675374|NCT02915016|528988893|FG005|Overall Study|Elected not to continue|0|||
146675375|NCT02915016|528988894|FG006|Overall Study|Elected not to continue|1|||
146675376|NCT02915016|528988895|FG007|Overall Study|Elected not to continue|0|||
146675377|NCT02915016|528988888|FG000|Overall Study|HIV infection|1|||
146675378|NCT02915016|528988889|FG001|Overall Study|HIV infection|1|||
146675379|NCT02915016|528988890|FG002|Overall Study|HIV infection|1|||
146675380|NCT02915016|528988891|FG003|Overall Study|HIV infection|0|||
146675381|NCT02915016|528988892|FG004|Overall Study|HIV infection|1|||
146675382|NCT02915016|528988893|FG005|Overall Study|HIV infection|0|||
146675383|NCT02915016|528988894|FG006|Overall Study|HIV infection|0|||
146675384|NCT02915016|528988895|FG007|Overall Study|HIV infection|0|||
146675385|NCT02915016|528988888|FG000|Overall Study|Participant unable to adhere|0|||
146675386|NCT02915016|528988889|FG001|Overall Study|Participant unable to adhere|0|||
146675387|NCT02915016|528988890|FG002|Overall Study|Participant unable to adhere|0|||
146675388|NCT02915016|528988891|FG003|Overall Study|Participant unable to adhere|0|||
146675389|NCT02915016|528988892|FG004|Overall Study|Participant unable to adhere|0|||
146675390|NCT02915016|528988893|FG005|Overall Study|Participant unable to adhere|0|||
146675391|NCT02915016|528988894|FG006|Overall Study|Participant unable to adhere|0|||
146675392|NCT02915016|528988895|FG007|Overall Study|Participant unable to adhere|1|||
146675393|NCT02166905|528988896|FG000|Overall Study|Withdrawal by Subject|1|||
146675394|NCT02166905|528988897|FG001|Overall Study|Withdrawal by Subject|0|||
146675395|NCT02166905|528988898|FG002|Overall Study|Withdrawal by Subject|0|||
146675396|NCT02166905|528988899|FG003|Overall Study|Withdrawal by Subject|0|||
146675397|NCT02617628|528988900|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
146675398|NCT02617628|528988901|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
146675399|NCT03278873|528988902|FG000|Overall Study|Withdrawal by Subject|0|||
146675400|NCT03278873|528988903|FG001|Overall Study|Withdrawal by Subject|1|||
146675401|NCT03278873|528988904|FG002|Overall Study|Withdrawal by Subject|0|||
146675402|NCT03278873|528988905|FG003|Overall Study|Withdrawal by Subject|0|||
146675403|NCT03278873|528988902|FG000|Overall Study|Sponsor's decision|0|||
146675404|NCT03278873|528988903|FG001|Overall Study|Sponsor's decision|1|||
146675405|NCT03278873|528988904|FG002|Overall Study|Sponsor's decision|0|||
146675406|NCT03278873|528988905|FG003|Overall Study|Sponsor's decision|0|||
146675407|NCT03278873|528988902|FG000|Overall Study|Early Termination|2|||
146675408|NCT03278873|528988903|FG001|Overall Study|Early Termination|6|||
146675409|NCT03278873|528988904|FG002|Overall Study|Early Termination|0|||
146675410|NCT03278873|528988905|FG003|Overall Study|Early Termination|4|||
146675411|NCT03278873|528988902|FG000|Overall Study|Lost to Follow-up|0|||
146675412|NCT03278873|528988903|FG001|Overall Study|Lost to Follow-up|0|||
146675413|NCT03278873|528988904|FG002|Overall Study|Lost to Follow-up|2|||
146675414|NCT03278873|528988905|FG003|Overall Study|Lost to Follow-up|0|||
146675415|NCT03278873|528988902|FG000|Overall Study|The patient decided to withdraw via email|1|||
146675416|NCT03278873|528988903|FG001|Overall Study|The patient decided to withdraw via email|0|||
146675417|NCT03278873|528988904|FG002|Overall Study|The patient decided to withdraw via email|0|||
146675418|NCT03278873|528988905|FG003|Overall Study|The patient decided to withdraw via email|0|||
146675419|NCT03278873|528988902|FG000|Overall Study|The patient was unresponsive to contact|0|||
146675420|NCT03278873|528988903|FG001|Overall Study|The patient was unresponsive to contact|0|||
146675421|NCT03278873|528988904|FG002|Overall Study|The patient was unresponsive to contact|0|||
146675422|NCT03278873|528988905|FG003|Overall Study|The patient was unresponsive to contact|4|||
146675423|NCT03278873|528988902|FG000|Overall Study|The patient wished to participate no longer|0|||
146675424|NCT03278873|528988903|FG001|Overall Study|The patient wished to participate no longer|1|||
146675425|NCT03278873|528988904|FG002|Overall Study|The patient wished to participate no longer|0|||
146675426|NCT03278873|528988905|FG003|Overall Study|The patient wished to participate no longer|0|||
146675427|NCT03278873|528988902|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
146675428|NCT03278873|528988903|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
146675429|NCT03278873|528988904|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
146675430|NCT03278873|528988905|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
146675431|NCT04518306|528988920|FG000|Double-Blind Period|Run in failure|0|||
146675432|NCT04518306|528988921|FG001|Double-Blind Period|Run in failure|0|||
146675433|NCT04518306|528988922|FG002|Double-Blind Period|Run in failure|1|||
146675434|NCT04518306|528988920|FG000|Double-Blind Period|Adverse Event|0|||
146675435|NCT04518306|528988921|FG001|Double-Blind Period|Adverse Event|2|||
146675436|NCT04518306|528988922|FG002|Double-Blind Period|Adverse Event|2|||
146675437|NCT04518306|528988920|FG000|Double-Blind Period|Lost to Follow-up|1|||
146675438|NCT04518306|528988921|FG001|Double-Blind Period|Lost to Follow-up|2|||
146675439|NCT04518306|528988922|FG002|Double-Blind Period|Lost to Follow-up|2|||
146926355|NCT04105244|529890779|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
146774293|NCT00311363|529343557|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
146926356|NCT04633473|529890780|FG000|Overall Study|Withdrawal by Subject|6|||
146926357|NCT04387136|529890781|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
146675440|NCT04518306|528988920|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
146675441|NCT04518306|528988921|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
146675442|NCT04518306|528988922|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
146926358|NCT04387136|529890782|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
146926359|NCT03294681|529890785|FG000|Overall Study|Withdrawal by Subject|1|||
146675443|NCT04518306|528988920|FG000|Double-Blind Period|Other|0|||
146675444|NCT04518306|528988921|FG001|Double-Blind Period|Other|2|||
146675445|NCT04518306|528988922|FG002|Double-Blind Period|Other|0|||
146675446|NCT04518306|528988920|FG000|Double-Blind Period|Missing|0|||
146675447|NCT04518306|528988921|FG001|Double-Blind Period|Missing|1|||
146675448|NCT04518306|528988922|FG002|Double-Blind Period|Missing|0|||
146675449|NCT02801331|528988923|FG000|Overall Study|Transferred to another hospital|8|||
146675450|NCT02801331|528988924|FG001|Overall Study|Transferred to another hospital|7|||
146675451|NCT02801331|528988923|FG000|Overall Study|Withdrawal by Subject|0|||
146675452|NCT02801331|528988924|FG001|Overall Study|Withdrawal by Subject|4|||
146675453|NCT02801331|528988923|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
146675454|NCT02801331|528988924|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
146675455|NCT02443987|528988925|FG000|Overall Study|Bladder injury|1|||
146675456|NCT02443987|528988926|FG001|Overall Study|Bladder injury|1|||
146675457|NCT02443987|528988925|FG000|Overall Study|Other|0|||
146675458|NCT02443987|528988926|FG001|Overall Study|Other|1|||
146675459|NCT01397708|528988927|FG000|Overall Study|Withdrawal by Subject|0|||
146675460|NCT01397708|528988928|FG001|Overall Study|Withdrawal by Subject|0|||
146675461|NCT01397708|528988929|FG002|Overall Study|Withdrawal by Subject|1|||
146675462|NCT01397708|528988930|FG003|Overall Study|Withdrawal by Subject|0|||
146675463|NCT01397708|528988931|FG004|Overall Study|Withdrawal by Subject|0|||
146675464|NCT01397708|528988932|FG005|Overall Study|Withdrawal by Subject|0|||
146675465|NCT01397708|528988933|FG006|Overall Study|Withdrawal by Subject|0|||
146675466|NCT01397708|528988934|FG007|Overall Study|Withdrawal by Subject|1|||
146675467|NCT01397708|528988927|FG000|Overall Study|Death|0|||
146675468|NCT01397708|528988928|FG001|Overall Study|Death|0|||
146675469|NCT01397708|528988929|FG002|Overall Study|Death|1|||
146675470|NCT01397708|528988930|FG003|Overall Study|Death|1|||
146675471|NCT01397708|528988931|FG004|Overall Study|Death|0|||
146675472|NCT01397708|528988932|FG005|Overall Study|Death|0|||
146675473|NCT01397708|528988933|FG006|Overall Study|Death|0|||
146675474|NCT01397708|528988934|FG007|Overall Study|Death|0|||
146675475|NCT01397708|528988927|FG000|Overall Study|Lost to Follow-up|0|||
146675476|NCT01397708|528988928|FG001|Overall Study|Lost to Follow-up|0|||
146675477|NCT01397708|528988929|FG002|Overall Study|Lost to Follow-up|0|||
146675478|NCT01397708|528988930|FG003|Overall Study|Lost to Follow-up|0|||
146675479|NCT01397708|528988931|FG004|Overall Study|Lost to Follow-up|1|||
146675480|NCT01397708|528988932|FG005|Overall Study|Lost to Follow-up|0|||
146675481|NCT01397708|528988933|FG006|Overall Study|Lost to Follow-up|0|||
146675482|NCT01397708|528988934|FG007|Overall Study|Lost to Follow-up|0|||
146675483|NCT01397708|528988927|FG000|Overall Study|Other|0|||
146675484|NCT01397708|528988928|FG001|Overall Study|Other|0|||
146675485|NCT01397708|528988929|FG002|Overall Study|Other|0|||
146675486|NCT01397708|528988930|FG003|Overall Study|Other|0|||
146675487|NCT01397708|528988931|FG004|Overall Study|Other|0|||
146675488|NCT01397708|528988932|FG005|Overall Study|Other|0|||
146675489|NCT01397708|528988933|FG006|Overall Study|Other|1|||
146675490|NCT01397708|528988934|FG007|Overall Study|Other|0|||
146675491|NCT01638546|528988937|FG000|Overall Study|Adverse Event|1|||
146675492|NCT01638546|528988938|FG001|Overall Study|Adverse Event|3|||
146675493|NCT05330702|528988941|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
146675494|NCT05330702|528988942|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
146675495|NCT05330702|528988943|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
146675496|NCT02881554|528988944|FG000|Overall Study|Withdrawal by Subject|2|||
146675497|NCT02881554|528988945|FG001|Overall Study|Withdrawal by Subject|0|||
146675498|NCT02397278|528990456|FG000|Overall Study|Withdrawal by Subject|0|||
146675499|NCT02397278|528990457|FG001|Overall Study|Withdrawal by Subject|2|||
146675500|NCT02397278|528990456|FG000|Overall Study|Deemed ineligible following surgery|1|||
146675501|NCT02397278|528990457|FG001|Overall Study|Deemed ineligible following surgery|1|||
146675502|NCT02161731|528990459|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
146675503|NCT02161731|528990460|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
146675504|NCT02161731|528990459|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
146926360|NCT03089216|529890786|FG000|Overall Study|Adverse Event|0|||
146926361|NCT03089216|529890787|FG001|Overall Study|Adverse Event|0|||
146675505|NCT02161731|528990460|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
146675506|NCT01315678|528990465|FG000|Overall Study|Withdrawal by Subject|7|||
146675507|NCT01315678|528990466|FG001|Overall Study|Withdrawal by Subject|3|||
146675508|NCT01315678|528990465|FG000|Overall Study|Adverse Event|3|||
146675509|NCT01315678|528990466|FG001|Overall Study|Adverse Event|1|||
146675510|NCT01315678|528990465|FG000|Overall Study|Lost to Follow-up|1|||
146675511|NCT01315678|528990466|FG001|Overall Study|Lost to Follow-up|0|||
146675512|NCT01315678|528990465|FG000|Overall Study|similar reason to those listed above|3|||
146675513|NCT01315678|528990466|FG001|Overall Study|similar reason to those listed above|2|||
146675514|NCT00331682|528990470|FG000|Overall Study|Adverse Event|1|||
146675515|NCT00004978|528990471|FG000|Overall Study|Death|107|||
146926362|NCT03089216|529890788|FG002|Overall Study|Adverse Event|0|||
146926363|NCT03089216|529890789|FG003|Overall Study|Adverse Event|1|||
146926364|NCT00417976|529890790|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
146926365|NCT00417976|529890790|FG000|Overall Study|Treatment -related toxicity|2|||
146926366|NCT01348425|529890793|FG000|Overall Study|Imaging was not taken.|1|||
146675516|NCT00004978|528990472|FG001|Overall Study|Death|116|||
146675517|NCT00004978|528990471|FG000|Overall Study|Lost to Follow-up|101|||
146675518|NCT00004978|528990472|FG001|Overall Study|Lost to Follow-up|108|||
146675519|NCT00004978|528990471|FG000|Overall Study|Withdrawal by Subject|17|||
146675520|NCT00004978|528990472|FG001|Overall Study|Withdrawal by Subject|26|||
146675521|NCT00004978|528990471|FG000|Overall Study|site closure - not in analysis cohort|19|||
146675522|NCT00004978|528990472|FG001|Overall Study|site closure - not in analysis cohort|20|||
146675523|NCT01652703|528990473|FG000|Overall Study|Withdrawal by Subject|0|||
146675524|NCT01652703|528990474|FG001|Overall Study|Withdrawal by Subject|1|||
146675525|NCT01652703|528990475|FG002|Overall Study|Withdrawal by Subject|3|||
146675526|NCT01652703|528990476|FG003|Overall Study|Withdrawal by Subject|1|||
146675527|NCT01652703|528990477|FG004|Overall Study|Withdrawal by Subject|0|||
146675528|NCT01652703|528990478|FG005|Overall Study|Withdrawal by Subject|1|||
146675529|NCT01652703|528990473|FG000|Overall Study|Other|0|||
146675530|NCT01652703|528990474|FG001|Overall Study|Other|0|||
146675531|NCT01652703|528990475|FG002|Overall Study|Other|0|||
146675532|NCT01652703|528990476|FG003|Overall Study|Other|1|||
146675533|NCT01652703|528990477|FG004|Overall Study|Other|1|||
146675534|NCT01652703|528990478|FG005|Overall Study|Other|1|||
146675535|NCT00062374|528990482|FG000|Overall Study|Not treated|12|||
146675536|NCT02155608|528990483|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
146675537|NCT02155608|528990484|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
146675538|NCT02155608|528990483|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
146675539|NCT02155608|528990484|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
146675540|NCT01532414|528990485|FG000|Overall Study|Lost to Follow-up|3|||
146675541|NCT01532414|528990486|FG001|Overall Study|Lost to Follow-up|0|||
146675542|NCT01532414|528990487|FG002|Overall Study|Lost to Follow-up|1|||
146675543|NCT01532414|528990485|FG000|Overall Study|Withdrawal by Subject|3|||
146675544|NCT01532414|528990486|FG001|Overall Study|Withdrawal by Subject|0|||
146675545|NCT01532414|528990487|FG002|Overall Study|Withdrawal by Subject|0|||
146675546|NCT01532414|528990485|FG000|Overall Study|No V6 semen sample|0|||
146675547|NCT01532414|528990486|FG001|Overall Study|No V6 semen sample|1|||
146675548|NCT01532414|528990487|FG002|Overall Study|No V6 semen sample|0|||
146675549|NCT01532414|528990485|FG000|Overall Study|Adverse Event|0|||
146675550|NCT01532414|528990486|FG001|Overall Study|Adverse Event|1|||
146675551|NCT01532414|528990487|FG002|Overall Study|Adverse Event|1|||
146675552|NCT01532414|528990485|FG000|Overall Study|Unable to complete 24 hour PK|0|||
146675553|NCT01532414|528990486|FG001|Overall Study|Unable to complete 24 hour PK|0|||
146675554|NCT01532414|528990487|FG002|Overall Study|Unable to complete 24 hour PK|1|||
146675555|NCT01532414|528990485|FG000|Overall Study|Withdrawn by sponsor|1|||
146675556|NCT01532414|528990486|FG001|Overall Study|Withdrawn by sponsor|0|||
146675557|NCT01532414|528990487|FG002|Overall Study|Withdrawn by sponsor|0|||
146675558|NCT00187486|528990490|FG000|Overall Study|Protocol Violation|1|||
146675559|NCT02380677|528990491|FG000|Overall Study|Adverse Event|0|||
146675560|NCT02380677|528990492|FG001|Overall Study|Adverse Event|0|||
146675561|NCT02380677|528990493|FG002|Overall Study|Adverse Event|0|||
146675562|NCT02380677|528990494|FG003|Overall Study|Adverse Event|1|||
146675563|NCT02380677|528990495|FG004|Overall Study|Adverse Event|1|||
146675564|NCT02380677|528990496|FG005|Overall Study|Adverse Event|4|||
146675565|NCT02380677|528990497|FG006|Overall Study|Adverse Event|2|||
146675566|NCT02380677|528990498|FG007|Overall Study|Adverse Event|2|||
146675567|NCT02380677|528990499|FG008|Overall Study|Adverse Event|2|||
146675568|NCT02380677|528990500|FG009|Overall Study|Adverse Event|1|||
146675569|NCT02380677|528990501|FG010|Overall Study|Adverse Event|2|||
146675570|NCT02380677|528990502|FG011|Overall Study|Adverse Event|1|||
146675571|NCT02380677|528990491|FG000|Overall Study|Physician Decision|1|||
146926367|NCT01348425|529890794|FG001|Overall Study|Imaging was not taken.|1|||
146675572|NCT02380677|528990492|FG001|Overall Study|Physician Decision|0|||
146675573|NCT02380677|528990493|FG002|Overall Study|Physician Decision|1|||
146926368|NCT01968954|529890800|FG000|Overall Study|Adverse Event|6|||
146675574|NCT02380677|528990494|FG003|Overall Study|Physician Decision|1|||
146675575|NCT02380677|528990495|FG004|Overall Study|Physician Decision|0|||
146675576|NCT02380677|528990496|FG005|Overall Study|Physician Decision|0|||
146926369|NCT01968954|529890801|FG001|Overall Study|Adverse Event|3|||
146926370|NCT01968954|529890800|FG000|Overall Study|Death|1|||
146675577|NCT02380677|528990497|FG006|Overall Study|Physician Decision|0|||
146675578|NCT02380677|528990498|FG007|Overall Study|Physician Decision|0|||
146675579|NCT02380677|528990499|FG008|Overall Study|Physician Decision|0|||
146675580|NCT02380677|528990500|FG009|Overall Study|Physician Decision|0|||
146675581|NCT02380677|528990501|FG010|Overall Study|Physician Decision|0|||
146675582|NCT02380677|528990502|FG011|Overall Study|Physician Decision|0|||
146675583|NCT02380677|528990491|FG000|Overall Study|Lack of Efficacy|0|||
146675584|NCT02380677|528990492|FG001|Overall Study|Lack of Efficacy|1|||
146675585|NCT02380677|528990493|FG002|Overall Study|Lack of Efficacy|2|||
146675586|NCT02380677|528990494|FG003|Overall Study|Lack of Efficacy|0|||
146675587|NCT02380677|528990495|FG004|Overall Study|Lack of Efficacy|4|||
146675588|NCT02380677|528990496|FG005|Overall Study|Lack of Efficacy|1|||
146675589|NCT02380677|528990497|FG006|Overall Study|Lack of Efficacy|1|||
146675590|NCT02380677|528990498|FG007|Overall Study|Lack of Efficacy|2|||
146675591|NCT02380677|528990499|FG008|Overall Study|Lack of Efficacy|2|||
146675592|NCT02380677|528990500|FG009|Overall Study|Lack of Efficacy|0|||
146675593|NCT02380677|528990501|FG010|Overall Study|Lack of Efficacy|2|||
146675594|NCT02380677|528990502|FG011|Overall Study|Lack of Efficacy|1|||
146675595|NCT02380677|528990491|FG000|Overall Study|Withdrawal by Subject|0|||
146675596|NCT02380677|528990492|FG001|Overall Study|Withdrawal by Subject|0|||
146675597|NCT02380677|528990493|FG002|Overall Study|Withdrawal by Subject|0|||
146675598|NCT02380677|528990494|FG003|Overall Study|Withdrawal by Subject|0|||
146675599|NCT02380677|528990495|FG004|Overall Study|Withdrawal by Subject|0|||
146675600|NCT02380677|528990496|FG005|Overall Study|Withdrawal by Subject|0|||
146675601|NCT02380677|528990497|FG006|Overall Study|Withdrawal by Subject|0|||
146675602|NCT02380677|528990498|FG007|Overall Study|Withdrawal by Subject|0|||
146675603|NCT02380677|528990499|FG008|Overall Study|Withdrawal by Subject|0|||
146926371|NCT01968954|529890801|FG001|Overall Study|Death|2|||
146926372|NCT01968954|529890800|FG000|Overall Study|Lost to Follow-up|6|||
146926373|NCT01968954|529890801|FG001|Overall Study|Lost to Follow-up|4|||
146926374|NCT01968954|529890800|FG000|Overall Study|Withdrawal by Subject|20|||
146926375|NCT01968954|529890801|FG001|Overall Study|Withdrawal by Subject|23|||
146926376|NCT01968954|529890800|FG000|Overall Study|Other|7|||
146926377|NCT01968954|529890801|FG001|Overall Study|Other|8|||
146926378|NCT01968954|529890800|FG000|Overall Study|Protocol Violation|0|||
146926379|NCT01968954|529890801|FG001|Overall Study|Protocol Violation|1|||
146926380|NCT01968954|529890800|FG000|Overall Study|Did not met inclusion criteria|0|||
146926381|NCT01968954|529890801|FG001|Overall Study|Did not met inclusion criteria|2|||
146926382|NCT00064350|529890802|FG000|Induction Treatment|Disease Progression|5|||
146926383|NCT00064350|529890803|FG001|Induction Treatment|Disease Progression|1|||
146675604|NCT02380677|528990500|FG009|Overall Study|Withdrawal by Subject|1|||
146675605|NCT02380677|528990501|FG010|Overall Study|Withdrawal by Subject|0|||
146675606|NCT02380677|528990502|FG011|Overall Study|Withdrawal by Subject|3|||
146675607|NCT02380677|528990491|FG000|Overall Study|Other|0|||
146675608|NCT02380677|528990492|FG001|Overall Study|Other|0|||
146675609|NCT02380677|528990493|FG002|Overall Study|Other|0|||
146675610|NCT02380677|528990494|FG003|Overall Study|Other|1|||
146675611|NCT02380677|528990495|FG004|Overall Study|Other|1|||
146675612|NCT02380677|528990496|FG005|Overall Study|Other|1|||
146675613|NCT02380677|528990497|FG006|Overall Study|Other|0|||
146675614|NCT02380677|528990498|FG007|Overall Study|Other|0|||
146675615|NCT02380677|528990499|FG008|Overall Study|Other|0|||
146675616|NCT02380677|528990500|FG009|Overall Study|Other|0|||
146675617|NCT02380677|528990501|FG010|Overall Study|Other|0|||
146675618|NCT02380677|528990502|FG011|Overall Study|Other|0|||
146675619|NCT02599129|528990508|FG000|Overall Study|Lack of Efficacy|2|||
146675620|NCT02599129|528990509|FG001|Overall Study|Lack of Efficacy|2|||
146675621|NCT02599129|528990508|FG000|Overall Study|Lost to Follow-up|1|||
146675622|NCT02599129|528990509|FG001|Overall Study|Lost to Follow-up|0|||
146675623|NCT02599129|528990508|FG000|Overall Study|Withdrawal by Subject|2|||
146675624|NCT02599129|528990509|FG001|Overall Study|Withdrawal by Subject|1|||
146675625|NCT01029795|528990514|FG000|Overall Study|Entry Criteria Not Met|2|||
146675626|NCT01029795|528990515|FG001|Overall Study|Entry Criteria Not Met|1|||
146675627|NCT01029795|528990514|FG000|Overall Study|Physician Decision|2|||
146675628|NCT01029795|528990515|FG001|Overall Study|Physician Decision|1|||
146675629|NCT01029795|528990514|FG000|Overall Study|Sponsor Decision|11|||
146675630|NCT01029795|528990515|FG001|Overall Study|Sponsor Decision|17|||
146675631|NCT01029795|528990514|FG000|Overall Study|Withdrawal by Subject|1|||
146675632|NCT01029795|528990515|FG001|Overall Study|Withdrawal by Subject|3|||
146675633|NCT03217175|528990516|FG000|Overall Study|Physician Decision|4|||
146675634|NCT03217175|528990517|FG001|Overall Study|Physician Decision|1|||
146675635|NCT05035550|528990525|FG000|Overall Study|Withdrawal by Subject|3|||
146675636|NCT05035550|528990526|FG001|Overall Study|Withdrawal by Subject|0|||
146675637|NCT01806545|528990527|FG000|Overall Study|Adverse Event|2|||
146675638|NCT01806545|528990528|FG001|Overall Study|Adverse Event|3|||
146675639|NCT01806545|528990527|FG000|Overall Study|Lost to Follow-up|1|||
146675640|NCT01806545|528990528|FG001|Overall Study|Lost to Follow-up|0|||
146675641|NCT01806545|528990527|FG000|Overall Study|Withdrawal by Subject|3|||
146675642|NCT01806545|528990528|FG001|Overall Study|Withdrawal by Subject|2|||
146675643|NCT00429273|528990529|FG000|Overall Study|Lost to Follow-up|1|||
146675644|NCT00429273|528990530|FG001|Overall Study|Lost to Follow-up|2|||
146675645|NCT00429273|528990531|FG002|Overall Study|Lost to Follow-up|2|||
146675646|NCT00429273|528990529|FG000|Overall Study|Physician Decision|6|||
146675647|NCT00429273|528990530|FG001|Overall Study|Physician Decision|5|||
146675648|NCT00429273|528990531|FG002|Overall Study|Physician Decision|5|||
146675649|NCT00429273|528990529|FG000|Overall Study|Adverse Event|1|||
146675650|NCT00429273|528990530|FG001|Overall Study|Adverse Event|1|||
146926384|NCT00064350|529890804|FG002|Induction Treatment|Disease Progression|110|||
146675651|NCT00429273|528990531|FG002|Overall Study|Adverse Event|2|||
146675652|NCT00884312|528990533|FG000|Overall Study|Non-fatal Progressive Disease|0|||
146675653|NCT00884312|528990534|FG001|Overall Study|Non-fatal Progressive Disease|8|||
146675654|NCT00884312|528990533|FG000|Overall Study|Fatal Progressive Disease|0|||
146675655|NCT00884312|528990534|FG001|Overall Study|Fatal Progressive Disease|1|||
146675656|NCT00884312|528990533|FG000|Overall Study|Non-fatal Adverse Event|1|||
146675657|NCT00884312|528990534|FG001|Overall Study|Non-fatal Adverse Event|0|||
146675658|NCT00884312|528990533|FG000|Overall Study|Fatal Adverse Event|1|||
146675659|NCT00884312|528990534|FG001|Overall Study|Fatal Adverse Event|4|||
146675660|NCT00884312|528990533|FG000|Overall Study|Withdrawal by Subject|0|||
146675661|NCT00884312|528990534|FG001|Overall Study|Withdrawal by Subject|6|||
146675662|NCT00884312|528990533|FG000|Overall Study|Physician Decision|0|||
146675663|NCT00884312|528990534|FG001|Overall Study|Physician Decision|1|||
146675664|NCT00884312|528990533|FG000|Overall Study|Other|0|||
146675665|NCT00884312|528990534|FG001|Overall Study|Other|4|||
146675666|NCT00884312|528990533|FG000|Overall Study|Did Not Receive Study Drug|0|||
146675667|NCT00884312|528990534|FG001|Overall Study|Did Not Receive Study Drug|1|||
146675668|NCT00224042|528990535|FG000|Overall Study|Adverse Event|2|||
146675669|NCT00224042|528990536|FG001|Overall Study|Adverse Event|1|||
146675670|NCT00224042|528990535|FG000|Overall Study|Protocol Violation|0|||
146675671|NCT00224042|528990536|FG001|Overall Study|Protocol Violation|1|||
146675672|NCT00224042|528990535|FG000|Overall Study|Physician Decision|0|||
146675673|NCT00224042|528990536|FG001|Overall Study|Physician Decision|1|||
146675674|NCT00224042|528990535|FG000|Overall Study|Did not meet lab incusion criteria|2|||
146675675|NCT00224042|528990536|FG001|Overall Study|Did not meet lab incusion criteria|3|||
146675676|NCT00224042|528990535|FG000|Overall Study|Other|2|||
146675677|NCT00224042|528990536|FG001|Overall Study|Other|0|||
146675678|NCT00840450|528990537|FG000|Overall Study|Adverse Event|1|||
146675679|NCT00840450|528990537|FG000|Overall Study|Lack of Efficacy|2|||
146675680|NCT03052725|528990539|FG000|Overall Study|Adverse Event|2|||
146675681|NCT03052725|528990540|FG001|Overall Study|Adverse Event|0|||
146675682|NCT03052725|528990539|FG000|Overall Study|Withdrawal by Subject|3|||
146675683|NCT03052725|528990540|FG001|Overall Study|Withdrawal by Subject|4|||
146675684|NCT03052725|528990539|FG000|Overall Study|Pregnancy|0|||
146675685|NCT03052725|528990540|FG001|Overall Study|Pregnancy|1|||
146675686|NCT03052725|528990539|FG000|Overall Study|Site closure|0|||
146675687|NCT03052725|528990540|FG001|Overall Study|Site closure|1|||
146675688|NCT03052725|528990539|FG000|Overall Study|Study terminated by sponsor|143|||
146675689|NCT03052725|528990540|FG001|Overall Study|Study terminated by sponsor|144|||
146675690|NCT01061177|528990543|FG000|Overall Study|Adverse Event|117|||
146675691|NCT01061177|528990543|FG000|Overall Study|Withdrawal by Subject|27|||
146675692|NCT01061177|528990543|FG000|Overall Study|Disease progression|17|||
146675693|NCT01061177|528990543|FG000|Overall Study|Protocol Violation|11|||
146675694|NCT01061177|528990543|FG000|Overall Study|Lost to Follow-up|9|||
146675695|NCT01061177|528990543|FG000|Overall Study|New cancer therapy|9|||
146675696|NCT01061177|528990543|FG000|Overall Study|Abnormal laboratory values|6|||
146675697|NCT01061177|528990543|FG000|Overall Study|Abnormal test procedure results|4|||
146675698|NCT01061177|528990543|FG000|Overall Study|Administratie problems|4|||
146675699|NCT01061177|528990543|FG000|Overall Study|Death|4|||
146675700|NCT01539538|528990545|FG000|Overall Study|Adverse Event|13|||
146675701|NCT01539538|528990546|FG001|Overall Study|Adverse Event|18|||
146675702|NCT01539538|528990545|FG000|Overall Study|Lack of Efficacy|13|||
146675703|NCT01539538|528990546|FG001|Overall Study|Lack of Efficacy|16|||
146675704|NCT01539538|528990545|FG000|Overall Study|Withdrawal by Subject|2|||
146675705|NCT01539538|528990546|FG001|Overall Study|Withdrawal by Subject|3|||
146675706|NCT01539538|528990545|FG000|Overall Study|PCA no longer required or PCA problem|3|||
146675707|NCT01539538|528990546|FG001|Overall Study|PCA no longer required or PCA problem|7|||
146675708|NCT00847379|528990547|FG000|Overall Study|Study terminated by Sponsor|59|||
146675709|NCT00847379|528990548|FG001|Overall Study|Study terminated by Sponsor|57|||
146675710|NCT00847379|528990549|FG002|Overall Study|Study terminated by Sponsor|57|||
146675711|NCT02864498|528990550|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
146675712|NCT02864498|528990551|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
146675713|NCT02864498|528990552|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
146675714|NCT02864498|528990550|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
146675715|NCT02864498|528990551|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
146675716|NCT02864498|528990552|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
146675717|NCT02864498|528990550|FG000|Overall Study|Investigator Discretion|0|||
146675718|NCT02864498|528990551|FG001|Overall Study|Investigator Discretion|2|||
146675719|NCT02864498|528990552|FG002|Overall Study|Investigator Discretion|1|||
146675720|NCT02864498|528990550|FG000|Overall Study|Lost to Follow-up|8|||
146675721|NCT02864498|528990551|FG001|Overall Study|Lost to Follow-up|6|||
146675722|NCT02864498|528990552|FG002|Overall Study|Lost to Follow-up|3|||
146675723|NCT02864498|528990550|FG000|Overall Study|Lack of Efficacy|5|||
146675724|NCT02864498|528990551|FG001|Overall Study|Lack of Efficacy|3|||
146675725|NCT02864498|528990552|FG002|Overall Study|Lack of Efficacy|3|||
146675726|NCT02864498|528990550|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
146926385|NCT00064350|529890802|FG000|Induction Treatment|Adverse Event|0|||
146926386|NCT00064350|529890803|FG001|Induction Treatment|Adverse Event|2|||
146926387|NCT00064350|529890804|FG002|Induction Treatment|Adverse Event|49|||
146926388|NCT00064350|529890802|FG000|Induction Treatment|Death|0|||
146926389|NCT00064350|529890803|FG001|Induction Treatment|Death|0|||
146926390|NCT00064350|529890804|FG002|Induction Treatment|Death|9|||
146926391|NCT00064350|529890802|FG000|Induction Treatment|Withdrawal by Subject|0|||
146926392|NCT00064350|529890803|FG001|Induction Treatment|Withdrawal by Subject|0|||
146926393|NCT00064350|529890804|FG002|Induction Treatment|Withdrawal by Subject|21|||
146926394|NCT00064350|529890802|FG000|Induction Treatment|Ineligible or never started treatment|3|||
146926395|NCT00064350|529890803|FG001|Induction Treatment|Ineligible or never started treatment|6|||
146926396|NCT00064350|529890804|FG002|Induction Treatment|Ineligible or never started treatment|34|||
146926397|NCT00064350|529890802|FG000|Induction Treatment|Other|0|||
146926398|NCT00064350|529890803|FG001|Induction Treatment|Other|0|||
146926399|NCT00064350|529890804|FG002|Induction Treatment|Other|13|||
146926400|NCT00064350|529890802|FG000|Randomization|Adverse Event|8|||
146926401|NCT00064350|529890803|FG001|Randomization|Adverse Event|3|||
146675727|NCT02864498|528990551|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
146675728|NCT02864498|528990552|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
146675729|NCT02864498|528990550|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
146675730|NCT02864498|528990551|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
146675731|NCT02864498|528990552|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
146675732|NCT02864498|528990550|FG000|Overall Study|Subject moved out of the country.|0|||
146675733|NCT02864498|528990551|FG001|Overall Study|Subject moved out of the country.|0|||
146675734|NCT02864498|528990552|FG002|Overall Study|Subject moved out of the country.|1|||
146675735|NCT00378378|528990555|FG000|Overall Study|Withdrawal by Subject|0|||
146675736|NCT00378378|528990556|FG001|Overall Study|Withdrawal by Subject|1|||
146675737|NCT00378378|528990557|FG002|Overall Study|Withdrawal by Subject|0|||
146675738|NCT00378378|528990555|FG000|Overall Study|Treatment Failure|0|||
146675739|NCT00378378|528990556|FG001|Overall Study|Treatment Failure|0|||
146675740|NCT00378378|528990557|FG002|Overall Study|Treatment Failure|1|||
146675741|NCT00378378|528990555|FG000|Overall Study|Non-compliance with protocol|0|||
146675742|NCT00378378|528990556|FG001|Overall Study|Non-compliance with protocol|0|||
146675743|NCT00378378|528990557|FG002|Overall Study|Non-compliance with protocol|1|||
146675744|NCT01854710|528990567|FG000|Overall Study|Withdrawal by Subject|2|||
146675745|NCT01854710|528990568|FG001|Overall Study|Withdrawal by Subject|1|||
146675746|NCT01854710|528990569|FG002|Overall Study|Withdrawal by Subject|0|||
146675747|NCT01854710|528990570|FG003|Overall Study|Withdrawal by Subject|0|||
146675748|NCT01854710|528990571|FG004|Overall Study|Withdrawal by Subject|0|||
146675749|NCT01854710|528990572|FG005|Overall Study|Withdrawal by Subject|0|||
146675750|NCT01854710|528990567|FG000|Overall Study|CRI procedural error|2|||
146675751|NCT01854710|528990568|FG001|Overall Study|CRI procedural error|2|||
146675752|NCT01854710|528990569|FG002|Overall Study|CRI procedural error|2|||
146675753|NCT01854710|528990570|FG003|Overall Study|CRI procedural error|2|||
146675754|NCT01854710|528990571|FG004|Overall Study|CRI procedural error|2|||
146675755|NCT01854710|528990572|FG005|Overall Study|CRI procedural error|2|||
146675756|NCT03132220|528990573|FG000|Overall Study|Lost to Follow-up|17|||
146675757|NCT03132220|528990574|FG001|Overall Study|Lost to Follow-up|8|||
146675758|NCT03132220|528990573|FG000|Overall Study|Withdrawal by Subject|1|||
146675759|NCT03132220|528990574|FG001|Overall Study|Withdrawal by Subject|4|||
146675760|NCT00730132|528990575|FG000|Overall Study|Protocol Violation|154|||
146675761|NCT00730132|528990575|FG000|Overall Study|Death|1|||
146675762|NCT02296320|528990577|FG000|Overall Study|Withdrawal by Subject|4|||
146675763|NCT02296320|528990578|FG001|Overall Study|Withdrawal by Subject|0|||
146675764|NCT02296320|528990579|FG002|Overall Study|Withdrawal by Subject|2|||
146675765|NCT02296320|528990577|FG000|Overall Study|Death|24|||
146675766|NCT02296320|528990578|FG001|Overall Study|Death|3|||
146675767|NCT02296320|528990579|FG002|Overall Study|Death|27|||
146675768|NCT02296320|528990577|FG000|Overall Study|Lost to Follow-up|5|||
146675769|NCT02296320|528990578|FG001|Overall Study|Lost to Follow-up|2|||
146675770|NCT02296320|528990579|FG002|Overall Study|Lost to Follow-up|7|||
146675771|NCT02296320|528990577|FG000|Overall Study|Not treated|2|||
146675772|NCT02296320|528990578|FG001|Overall Study|Not treated|0|||
146675773|NCT02296320|528990579|FG002|Overall Study|Not treated|0|||
146675774|NCT02296320|528990577|FG000|Overall Study|Not - specified|0|||
146675775|NCT02296320|528990578|FG001|Overall Study|Not - specified|0|||
146675776|NCT02296320|528990579|FG002|Overall Study|Not - specified|1|||
146675777|NCT05466682|528990583|FG000|Overall Study|Withdrawal by Subject|0|||
146675778|NCT05466682|528990584|FG001|Overall Study|Withdrawal by Subject|2|||
146675779|NCT05466682|528990583|FG000|Overall Study|Lost to Follow-up|2|||
146675780|NCT05466682|528990584|FG001|Overall Study|Lost to Follow-up|1|||
146675781|NCT01930123|528990585|FG000|Overall Study|Adverse Event|1|||
146675782|NCT01930123|528990586|FG001|Overall Study|Adverse Event|0|||
146926402|NCT00064350|529890804|FG002|Randomization|Adverse Event|0|||
146926403|NCT00064350|529890802|FG000|Randomization|Death|3|||
146926404|NCT00064350|529890803|FG001|Randomization|Death|0|||
146926405|NCT00064350|529890804|FG002|Randomization|Death|0|||
146675783|NCT01930123|528990585|FG000|Overall Study|Physician Decision|21|||
146675784|NCT01930123|528990586|FG001|Overall Study|Physician Decision|8|||
146675785|NCT01930123|528990585|FG000|Overall Study|Withdrawal by Subject|1|||
146675786|NCT01930123|528990586|FG001|Overall Study|Withdrawal by Subject|0|||
146675787|NCT03208244|528990587|FG000|Overall Study|Death|1|||
146675788|NCT03953820|528990589|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
146675789|NCT03953820|528990590|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
146675790|NCT03953820|528990591|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
146675791|NCT03953820|528990589|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
146675792|NCT03953820|528990590|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
146675793|NCT03953820|528990591|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
146675794|NCT03334539|528990592|FG000|Overall Study|Adverse Event|3|||
146675795|NCT03334539|528990593|FG001|Overall Study|Adverse Event|5|||
146675796|NCT03334539|528990594|FG002|Overall Study|Adverse Event|0|||
146675797|NCT03334539|528990592|FG000|Overall Study|Withdrawal by Subject|0|||
146675798|NCT03334539|528990593|FG001|Overall Study|Withdrawal by Subject|1|||
146675799|NCT03334539|528990594|FG002|Overall Study|Withdrawal by Subject|1|||
146675800|NCT03334539|528990592|FG000|Overall Study|Administrative Reasons|1|||
146675801|NCT03334539|528990593|FG001|Overall Study|Administrative Reasons|0|||
146675802|NCT03334539|528990594|FG002|Overall Study|Administrative Reasons|0|||
146675803|NCT03334539|528990592|FG000|Overall Study|Hypertension Not Controlled|0|||
146675804|NCT03334539|528990593|FG001|Overall Study|Hypertension Not Controlled|1|||
146675805|NCT03334539|528990594|FG002|Overall Study|Hypertension Not Controlled|0|||
146675806|NCT03547583|528990599|FG000|Overall Study|Adverse Event|16|||
146675807|NCT03547583|528990600|FG001|Overall Study|Adverse Event|11|||
146675808|NCT03547583|528990601|FG002|Overall Study|Adverse Event|10|||
146675809|NCT03547583|528990599|FG000|Overall Study|Death|11|||
146675810|NCT03547583|528990600|FG001|Overall Study|Death|7|||
146675811|NCT03547583|528990601|FG002|Overall Study|Death|4|||
146675812|NCT03547583|528990599|FG000|Overall Study|Lost to Follow-up|1|||
146675813|NCT03547583|528990600|FG001|Overall Study|Lost to Follow-up|0|||
146675814|NCT03547583|528990601|FG002|Overall Study|Lost to Follow-up|0|||
146675815|NCT03547583|528990599|FG000|Overall Study|Non-compliance with study drug|0|||
146675816|NCT03547583|528990600|FG001|Overall Study|Non-compliance with study drug|0|||
146675817|NCT03547583|528990601|FG002|Overall Study|Non-compliance with study drug|1|||
146675818|NCT03547583|528990599|FG000|Overall Study|Physician Decision|1|||
146675819|NCT03547583|528990600|FG001|Overall Study|Physician Decision|0|||
146675820|NCT03547583|528990601|FG002|Overall Study|Physician Decision|3|||
146675821|NCT03547583|528990599|FG000|Overall Study|Protocol Violation|2|||
146675822|NCT03547583|528990600|FG001|Overall Study|Protocol Violation|1|||
146675823|NCT03547583|528990601|FG002|Overall Study|Protocol Violation|1|||
146675824|NCT03547583|528990599|FG000|Overall Study|Withdrawal by Subject|12|||
146675825|NCT03547583|528990600|FG001|Overall Study|Withdrawal by Subject|19|||
146675826|NCT03547583|528990601|FG002|Overall Study|Withdrawal by Subject|10|||
146675827|NCT03547583|528990599|FG000|Overall Study|Other|2|||
146675828|NCT03547583|528990600|FG001|Overall Study|Other|2|||
146675829|NCT03547583|528990601|FG002|Overall Study|Other|3|||
146675830|NCT04706091|528990604|FG000|Treatment 2|Withdrawal by Subject|1|||
146675831|NCT04706091|528990605|FG001|Treatment 2|Withdrawal by Subject|0|||
146675832|NCT01063868|528990606|FG000|Overall Study|Adverse Event|9|||
146675833|NCT01063868|528990607|FG001|Overall Study|Adverse Event|7|||
146675834|NCT01063868|528990606|FG000|Overall Study|Withdrawal by Subject|3|||
146675835|NCT01063868|528990607|FG001|Overall Study|Withdrawal by Subject|1|||
146675836|NCT01063868|528990606|FG000|Overall Study|Study Terminated By Sponsor|23|||
146675837|NCT01063868|528990607|FG001|Overall Study|Study Terminated By Sponsor|4|||
146675838|NCT03069378|528990611|FG000|Overall Study|Withdrawal by Subject|1|||
146675839|NCT01892293|528992005|FG000|Overall Study|Apheresed but not treated|4|||
146675840|NCT03602482|528992006|FG000|Overall Study|Withdrawal by Subject|6|||
146675841|NCT03602482|528992007|FG001|Overall Study|Withdrawal by Subject|7|||
146675842|NCT03602482|528992008|FG002|Overall Study|Withdrawal by Subject|0|||
146675843|NCT03602482|528992009|FG003|Overall Study|Withdrawal by Subject|0|||
146675844|NCT02601469|528992012|FG000|Overall Study|Enrolled in Error|1|||
146675845|NCT02601469|528992013|FG001|Overall Study|Enrolled in Error|0|||
146675846|NCT01411774|528992018|FG000|Overall Study|Withdrawal by Subject|0|||
146926406|NCT00064350|529890802|FG000|Randomization|Withdrawal by Subject|1|||
146926407|NCT00064350|529890803|FG001|Randomization|Withdrawal by Subject|0|||
146675847|NCT01411774|528992019|FG001|Overall Study|Withdrawal by Subject|3|||
146675848|NCT00056316|528992020|FG000|Overall Study|Withdrawal by Subject|2|||
146675849|NCT00056316|528992021|FG001|Overall Study|Withdrawal by Subject|2|||
146675850|NCT00056316|528992020|FG000|Overall Study|Death/NH placement of pt|1|||
146675851|NCT00056316|528992021|FG001|Overall Study|Death/NH placement of pt|1|||
146675852|NCT02820753|528992022|FG000|2 Month|Withdrawal by Subject|3|||
146675853|NCT02820753|528992023|FG001|2 Month|Withdrawal by Subject|3|||
146675854|NCT02820753|528992022|FG000|2 Month|Lost to Follow-up|24|||
146675855|NCT02820753|528992023|FG001|2 Month|Lost to Follow-up|26|||
146675856|NCT02820753|528992022|FG000|2 Month|Stopped per NIH Hold|51|||
146675857|NCT02820753|528992023|FG001|2 Month|Stopped per NIH Hold|13|||
146926408|NCT00064350|529890804|FG002|Randomization|Withdrawal by Subject|0|||
146675858|NCT02820753|528992022|FG000|6 Month|Withdrawal by Subject|2|||
146675859|NCT02820753|528992023|FG001|6 Month|Withdrawal by Subject|2|||
146675860|NCT02820753|528992022|FG000|6 Month|Lost to Follow-up|20|||
146675861|NCT02820753|528992023|FG001|6 Month|Lost to Follow-up|27|||
146675862|NCT02820753|528992022|FG000|6 Month|Stopped per NIH Hold|81|||
146675863|NCT02820753|528992023|FG001|6 Month|Stopped per NIH Hold|81|||
146675864|NCT02820753|528992022|FG000|6 Month|Death|0|||
146675865|NCT02820753|528992023|FG001|6 Month|Death|1|||
146675866|NCT03292588|528992027|FG000|Overall Study|Death|1|||
146675867|NCT03292588|528992028|FG001|Overall Study|Death|0|||
146675868|NCT03292588|528992027|FG000|Overall Study|Lost to Follow-up|12|||
146675869|NCT03292588|528992028|FG001|Overall Study|Lost to Follow-up|16|||
146675870|NCT03292588|528992027|FG000|Overall Study|Physician Decision|0|||
146675871|NCT03292588|528992028|FG001|Overall Study|Physician Decision|1|||
146675872|NCT03292588|528992027|FG000|Overall Study|Withdrawal by Subject|4|||
146675873|NCT03292588|528992028|FG001|Overall Study|Withdrawal by Subject|4|||
146675874|NCT03292588|528992027|FG000|Overall Study|Move out of town|1|||
146675875|NCT03292588|528992028|FG001|Overall Study|Move out of town|0|||
146675876|NCT03292588|528992027|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
146675877|NCT03292588|528992028|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
146675878|NCT00617123|528992031|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
146675879|NCT00617123|528992032|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
146675880|NCT00617123|528992031|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
146675881|NCT00617123|528992032|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
146675882|NCT00617123|528992031|FG000|Referral Screening Period|Adverse Event|0|||
146675883|NCT00617123|528992032|FG001|Referral Screening Period|Adverse Event|1|||
146675884|NCT00617123|528992031|FG000|Study Treatment Period|Withdrawal by Subject|8|||
146675885|NCT00617123|528992032|FG001|Study Treatment Period|Withdrawal by Subject|12|||
146675886|NCT00617123|528992031|FG000|Study Treatment Period|Adverse Event|7|||
146675887|NCT00617123|528992032|FG001|Study Treatment Period|Adverse Event|3|||
146675888|NCT00617123|528992031|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
146675889|NCT00617123|528992032|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
146675890|NCT00617123|528992031|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
146675891|NCT00617123|528992032|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
146675892|NCT00133952|528992033|FG000|Overall Study|Adverse Event|1|||
146675893|NCT00133952|528992034|FG001|Overall Study|Adverse Event|2|||
146675894|NCT00133952|528992033|FG000|Overall Study|Death|3|||
146675895|NCT00133952|528992034|FG001|Overall Study|Death|2|||
146675896|NCT00133952|528992033|FG000|Overall Study|Lost to Follow-up|9|||
146675897|NCT00133952|528992034|FG001|Overall Study|Lost to Follow-up|14|||
146675898|NCT00133952|528992033|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
146675899|NCT00133952|528992034|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
146675900|NCT00133952|528992033|FG000|Overall Study|Protocol Violation|1|||
146675901|NCT00133952|528992034|FG001|Overall Study|Protocol Violation|1|||
146675902|NCT00133952|528992033|FG000|Overall Study|Withdrawal by Subject|20|||
146675903|NCT00133952|528992034|FG001|Overall Study|Withdrawal by Subject|4|||
146675904|NCT00133952|528992033|FG000|Overall Study|Physician Decision|4|||
146675905|NCT00133952|528992034|FG001|Overall Study|Physician Decision|3|||
146675906|NCT00133952|528992033|FG000|Overall Study|Sponsor Decision|0|||
146675907|NCT00133952|528992034|FG001|Overall Study|Sponsor Decision|1|||
146675908|NCT05048784|528992038|FG000|Period 1|Adverse Event|3|||
146675909|NCT05048784|528992039|FG001|Period 1|Adverse Event|1|||
146675910|NCT05048784|528992040|FG002|Period 1|Adverse Event|0|||
146675911|NCT05048784|528992041|FG003|Period 1|Adverse Event|0|||
146675912|NCT05048784|528992038|FG000|Period 2|Lost to Follow-up|0|||
146774294|NCT00311363|529343558|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
146774295|NCT00311363|529343559|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
146774296|NCT00311363|529343557|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
146774297|NCT00311363|529343558|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
146774298|NCT00311363|529343559|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
146774299|NCT00311363|529343557|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
146774300|NCT00311363|529343558|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
146774301|NCT00311363|529343559|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
146774302|NCT00311363|529343557|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
146774303|NCT00311363|529343558|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
146926409|NCT00064350|529890802|FG000|Randomization|Ineligible or never started treatment|9|||
146675913|NCT05048784|528992039|FG001|Period 2|Lost to Follow-up|1|||
146675914|NCT05048784|528992040|FG002|Period 2|Lost to Follow-up|0|||
146675915|NCT05048784|528992041|FG003|Period 2|Lost to Follow-up|0|||
146675916|NCT03462082|528992046|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
146675917|NCT03462082|528992047|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
146675918|NCT03462082|528992048|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
146675919|NCT03462082|528992049|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
146675920|NCT03462082|528992050|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
146675921|NCT03462082|528992051|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
146675922|NCT03462082|528992052|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
146675923|NCT03462082|528992053|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
146675924|NCT00166114|528992056|FG000|Overall Study|Protocol Violation|2|||
146675925|NCT00166114|528992057|FG001|Overall Study|Protocol Violation|1|||
146675926|NCT00166114|528992056|FG000|Overall Study|Withdrawal by Subject|10|||
146675927|NCT00166114|528992057|FG001|Overall Study|Withdrawal by Subject|4|||
146675928|NCT00166114|528992056|FG000|Overall Study|Adverse Event|2|||
146675929|NCT00166114|528992057|FG001|Overall Study|Adverse Event|1|||
146675930|NCT00545168|528992064|FG000|Overall Study|Lost to Follow-up|5|||
146675931|NCT00545168|528992065|FG001|Overall Study|Lost to Follow-up|5|||
146675932|NCT00545168|528992066|FG002|Overall Study|Lost to Follow-up|5|||
146675933|NCT00545168|528992064|FG000|Overall Study|Withdrawal by Subject|9|||
146675934|NCT00545168|528992065|FG001|Overall Study|Withdrawal by Subject|0|||
146675935|NCT00545168|528992066|FG002|Overall Study|Withdrawal by Subject|13|||
146675936|NCT00545168|528992064|FG000|Overall Study|Protocol Violation|1|||
146675937|NCT00545168|528992065|FG001|Overall Study|Protocol Violation|0|||
146675938|NCT00545168|528992066|FG002|Overall Study|Protocol Violation|1|||
146675939|NCT00545168|528992064|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
146675940|NCT00545168|528992065|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
146675941|NCT00545168|528992066|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
146675942|NCT02548650|528992079|FG000|Triple Therapy|Adverse Event|1|||
146675943|NCT02548650|528992080|FG001|Triple Therapy|Adverse Event|0|||
146675944|NCT02548650|528992079|FG000|Triple Therapy|Withdrawal by Subject|0|||
146675945|NCT02548650|528992080|FG001|Triple Therapy|Withdrawal by Subject|4|||
146675946|NCT02548650|528992079|FG000|Double Therapy|Adverse Event|1|||
146675947|NCT02548650|528992080|FG001|Double Therapy|Adverse Event|1|||
146675948|NCT02548650|528992079|FG000|Double Therapy|Withdrawal by Subject|0|||
146675949|NCT02548650|528992080|FG001|Double Therapy|Withdrawal by Subject|1|||
146675950|NCT02128113|528992082|FG000|Overall Study|Withdrawal by Subject|3|||
146675951|NCT02128113|528992083|FG001|Overall Study|Withdrawal by Subject|1|||
146675952|NCT02128113|528992084|FG002|Overall Study|Withdrawal by Subject|0|||
146675953|NCT02128113|528992082|FG000|Overall Study|Protocol Violation|0|||
146675954|NCT02128113|528992083|FG001|Overall Study|Protocol Violation|1|||
146675955|NCT02128113|528992084|FG002|Overall Study|Protocol Violation|0|||
146675956|NCT02128113|528992082|FG000|Overall Study|Surgery cancelled|0|||
146675957|NCT02128113|528992083|FG001|Overall Study|Surgery cancelled|1|||
146675958|NCT02128113|528992084|FG002|Overall Study|Surgery cancelled|0|||
146675959|NCT02128113|528992082|FG000|Overall Study|Adverse Event|0|||
146675960|NCT02128113|528992083|FG001|Overall Study|Adverse Event|0|||
146675961|NCT02128113|528992084|FG002|Overall Study|Adverse Event|1|||
146675962|NCT00299104|528992085|FG000|Treatment Period|Adverse Event|14|||
146675963|NCT00299104|528992086|FG001|Treatment Period|Adverse Event|9|||
146675964|NCT00299104|528992087|FG002|Treatment Period|Adverse Event|7|||
146675965|NCT00299104|528992085|FG000|Treatment Period|Death|1|||
146675966|NCT00299104|528992086|FG001|Treatment Period|Death|1|||
146675967|NCT00299104|528992087|FG002|Treatment Period|Death|1|||
146675968|NCT00299104|528992085|FG000|Treatment Period|Insufficient therapeutic response|34|||
146675969|NCT00299104|528992086|FG001|Treatment Period|Insufficient therapeutic response|13|||
146675970|NCT00299104|528992087|FG002|Treatment Period|Insufficient therapeutic response|8|||
146675971|NCT00299104|528992085|FG000|Treatment Period|Failure to return|9|||
146675972|NCT00299104|528992086|FG001|Treatment Period|Failure to return|8|||
146675973|NCT00299104|528992087|FG002|Treatment Period|Failure to return|8|||
146675974|NCT00299104|528992085|FG000|Treatment Period|Violation of selection criteria|1|||
146675975|NCT00299104|528992086|FG001|Treatment Period|Violation of selection criteria|2|||
146675976|NCT00299104|528992087|FG002|Treatment Period|Violation of selection criteria|0|||
146675977|NCT00299104|528992085|FG000|Treatment Period|Protocol Violation|1|||
146675978|NCT00299104|528992086|FG001|Treatment Period|Protocol Violation|1|||
146675979|NCT00299104|528992087|FG002|Treatment Period|Protocol Violation|0|||
146675980|NCT00299104|528992085|FG000|Treatment Period|Refused treatment|9|||
146675981|NCT00299104|528992086|FG001|Treatment Period|Refused treatment|2|||
146675982|NCT00299104|528992087|FG002|Treatment Period|Refused treatment|2|||
146675983|NCT00299104|528992085|FG000|Treatment Period|Withdrew consent|14|||
146675984|NCT00299104|528992086|FG001|Treatment Period|Withdrew consent|19|||
146675985|NCT00299104|528992087|FG002|Treatment Period|Withdrew consent|9|||
146675986|NCT00299104|528992085|FG000|Treatment Period|Administrative reasons|106|||
146675987|NCT00299104|528992086|FG001|Treatment Period|Administrative reasons|120|||
146675988|NCT00299104|528992087|FG002|Treatment Period|Administrative reasons|137|||
146675989|NCT00299104|528992085|FG000|Safety Follow-Up (SFU) Period|Death|3|||
146675990|NCT00299104|528992086|FG001|Safety Follow-Up (SFU) Period|Death|2|||
146675991|NCT00299104|528992087|FG002|Safety Follow-Up (SFU) Period|Death|1|||
146675992|NCT00299104|528992085|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
146675993|NCT00299104|528992086|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
146675994|NCT00299104|528992087|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
146675995|NCT00299104|528992085|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
146675996|NCT00299104|528992086|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
146675997|NCT00299104|528992087|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
146675998|NCT00299104|528992085|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
146675999|NCT00299104|528992086|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
146676000|NCT00299104|528992087|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
146676001|NCT00299104|528992085|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
146676002|NCT00299104|528992086|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
146676003|NCT00299104|528992087|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
146676004|NCT00299104|528992085|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
146676005|NCT00299104|528992086|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
146676006|NCT00299104|528992087|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
146676007|NCT00299104|528992085|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
146676008|NCT00299104|528992086|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
146676009|NCT00299104|528992087|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
146676010|NCT00299104|528992085|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
146676011|NCT00299104|528992086|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
146676012|NCT00299104|528992087|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
146676013|NCT05147350|528992099|FG000|Overall Study|Death|2|||
146676014|NCT05147350|528992100|FG001|Overall Study|Death|3|||
146676015|NCT05147350|528992101|FG002|Overall Study|Death|3|||
146676016|NCT05147350|528992102|FG003|Overall Study|Death|2|||
146676017|NCT05147350|528992103|FG004|Overall Study|Death|2|||
146676018|NCT05147350|528992104|FG005|Overall Study|Death|1|||
146676019|NCT05147350|528992105|FG006|Overall Study|Death|1|||
146676020|NCT05147350|528992106|FG007|Overall Study|Death|3|||
146676021|NCT05147350|528992099|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
146676022|NCT05147350|528992100|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
146676023|NCT05147350|528992101|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
146676024|NCT05147350|528992102|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
146676025|NCT05147350|528992103|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
146676026|NCT05147350|528992104|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
146676027|NCT05147350|528992105|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
146676028|NCT05147350|528992106|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
146676029|NCT05147350|528992099|FG000|Overall Study|Withdrawal by Subject|0|||
146676030|NCT05147350|528992100|FG001|Overall Study|Withdrawal by Subject|0|||
146676031|NCT05147350|528992101|FG002|Overall Study|Withdrawal by Subject|3|||
146676032|NCT05147350|528992102|FG003|Overall Study|Withdrawal by Subject|1|||
146676033|NCT05147350|528992103|FG004|Overall Study|Withdrawal by Subject|1|||
146676034|NCT05147350|528992104|FG005|Overall Study|Withdrawal by Subject|0|||
146676035|NCT05147350|528992105|FG006|Overall Study|Withdrawal by Subject|1|||
146676036|NCT05147350|528992106|FG007|Overall Study|Withdrawal by Subject|0|||
146676037|NCT05147350|528992099|FG000|Overall Study|Other Reasons|0|||
146676038|NCT05147350|528992100|FG001|Overall Study|Other Reasons|0|||
146676039|NCT05147350|528992101|FG002|Overall Study|Other Reasons|2|||
146676040|NCT05147350|528992102|FG003|Overall Study|Other Reasons|0|||
146676041|NCT05147350|528992103|FG004|Overall Study|Other Reasons|0|||
146676042|NCT05147350|528992104|FG005|Overall Study|Other Reasons|2|||
146676043|NCT05147350|528992105|FG006|Overall Study|Other Reasons|1|||
146676044|NCT05147350|528992106|FG007|Overall Study|Other Reasons|1|||
146676045|NCT00521014|528992107|FG000|Overall Study|Inevaluable, not treated|1|||
146676046|NCT04390191|528992108|FG000|Overall Study|Withdrawal by Subject|1|||
146676047|NCT04390191|528992109|FG001|Overall Study|Withdrawal by Subject|0|||
146676048|NCT03978832|528992110|FG000|Overall Study|Adverse Event|1|||
146676049|NCT03978832|528992110|FG000|Overall Study|Lost to Follow-up|1|||
146676050|NCT03978832|528992110|FG000|Overall Study|Withdrawal by Subject|6|||
146676051|NCT03978832|528992110|FG000|Overall Study|Physician Decision|2|||
146676052|NCT03978832|528992110|FG000|Overall Study|did not pass screening criteria|44|||
146676053|NCT00003499|528992111|FG000|Overall Study|Not evaluable|8|||
146676054|NCT01256008|528992116|FG000|Overall Study|Lost to Follow-up|6|||
146676055|NCT01256008|528992117|FG001|Overall Study|Lost to Follow-up|4|||
146676056|NCT01256008|528992118|FG002|Overall Study|Lost to Follow-up|11|||
146676057|NCT01256008|528992116|FG000|Overall Study|Withdrawal by Subject|2|||
146676058|NCT01256008|528992117|FG001|Overall Study|Withdrawal by Subject|3|||
146676059|NCT01256008|528992118|FG002|Overall Study|Withdrawal by Subject|10|||
146676060|NCT02244606|528992119|FG000|Overall Study|Adverse Event|0|||
146676061|NCT02244606|528992120|FG001|Overall Study|Adverse Event|1|||
146926410|NCT00064350|529890803|FG001|Randomization|Ineligible or never started treatment|15|||
146676062|NCT02244606|528992121|FG002|Overall Study|Adverse Event|1|||
146676063|NCT02244606|528992122|FG003|Overall Study|Adverse Event|0|||
146676064|NCT02244606|528992119|FG000|Overall Study|Lost to Follow-up|2|||
146676065|NCT02244606|528992120|FG001|Overall Study|Lost to Follow-up|2|||
146676066|NCT02244606|528992121|FG002|Overall Study|Lost to Follow-up|1|||
146676067|NCT02244606|528992122|FG003|Overall Study|Lost to Follow-up|0|||
146676068|NCT02244606|528992119|FG000|Overall Study|Protocol Violation|0|||
146978908|NCT01078623|530085504|FG008|Treatment Period 4|Adverse Event|0|||
146676069|NCT02244606|528992120|FG001|Overall Study|Protocol Violation|0|||
146676070|NCT02244606|528992121|FG002|Overall Study|Protocol Violation|0|||
146676071|NCT02244606|528992122|FG003|Overall Study|Protocol Violation|1|||
146676072|NCT02244606|528992119|FG000|Overall Study|Withdrawal by Subject|1|||
146676073|NCT02244606|528992120|FG001|Overall Study|Withdrawal by Subject|1|||
146676074|NCT02244606|528992121|FG002|Overall Study|Withdrawal by Subject|0|||
146676075|NCT02244606|528992122|FG003|Overall Study|Withdrawal by Subject|0|||
146676076|NCT02244606|528992119|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
146676077|NCT02244606|528992120|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
146676078|NCT02244606|528992121|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
146676079|NCT02244606|528992122|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
146676080|NCT01402492|528992125|FG000|Overall Study|Withdrawal by Subject|17|||
146676081|NCT01402492|528992126|FG001|Overall Study|Withdrawal by Subject|11|||
146676082|NCT01402492|528992127|FG002|Overall Study|Withdrawal by Subject|11|||
146676083|NCT01402492|528992125|FG000|Overall Study|Adverse Event|2|||
146676084|NCT01402492|528992126|FG001|Overall Study|Adverse Event|3|||
146676085|NCT01402492|528992127|FG002|Overall Study|Adverse Event|4|||
146676086|NCT01402492|528992125|FG000|Overall Study|Physician Decision|0|||
146676087|NCT01402492|528992126|FG001|Overall Study|Physician Decision|3|||
146676088|NCT01402492|528992127|FG002|Overall Study|Physician Decision|0|||
146676089|NCT01402492|528992125|FG000|Overall Study|Incarcerated (N=3)|2|||
146676090|NCT01402492|528992126|FG001|Overall Study|Incarcerated (N=3)|0|||
146676091|NCT01402492|528992127|FG002|Overall Study|Incarcerated (N=3)|1|||
146676092|NCT01336764|528992129|FG000|Overall Study|Withdrawal by Subject|5|||
146676093|NCT01336764|528992130|FG001|Overall Study|Withdrawal by Subject|5|||
146676094|NCT05537883|528992131|FG000|Overall Study|revisional surgery|4|||
146676095|NCT05537883|528992132|FG001|Overall Study|revisional surgery|2|||
146926411|NCT00064350|529890804|FG002|Randomization|Ineligible or never started treatment|0|||
146926412|NCT00064350|529890802|FG000|Randomization|Other|5|||
146926413|NCT00064350|529890803|FG001|Randomization|Other|0|||
146926414|NCT00064350|529890804|FG002|Randomization|Other|0|||
146926415|NCT00064350|529890802|FG000|Cross-Over|Adverse Event|0|||
146926416|NCT00064350|529890803|FG001|Cross-Over|Adverse Event|1|||
146926417|NCT00064350|529890804|FG002|Cross-Over|Adverse Event|0|||
146926418|NCT00064350|529890802|FG000|Cross-Over|Death|1|||
146926419|NCT00064350|529890803|FG001|Cross-Over|Death|3|||
146926420|NCT00064350|529890804|FG002|Cross-Over|Death|0|||
146926421|NCT00064350|529890802|FG000|Cross-Over|Withdrawal by Subject|2|||
146926422|NCT00064350|529890803|FG001|Cross-Over|Withdrawal by Subject|2|||
146926423|NCT00064350|529890804|FG002|Cross-Over|Withdrawal by Subject|0|||
146926424|NCT00064350|529890802|FG000|Cross-Over|Ineligible or never started treatment|3|||
146926425|NCT00064350|529890803|FG001|Cross-Over|Ineligible or never started treatment|6|||
146926426|NCT00064350|529890804|FG002|Cross-Over|Ineligible or never started treatment|0|||
146926427|NCT00064350|529890802|FG000|Cross-Over|Other|0|||
146926428|NCT00064350|529890803|FG001|Cross-Over|Other|2|||
146926429|NCT00064350|529890804|FG002|Cross-Over|Other|0|||
146926430|NCT03600714|529890805|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
146926431|NCT01935336|529890808|FG000|Overall Study|Adverse Event|1|||
146926432|NCT01935336|529890809|FG001|Overall Study|Adverse Event|0|||
146676096|NCT05537883|528992131|FG000|Overall Study|surgeries were cancelled|0|||
146676097|NCT05537883|528992132|FG001|Overall Study|surgeries were cancelled|2|||
146676098|NCT05537883|528992131|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
146676099|NCT05537883|528992132|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
146676100|NCT02099708|528992133|FG000|Overall Study|Data Not Available|30|||
146676101|NCT02099708|528992133|FG000|Overall Study|Lost to Follow-up|141|||
146676102|NCT02099708|528992133|FG000|Overall Study|Other|29|||
146676103|NCT01049308|528992134|FG000|Pill Counts|Withdrawal by Subject|83|||
146676104|NCT03845985|528992135|FG000|Overall Study|Lost to Follow-up|2|||
146676105|NCT03845985|528992136|FG001|Overall Study|Lost to Follow-up|1|||
146676106|NCT03845985|528992135|FG000|Overall Study|Physician Decision|1|||
146774304|NCT00311363|529343559|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
146774305|NCT00311363|529343557|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
146926433|NCT01935336|529890810|FG002|Overall Study|Adverse Event|0|||
146926434|NCT01935336|529890811|FG003|Overall Study|Adverse Event|0|||
146926435|NCT01935336|529890808|FG000|Overall Study|Progressive disease|5|||
146926436|NCT01935336|529890809|FG001|Overall Study|Progressive disease|3|||
146676107|NCT03845985|528992136|FG001|Overall Study|Physician Decision|0|||
146676108|NCT03845985|528992135|FG000|Overall Study|Withdrawal by Subject|4|||
146676109|NCT03845985|528992136|FG001|Overall Study|Withdrawal by Subject|1|||
146676110|NCT01318993|528992137|FG000|Overall Study|Adverse Event|53|||
146926437|NCT01935336|529890810|FG002|Overall Study|Progressive disease|47|||
146926438|NCT01935336|529890811|FG003|Overall Study|Progressive disease|66|||
146926439|NCT00592553|529890812|FG000|Overall Study|Protocol Noncompliance|1|||
146676111|NCT01318993|528992137|FG000|Overall Study|Lack of Efficacy|121|||
146676112|NCT01318993|528992137|FG000|Overall Study|Protocol Violation|3|||
146774306|NCT00311363|529343558|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
146926440|NCT00592553|529890813|FG001|Overall Study|Protocol Noncompliance|0|||
146926441|NCT00592553|529890814|FG002|Overall Study|Protocol Noncompliance|0|||
146676113|NCT01318993|528992137|FG000|Overall Study|Protocol based stopping criteria|6|||
146676114|NCT01318993|528992137|FG000|Overall Study|Study closed or terminated|174|||
146676115|NCT01318993|528992137|FG000|Overall Study|Lost to Follow-up|4|||
146676116|NCT01318993|528992137|FG000|Overall Study|Physician Decision|13|||
146676117|NCT01318993|528992137|FG000|Overall Study|Withdrawal by Subject|24|||
146676118|NCT04974697|528992138|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
146676119|NCT04974697|528992138|FG000|Overall Study|Lens discomfort|1|||
146676120|NCT03706456|528992139|FG000|Overall Study|Adverse Event|1|||
146676121|NCT03706456|528992139|FG000|Overall Study|Lack of Efficacy|2|||
146676122|NCT03302234|528992140|FG000|Overall Study|Death|191|||
146676123|NCT03302234|528992141|FG001|Overall Study|Death|192|||
146676124|NCT03302234|528992140|FG000|Overall Study|Withdrawal by Subject|2|||
146676125|NCT03302234|528992141|FG001|Overall Study|Withdrawal by Subject|2|||
146676126|NCT03302234|528992140|FG000|Overall Study|Sponsor Decision|90|||
146676127|NCT03302234|528992141|FG001|Overall Study|Sponsor Decision|89|||
146676128|NCT03302234|528992140|FG000|Overall Study|Laryngeal carcinoma|0|||
146676129|NCT03302234|528992141|FG001|Overall Study|Laryngeal carcinoma|1|||
146676130|NCT03302234|528992140|FG000|Overall Study|Not Reported|1|||
146676131|NCT03302234|528992141|FG001|Overall Study|Not Reported|0|||
146676132|NCT02795832|528992144|FG000|Overall Study|Adverse Event|0|||
146676133|NCT02795832|528992145|FG001|Overall Study|Adverse Event|0|||
146676134|NCT02795832|528992146|FG002|Overall Study|Adverse Event|0|||
146676135|NCT02795832|528992147|FG003|Overall Study|Adverse Event|0|||
146676136|NCT02795832|528992148|FG004|Overall Study|Adverse Event|0|||
146676137|NCT02795832|528992149|FG005|Overall Study|Adverse Event|3|||
146676138|NCT01845831|528992150|FG000|Inpatient Phase|Withdrawal by Subject|1|||
146676139|NCT01845831|528992151|FG001|Inpatient Phase|Withdrawal by Subject|1|||
146676140|NCT01845831|528992152|FG002|Inpatient Phase|Withdrawal by Subject|0|||
146676141|NCT01845831|528992153|FG003|Inpatient Phase|Withdrawal by Subject|0|||
146676142|NCT01845831|528992154|FG004|Inpatient Phase|Withdrawal by Subject|0|||
146676143|NCT00221403|528992155|FG000|Overall Study|Protocol Violation|1|||
146676144|NCT00221403|528992156|FG001|Overall Study|Protocol Violation|0|||
146676145|NCT00221403|528992157|FG002|Overall Study|Protocol Violation|0|||
146676146|NCT00221403|528992155|FG000|Overall Study|Physician Decision|1|||
146676147|NCT00221403|528992156|FG001|Overall Study|Physician Decision|0|||
146676148|NCT00221403|528992157|FG002|Overall Study|Physician Decision|0|||
146676149|NCT00221403|528992155|FG000|Overall Study|Withdrawal by Subject|0|||
146676150|NCT00221403|528992156|FG001|Overall Study|Withdrawal by Subject|3|||
146676151|NCT00221403|528992157|FG002|Overall Study|Withdrawal by Subject|0|||
146676152|NCT00221403|528992155|FG000|Overall Study|Lack of Efficacy|0|||
146676153|NCT00221403|528992156|FG001|Overall Study|Lack of Efficacy|1|||
146676154|NCT00221403|528992157|FG002|Overall Study|Lack of Efficacy|0|||
146676155|NCT00221403|528992155|FG000|Overall Study|Adverse Event|0|||
146676156|NCT00221403|528992156|FG001|Overall Study|Adverse Event|1|||
146676157|NCT00221403|528992157|FG002|Overall Study|Adverse Event|0|||
146676158|NCT02695329|528992158|FG000|Overall Study|Adverse Event|1|||
146676159|NCT02695329|528992159|FG001|Overall Study|Adverse Event|0|||
146676160|NCT02695329|528992158|FG000|Overall Study|Poor X-ray quality for measurement|4|||
146676161|NCT02695329|528992159|FG001|Overall Study|Poor X-ray quality for measurement|5|||
146676162|NCT01348165|528992160|FG000|Overall Study|Adverse Event|0|||
146676163|NCT01348165|528992161|FG001|Overall Study|Adverse Event|0|||
146676164|NCT01348165|528992162|FG002|Overall Study|Adverse Event|0|||
146676165|NCT01348165|528992163|FG003|Overall Study|Adverse Event|0|||
146676166|NCT01348165|528992164|FG004|Overall Study|Adverse Event|0|||
146676167|NCT01348165|528992165|FG005|Overall Study|Adverse Event|0|||
146676168|NCT01348165|528992166|FG006|Overall Study|Adverse Event|1|||
146676169|NCT01929343|528992167|FG000|Overall Study|Physician Decision|0|||
146676170|NCT01929343|528992168|FG001|Overall Study|Physician Decision|2|||
146676171|NCT01929343|528992169|FG002|Overall Study|Physician Decision|0|||
146676172|NCT01929343|528992167|FG000|Overall Study|Withdrawal by Subject|1|||
146676173|NCT01929343|528992168|FG001|Overall Study|Withdrawal by Subject|0|||
146676174|NCT01929343|528992169|FG002|Overall Study|Withdrawal by Subject|0|||
146676175|NCT00638378|528993867|FG000|Overall Study|Death|2|||
146676176|NCT00638378|528993867|FG000|Overall Study|Adverse Event|1|||
146676177|NCT00638378|528993867|FG000|Overall Study|Disease progression|15|||
146676178|NCT00638378|528993867|FG000|Overall Study|Physician Decision|4|||
146676179|NCT03761277|528993875|FG000|Enrollment to Implant|Screen Failure|17|||
146676180|NCT03761277|528993875|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
146676181|NCT03761277|528993875|FG000|Enrollment to Implant|Physician Decision|2|||
146774307|NCT00311363|529343559|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
146774308|NCT00311363|529343557|FG000|24-Week Single-Blind Treatment Period|Death|1|||
146676182|NCT03761277|528993875|FG000|Enrollment to Implant|Site Closure|3|||
146676183|NCT03761277|528993875|FG000|Enrollment to Implant|Sponsor Request|2|||
146676184|NCT03761277|528993875|FG000|Post-Implant to 6 Months|Adverse Event|2|||
146676185|NCT03761277|528993875|FG000|Post-Implant to 6 Months|Death|1|||
146676186|NCT03761277|528993875|FG000|Post-Implant to 6 Months|Site Closure|2|||
146676187|NCT03761277|528993875|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
146676188|NCT03761277|528993875|FG000|6 Months to 12 Months|Physician Decision|2|||
146676189|NCT03761277|528993875|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
146676190|NCT00684307|528993876|FG000|Overall Study|Adverse Event|11|||
146676191|NCT00684307|528993877|FG001|Overall Study|Adverse Event|6|||
146676192|NCT00684307|528993878|FG002|Overall Study|Adverse Event|15|||
146676193|NCT00684307|528993879|FG003|Overall Study|Adverse Event|16|||
146676194|NCT00684307|528993880|FG004|Overall Study|Adverse Event|8|||
146676195|NCT00684307|528993876|FG000|Overall Study|Development of increasing Liver Function|0|||
146676196|NCT00684307|528993877|FG001|Overall Study|Development of increasing Liver Function|2|||
146676197|NCT00684307|528993878|FG002|Overall Study|Development of increasing Liver Function|0|||
146676198|NCT00684307|528993879|FG003|Overall Study|Development of increasing Liver Function|1|||
146676199|NCT00684307|528993880|FG004|Overall Study|Development of increasing Liver Function|0|||
146676200|NCT00684307|528993876|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
146676201|NCT00684307|528993877|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
146676202|NCT00684307|528993878|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
146676203|NCT00684307|528993879|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
146676204|NCT00684307|528993880|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
146676205|NCT00684307|528993876|FG000|Overall Study|Incorrect enrolment or randomization|4|||
146676206|NCT00684307|528993877|FG001|Overall Study|Incorrect enrolment or randomization|0|||
146676207|NCT00684307|528993878|FG002|Overall Study|Incorrect enrolment or randomization|0|||
146676208|NCT00684307|528993879|FG003|Overall Study|Incorrect enrolment or randomization|0|||
146676209|NCT00684307|528993880|FG004|Overall Study|Incorrect enrolment or randomization|0|||
146676210|NCT00684307|528993876|FG000|Overall Study|Interupted IP for more than 7 days|0|||
146676211|NCT00684307|528993877|FG001|Overall Study|Interupted IP for more than 7 days|4|||
146676212|NCT00684307|528993878|FG002|Overall Study|Interupted IP for more than 7 days|1|||
146676213|NCT00684307|528993879|FG003|Overall Study|Interupted IP for more than 7 days|3|||
146676214|NCT00684307|528993880|FG004|Overall Study|Interupted IP for more than 7 days|3|||
146676215|NCT00684307|528993876|FG000|Overall Study|Severe non compliance to protocol|1|||
146676216|NCT00684307|528993877|FG001|Overall Study|Severe non compliance to protocol|0|||
146676217|NCT00684307|528993878|FG002|Overall Study|Severe non compliance to protocol|0|||
146676218|NCT00684307|528993879|FG003|Overall Study|Severe non compliance to protocol|1|||
146676219|NCT00684307|528993880|FG004|Overall Study|Severe non compliance to protocol|2|||
146676220|NCT00684307|528993876|FG000|Overall Study|Participant not willing to continue|7|||
146676221|NCT00684307|528993877|FG001|Overall Study|Participant not willing to continue|10|||
146676222|NCT00684307|528993878|FG002|Overall Study|Participant not willing to continue|11|||
146676223|NCT00684307|528993879|FG003|Overall Study|Participant not willing to continue|5|||
146676224|NCT00684307|528993880|FG004|Overall Study|Participant not willing to continue|8|||
146676225|NCT00684307|528993876|FG000|Overall Study|Criteria from the CSR|0|||
146676226|NCT00684307|528993877|FG001|Overall Study|Criteria from the CSR|0|||
146676227|NCT00684307|528993878|FG002|Overall Study|Criteria from the CSR|1|||
146676228|NCT00684307|528993879|FG003|Overall Study|Criteria from the CSR|3|||
146676229|NCT00684307|528993880|FG004|Overall Study|Criteria from the CSR|3|||
146676230|NCT00543140|528993881|FG000|Overall Study|Lost to Follow-up|33|||
146676231|NCT00543140|528993881|FG000|Overall Study|Withdrawal by Subject|13|||
146676232|NCT00543140|528993881|FG000|Overall Study|Protocol Violation|10|||
146676233|NCT00543140|528993881|FG000|Overall Study|Insufficient weight loss|10|||
146676234|NCT00543140|528993881|FG000|Overall Study|SAE leading to explant of SAGB|3|||
146676235|NCT00543140|528993881|FG000|Overall Study|Death|1|||
146676236|NCT00543140|528993881|FG000|Overall Study|Subject moved|1|||
146676237|NCT00543140|528993881|FG000|Overall Study|Conversion to different procedure|1|||
146676238|NCT00578812|528993882|FG000|Overall Study|Not treated|6|||
146676239|NCT00578812|528993883|FG001|Overall Study|Not treated|7|||
146676240|NCT04532164|528993884|FG000|Overall Study|Adverse Event|1|||
146676241|NCT04532164|528993884|FG000|Overall Study|Protocol Violation|5|||
146676242|NCT04532164|528993884|FG000|Overall Study|Lost to Follow-up|1|||
146676243|NCT04532164|528993884|FG000|Overall Study|Found to be Ineligible|3|||
146676244|NCT04532164|528993884|FG000|Overall Study|Withdrawal by Subject|14|||
146676245|NCT02483520|528993885|FG000|Overall Study|Lost to Follow-up|3|||
146676246|NCT02483520|528993886|FG001|Overall Study|Lost to Follow-up|4|||
146676247|NCT02483520|528993885|FG000|Overall Study|Withdrawal by Subject|4|||
146676248|NCT02483520|528993886|FG001|Overall Study|Withdrawal by Subject|14|||
146676249|NCT02483520|528993885|FG000|Overall Study|Hospitalized|2|||
146676250|NCT02483520|528993886|FG001|Overall Study|Hospitalized|3|||
146926442|NCT01752842|529890815|FG000|Overall Study|Adverse Event|3|||
146676251|NCT02483520|528993885|FG000|Overall Study|Moved to LTC|2|||
146676252|NCT02483520|528993886|FG001|Overall Study|Moved to LTC|3|||
146676253|NCT01104493|528993887|FG000|Overall Study|Lost to Follow-up|0|||
146676254|NCT01104493|528993888|FG001|Overall Study|Lost to Follow-up|2|||
146676255|NCT02269241|528993890|FG000|Overall Study|Lost to Follow-up|269|||
146676256|NCT02269241|528993890|FG000|Overall Study|Withdrawal by Subject|155|||
146676257|NCT02269241|528993890|FG000|Overall Study|Protocol Violation|1|||
146676258|NCT02269241|528993890|FG000|Overall Study|Physician Decision|7|||
146676259|NCT02269241|528993890|FG000|Overall Study|Pregnancy|15|||
146676260|NCT02269241|528993890|FG000|Overall Study|Wish for pregnancy|5|||
146676261|NCT02269241|528993890|FG000|Overall Study|Development of an exclusion criteria|16|||
146676262|NCT02269241|528993890|FG000|Overall Study|Adverse Event|113|||
146676263|NCT02269241|528993890|FG000|Overall Study|At the specific request of the sponsor|20|||
146676264|NCT02269241|528993890|FG000|Overall Study|Several reasons not classified|53|||
146676265|NCT02269241|528993890|FG000|Overall Study|Screening failures|546|||
146676266|NCT03020160|528993891|FG000|Overall Study|Withdrawal by Subject|1|||
146676267|NCT03020160|528993892|FG001|Overall Study|Withdrawal by Subject|0|||
146676268|NCT02270957|528993893|FG000|Overall Study|Lack of Efficacy|2|||
146676269|NCT02270957|528993894|FG001|Overall Study|Lack of Efficacy|4|||
146676270|NCT02270957|528993893|FG000|Overall Study|Adverse Event|2|||
146676271|NCT02270957|528993894|FG001|Overall Study|Adverse Event|0|||
146676272|NCT01513473|528993895|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
146676273|NCT01513473|528993896|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
146676274|NCT01513473|528993895|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
146676275|NCT01513473|528993896|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
146676276|NCT01513473|528993895|FG000|Main Trial (26 Weeks)|Unclassified|0|||
146676277|NCT01513473|528993896|FG001|Main Trial (26 Weeks)|Unclassified|2|||
146676278|NCT01513473|528993895|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
146676279|NCT01513473|528993896|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
146676280|NCT01513473|528993895|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
146676281|NCT01513473|528993896|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
146676282|NCT01218204|528993898|FG000|Part B Washout|Adverse Event|0|||
146676283|NCT01218204|528993899|FG001|Part B Washout|Adverse Event|1|||
146676284|NCT01218204|528993900|FG002|Part B Washout|Adverse Event|0|||
146676285|NCT01218204|528993901|FG003|Part B Washout|Adverse Event|0|||
146676286|NCT01218204|528993898|FG000|Part B Washout|Lost to Follow-up|0|||
146676287|NCT01218204|528993899|FG001|Part B Washout|Lost to Follow-up|2|||
146676288|NCT01218204|528993900|FG002|Part B Washout|Lost to Follow-up|0|||
146676289|NCT01218204|528993901|FG003|Part B Washout|Lost to Follow-up|0|||
146676290|NCT01218204|528993898|FG000|Part B Washout|Physician Decision|0|||
146676291|NCT01218204|528993899|FG001|Part B Washout|Physician Decision|14|||
146676292|NCT01218204|528993900|FG002|Part B Washout|Physician Decision|0|||
146676293|NCT01218204|528993901|FG003|Part B Washout|Physician Decision|0|||
146676294|NCT01218204|528993898|FG000|Part B Washout|Withdrawal by Subject|0|||
146676295|NCT01218204|528993899|FG001|Part B Washout|Withdrawal by Subject|14|||
146676296|NCT01218204|528993900|FG002|Part B Washout|Withdrawal by Subject|0|||
146676297|NCT01218204|528993901|FG003|Part B Washout|Withdrawal by Subject|0|||
146676298|NCT01218204|528993898|FG000|Part B Washout|Reached defined stopping criteria|0|||
146676299|NCT01218204|528993899|FG001|Part B Washout|Reached defined stopping criteria|2|||
146676300|NCT01218204|528993900|FG002|Part B Washout|Reached defined stopping criteria|0|||
146676301|NCT01218204|528993901|FG003|Part B Washout|Reached defined stopping criteria|0|||
146676302|NCT01218204|528993898|FG000|Part B Washout|Did not meet continuation criteria|0|||
146676303|NCT01218204|528993899|FG001|Part B Washout|Did not meet continuation criteria|112|||
146676304|NCT01218204|528993900|FG002|Part B Washout|Did not meet continuation criteria|0|||
146676305|NCT01218204|528993901|FG003|Part B Washout|Did not meet continuation criteria|0|||
146676306|NCT01218204|528993898|FG000|Part B Run-in|Adverse Event|0|||
146676307|NCT01218204|528993899|FG001|Part B Run-in|Adverse Event|0|||
146676308|NCT01218204|528993900|FG002|Part B Run-in|Adverse Event|1|||
146676309|NCT01218204|528993901|FG003|Part B Run-in|Adverse Event|0|||
146676310|NCT01218204|528993898|FG000|Part B Run-in|Protocol Violation|0|||
146676311|NCT01218204|528993899|FG001|Part B Run-in|Protocol Violation|0|||
146676312|NCT01218204|528993900|FG002|Part B Run-in|Protocol Violation|2|||
146676313|NCT01218204|528993901|FG003|Part B Run-in|Protocol Violation|0|||
146676314|NCT01218204|528993898|FG000|Part B Run-in|Withdrawal by Subject|0|||
146676315|NCT01218204|528993899|FG001|Part B Run-in|Withdrawal by Subject|0|||
146676316|NCT01218204|528993900|FG002|Part B Run-in|Withdrawal by Subject|3|||
146676317|NCT01218204|528993901|FG003|Part B Run-in|Withdrawal by Subject|0|||
146676318|NCT01218204|528993898|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
146676319|NCT01218204|528993899|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
146676320|NCT01218204|528993900|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
146676321|NCT01218204|528993901|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
146676322|NCT01218204|528993898|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
146676323|NCT01218204|528993899|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
146676324|NCT01218204|528993900|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
146676325|NCT01218204|528993901|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
146676326|NCT00743340|528993902|FG000|Overall Study|Study medication non-compliance|1|||
146676327|NCT00743340|528993902|FG000|Overall Study|Lost to Follow-up|1|||
146676328|NCT00743340|528993902|FG000|Overall Study|Withdrawal from the Study|5|||
146676329|NCT00743340|528993902|FG000|Overall Study|Protocol Violation|1|||
146676330|NCT00743340|528993902|FG000|Overall Study|Virologic failure|8|||
146676331|NCT00743340|528993902|FG000|Overall Study|Pregnancy|1|||
146676332|NCT00743340|528993902|FG000|Overall Study|Rolled over to other Gilead Study|23|||
146676333|NCT00743340|528993902|FG000|Overall Study|Participant Relocated|1|||
146676334|NCT02321800|528993903|FG000|Overall Study|Withdrawal by Subject|3|||
146676335|NCT02321800|528993904|FG001|Overall Study|Withdrawal by Subject|3|||
146676336|NCT02321800|528993903|FG000|Overall Study|Death|1|||
146676337|NCT02321800|528993904|FG001|Overall Study|Death|0|||
146676338|NCT02321800|528993903|FG000|Overall Study|Protocol Violation|1|||
146676339|NCT02321800|528993904|FG001|Overall Study|Protocol Violation|0|||
146676340|NCT02321800|528993903|FG000|Overall Study|Lost to Follow-up|10|||
146676341|NCT02321800|528993904|FG001|Overall Study|Lost to Follow-up|4|||
146676342|NCT02321800|528993903|FG000|Overall Study|Adverse Event|2|||
146676343|NCT02321800|528993904|FG001|Overall Study|Adverse Event|3|||
146676344|NCT02321800|528993903|FG000|Overall Study|Other, Miscellaneous|3|||
146676345|NCT02321800|528993904|FG001|Overall Study|Other, Miscellaneous|1|||
146676346|NCT00982878|528993905|FG000|Overall Study|Physician Decision|1|||
146676347|NCT01051323|528993910|FG000|Overall Study|Discontinuation of treatment|103|||
146676348|NCT01051323|528993910|FG000|Overall Study|Transplantation|28|||
146676349|NCT01051323|528993910|FG000|Overall Study|Dialysis dependency|22|||
146676350|NCT01051323|528993910|FG000|Overall Study|Withdrawal by Subject|13|||
146676351|NCT01051323|528993910|FG000|Overall Study|Lost to Follow-up|31|||
146676352|NCT01051323|528993910|FG000|Overall Study|Death|129|||
146676353|NCT01051323|528993910|FG000|Overall Study|Hospitalization|28|||
146676354|NCT01051323|528993910|FG000|Overall Study|Other|148|||
146676355|NCT01051323|528993910|FG000|Overall Study|Missing|37|||
146676356|NCT01626391|528993911|FG000|Overall Study|Physician Decision|1|||
146676357|NCT01626391|528993912|FG001|Overall Study|Physician Decision|0|||
146676358|NCT01626391|528993911|FG000|Overall Study|Withdrawal by Subject|1|||
146676359|NCT01626391|528993912|FG001|Overall Study|Withdrawal by Subject|0|||
146676360|NCT02573311|528993913|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
146676361|NCT02573311|528993914|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
146676362|NCT02573311|528993913|FG000|Disposition for Part 2|Physician Decision|25|||
146676363|NCT02573311|528993914|FG001|Disposition for Part 2|Physician Decision|7|||
146676364|NCT02573311|528993913|FG000|Disposition for Part 2|Adverse Event|36|||
146676365|NCT02573311|528993914|FG001|Disposition for Part 2|Adverse Event|5|||
146676366|NCT02573311|528993913|FG000|Disposition for Part 2|Lost to Follow-up|76|||
146676367|NCT02573311|528993914|FG001|Disposition for Part 2|Lost to Follow-up|7|||
146676368|NCT02573311|528993913|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
146676369|NCT02573311|528993914|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
146676370|NCT02573311|528993913|FG000|Disposition for Part 2|Investigator decision|0|||
146676371|NCT02573311|528993914|FG001|Disposition for Part 2|Investigator decision|1|||
146676372|NCT02573311|528993913|FG000|Disposition for Part 2|Other than specified above|13|||
146676373|NCT02573311|528993914|FG001|Disposition for Part 2|Other than specified above|3|||
146676374|NCT05229406|528993916|FG000|Overall Study|Withdrawal by Subject|1|||
146676375|NCT05229406|528993917|FG001|Overall Study|Withdrawal by Subject|2|||
146676376|NCT01697566|528993918|FG000|Overall Study|Withdrawal by Subject|0|||
146676377|NCT01697566|528993919|FG001|Overall Study|Withdrawal by Subject|0|||
146676378|NCT01697566|528993920|FG002|Overall Study|Withdrawal by Subject|1|||
146676379|NCT01697566|528993921|FG003|Overall Study|Withdrawal by Subject|1|||
146676380|NCT01697566|528993918|FG000|Overall Study|Final biopsy not obtained|0|||
146676381|NCT01697566|528993919|FG001|Overall Study|Final biopsy not obtained|0|||
146676382|NCT01697566|528993920|FG002|Overall Study|Final biopsy not obtained|1|||
146676383|NCT01697566|528993921|FG003|Overall Study|Final biopsy not obtained|0|||
146676384|NCT00036270|528993924|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
146676385|NCT00036270|528993925|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
146676386|NCT00036270|528993924|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
146676387|NCT00036270|528993925|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
146676388|NCT00036270|528993924|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
146676389|NCT00036270|528993925|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
146676390|NCT00036270|528993924|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
146676391|NCT00036270|528993925|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
146676392|NCT00036270|528993924|FG000|Study Treatment to 5 Year Report|Other|277|||
146676393|NCT00036270|528993925|FG001|Study Treatment to 5 Year Report|Other|288|||
146676394|NCT00036270|528993924|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
146676395|NCT00036270|528993925|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
146676396|NCT00036270|528993924|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
146676397|NCT00036270|528993925|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
146676398|NCT00036270|528993924|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
146676399|NCT00036270|528993925|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
146676400|NCT00036270|528993924|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
146676401|NCT00036270|528993925|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
146676402|NCT00036270|528993924|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
146676403|NCT00036270|528993925|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
146676404|NCT00036270|528993924|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
146676405|NCT00036270|528993925|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
146676406|NCT02516163|528993926|FG000|Overall Study|Withdrawal by Subject|1|||
146676407|NCT02516163|528993926|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
146676408|NCT02516163|528993926|FG000|Overall Study|Unfit/delay in surgery|3|||
146676409|NCT02516163|528993926|FG000|Overall Study|Use of incorrect measurement technique|5|||
146676410|NCT02516163|528993926|FG000|Overall Study|Data not recorded|2|||
146676411|NCT02516163|528993926|FG000|Overall Study|MRI contraindication exclusion|6|||
146676412|NCT01370356|528993927|FG000|Overall Study|Death|1|||
146676413|NCT01370356|528993928|FG001|Overall Study|Death|0|||
146676414|NCT01370356|528993927|FG000|Overall Study|Lack of Efficacy|6|||
146676415|NCT01370356|528993928|FG001|Overall Study|Lack of Efficacy|28|||
146676416|NCT01370356|528993927|FG000|Overall Study|Lost to Follow-up|76|||
146676417|NCT01370356|528993928|FG001|Overall Study|Lost to Follow-up|81|||
146676418|NCT01370356|528993927|FG000|Overall Study|Withdrawal by Subject|54|||
146676419|NCT01370356|528993928|FG001|Overall Study|Withdrawal by Subject|59|||
146676420|NCT01370356|528993927|FG000|Overall Study|Reason not specified|39|||
146676421|NCT01370356|528993928|FG001|Overall Study|Reason not specified|43|||
146676422|NCT01370356|528993927|FG000|Overall Study|Protocol Violation|3|||
146676423|NCT01370356|528993928|FG001|Overall Study|Protocol Violation|3|||
146676424|NCT01370356|528993927|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
146676425|NCT01370356|528993928|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
146676426|NCT01370356|528993927|FG000|Overall Study|AE Not Related to Study Drug|1|||
146676427|NCT01370356|528993928|FG001|Overall Study|AE Not Related to Study Drug|4|||
146676428|NCT01658072|528993929|FG000|Overall Study|Protocol Violation|4|||
146676429|NCT01658072|528993930|FG001|Overall Study|Protocol Violation|2|||
146676430|NCT00040664|528993933|FG000|Overall Study|Adverse Event|12|||
146676431|NCT00040664|528993934|FG001|Overall Study|Adverse Event|3|||
146676432|NCT00040664|528993935|FG002|Overall Study|Adverse Event|2|||
146676433|NCT00040664|528993936|FG003|Overall Study|Adverse Event|7|||
146676434|NCT00040664|528993933|FG000|Overall Study|Lack of Efficacy|9|||
146676435|NCT00040664|528993934|FG001|Overall Study|Lack of Efficacy|2|||
146676436|NCT00040664|528993935|FG002|Overall Study|Lack of Efficacy|3|||
146676437|NCT00040664|528993936|FG003|Overall Study|Lack of Efficacy|4|||
146676438|NCT00040664|528993933|FG000|Overall Study|Insufficient CD4 response|1|||
146676439|NCT00040664|528993934|FG001|Overall Study|Insufficient CD4 response|0|||
146676440|NCT00040664|528993935|FG002|Overall Study|Insufficient CD4 response|1|||
146676441|NCT00040664|528993936|FG003|Overall Study|Insufficient CD4 response|0|||
146676442|NCT00040664|528993933|FG000|Overall Study|Lost to Follow-up|4|||
146676443|NCT00040664|528993934|FG001|Overall Study|Lost to Follow-up|2|||
146676444|NCT00040664|528993935|FG002|Overall Study|Lost to Follow-up|0|||
146676445|NCT00040664|528993936|FG003|Overall Study|Lost to Follow-up|2|||
146676446|NCT00040664|528993933|FG000|Overall Study|Protocol Violation|2|||
146676447|NCT00040664|528993934|FG001|Overall Study|Protocol Violation|1|||
146676448|NCT00040664|528993935|FG002|Overall Study|Protocol Violation|0|||
146676449|NCT00040664|528993936|FG003|Overall Study|Protocol Violation|1|||
146676450|NCT00040664|528993933|FG000|Overall Study|Withdrawal by Subject|7|||
146676451|NCT00040664|528993934|FG001|Overall Study|Withdrawal by Subject|0|||
146676452|NCT00040664|528993935|FG002|Overall Study|Withdrawal by Subject|3|||
146676453|NCT00040664|528993936|FG003|Overall Study|Withdrawal by Subject|4|||
146676454|NCT00040664|528993933|FG000|Overall Study|Pregnancy|3|||
146676455|NCT00040664|528993934|FG001|Overall Study|Pregnancy|0|||
146676456|NCT00040664|528993935|FG002|Overall Study|Pregnancy|0|||
146676457|NCT00040664|528993936|FG003|Overall Study|Pregnancy|3|||
146676458|NCT00040664|528993933|FG000|Overall Study|Medication adherence/compliance problems|8|||
146676459|NCT00040664|528993934|FG001|Overall Study|Medication adherence/compliance problems|2|||
146676460|NCT00040664|528993935|FG002|Overall Study|Medication adherence/compliance problems|1|||
146676461|NCT00040664|528993936|FG003|Overall Study|Medication adherence/compliance problems|5|||
146676462|NCT00040664|528993933|FG000|Overall Study|Poor taste|2|||
146676463|NCT00040664|528993934|FG001|Overall Study|Poor taste|0|||
146676464|NCT00040664|528993935|FG002|Overall Study|Poor taste|2|||
146676465|NCT00040664|528993936|FG003|Overall Study|Poor taste|0|||
146676466|NCT00040664|528993933|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
146676467|NCT00040664|528993934|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
146676468|NCT00040664|528993935|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
146676469|NCT00040664|528993936|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
146676470|NCT00040664|528993933|FG000|Overall Study|Change of formulation|2|||
146676471|NCT00040664|528993934|FG001|Overall Study|Change of formulation|2|||
146676472|NCT00040664|528993935|FG002|Overall Study|Change of formulation|0|||
146676473|NCT00040664|528993936|FG003|Overall Study|Change of formulation|0|||
146676474|NCT00040664|528993933|FG000|Overall Study|Non-viability of oral suspension|1|||
146676475|NCT00040664|528993934|FG001|Overall Study|Non-viability of oral suspension|0|||
146676476|NCT00040664|528993935|FG002|Overall Study|Non-viability of oral suspension|1|||
146676477|NCT00040664|528993936|FG003|Overall Study|Non-viability of oral suspension|0|||
146676478|NCT01709162|528993937|FG000|Overall Study|Disease progression|3|||
146676479|NCT01709162|528993938|FG001|Overall Study|Disease progression|3|||
146676480|NCT01709162|528993937|FG000|Overall Study|Study drug toxicity|2|||
146676481|NCT01709162|528993938|FG001|Overall Study|Study drug toxicity|0|||
146676482|NCT01709162|528993937|FG000|Overall Study|Administrative reason by sponsor|0|||
146676483|NCT01709162|528993938|FG001|Overall Study|Administrative reason by sponsor|1|||
146676484|NCT01709162|528993937|FG000|Overall Study|Other|1|||
146676485|NCT01709162|528993938|FG001|Overall Study|Other|0|||
146676486|NCT01709162|528993937|FG000|Overall Study|Withdrawal by Subject|0|||
146676487|NCT01709162|528993938|FG001|Overall Study|Withdrawal by Subject|1|||
146676488|NCT01874054|528993939|FG000|Overall Study|Withdrawal by Subject|3|||
146676489|NCT01874054|528993939|FG000|Overall Study|Study Termination by Sponsor|42|||
146676490|NCT01874054|528993939|FG000|Overall Study|Lost to Follow-up|5|||
146676491|NCT01874054|528993939|FG000|Overall Study|Death|5|||
146676492|NCT01233258|528993942|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
146676493|NCT01233258|528993943|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
146676494|NCT01233258|528993944|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
146676495|NCT01233258|528993945|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
146676496|NCT01233258|528993946|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
146676497|NCT01233258|528993947|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
146676498|NCT01233258|528993942|FG000|First Intervention (6 Months)|Protocol Violation|0|||
146676499|NCT01233258|528993943|FG001|First Intervention (6 Months)|Protocol Violation|0|||
146676500|NCT01233258|528993944|FG002|First Intervention (6 Months)|Protocol Violation|1|||
146676501|NCT01233258|528993945|FG003|First Intervention (6 Months)|Protocol Violation|0|||
146676502|NCT01233258|528993946|FG004|First Intervention (6 Months)|Protocol Violation|0|||
146676503|NCT01233258|528993947|FG005|First Intervention (6 Months)|Protocol Violation|0|||
146676504|NCT01233258|528993942|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
146676505|NCT01233258|528993943|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
146676506|NCT01233258|528993944|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
146676507|NCT01233258|528993945|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
146676508|NCT01233258|528993946|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
146676509|NCT01233258|528993947|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
146676510|NCT00799422|528993951|FG000|First Week of Wear|Lost to Follow-up|0|||
146676511|NCT00799422|528993952|FG001|First Week of Wear|Lost to Follow-up|0|||
146676512|NCT00799422|528993953|FG002|First Week of Wear|Lost to Follow-up|1|||
146676513|NCT00799422|528993954|FG003|First Week of Wear|Lost to Follow-up|0|||
146676514|NCT00799422|528993955|FG004|First Week of Wear|Lost to Follow-up|0|||
146676515|NCT00799422|528993956|FG005|First Week of Wear|Lost to Follow-up|0|||
146676516|NCT00799422|528993951|FG000|First Week of Wear|Adverse Event|0|||
146676517|NCT00799422|528993952|FG001|First Week of Wear|Adverse Event|0|||
146676518|NCT00799422|528993953|FG002|First Week of Wear|Adverse Event|0|||
146676519|NCT00799422|528993954|FG003|First Week of Wear|Adverse Event|1|||
146676520|NCT00799422|528993955|FG004|First Week of Wear|Adverse Event|0|||
146676521|NCT00799422|528993956|FG005|First Week of Wear|Adverse Event|0|||
146676522|NCT00880009|528993957|FG000|Overall Study|Study terminated by sponsor|14|||
146676523|NCT00880009|528993957|FG000|Overall Study|Withdrawal by Subject|1|||
146676524|NCT00880009|528993957|FG000|Overall Study|Protocol Violation|1|||
146676525|NCT04112784|528993961|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
146676526|NCT04112784|528993961|FG000|Overall Study|Screen Failures|4|||
146676527|NCT02010775|528993963|FG000|Overall Study|Adverse Event|0|||
146676528|NCT02010775|528993964|FG001|Overall Study|Adverse Event|0|||
146676529|NCT02010775|528993965|FG002|Overall Study|Adverse Event|0|||
146676530|NCT02010775|528993966|FG003|Overall Study|Adverse Event|0|||
146676531|NCT02010775|528993967|FG004|Overall Study|Adverse Event|1|||
146676532|NCT02010775|528993963|FG000|Overall Study|Pregnancy|0|||
146676533|NCT02010775|528993964|FG001|Overall Study|Pregnancy|0|||
146676534|NCT02010775|528993965|FG002|Overall Study|Pregnancy|2|||
146676535|NCT02010775|528993966|FG003|Overall Study|Pregnancy|0|||
146676536|NCT02010775|528993967|FG004|Overall Study|Pregnancy|0|||
146676537|NCT02010775|528993963|FG000|Overall Study|Lost to Follow-up|2|||
146676538|NCT02010775|528993964|FG001|Overall Study|Lost to Follow-up|0|||
146676539|NCT02010775|528993965|FG002|Overall Study|Lost to Follow-up|0|||
146676540|NCT02010775|528993966|FG003|Overall Study|Lost to Follow-up|1|||
146676541|NCT02010775|528993967|FG004|Overall Study|Lost to Follow-up|1|||
146676542|NCT02010775|528993963|FG000|Overall Study|Personal Reasons|3|||
146676543|NCT02010775|528993964|FG001|Overall Study|Personal Reasons|3|||
146676544|NCT02010775|528993965|FG002|Overall Study|Personal Reasons|1|||
146676545|NCT02010775|528993966|FG003|Overall Study|Personal Reasons|2|||
146676546|NCT02010775|528993967|FG004|Overall Study|Personal Reasons|4|||
146676547|NCT00256750|528993968|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
146676548|NCT00256750|528993969|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
146676549|NCT00256750|528993970|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
146676550|NCT00256750|528993968|FG000|Transplanted Pre-Treatment|Other|2|||
146676551|NCT00256750|528993969|FG001|Transplanted Pre-Treatment|Other|0|||
146676552|NCT00256750|528993970|FG002|Transplanted Pre-Treatment|Other|0|||
146676553|NCT00256750|528993968|FG000|Transplanted Pre-Treatment|Death|1|||
146676554|NCT00256750|528993969|FG001|Transplanted Pre-Treatment|Death|0|||
146676555|NCT00256750|528993970|FG002|Transplanted Pre-Treatment|Death|0|||
146676556|NCT00256750|528993968|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
146676557|NCT00256750|528993969|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
146676558|NCT00256750|528993970|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
146676559|NCT00256750|528993968|FG000|Post-Transplant Treated (12 Months)|Death|3|||
146676560|NCT00256750|528993969|FG001|Post-Transplant Treated (12 Months)|Death|2|||
146676561|NCT00256750|528993970|FG002|Post-Transplant Treated (12 Months)|Death|4|||
146926443|NCT01752842|529890816|FG001|Overall Study|Adverse Event|0|||
146676562|NCT00256750|528993968|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
146676563|NCT00256750|528993969|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
146676564|NCT00256750|528993970|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
146676565|NCT00256750|528993968|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
146676566|NCT00256750|528993969|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
146676567|NCT00256750|528993970|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
146676568|NCT00256750|528993968|FG000|Post-Transplant Treated (12 Months)|Other|5|||
146676569|NCT00256750|528993969|FG001|Post-Transplant Treated (12 Months)|Other|4|||
146676570|NCT00256750|528993970|FG002|Post-Transplant Treated (12 Months)|Other|2|||
146676571|NCT00256750|528993968|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
146676572|NCT00256750|528993969|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
146676573|NCT00256750|528993970|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
146676574|NCT00256750|528993968|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
146676575|NCT00256750|528993969|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
146676576|NCT00256750|528993970|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
146676577|NCT00256750|528993968|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
146676578|NCT00256750|528993969|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
146676579|NCT00256750|528993970|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
146676580|NCT00256750|528993968|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
146676581|NCT00256750|528993969|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
146676582|NCT00256750|528993970|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
146676583|NCT00256750|528993968|FG000|Post-Transplant Treated (24 Months)|Death|3|||
146676584|NCT00256750|528993969|FG001|Post-Transplant Treated (24 Months)|Death|0|||
146676585|NCT00256750|528993970|FG002|Post-Transplant Treated (24 Months)|Death|0|||
146676586|NCT00256750|528993968|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
146676587|NCT00256750|528993969|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
146676588|NCT00256750|528993970|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
146676589|NCT00256750|528993968|FG000|Post-Transplant Treated (24 Months)|Other|2|||
146676590|NCT00256750|528993969|FG001|Post-Transplant Treated (24 Months)|Other|0|||
146676591|NCT00256750|528993970|FG002|Post-Transplant Treated (24 Months)|Other|1|||
146676592|NCT00256750|528993968|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
146676593|NCT00256750|528993969|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
146676594|NCT00256750|528993970|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
146676595|NCT00256750|528993968|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
146676596|NCT00256750|528993969|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
146676597|NCT00256750|528993970|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
146676598|NCT00256750|528993968|FG000|Post-Transplant Treated (36 Months)|Death|0|||
146676599|NCT00256750|528993969|FG001|Post-Transplant Treated (36 Months)|Death|2|||
146676600|NCT00256750|528993970|FG002|Post-Transplant Treated (36 Months)|Death|1|||
146676601|NCT00256750|528993968|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
146676602|NCT00256750|528993969|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
146676603|NCT00256750|528993970|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
146676604|NCT00256750|528993968|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
146676605|NCT00256750|528993969|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
146676606|NCT00256750|528993970|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
146676607|NCT00256750|528993968|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
146676608|NCT00256750|528993969|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
146676609|NCT00256750|528993970|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
146676610|NCT00256750|528993968|FG000|Post-Transplant Treated (36 Months)|Other|0|||
146676611|NCT00256750|528993969|FG001|Post-Transplant Treated (36 Months)|Other|1|||
146676612|NCT00256750|528993970|FG002|Post-Transplant Treated (36 Months)|Other|1|||
146676613|NCT00256750|528993968|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
146676614|NCT00256750|528993969|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
146676615|NCT00256750|528993970|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
146676616|NCT00256750|528993968|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
146676617|NCT00256750|528993969|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
146676618|NCT00256750|528993970|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
146676619|NCT00256750|528993968|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
146676620|NCT00256750|528993969|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
146676621|NCT00256750|528993970|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
146676622|NCT00256750|528993968|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
146676623|NCT00256750|528993969|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
146676624|NCT00256750|528993970|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
146676625|NCT00256750|528993968|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
146676626|NCT00256750|528993969|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
146676627|NCT00256750|528993970|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
146676628|NCT00256750|528993968|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
146676629|NCT00256750|528993969|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
146676630|NCT00256750|528993970|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
146676631|NCT00256750|528993968|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
146676632|NCT00256750|528993969|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
146676633|NCT00256750|528993970|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
146676634|NCT00256750|528993968|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
146676635|NCT00256750|528993969|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
146676636|NCT00256750|528993970|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
146676637|NCT00256750|528993968|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
146676638|NCT00256750|528993969|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
146676639|NCT00256750|528993970|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
146676640|NCT04659161|528993971|FG000|Overall Study|Adverse Event|10|||
146676641|NCT04659161|528993972|FG001|Overall Study|Adverse Event|6|||
146676642|NCT04659161|528993971|FG000|Overall Study|Withdrawal by Subject|13|||
146676643|NCT04659161|528993972|FG001|Overall Study|Withdrawal by Subject|12|||
146676644|NCT04659161|528993971|FG000|Overall Study|Other|9|||
146676645|NCT04659161|528993972|FG001|Overall Study|Other|8|||
146676646|NCT02197130|528993976|FG000|Overall Study|Adverse Event|13|||
146676647|NCT02197130|528993977|FG001|Overall Study|Adverse Event|4|||
146676648|NCT02197130|528993978|FG002|Overall Study|Adverse Event|23|||
146676649|NCT02197130|528993976|FG000|Overall Study|Death|0|||
146676650|NCT02197130|528993977|FG001|Overall Study|Death|1|||
146676651|NCT02197130|528993978|FG002|Overall Study|Death|0|||
146676652|NCT02197130|528993976|FG000|Overall Study|Lost to Follow-up|2|||
146676653|NCT02197130|528993977|FG001|Overall Study|Lost to Follow-up|0|||
146676654|NCT02197130|528993978|FG002|Overall Study|Lost to Follow-up|1|||
146676655|NCT02197130|528993976|FG000|Overall Study|Does not meet entrance criteria|0|||
146676656|NCT02197130|528993977|FG001|Overall Study|Does not meet entrance criteria|0|||
146676657|NCT02197130|528993978|FG002|Overall Study|Does not meet entrance criteria|1|||
146676658|NCT02197130|528993976|FG000|Overall Study|Withdrawal by Subject|0|||
146676659|NCT02197130|528993977|FG001|Overall Study|Withdrawal by Subject|3|||
146676660|NCT02197130|528993978|FG002|Overall Study|Withdrawal by Subject|4|||
146676661|NCT02197130|528993976|FG000|Overall Study|Other|1|||
146676662|NCT02197130|528993977|FG001|Overall Study|Other|0|||
146676663|NCT02197130|528993978|FG002|Overall Study|Other|3|||
146676664|NCT02615145|528993979|FG000|Overall Study|Did Not Start Treatment|0|||
146676665|NCT02615145|528993980|FG001|Overall Study|Did Not Start Treatment|0|||
146676666|NCT02615145|528993981|FG002|Overall Study|Did Not Start Treatment|1|||
146676667|NCT02615145|528993982|FG003|Overall Study|Did Not Start Treatment|1|||
146676668|NCT02615145|528993979|FG000|Overall Study|Failure to Return|20|||
146676669|NCT02615145|528993980|FG001|Overall Study|Failure to Return|10|||
146676670|NCT02615145|528993981|FG002|Overall Study|Failure to Return|7|||
146676671|NCT02615145|528993982|FG003|Overall Study|Failure to Return|0|||
146676672|NCT02615145|528993979|FG000|Overall Study|Death|2|||
146676673|NCT02615145|528993980|FG001|Overall Study|Death|3|||
146676674|NCT02615145|528993981|FG002|Overall Study|Death|0|||
146676675|NCT02615145|528993982|FG003|Overall Study|Death|0|||
146676676|NCT02615145|528993979|FG000|Overall Study|Other, Not Specified|5|||
146676677|NCT02615145|528993980|FG001|Overall Study|Other, Not Specified|2|||
146676678|NCT02615145|528993981|FG002|Overall Study|Other, Not Specified|0|||
146676679|NCT02615145|528993982|FG003|Overall Study|Other, Not Specified|0|||
146676680|NCT01269463|528993991|FG000|First Intervention|Withdrawal by Subject|1|||
146676681|NCT01269463|528993992|FG001|First Intervention|Withdrawal by Subject|0|||
146676682|NCT01269463|528993991|FG000|First Intervention|Adverse Event|1|||
146676683|NCT01269463|528993992|FG001|First Intervention|Adverse Event|0|||
146676684|NCT01269463|528993991|FG000|First Intervention|Lack of Efficacy|0|||
146676685|NCT01269463|528993992|FG001|First Intervention|Lack of Efficacy|1|||
146676686|NCT01269463|528993991|FG000|First Intervention|Physician Decision|0|||
146676687|NCT01269463|528993992|FG001|First Intervention|Physician Decision|1|||
146676688|NCT04404361|528993994|FG000|Overall Study|Death|12|||
146676689|NCT04404361|528993995|FG001|Overall Study|Death|12|||
146676690|NCT04404361|528993994|FG000|Overall Study|Withdrawal by Subject|13|||
146676691|NCT04404361|528993995|FG001|Overall Study|Withdrawal by Subject|5|||
146676692|NCT04404361|528993994|FG000|Overall Study|Lost to Follow-up|6|||
146676693|NCT04404361|528993995|FG001|Overall Study|Lost to Follow-up|3|||
146676694|NCT04404361|528993994|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
146676695|NCT04404361|528993995|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
146676696|NCT00558558|528993996|FG000|Overall Study|Unable to swallow|1|||
146676697|NCT00558558|528993996|FG000|Overall Study|Withdrawal by Subject|1|||
146676698|NCT00558558|528993996|FG000|Overall Study|Lack of Efficacy|4|||
146926444|NCT01752842|529890815|FG000|Overall Study|Withdrawal by Subject|0|||
146926445|NCT01752842|529890816|FG001|Overall Study|Withdrawal by Subject|2|||
146926446|NCT01208038|529890820|FG000|Overall Study|Withdrawal by Subject|1|||
146926447|NCT03260205|529890821|FG000|Overall Study|Adverse Event|2|||
146926448|NCT03260205|529890822|FG001|Overall Study|Adverse Event|0|||
146926449|NCT03260205|529890823|FG002|Overall Study|Adverse Event|2|||
146676699|NCT02549937|528993998|FG000|Overall Study|Death|0|||
146676700|NCT02549937|528993999|FG001|Overall Study|Death|1|||
146676701|NCT02549937|528994000|FG002|Overall Study|Death|0|||
146676702|NCT02549937|528994001|FG003|Overall Study|Death|1|||
146676703|NCT02549937|528994002|FG004|Overall Study|Death|0|||
146676704|NCT02549937|528994003|FG005|Overall Study|Death|8|||
146676705|NCT02549937|528994004|FG006|Overall Study|Death|0|||
146676706|NCT02549937|528994005|FG007|Overall Study|Death|0|||
146676707|NCT02549937|528994006|FG008|Overall Study|Death|19|||
146676708|NCT02549937|528993998|FG000|Overall Study|No follow up required|3|||
146676709|NCT02549937|528993999|FG001|Overall Study|No follow up required|6|||
146676710|NCT02549937|528994000|FG002|Overall Study|No follow up required|3|||
146676711|NCT02549937|528994001|FG003|Overall Study|No follow up required|8|||
146676712|NCT02549937|528994002|FG004|Overall Study|No follow up required|12|||
146676713|NCT02549937|528994003|FG005|Overall Study|No follow up required|21|||
146676714|NCT02549937|528994004|FG006|Overall Study|No follow up required|9|||
146676715|NCT02549937|528994005|FG007|Overall Study|No follow up required|11|||
146676716|NCT02549937|528994006|FG008|Overall Study|No follow up required|0|||
146676717|NCT02549937|528993998|FG000|Overall Study|Other|0|||
146676718|NCT02549937|528993999|FG001|Overall Study|Other|0|||
146676719|NCT02549937|528994000|FG002|Overall Study|Other|0|||
146676720|NCT02549937|528994001|FG003|Overall Study|Other|0|||
146676721|NCT02549937|528994002|FG004|Overall Study|Other|1|||
146676722|NCT02549937|528994003|FG005|Overall Study|Other|0|||
146676723|NCT02549937|528994004|FG006|Overall Study|Other|3|||
146676724|NCT02549937|528994005|FG007|Overall Study|Other|2|||
146676725|NCT02549937|528994006|FG008|Overall Study|Other|3|||
146676726|NCT02549937|528993998|FG000|Overall Study|Lost to Follow-up|0|||
146676727|NCT02549937|528993999|FG001|Overall Study|Lost to Follow-up|0|||
146676728|NCT02549937|528994000|FG002|Overall Study|Lost to Follow-up|0|||
146676729|NCT02549937|528994001|FG003|Overall Study|Lost to Follow-up|0|||
146676730|NCT02549937|528994002|FG004|Overall Study|Lost to Follow-up|0|||
146676731|NCT02549937|528994003|FG005|Overall Study|Lost to Follow-up|0|||
146676732|NCT02549937|528994004|FG006|Overall Study|Lost to Follow-up|0|||
146676733|NCT02549937|528994005|FG007|Overall Study|Lost to Follow-up|0|||
146676734|NCT02549937|528994006|FG008|Overall Study|Lost to Follow-up|3|||
146676735|NCT02549937|528993998|FG000|Overall Study|Withdrawal by Subject|0|||
146676736|NCT02549937|528993999|FG001|Overall Study|Withdrawal by Subject|0|||
146676737|NCT02549937|528994000|FG002|Overall Study|Withdrawal by Subject|0|||
146676738|NCT02549937|528994001|FG003|Overall Study|Withdrawal by Subject|0|||
146676739|NCT02549937|528994002|FG004|Overall Study|Withdrawal by Subject|0|||
146676740|NCT02549937|528994003|FG005|Overall Study|Withdrawal by Subject|1|||
146676741|NCT02549937|528994004|FG006|Overall Study|Withdrawal by Subject|4|||
146676742|NCT02549937|528994005|FG007|Overall Study|Withdrawal by Subject|3|||
146676743|NCT02549937|528994006|FG008|Overall Study|Withdrawal by Subject|2|||
146676744|NCT02549937|528993998|FG000|Overall Study|Sponsor Decision|0|||
146676745|NCT02549937|528993999|FG001|Overall Study|Sponsor Decision|0|||
146676746|NCT02549937|528994000|FG002|Overall Study|Sponsor Decision|0|||
146676747|NCT02549937|528994001|FG003|Overall Study|Sponsor Decision|0|||
146676748|NCT02549937|528994002|FG004|Overall Study|Sponsor Decision|0|||
146676749|NCT02549937|528994003|FG005|Overall Study|Sponsor Decision|0|||
146676750|NCT02549937|528994004|FG006|Overall Study|Sponsor Decision|0|||
146676751|NCT02549937|528994005|FG007|Overall Study|Sponsor Decision|0|||
146676752|NCT02549937|528994006|FG008|Overall Study|Sponsor Decision|6|||
146676753|NCT00317356|528994007|FG000|Overall Study|Adverse Event|0|||
146676754|NCT00317356|528994008|FG001|Overall Study|Adverse Event|0|||
146676755|NCT00317356|528994009|FG002|Overall Study|Adverse Event|1|||
146676756|NCT00317356|528994010|FG003|Overall Study|Adverse Event|0|||
146676757|NCT00317356|528994007|FG000|Overall Study|Lack of Efficacy|1|||
146676758|NCT00317356|528994008|FG001|Overall Study|Lack of Efficacy|1|||
146676759|NCT00317356|528994009|FG002|Overall Study|Lack of Efficacy|0|||
146676760|NCT00317356|528994010|FG003|Overall Study|Lack of Efficacy|3|||
146676761|NCT00317356|528994007|FG000|Overall Study|Physician Decision|0|||
146676762|NCT00317356|528994008|FG001|Overall Study|Physician Decision|1|||
146676763|NCT00317356|528994009|FG002|Overall Study|Physician Decision|0|||
146676764|NCT00317356|528994010|FG003|Overall Study|Physician Decision|0|||
146676765|NCT03199274|528994011|FG000|Overall Study|Withdrawal by Subject|4|||
146676766|NCT03199274|528994012|FG001|Overall Study|Withdrawal by Subject|0|||
146676767|NCT03199274|528994011|FG000|Overall Study|Lost to Follow-up|0|||
146676768|NCT03199274|528994012|FG001|Overall Study|Lost to Follow-up|1|||
146676769|NCT03199274|528994011|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
146676770|NCT03199274|528994012|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
146676771|NCT05980182|528994013|FG000|Overall Study|Lost to Follow-up|10|||
146676772|NCT02101060|528995802|FG000|Overall Study|Adverse Event|1|||
146676773|NCT02101060|528995803|FG001|Overall Study|Adverse Event|0|||
146676774|NCT02101060|528995802|FG000|Overall Study|Withdrawal by Subject|1|||
146676775|NCT02101060|528995803|FG001|Overall Study|Withdrawal by Subject|1|||
146676776|NCT02101060|528995802|FG000|Overall Study|Lost to Follow-up|3|||
146676777|NCT02101060|528995803|FG001|Overall Study|Lost to Follow-up|3|||
146676778|NCT04166435|528995804|FG000|Overall Study|2 patients ineligible for response|2|||
146676779|NCT00127660|528995809|FG000|Overall Study|Protocol Violation|3|||
146676780|NCT00127660|528995810|FG001|Overall Study|Protocol Violation|3|||
146676781|NCT00127660|528995811|FG002|Overall Study|Protocol Violation|5|||
146676782|NCT00127660|528995812|FG003|Overall Study|Protocol Violation|0|||
146676783|NCT00489541|528995813|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
146676784|NCT00489541|528995814|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
146676785|NCT00489541|528995813|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
146676786|NCT00489541|528995814|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
146676787|NCT00489541|528995813|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
146676788|NCT00489541|528995814|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
146676789|NCT00489541|528995813|FG000|12-Month Clinical Follow-up|Death|3|||
146676790|NCT00489541|528995814|FG001|12-Month Clinical Follow-up|Death|2|||
146676791|NCT00489541|528995813|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
146676792|NCT00489541|528995814|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
146676793|NCT00489541|528995813|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
146676794|NCT00489541|528995814|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
146676795|NCT05131646|528995815|FG000|Overall Study|Withdrawal by Subject|1|||
146676796|NCT05131646|528995816|FG001|Overall Study|Withdrawal by Subject|0|||
146676797|NCT05131646|528995817|FG002|Overall Study|Withdrawal by Subject|0|||
146676798|NCT00003479|528995818|FG000|Overall Study|Not evaluable|3|||
146676799|NCT02042183|528995821|FG000|Overall Study|Physician Decision|7|||
146676800|NCT02042183|528995822|FG001|Overall Study|Physician Decision|2|||
146676801|NCT02042183|528995821|FG000|Overall Study|Lack of Efficacy|4|||
146676802|NCT02042183|528995822|FG001|Overall Study|Lack of Efficacy|3|||
146676803|NCT02042183|528995821|FG000|Overall Study|Non-compliance with Study Drug|2|||
146676804|NCT02042183|528995822|FG001|Overall Study|Non-compliance with Study Drug|3|||
146676805|NCT02042183|528995821|FG000|Overall Study|Adverse Event|17|||
146676806|NCT02042183|528995822|FG001|Overall Study|Adverse Event|6|||
146676807|NCT02042183|528995821|FG000|Overall Study|Other|3|||
146774309|NCT00311363|529343558|FG001|24-Week Single-Blind Treatment Period|Death|0|||
146774310|NCT00311363|529343559|FG002|24-Week Single-Blind Treatment Period|Death|0|||
146774311|NCT00311363|529343557|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
146774312|NCT00311363|529343558|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
146774313|NCT00311363|529343559|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
146774314|NCT00311363|529343557|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
146774315|NCT00311363|529343558|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
146774316|NCT00311363|529343559|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
146774317|NCT00311363|529343557|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
146774318|NCT00311363|529343558|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
146774319|NCT00311363|529343559|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
146774320|NCT00311363|529343557|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
146774321|NCT00311363|529343558|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
146774322|NCT00311363|529343559|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
146774323|NCT00311363|529343557|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
146774324|NCT00311363|529343558|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
146774325|NCT00311363|529343559|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
146774326|NCT00311363|529343557|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
146774327|NCT00311363|529343558|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
146676808|NCT02042183|528995822|FG001|Overall Study|Other|3|||
146676809|NCT02042183|528995821|FG000|Overall Study|Withdrawal by Subject|21|||
146676810|NCT02042183|528995822|FG001|Overall Study|Withdrawal by Subject|16|||
146676811|NCT02042183|528995821|FG000|Overall Study|Site Terminated by Sponsor|2|||
146676812|NCT02042183|528995822|FG001|Overall Study|Site Terminated by Sponsor|1|||
146676813|NCT02042183|528995821|FG000|Overall Study|Lost to Follow-up|9|||
146676814|NCT02042183|528995822|FG001|Overall Study|Lost to Follow-up|2|||
146676815|NCT01192516|528995823|FG000|Overall Study|Lost to Follow-up|7|||
146676816|NCT01192516|528995824|FG001|Overall Study|Lost to Follow-up|10|||
146676817|NCT01192516|528995825|FG002|Overall Study|Lost to Follow-up|7|||
146676818|NCT01192516|528995823|FG000|Overall Study|Withdrawal by Subject|4|||
146774328|NCT00311363|529343559|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
146676819|NCT01192516|528995824|FG001|Overall Study|Withdrawal by Subject|4|||
146676820|NCT01192516|528995825|FG002|Overall Study|Withdrawal by Subject|1|||
146676821|NCT01192516|528995823|FG000|Overall Study|started new treatment|5|||
146676822|NCT01192516|528995824|FG001|Overall Study|started new treatment|1|||
146676823|NCT01192516|528995825|FG002|Overall Study|started new treatment|0|||
146676824|NCT01192516|528995823|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
146676825|NCT01192516|528995824|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
146676826|NCT01192516|528995825|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
146676827|NCT04605484|528995831|FG000|Overall Study|Lost to Follow-up|0|||
146676828|NCT04605484|528995832|FG001|Overall Study|Lost to Follow-up|1|||
146676829|NCT04605484|528995833|FG002|Overall Study|Lost to Follow-up|1|||
146676830|NCT04605484|528995831|FG000|Overall Study|Other|0|||
146676831|NCT04605484|528995832|FG001|Overall Study|Other|1|||
146676832|NCT04605484|528995833|FG002|Overall Study|Other|0|||
146676833|NCT04171531|528995834|FG000|Overall Study|Lost to Follow-up|4|||
146676834|NCT04171531|528995835|FG001|Overall Study|Lost to Follow-up|5|||
146676835|NCT04171531|528995834|FG000|Overall Study|Consent only through 6 months|1|||
146676836|NCT04171531|528995835|FG001|Overall Study|Consent only through 6 months|1|||
146676837|NCT04171531|528995834|FG000|Overall Study|Insurance did not cover procedure|0|||
146676838|NCT04171531|528995835|FG001|Overall Study|Insurance did not cover procedure|1|||
146676839|NCT04171531|528995834|FG000|Overall Study|Physician Decision|0|||
146676840|NCT04171531|528995835|FG001|Overall Study|Physician Decision|3|||
146676841|NCT04171531|528995834|FG000|Overall Study|Withdrawal by Subject|1|||
146676842|NCT04171531|528995835|FG001|Overall Study|Withdrawal by Subject|5|||
146676843|NCT04862585|528995839|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
146676844|NCT04862585|528995840|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
146676845|NCT04862585|528995839|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
146676846|NCT04862585|528995840|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
146676847|NCT04862585|528995839|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
146676848|NCT04862585|528995840|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
146676849|NCT04862585|528995839|FG000|Overall Study|one withdrew without providing a reason|0|||
146676850|NCT04862585|528995840|FG001|Overall Study|one withdrew without providing a reason|1|||
146676851|NCT03366337|528995843|FG000|Overall Study|Lost to Follow-up|1|||
146676852|NCT03366337|528995844|FG001|Overall Study|Lost to Follow-up|0|||
146676853|NCT03366337|528995845|FG002|Overall Study|Lost to Follow-up|1|||
146676854|NCT03366337|528995846|FG003|Overall Study|Lost to Follow-up|0|||
146676855|NCT03366337|528995843|FG000|Overall Study|Withdrawal by Subject|2|||
146676856|NCT03366337|528995844|FG001|Overall Study|Withdrawal by Subject|0|||
146676857|NCT03366337|528995845|FG002|Overall Study|Withdrawal by Subject|1|||
146676858|NCT03366337|528995846|FG003|Overall Study|Withdrawal by Subject|1|||
146676859|NCT05288062|528995847|FG000|Overall Study|Ineligible|0|||
146676860|NCT05288062|528995848|FG001|Overall Study|Ineligible|0|||
146676861|NCT05288062|528995849|FG002|Overall Study|Ineligible|1|||
146676862|NCT05288062|528995850|FG003|Overall Study|Ineligible|0|||
146676863|NCT05288062|528995847|FG000|Overall Study|Withdrawal by Subject|0|||
146676864|NCT05288062|528995848|FG001|Overall Study|Withdrawal by Subject|0|||
146676865|NCT05288062|528995849|FG002|Overall Study|Withdrawal by Subject|1|||
146676866|NCT05288062|528995850|FG003|Overall Study|Withdrawal by Subject|0|||
146676867|NCT01025752|528995854|FG000|Overall Study|Lost to Follow-up|7|||
146676868|NCT01025752|528995855|FG001|Overall Study|Lost to Follow-up|10|||
146676869|NCT01025752|528995854|FG000|Overall Study|Physician Decision|1|||
146676870|NCT01025752|528995855|FG001|Overall Study|Physician Decision|3|||
146676871|NCT01537393|528995858|FG000|Overall Study|Exclude prior to study|32|||
146676872|NCT01537393|528995859|FG001|Overall Study|Exclude prior to study|44|||
146676873|NCT01537393|528995858|FG000|Overall Study|Death|20|||
146676874|NCT01537393|528995859|FG001|Overall Study|Death|32|||
146676875|NCT01537393|528995858|FG000|Overall Study|Withdrawal by Subject|18|||
146774329|NCT00396084|529343560|FG000|Overall Study|Adverse Event|0|||
146774330|NCT00396084|529343561|FG001|Overall Study|Adverse Event|0|||
146774331|NCT00396084|529343562|FG002|Overall Study|Adverse Event|0|||
146774332|NCT00396084|529343563|FG003|Overall Study|Adverse Event|0|||
146774333|NCT00396084|529343564|FG004|Overall Study|Adverse Event|1|||
146774334|NCT00396084|529343565|FG005|Overall Study|Adverse Event|2|||
146774335|NCT00396084|529343560|FG000|Overall Study|Withdrawal by Subject|0|||
146774336|NCT00396084|529343561|FG001|Overall Study|Withdrawal by Subject|0|||
146774337|NCT00396084|529343562|FG002|Overall Study|Withdrawal by Subject|0|||
146774338|NCT00396084|529343563|FG003|Overall Study|Withdrawal by Subject|1|||
146774339|NCT00396084|529343564|FG004|Overall Study|Withdrawal by Subject|0|||
146774340|NCT00396084|529343565|FG005|Overall Study|Withdrawal by Subject|0|||
146774341|NCT01697969|529343566|FG000|Overall Study|Did not meet inc/exc criteria|3|||
146774342|NCT01759771|529343567|FG000|Overall Study|Withdrawal by Subject|1|||
146774343|NCT01759771|529343568|FG001|Overall Study|Withdrawal by Subject|1|||
146774344|NCT02528188|529343569|FG000|Overall Study|Adverse Event|23|||
146774345|NCT02528188|529343570|FG001|Overall Study|Adverse Event|22|||
146774346|NCT02528188|529343571|FG002|Overall Study|Adverse Event|8|||
146774347|NCT02528188|529343569|FG000|Overall Study|Protocol Violation|4|||
146676876|NCT01537393|528995859|FG001|Overall Study|Withdrawal by Subject|17|||
146676877|NCT01537393|528995858|FG000|Overall Study|Lost to Follow-up|53|||
146676878|NCT01537393|528995859|FG001|Overall Study|Lost to Follow-up|48|||
146676879|NCT01537393|528995858|FG000|Overall Study|Failure - Regrafted|28|||
146676880|NCT01537393|528995859|FG001|Overall Study|Failure - Regrafted|43|||
146676881|NCT01537393|528995858|FG000|Overall Study|Failure - Not regrafted|2|||
146676882|NCT01537393|528995859|FG001|Overall Study|Failure - Not regrafted|6|||
146774348|NCT02528188|529343570|FG001|Overall Study|Protocol Violation|6|||
146676883|NCT01537393|528995858|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
146676884|NCT01537393|528995859|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
146774349|NCT02528188|529343571|FG002|Overall Study|Protocol Violation|4|||
146676885|NCT00459953|528995860|FG000|Overall Study|not analyzed-household member in study|1|||
146676886|NCT00459953|528995861|FG001|Overall Study|not analyzed-household member in study|1|||
146676887|NCT01447433|528995862|FG000|Overall Study|Lost to Follow-up|0|||
146676888|NCT01447433|528995863|FG001|Overall Study|Lost to Follow-up|2|||
146676889|NCT01447433|528995862|FG000|Overall Study|Withdrawal by Subject|3|||
146676890|NCT01447433|528995863|FG001|Overall Study|Withdrawal by Subject|3|||
146676891|NCT01447433|528995862|FG000|Overall Study|Protocol Violation|1|||
146676892|NCT01447433|528995863|FG001|Overall Study|Protocol Violation|1|||
146676893|NCT01578187|528995864|FG000|Usability Phase|Withdrawal by Subject|1|||
146676894|NCT01217801|528995869|FG000|Period 1|Protocol Violation|1|||
146676895|NCT01217801|528995870|FG001|Period 1|Protocol Violation|1|||
146676896|NCT01217801|528995869|FG000|Period 1|Withdrawal by Subject|0|||
146676897|NCT01217801|528995870|FG001|Period 1|Withdrawal by Subject|1|||
146676898|NCT04584645|528995871|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
146676899|NCT04584645|528995872|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
146676900|NCT00390468|528995873|FG000|Overall Study|Protocol Violation|2|||
146676901|NCT00390468|528995873|FG000|Overall Study|Lack of Efficacy|1|||
146676902|NCT03926169|528995880|FG000|Period A|Adverse Event|2|||
146676903|NCT03926169|528995881|FG001|Period A|Adverse Event|2|||
146676904|NCT03926169|528995882|FG002|Period A|Adverse Event|1|||
146676905|NCT03926169|528995880|FG000|Period A|Withdrawal by Subject|2|||
146676906|NCT03926169|528995881|FG001|Period A|Withdrawal by Subject|2|||
146676907|NCT03926169|528995882|FG002|Period A|Withdrawal by Subject|2|||
146676908|NCT03926169|528995880|FG000|Period A|Lost to Follow-up|3|||
146676909|NCT03926169|528995881|FG001|Period A|Lost to Follow-up|1|||
146676910|NCT03926169|528995882|FG002|Period A|Lost to Follow-up|0|||
146676911|NCT03926169|528995880|FG000|Period A|Lack of Efficacy|0|||
146676912|NCT03926169|528995881|FG001|Period A|Lack of Efficacy|2|||
146676913|NCT03926169|528995882|FG002|Period A|Lack of Efficacy|2|||
146676914|NCT03926169|528995880|FG000|Period A|COVID-19 Infection|0|||
146676915|NCT03926169|528995881|FG001|Period A|COVID-19 Infection|1|||
146676916|NCT03926169|528995882|FG002|Period A|COVID-19 Infection|0|||
146676917|NCT03926169|528995880|FG000|Period A|COVID-19 Logistical Restrictions|0|||
146676918|NCT03926169|528995881|FG001|Period A|COVID-19 Logistical Restrictions|2|||
146676919|NCT03926169|528995882|FG002|Period A|COVID-19 Logistical Restrictions|1|||
146676920|NCT03926169|528995880|FG000|Period A|Other, Not Specified|1|||
146676921|NCT03926169|528995881|FG001|Period A|Other, Not Specified|0|||
146676922|NCT03926169|528995882|FG002|Period A|Other, Not Specified|0|||
146676923|NCT03926169|528995880|FG000|Period B|Adverse Event|3|||
146676924|NCT03926169|528995881|FG001|Period B|Adverse Event|1|||
146676925|NCT03926169|528995882|FG002|Period B|Adverse Event|1|||
146676926|NCT03926169|528995880|FG000|Period B|Withdrawal by Subject|1|||
146676927|NCT03926169|528995881|FG001|Period B|Withdrawal by Subject|3|||
146676928|NCT03926169|528995882|FG002|Period B|Withdrawal by Subject|0|||
146676929|NCT03926169|528995880|FG000|Period B|Lack of Efficacy|3|||
146676930|NCT03926169|528995881|FG001|Period B|Lack of Efficacy|1|||
146676931|NCT03926169|528995882|FG002|Period B|Lack of Efficacy|1|||
146676932|NCT03926169|528995880|FG000|Period B|Lost to Follow-up|1|||
146676933|NCT03926169|528995881|FG001|Period B|Lost to Follow-up|1|||
146676934|NCT03926169|528995882|FG002|Period B|Lost to Follow-up|4|||
146676935|NCT03926169|528995880|FG000|Period B|Other, Not Specified|62|||
146676936|NCT03926169|528995881|FG001|Period B|Other, Not Specified|57|||
146676937|NCT03926169|528995882|FG002|Period B|Other, Not Specified|65|||
146676938|NCT03708328|528995885|FG000|Overall Study|Death|3|||
146676939|NCT03708328|528995886|FG001|Overall Study|Death|3|||
146676940|NCT03708328|528995887|FG002|Overall Study|Death|4|||
146676941|NCT03708328|528995888|FG003|Overall Study|Death|2|||
146676942|NCT03708328|528995889|FG004|Overall Study|Death|2|||
146676943|NCT03708328|528995890|FG005|Overall Study|Death|13|||
146676944|NCT03708328|528995891|FG006|Overall Study|Death|26|||
146676945|NCT03708328|528995892|FG007|Overall Study|Death|18|||
146676946|NCT03708328|528995893|FG008|Overall Study|Death|13|||
146676947|NCT03708328|528995894|FG009|Overall Study|Death|8|||
146676948|NCT03708328|528995885|FG000|Overall Study|Lost to Follow-up|0|||
146676949|NCT03708328|528995886|FG001|Overall Study|Lost to Follow-up|1|||
146676950|NCT03708328|528995887|FG002|Overall Study|Lost to Follow-up|0|||
146676951|NCT03708328|528995888|FG003|Overall Study|Lost to Follow-up|1|||
146676952|NCT03708328|528995889|FG004|Overall Study|Lost to Follow-up|0|||
146676953|NCT03708328|528995890|FG005|Overall Study|Lost to Follow-up|3|||
146676954|NCT03708328|528995891|FG006|Overall Study|Lost to Follow-up|3|||
146676955|NCT03708328|528995892|FG007|Overall Study|Lost to Follow-up|0|||
146676956|NCT03708328|528995893|FG008|Overall Study|Lost to Follow-up|0|||
146676957|NCT03708328|528995894|FG009|Overall Study|Lost to Follow-up|1|||
146676958|NCT03708328|528995885|FG000|Overall Study|Physician Decision|0|||
146676959|NCT03708328|528995886|FG001|Overall Study|Physician Decision|0|||
146676960|NCT03708328|528995887|FG002|Overall Study|Physician Decision|0|||
146676961|NCT03708328|528995888|FG003|Overall Study|Physician Decision|0|||
146676962|NCT03708328|528995889|FG004|Overall Study|Physician Decision|0|||
146676963|NCT03708328|528995890|FG005|Overall Study|Physician Decision|1|||
146676964|NCT03708328|528995891|FG006|Overall Study|Physician Decision|0|||
146676965|NCT03708328|528995892|FG007|Overall Study|Physician Decision|0|||
146676966|NCT03708328|528995893|FG008|Overall Study|Physician Decision|0|||
146676967|NCT03708328|528995894|FG009|Overall Study|Physician Decision|0|||
146676968|NCT03708328|528995885|FG000|Overall Study|Withdrawal by Subject|0|||
146676969|NCT03708328|528995886|FG001|Overall Study|Withdrawal by Subject|0|||
146676970|NCT03708328|528995887|FG002|Overall Study|Withdrawal by Subject|0|||
146676971|NCT03708328|528995888|FG003|Overall Study|Withdrawal by Subject|0|||
146676972|NCT03708328|528995889|FG004|Overall Study|Withdrawal by Subject|1|||
146676973|NCT03708328|528995890|FG005|Overall Study|Withdrawal by Subject|0|||
146676974|NCT03708328|528995891|FG006|Overall Study|Withdrawal by Subject|2|||
146676975|NCT03708328|528995892|FG007|Overall Study|Withdrawal by Subject|4|||
146676976|NCT03708328|528995893|FG008|Overall Study|Withdrawal by Subject|1|||
146676977|NCT03708328|528995894|FG009|Overall Study|Withdrawal by Subject|5|||
146676978|NCT03708328|528995885|FG000|Overall Study|Study Closed Locally|0|||
146676979|NCT03708328|528995886|FG001|Overall Study|Study Closed Locally|0|||
146676980|NCT03708328|528995887|FG002|Overall Study|Study Closed Locally|0|||
146676981|NCT03708328|528995888|FG003|Overall Study|Study Closed Locally|0|||
146676982|NCT03708328|528995889|FG004|Overall Study|Study Closed Locally|0|||
146676983|NCT03708328|528995890|FG005|Overall Study|Study Closed Locally|0|||
146676984|NCT03708328|528995891|FG006|Overall Study|Study Closed Locally|0|||
146676985|NCT03708328|528995892|FG007|Overall Study|Study Closed Locally|1|||
146676986|NCT03708328|528995893|FG008|Overall Study|Study Closed Locally|0|||
146676987|NCT03708328|528995894|FG009|Overall Study|Study Closed Locally|0|||
146676988|NCT03708328|528995885|FG000|Overall Study|Study Ended By Sponsor|0|||
146676989|NCT03708328|528995886|FG001|Overall Study|Study Ended By Sponsor|0|||
146676990|NCT03708328|528995887|FG002|Overall Study|Study Ended By Sponsor|0|||
146676991|NCT03708328|528995888|FG003|Overall Study|Study Ended By Sponsor|0|||
146676992|NCT03708328|528995889|FG004|Overall Study|Study Ended By Sponsor|0|||
146676993|NCT03708328|528995890|FG005|Overall Study|Study Ended By Sponsor|1|||
146676994|NCT03708328|528995891|FG006|Overall Study|Study Ended By Sponsor|0|||
146676995|NCT03708328|528995892|FG007|Overall Study|Study Ended By Sponsor|1|||
146676996|NCT03708328|528995893|FG008|Overall Study|Study Ended By Sponsor|0|||
146676997|NCT03708328|528995894|FG009|Overall Study|Study Ended By Sponsor|0|||
146676998|NCT03708328|528995885|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146676999|NCT03708328|528995886|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146677000|NCT03708328|528995887|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146677001|NCT03708328|528995888|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146677002|NCT03708328|528995889|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146677003|NCT03708328|528995890|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146677004|NCT03708328|528995891|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146677005|NCT03708328|528995892|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146677006|NCT03708328|528995893|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
146677007|NCT03708328|528995894|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146677008|NCT04523220|528995895|FG000|Main Treatment Period|Physician Decision|1|||
146677009|NCT04523220|528995896|FG001|Main Treatment Period|Physician Decision|1|||
146677010|NCT04523220|528995897|FG002|Main Treatment Period|Physician Decision|0|||
146677011|NCT04523220|528995895|FG000|Main Treatment Period|Other|5|||
146677012|NCT04523220|528995896|FG001|Main Treatment Period|Other|2|||
146677013|NCT04523220|528995897|FG002|Main Treatment Period|Other|4|||
146677014|NCT04523220|528995895|FG000|Main Treatment Period|Subject Decision|5|||
146677015|NCT04523220|528995896|FG001|Main Treatment Period|Subject Decision|7|||
146677016|NCT04523220|528995897|FG002|Main Treatment Period|Subject Decision|3|||
146677017|NCT04523220|528995895|FG000|Main Treatment Period|Death|5|||
146677018|NCT04523220|528995896|FG001|Main Treatment Period|Death|11|||
146677019|NCT04523220|528995897|FG002|Main Treatment Period|Death|4|||
146677020|NCT04523220|528995895|FG000|Main Treatment Period|Adverse Event|11|||
146774350|NCT02528188|529343569|FG000|Overall Study|Lack of Efficacy|19|||
146774351|NCT02528188|529343570|FG001|Overall Study|Lack of Efficacy|21|||
146774352|NCT02528188|529343571|FG002|Overall Study|Lack of Efficacy|22|||
146774353|NCT02528188|529343569|FG000|Overall Study|Withdrawal by Subject|97|||
146774354|NCT02528188|529343570|FG001|Overall Study|Withdrawal by Subject|104|||
146926450|NCT03260205|529890824|FG003|Overall Study|Adverse Event|2|||
146677021|NCT04523220|528995896|FG001|Main Treatment Period|Adverse Event|9|||
146677022|NCT04523220|528995897|FG002|Main Treatment Period|Adverse Event|9|||
146774355|NCT02528188|529343571|FG002|Overall Study|Withdrawal by Subject|100|||
146677023|NCT04523220|528995895|FG000|Main Treatment Period|Withdrawal by Subject|3|||
146677024|NCT04523220|528995896|FG001|Main Treatment Period|Withdrawal by Subject|3|||
146677025|NCT04523220|528995897|FG002|Main Treatment Period|Withdrawal by Subject|4|||
146677026|NCT04523220|528995895|FG000|Main Treatment Period|Study drug never adminstered|10|||
146677027|NCT04523220|528995896|FG001|Main Treatment Period|Study drug never adminstered|3|||
146677028|NCT04523220|528995897|FG002|Main Treatment Period|Study drug never adminstered|5|||
146677029|NCT04523220|528995895|FG000|Extension Treatment Period|Physician Decision|1|||
146677030|NCT04523220|528995896|FG001|Extension Treatment Period|Physician Decision|0|||
146677031|NCT04523220|528995897|FG002|Extension Treatment Period|Physician Decision|3|||
146677032|NCT04523220|528995895|FG000|Extension Treatment Period|Other|2|||
146677033|NCT04523220|528995896|FG001|Extension Treatment Period|Other|6|||
146677034|NCT04523220|528995897|FG002|Extension Treatment Period|Other|6|||
146677035|NCT04523220|528995895|FG000|Extension Treatment Period|Subject Decision|5|||
146677036|NCT04523220|528995896|FG001|Extension Treatment Period|Subject Decision|2|||
146677037|NCT04523220|528995897|FG002|Extension Treatment Period|Subject Decision|4|||
146677038|NCT04523220|528995895|FG000|Extension Treatment Period|Death|6|||
146677039|NCT04523220|528995896|FG001|Extension Treatment Period|Death|4|||
146677040|NCT04523220|528995897|FG002|Extension Treatment Period|Death|7|||
146677041|NCT04523220|528995895|FG000|Extension Treatment Period|Adverse Event|6|||
146677042|NCT04523220|528995896|FG001|Extension Treatment Period|Adverse Event|7|||
146677043|NCT04523220|528995897|FG002|Extension Treatment Period|Adverse Event|9|||
146677044|NCT04523220|528995895|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
146677045|NCT04523220|528995896|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
146677046|NCT04523220|528995897|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
146677047|NCT04523220|528995895|FG000|Extension Treatment Period|Study drug never administered|0|||
146677048|NCT04523220|528995896|FG001|Extension Treatment Period|Study drug never administered|1|||
146677049|NCT04523220|528995897|FG002|Extension Treatment Period|Study drug never administered|0|||
146677050|NCT00571948|528995898|FG000|Overall Study|Lost to Follow-up|2|||
146677051|NCT00571948|528995899|FG001|Overall Study|Lost to Follow-up|0|||
146677052|NCT00571948|528995898|FG000|Overall Study|Withdrawal by Subject|1|||
146677053|NCT00571948|528995899|FG001|Overall Study|Withdrawal by Subject|2|||
146677054|NCT00571948|528995898|FG000|Overall Study|Protocol Violation|3|||
146677055|NCT00571948|528995899|FG001|Overall Study|Protocol Violation|3|||
146677056|NCT00571948|528995898|FG000|Overall Study|infant refused study meal|3|||
146677057|NCT00571948|528995899|FG001|Overall Study|infant refused study meal|4|||
146677058|NCT00571948|528995898|FG000|Overall Study|Parent were afraid of blood colection|2|||
146677059|NCT00571948|528995899|FG001|Overall Study|Parent were afraid of blood colection|5|||
146677060|NCT02030041|528995901|FG000|Overall Study|Withdrawal by Subject|2|||
146677061|NCT02030041|528995902|FG001|Overall Study|Withdrawal by Subject|2|||
146677062|NCT02030041|528995903|FG002|Overall Study|Withdrawal by Subject|1|||
146677063|NCT00843024|528995904|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
146677064|NCT00843024|528995905|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
146677065|NCT00843024|528995906|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
146677066|NCT00843024|528995907|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
146677067|NCT00843024|528995908|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
146677068|NCT00843024|528995909|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
146677069|NCT00843024|528995904|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
146677070|NCT00843024|528995905|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
146677071|NCT00843024|528995906|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
146677072|NCT00843024|528995907|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
146677073|NCT00843024|528995908|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
146677074|NCT00843024|528995909|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
146677075|NCT00843024|528995904|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
146677076|NCT00843024|528995905|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
146677077|NCT00843024|528995906|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
146677078|NCT00843024|528995907|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
146677079|NCT00843024|528995908|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
146677080|NCT00843024|528995909|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
146677081|NCT00843024|528995904|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
146677082|NCT00843024|528995905|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
146677083|NCT00843024|528995906|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
146677084|NCT00843024|528995907|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
146677085|NCT00843024|528995908|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
146677086|NCT00843024|528995909|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
146677087|NCT00843024|528995904|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
146677088|NCT00843024|528995905|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
146677089|NCT00843024|528995906|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
146677090|NCT00843024|528995907|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
146677091|NCT00843024|528995908|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
146677092|NCT00843024|528995909|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
146677093|NCT00843024|528995904|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
146926451|NCT03260205|529890825|FG004|Overall Study|Adverse Event|4|||
146926452|NCT03260205|529890821|FG000|Overall Study|Lost to Follow-up|2|||
146677094|NCT00843024|528995905|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
146677095|NCT00843024|528995906|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
146677096|NCT00843024|528995907|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
146774356|NCT02528188|529343569|FG000|Overall Study|Lost to Follow-up|25|||
146677097|NCT00843024|528995908|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
146677098|NCT00843024|528995909|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
146677099|NCT00843024|528995904|FG000|Single-blind Placebo Run-In Phase|Other|0|||
146677100|NCT00843024|528995905|FG001|Single-blind Placebo Run-In Phase|Other|1|||
146677101|NCT00843024|528995906|FG002|Single-blind Placebo Run-In Phase|Other|0|||
146677102|NCT00843024|528995907|FG003|Single-blind Placebo Run-In Phase|Other|0|||
146677103|NCT00843024|528995908|FG004|Single-blind Placebo Run-In Phase|Other|0|||
146677104|NCT00843024|528995909|FG005|Single-blind Placebo Run-In Phase|Other|0|||
146677105|NCT00843024|528995904|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
146677106|NCT00843024|528995905|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
146677107|NCT00843024|528995906|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
146677108|NCT00843024|528995907|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
146677109|NCT00843024|528995908|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
146677110|NCT00843024|528995909|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
146677111|NCT00843024|528995904|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
146677112|NCT00843024|528995905|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
146677113|NCT00843024|528995906|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
146677114|NCT00843024|528995907|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
146677115|NCT00843024|528995908|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
146677116|NCT00843024|528995909|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
146677117|NCT00843024|528995904|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146677118|NCT00843024|528995905|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146677119|NCT00843024|528995906|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146677120|NCT00843024|528995907|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
146677121|NCT00843024|528995908|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146677122|NCT00843024|528995909|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
146677123|NCT00843024|528995904|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
146677124|NCT00843024|528995905|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
146677125|NCT00843024|528995906|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
146677126|NCT00843024|528995907|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
146677127|NCT00843024|528995908|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
146677128|NCT00843024|528995909|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
146677129|NCT00843024|528995904|FG000|Double-blind Treatment Phase|Physician Decision|0|||
146677130|NCT00843024|528995905|FG001|Double-blind Treatment Phase|Physician Decision|0|||
146677131|NCT00843024|528995906|FG002|Double-blind Treatment Phase|Physician Decision|0|||
146677132|NCT00843024|528995907|FG003|Double-blind Treatment Phase|Physician Decision|3|||
146677133|NCT00843024|528995908|FG004|Double-blind Treatment Phase|Physician Decision|1|||
146677134|NCT00843024|528995909|FG005|Double-blind Treatment Phase|Physician Decision|1|||
146677135|NCT00843024|528995904|FG000|Double-blind Treatment Phase|Adverse Event|0|||
146677136|NCT00843024|528995905|FG001|Double-blind Treatment Phase|Adverse Event|0|||
146677137|NCT00843024|528995906|FG002|Double-blind Treatment Phase|Adverse Event|0|||
146677138|NCT00843024|528995907|FG003|Double-blind Treatment Phase|Adverse Event|0|||
146677139|NCT00843024|528995908|FG004|Double-blind Treatment Phase|Adverse Event|1|||
146677140|NCT00843024|528995909|FG005|Double-blind Treatment Phase|Adverse Event|1|||
146677141|NCT00843024|528995904|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
146677142|NCT00843024|528995905|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
146677143|NCT00843024|528995906|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
146677144|NCT00843024|528995907|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
146677145|NCT00843024|528995908|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
146677146|NCT00843024|528995909|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
146677147|NCT01032837|528995910|FG000|Overall Study|Adverse event/internal illness|0|||
146677148|NCT01032837|528995911|FG001|Overall Study|Adverse event/internal illness|1|||
146677149|NCT01032837|528995912|FG002|Overall Study|Adverse event/internal illness|0|||
146677150|NCT01032837|528995913|FG003|Overall Study|Adverse event/internal illness|1|||
146677151|NCT01032837|528995910|FG000|Overall Study|Withdrew consent|0|||
146677152|NCT01032837|528995911|FG001|Overall Study|Withdrew consent|2|||
146677153|NCT01032837|528995912|FG002|Overall Study|Withdrew consent|0|||
146677154|NCT01032837|528995913|FG003|Overall Study|Withdrew consent|1|||
146677155|NCT01032837|528995910|FG000|Overall Study|Failed to return|0|||
146677156|NCT01032837|528995911|FG001|Overall Study|Failed to return|0|||
146677157|NCT01032837|528995912|FG002|Overall Study|Failed to return|1|||
146677158|NCT01032837|528995913|FG003|Overall Study|Failed to return|0|||
146677159|NCT01032837|528995910|FG000|Overall Study|Refused treatment|0|||
146677160|NCT01032837|528995911|FG001|Overall Study|Refused treatment|0|||
146677161|NCT01032837|528995912|FG002|Overall Study|Refused treatment|0|||
146677162|NCT01032837|528995913|FG003|Overall Study|Refused treatment|1|||
146677163|NCT05201703|528995914|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
146677164|NCT05201703|528995915|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
146677165|NCT05201703|528995914|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
146774357|NCT02528188|529343570|FG001|Overall Study|Lost to Follow-up|21|||
146926453|NCT03260205|529890822|FG001|Overall Study|Lost to Follow-up|2|||
146926454|NCT03260205|529890823|FG002|Overall Study|Lost to Follow-up|1|||
146926455|NCT03260205|529890824|FG003|Overall Study|Lost to Follow-up|1|||
146926456|NCT03260205|529890825|FG004|Overall Study|Lost to Follow-up|5|||
146926457|NCT03260205|529890821|FG000|Overall Study|Protocol Violation|0|||
146926458|NCT03260205|529890822|FG001|Overall Study|Protocol Violation|0|||
146677166|NCT05201703|528995915|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
146926459|NCT03260205|529890823|FG002|Overall Study|Protocol Violation|2|||
146926460|NCT03260205|529890824|FG003|Overall Study|Protocol Violation|0|||
146926461|NCT03260205|529890825|FG004|Overall Study|Protocol Violation|1|||
146926462|NCT03260205|529890821|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
146926463|NCT03260205|529890822|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
146926464|NCT03260205|529890823|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
146926465|NCT03260205|529890824|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
146926466|NCT03260205|529890825|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
146926467|NCT03260205|529890821|FG000|Overall Study|Other: Unspecified|0|||
146926468|NCT03260205|529890822|FG001|Overall Study|Other: Unspecified|0|||
146926469|NCT03260205|529890823|FG002|Overall Study|Other: Unspecified|3|||
146926470|NCT03260205|529890824|FG003|Overall Study|Other: Unspecified|1|||
146926471|NCT03260205|529890825|FG004|Overall Study|Other: Unspecified|1|||
146926472|NCT03260205|529890821|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
146926473|NCT03260205|529890822|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
146926474|NCT03260205|529890823|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
146926475|NCT03260205|529890824|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
146926476|NCT03260205|529890825|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
146926477|NCT01968187|529890828|FG000|Overall Study|Adverse Event|0|||
146926478|NCT01968187|529890829|FG001|Overall Study|Adverse Event|1|||
146926479|NCT01968187|529890828|FG000|Overall Study|Randomized but not treated|1|||
146677167|NCT02006719|528995916|FG000|Overall Study|Withdrawal by Subject|10|||
146677168|NCT02006719|528995917|FG001|Overall Study|Withdrawal by Subject|2|||
146677169|NCT02006719|528995916|FG000|Overall Study|Lost to Follow-up|5|||
146677170|NCT02006719|528995917|FG001|Overall Study|Lost to Follow-up|1|||
146677171|NCT02006719|528995916|FG000|Overall Study|Protocol Violation|2|||
146677172|NCT02006719|528995917|FG001|Overall Study|Protocol Violation|0|||
146677173|NCT02006719|528995916|FG000|Overall Study|Adverse Event|1|||
146677174|NCT02006719|528995917|FG001|Overall Study|Adverse Event|1|||
146677175|NCT02006719|528995916|FG000|Overall Study|Other/Unknown|0|||
146677176|NCT02006719|528995917|FG001|Overall Study|Other/Unknown|1|||
146677177|NCT02439138|528995919|FG000|Overall Study|Adverse Event|1|||
146677178|NCT02439138|528995919|FG000|Overall Study|PI decision to terminate the study|2|||
146677179|NCT00006237|528995924|FG000|Overall Study|Adverse Event|39|||
146677180|NCT00006237|528995925|FG001|Overall Study|Adverse Event|29|||
146677181|NCT00006237|528995924|FG000|Overall Study|Death|1|||
146677182|NCT00006237|528995925|FG001|Overall Study|Death|0|||
146677183|NCT00006237|528995924|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
146677184|NCT00006237|528995925|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
146677185|NCT00006237|528995924|FG000|Overall Study|Progression/relapse|54|||
146677186|NCT00006237|528995925|FG001|Overall Study|Progression/relapse|2|||
146677187|NCT00006237|528995924|FG000|Overall Study|Not eligible|9|||
146677188|NCT00006237|528995925|FG001|Overall Study|Not eligible|20|||
146677189|NCT00006237|528995924|FG000|Overall Study|Withdrawal by Subject|0|||
146677190|NCT00006237|528995925|FG001|Overall Study|Withdrawal by Subject|1|||
146677191|NCT00006237|528995924|FG000|Overall Study|Not protocol specified|14|||
146677192|NCT00006237|528995925|FG001|Overall Study|Not protocol specified|5|||
146677193|NCT03727347|528995926|FG000|Overall Study|Withdrawal by Subject|2|||
146677194|NCT03727347|528995926|FG000|Overall Study|Lost to Follow-up|1|||
146677195|NCT01846416|528995929|FG000|Treatment Phase|Death|2|||
146677196|NCT01846416|528995930|FG001|Treatment Phase|Death|9|||
146677197|NCT01846416|528995931|FG002|Treatment Phase|Death|1|||
146677198|NCT01846416|528995929|FG000|Treatment Phase|Withdrawal by Subject|2|||
146677199|NCT01846416|528995930|FG001|Treatment Phase|Withdrawal by Subject|4|||
146677200|NCT01846416|528995931|FG002|Treatment Phase|Withdrawal by Subject|2|||
146677201|NCT01846416|528995929|FG000|Treatment Phase|Other|1|||
146677202|NCT01846416|528995930|FG001|Treatment Phase|Other|5|||
146774358|NCT02528188|529343571|FG002|Overall Study|Lost to Follow-up|31|||
146926480|NCT01968187|529890829|FG001|Overall Study|Randomized but not treated|0|||
146926481|NCT00430521|529890830|FG000|Overall Study|Adverse Event|0|||
146926482|NCT00430521|529890831|FG001|Overall Study|Adverse Event|0|||
146926483|NCT00430521|529890832|FG002|Overall Study|Adverse Event|0|||
146926484|NCT00430521|529890833|FG003|Overall Study|Adverse Event|0|||
146677203|NCT01846416|528995931|FG002|Treatment Phase|Other|1|||
146677204|NCT01846416|528995929|FG000|Treatment Phase|Physician Decision|1|||
146677205|NCT01846416|528995930|FG001|Treatment Phase|Physician Decision|2|||
146926485|NCT00430521|529890834|FG004|Overall Study|Adverse Event|0|||
146677206|NCT01846416|528995931|FG002|Treatment Phase|Physician Decision|0|||
146677207|NCT01846416|528995929|FG000|Treatment Phase|Adverse Event|3|||
146677208|NCT01846416|528995930|FG001|Treatment Phase|Adverse Event|4|||
146677209|NCT01846416|528995931|FG002|Treatment Phase|Adverse Event|0|||
146677210|NCT01846416|528995929|FG000|Treatment Phase|Non-compliance|0|||
146677211|NCT01846416|528995930|FG001|Treatment Phase|Non-compliance|2|||
146677212|NCT01846416|528995931|FG002|Treatment Phase|Non-compliance|0|||
146677213|NCT01846416|528995929|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
146677214|NCT01846416|528995930|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
146677215|NCT01846416|528995931|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
146677216|NCT01846416|528995929|FG000|Treatment Phase|Progressive Disease|21|||
146677217|NCT01846416|528995930|FG001|Treatment Phase|Progressive Disease|63|||
146677218|NCT01846416|528995931|FG002|Treatment Phase|Progressive Disease|9|||
146677219|NCT01846416|528995929|FG000|Survival Follow-up|Death|21|||
146677220|NCT01846416|528995930|FG001|Survival Follow-up|Death|62|||
146677221|NCT01846416|528995931|FG002|Survival Follow-up|Death|9|||
146677222|NCT01846416|528995929|FG000|Survival Follow-up|Lost to Follow-up|0|||
146677223|NCT01846416|528995930|FG001|Survival Follow-up|Lost to Follow-up|2|||
146677224|NCT01846416|528995931|FG002|Survival Follow-up|Lost to Follow-up|2|||
146677225|NCT01846416|528995929|FG000|Survival Follow-up|Withdrawal by Subject|2|||
146677226|NCT01846416|528995930|FG001|Survival Follow-up|Withdrawal by Subject|7|||
146677227|NCT01846416|528995931|FG002|Survival Follow-up|Withdrawal by Subject|0|||
146677228|NCT01846416|528995929|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
146677229|NCT01846416|528995930|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
146677230|NCT01846416|528995931|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
146677231|NCT01846416|528995929|FG000|Survival Follow-up|Other|3|||
146677232|NCT01846416|528995930|FG001|Survival Follow-up|Other|1|||
146677233|NCT01846416|528995931|FG002|Survival Follow-up|Other|1|||
146677234|NCT01737697|528995934|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146677235|NCT01737697|528995935|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
146677236|NCT01737697|528995936|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146677237|NCT01737697|528995937|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
146677238|NCT01737697|528995938|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
146677239|NCT01737697|528995939|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146677240|NCT01737697|528995940|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146677241|NCT01737697|528995941|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146677242|NCT01737697|528995942|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146677243|NCT01737697|528995943|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146677244|NCT01737697|528995944|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146677245|NCT01737697|528995945|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146677246|NCT01737697|528995946|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146677247|NCT01737697|528995947|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146677248|NCT01737697|528995948|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146677249|NCT01737697|528995934|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
146677250|NCT01737697|528995935|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
146677251|NCT01737697|528995936|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
146677252|NCT01737697|528995937|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146677253|NCT01737697|528995938|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146677254|NCT01737697|528995939|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146677255|NCT01737697|528995940|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146677256|NCT01737697|528995941|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146677257|NCT01737697|528995942|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146677258|NCT01737697|528995943|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146677259|NCT01737697|528995944|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146677260|NCT01737697|528995945|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146677261|NCT01737697|528995946|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146677262|NCT01737697|528995947|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146677263|NCT01737697|528995948|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146677264|NCT01737697|528995934|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
146677265|NCT01737697|528995935|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
146677266|NCT01737697|528995936|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
146677267|NCT01737697|528995937|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
146677268|NCT01737697|528995938|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
146677269|NCT01737697|528995939|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
146677270|NCT01737697|528995940|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
146677271|NCT01737697|528995941|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
146677272|NCT01737697|528995942|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
146677273|NCT01737697|528995943|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
146677274|NCT01737697|528995944|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
146677275|NCT01737697|528995945|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
146677276|NCT01737697|528995946|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
146677277|NCT01737697|528995947|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
146677278|NCT01737697|528995948|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
146677279|NCT01737697|528995934|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146677280|NCT01737697|528995935|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
146926486|NCT00430521|529890835|FG005|Overall Study|Adverse Event|2|||
146926487|NCT00430521|529890836|FG006|Overall Study|Adverse Event|1|||
146926488|NCT00430521|529890837|FG007|Overall Study|Adverse Event|0|||
146926489|NCT00430521|529890830|FG000|Overall Study|Lost to Follow-up|7|||
146926490|NCT00430521|529890831|FG001|Overall Study|Lost to Follow-up|8|||
146677281|NCT01737697|528995936|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146677282|NCT01737697|528995937|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146677283|NCT01737697|528995938|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146677284|NCT01737697|528995939|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146677285|NCT01737697|528995940|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146677286|NCT01737697|528995941|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146677287|NCT01737697|528995942|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146677288|NCT01737697|528995943|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146677289|NCT01737697|528995944|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146677290|NCT01737697|528995945|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146677291|NCT01737697|528995946|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146677292|NCT01737697|528995947|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146677293|NCT01737697|528995948|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146677294|NCT01737697|528995934|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146677295|NCT01737697|528995935|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146677296|NCT01737697|528995936|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146677297|NCT01737697|528995937|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146677298|NCT01737697|528995938|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
146677299|NCT01737697|528995939|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146677300|NCT01737697|528995940|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146677301|NCT01737697|528995941|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146677302|NCT01737697|528995942|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146677303|NCT01737697|528995943|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146677304|NCT01737697|528995944|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146677305|NCT01737697|528995945|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146677306|NCT01737697|528995946|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146677307|NCT01737697|528995947|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146677308|NCT01737697|528995948|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146677309|NCT01737697|528995934|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146677310|NCT01737697|528995935|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
146677311|NCT01737697|528995936|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
146677312|NCT01737697|528995937|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
146677313|NCT01737697|528995938|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
146677314|NCT01737697|528995939|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146677315|NCT01737697|528995940|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146677316|NCT01737697|528995941|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146677317|NCT01737697|528995942|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146677318|NCT01737697|528995943|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146677319|NCT01737697|528995944|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146677320|NCT01737697|528995945|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146677321|NCT01737697|528995946|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146677322|NCT01737697|528995947|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146677323|NCT01737697|528995948|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146677324|NCT01737697|528995934|FG000|Subacute Phase|Adverse Event|0|||
146677325|NCT01737697|528995935|FG001|Subacute Phase|Adverse Event|0|||
146677326|NCT01737697|528995936|FG002|Subacute Phase|Adverse Event|0|||
146677327|NCT01737697|528995937|FG003|Subacute Phase|Adverse Event|0|||
146677328|NCT01737697|528995938|FG004|Subacute Phase|Adverse Event|0|||
146677329|NCT01737697|528995939|FG005|Subacute Phase|Adverse Event|1|||
146677330|NCT01737697|528995940|FG006|Subacute Phase|Adverse Event|1|||
146677331|NCT01737697|528995941|FG007|Subacute Phase|Adverse Event|1|||
146677332|NCT01737697|528995942|FG008|Subacute Phase|Adverse Event|1|||
146677333|NCT01737697|528995943|FG009|Subacute Phase|Adverse Event|1|||
146677334|NCT01737697|528995944|FG010|Subacute Phase|Adverse Event|4|||
146677335|NCT01737697|528995945|FG011|Subacute Phase|Adverse Event|1|||
146677336|NCT01737697|528995946|FG012|Subacute Phase|Adverse Event|1|||
146677337|NCT01737697|528995947|FG013|Subacute Phase|Adverse Event|0|||
146926491|NCT00430521|529890832|FG002|Overall Study|Lost to Follow-up|3|||
146677338|NCT01737697|528995948|FG014|Subacute Phase|Adverse Event|0|||
146677339|NCT01737697|528995934|FG000|Subacute Phase|Withdrawal by Subject|0|||
146677340|NCT01737697|528995935|FG001|Subacute Phase|Withdrawal by Subject|0|||
146677341|NCT01737697|528995936|FG002|Subacute Phase|Withdrawal by Subject|0|||
146677342|NCT01737697|528995937|FG003|Subacute Phase|Withdrawal by Subject|0|||
146677343|NCT01737697|528995938|FG004|Subacute Phase|Withdrawal by Subject|0|||
146677344|NCT01737697|528995939|FG005|Subacute Phase|Withdrawal by Subject|1|||
146677345|NCT01737697|528995940|FG006|Subacute Phase|Withdrawal by Subject|0|||
146677346|NCT01737697|528995941|FG007|Subacute Phase|Withdrawal by Subject|2|||
146677347|NCT01737697|528995942|FG008|Subacute Phase|Withdrawal by Subject|0|||
146677348|NCT01737697|528995943|FG009|Subacute Phase|Withdrawal by Subject|1|||
146677349|NCT01737697|528995944|FG010|Subacute Phase|Withdrawal by Subject|0|||
146677350|NCT01737697|528995945|FG011|Subacute Phase|Withdrawal by Subject|1|||
146677351|NCT01737697|528995946|FG012|Subacute Phase|Withdrawal by Subject|1|||
146677352|NCT01737697|528995947|FG013|Subacute Phase|Withdrawal by Subject|1|||
146677353|NCT01737697|528995948|FG014|Subacute Phase|Withdrawal by Subject|0|||
146677354|NCT01737697|528995934|FG000|Subacute Phase|Lost to Follow-up|0|||
146677355|NCT01737697|528995935|FG001|Subacute Phase|Lost to Follow-up|0|||
146677356|NCT01737697|528995936|FG002|Subacute Phase|Lost to Follow-up|0|||
146677357|NCT01737697|528995937|FG003|Subacute Phase|Lost to Follow-up|0|||
146677358|NCT01737697|528995938|FG004|Subacute Phase|Lost to Follow-up|0|||
146677359|NCT01737697|528995939|FG005|Subacute Phase|Lost to Follow-up|0|||
146677360|NCT01737697|528995940|FG006|Subacute Phase|Lost to Follow-up|0|||
146677361|NCT01737697|528995941|FG007|Subacute Phase|Lost to Follow-up|0|||
146677362|NCT01737697|528995942|FG008|Subacute Phase|Lost to Follow-up|0|||
146677363|NCT01737697|528995943|FG009|Subacute Phase|Lost to Follow-up|0|||
146677364|NCT01737697|528995944|FG010|Subacute Phase|Lost to Follow-up|0|||
146677365|NCT01737697|528995945|FG011|Subacute Phase|Lost to Follow-up|0|||
146677366|NCT01737697|528995946|FG012|Subacute Phase|Lost to Follow-up|0|||
146677367|NCT01737697|528995947|FG013|Subacute Phase|Lost to Follow-up|0|||
146677368|NCT01737697|528995948|FG014|Subacute Phase|Lost to Follow-up|1|||
146677369|NCT01737697|528995934|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
146677370|NCT01737697|528995935|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
146677371|NCT01737697|528995936|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
146677372|NCT01737697|528995937|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
146677373|NCT01737697|528995938|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
146677374|NCT01737697|528995939|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
146677375|NCT01737697|528995940|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
146677376|NCT01737697|528995941|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
146677377|NCT01737697|528995942|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
146677378|NCT01737697|528995943|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
146677379|NCT01737697|528995944|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
146677380|NCT01737697|528995945|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
146677381|NCT01737697|528995946|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
146677382|NCT01737697|528995947|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
146677383|NCT01737697|528995948|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
146677384|NCT01737697|528995934|FG000|Subacute Phase|Protocol Violation|0|||
146677385|NCT01737697|528995935|FG001|Subacute Phase|Protocol Violation|0|||
146677386|NCT01737697|528995936|FG002|Subacute Phase|Protocol Violation|0|||
146677387|NCT01737697|528995937|FG003|Subacute Phase|Protocol Violation|0|||
146677388|NCT01737697|528995938|FG004|Subacute Phase|Protocol Violation|0|||
146677389|NCT01737697|528995939|FG005|Subacute Phase|Protocol Violation|1|||
146677390|NCT01737697|528995940|FG006|Subacute Phase|Protocol Violation|0|||
146677391|NCT01737697|528995941|FG007|Subacute Phase|Protocol Violation|0|||
146677392|NCT01737697|528995942|FG008|Subacute Phase|Protocol Violation|0|||
146677393|NCT01737697|528995943|FG009|Subacute Phase|Protocol Violation|0|||
146677394|NCT01737697|528995944|FG010|Subacute Phase|Protocol Violation|1|||
146677395|NCT01737697|528995945|FG011|Subacute Phase|Protocol Violation|0|||
146677396|NCT01737697|528995946|FG012|Subacute Phase|Protocol Violation|0|||
146677397|NCT01737697|528995947|FG013|Subacute Phase|Protocol Violation|0|||
146677398|NCT01737697|528995948|FG014|Subacute Phase|Protocol Violation|0|||
146677399|NCT01737697|528995934|FG000|Subacute Phase|Physician Decision|0|||
146677400|NCT01737697|528995935|FG001|Subacute Phase|Physician Decision|0|||
146677401|NCT01737697|528995936|FG002|Subacute Phase|Physician Decision|0|||
146677402|NCT01737697|528995937|FG003|Subacute Phase|Physician Decision|0|||
146677403|NCT01737697|528995938|FG004|Subacute Phase|Physician Decision|0|||
146774359|NCT02528188|529343569|FG000|Overall Study|Death|4|||
146774360|NCT02528188|529343570|FG001|Overall Study|Death|4|||
146677404|NCT01737697|528995939|FG005|Subacute Phase|Physician Decision|0|||
146677405|NCT01737697|528995940|FG006|Subacute Phase|Physician Decision|0|||
146677406|NCT01737697|528995941|FG007|Subacute Phase|Physician Decision|0|||
146677407|NCT01737697|528995942|FG008|Subacute Phase|Physician Decision|1|||
146677408|NCT01737697|528995943|FG009|Subacute Phase|Physician Decision|0|||
146677409|NCT01737697|528995944|FG010|Subacute Phase|Physician Decision|0|||
146677410|NCT01737697|528995945|FG011|Subacute Phase|Physician Decision|0|||
146677411|NCT01737697|528995946|FG012|Subacute Phase|Physician Decision|0|||
146677412|NCT01737697|528995947|FG013|Subacute Phase|Physician Decision|0|||
146677413|NCT01737697|528995948|FG014|Subacute Phase|Physician Decision|0|||
146677414|NCT01737697|528995934|FG000|Subacute Phase|Death|0|||
146677415|NCT01737697|528995935|FG001|Subacute Phase|Death|0|||
146677416|NCT01737697|528995936|FG002|Subacute Phase|Death|0|||
146677417|NCT01737697|528995937|FG003|Subacute Phase|Death|0|||
146677418|NCT01737697|528995938|FG004|Subacute Phase|Death|0|||
146677419|NCT01737697|528995939|FG005|Subacute Phase|Death|0|||
146774361|NCT02528188|529343571|FG002|Overall Study|Death|0|||
146677420|NCT01737697|528995940|FG006|Subacute Phase|Death|0|||
146677421|NCT01737697|528995941|FG007|Subacute Phase|Death|0|||
146677422|NCT01737697|528995942|FG008|Subacute Phase|Death|0|||
146677423|NCT01737697|528995943|FG009|Subacute Phase|Death|0|||
146774362|NCT02528188|529343569|FG000|Overall Study|Other|89|||
146677424|NCT01737697|528995944|FG010|Subacute Phase|Death|1|||
146677425|NCT01737697|528995945|FG011|Subacute Phase|Death|0|||
146677426|NCT01737697|528995946|FG012|Subacute Phase|Death|0|||
146677427|NCT01737697|528995947|FG013|Subacute Phase|Death|0|||
146677428|NCT01737697|528995948|FG014|Subacute Phase|Death|0|||
146677429|NCT03648983|528995950|FG000|Overall Study|Study was terminated due to PI departure|95|||
146677430|NCT01866930|528995951|FG000|Treatment Period|Other|1|||
146677431|NCT01866930|528995952|FG001|Treatment Period|Other|0|||
146677432|NCT01866930|528995951|FG000|Treatment Period|Death|0|||
146677433|NCT01866930|528995952|FG001|Treatment Period|Death|2|||
146677434|NCT01866930|528995951|FG000|Treatment Period|Poor/non compliance|0|||
146677435|NCT01866930|528995952|FG001|Treatment Period|Poor/non compliance|2|||
146677436|NCT01866930|528995951|FG000|Treatment Period|No longer meets study criteria|0|||
146677437|NCT01866930|528995952|FG001|Treatment Period|No longer meets study criteria|1|||
146677438|NCT01866930|528995951|FG000|Treatment Period|Withdrawal by Subject|2|||
146677439|NCT01866930|528995952|FG001|Treatment Period|Withdrawal by Subject|8|||
146677440|NCT01866930|528995951|FG000|Treatment Period|Lack of Efficacy|1|||
146677441|NCT01866930|528995952|FG001|Treatment Period|Lack of Efficacy|9|||
146677442|NCT01866930|528995951|FG000|Treatment Period|Adverse Event|4|||
146677443|NCT01866930|528995952|FG001|Treatment Period|Adverse Event|12|||
146677444|NCT01866930|528995951|FG000|Treatment Period|Lost to Follow-up|1|||
146677445|NCT01866930|528995952|FG001|Treatment Period|Lost to Follow-up|1|||
146677446|NCT01866930|528995951|FG000|Follow-up Period|Lost to Follow-up|1|||
146677447|NCT01866930|528995952|FG001|Follow-up Period|Lost to Follow-up|1|||
146677448|NCT01866930|528995951|FG000|Follow-up Period|Other|1|||
146677449|NCT01866930|528995952|FG001|Follow-up Period|Other|5|||
146677450|NCT01866930|528995951|FG000|Follow-up Period|No longer required per protocol|1|||
146677451|NCT01866930|528995952|FG001|Follow-up Period|No longer required per protocol|0|||
146677452|NCT01866930|528995951|FG000|Follow-up Period|Withdrawal by Subject|3|||
146677453|NCT01866930|528995952|FG001|Follow-up Period|Withdrawal by Subject|3|||
146677454|NCT02521870|528995955|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146677455|NCT02521870|528995956|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
146677456|NCT02521870|528995957|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146677457|NCT02521870|528995958|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146677458|NCT02521870|528995959|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146677459|NCT02521870|528995960|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146677460|NCT02521870|528995961|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146677461|NCT02521870|528995962|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146677462|NCT02521870|528995963|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146677463|NCT02521870|528995964|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146677464|NCT02521870|528995965|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146677465|NCT02521870|528995966|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146677466|NCT02521870|528995955|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
146677467|NCT02521870|528995956|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
146677468|NCT02521870|528995957|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
146677469|NCT02521870|528995958|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
146677470|NCT02521870|528995959|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
146677471|NCT02521870|528995960|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
146677472|NCT02521870|528995961|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
146677473|NCT02521870|528995962|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
146677474|NCT02521870|528995963|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
146677475|NCT02521870|528995964|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
146677476|NCT02521870|528995965|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
146677477|NCT02521870|528995966|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
146677478|NCT02521870|528995955|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
146677479|NCT02521870|528995956|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
146677480|NCT02521870|528995957|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
146677481|NCT02521870|528995958|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
146677482|NCT02521870|528995959|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
146677483|NCT02521870|528995960|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
146677484|NCT02521870|528995961|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
146677485|NCT02521870|528995962|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
146677486|NCT02521870|528995963|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
146677487|NCT02521870|528995964|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
146774363|NCT02528188|529343570|FG001|Overall Study|Other|91|||
146774364|NCT02528188|529343571|FG002|Overall Study|Other|74|||
146774365|NCT02528188|529343569|FG000|Overall Study|Randomized but not treated|6|||
146677488|NCT02521870|528995965|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
146677489|NCT02521870|528995966|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
146677490|NCT02521870|528995955|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146677491|NCT02521870|528995956|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146677492|NCT02521870|528995957|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146677493|NCT02521870|528995958|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146677494|NCT02521870|528995959|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
146774366|NCT02528188|529343570|FG001|Overall Study|Randomized but not treated|7|||
146926492|NCT00430521|529890833|FG003|Overall Study|Lost to Follow-up|5|||
146926493|NCT00430521|529890834|FG004|Overall Study|Lost to Follow-up|5|||
146926494|NCT00430521|529890835|FG005|Overall Study|Lost to Follow-up|2|||
146677495|NCT02521870|528995960|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
146677496|NCT02521870|528995961|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
146677497|NCT02521870|528995962|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146677498|NCT02521870|528995963|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
146677499|NCT02521870|528995964|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
146677500|NCT02521870|528995965|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
146677501|NCT02521870|528995966|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146677502|NCT02521870|528995955|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
146677503|NCT02521870|528995956|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
146677504|NCT02521870|528995957|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
146677505|NCT02521870|528995958|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
146677506|NCT02521870|528995959|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
146677507|NCT02521870|528995960|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
146677508|NCT02521870|528995961|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
146677509|NCT02521870|528995962|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
146677510|NCT02521870|528995963|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
146677511|NCT02521870|528995964|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
146677512|NCT02521870|528995965|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
146677513|NCT02521870|528995966|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
146677514|NCT02521870|528995955|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
146677515|NCT02521870|528995956|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
146677516|NCT02521870|528995957|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
146677517|NCT02521870|528995958|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
146677518|NCT02521870|528995959|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
146677519|NCT02521870|528995960|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
146677520|NCT02521870|528995961|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
146677521|NCT02521870|528995962|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
146677522|NCT02521870|528995963|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
146677523|NCT02521870|528995964|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
146677524|NCT02521870|528995965|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
146677525|NCT02521870|528995966|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
146677526|NCT02521870|528995955|FG000|Phase 2: Dose Expansion|Death|0|||
146677527|NCT02521870|528995956|FG001|Phase 2: Dose Expansion|Death|0|||
146677528|NCT02521870|528995957|FG002|Phase 2: Dose Expansion|Death|0|||
146677529|NCT02521870|528995958|FG003|Phase 2: Dose Expansion|Death|0|||
146677530|NCT02521870|528995959|FG004|Phase 2: Dose Expansion|Death|1|||
146677531|NCT02521870|528995960|FG005|Phase 2: Dose Expansion|Death|1|||
146677532|NCT02521870|528995961|FG006|Phase 2: Dose Expansion|Death|3|||
146677533|NCT02521870|528995962|FG007|Phase 2: Dose Expansion|Death|1|||
146677534|NCT02521870|528995963|FG008|Phase 2: Dose Expansion|Death|1|||
146677535|NCT02521870|528995964|FG009|Phase 2: Dose Expansion|Death|5|||
146677536|NCT02521870|528995965|FG010|Phase 2: Dose Expansion|Death|2|||
146677537|NCT02521870|528995966|FG011|Phase 2: Dose Expansion|Death|2|||
146677538|NCT02521870|528995955|FG000|Phase 2: Dose Expansion|Other|0|||
146677539|NCT02521870|528995956|FG001|Phase 2: Dose Expansion|Other|0|||
146677540|NCT02521870|528995957|FG002|Phase 2: Dose Expansion|Other|0|||
146677541|NCT02521870|528995958|FG003|Phase 2: Dose Expansion|Other|0|||
146677542|NCT02521870|528995959|FG004|Phase 2: Dose Expansion|Other|10|||
146677543|NCT02521870|528995960|FG005|Phase 2: Dose Expansion|Other|3|||
146677544|NCT02521870|528995961|FG006|Phase 2: Dose Expansion|Other|2|||
146677545|NCT02521870|528995962|FG007|Phase 2: Dose Expansion|Other|0|||
146677546|NCT02521870|528995963|FG008|Phase 2: Dose Expansion|Other|10|||
146677547|NCT02521870|528995964|FG009|Phase 2: Dose Expansion|Other|5|||
146677548|NCT02521870|528995965|FG010|Phase 2: Dose Expansion|Other|1|||
146677549|NCT02521870|528995966|FG011|Phase 2: Dose Expansion|Other|7|||
146677550|NCT02521870|528995955|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146926495|NCT00430521|529890836|FG006|Overall Study|Lost to Follow-up|8|||
146926496|NCT00430521|529890837|FG007|Overall Study|Lost to Follow-up|10|||
146926497|NCT00430521|529890830|FG000|Overall Study|Pregnancy|0|||
146677551|NCT02521870|528995956|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146677552|NCT02521870|528995957|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146677553|NCT02521870|528995958|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146677554|NCT02521870|528995959|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
146677555|NCT02521870|528995960|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146677556|NCT02521870|528995961|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146677557|NCT02521870|528995962|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146677558|NCT02521870|528995963|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146677559|NCT02521870|528995964|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146677560|NCT02521870|528995965|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146677561|NCT02521870|528995966|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146677562|NCT02521870|528995955|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146774367|NCT02528188|529343571|FG002|Overall Study|Randomized but not treated|12|||
146926498|NCT00430521|529890831|FG001|Overall Study|Pregnancy|0|||
146774368|NCT05368831|529343572|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
146774369|NCT00529659|529343573|FG000|Overall Study|Adverse Event|8|||
146774370|NCT00529659|529343574|FG001|Overall Study|Adverse Event|7|||
146774371|NCT00529659|529343573|FG000|Overall Study|Lost to Follow-up|0|||
146774372|NCT00529659|529343574|FG001|Overall Study|Lost to Follow-up|2|||
146774373|NCT00529659|529343573|FG000|Overall Study|Physician Decision|0|||
146774374|NCT00529659|529343574|FG001|Overall Study|Physician Decision|2|||
146774375|NCT00529659|529343573|FG000|Overall Study|Protocol Violation|2|||
146774376|NCT00529659|529343574|FG001|Overall Study|Protocol Violation|6|||
146774377|NCT00529659|529343573|FG000|Overall Study|Withdrawal by Subject|1|||
146774378|NCT00529659|529343574|FG001|Overall Study|Withdrawal by Subject|6|||
146774379|NCT03887650|529343575|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
146926499|NCT00430521|529890832|FG002|Overall Study|Pregnancy|0|||
146926500|NCT00430521|529890833|FG003|Overall Study|Pregnancy|0|||
146926501|NCT00430521|529890834|FG004|Overall Study|Pregnancy|0|||
146926502|NCT00430521|529890835|FG005|Overall Study|Pregnancy|0|||
146926503|NCT00430521|529890836|FG006|Overall Study|Pregnancy|1|||
146926504|NCT00430521|529890837|FG007|Overall Study|Pregnancy|0|||
146926505|NCT00430521|529890830|FG000|Overall Study|Vaccine Expired|0|||
146677563|NCT02521870|528995956|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146677564|NCT02521870|528995957|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146677565|NCT02521870|528995958|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146677566|NCT02521870|528995959|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
146677567|NCT02521870|528995960|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146677568|NCT02521870|528995961|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146677569|NCT02521870|528995962|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146677570|NCT02521870|528995963|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146677571|NCT02521870|528995964|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146677572|NCT02521870|528995965|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146677573|NCT02521870|528995966|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146677574|NCT00279305|528995967|FG000|Overall Study|Pregnancy|1|||
146677575|NCT00279305|528995968|FG001|Overall Study|Pregnancy|0|||
146677576|NCT00279305|528995967|FG000|Overall Study|Withdrawal by Subject|2|||
146677577|NCT00279305|528995968|FG001|Overall Study|Withdrawal by Subject|0|||
146677578|NCT00279305|528995967|FG000|Overall Study|Dificulting establishing IV|1|||
146677579|NCT00279305|528995968|FG001|Overall Study|Dificulting establishing IV|0|||
146677580|NCT00279305|528995967|FG000|Overall Study|FDA Safety Alert|4|||
146677581|NCT00279305|528995968|FG001|Overall Study|FDA Safety Alert|1|||
146677582|NCT02862171|528995973|FG000|Overall Study|Death|1|||
146677583|NCT02862171|528995973|FG000|Overall Study|Lost to Follow-up|13|||
146677584|NCT02862171|528995973|FG000|Overall Study|Withdrawal by Subject|57|||
146677585|NCT02862171|528995973|FG000|Overall Study|Non-compliance|4|||
146677586|NCT02862171|528995973|FG000|Overall Study|HIV-1 seroconversion|18|||
146677587|NCT03930797|528995974|FG000|Overall Study|Lost to Follow-up|3|||
146677588|NCT03930797|528995975|FG001|Overall Study|Lost to Follow-up|10|||
146677589|NCT00662012|528995976|FG000|Overall Study|Lost to Follow-up|85|||
146677590|NCT00662012|528995976|FG000|Overall Study|Death|1|||
146677591|NCT00662012|528995976|FG000|Overall Study|Withdrawal by Subject|1|||
146677592|NCT04656691|528995980|FG000|Overall Study|Adverse Event|1|||
146677593|NCT02846779|528995983|FG000|Overall Study|Lost Enrollment|83|||
146677594|NCT02846779|528995984|FG001|Overall Study|Lost Enrollment|82|||
146677595|NCT02846779|528995985|FG002|Overall Study|Lost Enrollment|86|||
146677596|NCT02846779|528995983|FG000|Overall Study|Less than 31 days of follow-up|56|||
146677597|NCT02846779|528995984|FG001|Overall Study|Less than 31 days of follow-up|45|||
146677598|NCT02846779|528995985|FG002|Overall Study|Less than 31 days of follow-up|52|||
146677599|NCT00887978|528995988|FG000|Overall Study|Adverse Event|18|||
146677600|NCT00887978|528995989|FG001|Overall Study|Adverse Event|5|||
146677601|NCT00887978|528995988|FG000|Overall Study|Clinical Worsening|4|||
146677602|NCT00887978|528995989|FG001|Overall Study|Clinical Worsening|4|||
146677603|NCT00887978|528995988|FG000|Overall Study|Death|2|||
146677604|NCT00887978|528995989|FG001|Overall Study|Death|3|||
146677605|NCT00887978|528995988|FG000|Overall Study|Withdrawal by Subject|1|||
146677606|NCT00887978|528995989|FG001|Overall Study|Withdrawal by Subject|2|||
146677607|NCT00887978|528995988|FG000|Overall Study|Lost to Follow-up|0|||
146774380|NCT03887650|529343576|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
146677608|NCT00887978|528995989|FG001|Overall Study|Lost to Follow-up|1|||
146677609|NCT04023526|528997622|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
146677610|NCT04023526|528997623|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
146774381|NCT03887650|529343575|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
146677611|NCT04023526|528997622|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
146677612|NCT04023526|528997623|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
146677613|NCT02324569|528997628|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
146677614|NCT02324569|528997629|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
146677615|NCT02324569|528997628|FG000|Overall Study|Voluntary Withdrawal|3|||
146926506|NCT00430521|529890831|FG001|Overall Study|Vaccine Expired|0|||
146926507|NCT00430521|529890832|FG002|Overall Study|Vaccine Expired|0|||
146677616|NCT02324569|528997629|FG001|Overall Study|Voluntary Withdrawal|6|||
146677617|NCT02324569|528997628|FG000|Overall Study|Lack of Efficacy|2|||
146677618|NCT02324569|528997629|FG001|Overall Study|Lack of Efficacy|3|||
146677619|NCT02324569|528997628|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
146677620|NCT02324569|528997629|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
146677621|NCT02324569|528997628|FG000|Overall Study|Inconvenient Schedule|2|||
146677622|NCT02324569|528997629|FG001|Overall Study|Inconvenient Schedule|0|||
146677623|NCT01943292|528997630|FG000|Overall Study|Withdrawal by Subject|1|||
146677624|NCT01943292|528997631|FG001|Overall Study|Withdrawal by Subject|0|||
146677625|NCT01943292|528997632|FG002|Overall Study|Withdrawal by Subject|0|||
146677626|NCT00996216|528997633|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
146677627|NCT00996216|528997633|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
146677628|NCT00996216|528997633|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
146774382|NCT03887650|529343576|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
146774383|NCT03887650|529343575|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
146774384|NCT03887650|529343576|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
146774385|NCT04200365|529343580|FG000|Overall Study|Adverse Event|2|||
146774386|NCT04200365|529343580|FG000|Overall Study|Progressive Disease|4|||
146774387|NCT04200365|529343580|FG000|Overall Study|Lack of Efficacy|1|||
146774388|NCT04200365|529343580|FG000|Overall Study|Study Closure|4|||
146774389|NCT01499199|529343583|FG000|Overall Study|Adverse Event|1|||
146774390|NCT01499199|529343583|FG000|Overall Study|Lack of Efficacy|1|||
146774391|NCT01692730|529343584|FG000|Overall Study|Lost to Follow-up|225|||
146774392|NCT01692730|529343585|FG001|Overall Study|Lost to Follow-up|227|||
146774393|NCT01849055|529343586|FG000|Overall Study|Withdrawal by Subject|0|||
146774394|NCT01849055|529343587|FG001|Overall Study|Withdrawal by Subject|0|||
146774395|NCT01849055|529343588|FG002|Overall Study|Withdrawal by Subject|1|||
146774396|NCT01849055|529343589|FG003|Overall Study|Withdrawal by Subject|0|||
146774397|NCT01849055|529343590|FG004|Overall Study|Withdrawal by Subject|0|||
146774398|NCT01849055|529343591|FG005|Overall Study|Withdrawal by Subject|0|||
146774399|NCT01199575|529343592|FG000|Overall Study|Withdrawal by Subject|5|||
146774400|NCT00223795|529343597|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
146926508|NCT00430521|529890833|FG003|Overall Study|Vaccine Expired|0|||
146926509|NCT00430521|529890834|FG004|Overall Study|Vaccine Expired|0|||
146926510|NCT00430521|529890835|FG005|Overall Study|Vaccine Expired|1|||
146774401|NCT00223795|529343598|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
146774402|NCT00223795|529343597|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
146774403|NCT00223795|529343598|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
146774404|NCT02139943|529343599|FG000|Overall Study|Adverse Event|0|||
146774405|NCT02139943|529343600|FG001|Overall Study|Adverse Event|1|||
146774406|NCT02139943|529343601|FG002|Overall Study|Adverse Event|2|||
146774407|NCT02139943|529343599|FG000|Overall Study|Lost to Follow-up|3|||
146774408|NCT02139943|529343600|FG001|Overall Study|Lost to Follow-up|2|||
146774409|NCT02139943|529343601|FG002|Overall Study|Lost to Follow-up|2|||
146774410|NCT02139943|529343599|FG000|Overall Study|Withdrawal by Subject|4|||
146774411|NCT02139943|529343600|FG001|Overall Study|Withdrawal by Subject|3|||
146774412|NCT02139943|529343601|FG002|Overall Study|Withdrawal by Subject|0|||
146774413|NCT02139943|529343599|FG000|Overall Study|Other|0|||
146774414|NCT02139943|529343600|FG001|Overall Study|Other|0|||
146774415|NCT02139943|529343601|FG002|Overall Study|Other|1|||
146774416|NCT02139943|529343599|FG000|Overall Study|Participant wishes to discontinue|2|||
146774417|NCT02139943|529343600|FG001|Overall Study|Participant wishes to discontinue|0|||
146774418|NCT02139943|529343601|FG002|Overall Study|Participant wishes to discontinue|0|||
146774419|NCT02139943|529343599|FG000|Overall Study|Participant in Poor Compliance|1|||
146774420|NCT02139943|529343600|FG001|Overall Study|Participant in Poor Compliance|0|||
146774421|NCT02139943|529343601|FG002|Overall Study|Participant in Poor Compliance|1|||
146774422|NCT02139943|529343599|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
146774423|NCT02139943|529343600|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
146774424|NCT02139943|529343601|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
146774425|NCT02299375|529343604|FG000|Overall Study|Adverse Event, serious fatal|1|||
146774426|NCT02299375|529343605|FG001|Overall Study|Adverse Event, serious fatal|3|||
146774427|NCT02299375|529343604|FG000|Overall Study|Adverse Event, non-fatal|8|||
146774428|NCT02299375|529343605|FG001|Overall Study|Adverse Event, non-fatal|9|||
146774429|NCT02299375|529343604|FG000|Overall Study|Lack of Efficacy|1|||
146774430|NCT02299375|529343605|FG001|Overall Study|Lack of Efficacy|3|||
146774431|NCT02299375|529343604|FG000|Overall Study|Protocol Violation|1|||
146774432|NCT02299375|529343605|FG001|Overall Study|Protocol Violation|3|||
146774433|NCT02299375|529343604|FG000|Overall Study|Other: Met stopping criteria|1|||
146926511|NCT00430521|529890836|FG006|Overall Study|Vaccine Expired|0|||
146926512|NCT00430521|529890837|FG007|Overall Study|Vaccine Expired|0|||
146677629|NCT00903695|528997639|FG000|Overall Study|medical exclusion after 1st testing|1|||
146774434|NCT02299375|529343605|FG001|Overall Study|Other: Met stopping criteria|0|||
146774435|NCT02299375|529343604|FG000|Overall Study|Other: Study closed/terminated|66|||
146774436|NCT02299375|529343605|FG001|Overall Study|Other: Study closed/terminated|55|||
146926513|NCT00430521|529890830|FG000|Overall Study|Protocol Violation|1|||
146677630|NCT00903695|528997640|FG001|Overall Study|medical exclusion after 1st testing|0|||
146677631|NCT00903695|528997639|FG000|Overall Study|lung cancer|1|||
146677632|NCT00903695|528997640|FG001|Overall Study|lung cancer|0|||
146677633|NCT01342796|528997644|FG000|Overall Study|Withdrawal by Subject|2|||
146677634|NCT01342796|528997645|FG001|Overall Study|Withdrawal by Subject|0|||
146677635|NCT01342796|528997644|FG000|Overall Study|Lost to Follow-up|0|||
146677636|NCT01342796|528997645|FG001|Overall Study|Lost to Follow-up|3|||
146677637|NCT01342796|528997644|FG000|Overall Study|Inappropriate enrollment|1|||
146677638|NCT01342796|528997645|FG001|Overall Study|Inappropriate enrollment|0|||
146677639|NCT01599234|528997657|FG000|Overall Study|Adverse Event|9|||
146677640|NCT01599234|528997658|FG001|Overall Study|Adverse Event|5|||
146677641|NCT01599234|528997657|FG000|Overall Study|Withdrawal by Subject|2|||
146677642|NCT01599234|528997658|FG001|Overall Study|Withdrawal by Subject|1|||
146677643|NCT01599234|528997657|FG000|Overall Study|Lost to Follow-up|1|||
146677644|NCT01599234|528997658|FG001|Overall Study|Lost to Follow-up|2|||
146677645|NCT01599234|528997657|FG000|Overall Study|Lack of Efficacy|2|||
146677646|NCT01599234|528997658|FG001|Overall Study|Lack of Efficacy|4|||
146677647|NCT01599234|528997657|FG000|Overall Study|Unable to operate spray|1|||
146677648|NCT01599234|528997658|FG001|Overall Study|Unable to operate spray|0|||
146677649|NCT01599234|528997657|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
146677650|NCT01599234|528997658|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
146677651|NCT01599234|528997657|FG000|Overall Study|Death|1|||
146677652|NCT01599234|528997658|FG001|Overall Study|Death|0|||
146677653|NCT01599234|528997657|FG000|Overall Study|Patient would not stop driving|1|||
146677654|NCT01599234|528997658|FG001|Overall Study|Patient would not stop driving|0|||
146677655|NCT01599234|528997657|FG000|Overall Study|Contra-indication discovered|0|||
146677656|NCT01599234|528997658|FG001|Overall Study|Contra-indication discovered|1|||
146677657|NCT01599234|528997657|FG000|Overall Study|Pregnancy|0|||
146677658|NCT01599234|528997658|FG001|Overall Study|Pregnancy|1|||
146677659|NCT04492618|528997661|FG000|Overall Study|Withdrawal by Subject|1|||
146677660|NCT03489720|528997662|FG000|Overall Study|Withdrawal by Subject|2|||
146677661|NCT03489720|528997663|FG001|Overall Study|Withdrawal by Subject|0|||
146677662|NCT02495168|528997667|FG000|Overall Study|Other than Specified|18|||
146677663|NCT02495168|528997668|FG001|Overall Study|Other than Specified|22|||
146677664|NCT02495168|528997669|FG002|Overall Study|Other than Specified|5|||
146677665|NCT02495168|528997667|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
146677666|NCT02495168|528997668|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
146677667|NCT02495168|528997669|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
146677668|NCT02495168|528997667|FG000|Overall Study|Physician Decision|1|||
146677669|NCT02495168|528997668|FG001|Overall Study|Physician Decision|1|||
146677670|NCT02495168|528997669|FG002|Overall Study|Physician Decision|0|||
146677671|NCT02495168|528997667|FG000|Overall Study|Lost to Follow-up|10|||
146677672|NCT02495168|528997668|FG001|Overall Study|Lost to Follow-up|6|||
146677673|NCT02495168|528997669|FG002|Overall Study|Lost to Follow-up|1|||
146677674|NCT02495168|528997667|FG000|Overall Study|Withdrawal by Subject|1|||
146677675|NCT02495168|528997668|FG001|Overall Study|Withdrawal by Subject|4|||
146677676|NCT02495168|528997669|FG002|Overall Study|Withdrawal by Subject|2|||
146677677|NCT02495168|528997667|FG000|Overall Study|Protocol Violation|0|||
146677678|NCT02495168|528997668|FG001|Overall Study|Protocol Violation|10|||
146677679|NCT02495168|528997669|FG002|Overall Study|Protocol Violation|1|||
146677680|NCT02495168|528997667|FG000|Overall Study|Adverse Event|4|||
146677681|NCT02495168|528997668|FG001|Overall Study|Adverse Event|8|||
146677682|NCT02495168|528997669|FG002|Overall Study|Adverse Event|3|||
146677683|NCT02495168|528997667|FG000|Overall Study|Lack of Efficacy|0|||
146677684|NCT02495168|528997668|FG001|Overall Study|Lack of Efficacy|0|||
146677685|NCT02495168|528997669|FG002|Overall Study|Lack of Efficacy|3|||
146677686|NCT03521934|528997670|FG000|Overall Study|Death|65|||
146677687|NCT03521934|528997671|FG001|Overall Study|Death|73|||
146677688|NCT03521934|528997670|FG000|Overall Study|Withdrawal by Subject|18|||
146677689|NCT03521934|528997671|FG001|Overall Study|Withdrawal by Subject|23|||
146677690|NCT03521934|528997670|FG000|Overall Study|Site Terminated by Sponsor|39|||
146677691|NCT03521934|528997671|FG001|Overall Study|Site Terminated by Sponsor|35|||
146677692|NCT03521934|528997670|FG000|Overall Study|Study Terminated by Sponsor|483|||
146677693|NCT03521934|528997671|FG001|Overall Study|Study Terminated by Sponsor|477|||
146677694|NCT03521934|528997670|FG000|Overall Study|Reason not Specified|3|||
146774437|NCT02299375|529343604|FG000|Overall Study|Lost to Follow-up|0|||
146677695|NCT03521934|528997671|FG001|Overall Study|Reason not Specified|6|||
146677696|NCT00727025|528997672|FG000|Overall Study|Physician Decision|23|||
146677697|NCT01987505|528997676|FG000|Overall Study|Other|9|||
146677698|NCT01987505|528997676|FG000|Overall Study|Withdrawal by Subject|2|||
146677699|NCT01987505|528997676|FG000|Overall Study|Other Reason|2|||
146677700|NCT01987505|528997676|FG000|Overall Study|Lost to Follow-up|15|||
146677701|NCT01987505|528997676|FG000|Overall Study|Investigator Decision|2|||
146677702|NCT01987505|528997676|FG000|Overall Study|Death|4|||
146677703|NCT01425281|528997677|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
146677704|NCT01425281|528997678|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
146677705|NCT01425281|528997677|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
146677706|NCT01425281|528997678|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
146677707|NCT01425281|528997677|FG000|At 180-day Clinical Follow-up|Death|0|||
146677708|NCT01425281|528997678|FG001|At 180-day Clinical Follow-up|Death|1|||
146677709|NCT01425281|528997677|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
146677710|NCT01425281|528997678|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
146677711|NCT01425281|528997677|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
146677712|NCT01425281|528997678|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
146677713|NCT01425281|528997677|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
146677714|NCT01425281|528997678|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
146677715|NCT01425281|528997677|FG000|At 2-year Clinical Follow-up|Death|2|||
146677716|NCT01425281|528997678|FG001|At 2-year Clinical Follow-up|Death|0|||
146677717|NCT01425281|528997677|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
146677718|NCT01425281|528997678|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
146677719|NCT01425281|528997677|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
146677720|NCT01425281|528997678|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
146677721|NCT01425281|528997677|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
146677722|NCT01425281|528997678|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
146677723|NCT01425281|528997677|FG000|At 3-year Clinical Follow-up|Death|2|||
146677724|NCT01425281|528997678|FG001|At 3-year Clinical Follow-up|Death|3|||
146677725|NCT01425281|528997677|FG000|At 4-year Clinical Follow-up|Death|7|||
146677726|NCT01425281|528997678|FG001|At 4-year Clinical Follow-up|Death|3|||
146677727|NCT01425281|528997677|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
146677728|NCT01425281|528997678|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
146677729|NCT01425281|528997677|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
146677730|NCT01425281|528997678|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
146677731|NCT01425281|528997677|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
146677732|NCT01425281|528997678|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
146677733|NCT01425281|528997677|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
146677734|NCT01425281|528997678|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
146677735|NCT01425281|528997677|FG000|At 5-year Clinical Follow-up|Death|2|||
146677736|NCT01425281|528997678|FG001|At 5-year Clinical Follow-up|Death|0|||
146677737|NCT01425281|528997677|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
146677738|NCT01425281|528997678|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
146677739|NCT01425281|528997677|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
146677740|NCT01425281|528997678|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
146677741|NCT01425281|528997677|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
146677742|NCT01425281|528997678|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
146677743|NCT01833520|528997679|FG000|Overall Study|Lack of Efficacy|3|||
146677744|NCT01833520|528997680|FG001|Overall Study|Lack of Efficacy|3|||
146677745|NCT01833520|528997681|FG002|Overall Study|Lack of Efficacy|8|||
146677746|NCT01833520|528997682|FG003|Overall Study|Lack of Efficacy|3|||
146677747|NCT03266107|528997683|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
146677748|NCT03266107|528997683|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
146677749|NCT03266107|528997683|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
146677750|NCT03266107|528997683|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
146677751|NCT03454997|528997684|FG000|Overall Study|Staff Coach - Left Oranization|1|||
146677752|NCT03454997|528997685|FG001|Overall Study|Staff Coach - Left Oranization|1|||
146677753|NCT03454997|528997684|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
146677754|NCT03454997|528997685|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
146677755|NCT03454997|528997684|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
146677756|NCT03454997|528997685|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
146677757|NCT03454997|528997684|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
146677758|NCT03454997|528997685|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
146677759|NCT03454997|528997684|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
146677760|NCT03454997|528997685|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
146677761|NCT03454997|528997684|FG000|Overall Study|Client with SMI - Left organization|0|||
146677762|NCT03454997|528997685|FG001|Overall Study|Client with SMI - Left organization|1|||
146677763|NCT03454997|528997684|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
146677764|NCT03454997|528997685|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
146774438|NCT02299375|529343605|FG001|Overall Study|Lost to Follow-up|2|||
146926514|NCT00430521|529890831|FG001|Overall Study|Protocol Violation|0|||
146926515|NCT00430521|529890832|FG002|Overall Study|Protocol Violation|0|||
146926516|NCT00430521|529890833|FG003|Overall Study|Protocol Violation|0|||
146926517|NCT00430521|529890834|FG004|Overall Study|Protocol Violation|0|||
146926518|NCT00430521|529890835|FG005|Overall Study|Protocol Violation|0|||
146677765|NCT01191801|528997688|FG000|Overall Study|Death|36|||
146677766|NCT01191801|528997689|FG001|Overall Study|Death|12|||
146677767|NCT01191801|528997688|FG000|Overall Study|Lack of Efficacy|176|||
146677768|NCT01191801|528997689|FG001|Overall Study|Lack of Efficacy|258|||
146926519|NCT00430521|529890836|FG006|Overall Study|Protocol Violation|0|||
146677769|NCT01191801|528997688|FG000|Overall Study|Adverse Event|9|||
146677770|NCT01191801|528997689|FG001|Overall Study|Adverse Event|8|||
146677771|NCT01191801|528997688|FG000|Overall Study|Protocol Violation|2|||
146677772|NCT01191801|528997689|FG001|Overall Study|Protocol Violation|4|||
146677773|NCT01191801|528997688|FG000|Overall Study|Physician Decision|47|||
146677774|NCT01191801|528997689|FG001|Overall Study|Physician Decision|24|||
146677775|NCT01191801|528997688|FG000|Overall Study|Withdrawal by Subject|1|||
146677776|NCT01191801|528997689|FG001|Overall Study|Withdrawal by Subject|4|||
146677777|NCT01191801|528997688|FG000|Overall Study|Not Provided|45|||
146677778|NCT01191801|528997689|FG001|Overall Study|Not Provided|27|||
146677779|NCT02794883|528997697|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
146677780|NCT02794883|528997698|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
146677781|NCT02794883|528997699|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
146677782|NCT02794883|528997697|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
146677783|NCT02794883|528997698|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
146677784|NCT02794883|528997699|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
146677785|NCT02794883|528997697|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
146677786|NCT02794883|528997698|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
146677787|NCT02794883|528997699|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
146677788|NCT02794883|528997697|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
146677789|NCT02794883|528997698|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
146677790|NCT02794883|528997699|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
146677791|NCT02794883|528997697|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
146677792|NCT02794883|528997698|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
146677793|NCT02794883|528997699|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
146677794|NCT02794883|528997697|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
146677795|NCT02794883|528997698|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
146677796|NCT02794883|528997699|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
146677797|NCT02794883|528997697|FG000|Follow-up Period (up to 2 Years)|Death|12|||
146677798|NCT02794883|528997698|FG001|Follow-up Period (up to 2 Years)|Death|10|||
146677799|NCT02794883|528997699|FG002|Follow-up Period (up to 2 Years)|Death|10|||
146677800|NCT01727297|528997704|FG000|Overall Study|Death|13|||
146677801|NCT01727297|528997705|FG001|Overall Study|Death|0|||
146677802|NCT01727297|528997704|FG000|Overall Study|Protocol Violation|1|||
146677803|NCT01727297|528997705|FG001|Overall Study|Protocol Violation|10|||
146677804|NCT01727297|528997704|FG000|Overall Study|Adverse Event|3|||
146677805|NCT01727297|528997705|FG001|Overall Study|Adverse Event|1|||
146677806|NCT01727297|528997704|FG000|Overall Study|Lost to Follow-up|11|||
146677807|NCT01727297|528997705|FG001|Overall Study|Lost to Follow-up|0|||
146774439|NCT02299375|529343604|FG000|Overall Study|Physician Decision|1|||
146774440|NCT02299375|529343605|FG001|Overall Study|Physician Decision|1|||
146774441|NCT02299375|529343604|FG000|Overall Study|Withdrawal by Subject|1|||
146774442|NCT02299375|529343605|FG001|Overall Study|Withdrawal by Subject|4|||
146774443|NCT00704184|529343610|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
146774444|NCT00704184|529343611|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
146774445|NCT00704184|529343612|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
146774446|NCT00704184|529343613|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
146774447|NCT00704184|529343614|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
146774448|NCT00704184|529343610|FG000|Open-Label Treatment|Adverse Event|0|||
146774449|NCT00704184|529343611|FG001|Open-Label Treatment|Adverse Event|0|||
146774450|NCT00704184|529343612|FG002|Open-Label Treatment|Adverse Event|2|||
146774451|NCT00704184|529343613|FG003|Open-Label Treatment|Adverse Event|0|||
146774452|NCT00704184|529343614|FG004|Open-Label Treatment|Adverse Event|1|||
146774453|NCT00704184|529343610|FG000|Open-Label Treatment|Lack of Efficacy|0|||
146774454|NCT00704184|529343611|FG001|Open-Label Treatment|Lack of Efficacy|2|||
146774455|NCT00704184|529343612|FG002|Open-Label Treatment|Lack of Efficacy|2|||
146774456|NCT00704184|529343613|FG003|Open-Label Treatment|Lack of Efficacy|2|||
146774457|NCT00704184|529343614|FG004|Open-Label Treatment|Lack of Efficacy|1|||
146774458|NCT00704184|529343610|FG000|Open-Label Treatment|Physician Decision|0|||
146774459|NCT00704184|529343611|FG001|Open-Label Treatment|Physician Decision|0|||
146774460|NCT00704184|529343612|FG002|Open-Label Treatment|Physician Decision|0|||
146774461|NCT00704184|529343613|FG003|Open-Label Treatment|Physician Decision|0|||
146774462|NCT00704184|529343614|FG004|Open-Label Treatment|Physician Decision|1|||
146774463|NCT00704184|529343610|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
146774464|NCT00704184|529343611|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
146677808|NCT01727297|528997704|FG000|Overall Study|Withdrawal by Subject|26|||
146677809|NCT01727297|528997705|FG001|Overall Study|Withdrawal by Subject|27|||
146677810|NCT01727297|528997704|FG000|Overall Study|Physician Decision|19|||
146774465|NCT00704184|529343612|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
146677811|NCT01727297|528997705|FG001|Overall Study|Physician Decision|5|||
146677812|NCT01727297|528997704|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
146774466|NCT00704184|529343613|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
146774467|NCT00704184|529343614|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
146774468|NCT00716859|529343615|FG000|Overall Study|Adverse Event|4|||
146677813|NCT01727297|528997705|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
146677814|NCT03018704|528997718|FG000|Overall Study|Lost to Follow-up|1|||
146677815|NCT03018704|528997719|FG001|Overall Study|Lost to Follow-up|1|||
146677816|NCT04448171|528997720|FG000|Overall Study|Procedure Cancelled|1|||
146677817|NCT04448171|528997721|FG001|Overall Study|Procedure Cancelled|0|||
146677818|NCT04448171|528997720|FG000|Overall Study|Protocol Violation|1|||
146677819|NCT04448171|528997721|FG001|Overall Study|Protocol Violation|0|||
146677820|NCT00211809|528997726|FG000|Overall Study|Lack of Efficacy|1|||
146677821|NCT00211809|528997726|FG000|Overall Study|Lost to Follow-up|2|||
146677822|NCT00211809|528997726|FG000|Overall Study|Pregnancy|1|||
146677823|NCT00211809|528997726|FG000|Overall Study|side effects|2|||
146677824|NCT01417234|528997727|FG000|Overall Study|Subject non-compliant|3|||
146677825|NCT00023764|528997728|FG000|Overall Study|Other|1|||
146677826|NCT00023764|528997728|FG000|Overall Study|Adverse Event|4|||
146677827|NCT00023764|528997728|FG000|Overall Study|Withdrawal by Subject|1|||
146677828|NCT00023764|528997728|FG000|Overall Study|Progression of disease|6|||
146677829|NCT00023764|528997728|FG000|Overall Study|patient received other treatment|1|||
146677830|NCT00023764|528997728|FG000|Overall Study|delay in obtaining staging images|1|||
146677831|NCT02756013|528997732|FG000|Overall Study|Adverse Event|1|||
146677832|NCT02756013|528997732|FG000|Overall Study|Hypersensitivity|1|||
146677833|NCT00211510|528997733|FG000|Overall Study|Physician Decision|3|||
146677834|NCT00211510|528997734|FG001|Overall Study|Physician Decision|1|||
146677835|NCT00211510|528997733|FG000|Overall Study|Withdrawal by Subject|3|||
146677836|NCT00211510|528997734|FG001|Overall Study|Withdrawal by Subject|1|||
146677837|NCT02837783|528997735|FG000|Overall Study|Adverse Event|1|||
146677838|NCT02837783|528997736|FG001|Overall Study|Adverse Event|0|||
146677839|NCT02837783|528997735|FG000|Overall Study|Other, Not Specified|1|||
146677840|NCT02837783|528997736|FG001|Overall Study|Other, Not Specified|2|||
146677841|NCT01487200|528997737|FG000|Overall Study|Withdrawal by Subject|0|||
146926520|NCT00430521|529890837|FG007|Overall Study|Protocol Violation|0|||
146926521|NCT00430521|529890830|FG000|Overall Study|Withdrawal by Subject|3|||
146926522|NCT00430521|529890831|FG001|Overall Study|Withdrawal by Subject|1|||
146926523|NCT00430521|529890832|FG002|Overall Study|Withdrawal by Subject|0|||
146926524|NCT00430521|529890833|FG003|Overall Study|Withdrawal by Subject|3|||
146926525|NCT00430521|529890834|FG004|Overall Study|Withdrawal by Subject|0|||
146926526|NCT00430521|529890835|FG005|Overall Study|Withdrawal by Subject|0|||
146926527|NCT00430521|529890836|FG006|Overall Study|Withdrawal by Subject|0|||
146926528|NCT00430521|529890837|FG007|Overall Study|Withdrawal by Subject|2|||
146926529|NCT05108805|529890840|FG000|Overall Study|T-cell expansion was not successful.|5|||
146926530|NCT00369967|529892715|FG000|Overall Study|Lost to Follow-up|23|||
146926531|NCT00369967|529892716|FG001|Overall Study|Lost to Follow-up|12|||
146926532|NCT02282982|529892722|FG000|Overall Study|Lost to Follow-up|15|||
146926533|NCT02282982|529892722|FG000|Overall Study|Withdrew consent|2|||
146926534|NCT02282982|529892722|FG000|Overall Study|Death|4|||
146926535|NCT02282982|529892722|FG000|Overall Study|Lack of product|156|||
146926536|NCT02282982|529892722|FG000|Overall Study|Palivizumab is ended|11|||
146926537|NCT02282982|529892722|FG000|Overall Study|Other, not specified|18|||
146926538|NCT02924688|529892725|FG000|Overall Study|Adverse Event|9|||
146926539|NCT02924688|529892726|FG001|Overall Study|Adverse Event|3|||
146926540|NCT02924688|529892727|FG002|Overall Study|Adverse Event|2|||
146926541|NCT02924688|529892728|FG003|Overall Study|Adverse Event|2|||
146677842|NCT01487200|528997738|FG001|Overall Study|Withdrawal by Subject|1|||
146926542|NCT02924688|529892729|FG004|Overall Study|Adverse Event|3|||
146677843|NCT01487200|528997739|FG002|Overall Study|Withdrawal by Subject|0|||
146677844|NCT01487200|528997740|FG003|Overall Study|Withdrawal by Subject|0|||
146677845|NCT01962896|528997741|FG000|Overall Study|Lack of Efficacy|4|||
146677846|NCT02207244|528997744|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
146677847|NCT02207244|528997745|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
146677848|NCT02207244|528997746|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
146926543|NCT02924688|529892730|FG005|Overall Study|Adverse Event|2|||
146677849|NCT02207244|528997747|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
146677850|NCT02207244|528997748|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
146926544|NCT02924688|529892725|FG000|Overall Study|Lack of Efficacy|2|||
146677851|NCT02207244|528997749|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
146677852|NCT02207244|528997750|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
146677853|NCT02207244|528997751|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
146926545|NCT02924688|529892726|FG001|Overall Study|Lack of Efficacy|3|||
146926546|NCT02924688|529892727|FG002|Overall Study|Lack of Efficacy|4|||
146677854|NCT02207244|528997752|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
146677855|NCT02207244|528997753|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
146677856|NCT02207244|528997754|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
146926547|NCT02924688|529892728|FG003|Overall Study|Lack of Efficacy|2|||
146926548|NCT02924688|529892729|FG004|Overall Study|Lack of Efficacy|1|||
146926549|NCT02924688|529892730|FG005|Overall Study|Lack of Efficacy|1|||
146926550|NCT02924688|529892725|FG000|Overall Study|Protocol Violation|3|||
146774469|NCT00716859|529343616|FG001|Overall Study|Adverse Event|1|||
146926551|NCT02924688|529892726|FG001|Overall Study|Protocol Violation|7|||
146926552|NCT02924688|529892727|FG002|Overall Study|Protocol Violation|5|||
146926553|NCT02924688|529892728|FG003|Overall Study|Protocol Violation|6|||
146926554|NCT02924688|529892729|FG004|Overall Study|Protocol Violation|2|||
146926555|NCT02924688|529892730|FG005|Overall Study|Protocol Violation|2|||
146926556|NCT02924688|529892725|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
146926557|NCT02924688|529892726|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
146926558|NCT02924688|529892727|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
146926559|NCT02924688|529892728|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
146926560|NCT02924688|529892729|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
146926561|NCT02924688|529892730|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
146926562|NCT02924688|529892725|FG000|Overall Study|Lost to Follow-up|2|||
146926563|NCT02924688|529892726|FG001|Overall Study|Lost to Follow-up|4|||
146926564|NCT02924688|529892727|FG002|Overall Study|Lost to Follow-up|2|||
146926565|NCT02924688|529892728|FG003|Overall Study|Lost to Follow-up|4|||
146926566|NCT02924688|529892729|FG004|Overall Study|Lost to Follow-up|2|||
146926567|NCT02924688|529892730|FG005|Overall Study|Lost to Follow-up|4|||
146677857|NCT02207244|528997744|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
146677858|NCT02207244|528997745|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146677859|NCT02207244|528997746|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
146677860|NCT02207244|528997747|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146677861|NCT02207244|528997748|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146677862|NCT02207244|528997749|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146677863|NCT02207244|528997750|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146926568|NCT02924688|529892725|FG000|Overall Study|Physician Decision|2|||
146926569|NCT02924688|529892726|FG001|Overall Study|Physician Decision|1|||
146926570|NCT02924688|529892727|FG002|Overall Study|Physician Decision|0|||
146926571|NCT02924688|529892728|FG003|Overall Study|Physician Decision|1|||
146926572|NCT02924688|529892729|FG004|Overall Study|Physician Decision|1|||
146926573|NCT02924688|529892730|FG005|Overall Study|Physician Decision|1|||
146926574|NCT02924688|529892725|FG000|Overall Study|Withdrawal by Subject|14|||
146926575|NCT02924688|529892726|FG001|Overall Study|Withdrawal by Subject|13|||
146926576|NCT02924688|529892727|FG002|Overall Study|Withdrawal by Subject|9|||
146926577|NCT02924688|529892728|FG003|Overall Study|Withdrawal by Subject|12|||
146926578|NCT02924688|529892729|FG004|Overall Study|Withdrawal by Subject|13|||
146677864|NCT02207244|528997751|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146677865|NCT02207244|528997752|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146677866|NCT02207244|528997753|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146677867|NCT02207244|528997754|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146926579|NCT02924688|529892730|FG005|Overall Study|Withdrawal by Subject|14|||
146926580|NCT01205451|529892743|FG000|Overall Study|Lost to Follow-up|1|||
146926581|NCT01205451|529892744|FG001|Overall Study|Lost to Follow-up|1|||
146926582|NCT01205451|529892743|FG000|Overall Study|Withdrawal by Subject|5|||
146926583|NCT01205451|529892744|FG001|Overall Study|Withdrawal by Subject|9|||
146926584|NCT00229203|529892745|FG000|Overall Study|Progressive disease|18|||
146926585|NCT00229203|529892746|FG001|Overall Study|Progressive disease|9|||
146926586|NCT00229203|529892745|FG000|Overall Study|Toxicity|6|||
146926587|NCT00229203|529892746|FG001|Overall Study|Toxicity|1|||
146926588|NCT00229203|529892745|FG000|Overall Study|Death|4|||
146926589|NCT00229203|529892746|FG001|Overall Study|Death|2|||
146677868|NCT02207244|528997744|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
146677869|NCT02207244|528997745|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
146677870|NCT02207244|528997746|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
146926590|NCT00229203|529892745|FG000|Overall Study|Other|3|||
146926591|NCT00229203|529892746|FG001|Overall Study|Other|3|||
146926592|NCT00229203|529892745|FG000|Overall Study|Withdrawal by Subject|1|||
146926593|NCT00229203|529892746|FG001|Overall Study|Withdrawal by Subject|4|||
146926594|NCT03457103|529892747|FG000|Overall Study|illness/hospitalization|4|||
146926595|NCT03457103|529892748|FG001|Overall Study|illness/hospitalization|2|||
146926596|NCT03457103|529892747|FG000|Overall Study|Lost to Follow-up|2|||
146926597|NCT03457103|529892748|FG001|Overall Study|Lost to Follow-up|1|||
146926598|NCT03457103|529892747|FG000|Overall Study|Withdrawal by Subject|1|||
146926599|NCT03457103|529892748|FG001|Overall Study|Withdrawal by Subject|2|||
146926600|NCT03457103|529892747|FG000|Overall Study|financial/ insurance issues|1|||
146926601|NCT03457103|529892748|FG001|Overall Study|financial/ insurance issues|1|||
146677871|NCT02207244|528997747|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
146926602|NCT03004469|529892749|FG000|Overall Study|Adverse Event|6|||
146926603|NCT03004469|529892750|FG001|Overall Study|Adverse Event|4|||
146926604|NCT03004469|529892751|FG002|Overall Study|Adverse Event|6|||
146926605|NCT03004469|529892749|FG000|Overall Study|Lack of Efficacy|1|||
146926606|NCT03004469|529892750|FG001|Overall Study|Lack of Efficacy|0|||
146926607|NCT03004469|529892751|FG002|Overall Study|Lack of Efficacy|1|||
146926608|NCT03004469|529892749|FG000|Overall Study|Lost to Follow-up|23|||
146926609|NCT03004469|529892750|FG001|Overall Study|Lost to Follow-up|14|||
146926610|NCT03004469|529892751|FG002|Overall Study|Lost to Follow-up|6|||
146926611|NCT03004469|529892749|FG000|Overall Study|Non-Compliance with Study Drug|2|||
146677872|NCT02207244|528997748|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
146677873|NCT02207244|528997749|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
146677874|NCT02207244|528997750|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
146677875|NCT02207244|528997751|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
146677876|NCT02207244|528997752|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
146677877|NCT02207244|528997753|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
146677878|NCT02207244|528997754|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
146677879|NCT02207244|528997744|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
146677880|NCT02207244|528997745|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
146677881|NCT02207244|528997746|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146677882|NCT02207244|528997747|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146677883|NCT02207244|528997748|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146677884|NCT02207244|528997749|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146677885|NCT02207244|528997750|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146677886|NCT02207244|528997751|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146677887|NCT02207244|528997752|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146677888|NCT02207244|528997753|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146677889|NCT02207244|528997754|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146677890|NCT02207244|528997744|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
146677891|NCT02207244|528997745|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
146677892|NCT02207244|528997746|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
146677893|NCT02207244|528997747|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
146677894|NCT02207244|528997748|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
146677895|NCT02207244|528997749|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
146677896|NCT02207244|528997750|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
146677897|NCT02207244|528997751|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
146677898|NCT02207244|528997752|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
146677899|NCT02207244|528997753|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
146677900|NCT02207244|528997754|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
146677901|NCT02207244|528997744|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146677902|NCT02207244|528997745|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
146677903|NCT02207244|528997746|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
146677904|NCT02207244|528997747|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146677905|NCT02207244|528997748|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146677906|NCT02207244|528997749|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146677907|NCT02207244|528997750|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146677908|NCT02207244|528997751|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146677909|NCT02207244|528997752|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146677910|NCT02207244|528997753|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146677911|NCT02207244|528997754|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146677912|NCT02207244|528997744|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
146677913|NCT02207244|528997745|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
146677914|NCT02207244|528997746|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
146677915|NCT02207244|528997747|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
146677916|NCT02207244|528997748|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
146677917|NCT02207244|528997749|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
146677918|NCT02207244|528997750|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
146677919|NCT02207244|528997751|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
146677920|NCT02207244|528997752|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
146677921|NCT02207244|528997753|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
146677922|NCT02207244|528997754|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
146677923|NCT02207244|528997744|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146677924|NCT02207244|528997745|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146677925|NCT02207244|528997746|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146677926|NCT02207244|528997747|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146677927|NCT02207244|528997748|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
146677928|NCT02207244|528997749|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
146677929|NCT02207244|528997750|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146926612|NCT03004469|529892750|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146926613|NCT03004469|529892751|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146926614|NCT03004469|529892749|FG000|Overall Study|Protocol Violation|0|||
146926615|NCT03004469|529892750|FG001|Overall Study|Protocol Violation|0|||
146926616|NCT03004469|529892751|FG002|Overall Study|Protocol Violation|1|||
146926617|NCT03004469|529892749|FG000|Overall Study|Withdrawal by Subject|29|||
146926618|NCT03004469|529892750|FG001|Overall Study|Withdrawal by Subject|27|||
146926619|NCT03004469|529892751|FG002|Overall Study|Withdrawal by Subject|10|||
146677930|NCT02207244|528997751|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146677931|NCT02207244|528997752|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146677932|NCT02207244|528997753|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146677933|NCT02207244|528997754|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146677934|NCT02207244|528997744|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146677935|NCT02207244|528997745|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146677936|NCT02207244|528997746|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146677937|NCT02207244|528997747|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146677938|NCT02207244|528997748|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146677939|NCT02207244|528997749|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
146677940|NCT02207244|528997750|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146677941|NCT02207244|528997751|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146677942|NCT02207244|528997752|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146677943|NCT02207244|528997753|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146677944|NCT02207244|528997754|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146677945|NCT02207244|528997744|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
146677946|NCT02207244|528997745|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
146677947|NCT02207244|528997746|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
146677948|NCT02207244|528997747|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
146677949|NCT02207244|528997748|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
146677950|NCT02207244|528997749|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
146677951|NCT02207244|528997750|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
146677952|NCT02207244|528997751|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
146677953|NCT02207244|528997752|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
146677954|NCT02207244|528997753|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
146677955|NCT02207244|528997754|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
146677956|NCT02207244|528997744|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
146677957|NCT02207244|528997745|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
146677958|NCT02207244|528997746|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
146677959|NCT02207244|528997747|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
146677960|NCT02207244|528997748|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
146677961|NCT02207244|528997749|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
146677962|NCT02207244|528997750|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
146677963|NCT02207244|528997751|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
146677964|NCT02207244|528997752|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
146677965|NCT02207244|528997753|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
146677966|NCT02207244|528997754|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
146677967|NCT02207244|528997744|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146677968|NCT02207244|528997745|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146677969|NCT02207244|528997746|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146677970|NCT02207244|528997747|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
146677971|NCT02207244|528997748|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146677972|NCT02207244|528997749|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
146677973|NCT02207244|528997750|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146677974|NCT02207244|528997751|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146677975|NCT02207244|528997752|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146677976|NCT02207244|528997753|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146677977|NCT02207244|528997754|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146677978|NCT02207244|528997744|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
146677979|NCT02207244|528997745|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
146677980|NCT02207244|528997746|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
146677981|NCT02207244|528997747|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
146677982|NCT02207244|528997748|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
146677983|NCT02207244|528997749|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
146677984|NCT02207244|528997750|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
146677985|NCT02207244|528997751|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
146677986|NCT02207244|528997752|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
146677987|NCT02207244|528997753|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
146677988|NCT02207244|528997754|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
146677989|NCT02207244|528997744|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
146677990|NCT02207244|528997745|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
146677991|NCT02207244|528997746|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
146677992|NCT02207244|528997747|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
146677993|NCT02207244|528997748|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
146677994|NCT02207244|528997749|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
146774470|NCT00716859|529343615|FG000|Overall Study|Lack of Efficacy|3|||
146677995|NCT02207244|528997750|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
146677996|NCT02207244|528997751|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
146677997|NCT02207244|528997752|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
146677998|NCT02207244|528997753|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
146677999|NCT02207244|528997754|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
146678000|NCT02207244|528997744|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146678001|NCT02207244|528997745|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146678002|NCT02207244|528997746|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146678003|NCT02207244|528997747|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146678004|NCT02207244|528997748|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146678005|NCT02207244|528997749|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146678006|NCT02207244|528997750|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146678007|NCT02207244|528997751|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
146678008|NCT02207244|528997752|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146678009|NCT02207244|528997753|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146678010|NCT02207244|528997754|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146678011|NCT02207244|528997744|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
146678012|NCT02207244|528997745|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
146678013|NCT02207244|528997746|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
146678014|NCT02207244|528997747|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
146678015|NCT02207244|528997748|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
146678016|NCT02207244|528997749|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
146678017|NCT02207244|528997750|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
146678018|NCT02207244|528997751|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
146678019|NCT02207244|528997752|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
146678020|NCT02207244|528997753|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
146678021|NCT02207244|528997754|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
146678022|NCT02207244|528997744|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
146678023|NCT02207244|528997745|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
146678024|NCT02207244|528997746|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
146678025|NCT02207244|528997747|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
146678026|NCT02207244|528997748|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
146678027|NCT02207244|528997749|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
146678028|NCT02207244|528997750|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
146678029|NCT02207244|528997751|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
146678030|NCT02207244|528997752|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
146678031|NCT02207244|528997753|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
146678032|NCT02207244|528997754|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
146678033|NCT02207244|528997744|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
146678034|NCT02207244|528997745|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
146678035|NCT02207244|528997746|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
146678036|NCT02207244|528997747|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
146678037|NCT02207244|528997748|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
146678038|NCT02207244|528997749|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
146678039|NCT02207244|528997750|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
146678040|NCT02207244|528997751|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
146678041|NCT02207244|528997752|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
146678042|NCT02207244|528997753|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
146678043|NCT02207244|528997754|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
146678044|NCT02207244|528997744|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146678045|NCT02207244|528997745|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146678046|NCT02207244|528997746|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146678047|NCT02207244|528997747|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146678048|NCT02207244|528997748|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146678049|NCT02207244|528997749|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146678050|NCT02207244|528997750|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146678051|NCT02207244|528997751|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
146678052|NCT02207244|528997752|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
146678053|NCT02207244|528997753|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146678054|NCT02207244|528997754|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146678055|NCT02207244|528997744|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146678056|NCT02207244|528997745|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146678057|NCT02207244|528997746|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146678058|NCT02207244|528997747|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146678059|NCT02207244|528997748|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146678060|NCT02207244|528997749|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146678061|NCT02207244|528997750|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146678062|NCT02207244|528997751|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146678063|NCT02207244|528997752|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
146678064|NCT02207244|528997753|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146678065|NCT02207244|528997754|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146678066|NCT02207244|528997744|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146678067|NCT02207244|528997745|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146678068|NCT02207244|528997746|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146678069|NCT02207244|528997747|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146926620|NCT03004469|529892749|FG000|Overall Study|Other unspecified reason|0|||
146926621|NCT03004469|529892750|FG001|Overall Study|Other unspecified reason|4|||
146926622|NCT03004469|529892751|FG002|Overall Study|Other unspecified reason|1|||
146926623|NCT01163253|529892752|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
146926624|NCT01163253|529892753|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
146926625|NCT01163253|529892752|FG000|Overall Study|Study Terminated by Sponsor|978|||
146926626|NCT01163253|529892753|FG001|Overall Study|Study Terminated by Sponsor|349|||
146926627|NCT01163253|529892752|FG000|Overall Study|Protocol Violation|43|||
146926628|NCT01163253|529892753|FG001|Overall Study|Protocol Violation|12|||
146926629|NCT01163253|529892752|FG000|Overall Study|Withdrawal by Subject|199|||
146926630|NCT01163253|529892753|FG001|Overall Study|Withdrawal by Subject|50|||
146926631|NCT01163253|529892752|FG000|Overall Study|Medication Error|1|||
146926632|NCT01163253|529892753|FG001|Overall Study|Medication Error|0|||
146926633|NCT01163253|529892752|FG000|Overall Study|Lost to Follow-up|125|||
146926634|NCT01163253|529892753|FG001|Overall Study|Lost to Follow-up|23|||
146926635|NCT01163253|529892752|FG000|Overall Study|Insufficient Clinical Response|423|||
146926636|NCT01163253|529892753|FG001|Overall Study|Insufficient Clinical Response|29|||
146926637|NCT01163253|529892752|FG000|Overall Study|Adverse Event|300|||
146926638|NCT01163253|529892753|FG001|Overall Study|Adverse Event|78|||
146926639|NCT01163253|529892752|FG000|Overall Study|Death|17|||
146926640|NCT01163253|529892753|FG001|Overall Study|Death|5|||
146926641|NCT01163253|529892752|FG000|Overall Study|Ongoing|13|||
146926642|NCT01163253|529892753|FG001|Overall Study|Ongoing|4|||
146926643|NCT01163253|529892752|FG000|Overall Study|Other Unspecified|170|||
146926644|NCT01163253|529892753|FG001|Overall Study|Other Unspecified|34|||
146926645|NCT02492997|529892754|FG000|Overall Study|Withdrawal by Subject|1|||
146926646|NCT02492997|529892755|FG001|Overall Study|Withdrawal by Subject|0|||
146926647|NCT02492997|529892754|FG000|Overall Study|Gained Weight|1|||
146926648|NCT02492997|529892755|FG001|Overall Study|Gained Weight|0|||
146678070|NCT02207244|528997748|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146678071|NCT02207244|528997749|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146678072|NCT02207244|528997750|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146678073|NCT02207244|528997751|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
146678074|NCT02207244|528997752|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146678075|NCT02207244|528997753|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146678076|NCT02207244|528997754|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146678077|NCT02207244|528997744|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146678078|NCT02207244|528997745|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146678079|NCT02207244|528997746|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146678080|NCT02207244|528997747|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146678081|NCT02207244|528997748|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146678082|NCT02207244|528997749|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146678083|NCT02207244|528997750|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
146678084|NCT02207244|528997751|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146678085|NCT02207244|528997752|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146678086|NCT02207244|528997753|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146678087|NCT02207244|528997754|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146678088|NCT02207244|528997744|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146678089|NCT02207244|528997745|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146678090|NCT02207244|528997746|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146678091|NCT02207244|528997747|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146678092|NCT02207244|528997748|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146678093|NCT02207244|528997749|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146678094|NCT02207244|528997750|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146926649|NCT02492997|529892754|FG000|Overall Study|Lost to Follow-up|0|||
146926650|NCT02492997|529892755|FG001|Overall Study|Lost to Follow-up|1|||
146926651|NCT01397552|529892756|FG000|Overall Study|Adverse Event|1|||
146926652|NCT01397552|529892757|FG001|Overall Study|Adverse Event|0|||
146926653|NCT01397552|529892756|FG000|Overall Study|Withdrawal by Subject|2|||
146926654|NCT01397552|529892757|FG001|Overall Study|Withdrawal by Subject|1|||
146926655|NCT00579501|529892760|FG000|Overall Study|Death|1|||
146926656|NCT00579501|529892760|FG000|Overall Study|End of neoadjuvant therapy|25|||
146678095|NCT02207244|528997751|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146678096|NCT02207244|528997752|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
146678097|NCT02207244|528997753|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146678098|NCT02207244|528997754|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
146678099|NCT02207244|528997744|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146678100|NCT02207244|528997745|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146678101|NCT02207244|528997746|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146678102|NCT02207244|528997747|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146678103|NCT02207244|528997748|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146678104|NCT02207244|528997749|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146678105|NCT02207244|528997750|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146678106|NCT02207244|528997751|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146678107|NCT02207244|528997752|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
146678108|NCT02207244|528997753|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146678109|NCT02207244|528997754|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
146678110|NCT02207244|528997744|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146678111|NCT02207244|528997745|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146678112|NCT02207244|528997746|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146678113|NCT02207244|528997747|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146678114|NCT02207244|528997748|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146678115|NCT02207244|528997749|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146678116|NCT02207244|528997750|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146678117|NCT02207244|528997751|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146678118|NCT02207244|528997752|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
146678119|NCT02207244|528997753|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146678120|NCT02207244|528997754|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
146678121|NCT02207244|528997744|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146678122|NCT02207244|528997745|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146678123|NCT02207244|528997746|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146678124|NCT02207244|528997747|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146678125|NCT02207244|528997748|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146678126|NCT02207244|528997749|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146678127|NCT02207244|528997750|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146678128|NCT02207244|528997751|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146678129|NCT02207244|528997752|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
146678130|NCT02207244|528997753|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146678131|NCT02207244|528997754|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
146678132|NCT02207244|528997744|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
146678133|NCT02207244|528997745|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
146678134|NCT02207244|528997746|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
146678135|NCT02207244|528997747|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
146678136|NCT02207244|528997748|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
146678137|NCT02207244|528997749|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
146678138|NCT02207244|528997750|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
146678139|NCT02207244|528997751|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
146678140|NCT02207244|528997752|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
146678141|NCT02207244|528997753|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
146678142|NCT02207244|528997754|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
146678143|NCT02207244|528997744|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
146678144|NCT02207244|528997745|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
146678145|NCT02207244|528997746|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
146678146|NCT02207244|528997747|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
146678147|NCT02207244|528997748|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
146678148|NCT02207244|528997749|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
146774471|NCT00716859|529343616|FG001|Overall Study|Lack of Efficacy|0|||
146926657|NCT00579501|529892760|FG000|Overall Study|toxicity|1|||
146926658|NCT00579501|529892760|FG000|Overall Study|Secondary lesion|1|||
146926659|NCT00579501|529892760|FG000|Overall Study|Radiation therapy before surgery|1|||
146926660|NCT01089582|529892761|FG000|Overall Study|Death|2|||
146926661|NCT01089582|529892761|FG000|Overall Study|Adverse Event|15|||
146926662|NCT01089582|529892761|FG000|Overall Study|Lost to Follow-up|8|||
146678149|NCT02207244|528997750|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
146678150|NCT02207244|528997751|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
146678151|NCT02207244|528997752|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
146678152|NCT02207244|528997753|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
146678153|NCT02207244|528997754|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
146678154|NCT02207244|528997744|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146926663|NCT01089582|529892761|FG000|Overall Study|Other|4|||
146678155|NCT02207244|528997745|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146678156|NCT02207244|528997746|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146678157|NCT02207244|528997747|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146678158|NCT02207244|528997748|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146678159|NCT02207244|528997749|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146678160|NCT02207244|528997750|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146678161|NCT02207244|528997751|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146678162|NCT02207244|528997752|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146678163|NCT02207244|528997753|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146678164|NCT02207244|528997754|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
146678165|NCT02144012|528997759|FG000|Overall Study|Adverse Event|1|||
146678166|NCT02144012|528997760|FG001|Overall Study|Adverse Event|0|||
146678167|NCT02144012|528997759|FG000|Overall Study|Death|1|||
146678168|NCT02144012|528997760|FG001|Overall Study|Death|0|||
146678169|NCT02144012|528997759|FG000|Overall Study|Withdrawal by Subject|11|||
146678170|NCT02144012|528997760|FG001|Overall Study|Withdrawal by Subject|3|||
146678171|NCT02144012|528997759|FG000|Overall Study|Study Terminated by Sponsor|18|||
146678172|NCT02144012|528997760|FG001|Overall Study|Study Terminated by Sponsor|12|||
146678173|NCT02144012|528997759|FG000|Overall Study|Other|3|||
146678174|NCT02144012|528997760|FG001|Overall Study|Other|0|||
146678175|NCT00911820|528999417|FG000|Overall Study|RECIST progression|12|||
146678176|NCT00911820|528999418|FG001|Overall Study|RECIST progression|8|||
146678177|NCT00911820|528999417|FG000|Overall Study|Adverse Event|8|||
146678178|NCT00911820|528999418|FG001|Overall Study|Adverse Event|8|||
146678179|NCT00911820|528999417|FG000|Overall Study|Clinical Progression|7|||
146678180|NCT00911820|528999418|FG001|Overall Study|Clinical Progression|5|||
146678181|NCT00911820|528999417|FG000|Overall Study|Physician Decision|5|||
146678182|NCT00911820|528999418|FG001|Overall Study|Physician Decision|9|||
146678183|NCT00911820|528999417|FG000|Overall Study|Decline in Performance Status|4|||
146678184|NCT00911820|528999418|FG001|Overall Study|Decline in Performance Status|2|||
146678185|NCT00911820|528999417|FG000|Overall Study|Withdrawal by Subject|3|||
146678186|NCT00911820|528999418|FG001|Overall Study|Withdrawal by Subject|4|||
146678187|NCT00911820|528999417|FG000|Overall Study|Death|1|||
146678188|NCT00911820|528999418|FG001|Overall Study|Death|2|||
146678189|NCT00911820|528999417|FG000|Overall Study|Pursue surgery|1|||
146678190|NCT00911820|528999418|FG001|Overall Study|Pursue surgery|1|||
146678191|NCT00911820|528999417|FG000|Overall Study|Pursue Radiation|1|||
146678192|NCT00911820|528999418|FG001|Overall Study|Pursue Radiation|0|||
146678193|NCT00911820|528999417|FG000|Overall Study|Still on Therapy|2|||
146678194|NCT00911820|528999418|FG001|Overall Study|Still on Therapy|2|||
146678195|NCT00911820|528999417|FG000|Overall Study|Pathology Not Confirmed|1|||
146678196|NCT00911820|528999418|FG001|Overall Study|Pathology Not Confirmed|0|||
146678197|NCT00911820|528999417|FG000|Overall Study|Withdraw before Receive Treatment|0|||
146678198|NCT00911820|528999418|FG001|Overall Study|Withdraw before Receive Treatment|2|||
146678199|NCT00963547|528999425|FG000|Overall Study|Adverse Event|0|||
146678200|NCT00963547|528999426|FG001|Overall Study|Adverse Event|1|||
146678201|NCT00963547|528999427|FG002|Overall Study|Adverse Event|0|||
146678202|NCT00963547|528999428|FG003|Overall Study|Adverse Event|1|||
146678203|NCT00963547|528999429|FG004|Overall Study|Adverse Event|0|||
146678204|NCT00963547|528999430|FG005|Overall Study|Adverse Event|0|||
146678205|NCT00963547|528999431|FG006|Overall Study|Adverse Event|0|||
146678206|NCT00963547|528999425|FG000|Overall Study|Physician Decision|1|||
146678207|NCT00963547|528999426|FG001|Overall Study|Physician Decision|1|||
146678208|NCT00963547|528999427|FG002|Overall Study|Physician Decision|0|||
146678209|NCT00963547|528999428|FG003|Overall Study|Physician Decision|0|||
146678210|NCT00963547|528999429|FG004|Overall Study|Physician Decision|0|||
146678211|NCT00963547|528999430|FG005|Overall Study|Physician Decision|0|||
146678212|NCT00963547|528999431|FG006|Overall Study|Physician Decision|0|||
146678213|NCT00963547|528999425|FG000|Overall Study|Progressive Disease|3|||
146678214|NCT00963547|528999426|FG001|Overall Study|Progressive Disease|8|||
146678215|NCT00963547|528999427|FG002|Overall Study|Progressive Disease|9|||
146678216|NCT00963547|528999428|FG003|Overall Study|Progressive Disease|5|||
146678217|NCT00963547|528999429|FG004|Overall Study|Progressive Disease|0|||
146926664|NCT01089582|529892761|FG000|Overall Study|Withdrawal by Subject|1|||
146926665|NCT02287402|529892762|FG000|Treatment Period|Adverse Event|17|||
146926666|NCT02287402|529892762|FG000|Treatment Period|Voluntary Withdrawal|10|||
146926667|NCT02287402|529892762|FG000|Follow-up|Lost to Follow-up|1|||
146678218|NCT00963547|528999430|FG005|Overall Study|Progressive Disease|0|||
146678219|NCT00963547|528999431|FG006|Overall Study|Progressive Disease|0|||
146678220|NCT00963547|528999425|FG000|Overall Study|Withdrawal by Subject|0|||
146678221|NCT00963547|528999426|FG001|Overall Study|Withdrawal by Subject|0|||
146678222|NCT00963547|528999427|FG002|Overall Study|Withdrawal by Subject|3|||
146678223|NCT00963547|528999428|FG003|Overall Study|Withdrawal by Subject|0|||
146678224|NCT00963547|528999429|FG004|Overall Study|Withdrawal by Subject|0|||
146678225|NCT00963547|528999430|FG005|Overall Study|Withdrawal by Subject|0|||
146678226|NCT00963547|528999431|FG006|Overall Study|Withdrawal by Subject|0|||
146926668|NCT02287402|529892762|FG000|Follow-up|Voluntary Withdrawal|2|||
146926669|NCT02394808|529892763|FG000|Period 1|Unsatisfactory lens fitting|0|||
146678227|NCT00963547|528999425|FG000|Overall Study|Reason Unknown|0|||
146678228|NCT00963547|528999426|FG001|Overall Study|Reason Unknown|1|||
146678229|NCT00963547|528999427|FG002|Overall Study|Reason Unknown|0|||
146678230|NCT00963547|528999428|FG003|Overall Study|Reason Unknown|0|||
146678231|NCT00963547|528999429|FG004|Overall Study|Reason Unknown|0|||
146678232|NCT00963547|528999430|FG005|Overall Study|Reason Unknown|0|||
146678233|NCT00963547|528999431|FG006|Overall Study|Reason Unknown|0|||
146678234|NCT00759031|528999434|FG000|First Intervention (1 Day)|Physician Decision|1|||
146678235|NCT00759031|528999435|FG001|First Intervention (1 Day)|Physician Decision|0|||
146678236|NCT00759031|528999434|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
146678237|NCT00759031|528999435|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
146678238|NCT00759031|528999434|FG000|First Intervention (1 Day)|Screening failure|1|||
146678239|NCT00759031|528999435|FG001|First Intervention (1 Day)|Screening failure|0|||
146678240|NCT02430311|528999436|FG000|Part A|Adverse Event|0|||
146678241|NCT02430311|528999437|FG001|Part A|Adverse Event|1|||
146678242|NCT02430311|528999436|FG000|Part A|Withdrawal by Subject|1|||
146678243|NCT02430311|528999437|FG001|Part A|Withdrawal by Subject|0|||
146678244|NCT02430311|528999436|FG000|Part B|Meet study-specific withdrawal criteria|6|||
146678245|NCT02430311|528999437|FG001|Part B|Meet study-specific withdrawal criteria|6|||
146678246|NCT02430311|528999436|FG000|Part B|Withdrawal by Subject|2|||
146678247|NCT02430311|528999437|FG001|Part B|Withdrawal by Subject|2|||
146678248|NCT02430311|528999436|FG000|Part B|Adverse Event|1|||
146678249|NCT02430311|528999437|FG001|Part B|Adverse Event|0|||
146678250|NCT02430311|528999436|FG000|Part B|Death|1|||
146678251|NCT02430311|528999437|FG001|Part B|Death|0|||
146678252|NCT00309387|528999438|FG000|Overall Study|Death|72|||
146678253|NCT00309387|528999439|FG001|Overall Study|Death|73|||
146678254|NCT00309387|528999438|FG000|Overall Study|Lost to Follow-up|70|||
146678255|NCT00309387|528999439|FG001|Overall Study|Lost to Follow-up|86|||
146678256|NCT00085631|528999446|FG000|Overall Study|Missing Data|4|||
146678257|NCT00085631|528999447|FG001|Overall Study|Missing Data|11|||
146678258|NCT00085631|528999448|FG002|Overall Study|Missing Data|7|||
146678259|NCT03902574|528999449|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
146678260|NCT03902574|528999450|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
146678261|NCT03902574|528999451|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
146678262|NCT00284050|528999454|FG000|Overall Study|Adverse Event|1|||
146678263|NCT00284050|528999455|FG001|Overall Study|Adverse Event|1|||
146678264|NCT00284050|528999456|FG002|Overall Study|Adverse Event|1|||
146678265|NCT00284050|528999454|FG000|Overall Study|Lack of Efficacy|0|||
146678266|NCT00284050|528999455|FG001|Overall Study|Lack of Efficacy|1|||
146678267|NCT00284050|528999456|FG002|Overall Study|Lack of Efficacy|3|||
146678268|NCT00284050|528999454|FG000|Overall Study|Protocol Violation|0|||
146678269|NCT00284050|528999455|FG001|Overall Study|Protocol Violation|1|||
146678270|NCT00284050|528999456|FG002|Overall Study|Protocol Violation|2|||
146678271|NCT00284050|528999454|FG000|Overall Study|Withdrawal by Subject|2|||
146678272|NCT00284050|528999455|FG001|Overall Study|Withdrawal by Subject|2|||
146678273|NCT00284050|528999456|FG002|Overall Study|Withdrawal by Subject|2|||
146678274|NCT00284050|528999454|FG000|Overall Study|Lost to Follow-up|1|||
146678275|NCT00284050|528999455|FG001|Overall Study|Lost to Follow-up|0|||
146678276|NCT00284050|528999456|FG002|Overall Study|Lost to Follow-up|1|||
146678277|NCT00284050|528999454|FG000|Overall Study|Death|1|||
146678278|NCT00284050|528999455|FG001|Overall Study|Death|0|||
146678279|NCT00284050|528999456|FG002|Overall Study|Death|0|||
146678280|NCT02708121|528999457|FG000|Overall Study|Withdrawn by Study Team|1|||
146678281|NCT02708121|528999458|FG001|Overall Study|Withdrawn by Study Team|1|||
146678282|NCT02708121|528999457|FG000|Overall Study|Withdrawal by Subject|0|||
146678283|NCT02708121|528999458|FG001|Overall Study|Withdrawal by Subject|4|||
146678284|NCT01111149|528999459|FG000|Overall Study|Protocol Violation|1|||
146678285|NCT01111149|528999460|FG001|Overall Study|Protocol Violation|1|||
146678286|NCT01111149|528999461|FG002|Overall Study|Protocol Violation|2|||
146678287|NCT01111149|528999459|FG000|Overall Study|Withdrawal by Subject|1|||
146678288|NCT01111149|528999460|FG001|Overall Study|Withdrawal by Subject|0|||
146678289|NCT01111149|528999461|FG002|Overall Study|Withdrawal by Subject|2|||
146678290|NCT03765918|528999466|FG000|Overall Study|Death|109|||
146926670|NCT02394808|529892764|FG001|Period 1|Unsatisfactory lens fitting|1|||
146926671|NCT02394808|529892763|FG000|Period 2|Lost to Follow-up|1|||
146926672|NCT02394808|529892764|FG001|Period 2|Lost to Follow-up|0|||
146926673|NCT00209170|529892765|FG000|Overall Study|Adverse Event|0|||
146926674|NCT00209170|529892766|FG001|Overall Study|Adverse Event|1|||
146926675|NCT00209170|529892765|FG000|Overall Study|Withdrawal by Subject|2|||
146926676|NCT00209170|529892766|FG001|Overall Study|Withdrawal by Subject|1|||
146926677|NCT00209170|529892765|FG000|Overall Study|Lack of Efficacy|0|||
146926678|NCT00209170|529892766|FG001|Overall Study|Lack of Efficacy|1|||
146678291|NCT03765918|528999467|FG001|Overall Study|Death|127|||
146678292|NCT03765918|528999466|FG000|Overall Study|Lost to Follow-up|2|||
146926679|NCT02130427|529892767|FG000|Overall Study|Imaging results not interpretable|30|||
146926680|NCT02108600|529892772|FG000|Overall Study|Withdrawal by Subject|2|||
146678293|NCT03765918|528999467|FG001|Overall Study|Lost to Follow-up|3|||
146678294|NCT03765918|528999466|FG000|Overall Study|Withdrawal by Subject|12|||
146926681|NCT02108600|529892773|FG001|Overall Study|Withdrawal by Subject|0|||
146926682|NCT02108600|529892772|FG000|Overall Study|Lost to Follow-up|1|||
146926683|NCT02108600|529892773|FG001|Overall Study|Lost to Follow-up|1|||
146926684|NCT01295580|529892775|FG000|Overall Study|Protocol Violation|4|||
146926685|NCT01295580|529892776|FG001|Overall Study|Protocol Violation|2|||
146678295|NCT03765918|528999467|FG001|Overall Study|Withdrawal by Subject|16|||
146678296|NCT03765918|528999466|FG000|Overall Study|Participants Ongoing|240|||
146678297|NCT03765918|528999467|FG001|Overall Study|Participants Ongoing|205|||
146678298|NCT04202965|528999468|FG000|Overall Study|Adverse Event|3|||
146678299|NCT04202965|528999468|FG000|Overall Study|Did not meet inclusion criteria|1|||
146678300|NCT01484197|528999472|FG000|Treatment Period 1|Adverse Event|1|||
146678301|NCT01484197|528999473|FG001|Treatment Period 1|Adverse Event|0|||
146678302|NCT01484197|528999474|FG002|Treatment Period 1|Adverse Event|0|||
146678303|NCT01484197|528999475|FG003|Treatment Period 1|Adverse Event|0|||
146678304|NCT01484197|528999472|FG000|Treatment Period 2|Subject withdrew consent|0|||
146678305|NCT01484197|528999473|FG001|Treatment Period 2|Subject withdrew consent|0|||
146678306|NCT01484197|528999474|FG002|Treatment Period 2|Subject withdrew consent|0|||
146678307|NCT01484197|528999475|FG003|Treatment Period 2|Subject withdrew consent|1|||
146678308|NCT00814164|528999476|FG000|Overall Study|Progression|7|||
146678309|NCT00814164|528999476|FG000|Overall Study|not stated|7|||
146678310|NCT00814164|528999476|FG000|Overall Study|Death|5|||
146678311|NCT00299975|528999477|FG000|Overall Study|Adverse Event|1|||
146678312|NCT00299975|528999478|FG001|Overall Study|Adverse Event|0|||
146678313|NCT00299975|528999479|FG002|Overall Study|Adverse Event|2|||
146678314|NCT00299975|528999477|FG000|Overall Study|Pregnancy|0|||
146678315|NCT00299975|528999478|FG001|Overall Study|Pregnancy|0|||
146678316|NCT00299975|528999479|FG002|Overall Study|Pregnancy|1|||
146678317|NCT00299975|528999477|FG000|Overall Study|Lack of Efficacy|1|||
146678318|NCT00299975|528999478|FG001|Overall Study|Lack of Efficacy|0|||
146678319|NCT00299975|528999479|FG002|Overall Study|Lack of Efficacy|1|||
146678320|NCT00299975|528999477|FG000|Overall Study|Lost to Follow-up|1|||
146678321|NCT00299975|528999478|FG001|Overall Study|Lost to Follow-up|0|||
146678322|NCT00299975|528999479|FG002|Overall Study|Lost to Follow-up|0|||
146678323|NCT00299975|528999477|FG000|Overall Study|Withdrawal by Subject|0|||
146678324|NCT00299975|528999478|FG001|Overall Study|Withdrawal by Subject|1|||
146678325|NCT00299975|528999479|FG002|Overall Study|Withdrawal by Subject|3|||
146678326|NCT00299975|528999477|FG000|Overall Study|Physician Decision|0|||
146678327|NCT00299975|528999478|FG001|Overall Study|Physician Decision|0|||
146678328|NCT00299975|528999479|FG002|Overall Study|Physician Decision|1|||
146678329|NCT01169493|528999483|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
146678330|NCT01169493|528999484|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
146678331|NCT01169493|528999485|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
146678332|NCT01169493|528999486|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
146678333|NCT01169493|528999487|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
146678334|NCT01169493|528999488|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
146678335|NCT01169493|528999483|FG000|Period 3 (6 Months)|Adverse Event|0|||
146678336|NCT01169493|528999484|FG001|Period 3 (6 Months)|Adverse Event|1|||
146774472|NCT00716859|529343615|FG000|Overall Study|Withdrawal by Subject|1|||
146774473|NCT00716859|529343616|FG001|Overall Study|Withdrawal by Subject|3|||
146774474|NCT00716859|529343615|FG000|Overall Study|Not treated|1|||
146774475|NCT00716859|529343616|FG001|Overall Study|Not treated|1|||
146774476|NCT00411216|529343627|FG000|Overall Study|Ten participants were entered into the c|0|||
146774477|NCT00411216|529343628|FG001|Overall Study|Ten participants were entered into the c|2|||
146774478|NCT01251354|529343633|FG000|Overall Study|Adverse Event|1|||
146774479|NCT01251354|529343633|FG000|Overall Study|Investigator's Decision|1|||
146774480|NCT01251354|529343633|FG000|Overall Study|Disease Progression|4|||
146774481|NCT03422276|529345295|FG000|Overall Study|Withdrawal by Subject|21|||
146774482|NCT03422276|529345296|FG001|Overall Study|Withdrawal by Subject|25|||
146774483|NCT03422276|529345297|FG002|Overall Study|Withdrawal by Subject|14|||
146774484|NCT03422276|529345298|FG003|Overall Study|Withdrawal by Subject|16|||
146774485|NCT03422276|529345295|FG000|Overall Study|Death|14|||
146774486|NCT03422276|529345296|FG001|Overall Study|Death|21|||
146926686|NCT01295580|529892775|FG000|Overall Study|Withdrawal by Subject|1|||
146926687|NCT01295580|529892776|FG001|Overall Study|Withdrawal by Subject|4|||
146678337|NCT01169493|528999485|FG002|Period 3 (6 Months)|Adverse Event|0|||
146678338|NCT01169493|528999486|FG003|Period 3 (6 Months)|Adverse Event|0|||
146678339|NCT01169493|528999487|FG004|Period 3 (6 Months)|Adverse Event|0|||
146678340|NCT01169493|528999488|FG005|Period 3 (6 Months)|Adverse Event|0|||
146678341|NCT01169493|528999483|FG000|Period 3 (6 Months)|Physician Decision|0|||
146774487|NCT03422276|529345297|FG002|Overall Study|Death|3|||
146774488|NCT03422276|529345298|FG003|Overall Study|Death|1|||
146678342|NCT01169493|528999484|FG001|Period 3 (6 Months)|Physician Decision|1|||
146678343|NCT01169493|528999485|FG002|Period 3 (6 Months)|Physician Decision|1|||
146678344|NCT01169493|528999486|FG003|Period 3 (6 Months)|Physician Decision|0|||
146678345|NCT01169493|528999487|FG004|Period 3 (6 Months)|Physician Decision|0|||
146774489|NCT03422276|529345295|FG000|Overall Study|Discontinued, ineligible|4|||
146774490|NCT03422276|529345296|FG001|Overall Study|Discontinued, ineligible|3|||
146926688|NCT01295580|529892775|FG000|Overall Study|Adverse Event|2|||
146926689|NCT01295580|529892776|FG001|Overall Study|Adverse Event|1|||
146678346|NCT01169493|528999488|FG005|Period 3 (6 Months)|Physician Decision|0|||
146678347|NCT05228132|528999489|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
146678348|NCT05228132|528999489|FG000|Overall Study|Adverse Event|3|||
146678349|NCT05228132|528999489|FG000|Overall Study|Lost to Follow-up|1|||
146678350|NCT05228132|528999489|FG000|Overall Study|Arteriovenous-fistula mature|1|||
146678351|NCT03167411|528999490|FG000|Overall Study|Adverse Event|0|||
146678352|NCT03167411|528999491|FG001|Overall Study|Adverse Event|1|||
146678353|NCT02266225|528999496|FG000|Overall Study|Lost to Follow-up|2|||
146678354|NCT02266225|528999496|FG000|Overall Study|Death|1|||
146678355|NCT02266225|528999496|FG000|Overall Study|Withdrawal by Subject|13|||
146926690|NCT01295580|529892775|FG000|Overall Study|Lost to Follow-up|1|||
146678356|NCT00420927|528999497|FG000|Period 1|Adverse Event|19|||
146678357|NCT00420927|528999498|FG001|Period 1|Adverse Event|15|||
146678358|NCT00420927|528999499|FG002|Period 1|Adverse Event|0|||
146678359|NCT00420927|528999500|FG003|Period 1|Adverse Event|0|||
146678360|NCT00420927|528999501|FG004|Period 1|Adverse Event|0|||
146678361|NCT00420927|528999502|FG005|Period 1|Adverse Event|0|||
146678362|NCT00420927|528999503|FG006|Period 1|Adverse Event|0|||
146678363|NCT00420927|528999497|FG000|Period 1|Withdrawal by Subject|7|||
146678364|NCT00420927|528999498|FG001|Period 1|Withdrawal by Subject|12|||
146678365|NCT00420927|528999499|FG002|Period 1|Withdrawal by Subject|0|||
146678366|NCT00420927|528999500|FG003|Period 1|Withdrawal by Subject|0|||
146678367|NCT00420927|528999501|FG004|Period 1|Withdrawal by Subject|0|||
146678368|NCT00420927|528999502|FG005|Period 1|Withdrawal by Subject|0|||
146678369|NCT00420927|528999503|FG006|Period 1|Withdrawal by Subject|0|||
146678370|NCT00420927|528999497|FG000|Period 1|Lost to Follow-up|8|||
146678371|NCT00420927|528999498|FG001|Period 1|Lost to Follow-up|6|||
146678372|NCT00420927|528999499|FG002|Period 1|Lost to Follow-up|0|||
146678373|NCT00420927|528999500|FG003|Period 1|Lost to Follow-up|0|||
146678374|NCT00420927|528999501|FG004|Period 1|Lost to Follow-up|0|||
146678375|NCT00420927|528999502|FG005|Period 1|Lost to Follow-up|0|||
146678376|NCT00420927|528999503|FG006|Period 1|Lost to Follow-up|0|||
146678377|NCT00420927|528999497|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
146678378|NCT00420927|528999498|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
146678379|NCT00420927|528999499|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
146678380|NCT00420927|528999500|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
146678381|NCT00420927|528999501|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
146678382|NCT00420927|528999502|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
146678383|NCT00420927|528999503|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
146678384|NCT00420927|528999497|FG000|Period 1|Death|2|||
146678385|NCT00420927|528999498|FG001|Period 1|Death|0|||
146678386|NCT00420927|528999499|FG002|Period 1|Death|0|||
146678387|NCT00420927|528999500|FG003|Period 1|Death|0|||
146678388|NCT00420927|528999501|FG004|Period 1|Death|0|||
146678389|NCT00420927|528999502|FG005|Period 1|Death|0|||
146678390|NCT00420927|528999503|FG006|Period 1|Death|0|||
146678391|NCT00420927|528999497|FG000|Period 1|Subject moved/relocated|0|||
146678392|NCT00420927|528999498|FG001|Period 1|Subject moved/relocated|2|||
146678393|NCT00420927|528999499|FG002|Period 1|Subject moved/relocated|0|||
146678394|NCT00420927|528999500|FG003|Period 1|Subject moved/relocated|0|||
146678395|NCT00420927|528999501|FG004|Period 1|Subject moved/relocated|0|||
146678396|NCT00420927|528999502|FG005|Period 1|Subject moved/relocated|0|||
146678397|NCT00420927|528999503|FG006|Period 1|Subject moved/relocated|0|||
146926691|NCT01295580|529892776|FG001|Overall Study|Lost to Follow-up|0|||
146926692|NCT01295580|529892775|FG000|Overall Study|Lack of Efficacy|1|||
146678398|NCT00420927|528999497|FG000|Period 1|Noncompliant with study drug|1|||
146678399|NCT00420927|528999498|FG001|Period 1|Noncompliant with study drug|1|||
146678400|NCT00420927|528999499|FG002|Period 1|Noncompliant with study drug|0|||
146678401|NCT00420927|528999500|FG003|Period 1|Noncompliant with study drug|0|||
146678402|NCT00420927|528999501|FG004|Period 1|Noncompliant with study drug|0|||
146926693|NCT01295580|529892776|FG001|Overall Study|Lack of Efficacy|0|||
146926694|NCT01295580|529892775|FG000|Overall Study|Other: inconvenience|1|||
146926695|NCT01295580|529892776|FG001|Overall Study|Other: inconvenience|0|||
146678403|NCT00420927|528999502|FG005|Period 1|Noncompliant with study drug|0|||
146678404|NCT00420927|528999503|FG006|Period 1|Noncompliant with study drug|0|||
146678405|NCT00420927|528999497|FG000|Period 1|Randomization error|1|||
146678406|NCT00420927|528999498|FG001|Period 1|Randomization error|0|||
146926696|NCT01295580|529892775|FG000|Overall Study|Other: family objection|0|||
146926697|NCT01295580|529892776|FG001|Overall Study|Other: family objection|1|||
146678407|NCT00420927|528999499|FG002|Period 1|Randomization error|0|||
146678408|NCT00420927|528999500|FG003|Period 1|Randomization error|0|||
146678409|NCT00420927|528999501|FG004|Period 1|Randomization error|0|||
146678410|NCT00420927|528999502|FG005|Period 1|Randomization error|0|||
146926698|NCT04032171|529892777|FG000|Overall Study|Study Termination|1|||
146926699|NCT04032171|529892778|FG001|Overall Study|Study Termination|0|||
146678411|NCT00420927|528999503|FG006|Period 1|Randomization error|0|||
146678412|NCT00420927|528999497|FG000|Period 1|Suspected tuberculosis/positive test|1|||
146678413|NCT00420927|528999498|FG001|Period 1|Suspected tuberculosis/positive test|1|||
146678414|NCT00420927|528999499|FG002|Period 1|Suspected tuberculosis/positive test|0|||
146678415|NCT00420927|528999500|FG003|Period 1|Suspected tuberculosis/positive test|0|||
146926700|NCT00992784|529892779|FG000|Overall Study|Adverse Event|2|||
146926701|NCT00992784|529892780|FG001|Overall Study|Adverse Event|1|||
146926702|NCT00992784|529892781|FG002|Overall Study|Adverse Event|0|||
146926703|NCT00992784|529892779|FG000|Overall Study|Withdrawal by Subject|1|||
146926704|NCT00992784|529892780|FG001|Overall Study|Withdrawal by Subject|1|||
146926705|NCT00992784|529892781|FG002|Overall Study|Withdrawal by Subject|1|||
146926706|NCT00642746|529892782|FG000|Overall Study|Patient unevaluable|1|||
146926707|NCT00642746|529892783|FG001|Overall Study|Patient unevaluable|0|||
146926708|NCT00424294|529892784|FG000|Overall Study|Adverse Event|4|||
146926709|NCT00424294|529892785|FG001|Overall Study|Adverse Event|10|||
146926710|NCT00424294|529892784|FG000|Overall Study|Lack of Efficacy|2|||
146926711|NCT00424294|529892785|FG001|Overall Study|Lack of Efficacy|1|||
146926712|NCT00424294|529892784|FG000|Overall Study|Withdrawal by Subject|1|||
146926713|NCT00424294|529892785|FG001|Overall Study|Withdrawal by Subject|2|||
146926714|NCT00424294|529892784|FG000|Overall Study|Other|0|||
146926715|NCT00424294|529892785|FG001|Overall Study|Other|2|||
146926716|NCT00424294|529892784|FG000|Overall Study|Randomized but not Treated|1|||
146926717|NCT00424294|529892785|FG001|Overall Study|Randomized but not Treated|0|||
146926718|NCT00976950|529892788|FG000|Overall Study|Adverse Event|3|||
146926719|NCT00976950|529892788|FG000|Overall Study|Events with no relationship to Aptivus|3|||
146926720|NCT02932332|529892798|FG000|Overall Study|Withdrawal by Subject|1|||
146926721|NCT02932332|529892799|FG001|Overall Study|Withdrawal by Subject|1|||
146926722|NCT02932332|529892800|FG002|Overall Study|Withdrawal by Subject|0|||
146926723|NCT02932332|529892801|FG003|Overall Study|Withdrawal by Subject|1|||
146926724|NCT02932332|529892798|FG000|Overall Study|Chest pain|0|||
146926725|NCT02932332|529892799|FG001|Overall Study|Chest pain|0|||
146678416|NCT00420927|528999501|FG004|Period 1|Suspected tuberculosis/positive test|0|||
146678417|NCT00420927|528999502|FG005|Period 1|Suspected tuberculosis/positive test|0|||
146678418|NCT00420927|528999503|FG006|Period 1|Suspected tuberculosis/positive test|0|||
146678419|NCT00420927|528999497|FG000|Period 1|Study site closure|0|||
146678420|NCT00420927|528999498|FG001|Period 1|Study site closure|1|||
146678421|NCT00420927|528999499|FG002|Period 1|Study site closure|0|||
146678422|NCT00420927|528999500|FG003|Period 1|Study site closure|0|||
146678423|NCT00420927|528999501|FG004|Period 1|Study site closure|0|||
146678424|NCT00420927|528999502|FG005|Period 1|Study site closure|0|||
146678425|NCT00420927|528999503|FG006|Period 1|Study site closure|0|||
146678426|NCT00420927|528999497|FG000|Period 1|Subject received new diagnosis|0|||
146678427|NCT00420927|528999498|FG001|Period 1|Subject received new diagnosis|2|||
146678428|NCT00420927|528999499|FG002|Period 1|Subject received new diagnosis|0|||
146678429|NCT00420927|528999500|FG003|Period 1|Subject received new diagnosis|0|||
146678430|NCT00420927|528999501|FG004|Period 1|Subject received new diagnosis|0|||
146678431|NCT00420927|528999502|FG005|Period 1|Subject received new diagnosis|0|||
146678432|NCT00420927|528999503|FG006|Period 1|Subject received new diagnosis|0|||
146678433|NCT00420927|528999497|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
146678434|NCT00420927|528999498|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
146678435|NCT00420927|528999499|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
146678436|NCT00420927|528999500|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
146678437|NCT00420927|528999501|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
146678438|NCT00420927|528999502|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
146678439|NCT00420927|528999503|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
146678440|NCT00420927|528999497|FG000|Period 1|Failed to meet entry criteria|8|||
146678441|NCT00420927|528999498|FG001|Period 1|Failed to meet entry criteria|7|||
146678442|NCT00420927|528999499|FG002|Period 1|Failed to meet entry criteria|0|||
146678443|NCT00420927|528999500|FG003|Period 1|Failed to meet entry criteria|0|||
146678444|NCT00420927|528999501|FG004|Period 1|Failed to meet entry criteria|0|||
146678445|NCT00420927|528999502|FG005|Period 1|Failed to meet entry criteria|0|||
146678446|NCT00420927|528999503|FG006|Period 1|Failed to meet entry criteria|0|||
146774491|NCT03422276|529345297|FG002|Overall Study|Discontinued, ineligible|0|||
146926726|NCT02932332|529892800|FG002|Overall Study|Chest pain|0|||
146678447|NCT00420927|528999497|FG000|Period 1|Took prohibited medication|1|||
146678448|NCT00420927|528999498|FG001|Period 1|Took prohibited medication|3|||
146678449|NCT00420927|528999499|FG002|Period 1|Took prohibited medication|0|||
146678450|NCT00420927|528999500|FG003|Period 1|Took prohibited medication|0|||
146926727|NCT02932332|529892801|FG003|Overall Study|Chest pain|1|||
146926728|NCT02932332|529892798|FG000|Overall Study|Not Dyspneic cough|1|||
146678451|NCT00420927|528999501|FG004|Period 1|Took prohibited medication|0|||
146678452|NCT00420927|528999502|FG005|Period 1|Took prohibited medication|0|||
146774492|NCT03422276|529345298|FG003|Overall Study|Discontinued, ineligible|0|||
146926729|NCT02932332|529892799|FG001|Overall Study|Not Dyspneic cough|2|||
146926730|NCT02932332|529892800|FG002|Overall Study|Not Dyspneic cough|1|||
146926731|NCT02932332|529892801|FG003|Overall Study|Not Dyspneic cough|0|||
146926732|NCT01021852|529892802|FG000|Treatment Period 1|Adverse Event|3|||
146926733|NCT01021852|529892803|FG001|Treatment Period 1|Adverse Event|1|||
146678453|NCT00420927|528999503|FG006|Period 1|Took prohibited medication|0|||
146678454|NCT00420927|528999497|FG000|Period 2|Adverse Event|0|||
146678455|NCT00420927|528999498|FG001|Period 2|Adverse Event|0|||
146926734|NCT01021852|529892804|FG002|Treatment Period 1|Adverse Event|1|||
146678456|NCT00420927|528999499|FG002|Period 2|Adverse Event|7|||
146678457|NCT00420927|528999500|FG003|Period 2|Adverse Event|3|||
146678458|NCT00420927|528999501|FG004|Period 2|Adverse Event|17|||
146678459|NCT00420927|528999502|FG005|Period 2|Adverse Event|6|||
146678460|NCT00420927|528999503|FG006|Period 2|Adverse Event|20|||
146678461|NCT00420927|528999497|FG000|Period 2|Withdrawal by Subject|0|||
146678462|NCT00420927|528999498|FG001|Period 2|Withdrawal by Subject|0|||
146678463|NCT00420927|528999499|FG002|Period 2|Withdrawal by Subject|1|||
146678464|NCT00420927|528999500|FG003|Period 2|Withdrawal by Subject|3|||
146678465|NCT00420927|528999501|FG004|Period 2|Withdrawal by Subject|11|||
146678466|NCT00420927|528999502|FG005|Period 2|Withdrawal by Subject|2|||
146678467|NCT00420927|528999503|FG006|Period 2|Withdrawal by Subject|12|||
146678468|NCT00420927|528999497|FG000|Period 2|Lost to Follow-up|0|||
146678469|NCT00420927|528999498|FG001|Period 2|Lost to Follow-up|0|||
146678470|NCT00420927|528999499|FG002|Period 2|Lost to Follow-up|2|||
146678471|NCT00420927|528999500|FG003|Period 2|Lost to Follow-up|2|||
146678472|NCT00420927|528999501|FG004|Period 2|Lost to Follow-up|6|||
146678473|NCT00420927|528999502|FG005|Period 2|Lost to Follow-up|3|||
146678474|NCT00420927|528999503|FG006|Period 2|Lost to Follow-up|9|||
146678475|NCT00420927|528999497|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
146678476|NCT00420927|528999498|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
146678477|NCT00420927|528999499|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
146678478|NCT00420927|528999500|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
146678479|NCT00420927|528999501|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
146678480|NCT00420927|528999502|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
146678481|NCT00420927|528999503|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
146678482|NCT00420927|528999497|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
146678483|NCT00420927|528999498|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
146678484|NCT00420927|528999499|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
146678485|NCT00420927|528999500|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
146678486|NCT00420927|528999501|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
146678487|NCT00420927|528999502|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
146678488|NCT00420927|528999503|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
146678489|NCT00420927|528999497|FG000|Period 2|Subject unable to find transportation|0|||
146678490|NCT00420927|528999498|FG001|Period 2|Subject unable to find transportation|0|||
146678491|NCT00420927|528999499|FG002|Period 2|Subject unable to find transportation|0|||
146678492|NCT00420927|528999500|FG003|Period 2|Subject unable to find transportation|0|||
146678493|NCT00420927|528999501|FG004|Period 2|Subject unable to find transportation|0|||
146678494|NCT00420927|528999502|FG005|Period 2|Subject unable to find transportation|0|||
146678495|NCT00420927|528999503|FG006|Period 2|Subject unable to find transportation|1|||
146678496|NCT00420927|528999497|FG000|Period 2|Physician Decision|0|||
146678497|NCT00420927|528999498|FG001|Period 2|Physician Decision|0|||
146678498|NCT00420927|528999499|FG002|Period 2|Physician Decision|0|||
146678499|NCT00420927|528999500|FG003|Period 2|Physician Decision|0|||
146678500|NCT00420927|528999501|FG004|Period 2|Physician Decision|1|||
146678501|NCT00420927|528999502|FG005|Period 2|Physician Decision|1|||
146678502|NCT00420927|528999503|FG006|Period 2|Physician Decision|0|||
146678503|NCT00420927|528999497|FG000|Period 2|Sponsor decision|0|||
146678504|NCT00420927|528999498|FG001|Period 2|Sponsor decision|0|||
146678505|NCT00420927|528999499|FG002|Period 2|Sponsor decision|1|||
146678506|NCT00420927|528999500|FG003|Period 2|Sponsor decision|0|||
146678507|NCT00420927|528999501|FG004|Period 2|Sponsor decision|0|||
146678508|NCT00420927|528999502|FG005|Period 2|Sponsor decision|0|||
146678509|NCT00420927|528999503|FG006|Period 2|Sponsor decision|1|||
146678510|NCT00420927|528999497|FG000|Period 2|Randomization error|0|||
146678511|NCT00420927|528999498|FG001|Period 2|Randomization error|0|||
146678512|NCT00420927|528999499|FG002|Period 2|Randomization error|0|||
146678513|NCT00420927|528999500|FG003|Period 2|Randomization error|0|||
146678514|NCT00420927|528999501|FG004|Period 2|Randomization error|1|||
146678515|NCT00420927|528999502|FG005|Period 2|Randomization error|1|||
146678516|NCT00420927|528999503|FG006|Period 2|Randomization error|0|||
146678517|NCT00420927|528999497|FG000|Period 2|Noncompliant with study drug|0|||
146678518|NCT00420927|528999498|FG001|Period 2|Noncompliant with study drug|0|||
146926735|NCT01021852|529892805|FG003|Treatment Period 1|Adverse Event|0|||
146926736|NCT01021852|529892806|FG004|Treatment Period 1|Adverse Event|2|||
146678519|NCT00420927|528999499|FG002|Period 2|Noncompliant with study drug|0|||
146926737|NCT01021852|529892807|FG005|Treatment Period 1|Adverse Event|2|||
146678520|NCT00420927|528999500|FG003|Period 2|Noncompliant with study drug|1|||
146678521|NCT00420927|528999501|FG004|Period 2|Noncompliant with study drug|0|||
146678522|NCT00420927|528999502|FG005|Period 2|Noncompliant with study drug|0|||
146678523|NCT00420927|528999503|FG006|Period 2|Noncompliant with study drug|2|||
146926738|NCT01021852|529892808|FG006|Treatment Period 1|Adverse Event|0|||
146678524|NCT00420927|528999497|FG000|Period 2|Methotrexate intolerance|0|||
146678525|NCT00420927|528999498|FG001|Period 2|Methotrexate intolerance|0|||
146678526|NCT00420927|528999499|FG002|Period 2|Methotrexate intolerance|0|||
146678527|NCT00420927|528999500|FG003|Period 2|Methotrexate intolerance|0|||
146926739|NCT01021852|529892809|FG007|Treatment Period 1|Adverse Event|0|||
146926740|NCT01021852|529892802|FG000|Treatment Period 1|Pregnancy|0|||
146678528|NCT00420927|528999501|FG004|Period 2|Methotrexate intolerance|0|||
146678529|NCT00420927|528999502|FG005|Period 2|Methotrexate intolerance|0|||
146678530|NCT00420927|528999503|FG006|Period 2|Methotrexate intolerance|1|||
146678531|NCT00420927|528999497|FG000|Period 2|Took prohibited medication|0|||
146678532|NCT00420927|528999498|FG001|Period 2|Took prohibited medication|0|||
146678533|NCT00420927|528999499|FG002|Period 2|Took prohibited medication|0|||
146678534|NCT00420927|528999500|FG003|Period 2|Took prohibited medication|0|||
146678535|NCT00420927|528999501|FG004|Period 2|Took prohibited medication|1|||
146678536|NCT00420927|528999502|FG005|Period 2|Took prohibited medication|0|||
146678537|NCT00420927|528999503|FG006|Period 2|Took prohibited medication|0|||
146678538|NCT00320411|528999504|FG000|Overall Study|No investigational product admin.|4|||
146678539|NCT02088047|528999507|FG000|Overall Study|Withdrawal by Subject|1|||
146678540|NCT02088047|528999508|FG001|Overall Study|Withdrawal by Subject|0|||
146678541|NCT00660309|528999509|FG000|Overall Study|Adverse Event|2|||
146678542|NCT00660309|528999510|FG001|Overall Study|Adverse Event|0|||
146678543|NCT00660309|528999509|FG000|Overall Study|Withdrawal by Subject|0|||
146678544|NCT00660309|528999510|FG001|Overall Study|Withdrawal by Subject|3|||
146678545|NCT01217814|528999514|FG000|Overall Study|Adverse Event|1|||
146678546|NCT01217814|528999515|FG001|Overall Study|Adverse Event|1|||
146678547|NCT01217814|528999516|FG002|Overall Study|Adverse Event|0|||
146678548|NCT01217814|528999514|FG000|Overall Study|Lack of Efficacy|0|||
146678549|NCT01217814|528999515|FG001|Overall Study|Lack of Efficacy|0|||
146678550|NCT01217814|528999516|FG002|Overall Study|Lack of Efficacy|1|||
146678551|NCT01218243|528999517|FG000|Overall Study|Lack of Efficacy|1|||
146678552|NCT01218243|528999518|FG001|Overall Study|Lack of Efficacy|1|||
146678553|NCT01218243|528999517|FG000|Overall Study|Lost to Follow-up|3|||
146678554|NCT01218243|528999518|FG001|Overall Study|Lost to Follow-up|3|||
146678555|NCT01218243|528999517|FG000|Overall Study|Protocol Violation|5|||
146678556|NCT01218243|528999518|FG001|Overall Study|Protocol Violation|10|||
146678557|NCT01844518|528999520|FG000|Overall Study|Adverse Event|7|||
146678558|NCT01844518|528999521|FG001|Overall Study|Adverse Event|1|||
146678559|NCT01844518|528999520|FG000|Overall Study|Lack of Efficacy|17|||
146678560|NCT01844518|528999521|FG001|Overall Study|Lack of Efficacy|5|||
146678561|NCT01844518|528999520|FG000|Overall Study|Participant's request to discontinue|4|||
146678562|NCT01844518|528999521|FG001|Overall Study|Participant's request to discontinue|1|||
146678563|NCT01844518|528999520|FG000|Overall Study|Poor/Non-compliance|1|||
146678564|NCT01844518|528999521|FG001|Overall Study|Poor/Non-compliance|0|||
146678565|NCT01844518|528999520|FG000|Overall Study|No Longer Met Study Criteria|2|||
146678566|NCT01844518|528999521|FG001|Overall Study|No Longer Met Study Criteria|0|||
146678567|NCT01844518|528999520|FG000|Overall Study|Withdrawal by Subject|9|||
146678568|NCT01844518|528999521|FG001|Overall Study|Withdrawal by Subject|0|||
146678569|NCT01844518|528999520|FG000|Overall Study|Pregnancy|1|||
146678570|NCT01844518|528999521|FG001|Overall Study|Pregnancy|0|||
146678571|NCT03129100|528999524|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
146678572|NCT03129100|528999525|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
146678573|NCT03129100|528999526|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
146678574|NCT03129100|528999527|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
146678575|NCT03129100|528999528|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
146678576|NCT03129100|528999529|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
146678577|NCT03129100|528999530|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
146678578|NCT03129100|528999531|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
146678579|NCT03129100|528999532|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
146678580|NCT03129100|528999533|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
146678581|NCT03129100|528999534|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
146678582|NCT03129100|528999535|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
146678583|NCT03129100|528999536|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
146678584|NCT03129100|528999537|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
146678585|NCT03129100|528999538|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
146678586|NCT03129100|528999539|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
146678587|NCT03129100|528999540|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
146678588|NCT03129100|528999541|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
146678589|NCT03129100|528999542|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
146678590|NCT03129100|528999543|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
146678591|NCT03129100|528999544|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
146678592|NCT03129100|528999545|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
146678593|NCT03129100|528999546|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
146678594|NCT03129100|528999547|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
146678595|NCT03129100|528999548|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
146678596|NCT03129100|528999549|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
146678597|NCT03129100|528999524|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
146678598|NCT03129100|528999525|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678599|NCT03129100|528999526|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678600|NCT03129100|528999527|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678601|NCT03129100|528999528|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678602|NCT03129100|528999529|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678603|NCT03129100|528999530|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678604|NCT03129100|528999531|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678605|NCT03129100|528999532|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678606|NCT03129100|528999533|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678607|NCT03129100|528999534|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678608|NCT03129100|528999535|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678609|NCT03129100|528999536|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678610|NCT03129100|528999537|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678611|NCT03129100|528999538|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678612|NCT03129100|528999539|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678613|NCT03129100|528999540|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678614|NCT03129100|528999541|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678615|NCT03129100|528999542|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678616|NCT03129100|528999543|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678617|NCT03129100|528999544|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678618|NCT03129100|528999545|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678619|NCT03129100|528999546|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678620|NCT03129100|528999547|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678621|NCT03129100|528999548|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678622|NCT03129100|528999549|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146678623|NCT03129100|528999524|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
146678624|NCT03129100|528999525|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
146678625|NCT03129100|528999526|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678626|NCT03129100|528999527|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678627|NCT03129100|528999528|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678628|NCT03129100|528999529|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678629|NCT03129100|528999530|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678630|NCT03129100|528999531|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678631|NCT03129100|528999532|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678632|NCT03129100|528999533|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678633|NCT03129100|528999534|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678634|NCT03129100|528999535|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678635|NCT03129100|528999536|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678636|NCT03129100|528999537|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678637|NCT03129100|528999538|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678638|NCT03129100|528999539|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678639|NCT03129100|528999540|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678640|NCT03129100|528999541|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678641|NCT03129100|528999542|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678642|NCT03129100|528999543|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678643|NCT03129100|528999544|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678644|NCT03129100|528999545|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678645|NCT03129100|528999546|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678646|NCT03129100|528999547|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678647|NCT03129100|528999548|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678648|NCT03129100|528999549|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146678649|NCT03129100|528999524|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
146678650|NCT03129100|528999525|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
146678651|NCT03129100|528999526|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678652|NCT03129100|528999527|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678653|NCT03129100|528999528|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678654|NCT03129100|528999529|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678655|NCT03129100|528999530|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678656|NCT03129100|528999531|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678657|NCT03129100|528999532|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678658|NCT03129100|528999533|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678659|NCT03129100|528999534|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678660|NCT03129100|528999535|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678661|NCT03129100|528999536|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678662|NCT03129100|528999537|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146926741|NCT01021852|529892803|FG001|Treatment Period 1|Pregnancy|0|||
146926742|NCT01021852|529892804|FG002|Treatment Period 1|Pregnancy|1|||
146926743|NCT01021852|529892805|FG003|Treatment Period 1|Pregnancy|0|||
146678663|NCT03129100|528999538|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678664|NCT03129100|528999539|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146926744|NCT01021852|529892806|FG004|Treatment Period 1|Pregnancy|0|||
146926745|NCT01021852|529892807|FG005|Treatment Period 1|Pregnancy|0|||
146926746|NCT01021852|529892808|FG006|Treatment Period 1|Pregnancy|0|||
146678665|NCT03129100|528999540|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678666|NCT03129100|528999541|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146926747|NCT01021852|529892809|FG007|Treatment Period 1|Pregnancy|0|||
146926748|NCT01021852|529892802|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146678667|NCT03129100|528999542|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678668|NCT03129100|528999543|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678669|NCT03129100|528999544|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678670|NCT03129100|528999545|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678671|NCT03129100|528999546|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678672|NCT03129100|528999547|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678673|NCT03129100|528999548|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678674|NCT03129100|528999549|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146678675|NCT03129100|528999524|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678676|NCT03129100|528999525|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
146678677|NCT03129100|528999526|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678678|NCT03129100|528999527|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678679|NCT03129100|528999528|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678680|NCT03129100|528999529|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678681|NCT03129100|528999530|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678682|NCT03129100|528999531|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678683|NCT03129100|528999532|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678684|NCT03129100|528999533|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678685|NCT03129100|528999534|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678686|NCT03129100|528999535|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678687|NCT03129100|528999536|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678688|NCT03129100|528999537|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678689|NCT03129100|528999538|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678690|NCT03129100|528999539|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678691|NCT03129100|528999540|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678692|NCT03129100|528999541|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678693|NCT03129100|528999542|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678694|NCT03129100|528999543|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678695|NCT03129100|528999544|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678696|NCT03129100|528999545|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678697|NCT03129100|528999546|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678698|NCT03129100|528999547|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678699|NCT03129100|528999548|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678700|NCT03129100|528999549|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
146678701|NCT03129100|528999524|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678702|NCT03129100|528999525|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678703|NCT03129100|528999526|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
146678704|NCT03129100|528999527|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
146678705|NCT03129100|528999528|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678706|NCT03129100|528999529|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
146678707|NCT03129100|528999530|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678708|NCT03129100|528999531|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678709|NCT03129100|528999532|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678710|NCT03129100|528999533|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678711|NCT03129100|528999534|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678712|NCT03129100|528999535|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678713|NCT03129100|528999536|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678714|NCT03129100|528999537|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678715|NCT03129100|528999538|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678716|NCT03129100|528999539|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678717|NCT03129100|528999540|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678718|NCT03129100|528999541|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678719|NCT03129100|528999542|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678720|NCT03129100|528999543|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678721|NCT03129100|528999544|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678722|NCT03129100|528999545|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678723|NCT03129100|528999546|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678724|NCT03129100|528999547|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678725|NCT03129100|528999548|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678726|NCT03129100|528999549|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146678727|NCT03129100|528999524|FG000|Period2 Extension Period (Group A and B)|Death|0|||
146678728|NCT03129100|528999525|FG001|Period2 Extension Period (Group A and B)|Death|0|||
146678729|NCT03129100|528999526|FG002|Period2 Extension Period (Group A and B)|Death|1|||
146678730|NCT03129100|528999527|FG003|Period2 Extension Period (Group A and B)|Death|0|||
146678731|NCT03129100|528999528|FG004|Period2 Extension Period (Group A and B)|Death|0|||
146678732|NCT03129100|528999529|FG005|Period2 Extension Period (Group A and B)|Death|0|||
146678733|NCT03129100|528999530|FG006|Period2 Extension Period (Group A and B)|Death|0|||
146678734|NCT03129100|528999531|FG007|Period2 Extension Period (Group A and B)|Death|0|||
146678735|NCT03129100|528999532|FG008|Period2 Extension Period (Group A and B)|Death|0|||
146678736|NCT03129100|528999533|FG009|Period2 Extension Period (Group A and B)|Death|0|||
146678737|NCT03129100|528999534|FG010|Period2 Extension Period (Group A and B)|Death|0|||
146678738|NCT03129100|528999535|FG011|Period2 Extension Period (Group A and B)|Death|0|||
146678739|NCT03129100|528999536|FG012|Period2 Extension Period (Group A and B)|Death|0|||
146678740|NCT03129100|528999537|FG013|Period2 Extension Period (Group A and B)|Death|0|||
146678741|NCT03129100|528999538|FG014|Period2 Extension Period (Group A and B)|Death|0|||
146678742|NCT03129100|528999539|FG015|Period2 Extension Period (Group A and B)|Death|0|||
146678743|NCT03129100|528999540|FG016|Period2 Extension Period (Group A and B)|Death|0|||
146678744|NCT03129100|528999541|FG017|Period2 Extension Period (Group A and B)|Death|0|||
146678745|NCT03129100|528999542|FG018|Period2 Extension Period (Group A and B)|Death|0|||
146678746|NCT03129100|528999543|FG019|Period2 Extension Period (Group A and B)|Death|0|||
146678747|NCT03129100|528999544|FG020|Period2 Extension Period (Group A and B)|Death|0|||
146678748|NCT03129100|528999545|FG021|Period2 Extension Period (Group A and B)|Death|0|||
146678749|NCT03129100|528999546|FG022|Period2 Extension Period (Group A and B)|Death|0|||
146678750|NCT03129100|528999547|FG023|Period2 Extension Period (Group A and B)|Death|0|||
146678751|NCT03129100|528999548|FG024|Period2 Extension Period (Group A and B)|Death|0|||
146678752|NCT03129100|528999549|FG025|Period2 Extension Period (Group A and B)|Death|0|||
146678753|NCT03129100|528999524|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678754|NCT03129100|528999525|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678755|NCT03129100|528999526|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
146678756|NCT03129100|528999527|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
146678757|NCT03129100|528999528|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
146678758|NCT03129100|528999529|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
146678759|NCT03129100|528999530|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
146678760|NCT03129100|528999531|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678761|NCT03129100|528999532|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678762|NCT03129100|528999533|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678763|NCT03129100|528999534|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678764|NCT03129100|528999535|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678765|NCT03129100|528999536|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678766|NCT03129100|528999537|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678767|NCT03129100|528999538|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678768|NCT03129100|528999539|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678769|NCT03129100|528999540|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678770|NCT03129100|528999541|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678771|NCT03129100|528999542|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678772|NCT03129100|528999543|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678773|NCT03129100|528999544|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678774|NCT03129100|528999545|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678775|NCT03129100|528999546|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678776|NCT03129100|528999547|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678777|NCT03129100|528999548|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678778|NCT03129100|528999549|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146678779|NCT03129100|528999524|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678780|NCT03129100|528999525|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678781|NCT03129100|528999526|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
146678782|NCT03129100|528999527|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678783|NCT03129100|528999528|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678784|NCT03129100|528999529|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678785|NCT03129100|528999530|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678786|NCT03129100|528999531|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678787|NCT03129100|528999532|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678788|NCT03129100|528999533|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678789|NCT03129100|528999534|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678790|NCT03129100|528999535|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678791|NCT03129100|528999536|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678792|NCT03129100|528999537|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678793|NCT03129100|528999538|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678794|NCT03129100|528999539|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146774493|NCT03422276|529345295|FG000|Overall Study|Lost to Follow-up|15|||
146774494|NCT03422276|529345296|FG001|Overall Study|Lost to Follow-up|8|||
146926749|NCT01021852|529892803|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146926750|NCT01021852|529892804|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146926751|NCT01021852|529892805|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146678795|NCT03129100|528999540|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678796|NCT03129100|528999541|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678797|NCT03129100|528999542|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678798|NCT03129100|528999543|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678799|NCT03129100|528999544|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678800|NCT03129100|528999545|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678801|NCT03129100|528999546|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678802|NCT03129100|528999547|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678803|NCT03129100|528999548|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678804|NCT03129100|528999549|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146678805|NCT03129100|528999524|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678806|NCT03129100|528999525|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678807|NCT03129100|528999526|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
146678808|NCT03129100|528999527|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678809|NCT03129100|528999528|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678810|NCT03129100|528999529|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678811|NCT03129100|528999530|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678812|NCT03129100|528999531|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678813|NCT03129100|528999532|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678814|NCT03129100|528999533|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678815|NCT03129100|528999534|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678816|NCT03129100|528999535|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678817|NCT03129100|528999536|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678818|NCT03129100|528999537|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678819|NCT03129100|528999538|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678820|NCT03129100|528999539|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678821|NCT03129100|528999540|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678822|NCT03129100|528999541|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678823|NCT03129100|528999542|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678824|NCT03129100|528999543|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678825|NCT03129100|528999544|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678826|NCT03129100|528999545|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678827|NCT03129100|528999546|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678828|NCT03129100|528999547|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678829|NCT03129100|528999548|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678830|NCT03129100|528999549|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146678831|NCT03129100|528999524|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678832|NCT03129100|528999525|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678833|NCT03129100|528999526|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
146678834|NCT03129100|528999527|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678835|NCT03129100|528999528|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678836|NCT03129100|528999529|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678837|NCT03129100|528999530|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678838|NCT03129100|528999531|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678839|NCT03129100|528999532|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678840|NCT03129100|528999533|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678841|NCT03129100|528999534|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678842|NCT03129100|528999535|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678843|NCT03129100|528999536|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678844|NCT03129100|528999537|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678845|NCT03129100|528999538|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678846|NCT03129100|528999539|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678847|NCT03129100|528999540|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678848|NCT03129100|528999541|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678849|NCT03129100|528999542|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678850|NCT03129100|528999543|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678851|NCT03129100|528999544|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678852|NCT03129100|528999545|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678853|NCT03129100|528999546|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678854|NCT03129100|528999547|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678855|NCT03129100|528999548|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678856|NCT03129100|528999549|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146678857|NCT03129100|528999524|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146926752|NCT01021852|529892806|FG004|Treatment Period 1|Withdrawal by Subject|1|||
146926753|NCT01021852|529892807|FG005|Treatment Period 1|Withdrawal by Subject|0|||
146926754|NCT01021852|529892808|FG006|Treatment Period 1|Withdrawal by Subject|0|||
146926755|NCT01021852|529892809|FG007|Treatment Period 1|Withdrawal by Subject|1|||
146678858|NCT03129100|528999525|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678859|NCT03129100|528999526|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678860|NCT03129100|528999527|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678861|NCT03129100|528999528|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
146678862|NCT03129100|528999529|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
146678863|NCT03129100|528999530|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
146678864|NCT03129100|528999531|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678865|NCT03129100|528999532|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678866|NCT03129100|528999533|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678867|NCT03129100|528999534|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678868|NCT03129100|528999535|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678869|NCT03129100|528999536|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678870|NCT03129100|528999537|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678871|NCT03129100|528999538|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678872|NCT03129100|528999539|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678873|NCT03129100|528999540|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678874|NCT03129100|528999541|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678875|NCT03129100|528999542|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678876|NCT03129100|528999543|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146926756|NCT01021852|529892802|FG000|Treatment Period 1|Not Treated|0|||
146926757|NCT01021852|529892803|FG001|Treatment Period 1|Not Treated|0|||
146926758|NCT01021852|529892804|FG002|Treatment Period 1|Not Treated|0|||
146926759|NCT01021852|529892805|FG003|Treatment Period 1|Not Treated|2|||
146926760|NCT01021852|529892806|FG004|Treatment Period 1|Not Treated|0|||
146926761|NCT01021852|529892807|FG005|Treatment Period 1|Not Treated|0|||
146926762|NCT01021852|529892808|FG006|Treatment Period 1|Not Treated|0|||
146926763|NCT01021852|529892809|FG007|Treatment Period 1|Not Treated|0|||
146926764|NCT01021852|529892802|FG000|Washout Period-Placebo|Adverse Event|0|||
146926765|NCT01021852|529892803|FG001|Washout Period-Placebo|Adverse Event|0|||
146926766|NCT01021852|529892804|FG002|Washout Period-Placebo|Adverse Event|0|||
146926767|NCT01021852|529892805|FG003|Washout Period-Placebo|Adverse Event|1|||
146926768|NCT01021852|529892806|FG004|Washout Period-Placebo|Adverse Event|0|||
146926769|NCT01021852|529892807|FG005|Washout Period-Placebo|Adverse Event|1|||
146926770|NCT01021852|529892808|FG006|Washout Period-Placebo|Adverse Event|0|||
146926771|NCT01021852|529892809|FG007|Washout Period-Placebo|Adverse Event|0|||
146926772|NCT01021852|529892802|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
146926773|NCT01021852|529892803|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
146926774|NCT01021852|529892804|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
146926775|NCT01021852|529892805|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
146926776|NCT01021852|529892806|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
146926777|NCT01021852|529892807|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
146926778|NCT01021852|529892808|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
146926779|NCT01021852|529892809|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
146926780|NCT01021852|529892802|FG000|Washout Period-Placebo|Protocol Violation|0|||
146926781|NCT01021852|529892803|FG001|Washout Period-Placebo|Protocol Violation|0|||
146926782|NCT01021852|529892804|FG002|Washout Period-Placebo|Protocol Violation|0|||
146926783|NCT01021852|529892805|FG003|Washout Period-Placebo|Protocol Violation|0|||
146926784|NCT01021852|529892806|FG004|Washout Period-Placebo|Protocol Violation|0|||
146926785|NCT01021852|529892807|FG005|Washout Period-Placebo|Protocol Violation|0|||
146926786|NCT01021852|529892808|FG006|Washout Period-Placebo|Protocol Violation|1|||
146926787|NCT01021852|529892809|FG007|Washout Period-Placebo|Protocol Violation|0|||
146926788|NCT01021852|529892802|FG000|Washout Period-No Drug|Adverse Event|1|||
146926789|NCT01021852|529892803|FG001|Washout Period-No Drug|Adverse Event|0|||
146926790|NCT01021852|529892804|FG002|Washout Period-No Drug|Adverse Event|0|||
146926791|NCT01021852|529892805|FG003|Washout Period-No Drug|Adverse Event|0|||
146926792|NCT01021852|529892806|FG004|Washout Period-No Drug|Adverse Event|0|||
146926793|NCT01021852|529892807|FG005|Washout Period-No Drug|Adverse Event|1|||
146926794|NCT01021852|529892808|FG006|Washout Period-No Drug|Adverse Event|0|||
146926795|NCT01021852|529892809|FG007|Washout Period-No Drug|Adverse Event|0|||
146926796|NCT01021852|529892802|FG000|Treatment Period 2|Adverse Event|0|||
146926797|NCT01021852|529892803|FG001|Treatment Period 2|Adverse Event|1|||
146926798|NCT01021852|529892804|FG002|Treatment Period 2|Adverse Event|0|||
146926799|NCT01021852|529892805|FG003|Treatment Period 2|Adverse Event|0|||
146926800|NCT01021852|529892806|FG004|Treatment Period 2|Adverse Event|1|||
146926801|NCT01021852|529892807|FG005|Treatment Period 2|Adverse Event|0|||
146926802|NCT01021852|529892808|FG006|Treatment Period 2|Adverse Event|1|||
146926803|NCT01021852|529892809|FG007|Treatment Period 2|Adverse Event|0|||
146926804|NCT01021852|529892802|FG000|Treatment Period 2|Lack of Efficacy|0|||
146926805|NCT01021852|529892803|FG001|Treatment Period 2|Lack of Efficacy|0|||
146926806|NCT01021852|529892804|FG002|Treatment Period 2|Lack of Efficacy|0|||
146926807|NCT01021852|529892805|FG003|Treatment Period 2|Lack of Efficacy|0|||
146678877|NCT03129100|528999544|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678878|NCT03129100|528999545|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678879|NCT03129100|528999546|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678880|NCT03129100|528999547|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678881|NCT03129100|528999548|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678882|NCT03129100|528999549|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146678883|NCT03129100|528999524|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678884|NCT03129100|528999525|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678885|NCT03129100|528999526|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678886|NCT03129100|528999527|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678887|NCT03129100|528999528|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678888|NCT03129100|528999529|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678889|NCT03129100|528999530|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678890|NCT03129100|528999531|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678891|NCT03129100|528999532|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678892|NCT03129100|528999533|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
146678893|NCT03129100|528999534|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678894|NCT03129100|528999535|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678895|NCT03129100|528999536|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678896|NCT03129100|528999537|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678897|NCT03129100|528999538|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678898|NCT03129100|528999539|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678899|NCT03129100|528999540|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678900|NCT03129100|528999541|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678901|NCT03129100|528999542|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678902|NCT03129100|528999543|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678903|NCT03129100|528999544|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678904|NCT03129100|528999545|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678905|NCT03129100|528999546|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678906|NCT03129100|528999547|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678907|NCT03129100|528999548|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678908|NCT03129100|528999549|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146678909|NCT03129100|528999524|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678910|NCT03129100|528999525|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678911|NCT03129100|528999526|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678912|NCT03129100|528999527|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678913|NCT03129100|528999528|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678914|NCT03129100|528999529|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678915|NCT03129100|528999530|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678916|NCT03129100|528999531|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678917|NCT03129100|528999532|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678918|NCT03129100|528999533|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678919|NCT03129100|528999534|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678920|NCT03129100|528999535|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
146678921|NCT03129100|528999536|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678922|NCT03129100|528999537|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678923|NCT03129100|528999538|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678924|NCT03129100|528999539|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678925|NCT03129100|528999540|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678926|NCT03129100|528999541|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146926808|NCT01021852|529892806|FG004|Treatment Period 2|Lack of Efficacy|0|||
146926809|NCT01021852|529892807|FG005|Treatment Period 2|Lack of Efficacy|1|||
146678927|NCT03129100|528999542|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678928|NCT03129100|528999543|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678929|NCT03129100|528999544|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678930|NCT03129100|528999545|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146774495|NCT03422276|529345297|FG002|Overall Study|Lost to Follow-up|13|||
146926810|NCT01021852|529892808|FG006|Treatment Period 2|Lack of Efficacy|0|||
146926811|NCT01021852|529892809|FG007|Treatment Period 2|Lack of Efficacy|0|||
146926812|NCT01021852|529892802|FG000|Treatment Period 2|Physician Decision|0|||
146926813|NCT01021852|529892803|FG001|Treatment Period 2|Physician Decision|0|||
146926814|NCT01021852|529892804|FG002|Treatment Period 2|Physician Decision|1|||
146678931|NCT03129100|528999546|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678932|NCT03129100|528999547|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678933|NCT03129100|528999548|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678934|NCT03129100|528999549|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146678935|NCT03129100|528999524|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678936|NCT03129100|528999525|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678937|NCT03129100|528999526|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678938|NCT03129100|528999527|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678939|NCT03129100|528999528|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678940|NCT03129100|528999529|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678941|NCT03129100|528999530|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678942|NCT03129100|528999531|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678943|NCT03129100|528999532|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678944|NCT03129100|528999533|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678945|NCT03129100|528999534|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678946|NCT03129100|528999535|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
146678947|NCT03129100|528999536|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
146678948|NCT03129100|528999537|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
146678949|NCT03129100|528999538|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
146678950|NCT03129100|528999539|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678951|NCT03129100|528999540|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678952|NCT03129100|528999541|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678953|NCT03129100|528999542|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678954|NCT03129100|528999543|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678955|NCT03129100|528999544|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678956|NCT03129100|528999545|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678957|NCT03129100|528999546|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146774496|NCT03422276|529345298|FG003|Overall Study|Lost to Follow-up|4|||
146774497|NCT03422276|529345295|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
146774498|NCT03422276|529345296|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
146774499|NCT03422276|529345297|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
146774500|NCT03422276|529345298|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
146774501|NCT03422276|529345295|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
146774502|NCT03422276|529345296|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
146774503|NCT03422276|529345297|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
146774504|NCT03422276|529345298|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
146774505|NCT03422276|529345295|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
146774506|NCT03422276|529345296|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
146774507|NCT03422276|529345297|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
146774508|NCT03422276|529345298|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
146774509|NCT03422276|529345295|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
146774510|NCT03422276|529345296|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
146774511|NCT03422276|529345297|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
146774512|NCT03422276|529345298|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
146774513|NCT03422276|529345295|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
146774514|NCT03422276|529345296|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
146774515|NCT03422276|529345297|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
146774516|NCT03422276|529345298|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
146774517|NCT02279095|529345304|FG000|Overall Study|Non-Compliance|1|||
146774518|NCT02279095|529345304|FG000|Overall Study|Withdrawal by Subject|8|||
146774519|NCT02279095|529345304|FG000|Overall Study|Adverse Event|2|||
146774520|NCT02279095|529345304|FG000|Overall Study|Other|7|||
146774521|NCT02279095|529345304|FG000|Overall Study|Lost to Follow-up|1|||
146774522|NCT05938413|529345305|FG000|Overall Study|Lost to Follow-up|1|||
146774523|NCT05938413|529345306|FG001|Overall Study|Lost to Follow-up|7|||
146774524|NCT05938413|529345305|FG000|Overall Study|Withdrawal by Subject|1|||
146774525|NCT05938413|529345306|FG001|Overall Study|Withdrawal by Subject|1|||
146774526|NCT04922021|529345307|FG000|Overall Study|Withdrawal by Subject|4|||
146926815|NCT01021852|529892805|FG003|Treatment Period 2|Physician Decision|0|||
146926816|NCT01021852|529892806|FG004|Treatment Period 2|Physician Decision|0|||
146926817|NCT01021852|529892807|FG005|Treatment Period 2|Physician Decision|0|||
146926818|NCT01021852|529892808|FG006|Treatment Period 2|Physician Decision|0|||
146926819|NCT01021852|529892809|FG007|Treatment Period 2|Physician Decision|0|||
146926820|NCT01021852|529892802|FG000|Treatment Period 2|Protocol Violation|0|||
146926821|NCT01021852|529892803|FG001|Treatment Period 2|Protocol Violation|0|||
146926822|NCT01021852|529892804|FG002|Treatment Period 2|Protocol Violation|0|||
146926823|NCT01021852|529892805|FG003|Treatment Period 2|Protocol Violation|0|||
146926824|NCT01021852|529892806|FG004|Treatment Period 2|Protocol Violation|1|||
146926825|NCT01021852|529892807|FG005|Treatment Period 2|Protocol Violation|0|||
146926826|NCT01021852|529892808|FG006|Treatment Period 2|Protocol Violation|1|||
146926827|NCT01021852|529892809|FG007|Treatment Period 2|Protocol Violation|0|||
146678958|NCT03129100|528999547|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146926828|NCT01021852|529892802|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146926829|NCT01021852|529892803|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146926830|NCT01021852|529892804|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146926831|NCT01021852|529892805|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146926832|NCT01021852|529892806|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146926833|NCT01021852|529892807|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146926834|NCT01021852|529892808|FG006|Treatment Period 2|Withdrawal by Subject|1|||
146926835|NCT01021852|529892809|FG007|Treatment Period 2|Withdrawal by Subject|2|||
146678959|NCT03129100|528999548|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678960|NCT03129100|528999549|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146678961|NCT03129100|528999524|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678962|NCT03129100|528999525|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678963|NCT03129100|528999526|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678964|NCT03129100|528999527|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678965|NCT03129100|528999528|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678966|NCT03129100|528999529|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678967|NCT03129100|528999530|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678968|NCT03129100|528999531|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678969|NCT03129100|528999532|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678970|NCT03129100|528999533|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678971|NCT03129100|528999534|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678972|NCT03129100|528999535|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
146678973|NCT03129100|528999536|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678974|NCT03129100|528999537|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
146678975|NCT03129100|528999538|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
146678976|NCT03129100|528999539|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678977|NCT03129100|528999540|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678978|NCT03129100|528999541|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678979|NCT03129100|528999542|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678980|NCT03129100|528999543|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678981|NCT03129100|528999544|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678982|NCT03129100|528999545|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678983|NCT03129100|528999546|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678984|NCT03129100|528999547|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678985|NCT03129100|528999548|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678986|NCT03129100|528999549|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146678987|NCT03129100|528999524|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146678988|NCT03129100|528999525|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146678989|NCT03129100|528999526|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146678990|NCT03129100|528999527|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146678991|NCT03129100|528999528|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146678992|NCT03129100|528999529|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146678993|NCT03129100|528999530|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146678994|NCT03129100|528999531|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146678995|NCT03129100|528999532|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146678996|NCT03129100|528999533|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146678997|NCT03129100|528999534|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146678998|NCT03129100|528999535|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146678999|NCT03129100|528999536|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146679000|NCT03129100|528999537|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146679001|NCT03129100|528999538|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146679002|NCT03129100|528999539|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
146679003|NCT03129100|528999540|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146926836|NCT01069523|529892810|FG000|Overall Study|Withdrawal by Subject|4|||
146926837|NCT01069523|529892811|FG001|Overall Study|Withdrawal by Subject|7|||
146926838|NCT01025817|529892815|FG000|Completed Study Medication|Adverse Event|66|||
146926839|NCT01025817|529892816|FG001|Completed Study Medication|Adverse Event|39|||
146926840|NCT01025817|529892815|FG000|Completed Study Medication|Protocol Deviation|9|||
146926841|NCT01025817|529892816|FG001|Completed Study Medication|Protocol Deviation|8|||
146926842|NCT01025817|529892815|FG000|Completed Study Medication|Withdrawal by Subject|8|||
146926843|NCT01025817|529892816|FG001|Completed Study Medication|Withdrawal by Subject|9|||
146926844|NCT01025817|529892815|FG000|Completed Study Medication|Administrative problems|7|||
146926845|NCT01025817|529892816|FG001|Completed Study Medication|Administrative problems|5|||
146926846|NCT01025817|529892815|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
146926847|NCT01025817|529892816|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
146679004|NCT03129100|528999541|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146679005|NCT03129100|528999542|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146679006|NCT03129100|528999543|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146679007|NCT03129100|528999544|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146926848|NCT01025817|529892815|FG000|Completed Study Medication|Abnormal test procedure|4|||
146679008|NCT03129100|528999545|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146679009|NCT03129100|528999546|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146679010|NCT03129100|528999547|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146679011|NCT03129100|528999548|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146679012|NCT03129100|528999549|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146679013|NCT03129100|528999524|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679014|NCT03129100|528999525|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679015|NCT03129100|528999526|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679016|NCT03129100|528999527|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679017|NCT03129100|528999528|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679018|NCT03129100|528999529|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679019|NCT03129100|528999530|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679020|NCT03129100|528999531|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679021|NCT03129100|528999532|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679022|NCT03129100|528999533|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679023|NCT03129100|528999534|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679024|NCT03129100|528999535|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679025|NCT03129100|528999536|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
146679026|NCT03129100|528999537|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679027|NCT03129100|528999538|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
146679028|NCT03129100|528999539|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
146679029|NCT03129100|528999540|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679030|NCT03129100|528999541|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679031|NCT03129100|528999542|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679032|NCT03129100|528999543|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679033|NCT03129100|528999544|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679034|NCT03129100|528999545|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679035|NCT03129100|528999546|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679036|NCT03129100|528999547|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679037|NCT03129100|528999548|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679038|NCT03129100|528999549|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146679039|NCT03129100|528999524|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679040|NCT03129100|528999525|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679041|NCT03129100|528999526|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679042|NCT03129100|528999527|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679043|NCT03129100|528999528|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679044|NCT03129100|528999529|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679045|NCT03129100|528999530|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679046|NCT03129100|528999531|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679047|NCT03129100|528999532|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679048|NCT03129100|528999533|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679049|NCT03129100|528999534|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679050|NCT03129100|528999535|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679051|NCT03129100|528999536|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679052|NCT03129100|528999537|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679053|NCT03129100|528999538|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679054|NCT03129100|528999539|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679055|NCT03129100|528999540|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146774527|NCT04922021|529345308|FG001|Overall Study|Withdrawal by Subject|10|||
146774528|NCT04922021|529345307|FG000|Overall Study|Adverse Event|2|||
146926849|NCT01025817|529892816|FG001|Completed Study Medication|Abnormal test procedure|0|||
146926850|NCT01025817|529892815|FG000|Completed Study Medication|Graft loss|2|||
146926851|NCT01025817|529892816|FG001|Completed Study Medication|Graft loss|5|||
146926852|NCT01025817|529892815|FG000|Completed Study Medication|Death|2|||
146926853|NCT01025817|529892816|FG001|Completed Study Medication|Death|2|||
146679056|NCT03129100|528999541|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
146679057|NCT03129100|528999542|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679058|NCT03129100|528999543|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
146679059|NCT03129100|528999544|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679060|NCT03129100|528999545|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679061|NCT03129100|528999546|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679062|NCT03129100|528999547|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679063|NCT03129100|528999548|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679064|NCT03129100|528999549|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146679065|NCT03129100|528999524|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679066|NCT03129100|528999525|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679067|NCT03129100|528999526|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679068|NCT03129100|528999527|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679069|NCT03129100|528999528|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679070|NCT03129100|528999529|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679071|NCT03129100|528999530|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679072|NCT03129100|528999531|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679073|NCT03129100|528999532|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679074|NCT03129100|528999533|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679075|NCT03129100|528999534|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679076|NCT03129100|528999535|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679077|NCT03129100|528999536|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679078|NCT03129100|528999537|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679079|NCT03129100|528999538|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679080|NCT03129100|528999539|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679081|NCT03129100|528999540|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146774529|NCT04922021|529345308|FG001|Overall Study|Adverse Event|2|||
146774530|NCT04922021|529345307|FG000|Overall Study|Lack of Efficacy|0|||
146774531|NCT04922021|529345308|FG001|Overall Study|Lack of Efficacy|1|||
146774532|NCT04922021|529345307|FG000|Overall Study|Multiple reasons|1|||
146774533|NCT04922021|529345308|FG001|Overall Study|Multiple reasons|0|||
146774534|NCT03237481|529345317|FG000|Overall Study|Lost to Follow-up|1|||
146774535|NCT03237481|529345318|FG001|Overall Study|Lost to Follow-up|0|||
146774536|NCT03237481|529345319|FG002|Overall Study|Lost to Follow-up|0|||
146774537|NCT03237481|529345317|FG000|Overall Study|Protocol Violation|1|||
146774538|NCT03237481|529345318|FG001|Overall Study|Protocol Violation|0|||
146774539|NCT03237481|529345319|FG002|Overall Study|Protocol Violation|0|||
146774540|NCT03237481|529345317|FG000|Overall Study|Withdrawal by Subject|3|||
146774541|NCT03237481|529345318|FG001|Overall Study|Withdrawal by Subject|2|||
146774542|NCT03237481|529345319|FG002|Overall Study|Withdrawal by Subject|1|||
146774543|NCT03481777|529345320|FG000|Overall Study|Withdrawal by Subject|36|||
146774544|NCT03481777|529345321|FG001|Overall Study|Withdrawal by Subject|31|||
146774545|NCT03481777|529345320|FG000|Overall Study|Non stroke = non target population|277|||
146774546|NCT03481777|529345321|FG001|Overall Study|Non stroke = non target population|254|||
146774547|NCT04139668|529345326|FG000|Overall Study|Withdrawal by Subject|1|||
146774548|NCT04300647|529345331|FG000|Pre-Crossover|Death|19|||
146774549|NCT04300647|529345332|FG001|Pre-Crossover|Death|58|||
146774550|NCT04300647|529345333|FG002|Pre-Crossover|Death|0|||
146774551|NCT04300647|529345331|FG000|Pre-Crossover|Lost to Follow-up|0|||
146774552|NCT04300647|529345332|FG001|Pre-Crossover|Lost to Follow-up|3|||
146774553|NCT04300647|529345333|FG002|Pre-Crossover|Lost to Follow-up|0|||
146774554|NCT04300647|529345331|FG000|Pre-Crossover|Withdrawal by Subject|2|||
146774555|NCT04300647|529345332|FG001|Pre-Crossover|Withdrawal by Subject|4|||
146774556|NCT04300647|529345333|FG002|Pre-Crossover|Withdrawal by Subject|0|||
146774557|NCT04300647|529345331|FG000|Pre-Crossover|On-going in Study|24|||
146774558|NCT04300647|529345332|FG001|Pre-Crossover|On-going in Study|61|||
146774559|NCT04300647|529345333|FG002|Pre-Crossover|On-going in Study|0|||
146774560|NCT04300647|529345331|FG000|Post-Crossover|Death|0|||
146774561|NCT04300647|529345332|FG001|Post-Crossover|Death|0|||
146774562|NCT04300647|529345333|FG002|Post-Crossover|Death|3|||
146926854|NCT01025817|529892815|FG000|Completed Study Medication|Abnormal lab values|0|||
146679082|NCT03129100|528999541|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146774563|NCT04300647|529345331|FG000|Post-Crossover|Lost to Follow-up|0|||
146774564|NCT04300647|529345332|FG001|Post-Crossover|Lost to Follow-up|0|||
146774565|NCT04300647|529345333|FG002|Post-Crossover|Lost to Follow-up|1|||
146774566|NCT04300647|529345331|FG000|Post-Crossover|Withdrawal by Subject|0|||
146774567|NCT04300647|529345332|FG001|Post-Crossover|Withdrawal by Subject|0|||
146774568|NCT04300647|529345333|FG002|Post-Crossover|Withdrawal by Subject|1|||
146774569|NCT04300647|529345331|FG000|Post-Crossover|On-going in Study|0|||
146774570|NCT04300647|529345332|FG001|Post-Crossover|On-going in Study|0|||
146774571|NCT04300647|529345333|FG002|Post-Crossover|On-going in Study|8|||
146774572|NCT05386238|529345339|FG000|Overall Study|Lost to Follow-up|3|||
146774573|NCT05386238|529345340|FG001|Overall Study|Lost to Follow-up|2|||
146774574|NCT05386238|529345339|FG000|Overall Study|Withdrawal by Subject|0|||
146774575|NCT05386238|529345340|FG001|Overall Study|Withdrawal by Subject|1|||
146774576|NCT04907474|529345341|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
146679083|NCT03129100|528999542|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679084|NCT03129100|528999543|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679085|NCT03129100|528999544|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
146679086|NCT03129100|528999545|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679087|NCT03129100|528999546|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679088|NCT03129100|528999547|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679089|NCT03129100|528999548|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679090|NCT03129100|528999549|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146679091|NCT03129100|528999524|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
146679092|NCT03129100|528999525|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
146679093|NCT03129100|528999526|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
146679094|NCT03129100|528999527|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
146679095|NCT03129100|528999528|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
146679096|NCT03129100|528999529|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
146679097|NCT03129100|528999530|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
146679098|NCT03129100|528999531|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
146679099|NCT03129100|528999532|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
146679100|NCT03129100|528999533|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
146679101|NCT03129100|528999534|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
146679102|NCT03129100|528999535|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
146679103|NCT03129100|528999536|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
146679104|NCT03129100|528999537|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
146679105|NCT03129100|528999538|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
146679106|NCT03129100|528999539|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
146679107|NCT03129100|528999540|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
146679108|NCT03129100|528999541|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
146679109|NCT03129100|528999542|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
146679110|NCT03129100|528999543|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
146679111|NCT03129100|528999544|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
146679112|NCT03129100|528999545|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
146679113|NCT03129100|528999546|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
146679114|NCT03129100|528999547|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
146679115|NCT03129100|528999548|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
146679116|NCT03129100|528999549|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
146679117|NCT03129100|528999524|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679118|NCT03129100|528999525|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679119|NCT03129100|528999526|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679120|NCT03129100|528999527|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679121|NCT03129100|528999528|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679122|NCT03129100|528999529|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679123|NCT03129100|528999530|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679124|NCT03129100|528999531|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679125|NCT03129100|528999532|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679126|NCT03129100|528999533|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679127|NCT03129100|528999534|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679128|NCT03129100|528999535|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679129|NCT03129100|528999536|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679130|NCT03129100|528999537|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679131|NCT03129100|528999538|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679132|NCT03129100|528999539|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679133|NCT03129100|528999540|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679134|NCT03129100|528999541|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679135|NCT03129100|528999542|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679136|NCT03129100|528999543|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679137|NCT03129100|528999544|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
146679138|NCT03129100|528999545|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679139|NCT03129100|528999546|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679140|NCT03129100|528999547|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679141|NCT03129100|528999548|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679142|NCT03129100|528999549|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146679143|NCT03129100|528999524|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
146679144|NCT03129100|528999525|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
146679145|NCT03129100|528999526|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
146679146|NCT03129100|528999527|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
146848204|NCT00948766|529614050|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
146848205|NCT00948766|529614049|FG000|Core Study|Patient Withdrew Consent|27|||
146848206|NCT00948766|529614050|FG001|Core Study|Patient Withdrew Consent|46|||
146848207|NCT00948766|529614049|FG000|Core Study|Lost to Follow-up|3|||
146848208|NCT00948766|529614050|FG001|Core Study|Lost to Follow-up|2|||
146848209|NCT00948766|529614049|FG000|Core Study|Administrative Problems|2|||
146848210|NCT00948766|529614050|FG001|Core Study|Administrative Problems|2|||
146679147|NCT03129100|528999528|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
146679148|NCT03129100|528999529|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
146679149|NCT03129100|528999530|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
146679150|NCT03129100|528999531|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
146679151|NCT03129100|528999532|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
146679152|NCT03129100|528999533|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
146679153|NCT03129100|528999534|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
146679154|NCT03129100|528999535|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
146679155|NCT03129100|528999536|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
146679156|NCT03129100|528999537|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
146679157|NCT03129100|528999538|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
146679158|NCT03129100|528999539|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
146679159|NCT03129100|528999540|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
146679160|NCT03129100|528999541|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
146679161|NCT03129100|528999542|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
146679162|NCT03129100|528999543|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
146679163|NCT03129100|528999544|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
146679164|NCT03129100|528999545|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
146679165|NCT03129100|528999546|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
146679166|NCT03129100|528999547|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
146679167|NCT03129100|528999548|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
146679168|NCT03129100|528999549|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
146679169|NCT03129100|528999524|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679170|NCT03129100|528999525|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679171|NCT03129100|528999526|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679172|NCT03129100|528999527|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679173|NCT03129100|528999528|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679174|NCT03129100|528999529|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679175|NCT03129100|528999530|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146848211|NCT00948766|529614049|FG000|Core Study|Death|1|||
146848212|NCT00948766|529614050|FG001|Core Study|Death|1|||
146848213|NCT00948766|529614049|FG000|Core Study|Protocol Deviation|8|||
146848214|NCT00948766|529614050|FG001|Core Study|Protocol Deviation|10|||
146848215|NCT00948766|529614049|FG000|Extension Study|Adverse Event|43|||
146848216|NCT00948766|529614050|FG001|Extension Study|Adverse Event|0|||
146848217|NCT00948766|529614049|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
146848218|NCT00948766|529614050|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
146848219|NCT00948766|529614049|FG000|Extension Study|Study Drug No Longer Required|1|||
146848220|NCT00948766|529614050|FG001|Extension Study|Study Drug No Longer Required|0|||
146848221|NCT00948766|529614049|FG000|Extension Study|Patient Withdrew Consent|32|||
146848222|NCT00948766|529614050|FG001|Extension Study|Patient Withdrew Consent|0|||
146848223|NCT00948766|529614049|FG000|Extension Study|Lost to Follow-up|8|||
146848224|NCT00948766|529614050|FG001|Extension Study|Lost to Follow-up|0|||
146848225|NCT00948766|529614049|FG000|Extension Study|Administrative Problems|1|||
146848226|NCT00948766|529614050|FG001|Extension Study|Administrative Problems|0|||
146848227|NCT00948766|529614049|FG000|Extension Study|Death|4|||
146848228|NCT00948766|529614050|FG001|Extension Study|Death|0|||
146848229|NCT00777088|529614051|FG000|Overall Study|PED Treatment not attempted|1|||
146848230|NCT01278173|529614052|FG000|Overall Study|Lack of Efficacy|13|||
146848231|NCT01278173|529614052|FG000|Overall Study|Adverse Event|8|||
146848232|NCT01278173|529614052|FG000|Overall Study|Administrative or other reason|4|||
146848233|NCT01278173|529614052|FG000|Overall Study|Protocol Violation|1|||
146848234|NCT01278173|529614052|FG000|Overall Study|Withdrawal by Subject|1|||
146848235|NCT02546921|529614053|FG000|Overall Study|Adverse Event|0|||
146848236|NCT02546921|529614054|FG001|Overall Study|Adverse Event|5|||
146848237|NCT02546921|529614055|FG002|Overall Study|Adverse Event|2|||
146848238|NCT02546921|529614056|FG003|Overall Study|Adverse Event|0|||
146848239|NCT02546921|529614057|FG004|Overall Study|Adverse Event|0|||
146848240|NCT02546921|529614058|FG005|Overall Study|Adverse Event|0|||
146848241|NCT02546921|529614059|FG006|Overall Study|Adverse Event|0|||
146848242|NCT02546921|529614053|FG000|Overall Study|Evidence of Disease Progression|1|||
146848243|NCT02546921|529614054|FG001|Overall Study|Evidence of Disease Progression|0|||
146848244|NCT02546921|529614055|FG002|Overall Study|Evidence of Disease Progression|0|||
146848245|NCT02546921|529614056|FG003|Overall Study|Evidence of Disease Progression|0|||
146848246|NCT02546921|529614057|FG004|Overall Study|Evidence of Disease Progression|1|||
146848247|NCT02546921|529614058|FG005|Overall Study|Evidence of Disease Progression|0|||
146848248|NCT02546921|529614059|FG006|Overall Study|Evidence of Disease Progression|0|||
146848249|NCT02546921|529614053|FG000|Overall Study|Patient Choice|0|||
146848250|NCT02546921|529614054|FG001|Overall Study|Patient Choice|1|||
146848251|NCT02546921|529614055|FG002|Overall Study|Patient Choice|0|||
146848252|NCT02546921|529614056|FG003|Overall Study|Patient Choice|0|||
146848253|NCT02546921|529614057|FG004|Overall Study|Patient Choice|0|||
146848254|NCT02546921|529614058|FG005|Overall Study|Patient Choice|1|||
146848255|NCT02546921|529614059|FG006|Overall Study|Patient Choice|0|||
146679176|NCT03129100|528999531|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679177|NCT03129100|528999532|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679178|NCT03129100|528999533|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679179|NCT03129100|528999534|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679180|NCT03129100|528999535|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679181|NCT03129100|528999536|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679182|NCT03129100|528999537|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679183|NCT03129100|528999538|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679184|NCT03129100|528999539|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679185|NCT03129100|528999540|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679186|NCT03129100|528999541|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679187|NCT03129100|528999542|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679188|NCT03129100|528999543|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679189|NCT03129100|528999544|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679190|NCT03129100|528999545|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679191|NCT03129100|528999546|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679192|NCT03129100|528999547|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146679193|NCT03129100|528999548|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
146679194|NCT03129100|528999549|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
146679195|NCT03129100|528999524|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679196|NCT03129100|528999525|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679197|NCT03129100|528999526|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679198|NCT03129100|528999527|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679199|NCT03129100|528999528|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679200|NCT03129100|528999529|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679201|NCT03129100|528999530|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679202|NCT03129100|528999531|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679203|NCT03129100|528999532|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679204|NCT03129100|528999533|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679205|NCT03129100|528999534|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679206|NCT03129100|528999535|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679207|NCT03129100|528999536|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679208|NCT03129100|528999537|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679209|NCT03129100|528999538|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679210|NCT03129100|528999539|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679211|NCT03129100|528999540|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679212|NCT03129100|528999541|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679213|NCT03129100|528999542|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679214|NCT03129100|528999543|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679215|NCT03129100|528999544|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679216|NCT03129100|528999545|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679217|NCT03129100|528999546|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146679218|NCT03129100|528999547|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
146679219|NCT03129100|528999548|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
146679220|NCT03129100|528999549|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
146679221|NCT03129100|528999524|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146848256|NCT02091206|529614060|FG000|Treatment Period|Adverse Event|0|||
146848257|NCT02091206|529614061|FG001|Treatment Period|Adverse Event|1|||
146848258|NCT02091206|529614062|FG002|Treatment Period|Adverse Event|0|||
146848259|NCT02091206|529614063|FG003|Treatment Period|Adverse Event|0|||
146848260|NCT02091206|529614060|FG000|Treatment Period|Met withdrawal criteria|0|||
146848261|NCT02091206|529614061|FG001|Treatment Period|Met withdrawal criteria|0|||
146848262|NCT02091206|529614062|FG002|Treatment Period|Met withdrawal criteria|1|||
146848263|NCT02091206|529614063|FG003|Treatment Period|Met withdrawal criteria|0|||
146848264|NCT02091206|529614060|FG000|Taper Period|Participant refused study drug|1|||
146848265|NCT02091206|529614061|FG001|Taper Period|Participant refused study drug|0|||
146848266|NCT02091206|529614062|FG002|Taper Period|Participant refused study drug|0|||
146848267|NCT02091206|529614063|FG003|Taper Period|Participant refused study drug|1|||
146848268|NCT02091206|529614060|FG000|Taper Period|Lost to Follow-up|0|||
146848269|NCT02091206|529614061|FG001|Taper Period|Lost to Follow-up|0|||
146848270|NCT02091206|529614062|FG002|Taper Period|Lost to Follow-up|0|||
146848271|NCT02091206|529614063|FG003|Taper Period|Lost to Follow-up|1|||
146848272|NCT03037931|529615639|FG000|Overall Study|Death|354|||
146848273|NCT03037931|529615640|FG001|Overall Study|Death|367|||
146848274|NCT03037931|529615639|FG000|Overall Study|Lost to Follow-up|7|||
146848275|NCT03037931|529615640|FG001|Overall Study|Lost to Follow-up|4|||
146848276|NCT03037931|529615639|FG000|Overall Study|Withdrawal by Subject|48|||
146848277|NCT03037931|529615640|FG001|Overall Study|Withdrawal by Subject|41|||
146679222|NCT03129100|528999525|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679223|NCT03129100|528999526|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679224|NCT03129100|528999527|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679225|NCT03129100|528999528|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679226|NCT03129100|528999529|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679227|NCT03129100|528999530|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679228|NCT03129100|528999531|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679229|NCT03129100|528999532|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679230|NCT03129100|528999533|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679231|NCT03129100|528999534|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679232|NCT03129100|528999535|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679233|NCT03129100|528999536|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679234|NCT03129100|528999537|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679235|NCT03129100|528999538|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679236|NCT03129100|528999539|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679237|NCT03129100|528999540|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679238|NCT03129100|528999541|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679239|NCT03129100|528999542|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679240|NCT03129100|528999543|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679241|NCT03129100|528999544|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679242|NCT03129100|528999545|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679243|NCT03129100|528999546|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679244|NCT03129100|528999547|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679245|NCT03129100|528999548|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
146679246|NCT03129100|528999549|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146679247|NCT03129100|528999524|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679248|NCT03129100|528999525|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679249|NCT03129100|528999526|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679250|NCT03129100|528999527|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679251|NCT03129100|528999528|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679252|NCT03129100|528999529|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679253|NCT03129100|528999530|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679254|NCT03129100|528999531|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679255|NCT03129100|528999532|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679256|NCT03129100|528999533|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679257|NCT03129100|528999534|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679258|NCT03129100|528999535|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679259|NCT03129100|528999536|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679260|NCT03129100|528999537|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679261|NCT03129100|528999538|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679262|NCT03129100|528999539|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679263|NCT03129100|528999540|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679264|NCT03129100|528999541|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679265|NCT03129100|528999542|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679266|NCT03129100|528999543|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679267|NCT03129100|528999544|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679268|NCT03129100|528999545|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679269|NCT03129100|528999546|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679270|NCT03129100|528999547|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679271|NCT03129100|528999548|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146679272|NCT03129100|528999549|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
146679273|NCT03129100|528999524|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
146679274|NCT03129100|528999525|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
146679275|NCT03129100|528999526|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
146679276|NCT03129100|528999527|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
146679277|NCT03129100|528999528|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
146679278|NCT03129100|528999529|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
146679279|NCT03129100|528999530|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
146679280|NCT03129100|528999531|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
146679281|NCT03129100|528999532|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
146679282|NCT03129100|528999533|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
146679283|NCT03129100|528999534|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
146679284|NCT03129100|528999535|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
146679285|NCT03129100|528999536|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
146679286|NCT03129100|528999537|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
146679287|NCT03129100|528999538|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
146679288|NCT03129100|528999539|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
146679289|NCT03129100|528999540|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
146679290|NCT03129100|528999541|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
146679291|NCT03129100|528999542|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
146679292|NCT03129100|528999543|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
146679293|NCT03129100|528999544|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
146679294|NCT03129100|528999545|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
146679295|NCT03129100|528999546|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
146679296|NCT03129100|528999547|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
146679297|NCT03129100|528999548|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
146679298|NCT03129100|528999549|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
146679299|NCT01587001|528999550|FG000|Overall Study|Lost to Follow-up|2|||
146679300|NCT01587001|528999551|FG001|Overall Study|Lost to Follow-up|0|||
146679301|NCT01587001|528999550|FG000|Overall Study|Insufficient samples to complete testing|4|||
146679302|NCT01587001|528999551|FG001|Overall Study|Insufficient samples to complete testing|1|||
146679303|NCT01197560|528999552|FG000|Overall Study|Adverse Event|6|||
146679304|NCT01197560|528999553|FG001|Overall Study|Adverse Event|8|||
146679305|NCT01197560|528999552|FG000|Overall Study|Death|3|||
146679306|NCT01197560|528999553|FG001|Overall Study|Death|5|||
146679307|NCT01197560|528999552|FG000|Overall Study|Withdrawal by Subject|1|||
146679308|NCT01197560|528999553|FG001|Overall Study|Withdrawal by Subject|1|||
146679309|NCT01197560|528999552|FG000|Overall Study|Disease progression|40|||
146679310|NCT01197560|528999553|FG001|Overall Study|Disease progression|35|||
146679311|NCT01197560|528999552|FG000|Overall Study|Miscellaneous|4|||
146679312|NCT01197560|528999553|FG001|Overall Study|Miscellaneous|3|||
146679313|NCT01197560|528999552|FG000|Overall Study|Missing|0|||
146679314|NCT01197560|528999553|FG001|Overall Study|Missing|1|||
146679315|NCT00496054|528999554|FG000|Overall Study|Adverse Event|1|||
146679316|NCT00496054|528999554|FG000|Overall Study|Lost to Follow-up|7|||
146679317|NCT02216591|528999555|FG000|Overall Study|Lost to Follow-up|0|||
146679318|NCT02216591|528999556|FG001|Overall Study|Lost to Follow-up|1|||
146679319|NCT01950741|528999559|FG000|Overall Study|Lost to Follow-up|1|||
146679320|NCT01950741|528999559|FG000|Overall Study|Death|1|||
146679321|NCT01950741|528999559|FG000|Overall Study|Withdrawal by Subject|1|||
146679322|NCT02854631|528999562|FG000|Overall Study|Adverse Event|1|||
146679323|NCT02854631|528999563|FG001|Overall Study|Adverse Event|2|||
146679324|NCT02854631|528999562|FG000|Overall Study|Withdrew Consent|3|||
146679325|NCT02854631|528999563|FG001|Overall Study|Withdrew Consent|2|||
146679326|NCT02854631|528999562|FG000|Overall Study|Investigator's Discretion|2|||
146679327|NCT02854631|528999563|FG001|Overall Study|Investigator's Discretion|0|||
146679328|NCT02854631|528999562|FG000|Overall Study|Death|12|||
146679329|NCT02854631|528999563|FG001|Overall Study|Death|8|||
146679330|NCT02854631|528999562|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
146679331|NCT02854631|528999563|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
146679332|NCT02854631|528999562|FG000|Overall Study|Protocol Violation|0|||
146679333|NCT02854631|528999563|FG001|Overall Study|Protocol Violation|1|||
146679334|NCT02854631|528999562|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
146679335|NCT02854631|528999563|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
146679336|NCT02854631|528999562|FG000|Overall Study|Lost to Follow-up|4|||
146679337|NCT02854631|528999563|FG001|Overall Study|Lost to Follow-up|2|||
146679338|NCT02233647|528999564|FG000|Overall Study|Adverse Event|1|||
146679339|NCT00621153|528999568|FG000|Overall Study|Safety Reason|8|||
146679340|NCT00621153|528999569|FG001|Overall Study|Safety Reason|7|||
146679341|NCT00621153|528999568|FG000|Overall Study|Adverse Event|3|||
146679342|NCT00621153|528999569|FG001|Overall Study|Adverse Event|2|||
146679343|NCT00621153|528999568|FG000|Overall Study|Lost to Follow-up|5|||
146679344|NCT00621153|528999569|FG001|Overall Study|Lost to Follow-up|1|||
146679345|NCT00621153|528999568|FG000|Overall Study|Withdrawal by Subject|4|||
146679346|NCT00621153|528999569|FG001|Overall Study|Withdrawal by Subject|5|||
146679347|NCT00753415|528999570|FG000|Part A|Disease progression|1|||
146679348|NCT00753415|528999571|FG001|Part A|Disease progression|0|||
146679349|NCT00753415|528999572|FG002|Part A|Disease progression|1|||
146679350|NCT00753415|528999573|FG003|Part A|Disease progression|2|||
146679351|NCT00753415|528999574|FG004|Part A|Disease progression|0|||
146679352|NCT00753415|528999575|FG005|Part A|Disease progression|0|||
146679353|NCT00753415|528999576|FG006|Part A|Disease progression|0|||
146679354|NCT00753415|528999577|FG007|Part A|Disease progression|0|||
146679355|NCT00753415|528999578|FG008|Part A|Disease progression|0|||
146679356|NCT00753415|528999579|FG009|Part A|Disease progression|0|||
146926855|NCT01025817|529892816|FG001|Completed Study Medication|Abnormal lab values|2|||
146679357|NCT00753415|528999570|FG000|Part A|Withdrawal by Subject|0|||
146679358|NCT00753415|528999571|FG001|Part A|Withdrawal by Subject|0|||
146679359|NCT00753415|528999572|FG002|Part A|Withdrawal by Subject|1|||
146679360|NCT00753415|528999573|FG003|Part A|Withdrawal by Subject|0|||
146679361|NCT00753415|528999574|FG004|Part A|Withdrawal by Subject|0|||
146679362|NCT00753415|528999575|FG005|Part A|Withdrawal by Subject|0|||
146679363|NCT00753415|528999576|FG006|Part A|Withdrawal by Subject|0|||
146679364|NCT00753415|528999577|FG007|Part A|Withdrawal by Subject|0|||
146679365|NCT00753415|528999578|FG008|Part A|Withdrawal by Subject|0|||
146679366|NCT00753415|528999579|FG009|Part A|Withdrawal by Subject|0|||
146679367|NCT00753415|528999570|FG000|Part B|Lost to Follow-up|0|||
146926856|NCT01025817|529892815|FG000|Completed Study Medication|Subject no longer required study drug|0|||
146679368|NCT00753415|528999571|FG001|Part B|Lost to Follow-up|0|||
146679369|NCT00753415|528999572|FG002|Part B|Lost to Follow-up|0|||
146679370|NCT00753415|528999573|FG003|Part B|Lost to Follow-up|0|||
146679371|NCT00753415|528999574|FG004|Part B|Lost to Follow-up|0|||
146679372|NCT00753415|528999575|FG005|Part B|Lost to Follow-up|0|||
146679373|NCT00753415|528999576|FG006|Part B|Lost to Follow-up|0|||
146679374|NCT00753415|528999577|FG007|Part B|Lost to Follow-up|1|||
146679375|NCT00753415|528999578|FG008|Part B|Lost to Follow-up|1|||
146679376|NCT00753415|528999579|FG009|Part B|Lost to Follow-up|0|||
146679377|NCT00753415|528999570|FG000|Part B|Disease progression|0|||
146679378|NCT00753415|528999571|FG001|Part B|Disease progression|0|||
146679379|NCT00753415|528999572|FG002|Part B|Disease progression|0|||
146679380|NCT00753415|528999573|FG003|Part B|Disease progression|0|||
146679381|NCT00753415|528999574|FG004|Part B|Disease progression|0|||
146679382|NCT00753415|528999575|FG005|Part B|Disease progression|0|||
146679383|NCT00753415|528999576|FG006|Part B|Disease progression|0|||
146679384|NCT00753415|528999577|FG007|Part B|Disease progression|0|||
146679385|NCT00753415|528999578|FG008|Part B|Disease progression|2|||
146679386|NCT00753415|528999579|FG009|Part B|Disease progression|1|||
146679387|NCT04212650|528999580|FG000|Overall Study|Withdrawal by Subject|1|||
146679388|NCT04212650|528999581|FG001|Overall Study|Withdrawal by Subject|0|||
146679389|NCT00679302|528999583|FG000|Overall Study|Lost to Follow-up|8|||
146679390|NCT00679302|528999584|FG001|Overall Study|Lost to Follow-up|4|||
146679391|NCT01753856|528999585|FG000|Overall Study|Adverse Event|1|||
146774577|NCT04907474|529345342|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
146774578|NCT04714320|529345344|FG000|Overall Study|Voluntary Withdrawal|4|||
146774579|NCT04714320|529345345|FG001|Overall Study|Voluntary Withdrawal|1|||
146774580|NCT04714320|529345346|FG002|Overall Study|Voluntary Withdrawal|2|||
146774581|NCT04714320|529345344|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
146774582|NCT04714320|529345345|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
146774583|NCT04714320|529345346|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
146774584|NCT04714320|529345344|FG000|Overall Study|Reason Not Specified|1|||
146774585|NCT04714320|529345345|FG001|Overall Study|Reason Not Specified|3|||
146774586|NCT04714320|529345346|FG002|Overall Study|Reason Not Specified|3|||
146774587|NCT01353313|529345351|FG000|Overall Study|Lost to Follow-up|22|||
146774588|NCT01353313|529345352|FG001|Overall Study|Lost to Follow-up|23|||
146774589|NCT01353313|529345351|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
146774590|NCT01353313|529345352|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
146774591|NCT04755660|529345353|FG000|Overall Study|Lost to Follow-up|1|||
146774592|NCT04755660|529345354|FG001|Overall Study|Lost to Follow-up|1|||
146774593|NCT04755660|529345355|FG002|Overall Study|Lost to Follow-up|0|||
146774594|NCT04755660|529345353|FG000|Overall Study|Withdrawal by Subject|0|||
146926857|NCT01025817|529892816|FG001|Completed Study Medication|Subject no longer required study drug|1|||
146926858|NCT01025817|529892815|FG000|Completed Study Medication|Lost to Follow-up|0|||
146679392|NCT01753856|528999586|FG001|Overall Study|Adverse Event|0|||
146679393|NCT01753856|528999585|FG000|Overall Study|Withdrawal by Subject|0|||
146679394|NCT01753856|528999586|FG001|Overall Study|Withdrawal by Subject|2|||
146679395|NCT01753856|528999585|FG000|Overall Study|Sponsor Decision|2|||
146679396|NCT01753856|528999586|FG001|Overall Study|Sponsor Decision|0|||
146679397|NCT01852110|529001388|FG000|Overall Study|Adverse Event|12|||
146679398|NCT01852110|529001389|FG001|Overall Study|Adverse Event|5|||
146679399|NCT01852110|529001390|FG002|Overall Study|Adverse Event|0|||
146679400|NCT01852110|529001391|FG003|Overall Study|Adverse Event|0|||
146679401|NCT01852110|529001392|FG004|Overall Study|Adverse Event|0|||
146679402|NCT01852110|529001393|FG005|Overall Study|Adverse Event|0|||
146679403|NCT01852110|529001388|FG000|Overall Study|Lost to Follow-up|1|||
146679404|NCT01852110|529001389|FG001|Overall Study|Lost to Follow-up|3|||
146679405|NCT01852110|529001390|FG002|Overall Study|Lost to Follow-up|0|||
146926859|NCT01025817|529892816|FG001|Completed Study Medication|Lost to Follow-up|1|||
146926860|NCT01025817|529892815|FG000|Completed Study|Withdrawal by Subject|8|||
146926861|NCT01025817|529892816|FG001|Completed Study|Withdrawal by Subject|16|||
146926862|NCT01025817|529892815|FG000|Completed Study|Death|6|||
146679406|NCT01852110|529001391|FG003|Overall Study|Lost to Follow-up|0|||
146679407|NCT01852110|529001392|FG004|Overall Study|Lost to Follow-up|0|||
146679408|NCT01852110|529001393|FG005|Overall Study|Lost to Follow-up|0|||
146679409|NCT01852110|529001388|FG000|Overall Study|Non-compliance with Study Drug|2|||
146679410|NCT01852110|529001389|FG001|Overall Study|Non-compliance with Study Drug|1|||
146679411|NCT01852110|529001390|FG002|Overall Study|Non-compliance with Study Drug|0|||
146679412|NCT01852110|529001391|FG003|Overall Study|Non-compliance with Study Drug|0|||
146679413|NCT01852110|529001392|FG004|Overall Study|Non-compliance with Study Drug|0|||
146679414|NCT01852110|529001393|FG005|Overall Study|Non-compliance with Study Drug|0|||
146679415|NCT01852110|529001388|FG000|Overall Study|Physician Decision|1|||
146679416|NCT01852110|529001389|FG001|Overall Study|Physician Decision|0|||
146679417|NCT01852110|529001390|FG002|Overall Study|Physician Decision|0|||
146679418|NCT01852110|529001391|FG003|Overall Study|Physician Decision|0|||
146679419|NCT01852110|529001392|FG004|Overall Study|Physician Decision|0|||
146679420|NCT01852110|529001393|FG005|Overall Study|Physician Decision|0|||
146679421|NCT01852110|529001388|FG000|Overall Study|Protocol Violation|0|||
146679422|NCT01852110|529001389|FG001|Overall Study|Protocol Violation|1|||
146679423|NCT01852110|529001390|FG002|Overall Study|Protocol Violation|0|||
146679424|NCT01852110|529001391|FG003|Overall Study|Protocol Violation|0|||
146679425|NCT01852110|529001392|FG004|Overall Study|Protocol Violation|0|||
146679426|NCT01852110|529001393|FG005|Overall Study|Protocol Violation|0|||
146679427|NCT01852110|529001388|FG000|Overall Study|Study Terminated by Sponsor|30|||
146679428|NCT01852110|529001389|FG001|Overall Study|Study Terminated by Sponsor|32|||
146679429|NCT01852110|529001390|FG002|Overall Study|Study Terminated by Sponsor|0|||
146679430|NCT01852110|529001391|FG003|Overall Study|Study Terminated by Sponsor|0|||
146679431|NCT01852110|529001392|FG004|Overall Study|Study Terminated by Sponsor|0|||
146679432|NCT01852110|529001393|FG005|Overall Study|Study Terminated by Sponsor|0|||
146679433|NCT01852110|529001388|FG000|Overall Study|Withdrawal by Subject|4|||
146679434|NCT01852110|529001389|FG001|Overall Study|Withdrawal by Subject|4|||
146679435|NCT01852110|529001390|FG002|Overall Study|Withdrawal by Subject|0|||
146679436|NCT01852110|529001391|FG003|Overall Study|Withdrawal by Subject|0|||
146774595|NCT04755660|529345354|FG001|Overall Study|Withdrawal by Subject|1|||
146774596|NCT04755660|529345355|FG002|Overall Study|Withdrawal by Subject|1|||
146774597|NCT04755660|529345353|FG000|Overall Study|Physician Decision|0|||
146774598|NCT04755660|529345354|FG001|Overall Study|Physician Decision|0|||
146774599|NCT04755660|529345355|FG002|Overall Study|Physician Decision|1|||
146774600|NCT02824029|529345357|FG000|Overall Study|Didn't receive treatment|2|||
146774601|NCT02824029|529345357|FG000|Overall Study|Patient decision to discontinue treatment|3|||
146774602|NCT02824029|529345357|FG000|Overall Study|Non-compliant|5|||
146774603|NCT02824029|529345357|FG000|Overall Study|Progression of disease|15|||
146774604|NCT02824029|529345357|FG000|Overall Study|Inadequate response to therapy|2|||
146774605|NCT02824029|529345357|FG000|Overall Study|Possible progression per treating physician|1|||
146774606|NCT04279574|529345358|FG000|Overall Study|Death|1|||
146774607|NCT04279574|529345359|FG001|Overall Study|Death|0|||
146774608|NCT04279574|529345358|FG000|Overall Study|lost restoration, tooth fracture|1|||
146774609|NCT04279574|529345359|FG001|Overall Study|lost restoration, tooth fracture|0|||
146774610|NCT04279574|529345358|FG000|Overall Study|Lost to Follow-up|0|||
146774611|NCT04279574|529345359|FG001|Overall Study|Lost to Follow-up|1|||
146774612|NCT03112174|529345361|FG000|Overall Study|Withdrawal by Subject|3|||
146774613|NCT03112174|529345362|FG001|Overall Study|Withdrawal by Subject|0|||
146774614|NCT03112174|529345363|FG002|Overall Study|Withdrawal by Subject|11|||
146774615|NCT03112174|529345364|FG003|Overall Study|Withdrawal by Subject|9|||
146774616|NCT03112174|529345365|FG004|Overall Study|Withdrawal by Subject|7|||
146774617|NCT03112174|529345361|FG000|Overall Study|Lost to Follow-up|1|||
146774618|NCT03112174|529345362|FG001|Overall Study|Lost to Follow-up|1|||
146774619|NCT03112174|529345363|FG002|Overall Study|Lost to Follow-up|2|||
146774620|NCT03112174|529345364|FG003|Overall Study|Lost to Follow-up|3|||
146774621|NCT03112174|529345365|FG004|Overall Study|Lost to Follow-up|2|||
146774622|NCT03112174|529345361|FG000|Overall Study|Death|8|||
146774623|NCT03112174|529345362|FG001|Overall Study|Death|3|||
146774624|NCT03112174|529345363|FG002|Overall Study|Death|67|||
146774625|NCT03112174|529345364|FG003|Overall Study|Death|73|||
146774626|NCT03112174|529345365|FG004|Overall Study|Death|18|||
146774627|NCT03112174|529345361|FG000|Overall Study|Other, Not Specified|1|||
146774628|NCT03112174|529345362|FG001|Overall Study|Other, Not Specified|0|||
146774629|NCT03112174|529345363|FG002|Overall Study|Other, Not Specified|1|||
146774630|NCT03112174|529345364|FG003|Overall Study|Other, Not Specified|2|||
146774631|NCT03112174|529345365|FG004|Overall Study|Other, Not Specified|0|||
146774632|NCT00802464|529345367|FG000|Month 0 - Month 8|Adverse Event|0|||
146774633|NCT00802464|529345368|FG001|Month 0 - Month 8|Adverse Event|1|||
146774634|NCT00802464|529345369|FG002|Month 0 - Month 8|Adverse Event|1|||
146774635|NCT00802464|529345370|FG003|Month 0 - Month 8|Adverse Event|2|||
146774636|NCT00802464|529345367|FG000|Month 0 - Month 8|Protocol Violation|0|||
146774637|NCT00802464|529345368|FG001|Month 0 - Month 8|Protocol Violation|0|||
146679437|NCT01852110|529001392|FG004|Overall Study|Withdrawal by Subject|0|||
146679438|NCT01852110|529001393|FG005|Overall Study|Withdrawal by Subject|0|||
146679439|NCT02141282|529001394|FG000|Overall Study|Adverse event, not related to progression|8|||
146679440|NCT02141282|529001395|FG001|Overall Study|Adverse event, not related to progression|1|||
146774638|NCT00802464|529345369|FG002|Month 0 - Month 8|Protocol Violation|1|||
146774639|NCT00802464|529345370|FG003|Month 0 - Month 8|Protocol Violation|0|||
146774640|NCT00802464|529345367|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
146774641|NCT00802464|529345368|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
146679441|NCT02141282|529001396|FG002|Overall Study|Adverse event, not related to progression|3|||
146679442|NCT02141282|529001397|FG003|Overall Study|Adverse event, not related to progression|1|||
146774642|NCT00802464|529345369|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
146774643|NCT00802464|529345370|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
146774644|NCT00802464|529345367|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
146774645|NCT00802464|529345368|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
146774646|NCT00802464|529345369|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
146774647|NCT00802464|529345370|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
146774648|NCT00802464|529345367|FG000|Month 0 - Month 8|Other|0|||
146774649|NCT00802464|529345368|FG001|Month 0 - Month 8|Other|0|||
146774650|NCT00802464|529345369|FG002|Month 0 - Month 8|Other|1|||
146774651|NCT00802464|529345370|FG003|Month 0 - Month 8|Other|0|||
146774652|NCT00802464|529345367|FG000|Month 8 - Month 14|Adverse Event|0|||
146774653|NCT00802464|529345368|FG001|Month 8 - Month 14|Adverse Event|1|||
146774654|NCT00802464|529345369|FG002|Month 8 - Month 14|Adverse Event|0|||
146774655|NCT00802464|529345370|FG003|Month 8 - Month 14|Adverse Event|0|||
146774656|NCT00802464|529345367|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
146774657|NCT00802464|529345368|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
146774658|NCT00802464|529345369|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
146774659|NCT00802464|529345370|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
146774660|NCT00802464|529345367|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
146774661|NCT00802464|529345368|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
146774662|NCT00802464|529345369|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
146774663|NCT00802464|529345370|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
146774664|NCT04512482|529345380|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
146774665|NCT04512482|529345381|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
146774666|NCT01939899|529345382|FG000|Lead-in Dose Finding Phase|Death|0|||
146774667|NCT01939899|529345383|FG001|Lead-in Dose Finding Phase|Death|3|||
146774668|NCT01939899|529345384|FG002|Lead-in Dose Finding Phase|Death|1|||
146774669|NCT01939899|529345385|FG003|Lead-in Dose Finding Phase|Death|0|||
146774670|NCT01939899|529345386|FG004|Lead-in Dose Finding Phase|Death|0|||
146774671|NCT01939899|529345382|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
146774672|NCT01939899|529345383|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
146774673|NCT01939899|529345384|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
146774674|NCT01939899|529345385|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
146774675|NCT01939899|529345386|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
146774676|NCT01939899|529345382|FG000|Lead-in Dose Finding Phase|Other|0|||
146774677|NCT01939899|529345383|FG001|Lead-in Dose Finding Phase|Other|0|||
146774678|NCT01939899|529345384|FG002|Lead-in Dose Finding Phase|Other|1|||
146774679|NCT01939899|529345385|FG003|Lead-in Dose Finding Phase|Other|0|||
146774680|NCT01939899|529345386|FG004|Lead-in Dose Finding Phase|Other|0|||
146774681|NCT01939899|529345382|FG000|Phase 2|Withdrawal by Subject|0|||
146774682|NCT01939899|529345383|FG001|Phase 2|Withdrawal by Subject|0|||
146774683|NCT01939899|529345384|FG002|Phase 2|Withdrawal by Subject|0|||
146774684|NCT01939899|529345385|FG003|Phase 2|Withdrawal by Subject|2|||
146774685|NCT01939899|529345386|FG004|Phase 2|Withdrawal by Subject|0|||
146774686|NCT01939899|529345382|FG000|Phase 2|Disease Progression|0|||
146774687|NCT01939899|529345383|FG001|Phase 2|Disease Progression|0|||
146774688|NCT01939899|529345384|FG002|Phase 2|Disease Progression|0|||
146679443|NCT02141282|529001394|FG000|Overall Study|Adverse event, related to progression|1|||
146679444|NCT02141282|529001395|FG001|Overall Study|Adverse event, related to progression|0|||
146679445|NCT02141282|529001396|FG002|Overall Study|Adverse event, related to progression|2|||
146679446|NCT02141282|529001397|FG003|Overall Study|Adverse event, related to progression|0|||
146679447|NCT02141282|529001394|FG000|Overall Study|COVID-19 infection|1|||
146679448|NCT02141282|529001395|FG001|Overall Study|COVID-19 infection|0|||
146679449|NCT02141282|529001396|FG002|Overall Study|COVID-19 infection|0|||
146679450|NCT02141282|529001397|FG003|Overall Study|COVID-19 infection|0|||
146679451|NCT02141282|529001394|FG000|Overall Study|Lost to Follow-up|0|||
146679452|NCT02141282|529001395|FG001|Overall Study|Lost to Follow-up|0|||
146679453|NCT02141282|529001396|FG002|Overall Study|Lost to Follow-up|4|||
146679454|NCT02141282|529001397|FG003|Overall Study|Lost to Follow-up|2|||
146679455|NCT02141282|529001394|FG000|Overall Study|Other, not specified|14|||
146679456|NCT02141282|529001395|FG001|Overall Study|Other, not specified|11|||
146679457|NCT02141282|529001396|FG002|Overall Study|Other, not specified|23|||
146679458|NCT02141282|529001397|FG003|Overall Study|Other, not specified|9|||
146679459|NCT02141282|529001394|FG000|Overall Study|Progressive disease, Richter's|4|||
146679460|NCT02141282|529001395|FG001|Overall Study|Progressive disease, Richter's|1|||
146679461|NCT02141282|529001396|FG002|Overall Study|Progressive disease, Richter's|1|||
146679462|NCT02141282|529001397|FG003|Overall Study|Progressive disease, Richter's|1|||
146679463|NCT02141282|529001394|FG000|Overall Study|Progressive disease per protocol|12|||
146679464|NCT02141282|529001395|FG001|Overall Study|Progressive disease per protocol|7|||
146679465|NCT02141282|529001396|FG002|Overall Study|Progressive disease per protocol|9|||
146679466|NCT02141282|529001397|FG003|Overall Study|Progressive disease per protocol|2|||
146679467|NCT02141282|529001394|FG000|Overall Study|Stem cell transplant|1|||
146679468|NCT02141282|529001395|FG001|Overall Study|Stem cell transplant|0|||
146679469|NCT02141282|529001396|FG002|Overall Study|Stem cell transplant|1|||
146679470|NCT02141282|529001397|FG003|Overall Study|Stem cell transplant|0|||
146679471|NCT02141282|529001394|FG000|Overall Study|Study terminated by Sponsor|0|||
146679472|NCT02141282|529001395|FG001|Overall Study|Study terminated by Sponsor|1|||
146679473|NCT02141282|529001396|FG002|Overall Study|Study terminated by Sponsor|0|||
146774689|NCT01939899|529345385|FG003|Phase 2|Disease Progression|9|||
146774690|NCT01939899|529345386|FG004|Phase 2|Disease Progression|1|||
146774691|NCT02706717|529345389|FG000|Overall Study|Withdrawal by Subject|1|||
146774692|NCT02706717|529345390|FG001|Overall Study|Withdrawal by Subject|8|||
146774693|NCT02706717|529345389|FG000|Overall Study|Lost to Follow-up|0|||
146679474|NCT02141282|529001397|FG003|Overall Study|Study terminated by Sponsor|0|||
146679475|NCT02141282|529001394|FG000|Overall Study|Subject non-compliance|0|||
146679476|NCT02141282|529001395|FG001|Overall Study|Subject non-compliance|0|||
146679477|NCT02141282|529001396|FG002|Overall Study|Subject non-compliance|1|||
146679478|NCT02141282|529001397|FG003|Overall Study|Subject non-compliance|0|||
146679479|NCT02141282|529001394|FG000|Overall Study|Withdrew consent|2|||
146679480|NCT02141282|529001395|FG001|Overall Study|Withdrew consent|0|||
146679481|NCT02141282|529001396|FG002|Overall Study|Withdrew consent|4|||
146679482|NCT02141282|529001397|FG003|Overall Study|Withdrew consent|0|||
146679483|NCT01752907|529001399|FG000|Overall Study|Withdrawal by Subject|4|||
146679484|NCT01752907|529001400|FG001|Overall Study|Withdrawal by Subject|10|||
146679485|NCT01752907|529001399|FG000|Overall Study|Lost to Follow-up|2|||
146679486|NCT01752907|529001400|FG001|Overall Study|Lost to Follow-up|1|||
146679487|NCT01752907|529001399|FG000|Overall Study|Decision by Sponsor|6|||
146679488|NCT01752907|529001400|FG001|Overall Study|Decision by Sponsor|9|||
146679489|NCT03098550|529001401|FG000|Overall Study|Disease Progression|30|||
146679490|NCT03098550|529001402|FG001|Overall Study|Disease Progression|19|||
146679491|NCT03098550|529001403|FG002|Overall Study|Disease Progression|41|||
146679492|NCT03098550|529001401|FG000|Overall Study|Study Drug Toxicity|2|||
146679493|NCT03098550|529001402|FG001|Overall Study|Study Drug Toxicity|1|||
146679494|NCT03098550|529001403|FG002|Overall Study|Study Drug Toxicity|0|||
146679495|NCT03098550|529001401|FG000|Overall Study|Death|1|||
146679496|NCT03098550|529001402|FG001|Overall Study|Death|0|||
146679497|NCT03098550|529001403|FG002|Overall Study|Death|0|||
146679498|NCT03098550|529001401|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
146679499|NCT03098550|529001402|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
146679500|NCT03098550|529001403|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
146679501|NCT03098550|529001401|FG000|Overall Study|Administrative reason by sponsor|0|||
146679502|NCT03098550|529001402|FG001|Overall Study|Administrative reason by sponsor|0|||
146679503|NCT03098550|529001403|FG002|Overall Study|Administrative reason by sponsor|1|||
146679504|NCT03098550|529001401|FG000|Overall Study|Other reasons|2|||
146679505|NCT03098550|529001402|FG001|Overall Study|Other reasons|0|||
146679506|NCT03098550|529001403|FG002|Overall Study|Other reasons|0|||
146679507|NCT01384760|529001405|FG000|Overall Study|Lost to Follow-up|0|||
146679508|NCT01384760|529001406|FG001|Overall Study|Lost to Follow-up|6|||
146679509|NCT01384760|529001405|FG000|Overall Study|Protocol Violation|16|||
146679510|NCT01384760|529001406|FG001|Overall Study|Protocol Violation|0|||
146774694|NCT02706717|529345390|FG001|Overall Study|Lost to Follow-up|1|||
146774695|NCT02706717|529345389|FG000|Overall Study|Physician Decision|0|||
146774696|NCT02706717|529345390|FG001|Overall Study|Physician Decision|1|||
146774697|NCT02706717|529345389|FG000|Overall Study|Death|0|||
146774698|NCT02706717|529345390|FG001|Overall Study|Death|1|||
146926863|NCT01025817|529892816|FG001|Completed Study|Death|5|||
146926864|NCT01025817|529892815|FG000|Completed Study|Missing|2|||
146926865|NCT01025817|529892816|FG001|Completed Study|Missing|0|||
146926866|NCT01025817|529892815|FG000|Completed Study|Lost to Follow-up|0|||
146926867|NCT01025817|529892816|FG001|Completed Study|Lost to Follow-up|1|||
146926868|NCT04533815|529892820|FG000|Overall Study|Adverse Event|2|||
146926869|NCT04533815|529892820|FG000|Overall Study|Site withdrew|5|||
146926870|NCT00488592|529892823|FG000|Overall Study|Withdrawal by Subject|1|||
146774699|NCT01414738|529345395|FG000|Overall Study|Death|26|||
146774700|NCT01414738|529345395|FG000|Overall Study|Refused testing|5|||
146774701|NCT01414738|529345395|FG000|Overall Study|Lost to Follow-up|2|||
146774702|NCT01414738|529345395|FG000|Overall Study|Refused, disease progression|8|||
146679511|NCT00630396|529001407|FG000|Overall Study|Death|4|||
146679512|NCT00630396|529001407|FG000|Overall Study|Lost to Follow-up|3|||
146679513|NCT02989194|529001410|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
146679514|NCT02989194|529001411|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
146679515|NCT02989194|529001412|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
146679516|NCT02989194|529001410|FG000|Overall Study|Lost to Follow-up|0|||
146774703|NCT01414738|529345395|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
146774704|NCT01266122|529345396|FG000|Overall Study|Lost to Follow-up|6|||
146774705|NCT01266122|529345397|FG001|Overall Study|Lost to Follow-up|6|||
146774706|NCT00421889|529345398|FG000|Overall Study|Adverse Event|1|||
146774707|NCT00421889|529345399|FG001|Overall Study|Adverse Event|0|||
146774708|NCT00421889|529345400|FG002|Overall Study|Adverse Event|1|||
146774709|NCT00421889|529345401|FG003|Overall Study|Adverse Event|1|||
146774710|NCT00421889|529345402|FG004|Overall Study|Adverse Event|1|||
146679517|NCT02989194|529001411|FG001|Overall Study|Lost to Follow-up|1|||
146679518|NCT02989194|529001412|FG002|Overall Study|Lost to Follow-up|0|||
146774711|NCT00421889|529345403|FG005|Overall Study|Adverse Event|4|||
146679519|NCT02989194|529001410|FG000|Overall Study|Withdrawal by Subject|0|||
146679520|NCT02989194|529001411|FG001|Overall Study|Withdrawal by Subject|1|||
146679521|NCT02989194|529001412|FG002|Overall Study|Withdrawal by Subject|0|||
146774712|NCT00421889|529345404|FG006|Overall Study|Adverse Event|1|||
146774713|NCT00421889|529345405|FG007|Overall Study|Adverse Event|0|||
146774714|NCT00421889|529345406|FG008|Overall Study|Adverse Event|2|||
146774715|NCT00421889|529345398|FG000|Overall Study|Withdrawal by Subject|1|||
146774716|NCT00421889|529345399|FG001|Overall Study|Withdrawal by Subject|3|||
146774717|NCT00421889|529345400|FG002|Overall Study|Withdrawal by Subject|0|||
146774718|NCT00421889|529345401|FG003|Overall Study|Withdrawal by Subject|0|||
146774719|NCT00421889|529345402|FG004|Overall Study|Withdrawal by Subject|2|||
146774720|NCT00421889|529345403|FG005|Overall Study|Withdrawal by Subject|0|||
146774721|NCT00421889|529345404|FG006|Overall Study|Withdrawal by Subject|0|||
146774722|NCT00421889|529345405|FG007|Overall Study|Withdrawal by Subject|0|||
146774723|NCT00421889|529345406|FG008|Overall Study|Withdrawal by Subject|0|||
146774724|NCT00421889|529345398|FG000|Overall Study|Death|0|||
146774725|NCT00421889|529345399|FG001|Overall Study|Death|0|||
146774726|NCT00421889|529345400|FG002|Overall Study|Death|0|||
146774727|NCT00421889|529345401|FG003|Overall Study|Death|0|||
146774728|NCT00421889|529345402|FG004|Overall Study|Death|1|||
146774729|NCT00421889|529345403|FG005|Overall Study|Death|1|||
146774730|NCT00421889|529345404|FG006|Overall Study|Death|0|||
146774731|NCT00421889|529345405|FG007|Overall Study|Death|0|||
146774732|NCT00421889|529345406|FG008|Overall Study|Death|0|||
146774733|NCT00421889|529345398|FG000|Overall Study|Progressive disease|3|||
146774734|NCT00421889|529345399|FG001|Overall Study|Progressive disease|2|||
146774735|NCT00421889|529345400|FG002|Overall Study|Progressive disease|2|||
146774736|NCT00421889|529345401|FG003|Overall Study|Progressive disease|3|||
146774737|NCT00421889|529345402|FG004|Overall Study|Progressive disease|2|||
146774738|NCT00421889|529345403|FG005|Overall Study|Progressive disease|21|||
146774739|NCT00421889|529345404|FG006|Overall Study|Progressive disease|3|||
146774740|NCT00421889|529345405|FG007|Overall Study|Progressive disease|1|||
146774741|NCT00421889|529345406|FG008|Overall Study|Progressive disease|5|||
146774742|NCT00421889|529345398|FG000|Overall Study|Patient/Investigator request|0|||
146774743|NCT00421889|529345399|FG001|Overall Study|Patient/Investigator request|0|||
146774744|NCT00421889|529345400|FG002|Overall Study|Patient/Investigator request|0|||
146774745|NCT00421889|529345401|FG003|Overall Study|Patient/Investigator request|0|||
146774746|NCT00421889|529345402|FG004|Overall Study|Patient/Investigator request|0|||
146774747|NCT00421889|529345403|FG005|Overall Study|Patient/Investigator request|9|||
146774748|NCT00421889|529345404|FG006|Overall Study|Patient/Investigator request|0|||
146774749|NCT00421889|529345405|FG007|Overall Study|Patient/Investigator request|1|||
146774750|NCT00421889|529345406|FG008|Overall Study|Patient/Investigator request|3|||
146774751|NCT00421889|529345398|FG000|Overall Study|Lost to Follow-up|0|||
146774752|NCT00421889|529345399|FG001|Overall Study|Lost to Follow-up|0|||
146774753|NCT00421889|529345400|FG002|Overall Study|Lost to Follow-up|0|||
146679522|NCT04160091|529001415|FG000|Overall Study|Terminated by Sponsor|7|||
146679523|NCT04160091|529001416|FG001|Overall Study|Terminated by Sponsor|3|||
146679524|NCT04160091|529001417|FG002|Overall Study|Terminated by Sponsor|5|||
146679525|NCT04160091|529001418|FG003|Overall Study|Terminated by Sponsor|2|||
146679526|NCT04160091|529001415|FG000|Overall Study|Noncompliance|0|||
146679527|NCT04160091|529001416|FG001|Overall Study|Noncompliance|0|||
146679528|NCT04160091|529001417|FG002|Overall Study|Noncompliance|0|||
146679529|NCT04160091|529001418|FG003|Overall Study|Noncompliance|1|||
146679530|NCT04160091|529001415|FG000|Overall Study|Withdrawal by Subject|0|||
146679531|NCT04160091|529001416|FG001|Overall Study|Withdrawal by Subject|0|||
146679532|NCT04160091|529001417|FG002|Overall Study|Withdrawal by Subject|0|||
146679533|NCT04160091|529001418|FG003|Overall Study|Withdrawal by Subject|1|||
146679534|NCT00381095|529001420|FG000|Overall Study|Death|3|||
146679535|NCT00381095|529001421|FG001|Overall Study|Death|4|||
146679536|NCT00381095|529001420|FG000|Overall Study|Lack of Efficacy|2|||
146679537|NCT00381095|529001421|FG001|Overall Study|Lack of Efficacy|4|||
146679538|NCT00381095|529001420|FG000|Overall Study|Other|2|||
146679539|NCT00381095|529001421|FG001|Overall Study|Other|2|||
146679540|NCT00381095|529001420|FG000|Overall Study|Protocol Violation|1|||
146679541|NCT00381095|529001421|FG001|Overall Study|Protocol Violation|1|||
146679542|NCT00381095|529001420|FG000|Overall Study|Withdrawal by Subject|3|||
146679543|NCT00381095|529001421|FG001|Overall Study|Withdrawal by Subject|3|||
146679544|NCT00381095|529001420|FG000|Overall Study|Adverse Event|2|||
146774754|NCT00421889|529345401|FG003|Overall Study|Lost to Follow-up|0|||
146679545|NCT00381095|529001421|FG001|Overall Study|Adverse Event|7|||
146679546|NCT02511184|529001423|FG000|Overall Study|Death|1|||
146774755|NCT00421889|529345402|FG004|Overall Study|Lost to Follow-up|0|||
146774756|NCT00421889|529345403|FG005|Overall Study|Lost to Follow-up|0|||
146774757|NCT00421889|529345404|FG006|Overall Study|Lost to Follow-up|0|||
146774758|NCT00421889|529345405|FG007|Overall Study|Lost to Follow-up|0|||
146774759|NCT00421889|529345406|FG008|Overall Study|Lost to Follow-up|1|||
146774760|NCT04556981|529345415|FG000|Overall Study|Death|0|||
146679547|NCT02511184|529001424|FG001|Overall Study|Death|0|||
146679548|NCT02511184|529001423|FG000|Overall Study|Lost to Follow-up|0|||
146774761|NCT04556981|529345416|FG001|Overall Study|Death|1|||
146774762|NCT04556981|529345415|FG000|Overall Study|Lost to Follow-up|2|||
146774763|NCT04556981|529345416|FG001|Overall Study|Lost to Follow-up|11|||
146679549|NCT02511184|529001424|FG001|Overall Study|Lost to Follow-up|1|||
146679550|NCT02511184|529001423|FG000|Overall Study|Study terminated by sponsor|1|||
146679551|NCT02511184|529001424|FG001|Overall Study|Study terminated by sponsor|5|||
146679552|NCT02511184|529001423|FG000|Overall Study|Withdrawal by Subject|0|||
146926871|NCT00488592|529892823|FG000|Overall Study|Disease progression|1|||
146926872|NCT00488592|529892823|FG000|Overall Study|Enrolled but not treated|1|||
146926873|NCT00441103|529892824|FG000|Overall Study|Adverse Event|2|||
146926874|NCT00441103|529892825|FG001|Overall Study|Adverse Event|1|||
146926875|NCT00441103|529892824|FG000|Overall Study|Death|1|||
146926876|NCT00441103|529892825|FG001|Overall Study|Death|0|||
146926877|NCT00441103|529892824|FG000|Overall Study|Disease Progression|2|||
146926878|NCT00441103|529892825|FG001|Overall Study|Disease Progression|0|||
146926879|NCT00441103|529892824|FG000|Overall Study|Lost to Follow-up|1|||
146926880|NCT00441103|529892825|FG001|Overall Study|Lost to Follow-up|0|||
146679553|NCT02511184|529001424|FG001|Overall Study|Withdrawal by Subject|1|||
146926881|NCT00441103|529892824|FG000|Overall Study|Protocol Violation|1|||
146926882|NCT00441103|529892825|FG001|Overall Study|Protocol Violation|0|||
146926883|NCT00441103|529892824|FG000|Overall Study|Participant unable to use Rebiject II|1|||
146926884|NCT00441103|529892825|FG001|Overall Study|Participant unable to use Rebiject II|0|||
146926885|NCT00441103|529892824|FG000|Overall Study|Participant refused MRI|1|||
146926886|NCT00441103|529892825|FG001|Overall Study|Participant refused MRI|0|||
146926887|NCT00441103|529892824|FG000|Overall Study|Inclusion criteria absent|1|||
146926888|NCT00441103|529892825|FG001|Overall Study|Inclusion criteria absent|0|||
146926889|NCT00441103|529892824|FG000|Overall Study|Non-compliant|0|||
146926890|NCT00441103|529892825|FG001|Overall Study|Non-compliant|1|||
146926891|NCT00441103|529892824|FG000|Overall Study|Participant decided to withdraw|1|||
146926892|NCT00441103|529892825|FG001|Overall Study|Participant decided to withdraw|0|||
146926893|NCT00441103|529892824|FG000|Overall Study|Participant's reason|0|||
146926894|NCT00441103|529892825|FG001|Overall Study|Participant's reason|1|||
146926895|NCT00441103|529892824|FG000|Overall Study|Participant decided to stop|0|||
146926896|NCT00441103|529892825|FG001|Overall Study|Participant decided to stop|1|||
146926897|NCT00807846|529892826|FG000|Overall Study|Adverse Event|5|||
146926898|NCT00807846|529892827|FG001|Overall Study|Adverse Event|0|||
146926899|NCT00807846|529892826|FG000|Overall Study|Lack of Efficacy|2|||
146926900|NCT00807846|529892827|FG001|Overall Study|Lack of Efficacy|0|||
146926901|NCT00807846|529892826|FG000|Overall Study|Protocol Violation|2|||
146926902|NCT00807846|529892827|FG001|Overall Study|Protocol Violation|1|||
146926903|NCT00807846|529892826|FG000|Overall Study|Withdrawal by Subject|2|||
146926904|NCT00807846|529892827|FG001|Overall Study|Withdrawal by Subject|1|||
146926905|NCT00807846|529892826|FG000|Overall Study|Other|1|||
146926906|NCT00807846|529892827|FG001|Overall Study|Other|2|||
146926907|NCT01081873|529892828|FG000|Overall Study|Death|86|||
146926908|NCT01081873|529892828|FG000|Overall Study|Withdrawal by Subject|10|||
146926909|NCT01081873|529892828|FG000|Overall Study|Lost to Follow-up|142|||
146926910|NCT01081873|529892828|FG000|Overall Study|Progression of prostate cancer|13|||
146926911|NCT01081873|529892828|FG000|Overall Study|Other|47|||
146926912|NCT04799405|529892830|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
146926913|NCT00603980|529892831|FG000|Study Qualification|Protocol Violation|3|||
146926914|NCT00603980|529892831|FG000|Study Qualification|Inconsistent data reporting|13|||
146926915|NCT00603980|529892831|FG000|Main Study|14th subject completed trial|1|||
146926916|NCT01029002|529892832|FG000|Overall Study|Lost to Follow-up|2|||
146926917|NCT01029002|529892833|FG001|Overall Study|Lost to Follow-up|4|||
146926918|NCT02683525|529892834|FG000|Overall Study|Lost to Follow-up|1|||
146926919|NCT02683525|529892834|FG000|Overall Study|Physician Decision|1|||
146926920|NCT02683525|529892834|FG000|Overall Study|Disease Progression|6|||
146926921|NCT04167306|529892842|FG000|Overall Study|Lost to Follow-up|2|||
146926922|NCT04167306|529892843|FG001|Overall Study|Lost to Follow-up|2|||
146926923|NCT04167306|529892844|FG002|Overall Study|Lost to Follow-up|5|||
146926924|NCT04167306|529892845|FG003|Overall Study|Lost to Follow-up|5|||
146926925|NCT04167306|529892842|FG000|Overall Study|Adverse Event|13|||
146926926|NCT04167306|529892843|FG001|Overall Study|Adverse Event|14|||
146926927|NCT04167306|529892844|FG002|Overall Study|Adverse Event|5|||
146926928|NCT04167306|529892845|FG003|Overall Study|Adverse Event|4|||
146679554|NCT04271605|529001425|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
146679555|NCT02485301|529001426|FG000|Overall Study|Serious Adverse Events|2|||
146926929|NCT04167306|529892842|FG000|Overall Study|Withdrawal by Subject|4|||
146926930|NCT04167306|529892843|FG001|Overall Study|Withdrawal by Subject|6|||
146926931|NCT04167306|529892844|FG002|Overall Study|Withdrawal by Subject|8|||
146926932|NCT04167306|529892845|FG003|Overall Study|Withdrawal by Subject|3|||
146926933|NCT04167306|529892842|FG000|Overall Study|covid|1|||
146926934|NCT04167306|529892843|FG001|Overall Study|covid|1|||
146926935|NCT04167306|529892844|FG002|Overall Study|covid|2|||
146926936|NCT04167306|529892845|FG003|Overall Study|covid|1|||
146926937|NCT04167306|529892842|FG000|Overall Study|concomitant medication|0|||
146926938|NCT04167306|529892843|FG001|Overall Study|concomitant medication|0|||
146926939|NCT04167306|529892844|FG002|Overall Study|concomitant medication|0|||
146926940|NCT04167306|529892845|FG003|Overall Study|concomitant medication|1|||
146926941|NCT04167306|529892842|FG000|Overall Study|Alcohol treatment|0|||
146679556|NCT02485301|529001427|FG001|Overall Study|Serious Adverse Events|1|||
146679557|NCT02485301|529001426|FG000|Overall Study|Protocol Violation|0|||
146926942|NCT04167306|529892843|FG001|Overall Study|Alcohol treatment|4|||
146926943|NCT04167306|529892844|FG002|Overall Study|Alcohol treatment|3|||
146679558|NCT02485301|529001427|FG001|Overall Study|Protocol Violation|1|||
146679559|NCT02485301|529001426|FG000|Overall Study|Withdrawal by Subject|6|||
146679560|NCT02485301|529001427|FG001|Overall Study|Withdrawal by Subject|7|||
146679561|NCT02485301|529001426|FG000|Overall Study|Migrated/moved from study area|10|||
146679562|NCT02485301|529001427|FG001|Overall Study|Migrated/moved from study area|19|||
146679563|NCT02485301|529001426|FG000|Overall Study|Lost to Follow-up|17|||
146679564|NCT02485301|529001427|FG001|Overall Study|Lost to Follow-up|17|||
146679565|NCT02485301|529001426|FG000|Overall Study|Other|3|||
146679566|NCT02485301|529001427|FG001|Overall Study|Other|4|||
146679567|NCT02041286|529001428|FG000|Overall Study|Adverse Event|1|||
146679568|NCT03138889|529001433|FG000|Overall Study|Withdrawal by Subject|5|||
146679569|NCT03138889|529001434|FG001|Overall Study|Withdrawal by Subject|5|||
146679570|NCT03138889|529001435|FG002|Overall Study|Withdrawal by Subject|0|||
146679571|NCT03138889|529001436|FG003|Overall Study|Withdrawal by Subject|2|||
146679572|NCT03138889|529001437|FG004|Overall Study|Withdrawal by Subject|1|||
146679573|NCT03138889|529001438|FG005|Overall Study|Withdrawal by Subject|3|||
146679574|NCT03138889|529001439|FG006|Overall Study|Withdrawal by Subject|0|||
146679575|NCT03138889|529001440|FG007|Overall Study|Withdrawal by Subject|1|||
146679576|NCT00411645|529001441|FG000|Overall Study|Consent Withdrawn|13|||
146679577|NCT00411645|529001442|FG001|Overall Study|Consent Withdrawn|22|||
146679578|NCT00411645|529001441|FG000|Overall Study|Death|56|||
146679579|NCT00411645|529001442|FG001|Overall Study|Death|135|||
146679580|NCT00411645|529001441|FG000|Overall Study|Investigator/Sponsor Decision|10|||
146679581|NCT00411645|529001442|FG001|Overall Study|Investigator/Sponsor Decision|7|||
146679582|NCT00411645|529001441|FG000|Overall Study|Lost to Follow-up|2|||
146679583|NCT00411645|529001442|FG001|Overall Study|Lost to Follow-up|0|||
146679584|NCT01349790|529001443|FG000|Overall Study|Investigator Judgement|3|||
146679585|NCT01349790|529001443|FG000|Overall Study|Death|2|||
146679586|NCT01349790|529001443|FG000|Overall Study|Withdrawal by Patient|2|||
146679587|NCT01349790|529001443|FG000|Overall Study|Adverse Event|1|||
146679588|NCT01349790|529001443|FG000|Overall Study|Lost to Follow-up|1|||
146679589|NCT02573350|529001444|FG000|Overall Study|Lost to Follow-up|2|||
146679590|NCT02573350|529001445|FG001|Overall Study|Lost to Follow-up|1|||
146679591|NCT02573350|529001444|FG000|Overall Study|Adverse Event|3|||
146679592|NCT02573350|529001445|FG001|Overall Study|Adverse Event|4|||
146679593|NCT02573350|529001444|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
146679594|NCT02573350|529001445|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
146679595|NCT02573350|529001444|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
146679596|NCT02573350|529001445|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
146679597|NCT02573350|529001444|FG000|Overall Study|Subject withdrew consent to participate|6|||
146679598|NCT02573350|529001445|FG001|Overall Study|Subject withdrew consent to participate|1|||
146679599|NCT02573350|529001444|FG000|Overall Study|Protocol Deviation|1|||
146679600|NCT02573350|529001445|FG001|Overall Study|Protocol Deviation|1|||
146679601|NCT01980992|529001446|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
146679602|NCT01980992|529001447|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
146679603|NCT01980992|529001446|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
146679604|NCT01980992|529001447|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
146679605|NCT01980992|529001446|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
146679606|NCT01980992|529001447|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
146679607|NCT01980992|529001446|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
146679608|NCT01980992|529001447|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
146679609|NCT01980992|529001446|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
146679610|NCT01980992|529001447|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
146679611|NCT01980992|529001446|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
146679612|NCT01980992|529001447|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
146679613|NCT02627144|529001455|FG000|Overall Study|Serious adverse event|32|||
146679614|NCT02627144|529001455|FG000|Overall Study|Cancer progression|171|||
146679615|NCT02627144|529001455|FG000|Overall Study|Death from cancer|20|||
146679616|NCT02627144|529001455|FG000|Overall Study|Death from other cause|8|||
146679617|NCT02627144|529001455|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
146679618|NCT02627144|529001455|FG000|Overall Study|Administrative reasons|65|||
146679619|NCT02627144|529001455|FG000|Overall Study|Lost to Follow-up|8|||
146679620|NCT02627144|529001455|FG000|Overall Study|Enrolled, not treated|6|||
146679621|NCT02627144|529001455|FG000|Overall Study|Other|17|||
146679622|NCT00642460|529001456|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
146679623|NCT00642460|529001457|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
146679624|NCT00642460|529001458|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
146679625|NCT00642460|529001459|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
146679626|NCT00642460|529001460|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
146679627|NCT00642460|529001461|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
146679628|NCT00642460|529001456|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
146679629|NCT00642460|529001457|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
146679630|NCT00642460|529001458|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
146679631|NCT00642460|529001459|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
146679632|NCT00642460|529001460|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
146679633|NCT00642460|529001461|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
146679634|NCT00642460|529001456|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
146679635|NCT00642460|529001457|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
146679636|NCT00642460|529001458|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
146679637|NCT00642460|529001459|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
146679638|NCT00642460|529001460|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
146679639|NCT00642460|529001461|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
146679640|NCT00642460|529001456|FG000|Part II: Open-Label Up to Week 92|Death|0|||
146679641|NCT00642460|529001457|FG001|Part II: Open-Label Up to Week 92|Death|1|||
146679642|NCT00642460|529001458|FG002|Part II: Open-Label Up to Week 92|Death|0|||
146679643|NCT00642460|529001459|FG003|Part II: Open-Label Up to Week 92|Death|2|||
146679644|NCT00642460|529001460|FG004|Part II: Open-Label Up to Week 92|Death|0|||
146679645|NCT00642460|529001461|FG005|Part II: Open-Label Up to Week 92|Death|0|||
146679646|NCT00642460|529001456|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
146679647|NCT00642460|529001457|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
146679648|NCT00642460|529001458|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
146679649|NCT00642460|529001459|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
146679650|NCT00642460|529001460|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
146679651|NCT00642460|529001461|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
146679652|NCT00642460|529001456|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
146679653|NCT00642460|529001457|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
146679654|NCT00642460|529001458|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
146679655|NCT00642460|529001459|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
146679656|NCT00642460|529001460|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
146679657|NCT00642460|529001461|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
146679658|NCT00642460|529001456|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
146679659|NCT00642460|529001457|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
146679660|NCT00642460|529001458|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
146679661|NCT00642460|529001459|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
146679662|NCT00642460|529001460|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
146679663|NCT00642460|529001461|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
146679664|NCT00642460|529001456|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
146679665|NCT00642460|529001457|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
146679666|NCT00642460|529001458|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
146679667|NCT00642460|529001459|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
146679668|NCT00642460|529001460|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
146679669|NCT00642460|529001461|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
146679670|NCT00642460|529001456|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
146679671|NCT00642460|529001457|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
146679672|NCT00642460|529001458|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
146679673|NCT00642460|529001459|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
146679674|NCT00642460|529001460|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
146679675|NCT00642460|529001461|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
146679676|NCT00642460|529001456|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
146679677|NCT00642460|529001457|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
146679678|NCT00642460|529001458|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
146679679|NCT00642460|529001459|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
146679680|NCT00642460|529001460|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
146679681|NCT00642460|529001461|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
146679682|NCT00642460|529001456|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
146679683|NCT00642460|529001457|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
146679684|NCT00642460|529001458|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
146679685|NCT00642460|529001459|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
146679686|NCT00642460|529001460|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
146679687|NCT00642460|529001461|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
146679688|NCT00642460|529001456|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
146679689|NCT00642460|529001457|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
146679690|NCT00642460|529001458|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
146679691|NCT00642460|529001459|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
146679692|NCT00642460|529001460|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
146679693|NCT00642460|529001461|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
146679694|NCT00642460|529001456|FG000|Part III: Open-Label Up to Week 260|Other|0|||
146679695|NCT00642460|529001457|FG001|Part III: Open-Label Up to Week 260|Other|0|||
146679696|NCT00642460|529001458|FG002|Part III: Open-Label Up to Week 260|Other|0|||
146679697|NCT00642460|529001459|FG003|Part III: Open-Label Up to Week 260|Other|0|||
146926944|NCT04167306|529892845|FG003|Overall Study|Alcohol treatment|2|||
146679698|NCT00642460|529001460|FG004|Part III: Open-Label Up to Week 260|Other|2|||
146679699|NCT00642460|529001461|FG005|Part III: Open-Label Up to Week 260|Other|2|||
146679700|NCT00642460|529001456|FG000|Part III: Open-Label Up to Week 260|Death|0|||
146679701|NCT00642460|529001457|FG001|Part III: Open-Label Up to Week 260|Death|0|||
146679702|NCT00642460|529001458|FG002|Part III: Open-Label Up to Week 260|Death|0|||
146679703|NCT00642460|529001459|FG003|Part III: Open-Label Up to Week 260|Death|0|||
146679704|NCT00642460|529001460|FG004|Part III: Open-Label Up to Week 260|Death|0|||
146679705|NCT00642460|529001461|FG005|Part III: Open-Label Up to Week 260|Death|3|||
146679706|NCT00642460|529001456|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
146679707|NCT00642460|529001457|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
146679708|NCT00642460|529001458|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
146679709|NCT00642460|529001459|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
146679710|NCT00642460|529001460|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
146679711|NCT00642460|529001461|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
146679712|NCT00642460|529001456|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
146679713|NCT00642460|529001457|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
146679714|NCT00642460|529001458|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
146679715|NCT00642460|529001459|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
146679716|NCT00642460|529001460|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
146679717|NCT00642460|529001461|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
146679718|NCT00496470|529001464|FG000|Overall Study|Adverse Event|8|||
146679719|NCT00496470|529001465|FG001|Overall Study|Adverse Event|10|||
146679720|NCT00496470|529001464|FG000|Overall Study|Withdrawal by Subject|5|||
146679721|NCT00496470|529001465|FG001|Overall Study|Withdrawal by Subject|12|||
146679722|NCT00496470|529001464|FG000|Overall Study|Incorrectly enrolled|13|||
146679723|NCT00496470|529001465|FG001|Overall Study|Incorrectly enrolled|5|||
146679724|NCT00496470|529001464|FG000|Overall Study|Other reason|0|||
146679725|NCT00496470|529001465|FG001|Overall Study|Other reason|2|||
146679726|NCT00729651|529001467|FG000|Overall Study|Withdrawal by Subject|5|||
146679727|NCT00729651|529001468|FG001|Overall Study|Withdrawal by Subject|6|||
146679728|NCT00729651|529001467|FG000|Overall Study|Lost to Follow-up|5|||
146679729|NCT00729651|529001468|FG001|Overall Study|Lost to Follow-up|4|||
146679730|NCT00729651|529001467|FG000|Overall Study|Protocol Violation|0|||
146679731|NCT00729651|529001468|FG001|Overall Study|Protocol Violation|1|||
146679732|NCT00729651|529001467|FG000|Overall Study|Adverse Event|7|||
146679733|NCT00729651|529001468|FG001|Overall Study|Adverse Event|3|||
146679734|NCT00729651|529001467|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
146679735|NCT00729651|529001468|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
146679736|NCT00729651|529001467|FG000|Overall Study|Subject's private reason|2|||
146679737|NCT00729651|529001468|FG001|Overall Study|Subject's private reason|0|||
146679738|NCT00291577|529001469|FG000|Overall Study|Adverse Event|1|||
146679739|NCT00291577|529001469|FG000|Overall Study|Other|4|||
146679740|NCT00291577|529001469|FG000|Overall Study|Withdrawal by Subject|2|||
146679741|NCT00291577|529001469|FG000|Overall Study|Lack of Efficacy|14|||
146679742|NCT00833794|529001474|FG000|Open-label Phase|Adverse Event|225|||
146679743|NCT00833794|529001475|FG001|Open-label Phase|Adverse Event|0|||
146679744|NCT00833794|529001474|FG000|Open-label Phase|Lack of Efficacy|28|||
146679745|NCT00833794|529001475|FG001|Open-label Phase|Lack of Efficacy|0|||
146679746|NCT00833794|529001474|FG000|Open-label Phase|Withdrawal by Subject|48|||
146679747|NCT00833794|529001475|FG001|Open-label Phase|Withdrawal by Subject|0|||
146679748|NCT00833794|529001474|FG000|Open-label Phase|Physician Decision|20|||
146679749|NCT00833794|529001475|FG001|Open-label Phase|Physician Decision|0|||
146679750|NCT00833794|529001474|FG000|Open-label Phase|Administrative reason|1|||
146679751|NCT00833794|529001475|FG001|Open-label Phase|Administrative reason|0|||
146679752|NCT00833794|529001474|FG000|Open-label Phase|Protocol Violation|47|||
146679753|NCT00833794|529001475|FG001|Open-label Phase|Protocol Violation|0|||
146679754|NCT00833794|529001474|FG000|Open-label Phase|Did not complete wash-out period|12|||
146679755|NCT00833794|529001475|FG001|Open-label Phase|Did not complete wash-out period|0|||
146679756|NCT00833794|529001474|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
146679757|NCT00833794|529001475|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
146679758|NCT00833794|529001474|FG000|Double-blind Phase|Adverse Event|44|||
146926945|NCT04167306|529892842|FG000|Overall Study|non-compliance|0|||
146926946|NCT04167306|529892843|FG001|Overall Study|non-compliance|0|||
146926947|NCT04167306|529892844|FG002|Overall Study|non-compliance|1|||
146679759|NCT00833794|529001475|FG001|Double-blind Phase|Adverse Event|11|||
146926948|NCT04167306|529892845|FG003|Overall Study|non-compliance|0|||
146926949|NCT04167306|529892842|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
146926950|NCT04167306|529892843|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
146679760|NCT00833794|529001474|FG000|Double-blind Phase|Lack of Efficacy|34|||
146679761|NCT00833794|529001475|FG001|Double-blind Phase|Lack of Efficacy|22|||
146679762|NCT00833794|529001474|FG000|Double-blind Phase|Withdrawal by Subject|23|||
146926951|NCT04167306|529892844|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
146962303|NCT01049360|530021575|FG001|Period 1|Did not meet inc/exc criteria|0|||
146679763|NCT00833794|529001475|FG001|Double-blind Phase|Withdrawal by Subject|6|||
146679764|NCT00833794|529001474|FG000|Double-blind Phase|Physician Decision|4|||
146679765|NCT00833794|529001475|FG001|Double-blind Phase|Physician Decision|7|||
146679766|NCT00833794|529001474|FG000|Double-blind Phase|Administrative reason|1|||
146679767|NCT00833794|529001475|FG001|Double-blind Phase|Administrative reason|3|||
146679768|NCT00471328|529001478|FG000|Core Phase|Adverse Event|18|||
146679769|NCT00471328|529001479|FG001|Core Phase|Adverse Event|6|||
146679770|NCT00471328|529001478|FG000|Core Phase|Death|8|||
146679771|NCT00471328|529001479|FG001|Core Phase|Death|4|||
146679772|NCT00471328|529001478|FG000|Core Phase|Withdrawal by Subject|2|||
146679773|NCT00471328|529001479|FG001|Core Phase|Withdrawal by Subject|2|||
146679774|NCT00471328|529001478|FG000|Core Phase|Abnormal laboratory value|1|||
146679775|NCT00471328|529001479|FG001|Core Phase|Abnormal laboratory value|0|||
146679776|NCT00471328|529001478|FG000|Core Phase|Disease Progression|78|||
146679777|NCT00471328|529001479|FG001|Core Phase|Disease Progression|53|||
146679778|NCT00471328|529001478|FG000|Core Phase|Administrative Problem|0|||
146679779|NCT00471328|529001479|FG001|Core Phase|Administrative Problem|1|||
146679780|NCT00471328|529001478|FG000|Core Phase|Protocol Deviation|0|||
146679781|NCT00471328|529001479|FG001|Core Phase|Protocol Deviation|1|||
146679782|NCT00471328|529001478|FG000|Extension Phase|Adverse Event|3|||
146679783|NCT00471328|529001479|FG001|Extension Phase|Adverse Event|12|||
146679784|NCT00471328|529001478|FG000|Extension Phase|Withdrawal by Subject|0|||
146679785|NCT00471328|529001479|FG001|Extension Phase|Withdrawal by Subject|2|||
146679786|NCT00471328|529001478|FG000|Extension Phase|Death|1|||
146679787|NCT00471328|529001479|FG001|Extension Phase|Death|7|||
146679788|NCT00471328|529001478|FG000|Extension Phase|Protocol Deviation|3|||
146679789|NCT00471328|529001479|FG001|Extension Phase|Protocol Deviation|1|||
146679790|NCT00471328|529001478|FG000|Extension Phase|Treatment duration as per protocol|0|||
146679791|NCT00471328|529001479|FG001|Extension Phase|Treatment duration as per protocol|1|||
146679792|NCT00471328|529001478|FG000|Extension Phase|Disease Progression|32|||
146679793|NCT00471328|529001479|FG001|Extension Phase|Disease Progression|44|||
146679794|NCT00471328|529001478|FG000|Extension Phase|New cancer Therapy|1|||
146679795|NCT00471328|529001479|FG001|Extension Phase|New cancer Therapy|0|||
146679796|NCT00471328|529001478|FG000|Extension Phase|Administrative Problem|1|||
146679797|NCT00471328|529001479|FG001|Extension Phase|Administrative Problem|0|||
146679798|NCT00519831|529001480|FG000|Overall Study|Adverse Event|3|||
146679799|NCT04051008|529001481|FG000|Overall Study|Withdrawal by Subject|2|||
146679800|NCT04051008|529001482|FG001|Overall Study|Withdrawal by Subject|0|||
146679801|NCT04051008|529001483|FG002|Overall Study|Withdrawal by Subject|1|||
146679802|NCT03200860|529001484|FG000|Overall Study|Withdrawal by Subject|1|||
146679803|NCT03200860|529001485|FG001|Overall Study|Withdrawal by Subject|0|||
146679804|NCT00844896|529001486|FG000|Overall Study|Lost to Follow-up|12|||
146679805|NCT00844896|529001487|FG001|Overall Study|Lost to Follow-up|16|||
146679806|NCT00844896|529001486|FG000|Overall Study|Parents did not have time to complete|0|||
146679807|NCT00844896|529001487|FG001|Overall Study|Parents did not have time to complete|1|||
146679808|NCT00458211|529001491|FG000|Overall Study|Lack of Efficacy|12|||
146679809|NCT00458211|529001491|FG000|Overall Study|Withdrawal by Subject|2|||
146679810|NCT00458211|529001491|FG000|Overall Study|Protocol Violation|2|||
146679811|NCT04342897|529001492|FG000|Overall Study|Death|7|||
146679812|NCT04342897|529001493|FG001|Overall Study|Death|4|||
146679813|NCT04342897|529001492|FG000|Overall Study|Lost to Follow-up|6|||
146679814|NCT04342897|529001493|FG001|Overall Study|Lost to Follow-up|6|||
146679815|NCT04342897|529001492|FG000|Overall Study|Withdrawal by Subject|1|||
146679816|NCT04342897|529001493|FG001|Overall Study|Withdrawal by Subject|2|||
146679817|NCT02634320|529001498|FG000|Overall Study|Adverse Event|2|||
146679818|NCT02634320|529001498|FG000|Overall Study|Lost to Follow-up|3|||
146679819|NCT02634320|529001498|FG000|Overall Study|Moved out of area|2|||
146679820|NCT02634320|529001498|FG000|Overall Study|Out of window for study visits|1|||
146679821|NCT02634320|529001498|FG000|Overall Study|Protocol Violation|1|||
146679822|NCT02634320|529001498|FG000|Overall Study|Withdrawal by Subject|5|||
146679823|NCT02634320|529001498|FG000|Overall Study|Lack of Efficacy|2|||
146679824|NCT00838578|529001503|FG000|Overall Study|Protocol Violation|2|||
146679825|NCT00598832|529001504|FG000|Overall Study|Lack of Efficacy|3|||
146679826|NCT00598832|529001505|FG001|Overall Study|Lack of Efficacy|7|||
146679827|NCT00598832|529001504|FG000|Overall Study|Adverse Event|6|||
146679828|NCT00598832|529001505|FG001|Overall Study|Adverse Event|2|||
146679829|NCT00598832|529001504|FG000|Overall Study|Withdrawal by Subject|25|||
146679830|NCT00598832|529001505|FG001|Overall Study|Withdrawal by Subject|36|||
146679831|NCT00598832|529001504|FG000|Overall Study|Protocol Violation|0|||
146679832|NCT00598832|529001505|FG001|Overall Study|Protocol Violation|2|||
146679833|NCT00598832|529001504|FG000|Overall Study|Lost to Follow-up|24|||
146679834|NCT00598832|529001505|FG001|Overall Study|Lost to Follow-up|29|||
146679835|NCT00598832|529001504|FG000|Overall Study|Pregnancy|2|||
146679836|NCT00598832|529001505|FG001|Overall Study|Pregnancy|2|||
146679837|NCT00598832|529001504|FG000|Overall Study|Physician Decision|1|||
146679838|NCT00598832|529001505|FG001|Overall Study|Physician Decision|4|||
146679839|NCT00598832|529001504|FG000|Overall Study|Non compliance|1|||
146679840|NCT00598832|529001505|FG001|Overall Study|Non compliance|0|||
146679841|NCT00357968|529001513|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
146679842|NCT00357968|529001514|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
146679843|NCT00357968|529001513|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
146679844|NCT00357968|529001514|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
146679845|NCT03919799|529001515|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
146679846|NCT03919799|529001516|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
146679847|NCT03919799|529001517|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
146679848|NCT03919799|529001518|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
146679849|NCT03919799|529001519|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
146679850|NCT03919799|529001515|FG000|DB Period (28 Weeks)|Adverse Event|1|||
146679851|NCT03919799|529001516|FG001|DB Period (28 Weeks)|Adverse Event|1|||
146679852|NCT03919799|529001517|FG002|DB Period (28 Weeks)|Adverse Event|1|||
146679853|NCT03919799|529001518|FG003|DB Period (28 Weeks)|Adverse Event|0|||
146679854|NCT03919799|529001519|FG004|DB Period (28 Weeks)|Adverse Event|0|||
146679855|NCT03919799|529001515|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
146679856|NCT03919799|529001516|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
146679857|NCT03919799|529001517|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
146679858|NCT03919799|529001518|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
146679859|NCT03919799|529001519|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
146679860|NCT03919799|529001515|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
146679861|NCT03919799|529001516|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
146679862|NCT03919799|529001517|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
146679863|NCT03919799|529001518|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
146679864|NCT03919799|529001519|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
146679865|NCT03919799|529001515|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
146679866|NCT03919799|529001516|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
146679867|NCT03919799|529001517|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
146679868|NCT03919799|529001518|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
146679869|NCT03919799|529001519|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
146679870|NCT02142959|529001521|FG000|Overall Study|Adverse Event|1|||
146679871|NCT02142959|529001522|FG001|Overall Study|Adverse Event|0|||
146679872|NCT02142959|529001523|FG002|Overall Study|Adverse Event|0|||
146679873|NCT02142959|529001521|FG000|Overall Study|Death|0|||
146679874|NCT02142959|529001522|FG001|Overall Study|Death|1|||
146679875|NCT02142959|529001523|FG002|Overall Study|Death|0|||
146679876|NCT02142959|529001521|FG000|Overall Study|Withdrawal by Subject|3|||
146679877|NCT02142959|529001522|FG001|Overall Study|Withdrawal by Subject|1|||
146679878|NCT02142959|529001523|FG002|Overall Study|Withdrawal by Subject|3|||
146679879|NCT02142959|529001521|FG000|Overall Study|Administrative Reasons|1|||
146679880|NCT02142959|529001522|FG001|Overall Study|Administrative Reasons|0|||
146679881|NCT02142959|529001523|FG002|Overall Study|Administrative Reasons|1|||
146679882|NCT02142959|529001521|FG000|Overall Study|Missing|0|||
146679883|NCT02142959|529001522|FG001|Overall Study|Missing|1|||
146679884|NCT02142959|529001523|FG002|Overall Study|Missing|0|||
146679885|NCT02142959|529001521|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
146679886|NCT02142959|529001522|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
146679887|NCT02142959|529001523|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
146679888|NCT02142959|529001521|FG000|Overall Study|Patient didn't complete end of study visit|0|||
146679889|NCT02142959|529001522|FG001|Overall Study|Patient didn't complete end of study visit|0|||
146679890|NCT02142959|529001523|FG002|Overall Study|Patient didn't complete end of study visit|1|||
146679891|NCT03547687|529001524|FG000|Overall Study|Withdrawal by Subject|1|||
146679892|NCT03547687|529001524|FG000|Overall Study|Death|1|||
146679893|NCT04600921|529001527|FG000|Overall Study|Withdrawal by Subject|3|||
146679894|NCT04600921|529001528|FG001|Overall Study|Withdrawal by Subject|5|||
146679895|NCT04600921|529001527|FG000|Overall Study|Death|0|||
146679896|NCT04600921|529001528|FG001|Overall Study|Death|1|||
146679897|NCT05425745|529001531|FG000|Overall Study|Withdrawal of Consent|3|||
146679898|NCT05425745|529001532|FG001|Overall Study|Withdrawal of Consent|3|||
146679899|NCT05425745|529001531|FG000|Overall Study|Death|2|||
146679900|NCT05425745|529001532|FG001|Overall Study|Death|3|||
146679901|NCT05425745|529001531|FG000|Overall Study|Lost to Follow-up|1|||
146679902|NCT05425745|529001532|FG001|Overall Study|Lost to Follow-up|2|||
146679903|NCT05425745|529001531|FG000|Overall Study|Adverse Event|0|||
146679904|NCT05425745|529001532|FG001|Overall Study|Adverse Event|1|||
146679905|NCT05425745|529001531|FG000|Overall Study|Did not return for end of study visit|0|||
146679906|NCT05425745|529001532|FG001|Overall Study|Did not return for end of study visit|1|||
146679907|NCT05425745|529001531|FG000|Overall Study|End of study visit completed by phone|1|||
146679908|NCT05425745|529001532|FG001|Overall Study|End of study visit completed by phone|0|||
146679909|NCT05425745|529001531|FG000|Overall Study|Subject decision|1|||
146679910|NCT05425745|529001532|FG001|Overall Study|Subject decision|0|||
146679911|NCT02700815|529003001|FG000|Overall Study|Adverse Event|0|||
146679912|NCT02700815|529003002|FG001|Overall Study|Adverse Event|6|||
146679913|NCT02700815|529003003|FG002|Overall Study|Adverse Event|2|||
146679914|NCT02700815|529003004|FG003|Overall Study|Adverse Event|3|||
146679915|NCT02700815|529003001|FG000|Overall Study|Lack of Efficacy|0|||
146679916|NCT02700815|529003002|FG001|Overall Study|Lack of Efficacy|0|||
146679917|NCT02700815|529003003|FG002|Overall Study|Lack of Efficacy|1|||
146679918|NCT02700815|529003004|FG003|Overall Study|Lack of Efficacy|2|||
146679919|NCT02700815|529003001|FG000|Overall Study|Lost to Follow-up|1|||
146679920|NCT02700815|529003002|FG001|Overall Study|Lost to Follow-up|0|||
146679921|NCT02700815|529003003|FG002|Overall Study|Lost to Follow-up|0|||
146679922|NCT02700815|529003004|FG003|Overall Study|Lost to Follow-up|1|||
146679923|NCT02700815|529003001|FG000|Overall Study|Refusal to continue medication|0|||
146679924|NCT02700815|529003002|FG001|Overall Study|Refusal to continue medication|1|||
146679925|NCT02700815|529003003|FG002|Overall Study|Refusal to continue medication|0|||
146679926|NCT02700815|529003004|FG003|Overall Study|Refusal to continue medication|1|||
146679927|NCT02700815|529003001|FG000|Overall Study|Withdrawal by Subject|0|||
146679928|NCT02700815|529003002|FG001|Overall Study|Withdrawal by Subject|0|||
146679929|NCT02700815|529003003|FG002|Overall Study|Withdrawal by Subject|1|||
146679930|NCT02700815|529003004|FG003|Overall Study|Withdrawal by Subject|0|||
146679931|NCT02239978|529003006|FG000|Overall Study|Withdrawal by Subject|2|||
146679932|NCT02239978|529003007|FG001|Overall Study|Withdrawal by Subject|0|||
146679933|NCT00793403|529003010|FG000|Overall Study|Other|73|||
146679934|NCT02990910|529003016|FG000|Overall Study|Lack of Efficacy|6|||
146679935|NCT02990910|529003017|FG001|Overall Study|Lack of Efficacy|10|||
146679936|NCT03506815|529003023|FG000|Overall Study|Adverse Event|8|||
146679937|NCT03506815|529003024|FG001|Overall Study|Adverse Event|0|||
146679938|NCT03506815|529003023|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
146679939|NCT03506815|529003024|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
146679940|NCT03506815|529003023|FG000|Overall Study|Protocol Violation|1|||
146679941|NCT03506815|529003024|FG001|Overall Study|Protocol Violation|0|||
146679942|NCT03506815|529003023|FG000|Overall Study|Elective Surgery|1|||
146679943|NCT03506815|529003024|FG001|Overall Study|Elective Surgery|0|||
146679944|NCT02692716|529003028|FG000|Overall Study|Lost to Follow-up|2|||
146679945|NCT02692716|529003029|FG001|Overall Study|Lost to Follow-up|5|||
146679946|NCT02692716|529003028|FG000|Overall Study|Withdrawal by Subject|3|||
146679947|NCT02692716|529003029|FG001|Overall Study|Withdrawal by Subject|1|||
146679948|NCT00856284|529003034|FG000|Overall Study|Hyperglycemic rescue|231|||
146679949|NCT00856284|529003035|FG001|Overall Study|Hyperglycemic rescue|201|||
146679950|NCT00856284|529003036|FG002|Overall Study|Hyperglycemic rescue|235|||
146679951|NCT00856284|529003034|FG000|Overall Study|Adverse Event|60|||
146679952|NCT00856284|529003035|FG001|Overall Study|Adverse Event|74|||
146679953|NCT00856284|529003036|FG002|Overall Study|Adverse Event|82|||
146679954|NCT00856284|529003034|FG000|Overall Study|Major protocol deviation|24|||
146679955|NCT00856284|529003035|FG001|Overall Study|Major protocol deviation|16|||
146679956|NCT00856284|529003036|FG002|Overall Study|Major protocol deviation|15|||
146679957|NCT00856284|529003034|FG000|Overall Study|Lost to Follow-up|20|||
146679958|NCT00856284|529003035|FG001|Overall Study|Lost to Follow-up|22|||
146679959|NCT00856284|529003036|FG002|Overall Study|Lost to Follow-up|28|||
146679960|NCT00856284|529003034|FG000|Overall Study|Voluntary withdrawal|48|||
146679961|NCT00856284|529003035|FG001|Overall Study|Voluntary withdrawal|52|||
146679962|NCT00856284|529003036|FG002|Overall Study|Voluntary withdrawal|62|||
146679963|NCT00856284|529003034|FG000|Overall Study|Pregnancy|1|||
146679964|NCT00856284|529003035|FG001|Overall Study|Pregnancy|2|||
146679965|NCT00856284|529003036|FG002|Overall Study|Pregnancy|0|||
146679966|NCT00856284|529003034|FG000|Overall Study|Investigator discretion|9|||
146679967|NCT00856284|529003035|FG001|Overall Study|Investigator discretion|8|||
146679968|NCT00856284|529003036|FG002|Overall Study|Investigator discretion|10|||
146679969|NCT00856284|529003034|FG000|Overall Study|Other|15|||
146679970|NCT00856284|529003035|FG001|Overall Study|Other|17|||
146679971|NCT00856284|529003036|FG002|Overall Study|Other|14|||
146679972|NCT00856284|529003034|FG000|Overall Study|Randomized in error|0|||
146679973|NCT00856284|529003035|FG001|Overall Study|Randomized in error|0|||
146679974|NCT00856284|529003036|FG002|Overall Study|Randomized in error|1|||
146679975|NCT01059825|529003041|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
146679976|NCT01059825|529003042|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
146679977|NCT01059825|529003043|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
146679978|NCT01059825|529003044|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
146679979|NCT01059825|529003045|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
146679980|NCT01059825|529003046|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
146679981|NCT01059825|529003047|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
146679982|NCT01059825|529003041|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
146679983|NCT01059825|529003042|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
146679984|NCT01059825|529003043|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
146679985|NCT01059825|529003044|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
146679986|NCT01059825|529003045|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
146679987|NCT01059825|529003046|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
146679988|NCT01059825|529003047|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
146679989|NCT01059825|529003041|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
146679990|NCT01059825|529003042|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
146679991|NCT01059825|529003043|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
146679992|NCT01059825|529003044|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
146679993|NCT01059825|529003045|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
146679994|NCT01059825|529003046|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
146926952|NCT04167306|529892845|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
146926953|NCT01253421|529892850|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
146679995|NCT01059825|529003047|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
146679996|NCT01059825|529003041|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
146679997|NCT01059825|529003042|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
146679998|NCT01059825|529003043|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
146679999|NCT01059825|529003044|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
146680000|NCT01059825|529003045|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
146680001|NCT01059825|529003046|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
146680002|NCT01059825|529003047|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
146680003|NCT01059825|529003041|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
146680004|NCT01059825|529003042|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
146680005|NCT01059825|529003043|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
146680006|NCT01059825|529003044|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
146680007|NCT01059825|529003045|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
146680008|NCT01059825|529003046|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
146680009|NCT01059825|529003047|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
146680010|NCT01059825|529003041|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
146680011|NCT01059825|529003042|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
146680012|NCT01059825|529003043|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
146680013|NCT01059825|529003044|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
146680014|NCT01059825|529003045|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
146680015|NCT01059825|529003046|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
146680016|NCT01059825|529003047|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
146680017|NCT01059825|529003041|FG000|Treatment Period|Lost to Follow-up|2|||
146680018|NCT01059825|529003042|FG001|Treatment Period|Lost to Follow-up|1|||
146680019|NCT01059825|529003043|FG002|Treatment Period|Lost to Follow-up|0|||
146680020|NCT01059825|529003044|FG003|Treatment Period|Lost to Follow-up|1|||
146680021|NCT01059825|529003045|FG004|Treatment Period|Lost to Follow-up|2|||
146680022|NCT01059825|529003046|FG005|Treatment Period|Lost to Follow-up|0|||
146680023|NCT01059825|529003047|FG006|Treatment Period|Lost to Follow-up|0|||
146680024|NCT01059825|529003041|FG000|Treatment Period|Withdrawal by Subject|3|||
146680025|NCT01059825|529003042|FG001|Treatment Period|Withdrawal by Subject|0|||
146680026|NCT01059825|529003043|FG002|Treatment Period|Withdrawal by Subject|1|||
146680027|NCT01059825|529003044|FG003|Treatment Period|Withdrawal by Subject|5|||
146680028|NCT01059825|529003045|FG004|Treatment Period|Withdrawal by Subject|4|||
146680029|NCT01059825|529003046|FG005|Treatment Period|Withdrawal by Subject|1|||
146680030|NCT01059825|529003047|FG006|Treatment Period|Withdrawal by Subject|0|||
146680031|NCT01059825|529003041|FG000|Treatment Period|Other reason not specified|1|||
146680032|NCT01059825|529003042|FG001|Treatment Period|Other reason not specified|2|||
146680033|NCT01059825|529003043|FG002|Treatment Period|Other reason not specified|1|||
146680034|NCT01059825|529003044|FG003|Treatment Period|Other reason not specified|2|||
146680035|NCT01059825|529003045|FG004|Treatment Period|Other reason not specified|0|||
146680036|NCT01059825|529003046|FG005|Treatment Period|Other reason not specified|0|||
146680037|NCT01059825|529003047|FG006|Treatment Period|Other reason not specified|0|||
146680038|NCT01059825|529003041|FG000|Treatment Period|Protocol Violation|0|||
146680039|NCT01059825|529003042|FG001|Treatment Period|Protocol Violation|0|||
146680040|NCT01059825|529003043|FG002|Treatment Period|Protocol Violation|1|||
146774764|NCT04556981|529345415|FG000|Overall Study|Moved from the study area|1|||
146926954|NCT01253421|529892851|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
146926955|NCT01253421|529892852|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
146926956|NCT01253421|529892853|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
146926957|NCT01253421|529892854|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
146926958|NCT01253421|529892850|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
146926959|NCT01253421|529892851|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
146926960|NCT01253421|529892852|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
146926961|NCT01253421|529892853|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
146926962|NCT01253421|529892854|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
146774765|NCT04556981|529345416|FG001|Overall Study|Moved from the study area|4|||
146774766|NCT04556981|529345415|FG000|Overall Study|Withdrawal by Subject|2|||
146680041|NCT01059825|529003044|FG003|Treatment Period|Protocol Violation|1|||
146774767|NCT04556981|529345416|FG001|Overall Study|Withdrawal by Subject|2|||
146774768|NCT04556981|529345415|FG000|Overall Study|Other|2|||
146774769|NCT04556981|529345416|FG001|Overall Study|Other|1|||
146774770|NCT02574455|529345420|FG000|Overall Study|Death|197|||
146774771|NCT02574455|529345421|FG001|Overall Study|Death|210|||
146774772|NCT02574455|529345420|FG000|Overall Study|Withdrawal of Consent|11|||
146774773|NCT02574455|529345421|FG001|Overall Study|Withdrawal of Consent|28|||
146680042|NCT01059825|529003045|FG004|Treatment Period|Protocol Violation|1|||
146680043|NCT01059825|529003046|FG005|Treatment Period|Protocol Violation|1|||
146680044|NCT01059825|529003047|FG006|Treatment Period|Protocol Violation|0|||
146680045|NCT01059825|529003041|FG000|Treatment Period|Adverse event related to study drug|1|||
146680046|NCT01059825|529003042|FG001|Treatment Period|Adverse event related to study drug|0|||
146680047|NCT01059825|529003043|FG002|Treatment Period|Adverse event related to study drug|1|||
146680048|NCT01059825|529003044|FG003|Treatment Period|Adverse event related to study drug|1|||
146680049|NCT01059825|529003045|FG004|Treatment Period|Adverse event related to study drug|0|||
146680050|NCT01059825|529003046|FG005|Treatment Period|Adverse event related to study drug|0|||
146680051|NCT01059825|529003047|FG006|Treatment Period|Adverse event related to study drug|0|||
146680052|NCT01059825|529003041|FG000|Treatment Period|Insufficient clinical response|3|||
146680053|NCT01059825|529003042|FG001|Treatment Period|Insufficient clinical response|0|||
146680054|NCT01059825|529003043|FG002|Treatment Period|Insufficient clinical response|0|||
146680055|NCT01059825|529003044|FG003|Treatment Period|Insufficient clinical response|0|||
146680056|NCT01059825|529003045|FG004|Treatment Period|Insufficient clinical response|0|||
146680057|NCT01059825|529003046|FG005|Treatment Period|Insufficient clinical response|0|||
146680058|NCT01059825|529003047|FG006|Treatment Period|Insufficient clinical response|0|||
146680059|NCT01059825|529003041|FG000|Treatment Period|Adverse event not related to study drug|0|||
146680060|NCT01059825|529003042|FG001|Treatment Period|Adverse event not related to study drug|1|||
146680061|NCT01059825|529003043|FG002|Treatment Period|Adverse event not related to study drug|2|||
146680062|NCT01059825|529003044|FG003|Treatment Period|Adverse event not related to study drug|1|||
146680063|NCT01059825|529003045|FG004|Treatment Period|Adverse event not related to study drug|1|||
146680064|NCT01059825|529003046|FG005|Treatment Period|Adverse event not related to study drug|1|||
146680065|NCT01059825|529003047|FG006|Treatment Period|Adverse event not related to study drug|0|||
146680066|NCT03342690|529003050|FG000|Overall Study|Missing Information|9|||
146680067|NCT03342690|529003050|FG000|Overall Study|Protocol Violation|16|||
146680068|NCT00105482|529003051|FG000|Overall Study|Adverse Event|1|||
146680069|NCT00105482|529003052|FG001|Overall Study|Adverse Event|1|||
146680070|NCT00105482|529003051|FG000|Overall Study|Lost to Follow-up|26|||
146680071|NCT00105482|529003052|FG001|Overall Study|Lost to Follow-up|17|||
146680072|NCT00105482|529003051|FG000|Overall Study|Withdrawal by Subject|0|||
146680073|NCT00105482|529003052|FG001|Overall Study|Withdrawal by Subject|1|||
146680074|NCT00105482|529003051|FG000|Overall Study|Lost Interest|29|||
146680075|NCT00105482|529003052|FG001|Overall Study|Lost Interest|32|||
146680076|NCT00105482|529003051|FG000|Overall Study|Scheduling Conflict|2|||
146680077|NCT00105482|529003052|FG001|Overall Study|Scheduling Conflict|3|||
146680078|NCT00105482|529003051|FG000|Overall Study|Withdrawn by PI|1|||
146680079|NCT00105482|529003052|FG001|Overall Study|Withdrawn by PI|1|||
146680080|NCT04016285|529003053|FG000|Overall Study|Did not progress to surgery|2|||
146680081|NCT04016285|529003054|FG001|Overall Study|Did not progress to surgery|5|||
146680082|NCT04016285|529003053|FG000|Overall Study|Failed to collect outcome data|5|||
146680083|NCT04016285|529003054|FG001|Overall Study|Failed to collect outcome data|3|||
146680084|NCT02509156|529003057|FG000|Randomized Phase|Death|1|||
146680085|NCT02509156|529003058|FG001|Randomized Phase|Death|0|||
146680086|NCT02509156|529003057|FG000|Randomized Phase|Withdrawal by Subject|1|||
146680087|NCT02509156|529003058|FG001|Randomized Phase|Withdrawal by Subject|1|||
146680088|NCT02547649|529003059|FG000|Overall Study|Lost to Follow-up|3|||
146680089|NCT02547649|529003060|FG001|Overall Study|Lost to Follow-up|1|||
146680090|NCT02547649|529003061|FG002|Overall Study|Lost to Follow-up|1|||
146680091|NCT02547649|529003059|FG000|Overall Study|Not vaccinated|0|||
146680092|NCT02547649|529003060|FG001|Overall Study|Not vaccinated|0|||
146680093|NCT02547649|529003061|FG002|Overall Study|Not vaccinated|1|||
146680094|NCT02547649|529003059|FG000|Overall Study|Withdrawal by Subject|0|||
146680095|NCT02547649|529003060|FG001|Overall Study|Withdrawal by Subject|4|||
146680096|NCT02547649|529003061|FG002|Overall Study|Withdrawal by Subject|2|||
146680097|NCT01750242|529003067|FG000|Overall Study|Unreadable Images|3|||
146680098|NCT00006903|529003068|FG000|Overall Study|Still receiving treatment|0|||
146680099|NCT00006903|529003069|FG001|Overall Study|Still receiving treatment|0|||
146680100|NCT00006903|529003070|FG002|Overall Study|Still receiving treatment|1|||
146680101|NCT00006903|529003068|FG000|Overall Study|Refused further treatment|0|||
146680102|NCT00006903|529003069|FG001|Overall Study|Refused further treatment|2|||
146680103|NCT00006903|529003070|FG002|Overall Study|Refused further treatment|1|||
146680104|NCT00006903|529003068|FG000|Overall Study|Adverse Event|0|||
146680105|NCT00006903|529003069|FG001|Overall Study|Adverse Event|0|||
146680106|NCT00006903|529003070|FG002|Overall Study|Adverse Event|1|||
146774774|NCT02574455|529345420|FG000|Overall Study|Lost to Follow-up|4|||
146774775|NCT02574455|529345421|FG001|Overall Study|Lost to Follow-up|4|||
146774776|NCT02574455|529345420|FG000|Overall Study|Sponsor's Decision|55|||
146774777|NCT02574455|529345421|FG001|Overall Study|Sponsor's Decision|20|||
146774778|NCT03565315|529345426|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
146774779|NCT03565315|529345427|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
146774780|NCT03565315|529345428|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
146774781|NCT03565315|529345429|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
146774782|NCT00440011|529345430|FG000|Overall Study|Adverse Event|2|||
146926963|NCT01253421|529892850|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
146926964|NCT01253421|529892851|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
146680107|NCT00006903|529003068|FG000|Overall Study|Death|0|||
146680108|NCT00006903|529003069|FG001|Overall Study|Death|1|||
146680109|NCT00006903|529003070|FG002|Overall Study|Death|0|||
146680110|NCT00006903|529003068|FG000|Overall Study|Patient never treated|0|||
146680111|NCT00006903|529003069|FG001|Overall Study|Patient never treated|0|||
146680112|NCT00006903|529003070|FG002|Overall Study|Patient never treated|1|||
146680113|NCT00006903|529003068|FG000|Overall Study|Ineligible|10|||
146680114|NCT00006903|529003069|FG001|Overall Study|Ineligible|1|||
146680115|NCT00006903|529003070|FG002|Overall Study|Ineligible|2|||
146680116|NCT01909674|529003071|FG000|Overall Study|Withdrawal by Subject|5|||
146680117|NCT01909674|529003072|FG001|Overall Study|Withdrawal by Subject|2|||
146680118|NCT02969369|529003073|FG000|Study|Adverse Event|1|||
146680119|NCT02969369|529003074|FG001|Study|Adverse Event|6|||
146680120|NCT02969369|529003073|FG000|Study|Lack of Efficacy|0|||
146680121|NCT02969369|529003074|FG001|Study|Lack of Efficacy|1|||
146680122|NCT02969369|529003073|FG000|Study|Lost to Follow-up|0|||
146680123|NCT02969369|529003074|FG001|Study|Lost to Follow-up|1|||
146680124|NCT02969369|529003073|FG000|Study|Withdrawal by Subject|3|||
146680125|NCT02969369|529003074|FG001|Study|Withdrawal by Subject|5|||
146680126|NCT02969369|529003073|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
146680127|NCT02969369|529003074|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
146680128|NCT02969369|529003073|FG000|Double-blind Period|Adverse Event|1|||
146680129|NCT02969369|529003074|FG001|Double-blind Period|Adverse Event|5|||
146680130|NCT02969369|529003073|FG000|Double-blind Period|Lost to Follow-up|0|||
146680131|NCT02969369|529003074|FG001|Double-blind Period|Lost to Follow-up|1|||
146680132|NCT02969369|529003073|FG000|Double-blind Period|Withdrawal by Subject|2|||
146680133|NCT02969369|529003074|FG001|Double-blind Period|Withdrawal by Subject|3|||
146680134|NCT02969369|529003073|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
146680135|NCT02969369|529003074|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
146680136|NCT02969369|529003073|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
146680137|NCT02969369|529003074|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
146680138|NCT02969369|529003073|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
146680139|NCT02969369|529003074|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
146680140|NCT02969369|529003073|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
146680141|NCT02969369|529003074|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
146680142|NCT02651922|529003076|FG000|Overall Study|due to exclusion criteria|2|||
146680143|NCT01366209|529003077|FG000|Overall Study|Adverse Event|6|||
146680144|NCT01366209|529003078|FG001|Overall Study|Adverse Event|7|||
146680145|NCT01366209|529003077|FG000|Overall Study|Withdrawal by Subject|4|||
146680146|NCT01366209|529003078|FG001|Overall Study|Withdrawal by Subject|4|||
146680147|NCT01366209|529003077|FG000|Overall Study|Death|12|||
146680148|NCT01366209|529003078|FG001|Overall Study|Death|19|||
146680149|NCT01366209|529003077|FG000|Overall Study|Lung transplantation|6|||
146680150|NCT01366209|529003078|FG001|Overall Study|Lung transplantation|1|||
146680151|NCT01366209|529003077|FG000|Overall Study|Lost to Follow-up|2|||
146680152|NCT01366209|529003078|FG001|Overall Study|Lost to Follow-up|1|||
146680153|NCT01366209|529003077|FG000|Overall Study|Physician Decision|1|||
146680154|NCT01366209|529003078|FG001|Overall Study|Physician Decision|0|||
146680155|NCT01366209|529003077|FG000|Overall Study|Sponsors decision|0|||
146680156|NCT01366209|529003078|FG001|Overall Study|Sponsors decision|1|||
146680157|NCT01366209|529003077|FG000|Overall Study|Withdrew consent|4|||
146680158|NCT01366209|529003078|FG001|Overall Study|Withdrew consent|3|||
146680159|NCT01053221|529003079|FG000|Overall Study|The study was closed prematurely|5|||
146680160|NCT01053221|529003080|FG001|Overall Study|The study was closed prematurely|9|||
146680161|NCT01465997|529003081|FG000|Overall Study|Adverse Event|12|||
146926965|NCT01253421|529892852|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
146680162|NCT01465997|529003082|FG001|Overall Study|Adverse Event|22|||
146680163|NCT01465997|529003081|FG000|Overall Study|Lack of Efficacy|13|||
146680164|NCT01465997|529003082|FG001|Overall Study|Lack of Efficacy|1|||
146680165|NCT01465997|529003081|FG000|Overall Study|Protocol Violation|1|||
146680166|NCT01465997|529003082|FG001|Overall Study|Protocol Violation|4|||
146680167|NCT01465997|529003081|FG000|Overall Study|Lost to Follow-up|6|||
146680168|NCT01465997|529003082|FG001|Overall Study|Lost to Follow-up|9|||
146680169|NCT01465997|529003081|FG000|Overall Study|Withdrawal by Subject|32|||
146680170|NCT01465997|529003082|FG001|Overall Study|Withdrawal by Subject|35|||
146680171|NCT01465997|529003081|FG000|Overall Study|investigator's decision|1|||
146680172|NCT01465997|529003082|FG001|Overall Study|investigator's decision|1|||
146680173|NCT01465997|529003081|FG000|Overall Study|Death|0|||
146680174|NCT01465997|529003082|FG001|Overall Study|Death|1|||
146926966|NCT01253421|529892853|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
146680175|NCT01465997|529003081|FG000|Overall Study|sponsor's decision|1|||
146680176|NCT01465997|529003082|FG001|Overall Study|sponsor's decision|1|||
146680177|NCT01465997|529003081|FG000|Overall Study|subject withdrew consent|1|||
146680178|NCT01465997|529003082|FG001|Overall Study|subject withdrew consent|0|||
146680179|NCT01465997|529003081|FG000|Overall Study|local lab unblinded site|1|||
146926967|NCT01253421|529892854|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
146926968|NCT01253421|529892850|FG000|Assessment and Scheduling|Physician Decision|1|||
146926969|NCT01253421|529892851|FG001|Assessment and Scheduling|Physician Decision|0|||
146926970|NCT01253421|529892852|FG002|Assessment and Scheduling|Physician Decision|0|||
146926971|NCT01253421|529892853|FG003|Assessment and Scheduling|Physician Decision|0|||
146926972|NCT01253421|529892854|FG004|Assessment and Scheduling|Physician Decision|0|||
146926973|NCT01253421|529892850|FG000|Drug+Scanning Visit|Physician Decision|0|||
146926974|NCT01253421|529892851|FG001|Drug+Scanning Visit|Physician Decision|0|||
146926975|NCT01253421|529892852|FG002|Drug+Scanning Visit|Physician Decision|0|||
146926976|NCT01253421|529892853|FG003|Drug+Scanning Visit|Physician Decision|0|||
146926977|NCT01253421|529892854|FG004|Drug+Scanning Visit|Physician Decision|1|||
146926978|NCT04863014|529892855|FG000|Overall Study|Lost to Follow-up|3|||
146926979|NCT04863014|529892856|FG001|Overall Study|Lost to Follow-up|2|||
146926980|NCT04863014|529892855|FG000|Overall Study|Subject Decision|0|||
146926981|NCT04863014|529892856|FG001|Overall Study|Subject Decision|4|||
146926982|NCT03707158|529892857|FG000|Midtreatment|Lost to Follow-up|16|||
146926983|NCT03707158|529892858|FG001|Midtreatment|Lost to Follow-up|7|||
146680180|NCT01465997|529003082|FG001|Overall Study|local lab unblinded site|0|||
146680181|NCT01465997|529003081|FG000|Overall Study|withdrew before follow-up|0|||
146680182|NCT01465997|529003082|FG001|Overall Study|withdrew before follow-up|13|||
146680183|NCT01465997|529003081|FG000|Overall Study|decision by site staff|0|||
146680184|NCT01465997|529003082|FG001|Overall Study|decision by site staff|1|||
146680185|NCT01465997|529003081|FG000|Overall Study|subject left participation SP0993|0|||
146680186|NCT01465997|529003082|FG001|Overall Study|subject left participation SP0993|1|||
146680187|NCT02246660|529003083|FG000|Overall Study|Withdrawal by Subject|0|||
146680188|NCT02246660|529003084|FG001|Overall Study|Withdrawal by Subject|1|||
146680189|NCT02246660|529003085|FG002|Overall Study|Withdrawal by Subject|0|||
146680190|NCT02246660|529003083|FG000|Overall Study|Death|0|||
146680191|NCT02246660|529003084|FG001|Overall Study|Death|0|||
146680192|NCT02246660|529003085|FG002|Overall Study|Death|1|||
146680193|NCT02557646|529003088|FG000|Overall Study|Adverse Event|40|||
146680194|NCT02557646|529003088|FG000|Overall Study|Death|1|||
146680195|NCT02557646|529003088|FG000|Overall Study|Lack of Efficacy|186|||
146680196|NCT02557646|529003088|FG000|Overall Study|Withdrawal by Subject|18|||
146680197|NCT02557646|529003088|FG000|Overall Study|Lost to Follow-up|17|||
146680198|NCT02557646|529003088|FG000|Overall Study|Other|14|||
146680199|NCT01637272|529003091|FG000|Overall Study|Adverse Event|6|||
146680200|NCT01637272|529003091|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146680201|NCT01637272|529003091|FG000|Overall Study|Withdrawal by Subject|3|||
146680202|NCT01637272|529003091|FG000|Overall Study|Lost to Follow-up|2|||
146680203|NCT01637272|529003091|FG000|Overall Study|completed core, did not enter ext. phase|4|||
146680204|NCT01637272|529003091|FG000|Overall Study|Administrative problems|1|||
146680205|NCT01637272|529003091|FG000|Overall Study|Protocol Violation|2|||
146680206|NCT01496612|529003092|FG000|1st Intervention|Adverse Event|1|||
146680207|NCT01496612|529003093|FG001|1st Intervention|Adverse Event|0|||
146680208|NCT01496612|529003092|FG000|1st Intervention|Withdrawal by Subject|1|||
146680209|NCT01496612|529003093|FG001|1st Intervention|Withdrawal by Subject|0|||
146680210|NCT01666782|529003094|FG000|Overall Study|Received 2 doses of vaccine|0|||
146680211|NCT01666782|529003095|FG001|Overall Study|Received 2 doses of vaccine|1|||
146680212|NCT01666782|529003094|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
146680213|NCT01666782|529003095|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
146680214|NCT02132130|529003111|FG000|Overall Study|Lost to Follow-up|0|||
146680215|NCT02132130|529003112|FG001|Overall Study|Lost to Follow-up|2|||
146680216|NCT02132130|529003113|FG002|Overall Study|Lost to Follow-up|0|||
146680217|NCT02132130|529003114|FG003|Overall Study|Lost to Follow-up|0|||
146680218|NCT02132130|529003111|FG000|Overall Study|Withdrawal by Subject|0|||
146680219|NCT02132130|529003112|FG001|Overall Study|Withdrawal by Subject|0|||
146680220|NCT02132130|529003113|FG002|Overall Study|Withdrawal by Subject|0|||
146680221|NCT02132130|529003114|FG003|Overall Study|Withdrawal by Subject|1|||
146680222|NCT00646776|529003124|FG000|Overall Study|Adverse Event|1|||
146680223|NCT00646776|529003125|FG001|Overall Study|Adverse Event|9|||
146680224|NCT00646776|529003124|FG000|Overall Study|Investigator discretion|0|||
146680225|NCT00646776|529003125|FG001|Overall Study|Investigator discretion|4|||
146680226|NCT00600483|529003130|FG000|Overall Study|Lost to Follow-up|26|||
146680227|NCT00600483|529003131|FG001|Overall Study|Lost to Follow-up|47|||
146680228|NCT00600483|529003130|FG000|Overall Study|Randomized but not treated|10|||
146680229|NCT00600483|529003131|FG001|Overall Study|Randomized but not treated|0|||
146680230|NCT01482884|529003140|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
146680231|NCT01482884|529003141|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
146680232|NCT01482884|529003140|FG000|Overall Study|Protocol Violation|1|||
146774783|NCT00440011|529345431|FG001|Overall Study|Adverse Event|0|||
146926984|NCT03707158|529892857|FG000|Midtreatment|Withdrawal by Subject|28|||
146680233|NCT01482884|529003141|FG001|Overall Study|Protocol Violation|0|||
146680234|NCT01482884|529003140|FG000|Overall Study|Lost to Follow-up|2|||
146680235|NCT01482884|529003141|FG001|Overall Study|Lost to Follow-up|2|||
146680236|NCT01482884|529003140|FG000|Overall Study|Lack of Efficacy|0|||
146926985|NCT03707158|529892858|FG001|Midtreatment|Withdrawal by Subject|19|||
146926986|NCT03707158|529892857|FG000|Posttreatment|Lost to Follow-up|0|||
146680237|NCT01482884|529003141|FG001|Overall Study|Lack of Efficacy|1|||
146680238|NCT01482884|529003140|FG000|Overall Study|Adverse Event|2|||
146680239|NCT01482884|529003141|FG001|Overall Study|Adverse Event|1|||
146680240|NCT01482884|529003140|FG000|Overall Study|Withdrawal by Subject|8|||
146680241|NCT01482884|529003141|FG001|Overall Study|Withdrawal by Subject|13|||
146680242|NCT00439244|529003144|FG000|Overall Study|Adverse Event|5|||
146680243|NCT00439244|529003145|FG001|Overall Study|Adverse Event|2|||
146680244|NCT00439244|529003146|FG002|Overall Study|Adverse Event|3|||
146680245|NCT00439244|529003144|FG000|Overall Study|Withdrawal by Subject|3|||
146680246|NCT00439244|529003145|FG001|Overall Study|Withdrawal by Subject|1|||
146680247|NCT00439244|529003146|FG002|Overall Study|Withdrawal by Subject|2|||
146680248|NCT00439244|529003144|FG000|Overall Study|Lost to Follow-up|2|||
146680249|NCT00439244|529003145|FG001|Overall Study|Lost to Follow-up|1|||
146680250|NCT00439244|529003146|FG002|Overall Study|Lost to Follow-up|2|||
146680251|NCT00439244|529003144|FG000|Overall Study|Death|0|||
146680252|NCT00439244|529003145|FG001|Overall Study|Death|1|||
146680253|NCT00439244|529003146|FG002|Overall Study|Death|0|||
146680254|NCT00439244|529003144|FG000|Overall Study|Protocol Violation|0|||
146680255|NCT00439244|529003145|FG001|Overall Study|Protocol Violation|1|||
146680256|NCT00439244|529003146|FG002|Overall Study|Protocol Violation|0|||
146680257|NCT00439244|529003144|FG000|Overall Study|Administrative problems|1|||
146680258|NCT00439244|529003145|FG001|Overall Study|Administrative problems|0|||
146680259|NCT00439244|529003146|FG002|Overall Study|Administrative problems|0|||
146680260|NCT01774968|529003151|FG000|Overall Study|Adverse Event|4|||
146680261|NCT01774968|529003152|FG001|Overall Study|Adverse Event|4|||
146680262|NCT01774968|529003151|FG000|Overall Study|Death|0|||
146680263|NCT01774968|529003152|FG001|Overall Study|Death|1|||
146926987|NCT03707158|529892858|FG001|Posttreatment|Lost to Follow-up|5|||
146926988|NCT03707158|529892857|FG000|Follow-up|Lost to Follow-up|19|||
146926989|NCT03707158|529892858|FG001|Follow-up|Lost to Follow-up|18|||
146926990|NCT03707158|529892857|FG000|Follow-up|Withdrawal by Subject|13|||
146926991|NCT03707158|529892858|FG001|Follow-up|Withdrawal by Subject|6|||
146926992|NCT01877382|529892859|FG000|Dose Escalation|Progressive disease|2|||
146926993|NCT01877382|529892860|FG001|Dose Escalation|Progressive disease|0|||
146926994|NCT01877382|529892861|FG002|Dose Escalation|Progressive disease|1|||
146926995|NCT01877382|529892862|FG003|Dose Escalation|Progressive disease|6|||
146926996|NCT01877382|529892863|FG004|Dose Escalation|Progressive disease|1|||
146926997|NCT01877382|529892864|FG005|Dose Escalation|Progressive disease|0|||
146926998|NCT01877382|529892865|FG006|Dose Escalation|Progressive disease|3|||
146926999|NCT01877382|529892866|FG007|Dose Escalation|Progressive disease|10|||
146927000|NCT01877382|529892867|FG008|Dose Escalation|Progressive disease|4|||
146927001|NCT01877382|529892868|FG009|Dose Escalation|Progressive disease|2|||
146927002|NCT01877382|529892869|FG010|Dose Escalation|Progressive disease|3|||
146927003|NCT01877382|529892870|FG011|Dose Escalation|Progressive disease|3|||
146927004|NCT01877382|529892871|FG012|Dose Escalation|Progressive disease|13|||
146927005|NCT01877382|529892872|FG013|Dose Escalation|Progressive disease|1|||
146927006|NCT01877382|529892873|FG014|Dose Escalation|Progressive disease|0|||
146927007|NCT01877382|529892859|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
146927008|NCT01877382|529892860|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927009|NCT01877382|529892861|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927010|NCT01877382|529892862|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
146927011|NCT01877382|529892863|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927012|NCT01877382|529892864|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927013|NCT01877382|529892865|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
146680264|NCT01774968|529003151|FG000|Overall Study|Lost to Follow-up|1|||
146680265|NCT01774968|529003152|FG001|Overall Study|Lost to Follow-up|3|||
146680266|NCT01774968|529003151|FG000|Overall Study|Physician Decision|5|||
146680267|NCT01774968|529003152|FG001|Overall Study|Physician Decision|1|||
146680268|NCT01774968|529003151|FG000|Overall Study|Protocol Violation|14|||
146927014|NCT01877382|529892866|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927015|NCT01877382|529892867|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927016|NCT01877382|529892868|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146680269|NCT01774968|529003152|FG001|Overall Study|Protocol Violation|13|||
146680270|NCT01774968|529003151|FG000|Overall Study|Sponsor Decision|0|||
146680271|NCT01774968|529003152|FG001|Overall Study|Sponsor Decision|2|||
146680272|NCT01774968|529003151|FG000|Overall Study|Withdrawal by Subject|6|||
146680273|NCT01774968|529003152|FG001|Overall Study|Withdrawal by Subject|11|||
146680274|NCT04847557|529003153|FG000|Overall Study|Adverse Event|1|||
146680275|NCT04847557|529003154|FG001|Overall Study|Adverse Event|0|||
146680276|NCT04847557|529003153|FG000|Overall Study|Death|19|||
146680277|NCT04847557|529003154|FG001|Overall Study|Death|15|||
146680278|NCT04847557|529003153|FG000|Overall Study|Lost to Follow-up|3|||
146680279|NCT04847557|529003154|FG001|Overall Study|Lost to Follow-up|6|||
146680280|NCT04847557|529003153|FG000|Overall Study|Physician Decision|1|||
146680281|NCT04847557|529003154|FG001|Overall Study|Physician Decision|0|||
146680282|NCT04847557|529003153|FG000|Overall Study|Protocol Violation|0|||
146680283|NCT04847557|529003154|FG001|Overall Study|Protocol Violation|1|||
146680284|NCT04847557|529003153|FG000|Overall Study|Withdrawal by Subject|8|||
146680285|NCT04847557|529003154|FG001|Overall Study|Withdrawal by Subject|14|||
146736244|NCT00279201|529205302|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
146736245|NCT00279201|529205303|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
146736246|NCT00279201|529205304|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
146736247|NCT00279201|529205305|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
146927017|NCT01877382|529892869|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927018|NCT01877382|529892870|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927019|NCT01877382|529892871|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927020|NCT01877382|529892872|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927021|NCT01877382|529892873|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927022|NCT01877382|529892859|FG000|Dose Escalation|Clinical progression|0|||
146927023|NCT01877382|529892860|FG001|Dose Escalation|Clinical progression|1|||
146927024|NCT01877382|529892861|FG002|Dose Escalation|Clinical progression|0|||
146927025|NCT01877382|529892862|FG003|Dose Escalation|Clinical progression|2|||
146927026|NCT01877382|529892863|FG004|Dose Escalation|Clinical progression|0|||
146927027|NCT01877382|529892864|FG005|Dose Escalation|Clinical progression|0|||
146927028|NCT01877382|529892865|FG006|Dose Escalation|Clinical progression|1|||
146927029|NCT01877382|529892866|FG007|Dose Escalation|Clinical progression|0|||
146927030|NCT01877382|529892867|FG008|Dose Escalation|Clinical progression|0|||
146927031|NCT01877382|529892868|FG009|Dose Escalation|Clinical progression|1|||
146736248|NCT00279201|529205306|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
146736249|NCT00279201|529205301|FG000|Intensification Addendum|Lack of Efficacy|0|||
146736250|NCT00279201|529205302|FG001|Intensification Addendum|Lack of Efficacy|0|||
146736251|NCT00279201|529205303|FG002|Intensification Addendum|Lack of Efficacy|0|||
146736252|NCT00279201|529205304|FG003|Intensification Addendum|Lack of Efficacy|1|||
146736253|NCT00279201|529205305|FG004|Intensification Addendum|Lack of Efficacy|1|||
146736254|NCT00279201|529205306|FG005|Intensification Addendum|Lack of Efficacy|0|||
146736255|NCT00279201|529205301|FG000|Intensification Addendum|Death|0|||
146736256|NCT00279201|529205302|FG001|Intensification Addendum|Death|0|||
146736257|NCT00279201|529205303|FG002|Intensification Addendum|Death|0|||
146736258|NCT00279201|529205304|FG003|Intensification Addendum|Death|0|||
146736259|NCT00279201|529205305|FG004|Intensification Addendum|Death|1|||
146736260|NCT00279201|529205306|FG005|Intensification Addendum|Death|0|||
146736261|NCT01061333|529205311|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
146736262|NCT01061333|529205312|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
146736263|NCT01966003|529206797|FG000|Overall Study|Death|43|||
146736264|NCT01966003|529206798|FG001|Overall Study|Death|36|||
146736265|NCT01966003|529206797|FG000|Overall Study|Protocol Violation|6|||
146736266|NCT01966003|529206798|FG001|Overall Study|Protocol Violation|4|||
146736267|NCT01966003|529206797|FG000|Overall Study|Lost to Follow-up|4|||
146736268|NCT01966003|529206798|FG001|Overall Study|Lost to Follow-up|3|||
146736269|NCT01966003|529206797|FG000|Overall Study|Physician Decision|12|||
146736270|NCT01966003|529206798|FG001|Overall Study|Physician Decision|13|||
146736271|NCT01966003|529206797|FG000|Overall Study|Withdrawal by Subject|29|||
146736272|NCT01966003|529206798|FG001|Overall Study|Withdrawal by Subject|19|||
146736273|NCT01966003|529206797|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
146736274|NCT01966003|529206798|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
146736275|NCT01966003|529206797|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
146736276|NCT01966003|529206798|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
146736277|NCT01966003|529206797|FG000|Overall Study|Other|1|||
146736278|NCT01966003|529206798|FG001|Overall Study|Other|1|||
146736279|NCT00674570|529206799|FG000|Overall Study|Withdrawal by Subject|0|||
146736280|NCT00674570|529206800|FG001|Overall Study|Withdrawal by Subject|2|||
146736281|NCT00674570|529206801|FG002|Overall Study|Withdrawal by Subject|0|||
146736282|NCT00633932|529206803|FG000|Overall Study|Adverse Event|1|||
146736283|NCT00633932|529206804|FG001|Overall Study|Adverse Event|3|||
146736284|NCT00633932|529206805|FG002|Overall Study|Adverse Event|4|||
146927032|NCT01877382|529892869|FG010|Dose Escalation|Clinical progression|0|||
146927033|NCT01877382|529892870|FG011|Dose Escalation|Clinical progression|0|||
146978909|NCT01078623|530085505|FG009|Treatment Period 4|Adverse Event|0|||
146736285|NCT00633932|529206803|FG000|Overall Study|Withdrawal by Subject|3|||
146736286|NCT00633932|529206804|FG001|Overall Study|Withdrawal by Subject|9|||
146736287|NCT00633932|529206805|FG002|Overall Study|Withdrawal by Subject|1|||
146736288|NCT00633932|529206803|FG000|Overall Study|Lost to Follow-up|1|||
146736289|NCT00633932|529206804|FG001|Overall Study|Lost to Follow-up|0|||
146736290|NCT00633932|529206805|FG002|Overall Study|Lost to Follow-up|2|||
146736291|NCT00633932|529206803|FG000|Overall Study|Protocol Violation|5|||
146736292|NCT00633932|529206804|FG001|Overall Study|Protocol Violation|2|||
146736293|NCT00633932|529206805|FG002|Overall Study|Protocol Violation|3|||
146736294|NCT00633932|529206803|FG000|Overall Study|Physician Decision|0|||
146736295|NCT00633932|529206804|FG001|Overall Study|Physician Decision|0|||
146927034|NCT01877382|529892871|FG012|Dose Escalation|Clinical progression|2|||
146927035|NCT01877382|529892872|FG013|Dose Escalation|Clinical progression|1|||
146927036|NCT01877382|529892873|FG014|Dose Escalation|Clinical progression|0|||
146680286|NCT01955733|529005557|FG000|Period 1|Lost to Follow-up|1|||
146680287|NCT01955733|529005558|FG001|Period 1|Lost to Follow-up|0|||
146680288|NCT01955733|529005559|FG002|Period 1|Lost to Follow-up|0|||
146680289|NCT01955733|529005557|FG000|Period 2|Adverse Event|1|||
146680290|NCT01955733|529005558|FG001|Period 2|Adverse Event|0|||
146680291|NCT01955733|529005559|FG002|Period 2|Adverse Event|0|||
146680292|NCT01955733|529005557|FG000|Period 2|Physician Decision|0|||
146680293|NCT01955733|529005558|FG001|Period 2|Physician Decision|0|||
146927037|NCT01877382|529892859|FG000|Dose Escalation|Adverse Event|0|||
146927038|NCT01877382|529892860|FG001|Dose Escalation|Adverse Event|0|||
146927039|NCT01877382|529892861|FG002|Dose Escalation|Adverse Event|0|||
146927040|NCT01877382|529892862|FG003|Dose Escalation|Adverse Event|4|||
146927041|NCT01877382|529892863|FG004|Dose Escalation|Adverse Event|1|||
146927042|NCT01877382|529892864|FG005|Dose Escalation|Adverse Event|2|||
146927043|NCT01877382|529892865|FG006|Dose Escalation|Adverse Event|1|||
146927044|NCT01877382|529892866|FG007|Dose Escalation|Adverse Event|2|||
146927045|NCT01877382|529892867|FG008|Dose Escalation|Adverse Event|0|||
146927046|NCT01877382|529892868|FG009|Dose Escalation|Adverse Event|0|||
146927047|NCT01877382|529892869|FG010|Dose Escalation|Adverse Event|0|||
146680294|NCT01955733|529005559|FG002|Period 2|Physician Decision|1|||
146680295|NCT01955733|529005557|FG000|Period 2|Withdrawal by Subject|1|||
146680296|NCT01955733|529005558|FG001|Period 2|Withdrawal by Subject|3|||
146680297|NCT01955733|529005559|FG002|Period 2|Withdrawal by Subject|2|||
146680298|NCT01955733|529005557|FG000|Period 2|Study terminated by sponsor|8|||
146680299|NCT01955733|529005558|FG001|Period 2|Study terminated by sponsor|14|||
146680300|NCT01955733|529005559|FG002|Period 2|Study terminated by sponsor|16|||
146680301|NCT01955733|529005557|FG000|Period 2|Lost to Follow-up|2|||
146927048|NCT01877382|529892870|FG011|Dose Escalation|Adverse Event|0|||
146927049|NCT01877382|529892871|FG012|Dose Escalation|Adverse Event|1|||
146927050|NCT01877382|529892872|FG013|Dose Escalation|Adverse Event|0|||
146927051|NCT01877382|529892873|FG014|Dose Escalation|Adverse Event|0|||
146927052|NCT01877382|529892859|FG000|Dose Escalation|Withdrawal by Subject|0|||
146927053|NCT01877382|529892860|FG001|Dose Escalation|Withdrawal by Subject|0|||
146927054|NCT01877382|529892861|FG002|Dose Escalation|Withdrawal by Subject|0|||
146927055|NCT01877382|529892862|FG003|Dose Escalation|Withdrawal by Subject|0|||
146927056|NCT01877382|529892863|FG004|Dose Escalation|Withdrawal by Subject|0|||
146927057|NCT01877382|529892864|FG005|Dose Escalation|Withdrawal by Subject|3|||
146927058|NCT01877382|529892865|FG006|Dose Escalation|Withdrawal by Subject|2|||
146927059|NCT01877382|529892866|FG007|Dose Escalation|Withdrawal by Subject|1|||
146927060|NCT01877382|529892867|FG008|Dose Escalation|Withdrawal by Subject|1|||
146927061|NCT01877382|529892868|FG009|Dose Escalation|Withdrawal by Subject|0|||
146927062|NCT01877382|529892869|FG010|Dose Escalation|Withdrawal by Subject|0|||
146927063|NCT01877382|529892870|FG011|Dose Escalation|Withdrawal by Subject|0|||
146927064|NCT01877382|529892871|FG012|Dose Escalation|Withdrawal by Subject|0|||
146927065|NCT01877382|529892872|FG013|Dose Escalation|Withdrawal by Subject|0|||
146927066|NCT01877382|529892873|FG014|Dose Escalation|Withdrawal by Subject|0|||
146927067|NCT01877382|529892859|FG000|Dose Escalation|Protocol Violation|0|||
146927068|NCT01877382|529892860|FG001|Dose Escalation|Protocol Violation|0|||
146927069|NCT01877382|529892861|FG002|Dose Escalation|Protocol Violation|0|||
146927070|NCT01877382|529892862|FG003|Dose Escalation|Protocol Violation|0|||
146927071|NCT01877382|529892863|FG004|Dose Escalation|Protocol Violation|0|||
146927072|NCT01877382|529892864|FG005|Dose Escalation|Protocol Violation|0|||
146927073|NCT01877382|529892865|FG006|Dose Escalation|Protocol Violation|1|||
146680302|NCT01955733|529005558|FG001|Period 2|Lost to Follow-up|0|||
146680303|NCT01955733|529005559|FG002|Period 2|Lost to Follow-up|0|||
146680304|NCT01955733|529005557|FG000|Period 2|Other not defined above|0|||
146927074|NCT01877382|529892866|FG007|Dose Escalation|Protocol Violation|0|||
146927075|NCT01877382|529892867|FG008|Dose Escalation|Protocol Violation|0|||
146927076|NCT01877382|529892868|FG009|Dose Escalation|Protocol Violation|0|||
146927077|NCT01877382|529892869|FG010|Dose Escalation|Protocol Violation|0|||
146927078|NCT01877382|529892870|FG011|Dose Escalation|Protocol Violation|0|||
146927079|NCT01877382|529892871|FG012|Dose Escalation|Protocol Violation|0|||
146927080|NCT01877382|529892872|FG013|Dose Escalation|Protocol Violation|0|||
146927081|NCT01877382|529892873|FG014|Dose Escalation|Protocol Violation|0|||
146927082|NCT01877382|529892859|FG000|Dose Escalation|Study terminated by sponsor|0|||
146680305|NCT01955733|529005558|FG001|Period 2|Other not defined above|2|||
146680306|NCT01955733|529005559|FG002|Period 2|Other not defined above|2|||
146927083|NCT01877382|529892860|FG001|Dose Escalation|Study terminated by sponsor|0|||
146927084|NCT01877382|529892861|FG002|Dose Escalation|Study terminated by sponsor|0|||
146927085|NCT01877382|529892862|FG003|Dose Escalation|Study terminated by sponsor|0|||
146927086|NCT01877382|529892863|FG004|Dose Escalation|Study terminated by sponsor|0|||
146927087|NCT01877382|529892864|FG005|Dose Escalation|Study terminated by sponsor|0|||
146680307|NCT00793598|529005560|FG000|Overall Study|Patient Request|0|||
146680308|NCT00793598|529005561|FG001|Overall Study|Patient Request|1|||
146680309|NCT00793598|529005562|FG002|Overall Study|Patient Request|0|||
146680310|NCT00793598|529005563|FG003|Overall Study|Patient Request|0|||
146680311|NCT00793598|529005564|FG004|Overall Study|Patient Request|0|||
146680312|NCT00793598|529005565|FG005|Overall Study|Patient Request|0|||
146680313|NCT00793598|529005566|FG006|Overall Study|Patient Request|0|||
146680314|NCT00793598|529005567|FG007|Overall Study|Patient Request|0|||
146680315|NCT00793598|529005560|FG000|Overall Study|Protocol Violation|0|||
146680316|NCT00793598|529005561|FG001|Overall Study|Protocol Violation|0|||
146680317|NCT00793598|529005562|FG002|Overall Study|Protocol Violation|0|||
146680318|NCT00793598|529005563|FG003|Overall Study|Protocol Violation|0|||
146680319|NCT00793598|529005564|FG004|Overall Study|Protocol Violation|0|||
146680320|NCT00793598|529005565|FG005|Overall Study|Protocol Violation|0|||
146680321|NCT00793598|529005566|FG006|Overall Study|Protocol Violation|0|||
146680322|NCT00793598|529005567|FG007|Overall Study|Protocol Violation|1|||
146680323|NCT00793598|529005560|FG000|Overall Study|Subject not dosed|0|||
146680324|NCT00793598|529005561|FG001|Overall Study|Subject not dosed|0|||
146680325|NCT00793598|529005562|FG002|Overall Study|Subject not dosed|0|||
146680326|NCT00793598|529005563|FG003|Overall Study|Subject not dosed|0|||
146680327|NCT00793598|529005564|FG004|Overall Study|Subject not dosed|0|||
146680328|NCT00793598|529005565|FG005|Overall Study|Subject not dosed|1|||
146680329|NCT00793598|529005566|FG006|Overall Study|Subject not dosed|0|||
146680330|NCT00793598|529005567|FG007|Overall Study|Subject not dosed|0|||
146680331|NCT02762266|529005568|FG000|Overall Study|Physician Decision|2|||
146680332|NCT02762266|529005569|FG001|Overall Study|Physician Decision|0|||
146680333|NCT02961751|529005582|FG000|Overall Study|Lost to Follow-up|11|||
146680334|NCT02961751|529005582|FG000|Overall Study|Physician Decision|2|||
146680335|NCT02961751|529005582|FG000|Overall Study|Not Eligible at Enrollment|1|||
146680336|NCT02961751|529005582|FG000|Overall Study|Protocol Violation|1|||
146680337|NCT00842712|529005583|FG000|Safety Run-in Part|Adverse Event|0|||
146680338|NCT00842712|529005584|FG001|Safety Run-in Part|Adverse Event|1|||
146680339|NCT00842712|529005585|FG002|Safety Run-in Part|Adverse Event|0|||
146680340|NCT00842712|529005586|FG003|Safety Run-in Part|Adverse Event|0|||
146680341|NCT00842712|529005587|FG004|Safety Run-in Part|Adverse Event|0|||
146680342|NCT00842712|529005588|FG005|Safety Run-in Part|Adverse Event|0|||
146680343|NCT00842712|529005589|FG006|Safety Run-in Part|Adverse Event|0|||
146680344|NCT00842712|529005583|FG000|Safety Run-in Part|Progressive disease|3|||
146680345|NCT00842712|529005584|FG001|Safety Run-in Part|Progressive disease|1|||
146680346|NCT00842712|529005585|FG002|Safety Run-in Part|Progressive disease|0|||
146680347|NCT00842712|529005586|FG003|Safety Run-in Part|Progressive disease|1|||
146680348|NCT00842712|529005587|FG004|Safety Run-in Part|Progressive disease|0|||
146680349|NCT00842712|529005588|FG005|Safety Run-in Part|Progressive disease|0|||
146680350|NCT00842712|529005589|FG006|Safety Run-in Part|Progressive disease|0|||
146680351|NCT00842712|529005583|FG000|Randomized Part|Randomized but not treated|0|||
146680352|NCT00842712|529005584|FG001|Randomized Part|Randomized but not treated|0|||
146680353|NCT00842712|529005585|FG002|Randomized Part|Randomized but not treated|0|||
146680354|NCT00842712|529005586|FG003|Randomized Part|Randomized but not treated|0|||
146680355|NCT00842712|529005587|FG004|Randomized Part|Randomized but not treated|0|||
146680356|NCT00842712|529005588|FG005|Randomized Part|Randomized but not treated|1|||
146680357|NCT00842712|529005589|FG006|Randomized Part|Randomized but not treated|4|||
146680358|NCT00842712|529005583|FG000|Randomized Part|Ongoing at cut-off date|0|||
146680359|NCT00842712|529005584|FG001|Randomized Part|Ongoing at cut-off date|0|||
146680360|NCT00842712|529005585|FG002|Randomized Part|Ongoing at cut-off date|0|||
146680361|NCT00842712|529005586|FG003|Randomized Part|Ongoing at cut-off date|0|||
146680362|NCT00842712|529005587|FG004|Randomized Part|Ongoing at cut-off date|0|||
146680363|NCT00842712|529005588|FG005|Randomized Part|Ongoing at cut-off date|0|||
146680364|NCT00842712|529005589|FG006|Randomized Part|Ongoing at cut-off date|2|||
146680365|NCT00410046|529005591|FG000|Overall Study|Adverse Event|3|||
146680366|NCT00410046|529005591|FG000|Overall Study|Withdrawal by Subject|1|||
146680367|NCT00410046|529005591|FG000|Overall Study|Lost to Follow-up|1|||
146680368|NCT03909295|529005599|FG000|Overall Study|Adverse Event|2|||
146680369|NCT03909295|529005599|FG000|Overall Study|Study terminated by sponsor|50|||
146680370|NCT03312933|529005606|FG000|Overall Study|Protocol Violation|15|||
146680371|NCT03312933|529005606|FG000|Overall Study|Lost to Follow-up|36|||
146680372|NCT03312933|529005606|FG000|Overall Study|Withdrawal by Subject|3|||
146680373|NCT02310568|529005607|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
146680374|NCT02310568|529005608|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
146680375|NCT02310568|529005609|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
146680376|NCT02310568|529005610|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
146680377|NCT02310568|529005611|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
146680378|NCT02310568|529005607|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
146680379|NCT02310568|529005608|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
146680380|NCT02310568|529005609|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
146680381|NCT02310568|529005610|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
146680382|NCT02310568|529005611|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
146680383|NCT02310568|529005607|FG000|Stage 1 ( 4 Weeks)|Other|1|||
146680384|NCT02310568|529005608|FG001|Stage 1 ( 4 Weeks)|Other|1|||
146680385|NCT02310568|529005609|FG002|Stage 1 ( 4 Weeks)|Other|0|||
146680386|NCT02310568|529005610|FG003|Stage 1 ( 4 Weeks)|Other|0|||
146680387|NCT02310568|529005611|FG004|Stage 1 ( 4 Weeks)|Other|0|||
146680388|NCT02310568|529005607|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
146680389|NCT02310568|529005608|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
146680390|NCT02310568|529005609|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
146680391|NCT02310568|529005610|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
146680392|NCT02310568|529005611|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
146680393|NCT02310568|529005607|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
146680394|NCT02310568|529005608|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
146680395|NCT02310568|529005609|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
146680396|NCT02310568|529005610|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
146680397|NCT02310568|529005611|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
146680398|NCT02310568|529005607|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
146680399|NCT02310568|529005608|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
146680400|NCT02310568|529005609|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
146680401|NCT02310568|529005610|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
146680402|NCT02310568|529005611|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
146680403|NCT02310568|529005607|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
146680404|NCT02310568|529005608|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
146680405|NCT02310568|529005609|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
146680406|NCT02310568|529005610|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
146680407|NCT02310568|529005611|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
146680408|NCT02310568|529005607|FG000|Stage 2 (4 Weeks)|Other|0|||
146680409|NCT02310568|529005608|FG001|Stage 2 (4 Weeks)|Other|1|||
146680410|NCT02310568|529005609|FG002|Stage 2 (4 Weeks)|Other|1|||
146680411|NCT02310568|529005610|FG003|Stage 2 (4 Weeks)|Other|0|||
146680412|NCT02310568|529005611|FG004|Stage 2 (4 Weeks)|Other|0|||
146680413|NCT02310568|529005607|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
146680414|NCT02310568|529005608|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
146680415|NCT02310568|529005609|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
146680416|NCT02310568|529005610|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
146680417|NCT02310568|529005611|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
146680418|NCT02310568|529005607|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
146680419|NCT02310568|529005608|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
146680420|NCT02310568|529005609|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
146680421|NCT02310568|529005610|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
146680422|NCT02310568|529005611|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
146680423|NCT02310568|529005607|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
146680424|NCT02310568|529005608|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
146680425|NCT02310568|529005609|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
146680426|NCT02310568|529005610|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
146680427|NCT02310568|529005611|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
146680428|NCT01549860|529005618|FG000|Overall Study|Withdrawal by Subject|1|||
146680429|NCT01549860|529005619|FG001|Overall Study|Withdrawal by Subject|0|||
146680430|NCT01549860|529005618|FG000|Overall Study|Physician Decision|1|||
146680431|NCT01549860|529005619|FG001|Overall Study|Physician Decision|1|||
146680432|NCT01366521|529005620|FG000|Overall Study|Adverse Event|1|||
146680433|NCT01366521|529005621|FG001|Overall Study|Adverse Event|0|||
146680434|NCT01366521|529005622|FG002|Overall Study|Adverse Event|0|||
146680435|NCT01366521|529005623|FG003|Overall Study|Adverse Event|0|||
146680436|NCT01366521|529005620|FG000|Overall Study|Protocol Violation|0|||
146680437|NCT01366521|529005621|FG001|Overall Study|Protocol Violation|0|||
146680438|NCT01366521|529005622|FG002|Overall Study|Protocol Violation|1|||
146680439|NCT01366521|529005623|FG003|Overall Study|Protocol Violation|0|||
146680440|NCT01366521|529005620|FG000|Overall Study|Physician Decision|0|||
146680441|NCT01366521|529005621|FG001|Overall Study|Physician Decision|0|||
146680442|NCT01366521|529005622|FG002|Overall Study|Physician Decision|1|||
146680443|NCT01366521|529005623|FG003|Overall Study|Physician Decision|0|||
146680444|NCT01366521|529005620|FG000|Overall Study|Withdrawal by Subject|0|||
146680445|NCT01366521|529005621|FG001|Overall Study|Withdrawal by Subject|1|||
146680446|NCT01366521|529005622|FG002|Overall Study|Withdrawal by Subject|0|||
146680447|NCT01366521|529005623|FG003|Overall Study|Withdrawal by Subject|0|||
146680448|NCT00660023|529005624|FG000|Overall Study|Adverse Event|2|||
146680449|NCT00660023|529005624|FG000|Overall Study|Death|8|||
146680450|NCT00660023|529005624|FG000|Overall Study|Blood Transfusion|5|||
146680451|NCT00660023|529005624|FG000|Overall Study|Renal Transplantation|3|||
146680452|NCT00660023|529005624|FG000|Overall Study|Withdrawal by Subject|1|||
146680453|NCT00660023|529005624|FG000|Overall Study|Missed Pregnancy Test|1|||
146680454|NCT00660023|529005624|FG000|Overall Study|Other Screening Failure|9|||
146680455|NCT04180488|529005625|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
146680456|NCT04180488|529005626|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
146680457|NCT04180488|529005627|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
146680458|NCT04180488|529005628|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
146680459|NCT04180488|529005629|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
146680460|NCT04180488|529005630|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
146680461|NCT04180488|529005625|FG000|Overall Study|Withdrawal by Subject|8|||
146680462|NCT04180488|529005626|FG001|Overall Study|Withdrawal by Subject|4|||
146680463|NCT04180488|529005627|FG002|Overall Study|Withdrawal by Subject|5|||
146680464|NCT04180488|529005628|FG003|Overall Study|Withdrawal by Subject|2|||
146680465|NCT04180488|529005629|FG004|Overall Study|Withdrawal by Subject|8|||
146680466|NCT04180488|529005630|FG005|Overall Study|Withdrawal by Subject|6|||
146680467|NCT04180488|529005625|FG000|Overall Study|Adverse Event|3|||
146680468|NCT04180488|529005626|FG001|Overall Study|Adverse Event|2|||
146680469|NCT04180488|529005627|FG002|Overall Study|Adverse Event|0|||
146680470|NCT04180488|529005628|FG003|Overall Study|Adverse Event|0|||
146680471|NCT04180488|529005629|FG004|Overall Study|Adverse Event|0|||
146680472|NCT04180488|529005630|FG005|Overall Study|Adverse Event|0|||
146680473|NCT04180488|529005625|FG000|Overall Study|Poor compliance to protocol|0|||
146680474|NCT04180488|529005626|FG001|Overall Study|Poor compliance to protocol|0|||
146680475|NCT04180488|529005627|FG002|Overall Study|Poor compliance to protocol|1|||
146680476|NCT04180488|529005628|FG003|Overall Study|Poor compliance to protocol|0|||
146680477|NCT04180488|529005629|FG004|Overall Study|Poor compliance to protocol|0|||
146680478|NCT04180488|529005630|FG005|Overall Study|Poor compliance to protocol|0|||
146680479|NCT02899988|529005635|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
146680480|NCT02899988|529005636|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
146680481|NCT02899988|529005637|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146680482|NCT02899988|529005638|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146680483|NCT02899988|529005639|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146680484|NCT02899988|529005640|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146680485|NCT02899988|529005641|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146680486|NCT02899988|529005642|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146680487|NCT02899988|529005643|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146680488|NCT02899988|529005644|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146680489|NCT02899988|529005645|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146680490|NCT02899988|529005635|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
146680491|NCT02899988|529005636|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
146680492|NCT02899988|529005637|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
146680493|NCT02899988|529005638|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
146680494|NCT02899988|529005639|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
146680495|NCT02899988|529005640|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
146680496|NCT02899988|529005641|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
146680497|NCT02899988|529005642|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
146680498|NCT02899988|529005643|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
146680499|NCT02899988|529005644|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
146680500|NCT02899988|529005645|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
146680501|NCT02899988|529005635|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
146680502|NCT02899988|529005636|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
146680503|NCT02899988|529005637|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
146680504|NCT02899988|529005638|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
146680505|NCT02899988|529005639|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
146680506|NCT02899988|529005640|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
146680507|NCT02899988|529005641|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
146680508|NCT02899988|529005642|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
146680509|NCT02899988|529005643|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
146680510|NCT02899988|529005644|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
146680511|NCT02899988|529005645|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
146680512|NCT02899988|529005635|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
146680513|NCT02899988|529005636|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
146680514|NCT02899988|529005637|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
146680515|NCT02899988|529005638|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
146680516|NCT02899988|529005639|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
146680517|NCT02899988|529005640|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
146680518|NCT02899988|529005641|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
146680519|NCT02899988|529005642|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
146680520|NCT02899988|529005643|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
146680521|NCT02899988|529005644|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
146927088|NCT01877382|529892865|FG006|Dose Escalation|Study terminated by sponsor|0|||
146680522|NCT02899988|529005645|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
146680523|NCT02899988|529005635|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146680524|NCT02899988|529005636|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146680525|NCT02899988|529005637|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146680526|NCT02899988|529005638|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146680527|NCT02899988|529005639|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146680528|NCT02899988|529005640|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
146680529|NCT02899988|529005641|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146680530|NCT02899988|529005642|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
146680531|NCT02899988|529005643|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146680532|NCT02899988|529005644|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146680533|NCT02899988|529005645|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146680534|NCT02899988|529005635|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
146680535|NCT02899988|529005636|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
146680536|NCT02899988|529005637|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
146680537|NCT02899988|529005638|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
146680538|NCT02899988|529005639|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
146680539|NCT02899988|529005640|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
146680540|NCT02899988|529005641|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
146680541|NCT02899988|529005642|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
146680542|NCT02899988|529005643|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
146680543|NCT02899988|529005644|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
146680544|NCT02899988|529005645|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
146680545|NCT01327885|529005649|FG000|Overall Study|Disease progression-according to RECIST|173|||
146680546|NCT01327885|529005650|FG001|Overall Study|Disease progression-according to RECIST|165|||
146680547|NCT01327885|529005649|FG000|Overall Study|Clinical progression|24|||
146680548|NCT01327885|529005650|FG001|Overall Study|Clinical progression|27|||
146680549|NCT01327885|529005649|FG000|Overall Study|Adverse Event|14|||
146680550|NCT01327885|529005650|FG001|Overall Study|Adverse Event|10|||
146680551|NCT01327885|529005649|FG000|Overall Study|Subject choice|5|||
146680552|NCT01327885|529005650|FG001|Overall Study|Subject choice|10|||
146680553|NCT01327885|529005649|FG000|Overall Study|Other|8|||
146680554|NCT01327885|529005650|FG001|Overall Study|Other|6|||
146680555|NCT01327885|529005649|FG000|Overall Study|Withdrawal of consent from study|3|||
146680556|NCT01327885|529005650|FG001|Overall Study|Withdrawal of consent from study|4|||
146680557|NCT01327885|529005649|FG000|Overall Study|Not treated|1|||
146680558|NCT01327885|529005650|FG001|Overall Study|Not treated|1|||
146680559|NCT01327885|529005649|FG000|Overall Study|Administrative decision|0|||
146680560|NCT01327885|529005650|FG001|Overall Study|Administrative decision|1|||
146680561|NCT03824912|529005654|FG000|Overall Study|Lost to Follow-up|18|||
146680562|NCT03824912|529005655|FG001|Overall Study|Lost to Follow-up|15|||
146680563|NCT03824912|529005656|FG002|Overall Study|Lost to Follow-up|8|||
146680564|NCT03824912|529005654|FG000|Overall Study|Negative Baseline Culture Result|118|||
146680565|NCT03824912|529005655|FG001|Overall Study|Negative Baseline Culture Result|112|||
146680566|NCT03824912|529005656|FG002|Overall Study|Negative Baseline Culture Result|57|||
146680567|NCT03824912|529005654|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146680568|NCT03824912|529005655|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146680569|NCT03824912|529005656|FG002|Overall Study|Non-Compliance with Study Drug|1|||
146680570|NCT03824912|529005654|FG000|Overall Study|Protocol Violation|1|||
146680571|NCT03824912|529005655|FG001|Overall Study|Protocol Violation|4|||
146680572|NCT03824912|529005656|FG002|Overall Study|Protocol Violation|1|||
146680573|NCT03824912|529005654|FG000|Overall Study|Withdrawal by Subject|3|||
146680574|NCT03824912|529005655|FG001|Overall Study|Withdrawal by Subject|2|||
146680575|NCT03824912|529005656|FG002|Overall Study|Withdrawal by Subject|1|||
146680576|NCT03824912|529005654|FG000|Overall Study|Participation in another study|0|||
146680577|NCT03824912|529005655|FG001|Overall Study|Participation in another study|1|||
146680578|NCT03824912|529005656|FG002|Overall Study|Participation in another study|0|||
146680579|NCT01749514|529005661|FG000|Overall Study|Lost to Follow-up|0|||
146680580|NCT01749514|529005662|FG001|Overall Study|Lost to Follow-up|0|||
146680581|NCT01749514|529005663|FG002|Overall Study|Lost to Follow-up|0|||
146680582|NCT01749514|529005664|FG003|Overall Study|Lost to Follow-up|0|||
146680583|NCT01749514|529005665|FG004|Overall Study|Lost to Follow-up|0|||
146680584|NCT01749514|529005666|FG005|Overall Study|Lost to Follow-up|0|||
146680585|NCT01749514|529005667|FG006|Overall Study|Lost to Follow-up|0|||
146680586|NCT01749514|529005668|FG007|Overall Study|Lost to Follow-up|1|||
146680587|NCT01749514|529005661|FG000|Overall Study|Withdrawal by Subject|0|||
146680588|NCT01749514|529005662|FG001|Overall Study|Withdrawal by Subject|0|||
146680589|NCT01749514|529005663|FG002|Overall Study|Withdrawal by Subject|0|||
146680590|NCT01749514|529005664|FG003|Overall Study|Withdrawal by Subject|0|||
146680591|NCT01749514|529005665|FG004|Overall Study|Withdrawal by Subject|0|||
146680592|NCT01749514|529005666|FG005|Overall Study|Withdrawal by Subject|1|||
146680593|NCT01749514|529005667|FG006|Overall Study|Withdrawal by Subject|0|||
146680594|NCT01749514|529005668|FG007|Overall Study|Withdrawal by Subject|1|||
146680595|NCT01749514|529005661|FG000|Overall Study|Not Reported|0|||
146680596|NCT01749514|529005662|FG001|Overall Study|Not Reported|0|||
146680597|NCT01749514|529005663|FG002|Overall Study|Not Reported|0|||
146680598|NCT01749514|529005664|FG003|Overall Study|Not Reported|0|||
146680599|NCT01749514|529005665|FG004|Overall Study|Not Reported|0|||
146680600|NCT01749514|529005666|FG005|Overall Study|Not Reported|0|||
146680601|NCT01749514|529005667|FG006|Overall Study|Not Reported|0|||
146680602|NCT01749514|529005668|FG007|Overall Study|Not Reported|5|||
146680603|NCT03042533|529005669|FG000|Overall Study|MD left program|1|||
146680604|NCT03042533|529005670|FG001|Overall Study|MD left program|4|||
146680605|NCT03042533|529005671|FG002|Overall Study|MD left program|1|||
146680606|NCT01906008|529005678|FG000|Overall Study|Lost to Follow-up|2|||
146680607|NCT01906008|529005679|FG001|Overall Study|Lost to Follow-up|0|||
146680608|NCT01906008|529005678|FG000|Overall Study|Oxaliplatin toxicity|2|||
146680609|NCT01906008|529005679|FG001|Overall Study|Oxaliplatin toxicity|0|||
146680610|NCT01906008|529005678|FG000|Overall Study|Protocol Violation|0|||
146680611|NCT01906008|529005679|FG001|Overall Study|Protocol Violation|1|||
146680612|NCT01906008|529005678|FG000|Overall Study|Withdrawal by Subject|1|||
146680613|NCT01906008|529005679|FG001|Overall Study|Withdrawal by Subject|5|||
146680614|NCT01906008|529005678|FG000|Overall Study|Did not start study med|3|||
146680615|NCT01906008|529005679|FG001|Overall Study|Did not start study med|4|||
146680616|NCT01906008|529005678|FG000|Overall Study|Oxaliplatin stops|10|||
146680617|NCT01906008|529005679|FG001|Overall Study|Oxaliplatin stops|8|||
146680618|NCT01906008|529005678|FG000|Overall Study|Hospice|1|||
146680619|NCT01906008|529005679|FG001|Overall Study|Hospice|0|||
146680620|NCT01906008|529005678|FG000|Overall Study|Physician Decision|3|||
146680621|NCT01906008|529005679|FG001|Overall Study|Physician Decision|3|||
146680622|NCT01906008|529005678|FG000|Overall Study|Lack of compliance of study med|5|||
146680623|NCT01906008|529005679|FG001|Overall Study|Lack of compliance of study med|3|||
146680624|NCT01906008|529005678|FG000|Overall Study|Adverse Event|0|||
146680625|NCT01906008|529005679|FG001|Overall Study|Adverse Event|3|||
146680626|NCT02117648|529005680|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
146680627|NCT02117648|529005680|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
146680628|NCT02117648|529005680|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
146680629|NCT02117648|529005680|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
146680630|NCT02117648|529005680|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
146680631|NCT02117648|529005680|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
146680632|NCT02117648|529005680|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
146680633|NCT02117648|529005680|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
146680634|NCT02117648|529005680|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
146680635|NCT02117648|529005680|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
146680636|NCT02117648|529005680|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
146680637|NCT00171730|529005682|FG000|Overall Study|Adverse Event|3|||
146680638|NCT00171730|529005682|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
146680639|NCT00171730|529005682|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
146680640|NCT00171730|529005682|FG000|Overall Study|Withdrawal by Subject|3|||
146680641|NCT05025241|529005683|FG000|Screening|Failed Screening|5|||
146680642|NCT05025241|529005683|FG000|Treatment and Follow Up|Adverse Event|3|||
146680643|NCT02220205|529005684|FG000|Overall Study|Withdrawal by Subject|1|||
146680644|NCT02220205|529005685|FG001|Overall Study|Withdrawal by Subject|0|||
146680645|NCT04294472|529005686|FG000|Overall Study|Adverse Event|0|||
146680646|NCT04294472|529005687|FG001|Overall Study|Adverse Event|1|||
146680647|NCT04294472|529005688|FG002|Overall Study|Adverse Event|1|||
146680648|NCT04294472|529005686|FG000|Overall Study|Randomized but not treated|0|||
146680649|NCT04294472|529005687|FG001|Overall Study|Randomized but not treated|1|||
146680650|NCT04294472|529005688|FG002|Overall Study|Randomized but not treated|1|||
146680651|NCT03944954|529005689|FG000|Overall Study|Withdrawal by Subject|22|||
146680652|NCT03944954|529005690|FG001|Overall Study|Withdrawal by Subject|4|||
146680653|NCT03944954|529005689|FG000|Overall Study|Lost to Follow-up|18|||
146680654|NCT03944954|529005690|FG001|Overall Study|Lost to Follow-up|0|||
146680655|NCT03944954|529005689|FG000|Overall Study|Failed Medical Screening|7|||
146680656|NCT03944954|529005690|FG001|Overall Study|Failed Medical Screening|0|||
146680657|NCT02268084|529005693|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
146680658|NCT02268084|529005694|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
146680659|NCT02268084|529005693|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
146680660|NCT02268084|529005694|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
146680661|NCT05227027|529005695|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
146680662|NCT05227027|529005696|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
146680663|NCT02603419|529005697|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
146680664|NCT02603419|529005698|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
146680665|NCT02603419|529005699|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
146680666|NCT02603419|529005700|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
146680667|NCT02603419|529005701|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
146680668|NCT02603419|529005702|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
146680669|NCT02603419|529005697|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
146680670|NCT02603419|529005698|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
146680671|NCT02603419|529005699|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
146927089|NCT01877382|529892866|FG007|Dose Escalation|Study terminated by sponsor|1|||
146680672|NCT02603419|529005700|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
146927090|NCT01877382|529892867|FG008|Dose Escalation|Study terminated by sponsor|1|||
146927091|NCT01877382|529892868|FG009|Dose Escalation|Study terminated by sponsor|0|||
146680673|NCT02603419|529005701|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
146927092|NCT01877382|529892869|FG010|Dose Escalation|Study terminated by sponsor|0|||
146680674|NCT02603419|529005702|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
146680675|NCT02603419|529005697|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
146680676|NCT02603419|529005698|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
146680677|NCT02603419|529005699|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
146680678|NCT02603419|529005700|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
146680679|NCT02603419|529005701|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
146680680|NCT02603419|529005702|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
146680681|NCT02603419|529005697|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
146680682|NCT02603419|529005698|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
146680683|NCT02603419|529005699|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
146680684|NCT02603419|529005700|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
146680685|NCT02603419|529005701|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
146680686|NCT02603419|529005702|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
146680687|NCT02603419|529005697|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
146680688|NCT02603419|529005698|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
146680689|NCT02603419|529005699|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
146680690|NCT02603419|529005700|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
146680691|NCT02603419|529005701|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
146680692|NCT02603419|529005702|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
146680693|NCT02603419|529005697|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
146680694|NCT02603419|529005698|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
146680695|NCT02603419|529005699|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
146680696|NCT02603419|529005700|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
146680697|NCT02603419|529005701|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
146680698|NCT02603419|529005702|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
146680699|NCT02603419|529005697|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
146680700|NCT02603419|529005698|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
146680701|NCT02603419|529005699|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
146680702|NCT02603419|529005700|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
146680703|NCT02603419|529005701|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
146680704|NCT02603419|529005702|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
146680705|NCT02603419|529005697|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
146680706|NCT02603419|529005698|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
146680707|NCT02603419|529005699|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
146680708|NCT02603419|529005700|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
146680709|NCT02603419|529005701|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
146680710|NCT02603419|529005702|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
146680711|NCT02603419|529005697|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
146680712|NCT02603419|529005698|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
146680713|NCT02603419|529005699|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
146680714|NCT02603419|529005700|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
146680715|NCT02603419|529005701|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
146680716|NCT02603419|529005702|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
146680717|NCT02603419|529005697|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
146680718|NCT02603419|529005698|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
146680719|NCT02603419|529005699|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
146680720|NCT02603419|529005700|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
146680721|NCT02603419|529005701|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
146680722|NCT02603419|529005702|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
146680723|NCT03552198|529005703|FG000|Overall Study|Lost to Follow-up|42|||
146680724|NCT03552198|529005704|FG001|Overall Study|Lost to Follow-up|48|||
146680725|NCT03552198|529005705|FG002|Overall Study|Lost to Follow-up|15|||
146680726|NCT03552198|529005706|FG003|Overall Study|Lost to Follow-up|19|||
146680727|NCT03552198|529005703|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
146680728|NCT03552198|529005704|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
146680729|NCT03552198|529005705|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
146680730|NCT03552198|529005706|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
146680731|NCT03552198|529005703|FG000|Overall Study|Did not receive air alerts|1|||
146680732|NCT03552198|529005704|FG001|Overall Study|Did not receive air alerts|0|||
146680733|NCT03552198|529005705|FG002|Overall Study|Did not receive air alerts|0|||
146680734|NCT03552198|529005706|FG003|Overall Study|Did not receive air alerts|1|||
146680735|NCT06149247|529005711|FG000|Overall Study|Adverse Event|0|||
146680736|NCT06149247|529005712|FG001|Overall Study|Adverse Event|1|||
146680737|NCT00855920|529005713|FG000|Overall Study|Protocol Violation|0|||
146680738|NCT00855920|529005714|FG001|Overall Study|Protocol Violation|0|||
146680739|NCT00855920|529005715|FG002|Overall Study|Protocol Violation|2|||
146680740|NCT00855920|529005713|FG000|Overall Study|Adverse Event|2|||
146680741|NCT00855920|529005714|FG001|Overall Study|Adverse Event|1|||
146680742|NCT00855920|529005715|FG002|Overall Study|Adverse Event|1|||
146680743|NCT00855920|529005713|FG000|Overall Study|Lack of Efficacy|2|||
146680744|NCT00855920|529005714|FG001|Overall Study|Lack of Efficacy|2|||
146680745|NCT00855920|529005715|FG002|Overall Study|Lack of Efficacy|2|||
146680746|NCT00855920|529005713|FG000|Overall Study|Withdrawal by Subject|2|||
146680747|NCT00855920|529005714|FG001|Overall Study|Withdrawal by Subject|3|||
146680748|NCT00855920|529005715|FG002|Overall Study|Withdrawal by Subject|2|||
146680749|NCT00855920|529005713|FG000|Overall Study|Lost to Follow-up|1|||
146680750|NCT00855920|529005714|FG001|Overall Study|Lost to Follow-up|0|||
146680751|NCT00855920|529005715|FG002|Overall Study|Lost to Follow-up|2|||
146680752|NCT00855920|529005713|FG000|Overall Study|Death|0|||
146680753|NCT00855920|529005714|FG001|Overall Study|Death|1|||
146680754|NCT00855920|529005715|FG002|Overall Study|Death|0|||
146680755|NCT00855920|529005713|FG000|Overall Study|Decision by the sponsor|0|||
146680756|NCT00855920|529005714|FG001|Overall Study|Decision by the sponsor|1|||
146680757|NCT00855920|529005715|FG002|Overall Study|Decision by the sponsor|1|||
146680758|NCT00855920|529005713|FG000|Overall Study|Other than specified above|1|||
146680759|NCT00855920|529005714|FG001|Overall Study|Other than specified above|1|||
146680760|NCT00855920|529005715|FG002|Overall Study|Other than specified above|1|||
146680761|NCT02289417|529005716|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
146680762|NCT02289417|529005717|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
146680763|NCT02289417|529005718|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
146680764|NCT02289417|529005719|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
146680765|NCT02289417|529005720|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
146680766|NCT02289417|529005721|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
146680767|NCT02289417|529005722|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
146680768|NCT02289417|529005723|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
146680769|NCT02289417|529005724|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
146680770|NCT02289417|529005716|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
146680771|NCT02289417|529005717|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
146680772|NCT02289417|529005718|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
146680773|NCT02289417|529005719|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
146680774|NCT02289417|529005720|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
146680775|NCT02289417|529005721|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
146680776|NCT02289417|529005722|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
146680777|NCT02289417|529005723|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
146680778|NCT02289417|529005724|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
146680779|NCT02289417|529005716|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
146680780|NCT02289417|529005717|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
146680781|NCT02289417|529005718|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
146680782|NCT02289417|529005719|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
146680783|NCT02289417|529005720|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
146680784|NCT02289417|529005721|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
146680785|NCT02289417|529005722|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
146680786|NCT02289417|529005723|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
146680787|NCT02289417|529005724|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
146680788|NCT02289417|529005716|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
146680789|NCT02289417|529005717|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
146680790|NCT02289417|529005718|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
146680791|NCT02289417|529005719|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
146680792|NCT02289417|529005720|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
146680793|NCT02289417|529005721|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
146680794|NCT02289417|529005722|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
146680795|NCT02289417|529005723|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
146680796|NCT02289417|529005724|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
146680797|NCT02289417|529005716|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
146680798|NCT02289417|529005717|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
146680799|NCT02289417|529005718|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
146680800|NCT02289417|529005719|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
146680801|NCT02289417|529005720|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
146680802|NCT02289417|529005721|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
146680803|NCT02289417|529005722|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
146680804|NCT02289417|529005723|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
146680805|NCT02289417|529005724|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
146680806|NCT02289417|529005716|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
146680807|NCT02289417|529005717|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
146680808|NCT02289417|529005718|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
146680809|NCT02289417|529005719|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
146680810|NCT02289417|529005720|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
146680811|NCT02289417|529005721|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
146927093|NCT01877382|529892870|FG011|Dose Escalation|Study terminated by sponsor|0|||
146680812|NCT02289417|529005722|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
146680813|NCT02289417|529005723|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
146680814|NCT02289417|529005724|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
146680815|NCT02289417|529005716|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
146680816|NCT02289417|529005717|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
146680817|NCT02289417|529005718|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
146680818|NCT02289417|529005719|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
146680819|NCT02289417|529005720|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
146680820|NCT02289417|529005721|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
146680821|NCT02289417|529005722|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
146680822|NCT02289417|529005723|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
146680823|NCT02289417|529005724|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
146680824|NCT02289417|529005716|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
146680825|NCT02289417|529005717|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
146680826|NCT02289417|529005718|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
146680827|NCT02289417|529005719|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
146680828|NCT02289417|529005720|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
146680829|NCT02289417|529005721|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
146680830|NCT02289417|529005722|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
146680831|NCT02289417|529005723|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
146680832|NCT02289417|529005724|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
146680833|NCT02289417|529005716|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
146680834|NCT02289417|529005717|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
146680835|NCT02289417|529005718|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
146680836|NCT02289417|529005719|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
146680837|NCT02289417|529005720|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
146680838|NCT02289417|529005721|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
146680839|NCT02289417|529005722|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
146680840|NCT02289417|529005723|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
146680841|NCT02289417|529005724|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
146680842|NCT02289417|529005716|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
146680843|NCT02289417|529005717|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
146680844|NCT02289417|529005718|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
146680845|NCT02289417|529005719|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
146680846|NCT02289417|529005720|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
146680847|NCT02289417|529005721|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
146680848|NCT02289417|529005722|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
146680849|NCT02289417|529005723|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
146680850|NCT02289417|529005724|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
146680851|NCT02289417|529005716|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
146680852|NCT02289417|529005717|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
146680853|NCT02289417|529005718|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
146680854|NCT02289417|529005719|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
146680855|NCT02289417|529005720|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
146927094|NCT01877382|529892871|FG012|Dose Escalation|Study terminated by sponsor|3|||
146927095|NCT01877382|529892872|FG013|Dose Escalation|Study terminated by sponsor|0|||
146927096|NCT01877382|529892873|FG014|Dose Escalation|Study terminated by sponsor|0|||
146927097|NCT01877382|529892859|FG000|Dose Escalation|Death|0|||
146927098|NCT01877382|529892860|FG001|Dose Escalation|Death|0|||
146927099|NCT01877382|529892861|FG002|Dose Escalation|Death|0|||
146680856|NCT02289417|529005721|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
146680857|NCT02289417|529005722|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
146927100|NCT01877382|529892862|FG003|Dose Escalation|Death|0|||
146927101|NCT01877382|529892863|FG004|Dose Escalation|Death|0|||
146927102|NCT01877382|529892864|FG005|Dose Escalation|Death|0|||
146927103|NCT01877382|529892865|FG006|Dose Escalation|Death|0|||
146680858|NCT02289417|529005723|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
146680859|NCT02289417|529005724|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
146680860|NCT02289417|529005716|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
146680861|NCT02289417|529005717|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
146680862|NCT02289417|529005718|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
146680863|NCT02289417|529005719|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
146680864|NCT02289417|529005720|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
146680865|NCT02289417|529005721|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
146680866|NCT02289417|529005722|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
146927104|NCT01877382|529892866|FG007|Dose Escalation|Death|1|||
146680867|NCT02289417|529005723|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
146927105|NCT01877382|529892867|FG008|Dose Escalation|Death|0|||
146927106|NCT01877382|529892868|FG009|Dose Escalation|Death|0|||
146927107|NCT01877382|529892869|FG010|Dose Escalation|Death|0|||
146927108|NCT01877382|529892870|FG011|Dose Escalation|Death|0|||
146680868|NCT02289417|529005724|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
146680869|NCT02289417|529005716|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
146680870|NCT02289417|529005717|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
146680871|NCT02289417|529005718|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
146680872|NCT02289417|529005719|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
146680873|NCT02289417|529005720|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
146680874|NCT02289417|529005721|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
146680875|NCT02289417|529005722|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
146680876|NCT02289417|529005723|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
146680877|NCT02289417|529005724|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
146680878|NCT02289417|529005716|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
146680879|NCT02289417|529005717|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
146680880|NCT02289417|529005718|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
146680881|NCT02289417|529005719|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
146680882|NCT02289417|529005720|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
146680883|NCT02289417|529005721|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
146680884|NCT02289417|529005722|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
146680885|NCT02289417|529005723|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
146680886|NCT02289417|529005724|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
146680887|NCT01782222|529005727|FG000|Overall Study|Adverse Event|4|||
146680888|NCT01782222|529005728|FG001|Overall Study|Adverse Event|5|||
146680889|NCT01782222|529005729|FG002|Overall Study|Adverse Event|3|||
146680890|NCT01782222|529005727|FG000|Overall Study|Lack of Efficacy|2|||
146680891|NCT01782222|529005728|FG001|Overall Study|Lack of Efficacy|1|||
146680892|NCT01782222|529005729|FG002|Overall Study|Lack of Efficacy|0|||
146680893|NCT01782222|529005727|FG000|Overall Study|Protocol Violation|1|||
146680894|NCT01782222|529005728|FG001|Overall Study|Protocol Violation|0|||
146680895|NCT01782222|529005729|FG002|Overall Study|Protocol Violation|0|||
146680896|NCT01782222|529005727|FG000|Overall Study|Withdrawal by Subject|1|||
146680897|NCT01782222|529005728|FG001|Overall Study|Withdrawal by Subject|4|||
146680898|NCT01782222|529005729|FG002|Overall Study|Withdrawal by Subject|1|||
146680899|NCT01782222|529005727|FG000|Overall Study|Moved to other state|0|||
146680900|NCT01782222|529005728|FG001|Overall Study|Moved to other state|1|||
146680901|NCT01782222|529005729|FG002|Overall Study|Moved to other state|0|||
146680902|NCT01756898|529005733|FG000|Overall Study|Adverse Event|7|||
146680903|NCT01756898|529005734|FG001|Overall Study|Adverse Event|1|||
146680904|NCT01756898|529005735|FG002|Overall Study|Adverse Event|0|||
146680905|NCT01756898|529005736|FG003|Overall Study|Adverse Event|0|||
146680906|NCT01756898|529005733|FG000|Overall Study|Lack of Efficacy|4|||
146680907|NCT01756898|529005734|FG001|Overall Study|Lack of Efficacy|7|||
146680908|NCT01756898|529005735|FG002|Overall Study|Lack of Efficacy|6|||
146680909|NCT01756898|529005736|FG003|Overall Study|Lack of Efficacy|6|||
146680910|NCT01756898|529005733|FG000|Overall Study|Lost to Follow-up|2|||
146680911|NCT01756898|529005734|FG001|Overall Study|Lost to Follow-up|4|||
146680912|NCT01756898|529005735|FG002|Overall Study|Lost to Follow-up|2|||
146680913|NCT01756898|529005736|FG003|Overall Study|Lost to Follow-up|3|||
146680914|NCT01756898|529005733|FG000|Overall Study|Protocol Violation|1|||
146680915|NCT01756898|529005734|FG001|Overall Study|Protocol Violation|2|||
146680916|NCT01756898|529005735|FG002|Overall Study|Protocol Violation|2|||
146680917|NCT01756898|529005736|FG003|Overall Study|Protocol Violation|1|||
146680918|NCT01756898|529005733|FG000|Overall Study|Withdrew Consent|5|||
146680919|NCT01756898|529005734|FG001|Overall Study|Withdrew Consent|3|||
146680920|NCT01756898|529005735|FG002|Overall Study|Withdrew Consent|5|||
146680921|NCT01756898|529005736|FG003|Overall Study|Withdrew Consent|6|||
146680922|NCT01756898|529005733|FG000|Overall Study|Other|0|||
146680923|NCT01756898|529005734|FG001|Overall Study|Other|2|||
146680924|NCT01756898|529005735|FG002|Overall Study|Other|2|||
146680925|NCT01756898|529005736|FG003|Overall Study|Other|0|||
146680926|NCT01500694|529005737|FG000|Overall Study|Adverse Event|4|||
146680927|NCT01500694|529005738|FG001|Overall Study|Adverse Event|3|||
146680928|NCT01500694|529005737|FG000|Overall Study|Protocol Violation|0|||
146680929|NCT01500694|529005738|FG001|Overall Study|Protocol Violation|1|||
146680930|NCT01500694|529005737|FG000|Overall Study|Withdrawal by Subject|23|||
146927109|NCT01877382|529892871|FG012|Dose Escalation|Death|1|||
146680931|NCT01500694|529005738|FG001|Overall Study|Withdrawal by Subject|14|||
146680932|NCT01500694|529005737|FG000|Overall Study|Lost to Follow-up|2|||
146680933|NCT01500694|529005738|FG001|Overall Study|Lost to Follow-up|3|||
146680934|NCT01500694|529005737|FG000|Overall Study|Lack of Efficacy|14|||
146680935|NCT01500694|529005738|FG001|Overall Study|Lack of Efficacy|5|||
146680936|NCT01500694|529005737|FG000|Overall Study|Other|9|||
146680937|NCT01500694|529005738|FG001|Overall Study|Other|3|||
146680938|NCT02007109|529005739|FG000|Overall Study|Diary not returned or excluded|102|||
146680939|NCT02007109|529005739|FG000|Overall Study|Excluded - Age<7yo|9|||
146680940|NCT01858389|529005741|FG000|Overall Study|Death|1|||
146680941|NCT01858389|529005742|FG001|Overall Study|Death|3|||
146680942|NCT01858389|529005741|FG000|Overall Study|Study terminated by sponsor|0|||
146680943|NCT01858389|529005742|FG001|Overall Study|Study terminated by sponsor|2|||
146680944|NCT01858389|529005741|FG000|Overall Study|Withdrawal by Subject|0|||
146680945|NCT01858389|529005742|FG001|Overall Study|Withdrawal by Subject|1|||
146680946|NCT01858389|529005741|FG000|Overall Study|Progressive disease|10|||
146680947|NCT01858389|529005742|FG001|Overall Study|Progressive disease|11|||
146680948|NCT01858389|529005741|FG000|Overall Study|Other|2|||
146680949|NCT01858389|529005742|FG001|Overall Study|Other|4|||
146680950|NCT01858389|529005741|FG000|Overall Study|Adverse Event|3|||
146680951|NCT01858389|529005742|FG001|Overall Study|Adverse Event|1|||
146680952|NCT01858389|529005741|FG000|Overall Study|Did not receive treatment|0|||
146680953|NCT01858389|529005742|FG001|Overall Study|Did not receive treatment|3|||
146680954|NCT03572062|529005743|FG000|Overall Study|Adverse Event|0|||
146680955|NCT03572062|529005744|FG001|Overall Study|Adverse Event|0|||
146680956|NCT03572062|529005745|FG002|Overall Study|Adverse Event|0|||
146680957|NCT03572062|529005746|FG003|Overall Study|Adverse Event|0|||
146680958|NCT03572062|529005747|FG004|Overall Study|Adverse Event|0|||
146680959|NCT03572062|529005748|FG005|Overall Study|Adverse Event|0|||
146680960|NCT03572062|529005749|FG006|Overall Study|Adverse Event|0|||
146680961|NCT03572062|529005750|FG007|Overall Study|Adverse Event|0|||
146680962|NCT03572062|529005751|FG008|Overall Study|Adverse Event|1|||
146680963|NCT03572062|529005752|FG009|Overall Study|Adverse Event|3|||
146680964|NCT03572062|529005743|FG000|Overall Study|Death|0|||
146680965|NCT03572062|529005744|FG001|Overall Study|Death|0|||
146680966|NCT03572062|529005745|FG002|Overall Study|Death|0|||
146680967|NCT03572062|529005746|FG003|Overall Study|Death|0|||
146680968|NCT03572062|529005747|FG004|Overall Study|Death|0|||
146680969|NCT03572062|529005748|FG005|Overall Study|Death|1|||
146680970|NCT03572062|529005749|FG006|Overall Study|Death|0|||
146680971|NCT03572062|529005750|FG007|Overall Study|Death|0|||
146680972|NCT03572062|529005751|FG008|Overall Study|Death|0|||
146680973|NCT03572062|529005752|FG009|Overall Study|Death|0|||
146680974|NCT03572062|529005743|FG000|Overall Study|Lost to Follow-up|0|||
146680975|NCT03572062|529005744|FG001|Overall Study|Lost to Follow-up|0|||
146680976|NCT03572062|529005745|FG002|Overall Study|Lost to Follow-up|0|||
146680977|NCT03572062|529005746|FG003|Overall Study|Lost to Follow-up|0|||
146680978|NCT03572062|529005747|FG004|Overall Study|Lost to Follow-up|0|||
146680979|NCT03572062|529005748|FG005|Overall Study|Lost to Follow-up|1|||
146680980|NCT03572062|529005749|FG006|Overall Study|Lost to Follow-up|1|||
146680981|NCT03572062|529005750|FG007|Overall Study|Lost to Follow-up|0|||
146680982|NCT03572062|529005751|FG008|Overall Study|Lost to Follow-up|0|||
146680983|NCT03572062|529005752|FG009|Overall Study|Lost to Follow-up|0|||
146680984|NCT03572062|529005743|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
146680985|NCT03572062|529005744|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146680986|NCT03572062|529005745|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
146680987|NCT03572062|529005746|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
146680988|NCT03572062|529005747|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
146680989|NCT03572062|529005748|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
146680990|NCT03572062|529005749|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
146680991|NCT03572062|529005750|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
146680992|NCT03572062|529005751|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
146680993|NCT03572062|529005752|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
146680994|NCT03572062|529005743|FG000|Overall Study|Study Terminated By Sponsor|0|||
146680995|NCT03572062|529005744|FG001|Overall Study|Study Terminated By Sponsor|0|||
146680996|NCT03572062|529005745|FG002|Overall Study|Study Terminated By Sponsor|0|||
146680997|NCT03572062|529005746|FG003|Overall Study|Study Terminated By Sponsor|0|||
146680998|NCT03572062|529005747|FG004|Overall Study|Study Terminated By Sponsor|0|||
146680999|NCT03572062|529005748|FG005|Overall Study|Study Terminated By Sponsor|0|||
146681000|NCT03572062|529005749|FG006|Overall Study|Study Terminated By Sponsor|0|||
146681001|NCT03572062|529005750|FG007|Overall Study|Study Terminated By Sponsor|0|||
146681002|NCT03572062|529005751|FG008|Overall Study|Study Terminated By Sponsor|29|||
146681003|NCT03572062|529005752|FG009|Overall Study|Study Terminated By Sponsor|27|||
146681004|NCT03572062|529005743|FG000|Overall Study|Physician Decision|0|||
146681005|NCT03572062|529005744|FG001|Overall Study|Physician Decision|0|||
146681006|NCT03572062|529005745|FG002|Overall Study|Physician Decision|0|||
146681007|NCT03572062|529005746|FG003|Overall Study|Physician Decision|0|||
146681008|NCT03572062|529005747|FG004|Overall Study|Physician Decision|0|||
146774784|NCT00440011|529345430|FG000|Overall Study|Lost to Follow-up|0|||
146681009|NCT03572062|529005748|FG005|Overall Study|Physician Decision|0|||
146681010|NCT03572062|529005749|FG006|Overall Study|Physician Decision|0|||
146681011|NCT03572062|529005750|FG007|Overall Study|Physician Decision|0|||
146681012|NCT03572062|529005751|FG008|Overall Study|Physician Decision|1|||
146681013|NCT03572062|529005752|FG009|Overall Study|Physician Decision|0|||
146681014|NCT03572062|529005743|FG000|Overall Study|Withdrawal by Subject|0|||
146681015|NCT03572062|529005744|FG001|Overall Study|Withdrawal by Subject|0|||
146681016|NCT03572062|529005745|FG002|Overall Study|Withdrawal by Subject|0|||
146681017|NCT03572062|529005746|FG003|Overall Study|Withdrawal by Subject|0|||
146681018|NCT03572062|529005747|FG004|Overall Study|Withdrawal by Subject|0|||
146681019|NCT03572062|529005748|FG005|Overall Study|Withdrawal by Subject|0|||
146681020|NCT03572062|529005749|FG006|Overall Study|Withdrawal by Subject|0|||
146681021|NCT03572062|529005750|FG007|Overall Study|Withdrawal by Subject|0|||
146681022|NCT03572062|529005751|FG008|Overall Study|Withdrawal by Subject|0|||
146681023|NCT03572062|529005752|FG009|Overall Study|Withdrawal by Subject|1|||
146681024|NCT03572062|529005743|FG000|Overall Study|Randomized But Not Treated|0|||
146681025|NCT03572062|529005744|FG001|Overall Study|Randomized But Not Treated|0|||
146681026|NCT03572062|529005745|FG002|Overall Study|Randomized But Not Treated|0|||
146681027|NCT03572062|529005746|FG003|Overall Study|Randomized But Not Treated|0|||
146681028|NCT03572062|529005747|FG004|Overall Study|Randomized But Not Treated|1|||
146681029|NCT03572062|529005748|FG005|Overall Study|Randomized But Not Treated|2|||
146681030|NCT03572062|529005749|FG006|Overall Study|Randomized But Not Treated|0|||
146681031|NCT03572062|529005750|FG007|Overall Study|Randomized But Not Treated|1|||
146681032|NCT03572062|529005751|FG008|Overall Study|Randomized But Not Treated|0|||
146681033|NCT03572062|529005752|FG009|Overall Study|Randomized But Not Treated|0|||
146681034|NCT01691781|529005753|FG000|Overall Study|Withdrawal by Subject|4|||
146681035|NCT01691781|529005754|FG001|Overall Study|Withdrawal by Subject|3|||
146681036|NCT01691781|529005753|FG000|Overall Study|Physician Decision|1|||
146681037|NCT01691781|529005754|FG001|Overall Study|Physician Decision|1|||
146681038|NCT01691781|529005753|FG000|Overall Study|Protocol Violation|2|||
146681039|NCT01691781|529005754|FG001|Overall Study|Protocol Violation|2|||
146681040|NCT01691781|529005753|FG000|Overall Study|Adverse Event|0|||
146681041|NCT01691781|529005754|FG001|Overall Study|Adverse Event|1|||
146681042|NCT03978520|529005755|FG000|Overall Study|Adverse Event|2|||
146681043|NCT03978520|529005756|FG001|Overall Study|Adverse Event|5|||
146681044|NCT03978520|529005757|FG002|Overall Study|Adverse Event|3|||
146681045|NCT03978520|529005758|FG003|Overall Study|Adverse Event|5|||
146681046|NCT03978520|529005759|FG004|Overall Study|Adverse Event|6|||
146681047|NCT03978520|529005755|FG000|Overall Study|Withdrawal by Subject|10|||
146681048|NCT03978520|529005756|FG001|Overall Study|Withdrawal by Subject|4|||
146681049|NCT03978520|529005757|FG002|Overall Study|Withdrawal by Subject|5|||
146681050|NCT03978520|529005758|FG003|Overall Study|Withdrawal by Subject|6|||
146681051|NCT03978520|529005759|FG004|Overall Study|Withdrawal by Subject|5|||
146681052|NCT03978520|529005755|FG000|Overall Study|Lost to Follow-up|2|||
146681053|NCT03978520|529005756|FG001|Overall Study|Lost to Follow-up|2|||
146681054|NCT03978520|529005757|FG002|Overall Study|Lost to Follow-up|2|||
146681055|NCT03978520|529005758|FG003|Overall Study|Lost to Follow-up|0|||
146681056|NCT03978520|529005759|FG004|Overall Study|Lost to Follow-up|1|||
146681057|NCT03978520|529005755|FG000|Overall Study|COVID-19 infection|0|||
146681058|NCT03978520|529005756|FG001|Overall Study|COVID-19 infection|1|||
146681059|NCT03978520|529005757|FG002|Overall Study|COVID-19 infection|0|||
146681060|NCT03978520|529005758|FG003|Overall Study|COVID-19 infection|0|||
146681061|NCT03978520|529005759|FG004|Overall Study|COVID-19 infection|0|||
146681062|NCT03978520|529005755|FG000|Overall Study|Other, not specified|9|||
146681063|NCT03978520|529005756|FG001|Overall Study|Other, not specified|4|||
146681064|NCT03978520|529005757|FG002|Overall Study|Other, not specified|1|||
146681065|NCT03978520|529005758|FG003|Overall Study|Other, not specified|1|||
146681066|NCT03978520|529005759|FG004|Overall Study|Other, not specified|2|||
146681067|NCT03978520|529005755|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
146681068|NCT03978520|529005756|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
146681069|NCT03978520|529005757|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
146681070|NCT03978520|529005758|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
146681071|NCT03978520|529005759|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
146681072|NCT01605877|529005760|FG000|Overall Study|Withdrawal by Subject|1|||
146681073|NCT01918085|529005763|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
146681074|NCT01918085|529005764|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
146681075|NCT00687323|529005765|FG000|Overall Study|Death|25|||
146681076|NCT00687323|529005765|FG000|Overall Study|Withdrawal by Subject|1|||
146681077|NCT00687323|529005765|FG000|Overall Study|Excluded from efficacy evaluations|6|||
146681078|NCT00687323|529005765|FG000|Overall Study|Screen failure|148|||
146681079|NCT02760069|529005768|FG000|Overall Study|Withdrawal by Subject|0|||
146681080|NCT02760069|529005769|FG001|Overall Study|Withdrawal by Subject|1|||
146681081|NCT02760069|529005770|FG002|Overall Study|Withdrawal by Subject|1|||
146681082|NCT03031678|529005771|FG000|Overall Study|Study closed prior to completion|1|||
146681083|NCT04557371|529005774|FG000|Overall Study|Covid-19-related|0|||
146681084|NCT04557371|529005775|FG001|Overall Study|Covid-19-related|1|||
146681085|NCT04557371|529005776|FG002|Overall Study|Covid-19-related|0|||
146681086|NCT04557371|529005774|FG000|Overall Study|Withdrawal by Subject|0|||
146681087|NCT04557371|529005775|FG001|Overall Study|Withdrawal by Subject|1|||
146681088|NCT04557371|529005776|FG002|Overall Study|Withdrawal by Subject|0|||
146774785|NCT00440011|529345431|FG001|Overall Study|Lost to Follow-up|2|||
146774786|NCT00440011|529345430|FG000|Overall Study|Protocol Violation|1|||
146774787|NCT00440011|529345431|FG001|Overall Study|Protocol Violation|1|||
146681089|NCT04557371|529005774|FG000|Overall Study|Adverse Event|1|||
146681090|NCT04557371|529005775|FG001|Overall Study|Adverse Event|0|||
146681091|NCT04557371|529005776|FG002|Overall Study|Adverse Event|0|||
146681092|NCT03694821|529005777|FG000|Overall Study|Study terminated|4|||
146681093|NCT03694821|529005778|FG001|Overall Study|Study terminated|8|||
146681094|NCT03694821|529005779|FG002|Overall Study|Study terminated|4|||
146681095|NCT04102020|529005780|FG000|Overall Study|Adverse Event|1|||
146681096|NCT04102020|529005781|FG001|Overall Study|Adverse Event|0|||
146681097|NCT04102020|529005782|FG002|Overall Study|Adverse Event|0|||
146681098|NCT04102020|529005783|FG003|Overall Study|Adverse Event|1|||
146681099|NCT04102020|529005784|FG004|Overall Study|Adverse Event|0|||
146681100|NCT04102020|529005780|FG000|Overall Study|Withdrawal by Subject|0|||
146681101|NCT04102020|529005781|FG001|Overall Study|Withdrawal by Subject|1|||
146681102|NCT04102020|529005782|FG002|Overall Study|Withdrawal by Subject|1|||
146681103|NCT04102020|529005783|FG003|Overall Study|Withdrawal by Subject|1|||
146681104|NCT04102020|529005784|FG004|Overall Study|Withdrawal by Subject|1|||
146681105|NCT04102020|529005780|FG000|Overall Study|Death|1|||
146681106|NCT04102020|529005781|FG001|Overall Study|Death|4|||
146681107|NCT04102020|529005782|FG002|Overall Study|Death|1|||
146681108|NCT04102020|529005783|FG003|Overall Study|Death|1|||
146681109|NCT04102020|529005784|FG004|Overall Study|Death|0|||
146681110|NCT04102020|529005780|FG000|Overall Study|Physician Decision|1|||
146681111|NCT04102020|529005781|FG001|Overall Study|Physician Decision|2|||
146681112|NCT04102020|529005782|FG002|Overall Study|Physician Decision|2|||
146681113|NCT04102020|529005783|FG003|Overall Study|Physician Decision|0|||
146681114|NCT04102020|529005784|FG004|Overall Study|Physician Decision|1|||
146681115|NCT04102020|529005780|FG000|Overall Study|COVID-19 Infection|1|||
146681116|NCT04102020|529005781|FG001|Overall Study|COVID-19 Infection|0|||
146681117|NCT04102020|529005782|FG002|Overall Study|COVID-19 Infection|0|||
146681118|NCT04102020|529005783|FG003|Overall Study|COVID-19 Infection|0|||
146681119|NCT04102020|529005784|FG004|Overall Study|COVID-19 Infection|0|||
146681120|NCT04102020|529005780|FG000|Overall Study|Not disclosed|5|||
146681121|NCT04102020|529005781|FG001|Overall Study|Not disclosed|3|||
146681122|NCT04102020|529005782|FG002|Overall Study|Not disclosed|8|||
146681123|NCT04102020|529005783|FG003|Overall Study|Not disclosed|0|||
146681124|NCT04102020|529005784|FG004|Overall Study|Not disclosed|1|||
146681125|NCT04102020|529005780|FG000|Overall Study|MIssing|1|||
146681126|NCT04102020|529005781|FG001|Overall Study|MIssing|0|||
146681127|NCT04102020|529005782|FG002|Overall Study|MIssing|1|||
146681128|NCT04102020|529005783|FG003|Overall Study|MIssing|1|||
146681129|NCT04102020|529005784|FG004|Overall Study|MIssing|1|||
146681130|NCT04102020|529005780|FG000|Overall Study|Continuing in ongoing study|13|||
146681131|NCT04102020|529005781|FG001|Overall Study|Continuing in ongoing study|13|||
146681132|NCT04102020|529005782|FG002|Overall Study|Continuing in ongoing study|7|||
146681133|NCT04102020|529005783|FG003|Overall Study|Continuing in ongoing study|26|||
146681134|NCT04102020|529005784|FG004|Overall Study|Continuing in ongoing study|12|||
146681135|NCT05109442|529005785|FG000|Overall Study|Withdrawal by Subject|0|||
146681136|NCT05109442|529005786|FG001|Overall Study|Withdrawal by Subject|0|||
146681137|NCT05109442|529005787|FG002|Overall Study|Withdrawal by Subject|1|||
146681138|NCT05109442|529005788|FG003|Overall Study|Withdrawal by Subject|0|||
146681139|NCT05109442|529005789|FG004|Overall Study|Withdrawal by Subject|0|||
146681140|NCT05109442|529005790|FG005|Overall Study|Withdrawal by Subject|0|||
146681141|NCT05109442|529005785|FG000|Overall Study|Adverse Event|0|||
146681142|NCT05109442|529005786|FG001|Overall Study|Adverse Event|1|||
146681143|NCT05109442|529005787|FG002|Overall Study|Adverse Event|5|||
146681144|NCT05109442|529005788|FG003|Overall Study|Adverse Event|0|||
146681145|NCT05109442|529005789|FG004|Overall Study|Adverse Event|0|||
146681146|NCT05109442|529005790|FG005|Overall Study|Adverse Event|2|||
146681147|NCT05109442|529005785|FG000|Overall Study|Death|0|||
146681148|NCT05109442|529005786|FG001|Overall Study|Death|0|||
146681149|NCT05109442|529005787|FG002|Overall Study|Death|4|||
146681150|NCT05109442|529005788|FG003|Overall Study|Death|0|||
146681151|NCT05109442|529005789|FG004|Overall Study|Death|0|||
146681152|NCT05109442|529005790|FG005|Overall Study|Death|1|||
146681153|NCT05109442|529005785|FG000|Overall Study|Physician Decision|1|||
146681154|NCT05109442|529005786|FG001|Overall Study|Physician Decision|0|||
146681155|NCT05109442|529005787|FG002|Overall Study|Physician Decision|1|||
146681156|NCT05109442|529005788|FG003|Overall Study|Physician Decision|0|||
146681157|NCT05109442|529005789|FG004|Overall Study|Physician Decision|0|||
146681158|NCT05109442|529005790|FG005|Overall Study|Physician Decision|2|||
146681159|NCT05109442|529005785|FG000|Overall Study|Other than listed|0|||
146681160|NCT05109442|529005786|FG001|Overall Study|Other than listed|0|||
146681161|NCT05109442|529005787|FG002|Overall Study|Other than listed|9|||
146681162|NCT05109442|529005788|FG003|Overall Study|Other than listed|2|||
146681163|NCT05109442|529005789|FG004|Overall Study|Other than listed|0|||
146681164|NCT05109442|529005790|FG005|Overall Study|Other than listed|8|||
146681165|NCT05109442|529005785|FG000|Overall Study|Lack of Efficacy|3|||
146681166|NCT05109442|529005786|FG001|Overall Study|Lack of Efficacy|5|||
146681167|NCT05109442|529005787|FG002|Overall Study|Lack of Efficacy|29|||
146681168|NCT05109442|529005788|FG003|Overall Study|Lack of Efficacy|10|||
146681169|NCT05109442|529005789|FG004|Overall Study|Lack of Efficacy|11|||
146681170|NCT05109442|529005790|FG005|Overall Study|Lack of Efficacy|17|||
146774788|NCT00440011|529345430|FG000|Overall Study|Withdrawal by Subject|1|||
146681171|NCT04419714|529005797|FG000|Overall Study|Technical Fault|5|||
146681172|NCT04419714|529005797|FG000|Overall Study|Protocol Deviation|2|||
146681173|NCT04419714|529005797|FG000|Overall Study|Withdrawal by Subject|1|||
146681174|NCT01325584|529005798|FG000|Overall Study|Death|1|||
146681175|NCT00524368|529007172|FG000|Overall Study|Adverse Event|10|||
146681176|NCT00524368|529007173|FG001|Overall Study|Adverse Event|12|||
146681177|NCT00524368|529007172|FG000|Overall Study|Lost to Follow-up|9|||
146681178|NCT00524368|529007173|FG001|Overall Study|Lost to Follow-up|13|||
146681179|NCT00524368|529007172|FG000|Overall Study|Withdrawal by Subject|4|||
146681180|NCT00524368|529007173|FG001|Overall Study|Withdrawal by Subject|5|||
146681181|NCT00524368|529007172|FG000|Overall Study|Non-compliant|8|||
146681182|NCT00524368|529007173|FG001|Overall Study|Non-compliant|9|||
146681183|NCT00524368|529007172|FG000|Overall Study|Reached a Virologic Endpoint|3|||
146681184|NCT00524368|529007173|FG001|Overall Study|Reached a Virologic Endpoint|2|||
146681185|NCT00524368|529007172|FG000|Overall Study|Sponsor's Decision|2|||
146681186|NCT00524368|529007173|FG001|Overall Study|Sponsor's Decision|0|||
146681187|NCT00524368|529007172|FG000|Overall Study|Ineligible to Continue the study|2|||
146681188|NCT00524368|529007173|FG001|Overall Study|Ineligible to Continue the study|5|||
146681189|NCT00524368|529007172|FG000|Overall Study|Other|3|||
146681190|NCT00524368|529007173|FG001|Overall Study|Other|2|||
146681191|NCT02154490|529007174|FG000|Overall Study|No tissue submitted|23|||
146681192|NCT02154490|529007174|FG000|Overall Study|No biomarker results|167|||
146681193|NCT02154490|529007174|FG000|Overall Study|Not assigned to a sub-study|270|||
146681194|NCT02154490|529007174|FG000|Overall Study|Did not register to a sub-study|749|||
146681195|NCT02373202|529007175|FG000|Overall Study|Adverse Event|2|||
146681196|NCT02373202|529007176|FG001|Overall Study|Adverse Event|5|||
146681197|NCT02373202|529007177|FG002|Overall Study|Adverse Event|2|||
146681198|NCT02373202|529007178|FG003|Overall Study|Adverse Event|1|||
146681199|NCT02373202|529007175|FG000|Overall Study|Lack of Efficacy|0|||
146681200|NCT02373202|529007176|FG001|Overall Study|Lack of Efficacy|0|||
146681201|NCT02373202|529007177|FG002|Overall Study|Lack of Efficacy|1|||
146681202|NCT02373202|529007178|FG003|Overall Study|Lack of Efficacy|0|||
146681203|NCT02373202|529007175|FG000|Overall Study|Other|0|||
146681204|NCT02373202|529007176|FG001|Overall Study|Other|1|||
146681205|NCT02373202|529007177|FG002|Overall Study|Other|0|||
146681206|NCT02373202|529007178|FG003|Overall Study|Other|0|||
146681207|NCT00464087|529007183|FG000|Overall Study|No PCI per inclusion criteria|0|||
146681208|NCT00464087|529007184|FG001|Overall Study|No PCI per inclusion criteria|0|||
146681209|NCT00464087|529007185|FG002|Overall Study|No PCI per inclusion criteria|29|||
146681210|NCT00418314|529007187|FG000|Overall Study|Withdrawal by Subject|1|||
146681211|NCT00418314|529007188|FG001|Overall Study|Withdrawal by Subject|2|||
146681212|NCT02289690|529007193|FG000|Overall Study|Adverse Event Related to Progression|0|||
146681213|NCT02289690|529007194|FG001|Overall Study|Adverse Event Related to Progression|1|||
146681214|NCT02289690|529007195|FG002|Overall Study|Adverse Event Related to Progression|1|||
146681215|NCT02289690|529007196|FG003|Overall Study|Adverse Event Related to Progression|0|||
146681216|NCT02289690|529007197|FG004|Overall Study|Adverse Event Related to Progression|1|||
146681217|NCT02289690|529007198|FG005|Overall Study|Adverse Event Related to Progression|0|||
146681218|NCT02289690|529007199|FG006|Overall Study|Adverse Event Related to Progression|1|||
146681219|NCT02289690|529007200|FG007|Overall Study|Adverse Event Related to Progression|0|||
146681220|NCT02289690|529007201|FG008|Overall Study|Adverse Event Related to Progression|0|||
146681221|NCT02289690|529007202|FG009|Overall Study|Adverse Event Related to Progression|0|||
146681222|NCT02289690|529007193|FG000|Overall Study|Withdrawal by Subject|1|||
146681223|NCT02289690|529007194|FG001|Overall Study|Withdrawal by Subject|0|||
146681224|NCT02289690|529007195|FG002|Overall Study|Withdrawal by Subject|0|||
146681225|NCT02289690|529007196|FG003|Overall Study|Withdrawal by Subject|0|||
146681226|NCT02289690|529007197|FG004|Overall Study|Withdrawal by Subject|1|||
146681227|NCT02289690|529007198|FG005|Overall Study|Withdrawal by Subject|1|||
146681228|NCT02289690|529007199|FG006|Overall Study|Withdrawal by Subject|0|||
146681229|NCT02289690|529007200|FG007|Overall Study|Withdrawal by Subject|0|||
146681230|NCT02289690|529007201|FG008|Overall Study|Withdrawal by Subject|4|||
146681231|NCT02289690|529007202|FG009|Overall Study|Withdrawal by Subject|2|||
146681232|NCT02289690|529007193|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
146681233|NCT02289690|529007194|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
146681234|NCT02289690|529007195|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
146681235|NCT02289690|529007196|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
146681236|NCT02289690|529007197|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
146681237|NCT02289690|529007198|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
146681238|NCT02289690|529007199|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
146681239|NCT02289690|529007200|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
146681240|NCT02289690|529007201|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
146681241|NCT02289690|529007202|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
146681242|NCT02289690|529007193|FG000|Overall Study|Lost to Follow-up|0|||
146681243|NCT02289690|529007194|FG001|Overall Study|Lost to Follow-up|0|||
146681244|NCT02289690|529007195|FG002|Overall Study|Lost to Follow-up|0|||
146681245|NCT02289690|529007196|FG003|Overall Study|Lost to Follow-up|0|||
146681246|NCT02289690|529007197|FG004|Overall Study|Lost to Follow-up|0|||
146681247|NCT02289690|529007198|FG005|Overall Study|Lost to Follow-up|0|||
146681248|NCT02289690|529007199|FG006|Overall Study|Lost to Follow-up|0|||
146927110|NCT01877382|529892872|FG013|Dose Escalation|Death|1|||
146927111|NCT01877382|529892873|FG014|Dose Escalation|Death|0|||
146927112|NCT01877382|529892859|FG000|Dose Expansion|Progressive disease|0|||
146927113|NCT01877382|529892860|FG001|Dose Expansion|Progressive disease|0|||
146927114|NCT01877382|529892861|FG002|Dose Expansion|Progressive disease|0|||
146927115|NCT01877382|529892862|FG003|Dose Expansion|Progressive disease|0|||
146927116|NCT01877382|529892863|FG004|Dose Expansion|Progressive disease|0|||
146927117|NCT01877382|529892864|FG005|Dose Expansion|Progressive disease|0|||
146927118|NCT01877382|529892865|FG006|Dose Expansion|Progressive disease|0|||
146681249|NCT02289690|529007200|FG007|Overall Study|Lost to Follow-up|1|||
146681250|NCT02289690|529007201|FG008|Overall Study|Lost to Follow-up|0|||
146681251|NCT02289690|529007202|FG009|Overall Study|Lost to Follow-up|2|||
146681252|NCT02289690|529007193|FG000|Overall Study|Death|0|||
146681253|NCT02289690|529007194|FG001|Overall Study|Death|0|||
146681254|NCT02289690|529007195|FG002|Overall Study|Death|0|||
146681255|NCT02289690|529007196|FG003|Overall Study|Death|0|||
146681256|NCT02289690|529007197|FG004|Overall Study|Death|0|||
146681257|NCT02289690|529007198|FG005|Overall Study|Death|0|||
146681258|NCT02289690|529007199|FG006|Overall Study|Death|0|||
146681259|NCT02289690|529007200|FG007|Overall Study|Death|49|||
146681260|NCT02289690|529007201|FG008|Overall Study|Death|45|||
146681261|NCT02289690|529007202|FG009|Overall Study|Death|41|||
146681262|NCT02289690|529007193|FG000|Overall Study|Sponsor Discontinued Study|0|||
146681263|NCT02289690|529007194|FG001|Overall Study|Sponsor Discontinued Study|0|||
146681264|NCT02289690|529007195|FG002|Overall Study|Sponsor Discontinued Study|0|||
146681265|NCT02289690|529007196|FG003|Overall Study|Sponsor Discontinued Study|0|||
146681266|NCT02289690|529007197|FG004|Overall Study|Sponsor Discontinued Study|0|||
146681267|NCT02289690|529007198|FG005|Overall Study|Sponsor Discontinued Study|0|||
146681268|NCT02289690|529007199|FG006|Overall Study|Sponsor Discontinued Study|0|||
146681269|NCT02289690|529007200|FG007|Overall Study|Sponsor Discontinued Study|9|||
146681270|NCT02289690|529007201|FG008|Overall Study|Sponsor Discontinued Study|7|||
146681271|NCT02289690|529007202|FG009|Overall Study|Sponsor Discontinued Study|15|||
146681272|NCT02289690|529007193|FG000|Overall Study|Other|0|||
146681273|NCT02289690|529007194|FG001|Overall Study|Other|0|||
146681274|NCT02289690|529007195|FG002|Overall Study|Other|0|||
146681275|NCT02289690|529007196|FG003|Overall Study|Other|1|||
146681276|NCT02289690|529007197|FG004|Overall Study|Other|1|||
146681277|NCT02289690|529007198|FG005|Overall Study|Other|0|||
146681278|NCT02289690|529007199|FG006|Overall Study|Other|1|||
146681279|NCT02289690|529007200|FG007|Overall Study|Other|2|||
146681280|NCT02289690|529007201|FG008|Overall Study|Other|3|||
146681281|NCT02289690|529007202|FG009|Overall Study|Other|1|||
146681282|NCT02085785|529007205|FG000|Overall Study|Withdrawal by Subject|2|||
146681283|NCT02085785|529007206|FG001|Overall Study|Withdrawal by Subject|1|||
146681284|NCT02085785|529007205|FG000|Overall Study|Lost to Follow-up|0|||
146681285|NCT02085785|529007206|FG001|Overall Study|Lost to Follow-up|1|||
146681286|NCT00779467|529007207|FG000|Overall Study|Lack of Efficacy|11|||
146681287|NCT00779467|529007208|FG001|Overall Study|Lack of Efficacy|2|||
146681288|NCT00779467|529007209|FG002|Overall Study|Lack of Efficacy|6|||
146681289|NCT00779467|529007210|FG003|Overall Study|Lack of Efficacy|11|||
146681290|NCT00779467|529007207|FG000|Overall Study|failed inclusion criteria|3|||
146681291|NCT00779467|529007208|FG001|Overall Study|failed inclusion criteria|3|||
146681292|NCT00779467|529007209|FG002|Overall Study|failed inclusion criteria|1|||
146681293|NCT00779467|529007210|FG003|Overall Study|failed inclusion criteria|2|||
146681294|NCT00779467|529007207|FG000|Overall Study|missing data|1|||
146681295|NCT00779467|529007208|FG001|Overall Study|missing data|0|||
146681296|NCT00779467|529007209|FG002|Overall Study|missing data|1|||
146681297|NCT00779467|529007210|FG003|Overall Study|missing data|4|||
146681298|NCT00779467|529007207|FG000|Overall Study|technical issue|0|||
146681299|NCT00779467|529007208|FG001|Overall Study|technical issue|0|||
146681300|NCT00779467|529007209|FG002|Overall Study|technical issue|2|||
146681301|NCT00779467|529007210|FG003|Overall Study|technical issue|1|||
146681302|NCT00779467|529007207|FG000|Overall Study|unavailable research staff|0|||
146774789|NCT00440011|529345431|FG001|Overall Study|Withdrawal by Subject|0|||
146774790|NCT01083316|529345432|FG000|Overall Study|Adverse Event|2|||
146927119|NCT01877382|529892866|FG007|Dose Expansion|Progressive disease|0|||
146927120|NCT01877382|529892867|FG008|Dose Expansion|Progressive disease|0|||
146681303|NCT00779467|529007208|FG001|Overall Study|unavailable research staff|0|||
146681304|NCT00779467|529007209|FG002|Overall Study|unavailable research staff|0|||
146681305|NCT00779467|529007210|FG003|Overall Study|unavailable research staff|1|||
146927121|NCT01877382|529892868|FG009|Dose Expansion|Progressive disease|0|||
146681306|NCT03590041|529007211|FG000|Overall Study|Protocol Violation|4|||
146681307|NCT03590041|529007212|FG001|Overall Study|Protocol Violation|3|||
146681308|NCT03590041|529007211|FG000|Overall Study|No session data recorded|14|||
146681309|NCT03590041|529007212|FG001|Overall Study|No session data recorded|2|||
146681310|NCT02692703|529007213|FG000|Overall Study|Lost to Follow-up|1|||
146681311|NCT02692703|529007213|FG000|Overall Study|Other|1|||
146681312|NCT04626297|529007214|FG000|Overall Study|Adverse Event|5|||
146681313|NCT04626297|529007215|FG001|Overall Study|Adverse Event|3|||
146774791|NCT01083316|529345432|FG000|Overall Study|Withdrawal by Subject|1|||
146681314|NCT04626297|529007214|FG000|Overall Study|Lost to Follow-up|7|||
146681315|NCT04626297|529007215|FG001|Overall Study|Lost to Follow-up|3|||
146681316|NCT04626297|529007214|FG000|Overall Study|Protocol Violation|5|||
146681317|NCT04626297|529007215|FG001|Overall Study|Protocol Violation|1|||
146681318|NCT04626297|529007214|FG000|Overall Study|Withdrawal by Subject|20|||
146681319|NCT04626297|529007215|FG001|Overall Study|Withdrawal by Subject|6|||
146681320|NCT04626297|529007214|FG000|Overall Study|Sponsor decision|2|||
146681321|NCT04626297|529007215|FG001|Overall Study|Sponsor decision|1|||
146681322|NCT04118166|529007216|FG000|Overall Study|Adverse Event|1|||
146681323|NCT00644995|529007219|FG000|Overall Study|Lost to Follow-up|1|||
146681324|NCT00644995|529007220|FG001|Overall Study|Lost to Follow-up|4|||
146681325|NCT00644995|529007219|FG000|Overall Study|Refused|1|||
146681326|NCT00644995|529007220|FG001|Overall Study|Refused|0|||
146681327|NCT03519932|529007221|FG000|First Intervention|Adverse Event|1|||
146681328|NCT03519932|529007222|FG001|First Intervention|Adverse Event|3|||
146681329|NCT02254486|529007223|FG000|Overall Study|Adverse Event|1|||
146681330|NCT02254486|529007224|FG001|Overall Study|Adverse Event|1|||
146681331|NCT02254486|529007223|FG000|Overall Study|Lack of Efficacy|1|||
146681332|NCT02254486|529007224|FG001|Overall Study|Lack of Efficacy|0|||
146681333|NCT02254486|529007223|FG000|Overall Study|Lost to Follow-up|2|||
146681334|NCT02254486|529007224|FG001|Overall Study|Lost to Follow-up|4|||
146681335|NCT02254486|529007223|FG000|Overall Study|Protocol Violation|1|||
146681336|NCT02254486|529007224|FG001|Overall Study|Protocol Violation|2|||
146681337|NCT02254486|529007223|FG000|Overall Study|Withdrawal by Subject|17|||
146681338|NCT02254486|529007224|FG001|Overall Study|Withdrawal by Subject|15|||
146681339|NCT02254486|529007223|FG000|Overall Study|GFR<60mL/min|16|||
146681340|NCT02254486|529007224|FG001|Overall Study|GFR<60mL/min|21|||
146681341|NCT02254486|529007223|FG000|Overall Study|Various|12|||
146681342|NCT02254486|529007224|FG001|Overall Study|Various|12|||
146681343|NCT01350414|529007231|FG000|Overall Study|Lost to Follow-up|13|||
146681344|NCT01350414|529007231|FG000|Overall Study|Withdrawal by Subject|4|||
146681345|NCT01350414|529007231|FG000|Overall Study|Physician Decision|2|||
146681346|NCT00865124|529007232|FG000|Overall Study|Physician Decision|2|||
146681347|NCT00865124|529007233|FG001|Overall Study|Physician Decision|1|||
146681348|NCT00865124|529007234|FG002|Overall Study|Physician Decision|0|||
146681349|NCT00865124|529007232|FG000|Overall Study|Withdrawn consent|2|||
146681350|NCT00865124|529007233|FG001|Overall Study|Withdrawn consent|0|||
146681351|NCT00865124|529007234|FG002|Overall Study|Withdrawn consent|0|||
146681352|NCT02743520|529007235|FG000|Overall Study|Withdrawal by Subject|1|||
146681353|NCT03247530|529007236|FG000|Overall Study|Withdrawal by caregiver|19|||
146681354|NCT03247530|529007237|FG001|Overall Study|Withdrawal by caregiver|8|||
146681355|NCT03247530|529007238|FG002|Overall Study|Withdrawal by caregiver|10|||
146681356|NCT03247530|529007236|FG000|Overall Study|Lost to Follow-up|3|||
146681357|NCT03247530|529007237|FG001|Overall Study|Lost to Follow-up|9|||
146681358|NCT03247530|529007238|FG002|Overall Study|Lost to Follow-up|6|||
146681359|NCT03247530|529007236|FG000|Overall Study|Adverse Event|2|||
146681360|NCT03247530|529007237|FG001|Overall Study|Adverse Event|5|||
146681361|NCT03247530|529007238|FG002|Overall Study|Adverse Event|2|||
146681362|NCT03247530|529007236|FG000|Overall Study|Failure to follow procedure|1|||
146681363|NCT03247530|529007237|FG001|Overall Study|Failure to follow procedure|1|||
146681364|NCT03247530|529007238|FG002|Overall Study|Failure to follow procedure|1|||
146681365|NCT03247530|529007236|FG000|Overall Study|Withdrawal by Subject|1|||
146681366|NCT03247530|529007237|FG001|Overall Study|Withdrawal by Subject|1|||
146681367|NCT03247530|529007238|FG002|Overall Study|Withdrawal by Subject|0|||
146681368|NCT03247530|529007236|FG000|Overall Study|Study medication misuse|0|||
146681369|NCT03247530|529007237|FG001|Overall Study|Study medication misuse|1|||
146681370|NCT03247530|529007238|FG002|Overall Study|Study medication misuse|0|||
146681371|NCT03247530|529007236|FG000|Overall Study|Other, multiple categories|1|||
146681372|NCT03247530|529007237|FG001|Overall Study|Other, multiple categories|3|||
146681373|NCT03247530|529007238|FG002|Overall Study|Other, multiple categories|1|||
146681374|NCT02551731|529007244|FG000|Overall Study|Withdrawal by Subject|2|||
146681375|NCT00010374|529007245|FG000|Overall Study|False positive phrenic nerve test|1|||
146681376|NCT01678911|529007248|FG000|Second Intervention|Lost to Follow-up|2|||
146681377|NCT01678911|529007249|FG001|Second Intervention|Lost to Follow-up|0|||
146681378|NCT04649060|529007250|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
146681379|NCT04649060|529007251|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
146681380|NCT04649060|529007250|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
146681381|NCT04649060|529007251|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
146681382|NCT04649060|529007250|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
146681383|NCT04649060|529007251|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
146681384|NCT04649060|529007250|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
146681385|NCT04649060|529007251|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
146681386|NCT04649060|529007250|FG000|Arm A/Arm B Treatment|Patient Request|1|||
146681387|NCT04649060|529007251|FG001|Arm A/Arm B Treatment|Patient Request|0|||
146681388|NCT04649060|529007250|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
146681389|NCT04649060|529007251|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
146681390|NCT04649060|529007250|FG000|Arm A/Arm B Treatment|Other|1|||
146681391|NCT04649060|529007251|FG001|Arm A/Arm B Treatment|Other|0|||
146927122|NCT01877382|529892869|FG010|Dose Expansion|Progressive disease|0|||
146927123|NCT01877382|529892870|FG011|Dose Expansion|Progressive disease|0|||
146927124|NCT01877382|529892871|FG012|Dose Expansion|Progressive disease|0|||
146927125|NCT01877382|529892872|FG013|Dose Expansion|Progressive disease|0|||
146681392|NCT04649060|529007250|FG000|Crossover (Arm B)|Adverse Event|0|||
146681393|NCT04649060|529007251|FG001|Crossover (Arm B)|Adverse Event|1|||
146681394|NCT04649060|529007250|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
146681395|NCT04649060|529007251|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
146681396|NCT02706691|529007252|FG000|Overall Study|Adverse Event|1|||
146681397|NCT01985867|529007253|FG000|Overall Study|Lost to Follow-up|3|||
146681398|NCT01985867|529007254|FG001|Overall Study|Lost to Follow-up|4|||
146681399|NCT01985867|529007253|FG000|Overall Study|Adverse Event|3|||
146681400|NCT01985867|529007254|FG001|Overall Study|Adverse Event|2|||
146681401|NCT01985867|529007253|FG000|Overall Study|Lack of Efficacy|1|||
146681402|NCT01985867|529007254|FG001|Overall Study|Lack of Efficacy|0|||
146681403|NCT02670837|529007255|FG000|Overall Study|Death|2|||
146681404|NCT02670837|529007256|FG001|Overall Study|Death|0|||
146681405|NCT02670837|529007257|FG002|Overall Study|Death|0|||
146681406|NCT02725710|529007258|FG000|Overall Study|Lost to Follow-up|1|||
146681407|NCT02725710|529007259|FG001|Overall Study|Lost to Follow-up|0|||
146681408|NCT04786990|529007260|FG000|Overall Study|Withdrawal by Subject|1|||
146681409|NCT04786990|529007260|FG000|Overall Study|Adverse Event|1|||
146681410|NCT04786990|529007260|FG000|Overall Study|Lost to Follow-up|1|||
146681411|NCT04786990|529007260|FG000|Overall Study|Noncompliance|1|||
146681412|NCT04786990|529007260|FG000|Overall Study|Unable to complete site visits|1|||
146681413|NCT04786990|529007260|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
146681414|NCT02547454|529007272|FG000|Overall Study|Due to hemodialysis|53|||
146681415|NCT02547454|529007272|FG000|Overall Study|Due to transplantation|1|||
146681416|NCT02547454|529007272|FG000|Overall Study|Due to no further need to treat|4|||
146681417|NCT02547454|529007272|FG000|Overall Study|Death|38|||
146681418|NCT02547454|529007272|FG000|Overall Study|Lost to Follow-up|26|||
146681419|NCT02547454|529007272|FG000|Overall Study|Other|39|||
146681420|NCT02547454|529007272|FG000|Overall Study|No data|11|||
146681421|NCT00580606|529007273|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
146681422|NCT00580606|529007274|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
146681423|NCT00580606|529007273|FG000|Open Label (OL)|Withdrawal by Subject|4|||
146681424|NCT00580606|529007274|FG001|Open Label (OL)|Withdrawal by Subject|6|||
146681425|NCT00580606|529007273|FG000|Open Label (OL)|Dosing Symptoms|0|||
146681426|NCT00580606|529007274|FG001|Open Label (OL)|Dosing Symptoms|1|||
146681427|NCT00580606|529007273|FG000|Open Label (OL)|Lost to Follow-up|0|||
146681428|NCT00580606|529007274|FG001|Open Label (OL)|Lost to Follow-up|1|||
146681429|NCT00580606|529007273|FG000|Open Label (OL)|Pregnancy|0|||
146681430|NCT00580606|529007274|FG001|Open Label (OL)|Pregnancy|1|||
146681431|NCT00580606|529007273|FG000|Open Label (OL)|Non-compliance|2|||
146681432|NCT00580606|529007274|FG001|Open Label (OL)|Non-compliance|0|||
146681433|NCT00580606|529007273|FG000|Open Label (OL)|Physician Decision|1|||
146681434|NCT00580606|529007274|FG001|Open Label (OL)|Physician Decision|1|||
146681435|NCT00580606|529007273|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
146681436|NCT00580606|529007274|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
146681437|NCT03655691|529007276|FG000|Overall Study|Adverse Event|0|||
146681438|NCT03655691|529007277|FG001|Overall Study|Adverse Event|0|||
146681439|NCT03655691|529007278|FG002|Overall Study|Adverse Event|1|||
146681440|NCT03655691|529007276|FG000|Overall Study|Lost to Follow-up|1|||
146681441|NCT03655691|529007277|FG001|Overall Study|Lost to Follow-up|1|||
146681442|NCT03655691|529007278|FG002|Overall Study|Lost to Follow-up|2|||
146681443|NCT03655691|529007276|FG000|Overall Study|Protocol Violation|0|||
146681444|NCT03655691|529007277|FG001|Overall Study|Protocol Violation|1|||
146681445|NCT03655691|529007278|FG002|Overall Study|Protocol Violation|0|||
146681446|NCT03655691|529007276|FG000|Overall Study|Withdrawal by Subject|1|||
146681447|NCT03655691|529007277|FG001|Overall Study|Withdrawal by Subject|1|||
146681448|NCT03655691|529007278|FG002|Overall Study|Withdrawal by Subject|0|||
146681449|NCT03918447|529007281|FG000|Overall Study|Death|1|||
146681450|NCT03918447|529007282|FG001|Overall Study|Death|0|||
146681451|NCT03918447|529007281|FG000|Overall Study|Lost to Follow-up|13|||
146681452|NCT03918447|529007282|FG001|Overall Study|Lost to Follow-up|6|||
146681453|NCT03918447|529007281|FG000|Overall Study|Withdrawal by Subject|19|||
146774792|NCT01239316|529345440|FG000|Overall Study|Progression/Relapse|11|||
146774793|NCT01239316|529345440|FG000|Overall Study|Adverse Event|1|||
146774794|NCT05057897|529346781|FG000|Overall Study|Site closure|2|||
146927126|NCT01877382|529892873|FG014|Dose Expansion|Progressive disease|11|||
146927127|NCT01877382|529892859|FG000|Dose Expansion|Clinical progression|0|||
146681454|NCT03918447|529007282|FG001|Overall Study|Withdrawal by Subject|17|||
146681455|NCT03918447|529007281|FG000|Overall Study|Study Terminated by Sponsor|195|||
146681456|NCT03918447|529007282|FG001|Overall Study|Study Terminated by Sponsor|197|||
146681457|NCT03918447|529007281|FG000|Overall Study|Reason not Specified|0|||
146774795|NCT05057897|529346782|FG001|Overall Study|Site closure|2|||
146681458|NCT03918447|529007282|FG001|Overall Study|Reason not Specified|1|||
146681459|NCT03278613|529007283|FG000|Overall Study|Lost to Follow-up|3|||
146681460|NCT03278613|529007284|FG001|Overall Study|Lost to Follow-up|1|||
146681461|NCT01405456|529007285|FG000|Overall Study|Lost to Follow-up|2|||
146681462|NCT01405456|529007286|FG001|Overall Study|Lost to Follow-up|1|||
146681463|NCT01405456|529007285|FG000|Overall Study|Physician Decision|1|||
146681464|NCT01405456|529007286|FG001|Overall Study|Physician Decision|0|||
146681465|NCT05475236|529007288|FG000|Overall Study|Withdrawal by Subject|0|||
146681466|NCT05475236|529007289|FG001|Overall Study|Withdrawal by Subject|1|||
146681467|NCT00477971|529007290|FG000|Overall Study|Disease progression|6|||
146681468|NCT00477971|529007291|FG001|Overall Study|Disease progression|0|||
146681469|NCT00477971|529007290|FG000|Overall Study|Withdrawal by Subject|3|||
146681470|NCT00477971|529007291|FG001|Overall Study|Withdrawal by Subject|1|||
146681471|NCT00477971|529007290|FG000|Overall Study|Adverse Event|3|||
146681472|NCT00477971|529007291|FG001|Overall Study|Adverse Event|0|||
146681473|NCT00477971|529007290|FG000|Overall Study|Death|2|||
146681474|NCT00477971|529007291|FG001|Overall Study|Death|4|||
146681475|NCT00477971|529007290|FG000|Overall Study|Alternative treatment|3|||
146681476|NCT00477971|529007291|FG001|Overall Study|Alternative treatment|1|||
146681477|NCT05355805|529007292|FG000|Overall Study|Lost to Follow-up|6|||
146681478|NCT05355805|529007293|FG001|Overall Study|Lost to Follow-up|11|||
146681479|NCT05355805|529007294|FG002|Overall Study|Lost to Follow-up|10|||
146681480|NCT05355805|529007295|FG003|Overall Study|Lost to Follow-up|6|||
146681481|NCT05355805|529007292|FG000|Overall Study|Decision by Sponsor|0|||
146681482|NCT05355805|529007293|FG001|Overall Study|Decision by Sponsor|0|||
146681483|NCT05355805|529007294|FG002|Overall Study|Decision by Sponsor|1|||
146681484|NCT05355805|529007295|FG003|Overall Study|Decision by Sponsor|0|||
146681485|NCT05355805|529007292|FG000|Overall Study|Withdrawal by Subject|7|||
146681486|NCT05355805|529007293|FG001|Overall Study|Withdrawal by Subject|14|||
146681487|NCT05355805|529007294|FG002|Overall Study|Withdrawal by Subject|15|||
146681488|NCT05355805|529007295|FG003|Overall Study|Withdrawal by Subject|13|||
146681489|NCT05353985|529007296|FG000|Overall Study|Adverse Event|5|||
146681490|NCT05353985|529007297|FG001|Overall Study|Adverse Event|7|||
146681491|NCT05353985|529007296|FG000|Overall Study|Lost to Follow-up|1|||
146681492|NCT05353985|529007297|FG001|Overall Study|Lost to Follow-up|1|||
146681493|NCT05353985|529007296|FG000|Overall Study|Protocol Violation|1|||
146681494|NCT05353985|529007297|FG001|Overall Study|Protocol Violation|0|||
146681495|NCT05353985|529007296|FG000|Overall Study|Withdrawal by Subject|13|||
146681496|NCT05353985|529007297|FG001|Overall Study|Withdrawal by Subject|17|||
146681497|NCT05353985|529007296|FG000|Overall Study|Reason Not Specified|1|||
146681498|NCT05353985|529007297|FG001|Overall Study|Reason Not Specified|0|||
146681499|NCT05353985|529007296|FG000|Overall Study|Randomized in Error & Not Treated|0|||
146681500|NCT05353985|529007297|FG001|Overall Study|Randomized in Error & Not Treated|1|||
146681501|NCT04221009|529008810|FG000|Overall Study|Withdrawal by Subject|4|||
146681502|NCT03010254|529008811|FG000|Overall Study|Adverse Event|0|||
146927128|NCT01877382|529892860|FG001|Dose Expansion|Clinical progression|0|||
146681503|NCT03010254|529008812|FG001|Overall Study|Adverse Event|1|||
146681504|NCT03010254|529008811|FG000|Overall Study|Lost to Follow-up|4|||
146681505|NCT03010254|529008812|FG001|Overall Study|Lost to Follow-up|0|||
146681506|NCT03010254|529008811|FG000|Overall Study|Withdrawal by Subject|1|||
146681507|NCT03010254|529008812|FG001|Overall Study|Withdrawal by Subject|1|||
146681508|NCT03010254|529008811|FG000|Overall Study|Other|2|||
146681509|NCT03010254|529008812|FG001|Overall Study|Other|3|||
146681510|NCT00482612|529008815|FG000|In-treatment Period|No study medication administered|0|||
146681511|NCT00482612|529008816|FG001|In-treatment Period|No study medication administered|0|||
146681512|NCT00482612|529008817|FG002|In-treatment Period|No study medication administered|1|||
146681513|NCT00482612|529008818|FG003|In-treatment Period|No study medication administered|0|||
146681514|NCT00482612|529008815|FG000|Follow-up Period|Other|4|||
146681515|NCT00482612|529008816|FG001|Follow-up Period|Other|2|||
146681516|NCT00482612|529008817|FG002|Follow-up Period|Other|1|||
146681517|NCT00482612|529008818|FG003|Follow-up Period|Other|2|||
146927129|NCT01877382|529892861|FG002|Dose Expansion|Clinical progression|0|||
146681518|NCT00482612|529008815|FG000|Follow-up Period|Lack of compliance|0|||
146681519|NCT00482612|529008816|FG001|Follow-up Period|Lack of compliance|0|||
146681520|NCT00482612|529008817|FG002|Follow-up Period|Lack of compliance|1|||
146681521|NCT00482612|529008818|FG003|Follow-up Period|Lack of compliance|0|||
146681522|NCT00482612|529008815|FG000|Follow-up Period|Lost to Follow-up|0|||
146681523|NCT00482612|529008816|FG001|Follow-up Period|Lost to Follow-up|4|||
146681524|NCT00482612|529008817|FG002|Follow-up Period|Lost to Follow-up|2|||
146681525|NCT00482612|529008818|FG003|Follow-up Period|Lost to Follow-up|1|||
146681526|NCT00482612|529008815|FG000|Follow-up Period|Adverse Event|4|||
146681527|NCT00482612|529008816|FG001|Follow-up Period|Adverse Event|7|||
146681528|NCT00482612|529008817|FG002|Follow-up Period|Adverse Event|9|||
146681529|NCT00482612|529008818|FG003|Follow-up Period|Adverse Event|0|||
146681530|NCT00482612|529008815|FG000|Follow-up Period|Lack of Efficacy|2|||
146681531|NCT00482612|529008816|FG001|Follow-up Period|Lack of Efficacy|0|||
146681532|NCT00482612|529008817|FG002|Follow-up Period|Lack of Efficacy|1|||
146927130|NCT01877382|529892862|FG003|Dose Expansion|Clinical progression|0|||
146681533|NCT00482612|529008818|FG003|Follow-up Period|Lack of Efficacy|0|||
146681534|NCT00482612|529008815|FG000|Follow-up Period|Withdrawal by Subject|3|||
146681535|NCT00482612|529008816|FG001|Follow-up Period|Withdrawal by Subject|5|||
146681536|NCT00482612|529008817|FG002|Follow-up Period|Withdrawal by Subject|7|||
146681537|NCT00482612|529008818|FG003|Follow-up Period|Withdrawal by Subject|2|||
146681538|NCT00482612|529008815|FG000|Follow-up Period|Reasons not related to trial|1|||
146681539|NCT00482612|529008816|FG001|Follow-up Period|Reasons not related to trial|0|||
146681540|NCT00482612|529008817|FG002|Follow-up Period|Reasons not related to trial|1|||
146681541|NCT00482612|529008818|FG003|Follow-up Period|Reasons not related to trial|3|||
146681542|NCT01224431|529008819|FG000|Overall Study|not randomized|0|||
146681543|NCT01224431|529008820|FG001|Overall Study|not randomized|4|||
146681544|NCT01224431|529008819|FG000|Overall Study|no video record|0|||
146681545|NCT01224431|529008820|FG001|Overall Study|no video record|1|||
146681546|NCT02057406|529008821|FG000|Overall Study|Physician Decision|0|||
146681547|NCT02057406|529008822|FG001|Overall Study|Physician Decision|0|||
146681548|NCT02057406|529008823|FG002|Overall Study|Physician Decision|2|||
146681549|NCT02057406|529008821|FG000|Overall Study|Withdrawal by Subject|0|||
146681550|NCT02057406|529008822|FG001|Overall Study|Withdrawal by Subject|2|||
146681551|NCT02057406|529008823|FG002|Overall Study|Withdrawal by Subject|0|||
146681552|NCT02057406|529008821|FG000|Overall Study|Lost to Follow-up|0|||
146681553|NCT02057406|529008822|FG001|Overall Study|Lost to Follow-up|0|||
146681554|NCT02057406|529008823|FG002|Overall Study|Lost to Follow-up|1|||
146681555|NCT02057406|529008821|FG000|Overall Study|Death|1|||
146681556|NCT02057406|529008822|FG001|Overall Study|Death|0|||
146681557|NCT02057406|529008823|FG002|Overall Study|Death|0|||
146681558|NCT02057406|529008821|FG000|Overall Study|Protocol Violation|0|||
146681559|NCT02057406|529008822|FG001|Overall Study|Protocol Violation|1|||
146681560|NCT02057406|529008823|FG002|Overall Study|Protocol Violation|0|||
146681561|NCT02057406|529008821|FG000|Overall Study|Patient transportation issues|0|||
146681562|NCT02057406|529008822|FG001|Overall Study|Patient transportation issues|0|||
146681563|NCT02057406|529008823|FG002|Overall Study|Patient transportation issues|1|||
146681564|NCT03654651|529008825|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
146681565|NCT03654651|529008826|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
146681566|NCT01401283|529008827|FG000|Overall Study|surgery cancelled|5|||
146681567|NCT01401283|529008828|FG001|Overall Study|surgery cancelled|8|||
146681568|NCT01401283|529008827|FG000|Overall Study|preoperative arrhythmia|5|||
146681569|NCT01401283|529008828|FG001|Overall Study|preoperative arrhythmia|0|||
146681570|NCT01401283|529008827|FG000|Overall Study|no central venous access|0|||
146681571|NCT01401283|529008828|FG001|Overall Study|no central venous access|1|||
146681572|NCT01401283|529008827|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
146681573|NCT01401283|529008828|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
146681574|NCT02433483|529008829|FG000|Overall Study|Unacceptable toxicity|1|||
146681575|NCT02433483|529008829|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
146681576|NCT02904512|529008831|FG000|Overall Study|Withdrawal by Subject|1|||
146681577|NCT02904512|529008832|FG001|Overall Study|Withdrawal by Subject|0|||
146681578|NCT02904512|529008831|FG000|Overall Study|Transferred to ICU|1|||
146681579|NCT02904512|529008832|FG001|Overall Study|Transferred to ICU|0|||
146681580|NCT02904512|529008831|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
146681581|NCT02904512|529008832|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
146681582|NCT01963403|529008837|FG000|Overall Study|Lost to Follow-up|2|||
146681583|NCT01963403|529008838|FG001|Overall Study|Lost to Follow-up|3|||
146681584|NCT01963403|529008837|FG000|Overall Study|Implant removal|0|||
146681585|NCT01963403|529008838|FG001|Overall Study|Implant removal|1|||
146681586|NCT00549302|529008843|FG000|Double-Blind|Death|2|||
146681587|NCT00549302|529008844|FG001|Double-Blind|Death|9|||
146681588|NCT00549302|529008845|FG002|Double-Blind|Death|0|||
146681589|NCT00549302|529008843|FG000|Double-Blind|Adverse Event|3|||
146681590|NCT00549302|529008844|FG001|Double-Blind|Adverse Event|16|||
146681591|NCT00549302|529008845|FG002|Double-Blind|Adverse Event|0|||
146681592|NCT00549302|529008843|FG000|Double-Blind|Withdrawal by Subject|3|||
146681593|NCT00549302|529008844|FG001|Double-Blind|Withdrawal by Subject|8|||
146681594|NCT00549302|529008845|FG002|Double-Blind|Withdrawal by Subject|0|||
146681595|NCT00549302|529008843|FG000|Double-Blind|Investigator Decision|1|||
146681596|NCT00549302|529008844|FG001|Double-Blind|Investigator Decision|5|||
146681597|NCT00549302|529008845|FG002|Double-Blind|Investigator Decision|0|||
146681598|NCT00549302|529008843|FG000|Double-Blind|Sponsor Decision|0|||
146681599|NCT00549302|529008844|FG001|Double-Blind|Sponsor Decision|1|||
146681600|NCT00549302|529008845|FG002|Double-Blind|Sponsor Decision|0|||
146681601|NCT00549302|529008843|FG000|Double-Blind|Lost to Follow-up|1|||
146681602|NCT00549302|529008844|FG001|Double-Blind|Lost to Follow-up|2|||
146681603|NCT00549302|529008845|FG002|Double-Blind|Lost to Follow-up|0|||
146681604|NCT00549302|529008843|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
146681605|NCT00549302|529008844|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
146681606|NCT00549302|529008845|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
146681607|NCT00549302|529008843|FG000|Double-Blind|New condition or starts new therapy|0|||
146681608|NCT00549302|529008844|FG001|Double-Blind|New condition or starts new therapy|2|||
146681609|NCT00549302|529008845|FG002|Double-Blind|New condition or starts new therapy|0|||
146681610|NCT00549302|529008843|FG000|Open-Label|Adverse Event|0|||
146681611|NCT00549302|529008844|FG001|Open-Label|Adverse Event|0|||
146681612|NCT00549302|529008845|FG002|Open-Label|Adverse Event|11|||
146681613|NCT00549302|529008843|FG000|Open-Label|Death|0|||
146681614|NCT00549302|529008844|FG001|Open-Label|Death|0|||
146681615|NCT00549302|529008845|FG002|Open-Label|Death|40|||
146681616|NCT00549302|529008843|FG000|Open-Label|Investigator Decision|0|||
146681617|NCT00549302|529008844|FG001|Open-Label|Investigator Decision|0|||
146681618|NCT00549302|529008845|FG002|Open-Label|Investigator Decision|5|||
146681619|NCT00549302|529008843|FG000|Open-Label|Lost to Follow-up|0|||
146681620|NCT00549302|529008844|FG001|Open-Label|Lost to Follow-up|0|||
146681621|NCT00549302|529008845|FG002|Open-Label|Lost to Follow-up|2|||
146681622|NCT00549302|529008843|FG000|Open-Label|Other|0|||
146681623|NCT00549302|529008844|FG001|Open-Label|Other|0|||
146681624|NCT00549302|529008845|FG002|Open-Label|Other|3|||
146681625|NCT00549302|529008843|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
146681626|NCT00549302|529008844|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
146681627|NCT00549302|529008845|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
146681628|NCT00549302|529008843|FG000|Open-Label|Withdrawal by Subject|0|||
146681629|NCT00549302|529008844|FG001|Open-Label|Withdrawal by Subject|0|||
146681630|NCT00549302|529008845|FG002|Open-Label|Withdrawal by Subject|6|||
146681631|NCT03585504|529008846|FG000|Overall Study|Lost to Follow-up|26|||
146681632|NCT03585504|529008847|FG001|Overall Study|Lost to Follow-up|29|||
146681633|NCT01414114|529008848|FG000|Overall Study|Adverse Event|2|||
146681634|NCT01414114|529008848|FG000|Overall Study|Withdrawal by Subject|1|||
146681635|NCT01414114|529008848|FG000|Overall Study|Other|2|||
146681636|NCT05620563|529008849|FG000|Overall Study|Adverse Event|3|||
146681637|NCT05620563|529008850|FG001|Overall Study|Adverse Event|1|||
146681638|NCT05620563|529008849|FG000|Overall Study|Lost to Follow-up|0|||
146681639|NCT05620563|529008850|FG001|Overall Study|Lost to Follow-up|2|||
146681640|NCT05620563|529008849|FG000|Overall Study|Protocol Deviation|1|||
146681641|NCT05620563|529008850|FG001|Overall Study|Protocol Deviation|2|||
146681642|NCT05620563|529008849|FG000|Overall Study|Withdrawal by Subject|3|||
146681643|NCT05620563|529008850|FG001|Overall Study|Withdrawal by Subject|3|||
146681644|NCT05620563|529008849|FG000|Overall Study|Physician Decision|0|||
146681645|NCT05620563|529008850|FG001|Overall Study|Physician Decision|1|||
146681646|NCT00372112|529008854|FG000|Overall Study|Adverse Event|0|||
146681647|NCT00372112|529008855|FG001|Overall Study|Adverse Event|1|||
146681648|NCT00372112|529008856|FG002|Overall Study|Adverse Event|1|||
146681649|NCT00372112|529008857|FG003|Overall Study|Adverse Event|1|||
146681650|NCT00372112|529008854|FG000|Overall Study|Withdrawal by Subject|0|||
146681651|NCT00372112|529008855|FG001|Overall Study|Withdrawal by Subject|0|||
146681652|NCT00372112|529008856|FG002|Overall Study|Withdrawal by Subject|2|||
146681653|NCT00372112|529008857|FG003|Overall Study|Withdrawal by Subject|1|||
146681654|NCT00372112|529008854|FG000|Overall Study|Exacerbation|0|||
146681655|NCT00372112|529008855|FG001|Overall Study|Exacerbation|0|||
146681656|NCT00372112|529008856|FG002|Overall Study|Exacerbation|0|||
146681657|NCT00372112|529008857|FG003|Overall Study|Exacerbation|1|||
146681658|NCT00372112|529008854|FG000|Overall Study|PR >240 at Visit 3|0|||
146681659|NCT00372112|529008855|FG001|Overall Study|PR >240 at Visit 3|0|||
146681660|NCT00372112|529008856|FG002|Overall Study|PR >240 at Visit 3|0|||
146681661|NCT00372112|529008857|FG003|Overall Study|PR >240 at Visit 3|1|||
146681662|NCT00372112|529008854|FG000|Overall Study|Hepatitis B|1|||
146681663|NCT00372112|529008855|FG001|Overall Study|Hepatitis B|0|||
146681664|NCT00372112|529008856|FG002|Overall Study|Hepatitis B|0|||
146681665|NCT00372112|529008857|FG003|Overall Study|Hepatitis B|0|||
146681666|NCT00372112|529008854|FG000|Overall Study|Other-protocol violation|0|||
146681667|NCT00372112|529008855|FG001|Overall Study|Other-protocol violation|0|||
146681668|NCT00372112|529008856|FG002|Overall Study|Other-protocol violation|1|||
146681669|NCT00372112|529008857|FG003|Overall Study|Other-protocol violation|0|||
146681670|NCT00356369|529008858|FG000|Active Phase|Withdrawal by Subject|2|||
146681671|NCT00356369|529008859|FG001|Active Phase|Withdrawal by Subject|1|||
146681672|NCT02205814|529008867|FG000|Overall Study|Lost to Follow-up|0|||
146681673|NCT02205814|529008868|FG001|Overall Study|Lost to Follow-up|0|||
146681674|NCT02205814|529008869|FG002|Overall Study|Lost to Follow-up|0|||
146681675|NCT02205814|529008870|FG003|Overall Study|Lost to Follow-up|1|||
146681676|NCT02205814|529008867|FG000|Overall Study|Lack of Efficacy|1|||
146681677|NCT02205814|529008868|FG001|Overall Study|Lack of Efficacy|0|||
146681678|NCT02205814|529008869|FG002|Overall Study|Lack of Efficacy|1|||
146681679|NCT02205814|529008870|FG003|Overall Study|Lack of Efficacy|1|||
146681680|NCT02205814|529008867|FG000|Overall Study|Physician Decision|0|||
146681681|NCT02205814|529008868|FG001|Overall Study|Physician Decision|0|||
146927131|NCT01877382|529892863|FG004|Dose Expansion|Clinical progression|0|||
146681682|NCT02205814|529008869|FG002|Overall Study|Physician Decision|1|||
146681683|NCT02205814|529008870|FG003|Overall Study|Physician Decision|0|||
146681684|NCT02205814|529008867|FG000|Overall Study|Protocol Violation|1|||
146681685|NCT02205814|529008868|FG001|Overall Study|Protocol Violation|0|||
146681686|NCT02205814|529008869|FG002|Overall Study|Protocol Violation|0|||
146681687|NCT02205814|529008870|FG003|Overall Study|Protocol Violation|1|||
146681688|NCT02205814|529008867|FG000|Overall Study|Withdrawal by Subject|0|||
146681689|NCT02205814|529008868|FG001|Overall Study|Withdrawal by Subject|1|||
146681690|NCT02205814|529008869|FG002|Overall Study|Withdrawal by Subject|2|||
146681691|NCT02205814|529008870|FG003|Overall Study|Withdrawal by Subject|1|||
146927132|NCT01877382|529892864|FG005|Dose Expansion|Clinical progression|0|||
146681692|NCT02205814|529008867|FG000|Overall Study|not compliant with study procedures|0|||
146681693|NCT02205814|529008868|FG001|Overall Study|not compliant with study procedures|0|||
146681694|NCT02205814|529008869|FG002|Overall Study|not compliant with study procedures|1|||
146681695|NCT02205814|529008870|FG003|Overall Study|not compliant with study procedures|0|||
146681696|NCT01426373|529008871|FG000|Overall Study|Adverse Event|6|||
146681697|NCT01426373|529008871|FG000|Overall Study|Lost to Follow-up|14|||
146681698|NCT01426373|529008871|FG000|Overall Study|Participant Convenience|10|||
146681699|NCT01426373|529008871|FG000|Overall Study|Miscellaneous Reasons|4|||
146681700|NCT00143403|529008872|FG000|Overall Study|Adverse Event|3|||
146681701|NCT00143403|529008873|FG001|Overall Study|Adverse Event|8|||
146681702|NCT00143403|529008872|FG000|Overall Study|Death|1|||
146681703|NCT00143403|529008873|FG001|Overall Study|Death|0|||
146681704|NCT00143403|529008872|FG000|Overall Study|Withdrawal by Subject|3|||
146681705|NCT00143403|529008873|FG001|Overall Study|Withdrawal by Subject|12|||
146681706|NCT00143403|529008872|FG000|Overall Study|Relapse|15|||
146681707|NCT00143403|529008873|FG001|Overall Study|Relapse|7|||
146681708|NCT00143403|529008872|FG000|Overall Study|Protocol Violation|2|||
146681709|NCT00143403|529008873|FG001|Overall Study|Protocol Violation|2|||
146681710|NCT00143403|529008872|FG000|Overall Study|specified by site|4|||
146681711|NCT00143403|529008873|FG001|Overall Study|specified by site|9|||
146681712|NCT00143403|529008872|FG000|Overall Study|Randomized Not Treated|7|||
146681713|NCT00143403|529008873|FG001|Overall Study|Randomized Not Treated|8|||
146681714|NCT01574326|529008874|FG000|Overall Study|Randomized but not treated|0|||
146681715|NCT01574326|529008875|FG001|Overall Study|Randomized but not treated|1|||
146681716|NCT01574326|529008874|FG000|Overall Study|Withdrawal by Participant|2|||
146681717|NCT01574326|529008875|FG001|Overall Study|Withdrawal by Participant|4|||
146681718|NCT01574326|529008874|FG000|Overall Study|Physician Decision|5|||
146681719|NCT01574326|529008875|FG001|Overall Study|Physician Decision|3|||
146681720|NCT01574326|529008874|FG000|Overall Study|Adverse Event|1|||
146681721|NCT01574326|529008875|FG001|Overall Study|Adverse Event|3|||
146681722|NCT01574326|529008874|FG000|Overall Study|Other: Mainly kidney transplant|8|||
146681723|NCT01574326|529008875|FG001|Overall Study|Other: Mainly kidney transplant|8|||
146681724|NCT01919723|529008878|FG000|Overall Study|Blood Samples Hemolyzed|2|||
146681725|NCT01919723|529008879|FG001|Overall Study|Blood Samples Hemolyzed|2|||
146681726|NCT04502589|529008880|FG000|Overall Study|Physician Decision|1|||
146681727|NCT04502589|529008881|FG001|Overall Study|Physician Decision|0|||
146681728|NCT00137046|529008887|FG000|Overall Study|Death|2|||
146681729|NCT00137046|529008888|FG001|Overall Study|Death|1|||
146681730|NCT00137046|529008887|FG000|Overall Study|Adverse Event|16|||
146681731|NCT00137046|529008888|FG001|Overall Study|Adverse Event|5|||
146681732|NCT00137046|529008887|FG000|Overall Study|Laboratory Abnormality|2|||
146681733|NCT00137046|529008888|FG001|Overall Study|Laboratory Abnormality|0|||
146681734|NCT00137046|529008887|FG000|Overall Study|Lack of Efficacy|13|||
146681735|NCT00137046|529008888|FG001|Overall Study|Lack of Efficacy|1|||
146681736|NCT00137046|529008887|FG000|Overall Study|Lost to Follow-up|8|||
146681737|NCT00137046|529008888|FG001|Overall Study|Lost to Follow-up|24|||
146681738|NCT00137046|529008887|FG000|Overall Study|Other|23|||
146681739|NCT00137046|529008888|FG001|Overall Study|Other|19|||
146681740|NCT00137046|529008887|FG000|Overall Study|Withdrawal by Subject|33|||
146681741|NCT00137046|529008888|FG001|Overall Study|Withdrawal by Subject|42|||
146681742|NCT00137046|529008887|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
146681743|NCT00137046|529008888|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
146681744|NCT00137046|529008887|FG000|Overall Study|Withdrew prior to study treatment|1|||
146681745|NCT00137046|529008888|FG001|Overall Study|Withdrew prior to study treatment|1|||
146681746|NCT02532972|529008892|FG000|Overall Study|Withdrawal by Subject|1|||
146681747|NCT02859454|529008895|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
146681748|NCT02925494|529008896|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
146681749|NCT02925494|529008897|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
146681750|NCT02925494|529008898|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
146681751|NCT02925494|529008899|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
146681752|NCT02925494|529008896|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
146681753|NCT02925494|529008897|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
146681754|NCT02925494|529008898|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
146681755|NCT02925494|529008899|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
146681756|NCT02925494|529008896|FG000|Post-Treatment Follow-Up Period|Other|1|||
146681757|NCT02925494|529008897|FG001|Post-Treatment Follow-Up Period|Other|4|||
146681758|NCT02925494|529008898|FG002|Post-Treatment Follow-Up Period|Other|3|||
146681759|NCT02925494|529008899|FG003|Post-Treatment Follow-Up Period|Other|6|||
146681760|NCT02925494|529008896|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
146681761|NCT02925494|529008897|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
146681762|NCT02925494|529008898|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
146681763|NCT02925494|529008899|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
146681764|NCT02925494|529008896|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
146681765|NCT02925494|529008897|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
146681766|NCT02925494|529008898|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
146927133|NCT01877382|529892865|FG006|Dose Expansion|Clinical progression|0|||
146927134|NCT01877382|529892866|FG007|Dose Expansion|Clinical progression|0|||
146927135|NCT01877382|529892867|FG008|Dose Expansion|Clinical progression|0|||
146927136|NCT01877382|529892868|FG009|Dose Expansion|Clinical progression|0|||
146927137|NCT01877382|529892869|FG010|Dose Expansion|Clinical progression|0|||
146927138|NCT01877382|529892870|FG011|Dose Expansion|Clinical progression|0|||
146927139|NCT01877382|529892871|FG012|Dose Expansion|Clinical progression|0|||
146927140|NCT01877382|529892872|FG013|Dose Expansion|Clinical progression|0|||
146927141|NCT01877382|529892873|FG014|Dose Expansion|Clinical progression|6|||
146927142|NCT01877382|529892859|FG000|Dose Expansion|Adverse Event|0|||
146927143|NCT01877382|529892860|FG001|Dose Expansion|Adverse Event|0|||
146927144|NCT01877382|529892861|FG002|Dose Expansion|Adverse Event|0|||
146927145|NCT01877382|529892862|FG003|Dose Expansion|Adverse Event|0|||
146927146|NCT01877382|529892863|FG004|Dose Expansion|Adverse Event|0|||
146927147|NCT01877382|529892864|FG005|Dose Expansion|Adverse Event|0|||
146927148|NCT01877382|529892865|FG006|Dose Expansion|Adverse Event|0|||
146927149|NCT01877382|529892866|FG007|Dose Expansion|Adverse Event|0|||
146927150|NCT01877382|529892867|FG008|Dose Expansion|Adverse Event|0|||
146927151|NCT01877382|529892868|FG009|Dose Expansion|Adverse Event|0|||
146927152|NCT01877382|529892869|FG010|Dose Expansion|Adverse Event|0|||
146927153|NCT01877382|529892870|FG011|Dose Expansion|Adverse Event|0|||
146927154|NCT01877382|529892871|FG012|Dose Expansion|Adverse Event|0|||
146927155|NCT01877382|529892872|FG013|Dose Expansion|Adverse Event|0|||
146927156|NCT01877382|529892873|FG014|Dose Expansion|Adverse Event|1|||
146927157|NCT01877382|529892859|FG000|Dose Expansion|Death|0|||
146927158|NCT01877382|529892860|FG001|Dose Expansion|Death|0|||
146927159|NCT01877382|529892861|FG002|Dose Expansion|Death|0|||
146927160|NCT01877382|529892862|FG003|Dose Expansion|Death|0|||
146927161|NCT01877382|529892863|FG004|Dose Expansion|Death|0|||
146927162|NCT01877382|529892864|FG005|Dose Expansion|Death|0|||
146927163|NCT01877382|529892865|FG006|Dose Expansion|Death|0|||
146927164|NCT01877382|529892866|FG007|Dose Expansion|Death|0|||
146927165|NCT01877382|529892867|FG008|Dose Expansion|Death|0|||
146927166|NCT01877382|529892868|FG009|Dose Expansion|Death|0|||
146927167|NCT01877382|529892869|FG010|Dose Expansion|Death|0|||
146927168|NCT01877382|529892870|FG011|Dose Expansion|Death|0|||
146927169|NCT01877382|529892871|FG012|Dose Expansion|Death|0|||
146927170|NCT01877382|529892872|FG013|Dose Expansion|Death|0|||
146927171|NCT01877382|529892873|FG014|Dose Expansion|Death|1|||
146927172|NCT01877382|529892859|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927173|NCT01877382|529892860|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146681767|NCT02925494|529008899|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
146681768|NCT02925494|529008896|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
146681769|NCT02925494|529008897|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
146681770|NCT02925494|529008898|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
146681771|NCT02925494|529008899|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
146681772|NCT02925494|529008896|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
146681773|NCT02925494|529008897|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
146681774|NCT02925494|529008898|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
146681775|NCT02925494|529008899|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
146681776|NCT03334448|529008900|FG000|Washout|Personal Reason|0|||
146681777|NCT03334448|529008901|FG001|Washout|Personal Reason|1|||
146681778|NCT03334448|529008902|FG002|Washout|Personal Reason|0|||
146681779|NCT03334448|529008903|FG003|Washout|Personal Reason|0|||
146681780|NCT03334448|529008900|FG000|Washout|Protocol Violation|0|||
146681781|NCT03334448|529008901|FG001|Washout|Protocol Violation|0|||
146681782|NCT03334448|529008902|FG002|Washout|Protocol Violation|0|||
146681783|NCT03334448|529008903|FG003|Washout|Protocol Violation|1|||
146681784|NCT02496611|529008909|FG000|Overall Study|Lost to Follow-up|2|||
146681785|NCT02496611|529008910|FG001|Overall Study|Lost to Follow-up|1|||
146681786|NCT02496611|529008909|FG000|Overall Study|Withdrawal by Subject|5|||
146681787|NCT02496611|529008910|FG001|Overall Study|Withdrawal by Subject|2|||
146927174|NCT01877382|529892861|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927175|NCT01877382|529892862|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927176|NCT01877382|529892863|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146681788|NCT02850965|529008911|FG000|Overall Study|Other than listed|3|||
146681789|NCT02850965|529008912|FG001|Overall Study|Other than listed|4|||
146681790|NCT02850965|529008911|FG000|Overall Study|Protocol Violation|0|||
146927177|NCT01877382|529892864|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927178|NCT01877382|529892865|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927179|NCT01877382|529892866|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146681791|NCT02850965|529008912|FG001|Overall Study|Protocol Violation|2|||
146681792|NCT02850965|529008911|FG000|Overall Study|Lost to Follow-up|5|||
146681793|NCT02850965|529008912|FG001|Overall Study|Lost to Follow-up|3|||
146927180|NCT01877382|529892867|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927181|NCT01877382|529892868|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927182|NCT01877382|529892869|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927183|NCT01877382|529892870|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927184|NCT01877382|529892871|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927185|NCT01877382|529892872|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146927186|NCT01877382|529892873|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
146927187|NCT01146951|529894514|FG000|Overall Study|Adverse Event|4|||
146927188|NCT01146951|529894515|FG001|Overall Study|Adverse Event|1|||
146927189|NCT02198651|529894516|FG000|Lead-in Period|Withdrew consent|13|||
146927190|NCT02198651|529894517|FG001|Lead-in Period|Withdrew consent|0|||
146927191|NCT02198651|529894518|FG002|Lead-in Period|Withdrew consent|0|||
146927192|NCT02198651|529894519|FG003|Lead-in Period|Withdrew consent|0|||
146927193|NCT02198651|529894520|FG004|Lead-in Period|Withdrew consent|0|||
146927194|NCT02198651|529894516|FG000|Lead-in Period|Adverse Event|2|||
146927195|NCT02198651|529894517|FG001|Lead-in Period|Adverse Event|0|||
146927196|NCT02198651|529894518|FG002|Lead-in Period|Adverse Event|0|||
146927197|NCT02198651|529894519|FG003|Lead-in Period|Adverse Event|0|||
146927198|NCT02198651|529894520|FG004|Lead-in Period|Adverse Event|0|||
146927199|NCT02198651|529894516|FG000|Lead-in Period|Other, not specified|22|||
146927200|NCT02198651|529894517|FG001|Lead-in Period|Other, not specified|0|||
146927201|NCT02198651|529894518|FG002|Lead-in Period|Other, not specified|0|||
146927202|NCT02198651|529894519|FG003|Lead-in Period|Other, not specified|0|||
146927203|NCT02198651|529894520|FG004|Lead-in Period|Other, not specified|0|||
146927204|NCT02198651|529894516|FG000|Double-blind Period|Withdrew consent|0|||
146927205|NCT02198651|529894517|FG001|Double-blind Period|Withdrew consent|4|||
146927206|NCT02198651|529894518|FG002|Double-blind Period|Withdrew consent|0|||
146927207|NCT02198651|529894519|FG003|Double-blind Period|Withdrew consent|0|||
146927208|NCT02198651|529894520|FG004|Double-blind Period|Withdrew consent|0|||
146927209|NCT02198651|529894516|FG000|Double-blind Period|Adverse Event|0|||
146927210|NCT02198651|529894517|FG001|Double-blind Period|Adverse Event|1|||
146927211|NCT02198651|529894518|FG002|Double-blind Period|Adverse Event|0|||
146927212|NCT02198651|529894519|FG003|Double-blind Period|Adverse Event|0|||
146927213|NCT02198651|529894520|FG004|Double-blind Period|Adverse Event|0|||
146927214|NCT02198651|529894516|FG000|Double-blind Period|Other, not specified|0|||
146927215|NCT02198651|529894517|FG001|Double-blind Period|Other, not specified|4|||
146927216|NCT02198651|529894518|FG002|Double-blind Period|Other, not specified|1|||
146681794|NCT02850965|529008911|FG000|Overall Study|Lack of Efficacy|4|||
146681795|NCT02850965|529008912|FG001|Overall Study|Lack of Efficacy|8|||
146681796|NCT02850965|529008911|FG000|Overall Study|Adverse Event|3|||
146681797|NCT02850965|529008912|FG001|Overall Study|Adverse Event|2|||
146681798|NCT02850965|529008911|FG000|Overall Study|Withdrawal by Subject|3|||
146681799|NCT02850965|529008912|FG001|Overall Study|Withdrawal by Subject|4|||
146681800|NCT02850965|529008911|FG000|Overall Study|Physician Decision|0|||
146681801|NCT02850965|529008912|FG001|Overall Study|Physician Decision|1|||
146681802|NCT02850965|529008911|FG000|Overall Study|Randomized but not treated|0|||
146681803|NCT02850965|529008912|FG001|Overall Study|Randomized but not treated|1|||
146681804|NCT02788357|529008916|FG000|Overall Study|Lost to Follow-up|3|||
146681805|NCT02788357|529008917|FG001|Overall Study|Lost to Follow-up|0|||
146681806|NCT01365910|529008918|FG000|Overall Study|Withdrawal by Subject|7|||
146681807|NCT01365910|529008918|FG000|Overall Study|disease progression|18|||
146681808|NCT01365910|529008918|FG000|Overall Study|Adverse Event|3|||
146681809|NCT01365910|529008918|FG000|Overall Study|other complicating disease|1|||
146681810|NCT01365910|529008918|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
146681811|NCT00371137|529008919|FG000|Overall Study|Adverse Event|20|||
146681812|NCT00371137|529008920|FG001|Overall Study|Adverse Event|35|||
146681813|NCT00371137|529008921|FG002|Overall Study|Adverse Event|42|||
146681814|NCT00371137|529008919|FG000|Overall Study|Withdrawal by Subject|11|||
146681815|NCT00371137|529008920|FG001|Overall Study|Withdrawal by Subject|10|||
146681816|NCT00371137|529008921|FG002|Overall Study|Withdrawal by Subject|15|||
146681817|NCT00371137|529008919|FG000|Overall Study|Lost to Follow-up|6|||
146681818|NCT00371137|529008920|FG001|Overall Study|Lost to Follow-up|3|||
146681819|NCT00371137|529008921|FG002|Overall Study|Lost to Follow-up|5|||
146681820|NCT00371137|529008919|FG000|Overall Study|Lack of Efficacy|30|||
146681821|NCT00371137|529008920|FG001|Overall Study|Lack of Efficacy|12|||
146681822|NCT00371137|529008921|FG002|Overall Study|Lack of Efficacy|13|||
146927217|NCT02198651|529894519|FG003|Double-blind Period|Other, not specified|0|||
146927218|NCT02198651|529894520|FG004|Double-blind Period|Other, not specified|0|||
146927219|NCT02198651|529894516|FG000|Open-label Rescue Period|Withdrew consent|0|||
146927220|NCT02198651|529894517|FG001|Open-label Rescue Period|Withdrew consent|0|||
146681823|NCT00371137|529008919|FG000|Overall Study|Sponsor Decision|2|||
146927221|NCT02198651|529894518|FG002|Open-label Rescue Period|Withdrew consent|0|||
146927222|NCT02198651|529894519|FG003|Open-label Rescue Period|Withdrew consent|2|||
146927223|NCT02198651|529894520|FG004|Open-label Rescue Period|Withdrew consent|0|||
146681824|NCT00371137|529008920|FG001|Overall Study|Sponsor Decision|1|||
146681825|NCT00371137|529008921|FG002|Overall Study|Sponsor Decision|2|||
146681826|NCT00371137|529008919|FG000|Overall Study|Physician Decision|1|||
146681827|NCT00371137|529008920|FG001|Overall Study|Physician Decision|1|||
146681828|NCT00371137|529008921|FG002|Overall Study|Physician Decision|1|||
146681829|NCT00371137|529008919|FG000|Overall Study|Protocol Violation|2|||
146681830|NCT00371137|529008920|FG001|Overall Study|Protocol Violation|1|||
146681831|NCT00371137|529008921|FG002|Overall Study|Protocol Violation|1|||
146681832|NCT02013791|529008922|FG000|Period 1|Lost to Follow-up|0|||
146681833|NCT02013791|529008923|FG001|Period 1|Lost to Follow-up|0|||
146681834|NCT02013791|529008924|FG002|Period 1|Lost to Follow-up|0|||
146681835|NCT02013791|529008925|FG003|Period 1|Lost to Follow-up|1|||
146681836|NCT02013791|529008926|FG004|Period 1|Lost to Follow-up|0|||
146681837|NCT02013791|529008927|FG005|Period 1|Lost to Follow-up|0|||
146681838|NCT02013791|529008928|FG006|Period 1|Lost to Follow-up|1|||
146681839|NCT02013791|529008929|FG007|Period 1|Lost to Follow-up|1|||
146681840|NCT02013791|529008930|FG008|Period 1|Lost to Follow-up|0|||
146681841|NCT02013791|529008922|FG000|Period 1|Other Miscellaneous Reasons|0|||
146681842|NCT02013791|529008923|FG001|Period 1|Other Miscellaneous Reasons|2|||
146681843|NCT02013791|529008924|FG002|Period 1|Other Miscellaneous Reasons|0|||
146681844|NCT02013791|529008925|FG003|Period 1|Other Miscellaneous Reasons|0|||
146681845|NCT02013791|529008926|FG004|Period 1|Other Miscellaneous Reasons|0|||
146681846|NCT02013791|529008927|FG005|Period 1|Other Miscellaneous Reasons|0|||
146681847|NCT02013791|529008928|FG006|Period 1|Other Miscellaneous Reasons|0|||
146681848|NCT02013791|529008929|FG007|Period 1|Other Miscellaneous Reasons|0|||
146681849|NCT02013791|529008930|FG008|Period 1|Other Miscellaneous Reasons|0|||
146681850|NCT02170051|529008931|FG000|Overall Study|Withdrawal by Subject|10|||
146681851|NCT02170051|529008932|FG001|Overall Study|Withdrawal by Subject|10|||
146681852|NCT02170051|529008931|FG000|Overall Study|Lost to Follow-up|1|||
146681853|NCT02170051|529008932|FG001|Overall Study|Lost to Follow-up|3|||
146681854|NCT03798483|529008933|FG000|Overall Study|Lost to Follow-up|2|||
146681855|NCT00276744|529008934|FG000|PART A|Reason unknown|98|||
146681856|NCT01835587|529008941|FG000|Overall Study|Disease Recurrence or Relapse|0|||
146681857|NCT01835587|529008942|FG001|Overall Study|Disease Recurrence or Relapse|3|||
146681858|NCT01835587|529008943|FG002|Overall Study|Disease Recurrence or Relapse|0|||
146681859|NCT01835587|529008944|FG003|Overall Study|Disease Recurrence or Relapse|3|||
146681860|NCT01835587|529008941|FG000|Overall Study|Withdrawal by Subject|2|||
146681861|NCT01835587|529008942|FG001|Overall Study|Withdrawal by Subject|0|||
146681862|NCT01835587|529008943|FG002|Overall Study|Withdrawal by Subject|0|||
146681863|NCT01835587|529008944|FG003|Overall Study|Withdrawal by Subject|3|||
146681864|NCT01835587|529008941|FG000|Overall Study|Adverse Event|0|||
146681865|NCT01835587|529008942|FG001|Overall Study|Adverse Event|0|||
146681866|NCT01835587|529008943|FG002|Overall Study|Adverse Event|2|||
146681867|NCT01835587|529008944|FG003|Overall Study|Adverse Event|2|||
146681868|NCT01835587|529008941|FG000|Overall Study|Death|0|||
146681869|NCT01835587|529008942|FG001|Overall Study|Death|0|||
146681870|NCT01835587|529008943|FG002|Overall Study|Death|0|||
146681871|NCT01835587|529008944|FG003|Overall Study|Death|1|||
146681872|NCT01835587|529008941|FG000|Overall Study|Miscellaneous|0|||
146681873|NCT01835587|529008942|FG001|Overall Study|Miscellaneous|1|||
146681874|NCT01835587|529008943|FG002|Overall Study|Miscellaneous|0|||
146681875|NCT01835587|529008944|FG003|Overall Study|Miscellaneous|0|||
146927224|NCT02198651|529894516|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
146681876|NCT03310775|529008948|FG000|Overall Study|Lost to Follow-up|2|||
146681877|NCT03310775|529008949|FG001|Overall Study|Lost to Follow-up|3|||
146681878|NCT03310775|529008948|FG000|Overall Study|aggravation of depression|0|||
146681879|NCT03310775|529008949|FG001|Overall Study|aggravation of depression|1|||
146681880|NCT00126568|529008950|FG000|Overall Study|Death|2|||
146681881|NCT03064451|529008951|FG000|Overall Study|Lost to Follow-up|1|||
146681882|NCT03064451|529008951|FG000|Overall Study|Mapping Failure|4|||
146681883|NCT03064451|529008951|FG000|Overall Study|Exited prior to procedure|8|||
146681884|NCT03064451|529008951|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
146681885|NCT00750204|529008952|FG000|Overall Study|study halted prematurely|1|||
146681886|NCT00750204|529008953|FG001|Overall Study|study halted prematurely|1|||
146681887|NCT04853225|529008956|FG000|Overall Study|Withdrawal by Subject|81|||
146681888|NCT04853225|529008957|FG001|Overall Study|Withdrawal by Subject|4|||
146681889|NCT04853225|529008958|FG002|Overall Study|Withdrawal by Subject|1|||
146681890|NCT04853225|529008956|FG000|Overall Study|Physician Decision|12|||
146681891|NCT04853225|529008957|FG001|Overall Study|Physician Decision|4|||
146681892|NCT04853225|529008958|FG002|Overall Study|Physician Decision|1|||
146681893|NCT04853225|529008956|FG000|Overall Study|Lost to Follow-up|50|||
146681894|NCT04853225|529008957|FG001|Overall Study|Lost to Follow-up|0|||
146927225|NCT02198651|529894517|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
146681895|NCT04853225|529008958|FG002|Overall Study|Lost to Follow-up|0|||
146681896|NCT04853225|529008956|FG000|Overall Study|Other|102|||
146681897|NCT04853225|529008957|FG001|Overall Study|Other|11|||
146681898|NCT04853225|529008958|FG002|Overall Study|Other|5|||
146681899|NCT04853225|529008956|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
146681900|NCT04853225|529008957|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
146681901|NCT04853225|529008958|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
146736296|NCT00633932|529206805|FG002|Overall Study|Physician Decision|1|||
146927226|NCT02198651|529894518|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
146927227|NCT02198651|529894519|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
146927228|NCT02198651|529894520|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
146927229|NCT04092816|529894524|FG000|Overall Study|Lost to Follow-up|1|||
146927230|NCT04092816|529894525|FG001|Overall Study|Lost to Follow-up|2|||
146927231|NCT01747811|529894526|FG000|Overall Study|Lack of Efficacy|2|||
146927232|NCT01747811|529894527|FG001|Overall Study|Lack of Efficacy|4|||
146927233|NCT03073213|529894528|FG000|Multiple Dose Period|Protocol Violation|0|||
146927234|NCT03073213|529894529|FG001|Multiple Dose Period|Protocol Violation|0|||
146927235|NCT03073213|529894530|FG002|Multiple Dose Period|Protocol Violation|1|||
146927236|NCT02690207|529894531|FG000|Overall Study|Lost to Follow-up|48|||
146927237|NCT02690207|529894531|FG000|Overall Study|Withdrawal by Subject|46|||
146927238|NCT02690207|529894531|FG000|Overall Study|Protocol Violation|2|||
146927239|NCT02690207|529894531|FG000|Overall Study|Serious adverse event|110|||
146927240|NCT02690207|529894531|FG000|Overall Study|Non-serious Adverse Event|18|||
146927241|NCT02690207|529894531|FG000|Overall Study|Migrated/moved from study area|5|||
146927242|NCT02690207|529894531|FG000|Overall Study|Suspected HZ Episode|1|||
146681902|NCT04853225|529008956|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
146681903|NCT04853225|529008957|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
146681904|NCT04853225|529008958|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
146681905|NCT01404325|529010815|FG000|Overall Study|Lost to Follow-up|1|||
146681906|NCT01404325|529010816|FG001|Overall Study|Lost to Follow-up|0|||
146681907|NCT01404325|529010815|FG000|Overall Study|Death|2|||
146681908|NCT01404325|529010816|FG001|Overall Study|Death|0|||
146681909|NCT01404325|529010815|FG000|Overall Study|Graft loss/Retransplantation|1|||
146681910|NCT01404325|529010816|FG001|Overall Study|Graft loss/Retransplantation|0|||
146681911|NCT01404325|529010815|FG000|Overall Study|non-specified reason|0|||
146681912|NCT01404325|529010816|FG001|Overall Study|non-specified reason|2|||
146681913|NCT01411228|529010819|FG000|Overall Study|Lost to Follow-up|0|||
146681914|NCT01411228|529010820|FG001|Overall Study|Lost to Follow-up|0|||
146681915|NCT01411228|529010821|FG002|Overall Study|Lost to Follow-up|1|||
146681916|NCT01411228|529010819|FG000|Overall Study|Withdrawal by Subject|1|||
146681917|NCT01411228|529010820|FG001|Overall Study|Withdrawal by Subject|0|||
146681918|NCT01411228|529010821|FG002|Overall Study|Withdrawal by Subject|0|||
146681919|NCT01986855|529010822|FG000|Overall Study|Adverse Event|1|||
146681920|NCT01986855|529010823|FG001|Overall Study|Adverse Event|0|||
146681921|NCT01986855|529010824|FG002|Overall Study|Adverse Event|0|||
146681922|NCT01986855|529010822|FG000|Overall Study|Death|3|||
146681923|NCT01986855|529010823|FG001|Overall Study|Death|4|||
146681924|NCT01986855|529010824|FG002|Overall Study|Death|4|||
146681925|NCT01986855|529010822|FG000|Overall Study|Lost to Follow-up|2|||
146681926|NCT01986855|529010823|FG001|Overall Study|Lost to Follow-up|1|||
146681927|NCT01986855|529010824|FG002|Overall Study|Lost to Follow-up|0|||
146681928|NCT01986855|529010822|FG000|Overall Study|Screen Failure|0|||
146681929|NCT01986855|529010823|FG001|Overall Study|Screen Failure|1|||
146681930|NCT01986855|529010824|FG002|Overall Study|Screen Failure|0|||
146681931|NCT01986855|529010822|FG000|Overall Study|Participant Moved|0|||
146681932|NCT01986855|529010823|FG001|Overall Study|Participant Moved|0|||
146681933|NCT01986855|529010824|FG002|Overall Study|Participant Moved|2|||
146681934|NCT01986855|529010822|FG000|Overall Study|Withdrawal by Subject|7|||
146681935|NCT01986855|529010823|FG001|Overall Study|Withdrawal by Subject|8|||
146681936|NCT01986855|529010824|FG002|Overall Study|Withdrawal by Subject|5|||
146681937|NCT02064868|529010828|FG000|Overall Study|Lost to Follow-up|14|||
146681938|NCT02064868|529010829|FG001|Overall Study|Lost to Follow-up|8|||
146681939|NCT02064868|529010828|FG000|Overall Study|Physician Decision|1|||
146681940|NCT02064868|529010829|FG001|Overall Study|Physician Decision|0|||
146681941|NCT02064868|529010828|FG000|Overall Study|Withdrawal by Subject|14|||
146681942|NCT02064868|529010829|FG001|Overall Study|Withdrawal by Subject|3|||
146681943|NCT02064868|529010828|FG000|Overall Study|Technical Problems or Missing|5|||
146681944|NCT02064868|529010829|FG001|Overall Study|Technical Problems or Missing|2|||
146681945|NCT02670083|529010830|FG000|Overall Study|Adverse Event|16|||
146681946|NCT02670083|529010831|FG001|Overall Study|Adverse Event|13|||
146681947|NCT02670083|529010830|FG000|Overall Study|Death|4|||
146681948|NCT02670083|529010831|FG001|Overall Study|Death|6|||
146681949|NCT02670083|529010830|FG000|Overall Study|Lost to Follow-up|2|||
146681950|NCT02670083|529010831|FG001|Overall Study|Lost to Follow-up|2|||
146681951|NCT02670083|529010830|FG000|Overall Study|Multiple Reasons|9|||
146681952|NCT02670083|529010831|FG001|Overall Study|Multiple Reasons|9|||
146927243|NCT02690207|529894531|FG000|Overall Study|Other reasons for withdrawal|23|||
146681953|NCT02670083|529010830|FG000|Overall Study|Physician Decision|0|||
146681954|NCT02670083|529010831|FG001|Overall Study|Physician Decision|2|||
146681955|NCT02670083|529010830|FG000|Overall Study|Study Terminated By Sponsor|257|||
146681956|NCT02670083|529010831|FG001|Overall Study|Study Terminated By Sponsor|254|||
146681957|NCT02670083|529010830|FG000|Overall Study|Symptomatic Deterioration|0|||
146681958|NCT02670083|529010831|FG001|Overall Study|Symptomatic Deterioration|2|||
146681959|NCT02670083|529010830|FG000|Overall Study|Withdrawal by Subject|32|||
146681960|NCT02670083|529010831|FG001|Overall Study|Withdrawal by Subject|31|||
146681961|NCT02670083|529010830|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146681962|NCT02670083|529010831|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146681963|NCT00609492|529010837|FG000|Overall Study|Withdrawal by Subject|0|||
146681964|NCT00609492|529010838|FG001|Overall Study|Withdrawal by Subject|2|||
146681965|NCT00609492|529010839|FG002|Overall Study|Withdrawal by Subject|3|||
146681966|NCT00609492|529010837|FG000|Overall Study|Lost to Follow-up|1|||
146681967|NCT00609492|529010838|FG001|Overall Study|Lost to Follow-up|1|||
146681968|NCT00609492|529010839|FG002|Overall Study|Lost to Follow-up|4|||
146681969|NCT00720434|529010840|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
146681970|NCT00720434|529010841|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
146681971|NCT00720434|529010842|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
146681972|NCT00720434|529010843|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
146681973|NCT00720434|529010840|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
146681974|NCT00720434|529010841|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
146681975|NCT00720434|529010842|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
146681976|NCT00720434|529010843|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
146681977|NCT00720434|529010840|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
146681978|NCT00720434|529010841|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
146681979|NCT00720434|529010842|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
146681980|NCT00720434|529010843|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
146681981|NCT00720434|529010840|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
146681982|NCT00720434|529010841|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
146681983|NCT00720434|529010842|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
146681984|NCT00720434|529010843|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
146681985|NCT00720434|529010840|FG000|Open-Label Period (Week 5-72)|Other|4|||
146681986|NCT00720434|529010841|FG001|Open-Label Period (Week 5-72)|Other|3|||
146681987|NCT00720434|529010842|FG002|Open-Label Period (Week 5-72)|Other|3|||
146681988|NCT00720434|529010843|FG003|Open-Label Period (Week 5-72)|Other|2|||
146681989|NCT02425046|529010844|FG000|Overall Study|Lost to Follow-up|52|||
146681990|NCT02425046|529010845|FG001|Overall Study|Lost to Follow-up|50|||
146681991|NCT02425046|529010846|FG002|Overall Study|Lost to Follow-up|56|||
146681992|NCT02425046|529010844|FG000|Overall Study|Withdrawal by Subject|16|||
146681993|NCT02425046|529010845|FG001|Overall Study|Withdrawal by Subject|12|||
146681994|NCT02425046|529010846|FG002|Overall Study|Withdrawal by Subject|0|||
146681995|NCT02782780|529010847|FG000|Overall Study|dropped out after randomization.|7|||
146681996|NCT02782780|529010848|FG001|Overall Study|dropped out after randomization.|5|||
146681997|NCT02782780|529010847|FG000|Overall Study|Protocol Violation|0|||
146681998|NCT02782780|529010848|FG001|Overall Study|Protocol Violation|2|||
146681999|NCT03562481|529010849|FG000|First Intervention|Lost to Follow-up|1|||
146682000|NCT03562481|529010850|FG001|First Intervention|Lost to Follow-up|0|||
146682001|NCT01413191|529010851|FG000|Overall Study|Lost to Follow-up|5|||
146682002|NCT01413191|529010851|FG000|Overall Study|Disease Progression|5|||
146682003|NCT01413191|529010851|FG000|Overall Study|Death|1|||
146682004|NCT00267046|529010865|FG000|Overall Study|Disease progression|4|||
146682005|NCT00267046|529010866|FG001|Overall Study|Disease progression|2|||
146682006|NCT00267046|529010865|FG000|Overall Study|Chemotoxicity|2|||
146682007|NCT00267046|529010866|FG001|Overall Study|Chemotoxicity|0|||
146682008|NCT00267046|529010865|FG000|Overall Study|Open-label palifermin|2|||
146927244|NCT01617655|529894532|FG000|Overall Study|Adverse Event|2|||
146927245|NCT01617655|529894533|FG001|Overall Study|Adverse Event|3|||
146927246|NCT01617655|529894532|FG000|Overall Study|Poor compliance to protocol|1|||
146927247|NCT01617655|529894533|FG001|Overall Study|Poor compliance to protocol|4|||
146927248|NCT01617655|529894532|FG000|Overall Study|Participants moved|0|||
146927249|NCT01617655|529894533|FG001|Overall Study|Participants moved|4|||
146927250|NCT01617655|529894532|FG000|Overall Study|Consent withdrawn by participant|1|||
146927251|NCT01617655|529894533|FG001|Overall Study|Consent withdrawn by participant|1|||
146927252|NCT01617655|529894532|FG000|Overall Study|Last visit outside protocol visit window|1|||
146682009|NCT00267046|529010866|FG001|Overall Study|Open-label palifermin|7|||
146682010|NCT00267046|529010865|FG000|Overall Study|Surgery|3|||
146682011|NCT00267046|529010866|FG001|Overall Study|Surgery|1|||
146682012|NCT00267046|529010865|FG000|Overall Study|Withdrawal by Subject|1|||
146682013|NCT00267046|529010866|FG001|Overall Study|Withdrawal by Subject|0|||
146682014|NCT00267046|529010865|FG000|Overall Study|Radiation|0|||
146682015|NCT00267046|529010866|FG001|Overall Study|Radiation|1|||
146682016|NCT00460408|529010867|FG000|Overall Study|Adverse Event|1|||
146682017|NCT00460408|529010868|FG001|Overall Study|Adverse Event|0|||
146682018|NCT00460408|529010869|FG002|Overall Study|Adverse Event|0|||
146682019|NCT00460408|529010870|FG003|Overall Study|Adverse Event|0|||
146682020|NCT00460408|529010867|FG000|Overall Study|Death|7|||
146682021|NCT00460408|529010868|FG001|Overall Study|Death|0|||
146682022|NCT00460408|529010869|FG002|Overall Study|Death|0|||
146682023|NCT00460408|529010870|FG003|Overall Study|Death|0|||
146682024|NCT00460408|529010867|FG000|Overall Study|Lost to Follow-up|11|||
146682025|NCT00460408|529010868|FG001|Overall Study|Lost to Follow-up|0|||
146682026|NCT00460408|529010869|FG002|Overall Study|Lost to Follow-up|1|||
146927253|NCT01617655|529894533|FG001|Overall Study|Last visit outside protocol visit window|10|||
146682027|NCT00460408|529010870|FG003|Overall Study|Lost to Follow-up|0|||
146682028|NCT00460408|529010867|FG000|Overall Study|Withdrawal by Subject|31|||
146682029|NCT00460408|529010868|FG001|Overall Study|Withdrawal by Subject|0|||
146682030|NCT00460408|529010869|FG002|Overall Study|Withdrawal by Subject|0|||
146682031|NCT00460408|529010870|FG003|Overall Study|Withdrawal by Subject|0|||
146682032|NCT00460408|529010867|FG000|Overall Study|Insufficient clinical response|5|||
146682033|NCT00460408|529010868|FG001|Overall Study|Insufficient clinical response|1|||
146682034|NCT00460408|529010869|FG002|Overall Study|Insufficient clinical response|5|||
146682035|NCT00460408|529010870|FG003|Overall Study|Insufficient clinical response|0|||
146682036|NCT00460408|529010867|FG000|Overall Study|Other|12|||
146682037|NCT00460408|529010868|FG001|Overall Study|Other|2|||
146682038|NCT00460408|529010869|FG002|Overall Study|Other|0|||
146682039|NCT00460408|529010870|FG003|Overall Study|Other|0|||
146682040|NCT01979016|529010871|FG000|Overall Study|Withdrawal by Subject|2|||
146682041|NCT01979016|529010872|FG001|Overall Study|Withdrawal by Subject|0|||
146682042|NCT01979016|529010871|FG000|Overall Study|Adverse Event|0|||
146682043|NCT01979016|529010872|FG001|Overall Study|Adverse Event|1|||
146682044|NCT04983264|529010873|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
146682045|NCT04983264|529010874|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
146682046|NCT04983264|529010875|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
146682047|NCT04983264|529010873|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
146682048|NCT04983264|529010874|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
146682049|NCT04983264|529010875|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
146682050|NCT01124422|529010876|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
146682051|NCT01124422|529010877|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
146682052|NCT01124422|529010878|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
146682053|NCT01124422|529010876|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
146682054|NCT01124422|529010877|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
146682055|NCT01124422|529010878|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
146682056|NCT01124422|529010876|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
146682057|NCT01124422|529010877|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
146682058|NCT01124422|529010878|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
146682059|NCT01124422|529010876|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
146682060|NCT01124422|529010877|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
146682061|NCT01124422|529010878|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
146682062|NCT01124422|529010876|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
146682063|NCT01124422|529010877|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
146682064|NCT01124422|529010878|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
146682065|NCT01124422|529010876|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
146682066|NCT01124422|529010877|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
146682067|NCT01124422|529010878|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
146682068|NCT01124422|529010876|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
146682069|NCT01124422|529010877|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
146682070|NCT01124422|529010878|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
146682071|NCT01124422|529010876|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
146682072|NCT01124422|529010877|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
146682073|NCT01124422|529010878|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
146682074|NCT01124422|529010876|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
146682075|NCT01124422|529010877|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
146682076|NCT01124422|529010878|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
146682077|NCT01124422|529010876|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
146682078|NCT01124422|529010877|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
146682079|NCT01124422|529010878|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
146682080|NCT00938639|529010879|FG000|Overall Study|Moved away from study area|0|||
146682081|NCT00938639|529010880|FG001|Overall Study|Moved away from study area|1|||
146682082|NCT00938639|529010879|FG000|Overall Study|Lost to Follow-up|1|||
146682083|NCT00938639|529010880|FG001|Overall Study|Lost to Follow-up|2|||
146682084|NCT00938639|529010879|FG000|Overall Study|Family issues|1|||
146682085|NCT00938639|529010880|FG001|Overall Study|Family issues|1|||
146682086|NCT00938639|529010879|FG000|Overall Study|Participant noncompliance|1|||
146682087|NCT00938639|529010880|FG001|Overall Study|Participant noncompliance|0|||
146682088|NCT04326231|529010887|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
146682089|NCT03303079|529010888|FG000|Overall Study|Adverse Event|0|||
146682090|NCT03303079|529010889|FG001|Overall Study|Adverse Event|1|||
146682091|NCT03303079|529010890|FG002|Overall Study|Adverse Event|3|||
146682092|NCT03303079|529010888|FG000|Overall Study|Protocol Violation|5|||
146682093|NCT03303079|529010889|FG001|Overall Study|Protocol Violation|4|||
146682094|NCT03303079|529010890|FG002|Overall Study|Protocol Violation|7|||
146682095|NCT03303079|529010888|FG000|Overall Study|Withdrawal by Subject|2|||
146682096|NCT03303079|529010889|FG001|Overall Study|Withdrawal by Subject|4|||
146682097|NCT03303079|529010890|FG002|Overall Study|Withdrawal by Subject|2|||
146682098|NCT03303079|529010888|FG000|Overall Study|Other than specified|0|||
146682099|NCT03303079|529010889|FG001|Overall Study|Other than specified|2|||
146682100|NCT03303079|529010890|FG002|Overall Study|Other than specified|0|||
146682101|NCT03315208|529010891|FG000|Overall Study|Lost to Follow-up|11|||
146682102|NCT03315208|529010892|FG001|Overall Study|Lost to Follow-up|6|||
146682103|NCT03315208|529010891|FG000|Overall Study|Withdrawal by Subject|2|||
146682104|NCT03315208|529010892|FG001|Overall Study|Withdrawal by Subject|0|||
146682105|NCT00587639|529010923|FG000|Overall Study|Withdrawal by Subject|1|||
146682106|NCT00160251|529010928|FG000|Prior to Amendment 2|Adverse Event|2|||
146682107|NCT00160251|529010929|FG001|Prior to Amendment 2|Adverse Event|1|||
146682108|NCT00160251|529010930|FG002|Prior to Amendment 2|Adverse Event|3|||
146682109|NCT00160251|529010931|FG003|Prior to Amendment 2|Adverse Event|1|||
146682110|NCT00160251|529010932|FG004|Prior to Amendment 2|Adverse Event|1|||
146682111|NCT00160251|529010933|FG005|Prior to Amendment 2|Adverse Event|1|||
146682112|NCT00160251|529010934|FG006|Prior to Amendment 2|Adverse Event|1|||
146682113|NCT00160251|529010935|FG007|Prior to Amendment 2|Adverse Event|0|||
146682114|NCT00160251|529010928|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
146682115|NCT00160251|529010929|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
146682116|NCT00160251|529010930|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
146682117|NCT00160251|529010931|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
146682118|NCT00160251|529010932|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
146682119|NCT00160251|529010933|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
146682120|NCT00160251|529010934|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
146682121|NCT00160251|529010935|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
146682122|NCT00160251|529010928|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
146682123|NCT00160251|529010929|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
146682124|NCT00160251|529010930|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
146682125|NCT00160251|529010931|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
146682126|NCT00160251|529010932|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
146682127|NCT00160251|529010933|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
146682128|NCT00160251|529010934|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
146682129|NCT00160251|529010935|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
146682130|NCT00160251|529010928|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
146682131|NCT00160251|529010929|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
146682132|NCT00160251|529010930|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
146682133|NCT00160251|529010931|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
146682134|NCT00160251|529010932|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
146682135|NCT00160251|529010933|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
146682136|NCT00160251|529010934|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
146682137|NCT00160251|529010935|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
146682138|NCT00160251|529010928|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
146682139|NCT00160251|529010929|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
146682140|NCT00160251|529010930|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
146682141|NCT00160251|529010931|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
146682142|NCT00160251|529010932|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
146682143|NCT00160251|529010933|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
146682144|NCT00160251|529010934|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
146682145|NCT00160251|529010935|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
146682146|NCT00160251|529010928|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
146682147|NCT00160251|529010929|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
146682148|NCT00160251|529010930|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
146682149|NCT00160251|529010931|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
146682150|NCT00160251|529010932|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
146682151|NCT00160251|529010933|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
146682152|NCT00160251|529010934|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
146682153|NCT00160251|529010935|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
146682154|NCT00160251|529010928|FG000|Post-amendment 2|Adverse Event|0|||
146682155|NCT00160251|529010929|FG001|Post-amendment 2|Adverse Event|0|||
146682156|NCT00160251|529010930|FG002|Post-amendment 2|Adverse Event|0|||
146682157|NCT00160251|529010931|FG003|Post-amendment 2|Adverse Event|0|||
146682158|NCT00160251|529010932|FG004|Post-amendment 2|Adverse Event|0|||
146682159|NCT00160251|529010933|FG005|Post-amendment 2|Adverse Event|0|||
146682160|NCT00160251|529010934|FG006|Post-amendment 2|Adverse Event|0|||
146682161|NCT00160251|529010935|FG007|Post-amendment 2|Adverse Event|20|||
146682162|NCT00160251|529010928|FG000|Post-amendment 2|Lack of Efficacy|0|||
146682163|NCT00160251|529010929|FG001|Post-amendment 2|Lack of Efficacy|0|||
146682164|NCT00160251|529010930|FG002|Post-amendment 2|Lack of Efficacy|0|||
146682165|NCT00160251|529010931|FG003|Post-amendment 2|Lack of Efficacy|0|||
146682166|NCT00160251|529010932|FG004|Post-amendment 2|Lack of Efficacy|0|||
146682167|NCT00160251|529010933|FG005|Post-amendment 2|Lack of Efficacy|0|||
146682168|NCT00160251|529010934|FG006|Post-amendment 2|Lack of Efficacy|0|||
146682169|NCT00160251|529010935|FG007|Post-amendment 2|Lack of Efficacy|24|||
146682170|NCT00160251|529010928|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
146682171|NCT00160251|529010929|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
146682172|NCT00160251|529010930|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
146682173|NCT00160251|529010931|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
146682174|NCT00160251|529010932|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
146682175|NCT00160251|529010933|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
146682176|NCT00160251|529010934|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
146682177|NCT00160251|529010935|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
146682178|NCT01288469|529010936|FG000|Overall Study|Adverse Event|4|||
146682179|NCT01288469|529010937|FG001|Overall Study|Adverse Event|1|||
146682180|NCT01288469|529010938|FG002|Overall Study|Adverse Event|1|||
146682181|NCT01288469|529010936|FG000|Overall Study|Poor compliance to protocol|0|||
146682182|NCT01288469|529010937|FG001|Overall Study|Poor compliance to protocol|1|||
146682183|NCT01288469|529010938|FG002|Overall Study|Poor compliance to protocol|0|||
146682184|NCT01288469|529010936|FG000|Overall Study|Participant Moved|1|||
146682185|NCT01288469|529010937|FG001|Overall Study|Participant Moved|0|||
146682186|NCT01288469|529010938|FG002|Overall Study|Participant Moved|0|||
146682187|NCT01288469|529010936|FG000|Overall Study|Consent withdrawn by subject|1|||
146682188|NCT01288469|529010937|FG001|Overall Study|Consent withdrawn by subject|1|||
146682189|NCT01288469|529010938|FG002|Overall Study|Consent withdrawn by subject|1|||
146682190|NCT01288469|529010936|FG000|Overall Study|Exclusion criteria finally met|1|||
146682191|NCT01288469|529010937|FG001|Overall Study|Exclusion criteria finally met|0|||
146682192|NCT01288469|529010938|FG002|Overall Study|Exclusion criteria finally met|0|||
146682193|NCT01574612|529010939|FG000|Overall Study|Adverse Event|3|||
146682194|NCT01574612|529010939|FG000|Overall Study|non compliant with drug|2|||
146682195|NCT01574612|529010939|FG000|Overall Study|Withdrawal by Subject|1|||
146682196|NCT01574612|529010939|FG000|Overall Study|Lost to Follow-up|2|||
146682197|NCT00582166|529010940|FG000|Overall Study|Death|1|||
146682198|NCT00582166|529010940|FG000|Overall Study|Ineligible pathology|1|||
146682199|NCT01606436|529010941|FG000|Overall Study|Withdrawal by Subject|0|||
146682200|NCT01606436|529010942|FG001|Overall Study|Withdrawal by Subject|0|||
146682201|NCT01606436|529010943|FG002|Overall Study|Withdrawal by Subject|1|||
146682202|NCT01606436|529010944|FG003|Overall Study|Withdrawal by Subject|1|||
146682203|NCT01606436|529010945|FG004|Overall Study|Withdrawal by Subject|1|||
146682204|NCT01606436|529010946|FG005|Overall Study|Withdrawal by Subject|0|||
146682205|NCT01606436|529010941|FG000|Overall Study|Adverse Event|0|||
146682206|NCT01606436|529010942|FG001|Overall Study|Adverse Event|0|||
146682207|NCT01606436|529010943|FG002|Overall Study|Adverse Event|1|||
146682208|NCT01606436|529010944|FG003|Overall Study|Adverse Event|0|||
146682209|NCT01606436|529010945|FG004|Overall Study|Adverse Event|0|||
146774796|NCT05057897|529346781|FG000|Overall Study|Death|1|||
146927254|NCT01617655|529894532|FG000|Overall Study|Site closure|3|||
146927255|NCT01617655|529894533|FG001|Overall Study|Site closure|5|||
146927256|NCT01617655|529894532|FG000|Overall Study|Other than specified above|1|||
146927257|NCT01617655|529894533|FG001|Overall Study|Other than specified above|2|||
146927258|NCT00190983|529894537|FG000|Overall Study|Inevaluable (never treated)|2|||
146927259|NCT04069156|529894538|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
146927260|NCT04069156|529894539|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
146927261|NCT04069156|529894538|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
146927262|NCT04069156|529894539|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
146927263|NCT04069156|529894538|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
146927264|NCT04069156|529894539|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
146927265|NCT04069156|529894538|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
146927266|NCT04069156|529894539|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
146927267|NCT04247815|529894540|FG000|Overall Study|Adverse Event|1|||
146927268|NCT04247815|529894541|FG001|Overall Study|Adverse Event|0|||
146927269|NCT04247815|529894540|FG000|Overall Study|Withdrawal by Subject|1|||
146927270|NCT04247815|529894541|FG001|Overall Study|Withdrawal by Subject|0|||
146927271|NCT04247815|529894540|FG000|Overall Study|Protocol Violation|0|||
146927272|NCT04247815|529894541|FG001|Overall Study|Protocol Violation|1|||
146927273|NCT00089479|529894550|FG000|Overall Study|Death|108|||
146927274|NCT00089479|529894551|FG001|Overall Study|Death|75|||
146927275|NCT00089479|529894550|FG000|Overall Study|Withdrawal by Subject|86|||
146927276|NCT00089479|529894551|FG001|Overall Study|Withdrawal by Subject|107|||
146927277|NCT00089479|529894550|FG000|Overall Study|Lost to Follow-up|137|||
146927278|NCT00089479|529894551|FG001|Overall Study|Lost to Follow-up|107|||
146927279|NCT03943953|529894552|FG000|Trial of ITG 1|Lost to Follow-up|19|||
146927280|NCT03943953|529894553|FG001|Trial of ITG 1|Lost to Follow-up|1|||
146927281|NCT03943953|529894552|FG000|Trial of ITG 2|Lost to Follow-up|8|||
146927282|NCT03943953|529894553|FG001|Trial of ITG 2|Lost to Follow-up|0|||
146927283|NCT03943953|529894552|FG000|Trial of ITG 3|Lost to Follow-up|2|||
146927284|NCT03943953|529894553|FG001|Trial of ITG 3|Lost to Follow-up|0|||
146682210|NCT01606436|529010946|FG005|Overall Study|Adverse Event|0|||
146927285|NCT03943953|529894552|FG000|Trial of ITG 4|Lost to Follow-up|2|||
146927286|NCT03943953|529894553|FG001|Trial of ITG 4|Lost to Follow-up|0|||
146927287|NCT00289185|529894556|FG000|Overall Study|Withdrawal by Subject|4|||
146682211|NCT01606436|529010941|FG000|Overall Study|Sponsor Decision|0|||
146774797|NCT05057897|529346782|FG001|Overall Study|Death|0|||
146927288|NCT00289185|529894557|FG001|Overall Study|Withdrawal by Subject|8|||
146927289|NCT00289185|529894556|FG000|Overall Study|Lost to Follow-up|23|||
146927290|NCT00289185|529894557|FG001|Overall Study|Lost to Follow-up|17|||
146682212|NCT01606436|529010942|FG001|Overall Study|Sponsor Decision|0|||
146682213|NCT01606436|529010943|FG002|Overall Study|Sponsor Decision|0|||
146682214|NCT01606436|529010944|FG003|Overall Study|Sponsor Decision|1|||
146682215|NCT01606436|529010945|FG004|Overall Study|Sponsor Decision|0|||
146682216|NCT01606436|529010946|FG005|Overall Study|Sponsor Decision|0|||
146682217|NCT00110149|529010947|FG000|Overall Study|Physician Decision|3|||
146682218|NCT02452398|529010950|FG000|Overall Study|Adverse Event|1|||
146682219|NCT02452398|529010950|FG000|Overall Study|Lost to Follow-up|28|||
146682220|NCT02452398|529010950|FG000|Overall Study|Physician Decision|2|||
146682221|NCT02452398|529010950|FG000|Overall Study|Withdrawal by Subject|6|||
146682222|NCT02452398|529010950|FG000|Overall Study|Moved away|4|||
146682223|NCT02407704|529010951|FG000|Overall Study|Lost to Follow-up|0|||
146682224|NCT02407704|529010952|FG001|Overall Study|Lost to Follow-up|0|||
146682225|NCT02407704|529010953|FG002|Overall Study|Lost to Follow-up|0|||
146682226|NCT02407704|529010954|FG003|Overall Study|Lost to Follow-up|2|||
146682227|NCT02407704|529010951|FG000|Overall Study|Protocol Violation|0|||
146682228|NCT02407704|529010952|FG001|Overall Study|Protocol Violation|0|||
146682229|NCT02407704|529010953|FG002|Overall Study|Protocol Violation|0|||
146682230|NCT02407704|529010954|FG003|Overall Study|Protocol Violation|1|||
146682231|NCT02407704|529010951|FG000|Overall Study|Withdrawal by Subject|0|||
146682232|NCT02407704|529010952|FG001|Overall Study|Withdrawal by Subject|0|||
146682233|NCT02407704|529010953|FG002|Overall Study|Withdrawal by Subject|1|||
146682234|NCT02407704|529010954|FG003|Overall Study|Withdrawal by Subject|0|||
146682235|NCT00748033|529010957|FG000|Overall Study|Adverse Event|0|||
146682236|NCT00748033|529010958|FG001|Overall Study|Adverse Event|1|||
146682237|NCT01018186|529010959|FG000|2-week Run-in Period|Protocol Violation|1|||
146682238|NCT01018186|529010960|FG001|2-week Run-in Period|Protocol Violation|0|||
146682239|NCT01018186|529010961|FG002|2-week Run-in Period|Protocol Violation|0|||
146682240|NCT01018186|529010962|FG003|2-week Run-in Period|Protocol Violation|0|||
146682241|NCT01018186|529010959|FG000|2-week Run-in Period|Lost to Follow-up|2|||
146682242|NCT01018186|529010960|FG001|2-week Run-in Period|Lost to Follow-up|0|||
146682243|NCT01018186|529010961|FG002|2-week Run-in Period|Lost to Follow-up|0|||
146682244|NCT01018186|529010962|FG003|2-week Run-in Period|Lost to Follow-up|0|||
146682245|NCT01018186|529010959|FG000|2-week Run-in Period|Physician Decision|3|||
146682246|NCT01018186|529010960|FG001|2-week Run-in Period|Physician Decision|0|||
146682247|NCT01018186|529010961|FG002|2-week Run-in Period|Physician Decision|0|||
146682248|NCT01018186|529010962|FG003|2-week Run-in Period|Physician Decision|0|||
146682249|NCT01018186|529010959|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
146682250|NCT01018186|529010960|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
146682251|NCT01018186|529010961|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
146682252|NCT01018186|529010962|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
146682253|NCT01018186|529010959|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
146682254|NCT01018186|529010960|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
146682255|NCT01018186|529010961|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
146682256|NCT01018186|529010962|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
146682257|NCT01018186|529010959|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
146682258|NCT01018186|529010960|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
146682259|NCT01018186|529010961|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
146682260|NCT01018186|529010962|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
146682261|NCT01018186|529010959|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
146682262|NCT01018186|529010960|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
146682263|NCT01018186|529010961|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
146682264|NCT01018186|529010962|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
146682265|NCT01018186|529010959|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
146682266|NCT01018186|529010960|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
146682267|NCT01018186|529010961|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
146682268|NCT01018186|529010962|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
146682269|NCT01018186|529010959|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
146682270|NCT01018186|529010960|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
146682271|NCT01018186|529010961|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
146682272|NCT01018186|529010962|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
146927291|NCT00289185|529894556|FG000|Overall Study|Death|1|||
146682273|NCT01018186|529010959|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
146682274|NCT01018186|529010960|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
146682275|NCT01018186|529010961|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
146682276|NCT01018186|529010962|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
146927292|NCT00289185|529894557|FG001|Overall Study|Death|1|||
146927293|NCT01742078|529894558|FG000|Overall Study|Withdrawal by Subject|0|||
146927294|NCT01742078|529894559|FG001|Overall Study|Withdrawal by Subject|0|||
146927295|NCT01742078|529894560|FG002|Overall Study|Withdrawal by Subject|0|||
146927296|NCT01742078|529894561|FG003|Overall Study|Withdrawal by Subject|1|||
146682277|NCT01018186|529010959|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
146682278|NCT01018186|529010960|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
146682279|NCT01018186|529010961|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
146682280|NCT01018186|529010962|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
146682281|NCT01018186|529010959|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
146682282|NCT01018186|529010960|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
146682283|NCT01018186|529010961|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
146682284|NCT01018186|529010962|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
146682285|NCT03235154|529010965|FG000|Overall Study|Withdrawal by Subject|1|||
146682286|NCT03235154|529010965|FG000|Overall Study|Adverse Event|1|||
146682287|NCT03235154|529010965|FG000|Overall Study|Lost to Follow-up|2|||
146682288|NCT01922089|529010966|FG000|Overall Study|Adverse Event|18|||
146682289|NCT01922089|529010967|FG001|Overall Study|Adverse Event|13|||
146682290|NCT01922089|529010966|FG000|Overall Study|Protocol Deviation|10|||
146682291|NCT01922089|529010967|FG001|Overall Study|Protocol Deviation|7|||
146682292|NCT01922089|529010966|FG000|Overall Study|Withdrawal by Subject|3|||
146682293|NCT01922089|529010967|FG001|Overall Study|Withdrawal by Subject|4|||
146682294|NCT01922089|529010966|FG000|Overall Study|administrative problems|4|||
146682295|NCT01922089|529010967|FG001|Overall Study|administrative problems|1|||
146682296|NCT01922089|529010966|FG000|Overall Study|Physician Decision|2|||
146682297|NCT01922089|529010967|FG001|Overall Study|Physician Decision|3|||
146682298|NCT01922089|529010966|FG000|Overall Study|Death|2|||
146682299|NCT01922089|529010967|FG001|Overall Study|Death|1|||
146682300|NCT01922089|529010966|FG000|Overall Study|Lost to Follow-up|0|||
146682301|NCT01922089|529010967|FG001|Overall Study|Lost to Follow-up|1|||
146682302|NCT00434330|529010972|FG000|Overall Study|Adverse Event|0|||
146682303|NCT00434330|529010973|FG001|Overall Study|Adverse Event|0|||
146682304|NCT00434330|529010974|FG002|Overall Study|Adverse Event|1|||
146682305|NCT00434330|529010975|FG003|Overall Study|Adverse Event|0|||
146682306|NCT00434330|529010976|FG004|Overall Study|Adverse Event|0|||
146682307|NCT00434330|529010977|FG005|Overall Study|Adverse Event|0|||
146682308|NCT00434330|529010972|FG000|Overall Study|Death|1|||
146682309|NCT00434330|529010973|FG001|Overall Study|Death|0|||
146682310|NCT00434330|529010974|FG002|Overall Study|Death|0|||
146682311|NCT00434330|529010975|FG003|Overall Study|Death|0|||
146682312|NCT00434330|529010976|FG004|Overall Study|Death|1|||
146682313|NCT00434330|529010977|FG005|Overall Study|Death|1|||
146682314|NCT00434330|529010972|FG000|Overall Study|Withdrawal by Subject|0|||
146682315|NCT00434330|529010973|FG001|Overall Study|Withdrawal by Subject|0|||
146682316|NCT00434330|529010974|FG002|Overall Study|Withdrawal by Subject|1|||
146682317|NCT00434330|529010975|FG003|Overall Study|Withdrawal by Subject|1|||
146682318|NCT00434330|529010976|FG004|Overall Study|Withdrawal by Subject|0|||
146682319|NCT00434330|529010977|FG005|Overall Study|Withdrawal by Subject|0|||
146682320|NCT00434330|529010972|FG000|Overall Study|Renal transplant|0|||
146682321|NCT00434330|529010973|FG001|Overall Study|Renal transplant|0|||
146682322|NCT00434330|529010974|FG002|Overall Study|Renal transplant|0|||
146682323|NCT00434330|529010975|FG003|Overall Study|Renal transplant|1|||
146682324|NCT00434330|529010976|FG004|Overall Study|Renal transplant|0|||
146682325|NCT00434330|529010977|FG005|Overall Study|Renal transplant|0|||
146682326|NCT00434330|529010972|FG000|Overall Study|Subject Not Compliant With Study|0|||
146682327|NCT00434330|529010973|FG001|Overall Study|Subject Not Compliant With Study|0|||
146682328|NCT00434330|529010974|FG002|Overall Study|Subject Not Compliant With Study|1|||
146682329|NCT00434330|529010975|FG003|Overall Study|Subject Not Compliant With Study|0|||
146682330|NCT00434330|529010976|FG004|Overall Study|Subject Not Compliant With Study|0|||
146682331|NCT00434330|529010977|FG005|Overall Study|Subject Not Compliant With Study|0|||
146682332|NCT01428453|529010978|FG000|Overall Study|Adverse Event|2|||
146682333|NCT01428453|529010979|FG001|Overall Study|Adverse Event|7|||
146682334|NCT01428453|529010978|FG000|Overall Study|Protocol Violation|1|||
146682335|NCT01428453|529010979|FG001|Overall Study|Protocol Violation|0|||
146682336|NCT01428453|529010978|FG000|Overall Study|Lost to Follow-up|0|||
146927297|NCT01742078|529894562|FG004|Overall Study|Withdrawal by Subject|0|||
146927298|NCT01742078|529894563|FG005|Overall Study|Withdrawal by Subject|0|||
146927299|NCT01742078|529894564|FG006|Overall Study|Withdrawal by Subject|0|||
146682337|NCT01428453|529010979|FG001|Overall Study|Lost to Follow-up|1|||
146682338|NCT01428453|529010978|FG000|Overall Study|Withdrawal by Subject|3|||
146682339|NCT01428453|529010979|FG001|Overall Study|Withdrawal by Subject|1|||
146682340|NCT01996709|529010980|FG000|Overall Study|Withdrawal by Subject|1|||
146682341|NCT01996709|529010981|FG001|Overall Study|Withdrawal by Subject|0|||
146682342|NCT01996709|529010980|FG000|Overall Study|Lost to Follow-up|3|||
146682343|NCT01996709|529010981|FG001|Overall Study|Lost to Follow-up|0|||
146682344|NCT01996709|529010980|FG000|Overall Study|Subject Non-Compliant|1|||
146682345|NCT01996709|529010981|FG001|Overall Study|Subject Non-Compliant|0|||
146682346|NCT01996709|529010980|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
146682347|NCT01996709|529010981|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
146682348|NCT00850564|529010982|FG000|Overall Study|Withdrawal by Subject|2|||
146682349|NCT00848081|529012905|FG000|Overall Study|Adverse Event|6|||
146927300|NCT01742078|529894565|FG007|Overall Study|Withdrawal by Subject|0|||
146774798|NCT04524390|529346783|FG000|Double Blind|Consent Withdrawal by subject|2|||
146682350|NCT00848081|529012906|FG001|Overall Study|Adverse Event|7|||
146682351|NCT00848081|529012905|FG000|Overall Study|Protocol Violation|8|||
146682352|NCT00848081|529012906|FG001|Overall Study|Protocol Violation|5|||
146682353|NCT00848081|529012905|FG000|Overall Study|Lost to Follow-up|1|||
146682354|NCT00848081|529012906|FG001|Overall Study|Lost to Follow-up|0|||
146682355|NCT00848081|529012905|FG000|Overall Study|Physician Decision|0|||
146682356|NCT00848081|529012906|FG001|Overall Study|Physician Decision|3|||
146682357|NCT00848081|529012905|FG000|Overall Study|Withdrawal by Subject|5|||
146682358|NCT00848081|529012906|FG001|Overall Study|Withdrawal by Subject|3|||
146682359|NCT00589914|529012907|FG000|Overall Study|Adverse Event|19|||
146682360|NCT00589914|529012908|FG001|Overall Study|Adverse Event|10|||
146682361|NCT00589914|529012907|FG000|Overall Study|Death|2|||
146682362|NCT00589914|529012908|FG001|Overall Study|Death|0|||
146682363|NCT00589914|529012907|FG000|Overall Study|Lack of Efficacy|40|||
146682364|NCT00589914|529012908|FG001|Overall Study|Lack of Efficacy|43|||
146682365|NCT00589914|529012907|FG000|Overall Study|Lost to Follow-up|11|||
146682366|NCT00589914|529012908|FG001|Overall Study|Lost to Follow-up|18|||
146682367|NCT00589914|529012907|FG000|Overall Study|Pregnancy|1|||
146682368|NCT00589914|529012908|FG001|Overall Study|Pregnancy|0|||
146682369|NCT00589914|529012907|FG000|Overall Study|Withdrawal by Subject|55|||
146682370|NCT00589914|529012908|FG001|Overall Study|Withdrawal by Subject|49|||
146682371|NCT00589914|529012907|FG000|Overall Study|Other|22|||
146682372|NCT00589914|529012908|FG001|Overall Study|Other|17|||
146682373|NCT01356966|529012913|FG000|Overall Study|Withdrawal by Subject|1|||
146682374|NCT01356966|529012914|FG001|Overall Study|Withdrawal by Subject|2|||
146682375|NCT01356966|529012913|FG000|Overall Study|Physician Decision|1|||
146682376|NCT01356966|529012914|FG001|Overall Study|Physician Decision|0|||
146682377|NCT02289898|529012921|FG000|Overall Study|Death|5|||
146682378|NCT02289898|529012922|FG001|Overall Study|Death|4|||
146682379|NCT02289898|529012923|FG002|Overall Study|Death|3|||
146682380|NCT02289898|529012921|FG000|Overall Study|Physician Decision|2|||
146682381|NCT02289898|529012922|FG001|Overall Study|Physician Decision|5|||
146682382|NCT02289898|529012923|FG002|Overall Study|Physician Decision|2|||
146682383|NCT02289898|529012921|FG000|Overall Study|Withdrawal by Subject|0|||
146682384|NCT02289898|529012922|FG001|Overall Study|Withdrawal by Subject|4|||
146682385|NCT02289898|529012923|FG002|Overall Study|Withdrawal by Subject|1|||
146682386|NCT02289898|529012921|FG000|Overall Study|Adverse Event|3|||
146682387|NCT02289898|529012922|FG001|Overall Study|Adverse Event|5|||
146682388|NCT02289898|529012923|FG002|Overall Study|Adverse Event|5|||
146682389|NCT02289898|529012921|FG000|Overall Study|Disease progression|34|||
146682390|NCT02289898|529012922|FG001|Overall Study|Disease progression|28|||
146682391|NCT02289898|529012923|FG002|Overall Study|Disease progression|34|||
146682392|NCT02289898|529012921|FG000|Overall Study|Use of another anticancer therapy|0|||
146682393|NCT02289898|529012922|FG001|Overall Study|Use of another anticancer therapy|0|||
146682394|NCT02289898|529012923|FG002|Overall Study|Use of another anticancer therapy|1|||
146682395|NCT02289898|529012921|FG000|Overall Study|Other|8|||
146682396|NCT02289898|529012922|FG001|Overall Study|Other|7|||
146682397|NCT02289898|529012923|FG002|Overall Study|Other|10|||
146682398|NCT00103142|529012924|FG000|Overall Study|Adverse Event|1|||
146682399|NCT00103142|529012925|FG001|Overall Study|Adverse Event|0|||
146682400|NCT00103142|529012924|FG000|Overall Study|Progression of disease|2|||
146682401|NCT00103142|529012925|FG001|Overall Study|Progression of disease|1|||
146682402|NCT00142584|529012926|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
146682403|NCT00142584|529012927|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
146682404|NCT00142584|529012926|FG000|Overall Study|Withdrawal by Subject|30|||
146682405|NCT00142584|529012927|FG001|Overall Study|Withdrawal by Subject|16|||
146682406|NCT00142584|529012926|FG000|Overall Study|Lost to Follow-up|22|||
146682407|NCT00142584|529012927|FG001|Overall Study|Lost to Follow-up|12|||
146682408|NCT00142584|529012926|FG000|Overall Study|Adverse Event|14|||
146682409|NCT00142584|529012927|FG001|Overall Study|Adverse Event|5|||
146682410|NCT00142584|529012926|FG000|Overall Study|Protocol Violation|4|||
146682411|NCT00142584|529012927|FG001|Overall Study|Protocol Violation|7|||
146682412|NCT00142584|529012926|FG000|Overall Study|Treatment Failure|2|||
146682413|NCT00142584|529012927|FG001|Overall Study|Treatment Failure|0|||
146682414|NCT00759954|529012930|FG000|Overall Study|Personal reason|1|||
146682415|NCT00759954|529012931|FG001|Overall Study|Personal reason|0|||
146682416|NCT00759954|529012930|FG000|Overall Study|Adverse Event|1|||
146682417|NCT00759954|529012931|FG001|Overall Study|Adverse Event|2|||
146682418|NCT02875860|529012935|FG000|Overall Study|Withdrawal by Subject|0|||
146682419|NCT02875860|529012936|FG001|Overall Study|Withdrawal by Subject|1|||
146682420|NCT01156311|529012940|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
146682421|NCT01156311|529012941|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
146682422|NCT01156311|529012942|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
146774799|NCT04524390|529346784|FG001|Double Blind|Consent Withdrawal by subject|1|||
146774800|NCT04524390|529346785|FG002|Double Blind|Consent Withdrawal by subject|0|||
146682423|NCT01156311|529012943|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
146682424|NCT01156311|529012940|FG000|2-Month Monotherapy Period|Physician Decision|0|||
146682425|NCT01156311|529012941|FG001|2-Month Monotherapy Period|Physician Decision|1|||
146927301|NCT01742078|529894566|FG008|Overall Study|Withdrawal by Subject|0|||
146682426|NCT01156311|529012942|FG002|2-Month Monotherapy Period|Physician Decision|0|||
146682427|NCT01156311|529012943|FG003|2-Month Monotherapy Period|Physician Decision|0|||
146682428|NCT01156311|529012940|FG000|2-Month Monotherapy Period|Other|1|||
146682429|NCT01156311|529012941|FG001|2-Month Monotherapy Period|Other|0|||
146682430|NCT01156311|529012942|FG002|2-Month Monotherapy Period|Other|0|||
146682431|NCT01156311|529012943|FG003|2-Month Monotherapy Period|Other|0|||
146682432|NCT01156311|529012940|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
146682433|NCT01156311|529012941|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
146682434|NCT01156311|529012942|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
146682435|NCT01156311|529012943|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
146682436|NCT01156311|529012940|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
146682437|NCT01156311|529012941|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
146682438|NCT01156311|529012942|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
146682439|NCT01156311|529012943|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
146682440|NCT01156311|529012940|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
146682441|NCT01156311|529012941|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
146682442|NCT01156311|529012942|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
146682443|NCT01156311|529012943|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
146682444|NCT01156311|529012940|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
146682445|NCT01156311|529012941|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
146682446|NCT01156311|529012942|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
146682447|NCT01156311|529012943|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
146682448|NCT01156311|529012940|FG000|6-month Add-on Therapy Period|Other|0|||
146682449|NCT01156311|529012941|FG001|6-month Add-on Therapy Period|Other|0|||
146682450|NCT01156311|529012942|FG002|6-month Add-on Therapy Period|Other|1|||
146682451|NCT01156311|529012943|FG003|6-month Add-on Therapy Period|Other|2|||
146682452|NCT01741701|529012946|FG000|Overall Study|Adverse Event|5|||
146682453|NCT01741701|529012947|FG001|Overall Study|Adverse Event|1|||
146682454|NCT01741701|529012946|FG000|Overall Study|Withdrawal by Subject|0|||
146682455|NCT01741701|529012947|FG001|Overall Study|Withdrawal by Subject|1|||
146682456|NCT03033394|529012948|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
146682457|NCT03033394|529012948|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
146682458|NCT03033394|529012948|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
146682459|NCT03033394|529012948|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
146682460|NCT03033394|529012948|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
146682461|NCT02927431|529012950|FG000|Overall Study|Withdrawal by Subject|0|||
146682462|NCT02927431|529012951|FG001|Overall Study|Withdrawal by Subject|0|||
146682463|NCT02927431|529012952|FG002|Overall Study|Withdrawal by Subject|1|||
146682464|NCT01830972|529012953|FG000|Part II|Withdrawal by Subject|2|||
146682465|NCT01830972|529012954|FG001|Part II|Withdrawal by Subject|2|||
146682466|NCT01830972|529012953|FG000|Part III|Withdrawal by Subject|1|||
146682467|NCT01830972|529012954|FG001|Part III|Withdrawal by Subject|0|||
146682468|NCT01830972|529012953|FG000|Part III|Noncompliance|1|||
146682469|NCT01830972|529012954|FG001|Part III|Noncompliance|0|||
146682470|NCT01830972|529012953|FG000|Part IV|Withdrawal by Subject|2|||
146682471|NCT01830972|529012954|FG001|Part IV|Withdrawal by Subject|1|||
146682472|NCT01830972|529012953|FG000|Part IV|Non-Compliance|1|||
146682473|NCT01830972|529012954|FG001|Part IV|Non-Compliance|0|||
146682474|NCT00673465|529012955|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
146682475|NCT00673465|529012956|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
146682476|NCT00673465|529012957|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
146682477|NCT00673465|529012958|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
146682478|NCT00673465|529012959|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
146682479|NCT00673465|529012960|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
146682480|NCT00673465|529012961|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
146682481|NCT00673465|529012962|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
146682482|NCT00673465|529012963|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
146682483|NCT00673465|529012964|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
146682484|NCT00673465|529012965|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
146682485|NCT00673465|529012966|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
146682486|NCT00673465|529012955|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
146682487|NCT00673465|529012956|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
146682488|NCT00673465|529012957|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
146927302|NCT01124448|529894571|FG000|Overall Study|Lost to Follow-up|0|||
146927303|NCT01124448|529894572|FG001|Overall Study|Lost to Follow-up|3|||
146682489|NCT00673465|529012958|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
146682490|NCT00673465|529012959|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
146682491|NCT00673465|529012960|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
146682492|NCT00673465|529012961|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
146927304|NCT01124448|529894571|FG000|Overall Study|Protocol Violation|2|||
146682493|NCT00673465|529012962|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
146682494|NCT00673465|529012963|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
146682495|NCT00673465|529012964|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
146682496|NCT00673465|529012965|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
146682497|NCT00673465|529012966|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
146682498|NCT01829191|529012967|FG000|Overall Study|Relocation|0|||
146682499|NCT01829191|529012968|FG001|Overall Study|Relocation|1|||
146682500|NCT01829191|529012967|FG000|Overall Study|Lens discomfort|0|||
146682501|NCT01829191|529012968|FG001|Overall Study|Lens discomfort|3|||
146682502|NCT01829191|529012967|FG000|Overall Study|Lens handling difficulty|1|||
146682503|NCT01829191|529012968|FG001|Overall Study|Lens handling difficulty|4|||
146682504|NCT01829191|529012967|FG000|Overall Study|Protocol Violation|4|||
146682505|NCT01829191|529012968|FG001|Overall Study|Protocol Violation|1|||
146682506|NCT01829191|529012967|FG000|Overall Study|Withdrawal by Subject|2|||
146682507|NCT01829191|529012968|FG001|Overall Study|Withdrawal by Subject|3|||
146682508|NCT01829191|529012967|FG000|Overall Study|Lost to Follow-up|0|||
146682509|NCT01829191|529012968|FG001|Overall Study|Lost to Follow-up|1|||
146682510|NCT01829191|529012967|FG000|Overall Study|Subject was fit for ortho - k|0|||
146682511|NCT01829191|529012968|FG001|Overall Study|Subject was fit for ortho - k|1|||
146682512|NCT01276353|529012969|FG000|Double-blind|Adverse Event|2|||
146682513|NCT01276353|529012970|FG001|Double-blind|Adverse Event|0|||
146682514|NCT01276353|529012969|FG000|Double-blind|Withdrawal by Subject|1|||
146682515|NCT01276353|529012970|FG001|Double-blind|Withdrawal by Subject|0|||
146682516|NCT01276353|529012969|FG000|Extension|Adverse Event|2|||
146682517|NCT01276353|529012970|FG001|Extension|Adverse Event|5|||
146682518|NCT01276353|529012969|FG000|Extension|Withdrawal by Subject|1|||
146682519|NCT01276353|529012970|FG001|Extension|Withdrawal by Subject|2|||
146682520|NCT01276353|529012969|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
146682521|NCT01276353|529012970|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
146682522|NCT01276353|529012969|FG000|Extension|Physician Decision|1|||
146682523|NCT01276353|529012970|FG001|Extension|Physician Decision|0|||
146682524|NCT01276353|529012969|FG000|Extension|Prohibited concomitant medications|0|||
146682525|NCT01276353|529012970|FG001|Extension|Prohibited concomitant medications|1|||
146682526|NCT00553514|529012971|FG000|Overall Study|Protocol deviation|0|||
146682527|NCT00553514|529012972|FG001|Overall Study|Protocol deviation|0|||
146682528|NCT00553514|529012973|FG002|Overall Study|Protocol deviation|0|||
146682529|NCT00553514|529012974|FG003|Overall Study|Protocol deviation|1|||
146682530|NCT00553514|529012975|FG004|Overall Study|Protocol deviation|0|||
146682531|NCT00553514|529012971|FG000|Overall Study|Lack of ovarian response|4|||
146682532|NCT00553514|529012972|FG001|Overall Study|Lack of ovarian response|5|||
146682533|NCT00553514|529012973|FG002|Overall Study|Lack of ovarian response|5|||
146682534|NCT00553514|529012974|FG003|Overall Study|Lack of ovarian response|5|||
146682535|NCT00553514|529012975|FG004|Overall Study|Lack of ovarian response|6|||
146682536|NCT00553514|529012971|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
146682537|NCT00553514|529012972|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
146682538|NCT00553514|529012973|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
146682539|NCT00553514|529012974|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
146682540|NCT00553514|529012975|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
146682541|NCT00553514|529012971|FG000|Overall Study|Risk of multiple pregnancy|0|||
146682542|NCT00553514|529012972|FG001|Overall Study|Risk of multiple pregnancy|2|||
146682543|NCT00553514|529012973|FG002|Overall Study|Risk of multiple pregnancy|0|||
146682544|NCT00553514|529012974|FG003|Overall Study|Risk of multiple pregnancy|1|||
146682545|NCT00553514|529012975|FG004|Overall Study|Risk of multiple pregnancy|0|||
146682546|NCT00553514|529012971|FG000|Overall Study|Other|1|||
146774801|NCT04524390|529346783|FG000|Double Blind|Adverse Event|5|||
146774802|NCT04524390|529346784|FG001|Double Blind|Adverse Event|3|||
146774803|NCT04524390|529346785|FG002|Double Blind|Adverse Event|0|||
146774804|NCT04524390|529346783|FG000|Double Blind|Liver Transplant|5|||
146774805|NCT04524390|529346784|FG001|Double Blind|Liver Transplant|6|||
146774806|NCT04524390|529346785|FG002|Double Blind|Liver Transplant|0|||
146774807|NCT04524390|529346783|FG000|Double Blind|Disease Progression|0|||
146774808|NCT04524390|529346784|FG001|Double Blind|Disease Progression|1|||
146682547|NCT00553514|529012972|FG001|Overall Study|Other|1|||
146682548|NCT00553514|529012973|FG002|Overall Study|Other|0|||
146682549|NCT00553514|529012974|FG003|Overall Study|Other|0|||
146682550|NCT00553514|529012975|FG004|Overall Study|Other|1|||
146682551|NCT04952402|529012976|FG000|Overall Study|Lost to Follow-up|1|||
146682552|NCT04952402|529012977|FG001|Overall Study|Lost to Follow-up|3|||
146682553|NCT04952402|529012976|FG000|Overall Study|Lack Of Venous Access|0|||
146774809|NCT04524390|529346785|FG002|Double Blind|Disease Progression|0|||
146682554|NCT04952402|529012977|FG001|Overall Study|Lack Of Venous Access|1|||
146774810|NCT04524390|529346783|FG000|Open-Label|Drug interruption criteria|0|||
146682555|NCT00726661|529012978|FG000|Overall Study|Lost to Follow-up|36|||
146774811|NCT04524390|529346784|FG001|Open-Label|Drug interruption criteria|0|||
146682556|NCT00726661|529012979|FG001|Overall Study|Lost to Follow-up|11|||
146682557|NCT00726661|529012978|FG000|Overall Study|Withdrawal by Subject|17|||
146682558|NCT00726661|529012979|FG001|Overall Study|Withdrawal by Subject|13|||
146682559|NCT00726661|529012978|FG000|Overall Study|Trial terminated by sponsor|214|||
146682560|NCT00726661|529012979|FG001|Overall Study|Trial terminated by sponsor|187|||
146682561|NCT00726661|529012978|FG000|Overall Study|Death|475|||
146682562|NCT00726661|529012979|FG001|Overall Study|Death|159|||
146682563|NCT00726661|529012978|FG000|Overall Study|Physician Decision|25|||
146682564|NCT00726661|529012979|FG001|Overall Study|Physician Decision|13|||
146682565|NCT00726661|529012978|FG000|Overall Study|Other|47|||
146682566|NCT00726661|529012979|FG001|Overall Study|Other|35|||
146682567|NCT01285310|529012982|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
146682568|NCT01285310|529012983|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
146682569|NCT01285310|529012984|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
146682570|NCT01285310|529012985|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
146682571|NCT01285310|529012986|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
146682572|NCT01285310|529012982|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
146682573|NCT01285310|529012983|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
146682574|NCT01285310|529012984|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
146682575|NCT01285310|529012985|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
146682576|NCT01285310|529012986|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
146682577|NCT01285310|529012982|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
146682578|NCT01285310|529012983|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
146682579|NCT01285310|529012984|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
146682580|NCT01285310|529012985|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
146682581|NCT01285310|529012986|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
146682582|NCT01285310|529012982|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
146682583|NCT01285310|529012983|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
146682584|NCT01285310|529012984|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
146682585|NCT01285310|529012985|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
146682586|NCT01285310|529012986|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
146682587|NCT01285310|529012982|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
146682588|NCT01285310|529012983|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
146682589|NCT01285310|529012984|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
146682590|NCT01285310|529012985|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
146682591|NCT01285310|529012986|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
146682592|NCT01285310|529012982|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
146682593|NCT01285310|529012983|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
146682594|NCT01285310|529012984|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
146682595|NCT01285310|529012985|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
146682596|NCT01285310|529012986|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
146682597|NCT01285310|529012982|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
146682598|NCT01285310|529012983|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
146682599|NCT01285310|529012984|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
146682600|NCT01285310|529012985|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
146682601|NCT01285310|529012986|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
146682602|NCT01285310|529012982|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
146682603|NCT01285310|529012983|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
146682604|NCT01285310|529012984|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
146682605|NCT01285310|529012985|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
146682606|NCT01285310|529012986|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
146682607|NCT01285310|529012982|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
146682608|NCT01285310|529012983|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
146682609|NCT01285310|529012984|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
146682610|NCT01285310|529012985|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
146682611|NCT01285310|529012986|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
146682612|NCT01285310|529012982|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
146682613|NCT01285310|529012983|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
146682614|NCT01285310|529012984|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
146682615|NCT01285310|529012985|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
146682616|NCT01285310|529012986|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
146682617|NCT01285310|529012982|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
146682618|NCT01285310|529012983|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
146682619|NCT01285310|529012984|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
146682620|NCT01285310|529012985|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
146682621|NCT01285310|529012986|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
146682622|NCT01285310|529012982|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
146682623|NCT01285310|529012983|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
146682624|NCT01285310|529012984|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
146682625|NCT01285310|529012985|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
146682626|NCT01285310|529012986|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
146682627|NCT00514540|529012987|FG000|First-Line Chemo|Withdrawal by Subject|1|||
146682628|NCT00514540|529012987|FG000|First-Line Chemo|Protocol Violation|7|||
146682629|NCT00514540|529012987|FG000|Second-Line|Physician/Patient Decision|31|||
146682630|NCT00752232|529012990|FG000|Overall Study|Protocol Violation|0|||
146682631|NCT00752232|529012991|FG001|Overall Study|Protocol Violation|0|||
146682632|NCT00752232|529012992|FG002|Overall Study|Protocol Violation|0|||
146682633|NCT00752232|529012993|FG003|Overall Study|Protocol Violation|0|||
146682634|NCT00752232|529012994|FG004|Overall Study|Protocol Violation|0|||
146682635|NCT00752232|529012995|FG005|Overall Study|Protocol Violation|1|||
146682636|NCT00752232|529012996|FG006|Overall Study|Protocol Violation|0|||
146682637|NCT00752232|529012990|FG000|Overall Study|Caregiver request|2|||
146682638|NCT00752232|529012991|FG001|Overall Study|Caregiver request|0|||
146682639|NCT00752232|529012992|FG002|Overall Study|Caregiver request|0|||
146682640|NCT00752232|529012993|FG003|Overall Study|Caregiver request|0|||
146682641|NCT00752232|529012994|FG004|Overall Study|Caregiver request|1|||
146682642|NCT00752232|529012995|FG005|Overall Study|Caregiver request|0|||
146682643|NCT00752232|529012996|FG006|Overall Study|Caregiver request|0|||
146682644|NCT00752232|529012990|FG000|Overall Study|Investigator request|0|||
146682645|NCT00752232|529012991|FG001|Overall Study|Investigator request|0|||
146682646|NCT00752232|529012992|FG002|Overall Study|Investigator request|0|||
146682647|NCT00752232|529012993|FG003|Overall Study|Investigator request|0|||
146682648|NCT00752232|529012994|FG004|Overall Study|Investigator request|1|||
146682649|NCT00752232|529012995|FG005|Overall Study|Investigator request|0|||
146682650|NCT00752232|529012996|FG006|Overall Study|Investigator request|0|||
146682651|NCT00752232|529012990|FG000|Overall Study|Subject request|0|||
146682652|NCT00752232|529012991|FG001|Overall Study|Subject request|0|||
146682653|NCT00752232|529012992|FG002|Overall Study|Subject request|1|||
146682654|NCT00752232|529012993|FG003|Overall Study|Subject request|0|||
146682655|NCT00752232|529012994|FG004|Overall Study|Subject request|0|||
146682656|NCT00752232|529012995|FG005|Overall Study|Subject request|0|||
146682657|NCT00752232|529012996|FG006|Overall Study|Subject request|0|||
146682658|NCT00752232|529012990|FG000|Overall Study|Group home admission|0|||
146682659|NCT00752232|529012991|FG001|Overall Study|Group home admission|0|||
146682660|NCT00752232|529012992|FG002|Overall Study|Group home admission|0|||
146682661|NCT00752232|529012993|FG003|Overall Study|Group home admission|1|||
146682662|NCT00752232|529012994|FG004|Overall Study|Group home admission|0|||
146682663|NCT00752232|529012995|FG005|Overall Study|Group home admission|0|||
146682664|NCT00752232|529012996|FG006|Overall Study|Group home admission|0|||
146682665|NCT00752232|529012990|FG000|Overall Study|Caregiver could not attend the subject|0|||
146682666|NCT00752232|529012991|FG001|Overall Study|Caregiver could not attend the subject|0|||
146682667|NCT00752232|529012992|FG002|Overall Study|Caregiver could not attend the subject|0|||
146682668|NCT00752232|529012993|FG003|Overall Study|Caregiver could not attend the subject|0|||
146682669|NCT00752232|529012994|FG004|Overall Study|Caregiver could not attend the subject|1|||
146682670|NCT00752232|529012995|FG005|Overall Study|Caregiver could not attend the subject|0|||
146682671|NCT00752232|529012996|FG006|Overall Study|Caregiver could not attend the subject|0|||
146682672|NCT00555321|529012997|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
146682673|NCT00555321|529012998|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
146682674|NCT00555321|529012999|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
146682675|NCT00555321|529013000|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
146682676|NCT00555321|529013001|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
146682677|NCT00555321|529012997|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
146682678|NCT00555321|529012998|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
146682679|NCT00555321|529012999|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
146682680|NCT00555321|529013000|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
146682681|NCT00555321|529013001|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
146682682|NCT00555321|529012997|FG000|Treatment Phase up to 12-months|Death|2|||
146682683|NCT00555321|529012998|FG001|Treatment Phase up to 12-months|Death|1|||
146682684|NCT00555321|529012999|FG002|Treatment Phase up to 12-months|Death|4|||
146682685|NCT00555321|529013000|FG003|Treatment Phase up to 12-months|Death|0|||
146682686|NCT00555321|529013001|FG004|Treatment Phase up to 12-months|Death|0|||
146848278|NCT00872989|529615643|FG000|Overall Study|Adverse Event|7|||
146682687|NCT00555321|529012997|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
146682688|NCT00555321|529012998|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
146682689|NCT00555321|529012999|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
146682690|NCT00555321|529013000|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
146682691|NCT00555321|529013001|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
146682692|NCT00555321|529012997|FG000|Treatment Phase up to 12-months|Other Reason|1|||
146848279|NCT00872989|529615644|FG001|Overall Study|Adverse Event|15|||
146848280|NCT00872989|529615643|FG000|Overall Study|Withdrawal by Subject|8|||
146848281|NCT00872989|529615644|FG001|Overall Study|Withdrawal by Subject|5|||
146848282|NCT00872989|529615643|FG000|Overall Study|Progression/relapse|47|||
146848283|NCT00872989|529615644|FG001|Overall Study|Progression/relapse|35|||
146848284|NCT00872989|529615643|FG000|Overall Study|Not protocol specified|3|||
146848285|NCT00872989|529615644|FG001|Overall Study|Not protocol specified|8|||
146682693|NCT00555321|529012998|FG001|Treatment Phase up to 12-months|Other Reason|3|||
146682694|NCT00555321|529012999|FG002|Treatment Phase up to 12-months|Other Reason|2|||
146682695|NCT00555321|529013000|FG003|Treatment Phase up to 12-months|Other Reason|0|||
146682696|NCT00555321|529013001|FG004|Treatment Phase up to 12-months|Other Reason|0|||
146682697|NCT00555321|529012997|FG000|Treatment Phase up to 12-months|Never treated|2|||
146682698|NCT00555321|529012998|FG001|Treatment Phase up to 12-months|Never treated|3|||
146682699|NCT00555321|529012999|FG002|Treatment Phase up to 12-months|Never treated|1|||
146682700|NCT00555321|529013000|FG003|Treatment Phase up to 12-months|Never treated|0|||
146927305|NCT01124448|529894572|FG001|Overall Study|Protocol Violation|0|||
146927306|NCT03247413|529894576|FG000|Overall Study|Lost to Follow-up|28|||
146927307|NCT03337152|529894577|FG000|Overall Study|Physician Decision|1|||
146682701|NCT00555321|529013001|FG004|Treatment Phase up to 12-months|Never treated|4|||
146682702|NCT00555321|529012997|FG000|Long-term Extension Phase|Adverse Event|2|||
146682703|NCT00555321|529012998|FG001|Long-term Extension Phase|Adverse Event|5|||
146682704|NCT00555321|529012999|FG002|Long-term Extension Phase|Adverse Event|2|||
146682705|NCT00555321|529013000|FG003|Long-term Extension Phase|Adverse Event|1|||
146682706|NCT00555321|529013001|FG004|Long-term Extension Phase|Adverse Event|0|||
146682707|NCT00555321|529012997|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
146682708|NCT00555321|529012998|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
146682709|NCT00555321|529012999|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
146682710|NCT00555321|529013000|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
146682711|NCT00555321|529013001|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
146682712|NCT00555321|529012997|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
146682713|NCT00555321|529012998|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
146682714|NCT00555321|529012999|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
146682715|NCT00555321|529013000|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
146682716|NCT00555321|529013001|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
146682717|NCT00555321|529012997|FG000|Long-term Extension Phase|Death|2|||
146682718|NCT00555321|529012998|FG001|Long-term Extension Phase|Death|0|||
146682719|NCT00555321|529012999|FG002|Long-term Extension Phase|Death|0|||
146682720|NCT00555321|529013000|FG003|Long-term Extension Phase|Death|3|||
146682721|NCT00555321|529013001|FG004|Long-term Extension Phase|Death|0|||
146682722|NCT00555321|529012997|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
146682723|NCT00555321|529012998|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
146682724|NCT00555321|529012999|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
146682725|NCT00555321|529013000|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
146682726|NCT00555321|529013001|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
146682727|NCT00555321|529012997|FG000|Long-term Extension Phase|Other Reason|1|||
146682728|NCT00555321|529012998|FG001|Long-term Extension Phase|Other Reason|0|||
146682729|NCT00555321|529012999|FG002|Long-term Extension Phase|Other Reason|2|||
146682730|NCT00555321|529013000|FG003|Long-term Extension Phase|Other Reason|0|||
146682731|NCT00555321|529013001|FG004|Long-term Extension Phase|Other Reason|0|||
146682732|NCT00005937|529013002|FG000|Overall Study|Lack of Efficacy|5|||
146682733|NCT00563381|529013003|FG000|Overall Study|Adverse Event|264|||
146682734|NCT00563381|529013004|FG001|Overall Study|Adverse Event|292|||
146682735|NCT00563381|529013003|FG000|Overall Study|Protocol Violation|66|||
146682736|NCT00563381|529013004|FG001|Overall Study|Protocol Violation|74|||
146682737|NCT00563381|529013003|FG000|Overall Study|Lost to Follow-up|7|||
146682738|NCT00563381|529013004|FG001|Overall Study|Lost to Follow-up|15|||
146682739|NCT00563381|529013003|FG000|Overall Study|Withdrawal by Subject|192|||
146682740|NCT00563381|529013004|FG001|Overall Study|Withdrawal by Subject|209|||
146682741|NCT00563381|529013003|FG000|Overall Study|Lack of Efficacy|32|||
146682742|NCT00563381|529013004|FG001|Overall Study|Lack of Efficacy|24|||
146682743|NCT00563381|529013003|FG000|Overall Study|Individual different reasons|24|||
146682744|NCT00563381|529013004|FG001|Overall Study|Individual different reasons|34|||
146682745|NCT02730455|529013005|FG000|Overall Study|Death|5|||
146682746|NCT02730455|529013006|FG001|Overall Study|Death|6|||
146682747|NCT02730455|529013007|FG002|Overall Study|Death|4|||
146682748|NCT02730455|529013005|FG000|Overall Study|Consent withdrawn|2|||
146682749|NCT02730455|529013006|FG001|Overall Study|Consent withdrawn|4|||
146682750|NCT02730455|529013007|FG002|Overall Study|Consent withdrawn|1|||
146682751|NCT02730455|529013005|FG000|Overall Study|Lost to Follow-up|3|||
146682752|NCT02730455|529013006|FG001|Overall Study|Lost to Follow-up|1|||
146682753|NCT02730455|529013007|FG002|Overall Study|Lost to Follow-up|4|||
146682754|NCT02730455|529013005|FG000|Overall Study|Other|1|||
146682755|NCT02730455|529013006|FG001|Overall Study|Other|1|||
146774812|NCT04524390|529346785|FG002|Open-Label|Drug interruption criteria|1|||
146682756|NCT02730455|529013007|FG002|Overall Study|Other|2|||
146682757|NCT02730455|529013005|FG000|Overall Study|Other|2|||
146682758|NCT02730455|529013006|FG001|Overall Study|Other|2|||
146682759|NCT02730455|529013007|FG002|Overall Study|Other|0|||
146682760|NCT01683383|529013011|FG000|Overall Study|Infant was not transported|1|||
146682761|NCT01683383|529013012|FG001|Overall Study|Infant was not transported|0|||
146774813|NCT04524390|529346783|FG000|Open-Label|Liver Transplant|0|||
146927308|NCT03337152|529894578|FG001|Overall Study|Physician Decision|0|||
146682762|NCT00996307|529013013|FG000|Overall Study|Adverse Event|0|||
146682763|NCT00996307|529013014|FG001|Overall Study|Adverse Event|1|||
146682764|NCT00996307|529013015|FG002|Overall Study|Adverse Event|0|||
146682765|NCT00996307|529013016|FG003|Overall Study|Adverse Event|0|||
146682766|NCT00996307|529013013|FG000|Overall Study|Withdrawal by Subject|3|||
146682767|NCT00996307|529013014|FG001|Overall Study|Withdrawal by Subject|2|||
146682768|NCT00996307|529013015|FG002|Overall Study|Withdrawal by Subject|5|||
146682769|NCT00996307|529013016|FG003|Overall Study|Withdrawal by Subject|5|||
146682770|NCT00996307|529013013|FG000|Overall Study|Lost to Follow-up|13|||
146682771|NCT00996307|529013014|FG001|Overall Study|Lost to Follow-up|13|||
146682772|NCT00996307|529013015|FG002|Overall Study|Lost to Follow-up|7|||
146682773|NCT00996307|529013016|FG003|Overall Study|Lost to Follow-up|15|||
146682774|NCT00996307|529013013|FG000|Overall Study|Administrative reason|0|||
146682775|NCT00996307|529013014|FG001|Overall Study|Administrative reason|1|||
146682776|NCT00996307|529013015|FG002|Overall Study|Administrative reason|0|||
146682777|NCT00996307|529013016|FG003|Overall Study|Administrative reason|0|||
146682778|NCT00996307|529013013|FG000|Overall Study|Unable to classify|4|||
146682779|NCT00996307|529013014|FG001|Overall Study|Unable to classify|0|||
146682780|NCT00996307|529013015|FG002|Overall Study|Unable to classify|2|||
146682781|NCT00996307|529013016|FG003|Overall Study|Unable to classify|1|||
146682782|NCT02326025|529013017|FG000|Overall Study|Adverse Event|3|||
146682783|NCT02326025|529013018|FG001|Overall Study|Adverse Event|0|||
146682784|NCT02326025|529013017|FG000|Overall Study|Physician Decision|1|||
146682785|NCT02326025|529013018|FG001|Overall Study|Physician Decision|2|||
146682786|NCT02326025|529013017|FG000|Overall Study|Physician and Participant Decision|1|||
146682787|NCT02326025|529013018|FG001|Overall Study|Physician and Participant Decision|0|||
146682788|NCT02326025|529013017|FG000|Overall Study|Withdrawal by Subject|0|||
146682789|NCT02326025|529013018|FG001|Overall Study|Withdrawal by Subject|2|||
146682790|NCT02326025|529013017|FG000|Overall Study|Protocol Violation|0|||
146682791|NCT02326025|529013018|FG001|Overall Study|Protocol Violation|1|||
146682792|NCT00001723|529013019|FG000|Overall Study|Lack of Efficacy|6|||
146682793|NCT00001723|529013020|FG001|Overall Study|Lack of Efficacy|7|||
146682794|NCT00001723|529013019|FG000|Overall Study|Lack of family interest|4|||
146682795|NCT00001723|529013020|FG001|Overall Study|Lack of family interest|5|||
146682796|NCT00001723|529013019|FG000|Overall Study|Lost to Follow-up|2|||
146682797|NCT00001723|529013020|FG001|Overall Study|Lost to Follow-up|2|||
146682798|NCT00001723|529013019|FG000|Overall Study|medication intolerance|1|||
146682799|NCT00001723|529013020|FG001|Overall Study|medication intolerance|2|||
146682800|NCT00536198|529013021|FG000|Overall Study|Lost to Follow-up|15|||
146682801|NCT00536198|529013022|FG001|Overall Study|Lost to Follow-up|14|||
146682802|NCT00536198|529013021|FG000|Overall Study|Withdrawal by Subject|16|||
146682803|NCT00536198|529013022|FG001|Overall Study|Withdrawal by Subject|12|||
146682804|NCT00536198|529013021|FG000|Overall Study|Adverse Event|2|||
146682805|NCT00536198|529013022|FG001|Overall Study|Adverse Event|2|||
146682806|NCT00536198|529013021|FG000|Overall Study|Rescue|3|||
146682807|NCT00536198|529013022|FG001|Overall Study|Rescue|9|||
146682808|NCT00536198|529013021|FG000|Overall Study|Pregnancy|1|||
146682809|NCT00536198|529013022|FG001|Overall Study|Pregnancy|1|||
146682810|NCT00536198|529013021|FG000|Overall Study|Protocol Violation|0|||
146682811|NCT00536198|529013022|FG001|Overall Study|Protocol Violation|1|||
146682812|NCT02643082|529013023|FG000|Period 1|Adverse Event|1|||
146682813|NCT02643082|529013024|FG001|Period 1|Adverse Event|0|||
146682814|NCT00881712|529013025|FG000|Overall Study|Death|1|||
146682815|NCT00881712|529013026|FG001|Overall Study|Death|0|||
146682816|NCT00881712|529013027|FG002|Overall Study|Death|0|||
146682817|NCT00881712|529013025|FG000|Overall Study|Withdrawal by Subject|1|||
146927309|NCT03337152|529894577|FG000|Overall Study|Lost to Follow-up|1|||
146927310|NCT03337152|529894578|FG001|Overall Study|Lost to Follow-up|3|||
146927311|NCT03337152|529894577|FG000|Overall Study|Adverse Event|3|||
146927312|NCT03337152|529894578|FG001|Overall Study|Adverse Event|1|||
146682818|NCT00881712|529013026|FG001|Overall Study|Withdrawal by Subject|0|||
146682819|NCT00881712|529013027|FG002|Overall Study|Withdrawal by Subject|0|||
146682820|NCT01324999|529013028|FG000|Overall Study|Adverse Event|3|||
146927313|NCT03337152|529894577|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
146927314|NCT03337152|529894578|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
146682821|NCT01324999|529013028|FG000|Overall Study|Withdrawal by Subject|2|||
146682822|NCT02505867|529013030|FG000|Overall Study|Lack of Efficacy|6|||
146682823|NCT02505867|529013031|FG001|Overall Study|Lack of Efficacy|6|||
146682824|NCT00230607|529013036|FG000|Overall Study|Other|3|||
146682825|NCT02860169|529013037|FG000|Part A|Withdrawal by Subject|1|||
146682826|NCT02860169|529013037|FG000|Part A|Other (Screening failure)|6|||
146682827|NCT02860169|529013037|FG000|Part A|Other (Survey not completed)|3|||
146682828|NCT02860169|529013037|FG000|Part A|Other (did not completed consent)|1|||
146682829|NCT02860169|529013037|FG000|Part B|Other (Screening failure)|10|||
146682830|NCT02860169|529013037|FG000|Part B|Withdrawal by Subject|1|||
146682831|NCT02860169|529013037|FG000|Part C|Other (Screening failure)|1|||
146682832|NCT00165776|529013038|FG000|Overall Study|Lack of Efficacy|0|||
146682833|NCT00165776|529013039|FG001|Overall Study|Lack of Efficacy|0|||
146682834|NCT00165776|529013040|FG002|Overall Study|Lack of Efficacy|0|||
146682835|NCT00165776|529013041|FG003|Overall Study|Lack of Efficacy|1|||
146682836|NCT00165776|529013038|FG000|Overall Study|Withdrawal by Subject|4|||
146682837|NCT00165776|529013039|FG001|Overall Study|Withdrawal by Subject|1|||
146682838|NCT00165776|529013040|FG002|Overall Study|Withdrawal by Subject|2|||
146682839|NCT00165776|529013041|FG003|Overall Study|Withdrawal by Subject|0|||
146682840|NCT00165776|529013038|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
146682841|NCT00165776|529013039|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
146682842|NCT00165776|529013040|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
146682843|NCT00165776|529013041|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
146682844|NCT01648205|529013049|FG000|Placebo|Pregnancy|1|||
146682845|NCT01648205|529013049|FG000|Placebo|Withdrawal by Subject|1|||
146682846|NCT01648205|529013049|FG000|Placebo|Protocol Violation|2|||
146682847|NCT01648205|529013049|FG000|Ranolazine|Death|1|||
146682848|NCT01648205|529013049|FG000|Ranolazine|Withdrawal by Subject|1|||
146682849|NCT01648205|529013049|FG000|Ranolazine|Protocol Violation|3|||
146682850|NCT00203996|529013050|FG000|Overall Study|Lost to Follow-up|0|||
146682851|NCT00203996|529013051|FG001|Overall Study|Lost to Follow-up|0|||
146682852|NCT00203996|529013052|FG002|Overall Study|Lost to Follow-up|0|||
146682853|NCT00203996|529013053|FG003|Overall Study|Lost to Follow-up|1|||
146682854|NCT00203996|529013054|FG004|Overall Study|Lost to Follow-up|0|||
146682855|NCT00203996|529013055|FG005|Overall Study|Lost to Follow-up|0|||
146682856|NCT00203996|529013056|FG006|Overall Study|Lost to Follow-up|0|||
146682857|NCT00203996|529013057|FG007|Overall Study|Lost to Follow-up|0|||
146682858|NCT00203996|529013058|FG008|Overall Study|Lost to Follow-up|0|||
146682859|NCT00203996|529013059|FG009|Overall Study|Lost to Follow-up|0|||
146682860|NCT00203996|529013050|FG000|Overall Study|Protocol Violation|0|||
146682861|NCT00203996|529013051|FG001|Overall Study|Protocol Violation|0|||
146682862|NCT00203996|529013052|FG002|Overall Study|Protocol Violation|0|||
146682863|NCT00203996|529013053|FG003|Overall Study|Protocol Violation|6|||
146682864|NCT00203996|529013054|FG004|Overall Study|Protocol Violation|1|||
146682865|NCT00203996|529013055|FG005|Overall Study|Protocol Violation|0|||
146682866|NCT00203996|529013056|FG006|Overall Study|Protocol Violation|0|||
146682867|NCT00203996|529013057|FG007|Overall Study|Protocol Violation|0|||
146682868|NCT00203996|529013058|FG008|Overall Study|Protocol Violation|0|||
146682869|NCT00203996|529013059|FG009|Overall Study|Protocol Violation|0|||
146682870|NCT00203996|529013050|FG000|Overall Study|Physician Decision|0|||
146682871|NCT00203996|529013051|FG001|Overall Study|Physician Decision|0|||
146682872|NCT00203996|529013052|FG002|Overall Study|Physician Decision|0|||
146682873|NCT00203996|529013053|FG003|Overall Study|Physician Decision|2|||
146682874|NCT00203996|529013054|FG004|Overall Study|Physician Decision|0|||
146682875|NCT00203996|529013055|FG005|Overall Study|Physician Decision|0|||
146682876|NCT00203996|529013056|FG006|Overall Study|Physician Decision|0|||
146682877|NCT00203996|529013057|FG007|Overall Study|Physician Decision|0|||
146682878|NCT00203996|529013058|FG008|Overall Study|Physician Decision|0|||
146682879|NCT00203996|529013059|FG009|Overall Study|Physician Decision|1|||
146682880|NCT00203996|529013050|FG000|Overall Study|CPAP machine malfunction|0|||
146682881|NCT00203996|529013051|FG001|Overall Study|CPAP machine malfunction|0|||
146682882|NCT00203996|529013052|FG002|Overall Study|CPAP machine malfunction|0|||
146682883|NCT00203996|529013053|FG003|Overall Study|CPAP machine malfunction|1|||
146682884|NCT00203996|529013054|FG004|Overall Study|CPAP machine malfunction|0|||
146682885|NCT00203996|529013055|FG005|Overall Study|CPAP machine malfunction|0|||
146682886|NCT00203996|529013056|FG006|Overall Study|CPAP machine malfunction|0|||
146682887|NCT00203996|529013057|FG007|Overall Study|CPAP machine malfunction|0|||
146682888|NCT00203996|529013058|FG008|Overall Study|CPAP machine malfunction|0|||
146682889|NCT00203996|529013059|FG009|Overall Study|CPAP machine malfunction|0|||
146682890|NCT00203996|529013050|FG000|Overall Study|Scheduling issue|0|||
146682891|NCT00203996|529013051|FG001|Overall Study|Scheduling issue|0|||
146682892|NCT00203996|529013052|FG002|Overall Study|Scheduling issue|0|||
146682893|NCT00203996|529013053|FG003|Overall Study|Scheduling issue|0|||
146682894|NCT00203996|529013054|FG004|Overall Study|Scheduling issue|0|||
146682895|NCT00203996|529013055|FG005|Overall Study|Scheduling issue|0|||
146682896|NCT00203996|529013056|FG006|Overall Study|Scheduling issue|0|||
146682897|NCT00203996|529013057|FG007|Overall Study|Scheduling issue|2|||
146927315|NCT02493426|529894579|FG000|Overall Study|Withdrawal by Subject|0|||
146682898|NCT00203996|529013058|FG008|Overall Study|Scheduling issue|0|||
146682899|NCT00203996|529013059|FG009|Overall Study|Scheduling issue|0|||
146682900|NCT00897104|529013062|FG000|Overall Study|Lost to Follow-up|12|||
146927316|NCT02493426|529894580|FG001|Overall Study|Withdrawal by Subject|1|||
146682901|NCT00897104|529013063|FG001|Overall Study|Lost to Follow-up|17|||
146682902|NCT00897104|529013064|FG002|Overall Study|Lost to Follow-up|2|||
146682903|NCT00897104|529013062|FG000|Overall Study|Pregnancy|0|||
146927317|NCT02618928|529894581|FG000|Overall Study|Failure to Return|28|||
146682904|NCT00897104|529013063|FG001|Overall Study|Pregnancy|1|||
146682905|NCT00897104|529013064|FG002|Overall Study|Pregnancy|0|||
146682906|NCT00897104|529013062|FG000|Overall Study|Protocol Violation|0|||
146927318|NCT02618928|529894581|FG000|Overall Study|Insufficient Virological Response|1|||
146682907|NCT00897104|529013063|FG001|Overall Study|Protocol Violation|1|||
146682908|NCT00897104|529013064|FG002|Overall Study|Protocol Violation|0|||
146682909|NCT00897104|529013062|FG000|Overall Study|Withdrawal by Subject|23|||
146927319|NCT02618928|529894581|FG000|Overall Study|Withdrawal by Subject|2|||
146927320|NCT02618928|529894581|FG000|Overall Study|Death|3|||
146927321|NCT02618928|529894581|FG000|Overall Study|Other|11|||
146682910|NCT00897104|529013063|FG001|Overall Study|Withdrawal by Subject|27|||
146682911|NCT00897104|529013064|FG002|Overall Study|Withdrawal by Subject|3|||
146682912|NCT00897104|529013062|FG000|Overall Study|Abnormal Prestudy Labs|2|||
146682913|NCT00897104|529013063|FG001|Overall Study|Abnormal Prestudy Labs|0|||
146682914|NCT00897104|529013064|FG002|Overall Study|Abnormal Prestudy Labs|0|||
146682915|NCT00897104|529013062|FG000|Overall Study|Abnormal Baseline ECG|2|||
146682916|NCT00897104|529013063|FG001|Overall Study|Abnormal Baseline ECG|2|||
146682917|NCT00897104|529013064|FG002|Overall Study|Abnormal Baseline ECG|0|||
146682918|NCT00897104|529013062|FG000|Overall Study|Need for Concom. Med.|0|||
146682919|NCT00897104|529013063|FG001|Overall Study|Need for Concom. Med.|1|||
146682920|NCT00897104|529013064|FG002|Overall Study|Need for Concom. Med.|1|||
146682921|NCT00897104|529013062|FG000|Overall Study|Lack of Migraine Attack|20|||
146682922|NCT00897104|529013063|FG001|Overall Study|Lack of Migraine Attack|22|||
146682923|NCT00897104|529013064|FG002|Overall Study|Lack of Migraine Attack|1|||
146682924|NCT00897104|529013062|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
146682925|NCT00897104|529013063|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
146682926|NCT00897104|529013064|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
146682927|NCT00897104|529013062|FG000|Overall Study|Other|3|||
146682928|NCT00897104|529013063|FG001|Overall Study|Other|0|||
146682929|NCT00897104|529013064|FG002|Overall Study|Other|0|||
146682930|NCT00897104|529013062|FG000|Overall Study|Protocol Violation|1|||
146682931|NCT00897104|529013063|FG001|Overall Study|Protocol Violation|0|||
146682932|NCT00897104|529013064|FG002|Overall Study|Protocol Violation|0|||
146682933|NCT00897104|529013062|FG000|Overall Study|Withdrawal by Subject|0|||
146682934|NCT00897104|529013063|FG001|Overall Study|Withdrawal by Subject|0|||
146682935|NCT00897104|529013064|FG002|Overall Study|Withdrawal by Subject|1|||
146682936|NCT01937559|529013065|FG000|Overall Study|Physician Decision|3|||
146682937|NCT01937559|529013066|FG001|Overall Study|Physician Decision|3|||
146682938|NCT01937559|529013067|FG002|Overall Study|Physician Decision|0|||
146682939|NCT01937559|529013065|FG000|Overall Study|Withdrawal by Subject|6|||
146682940|NCT01937559|529013066|FG001|Overall Study|Withdrawal by Subject|4|||
146682941|NCT01937559|529013067|FG002|Overall Study|Withdrawal by Subject|0|||
146682942|NCT01937559|529013065|FG000|Overall Study|screen fail|2|||
146682943|NCT01937559|529013066|FG001|Overall Study|screen fail|4|||
146682944|NCT01937559|529013067|FG002|Overall Study|screen fail|0|||
146682945|NCT02167893|529013068|FG000|Overall Study|Investigator transferred|85|||
146682946|NCT02167893|529013068|FG000|Overall Study|Investigator health reasons|10|||
146682947|NCT02167893|529013068|FG000|Overall Study|Case report forms not collected|68|||
146682948|NCT04818840|529013069|FG000|Overall Study|Lost to Follow-up|0|||
146682949|NCT04818840|529013070|FG001|Overall Study|Lost to Follow-up|5|||
146682950|NCT04818840|529013069|FG000|Overall Study|Physician Decision|1|||
146682951|NCT04818840|529013070|FG001|Overall Study|Physician Decision|0|||
146682952|NCT04818840|529013069|FG000|Overall Study|Site Terminated by Sponsor|0|||
146682953|NCT04818840|529013070|FG001|Overall Study|Site Terminated by Sponsor|3|||
146682954|NCT04818840|529013069|FG000|Overall Study|Study Terminated by Sponsor|43|||
146682955|NCT04818840|529013070|FG001|Overall Study|Study Terminated by Sponsor|7|||
146682956|NCT04818840|529013069|FG000|Overall Study|Withdrawal by Subject|0|||
146682957|NCT04818840|529013070|FG001|Overall Study|Withdrawal by Subject|1|||
146682958|NCT01438424|529015075|FG000|Overall Study|Continuing treatment|29|||
146682959|NCT01438424|529015075|FG000|Overall Study|Minimal virologic response|95|||
146682960|NCT01438424|529015075|FG000|Overall Study|Not identified|55|||
146682961|NCT01438424|529015075|FG000|Overall Study|Withdrawal by Subject|104|||
146682962|NCT01438424|529015075|FG000|Overall Study|Progression of chronic hepatitis B|22|||
146682963|NCT01438424|529015075|FG000|Overall Study|Death|22|||
146682964|NCT01438424|529015075|FG000|Overall Study|Adverse Event|17|||
146682965|NCT01438424|529015075|FG000|Overall Study|Lost to Follow-up|17|||
146682966|NCT01438424|529015075|FG000|Overall Study|Abnormal laboratory test result|14|||
146682967|NCT01438424|529015075|FG000|Overall Study|Need for drug prohibited by protocol|14|||
146927322|NCT02618928|529894581|FG000|Overall Study|Missing|6|||
146927323|NCT02618928|529894581|FG000|Overall Study|Treatment Never Started|7|||
146927324|NCT01096849|529894586|FG000|Overall Study|Consent Withdrawn|1|||
146682968|NCT01438424|529015075|FG000|Overall Study|Pregnancy|7|||
146682969|NCT01438424|529015075|FG000|Overall Study|No longer met inclusion criteria|1|||
146682970|NCT01438424|529015075|FG000|Overall Study|Participant noncompliance|20|||
146682971|NCT02329730|529015081|FG000|Overall Study|Protocol Violation|0|||
146682972|NCT02329730|529015082|FG001|Overall Study|Protocol Violation|0|||
146682973|NCT02329730|529015083|FG002|Overall Study|Protocol Violation|0|||
146682974|NCT02329730|529015084|FG003|Overall Study|Protocol Violation|0|||
146927325|NCT01096849|529894587|FG001|Overall Study|Consent Withdrawn|4|||
146682975|NCT02329730|529015085|FG004|Overall Study|Protocol Violation|2|||
146682976|NCT02329730|529015086|FG005|Overall Study|Protocol Violation|2|||
146682977|NCT02329730|529015087|FG006|Overall Study|Protocol Violation|0|||
146682978|NCT02329730|529015088|FG007|Overall Study|Protocol Violation|0|||
146682979|NCT02329730|529015089|FG008|Overall Study|Protocol Violation|0|||
146682980|NCT02329730|529015090|FG009|Overall Study|Protocol Violation|0|||
146927326|NCT01096849|529894588|FG002|Overall Study|Consent Withdrawn|2|||
146682981|NCT02329730|529015091|FG010|Overall Study|Protocol Violation|0|||
146682982|NCT02329730|529015092|FG011|Overall Study|Protocol Violation|0|||
146682983|NCT02329730|529015081|FG000|Overall Study|Withdrawal by Subject|0|||
146682984|NCT02329730|529015082|FG001|Overall Study|Withdrawal by Subject|0|||
146682985|NCT02329730|529015083|FG002|Overall Study|Withdrawal by Subject|0|||
146682986|NCT02329730|529015084|FG003|Overall Study|Withdrawal by Subject|0|||
146682987|NCT02329730|529015085|FG004|Overall Study|Withdrawal by Subject|1|||
146682988|NCT02329730|529015086|FG005|Overall Study|Withdrawal by Subject|0|||
146682989|NCT02329730|529015087|FG006|Overall Study|Withdrawal by Subject|1|||
146682990|NCT02329730|529015088|FG007|Overall Study|Withdrawal by Subject|1|||
146682991|NCT02329730|529015089|FG008|Overall Study|Withdrawal by Subject|1|||
146682992|NCT02329730|529015090|FG009|Overall Study|Withdrawal by Subject|1|||
146682993|NCT02329730|529015091|FG010|Overall Study|Withdrawal by Subject|0|||
146682994|NCT02329730|529015092|FG011|Overall Study|Withdrawal by Subject|0|||
146682995|NCT01991067|529015096|FG000|Overall Study|Lost to Follow-up|6|||
146682996|NCT01991067|529015097|FG001|Overall Study|Lost to Follow-up|5|||
146682997|NCT01320085|529015099|FG000|Overall Study|Disease Progression|26|||
146682998|NCT01320085|529015100|FG001|Overall Study|Disease Progression|93|||
146682999|NCT01320085|529015101|FG002|Overall Study|Disease Progression|17|||
146683000|NCT01320085|529015099|FG000|Overall Study|Adverse Event|12|||
146683001|NCT01320085|529015100|FG001|Overall Study|Adverse Event|20|||
146683002|NCT01320085|529015101|FG002|Overall Study|Adverse Event|5|||
146683003|NCT01320085|529015099|FG000|Overall Study|Withdrawal by Subject|2|||
146683004|NCT01320085|529015100|FG001|Overall Study|Withdrawal by Subject|4|||
146683005|NCT01320085|529015101|FG002|Overall Study|Withdrawal by Subject|1|||
146683006|NCT01320085|529015099|FG000|Overall Study|Protocol Deviation|1|||
146683007|NCT01320085|529015100|FG001|Overall Study|Protocol Deviation|0|||
146683008|NCT01320085|529015101|FG002|Overall Study|Protocol Deviation|1|||
146683009|NCT01320085|529015099|FG000|Overall Study|Administrative problems|0|||
146683010|NCT01320085|529015100|FG001|Overall Study|Administrative problems|0|||
146683011|NCT01320085|529015101|FG002|Overall Study|Administrative problems|1|||
146683012|NCT01702454|529015102|FG000|Overall Study|Consent withdrawal|0|||
146683013|NCT01702454|529015103|FG001|Overall Study|Consent withdrawal|1|||
146683014|NCT01702454|529015102|FG000|Overall Study|Migrated/moved from study area|0|||
146683015|NCT01702454|529015103|FG001|Overall Study|Migrated/moved from study area|1|||
146683016|NCT01702454|529015102|FG000|Overall Study|Lost to Follow-up|3|||
146683017|NCT01702454|529015103|FG001|Overall Study|Lost to Follow-up|6|||
146683018|NCT00710710|529015104|FG000|Overall Study|Consent withdrawn|2|||
146683019|NCT00710710|529015105|FG001|Overall Study|Consent withdrawn|2|||
146683020|NCT00710710|529015104|FG000|Overall Study|Protocol Violation|0|||
146683021|NCT00710710|529015105|FG001|Overall Study|Protocol Violation|1|||
146683022|NCT00710710|529015104|FG000|Overall Study|Adverse Event|3|||
146683023|NCT00710710|529015105|FG001|Overall Study|Adverse Event|3|||
146683024|NCT00710710|529015104|FG000|Overall Study|Progressive disease|40|||
146683025|NCT00710710|529015105|FG001|Overall Study|Progressive disease|38|||
146683026|NCT03510884|529015106|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
146683027|NCT03510884|529015107|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
146683028|NCT03510884|529015108|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
146683029|NCT03510884|529015109|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
146683030|NCT03510884|529015106|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
146683031|NCT03510884|529015107|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
146683032|NCT03510884|529015108|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
146683033|NCT03510884|529015109|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
146683034|NCT03510884|529015106|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
146683035|NCT03510884|529015107|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
146683036|NCT03510884|529015108|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
146683037|NCT03510884|529015109|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
146683038|NCT03510884|529015106|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
146683039|NCT03510884|529015107|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
146683040|NCT03510884|529015108|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
146683041|NCT03510884|529015109|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
146683042|NCT03510884|529015106|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
146683043|NCT03510884|529015107|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
146683044|NCT03510884|529015108|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
146683045|NCT03510884|529015109|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
146683046|NCT03510884|529015106|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
146683047|NCT03510884|529015107|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
146683048|NCT03510884|529015108|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
146683049|NCT03510884|529015109|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
146683050|NCT03510884|529015106|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
146683051|NCT03510884|529015107|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
146683052|NCT03510884|529015108|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
146683053|NCT03510884|529015109|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
146683054|NCT03510884|529015106|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
146683055|NCT03510884|529015107|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
146683056|NCT03510884|529015108|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
146683057|NCT03510884|529015109|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
146683058|NCT03510884|529015106|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
146683059|NCT03510884|529015107|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
146683060|NCT03510884|529015108|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
146683061|NCT03510884|529015109|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
146683062|NCT03510884|529015106|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
146683063|NCT03510884|529015107|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
146683064|NCT03510884|529015108|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
146683065|NCT03510884|529015109|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
146683066|NCT02564042|529015111|FG000|Overall Study|Adverse Event|4|||
146683067|NCT02564042|529015112|FG001|Overall Study|Adverse Event|4|||
146683068|NCT02564042|529015113|FG002|Overall Study|Adverse Event|3|||
146683069|NCT02564042|529015114|FG003|Overall Study|Adverse Event|0|||
146683070|NCT02564042|529015115|FG004|Overall Study|Adverse Event|0|||
146683071|NCT02564042|529015116|FG005|Overall Study|Adverse Event|1|||
146683072|NCT02564042|529015111|FG000|Overall Study|Lost to Follow-up|1|||
146683073|NCT02564042|529015112|FG001|Overall Study|Lost to Follow-up|1|||
146683074|NCT02564042|529015113|FG002|Overall Study|Lost to Follow-up|1|||
146683075|NCT02564042|529015114|FG003|Overall Study|Lost to Follow-up|0|||
146683076|NCT02564042|529015115|FG004|Overall Study|Lost to Follow-up|1|||
146683077|NCT02564042|529015116|FG005|Overall Study|Lost to Follow-up|1|||
146683078|NCT02564042|529015111|FG000|Overall Study|Physician Decision|1|||
146683079|NCT02564042|529015112|FG001|Overall Study|Physician Decision|0|||
146683080|NCT02564042|529015113|FG002|Overall Study|Physician Decision|0|||
146683081|NCT02564042|529015114|FG003|Overall Study|Physician Decision|1|||
146683082|NCT02564042|529015115|FG004|Overall Study|Physician Decision|0|||
146683083|NCT02564042|529015116|FG005|Overall Study|Physician Decision|0|||
146683084|NCT02564042|529015111|FG000|Overall Study|Withdrawal by Subject|5|||
146683085|NCT02564042|529015112|FG001|Overall Study|Withdrawal by Subject|3|||
146683086|NCT02564042|529015113|FG002|Overall Study|Withdrawal by Subject|2|||
146683087|NCT02564042|529015114|FG003|Overall Study|Withdrawal by Subject|2|||
146683088|NCT02564042|529015115|FG004|Overall Study|Withdrawal by Subject|10|||
146683089|NCT02564042|529015116|FG005|Overall Study|Withdrawal by Subject|12|||
146683090|NCT00885105|529015118|FG000|Overall Study|Withdrawal by Subject|0|||
146683091|NCT00885105|529015119|FG001|Overall Study|Withdrawal by Subject|8|||
146683092|NCT00885105|529015118|FG000|Overall Study|Adverse Event|1|||
146683093|NCT00885105|529015119|FG001|Overall Study|Adverse Event|0|||
146683094|NCT00885105|529015118|FG000|Overall Study|Protocol Violation|0|||
146683095|NCT00885105|529015119|FG001|Overall Study|Protocol Violation|2|||
146683096|NCT02066233|529015120|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
146683097|NCT02066233|529015121|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
146683098|NCT02772081|529015122|FG000|Overall Study|Physician Decision|1|||
146683099|NCT02772081|529015123|FG001|Overall Study|Physician Decision|1|||
146683100|NCT02772081|529015122|FG000|Overall Study|Death|1|||
146683101|NCT02772081|529015123|FG001|Overall Study|Death|1|||
146683102|NCT01402544|529015130|FG000|Overall Study|Withdrawal by Subject|6|||
146683103|NCT01828281|529015131|FG000|Overall Study|Withdrawal by Subject|1|||
146683104|NCT01828281|529015132|FG001|Overall Study|Withdrawal by Subject|0|||
146683105|NCT01442493|529015133|FG000|Overall Study|withdrawn from study|3|||
146683106|NCT01442493|529015134|FG001|Overall Study|withdrawn from study|2|||
146683107|NCT02051608|529015135|FG000|Part 1: Double Blind Treatment|Death|3|||
146683108|NCT02051608|529015136|FG001|Part 1: Double Blind Treatment|Death|3|||
146683109|NCT02051608|529015137|FG002|Part 1: Double Blind Treatment|Death|0|||
146927327|NCT01096849|529894586|FG000|Overall Study|Lack of Efficacy|0|||
146683110|NCT02051608|529015138|FG003|Part 1: Double Blind Treatment|Death|0|||
146683111|NCT02051608|529015135|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
146683112|NCT02051608|529015136|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
146683113|NCT02051608|529015137|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
146683114|NCT02051608|529015138|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
146683115|NCT02051608|529015135|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
146683116|NCT02051608|529015136|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
146683117|NCT02051608|529015137|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
146683118|NCT02051608|529015138|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
146683119|NCT02051608|529015135|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
146683120|NCT02051608|529015136|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
146683121|NCT02051608|529015137|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
146683122|NCT02051608|529015138|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
146736297|NCT00633932|529206803|FG000|Overall Study|Doctor's judgement|1|||
146774814|NCT04524390|529346784|FG001|Open-Label|Liver Transplant|0|||
146774815|NCT04524390|529346785|FG002|Open-Label|Liver Transplant|1|||
146683123|NCT02051608|529015135|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
146683124|NCT02051608|529015136|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
146683125|NCT02051608|529015137|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
146683126|NCT02051608|529015138|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
146683127|NCT02051608|529015135|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
146683128|NCT02051608|529015136|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
146683129|NCT02051608|529015137|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
146683130|NCT02051608|529015138|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
146683131|NCT02051608|529015135|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
146683132|NCT02051608|529015136|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
146683133|NCT02051608|529015137|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
146683134|NCT02051608|529015138|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
146683135|NCT02051608|529015135|FG000|Part 1: Double Blind Treatment|Other|6|||
146683136|NCT02051608|529015136|FG001|Part 1: Double Blind Treatment|Other|3|||
146683137|NCT02051608|529015137|FG002|Part 1: Double Blind Treatment|Other|0|||
146683138|NCT02051608|529015138|FG003|Part 1: Double Blind Treatment|Other|0|||
146683139|NCT02051608|529015135|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
146683140|NCT02051608|529015136|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
146683141|NCT02051608|529015137|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
146683142|NCT02051608|529015138|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
146683143|NCT02051608|529015135|FG000|Part 2: Open-label Extension|Adverse Event|0|||
146683144|NCT02051608|529015136|FG001|Part 2: Open-label Extension|Adverse Event|0|||
146683145|NCT02051608|529015137|FG002|Part 2: Open-label Extension|Adverse Event|6|||
146683146|NCT02051608|529015138|FG003|Part 2: Open-label Extension|Adverse Event|8|||
146683147|NCT02051608|529015135|FG000|Part 2: Open-label Extension|Death|0|||
146683148|NCT02051608|529015136|FG001|Part 2: Open-label Extension|Death|0|||
146683149|NCT02051608|529015137|FG002|Part 2: Open-label Extension|Death|7|||
146683150|NCT02051608|529015138|FG003|Part 2: Open-label Extension|Death|4|||
146683151|NCT02051608|529015135|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
146683152|NCT02051608|529015136|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
146683153|NCT02051608|529015137|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
146683154|NCT02051608|529015138|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
146683155|NCT02051608|529015135|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
146683156|NCT02051608|529015136|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
146683157|NCT02051608|529015137|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
146683158|NCT02051608|529015138|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
146683159|NCT02051608|529015135|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
146683160|NCT02051608|529015136|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
146683161|NCT02051608|529015137|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
146683162|NCT02051608|529015138|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
146683163|NCT02051608|529015135|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
146683164|NCT02051608|529015136|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
146683165|NCT02051608|529015137|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
146683166|NCT02051608|529015138|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
146683167|NCT02051608|529015135|FG000|Part 2: Open-label Extension|Physician Decision|0|||
146683168|NCT02051608|529015136|FG001|Part 2: Open-label Extension|Physician Decision|0|||
146683169|NCT02051608|529015137|FG002|Part 2: Open-label Extension|Physician Decision|8|||
146683170|NCT02051608|529015138|FG003|Part 2: Open-label Extension|Physician Decision|5|||
146683171|NCT02051608|529015135|FG000|Part 2: Open-label Extension|Other|0|||
146683172|NCT02051608|529015136|FG001|Part 2: Open-label Extension|Other|0|||
146683173|NCT02051608|529015137|FG002|Part 2: Open-label Extension|Other|9|||
146683174|NCT02051608|529015138|FG003|Part 2: Open-label Extension|Other|9|||
146683175|NCT01986985|529015139|FG000|Overall Study|Withdrawal by Subject|4|||
146683176|NCT01986985|529015139|FG000|Overall Study|Scan not completed due to malfunction|3|||
146683177|NCT01083576|529015142|FG000|Overall Study|Treatment Failure|6|||
146683178|NCT01083576|529015143|FG001|Overall Study|Treatment Failure|1|||
146683179|NCT02709785|529015144|FG000|Overall Study|Withdrawal by Subject|1|||
146683180|NCT02709785|529015145|FG001|Overall Study|Withdrawal by Subject|2|||
146683181|NCT02709785|529015146|FG002|Overall Study|Withdrawal by Subject|1|||
146683182|NCT01961323|529015147|FG000|Overall Study|Withdrawal by Subject|7|||
146683183|NCT01961323|529015147|FG000|Overall Study|Lost to Follow-up|8|||
146683184|NCT01961323|529015147|FG000|Overall Study|screen failure|34|||
146683185|NCT01996982|529015149|FG000|Overall Study|PI/team left institution|7|||
146774816|NCT04524390|529346783|FG000|Open-Label|Disease Progression|0|||
146683186|NCT01195415|529015170|FG000|Overall Study|No repeat biopsy due to progression|2|||
146683187|NCT00533845|529015173|FG000|Overall Study|Physician Decision|1|||
146774817|NCT04524390|529346784|FG001|Open-Label|Disease Progression|0|||
146774818|NCT04524390|529346785|FG002|Open-Label|Disease Progression|1|||
146774819|NCT04524390|529346783|FG000|Open-Label|Adverse Event|0|||
146774820|NCT04524390|529346784|FG001|Open-Label|Adverse Event|0|||
146927328|NCT01096849|529894587|FG001|Overall Study|Lack of Efficacy|2|||
146927329|NCT01096849|529894588|FG002|Overall Study|Lack of Efficacy|0|||
146927330|NCT01096849|529894586|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
146927331|NCT01096849|529894587|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
146927332|NCT01096849|529894588|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
146683188|NCT00533845|529015174|FG001|Overall Study|Physician Decision|0|||
146683189|NCT01442675|529015189|FG000|Overall Study|Protocol Violation|6|||
146683190|NCT01442675|529015189|FG000|Overall Study|Lost to Follow-up|2|||
146683191|NCT01442675|529015189|FG000|Overall Study|Withdrawal by Subject|4|||
146683192|NCT01957644|529015193|FG000|Overall Study|Adverse Event|4|||
146683193|NCT01957644|529015194|FG001|Overall Study|Adverse Event|2|||
146683194|NCT01957644|529015195|FG002|Overall Study|Adverse Event|0|||
146683195|NCT01957644|529015196|FG003|Overall Study|Adverse Event|0|||
146683196|NCT01957644|529015197|FG004|Overall Study|Adverse Event|1|||
146683197|NCT01957644|529015193|FG000|Overall Study|Progressive disease / relapse|0|||
146683198|NCT01957644|529015194|FG001|Overall Study|Progressive disease / relapse|1|||
146683199|NCT01957644|529015195|FG002|Overall Study|Progressive disease / relapse|0|||
146683200|NCT01957644|529015196|FG003|Overall Study|Progressive disease / relapse|1|||
146683201|NCT01957644|529015197|FG004|Overall Study|Progressive disease / relapse|0|||
146683202|NCT01957644|529015193|FG000|Overall Study|Other reason|1|||
146683203|NCT01957644|529015194|FG001|Overall Study|Other reason|2|||
146683204|NCT01957644|529015195|FG002|Overall Study|Other reason|1|||
146683205|NCT01957644|529015196|FG003|Overall Study|Other reason|1|||
146683206|NCT01957644|529015197|FG004|Overall Study|Other reason|0|||
146683207|NCT01957644|529015193|FG000|Overall Study|Withdrawal by Subject|1|||
146683208|NCT01957644|529015194|FG001|Overall Study|Withdrawal by Subject|0|||
146683209|NCT01957644|529015195|FG002|Overall Study|Withdrawal by Subject|0|||
146683210|NCT01957644|529015196|FG003|Overall Study|Withdrawal by Subject|0|||
146683211|NCT01957644|529015197|FG004|Overall Study|Withdrawal by Subject|0|||
146683212|NCT01957644|529015193|FG000|Overall Study|Protocol Violation|0|||
146683213|NCT01957644|529015194|FG001|Overall Study|Protocol Violation|1|||
146683214|NCT01957644|529015195|FG002|Overall Study|Protocol Violation|0|||
146683215|NCT01957644|529015196|FG003|Overall Study|Protocol Violation|0|||
146683216|NCT01957644|529015197|FG004|Overall Study|Protocol Violation|0|||
146683217|NCT02733367|529015198|FG000|Overall Study|Withdrawal by Subject|6|||
146683218|NCT01348347|529015199|FG000|Overall Study|Withdrawal by Subject|1|||
146683219|NCT01348347|529015200|FG001|Overall Study|Withdrawal by Subject|1|||
146683220|NCT01348347|529015201|FG002|Overall Study|Withdrawal by Subject|1|||
146683221|NCT01348347|529015199|FG000|Overall Study|Progressive disease|2|||
146683222|NCT01348347|529015200|FG001|Overall Study|Progressive disease|5|||
146683223|NCT01348347|529015201|FG002|Overall Study|Progressive disease|5|||
146683224|NCT03049280|529015205|FG000|Overall Study|Physician Decision|1|||
146683225|NCT01867021|529015206|FG000|Overall Study|Adverse Event|0|||
146683226|NCT01867021|529015207|FG001|Overall Study|Adverse Event|1|||
146683227|NCT01867021|529015206|FG000|Overall Study|Not Eligible|0|||
146683228|NCT01867021|529015207|FG001|Overall Study|Not Eligible|1|||
146683229|NCT01867021|529015206|FG000|Overall Study|Death|1|||
146683230|NCT01867021|529015207|FG001|Overall Study|Death|0|||
146683231|NCT01867021|529015206|FG000|Overall Study|Lost to Follow-up|0|||
146683232|NCT01867021|529015207|FG001|Overall Study|Lost to Follow-up|2|||
146683233|NCT01867021|529015206|FG000|Overall Study|Withdrawal by Subject|1|||
146683234|NCT01867021|529015207|FG001|Overall Study|Withdrawal by Subject|6|||
146683235|NCT00640601|529015208|FG000|Overall Study|Adverse Event|43|||
146683236|NCT00640601|529015208|FG000|Overall Study|Withdrawal by Subject|20|||
146683237|NCT00640601|529015208|FG000|Overall Study|Protocol Violation|6|||
146683238|NCT00640601|529015208|FG000|Overall Study|Lack of Efficacy|16|||
146927333|NCT01096849|529894586|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
146927334|NCT01096849|529894587|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
146927335|NCT01096849|529894588|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
146683239|NCT00640601|529015208|FG000|Overall Study|Lost to Follow-up|9|||
146683240|NCT00640601|529015208|FG000|Overall Study|Physician Decision|8|||
146683241|NCT00640601|529015208|FG000|Overall Study|treatment naive, combination therapy|10|||
146683242|NCT03681405|529015209|FG000|Overall Study|Found to be ineligible after randomized|1|||
146683243|NCT03681405|529015210|FG001|Overall Study|Found to be ineligible after randomized|0|||
146683244|NCT01958008|529015213|FG000|Overall Study|Worsening of disease under study|0|||
146683245|NCT01958008|529015214|FG001|Overall Study|Worsening of disease under study|0|||
146683246|NCT01958008|529015215|FG002|Overall Study|Worsening of disease under study|1|||
146683247|NCT01958008|529015216|FG003|Overall Study|Worsening of disease under study|0|||
146683248|NCT01958008|529015213|FG000|Overall Study|Other adverse event|1|||
146683249|NCT01958008|529015214|FG001|Overall Study|Other adverse event|0|||
146683250|NCT01958008|529015215|FG002|Overall Study|Other adverse event|0|||
146683251|NCT01958008|529015216|FG003|Overall Study|Other adverse event|0|||
146683252|NCT03789318|529015217|FG000|Overall Study|Adverse Event|0|||
146683253|NCT03789318|529015218|FG001|Overall Study|Adverse Event|0|||
146683254|NCT03789318|529015219|FG002|Overall Study|Adverse Event|1|||
146683255|NCT03789318|529015220|FG003|Overall Study|Adverse Event|1|||
146683256|NCT03789318|529015221|FG004|Overall Study|Adverse Event|0|||
146683257|NCT03789318|529015217|FG000|Overall Study|Lost to Follow-up|0|||
146683258|NCT03789318|529015218|FG001|Overall Study|Lost to Follow-up|0|||
146683259|NCT03789318|529015219|FG002|Overall Study|Lost to Follow-up|1|||
146683260|NCT03789318|529015220|FG003|Overall Study|Lost to Follow-up|0|||
146683261|NCT03789318|529015221|FG004|Overall Study|Lost to Follow-up|0|||
146683262|NCT03789318|529015217|FG000|Overall Study|Withdrawal by Subject|0|||
146683263|NCT03789318|529015218|FG001|Overall Study|Withdrawal by Subject|0|||
146683264|NCT03789318|529015219|FG002|Overall Study|Withdrawal by Subject|1|||
146683265|NCT03789318|529015220|FG003|Overall Study|Withdrawal by Subject|0|||
146683266|NCT03789318|529015221|FG004|Overall Study|Withdrawal by Subject|0|||
146683267|NCT00733408|529017024|FG000|Overall Study|Adverse Event|4|||
146683268|NCT00531232|529017025|FG000|Overall Study|Investigator decision|0|||
146683269|NCT00531232|529017026|FG001|Overall Study|Investigator decision|0|||
146683270|NCT00531232|529017027|FG002|Overall Study|Investigator decision|4|||
146683271|NCT00531232|529017025|FG000|Overall Study|Participants refused further treatment|0|||
146683272|NCT00531232|529017026|FG001|Overall Study|Participants refused further treatment|1|||
146683273|NCT00531232|529017027|FG002|Overall Study|Participants refused further treatment|2|||
146683274|NCT00531232|529017025|FG000|Overall Study|Adverse events (AEs)|1|||
146683275|NCT00531232|529017026|FG001|Overall Study|Adverse events (AEs)|2|||
146683276|NCT00531232|529017027|FG002|Overall Study|Adverse events (AEs)|2|||
146683277|NCT00531232|529017025|FG000|Overall Study|Treatment failure|1|||
146683278|NCT00531232|529017026|FG001|Overall Study|Treatment failure|3|||
146683279|NCT00531232|529017027|FG002|Overall Study|Treatment failure|7|||
146683280|NCT00531232|529017025|FG000|Overall Study|Disease recurrence|0|||
146683281|NCT00531232|529017026|FG001|Overall Study|Disease recurrence|0|||
146683282|NCT00531232|529017027|FG002|Overall Study|Disease recurrence|1|||
146683283|NCT00531232|529017025|FG000|Overall Study|Deceased|2|||
146683284|NCT00531232|529017026|FG001|Overall Study|Deceased|2|||
146683285|NCT00531232|529017027|FG002|Overall Study|Deceased|2|||
146683286|NCT00531232|529017025|FG000|Overall Study|Withdrawal by Subject|0|||
146683287|NCT00531232|529017026|FG001|Overall Study|Withdrawal by Subject|1|||
146683288|NCT00531232|529017027|FG002|Overall Study|Withdrawal by Subject|2|||
146683289|NCT00531232|529017025|FG000|Overall Study|Other|0|||
146683290|NCT00531232|529017026|FG001|Overall Study|Other|0|||
146683291|NCT00531232|529017027|FG002|Overall Study|Other|5|||
146683292|NCT04232124|529017028|FG000|Overall Study|Lost to Follow-up|3|||
146683293|NCT02345850|529017029|FG000|Overall Study|Not transplanted|10|||
146683294|NCT02345850|529017030|FG001|Overall Study|Not transplanted|5|||
146683295|NCT02345850|529017031|FG002|Overall Study|Not transplanted|4|||
146683296|NCT02345850|529017029|FG000|Overall Study|Lost to Follow-up|2|||
146683297|NCT02345850|529017030|FG001|Overall Study|Lost to Follow-up|3|||
146683298|NCT02345850|529017031|FG002|Overall Study|Lost to Follow-up|2|||
146683299|NCT02345850|529017029|FG000|Overall Study|Withdrawal by Subject|1|||
146683300|NCT02345850|529017030|FG001|Overall Study|Withdrawal by Subject|0|||
146683301|NCT02345850|529017031|FG002|Overall Study|Withdrawal by Subject|0|||
146683302|NCT02392247|529017034|FG000|Overall Study|Withdrawal by Subject|1|||
146683303|NCT02392247|529017034|FG000|Overall Study|Surgery cancelled; no data|1|||
146683304|NCT02927080|529017035|FG000|Overall Study|Withdrawal by Subject|0|||
146683305|NCT02927080|529017036|FG001|Overall Study|Withdrawal by Subject|0|||
146683306|NCT02927080|529017037|FG002|Overall Study|Withdrawal by Subject|0|||
146683307|NCT02927080|529017038|FG003|Overall Study|Withdrawal by Subject|0|||
146683308|NCT02927080|529017039|FG004|Overall Study|Withdrawal by Subject|1|||
146683309|NCT02927080|529017040|FG005|Overall Study|Withdrawal by Subject|0|||
146683310|NCT02927080|529017041|FG006|Overall Study|Withdrawal by Subject|1|||
146683311|NCT02927080|529017042|FG007|Overall Study|Withdrawal by Subject|1|||
146683312|NCT02927080|529017043|FG008|Overall Study|Withdrawal by Subject|0|||
146683313|NCT02927080|529017044|FG009|Overall Study|Withdrawal by Subject|2|||
146683314|NCT02927080|529017035|FG000|Overall Study|Willingness to comply with protocol|0|||
146683315|NCT02927080|529017036|FG001|Overall Study|Willingness to comply with protocol|0|||
146683316|NCT02927080|529017037|FG002|Overall Study|Willingness to comply with protocol|0|||
146683317|NCT02927080|529017038|FG003|Overall Study|Willingness to comply with protocol|0|||
146683318|NCT02927080|529017039|FG004|Overall Study|Willingness to comply with protocol|0|||
146683319|NCT02927080|529017040|FG005|Overall Study|Willingness to comply with protocol|0|||
146683320|NCT02927080|529017041|FG006|Overall Study|Willingness to comply with protocol|0|||
146774821|NCT04524390|529346785|FG002|Open-Label|Adverse Event|3|||
146774822|NCT04524390|529346783|FG000|Open-Label|Study Termination by sponsor|0|||
146683321|NCT02927080|529017042|FG007|Overall Study|Willingness to comply with protocol|0|||
146683322|NCT02927080|529017043|FG008|Overall Study|Willingness to comply with protocol|0|||
146683323|NCT02927080|529017044|FG009|Overall Study|Willingness to comply with protocol|1|||
146683324|NCT02927080|529017035|FG000|Overall Study|Study terminated by Sponsor|0|||
146683325|NCT02927080|529017036|FG001|Overall Study|Study terminated by Sponsor|0|||
146683326|NCT02927080|529017037|FG002|Overall Study|Study terminated by Sponsor|0|||
146683327|NCT02927080|529017038|FG003|Overall Study|Study terminated by Sponsor|0|||
146683328|NCT02927080|529017039|FG004|Overall Study|Study terminated by Sponsor|0|||
146683329|NCT02927080|529017040|FG005|Overall Study|Study terminated by Sponsor|0|||
146683330|NCT02927080|529017041|FG006|Overall Study|Study terminated by Sponsor|6|||
146683331|NCT02927080|529017042|FG007|Overall Study|Study terminated by Sponsor|7|||
146683332|NCT02927080|529017043|FG008|Overall Study|Study terminated by Sponsor|2|||
146683333|NCT02927080|529017044|FG009|Overall Study|Study terminated by Sponsor|3|||
146683334|NCT02927080|529017035|FG000|Overall Study|Adverse Event|0|||
146683335|NCT02927080|529017036|FG001|Overall Study|Adverse Event|1|||
146683336|NCT02927080|529017037|FG002|Overall Study|Adverse Event|0|||
146683337|NCT02927080|529017038|FG003|Overall Study|Adverse Event|0|||
146683338|NCT02927080|529017039|FG004|Overall Study|Adverse Event|0|||
146683339|NCT02927080|529017040|FG005|Overall Study|Adverse Event|0|||
146683340|NCT02927080|529017041|FG006|Overall Study|Adverse Event|0|||
146683341|NCT02927080|529017042|FG007|Overall Study|Adverse Event|1|||
146683342|NCT02927080|529017043|FG008|Overall Study|Adverse Event|0|||
146683343|NCT02927080|529017044|FG009|Overall Study|Adverse Event|1|||
146683344|NCT02927080|529017035|FG000|Overall Study|Other|0|||
146683345|NCT02927080|529017036|FG001|Overall Study|Other|0|||
146683346|NCT02927080|529017037|FG002|Overall Study|Other|0|||
146683347|NCT02927080|529017038|FG003|Overall Study|Other|0|||
146683348|NCT02927080|529017039|FG004|Overall Study|Other|0|||
146683349|NCT02927080|529017040|FG005|Overall Study|Other|0|||
146683350|NCT02927080|529017041|FG006|Overall Study|Other|1|||
146683351|NCT02927080|529017042|FG007|Overall Study|Other|0|||
146683352|NCT02927080|529017043|FG008|Overall Study|Other|1|||
146683353|NCT02927080|529017044|FG009|Overall Study|Other|0|||
146683354|NCT00224055|529017047|FG000|Overall Study|Adverse Event|9|||
146683355|NCT00224055|529017048|FG001|Overall Study|Adverse Event|3|||
146683356|NCT00224055|529017047|FG000|Overall Study|Lost to Follow-up|1|||
146683357|NCT00224055|529017048|FG001|Overall Study|Lost to Follow-up|2|||
146683358|NCT00224055|529017047|FG000|Overall Study|Protocol Violation|1|||
146683359|NCT00224055|529017048|FG001|Overall Study|Protocol Violation|1|||
146683360|NCT00224055|529017047|FG000|Overall Study|Inclusion Violation|3|||
146683361|NCT00224055|529017048|FG001|Overall Study|Inclusion Violation|6|||
146683362|NCT00224055|529017047|FG000|Overall Study|Withdrawal by Subject|0|||
146683363|NCT00224055|529017048|FG001|Overall Study|Withdrawal by Subject|2|||
146683364|NCT00224055|529017047|FG000|Overall Study|Other|1|||
146683365|NCT00224055|529017048|FG001|Overall Study|Other|0|||
146683366|NCT02068443|529017049|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
146683367|NCT02068443|529017050|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
146683368|NCT02068443|529017051|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
146683369|NCT02068443|529017049|FG000|Overall Study|Voluntary Withdrawal|4|||
146683370|NCT02068443|529017050|FG001|Overall Study|Voluntary Withdrawal|0|||
146683371|NCT02068443|529017051|FG002|Overall Study|Voluntary Withdrawal|1|||
146683372|NCT02068443|529017049|FG000|Overall Study|Lack of Efficacy|2|||
146683373|NCT02068443|529017050|FG001|Overall Study|Lack of Efficacy|1|||
146683374|NCT02068443|529017051|FG002|Overall Study|Lack of Efficacy|0|||
146683375|NCT02068443|529017049|FG000|Overall Study|Other Reason Not Specified|1|||
146683376|NCT02068443|529017050|FG001|Overall Study|Other Reason Not Specified|0|||
146683377|NCT02068443|529017051|FG002|Overall Study|Other Reason Not Specified|0|||
146683378|NCT00664742|529017052|FG000|Overall Study|Withdrawn due to adverse events|3|||
146683379|NCT00664742|529017052|FG000|Overall Study|Withdrawal by Subject|31|||
146683380|NCT00664742|529017052|FG000|Overall Study|Lost to Follow-up|92|||
146683381|NCT04317066|529017053|FG000|Overall Study|Sponsor decision|5|||
146683382|NCT04317066|529017053|FG000|Overall Study|Death|2|||
146683383|NCT02014597|529017056|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
146683384|NCT02014597|529017057|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
146683385|NCT02825992|529017058|FG000|Overall Study|Withdrawal by Subject|4|||
146683386|NCT02825992|529017058|FG000|Overall Study|Lost to Follow-up|2|||
146683387|NCT02825992|529017058|FG000|Overall Study|Procedure terminated|2|||
146683388|NCT02279173|529017059|FG000|Overall Study|Protocol-specified Criteria|67|||
146683389|NCT02279173|529017059|FG000|Overall Study|Withdrawal by Subject|20|||
146683390|NCT02279173|529017059|FG000|Overall Study|Decision by Sponsor|4|||
146683391|NCT02279173|529017059|FG000|Overall Study|Lost to Follow-up|3|||
146683392|NCT01164956|529017060|FG000|Overall Study|Side Effects|1|||
146683393|NCT01164956|529017061|FG001|Overall Study|Side Effects|0|||
146683394|NCT01164956|529017062|FG002|Overall Study|Side Effects|1|||
146683395|NCT00931762|529017063|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
146683396|NCT00931762|529017063|FG000|Overall Study|Administrative Problems|5|||
146683397|NCT00931762|529017063|FG000|Overall Study|Death|1|||
146683398|NCT00931762|529017063|FG000|Overall Study|Disease Progression|3|||
146927336|NCT01096849|529894586|FG000|Overall Study|Administrative Reasons|0|||
146683399|NCT00931762|529017063|FG000|Overall Study|Adverse Event (s)|11|||
146683400|NCT00931762|529017063|FG000|Overall Study|Subject withdrew consent|13|||
146683401|NCT02282020|529017064|FG000|Overall Study|Objective Disease Progression|128|||
146683402|NCT02282020|529017065|FG001|Overall Study|Objective Disease Progression|30|||
146683403|NCT02282020|529017064|FG000|Overall Study|Adverse Event|18|||
146683404|NCT02282020|529017065|FG001|Overall Study|Adverse Event|15|||
146683405|NCT02282020|529017064|FG000|Overall Study|Withdrawal by Subject|7|||
146683406|NCT02282020|529017065|FG001|Overall Study|Withdrawal by Subject|10|||
146683407|NCT02282020|529017064|FG000|Overall Study|Miscellaneous|5|||
146683408|NCT02282020|529017065|FG001|Overall Study|Miscellaneous|19|||
146683409|NCT02282020|529017064|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
146683410|NCT02282020|529017065|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
146683411|NCT02282020|529017064|FG000|Overall Study|Developed Discontinuation Criteria|0|||
146683412|NCT02282020|529017065|FG001|Overall Study|Developed Discontinuation Criteria|2|||
146683413|NCT02282020|529017064|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
146683414|NCT02282020|529017065|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
146683415|NCT01500629|529017066|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
146683416|NCT01500629|529017067|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
146683417|NCT00849381|529017068|FG000|Overall Study|Adverse Event|1|||
146683418|NCT00849381|529017068|FG000|Overall Study|Lost to Follow-up|129|||
146683419|NCT00849381|529017068|FG000|Overall Study|Protocol Violation|5|||
146683420|NCT00849381|529017068|FG000|Overall Study|Withdrawal by Subject|6|||
146683421|NCT00849381|529017068|FG000|Overall Study|Other|4|||
146683422|NCT04429061|529017071|FG000|Overall Study|Lost to Follow-up|62|||
146683423|NCT04429061|529017072|FG001|Overall Study|Lost to Follow-up|87|||
146683424|NCT04429061|529017071|FG000|Overall Study|Withdrawal by Subject|3|||
146683425|NCT04429061|529017072|FG001|Overall Study|Withdrawal by Subject|4|||
146683426|NCT02618434|529017073|FG000|Overall Study|Withdrawal by Subject|0|||
146683427|NCT02618434|529017074|FG001|Overall Study|Withdrawal by Subject|2|||
146683428|NCT02618434|529017075|FG002|Overall Study|Withdrawal by Subject|3|||
146683429|NCT02618434|529017073|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
146683430|NCT02618434|529017074|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
146683431|NCT02618434|529017075|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
146683432|NCT02618434|529017073|FG000|Overall Study|Lost to Follow-up|3|||
146683433|NCT02618434|529017074|FG001|Overall Study|Lost to Follow-up|1|||
146683434|NCT02618434|529017075|FG002|Overall Study|Lost to Follow-up|3|||
146683435|NCT02618434|529017073|FG000|Overall Study|Adverse Event|1|||
146683436|NCT02618434|529017074|FG001|Overall Study|Adverse Event|0|||
146683437|NCT02618434|529017075|FG002|Overall Study|Adverse Event|12|||
146683438|NCT02618434|529017073|FG000|Overall Study|Physician Decision|0|||
146683439|NCT02618434|529017074|FG001|Overall Study|Physician Decision|1|||
146683440|NCT02618434|529017075|FG002|Overall Study|Physician Decision|0|||
146683441|NCT02618434|529017073|FG000|Overall Study|Protocol Violation|0|||
146683442|NCT02618434|529017074|FG001|Overall Study|Protocol Violation|0|||
146683443|NCT02618434|529017075|FG002|Overall Study|Protocol Violation|1|||
146683444|NCT02618434|529017073|FG000|Overall Study|Other, Multiple categories|1|||
146683445|NCT02618434|529017074|FG001|Overall Study|Other, Multiple categories|1|||
146683446|NCT02618434|529017075|FG002|Overall Study|Other, Multiple categories|1|||
146683447|NCT02005445|529017082|FG000|Overall Study|Dual study enrollment|0|||
146683448|NCT02005445|529017083|FG001|Overall Study|Dual study enrollment|1|||
146683449|NCT01881776|529017084|FG000|Overall Study|Lost to Follow-up|1|||
146683450|NCT01881776|529017085|FG001|Overall Study|Lost to Follow-up|2|||
146683451|NCT01881776|529017086|FG002|Overall Study|Lost to Follow-up|1|||
146683452|NCT01881776|529017084|FG000|Overall Study|Protocol Violation|0|||
146683453|NCT01881776|529017085|FG001|Overall Study|Protocol Violation|2|||
146683454|NCT01881776|529017086|FG002|Overall Study|Protocol Violation|1|||
146683455|NCT02320149|529017087|FG000|Overall Study|Adverse Event|3|||
146683456|NCT02320149|529017088|FG001|Overall Study|Adverse Event|7|||
146683457|NCT02320149|529017087|FG000|Overall Study|Withdrawal of Consent|28|||
146683458|NCT02320149|529017088|FG001|Overall Study|Withdrawal of Consent|32|||
146683459|NCT02320149|529017087|FG000|Overall Study|Lost to Follow-up|21|||
146683460|NCT02320149|529017088|FG001|Overall Study|Lost to Follow-up|34|||
146683461|NCT02320149|529017087|FG000|Overall Study|Protocol Violation|2|||
146683462|NCT02320149|529017088|FG001|Overall Study|Protocol Violation|1|||
146683463|NCT02320149|529017087|FG000|Overall Study|Noncompliance with Study Treatment|7|||
146683464|NCT02320149|529017088|FG001|Overall Study|Noncompliance with Study Treatment|2|||
146683465|NCT02320149|529017087|FG000|Overall Study|Lack of Efficacy|0|||
146683466|NCT02320149|529017088|FG001|Overall Study|Lack of Efficacy|1|||
146683467|NCT02320149|529017087|FG000|Overall Study|Other Miscellaneous Reasons|2|||
146683468|NCT02320149|529017088|FG001|Overall Study|Other Miscellaneous Reasons|3|||
146683469|NCT00022633|529017089|FG000|Overall Study|Adverse Event|11|||
146683470|NCT00022633|529017090|FG001|Overall Study|Adverse Event|1|||
146683471|NCT00022633|529017089|FG000|Overall Study|Refusal unrelated to adverse event|1|||
146683472|NCT00022633|529017090|FG001|Overall Study|Refusal unrelated to adverse event|0|||
146683473|NCT00022633|529017089|FG000|Overall Study|Progression/relapse|9|||
146683474|NCT00022633|529017090|FG001|Overall Study|Progression/relapse|2|||
146683475|NCT00022633|529017089|FG000|Overall Study|Death|4|||
146683476|NCT00022633|529017090|FG001|Overall Study|Death|0|||
146683477|NCT00022633|529017089|FG000|Overall Study|Other - not protocol specified|3|||
146683478|NCT00022633|529017090|FG001|Overall Study|Other - not protocol specified|2|||
146683479|NCT00022633|529017089|FG000|Overall Study|Ineligible|4|||
146683480|NCT00022633|529017090|FG001|Overall Study|Ineligible|0|||
146683481|NCT06133348|529017091|FG000|Overall Study|Death|3|||
146683482|NCT06133348|529017091|FG000|Overall Study|Lost to Follow-up|1|||
146683483|NCT06133348|529017091|FG000|Overall Study|Physician Decision|1|||
146683484|NCT06133348|529017091|FG000|Overall Study|Withdrawal by Subject|5|||
146683485|NCT00487747|529017092|FG000|Overall Study|Adverse Event|1|||
146774823|NCT04524390|529346784|FG001|Open-Label|Study Termination by sponsor|0|||
146683486|NCT00487747|529017092|FG000|Overall Study|Lost to Follow-up|9|||
146683487|NCT00487747|529017092|FG000|Overall Study|Lack of Efficacy|1|||
146683488|NCT01359449|529017093|FG000|Overall Study|Lost to Follow-up|1|||
146683489|NCT01359449|529017094|FG001|Overall Study|Lost to Follow-up|0|||
146683490|NCT01359449|529017093|FG000|Overall Study|Protocol Violation|0|||
146683491|NCT01359449|529017094|FG001|Overall Study|Protocol Violation|2|||
146683492|NCT01359449|529017093|FG000|Overall Study|Withdrawal by Subject|3|||
146683493|NCT01359449|529017094|FG001|Overall Study|Withdrawal by Subject|2|||
146683494|NCT02036294|529017096|FG000|Overall Study|Death|7|||
146683495|NCT02036294|529017097|FG001|Overall Study|Death|8|||
146683496|NCT02036294|529017096|FG000|Overall Study|Withdrawal by Subject|2|||
146683497|NCT02036294|529017097|FG001|Overall Study|Withdrawal by Subject|3|||
146683498|NCT00429104|529017100|FG000|Overall Study|Protocol Violation|1|||
146683499|NCT01907815|529017101|FG000|Overall Study|Withdrawal by Subject|1|||
146683500|NCT01907815|529017102|FG001|Overall Study|Withdrawal by Subject|0|||
146683501|NCT04997161|529017105|FG000|Overall Study|Study terminated by sponsor|3|||
146683502|NCT02485574|529017110|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
146683503|NCT01408914|529017113|FG000|Overall Study|Could not complete tx in protocol period|5|||
146683504|NCT01408914|529017114|FG001|Overall Study|Could not complete tx in protocol period|5|||
146683505|NCT01408914|529017115|FG002|Overall Study|Could not complete tx in protocol period|6|||
146683506|NCT01408914|529017113|FG000|Overall Study|Lost to Follow-up|4|||
146683507|NCT01408914|529017114|FG001|Overall Study|Lost to Follow-up|1|||
146683508|NCT01408914|529017115|FG002|Overall Study|Lost to Follow-up|2|||
146683509|NCT01408914|529017113|FG000|Overall Study|Physician Decision|1|||
146683510|NCT01408914|529017114|FG001|Overall Study|Physician Decision|1|||
146683511|NCT01408914|529017115|FG002|Overall Study|Physician Decision|0|||
146683512|NCT01408914|529017113|FG000|Overall Study|Withdrawal by Subject|1|||
146683513|NCT01408914|529017114|FG001|Overall Study|Withdrawal by Subject|0|||
146683514|NCT01408914|529017115|FG002|Overall Study|Withdrawal by Subject|1|||
146683515|NCT01408914|529017113|FG000|Overall Study|Moved out of study jurisdiction|1|||
146683516|NCT01408914|529017114|FG001|Overall Study|Moved out of study jurisdiction|1|||
146683517|NCT01408914|529017115|FG002|Overall Study|Moved out of study jurisdiction|0|||
146683518|NCT01408914|529017113|FG000|Overall Study|Late exclusion|0|||
146683519|NCT01408914|529017114|FG001|Overall Study|Late exclusion|3|||
146683520|NCT01408914|529017115|FG002|Overall Study|Late exclusion|3|||
146683521|NCT01408914|529017113|FG000|Overall Study|Change in local TB/HIV norms|0|||
146683522|NCT01408914|529017114|FG001|Overall Study|Change in local TB/HIV norms|1|||
146683523|NCT01408914|529017115|FG002|Overall Study|Change in local TB/HIV norms|1|||
146683524|NCT04044716|529017123|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
146683525|NCT04044716|529017124|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
146683526|NCT04044716|529017125|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
146683527|NCT04044716|529017123|FG000|Overall Study|Lost to Follow-up|2|||
146683528|NCT04044716|529017124|FG001|Overall Study|Lost to Follow-up|3|||
146683529|NCT04044716|529017125|FG002|Overall Study|Lost to Follow-up|0|||
146683530|NCT01957553|529017126|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
146683531|NCT01957553|529017127|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
146683532|NCT01957553|529017126|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
146683533|NCT01957553|529017127|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
146683534|NCT01957553|529017126|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
146683535|NCT01957553|529017127|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
146683536|NCT01957553|529017126|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
146683537|NCT01957553|529017127|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
146683538|NCT01957553|529017126|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
146683539|NCT01957553|529017127|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
146683540|NCT01957553|529017126|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
146683541|NCT01957553|529017127|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
146683542|NCT01957553|529017126|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
146683543|NCT01957553|529017127|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
146683544|NCT01957553|529017126|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
146683545|NCT01957553|529017127|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
146927337|NCT01096849|529894587|FG001|Overall Study|Administrative Reasons|1|||
146683546|NCT01957553|529017126|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
146683547|NCT01957553|529017127|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
146683548|NCT01714635|529017135|FG000|Overall Study|Discontinued|1|||
146683549|NCT01714635|529017136|FG001|Overall Study|Discontinued|0|||
146683550|NCT01714635|529017137|FG002|Overall Study|Discontinued|2|||
146683551|NCT01714635|529017135|FG000|Overall Study|Missed 6-month exam|1|||
146683552|NCT01714635|529017136|FG001|Overall Study|Missed 6-month exam|0|||
146683553|NCT01714635|529017137|FG002|Overall Study|Missed 6-month exam|0|||
146927338|NCT01096849|529894588|FG002|Overall Study|Administrative Reasons|2|||
146683554|NCT03672747|529017139|FG000|Overall Study|Lost to Follow-up|1|||
146683555|NCT03672747|529017140|FG001|Overall Study|Lost to Follow-up|1|||
146683556|NCT03672747|529017141|FG002|Overall Study|Lost to Follow-up|2|||
146927339|NCT01096849|529894586|FG000|Overall Study|Lost to Follow-up|1|||
146683557|NCT03672747|529017142|FG003|Overall Study|Lost to Follow-up|2|||
146683558|NCT03672747|529017143|FG004|Overall Study|Lost to Follow-up|2|||
146683559|NCT03672747|529017144|FG005|Overall Study|Lost to Follow-up|1|||
146683560|NCT04285879|529017145|FG000|Overall Study|Lost to Follow-up|1|||
146683561|NCT04285879|529017146|FG001|Overall Study|Lost to Follow-up|8|||
146683562|NCT04285879|529017145|FG000|Overall Study|medical/surgical exclusion|16|||
146683563|NCT04285879|529017146|FG001|Overall Study|medical/surgical exclusion|0|||
146683564|NCT00071513|529017149|FG000|Intervention Component|Withdrawal by Subject|2|||
146683565|NCT00071513|529017150|FG001|Intervention Component|Withdrawal by Subject|3|||
146683566|NCT00071513|529017149|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
146683567|NCT00071513|529017150|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
146683568|NCT03667924|529017151|FG000|Baseline Completed|Lost to Follow-up|0|||
146683569|NCT03667924|529017152|FG001|Baseline Completed|Lost to Follow-up|2|||
146683570|NCT03667924|529017153|FG002|Baseline Completed|Lost to Follow-up|0|||
146683571|NCT03667924|529017151|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
146683572|NCT03667924|529017152|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
146683573|NCT03667924|529017153|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
146683574|NCT03667924|529017151|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
146683575|NCT03667924|529017152|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
146683576|NCT03667924|529017153|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
146683577|NCT03667924|529017151|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
146683578|NCT03667924|529017152|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
146683579|NCT03667924|529017153|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
146683580|NCT03667924|529017151|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
146683581|NCT03667924|529017152|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
146683582|NCT03667924|529017153|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
146683583|NCT03667924|529017151|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
146683584|NCT03667924|529017152|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
146683585|NCT03667924|529017153|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
146683586|NCT03667924|529017151|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
146683587|NCT03667924|529017152|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
146683588|NCT03667924|529017153|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
146683589|NCT03358290|529017154|FG000|Overall Study|Study discontinued by Sponsor|0|||
146683590|NCT03358290|529017155|FG001|Overall Study|Study discontinued by Sponsor|1|||
146683591|NCT03358290|529017156|FG002|Overall Study|Study discontinued by Sponsor|1|||
146683592|NCT03358290|529017157|FG003|Overall Study|Study discontinued by Sponsor|0|||
146683593|NCT03358290|529017158|FG004|Overall Study|Study discontinued by Sponsor|0|||
146683594|NCT03358290|529017154|FG000|Overall Study|Adverse Event|0|||
146683595|NCT03358290|529017155|FG001|Overall Study|Adverse Event|0|||
146683596|NCT03358290|529017156|FG002|Overall Study|Adverse Event|1|||
146683597|NCT03358290|529017157|FG003|Overall Study|Adverse Event|2|||
146683598|NCT03358290|529017158|FG004|Overall Study|Adverse Event|0|||
146683599|NCT03358290|529017154|FG000|Overall Study|Withdrawal by Subject|0|||
146683600|NCT03358290|529017155|FG001|Overall Study|Withdrawal by Subject|0|||
146683601|NCT03358290|529017156|FG002|Overall Study|Withdrawal by Subject|0|||
146683602|NCT03358290|529017157|FG003|Overall Study|Withdrawal by Subject|0|||
146683603|NCT03358290|529017158|FG004|Overall Study|Withdrawal by Subject|1|||
146683604|NCT02743871|529017159|FG000|Overall Study|Lost to Follow-up|0|||
146683605|NCT02743871|529017160|FG001|Overall Study|Lost to Follow-up|0|||
146683606|NCT02743871|529017161|FG002|Overall Study|Lost to Follow-up|0|||
146683607|NCT02743871|529017162|FG003|Overall Study|Lost to Follow-up|1|||
146683608|NCT02743871|529017163|FG004|Overall Study|Lost to Follow-up|0|||
146683609|NCT02743871|529017164|FG005|Overall Study|Lost to Follow-up|0|||
146683610|NCT02743871|529017165|FG006|Overall Study|Lost to Follow-up|1|||
146683611|NCT02743871|529017166|FG007|Overall Study|Lost to Follow-up|0|||
146683612|NCT02743871|529017167|FG008|Overall Study|Lost to Follow-up|0|||
146683613|NCT02743871|529017168|FG009|Overall Study|Lost to Follow-up|0|||
146683614|NCT02743871|529017169|FG010|Overall Study|Lost to Follow-up|0|||
146683615|NCT02743871|529017170|FG011|Overall Study|Lost to Follow-up|2|||
146683616|NCT02743871|529017171|FG012|Overall Study|Lost to Follow-up|0|||
146683617|NCT02743871|529017172|FG013|Overall Study|Lost to Follow-up|0|||
146683618|NCT02743871|529017159|FG000|Overall Study|Withdrawal by Subject|0|||
146683619|NCT02743871|529017160|FG001|Overall Study|Withdrawal by Subject|0|||
146683620|NCT02743871|529017161|FG002|Overall Study|Withdrawal by Subject|0|||
146927340|NCT01096849|529894587|FG001|Overall Study|Lost to Follow-up|3|||
146683621|NCT02743871|529017162|FG003|Overall Study|Withdrawal by Subject|0|||
146683622|NCT02743871|529017163|FG004|Overall Study|Withdrawal by Subject|0|||
146683623|NCT02743871|529017164|FG005|Overall Study|Withdrawal by Subject|0|||
146683624|NCT02743871|529017165|FG006|Overall Study|Withdrawal by Subject|0|||
146683625|NCT02743871|529017166|FG007|Overall Study|Withdrawal by Subject|0|||
146683626|NCT02743871|529017167|FG008|Overall Study|Withdrawal by Subject|0|||
146683627|NCT02743871|529017168|FG009|Overall Study|Withdrawal by Subject|0|||
146683628|NCT02743871|529017169|FG010|Overall Study|Withdrawal by Subject|1|||
146683629|NCT02743871|529017170|FG011|Overall Study|Withdrawal by Subject|0|||
146683630|NCT02743871|529017171|FG012|Overall Study|Withdrawal by Subject|12|||
146683631|NCT02743871|529017172|FG013|Overall Study|Withdrawal by Subject|6|||
146683632|NCT02743871|529017159|FG000|Overall Study|Adverse Event|1|||
146683633|NCT02743871|529017160|FG001|Overall Study|Adverse Event|0|||
146683634|NCT02743871|529017161|FG002|Overall Study|Adverse Event|0|||
146683635|NCT02743871|529017162|FG003|Overall Study|Adverse Event|0|||
146683636|NCT02743871|529017163|FG004|Overall Study|Adverse Event|0|||
146683637|NCT02743871|529017164|FG005|Overall Study|Adverse Event|0|||
146683638|NCT02743871|529017165|FG006|Overall Study|Adverse Event|0|||
146683639|NCT02743871|529017166|FG007|Overall Study|Adverse Event|0|||
146683640|NCT02743871|529017167|FG008|Overall Study|Adverse Event|0|||
146683641|NCT02743871|529017168|FG009|Overall Study|Adverse Event|0|||
146683642|NCT02743871|529017169|FG010|Overall Study|Adverse Event|0|||
146683643|NCT02743871|529017170|FG011|Overall Study|Adverse Event|0|||
146683644|NCT02743871|529017171|FG012|Overall Study|Adverse Event|0|||
146683645|NCT02743871|529017172|FG013|Overall Study|Adverse Event|0|||
146683646|NCT02743871|529017159|FG000|Overall Study|Other|0|||
146683647|NCT02743871|529017160|FG001|Overall Study|Other|0|||
146683648|NCT02743871|529017161|FG002|Overall Study|Other|0|||
146683649|NCT02743871|529017162|FG003|Overall Study|Other|0|||
146683650|NCT02743871|529017163|FG004|Overall Study|Other|0|||
146683651|NCT02743871|529017164|FG005|Overall Study|Other|0|||
146683652|NCT02743871|529017165|FG006|Overall Study|Other|0|||
146683653|NCT02743871|529017166|FG007|Overall Study|Other|0|||
146683654|NCT02743871|529017167|FG008|Overall Study|Other|0|||
146683655|NCT02743871|529017168|FG009|Overall Study|Other|0|||
146683656|NCT02743871|529017169|FG010|Overall Study|Other|0|||
146683657|NCT02743871|529017170|FG011|Overall Study|Other|1|||
146683658|NCT02743871|529017171|FG012|Overall Study|Other|1|||
146683659|NCT02743871|529017172|FG013|Overall Study|Other|1|||
146683660|NCT02743871|529017159|FG000|Overall Study|Protocol Violation|0|||
146683661|NCT02743871|529017160|FG001|Overall Study|Protocol Violation|0|||
146683662|NCT02743871|529017161|FG002|Overall Study|Protocol Violation|0|||
146683663|NCT02743871|529017162|FG003|Overall Study|Protocol Violation|0|||
146683664|NCT02743871|529017163|FG004|Overall Study|Protocol Violation|0|||
146683665|NCT02743871|529017164|FG005|Overall Study|Protocol Violation|0|||
146683666|NCT02743871|529017165|FG006|Overall Study|Protocol Violation|0|||
146683667|NCT02743871|529017166|FG007|Overall Study|Protocol Violation|0|||
146683668|NCT02743871|529017167|FG008|Overall Study|Protocol Violation|0|||
146683669|NCT02743871|529017168|FG009|Overall Study|Protocol Violation|0|||
146683670|NCT02743871|529017169|FG010|Overall Study|Protocol Violation|0|||
146683671|NCT02743871|529017170|FG011|Overall Study|Protocol Violation|0|||
146683672|NCT02743871|529017171|FG012|Overall Study|Protocol Violation|2|||
146683673|NCT02743871|529017172|FG013|Overall Study|Protocol Violation|0|||
146683674|NCT04405037|529017176|FG000|Overall Study|Withdrawal by Subject|1|||
146683675|NCT04405037|529017177|FG001|Overall Study|Withdrawal by Subject|0|||
146683676|NCT04405037|529017176|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
146683677|NCT04405037|529017177|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
146683678|NCT05126901|529019173|FG000|Overall Study|Withdrawal by Subject|1|||
146683679|NCT05126901|529019174|FG001|Overall Study|Withdrawal by Subject|1|||
146683680|NCT05126901|529019175|FG002|Overall Study|Withdrawal by Subject|4|||
146683681|NCT05126901|529019173|FG000|Overall Study|Adverse Event|0|||
146683682|NCT05126901|529019174|FG001|Overall Study|Adverse Event|0|||
146683683|NCT05126901|529019175|FG002|Overall Study|Adverse Event|1|||
146683684|NCT05126901|529019173|FG000|Overall Study|Lost to Follow-up|0|||
146683685|NCT05126901|529019174|FG001|Overall Study|Lost to Follow-up|2|||
146774824|NCT04524390|529346785|FG002|Open-Label|Study Termination by sponsor|45|||
146774825|NCT03088813|529346788|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
146774826|NCT03088813|529346789|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
146683686|NCT05126901|529019175|FG002|Overall Study|Lost to Follow-up|0|||
146683687|NCT00754624|529019176|FG000|Overall Study|Adverse Event|16|||
146683688|NCT00754624|529019176|FG000|Overall Study|Death|1|||
146683689|NCT00754624|529019176|FG000|Overall Study|Physician Decision|8|||
146683690|NCT00754624|529019176|FG000|Overall Study|Protocol Violation|1|||
146683691|NCT00754624|529019176|FG000|Overall Study|Withdrawal by Subject|28|||
146683692|NCT00754624|529019176|FG000|Overall Study|Various|12|||
146683693|NCT00754624|529019176|FG000|Overall Study|Lost to Follow-up|3|||
146683694|NCT04067544|529019177|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
146683695|NCT01529346|529019180|FG000|Overall Study|Lost to Follow-up|2|||
146683696|NCT01529346|529019181|FG001|Overall Study|Lost to Follow-up|0|||
146683697|NCT01529346|529019182|FG002|Overall Study|Lost to Follow-up|1|||
146683698|NCT01529346|529019183|FG003|Overall Study|Lost to Follow-up|0|||
146683699|NCT01529346|529019184|FG004|Overall Study|Lost to Follow-up|0|||
146683700|NCT01529346|529019180|FG000|Overall Study|Other|0|||
146683701|NCT01529346|529019181|FG001|Overall Study|Other|1|||
146683702|NCT01529346|529019182|FG002|Overall Study|Other|1|||
146683703|NCT01529346|529019183|FG003|Overall Study|Other|0|||
146683704|NCT01529346|529019184|FG004|Overall Study|Other|0|||
146683705|NCT01499667|529019185|FG000|Overall Study|administrative problems|4|||
146683706|NCT01499667|529019186|FG001|Overall Study|administrative problems|5|||
146683707|NCT01499667|529019187|FG002|Overall Study|administrative problems|5|||
146683708|NCT01499667|529019185|FG000|Overall Study|Protocol Violation|1|||
146683709|NCT01499667|529019186|FG001|Overall Study|Protocol Violation|3|||
146683710|NCT01499667|529019187|FG002|Overall Study|Protocol Violation|2|||
146683711|NCT01499667|529019185|FG000|Overall Study|Adverse Event|0|||
146683712|NCT01499667|529019186|FG001|Overall Study|Adverse Event|2|||
146683713|NCT01499667|529019187|FG002|Overall Study|Adverse Event|2|||
146683714|NCT01499667|529019185|FG000|Overall Study|Withdrawal by Subject|2|||
146927341|NCT01096849|529894588|FG002|Overall Study|Lost to Follow-up|1|||
146683715|NCT01499667|529019186|FG001|Overall Study|Withdrawal by Subject|1|||
146683716|NCT01499667|529019187|FG002|Overall Study|Withdrawal by Subject|1|||
146683717|NCT01499667|529019185|FG000|Overall Study|Lack of Efficacy|2|||
146683718|NCT01499667|529019186|FG001|Overall Study|Lack of Efficacy|0|||
146683719|NCT01499667|529019187|FG002|Overall Study|Lack of Efficacy|0|||
146683720|NCT00460031|529019190|FG000|Overall Study|Adverse Event|5|||
146683721|NCT00460031|529019190|FG000|Overall Study|Withdrawal by Subject|5|||
146683722|NCT00460031|529019190|FG000|Overall Study|Death|1|||
146683723|NCT02506153|529019191|FG000|Overall Study|Adverse Event|359|||
146683724|NCT02506153|529019192|FG001|Overall Study|Adverse Event|114|||
146683725|NCT02506153|529019191|FG000|Overall Study|Refused unrelated to adverse event|127|||
146683726|NCT02506153|529019192|FG001|Overall Study|Refused unrelated to adverse event|18|||
146683727|NCT02506153|529019191|FG000|Overall Study|Progression/relapse|91|||
146683728|NCT02506153|529019192|FG001|Overall Study|Progression/relapse|136|||
146683729|NCT02506153|529019191|FG000|Overall Study|Death|2|||
146683730|NCT02506153|529019192|FG001|Overall Study|Death|1|||
146683731|NCT02506153|529019191|FG000|Overall Study|Other - not protocol specified|23|||
146683732|NCT02506153|529019192|FG001|Overall Study|Other - not protocol specified|12|||
146683733|NCT00311623|529019198|FG000|Overall Study|Physician Decision|0|||
146683734|NCT00311623|529019199|FG001|Overall Study|Physician Decision|0|||
146683735|NCT00311623|529019200|FG002|Overall Study|Physician Decision|2|||
146683736|NCT03103919|529019201|FG000|Overall Study|Adverse Event|2|||
146683737|NCT03103919|529019202|FG001|Overall Study|Adverse Event|2|||
146683738|NCT05682326|529019203|FG000|Overall Study|Withdrawal by Subject|1|||
146683739|NCT05682326|529019204|FG001|Overall Study|Withdrawal by Subject|0|||
146683740|NCT03998189|529019205|FG000|Overall Study|Lack of Efficacy|0|||
146683741|NCT03998189|529019206|FG001|Overall Study|Lack of Efficacy|1|||
146683742|NCT03454893|529019209|FG000|Overall Study|Study Terminated by the Sponsor|5|||
146683743|NCT03454893|529019209|FG000|Overall Study|Did not pass screening|4|||
146683744|NCT03414424|529019210|FG000|Overall Study|Screened out after consent|0|||
146927342|NCT04146467|529894589|FG000|Overall Study|Adverse Event|0|||
146927343|NCT04146467|529894590|FG001|Overall Study|Adverse Event|1|||
146927344|NCT04146467|529894589|FG000|Overall Study|Lost to Follow-up|0|||
146927345|NCT04146467|529894590|FG001|Overall Study|Lost to Follow-up|2|||
146927346|NCT01189435|529894593|FG000|Overall Study|Withdrawal by Subject|1|||
146927347|NCT01189435|529894593|FG000|Overall Study|Physician Decision|1|||
146927348|NCT00547378|529894594|FG000|Randomized Cohort|Withdrawal by Subject|7|||
146927349|NCT00547378|529894595|FG001|Randomized Cohort|Withdrawal by Subject|5|||
146927350|NCT00547378|529894596|FG002|Randomized Cohort|Withdrawal by Subject|0|||
146927351|NCT00547378|529894594|FG000|Randomized Cohort|Death|0|||
146927352|NCT00547378|529894595|FG001|Randomized Cohort|Death|1|||
146927353|NCT00547378|529894596|FG002|Randomized Cohort|Death|0|||
146927354|NCT00547378|529894594|FG000|Randomized Cohort|Lost to Follow-up|1|||
146927355|NCT00547378|529894595|FG001|Randomized Cohort|Lost to Follow-up|0|||
146927356|NCT00547378|529894596|FG002|Randomized Cohort|Lost to Follow-up|0|||
146927357|NCT00547378|529894594|FG000|Randomized Cohort|Adverse Event|1|||
146927358|NCT00547378|529894595|FG001|Randomized Cohort|Adverse Event|0|||
146927359|NCT00547378|529894596|FG002|Randomized Cohort|Adverse Event|0|||
146927360|NCT00547378|529894594|FG000|Randomized Cohort|Other reasons|2|||
146927361|NCT00547378|529894595|FG001|Randomized Cohort|Other reasons|0|||
146927362|NCT00547378|529894596|FG002|Randomized Cohort|Other reasons|0|||
146927363|NCT00547378|529894594|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
146683745|NCT03414424|529019211|FG001|Overall Study|Screened out after consent|2|||
146683746|NCT03414424|529019210|FG000|Overall Study|Lost to Follow-up|0|||
146683747|NCT03414424|529019211|FG001|Overall Study|Lost to Follow-up|1|||
146683748|NCT03070782|529019213|FG000|Overall Study|Adverse Event|3|||
146683749|NCT03070782|529019214|FG001|Overall Study|Adverse Event|0|||
146683750|NCT03070782|529019215|FG002|Overall Study|Adverse Event|3|||
146683751|NCT03070782|529019216|FG003|Overall Study|Adverse Event|1|||
146683752|NCT03070782|529019217|FG004|Overall Study|Adverse Event|6|||
146683753|NCT03070782|529019218|FG005|Overall Study|Adverse Event|2|||
146683754|NCT03070782|529019213|FG000|Overall Study|Withdrawal by Subject|2|||
146927364|NCT00547378|529894595|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
146927365|NCT00547378|529894596|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
146927366|NCT00547378|529894594|FG000|All Implanted Cohort|Adverse Event|4|||
146927367|NCT00547378|529894595|FG001|All Implanted Cohort|Adverse Event|10|||
146927368|NCT00547378|529894596|FG002|All Implanted Cohort|Adverse Event|17|||
146683755|NCT03070782|529019214|FG001|Overall Study|Withdrawal by Subject|1|||
146683756|NCT03070782|529019215|FG002|Overall Study|Withdrawal by Subject|1|||
146683757|NCT03070782|529019216|FG003|Overall Study|Withdrawal by Subject|0|||
146683758|NCT03070782|529019217|FG004|Overall Study|Withdrawal by Subject|4|||
146683759|NCT03070782|529019218|FG005|Overall Study|Withdrawal by Subject|3|||
146683760|NCT03070782|529019213|FG000|Overall Study|Reason Not Specified|2|||
146683761|NCT03070782|529019214|FG001|Overall Study|Reason Not Specified|0|||
146683762|NCT03070782|529019215|FG002|Overall Study|Reason Not Specified|0|||
146683763|NCT03070782|529019216|FG003|Overall Study|Reason Not Specified|1|||
146683764|NCT03070782|529019217|FG004|Overall Study|Reason Not Specified|2|||
146683765|NCT03070782|529019218|FG005|Overall Study|Reason Not Specified|1|||
146683766|NCT03070782|529019213|FG000|Overall Study|Ineligibility|0|||
146683767|NCT03070782|529019214|FG001|Overall Study|Ineligibility|0|||
146683768|NCT03070782|529019215|FG002|Overall Study|Ineligibility|0|||
146683769|NCT03070782|529019216|FG003|Overall Study|Ineligibility|1|||
146683770|NCT03070782|529019217|FG004|Overall Study|Ineligibility|0|||
146683771|NCT03070782|529019218|FG005|Overall Study|Ineligibility|1|||
146683772|NCT03070782|529019213|FG000|Overall Study|Pregnancy|0|||
146683773|NCT03070782|529019214|FG001|Overall Study|Pregnancy|0|||
146683774|NCT03070782|529019215|FG002|Overall Study|Pregnancy|0|||
146683775|NCT03070782|529019216|FG003|Overall Study|Pregnancy|1|||
146683776|NCT03070782|529019217|FG004|Overall Study|Pregnancy|0|||
146683777|NCT03070782|529019218|FG005|Overall Study|Pregnancy|0|||
146683778|NCT03070782|529019213|FG000|Overall Study|Investigator Judgement|0|||
146683779|NCT03070782|529019214|FG001|Overall Study|Investigator Judgement|0|||
146683780|NCT03070782|529019215|FG002|Overall Study|Investigator Judgement|0|||
146683781|NCT03070782|529019216|FG003|Overall Study|Investigator Judgement|1|||
146683782|NCT03070782|529019217|FG004|Overall Study|Investigator Judgement|0|||
146683783|NCT03070782|529019218|FG005|Overall Study|Investigator Judgement|0|||
146683784|NCT03527966|529019219|FG000|Overall Study|Lost to Follow-up|3|||
146683785|NCT03527966|529019220|FG001|Overall Study|Lost to Follow-up|0|||
146683786|NCT02288559|529019221|FG000|Overall Study|Adverse Event|1|||
146683787|NCT02288559|529019222|FG001|Overall Study|Adverse Event|1|||
146683788|NCT02288559|529019223|FG002|Overall Study|Adverse Event|5|||
146683789|NCT02288559|529019224|FG003|Overall Study|Adverse Event|0|||
146683790|NCT02288559|529019221|FG000|Overall Study|Death|0|||
146683791|NCT02288559|529019222|FG001|Overall Study|Death|0|||
146683792|NCT02288559|529019223|FG002|Overall Study|Death|1|||
146683793|NCT02288559|529019224|FG003|Overall Study|Death|0|||
146683794|NCT02288559|529019221|FG000|Overall Study|Lost to Follow-up|0|||
146683795|NCT02288559|529019222|FG001|Overall Study|Lost to Follow-up|0|||
146683796|NCT02288559|529019223|FG002|Overall Study|Lost to Follow-up|0|||
146683797|NCT02288559|529019224|FG003|Overall Study|Lost to Follow-up|1|||
146683798|NCT02288559|529019221|FG000|Overall Study|Withdrawal by Subject|0|||
146683799|NCT02288559|529019222|FG001|Overall Study|Withdrawal by Subject|0|||
146683800|NCT02288559|529019223|FG002|Overall Study|Withdrawal by Subject|2|||
146683801|NCT02288559|529019224|FG003|Overall Study|Withdrawal by Subject|1|||
146683802|NCT02288559|529019221|FG000|Overall Study|Reason Not Specified|0|||
146683803|NCT02288559|529019222|FG001|Overall Study|Reason Not Specified|0|||
146683804|NCT02288559|529019223|FG002|Overall Study|Reason Not Specified|3|||
146683805|NCT02288559|529019224|FG003|Overall Study|Reason Not Specified|0|||
146683806|NCT00558025|529019225|FG000|Overall Study|Adverse Event|1|||
146683807|NCT00558025|529019226|FG001|Overall Study|Adverse Event|1|||
146683808|NCT00558025|529019225|FG000|Overall Study|Withdrawal by Subject|2|||
146683809|NCT00558025|529019226|FG001|Overall Study|Withdrawal by Subject|2|||
146683810|NCT00558025|529019225|FG000|Overall Study|Protocol Violation|1|||
146683811|NCT00558025|529019226|FG001|Overall Study|Protocol Violation|0|||
146683812|NCT01314443|529019227|FG000|Overall Study|Withdrawal by Subject|2|||
146683813|NCT01314443|529019228|FG001|Overall Study|Withdrawal by Subject|1|||
146927369|NCT00547378|529894594|FG000|All Implanted Cohort|Lost to Follow-up|0|||
146927370|NCT00547378|529894595|FG001|All Implanted Cohort|Lost to Follow-up|1|||
146927371|NCT00547378|529894596|FG002|All Implanted Cohort|Lost to Follow-up|14|||
146927372|NCT00547378|529894594|FG000|All Implanted Cohort|Death|3|||
146927373|NCT00547378|529894595|FG001|All Implanted Cohort|Death|1|||
146927374|NCT00547378|529894596|FG002|All Implanted Cohort|Death|4|||
146683814|NCT01314443|529019229|FG002|Overall Study|Withdrawal by Subject|1|||
146683815|NCT01314443|529019230|FG003|Overall Study|Withdrawal by Subject|1|||
146683816|NCT01314443|529019227|FG000|Overall Study|Protocol Violation|2|||
146683817|NCT01314443|529019228|FG001|Overall Study|Protocol Violation|2|||
146683818|NCT01314443|529019229|FG002|Overall Study|Protocol Violation|1|||
146683819|NCT01314443|529019230|FG003|Overall Study|Protocol Violation|1|||
146683820|NCT06073119|529019231|FG000|Overall Study|Adverse Event|1|||
146683821|NCT06073119|529019232|FG001|Overall Study|Adverse Event|3|||
146683822|NCT06073119|529019233|FG002|Overall Study|Adverse Event|0|||
146683823|NCT06073119|529019234|FG003|Overall Study|Adverse Event|0|||
146683824|NCT06073119|529019235|FG004|Overall Study|Adverse Event|1|||
146683825|NCT06073119|529019236|FG005|Overall Study|Adverse Event|0|||
146683826|NCT06073119|529019231|FG000|Overall Study|Non-compliance with study schedule|1|||
146927375|NCT00547378|529894594|FG000|All Implanted Cohort|Physician Decision|0|||
146683827|NCT06073119|529019232|FG001|Overall Study|Non-compliance with study schedule|0|||
146683828|NCT06073119|529019233|FG002|Overall Study|Non-compliance with study schedule|0|||
146683829|NCT06073119|529019234|FG003|Overall Study|Non-compliance with study schedule|0|||
146683830|NCT06073119|529019235|FG004|Overall Study|Non-compliance with study schedule|1|||
146683831|NCT06073119|529019236|FG005|Overall Study|Non-compliance with study schedule|0|||
146683832|NCT06073119|529019231|FG000|Overall Study|Withdrawal by Subject|4|||
146683833|NCT06073119|529019232|FG001|Overall Study|Withdrawal by Subject|4|||
146683834|NCT06073119|529019233|FG002|Overall Study|Withdrawal by Subject|3|||
146683835|NCT06073119|529019234|FG003|Overall Study|Withdrawal by Subject|5|||
146683836|NCT06073119|529019235|FG004|Overall Study|Withdrawal by Subject|3|||
146683837|NCT06073119|529019236|FG005|Overall Study|Withdrawal by Subject|1|||
146683838|NCT06073119|529019231|FG000|Overall Study|Other|2|||
146683839|NCT06073119|529019232|FG001|Overall Study|Other|4|||
146683840|NCT06073119|529019233|FG002|Overall Study|Other|1|||
146683841|NCT06073119|529019234|FG003|Overall Study|Other|0|||
146683842|NCT06073119|529019235|FG004|Overall Study|Other|1|||
146683843|NCT06073119|529019236|FG005|Overall Study|Other|0|||
146683844|NCT02393547|529019239|FG000|Overall Study|Adverse Event|2|||
146683845|NCT02393547|529019239|FG000|Overall Study|Withdrawal by Subject|3|||
146683846|NCT02393547|529019239|FG000|Overall Study|Lost to Follow-up|1|||
146683847|NCT02979522|529019240|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
146683848|NCT02979522|529019241|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
146683849|NCT02979522|529019240|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
146683850|NCT02979522|529019241|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
146683851|NCT05185089|529019242|FG000|First Intervention (4 weeks)|Adverse Event|0|||
146683852|NCT05185089|529019243|FG001|First Intervention (4 weeks)|Adverse Event|0|||
146683853|NCT05185089|529019244|FG002|First Intervention (4 weeks)|Adverse Event|0|||
146683854|NCT05185089|529019245|FG003|First Intervention (4 weeks)|Adverse Event|1|||
146683855|NCT05185089|529019242|FG000|Second Intervention (4 weeks)|Death|0|||
146683856|NCT05185089|529019243|FG001|Second Intervention (4 weeks)|Death|1|||
146683857|NCT05185089|529019244|FG002|Second Intervention (4 weeks)|Death|0|||
146683858|NCT05185089|529019245|FG003|Second Intervention (4 weeks)|Death|0|||
146683859|NCT05185089|529019242|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
146683860|NCT05185089|529019243|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
146683861|NCT05185089|529019244|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
146683862|NCT05185089|529019245|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
146683863|NCT00667368|529019246|FG000|Overall Study|Lost to Follow-up|176|||
146683864|NCT00667368|529019247|FG001|Overall Study|Lost to Follow-up|155|||
146683865|NCT00667368|529019246|FG000|Overall Study|Discontinued early|24|||
146683866|NCT00667368|529019247|FG001|Overall Study|Discontinued early|17|||
146683867|NCT00191789|529019249|FG000|Overall Study|Adverse Event|5|||
146683868|NCT00191789|529019249|FG000|Overall Study|Patient: Satisfactory Response|5|||
146683869|NCT00191789|529019249|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
146683870|NCT00191789|529019249|FG000|Overall Study|Withdrawal by Subject|4|||
146683871|NCT00191789|529019249|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
146683872|NCT00191789|529019249|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
146683873|NCT00191789|529019249|FG000|Overall Study|Death - Not Study-Drug Related|1|||
146683874|NCT05582889|529019250|FG000|Overall Study|Health event|3|||
146683875|NCT05582889|529019251|FG001|Overall Study|Health event|2|||
146683876|NCT05582889|529019250|FG000|Overall Study|Lost to Follow-up|2|||
146683877|NCT05582889|529019251|FG001|Overall Study|Lost to Follow-up|4|||
146683878|NCT06112756|529019252|FG000|Overall Study|Withdrawal by Subject|0|||
146683879|NCT06112756|529019253|FG001|Overall Study|Withdrawal by Subject|2|||
146683880|NCT06112756|529019252|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
146683881|NCT06112756|529019253|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
146683882|NCT06112756|529019252|FG000|Overall Study|Adverse Event|2|||
146683883|NCT06112756|529019253|FG001|Overall Study|Adverse Event|2|||
146683884|NCT04551092|529019254|FG000|Overall Study|Lost to Follow-up|7|||
146683885|NCT04551092|529019254|FG000|Overall Study|Withdrawal by Subject|4|||
146683886|NCT01712490|529019255|FG000|Overall Study|Ongoing|601|||
146683887|NCT01712490|529019256|FG001|Overall Study|Ongoing|586|||
146683888|NCT01712490|529019255|FG000|Overall Study|Other|11|||
146683889|NCT01712490|529019256|FG001|Overall Study|Other|11|||
146683890|NCT01712490|529019255|FG000|Overall Study|Withdrawal by Subject|36|||
146927376|NCT00547378|529894595|FG001|All Implanted Cohort|Physician Decision|2|||
146683891|NCT01712490|529019256|FG001|Overall Study|Withdrawal by Subject|44|||
146683892|NCT01712490|529019255|FG000|Overall Study|Lost to Follow-up|16|||
146683893|NCT01712490|529019256|FG001|Overall Study|Lost to Follow-up|29|||
146683894|NCT03060629|529019261|FG000|Overall Study|Death|4|||
146683895|NCT03060629|529019262|FG001|Overall Study|Death|5|||
146683896|NCT03060629|529019261|FG000|Overall Study|Withdrawal by Subject|50|||
146683897|NCT03060629|529019262|FG001|Overall Study|Withdrawal by Subject|35|||
146683898|NCT03060629|529019261|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
146683899|NCT03060629|529019262|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
146683900|NCT03060629|529019261|FG000|Overall Study|Participant Relocate|15|||
146683901|NCT03060629|529019262|FG001|Overall Study|Participant Relocate|15|||
146683902|NCT03060629|529019261|FG000|Overall Study|Unable to Contact Participant|34|||
146683903|NCT03060629|529019262|FG001|Overall Study|Unable to Contact Participant|23|||
146683904|NCT03060629|529019261|FG000|Overall Study|Investigator Decision|7|||
146927377|NCT00547378|529894596|FG002|All Implanted Cohort|Physician Decision|6|||
146927378|NCT00547378|529894594|FG000|All Implanted Cohort|Site closure|2|||
146927379|NCT00547378|529894595|FG001|All Implanted Cohort|Site closure|0|||
146927380|NCT00547378|529894596|FG002|All Implanted Cohort|Site closure|1|||
146927381|NCT00547378|529894594|FG000|All Implanted Cohort|Other reasons|1|||
146683905|NCT03060629|529019262|FG001|Overall Study|Investigator Decision|7|||
146683906|NCT03060629|529019261|FG000|Overall Study|Study Terminated by Sponsor|1100|||
146683907|NCT03060629|529019262|FG001|Overall Study|Study Terminated by Sponsor|1123|||
146683908|NCT03060629|529019261|FG000|Overall Study|Other|4|||
146683909|NCT03060629|529019262|FG001|Overall Study|Other|4|||
146683910|NCT01862874|529019263|FG000|Overall Study|Randomized not treated|1|||
146683911|NCT01862874|529019264|FG001|Overall Study|Randomized not treated|0|||
146683912|NCT01862874|529019263|FG000|Overall Study|Adverse Event|0|||
146683913|NCT01862874|529019264|FG001|Overall Study|Adverse Event|3|||
146683914|NCT01862874|529019263|FG000|Overall Study|Lost to Follow-up|26|||
146683915|NCT01862874|529019264|FG001|Overall Study|Lost to Follow-up|29|||
146683916|NCT01862874|529019263|FG000|Overall Study|Physician Decision|5|||
146683917|NCT01862874|529019264|FG001|Overall Study|Physician Decision|3|||
146683918|NCT01862874|529019263|FG000|Overall Study|Withdrawn by parent/guardian|1|||
146683919|NCT01862874|529019264|FG001|Overall Study|Withdrawn by parent/guardian|1|||
146683920|NCT01862874|529019263|FG000|Overall Study|Withdrawal by Subject|46|||
146683921|NCT01862874|529019264|FG001|Overall Study|Withdrawal by Subject|40|||
146683922|NCT01862874|529019263|FG000|Overall Study|Death|0|||
146683923|NCT01862874|529019264|FG001|Overall Study|Death|1|||
146683924|NCT01782495|529019272|FG000|Overall Study|Adverse Event|0|||
146683925|NCT01782495|529019273|FG001|Overall Study|Adverse Event|0|||
146683926|NCT01782495|529019274|FG002|Overall Study|Adverse Event|0|||
146683927|NCT01782495|529019275|FG003|Overall Study|Adverse Event|0|||
146683928|NCT01782495|529019276|FG004|Overall Study|Adverse Event|0|||
146683929|NCT01782495|529019277|FG005|Overall Study|Adverse Event|0|||
146683930|NCT01782495|529019278|FG006|Overall Study|Adverse Event|0|||
146683931|NCT01782495|529019279|FG007|Overall Study|Adverse Event|2|||
146683932|NCT01782495|529019280|FG008|Overall Study|Adverse Event|0|||
146683933|NCT01782495|529019281|FG009|Overall Study|Adverse Event|0|||
146683934|NCT01782495|529019282|FG010|Overall Study|Adverse Event|0|||
146683935|NCT01782495|529019272|FG000|Overall Study|Withdrew Consent|0|||
146683936|NCT01782495|529019273|FG001|Overall Study|Withdrew Consent|1|||
146683937|NCT01782495|529019274|FG002|Overall Study|Withdrew Consent|0|||
146683938|NCT01782495|529019275|FG003|Overall Study|Withdrew Consent|0|||
146683939|NCT01782495|529019276|FG004|Overall Study|Withdrew Consent|0|||
146683940|NCT01782495|529019277|FG005|Overall Study|Withdrew Consent|0|||
146683941|NCT01782495|529019278|FG006|Overall Study|Withdrew Consent|0|||
146683942|NCT01782495|529019279|FG007|Overall Study|Withdrew Consent|1|||
146683943|NCT01782495|529019280|FG008|Overall Study|Withdrew Consent|0|||
146683944|NCT01782495|529019281|FG009|Overall Study|Withdrew Consent|0|||
146683945|NCT01782495|529019282|FG010|Overall Study|Withdrew Consent|0|||
146683946|NCT01927367|529019283|FG000|Overall Study|Withdrawal by Subject|7|||
146683947|NCT01927367|529019284|FG001|Overall Study|Withdrawal by Subject|4|||
146683948|NCT01927367|529019283|FG000|Overall Study|No baseline data|0|||
146683949|NCT01927367|529019284|FG001|Overall Study|No baseline data|1|||
146683950|NCT00241280|529019289|FG000|Overall Study|Adverse Event|2|||
146683951|NCT00241280|529019290|FG001|Overall Study|Adverse Event|6|||
146683952|NCT00241280|529019289|FG000|Overall Study|Discomfort|11|||
146683953|NCT00241280|529019290|FG001|Overall Study|Discomfort|16|||
146683954|NCT00241280|529019289|FG000|Overall Study|Pregnancy|1|||
146683955|NCT00241280|529019290|FG001|Overall Study|Pregnancy|5|||
146683956|NCT00241280|529019289|FG000|Overall Study|Lost to Follow-up|5|||
146683957|NCT00241280|529019290|FG001|Overall Study|Lost to Follow-up|8|||
146683958|NCT00241280|529019289|FG000|Overall Study|Withdrawal by Subject|7|||
146683959|NCT00241280|529019290|FG001|Overall Study|Withdrawal by Subject|4|||
146683960|NCT00241280|529019289|FG000|Overall Study|Protocol Violation|4|||
146683961|NCT00241280|529019290|FG001|Overall Study|Protocol Violation|10|||
146683962|NCT00241280|529019289|FG000|Overall Study|Relocation|4|||
146683963|NCT00241280|529019290|FG001|Overall Study|Relocation|4|||
146683964|NCT00241280|529019289|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
146683965|NCT00241280|529019290|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
146683966|NCT00241280|529019289|FG000|Overall Study|Unsatisfactory Visual Response|1|||
146683967|NCT00241280|529019290|FG001|Overall Study|Unsatisfactory Visual Response|1|||
146683968|NCT00241280|529019289|FG000|Overall Study|Diabetic|1|||
146683969|NCT00241280|529019290|FG001|Overall Study|Diabetic|0|||
146683970|NCT00241280|529019289|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
146683971|NCT00241280|529019290|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
146683972|NCT00241280|529019289|FG000|Overall Study|Dispensed incorrect test article|1|||
146683973|NCT00241280|529019290|FG001|Overall Study|Dispensed incorrect test article|2|||
146927382|NCT00547378|529894595|FG001|All Implanted Cohort|Other reasons|0|||
146683974|NCT00241280|529019289|FG000|Overall Study|Unacceptable Fit|0|||
146683975|NCT00241280|529019290|FG001|Overall Study|Unacceptable Fit|1|||
146683976|NCT00241280|529019289|FG000|Overall Study|Scheduling Conflict|0|||
146683977|NCT00241280|529019290|FG001|Overall Study|Scheduling Conflict|2|||
146683978|NCT00241280|529019289|FG000|Overall Study|History of Ocular Surgery|0|||
146683979|NCT00241280|529019290|FG001|Overall Study|History of Ocular Surgery|1|||
146683980|NCT00241280|529019289|FG000|Overall Study|Coating on Lens|1|||
146683981|NCT00241280|529019290|FG001|Overall Study|Coating on Lens|0|||
146683982|NCT00241280|529019289|FG000|Overall Study|Excessive Dryness|0|||
146683983|NCT00241280|529019290|FG001|Overall Study|Excessive Dryness|1|||
146683984|NCT01634360|529019291|FG000|Overall Study|Adverse Event|10|||
146683985|NCT01634360|529019292|FG001|Overall Study|Adverse Event|34|||
146683986|NCT01634360|529019291|FG000|Overall Study|subject withdrew consent|13|||
146683987|NCT01634360|529019292|FG001|Overall Study|subject withdrew consent|23|||
146683988|NCT01634360|529019291|FG000|Overall Study|Protocol Violation|1|||
146683989|NCT01634360|529019292|FG001|Overall Study|Protocol Violation|1|||
146683990|NCT01634360|529019291|FG000|Overall Study|Lack of Efficacy|4|||
146683991|NCT01634360|529019292|FG001|Overall Study|Lack of Efficacy|14|||
146683992|NCT01634360|529019291|FG000|Overall Study|Other|3|||
146683993|NCT01634360|529019292|FG001|Overall Study|Other|20|||
146683994|NCT01634360|529019291|FG000|Overall Study|Study termination by sponsor|18|||
146683995|NCT01634360|529019292|FG001|Overall Study|Study termination by sponsor|44|||
146683996|NCT02260921|529019299|FG000|Overall Study|Adverse Event|1|||
146683997|NCT02260921|529019300|FG001|Overall Study|Adverse Event|0|||
146683998|NCT02260921|529019299|FG000|Overall Study|Lost to Follow-up|4|||
146683999|NCT02260921|529019300|FG001|Overall Study|Lost to Follow-up|3|||
146684000|NCT02260921|529019299|FG000|Overall Study|Withdraw Consent|4|||
146684001|NCT02260921|529019300|FG001|Overall Study|Withdraw Consent|1|||
146684002|NCT02260921|529019299|FG000|Overall Study|Death|1|||
146684003|NCT02260921|529019300|FG001|Overall Study|Death|0|||
146684004|NCT02260921|529019299|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
146684005|NCT02260921|529019300|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
146684006|NCT01244425|529019301|FG000|Overall Study|Withdrawal by Subject|2|||
146684007|NCT01244425|529019302|FG001|Overall Study|Withdrawal by Subject|2|||
146684008|NCT01244425|529019301|FG000|Overall Study|Adverse Event|1|||
146684009|NCT01244425|529019302|FG001|Overall Study|Adverse Event|1|||
146684010|NCT02999854|529019303|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
146684011|NCT02999854|529019304|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
146684012|NCT02999854|529019303|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
146684013|NCT02999854|529019304|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
146684014|NCT02999854|529019303|FG000|Active Study Phase (up to 18 Months)|Death|7|||
146684015|NCT02999854|529019304|FG001|Active Study Phase (up to 18 Months)|Death|5|||
146684016|NCT02999854|529019303|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
146684017|NCT02999854|529019304|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
146684018|NCT02999854|529019303|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
146684019|NCT02999854|529019304|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
146684020|NCT02999854|529019303|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
146684021|NCT02999854|529019304|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
146684022|NCT02999854|529019303|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
146684023|NCT02999854|529019304|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
146684024|NCT02999854|529019303|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
146684025|NCT02999854|529019304|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
146684026|NCT02848651|529019305|FG000|Overall Study|Death|85|||
146684027|NCT02848651|529019305|FG000|Overall Study|Lost to Follow-up|1|||
146684028|NCT02848651|529019305|FG000|Overall Study|Non-Compliance|1|||
146684029|NCT02848651|529019305|FG000|Overall Study|Symptomatic Deterioration|1|||
146684030|NCT02848651|529019305|FG000|Overall Study|Physician Decision|4|||
146684031|NCT02848651|529019305|FG000|Overall Study|Withdrawal by Subject|14|||
146684032|NCT04140292|529019306|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
146684033|NCT04140292|529019307|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
146684034|NCT02484729|529019308|FG000|Overall Study|Failure of IntelliCap Error|0|||
146684035|NCT02484729|529019309|FG001|Overall Study|Failure of IntelliCap Error|0|||
146684036|NCT02484729|529019310|FG002|Overall Study|Failure of IntelliCap Error|0|||
146684037|NCT02484729|529019311|FG003|Overall Study|Failure of IntelliCap Error|0|||
146684038|NCT02484729|529019312|FG004|Overall Study|Failure of IntelliCap Error|0|||
146848286|NCT02407990|529615645|FG000|Overall Study|Death|2|||
146684039|NCT02484729|529019313|FG005|Overall Study|Failure of IntelliCap Error|0|||
146684040|NCT02484729|529019314|FG006|Overall Study|Failure of IntelliCap Error|0|||
146684041|NCT02484729|529019315|FG007|Overall Study|Failure of IntelliCap Error|0|||
146684042|NCT02484729|529019316|FG008|Overall Study|Failure of IntelliCap Error|0|||
146684043|NCT02484729|529019317|FG009|Overall Study|Failure of IntelliCap Error|1|||
146684044|NCT04772755|529019320|FG000|Overall Study|Withdrawal by Subject|1|||
146684045|NCT04772755|529019321|FG001|Overall Study|Withdrawal by Subject|0|||
146684046|NCT04772755|529019320|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
146684047|NCT04772755|529019321|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
146684048|NCT02480114|529019322|FG000|Overall Study|Not completing surveys|3|||
146684049|NCT02480114|529019323|FG001|Overall Study|Not completing surveys|2|||
146684050|NCT02480114|529019322|FG000|Overall Study|Withdrawal by Subject|2|||
146684051|NCT02480114|529019323|FG001|Overall Study|Withdrawal by Subject|4|||
146684052|NCT02480114|529019322|FG000|Overall Study|Disease progression|3|||
146684053|NCT02480114|529019323|FG001|Overall Study|Disease progression|0|||
146684054|NCT02480114|529019322|FG000|Overall Study|Improper completion of survey|1|||
146684055|NCT02480114|529019323|FG001|Overall Study|Improper completion of survey|1|||
146684056|NCT02480114|529019322|FG000|Overall Study|Not eligible|0|||
146684057|NCT02480114|529019323|FG001|Overall Study|Not eligible|1|||
146684058|NCT01535053|529019324|FG000|Overall Study|Ineligible|1|||
146684059|NCT01535053|529019325|FG001|Overall Study|Ineligible|2|||
146684060|NCT01031069|529019326|FG000|Overall Study|Serious Adverse Event|0|||
146684061|NCT01031069|529019327|FG001|Overall Study|Serious Adverse Event|1|||
146684062|NCT01031069|529019328|FG002|Overall Study|Serious Adverse Event|0|||
146684063|NCT01031069|529019329|FG003|Overall Study|Serious Adverse Event|0|||
146684064|NCT01031069|529019326|FG000|Overall Study|Withdrawal by Subject|2|||
146684065|NCT01031069|529019327|FG001|Overall Study|Withdrawal by Subject|3|||
146684066|NCT01031069|529019328|FG002|Overall Study|Withdrawal by Subject|18|||
146684067|NCT01031069|529019329|FG003|Overall Study|Withdrawal by Subject|18|||
146684068|NCT01031069|529019326|FG000|Overall Study|Migrated/moved from study area|1|||
146684069|NCT01031069|529019327|FG001|Overall Study|Migrated/moved from study area|2|||
146684070|NCT01031069|529019328|FG002|Overall Study|Migrated/moved from study area|1|||
146684071|NCT01031069|529019329|FG003|Overall Study|Migrated/moved from study area|1|||
146684072|NCT01031069|529019326|FG000|Overall Study|Lost to Follow-up|9|||
146684073|NCT01031069|529019327|FG001|Overall Study|Lost to Follow-up|5|||
146684074|NCT01031069|529019328|FG002|Overall Study|Lost to Follow-up|21|||
146684075|NCT01031069|529019329|FG003|Overall Study|Lost to Follow-up|15|||
146684076|NCT01031069|529019326|FG000|Overall Study|Other|0|||
146684077|NCT01031069|529019327|FG001|Overall Study|Other|0|||
146684078|NCT01031069|529019328|FG002|Overall Study|Other|1|||
146684079|NCT01031069|529019329|FG003|Overall Study|Other|0|||
146684080|NCT00512707|529019330|FG000|Overall Study|Lost to Follow-up|5|||
146684081|NCT00512707|529019331|FG001|Overall Study|Lost to Follow-up|11|||
146684082|NCT00512707|529019330|FG000|Overall Study|Developed skin irritation|2|||
146684083|NCT00512707|529019331|FG001|Overall Study|Developed skin irritation|1|||
146684084|NCT00512707|529019330|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
146684085|NCT00512707|529019331|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
146684086|NCT00512707|529019330|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
146684087|NCT00512707|529019331|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
146684088|NCT01317160|529019332|FG000|Overall Study|Incorrect inclusion|1|||
146684089|NCT01317160|529019333|FG001|Overall Study|Incorrect inclusion|1|||
146684090|NCT01317160|529019332|FG000|Overall Study|Lost to Follow-up|3|||
146684091|NCT01317160|529019333|FG001|Overall Study|Lost to Follow-up|3|||
146684092|NCT01317160|529019332|FG000|Overall Study|Withdrawal by Subject|0|||
146684093|NCT01317160|529019333|FG001|Overall Study|Withdrawal by Subject|2|||
146684094|NCT03032705|529019339|FG000|Overall Study|Lost to Follow-up|16|||
146684095|NCT03032705|529019340|FG001|Overall Study|Lost to Follow-up|17|||
146684096|NCT03032705|529019339|FG000|Overall Study|did not quality|6|||
146684097|NCT03032705|529019340|FG001|Overall Study|did not quality|6|||
146684098|NCT01853826|529021004|FG000|Overall Study|Patients who switched to commercial drug|11|||
146684099|NCT01853826|529021004|FG000|Overall Study|Patient refused to continue medication|21|||
146684100|NCT01853826|529021004|FG000|Overall Study|Lost to Follow-up|2|||
146684101|NCT01853826|529021004|FG000|Overall Study|Non-compliant with protocol|4|||
146684102|NCT01853826|529021004|FG000|Overall Study|Other adverse events (AE)|62|||
146684103|NCT01853826|529021004|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
146684104|NCT01853826|529021004|FG000|Overall Study|Progressive disease|342|||
146684105|NCT01853826|529021004|FG000|Overall Study|Other than listed|13|||
146684106|NCT01853826|529021004|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
146684107|NCT03653637|529021005|FG000|Overall Study|Death|1|||
146684108|NCT03653637|529021006|FG001|Overall Study|Death|3|||
146684109|NCT03653637|529021005|FG000|Overall Study|Lost to Follow-up|29|||
146684110|NCT03653637|529021006|FG001|Overall Study|Lost to Follow-up|30|||
146684111|NCT03653637|529021005|FG000|Overall Study|Physician Decision|1|||
146684112|NCT03653637|529021006|FG001|Overall Study|Physician Decision|1|||
146684113|NCT03653637|529021005|FG000|Overall Study|Withdrawal by Subject|7|||
146684114|NCT03653637|529021006|FG001|Overall Study|Withdrawal by Subject|4|||
146684115|NCT05661942|529021008|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
146684116|NCT05661942|529021009|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
146684117|NCT02081690|529021012|FG000|Overall Study|Death|3|||
146684118|NCT02081690|529021012|FG000|Overall Study|Physician Decision|3|||
146684119|NCT02081690|529021012|FG000|Overall Study|Withdrawal by Subject|1|||
146684120|NCT00982488|529021015|FG000|Overall Study|Administrative reason by sponsor|81|||
146684121|NCT00982488|529021016|FG001|Overall Study|Administrative reason by sponsor|3|||
146684122|NCT00982488|529021017|FG002|Overall Study|Administrative reason by sponsor|11|||
146684123|NCT00982488|529021018|FG003|Overall Study|Administrative reason by sponsor|0|||
146684124|NCT00982488|529021019|FG004|Overall Study|Administrative reason by sponsor|0|||
146684125|NCT00982488|529021015|FG000|Overall Study|Adverse event unrelated to study drug|5|||
146684126|NCT00982488|529021016|FG001|Overall Study|Adverse event unrelated to study drug|1|||
146684127|NCT00982488|529021017|FG002|Overall Study|Adverse event unrelated to study drug|0|||
146684128|NCT00982488|529021018|FG003|Overall Study|Adverse event unrelated to study drug|0|||
146684129|NCT00982488|529021019|FG004|Overall Study|Adverse event unrelated to study drug|0|||
146684130|NCT00982488|529021015|FG000|Overall Study|Death|11|||
146684131|NCT00982488|529021016|FG001|Overall Study|Death|0|||
146684132|NCT00982488|529021017|FG002|Overall Study|Death|2|||
146684133|NCT00982488|529021018|FG003|Overall Study|Death|0|||
146684134|NCT00982488|529021019|FG004|Overall Study|Death|0|||
146684135|NCT00982488|529021015|FG000|Overall Study|Disease progression|30|||
146684136|NCT00982488|529021016|FG001|Overall Study|Disease progression|5|||
146684137|NCT00982488|529021017|FG002|Overall Study|Disease progression|10|||
146684138|NCT00982488|529021018|FG003|Overall Study|Disease progression|1|||
146684139|NCT00982488|529021019|FG004|Overall Study|Disease progression|1|||
146684140|NCT00982488|529021015|FG000|Overall Study|Lost to Follow-up|1|||
146684141|NCT00982488|529021016|FG001|Overall Study|Lost to Follow-up|0|||
146684142|NCT00982488|529021017|FG002|Overall Study|Lost to Follow-up|0|||
146684143|NCT00982488|529021018|FG003|Overall Study|Lost to Follow-up|0|||
146684144|NCT00982488|529021019|FG004|Overall Study|Lost to Follow-up|0|||
146684145|NCT00982488|529021015|FG000|Overall Study|Maximum clinical benefit|1|||
146684146|NCT00982488|529021016|FG001|Overall Study|Maximum clinical benefit|1|||
146684147|NCT00982488|529021017|FG002|Overall Study|Maximum clinical benefit|1|||
146684148|NCT00982488|529021018|FG003|Overall Study|Maximum clinical benefit|0|||
146684149|NCT00982488|529021019|FG004|Overall Study|Maximum clinical benefit|0|||
146684150|NCT00982488|529021015|FG000|Overall Study|Other|15|||
146684151|NCT00982488|529021016|FG001|Overall Study|Other|1|||
146684152|NCT00982488|529021017|FG002|Overall Study|Other|3|||
146684153|NCT00982488|529021018|FG003|Overall Study|Other|1|||
146684154|NCT00982488|529021019|FG004|Overall Study|Other|0|||
146684155|NCT00982488|529021015|FG000|Overall Study|Poor compliance/noncompliance|0|||
146684156|NCT00982488|529021016|FG001|Overall Study|Poor compliance/noncompliance|1|||
146684157|NCT00982488|529021017|FG002|Overall Study|Poor compliance/noncompliance|0|||
146684158|NCT00982488|529021018|FG003|Overall Study|Poor compliance/noncompliance|0|||
146684159|NCT00982488|529021019|FG004|Overall Study|Poor compliance/noncompliance|0|||
146684160|NCT00982488|529021015|FG000|Overall Study|Stem cell transplant|2|||
146684161|NCT00982488|529021016|FG001|Overall Study|Stem cell transplant|0|||
146684162|NCT00982488|529021017|FG002|Overall Study|Stem cell transplant|0|||
146684163|NCT00982488|529021018|FG003|Overall Study|Stem cell transplant|1|||
146684164|NCT00982488|529021019|FG004|Overall Study|Stem cell transplant|0|||
146684165|NCT00982488|529021015|FG000|Overall Study|Study drug toxicity|34|||
146684166|NCT00982488|529021016|FG001|Overall Study|Study drug toxicity|1|||
146684167|NCT00982488|529021017|FG002|Overall Study|Study drug toxicity|6|||
146684168|NCT00982488|529021018|FG003|Overall Study|Study drug toxicity|0|||
146684169|NCT00982488|529021019|FG004|Overall Study|Study drug toxicity|0|||
146684170|NCT00982488|529021015|FG000|Overall Study|Withdrawal by Subject|5|||
146684171|NCT00982488|529021016|FG001|Overall Study|Withdrawal by Subject|1|||
146684172|NCT00982488|529021017|FG002|Overall Study|Withdrawal by Subject|1|||
146684173|NCT00982488|529021018|FG003|Overall Study|Withdrawal by Subject|0|||
146684174|NCT00982488|529021019|FG004|Overall Study|Withdrawal by Subject|0|||
146684175|NCT04203238|529021020|FG000|Overall Study|Withdrawal by Subject|1|||
146684176|NCT04203238|529021021|FG001|Overall Study|Withdrawal by Subject|1|||
146684177|NCT04203238|529021020|FG000|Overall Study|Covid-19|3|||
146684178|NCT04203238|529021021|FG001|Overall Study|Covid-19|0|||
146684179|NCT00951665|529021027|FG000|Phase 1b|Adverse Event|2|||
146684180|NCT00951665|529021028|FG001|Phase 1b|Adverse Event|1|||
146684181|NCT00951665|529021029|FG002|Phase 1b|Adverse Event|0|||
146684182|NCT00951665|529021030|FG003|Phase 1b|Adverse Event|1|||
146684183|NCT00951665|529021031|FG004|Phase 1b|Adverse Event|0|||
146684184|NCT00951665|529021032|FG005|Phase 1b|Adverse Event|0|||
146684185|NCT00951665|529021027|FG000|Phase 1b|Death|1|||
146684186|NCT00951665|529021028|FG001|Phase 1b|Death|0|||
146684187|NCT00951665|529021029|FG002|Phase 1b|Death|2|||
146684188|NCT00951665|529021030|FG003|Phase 1b|Death|0|||
146684189|NCT00951665|529021031|FG004|Phase 1b|Death|0|||
146684190|NCT00951665|529021032|FG005|Phase 1b|Death|0|||
146684191|NCT00951665|529021027|FG000|Phase 1b|Physician Decision|4|||
146684192|NCT00951665|529021028|FG001|Phase 1b|Physician Decision|0|||
146684193|NCT00951665|529021029|FG002|Phase 1b|Physician Decision|1|||
146684194|NCT00951665|529021030|FG003|Phase 1b|Physician Decision|0|||
146684195|NCT00951665|529021031|FG004|Phase 1b|Physician Decision|0|||
146684196|NCT00951665|529021032|FG005|Phase 1b|Physician Decision|0|||
146684197|NCT00951665|529021027|FG000|Phase 1b|Withdrawal by Subject|0|||
146684198|NCT00951665|529021028|FG001|Phase 1b|Withdrawal by Subject|1|||
146684199|NCT00951665|529021029|FG002|Phase 1b|Withdrawal by Subject|0|||
146684200|NCT00951665|529021030|FG003|Phase 1b|Withdrawal by Subject|0|||
146684201|NCT00951665|529021031|FG004|Phase 1b|Withdrawal by Subject|0|||
146684202|NCT00951665|529021032|FG005|Phase 1b|Withdrawal by Subject|0|||
146684203|NCT00951665|529021027|FG000|Phase 1b|Disease Progression|13|||
146684204|NCT00951665|529021028|FG001|Phase 1b|Disease Progression|2|||
146684205|NCT00951665|529021029|FG002|Phase 1b|Disease Progression|14|||
146684206|NCT00951665|529021030|FG003|Phase 1b|Disease Progression|0|||
146684207|NCT00951665|529021031|FG004|Phase 1b|Disease Progression|0|||
146684208|NCT00951665|529021032|FG005|Phase 1b|Disease Progression|0|||
146684209|NCT00951665|529021027|FG000|Phase 1b|Protocol Violation|2|||
146684210|NCT00951665|529021028|FG001|Phase 1b|Protocol Violation|0|||
146684211|NCT00951665|529021029|FG002|Phase 1b|Protocol Violation|0|||
146684212|NCT00951665|529021030|FG003|Phase 1b|Protocol Violation|0|||
146684213|NCT00951665|529021031|FG004|Phase 1b|Protocol Violation|0|||
146684214|NCT00951665|529021032|FG005|Phase 1b|Protocol Violation|0|||
146684215|NCT00951665|529021027|FG000|Phase 2a|Adverse Event|0|||
146684216|NCT00951665|529021028|FG001|Phase 2a|Adverse Event|0|||
146684217|NCT00951665|529021029|FG002|Phase 2a|Adverse Event|0|||
146684218|NCT00951665|529021030|FG003|Phase 2a|Adverse Event|0|||
146684219|NCT00951665|529021031|FG004|Phase 2a|Adverse Event|2|||
146684220|NCT00951665|529021032|FG005|Phase 2a|Adverse Event|0|||
146684221|NCT00951665|529021027|FG000|Phase 2a|Death|0|||
146684222|NCT00951665|529021028|FG001|Phase 2a|Death|0|||
146684223|NCT00951665|529021029|FG002|Phase 2a|Death|0|||
146684224|NCT00951665|529021030|FG003|Phase 2a|Death|0|||
146684225|NCT00951665|529021031|FG004|Phase 2a|Death|1|||
146684226|NCT00951665|529021032|FG005|Phase 2a|Death|1|||
146684227|NCT00951665|529021027|FG000|Phase 2a|Lost to Follow-up|0|||
146684228|NCT00951665|529021028|FG001|Phase 2a|Lost to Follow-up|0|||
146684229|NCT00951665|529021029|FG002|Phase 2a|Lost to Follow-up|0|||
146684230|NCT00951665|529021030|FG003|Phase 2a|Lost to Follow-up|0|||
146684231|NCT00951665|529021031|FG004|Phase 2a|Lost to Follow-up|1|||
146684232|NCT00951665|529021032|FG005|Phase 2a|Lost to Follow-up|0|||
146684233|NCT00951665|529021027|FG000|Phase 2a|Physician Decision|0|||
146684234|NCT00951665|529021028|FG001|Phase 2a|Physician Decision|0|||
146684235|NCT00951665|529021029|FG002|Phase 2a|Physician Decision|0|||
146684236|NCT00951665|529021030|FG003|Phase 2a|Physician Decision|0|||
146684237|NCT00951665|529021031|FG004|Phase 2a|Physician Decision|0|||
146684238|NCT00951665|529021032|FG005|Phase 2a|Physician Decision|1|||
146684239|NCT00951665|529021027|FG000|Phase 2a|Withdrawal by Subject|0|||
146684240|NCT00951665|529021028|FG001|Phase 2a|Withdrawal by Subject|0|||
146684241|NCT00951665|529021029|FG002|Phase 2a|Withdrawal by Subject|0|||
146684242|NCT00951665|529021030|FG003|Phase 2a|Withdrawal by Subject|0|||
146684243|NCT00951665|529021031|FG004|Phase 2a|Withdrawal by Subject|2|||
146684244|NCT00951665|529021032|FG005|Phase 2a|Withdrawal by Subject|0|||
146684245|NCT00951665|529021027|FG000|Phase 2a|Disease Progression|0|||
146684246|NCT00951665|529021028|FG001|Phase 2a|Disease Progression|0|||
146684247|NCT00951665|529021029|FG002|Phase 2a|Disease Progression|0|||
146684248|NCT00951665|529021030|FG003|Phase 2a|Disease Progression|0|||
146684249|NCT00951665|529021031|FG004|Phase 2a|Disease Progression|6|||
146684250|NCT00951665|529021032|FG005|Phase 2a|Disease Progression|5|||
146684251|NCT02734810|529021034|FG000|Overall Study|Adverse Event|1|||
146684252|NCT02734810|529021035|FG001|Overall Study|Adverse Event|0|||
146684253|NCT02734810|529021034|FG000|Overall Study|Lack of Efficacy|1|||
146684254|NCT02734810|529021035|FG001|Overall Study|Lack of Efficacy|0|||
146684255|NCT00127712|529021036|FG000|Overall Study|Adverse Event|3|||
146684256|NCT00127712|529021037|FG001|Overall Study|Adverse Event|0|||
146684257|NCT00127712|529021036|FG000|Overall Study|Lack of GI access to continue|2|||
146684258|NCT00127712|529021037|FG001|Overall Study|Lack of GI access to continue|0|||
146684259|NCT02664441|529021038|FG000|Randomization|Withdrawal by Subject|0|||
146684260|NCT02664441|529021039|FG001|Randomization|Withdrawal by Subject|1|||
146684261|NCT02664441|529021038|FG000|36-week Randomized Trial|Adverse Event|2|||
146684262|NCT02664441|529021039|FG001|36-week Randomized Trial|Adverse Event|0|||
146684263|NCT02664441|529021038|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
146684264|NCT02664441|529021039|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
146684265|NCT02664441|529021038|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
146684266|NCT02664441|529021039|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
146684267|NCT02664441|529021038|FG000|18-week Open Label Extension|Adverse Event|1|||
146684268|NCT02664441|529021039|FG001|18-week Open Label Extension|Adverse Event|0|||
146684269|NCT02664441|529021038|FG000|18-week Open Label Extension|Physician Decision|1|||
146684270|NCT02664441|529021039|FG001|18-week Open Label Extension|Physician Decision|0|||
146684271|NCT02664441|529021038|FG000|18-week Open Label Extension|Death|1|||
146684272|NCT02664441|529021039|FG001|18-week Open Label Extension|Death|0|||
146684273|NCT02664441|529021038|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
146684274|NCT02664441|529021039|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
146684275|NCT05040386|529021040|FG000|Overall Study|Withdrawal by Subject|1|||
146684276|NCT05040386|529021041|FG001|Overall Study|Withdrawal by Subject|0|||
146927383|NCT00547378|529894596|FG002|All Implanted Cohort|Other reasons|1|||
146684277|NCT05040386|529021042|FG002|Overall Study|Withdrawal by Subject|1|||
146684278|NCT05040386|529021043|FG003|Overall Study|Withdrawal by Subject|0|||
146684279|NCT05040386|529021040|FG000|Overall Study|Lost to Follow-up|0|||
146684280|NCT05040386|529021041|FG001|Overall Study|Lost to Follow-up|0|||
146684281|NCT05040386|529021042|FG002|Overall Study|Lost to Follow-up|1|||
146684282|NCT05040386|529021043|FG003|Overall Study|Lost to Follow-up|0|||
146684283|NCT00715078|529021045|FG000|Overall Study|Death|29|||
146927384|NCT00414960|529894597|FG000|Overall Study|Adverse Event|4|||
146927385|NCT00414960|529894598|FG001|Overall Study|Adverse Event|0|||
146927386|NCT00414960|529894597|FG000|Overall Study|Withdrawal by Subject|3|||
146927387|NCT00414960|529894598|FG001|Overall Study|Withdrawal by Subject|0|||
146927388|NCT00414960|529894597|FG000|Overall Study|Physician Decision|0|||
146927389|NCT00414960|529894598|FG001|Overall Study|Physician Decision|1|||
146927390|NCT01449682|529894600|FG000|Overall Study|Death|0|||
146927391|NCT01449682|529894601|FG001|Overall Study|Death|1|||
146927392|NCT01449682|529894600|FG000|Overall Study|Adverse Event|1|||
146927393|NCT01449682|529894601|FG001|Overall Study|Adverse Event|0|||
146927394|NCT00264849|529894607|FG000|Overall Study|Adverse Event|7|||
146927395|NCT00264849|529894608|FG001|Overall Study|Adverse Event|2|||
146927396|NCT00264849|529894607|FG000|Overall Study|Withdrawal by Subject|7|||
146927397|NCT00264849|529894608|FG001|Overall Study|Withdrawal by Subject|11|||
146927398|NCT00264849|529894607|FG000|Overall Study|Protocol Violation|5|||
146927399|NCT00264849|529894608|FG001|Overall Study|Protocol Violation|3|||
146927400|NCT00264849|529894607|FG000|Overall Study|Lack of Efficacy|1|||
146927401|NCT00264849|529894608|FG001|Overall Study|Lack of Efficacy|6|||
146927402|NCT00264849|529894607|FG000|Overall Study|Lost to Follow-up|0|||
146927403|NCT00264849|529894608|FG001|Overall Study|Lost to Follow-up|2|||
146927404|NCT00264849|529894607|FG000|Overall Study|Death|0|||
146927405|NCT00264849|529894608|FG001|Overall Study|Death|1|||
146927406|NCT00264849|529894607|FG000|Overall Study|Administrative Problems|2|||
146927407|NCT00264849|529894608|FG001|Overall Study|Administrative Problems|0|||
146927408|NCT00099359|529894609|FG000|Overall Study|Death|11|||
146927409|NCT00099359|529894610|FG001|Overall Study|Death|15|||
146927410|NCT00099359|529894611|FG002|Overall Study|Death|17|||
146927411|NCT00099359|529894609|FG000|Overall Study|Withdrawal by Subject|19|||
146927412|NCT00099359|529894610|FG001|Overall Study|Withdrawal by Subject|19|||
146927413|NCT00099359|529894611|FG002|Overall Study|Withdrawal by Subject|23|||
146927414|NCT00099359|529894609|FG000|Overall Study|Lost to Follow-up|15|||
146927415|NCT00099359|529894610|FG001|Overall Study|Lost to Follow-up|24|||
146684284|NCT00715078|529021046|FG001|Overall Study|Death|36|||
146684285|NCT00715078|529021047|FG002|Overall Study|Death|36|||
146684286|NCT00715078|529021045|FG000|Overall Study|Withdrawal by Subject|1|||
146684287|NCT00715078|529021046|FG001|Overall Study|Withdrawal by Subject|0|||
146684288|NCT00715078|529021047|FG002|Overall Study|Withdrawal by Subject|1|||
146684289|NCT00715078|529021045|FG000|Overall Study|Unable to start due to disease prog.|0|||
146684290|NCT00715078|529021046|FG001|Overall Study|Unable to start due to disease prog.|0|||
146684291|NCT00715078|529021047|FG002|Overall Study|Unable to start due to disease prog.|1|||
146684292|NCT02892760|529021048|FG000|Overall Study|Withdrawal by Subject|3|||
146684293|NCT00386776|529021051|FG000|Overall Study|Withdrawal by Subject|8|||
146684294|NCT00588848|529021052|FG000|Overall Study|Physician Decision|0|||
146684295|NCT00588848|529021053|FG001|Overall Study|Physician Decision|3|||
146684296|NCT00249444|529021054|FG000|Overall Study|Lost to Follow-up|2|||
146684297|NCT00249444|529021055|FG001|Overall Study|Lost to Follow-up|2|||
146684298|NCT00249444|529021054|FG000|Overall Study|non-compliant|9|||
146684299|NCT00249444|529021055|FG001|Overall Study|non-compliant|11|||
146684300|NCT00249444|529021054|FG000|Overall Study|Adverse Event|1|||
146684301|NCT00249444|529021055|FG001|Overall Study|Adverse Event|1|||
146684302|NCT00249444|529021054|FG000|Overall Study|life event|0|||
146684303|NCT00249444|529021055|FG001|Overall Study|life event|1|||
146684304|NCT02673489|529021056|FG000|Treatment Period|Lost to Follow-up|3|||
146684305|NCT02673489|529021057|FG001|Treatment Period|Lost to Follow-up|0|||
146927416|NCT00099359|529894611|FG002|Overall Study|Lost to Follow-up|24|||
146927417|NCT00099359|529894609|FG000|Overall Study|moved out of area|9|||
146684306|NCT02673489|529021056|FG000|Treatment Period|Participant request to discontinue|1|||
146684307|NCT02673489|529021057|FG001|Treatment Period|Participant request to discontinue|1|||
146684308|NCT02673489|529021056|FG000|Treatment Period|Participant moved to another province|1|||
146684309|NCT02673489|529021057|FG001|Treatment Period|Participant moved to another province|0|||
146684310|NCT02673489|529021056|FG000|Treatment Period|Participant was incarcerated|0|||
146927418|NCT00099359|529894610|FG001|Overall Study|moved out of area|7|||
146927419|NCT00099359|529894611|FG002|Overall Study|moved out of area|4|||
146927420|NCT00717366|529894612|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
146927421|NCT00717366|529894613|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
146684311|NCT02673489|529021057|FG001|Treatment Period|Participant was incarcerated|1|||
146684312|NCT02673489|529021056|FG000|Treatment Period|Adverse Event|0|||
146684313|NCT02673489|529021057|FG001|Treatment Period|Adverse Event|1|||
146927422|NCT00717366|529894612|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
146927423|NCT00717366|529894613|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
146927424|NCT00717366|529894612|FG000|Core Study Period (20 Weeks)|Death|0|||
146684314|NCT02673489|529021056|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
146684315|NCT02673489|529021057|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
146684316|NCT02673489|529021056|FG000|Follow Up Period|Unable to return for follow-up|0|||
146684317|NCT02673489|529021057|FG001|Follow Up Period|Unable to return for follow-up|1|||
146684318|NCT00082355|529021058|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
146684319|NCT00082355|529021058|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
146684320|NCT00082355|529021058|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
146684321|NCT00759863|529021059|FG000|Overall Study|Death, moved, or lost contact|20|||
146684322|NCT00759863|529021060|FG001|Overall Study|Death, moved, or lost contact|18|||
146684323|NCT00412854|529021061|FG000|Overall Study|Withdrawn due to adverse events|1|||
146684324|NCT00412854|529021062|FG001|Overall Study|Withdrawn due to adverse events|5|||
146684325|NCT00412854|529021061|FG000|Overall Study|Withdrawn for other reasons|13|||
146684326|NCT00412854|529021062|FG001|Overall Study|Withdrawn for other reasons|11|||
146684327|NCT01084174|529021063|FG000|Overall Study|gastrointestinal symptoms|1|||
146684328|NCT01084174|529021064|FG001|Overall Study|gastrointestinal symptoms|1|||
146684329|NCT01084174|529021063|FG000|Overall Study|Eosinophilic esophagitis|0|||
146684330|NCT01084174|529021064|FG001|Overall Study|Eosinophilic esophagitis|1|||
146684331|NCT01084174|529021063|FG000|Overall Study|Anaphylaxis|0|||
146684332|NCT01084174|529021064|FG001|Overall Study|Anaphylaxis|1|||
146684333|NCT01084174|529021063|FG000|Overall Study|Participant noncompliance|0|||
146684334|NCT01084174|529021064|FG001|Overall Study|Participant noncompliance|1|||
146684335|NCT01594125|529021065|FG000|Overall Study|Withdrawal by Subject|1|||
146684336|NCT01594125|529021066|FG001|Overall Study|Withdrawal by Subject|0|||
146684337|NCT01594125|529021067|FG002|Overall Study|Withdrawal by Subject|0|||
146684338|NCT01594125|529021068|FG003|Overall Study|Withdrawal by Subject|1|||
146684339|NCT01594125|529021069|FG004|Overall Study|Withdrawal by Subject|0|||
146684340|NCT01594125|529021065|FG000|Overall Study|Progressive Disease|3|||
146684341|NCT01594125|529021066|FG001|Overall Study|Progressive Disease|12|||
146684342|NCT01594125|529021067|FG002|Overall Study|Progressive Disease|3|||
146684343|NCT01594125|529021068|FG003|Overall Study|Progressive Disease|3|||
146684344|NCT01594125|529021069|FG004|Overall Study|Progressive Disease|7|||
146684345|NCT01484873|529021070|FG000|Overall Study|Withdrawal by Subject|2|||
146684346|NCT01549392|529021071|FG000|Overall Study|Withdrawal by Subject|1|||
146684347|NCT01549392|529021072|FG001|Overall Study|Withdrawal by Subject|0|||
146684348|NCT02743806|529021073|FG000|Overall Study|Adverse Event|9|||
146684349|NCT02743806|529021073|FG000|Overall Study|Lost to Follow-up|8|||
146684350|NCT02743806|529021073|FG000|Overall Study|Voluntary Withdrawal|54|||
146684351|NCT02743806|529021073|FG000|Overall Study|Study Termination|65|||
146684352|NCT02743806|529021073|FG000|Overall Study|Pregnancy|6|||
146684353|NCT02743806|529021073|FG000|Overall Study|No Longer Clinically Benefiting|27|||
146684354|NCT02743806|529021073|FG000|Overall Study|Reason Not Specified|12|||
146684355|NCT01988103|529021074|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
146684356|NCT01988103|529021075|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
146684357|NCT01988103|529021076|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
146684358|NCT01988103|529021077|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
146684359|NCT01988103|529021078|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
146684360|NCT01988103|529021074|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
146684361|NCT01988103|529021075|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
146684362|NCT01988103|529021076|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
146684363|NCT01988103|529021077|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
146684364|NCT01988103|529021078|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
146684365|NCT01988103|529021074|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
146684366|NCT01988103|529021075|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
146684367|NCT01988103|529021076|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
146684368|NCT01988103|529021077|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
146684369|NCT01988103|529021078|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
146684370|NCT01988103|529021074|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
146684371|NCT01988103|529021075|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
146684372|NCT01988103|529021076|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
146684373|NCT01988103|529021077|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
146684374|NCT01988103|529021078|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
146684375|NCT01988103|529021074|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
146684376|NCT01988103|529021075|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
146684377|NCT01988103|529021076|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
146684378|NCT01988103|529021077|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
146684379|NCT01988103|529021078|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
146684380|NCT01988103|529021074|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
146684381|NCT01988103|529021075|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
146684382|NCT01988103|529021076|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
146684383|NCT01988103|529021077|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
146684384|NCT01988103|529021078|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
146684385|NCT01988103|529021074|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
146684386|NCT01988103|529021075|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
146684387|NCT01988103|529021076|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
146684388|NCT01988103|529021077|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
146684389|NCT01988103|529021078|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
146684390|NCT05492942|529021079|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
146684391|NCT05492942|529021080|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
146684392|NCT05492942|529021081|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
146684393|NCT05492942|529021082|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
146684394|NCT02598076|529021085|FG000|Overall Study|Lost to Follow-up|2|||
146684395|NCT02598076|529021086|FG001|Overall Study|Lost to Follow-up|3|||
146684396|NCT01946425|529021088|FG000|Overall Study|Protocol Violation|1|||
146684397|NCT01946425|529021089|FG001|Overall Study|Protocol Violation|0|||
146684398|NCT01946425|529021088|FG000|Overall Study|Withdrawal by Subject|1|||
146684399|NCT01946425|529021089|FG001|Overall Study|Withdrawal by Subject|0|||
146684400|NCT04876274|529021092|FG000|Overall Study|Lost to Follow-up|9|||
146684401|NCT04876274|529021093|FG001|Overall Study|Lost to Follow-up|12|||
146684402|NCT01948050|529021094|FG000|Overall Study|Withdrawal by Subject|0|||
146684403|NCT01948050|529021095|FG001|Overall Study|Withdrawal by Subject|1|||
146684404|NCT00449540|529021097|FG000|Pretreatment Phase|No migraine experienced|66|||
146684405|NCT00449540|529021098|FG001|Pretreatment Phase|No migraine experienced|0|||
146684406|NCT00449540|529021099|FG002|Pretreatment Phase|No migraine experienced|0|||
146684407|NCT00449540|529021097|FG000|Treatment Phase|did not experience or treat migraine|0|||
146684408|NCT00449540|529021098|FG001|Treatment Phase|did not experience or treat migraine|20|||
146684409|NCT00449540|529021099|FG002|Treatment Phase|did not experience or treat migraine|17|||
146684410|NCT04545866|529021100|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
146684411|NCT04545866|529021101|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
146684412|NCT04545866|529021100|FG000|Overall Study|Withdrawal by Physician|1|||
146684413|NCT04545866|529021101|FG001|Overall Study|Withdrawal by Physician|0|||
146684414|NCT05247866|529021102|FG000|Overall Study|Adverse Event|2|||
146684415|NCT05247866|529021102|FG000|Overall Study|Lack of Efficacy|1|||
146684416|NCT05247866|529021102|FG000|Overall Study|Protocol Violation|1|||
146684417|NCT05247866|529021102|FG000|Overall Study|Withdrawal by Subject|3|||
146684418|NCT04463719|529021103|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
146684419|NCT04463719|529021104|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
146684420|NCT04463719|529021105|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
146684421|NCT00333866|529021108|FG000|Overall Study|Adverse Event|23|||
146684422|NCT00333866|529021109|FG001|Overall Study|Adverse Event|37|||
146684423|NCT00333866|529021110|FG002|Overall Study|Adverse Event|38|||
146684424|NCT00333866|529021111|FG003|Overall Study|Adverse Event|47|||
146684425|NCT00333866|529021108|FG000|Overall Study|Other|3|||
146684426|NCT00333866|529021109|FG001|Overall Study|Other|2|||
146684427|NCT00333866|529021110|FG002|Overall Study|Other|2|||
146684428|NCT00333866|529021111|FG003|Overall Study|Other|2|||
146684429|NCT00333866|529021108|FG000|Overall Study|Lack of Efficacy|8|||
146684430|NCT00333866|529021109|FG001|Overall Study|Lack of Efficacy|6|||
146684431|NCT00333866|529021110|FG002|Overall Study|Lack of Efficacy|3|||
146684432|NCT00333866|529021111|FG003|Overall Study|Lack of Efficacy|5|||
146684433|NCT00333866|529021108|FG000|Overall Study|Lost to Follow-up|1|||
146684434|NCT00333866|529021109|FG001|Overall Study|Lost to Follow-up|2|||
146684435|NCT00333866|529021110|FG002|Overall Study|Lost to Follow-up|2|||
146684436|NCT00333866|529021111|FG003|Overall Study|Lost to Follow-up|2|||
146684437|NCT00333866|529021108|FG000|Overall Study|Withdrawal by Subject|8|||
146684438|NCT00333866|529021109|FG001|Overall Study|Withdrawal by Subject|14|||
146684439|NCT00333866|529021110|FG002|Overall Study|Withdrawal by Subject|4|||
146684440|NCT00333866|529021111|FG003|Overall Study|Withdrawal by Subject|9|||
146684441|NCT00333866|529021108|FG000|Overall Study|Randomized but not Treated|5|||
146684442|NCT00333866|529021109|FG001|Overall Study|Randomized but not Treated|3|||
146684443|NCT00333866|529021110|FG002|Overall Study|Randomized but not Treated|2|||
146774827|NCT03088813|529346790|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
146774828|NCT03088813|529346791|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
146774829|NCT03088813|529346788|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
146848287|NCT02407990|529615646|FG001|Overall Study|Death|22|||
146684444|NCT00333866|529021111|FG003|Overall Study|Randomized but not Treated|1|||
146684445|NCT01129960|529021112|FG000|Overall Study|Withdrawal by Subject|3|||
146684446|NCT01129960|529021113|FG001|Overall Study|Withdrawal by Subject|0|||
146684447|NCT01129960|529021114|FG002|Overall Study|Withdrawal by Subject|3|||
146684448|NCT01129960|529021115|FG003|Overall Study|Withdrawal by Subject|2|||
146684449|NCT01129960|529021112|FG000|Overall Study|Lack of Efficacy|1|||
146684450|NCT01129960|529021113|FG001|Overall Study|Lack of Efficacy|1|||
146684451|NCT01129960|529021114|FG002|Overall Study|Lack of Efficacy|1|||
146684452|NCT01129960|529021115|FG003|Overall Study|Lack of Efficacy|1|||
146848288|NCT02407990|529615647|FG002|Overall Study|Death|23|||
146848289|NCT02407990|529615648|FG003|Overall Study|Death|7|||
146684453|NCT01129960|529021112|FG000|Overall Study|Adverse Event|23|||
146684454|NCT01129960|529021113|FG001|Overall Study|Adverse Event|16|||
146684455|NCT01129960|529021114|FG002|Overall Study|Adverse Event|16|||
146684456|NCT01129960|529021115|FG003|Overall Study|Adverse Event|7|||
146684457|NCT01129960|529021112|FG000|Overall Study|Protocol Violation|1|||
146684458|NCT01129960|529021113|FG001|Overall Study|Protocol Violation|2|||
146684459|NCT01129960|529021114|FG002|Overall Study|Protocol Violation|3|||
146684460|NCT01129960|529021115|FG003|Overall Study|Protocol Violation|0|||
146684461|NCT01129960|529021112|FG000|Overall Study|Lost to Follow-up|0|||
146684462|NCT01129960|529021113|FG001|Overall Study|Lost to Follow-up|2|||
146684463|NCT01129960|529021114|FG002|Overall Study|Lost to Follow-up|3|||
146684464|NCT01129960|529021115|FG003|Overall Study|Lost to Follow-up|3|||
146684465|NCT01129960|529021112|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
146927425|NCT00717366|529894613|FG001|Core Study Period (20 Weeks)|Death|1|||
146927426|NCT00717366|529894612|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
146927427|NCT00717366|529894613|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
146927428|NCT00717366|529894612|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
146927429|NCT00717366|529894613|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
146927430|NCT00717366|529894612|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
146927431|NCT00717366|529894613|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
146927432|NCT00717366|529894612|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
146927433|NCT00717366|529894613|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
146927434|NCT02104804|529894614|FG000|Overall Study|Did not take study medication|0|||
146927435|NCT02104804|529894615|FG001|Overall Study|Did not take study medication|1|||
146927436|NCT02104804|529894614|FG000|Overall Study|Study specific discontinuation criteria|6|||
146927437|NCT02104804|529894615|FG001|Overall Study|Study specific discontinuation criteria|1|||
146927438|NCT02104804|529894614|FG000|Overall Study|Other listed|2|||
146927439|NCT02104804|529894615|FG001|Overall Study|Other listed|1|||
146927440|NCT02104804|529894614|FG000|Overall Study|Protocol Violation|0|||
146927441|NCT02104804|529894615|FG001|Overall Study|Protocol Violation|1|||
146927442|NCT02104804|529894614|FG000|Overall Study|Adverse Event|4|||
146927443|NCT02104804|529894615|FG001|Overall Study|Adverse Event|3|||
146927444|NCT02104804|529894614|FG000|Overall Study|Withdrawal by Subject|4|||
146927445|NCT02104804|529894615|FG001|Overall Study|Withdrawal by Subject|12|||
146927446|NCT04501679|529894616|FG000|Overall Study|Pregnancy|0|||
146927447|NCT04501679|529894617|FG001|Overall Study|Pregnancy|1|||
146927448|NCT04501679|529894616|FG000|Overall Study|Adverse Event|4|||
146927449|NCT04501679|529894617|FG001|Overall Study|Adverse Event|2|||
146927450|NCT04501679|529894616|FG000|Overall Study|Withdrawal by Subject|2|||
146927451|NCT04501679|529894617|FG001|Overall Study|Withdrawal by Subject|0|||
146927452|NCT04501679|529894616|FG000|Overall Study|Physician Decision|1|||
146927453|NCT04501679|529894617|FG001|Overall Study|Physician Decision|0|||
146927454|NCT04501679|529894616|FG000|Overall Study|Lost to Follow-up|2|||
146927455|NCT04501679|529894617|FG001|Overall Study|Lost to Follow-up|0|||
146927456|NCT02121756|529894622|FG000|Overall Study|Adverse Event|3|||
146927457|NCT02121756|529894623|FG001|Overall Study|Adverse Event|0|||
146927458|NCT02121756|529894622|FG000|Overall Study|Protocol Violation|1|||
146927459|NCT02121756|529894623|FG001|Overall Study|Protocol Violation|1|||
146927460|NCT02121756|529894622|FG000|Overall Study|Physician Decision|2|||
146684466|NCT01129960|529021113|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
146684467|NCT01129960|529021114|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
146684468|NCT01129960|529021115|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
146684469|NCT01129960|529021112|FG000|Overall Study|Physician Decision|1|||
146684470|NCT01129960|529021113|FG001|Overall Study|Physician Decision|0|||
146684471|NCT01129960|529021114|FG002|Overall Study|Physician Decision|0|||
146684472|NCT01129960|529021115|FG003|Overall Study|Physician Decision|0|||
146684473|NCT01129960|529021112|FG000|Overall Study|Pregnancy|1|||
146927461|NCT02121756|529894623|FG001|Overall Study|Physician Decision|1|||
146927462|NCT04191577|529894627|FG000|Overall Study|Withdrawal by Subject|2|||
146927463|NCT04191577|529894628|FG001|Overall Study|Withdrawal by Subject|2|||
146927464|NCT04191577|529894629|FG002|Overall Study|Withdrawal by Subject|1|||
146927465|NCT04191577|529894627|FG000|Overall Study|Physician Decision|1|||
146927466|NCT04191577|529894628|FG001|Overall Study|Physician Decision|1|||
146927467|NCT04191577|529894629|FG002|Overall Study|Physician Decision|0|||
146927468|NCT04191577|529894627|FG000|Overall Study|Adverse Event|0|||
146927469|NCT04191577|529894628|FG001|Overall Study|Adverse Event|0|||
146927470|NCT04191577|529894629|FG002|Overall Study|Adverse Event|1|||
146927471|NCT04191577|529894627|FG000|Overall Study|Death|0|||
146927472|NCT04191577|529894628|FG001|Overall Study|Death|0|||
146684474|NCT01129960|529021113|FG001|Overall Study|Pregnancy|0|||
146684475|NCT01129960|529021114|FG002|Overall Study|Pregnancy|0|||
146684476|NCT01129960|529021115|FG003|Overall Study|Pregnancy|0|||
146684477|NCT03198234|529021116|FG000|Overall Study|Relapse of primary disease|0|||
146684478|NCT03198234|529021117|FG001|Overall Study|Relapse of primary disease|1|||
146684479|NCT03198234|529021118|FG002|Overall Study|Relapse of primary disease|0|||
146927473|NCT04191577|529894629|FG002|Overall Study|Death|1|||
146927474|NCT02365584|529894630|FG000|Overall Study|Adverse Event|2|||
146927475|NCT02365584|529894631|FG001|Overall Study|Adverse Event|2|||
146684480|NCT03228537|529021119|FG000|Neoadjuvant|Adverse Event|2|||
146684481|NCT03228537|529021119|FG000|Neoadjuvant|Progression/Relapse|4|||
146684482|NCT03228537|529021119|FG000|Neoadjuvant|Death|1|||
146684483|NCT03228537|529021119|FG000|Surgery|Death|1|||
146684484|NCT03228537|529021119|FG000|Surgery|Other - Not Protocol Specified|2|||
146684485|NCT03228537|529021119|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
146684486|NCT03228537|529021119|FG000|Maintenance|Progression/Relapse|10|||
146684487|NCT02622321|529021120|FG000|Overall Study|Withdrawal by Subject|2|||
146684488|NCT02622321|529021121|FG001|Overall Study|Withdrawal by Subject|0|||
146684489|NCT02622321|529021122|FG002|Overall Study|Withdrawal by Subject|0|||
146684490|NCT02622321|529021123|FG003|Overall Study|Withdrawal by Subject|0|||
146684491|NCT02622321|529021120|FG000|Overall Study|Death|0|||
146684492|NCT02622321|529021121|FG001|Overall Study|Death|0|||
146684493|NCT02622321|529021122|FG002|Overall Study|Death|1|||
146684494|NCT02622321|529021123|FG003|Overall Study|Death|0|||
146684495|NCT02622321|529021120|FG000|Overall Study|Physician Decision|1|||
146684496|NCT02622321|529021121|FG001|Overall Study|Physician Decision|0|||
146684497|NCT02622321|529021122|FG002|Overall Study|Physician Decision|0|||
146684498|NCT02622321|529021123|FG003|Overall Study|Physician Decision|0|||
146684499|NCT00965718|529021125|FG000|Overall Study|Withdrawal by Subject|4|||
146684500|NCT01013701|529021130|FG000|Overall Study|study prematurely terminated|7|||
146684501|NCT03241342|529021132|FG000|Overall Study|Adverse Event|5|||
146684502|NCT03241342|529021133|FG001|Overall Study|Adverse Event|8|||
146684503|NCT03241342|529021134|FG002|Overall Study|Adverse Event|4|||
146684504|NCT03241342|529021132|FG000|Overall Study|Lack of Efficacy|0|||
146684505|NCT03241342|529021133|FG001|Overall Study|Lack of Efficacy|0|||
146684506|NCT03241342|529021134|FG002|Overall Study|Lack of Efficacy|1|||
146684507|NCT03241342|529021132|FG000|Overall Study|noncompliance with study drug|2|||
146684508|NCT03241342|529021133|FG001|Overall Study|noncompliance with study drug|1|||
146684509|NCT03241342|529021134|FG002|Overall Study|noncompliance with study drug|1|||
146684510|NCT03241342|529021132|FG000|Overall Study|sponsor decision|0|||
146684511|NCT03241342|529021133|FG001|Overall Study|sponsor decision|1|||
146684512|NCT03241342|529021134|FG002|Overall Study|sponsor decision|2|||
146684513|NCT03241342|529021132|FG000|Overall Study|not reported|15|||
146684514|NCT03241342|529021133|FG001|Overall Study|not reported|21|||
146684515|NCT03241342|529021134|FG002|Overall Study|not reported|19|||
146684516|NCT00556712|529021135|FG000|Overall Study|Adverse Event|7|||
146684517|NCT00556712|529021136|FG001|Overall Study|Adverse Event|19|||
146684518|NCT00556712|529021135|FG000|Overall Study|Death|5|||
146684519|NCT00556712|529021136|FG001|Overall Study|Death|10|||
146684520|NCT00556712|529021135|FG000|Overall Study|Progressive Disease|383|||
146684521|NCT00556712|529021136|FG001|Overall Study|Progressive Disease|320|||
146684522|NCT00556712|529021135|FG000|Overall Study|Protocol Violation|3|||
146684523|NCT00556712|529021136|FG001|Overall Study|Protocol Violation|2|||
146684524|NCT00556712|529021135|FG000|Overall Study|Refused Treatment|17|||
146684525|NCT00556712|529021136|FG001|Overall Study|Refused Treatment|16|||
146684526|NCT00556712|529021135|FG000|Overall Study|Failure to Return|2|||
146684527|NCT00556712|529021136|FG001|Overall Study|Failure to Return|3|||
146684528|NCT00556712|529021135|FG000|Overall Study|Other|2|||
146684529|NCT00556712|529021136|FG001|Overall Study|Other|2|||
146684530|NCT00556712|529021135|FG000|Overall Study|Ongoing at Data Cutoff|32|||
146684531|NCT00556712|529021136|FG001|Overall Study|Ongoing at Data Cutoff|66|||
146684532|NCT01059799|529021139|FG000|Overall Study|Adverse Event|2|||
146684533|NCT01059799|529021140|FG001|Overall Study|Adverse Event|3|||
146684534|NCT01059799|529021139|FG000|Overall Study|Lack of Efficacy|1|||
146684535|NCT01059799|529021140|FG001|Overall Study|Lack of Efficacy|0|||
146684536|NCT01059799|529021139|FG000|Overall Study|Protocol Violation|3|||
146684537|NCT01059799|529021140|FG001|Overall Study|Protocol Violation|2|||
146684538|NCT01059799|529021139|FG000|Overall Study|Withdrawal criteria|13|||
146684539|NCT01059799|529021140|FG001|Overall Study|Withdrawal criteria|2|||
146684540|NCT01059799|529021139|FG000|Overall Study|Other|12|||
146684541|NCT01059799|529021140|FG001|Overall Study|Other|3|||
146684542|NCT01962207|529021143|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
146684543|NCT01962207|529021144|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
146684544|NCT01962207|529021145|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
146684545|NCT01962207|529021146|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
146684546|NCT01962207|529021143|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
146684547|NCT01962207|529021144|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
146684548|NCT01962207|529021145|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
146684549|NCT01962207|529021146|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
146684550|NCT01962207|529021143|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
146684551|NCT01962207|529021144|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
146684552|NCT01962207|529021145|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
146684553|NCT01962207|529021146|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
146684554|NCT01962207|529021143|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
146684555|NCT01962207|529021144|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
146684556|NCT01962207|529021145|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
146684557|NCT01962207|529021146|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
146684558|NCT01962207|529021143|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
146684559|NCT01962207|529021144|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
146684560|NCT01962207|529021145|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
146684561|NCT01962207|529021146|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
146684562|NCT01962207|529021143|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
146684563|NCT01962207|529021144|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
146684564|NCT01962207|529021145|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
146684565|NCT01962207|529021146|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
146684566|NCT02289079|529021150|FG000|Overall Study|Physician Decision|2|||
146684567|NCT02289079|529021151|FG001|Overall Study|Physician Decision|0|||
146684568|NCT02289079|529021150|FG000|Overall Study|Lost to Follow-up|0|||
146684569|NCT02289079|529021151|FG001|Overall Study|Lost to Follow-up|1|||
146684570|NCT02671422|529021152|FG000|Overall Study|Lost to Follow-up|1|||
146684571|NCT02671422|529021152|FG000|Overall Study|Adverse Event|68|||
146684572|NCT02671422|529021152|FG000|Overall Study|Lack of Efficacy|1|||
146684573|NCT02671422|529021152|FG000|Overall Study|Lost to Follow-up|4|||
146684574|NCT02671422|529021152|FG000|Overall Study|Withdrawal by Subject|7|||
146684575|NCT02671422|529021152|FG000|Overall Study|Progressive Disease|156|||
146684576|NCT02671422|529021152|FG000|Overall Study|Worsening of Disease|4|||
146684577|NCT02671422|529021152|FG000|Overall Study|Sponsor decision|5|||
146684578|NCT02671422|529021152|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
146684579|NCT02671422|529021152|FG000|Overall Study|Not treated with Vargatef®|3|||
146684580|NCT02671422|529021152|FG000|Overall Study|Other not defined above|3|||
146684581|NCT03036072|529021153|FG000|Overall Study|Death|0|||
146684582|NCT03036072|529021154|FG001|Overall Study|Death|1|||
146684583|NCT03036072|529021153|FG000|Overall Study|Withdrawal by Subject|0|||
146684584|NCT03036072|529021154|FG001|Overall Study|Withdrawal by Subject|1|||
146684585|NCT03036072|529021153|FG000|Overall Study|Physician Decision|0|||
146684586|NCT03036072|529021154|FG001|Overall Study|Physician Decision|1|||
146684587|NCT00662363|529021155|FG000|Overall Study|Withdrawal by Subject|6|||
146684588|NCT00662363|529021156|FG001|Overall Study|Withdrawal by Subject|5|||
146684589|NCT00662363|529021155|FG000|Overall Study|Adverse Event|0|||
146684590|NCT00662363|529021156|FG001|Overall Study|Adverse Event|3|||
146684591|NCT00662363|529021155|FG000|Overall Study|Discharged early from rehab|4|||
146684592|NCT00662363|529021156|FG001|Overall Study|Discharged early from rehab|1|||
146684593|NCT00662363|529021155|FG000|Overall Study|Protocol Violation|1|||
146684594|NCT00662363|529021156|FG001|Overall Study|Protocol Violation|1|||
146684595|NCT01905657|529021157|FG000|Overall Study|Adverse Event|23|||
146684596|NCT01905657|529021158|FG001|Overall Study|Adverse Event|17|||
146684597|NCT01905657|529021159|FG002|Overall Study|Adverse Event|18|||
146684598|NCT01905657|529021157|FG000|Overall Study|Clinical Progression|103|||
146684599|NCT01905657|529021158|FG001|Overall Study|Clinical Progression|78|||
146684600|NCT01905657|529021159|FG002|Overall Study|Clinical Progression|59|||
146684601|NCT01905657|529021157|FG000|Overall Study|Death|40|||
146684602|NCT01905657|529021158|FG001|Overall Study|Death|43|||
146684603|NCT01905657|529021159|FG002|Overall Study|Death|47|||
146684604|NCT01905657|529021157|FG000|Overall Study|Excluded Medication|13|||
146684605|NCT01905657|529021158|FG001|Overall Study|Excluded Medication|16|||
146684606|NCT01905657|529021159|FG002|Overall Study|Excluded Medication|9|||
146684607|NCT01905657|529021157|FG000|Overall Study|Lost to Follow-up|1|||
146684608|NCT01905657|529021158|FG001|Overall Study|Lost to Follow-up|2|||
146684609|NCT01905657|529021159|FG002|Overall Study|Lost to Follow-up|1|||
146684610|NCT01905657|529021157|FG000|Overall Study|Physician Decision|5|||
146684611|NCT01905657|529021158|FG001|Overall Study|Physician Decision|8|||
146684612|NCT01905657|529021159|FG002|Overall Study|Physician Decision|12|||
146684613|NCT01905657|529021157|FG000|Overall Study|Protocol Violation|2|||
146684614|NCT01905657|529021158|FG001|Overall Study|Protocol Violation|1|||
146927476|NCT02365584|529894630|FG000|Overall Study|Withdrawal by Subject|1|||
146927477|NCT02365584|529894631|FG001|Overall Study|Withdrawal by Subject|0|||
146927478|NCT02365584|529894630|FG000|Overall Study|Disease Progression|9|||
146684615|NCT01905657|529021159|FG002|Overall Study|Protocol Violation|1|||
146684616|NCT01905657|529021157|FG000|Overall Study|Screen Failure|0|||
146684617|NCT01905657|529021158|FG001|Overall Study|Screen Failure|1|||
146684618|NCT01905657|529021159|FG002|Overall Study|Screen Failure|0|||
146774830|NCT03088813|529346789|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
146774831|NCT03088813|529346790|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
146774832|NCT03088813|529346791|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
146684619|NCT01905657|529021157|FG000|Overall Study|Withdrawal by Subject|15|||
146684620|NCT01905657|529021158|FG001|Overall Study|Withdrawal by Subject|21|||
146927479|NCT02365584|529894631|FG001|Overall Study|Disease Progression|12|||
146684621|NCT01905657|529021159|FG002|Overall Study|Withdrawal by Subject|53|||
146684622|NCT01905657|529021157|FG000|Overall Study|Sponsor Decision|1|||
146684623|NCT01905657|529021158|FG001|Overall Study|Sponsor Decision|0|||
146684624|NCT01905657|529021159|FG002|Overall Study|Sponsor Decision|0|||
146684625|NCT04080297|529021160|FG000|Overall Study|Adverse Event|1|||
146684626|NCT04080297|529021161|FG001|Overall Study|Adverse Event|3|||
146684627|NCT04080297|529021160|FG000|Overall Study|concurrent illness|1|||
146684628|NCT04080297|529021161|FG001|Overall Study|concurrent illness|0|||
146684629|NCT02744391|529021162|FG000|Overall Study|Lost to Follow-up|9|||
146684630|NCT02744391|529021162|FG000|Overall Study|Physician Decision|2|||
146684631|NCT02744391|529021162|FG000|Overall Study|Withdrawal by Subject|3|||
146684632|NCT05838742|529021163|FG000|Overall Study|Adverse Event|2|||
146684633|NCT05838742|529021164|FG001|Overall Study|Adverse Event|0|||
146684634|NCT05838742|529021165|FG002|Overall Study|Adverse Event|1|||
146684635|NCT05838742|529021166|FG003|Overall Study|Adverse Event|0|||
146684636|NCT05838742|529021167|FG004|Overall Study|Adverse Event|1|||
146684637|NCT05838742|529021163|FG000|Overall Study|Lost to Follow-up|1|||
146684638|NCT05838742|529021164|FG001|Overall Study|Lost to Follow-up|1|||
146684639|NCT05838742|529021165|FG002|Overall Study|Lost to Follow-up|1|||
146684640|NCT05838742|529021166|FG003|Overall Study|Lost to Follow-up|0|||
146684641|NCT05838742|529021167|FG004|Overall Study|Lost to Follow-up|0|||
146684642|NCT05838742|529021163|FG000|Overall Study|Physician Decision|0|||
146684643|NCT05838742|529021164|FG001|Overall Study|Physician Decision|0|||
146684644|NCT05838742|529021165|FG002|Overall Study|Physician Decision|0|||
146684645|NCT05838742|529021166|FG003|Overall Study|Physician Decision|0|||
146684646|NCT05838742|529021167|FG004|Overall Study|Physician Decision|1|||
146684647|NCT05838742|529021163|FG000|Overall Study|Withdrawal by Subject|8|||
146684648|NCT05838742|529021164|FG001|Overall Study|Withdrawal by Subject|3|||
146684649|NCT05838742|529021165|FG002|Overall Study|Withdrawal by Subject|3|||
146684650|NCT05838742|529021166|FG003|Overall Study|Withdrawal by Subject|1|||
146684651|NCT05838742|529021167|FG004|Overall Study|Withdrawal by Subject|4|||
146684652|NCT05838742|529021163|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
146684653|NCT05838742|529021164|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
146684654|NCT05838742|529021165|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
146684655|NCT05838742|529021166|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
146684656|NCT05838742|529021167|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
146774833|NCT03088813|529346788|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
146774834|NCT03088813|529346789|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
146684657|NCT05838742|529021163|FG000|Overall Study|Lack of Efficacy|0|||
146684658|NCT05838742|529021164|FG001|Overall Study|Lack of Efficacy|0|||
146684659|NCT05838742|529021165|FG002|Overall Study|Lack of Efficacy|0|||
146684660|NCT05838742|529021166|FG003|Overall Study|Lack of Efficacy|1|||
146684661|NCT05838742|529021167|FG004|Overall Study|Lack of Efficacy|0|||
146684662|NCT05838742|529021163|FG000|Overall Study|Randomized, not treated|2|||
146684663|NCT05838742|529021164|FG001|Overall Study|Randomized, not treated|1|||
146684664|NCT05838742|529021165|FG002|Overall Study|Randomized, not treated|0|||
146684665|NCT05838742|529021166|FG003|Overall Study|Randomized, not treated|1|||
146684666|NCT05838742|529021167|FG004|Overall Study|Randomized, not treated|0|||
146684667|NCT05119569|529021172|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
146684668|NCT05119569|529021173|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
146684669|NCT05119569|529021174|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
146684670|NCT05119569|529021175|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
146684671|NCT05119569|529021172|FG000|Double Blind Treatment Phase|Adverse Event|6|||
146684672|NCT05119569|529021173|FG001|Double Blind Treatment Phase|Adverse Event|0|||
146927480|NCT01185249|529894632|FG000|Overall Study|Patients discharged or change in status|42|||
146927481|NCT01973452|529894633|FG000|Overall Study|Lack of Efficacy|0|||
146927482|NCT01973452|529894634|FG001|Overall Study|Lack of Efficacy|1|||
146927483|NCT01973452|529894633|FG000|Overall Study|Lost to Follow-up|1|||
146927484|NCT01973452|529894634|FG001|Overall Study|Lost to Follow-up|0|||
146927485|NCT01973452|529894633|FG000|Overall Study|Withdrawal by Subject|10|||
146684673|NCT05119569|529021174|FG002|Double Blind Treatment Phase|Adverse Event|0|||
146774835|NCT03088813|529346790|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
146774836|NCT03088813|529346791|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
146774837|NCT03088813|529346788|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
146927486|NCT01973452|529894634|FG001|Overall Study|Withdrawal by Subject|9|||
146927487|NCT01973452|529894633|FG000|Overall Study|Ineligible|1|||
146927488|NCT01973452|529894634|FG001|Overall Study|Ineligible|1|||
146927489|NCT01973452|529894633|FG000|Overall Study|Surgery canceled by participant|5|||
146684674|NCT05119569|529021175|FG003|Double Blind Treatment Phase|Adverse Event|0|||
146774838|NCT03088813|529346789|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
146927490|NCT01973452|529894634|FG001|Overall Study|Surgery canceled by participant|3|||
146684675|NCT05119569|529021172|FG000|Open Label Extension Phase|Ongoing in the study|0|||
146684676|NCT05119569|529021173|FG001|Open Label Extension Phase|Ongoing in the study|0|||
146684677|NCT05119569|529021174|FG002|Open Label Extension Phase|Ongoing in the study|65|||
146684678|NCT05119569|529021175|FG003|Open Label Extension Phase|Ongoing in the study|34|||
146684679|NCT02623439|529021178|FG000|Overall Study|Withdrawal by Subject|1|||
146684680|NCT02623439|529021178|FG000|Overall Study|Screen Failure|1|||
146684681|NCT04484142|529021182|FG000|Overall Study|Adverse Event|13|||
146684682|NCT04484142|529021182|FG000|Overall Study|Progressive Disease|87|||
146684683|NCT04484142|529021182|FG000|Overall Study|Clinical Progression|10|||
146684684|NCT04484142|529021182|FG000|Overall Study|Withdrawal by Subject|6|||
146684685|NCT04484142|529021182|FG000|Overall Study|Physician Decision|1|||
146684686|NCT03700671|529021183|FG000|Overall Study|Lack of Efficacy|1|||
146684687|NCT03700671|529021184|FG001|Overall Study|Lack of Efficacy|2|||
146684688|NCT05371509|529021185|FG000|Overall Study|Physician Decision|1|||
146684689|NCT05371509|529021186|FG001|Overall Study|Physician Decision|0|||
146684690|NCT03578367|529021187|FG000|Overall Study|Adverse Event|0|||
146684691|NCT03578367|529021188|FG001|Overall Study|Adverse Event|3|||
146684692|NCT03578367|529021189|FG002|Overall Study|Adverse Event|0|||
146684693|NCT03578367|529021190|FG003|Overall Study|Adverse Event|5|||
146684694|NCT03578367|529021187|FG000|Overall Study|Withdrawal by Subject|2|||
146684695|NCT03578367|529021188|FG001|Overall Study|Withdrawal by Subject|2|||
146684696|NCT03578367|529021189|FG002|Overall Study|Withdrawal by Subject|1|||
146684697|NCT03578367|529021190|FG003|Overall Study|Withdrawal by Subject|3|||
146684698|NCT03578367|529021187|FG000|Overall Study|Physician Decision|0|||
146684699|NCT03578367|529021188|FG001|Overall Study|Physician Decision|0|||
146684700|NCT03578367|529021189|FG002|Overall Study|Physician Decision|14|||
146684701|NCT03578367|529021190|FG003|Overall Study|Physician Decision|0|||
146684702|NCT03578367|529021187|FG000|Overall Study|Death|1|||
146684703|NCT03578367|529021188|FG001|Overall Study|Death|0|||
146684704|NCT03578367|529021189|FG002|Overall Study|Death|0|||
146684705|NCT03578367|529021190|FG003|Overall Study|Death|0|||
146684706|NCT03578367|529021187|FG000|Overall Study|Not treated|0|||
146684707|NCT03578367|529021188|FG001|Overall Study|Not treated|0|||
146684708|NCT03578367|529021189|FG002|Overall Study|Not treated|1|||
146684709|NCT03578367|529021190|FG003|Overall Study|Not treated|0|||
146684710|NCT01134783|529022700|FG000|Overall Study|Pregnancy|16|||
146684711|NCT01134783|529022701|FG001|Overall Study|Pregnancy|8|||
146684712|NCT01134783|529022700|FG000|Overall Study|Withdrawal by Subject|15|||
146684713|NCT01134783|529022701|FG001|Overall Study|Withdrawal by Subject|9|||
146684714|NCT01134783|529022700|FG000|Overall Study|Lost to Follow-up|5|||
146684715|NCT01134783|529022701|FG001|Overall Study|Lost to Follow-up|20|||
146684716|NCT00001596|529022703|FG000|Overall Study|Death|1|||
146684717|NCT00001596|529022704|FG001|Overall Study|Death|0|||
146684718|NCT00001596|529022703|FG000|Overall Study|Withdrawal by Subject|3|||
146684719|NCT00001596|529022704|FG001|Overall Study|Withdrawal by Subject|1|||
146684720|NCT00001596|529022703|FG000|Overall Study|Study Termination|12|||
146684721|NCT00001596|529022704|FG001|Overall Study|Study Termination|9|||
146684722|NCT00001596|529022703|FG000|Overall Study|Adverse Event|1|||
146684723|NCT00001596|529022704|FG001|Overall Study|Adverse Event|0|||
146684724|NCT00180414|529022708|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
146684725|NCT00180414|529022709|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
146684726|NCT00463346|529022710|FG000|Overall Study|Withdrawal by Subject|3|||
146684727|NCT00463346|529022711|FG001|Overall Study|Withdrawal by Subject|3|||
146684728|NCT01572909|529022713|FG000|Overall Study|Adverse Event|7|||
146684729|NCT01572909|529022714|FG001|Overall Study|Adverse Event|2|||
146684730|NCT01572909|529022713|FG000|Overall Study|Death|3|||
146684731|NCT01572909|529022714|FG001|Overall Study|Death|1|||
146684732|NCT01572909|529022713|FG000|Overall Study|Lost to Follow-up|8|||
146684733|NCT01572909|529022714|FG001|Overall Study|Lost to Follow-up|7|||
146684734|NCT01572909|529022713|FG000|Overall Study|Physician Decision|1|||
146684735|NCT01572909|529022714|FG001|Overall Study|Physician Decision|1|||
146684736|NCT01572909|529022713|FG000|Overall Study|Technical Issues|1|||
146684737|NCT01572909|529022714|FG001|Overall Study|Technical Issues|0|||
146684738|NCT01572909|529022713|FG000|Overall Study|Withdrawal by Subject|12|||
146684739|NCT01572909|529022714|FG001|Overall Study|Withdrawal by Subject|11|||
146684740|NCT01572909|529022713|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
146684741|NCT01572909|529022714|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
146684742|NCT03641651|529022719|FG000|Overall Study|organizational issues at one study site|1|||
146684743|NCT04779489|529022720|FG000|Overall Study|Physician Decision|1|||
146684744|NCT02723084|529022723|FG000|Overall Study|Withdrawal by Subject|1|||
146684745|NCT02723084|529022724|FG001|Overall Study|Withdrawal by Subject|1|||
146684746|NCT02723084|529022723|FG000|Overall Study|Lost to Follow-up|3|||
146684747|NCT02723084|529022724|FG001|Overall Study|Lost to Follow-up|0|||
146684748|NCT00415909|529022727|FG000|Overall Study|Withdrawal by Subject|2|||
146684749|NCT00415909|529022727|FG000|Overall Study|Death|1|||
146684750|NCT05024058|529022728|FG000|Treatment|Study terminated by sponsor|5|||
146684751|NCT05024058|529022729|FG001|Treatment|Study terminated by sponsor|6|||
146684752|NCT05024058|529022730|FG002|Treatment|Study terminated by sponsor|4|||
146684753|NCT05024058|529022731|FG003|Treatment|Study terminated by sponsor|2|||
146684754|NCT05024058|529022732|FG004|Treatment|Study terminated by sponsor|3|||
146684755|NCT05024058|529022733|FG005|Treatment|Study terminated by sponsor|3|||
146684756|NCT05024058|529022734|FG006|Treatment|Study terminated by sponsor|1|||
146684757|NCT05024058|529022735|FG007|Treatment|Study terminated by sponsor|3|||
146684758|NCT05024058|529022736|FG008|Treatment|Study terminated by sponsor|6|||
146684759|NCT05024058|529022737|FG009|Treatment|Study terminated by sponsor|6|||
146684760|NCT05024058|529022728|FG000|Follow-up|Withdrawal by Subject|1|||
146684761|NCT05024058|529022729|FG001|Follow-up|Withdrawal by Subject|0|||
146684762|NCT05024058|529022730|FG002|Follow-up|Withdrawal by Subject|1|||
146684763|NCT05024058|529022731|FG003|Follow-up|Withdrawal by Subject|0|||
146684764|NCT05024058|529022732|FG004|Follow-up|Withdrawal by Subject|0|||
146684765|NCT05024058|529022733|FG005|Follow-up|Withdrawal by Subject|0|||
146684766|NCT05024058|529022734|FG006|Follow-up|Withdrawal by Subject|0|||
146684767|NCT05024058|529022735|FG007|Follow-up|Withdrawal by Subject|1|||
146684768|NCT05024058|529022736|FG008|Follow-up|Withdrawal by Subject|0|||
146684769|NCT05024058|529022737|FG009|Follow-up|Withdrawal by Subject|1|||
146684770|NCT00407563|529022743|FG000|Overall Study|Patient continues on treatment|1|||
146684771|NCT02450903|529022744|FG000|Overall Study|Adverse Event|3|||
146684772|NCT02450903|529022744|FG000|Overall Study|Progressive disease|15|||
146684773|NCT02450903|529022744|FG000|Overall Study|Switched to commercial drug|1|||
146684774|NCT02450903|529022744|FG000|Overall Study|Subject/guardian decision|1|||
146684775|NCT01287897|529022755|FG000|Overall Study|Adverse Event|5|||
146684776|NCT01287897|529022756|FG001|Overall Study|Adverse Event|3|||
146684777|NCT01287897|529022757|FG002|Overall Study|Adverse Event|6|||
146684778|NCT01287897|529022758|FG003|Overall Study|Adverse Event|4|||
146684779|NCT01287897|529022755|FG000|Overall Study|Lack of Efficacy|2|||
146684780|NCT01287897|529022756|FG001|Overall Study|Lack of Efficacy|0|||
146684781|NCT01287897|529022757|FG002|Overall Study|Lack of Efficacy|0|||
146684782|NCT01287897|529022758|FG003|Overall Study|Lack of Efficacy|0|||
146684783|NCT01287897|529022755|FG000|Overall Study|Protocol Violation|1|||
146684784|NCT01287897|529022756|FG001|Overall Study|Protocol Violation|1|||
146684785|NCT01287897|529022757|FG002|Overall Study|Protocol Violation|0|||
146684786|NCT01287897|529022758|FG003|Overall Study|Protocol Violation|1|||
146684787|NCT01287897|529022755|FG000|Overall Study|Lost to Follow-up|0|||
146684788|NCT01287897|529022756|FG001|Overall Study|Lost to Follow-up|0|||
146684789|NCT01287897|529022757|FG002|Overall Study|Lost to Follow-up|2|||
146684790|NCT01287897|529022758|FG003|Overall Study|Lost to Follow-up|0|||
146684791|NCT01287897|529022755|FG000|Overall Study|Withdrawal by Subject|1|||
146684792|NCT01287897|529022756|FG001|Overall Study|Withdrawal by Subject|5|||
146684793|NCT01287897|529022757|FG002|Overall Study|Withdrawal by Subject|3|||
146684794|NCT01287897|529022758|FG003|Overall Study|Withdrawal by Subject|2|||
146684795|NCT01287897|529022755|FG000|Overall Study|Not consented properly|0|||
146684796|NCT01287897|529022756|FG001|Overall Study|Not consented properly|1|||
146684797|NCT01287897|529022757|FG002|Overall Study|Not consented properly|0|||
146684798|NCT01287897|529022758|FG003|Overall Study|Not consented properly|0|||
146684799|NCT01287897|529022755|FG000|Overall Study|Not meeting entrance criteria|1|||
146684800|NCT01287897|529022756|FG001|Overall Study|Not meeting entrance criteria|1|||
146684801|NCT01287897|529022757|FG002|Overall Study|Not meeting entrance criteria|0|||
146684802|NCT01287897|529022758|FG003|Overall Study|Not meeting entrance criteria|0|||
146684803|NCT01287897|529022755|FG000|Overall Study|Other|1|||
146684804|NCT01287897|529022756|FG001|Overall Study|Other|0|||
146684805|NCT01287897|529022757|FG002|Overall Study|Other|1|||
146684806|NCT01287897|529022758|FG003|Overall Study|Other|0|||
146684807|NCT02902965|529022763|FG000|Overall Study|Withdrawal by Subject|10|||
146684808|NCT00293254|529022764|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
146684809|NCT00293254|529022765|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
146684810|NCT00293254|529022764|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
146684811|NCT00293254|529022765|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
146684812|NCT00293254|529022764|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
146684813|NCT00293254|529022765|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
146684814|NCT00293254|529022764|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
146684815|NCT00293254|529022765|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
146684816|NCT00293254|529022764|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
146684817|NCT00293254|529022765|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
146684818|NCT00293254|529022764|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
146684819|NCT00293254|529022765|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
146684820|NCT00293254|529022764|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
146684821|NCT00293254|529022765|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
146684822|NCT00293254|529022764|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
146684823|NCT00293254|529022765|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
146684824|NCT00293254|529022764|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
146684825|NCT00293254|529022765|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
146684826|NCT00293254|529022764|FG000|Extension - Double-Blind Week 49-156|Death|4|||
146684827|NCT00293254|529022765|FG001|Extension - Double-Blind Week 49-156|Death|1|||
146684828|NCT00293254|529022764|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
146684829|NCT00293254|529022765|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
146684830|NCT00293254|529022764|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
146684831|NCT00293254|529022765|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
146684832|NCT00293254|529022764|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
146684833|NCT00293254|529022765|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
146684834|NCT00293254|529022764|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
146684835|NCT00293254|529022765|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
146927491|NCT00406783|529894638|FG000|Overall Study|Adverse Event|4|||
146927492|NCT00406783|529894639|FG001|Overall Study|Adverse Event|4|||
146927493|NCT00406783|529894638|FG000|Overall Study|Treatment Failure|2|||
146927494|NCT00406783|529894639|FG001|Overall Study|Treatment Failure|3|||
146927495|NCT00406783|529894638|FG000|Overall Study|Lost to Follow-up|3|||
146927496|NCT00406783|529894639|FG001|Overall Study|Lost to Follow-up|0|||
146927497|NCT00406783|529894638|FG000|Overall Study|Withdrawal by Subject|1|||
146927498|NCT00406783|529894639|FG001|Overall Study|Withdrawal by Subject|4|||
146927499|NCT00406783|529894638|FG000|Overall Study|Protocol Violation|4|||
146927500|NCT00406783|529894639|FG001|Overall Study|Protocol Violation|4|||
146927501|NCT05294211|529894640|FG000|Overall Study|Withdrawal by Subject|3|||
146927502|NCT05294211|529894640|FG000|Overall Study|Physician Decision|2|||
146927503|NCT05294211|529894640|FG000|Overall Study|Progressed to active labor|1|||
146927504|NCT05294211|529894640|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
146927505|NCT05294211|529894640|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
146927506|NCT00838916|529894641|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
146927507|NCT00838916|529894642|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
146927508|NCT00838916|529894641|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
146927509|NCT00838916|529894642|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
146927510|NCT00838916|529894641|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
146927511|NCT00838916|529894642|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
146927512|NCT00838916|529894641|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
146927513|NCT00838916|529894642|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
146927514|NCT00838916|529894641|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
146927515|NCT00838916|529894642|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
146927516|NCT00838916|529894641|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
146927517|NCT00838916|529894642|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
146927518|NCT00838916|529894641|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
146927519|NCT00838916|529894642|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
146927520|NCT00838916|529894641|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
146927521|NCT00838916|529894642|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
146927522|NCT00838916|529894641|FG000|Treatment Period (156 Weeks)|Missing|3|||
146927523|NCT00838916|529894642|FG001|Treatment Period (156 Weeks)|Missing|1|||
146927524|NCT00838916|529894641|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
146927525|NCT00838916|529894642|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
146927526|NCT00838916|529894641|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
146927527|NCT00838916|529894642|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
146927528|NCT00838916|529894641|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
146927529|NCT00838916|529894642|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
146684836|NCT00293254|529022764|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
146684837|NCT00293254|529022765|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
146684838|NCT00293254|529022764|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
146684839|NCT00293254|529022765|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
146684840|NCT00293254|529022764|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
146684841|NCT00293254|529022765|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
146684842|NCT00293254|529022764|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
146684843|NCT00293254|529022765|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
146684844|NCT00293254|529022764|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
146684845|NCT00293254|529022765|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
146684846|NCT00293254|529022764|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
146684847|NCT00293254|529022765|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
146684848|NCT00293254|529022764|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
146684849|NCT00293254|529022765|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
146684850|NCT00293254|529022764|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
146684851|NCT00293254|529022765|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
146684852|NCT00293254|529022764|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
146684853|NCT00293254|529022765|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
146684854|NCT00293254|529022764|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
146684855|NCT00293254|529022765|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
146684856|NCT00293254|529022764|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
146684857|NCT00293254|529022765|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
146684858|NCT00293254|529022764|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
146684859|NCT00293254|529022765|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
146684860|NCT00293254|529022764|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
146774839|NCT03088813|529346790|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
146927530|NCT00838916|529894641|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
146774840|NCT03088813|529346791|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
146774841|NCT03088813|529346788|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
146927531|NCT00838916|529894642|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
146927532|NCT00838916|529894641|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
146927533|NCT00838916|529894642|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
146927534|NCT00838916|529894641|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
146927535|NCT00838916|529894642|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
146927536|NCT00838916|529894641|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
146927537|NCT00838916|529894642|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
146927538|NCT00838916|529894641|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
146927539|NCT00838916|529894642|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
146927540|NCT00838916|529894641|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
146927541|NCT00838916|529894642|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
146927542|NCT00838916|529894641|FG000|Follow-up Period (8 Weeks)|Missing|3|||
146927543|NCT00838916|529894642|FG001|Follow-up Period (8 Weeks)|Missing|0|||
146927544|NCT04095286|529894643|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146927545|NCT04095286|529894644|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
146927546|NCT04095286|529894645|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146927547|NCT04095286|529894646|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146927548|NCT04095286|529894647|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146927549|NCT04095286|529894648|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146927550|NCT04095286|529894643|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
146927551|NCT04095286|529894644|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
146927552|NCT04095286|529894645|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
146927553|NCT04095286|529894646|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
146684861|NCT00293254|529022765|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
146684862|NCT02259582|529022766|FG000|Overall Study|Physician Decision|0|||
146684863|NCT02259582|529022767|FG001|Overall Study|Physician Decision|1|||
146684864|NCT02259582|529022768|FG002|Overall Study|Physician Decision|0|||
146684865|NCT02259582|529022766|FG000|Overall Study|Death|0|||
146684866|NCT02259582|529022767|FG001|Overall Study|Death|0|||
146684867|NCT02259582|529022768|FG002|Overall Study|Death|1|||
146684868|NCT02259582|529022766|FG000|Overall Study|Adverse Event|1|||
146684869|NCT02259582|529022767|FG001|Overall Study|Adverse Event|0|||
146684870|NCT02259582|529022768|FG002|Overall Study|Adverse Event|1|||
146684871|NCT02259582|529022766|FG000|Overall Study|Withdrawal by Subject|0|||
146684872|NCT02259582|529022767|FG001|Overall Study|Withdrawal by Subject|0|||
146684873|NCT02259582|529022768|FG002|Overall Study|Withdrawal by Subject|1|||
146684874|NCT02259582|529022766|FG000|Overall Study|Disease progression|14|||
146684875|NCT02259582|529022767|FG001|Overall Study|Disease progression|15|||
146684876|NCT02259582|529022768|FG002|Overall Study|Disease progression|17|||
146684877|NCT02259582|529022766|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
146684878|NCT02259582|529022767|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
146684879|NCT02259582|529022768|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
146684880|NCT00503308|529022770|FG000|Overall Study|Protocol Violation|2|||
146684881|NCT00503308|529022771|FG001|Overall Study|Protocol Violation|1|||
146684882|NCT03263442|529022772|FG000|Inpatient Phase|Death|1|||
146684883|NCT03263442|529022773|FG001|Inpatient Phase|Death|0|||
146684884|NCT03263442|529022772|FG000|Inpatient Phase|Withdrawal by Subject|1|||
146684885|NCT03263442|529022773|FG001|Inpatient Phase|Withdrawal by Subject|0|||
146684886|NCT03263442|529022772|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
146684887|NCT03263442|529022773|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
146684888|NCT03263442|529022772|FG000|1-month Follow-Up|Lost to Follow-up|1|||
146684889|NCT03263442|529022773|FG001|1-month Follow-Up|Lost to Follow-up|0|||
146684890|NCT03263442|529022772|FG000|3-month Follow-Up|Lost to Follow-up|1|||
146684891|NCT03263442|529022773|FG001|3-month Follow-Up|Lost to Follow-up|3|||
146684892|NCT03263442|529022772|FG000|6-month Follow-Up|Lost to Follow-up|2|||
146684893|NCT03263442|529022773|FG001|6-month Follow-Up|Lost to Follow-up|2|||
146684894|NCT01463878|529022774|FG000|Overall Study|no longer met criteria for tube feed|2|||
146684895|NCT01463878|529022775|FG001|Overall Study|no longer met criteria for tube feed|2|||
146684896|NCT03804879|529022776|FG000|Overall Study|Adverse Event|3|||
146927554|NCT04095286|529894647|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
146927555|NCT04095286|529894648|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
146927556|NCT04095286|529894643|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
146927557|NCT04095286|529894644|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
146684897|NCT03804879|529022777|FG001|Overall Study|Adverse Event|0|||
146684898|NCT03804879|529022776|FG000|Overall Study|Study Terminated By Sponsor|10|||
146684899|NCT03804879|529022777|FG001|Overall Study|Study Terminated By Sponsor|12|||
146684900|NCT03804879|529022776|FG000|Overall Study|Withdrawal by Subject|3|||
146684901|NCT03804879|529022777|FG001|Overall Study|Withdrawal by Subject|1|||
146684902|NCT01034462|529022778|FG000|Overall Study|Adverse Event|7|||
146684903|NCT01034462|529022779|FG001|Overall Study|Adverse Event|17|||
146684904|NCT01034462|529022778|FG000|Overall Study|Lack of Efficacy|4|||
146684905|NCT01034462|529022779|FG001|Overall Study|Lack of Efficacy|4|||
146927558|NCT04095286|529894645|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
146927559|NCT04095286|529894646|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
146927560|NCT04095286|529894647|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
146927561|NCT04095286|529894648|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
146927562|NCT04095286|529894643|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146927563|NCT04095286|529894644|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146927564|NCT04095286|529894645|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
146927565|NCT04095286|529894646|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146927566|NCT04095286|529894647|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146927567|NCT04095286|529894648|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146927568|NCT04095286|529894643|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
146927569|NCT04095286|529894644|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
146684906|NCT01034462|529022778|FG000|Overall Study|Protocol Violation|10|||
146684907|NCT01034462|529022779|FG001|Overall Study|Protocol Violation|7|||
146684908|NCT01034462|529022778|FG000|Overall Study|Withdrawal by Subject|9|||
146684909|NCT01034462|529022779|FG001|Overall Study|Withdrawal by Subject|8|||
146927570|NCT04095286|529894645|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
146684910|NCT01034462|529022778|FG000|Overall Study|Lost to Follow-up|14|||
146684911|NCT01034462|529022779|FG001|Overall Study|Lost to Follow-up|16|||
146684912|NCT01034462|529022778|FG000|Overall Study|Other reasons|1|||
146684913|NCT01034462|529022779|FG001|Overall Study|Other reasons|2|||
146684914|NCT00708643|529022780|FG000|Overall Study|Adverse Event|0|||
146684915|NCT00708643|529022781|FG001|Overall Study|Adverse Event|1|||
146684916|NCT06079320|529022784|FG000|Follow up Phase|Lost to Follow-up|1|||
146684917|NCT06079320|529022785|FG001|Follow up Phase|Lost to Follow-up|0|||
146684918|NCT03428360|529022786|FG000|Overall Study|Informed consent withdrawn|5|||
146684919|NCT03428360|529022786|FG000|Overall Study|Withdrawal by Subject|4|||
146684920|NCT03428360|529022786|FG000|Overall Study|Lost to Follow-up|5|||
146684921|NCT03428360|529022786|FG000|Overall Study|Physician Decision|2|||
146684922|NCT03428360|529022786|FG000|Overall Study|Informed consent withdrawn|5|||
146684923|NCT03428360|529022786|FG000|Overall Study|Study terminated by sponsor|10|||
146684924|NCT03428360|529022786|FG000|Overall Study|Non-compliant with study|1|||
146684925|NCT03428360|529022786|FG000|Overall Study|Non-compliant with study drug|3|||
146684926|NCT03428360|529022786|FG000|Overall Study|Death|3|||
146684927|NCT03428360|529022786|FG000|Overall Study|Adverse Event|1|||
146684928|NCT03428360|529022786|FG000|Overall Study|Not on antiepileptic drug|1|||
146684929|NCT01414855|529022789|FG000|Overall Study|Death|17|||
146684930|NCT01414855|529022789|FG000|Overall Study|Lost to Follow-up|5|||
146684931|NCT01414855|529022789|FG000|Overall Study|Withdrawal by Subject|7|||
146684932|NCT04851314|529022790|FG000|Overall Study|Unable to complete research set-up procedures|0|||
146684933|NCT04851314|529022791|FG001|Overall Study|Unable to complete research set-up procedures|2|||
146684934|NCT04851314|529022790|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
146684935|NCT04851314|529022791|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
146684936|NCT03266094|529022792|FG000|Overall Study|Lost to Follow-up|1|||
146684937|NCT03266094|529022792|FG000|Overall Study|Withdrawal by Subject|1|||
146684938|NCT00368355|529022796|FG000|Overall Study|Adverse Event|1|||
146684939|NCT00368355|529022797|FG001|Overall Study|Adverse Event|0|||
146684940|NCT00368355|529022796|FG000|Overall Study|Death|2|||
146684941|NCT00368355|529022797|FG001|Overall Study|Death|4|||
146684942|NCT00368355|529022796|FG000|Overall Study|Relapse|6|||
146684943|NCT00368355|529022797|FG001|Overall Study|Relapse|10|||
146684944|NCT00368355|529022796|FG000|Overall Study|Subsequent transplant|0|||
146684945|NCT00368355|529022797|FG001|Overall Study|Subsequent transplant|3|||
146684946|NCT00368355|529022796|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
146684947|NCT00368355|529022797|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
146684948|NCT03473808|529022801|FG000|Overall Study|Withdrawal by Subject|1|||
146684949|NCT03171415|529022802|FG000|Overall Study|Lost to Follow-up|0|||
146684950|NCT03171415|529022803|FG001|Overall Study|Lost to Follow-up|0|||
146684951|NCT03171415|529022804|FG002|Overall Study|Lost to Follow-up|0|||
146684952|NCT03171415|529022805|FG003|Overall Study|Lost to Follow-up|0|||
146684953|NCT03171415|529022806|FG004|Overall Study|Lost to Follow-up|2|||
146684954|NCT04059094|529022807|FG000|Overall Study|Adverse Event|0|||
146684955|NCT04059094|529022808|FG001|Overall Study|Adverse Event|0|||
146684956|NCT04059094|529022809|FG002|Overall Study|Adverse Event|0|||
146684957|NCT04059094|529022810|FG003|Overall Study|Adverse Event|0|||
146684958|NCT04059094|529022811|FG004|Overall Study|Adverse Event|1|||
146684959|NCT04059094|529022807|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
146684960|NCT04059094|529022808|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
146684961|NCT04059094|529022809|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
146684962|NCT04059094|529022810|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
146684963|NCT04059094|529022811|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
146684964|NCT01339429|529022812|FG000|Overall Study|Withdrawal by Subject|1|||
146684965|NCT01339429|529022812|FG000|Overall Study|Physician Decision|3|||
146684966|NCT01085591|529022817|FG000|Overall Study|Adverse Event|0|||
146684967|NCT01085591|529022818|FG001|Overall Study|Adverse Event|1|||
146684968|NCT01085591|529022819|FG002|Overall Study|Adverse Event|3|||
146684969|NCT01085591|529022817|FG000|Overall Study|Physician Decision|1|||
146684970|NCT01085591|529022818|FG001|Overall Study|Physician Decision|0|||
146684971|NCT01085591|529022819|FG002|Overall Study|Physician Decision|1|||
146684972|NCT01085591|529022817|FG000|Overall Study|Withdrawal by Subject|0|||
146684973|NCT01085591|529022818|FG001|Overall Study|Withdrawal by Subject|2|||
146684974|NCT01085591|529022819|FG002|Overall Study|Withdrawal by Subject|1|||
146684975|NCT01085591|529022817|FG000|Overall Study|Lost to Follow-up|0|||
146684976|NCT01085591|529022818|FG001|Overall Study|Lost to Follow-up|1|||
146684977|NCT01085591|529022819|FG002|Overall Study|Lost to Follow-up|1|||
146684978|NCT01085591|529022817|FG000|Overall Study|Protocol Violation|1|||
146684979|NCT01085591|529022818|FG001|Overall Study|Protocol Violation|1|||
146684980|NCT01085591|529022819|FG002|Overall Study|Protocol Violation|1|||
146684981|NCT01085591|529022817|FG000|Overall Study|Other|0|||
146684982|NCT01085591|529022818|FG001|Overall Study|Other|1|||
146684983|NCT01085591|529022819|FG002|Overall Study|Other|0|||
146684984|NCT01085591|529022817|FG000|Overall Study|Not Properly Consented|1|||
146684985|NCT01085591|529022818|FG001|Overall Study|Not Properly Consented|0|||
146684986|NCT01085591|529022819|FG002|Overall Study|Not Properly Consented|0|||
146684987|NCT00459667|529022824|FG000|Overall Study|Adverse Event|9|||
146684988|NCT00459667|529022825|FG001|Overall Study|Adverse Event|12|||
146774842|NCT03088813|529346789|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
146774843|NCT03088813|529346790|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
146848290|NCT02407990|529615649|FG004|Overall Study|Death|17|||
146684989|NCT00459667|529022826|FG002|Overall Study|Adverse Event|8|||
146684990|NCT00459667|529022824|FG000|Overall Study|Lost to Follow-up|5|||
146684991|NCT00459667|529022825|FG001|Overall Study|Lost to Follow-up|9|||
146684992|NCT00459667|529022826|FG002|Overall Study|Lost to Follow-up|3|||
146684993|NCT00459667|529022824|FG000|Overall Study|Pregnancy|1|||
146684994|NCT00459667|529022825|FG001|Overall Study|Pregnancy|1|||
146684995|NCT00459667|529022826|FG002|Overall Study|Pregnancy|1|||
146684996|NCT00459667|529022824|FG000|Overall Study|Protocol Violation|1|||
146684997|NCT00459667|529022825|FG001|Overall Study|Protocol Violation|0|||
146684998|NCT00459667|529022826|FG002|Overall Study|Protocol Violation|0|||
146684999|NCT00459667|529022824|FG000|Overall Study|Withdrawal by Subject|3|||
146685000|NCT00459667|529022825|FG001|Overall Study|Withdrawal by Subject|5|||
146685001|NCT00459667|529022826|FG002|Overall Study|Withdrawal by Subject|5|||
146685002|NCT00459667|529022824|FG000|Overall Study|Other disease modifying treatment|1|||
146685003|NCT00459667|529022825|FG001|Overall Study|Other disease modifying treatment|2|||
146685004|NCT00459667|529022826|FG002|Overall Study|Other disease modifying treatment|1|||
146685005|NCT00459667|529022824|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
146685006|NCT00459667|529022825|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
146685007|NCT00459667|529022826|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
146685008|NCT00459667|529022824|FG000|Overall Study|No treatment administered|6|||
146685009|NCT00459667|529022825|FG001|Overall Study|No treatment administered|3|||
146685010|NCT00459667|529022826|FG002|Overall Study|No treatment administered|1|||
146685011|NCT00396591|529022827|FG000|Overall Study|Disease Progression|13|||
146685012|NCT00396591|529022827|FG000|Overall Study|Adverse Event|2|||
146685013|NCT00396591|529022827|FG000|Overall Study|Participant request|1|||
146685014|NCT03851302|529022835|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
146685015|NCT03851302|529022836|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
146685016|NCT03851302|529022837|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
146685017|NCT03851302|529022838|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
146685018|NCT03851302|529022839|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
146685019|NCT03851302|529022840|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
146685020|NCT03851302|529022835|FG000|Screening (1 Day)|Screened out|0|||
146685021|NCT03851302|529022836|FG001|Screening (1 Day)|Screened out|0|||
146685022|NCT03851302|529022837|FG002|Screening (1 Day)|Screened out|1|||
146685023|NCT03851302|529022838|FG003|Screening (1 Day)|Screened out|1|||
146685024|NCT03851302|529022839|FG004|Screening (1 Day)|Screened out|0|||
146685025|NCT03851302|529022840|FG005|Screening (1 Day)|Screened out|0|||
146685026|NCT03851302|529022835|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
146685027|NCT03851302|529022836|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
146685028|NCT03851302|529022837|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
146685029|NCT03851302|529022838|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
146848291|NCT02407990|529615650|FG005|Overall Study|Death|16|||
146848292|NCT02407990|529615651|FG006|Overall Study|Death|10|||
146848293|NCT02407990|529615652|FG007|Overall Study|Death|248|||
146848294|NCT02407990|529615645|FG000|Overall Study|Lost to Follow-up|0|||
146848295|NCT02407990|529615646|FG001|Overall Study|Lost to Follow-up|1|||
146848296|NCT02407990|529615647|FG002|Overall Study|Lost to Follow-up|0|||
146848297|NCT02407990|529615648|FG003|Overall Study|Lost to Follow-up|0|||
146848298|NCT02407990|529615649|FG004|Overall Study|Lost to Follow-up|0|||
146848299|NCT02407990|529615650|FG005|Overall Study|Lost to Follow-up|0|||
146848300|NCT02407990|529615651|FG006|Overall Study|Lost to Follow-up|0|||
146685030|NCT03851302|529022839|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
146685031|NCT03851302|529022840|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
146685032|NCT04434092|529022841|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
146685033|NCT04434092|529022842|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
146685034|NCT04434092|529022843|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
146685035|NCT04434092|529022841|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
146685036|NCT04434092|529022842|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
146685037|NCT04434092|529022843|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
146685038|NCT04434092|529022841|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
146685039|NCT04434092|529022842|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
146685040|NCT04434092|529022843|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
146685041|NCT04434092|529022841|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
146685042|NCT04434092|529022842|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
146685043|NCT04434092|529022843|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
146685044|NCT04434092|529022841|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
146685045|NCT04434092|529022842|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
146685046|NCT04434092|529022843|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
146685047|NCT04434092|529022841|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
146685048|NCT04434092|529022842|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
146685049|NCT04434092|529022843|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
146685050|NCT04434092|529022841|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
146685051|NCT04434092|529022842|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
146685052|NCT04434092|529022843|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
146685053|NCT00397982|529024571|FG000|Overall Study|Withdrawal by Subject|1|||
146685054|NCT00397982|529024571|FG000|Overall Study|Adverse Event|1|||
146685055|NCT00397982|529024571|FG000|Overall Study|noncompliance|1|||
146685056|NCT00397982|529024571|FG000|Overall Study|Unrelated health issues|1|||
146685057|NCT01199289|529024575|FG000|Overall Study|Ineligibility determined|2|||
146685058|NCT01199289|529024576|FG001|Overall Study|Ineligibility determined|1|||
146685059|NCT01199289|529024577|FG002|Overall Study|Ineligibility determined|0|||
146685060|NCT01199289|529024578|FG003|Overall Study|Ineligibility determined|0|||
146685061|NCT01199289|529024575|FG000|Overall Study|Protocol Violation|1|||
146685062|NCT01199289|529024576|FG001|Overall Study|Protocol Violation|0|||
146685063|NCT01199289|529024577|FG002|Overall Study|Protocol Violation|0|||
146685064|NCT01199289|529024578|FG003|Overall Study|Protocol Violation|1|||
146685065|NCT01199289|529024575|FG000|Overall Study|Noncompliance|1|||
146685066|NCT01199289|529024576|FG001|Overall Study|Noncompliance|0|||
146685067|NCT01199289|529024577|FG002|Overall Study|Noncompliance|2|||
146685068|NCT01199289|529024578|FG003|Overall Study|Noncompliance|0|||
146685069|NCT01199289|529024575|FG000|Overall Study|Adverse Event|0|||
146685070|NCT01199289|529024576|FG001|Overall Study|Adverse Event|3|||
146685071|NCT01199289|529024577|FG002|Overall Study|Adverse Event|1|||
146685072|NCT01199289|529024578|FG003|Overall Study|Adverse Event|4|||
146685073|NCT01199289|529024575|FG000|Overall Study|Full consent withdrawn|2|||
146685074|NCT01199289|529024576|FG001|Overall Study|Full consent withdrawn|2|||
146685075|NCT01199289|529024577|FG002|Overall Study|Full consent withdrawn|2|||
146685076|NCT01199289|529024578|FG003|Overall Study|Full consent withdrawn|3|||
146685077|NCT01199289|529024575|FG000|Overall Study|Administrative decision|0|||
146685078|NCT01199289|529024576|FG001|Overall Study|Administrative decision|0|||
146685079|NCT01199289|529024577|FG002|Overall Study|Administrative decision|0|||
146685080|NCT01199289|529024578|FG003|Overall Study|Administrative decision|1|||
146685081|NCT01199289|529024575|FG000|Overall Study|Lost to Follow-up|0|||
146685082|NCT01199289|529024576|FG001|Overall Study|Lost to Follow-up|0|||
146685083|NCT01199289|529024577|FG002|Overall Study|Lost to Follow-up|0|||
146685084|NCT01199289|529024578|FG003|Overall Study|Lost to Follow-up|1|||
146927571|NCT04095286|529894646|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
146685085|NCT01199289|529024575|FG000|Overall Study|Protocol-specified criteria|3|||
146685086|NCT01199289|529024576|FG001|Overall Study|Protocol-specified criteria|0|||
146685087|NCT01199289|529024577|FG002|Overall Study|Protocol-specified criteria|0|||
146685088|NCT01199289|529024578|FG003|Overall Study|Protocol-specified criteria|1|||
146685089|NCT01199289|529024575|FG000|Overall Study|Pregnancy|0|||
146685090|NCT01199289|529024576|FG001|Overall Study|Pregnancy|1|||
146685091|NCT01199289|529024577|FG002|Overall Study|Pregnancy|0|||
146685092|NCT01199289|529024578|FG003|Overall Study|Pregnancy|1|||
146685093|NCT03055260|529024579|FG000|Overall Study|Withdrawal by Subject|1|||
146685094|NCT03055260|529024580|FG001|Overall Study|Withdrawal by Subject|0|||
146685095|NCT02507505|529024581|FG000|Overall Study|Withdrawal by Subject|13|||
146685096|NCT02507505|529024582|FG001|Overall Study|Withdrawal by Subject|11|||
146685097|NCT02507505|529024581|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
146774844|NCT03088813|529346791|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
146927572|NCT04095286|529894647|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
146685098|NCT02507505|529024582|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
146685099|NCT02507505|529024581|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
146685100|NCT02507505|529024582|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
146685101|NCT02507505|529024581|FG000|Overall Study|Death before receipt of anesthesia|0|||
146685102|NCT02507505|529024582|FG001|Overall Study|Death before receipt of anesthesia|1|||
146685103|NCT00967798|529024583|FG000|Overall Study|Withdrawal by Subject|5|||
146685104|NCT00967798|529024584|FG001|Overall Study|Withdrawal by Subject|2|||
146685105|NCT00967798|529024583|FG000|Overall Study|Lost to Follow-up|4|||
146685106|NCT00967798|529024584|FG001|Overall Study|Lost to Follow-up|1|||
146685107|NCT01409564|529024585|FG000|Overall Study|low medication compliance|4|||
146685108|NCT01409564|529024586|FG001|Overall Study|low medication compliance|3|||
146685109|NCT01409564|529024585|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
146685110|NCT01409564|529024586|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
146685111|NCT00254540|529024587|FG000|Overall Study|Adverse Event|6|||
146685112|NCT00254540|529024588|FG001|Overall Study|Adverse Event|7|||
146685113|NCT00254540|529024587|FG000|Overall Study|Lack of Efficacy|13|||
146685114|NCT00254540|529024588|FG001|Overall Study|Lack of Efficacy|13|||
146685115|NCT00254540|529024587|FG000|Overall Study|Death|0|||
146685116|NCT00254540|529024588|FG001|Overall Study|Death|1|||
146685117|NCT00254540|529024587|FG000|Overall Study|Laboratory Test Abnormality|0|||
146685118|NCT00254540|529024588|FG001|Overall Study|Laboratory Test Abnormality|1|||
146685119|NCT00225251|529024589|FG000|Overall Study|Withdrawal by Subject|1|||
146685120|NCT00225251|529024590|FG001|Overall Study|Withdrawal by Subject|1|||
146685121|NCT03045328|529024591|FG000|Overall Study|Withdrawal by Subject|2|||
146685122|NCT00592839|529024594|FG000|Overall Study|Withdrawal by Subject|1|||
146685123|NCT00592839|529024595|FG001|Overall Study|Withdrawal by Subject|1|||
146685124|NCT00592839|529024596|FG002|Overall Study|Withdrawal by Subject|3|||
146685125|NCT00592839|529024594|FG000|Overall Study|Protocol Violation|1|||
146685126|NCT00592839|529024595|FG001|Overall Study|Protocol Violation|1|||
146685127|NCT00592839|529024596|FG002|Overall Study|Protocol Violation|2|||
146685128|NCT00592839|529024594|FG000|Overall Study|Adverse Event|0|||
146685129|NCT00592839|529024595|FG001|Overall Study|Adverse Event|1|||
146685130|NCT00592839|529024596|FG002|Overall Study|Adverse Event|0|||
146685131|NCT00592839|529024594|FG000|Overall Study|Lost to Follow-up|0|||
146685132|NCT00592839|529024595|FG001|Overall Study|Lost to Follow-up|1|||
146685133|NCT00592839|529024596|FG002|Overall Study|Lost to Follow-up|1|||
146685134|NCT01313767|529024597|FG000|Overall Study|Adverse Event|1|||
146685135|NCT01313767|529024598|FG001|Overall Study|Adverse Event|0|||
146685136|NCT01313767|529024597|FG000|Overall Study|Lost to Follow-up|1|||
146685137|NCT01313767|529024598|FG001|Overall Study|Lost to Follow-up|0|||
146685138|NCT01313767|529024597|FG000|Overall Study|Withdrawal by Subject|2|||
146685139|NCT01313767|529024598|FG001|Overall Study|Withdrawal by Subject|1|||
146685140|NCT01313767|529024597|FG000|Overall Study|Protocol Violation|3|||
146685141|NCT01313767|529024598|FG001|Overall Study|Protocol Violation|1|||
146685142|NCT00157950|529024599|FG000|Overall Study|Death|1|||
146685143|NCT00157950|529024600|FG001|Overall Study|Death|0|||
146685144|NCT02335489|529024601|FG000|Overall Study|Sponsor terminated study|4|||
146685145|NCT02335489|529024601|FG000|Overall Study|Lost to Follow-up|1|||
146685146|NCT02335489|529024601|FG000|Overall Study|Withdrawal by Subject|2|||
146685147|NCT02335489|529024601|FG000|Overall Study|Physician Decision|2|||
146685148|NCT02335489|529024601|FG000|Overall Study|Lack of Efficacy|1|||
146685149|NCT00531050|529024608|FG000|Part 1: Period 1|Adverse Event|0|||
146685150|NCT00531050|529024609|FG001|Part 1: Period 1|Adverse Event|1|||
146685151|NCT00531050|529024610|FG002|Part 1: Period 1|Adverse Event|0|||
146685152|NCT00531050|529024611|FG003|Part 1: Period 1|Adverse Event|0|||
146685153|NCT00531050|529024612|FG004|Part 1: Period 1|Adverse Event|0|||
146685154|NCT00531050|529024613|FG005|Part 1: Period 1|Adverse Event|0|||
146685155|NCT00531050|529024608|FG000|Part 1: Period 1|Protocol Deviation|0|||
146685156|NCT00531050|529024609|FG001|Part 1: Period 1|Protocol Deviation|0|||
146685157|NCT00531050|529024610|FG002|Part 1: Period 1|Protocol Deviation|0|||
146685158|NCT00531050|529024611|FG003|Part 1: Period 1|Protocol Deviation|1|||
146685159|NCT00531050|529024612|FG004|Part 1: Period 1|Protocol Deviation|0|||
146685160|NCT00531050|529024613|FG005|Part 1: Period 1|Protocol Deviation|0|||
146685161|NCT00531050|529024608|FG000|Part 1: Period 3|Adverse Event|1|||
146685162|NCT00531050|529024609|FG001|Part 1: Period 3|Adverse Event|0|||
146685163|NCT00531050|529024610|FG002|Part 1: Period 3|Adverse Event|0|||
146685164|NCT00531050|529024611|FG003|Part 1: Period 3|Adverse Event|0|||
146685165|NCT00531050|529024612|FG004|Part 1: Period 3|Adverse Event|0|||
146685166|NCT00531050|529024613|FG005|Part 1: Period 3|Adverse Event|0|||
146685167|NCT00531050|529024608|FG000|Part 2: Period 1|Adverse Event|0|||
146685168|NCT00531050|529024609|FG001|Part 2: Period 1|Adverse Event|0|||
146685169|NCT00531050|529024610|FG002|Part 2: Period 1|Adverse Event|0|||
146685170|NCT00531050|529024611|FG003|Part 2: Period 1|Adverse Event|0|||
146685171|NCT00531050|529024612|FG004|Part 2: Period 1|Adverse Event|0|||
146685172|NCT00531050|529024613|FG005|Part 2: Period 1|Adverse Event|1|||
146685173|NCT00531050|529024608|FG000|Part 2: Period 3|Abnormal test procedure|1|||
146685174|NCT00531050|529024609|FG001|Part 2: Period 3|Abnormal test procedure|0|||
146685175|NCT00531050|529024610|FG002|Part 2: Period 3|Abnormal test procedure|0|||
146685176|NCT00531050|529024611|FG003|Part 2: Period 3|Abnormal test procedure|0|||
146685177|NCT00531050|529024612|FG004|Part 2: Period 3|Abnormal test procedure|0|||
146685178|NCT00531050|529024613|FG005|Part 2: Period 3|Abnormal test procedure|1|||
146685179|NCT02233309|529024614|FG000|Overall Study|Physician Decision|5|||
146685180|NCT00799487|529024620|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
146685181|NCT00799487|529024621|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
146685182|NCT00799487|529024622|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
146685183|NCT00799487|529024620|FG000|Dose Adjustment Period|Adverse Event|2|||
146685184|NCT00799487|529024621|FG001|Dose Adjustment Period|Adverse Event|0|||
146685185|NCT00799487|529024622|FG002|Dose Adjustment Period|Adverse Event|0|||
146685186|NCT00799487|529024620|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
146685187|NCT00799487|529024621|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
146685188|NCT00799487|529024622|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
146685189|NCT00799487|529024620|FG000|Dose Adjustment Period|Investigator Discretion|2|||
146685190|NCT00799487|529024621|FG001|Dose Adjustment Period|Investigator Discretion|0|||
146685191|NCT00799487|529024622|FG002|Dose Adjustment Period|Investigator Discretion|0|||
146685192|NCT00799487|529024620|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
146685193|NCT00799487|529024621|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
146685194|NCT00799487|529024622|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
146685195|NCT00799487|529024620|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
146685196|NCT00799487|529024621|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
146685197|NCT00799487|529024622|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
146927573|NCT04095286|529894648|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
146685198|NCT00799487|529024620|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
146927574|NCT00479557|529894649|FG000|Overall Study|Death|0|||
146927575|NCT00479557|529894650|FG001|Overall Study|Death|0|||
146927576|NCT00479557|529894651|FG002|Overall Study|Death|0|||
146927577|NCT00479557|529894652|FG003|Overall Study|Death|0|||
146927578|NCT00479557|529894653|FG004|Overall Study|Death|0|||
146927579|NCT00479557|529894654|FG005|Overall Study|Death|1|||
146927580|NCT00479557|529894655|FG006|Overall Study|Death|0|||
146927581|NCT00479557|529894649|FG000|Overall Study|Lack of Efficacy|1|||
146927582|NCT00479557|529894650|FG001|Overall Study|Lack of Efficacy|0|||
146927583|NCT00479557|529894651|FG002|Overall Study|Lack of Efficacy|0|||
146927584|NCT00479557|529894652|FG003|Overall Study|Lack of Efficacy|0|||
146927585|NCT00479557|529894653|FG004|Overall Study|Lack of Efficacy|0|||
146927586|NCT00479557|529894654|FG005|Overall Study|Lack of Efficacy|0|||
146685199|NCT00799487|529024621|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
146685200|NCT00799487|529024622|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
146685201|NCT00799487|529024620|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
146685202|NCT00799487|529024621|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
146927587|NCT00479557|529894655|FG006|Overall Study|Lack of Efficacy|0|||
146927588|NCT00479557|529894649|FG000|Overall Study|Lost to Follow-up|0|||
146927589|NCT00479557|529894650|FG001|Overall Study|Lost to Follow-up|2|||
146685203|NCT00799487|529024622|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
146685204|NCT00799487|529024620|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
146685205|NCT00799487|529024621|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
146685206|NCT00799487|529024622|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
146685207|NCT00799487|529024620|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
146685208|NCT00799487|529024621|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
146685209|NCT00799487|529024622|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
146685210|NCT00799487|529024620|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
146685211|NCT00799487|529024621|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
146685212|NCT00799487|529024622|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
146685213|NCT00799487|529024620|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
146685214|NCT00799487|529024621|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
146685215|NCT00799487|529024622|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
146685216|NCT00232817|529024623|FG000|Overall Study|Protocol Violation|2|||
146927590|NCT00479557|529894651|FG002|Overall Study|Lost to Follow-up|0|||
146685217|NCT00232817|529024624|FG001|Overall Study|Protocol Violation|1|||
146685218|NCT04481750|529024625|FG000|Period 1 (Fasted)|Adverse Event|0|||
146685219|NCT04481750|529024626|FG001|Period 1 (Fasted)|Adverse Event|0|||
146685220|NCT04481750|529024627|FG002|Period 1 (Fasted)|Adverse Event|1|||
146927591|NCT00479557|529894652|FG003|Overall Study|Lost to Follow-up|2|||
146927592|NCT00479557|529894653|FG004|Overall Study|Lost to Follow-up|0|||
146685221|NCT04481750|529024628|FG003|Period 1 (Fasted)|Adverse Event|0|||
146927593|NCT00479557|529894654|FG005|Overall Study|Lost to Follow-up|0|||
146927594|NCT00479557|529894655|FG006|Overall Study|Lost to Follow-up|0|||
146685222|NCT04481750|529024629|FG004|Period 1 (Fasted)|Adverse Event|0|||
146685223|NCT04481750|529024630|FG005|Period 1 (Fasted)|Adverse Event|0|||
146927595|NCT00479557|529894649|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
146927596|NCT00479557|529894650|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
146927597|NCT00479557|529894651|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
146927598|NCT00479557|529894652|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
146927599|NCT00479557|529894653|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
146927600|NCT00479557|529894654|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
146927601|NCT00479557|529894655|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
146927602|NCT00479557|529894649|FG000|Overall Study|AE not related to Study Drug|1|||
146927603|NCT00479557|529894650|FG001|Overall Study|AE not related to Study Drug|3|||
146927604|NCT00479557|529894651|FG002|Overall Study|AE not related to Study Drug|0|||
146927605|NCT00479557|529894652|FG003|Overall Study|AE not related to Study Drug|0|||
146685224|NCT04481750|529024631|FG006|Period 1 (Fasted)|Adverse Event|0|||
146685225|NCT04481750|529024632|FG007|Period 1 (Fasted)|Adverse Event|0|||
146685226|NCT04481750|529024633|FG008|Period 1 (Fasted)|Adverse Event|0|||
146685227|NCT04481750|529024634|FG009|Period 1 (Fasted)|Adverse Event|0|||
146685228|NCT04481750|529024635|FG010|Period 1 (Fasted)|Adverse Event|0|||
146685229|NCT02436889|529024636|FG000|Overall Study|No improvement in symptoms|1|||
146685230|NCT02436889|529024637|FG001|Overall Study|No improvement in symptoms|0|||
146685231|NCT02436889|529024636|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
146685232|NCT02436889|529024637|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
146685233|NCT00227903|529024638|FG000|Overall Study|Withdrawal by Subject|2|||
146685234|NCT00227903|529024639|FG001|Overall Study|Withdrawal by Subject|5|||
146685235|NCT00227903|529024638|FG000|Overall Study|Subject moved out of area|1|||
146685236|NCT00227903|529024639|FG001|Overall Study|Subject moved out of area|2|||
146685237|NCT00227903|529024638|FG000|Overall Study|Lost to Follow-up|1|||
146685238|NCT00227903|529024639|FG001|Overall Study|Lost to Follow-up|3|||
146685239|NCT00227903|529024638|FG000|Overall Study|Miscarriage|1|||
146685240|NCT00227903|529024639|FG001|Overall Study|Miscarriage|0|||
146685241|NCT04273217|529024640|FG000|Overall Study|Lost to Follow-up|0|||
146685242|NCT04273217|529024641|FG001|Overall Study|Lost to Follow-up|0|||
146685243|NCT04273217|529024642|FG002|Overall Study|Lost to Follow-up|0|||
146685244|NCT04273217|529024643|FG003|Overall Study|Lost to Follow-up|0|||
146685245|NCT04273217|529024644|FG004|Overall Study|Lost to Follow-up|0|||
146685246|NCT04273217|529024645|FG005|Overall Study|Lost to Follow-up|1|||
146685247|NCT04273217|529024640|FG000|Overall Study|Participant non-compliance|0|||
146685248|NCT04273217|529024641|FG001|Overall Study|Participant non-compliance|0|||
146685249|NCT04273217|529024642|FG002|Overall Study|Participant non-compliance|0|||
146685250|NCT04273217|529024643|FG003|Overall Study|Participant non-compliance|0|||
146685251|NCT04273217|529024644|FG004|Overall Study|Participant non-compliance|1|||
146685252|NCT04273217|529024645|FG005|Overall Study|Participant non-compliance|0|||
146685253|NCT04273217|529024640|FG000|Overall Study|Positive urine drug screen|1|||
146685254|NCT04273217|529024641|FG001|Overall Study|Positive urine drug screen|0|||
146685255|NCT04273217|529024642|FG002|Overall Study|Positive urine drug screen|1|||
146685256|NCT04273217|529024643|FG003|Overall Study|Positive urine drug screen|0|||
146685257|NCT04273217|529024644|FG004|Overall Study|Positive urine drug screen|0|||
146685258|NCT04273217|529024645|FG005|Overall Study|Positive urine drug screen|1|||
146685259|NCT03720470|529024648|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
146685260|NCT03720470|529024649|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
146685261|NCT03720470|529024650|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
146685262|NCT03720470|529024651|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
146685263|NCT03720470|529024652|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
146685264|NCT03720470|529024653|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
146685265|NCT03720470|529024648|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
146685266|NCT03720470|529024649|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
146685267|NCT03720470|529024650|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
146685268|NCT03720470|529024651|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
146685269|NCT03720470|529024652|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
146685270|NCT03720470|529024653|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
146685271|NCT03720470|529024648|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
146685272|NCT03720470|529024649|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
146685273|NCT03720470|529024650|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
146685274|NCT03720470|529024651|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
146685275|NCT03720470|529024652|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
146685276|NCT03720470|529024653|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
146685277|NCT03720470|529024648|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
146685278|NCT03720470|529024649|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
146685279|NCT03720470|529024650|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
146685280|NCT03720470|529024651|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
146685281|NCT03720470|529024652|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
146685282|NCT03720470|529024653|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
146685283|NCT03720470|529024648|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
146685284|NCT03720470|529024649|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
146685285|NCT03720470|529024650|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
146774845|NCT03088813|529346788|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
146927606|NCT00479557|529894653|FG004|Overall Study|AE not related to Study Drug|2|||
146927607|NCT00479557|529894654|FG005|Overall Study|AE not related to Study Drug|2|||
146685286|NCT03720470|529024651|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
146685287|NCT03720470|529024652|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
146685288|NCT03720470|529024653|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
146685289|NCT03720470|529024648|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
146685290|NCT03720470|529024649|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
146685291|NCT03720470|529024650|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
146685292|NCT03720470|529024651|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
146685293|NCT03720470|529024652|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
146685294|NCT03720470|529024653|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
146685295|NCT03720470|529024648|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
146685296|NCT03720470|529024649|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
146685297|NCT03720470|529024650|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
146685298|NCT03720470|529024651|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
146685299|NCT03720470|529024652|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
146685300|NCT03720470|529024653|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
146685301|NCT03720470|529024648|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
146685302|NCT03720470|529024649|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
146685303|NCT03720470|529024650|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
146685304|NCT03720470|529024651|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
146685305|NCT03720470|529024652|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
146685306|NCT03720470|529024653|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
146685307|NCT03720470|529024648|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
146685308|NCT03720470|529024649|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
146685309|NCT03720470|529024650|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
146685310|NCT03720470|529024651|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
146685311|NCT03720470|529024652|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
146685312|NCT03720470|529024653|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
146685313|NCT03720470|529024648|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
146685314|NCT03720470|529024649|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
146685315|NCT03720470|529024650|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
146685316|NCT03720470|529024651|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
146685317|NCT03720470|529024652|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
146685318|NCT03720470|529024653|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
146685319|NCT03720470|529024648|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
146685320|NCT03720470|529024649|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
146685321|NCT03720470|529024650|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
146685322|NCT03720470|529024651|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
146685323|NCT03720470|529024652|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
146685324|NCT03720470|529024653|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
146685325|NCT03720470|529024648|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
146685326|NCT03720470|529024649|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
146685327|NCT03720470|529024650|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
146685328|NCT03720470|529024651|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
146685329|NCT03720470|529024652|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
146685330|NCT03720470|529024653|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
146685331|NCT03720470|529024648|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
146685332|NCT03720470|529024649|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
146685333|NCT03720470|529024650|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
146685334|NCT03720470|529024651|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
146685335|NCT03720470|529024652|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
146685336|NCT03720470|529024653|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
146685337|NCT03720470|529024648|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
146685338|NCT03720470|529024649|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
146685339|NCT03720470|529024650|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
146685340|NCT03720470|529024651|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
146685341|NCT03720470|529024652|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
146685342|NCT03720470|529024653|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
146685343|NCT03720470|529024648|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
146685344|NCT03720470|529024649|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
146685345|NCT03720470|529024650|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
146685346|NCT03720470|529024651|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
146685347|NCT03720470|529024652|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
146685348|NCT03720470|529024653|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
146685349|NCT03720470|529024648|FG000|Treatment Period: Final 4 Weeks|Other|0|||
146685350|NCT03720470|529024649|FG001|Treatment Period: Final 4 Weeks|Other|1|||
146685351|NCT03720470|529024650|FG002|Treatment Period: Final 4 Weeks|Other|0|||
146927608|NCT00479557|529894655|FG006|Overall Study|AE not related to Study Drug|1|||
146927609|NCT00479557|529894649|FG000|Overall Study|Caregiver Request|2|||
146927610|NCT00479557|529894650|FG001|Overall Study|Caregiver Request|2|||
146685352|NCT03720470|529024651|FG003|Treatment Period: Final 4 Weeks|Other|2|||
146685353|NCT03720470|529024652|FG004|Treatment Period: Final 4 Weeks|Other|1|||
146685354|NCT03720470|529024653|FG005|Treatment Period: Final 4 Weeks|Other|0|||
146685355|NCT00498602|529024658|FG000|Overall Study|Death|0|||
146685356|NCT00498602|529024659|FG001|Overall Study|Death|0|||
146685357|NCT00498602|529024660|FG002|Overall Study|Death|0|||
146685358|NCT00498602|529024661|FG003|Overall Study|Death|0|||
146685359|NCT00498602|529024662|FG004|Overall Study|Death|0|||
146685360|NCT00498602|529024663|FG005|Overall Study|Death|1|||
146685361|NCT00498602|529024664|FG006|Overall Study|Death|0|||
146685362|NCT00498602|529024658|FG000|Overall Study|Lack of Efficacy|1|||
146685363|NCT00498602|529024659|FG001|Overall Study|Lack of Efficacy|0|||
146685364|NCT00498602|529024660|FG002|Overall Study|Lack of Efficacy|0|||
146685365|NCT00498602|529024661|FG003|Overall Study|Lack of Efficacy|0|||
146685366|NCT00498602|529024662|FG004|Overall Study|Lack of Efficacy|0|||
146685367|NCT00498602|529024663|FG005|Overall Study|Lack of Efficacy|0|||
146685368|NCT00498602|529024664|FG006|Overall Study|Lack of Efficacy|0|||
146685369|NCT00498602|529024658|FG000|Overall Study|Lost to Follow-up|0|||
146685370|NCT00498602|529024659|FG001|Overall Study|Lost to Follow-up|2|||
146685371|NCT00498602|529024660|FG002|Overall Study|Lost to Follow-up|0|||
146685372|NCT00498602|529024661|FG003|Overall Study|Lost to Follow-up|2|||
146685373|NCT00498602|529024662|FG004|Overall Study|Lost to Follow-up|0|||
146685374|NCT00498602|529024663|FG005|Overall Study|Lost to Follow-up|0|||
146685375|NCT00498602|529024664|FG006|Overall Study|Lost to Follow-up|0|||
146685376|NCT00498602|529024658|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
146685377|NCT00498602|529024659|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
146685378|NCT00498602|529024660|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
146685379|NCT00498602|529024661|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
146685380|NCT00498602|529024662|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
146685381|NCT00498602|529024663|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
146685382|NCT00498602|529024664|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
146685383|NCT00498602|529024658|FG000|Overall Study|AE not related to Study Drug|1|||
146685384|NCT00498602|529024659|FG001|Overall Study|AE not related to Study Drug|3|||
146685385|NCT00498602|529024660|FG002|Overall Study|AE not related to Study Drug|0|||
146685386|NCT00498602|529024661|FG003|Overall Study|AE not related to Study Drug|0|||
146685387|NCT00498602|529024662|FG004|Overall Study|AE not related to Study Drug|2|||
146685388|NCT00498602|529024663|FG005|Overall Study|AE not related to Study Drug|2|||
146685389|NCT00498602|529024664|FG006|Overall Study|AE not related to Study Drug|1|||
146685390|NCT00498602|529024658|FG000|Overall Study|Caregiver Request|2|||
146685391|NCT00498602|529024659|FG001|Overall Study|Caregiver Request|2|||
146685392|NCT00498602|529024660|FG002|Overall Study|Caregiver Request|2|||
146685393|NCT00498602|529024661|FG003|Overall Study|Caregiver Request|0|||
146685394|NCT00498602|529024662|FG004|Overall Study|Caregiver Request|1|||
146685395|NCT00498602|529024663|FG005|Overall Study|Caregiver Request|2|||
146685396|NCT00498602|529024664|FG006|Overall Study|Caregiver Request|0|||
146685397|NCT00498602|529024658|FG000|Overall Study|Investigator Request|0|||
146685398|NCT00498602|529024659|FG001|Overall Study|Investigator Request|0|||
146685399|NCT00498602|529024660|FG002|Overall Study|Investigator Request|1|||
146685400|NCT00498602|529024661|FG003|Overall Study|Investigator Request|0|||
146685401|NCT00498602|529024662|FG004|Overall Study|Investigator Request|0|||
146685402|NCT00498602|529024663|FG005|Overall Study|Investigator Request|0|||
146685403|NCT00498602|529024664|FG006|Overall Study|Investigator Request|0|||
146685404|NCT00498602|529024658|FG000|Overall Study|Subject Request|3|||
146685405|NCT00498602|529024659|FG001|Overall Study|Subject Request|0|||
146685406|NCT00498602|529024660|FG002|Overall Study|Subject Request|1|||
146685407|NCT00498602|529024661|FG003|Overall Study|Subject Request|1|||
146685408|NCT00498602|529024662|FG004|Overall Study|Subject Request|1|||
146685409|NCT00498602|529024663|FG005|Overall Study|Subject Request|4|||
146685410|NCT00498602|529024664|FG006|Overall Study|Subject Request|1|||
146927611|NCT00479557|529894651|FG002|Overall Study|Caregiver Request|2|||
146685411|NCT00498602|529024658|FG000|Overall Study|Other|2|||
146685412|NCT00498602|529024659|FG001|Overall Study|Other|3|||
146685413|NCT00498602|529024660|FG002|Overall Study|Other|1|||
146685414|NCT00498602|529024661|FG003|Overall Study|Other|0|||
146774846|NCT03088813|529346789|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
146927612|NCT00479557|529894652|FG003|Overall Study|Caregiver Request|0|||
146685415|NCT00498602|529024662|FG004|Overall Study|Other|0|||
146685416|NCT00498602|529024663|FG005|Overall Study|Other|3|||
146685417|NCT00498602|529024664|FG006|Overall Study|Other|0|||
146685418|NCT01113801|529024668|FG000|Overall Study|Adverse Event|4|||
146685419|NCT01113801|529024669|FG001|Overall Study|Adverse Event|0|||
146685420|NCT01113801|529024670|FG002|Overall Study|Adverse Event|2|||
146685421|NCT01113801|529024671|FG003|Overall Study|Adverse Event|6|||
146685422|NCT01113801|529024668|FG000|Overall Study|Death|4|||
146685423|NCT01113801|529024669|FG001|Overall Study|Death|5|||
146685424|NCT01113801|529024670|FG002|Overall Study|Death|3|||
146685425|NCT01113801|529024671|FG003|Overall Study|Death|4|||
146685426|NCT01113801|529024668|FG000|Overall Study|Protocol Violation|0|||
146685427|NCT01113801|529024669|FG001|Overall Study|Protocol Violation|1|||
146685428|NCT01113801|529024670|FG002|Overall Study|Protocol Violation|0|||
146685429|NCT01113801|529024671|FG003|Overall Study|Protocol Violation|0|||
146685430|NCT01113801|529024668|FG000|Overall Study|Withdrawal by Subject|9|||
146685431|NCT01113801|529024669|FG001|Overall Study|Withdrawal by Subject|7|||
146685432|NCT01113801|529024670|FG002|Overall Study|Withdrawal by Subject|7|||
146685433|NCT01113801|529024671|FG003|Overall Study|Withdrawal by Subject|8|||
146685434|NCT01113801|529024668|FG000|Overall Study|Physician Decision|2|||
146685435|NCT01113801|529024669|FG001|Overall Study|Physician Decision|2|||
146685436|NCT01113801|529024670|FG002|Overall Study|Physician Decision|3|||
146685437|NCT01113801|529024671|FG003|Overall Study|Physician Decision|3|||
146685438|NCT01113801|529024668|FG000|Overall Study|Sponsor Decision|15|||
146685439|NCT01113801|529024669|FG001|Overall Study|Sponsor Decision|21|||
146685440|NCT01113801|529024670|FG002|Overall Study|Sponsor Decision|20|||
146685441|NCT01113801|529024671|FG003|Overall Study|Sponsor Decision|15|||
146685442|NCT01113801|529024668|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
146685443|NCT01113801|529024669|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
146685444|NCT01113801|529024670|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
146685445|NCT01113801|529024671|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
146685446|NCT01949051|529024674|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
146685447|NCT01949051|529024675|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
146685448|NCT01949051|529024676|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
146685449|NCT01949051|529024677|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
146685450|NCT01949051|529024678|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
146685451|NCT01949051|529024679|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
146685452|NCT01949051|529024674|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
146685453|NCT01949051|529024675|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146685454|NCT01949051|529024676|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146685455|NCT01949051|529024677|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146685456|NCT01949051|529024678|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146685457|NCT01949051|529024679|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146685458|NCT01949051|529024674|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
146685459|NCT01949051|529024675|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
146685460|NCT01949051|529024676|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
146685461|NCT01949051|529024677|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
146685462|NCT01949051|529024678|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
146685463|NCT01949051|529024679|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
146685464|NCT01949051|529024674|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
146685465|NCT01949051|529024675|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
146685466|NCT01949051|529024676|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
146685467|NCT01949051|529024677|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
146685468|NCT01949051|529024678|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
146685469|NCT01949051|529024679|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
146685470|NCT01949051|529024674|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
146685471|NCT01949051|529024675|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
146685472|NCT01949051|529024676|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
146685473|NCT01949051|529024677|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
146685474|NCT01949051|529024678|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
146685475|NCT01949051|529024679|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
146685476|NCT04483011|529024681|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
146685477|NCT04483011|529024682|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
146685478|NCT03325075|529024683|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
146685479|NCT03325075|529024684|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
146685480|NCT03325075|529024685|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
146685481|NCT03325075|529024686|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
146685482|NCT03325075|529024683|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
146685483|NCT03325075|529024684|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
146685484|NCT03325075|529024685|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
146685485|NCT03325075|529024686|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
146685486|NCT03325075|529024683|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
146685487|NCT03325075|529024684|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
146685488|NCT03325075|529024685|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
146685489|NCT03325075|529024686|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
146685490|NCT01585194|529024689|FG000|Overall Study|Withdrawal by Subject|1|||
146685491|NCT01585194|529024689|FG000|Overall Study|Physician Decision|2|||
146685492|NCT01585194|529024689|FG000|Overall Study|Lack of insurance|1|||
146685493|NCT01333059|529024690|FG000|Overall Study|Physician Decision|3|||
146685494|NCT01333059|529024691|FG001|Overall Study|Physician Decision|3|||
146685495|NCT01333059|529024690|FG000|Overall Study|Protocol Violation|3|||
146685496|NCT01333059|529024691|FG001|Overall Study|Protocol Violation|0|||
146685497|NCT03035409|529024703|FG000|Overall Study|Adverse Event|5|||
146685498|NCT03035409|529024703|FG000|Overall Study|Death|2|||
146685499|NCT03035409|529024703|FG000|Overall Study|Withdrawal by Subject|2|||
146685500|NCT03035409|529024703|FG000|Overall Study|Non compliance|4|||
146685501|NCT03035409|529024703|FG000|Overall Study|Patient was jittery|1|||
146685502|NCT03035409|529024703|FG000|Overall Study|Did not like Questionnaire|1|||
146685503|NCT03035409|529024703|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
146685504|NCT03035409|529024703|FG000|Overall Study|Did not like taking drugs|1|||
146685505|NCT01405742|529024706|FG000|Overall Study|Lost to Follow-up|1|||
146685506|NCT01405742|529024707|FG001|Overall Study|Lost to Follow-up|0|||
146685507|NCT02056340|529024709|FG000|Overall Study|Lost to Follow-up|5|||
146685508|NCT02056340|529024710|FG001|Overall Study|Lost to Follow-up|5|||
146685509|NCT02056340|529024709|FG000|Overall Study|Withdrawal by Subject|2|||
146685510|NCT02056340|529024710|FG001|Overall Study|Withdrawal by Subject|6|||
146685511|NCT04900220|529024711|FG000|Overall Study|Lost to Follow-up|1|||
146685512|NCT04900220|529024712|FG001|Overall Study|Lost to Follow-up|1|||
146685513|NCT02028065|529024713|FG000|Randomization Through Start Treatment|Not treated|1|||
146685514|NCT02028065|529024714|FG001|Randomization Through Start Treatment|Not treated|3|||
146685515|NCT02028065|529024715|FG002|Randomization Through Start Treatment|Not treated|3|||
146685516|NCT02028065|529024713|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
146685517|NCT02028065|529024714|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
146685518|NCT02028065|529024715|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
146685519|NCT02028065|529024713|FG000|Treatment Through Study Completion|Physician Decision|1|||
146685520|NCT02028065|529024714|FG001|Treatment Through Study Completion|Physician Decision|0|||
146685521|NCT02028065|529024715|FG002|Treatment Through Study Completion|Physician Decision|0|||
146685522|NCT02028065|529024713|FG000|Treatment Through Study Completion|Protocol Violation|1|||
146685523|NCT02028065|529024714|FG001|Treatment Through Study Completion|Protocol Violation|4|||
146685524|NCT02028065|529024715|FG002|Treatment Through Study Completion|Protocol Violation|0|||
146685525|NCT02028065|529024713|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
146685526|NCT02028065|529024714|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
146685527|NCT02028065|529024715|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
146685528|NCT02028065|529024713|FG000|Treatment Through Study Completion|Adverse Event|3|||
146685529|NCT02028065|529024714|FG001|Treatment Through Study Completion|Adverse Event|3|||
146685530|NCT02028065|529024715|FG002|Treatment Through Study Completion|Adverse Event|5|||
146685531|NCT02107482|529024719|FG000|Overall Study|inconveinence|2|||
146685532|NCT02107482|529024719|FG000|Overall Study|Lost to Follow-up|1|||
146685533|NCT02107482|529024719|FG000|Overall Study|Lack of Efficacy|1|||
146685534|NCT00867009|529024720|FG000|Induction Period|Nonserious Adverse Event|5|||
146685535|NCT00867009|529024720|FG000|Induction Period|Serious Adverse Event|10|||
146685536|NCT00867009|529024720|FG000|Induction Period|Death due to serious adverse event|6|||
146685537|NCT00867009|529024720|FG000|Induction Period|Death due to Study Disease|4|||
146685538|NCT00867009|529024720|FG000|Induction Period|Protocol Violation|1|||
146685539|NCT00867009|529024720|FG000|Induction Period|Withdrawal by Subject|8|||
146685540|NCT00867009|529024720|FG000|Induction Period|Physician Decision|3|||
146685541|NCT00867009|529024720|FG000|Induction Period|Progressive Disease (PD)|25|||
146685542|NCT00867009|529024720|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
146685543|NCT03128892|529024723|FG000|Overall Study|Withdrawal by Subject|2|||
146685544|NCT03128892|529024723|FG000|Overall Study|Physician Decision|1|||
146685545|NCT01850524|529024726|FG000|Overall Study|Lost to Follow-up|5|||
146685546|NCT01850524|529024727|FG001|Overall Study|Lost to Follow-up|10|||
146685547|NCT01850524|529024726|FG000|Overall Study|Withdrawal by Subject|24|||
146685548|NCT01850524|529024727|FG001|Overall Study|Withdrawal by Subject|22|||
146685549|NCT01850524|529024726|FG000|Overall Study|Reason not Specified|142|||
146685550|NCT01850524|529024727|FG001|Overall Study|Reason not Specified|141|||
146685551|NCT00847704|529024728|FG000|Overall Study|Withdrawal by Subject|1|||
146685552|NCT02111850|529024729|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146685553|NCT02111850|529024730|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146685554|NCT02111850|529024731|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146685555|NCT02111850|529024732|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146685556|NCT02111850|529024733|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
146685557|NCT02111850|529024734|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146927613|NCT00479557|529894653|FG004|Overall Study|Caregiver Request|1|||
146685558|NCT02111850|529024735|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146685559|NCT02111850|529024736|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146685560|NCT02111850|529024737|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146927614|NCT00479557|529894654|FG005|Overall Study|Caregiver Request|2|||
146927615|NCT00479557|529894655|FG006|Overall Study|Caregiver Request|0|||
146927616|NCT00479557|529894649|FG000|Overall Study|Investigator Request|0|||
146927617|NCT00479557|529894650|FG001|Overall Study|Investigator Request|0|||
146736298|NCT00633932|529206804|FG001|Overall Study|Doctor's judgement|0|||
146927618|NCT00479557|529894651|FG002|Overall Study|Investigator Request|1|||
146685561|NCT02111850|529024738|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146685562|NCT02111850|529024739|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146685563|NCT02636868|529026573|FG000|Overall Study|Death|0|||
146685564|NCT02636868|529026574|FG001|Overall Study|Death|1|||
146685565|NCT02636868|529026575|FG002|Overall Study|Death|2|||
146685566|NCT03220217|529026576|FG000|Overall Study|Withdrawal by Subject|0|||
146685567|NCT03220217|529026577|FG001|Overall Study|Withdrawal by Subject|1|||
146685568|NCT03220217|529026578|FG002|Overall Study|Withdrawal by Subject|0|||
146685569|NCT03220217|529026576|FG000|Overall Study|Subject Missed Procedure|0|||
146685570|NCT03220217|529026577|FG001|Overall Study|Subject Missed Procedure|0|||
146685571|NCT03220217|529026578|FG002|Overall Study|Subject Missed Procedure|1|||
146685572|NCT03025542|529026579|FG000|Overall Study|Adverse Event|0|||
146685573|NCT03025542|529026580|FG001|Overall Study|Adverse Event|2|||
146685574|NCT03025542|529026579|FG000|Overall Study|Lost to Follow-up|1|||
146685575|NCT03025542|529026580|FG001|Overall Study|Lost to Follow-up|0|||
146685576|NCT03025542|529026579|FG000|Overall Study|Withdrawal by Subject|1|||
146685577|NCT03025542|529026580|FG001|Overall Study|Withdrawal by Subject|0|||
146685578|NCT00501293|529026581|FG000|Optimization Period|Enrolled in error|1|||
146685579|NCT00501293|529026582|FG001|Optimization Period|Enrolled in error|0|||
146685580|NCT00501293|529026581|FG000|Maintenance Period|Withdrawal by Subject|14|||
146685581|NCT00501293|529026582|FG001|Maintenance Period|Withdrawal by Subject|13|||
146685582|NCT00501293|529026581|FG000|Maintenance Period|Lost to Follow-up|12|||
146685583|NCT00501293|529026582|FG001|Maintenance Period|Lost to Follow-up|7|||
146685584|NCT00501293|529026581|FG000|Maintenance Period|Adverse Event|6|||
146685585|NCT00501293|529026582|FG001|Maintenance Period|Adverse Event|6|||
146685586|NCT00501293|529026581|FG000|Maintenance Period|Protocol Violation|2|||
146685587|NCT00501293|529026582|FG001|Maintenance Period|Protocol Violation|1|||
146685588|NCT00501293|529026581|FG000|Maintenance Period|Lack of Efficacy|4|||
146685589|NCT00501293|529026582|FG001|Maintenance Period|Lack of Efficacy|1|||
146685590|NCT00501293|529026581|FG000|Maintenance Period|Noncompliant with study medication|5|||
146685591|NCT00501293|529026582|FG001|Maintenance Period|Noncompliant with study medication|0|||
146685592|NCT00501293|529026581|FG000|Maintenance Period|Went into rehabilitation|1|||
146685593|NCT00501293|529026582|FG001|Maintenance Period|Went into rehabilitation|0|||
146685594|NCT00501293|529026581|FG000|Maintenance Period|Would not wear patch|1|||
146685595|NCT00501293|529026582|FG001|Maintenance Period|Would not wear patch|0|||
146685596|NCT00501293|529026581|FG000|Maintenance Period|Application site reaction|1|||
146685597|NCT00501293|529026582|FG001|Maintenance Period|Application site reaction|0|||
146685598|NCT00488345|529026583|FG000|Overall Study|Adverse Event|0|||
146685599|NCT00488345|529026584|FG001|Overall Study|Adverse Event|1|||
146685600|NCT00488345|529026585|FG002|Overall Study|Adverse Event|1|||
146685601|NCT00488345|529026583|FG000|Overall Study|Unable to administer antibiotics at home|0|||
146685602|NCT00488345|529026584|FG001|Overall Study|Unable to administer antibiotics at home|1|||
146685603|NCT00488345|529026585|FG002|Overall Study|Unable to administer antibiotics at home|0|||
146774847|NCT03088813|529346790|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
146685604|NCT00488345|529026583|FG000|Overall Study|Institutional Review Board review|0|||
146685605|NCT00488345|529026584|FG001|Overall Study|Institutional Review Board review|0|||
146685606|NCT00488345|529026585|FG002|Overall Study|Institutional Review Board review|1|||
146685607|NCT00488345|529026583|FG000|Overall Study|Surgical team recommendation|0|||
146685608|NCT00488345|529026584|FG001|Overall Study|Surgical team recommendation|1|||
146685609|NCT00488345|529026585|FG002|Overall Study|Surgical team recommendation|0|||
146685610|NCT00488345|529026583|FG000|Overall Study|Parent/legal guardian request|0|||
146774848|NCT03088813|529346791|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
146774849|NCT03088813|529346788|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
146774850|NCT03088813|529346789|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
146774851|NCT03088813|529346790|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
146774852|NCT03088813|529346791|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
146774853|NCT03613740|529346795|FG000|Overall Study|Lost to Follow-up|1|||
146774854|NCT03613740|529346796|FG001|Overall Study|Lost to Follow-up|1|||
146774855|NCT03575052|529346797|FG000|Overall Study|Adverse Event|6|||
146774856|NCT03575052|529346798|FG001|Overall Study|Adverse Event|10|||
146774857|NCT03575052|529346797|FG000|Overall Study|Not further specified|5|||
146774858|NCT03575052|529346798|FG001|Overall Study|Not further specified|7|||
146774859|NCT03575052|529346797|FG000|Overall Study|Withdrawal by Subject|5|||
146774860|NCT03575052|529346798|FG001|Overall Study|Withdrawal by Subject|6|||
146774861|NCT03575052|529346797|FG000|Overall Study|Lost to Follow-up|3|||
146774862|NCT03575052|529346798|FG001|Overall Study|Lost to Follow-up|0|||
146774863|NCT03575052|529346797|FG000|Overall Study|Death|2|||
146774864|NCT03575052|529346798|FG001|Overall Study|Death|1|||
146774865|NCT03575052|529346797|FG000|Overall Study|Lack of Efficacy|2|||
146774866|NCT03575052|529346798|FG001|Overall Study|Lack of Efficacy|1|||
146774867|NCT03575052|529346797|FG000|Overall Study|Study drug noncompliance|1|||
146774868|NCT03575052|529346798|FG001|Overall Study|Study drug noncompliance|2|||
146774869|NCT03575052|529346797|FG000|Overall Study|Protocol Violation|0|||
146774870|NCT03575052|529346798|FG001|Overall Study|Protocol Violation|2|||
146927619|NCT00479557|529894652|FG003|Overall Study|Investigator Request|0|||
146927620|NCT00479557|529894653|FG004|Overall Study|Investigator Request|0|||
146927621|NCT00479557|529894654|FG005|Overall Study|Investigator Request|0|||
146685611|NCT00488345|529026584|FG001|Overall Study|Parent/legal guardian request|1|||
146685612|NCT00488345|529026585|FG002|Overall Study|Parent/legal guardian request|1|||
146685613|NCT00903617|529026588|FG000|Overall Study|Adverse Event|0|||
146685614|NCT00903617|529026589|FG001|Overall Study|Adverse Event|1|||
146685615|NCT00903617|529026590|FG002|Overall Study|Adverse Event|1|||
146685616|NCT00903617|529026591|FG003|Overall Study|Adverse Event|0|||
146685617|NCT00903617|529026588|FG000|Overall Study|Protocol-defined stopping criteria|0|||
146685618|NCT00903617|529026589|FG001|Overall Study|Protocol-defined stopping criteria|2|||
146685619|NCT00903617|529026590|FG002|Overall Study|Protocol-defined stopping criteria|0|||
146685620|NCT00903617|529026591|FG003|Overall Study|Protocol-defined stopping criteria|0|||
146685621|NCT00903617|529026588|FG000|Overall Study|Lost to Follow-up|2|||
146685622|NCT00903617|529026589|FG001|Overall Study|Lost to Follow-up|0|||
146685623|NCT00903617|529026590|FG002|Overall Study|Lost to Follow-up|1|||
146685624|NCT00903617|529026591|FG003|Overall Study|Lost to Follow-up|1|||
146685625|NCT00903617|529026588|FG000|Overall Study|Withdrawal by Subject|1|||
146685626|NCT00903617|529026589|FG001|Overall Study|Withdrawal by Subject|2|||
146685627|NCT00903617|529026590|FG002|Overall Study|Withdrawal by Subject|3|||
146685628|NCT00903617|529026591|FG003|Overall Study|Withdrawal by Subject|0|||
146685629|NCT03518073|529026592|FG000|Overall Study|Adverse Event|2|||
146685630|NCT03518073|529026593|FG001|Overall Study|Adverse Event|4|||
146685631|NCT03518073|529026594|FG002|Overall Study|Adverse Event|2|||
146685632|NCT03518073|529026592|FG000|Overall Study|Death|2|||
146685633|NCT03518073|529026593|FG001|Overall Study|Death|1|||
146685634|NCT03518073|529026594|FG002|Overall Study|Death|3|||
146685635|NCT03518073|529026592|FG000|Overall Study|Lost to Follow-up|1|||
146685636|NCT03518073|529026593|FG001|Overall Study|Lost to Follow-up|0|||
146685637|NCT03518073|529026594|FG002|Overall Study|Lost to Follow-up|1|||
146685638|NCT03518073|529026592|FG000|Overall Study|Physician Decision|5|||
146685639|NCT03518073|529026593|FG001|Overall Study|Physician Decision|0|||
146685640|NCT03518073|529026594|FG002|Overall Study|Physician Decision|2|||
146685641|NCT03518073|529026592|FG000|Overall Study|Progressive disease|1|||
146685642|NCT03518073|529026593|FG001|Overall Study|Progressive disease|1|||
146685643|NCT03518073|529026594|FG002|Overall Study|Progressive disease|1|||
146685644|NCT03518073|529026592|FG000|Overall Study|Protocol Violation|1|||
146685645|NCT03518073|529026593|FG001|Overall Study|Protocol Violation|0|||
146685646|NCT03518073|529026594|FG002|Overall Study|Protocol Violation|0|||
146685647|NCT03518073|529026592|FG000|Overall Study|Withdrawal by Subject|30|||
146685648|NCT03518073|529026593|FG001|Overall Study|Withdrawal by Subject|34|||
146685649|NCT03518073|529026594|FG002|Overall Study|Withdrawal by Subject|29|||
146685650|NCT03518073|529026592|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
146685651|NCT03518073|529026593|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
146685652|NCT03518073|529026594|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
146685653|NCT03518073|529026592|FG000|Overall Study|Covid-19|1|||
146685654|NCT03518073|529026593|FG001|Overall Study|Covid-19|2|||
146685655|NCT03518073|529026594|FG002|Overall Study|Covid-19|1|||
146685656|NCT03045081|529026595|FG000|Overall Study|Withdrawal by Subject|6|||
146685657|NCT03045081|529026596|FG001|Overall Study|Withdrawal by Subject|11|||
146685658|NCT00475176|529026597|FG000|Overall Study|Adverse Event|2|||
146685659|NCT00475176|529026597|FG000|Overall Study|Withdrawal by Subject|1|||
146685660|NCT00475176|529026597|FG000|Overall Study|Protocol Violation|1|||
146685661|NCT01853046|529026598|FG000|Overall Study|Withdrawal by Subject|1|||
146685662|NCT01853046|529026599|FG001|Overall Study|Withdrawal by Subject|1|||
146685663|NCT01853046|529026598|FG000|Overall Study|Adverse Event|4|||
146685664|NCT01853046|529026599|FG001|Overall Study|Adverse Event|2|||
146685665|NCT01853046|529026598|FG000|Overall Study|Disease progression|13|||
146685666|NCT01853046|529026599|FG001|Overall Study|Disease progression|3|||
146685667|NCT00708162|529026603|FG000|Randomized Phase|Randomized but Not Treated|7|||
146685668|NCT00708162|529026604|FG001|Randomized Phase|Randomized but Not Treated|5|||
146927622|NCT00479557|529894655|FG006|Overall Study|Investigator Request|0|||
146927623|NCT00479557|529894649|FG000|Overall Study|Subject Request|3|||
146685669|NCT00708162|529026603|FG000|Randomized Phase|Participant Noncompliance|40|||
146685670|NCT00708162|529026604|FG001|Randomized Phase|Participant Noncompliance|32|||
146685671|NCT00708162|529026603|FG000|Randomized Phase|Lost to Follow-up|34|||
146685672|NCT00708162|529026604|FG001|Randomized Phase|Lost to Follow-up|34|||
146685673|NCT00708162|529026603|FG000|Randomized Phase|Withdrew Consent|31|||
146685674|NCT00708162|529026604|FG001|Randomized Phase|Withdrew Consent|22|||
146685675|NCT00708162|529026603|FG000|Randomized Phase|Lack of Efficacy|14|||
146685676|NCT00708162|529026604|FG001|Randomized Phase|Lack of Efficacy|19|||
146685677|NCT00708162|529026603|FG000|Randomized Phase|Protocol Violation|10|||
146685678|NCT00708162|529026604|FG001|Randomized Phase|Protocol Violation|11|||
146685679|NCT00708162|529026603|FG000|Randomized Phase|Adverse Event|8|||
146927624|NCT00479557|529894650|FG001|Overall Study|Subject Request|0|||
146685680|NCT00708162|529026604|FG001|Randomized Phase|Adverse Event|12|||
146927625|NCT00479557|529894651|FG002|Overall Study|Subject Request|1|||
146927626|NCT00479557|529894652|FG003|Overall Study|Subject Request|1|||
146685681|NCT00708162|529026603|FG000|Randomized Phase|Investigator's Discretion|7|||
146685682|NCT00708162|529026604|FG001|Randomized Phase|Investigator's Discretion|10|||
146927627|NCT00479557|529894653|FG004|Overall Study|Subject Request|1|||
146927628|NCT00479557|529894654|FG005|Overall Study|Subject Request|4|||
146927629|NCT00479557|529894655|FG006|Overall Study|Subject Request|1|||
146685683|NCT00708162|529026603|FG000|Randomized Phase|Death|2|||
146685684|NCT00708162|529026604|FG001|Randomized Phase|Death|9|||
146685685|NCT00708162|529026603|FG000|Randomized Phase|Pregnancy|3|||
146685686|NCT00708162|529026604|FG001|Randomized Phase|Pregnancy|0|||
146685687|NCT00708162|529026603|FG000|Open-Label Phase|Lost to Follow-up|10|||
146685688|NCT00708162|529026604|FG001|Open-Label Phase|Lost to Follow-up|8|||
146685689|NCT00708162|529026603|FG000|Open-Label Phase|Withdrew Consent|12|||
146685690|NCT00708162|529026604|FG001|Open-Label Phase|Withdrew Consent|6|||
146685691|NCT00708162|529026603|FG000|Open-Label Phase|Participant Noncompliance|7|||
146685692|NCT00708162|529026604|FG001|Open-Label Phase|Participant Noncompliance|7|||
146685693|NCT00708162|529026603|FG000|Open-Label Phase|Lack of Efficacy|7|||
146685694|NCT00708162|529026604|FG001|Open-Label Phase|Lack of Efficacy|4|||
146685695|NCT00708162|529026603|FG000|Open-Label Phase|Investigator's Discretion|3|||
146685696|NCT00708162|529026604|FG001|Open-Label Phase|Investigator's Discretion|2|||
146685697|NCT00708162|529026603|FG000|Open-Label Phase|Death|3|||
146685698|NCT00708162|529026604|FG001|Open-Label Phase|Death|1|||
146685699|NCT00708162|529026603|FG000|Open-Label Phase|Adverse Event|1|||
146685700|NCT00708162|529026604|FG001|Open-Label Phase|Adverse Event|2|||
146685701|NCT00708162|529026603|FG000|Open-Label Phase|Other|1|||
146685702|NCT00708162|529026604|FG001|Open-Label Phase|Other|0|||
146685703|NCT00065507|529026608|FG000|Overall Study|Death|16|||
146685704|NCT00065507|529026609|FG001|Overall Study|Death|17|||
146685705|NCT00065507|529026608|FG000|Overall Study|Adverse Event|4|||
146685706|NCT00065507|529026609|FG001|Overall Study|Adverse Event|3|||
146685707|NCT00065507|529026608|FG000|Overall Study|Lack of Efficacy|0|||
146685708|NCT00065507|529026609|FG001|Overall Study|Lack of Efficacy|6|||
146685709|NCT00065507|529026608|FG000|Overall Study|Poor/Non-compliance|3|||
146685710|NCT00065507|529026609|FG001|Overall Study|Poor/Non-compliance|2|||
146685711|NCT00065507|529026608|FG000|Overall Study|Lost to Follow-up|3|||
146685712|NCT00065507|529026609|FG001|Overall Study|Lost to Follow-up|0|||
146685713|NCT00065507|529026608|FG000|Overall Study|Subject Withdrew Consent|2|||
146685714|NCT00065507|529026609|FG001|Overall Study|Subject Withdrew Consent|1|||
146685715|NCT00065507|529026608|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
146685716|NCT00065507|529026609|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
146685717|NCT00100815|529026610|FG000|Overall Study|Progression|24|||
146685718|NCT00100815|529026610|FG000|Overall Study|Adverse Event|18|||
146685719|NCT00100815|529026610|FG000|Overall Study|Death|4|||
146685720|NCT00100815|529026610|FG000|Overall Study|Other|3|||
146685721|NCT01475331|529026611|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
146685722|NCT01475331|529026612|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
146685723|NCT01475331|529026611|FG000|Overall Study|excessive main duct communication|1|||
146685724|NCT01475331|529026612|FG001|Overall Study|excessive main duct communication|1|||
146685725|NCT01475331|529026611|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
146685726|NCT01475331|529026612|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
146685727|NCT01475331|529026611|FG000|Overall Study|Sign of malignancy during the procedure|2|||
146685728|NCT01475331|529026612|FG001|Overall Study|Sign of malignancy during the procedure|0|||
146685729|NCT01475331|529026611|FG000|Overall Study|cyst found to be prohibitively small|0|||
146685730|NCT01475331|529026612|FG001|Overall Study|cyst found to be prohibitively small|1|||
146685731|NCT00462761|529026613|FG000|Overall Study|Adverse Event|6|||
146685732|NCT00462761|529026613|FG000|Overall Study|Withdrawal by Subject|9|||
146685733|NCT00462761|529026613|FG000|Overall Study|Physician Decision|5|||
146685734|NCT00462761|529026613|FG000|Overall Study|Disease progression|43|||
146685735|NCT00462761|529026613|FG000|Overall Study|Death|12|||
146685736|NCT00462761|529026613|FG000|Overall Study|Other|1|||
146685737|NCT01244906|529026614|FG000|Overall Study|Death|2|||
146685738|NCT01244906|529026614|FG000|Overall Study|Progression of disease post treatment|6|||
146685739|NCT03480750|529026615|FG000|Overall Study|Withdrawal by Subject|0|||
146685740|NCT03480750|529026616|FG001|Overall Study|Withdrawal by Subject|1|||
146685741|NCT03480750|529026617|FG002|Overall Study|Withdrawal by Subject|0|||
146685742|NCT03480750|529026618|FG003|Overall Study|Withdrawal by Subject|0|||
146927630|NCT00479557|529894649|FG000|Overall Study|Other|2|||
146685743|NCT03480750|529026619|FG004|Overall Study|Withdrawal by Subject|0|||
146685744|NCT03480750|529026620|FG005|Overall Study|Withdrawal by Subject|0|||
146685745|NCT03480750|529026615|FG000|Overall Study|The interruption in Trientine shippment|0|||
146685746|NCT03480750|529026616|FG001|Overall Study|The interruption in Trientine shippment|0|||
146685747|NCT03480750|529026617|FG002|Overall Study|The interruption in Trientine shippment|0|||
146685748|NCT03480750|529026618|FG003|Overall Study|The interruption in Trientine shippment|0|||
146927631|NCT00479557|529894650|FG001|Overall Study|Other|3|||
146685749|NCT03480750|529026619|FG004|Overall Study|The interruption in Trientine shippment|0|||
146685750|NCT03480750|529026620|FG005|Overall Study|The interruption in Trientine shippment|1|||
146927632|NCT00479557|529894651|FG002|Overall Study|Other|1|||
146927633|NCT00479557|529894652|FG003|Overall Study|Other|0|||
146927634|NCT00479557|529894653|FG004|Overall Study|Other|0|||
146927635|NCT00479557|529894654|FG005|Overall Study|Other|3|||
146927636|NCT00479557|529894655|FG006|Overall Study|Other|0|||
146927637|NCT02509494|529894658|FG000|Overall Study|Lost to Follow-up|8|||
146927638|NCT02509494|529894659|FG001|Overall Study|Lost to Follow-up|47|||
146927639|NCT02509494|529894660|FG002|Overall Study|Lost to Follow-up|19|||
146927640|NCT02509494|529894661|FG003|Overall Study|Lost to Follow-up|6|||
146927641|NCT02509494|529894662|FG004|Overall Study|Lost to Follow-up|3|||
146685751|NCT00723892|529026621|FG000|Overall Study|Participant not tracked|33|||
146685752|NCT00723892|529026622|FG001|Overall Study|Participant not tracked|35|||
146685753|NCT00723892|529026621|FG000|Overall Study|Virological criterion|24|||
146685754|NCT00723892|529026622|FG001|Overall Study|Virological criterion|9|||
146685755|NCT00723892|529026621|FG000|Overall Study|Withdrawal by Subject|6|||
146685756|NCT00723892|529026622|FG001|Overall Study|Withdrawal by Subject|9|||
146685757|NCT00723892|529026621|FG000|Overall Study|End planned|11|||
146685758|NCT00723892|529026622|FG001|Overall Study|End planned|7|||
146685759|NCT00723892|529026621|FG000|Overall Study|Bad tolerance|5|||
146685760|NCT00723892|529026622|FG001|Overall Study|Bad tolerance|5|||
146685761|NCT00723892|529026621|FG000|Overall Study|Multiple reasons|17|||
146685762|NCT00723892|529026622|FG001|Overall Study|Multiple reasons|12|||
146685763|NCT00723892|529026621|FG000|Overall Study|Other|6|||
146685764|NCT00723892|529026622|FG001|Overall Study|Other|3|||
146685765|NCT00723892|529026621|FG000|Overall Study|Study end|1|||
146685766|NCT00723892|529026622|FG001|Overall Study|Study end|3|||
146685767|NCT00723892|529026621|FG000|Overall Study|Weight loss|1|||
146685768|NCT00723892|529026622|FG001|Overall Study|Weight loss|3|||
146685769|NCT00723892|529026621|FG000|Overall Study|Alcohol abuse|0|||
146685770|NCT00723892|529026622|FG001|Overall Study|Alcohol abuse|1|||
146685771|NCT00723892|529026621|FG000|Overall Study|Intercurrent infection|2|||
146685772|NCT00723892|529026622|FG001|Overall Study|Intercurrent infection|0|||
146685773|NCT00723892|529026621|FG000|Overall Study|Drug addiction|1|||
146685774|NCT00723892|529026622|FG001|Overall Study|Drug addiction|0|||
146685775|NCT04532099|529026623|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
146685776|NCT04532099|529026624|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
146685777|NCT04532099|529026625|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
146685778|NCT01506479|529026626|FG000|Overall Study|Lost to Follow-up|1|||
146685779|NCT01506479|529026627|FG001|Overall Study|Lost to Follow-up|2|||
146927642|NCT02509494|529894663|FG005|Overall Study|Lost to Follow-up|3|||
146927643|NCT02509494|529894664|FG006|Overall Study|Lost to Follow-up|1|||
146927644|NCT02509494|529894665|FG007|Overall Study|Lost to Follow-up|3|||
146927645|NCT02509494|529894666|FG008|Overall Study|Lost to Follow-up|1|||
146927646|NCT02509494|529894658|FG000|Overall Study|Physician Decision|2|||
146927647|NCT02509494|529894659|FG001|Overall Study|Physician Decision|1|||
146927648|NCT02509494|529894660|FG002|Overall Study|Physician Decision|0|||
146927649|NCT02509494|529894661|FG003|Overall Study|Physician Decision|0|||
146927650|NCT02509494|529894662|FG004|Overall Study|Physician Decision|0|||
146927651|NCT02509494|529894663|FG005|Overall Study|Physician Decision|0|||
146927652|NCT02509494|529894664|FG006|Overall Study|Physician Decision|0|||
146927653|NCT02509494|529894665|FG007|Overall Study|Physician Decision|0|||
146927654|NCT02509494|529894666|FG008|Overall Study|Physician Decision|0|||
146927655|NCT02509494|529894658|FG000|Overall Study|Withdrawal by Subject|4|||
146927656|NCT02509494|529894659|FG001|Overall Study|Withdrawal by Subject|17|||
146927657|NCT02509494|529894660|FG002|Overall Study|Withdrawal by Subject|7|||
146927658|NCT02509494|529894661|FG003|Overall Study|Withdrawal by Subject|5|||
146927659|NCT02509494|529894662|FG004|Overall Study|Withdrawal by Subject|0|||
146927660|NCT02509494|529894663|FG005|Overall Study|Withdrawal by Subject|6|||
146685780|NCT01506479|529026628|FG002|Overall Study|Lost to Follow-up|2|||
146685781|NCT01506479|529026626|FG000|Overall Study|Withdrawal by Subject|1|||
146927661|NCT02509494|529894664|FG006|Overall Study|Withdrawal by Subject|1|||
146685782|NCT01506479|529026627|FG001|Overall Study|Withdrawal by Subject|2|||
146927662|NCT02509494|529894665|FG007|Overall Study|Withdrawal by Subject|2|||
146927663|NCT02509494|529894666|FG008|Overall Study|Withdrawal by Subject|1|||
146927664|NCT02509494|529894658|FG000|Overall Study|Death|0|||
146978910|NCT01078623|530085506|FG010|Treatment Period 4|Adverse Event|0|||
146685783|NCT01506479|529026628|FG002|Overall Study|Withdrawal by Subject|1|||
146927665|NCT02509494|529894659|FG001|Overall Study|Death|1|||
146927666|NCT02509494|529894660|FG002|Overall Study|Death|0|||
146927667|NCT02509494|529894661|FG003|Overall Study|Death|0|||
146927668|NCT02509494|529894662|FG004|Overall Study|Death|1|||
146927669|NCT02509494|529894663|FG005|Overall Study|Death|0|||
146927670|NCT02509494|529894664|FG006|Overall Study|Death|0|||
146685784|NCT01506479|529026626|FG000|Overall Study|Missing assessment|1|||
146927671|NCT02509494|529894665|FG007|Overall Study|Death|1|||
146927672|NCT02509494|529894666|FG008|Overall Study|Death|0|||
146927673|NCT02509494|529894658|FG000|Overall Study|Other|0|||
146978911|NCT01078623|530085507|FG011|Treatment Period 4|Adverse Event|0|||
146685785|NCT01506479|529026627|FG001|Overall Study|Missing assessment|0|||
146685786|NCT01506479|529026628|FG002|Overall Study|Missing assessment|0|||
146685787|NCT01506479|529026626|FG000|Overall Study|Adverse Event|0|||
146927674|NCT02509494|529894659|FG001|Overall Study|Other|4|||
146685788|NCT01506479|529026627|FG001|Overall Study|Adverse Event|1|||
146685789|NCT01506479|529026628|FG002|Overall Study|Adverse Event|0|||
146685790|NCT01846507|529026629|FG000|Overall Study|Lost to Follow-up|4|||
146685791|NCT01846507|529026629|FG000|Overall Study|Protocol Violation|1|||
146685792|NCT01846507|529026629|FG000|Overall Study|Missing data|2|||
146685793|NCT01782859|529026630|FG000|Overall Study|Protocol Violation|6|||
146685794|NCT01782859|529026631|FG001|Overall Study|Protocol Violation|6|||
146685795|NCT01782859|529026630|FG000|Overall Study|Withdrawal by Subject|0|||
146685796|NCT01782859|529026631|FG001|Overall Study|Withdrawal by Subject|1|||
146685797|NCT02611778|529026638|FG000|Overall Study|Withdrawal by Subject|2|||
146685798|NCT02611778|529026639|FG001|Overall Study|Withdrawal by Subject|8|||
146685799|NCT02611778|529026638|FG000|Overall Study|Adverse Event|1|||
146685800|NCT02611778|529026639|FG001|Overall Study|Adverse Event|2|||
146685801|NCT02611778|529026638|FG000|Overall Study|Death|2|||
146685802|NCT02611778|529026639|FG001|Overall Study|Death|1|||
146685803|NCT02611778|529026638|FG000|Overall Study|Protocol Violation|1|||
146685804|NCT02611778|529026639|FG001|Overall Study|Protocol Violation|0|||
146685805|NCT02611778|529026638|FG000|Overall Study|Lost to Follow-up|3|||
146685806|NCT02611778|529026639|FG001|Overall Study|Lost to Follow-up|1|||
146685807|NCT02611778|529026638|FG000|Overall Study|Need for alternative treatment|1|||
146685808|NCT02611778|529026639|FG001|Overall Study|Need for alternative treatment|0|||
146685809|NCT02611778|529026638|FG000|Overall Study|Other Reason|2|||
146685810|NCT02611778|529026639|FG001|Overall Study|Other Reason|1|||
146685811|NCT02746874|529026640|FG000|Overall Study|Withdrawal by Subject|0|||
146685812|NCT02746874|529026641|FG001|Overall Study|Withdrawal by Subject|1|||
146685813|NCT02746874|529026640|FG000|Overall Study|Surgery Date Changed|0|||
146685814|NCT02746874|529026641|FG001|Overall Study|Surgery Date Changed|2|||
146685815|NCT00276159|529026648|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
146685816|NCT02426892|529026659|FG000|Overall Study|Adverse Event|2|||
146685817|NCT02426892|529026659|FG000|Overall Study|Lack of Efficacy|17|||
146685818|NCT02426892|529026659|FG000|Overall Study|Withdrawal by Subject|1|||
146685819|NCT03402386|529026663|FG000|Overall Study|Adverse Event|3|||
146685820|NCT03402386|529026663|FG000|Overall Study|Physician Decision|1|||
146685821|NCT03402386|529026663|FG000|Overall Study|Difficult to control Hb|2|||
146685822|NCT01896531|529026664|FG000|Overall Study|Death|57|||
146685823|NCT01896531|529026665|FG001|Overall Study|Death|59|||
146685824|NCT01896531|529026664|FG000|Overall Study|Lost to Follow-up|3|||
146685825|NCT01896531|529026665|FG001|Overall Study|Lost to Follow-up|0|||
146685826|NCT01896531|529026664|FG000|Overall Study|Non-compliance|0|||
146685827|NCT01896531|529026665|FG001|Overall Study|Non-compliance|1|||
146685828|NCT01896531|529026664|FG000|Overall Study|Study Ended by Sponsor|7|||
146685829|NCT01896531|529026665|FG001|Overall Study|Study Ended by Sponsor|20|||
146685830|NCT01896531|529026664|FG000|Overall Study|Withdrawal by Subject|3|||
146685831|NCT01896531|529026665|FG001|Overall Study|Withdrawal by Subject|2|||
146685832|NCT01896531|529026664|FG000|Overall Study|Death Prior to Treatment|1|||
146685833|NCT01896531|529026665|FG001|Overall Study|Death Prior to Treatment|0|||
146685834|NCT00268996|529026666|FG000|Overall Study|Adverse Event|11|||
146685835|NCT00268996|529026667|FG001|Overall Study|Adverse Event|7|||
146685836|NCT00268996|529026666|FG000|Overall Study|Lost to Follow-up|3|||
146685837|NCT00268996|529026667|FG001|Overall Study|Lost to Follow-up|1|||
146685838|NCT00268996|529026666|FG000|Overall Study|Withdrawal by Subject|5|||
146685839|NCT00268996|529026667|FG001|Overall Study|Withdrawal by Subject|11|||
146685840|NCT00268996|529026666|FG000|Overall Study|Non-compliance|1|||
146685841|NCT00268996|529026667|FG001|Overall Study|Non-compliance|0|||
146685842|NCT00268996|529026666|FG000|Overall Study|Other|1|||
146685843|NCT00268996|529026667|FG001|Overall Study|Other|1|||
146685844|NCT02956486|529026668|FG000|Core Phase|Adverse Event|51|||
146685845|NCT02956486|529026669|FG001|Core Phase|Adverse Event|88|||
146685846|NCT02956486|529026670|FG002|Core Phase|Adverse Event|0|||
146685847|NCT02956486|529026668|FG000|Core Phase|Lost to Follow-up|8|||
146685848|NCT02956486|529026669|FG001|Core Phase|Lost to Follow-up|6|||
146685849|NCT02956486|529026670|FG002|Core Phase|Lost to Follow-up|0|||
146685850|NCT02956486|529026668|FG000|Core Phase|Inadequate therapeutic effect|4|||
146685851|NCT02956486|529026669|FG001|Core Phase|Inadequate therapeutic effect|5|||
146685852|NCT02956486|529026670|FG002|Core Phase|Inadequate therapeutic effect|0|||
146685853|NCT02956486|529026668|FG000|Core Phase|Withdrawal by Subject|101|||
146685854|NCT02956486|529026669|FG001|Core Phase|Withdrawal by Subject|104|||
146685855|NCT02956486|529026670|FG002|Core Phase|Withdrawal by Subject|0|||
146685856|NCT02956486|529026668|FG000|Core Phase|Study terminated by sponsor|888|||
146685857|NCT02956486|529026669|FG001|Core Phase|Study terminated by sponsor|848|||
146685858|NCT02956486|529026670|FG002|Core Phase|Study terminated by sponsor|0|||
146685859|NCT02956486|529026668|FG000|Core Phase|Other|27|||
146685860|NCT02956486|529026669|FG001|Core Phase|Other|18|||
146685861|NCT02956486|529026670|FG002|Core Phase|Other|0|||
146685862|NCT02956486|529026668|FG000|Core Phase|Not treated|0|||
146685863|NCT02956486|529026669|FG001|Core Phase|Not treated|3|||
146685864|NCT02956486|529026670|FG002|Core Phase|Not treated|0|||
146685865|NCT02956486|529026668|FG000|Extension Phase|Adverse Event|0|||
146685866|NCT02956486|529026669|FG001|Extension Phase|Adverse Event|0|||
146685867|NCT02956486|529026670|FG002|Extension Phase|Adverse Event|2|||
146685868|NCT02956486|529026668|FG000|Extension Phase|Study terminated by sponsor|0|||
146685869|NCT02956486|529026669|FG001|Extension Phase|Study terminated by sponsor|0|||
146685870|NCT02956486|529026670|FG002|Extension Phase|Study terminated by sponsor|16|||
146685871|NCT02956486|529026668|FG000|Extension Phase|Not Treated|0|||
146685872|NCT02956486|529026669|FG001|Extension Phase|Not Treated|0|||
146685873|NCT02956486|529026670|FG002|Extension Phase|Not Treated|1|||
146685874|NCT00422591|529026673|FG000|Overall Study|Physician Decision|4|||
146685875|NCT00422591|529026673|FG000|Overall Study|Withdrawal by Subject|2|||
146685876|NCT02377466|529026674|FG000|Overall Study|Other: Randomized and not treated|0|||
146685877|NCT02377466|529026675|FG001|Overall Study|Other: Randomized and not treated|2|||
146685878|NCT04210310|529026676|FG000|Overall Study|Lost to Follow-up|32|||
146685879|NCT04210310|529026677|FG001|Overall Study|Lost to Follow-up|1|||
146685880|NCT00330616|529026678|FG000|Overall Study|Adverse Event|13|||
146685881|NCT00330616|529026678|FG000|Overall Study|Lack of Efficacy|1|||
146685882|NCT00330616|529026678|FG000|Overall Study|Lost to Follow-up|2|||
146685883|NCT00330616|529026678|FG000|Overall Study|Withdrawal by Subject|4|||
146685884|NCT00330616|529026678|FG000|Overall Study|Other|1|||
146685885|NCT02617511|529026685|FG000|Overall Study|Withdrawal by Subject|1|||
146685886|NCT02617511|529026686|FG001|Overall Study|Withdrawal by Subject|0|||
146685887|NCT00255047|529026687|FG000|Overall Study|Serious Adverse Events|2|||
146685888|NCT00255047|529026688|FG001|Overall Study|Serious Adverse Events|1|||
146685889|NCT00255047|529026689|FG002|Overall Study|Serious Adverse Events|2|||
146685890|NCT00255047|529026690|FG003|Overall Study|Serious Adverse Events|1|||
146685891|NCT00255047|529026687|FG000|Overall Study|Adverse Event|0|||
146685892|NCT00255047|529026688|FG001|Overall Study|Adverse Event|3|||
146685893|NCT00255047|529026689|FG002|Overall Study|Adverse Event|2|||
146685894|NCT00255047|529026690|FG003|Overall Study|Adverse Event|1|||
146685895|NCT00255047|529026687|FG000|Overall Study|Protocol Violation|13|||
146685896|NCT00255047|529026688|FG001|Overall Study|Protocol Violation|13|||
146685897|NCT00255047|529026689|FG002|Overall Study|Protocol Violation|16|||
146685898|NCT00255047|529026690|FG003|Overall Study|Protocol Violation|20|||
146685899|NCT00255047|529026687|FG000|Overall Study|Lost to Follow-up|9|||
146685900|NCT00255047|529026688|FG001|Overall Study|Lost to Follow-up|8|||
146685901|NCT00255047|529026689|FG002|Overall Study|Lost to Follow-up|5|||
146685902|NCT00255047|529026690|FG003|Overall Study|Lost to Follow-up|6|||
146685903|NCT00255047|529026687|FG000|Overall Study|Withdrawal by Subject|24|||
146685904|NCT00255047|529026688|FG001|Overall Study|Withdrawal by Subject|23|||
146685905|NCT00255047|529026689|FG002|Overall Study|Withdrawal by Subject|25|||
146685906|NCT00255047|529026690|FG003|Overall Study|Withdrawal by Subject|18|||
146685907|NCT00811473|529026691|FG000|Overall Study|Adverse Event|3|||
146685908|NCT00811473|529026692|FG001|Overall Study|Adverse Event|12|||
146685909|NCT00811473|529026691|FG000|Overall Study|Lost to Follow-up|5|||
146685910|NCT00811473|529026692|FG001|Overall Study|Lost to Follow-up|1|||
146685911|NCT00811473|529026691|FG000|Overall Study|Withdrawal by Subject|2|||
146685912|NCT00811473|529026692|FG001|Overall Study|Withdrawal by Subject|4|||
146685913|NCT00811473|529026691|FG000|Overall Study|Severe non-compliance to protocol|2|||
146685914|NCT00811473|529026692|FG001|Overall Study|Severe non-compliance to protocol|4|||
146685915|NCT00811473|529026691|FG000|Overall Study|Lack of therapeutic response|4|||
146685916|NCT00811473|529026692|FG001|Overall Study|Lack of therapeutic response|1|||
146685917|NCT00811473|529026691|FG000|Overall Study|Condition under investigation worsened|1|||
146685918|NCT00811473|529026692|FG001|Overall Study|Condition under investigation worsened|3|||
146685919|NCT00811473|529026691|FG000|Overall Study|Other 2|4|||
146685920|NCT00811473|529026692|FG001|Overall Study|Other 2|1|||
146685921|NCT00811473|529026691|FG000|Overall Study|Incorrect Enrollment|1|||
146685922|NCT00811473|529026692|FG001|Overall Study|Incorrect Enrollment|0|||
146685923|NCT00811473|529026691|FG000|Overall Study|Safety Reasons|1|||
146685924|NCT00811473|529026692|FG001|Overall Study|Safety Reasons|0|||
146685925|NCT04446377|529026702|FG000|Overall Study|Withdrawal by Subject|6|||
146685926|NCT04446377|529026703|FG001|Overall Study|Withdrawal by Subject|1|||
146685927|NCT04446377|529026702|FG000|Overall Study|Physician Decision|1|||
146685928|NCT04446377|529026703|FG001|Overall Study|Physician Decision|1|||
146685929|NCT04446377|529026702|FG000|Overall Study|Lost to Follow-up|0|||
146685930|NCT04446377|529026703|FG001|Overall Study|Lost to Follow-up|2|||
146927675|NCT02509494|529894660|FG002|Overall Study|Other|5|||
146927676|NCT02509494|529894661|FG003|Overall Study|Other|0|||
146685931|NCT04446377|529026702|FG000|Overall Study|Not eligible|0|||
146685932|NCT04446377|529026703|FG001|Overall Study|Not eligible|1|||
146927677|NCT02509494|529894662|FG004|Overall Study|Other|0|||
146685933|NCT01187043|529026705|FG000|Overall Study|Adverse Event|0|||
146685934|NCT01187043|529026706|FG001|Overall Study|Adverse Event|0|||
146685935|NCT01187043|529026707|FG002|Overall Study|Adverse Event|0|||
146685936|NCT01187043|529026708|FG003|Overall Study|Adverse Event|0|||
146685937|NCT01187043|529026709|FG004|Overall Study|Adverse Event|1|||
146685938|NCT01187043|529026705|FG000|Overall Study|Unable to make scheduled visits|1|||
146927678|NCT02509494|529894663|FG005|Overall Study|Other|0|||
146685939|NCT01187043|529026706|FG001|Overall Study|Unable to make scheduled visits|0|||
146736299|NCT00633932|529206805|FG002|Overall Study|Doctor's judgement|0|||
146736300|NCT00633932|529206803|FG000|Overall Study|Moved Away|1|||
146978912|NCT01078623|530085508|FG012|Treatment Period 4|Adverse Event|0|||
146978913|NCT01078623|530085509|FG013|Treatment Period 4|Adverse Event|0|||
146685940|NCT01187043|529026707|FG002|Overall Study|Unable to make scheduled visits|4|||
146685941|NCT01187043|529026708|FG003|Overall Study|Unable to make scheduled visits|0|||
146685942|NCT01187043|529026709|FG004|Overall Study|Unable to make scheduled visits|1|||
146685943|NCT04903626|529026710|FG000|Overall Study|Lost to Follow-up|6|||
146685944|NCT04903626|529026710|FG000|Overall Study|Withdrawal by Subject|1|||
146685945|NCT04903626|529026710|FG000|Overall Study|Other, Not Specified|1|||
146685946|NCT00573534|529026711|FG000|Overall Study|oppositional behavior|3|||
146685947|NCT00927784|529026714|FG000|Overall Study|Death|1|||
146685948|NCT00927784|529026715|FG001|Overall Study|Death|0|||
146685949|NCT00927784|529026714|FG000|Overall Study|Withdrawal by Subject|1|||
146685950|NCT00927784|529026715|FG001|Overall Study|Withdrawal by Subject|0|||
146685951|NCT02457910|529026716|FG000|Overall Study|Withdrawal by Subject|0|||
146685952|NCT02457910|529026717|FG001|Overall Study|Withdrawal by Subject|0|||
146685953|NCT02457910|529026718|FG002|Overall Study|Withdrawal by Subject|0|||
146685954|NCT02457910|529026719|FG003|Overall Study|Withdrawal by Subject|0|||
146685955|NCT02457910|529026720|FG004|Overall Study|Withdrawal by Subject|0|||
146685956|NCT02457910|529026721|FG005|Overall Study|Withdrawal by Subject|1|||
146685957|NCT02457910|529026716|FG000|Overall Study|Adverse Event|0|||
146685958|NCT02457910|529026717|FG001|Overall Study|Adverse Event|2|||
146685959|NCT02457910|529026718|FG002|Overall Study|Adverse Event|1|||
146685960|NCT02457910|529026719|FG003|Overall Study|Adverse Event|1|||
146685961|NCT02457910|529026720|FG004|Overall Study|Adverse Event|1|||
146685962|NCT02457910|529026721|FG005|Overall Study|Adverse Event|3|||
146685963|NCT02457910|529026716|FG000|Overall Study|Disease progression|3|||
146685964|NCT02457910|529026717|FG001|Overall Study|Disease progression|3|||
146685965|NCT02457910|529026718|FG002|Overall Study|Disease progression|1|||
146685966|NCT02457910|529026719|FG003|Overall Study|Disease progression|1|||
146685967|NCT02457910|529026720|FG004|Overall Study|Disease progression|4|||
146685968|NCT02457910|529026721|FG005|Overall Study|Disease progression|6|||
146685969|NCT02457910|529026716|FG000|Overall Study|Other complicating illness|0|||
146685970|NCT02457910|529026717|FG001|Overall Study|Other complicating illness|0|||
146685971|NCT02457910|529026718|FG002|Overall Study|Other complicating illness|0|||
146685972|NCT02457910|529026719|FG003|Overall Study|Other complicating illness|0|||
146685973|NCT02457910|529026720|FG004|Overall Study|Other complicating illness|0|||
146685974|NCT02457910|529026721|FG005|Overall Study|Other complicating illness|1|||
146685975|NCT02457910|529026716|FG000|Overall Study|Death|0|||
146685976|NCT02457910|529026717|FG001|Overall Study|Death|0|||
146685977|NCT02457910|529026718|FG002|Overall Study|Death|1|||
146685978|NCT02457910|529026719|FG003|Overall Study|Death|0|||
146685979|NCT02457910|529026720|FG004|Overall Study|Death|0|||
146685980|NCT02457910|529026721|FG005|Overall Study|Death|0|||
146685981|NCT00467259|529026722|FG000|Overall Study|Adverse Event|24|||
146685982|NCT00467259|529026723|FG001|Overall Study|Adverse Event|90|||
146685983|NCT00467259|529026722|FG000|Overall Study|Protocol Violation|1|||
146685984|NCT00467259|529026723|FG001|Overall Study|Protocol Violation|7|||
146685985|NCT00467259|529026722|FG000|Overall Study|Withdrawal by Subject|34|||
146685986|NCT00467259|529026723|FG001|Overall Study|Withdrawal by Subject|108|||
146685987|NCT00467259|529026722|FG000|Overall Study|Physician Decision|0|||
146685988|NCT00467259|529026723|FG001|Overall Study|Physician Decision|2|||
146685989|NCT00467259|529026722|FG000|Overall Study|Lost to Follow-up|14|||
146685990|NCT00467259|529026723|FG001|Overall Study|Lost to Follow-up|34|||
146685991|NCT00467259|529026722|FG000|Overall Study|Site Closed|2|||
146685992|NCT00467259|529026723|FG001|Overall Study|Site Closed|1|||
146685993|NCT02196558|529026724|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
146685994|NCT02196558|529026725|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
146685995|NCT02196558|529026726|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
146685996|NCT02196558|529026724|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
146685997|NCT02196558|529026725|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
146685998|NCT02196558|529026726|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
146685999|NCT02196558|529026724|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
146686000|NCT02196558|529026725|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
146686001|NCT02196558|529026726|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
146978914|NCT01078623|530085510|FG014|Treatment Period 4|Adverse Event|0|||
146686002|NCT02196558|529026724|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
146686003|NCT02196558|529026725|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
146686004|NCT02196558|529026726|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
146686005|NCT02196558|529026724|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
146686006|NCT02196558|529026725|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
146686007|NCT02196558|529026726|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
146686008|NCT01846611|529026736|FG000|Overall Study|Lost to Follow-up|4|||
146686009|NCT01846611|529026737|FG001|Overall Study|Lost to Follow-up|6|||
146686010|NCT01846611|529026736|FG000|Overall Study|Withdrawal by Subject|15|||
146686011|NCT01846611|529026737|FG001|Overall Study|Withdrawal by Subject|19|||
146686012|NCT01846611|529026736|FG000|Overall Study|Other|19|||
146686013|NCT01846611|529026737|FG001|Overall Study|Other|18|||
146978915|NCT01078623|530085511|FG015|Treatment Period 4|Adverse Event|0|||
146927679|NCT02509494|529894664|FG006|Overall Study|Other|0|||
146927680|NCT02509494|529894665|FG007|Overall Study|Other|0|||
146927681|NCT02509494|529894666|FG008|Overall Study|Other|0|||
146927682|NCT02509494|529894658|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146686014|NCT00680043|529026738|FG000|Overall Study|Withdrawal by Subject|1|||
146686015|NCT00680043|529026739|FG001|Overall Study|Withdrawal by Subject|0|||
146686016|NCT00680043|529026740|FG002|Overall Study|Withdrawal by Subject|0|||
146686017|NCT00680043|529026738|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
146686018|NCT00680043|529026739|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
146686019|NCT00680043|529026740|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
146686020|NCT00680043|529026738|FG000|Overall Study|Renal Transplant|1|||
146686021|NCT00680043|529026739|FG001|Overall Study|Renal Transplant|0|||
146686022|NCT00680043|529026740|FG002|Overall Study|Renal Transplant|4|||
146686023|NCT03061331|529026741|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
146686024|NCT03061331|529026742|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
146686025|NCT01980875|529026743|FG000|Overall Study|Withdrew Consent|1|||
146686026|NCT01980875|529026744|FG001|Overall Study|Withdrew Consent|1|||
146686027|NCT01980875|529026745|FG002|Overall Study|Withdrew Consent|1|||
146686028|NCT01980875|529026743|FG000|Overall Study|Study Terminated by Sponsor|7|||
146686029|NCT01980875|529026744|FG001|Overall Study|Study Terminated by Sponsor|24|||
146686030|NCT01980875|529026745|FG002|Overall Study|Study Terminated by Sponsor|22|||
146686031|NCT01980875|529026743|FG000|Overall Study|Lost to Follow-up|0|||
146686032|NCT01980875|529026744|FG001|Overall Study|Lost to Follow-up|0|||
146686033|NCT01980875|529026745|FG002|Overall Study|Lost to Follow-up|1|||
146686034|NCT00513474|529026746|FG000|Overall Study|Death|6|||
146686035|NCT00513474|529026747|FG001|Overall Study|Death|9|||
146686036|NCT00513474|529026746|FG000|Overall Study|Participant Withdrew Consent|1|||
146686037|NCT00513474|529026747|FG001|Overall Study|Participant Withdrew Consent|0|||
146686038|NCT01686633|529026748|FG000|Overall Study|Lack of Efficacy|33|||
146686039|NCT01686633|529026749|FG001|Overall Study|Lack of Efficacy|13|||
146686040|NCT01686633|529026750|FG002|Overall Study|Lack of Efficacy|11|||
146686041|NCT01686633|529026748|FG000|Overall Study|Withdrawal by Subject|8|||
146686042|NCT01686633|529026749|FG001|Overall Study|Withdrawal by Subject|8|||
146686043|NCT01686633|529026750|FG002|Overall Study|Withdrawal by Subject|5|||
146686044|NCT01686633|529026748|FG000|Overall Study|Physician Decision|3|||
146686045|NCT01686633|529026749|FG001|Overall Study|Physician Decision|4|||
146686046|NCT01686633|529026750|FG002|Overall Study|Physician Decision|4|||
146686047|NCT01686633|529026748|FG000|Overall Study|Adverse Event|4|||
146686048|NCT01686633|529026749|FG001|Overall Study|Adverse Event|3|||
146686049|NCT01686633|529026750|FG002|Overall Study|Adverse Event|3|||
146686050|NCT01686633|529026748|FG000|Overall Study|Protocol Violation|2|||
146686051|NCT01686633|529026749|FG001|Overall Study|Protocol Violation|3|||
146686052|NCT01686633|529026750|FG002|Overall Study|Protocol Violation|0|||
146686053|NCT01686633|529026748|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
146686054|NCT01686633|529026749|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
146686055|NCT01686633|529026750|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
146686056|NCT01686633|529026748|FG000|Overall Study|Lost to Follow-up|0|||
146686057|NCT01686633|529026749|FG001|Overall Study|Lost to Follow-up|1|||
146686058|NCT01686633|529026750|FG002|Overall Study|Lost to Follow-up|1|||
146686059|NCT00195676|529026756|FG000|Period O - Open-label Treatment|Adverse Event|82|||
146686060|NCT00195676|529026756|FG000|Period O - Open-label Treatment|Death|6|||
146686061|NCT00195676|529026756|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
146686062|NCT00195676|529026756|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
146686063|NCT00195676|529026756|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
146686064|NCT00195676|529026756|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
146686065|NCT00195676|529026756|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
146686066|NCT00195676|529026756|FG000|Period O - Open-label Treatment|Other reasons|68|||
146686067|NCT00195676|529026756|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
146686068|NCT00195676|529026756|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
146686069|NCT00195676|529026756|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
146686070|NCT00195676|529026756|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
146686071|NCT00195676|529026756|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
146686072|NCT00195676|529026756|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
146686073|NCT00195676|529026756|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
146686074|NCT00195676|529026756|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
146686075|NCT00195676|529026756|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
146686076|NCT00195676|529026756|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
146686077|NCT00195676|529026756|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
146686078|NCT00195676|529026756|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
146927683|NCT02509494|529894659|FG001|Overall Study|Non-Compliance With Study Drug|11|||
146686079|NCT00195676|529026756|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
146927684|NCT02509494|529894660|FG002|Overall Study|Non-Compliance With Study Drug|7|||
146927685|NCT02509494|529894661|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146927686|NCT02509494|529894662|FG004|Overall Study|Non-Compliance With Study Drug|1|||
146686080|NCT03334903|529026758|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
146686081|NCT03334903|529026759|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
146686082|NCT03334903|529026758|FG000|Overall Study|Protocol Violation|1|||
146686083|NCT03334903|529026759|FG001|Overall Study|Protocol Violation|3|||
146686084|NCT03334903|529026758|FG000|Overall Study|Surgery postponed|1|||
146686085|NCT03334903|529026759|FG001|Overall Study|Surgery postponed|0|||
146686086|NCT03334903|529026758|FG000|Overall Study|Adverse Event|1|||
146686087|NCT03334903|529026759|FG001|Overall Study|Adverse Event|1|||
146686088|NCT03334903|529026758|FG000|Overall Study|Withdrawal by Subject|0|||
146686089|NCT03334903|529026759|FG001|Overall Study|Withdrawal by Subject|1|||
146686090|NCT02879305|529026760|FG000|Overall Study|Investigator Site Closed|55|||
146686091|NCT02879305|529026761|FG001|Overall Study|Investigator Site Closed|57|||
146686092|NCT02879305|529026760|FG000|Overall Study|Withdrawal by Subject|44|||
146686093|NCT02879305|529026761|FG001|Overall Study|Withdrawal by Subject|42|||
146686094|NCT02879305|529026760|FG000|Overall Study|Lost to Follow-up|17|||
146686095|NCT02879305|529026761|FG001|Overall Study|Lost to Follow-up|12|||
146686096|NCT02879305|529026760|FG000|Overall Study|Other|1|||
146686097|NCT02879305|529026761|FG001|Overall Study|Other|0|||
146686098|NCT00312494|529028253|FG000|Overall Study|Randomized; not treated with study drug|9|||
146686099|NCT00312494|529028254|FG001|Overall Study|Randomized; not treated with study drug|10|||
146686100|NCT00312494|529028255|FG002|Overall Study|Randomized; not treated with study drug|5|||
146686101|NCT00312494|529028253|FG000|Overall Study|Adverse Event|33|||
146686102|NCT00312494|529028254|FG001|Overall Study|Adverse Event|15|||
146686103|NCT00312494|529028255|FG002|Overall Study|Adverse Event|11|||
146686104|NCT00312494|529028253|FG000|Overall Study|Lack of Efficacy|4|||
146686105|NCT00312494|529028254|FG001|Overall Study|Lack of Efficacy|6|||
146686106|NCT00312494|529028255|FG002|Overall Study|Lack of Efficacy|8|||
146686107|NCT00312494|529028253|FG000|Overall Study|Laboratory abnormality|1|||
146686108|NCT00312494|529028254|FG001|Overall Study|Laboratory abnormality|0|||
146686109|NCT00312494|529028255|FG002|Overall Study|Laboratory abnormality|0|||
146686110|NCT00312494|529028253|FG000|Overall Study|Lost to Follow-up|8|||
146686111|NCT00312494|529028254|FG001|Overall Study|Lost to Follow-up|8|||
146686112|NCT00312494|529028255|FG002|Overall Study|Lost to Follow-up|8|||
146686113|NCT00312494|529028253|FG000|Overall Study|Withdrawal by Subject|6|||
146686114|NCT00312494|529028254|FG001|Overall Study|Withdrawal by Subject|9|||
146686115|NCT00312494|529028255|FG002|Overall Study|Withdrawal by Subject|10|||
146686116|NCT00312494|529028253|FG000|Overall Study|Other|10|||
146686117|NCT00312494|529028254|FG001|Overall Study|Other|10|||
146686118|NCT00312494|529028255|FG002|Overall Study|Other|1|||
146686119|NCT01104636|529028256|FG000|Overall Study|Lack of Efficacy|43|||
146686120|NCT01104636|529028256|FG000|Overall Study|Lost to Follow-up|24|||
146686121|NCT01104636|529028256|FG000|Overall Study|Withdrawal by Subject|4|||
146686122|NCT01104636|529028256|FG000|Overall Study|Other|43|||
146686123|NCT01104636|529028256|FG000|Overall Study|Study terminated by sponsor|1|||
146686124|NCT01104636|529028256|FG000|Overall Study|Pregnancy|2|||
146686125|NCT01104636|529028256|FG000|Overall Study|Adverse Event|40|||
146686126|NCT01104636|529028256|FG000|Overall Study|Ongoing|21|||
146686127|NCT01710033|529028261|FG000|Stage 2|Adverse Event|0|||
146686128|NCT01710033|529028262|FG001|Stage 2|Adverse Event|0|||
146686129|NCT01710033|529028263|FG002|Stage 2|Adverse Event|0|||
146686130|NCT01710033|529028264|FG003|Stage 2|Adverse Event|0|||
146686131|NCT01710033|529028265|FG004|Stage 2|Adverse Event|1|||
146686132|NCT01525550|529028266|FG000|Overall Study|Lost to Follow-up|8|||
146686133|NCT01525550|529028267|FG001|Overall Study|Lost to Follow-up|2|||
146927687|NCT02509494|529894663|FG005|Overall Study|Non-Compliance With Study Drug|2|||
146927688|NCT02509494|529894664|FG006|Overall Study|Non-Compliance With Study Drug|1|||
146927689|NCT02509494|529894665|FG007|Overall Study|Non-Compliance With Study Drug|1|||
146927690|NCT02509494|529894666|FG008|Overall Study|Non-Compliance With Study Drug|0|||
146927691|NCT01511107|529894667|FG000|Overall Study|Ineligible|3|||
146927692|NCT01511107|529894668|FG001|Overall Study|Ineligible|2|||
146927693|NCT01511107|529894667|FG000|Overall Study|Lost to Follow-up|10|||
146927694|NCT01511107|529894668|FG001|Overall Study|Lost to Follow-up|19|||
146686134|NCT01525550|529028266|FG000|Overall Study|Death|19|||
146927695|NCT01511107|529894667|FG000|Overall Study|Withdrawal by Subject|9|||
146927696|NCT01511107|529894668|FG001|Overall Study|Withdrawal by Subject|20|||
146927697|NCT04752189|529894669|FG000|Overall Study|Withdrawal by Subject|0|||
146978916|NCT01078623|530085512|FG016|Treatment Period 4|Adverse Event|0|||
146686135|NCT01525550|529028267|FG001|Overall Study|Death|28|||
146686136|NCT01525550|529028266|FG000|Overall Study|Other|0|||
146686137|NCT01525550|529028267|FG001|Overall Study|Other|4|||
146686138|NCT01525550|529028266|FG000|Overall Study|Sponsor's Decision|30|||
146686139|NCT01525550|529028267|FG001|Overall Study|Sponsor's Decision|11|||
146686140|NCT01525550|529028266|FG000|Overall Study|Withdrawal by Subject|4|||
146686141|NCT01525550|529028267|FG001|Overall Study|Withdrawal by Subject|0|||
146686142|NCT02877082|529028268|FG000|Overall Study|Trial was closed early|5|||
146686143|NCT04984993|529028269|FG000|Overall Study|Withdrawal by Subject|8|||
146686144|NCT04984993|529028270|FG001|Overall Study|Withdrawal by Subject|2|||
146686145|NCT04984993|529028269|FG000|Overall Study|Lost to Follow-up|2|||
146927698|NCT04752189|529894670|FG001|Overall Study|Withdrawal by Subject|150|||
146686146|NCT04984993|529028270|FG001|Overall Study|Lost to Follow-up|2|||
146686147|NCT04984993|529028269|FG000|Overall Study|Both patients moved to another country|4|||
146686148|NCT04984993|529028270|FG001|Overall Study|Both patients moved to another country|0|||
146686149|NCT03318315|529028271|FG000|Overall Study|Lost to Follow-up|3|||
146686150|NCT03318315|529028272|FG001|Overall Study|Lost to Follow-up|2|||
146686151|NCT03318315|529028273|FG002|Overall Study|Lost to Follow-up|1|||
146686152|NCT03318315|529028271|FG000|Overall Study|Protocol Violation|1|||
146927699|NCT04752189|529894669|FG000|Overall Study|Lost to Follow-up|261|||
146927700|NCT04752189|529894670|FG001|Overall Study|Lost to Follow-up|126|||
146927701|NCT01274338|529895997|FG000|Overall Study|Lack of Efficacy|72|||
146686153|NCT03318315|529028272|FG001|Overall Study|Protocol Violation|1|||
146686154|NCT03318315|529028273|FG002|Overall Study|Protocol Violation|1|||
146686155|NCT03318315|529028271|FG000|Overall Study|Withdrawal by Subject|0|||
146686156|NCT03318315|529028272|FG001|Overall Study|Withdrawal by Subject|0|||
146686157|NCT03318315|529028273|FG002|Overall Study|Withdrawal by Subject|2|||
146686158|NCT02436356|529028274|FG000|Overall Study|Excluded by MRI Screening|0|||
146686159|NCT02436356|529028275|FG001|Overall Study|Excluded by MRI Screening|0|||
146686160|NCT02436356|529028276|FG002|Overall Study|Excluded by MRI Screening|2|||
146686161|NCT02436356|529028274|FG000|Overall Study|Lost to Follow-up|0|||
146686162|NCT02436356|529028275|FG001|Overall Study|Lost to Follow-up|1|||
146686163|NCT02436356|529028276|FG002|Overall Study|Lost to Follow-up|0|||
146686164|NCT02436356|529028274|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
146686165|NCT02436356|529028275|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
146686166|NCT02436356|529028276|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
146686167|NCT02436356|529028274|FG000|Overall Study|Excluded due to other medical conditions|3|||
146686168|NCT02436356|529028275|FG001|Overall Study|Excluded due to other medical conditions|0|||
146686169|NCT02436356|529028276|FG002|Overall Study|Excluded due to other medical conditions|0|||
146686170|NCT02436356|529028274|FG000|Overall Study|Withdrawal by Subject|1|||
146686171|NCT02436356|529028275|FG001|Overall Study|Withdrawal by Subject|0|||
146686172|NCT02436356|529028276|FG002|Overall Study|Withdrawal by Subject|0|||
146686173|NCT04577118|529028277|FG000|Overall Study|Withdrawal by Subject|4|||
146686174|NCT00810407|529028278|FG000|Overall Study|Protocol Violation|3|||
146686175|NCT00810407|529028278|FG000|Overall Study|No Visit After First Day of Treatment|3|||
146686176|NCT02968563|529028279|FG000|Overall Study|Adverse Event|0|||
146686177|NCT02968563|529028280|FG001|Overall Study|Adverse Event|6|||
146686178|NCT02968563|529028279|FG000|Overall Study|Death|1|||
146686179|NCT02968563|529028280|FG001|Overall Study|Death|1|||
146686180|NCT02968563|529028279|FG000|Overall Study|Lost to Follow-up|0|||
146686181|NCT02968563|529028280|FG001|Overall Study|Lost to Follow-up|1|||
146686182|NCT03287804|529028281|FG000|Overall Study|Death|1|||
146686183|NCT03287804|529028281|FG000|Overall Study|Physician Decision|2|||
146686184|NCT03287804|529028281|FG000|Overall Study|Progressive disease|8|||
146686185|NCT04008030|529028284|FG000|Pre-Treatment|Withdrawal by Subject|0|||
146686186|NCT04008030|529028285|FG001|Pre-Treatment|Withdrawal by Subject|0|||
146686187|NCT04008030|529028286|FG002|Pre-Treatment|Withdrawal by Subject|9|||
146686188|NCT04008030|529028284|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
146686189|NCT04008030|529028285|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
146686190|NCT04008030|529028286|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
146686191|NCT04008030|529028284|FG000|Pre-Treatment|Other reasons|0|||
146686192|NCT04008030|529028285|FG001|Pre-Treatment|Other reasons|1|||
146686193|NCT04008030|529028286|FG002|Pre-Treatment|Other reasons|6|||
146686194|NCT04008030|529028284|FG000|Treatment|Withdrawal by Subject|1|||
146686195|NCT04008030|529028285|FG001|Treatment|Withdrawal by Subject|1|||
146686196|NCT04008030|529028286|FG002|Treatment|Withdrawal by Subject|1|||
146686197|NCT04008030|529028284|FG000|Treatment|Death|2|||
146686198|NCT04008030|529028285|FG001|Treatment|Death|4|||
146686199|NCT04008030|529028286|FG002|Treatment|Death|0|||
146686200|NCT04008030|529028284|FG000|Treatment|Pregnancy|0|||
146686201|NCT04008030|529028285|FG001|Treatment|Pregnancy|1|||
146686202|NCT04008030|529028286|FG002|Treatment|Pregnancy|0|||
146686203|NCT04008030|529028284|FG000|Treatment|Participant no longer meets study criteria|0|||
146927702|NCT01274338|529895998|FG001|Overall Study|Lack of Efficacy|108|||
146686204|NCT04008030|529028285|FG001|Treatment|Participant no longer meets study criteria|1|||
146686205|NCT04008030|529028286|FG002|Treatment|Participant no longer meets study criteria|0|||
146686206|NCT04008030|529028284|FG000|Treatment|Other reasons|5|||
146927703|NCT01274338|529895999|FG002|Overall Study|Lack of Efficacy|116|||
146686207|NCT04008030|529028285|FG001|Treatment|Other reasons|13|||
146686208|NCT04008030|529028286|FG002|Treatment|Other reasons|6|||
146686209|NCT04008030|529028284|FG000|Treatment|Disease Progression|137|||
146686210|NCT04008030|529028285|FG001|Treatment|Disease Progression|82|||
146686211|NCT04008030|529028286|FG002|Treatment|Disease Progression|85|||
146686212|NCT04008030|529028284|FG000|Treatment|Study drug toxicity|28|||
146686213|NCT04008030|529028285|FG001|Treatment|Study drug toxicity|48|||
146686214|NCT04008030|529028286|FG002|Treatment|Study drug toxicity|8|||
146686215|NCT04008030|529028284|FG000|Treatment|Adverse Event unrelated to study drug|28|||
146686216|NCT04008030|529028285|FG001|Treatment|Adverse Event unrelated to study drug|22|||
146927704|NCT01274338|529896000|FG003|Overall Study|Lack of Efficacy|0|||
146927705|NCT01274338|529896001|FG004|Overall Study|Lack of Efficacy|0|||
146927706|NCT01274338|529896002|FG005|Overall Study|Lack of Efficacy|0|||
146927707|NCT01274338|529895997|FG000|Overall Study|Adverse Event|272|||
146927708|NCT01274338|529895998|FG001|Overall Study|Adverse Event|105|||
146927709|NCT01274338|529895999|FG002|Overall Study|Adverse Event|180|||
146927710|NCT01274338|529896000|FG003|Overall Study|Adverse Event|1|||
146927711|NCT01274338|529896001|FG004|Overall Study|Adverse Event|0|||
146927712|NCT01274338|529896002|FG005|Overall Study|Adverse Event|0|||
146927713|NCT01274338|529895997|FG000|Overall Study|Death|8|||
146927714|NCT01274338|529895998|FG001|Overall Study|Death|1|||
146978917|NCT01078623|530085513|FG017|Treatment Period 4|Adverse Event|0|||
146978918|NCT01078623|530085514|FG018|Treatment Period 4|Adverse Event|0|||
146978919|NCT01078623|530085515|FG019|Treatment Period 4|Adverse Event|0|||
146978920|NCT01078623|530085496|FG000|Treatment Period 4|Withdrawal by Subject|0|||
146978921|NCT01078623|530085497|FG001|Treatment Period 4|Withdrawal by Subject|0|||
146978922|NCT01078623|530085498|FG002|Treatment Period 4|Withdrawal by Subject|0|||
146978923|NCT01078623|530085499|FG003|Treatment Period 4|Withdrawal by Subject|0|||
146978924|NCT01078623|530085500|FG004|Treatment Period 4|Withdrawal by Subject|0|||
146978925|NCT01078623|530085501|FG005|Treatment Period 4|Withdrawal by Subject|0|||
146978926|NCT01078623|530085502|FG006|Treatment Period 4|Withdrawal by Subject|0|||
146978927|NCT01078623|530085503|FG007|Treatment Period 4|Withdrawal by Subject|0|||
146978928|NCT01078623|530085504|FG008|Treatment Period 4|Withdrawal by Subject|0|||
146978929|NCT01078623|530085505|FG009|Treatment Period 4|Withdrawal by Subject|0|||
146978930|NCT01078623|530085506|FG010|Treatment Period 4|Withdrawal by Subject|0|||
146978931|NCT01078623|530085507|FG011|Treatment Period 4|Withdrawal by Subject|0|||
146978932|NCT01078623|530085508|FG012|Treatment Period 4|Withdrawal by Subject|0|||
146978933|NCT01078623|530085509|FG013|Treatment Period 4|Withdrawal by Subject|0|||
146978934|NCT01078623|530085510|FG014|Treatment Period 4|Withdrawal by Subject|0|||
146978935|NCT01078623|530085511|FG015|Treatment Period 4|Withdrawal by Subject|1|||
146978936|NCT01078623|530085512|FG016|Treatment Period 4|Withdrawal by Subject|0|||
146978937|NCT01078623|530085513|FG017|Treatment Period 4|Withdrawal by Subject|0|||
146978938|NCT01078623|530085514|FG018|Treatment Period 4|Withdrawal by Subject|0|||
146978939|NCT01078623|530085515|FG019|Treatment Period 4|Withdrawal by Subject|0|||
146978940|NCT00463866|530085516|FG000|Overall Study|Adverse Event|70|||
146978941|NCT00463866|530085517|FG001|Overall Study|Adverse Event|93|||
146686217|NCT04008030|529028286|FG002|Treatment|Adverse Event unrelated to study drug|6|||
146686218|NCT04008030|529028284|FG000|Treatment|Maximum Clinical Benefit|0|||
146686219|NCT04008030|529028285|FG001|Treatment|Maximum Clinical Benefit|1|||
146686220|NCT04008030|529028286|FG002|Treatment|Maximum Clinical Benefit|9|||
146686221|NCT04008030|529028284|FG000|Treatment|On-going treatment|13|||
146686222|NCT04008030|529028285|FG001|Treatment|On-going treatment|20|||
146686223|NCT04008030|529028286|FG002|Treatment|On-going treatment|0|||
146978942|NCT00463866|530085516|FG000|Overall Study|Withdrawal by Subject|81|||
146686224|NCT03108027|529028287|FG000|Period 1|Subject/Guardian Decision|0|||
146686225|NCT03108027|529028288|FG001|Period 1|Subject/Guardian Decision|0|||
146686226|NCT03108027|529028289|FG002|Period 1|Subject/Guardian Decision|0|||
146686227|NCT03108027|529028290|FG003|Period 1|Subject/Guardian Decision|2|||
146686228|NCT03108027|529028291|FG004|Period 1|Subject/Guardian Decision|0|||
146686229|NCT03108027|529028292|FG005|Period 1|Subject/Guardian Decision|0|||
146686230|NCT03108027|529028287|FG000|Period 3|Adverse Event|0|||
146686231|NCT03108027|529028288|FG001|Period 3|Adverse Event|1|||
146686232|NCT03108027|529028289|FG002|Period 3|Adverse Event|0|||
146686233|NCT03108027|529028290|FG003|Period 3|Adverse Event|0|||
146686234|NCT03108027|529028291|FG004|Period 3|Adverse Event|0|||
146686235|NCT03108027|529028292|FG005|Period 3|Adverse Event|0|||
146686236|NCT02574247|529028293|FG000|Overall Study|Withdrawal by Subject|1|||
146686237|NCT02574247|529028294|FG001|Overall Study|Withdrawal by Subject|0|||
146686238|NCT02574247|529028295|FG002|Overall Study|Withdrawal by Subject|0|||
146978943|NCT00463866|530085517|FG001|Overall Study|Withdrawal by Subject|79|||
146978944|NCT00463866|530085516|FG000|Overall Study|Lost to Follow-up|46|||
146686239|NCT02574247|529028293|FG000|Overall Study|Did not meet inclusion criteria|4|||
146927715|NCT01274338|529895999|FG002|Overall Study|Death|0|||
146978945|NCT00463866|530085517|FG001|Overall Study|Lost to Follow-up|55|||
146686240|NCT02574247|529028294|FG001|Overall Study|Did not meet inclusion criteria|3|||
146686241|NCT02574247|529028295|FG002|Overall Study|Did not meet inclusion criteria|5|||
146686242|NCT01382446|529028296|FG000|Overall Study|Withdrawal by Subject|0|||
146686243|NCT01382446|529028297|FG001|Overall Study|Withdrawal by Subject|1|||
146686244|NCT01382446|529028296|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
146978946|NCT00463866|530085516|FG000|Overall Study|Incorrect Enrolment|64|||
146978947|NCT00463866|530085517|FG001|Overall Study|Incorrect Enrolment|66|||
146978948|NCT00463866|530085516|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
146978949|NCT00463866|530085517|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
146978950|NCT00463866|530085516|FG000|Overall Study|Safety Reason|1|||
146736301|NCT00633932|529206804|FG001|Overall Study|Moved Away|0|||
146927716|NCT01274338|529896000|FG003|Overall Study|Death|0|||
146927717|NCT01274338|529896001|FG004|Overall Study|Death|0|||
146927718|NCT01274338|529896002|FG005|Overall Study|Death|0|||
146927719|NCT01274338|529895997|FG000|Overall Study|Withdrawal by Subject|27|||
146686245|NCT01382446|529028297|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
146686246|NCT00770289|529028304|FG000|Overall Study|Other|6|||
146686247|NCT02733991|529028305|FG000|Overall Study|Adverse Event|1|||
146686248|NCT02733991|529028306|FG001|Overall Study|Adverse Event|0|||
146686249|NCT02733991|529028305|FG000|Overall Study|Withdrawal by Subject|0|||
146686250|NCT02733991|529028306|FG001|Overall Study|Withdrawal by Subject|5|||
146686251|NCT02659631|529028309|FG000|Overall Study|Lost to Follow-up|0|||
146686252|NCT02659631|529028310|FG001|Overall Study|Lost to Follow-up|0|||
146686253|NCT02659631|529028311|FG002|Overall Study|Lost to Follow-up|2|||
146686254|NCT02659631|529028312|FG003|Overall Study|Lost to Follow-up|0|||
146686255|NCT02659631|529028313|FG004|Overall Study|Lost to Follow-up|0|||
146686256|NCT02659631|529028314|FG005|Overall Study|Lost to Follow-up|1|||
146686257|NCT02659631|529028315|FG006|Overall Study|Lost to Follow-up|0|||
146686258|NCT02659631|529028316|FG007|Overall Study|Lost to Follow-up|0|||
146686259|NCT02659631|529028317|FG008|Overall Study|Lost to Follow-up|0|||
146686260|NCT02659631|529028318|FG009|Overall Study|Lost to Follow-up|0|||
146686261|NCT02659631|529028309|FG000|Overall Study|Withdrawal prior to treatment|0|||
146686262|NCT02659631|529028310|FG001|Overall Study|Withdrawal prior to treatment|0|||
146686263|NCT02659631|529028311|FG002|Overall Study|Withdrawal prior to treatment|0|||
146686264|NCT02659631|529028312|FG003|Overall Study|Withdrawal prior to treatment|0|||
146686265|NCT02659631|529028313|FG004|Overall Study|Withdrawal prior to treatment|1|||
146927720|NCT01274338|529895998|FG001|Overall Study|Withdrawal by Subject|99|||
146927721|NCT01274338|529895999|FG002|Overall Study|Withdrawal by Subject|17|||
146927722|NCT01274338|529896000|FG003|Overall Study|Withdrawal by Subject|0|||
146927723|NCT01274338|529896001|FG004|Overall Study|Withdrawal by Subject|0|||
146927724|NCT01274338|529896002|FG005|Overall Study|Withdrawal by Subject|0|||
146927725|NCT01274338|529895997|FG000|Overall Study|Did not start treatment|8|||
146927726|NCT01274338|529895998|FG001|Overall Study|Did not start treatment|116|||
146927727|NCT01274338|529895999|FG002|Overall Study|Did not start treatment|7|||
146927728|NCT01274338|529896000|FG003|Overall Study|Did not start treatment|0|||
146927729|NCT01274338|529896001|FG004|Overall Study|Did not start treatment|0|||
146927730|NCT01274338|529896002|FG005|Overall Study|Did not start treatment|0|||
146927731|NCT01274338|529895997|FG000|Overall Study|Alternative therapy|0|||
146927732|NCT01274338|529895998|FG001|Overall Study|Alternative therapy|1|||
146927733|NCT01274338|529895999|FG002|Overall Study|Alternative therapy|0|||
146927734|NCT01274338|529896000|FG003|Overall Study|Alternative therapy|0|||
146927735|NCT01274338|529896001|FG004|Overall Study|Alternative therapy|0|||
146927736|NCT01274338|529896002|FG005|Overall Study|Alternative therapy|0|||
146927737|NCT01274338|529895997|FG000|Overall Study|Other complicating diseases|0|||
146927738|NCT01274338|529895998|FG001|Overall Study|Other complicating diseases|3|||
146927739|NCT01274338|529895999|FG002|Overall Study|Other complicating diseases|1|||
146927740|NCT01274338|529896000|FG003|Overall Study|Other complicating diseases|0|||
146927741|NCT01274338|529896001|FG004|Overall Study|Other complicating diseases|0|||
146927742|NCT01274338|529896002|FG005|Overall Study|Other complicating diseases|0|||
146927743|NCT01274338|529895997|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
146927744|NCT01274338|529895998|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
146927745|NCT01274338|529895999|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
146927746|NCT01274338|529896000|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
146927747|NCT01274338|529896001|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
146927748|NCT01274338|529896002|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
146927749|NCT01274338|529895997|FG000|Overall Study|Pregnancy|0|||
146927750|NCT01274338|529895998|FG001|Overall Study|Pregnancy|0|||
146927751|NCT01274338|529895999|FG002|Overall Study|Pregnancy|1|||
146927752|NCT01274338|529896000|FG003|Overall Study|Pregnancy|0|||
146927753|NCT01274338|529896001|FG004|Overall Study|Pregnancy|0|||
146927754|NCT01274338|529896002|FG005|Overall Study|Pregnancy|0|||
146927755|NCT01274338|529895997|FG000|Overall Study|Reason not reported|12|||
146927756|NCT01274338|529895998|FG001|Overall Study|Reason not reported|21|||
146927757|NCT01274338|529895999|FG002|Overall Study|Reason not reported|3|||
146927758|NCT01274338|529896000|FG003|Overall Study|Reason not reported|0|||
146686266|NCT02659631|529028314|FG005|Overall Study|Withdrawal prior to treatment|0|||
146927759|NCT01274338|529896001|FG004|Overall Study|Reason not reported|1|||
146927760|NCT01274338|529896002|FG005|Overall Study|Reason not reported|0|||
146686267|NCT02659631|529028315|FG006|Overall Study|Withdrawal prior to treatment|0|||
146686268|NCT02659631|529028316|FG007|Overall Study|Withdrawal prior to treatment|0|||
146686269|NCT02659631|529028317|FG008|Overall Study|Withdrawal prior to treatment|0|||
146686270|NCT02659631|529028318|FG009|Overall Study|Withdrawal prior to treatment|0|||
146686271|NCT02659631|529028309|FG000|Overall Study|Participant refused further follow-up|0|||
146927761|NCT01927744|529896003|FG000|Overall Study|Death|2|||
146927762|NCT01927744|529896004|FG001|Overall Study|Death|9|||
146927763|NCT05458011|529896013|FG000|DB Period (12 Weeks)|Adverse Event|2|||
146927764|NCT05458011|529896014|FG001|DB Period (12 Weeks)|Adverse Event|1|||
146927765|NCT05458011|529896015|FG002|DB Period (12 Weeks)|Adverse Event|1|||
146927766|NCT05458011|529896013|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
146927767|NCT05458011|529896014|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
146927768|NCT05458011|529896015|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
146686272|NCT02659631|529028310|FG001|Overall Study|Participant refused further follow-up|0|||
146686273|NCT02659631|529028311|FG002|Overall Study|Participant refused further follow-up|0|||
146686274|NCT02659631|529028312|FG003|Overall Study|Participant refused further follow-up|1|||
146686275|NCT02659631|529028313|FG004|Overall Study|Participant refused further follow-up|0|||
146686276|NCT02659631|529028314|FG005|Overall Study|Participant refused further follow-up|0|||
146686277|NCT02659631|529028315|FG006|Overall Study|Participant refused further follow-up|0|||
146686278|NCT02659631|529028316|FG007|Overall Study|Participant refused further follow-up|0|||
146686279|NCT02659631|529028317|FG008|Overall Study|Participant refused further follow-up|1|||
146686280|NCT02659631|529028318|FG009|Overall Study|Participant refused further follow-up|0|||
146686281|NCT02659631|529028309|FG000|Overall Study|Death (follow-up phase)|1|||
146686282|NCT02659631|529028310|FG001|Overall Study|Death (follow-up phase)|2|||
146686283|NCT02659631|529028311|FG002|Overall Study|Death (follow-up phase)|1|||
146686284|NCT02659631|529028312|FG003|Overall Study|Death (follow-up phase)|1|||
146686285|NCT02659631|529028313|FG004|Overall Study|Death (follow-up phase)|3|||
146686286|NCT02659631|529028314|FG005|Overall Study|Death (follow-up phase)|2|||
146686287|NCT02659631|529028315|FG006|Overall Study|Death (follow-up phase)|0|||
146686288|NCT02659631|529028316|FG007|Overall Study|Death (follow-up phase)|3|||
146686289|NCT02659631|529028317|FG008|Overall Study|Death (follow-up phase)|1|||
146686290|NCT02659631|529028318|FG009|Overall Study|Death (follow-up phase)|0|||
146686291|NCT02659631|529028309|FG000|Overall Study|Death (treatment phase)|0|||
146686292|NCT02659631|529028310|FG001|Overall Study|Death (treatment phase)|0|||
146686293|NCT02659631|529028311|FG002|Overall Study|Death (treatment phase)|0|||
146686294|NCT02659631|529028312|FG003|Overall Study|Death (treatment phase)|0|||
146686295|NCT02659631|529028313|FG004|Overall Study|Death (treatment phase)|1|||
146686296|NCT02659631|529028314|FG005|Overall Study|Death (treatment phase)|0|||
146686297|NCT02659631|529028315|FG006|Overall Study|Death (treatment phase)|1|||
146686298|NCT02659631|529028316|FG007|Overall Study|Death (treatment phase)|0|||
146686299|NCT02659631|529028317|FG008|Overall Study|Death (treatment phase)|0|||
146686300|NCT02659631|529028318|FG009|Overall Study|Death (treatment phase)|0|||
146686301|NCT00495170|529028319|FG000|Overall Study|Lost to Follow-up|9|||
146686302|NCT00495170|529028319|FG000|Overall Study|Withdrawal by Subject|3|||
146686303|NCT00495170|529028319|FG000|Overall Study|Inappropriate staging|8|||
146686304|NCT04191499|529028320|FG000|Overall Study|Adverse Event|1|||
146686305|NCT04191499|529028321|FG001|Overall Study|Adverse Event|0|||
146686306|NCT04191499|529028320|FG000|Overall Study|Death|42|||
146686307|NCT04191499|529028321|FG001|Overall Study|Death|55|||
146686308|NCT04191499|529028320|FG000|Overall Study|Lost to Follow-up|4|||
146686309|NCT04191499|529028321|FG001|Overall Study|Lost to Follow-up|1|||
146686310|NCT04191499|529028320|FG000|Overall Study|Physician Decision|1|||
146686311|NCT04191499|529028321|FG001|Overall Study|Physician Decision|0|||
146686312|NCT04191499|529028320|FG000|Overall Study|Progressive Disease|1|||
146686313|NCT04191499|529028321|FG001|Overall Study|Progressive Disease|0|||
146686314|NCT04191499|529028320|FG000|Overall Study|Symptomatic Deterioration|1|||
146686315|NCT04191499|529028321|FG001|Overall Study|Symptomatic Deterioration|0|||
146686316|NCT04191499|529028320|FG000|Overall Study|Withdrawal by Subject|7|||
146686317|NCT04191499|529028321|FG001|Overall Study|Withdrawal by Subject|11|||
146686318|NCT04191499|529028320|FG000|Overall Study|Ongoing in the study|104|||
146686319|NCT04191499|529028321|FG001|Overall Study|Ongoing in the study|97|||
146686320|NCT00680745|529028322|FG000|Overall Study|Withdrawal by Subject|8|||
146686321|NCT00680745|529028323|FG001|Overall Study|Withdrawal by Subject|3|||
146686322|NCT00680745|529028324|FG002|Overall Study|Withdrawal by Subject|2|||
146686323|NCT00680745|529028325|FG003|Overall Study|Withdrawal by Subject|8|||
146686324|NCT00680745|529028322|FG000|Overall Study|Lost to Follow-up|0|||
146686325|NCT00680745|529028323|FG001|Overall Study|Lost to Follow-up|1|||
146686326|NCT00680745|529028324|FG002|Overall Study|Lost to Follow-up|1|||
146686327|NCT00680745|529028325|FG003|Overall Study|Lost to Follow-up|0|||
146686328|NCT00680745|529028322|FG000|Overall Study|Death|1|||
146686329|NCT00680745|529028323|FG001|Overall Study|Death|0|||
146686330|NCT00680745|529028324|FG002|Overall Study|Death|1|||
146686331|NCT00680745|529028325|FG003|Overall Study|Death|0|||
146686332|NCT00680745|529028322|FG000|Overall Study|Adverse Event|5|||
146686333|NCT00680745|529028323|FG001|Overall Study|Adverse Event|3|||
146686334|NCT00680745|529028324|FG002|Overall Study|Adverse Event|3|||
146686335|NCT00680745|529028325|FG003|Overall Study|Adverse Event|3|||
146686336|NCT00680745|529028322|FG000|Overall Study|Poor/Non-compliance|0|||
146686337|NCT00680745|529028323|FG001|Overall Study|Poor/Non-compliance|3|||
146686338|NCT00680745|529028324|FG002|Overall Study|Poor/Non-compliance|0|||
146686339|NCT00680745|529028325|FG003|Overall Study|Poor/Non-compliance|0|||
146686340|NCT00680745|529028322|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
146686341|NCT00680745|529028323|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
146686342|NCT00680745|529028324|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
146686343|NCT00680745|529028325|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
146686344|NCT00680745|529028322|FG000|Overall Study|False Treatment|0|||
146686345|NCT00680745|529028323|FG001|Overall Study|False Treatment|1|||
146686346|NCT00680745|529028324|FG002|Overall Study|False Treatment|3|||
146686347|NCT00680745|529028325|FG003|Overall Study|False Treatment|0|||
146686348|NCT01928329|529028328|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
146686349|NCT01928329|529028329|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
146686350|NCT01928329|529028328|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
146686351|NCT01928329|529028329|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
146686352|NCT01928329|529028328|FG000|Overall Study|Adverse Event|5|||
146686353|NCT01928329|529028329|FG001|Overall Study|Adverse Event|3|||
146686354|NCT01928329|529028328|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
146686355|NCT01928329|529028329|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
146686356|NCT01928329|529028328|FG000|Overall Study|Withdrawal by Subject|1|||
146686357|NCT01928329|529028329|FG001|Overall Study|Withdrawal by Subject|5|||
146686358|NCT01928329|529028328|FG000|Overall Study|Physician Decision|1|||
146686359|NCT01928329|529028329|FG001|Overall Study|Physician Decision|1|||
146686360|NCT01119131|529028333|FG000|Overall Study|Adverse Event|1|||
146686361|NCT01119131|529028334|FG001|Overall Study|Adverse Event|1|||
146686362|NCT01119131|529028335|FG002|Overall Study|Adverse Event|1|||
146686363|NCT01119131|529028333|FG000|Overall Study|Non-Compliance|1|||
146686364|NCT01119131|529028334|FG001|Overall Study|Non-Compliance|0|||
146686365|NCT01119131|529028335|FG002|Overall Study|Non-Compliance|4|||
146686366|NCT01119131|529028333|FG000|Overall Study|Physician Decision|0|||
146686367|NCT01119131|529028334|FG001|Overall Study|Physician Decision|0|||
146686368|NCT01119131|529028335|FG002|Overall Study|Physician Decision|1|||
146686369|NCT00732615|529028336|FG000|Overall Study|Withdrawal by Subject|3|||
146686370|NCT00732615|529028337|FG001|Overall Study|Withdrawal by Subject|1|||
146686371|NCT00732615|529028336|FG000|Overall Study|Lost to Follow-up|0|||
146686372|NCT00732615|529028337|FG001|Overall Study|Lost to Follow-up|1|||
146686373|NCT00732615|529028336|FG000|Overall Study|Adverse Event|0|||
146686374|NCT00732615|529028337|FG001|Overall Study|Adverse Event|2|||
146686375|NCT00732615|529028336|FG000|Overall Study|Physician Decision|3|||
146686376|NCT00732615|529028337|FG001|Overall Study|Physician Decision|0|||
146686377|NCT00732615|529028336|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
146686378|NCT00732615|529028337|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
146686379|NCT00993291|529028338|FG000|Overall Study|Withdrawal by Subject|1|||
146686380|NCT00003492|529028339|FG000|Overall Study|Not evaluable|6|||
146686381|NCT03566823|529028340|FG000|Overall Study|Lack of Efficacy|0|||
146686382|NCT03566823|529028341|FG001|Overall Study|Lack of Efficacy|1|||
146686383|NCT03566823|529028342|FG002|Overall Study|Lack of Efficacy|0|||
146686384|NCT03566823|529028340|FG000|Overall Study|Withdrawal by Subject|1|||
146686385|NCT03566823|529028341|FG001|Overall Study|Withdrawal by Subject|2|||
146686386|NCT03566823|529028342|FG002|Overall Study|Withdrawal by Subject|0|||
146686387|NCT03566823|529028340|FG000|Overall Study|Adverse Event|1|||
146686388|NCT03566823|529028341|FG001|Overall Study|Adverse Event|0|||
146686389|NCT03566823|529028342|FG002|Overall Study|Adverse Event|2|||
146686390|NCT01528254|529028343|FG000|Overall Study|Administrative problems|96|||
146686391|NCT01528254|529028344|FG001|Overall Study|Administrative problems|94|||
146686392|NCT01528254|529028343|FG000|Overall Study|Adverse Event|28|||
146686393|NCT01528254|529028344|FG001|Overall Study|Adverse Event|44|||
146686394|NCT01528254|529028343|FG000|Overall Study|Lost to Follow-up|17|||
146686395|NCT01528254|529028344|FG001|Overall Study|Lost to Follow-up|24|||
146686396|NCT01528254|529028343|FG000|Overall Study|Death|13|||
146686397|NCT01528254|529028344|FG001|Overall Study|Death|9|||
146686398|NCT01528254|529028343|FG000|Overall Study|Protocol deviation|9|||
146686399|NCT01528254|529028344|FG001|Overall Study|Protocol deviation|19|||
146686400|NCT01528254|529028343|FG000|Overall Study|New therapy for study indication|8|||
146686401|NCT01528254|529028344|FG001|Overall Study|New therapy for study indication|6|||
146686402|NCT01528254|529028343|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
146686403|NCT01528254|529028344|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
146686404|NCT01528254|529028343|FG000|Overall Study|Withdrawal by Subject|5|||
146686405|NCT01528254|529028344|FG001|Overall Study|Withdrawal by Subject|4|||
146686406|NCT01528254|529028343|FG000|Overall Study|Abnormal laboratory value(s)|3|||
146686407|NCT01528254|529028344|FG001|Overall Study|Abnormal laboratory value(s)|7|||
146686408|NCT01528254|529028343|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146686409|NCT01528254|529028344|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146927769|NCT05458011|529896013|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
146927770|NCT05458011|529896014|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
146686410|NCT01528254|529028343|FG000|Overall Study|No longer requires study drug|1|||
146686411|NCT01528254|529028344|FG001|Overall Study|No longer requires study drug|1|||
146686412|NCT00737282|529028345|FG000|Overall Study|Study prematurely terminated|175|||
146686413|NCT02763189|529028346|FG000|Overall Study|Device failure|0|||
146686414|NCT02763189|529028347|FG001|Overall Study|Device failure|2|||
146686415|NCT02049957|529028348|FG000|Overall Study|Progressive Disease|5|||
146686416|NCT02049957|529028349|FG001|Overall Study|Progressive Disease|4|||
146686417|NCT02049957|529028350|FG002|Overall Study|Progressive Disease|2|||
146686418|NCT02049957|529028351|FG003|Overall Study|Progressive Disease|2|||
146927771|NCT05458011|529896015|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
146686419|NCT02049957|529028352|FG004|Overall Study|Progressive Disease|6|||
146686420|NCT02049957|529028353|FG005|Overall Study|Progressive Disease|35|||
146686421|NCT02049957|529028354|FG006|Overall Study|Progressive Disease|7|||
146686422|NCT02049957|529028355|FG007|Overall Study|Progressive Disease|26|||
146686423|NCT02049957|529028356|FG008|Overall Study|Progressive Disease|6|||
146686424|NCT02049957|529028348|FG000|Overall Study|Adverse Event|1|||
146686425|NCT02049957|529028349|FG001|Overall Study|Adverse Event|1|||
146686426|NCT02049957|529028350|FG002|Overall Study|Adverse Event|1|||
146686427|NCT02049957|529028351|FG003|Overall Study|Adverse Event|0|||
146686428|NCT02049957|529028352|FG004|Overall Study|Adverse Event|0|||
146686429|NCT02049957|529028353|FG005|Overall Study|Adverse Event|5|||
146686430|NCT02049957|529028354|FG006|Overall Study|Adverse Event|0|||
146686431|NCT02049957|529028355|FG007|Overall Study|Adverse Event|6|||
146686432|NCT02049957|529028356|FG008|Overall Study|Adverse Event|1|||
146686433|NCT02049957|529028348|FG000|Overall Study|Study Terminated by Sponsor|0|||
146686434|NCT02049957|529028349|FG001|Overall Study|Study Terminated by Sponsor|1|||
146686435|NCT02049957|529028350|FG002|Overall Study|Study Terminated by Sponsor|0|||
146686436|NCT02049957|529028351|FG003|Overall Study|Study Terminated by Sponsor|0|||
146686437|NCT02049957|529028352|FG004|Overall Study|Study Terminated by Sponsor|0|||
146686438|NCT02049957|529028353|FG005|Overall Study|Study Terminated by Sponsor|0|||
146686439|NCT02049957|529028354|FG006|Overall Study|Study Terminated by Sponsor|1|||
146686440|NCT02049957|529028355|FG007|Overall Study|Study Terminated by Sponsor|0|||
146686441|NCT02049957|529028356|FG008|Overall Study|Study Terminated by Sponsor|0|||
146686442|NCT02049957|529028348|FG000|Overall Study|Withdrawal by Subject|0|||
146686443|NCT02049957|529028349|FG001|Overall Study|Withdrawal by Subject|0|||
146686444|NCT02049957|529028350|FG002|Overall Study|Withdrawal by Subject|0|||
146686445|NCT02049957|529028351|FG003|Overall Study|Withdrawal by Subject|1|||
146686446|NCT02049957|529028352|FG004|Overall Study|Withdrawal by Subject|0|||
146686447|NCT02049957|529028353|FG005|Overall Study|Withdrawal by Subject|2|||
146686448|NCT02049957|529028354|FG006|Overall Study|Withdrawal by Subject|0|||
146686449|NCT02049957|529028355|FG007|Overall Study|Withdrawal by Subject|3|||
146686450|NCT02049957|529028356|FG008|Overall Study|Withdrawal by Subject|1|||
146686451|NCT02049957|529028348|FG000|Overall Study|Physician Decision|0|||
146686452|NCT02049957|529028349|FG001|Overall Study|Physician Decision|0|||
146686453|NCT02049957|529028350|FG002|Overall Study|Physician Decision|0|||
146686454|NCT02049957|529028351|FG003|Overall Study|Physician Decision|0|||
146686455|NCT02049957|529028352|FG004|Overall Study|Physician Decision|0|||
146686456|NCT02049957|529028353|FG005|Overall Study|Physician Decision|1|||
146686457|NCT02049957|529028354|FG006|Overall Study|Physician Decision|0|||
146686458|NCT02049957|529028355|FG007|Overall Study|Physician Decision|0|||
146686459|NCT02049957|529028356|FG008|Overall Study|Physician Decision|0|||
146686460|NCT01414075|529028357|FG000|Overall Study|Adverse Event|1|||
146686461|NCT01414075|529028358|FG001|Overall Study|Adverse Event|0|||
146686462|NCT01414075|529028359|FG002|Overall Study|Adverse Event|1|||
146686463|NCT01414075|529028360|FG003|Overall Study|Adverse Event|0|||
146686464|NCT01414075|529028357|FG000|Overall Study|Death|1|||
146686465|NCT01414075|529028358|FG001|Overall Study|Death|0|||
146686466|NCT01414075|529028359|FG002|Overall Study|Death|0|||
146686467|NCT01414075|529028360|FG003|Overall Study|Death|1|||
146686468|NCT01414075|529028357|FG000|Overall Study|Withdrawal by Subject|0|||
146686469|NCT01414075|529028358|FG001|Overall Study|Withdrawal by Subject|0|||
146686470|NCT01414075|529028359|FG002|Overall Study|Withdrawal by Subject|0|||
146686471|NCT01414075|529028360|FG003|Overall Study|Withdrawal by Subject|1|||
146686472|NCT01414075|529028357|FG000|Overall Study|Other than specified|1|||
146686473|NCT01414075|529028358|FG001|Overall Study|Other than specified|0|||
146686474|NCT01414075|529028359|FG002|Overall Study|Other than specified|1|||
146686475|NCT01414075|529028360|FG003|Overall Study|Other than specified|0|||
146774871|NCT03575052|529346797|FG000|Overall Study|Physician Decision|1|||
146774872|NCT03575052|529346798|FG001|Overall Study|Physician Decision|0|||
146927772|NCT05458011|529896013|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
146927773|NCT05458011|529896014|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
146978951|NCT00463866|530085517|FG001|Overall Study|Safety Reason|3|||
146686476|NCT02810392|529028362|FG000|Overall Study|Subject too ill to continue|1|||
146774873|NCT04188379|529346799|FG000|Overall Study|Withdrawal by Subject|10|||
146774874|NCT04188379|529346800|FG001|Overall Study|Withdrawal by Subject|3|||
146774875|NCT04188379|529346799|FG000|Overall Study|Physician Decision|0|||
146686477|NCT02810392|529028363|FG001|Overall Study|Subject too ill to continue|0|||
146686478|NCT02810392|529028362|FG000|Overall Study|COVID 19 research restrictions|0|||
146686479|NCT02810392|529028363|FG001|Overall Study|COVID 19 research restrictions|1|||
146686480|NCT00840294|529028364|FG000|Overall Study|Withdrawal by Subject|2|||
146686481|NCT00840294|529028365|FG001|Overall Study|Withdrawal by Subject|1|||
146686482|NCT00840294|529028364|FG000|Overall Study|Protocol Violation|1|||
146686483|NCT00840294|529028365|FG001|Overall Study|Protocol Violation|3|||
146686484|NCT00840294|529028364|FG000|Overall Study|Illness|0|||
146686485|NCT00840294|529028365|FG001|Overall Study|Illness|1|||
146686486|NCT02669433|529028370|FG000|Overall Study|Protocol Violation|0|||
146686487|NCT02669433|529028371|FG001|Overall Study|Protocol Violation|4|||
146686488|NCT02669433|529028372|FG002|Overall Study|Protocol Violation|1|||
146686489|NCT02669433|529028370|FG000|Overall Study|Disease Progression|1|||
146774876|NCT04188379|529346800|FG001|Overall Study|Physician Decision|1|||
146927774|NCT05458011|529896015|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
146686490|NCT02669433|529028371|FG001|Overall Study|Disease Progression|0|||
146686491|NCT02669433|529028372|FG002|Overall Study|Disease Progression|0|||
146686492|NCT02669433|529028370|FG000|Overall Study|Physician Decision|1|||
146686493|NCT02669433|529028371|FG001|Overall Study|Physician Decision|1|||
146686494|NCT02669433|529028372|FG002|Overall Study|Physician Decision|0|||
146686495|NCT02669433|529028370|FG000|Overall Study|Adverse Event|6|||
146686496|NCT02669433|529028371|FG001|Overall Study|Adverse Event|7|||
146686497|NCT02669433|529028372|FG002|Overall Study|Adverse Event|10|||
146686498|NCT02669433|529028370|FG000|Overall Study|Sponsor Termination|1|||
146686499|NCT02669433|529028371|FG001|Overall Study|Sponsor Termination|0|||
146686500|NCT02669433|529028372|FG002|Overall Study|Sponsor Termination|1|||
146686501|NCT02669433|529028370|FG000|Overall Study|Withdrawal by Subject|5|||
146686502|NCT02669433|529028371|FG001|Overall Study|Withdrawal by Subject|1|||
146686503|NCT02669433|529028372|FG002|Overall Study|Withdrawal by Subject|0|||
146686504|NCT02669433|529028370|FG000|Overall Study|Withdrawal by Caregiver|1|||
146686505|NCT02669433|529028371|FG001|Overall Study|Withdrawal by Caregiver|0|||
146686506|NCT02669433|529028372|FG002|Overall Study|Withdrawal by Caregiver|2|||
146686507|NCT02669433|529028370|FG000|Overall Study|Death|0|||
146686508|NCT02669433|529028371|FG001|Overall Study|Death|1|||
146686509|NCT02669433|529028372|FG002|Overall Study|Death|1|||
146686510|NCT00576927|529028373|FG000|Clinical Assessment|Lack of Efficacy|24|||
146686511|NCT00576927|529028373|FG000|Clinical Assessment|Death|1|||
146686512|NCT00576927|529028373|FG000|Clinical Assessment|Withdrawal by Subject|10|||
146686513|NCT00576927|529028373|FG000|Clinical Assessment|Physician Decision|1|||
146686514|NCT00576927|529028373|FG000|Baseline|Physician Decision|9|||
146686515|NCT00576927|529028373|FG000|Baseline|Medication Change by PCP of subject|1|||
146686516|NCT00576927|529028373|FG000|Baseline|Withdrawal by Subject|3|||
146686517|NCT00576927|529028373|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
146686518|NCT00576927|529028373|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
146774877|NCT04188379|529346799|FG000|Overall Study|Adverse Event|3|||
146927775|NCT05458011|529896013|FG000|OL Period (12 Weeks)|Adverse Event|1|||
146927776|NCT05458011|529896014|FG001|OL Period (12 Weeks)|Adverse Event|2|||
146927777|NCT05458011|529896015|FG002|OL Period (12 Weeks)|Adverse Event|1|||
146927778|NCT05458011|529896013|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
146927779|NCT05458011|529896014|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
146927780|NCT05458011|529896015|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
146927781|NCT01175213|529896018|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
146927782|NCT01175213|529896019|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
146927783|NCT01175213|529896018|FG000|IGSC, 10%/rHuPH20|Death|1|||
146927784|NCT01175213|529896019|FG001|IGSC, 10%/rHuPH20|Death|0|||
146927785|NCT01175213|529896018|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
146927786|NCT01175213|529896019|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
146927787|NCT01175213|529896018|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
146927788|NCT01175213|529896019|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
146927789|NCT01175213|529896018|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
146927790|NCT01175213|529896019|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
146927791|NCT01175213|529896018|FG000|Safety Follow-up|Adverse Event|1|||
146927792|NCT01175213|529896019|FG001|Safety Follow-up|Adverse Event|0|||
146927793|NCT03057951|529896023|FG000|Overall Study|Adverse Event|553|||
146927794|NCT03057951|529896024|FG001|Overall Study|Adverse Event|575|||
146927795|NCT03057951|529896023|FG000|Overall Study|Protocol Violation|30|||
146927796|NCT03057951|529896024|FG001|Overall Study|Protocol Violation|24|||
146927797|NCT03057951|529896023|FG000|Overall Study|Lost to Follow-up|6|||
146927798|NCT03057951|529896024|FG001|Overall Study|Lost to Follow-up|16|||
146927799|NCT03057951|529896023|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
146927800|NCT03057951|529896024|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
146927801|NCT03057951|529896023|FG000|Overall Study|Study drug stopped, reason missing|6|||
146927802|NCT03057951|529896024|FG001|Overall Study|Study drug stopped, reason missing|1|||
146927803|NCT03057951|529896023|FG000|Overall Study|Medical advice|6|||
146927804|NCT03057951|529896024|FG001|Overall Study|Medical advice|2|||
146927805|NCT03057951|529896023|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
146927806|NCT03057951|529896024|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
146927807|NCT03057951|529896023|FG000|Overall Study|Investigator decision|2|||
146927808|NCT03057951|529896024|FG001|Overall Study|Investigator decision|0|||
146927809|NCT03057951|529896023|FG000|Overall Study|Patient decision|5|||
146927810|NCT03057951|529896024|FG001|Overall Study|Patient decision|2|||
146927811|NCT03057951|529896023|FG000|Overall Study|Not attending study visits|3|||
146927812|NCT03057951|529896024|FG001|Overall Study|Not attending study visits|0|||
146927813|NCT03057951|529896023|FG000|Overall Study|Patient moved away|3|||
146686519|NCT00576927|529028373|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
146774878|NCT04188379|529346800|FG001|Overall Study|Adverse Event|1|||
146927814|NCT03057951|529896024|FG001|Overall Study|Patient moved away|4|||
146927815|NCT03057951|529896023|FG000|Overall Study|Other reason than stated above|23|||
146927816|NCT03057951|529896024|FG001|Overall Study|Other reason than stated above|29|||
146927817|NCT03057951|529896023|FG000|Overall Study|Not treated|2|||
146927818|NCT03057951|529896024|FG001|Overall Study|Not treated|1|||
146927819|NCT02064205|529896025|FG000|Overall Study|Withdrawal by Subject|1|||
146686520|NCT00576927|529028373|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
146686521|NCT00576927|529028373|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
146686522|NCT00883116|529028374|FG000|Overall Study|Adverse event unrelated to study drug|5|||
146686523|NCT00883116|529028375|FG001|Overall Study|Adverse event unrelated to study drug|10|||
146686524|NCT00883116|529028374|FG000|Overall Study|Death|6|||
146686525|NCT00883116|529028375|FG001|Overall Study|Death|2|||
146686526|NCT00883116|529028374|FG000|Overall Study|Disease progression|130|||
146686527|NCT00883116|529028375|FG001|Overall Study|Disease progression|128|||
146686528|NCT00883116|529028374|FG000|Overall Study|Lost to Follow-up|0|||
146686529|NCT00883116|529028375|FG001|Overall Study|Lost to Follow-up|1|||
146686530|NCT00883116|529028374|FG000|Overall Study|Maximum clinical benefit|13|||
146686531|NCT00883116|529028375|FG001|Overall Study|Maximum clinical benefit|46|||
146686532|NCT00883116|529028374|FG000|Overall Study|Not identified|3|||
146686533|NCT00883116|529028375|FG001|Overall Study|Not identified|6|||
146686534|NCT00883116|529028374|FG000|Overall Study|Study drug toxicity|36|||
146686535|NCT00883116|529028375|FG001|Overall Study|Study drug toxicity|16|||
146686536|NCT00883116|529028374|FG000|Overall Study|Withdrawal by Subject|14|||
146686537|NCT00883116|529028375|FG001|Overall Study|Withdrawal by Subject|8|||
146686538|NCT00883116|529028374|FG000|Overall Study|No longer meets study criteria|2|||
146686539|NCT00883116|529028375|FG001|Overall Study|No longer meets study criteria|2|||
146686540|NCT03715764|529028376|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
146686541|NCT03715764|529028377|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
146686542|NCT03715764|529028376|FG000|3 Month Follow-up|Lost to Follow-up|2|||
146686543|NCT03715764|529028377|FG001|3 Month Follow-up|Lost to Follow-up|2|||
146686544|NCT03715764|529028376|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
146686545|NCT03715764|529028377|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
146686546|NCT03715764|529028376|FG000|6 Month Follow-up|Lost to Follow-up|3|||
146686547|NCT03715764|529028377|FG001|6 Month Follow-up|Lost to Follow-up|0|||
146686548|NCT03715764|529028376|FG000|12 Month Follow-up|Lost to Follow-up|2|||
146686549|NCT03715764|529028377|FG001|12 Month Follow-up|Lost to Follow-up|3|||
146686550|NCT03715764|529028376|FG000|12 Month Follow-up|Pregnancy|0|||
146686551|NCT03715764|529028377|FG001|12 Month Follow-up|Pregnancy|1|||
146686552|NCT03715764|529028376|FG000|12 Month Follow-up|Surgery|2|||
146686553|NCT03715764|529028377|FG001|12 Month Follow-up|Surgery|0|||
146686554|NCT03715764|529028376|FG000|12 Month Follow-up|Wrong address|1|||
146686555|NCT03715764|529028377|FG001|12 Month Follow-up|Wrong address|0|||
146686556|NCT03715764|529028376|FG000|12 Month Follow-up|No symptoms|1|||
146686557|NCT03715764|529028377|FG001|12 Month Follow-up|No symptoms|0|||
146686558|NCT03715764|529028376|FG000|12 Month Follow-up|Changed primary care centre|0|||
146927820|NCT02700919|529896026|FG000|Overall Study|Physician Decision|1|||
146686559|NCT03715764|529028377|FG001|12 Month Follow-up|Changed primary care centre|1|||
146686560|NCT01361464|529028380|FG000|Overall Study|Death|1|||
146686561|NCT01361464|529028380|FG000|Overall Study|Withdrawal by Subject|2|||
146686562|NCT03021265|529028381|FG000|Overall Study|Adverse Event|29|||
146686563|NCT03021265|529028381|FG000|Overall Study|Lack of Efficacy|3|||
146686564|NCT03021265|529028381|FG000|Overall Study|Improved|17|||
146686565|NCT03021265|529028381|FG000|Overall Study|Lost to Follow-up|67|||
146686566|NCT03021265|529028381|FG000|Overall Study|No reason given|2|||
146686567|NCT03021265|529028381|FG000|Overall Study|No visit since the first visit|4|||
146686568|NCT01106898|529028382|FG000|Overall Study|Adverse Event|6|||
146686569|NCT01698801|529028383|FG000|Treatment Phase|Adverse Event|4|||
146686570|NCT01698801|529028383|FG000|Treatment Phase|Protocol Violation|1|||
146686571|NCT01698801|529028383|FG000|Treatment Phase|Other|4|||
146686572|NCT01698801|529028383|FG000|Treatment Phase|Withdrawal by Subject|1|||
146686573|NCT01698801|529028383|FG000|Treatment Phase|Disease progression|1|||
146686574|NCT01698801|529028383|FG000|Follow Up Phase|Withdrawal by Subject|1|||
146686575|NCT01698801|529028383|FG000|Follow Up Phase|Death|4|||
146686576|NCT00541034|529028384|FG000|Overall Study|Non-Compliance|3|||
146927821|NCT02700919|529896027|FG001|Overall Study|Physician Decision|0|||
146927822|NCT02700919|529896028|FG002|Overall Study|Physician Decision|0|||
146686577|NCT01614067|529028386|FG000|Overall Study|Pregnancy|1|||
146686578|NCT01614067|529028387|FG001|Overall Study|Pregnancy|0|||
146927823|NCT02700919|529896026|FG000|Overall Study|Protocol Violation|1|||
146686579|NCT01614067|529028386|FG000|Overall Study|Physician Decision|6|||
146686580|NCT01614067|529028387|FG001|Overall Study|Physician Decision|5|||
146686581|NCT01614067|529028386|FG000|Overall Study|Withdrawal by Subject|0|||
146686582|NCT01614067|529028387|FG001|Overall Study|Withdrawal by Subject|1|||
146686583|NCT01614067|529028386|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
146927824|NCT02700919|529896027|FG001|Overall Study|Protocol Violation|0|||
146686584|NCT01614067|529028387|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
146686585|NCT01505868|529028388|FG000|Overall Study|Withdrawal by Subject|1|||
146686586|NCT01505868|529028389|FG001|Overall Study|Withdrawal by Subject|0|||
146686587|NCT01505868|529028390|FG002|Overall Study|Withdrawal by Subject|0|||
146686588|NCT01505868|529028391|FG003|Overall Study|Withdrawal by Subject|0|||
146686589|NCT01505868|529028392|FG004|Overall Study|Withdrawal by Subject|0|||
146686590|NCT02998840|529028395|FG000|Overall Study|Lost to Follow-up|1|||
146927825|NCT02700919|529896028|FG002|Overall Study|Protocol Violation|0|||
146686591|NCT02998840|529028396|FG001|Overall Study|Lost to Follow-up|1|||
146686592|NCT02998840|529028397|FG002|Overall Study|Lost to Follow-up|2|||
146686593|NCT02998840|529028398|FG003|Overall Study|Lost to Follow-up|3|||
146686594|NCT02998840|529028395|FG000|Overall Study|Withdrawal by Subject|1|||
146686595|NCT02998840|529028396|FG001|Overall Study|Withdrawal by Subject|1|||
146686596|NCT02998840|529028397|FG002|Overall Study|Withdrawal by Subject|0|||
146686597|NCT02998840|529028398|FG003|Overall Study|Withdrawal by Subject|1|||
146686598|NCT02998840|529028395|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
146686599|NCT02998840|529028396|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
146686600|NCT02998840|529028397|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
146686601|NCT02998840|529028398|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
146686602|NCT02625259|529028399|FG000|First Intervention (Day 1)|Other|0|||
146686603|NCT02625259|529028400|FG001|First Intervention (Day 1)|Other|0|||
146686604|NCT02625259|529028401|FG002|First Intervention (Day 1)|Other|1|||
146686605|NCT02625259|529028402|FG003|First Intervention (Day 1)|Other|0|||
146686606|NCT02625259|529028403|FG004|First Intervention (Day 1)|Other|0|||
146686607|NCT02625259|529028399|FG000|First Intervention (Day 1)|Adverse Event|2|||
146686608|NCT02625259|529028400|FG001|First Intervention (Day 1)|Adverse Event|1|||
146686609|NCT02625259|529028401|FG002|First Intervention (Day 1)|Adverse Event|0|||
146686610|NCT02625259|529028402|FG003|First Intervention (Day 1)|Adverse Event|0|||
146686611|NCT02625259|529028403|FG004|First Intervention (Day 1)|Adverse Event|0|||
146686612|NCT02625259|529028399|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
146686613|NCT02625259|529028400|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
146686614|NCT02625259|529028401|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
146686615|NCT02625259|529028402|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
146686616|NCT02625259|529028403|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
146686617|NCT00665847|529028404|FG000|Overall Study|Adverse Event|8|||
146686618|NCT00665847|529028404|FG000|Overall Study|Withdrawal by Subject|2|||
146686619|NCT00665847|529028404|FG000|Overall Study|Subject non-compliant|8|||
146686620|NCT00665847|529028404|FG000|Overall Study|Subject reached a virologic endpoint|4|||
146686621|NCT00665847|529028404|FG000|Overall Study|Resistance to TMC125|1|||
146686622|NCT00665847|529028404|FG000|Overall Study|Subject ineligible to continue the trial|1|||
146686623|NCT00665847|529028404|FG000|Overall Study|Switch to Commercial Medication|1|||
146686624|NCT01189812|529028405|FG000|Overall Study|Withdrawal by Subject|2|||
146686625|NCT01189812|529028406|FG001|Overall Study|Withdrawal by Subject|3|||
146686626|NCT01189812|529028405|FG000|Overall Study|Adverse Event|1|||
146686627|NCT01189812|529028406|FG001|Overall Study|Adverse Event|0|||
146686628|NCT01189812|529028405|FG000|Overall Study|Out of Window|4|||
146686629|NCT01189812|529028406|FG001|Overall Study|Out of Window|3|||
146686630|NCT01189812|529028405|FG000|Overall Study|Moved out of State|1|||
146686631|NCT01189812|529028406|FG001|Overall Study|Moved out of State|2|||
146686632|NCT02200445|529028408|FG000|Overall Study|Lack of Efficacy|1|||
146686633|NCT02200445|529028409|FG001|Overall Study|Lack of Efficacy|2|||
146686634|NCT02200445|529028410|FG002|Overall Study|Lack of Efficacy|2|||
146686635|NCT02200445|529028408|FG000|Overall Study|Adverse Event|0|||
146686636|NCT02200445|529028409|FG001|Overall Study|Adverse Event|2|||
146686637|NCT02200445|529028410|FG002|Overall Study|Adverse Event|0|||
146927826|NCT02700919|529896026|FG000|Overall Study|Adverse Event|1|||
146927827|NCT02700919|529896027|FG001|Overall Study|Adverse Event|3|||
146927828|NCT02700919|529896028|FG002|Overall Study|Adverse Event|1|||
146927829|NCT02700919|529896026|FG000|Overall Study|Withdrawal by Subject|5|||
146927830|NCT02700919|529896027|FG001|Overall Study|Withdrawal by Subject|8|||
146927831|NCT02700919|529896028|FG002|Overall Study|Withdrawal by Subject|2|||
146927832|NCT02700919|529896026|FG000|Overall Study|Lost to Follow-up|2|||
146686638|NCT00587561|529030944|FG000|Overall Study|Lost to Follow-up|6|||
146686639|NCT00587561|529030945|FG001|Overall Study|Lost to Follow-up|4|||
146686640|NCT03204981|529030947|FG000|Overall Study|Physician Decision|2|||
146686641|NCT03204981|529030947|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
146686642|NCT04244786|529030950|FG000|Overall Study|Adverse Event|0|||
146686643|NCT04244786|529030951|FG001|Overall Study|Adverse Event|0|||
146686644|NCT04244786|529030952|FG002|Overall Study|Adverse Event|2|||
146686645|NCT04244786|529030950|FG000|Overall Study|Withdrawal by Subject|0|||
146686646|NCT04244786|529030951|FG001|Overall Study|Withdrawal by Subject|0|||
146686647|NCT04244786|529030952|FG002|Overall Study|Withdrawal by Subject|5|||
146686648|NCT03274687|529030953|FG000|Overall Study|Protocol Violation|1|||
146927833|NCT02700919|529896027|FG001|Overall Study|Lost to Follow-up|0|||
146927834|NCT02700919|529896028|FG002|Overall Study|Lost to Follow-up|0|||
146686649|NCT03274687|529030954|FG001|Overall Study|Protocol Violation|1|||
146686650|NCT00613938|529030955|FG000|Overall Study|Withdrawal by Subject|2|||
146686651|NCT00613938|529030956|FG001|Overall Study|Withdrawal by Subject|4|||
146686652|NCT00613938|529030957|FG002|Overall Study|Withdrawal by Subject|9|||
146686653|NCT00613938|529030958|FG003|Overall Study|Withdrawal by Subject|9|||
146686654|NCT00613938|529030955|FG000|Overall Study|Adverse Event|1|||
146686655|NCT00613938|529030956|FG001|Overall Study|Adverse Event|4|||
146686656|NCT00613938|529030957|FG002|Overall Study|Adverse Event|8|||
146927835|NCT02700919|529896026|FG000|Overall Study|Other|2|||
146927836|NCT02700919|529896027|FG001|Overall Study|Other|1|||
146927837|NCT02700919|529896028|FG002|Overall Study|Other|1|||
146927838|NCT05136170|529896029|FG000|Overall Study|Withdrawal by Subject|2|||
146927839|NCT05136170|529896030|FG001|Overall Study|Withdrawal by Subject|2|||
146927840|NCT05136170|529896029|FG000|Overall Study|Can no longer make office visits|1|||
146927841|NCT05136170|529896030|FG001|Overall Study|Can no longer make office visits|0|||
146927842|NCT04393038|529896031|FG000|Overall Study|Adverse Event|11|||
146927843|NCT04393038|529896032|FG001|Overall Study|Adverse Event|2|||
146927844|NCT04393038|529896031|FG000|Overall Study|Protocol Violation|1|||
146927845|NCT04393038|529896032|FG001|Overall Study|Protocol Violation|0|||
146927846|NCT04393038|529896031|FG000|Overall Study|Death|6|||
146927847|NCT04393038|529896032|FG001|Overall Study|Death|4|||
146927848|NCT04393038|529896031|FG000|Overall Study|Withdrawal by Subject|24|||
146686657|NCT00613938|529030958|FG003|Overall Study|Adverse Event|5|||
146686658|NCT00613938|529030955|FG000|Overall Study|Lack of Efficacy|16|||
146686659|NCT00613938|529030956|FG001|Overall Study|Lack of Efficacy|18|||
146927849|NCT04393038|529896032|FG001|Overall Study|Withdrawal by Subject|8|||
146927850|NCT04393038|529896031|FG000|Overall Study|Lost to Follow-up|5|||
146927851|NCT04393038|529896032|FG001|Overall Study|Lost to Follow-up|4|||
146927852|NCT04393038|529896031|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
146927853|NCT04393038|529896032|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
146686660|NCT00613938|529030957|FG002|Overall Study|Lack of Efficacy|5|||
146686661|NCT00613938|529030958|FG003|Overall Study|Lack of Efficacy|9|||
146686662|NCT00613938|529030955|FG000|Overall Study|Other|1|||
146686663|NCT00613938|529030956|FG001|Overall Study|Other|2|||
146686664|NCT00613938|529030957|FG002|Overall Study|Other|1|||
146686665|NCT00613938|529030958|FG003|Overall Study|Other|3|||
146686666|NCT00623727|529030959|FG000|Double Blind (DB)|Adverse Event|1|||
146686667|NCT00623727|529030960|FG001|Double Blind (DB)|Adverse Event|3|||
146686668|NCT00623727|529030959|FG000|Double Blind (DB)|Physician Decision|0|||
146686669|NCT00623727|529030960|FG001|Double Blind (DB)|Physician Decision|1|||
146686670|NCT00623727|529030959|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
146686671|NCT00623727|529030960|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
146686672|NCT00623727|529030959|FG000|Double Blind (DB)|Lack of Efficacy|2|||
146686673|NCT00623727|529030960|FG001|Double Blind (DB)|Lack of Efficacy|2|||
146686674|NCT00623727|529030959|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
146686675|NCT00623727|529030960|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
146686676|NCT00623727|529030959|FG000|Double Blind (DB)|Lost to Follow-up|1|||
146686677|NCT00623727|529030960|FG001|Double Blind (DB)|Lost to Follow-up|1|||
146686678|NCT00623727|529030959|FG000|Double Blind (DB)|Protocol Violation|2|||
146736302|NCT00633932|529206805|FG002|Overall Study|Moved Away|0|||
146736303|NCT00482274|529206806|FG000|Overall Study|Adverse Event|1|||
146736304|NCT04836858|529206807|FG000|Overall Study|Adverse Event|0|||
146736305|NCT04836858|529206808|FG001|Overall Study|Adverse Event|0|||
146736306|NCT04836858|529206809|FG002|Overall Study|Adverse Event|0|||
146736307|NCT04836858|529206810|FG003|Overall Study|Adverse Event|1|||
146736308|NCT04836858|529206807|FG000|Overall Study|Lost to Follow-up|1|||
146736309|NCT04836858|529206808|FG001|Overall Study|Lost to Follow-up|0|||
146736310|NCT04836858|529206809|FG002|Overall Study|Lost to Follow-up|0|||
146736311|NCT04836858|529206810|FG003|Overall Study|Lost to Follow-up|0|||
146736312|NCT04836858|529206807|FG000|Overall Study|Subject/Guardian decision|3|||
146736313|NCT04836858|529206808|FG001|Overall Study|Subject/Guardian decision|0|||
146736314|NCT04836858|529206809|FG002|Overall Study|Subject/Guardian decision|0|||
146736315|NCT04836858|529206810|FG003|Overall Study|Subject/Guardian decision|1|||
146736316|NCT04836858|529206807|FG000|Overall Study|Randomized but not treated|4|||
146736317|NCT04836858|529206808|FG001|Overall Study|Randomized but not treated|0|||
146736318|NCT04836858|529206809|FG002|Overall Study|Randomized but not treated|0|||
146736319|NCT04836858|529206810|FG003|Overall Study|Randomized but not treated|0|||
146736320|NCT04887948|529206814|FG000|Overall Study|Death|1|||
146736321|NCT04887948|529206815|FG001|Overall Study|Death|0|||
146736322|NCT04887948|529206816|FG002|Overall Study|Death|0|||
146736323|NCT04887948|529206814|FG000|Overall Study|Lost to Follow-up|1|||
146736324|NCT04887948|529206815|FG001|Overall Study|Lost to Follow-up|0|||
146736325|NCT04887948|529206816|FG002|Overall Study|Lost to Follow-up|3|||
146736326|NCT04887948|529206814|FG000|Overall Study|Physician Decision|0|||
146736327|NCT04887948|529206815|FG001|Overall Study|Physician Decision|4|||
146736328|NCT04887948|529206816|FG002|Overall Study|Physician Decision|1|||
146736329|NCT04887948|529206814|FG000|Overall Study|Protocol Violation|1|||
146736330|NCT04887948|529206815|FG001|Overall Study|Protocol Violation|1|||
146736331|NCT04887948|529206816|FG002|Overall Study|Protocol Violation|0|||
146736332|NCT04887948|529206814|FG000|Overall Study|Withdrawal by Subject|0|||
146736333|NCT04887948|529206815|FG001|Overall Study|Withdrawal by Subject|6|||
146736334|NCT04887948|529206816|FG002|Overall Study|Withdrawal by Subject|1|||
146736335|NCT04887948|529206814|FG000|Overall Study|No longer met eligibility criteria|1|||
146736336|NCT04887948|529206815|FG001|Overall Study|No longer met eligibility criteria|2|||
146736337|NCT04887948|529206816|FG002|Overall Study|No longer met eligibility criteria|1|||
146686679|NCT00623727|529030960|FG001|Double Blind (DB)|Protocol Violation|2|||
146686680|NCT00623727|529030959|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
146686681|NCT00623727|529030960|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
146686682|NCT00623727|529030959|FG000|Open Label Follow-up|Study termination|0|||
146686683|NCT00623727|529030960|FG001|Open Label Follow-up|Study termination|6|||
146686684|NCT00623727|529030959|FG000|Open Label Follow-up|Participant convenience|0|||
146686685|NCT00623727|529030960|FG001|Open Label Follow-up|Participant convenience|1|||
146686686|NCT03745937|529030961|FG000|Overall Study|Withdrawal by Subject|0|||
146686687|NCT03745937|529030962|FG001|Overall Study|Withdrawal by Subject|0|||
146686688|NCT03745937|529030963|FG002|Overall Study|Withdrawal by Subject|0|||
146686689|NCT03745937|529030964|FG003|Overall Study|Withdrawal by Subject|1|||
146686690|NCT03745937|529030961|FG000|Overall Study|Not-specifed|0|||
146686691|NCT03745937|529030962|FG001|Overall Study|Not-specifed|1|||
146686692|NCT03745937|529030963|FG002|Overall Study|Not-specifed|0|||
146686693|NCT03745937|529030964|FG003|Overall Study|Not-specifed|1|||
146686694|NCT01706003|529030970|FG000|Overall Study|Withdrawal by Subject|2|||
146686695|NCT01706003|529030971|FG001|Overall Study|Withdrawal by Subject|0|||
146686696|NCT01706003|529030970|FG000|Overall Study|Not scheduled|3|||
146686697|NCT01706003|529030971|FG001|Overall Study|Not scheduled|0|||
146686698|NCT01706003|529030970|FG000|Overall Study|Lost to Follow-up|6|||
146686699|NCT01706003|529030971|FG001|Overall Study|Lost to Follow-up|4|||
146686700|NCT03316131|529030972|FG000|Treatment Period 2|Protocol deviation|1|||
146686701|NCT03316131|529030973|FG001|Treatment Period 2|Protocol deviation|0|||
146686702|NCT02699554|529030975|FG000|Overall Study|Lost to Follow-up|9|||
146686703|NCT00788151|529030976|FG000|Overall Study|Other adverse event|0|||
146686704|NCT00788151|529030977|FG001|Overall Study|Other adverse event|2|||
146686705|NCT00788151|529030976|FG000|Overall Study|Protocol Violation|0|||
146686706|NCT00788151|529030977|FG001|Overall Study|Protocol Violation|1|||
146686707|NCT00788151|529030976|FG000|Overall Study|Withdrawal by Subject|13|||
146686708|NCT00788151|529030977|FG001|Overall Study|Withdrawal by Subject|6|||
146686709|NCT00788151|529030976|FG000|Overall Study|Enrolled but not treated|1|||
146686710|NCT00788151|529030977|FG001|Overall Study|Enrolled but not treated|1|||
146686711|NCT00503009|529030978|FG000|Overall Study|Protocol Violation|1|||
146686712|NCT00503009|529030979|FG001|Overall Study|Protocol Violation|0|||
146686713|NCT00503009|529030980|FG002|Overall Study|Protocol Violation|1|||
146686714|NCT00503009|529030978|FG000|Overall Study|Withdrawal by Subject|0|||
146686715|NCT00503009|529030979|FG001|Overall Study|Withdrawal by Subject|1|||
146686716|NCT00503009|529030980|FG002|Overall Study|Withdrawal by Subject|1|||
146686717|NCT00503009|529030978|FG000|Overall Study|Physician Decision|0|||
146686718|NCT00503009|529030979|FG001|Overall Study|Physician Decision|1|||
146686719|NCT00503009|529030980|FG002|Overall Study|Physician Decision|1|||
146686720|NCT02169739|529030981|FG000|Overall Study|Lost to Follow-up|0|||
146686721|NCT02169739|529030982|FG001|Overall Study|Lost to Follow-up|4|||
146686722|NCT03635957|529030983|FG000|Run-In Period|Lost to Follow-up|1|||
146686723|NCT03635957|529030983|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
146686724|NCT00350636|529030984|FG000|Overall Study|Adverse Event|19|||
146686725|NCT00350636|529030985|FG001|Overall Study|Adverse Event|13|||
146686726|NCT00350636|529030984|FG000|Overall Study|Protocol Violation|1|||
146686727|NCT00350636|529030985|FG001|Overall Study|Protocol Violation|3|||
146686728|NCT00350636|529030984|FG000|Overall Study|Withdrawal by Subject|13|||
146686729|NCT00350636|529030985|FG001|Overall Study|Withdrawal by Subject|17|||
146686730|NCT00350636|529030984|FG000|Overall Study|Lost to Follow-up|9|||
146686731|NCT00350636|529030985|FG001|Overall Study|Lost to Follow-up|8|||
146686732|NCT00350636|529030984|FG000|Overall Study|Physician Decision|0|||
146686733|NCT00350636|529030985|FG001|Overall Study|Physician Decision|2|||
146686734|NCT00350636|529030984|FG000|Overall Study|Other|1|||
146927854|NCT04393038|529896031|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
146927855|NCT04393038|529896032|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
146927856|NCT05168813|529896033|FG000|Part A (Open-label)|Lost to Follow-up|21|||
146927857|NCT05168813|529896034|FG001|Part A (Open-label)|Lost to Follow-up|39|||
146927858|NCT05168813|529896035|FG002|Part A (Open-label)|Lost to Follow-up|8|||
146686735|NCT00350636|529030985|FG001|Overall Study|Other|2|||
146686736|NCT01647282|529030989|FG000|Overall Study|Physician Decision|7|||
146686737|NCT01647282|529030990|FG001|Overall Study|Physician Decision|5|||
146686738|NCT03683758|529030997|FG000|Overall Study|Non-study commitment conflict|1|||
146686739|NCT03683758|529030998|FG001|Overall Study|Non-study commitment conflict|3|||
146686740|NCT03683758|529030997|FG000|Overall Study|Illness preventing participation|1|||
146686741|NCT03683758|529030998|FG001|Overall Study|Illness preventing participation|0|||
146686742|NCT03683758|529030997|FG000|Overall Study|Adverse Event|1|||
146686743|NCT03683758|529030998|FG001|Overall Study|Adverse Event|0|||
146686744|NCT01172847|529030999|FG000|Overall Study|Withdrawal by Subject|3|||
146686745|NCT01163279|529031000|FG000|Overall Study|Withdrawal by Subject|2|||
146686746|NCT01163279|529031001|FG001|Overall Study|Withdrawal by Subject|0|||
146686747|NCT02232425|529031004|FG000|Overall Study|Lost to Follow-up|6|||
146686748|NCT02232425|529031005|FG001|Overall Study|Lost to Follow-up|2|||
146686749|NCT02232425|529031004|FG000|Overall Study|Adverse Event|2|||
146686750|NCT02232425|529031005|FG001|Overall Study|Adverse Event|0|||
146686751|NCT02232425|529031004|FG000|Overall Study|Withdrawal by Subject|5|||
146686752|NCT02232425|529031005|FG001|Overall Study|Withdrawal by Subject|6|||
146686753|NCT02232425|529031004|FG000|Overall Study|Lack of Efficacy|1|||
146686754|NCT02232425|529031005|FG001|Overall Study|Lack of Efficacy|0|||
146686755|NCT01601626|529031006|FG000|Overall Study|Death|1|||
146686756|NCT01601626|529031007|FG001|Overall Study|Death|1|||
146686757|NCT01601626|529031008|FG002|Overall Study|Death|1|||
146686758|NCT01601626|529031006|FG000|Overall Study|Lost to Follow-up|1|||
146686759|NCT01601626|529031007|FG001|Overall Study|Lost to Follow-up|2|||
146686760|NCT01601626|529031008|FG002|Overall Study|Lost to Follow-up|0|||
146686761|NCT01601626|529031006|FG000|Overall Study|Unable to Get to Clinic|0|||
146686762|NCT01601626|529031007|FG001|Overall Study|Unable to Get to Clinic|1|||
146686763|NCT01601626|529031008|FG002|Overall Study|Unable to Get to Clinic|0|||
146686764|NCT01601626|529031006|FG000|Overall Study|Withdrawal by Subject|0|||
146686765|NCT01601626|529031007|FG001|Overall Study|Withdrawal by Subject|1|||
146686766|NCT01601626|529031008|FG002|Overall Study|Withdrawal by Subject|1|||
146686767|NCT01601626|529031006|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
146686768|NCT01601626|529031007|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
146686769|NCT01601626|529031008|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
146686770|NCT03914326|529031009|FG000|Overall Study|Withdrawal by Subject|27|||
146686771|NCT03914326|529031010|FG001|Overall Study|Withdrawal by Subject|34|||
146686772|NCT03914326|529031009|FG000|Overall Study|Lost to Follow-up|43|||
146686773|NCT03914326|529031010|FG001|Overall Study|Lost to Follow-up|51|||
146686774|NCT03914326|529031009|FG000|Overall Study|Randomised more than once|0|||
146686775|NCT03914326|529031010|FG001|Overall Study|Randomised more than once|1|||
146686776|NCT03274440|529031011|FG000|Overall Study|Time commitment too great|1|||
146686777|NCT03274440|529031012|FG001|Overall Study|Time commitment too great|0|||
146686778|NCT03274440|529031013|FG002|Overall Study|Time commitment too great|0|||
146686779|NCT03274440|529031014|FG003|Overall Study|Time commitment too great|1|||
146686780|NCT03274440|529031015|FG004|Overall Study|Time commitment too great|0|||
146686781|NCT03274440|529031016|FG005|Overall Study|Time commitment too great|0|||
146686782|NCT01291173|529031017|FG000|Overall Study|Adverse Event|0|||
146686783|NCT01291173|529031018|FG001|Overall Study|Adverse Event|3|||
146686784|NCT01291173|529031019|FG002|Overall Study|Adverse Event|1|||
146686785|NCT01291173|529031020|FG003|Overall Study|Adverse Event|3|||
146686786|NCT01291173|529031017|FG000|Overall Study|Protocol Violation|7|||
146686787|NCT01291173|529031018|FG001|Overall Study|Protocol Violation|2|||
146686788|NCT01291173|529031019|FG002|Overall Study|Protocol Violation|2|||
146686789|NCT01291173|529031020|FG003|Overall Study|Protocol Violation|5|||
146686790|NCT01291173|529031017|FG000|Overall Study|Withdrawal by Subject|6|||
146686791|NCT01291173|529031018|FG001|Overall Study|Withdrawal by Subject|4|||
146686792|NCT01291173|529031019|FG002|Overall Study|Withdrawal by Subject|4|||
146686793|NCT01291173|529031020|FG003|Overall Study|Withdrawal by Subject|2|||
146686794|NCT01291173|529031017|FG000|Overall Study|Lost to Follow-up|4|||
146686795|NCT01291173|529031018|FG001|Overall Study|Lost to Follow-up|6|||
146686796|NCT01291173|529031019|FG002|Overall Study|Lost to Follow-up|3|||
146686797|NCT01291173|529031020|FG003|Overall Study|Lost to Follow-up|2|||
146686798|NCT01291173|529031017|FG000|Overall Study|Unable to meet visit schedule|0|||
146686799|NCT01291173|529031018|FG001|Overall Study|Unable to meet visit schedule|0|||
146686800|NCT01291173|529031019|FG002|Overall Study|Unable to meet visit schedule|1|||
146686801|NCT01291173|529031020|FG003|Overall Study|Unable to meet visit schedule|0|||
146686802|NCT01291173|529031017|FG000|Overall Study|Lack of compliance|0|||
146686803|NCT01291173|529031018|FG001|Overall Study|Lack of compliance|0|||
146686804|NCT01291173|529031019|FG002|Overall Study|Lack of compliance|0|||
146686805|NCT01291173|529031020|FG003|Overall Study|Lack of compliance|1|||
146686806|NCT01291173|529031017|FG000|Overall Study|Subject was unblinded|0|||
146686807|NCT01291173|529031018|FG001|Overall Study|Subject was unblinded|0|||
146686808|NCT01291173|529031019|FG002|Overall Study|Subject was unblinded|1|||
146686809|NCT01291173|529031020|FG003|Overall Study|Subject was unblinded|0|||
146686810|NCT01291173|529031017|FG000|Overall Study|Excluded therapy|0|||
146686811|NCT01291173|529031018|FG001|Overall Study|Excluded therapy|0|||
146686812|NCT01291173|529031019|FG002|Overall Study|Excluded therapy|1|||
146686813|NCT01291173|529031020|FG003|Overall Study|Excluded therapy|0|||
146686814|NCT00390858|529031021|FG000|Overall Study|Adverse Event|6|||
146686815|NCT00390858|529031022|FG001|Overall Study|Adverse Event|2|||
146686816|NCT00390858|529031021|FG000|Overall Study|Lack of Efficacy|0|||
146686817|NCT00390858|529031022|FG001|Overall Study|Lack of Efficacy|1|||
146686818|NCT00390858|529031021|FG000|Overall Study|Withdrawal by Subject|3|||
146686819|NCT00390858|529031022|FG001|Overall Study|Withdrawal by Subject|4|||
146686820|NCT00450450|529031026|FG000|Overall Study|Death|1|||
146686821|NCT00450450|529031027|FG001|Overall Study|Death|3|||
146686822|NCT00450450|529031026|FG000|Overall Study|Relapse|2|||
146686823|NCT00450450|529031027|FG001|Overall Study|Relapse|0|||
146686824|NCT00450450|529031026|FG000|Overall Study|Missing Data|2|||
146686825|NCT00450450|529031027|FG001|Overall Study|Missing Data|0|||
146686826|NCT03178773|529031031|FG000|Overall Study|Death|0|||
146686827|NCT03178773|529031032|FG001|Overall Study|Death|1|||
146686828|NCT03178773|529031031|FG000|Overall Study|Lost to Follow-up|29|||
146686829|NCT03178773|529031032|FG001|Overall Study|Lost to Follow-up|25|||
146686830|NCT03178773|529031031|FG000|Overall Study|Withdrawal by Subject|10|||
146686831|NCT03178773|529031032|FG001|Overall Study|Withdrawal by Subject|14|||
146686832|NCT02141997|529031034|FG000|Overall Study|Adverse Event|0|||
146686833|NCT02141997|529031035|FG001|Overall Study|Adverse Event|2|||
146686834|NCT02141997|529031036|FG002|Overall Study|Adverse Event|0|||
146686835|NCT02141997|529031037|FG003|Overall Study|Adverse Event|1|||
146686836|NCT02141997|529031034|FG000|Overall Study|Participant noncompliance|1|||
146686837|NCT02141997|529031035|FG001|Overall Study|Participant noncompliance|0|||
146686838|NCT02141997|529031036|FG002|Overall Study|Participant noncompliance|0|||
146686839|NCT02141997|529031037|FG003|Overall Study|Participant noncompliance|0|||
146686840|NCT02141997|529031034|FG000|Overall Study|Withdrew consent|1|||
146686841|NCT02141997|529031035|FG001|Overall Study|Withdrew consent|0|||
146686842|NCT02141997|529031036|FG002|Overall Study|Withdrew consent|3|||
146686843|NCT02141997|529031037|FG003|Overall Study|Withdrew consent|0|||
146686844|NCT02141997|529031034|FG000|Overall Study|Other|1|||
146686845|NCT02141997|529031035|FG001|Overall Study|Other|4|||
146686846|NCT02141997|529031036|FG002|Overall Study|Other|0|||
146686847|NCT02141997|529031037|FG003|Overall Study|Other|0|||
146686848|NCT01496313|529031038|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
146686849|NCT01496313|529031039|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
146686850|NCT01496313|529031040|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
146686851|NCT01496313|529031041|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
146686852|NCT01496313|529031042|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
146686853|NCT01496313|529031043|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
146686854|NCT01496313|529031038|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
146686855|NCT01496313|529031039|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
146686856|NCT01496313|529031040|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
146686857|NCT01496313|529031041|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
146686858|NCT01496313|529031042|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
146686859|NCT01496313|529031043|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
146686860|NCT01496313|529031038|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
146686861|NCT01496313|529031039|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
146686862|NCT01496313|529031040|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
146686863|NCT01496313|529031041|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
146686864|NCT01496313|529031042|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
146686865|NCT01496313|529031043|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
146686866|NCT01496313|529031038|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
146686867|NCT01496313|529031039|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
146686868|NCT01496313|529031040|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
146686869|NCT01496313|529031041|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
146686870|NCT01496313|529031042|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
146686871|NCT01496313|529031043|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
146686872|NCT01496313|529031038|FG000|Randomized Period (up to 14 Months)|Other|1|||
146686873|NCT01496313|529031039|FG001|Randomized Period (up to 14 Months)|Other|2|||
146686874|NCT01496313|529031040|FG002|Randomized Period (up to 14 Months)|Other|0|||
146686875|NCT01496313|529031041|FG003|Randomized Period (up to 14 Months)|Other|0|||
146686876|NCT01496313|529031042|FG004|Randomized Period (up to 14 Months)|Other|0|||
146686877|NCT01496313|529031043|FG005|Randomized Period (up to 14 Months)|Other|0|||
146686878|NCT01496313|529031038|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
146686879|NCT01496313|529031039|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
146686880|NCT01496313|529031040|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
146686881|NCT01496313|529031041|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
146686882|NCT01496313|529031042|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
146686883|NCT01496313|529031043|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
146686884|NCT01496313|529031038|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
146686885|NCT01496313|529031039|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
146686886|NCT01496313|529031040|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
146686887|NCT01496313|529031041|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
146686888|NCT01496313|529031042|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
146686889|NCT01496313|529031043|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
146686890|NCT01496313|529031038|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
146686891|NCT01496313|529031039|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
146686892|NCT01496313|529031040|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
146686893|NCT01496313|529031041|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
146686894|NCT01496313|529031042|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
146686895|NCT01496313|529031043|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
146774879|NCT04188379|529346799|FG000|Overall Study|Pregnancy|1|||
146774880|NCT04188379|529346800|FG001|Overall Study|Pregnancy|0|||
146774881|NCT04188379|529346799|FG000|Overall Study|Lack of Efficacy|8|||
146774882|NCT04188379|529346800|FG001|Overall Study|Lack of Efficacy|5|||
146774883|NCT04188379|529346799|FG000|Overall Study|Other|0|||
146774884|NCT04188379|529346800|FG001|Overall Study|Other|3|||
146774885|NCT01693120|529346802|FG000|Enrollment|Lost to Follow-up|1|||
146774886|NCT01693120|529346802|FG000|Enrollment|Withdrawal by Subject|10|||
146774887|NCT01693120|529346802|FG000|Enrollment|Protocol Violation|46|||
146686896|NCT00451321|529031047|FG000|Overall Study|Lost to Follow-up|3|||
146686897|NCT00451321|529031048|FG001|Overall Study|Lost to Follow-up|3|||
146686898|NCT00451321|529031049|FG002|Overall Study|Lost to Follow-up|1|||
146686899|NCT00451321|529031050|FG003|Overall Study|Lost to Follow-up|3|||
146686900|NCT00451321|529031051|FG004|Overall Study|Lost to Follow-up|0|||
146686901|NCT00451321|529031052|FG005|Overall Study|Lost to Follow-up|1|||
146686902|NCT00451321|529031053|FG006|Overall Study|Lost to Follow-up|0|||
146686903|NCT00451321|529031054|FG007|Overall Study|Lost to Follow-up|0|||
146686904|NCT00451321|529031047|FG000|Overall Study|Withdrawal by Subject|3|||
146686905|NCT00451321|529031048|FG001|Overall Study|Withdrawal by Subject|1|||
146686906|NCT00451321|529031049|FG002|Overall Study|Withdrawal by Subject|0|||
146686907|NCT00451321|529031050|FG003|Overall Study|Withdrawal by Subject|4|||
146686908|NCT00451321|529031051|FG004|Overall Study|Withdrawal by Subject|0|||
146686909|NCT00451321|529031052|FG005|Overall Study|Withdrawal by Subject|0|||
146686910|NCT00451321|529031053|FG006|Overall Study|Withdrawal by Subject|0|||
146686911|NCT00451321|529031054|FG007|Overall Study|Withdrawal by Subject|0|||
146686912|NCT00451321|529031047|FG000|Overall Study|Study closed/terminated|1|||
146686913|NCT00451321|529031048|FG001|Overall Study|Study closed/terminated|1|||
146686914|NCT00451321|529031049|FG002|Overall Study|Study closed/terminated|17|||
146686915|NCT00451321|529031050|FG003|Overall Study|Study closed/terminated|5|||
146686916|NCT00451321|529031051|FG004|Overall Study|Study closed/terminated|7|||
146686917|NCT00451321|529031052|FG005|Overall Study|Study closed/terminated|7|||
146686918|NCT00451321|529031053|FG006|Overall Study|Study closed/terminated|5|||
146686919|NCT00451321|529031054|FG007|Overall Study|Study closed/terminated|3|||
146686920|NCT00451321|529031047|FG000|Overall Study|Sponsor decision to amend protocol|0|||
146686921|NCT00451321|529031048|FG001|Overall Study|Sponsor decision to amend protocol|0|||
146686922|NCT00451321|529031049|FG002|Overall Study|Sponsor decision to amend protocol|0|||
146686923|NCT00451321|529031050|FG003|Overall Study|Sponsor decision to amend protocol|0|||
146686924|NCT00451321|529031051|FG004|Overall Study|Sponsor decision to amend protocol|0|||
146686925|NCT00451321|529031052|FG005|Overall Study|Sponsor decision to amend protocol|1|||
146686926|NCT00451321|529031053|FG006|Overall Study|Sponsor decision to amend protocol|1|||
146686927|NCT00451321|529031054|FG007|Overall Study|Sponsor decision to amend protocol|3|||
146686928|NCT00909389|529031056|FG000|Overall Study|Adverse Event|6|||
146686929|NCT00909389|529031056|FG000|Overall Study|Death|4|||
146686930|NCT00909389|529031056|FG000|Overall Study|Poor Compliance|16|||
146686931|NCT00909389|529031056|FG000|Overall Study|Lost to Follow-up|4|||
146686932|NCT00909389|529031056|FG000|Overall Study|No Information|103|||
146686933|NCT03557151|529031057|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
146686934|NCT03557151|529031058|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
146686935|NCT03557151|529031057|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
146686936|NCT03557151|529031058|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
146686937|NCT03557151|529031057|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
146686938|NCT03557151|529031058|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
146686939|NCT04868890|529031064|FG000|Overall Study|Death|2|||
146686940|NCT04868890|529031065|FG001|Overall Study|Death|1|||
146686941|NCT04868890|529031064|FG000|Overall Study|Withdrawal by Subject|1|||
146686942|NCT04868890|529031065|FG001|Overall Study|Withdrawal by Subject|5|||
146686943|NCT02157298|529031075|FG000|Overall Study|Adverse Event|1|||
146686944|NCT02157298|529031076|FG001|Overall Study|Adverse Event|0|||
146686945|NCT02157298|529031075|FG000|Overall Study|Subject no longer meets study criteria|1|||
146686946|NCT02157298|529031076|FG001|Overall Study|Subject no longer meets study criteria|2|||
146686947|NCT02157298|529031075|FG000|Overall Study|Poor/Non-compliance|1|||
146686948|NCT02157298|529031076|FG001|Overall Study|Poor/Non-compliance|0|||
146774888|NCT01693120|529346802|FG000|Enrollment|Physician Decision|3|||
146774889|NCT01693120|529346802|FG000|Enrollment|Adverse Event|1|||
146774890|NCT01693120|529346802|FG000|Enrollment|Study closed|8|||
146774891|NCT01693120|529346802|FG000|Enrollment|Other|1|||
146686949|NCT02157298|529031075|FG000|Overall Study|Withdrawal by Subject|1|||
146686950|NCT02157298|529031076|FG001|Overall Study|Withdrawal by Subject|0|||
146686951|NCT00818662|529031081|FG000|Overall Study|Adverse Event|5|||
146686952|NCT00818662|529031082|FG001|Overall Study|Adverse Event|14|||
146686953|NCT00818662|529031083|FG002|Overall Study|Adverse Event|4|||
146686954|NCT00818662|529031084|FG003|Overall Study|Adverse Event|3|||
146686955|NCT00818662|529031081|FG000|Overall Study|Withdrawal by Subject|5|||
146686956|NCT00818662|529031082|FG001|Overall Study|Withdrawal by Subject|4|||
146774892|NCT01693120|529346802|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
146774893|NCT01693120|529346802|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
146686957|NCT00818662|529031083|FG002|Overall Study|Withdrawal by Subject|2|||
146686958|NCT00818662|529031084|FG003|Overall Study|Withdrawal by Subject|2|||
146686959|NCT00818662|529031081|FG000|Overall Study|Death|1|||
146686960|NCT00818662|529031082|FG001|Overall Study|Death|3|||
146686961|NCT00818662|529031083|FG002|Overall Study|Death|0|||
146686962|NCT00818662|529031084|FG003|Overall Study|Death|0|||
146686963|NCT00818662|529031081|FG000|Overall Study|Physician Decision|1|||
146686964|NCT00818662|529031082|FG001|Overall Study|Physician Decision|0|||
146686965|NCT00818662|529031083|FG002|Overall Study|Physician Decision|0|||
146686966|NCT00818662|529031084|FG003|Overall Study|Physician Decision|0|||
146686967|NCT00818662|529031081|FG000|Overall Study|Lost to Follow-up|0|||
146686968|NCT00818662|529031082|FG001|Overall Study|Lost to Follow-up|0|||
146686969|NCT00818662|529031083|FG002|Overall Study|Lost to Follow-up|0|||
146686970|NCT00818662|529031084|FG003|Overall Study|Lost to Follow-up|1|||
146686971|NCT00818662|529031081|FG000|Overall Study|Unwilling or Unable to Participate|4|||
146686972|NCT00818662|529031082|FG001|Overall Study|Unwilling or Unable to Participate|6|||
146686973|NCT00818662|529031083|FG002|Overall Study|Unwilling or Unable to Participate|2|||
146686974|NCT00818662|529031084|FG003|Overall Study|Unwilling or Unable to Participate|4|||
146686975|NCT00818662|529031081|FG000|Overall Study|Protocol Violation|1|||
146686976|NCT00818662|529031082|FG001|Overall Study|Protocol Violation|1|||
146686977|NCT00818662|529031083|FG002|Overall Study|Protocol Violation|0|||
146686978|NCT00818662|529031084|FG003|Overall Study|Protocol Violation|0|||
146686979|NCT00818662|529031081|FG000|Overall Study|Requires a Prohibited Medication|1|||
146686980|NCT00818662|529031082|FG001|Overall Study|Requires a Prohibited Medication|0|||
146686981|NCT00818662|529031083|FG002|Overall Study|Requires a Prohibited Medication|0|||
146686982|NCT00818662|529031084|FG003|Overall Study|Requires a Prohibited Medication|0|||
146686983|NCT00818662|529031081|FG000|Overall Study|Safety Risk|1|||
146686984|NCT00818662|529031082|FG001|Overall Study|Safety Risk|1|||
146686985|NCT00818662|529031083|FG002|Overall Study|Safety Risk|0|||
146686986|NCT00818662|529031084|FG003|Overall Study|Safety Risk|1|||
146686987|NCT00818662|529031081|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
146686988|NCT00818662|529031082|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
146686989|NCT00818662|529031083|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
146686990|NCT00818662|529031084|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
146686991|NCT00818662|529031081|FG000|Overall Study|Participant's health declined|0|||
146686992|NCT00818662|529031082|FG001|Overall Study|Participant's health declined|0|||
146686993|NCT00818662|529031083|FG002|Overall Study|Participant's health declined|0|||
146686994|NCT00818662|529031084|FG003|Overall Study|Participant's health declined|1|||
146686995|NCT00818662|529031081|FG000|Overall Study|Caregiver to pursue other treatment|0|||
146686996|NCT00818662|529031082|FG001|Overall Study|Caregiver to pursue other treatment|1|||
146686997|NCT00818662|529031083|FG002|Overall Study|Caregiver to pursue other treatment|0|||
146686998|NCT00818662|529031084|FG003|Overall Study|Caregiver to pursue other treatment|0|||
146686999|NCT00818662|529031081|FG000|Overall Study|Moving out of state|0|||
146687000|NCT00818662|529031082|FG001|Overall Study|Moving out of state|0|||
146687001|NCT00818662|529031083|FG002|Overall Study|Moving out of state|0|||
146687002|NCT00818662|529031084|FG003|Overall Study|Moving out of state|1|||
146687003|NCT00818662|529031081|FG000|Overall Study|Declined move to another study site|1|||
146687004|NCT00818662|529031082|FG001|Overall Study|Declined move to another study site|0|||
146687005|NCT00818662|529031083|FG002|Overall Study|Declined move to another study site|0|||
146687006|NCT00818662|529031084|FG003|Overall Study|Declined move to another study site|0|||
146687007|NCT00818662|529031081|FG000|Overall Study|Change in living situation|0|||
146687008|NCT00818662|529031082|FG001|Overall Study|Change in living situation|0|||
146687009|NCT00818662|529031083|FG002|Overall Study|Change in living situation|0|||
146687010|NCT00818662|529031084|FG003|Overall Study|Change in living situation|1|||
146687011|NCT00818662|529031081|FG000|Overall Study|Study partner decision|0|||
146687012|NCT00818662|529031082|FG001|Overall Study|Study partner decision|0|||
146687013|NCT00818662|529031083|FG002|Overall Study|Study partner decision|0|||
146687014|NCT00818662|529031084|FG003|Overall Study|Study partner decision|1|||
146687015|NCT00818662|529031081|FG000|Overall Study|Admitted to long term nursing care|0|||
146927859|NCT05168813|529896036|FG003|Part A (Open-label)|Lost to Follow-up|26|||
146927860|NCT05168813|529896037|FG004|Part A (Open-label)|Lost to Follow-up|0|||
146687016|NCT00818662|529031082|FG001|Overall Study|Admitted to long term nursing care|1|||
146687017|NCT00818662|529031083|FG002|Overall Study|Admitted to long term nursing care|0|||
146687018|NCT00818662|529031084|FG003|Overall Study|Admitted to long term nursing care|0|||
146687019|NCT01722071|529031085|FG000|Overall Study|Protocol Violation|1|||
146687020|NCT01722071|529031086|FG001|Overall Study|Protocol Violation|0|||
146687021|NCT01338493|529031087|FG000|Enrolled|Withdrawal by Subject|1|||
146687022|NCT01338493|529031087|FG000|Enrolled|Patient not implanted|4|||
146687023|NCT01338493|529031087|FG000|Discharge|Death|1|||
146687024|NCT01338493|529031087|FG000|Discharge|Missed visit|1|||
146687025|NCT01338493|529031087|FG000|6 Months Follow up|Lost to Follow-up|11|||
146927861|NCT05168813|529896038|FG005|Part A (Open-label)|Lost to Follow-up|0|||
146687026|NCT01338493|529031087|FG000|6 Months Follow up|Missed visit|8|||
146687027|NCT01338493|529031087|FG000|12 Months Follow up|Lost to Follow-up|9|||
146687028|NCT01472081|529031088|FG000|Overall Study|Continuing treatment at time of analysis|1|||
146687029|NCT01472081|529031089|FG001|Overall Study|Continuing treatment at time of analysis|4|||
146687030|NCT01472081|529031090|FG002|Overall Study|Continuing treatment at time of analysis|1|||
146687031|NCT01472081|529031091|FG003|Overall Study|Continuing treatment at time of analysis|8|||
146687032|NCT01472081|529031092|FG004|Overall Study|Continuing treatment at time of analysis|9|||
146687033|NCT01472081|529031093|FG005|Overall Study|Continuing treatment at time of analysis|0|||
146687034|NCT01472081|529031088|FG000|Overall Study|Disease Progression|4|||
146687035|NCT01472081|529031089|FG001|Overall Study|Disease Progression|10|||
146687036|NCT01472081|529031090|FG002|Overall Study|Disease Progression|12|||
146687037|NCT01472081|529031091|FG003|Overall Study|Disease Progression|31|||
146687038|NCT01472081|529031092|FG004|Overall Study|Disease Progression|22|||
146687039|NCT01472081|529031093|FG005|Overall Study|Disease Progression|3|||
146687040|NCT01472081|529031088|FG000|Overall Study|Study drug toxicity|2|||
146687041|NCT01472081|529031089|FG001|Overall Study|Study drug toxicity|9|||
146687042|NCT01472081|529031090|FG002|Overall Study|Study drug toxicity|4|||
146687043|NCT01472081|529031091|FG003|Overall Study|Study drug toxicity|6|||
146687044|NCT01472081|529031092|FG004|Overall Study|Study drug toxicity|13|||
146687045|NCT01472081|529031093|FG005|Overall Study|Study drug toxicity|2|||
146687046|NCT01472081|529031088|FG000|Overall Study|Death|0|||
146927862|NCT05168813|529896033|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
146927863|NCT05168813|529896034|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
146927864|NCT05168813|529896035|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
146927865|NCT05168813|529896036|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
146927866|NCT05168813|529896037|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
146927867|NCT05168813|529896038|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
146927868|NCT05168813|529896033|FG000|Part A (Open-label)|Death|23|||
146927869|NCT05168813|529896034|FG001|Part A (Open-label)|Death|28|||
146927870|NCT05168813|529896035|FG002|Part A (Open-label)|Death|1|||
146927871|NCT05168813|529896036|FG003|Part A (Open-label)|Death|9|||
146927872|NCT05168813|529896037|FG004|Part A (Open-label)|Death|0|||
146927873|NCT05168813|529896038|FG005|Part A (Open-label)|Death|0|||
146927874|NCT05168813|529896033|FG000|Part A (Open-label)|Physician Decision|0|||
146927875|NCT05168813|529896034|FG001|Part A (Open-label)|Physician Decision|1|||
146927876|NCT05168813|529896035|FG002|Part A (Open-label)|Physician Decision|0|||
146927877|NCT05168813|529896036|FG003|Part A (Open-label)|Physician Decision|2|||
146927878|NCT05168813|529896037|FG004|Part A (Open-label)|Physician Decision|0|||
146927879|NCT05168813|529896038|FG005|Part A (Open-label)|Physician Decision|0|||
146927880|NCT05168813|529896033|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
146927881|NCT05168813|529896034|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
146927882|NCT05168813|529896035|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
146927883|NCT05168813|529896036|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
146927884|NCT05168813|529896037|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
146927885|NCT05168813|529896038|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
146927886|NCT05168813|529896033|FG000|Part A (Open-label)|Protocol Violation|0|||
146927887|NCT05168813|529896034|FG001|Part A (Open-label)|Protocol Violation|1|||
146927888|NCT05168813|529896035|FG002|Part A (Open-label)|Protocol Violation|0|||
146927889|NCT05168813|529896036|FG003|Part A (Open-label)|Protocol Violation|0|||
146927890|NCT05168813|529896037|FG004|Part A (Open-label)|Protocol Violation|0|||
146927891|NCT05168813|529896038|FG005|Part A (Open-label)|Protocol Violation|0|||
146927892|NCT05168813|529896033|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
146927893|NCT05168813|529896034|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
146927894|NCT05168813|529896035|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
146927895|NCT05168813|529896036|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
146927896|NCT05168813|529896037|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
146927897|NCT05168813|529896038|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
146927898|NCT05168813|529896033|FG000|Part A (Open-label)|Other|0|||
146927899|NCT05168813|529896034|FG001|Part A (Open-label)|Other|1|||
146927900|NCT05168813|529896035|FG002|Part A (Open-label)|Other|0|||
146927901|NCT05168813|529896036|FG003|Part A (Open-label)|Other|0|||
146927902|NCT05168813|529896037|FG004|Part A (Open-label)|Other|0|||
146927903|NCT05168813|529896038|FG005|Part A (Open-label)|Other|0|||
146927904|NCT05168813|529896033|FG000|Part B (Blinded)|Lost to Follow-up|0|||
146927905|NCT05168813|529896034|FG001|Part B (Blinded)|Lost to Follow-up|0|||
146927906|NCT05168813|529896035|FG002|Part B (Blinded)|Lost to Follow-up|0|||
146927907|NCT05168813|529896036|FG003|Part B (Blinded)|Lost to Follow-up|0|||
146927908|NCT05168813|529896037|FG004|Part B (Blinded)|Lost to Follow-up|219|||
146927909|NCT05168813|529896038|FG005|Part B (Blinded)|Lost to Follow-up|88|||
146927910|NCT05168813|529896033|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
146927911|NCT05168813|529896034|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
146927912|NCT05168813|529896035|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
146927913|NCT05168813|529896036|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
146927914|NCT05168813|529896037|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
146927915|NCT05168813|529896038|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
146978952|NCT00463866|530085516|FG000|Overall Study|Mis-Randomization of subject|0|||
146687047|NCT01472081|529031089|FG001|Overall Study|Death|0|||
146687048|NCT01472081|529031090|FG002|Overall Study|Death|0|||
146687049|NCT01472081|529031091|FG003|Overall Study|Death|0|||
146687050|NCT01472081|529031092|FG004|Overall Study|Death|1|||
146687051|NCT01472081|529031093|FG005|Overall Study|Death|0|||
146687052|NCT01472081|529031088|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
146687053|NCT01472081|529031089|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
146687054|NCT01472081|529031090|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
146687055|NCT01472081|529031091|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
146687056|NCT01472081|529031092|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
146687057|NCT01472081|529031093|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
146687058|NCT01472081|529031088|FG000|Overall Study|Withdrawal by Subject|0|||
146687059|NCT01472081|529031089|FG001|Overall Study|Withdrawal by Subject|0|||
146687060|NCT01472081|529031090|FG002|Overall Study|Withdrawal by Subject|0|||
146687061|NCT01472081|529031091|FG003|Overall Study|Withdrawal by Subject|0|||
146687062|NCT01472081|529031092|FG004|Overall Study|Withdrawal by Subject|0|||
146687063|NCT01472081|529031093|FG005|Overall Study|Withdrawal by Subject|1|||
146687064|NCT01472081|529031088|FG000|Overall Study|Poor/non-compliance|0|||
146687065|NCT01472081|529031089|FG001|Overall Study|Poor/non-compliance|0|||
146687066|NCT01472081|529031090|FG002|Overall Study|Poor/non-compliance|1|||
146687067|NCT01472081|529031091|FG003|Overall Study|Poor/non-compliance|0|||
146687068|NCT01472081|529031092|FG004|Overall Study|Poor/non-compliance|1|||
146687069|NCT01472081|529031093|FG005|Overall Study|Poor/non-compliance|0|||
146687070|NCT01472081|529031088|FG000|Overall Study|No longer meets study criteria|0|||
146687071|NCT01472081|529031089|FG001|Overall Study|No longer meets study criteria|0|||
146687072|NCT01472081|529031090|FG002|Overall Study|No longer meets study criteria|1|||
146687073|NCT01472081|529031091|FG003|Overall Study|No longer meets study criteria|0|||
146687074|NCT01472081|529031092|FG004|Overall Study|No longer meets study criteria|0|||
146687075|NCT01472081|529031093|FG005|Overall Study|No longer meets study criteria|0|||
146687076|NCT01472081|529031088|FG000|Overall Study|Subject request to discontinue treatment|0|||
146687077|NCT01472081|529031089|FG001|Overall Study|Subject request to discontinue treatment|3|||
146687078|NCT01472081|529031090|FG002|Overall Study|Subject request to discontinue treatment|1|||
146687079|NCT01472081|529031091|FG003|Overall Study|Subject request to discontinue treatment|1|||
146687080|NCT01472081|529031092|FG004|Overall Study|Subject request to discontinue treatment|0|||
146687081|NCT01472081|529031093|FG005|Overall Study|Subject request to discontinue treatment|0|||
146687082|NCT01705652|529031095|FG000|Overall Study|Adverse Event|1|||
146687083|NCT01705652|529031096|FG001|Overall Study|Adverse Event|0|||
146687084|NCT01705652|529031095|FG000|Overall Study|Withdrawal by Subject|1|||
146687085|NCT01705652|529031096|FG001|Overall Study|Withdrawal by Subject|2|||
146687086|NCT01705652|529031095|FG000|Overall Study|non-compliance|1|||
146687087|NCT01705652|529031096|FG001|Overall Study|non-compliance|1|||
146687088|NCT00656474|529031097|FG000|Overall Study|Other Reason|1|||
146687089|NCT00511667|529031101|FG000|Overall Study|Adverse Event|1|||
146687090|NCT00511667|529031102|FG001|Overall Study|Adverse Event|0|||
146687091|NCT00511667|529031101|FG000|Overall Study|Protocol Violation|1|||
146687092|NCT00511667|529031102|FG001|Overall Study|Protocol Violation|1|||
146687093|NCT00511667|529031101|FG000|Overall Study|Withdrawal by Subject|2|||
146687094|NCT00511667|529031102|FG001|Overall Study|Withdrawal by Subject|0|||
146687095|NCT00511667|529031101|FG000|Overall Study|Site terminated|6|||
146687096|NCT00511667|529031102|FG001|Overall Study|Site terminated|1|||
146687097|NCT00511667|529031101|FG000|Overall Study|Other|2|||
146687098|NCT00511667|529031102|FG001|Overall Study|Other|1|||
146687099|NCT03605303|529031103|FG000|Period 1|Study Terminated|2|||
146687100|NCT03605303|529031104|FG001|Period 1|Study Terminated|1|||
146687101|NCT00309842|529031105|FG000|Overall Study|Lost to Follow-up|1|||
146687102|NCT03564145|529031106|FG000|Overall Study|Adverse Event|4|||
146687103|NCT03564145|529031106|FG000|Overall Study|Lost to Follow-up|21|||
146687104|NCT03564145|529031106|FG000|Overall Study|Protocol Violation|2|||
146687105|NCT03564145|529031106|FG000|Overall Study|Withdrawal by Subject|48|||
146687106|NCT03564145|529031106|FG000|Overall Study|Study Terminated by Sponsor|146|||
146687107|NCT03564145|529031106|FG000|Overall Study|Physician Decision|1|||
146687108|NCT03564145|529031106|FG000|Overall Study|Other Than Specified|1|||
146687109|NCT03564145|529031106|FG000|Overall Study|Pregnancy|1|||
146687110|NCT04702997|529031107|FG000|Overall Study|Withdrawal by Subject|1|||
146687111|NCT04702997|529031108|FG001|Overall Study|Withdrawal by Subject|1|||
146687112|NCT01386554|529031114|FG000|Overall Study|Lost to Follow-up|0|||
146687113|NCT01386554|529031115|FG001|Overall Study|Lost to Follow-up|0|||
146687114|NCT01386554|529031116|FG002|Overall Study|Lost to Follow-up|1|||
146687115|NCT01386554|529031114|FG000|Overall Study|Adverse Event|2|||
146687116|NCT01386554|529031115|FG001|Overall Study|Adverse Event|5|||
146687117|NCT01386554|529031116|FG002|Overall Study|Adverse Event|2|||
146687118|NCT01386554|529031114|FG000|Overall Study|Progressive disease|1|||
146687119|NCT01386554|529031115|FG001|Overall Study|Progressive disease|2|||
146687120|NCT01386554|529031116|FG002|Overall Study|Progressive disease|2|||
146687121|NCT01386554|529031114|FG000|Overall Study|Administration of live vaccines|0|||
146687122|NCT01386554|529031115|FG001|Overall Study|Administration of live vaccines|1|||
146687123|NCT01386554|529031116|FG002|Overall Study|Administration of live vaccines|0|||
146687124|NCT01386554|529031114|FG000|Overall Study|Investigator discretion|0|||
146687125|NCT01386554|529031115|FG001|Overall Study|Investigator discretion|0|||
146978953|NCT00463866|530085517|FG001|Overall Study|Mis-Randomization of subject|1|||
146978954|NCT00463866|530085516|FG000|Overall Study|Other|22|||
146978955|NCT00463866|530085517|FG001|Overall Study|Other|22|||
146978956|NCT03568500|530085523|FG000|Overall Study|Lost to Follow-up|1|||
146978957|NCT03568500|530085524|FG001|Overall Study|Lost to Follow-up|1|||
146978958|NCT03568500|530085525|FG002|Overall Study|Lost to Follow-up|2|||
146978959|NCT03568500|530085523|FG000|Overall Study|Adverse Event|1|||
146978960|NCT03568500|530085524|FG001|Overall Study|Adverse Event|1|||
146978961|NCT03568500|530085525|FG002|Overall Study|Adverse Event|2|||
146978962|NCT03568500|530085523|FG000|Overall Study|Physician Decision|1|||
146978963|NCT03568500|530085524|FG001|Overall Study|Physician Decision|0|||
146978964|NCT03568500|530085525|FG002|Overall Study|Physician Decision|0|||
146978965|NCT03568500|530085523|FG000|Overall Study|Withdrawal by Subject|4|||
146978966|NCT03568500|530085524|FG001|Overall Study|Withdrawal by Subject|2|||
146978967|NCT03568500|530085525|FG002|Overall Study|Withdrawal by Subject|0|||
146978968|NCT03568500|530085523|FG000|Overall Study|Technical Problems|2|||
146978969|NCT03568500|530085524|FG001|Overall Study|Technical Problems|1|||
146978970|NCT03568500|530085525|FG002|Overall Study|Technical Problems|0|||
146978971|NCT03568500|530085523|FG000|Overall Study|Participant Noncompliance|1|||
146978972|NCT03568500|530085524|FG001|Overall Study|Participant Noncompliance|1|||
146978973|NCT03568500|530085525|FG002|Overall Study|Participant Noncompliance|0|||
146978974|NCT01170364|530085537|FG000|Overall Study|Protocol Violation|4|||
146978975|NCT01170364|530085538|FG001|Overall Study|Protocol Violation|1|||
146978976|NCT01368276|530085539|FG000|Overall Study|Death|1|||
146978977|NCT01368276|530085540|FG001|Overall Study|Death|10|||
146978978|NCT02041494|530085541|FG000|Overall Study|Death|1|||
146978979|NCT02041494|530085542|FG001|Overall Study|Death|3|||
146978980|NCT02041494|530085541|FG000|Overall Study|Lost to Follow-up|2|||
146978981|NCT02041494|530085542|FG001|Overall Study|Lost to Follow-up|6|||
146978982|NCT02041494|530085541|FG000|Overall Study|study terminated|16|||
146978983|NCT02041494|530085542|FG001|Overall Study|study terminated|11|||
146978984|NCT03341273|530085543|FG000|Overall Study|Lost to Follow-up|7|||
146978985|NCT03341273|530085544|FG001|Overall Study|Lost to Follow-up|7|||
146978986|NCT03341273|530085543|FG000|Overall Study|Withdrawal by Subject|4|||
146978987|NCT03341273|530085544|FG001|Overall Study|Withdrawal by Subject|2|||
146978988|NCT03341273|530085543|FG000|Overall Study|Physician Decision|1|||
146978989|NCT03341273|530085544|FG001|Overall Study|Physician Decision|0|||
146978990|NCT03341273|530085543|FG000|Overall Study|Protocol Violation|0|||
146687126|NCT01386554|529031116|FG002|Overall Study|Investigator discretion|1|||
146687127|NCT01386554|529031114|FG000|Overall Study|Reason not collected|0|||
146687128|NCT01386554|529031115|FG001|Overall Study|Reason not collected|1|||
146687129|NCT01386554|529031116|FG002|Overall Study|Reason not collected|0|||
146687130|NCT00353262|529031117|FG000|Overall Study|Adverse Event|8|||
146687131|NCT00353262|529031117|FG000|Overall Study|Withdrawal by Subject|2|||
146687132|NCT00353262|529031117|FG000|Overall Study|Insufficient Therapeutic Response|13|||
146687133|NCT00353262|529031117|FG000|Overall Study|Progression|1|||
146687134|NCT00353262|529031117|FG000|Overall Study|Surgery|4|||
146687135|NCT00353262|529031117|FG000|Overall Study|Break from Chemotherapy|1|||
146687136|NCT05286307|529031118|FG000|Overall Study|Incomplete outcome assessments|2|||
146687137|NCT05286307|529031119|FG001|Overall Study|Incomplete outcome assessments|1|||
146687138|NCT05286307|529031118|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
146687139|NCT05286307|529031119|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
146687140|NCT05286307|529031118|FG000|Overall Study|Lost to follow up at 6 months|25|||
146687141|NCT05286307|529031119|FG001|Overall Study|Lost to follow up at 6 months|35|||
146687142|NCT05286307|529031118|FG000|Overall Study|Study medication not available|1|||
146687143|NCT05286307|529031119|FG001|Overall Study|Study medication not available|1|||
146687144|NCT02759471|529031120|FG000|Overall Study|discomfort|2|||
146687145|NCT02554812|529031121|FG000|Overall Study|Adverse Event|2|||
146687146|NCT02554812|529031122|FG001|Overall Study|Adverse Event|5|||
146687147|NCT02554812|529031123|FG002|Overall Study|Adverse Event|3|||
146687148|NCT02554812|529031124|FG003|Overall Study|Adverse Event|0|||
146687149|NCT02554812|529031125|FG004|Overall Study|Adverse Event|5|||
146687150|NCT02554812|529031126|FG005|Overall Study|Adverse Event|0|||
146687151|NCT02554812|529031127|FG006|Overall Study|Adverse Event|1|||
146687152|NCT02554812|529031128|FG007|Overall Study|Adverse Event|6|||
146687153|NCT02554812|529031129|FG008|Overall Study|Adverse Event|2|||
146687154|NCT02554812|529031130|FG009|Overall Study|Adverse Event|2|||
146687155|NCT02554812|529031131|FG010|Overall Study|Adverse Event|1|||
146687156|NCT02554812|529031132|FG011|Overall Study|Adverse Event|2|||
146687157|NCT02554812|529031133|FG012|Overall Study|Adverse Event|0|||
146687158|NCT02554812|529031134|FG013|Overall Study|Adverse Event|3|||
146687159|NCT02554812|529031135|FG014|Overall Study|Adverse Event|2|||
146687160|NCT02554812|529031136|FG015|Overall Study|Adverse Event|1|||
146978991|NCT03341273|530085544|FG001|Overall Study|Protocol Violation|1|||
146978992|NCT03341273|530085543|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
146978993|NCT03341273|530085544|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
146978994|NCT03341273|530085543|FG000|Overall Study|Became ineligible after enrollment|1|||
146978995|NCT03341273|530085544|FG001|Overall Study|Became ineligible after enrollment|0|||
146687161|NCT02554812|529031137|FG016|Overall Study|Adverse Event|0|||
146687162|NCT02554812|529031138|FG017|Overall Study|Adverse Event|1|||
146687163|NCT02554812|529031139|FG018|Overall Study|Adverse Event|0|||
146687164|NCT02554812|529031140|FG019|Overall Study|Adverse Event|0|||
146687165|NCT02554812|529031141|FG020|Overall Study|Adverse Event|0|||
146687166|NCT02554812|529031142|FG021|Overall Study|Adverse Event|2|||
146687167|NCT02554812|529031143|FG022|Overall Study|Adverse Event|1|||
146687168|NCT02554812|529031144|FG023|Overall Study|Adverse Event|1|||
146687169|NCT02554812|529031145|FG024|Overall Study|Adverse Event|1|||
146687170|NCT02554812|529031146|FG025|Overall Study|Adverse Event|2|||
146687171|NCT02554812|529031147|FG026|Overall Study|Adverse Event|1|||
146687172|NCT02554812|529031121|FG000|Overall Study|Death|1|||
146687173|NCT02554812|529031122|FG001|Overall Study|Death|2|||
146687174|NCT02554812|529031123|FG002|Overall Study|Death|2|||
146687175|NCT02554812|529031124|FG003|Overall Study|Death|2|||
146687176|NCT02554812|529031125|FG004|Overall Study|Death|0|||
146687177|NCT02554812|529031126|FG005|Overall Study|Death|1|||
146687178|NCT02554812|529031127|FG006|Overall Study|Death|1|||
146687179|NCT02554812|529031128|FG007|Overall Study|Death|1|||
146687180|NCT02554812|529031129|FG008|Overall Study|Death|0|||
146687181|NCT02554812|529031130|FG009|Overall Study|Death|0|||
146687182|NCT02554812|529031131|FG010|Overall Study|Death|0|||
146687183|NCT02554812|529031132|FG011|Overall Study|Death|0|||
146687184|NCT02554812|529031133|FG012|Overall Study|Death|0|||
146687185|NCT02554812|529031134|FG013|Overall Study|Death|0|||
146687186|NCT02554812|529031135|FG014|Overall Study|Death|1|||
146687187|NCT02554812|529031136|FG015|Overall Study|Death|1|||
146687188|NCT02554812|529031137|FG016|Overall Study|Death|1|||
146687189|NCT02554812|529031138|FG017|Overall Study|Death|0|||
146687190|NCT02554812|529031139|FG018|Overall Study|Death|1|||
146687191|NCT02554812|529031140|FG019|Overall Study|Death|2|||
146687192|NCT02554812|529031141|FG020|Overall Study|Death|0|||
146687193|NCT02554812|529031142|FG021|Overall Study|Death|1|||
146687194|NCT02554812|529031143|FG022|Overall Study|Death|1|||
146687195|NCT02554812|529031144|FG023|Overall Study|Death|0|||
146687196|NCT02554812|529031145|FG024|Overall Study|Death|0|||
146687197|NCT02554812|529031146|FG025|Overall Study|Death|0|||
146687198|NCT02554812|529031147|FG026|Overall Study|Death|0|||
146687199|NCT02554812|529031121|FG000|Overall Study|Lost to Follow-up|0|||
146687200|NCT02554812|529031122|FG001|Overall Study|Lost to Follow-up|1|||
146687201|NCT02554812|529031123|FG002|Overall Study|Lost to Follow-up|0|||
146687202|NCT02554812|529031124|FG003|Overall Study|Lost to Follow-up|0|||
146687203|NCT02554812|529031125|FG004|Overall Study|Lost to Follow-up|0|||
146687204|NCT02554812|529031126|FG005|Overall Study|Lost to Follow-up|0|||
146687205|NCT02554812|529031127|FG006|Overall Study|Lost to Follow-up|0|||
146687206|NCT02554812|529031128|FG007|Overall Study|Lost to Follow-up|0|||
146687207|NCT02554812|529031129|FG008|Overall Study|Lost to Follow-up|0|||
146687208|NCT02554812|529031130|FG009|Overall Study|Lost to Follow-up|0|||
146687209|NCT02554812|529031131|FG010|Overall Study|Lost to Follow-up|0|||
146687210|NCT02554812|529031132|FG011|Overall Study|Lost to Follow-up|0|||
146687211|NCT02554812|529031133|FG012|Overall Study|Lost to Follow-up|0|||
146687212|NCT02554812|529031134|FG013|Overall Study|Lost to Follow-up|0|||
146687213|NCT02554812|529031135|FG014|Overall Study|Lost to Follow-up|0|||
146687214|NCT02554812|529031136|FG015|Overall Study|Lost to Follow-up|0|||
146687215|NCT02554812|529031137|FG016|Overall Study|Lost to Follow-up|0|||
146687216|NCT02554812|529031138|FG017|Overall Study|Lost to Follow-up|0|||
146687217|NCT02554812|529031139|FG018|Overall Study|Lost to Follow-up|0|||
146687218|NCT02554812|529031140|FG019|Overall Study|Lost to Follow-up|0|||
146687219|NCT02554812|529031141|FG020|Overall Study|Lost to Follow-up|0|||
146687220|NCT02554812|529031142|FG021|Overall Study|Lost to Follow-up|0|||
146687221|NCT02554812|529031143|FG022|Overall Study|Lost to Follow-up|0|||
146687222|NCT02554812|529031144|FG023|Overall Study|Lost to Follow-up|0|||
146687223|NCT02554812|529031145|FG024|Overall Study|Lost to Follow-up|0|||
146687224|NCT02554812|529031146|FG025|Overall Study|Lost to Follow-up|0|||
146687225|NCT02554812|529031147|FG026|Overall Study|Lost to Follow-up|0|||
146687226|NCT02554812|529031121|FG000|Overall Study|Global deterioration of health status|4|||
146687227|NCT02554812|529031122|FG001|Overall Study|Global deterioration of health status|3|||
146687228|NCT02554812|529031123|FG002|Overall Study|Global deterioration of health status|3|||
146687229|NCT02554812|529031124|FG003|Overall Study|Global deterioration of health status|2|||
146687230|NCT02554812|529031125|FG004|Overall Study|Global deterioration of health status|5|||
146687231|NCT02554812|529031126|FG005|Overall Study|Global deterioration of health status|0|||
146687232|NCT02554812|529031127|FG006|Overall Study|Global deterioration of health status|2|||
146687233|NCT02554812|529031128|FG007|Overall Study|Global deterioration of health status|1|||
146687234|NCT02554812|529031129|FG008|Overall Study|Global deterioration of health status|1|||
146687235|NCT02554812|529031130|FG009|Overall Study|Global deterioration of health status|1|||
146687236|NCT02554812|529031131|FG010|Overall Study|Global deterioration of health status|2|||
146687237|NCT02554812|529031132|FG011|Overall Study|Global deterioration of health status|1|||
146687238|NCT02554812|529031133|FG012|Overall Study|Global deterioration of health status|0|||
146687239|NCT02554812|529031134|FG013|Overall Study|Global deterioration of health status|0|||
146687240|NCT02554812|529031135|FG014|Overall Study|Global deterioration of health status|0|||
146687241|NCT02554812|529031136|FG015|Overall Study|Global deterioration of health status|1|||
146687242|NCT02554812|529031137|FG016|Overall Study|Global deterioration of health status|0|||
146687243|NCT02554812|529031138|FG017|Overall Study|Global deterioration of health status|0|||
146687244|NCT02554812|529031139|FG018|Overall Study|Global deterioration of health status|0|||
146687245|NCT02554812|529031140|FG019|Overall Study|Global deterioration of health status|0|||
146687246|NCT02554812|529031141|FG020|Overall Study|Global deterioration of health status|0|||
146687247|NCT02554812|529031142|FG021|Overall Study|Global deterioration of health status|0|||
146687248|NCT02554812|529031143|FG022|Overall Study|Global deterioration of health status|0|||
146687249|NCT02554812|529031144|FG023|Overall Study|Global deterioration of health status|0|||
146687250|NCT02554812|529031145|FG024|Overall Study|Global deterioration of health status|0|||
146687251|NCT02554812|529031146|FG025|Overall Study|Global deterioration of health status|0|||
146687252|NCT02554812|529031147|FG026|Overall Study|Global deterioration of health status|0|||
146687253|NCT02554812|529031121|FG000|Overall Study|Progressive disease|20|||
146687254|NCT02554812|529031122|FG001|Overall Study|Progressive disease|16|||
146687255|NCT02554812|529031123|FG002|Overall Study|Progressive disease|19|||
146687256|NCT02554812|529031124|FG003|Overall Study|Progressive disease|18|||
146687257|NCT02554812|529031125|FG004|Overall Study|Progressive disease|21|||
146687258|NCT02554812|529031126|FG005|Overall Study|Progressive disease|15|||
146687259|NCT02554812|529031127|FG006|Overall Study|Progressive disease|6|||
146687260|NCT02554812|529031128|FG007|Overall Study|Progressive disease|13|||
146687261|NCT02554812|529031129|FG008|Overall Study|Progressive disease|6|||
146687262|NCT02554812|529031130|FG009|Overall Study|Progressive disease|6|||
146687263|NCT02554812|529031131|FG010|Overall Study|Progressive disease|8|||
146687264|NCT02554812|529031132|FG011|Overall Study|Progressive disease|8|||
146687265|NCT02554812|529031133|FG012|Overall Study|Progressive disease|6|||
146687266|NCT02554812|529031134|FG013|Overall Study|Progressive disease|10|||
146687267|NCT02554812|529031135|FG014|Overall Study|Progressive disease|20|||
146687268|NCT02554812|529031136|FG015|Overall Study|Progressive disease|6|||
146687269|NCT02554812|529031137|FG016|Overall Study|Progressive disease|3|||
146687270|NCT02554812|529031138|FG017|Overall Study|Progressive disease|3|||
146687271|NCT02554812|529031139|FG018|Overall Study|Progressive disease|11|||
146687272|NCT02554812|529031140|FG019|Overall Study|Progressive disease|7|||
146687273|NCT02554812|529031141|FG020|Overall Study|Progressive disease|11|||
146687274|NCT02554812|529031142|FG021|Overall Study|Progressive disease|6|||
146687275|NCT02554812|529031143|FG022|Overall Study|Progressive disease|9|||
146687276|NCT02554812|529031144|FG023|Overall Study|Progressive disease|9|||
146687277|NCT02554812|529031145|FG024|Overall Study|Progressive disease|4|||
146687278|NCT02554812|529031146|FG025|Overall Study|Progressive disease|5|||
146687279|NCT02554812|529031147|FG026|Overall Study|Progressive disease|5|||
146687280|NCT02554812|529031121|FG000|Overall Study|Other|0|||
146687281|NCT02554812|529031122|FG001|Overall Study|Other|0|||
146687282|NCT02554812|529031123|FG002|Overall Study|Other|2|||
146687283|NCT02554812|529031124|FG003|Overall Study|Other|3|||
146687284|NCT02554812|529031125|FG004|Overall Study|Other|2|||
146687285|NCT02554812|529031126|FG005|Overall Study|Other|1|||
146774894|NCT01693120|529346802|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
146774895|NCT01693120|529346802|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
146774896|NCT01693120|529346802|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
146774897|NCT02411084|529346812|FG000|Overall Study|Lack of Efficacy|6|||
146774898|NCT02411084|529346813|FG001|Overall Study|Lack of Efficacy|3|||
146774899|NCT02411084|529346812|FG000|Overall Study|Death|5|||
146774900|NCT02411084|529346813|FG001|Overall Study|Death|4|||
146774901|NCT02411084|529346812|FG000|Overall Study|Adverse Event|2|||
146774902|NCT02411084|529346813|FG001|Overall Study|Adverse Event|1|||
146774903|NCT02411084|529346812|FG000|Overall Study|Other reasons|0|||
146774904|NCT02411084|529346813|FG001|Overall Study|Other reasons|5|||
146927916|NCT05168813|529896033|FG000|Part B (Blinded)|Death|0|||
146927917|NCT05168813|529896034|FG001|Part B (Blinded)|Death|0|||
146927918|NCT05168813|529896035|FG002|Part B (Blinded)|Death|0|||
146927919|NCT05168813|529896036|FG003|Part B (Blinded)|Death|0|||
146927920|NCT05168813|529896037|FG004|Part B (Blinded)|Death|63|||
146927921|NCT05168813|529896038|FG005|Part B (Blinded)|Death|19|||
146927922|NCT05168813|529896033|FG000|Part B (Blinded)|Physician Decision|0|||
146927923|NCT05168813|529896034|FG001|Part B (Blinded)|Physician Decision|0|||
146927924|NCT05168813|529896035|FG002|Part B (Blinded)|Physician Decision|0|||
146927925|NCT05168813|529896036|FG003|Part B (Blinded)|Physician Decision|0|||
146927926|NCT05168813|529896037|FG004|Part B (Blinded)|Physician Decision|6|||
146687286|NCT02554812|529031127|FG006|Overall Study|Other|0|||
146687287|NCT02554812|529031128|FG007|Overall Study|Other|0|||
146687288|NCT02554812|529031129|FG008|Overall Study|Other|1|||
146687289|NCT02554812|529031130|FG009|Overall Study|Other|1|||
146687290|NCT02554812|529031131|FG010|Overall Study|Other|0|||
146687291|NCT02554812|529031132|FG011|Overall Study|Other|0|||
146687292|NCT02554812|529031133|FG012|Overall Study|Other|1|||
146774905|NCT03624972|529346814|FG000|Overall Study|Lost to Follow-up|2|||
146774906|NCT03624972|529346815|FG001|Overall Study|Lost to Follow-up|0|||
146774907|NCT03624972|529346816|FG002|Overall Study|Lost to Follow-up|0|||
146927927|NCT05168813|529896038|FG005|Part B (Blinded)|Physician Decision|1|||
146687293|NCT02554812|529031134|FG013|Overall Study|Other|0|||
146687294|NCT02554812|529031135|FG014|Overall Study|Other|1|||
146687295|NCT02554812|529031136|FG015|Overall Study|Other|0|||
146687296|NCT02554812|529031137|FG016|Overall Study|Other|0|||
146687297|NCT02554812|529031138|FG017|Overall Study|Other|0|||
146687298|NCT02554812|529031139|FG018|Overall Study|Other|0|||
146687299|NCT02554812|529031140|FG019|Overall Study|Other|0|||
146687300|NCT02554812|529031141|FG020|Overall Study|Other|0|||
146687301|NCT02554812|529031142|FG021|Overall Study|Other|2|||
146687302|NCT02554812|529031143|FG022|Overall Study|Other|0|||
146687303|NCT02554812|529031144|FG023|Overall Study|Other|0|||
146687304|NCT02554812|529031145|FG024|Overall Study|Other|0|||
146687305|NCT02554812|529031146|FG025|Overall Study|Other|0|||
146687306|NCT02554812|529031147|FG026|Overall Study|Other|0|||
146687307|NCT02554812|529031121|FG000|Overall Study|Withdrawal by Subject|1|||
146687308|NCT02554812|529031122|FG001|Overall Study|Withdrawal by Subject|0|||
146687309|NCT02554812|529031123|FG002|Overall Study|Withdrawal by Subject|0|||
146687310|NCT02554812|529031124|FG003|Overall Study|Withdrawal by Subject|2|||
146687311|NCT02554812|529031125|FG004|Overall Study|Withdrawal by Subject|2|||
146687312|NCT02554812|529031126|FG005|Overall Study|Withdrawal by Subject|3|||
146687313|NCT02554812|529031127|FG006|Overall Study|Withdrawal by Subject|0|||
146687314|NCT02554812|529031128|FG007|Overall Study|Withdrawal by Subject|0|||
146687315|NCT02554812|529031129|FG008|Overall Study|Withdrawal by Subject|1|||
146687316|NCT02554812|529031130|FG009|Overall Study|Withdrawal by Subject|1|||
146687317|NCT02554812|529031131|FG010|Overall Study|Withdrawal by Subject|0|||
146687318|NCT02554812|529031132|FG011|Overall Study|Withdrawal by Subject|1|||
146687319|NCT02554812|529031133|FG012|Overall Study|Withdrawal by Subject|1|||
146687320|NCT02554812|529031134|FG013|Overall Study|Withdrawal by Subject|1|||
146687321|NCT02554812|529031135|FG014|Overall Study|Withdrawal by Subject|1|||
146687322|NCT02554812|529031136|FG015|Overall Study|Withdrawal by Subject|1|||
146687323|NCT02554812|529031137|FG016|Overall Study|Withdrawal by Subject|3|||
146687324|NCT02554812|529031138|FG017|Overall Study|Withdrawal by Subject|1|||
146687325|NCT02554812|529031139|FG018|Overall Study|Withdrawal by Subject|0|||
146687326|NCT02554812|529031140|FG019|Overall Study|Withdrawal by Subject|2|||
146687327|NCT02554812|529031141|FG020|Overall Study|Withdrawal by Subject|0|||
146687328|NCT02554812|529031142|FG021|Overall Study|Withdrawal by Subject|1|||
146687329|NCT02554812|529031143|FG022|Overall Study|Withdrawal by Subject|0|||
146687330|NCT02554812|529031144|FG023|Overall Study|Withdrawal by Subject|1|||
146687331|NCT02554812|529031145|FG024|Overall Study|Withdrawal by Subject|0|||
146687332|NCT02554812|529031146|FG025|Overall Study|Withdrawal by Subject|0|||
146687333|NCT02554812|529031147|FG026|Overall Study|Withdrawal by Subject|1|||
146687334|NCT02554812|529031121|FG000|Overall Study|Physician Decision|1|||
146687335|NCT02554812|529031122|FG001|Overall Study|Physician Decision|0|||
146687336|NCT02554812|529031123|FG002|Overall Study|Physician Decision|0|||
146687337|NCT02554812|529031124|FG003|Overall Study|Physician Decision|1|||
146687338|NCT02554812|529031125|FG004|Overall Study|Physician Decision|0|||
146687339|NCT02554812|529031126|FG005|Overall Study|Physician Decision|1|||
146687340|NCT02554812|529031127|FG006|Overall Study|Physician Decision|0|||
146687341|NCT02554812|529031128|FG007|Overall Study|Physician Decision|0|||
146687342|NCT02554812|529031129|FG008|Overall Study|Physician Decision|0|||
146687343|NCT02554812|529031130|FG009|Overall Study|Physician Decision|0|||
146687344|NCT02554812|529031131|FG010|Overall Study|Physician Decision|1|||
146687345|NCT02554812|529031132|FG011|Overall Study|Physician Decision|0|||
146687346|NCT02554812|529031133|FG012|Overall Study|Physician Decision|0|||
146687347|NCT02554812|529031134|FG013|Overall Study|Physician Decision|0|||
146687348|NCT02554812|529031135|FG014|Overall Study|Physician Decision|0|||
146687349|NCT02554812|529031136|FG015|Overall Study|Physician Decision|0|||
146687350|NCT02554812|529031137|FG016|Overall Study|Physician Decision|1|||
146687351|NCT02554812|529031138|FG017|Overall Study|Physician Decision|1|||
146687352|NCT02554812|529031139|FG018|Overall Study|Physician Decision|0|||
146687353|NCT02554812|529031140|FG019|Overall Study|Physician Decision|1|||
146687354|NCT02554812|529031141|FG020|Overall Study|Physician Decision|1|||
146687355|NCT02554812|529031142|FG021|Overall Study|Physician Decision|0|||
146687356|NCT02554812|529031143|FG022|Overall Study|Physician Decision|1|||
146687357|NCT02554812|529031144|FG023|Overall Study|Physician Decision|0|||
146687358|NCT02554812|529031145|FG024|Overall Study|Physician Decision|0|||
146687359|NCT02554812|529031146|FG025|Overall Study|Physician Decision|0|||
146687360|NCT02554812|529031147|FG026|Overall Study|Physician Decision|0|||
146687361|NCT02554812|529031121|FG000|Overall Study|Study terminated by sponsor|0|||
146687362|NCT02554812|529031122|FG001|Overall Study|Study terminated by sponsor|0|||
146687363|NCT02554812|529031123|FG002|Overall Study|Study terminated by sponsor|0|||
146687364|NCT02554812|529031124|FG003|Overall Study|Study terminated by sponsor|0|||
146687365|NCT02554812|529031125|FG004|Overall Study|Study terminated by sponsor|0|||
146687366|NCT02554812|529031126|FG005|Overall Study|Study terminated by sponsor|0|||
146687367|NCT02554812|529031127|FG006|Overall Study|Study terminated by sponsor|0|||
146687368|NCT02554812|529031128|FG007|Overall Study|Study terminated by sponsor|0|||
146687369|NCT02554812|529031129|FG008|Overall Study|Study terminated by sponsor|0|||
146687370|NCT02554812|529031130|FG009|Overall Study|Study terminated by sponsor|0|||
146687371|NCT02554812|529031131|FG010|Overall Study|Study terminated by sponsor|0|||
146687372|NCT02554812|529031132|FG011|Overall Study|Study terminated by sponsor|0|||
146687373|NCT02554812|529031133|FG012|Overall Study|Study terminated by sponsor|0|||
146687374|NCT02554812|529031134|FG013|Overall Study|Study terminated by sponsor|0|||
146687375|NCT02554812|529031135|FG014|Overall Study|Study terminated by sponsor|0|||
146687376|NCT02554812|529031136|FG015|Overall Study|Study terminated by sponsor|0|||
146687377|NCT02554812|529031137|FG016|Overall Study|Study terminated by sponsor|0|||
146687378|NCT02554812|529031138|FG017|Overall Study|Study terminated by sponsor|0|||
146687379|NCT02554812|529031139|FG018|Overall Study|Study terminated by sponsor|0|||
146687380|NCT02554812|529031140|FG019|Overall Study|Study terminated by sponsor|0|||
146687381|NCT02554812|529031141|FG020|Overall Study|Study terminated by sponsor|0|||
146687382|NCT02554812|529031142|FG021|Overall Study|Study terminated by sponsor|0|||
146687383|NCT02554812|529031143|FG022|Overall Study|Study terminated by sponsor|0|||
146687384|NCT02554812|529031144|FG023|Overall Study|Study terminated by sponsor|0|||
146687385|NCT02554812|529031145|FG024|Overall Study|Study terminated by sponsor|1|||
146687386|NCT02554812|529031146|FG025|Overall Study|Study terminated by sponsor|0|||
146687387|NCT02554812|529031147|FG026|Overall Study|Study terminated by sponsor|0|||
146687388|NCT02554812|529031121|FG000|Overall Study|No longer meets eligibility criteria|0|||
146687389|NCT02554812|529031122|FG001|Overall Study|No longer meets eligibility criteria|1|||
146687390|NCT02554812|529031123|FG002|Overall Study|No longer meets eligibility criteria|0|||
146687391|NCT02554812|529031124|FG003|Overall Study|No longer meets eligibility criteria|0|||
146687392|NCT02554812|529031125|FG004|Overall Study|No longer meets eligibility criteria|0|||
146687393|NCT02554812|529031126|FG005|Overall Study|No longer meets eligibility criteria|0|||
146687394|NCT02554812|529031127|FG006|Overall Study|No longer meets eligibility criteria|0|||
146687395|NCT02554812|529031128|FG007|Overall Study|No longer meets eligibility criteria|0|||
146687396|NCT02554812|529031129|FG008|Overall Study|No longer meets eligibility criteria|0|||
146687397|NCT02554812|529031130|FG009|Overall Study|No longer meets eligibility criteria|0|||
146687398|NCT02554812|529031131|FG010|Overall Study|No longer meets eligibility criteria|0|||
146687399|NCT02554812|529031132|FG011|Overall Study|No longer meets eligibility criteria|0|||
146687400|NCT02554812|529031133|FG012|Overall Study|No longer meets eligibility criteria|0|||
146687401|NCT02554812|529031134|FG013|Overall Study|No longer meets eligibility criteria|0|||
146687402|NCT02554812|529031135|FG014|Overall Study|No longer meets eligibility criteria|0|||
146687403|NCT02554812|529031136|FG015|Overall Study|No longer meets eligibility criteria|0|||
146687404|NCT02554812|529031137|FG016|Overall Study|No longer meets eligibility criteria|0|||
146687405|NCT02554812|529031138|FG017|Overall Study|No longer meets eligibility criteria|0|||
146687406|NCT02554812|529031139|FG018|Overall Study|No longer meets eligibility criteria|0|||
146687407|NCT02554812|529031140|FG019|Overall Study|No longer meets eligibility criteria|0|||
146687408|NCT02554812|529031141|FG020|Overall Study|No longer meets eligibility criteria|0|||
146687409|NCT02554812|529031142|FG021|Overall Study|No longer meets eligibility criteria|0|||
146687410|NCT02554812|529031143|FG022|Overall Study|No longer meets eligibility criteria|0|||
146687411|NCT02554812|529031144|FG023|Overall Study|No longer meets eligibility criteria|0|||
146687412|NCT02554812|529031145|FG024|Overall Study|No longer meets eligibility criteria|0|||
146687413|NCT02554812|529031146|FG025|Overall Study|No longer meets eligibility criteria|0|||
146687414|NCT02554812|529031147|FG026|Overall Study|No longer meets eligibility criteria|0|||
146687415|NCT01103284|529031148|FG000|Overall Study|Death|2|||
146687416|NCT01103284|529031149|FG001|Overall Study|Death|0|||
146687417|NCT01103284|529031148|FG000|Overall Study|Lost to Follow-up|9|||
146687418|NCT01103284|529031149|FG001|Overall Study|Lost to Follow-up|10|||
146687419|NCT01103284|529031148|FG000|Overall Study|Pregnancy|3|||
146687420|NCT01103284|529031149|FG001|Overall Study|Pregnancy|1|||
146687421|NCT01103284|529031148|FG000|Overall Study|Protocol Violation|12|||
146687422|NCT01103284|529031149|FG001|Overall Study|Protocol Violation|5|||
146687423|NCT01103284|529031148|FG000|Overall Study|Adverse Event|0|||
146687424|NCT01103284|529031149|FG001|Overall Study|Adverse Event|5|||
146687425|NCT01103284|529031148|FG000|Overall Study|Withdrawal by Subject|14|||
146687426|NCT01103284|529031149|FG001|Overall Study|Withdrawal by Subject|18|||
146687427|NCT01103284|529031148|FG000|Overall Study|Dermal Hypersensitivity|0|||
146687428|NCT01103284|529031149|FG001|Overall Study|Dermal Hypersensitivity|1|||
146687429|NCT01103284|529031148|FG000|Overall Study|Termination by the Sponsor|0|||
146687430|NCT01103284|529031149|FG001|Overall Study|Termination by the Sponsor|1|||
146687431|NCT01103284|529031148|FG000|Overall Study|Not described|2|||
146687432|NCT01103284|529031149|FG001|Overall Study|Not described|1|||
146687433|NCT01103284|529031148|FG000|Overall Study|Missing CRF entries for study completion|0|||
146687434|NCT01103284|529031149|FG001|Overall Study|Missing CRF entries for study completion|2|||
146687435|NCT03182829|529032907|FG000|Overall Study|Protocol Violation|12|||
146687436|NCT03182829|529032908|FG001|Overall Study|Protocol Violation|12|||
146687437|NCT03182829|529032907|FG000|Overall Study|Other|4|||
146687438|NCT03182829|529032908|FG001|Overall Study|Other|3|||
146687439|NCT05608005|529032909|FG000|Overall Study|Adverse Event|2|||
146687440|NCT05608005|529032910|FG001|Overall Study|Adverse Event|1|||
146687441|NCT05608005|529032911|FG002|Overall Study|Adverse Event|3|||
146687442|NCT05608005|529032909|FG000|Overall Study|Protocol Violation|2|||
146687443|NCT05608005|529032910|FG001|Overall Study|Protocol Violation|3|||
146687444|NCT05608005|529032911|FG002|Overall Study|Protocol Violation|0|||
146687445|NCT05608005|529032909|FG000|Overall Study|Withdrawal by Subject|10|||
146687446|NCT05608005|529032910|FG001|Overall Study|Withdrawal by Subject|12|||
146687447|NCT05608005|529032911|FG002|Overall Study|Withdrawal by Subject|4|||
146687448|NCT05608005|529032909|FG000|Overall Study|Lost to Follow-up|25|||
146687449|NCT05608005|529032910|FG001|Overall Study|Lost to Follow-up|27|||
146687450|NCT05608005|529032911|FG002|Overall Study|Lost to Follow-up|15|||
146687451|NCT05608005|529032909|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
146687452|NCT05608005|529032910|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
146687453|NCT05608005|529032911|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
146687454|NCT03020407|529032915|FG000|Overall Study|Withdrawal by Subject|2|||
146687455|NCT03020407|529032916|FG001|Overall Study|Withdrawal by Subject|1|||
146687456|NCT03020407|529032915|FG000|Overall Study|Lost to Follow-up|2|||
146687457|NCT03020407|529032916|FG001|Overall Study|Lost to Follow-up|3|||
146687458|NCT03020407|529032915|FG000|Overall Study|Protocol Violation|0|||
146687459|NCT03020407|529032916|FG001|Overall Study|Protocol Violation|1|||
146687460|NCT01585428|529032917|FG000|Overall Study|Death during treatment|1|||
146687461|NCT01585428|529032918|FG001|Overall Study|Death during treatment|0|||
146687462|NCT01349803|529032922|FG000|Overall Study|Adverse Event|0|||
146687463|NCT01349803|529032923|FG001|Overall Study|Adverse Event|0|||
146687464|NCT01349803|529032924|FG002|Overall Study|Adverse Event|0|||
146687465|NCT01349803|529032925|FG003|Overall Study|Adverse Event|2|||
146687466|NCT01349803|529032922|FG000|Overall Study|Withdrawal by Subject|1|||
146687467|NCT01349803|529032923|FG001|Overall Study|Withdrawal by Subject|0|||
146687468|NCT01349803|529032924|FG002|Overall Study|Withdrawal by Subject|0|||
146687469|NCT01349803|529032925|FG003|Overall Study|Withdrawal by Subject|0|||
146687470|NCT01349803|529032922|FG000|Overall Study|Protocol-specified criteria|0|||
146687471|NCT01349803|529032923|FG001|Overall Study|Protocol-specified criteria|1|||
146687472|NCT01349803|529032924|FG002|Overall Study|Protocol-specified criteria|3|||
146687473|NCT01349803|529032925|FG003|Overall Study|Protocol-specified criteria|0|||
146687474|NCT01042236|529032928|FG000|Treatment Period 1|Adverse Event|0|||
146687475|NCT01042236|529032929|FG001|Treatment Period 1|Adverse Event|1|||
146687476|NCT01042236|529032930|FG002|Treatment Period 1|Adverse Event|0|||
146687477|NCT01042236|529032931|FG003|Treatment Period 1|Adverse Event|0|||
146687478|NCT01042236|529032932|FG004|Treatment Period 1|Adverse Event|1|||
146687479|NCT01042236|529032933|FG005|Treatment Period 1|Adverse Event|0|||
146687480|NCT01042236|529032928|FG000|Treatment Period 3|Adverse Event|0|||
146687481|NCT01042236|529032929|FG001|Treatment Period 3|Adverse Event|0|||
146687482|NCT01042236|529032930|FG002|Treatment Period 3|Adverse Event|0|||
146687483|NCT01042236|529032931|FG003|Treatment Period 3|Adverse Event|1|||
146687484|NCT01042236|529032932|FG004|Treatment Period 3|Adverse Event|0|||
146687485|NCT01042236|529032933|FG005|Treatment Period 3|Adverse Event|0|||
146687486|NCT01042236|529032928|FG000|Treatment Period 3|Protocol Violation|0|||
146687487|NCT01042236|529032929|FG001|Treatment Period 3|Protocol Violation|0|||
146687488|NCT01042236|529032930|FG002|Treatment Period 3|Protocol Violation|0|||
146687489|NCT01042236|529032931|FG003|Treatment Period 3|Protocol Violation|1|||
146687490|NCT01042236|529032932|FG004|Treatment Period 3|Protocol Violation|0|||
146687491|NCT01042236|529032933|FG005|Treatment Period 3|Protocol Violation|0|||
146687492|NCT02522286|529032934|FG000|Overall Study|Withdrawal by Subject|3|||
146687493|NCT02522286|529032935|FG001|Overall Study|Withdrawal by Subject|0|||
146687494|NCT02522286|529032936|FG002|Overall Study|Withdrawal by Subject|0|||
146687495|NCT02522286|529032937|FG003|Overall Study|Withdrawal by Subject|3|||
146687496|NCT02411292|529032943|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
146687497|NCT02411292|529032943|FG000|Overall Study|Death|2|||
146687498|NCT02411292|529032943|FG000|Overall Study|Lost to Follow-up|3|||
146687499|NCT00453921|529032944|FG000|Overall Study|Withdrawal by Subject|1|||
146687500|NCT00453921|529032945|FG001|Overall Study|Withdrawal by Subject|1|||
146927928|NCT05168813|529896033|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
146927929|NCT05168813|529896034|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
146927930|NCT05168813|529896035|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
146927931|NCT05168813|529896036|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
146927932|NCT05168813|529896037|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
146927933|NCT05168813|529896038|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
146927934|NCT05168813|529896033|FG000|Part B (Blinded)|Pregnancy|0|||
146927935|NCT05168813|529896034|FG001|Part B (Blinded)|Pregnancy|0|||
146927936|NCT05168813|529896035|FG002|Part B (Blinded)|Pregnancy|0|||
146978996|NCT03341273|530085543|FG000|Overall Study|Not Eligible at Enrollment|0|||
146687501|NCT00453921|529032946|FG002|Overall Study|Withdrawal by Subject|1|||
146687502|NCT00453921|529032947|FG003|Overall Study|Withdrawal by Subject|1|||
146687503|NCT00453921|529032944|FG000|Overall Study|Lost to Follow-up|0|||
146687504|NCT00453921|529032945|FG001|Overall Study|Lost to Follow-up|0|||
146687505|NCT00453921|529032946|FG002|Overall Study|Lost to Follow-up|1|||
146687506|NCT00453921|529032947|FG003|Overall Study|Lost to Follow-up|0|||
146687507|NCT00303498|529032948|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
146687508|NCT00303498|529032949|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
146687509|NCT00303498|529032948|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
146774908|NCT03624972|529346814|FG000|Overall Study|Withdrawal by Subject|0|||
146927937|NCT05168813|529896036|FG003|Part B (Blinded)|Pregnancy|0|||
146687510|NCT00303498|529032949|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
146687511|NCT00303498|529032948|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
146687512|NCT00303498|529032949|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
146687513|NCT00303498|529032948|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
146687514|NCT00303498|529032949|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
146687515|NCT00303498|529032948|FG000|Run-In-Phase (10 Weeks)|Other|4|||
146687516|NCT00303498|529032949|FG001|Run-In-Phase (10 Weeks)|Other|1|||
146687517|NCT00303498|529032948|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
146687518|NCT00303498|529032949|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
146687519|NCT00303498|529032948|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
146687520|NCT00303498|529032949|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
146687521|NCT00303498|529032948|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
146687522|NCT00303498|529032949|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
146687523|NCT00303498|529032948|FG000|Maintenance Phase (24 Weeks)|Death|1|||
146687524|NCT00303498|529032949|FG001|Maintenance Phase (24 Weeks)|Death|0|||
146687525|NCT00303498|529032948|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
146687526|NCT00303498|529032949|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
146687527|NCT00303498|529032948|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
146687528|NCT00303498|529032949|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
146687529|NCT00303498|529032948|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
146687530|NCT00303498|529032949|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
146687531|NCT00303498|529032948|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
146687532|NCT00303498|529032949|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
146687533|NCT00303498|529032948|FG000|Maintenance Phase (24 Weeks)|Other|1|||
146687534|NCT00303498|529032949|FG001|Maintenance Phase (24 Weeks)|Other|0|||
146687535|NCT00303498|529032948|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
146687536|NCT00303498|529032949|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
146687537|NCT00303498|529032948|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
146687538|NCT00303498|529032949|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
146687539|NCT00174915|529032950|FG000|Overall Study|Lost to Follow-up|19|||
146687540|NCT00174915|529032951|FG001|Overall Study|Lost to Follow-up|17|||
146687541|NCT00174915|529032952|FG002|Overall Study|Lost to Follow-up|9|||
146687542|NCT00174915|529032953|FG003|Overall Study|Lost to Follow-up|17|||
146687543|NCT00174915|529032954|FG004|Overall Study|Lost to Follow-up|10|||
146687544|NCT00174915|529032950|FG000|Overall Study|Adverse Event|18|||
146687545|NCT00174915|529032951|FG001|Overall Study|Adverse Event|16|||
146687546|NCT00174915|529032952|FG002|Overall Study|Adverse Event|11|||
146687547|NCT00174915|529032953|FG003|Overall Study|Adverse Event|18|||
146687548|NCT00174915|529032954|FG004|Overall Study|Adverse Event|5|||
146687549|NCT00174915|529032950|FG000|Overall Study|Personal Reason(s)|16|||
146687550|NCT00174915|529032951|FG001|Overall Study|Personal Reason(s)|16|||
146687551|NCT00174915|529032952|FG002|Overall Study|Personal Reason(s)|9|||
146687552|NCT00174915|529032953|FG003|Overall Study|Personal Reason(s)|9|||
146687553|NCT00174915|529032954|FG004|Overall Study|Personal Reason(s)|9|||
146687554|NCT00174915|529032950|FG000|Overall Study|Other|15|||
146687555|NCT00174915|529032951|FG001|Overall Study|Other|8|||
146687556|NCT00174915|529032952|FG002|Overall Study|Other|6|||
146687557|NCT00174915|529032953|FG003|Overall Study|Other|5|||
146687558|NCT00174915|529032954|FG004|Overall Study|Other|3|||
146687559|NCT00174915|529032950|FG000|Overall Study|Gout Flare|13|||
146687560|NCT00174915|529032951|FG001|Overall Study|Gout Flare|6|||
146687561|NCT00174915|529032952|FG002|Overall Study|Gout Flare|8|||
146774909|NCT03624972|529346815|FG001|Overall Study|Withdrawal by Subject|2|||
146774910|NCT03624972|529346816|FG002|Overall Study|Withdrawal by Subject|0|||
146927938|NCT05168813|529896037|FG004|Part B (Blinded)|Pregnancy|1|||
146927939|NCT05168813|529896038|FG005|Part B (Blinded)|Pregnancy|0|||
146927940|NCT05168813|529896033|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
146927941|NCT05168813|529896034|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
146927942|NCT05168813|529896035|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
146927943|NCT05168813|529896036|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
146927944|NCT05168813|529896037|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
146927945|NCT05168813|529896038|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
146687562|NCT00174915|529032953|FG003|Overall Study|Gout Flare|1|||
146687563|NCT00174915|529032954|FG004|Overall Study|Gout Flare|0|||
146687564|NCT00174915|529032950|FG000|Overall Study|Protocol Violation|6|||
146687565|NCT00174915|529032951|FG001|Overall Study|Protocol Violation|3|||
146687566|NCT00174915|529032952|FG002|Overall Study|Protocol Violation|3|||
146687567|NCT00174915|529032953|FG003|Overall Study|Protocol Violation|6|||
146687568|NCT00174915|529032954|FG004|Overall Study|Protocol Violation|3|||
146774911|NCT01534494|529346819|FG000|Overall Study|Withdrawal by Subject|1|||
146927946|NCT05168813|529896033|FG000|Part B (Blinded)|Other|0|||
146687569|NCT00174915|529032950|FG000|Overall Study|Therapeutic Failure|6|||
146774912|NCT05137236|529346820|FG000|Part A|Other than Specified|1|||
146687570|NCT00174915|529032951|FG001|Overall Study|Therapeutic Failure|3|||
146687571|NCT00174915|529032952|FG002|Overall Study|Therapeutic Failure|2|||
146687572|NCT00174915|529032953|FG003|Overall Study|Therapeutic Failure|1|||
146687573|NCT00174915|529032954|FG004|Overall Study|Therapeutic Failure|3|||
146687574|NCT03060447|529032955|FG000|Overall Study|Withdrawal by Subject|2|||
146687575|NCT03060447|529032956|FG001|Overall Study|Withdrawal by Subject|0|||
146687576|NCT00665353|529032957|FG000|Study Step 1|Adverse Event|1|||
146687577|NCT00665353|529032957|FG000|Study Step 1|Withdrawal by Subject|2|||
146687578|NCT00665353|529032957|FG000|Study Step 2|Lost to Follow-up|2|||
146687579|NCT00665353|529032957|FG000|Study Step 2|Lack of Efficacy|12|||
146687580|NCT01870583|529032958|FG000|Overall Study|Protocol Violation|0|||
146687581|NCT01870583|529032959|FG001|Overall Study|Protocol Violation|5|||
146687582|NCT01870583|529032960|FG002|Overall Study|Protocol Violation|3|||
146687583|NCT01870583|529032958|FG000|Overall Study|Lost to Follow-up|11|||
146687584|NCT01870583|529032959|FG001|Overall Study|Lost to Follow-up|13|||
146687585|NCT01870583|529032960|FG002|Overall Study|Lost to Follow-up|5|||
146687586|NCT03045887|529032965|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
146687587|NCT03045887|529032966|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146687588|NCT03045887|529032967|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146687589|NCT03045887|529032968|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146687590|NCT03045887|529032969|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146687591|NCT03045887|529032970|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146687592|NCT03045887|529032971|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146687593|NCT03045887|529032972|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146687594|NCT03045887|529032973|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146687595|NCT03045887|529032974|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146687596|NCT03045887|529032965|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146687597|NCT03045887|529032966|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146687598|NCT03045887|529032967|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146687599|NCT03045887|529032968|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
146687600|NCT03045887|529032969|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146687601|NCT03045887|529032970|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146687602|NCT03045887|529032971|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146687603|NCT03045887|529032972|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146687604|NCT03045887|529032973|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146687605|NCT03045887|529032974|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146687606|NCT03045887|529032965|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
146687607|NCT03045887|529032966|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
146687608|NCT03045887|529032967|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
146687609|NCT03045887|529032968|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
146687610|NCT03045887|529032969|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
146687611|NCT03045887|529032970|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
146687612|NCT03045887|529032971|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
146687613|NCT03045887|529032972|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
146687614|NCT03045887|529032973|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
146774913|NCT05137236|529346821|FG001|Part A|Other than Specified|0|||
146774914|NCT05137236|529346822|FG002|Part A|Other than Specified|0|||
146774915|NCT05137236|529346823|FG003|Part A|Other than Specified|0|||
146774916|NCT05137236|529346824|FG004|Part A|Other than Specified|0|||
146774917|NCT05137236|529346825|FG005|Part A|Other than Specified|0|||
146774918|NCT05137236|529346826|FG006|Part A|Other than Specified|0|||
146774919|NCT05137236|529346827|FG007|Part A|Other than Specified|0|||
146774920|NCT05137236|529346820|FG000|Part A|Withdrawal by Subject|0|||
146774921|NCT05137236|529346821|FG001|Part A|Withdrawal by Subject|4|||
146774922|NCT05137236|529346822|FG002|Part A|Withdrawal by Subject|1|||
146774923|NCT05137236|529346823|FG003|Part A|Withdrawal by Subject|1|||
146774924|NCT05137236|529346824|FG004|Part A|Withdrawal by Subject|3|||
146774925|NCT05137236|529346825|FG005|Part A|Withdrawal by Subject|2|||
146687615|NCT03045887|529032974|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
146774926|NCT05137236|529346826|FG006|Part A|Withdrawal by Subject|0|||
146927947|NCT05168813|529896034|FG001|Part B (Blinded)|Other|0|||
146927948|NCT05168813|529896035|FG002|Part B (Blinded)|Other|0|||
146927949|NCT05168813|529896036|FG003|Part B (Blinded)|Other|0|||
146927950|NCT05168813|529896037|FG004|Part B (Blinded)|Other|41|||
146687616|NCT03045887|529032965|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
146687617|NCT03045887|529032966|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
146687618|NCT03045887|529032967|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
146687619|NCT03045887|529032968|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
146687620|NCT03045887|529032969|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
146774927|NCT05137236|529346827|FG007|Part A|Withdrawal by Subject|0|||
146774928|NCT05137236|529346820|FG000|Part A|Lost to Follow-up|5|||
146774929|NCT05137236|529346821|FG001|Part A|Lost to Follow-up|7|||
146774930|NCT05137236|529346822|FG002|Part A|Lost to Follow-up|1|||
146774931|NCT05137236|529346823|FG003|Part A|Lost to Follow-up|3|||
146927951|NCT05168813|529896038|FG005|Part B (Blinded)|Other|27|||
146687621|NCT03045887|529032970|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
146687622|NCT03045887|529032971|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
146687623|NCT03045887|529032972|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
146687624|NCT03045887|529032973|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
146687625|NCT03045887|529032974|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
146687626|NCT03045887|529032965|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146687627|NCT03045887|529032966|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146687628|NCT03045887|529032967|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146687629|NCT03045887|529032968|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
146687630|NCT03045887|529032969|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146687631|NCT03045887|529032970|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146687632|NCT03045887|529032971|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146687633|NCT03045887|529032972|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146687634|NCT03045887|529032973|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146687635|NCT03045887|529032974|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146687636|NCT02632552|529032975|FG000|Overall Study|Lost to Follow-up|14|||
146687637|NCT02632552|529032976|FG001|Overall Study|Lost to Follow-up|8|||
146687638|NCT02632552|529032975|FG000|Overall Study|Withdrawal by Subject|2|||
146687639|NCT02632552|529032976|FG001|Overall Study|Withdrawal by Subject|0|||
146687640|NCT02632552|529032975|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
146687641|NCT02632552|529032976|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
146687642|NCT02132767|529032977|FG000|Overall Study|Death|3|||
146687643|NCT02132767|529032978|FG001|Overall Study|Death|2|||
146774932|NCT05137236|529346824|FG004|Part A|Lost to Follow-up|3|||
146774933|NCT05137236|529346825|FG005|Part A|Lost to Follow-up|8|||
146927952|NCT02680587|529896042|FG000|Overall Study|Withdrawal by Subject|1|||
146927953|NCT02680587|529896043|FG001|Overall Study|Withdrawal by Subject|0|||
146927954|NCT01194869|529896045|FG000|Overall Study|Disease Progression|2|||
146927955|NCT01194869|529896045|FG000|Overall Study|Toxicity|2|||
146927956|NCT01708941|529896046|FG000|Overall Study|Adverse Event|4|||
146927957|NCT01708941|529896047|FG001|Overall Study|Adverse Event|6|||
146927958|NCT01708941|529896048|FG002|Overall Study|Adverse Event|1|||
146927959|NCT01708941|529896049|FG003|Overall Study|Adverse Event|0|||
146927960|NCT01708941|529896046|FG000|Overall Study|Death|1|||
146927961|NCT01708941|529896047|FG001|Overall Study|Death|1|||
146927962|NCT01708941|529896048|FG002|Overall Study|Death|2|||
146927963|NCT01708941|529896049|FG003|Overall Study|Death|14|||
146927964|NCT01708941|529896046|FG000|Overall Study|Withdrawal by Subject|1|||
146927965|NCT01708941|529896047|FG001|Overall Study|Withdrawal by Subject|0|||
146927966|NCT01708941|529896048|FG002|Overall Study|Withdrawal by Subject|3|||
146927967|NCT01708941|529896049|FG003|Overall Study|Withdrawal by Subject|4|||
146927968|NCT01708941|529896046|FG000|Overall Study|Disease progression|9|||
146927969|NCT01708941|529896047|FG001|Overall Study|Disease progression|10|||
146927970|NCT01708941|529896048|FG002|Overall Study|Disease progression|8|||
146927971|NCT01708941|529896049|FG003|Overall Study|Disease progression|0|||
146927972|NCT01708941|529896046|FG000|Overall Study|Alternative therapy|0|||
146927973|NCT01708941|529896047|FG001|Overall Study|Alternative therapy|0|||
146927974|NCT01708941|529896048|FG002|Overall Study|Alternative therapy|2|||
146927975|NCT01708941|529896049|FG003|Overall Study|Alternative therapy|0|||
146927976|NCT01708941|529896046|FG000|Overall Study|Ineligible and never started treatment|1|||
146927977|NCT01708941|529896047|FG001|Overall Study|Ineligible and never started treatment|0|||
146927978|NCT01708941|529896048|FG002|Overall Study|Ineligible and never started treatment|1|||
146927979|NCT01708941|529896049|FG003|Overall Study|Ineligible and never started treatment|0|||
146927980|NCT01708941|529896046|FG000|Overall Study|Never started treatment|2|||
146927981|NCT01708941|529896047|FG001|Overall Study|Never started treatment|1|||
146927982|NCT01708941|529896048|FG002|Overall Study|Never started treatment|0|||
146927983|NCT01708941|529896049|FG003|Overall Study|Never started treatment|0|||
146927984|NCT01708941|529896046|FG000|Overall Study|Ineligible|0|||
146687644|NCT02132767|529032977|FG000|Overall Study|Withdrawal by Subject|10|||
146687645|NCT02132767|529032978|FG001|Overall Study|Withdrawal by Subject|9|||
146687646|NCT02132767|529032977|FG000|Overall Study|Lost to Follow-up|4|||
146687647|NCT02132767|529032978|FG001|Overall Study|Lost to Follow-up|4|||
146687648|NCT00778700|529032981|FG000|Overall Study|Adverse Event|6|||
146687649|NCT00778700|529032982|FG001|Overall Study|Adverse Event|1|||
146687650|NCT00778700|529032983|FG002|Overall Study|Adverse Event|3|||
146687651|NCT00778700|529032984|FG003|Overall Study|Adverse Event|5|||
146774934|NCT05137236|529346826|FG006|Part A|Lost to Follow-up|0|||
146774935|NCT05137236|529346827|FG007|Part A|Lost to Follow-up|0|||
146774936|NCT05137236|529346820|FG000|Part B|Withdrawal by Subject|0|||
146927985|NCT01708941|529896047|FG001|Overall Study|Ineligible|0|||
146927986|NCT01708941|529896048|FG002|Overall Study|Ineligible|2|||
146927987|NCT01708941|529896049|FG003|Overall Study|Ineligible|0|||
146927988|NCT02226146|529896050|FG000|Overall Study|Received rescue therapy|1|||
146927989|NCT02226146|529896050|FG000|Overall Study|Withdrawal by Subject|2|||
146927990|NCT05464836|529896051|FG000|Overall Study|Progression of Disease|1|||
146774937|NCT05137236|529346821|FG001|Part B|Withdrawal by Subject|0|||
146774938|NCT05137236|529346822|FG002|Part B|Withdrawal by Subject|0|||
146774939|NCT05137236|529346823|FG003|Part B|Withdrawal by Subject|0|||
146774940|NCT05137236|529346824|FG004|Part B|Withdrawal by Subject|0|||
146774941|NCT05137236|529346825|FG005|Part B|Withdrawal by Subject|0|||
146774942|NCT05137236|529346826|FG006|Part B|Withdrawal by Subject|0|||
146774943|NCT05137236|529346827|FG007|Part B|Withdrawal by Subject|2|||
146687652|NCT00778700|529032981|FG000|Overall Study|Protocol Violation|1|||
146687653|NCT00778700|529032982|FG001|Overall Study|Protocol Violation|1|||
146687654|NCT00778700|529032983|FG002|Overall Study|Protocol Violation|0|||
146687655|NCT00778700|529032984|FG003|Overall Study|Protocol Violation|0|||
146687656|NCT00778700|529032981|FG000|Overall Study|Subject Withdrew Consent|6|||
146687657|NCT00778700|529032982|FG001|Overall Study|Subject Withdrew Consent|4|||
146687658|NCT00778700|529032983|FG002|Overall Study|Subject Withdrew Consent|1|||
146687659|NCT00778700|529032984|FG003|Overall Study|Subject Withdrew Consent|4|||
146687660|NCT00778700|529032981|FG000|Overall Study|Lost to Follow-up|3|||
146687661|NCT00778700|529032982|FG001|Overall Study|Lost to Follow-up|1|||
146687662|NCT00778700|529032983|FG002|Overall Study|Lost to Follow-up|0|||
146687663|NCT00778700|529032984|FG003|Overall Study|Lost to Follow-up|1|||
146687664|NCT00778700|529032981|FG000|Overall Study|Reason not Specified|2|||
146687665|NCT00778700|529032982|FG001|Overall Study|Reason not Specified|0|||
146687666|NCT00778700|529032983|FG002|Overall Study|Reason not Specified|1|||
146687667|NCT00778700|529032984|FG003|Overall Study|Reason not Specified|3|||
146687668|NCT00778700|529032981|FG000|Overall Study|Other|0|||
146687669|NCT00778700|529032982|FG001|Overall Study|Other|0|||
146687670|NCT00778700|529032983|FG002|Overall Study|Other|1|||
146687671|NCT00778700|529032984|FG003|Overall Study|Other|0|||
146687672|NCT03227029|529032987|FG000|Overall Study|Child Wheezed (no treatment)|0|||
146687673|NCT03227029|529032988|FG001|Overall Study|Child Wheezed (no treatment)|1|||
146687674|NCT03227029|529032989|FG002|Overall Study|Child Wheezed (no treatment)|0|||
146687675|NCT03227029|529032987|FG000|Overall Study|No post RSV season visit due to COVID|3|||
146687676|NCT03227029|529032988|FG001|Overall Study|No post RSV season visit due to COVID|3|||
146687677|NCT03227029|529032989|FG002|Overall Study|No post RSV season visit due to COVID|2|||
146687678|NCT03227029|529032987|FG000|Overall Study|Not able to get to clinic|0|||
146687679|NCT03227029|529032988|FG001|Overall Study|Not able to get to clinic|0|||
146687680|NCT03227029|529032989|FG002|Overall Study|Not able to get to clinic|1|||
146687681|NCT03227029|529032987|FG000|Overall Study|Withdrawal by Subject|1|||
146687682|NCT03227029|529032988|FG001|Overall Study|Withdrawal by Subject|0|||
146687683|NCT03227029|529032989|FG002|Overall Study|Withdrawal by Subject|0|||
146687684|NCT03227029|529032987|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
146687685|NCT03227029|529032988|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
146687686|NCT03227029|529032989|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
146687687|NCT02268864|529032990|FG000|Overall Study|Withdrawal by Subject|2|||
146687688|NCT02268864|529032991|FG001|Overall Study|Withdrawal by Subject|0|||
146687689|NCT02268864|529032992|FG002|Overall Study|Withdrawal by Subject|0|||
146687690|NCT02268864|529032990|FG000|Overall Study|Death|0|||
146687691|NCT02268864|529032991|FG001|Overall Study|Death|1|||
146687692|NCT02268864|529032992|FG002|Overall Study|Death|0|||
146687693|NCT02612428|529032995|FG000|VTL-308|Death|14|||
146687694|NCT02612428|529032996|FG001|VTL-308|Death|16|||
146687695|NCT02612428|529032995|FG000|VTL-308|Withdrawal by Subject|0|||
146687696|NCT02612428|529032996|FG001|VTL-308|Withdrawal by Subject|1|||
146687697|NCT02612428|529032995|FG000|VTL-308E|Death|9|||
146687698|NCT02612428|529032996|FG001|VTL-308E|Death|7|||
146687699|NCT02612428|529032995|FG000|VTL-308E|Lost to Follow-up|2|||
146687700|NCT02612428|529032996|FG001|VTL-308E|Lost to Follow-up|0|||
146774944|NCT05137236|529346820|FG000|Part B|Lost to Follow-up|0|||
146774945|NCT05137236|529346821|FG001|Part B|Lost to Follow-up|0|||
146774946|NCT05137236|529346822|FG002|Part B|Lost to Follow-up|0|||
146774947|NCT05137236|529346823|FG003|Part B|Lost to Follow-up|0|||
146774948|NCT05137236|529346824|FG004|Part B|Lost to Follow-up|0|||
146774949|NCT05137236|529346825|FG005|Part B|Lost to Follow-up|0|||
146774950|NCT05137236|529346826|FG006|Part B|Lost to Follow-up|5|||
146687701|NCT02064166|529032999|FG000|Overall Study|Adverse Event|1|||
146687702|NCT02064166|529033000|FG001|Overall Study|Adverse Event|0|||
146687703|NCT00597766|529033005|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
146687704|NCT00597766|529033006|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
146687705|NCT00597766|529033007|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
146687706|NCT00597766|529033005|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
146774951|NCT05137236|529346827|FG007|Part B|Lost to Follow-up|5|||
146774952|NCT05137236|529346820|FG000|Part B|Death|0|||
146774953|NCT05137236|529346821|FG001|Part B|Death|0|||
146774954|NCT05137236|529346822|FG002|Part B|Death|0|||
146687707|NCT00597766|529033006|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
146687708|NCT00597766|529033007|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
146687709|NCT04339296|529033009|FG000|Overall Study|Refuse to participate after allocation|1|||
146687710|NCT04339296|529033010|FG001|Overall Study|Refuse to participate after allocation|1|||
146687711|NCT04339296|529033009|FG000|Overall Study|Withdrew after completion of baseline|2|||
146774955|NCT05137236|529346823|FG003|Part B|Death|0|||
146978997|NCT03341273|530085544|FG001|Overall Study|Not Eligible at Enrollment|1|||
146978998|NCT03341273|530085543|FG000|Overall Study|Participant incarcerated|1|||
146978999|NCT03341273|530085544|FG001|Overall Study|Participant incarcerated|0|||
146979000|NCT00685919|530085545|FG000|Overall Study|Withdrawal by Subject|0|||
146979001|NCT00685919|530085546|FG001|Overall Study|Withdrawal by Subject|0|||
146979002|NCT00685919|530085547|FG002|Overall Study|Withdrawal by Subject|1|||
146979003|NCT00685919|530085548|FG003|Overall Study|Withdrawal by Subject|0|||
146979004|NCT00685919|530085545|FG000|Overall Study|Physician Decision|1|||
146979005|NCT00685919|530085546|FG001|Overall Study|Physician Decision|0|||
146979006|NCT00685919|530085547|FG002|Overall Study|Physician Decision|0|||
146979007|NCT00685919|530085548|FG003|Overall Study|Physician Decision|0|||
146979008|NCT02622074|530085549|FG000|Overall Study|Death|4|||
146979009|NCT02622074|530085550|FG001|Overall Study|Death|0|||
146979010|NCT02622074|530085551|FG002|Overall Study|Death|0|||
146979011|NCT02622074|530085552|FG003|Overall Study|Death|1|||
146979012|NCT02622074|530085553|FG004|Overall Study|Death|1|||
146979013|NCT02622074|530085554|FG005|Overall Study|Death|0|||
146979014|NCT02622074|530085549|FG000|Overall Study|Withdrawal by Subject|0|||
146687712|NCT04339296|529033010|FG001|Overall Study|Withdrew after completion of baseline|1|||
146687713|NCT04339296|529033009|FG000|Overall Study|Lost to Follow-up|0|||
146687714|NCT04339296|529033010|FG001|Overall Study|Lost to Follow-up|4|||
146687715|NCT04339296|529033009|FG000|Overall Study|Discontinued intervention|5|||
146687716|NCT04339296|529033010|FG001|Overall Study|Discontinued intervention|3|||
146687717|NCT02375113|529033015|FG000|Overall Study|Undisclosed Reason(s).|1|||
146687718|NCT02375113|529033016|FG001|Overall Study|Undisclosed Reason(s).|1|||
146687719|NCT02375113|529033015|FG000|Overall Study|Poor adherence (<70%).|1|||
146687720|NCT02375113|529033016|FG001|Overall Study|Poor adherence (<70%).|0|||
146687721|NCT02375113|529033015|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
146687722|NCT02375113|529033016|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
146687723|NCT00877383|529033019|FG000|Overall Study|Adverse Event|13|||
146687724|NCT00877383|529033020|FG001|Overall Study|Adverse Event|14|||
146687725|NCT00877383|529033019|FG000|Overall Study|Lost to Follow-up|5|||
146687726|NCT00877383|529033020|FG001|Overall Study|Lost to Follow-up|3|||
146687727|NCT00877383|529033019|FG000|Overall Study|Subject withdrew consent|3|||
146687728|NCT00877383|529033020|FG001|Overall Study|Subject withdrew consent|12|||
146687729|NCT00877383|529033019|FG000|Overall Study|Subject no longer requires study drug|2|||
146687730|NCT00877383|529033020|FG001|Overall Study|Subject no longer requires study drug|0|||
146687731|NCT00877383|529033019|FG000|Overall Study|Administrative problems|2|||
146927991|NCT05464836|529896051|FG000|Overall Study|Physician Decision|1|||
146927992|NCT01522976|529896052|FG000|Overall Study|Ineligible|4|||
146927993|NCT01522976|529896053|FG001|Overall Study|Ineligible|0|||
146927994|NCT01522976|529896054|FG002|Overall Study|Ineligible|1|||
146927995|NCT01522976|529896052|FG000|Overall Study|Death|7|||
146927996|NCT01522976|529896053|FG001|Overall Study|Death|6|||
146927997|NCT01522976|529896054|FG002|Overall Study|Death|2|||
146927998|NCT01522976|529896052|FG000|Overall Study|Still on treatment|9|||
146927999|NCT01522976|529896053|FG001|Overall Study|Still on treatment|9|||
146928000|NCT01522976|529896054|FG002|Overall Study|Still on treatment|6|||
146928001|NCT01522976|529896052|FG000|Overall Study|Disease progression|28|||
146928002|NCT01522976|529896053|FG001|Overall Study|Disease progression|30|||
146928003|NCT01522976|529896054|FG002|Overall Study|Disease progression|25|||
146928004|NCT01522976|529896052|FG000|Overall Study|Adverse Event|17|||
146928005|NCT01522976|529896053|FG001|Overall Study|Adverse Event|7|||
146928006|NCT01522976|529896054|FG002|Overall Study|Adverse Event|18|||
146928007|NCT01522976|529896052|FG000|Overall Study|Refusal unrelated to adverse event|10|||
146928008|NCT01522976|529896053|FG001|Overall Study|Refusal unrelated to adverse event|13|||
146928009|NCT01522976|529896054|FG002|Overall Study|Refusal unrelated to adverse event|14|||
146928010|NCT01522976|529896052|FG000|Overall Study|Not protocol specified|22|||
146928011|NCT01522976|529896053|FG001|Overall Study|Not protocol specified|27|||
146928012|NCT01522976|529896054|FG002|Overall Study|Not protocol specified|27|||
146928013|NCT02883049|529896055|FG000|Induction|Adverse Event|52|||
146928014|NCT02883049|529896056|FG001|Induction|Adverse Event|2|||
146928015|NCT02883049|529896057|FG002|Induction|Adverse Event|0|||
146928016|NCT02883049|529896058|FG003|Induction|Adverse Event|0|||
146928017|NCT02883049|529896059|FG004|Induction|Adverse Event|0|||
146979015|NCT02622074|530085550|FG001|Overall Study|Withdrawal by Subject|1|||
146687732|NCT00877383|529033020|FG001|Overall Study|Administrative problems|0|||
146928018|NCT02883049|529896060|FG005|Induction|Adverse Event|0|||
146928019|NCT02883049|529896061|FG006|Induction|Adverse Event|0|||
146928020|NCT02883049|529896062|FG007|Induction|Adverse Event|0|||
146687733|NCT00877383|529033019|FG000|Overall Study|Protocol deviation|2|||
146687734|NCT00877383|529033020|FG001|Overall Study|Protocol deviation|6|||
146687735|NCT00877383|529033019|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146928021|NCT02883049|529896063|FG008|Induction|Adverse Event|0|||
146928022|NCT02883049|529896064|FG009|Induction|Adverse Event|0|||
146928023|NCT02883049|529896065|FG010|Induction|Adverse Event|0|||
146928024|NCT02883049|529896066|FG011|Induction|Adverse Event|0|||
146979016|NCT02622074|530085551|FG002|Overall Study|Withdrawal by Subject|0|||
146979017|NCT02622074|530085552|FG003|Overall Study|Withdrawal by Subject|0|||
146687736|NCT00877383|529033020|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146687737|NCT00877383|529033019|FG000|Overall Study|Death|1|||
146687738|NCT00877383|529033020|FG001|Overall Study|Death|2|||
146687739|NCT00459108|529033021|FG000|Overall Study|Withdrawal by Subject|5|||
146687740|NCT00459108|529033021|FG000|Overall Study|Adverse Event|3|||
146687741|NCT00459108|529033021|FG000|Overall Study|Death|2|||
146687742|NCT00459108|529033021|FG000|Overall Study|Progression|1|||
146687743|NCT02062879|529033027|FG000|Overall Study|Withdrawal by Subject|4|||
146687744|NCT02062879|529033028|FG001|Overall Study|Withdrawal by Subject|1|||
146687745|NCT00056407|529033029|FG000|Overall Study|Adverse Event|282|||
146687746|NCT00056407|529033030|FG001|Overall Study|Adverse Event|364|||
146687747|NCT00056407|529033029|FG000|Overall Study|Withdrawal by Subject|377|||
146687748|NCT00056407|529033030|FG001|Overall Study|Withdrawal by Subject|361|||
146687749|NCT00056407|529033029|FG000|Overall Study|Lost to Follow-up|123|||
146687750|NCT00056407|529033030|FG001|Overall Study|Lost to Follow-up|113|||
146687751|NCT00056407|529033029|FG000|Overall Study|Protocol Violation|104|||
146687752|NCT00056407|529033030|FG001|Overall Study|Protocol Violation|95|||
146687753|NCT00056407|529033029|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
146687754|NCT00056407|529033030|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
146687755|NCT00056407|529033029|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
146687756|NCT00056407|529033030|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
146687757|NCT00056407|529033029|FG000|Overall Study|Missing|25|||
146687758|NCT00056407|529033030|FG001|Overall Study|Missing|34|||
146687759|NCT00616655|529033031|FG000|Overall Study|Adverse Event|10|||
146687760|NCT00616655|529033032|FG001|Overall Study|Adverse Event|7|||
146687761|NCT00616655|529033033|FG002|Overall Study|Adverse Event|12|||
146687762|NCT00616655|529033031|FG000|Overall Study|Lack of Efficacy|5|||
146687763|NCT00616655|529033032|FG001|Overall Study|Lack of Efficacy|5|||
146687764|NCT00616655|529033033|FG002|Overall Study|Lack of Efficacy|5|||
146687765|NCT00616655|529033031|FG000|Overall Study|Lost to Follow-up|3|||
146687766|NCT00616655|529033032|FG001|Overall Study|Lost to Follow-up|12|||
146687767|NCT00616655|529033033|FG002|Overall Study|Lost to Follow-up|10|||
146687768|NCT00616655|529033031|FG000|Overall Study|Protocol Violation|2|||
146687769|NCT00616655|529033032|FG001|Overall Study|Protocol Violation|4|||
146687770|NCT00616655|529033033|FG002|Overall Study|Protocol Violation|3|||
146687771|NCT00616655|529033031|FG000|Overall Study|Withdrawal by Subject|9|||
146687772|NCT00616655|529033032|FG001|Overall Study|Withdrawal by Subject|7|||
146687773|NCT00616655|529033033|FG002|Overall Study|Withdrawal by Subject|11|||
146687774|NCT00616655|529033031|FG000|Overall Study|Does not meet in/ex criteria|0|||
146687775|NCT00616655|529033032|FG001|Overall Study|Does not meet in/ex criteria|0|||
146687776|NCT00616655|529033033|FG002|Overall Study|Does not meet in/ex criteria|2|||
146687777|NCT00616655|529033031|FG000|Overall Study|Other|6|||
146687778|NCT00616655|529033032|FG001|Overall Study|Other|6|||
146687779|NCT00616655|529033033|FG002|Overall Study|Other|5|||
146687780|NCT03761147|529033034|FG000|Overall Study|Withdrawal by Subject|6|||
146687781|NCT03761147|529033035|FG001|Overall Study|Withdrawal by Subject|1|||
146687782|NCT03761147|529033034|FG000|Overall Study|Adverse Event|1|||
146687783|NCT03761147|529033035|FG001|Overall Study|Adverse Event|3|||
146687784|NCT01026792|529033036|FG000|Overall Study|Protocol Violation|1|||
146687785|NCT02626520|529033039|FG000|Overall Study|Physician Decision|1|||
146687786|NCT02626520|529033040|FG001|Overall Study|Physician Decision|1|||
146687787|NCT02626520|529033039|FG000|Overall Study|Adverse Event|0|||
146687788|NCT02626520|529033040|FG001|Overall Study|Adverse Event|4|||
146687789|NCT02626520|529033039|FG000|Overall Study|Lack of Efficacy|0|||
146687790|NCT02626520|529033040|FG001|Overall Study|Lack of Efficacy|2|||
146687791|NCT02626520|529033039|FG000|Overall Study|Did not start protocol therapy|0|||
146687792|NCT02626520|529033040|FG001|Overall Study|Did not start protocol therapy|2|||
146687793|NCT02626520|529033039|FG000|Overall Study|Study terminated|0|||
146687794|NCT02626520|529033040|FG001|Overall Study|Study terminated|1|||
146687795|NCT00492115|529033041|FG000|Overall Study|Withdrawal by Subject|3|||
146687796|NCT00492115|529033042|FG001|Overall Study|Withdrawal by Subject|4|||
146687797|NCT02045797|529033045|FG000|Overall Study|Adverse Event|3|||
146687798|NCT02045797|529033046|FG001|Overall Study|Adverse Event|1|||
146687799|NCT02045797|529033047|FG002|Overall Study|Adverse Event|0|||
146687800|NCT02045797|529033045|FG000|Overall Study|Lack of Efficacy|1|||
146687801|NCT02045797|529033046|FG001|Overall Study|Lack of Efficacy|0|||
146687802|NCT02045797|529033047|FG002|Overall Study|Lack of Efficacy|0|||
146687803|NCT02045797|529033045|FG000|Overall Study|Lost to Follow-up|2|||
146687804|NCT02045797|529033046|FG001|Overall Study|Lost to Follow-up|3|||
146687805|NCT02045797|529033047|FG002|Overall Study|Lost to Follow-up|1|||
146687806|NCT02045797|529033045|FG000|Overall Study|Physician Decision|0|||
146687807|NCT02045797|529033046|FG001|Overall Study|Physician Decision|1|||
146687808|NCT02045797|529033047|FG002|Overall Study|Physician Decision|0|||
146687809|NCT02045797|529033045|FG000|Overall Study|Withdrawal by Subject|1|||
146687810|NCT02045797|529033046|FG001|Overall Study|Withdrawal by Subject|2|||
146687811|NCT02045797|529033047|FG002|Overall Study|Withdrawal by Subject|0|||
146687812|NCT00696696|529033925|FG000|Overall Study|Adverse Event|5|||
146687813|NCT00696696|529033925|FG000|Overall Study|Withdrawal by Subject|8|||
146687814|NCT00696696|529033925|FG000|Overall Study|Physician Decision|2|||
146979018|NCT02622074|530085553|FG004|Overall Study|Withdrawal by Subject|0|||
146979019|NCT02622074|530085554|FG005|Overall Study|Withdrawal by Subject|0|||
146979020|NCT02114931|530085555|FG000|Overall Study|Withdrawal by Subject|15|||
146979021|NCT02114931|530085556|FG001|Overall Study|Withdrawal by Subject|18|||
146979022|NCT02114931|530085555|FG000|Overall Study|Adverse Event|4|||
146979023|NCT02114931|530085556|FG001|Overall Study|Adverse Event|6|||
146979024|NCT02114931|530085555|FG000|Overall Study|Lost to Follow-up|3|||
146979025|NCT02114931|530085556|FG001|Overall Study|Lost to Follow-up|3|||
146979026|NCT02114931|530085555|FG000|Overall Study|Physician Decision|1|||
146979027|NCT02114931|530085556|FG001|Overall Study|Physician Decision|2|||
146979028|NCT02114931|530085555|FG000|Overall Study|Other|2|||
146979029|NCT02114931|530085556|FG001|Overall Study|Other|1|||
146979030|NCT03726437|530085557|FG000|Overall Study|Lost to Follow-up|85|||
146979031|NCT03726437|530085558|FG001|Overall Study|Lost to Follow-up|76|||
146979032|NCT00267007|530085559|FG000|Overall Study|Withdrawal by Subject|6|||
146979033|NCT00267007|530085560|FG001|Overall Study|Withdrawal by Subject|0|||
146979034|NCT00267007|530085559|FG000|Overall Study|Lost to Follow-up|1|||
146979035|NCT00267007|530085560|FG001|Overall Study|Lost to Follow-up|0|||
146979036|NCT00267007|530085559|FG000|Overall Study|Non-compliance|0|||
146979037|NCT00267007|530085560|FG001|Overall Study|Non-compliance|1|||
146979038|NCT00267007|530085559|FG000|Overall Study|Adverse Event|1|||
146979039|NCT00267007|530085560|FG001|Overall Study|Adverse Event|0|||
146979040|NCT01205529|530085564|FG000|Overall Study|Procedure Cancelled|4|||
146979041|NCT01205529|530085564|FG000|Overall Study|Withdrawal by Subject|2|||
146979042|NCT01205529|530085564|FG000|Overall Study|Physician Decision|4|||
146979043|NCT01205529|530085564|FG000|Overall Study|Unstable post op|15|||
146979044|NCT01205529|530085564|FG000|Overall Study|No longer met criteria|30|||
146979045|NCT03840135|530085565|FG000|Overall Study|Protocol Violation|6|||
146979046|NCT03840135|530085566|FG001|Overall Study|Protocol Violation|1|||
146979047|NCT03840135|530085565|FG000|Overall Study|Withdrawal by Subject|1|||
146979048|NCT03840135|530085566|FG001|Overall Study|Withdrawal by Subject|0|||
146979049|NCT00667719|530085567|FG000|Overall Study|Adverse Event|39|||
146979050|NCT00667719|530085567|FG000|Overall Study|Abnormal Test Procedure|1|||
146979051|NCT00667719|530085567|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
146979052|NCT00667719|530085567|FG000|Overall Study|Protocol Violation|3|||
146979053|NCT00667719|530085567|FG000|Overall Study|Withdrawal by Subject|17|||
146979054|NCT00667719|530085567|FG000|Overall Study|Lost to Follow-up|8|||
146979055|NCT01159769|530085568|FG000|Overall Study|Adverse Event|1|||
146979056|NCT01827371|530085569|FG000|Overall Study|Adverse Event|0|||
146979057|NCT01827371|530085570|FG001|Overall Study|Adverse Event|0|||
146979058|NCT01827371|530085571|FG002|Overall Study|Adverse Event|4|||
146979059|NCT01827371|530085572|FG003|Overall Study|Adverse Event|2|||
146979060|NCT01827371|530085569|FG000|Overall Study|Lost to Follow-up|0|||
146979061|NCT01827371|530085570|FG001|Overall Study|Lost to Follow-up|2|||
146979062|NCT01827371|530085571|FG002|Overall Study|Lost to Follow-up|0|||
146979063|NCT01827371|530085572|FG003|Overall Study|Lost to Follow-up|4|||
146979064|NCT01827371|530085569|FG000|Overall Study|Protocol Violation|1|||
146687815|NCT00696696|529033925|FG000|Overall Study|Death|3|||
146687816|NCT02642614|529033926|FG000|Overall Study|Adverse Event|1|||
146687817|NCT02642614|529033927|FG001|Overall Study|Adverse Event|1|||
146687818|NCT02642614|529033928|FG002|Overall Study|Adverse Event|2|||
146687819|NCT02642614|529033929|FG003|Overall Study|Adverse Event|2|||
146687820|NCT02642614|529033926|FG000|Overall Study|Lost to Follow-up|1|||
146687821|NCT02642614|529033927|FG001|Overall Study|Lost to Follow-up|0|||
146687822|NCT02642614|529033928|FG002|Overall Study|Lost to Follow-up|0|||
146687823|NCT02642614|529033929|FG003|Overall Study|Lost to Follow-up|0|||
146687824|NCT02642614|529033926|FG000|Overall Study|Withdrawal by Subject|1|||
146687825|NCT02642614|529033927|FG001|Overall Study|Withdrawal by Subject|1|||
146979065|NCT01827371|530085570|FG001|Overall Study|Protocol Violation|0|||
146979066|NCT01827371|530085571|FG002|Overall Study|Protocol Violation|0|||
146979067|NCT01827371|530085572|FG003|Overall Study|Protocol Violation|0|||
146979068|NCT01827371|530085569|FG000|Overall Study|Withdrawal by Subject|1|||
146687826|NCT02642614|529033928|FG002|Overall Study|Withdrawal by Subject|0|||
146687827|NCT02642614|529033929|FG003|Overall Study|Withdrawal by Subject|0|||
146687828|NCT00936910|529033930|FG000|Overall Study|Lack of Efficacy|3|||
146687829|NCT01485640|529033931|FG000|Overall Study|Adverse Event|10|||
146687830|NCT01485640|529033931|FG000|Overall Study|Lack of Efficacy|2|||
146774956|NCT05137236|529346824|FG004|Part B|Death|0|||
146979069|NCT01827371|530085570|FG001|Overall Study|Withdrawal by Subject|2|||
146979070|NCT01827371|530085571|FG002|Overall Study|Withdrawal by Subject|2|||
146979071|NCT01827371|530085572|FG003|Overall Study|Withdrawal by Subject|3|||
146979072|NCT01827371|530085569|FG000|Overall Study|Physician Decision|0|||
146979073|NCT01827371|530085570|FG001|Overall Study|Physician Decision|1|||
146979074|NCT01827371|530085571|FG002|Overall Study|Physician Decision|0|||
146979075|NCT01827371|530085572|FG003|Overall Study|Physician Decision|1|||
146687831|NCT01485640|529033931|FG000|Overall Study|Protocol Violation|1|||
146979076|NCT01827371|530085569|FG000|Overall Study|Temporary study halt to vaccinations|11|||
146979077|NCT01827371|530085570|FG001|Overall Study|Temporary study halt to vaccinations|2|||
146979078|NCT01827371|530085571|FG002|Overall Study|Temporary study halt to vaccinations|5|||
146687832|NCT01485640|529033931|FG000|Overall Study|Withdrawal by Subject|14|||
146687833|NCT01485640|529033931|FG000|Overall Study|Terminated by Sponsor|95|||
146687834|NCT02057198|529033934|FG000|Overall Study|Death|0|||
146687835|NCT02057198|529033935|FG001|Overall Study|Death|0|||
146687836|NCT02057198|529033936|FG002|Overall Study|Death|1|||
146687837|NCT02057198|529033934|FG000|Overall Study|Discharged early; lost to followup|0|||
146687838|NCT02057198|529033935|FG001|Overall Study|Discharged early; lost to followup|1|||
146687839|NCT02057198|529033936|FG002|Overall Study|Discharged early; lost to followup|0|||
146687840|NCT02355691|529033937|FG000|Overall Study|Loss of Research Personnel|7|||
146687841|NCT02355691|529033938|FG001|Overall Study|Loss of Research Personnel|9|||
146687842|NCT03232281|529033940|FG000|Overall Study|Adverse Event|1|||
146687843|NCT03232281|529033941|FG001|Overall Study|Adverse Event|1|||
146687844|NCT03232281|529033940|FG000|Overall Study|Withdrawal by Subject|5|||
146687845|NCT03232281|529033941|FG001|Overall Study|Withdrawal by Subject|4|||
146687846|NCT03232281|529033940|FG000|Overall Study|Protocol Deviation|1|||
146687847|NCT03232281|529033941|FG001|Overall Study|Protocol Deviation|1|||
146687848|NCT02345811|529033943|FG000|First Intervention|Withdrawal by Subject|1|||
146687849|NCT02345811|529033944|FG001|First Intervention|Withdrawal by Subject|1|||
146687850|NCT02489344|529033946|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
146687851|NCT02489344|529033946|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
146687852|NCT02489344|529033946|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
146687853|NCT02489344|529033946|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
146687854|NCT00605813|529033947|FG000|Overall Study|Protocol Violation|25|||
146687855|NCT00573755|529033952|FG000|Overall Study|Still receiving treatment|1|||
146687856|NCT00573755|529033953|FG001|Overall Study|Still receiving treatment|0|||
146687857|NCT00546637|529033962|FG000|Overall Study|Adverse Event|46|||
146687858|NCT00546637|529033963|FG001|Overall Study|Adverse Event|20|||
146687859|NCT00546637|529033962|FG000|Overall Study|Lack of Efficacy|5|||
146687860|NCT00546637|529033963|FG001|Overall Study|Lack of Efficacy|5|||
146687861|NCT00546637|529033962|FG000|Overall Study|Lost to Follow-up|2|||
146687862|NCT00546637|529033963|FG001|Overall Study|Lost to Follow-up|2|||
146687863|NCT00546637|529033962|FG000|Overall Study|Other|10|||
146687864|NCT00546637|529033963|FG001|Overall Study|Other|12|||
146687865|NCT00546637|529033962|FG000|Overall Study|Withdrawal by Subject|7|||
146687866|NCT00546637|529033963|FG001|Overall Study|Withdrawal by Subject|9|||
146687867|NCT00546637|529033962|FG000|Overall Study|Randomized, but not treated|3|||
146687868|NCT00546637|529033963|FG001|Overall Study|Randomized, but not treated|1|||
146687869|NCT02024867|529033966|FG000|Overall Study|Protocol Violation|3|||
146687870|NCT02024867|529033967|FG001|Overall Study|Protocol Violation|3|||
146687871|NCT02024867|529033966|FG000|Overall Study|Lost to Follow-up|6|||
146687872|NCT02024867|529033967|FG001|Overall Study|Lost to Follow-up|4|||
146687873|NCT02865187|529033968|FG000|Overall Study|Lost to Follow-up|12|||
146687874|NCT02865187|529033969|FG001|Overall Study|Lost to Follow-up|7|||
146687875|NCT02865187|529033968|FG000|Overall Study|Adverse Event|1|||
146687876|NCT02865187|529033969|FG001|Overall Study|Adverse Event|0|||
146687877|NCT04267133|529033970|FG000|Overall Study|Withdrawal by Subject|1|||
146687878|NCT04267133|529033970|FG000|Overall Study|Adverse Event|4|||
146687879|NCT01110707|529033971|FG000|Overall Study|Protocol Violation|0|||
146687880|NCT01110707|529033972|FG001|Overall Study|Protocol Violation|3|||
146687881|NCT02369341|529033974|FG000|Overall Study|Migrated/moved from study area|1|||
146687882|NCT02369341|529033975|FG001|Overall Study|Migrated/moved from study area|0|||
146687883|NCT00674661|529033976|FG000|Overall Study|Other|5|||
146687884|NCT00674661|529033977|FG001|Overall Study|Other|7|||
146687885|NCT00674661|529033976|FG000|Overall Study|Lost to Follow-up|6|||
146687886|NCT00674661|529033977|FG001|Overall Study|Lost to Follow-up|3|||
146687887|NCT00674661|529033976|FG000|Overall Study|Withdrawal by Subject|0|||
146687888|NCT00674661|529033977|FG001|Overall Study|Withdrawal by Subject|5|||
146687889|NCT00003901|529033978|FG000|Overall Study|Adverse Event|1|||
146687890|NCT00003901|529033978|FG000|Overall Study|Withdrawal by Subject|1|||
146687891|NCT00003901|529033978|FG000|Overall Study|Ineligible|6|||
146687892|NCT00003901|529033978|FG000|Overall Study|CT Scan not within protocol requirement|2|||
146687893|NCT00003901|529033978|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
146687894|NCT00003901|529033978|FG000|Overall Study|Medical problems|6|||
146687895|NCT02707991|529033979|FG000|Overall Study|Protocol Violation|1|||
146687896|NCT02707991|529033980|FG001|Overall Study|Protocol Violation|0|||
146687897|NCT02707991|529033979|FG000|Overall Study|Became ineligible|0|||
146687898|NCT02707991|529033980|FG001|Overall Study|Became ineligible|1|||
146687899|NCT00857220|529033981|FG000|Overall Study|Adverse Event|35|||
146687900|NCT00857220|529033981|FG000|Overall Study|Death|1|||
146687901|NCT00857220|529033981|FG000|Overall Study|Lack of Efficacy|11|||
146687902|NCT00857220|529033981|FG000|Overall Study|Lost to Follow-up|30|||
146687903|NCT00857220|529033981|FG000|Overall Study|Physician Decision|4|||
146687904|NCT00857220|529033981|FG000|Overall Study|Protocol Violation|16|||
146687905|NCT00857220|529033981|FG000|Overall Study|Withdrawal by Subject|67|||
146687906|NCT00857220|529033981|FG000|Overall Study|Clinical Hold|6|||
146687907|NCT00857220|529033981|FG000|Overall Study|Site Closed|5|||
146687908|NCT00857220|529033981|FG000|Overall Study|Miscellaneous|8|||
146687909|NCT03187262|529033982|FG000|Induction|Lack of Efficacy|2|||
146774957|NCT05137236|529346825|FG005|Part B|Death|0|||
146774958|NCT05137236|529346826|FG006|Part B|Death|0|||
146774959|NCT05137236|529346827|FG007|Part B|Death|2|||
146774960|NCT00431834|529346829|FG000|Overall Study|Withdrawal by Subject|7|||
146774961|NCT00431834|529346829|FG000|Overall Study|Death|3|||
146774962|NCT00431834|529346829|FG000|Overall Study|Missed Endpoint Visit|2|||
146774963|NCT00431834|529346829|FG000|Overall Study|Lost to Follow-up|1|||
146774964|NCT02622568|529346832|FG000|Overall Study|Lost to Follow-up|5|||
146774965|NCT02622568|529346833|FG001|Overall Study|Lost to Follow-up|5|||
146774966|NCT02647905|529346838|FG000|Overall Study|Lost to Follow-up|1|||
146774967|NCT02647905|529346838|FG000|Overall Study|Withdrawal by Subject|2|||
146774968|NCT05119855|529346841|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
146774969|NCT05119855|529346842|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
146774970|NCT05119855|529346841|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
146774971|NCT05119855|529346842|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
146774972|NCT05119855|529346841|FG000|Overall Study|Lost to Follow-up|6|||
146774973|NCT05119855|529346842|FG001|Overall Study|Lost to Follow-up|8|||
146774974|NCT02597920|529346846|FG000|Overall Study|Worsening of other pre-existing disease|0|||
146774975|NCT02597920|529346847|FG001|Overall Study|Worsening of other pre-existing disease|1|||
146774976|NCT02597920|529346848|FG002|Overall Study|Worsening of other pre-existing disease|0|||
146774977|NCT02597920|529346846|FG000|Overall Study|Other adverse event|20|||
146774978|NCT02597920|529346847|FG001|Overall Study|Other adverse event|30|||
146774979|NCT02597920|529346848|FG002|Overall Study|Other adverse event|0|||
146774980|NCT02597920|529346846|FG000|Overall Study|Lost to Follow-up|7|||
146774981|NCT02597920|529346847|FG001|Overall Study|Lost to Follow-up|9|||
146774982|NCT02597920|529346848|FG002|Overall Study|Lost to Follow-up|0|||
146774983|NCT02597920|529346846|FG000|Overall Study|Refuse to continue in the study|3|||
146774984|NCT02597920|529346847|FG001|Overall Study|Refuse to continue in the study|13|||
146774985|NCT02597920|529346848|FG002|Overall Study|Refuse to continue in the study|1|||
146774986|NCT02597920|529346846|FG000|Overall Study|Other than specified|10|||
146774987|NCT02597920|529346847|FG001|Overall Study|Other than specified|31|||
146774988|NCT02597920|529346848|FG002|Overall Study|Other than specified|5|||
146774989|NCT02597920|529346846|FG000|Overall Study|Other|1|||
146774990|NCT02597920|529346847|FG001|Overall Study|Other|0|||
146928025|NCT02883049|529896067|FG012|Induction|Adverse Event|0|||
146928026|NCT02883049|529896068|FG013|Induction|Adverse Event|0|||
146928027|NCT02883049|529896069|FG014|Induction|Adverse Event|0|||
146928028|NCT02883049|529896070|FG015|Induction|Adverse Event|0|||
146928029|NCT02883049|529896055|FG000|Induction|Death|76|||
146687910|NCT03187262|529033982|FG000|Induction|Progressive Disease|4|||
146687911|NCT03187262|529033982|FG000|Consolidation|Progressive Disease|5|||
146687912|NCT01166763|529033985|FG000|Overall Study|Withdrawal by Subject|3|||
146687913|NCT01909479|529033986|FG000|From Baseline to Week 26|Adverse Event|3|||
146687914|NCT01909479|529033987|FG001|From Baseline to Week 26|Adverse Event|2|||
146687915|NCT01909479|529033986|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
146687916|NCT01909479|529033987|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
146687917|NCT01909479|529033986|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
146687918|NCT01909479|529033987|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
146687919|NCT01909479|529033986|FG000|26 - 52 Weeks|Adverse Event|0|||
146687920|NCT01909479|529033987|FG001|26 - 52 Weeks|Adverse Event|1|||
146687921|NCT01909479|529033986|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
146687922|NCT01909479|529033987|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
146687923|NCT01909479|529033986|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
146687924|NCT01909479|529033987|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
146928030|NCT02883049|529896056|FG001|Induction|Death|8|||
146928031|NCT02883049|529896057|FG002|Induction|Death|0|||
146928032|NCT02883049|529896058|FG003|Induction|Death|0|||
146928033|NCT02883049|529896059|FG004|Induction|Death|0|||
146687925|NCT01909479|529033986|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
146928034|NCT02883049|529896060|FG005|Induction|Death|0|||
146928035|NCT02883049|529896061|FG006|Induction|Death|0|||
146928036|NCT02883049|529896062|FG007|Induction|Death|0|||
146928037|NCT02883049|529896063|FG008|Induction|Death|0|||
146774991|NCT02597920|529346848|FG002|Overall Study|Other|0|||
146928038|NCT02883049|529896064|FG009|Induction|Death|0|||
146928039|NCT02883049|529896065|FG010|Induction|Death|0|||
146774992|NCT00642850|529346849|FG000|Overall Study|Death|7|||
146774993|NCT00642850|529346849|FG000|Overall Study|Adverse Event|2|||
146774994|NCT00642850|529346849|FG000|Overall Study|Lack of Efficacy|1|||
146774995|NCT00642850|529346849|FG000|Overall Study|Protocol Violation|2|||
146774996|NCT00642850|529346849|FG000|Overall Study|Kidney transplantation|8|||
146774997|NCT00642850|529346849|FG000|Overall Study|Blood transfusion|6|||
146928040|NCT02883049|529896066|FG011|Induction|Death|0|||
146928041|NCT02883049|529896067|FG012|Induction|Death|0|||
146928042|NCT02883049|529896068|FG013|Induction|Death|0|||
146687926|NCT01909479|529033987|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
146687927|NCT01909479|529033986|FG000|52 Weeks to End of Study|Adverse Event|2|||
146687928|NCT01909479|529033987|FG001|52 Weeks to End of Study|Adverse Event|1|||
146928043|NCT02883049|529896069|FG014|Induction|Death|0|||
146928044|NCT02883049|529896070|FG015|Induction|Death|0|||
146928045|NCT02883049|529896055|FG000|Induction|Lost to Follow-up|2|||
146928046|NCT02883049|529896056|FG001|Induction|Lost to Follow-up|0|||
146928047|NCT02883049|529896057|FG002|Induction|Lost to Follow-up|0|||
146928048|NCT02883049|529896058|FG003|Induction|Lost to Follow-up|0|||
146928049|NCT02883049|529896059|FG004|Induction|Lost to Follow-up|0|||
146928050|NCT02883049|529896060|FG005|Induction|Lost to Follow-up|0|||
146928051|NCT02883049|529896061|FG006|Induction|Lost to Follow-up|0|||
146928052|NCT02883049|529896062|FG007|Induction|Lost to Follow-up|0|||
146928053|NCT02883049|529896063|FG008|Induction|Lost to Follow-up|0|||
146928054|NCT02883049|529896064|FG009|Induction|Lost to Follow-up|0|||
146928055|NCT02883049|529896065|FG010|Induction|Lost to Follow-up|0|||
146928056|NCT02883049|529896066|FG011|Induction|Lost to Follow-up|0|||
146928057|NCT02883049|529896067|FG012|Induction|Lost to Follow-up|0|||
146928058|NCT02883049|529896068|FG013|Induction|Lost to Follow-up|0|||
146928059|NCT02883049|529896069|FG014|Induction|Lost to Follow-up|0|||
146928060|NCT02883049|529896070|FG015|Induction|Lost to Follow-up|0|||
146928061|NCT02883049|529896055|FG000|Induction|Physician Decision|1407|||
146928062|NCT02883049|529896056|FG001|Induction|Physician Decision|8|||
146928063|NCT02883049|529896057|FG002|Induction|Physician Decision|0|||
146928064|NCT02883049|529896058|FG003|Induction|Physician Decision|0|||
146928065|NCT02883049|529896059|FG004|Induction|Physician Decision|0|||
146928066|NCT02883049|529896060|FG005|Induction|Physician Decision|0|||
146928067|NCT02883049|529896061|FG006|Induction|Physician Decision|0|||
146928068|NCT02883049|529896062|FG007|Induction|Physician Decision|0|||
146928069|NCT02883049|529896063|FG008|Induction|Physician Decision|0|||
146928070|NCT02883049|529896064|FG009|Induction|Physician Decision|0|||
146928071|NCT02883049|529896065|FG010|Induction|Physician Decision|0|||
146928072|NCT02883049|529896066|FG011|Induction|Physician Decision|0|||
146928073|NCT02883049|529896067|FG012|Induction|Physician Decision|0|||
146928074|NCT02883049|529896068|FG013|Induction|Physician Decision|0|||
146928075|NCT02883049|529896069|FG014|Induction|Physician Decision|0|||
146928076|NCT02883049|529896070|FG015|Induction|Physician Decision|0|||
146928077|NCT02883049|529896055|FG000|Induction|Protocol Violation|6|||
146928078|NCT02883049|529896056|FG001|Induction|Protocol Violation|0|||
146928079|NCT02883049|529896057|FG002|Induction|Protocol Violation|0|||
146928080|NCT02883049|529896058|FG003|Induction|Protocol Violation|0|||
146928081|NCT02883049|529896059|FG004|Induction|Protocol Violation|0|||
146928082|NCT02883049|529896060|FG005|Induction|Protocol Violation|0|||
146928083|NCT02883049|529896061|FG006|Induction|Protocol Violation|0|||
146928084|NCT02883049|529896062|FG007|Induction|Protocol Violation|0|||
146928085|NCT02883049|529896063|FG008|Induction|Protocol Violation|0|||
146928086|NCT02883049|529896064|FG009|Induction|Protocol Violation|0|||
146928087|NCT02883049|529896065|FG010|Induction|Protocol Violation|0|||
146928088|NCT02883049|529896066|FG011|Induction|Protocol Violation|0|||
146928089|NCT02883049|529896067|FG012|Induction|Protocol Violation|0|||
146928090|NCT02883049|529896068|FG013|Induction|Protocol Violation|0|||
146928091|NCT02883049|529896069|FG014|Induction|Protocol Violation|0|||
146928092|NCT02883049|529896070|FG015|Induction|Protocol Violation|0|||
146928093|NCT02883049|529896055|FG000|Induction|Withdrawal by Subject|6|||
146928094|NCT02883049|529896056|FG001|Induction|Withdrawal by Subject|0|||
146928095|NCT02883049|529896057|FG002|Induction|Withdrawal by Subject|0|||
146928096|NCT02883049|529896058|FG003|Induction|Withdrawal by Subject|0|||
146928097|NCT02883049|529896059|FG004|Induction|Withdrawal by Subject|0|||
146928098|NCT02883049|529896060|FG005|Induction|Withdrawal by Subject|0|||
146928099|NCT02883049|529896061|FG006|Induction|Withdrawal by Subject|0|||
146687929|NCT01909479|529033986|FG000|52 Weeks to End of Study|Death|0|||
146687930|NCT01909479|529033987|FG001|52 Weeks to End of Study|Death|1|||
146687931|NCT01909479|529033986|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
146687932|NCT01909479|529033987|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
146928100|NCT02883049|529896062|FG007|Induction|Withdrawal by Subject|0|||
146928101|NCT02883049|529896063|FG008|Induction|Withdrawal by Subject|0|||
146928102|NCT02883049|529896064|FG009|Induction|Withdrawal by Subject|0|||
146928103|NCT02883049|529896065|FG010|Induction|Withdrawal by Subject|0|||
146928104|NCT02883049|529896066|FG011|Induction|Withdrawal by Subject|0|||
146928105|NCT02883049|529896067|FG012|Induction|Withdrawal by Subject|0|||
146928106|NCT02883049|529896068|FG013|Induction|Withdrawal by Subject|0|||
146928107|NCT02883049|529896069|FG014|Induction|Withdrawal by Subject|0|||
146928108|NCT02883049|529896070|FG015|Induction|Withdrawal by Subject|0|||
146928109|NCT02883049|529896055|FG000|Induction|Ineligible|35|||
146928110|NCT02883049|529896056|FG001|Induction|Ineligible|1|||
146928111|NCT02883049|529896057|FG002|Induction|Ineligible|0|||
146928112|NCT02883049|529896058|FG003|Induction|Ineligible|0|||
146928113|NCT02883049|529896059|FG004|Induction|Ineligible|0|||
146928114|NCT02883049|529896060|FG005|Induction|Ineligible|0|||
146928115|NCT02883049|529896061|FG006|Induction|Ineligible|0|||
146928116|NCT02883049|529896062|FG007|Induction|Ineligible|0|||
146979079|NCT01827371|530085572|FG003|Overall Study|Temporary study halt to vaccinations|13|||
146928117|NCT02883049|529896063|FG008|Induction|Ineligible|0|||
146928118|NCT02883049|529896064|FG009|Induction|Ineligible|0|||
146928119|NCT02883049|529896065|FG010|Induction|Ineligible|0|||
146928120|NCT02883049|529896066|FG011|Induction|Ineligible|0|||
146928121|NCT02883049|529896067|FG012|Induction|Ineligible|0|||
146928122|NCT02883049|529896068|FG013|Induction|Ineligible|0|||
146687933|NCT01909479|529033986|FG000|52 Weeks to End of Study|Protocol Violation|1|||
146687934|NCT01909479|529033987|FG001|52 Weeks to End of Study|Protocol Violation|0|||
146687935|NCT01909479|529033986|FG000|52 Weeks to End of Study|Progressive disease|1|||
146979080|NCT01361607|530085573|FG000|Overall Study|Adverse Event|38|||
146979081|NCT01361607|530085574|FG001|Overall Study|Adverse Event|29|||
146979082|NCT01361607|530085573|FG000|Overall Study|Withdrawal by Subject|19|||
146979083|NCT01361607|530085574|FG001|Overall Study|Withdrawal by Subject|8|||
146979084|NCT01361607|530085573|FG000|Overall Study|Withdrawal by Investigator|5|||
146979085|NCT01361607|530085574|FG001|Overall Study|Withdrawal by Investigator|3|||
146979086|NCT01361607|530085573|FG000|Overall Study|Lost to Follow-up|1|||
146979087|NCT01361607|530085574|FG001|Overall Study|Lost to Follow-up|0|||
146979088|NCT01361607|530085573|FG000|Overall Study|Met Withdrawal Criteria|1|||
146979089|NCT01361607|530085574|FG001|Overall Study|Met Withdrawal Criteria|1|||
146979090|NCT00373685|530085575|FG000|Overall Study|Death|2|||
146979091|NCT00373685|530085576|FG001|Overall Study|Death|1|||
146979092|NCT00373685|530085575|FG000|Overall Study|Adverse Event|278|||
146979093|NCT00373685|530085576|FG001|Overall Study|Adverse Event|253|||
146979094|NCT00373685|530085575|FG000|Overall Study|Insufficient clinical response|169|||
146979095|NCT00373685|530085576|FG001|Overall Study|Insufficient clinical response|119|||
146979096|NCT00373685|530085575|FG000|Overall Study|Did not meet entrance criteria|167|||
146979097|NCT00373685|530085576|FG001|Overall Study|Did not meet entrance criteria|184|||
146979098|NCT00373685|530085575|FG000|Overall Study|Lost to follow up|83|||
146979099|NCT00373685|530085576|FG001|Overall Study|Lost to follow up|103|||
146687936|NCT01909479|529033987|FG001|52 Weeks to End of Study|Progressive disease|1|||
146687937|NCT01909479|529033986|FG000|52 Weeks to End of Study|Personal reasons|2|||
146687938|NCT01909479|529033987|FG001|52 Weeks to End of Study|Personal reasons|1|||
146687939|NCT01909479|529033986|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
146687940|NCT01909479|529033987|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
146687941|NCT01909479|529033986|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
146687942|NCT01909479|529033987|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
146687943|NCT01909479|529033986|FG000|52 Weeks to End of Study|Lack of contact|1|||
146928123|NCT02883049|529896069|FG014|Induction|Ineligible|0|||
146928124|NCT02883049|529896070|FG015|Induction|Ineligible|0|||
146928125|NCT02883049|529896055|FG000|Induction|Refusal of further protocol therapy|466|||
146928126|NCT02883049|529896056|FG001|Induction|Refusal of further protocol therapy|2|||
146928127|NCT02883049|529896057|FG002|Induction|Refusal of further protocol therapy|0|||
146928128|NCT02883049|529896058|FG003|Induction|Refusal of further protocol therapy|0|||
146928129|NCT02883049|529896059|FG004|Induction|Refusal of further protocol therapy|0|||
146928130|NCT02883049|529896060|FG005|Induction|Refusal of further protocol therapy|0|||
146928131|NCT02883049|529896061|FG006|Induction|Refusal of further protocol therapy|0|||
146928132|NCT02883049|529896062|FG007|Induction|Refusal of further protocol therapy|0|||
146928133|NCT02883049|529896063|FG008|Induction|Refusal of further protocol therapy|0|||
146928134|NCT02883049|529896064|FG009|Induction|Refusal of further protocol therapy|0|||
146928135|NCT02883049|529896065|FG010|Induction|Refusal of further protocol therapy|0|||
146928136|NCT02883049|529896066|FG011|Induction|Refusal of further protocol therapy|0|||
146928137|NCT02883049|529896067|FG012|Induction|Refusal of further protocol therapy|0|||
146928138|NCT02883049|529896068|FG013|Induction|Refusal of further protocol therapy|0|||
146928139|NCT02883049|529896069|FG014|Induction|Refusal of further protocol therapy|0|||
146928140|NCT02883049|529896070|FG015|Induction|Refusal of further protocol therapy|0|||
146928141|NCT02883049|529896055|FG000|Induction|Identified as Ph+ patients|279|||
146928142|NCT02883049|529896056|FG001|Induction|Identified as Ph+ patients|1|||
146928143|NCT02883049|529896057|FG002|Induction|Identified as Ph+ patients|0|||
146928144|NCT02883049|529896058|FG003|Induction|Identified as Ph+ patients|0|||
146928145|NCT02883049|529896059|FG004|Induction|Identified as Ph+ patients|0|||
146928146|NCT02883049|529896060|FG005|Induction|Identified as Ph+ patients|0|||
146928147|NCT02883049|529896061|FG006|Induction|Identified as Ph+ patients|0|||
146928148|NCT02883049|529896062|FG007|Induction|Identified as Ph+ patients|0|||
146928149|NCT02883049|529896063|FG008|Induction|Identified as Ph+ patients|0|||
146928150|NCT02883049|529896064|FG009|Induction|Identified as Ph+ patients|0|||
146928151|NCT02883049|529896065|FG010|Induction|Identified as Ph+ patients|0|||
146928152|NCT02883049|529896066|FG011|Induction|Identified as Ph+ patients|0|||
146979100|NCT00373685|530085575|FG000|Overall Study|No longer willing to participate|337|||
146979101|NCT00373685|530085576|FG001|Overall Study|No longer willing to participate|352|||
146687944|NCT01909479|529033987|FG001|52 Weeks to End of Study|Lack of contact|0|||
146687945|NCT01909479|529033986|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
146928153|NCT02883049|529896067|FG012|Induction|Identified as Ph+ patients|0|||
146928154|NCT02883049|529896068|FG013|Induction|Identified as Ph+ patients|0|||
146928155|NCT02883049|529896069|FG014|Induction|Identified as Ph+ patients|0|||
146928156|NCT02883049|529896070|FG015|Induction|Identified as Ph+ patients|0|||
146928157|NCT02883049|529896055|FG000|Induction|M3 Marrow at Day29|8|||
146928158|NCT02883049|529896056|FG001|Induction|M3 Marrow at Day29|1|||
146979102|NCT00373685|530085575|FG000|Overall Study|Other|149|||
146979103|NCT00373685|530085576|FG001|Overall Study|Other|146|||
146979104|NCT00373685|530085575|FG000|Overall Study|Protocol Violation|191|||
146979105|NCT00373685|530085576|FG001|Overall Study|Protocol Violation|182|||
146979106|NCT00373685|530085575|FG000|Overall Study|Final Status Unknown|12|||
146979107|NCT00373685|530085576|FG001|Overall Study|Final Status Unknown|4|||
146979108|NCT00373685|530085575|FG000|Overall Study|Randomized, not treated|51|||
146979109|NCT00373685|530085576|FG001|Overall Study|Randomized, not treated|77|||
146979110|NCT02570165|530085577|FG000|Overall Study|Adverse Event|1|||
146979111|NCT02570165|530085578|FG001|Overall Study|Adverse Event|0|||
146979112|NCT02570165|530085579|FG002|Overall Study|Adverse Event|2|||
146979113|NCT02570165|530085580|FG003|Overall Study|Adverse Event|0|||
146979114|NCT02570165|530085581|FG004|Overall Study|Adverse Event|0|||
146979115|NCT02570165|530085582|FG005|Overall Study|Adverse Event|0|||
146979116|NCT02570165|530085583|FG006|Overall Study|Adverse Event|0|||
146979117|NCT02570165|530085577|FG000|Overall Study|Lack of Efficacy|0|||
146687946|NCT01909479|529033987|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
146979118|NCT02570165|530085578|FG001|Overall Study|Lack of Efficacy|1|||
146979119|NCT02570165|530085579|FG002|Overall Study|Lack of Efficacy|0|||
146979120|NCT02570165|530085580|FG003|Overall Study|Lack of Efficacy|0|||
146979121|NCT02570165|530085581|FG004|Overall Study|Lack of Efficacy|4|||
146979122|NCT02570165|530085582|FG005|Overall Study|Lack of Efficacy|0|||
146979123|NCT02570165|530085583|FG006|Overall Study|Lack of Efficacy|0|||
146979124|NCT02570165|530085577|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
146979125|NCT02570165|530085578|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
146979126|NCT02570165|530085579|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
146979127|NCT02570165|530085580|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
146979128|NCT02570165|530085581|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
146979129|NCT02570165|530085582|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
146979130|NCT02570165|530085583|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
146979131|NCT02570165|530085577|FG000|Overall Study|Lost to Follow-up|0|||
146979132|NCT02570165|530085578|FG001|Overall Study|Lost to Follow-up|0|||
146979133|NCT02570165|530085579|FG002|Overall Study|Lost to Follow-up|1|||
146979134|NCT02570165|530085580|FG003|Overall Study|Lost to Follow-up|1|||
146979135|NCT02570165|530085581|FG004|Overall Study|Lost to Follow-up|0|||
146979136|NCT02570165|530085582|FG005|Overall Study|Lost to Follow-up|0|||
146979137|NCT02570165|530085583|FG006|Overall Study|Lost to Follow-up|0|||
146979138|NCT02570165|530085577|FG000|Overall Study|Physician Decision|0|||
146979139|NCT02570165|530085578|FG001|Overall Study|Physician Decision|1|||
146979140|NCT02570165|530085579|FG002|Overall Study|Physician Decision|0|||
146979141|NCT02570165|530085580|FG003|Overall Study|Physician Decision|0|||
146979142|NCT02570165|530085581|FG004|Overall Study|Physician Decision|0|||
146979143|NCT02570165|530085582|FG005|Overall Study|Physician Decision|0|||
146979144|NCT02570165|530085583|FG006|Overall Study|Physician Decision|0|||
146979145|NCT02570165|530085577|FG000|Overall Study|Withdrawal by Subject|0|||
146979146|NCT02570165|530085578|FG001|Overall Study|Withdrawal by Subject|0|||
146979147|NCT02570165|530085579|FG002|Overall Study|Withdrawal by Subject|0|||
146979148|NCT02570165|530085580|FG003|Overall Study|Withdrawal by Subject|2|||
146979149|NCT02570165|530085581|FG004|Overall Study|Withdrawal by Subject|1|||
146979150|NCT02570165|530085582|FG005|Overall Study|Withdrawal by Subject|0|||
146979151|NCT02570165|530085583|FG006|Overall Study|Withdrawal by Subject|0|||
146979152|NCT02570165|530085577|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
146979153|NCT02570165|530085578|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
146979154|NCT02570165|530085579|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
146979155|NCT02570165|530085580|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
146979156|NCT02570165|530085581|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
146979157|NCT02570165|530085582|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
146979158|NCT02570165|530085583|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
146979159|NCT02570165|530085577|FG000|Overall Study|Withdrawal Request by GSK|0|||
146979160|NCT02570165|530085578|FG001|Overall Study|Withdrawal Request by GSK|0|||
146979161|NCT02570165|530085579|FG002|Overall Study|Withdrawal Request by GSK|2|||
146979162|NCT02570165|530085580|FG003|Overall Study|Withdrawal Request by GSK|0|||
146979163|NCT02570165|530085581|FG004|Overall Study|Withdrawal Request by GSK|0|||
146687947|NCT01909479|529033986|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
146687948|NCT01909479|529033987|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
146687949|NCT00416078|529033991|FG000|Overall Study|Death|3|||
146687950|NCT00416078|529033992|FG001|Overall Study|Death|4|||
146687951|NCT00416078|529033991|FG000|Overall Study|Withdrawal by Subject|3|||
146687952|NCT00416078|529033992|FG001|Overall Study|Withdrawal by Subject|2|||
146979164|NCT02570165|530085582|FG005|Overall Study|Withdrawal Request by GSK|0|||
146979165|NCT02570165|530085583|FG006|Overall Study|Withdrawal Request by GSK|0|||
146979166|NCT00411762|530085586|FG000|Overall Study|Withdrawal by Subject|5|||
146979167|NCT04428502|530085587|FG000|Overall Study|Did not meet entrance criteria|14|||
146979168|NCT03712228|530085591|FG000|Treatment Period 1|Lack of Efficacy|0|||
146979169|NCT03712228|530085592|FG001|Treatment Period 1|Lack of Efficacy|0|||
146979170|NCT03712228|530085593|FG002|Treatment Period 1|Lack of Efficacy|0|||
146979171|NCT03712228|530085594|FG003|Treatment Period 1|Lack of Efficacy|0|||
146979172|NCT03712228|530085595|FG004|Treatment Period 1|Lack of Efficacy|0|||
146979173|NCT03712228|530085596|FG005|Treatment Period 1|Lack of Efficacy|1|||
146774998|NCT00642850|529346849|FG000|Overall Study|Other reasons|7|||
146774999|NCT05489484|529346856|FG000|Overall Study|withdrawn|1|||
146775000|NCT03756571|529346857|FG000|Overall Study|Lost to Follow-up|1|||
146775001|NCT03756571|529346858|FG001|Overall Study|Lost to Follow-up|1|||
146775002|NCT01290341|529346859|FG000|Overall Study|Protocol Violation|7|||
146775003|NCT01290341|529346860|FG001|Overall Study|Protocol Violation|3|||
146775004|NCT01290341|529346859|FG000|Overall Study|Adverse Event|1|||
146775005|NCT01290341|529346860|FG001|Overall Study|Adverse Event|0|||
146775006|NCT01290341|529346859|FG000|Overall Study|Lost to Follow-up|21|||
146775007|NCT01290341|529346860|FG001|Overall Study|Lost to Follow-up|10|||
146775008|NCT01290341|529346859|FG000|Overall Study|Withdrawal by Subject|19|||
146775009|NCT01290341|529346860|FG001|Overall Study|Withdrawal by Subject|5|||
146775010|NCT01290341|529346859|FG000|Overall Study|Negative baseline culture and others|44|||
146775011|NCT01290341|529346860|FG001|Overall Study|Negative baseline culture and others|11|||
146775012|NCT00785512|529346867|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
146775013|NCT00785512|529346868|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
146775014|NCT00785512|529346867|FG000|Overall Study|Adverse Event|0|||
146775015|NCT00785512|529346868|FG001|Overall Study|Adverse Event|0|||
146775016|NCT00785512|529346867|FG000|Overall Study|Lack of Efficacy|0|||
146775017|NCT00785512|529346868|FG001|Overall Study|Lack of Efficacy|2|||
146775018|NCT00785512|529346867|FG000|Overall Study|Withdrawal by Subject|0|||
146775019|NCT00785512|529346868|FG001|Overall Study|Withdrawal by Subject|1|||
146775020|NCT00785512|529346867|FG000|Overall Study|Lost to Follow-up|3|||
146775021|NCT00785512|529346868|FG001|Overall Study|Lost to Follow-up|0|||
146775022|NCT00785512|529346867|FG000|Overall Study|Precedure Refused|0|||
146775023|NCT00785512|529346868|FG001|Overall Study|Precedure Refused|0|||
146775024|NCT00785512|529346867|FG000|Overall Study|IVRS Programing Error|0|||
146775025|NCT00785512|529346868|FG001|Overall Study|IVRS Programing Error|0|||
146775026|NCT00785512|529346867|FG000|Overall Study|Physician Decision|0|||
146775027|NCT00785512|529346868|FG001|Overall Study|Physician Decision|0|||
146775028|NCT00785512|529346867|FG000|Overall Study|Lack of compliance|0|||
146775029|NCT00785512|529346868|FG001|Overall Study|Lack of compliance|1|||
146775030|NCT03684044|529346877|FG000|Overall Study|Adverse Event|3|||
146775031|NCT03684044|529346878|FG001|Overall Study|Adverse Event|0|||
146775032|NCT03684044|529346877|FG000|Overall Study|Death|4|||
146775033|NCT03684044|529346878|FG001|Overall Study|Death|7|||
146775034|NCT03684044|529346877|FG000|Overall Study|Lost to Follow-up|3|||
146775035|NCT03684044|529346878|FG001|Overall Study|Lost to Follow-up|2|||
146775036|NCT03684044|529346877|FG000|Overall Study|Patient Not Available|0|||
146775037|NCT03684044|529346878|FG001|Overall Study|Patient Not Available|2|||
146775038|NCT03684044|529346877|FG000|Overall Study|Physician Decision|1|||
146775039|NCT03684044|529346878|FG001|Overall Study|Physician Decision|0|||
146775040|NCT03684044|529346877|FG000|Overall Study|Withdrawal by Subject|11|||
146775041|NCT03684044|529346878|FG001|Overall Study|Withdrawal by Subject|9|||
146775042|NCT00603954|529346883|FG000|Overall Study|Protocol Violation|1|||
146775043|NCT00603954|529346884|FG001|Overall Study|Protocol Violation|2|||
146775044|NCT02568683|529346885|FG000|Overall Study|Death|0|||
146775045|NCT02568683|529346886|FG001|Overall Study|Death|2|||
146687953|NCT00416078|529033991|FG000|Overall Study|Physician Decision|1|||
146687954|NCT00416078|529033992|FG001|Overall Study|Physician Decision|0|||
146687955|NCT00416078|529033991|FG000|Overall Study|Lost to Follow-up|4|||
146687956|NCT00416078|529033992|FG001|Overall Study|Lost to Follow-up|2|||
146687957|NCT01829230|529033993|FG000|Overall Study|Protocol Violation|0|||
146687958|NCT01829230|529033994|FG001|Overall Study|Protocol Violation|2|||
146687959|NCT01829230|529033993|FG000|Overall Study|Withdrawal by Subject|0|||
146687960|NCT01829230|529033994|FG001|Overall Study|Withdrawal by Subject|1|||
146687961|NCT01829230|529033993|FG000|Overall Study|Lost to Follow-up|1|||
146687962|NCT01829230|529033994|FG001|Overall Study|Lost to Follow-up|1|||
146687963|NCT04128267|529033996|FG000|Overall Study|Withdrawal by Subject|6|||
146687964|NCT04128267|529033996|FG000|Overall Study|Death|2|||
146687965|NCT04128267|529033996|FG000|Overall Study|Disease progression|1|||
146687966|NCT04128267|529033996|FG000|Overall Study|Participant had other medical issues|4|||
146687967|NCT04128267|529033996|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
146687968|NCT00553150|529033997|FG000|Overall Study|Withdrawal by Subject|0|||
146687969|NCT00553150|529033998|FG001|Overall Study|Withdrawal by Subject|0|||
146687970|NCT00553150|529033999|FG002|Overall Study|Withdrawal by Subject|0|||
146687971|NCT00553150|529034000|FG003|Overall Study|Withdrawal by Subject|2|||
146687972|NCT00553150|529033997|FG000|Overall Study|Protocol Violation|0|||
146775046|NCT02568683|529346885|FG000|Overall Study|Withdrew Consent|1|||
146775047|NCT02568683|529346886|FG001|Overall Study|Withdrew Consent|0|||
146687973|NCT00553150|529033998|FG001|Overall Study|Protocol Violation|0|||
146687974|NCT00553150|529033999|FG002|Overall Study|Protocol Violation|0|||
146775048|NCT02568683|529346885|FG000|Overall Study|Study Terminated By Sponsor|5|||
146775049|NCT02568683|529346886|FG001|Overall Study|Study Terminated By Sponsor|2|||
146775050|NCT02477605|529346898|FG000|Overall Study|Discontinued prior to treatment|1|||
146687975|NCT00553150|529034000|FG003|Overall Study|Protocol Violation|1|||
146775051|NCT02477605|529346899|FG001|Overall Study|Discontinued prior to treatment|0|||
146775052|NCT02477605|529346898|FG000|Overall Study|Lost to Follow-up|0|||
146687976|NCT00553150|529033997|FG000|Overall Study|Ineligible|0|||
146687977|NCT00553150|529033998|FG001|Overall Study|Ineligible|0|||
146687978|NCT00553150|529033999|FG002|Overall Study|Ineligible|0|||
146687979|NCT00553150|529034000|FG003|Overall Study|Ineligible|1|||
146687980|NCT02472795|529034001|FG000|Overall Study|Adverse Event|0|||
146687981|NCT02472795|529034002|FG001|Overall Study|Adverse Event|1|||
146687982|NCT02472795|529034003|FG002|Overall Study|Adverse Event|0|||
146687983|NCT02472795|529034004|FG003|Overall Study|Adverse Event|0|||
146687984|NCT02472795|529034005|FG004|Overall Study|Adverse Event|2|||
146687985|NCT02472795|529034001|FG000|Overall Study|Withdrawal by Subject|0|||
146687986|NCT02472795|529034002|FG001|Overall Study|Withdrawal by Subject|0|||
146687987|NCT02472795|529034003|FG002|Overall Study|Withdrawal by Subject|0|||
146687988|NCT02472795|529034004|FG003|Overall Study|Withdrawal by Subject|0|||
146687989|NCT02472795|529034005|FG004|Overall Study|Withdrawal by Subject|1|||
146687990|NCT04166513|529034006|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
146687991|NCT04166513|529034007|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
146687992|NCT04166513|529034008|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
146687993|NCT04166513|529034009|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
146687994|NCT04166513|529034006|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
146687995|NCT04166513|529034007|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
146687996|NCT04166513|529034008|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
146687997|NCT04166513|529034009|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
146687998|NCT04166513|529034006|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
146687999|NCT04166513|529034007|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
146688000|NCT04166513|529034008|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
146688001|NCT04166513|529034009|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
146688002|NCT04166513|529034006|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
146775053|NCT02477605|529346899|FG001|Overall Study|Lost to Follow-up|2|||
146775054|NCT02477605|529346898|FG000|Overall Study|Withdrawal by Subject|0|||
146979174|NCT03712228|530085591|FG000|Treatment Period 2|Pregnancy|0|||
146979175|NCT03712228|530085592|FG001|Treatment Period 2|Pregnancy|0|||
146979176|NCT03712228|530085593|FG002|Treatment Period 2|Pregnancy|0|||
146979177|NCT03712228|530085594|FG003|Treatment Period 2|Pregnancy|1|||
146979178|NCT03712228|530085595|FG004|Treatment Period 2|Pregnancy|0|||
146979179|NCT03712228|530085596|FG005|Treatment Period 2|Pregnancy|0|||
146979180|NCT03712228|530085591|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146979181|NCT03712228|530085592|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146979182|NCT03712228|530085593|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146979183|NCT03712228|530085594|FG003|Treatment Period 2|Withdrawal by Subject|1|||
146979184|NCT03712228|530085595|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146979185|NCT03712228|530085596|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146979186|NCT01430104|530085597|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
146979187|NCT05288673|530085598|FG000|Overall Study|Consent withdrawn by subject|0|||
146979188|NCT05288673|530085599|FG001|Overall Study|Consent withdrawn by subject|0|||
146979189|NCT05288673|530085600|FG002|Overall Study|Consent withdrawn by subject|1|||
146979190|NCT04147611|530085608|FG000|Overall Study|Physician Decision|0|||
146979191|NCT04147611|530085609|FG001|Overall Study|Physician Decision|1|||
146979192|NCT05003167|530085610|FG000|Overall Study|Withdrawal by Subject|1|||
146979193|NCT01010230|530085611|FG000|Overall Study|Withdrawal by Subject|6|||
146979194|NCT01010230|530085612|FG001|Overall Study|Withdrawal by Subject|5|||
146979195|NCT01010230|530085611|FG000|Overall Study|Lost to Follow-up|4|||
146979196|NCT01010230|530085612|FG001|Overall Study|Lost to Follow-up|2|||
146979197|NCT01585831|530085613|FG000|Overall Study|Physician Decision|0|||
146979198|NCT01585831|530085614|FG001|Overall Study|Physician Decision|1|||
146979199|NCT01585831|530085613|FG000|Overall Study|Withdrawal by Subject|2|||
146979200|NCT01585831|530085614|FG001|Overall Study|Withdrawal by Subject|1|||
146979201|NCT01123980|530085615|FG000|Overall Study|Adverse Event|1|||
146979202|NCT01123980|530085616|FG001|Overall Study|Adverse Event|1|||
146979203|NCT01123980|530085615|FG000|Overall Study|Lack of Efficacy|1|||
146979204|NCT01123980|530085616|FG001|Overall Study|Lack of Efficacy|0|||
146979205|NCT01123980|530085615|FG000|Overall Study|Physician Decision|0|||
146979206|NCT01123980|530085616|FG001|Overall Study|Physician Decision|1|||
146979207|NCT01123980|530085615|FG000|Overall Study|Lost to Follow-up|0|||
146979208|NCT01123980|530085616|FG001|Overall Study|Lost to Follow-up|6|||
146979209|NCT01123980|530085615|FG000|Overall Study|Protocol Violation|6|||
146979210|NCT01123980|530085616|FG001|Overall Study|Protocol Violation|6|||
146979211|NCT01123980|530085615|FG000|Overall Study|Withdrawal by Subject|5|||
146979212|NCT01123980|530085616|FG001|Overall Study|Withdrawal by Subject|3|||
146979213|NCT01123980|530085615|FG000|Overall Study|Unclassified|6|||
146979214|NCT01123980|530085616|FG001|Overall Study|Unclassified|7|||
146979215|NCT01225991|530085617|FG000|Overall Study|Withdrawal by Subject|6|||
146979216|NCT04444752|530085618|FG000|Overall Study|Adverse Event|1|||
146979217|NCT04444752|530085619|FG001|Overall Study|Adverse Event|0|||
146979218|NCT04444752|530085620|FG002|Overall Study|Adverse Event|0|||
146979219|NCT04444752|530085621|FG003|Overall Study|Adverse Event|2|||
146979220|NCT04444752|530085618|FG000|Overall Study|Lost to Follow-up|2|||
146688003|NCT04166513|529034007|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
146979221|NCT04444752|530085619|FG001|Overall Study|Lost to Follow-up|6|||
146979222|NCT04444752|530085620|FG002|Overall Study|Lost to Follow-up|2|||
146979223|NCT04444752|530085621|FG003|Overall Study|Lost to Follow-up|5|||
146979224|NCT04444752|530085618|FG000|Overall Study|Physician Decision|0|||
146979225|NCT04444752|530085619|FG001|Overall Study|Physician Decision|0|||
146979226|NCT04444752|530085620|FG002|Overall Study|Physician Decision|0|||
146979227|NCT04444752|530085621|FG003|Overall Study|Physician Decision|2|||
146688004|NCT04166513|529034008|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
146688005|NCT04166513|529034009|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
146688006|NCT04166513|529034006|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
146928159|NCT02883049|529896057|FG002|Induction|M3 Marrow at Day29|0|||
146928160|NCT02883049|529896058|FG003|Induction|M3 Marrow at Day29|0|||
146928161|NCT02883049|529896059|FG004|Induction|M3 Marrow at Day29|0|||
146928162|NCT02883049|529896060|FG005|Induction|M3 Marrow at Day29|0|||
146928163|NCT02883049|529896061|FG006|Induction|M3 Marrow at Day29|0|||
146928164|NCT02883049|529896062|FG007|Induction|M3 Marrow at Day29|0|||
146928165|NCT02883049|529896063|FG008|Induction|M3 Marrow at Day29|0|||
146928166|NCT02883049|529896064|FG009|Induction|M3 Marrow at Day29|0|||
146928167|NCT02883049|529896065|FG010|Induction|M3 Marrow at Day29|0|||
146928168|NCT02883049|529896066|FG011|Induction|M3 Marrow at Day29|0|||
146928169|NCT02883049|529896067|FG012|Induction|M3 Marrow at Day29|0|||
146928170|NCT02883049|529896068|FG013|Induction|M3 Marrow at Day29|0|||
146928171|NCT02883049|529896069|FG014|Induction|M3 Marrow at Day29|0|||
146928172|NCT02883049|529896070|FG015|Induction|M3 Marrow at Day29|0|||
146928173|NCT02883049|529896055|FG000|Induction|Inevaluable|33|||
146928174|NCT02883049|529896056|FG001|Induction|Inevaluable|1|||
146928175|NCT02883049|529896057|FG002|Induction|Inevaluable|0|||
146928176|NCT02883049|529896058|FG003|Induction|Inevaluable|0|||
146928177|NCT02883049|529896059|FG004|Induction|Inevaluable|0|||
146928178|NCT02883049|529896060|FG005|Induction|Inevaluable|0|||
146928179|NCT02883049|529896061|FG006|Induction|Inevaluable|0|||
146928180|NCT02883049|529896062|FG007|Induction|Inevaluable|0|||
146928181|NCT02883049|529896063|FG008|Induction|Inevaluable|0|||
146928182|NCT02883049|529896064|FG009|Induction|Inevaluable|0|||
146928183|NCT02883049|529896065|FG010|Induction|Inevaluable|0|||
146928184|NCT02883049|529896066|FG011|Induction|Inevaluable|0|||
146928185|NCT02883049|529896067|FG012|Induction|Inevaluable|0|||
146928186|NCT02883049|529896068|FG013|Induction|Inevaluable|0|||
146928187|NCT02883049|529896069|FG014|Induction|Inevaluable|0|||
146928188|NCT02883049|529896070|FG015|Induction|Inevaluable|0|||
146928189|NCT02883049|529896055|FG000|Induction|Identified as VHR at end of Induction|244|||
146928190|NCT02883049|529896056|FG001|Induction|Identified as VHR at end of Induction|0|||
146928191|NCT02883049|529896057|FG002|Induction|Identified as VHR at end of Induction|0|||
146928192|NCT02883049|529896058|FG003|Induction|Identified as VHR at end of Induction|0|||
146928193|NCT02883049|529896059|FG004|Induction|Identified as VHR at end of Induction|0|||
146928194|NCT02883049|529896060|FG005|Induction|Identified as VHR at end of Induction|0|||
146928195|NCT02883049|529896061|FG006|Induction|Identified as VHR at end of Induction|0|||
146928196|NCT02883049|529896062|FG007|Induction|Identified as VHR at end of Induction|0|||
146928197|NCT02883049|529896063|FG008|Induction|Identified as VHR at end of Induction|0|||
146928198|NCT02883049|529896064|FG009|Induction|Identified as VHR at end of Induction|0|||
146928199|NCT02883049|529896065|FG010|Induction|Identified as VHR at end of Induction|0|||
146928200|NCT02883049|529896066|FG011|Induction|Identified as VHR at end of Induction|0|||
146928201|NCT02883049|529896067|FG012|Induction|Identified as VHR at end of Induction|0|||
146928202|NCT02883049|529896068|FG013|Induction|Identified as VHR at end of Induction|0|||
146928203|NCT02883049|529896069|FG014|Induction|Identified as VHR at end of Induction|0|||
146928204|NCT02883049|529896070|FG015|Induction|Identified as VHR at end of Induction|0|||
146928205|NCT02883049|529896055|FG000|Induction|Moved to another non-COG institution|3|||
146928206|NCT02883049|529896056|FG001|Induction|Moved to another non-COG institution|0|||
146928207|NCT02883049|529896057|FG002|Induction|Moved to another non-COG institution|0|||
146928208|NCT02883049|529896058|FG003|Induction|Moved to another non-COG institution|0|||
146928209|NCT02883049|529896059|FG004|Induction|Moved to another non-COG institution|0|||
146928210|NCT02883049|529896060|FG005|Induction|Moved to another non-COG institution|0|||
146928211|NCT02883049|529896061|FG006|Induction|Moved to another non-COG institution|0|||
146928212|NCT02883049|529896062|FG007|Induction|Moved to another non-COG institution|0|||
146928213|NCT02883049|529896063|FG008|Induction|Moved to another non-COG institution|0|||
146928214|NCT02883049|529896064|FG009|Induction|Moved to another non-COG institution|0|||
146928215|NCT02883049|529896065|FG010|Induction|Moved to another non-COG institution|0|||
146979228|NCT04444752|530085618|FG000|Overall Study|Pregnancy|0|||
146928216|NCT02883049|529896066|FG011|Induction|Moved to another non-COG institution|0|||
146928217|NCT02883049|529896067|FG012|Induction|Moved to another non-COG institution|0|||
146928218|NCT02883049|529896068|FG013|Induction|Moved to another non-COG institution|0|||
146928219|NCT02883049|529896069|FG014|Induction|Moved to another non-COG institution|0|||
146928220|NCT02883049|529896070|FG015|Induction|Moved to another non-COG institution|0|||
146928221|NCT02883049|529896055|FG000|Induction|Randomization closed|41|||
146928222|NCT02883049|529896056|FG001|Induction|Randomization closed|0|||
146928223|NCT02883049|529896057|FG002|Induction|Randomization closed|0|||
146928224|NCT02883049|529896058|FG003|Induction|Randomization closed|0|||
146928225|NCT02883049|529896059|FG004|Induction|Randomization closed|0|||
146928226|NCT02883049|529896060|FG005|Induction|Randomization closed|0|||
146928227|NCT02883049|529896061|FG006|Induction|Randomization closed|0|||
146688007|NCT04166513|529034007|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
146688008|NCT04166513|529034008|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
146688009|NCT04166513|529034009|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
146688010|NCT04219891|529034012|FG000|Overall Study|Lost to Follow-up|3|||
146688011|NCT04219891|529034012|FG000|Overall Study|Withdrawal by Subject|2|||
146688012|NCT00597012|529034013|FG000|Overall Study|Death|1|||
146688013|NCT00597012|529034014|FG001|Overall Study|Death|1|||
146688014|NCT00597012|529034013|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
146688015|NCT00597012|529034014|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
146688016|NCT00597012|529034013|FG000|Overall Study|Withdrawal by Subject|7|||
146688017|NCT00597012|529034014|FG001|Overall Study|Withdrawal by Subject|4|||
146688018|NCT00597012|529034013|FG000|Overall Study|Ineligible|2|||
146688019|NCT00597012|529034014|FG001|Overall Study|Ineligible|0|||
146688020|NCT00597012|529034013|FG000|Overall Study|Lost to Follow-up|0|||
146688021|NCT00597012|529034014|FG001|Overall Study|Lost to Follow-up|2|||
146688022|NCT01786629|529035829|FG000|Overall Study|Lack of Efficacy|0|||
146688023|NCT01786629|529035830|FG001|Overall Study|Lack of Efficacy|4|||
146688024|NCT01786629|529035829|FG000|Overall Study|Adverse Event|0|||
146688025|NCT01786629|529035830|FG001|Overall Study|Adverse Event|1|||
146688026|NCT00410761|529035831|FG000|Randomized Treatment Period|Adverse Event|34|||
146688027|NCT00410761|529035832|FG001|Randomized Treatment Period|Adverse Event|3|||
146688028|NCT00410761|529035831|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
146688029|NCT00410761|529035832|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
146688030|NCT00410761|529035831|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
146688031|NCT00410761|529035832|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
146688032|NCT00410761|529035831|FG000|Randomized Treatment Period|Other|69|||
146688033|NCT00410761|529035832|FG001|Randomized Treatment Period|Other|21|||
146688034|NCT00410761|529035831|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
146688035|NCT00410761|529035832|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
146688036|NCT00410761|529035831|FG000|Open-Label Treatment Period|Adverse Event|13|||
146688037|NCT00410761|529035832|FG001|Open-Label Treatment Period|Adverse Event|15|||
146688038|NCT00410761|529035831|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
146688039|NCT00410761|529035832|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
146688040|NCT00410761|529035831|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
146688041|NCT00410761|529035832|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
146688042|NCT00410761|529035831|FG000|Open-Label Treatment Period|Other|18|||
146688043|NCT00410761|529035832|FG001|Open-Label Treatment Period|Other|9|||
146688044|NCT04708886|529035835|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
146688045|NCT04708886|529035835|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
146688046|NCT03724812|529035841|FG000|Overall Study|Missed Visit|1|||
146688047|NCT03724812|529035841|FG000|Overall Study|Death|2|||
146688048|NCT03724812|529035841|FG000|Overall Study|Withdrawal by Subject|1|||
146688049|NCT02389998|529035844|FG000|Overall Study|car accident|1|||
146688050|NCT02389998|529035845|FG001|Overall Study|car accident|0|||
146688051|NCT03525574|529035846|FG000|Overall Study|Adverse Event|15|||
146688052|NCT03525574|529035847|FG001|Overall Study|Adverse Event|0|||
146688053|NCT03525574|529035846|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
146688054|NCT03525574|529035847|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
146688055|NCT03525574|529035846|FG000|Overall Study|Lost to Follow-up|4|||
146688056|NCT03525574|529035847|FG001|Overall Study|Lost to Follow-up|0|||
146688057|NCT03525574|529035846|FG000|Overall Study|Commercial drug is Available for participant|48|||
146688058|NCT03525574|529035847|FG001|Overall Study|Commercial drug is Available for participant|0|||
146688059|NCT03525574|529035846|FG000|Overall Study|Death|1|||
146688060|NCT03525574|529035847|FG001|Overall Study|Death|0|||
146688061|NCT03525574|529035846|FG000|Overall Study|Other non-compliance|2|||
146688062|NCT03525574|529035847|FG001|Overall Study|Other non-compliance|0|||
146688063|NCT03525574|529035846|FG000|Overall Study|Physician Decision|6|||
146928228|NCT02883049|529896062|FG007|Induction|Randomization closed|0|||
146688064|NCT03525574|529035847|FG001|Overall Study|Physician Decision|0|||
146688065|NCT03525574|529035846|FG000|Overall Study|Other|58|||
146688066|NCT03525574|529035847|FG001|Overall Study|Other|0|||
146928229|NCT02883049|529896063|FG008|Induction|Randomization closed|0|||
146688067|NCT03525574|529035846|FG000|Overall Study|Enrolled but never dosed|1|||
146688068|NCT03525574|529035847|FG001|Overall Study|Enrolled but never dosed|0|||
146688069|NCT03525574|529035846|FG000|Overall Study|Not enrolled in 105 study|0|||
146688070|NCT03525574|529035847|FG001|Overall Study|Not enrolled in 105 study|3|||
146688071|NCT01770379|529035848|FG000|Overall Study|Technical issues|1|||
146688072|NCT01770379|529035849|FG001|Overall Study|Technical issues|0|||
146688073|NCT01770379|529035850|FG002|Overall Study|Technical issues|0|||
146688074|NCT01770379|529035848|FG000|Overall Study|Withdrawal by Subject|7|||
146688075|NCT01770379|529035849|FG001|Overall Study|Withdrawal by Subject|10|||
146688076|NCT01770379|529035850|FG002|Overall Study|Withdrawal by Subject|7|||
146688077|NCT01770379|529035848|FG000|Overall Study|study terminated by sponsor|22|||
146688078|NCT01770379|529035849|FG001|Overall Study|study terminated by sponsor|23|||
146688079|NCT01770379|529035850|FG002|Overall Study|study terminated by sponsor|22|||
146688080|NCT01770379|529035848|FG000|Overall Study|Protocol Violation|0|||
146688081|NCT01770379|529035849|FG001|Overall Study|Protocol Violation|1|||
146688082|NCT01770379|529035850|FG002|Overall Study|Protocol Violation|1|||
146688083|NCT01770379|529035848|FG000|Overall Study|Physician Decision|0|||
146688084|NCT01770379|529035849|FG001|Overall Study|Physician Decision|1|||
146688085|NCT01770379|529035850|FG002|Overall Study|Physician Decision|2|||
146688086|NCT01770379|529035848|FG000|Overall Study|Lost to Follow-up|0|||
146688087|NCT01770379|529035849|FG001|Overall Study|Lost to Follow-up|0|||
146688088|NCT01770379|529035850|FG002|Overall Study|Lost to Follow-up|2|||
146688089|NCT01770379|529035848|FG000|Overall Study|Lack of Efficacy|8|||
146688090|NCT01770379|529035849|FG001|Overall Study|Lack of Efficacy|6|||
146688091|NCT01770379|529035850|FG002|Overall Study|Lack of Efficacy|6|||
146688092|NCT01770379|529035848|FG000|Overall Study|Adverse Event|1|||
146688093|NCT01770379|529035849|FG001|Overall Study|Adverse Event|3|||
146688094|NCT01770379|529035850|FG002|Overall Study|Adverse Event|2|||
146688095|NCT02769247|529035855|FG000|Overall Study|Withdrawal by Subject|1|||
146688096|NCT02769247|529035856|FG001|Overall Study|Withdrawal by Subject|0|||
146688097|NCT02769247|529035857|FG002|Overall Study|Withdrawal by Subject|0|||
146688098|NCT02769247|529035858|FG003|Overall Study|Withdrawal by Subject|1|||
146688099|NCT02769247|529035855|FG000|Overall Study|Protocol Violation|0|||
146688100|NCT02769247|529035856|FG001|Overall Study|Protocol Violation|0|||
146688101|NCT02769247|529035857|FG002|Overall Study|Protocol Violation|1|||
146688102|NCT02769247|529035858|FG003|Overall Study|Protocol Violation|0|||
146688103|NCT02769247|529035855|FG000|Overall Study|Physician Decision|1|||
146688104|NCT02769247|529035856|FG001|Overall Study|Physician Decision|0|||
146688105|NCT02769247|529035857|FG002|Overall Study|Physician Decision|0|||
146688106|NCT02769247|529035858|FG003|Overall Study|Physician Decision|0|||
146688107|NCT05407675|529035866|FG000|Overall Study|Withdrawal by Subject|0|||
146688108|NCT05407675|529035867|FG001|Overall Study|Withdrawal by Subject|2|||
146688109|NCT05407675|529035868|FG002|Overall Study|Withdrawal by Subject|3|||
146688110|NCT05407675|529035869|FG003|Overall Study|Withdrawal by Subject|5|||
146688111|NCT05407675|529035870|FG004|Overall Study|Withdrawal by Subject|0|||
146688112|NCT05407675|529035871|FG005|Overall Study|Withdrawal by Subject|2|||
146688113|NCT05407675|529035872|FG006|Overall Study|Withdrawal by Subject|0|||
146688114|NCT05407675|529035873|FG007|Overall Study|Withdrawal by Subject|0|||
146688115|NCT05407675|529035874|FG008|Overall Study|Withdrawal by Subject|2|||
146688116|NCT05407675|529035875|FG009|Overall Study|Withdrawal by Subject|0|||
146688117|NCT05407675|529035876|FG010|Overall Study|Withdrawal by Subject|1|||
146688118|NCT05407675|529035877|FG011|Overall Study|Withdrawal by Subject|0|||
146688119|NCT05407675|529035878|FG012|Overall Study|Withdrawal by Subject|0|||
146688120|NCT05407675|529035866|FG000|Overall Study|Site terminated by sponsor|0|||
146688121|NCT05407675|529035867|FG001|Overall Study|Site terminated by sponsor|0|||
146688122|NCT05407675|529035868|FG002|Overall Study|Site terminated by sponsor|1|||
146688123|NCT05407675|529035869|FG003|Overall Study|Site terminated by sponsor|0|||
146688124|NCT05407675|529035870|FG004|Overall Study|Site terminated by sponsor|2|||
146688125|NCT05407675|529035871|FG005|Overall Study|Site terminated by sponsor|0|||
146688126|NCT05407675|529035872|FG006|Overall Study|Site terminated by sponsor|1|||
146688127|NCT05407675|529035873|FG007|Overall Study|Site terminated by sponsor|0|||
146688128|NCT05407675|529035874|FG008|Overall Study|Site terminated by sponsor|0|||
146688129|NCT05407675|529035875|FG009|Overall Study|Site terminated by sponsor|2|||
146688130|NCT05407675|529035876|FG010|Overall Study|Site terminated by sponsor|2|||
146688131|NCT05407675|529035877|FG011|Overall Study|Site terminated by sponsor|2|||
146688132|NCT05407675|529035878|FG012|Overall Study|Site terminated by sponsor|1|||
146688133|NCT05407675|529035866|FG000|Overall Study|Disease Progression|0|||
146688134|NCT05407675|529035867|FG001|Overall Study|Disease Progression|0|||
146688135|NCT05407675|529035868|FG002|Overall Study|Disease Progression|0|||
146688136|NCT05407675|529035869|FG003|Overall Study|Disease Progression|0|||
146688137|NCT05407675|529035870|FG004|Overall Study|Disease Progression|0|||
146688138|NCT05407675|529035871|FG005|Overall Study|Disease Progression|0|||
146688139|NCT05407675|529035872|FG006|Overall Study|Disease Progression|0|||
146688140|NCT05407675|529035873|FG007|Overall Study|Disease Progression|0|||
146688141|NCT05407675|529035874|FG008|Overall Study|Disease Progression|0|||
146688142|NCT05407675|529035875|FG009|Overall Study|Disease Progression|0|||
146688143|NCT05407675|529035876|FG010|Overall Study|Disease Progression|1|||
146688144|NCT05407675|529035877|FG011|Overall Study|Disease Progression|0|||
146688145|NCT05407675|529035878|FG012|Overall Study|Disease Progression|0|||
146688146|NCT05407675|529035866|FG000|Overall Study|Physician Decision|0|||
146688147|NCT05407675|529035867|FG001|Overall Study|Physician Decision|0|||
146688148|NCT05407675|529035868|FG002|Overall Study|Physician Decision|0|||
146688149|NCT05407675|529035869|FG003|Overall Study|Physician Decision|0|||
146688150|NCT05407675|529035870|FG004|Overall Study|Physician Decision|0|||
146688151|NCT05407675|529035871|FG005|Overall Study|Physician Decision|0|||
146688152|NCT05407675|529035872|FG006|Overall Study|Physician Decision|0|||
146688153|NCT05407675|529035873|FG007|Overall Study|Physician Decision|0|||
146688154|NCT05407675|529035874|FG008|Overall Study|Physician Decision|0|||
146688155|NCT05407675|529035875|FG009|Overall Study|Physician Decision|0|||
146688156|NCT05407675|529035876|FG010|Overall Study|Physician Decision|1|||
146688157|NCT05407675|529035877|FG011|Overall Study|Physician Decision|0|||
146688158|NCT05407675|529035878|FG012|Overall Study|Physician Decision|0|||
146688159|NCT05407675|529035866|FG000|Overall Study|Other reasons|0|||
146688160|NCT05407675|529035867|FG001|Overall Study|Other reasons|0|||
146688161|NCT05407675|529035868|FG002|Overall Study|Other reasons|0|||
146688162|NCT05407675|529035869|FG003|Overall Study|Other reasons|0|||
146688163|NCT05407675|529035870|FG004|Overall Study|Other reasons|0|||
146688164|NCT05407675|529035871|FG005|Overall Study|Other reasons|0|||
146688165|NCT05407675|529035872|FG006|Overall Study|Other reasons|0|||
146688166|NCT05407675|529035873|FG007|Overall Study|Other reasons|0|||
146688167|NCT05407675|529035874|FG008|Overall Study|Other reasons|1|||
146688168|NCT05407675|529035875|FG009|Overall Study|Other reasons|1|||
146688169|NCT05407675|529035876|FG010|Overall Study|Other reasons|1|||
146688170|NCT05407675|529035877|FG011|Overall Study|Other reasons|1|||
146688171|NCT05407675|529035878|FG012|Overall Study|Other reasons|0|||
146688172|NCT05407675|529035866|FG000|Overall Study|Death|3|||
146688173|NCT05407675|529035867|FG001|Overall Study|Death|4|||
146688174|NCT05407675|529035868|FG002|Overall Study|Death|3|||
146688175|NCT05407675|529035869|FG003|Overall Study|Death|6|||
146688176|NCT05407675|529035870|FG004|Overall Study|Death|0|||
146688177|NCT05407675|529035871|FG005|Overall Study|Death|2|||
146688178|NCT05407675|529035872|FG006|Overall Study|Death|4|||
146688179|NCT05407675|529035873|FG007|Overall Study|Death|2|||
146688180|NCT05407675|529035874|FG008|Overall Study|Death|2|||
146688181|NCT05407675|529035875|FG009|Overall Study|Death|4|||
146688182|NCT05407675|529035876|FG010|Overall Study|Death|2|||
146688183|NCT05407675|529035877|FG011|Overall Study|Death|1|||
146688184|NCT05407675|529035878|FG012|Overall Study|Death|0|||
146688185|NCT05407675|529035866|FG000|Overall Study|Adverse Event|0|||
146688186|NCT05407675|529035867|FG001|Overall Study|Adverse Event|0|||
146688187|NCT05407675|529035868|FG002|Overall Study|Adverse Event|0|||
146688188|NCT05407675|529035869|FG003|Overall Study|Adverse Event|0|||
146688189|NCT05407675|529035870|FG004|Overall Study|Adverse Event|1|||
146688190|NCT05407675|529035871|FG005|Overall Study|Adverse Event|0|||
146688191|NCT05407675|529035872|FG006|Overall Study|Adverse Event|0|||
146688192|NCT05407675|529035873|FG007|Overall Study|Adverse Event|0|||
146688193|NCT05407675|529035874|FG008|Overall Study|Adverse Event|0|||
146688194|NCT05407675|529035875|FG009|Overall Study|Adverse Event|0|||
146688195|NCT05407675|529035876|FG010|Overall Study|Adverse Event|0|||
146688196|NCT05407675|529035877|FG011|Overall Study|Adverse Event|1|||
146688197|NCT05407675|529035878|FG012|Overall Study|Adverse Event|0|||
146688198|NCT05407675|529035866|FG000|Overall Study|Ongoing Treatment|0|||
146688199|NCT05407675|529035867|FG001|Overall Study|Ongoing Treatment|0|||
146688200|NCT05407675|529035868|FG002|Overall Study|Ongoing Treatment|0|||
146688201|NCT05407675|529035869|FG003|Overall Study|Ongoing Treatment|0|||
146688202|NCT05407675|529035870|FG004|Overall Study|Ongoing Treatment|0|||
146688203|NCT05407675|529035871|FG005|Overall Study|Ongoing Treatment|0|||
146688204|NCT05407675|529035872|FG006|Overall Study|Ongoing Treatment|0|||
146688205|NCT05407675|529035873|FG007|Overall Study|Ongoing Treatment|0|||
146688206|NCT05407675|529035874|FG008|Overall Study|Ongoing Treatment|1|||
146688207|NCT05407675|529035875|FG009|Overall Study|Ongoing Treatment|0|||
146688208|NCT05407675|529035876|FG010|Overall Study|Ongoing Treatment|0|||
146688209|NCT05407675|529035877|FG011|Overall Study|Ongoing Treatment|0|||
146688210|NCT05407675|529035878|FG012|Overall Study|Ongoing Treatment|0|||
146775055|NCT02477605|529346899|FG001|Overall Study|Withdrawal by Subject|1|||
146775056|NCT02477605|529346898|FG000|Overall Study|Administered gas during surgery|0|||
146775057|NCT02477605|529346899|FG001|Overall Study|Administered gas during surgery|1|||
146775058|NCT01388361|529346900|FG000|Overall Study|Adverse Event|0|||
146775059|NCT01388361|529346901|FG001|Overall Study|Adverse Event|5|||
146775060|NCT01388361|529346902|FG002|Overall Study|Adverse Event|1|||
146775061|NCT01388361|529346900|FG000|Overall Study|Protocol Violation|0|||
146775062|NCT01388361|529346901|FG001|Overall Study|Protocol Violation|0|||
146688216|NCT00742001|529035880|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
146688217|NCT00742001|529035881|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
146688218|NCT00742001|529035882|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
146688219|NCT00137423|529035883|FG000|Overall Study|Adverse Event|7|||
146688220|NCT00137423|529035884|FG001|Overall Study|Adverse Event|9|||
146688221|NCT00137423|529035883|FG000|Overall Study|consent withdrawn|1|||
146688222|NCT00137423|529035884|FG001|Overall Study|consent withdrawn|1|||
146688223|NCT00137423|529035883|FG000|Overall Study|Lack of Efficacy|31|||
146688224|NCT00137423|529035884|FG001|Overall Study|Lack of Efficacy|33|||
146688225|NCT00137423|529035883|FG000|Overall Study|Death|0|||
146688226|NCT00137423|529035884|FG001|Overall Study|Death|1|||
146688227|NCT04105998|529035886|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
146688228|NCT04105998|529035887|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
146688229|NCT01050257|529035888|FG000|Overall Study|Adverse Event|4|||
146775063|NCT01388361|529346902|FG002|Overall Study|Protocol Violation|2|||
146775064|NCT01388361|529346900|FG000|Overall Study|Withdrawal criteria|12|||
146775065|NCT01388361|529346901|FG001|Overall Study|Withdrawal criteria|7|||
146775066|NCT01388361|529346902|FG002|Overall Study|Withdrawal criteria|10|||
146688230|NCT01050257|529035889|FG001|Overall Study|Adverse Event|4|||
146688231|NCT01050257|529035890|FG002|Overall Study|Adverse Event|2|||
146688232|NCT01050257|529035888|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
146688233|NCT01050257|529035889|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
146688234|NCT01050257|529035890|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
146688235|NCT01050257|529035888|FG000|Overall Study|Withdrawal by Subject|0|||
146928230|NCT02883049|529896064|FG009|Induction|Randomization closed|0|||
146928231|NCT02883049|529896065|FG010|Induction|Randomization closed|0|||
146928232|NCT02883049|529896066|FG011|Induction|Randomization closed|0|||
146928233|NCT02883049|529896067|FG012|Induction|Randomization closed|0|||
146688236|NCT01050257|529035889|FG001|Overall Study|Withdrawal by Subject|3|||
146688237|NCT01050257|529035890|FG002|Overall Study|Withdrawal by Subject|0|||
146688238|NCT01050257|529035888|FG000|Overall Study|No reason specified|0|||
146688239|NCT01050257|529035889|FG001|Overall Study|No reason specified|0|||
146928234|NCT02883049|529896068|FG013|Induction|Randomization closed|0|||
146928235|NCT02883049|529896069|FG014|Induction|Randomization closed|0|||
146928236|NCT02883049|529896070|FG015|Induction|Randomization closed|0|||
146928237|NCT02883049|529896055|FG000|Induction|MRD negative|36|||
146928238|NCT02883049|529896056|FG001|Induction|MRD negative|0|||
146928239|NCT02883049|529896057|FG002|Induction|MRD negative|0|||
146928240|NCT02883049|529896058|FG003|Induction|MRD negative|0|||
146928241|NCT02883049|529896059|FG004|Induction|MRD negative|0|||
146928242|NCT02883049|529896060|FG005|Induction|MRD negative|0|||
146928243|NCT02883049|529896061|FG006|Induction|MRD negative|0|||
146928244|NCT02883049|529896062|FG007|Induction|MRD negative|0|||
146928245|NCT02883049|529896063|FG008|Induction|MRD negative|0|||
146928246|NCT02883049|529896064|FG009|Induction|MRD negative|0|||
146928247|NCT02883049|529896065|FG010|Induction|MRD negative|0|||
146928248|NCT02883049|529896066|FG011|Induction|MRD negative|0|||
146928249|NCT02883049|529896067|FG012|Induction|MRD negative|0|||
146928250|NCT02883049|529896068|FG013|Induction|MRD negative|0|||
146928251|NCT02883049|529896069|FG014|Induction|MRD negative|0|||
146928252|NCT02883049|529896070|FG015|Induction|MRD negative|0|||
146928253|NCT02883049|529896055|FG000|Induction|Identified as HR patients|165|||
146928254|NCT02883049|529896056|FG001|Induction|Identified as HR patients|0|||
146928255|NCT02883049|529896057|FG002|Induction|Identified as HR patients|0|||
146928256|NCT02883049|529896058|FG003|Induction|Identified as HR patients|0|||
146928257|NCT02883049|529896059|FG004|Induction|Identified as HR patients|0|||
146928258|NCT02883049|529896060|FG005|Induction|Identified as HR patients|0|||
146928259|NCT02883049|529896061|FG006|Induction|Identified as HR patients|0|||
146928260|NCT02883049|529896062|FG007|Induction|Identified as HR patients|0|||
146688240|NCT01050257|529035890|FG002|Overall Study|No reason specified|2|||
146688241|NCT01050257|529035888|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
146688242|NCT01050257|529035889|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
146688243|NCT01050257|529035890|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
146688244|NCT01050257|529035888|FG000|Overall Study|Violation criteria|0|||
146688245|NCT01050257|529035889|FG001|Overall Study|Violation criteria|1|||
146688246|NCT01050257|529035890|FG002|Overall Study|Violation criteria|0|||
146688247|NCT01050257|529035888|FG000|Overall Study|Failure to return|0|||
146688248|NCT01050257|529035889|FG001|Overall Study|Failure to return|2|||
146688249|NCT01050257|529035890|FG002|Overall Study|Failure to return|0|||
146688250|NCT01050257|529035888|FG000|Overall Study|Death|0|||
146688251|NCT01050257|529035889|FG001|Overall Study|Death|0|||
146688252|NCT01050257|529035890|FG002|Overall Study|Death|1|||
146688253|NCT00171223|529035891|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
146688254|NCT00171223|529035892|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
146688255|NCT00171223|529035893|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
146688256|NCT00171223|529035891|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
146688257|NCT00171223|529035892|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
146688258|NCT00171223|529035893|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
146688259|NCT00171223|529035891|FG000|Overall Study|Abnormal Procedure|1|||
146928261|NCT02883049|529896063|FG008|Induction|Identified as HR patients|0|||
146928262|NCT02883049|529896064|FG009|Induction|Identified as HR patients|0|||
146928263|NCT02883049|529896065|FG010|Induction|Identified as HR patients|0|||
146688260|NCT00171223|529035892|FG001|Overall Study|Abnormal Procedure|0|||
146928264|NCT02883049|529896066|FG011|Induction|Identified as HR patients|0|||
146928265|NCT02883049|529896067|FG012|Induction|Identified as HR patients|0|||
146688261|NCT00171223|529035893|FG002|Overall Study|Abnormal Procedure|0|||
146928266|NCT02883049|529896068|FG013|Induction|Identified as HR patients|0|||
146775067|NCT01388361|529346900|FG000|Overall Study|Unclassified|0|||
146688262|NCT00171223|529035891|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
146688263|NCT00171223|529035892|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
146688264|NCT00171223|529035893|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
146688265|NCT00171223|529035891|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
146775068|NCT01388361|529346901|FG001|Overall Study|Unclassified|0|||
146928267|NCT02883049|529896069|FG014|Induction|Identified as HR patients|0|||
146928268|NCT02883049|529896070|FG015|Induction|Identified as HR patients|0|||
146928269|NCT02883049|529896055|FG000|Induction|Developed SMN|0|||
146688266|NCT00171223|529035892|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
146688267|NCT00171223|529035893|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
146688268|NCT00171223|529035891|FG000|Overall Study|Protocol Violation|2|||
146688269|NCT00171223|529035892|FG001|Overall Study|Protocol Violation|2|||
146688270|NCT00171223|529035893|FG002|Overall Study|Protocol Violation|3|||
146688271|NCT00171223|529035891|FG000|Overall Study|Participant Withdrew Consent|12|||
146688272|NCT00171223|529035892|FG001|Overall Study|Participant Withdrew Consent|21|||
146688273|NCT00171223|529035893|FG002|Overall Study|Participant Withdrew Consent|15|||
146688274|NCT00171223|529035891|FG000|Overall Study|Lost to Follow-up|5|||
146688275|NCT00171223|529035892|FG001|Overall Study|Lost to Follow-up|2|||
146688276|NCT00171223|529035893|FG002|Overall Study|Lost to Follow-up|3|||
146688277|NCT00171223|529035891|FG000|Overall Study|Administrative Problems|4|||
146688278|NCT00171223|529035892|FG001|Overall Study|Administrative Problems|7|||
146688279|NCT00171223|529035893|FG002|Overall Study|Administrative Problems|6|||
146688280|NCT00171223|529035891|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
146688281|NCT00171223|529035892|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
146688282|NCT00171223|529035893|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
146688283|NCT00171223|529035891|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
146688284|NCT00171223|529035892|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
146688285|NCT00171223|529035893|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
146688286|NCT02604212|529035895|FG000|Overall Study|Study Terminated by Sponsor|2|||
146688287|NCT02604212|529035896|FG001|Overall Study|Study Terminated by Sponsor|1|||
146688288|NCT02604212|529035897|FG002|Overall Study|Study Terminated by Sponsor|3|||
146688289|NCT02604212|529035898|FG003|Overall Study|Study Terminated by Sponsor|3|||
146688290|NCT02604212|529035895|FG000|Overall Study|Withdrawal by Subject|0|||
146688291|NCT02604212|529035896|FG001|Overall Study|Withdrawal by Subject|0|||
146688292|NCT02604212|529035897|FG002|Overall Study|Withdrawal by Subject|1|||
146688293|NCT02604212|529035898|FG003|Overall Study|Withdrawal by Subject|0|||
146688294|NCT00278109|529035899|FG000|Overall Study|Adverse Event|3|||
146688295|NCT00278109|529035899|FG000|Overall Study|social circumstances|1|||
146688296|NCT02580357|529035900|FG000|Overall Study|Lost to Follow-up|2|||
146688297|NCT02580357|529035901|FG001|Overall Study|Lost to Follow-up|0|||
146688298|NCT02580357|529035902|FG002|Overall Study|Lost to Follow-up|0|||
146688299|NCT02580357|529035900|FG000|Overall Study|Protocol Violation|1|||
146688300|NCT02580357|529035901|FG001|Overall Study|Protocol Violation|0|||
146688301|NCT02580357|529035902|FG002|Overall Study|Protocol Violation|0|||
146688302|NCT00383149|529035918|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
146688303|NCT00383149|529035918|FG000|Overall Study|Death|2|||
146688304|NCT00383149|529035918|FG000|Overall Study|Disease Progression|38|||
146688305|NCT00383149|529035918|FG000|Overall Study|Lost to Follow-up|1|||
146688306|NCT00383149|529035918|FG000|Overall Study|Other|1|||
146688307|NCT00383149|529035918|FG000|Overall Study|Study Drug Toxicity|4|||
146688308|NCT00383149|529035918|FG000|Overall Study|Request to Discontinue Treatment|4|||
146688309|NCT00383149|529035918|FG000|Overall Study|Participant Withdrew Consent|1|||
146688310|NCT00453544|529035919|FG000|Overall Study|Withdrawal by Subject|1|||
146688311|NCT00453544|529035920|FG001|Overall Study|Withdrawal by Subject|0|||
146688312|NCT00453544|529035921|FG002|Overall Study|Withdrawal by Subject|0|||
146688313|NCT00453544|529035922|FG003|Overall Study|Withdrawal by Subject|0|||
146688314|NCT00453544|529035919|FG000|Overall Study|Primary outcome measure not completed|1|||
146688315|NCT00453544|529035920|FG001|Overall Study|Primary outcome measure not completed|1|||
146688316|NCT00453544|529035921|FG002|Overall Study|Primary outcome measure not completed|0|||
146688317|NCT00453544|529035922|FG003|Overall Study|Primary outcome measure not completed|1|||
146688318|NCT03721276|529035925|FG000|Overall Study|Lost to Follow-up|5|||
146688319|NCT03721276|529035926|FG001|Overall Study|Lost to Follow-up|3|||
146688320|NCT03721276|529035925|FG000|Overall Study|Adverse Event|0|||
146688321|NCT03721276|529035926|FG001|Overall Study|Adverse Event|1|||
146688322|NCT00450333|529035927|FG000|Overall Study|Study terminated|47|||
146688323|NCT00450333|529035928|FG001|Overall Study|Study terminated|54|||
146688324|NCT00450333|529035929|FG002|Overall Study|Study terminated|16|||
146688325|NCT00450333|529035930|FG003|Overall Study|Study terminated|21|||
146688326|NCT00450333|529035927|FG000|Overall Study|Adverse Event|1|||
146688327|NCT00450333|529035928|FG001|Overall Study|Adverse Event|7|||
146688328|NCT00450333|529035929|FG002|Overall Study|Adverse Event|2|||
146688329|NCT00450333|529035930|FG003|Overall Study|Adverse Event|2|||
146688330|NCT00450333|529035927|FG000|Overall Study|Protocol Violation|1|||
146688331|NCT00450333|529035928|FG001|Overall Study|Protocol Violation|0|||
146688332|NCT00450333|529035929|FG002|Overall Study|Protocol Violation|1|||
146688333|NCT00450333|529035930|FG003|Overall Study|Protocol Violation|0|||
146688334|NCT00450333|529035927|FG000|Overall Study|Withdrawal by Subject|1|||
146688335|NCT00450333|529035928|FG001|Overall Study|Withdrawal by Subject|0|||
146688336|NCT00450333|529035929|FG002|Overall Study|Withdrawal by Subject|3|||
146688337|NCT00450333|529035930|FG003|Overall Study|Withdrawal by Subject|0|||
146688338|NCT00450333|529035927|FG000|Overall Study|Kidney transplant|1|||
146688339|NCT00450333|529035928|FG001|Overall Study|Kidney transplant|0|||
146688340|NCT00450333|529035929|FG002|Overall Study|Kidney transplant|1|||
146688341|NCT00450333|529035930|FG003|Overall Study|Kidney transplant|3|||
146979229|NCT04444752|530085619|FG001|Overall Study|Pregnancy|0|||
146979230|NCT04444752|530085620|FG002|Overall Study|Pregnancy|0|||
146979231|NCT04444752|530085621|FG003|Overall Study|Pregnancy|1|||
146979232|NCT04444752|530085618|FG000|Overall Study|Withdrawal by Subject|6|||
146979233|NCT04444752|530085619|FG001|Overall Study|Withdrawal by Subject|5|||
146979234|NCT04444752|530085620|FG002|Overall Study|Withdrawal by Subject|3|||
146979235|NCT04444752|530085621|FG003|Overall Study|Withdrawal by Subject|4|||
146979236|NCT04444752|530085618|FG000|Overall Study|Protocol Violation|1|||
146979237|NCT04444752|530085619|FG001|Overall Study|Protocol Violation|1|||
146979238|NCT04444752|530085620|FG002|Overall Study|Protocol Violation|0|||
146688342|NCT00450333|529035927|FG000|Overall Study|Death|3|||
146688343|NCT00450333|529035928|FG001|Overall Study|Death|2|||
146688344|NCT00450333|529035929|FG002|Overall Study|Death|2|||
146688345|NCT00450333|529035930|FG003|Overall Study|Death|2|||
146688346|NCT01340898|529035935|FG000|Primary Phase|Serious Adverse Events|0|||
146688347|NCT01340898|529035936|FG001|Primary Phase|Serious Adverse Events|0|||
146688348|NCT01340898|529035937|FG002|Primary Phase|Serious Adverse Events|1|||
146928270|NCT02883049|529896056|FG001|Induction|Developed SMN|1|||
146928271|NCT02883049|529896057|FG002|Induction|Developed SMN|0|||
146928272|NCT02883049|529896058|FG003|Induction|Developed SMN|0|||
146928273|NCT02883049|529896059|FG004|Induction|Developed SMN|0|||
146928274|NCT02883049|529896060|FG005|Induction|Developed SMN|0|||
146928275|NCT02883049|529896061|FG006|Induction|Developed SMN|0|||
146928276|NCT02883049|529896062|FG007|Induction|Developed SMN|0|||
146928277|NCT02883049|529896063|FG008|Induction|Developed SMN|0|||
146928278|NCT02883049|529896064|FG009|Induction|Developed SMN|0|||
146928279|NCT02883049|529896065|FG010|Induction|Developed SMN|0|||
146928280|NCT02883049|529896066|FG011|Induction|Developed SMN|0|||
146928281|NCT02883049|529896067|FG012|Induction|Developed SMN|0|||
146928282|NCT02883049|529896068|FG013|Induction|Developed SMN|0|||
146928283|NCT02883049|529896069|FG014|Induction|Developed SMN|0|||
146928284|NCT02883049|529896070|FG015|Induction|Developed SMN|0|||
146928285|NCT02883049|529896055|FG000|Induction|Enrolled onto another COG study|72|||
146928286|NCT02883049|529896056|FG001|Induction|Enrolled onto another COG study|0|||
146928287|NCT02883049|529896057|FG002|Induction|Enrolled onto another COG study|0|||
146928288|NCT02883049|529896058|FG003|Induction|Enrolled onto another COG study|0|||
146928289|NCT02883049|529896059|FG004|Induction|Enrolled onto another COG study|0|||
146928290|NCT02883049|529896060|FG005|Induction|Enrolled onto another COG study|0|||
146928291|NCT02883049|529896061|FG006|Induction|Enrolled onto another COG study|0|||
146928292|NCT02883049|529896062|FG007|Induction|Enrolled onto another COG study|0|||
146928293|NCT02883049|529896063|FG008|Induction|Enrolled onto another COG study|0|||
146928294|NCT02883049|529896064|FG009|Induction|Enrolled onto another COG study|0|||
146928295|NCT02883049|529896065|FG010|Induction|Enrolled onto another COG study|0|||
146928296|NCT02883049|529896066|FG011|Induction|Enrolled onto another COG study|0|||
146928297|NCT02883049|529896067|FG012|Induction|Enrolled onto another COG study|0|||
146928298|NCT02883049|529896068|FG013|Induction|Enrolled onto another COG study|0|||
146928299|NCT02883049|529896069|FG014|Induction|Enrolled onto another COG study|0|||
146928300|NCT02883049|529896070|FG015|Induction|Enrolled onto another COG study|0|||
146928301|NCT02883049|529896055|FG000|Induction|Incomplete induction data|17|||
146928302|NCT02883049|529896056|FG001|Induction|Incomplete induction data|0|||
146928303|NCT02883049|529896057|FG002|Induction|Incomplete induction data|0|||
146928304|NCT02883049|529896058|FG003|Induction|Incomplete induction data|0|||
146928305|NCT02883049|529896059|FG004|Induction|Incomplete induction data|0|||
146928306|NCT02883049|529896060|FG005|Induction|Incomplete induction data|0|||
146928307|NCT02883049|529896061|FG006|Induction|Incomplete induction data|0|||
146928308|NCT02883049|529896062|FG007|Induction|Incomplete induction data|0|||
146928309|NCT02883049|529896063|FG008|Induction|Incomplete induction data|0|||
146928310|NCT02883049|529896064|FG009|Induction|Incomplete induction data|0|||
146928311|NCT02883049|529896065|FG010|Induction|Incomplete induction data|0|||
146928312|NCT02883049|529896066|FG011|Induction|Incomplete induction data|0|||
146928313|NCT02883049|529896067|FG012|Induction|Incomplete induction data|0|||
146928314|NCT02883049|529896068|FG013|Induction|Incomplete induction data|0|||
146928315|NCT02883049|529896069|FG014|Induction|Incomplete induction data|0|||
146928316|NCT02883049|529896070|FG015|Induction|Incomplete induction data|0|||
146928317|NCT02883049|529896055|FG000|Post Induction|Adverse Event|0|||
146928318|NCT02883049|529896056|FG001|Post Induction|Adverse Event|0|||
146928319|NCT02883049|529896057|FG002|Post Induction|Adverse Event|0|||
146928320|NCT02883049|529896058|FG003|Post Induction|Adverse Event|7|||
146928321|NCT02883049|529896059|FG004|Post Induction|Adverse Event|8|||
146928322|NCT02883049|529896060|FG005|Post Induction|Adverse Event|3|||
146979239|NCT04444752|530085621|FG003|Overall Study|Protocol Violation|0|||
146688349|NCT01340898|529035935|FG000|Primary Phase|Withdrawal by Subject|8|||
146688350|NCT01340898|529035936|FG001|Primary Phase|Withdrawal by Subject|7|||
146688351|NCT01340898|529035937|FG002|Primary Phase|Withdrawal by Subject|5|||
146928323|NCT02883049|529896061|FG006|Post Induction|Adverse Event|4|||
146928324|NCT02883049|529896062|FG007|Post Induction|Adverse Event|5|||
146928325|NCT02883049|529896063|FG008|Post Induction|Adverse Event|6|||
146928326|NCT02883049|529896064|FG009|Post Induction|Adverse Event|7|||
146928327|NCT02883049|529896065|FG010|Post Induction|Adverse Event|2|||
146979240|NCT04444752|530085618|FG000|Overall Study|Patient moving out of town|1|||
146979241|NCT04444752|530085619|FG001|Overall Study|Patient moving out of town|0|||
146979242|NCT04444752|530085620|FG002|Overall Study|Patient moving out of town|0|||
146979243|NCT04444752|530085621|FG003|Overall Study|Patient moving out of town|1|||
146979244|NCT04444752|530085618|FG000|Overall Study|Lack of Efficacy|0|||
146979245|NCT04444752|530085619|FG001|Overall Study|Lack of Efficacy|0|||
146979246|NCT04444752|530085620|FG002|Overall Study|Lack of Efficacy|0|||
146979247|NCT04444752|530085621|FG003|Overall Study|Lack of Efficacy|1|||
146979248|NCT04444752|530085618|FG000|Overall Study|Death|0|||
146979249|NCT04444752|530085619|FG001|Overall Study|Death|0|||
146979250|NCT04444752|530085620|FG002|Overall Study|Death|1|||
146979251|NCT04444752|530085621|FG003|Overall Study|Death|0|||
146979252|NCT00579254|530085622|FG000|Overall Study|Lost to Follow-up|39|||
146979253|NCT00579254|530085622|FG000|Overall Study|Discontinued when study terminated|73|||
146979254|NCT02557672|530085623|FG000|Overall Study|Withdrawal by Subject|4|||
146979255|NCT02557672|530085624|FG001|Overall Study|Withdrawal by Subject|2|||
146979256|NCT00343642|530087026|FG000|Overall Study|Lost to Follow-up|0|||
146979257|NCT00343642|530087027|FG001|Overall Study|Lost to Follow-up|1|||
146979258|NCT00343642|530087028|FG002|Overall Study|Lost to Follow-up|0|||
146979259|NCT00343642|530087026|FG000|Overall Study|Pregnancy|1|||
146979260|NCT00343642|530087027|FG001|Overall Study|Pregnancy|0|||
146979261|NCT00343642|530087028|FG002|Overall Study|Pregnancy|2|||
146979262|NCT00343642|530087026|FG000|Overall Study|Withdrawal by Subject|2|||
146979263|NCT00343642|530087027|FG001|Overall Study|Withdrawal by Subject|3|||
146979264|NCT00343642|530087028|FG002|Overall Study|Withdrawal by Subject|4|||
146979265|NCT00343642|530087026|FG000|Overall Study|Adverse Event|0|||
146979266|NCT00343642|530087027|FG001|Overall Study|Adverse Event|0|||
146979267|NCT00343642|530087028|FG002|Overall Study|Adverse Event|1|||
146979268|NCT00343642|530087026|FG000|Overall Study|Flare up|6|||
146979269|NCT00343642|530087027|FG001|Overall Study|Flare up|4|||
146979270|NCT00343642|530087028|FG002|Overall Study|Flare up|0|||
146979271|NCT00860574|530087031|FG000|Overall Study|Death|2|||
146979272|NCT00860574|530087031|FG000|Overall Study|Relapse|1|||
146688352|NCT01340898|529035935|FG000|Primary Phase|Migrated/moved from study area|4|||
146928328|NCT02883049|529896066|FG011|Post Induction|Adverse Event|2|||
146928329|NCT02883049|529896067|FG012|Post Induction|Adverse Event|0|||
146928330|NCT02883049|529896068|FG013|Post Induction|Adverse Event|0|||
146928331|NCT02883049|529896069|FG014|Post Induction|Adverse Event|5|||
146928332|NCT02883049|529896070|FG015|Post Induction|Adverse Event|2|||
146928333|NCT02883049|529896055|FG000|Post Induction|Death|0|||
146928334|NCT02883049|529896056|FG001|Post Induction|Death|0|||
146928335|NCT02883049|529896057|FG002|Post Induction|Death|0|||
146928336|NCT02883049|529896058|FG003|Post Induction|Death|9|||
146928337|NCT02883049|529896059|FG004|Post Induction|Death|9|||
146928338|NCT02883049|529896060|FG005|Post Induction|Death|0|||
146928339|NCT02883049|529896061|FG006|Post Induction|Death|1|||
146928340|NCT02883049|529896062|FG007|Post Induction|Death|6|||
146928341|NCT02883049|529896063|FG008|Post Induction|Death|5|||
146928342|NCT02883049|529896064|FG009|Post Induction|Death|3|||
146928343|NCT02883049|529896065|FG010|Post Induction|Death|1|||
146928344|NCT02883049|529896066|FG011|Post Induction|Death|0|||
146928345|NCT02883049|529896067|FG012|Post Induction|Death|1|||
146928346|NCT02883049|529896068|FG013|Post Induction|Death|1|||
146928347|NCT02883049|529896069|FG014|Post Induction|Death|10|||
146928348|NCT02883049|529896070|FG015|Post Induction|Death|2|||
146928349|NCT02883049|529896055|FG000|Post Induction|Lost to Follow-up|0|||
146928350|NCT02883049|529896056|FG001|Post Induction|Lost to Follow-up|0|||
146928351|NCT02883049|529896057|FG002|Post Induction|Lost to Follow-up|0|||
146928352|NCT02883049|529896058|FG003|Post Induction|Lost to Follow-up|0|||
146928353|NCT02883049|529896059|FG004|Post Induction|Lost to Follow-up|1|||
146928354|NCT02883049|529896060|FG005|Post Induction|Lost to Follow-up|1|||
146928355|NCT02883049|529896061|FG006|Post Induction|Lost to Follow-up|0|||
146928356|NCT02883049|529896062|FG007|Post Induction|Lost to Follow-up|0|||
146979273|NCT01165242|530087035|FG000|Overall Study|Unreachable Subjects|1|||
146979274|NCT01165242|530087036|FG001|Overall Study|Unreachable Subjects|0|||
146979275|NCT01165242|530087037|FG002|Overall Study|Unreachable Subjects|0|||
146979276|NCT01165242|530087035|FG000|Overall Study|Incarcerated Subjects|0|||
146979277|NCT01165242|530087036|FG001|Overall Study|Incarcerated Subjects|1|||
146979278|NCT01165242|530087037|FG002|Overall Study|Incarcerated Subjects|0|||
146928357|NCT02883049|529896063|FG008|Post Induction|Lost to Follow-up|3|||
146928358|NCT02883049|529896064|FG009|Post Induction|Lost to Follow-up|0|||
146928359|NCT02883049|529896065|FG010|Post Induction|Lost to Follow-up|1|||
146928360|NCT02883049|529896066|FG011|Post Induction|Lost to Follow-up|0|||
146928361|NCT02883049|529896067|FG012|Post Induction|Lost to Follow-up|0|||
146928362|NCT02883049|529896068|FG013|Post Induction|Lost to Follow-up|0|||
146928363|NCT02883049|529896069|FG014|Post Induction|Lost to Follow-up|0|||
146928364|NCT02883049|529896070|FG015|Post Induction|Lost to Follow-up|0|||
146928365|NCT02883049|529896055|FG000|Post Induction|Physician Decision|0|||
146979279|NCT01165242|530087035|FG000|Overall Study|Visit 2 Declined by Subject|0|||
146979280|NCT01165242|530087036|FG001|Overall Study|Visit 2 Declined by Subject|0|||
146979281|NCT01165242|530087037|FG002|Overall Study|Visit 2 Declined by Subject|1|||
146979282|NCT01165242|530087035|FG000|Overall Study|Withdrawal by Subject|0|||
146979283|NCT01165242|530087036|FG001|Overall Study|Withdrawal by Subject|2|||
146688353|NCT01340898|529035936|FG001|Primary Phase|Migrated/moved from study area|1|||
146688354|NCT01340898|529035937|FG002|Primary Phase|Migrated/moved from study area|0|||
146688355|NCT01340898|529035935|FG000|Primary Phase|Lost to Follow-up|4|||
146688356|NCT01340898|529035936|FG001|Primary Phase|Lost to Follow-up|1|||
146688357|NCT01340898|529035937|FG002|Primary Phase|Lost to Follow-up|0|||
146688358|NCT01340898|529035935|FG000|Booster Phase|Withdrawal by Subject|3|||
146688359|NCT01340898|529035936|FG001|Booster Phase|Withdrawal by Subject|0|||
146688360|NCT01340898|529035937|FG002|Booster Phase|Withdrawal by Subject|4|||
146688361|NCT01340898|529035935|FG000|Booster Phase|Migrated/moved from study area|3|||
146688362|NCT01340898|529035936|FG001|Booster Phase|Migrated/moved from study area|0|||
146688363|NCT01340898|529035937|FG002|Booster Phase|Migrated/moved from study area|0|||
146688364|NCT01340898|529035935|FG000|Booster Phase|Lost to Follow-up|4|||
146688365|NCT01340898|529035936|FG001|Booster Phase|Lost to Follow-up|2|||
146688366|NCT01340898|529035937|FG002|Booster Phase|Lost to Follow-up|3|||
146688367|NCT01214629|529035939|FG000|Overall Study|Progressive Disease|1|||
146688368|NCT01214629|529035940|FG001|Overall Study|Progressive Disease|1|||
146688369|NCT01214629|529035941|FG002|Overall Study|Progressive Disease|0|||
146688370|NCT01214629|529035942|FG003|Overall Study|Progressive Disease|1|||
146688371|NCT01214629|529035943|FG004|Overall Study|Progressive Disease|2|||
146688372|NCT01214629|529035944|FG005|Overall Study|Progressive Disease|3|||
146688373|NCT01214629|529035945|FG006|Overall Study|Progressive Disease|1|||
146688374|NCT01214629|529035946|FG007|Overall Study|Progressive Disease|1|||
146688375|NCT01214629|529035947|FG008|Overall Study|Progressive Disease|1|||
146688376|NCT01214629|529035948|FG009|Overall Study|Progressive Disease|5|||
146688377|NCT01214629|529035949|FG010|Overall Study|Progressive Disease|1|||
146688378|NCT01214629|529035939|FG000|Overall Study|Adverse Event|0|||
146688379|NCT01214629|529035940|FG001|Overall Study|Adverse Event|0|||
146688380|NCT01214629|529035941|FG002|Overall Study|Adverse Event|0|||
146688381|NCT01214629|529035942|FG003|Overall Study|Adverse Event|1|||
146688382|NCT01214629|529035943|FG004|Overall Study|Adverse Event|0|||
146688383|NCT01214629|529035944|FG005|Overall Study|Adverse Event|1|||
146688384|NCT01214629|529035945|FG006|Overall Study|Adverse Event|0|||
146775069|NCT01388361|529346902|FG002|Overall Study|Unclassified|1|||
146775070|NCT01061671|529346904|FG000|Overall Study|Withdrawal by Subject|16|||
146775071|NCT01061671|529346905|FG001|Overall Study|Withdrawal by Subject|20|||
146775072|NCT01061671|529346904|FG000|Overall Study|Lost to Follow-up|3|||
146775073|NCT01061671|529346905|FG001|Overall Study|Lost to Follow-up|5|||
146775074|NCT01061671|529346904|FG000|Overall Study|Death|28|||
146775075|NCT01061671|529346905|FG001|Overall Study|Death|30|||
146775076|NCT03960463|529348000|FG000|Overall Study|Withdrawal by Subject|2|||
146775077|NCT03960463|529348001|FG001|Overall Study|Withdrawal by Subject|0|||
146775078|NCT05568615|529348002|FG000|Overall Study|Death|1|||
146775079|NCT05568615|529348002|FG000|Overall Study|Physician Decision|1|||
146775080|NCT05194917|529348003|FG000|Overall Study|Lost to Follow-up|7|||
146775081|NCT05194917|529348004|FG001|Overall Study|Lost to Follow-up|5|||
146775082|NCT05194917|529348005|FG002|Overall Study|Lost to Follow-up|6|||
146775083|NCT05194917|529348006|FG003|Overall Study|Lost to Follow-up|5|||
146775084|NCT05505045|529348010|FG000|Overall Study|Withdrawal by Subject|2|||
146775085|NCT05505045|529348011|FG001|Overall Study|Withdrawal by Subject|1|||
146775086|NCT03346538|529348015|FG000|Overall Study|Physician Decision|0|||
146775087|NCT03346538|529348016|FG001|Overall Study|Physician Decision|1|||
146775088|NCT03346538|529348017|FG002|Overall Study|Physician Decision|0|||
146775089|NCT03346538|529348015|FG000|Overall Study|Withdrawal by Subject|3|||
146775090|NCT03346538|529348016|FG001|Overall Study|Withdrawal by Subject|2|||
146775091|NCT03346538|529348017|FG002|Overall Study|Withdrawal by Subject|0|||
146775092|NCT03346538|529348015|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
146775093|NCT03346538|529348016|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
146775094|NCT03346538|529348017|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
146775095|NCT05672667|529348018|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
146775096|NCT01903811|529348026|FG000|Overall Study|No measurable disease|1|||
146775097|NCT01903811|529348027|FG001|Overall Study|No measurable disease|1|||
146775098|NCT01903811|529348026|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
146775099|NCT01903811|529348027|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
146775100|NCT01903811|529348026|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
146775101|NCT01903811|529348027|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
146775102|NCT01903811|529348026|FG000|Overall Study|Withdrawal by Subject|0|||
146775103|NCT01903811|529348027|FG001|Overall Study|Withdrawal by Subject|1|||
146688385|NCT01214629|529035946|FG007|Overall Study|Adverse Event|0|||
146688386|NCT01214629|529035947|FG008|Overall Study|Adverse Event|0|||
146688387|NCT01214629|529035948|FG009|Overall Study|Adverse Event|1|||
146688388|NCT01214629|529035949|FG010|Overall Study|Adverse Event|0|||
146688389|NCT01214629|529035939|FG000|Overall Study|Physician Decision|0|||
146688390|NCT01214629|529035940|FG001|Overall Study|Physician Decision|0|||
146688391|NCT01214629|529035941|FG002|Overall Study|Physician Decision|0|||
146688392|NCT01214629|529035942|FG003|Overall Study|Physician Decision|0|||
146688393|NCT01214629|529035943|FG004|Overall Study|Physician Decision|0|||
146688394|NCT01214629|529035944|FG005|Overall Study|Physician Decision|0|||
146688395|NCT01214629|529035945|FG006|Overall Study|Physician Decision|0|||
146688396|NCT01214629|529035946|FG007|Overall Study|Physician Decision|0|||
146688397|NCT01214629|529035947|FG008|Overall Study|Physician Decision|0|||
146928366|NCT02883049|529896056|FG001|Post Induction|Physician Decision|0|||
146928367|NCT02883049|529896057|FG002|Post Induction|Physician Decision|0|||
146928368|NCT02883049|529896058|FG003|Post Induction|Physician Decision|27|||
146928369|NCT02883049|529896059|FG004|Post Induction|Physician Decision|27|||
146928370|NCT02883049|529896060|FG005|Post Induction|Physician Decision|23|||
146928371|NCT02883049|529896061|FG006|Post Induction|Physician Decision|30|||
146928372|NCT02883049|529896062|FG007|Post Induction|Physician Decision|56|||
146928373|NCT02883049|529896063|FG008|Post Induction|Physician Decision|85|||
146928374|NCT02883049|529896064|FG009|Post Induction|Physician Decision|12|||
146928375|NCT02883049|529896065|FG010|Post Induction|Physician Decision|5|||
146928376|NCT02883049|529896066|FG011|Post Induction|Physician Decision|14|||
146928377|NCT02883049|529896067|FG012|Post Induction|Physician Decision|1|||
146928378|NCT02883049|529896068|FG013|Post Induction|Physician Decision|11|||
146928379|NCT02883049|529896069|FG014|Post Induction|Physician Decision|19|||
146928380|NCT02883049|529896070|FG015|Post Induction|Physician Decision|5|||
146928381|NCT02883049|529896055|FG000|Post Induction|Protocol Violation|0|||
146928382|NCT02883049|529896056|FG001|Post Induction|Protocol Violation|0|||
146928383|NCT02883049|529896057|FG002|Post Induction|Protocol Violation|0|||
146928384|NCT02883049|529896058|FG003|Post Induction|Protocol Violation|0|||
146928385|NCT02883049|529896059|FG004|Post Induction|Protocol Violation|0|||
146928386|NCT02883049|529896060|FG005|Post Induction|Protocol Violation|0|||
146928387|NCT02883049|529896061|FG006|Post Induction|Protocol Violation|0|||
146928388|NCT02883049|529896062|FG007|Post Induction|Protocol Violation|1|||
146928389|NCT02883049|529896063|FG008|Post Induction|Protocol Violation|0|||
146928390|NCT02883049|529896064|FG009|Post Induction|Protocol Violation|0|||
146928391|NCT02883049|529896065|FG010|Post Induction|Protocol Violation|0|||
146928392|NCT02883049|529896066|FG011|Post Induction|Protocol Violation|0|||
146928393|NCT02883049|529896067|FG012|Post Induction|Protocol Violation|0|||
146928394|NCT02883049|529896068|FG013|Post Induction|Protocol Violation|0|||
146928395|NCT02883049|529896069|FG014|Post Induction|Protocol Violation|0|||
146928396|NCT02883049|529896070|FG015|Post Induction|Protocol Violation|0|||
146928397|NCT02883049|529896055|FG000|Post Induction|Withdrawal by Subject|0|||
146928398|NCT02883049|529896056|FG001|Post Induction|Withdrawal by Subject|0|||
146928399|NCT02883049|529896057|FG002|Post Induction|Withdrawal by Subject|0|||
146928400|NCT02883049|529896058|FG003|Post Induction|Withdrawal by Subject|5|||
146928401|NCT02883049|529896059|FG004|Post Induction|Withdrawal by Subject|2|||
146928402|NCT02883049|529896060|FG005|Post Induction|Withdrawal by Subject|1|||
146928403|NCT02883049|529896061|FG006|Post Induction|Withdrawal by Subject|0|||
146928404|NCT02883049|529896062|FG007|Post Induction|Withdrawal by Subject|0|||
146928405|NCT02883049|529896063|FG008|Post Induction|Withdrawal by Subject|2|||
146928406|NCT02883049|529896064|FG009|Post Induction|Withdrawal by Subject|0|||
146928407|NCT02883049|529896065|FG010|Post Induction|Withdrawal by Subject|1|||
146928408|NCT02883049|529896066|FG011|Post Induction|Withdrawal by Subject|1|||
146928409|NCT02883049|529896067|FG012|Post Induction|Withdrawal by Subject|0|||
146928410|NCT02883049|529896068|FG013|Post Induction|Withdrawal by Subject|0|||
146928411|NCT02883049|529896069|FG014|Post Induction|Withdrawal by Subject|1|||
146928412|NCT02883049|529896070|FG015|Post Induction|Withdrawal by Subject|0|||
146928413|NCT02883049|529896055|FG000|Post Induction|Ineligible|0|||
146928414|NCT02883049|529896056|FG001|Post Induction|Ineligible|0|||
146928415|NCT02883049|529896057|FG002|Post Induction|Ineligible|2|||
146928416|NCT02883049|529896058|FG003|Post Induction|Ineligible|0|||
146928417|NCT02883049|529896059|FG004|Post Induction|Ineligible|0|||
146928418|NCT02883049|529896060|FG005|Post Induction|Ineligible|0|||
146928419|NCT02883049|529896061|FG006|Post Induction|Ineligible|1|||
146928420|NCT02883049|529896062|FG007|Post Induction|Ineligible|0|||
146928421|NCT02883049|529896063|FG008|Post Induction|Ineligible|0|||
146928422|NCT02883049|529896064|FG009|Post Induction|Ineligible|0|||
146688398|NCT01214629|529035948|FG009|Overall Study|Physician Decision|0|||
146688399|NCT01214629|529035949|FG010|Overall Study|Physician Decision|1|||
146688400|NCT01214629|529035939|FG000|Overall Study|Withdrawal by Subject|0|||
146688401|NCT01214629|529035940|FG001|Overall Study|Withdrawal by Subject|0|||
146688402|NCT01214629|529035941|FG002|Overall Study|Withdrawal by Subject|0|||
146688403|NCT01214629|529035942|FG003|Overall Study|Withdrawal by Subject|0|||
146775104|NCT04540913|529348028|FG000|Overall Study|Withdrawal by Subject|14|||
146928423|NCT02883049|529896065|FG010|Post Induction|Ineligible|1|||
146928424|NCT02883049|529896066|FG011|Post Induction|Ineligible|0|||
146928425|NCT02883049|529896067|FG012|Post Induction|Ineligible|0|||
146928426|NCT02883049|529896068|FG013|Post Induction|Ineligible|0|||
146928427|NCT02883049|529896069|FG014|Post Induction|Ineligible|0|||
146928428|NCT02883049|529896070|FG015|Post Induction|Ineligible|1|||
146928429|NCT02883049|529896055|FG000|Post Induction|Refusal of further protocol therapy|0|||
146928430|NCT02883049|529896056|FG001|Post Induction|Refusal of further protocol therapy|0|||
146928431|NCT02883049|529896057|FG002|Post Induction|Refusal of further protocol therapy|0|||
146928432|NCT02883049|529896058|FG003|Post Induction|Refusal of further protocol therapy|11|||
146688404|NCT01214629|529035943|FG004|Overall Study|Withdrawal by Subject|0|||
146688405|NCT01214629|529035944|FG005|Overall Study|Withdrawal by Subject|0|||
146688406|NCT01214629|529035945|FG006|Overall Study|Withdrawal by Subject|0|||
146688407|NCT01214629|529035946|FG007|Overall Study|Withdrawal by Subject|0|||
146688408|NCT01214629|529035947|FG008|Overall Study|Withdrawal by Subject|0|||
146688409|NCT01214629|529035948|FG009|Overall Study|Withdrawal by Subject|1|||
146688410|NCT01214629|529035949|FG010|Overall Study|Withdrawal by Subject|0|||
146688411|NCT00461682|529035952|FG000|Overall Study|Protocol Violation|1|||
146688412|NCT04501666|529035959|FG000|Overall Study|Physician Decision|0|||
146688413|NCT04501666|529035960|FG001|Overall Study|Physician Decision|1|||
146688414|NCT04501666|529035959|FG000|Overall Study|Adverse Event|12|||
146688415|NCT04501666|529035960|FG001|Overall Study|Adverse Event|4|||
146688416|NCT04501666|529035959|FG000|Overall Study|Subject's request|10|||
146688417|NCT04501666|529035960|FG001|Overall Study|Subject's request|6|||
146688418|NCT04501666|529035959|FG000|Overall Study|Protocol Deviation|2|||
146688419|NCT04501666|529035960|FG001|Overall Study|Protocol Deviation|1|||
146688420|NCT04501666|529035959|FG000|Overall Study|Other-- site permanently closing|0|||
146688421|NCT04501666|529035960|FG001|Overall Study|Other-- site permanently closing|1|||
146688422|NCT03204305|529035961|FG000|Overall Study|Lost to Follow-up|6|||
146688423|NCT03204305|529035962|FG001|Overall Study|Lost to Follow-up|4|||
146688424|NCT03204305|529035963|FG002|Overall Study|Lost to Follow-up|0|||
146688425|NCT03204305|529035964|FG003|Overall Study|Lost to Follow-up|0|||
146688426|NCT03204305|529035961|FG000|Overall Study|Physician Decision|1|||
146688427|NCT03204305|529035962|FG001|Overall Study|Physician Decision|0|||
146688428|NCT03204305|529035963|FG002|Overall Study|Physician Decision|0|||
146688429|NCT03204305|529035964|FG003|Overall Study|Physician Decision|0|||
146688430|NCT03204305|529035961|FG000|Overall Study|failure to place arterial line|2|||
146688431|NCT03204305|529035962|FG001|Overall Study|failure to place arterial line|1|||
146688432|NCT03204305|529035963|FG002|Overall Study|failure to place arterial line|0|||
146688433|NCT03204305|529035964|FG003|Overall Study|failure to place arterial line|0|||
146688434|NCT03204305|529035961|FG000|Overall Study|Withdrawal by Subject|2|||
146688435|NCT03204305|529035962|FG001|Overall Study|Withdrawal by Subject|0|||
146688436|NCT03204305|529035963|FG002|Overall Study|Withdrawal by Subject|0|||
146688437|NCT03204305|529035964|FG003|Overall Study|Withdrawal by Subject|0|||
146688438|NCT01165554|529035965|FG000|Overall Study|Withdrawal by Subject|23|||
146688439|NCT02953314|529035969|FG000|Overall Study|Adverse Event|0|||
146688440|NCT02953314|529035970|FG001|Overall Study|Adverse Event|1|||
146688441|NCT02953314|529035969|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
146688442|NCT02953314|529035970|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
146688443|NCT00535223|529035971|FG000|Overall Study|Withdrawal by Subject|4|||
146688444|NCT00535223|529035972|FG001|Overall Study|Withdrawal by Subject|1|||
146688445|NCT00101907|529035976|FG000|Overall Study|Adverse Event|1|||
146688446|NCT00101907|529035977|FG001|Overall Study|Adverse Event|0|||
146688447|NCT00101907|529035978|FG002|Overall Study|Adverse Event|0|||
146688448|NCT00101907|529035979|FG003|Overall Study|Adverse Event|0|||
146688449|NCT00101907|529035980|FG004|Overall Study|Adverse Event|0|||
146688450|NCT00101907|529035981|FG005|Overall Study|Adverse Event|0|||
146688451|NCT00101907|529035976|FG000|Overall Study|Death|0|||
146688452|NCT00101907|529035977|FG001|Overall Study|Death|1|||
146688453|NCT00101907|529035978|FG002|Overall Study|Death|0|||
146688454|NCT00101907|529035979|FG003|Overall Study|Death|0|||
146688455|NCT00101907|529035980|FG004|Overall Study|Death|3|||
146688456|NCT00101907|529035981|FG005|Overall Study|Death|0|||
146688457|NCT00101907|529035976|FG000|Overall Study|Physician Decision|0|||
146688458|NCT00101907|529035977|FG001|Overall Study|Physician Decision|0|||
146688459|NCT00101907|529035978|FG002|Overall Study|Physician Decision|0|||
146688460|NCT00101907|529035979|FG003|Overall Study|Physician Decision|1|||
146688461|NCT00101907|529035980|FG004|Overall Study|Physician Decision|1|||
146688462|NCT00101907|529035981|FG005|Overall Study|Physician Decision|0|||
146688463|NCT00101907|529035976|FG000|Overall Study|Withdrawal by Subject|1|||
146688464|NCT00101907|529035977|FG001|Overall Study|Withdrawal by Subject|0|||
146688465|NCT00101907|529035978|FG002|Overall Study|Withdrawal by Subject|1|||
146688466|NCT00101907|529035979|FG003|Overall Study|Withdrawal by Subject|0|||
146688467|NCT00101907|529035980|FG004|Overall Study|Withdrawal by Subject|1|||
146688468|NCT00101907|529035981|FG005|Overall Study|Withdrawal by Subject|0|||
146688469|NCT01765153|529035982|FG000|Training Phase 1|Format of intervention differed|1|||
146688470|NCT01765153|529035983|FG001|Training Phase 1|Format of intervention differed|0|||
146688471|NCT01765153|529035982|FG000|Training Phase 1|Poor participation in intervention|0|||
146688472|NCT01765153|529035983|FG001|Training Phase 1|Poor participation in intervention|1|||
146688473|NCT01765153|529035982|FG000|Rest Phase 1|Withdrawal by Subject|0|||
146688474|NCT01765153|529035983|FG001|Rest Phase 1|Withdrawal by Subject|1|||
146688475|NCT01765153|529035982|FG000|Training Phase 2|Withdrawal by Subject|0|||
146688476|NCT01765153|529035983|FG001|Training Phase 2|Withdrawal by Subject|1|||
146688477|NCT01765153|529035982|FG000|Rest Phase 2|Lost to Follow-up|2|||
146688478|NCT01765153|529035983|FG001|Rest Phase 2|Lost to Follow-up|1|||
146688479|NCT03915496|529035986|FG000|Overall Study|Adverse Event|2|||
146688480|NCT03915496|529035987|FG001|Overall Study|Adverse Event|1|||
146688481|NCT03915496|529035988|FG002|Overall Study|Adverse Event|2|||
146979284|NCT01165242|530087037|FG002|Overall Study|Withdrawal by Subject|2|||
146979285|NCT01165242|530087035|FG000|Overall Study|Extended Holiday|0|||
146979286|NCT01165242|530087036|FG001|Overall Study|Extended Holiday|0|||
146979287|NCT01165242|530087037|FG002|Overall Study|Extended Holiday|1|||
146979288|NCT01165242|530087035|FG000|Overall Study|Lost to Follow-up|9|||
146979289|NCT01165242|530087036|FG001|Overall Study|Lost to Follow-up|7|||
146979290|NCT01165242|530087037|FG002|Overall Study|Lost to Follow-up|10|||
146979291|NCT03877237|530087038|FG000|Overall Study|Adverse Event|1|||
146979292|NCT03877237|530087039|FG001|Overall Study|Adverse Event|2|||
146979293|NCT03877237|530087038|FG000|Overall Study|Death|3|||
146979294|NCT03877237|530087039|FG001|Overall Study|Death|2|||
146979295|NCT03877237|530087038|FG000|Overall Study|Physician Decision|1|||
146979296|NCT03877237|530087039|FG001|Overall Study|Physician Decision|0|||
146979297|NCT03877237|530087038|FG000|Overall Study|Withdrawal by Subject|0|||
146979298|NCT03877237|530087039|FG001|Overall Study|Withdrawal by Subject|2|||
146979299|NCT03372083|530087040|FG000|Overall Study|Adverse Event|3|||
146979300|NCT03372083|530087040|FG000|Overall Study|Physician Decision|1|||
146979301|NCT03372083|530087040|FG000|Overall Study|Withdrawal by Subject|1|||
146979302|NCT02236754|530087041|FG000|Overall Study|Withdrawal by Subject|1|||
146979303|NCT02236754|530087042|FG001|Overall Study|Withdrawal by Subject|0|||
146979304|NCT02544633|530087043|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
146979305|NCT02544633|530087044|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
146979306|NCT02544633|530087045|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
146688482|NCT02663674|529035989|FG000|Overall Study|Lost to Follow-up|5|||
146688483|NCT02663674|529035990|FG001|Overall Study|Lost to Follow-up|4|||
146688484|NCT02663674|529035989|FG000|Overall Study|Withdrawal by Subject|1|||
146688485|NCT02663674|529035990|FG001|Overall Study|Withdrawal by Subject|4|||
146688486|NCT02663674|529035989|FG000|Overall Study|Physician Decision|1|||
146688487|NCT02663674|529035990|FG001|Overall Study|Physician Decision|1|||
146688488|NCT02663674|529035989|FG000|Overall Study|Other Event (Health Related)|0|||
146688489|NCT02663674|529035990|FG001|Overall Study|Other Event (Health Related)|1|||
146688490|NCT00670800|529037013|FG000|Overall Study|2 controls were insulin resistant|0|||
146688491|NCT00670800|529037014|FG001|Overall Study|2 controls were insulin resistant|2|||
146688492|NCT03712904|529037016|FG000|Overall Study|Death|0|||
146688493|NCT03712904|529037017|FG001|Overall Study|Death|1|||
146688494|NCT03712904|529037016|FG000|Overall Study|Withdrawal by Subject|0|||
146688495|NCT03712904|529037017|FG001|Overall Study|Withdrawal by Subject|1|||
146688496|NCT03712904|529037016|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
146688497|NCT03712904|529037017|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
146688498|NCT01852942|529037018|FG000|Overall Study|Physician Decision|1|||
146688499|NCT01852942|529037019|FG001|Overall Study|Physician Decision|0|||
146688500|NCT01852942|529037018|FG000|Overall Study|Death|1|||
146688501|NCT01852942|529037019|FG001|Overall Study|Death|1|||
146688502|NCT01852942|529037018|FG000|Overall Study|Withdrawal by Subject|2|||
146688503|NCT01852942|529037019|FG001|Overall Study|Withdrawal by Subject|3|||
146688504|NCT01852942|529037018|FG000|Overall Study|Lost to Follow-up|1|||
146688505|NCT01852942|529037019|FG001|Overall Study|Lost to Follow-up|2|||
146688506|NCT04568590|529037021|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
146688507|NCT01372501|529037022|FG000|Overall Study|Adverse Event|4|||
146688508|NCT01372501|529037022|FG000|Overall Study|Device migration|1|||
146688509|NCT05333900|529037023|FG000|Overall Study|Protocol Violation|0|||
146688510|NCT05333900|529037024|FG001|Overall Study|Protocol Violation|1|||
146688511|NCT05333900|529037023|FG000|Overall Study|Withdrawal by Subject|0|||
146688512|NCT05333900|529037024|FG001|Overall Study|Withdrawal by Subject|1|||
146688513|NCT05333900|529037023|FG000|Overall Study|COVID-19 Pandemic|1|||
146688514|NCT05333900|529037024|FG001|Overall Study|COVID-19 Pandemic|1|||
146688515|NCT01277523|529037025|FG000|Overall Study|Adverse Event|1|||
146688516|NCT01277523|529037026|FG001|Overall Study|Adverse Event|0|||
146688517|NCT01277523|529037027|FG002|Overall Study|Adverse Event|0|||
146688518|NCT01277523|529037025|FG000|Overall Study|Protocol Violation|2|||
146688519|NCT01277523|529037026|FG001|Overall Study|Protocol Violation|0|||
146688520|NCT01277523|529037027|FG002|Overall Study|Protocol Violation|0|||
146688521|NCT01277523|529037025|FG000|Overall Study|Other Reason not Defined|0|||
146688522|NCT01277523|529037026|FG001|Overall Study|Other Reason not Defined|1|||
146688523|NCT01277523|529037027|FG002|Overall Study|Other Reason not Defined|0|||
146688524|NCT01851720|529037030|FG000|Overall Study|Lost to Follow-up|0|||
146688525|NCT01851720|529037031|FG001|Overall Study|Lost to Follow-up|1|||
146688526|NCT01074450|529037038|FG000|First Intervention|Emesis in Dosing Interval|0|||
146688527|NCT01074450|529037039|FG001|First Intervention|Emesis in Dosing Interval|2|||
146688528|NCT01074450|529037038|FG000|Second Intervention|Protocol Violation|1|||
146688529|NCT01074450|529037039|FG001|Second Intervention|Protocol Violation|0|||
146688530|NCT01074450|529037038|FG000|Second Intervention|Physician Decision|0|||
146688531|NCT01074450|529037039|FG001|Second Intervention|Physician Decision|1|||
146688532|NCT02728895|529037040|FG000|Overall Study|Other|1|||
146688533|NCT02728895|529037041|FG001|Overall Study|Other|2|||
146688534|NCT02728895|529037040|FG000|Overall Study|Withdrawal by Subject|0|||
146688535|NCT02728895|529037041|FG001|Overall Study|Withdrawal by Subject|3|||
146688536|NCT02150954|529037045|FG000|Overall Study|Protocol Violation|1|||
146688537|NCT02150954|529037046|FG001|Overall Study|Protocol Violation|0|||
146688538|NCT01086540|529037052|FG000|Overall Study|Death|3|||
146688539|NCT01086540|529037053|FG001|Overall Study|Death|1|||
146688540|NCT01086540|529037052|FG000|Overall Study|Physician Decision|2|||
146688541|NCT01086540|529037053|FG001|Overall Study|Physician Decision|1|||
146688542|NCT01086540|529037052|FG000|Overall Study|Addition of new therapy for PAH|1|||
146688543|NCT01086540|529037053|FG001|Overall Study|Addition of new therapy for PAH|0|||
146688544|NCT03164928|529037054|FG000|Overall Study|Lost to Follow-up|1|||
146688545|NCT03164928|529037055|FG001|Overall Study|Lost to Follow-up|0|||
146928433|NCT02883049|529896059|FG004|Post Induction|Refusal of further protocol therapy|15|||
146928434|NCT02883049|529896060|FG005|Post Induction|Refusal of further protocol therapy|9|||
146928435|NCT02883049|529896061|FG006|Post Induction|Refusal of further protocol therapy|13|||
146928436|NCT02883049|529896062|FG007|Post Induction|Refusal of further protocol therapy|5|||
146928437|NCT02883049|529896063|FG008|Post Induction|Refusal of further protocol therapy|21|||
146928438|NCT02883049|529896064|FG009|Post Induction|Refusal of further protocol therapy|7|||
146928439|NCT02883049|529896065|FG010|Post Induction|Refusal of further protocol therapy|0|||
146928440|NCT02883049|529896066|FG011|Post Induction|Refusal of further protocol therapy|7|||
146928441|NCT02883049|529896067|FG012|Post Induction|Refusal of further protocol therapy|3|||
146928442|NCT02883049|529896068|FG013|Post Induction|Refusal of further protocol therapy|0|||
146928443|NCT02883049|529896069|FG014|Post Induction|Refusal of further protocol therapy|4|||
146928444|NCT02883049|529896070|FG015|Post Induction|Refusal of further protocol therapy|1|||
146928445|NCT02883049|529896055|FG000|Post Induction|Inevaluable|0|||
146928446|NCT02883049|529896056|FG001|Post Induction|Inevaluable|0|||
146928447|NCT02883049|529896057|FG002|Post Induction|Inevaluable|0|||
146928448|NCT02883049|529896058|FG003|Post Induction|Inevaluable|1|||
146928449|NCT02883049|529896059|FG004|Post Induction|Inevaluable|1|||
146928450|NCT02883049|529896060|FG005|Post Induction|Inevaluable|2|||
146928451|NCT02883049|529896061|FG006|Post Induction|Inevaluable|7|||
146928452|NCT02883049|529896062|FG007|Post Induction|Inevaluable|6|||
146928453|NCT02883049|529896063|FG008|Post Induction|Inevaluable|4|||
146928454|NCT02883049|529896064|FG009|Post Induction|Inevaluable|4|||
146928455|NCT02883049|529896065|FG010|Post Induction|Inevaluable|1|||
146928456|NCT02883049|529896066|FG011|Post Induction|Inevaluable|1|||
146928457|NCT02883049|529896067|FG012|Post Induction|Inevaluable|2|||
146928458|NCT02883049|529896068|FG013|Post Induction|Inevaluable|0|||
146928459|NCT02883049|529896069|FG014|Post Induction|Inevaluable|0|||
146928460|NCT02883049|529896070|FG015|Post Induction|Inevaluable|1|||
146928461|NCT02883049|529896055|FG000|Post Induction|Moved to another non-COG institution|0|||
146928462|NCT02883049|529896056|FG001|Post Induction|Moved to another non-COG institution|0|||
146928463|NCT02883049|529896057|FG002|Post Induction|Moved to another non-COG institution|0|||
146928464|NCT02883049|529896058|FG003|Post Induction|Moved to another non-COG institution|0|||
146928465|NCT02883049|529896059|FG004|Post Induction|Moved to another non-COG institution|0|||
146928466|NCT02883049|529896060|FG005|Post Induction|Moved to another non-COG institution|0|||
146928467|NCT02883049|529896061|FG006|Post Induction|Moved to another non-COG institution|0|||
146928468|NCT02883049|529896062|FG007|Post Induction|Moved to another non-COG institution|2|||
146928469|NCT02883049|529896063|FG008|Post Induction|Moved to another non-COG institution|2|||
146928470|NCT02883049|529896064|FG009|Post Induction|Moved to another non-COG institution|0|||
146928471|NCT02883049|529896065|FG010|Post Induction|Moved to another non-COG institution|0|||
146928472|NCT02883049|529896066|FG011|Post Induction|Moved to another non-COG institution|1|||
146928473|NCT02883049|529896067|FG012|Post Induction|Moved to another non-COG institution|0|||
146688546|NCT01998737|529037056|FG000|Overall Study|Corrupted database|23|||
146688547|NCT01998737|529037057|FG001|Overall Study|Corrupted database|0|||
146688548|NCT00326950|529037058|FG000|Overall Study|Progressive Disease|1|||
146688549|NCT05811234|529037065|FG000|Overall Study|Loss of Effectiveness|2|||
146688550|NCT05811234|529037065|FG000|Overall Study|Adverse Event|4|||
146688551|NCT05811234|529037065|FG000|Overall Study|Pregnancy|1|||
146688552|NCT05811234|529037065|FG000|Overall Study|Disease progression|1|||
146688553|NCT05811234|529037065|FG000|Overall Study|Withdrawal by Subject|4|||
146928474|NCT02883049|529896068|FG013|Post Induction|Moved to another non-COG institution|0|||
146928475|NCT02883049|529896069|FG014|Post Induction|Moved to another non-COG institution|0|||
146688554|NCT05811234|529037065|FG000|Overall Study|Lost to Follow-up|13|||
146688555|NCT05811234|529037065|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
146688556|NCT01275833|529037066|FG000|Overall Study|Study terminated|1|||
146688557|NCT01275833|529037067|FG001|Overall Study|Study terminated|1|||
146688558|NCT02118012|529037068|FG000|Overall Study|Adverse Event|0|||
146688559|NCT02118012|529037069|FG001|Overall Study|Adverse Event|1|||
146928476|NCT02883049|529896070|FG015|Post Induction|Moved to another non-COG institution|0|||
146928477|NCT02883049|529896055|FG000|Post Induction|Randomization closed|0|||
146928478|NCT02883049|529896056|FG001|Post Induction|Randomization closed|0|||
146928479|NCT02883049|529896057|FG002|Post Induction|Randomization closed|0|||
146928480|NCT02883049|529896058|FG003|Post Induction|Randomization closed|0|||
146979307|NCT02544633|530087046|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
146979308|NCT02544633|530087043|FG000|Treatment Period|Adverse Event|7|||
146979309|NCT02544633|530087044|FG001|Treatment Period|Adverse Event|4|||
146979310|NCT02544633|530087045|FG002|Treatment Period|Adverse Event|0|||
146979311|NCT02544633|530087046|FG003|Treatment Period|Adverse Event|5|||
146979312|NCT02544633|530087043|FG000|Treatment Period|Lack of Efficacy|17|||
146979313|NCT02544633|530087044|FG001|Treatment Period|Lack of Efficacy|11|||
146688560|NCT02118012|529037068|FG000|Overall Study|Physician Decision|0|||
146688561|NCT02118012|529037069|FG001|Overall Study|Physician Decision|1|||
146688562|NCT03742037|529037078|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
146688563|NCT03742037|529037079|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
146688564|NCT03742037|529037080|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
146688565|NCT03742037|529037081|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
146688566|NCT03742037|529037082|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
146688567|NCT03742037|529037083|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
146688568|NCT03742037|529037084|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
146688569|NCT03742037|529037078|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
146688570|NCT03742037|529037079|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
146928481|NCT02883049|529896059|FG004|Post Induction|Randomization closed|0|||
146928482|NCT02883049|529896060|FG005|Post Induction|Randomization closed|0|||
146928483|NCT02883049|529896061|FG006|Post Induction|Randomization closed|0|||
146928484|NCT02883049|529896062|FG007|Post Induction|Randomization closed|20|||
146928485|NCT02883049|529896063|FG008|Post Induction|Randomization closed|0|||
146928486|NCT02883049|529896064|FG009|Post Induction|Randomization closed|0|||
146928487|NCT02883049|529896065|FG010|Post Induction|Randomization closed|0|||
146928488|NCT02883049|529896066|FG011|Post Induction|Randomization closed|0|||
146928489|NCT02883049|529896067|FG012|Post Induction|Randomization closed|0|||
146928490|NCT02883049|529896068|FG013|Post Induction|Randomization closed|0|||
146928491|NCT02883049|529896069|FG014|Post Induction|Randomization closed|0|||
146928492|NCT02883049|529896070|FG015|Post Induction|Randomization closed|0|||
146928493|NCT02883049|529896055|FG000|Post Induction|MRD negative|0|||
146928494|NCT02883049|529896056|FG001|Post Induction|MRD negative|0|||
146928495|NCT02883049|529896057|FG002|Post Induction|MRD negative|0|||
146928496|NCT02883049|529896058|FG003|Post Induction|MRD negative|0|||
146688571|NCT03742037|529037080|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
146688572|NCT03742037|529037081|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
146688573|NCT03742037|529037082|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
146688574|NCT03742037|529037083|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
146688575|NCT03742037|529037084|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
146688576|NCT03742037|529037078|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
146688577|NCT03742037|529037079|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
146688578|NCT03742037|529037080|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
146688579|NCT03742037|529037081|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
146688580|NCT03742037|529037082|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
146688581|NCT03742037|529037083|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
146688582|NCT03742037|529037084|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
146688583|NCT03742037|529037078|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
146688584|NCT03742037|529037079|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
146688585|NCT03742037|529037080|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
146688586|NCT03742037|529037081|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
146688587|NCT03742037|529037082|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
146688588|NCT03742037|529037083|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
146688589|NCT03742037|529037084|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
146688590|NCT03742037|529037078|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
146688591|NCT03742037|529037079|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
146688592|NCT03742037|529037080|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
146688593|NCT03742037|529037081|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
146688594|NCT03742037|529037082|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
146688595|NCT03742037|529037083|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
146688596|NCT03742037|529037084|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
146688597|NCT03742037|529037078|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
146775105|NCT04540913|529348029|FG001|Overall Study|Withdrawal by Subject|3|||
146928497|NCT02883049|529896059|FG004|Post Induction|MRD negative|0|||
146928498|NCT02883049|529896060|FG005|Post Induction|MRD negative|0|||
146928499|NCT02883049|529896061|FG006|Post Induction|MRD negative|0|||
146928500|NCT02883049|529896062|FG007|Post Induction|MRD negative|11|||
146979314|NCT02544633|530087045|FG002|Treatment Period|Lack of Efficacy|5|||
146979315|NCT02544633|530087046|FG003|Treatment Period|Lack of Efficacy|5|||
146979316|NCT02544633|530087043|FG000|Treatment Period|Global Deterioration of Health|3|||
146979317|NCT02544633|530087044|FG001|Treatment Period|Global Deterioration of Health|3|||
146688598|NCT03742037|529037079|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
146688599|NCT03742037|529037080|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
146688600|NCT03742037|529037081|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
146688601|NCT03742037|529037082|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
146688602|NCT03742037|529037083|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
146688603|NCT03742037|529037084|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
146688604|NCT03742037|529037078|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
146688605|NCT03742037|529037079|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
146688606|NCT03742037|529037080|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
146688607|NCT03742037|529037081|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
146688608|NCT03742037|529037082|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
146688609|NCT03742037|529037083|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
146688610|NCT03742037|529037084|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
146688611|NCT03742037|529037078|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
146688612|NCT03742037|529037079|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
146688613|NCT03742037|529037080|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
146688614|NCT03742037|529037081|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
146688615|NCT03742037|529037082|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
146688616|NCT03742037|529037083|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
146688617|NCT03742037|529037084|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
146688618|NCT03742037|529037078|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
146688619|NCT03742037|529037079|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
146928501|NCT02883049|529896063|FG008|Post Induction|MRD negative|0|||
146928502|NCT02883049|529896064|FG009|Post Induction|MRD negative|0|||
146928503|NCT02883049|529896065|FG010|Post Induction|MRD negative|0|||
146928504|NCT02883049|529896066|FG011|Post Induction|MRD negative|0|||
146928505|NCT02883049|529896067|FG012|Post Induction|MRD negative|0|||
146928506|NCT02883049|529896068|FG013|Post Induction|MRD negative|0|||
146928507|NCT02883049|529896069|FG014|Post Induction|MRD negative|0|||
146928508|NCT02883049|529896070|FG015|Post Induction|MRD negative|0|||
146928509|NCT02883049|529896055|FG000|Post Induction|Developed SMN|0|||
146928510|NCT02883049|529896056|FG001|Post Induction|Developed SMN|0|||
146928511|NCT02883049|529896057|FG002|Post Induction|Developed SMN|0|||
146928512|NCT02883049|529896058|FG003|Post Induction|Developed SMN|0|||
146928513|NCT02883049|529896059|FG004|Post Induction|Developed SMN|1|||
146928514|NCT02883049|529896060|FG005|Post Induction|Developed SMN|0|||
146928515|NCT02883049|529896061|FG006|Post Induction|Developed SMN|1|||
146928516|NCT02883049|529896062|FG007|Post Induction|Developed SMN|0|||
146928517|NCT02883049|529896063|FG008|Post Induction|Developed SMN|0|||
146928518|NCT02883049|529896064|FG009|Post Induction|Developed SMN|0|||
146928519|NCT02883049|529896065|FG010|Post Induction|Developed SMN|1|||
146928520|NCT02883049|529896066|FG011|Post Induction|Developed SMN|1|||
146928521|NCT02883049|529896067|FG012|Post Induction|Developed SMN|0|||
146928522|NCT02883049|529896068|FG013|Post Induction|Developed SMN|0|||
146928523|NCT02883049|529896069|FG014|Post Induction|Developed SMN|1|||
146928524|NCT02883049|529896070|FG015|Post Induction|Developed SMN|0|||
146928525|NCT02883049|529896055|FG000|Post Induction|Enrolled onto another COG study|0|||
146928526|NCT02883049|529896056|FG001|Post Induction|Enrolled onto another COG study|0|||
146928527|NCT02883049|529896057|FG002|Post Induction|Enrolled onto another COG study|0|||
146928528|NCT02883049|529896058|FG003|Post Induction|Enrolled onto another COG study|1|||
146928529|NCT02883049|529896059|FG004|Post Induction|Enrolled onto another COG study|1|||
146928530|NCT02883049|529896060|FG005|Post Induction|Enrolled onto another COG study|0|||
146928531|NCT02883049|529896061|FG006|Post Induction|Enrolled onto another COG study|0|||
146928532|NCT02883049|529896062|FG007|Post Induction|Enrolled onto another COG study|4|||
146928533|NCT02883049|529896063|FG008|Post Induction|Enrolled onto another COG study|0|||
146928534|NCT02883049|529896064|FG009|Post Induction|Enrolled onto another COG study|0|||
146928535|NCT02883049|529896065|FG010|Post Induction|Enrolled onto another COG study|0|||
146928536|NCT02883049|529896066|FG011|Post Induction|Enrolled onto another COG study|2|||
146928537|NCT02883049|529896067|FG012|Post Induction|Enrolled onto another COG study|0|||
146928538|NCT02883049|529896068|FG013|Post Induction|Enrolled onto another COG study|1|||
146928539|NCT02883049|529896069|FG014|Post Induction|Enrolled onto another COG study|0|||
146928540|NCT02883049|529896070|FG015|Post Induction|Enrolled onto another COG study|0|||
146928541|NCT02883049|529896055|FG000|Post Induction|Recurrent leukemia|0|||
146928542|NCT02883049|529896056|FG001|Post Induction|Recurrent leukemia|0|||
146928543|NCT02883049|529896057|FG002|Post Induction|Recurrent leukemia|0|||
146928544|NCT02883049|529896058|FG003|Post Induction|Recurrent leukemia|17|||
146928545|NCT02883049|529896059|FG004|Post Induction|Recurrent leukemia|12|||
146928546|NCT02883049|529896060|FG005|Post Induction|Recurrent leukemia|4|||
146928547|NCT02883049|529896061|FG006|Post Induction|Recurrent leukemia|1|||
146928548|NCT02883049|529896062|FG007|Post Induction|Recurrent leukemia|13|||
146928549|NCT02883049|529896063|FG008|Post Induction|Recurrent leukemia|27|||
146928550|NCT02883049|529896064|FG009|Post Induction|Recurrent leukemia|5|||
146928551|NCT02883049|529896065|FG010|Post Induction|Recurrent leukemia|3|||
146928552|NCT02883049|529896066|FG011|Post Induction|Recurrent leukemia|12|||
146928553|NCT02883049|529896067|FG012|Post Induction|Recurrent leukemia|1|||
146928554|NCT02883049|529896068|FG013|Post Induction|Recurrent leukemia|1|||
146928555|NCT02883049|529896069|FG014|Post Induction|Recurrent leukemia|9|||
146928556|NCT02883049|529896070|FG015|Post Induction|Recurrent leukemia|3|||
146928557|NCT02883049|529896055|FG000|Post Induction|Induction Failure|0|||
146928558|NCT02883049|529896056|FG001|Post Induction|Induction Failure|0|||
146928559|NCT02883049|529896057|FG002|Post Induction|Induction Failure|0|||
146928560|NCT02883049|529896058|FG003|Post Induction|Induction Failure|0|||
146928561|NCT02883049|529896059|FG004|Post Induction|Induction Failure|0|||
146928562|NCT02883049|529896060|FG005|Post Induction|Induction Failure|0|||
146928563|NCT02883049|529896061|FG006|Post Induction|Induction Failure|0|||
146928564|NCT02883049|529896062|FG007|Post Induction|Induction Failure|2|||
146928565|NCT02883049|529896063|FG008|Post Induction|Induction Failure|2|||
146928566|NCT02883049|529896064|FG009|Post Induction|Induction Failure|0|||
146928567|NCT02883049|529896065|FG010|Post Induction|Induction Failure|0|||
146928568|NCT02883049|529896066|FG011|Post Induction|Induction Failure|0|||
146928569|NCT02883049|529896067|FG012|Post Induction|Induction Failure|0|||
146928570|NCT02883049|529896068|FG013|Post Induction|Induction Failure|2|||
146928571|NCT02883049|529896069|FG014|Post Induction|Induction Failure|0|||
146928572|NCT02883049|529896070|FG015|Post Induction|Induction Failure|0|||
146928573|NCT06245044|529896077|FG000|No MI help|Technical issues|18|||
146928574|NCT00118482|529896082|FG000|Overall Study|Lost to Follow-up|7|||
146928575|NCT00118482|529896083|FG001|Overall Study|Lost to Follow-up|7|||
146928576|NCT00118482|529896082|FG000|Overall Study|Withdrawal by Subject|23|||
146928577|NCT00118482|529896083|FG001|Overall Study|Withdrawal by Subject|22|||
146928578|NCT00125190|529896084|FG000|Overall Study|Subject/Parent Decision|7|||
146928579|NCT00125190|529896084|FG000|Overall Study|Non-compliance|2|||
146928580|NCT00125190|529896084|FG000|Overall Study|Adverse Event|1|||
146928581|NCT00125190|529896084|FG000|Overall Study|Other|1|||
146928582|NCT00125190|529896084|FG000|Overall Study|Lost to Follow-up|4|||
146928583|NCT03259490|529896089|FG000|Period 1|Withdrawal by Subject|0|||
146928584|NCT03259490|529896090|FG001|Period 1|Withdrawal by Subject|1|||
146928585|NCT03259490|529896089|FG000|Period 2|Protocol Violation|1|||
146928586|NCT03259490|529896090|FG001|Period 2|Protocol Violation|0|||
146928587|NCT00255086|529896091|FG000|Overall Study|Adverse Event|1|||
146928588|NCT00255086|529896092|FG001|Overall Study|Adverse Event|1|||
146928589|NCT00255086|529896091|FG000|Overall Study|Protocol Violation|1|||
146928590|NCT00255086|529896092|FG001|Overall Study|Protocol Violation|1|||
146928591|NCT00434122|529896093|FG000|Overall Study|Non-compliance with protocol|0|||
146928592|NCT00434122|529896094|FG001|Overall Study|Non-compliance with protocol|1|||
146928593|NCT00434122|529896093|FG000|Overall Study|loss of subject contact|1|||
146928594|NCT00434122|529896094|FG001|Overall Study|loss of subject contact|1|||
146928595|NCT00434122|529896093|FG000|Overall Study|Personal reasons|1|||
146928596|NCT00434122|529896094|FG001|Overall Study|Personal reasons|1|||
146928597|NCT00434122|529896093|FG000|Overall Study|Large follicle size|2|||
146928598|NCT00434122|529896094|FG001|Overall Study|Large follicle size|2|||
146928599|NCT00434122|529896093|FG000|Overall Study|Low follicular response.|1|||
146928600|NCT00434122|529896094|FG001|Overall Study|Low follicular response.|2|||
146928601|NCT00434122|529896093|FG000|Overall Study|Travelling of subject.|1|||
146928602|NCT00434122|529896094|FG001|Overall Study|Travelling of subject.|0|||
146979318|NCT02544633|530087045|FG002|Treatment Period|Global Deterioration of Health|0|||
146979319|NCT02544633|530087046|FG003|Treatment Period|Global Deterioration of Health|1|||
146928603|NCT01963208|529896096|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
146928604|NCT01963208|529896097|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
146928605|NCT01963208|529896098|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
146928606|NCT01963208|529896099|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
146928607|NCT01963208|529896100|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
146928608|NCT01963208|529896101|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
146928609|NCT01963208|529896096|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
146928610|NCT01963208|529896097|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
146928611|NCT01963208|529896098|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
146928612|NCT01963208|529896099|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
146928613|NCT01963208|529896100|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
146979320|NCT02544633|530087043|FG000|Treatment Period|Withdrawal by Subject|1|||
146928614|NCT01963208|529896101|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
146928615|NCT01963208|529896096|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
146928616|NCT01963208|529896097|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
146928617|NCT01963208|529896098|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
146928618|NCT01963208|529896099|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
146928619|NCT01963208|529896100|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
146928620|NCT01963208|529896101|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
146928621|NCT01963208|529896096|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
146928622|NCT01963208|529896097|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
146979321|NCT02544633|530087044|FG001|Treatment Period|Withdrawal by Subject|0|||
146688620|NCT03742037|529037080|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
146688621|NCT03742037|529037081|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
146688622|NCT03742037|529037082|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
146688623|NCT03742037|529037083|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
146688624|NCT03742037|529037084|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
146688625|NCT03742037|529037078|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
146688626|NCT03742037|529037079|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
146688627|NCT03742037|529037080|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
146688628|NCT03742037|529037081|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
146688629|NCT03742037|529037082|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
146688630|NCT03742037|529037083|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
146688631|NCT03742037|529037084|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
146688632|NCT03742037|529037078|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
146688633|NCT03742037|529037079|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
146688634|NCT03742037|529037080|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
146688635|NCT03742037|529037081|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
146688636|NCT03742037|529037082|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
146688637|NCT03742037|529037083|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
146688638|NCT03742037|529037084|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
146688639|NCT03742037|529037078|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
146688640|NCT03742037|529037079|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
146688641|NCT03742037|529037080|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
146688642|NCT03742037|529037081|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
146688643|NCT03742037|529037082|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
146688644|NCT03742037|529037083|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
146688645|NCT03742037|529037084|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
146688646|NCT03742037|529037078|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
146688647|NCT03742037|529037079|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
146688648|NCT03742037|529037080|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
146688649|NCT03742037|529037081|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
146688650|NCT03742037|529037082|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
146688651|NCT03742037|529037083|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
146688652|NCT03742037|529037084|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
146688653|NCT03742037|529037078|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
146688654|NCT03742037|529037079|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
146688655|NCT03742037|529037080|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
146979322|NCT02544633|530087045|FG002|Treatment Period|Withdrawal by Subject|0|||
146979323|NCT02544633|530087046|FG003|Treatment Period|Withdrawal by Subject|0|||
146979324|NCT02544633|530087043|FG000|Treatment Period|Lost to Follow-up|0|||
146979325|NCT02544633|530087044|FG001|Treatment Period|Lost to Follow-up|1|||
146979326|NCT02544633|530087045|FG002|Treatment Period|Lost to Follow-up|0|||
146979327|NCT02544633|530087046|FG003|Treatment Period|Lost to Follow-up|0|||
146688656|NCT03742037|529037081|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
146688657|NCT03742037|529037082|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
146688658|NCT03742037|529037083|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
146688659|NCT03742037|529037084|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
146688660|NCT03742037|529037078|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
146688661|NCT03742037|529037079|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
146688662|NCT03742037|529037080|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
146688663|NCT03742037|529037081|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
146688664|NCT03742037|529037082|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
146688665|NCT03742037|529037083|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
146688666|NCT03742037|529037084|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
146688667|NCT04447755|529037085|FG000|Overall Study|Death|9|||
146688668|NCT04447755|529037086|FG001|Overall Study|Death|16|||
146688669|NCT04447755|529037087|FG002|Overall Study|Death|8|||
146688670|NCT04447755|529037088|FG003|Overall Study|Death|9|||
146688671|NCT04447755|529037089|FG004|Overall Study|Death|8|||
146688672|NCT04447755|529037090|FG005|Overall Study|Death|9|||
146688673|NCT04447755|529037091|FG006|Overall Study|Death|55|||
146688674|NCT04447755|529037085|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146688675|NCT04447755|529037086|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146775106|NCT00444600|529348030|FG000|Overall Study|Death|7|||
146979328|NCT02544633|530087043|FG000|Treatment Period|Death|0|||
146979329|NCT02544633|530087044|FG001|Treatment Period|Death|0|||
146979330|NCT02544633|530087045|FG002|Treatment Period|Death|1|||
146979331|NCT02544633|530087046|FG003|Treatment Period|Death|0|||
146979332|NCT02544633|530087043|FG000|Treatment Period|Non-compliance|0|||
146979333|NCT02544633|530087044|FG001|Treatment Period|Non-compliance|0|||
146979334|NCT02544633|530087045|FG002|Treatment Period|Non-compliance|1|||
146979335|NCT02544633|530087046|FG003|Treatment Period|Non-compliance|0|||
146979336|NCT02544633|530087043|FG000|Treatment Period|Clinical Disease Progression|0|||
146979337|NCT02544633|530087044|FG001|Treatment Period|Clinical Disease Progression|0|||
146979338|NCT02544633|530087045|FG002|Treatment Period|Clinical Disease Progression|0|||
146979339|NCT02544633|530087046|FG003|Treatment Period|Clinical Disease Progression|1|||
146979340|NCT02544633|530087043|FG000|Survival Follow-up Period|Death|12|||
146979341|NCT02544633|530087044|FG001|Survival Follow-up Period|Death|14|||
146979342|NCT02544633|530087045|FG002|Survival Follow-up Period|Death|3|||
146979343|NCT02544633|530087046|FG003|Survival Follow-up Period|Death|9|||
146979344|NCT02544633|530087043|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
146979345|NCT02544633|530087044|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
146979346|NCT02544633|530087045|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
146979347|NCT02544633|530087046|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
146979348|NCT02544633|530087043|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
146979349|NCT02544633|530087044|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
146979350|NCT02544633|530087045|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
146979351|NCT02544633|530087046|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
146979352|NCT02544633|530087043|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
146979353|NCT02544633|530087044|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
146979354|NCT02544633|530087045|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
146979355|NCT02544633|530087046|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
146979356|NCT02092961|530087047|FG000|Overall Study|Not reported|1|||
146688676|NCT04447755|529037087|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146688677|NCT04447755|529037088|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146688678|NCT04447755|529037089|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
146688679|NCT04447755|529037090|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
146688680|NCT04447755|529037091|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
146688681|NCT04447755|529037085|FG000|Overall Study|Sponsor Decision|0|||
146688682|NCT04447755|529037086|FG001|Overall Study|Sponsor Decision|0|||
146688683|NCT04447755|529037087|FG002|Overall Study|Sponsor Decision|0|||
146688684|NCT04447755|529037088|FG003|Overall Study|Sponsor Decision|0|||
146688685|NCT04447755|529037089|FG004|Overall Study|Sponsor Decision|1|||
146688686|NCT04447755|529037090|FG005|Overall Study|Sponsor Decision|0|||
146688687|NCT04447755|529037091|FG006|Overall Study|Sponsor Decision|10|||
146688688|NCT04447755|529037085|FG000|Overall Study|Lost to Follow-up|0|||
146688689|NCT04447755|529037086|FG001|Overall Study|Lost to Follow-up|0|||
146688690|NCT04447755|529037087|FG002|Overall Study|Lost to Follow-up|0|||
146688691|NCT04447755|529037088|FG003|Overall Study|Lost to Follow-up|0|||
146688692|NCT04447755|529037089|FG004|Overall Study|Lost to Follow-up|0|||
146688693|NCT04447755|529037090|FG005|Overall Study|Lost to Follow-up|0|||
146688694|NCT04447755|529037091|FG006|Overall Study|Lost to Follow-up|1|||
146688695|NCT03855280|529037101|FG000|Treatment Phase|Adverse Event|1|||
146688696|NCT03855280|529037101|FG000|Treatment Phase|Withdrawal by Subject|1|||
146688697|NCT03855280|529037101|FG000|Continuation Phase|Protocol Violation|1|||
146688698|NCT03855280|529037101|FG000|Continuation Phase|Adverse Event|1|||
146688699|NCT03855280|529037101|FG000|Continuation Phase|Sponsor Concluded Study|1|||
146688700|NCT00969150|529037102|FG000|Overall Study|Adverse Event|4|||
146688701|NCT00969150|529037103|FG001|Overall Study|Adverse Event|14|||
146688702|NCT00969150|529037102|FG000|Overall Study|Lack of Efficacy|1|||
146688703|NCT00969150|529037103|FG001|Overall Study|Lack of Efficacy|1|||
146688704|NCT00969150|529037102|FG000|Overall Study|Protocol Violation|9|||
146688705|NCT00969150|529037103|FG001|Overall Study|Protocol Violation|12|||
146688706|NCT00969150|529037102|FG000|Overall Study|Withdrawal by Subject|13|||
146688707|NCT00969150|529037103|FG001|Overall Study|Withdrawal by Subject|9|||
146688708|NCT00969150|529037102|FG000|Overall Study|Lost to Follow-up|5|||
146688709|NCT00969150|529037103|FG001|Overall Study|Lost to Follow-up|4|||
146688710|NCT00969150|529037102|FG000|Overall Study|Other reasons|1|||
146688711|NCT00969150|529037103|FG001|Overall Study|Other reasons|0|||
146688712|NCT00642941|529037109|FG000|Overall Study|Physician Decision|3|||
146688713|NCT00642941|529037110|FG001|Overall Study|Physician Decision|1|||
146688714|NCT00642941|529037111|FG002|Overall Study|Physician Decision|0|||
146688715|NCT00642941|529037112|FG003|Overall Study|Physician Decision|0|||
146688716|NCT00642941|529037113|FG004|Overall Study|Physician Decision|0|||
146688717|NCT00642941|529037114|FG005|Overall Study|Physician Decision|0|||
146688718|NCT00642941|529037115|FG006|Overall Study|Physician Decision|1|||
146688719|NCT00642941|529037116|FG007|Overall Study|Physician Decision|0|||
146979357|NCT02092961|530087048|FG001|Overall Study|Not reported|0|||
146979358|NCT02092961|530087049|FG002|Overall Study|Not reported|1|||
146979359|NCT02092961|530087047|FG000|Overall Study|Study stopped|13|||
146979360|NCT02092961|530087048|FG001|Overall Study|Study stopped|9|||
146979361|NCT02092961|530087049|FG002|Overall Study|Study stopped|12|||
146688720|NCT00642941|529037117|FG008|Overall Study|Physician Decision|0|||
146928623|NCT01963208|529896098|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
146928624|NCT01963208|529896099|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
146928625|NCT01963208|529896100|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
146928626|NCT01963208|529896101|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
146928627|NCT01963208|529896096|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
146928628|NCT01963208|529896097|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
146928629|NCT01963208|529896098|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
146928630|NCT01963208|529896099|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
146928631|NCT01963208|529896100|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
146928632|NCT01963208|529896101|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
146928633|NCT01963208|529896096|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
146928634|NCT01963208|529896097|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
146928635|NCT01963208|529896098|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
146688721|NCT00642941|529037118|FG009|Overall Study|Physician Decision|1|||
146688722|NCT00642941|529037119|FG010|Overall Study|Physician Decision|0|||
146688723|NCT00642941|529037120|FG011|Overall Study|Physician Decision|1|||
146688724|NCT00642941|529037109|FG000|Overall Study|Death|4|||
146688725|NCT00642941|529037110|FG001|Overall Study|Death|0|||
146688726|NCT00642941|529037111|FG002|Overall Study|Death|1|||
146688727|NCT00642941|529037112|FG003|Overall Study|Death|1|||
146688728|NCT00642941|529037113|FG004|Overall Study|Death|2|||
146688729|NCT00642941|529037114|FG005|Overall Study|Death|1|||
146688730|NCT00642941|529037115|FG006|Overall Study|Death|0|||
146688731|NCT00642941|529037116|FG007|Overall Study|Death|0|||
146688732|NCT00642941|529037117|FG008|Overall Study|Death|0|||
146688733|NCT00642941|529037118|FG009|Overall Study|Death|0|||
146688734|NCT00642941|529037119|FG010|Overall Study|Death|0|||
146688735|NCT00642941|529037120|FG011|Overall Study|Death|1|||
146688736|NCT00642941|529037109|FG000|Overall Study|Study closed by Sponsor|0|||
146688737|NCT00642941|529037110|FG001|Overall Study|Study closed by Sponsor|1|||
146688738|NCT00642941|529037111|FG002|Overall Study|Study closed by Sponsor|0|||
146688739|NCT00642941|529037112|FG003|Overall Study|Study closed by Sponsor|0|||
146688740|NCT00642941|529037113|FG004|Overall Study|Study closed by Sponsor|0|||
146688741|NCT00642941|529037114|FG005|Overall Study|Study closed by Sponsor|0|||
146688742|NCT00642941|529037115|FG006|Overall Study|Study closed by Sponsor|0|||
146688743|NCT00642941|529037116|FG007|Overall Study|Study closed by Sponsor|0|||
146688744|NCT00642941|529037117|FG008|Overall Study|Study closed by Sponsor|0|||
146688745|NCT00642941|529037118|FG009|Overall Study|Study closed by Sponsor|0|||
146688746|NCT00642941|529037119|FG010|Overall Study|Study closed by Sponsor|0|||
146688747|NCT00642941|529037120|FG011|Overall Study|Study closed by Sponsor|0|||
146688748|NCT00642941|529037109|FG000|Overall Study|Withdrawal by Subject|1|||
146688749|NCT00642941|529037110|FG001|Overall Study|Withdrawal by Subject|0|||
146688750|NCT00642941|529037111|FG002|Overall Study|Withdrawal by Subject|0|||
146688751|NCT00642941|529037112|FG003|Overall Study|Withdrawal by Subject|2|||
146688752|NCT00642941|529037113|FG004|Overall Study|Withdrawal by Subject|0|||
146688753|NCT00642941|529037114|FG005|Overall Study|Withdrawal by Subject|0|||
146688754|NCT00642941|529037115|FG006|Overall Study|Withdrawal by Subject|2|||
146688755|NCT00642941|529037116|FG007|Overall Study|Withdrawal by Subject|0|||
146688756|NCT00642941|529037117|FG008|Overall Study|Withdrawal by Subject|1|||
146688757|NCT00642941|529037118|FG009|Overall Study|Withdrawal by Subject|0|||
146688758|NCT00642941|529037119|FG010|Overall Study|Withdrawal by Subject|0|||
146688759|NCT00642941|529037120|FG011|Overall Study|Withdrawal by Subject|1|||
146688760|NCT00642941|529037109|FG000|Overall Study|Protocol Violation|0|||
146688761|NCT00642941|529037110|FG001|Overall Study|Protocol Violation|0|||
146688762|NCT00642941|529037111|FG002|Overall Study|Protocol Violation|0|||
146688763|NCT00642941|529037112|FG003|Overall Study|Protocol Violation|0|||
146688764|NCT00642941|529037113|FG004|Overall Study|Protocol Violation|0|||
146775107|NCT00444600|529348031|FG001|Overall Study|Death|5|||
146775108|NCT00444600|529348032|FG002|Overall Study|Death|3|||
146775109|NCT00444600|529348033|FG003|Overall Study|Death|2|||
146775110|NCT00444600|529348030|FG000|Overall Study|Dropped|11|||
146928636|NCT01963208|529896099|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
146928637|NCT01963208|529896100|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
146688765|NCT00642941|529037114|FG005|Overall Study|Protocol Violation|0|||
146688766|NCT00642941|529037115|FG006|Overall Study|Protocol Violation|1|||
146688767|NCT00642941|529037116|FG007|Overall Study|Protocol Violation|0|||
146688768|NCT00642941|529037117|FG008|Overall Study|Protocol Violation|0|||
146688769|NCT00642941|529037118|FG009|Overall Study|Protocol Violation|0|||
146688770|NCT00642941|529037119|FG010|Overall Study|Protocol Violation|0|||
146688771|NCT00642941|529037120|FG011|Overall Study|Protocol Violation|0|||
146688772|NCT00642941|529037109|FG000|Overall Study|Adverse Event|1|||
146688773|NCT00642941|529037110|FG001|Overall Study|Adverse Event|1|||
146688774|NCT00642941|529037111|FG002|Overall Study|Adverse Event|0|||
146688775|NCT00642941|529037112|FG003|Overall Study|Adverse Event|0|||
146688776|NCT00642941|529037113|FG004|Overall Study|Adverse Event|0|||
146775111|NCT00444600|529348031|FG001|Overall Study|Dropped|11|||
146688777|NCT00642941|529037114|FG005|Overall Study|Adverse Event|0|||
146688778|NCT00642941|529037115|FG006|Overall Study|Adverse Event|1|||
146688779|NCT00642941|529037116|FG007|Overall Study|Adverse Event|1|||
146688780|NCT00642941|529037117|FG008|Overall Study|Adverse Event|0|||
146688781|NCT00642941|529037118|FG009|Overall Study|Adverse Event|1|||
146688782|NCT00642941|529037119|FG010|Overall Study|Adverse Event|0|||
146688783|NCT00642941|529037120|FG011|Overall Study|Adverse Event|0|||
146688784|NCT00642941|529037109|FG000|Overall Study|Other|1|||
146688785|NCT00642941|529037110|FG001|Overall Study|Other|1|||
146688786|NCT00642941|529037111|FG002|Overall Study|Other|1|||
146928638|NCT01963208|529896101|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
146928639|NCT01963208|529896096|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
146928640|NCT01963208|529896097|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
146928641|NCT01963208|529896098|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
146928642|NCT01963208|529896099|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
146928643|NCT01963208|529896100|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
146928644|NCT01963208|529896101|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
146928645|NCT01963208|529896096|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
146928646|NCT01963208|529896097|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
146928647|NCT01963208|529896098|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
146928648|NCT01963208|529896099|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
146928649|NCT01963208|529896100|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
146928650|NCT01963208|529896101|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
146928651|NCT01963208|529896096|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
146928652|NCT01963208|529896097|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
146928653|NCT01963208|529896098|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
146928654|NCT01963208|529896099|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
146928655|NCT01963208|529896100|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
146928656|NCT01963208|529896101|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
146928657|NCT01963208|529896096|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
146928658|NCT01963208|529896097|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
146928659|NCT01963208|529896098|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
146928660|NCT01963208|529896099|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
146928661|NCT01963208|529896100|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
146928662|NCT01963208|529896101|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
146928663|NCT01963208|529896096|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
146928664|NCT01963208|529896097|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
146928665|NCT01963208|529896098|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
146928666|NCT01963208|529896099|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
146928667|NCT01963208|529896100|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
146928668|NCT01963208|529896101|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
146928669|NCT01963208|529896096|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
146928670|NCT01963208|529896097|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
146928671|NCT01963208|529896098|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
146928672|NCT01963208|529896099|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
146928673|NCT01963208|529896100|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
146928674|NCT01963208|529896101|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
146928675|NCT01963208|529896096|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
146928676|NCT01963208|529896097|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
146928677|NCT01963208|529896098|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
146928678|NCT01963208|529896099|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
146928679|NCT01963208|529896100|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
146928680|NCT01963208|529896101|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
146928681|NCT01963208|529896096|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
146928682|NCT01963208|529896097|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
146928683|NCT01963208|529896098|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
146928684|NCT01963208|529896099|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
146928685|NCT01963208|529896100|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
146928686|NCT01963208|529896101|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
146928687|NCT01842607|529896102|FG000|Overall Study|Adverse Event|11|||
146928688|NCT01842607|529896102|FG000|Overall Study|Lack of Efficacy|19|||
146928689|NCT01842607|529896102|FG000|Overall Study|Protocol Violation|8|||
146928690|NCT01842607|529896102|FG000|Overall Study|Protocol defined stopping criteria|2|||
146928691|NCT01842607|529896102|FG000|Overall Study|Lost to Follow-up|3|||
146928692|NCT01842607|529896102|FG000|Overall Study|Physician Decision|9|||
146928693|NCT01842607|529896102|FG000|Overall Study|Withdrawal by Subject|14|||
146928694|NCT00012012|529896103|FG000|Overall Study|Protocol Violation|1|||
146928695|NCT00012012|529896104|FG001|Overall Study|Protocol Violation|1|||
146979362|NCT02092961|530087047|FG000|Overall Study|Lack of therapeutic response|2|||
146688787|NCT00642941|529037112|FG003|Overall Study|Other|1|||
146688788|NCT00642941|529037113|FG004|Overall Study|Other|0|||
146688789|NCT00642941|529037114|FG005|Overall Study|Other|1|||
146979363|NCT02092961|530087048|FG001|Overall Study|Lack of therapeutic response|1|||
146979364|NCT02092961|530087049|FG002|Overall Study|Lack of therapeutic response|3|||
146979365|NCT02092961|530087047|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
146688790|NCT00642941|529037115|FG006|Overall Study|Other|0|||
146688791|NCT00642941|529037116|FG007|Overall Study|Other|1|||
146979366|NCT02092961|530087048|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
146979367|NCT02092961|530087049|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
146979368|NCT02092961|530087047|FG000|Overall Study|Adverse Event|2|||
146979369|NCT02092961|530087048|FG001|Overall Study|Adverse Event|4|||
146979370|NCT02092961|530087049|FG002|Overall Study|Adverse Event|0|||
146979371|NCT02270983|530087050|FG000|Overall Study|Adverse Event|3|||
146979372|NCT02270983|530087051|FG001|Overall Study|Adverse Event|2|||
146979373|NCT02270983|530087052|FG002|Overall Study|Adverse Event|6|||
146979374|NCT02270983|530087050|FG000|Overall Study|Lack of Efficacy|2|||
146979375|NCT02270983|530087051|FG001|Overall Study|Lack of Efficacy|1|||
146979376|NCT02270983|530087052|FG002|Overall Study|Lack of Efficacy|1|||
146979377|NCT02270983|530087050|FG000|Overall Study|Withdrawal by Subject|1|||
146979378|NCT02270983|530087051|FG001|Overall Study|Withdrawal by Subject|0|||
146979379|NCT02270983|530087052|FG002|Overall Study|Withdrawal by Subject|2|||
146979380|NCT02270983|530087050|FG000|Overall Study|Lost to Follow-up|1|||
146979381|NCT02270983|530087051|FG001|Overall Study|Lost to Follow-up|1|||
146979382|NCT02270983|530087052|FG002|Overall Study|Lost to Follow-up|2|||
146979383|NCT02270983|530087050|FG000|Overall Study|Protocol Violation|1|||
146979384|NCT02270983|530087051|FG001|Overall Study|Protocol Violation|1|||
146979385|NCT02270983|530087052|FG002|Overall Study|Protocol Violation|1|||
146979386|NCT02270983|530087050|FG000|Overall Study|family emergency|0|||
146979387|NCT02270983|530087051|FG001|Overall Study|family emergency|1|||
146979388|NCT02270983|530087052|FG002|Overall Study|family emergency|0|||
146979389|NCT02270983|530087050|FG000|Overall Study|study procedure non-compliance|1|||
146979390|NCT02270983|530087051|FG001|Overall Study|study procedure non-compliance|0|||
146979391|NCT02270983|530087052|FG002|Overall Study|study procedure non-compliance|0|||
146979392|NCT02270983|530087050|FG000|Overall Study|moved away from study site|0|||
146979393|NCT02270983|530087051|FG001|Overall Study|moved away from study site|1|||
146979394|NCT02270983|530087052|FG002|Overall Study|moved away from study site|0|||
146979395|NCT01623830|530087055|FG000|Overall Study|Withdrawal by Subject|6|||
146979396|NCT01623830|530087056|FG001|Overall Study|Withdrawal by Subject|7|||
146979397|NCT01623830|530087055|FG000|Overall Study|Exclusion from Study|1|||
146979398|NCT01623830|530087056|FG001|Overall Study|Exclusion from Study|2|||
146979399|NCT00928252|530087057|FG000|Overall Study|Physician Decision|3|||
146979400|NCT01605461|530087058|FG000|Overall Study|Lost to Follow-up|3|||
146979401|NCT01605461|530087058|FG000|Overall Study|Withdrawal by Subject|1|||
146979402|NCT02024698|530087059|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
146979403|NCT02024698|530087060|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
146979404|NCT04313283|530087061|FG000|Overall Study|did not complete intervention|4|||
146979405|NCT04132232|530087063|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
146979406|NCT04132232|530087064|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
146979407|NCT04132232|530087063|FG000|Overall Study|Lost to Follow-up|6|||
146979408|NCT04132232|530087064|FG001|Overall Study|Lost to Follow-up|7|||
146979409|NCT00368537|530087066|FG000|Randomization|No study drug dosed|13|||
146979410|NCT00368537|530087067|FG001|Randomization|No study drug dosed|6|||
146979411|NCT00368537|530087066|FG000|Baseline Participants|Lost to Follow-up|16|||
146979412|NCT00368537|530087067|FG001|Baseline Participants|Lost to Follow-up|17|||
146688792|NCT00642941|529037117|FG008|Overall Study|Other|0|||
146688793|NCT00642941|529037118|FG009|Overall Study|Other|0|||
146688794|NCT00642941|529037119|FG010|Overall Study|Other|0|||
146688795|NCT00642941|529037120|FG011|Overall Study|Other|1|||
146688796|NCT00642941|529037109|FG000|Overall Study|Disease progression|60|||
146688797|NCT00642941|529037110|FG001|Overall Study|Disease progression|50|||
146979413|NCT00368537|530087066|FG000|Baseline Participants|Withdrawal by Subject|6|||
146979414|NCT00368537|530087067|FG001|Baseline Participants|Withdrawal by Subject|4|||
146979415|NCT00368537|530087066|FG000|Baseline Participants|Death|1|||
146979416|NCT00368537|530087067|FG001|Baseline Participants|Death|2|||
146979417|NCT00368537|530087066|FG000|Baseline Participants|No susceptibility|1|||
146688798|NCT00642941|529037111|FG002|Overall Study|Disease progression|5|||
146688799|NCT00642941|529037112|FG003|Overall Study|Disease progression|36|||
146688800|NCT00642941|529037113|FG004|Overall Study|Disease progression|23|||
146688801|NCT00642941|529037114|FG005|Overall Study|Disease progression|39|||
146688802|NCT00642941|529037115|FG006|Overall Study|Disease progression|18|||
146688803|NCT00642941|529037116|FG007|Overall Study|Disease progression|12|||
146979418|NCT00368537|530087067|FG001|Baseline Participants|No susceptibility|0|||
146979419|NCT00368537|530087066|FG000|Baseline Participants|Patient uncompliant|0|||
146979420|NCT00368537|530087067|FG001|Baseline Participants|Patient uncompliant|1|||
146979421|NCT02732561|530087087|FG000|Overall Study|Lost to Follow-up|1|||
146979422|NCT02732561|530087088|FG001|Overall Study|Lost to Follow-up|1|||
146979423|NCT02732561|530087087|FG000|Overall Study|Withdrawal by Subject|1|||
146979424|NCT02732561|530087088|FG001|Overall Study|Withdrawal by Subject|0|||
146979425|NCT01886300|530087089|FG000|Overall Study|Trial terminated by sponsor|16|||
146688804|NCT00642941|529037117|FG008|Overall Study|Disease progression|10|||
146688805|NCT00642941|529037118|FG009|Overall Study|Disease progression|7|||
146688806|NCT00642941|529037119|FG010|Overall Study|Disease progression|12|||
146688807|NCT00642941|529037120|FG011|Overall Study|Disease progression|7|||
146688808|NCT00202644|529038563|FG000|Overall Study|Adverse Event|12|||
146688809|NCT00202644|529038564|FG001|Overall Study|Adverse Event|13|||
146688810|NCT00202644|529038563|FG000|Overall Study|Withdrawal by Subject|8|||
146688811|NCT00202644|529038564|FG001|Overall Study|Withdrawal by Subject|6|||
146688812|NCT00202644|529038563|FG000|Overall Study|Lack of Efficacy|6|||
146688813|NCT00202644|529038564|FG001|Overall Study|Lack of Efficacy|6|||
146688814|NCT00202644|529038563|FG000|Overall Study|Lost to Follow-up|0|||
146688815|NCT00202644|529038564|FG001|Overall Study|Lost to Follow-up|1|||
146688816|NCT00202644|529038563|FG000|Overall Study|Other|9|||
146688817|NCT00202644|529038564|FG001|Overall Study|Other|1|||
146688818|NCT02750592|529038565|FG000|Overall Study|Adverse Event|3|||
146688819|NCT02750592|529038565|FG000|Overall Study|Lack of Efficacy|2|||
146688820|NCT02981342|529038568|FG000|Overall Study|Adverse Event|0|||
146688821|NCT02981342|529038569|FG001|Overall Study|Adverse Event|0|||
146688822|NCT02981342|529038570|FG002|Overall Study|Adverse Event|0|||
146688823|NCT02981342|529038571|FG003|Overall Study|Adverse Event|1|||
146688824|NCT02981342|529038568|FG000|Overall Study|Death|0|||
146688825|NCT02981342|529038569|FG001|Overall Study|Death|9|||
146688826|NCT02981342|529038570|FG002|Overall Study|Death|9|||
146688827|NCT02981342|529038571|FG003|Overall Study|Death|4|||
146688828|NCT02981342|529038568|FG000|Overall Study|Withdrawal by Subject|0|||
146688829|NCT02981342|529038569|FG001|Overall Study|Withdrawal by Subject|0|||
146688830|NCT02981342|529038570|FG002|Overall Study|Withdrawal by Subject|3|||
146688831|NCT02981342|529038571|FG003|Overall Study|Withdrawal by Subject|1|||
146688832|NCT02981342|529038568|FG000|Overall Study|Study closed by sponsor|0|||
146688833|NCT02981342|529038569|FG001|Overall Study|Study closed by sponsor|0|||
146688834|NCT02981342|529038570|FG002|Overall Study|Study closed by sponsor|1|||
146688835|NCT02981342|529038571|FG003|Overall Study|Study closed by sponsor|1|||
146688836|NCT02981342|529038568|FG000|Overall Study|Randomized, Never Treated|0|||
146688837|NCT02981342|529038569|FG001|Overall Study|Randomized, Never Treated|1|||
146688838|NCT02981342|529038570|FG002|Overall Study|Randomized, Never Treated|0|||
146688839|NCT02981342|529038571|FG003|Overall Study|Randomized, Never Treated|7|||
146688840|NCT02981342|529038568|FG000|Overall Study|Lost to Follow-up|0|||
146688841|NCT02981342|529038569|FG001|Overall Study|Lost to Follow-up|1|||
146688842|NCT02981342|529038570|FG002|Overall Study|Lost to Follow-up|0|||
146928696|NCT00012012|529896103|FG000|Overall Study|Withdrawal by Subject|0|||
146928697|NCT00012012|529896104|FG001|Overall Study|Withdrawal by Subject|2|||
146928698|NCT02159469|529896105|FG000|Overall Study|Missing Completion status|1|||
146928699|NCT02159469|529896105|FG000|Overall Study|Adverse Event|5|||
146928700|NCT02159469|529896105|FG000|Overall Study|Non-compliance|2|||
146928701|NCT02159469|529896105|FG000|Overall Study|Withdrawal by Subject|9|||
146928702|NCT02159469|529896105|FG000|Overall Study|Lost to Follow-up|1|||
146928703|NCT02159469|529896105|FG000|Overall Study|Sponsor's request|2|||
146928704|NCT02159469|529896105|FG000|Overall Study|Met Stopping Criteria|3|||
146928705|NCT02159469|529896105|FG000|Overall Study|Other|1|||
146928706|NCT02159469|529896105|FG000|Overall Study|Multiple|29|||
146928707|NCT02034474|529896106|FG000|Overall Study|Adverse Event|3|||
146928708|NCT02034474|529896107|FG001|Overall Study|Adverse Event|2|||
146928709|NCT02034474|529896106|FG000|Overall Study|Withdrawal by Subject|1|||
146928710|NCT02034474|529896107|FG001|Overall Study|Withdrawal by Subject|2|||
146928711|NCT01391819|529896113|FG000|Overall Study|Withdrawal by Subject|56|||
146928712|NCT01391819|529896113|FG000|Overall Study|Migrated/moved from study area|82|||
146928713|NCT01391819|529896113|FG000|Overall Study|Lost to Follow-up|252|||
146928714|NCT01391819|529896113|FG000|Overall Study|Death|3|||
146688843|NCT02981342|529038571|FG003|Overall Study|Lost to Follow-up|0|||
146688844|NCT01132482|529038572|FG000|Overall Study|Adverse Event|1|||
146928715|NCT01391819|529896113|FG000|Overall Study|Other|9|||
146928716|NCT03629041|529896114|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
146928717|NCT03629041|529896115|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
146928718|NCT03629041|529896116|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
146688845|NCT01132482|529038573|FG001|Overall Study|Adverse Event|0|||
146688846|NCT01394523|529038574|FG000|Overall Study|Unable to place block|1|||
146688847|NCT01394523|529038575|FG001|Overall Study|Unable to place block|0|||
146979426|NCT01797120|530087092|FG000|Overall Study|Disesae progression|37|||
146688848|NCT01394523|529038576|FG002|Overall Study|Unable to place block|0|||
146688849|NCT00469092|529038577|FG000|Overall Study|Adverse Event|5|||
146688850|NCT00469092|529038578|FG001|Overall Study|Adverse Event|4|||
146688851|NCT00469092|529038577|FG000|Overall Study|Lack of Efficacy|1|||
146688852|NCT00469092|529038578|FG001|Overall Study|Lack of Efficacy|0|||
146688853|NCT00469092|529038577|FG000|Overall Study|Lost to Follow-up|1|||
146688854|NCT00469092|529038578|FG001|Overall Study|Lost to Follow-up|2|||
146688855|NCT00469092|529038577|FG000|Overall Study|Protocol Violation|3|||
146688856|NCT00469092|529038578|FG001|Overall Study|Protocol Violation|3|||
146928719|NCT03629041|529896117|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
146979427|NCT01797120|530087093|FG001|Overall Study|Disesae progression|49|||
146928720|NCT01927419|529896119|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
146928721|NCT01927419|529896120|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
146928722|NCT01927419|529896119|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
146928723|NCT01927419|529896120|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
146928724|NCT01927419|529896119|FG000|Treatment Period|Disease progression|17|||
146928725|NCT01927419|529896120|FG001|Treatment Period|Disease progression|20|||
146928726|NCT01927419|529896119|FG000|Treatment Period|Study drug toxicity|48|||
146928727|NCT01927419|529896120|FG001|Treatment Period|Study drug toxicity|10|||
146928728|NCT01927419|529896119|FG000|Treatment Period|Death|0|||
146928729|NCT01927419|529896120|FG001|Treatment Period|Death|1|||
146928730|NCT01927419|529896119|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
146928731|NCT01927419|529896120|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
146928732|NCT01927419|529896119|FG000|Treatment Period|Participant request to discontinue|12|||
146928733|NCT01927419|529896120|FG001|Treatment Period|Participant request to discontinue|4|||
146928734|NCT01927419|529896119|FG000|Treatment Period|Withdrawal by Subject|1|||
146928735|NCT01927419|529896120|FG001|Treatment Period|Withdrawal by Subject|1|||
146928736|NCT01927419|529896119|FG000|Treatment Period|Maximum Clinical Benefit|6|||
146928737|NCT01927419|529896120|FG001|Treatment Period|Maximum Clinical Benefit|2|||
146928738|NCT01927419|529896119|FG000|Treatment Period|Other reasons|3|||
146928739|NCT01927419|529896120|FG001|Treatment Period|Other reasons|4|||
146928740|NCT01927419|529896119|FG000|Treatment Period|Not Reported|1|||
146928741|NCT01927419|529896120|FG001|Treatment Period|Not Reported|1|||
146928742|NCT03488251|529896121|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
146928743|NCT03488251|529896122|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
146928744|NCT03488251|529896123|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
146928745|NCT03488251|529896124|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
146928746|NCT03488251|529896121|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
146928747|NCT03488251|529896122|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
146928748|NCT03488251|529896123|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
146928749|NCT03488251|529896124|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
146928750|NCT03488251|529896121|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
146928751|NCT03488251|529896122|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
146928752|NCT03488251|529896123|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
146928753|NCT03488251|529896124|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
146928754|NCT03488251|529896121|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
146928755|NCT03488251|529896122|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
146928756|NCT03488251|529896123|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
146928757|NCT03488251|529896124|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
146928758|NCT03488251|529896121|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
146928759|NCT03488251|529896122|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
146928760|NCT03488251|529896123|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
146928761|NCT03488251|529896124|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
146928762|NCT00115765|529896127|FG000|Overall Study|Withdrawal by Subject|22|||
146928763|NCT00115765|529896128|FG001|Overall Study|Withdrawal by Subject|53|||
146928764|NCT00115765|529896129|FG002|Overall Study|Withdrawal by Subject|76|||
146928765|NCT00115765|529896130|FG003|Overall Study|Withdrawal by Subject|15|||
146928766|NCT00115765|529896127|FG000|Overall Study|Physician Decision|4|||
146928767|NCT00115765|529896128|FG001|Overall Study|Physician Decision|15|||
146979428|NCT01797120|530087092|FG000|Overall Study|Adverse Event|13|||
146979429|NCT01797120|530087093|FG001|Overall Study|Adverse Event|5|||
146979430|NCT01797120|530087092|FG000|Overall Study|Withdrawal by Subject|6|||
146979431|NCT01797120|530087093|FG001|Overall Study|Withdrawal by Subject|6|||
146979432|NCT01797120|530087092|FG000|Overall Study|Symptomatic progression|2|||
146979433|NCT01797120|530087093|FG001|Overall Study|Symptomatic progression|1|||
146979434|NCT01797120|530087092|FG000|Overall Study|Non-compliance|1|||
146979435|NCT01797120|530087093|FG001|Overall Study|Non-compliance|0|||
146979436|NCT01797120|530087092|FG000|Overall Study|Physician Decision|3|||
146979437|NCT01797120|530087093|FG001|Overall Study|Physician Decision|0|||
146979438|NCT01797120|530087092|FG000|Overall Study|still on treatment|2|||
146979439|NCT01797120|530087093|FG001|Overall Study|still on treatment|4|||
146688857|NCT00469092|529038577|FG000|Overall Study|Withdrawal by Subject|4|||
146688858|NCT00469092|529038578|FG001|Overall Study|Withdrawal by Subject|4|||
146928768|NCT00115765|529896129|FG002|Overall Study|Physician Decision|18|||
146928769|NCT00115765|529896130|FG003|Overall Study|Physician Decision|13|||
146979440|NCT01797120|530087092|FG000|Overall Study|never start protocol therapy|2|||
146979441|NCT01797120|530087093|FG001|Overall Study|never start protocol therapy|0|||
146979442|NCT00295854|530087094|FG000|Overall Study|Adverse Event|7|||
146688859|NCT00469092|529038577|FG000|Overall Study|Withdrawal Criteria|3|||
146688860|NCT00469092|529038578|FG001|Overall Study|Withdrawal Criteria|4|||
146688861|NCT00469092|529038577|FG000|Overall Study|Incorrectly Randomised|4|||
146979443|NCT00295854|530087095|FG001|Overall Study|Adverse Event|7|||
146979444|NCT00295854|530087096|FG002|Overall Study|Adverse Event|6|||
146979445|NCT00295854|530087094|FG000|Overall Study|Protocol Violation|1|||
146979446|NCT00295854|530087095|FG001|Overall Study|Protocol Violation|1|||
146979447|NCT00295854|530087096|FG002|Overall Study|Protocol Violation|1|||
146979448|NCT00295854|530087094|FG000|Overall Study|Lost to Follow-up|2|||
146979449|NCT00295854|530087095|FG001|Overall Study|Lost to Follow-up|0|||
146979450|NCT00295854|530087096|FG002|Overall Study|Lost to Follow-up|1|||
146979451|NCT00295854|530087094|FG000|Overall Study|Withdrawal by Subject|3|||
146979452|NCT00295854|530087095|FG001|Overall Study|Withdrawal by Subject|7|||
146979453|NCT00295854|530087096|FG002|Overall Study|Withdrawal by Subject|4|||
146979454|NCT00295854|530087094|FG000|Overall Study|did not continue to meet criteria|1|||
146979455|NCT00295854|530087095|FG001|Overall Study|did not continue to meet criteria|1|||
146979456|NCT00295854|530087096|FG002|Overall Study|did not continue to meet criteria|2|||
146979457|NCT00295854|530087094|FG000|Overall Study|required a prohibited medication|1|||
146979458|NCT00295854|530087095|FG001|Overall Study|required a prohibited medication|0|||
146979459|NCT00295854|530087096|FG002|Overall Study|required a prohibited medication|0|||
146979460|NCT00295854|530087094|FG000|Overall Study|Other|3|||
146979461|NCT00295854|530087095|FG001|Overall Study|Other|5|||
146979462|NCT00295854|530087096|FG002|Overall Study|Other|1|||
146979463|NCT00672620|530087097|FG000|Overall Study|Adverse Event|7|||
146979464|NCT00672620|530087098|FG001|Overall Study|Adverse Event|7|||
146979465|NCT00672620|530087099|FG002|Overall Study|Adverse Event|12|||
146979466|NCT00672620|530087100|FG003|Overall Study|Adverse Event|17|||
146979467|NCT00672620|530087097|FG000|Overall Study|Lack of Efficacy|1|||
146979468|NCT00672620|530087098|FG001|Overall Study|Lack of Efficacy|2|||
146979469|NCT00672620|530087099|FG002|Overall Study|Lack of Efficacy|2|||
146979470|NCT00672620|530087100|FG003|Overall Study|Lack of Efficacy|0|||
146979471|NCT00672620|530087097|FG000|Overall Study|Noncompliance with Study Drug|3|||
146979472|NCT00672620|530087098|FG001|Overall Study|Noncompliance with Study Drug|4|||
146979473|NCT00672620|530087099|FG002|Overall Study|Noncompliance with Study Drug|0|||
146979474|NCT00672620|530087100|FG003|Overall Study|Noncompliance with Study Drug|2|||
146979475|NCT00672620|530087097|FG000|Overall Study|Protocol Deviations|5|||
146979476|NCT00672620|530087098|FG001|Overall Study|Protocol Deviations|7|||
146979477|NCT00672620|530087099|FG002|Overall Study|Protocol Deviations|2|||
146979478|NCT00672620|530087100|FG003|Overall Study|Protocol Deviations|5|||
146979479|NCT00672620|530087097|FG000|Overall Study|Withdrawal of Consent|6|||
146979480|NCT00672620|530087098|FG001|Overall Study|Withdrawal of Consent|12|||
146979481|NCT00672620|530087099|FG002|Overall Study|Withdrawal of Consent|5|||
146979482|NCT00672620|530087100|FG003|Overall Study|Withdrawal of Consent|6|||
146979483|NCT00672620|530087097|FG000|Overall Study|Lost to Follow-up|8|||
146979484|NCT00672620|530087098|FG001|Overall Study|Lost to Follow-up|19|||
146979485|NCT00672620|530087099|FG002|Overall Study|Lost to Follow-up|8|||
146979486|NCT00672620|530087100|FG003|Overall Study|Lost to Follow-up|11|||
146979487|NCT00672620|530087097|FG000|Overall Study|Reason not Specified|3|||
146979488|NCT00672620|530087098|FG001|Overall Study|Reason not Specified|3|||
146979489|NCT00672620|530087099|FG002|Overall Study|Reason not Specified|2|||
146979490|NCT00672620|530087100|FG003|Overall Study|Reason not Specified|1|||
146979491|NCT02736227|530087104|FG000|Overall Study|Withdrawal by Subject|0|||
146979492|NCT02736227|530087105|FG001|Overall Study|Withdrawal by Subject|0|||
146979493|NCT02736227|530087106|FG002|Overall Study|Withdrawal by Subject|1|||
146979494|NCT02736227|530087104|FG000|Overall Study|Physician Decision|0|||
146979495|NCT02736227|530087105|FG001|Overall Study|Physician Decision|0|||
146979496|NCT02736227|530087106|FG002|Overall Study|Physician Decision|5|||
146979497|NCT02736227|530087104|FG000|Overall Study|Non Compliant|0|||
146979498|NCT02736227|530087105|FG001|Overall Study|Non Compliant|0|||
146979499|NCT02736227|530087106|FG002|Overall Study|Non Compliant|2|||
146979500|NCT04120194|530087107|FG000|Overall Study|Lost to Follow-up|11|||
146979501|NCT04120194|530087108|FG001|Overall Study|Lost to Follow-up|8|||
146979502|NCT04120194|530087107|FG000|Overall Study|Adverse Event|4|||
146979503|NCT04120194|530087108|FG001|Overall Study|Adverse Event|5|||
146979504|NCT04120194|530087107|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
146979505|NCT04120194|530087108|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
146979506|NCT04120194|530087107|FG000|Overall Study|Miscellaneous|4|||
146979507|NCT04120194|530087108|FG001|Overall Study|Miscellaneous|5|||
146979508|NCT03870997|530087115|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
146979509|NCT03870997|530087116|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
146775112|NCT00444600|529348032|FG002|Overall Study|Dropped|7|||
146775113|NCT00444600|529348033|FG003|Overall Study|Dropped|7|||
146775114|NCT00444600|529348030|FG000|Overall Study|Missed visit|1|||
146775115|NCT00444600|529348031|FG001|Overall Study|Missed visit|0|||
146979510|NCT03870997|530087117|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
146979511|NCT03870997|530087118|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
146979512|NCT03870997|530087119|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
146979513|NCT03870997|530087120|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
146979514|NCT00219557|530087121|FG000|Phase 1|Lack of Efficacy|3|||
146775116|NCT00444600|529348032|FG002|Overall Study|Missed visit|0|||
146979515|NCT00219557|530087122|FG001|Phase 1|Lack of Efficacy|0|||
146775117|NCT00444600|529348033|FG003|Overall Study|Missed visit|1|||
146775118|NCT05132478|529348034|FG000|Overall Study|did not complete survey after consent|1|||
146775119|NCT05132478|529348035|FG001|Overall Study|did not complete survey after consent|1|||
146775120|NCT05132478|529348034|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
146775121|NCT05132478|529348035|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
146775122|NCT02549170|529348038|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
146775123|NCT02549170|529348039|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
146775124|NCT02549170|529348040|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
146775125|NCT02549170|529348041|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
146775126|NCT02549170|529348042|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
146775127|NCT02549170|529348038|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
146775128|NCT02549170|529348039|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
146775129|NCT02549170|529348040|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
146775130|NCT02549170|529348041|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
146775131|NCT02549170|529348042|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
146775132|NCT02549170|529348038|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
146775133|NCT02549170|529348039|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
146775134|NCT02549170|529348040|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
146775135|NCT02549170|529348041|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
146775136|NCT02549170|529348042|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
146775137|NCT03051165|529348043|FG000|Overall Study|Withdrawal by Subject|1|||
146775138|NCT03051165|529348043|FG000|Overall Study|Early termination of study|12|||
146775139|NCT00520546|529348046|FG000|Overall Study|Withdrawal by Subject|1|||
146775140|NCT00520546|529348046|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
146775141|NCT03076515|529348047|FG000|Overall Study|DMC decision based on interim analysis|25|||
146775142|NCT03076515|529348048|FG001|Overall Study|DMC decision based on interim analysis|29|||
146775143|NCT03988023|529348052|FG000|Overall Study|Non-compliance|3|||
146775144|NCT03988023|529348053|FG001|Overall Study|Non-compliance|0|||
146775145|NCT03988023|529348052|FG000|Overall Study|Withdrawal by Subject|39|||
146775146|NCT03988023|529348053|FG001|Overall Study|Withdrawal by Subject|37|||
146775147|NCT03988023|529348052|FG000|Overall Study|Adverse Event|0|||
146775148|NCT03988023|529348053|FG001|Overall Study|Adverse Event|2|||
146775149|NCT03988023|529348052|FG000|Overall Study|Physician Decision|0|||
146775150|NCT03988023|529348053|FG001|Overall Study|Physician Decision|1|||
146775151|NCT03988023|529348052|FG000|Overall Study|Lost to Follow-up|5|||
146775152|NCT03988023|529348053|FG001|Overall Study|Lost to Follow-up|8|||
146775153|NCT03988023|529348052|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
146775154|NCT03988023|529348053|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
146775155|NCT03988023|529348052|FG000|Overall Study|Lack of Efficacy|3|||
146775156|NCT03988023|529348053|FG001|Overall Study|Lack of Efficacy|1|||
146775157|NCT03988023|529348052|FG000|Overall Study|COVID-19 pandemic|225|||
146775158|NCT03988023|529348053|FG001|Overall Study|COVID-19 pandemic|227|||
146775159|NCT02101281|529348054|FG000|Overall Study|Adverse Event|0|||
146775160|NCT02101281|529348055|FG001|Overall Study|Adverse Event|1|||
146775161|NCT00174382|529348056|FG000|Overall Study|Death|2|||
146775162|NCT00174382|529348056|FG000|Overall Study|Adverse Event|19|||
146775163|NCT00174382|529348056|FG000|Overall Study|Withdrawal by Subject|6|||
146775164|NCT00174382|529348056|FG000|Overall Study|Protocol Violation|3|||
146775165|NCT00174382|529348056|FG000|Overall Study|Arrived early for last visit in error|1|||
146775166|NCT00174382|529348056|FG000|Overall Study|Subject felt pill not effective enough|1|||
146775167|NCT00174382|529348056|FG000|Overall Study|Lost to Follow-up|1|||
146775168|NCT00529100|529348058|FG000|Overall Study|Adverse Event|0|||
146775169|NCT00529100|529348059|FG001|Overall Study|Adverse Event|5|||
146928770|NCT00115765|529896127|FG000|Overall Study|Lost to Follow-up|3|||
146775170|NCT00529100|529348058|FG000|Overall Study|Protocol Violation|0|||
146775171|NCT00529100|529348059|FG001|Overall Study|Protocol Violation|1|||
146775172|NCT00529100|529348058|FG000|Overall Study|Progressive Disease|0|||
146775173|NCT00529100|529348059|FG001|Overall Study|Progressive Disease|1|||
146775174|NCT00529100|529348058|FG000|Overall Study|Withdrawal by Subject|0|||
146775175|NCT00529100|529348059|FG001|Overall Study|Withdrawal by Subject|1|||
146775176|NCT00529100|529348058|FG000|Overall Study|Participant Ineligibility|0|||
146775177|NCT00529100|529348059|FG001|Overall Study|Participant Ineligibility|1|||
146775178|NCT03733119|529348060|FG000|Overall Study|Physician Decision|2|||
146775179|NCT03733119|529348061|FG001|Overall Study|Physician Decision|1|||
146775180|NCT03733119|529348060|FG000|Overall Study|ineligible to treat per protocol|0|||
146775181|NCT03733119|529348061|FG001|Overall Study|ineligible to treat per protocol|1|||
146775182|NCT03703336|529348063|FG000|Overall Study|Parent withdrew consent|29|||
146775183|NCT03703336|529348064|FG001|Overall Study|Parent withdrew consent|8|||
146775184|NCT03703336|529348063|FG000|Overall Study|Migration|3|||
146775185|NCT03703336|529348064|FG001|Overall Study|Migration|3|||
146928771|NCT00115765|529896128|FG001|Overall Study|Lost to Follow-up|20|||
146928772|NCT00115765|529896129|FG002|Overall Study|Lost to Follow-up|18|||
146928773|NCT00115765|529896130|FG003|Overall Study|Lost to Follow-up|1|||
146928774|NCT00115765|529896127|FG000|Overall Study|Other|6|||
146928775|NCT00115765|529896128|FG001|Overall Study|Other|12|||
146928776|NCT00115765|529896129|FG002|Overall Study|Other|9|||
146928777|NCT00115765|529896130|FG003|Overall Study|Other|2|||
146928778|NCT00995670|529896131|FG000|Overall Study|Failed arterial cannulation|1|||
146688862|NCT00469092|529038578|FG001|Overall Study|Incorrectly Randomised|3|||
146688863|NCT00469092|529038577|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
146688864|NCT00469092|529038578|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
146688865|NCT00469092|529038577|FG000|Overall Study|Use of lipid lowering drug|1|||
146688866|NCT00469092|529038578|FG001|Overall Study|Use of lipid lowering drug|0|||
146688867|NCT00469092|529038577|FG000|Overall Study|Hypoglycaemic Episodes|1|||
146688868|NCT00469092|529038578|FG001|Overall Study|Hypoglycaemic Episodes|1|||
146688869|NCT00469092|529038577|FG000|Overall Study|Abnormal lab value|1|||
146688870|NCT00469092|529038578|FG001|Overall Study|Abnormal lab value|0|||
146688871|NCT00469092|529038577|FG000|Overall Study|Use of Corticosteroid|1|||
146688872|NCT00469092|529038578|FG001|Overall Study|Use of Corticosteroid|0|||
146688873|NCT04499781|529038586|FG000|Overall Study|Lost to Follow-up|2|||
146688874|NCT04499781|529038587|FG001|Overall Study|Lost to Follow-up|3|||
146688875|NCT04499781|529038586|FG000|Overall Study|Withdrawal by Subject|2|||
146688876|NCT04499781|529038587|FG001|Overall Study|Withdrawal by Subject|0|||
146688877|NCT00227305|529038588|FG000|Overall Study|Adverse Event|40|||
146688878|NCT00227305|529038588|FG000|Overall Study|Withdrawal by Subject|42|||
146688879|NCT00227305|529038588|FG000|Overall Study|Lost to Follow-up|33|||
146688880|NCT00227305|529038588|FG000|Overall Study|Study specific discontinuation|13|||
146688881|NCT00227305|529038588|FG000|Overall Study|MOVED OUT OF AREA|3|||
146688882|NCT00227305|529038588|FG000|Overall Study|Lack of Efficacy|7|||
146688883|NCT00227305|529038588|FG000|Overall Study|Physician Decision|3|||
146688884|NCT00227305|529038588|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
146688885|NCT00227305|529038588|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
146688886|NCT00227305|529038588|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
146688887|NCT04519645|529038591|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
146688888|NCT04519645|529038592|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
146688889|NCT04519645|529038593|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
146688890|NCT04519645|529038591|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
146688891|NCT04519645|529038592|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
146688892|NCT04519645|529038593|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
146688893|NCT04519645|529038591|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
146688894|NCT04519645|529038592|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
146688895|NCT04519645|529038593|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
146688896|NCT04519645|529038591|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
146688897|NCT04519645|529038592|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
146688898|NCT04519645|529038593|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
146688899|NCT00619801|529038594|FG000|Overall Study|Lack of Efficacy|0|||
146688900|NCT00619801|529038595|FG001|Overall Study|Lack of Efficacy|1|||
146688901|NCT00619801|529038594|FG000|Overall Study|Withdrawal by Subject|1|||
146688902|NCT00619801|529038595|FG001|Overall Study|Withdrawal by Subject|1|||
146688903|NCT00619801|529038594|FG000|Overall Study|Loss of efficacy|0|||
146688904|NCT00619801|529038595|FG001|Overall Study|Loss of efficacy|1|||
146688905|NCT03051607|529038596|FG000|Overall Study|Adverse Event|66|||
146688906|NCT03338855|529038598|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
146688907|NCT03338855|529038599|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
146688908|NCT00455429|529038600|FG000|Overall Study|Study Terminated by Sponsor|0|||
146688909|NCT00455429|529038601|FG001|Overall Study|Study Terminated by Sponsor|0|||
146688910|NCT00455429|529038602|FG002|Overall Study|Study Terminated by Sponsor|0|||
146688911|NCT00455429|529038603|FG003|Overall Study|Study Terminated by Sponsor|3|||
146688912|NCT00455429|529038600|FG000|Overall Study|Lost to Follow-up|1|||
146688913|NCT00455429|529038601|FG001|Overall Study|Lost to Follow-up|0|||
146688914|NCT00455429|529038602|FG002|Overall Study|Lost to Follow-up|0|||
146688915|NCT00455429|529038603|FG003|Overall Study|Lost to Follow-up|3|||
146688916|NCT00455429|529038600|FG000|Overall Study|Withdrawal by Subject|0|||
146688917|NCT00455429|529038601|FG001|Overall Study|Withdrawal by Subject|1|||
146688918|NCT00455429|529038602|FG002|Overall Study|Withdrawal by Subject|1|||
146688919|NCT00455429|529038603|FG003|Overall Study|Withdrawal by Subject|0|||
146688920|NCT00455429|529038600|FG000|Overall Study|Lack of Efficacy|0|||
146688921|NCT00455429|529038601|FG001|Overall Study|Lack of Efficacy|1|||
146688922|NCT00455429|529038602|FG002|Overall Study|Lack of Efficacy|0|||
146775186|NCT03703336|529348063|FG000|Overall Study|Protocol Violation|3|||
146928779|NCT00995670|529896132|FG001|Overall Study|Failed arterial cannulation|0|||
146688923|NCT00455429|529038603|FG003|Overall Study|Lack of Efficacy|1|||
146688924|NCT00455429|529038600|FG000|Overall Study|Adverse Event|0|||
146688925|NCT00455429|529038601|FG001|Overall Study|Adverse Event|1|||
146688926|NCT00455429|529038602|FG002|Overall Study|Adverse Event|0|||
146688927|NCT00455429|529038603|FG003|Overall Study|Adverse Event|3|||
146928780|NCT00995670|529896133|FG002|Overall Study|Failed arterial cannulation|3|||
146928781|NCT00675103|529896134|FG000|Overall Study|Lack of Efficacy|2|||
146928782|NCT00675103|529896134|FG000|Overall Study|Adverse Event|1|||
146928783|NCT02164513|529896138|FG000|Overall Study|Adverse Event|162|||
146928784|NCT02164513|529896139|FG001|Overall Study|Adverse Event|180|||
146928785|NCT02164513|529896140|FG002|Overall Study|Adverse Event|111|||
146928786|NCT02164513|529896138|FG000|Overall Study|Other: Study Closed or terminated|5|||
146928787|NCT02164513|529896139|FG001|Overall Study|Other: Study Closed or terminated|2|||
146928788|NCT02164513|529896140|FG002|Overall Study|Other: Study Closed or terminated|4|||
146928789|NCT02164513|529896138|FG000|Overall Study|Lost to Follow-up|30|||
146928790|NCT02164513|529896139|FG001|Overall Study|Lost to Follow-up|36|||
146928791|NCT02164513|529896140|FG002|Overall Study|Lost to Follow-up|22|||
146928792|NCT02164513|529896138|FG000|Overall Study|Physician Decision|47|||
146928793|NCT02164513|529896139|FG001|Overall Study|Physician Decision|57|||
146928794|NCT02164513|529896140|FG002|Overall Study|Physician Decision|28|||
146928795|NCT02164513|529896138|FG000|Overall Study|Withdrawal by Subject|192|||
146928796|NCT02164513|529896139|FG001|Overall Study|Withdrawal by Subject|261|||
146928797|NCT02164513|529896140|FG002|Overall Study|Withdrawal by Subject|130|||
146928798|NCT02164513|529896138|FG000|Overall Study|Other: Reason not provided by site|1|||
146928799|NCT02164513|529896139|FG001|Overall Study|Other: Reason not provided by site|0|||
146928800|NCT02164513|529896140|FG002|Overall Study|Other: Reason not provided by site|0|||
146928801|NCT02773238|529896142|FG000|Overall Study|Lack of Efficacy|4|||
146928802|NCT00975195|529896143|FG000|Overall Study|Adverse Event|108|||
146928803|NCT00975195|529896144|FG001|Overall Study|Adverse Event|101|||
146928804|NCT00975195|529896143|FG000|Overall Study|Lack of Efficacy|6|||
146928805|NCT00975195|529896144|FG001|Overall Study|Lack of Efficacy|6|||
146928806|NCT00975195|529896143|FG000|Overall Study|Protocol Violation|27|||
146928807|NCT00975195|529896144|FG001|Overall Study|Protocol Violation|23|||
146928808|NCT00975195|529896143|FG000|Overall Study|Lost to Follow-up|9|||
146928809|NCT00975195|529896144|FG001|Overall Study|Lost to Follow-up|7|||
146928810|NCT00975195|529896143|FG000|Overall Study|Withdrawal by Subject|48|||
146928811|NCT00975195|529896144|FG001|Overall Study|Withdrawal by Subject|61|||
146928812|NCT00975195|529896143|FG000|Overall Study|Other reason not defined above|29|||
146928813|NCT00975195|529896144|FG001|Overall Study|Other reason not defined above|33|||
146928814|NCT00975195|529896143|FG000|Overall Study|Not treated|1|||
146928815|NCT00975195|529896144|FG001|Overall Study|Not treated|2|||
146928816|NCT03422133|529896149|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
146928817|NCT03422133|529896150|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
146928818|NCT03003403|529896151|FG000|Overall Study|Ineligible|8|||
146928819|NCT03003403|529896152|FG001|Overall Study|Ineligible|7|||
146928820|NCT03003403|529896151|FG000|Overall Study|Withdrawal by Subject|3|||
146928821|NCT03003403|529896152|FG001|Overall Study|Withdrawal by Subject|1|||
146928822|NCT05084053|529897261|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
146928823|NCT05084053|529897262|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
146928824|NCT05084053|529897263|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
146928825|NCT05084053|529897264|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
146928826|NCT05084053|529897261|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
146928827|NCT05084053|529897262|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
146928828|NCT05084053|529897263|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
146928829|NCT05084053|529897264|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
146928830|NCT05084053|529897261|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
146688928|NCT00455429|529038600|FG000|Overall Study|Randomly assigned but not treated|0|||
146928831|NCT05084053|529897262|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
146928832|NCT05084053|529897263|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
146928833|NCT05084053|529897264|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
146928834|NCT02180724|529897265|FG000|Overall Study|Death|26|||
146928835|NCT02180724|529897266|FG001|Overall Study|Death|1|||
146928836|NCT02180724|529897265|FG000|Overall Study|Lost to Follow-up|3|||
146928837|NCT02180724|529897266|FG001|Overall Study|Lost to Follow-up|1|||
146928838|NCT02180724|529897265|FG000|Overall Study|Withdrawal by Subject|4|||
146928839|NCT02180724|529897266|FG001|Overall Study|Withdrawal by Subject|2|||
146928840|NCT02180724|529897265|FG000|Overall Study|PI Decision|5|||
146928841|NCT02180724|529897266|FG001|Overall Study|PI Decision|2|||
146928842|NCT02180724|529897265|FG000|Overall Study|Study terminated by sponsor|54|||
146928843|NCT02180724|529897266|FG001|Overall Study|Study terminated by sponsor|8|||
146928844|NCT05195359|529897267|FG000|Overall Study|Lost to Follow-up|124|||
146928845|NCT05195359|529897268|FG001|Overall Study|Lost to Follow-up|34|||
146928846|NCT03569449|529897271|FG000|Overall Study|Lost to Follow-up|0|||
146928847|NCT03569449|529897272|FG001|Overall Study|Lost to Follow-up|1|||
146688929|NCT00455429|529038601|FG001|Overall Study|Randomly assigned but not treated|0|||
146928848|NCT03569449|529897273|FG002|Overall Study|Lost to Follow-up|0|||
146928849|NCT03569449|529897274|FG003|Overall Study|Lost to Follow-up|2|||
146928850|NCT03569449|529897275|FG004|Overall Study|Lost to Follow-up|0|||
146928851|NCT03569449|529897276|FG005|Overall Study|Lost to Follow-up|0|||
146688930|NCT00455429|529038602|FG002|Overall Study|Randomly assigned but not treated|0|||
146688931|NCT00455429|529038603|FG003|Overall Study|Randomly assigned but not treated|2|||
146688932|NCT00455429|529038600|FG000|Overall Study|Personal Reason|1|||
146688933|NCT00455429|529038601|FG001|Overall Study|Personal Reason|0|||
146688934|NCT00455429|529038602|FG002|Overall Study|Personal Reason|0|||
146688935|NCT00455429|529038603|FG003|Overall Study|Personal Reason|0|||
146688936|NCT00455429|529038600|FG000|Overall Study|Non-compliance|0|||
146688937|NCT00455429|529038601|FG001|Overall Study|Non-compliance|0|||
146928852|NCT03569449|529897277|FG006|Overall Study|Lost to Follow-up|0|||
146928853|NCT03569449|529897278|FG007|Overall Study|Lost to Follow-up|0|||
146928854|NCT03569449|529897279|FG008|Overall Study|Lost to Follow-up|0|||
146928855|NCT03569449|529897280|FG009|Overall Study|Lost to Follow-up|0|||
146928856|NCT03569449|529897281|FG010|Overall Study|Lost to Follow-up|0|||
146928857|NCT03569449|529897282|FG011|Overall Study|Lost to Follow-up|0|||
146928858|NCT03569449|529897283|FG012|Overall Study|Lost to Follow-up|0|||
146928859|NCT03569449|529897284|FG013|Overall Study|Lost to Follow-up|0|||
146928860|NCT03569449|529897285|FG014|Overall Study|Lost to Follow-up|1|||
146928861|NCT03569449|529897286|FG015|Overall Study|Lost to Follow-up|0|||
146928862|NCT03569449|529897271|FG000|Overall Study|Withdrawal by Subject|0|||
146928863|NCT03569449|529897272|FG001|Overall Study|Withdrawal by Subject|1|||
146928864|NCT03569449|529897273|FG002|Overall Study|Withdrawal by Subject|0|||
146928865|NCT03569449|529897274|FG003|Overall Study|Withdrawal by Subject|0|||
146928866|NCT03569449|529897275|FG004|Overall Study|Withdrawal by Subject|1|||
146928867|NCT03569449|529897276|FG005|Overall Study|Withdrawal by Subject|0|||
146928868|NCT03569449|529897277|FG006|Overall Study|Withdrawal by Subject|0|||
146928869|NCT03569449|529897278|FG007|Overall Study|Withdrawal by Subject|0|||
146928870|NCT03569449|529897279|FG008|Overall Study|Withdrawal by Subject|0|||
146928871|NCT03569449|529897280|FG009|Overall Study|Withdrawal by Subject|0|||
146928872|NCT03569449|529897281|FG010|Overall Study|Withdrawal by Subject|0|||
146928873|NCT03569449|529897282|FG011|Overall Study|Withdrawal by Subject|0|||
146928874|NCT03569449|529897283|FG012|Overall Study|Withdrawal by Subject|0|||
146928875|NCT03569449|529897284|FG013|Overall Study|Withdrawal by Subject|0|||
146928876|NCT03569449|529897285|FG014|Overall Study|Withdrawal by Subject|0|||
146928877|NCT03569449|529897286|FG015|Overall Study|Withdrawal by Subject|0|||
146928878|NCT05279898|529897289|FG000|Overall Study|Withdrawal by Subject|1|||
146928879|NCT05279898|529897290|FG001|Overall Study|Withdrawal by Subject|0|||
146928880|NCT05279898|529897289|FG000|Overall Study|Physician Decision|1|||
146928881|NCT05279898|529897290|FG001|Overall Study|Physician Decision|1|||
146688938|NCT00455429|529038602|FG002|Overall Study|Non-compliance|0|||
146688939|NCT00455429|529038603|FG003|Overall Study|Non-compliance|1|||
146688940|NCT00455429|529038600|FG000|Overall Study|Other|0|||
146688941|NCT00455429|529038601|FG001|Overall Study|Other|2|||
146688942|NCT00455429|529038602|FG002|Overall Study|Other|0|||
146688943|NCT00455429|529038603|FG003|Overall Study|Other|1|||
146688944|NCT04948450|529038604|FG000|Overall Study|Return home|1|||
146688945|NCT04948450|529038605|FG001|Overall Study|Return home|3|||
146688946|NCT00529542|529038607|FG000|Overall Study|Withdrawal by Subject|1|||
146688947|NCT00529542|529038608|FG001|Overall Study|Withdrawal by Subject|0|||
146688948|NCT00529542|529038607|FG000|Overall Study|Lost to Follow-up|0|||
146688949|NCT00529542|529038608|FG001|Overall Study|Lost to Follow-up|1|||
146688950|NCT01474876|529038615|FG000|Overall Study|Adverse Event|11|||
146688951|NCT01474876|529038616|FG001|Overall Study|Adverse Event|5|||
146688952|NCT01474876|529038617|FG002|Overall Study|Adverse Event|0|||
146688953|NCT01474876|529038615|FG000|Overall Study|Serious Adverse Event|2|||
146688954|NCT01474876|529038616|FG001|Overall Study|Serious Adverse Event|3|||
146688955|NCT01474876|529038617|FG002|Overall Study|Serious Adverse Event|0|||
146688956|NCT01474876|529038615|FG000|Overall Study|Lost to Follow-up|5|||
146688957|NCT01474876|529038616|FG001|Overall Study|Lost to Follow-up|4|||
146688958|NCT01474876|529038617|FG002|Overall Study|Lost to Follow-up|0|||
146928882|NCT00571688|529897296|FG000|Overall Study|Lost to Follow-up|3|||
146928883|NCT00571688|529897297|FG001|Overall Study|Lost to Follow-up|6|||
146688959|NCT01474876|529038615|FG000|Overall Study|Investigator's decision|28|||
146928884|NCT00571688|529897296|FG000|Overall Study|subject did not tolerate Consta|1|||
146928885|NCT00571688|529897297|FG001|Overall Study|subject did not tolerate Consta|0|||
146928886|NCT00571688|529897296|FG000|Overall Study|subject moved out of the area|1|||
146928887|NCT00571688|529897297|FG001|Overall Study|subject moved out of the area|0|||
146928888|NCT01048853|529897298|FG000|Overall Study|Death|1|||
146928889|NCT01048853|529897299|FG001|Overall Study|Death|0|||
146928890|NCT01048853|529897300|FG002|Overall Study|Death|0|||
146688960|NCT01474876|529038616|FG001|Overall Study|Investigator's decision|6|||
146688961|NCT01474876|529038617|FG002|Overall Study|Investigator's decision|0|||
146688962|NCT01474876|529038615|FG000|Overall Study|Patient's request|19|||
146688963|NCT01474876|529038616|FG001|Overall Study|Patient's request|5|||
146928891|NCT01048853|529897298|FG000|Overall Study|Lost to Follow-up|1|||
146928892|NCT01048853|529897299|FG001|Overall Study|Lost to Follow-up|4|||
146928893|NCT01048853|529897300|FG002|Overall Study|Lost to Follow-up|0|||
146928894|NCT04999969|529897301|FG000|Overall Study|Death|76|||
146928895|NCT04999969|529897301|FG000|Overall Study|Progressive Disease|1|||
146928896|NCT04999969|529897301|FG000|Overall Study|Withdrawal by Subject|8|||
146928897|NCT03779334|529897306|FG000|Overall Study|Withdrawal by Subject|3|||
146928898|NCT03779334|529897307|FG001|Overall Study|Withdrawal by Subject|0|||
146928899|NCT03779334|529897308|FG002|Overall Study|Withdrawal by Subject|0|||
146928900|NCT03779334|529897306|FG000|Overall Study|Ongoing in Study|5|||
146928901|NCT03779334|529897307|FG001|Overall Study|Ongoing in Study|13|||
146928902|NCT03779334|529897308|FG002|Overall Study|Ongoing in Study|5|||
146928903|NCT06964165|529897309|FG000|Overall Study|Death|4|||
146928904|NCT06964165|529897310|FG001|Overall Study|Death|4|||
146928905|NCT06964165|529897309|FG000|Overall Study|Physician Decision|1|||
146928906|NCT06964165|529897310|FG001|Overall Study|Physician Decision|1|||
146928907|NCT06964165|529897309|FG000|Overall Study|Withdrawal by Subject|0|||
146928908|NCT06964165|529897310|FG001|Overall Study|Withdrawal by Subject|2|||
146928909|NCT06964165|529897309|FG000|Overall Study|Study terminated by sponsor|12|||
146928910|NCT06964165|529897310|FG001|Overall Study|Study terminated by sponsor|10|||
146928911|NCT06964165|529897309|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
146928912|NCT06964165|529897310|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
146928913|NCT06964165|529897309|FG000|Overall Study|Participant removed due to non-compliance|0|||
146928914|NCT06964165|529897310|FG001|Overall Study|Participant removed due to non-compliance|1|||
146928915|NCT04735393|529897314|FG000|Overall Study|Lost to Follow-up|46|||
146928916|NCT04735393|529897315|FG001|Overall Study|Lost to Follow-up|24|||
146928917|NCT04735393|529897314|FG000|Overall Study|Physician Decision|2|||
146928918|NCT04735393|529897315|FG001|Overall Study|Physician Decision|1|||
146928919|NCT04735393|529897314|FG000|Overall Study|Not Detailed|1|||
146928920|NCT04735393|529897315|FG001|Overall Study|Not Detailed|2|||
146928921|NCT04735393|529897314|FG000|Overall Study|Withdrawal by Subject|71|||
146928922|NCT04735393|529897315|FG001|Overall Study|Withdrawal by Subject|28|||
146928923|NCT04735393|529897314|FG000|Overall Study|Adverse Event|56|||
146928924|NCT04735393|529897315|FG001|Overall Study|Adverse Event|7|||
146928925|NCT04735393|529897314|FG000|Overall Study|Protocol Violation|6|||
146928926|NCT04735393|529897315|FG001|Overall Study|Protocol Violation|1|||
146928927|NCT04735393|529897314|FG000|Overall Study|Trial terminated by Sponsor|49|||
146928928|NCT04735393|529897315|FG001|Overall Study|Trial terminated by Sponsor|29|||
146928929|NCT03224104|529897316|FG000|Overall Study|Lack of Efficacy|2|||
146928930|NCT03224104|529897317|FG001|Overall Study|Lack of Efficacy|6|||
146928931|NCT03224104|529897318|FG002|Overall Study|Lack of Efficacy|3|||
146928932|NCT03224104|529897319|FG003|Overall Study|Lack of Efficacy|4|||
146928933|NCT03224104|529897320|FG004|Overall Study|Lack of Efficacy|42|||
146928934|NCT03224104|529897316|FG000|Overall Study|Withdrawal by Subject|0|||
146688964|NCT01474876|529038617|FG002|Overall Study|Patient's request|0|||
146688965|NCT01474876|529038615|FG000|Overall Study|Investigator's decision and pt request|1|||
146688966|NCT01474876|529038616|FG001|Overall Study|Investigator's decision and pt request|0|||
146688967|NCT01474876|529038617|FG002|Overall Study|Investigator's decision and pt request|0|||
146928935|NCT03224104|529897317|FG001|Overall Study|Withdrawal by Subject|2|||
146688968|NCT02291055|529038620|FG000|Overall Study|Death|2|||
146688969|NCT02291055|529038621|FG001|Overall Study|Death|2|||
146688970|NCT02291055|529038622|FG002|Overall Study|Death|5|||
146928936|NCT03224104|529897318|FG002|Overall Study|Withdrawal by Subject|0|||
146928937|NCT03224104|529897319|FG003|Overall Study|Withdrawal by Subject|1|||
146928938|NCT03224104|529897320|FG004|Overall Study|Withdrawal by Subject|3|||
146928939|NCT03224104|529897316|FG000|Overall Study|Death|0|||
146928940|NCT03224104|529897317|FG001|Overall Study|Death|1|||
146928941|NCT03224104|529897318|FG002|Overall Study|Death|0|||
146928942|NCT03224104|529897319|FG003|Overall Study|Death|0|||
146928943|NCT03224104|529897320|FG004|Overall Study|Death|0|||
146688971|NCT02291055|529038623|FG003|Overall Study|Death|8|||
146688972|NCT02291055|529038624|FG004|Overall Study|Death|12|||
146688973|NCT02291055|529038620|FG000|Overall Study|Lost to Follow-up|0|||
146688974|NCT02291055|529038621|FG001|Overall Study|Lost to Follow-up|0|||
146688975|NCT02291055|529038622|FG002|Overall Study|Lost to Follow-up|0|||
146688976|NCT02291055|529038623|FG003|Overall Study|Lost to Follow-up|1|||
146688977|NCT02291055|529038624|FG004|Overall Study|Lost to Follow-up|2|||
146688978|NCT02291055|529038620|FG000|Overall Study|Withdrawal by Subject|3|||
146688979|NCT02291055|529038621|FG001|Overall Study|Withdrawal by Subject|1|||
146688980|NCT02291055|529038622|FG002|Overall Study|Withdrawal by Subject|1|||
146688981|NCT02291055|529038623|FG003|Overall Study|Withdrawal by Subject|5|||
146688982|NCT02291055|529038624|FG004|Overall Study|Withdrawal by Subject|10|||
146688983|NCT02291055|529038620|FG000|Overall Study|Progressive Disease|0|||
146688984|NCT02291055|529038621|FG001|Overall Study|Progressive Disease|0|||
146688985|NCT02291055|529038622|FG002|Overall Study|Progressive Disease|1|||
146688986|NCT02291055|529038623|FG003|Overall Study|Progressive Disease|4|||
146688987|NCT02291055|529038624|FG004|Overall Study|Progressive Disease|2|||
146928944|NCT03224104|529897316|FG000|Overall Study|Adverse Event|1|||
146928945|NCT03224104|529897317|FG001|Overall Study|Adverse Event|0|||
146688988|NCT02291055|529038620|FG000|Overall Study|Study Terminated by Sponsor|0|||
146688989|NCT02291055|529038621|FG001|Overall Study|Study Terminated by Sponsor|0|||
146928946|NCT03224104|529897318|FG002|Overall Study|Adverse Event|0|||
146928947|NCT03224104|529897319|FG003|Overall Study|Adverse Event|1|||
146928948|NCT03224104|529897320|FG004|Overall Study|Adverse Event|3|||
146928949|NCT03224104|529897316|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
146928950|NCT03224104|529897317|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
146928951|NCT03224104|529897318|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
146928952|NCT03224104|529897319|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
146928953|NCT03224104|529897320|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
146928954|NCT03224104|529897316|FG000|Overall Study|Treatment ongoing|0|||
146928955|NCT03224104|529897317|FG001|Overall Study|Treatment ongoing|0|||
146928956|NCT03224104|529897318|FG002|Overall Study|Treatment ongoing|0|||
146928957|NCT03224104|529897319|FG003|Overall Study|Treatment ongoing|0|||
146928958|NCT03224104|529897320|FG004|Overall Study|Treatment ongoing|1|||
146928959|NCT05600309|529897321|FG000|Overall Study|Death|41|||
146928960|NCT05600309|529897322|FG001|Overall Study|Death|38|||
146928961|NCT05600309|529897321|FG000|Overall Study|Sponsor Decision|9|||
146928962|NCT05600309|529897322|FG001|Overall Study|Sponsor Decision|6|||
146928963|NCT06087328|529897323|FG000|28-Day Treatment|Lost to Follow-up|7|||
146928964|NCT06087328|529897324|FG001|28-Day Treatment|Lost to Follow-up|3|||
146928965|NCT06087328|529897325|FG002|28-Day Treatment|Lost to Follow-up|4|||
146928966|NCT06087328|529897323|FG000|1-month Follow-up|Lost to Follow-up|0|||
146928967|NCT06087328|529897324|FG001|1-month Follow-up|Lost to Follow-up|1|||
146928968|NCT06087328|529897325|FG002|1-month Follow-up|Lost to Follow-up|1|||
146928969|NCT05822830|529897326|FG000|Overall Study|Adverse Event|6|||
146928970|NCT05822830|529897327|FG001|Overall Study|Adverse Event|6|||
146928971|NCT05822830|529897326|FG000|Overall Study|Assigned Treatment by Mistake|5|||
146928972|NCT05822830|529897327|FG001|Overall Study|Assigned Treatment by Mistake|3|||
146928973|NCT05822830|529897326|FG000|Overall Study|Lost to Follow-up|16|||
146928974|NCT05822830|529897327|FG001|Overall Study|Lost to Follow-up|18|||
146928975|NCT05822830|529897326|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146928976|NCT05822830|529897327|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146928977|NCT05822830|529897326|FG000|Overall Study|Participant was Out of the Country|0|||
146928978|NCT05822830|529897327|FG001|Overall Study|Participant was Out of the Country|1|||
146928979|NCT05822830|529897326|FG000|Overall Study|Pregnancy|1|||
146928980|NCT05822830|529897327|FG001|Overall Study|Pregnancy|2|||
146928981|NCT05822830|529897326|FG000|Overall Study|Withdrawal by Subject|27|||
146928982|NCT05822830|529897327|FG001|Overall Study|Withdrawal by Subject|26|||
146928983|NCT03201965|529897331|FG000|Overall Study|Death|5|||
146928984|NCT03201965|529897332|FG001|Overall Study|Death|65|||
146928985|NCT03201965|529897333|FG002|Overall Study|Death|47|||
146928986|NCT03201965|529897331|FG000|Overall Study|Lost to Follow-up|0|||
146928987|NCT03201965|529897332|FG001|Overall Study|Lost to Follow-up|6|||
146928988|NCT03201965|529897333|FG002|Overall Study|Lost to Follow-up|0|||
146928989|NCT03201965|529897331|FG000|Overall Study|Withdrawal by Subject|3|||
146928990|NCT03201965|529897332|FG001|Overall Study|Withdrawal by Subject|23|||
146928991|NCT03201965|529897333|FG002|Overall Study|Withdrawal by Subject|8|||
146928992|NCT03201965|529897331|FG000|Overall Study|Sponsor's Decision|20|||
146928993|NCT03201965|529897332|FG001|Overall Study|Sponsor's Decision|99|||
146928994|NCT03201965|529897333|FG002|Overall Study|Sponsor's Decision|140|||
146928995|NCT03368664|529897334|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
146928996|NCT03368664|529897334|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
146928997|NCT03368664|529897334|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
146928998|NCT03368664|529897334|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
146928999|NCT03589326|529897342|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
146929000|NCT03589326|529897343|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
146929001|NCT03589326|529897342|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
146929002|NCT03589326|529897343|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
146929003|NCT03589326|529897342|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
146929004|NCT03589326|529897343|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
146929005|NCT03589326|529897342|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
146929006|NCT03589326|529897343|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
146929007|NCT03589326|529897342|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
146929008|NCT03589326|529897343|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
146929009|NCT05441592|529897344|FG000|Overall Study|Lost to Follow-up|1|||
146979516|NCT00219557|530087123|FG002|Phase 1|Lack of Efficacy|0|||
146979517|NCT00219557|530087121|FG000|Phase 1|Adverse Event|2|||
146929010|NCT05441592|529897345|FG001|Overall Study|Lost to Follow-up|5|||
146688990|NCT02291055|529038622|FG002|Overall Study|Study Terminated by Sponsor|0|||
146929011|NCT01371981|529897346|FG000|Overall Study|Adverse Event|12|||
146929012|NCT01371981|529897347|FG001|Overall Study|Adverse Event|17|||
146929013|NCT01371981|529897348|FG002|Overall Study|Adverse Event|0|||
146929014|NCT01371981|529897349|FG003|Overall Study|Adverse Event|4|||
146929015|NCT01371981|529897350|FG004|Overall Study|Adverse Event|1|||
146929016|NCT01371981|529897351|FG005|Overall Study|Adverse Event|0|||
146929017|NCT01371981|529897346|FG000|Overall Study|Death|22|||
146929018|NCT01371981|529897347|FG001|Overall Study|Death|16|||
146688991|NCT02291055|529038623|FG003|Overall Study|Study Terminated by Sponsor|5|||
146929019|NCT01371981|529897348|FG002|Overall Study|Death|0|||
146929020|NCT01371981|529897349|FG003|Overall Study|Death|0|||
146929021|NCT01371981|529897350|FG004|Overall Study|Death|2|||
146929022|NCT01371981|529897351|FG005|Overall Study|Death|2|||
146929023|NCT01371981|529897346|FG000|Overall Study|Lack of Efficacy|69|||
146929024|NCT01371981|529897347|FG001|Overall Study|Lack of Efficacy|61|||
146929025|NCT01371981|529897348|FG002|Overall Study|Lack of Efficacy|4|||
146929026|NCT01371981|529897349|FG003|Overall Study|Lack of Efficacy|8|||
146929027|NCT01371981|529897350|FG004|Overall Study|Lack of Efficacy|5|||
146929028|NCT01371981|529897351|FG005|Overall Study|Lack of Efficacy|0|||
146929029|NCT01371981|529897346|FG000|Overall Study|Physician Decision|48|||
146929030|NCT01371981|529897347|FG001|Overall Study|Physician Decision|63|||
146929031|NCT01371981|529897348|FG002|Overall Study|Physician Decision|1|||
146929032|NCT01371981|529897349|FG003|Overall Study|Physician Decision|7|||
146929033|NCT01371981|529897350|FG004|Overall Study|Physician Decision|14|||
146929034|NCT01371981|529897351|FG005|Overall Study|Physician Decision|3|||
146929035|NCT01371981|529897346|FG000|Overall Study|Withdrawal by Subject|12|||
146929036|NCT01371981|529897347|FG001|Overall Study|Withdrawal by Subject|19|||
146929037|NCT01371981|529897348|FG002|Overall Study|Withdrawal by Subject|1|||
146929038|NCT01371981|529897349|FG003|Overall Study|Withdrawal by Subject|2|||
146929039|NCT01371981|529897350|FG004|Overall Study|Withdrawal by Subject|10|||
146929040|NCT01371981|529897351|FG005|Overall Study|Withdrawal by Subject|3|||
146929041|NCT01371981|529897346|FG000|Overall Study|Ineligible|19|||
146929042|NCT01371981|529897347|FG001|Overall Study|Ineligible|13|||
146929043|NCT01371981|529897348|FG002|Overall Study|Ineligible|0|||
146929044|NCT01371981|529897349|FG003|Overall Study|Ineligible|0|||
146929045|NCT01371981|529897350|FG004|Overall Study|Ineligible|0|||
146929046|NCT01371981|529897351|FG005|Overall Study|Ineligible|4|||
146929047|NCT01371981|529897346|FG000|Overall Study|Did not start treatment|2|||
146929048|NCT01371981|529897347|FG001|Overall Study|Did not start treatment|3|||
146929049|NCT01371981|529897348|FG002|Overall Study|Did not start treatment|0|||
146929050|NCT01371981|529897349|FG003|Overall Study|Did not start treatment|0|||
146929051|NCT01371981|529897350|FG004|Overall Study|Did not start treatment|0|||
146979518|NCT00219557|530087122|FG001|Phase 1|Adverse Event|0|||
146979519|NCT00219557|530087123|FG002|Phase 1|Adverse Event|0|||
146979520|NCT00219557|530087121|FG000|Phase 1|Withdrawal by Subject|1|||
146979521|NCT00219557|530087122|FG001|Phase 1|Withdrawal by Subject|0|||
146688992|NCT02291055|529038624|FG004|Overall Study|Study Terminated by Sponsor|1|||
146688993|NCT02291055|529038620|FG000|Overall Study|Other|0|||
146688994|NCT02291055|529038621|FG001|Overall Study|Other|2|||
146688995|NCT02291055|529038622|FG002|Overall Study|Other|1|||
146688996|NCT02291055|529038623|FG003|Overall Study|Other|4|||
146688997|NCT02291055|529038624|FG004|Overall Study|Other|0|||
146688998|NCT01523886|529038625|FG000|Overall Study|surgery cancelled|0|||
146688999|NCT01523886|529038626|FG001|Overall Study|surgery cancelled|1|||
146689000|NCT01173718|529038635|FG000|Overall Study|Death|17|||
146689001|NCT01173718|529038635|FG000|Overall Study|Abandonment of study graft|27|||
146689002|NCT01367158|529038636|FG000|Overall Study|Withdrew consent|0|||
146689003|NCT01367158|529038637|FG001|Overall Study|Withdrew consent|2|||
146689004|NCT01367158|529038638|FG002|Overall Study|Withdrew consent|1|||
146689005|NCT01367158|529038639|FG003|Overall Study|Withdrew consent|0|||
146689006|NCT01367158|529038640|FG004|Overall Study|Withdrew consent|2|||
146689007|NCT01367158|529038641|FG005|Overall Study|Withdrew consent|0|||
146689008|NCT01367158|529038642|FG006|Overall Study|Withdrew consent|0|||
146689009|NCT01367158|529038643|FG007|Overall Study|Withdrew consent|1|||
146689010|NCT01367158|529038644|FG008|Overall Study|Withdrew consent|0|||
146689011|NCT01367158|529038645|FG009|Overall Study|Withdrew consent|0|||
146689012|NCT01367158|529038646|FG010|Overall Study|Withdrew consent|0|||
146689013|NCT01367158|529038636|FG000|Overall Study|Lost to Follow-up|0|||
146689014|NCT01367158|529038637|FG001|Overall Study|Lost to Follow-up|0|||
146689015|NCT01367158|529038638|FG002|Overall Study|Lost to Follow-up|0|||
146689016|NCT01367158|529038639|FG003|Overall Study|Lost to Follow-up|1|||
146689017|NCT01367158|529038640|FG004|Overall Study|Lost to Follow-up|0|||
146689018|NCT01367158|529038641|FG005|Overall Study|Lost to Follow-up|2|||
146689019|NCT01367158|529038642|FG006|Overall Study|Lost to Follow-up|0|||
146689020|NCT01367158|529038643|FG007|Overall Study|Lost to Follow-up|1|||
146979522|NCT00219557|530087123|FG002|Phase 1|Withdrawal by Subject|0|||
146979523|NCT00219557|530087121|FG000|Phase 1|Started chemotherapy at other institute|1|||
146979524|NCT00219557|530087122|FG001|Phase 1|Started chemotherapy at other institute|0|||
146689021|NCT01367158|529038644|FG008|Overall Study|Lost to Follow-up|0|||
146689022|NCT01367158|529038645|FG009|Overall Study|Lost to Follow-up|0|||
146689023|NCT01367158|529038646|FG010|Overall Study|Lost to Follow-up|1|||
146689024|NCT01367158|529038636|FG000|Overall Study|Protocol Violation|0|||
146689025|NCT01367158|529038637|FG001|Overall Study|Protocol Violation|1|||
146689026|NCT01367158|529038638|FG002|Overall Study|Protocol Violation|0|||
146929052|NCT01371981|529897351|FG005|Overall Study|Did not start treatment|2|||
146929053|NCT01586156|529897352|FG000|Overall Study|Pregnancy|0|||
146929054|NCT01586156|529897353|FG001|Overall Study|Pregnancy|1|||
146929055|NCT01586156|529897354|FG002|Overall Study|Pregnancy|0|||
146929056|NCT01244191|529897355|FG000|Overall Study|Progressive disease|295|||
146929057|NCT01244191|529897356|FG001|Overall Study|Progressive disease|350|||
146689027|NCT01367158|529038639|FG003|Overall Study|Protocol Violation|0|||
146689028|NCT01367158|529038640|FG004|Overall Study|Protocol Violation|0|||
146689029|NCT01367158|529038641|FG005|Overall Study|Protocol Violation|0|||
146689030|NCT01367158|529038642|FG006|Overall Study|Protocol Violation|0|||
146689031|NCT01367158|529038643|FG007|Overall Study|Protocol Violation|0|||
146689032|NCT01367158|529038644|FG008|Overall Study|Protocol Violation|0|||
146929058|NCT01244191|529897355|FG000|Overall Study|Clinical disease progression|54|||
146929059|NCT01244191|529897356|FG001|Overall Study|Clinical disease progression|36|||
146929060|NCT01244191|529897355|FG000|Overall Study|Adverse Event|65|||
146929061|NCT01244191|529897356|FG001|Overall Study|Adverse Event|48|||
146929062|NCT01244191|529897355|FG000|Overall Study|Death|22|||
146929063|NCT01244191|529897356|FG001|Overall Study|Death|29|||
146929064|NCT01244191|529897355|FG000|Overall Study|Lost to Follow-up|0|||
146689033|NCT01367158|529038645|FG009|Overall Study|Protocol Violation|0|||
146929065|NCT01244191|529897356|FG001|Overall Study|Lost to Follow-up|2|||
146929066|NCT01244191|529897355|FG000|Overall Study|Protocol Violation|1|||
146929067|NCT01244191|529897356|FG001|Overall Study|Protocol Violation|2|||
146929068|NCT01244191|529897355|FG000|Overall Study|Withdrawal by Subject|31|||
146929069|NCT01244191|529897356|FG001|Overall Study|Withdrawal by Subject|23|||
146929070|NCT01244191|529897355|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
146929071|NCT01244191|529897356|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
146929072|NCT05584202|529897357|FG000|Overall Study|Withdrawal of Consent|3|||
146929073|NCT05584202|529897358|FG001|Overall Study|Withdrawal of Consent|2|||
146929074|NCT05584202|529897357|FG000|Overall Study|Lost to Follow-up|2|||
146929075|NCT05584202|529897358|FG001|Overall Study|Lost to Follow-up|1|||
146929076|NCT05584202|529897357|FG000|Overall Study|Death|0|||
146929077|NCT05584202|529897358|FG001|Overall Study|Death|1|||
146929078|NCT05301322|529897359|FG000|Overall Study|Adverse Event|7|||
146929079|NCT05301322|529897360|FG001|Overall Study|Adverse Event|3|||
146929080|NCT05301322|529897359|FG000|Overall Study|Death|0|||
146929081|NCT05301322|529897360|FG001|Overall Study|Death|1|||
146929082|NCT05301322|529897359|FG000|Overall Study|Lost to Follow-up|2|||
146929083|NCT05301322|529897360|FG001|Overall Study|Lost to Follow-up|1|||
146929084|NCT05301322|529897359|FG000|Overall Study|Protocol Violation|3|||
146929085|NCT05301322|529897360|FG001|Overall Study|Protocol Violation|1|||
146929086|NCT05301322|529897359|FG000|Overall Study|Withdrawal by Subject|3|||
146929087|NCT05301322|529897360|FG001|Overall Study|Withdrawal by Subject|0|||
146929088|NCT05301322|529897359|FG000|Overall Study|Other|4|||
146929089|NCT05301322|529897360|FG001|Overall Study|Other|0|||
146929090|NCT00808249|529897361|FG000|Overall Study|Adverse Event|4|||
146929091|NCT00808249|529897362|FG001|Overall Study|Adverse Event|7|||
146929092|NCT00808249|529897363|FG002|Overall Study|Adverse Event|10|||
146929093|NCT00808249|529897364|FG003|Overall Study|Adverse Event|6|||
146929094|NCT00808249|529897361|FG000|Overall Study|Lost to Follow-up|2|||
146929095|NCT00808249|529897362|FG001|Overall Study|Lost to Follow-up|3|||
146929096|NCT00808249|529897363|FG002|Overall Study|Lost to Follow-up|3|||
146929097|NCT00808249|529897364|FG003|Overall Study|Lost to Follow-up|5|||
146929098|NCT00808249|529897361|FG000|Overall Study|Withdrawal by Subject|4|||
146929099|NCT00808249|529897362|FG001|Overall Study|Withdrawal by Subject|0|||
146929100|NCT00808249|529897363|FG002|Overall Study|Withdrawal by Subject|2|||
146929101|NCT00808249|529897364|FG003|Overall Study|Withdrawal by Subject|4|||
146929102|NCT00808249|529897361|FG000|Overall Study|Protocol Violation|3|||
146929103|NCT00808249|529897362|FG001|Overall Study|Protocol Violation|3|||
146929104|NCT00808249|529897363|FG002|Overall Study|Protocol Violation|3|||
146929105|NCT00808249|529897364|FG003|Overall Study|Protocol Violation|0|||
146929106|NCT00808249|529897361|FG000|Overall Study|Lack of Efficacy|1|||
146929107|NCT00808249|529897362|FG001|Overall Study|Lack of Efficacy|1|||
146929108|NCT00808249|529897363|FG002|Overall Study|Lack of Efficacy|0|||
146929109|NCT00808249|529897364|FG003|Overall Study|Lack of Efficacy|0|||
146689034|NCT01367158|529038646|FG010|Overall Study|Protocol Violation|0|||
146689035|NCT01499563|529038647|FG000|Overall Study|Withdrawal by Subject|10|||
146689036|NCT01499563|529038648|FG001|Overall Study|Withdrawal by Subject|11|||
146929110|NCT00808249|529897361|FG000|Overall Study|study specific discontinuation criteria|1|||
146929111|NCT00808249|529897362|FG001|Overall Study|study specific discontinuation criteria|0|||
146929112|NCT00808249|529897363|FG002|Overall Study|study specific discontinuation criteria|1|||
146689037|NCT01499563|529038649|FG002|Overall Study|Withdrawal by Subject|7|||
146689038|NCT01499563|529038650|FG003|Overall Study|Withdrawal by Subject|8|||
146929113|NCT00808249|529897364|FG003|Overall Study|study specific discontinuation criteria|0|||
146929114|NCT00808249|529897361|FG000|Overall Study|All other reasons|2|||
146929115|NCT00808249|529897362|FG001|Overall Study|All other reasons|1|||
146929116|NCT00808249|529897363|FG002|Overall Study|All other reasons|3|||
146929117|NCT00808249|529897364|FG003|Overall Study|All other reasons|1|||
146929118|NCT03829332|529897365|FG000|Overall Study|Death|225|||
146929119|NCT03829332|529897366|FG001|Overall Study|Death|230|||
146929120|NCT03829332|529897365|FG000|Overall Study|Lost to Follow-up|1|||
146929121|NCT03829332|529897366|FG001|Overall Study|Lost to Follow-up|3|||
146929122|NCT03829332|529897365|FG000|Overall Study|Physician Decision|1|||
146929123|NCT03829332|529897366|FG001|Overall Study|Physician Decision|0|||
146929124|NCT03829332|529897365|FG000|Overall Study|Sponsor Decision|71|||
146929125|NCT03829332|529897366|FG001|Overall Study|Sponsor Decision|72|||
146929126|NCT03829332|529897365|FG000|Overall Study|Withdrawal by Subject|11|||
146929127|NCT03829332|529897366|FG001|Overall Study|Withdrawal by Subject|9|||
146929128|NCT05371912|529897367|FG000|Overall Study|Lost to Follow-up|3|||
146929129|NCT05371912|529897368|FG001|Overall Study|Lost to Follow-up|2|||
146929130|NCT02598661|529897369|FG000|Overall Study|Death|27|||
146929131|NCT02598661|529897370|FG001|Overall Study|Death|34|||
146929132|NCT02598661|529897371|FG002|Overall Study|Death|14|||
146929133|NCT02598661|529897372|FG003|Overall Study|Death|1|||
146929134|NCT02598661|529897373|FG004|Overall Study|Death|0|||
146929135|NCT02598661|529897369|FG000|Overall Study|Lost to Follow-up|2|||
146929136|NCT02598661|529897370|FG001|Overall Study|Lost to Follow-up|3|||
146929137|NCT02598661|529897371|FG002|Overall Study|Lost to Follow-up|2|||
146929138|NCT02598661|529897372|FG003|Overall Study|Lost to Follow-up|0|||
146929139|NCT02598661|529897373|FG004|Overall Study|Lost to Follow-up|0|||
146929140|NCT02598661|529897369|FG000|Overall Study|Withdrawal by Subject|13|||
146929141|NCT02598661|529897370|FG001|Overall Study|Withdrawal by Subject|24|||
146929142|NCT02598661|529897371|FG002|Overall Study|Withdrawal by Subject|14|||
146929143|NCT02598661|529897372|FG003|Overall Study|Withdrawal by Subject|1|||
146929144|NCT02598661|529897373|FG004|Overall Study|Withdrawal by Subject|1|||
146929145|NCT02598661|529897369|FG000|Overall Study|Adverse Event|0|||
146929146|NCT02598661|529897370|FG001|Overall Study|Adverse Event|0|||
146929147|NCT02598661|529897371|FG002|Overall Study|Adverse Event|1|||
146929148|NCT02598661|529897372|FG003|Overall Study|Adverse Event|0|||
146929149|NCT02598661|529897373|FG004|Overall Study|Adverse Event|0|||
146929150|NCT02598661|529897369|FG000|Overall Study|Randomized, Never Treated|0|||
146929151|NCT02598661|529897370|FG001|Overall Study|Randomized, Never Treated|0|||
146929152|NCT02598661|529897371|FG002|Overall Study|Randomized, Never Treated|0|||
146929153|NCT02598661|529897372|FG003|Overall Study|Randomized, Never Treated|0|||
146929154|NCT02598661|529897373|FG004|Overall Study|Randomized, Never Treated|1|||
146929155|NCT03297216|529898857|FG000|Overall Study|Death|0|||
146929156|NCT03297216|529898858|FG001|Overall Study|Death|1|||
146929157|NCT03297216|529898857|FG000|Overall Study|Miscarriage|0|||
146929158|NCT03297216|529898858|FG001|Overall Study|Miscarriage|2|||
146929159|NCT03297216|529898857|FG000|Overall Study|Lost to Follow-up|3|||
146929160|NCT03297216|529898858|FG001|Overall Study|Lost to Follow-up|2|||
146929161|NCT00781963|529898859|FG000|Overall Study|Death|3|||
146929162|NCT00781963|529898860|FG001|Overall Study|Death|0|||
146929163|NCT00781963|529898859|FG000|Overall Study|Lost to Follow-up|2|||
146929164|NCT00781963|529898860|FG001|Overall Study|Lost to Follow-up|1|||
146929165|NCT00781963|529898859|FG000|Overall Study|Withdrawal by Subject|3|||
146929166|NCT00781963|529898860|FG001|Overall Study|Withdrawal by Subject|1|||
146929167|NCT00781963|529898859|FG000|Overall Study|Refused follow-up|9|||
146929168|NCT00781963|529898860|FG001|Overall Study|Refused follow-up|0|||
146929169|NCT01830816|529898863|FG000|Overall Study|Progressive Disease|12|||
146929170|NCT01830816|529898864|FG001|Overall Study|Progressive Disease|7|||
146929171|NCT01830816|529898865|FG002|Overall Study|Progressive Disease|7|||
146929172|NCT01830816|529898863|FG000|Overall Study|Adverse Event|3|||
146929173|NCT01830816|529898864|FG001|Overall Study|Adverse Event|4|||
146929174|NCT01830816|529898865|FG002|Overall Study|Adverse Event|0|||
146929175|NCT01830816|529898863|FG000|Overall Study|Study Terminated by Sponsor|1|||
146929176|NCT01830816|529898864|FG001|Overall Study|Study Terminated by Sponsor|1|||
146689039|NCT01499563|529038647|FG000|Overall Study|Physician Decision|2|||
146689040|NCT01499563|529038648|FG001|Overall Study|Physician Decision|1|||
146689041|NCT01499563|529038649|FG002|Overall Study|Physician Decision|3|||
146689042|NCT01499563|529038650|FG003|Overall Study|Physician Decision|0|||
146689043|NCT01499563|529038647|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
146689044|NCT01499563|529038648|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
146689045|NCT01499563|529038649|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
146689046|NCT01499563|529038650|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
146689047|NCT01499563|529038647|FG000|Overall Study|Adverse Event|2|||
146929177|NCT01830816|529898865|FG002|Overall Study|Study Terminated by Sponsor|0|||
146929178|NCT01830816|529898863|FG000|Overall Study|Withdrawal by Subject|1|||
146929179|NCT01830816|529898864|FG001|Overall Study|Withdrawal by Subject|1|||
146929180|NCT01830816|529898865|FG002|Overall Study|Withdrawal by Subject|0|||
146689048|NCT01499563|529038648|FG001|Overall Study|Adverse Event|0|||
146929181|NCT01830816|529898863|FG000|Overall Study|Lost to Follow-up|0|||
146929182|NCT01830816|529898864|FG001|Overall Study|Lost to Follow-up|1|||
146929183|NCT01830816|529898865|FG002|Overall Study|Lost to Follow-up|0|||
146929184|NCT01830816|529898863|FG000|Overall Study|Symptomatic Deterioration|1|||
146929185|NCT01830816|529898864|FG001|Overall Study|Symptomatic Deterioration|0|||
146929186|NCT01830816|529898865|FG002|Overall Study|Symptomatic Deterioration|0|||
146929187|NCT01830816|529898863|FG000|Overall Study|Reason not Specified|2|||
146929188|NCT01830816|529898864|FG001|Overall Study|Reason not Specified|0|||
146929189|NCT01830816|529898865|FG002|Overall Study|Reason not Specified|0|||
146929190|NCT04124692|529898866|FG000|Overall Study|Medical reason|0|||
146929191|NCT04124692|529898867|FG001|Overall Study|Medical reason|1|||
146929192|NCT04124692|529898866|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
146689049|NCT01499563|529038649|FG002|Overall Study|Adverse Event|1|||
146689050|NCT01499563|529038650|FG003|Overall Study|Adverse Event|3|||
146689051|NCT01499563|529038647|FG000|Overall Study|Lack of Efficacy|0|||
146689052|NCT01499563|529038648|FG001|Overall Study|Lack of Efficacy|1|||
146689053|NCT01499563|529038649|FG002|Overall Study|Lack of Efficacy|6|||
146929193|NCT04124692|529898867|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
146929194|NCT04124692|529898866|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
146929195|NCT04124692|529898867|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
146929196|NCT04124692|529898866|FG000|Overall Study|Lost to Follow-up|2|||
146929197|NCT04124692|529898867|FG001|Overall Study|Lost to Follow-up|4|||
146929198|NCT04124692|529898866|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
146929199|NCT04124692|529898867|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
146929200|NCT00205699|529898871|FG000|Overall Study|Lost to Follow-up|1|||
146929201|NCT00205699|529898872|FG001|Overall Study|Lost to Follow-up|3|||
146929202|NCT00205699|529898873|FG002|Overall Study|Lost to Follow-up|5|||
146929203|NCT00205699|529898871|FG000|Overall Study|Adverse Event|1|||
146929204|NCT00205699|529898872|FG001|Overall Study|Adverse Event|0|||
146929205|NCT00205699|529898873|FG002|Overall Study|Adverse Event|0|||
146929206|NCT00205699|529898871|FG000|Overall Study|Withdrawal by Subject|1|||
146929207|NCT00205699|529898872|FG001|Overall Study|Withdrawal by Subject|2|||
146929208|NCT00205699|529898873|FG002|Overall Study|Withdrawal by Subject|1|||
146929209|NCT00205699|529898871|FG000|Overall Study|Lack of Efficacy|0|||
146929210|NCT00205699|529898872|FG001|Overall Study|Lack of Efficacy|1|||
146929211|NCT00205699|529898873|FG002|Overall Study|Lack of Efficacy|0|||
146929212|NCT01754922|529898880|FG000|Overall Study|Adverse Event|0|||
146929213|NCT01754922|529898881|FG001|Overall Study|Adverse Event|1|||
146929214|NCT01207388|529898882|FG000|Overall Study|Death|67|||
146929215|NCT01207388|529898882|FG000|Overall Study|Withdrawal by Subject|1|||
146929216|NCT01885078|529898883|FG000|Treatment Period|Adverse Event|52|||
146929217|NCT01885078|529898884|FG001|Treatment Period|Adverse Event|136|||
146929218|NCT01885078|529898885|FG002|Treatment Period|Adverse Event|30|||
146929219|NCT01885078|529898886|FG003|Treatment Period|Adverse Event|73|||
146929220|NCT01885078|529898887|FG004|Treatment Period|Adverse Event|17|||
146929221|NCT01885078|529898888|FG005|Treatment Period|Adverse Event|72|||
146929222|NCT01885078|529898889|FG006|Treatment Period|Adverse Event|24|||
146929223|NCT01885078|529898890|FG007|Treatment Period|Adverse Event|5|||
146929224|NCT01885078|529898891|FG008|Treatment Period|Adverse Event|0|||
146929225|NCT01885078|529898892|FG009|Treatment Period|Adverse Event|0|||
146929226|NCT01885078|529898883|FG000|Treatment Period|Death|13|||
146929227|NCT01885078|529898884|FG001|Treatment Period|Death|33|||
146929228|NCT01885078|529898885|FG002|Treatment Period|Death|5|||
146689054|NCT01499563|529038650|FG003|Overall Study|Lack of Efficacy|3|||
146689055|NCT01499563|529038647|FG000|Overall Study|Other|8|||
146689056|NCT01499563|529038648|FG001|Overall Study|Other|6|||
146689057|NCT01499563|529038649|FG002|Overall Study|Other|6|||
146689058|NCT01499563|529038650|FG003|Overall Study|Other|4|||
146689059|NCT03658538|529038653|FG000|Overall Study|Death|2|||
146689060|NCT03658538|529038654|FG001|Overall Study|Death|1|||
146689061|NCT03658538|529038653|FG000|Overall Study|Cancer diagnosis|1|||
146689062|NCT03658538|529038654|FG001|Overall Study|Cancer diagnosis|0|||
146689063|NCT03658538|529038653|FG000|Overall Study|Change residence|1|||
146689064|NCT03658538|529038654|FG001|Overall Study|Change residence|2|||
146689065|NCT03658538|529038653|FG000|Overall Study|Lost to Follow-up|3|||
146689066|NCT03658538|529038654|FG001|Overall Study|Lost to Follow-up|3|||
146689067|NCT03658538|529038653|FG000|Overall Study|Unblinded|2|||
146689068|NCT03658538|529038654|FG001|Overall Study|Unblinded|3|||
146689069|NCT03658538|529038653|FG000|Overall Study|Physician Decision|0|||
146689070|NCT03658538|529038654|FG001|Overall Study|Physician Decision|1|||
146689071|NCT03658538|529038653|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
146689072|NCT03658538|529038654|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
146689073|NCT03658538|529038653|FG000|Overall Study|Evicted from home|1|||
146689074|NCT03658538|529038654|FG001|Overall Study|Evicted from home|0|||
146689075|NCT05198843|529038655|FG000|Overall Study|Lack of Efficacy|1|||
146689076|NCT02588833|529038656|FG000|Part 1|Withdrawal by Subject|1|||
146689077|NCT02588833|529038657|FG001|Part 1|Withdrawal by Subject|0|||
146689078|NCT02588833|529038656|FG000|Part 2A|Physician Decision|0|||
146689079|NCT02588833|529038657|FG001|Part 2A|Physician Decision|1|||
146929229|NCT01885078|529898886|FG003|Treatment Period|Death|9|||
146689080|NCT02588833|529038656|FG000|Part 2A|Withdrawal by Subject|0|||
146929230|NCT01885078|529898887|FG004|Treatment Period|Death|2|||
146929231|NCT01885078|529898888|FG005|Treatment Period|Death|10|||
146929232|NCT01885078|529898889|FG006|Treatment Period|Death|3|||
146929233|NCT01885078|529898890|FG007|Treatment Period|Death|2|||
146929234|NCT01885078|529898891|FG008|Treatment Period|Death|0|||
146929235|NCT01885078|529898892|FG009|Treatment Period|Death|0|||
146929236|NCT01885078|529898883|FG000|Treatment Period|Lack of Efficacy|12|||
146929237|NCT01885078|529898884|FG001|Treatment Period|Lack of Efficacy|33|||
146689081|NCT02588833|529038657|FG001|Part 2A|Withdrawal by Subject|1|||
146689082|NCT02588833|529038656|FG000|Part 2B|Adverse Event|0|||
146929238|NCT01885078|529898885|FG002|Treatment Period|Lack of Efficacy|10|||
146929239|NCT01885078|529898886|FG003|Treatment Period|Lack of Efficacy|23|||
146929240|NCT01885078|529898887|FG004|Treatment Period|Lack of Efficacy|24|||
146929241|NCT01885078|529898888|FG005|Treatment Period|Lack of Efficacy|58|||
146929242|NCT01885078|529898889|FG006|Treatment Period|Lack of Efficacy|9|||
146929243|NCT01885078|529898890|FG007|Treatment Period|Lack of Efficacy|5|||
146929244|NCT01885078|529898891|FG008|Treatment Period|Lack of Efficacy|0|||
146929245|NCT01885078|529898892|FG009|Treatment Period|Lack of Efficacy|0|||
146929246|NCT01885078|529898883|FG000|Treatment Period|Lost to Follow-up|16|||
146929247|NCT01885078|529898884|FG001|Treatment Period|Lost to Follow-up|19|||
146929248|NCT01885078|529898885|FG002|Treatment Period|Lost to Follow-up|7|||
146929249|NCT01885078|529898886|FG003|Treatment Period|Lost to Follow-up|9|||
146929250|NCT01885078|529898887|FG004|Treatment Period|Lost to Follow-up|2|||
146929251|NCT01885078|529898888|FG005|Treatment Period|Lost to Follow-up|8|||
146929252|NCT01885078|529898889|FG006|Treatment Period|Lost to Follow-up|2|||
146929253|NCT01885078|529898890|FG007|Treatment Period|Lost to Follow-up|0|||
146929254|NCT01885078|529898891|FG008|Treatment Period|Lost to Follow-up|0|||
146929255|NCT01885078|529898892|FG009|Treatment Period|Lost to Follow-up|0|||
146929256|NCT01885078|529898883|FG000|Treatment Period|Physician Decision|19|||
146929257|NCT01885078|529898884|FG001|Treatment Period|Physician Decision|21|||
146929258|NCT01885078|529898885|FG002|Treatment Period|Physician Decision|5|||
146929259|NCT01885078|529898886|FG003|Treatment Period|Physician Decision|12|||
146929260|NCT01885078|529898887|FG004|Treatment Period|Physician Decision|9|||
146929261|NCT01885078|529898888|FG005|Treatment Period|Physician Decision|24|||
146929262|NCT01885078|529898889|FG006|Treatment Period|Physician Decision|4|||
146929263|NCT01885078|529898890|FG007|Treatment Period|Physician Decision|3|||
146929264|NCT01885078|529898891|FG008|Treatment Period|Physician Decision|0|||
146929265|NCT01885078|529898892|FG009|Treatment Period|Physician Decision|0|||
146929266|NCT01885078|529898883|FG000|Treatment Period|Protocol Violation|3|||
146979525|NCT00219557|530087123|FG002|Phase 1|Started chemotherapy at other institute|0|||
146979526|NCT00219557|530087121|FG000|Phase 2|Lack of Efficacy|0|||
146979527|NCT00219557|530087122|FG001|Phase 2|Lack of Efficacy|21|||
146979528|NCT00219557|530087123|FG002|Phase 2|Lack of Efficacy|15|||
146979529|NCT00219557|530087121|FG000|Phase 2|Adverse Event|0|||
146689083|NCT02588833|529038657|FG001|Part 2B|Adverse Event|1|||
146689084|NCT02588833|529038656|FG000|Part 2C|Adverse Event|0|||
146689085|NCT02588833|529038657|FG001|Part 2C|Adverse Event|1|||
146689086|NCT02588833|529038656|FG000|Part 2C|Withdrawal by Subject|0|||
146689087|NCT02588833|529038657|FG001|Part 2C|Withdrawal by Subject|1|||
146689088|NCT02588833|529038656|FG000|Part 3 (Safety Follow-up)|Other|0|||
146689089|NCT02588833|529038657|FG001|Part 3 (Safety Follow-up)|Other|2|||
146689090|NCT03333044|529038658|FG000|Overall Study|Pregnancy|1|||
146689091|NCT03333044|529038659|FG001|Overall Study|Pregnancy|0|||
146689092|NCT03333044|529038660|FG002|Overall Study|Pregnancy|0|||
146689093|NCT03333044|529038658|FG000|Overall Study|Lost to Follow-up|0|||
146689094|NCT03333044|529038659|FG001|Overall Study|Lost to Follow-up|14|||
146689095|NCT03333044|529038660|FG002|Overall Study|Lost to Follow-up|6|||
146689096|NCT03649711|529038663|FG000|Overall Study|Adverse Event|0|||
146689097|NCT03649711|529038664|FG001|Overall Study|Adverse Event|1|||
146689098|NCT03649711|529038665|FG002|Overall Study|Adverse Event|0|||
146689099|NCT03649711|529038663|FG000|Overall Study|Kidney Transplant|1|||
146689100|NCT03649711|529038664|FG001|Overall Study|Kidney Transplant|0|||
146689101|NCT03649711|529038665|FG002|Overall Study|Kidney Transplant|0|||
146689102|NCT02921776|529038666|FG000|Overall Study|patient deterioration, fatigue|2|||
146689103|NCT02921776|529038667|FG001|Overall Study|patient deterioration, fatigue|6|||
146689104|NCT02921776|529038668|FG002|Overall Study|patient deterioration, fatigue|0|||
146689105|NCT02921776|529038669|FG003|Overall Study|patient deterioration, fatigue|0|||
146689106|NCT02921776|529038670|FG004|Overall Study|patient deterioration, fatigue|0|||
146689107|NCT02921776|529038671|FG005|Overall Study|patient deterioration, fatigue|0|||
146689108|NCT02921776|529038672|FG006|Overall Study|patient deterioration, fatigue|0|||
146689109|NCT02921776|529038673|FG007|Overall Study|patient deterioration, fatigue|0|||
146689110|NCT02921776|529038666|FG000|Overall Study|Withdrawal by Subject|0|||
146689111|NCT02921776|529038667|FG001|Overall Study|Withdrawal by Subject|2|||
146689112|NCT02921776|529038668|FG002|Overall Study|Withdrawal by Subject|0|||
146689113|NCT02921776|529038669|FG003|Overall Study|Withdrawal by Subject|1|||
146689114|NCT02921776|529038670|FG004|Overall Study|Withdrawal by Subject|1|||
146689115|NCT02921776|529038671|FG005|Overall Study|Withdrawal by Subject|0|||
146689116|NCT02921776|529038672|FG006|Overall Study|Withdrawal by Subject|8|||
146689117|NCT02921776|529038673|FG007|Overall Study|Withdrawal by Subject|1|||
146689118|NCT02921776|529038666|FG000|Overall Study|Death|0|||
146689119|NCT02921776|529038667|FG001|Overall Study|Death|0|||
146929267|NCT01885078|529898884|FG001|Treatment Period|Protocol Violation|5|||
146929268|NCT01885078|529898885|FG002|Treatment Period|Protocol Violation|0|||
146929269|NCT01885078|529898886|FG003|Treatment Period|Protocol Violation|3|||
146929270|NCT01885078|529898887|FG004|Treatment Period|Protocol Violation|1|||
146929271|NCT01885078|529898888|FG005|Treatment Period|Protocol Violation|6|||
146929272|NCT01885078|529898889|FG006|Treatment Period|Protocol Violation|0|||
146979530|NCT00219557|530087122|FG001|Phase 2|Adverse Event|22|||
146775187|NCT03703336|529348064|FG001|Overall Study|Protocol Violation|1|||
146775188|NCT03703336|529348063|FG000|Overall Study|Physician Decision|2|||
146775189|NCT03703336|529348064|FG001|Overall Study|Physician Decision|0|||
146775190|NCT03703336|529348063|FG000|Overall Study|Adverse Event|0|||
146775191|NCT03703336|529348064|FG001|Overall Study|Adverse Event|2|||
146775192|NCT03703336|529348063|FG000|Overall Study|Lost to Follow-up|1|||
146775193|NCT03703336|529348064|FG001|Overall Study|Lost to Follow-up|0|||
146775194|NCT00595413|529348065|FG000|Overall Study|Adverse Event|0|||
146775195|NCT00595413|529348066|FG001|Overall Study|Adverse Event|2|||
146775196|NCT00595413|529348067|FG002|Overall Study|Adverse Event|1|||
146775197|NCT00595413|529348068|FG003|Overall Study|Adverse Event|1|||
146775198|NCT00595413|529348065|FG000|Overall Study|Lost to Follow-up|2|||
146775199|NCT00595413|529348066|FG001|Overall Study|Lost to Follow-up|2|||
146775200|NCT00595413|529348067|FG002|Overall Study|Lost to Follow-up|1|||
146775201|NCT00595413|529348068|FG003|Overall Study|Lost to Follow-up|3|||
146775202|NCT00595413|529348065|FG000|Overall Study|Death|0|||
146775203|NCT00595413|529348066|FG001|Overall Study|Death|0|||
146775204|NCT00595413|529348067|FG002|Overall Study|Death|1|||
146775205|NCT00595413|529348068|FG003|Overall Study|Death|0|||
146775206|NCT00595413|529348065|FG000|Overall Study|Other|5|||
146775207|NCT00595413|529348066|FG001|Overall Study|Other|1|||
146775208|NCT00595413|529348067|FG002|Overall Study|Other|5|||
146775209|NCT00595413|529348068|FG003|Overall Study|Other|0|||
146775210|NCT00807937|529348069|FG000|Overall Study|Adverse Event|12|||
146775211|NCT00807937|529348070|FG001|Overall Study|Adverse Event|12|||
146775212|NCT00807937|529348071|FG002|Overall Study|Adverse Event|5|||
146775213|NCT00807937|529348072|FG003|Overall Study|Adverse Event|4|||
146775214|NCT00807937|529348069|FG000|Overall Study|Protocol Violation|4|||
146775215|NCT00807937|529348070|FG001|Overall Study|Protocol Violation|5|||
146775216|NCT00807937|529348071|FG002|Overall Study|Protocol Violation|3|||
146775217|NCT00807937|529348072|FG003|Overall Study|Protocol Violation|3|||
146775218|NCT00807937|529348069|FG000|Overall Study|Withdrawal by Subject|5|||
146775219|NCT00807937|529348070|FG001|Overall Study|Withdrawal by Subject|4|||
146775220|NCT00807937|529348071|FG002|Overall Study|Withdrawal by Subject|1|||
146775221|NCT00807937|529348072|FG003|Overall Study|Withdrawal by Subject|4|||
146775222|NCT00807937|529348069|FG000|Overall Study|Lost to Follow-up|4|||
146775223|NCT00807937|529348070|FG001|Overall Study|Lost to Follow-up|0|||
146775224|NCT00807937|529348071|FG002|Overall Study|Lost to Follow-up|2|||
146775225|NCT00807937|529348072|FG003|Overall Study|Lost to Follow-up|1|||
146775226|NCT00807937|529348069|FG000|Overall Study|Lack of Efficacy|0|||
146775227|NCT00807937|529348070|FG001|Overall Study|Lack of Efficacy|0|||
146775228|NCT00807937|529348071|FG002|Overall Study|Lack of Efficacy|1|||
146775229|NCT00807937|529348072|FG003|Overall Study|Lack of Efficacy|2|||
146775230|NCT00807937|529348069|FG000|Overall Study|Intake of prohibited medicine|0|||
146775231|NCT00807937|529348070|FG001|Overall Study|Intake of prohibited medicine|0|||
146775232|NCT00807937|529348071|FG002|Overall Study|Intake of prohibited medicine|2|||
146775233|NCT00807937|529348072|FG003|Overall Study|Intake of prohibited medicine|0|||
146775234|NCT00807937|529348069|FG000|Overall Study|All other reasons (not provided)|2|||
146775235|NCT00807937|529348070|FG001|Overall Study|All other reasons (not provided)|4|||
146775236|NCT00807937|529348071|FG002|Overall Study|All other reasons (not provided)|0|||
146775237|NCT00807937|529348072|FG003|Overall Study|All other reasons (not provided)|1|||
146929273|NCT01885078|529898890|FG007|Treatment Period|Protocol Violation|0|||
146929274|NCT01885078|529898891|FG008|Treatment Period|Protocol Violation|0|||
146929275|NCT01885078|529898892|FG009|Treatment Period|Protocol Violation|0|||
146929276|NCT01885078|529898883|FG000|Treatment Period|Sponsor Decision|245|||
146929277|NCT01885078|529898884|FG001|Treatment Period|Sponsor Decision|648|||
146929278|NCT01885078|529898885|FG002|Treatment Period|Sponsor Decision|49|||
146929279|NCT01885078|529898886|FG003|Treatment Period|Sponsor Decision|90|||
146929280|NCT01885078|529898887|FG004|Treatment Period|Sponsor Decision|20|||
146929281|NCT01885078|529898888|FG005|Treatment Period|Sponsor Decision|38|||
146929282|NCT01885078|529898889|FG006|Treatment Period|Sponsor Decision|162|||
146979531|NCT00219557|530087123|FG002|Phase 2|Adverse Event|2|||
146775238|NCT04629950|529348075|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
146775239|NCT04629950|529348076|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
146775240|NCT04629950|529348077|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
146775241|NCT04629950|529348078|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
146775242|NCT04629950|529348075|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
146775243|NCT04629950|529348076|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
146775244|NCT04629950|529348077|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
146929283|NCT01885078|529898890|FG007|Treatment Period|Sponsor Decision|3|||
146929284|NCT01885078|529898891|FG008|Treatment Period|Sponsor Decision|0|||
146775245|NCT04629950|529348078|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
146775246|NCT04629950|529348075|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
146775247|NCT04629950|529348076|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
146929285|NCT01885078|529898892|FG009|Treatment Period|Sponsor Decision|0|||
146929286|NCT01885078|529898883|FG000|Treatment Period|Withdrawal by Subject|72|||
146929287|NCT01885078|529898884|FG001|Treatment Period|Withdrawal by Subject|132|||
146979532|NCT00219557|530087121|FG000|Phase 2|Death|0|||
146979533|NCT00219557|530087122|FG001|Phase 2|Death|8|||
146979534|NCT00219557|530087123|FG002|Phase 2|Death|2|||
146979535|NCT00219557|530087121|FG000|Phase 2|Other|0|||
146979536|NCT00219557|530087122|FG001|Phase 2|Other|8|||
146689120|NCT02921776|529038668|FG002|Overall Study|Death|0|||
146689121|NCT02921776|529038669|FG003|Overall Study|Death|2|||
146689122|NCT02921776|529038670|FG004|Overall Study|Death|0|||
146689123|NCT02921776|529038671|FG005|Overall Study|Death|0|||
146689124|NCT02921776|529038672|FG006|Overall Study|Death|0|||
146689125|NCT02921776|529038673|FG007|Overall Study|Death|0|||
146689126|NCT02921776|529038666|FG000|Overall Study|extubation or early discharge|0|||
146689127|NCT02921776|529038667|FG001|Overall Study|extubation or early discharge|0|||
146689128|NCT02921776|529038668|FG002|Overall Study|extubation or early discharge|0|||
146689129|NCT02921776|529038669|FG003|Overall Study|extubation or early discharge|5|||
146689130|NCT02921776|529038670|FG004|Overall Study|extubation or early discharge|5|||
146689131|NCT02921776|529038671|FG005|Overall Study|extubation or early discharge|0|||
146689132|NCT02921776|529038672|FG006|Overall Study|extubation or early discharge|0|||
146689133|NCT02921776|529038673|FG007|Overall Study|extubation or early discharge|0|||
146689134|NCT02921776|529038666|FG000|Overall Study|Lost to Follow-up|0|||
146689135|NCT02921776|529038667|FG001|Overall Study|Lost to Follow-up|0|||
146689136|NCT02921776|529038668|FG002|Overall Study|Lost to Follow-up|0|||
146689137|NCT02921776|529038669|FG003|Overall Study|Lost to Follow-up|0|||
146689138|NCT02921776|529038670|FG004|Overall Study|Lost to Follow-up|0|||
146689139|NCT02921776|529038671|FG005|Overall Study|Lost to Follow-up|2|||
146689140|NCT02921776|529038672|FG006|Overall Study|Lost to Follow-up|3|||
146689141|NCT02921776|529038673|FG007|Overall Study|Lost to Follow-up|6|||
146689142|NCT04537234|529038675|FG000|Overall Study|Withdrawal by Subject|2|||
146689143|NCT04537234|529038676|FG001|Overall Study|Withdrawal by Subject|0|||
146689144|NCT00296374|529038677|FG000|Overall Study|Adverse Event|14|||
146689145|NCT00296374|529038678|FG001|Overall Study|Adverse Event|10|||
146689146|NCT00296374|529038679|FG002|Overall Study|Adverse Event|7|||
146689147|NCT00296374|529038677|FG000|Overall Study|Withdrawal by Subject|3|||
146689148|NCT00296374|529038678|FG001|Overall Study|Withdrawal by Subject|5|||
146689149|NCT00296374|529038679|FG002|Overall Study|Withdrawal by Subject|11|||
146689150|NCT00296374|529038677|FG000|Overall Study|Incorrect enrollment|3|||
146689151|NCT00296374|529038678|FG001|Overall Study|Incorrect enrollment|3|||
146689152|NCT00296374|529038679|FG002|Overall Study|Incorrect enrollment|4|||
146689153|NCT00296374|529038677|FG000|Overall Study|Protocol Violation|1|||
146689154|NCT00296374|529038678|FG001|Overall Study|Protocol Violation|2|||
146689155|NCT00296374|529038679|FG002|Overall Study|Protocol Violation|3|||
146689156|NCT00296374|529038677|FG000|Overall Study|Lost to Follow-up|3|||
146689157|NCT00296374|529038678|FG001|Overall Study|Lost to Follow-up|1|||
146689158|NCT00296374|529038679|FG002|Overall Study|Lost to Follow-up|1|||
146689159|NCT00296374|529038677|FG000|Overall Study|Relocated to another state|1|||
146689160|NCT00296374|529038678|FG001|Overall Study|Relocated to another state|0|||
146689161|NCT00296374|529038679|FG002|Overall Study|Relocated to another state|0|||
146689162|NCT00296374|529038677|FG000|Overall Study|Stopped drug before end of study visit|0|||
146689163|NCT00296374|529038678|FG001|Overall Study|Stopped drug before end of study visit|1|||
146689164|NCT00296374|529038679|FG002|Overall Study|Stopped drug before end of study visit|0|||
146689165|NCT00296374|529038677|FG000|Overall Study|Nephrologist introduced ACE|0|||
146689166|NCT00296374|529038678|FG001|Overall Study|Nephrologist introduced ACE|1|||
146689167|NCT00296374|529038679|FG002|Overall Study|Nephrologist introduced ACE|0|||
146689168|NCT00296374|529038677|FG000|Overall Study|Pregnancy|0|||
146689169|NCT00296374|529038678|FG001|Overall Study|Pregnancy|0|||
146689170|NCT00296374|529038679|FG002|Overall Study|Pregnancy|2|||
146689171|NCT00296374|529038677|FG000|Overall Study|Other|0|||
146689172|NCT00296374|529038678|FG001|Overall Study|Other|0|||
146689173|NCT00296374|529038679|FG002|Overall Study|Other|1|||
146689174|NCT01721330|529038680|FG000|Overall Study|Withdrawal by Subject|0|||
146689175|NCT01721330|529038681|FG001|Overall Study|Withdrawal by Subject|1|||
146689176|NCT04318080|529040951|FG000|Overall Study|Study closed by sponsor|10|||
146775248|NCT04629950|529348077|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
146775249|NCT04629950|529348078|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
146689177|NCT04318080|529040952|FG001|Overall Study|Study closed by sponsor|22|||
146689178|NCT04318080|529040951|FG000|Overall Study|Death|3|||
146689179|NCT04318080|529040952|FG001|Overall Study|Death|9|||
146689180|NCT04318080|529040951|FG000|Overall Study|Withdrawal by Subject|1|||
146689181|NCT04318080|529040952|FG001|Overall Study|Withdrawal by Subject|0|||
146689182|NCT04318080|529040951|FG000|Overall Study|Protocol Deviation|1|||
146689183|NCT04318080|529040952|FG001|Overall Study|Protocol Deviation|0|||
146689184|NCT06308822|529040953|FG000|Overall Study|Mutation Status Not Confirmed|17|||
146689185|NCT06308822|529040953|FG000|Overall Study|Adverse Event|1|||
146979537|NCT00219557|530087123|FG002|Phase 2|Other|6|||
146979538|NCT00219557|530087121|FG000|Phase 2|Withdrawal by Subject|0|||
146689186|NCT06308822|529040953|FG000|Overall Study|Death|5|||
146689187|NCT06308822|529040953|FG000|Overall Study|Disease progression|8|||
146689188|NCT06308822|529040953|FG000|Overall Study|Withdrawal by Subject|1|||
146979539|NCT00219557|530087122|FG001|Phase 2|Withdrawal by Subject|9|||
146689189|NCT06308822|529040953|FG000|Overall Study|Physician Decision|3|||
146689190|NCT00542919|529040961|FG000|Overall Study|Adverse Event|1|||
146929288|NCT01885078|529898885|FG002|Treatment Period|Withdrawal by Subject|25|||
146929289|NCT01885078|529898886|FG003|Treatment Period|Withdrawal by Subject|63|||
146929290|NCT01885078|529898887|FG004|Treatment Period|Withdrawal by Subject|15|||
146929291|NCT01885078|529898888|FG005|Treatment Period|Withdrawal by Subject|34|||
146929292|NCT01885078|529898889|FG006|Treatment Period|Withdrawal by Subject|17|||
146929293|NCT01885078|529898890|FG007|Treatment Period|Withdrawal by Subject|10|||
146929294|NCT01885078|529898891|FG008|Treatment Period|Withdrawal by Subject|0|||
146929295|NCT01885078|529898892|FG009|Treatment Period|Withdrawal by Subject|0|||
146929296|NCT01885078|529898883|FG000|Treatment Period|Other|0|||
146929297|NCT01885078|529898884|FG001|Treatment Period|Other|0|||
146929298|NCT01885078|529898885|FG002|Treatment Period|Other|0|||
146929299|NCT01885078|529898886|FG003|Treatment Period|Other|1|||
146929300|NCT01885078|529898887|FG004|Treatment Period|Other|0|||
146929301|NCT01885078|529898888|FG005|Treatment Period|Other|0|||
146929302|NCT01885078|529898889|FG006|Treatment Period|Other|0|||
146929303|NCT01885078|529898890|FG007|Treatment Period|Other|0|||
146929304|NCT01885078|529898891|FG008|Treatment Period|Other|0|||
146929305|NCT01885078|529898892|FG009|Treatment Period|Other|0|||
146929306|NCT01885078|529898883|FG000|Step-down Period|Sponsor Decision|0|||
146929307|NCT01885078|529898884|FG001|Step-down Period|Sponsor Decision|0|||
146929308|NCT01885078|529898885|FG002|Step-down Period|Sponsor Decision|0|||
146929309|NCT01885078|529898886|FG003|Step-down Period|Sponsor Decision|0|||
146929310|NCT01885078|529898887|FG004|Step-down Period|Sponsor Decision|0|||
146929311|NCT01885078|529898888|FG005|Step-down Period|Sponsor Decision|0|||
146929312|NCT01885078|529898889|FG006|Step-down Period|Sponsor Decision|0|||
146929313|NCT01885078|529898890|FG007|Step-down Period|Sponsor Decision|0|||
146929314|NCT01885078|529898891|FG008|Step-down Period|Sponsor Decision|1|||
146929315|NCT01885078|529898892|FG009|Step-down Period|Sponsor Decision|1|||
146929316|NCT01885078|529898883|FG000|Step-down Period|Adverse Event|0|||
146929317|NCT01885078|529898884|FG001|Step-down Period|Adverse Event|0|||
146929318|NCT01885078|529898885|FG002|Step-down Period|Adverse Event|0|||
146929319|NCT01885078|529898886|FG003|Step-down Period|Adverse Event|0|||
146929320|NCT01885078|529898887|FG004|Step-down Period|Adverse Event|0|||
146929321|NCT01885078|529898888|FG005|Step-down Period|Adverse Event|0|||
146929322|NCT01885078|529898889|FG006|Step-down Period|Adverse Event|0|||
146929323|NCT01885078|529898890|FG007|Step-down Period|Adverse Event|0|||
146929324|NCT01885078|529898891|FG008|Step-down Period|Adverse Event|29|||
146929325|NCT01885078|529898892|FG009|Step-down Period|Adverse Event|38|||
146929326|NCT01885078|529898883|FG000|Step-down Period|Withdrawal by Subject|0|||
146929327|NCT01885078|529898884|FG001|Step-down Period|Withdrawal by Subject|0|||
146929328|NCT01885078|529898885|FG002|Step-down Period|Withdrawal by Subject|0|||
146929329|NCT01885078|529898886|FG003|Step-down Period|Withdrawal by Subject|0|||
146929330|NCT01885078|529898887|FG004|Step-down Period|Withdrawal by Subject|0|||
146929331|NCT01885078|529898888|FG005|Step-down Period|Withdrawal by Subject|0|||
146929332|NCT01885078|529898889|FG006|Step-down Period|Withdrawal by Subject|0|||
146929333|NCT01885078|529898890|FG007|Step-down Period|Withdrawal by Subject|0|||
146929334|NCT01885078|529898891|FG008|Step-down Period|Withdrawal by Subject|25|||
146929335|NCT01885078|529898892|FG009|Step-down Period|Withdrawal by Subject|15|||
146929336|NCT01885078|529898883|FG000|Step-down Period|Physician Decision|0|||
146929337|NCT01885078|529898884|FG001|Step-down Period|Physician Decision|0|||
146929338|NCT01885078|529898885|FG002|Step-down Period|Physician Decision|0|||
146929339|NCT01885078|529898886|FG003|Step-down Period|Physician Decision|0|||
146929340|NCT01885078|529898887|FG004|Step-down Period|Physician Decision|0|||
146929341|NCT01885078|529898888|FG005|Step-down Period|Physician Decision|0|||
146929342|NCT01885078|529898889|FG006|Step-down Period|Physician Decision|0|||
146929343|NCT01885078|529898890|FG007|Step-down Period|Physician Decision|0|||
146929344|NCT01885078|529898891|FG008|Step-down Period|Physician Decision|7|||
146929345|NCT01885078|529898892|FG009|Step-down Period|Physician Decision|2|||
146929346|NCT01885078|529898883|FG000|Step-down Period|Death|0|||
146929347|NCT01885078|529898884|FG001|Step-down Period|Death|0|||
146929348|NCT01885078|529898885|FG002|Step-down Period|Death|0|||
146929349|NCT01885078|529898886|FG003|Step-down Period|Death|0|||
146929350|NCT01885078|529898887|FG004|Step-down Period|Death|0|||
146929351|NCT01885078|529898888|FG005|Step-down Period|Death|0|||
146929352|NCT01885078|529898889|FG006|Step-down Period|Death|0|||
146929353|NCT01885078|529898890|FG007|Step-down Period|Death|0|||
146929354|NCT01885078|529898891|FG008|Step-down Period|Death|4|||
146929355|NCT01885078|529898892|FG009|Step-down Period|Death|3|||
146929356|NCT01885078|529898883|FG000|Step-down Period|Lost to Follow-up|0|||
146929357|NCT01885078|529898884|FG001|Step-down Period|Lost to Follow-up|0|||
146929358|NCT01885078|529898885|FG002|Step-down Period|Lost to Follow-up|0|||
146929359|NCT01885078|529898886|FG003|Step-down Period|Lost to Follow-up|0|||
146929360|NCT01885078|529898887|FG004|Step-down Period|Lost to Follow-up|0|||
146929361|NCT01885078|529898888|FG005|Step-down Period|Lost to Follow-up|0|||
146929362|NCT01885078|529898889|FG006|Step-down Period|Lost to Follow-up|0|||
146929363|NCT01885078|529898890|FG007|Step-down Period|Lost to Follow-up|0|||
146929364|NCT01885078|529898891|FG008|Step-down Period|Lost to Follow-up|1|||
146929365|NCT01885078|529898892|FG009|Step-down Period|Lost to Follow-up|1|||
146929366|NCT01885078|529898883|FG000|Step-down Period|Lack of Efficacy|0|||
146929367|NCT01885078|529898884|FG001|Step-down Period|Lack of Efficacy|0|||
146929368|NCT01885078|529898885|FG002|Step-down Period|Lack of Efficacy|0|||
146689191|NCT00542919|529040962|FG001|Overall Study|Adverse Event|5|||
146689192|NCT00542919|529040963|FG002|Overall Study|Adverse Event|1|||
146689193|NCT00542919|529040961|FG000|Overall Study|Withdrawal by Subject|1|||
146689194|NCT00542919|529040962|FG001|Overall Study|Withdrawal by Subject|0|||
146689195|NCT00542919|529040963|FG002|Overall Study|Withdrawal by Subject|3|||
146689196|NCT00542919|529040961|FG000|Overall Study|Physician Decision|2|||
146689197|NCT00542919|529040962|FG001|Overall Study|Physician Decision|2|||
146689198|NCT00542919|529040963|FG002|Overall Study|Physician Decision|1|||
146689199|NCT00542919|529040961|FG000|Overall Study|Sponsor Decision|1|||
146689200|NCT00542919|529040962|FG001|Overall Study|Sponsor Decision|0|||
146689201|NCT00542919|529040963|FG002|Overall Study|Sponsor Decision|0|||
146689202|NCT00542919|529040961|FG000|Overall Study|Lost to Follow-up|2|||
146689203|NCT00542919|529040962|FG001|Overall Study|Lost to Follow-up|0|||
146689204|NCT00542919|529040963|FG002|Overall Study|Lost to Follow-up|1|||
146689205|NCT04788953|529040966|FG000|Overall Study|Adverse Event|1|||
146689206|NCT04788953|529040967|FG001|Overall Study|Adverse Event|1|||
146689207|NCT04788953|529040966|FG000|Overall Study|Withdrawal by Subject|1|||
146689208|NCT04788953|529040967|FG001|Overall Study|Withdrawal by Subject|0|||
146689209|NCT04788953|529040966|FG000|Overall Study|Protocol Violation|0|||
146689210|NCT04788953|529040967|FG001|Overall Study|Protocol Violation|1|||
146689211|NCT02278263|529040968|FG000|Overall Study|Protocol Violation|7|||
146689212|NCT02278263|529040969|FG001|Overall Study|Protocol Violation|0|||
146689213|NCT02278263|529040970|FG002|Overall Study|Protocol Violation|9|||
146689214|NCT02092662|529040971|FG000|Overall Study|Lost to Follow-up|13|||
146689215|NCT02092662|529040972|FG001|Overall Study|Lost to Follow-up|0|||
146689216|NCT02710045|529040973|FG000|Overall Study|Death|1|||
146689217|NCT02710045|529040974|FG001|Overall Study|Death|2|||
146689218|NCT02710045|529040975|FG002|Overall Study|Death|0|||
146689219|NCT02710045|529040973|FG000|Overall Study|Withdrawal by Subject|6|||
146689220|NCT02710045|529040974|FG001|Overall Study|Withdrawal by Subject|6|||
146689221|NCT02710045|529040975|FG002|Overall Study|Withdrawal by Subject|2|||
146689222|NCT02710045|529040973|FG000|Overall Study|Protocol Violation|1|||
146689223|NCT02710045|529040974|FG001|Overall Study|Protocol Violation|2|||
146689224|NCT02710045|529040975|FG002|Overall Study|Protocol Violation|3|||
146689225|NCT02710045|529040973|FG000|Overall Study|Lost to Follow-up|3|||
146689226|NCT02710045|529040974|FG001|Overall Study|Lost to Follow-up|6|||
146689227|NCT02710045|529040975|FG002|Overall Study|Lost to Follow-up|7|||
146689228|NCT02710045|529040973|FG000|Overall Study|Physician Decision|0|||
146689229|NCT02710045|529040974|FG001|Overall Study|Physician Decision|0|||
146929369|NCT01885078|529898886|FG003|Step-down Period|Lack of Efficacy|0|||
146929370|NCT01885078|529898887|FG004|Step-down Period|Lack of Efficacy|0|||
146929371|NCT01885078|529898888|FG005|Step-down Period|Lack of Efficacy|0|||
146929372|NCT01885078|529898889|FG006|Step-down Period|Lack of Efficacy|0|||
146929373|NCT01885078|529898890|FG007|Step-down Period|Lack of Efficacy|0|||
146929374|NCT01885078|529898891|FG008|Step-down Period|Lack of Efficacy|1|||
146929375|NCT01885078|529898892|FG009|Step-down Period|Lack of Efficacy|0|||
146929376|NCT01885078|529898883|FG000|Step-down Period|Protocol Violation|0|||
146929377|NCT01885078|529898884|FG001|Step-down Period|Protocol Violation|0|||
146929378|NCT01885078|529898885|FG002|Step-down Period|Protocol Violation|0|||
146689230|NCT02710045|529040975|FG002|Overall Study|Physician Decision|1|||
146689231|NCT02710045|529040973|FG000|Overall Study|Poor Attendance|0|||
146689232|NCT02710045|529040974|FG001|Overall Study|Poor Attendance|1|||
146689233|NCT02710045|529040975|FG002|Overall Study|Poor Attendance|0|||
146689234|NCT00071760|529040979|FG000|Overall Study|Adverse Event|2|||
146689235|NCT00071760|529040980|FG001|Overall Study|Adverse Event|1|||
146689236|NCT00071760|529040979|FG000|Overall Study|Lost to Follow-up|0|||
146689237|NCT00071760|529040980|FG001|Overall Study|Lost to Follow-up|3|||
146689238|NCT00071760|529040979|FG000|Overall Study|Protocol Violation|1|||
146689239|NCT00071760|529040980|FG001|Overall Study|Protocol Violation|0|||
146929379|NCT01885078|529898886|FG003|Step-down Period|Protocol Violation|0|||
146929380|NCT01885078|529898887|FG004|Step-down Period|Protocol Violation|0|||
146929381|NCT01885078|529898888|FG005|Step-down Period|Protocol Violation|0|||
146929382|NCT01885078|529898889|FG006|Step-down Period|Protocol Violation|0|||
146929383|NCT01885078|529898890|FG007|Step-down Period|Protocol Violation|0|||
146929384|NCT01885078|529898891|FG008|Step-down Period|Protocol Violation|1|||
146929385|NCT01885078|529898892|FG009|Step-down Period|Protocol Violation|1|||
146689240|NCT00071760|529040979|FG000|Overall Study|Withdrawal by Subject|0|||
146689241|NCT00071760|529040980|FG001|Overall Study|Withdrawal by Subject|1|||
146689242|NCT00071760|529040979|FG000|Overall Study|Insufficient Viral Load Response|1|||
146689243|NCT00071760|529040980|FG001|Overall Study|Insufficient Viral Load Response|1|||
146689244|NCT00071760|529040979|FG000|Overall Study|Lack of availability of RTV|1|||
146689245|NCT00071760|529040980|FG001|Overall Study|Lack of availability of RTV|0|||
146689246|NCT00071760|529040979|FG000|Overall Study|Physician Decision|2|||
146689247|NCT00071760|529040980|FG001|Overall Study|Physician Decision|1|||
146689248|NCT00071760|529040979|FG000|Overall Study|Relocation|0|||
146689249|NCT00071760|529040980|FG001|Overall Study|Relocation|1|||
146979540|NCT00219557|530087123|FG002|Phase 2|Withdrawal by Subject|5|||
146848301|NCT02407990|529615652|FG007|Overall Study|Lost to Follow-up|17|||
146848302|NCT02407990|529615645|FG000|Overall Study|Progressive Disease|0|||
146848303|NCT02407990|529615646|FG001|Overall Study|Progressive Disease|0|||
146848304|NCT02407990|529615647|FG002|Overall Study|Progressive Disease|0|||
146848305|NCT02407990|529615648|FG003|Overall Study|Progressive Disease|0|||
146848306|NCT02407990|529615649|FG004|Overall Study|Progressive Disease|0|||
146848307|NCT02407990|529615650|FG005|Overall Study|Progressive Disease|0|||
146848308|NCT02407990|529615651|FG006|Overall Study|Progressive Disease|0|||
146848309|NCT02407990|529615652|FG007|Overall Study|Progressive Disease|1|||
146848310|NCT02407990|529615645|FG000|Overall Study|Withdrawal by Subject|0|||
146848311|NCT02407990|529615646|FG001|Overall Study|Withdrawal by Subject|0|||
146848312|NCT02407990|529615647|FG002|Overall Study|Withdrawal by Subject|0|||
146848313|NCT02407990|529615648|FG003|Overall Study|Withdrawal by Subject|0|||
146848314|NCT02407990|529615649|FG004|Overall Study|Withdrawal by Subject|1|||
146848315|NCT02407990|529615650|FG005|Overall Study|Withdrawal by Subject|0|||
146848316|NCT02407990|529615651|FG006|Overall Study|Withdrawal by Subject|0|||
146848317|NCT02407990|529615652|FG007|Overall Study|Withdrawal by Subject|30|||
146848318|NCT02407990|529615645|FG000|Overall Study|Study Terminated by Sponsor|1|||
146848319|NCT02407990|529615646|FG001|Overall Study|Study Terminated by Sponsor|3|||
146848320|NCT02407990|529615647|FG002|Overall Study|Study Terminated by Sponsor|3|||
146848321|NCT02407990|529615648|FG003|Overall Study|Study Terminated by Sponsor|0|||
146848322|NCT02407990|529615649|FG004|Overall Study|Study Terminated by Sponsor|3|||
146848323|NCT02407990|529615650|FG005|Overall Study|Study Terminated by Sponsor|4|||
146848324|NCT02407990|529615651|FG006|Overall Study|Study Terminated by Sponsor|3|||
146848325|NCT02407990|529615652|FG007|Overall Study|Study Terminated by Sponsor|37|||
146848326|NCT02407990|529615645|FG000|Overall Study|Logistics|0|||
146848327|NCT02407990|529615646|FG001|Overall Study|Logistics|0|||
146848328|NCT02407990|529615647|FG002|Overall Study|Logistics|0|||
146848329|NCT02407990|529615648|FG003|Overall Study|Logistics|0|||
146848330|NCT02407990|529615649|FG004|Overall Study|Logistics|0|||
146848331|NCT02407990|529615650|FG005|Overall Study|Logistics|0|||
146848332|NCT02407990|529615651|FG006|Overall Study|Logistics|0|||
146848333|NCT02407990|529615652|FG007|Overall Study|Logistics|1|||
146848334|NCT02407990|529615645|FG000|Overall Study|Rolled into long-term extension study|0|||
146848335|NCT02407990|529615646|FG001|Overall Study|Rolled into long-term extension study|0|||
146848336|NCT02407990|529615647|FG002|Overall Study|Rolled into long-term extension study|0|||
146848337|NCT02407990|529615648|FG003|Overall Study|Rolled into long-term extension study|0|||
146848338|NCT02407990|529615649|FG004|Overall Study|Rolled into long-term extension study|0|||
146848339|NCT02407990|529615650|FG005|Overall Study|Rolled into long-term extension study|0|||
146848340|NCT02407990|529615651|FG006|Overall Study|Rolled into long-term extension study|0|||
146848341|NCT02407990|529615652|FG007|Overall Study|Rolled into long-term extension study|1|||
146848342|NCT00923260|529615653|FG000|Overall Study|Lost to Follow-up|1|||
146848343|NCT00923260|529615654|FG001|Overall Study|Lost to Follow-up|1|||
146848344|NCT00591721|529615655|FG000|Overall Study|Withdrawal by Subject|10|||
146848345|NCT00591721|529615656|FG001|Overall Study|Withdrawal by Subject|10|||
146848346|NCT00591721|529615655|FG000|Overall Study|Lost to Follow-up|1|||
146848347|NCT00591721|529615656|FG001|Overall Study|Lost to Follow-up|4|||
146848348|NCT00591721|529615655|FG000|Overall Study|Intervention not received|10|||
146848349|NCT00591721|529615656|FG001|Overall Study|Intervention not received|8|||
146848350|NCT00901186|529615657|FG000|Overall Study|Lack of Efficacy|0|||
146848351|NCT00901186|529615658|FG001|Overall Study|Lack of Efficacy|1|||
146848352|NCT00901186|529615657|FG000|Overall Study|Abnormal laboratory values|0|||
146848353|NCT00901186|529615658|FG001|Overall Study|Abnormal laboratory values|1|||
146848354|NCT00901186|529615657|FG000|Overall Study|Lost to Follow-up|2|||
146848355|NCT00901186|529615658|FG001|Overall Study|Lost to Follow-up|0|||
146848356|NCT00901186|529615657|FG000|Overall Study|Adverse Event|2|||
146848357|NCT00901186|529615658|FG001|Overall Study|Adverse Event|4|||
146848358|NCT00901186|529615657|FG000|Overall Study|Administration problems|0|||
146848359|NCT00901186|529615658|FG001|Overall Study|Administration problems|1|||
146848360|NCT00901186|529615657|FG000|Overall Study|Protocol deviations|5|||
146848361|NCT00901186|529615658|FG001|Overall Study|Protocol deviations|4|||
146848362|NCT02383056|529615661|FG000|Overall Study|Adverse Event|1|||
146848363|NCT02383056|529615662|FG001|Overall Study|Adverse Event|0|||
146848364|NCT02383056|529615661|FG000|Overall Study|Lost to Follow-up|0|||
146848365|NCT02383056|529615662|FG001|Overall Study|Lost to Follow-up|2|||
146848366|NCT03900416|529615663|FG000|Six Week Follow-up|Lost to Follow-up|1|||
146848367|NCT03900416|529615664|FG001|Six Week Follow-up|Lost to Follow-up|0|||
146848368|NCT03900416|529615663|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
146848369|NCT03900416|529615664|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
146848370|NCT03900416|529615663|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
146848371|NCT03900416|529615664|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
146848372|NCT03900416|529615663|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
146848373|NCT03900416|529615664|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
146929386|NCT02899377|529898896|FG000|Overall Study|Adverse Event|1|||
146929387|NCT02899377|529898897|FG001|Overall Study|Adverse Event|0|||
146929388|NCT01231607|529898898|FG000|Overall Study|Adverse Event|0|||
146929389|NCT01231607|529898899|FG001|Overall Study|Adverse Event|8|||
146929390|NCT01231607|529898900|FG002|Overall Study|Adverse Event|4|||
146929391|NCT01231607|529898901|FG003|Overall Study|Adverse Event|4|||
146929392|NCT01231607|529898902|FG004|Overall Study|Adverse Event|5|||
146929393|NCT01231607|529898898|FG000|Overall Study|Lost to Follow-up|13|||
146929394|NCT01231607|529898899|FG001|Overall Study|Lost to Follow-up|11|||
146929395|NCT01231607|529898900|FG002|Overall Study|Lost to Follow-up|10|||
146929396|NCT01231607|529898901|FG003|Overall Study|Lost to Follow-up|10|||
146929397|NCT01231607|529898902|FG004|Overall Study|Lost to Follow-up|4|||
146929398|NCT01231607|529898898|FG000|Overall Study|Physician Decision|4|||
146929399|NCT01231607|529898899|FG001|Overall Study|Physician Decision|4|||
146929400|NCT01231607|529898900|FG002|Overall Study|Physician Decision|3|||
146929401|NCT01231607|529898901|FG003|Overall Study|Physician Decision|5|||
146929402|NCT01231607|529898902|FG004|Overall Study|Physician Decision|4|||
146929403|NCT01231607|529898898|FG000|Overall Study|Protocol Violation|3|||
146929404|NCT01231607|529898899|FG001|Overall Study|Protocol Violation|2|||
146929405|NCT01231607|529898900|FG002|Overall Study|Protocol Violation|0|||
146929406|NCT01231607|529898901|FG003|Overall Study|Protocol Violation|2|||
146929407|NCT01231607|529898902|FG004|Overall Study|Protocol Violation|2|||
146929408|NCT01231607|529898898|FG000|Overall Study|Withdrawal by Subject|9|||
146929409|NCT01231607|529898899|FG001|Overall Study|Withdrawal by Subject|9|||
146929410|NCT01231607|529898900|FG002|Overall Study|Withdrawal by Subject|14|||
146929411|NCT01231607|529898901|FG003|Overall Study|Withdrawal by Subject|17|||
146929412|NCT01231607|529898902|FG004|Overall Study|Withdrawal by Subject|9|||
146929413|NCT01677507|529898903|FG000|Initial Assignment|Adverse Event|0|||
146929414|NCT01677507|529898904|FG001|Initial Assignment|Adverse Event|1|||
146929415|NCT01677507|529898903|FG000|Initial Assignment|Protocol Violation|0|||
146929416|NCT01677507|529898904|FG001|Initial Assignment|Protocol Violation|1|||
146929417|NCT01677507|529898903|FG000|Second Assigment|Withdrawal by Subject|2|||
146929418|NCT01677507|529898904|FG001|Second Assigment|Withdrawal by Subject|2|||
146929419|NCT01677507|529898903|FG000|Second Assigment|Adverse Event|1|||
146929420|NCT01677507|529898904|FG001|Second Assigment|Adverse Event|3|||
146929421|NCT04321252|529898905|FG000|Overall Study|Withdrawal by Subject|0|||
146929422|NCT04321252|529898906|FG001|Overall Study|Withdrawal by Subject|0|||
146929423|NCT04321252|529898907|FG002|Overall Study|Withdrawal by Subject|0|||
146929424|NCT04321252|529898908|FG003|Overall Study|Withdrawal by Subject|0|||
146929425|NCT04321252|529898909|FG004|Overall Study|Withdrawal by Subject|0|||
146929426|NCT04321252|529898910|FG005|Overall Study|Withdrawal by Subject|1|||
146929427|NCT04321252|529898911|FG006|Overall Study|Withdrawal by Subject|0|||
146929428|NCT04321252|529898912|FG007|Overall Study|Withdrawal by Subject|0|||
146929429|NCT04321252|529898913|FG008|Overall Study|Withdrawal by Subject|0|||
146929430|NCT00259740|529898916|FG000|Overall Study|Physician Decision|1|||
146929431|NCT00259740|529898917|FG001|Overall Study|Physician Decision|1|||
146929432|NCT00259740|529898916|FG000|Overall Study|Adverse Event|0|||
146929433|NCT00259740|529898917|FG001|Overall Study|Adverse Event|2|||
146929434|NCT00259740|529898916|FG000|Overall Study|Withdrawal by Subject|2|||
146929435|NCT00259740|529898917|FG001|Overall Study|Withdrawal by Subject|6|||
146929436|NCT00259740|529898916|FG000|Overall Study|Death|1|||
146929437|NCT00259740|529898917|FG001|Overall Study|Death|1|||
146979541|NCT00219557|530087121|FG000|Phase 2|Treatment not received|0|||
146979542|NCT00219557|530087122|FG001|Phase 2|Treatment not received|1|||
146979543|NCT00219557|530087123|FG002|Phase 2|Treatment not received|3|||
146979544|NCT03063632|530087124|FG000|Overall Study|Death|4|||
146979545|NCT03063632|530087125|FG001|Overall Study|Death|6|||
146979546|NCT03063632|530087124|FG000|Overall Study|Lost to Follow-up|0|||
146929438|NCT00259740|529898916|FG000|Overall Study|Disease progression|19|||
146929439|NCT00259740|529898917|FG001|Overall Study|Disease progression|36|||
146929440|NCT00259740|529898916|FG000|Overall Study|Ongoing|17|||
146929441|NCT00259740|529898917|FG001|Overall Study|Ongoing|3|||
146929442|NCT00259740|529898916|FG000|Overall Study|Other|3|||
146929443|NCT00259740|529898917|FG001|Overall Study|Other|0|||
146929444|NCT00259740|529898916|FG000|Overall Study|Requirement for alternative therapy|0|||
146929445|NCT00259740|529898917|FG001|Overall Study|Requirement for alternative therapy|4|||
146929446|NCT01844830|529898919|FG000|Overall Study|Withdrawal by Subject|1|||
146929447|NCT01844830|529898920|FG001|Overall Study|Withdrawal by Subject|0|||
146929448|NCT03150095|529898926|FG000|Overall Study|Death|0|||
146929449|NCT03150095|529898927|FG001|Overall Study|Death|1|||
146929450|NCT03150095|529898926|FG000|Overall Study|Lost to Follow-up|1|||
146929451|NCT03150095|529898927|FG001|Overall Study|Lost to Follow-up|1|||
146929452|NCT03150095|529898926|FG000|Overall Study|Withdrawal by Subject|4|||
146929453|NCT03150095|529898927|FG001|Overall Study|Withdrawal by Subject|0|||
146929454|NCT03150095|529898926|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
146979547|NCT03063632|530087125|FG001|Overall Study|Lost to Follow-up|1|||
146929455|NCT03150095|529898927|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
146929456|NCT05025787|529898929|FG000|Overall Study|Lack of Efficacy|0|||
146929457|NCT05025787|529898930|FG001|Overall Study|Lack of Efficacy|1|||
146929458|NCT05025787|529898929|FG000|Overall Study|Adverse Event|2|||
146929459|NCT05025787|529898930|FG001|Overall Study|Adverse Event|4|||
146929460|NCT05025787|529898929|FG000|Overall Study|Non compliance|0|||
146929461|NCT05025787|529898930|FG001|Overall Study|Non compliance|1|||
146929462|NCT05025787|529898929|FG000|Overall Study|Protocol Violation|3|||
146929463|NCT05025787|529898930|FG001|Overall Study|Protocol Violation|1|||
146929464|NCT05025787|529898929|FG000|Overall Study|Stopping criteria met|1|||
146929465|NCT05025787|529898930|FG001|Overall Study|Stopping criteria met|1|||
146929466|NCT05025787|529898929|FG000|Overall Study|Withdrawal by Subject|3|||
146929467|NCT05025787|529898930|FG001|Overall Study|Withdrawal by Subject|1|||
146929468|NCT01551758|529898933|FG000|Overall Study|Adverse Event|29|||
146929469|NCT01551758|529898934|FG001|Overall Study|Adverse Event|43|||
146929470|NCT01551758|529898933|FG000|Overall Study|Lack of Efficacy|0|||
146929471|NCT01551758|529898934|FG001|Overall Study|Lack of Efficacy|1|||
146929472|NCT01551758|529898933|FG000|Overall Study|Protocol Violation|5|||
146929473|NCT01551758|529898934|FG001|Overall Study|Protocol Violation|6|||
146929474|NCT01551758|529898933|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
146929475|NCT01551758|529898934|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
146929476|NCT01551758|529898933|FG000|Overall Study|Lost to Follow-up|29|||
146929477|NCT01551758|529898934|FG001|Overall Study|Lost to Follow-up|25|||
146929478|NCT01551758|529898933|FG000|Overall Study|Physician Decision|9|||
146929479|NCT01551758|529898934|FG001|Overall Study|Physician Decision|3|||
146929480|NCT01551758|529898933|FG000|Overall Study|Withdrawal by Subject|14|||
146929481|NCT01551758|529898934|FG001|Overall Study|Withdrawal by Subject|17|||
146929482|NCT03666858|529898935|FG000|Cohort 1|Adverse Event|1|||
146929483|NCT03666858|529898936|FG001|Cohort 1|Adverse Event|0|||
146929484|NCT03666858|529898935|FG000|Cohort 2|Adverse Event|0|||
146929485|NCT03666858|529898936|FG001|Cohort 2|Adverse Event|1|||
146929486|NCT00121992|529898937|FG000|Overall Study|Treatment not received|2|||
146929487|NCT00121992|529898938|FG001|Overall Study|Treatment not received|11|||
146929488|NCT00363246|529898939|FG000|Overall Study|Death|40|||
146929489|NCT00363246|529898939|FG000|Overall Study|Withdrawal by Subject|19|||
146929490|NCT00363246|529898939|FG000|Overall Study|Lost to Follow-up|14|||
146929491|NCT00363246|529898939|FG000|Overall Study|Bad health|6|||
146929492|NCT00363246|529898939|FG000|Overall Study|Stopped using wheelchair|11|||
146929493|NCT00363246|529898939|FG000|Overall Study|Subject expressed security concerns|2|||
146929494|NCT00363246|529898939|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
146929495|NCT01608724|529898940|FG000|Overall Study|Withdrawal by Subject|131|||
146929496|NCT01608724|529898940|FG000|Overall Study|Lost to Follow-up|41|||
146929497|NCT01608724|529898940|FG000|Overall Study|Study-specific discontinuation criteria|32|||
146929498|NCT01608724|529898940|FG000|Overall Study|Adverse Event|29|||
146929499|NCT01608724|529898940|FG000|Overall Study|Protocol Violation|6|||
146929500|NCT01608724|529898940|FG000|Overall Study|bood sugar too high, etc.|3|||
146929501|NCT01608724|529898940|FG000|Overall Study|Safety reasons|1|||
146929502|NCT05757427|529898947|FG000|Overall Study|Adverse Event|1|||
146929503|NCT05757427|529898947|FG000|Overall Study|Device deficiency|1|||
146929504|NCT05757427|529898947|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
146929505|NCT05757427|529898947|FG000|Overall Study|MWBI scan of only 1 breast|3|||
146929506|NCT05757427|529898947|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
146929507|NCT03423979|529898948|FG000|Overall Study|Death|5|||
146929508|NCT03423979|529898948|FG000|Overall Study|Adverse Event|4|||
146929509|NCT03423979|529898948|FG000|Overall Study|Withdrawal by Subject|3|||
146929510|NCT03423979|529898948|FG000|Overall Study|Lost to Follow-up|16|||
146929511|NCT04971785|529898949|FG000|Overall Study|Withdrew Consent|5|||
146929512|NCT04971785|529898950|FG001|Overall Study|Withdrew Consent|5|||
146929513|NCT04971785|529898951|FG002|Overall Study|Withdrew Consent|17|||
146929514|NCT04971785|529898952|FG003|Overall Study|Withdrew Consent|7|||
146929515|NCT04971785|529898949|FG000|Overall Study|Adverse Event|7|||
146929516|NCT04971785|529898950|FG001|Overall Study|Adverse Event|8|||
146929517|NCT04971785|529898951|FG002|Overall Study|Adverse Event|6|||
146929518|NCT04971785|529898952|FG003|Overall Study|Adverse Event|3|||
146929519|NCT04971785|529898949|FG000|Overall Study|Lost to Follow-up|2|||
146929520|NCT04971785|529898950|FG001|Overall Study|Lost to Follow-up|1|||
146929521|NCT04971785|529898951|FG002|Overall Study|Lost to Follow-up|6|||
146929522|NCT04971785|529898952|FG003|Overall Study|Lost to Follow-up|7|||
146929523|NCT04971785|529898949|FG000|Overall Study|Protocol Violation|3|||
146929524|NCT04971785|529898950|FG001|Overall Study|Protocol Violation|1|||
146929525|NCT04971785|529898951|FG002|Overall Study|Protocol Violation|1|||
146929526|NCT04971785|529898952|FG003|Overall Study|Protocol Violation|2|||
146929527|NCT04971785|529898949|FG000|Overall Study|Investigator's Discretion|3|||
146929528|NCT04971785|529898950|FG001|Overall Study|Investigator's Discretion|1|||
146929529|NCT04971785|529898951|FG002|Overall Study|Investigator's Discretion|1|||
146929530|NCT04971785|529898952|FG003|Overall Study|Investigator's Discretion|0|||
146929531|NCT04971785|529898949|FG000|Overall Study|Randomized but Never Treated|1|||
146929532|NCT04971785|529898950|FG001|Overall Study|Randomized but Never Treated|2|||
146929533|NCT04971785|529898951|FG002|Overall Study|Randomized but Never Treated|0|||
146929534|NCT04971785|529898952|FG003|Overall Study|Randomized but Never Treated|1|||
146929535|NCT04971785|529898949|FG000|Overall Study|Death|0|||
146979548|NCT03063632|530087124|FG000|Overall Study|Withdrawal by Subject|0|||
146979549|NCT03063632|530087125|FG001|Overall Study|Withdrawal by Subject|2|||
146979550|NCT03063632|530087124|FG000|Overall Study|Physician Decision|2|||
146979551|NCT03063632|530087125|FG001|Overall Study|Physician Decision|0|||
146979552|NCT03063632|530087124|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
146979553|NCT03063632|530087125|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
146979554|NCT00106028|530087126|FG000|Overall Study|Adverse Event|3|||
146979555|NCT00106028|530087127|FG001|Overall Study|Adverse Event|2|||
146979556|NCT00106028|530087126|FG000|Overall Study|Protocol Violation|1|||
146979557|NCT00106028|530087127|FG001|Overall Study|Protocol Violation|1|||
146979558|NCT00106028|530087126|FG000|Overall Study|Withdrawal by Subject|2|||
146979559|NCT00106028|530087127|FG001|Overall Study|Withdrawal by Subject|8|||
146979560|NCT00106028|530087126|FG000|Overall Study|Lost to Follow-up|0|||
146979561|NCT00106028|530087127|FG001|Overall Study|Lost to Follow-up|1|||
146979562|NCT00947011|530087129|FG000|Overall Study|Study was terminated,PI left institution|12|||
146979563|NCT00814658|530087130|FG000|Overall Study|Lost to Follow-up|0|||
146979564|NCT00814658|530087131|FG001|Overall Study|Lost to Follow-up|1|||
146979565|NCT00814658|530087130|FG000|Overall Study|Physician Decision|1|||
146979566|NCT00814658|530087131|FG001|Overall Study|Physician Decision|0|||
146979567|NCT00814658|530087130|FG000|Overall Study|Adverse Event|3|||
146979568|NCT00814658|530087131|FG001|Overall Study|Adverse Event|3|||
146979569|NCT05266456|530087132|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
146979570|NCT05266456|530087133|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
146979571|NCT05266456|530087134|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
146979572|NCT05266456|530087135|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
146979573|NCT05266456|530087132|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
146979574|NCT05266456|530087133|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
146979575|NCT05266456|530087134|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
146689250|NCT03424265|529040983|FG000|Overall Study|screening failure|1|||
146689251|NCT03424265|529040984|FG001|Overall Study|screening failure|0|||
146689252|NCT03424265|529040983|FG000|Overall Study|Withdrawal by Subject|0|||
146689253|NCT03424265|529040984|FG001|Overall Study|Withdrawal by Subject|2|||
146689254|NCT00391274|529040994|FG000|Overall Study|Death Due to Study Disease|55|||
146689255|NCT00391274|529040995|FG001|Overall Study|Death Due to Study Disease|45|||
146689256|NCT00391274|529040994|FG000|Overall Study|Lost to Follow-up|0|||
146689257|NCT00391274|529040995|FG001|Overall Study|Lost to Follow-up|3|||
146689258|NCT00391274|529040994|FG000|Overall Study|Physician Decision|4|||
146689259|NCT00391274|529040995|FG001|Overall Study|Physician Decision|2|||
146689260|NCT00391274|529040994|FG000|Overall Study|Withdrawal by Subject|0|||
146689261|NCT00391274|529040995|FG001|Overall Study|Withdrawal by Subject|3|||
146689262|NCT00391274|529040994|FG000|Overall Study|Death Due to Adverse Event|1|||
146689263|NCT00391274|529040995|FG001|Overall Study|Death Due to Adverse Event|3|||
146689264|NCT00391274|529040994|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
146689265|NCT00391274|529040995|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
146689266|NCT00391274|529040994|FG000|Overall Study|Death Not Study Related|0|||
146689267|NCT00391274|529040995|FG001|Overall Study|Death Not Study Related|1|||
146689268|NCT00894322|529040997|FG000|Overall Study|Withdrawal by Subject|1|||
146689269|NCT00894322|529040998|FG001|Overall Study|Withdrawal by Subject|0|||
146689270|NCT00894322|529040999|FG002|Overall Study|Withdrawal by Subject|0|||
146689271|NCT03447990|529041010|FG000|Overall Study|Withdrawal by Subject|0|||
146689272|NCT03447990|529041011|FG001|Overall Study|Withdrawal by Subject|0|||
146689273|NCT03447990|529041012|FG002|Overall Study|Withdrawal by Subject|0|||
146689274|NCT03447990|529041013|FG003|Overall Study|Withdrawal by Subject|0|||
146689275|NCT03447990|529041014|FG004|Overall Study|Withdrawal by Subject|0|||
146689276|NCT03447990|529041015|FG005|Overall Study|Withdrawal by Subject|0|||
146979576|NCT05266456|530087135|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
146689277|NCT03447990|529041016|FG006|Overall Study|Withdrawal by Subject|1|||
146689278|NCT02738450|529041019|FG000|Overall Study|Withdrawal by Subject|0|||
146689279|NCT02738450|529041020|FG001|Overall Study|Withdrawal by Subject|2|||
146689280|NCT02738450|529041021|FG002|Overall Study|Withdrawal by Subject|0|||
146689281|NCT03559257|529041022|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
146689282|NCT03559257|529041023|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
146979577|NCT05266456|530087132|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
146689283|NCT03559257|529041022|FG000|Double Blind Treatment Period|Protocol Violation|1|||
146979578|NCT05266456|530087133|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
146979579|NCT05266456|530087134|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
146979580|NCT05266456|530087135|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
146979581|NCT05266456|530087132|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
146689284|NCT03559257|529041023|FG001|Double Blind Treatment Period|Protocol Violation|4|||
146689285|NCT03559257|529041022|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
146689286|NCT03559257|529041023|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
146689287|NCT03559257|529041022|FG000|Double Blind Treatment Period|Adverse Event|0|||
146689288|NCT03559257|529041023|FG001|Double Blind Treatment Period|Adverse Event|1|||
146775250|NCT04629950|529348075|FG000|Extension Study|Withdrawal by Subject|0|||
146775251|NCT04629950|529348076|FG001|Extension Study|Withdrawal by Subject|0|||
146775252|NCT04629950|529348077|FG002|Extension Study|Withdrawal by Subject|1|||
146775253|NCT04629950|529348078|FG003|Extension Study|Withdrawal by Subject|0|||
146775254|NCT04629950|529348075|FG000|Extension Study|Adverse Event|0|||
146775255|NCT04629950|529348076|FG001|Extension Study|Adverse Event|0|||
146775256|NCT04629950|529348077|FG002|Extension Study|Adverse Event|0|||
146775257|NCT04629950|529348078|FG003|Extension Study|Adverse Event|1|||
146775258|NCT03233633|529348079|FG000|Overall Study|Adverse Event|2|||
146775259|NCT03233633|529348079|FG000|Overall Study|Less Than 3 Days of Data|6|||
146775260|NCT02088853|529348080|FG000|Overall Study|Pregnancy|1|||
146775261|NCT02088853|529348081|FG001|Overall Study|Pregnancy|0|||
146775262|NCT02708108|529348082|FG000|Overall Study|Death|1|||
146775263|NCT02708108|529348083|FG001|Overall Study|Death|2|||
146775264|NCT02708108|529348082|FG000|Overall Study|Regimen change|1|||
146775265|NCT02708108|529348083|FG001|Overall Study|Regimen change|0|||
146775266|NCT02708108|529348082|FG000|Overall Study|No MRD and no imaging available|0|||
146775267|NCT02708108|529348083|FG001|Overall Study|No MRD and no imaging available|1|||
146775268|NCT00580866|529348088|FG000|Overall Study|Lost to Follow-up|2|||
146775269|NCT00580866|529348089|FG001|Overall Study|Lost to Follow-up|2|||
146775270|NCT00609336|529348090|FG000|Overall Study|Protocol Violation|3|||
146775271|NCT00609336|529348090|FG000|Overall Study|Death|1|||
146775272|NCT00609336|529348090|FG000|Overall Study|LA or Met at Surgery|9|||
146775273|NCT00068601|529348091|FG000|Overall Study|Ineligible|11|||
146775274|NCT00068601|529348092|FG001|Overall Study|Ineligible|13|||
146775275|NCT00068601|529348091|FG000|Overall Study|Not evaluable: withdrew consent|5|||
146775276|NCT00068601|529348092|FG001|Overall Study|Not evaluable: withdrew consent|4|||
146775277|NCT00068601|529348091|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
146775278|NCT00068601|529348092|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
146775279|NCT00068601|529348091|FG000|Overall Study|Death|11|||
146775280|NCT00068601|529348092|FG001|Overall Study|Death|3|||
146775281|NCT00068601|529348091|FG000|Overall Study|Lost to Follow-up|3|||
146775282|NCT00068601|529348092|FG001|Overall Study|Lost to Follow-up|2|||
146775283|NCT00068601|529348091|FG000|Overall Study|Missing primary outcome data|30|||
146775284|NCT00068601|529348092|FG001|Overall Study|Missing primary outcome data|34|||
146775285|NCT00419341|529348098|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
146775286|NCT00419341|529348098|FG000|Wash in/Wash Out Period|Adverse Event|2|||
146775287|NCT00419341|529348098|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
146775288|NCT00419341|529348098|FG000|Efficacy Period|Withdrawal by Subject|6|||
146775289|NCT00419341|529348098|FG000|Efficacy Period|Protocol Violation|1|||
146775290|NCT00419341|529348098|FG000|Efficacy Period|Lost to Follow-up|1|||
146775291|NCT00419341|529348098|FG000|Efficacy Period|Non-compliance|1|||
146775292|NCT00419341|529348098|FG000|Efficacy Period|Termination of study site|1|||
146775293|NCT01925339|529348102|FG000|Overall Study|Adverse Event|2|||
146775294|NCT01925339|529348103|FG001|Overall Study|Adverse Event|0|||
146775295|NCT01205048|529348106|FG000|Overall Study|Withdrawal by Subject|14|||
146775296|NCT01205048|529348106|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
146775297|NCT01205048|529348106|FG000|Overall Study|Lost to Follow-up|4|||
146775298|NCT01205048|529348106|FG000|Overall Study|Other|2|||
146775299|NCT03892564|529348107|FG000|Overall Study|Withdrawal by Subject|2|||
146775300|NCT03997916|529348113|FG000|Overall Study|Protocol Violation|35|||
146775301|NCT01207492|529348114|FG000|Overall Study|Still on study|1|||
146775302|NCT01207492|529348114|FG000|Overall Study|Withdrawal by Subject|9|||
146775303|NCT01207492|529348114|FG000|Overall Study|Physician Decision|1|||
146775304|NCT01207492|529348114|FG000|Overall Study|Progressive disease|3|||
146775305|NCT01207492|529348114|FG000|Overall Study|Toxicity|1|||
146775306|NCT02769858|529348115|FG000|Overall Study|Withdrawal by Subject|2|||
146775307|NCT04043455|529349494|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
146775308|NCT04043455|529349495|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
146775309|NCT04043455|529349496|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
146775310|NCT04043455|529349497|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
146775311|NCT04043455|529349498|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
146775312|NCT04043455|529349499|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
146775313|NCT04043455|529349494|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
146775314|NCT04043455|529349495|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
146775315|NCT04043455|529349496|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
146929536|NCT04971785|529898950|FG001|Overall Study|Death|1|||
146929537|NCT04971785|529898951|FG002|Overall Study|Death|1|||
146929538|NCT04971785|529898952|FG003|Overall Study|Death|0|||
146929539|NCT04971785|529898949|FG000|Overall Study|Site Terminated by Sponsor|1|||
146929540|NCT04971785|529898950|FG001|Overall Study|Site Terminated by Sponsor|1|||
146929541|NCT04971785|529898951|FG002|Overall Study|Site Terminated by Sponsor|0|||
146929542|NCT04971785|529898952|FG003|Overall Study|Site Terminated by Sponsor|0|||
146929543|NCT01251861|529898953|FG000|Overall Study|Disease progression|6|||
146929544|NCT01251861|529898954|FG001|Overall Study|Disease progression|6|||
146929545|NCT01251861|529898953|FG000|Overall Study|Adverse Event|2|||
146929546|NCT01251861|529898954|FG001|Overall Study|Adverse Event|17|||
146929547|NCT01251861|529898953|FG000|Overall Study|Withdrawal by Subject|2|||
146929548|NCT01251861|529898954|FG001|Overall Study|Withdrawal by Subject|2|||
146929549|NCT01251861|529898953|FG000|Overall Study|Alternative therapy|1|||
146929550|NCT01251861|529898954|FG001|Overall Study|Alternative therapy|0|||
146929551|NCT01251861|529898953|FG000|Overall Study|Other complicating disease|0|||
146929552|NCT01251861|529898954|FG001|Overall Study|Other complicating disease|1|||
146689289|NCT03559257|529041022|FG000|Double Blind Treatment Period|Screen Failure|0|||
146689290|NCT03559257|529041023|FG001|Double Blind Treatment Period|Screen Failure|1|||
146689291|NCT03559257|529041022|FG000|Open-label Treatment Period|Adverse Event|1|||
146689292|NCT03559257|529041023|FG001|Open-label Treatment Period|Adverse Event|4|||
146689293|NCT03559257|529041022|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
146689294|NCT03559257|529041023|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
146929553|NCT01251861|529898953|FG000|Overall Study|Physician Decision|1|||
146689295|NCT03559257|529041022|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
146689296|NCT03559257|529041023|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
146689297|NCT03559257|529041022|FG000|Open-label Treatment Period|Protocol Violation|2|||
146689298|NCT03559257|529041023|FG001|Open-label Treatment Period|Protocol Violation|0|||
146689299|NCT03559257|529041022|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
146689300|NCT03559257|529041023|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
146689301|NCT03559257|529041022|FG000|Open-label Treatment Period|Physician Decision|0|||
146689302|NCT03559257|529041023|FG001|Open-label Treatment Period|Physician Decision|1|||
146689303|NCT01387347|529041025|FG000|Overall Study|Lost to Follow-up|2|||
146689304|NCT01387347|529041026|FG001|Overall Study|Lost to Follow-up|1|||
146689305|NCT03251079|529041027|FG000|Overall Study|Withdrawal by Subject|1|||
146689306|NCT00423150|529041036|FG000|Overall Study|Adverse Event|11|||
146689307|NCT00423150|529041036|FG000|Overall Study|Progression of disease being studied|69|||
146689308|NCT00423150|529041036|FG000|Overall Study|Withdrawal by Subject|1|||
146689309|NCT00423150|529041036|FG000|Overall Study|Non-compliance with protocol|1|||
146689310|NCT00423150|529041036|FG000|Overall Study|Administrative|4|||
146689311|NCT01603459|529041045|FG000|Overall Study|Adverse Event|5|||
146689312|NCT01603459|529041045|FG000|Overall Study|Withdrawal by Subject|5|||
146689313|NCT01603459|529041045|FG000|Overall Study|Lost to Follow-up|3|||
146689314|NCT01603459|529041045|FG000|Overall Study|Predefined discontinuation criteria|3|||
146689315|NCT01603459|529041045|FG000|Overall Study|Non-compliance|1|||
146689316|NCT01603459|529041045|FG000|Overall Study|Administrative reason|1|||
146689317|NCT00399360|529041046|FG000|Overall Study|Lost to Follow-up|2|||
146689318|NCT00399360|529041047|FG001|Overall Study|Lost to Follow-up|1|||
146689319|NCT00399360|529041048|FG002|Overall Study|Lost to Follow-up|2|||
146689320|NCT00399360|529041049|FG003|Overall Study|Lost to Follow-up|4|||
146689321|NCT00399360|529041046|FG000|Overall Study|Adverse Event|0|||
146689322|NCT00399360|529041047|FG001|Overall Study|Adverse Event|0|||
146689323|NCT00399360|529041048|FG002|Overall Study|Adverse Event|1|||
146689324|NCT00399360|529041049|FG003|Overall Study|Adverse Event|0|||
146689325|NCT00399360|529041046|FG000|Overall Study|Withdrawal by Subject|0|||
146689326|NCT00399360|529041047|FG001|Overall Study|Withdrawal by Subject|2|||
146689327|NCT00399360|529041048|FG002|Overall Study|Withdrawal by Subject|0|||
146689328|NCT00399360|529041049|FG003|Overall Study|Withdrawal by Subject|2|||
146689329|NCT02335099|529041053|FG000|Treatment|Withdrawal by Subject|1|||
146689330|NCT02335099|529041054|FG001|Treatment|Withdrawal by Subject|3|||
146689331|NCT02335099|529041053|FG000|Treatment|Lost to Follow-up|2|||
146689332|NCT02335099|529041054|FG001|Treatment|Lost to Follow-up|0|||
146689333|NCT02335099|529041053|FG000|Treatment|Death|1|||
146689334|NCT02335099|529041054|FG001|Treatment|Death|0|||
146689335|NCT02335099|529041053|FG000|Treatment|Adverse Event|1|||
146689336|NCT02335099|529041054|FG001|Treatment|Adverse Event|2|||
146689337|NCT02335099|529041053|FG000|Follow-up|Death|0|||
146689338|NCT02335099|529041054|FG001|Follow-up|Death|1|||
146689339|NCT01288287|529041055|FG000|Overall Study|Lost to Follow-up|8|||
146689340|NCT01288287|529041055|FG000|Overall Study|Withdrawal by Subject|4|||
146689341|NCT01288287|529041055|FG000|Overall Study|Lack of Efficacy|13|||
146689342|NCT01288287|529041055|FG000|Overall Study|Other Reason|13|||
146689343|NCT01288287|529041055|FG000|Overall Study|Unknown Reason|1|||
146689344|NCT01288287|529041055|FG000|Overall Study|Unknown Status|7|||
146689345|NCT03519347|529041056|FG000|Interventional Crossover Period 1|Death|0|||
146689346|NCT03519347|529041057|FG001|Interventional Crossover Period 1|Death|0|||
146689347|NCT03519347|529041058|FG002|Interventional Crossover Period 1|Death|0|||
146689348|NCT03519347|529041059|FG003|Interventional Crossover Period 1|Death|1|||
146689349|NCT01641692|529041065|FG000|Treatment Period 1|Adverse Event|1|||
146689350|NCT01641692|529041066|FG001|Treatment Period 1|Adverse Event|0|||
146689351|NCT01641692|529041067|FG002|Treatment Period 1|Adverse Event|0|||
146689352|NCT01641692|529041068|FG003|Treatment Period 1|Adverse Event|0|||
146689353|NCT01641692|529041069|FG004|Treatment Period 1|Adverse Event|0|||
146689354|NCT01641692|529041070|FG005|Treatment Period 1|Adverse Event|0|||
146689355|NCT01641692|529041071|FG006|Treatment Period 1|Adverse Event|0|||
146929554|NCT01251861|529898954|FG001|Overall Study|Physician Decision|0|||
146929555|NCT01251861|529898953|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
146929556|NCT01251861|529898954|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
146929557|NCT01251861|529898953|FG000|Overall Study|Other|1|||
146929558|NCT01251861|529898954|FG001|Overall Study|Other|0|||
146929559|NCT01251861|529898953|FG000|Overall Study|Never started therapy|4|||
146929560|NCT01251861|529898954|FG001|Overall Study|Never started therapy|1|||
146929561|NCT01251861|529898953|FG000|Overall Study|Potential interaction of drugs|0|||
146929562|NCT01251861|529898954|FG001|Overall Study|Potential interaction of drugs|1|||
146929563|NCT03363919|529900797|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
146929564|NCT03363919|529900798|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
146689356|NCT01641692|529041072|FG007|Treatment Period 1|Adverse Event|0|||
146689357|NCT01641692|529041065|FG000|Treatment Period 1|Lack of Efficacy|0|||
146689358|NCT01641692|529041066|FG001|Treatment Period 1|Lack of Efficacy|0|||
146689359|NCT01641692|529041067|FG002|Treatment Period 1|Lack of Efficacy|0|||
146689360|NCT01641692|529041068|FG003|Treatment Period 1|Lack of Efficacy|0|||
146689361|NCT01641692|529041069|FG004|Treatment Period 1|Lack of Efficacy|0|||
146689362|NCT01641692|529041070|FG005|Treatment Period 1|Lack of Efficacy|0|||
146689363|NCT01641692|529041071|FG006|Treatment Period 1|Lack of Efficacy|0|||
146689364|NCT01641692|529041072|FG007|Treatment Period 1|Lack of Efficacy|1|||
146689365|NCT01641692|529041065|FG000|Treatment Period 1|Protocol Violation|1|||
146689366|NCT01641692|529041066|FG001|Treatment Period 1|Protocol Violation|0|||
146689367|NCT01641692|529041067|FG002|Treatment Period 1|Protocol Violation|0|||
146689368|NCT01641692|529041068|FG003|Treatment Period 1|Protocol Violation|0|||
146689369|NCT01641692|529041069|FG004|Treatment Period 1|Protocol Violation|2|||
146689370|NCT01641692|529041070|FG005|Treatment Period 1|Protocol Violation|0|||
146689371|NCT01641692|529041071|FG006|Treatment Period 1|Protocol Violation|0|||
146689372|NCT01641692|529041072|FG007|Treatment Period 1|Protocol Violation|0|||
146689373|NCT01641692|529041065|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
146689374|NCT01641692|529041066|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
146689375|NCT01641692|529041067|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
146689376|NCT01641692|529041068|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
146689377|NCT01641692|529041069|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
146689378|NCT01641692|529041070|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
146689379|NCT01641692|529041071|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
146689380|NCT01641692|529041072|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
146689381|NCT01641692|529041065|FG000|Treatment Period 1|Lost to Follow-up|0|||
146689382|NCT01641692|529041066|FG001|Treatment Period 1|Lost to Follow-up|0|||
146689383|NCT01641692|529041067|FG002|Treatment Period 1|Lost to Follow-up|1|||
146689384|NCT01641692|529041068|FG003|Treatment Period 1|Lost to Follow-up|0|||
146689385|NCT01641692|529041069|FG004|Treatment Period 1|Lost to Follow-up|0|||
146689386|NCT01641692|529041070|FG005|Treatment Period 1|Lost to Follow-up|0|||
146689387|NCT01641692|529041071|FG006|Treatment Period 1|Lost to Follow-up|0|||
146689388|NCT01641692|529041072|FG007|Treatment Period 1|Lost to Follow-up|0|||
146689389|NCT01641692|529041065|FG000|Treatment Period 1|Physician Decision|0|||
146689390|NCT01641692|529041066|FG001|Treatment Period 1|Physician Decision|0|||
146689391|NCT01641692|529041067|FG002|Treatment Period 1|Physician Decision|0|||
146689392|NCT01641692|529041068|FG003|Treatment Period 1|Physician Decision|0|||
146689393|NCT01641692|529041069|FG004|Treatment Period 1|Physician Decision|1|||
146689394|NCT01641692|529041070|FG005|Treatment Period 1|Physician Decision|0|||
146689395|NCT01641692|529041071|FG006|Treatment Period 1|Physician Decision|0|||
146689396|NCT01641692|529041072|FG007|Treatment Period 1|Physician Decision|0|||
146689397|NCT01641692|529041065|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146689398|NCT01641692|529041066|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146689399|NCT01641692|529041067|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146689400|NCT01641692|529041068|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146689401|NCT01641692|529041069|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146689402|NCT01641692|529041070|FG005|Treatment Period 1|Withdrawal by Subject|2|||
146689403|NCT01641692|529041071|FG006|Treatment Period 1|Withdrawal by Subject|0|||
146689404|NCT01641692|529041072|FG007|Treatment Period 1|Withdrawal by Subject|1|||
146689405|NCT01641692|529041065|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
146689406|NCT01641692|529041066|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
146689407|NCT01641692|529041067|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
146689408|NCT01641692|529041068|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
146689409|NCT01641692|529041069|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
146689410|NCT01641692|529041070|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
146689411|NCT01641692|529041071|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
146929565|NCT03363919|529900797|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
146689412|NCT01641692|529041072|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
146689413|NCT01641692|529041065|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146689414|NCT01641692|529041066|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146689415|NCT01641692|529041067|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146736338|NCT04887948|529206814|FG000|Overall Study|Other|2|||
146736339|NCT04887948|529206815|FG001|Overall Study|Other|1|||
146736340|NCT04887948|529206816|FG002|Overall Study|Other|1|||
146736341|NCT00787319|529206817|FG000|Overall Study|Lost to Follow-up|2|||
146775316|NCT04043455|529349497|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
146775317|NCT04043455|529349498|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
146775318|NCT04043455|529349499|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
146775319|NCT04043455|529349494|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
146775320|NCT04043455|529349495|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
146775321|NCT04043455|529349496|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
146775322|NCT04043455|529349497|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
146775323|NCT04043455|529349498|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
146775324|NCT04043455|529349499|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
146775325|NCT04043455|529349494|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
146775326|NCT04043455|529349495|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
146775327|NCT04043455|529349496|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
146775328|NCT04043455|529349497|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
146775329|NCT04043455|529349498|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
146775330|NCT04043455|529349499|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
146775331|NCT04043455|529349494|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
146775332|NCT04043455|529349495|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
146775333|NCT04043455|529349496|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
146775334|NCT04043455|529349497|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
146775335|NCT04043455|529349498|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
146775336|NCT04043455|529349499|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
146775337|NCT04043455|529349494|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
146775338|NCT04043455|529349495|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
146775339|NCT04043455|529349496|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
146775340|NCT04043455|529349497|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
146775341|NCT04043455|529349498|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
146775342|NCT04043455|529349499|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
146775343|NCT04043455|529349494|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
146775344|NCT04043455|529349495|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
146775345|NCT04043455|529349496|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
146775346|NCT04043455|529349497|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
146775347|NCT04043455|529349498|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
146775348|NCT04043455|529349499|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
146775349|NCT04043455|529349494|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
146775350|NCT04043455|529349495|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
146775351|NCT04043455|529349496|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
146775352|NCT04043455|529349497|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
146775353|NCT04043455|529349498|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
146775354|NCT04043455|529349499|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
146775355|NCT04043455|529349494|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
146775356|NCT04043455|529349495|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
146775357|NCT04043455|529349496|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
146929566|NCT03363919|529900798|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
146929567|NCT01646398|529900799|FG000|Overall Study|Withdrawal by Subject|1|||
146929568|NCT01646398|529900800|FG001|Overall Study|Withdrawal by Subject|0|||
146929569|NCT00571519|529900801|FG000|Overall Study|Subject withdrew consent|0|||
146929570|NCT00571519|529900802|FG001|Overall Study|Subject withdrew consent|1|||
146929571|NCT00571519|529900803|FG002|Overall Study|Subject withdrew consent|0|||
146929572|NCT00571519|529900804|FG003|Overall Study|Subject withdrew consent|2|||
146929573|NCT00571519|529900805|FG004|Overall Study|Subject withdrew consent|1|||
146929574|NCT00571519|529900806|FG005|Overall Study|Subject withdrew consent|1|||
146929575|NCT00571519|529900807|FG006|Overall Study|Subject withdrew consent|2|||
146929576|NCT00571519|529900801|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
146929577|NCT00571519|529900802|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
146929578|NCT00571519|529900803|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
146929579|NCT00571519|529900804|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
146929580|NCT00571519|529900805|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
146929581|NCT00571519|529900806|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
146929582|NCT00571519|529900807|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
146929583|NCT00571519|529900801|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
146929584|NCT00571519|529900802|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
146929585|NCT00571519|529900803|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
146929586|NCT00571519|529900804|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
146979582|NCT05266456|530087133|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
146979583|NCT05266456|530087134|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
146979584|NCT05266456|530087135|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
146979585|NCT05266456|530087132|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
146979586|NCT05266456|530087133|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
146979587|NCT05266456|530087134|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
146979588|NCT05266456|530087135|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
146979589|NCT01610167|530087137|FG000|Overall Study|Scheduling conflict.|0|||
146979590|NCT01610167|530087138|FG001|Overall Study|Scheduling conflict.|0|||
146979591|NCT01610167|530087139|FG002|Overall Study|Scheduling conflict.|2|||
146979592|NCT06371079|530087141|FG000|Overall Study|Missing data|88|||
146979593|NCT06371079|530087142|FG001|Overall Study|Missing data|247|||
146979594|NCT01964105|530087143|FG000|Overall Study|Lost to Follow-up|2|||
146979595|NCT01964105|530087144|FG001|Overall Study|Lost to Follow-up|13|||
146979596|NCT01964105|530087145|FG002|Overall Study|Lost to Follow-up|0|||
146979597|NCT02746705|530087146|FG000|Overall Study|Physician Decision|1|||
146979598|NCT02746705|530087147|FG001|Overall Study|Physician Decision|1|||
146979599|NCT02746705|530087146|FG000|Overall Study|Lost to Follow-up|1|||
146979600|NCT02746705|530087147|FG001|Overall Study|Lost to Follow-up|0|||
146979601|NCT02746705|530087146|FG000|Overall Study|outlier scores deemed not valid|0|||
146979602|NCT02746705|530087147|FG001|Overall Study|outlier scores deemed not valid|1|||
146979603|NCT00575328|530087148|FG000|Overall Study|Adverse Event|1|||
146979604|NCT00575328|530087149|FG001|Overall Study|Adverse Event|1|||
146979605|NCT00575328|530087148|FG000|Overall Study|Lost to Follow-up|2|||
146979606|NCT00575328|530087149|FG001|Overall Study|Lost to Follow-up|1|||
146979607|NCT00124449|530087154|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
146979608|NCT00124449|530087155|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
146979609|NCT00124449|530087154|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
146979610|NCT00124449|530087155|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
146979611|NCT00124449|530087154|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
146979612|NCT00124449|530087155|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
146979613|NCT00124449|530087154|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
146979614|NCT00124449|530087155|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
146979615|NCT00124449|530087154|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
146979616|NCT00124449|530087155|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
146979617|NCT00124449|530087154|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
146979618|NCT00124449|530087155|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
146979619|NCT00124449|530087154|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
146979620|NCT00124449|530087155|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
146979621|NCT00124449|530087154|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
146979622|NCT00124449|530087155|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
146979623|NCT00124449|530087154|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
146979624|NCT00124449|530087155|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
146979625|NCT00124449|530087154|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
146979626|NCT00124449|530087155|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
146979627|NCT00124449|530087154|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
146979628|NCT00124449|530087155|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
146979629|NCT00124449|530087154|FG000|18-Month Untreated Observation Period|Relocated|1|||
146979630|NCT00124449|530087155|FG001|18-Month Untreated Observation Period|Relocated|0|||
146979631|NCT03940586|530087156|FG000|Overall Study|Death|3|||
146979632|NCT03940586|530087157|FG001|Overall Study|Death|2|||
146979633|NCT03940586|530087158|FG002|Overall Study|Death|0|||
146979634|NCT03940586|530087156|FG000|Overall Study|Physician Decision|1|||
146979635|NCT03940586|530087157|FG001|Overall Study|Physician Decision|0|||
146979636|NCT03940586|530087158|FG002|Overall Study|Physician Decision|1|||
146979637|NCT03940586|530087156|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
146979638|NCT03940586|530087157|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
146979639|NCT03940586|530087158|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
146689416|NCT01641692|529041068|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146689417|NCT01641692|529041069|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146689418|NCT01641692|529041070|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146689419|NCT01641692|529041071|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
146689420|NCT01641692|529041072|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146689421|NCT01641692|529041065|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
146979640|NCT03940586|530087156|FG000|Overall Study|Not Treated|0|||
146979641|NCT03940586|530087157|FG001|Overall Study|Not Treated|2|||
146979642|NCT03940586|530087158|FG002|Overall Study|Not Treated|0|||
146979643|NCT02006147|530087159|FG000|Overall Study|Protocol Violation|1|||
146979644|NCT02006147|530087160|FG001|Overall Study|Protocol Violation|1|||
146979645|NCT02006147|530087161|FG002|Overall Study|Protocol Violation|0|||
146979646|NCT02006147|530087162|FG003|Overall Study|Protocol Violation|0|||
146979647|NCT02006147|530087159|FG000|Overall Study|Withdrawal by Subject|0|||
146689422|NCT01641692|529041066|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146689423|NCT01641692|529041067|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
146689424|NCT01641692|529041068|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
146689425|NCT01641692|529041069|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
146689426|NCT01641692|529041070|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146689427|NCT01641692|529041071|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146689428|NCT01641692|529041072|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
146689429|NCT01641692|529041065|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
146689430|NCT01641692|529041066|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
146689431|NCT01641692|529041067|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
146689432|NCT01641692|529041068|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
146689433|NCT01641692|529041069|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
146689434|NCT01641692|529041070|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
146689435|NCT01641692|529041071|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
146689436|NCT01641692|529041072|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
146689437|NCT01641692|529041065|FG000|Treatment Period 2|Lack of Efficacy|1|||
146689438|NCT01641692|529041066|FG001|Treatment Period 2|Lack of Efficacy|0|||
146689439|NCT01641692|529041067|FG002|Treatment Period 2|Lack of Efficacy|0|||
146689440|NCT01641692|529041068|FG003|Treatment Period 2|Lack of Efficacy|0|||
146689441|NCT01641692|529041069|FG004|Treatment Period 2|Lack of Efficacy|0|||
146689442|NCT01641692|529041070|FG005|Treatment Period 2|Lack of Efficacy|0|||
146689443|NCT01641692|529041071|FG006|Treatment Period 2|Lack of Efficacy|0|||
146689444|NCT01641692|529041072|FG007|Treatment Period 2|Lack of Efficacy|0|||
146689445|NCT01641692|529041065|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
146689446|NCT01641692|529041066|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146689447|NCT01641692|529041067|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146689448|NCT01641692|529041068|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146689449|NCT01641692|529041069|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146689450|NCT01641692|529041070|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146689451|NCT01641692|529041071|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146689452|NCT01641692|529041072|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146689453|NCT01641692|529041065|FG000|Treatment Period 2|Lost to Follow-up|0|||
146689454|NCT01641692|529041066|FG001|Treatment Period 2|Lost to Follow-up|0|||
146689455|NCT01641692|529041067|FG002|Treatment Period 2|Lost to Follow-up|0|||
146689456|NCT01641692|529041068|FG003|Treatment Period 2|Lost to Follow-up|0|||
146689457|NCT01641692|529041069|FG004|Treatment Period 2|Lost to Follow-up|0|||
146689458|NCT01641692|529041070|FG005|Treatment Period 2|Lost to Follow-up|1|||
146689459|NCT01641692|529041071|FG006|Treatment Period 2|Lost to Follow-up|0|||
146689460|NCT01641692|529041072|FG007|Treatment Period 2|Lost to Follow-up|0|||
146689461|NCT01641692|529041065|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146689462|NCT01641692|529041066|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146689463|NCT01641692|529041067|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146689464|NCT01641692|529041068|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146689465|NCT01641692|529041069|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146689466|NCT01641692|529041070|FG005|Treatment Period 2|Withdrawal by Subject|1|||
146689467|NCT01641692|529041071|FG006|Treatment Period 2|Withdrawal by Subject|0|||
146689468|NCT01641692|529041072|FG007|Treatment Period 2|Withdrawal by Subject|1|||
146689469|NCT01641692|529041065|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146689470|NCT01641692|529041066|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146689471|NCT01641692|529041067|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146689472|NCT01641692|529041068|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146689473|NCT01641692|529041069|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
146689474|NCT01641692|529041070|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146689475|NCT01641692|529041071|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
146689476|NCT01641692|529041072|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146689477|NCT01641692|529041065|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146689478|NCT01641692|529041066|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146689479|NCT01641692|529041067|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
146689480|NCT01641692|529041068|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146689481|NCT01641692|529041069|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146689482|NCT01641692|529041070|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
146689483|NCT01641692|529041071|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146689484|NCT01641692|529041072|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
146689485|NCT01641692|529041065|FG000|Treatment Period 3|Adverse Event|0|||
146689486|NCT01641692|529041066|FG001|Treatment Period 3|Adverse Event|0|||
146689487|NCT01641692|529041067|FG002|Treatment Period 3|Adverse Event|0|||
146689488|NCT01641692|529041068|FG003|Treatment Period 3|Adverse Event|0|||
146689489|NCT01641692|529041069|FG004|Treatment Period 3|Adverse Event|0|||
146689490|NCT01641692|529041070|FG005|Treatment Period 3|Adverse Event|0|||
146689491|NCT01641692|529041071|FG006|Treatment Period 3|Adverse Event|1|||
146689492|NCT01641692|529041072|FG007|Treatment Period 3|Adverse Event|0|||
146689493|NCT01641692|529041065|FG000|Treatment Period 3|Protocol Violation|0|||
146689494|NCT01641692|529041066|FG001|Treatment Period 3|Protocol Violation|0|||
146689495|NCT01641692|529041067|FG002|Treatment Period 3|Protocol Violation|1|||
146689496|NCT01641692|529041068|FG003|Treatment Period 3|Protocol Violation|0|||
146689497|NCT01641692|529041069|FG004|Treatment Period 3|Protocol Violation|0|||
146689498|NCT01641692|529041070|FG005|Treatment Period 3|Protocol Violation|0|||
146689499|NCT01641692|529041071|FG006|Treatment Period 3|Protocol Violation|0|||
146689500|NCT01641692|529041072|FG007|Treatment Period 3|Protocol Violation|0|||
146689501|NCT01641692|529041065|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146689502|NCT01641692|529041066|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146689503|NCT01641692|529041067|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146689504|NCT01641692|529041068|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146689505|NCT01641692|529041069|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146689506|NCT01641692|529041070|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146689507|NCT01641692|529041071|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
146689508|NCT01641692|529041072|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146689509|NCT01641692|529041065|FG000|Treatment Period 3|Lost to Follow-up|0|||
146689510|NCT01641692|529041066|FG001|Treatment Period 3|Lost to Follow-up|1|||
146689511|NCT01641692|529041067|FG002|Treatment Period 3|Lost to Follow-up|0|||
146689512|NCT01641692|529041068|FG003|Treatment Period 3|Lost to Follow-up|0|||
146689513|NCT01641692|529041069|FG004|Treatment Period 3|Lost to Follow-up|0|||
146689514|NCT01641692|529041070|FG005|Treatment Period 3|Lost to Follow-up|0|||
146689515|NCT01641692|529041071|FG006|Treatment Period 3|Lost to Follow-up|0|||
146689516|NCT01641692|529041072|FG007|Treatment Period 3|Lost to Follow-up|0|||
146689517|NCT01641692|529041065|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
146689518|NCT01641692|529041066|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
146689519|NCT01641692|529041067|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
146689520|NCT01641692|529041068|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
146689521|NCT01641692|529041069|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
146689522|NCT01641692|529041070|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
146689523|NCT01641692|529041071|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
146689524|NCT01641692|529041072|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
146689525|NCT01641692|529041065|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
146689526|NCT01641692|529041066|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
146689527|NCT01641692|529041067|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
146689528|NCT01641692|529041068|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
146689529|NCT01641692|529041069|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
146689530|NCT01641692|529041070|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
146689531|NCT01641692|529041071|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
146689532|NCT01641692|529041072|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
146689533|NCT02515045|529041078|FG000|Overall Study|Adverse Event|0|||
146689534|NCT02515045|529041079|FG001|Overall Study|Adverse Event|3|||
146689535|NCT02515045|529041080|FG002|Overall Study|Adverse Event|3|||
146689536|NCT02515045|529041078|FG000|Overall Study|Lost to Follow-up|0|||
146689537|NCT02515045|529041079|FG001|Overall Study|Lost to Follow-up|1|||
146689538|NCT02515045|529041080|FG002|Overall Study|Lost to Follow-up|1|||
146689539|NCT01412021|529041081|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
146689540|NCT01412021|529041081|FG000|Overall Study|Treatment Prior to Approval|3|||
146689541|NCT01412021|529041081|FG000|Overall Study|Transferred to Other Hospital|9|||
146689542|NCT03255382|529041082|FG000|Overall Study|Adverse Event|3|||
146689543|NCT03255382|529041083|FG001|Overall Study|Adverse Event|0|||
146689544|NCT03255382|529041082|FG000|Overall Study|Lost to Follow-up|2|||
146689545|NCT03255382|529041083|FG001|Overall Study|Lost to Follow-up|0|||
146689546|NCT03255382|529041082|FG000|Overall Study|Withdrawal by Subject|2|||
146689547|NCT03255382|529041083|FG001|Overall Study|Withdrawal by Subject|0|||
146689548|NCT03255382|529041082|FG000|Overall Study|Other|6|||
146689549|NCT03255382|529041083|FG001|Overall Study|Other|0|||
146689550|NCT00238121|529041086|FG000|Overall Study|Withdrawal by Subject|1|||
146689551|NCT00238121|529041087|FG001|Overall Study|Withdrawal by Subject|1|||
146689552|NCT00238121|529041086|FG000|Overall Study|Adverse Event|2|||
146689553|NCT00238121|529041087|FG001|Overall Study|Adverse Event|1|||
146689554|NCT02221284|529041088|FG000|Overall Study|Case Report Forms Uncollected|56|||
146689555|NCT02221284|529041088|FG000|Overall Study|Protocol Deviation|5|||
146689556|NCT00484939|529041089|FG000|Overall Study|Death|9|||
146689557|NCT00484939|529041090|FG001|Overall Study|Death|13|||
146689558|NCT00484939|529041089|FG000|Overall Study|Adverse Event|22|||
146689559|NCT00484939|529041090|FG001|Overall Study|Adverse Event|12|||
146689560|NCT00484939|529041089|FG000|Overall Study|Patient Withdrew Consent|19|||
146689561|NCT00484939|529041090|FG001|Overall Study|Patient Withdrew Consent|10|||
146689562|NCT00484939|529041089|FG000|Overall Study|Protocol Violation|3|||
146979648|NCT02006147|530087160|FG001|Overall Study|Withdrawal by Subject|1|||
146979649|NCT02006147|530087161|FG002|Overall Study|Withdrawal by Subject|0|||
146979650|NCT02006147|530087162|FG003|Overall Study|Withdrawal by Subject|0|||
146979651|NCT02006147|530087159|FG000|Overall Study|Withdrawal by Sponsor|1|||
146979652|NCT02006147|530087160|FG001|Overall Study|Withdrawal by Sponsor|0|||
146979653|NCT02006147|530087161|FG002|Overall Study|Withdrawal by Sponsor|0|||
146979654|NCT02006147|530087162|FG003|Overall Study|Withdrawal by Sponsor|0|||
146979655|NCT00811070|530087166|FG000|Overall Study|Death|0|||
146979656|NCT00811070|530087167|FG001|Overall Study|Death|0|||
146979657|NCT00811070|530087168|FG002|Overall Study|Death|0|||
146979658|NCT00811070|530087169|FG003|Overall Study|Death|2|||
146979659|NCT00811070|530087170|FG004|Overall Study|Death|5|||
146979660|NCT00811070|530087171|FG005|Overall Study|Death|0|||
146979661|NCT00811070|530087166|FG000|Overall Study|Other|1|||
146979662|NCT00811070|530087167|FG001|Overall Study|Other|0|||
146979663|NCT00811070|530087168|FG002|Overall Study|Other|0|||
146979664|NCT00811070|530087169|FG003|Overall Study|Other|0|||
146979665|NCT00811070|530087170|FG004|Overall Study|Other|0|||
146979666|NCT00811070|530087171|FG005|Overall Study|Other|0|||
146979667|NCT00811070|530087166|FG000|Overall Study|Withdrawal by Subject|0|||
146979668|NCT00811070|530087167|FG001|Overall Study|Withdrawal by Subject|1|||
146979669|NCT00811070|530087168|FG002|Overall Study|Withdrawal by Subject|0|||
146979670|NCT00811070|530087169|FG003|Overall Study|Withdrawal by Subject|0|||
146979671|NCT00811070|530087170|FG004|Overall Study|Withdrawal by Subject|0|||
146979672|NCT00811070|530087171|FG005|Overall Study|Withdrawal by Subject|0|||
146979673|NCT00811070|530087166|FG000|Overall Study|Physician Decision|0|||
146979674|NCT00811070|530087167|FG001|Overall Study|Physician Decision|0|||
146979675|NCT00811070|530087168|FG002|Overall Study|Physician Decision|0|||
146979676|NCT00811070|530087169|FG003|Overall Study|Physician Decision|0|||
146979677|NCT00811070|530087170|FG004|Overall Study|Physician Decision|0|||
146979678|NCT00811070|530087171|FG005|Overall Study|Physician Decision|1|||
146979679|NCT00585039|530087173|FG000|Overall Study|medication spilled|2|||
146979680|NCT00585039|530087174|FG001|Overall Study|medication spilled|0|||
146979681|NCT01859390|530089399|FG000|Overall Study|Insufficient Sputum Collected|1|||
146979682|NCT01859390|530089400|FG001|Overall Study|Insufficient Sputum Collected|3|||
146979683|NCT01859390|530089399|FG000|Overall Study|Sample Missing Collection Date|0|||
146979684|NCT01859390|530089400|FG001|Overall Study|Sample Missing Collection Date|1|||
146979685|NCT01859390|530089399|FG000|Overall Study|Tube Cracked|0|||
146979686|NCT01859390|530089400|FG001|Overall Study|Tube Cracked|2|||
146979687|NCT01859390|530089399|FG000|Overall Study|Shipment Error|0|||
146979688|NCT01859390|530089400|FG001|Overall Study|Shipment Error|1|||
146979689|NCT01706198|530089402|FG000|Overall Study|Adverse Event|12|||
146979690|NCT01706198|530089403|FG001|Overall Study|Adverse Event|15|||
146979691|NCT01706198|530089402|FG000|Overall Study|Protocol Violation|7|||
146979692|NCT01706198|530089403|FG001|Overall Study|Protocol Violation|5|||
146979693|NCT01706198|530089402|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
146979694|NCT01706198|530089403|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
146979695|NCT01706198|530089402|FG000|Overall Study|Lost to Follow-up|97|||
146979696|NCT01706198|530089403|FG001|Overall Study|Lost to Follow-up|93|||
146979697|NCT01706198|530089402|FG000|Overall Study|Physician Decision|23|||
146979698|NCT01706198|530089403|FG001|Overall Study|Physician Decision|37|||
146979699|NCT01706198|530089402|FG000|Overall Study|Withdrawal by Subject|23|||
146979700|NCT01706198|530089403|FG001|Overall Study|Withdrawal by Subject|31|||
146979701|NCT01084005|530089404|FG000|Overall Study|Adverse Event|1|||
146979702|NCT01084005|530089405|FG001|Overall Study|Adverse Event|8|||
146979703|NCT01084005|530089404|FG000|Overall Study|Protocol Violation|3|||
146979704|NCT01084005|530089405|FG001|Overall Study|Protocol Violation|7|||
146979705|NCT01084005|530089404|FG000|Overall Study|Withdrawal by Subject|1|||
146689563|NCT00484939|529041090|FG001|Overall Study|Protocol Violation|3|||
146689564|NCT00484939|529041089|FG000|Overall Study|Lost to Follow-up|0|||
146689565|NCT00484939|529041090|FG001|Overall Study|Lost to Follow-up|3|||
146689566|NCT00484939|529041089|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
146689567|NCT00484939|529041090|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
146979706|NCT01084005|530089405|FG001|Overall Study|Withdrawal by Subject|1|||
146689568|NCT00484939|529041089|FG000|Overall Study|Disease progression|67|||
146689569|NCT00484939|529041090|FG001|Overall Study|Disease progression|88|||
146775358|NCT04043455|529349497|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
146979707|NCT03377556|530089410|FG000|Overall Study|Adverse Event|5|||
146979708|NCT03377556|530089410|FG000|Overall Study|Refusal unrelated to adverse events|1|||
146979709|NCT03377556|530089410|FG000|Overall Study|Progression/relapse|38|||
146979710|NCT03377556|530089410|FG000|Overall Study|Death|3|||
146979711|NCT00472446|530089411|FG000|Overall Study|Protocol Violation|0|||
146979712|NCT00472446|530089412|FG001|Overall Study|Protocol Violation|0|||
146979713|NCT00472446|530089413|FG002|Overall Study|Protocol Violation|0|||
146979714|NCT00472446|530089414|FG003|Overall Study|Protocol Violation|1|||
146689570|NCT00484939|529041089|FG000|Overall Study|Screen Failure|2|||
146979715|NCT00472446|530089411|FG000|Overall Study|Reintervention|0|||
146979716|NCT00472446|530089412|FG001|Overall Study|Reintervention|0|||
146979717|NCT00472446|530089413|FG002|Overall Study|Reintervention|1|||
146689571|NCT00484939|529041090|FG001|Overall Study|Screen Failure|2|||
146689572|NCT00484939|529041089|FG000|Overall Study|Reason Not Specified|11|||
146689573|NCT00484939|529041090|FG001|Overall Study|Reason Not Specified|6|||
146689574|NCT00449644|529041093|FG000|Overall Study|Adverse Event|0|||
146689575|NCT00449644|529041094|FG001|Overall Study|Adverse Event|0|||
146689576|NCT00449644|529041095|FG002|Overall Study|Adverse Event|3|||
146689577|NCT00449644|529041096|FG003|Overall Study|Adverse Event|5|||
146689578|NCT00449644|529041093|FG000|Overall Study|Death|1|||
146689579|NCT00449644|529041094|FG001|Overall Study|Death|0|||
146689580|NCT00449644|529041095|FG002|Overall Study|Death|6|||
146689581|NCT00449644|529041096|FG003|Overall Study|Death|1|||
146689582|NCT00449644|529041093|FG000|Overall Study|Lost to Follow-up|1|||
146689583|NCT00449644|529041094|FG001|Overall Study|Lost to Follow-up|1|||
146689584|NCT00449644|529041095|FG002|Overall Study|Lost to Follow-up|5|||
146689585|NCT00449644|529041096|FG003|Overall Study|Lost to Follow-up|3|||
146689586|NCT00449644|529041093|FG000|Overall Study|Pregnancy|0|||
146689587|NCT00449644|529041094|FG001|Overall Study|Pregnancy|0|||
146689588|NCT00449644|529041095|FG002|Overall Study|Pregnancy|3|||
146689589|NCT00449644|529041096|FG003|Overall Study|Pregnancy|2|||
146689590|NCT00449644|529041093|FG000|Overall Study|Protocol Violation|4|||
146689591|NCT00449644|529041094|FG001|Overall Study|Protocol Violation|4|||
146689592|NCT00449644|529041095|FG002|Overall Study|Protocol Violation|3|||
146689593|NCT00449644|529041096|FG003|Overall Study|Protocol Violation|7|||
146689594|NCT00449644|529041093|FG000|Overall Study|Withdrawal by Subject|3|||
146689595|NCT00449644|529041094|FG001|Overall Study|Withdrawal by Subject|4|||
146689596|NCT00449644|529041095|FG002|Overall Study|Withdrawal by Subject|6|||
146689597|NCT00449644|529041096|FG003|Overall Study|Withdrawal by Subject|7|||
146689598|NCT00449644|529041093|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
146689599|NCT00449644|529041094|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
146689600|NCT00449644|529041095|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
146689601|NCT00449644|529041096|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
146689602|NCT00449644|529041093|FG000|Overall Study|Other|1|||
146689603|NCT00449644|529041094|FG001|Overall Study|Other|4|||
146689604|NCT00449644|529041095|FG002|Overall Study|Other|1|||
146689605|NCT00449644|529041096|FG003|Overall Study|Other|0|||
146689606|NCT00449644|529041093|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
146689607|NCT00449644|529041094|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
146689608|NCT00449644|529041095|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
146689609|NCT00449644|529041096|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
146689610|NCT00733746|529041106|FG000|Overall Study|Ineligible|5|||
146689611|NCT02226003|529041107|FG000|Overall Study|Lost to Follow-up|2|||
146689612|NCT02226003|529041108|FG001|Overall Study|Lost to Follow-up|1|||
146689613|NCT02226003|529041109|FG002|Overall Study|Lost to Follow-up|3|||
146689614|NCT02226003|529041107|FG000|Overall Study|Withdrawal by Subject|0|||
146689615|NCT02226003|529041108|FG001|Overall Study|Withdrawal by Subject|0|||
146689616|NCT02226003|529041109|FG002|Overall Study|Withdrawal by Subject|3|||
146689617|NCT03279692|529041112|FG000|Overall Study|Withdrawal by Subject|1|||
146689618|NCT07114198|529041118|FG000|Overall Study|Protocol Violation|1|||
146689619|NCT07114198|529041119|FG001|Overall Study|Protocol Violation|1|||
146689620|NCT04734652|529042959|FG000|Overall Study|Withdrawal by Subject|2|||
146689621|NCT04734652|529042960|FG001|Overall Study|Withdrawal by Subject|0|||
146689622|NCT04734652|529042959|FG000|Overall Study|Death|0|||
146689623|NCT04734652|529042960|FG001|Overall Study|Death|1|||
146689624|NCT01921179|529042962|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
146689625|NCT01921179|529042963|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
146689626|NCT01921179|529042962|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
146689627|NCT01921179|529042963|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
146689628|NCT01190254|529042966|FG000|Overall Study|Adverse Event|3|||
146689629|NCT01190254|529042967|FG001|Overall Study|Adverse Event|6|||
146689630|NCT01190254|529042968|FG002|Overall Study|Adverse Event|8|||
146689631|NCT01190254|529042966|FG000|Overall Study|Lack of Efficacy|7|||
146689632|NCT01190254|529042967|FG001|Overall Study|Lack of Efficacy|4|||
146689633|NCT01190254|529042968|FG002|Overall Study|Lack of Efficacy|5|||
146689634|NCT01190254|529042966|FG000|Overall Study|Lost to Follow-up|4|||
146689635|NCT01190254|529042967|FG001|Overall Study|Lost to Follow-up|2|||
146689636|NCT01190254|529042968|FG002|Overall Study|Lost to Follow-up|0|||
146689637|NCT01190254|529042966|FG000|Overall Study|Withdrawal by Subject|4|||
146689638|NCT01190254|529042967|FG001|Overall Study|Withdrawal by Subject|5|||
146689639|NCT01190254|529042968|FG002|Overall Study|Withdrawal by Subject|7|||
146689640|NCT01190254|529042966|FG000|Overall Study|Protocol Violation|2|||
146929587|NCT00571519|529900805|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
146689641|NCT01190254|529042967|FG001|Overall Study|Protocol Violation|0|||
146689642|NCT01190254|529042968|FG002|Overall Study|Protocol Violation|2|||
146689643|NCT01190254|529042966|FG000|Overall Study|Did not meet protocol eligibility|1|||
146689644|NCT01190254|529042967|FG001|Overall Study|Did not meet protocol eligibility|0|||
146689645|NCT01190254|529042968|FG002|Overall Study|Did not meet protocol eligibility|0|||
146689646|NCT04146545|529042969|FG000|Overall Study|deemed ineligible after randomization|1|||
146689647|NCT04146545|529042970|FG001|Overall Study|deemed ineligible after randomization|0|||
146689648|NCT01729754|529042971|FG000|Part 1|Adverse Event|2|||
146689649|NCT01729754|529042972|FG001|Part 1|Adverse Event|0|||
146689650|NCT01729754|529042973|FG002|Part 1|Adverse Event|0|||
146689651|NCT01729754|529042974|FG003|Part 1|Adverse Event|1|||
146689652|NCT01729754|529042975|FG004|Part 1|Adverse Event|0|||
146689653|NCT01729754|529042976|FG005|Part 1|Adverse Event|0|||
146689654|NCT01729754|529042977|FG006|Part 1|Adverse Event|2|||
146689655|NCT01729754|529042978|FG007|Part 1|Adverse Event|0|||
146689656|NCT01729754|529042979|FG008|Part 1|Adverse Event|0|||
146689657|NCT01729754|529042980|FG009|Part 1|Adverse Event|5|||
146689658|NCT01729754|529042971|FG000|Part 1|Lack of Efficacy|1|||
146689659|NCT01729754|529042972|FG001|Part 1|Lack of Efficacy|0|||
146689660|NCT01729754|529042973|FG002|Part 1|Lack of Efficacy|0|||
146689661|NCT01729754|529042974|FG003|Part 1|Lack of Efficacy|0|||
146689662|NCT01729754|529042975|FG004|Part 1|Lack of Efficacy|0|||
146689663|NCT01729754|529042976|FG005|Part 1|Lack of Efficacy|0|||
146689664|NCT01729754|529042977|FG006|Part 1|Lack of Efficacy|2|||
146689665|NCT01729754|529042978|FG007|Part 1|Lack of Efficacy|0|||
146689666|NCT01729754|529042979|FG008|Part 1|Lack of Efficacy|0|||
146689667|NCT01729754|529042980|FG009|Part 1|Lack of Efficacy|0|||
146689668|NCT01729754|529042971|FG000|Part 1|Lost to Follow-up|1|||
146689669|NCT01729754|529042972|FG001|Part 1|Lost to Follow-up|0|||
146689670|NCT01729754|529042973|FG002|Part 1|Lost to Follow-up|0|||
146689671|NCT01729754|529042974|FG003|Part 1|Lost to Follow-up|2|||
146689672|NCT01729754|529042975|FG004|Part 1|Lost to Follow-up|0|||
146689673|NCT01729754|529042976|FG005|Part 1|Lost to Follow-up|0|||
146689674|NCT01729754|529042977|FG006|Part 1|Lost to Follow-up|3|||
146689675|NCT01729754|529042978|FG007|Part 1|Lost to Follow-up|0|||
146689676|NCT01729754|529042979|FG008|Part 1|Lost to Follow-up|0|||
146689677|NCT01729754|529042980|FG009|Part 1|Lost to Follow-up|3|||
146689678|NCT01729754|529042971|FG000|Part 1|Non-compliance with Study Drug|1|||
146689679|NCT01729754|529042972|FG001|Part 1|Non-compliance with Study Drug|0|||
146689680|NCT01729754|529042973|FG002|Part 1|Non-compliance with Study Drug|0|||
146689681|NCT01729754|529042974|FG003|Part 1|Non-compliance with Study Drug|0|||
146689682|NCT01729754|529042975|FG004|Part 1|Non-compliance with Study Drug|0|||
146689683|NCT01729754|529042976|FG005|Part 1|Non-compliance with Study Drug|0|||
146689684|NCT01729754|529042977|FG006|Part 1|Non-compliance with Study Drug|0|||
146689685|NCT01729754|529042978|FG007|Part 1|Non-compliance with Study Drug|0|||
146689686|NCT01729754|529042979|FG008|Part 1|Non-compliance with Study Drug|0|||
146689687|NCT01729754|529042980|FG009|Part 1|Non-compliance with Study Drug|0|||
146689688|NCT01729754|529042971|FG000|Part 1|Physician Decision|0|||
146689689|NCT01729754|529042972|FG001|Part 1|Physician Decision|0|||
146689690|NCT01729754|529042973|FG002|Part 1|Physician Decision|0|||
146689691|NCT01729754|529042974|FG003|Part 1|Physician Decision|0|||
146689692|NCT01729754|529042975|FG004|Part 1|Physician Decision|0|||
146689693|NCT01729754|529042976|FG005|Part 1|Physician Decision|0|||
146689694|NCT01729754|529042977|FG006|Part 1|Physician Decision|0|||
146689695|NCT01729754|529042978|FG007|Part 1|Physician Decision|0|||
146689696|NCT01729754|529042979|FG008|Part 1|Physician Decision|0|||
146689697|NCT01729754|529042980|FG009|Part 1|Physician Decision|4|||
146689698|NCT01729754|529042971|FG000|Part 1|Pregnancy|0|||
146689699|NCT01729754|529042972|FG001|Part 1|Pregnancy|0|||
146689700|NCT01729754|529042973|FG002|Part 1|Pregnancy|0|||
146689701|NCT01729754|529042974|FG003|Part 1|Pregnancy|1|||
146929588|NCT00571519|529900806|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
146929589|NCT00571519|529900807|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
146929590|NCT00571519|529900801|FG000|Overall Study|Termination of study by Sponsor|2|||
146929591|NCT00571519|529900802|FG001|Overall Study|Termination of study by Sponsor|7|||
146929592|NCT00571519|529900803|FG002|Overall Study|Termination of study by Sponsor|10|||
146929593|NCT00571519|529900804|FG003|Overall Study|Termination of study by Sponsor|24|||
146929594|NCT00571519|529900805|FG004|Overall Study|Termination of study by Sponsor|8|||
146929595|NCT00571519|529900806|FG005|Overall Study|Termination of study by Sponsor|9|||
146929596|NCT00571519|529900807|FG006|Overall Study|Termination of study by Sponsor|22|||
146929597|NCT00571519|529900801|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
146929598|NCT00571519|529900802|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
146929599|NCT00571519|529900803|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
146979718|NCT00472446|530089414|FG003|Overall Study|Reintervention|1|||
146689702|NCT01729754|529042975|FG004|Part 1|Pregnancy|0|||
146689703|NCT01729754|529042976|FG005|Part 1|Pregnancy|0|||
146689704|NCT01729754|529042977|FG006|Part 1|Pregnancy|0|||
146689705|NCT01729754|529042978|FG007|Part 1|Pregnancy|0|||
146689706|NCT01729754|529042979|FG008|Part 1|Pregnancy|0|||
146689707|NCT01729754|529042980|FG009|Part 1|Pregnancy|1|||
146689708|NCT01729754|529042971|FG000|Part 1|Progressive Disease|0|||
146689709|NCT01729754|529042972|FG001|Part 1|Progressive Disease|0|||
146689710|NCT01729754|529042973|FG002|Part 1|Progressive Disease|0|||
146689711|NCT01729754|529042974|FG003|Part 1|Progressive Disease|0|||
146689712|NCT01729754|529042975|FG004|Part 1|Progressive Disease|0|||
146689713|NCT01729754|529042976|FG005|Part 1|Progressive Disease|0|||
146689714|NCT01729754|529042977|FG006|Part 1|Progressive Disease|0|||
146689715|NCT01729754|529042978|FG007|Part 1|Progressive Disease|0|||
146689716|NCT01729754|529042979|FG008|Part 1|Progressive Disease|0|||
146689717|NCT01729754|529042980|FG009|Part 1|Progressive Disease|1|||
146689718|NCT01729754|529042971|FG000|Part 1|Protocol Violation|2|||
146689719|NCT01729754|529042972|FG001|Part 1|Protocol Violation|0|||
146689720|NCT01729754|529042973|FG002|Part 1|Protocol Violation|0|||
146689721|NCT01729754|529042974|FG003|Part 1|Protocol Violation|1|||
146689722|NCT01729754|529042975|FG004|Part 1|Protocol Violation|0|||
146689723|NCT01729754|529042976|FG005|Part 1|Protocol Violation|0|||
146689724|NCT01729754|529042977|FG006|Part 1|Protocol Violation|1|||
146689725|NCT01729754|529042978|FG007|Part 1|Protocol Violation|0|||
146689726|NCT01729754|529042979|FG008|Part 1|Protocol Violation|0|||
146689727|NCT01729754|529042980|FG009|Part 1|Protocol Violation|0|||
146689728|NCT01729754|529042971|FG000|Part 1|Withdrawal by Subject|5|||
146689729|NCT01729754|529042972|FG001|Part 1|Withdrawal by Subject|0|||
146689730|NCT01729754|529042973|FG002|Part 1|Withdrawal by Subject|0|||
146689731|NCT01729754|529042974|FG003|Part 1|Withdrawal by Subject|7|||
146689732|NCT01729754|529042975|FG004|Part 1|Withdrawal by Subject|0|||
146689733|NCT01729754|529042976|FG005|Part 1|Withdrawal by Subject|0|||
146689734|NCT01729754|529042977|FG006|Part 1|Withdrawal by Subject|5|||
146689735|NCT01729754|529042978|FG007|Part 1|Withdrawal by Subject|0|||
146689736|NCT01729754|529042979|FG008|Part 1|Withdrawal by Subject|0|||
146689737|NCT01729754|529042980|FG009|Part 1|Withdrawal by Subject|6|||
146689738|NCT01729754|529042971|FG000|Part 1|Other Protocol Specified Criteria|2|||
146689739|NCT01729754|529042972|FG001|Part 1|Other Protocol Specified Criteria|0|||
146689740|NCT01729754|529042973|FG002|Part 1|Other Protocol Specified Criteria|0|||
146689741|NCT01729754|529042974|FG003|Part 1|Other Protocol Specified Criteria|0|||
146689742|NCT01729754|529042975|FG004|Part 1|Other Protocol Specified Criteria|0|||
146689743|NCT01729754|529042976|FG005|Part 1|Other Protocol Specified Criteria|0|||
146689744|NCT01729754|529042977|FG006|Part 1|Other Protocol Specified Criteria|1|||
146689745|NCT01729754|529042978|FG007|Part 1|Other Protocol Specified Criteria|0|||
146689746|NCT01729754|529042979|FG008|Part 1|Other Protocol Specified Criteria|0|||
146689747|NCT01729754|529042980|FG009|Part 1|Other Protocol Specified Criteria|4|||
146689748|NCT01729754|529042971|FG000|Part 2|Adverse Event|2|||
146689749|NCT01729754|529042972|FG001|Part 2|Adverse Event|0|||
146689750|NCT01729754|529042973|FG002|Part 2|Adverse Event|0|||
146689751|NCT01729754|529042974|FG003|Part 2|Adverse Event|0|||
146689752|NCT01729754|529042975|FG004|Part 2|Adverse Event|0|||
146689753|NCT01729754|529042976|FG005|Part 2|Adverse Event|0|||
146689754|NCT01729754|529042977|FG006|Part 2|Adverse Event|0|||
146689755|NCT01729754|529042978|FG007|Part 2|Adverse Event|0|||
146689756|NCT01729754|529042979|FG008|Part 2|Adverse Event|1|||
146689757|NCT01729754|529042980|FG009|Part 2|Adverse Event|2|||
146689758|NCT01729754|529042971|FG000|Part 2|Lack of Efficacy|0|||
146689759|NCT01729754|529042972|FG001|Part 2|Lack of Efficacy|0|||
146689760|NCT01729754|529042973|FG002|Part 2|Lack of Efficacy|0|||
146689761|NCT01729754|529042974|FG003|Part 2|Lack of Efficacy|0|||
146689762|NCT01729754|529042975|FG004|Part 2|Lack of Efficacy|0|||
146689763|NCT01729754|529042976|FG005|Part 2|Lack of Efficacy|0|||
146689764|NCT01729754|529042977|FG006|Part 2|Lack of Efficacy|0|||
146689765|NCT01729754|529042978|FG007|Part 2|Lack of Efficacy|0|||
146689766|NCT01729754|529042979|FG008|Part 2|Lack of Efficacy|2|||
146689767|NCT01729754|529042980|FG009|Part 2|Lack of Efficacy|2|||
146689768|NCT01729754|529042971|FG000|Part 2|Lost to Follow-up|0|||
146689769|NCT01729754|529042972|FG001|Part 2|Lost to Follow-up|0|||
146689770|NCT01729754|529042973|FG002|Part 2|Lost to Follow-up|0|||
146689771|NCT01729754|529042974|FG003|Part 2|Lost to Follow-up|2|||
146689772|NCT01729754|529042975|FG004|Part 2|Lost to Follow-up|0|||
146689773|NCT01729754|529042976|FG005|Part 2|Lost to Follow-up|0|||
146689774|NCT01729754|529042977|FG006|Part 2|Lost to Follow-up|0|||
146689775|NCT01729754|529042978|FG007|Part 2|Lost to Follow-up|1|||
146689776|NCT01729754|529042979|FG008|Part 2|Lost to Follow-up|0|||
146689777|NCT01729754|529042980|FG009|Part 2|Lost to Follow-up|2|||
146689778|NCT01729754|529042971|FG000|Part 2|Non-Compliance with Study Drug|0|||
146689779|NCT01729754|529042972|FG001|Part 2|Non-Compliance with Study Drug|0|||
146689780|NCT01729754|529042973|FG002|Part 2|Non-Compliance with Study Drug|0|||
146689781|NCT01729754|529042974|FG003|Part 2|Non-Compliance with Study Drug|0|||
146689782|NCT01729754|529042975|FG004|Part 2|Non-Compliance with Study Drug|0|||
146689783|NCT01729754|529042976|FG005|Part 2|Non-Compliance with Study Drug|0|||
146689784|NCT01729754|529042977|FG006|Part 2|Non-Compliance with Study Drug|0|||
146689785|NCT01729754|529042978|FG007|Part 2|Non-Compliance with Study Drug|0|||
146689786|NCT01729754|529042979|FG008|Part 2|Non-Compliance with Study Drug|0|||
146689787|NCT01729754|529042980|FG009|Part 2|Non-Compliance with Study Drug|1|||
146689788|NCT01729754|529042971|FG000|Part 2|Pregnancy|0|||
146689789|NCT01729754|529042972|FG001|Part 2|Pregnancy|0|||
146689790|NCT01729754|529042973|FG002|Part 2|Pregnancy|0|||
146689791|NCT01729754|529042974|FG003|Part 2|Pregnancy|1|||
146689792|NCT01729754|529042975|FG004|Part 2|Pregnancy|0|||
146689793|NCT01729754|529042976|FG005|Part 2|Pregnancy|0|||
146689794|NCT01729754|529042977|FG006|Part 2|Pregnancy|0|||
146689795|NCT01729754|529042978|FG007|Part 2|Pregnancy|0|||
146689796|NCT01729754|529042979|FG008|Part 2|Pregnancy|0|||
146689797|NCT01729754|529042980|FG009|Part 2|Pregnancy|1|||
146689798|NCT01729754|529042971|FG000|Part 2|Withdrawal by Subject|3|||
146689799|NCT01729754|529042972|FG001|Part 2|Withdrawal by Subject|0|||
146689800|NCT01729754|529042973|FG002|Part 2|Withdrawal by Subject|0|||
146689801|NCT01729754|529042974|FG003|Part 2|Withdrawal by Subject|2|||
146689802|NCT01729754|529042975|FG004|Part 2|Withdrawal by Subject|0|||
146689803|NCT01729754|529042976|FG005|Part 2|Withdrawal by Subject|0|||
146689804|NCT01729754|529042977|FG006|Part 2|Withdrawal by Subject|0|||
146689805|NCT01729754|529042978|FG007|Part 2|Withdrawal by Subject|1|||
146689806|NCT01729754|529042979|FG008|Part 2|Withdrawal by Subject|1|||
146689807|NCT01729754|529042980|FG009|Part 2|Withdrawal by Subject|4|||
146689808|NCT01729754|529042971|FG000|Part 2|Other Protocol Specified Criteria|1|||
146689809|NCT01729754|529042972|FG001|Part 2|Other Protocol Specified Criteria|0|||
146689810|NCT01729754|529042973|FG002|Part 2|Other Protocol Specified Criteria|0|||
146689811|NCT01729754|529042974|FG003|Part 2|Other Protocol Specified Criteria|0|||
146689812|NCT01729754|529042975|FG004|Part 2|Other Protocol Specified Criteria|0|||
146689813|NCT01729754|529042976|FG005|Part 2|Other Protocol Specified Criteria|0|||
146689814|NCT01729754|529042977|FG006|Part 2|Other Protocol Specified Criteria|0|||
146689815|NCT01729754|529042978|FG007|Part 2|Other Protocol Specified Criteria|1|||
146689816|NCT01729754|529042979|FG008|Part 2|Other Protocol Specified Criteria|0|||
146689817|NCT01729754|529042980|FG009|Part 2|Other Protocol Specified Criteria|0|||
146689818|NCT01729754|529042971|FG000|Part 3|Adverse Event|0|||
146689819|NCT01729754|529042972|FG001|Part 3|Adverse Event|0|||
146689820|NCT01729754|529042973|FG002|Part 3|Adverse Event|1|||
146689821|NCT01729754|529042974|FG003|Part 3|Adverse Event|0|||
146689822|NCT01729754|529042975|FG004|Part 3|Adverse Event|0|||
146689823|NCT01729754|529042976|FG005|Part 3|Adverse Event|5|||
146689824|NCT01729754|529042977|FG006|Part 3|Adverse Event|0|||
146689825|NCT01729754|529042978|FG007|Part 3|Adverse Event|0|||
146689826|NCT01729754|529042979|FG008|Part 3|Adverse Event|0|||
146689827|NCT01729754|529042980|FG009|Part 3|Adverse Event|3|||
146689828|NCT01729754|529042971|FG000|Part 3|Death|0|||
146689829|NCT01729754|529042972|FG001|Part 3|Death|0|||
146689830|NCT01729754|529042973|FG002|Part 3|Death|0|||
146689831|NCT01729754|529042974|FG003|Part 3|Death|0|||
146689832|NCT01729754|529042975|FG004|Part 3|Death|0|||
146689833|NCT01729754|529042976|FG005|Part 3|Death|2|||
146689834|NCT01729754|529042977|FG006|Part 3|Death|0|||
146689835|NCT01729754|529042978|FG007|Part 3|Death|0|||
146689836|NCT01729754|529042979|FG008|Part 3|Death|0|||
146689837|NCT01729754|529042980|FG009|Part 3|Death|0|||
146689838|NCT01729754|529042971|FG000|Part 3|Lack of Efficacy|0|||
146689839|NCT01729754|529042972|FG001|Part 3|Lack of Efficacy|0|||
146689840|NCT01729754|529042973|FG002|Part 3|Lack of Efficacy|0|||
146689841|NCT01729754|529042974|FG003|Part 3|Lack of Efficacy|0|||
146689842|NCT01729754|529042975|FG004|Part 3|Lack of Efficacy|2|||
146689843|NCT01729754|529042976|FG005|Part 3|Lack of Efficacy|0|||
146689844|NCT01729754|529042977|FG006|Part 3|Lack of Efficacy|0|||
146689845|NCT01729754|529042978|FG007|Part 3|Lack of Efficacy|0|||
146689846|NCT01729754|529042979|FG008|Part 3|Lack of Efficacy|0|||
146689847|NCT01729754|529042980|FG009|Part 3|Lack of Efficacy|4|||
146689848|NCT01729754|529042971|FG000|Part 3|Lost to Follow-up|0|||
146689849|NCT01729754|529042972|FG001|Part 3|Lost to Follow-up|1|||
146929600|NCT00571519|529900804|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
146929601|NCT00571519|529900805|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
146929602|NCT00571519|529900806|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
146929603|NCT00571519|529900807|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
146929604|NCT02499575|529900808|FG000|Overall Study|Protocol Violation|0|||
146929605|NCT02499575|529900809|FG001|Overall Study|Protocol Violation|1|||
146929606|NCT04656418|529900810|FG000|Overall Study|Withdrawal by Subject|1|||
146929607|NCT04656418|529900811|FG001|Overall Study|Withdrawal by Subject|3|||
146979719|NCT00472446|530089411|FG000|Overall Study|Questionnaires not returned|5|||
146979720|NCT00472446|530089412|FG001|Overall Study|Questionnaires not returned|6|||
146689850|NCT01729754|529042973|FG002|Part 3|Lost to Follow-up|2|||
146689851|NCT01729754|529042974|FG003|Part 3|Lost to Follow-up|0|||
146689852|NCT01729754|529042975|FG004|Part 3|Lost to Follow-up|0|||
146689853|NCT01729754|529042976|FG005|Part 3|Lost to Follow-up|3|||
146689854|NCT01729754|529042977|FG006|Part 3|Lost to Follow-up|0|||
146689855|NCT01729754|529042978|FG007|Part 3|Lost to Follow-up|0|||
146689856|NCT01729754|529042979|FG008|Part 3|Lost to Follow-up|1|||
146689857|NCT01729754|529042980|FG009|Part 3|Lost to Follow-up|0|||
146929608|NCT02586077|529900812|FG000|Overall Study|Withdrawal by Subject|1|||
146979721|NCT00472446|530089413|FG002|Overall Study|Questionnaires not returned|6|||
146979722|NCT00472446|530089414|FG003|Overall Study|Questionnaires not returned|4|||
146689858|NCT01729754|529042971|FG000|Part 3|Physician Decision|0|||
146689859|NCT01729754|529042972|FG001|Part 3|Physician Decision|0|||
146929609|NCT02586077|529900812|FG000|Overall Study|Physician Decision|4|||
146929610|NCT02586077|529900812|FG000|Overall Study|Lost to Follow-up|3|||
146689860|NCT01729754|529042973|FG002|Part 3|Physician Decision|1|||
146689861|NCT01729754|529042974|FG003|Part 3|Physician Decision|0|||
146689862|NCT01729754|529042975|FG004|Part 3|Physician Decision|0|||
146689863|NCT01729754|529042976|FG005|Part 3|Physician Decision|0|||
146689864|NCT01729754|529042977|FG006|Part 3|Physician Decision|0|||
146689865|NCT01729754|529042978|FG007|Part 3|Physician Decision|0|||
146689866|NCT01729754|529042979|FG008|Part 3|Physician Decision|0|||
146689867|NCT01729754|529042980|FG009|Part 3|Physician Decision|0|||
146689868|NCT01729754|529042971|FG000|Part 3|Withdrawal by Subject|0|||
146689869|NCT01729754|529042972|FG001|Part 3|Withdrawal by Subject|4|||
146689870|NCT01729754|529042973|FG002|Part 3|Withdrawal by Subject|1|||
146689871|NCT01729754|529042974|FG003|Part 3|Withdrawal by Subject|0|||
146689872|NCT01729754|529042975|FG004|Part 3|Withdrawal by Subject|2|||
146689873|NCT01729754|529042976|FG005|Part 3|Withdrawal by Subject|1|||
146689874|NCT01729754|529042977|FG006|Part 3|Withdrawal by Subject|0|||
146689875|NCT01729754|529042978|FG007|Part 3|Withdrawal by Subject|2|||
146689876|NCT01729754|529042979|FG008|Part 3|Withdrawal by Subject|0|||
146689877|NCT01729754|529042980|FG009|Part 3|Withdrawal by Subject|0|||
146775359|NCT04043455|529349498|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
146689878|NCT01729754|529042971|FG000|Part 3|Other Protocol Specified Criteria|0|||
146689879|NCT01729754|529042972|FG001|Part 3|Other Protocol Specified Criteria|0|||
146775360|NCT04043455|529349499|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
146775361|NCT04043455|529349494|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
146775362|NCT04043455|529349495|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
146775363|NCT04043455|529349496|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
146775364|NCT04043455|529349497|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
146775365|NCT04043455|529349498|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
146775366|NCT04043455|529349499|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
146775367|NCT04043455|529349494|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
146775368|NCT04043455|529349495|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
146775369|NCT04043455|529349496|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
146775370|NCT04043455|529349497|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
146775371|NCT04043455|529349498|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
146775372|NCT04043455|529349499|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
146775373|NCT01998984|529349500|FG000|Overall Study|Adverse Event|0|||
146775374|NCT01998984|529349501|FG001|Overall Study|Adverse Event|0|||
146775375|NCT01998984|529349502|FG002|Overall Study|Adverse Event|0|||
146775376|NCT01998984|529349503|FG003|Overall Study|Adverse Event|1|||
146775377|NCT01998984|529349500|FG000|Overall Study|Lost to Follow-up|0|||
146775378|NCT01998984|529349501|FG001|Overall Study|Lost to Follow-up|1|||
146775379|NCT01998984|529349502|FG002|Overall Study|Lost to Follow-up|0|||
146775380|NCT01998984|529349503|FG003|Overall Study|Lost to Follow-up|1|||
146775381|NCT01998984|529349500|FG000|Overall Study|Withdrawal by Subject|0|||
146775382|NCT01998984|529349501|FG001|Overall Study|Withdrawal by Subject|0|||
146775383|NCT01998984|529349502|FG002|Overall Study|Withdrawal by Subject|1|||
146775384|NCT01998984|529349503|FG003|Overall Study|Withdrawal by Subject|0|||
146775385|NCT01998984|529349500|FG000|Overall Study|Other|0|||
146775386|NCT01998984|529349501|FG001|Overall Study|Other|0|||
146775387|NCT01998984|529349502|FG002|Overall Study|Other|0|||
146775388|NCT01998984|529349503|FG003|Overall Study|Other|1|||
146775389|NCT03025789|529349504|FG000|Overall Study|Lack of Efficacy|6|||
146775390|NCT03025789|529349505|FG001|Overall Study|Lack of Efficacy|1|||
146775391|NCT03025789|529349504|FG000|Overall Study|Death|1|||
146775392|NCT03025789|529349505|FG001|Overall Study|Death|0|||
146775393|NCT03025789|529349504|FG000|Overall Study|Withdrawal by Subject|0|||
146775394|NCT03025789|529349505|FG001|Overall Study|Withdrawal by Subject|2|||
146775395|NCT04440176|529349507|FG000|Overall Study|Withdrawal by Subject|5|||
146775396|NCT04440176|529349508|FG001|Overall Study|Withdrawal by Subject|3|||
146775397|NCT04440176|529349507|FG000|Overall Study|Withdrawal by parent/guardian|4|||
146775398|NCT04440176|529349508|FG001|Overall Study|Withdrawal by parent/guardian|5|||
146775399|NCT04440176|529349507|FG000|Overall Study|Adverse Event|2|||
146775400|NCT04440176|529349508|FG001|Overall Study|Adverse Event|6|||
146775401|NCT04440176|529349507|FG000|Overall Study|Lost to Follow-up|22|||
146775402|NCT04440176|529349508|FG001|Overall Study|Lost to Follow-up|23|||
146775403|NCT04440176|529349507|FG000|Overall Study|Medication error without associated adverse event|0|||
146775404|NCT04440176|529349508|FG001|Overall Study|Medication error without associated adverse event|1|||
146775405|NCT04440176|529349507|FG000|Overall Study|No longer met eligibility criteria|7|||
146775406|NCT04440176|529349508|FG001|Overall Study|No longer met eligibility criteria|1|||
146775407|NCT04440176|529349507|FG000|Overall Study|Other|1|||
146775408|NCT04440176|529349508|FG001|Overall Study|Other|2|||
146775409|NCT04440176|529349507|FG000|Overall Study|Protocol deviation|6|||
146929611|NCT01245764|529900813|FG000|Study Phase A|Other|3|||
146689880|NCT01729754|529042973|FG002|Part 3|Other Protocol Specified Criteria|0|||
146689881|NCT01729754|529042974|FG003|Part 3|Other Protocol Specified Criteria|0|||
146689882|NCT01729754|529042975|FG004|Part 3|Other Protocol Specified Criteria|0|||
146775410|NCT04440176|529349508|FG001|Overall Study|Protocol deviation|8|||
146775411|NCT04440176|529349507|FG000|Overall Study|Randomized but not vaccinated|6|||
146775412|NCT04440176|529349508|FG001|Overall Study|Randomized but not vaccinated|3|||
146775413|NCT01631214|529349509|FG000|Overall Study|Withdrawal by Subject|276|||
146775414|NCT01631214|529349510|FG001|Overall Study|Withdrawal by Subject|290|||
146689883|NCT01729754|529042976|FG005|Part 3|Other Protocol Specified Criteria|2|||
146689884|NCT01729754|529042977|FG006|Part 3|Other Protocol Specified Criteria|0|||
146775415|NCT01631214|529349509|FG000|Overall Study|Death|113|||
146689885|NCT01729754|529042978|FG007|Part 3|Other Protocol Specified Criteria|1|||
146689886|NCT01729754|529042979|FG008|Part 3|Other Protocol Specified Criteria|0|||
146689887|NCT01729754|529042980|FG009|Part 3|Other Protocol Specified Criteria|0|||
146689888|NCT00773292|529042981|FG000|Treatment 48 Weeks|Adverse Event|1|||
146689889|NCT00773292|529042981|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
146689890|NCT04729127|529042982|FG000|Overall Study|Suspended/Terminated EI Services|4|||
146689891|NCT04729127|529042983|FG001|Overall Study|Suspended/Terminated EI Services|0|||
146689892|NCT04729127|529042984|FG002|Overall Study|Suspended/Terminated EI Services|4|||
146689893|NCT04729127|529042985|FG003|Overall Study|Suspended/Terminated EI Services|6|||
146689894|NCT04729127|529042986|FG004|Overall Study|Suspended/Terminated EI Services|0|||
146689895|NCT04729127|529042987|FG005|Overall Study|Suspended/Terminated EI Services|6|||
146689896|NCT04729127|529042988|FG006|Overall Study|Suspended/Terminated EI Services|2|||
146689897|NCT04729127|529042989|FG007|Overall Study|Suspended/Terminated EI Services|0|||
146689898|NCT04729127|529042990|FG008|Overall Study|Suspended/Terminated EI Services|2|||
146689899|NCT04729127|529042982|FG000|Overall Study|Withdrawal by Subject|1|||
146689900|NCT04729127|529042983|FG001|Overall Study|Withdrawal by Subject|0|||
146689901|NCT04729127|529042984|FG002|Overall Study|Withdrawal by Subject|1|||
146689902|NCT04729127|529042985|FG003|Overall Study|Withdrawal by Subject|0|||
146689903|NCT04729127|529042986|FG004|Overall Study|Withdrawal by Subject|0|||
146689904|NCT04729127|529042987|FG005|Overall Study|Withdrawal by Subject|0|||
146689905|NCT04729127|529042988|FG006|Overall Study|Withdrawal by Subject|0|||
146689906|NCT04729127|529042989|FG007|Overall Study|Withdrawal by Subject|0|||
146689907|NCT04729127|529042990|FG008|Overall Study|Withdrawal by Subject|0|||
146689908|NCT04729127|529042982|FG000|Overall Study|Switched Agency/Setting|1|||
146689909|NCT04729127|529042983|FG001|Overall Study|Switched Agency/Setting|0|||
146689910|NCT04729127|529042984|FG002|Overall Study|Switched Agency/Setting|1|||
146689911|NCT04729127|529042985|FG003|Overall Study|Switched Agency/Setting|1|||
146689912|NCT04729127|529042986|FG004|Overall Study|Switched Agency/Setting|0|||
146689913|NCT04729127|529042987|FG005|Overall Study|Switched Agency/Setting|1|||
146689914|NCT04729127|529042988|FG006|Overall Study|Switched Agency/Setting|1|||
146689915|NCT04729127|529042989|FG007|Overall Study|Switched Agency/Setting|0|||
146689916|NCT04729127|529042990|FG008|Overall Study|Switched Agency/Setting|1|||
146689917|NCT03388138|529043001|FG000|Overall Study|Protocol Violation|1|||
146689918|NCT03388138|529043002|FG001|Overall Study|Protocol Violation|0|||
146689919|NCT01528072|529043003|FG000|Overall Study|Withdrawal by Subject|5|||
146689920|NCT01528072|529043003|FG000|Overall Study|Physician Decision|1|||
146689921|NCT01528072|529043003|FG000|Overall Study|Determined not eligible by AEAC|1|||
146689922|NCT01528072|529043003|FG000|Overall Study|Missed Visit|2|||
146689923|NCT01528072|529043003|FG000|Overall Study|Lost to Follow-up|5|||
146689924|NCT01528072|529043003|FG000|Overall Study|Explanted|2|||
146689925|NCT01528072|529043003|FG000|Overall Study|Site Closure|4|||
146689926|NCT01528072|529043003|FG000|Overall Study|Death|2|||
146689927|NCT01528072|529043003|FG000|Overall Study|Early Termination of Study|52|||
146689928|NCT04014075|529043005|FG000|Overall Study|Progressive Disease|53|||
146929612|NCT01245764|529900814|FG001|Study Phase A|Other|2|||
146929613|NCT01245764|529900815|FG002|Study Phase A|Other|3|||
146929614|NCT01245764|529900816|FG003|Study Phase A|Other|1|||
146929615|NCT01245764|529900813|FG000|Study Phase A|Protocol Violation|6|||
146929616|NCT01245764|529900814|FG001|Study Phase A|Protocol Violation|3|||
146929617|NCT01245764|529900815|FG002|Study Phase A|Protocol Violation|2|||
146929618|NCT01245764|529900816|FG003|Study Phase A|Protocol Violation|2|||
146929619|NCT01245764|529900813|FG000|Study Phase A|Lost to Follow-up|0|||
146929620|NCT01245764|529900814|FG001|Study Phase A|Lost to Follow-up|0|||
146929621|NCT01245764|529900815|FG002|Study Phase A|Lost to Follow-up|5|||
146929622|NCT01245764|529900816|FG003|Study Phase A|Lost to Follow-up|0|||
146929623|NCT00003476|529900817|FG000|Overall Study|Not evaluable|1|||
146929624|NCT02475850|529900818|FG000|Overall Study|Death|155|||
146929625|NCT02475850|529900819|FG001|Overall Study|Death|141|||
146929626|NCT02475850|529900818|FG000|Overall Study|Lost to Follow-up|217|||
146929627|NCT02475850|529900819|FG001|Overall Study|Lost to Follow-up|188|||
146929628|NCT02475850|529900818|FG000|Overall Study|Withdrawal by Subject|221|||
146979723|NCT02008721|530089419|FG000|Overall Study|Withdrawal by Subject|5|||
146979724|NCT02008721|530089420|FG001|Overall Study|Withdrawal by Subject|1|||
146689929|NCT04014075|529043005|FG000|Overall Study|Adverse Event|15|||
146689930|NCT04014075|529043005|FG000|Overall Study|Clinical Progression|4|||
146689931|NCT04014075|529043005|FG000|Overall Study|Death|2|||
146689932|NCT04014075|529043005|FG000|Overall Study|Withdrawal by Subject|2|||
146689933|NCT04014075|529043005|FG000|Overall Study|Miscellaneous|2|||
146689934|NCT04014075|529043005|FG000|Overall Study|Physician Decision|1|||
146689935|NCT04741074|529043010|FG000|Overall Study|Withdrawal by Subject|1|||
146689936|NCT04741074|529043011|FG001|Overall Study|Withdrawal by Subject|1|||
146689937|NCT04741074|529043010|FG000|Overall Study|Study terminated prematurely|1|||
146979725|NCT02008721|530089419|FG000|Overall Study|Death|4|||
146929629|NCT02475850|529900819|FG001|Overall Study|Withdrawal by Subject|155|||
146929630|NCT03434418|529900823|FG000|Overall Study|Disease Progression|11|||
146929631|NCT03434418|529900823|FG000|Overall Study|Adverse Event|2|||
146929632|NCT03434418|529900823|FG000|Overall Study|Physician Decision|1|||
146979726|NCT02008721|530089420|FG001|Overall Study|Death|2|||
146689938|NCT04741074|529043011|FG001|Overall Study|Study terminated prematurely|0|||
146689939|NCT02432846|529043012|FG000|Overall Study (4 Arms/Strata)|Death|3|||
146689940|NCT02432846|529043013|FG001|Overall Study (4 Arms/Strata)|Death|2|||
146689941|NCT02432846|529043014|FG002|Overall Study (4 Arms/Strata)|Death|4|||
146689942|NCT02432846|529043015|FG003|Overall Study (4 Arms/Strata)|Death|3|||
146689943|NCT02432846|529043016|FG004|Overall Study (4 Arms/Strata)|Death|0|||
146689944|NCT02432846|529043017|FG005|Overall Study (4 Arms/Strata)|Death|0|||
146689945|NCT02432846|529043012|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
146689946|NCT02432846|529043013|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
146689947|NCT02432846|529043014|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
146689948|NCT02432846|529043015|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
146689949|NCT02432846|529043016|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
146689950|NCT02432846|529043017|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
146689951|NCT02432846|529043012|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
146689952|NCT02432846|529043013|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
146689953|NCT02432846|529043014|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
146689954|NCT02432846|529043015|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
146689955|NCT02432846|529043016|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
146689956|NCT02432846|529043017|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
146689957|NCT02432846|529043012|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
146689958|NCT02432846|529043013|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
146689959|NCT02432846|529043014|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
146689960|NCT02432846|529043015|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
146689961|NCT02432846|529043016|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
146689962|NCT02432846|529043017|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
146689963|NCT02432846|529043012|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
146689964|NCT02432846|529043013|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
146689965|NCT02432846|529043014|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
146689966|NCT02432846|529043015|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
146689967|NCT02432846|529043016|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
146689968|NCT02432846|529043017|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
146689969|NCT02432846|529043012|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
146689970|NCT02432846|529043013|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
146689971|NCT02432846|529043014|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
146689972|NCT02432846|529043015|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
146689973|NCT02432846|529043016|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
146689974|NCT02432846|529043017|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
146689975|NCT02432846|529043012|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
146689976|NCT02432846|529043013|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
146689977|NCT02432846|529043014|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
146689978|NCT02432846|529043015|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
146689979|NCT02432846|529043016|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
146689980|NCT02432846|529043017|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
146689981|NCT02432846|529043012|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
146689982|NCT02432846|529043013|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
146689983|NCT02432846|529043014|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
146689984|NCT02432846|529043015|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
146689985|NCT02432846|529043016|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
146689986|NCT02432846|529043017|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
146689987|NCT02432846|529043012|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
146689988|NCT02432846|529043013|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
146689989|NCT02432846|529043014|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
146689990|NCT02432846|529043015|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
146689991|NCT02432846|529043016|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
146689992|NCT02432846|529043017|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
146689993|NCT02432846|529043012|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
146689994|NCT02432846|529043013|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
146689995|NCT02432846|529043014|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
146689996|NCT02432846|529043015|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
146689997|NCT02432846|529043016|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
146689998|NCT02432846|529043017|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
146689999|NCT02432846|529043012|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
146690000|NCT02432846|529043013|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
146690001|NCT02432846|529043014|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
146929633|NCT03434418|529900823|FG000|Overall Study|Decline in Performance Status (PS)|1|||
146929634|NCT00696436|529900824|FG000|Overall Study|Adverse Event|7|||
146929635|NCT00696436|529900825|FG001|Overall Study|Adverse Event|9|||
146929636|NCT00696436|529900826|FG002|Overall Study|Adverse Event|8|||
146690002|NCT02432846|529043015|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
146690003|NCT02432846|529043016|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
146690004|NCT02432846|529043017|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
146690005|NCT02432846|529043012|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
146690006|NCT02432846|529043013|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
146690007|NCT02432846|529043014|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
146690008|NCT02432846|529043015|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
146690009|NCT02432846|529043016|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
146690010|NCT02432846|529043017|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
146690011|NCT02432846|529043012|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
146690012|NCT02432846|529043013|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
146690013|NCT02432846|529043014|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
146690014|NCT02432846|529043015|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
146690015|NCT02432846|529043016|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
146690016|NCT02432846|529043017|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
146690017|NCT02432846|529043012|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
146690018|NCT02432846|529043013|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
146690019|NCT02432846|529043014|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
146690020|NCT02432846|529043015|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
146690021|NCT02432846|529043016|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
146690022|NCT02432846|529043017|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
146690023|NCT01912287|529043022|FG000|Overall Study|Ineligible|1|||
146690024|NCT01912287|529043023|FG001|Overall Study|Ineligible|0|||
146690025|NCT01912287|529043024|FG002|Overall Study|Ineligible|1|||
146690026|NCT01912287|529043022|FG000|Overall Study|No-show|0|||
146690027|NCT01912287|529043023|FG001|Overall Study|No-show|0|||
146690028|NCT01912287|529043024|FG002|Overall Study|No-show|1|||
146690029|NCT01912287|529043022|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
146690030|NCT01912287|529043023|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
146690031|NCT01912287|529043024|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
146690032|NCT01912287|529043022|FG000|Overall Study|Felt treatment no longer needed|0|||
146690033|NCT01912287|529043023|FG001|Overall Study|Felt treatment no longer needed|1|||
146690034|NCT01912287|529043024|FG002|Overall Study|Felt treatment no longer needed|0|||
146690035|NCT01912287|529043022|FG000|Overall Study|Life circumstances|4|||
146690036|NCT01912287|529043023|FG001|Overall Study|Life circumstances|2|||
146690037|NCT01912287|529043024|FG002|Overall Study|Life circumstances|0|||
146690038|NCT01912287|529043022|FG000|Overall Study|Lost Interest|1|||
146690039|NCT01912287|529043023|FG001|Overall Study|Lost Interest|0|||
146690040|NCT01912287|529043024|FG002|Overall Study|Lost Interest|0|||
146690041|NCT01912287|529043022|FG000|Overall Study|Uknown reason - subject drop out|5|||
146690042|NCT01912287|529043023|FG001|Overall Study|Uknown reason - subject drop out|7|||
146690043|NCT01912287|529043024|FG002|Overall Study|Uknown reason - subject drop out|3|||
146690044|NCT01912287|529043022|FG000|Overall Study|Missed Assesment|1|||
146690045|NCT01912287|529043023|FG001|Overall Study|Missed Assesment|1|||
146690046|NCT01912287|529043024|FG002|Overall Study|Missed Assesment|1|||
146690047|NCT01912287|529043022|FG000|Overall Study|Scheduling/change in availability|17|||
146690048|NCT01912287|529043023|FG001|Overall Study|Scheduling/change in availability|10|||
146690049|NCT01912287|529043024|FG002|Overall Study|Scheduling/change in availability|8|||
146690050|NCT03226392|529043025|FG000|Overall Study|Protocol Deviation|1|||
146690051|NCT03226392|529043026|FG001|Overall Study|Protocol Deviation|0|||
146690052|NCT03226392|529043025|FG000|Overall Study|Physician Decision|1|||
146690053|NCT03226392|529043026|FG001|Overall Study|Physician Decision|0|||
146929637|NCT00696436|529900827|FG003|Overall Study|Adverse Event|6|||
146929638|NCT00696436|529900828|FG004|Overall Study|Adverse Event|4|||
146929639|NCT00696436|529900824|FG000|Overall Study|Protocol Violation|3|||
146929640|NCT00696436|529900825|FG001|Overall Study|Protocol Violation|2|||
146929641|NCT00696436|529900826|FG002|Overall Study|Protocol Violation|2|||
146929642|NCT00696436|529900827|FG003|Overall Study|Protocol Violation|0|||
146929643|NCT00696436|529900828|FG004|Overall Study|Protocol Violation|1|||
146929644|NCT00696436|529900824|FG000|Overall Study|Lost to Follow-up|1|||
146929645|NCT00696436|529900825|FG001|Overall Study|Lost to Follow-up|6|||
146929646|NCT00696436|529900826|FG002|Overall Study|Lost to Follow-up|2|||
146929647|NCT00696436|529900827|FG003|Overall Study|Lost to Follow-up|4|||
146929648|NCT00696436|529900828|FG004|Overall Study|Lost to Follow-up|3|||
146690054|NCT03226392|529043025|FG000|Overall Study|Lost to Follow-up|1|||
146690055|NCT03226392|529043026|FG001|Overall Study|Lost to Follow-up|0|||
146929649|NCT00696436|529900824|FG000|Overall Study|Withdrawal by Subject|4|||
146929650|NCT00696436|529900825|FG001|Overall Study|Withdrawal by Subject|11|||
146929651|NCT00696436|529900826|FG002|Overall Study|Withdrawal by Subject|5|||
146929652|NCT00696436|529900827|FG003|Overall Study|Withdrawal by Subject|7|||
146929653|NCT00696436|529900828|FG004|Overall Study|Withdrawal by Subject|1|||
146929654|NCT00696436|529900824|FG000|Overall Study|Lack of Efficacy|3|||
146775416|NCT01631214|529349510|FG001|Overall Study|Death|106|||
146775417|NCT01631214|529349509|FG000|Overall Study|Lost to Follow-up|54|||
146775418|NCT01631214|529349510|FG001|Overall Study|Lost to Follow-up|40|||
146775419|NCT01631214|529349509|FG000|Overall Study|Adverse Event|45|||
146775420|NCT01631214|529349510|FG001|Overall Study|Adverse Event|45|||
146775421|NCT01631214|529349509|FG000|Overall Study|Other|22|||
146775422|NCT01631214|529349510|FG001|Overall Study|Other|19|||
146775423|NCT01631214|529349509|FG000|Overall Study|Noncompliance|16|||
146775424|NCT01631214|529349510|FG001|Overall Study|Noncompliance|15|||
146775425|NCT01631214|529349509|FG000|Overall Study|Requirement for Alternative Therapy|8|||
146775426|NCT01631214|529349510|FG001|Overall Study|Requirement for Alternative Therapy|3|||
146775427|NCT01631214|529349509|FG000|Overall Study|Protocol Deviation|4|||
146775428|NCT01631214|529349510|FG001|Overall Study|Protocol Deviation|3|||
146775429|NCT01631214|529349509|FG000|Overall Study|Ineligibility determined|5|||
146775430|NCT01631214|529349510|FG001|Overall Study|Ineligibility determined|2|||
146775431|NCT01631214|529349509|FG000|Overall Study|Administrative Decision|1|||
146775432|NCT01631214|529349510|FG001|Overall Study|Administrative Decision|0|||
146775433|NCT05288283|529349511|FG000|Overall Study|Study Terminated Early|1|||
146775434|NCT05288283|529349512|FG001|Overall Study|Study Terminated Early|1|||
146775435|NCT04153565|529349513|FG000|Overall Study|Death|13|||
146775436|NCT02991807|529349514|FG000|Overall Study|Withdrawal by Subject|2|||
146775437|NCT02991807|529349515|FG001|Overall Study|Withdrawal by Subject|1|||
146775438|NCT02991807|529349514|FG000|Overall Study|Physician Decision|0|||
146929655|NCT00696436|529900825|FG001|Overall Study|Lack of Efficacy|1|||
146929656|NCT00696436|529900826|FG002|Overall Study|Lack of Efficacy|5|||
146929657|NCT00696436|529900827|FG003|Overall Study|Lack of Efficacy|2|||
146690056|NCT03226392|529043025|FG000|Overall Study|Adverse Event|1|||
146690057|NCT03226392|529043026|FG001|Overall Study|Adverse Event|0|||
146690058|NCT03226392|529043025|FG000|Overall Study|Technical Problems|0|||
146690059|NCT03226392|529043026|FG001|Overall Study|Technical Problems|2|||
146690060|NCT03226392|529043025|FG000|Overall Study|Subject/Guardian Decision|7|||
146690061|NCT03226392|529043026|FG001|Overall Study|Subject/Guardian Decision|6|||
146690062|NCT00937157|529043027|FG000|Overall Study|Pregnancy|1|||
146690063|NCT00937157|529043027|FG000|Overall Study|Lost to Follow-up|3|||
146690064|NCT01998633|529043028|FG000|Overall Study|Death|1|||
146690065|NCT02631850|529043029|FG000|Treatment Period|Lost to Follow-up|0|||
146690066|NCT02631850|529043030|FG001|Treatment Period|Lost to Follow-up|1|||
146690067|NCT02631850|529043031|FG002|Treatment Period|Lost to Follow-up|0|||
146690068|NCT02631850|529043032|FG003|Treatment Period|Lost to Follow-up|0|||
146690069|NCT02631850|529043029|FG000|Treatment Period|Protocol Violation|1|||
146690070|NCT02631850|529043030|FG001|Treatment Period|Protocol Violation|0|||
146690071|NCT02631850|529043031|FG002|Treatment Period|Protocol Violation|0|||
146690072|NCT02631850|529043032|FG003|Treatment Period|Protocol Violation|0|||
146690073|NCT02631850|529043029|FG000|Treatment Period|Withdrawal by Subject|0|||
146690074|NCT02631850|529043030|FG001|Treatment Period|Withdrawal by Subject|5|||
146690075|NCT02631850|529043031|FG002|Treatment Period|Withdrawal by Subject|2|||
146690076|NCT02631850|529043032|FG003|Treatment Period|Withdrawal by Subject|2|||
146690077|NCT02631850|529043029|FG000|Treatment Period|Adverse Event|1|||
146690078|NCT02631850|529043030|FG001|Treatment Period|Adverse Event|0|||
146690079|NCT02631850|529043031|FG002|Treatment Period|Adverse Event|2|||
146690080|NCT02631850|529043032|FG003|Treatment Period|Adverse Event|3|||
146690081|NCT02631850|529043029|FG000|Treatment Period|Family medical issue|1|||
146690082|NCT02631850|529043030|FG001|Treatment Period|Family medical issue|0|||
146690083|NCT02631850|529043031|FG002|Treatment Period|Family medical issue|0|||
146690084|NCT02631850|529043032|FG003|Treatment Period|Family medical issue|0|||
146690085|NCT02631850|529043029|FG000|6 Month Follow up|Lost to Follow-up|5|||
146690086|NCT02631850|529043030|FG001|6 Month Follow up|Lost to Follow-up|8|||
146690087|NCT02631850|529043031|FG002|6 Month Follow up|Lost to Follow-up|3|||
146690088|NCT02631850|529043032|FG003|6 Month Follow up|Lost to Follow-up|5|||
146690089|NCT02631850|529043029|FG000|6 Month Follow up|Withdrawal by Subject|1|||
146929658|NCT00696436|529900828|FG004|Overall Study|Lack of Efficacy|4|||
146929659|NCT00696436|529900824|FG000|Overall Study|Participant Unavailability|2|||
146690090|NCT02631850|529043030|FG001|6 Month Follow up|Withdrawal by Subject|0|||
146690091|NCT02631850|529043031|FG002|6 Month Follow up|Withdrawal by Subject|0|||
146690092|NCT02631850|529043032|FG003|6 Month Follow up|Withdrawal by Subject|2|||
146775439|NCT02991807|529349515|FG001|Overall Study|Physician Decision|1|||
146775440|NCT02991807|529349514|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
146775441|NCT02991807|529349515|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
146775442|NCT02300298|529349516|FG000|Disposition for Nintedanib|Progressive disease|10|||
146929660|NCT00696436|529900825|FG001|Overall Study|Participant Unavailability|0|||
146775443|NCT02300298|529349517|FG001|Disposition for Nintedanib|Progressive disease|0|||
146929661|NCT00696436|529900826|FG002|Overall Study|Participant Unavailability|2|||
146690093|NCT02631850|529043029|FG000|6 Month Follow up|Adverse Event|1|||
146690094|NCT02631850|529043030|FG001|6 Month Follow up|Adverse Event|4|||
146690095|NCT02631850|529043031|FG002|6 Month Follow up|Adverse Event|1|||
146690096|NCT02631850|529043032|FG003|6 Month Follow up|Adverse Event|3|||
146690097|NCT02631850|529043029|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
146690098|NCT02631850|529043030|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
146690099|NCT02631850|529043031|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
146690100|NCT02631850|529043032|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
146690101|NCT01462084|529043034|FG000|Overall Study|Withdrawal by Subject|1|||
146690102|NCT01462084|529043035|FG001|Overall Study|Withdrawal by Subject|0|||
146690103|NCT01462084|529043034|FG000|Overall Study|Protocol Violation|1|||
146690104|NCT01462084|529043035|FG001|Overall Study|Protocol Violation|1|||
146690105|NCT03992781|529043036|FG000|Overall Study|Lost to Follow-up|5|||
146690106|NCT03992781|529043036|FG000|Overall Study|Adverse Event|1|||
146690107|NCT03992781|529043036|FG000|Overall Study|Lack of Efficacy|5|||
146690108|NCT01996826|529043037|FG000|Overall Study|Lost to Follow-up|6|||
146690109|NCT01996826|529043038|FG001|Overall Study|Lost to Follow-up|2|||
146690110|NCT01996826|529043037|FG000|Overall Study|Physician Decision|1|||
146690111|NCT01996826|529043038|FG001|Overall Study|Physician Decision|1|||
146690112|NCT00695396|529043039|FG000|Overall Study|Study Closed Prematurely|5|||
146690113|NCT00695396|529043040|FG001|Overall Study|Study Closed Prematurely|6|||
146690114|NCT00695396|529043041|FG002|Overall Study|Study Closed Prematurely|8|||
146690115|NCT00695396|529043039|FG000|Overall Study|Withdrawal by Subject|2|||
146690116|NCT00695396|529043040|FG001|Overall Study|Withdrawal by Subject|2|||
146690117|NCT00695396|529043041|FG002|Overall Study|Withdrawal by Subject|0|||
146690118|NCT00518323|529043043|FG000|Overall Study|Lack of Efficacy|14|||
146690119|NCT00518323|529043044|FG001|Overall Study|Lack of Efficacy|2|||
146690120|NCT00518323|529043045|FG002|Overall Study|Lack of Efficacy|4|||
146690121|NCT00518323|529043046|FG003|Overall Study|Lack of Efficacy|20|||
146690122|NCT00518323|529043043|FG000|Overall Study|Withdrawal by Subject|1|||
146690123|NCT00518323|529043044|FG001|Overall Study|Withdrawal by Subject|2|||
146690124|NCT00518323|529043045|FG002|Overall Study|Withdrawal by Subject|4|||
146690125|NCT00518323|529043046|FG003|Overall Study|Withdrawal by Subject|2|||
146690126|NCT00518323|529043043|FG000|Overall Study|Lost to Follow-up|0|||
146929662|NCT00696436|529900827|FG003|Overall Study|Participant Unavailability|1|||
146690127|NCT00518323|529043044|FG001|Overall Study|Lost to Follow-up|2|||
146690128|NCT00518323|529043045|FG002|Overall Study|Lost to Follow-up|1|||
146690129|NCT00518323|529043046|FG003|Overall Study|Lost to Follow-up|3|||
146690130|NCT00518323|529043043|FG000|Overall Study|Adverse Event|1|||
146690131|NCT00518323|529043044|FG001|Overall Study|Adverse Event|1|||
146690132|NCT00518323|529043045|FG002|Overall Study|Adverse Event|1|||
146690133|NCT00518323|529043046|FG003|Overall Study|Adverse Event|0|||
146690134|NCT00518323|529043043|FG000|Overall Study|Prohibited medication and others|3|||
146690135|NCT00518323|529043044|FG001|Overall Study|Prohibited medication and others|1|||
146690136|NCT00518323|529043045|FG002|Overall Study|Prohibited medication and others|1|||
146690137|NCT00518323|529043046|FG003|Overall Study|Prohibited medication and others|0|||
146929663|NCT00696436|529900828|FG004|Overall Study|Participant Unavailability|0|||
146690139|NCT01514760|529043049|FG000|Overall Study|Lost to Follow-up|2|||
146690140|NCT01132547|529043050|FG000|Overall Study|Withdrawal by Subject|3|||
146690141|NCT01132547|529043051|FG001|Overall Study|Withdrawal by Subject|1|||
146690142|NCT01132547|529043050|FG000|Overall Study|Death|1|||
146690143|NCT01132547|529043051|FG001|Overall Study|Death|0|||
146690144|NCT02337907|529043054|FG000|Overall Study|Other than listed|1|||
146690145|NCT02337907|529043055|FG001|Overall Study|Other than listed|0|||
146690146|NCT02337907|529043056|FG002|Overall Study|Other than listed|0|||
146690147|NCT02337907|529043057|FG003|Overall Study|Other than listed|1|||
146690148|NCT02337907|529043058|FG004|Overall Study|Other than listed|1|||
146690149|NCT02337907|529043059|FG005|Overall Study|Other than listed|0|||
146690150|NCT02337907|529043054|FG000|Overall Study|Withdrawal by Subject|2|||
146690151|NCT02337907|529043055|FG001|Overall Study|Withdrawal by Subject|3|||
146690152|NCT02337907|529043056|FG002|Overall Study|Withdrawal by Subject|0|||
146690153|NCT02337907|529043057|FG003|Overall Study|Withdrawal by Subject|2|||
146690154|NCT02337907|529043058|FG004|Overall Study|Withdrawal by Subject|5|||
146690155|NCT02337907|529043059|FG005|Overall Study|Withdrawal by Subject|0|||
146929664|NCT00696436|529900824|FG000|Overall Study|Administrative Error|2|||
146929665|NCT00696436|529900825|FG001|Overall Study|Administrative Error|0|||
146690156|NCT02337907|529043054|FG000|Overall Study|Lost to Follow-up|0|||
146690157|NCT02337907|529043055|FG001|Overall Study|Lost to Follow-up|0|||
146690158|NCT02337907|529043056|FG002|Overall Study|Lost to Follow-up|0|||
146775444|NCT02300298|529349516|FG000|Disposition for Docetaxel|Progressive disease|0|||
146690159|NCT02337907|529043057|FG003|Overall Study|Lost to Follow-up|0|||
146690160|NCT02337907|529043058|FG004|Overall Study|Lost to Follow-up|0|||
146690161|NCT02337907|529043059|FG005|Overall Study|Lost to Follow-up|1|||
146690162|NCT02337907|529043054|FG000|Overall Study|Adverse Event|1|||
146775445|NCT02300298|529349517|FG001|Disposition for Docetaxel|Progressive disease|6|||
146690163|NCT02337907|529043055|FG001|Overall Study|Adverse Event|1|||
146690164|NCT02337907|529043056|FG002|Overall Study|Adverse Event|1|||
146690165|NCT02337907|529043057|FG003|Overall Study|Adverse Event|1|||
146690166|NCT02337907|529043058|FG004|Overall Study|Adverse Event|4|||
146775446|NCT02300298|529349516|FG000|Disposition for Docetaxel|other adverse event|0|||
146929666|NCT00696436|529900826|FG002|Overall Study|Administrative Error|2|||
146929667|NCT00696436|529900827|FG003|Overall Study|Administrative Error|0|||
146690167|NCT02337907|529043059|FG005|Overall Study|Adverse Event|0|||
146690168|NCT01592344|529043060|FG000|Overall Study|Adverse Event|1|||
146690169|NCT01592344|529043061|FG001|Overall Study|Adverse Event|1|||
146690170|NCT01592344|529043060|FG000|Overall Study|Lack of Efficacy|1|||
146690171|NCT01592344|529043061|FG001|Overall Study|Lack of Efficacy|0|||
146690172|NCT01592344|529043060|FG000|Overall Study|not available at primary outcome visit|2|||
146690173|NCT01592344|529043061|FG001|Overall Study|not available at primary outcome visit|4|||
146690174|NCT03311659|529043067|FG000|Overall Study|Protocol Violation|1|||
146690175|NCT04327388|529043070|FG000|Overall Study|Adverse Event|17|||
146690176|NCT04327388|529043071|FG001|Overall Study|Adverse Event|18|||
146690177|NCT04327388|529043072|FG002|Overall Study|Adverse Event|9|||
146690178|NCT04327388|529043070|FG000|Overall Study|Other|1|||
146690179|NCT04327388|529043071|FG001|Overall Study|Other|2|||
146690180|NCT04327388|529043072|FG002|Overall Study|Other|0|||
146690181|NCT04327388|529043070|FG000|Overall Study|Randomized and not treated|2|||
146690182|NCT04327388|529043071|FG001|Overall Study|Randomized and not treated|0|||
146690183|NCT04327388|529043072|FG002|Overall Study|Randomized and not treated|2|||
146690184|NCT04053023|529043073|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
146690185|NCT04053023|529043074|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
146690186|NCT02073279|529043075|FG000|Double-blind Period|Adverse Event|1|||
146690187|NCT02073279|529043076|FG001|Double-blind Period|Adverse Event|1|||
146690188|NCT02073279|529043075|FG000|Double-blind Period|Switched to another treatment|1|||
146690189|NCT02073279|529043076|FG001|Double-blind Period|Switched to another treatment|2|||
146690190|NCT02073279|529043075|FG000|Double-blind Period|Protocol Violation|0|||
146690191|NCT02073279|529043076|FG001|Double-blind Period|Protocol Violation|1|||
146690192|NCT02073279|529043075|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
146690193|NCT02073279|529043076|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
146690194|NCT02073279|529043075|FG000|Double-blind Period|Withdrawal by Subject|2|||
146690195|NCT02073279|529043076|FG001|Double-blind Period|Withdrawal by Subject|2|||
146690196|NCT02073279|529043075|FG000|Open-label Extension Period|Adverse Event|1|||
146690197|NCT02073279|529043076|FG001|Open-label Extension Period|Adverse Event|0|||
146690198|NCT02073279|529043075|FG000|Open-label Extension Period|Lack of Efficacy|1|||
146690199|NCT02073279|529043076|FG001|Open-label Extension Period|Lack of Efficacy|0|||
146690200|NCT02073279|529043075|FG000|Open-label Extension Period|Lost to Follow-up|0|||
146690201|NCT02073279|529043076|FG001|Open-label Extension Period|Lost to Follow-up|4|||
146690202|NCT02073279|529043075|FG000|Open-label Extension Period|Switched to another treatment|1|||
146690203|NCT02073279|529043076|FG001|Open-label Extension Period|Switched to another treatment|4|||
146690204|NCT02073279|529043075|FG000|Open-label Extension Period|Protocol Violation|0|||
146690205|NCT02073279|529043076|FG001|Open-label Extension Period|Protocol Violation|1|||
146690206|NCT02073279|529043075|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
146690207|NCT02073279|529043076|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
146690208|NCT02073279|529043075|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
146690209|NCT02073279|529043076|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
146690210|NCT01558752|529043077|FG000|Overall Study|Physician Decision|2|||
146690211|NCT01558752|529043078|FG001|Overall Study|Physician Decision|0|||
146690212|NCT04387435|529043085|FG000|Overall Study|Physician Decision|1|||
146690213|NCT01092182|529043086|FG000|Overall Study|Death|0|||
146690214|NCT01092182|529043087|FG001|Overall Study|Death|5|||
146690215|NCT01092182|529043088|FG002|Overall Study|Death|3|||
146690216|NCT01092182|529043086|FG000|Overall Study|participant safety|1|||
146690217|NCT01092182|529043087|FG001|Overall Study|participant safety|2|||
146690218|NCT01092182|529043088|FG002|Overall Study|participant safety|0|||
146690219|NCT01092182|529043086|FG000|Overall Study|Physician Decision|0|||
146690220|NCT01092182|529043087|FG001|Overall Study|Physician Decision|6|||
146690221|NCT01092182|529043088|FG002|Overall Study|Physician Decision|0|||
146690222|NCT01092182|529043086|FG000|Overall Study|Did not meet criteria|0|||
146690223|NCT01092182|529043087|FG001|Overall Study|Did not meet criteria|0|||
146690224|NCT01092182|529043088|FG002|Overall Study|Did not meet criteria|25|||
146690225|NCT01092182|529043086|FG000|Overall Study|Non-compliance|0|||
146690226|NCT01092182|529043087|FG001|Overall Study|Non-compliance|3|||
146690227|NCT01092182|529043088|FG002|Overall Study|Non-compliance|0|||
146690228|NCT01092182|529043086|FG000|Overall Study|Participant refused follow-up|0|||
146690229|NCT01092182|529043087|FG001|Overall Study|Participant refused follow-up|2|||
146929668|NCT00696436|529900828|FG004|Overall Study|Administrative Error|0|||
146929669|NCT00696436|529900824|FG000|Overall Study|Participant Non-compliance|0|||
146690230|NCT01092182|529043088|FG002|Overall Study|Participant refused follow-up|0|||
146690231|NCT01166178|529043089|FG000|Overall Study|Withdrawal by Subject|1|||
146690232|NCT01166178|529043090|FG001|Overall Study|Withdrawal by Subject|0|||
146929670|NCT00696436|529900825|FG001|Overall Study|Participant Non-compliance|0|||
146690233|NCT01166178|529043089|FG000|Overall Study|Study was terminated|20|||
146690234|NCT01166178|529043090|FG001|Overall Study|Study was terminated|8|||
146929671|NCT00696436|529900826|FG002|Overall Study|Participant Non-compliance|1|||
146929672|NCT00696436|529900827|FG003|Overall Study|Participant Non-compliance|2|||
146690235|NCT02113956|529043091|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
146690236|NCT02113956|529043092|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
146690237|NCT02113956|529043091|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
146690238|NCT02113956|529043092|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
146690239|NCT02113956|529043091|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
146690240|NCT02113956|529043092|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
146690241|NCT02446990|529043093|FG000|Overall Study|Death|485|||
146690242|NCT02446990|529043094|FG001|Overall Study|Death|458|||
146690243|NCT02446990|529043093|FG000|Overall Study|Lost to Follow-up|3|||
146690244|NCT02446990|529043094|FG001|Overall Study|Lost to Follow-up|1|||
146690245|NCT02446990|529043093|FG000|Overall Study|Physician Decision|1|||
146690246|NCT02446990|529043094|FG001|Overall Study|Physician Decision|0|||
146690247|NCT02446990|529043093|FG000|Overall Study|Withdrawal by Subject|231|||
146690248|NCT02446990|529043094|FG001|Overall Study|Withdrawal by Subject|199|||
146690249|NCT01064401|529043095|FG000|Overall Study|Adverse Event|47|||
146690250|NCT01064401|529043096|FG001|Overall Study|Adverse Event|56|||
146690251|NCT01064401|529043095|FG000|Overall Study|Lack of Efficacy|46|||
146690252|NCT01064401|529043096|FG001|Overall Study|Lack of Efficacy|23|||
146690253|NCT01064401|529043095|FG000|Overall Study|Lost to Follow-up|12|||
146690254|NCT01064401|529043096|FG001|Overall Study|Lost to Follow-up|9|||
146690255|NCT01064401|529043095|FG000|Overall Study|Consent Withdrawn|98|||
146690256|NCT01064401|529043096|FG001|Overall Study|Consent Withdrawn|80|||
146690257|NCT01064401|529043095|FG000|Overall Study|Investigator Decision|4|||
146690258|NCT01064401|529043096|FG001|Overall Study|Investigator Decision|6|||
146690259|NCT01064401|529043095|FG000|Overall Study|Death|4|||
146690260|NCT01064401|529043096|FG001|Overall Study|Death|0|||
146690261|NCT01064401|529043095|FG000|Overall Study|Pregnancy|4|||
146690262|NCT01064401|529043096|FG001|Overall Study|Pregnancy|7|||
146690263|NCT01064401|529043095|FG000|Overall Study|Noncompliance|7|||
146690264|NCT01064401|529043096|FG001|Overall Study|Noncompliance|8|||
146690265|NCT01064401|529043095|FG000|Overall Study|Site Closure|4|||
146690266|NCT01064401|529043096|FG001|Overall Study|Site Closure|5|||
146690267|NCT01064401|529043095|FG000|Overall Study|Other|2|||
146690268|NCT01064401|529043096|FG001|Overall Study|Other|1|||
146690269|NCT03158051|529043097|FG000|Overall Study|Lost to Follow-up|41|||
146690270|NCT03158051|529043098|FG001|Overall Study|Lost to Follow-up|47|||
146690271|NCT03158051|529043097|FG000|Overall Study|Physician Decision|6|||
146690272|NCT03158051|529043098|FG001|Overall Study|Physician Decision|7|||
146690273|NCT03158051|529043097|FG000|Overall Study|Withdrawal by Subject|24|||
146690274|NCT03158051|529043098|FG001|Overall Study|Withdrawal by Subject|15|||
146690275|NCT03158051|529043097|FG000|Overall Study|Death|0|||
146690276|NCT03158051|529043098|FG001|Overall Study|Death|1|||
146690277|NCT02738151|529043099|FG000|Overall Study|Randomized but not treated|4|||
146690278|NCT02738151|529043100|FG001|Overall Study|Randomized but not treated|1|||
146690279|NCT02738151|529043099|FG000|Overall Study|Adverse Event|4|||
146690280|NCT02738151|529043100|FG001|Overall Study|Adverse Event|5|||
146690281|NCT02738151|529043099|FG000|Overall Study|Hypoglycemia|0|||
146690282|NCT02738151|529043100|FG001|Overall Study|Hypoglycemia|1|||
146690283|NCT02738151|529043099|FG000|Overall Study|Poor Compliance to Protocol|4|||
146690284|NCT02738151|529043100|FG001|Overall Study|Poor Compliance to Protocol|3|||
146690285|NCT02738151|529043099|FG000|Overall Study|Other than specified above|11|||
146690286|NCT02738151|529043100|FG001|Overall Study|Other than specified above|21|||
146690287|NCT04199117|529043112|FG000|Overall Study|Withdrawal by Subject|3|||
146690288|NCT04199117|529043113|FG001|Overall Study|Withdrawal by Subject|0|||
146690289|NCT04199117|529043114|FG002|Overall Study|Withdrawal by Subject|0|||
146690290|NCT04199117|529043115|FG003|Overall Study|Withdrawal by Subject|1|||
146690291|NCT04199117|529043116|FG004|Overall Study|Withdrawal by Subject|1|||
146690292|NCT04199117|529043117|FG005|Overall Study|Withdrawal by Subject|0|||
146690293|NCT04199117|529043118|FG006|Overall Study|Withdrawal by Subject|0|||
146929673|NCT00696436|529900828|FG004|Overall Study|Participant Non-compliance|0|||
146690294|NCT04199117|529043119|FG007|Overall Study|Withdrawal by Subject|2|||
146690295|NCT04199117|529043120|FG008|Overall Study|Withdrawal by Subject|0|||
146690296|NCT04199117|529043121|FG009|Overall Study|Withdrawal by Subject|0|||
146690297|NCT04199117|529043122|FG010|Overall Study|Withdrawal by Subject|1|||
146775447|NCT02300298|529349517|FG001|Disposition for Docetaxel|other adverse event|4|||
146775448|NCT03285763|529349518|FG000|Overall Study|Death|470|||
146775449|NCT03285763|529349518|FG000|Overall Study|Lost to Follow-up|18|||
146690298|NCT04199117|529043123|FG011|Overall Study|Withdrawal by Subject|1|||
146690299|NCT04199117|529043124|FG012|Overall Study|Withdrawal by Subject|2|||
146690300|NCT04199117|529043125|FG013|Overall Study|Withdrawal by Subject|1|||
146690301|NCT04199117|529043126|FG014|Overall Study|Withdrawal by Subject|1|||
146690302|NCT04199117|529043127|FG015|Overall Study|Withdrawal by Subject|1|||
146690303|NCT04199117|529043112|FG000|Overall Study|Death|1|||
146690304|NCT04199117|529043113|FG001|Overall Study|Death|1|||
146690305|NCT04199117|529043114|FG002|Overall Study|Death|0|||
146690306|NCT04199117|529043115|FG003|Overall Study|Death|0|||
146690307|NCT04199117|529043116|FG004|Overall Study|Death|0|||
146690308|NCT04199117|529043117|FG005|Overall Study|Death|0|||
146929674|NCT00696436|529900824|FG000|Overall Study|Administrative Decision|1|||
146929675|NCT00696436|529900825|FG001|Overall Study|Administrative Decision|0|||
146929676|NCT00696436|529900826|FG002|Overall Study|Administrative Decision|0|||
146929677|NCT00696436|529900827|FG003|Overall Study|Administrative Decision|0|||
146929678|NCT00696436|529900828|FG004|Overall Study|Administrative Decision|0|||
146929679|NCT00696436|529900824|FG000|Overall Study|Missing|0|||
146929680|NCT00696436|529900825|FG001|Overall Study|Missing|1|||
146929681|NCT00696436|529900826|FG002|Overall Study|Missing|1|||
146929682|NCT00696436|529900827|FG003|Overall Study|Missing|0|||
146929683|NCT00696436|529900828|FG004|Overall Study|Missing|0|||
146929684|NCT03039738|529900832|FG000|Overall Study|Incomplete data sets|54|||
146929685|NCT03039738|529900833|FG001|Overall Study|Incomplete data sets|0|||
146929686|NCT00912340|529900836|FG000|Overall Study|Adverse Event|2|||
146929687|NCT00912340|529900837|FG001|Overall Study|Adverse Event|4|||
146929688|NCT00912340|529900838|FG002|Overall Study|Adverse Event|0|||
146929689|NCT00912340|529900836|FG000|Overall Study|Protocol revised to remove arm|0|||
146929690|NCT00912340|529900837|FG001|Overall Study|Protocol revised to remove arm|0|||
146929691|NCT00912340|529900838|FG002|Overall Study|Protocol revised to remove arm|4|||
146929692|NCT01517412|529900839|FG000|Overall Study|Adverse Event|10|||
146929693|NCT01517412|529900840|FG001|Overall Study|Adverse Event|11|||
146929694|NCT01517412|529900839|FG000|Overall Study|Lack of Efficacy|10|||
146929695|NCT01517412|529900840|FG001|Overall Study|Lack of Efficacy|5|||
146929696|NCT01517412|529900839|FG000|Overall Study|Poor compliance to protocol|8|||
146929697|NCT01517412|529900840|FG001|Overall Study|Poor compliance to protocol|3|||
146929698|NCT01517412|529900839|FG000|Overall Study|Other than specified above|8|||
146690309|NCT04199117|529043118|FG006|Overall Study|Death|0|||
146690310|NCT04199117|529043119|FG007|Overall Study|Death|0|||
146690311|NCT04199117|529043120|FG008|Overall Study|Death|0|||
146690312|NCT04199117|529043121|FG009|Overall Study|Death|0|||
146690313|NCT04199117|529043122|FG010|Overall Study|Death|0|||
146690314|NCT04199117|529043123|FG011|Overall Study|Death|1|||
146690315|NCT04199117|529043124|FG012|Overall Study|Death|0|||
146690316|NCT04199117|529043125|FG013|Overall Study|Death|1|||
146690317|NCT04199117|529043126|FG014|Overall Study|Death|0|||
146690318|NCT04199117|529043127|FG015|Overall Study|Death|0|||
146690319|NCT04199117|529043112|FG000|Overall Study|Withdrawal by PI|0|||
146690320|NCT04199117|529043113|FG001|Overall Study|Withdrawal by PI|0|||
146690321|NCT04199117|529043114|FG002|Overall Study|Withdrawal by PI|0|||
146690322|NCT04199117|529043115|FG003|Overall Study|Withdrawal by PI|0|||
146690323|NCT04199117|529043116|FG004|Overall Study|Withdrawal by PI|0|||
146690324|NCT04199117|529043117|FG005|Overall Study|Withdrawal by PI|0|||
146690325|NCT04199117|529043118|FG006|Overall Study|Withdrawal by PI|0|||
146690326|NCT04199117|529043119|FG007|Overall Study|Withdrawal by PI|0|||
146690327|NCT04199117|529043120|FG008|Overall Study|Withdrawal by PI|0|||
146690328|NCT04199117|529043121|FG009|Overall Study|Withdrawal by PI|0|||
146690329|NCT04199117|529043122|FG010|Overall Study|Withdrawal by PI|0|||
146690330|NCT04199117|529043123|FG011|Overall Study|Withdrawal by PI|0|||
146690331|NCT04199117|529043124|FG012|Overall Study|Withdrawal by PI|1|||
146690332|NCT04199117|529043125|FG013|Overall Study|Withdrawal by PI|0|||
146690333|NCT04199117|529043126|FG014|Overall Study|Withdrawal by PI|0|||
146690334|NCT04199117|529043127|FG015|Overall Study|Withdrawal by PI|0|||
146690335|NCT02926924|529044750|FG000|Overall Study|withdrawal - reason unknown|0|||
146690336|NCT02926924|529044751|FG001|Overall Study|withdrawal - reason unknown|1|||
146690337|NCT02385266|529044752|FG000|Overall Study|Withdrawal by Subject|1|||
146690338|NCT02385266|529044753|FG001|Overall Study|Withdrawal by Subject|3|||
146690339|NCT03662542|529044756|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
146690340|NCT03662542|529044757|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
146690341|NCT03662542|529044758|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
146690342|NCT03662542|529044759|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
146690343|NCT03662542|529044760|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
146690344|NCT03662542|529044761|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
146690345|NCT03662542|529044762|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
146690346|NCT03662542|529044763|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
146690347|NCT03662542|529044764|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
146690348|NCT03662542|529044756|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
146690349|NCT03662542|529044757|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
146690350|NCT03662542|529044758|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
146690351|NCT03662542|529044759|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
146690352|NCT03662542|529044760|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
146690353|NCT03662542|529044761|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
146775450|NCT03285763|529349518|FG000|Overall Study|Physician Decision|2|||
146929699|NCT01517412|529900840|FG001|Overall Study|Other than specified above|5|||
146929700|NCT02062463|529900841|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
146929701|NCT02062463|529900842|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
146929702|NCT02062463|529900843|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
146690354|NCT03662542|529044762|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
146690355|NCT03662542|529044763|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
146690356|NCT03662542|529044764|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
146690357|NCT03662542|529044756|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
146690358|NCT03662542|529044757|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
146690359|NCT03662542|529044758|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
146690360|NCT03662542|529044759|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
146690361|NCT03662542|529044760|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
146690362|NCT03662542|529044761|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
146690363|NCT03662542|529044762|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
146690364|NCT03662542|529044763|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
146690365|NCT03662542|529044764|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
146690366|NCT03662542|529044756|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
146690367|NCT03662542|529044757|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
146690368|NCT03662542|529044758|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
146690369|NCT03662542|529044759|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
146690370|NCT03662542|529044760|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
146690371|NCT03662542|529044761|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
146690372|NCT03662542|529044762|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
146690373|NCT03662542|529044763|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
146690374|NCT03662542|529044764|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
146690375|NCT03662542|529044756|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
146690376|NCT03662542|529044757|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
146690377|NCT03662542|529044758|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
146690378|NCT03662542|529044759|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
146690379|NCT03662542|529044760|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
146690380|NCT03662542|529044761|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
146690381|NCT03662542|529044762|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
146690382|NCT03662542|529044763|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
146690383|NCT03662542|529044764|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
146690384|NCT03662542|529044756|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
146690385|NCT03662542|529044757|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
146690386|NCT03662542|529044758|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
146690387|NCT03662542|529044759|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
146690388|NCT03662542|529044760|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
146690389|NCT03662542|529044761|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
146690390|NCT03662542|529044762|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
146690391|NCT03662542|529044763|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
146690392|NCT03662542|529044764|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
146690393|NCT03662542|529044756|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
146690394|NCT03662542|529044757|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
146690395|NCT03662542|529044758|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
146690396|NCT03662542|529044759|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
146690397|NCT03662542|529044760|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
146690398|NCT03662542|529044761|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
146690399|NCT03662542|529044762|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
146690400|NCT03662542|529044763|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
146690401|NCT03662542|529044764|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
146690402|NCT03662542|529044756|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
146690403|NCT03662542|529044757|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
146929703|NCT02062463|529900844|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
146690404|NCT03662542|529044758|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
146690405|NCT03662542|529044759|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
146690406|NCT03662542|529044760|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
146690407|NCT03662542|529044761|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
146690408|NCT03662542|529044762|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
146690409|NCT03662542|529044763|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
146690410|NCT03662542|529044764|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
146690411|NCT03662542|529044756|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
146690412|NCT03662542|529044757|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
146690413|NCT03662542|529044758|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
146690414|NCT03662542|529044759|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
146690415|NCT03662542|529044760|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
146690416|NCT03662542|529044761|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
146690417|NCT03662542|529044762|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
146690418|NCT03662542|529044763|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
146690419|NCT03662542|529044764|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
146929704|NCT02062463|529900841|FG000|Stage 2|Adverse Event|0|||
146929705|NCT02062463|529900842|FG001|Stage 2|Adverse Event|0|||
146929706|NCT02062463|529900843|FG002|Stage 2|Adverse Event|12|||
146775451|NCT03285763|529349518|FG000|Overall Study|Study Terminated By Sponsor|79|||
146690420|NCT03662542|529044756|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
146690421|NCT03662542|529044757|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
146690422|NCT03662542|529044758|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
146690423|NCT03662542|529044759|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
146690424|NCT03662542|529044760|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
146690425|NCT03662542|529044761|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
146690426|NCT03662542|529044762|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
146690427|NCT03662542|529044763|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
146690428|NCT03662542|529044764|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
146690429|NCT03662542|529044756|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
146690430|NCT03662542|529044757|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
146690431|NCT03662542|529044758|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
146690432|NCT03662542|529044759|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
146690433|NCT03662542|529044760|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
146690434|NCT03662542|529044761|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
146690435|NCT03662542|529044762|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
146690436|NCT03662542|529044763|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
146690437|NCT03662542|529044764|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
146690438|NCT03662542|529044756|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
146690439|NCT03662542|529044757|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
146690440|NCT03662542|529044758|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
146690441|NCT03662542|529044759|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
146690442|NCT03662542|529044760|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
146690443|NCT03662542|529044761|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
146690444|NCT03662542|529044762|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
146690445|NCT03662542|529044763|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
146690446|NCT03662542|529044764|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
146690447|NCT03662542|529044756|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
146690448|NCT03662542|529044757|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
146690449|NCT03662542|529044758|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
146690450|NCT03662542|529044759|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
146690451|NCT03662542|529044760|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
146690452|NCT03662542|529044761|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
146690453|NCT03662542|529044762|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
146690454|NCT03662542|529044763|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
146690455|NCT03662542|529044764|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
146690456|NCT01217060|529044766|FG000|Overall Study|Withdrawal by Subject|1|||
146690457|NCT01859494|529044769|FG000|Overall Study|Adverse Event|1|||
146690458|NCT02357901|529044771|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
146690459|NCT02357901|529044772|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
146690460|NCT02357901|529044773|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
146690461|NCT02357901|529044774|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
146690462|NCT02357901|529044771|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
146690463|NCT02357901|529044772|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
146690464|NCT02357901|529044773|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
146690465|NCT02357901|529044774|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
146690466|NCT02357901|529044771|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
146690467|NCT02357901|529044772|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
146690468|NCT02357901|529044773|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
146690469|NCT02357901|529044774|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
146690470|NCT02357901|529044771|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
146690471|NCT02357901|529044772|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
146690472|NCT02357901|529044773|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
146690473|NCT02357901|529044774|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
146690474|NCT02357901|529044771|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
146690475|NCT02357901|529044772|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
146690476|NCT02357901|529044773|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
146690477|NCT02357901|529044774|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
146690478|NCT02357901|529044771|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
146690479|NCT02357901|529044772|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
146690480|NCT02357901|529044773|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
146690481|NCT02357901|529044774|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
146690482|NCT02357901|529044771|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
146690483|NCT02357901|529044772|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
146690484|NCT02357901|529044773|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
146690485|NCT02357901|529044774|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
146690486|NCT02357901|529044771|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
146690487|NCT02357901|529044772|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
146690488|NCT02357901|529044773|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
146690489|NCT02357901|529044774|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
146690490|NCT02357901|529044771|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
146690491|NCT02357901|529044772|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
146690492|NCT02357901|529044773|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
146690493|NCT02357901|529044774|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
146690494|NCT02357901|529044771|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
146690495|NCT02357901|529044772|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
146690496|NCT02357901|529044773|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
146690497|NCT02357901|529044774|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
146690498|NCT02357901|529044771|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
146690499|NCT02357901|529044772|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
146690500|NCT02357901|529044773|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
146690501|NCT02357901|529044774|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
146690502|NCT00491387|529044783|FG000|Overall Study|study terminated|20|||
146690503|NCT00413192|529044786|FG000|Overall Study|Disease progression|26|||
146690504|NCT00413192|529044787|FG001|Overall Study|Disease progression|31|||
146690505|NCT00413192|529044788|FG002|Overall Study|Disease progression|16|||
146690506|NCT00413192|529044789|FG003|Overall Study|Disease progression|25|||
146690507|NCT00413192|529044786|FG000|Overall Study|Toxicity|3|||
146690508|NCT00413192|529044787|FG001|Overall Study|Toxicity|2|||
146690509|NCT00413192|529044788|FG002|Overall Study|Toxicity|2|||
146690510|NCT00413192|529044789|FG003|Overall Study|Toxicity|2|||
146690511|NCT00413192|529044786|FG000|Overall Study|Withdrawal by Subject|3|||
146690512|NCT00413192|529044787|FG001|Overall Study|Withdrawal by Subject|5|||
146690513|NCT00413192|529044788|FG002|Overall Study|Withdrawal by Subject|0|||
146690514|NCT00413192|529044789|FG003|Overall Study|Withdrawal by Subject|1|||
146690515|NCT00413192|529044786|FG000|Overall Study|Intercurrent illness|0|||
146690516|NCT00413192|529044787|FG001|Overall Study|Intercurrent illness|0|||
146690517|NCT00413192|529044788|FG002|Overall Study|Intercurrent illness|0|||
146690518|NCT00413192|529044789|FG003|Overall Study|Intercurrent illness|1|||
146690519|NCT00413192|529044786|FG000|Overall Study|Intercurrent death|0|||
146690520|NCT00413192|529044787|FG001|Overall Study|Intercurrent death|1|||
146690521|NCT00413192|529044788|FG002|Overall Study|Intercurrent death|0|||
146690522|NCT00413192|529044789|FG003|Overall Study|Intercurrent death|0|||
146690523|NCT00413192|529044786|FG000|Overall Study|Other|5|||
146690524|NCT00413192|529044787|FG001|Overall Study|Other|1|||
146690525|NCT00413192|529044788|FG002|Overall Study|Other|1|||
146690526|NCT00413192|529044789|FG003|Overall Study|Other|2|||
146690527|NCT00413192|529044786|FG000|Overall Study|Not treated|0|||
146690528|NCT00413192|529044787|FG001|Overall Study|Not treated|0|||
146690529|NCT00413192|529044788|FG002|Overall Study|Not treated|0|||
146690530|NCT00413192|529044789|FG003|Overall Study|Not treated|1|||
146690531|NCT03814746|529044790|FG000|Overall Study|Participant decision|9|||
146690532|NCT03814746|529044791|FG001|Overall Study|Participant decision|6|||
146690533|NCT03814746|529044792|FG002|Overall Study|Participant decision|15|||
146690534|NCT03814746|529044790|FG000|Overall Study|Physician Decision|2|||
146690535|NCT03814746|529044791|FG001|Overall Study|Physician Decision|2|||
146690536|NCT03814746|529044792|FG002|Overall Study|Physician Decision|4|||
146690537|NCT03814746|529044790|FG000|Overall Study|Death|2|||
146690538|NCT03814746|529044791|FG001|Overall Study|Death|2|||
146690539|NCT03814746|529044792|FG002|Overall Study|Death|2|||
146690540|NCT03814746|529044790|FG000|Overall Study|Adverse Event|2|||
146690541|NCT03814746|529044791|FG001|Overall Study|Adverse Event|2|||
146690542|NCT03814746|529044792|FG002|Overall Study|Adverse Event|1|||
146690543|NCT03814746|529044790|FG000|Overall Study|Lost to Follow-up|2|||
146690544|NCT03814746|529044791|FG001|Overall Study|Lost to Follow-up|1|||
146690545|NCT03814746|529044792|FG002|Overall Study|Lost to Follow-up|2|||
146690546|NCT03814746|529044790|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146690547|NCT03814746|529044791|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146690548|NCT03814746|529044792|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
146690549|NCT03814746|529044790|FG000|Overall Study|Pregnancy|0|||
146690550|NCT03814746|529044791|FG001|Overall Study|Pregnancy|1|||
146929707|NCT02062463|529900844|FG003|Stage 2|Adverse Event|20|||
146690551|NCT03814746|529044792|FG002|Overall Study|Pregnancy|1|||
146690552|NCT03814746|529044790|FG000|Overall Study|Protocol Violation|1|||
146690553|NCT03814746|529044791|FG001|Overall Study|Protocol Violation|0|||
146690554|NCT03814746|529044792|FG002|Overall Study|Protocol Violation|0|||
146690555|NCT05089682|529044793|FG000|Overall Study|Withdrawal by Subject|2|||
146690556|NCT00772707|529044796|FG000|Overall Study|Withdrawn|3|||
146690557|NCT01266460|529044797|FG000|Overall Study|Adverse Event|3|||
146929708|NCT02062463|529900841|FG000|Stage 2|Lack of Efficacy|0|||
146690558|NCT01266460|529044797|FG000|Overall Study|Withdrawal by Subject|5|||
146690559|NCT01266460|529044797|FG000|Overall Study|Disease Progression|18|||
146929709|NCT02062463|529900842|FG001|Stage 2|Lack of Efficacy|0|||
146690560|NCT01266460|529044797|FG000|Overall Study|Not otherwise specified|8|||
146690561|NCT00483379|529044802|FG000|Treatment Period|Adverse Event|1|||
146690562|NCT00483379|529044803|FG001|Treatment Period|Adverse Event|0|||
146690563|NCT00483379|529044802|FG000|Treatment Period|Withdrawal by Subject|1|||
146690564|NCT00483379|529044803|FG001|Treatment Period|Withdrawal by Subject|0|||
146690565|NCT00536107|529044804|FG000|Overall Study|Death|5|||
146690566|NCT00536107|529044805|FG001|Overall Study|Death|1|||
146690567|NCT00536107|529044804|FG000|Overall Study|Incorrect enrolment|1|||
146690568|NCT00536107|529044805|FG001|Overall Study|Incorrect enrolment|0|||
146690569|NCT00536107|529044804|FG000|Overall Study|Withdrawal by Subject|0|||
146690570|NCT00536107|529044805|FG001|Overall Study|Withdrawal by Subject|1|||
146690571|NCT00536107|529044804|FG000|Overall Study|Study Termination|2|||
146690572|NCT00536107|529044805|FG001|Overall Study|Study Termination|4|||
146690573|NCT00371254|529044807|FG000|Overall Study|Disease progression|13|||
146690574|NCT00371254|529044808|FG001|Overall Study|Disease progression|13|||
146690575|NCT00371254|529044807|FG000|Overall Study|Study drug toxicity|3|||
146690576|NCT00371254|529044808|FG001|Overall Study|Study drug toxicity|5|||
146690577|NCT00371254|529044807|FG000|Overall Study|Subject request|5|||
146690578|NCT00371254|529044808|FG001|Overall Study|Subject request|0|||
146690579|NCT00371254|529044807|FG000|Overall Study|Investigator Decision|2|||
146690580|NCT00371254|529044808|FG001|Overall Study|Investigator Decision|0|||
146690581|NCT00371254|529044807|FG000|Overall Study|Adverse event unrelated to study drug|0|||
146690582|NCT00371254|529044808|FG001|Overall Study|Adverse event unrelated to study drug|1|||
146690583|NCT00371254|529044807|FG000|Overall Study|Lost to Follow-up|0|||
146690584|NCT00371254|529044808|FG001|Overall Study|Lost to Follow-up|1|||
146690585|NCT00371254|529044807|FG000|Overall Study|Withdrawal by Subject|0|||
146690586|NCT00371254|529044808|FG001|Overall Study|Withdrawal by Subject|1|||
146690587|NCT03329690|529044811|FG000|Overall Study|Progressive disease per RECIST|85|||
146690588|NCT03329690|529044812|FG001|Overall Study|Progressive disease per RECIST|44|||
146690589|NCT03329690|529044813|FG002|Overall Study|Progressive disease per RECIST|6|||
146690590|NCT03329690|529044814|FG003|Overall Study|Progressive disease per RECIST|16|||
146690591|NCT03329690|529044815|FG004|Overall Study|Progressive disease per RECIST|20|||
146690592|NCT03329690|529044811|FG000|Overall Study|Clinical progression|7|||
146690593|NCT03329690|529044812|FG001|Overall Study|Clinical progression|4|||
146690594|NCT03329690|529044813|FG002|Overall Study|Clinical progression|1|||
146690595|NCT03329690|529044814|FG003|Overall Study|Clinical progression|1|||
146690596|NCT03329690|529044815|FG004|Overall Study|Clinical progression|1|||
146690597|NCT03329690|529044811|FG000|Overall Study|Adverse Event|22|||
146690598|NCT03329690|529044812|FG001|Overall Study|Adverse Event|4|||
146690599|NCT03329690|529044813|FG002|Overall Study|Adverse Event|0|||
146690600|NCT03329690|529044814|FG003|Overall Study|Adverse Event|1|||
146690601|NCT03329690|529044815|FG004|Overall Study|Adverse Event|2|||
146690602|NCT03329690|529044811|FG000|Overall Study|Death|2|||
146690603|NCT03329690|529044812|FG001|Overall Study|Death|0|||
146690604|NCT03329690|529044813|FG002|Overall Study|Death|0|||
146690605|NCT03329690|529044814|FG003|Overall Study|Death|1|||
146690606|NCT03329690|529044815|FG004|Overall Study|Death|0|||
146690607|NCT03329690|529044811|FG000|Overall Study|Withdrawal by Subject|2|||
146690608|NCT03329690|529044812|FG001|Overall Study|Withdrawal by Subject|3|||
146690609|NCT03329690|529044813|FG002|Overall Study|Withdrawal by Subject|0|||
146690610|NCT03329690|529044814|FG003|Overall Study|Withdrawal by Subject|1|||
146690611|NCT03329690|529044815|FG004|Overall Study|Withdrawal by Subject|0|||
146690612|NCT03329690|529044811|FG000|Overall Study|Physician Decision|1|||
146690613|NCT03329690|529044812|FG001|Overall Study|Physician Decision|0|||
146690614|NCT03329690|529044813|FG002|Overall Study|Physician Decision|0|||
146690615|NCT03329690|529044814|FG003|Overall Study|Physician Decision|0|||
146690616|NCT03329690|529044815|FG004|Overall Study|Physician Decision|1|||
146690617|NCT03329690|529044811|FG000|Overall Study|Miscellaneous|6|||
146690618|NCT03329690|529044812|FG001|Overall Study|Miscellaneous|0|||
146690619|NCT03329690|529044813|FG002|Overall Study|Miscellaneous|0|||
146690620|NCT03329690|529044814|FG003|Overall Study|Miscellaneous|0|||
146690621|NCT03329690|529044815|FG004|Overall Study|Miscellaneous|0|||
146690622|NCT03329690|529044811|FG000|Overall Study|Did not receive treatment|1|||
146690623|NCT03329690|529044812|FG001|Overall Study|Did not receive treatment|0|||
146690624|NCT03329690|529044813|FG002|Overall Study|Did not receive treatment|0|||
146690625|NCT03329690|529044814|FG003|Overall Study|Did not receive treatment|1|||
146690626|NCT03329690|529044815|FG004|Overall Study|Did not receive treatment|0|||
146690627|NCT01817725|529044816|FG000|Overall Study|Withdrawal by Subject|1|||
146690628|NCT00909779|529044817|FG000|Overall Study|Adverse Event|53|||
146690629|NCT00909779|529044818|FG001|Overall Study|Adverse Event|55|||
146690630|NCT00909779|529044817|FG000|Overall Study|Lack of Efficacy|7|||
146690631|NCT00909779|529044818|FG001|Overall Study|Lack of Efficacy|4|||
146690632|NCT00909779|529044817|FG000|Overall Study|Lost to Follow-up|19|||
146690633|NCT00909779|529044818|FG001|Overall Study|Lost to Follow-up|15|||
146690634|NCT00909779|529044817|FG000|Overall Study|Physician Decision|8|||
146690635|NCT00909779|529044818|FG001|Overall Study|Physician Decision|2|||
146690636|NCT00909779|529044817|FG000|Overall Study|Protocol Violation|2|||
146690637|NCT00909779|529044818|FG001|Overall Study|Protocol Violation|5|||
146979727|NCT02008721|530089419|FG000|Overall Study|Adverse Event|3|||
146979728|NCT02008721|530089420|FG001|Overall Study|Adverse Event|5|||
146979729|NCT02008721|530089419|FG000|Overall Study|Protocol Violation|3|||
146979730|NCT02008721|530089420|FG001|Overall Study|Protocol Violation|2|||
146979731|NCT00772577|530089424|FG000|Overall Study|Adverse Event|6|||
146979732|NCT00772577|530089425|FG001|Overall Study|Adverse Event|3|||
146979733|NCT00772577|530089424|FG000|Overall Study|Abnormal laboratory values|0|||
146979734|NCT00772577|530089425|FG001|Overall Study|Abnormal laboratory values|1|||
146979735|NCT00772577|530089424|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146979736|NCT00772577|530089425|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
146979737|NCT00772577|530089424|FG000|Overall Study|Patient withdrew consent|8|||
146979738|NCT00772577|530089425|FG001|Overall Study|Patient withdrew consent|5|||
146979739|NCT00772577|530089424|FG000|Overall Study|Lost to Follow-up|4|||
146979740|NCT00772577|530089425|FG001|Overall Study|Lost to Follow-up|3|||
146979741|NCT00772577|530089424|FG000|Overall Study|Administrative problems|2|||
146979742|NCT00772577|530089425|FG001|Overall Study|Administrative problems|1|||
146979743|NCT00772577|530089424|FG000|Overall Study|Protocol Deviation|3|||
146690638|NCT00909779|529044817|FG000|Overall Study|Withdrawal by Subject|116|||
146690639|NCT00909779|529044818|FG001|Overall Study|Withdrawal by Subject|80|||
146690640|NCT00909779|529044817|FG000|Overall Study|Site Ceasing Operation|2|||
146690641|NCT00909779|529044818|FG001|Overall Study|Site Ceasing Operation|2|||
146690642|NCT00909779|529044817|FG000|Overall Study|Medical Monitor Decision|1|||
146690643|NCT00909779|529044818|FG001|Overall Study|Medical Monitor Decision|0|||
146690644|NCT00909779|529044817|FG000|Overall Study|Noncompliance|1|||
146690645|NCT00909779|529044818|FG001|Overall Study|Noncompliance|1|||
146690646|NCT00909779|529044817|FG000|Overall Study|Randomized in error|1|||
146690647|NCT00909779|529044818|FG001|Overall Study|Randomized in error|1|||
146690648|NCT03165110|529044819|FG000|Overall Study|Anroid phone software incompatibility|1|||
146690649|NCT00730912|529044824|FG000|Overall Study|Discontinued|0|||
146690650|NCT00730912|529044825|FG001|Overall Study|Discontinued|0|||
146690651|NCT00730912|529044826|FG002|Overall Study|Discontinued|1|||
146690652|NCT00613015|529044832|FG000|Overall Study|Lost to Follow-up|0|||
146690653|NCT00613015|529044833|FG001|Overall Study|Lost to Follow-up|1|||
146690654|NCT00613015|529044834|FG002|Overall Study|Lost to Follow-up|3|||
146690655|NCT00613015|529044835|FG003|Overall Study|Lost to Follow-up|3|||
146690656|NCT00613015|529044836|FG004|Overall Study|Lost to Follow-up|2|||
146690657|NCT00613015|529044837|FG005|Overall Study|Lost to Follow-up|3|||
146690658|NCT01179477|529044838|FG000|Overall Study|Death|542|||
146690659|NCT01179477|529044838|FG000|Overall Study|Unsuccessful implant|80|||
146690660|NCT01179477|529044838|FG000|Overall Study|Non-death withdrawal|438|||
146690661|NCT01179477|529044838|FG000|Overall Study|Did not complete final visit|27|||
146690662|NCT04829318|529044840|FG000|Overall Study|Adverse Event|6|||
146690663|NCT04829318|529044840|FG000|Overall Study|Death|1|||
146690664|NCT04829318|529044840|FG000|Overall Study|Lost to Follow-up|1|||
146690665|NCT04829318|529044840|FG000|Overall Study|Physician Decision|1|||
146690666|NCT04829318|529044840|FG000|Overall Study|Withdrawal by Subject|19|||
146690667|NCT04829318|529044840|FG000|Overall Study|Site terminated by sponsor|1|||
146690668|NCT04829318|529044840|FG000|Overall Study|Sponsor decision|5|||
146690669|NCT04829318|529044840|FG000|Overall Study|Other|1|||
146690670|NCT00728130|529044841|FG000|Overall Study|Withdrawal by Subject|1|||
146690671|NCT00728130|529044841|FG000|Overall Study|Paperwork not completed in time|1|||
146690672|NCT00728130|529044841|FG000|Overall Study|Physician Decision|1|||
146690673|NCT01994629|529044844|FG000|Overall Study|Withdrawal by Subject|1|||
146690674|NCT01994629|529044845|FG001|Overall Study|Withdrawal by Subject|0|||
146690675|NCT01994629|529044844|FG000|Overall Study|Lost to Follow-up|0|||
146690676|NCT01994629|529044845|FG001|Overall Study|Lost to Follow-up|3|||
146690677|NCT03338062|529044846|FG000|Overall Study|Alternative Therapy|1|||
146690678|NCT03338062|529044847|FG001|Overall Study|Alternative Therapy|0|||
146690679|NCT04340362|529044848|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
146690680|NCT00975481|529044849|FG000|Second Intervention Period|Adverse Event|2|||
146690681|NCT00975481|529044850|FG001|Second Intervention Period|Adverse Event|1|||
146690682|NCT00975481|529044851|FG002|Second Intervention Period|Adverse Event|0|||
146979744|NCT00772577|530089425|FG001|Overall Study|Protocol Deviation|2|||
146979745|NCT03211156|530089426|FG000|Overall Study|Withdrawal by Subject|0|||
146979746|NCT03211156|530089427|FG001|Overall Study|Withdrawal by Subject|2|||
146979747|NCT03211156|530089426|FG000|Overall Study|Lost to Follow-up|1|||
146979748|NCT03211156|530089427|FG001|Overall Study|Lost to Follow-up|1|||
146979749|NCT03211156|530089426|FG000|Overall Study|Adverse Event|1|||
146979750|NCT03211156|530089427|FG001|Overall Study|Adverse Event|0|||
146690683|NCT00975481|529044852|FG003|Second Intervention Period|Adverse Event|0|||
146979751|NCT00553540|530089438|FG000|Overall Study|discharged after first visit|2|||
146979752|NCT00553540|530089439|FG001|Overall Study|discharged after first visit|5|||
146690684|NCT00975481|529044853|FG004|Second Intervention Period|Adverse Event|0|||
146690685|NCT00975481|529044854|FG005|Second Intervention Period|Adverse Event|0|||
146690686|NCT00975481|529044849|FG000|Second Intervention Period|Withdrawal by Subject|0|||
146690687|NCT00975481|529044850|FG001|Second Intervention Period|Withdrawal by Subject|0|||
146690688|NCT00975481|529044851|FG002|Second Intervention Period|Withdrawal by Subject|1|||
146690689|NCT00975481|529044852|FG003|Second Intervention Period|Withdrawal by Subject|0|||
146690690|NCT00975481|529044853|FG004|Second Intervention Period|Withdrawal by Subject|0|||
146690691|NCT00975481|529044854|FG005|Second Intervention Period|Withdrawal by Subject|0|||
146690692|NCT00975481|529044849|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
146690693|NCT00975481|529044850|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
146690694|NCT00975481|529044851|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
146690695|NCT00975481|529044852|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
146690696|NCT00975481|529044853|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
146690697|NCT00975481|529044854|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
146690698|NCT00975481|529044849|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
146690699|NCT00975481|529044850|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
146690700|NCT00975481|529044851|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
146690701|NCT00975481|529044852|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
146690702|NCT00975481|529044853|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
146690703|NCT00975481|529044854|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
146690704|NCT03630120|529044855|FG000|Overall Study|Disease progression|0|||
146690705|NCT03630120|529044856|FG001|Overall Study|Disease progression|1|||
146690706|NCT03630120|529044857|FG002|Overall Study|Disease progression|1|||
146690707|NCT03630120|529044858|FG003|Overall Study|Disease progression|1|||
146690708|NCT01519960|529044859|FG000|Overall Study|Withdrawal from the study|26|||
146690709|NCT01519960|529044860|FG001|Overall Study|Withdrawal from the study|22|||
146690710|NCT01519960|529044861|FG002|Overall Study|Withdrawal from the study|5|||
146690711|NCT00561080|529044862|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
146690712|NCT00561080|529044863|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
146690713|NCT00561080|529044864|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
146690714|NCT00561080|529044862|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
146690715|NCT00561080|529044863|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
146690716|NCT00561080|529044864|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
146690717|NCT00561080|529044862|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
146690718|NCT00561080|529044863|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
146690719|NCT00561080|529044864|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
146690720|NCT00561080|529044862|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
146690721|NCT00561080|529044863|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
146690722|NCT00561080|529044864|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
146690723|NCT00561080|529044862|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
146690724|NCT00561080|529044863|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
146690725|NCT00561080|529044864|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
146690726|NCT00561080|529044862|FG000|Vaccination Period (up to Month 4)|Other|0|||
146690727|NCT00561080|529044863|FG001|Vaccination Period (up to Month 4)|Other|2|||
146690728|NCT00561080|529044864|FG002|Vaccination Period (up to Month 4)|Other|1|||
146690729|NCT00561080|529044862|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
146690730|NCT00561080|529044863|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
146690731|NCT00561080|529044864|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
146690732|NCT00561080|529044862|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
146690733|NCT00561080|529044863|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
146690734|NCT00561080|529044864|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
146690735|NCT00561080|529044862|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
146690736|NCT00561080|529044863|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
146690737|NCT00561080|529044864|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
146690738|NCT00561080|529044862|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
146690739|NCT00561080|529044863|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
146690740|NCT00561080|529044864|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
146690741|NCT02951156|529044865|FG000|Overall Study|Death|3|||
146690742|NCT02951156|529044866|FG001|Overall Study|Death|8|||
146690743|NCT02951156|529044867|FG002|Overall Study|Death|5|||
146690744|NCT02951156|529044865|FG000|Overall Study|Progressive disease|1|||
146690745|NCT02951156|529044866|FG001|Overall Study|Progressive disease|0|||
146690746|NCT02951156|529044867|FG002|Overall Study|Progressive disease|1|||
146690747|NCT02951156|529044865|FG000|Overall Study|Withdrawal by Subject|0|||
146690748|NCT02951156|529044866|FG001|Overall Study|Withdrawal by Subject|0|||
146775452|NCT03285763|529349518|FG000|Overall Study|Withdrawal by Subject|33|||
146690749|NCT02951156|529044867|FG002|Overall Study|Withdrawal by Subject|1|||
146690750|NCT02951156|529044865|FG000|Overall Study|Study terminated by sponsor|0|||
146690751|NCT02951156|529044866|FG001|Overall Study|Study terminated by sponsor|0|||
146775453|NCT00402246|529349519|FG000|Overall Study|Death|62|||
146775454|NCT00402246|529349520|FG001|Overall Study|Death|58|||
146775455|NCT00402246|529349519|FG000|Overall Study|Lost to Follow-up|20|||
146690752|NCT02951156|529044867|FG002|Overall Study|Study terminated by sponsor|1|||
146690753|NCT02951156|529044865|FG000|Overall Study|Other|5|||
146690754|NCT02951156|529044866|FG001|Overall Study|Other|1|||
146775456|NCT00402246|529349520|FG001|Overall Study|Lost to Follow-up|28|||
146775457|NCT00402246|529349519|FG000|Overall Study|Withdrawal by Subject|72|||
146690755|NCT02951156|529044867|FG002|Overall Study|Other|2|||
146690756|NCT00624052|529044871|FG000|Overall Study|Adverse Event|7|||
146690757|NCT00624052|529044872|FG001|Overall Study|Adverse Event|6|||
146690758|NCT00624052|529044873|FG002|Overall Study|Adverse Event|0|||
146690759|NCT00624052|529044874|FG003|Overall Study|Adverse Event|3|||
146690760|NCT00624052|529044871|FG000|Overall Study|Lack of Efficacy|1|||
146690761|NCT00624052|529044872|FG001|Overall Study|Lack of Efficacy|1|||
146690762|NCT00624052|529044873|FG002|Overall Study|Lack of Efficacy|0|||
146690763|NCT00624052|529044874|FG003|Overall Study|Lack of Efficacy|0|||
146690764|NCT00624052|529044871|FG000|Overall Study|Lost to Follow-up|2|||
146690765|NCT00624052|529044872|FG001|Overall Study|Lost to Follow-up|3|||
146690766|NCT00624052|529044873|FG002|Overall Study|Lost to Follow-up|1|||
146690767|NCT00624052|529044874|FG003|Overall Study|Lost to Follow-up|0|||
146690768|NCT00624052|529044871|FG000|Overall Study|Non compliant with the protocol|2|||
146690769|NCT00624052|529044872|FG001|Overall Study|Non compliant with the protocol|1|||
146690770|NCT00624052|529044873|FG002|Overall Study|Non compliant with the protocol|1|||
146690771|NCT00624052|529044874|FG003|Overall Study|Non compliant with the protocol|1|||
146690772|NCT00624052|529044871|FG000|Overall Study|Consent withdrawn|3|||
146690773|NCT00624052|529044872|FG001|Overall Study|Consent withdrawn|1|||
146690774|NCT00624052|529044873|FG002|Overall Study|Consent withdrawn|1|||
146690775|NCT00624052|529044874|FG003|Overall Study|Consent withdrawn|0|||
146690776|NCT00624052|529044871|FG000|Overall Study|Changed job/ran out if meds|0|||
146690777|NCT00624052|529044872|FG001|Overall Study|Changed job/ran out if meds|2|||
146690778|NCT00624052|529044873|FG002|Overall Study|Changed job/ran out if meds|0|||
146690779|NCT00624052|529044874|FG003|Overall Study|Changed job/ran out if meds|0|||
146690780|NCT02466555|529044875|FG000|Overall Study|Lost to Follow-up|2|||
146690781|NCT04170348|529044876|FG000|Overall Study|Lost to Follow-up|2|||
146690782|NCT04170348|529044877|FG001|Overall Study|Lost to Follow-up|2|||
146690783|NCT04170348|529044876|FG000|Overall Study|Withdrawal by Subject|1|||
146690784|NCT04170348|529044877|FG001|Overall Study|Withdrawal by Subject|5|||
146690785|NCT04170348|529044876|FG000|Overall Study|Non-adherence|1|||
146690786|NCT04170348|529044877|FG001|Overall Study|Non-adherence|1|||
146690787|NCT04170348|529044876|FG000|Overall Study|Adverse Event|1|||
146690788|NCT04170348|529044877|FG001|Overall Study|Adverse Event|0|||
146690789|NCT01120756|529044878|FG000|Overall Study|Withdrawal by Subject|1|||
146690790|NCT01120756|529044879|FG001|Overall Study|Withdrawal by Subject|1|||
146690791|NCT03839212|529044886|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
146690792|NCT00679263|529044887|FG000|Visit 2/Dose 1|Adverse Event|1|||
146690793|NCT00679263|529044888|FG001|Visit 2/Dose 1|Adverse Event|0|||
146690794|NCT00679263|529044889|FG002|Visit 2/Dose 1|Adverse Event|0|||
146690795|NCT00679263|529044887|FG000|Visit 2/Dose 1|subject not compliance|1|||
146690796|NCT00679263|529044888|FG001|Visit 2/Dose 1|subject not compliance|1|||
146690797|NCT00679263|529044889|FG002|Visit 2/Dose 1|subject not compliance|0|||
146690798|NCT05104567|529044890|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
146690799|NCT05104567|529044891|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
146690800|NCT05104567|529044892|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
146690801|NCT05104567|529044893|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
146690802|NCT05104567|529044894|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
146690803|NCT05104567|529044895|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
146690804|NCT05104567|529044896|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
146690805|NCT05104567|529044890|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
146690806|NCT05104567|529044891|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
146690807|NCT05104567|529044892|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
146690808|NCT05104567|529044893|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
146690809|NCT05104567|529044894|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
146690810|NCT05104567|529044895|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
146690811|NCT05104567|529044896|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
146690812|NCT05104567|529044890|FG000|Overall Study|Progressive disease|3|||
146690813|NCT05104567|529044891|FG001|Overall Study|Progressive disease|13|||
146690814|NCT05104567|529044892|FG002|Overall Study|Progressive disease|13|||
146690815|NCT05104567|529044893|FG003|Overall Study|Progressive disease|17|||
146690816|NCT05104567|529044894|FG004|Overall Study|Progressive disease|17|||
146775458|NCT00402246|529349520|FG001|Overall Study|Withdrawal by Subject|87|||
146690817|NCT05104567|529044895|FG005|Overall Study|Progressive disease|28|||
146690818|NCT05104567|529044896|FG006|Overall Study|Progressive disease|24|||
146775459|NCT00402246|529349519|FG000|Overall Study|Physician Decision|24|||
146775460|NCT00402246|529349520|FG001|Overall Study|Physician Decision|26|||
146775461|NCT00402246|529349519|FG000|Overall Study|Protocol Violation|25|||
146775462|NCT00402246|529349520|FG001|Overall Study|Protocol Violation|24|||
146775463|NCT00402246|529349519|FG000|Overall Study|Missed Final Visit|1|||
146775464|NCT00402246|529349520|FG001|Overall Study|Missed Final Visit|2|||
146775465|NCT00402246|529349519|FG000|Overall Study|Insurance Issues|2|||
146775466|NCT00402246|529349520|FG001|Overall Study|Insurance Issues|1|||
146690819|NCT05104567|529044890|FG000|Overall Study|Withdrawal by Subject|1|||
146690820|NCT05104567|529044891|FG001|Overall Study|Withdrawal by Subject|1|||
146690821|NCT05104567|529044892|FG002|Overall Study|Withdrawal by Subject|2|||
146690822|NCT05104567|529044893|FG003|Overall Study|Withdrawal by Subject|0|||
146690823|NCT05104567|529044894|FG004|Overall Study|Withdrawal by Subject|0|||
146690824|NCT05104567|529044895|FG005|Overall Study|Withdrawal by Subject|0|||
146690825|NCT05104567|529044896|FG006|Overall Study|Withdrawal by Subject|0|||
146690826|NCT05104567|529044890|FG000|Overall Study|Other|1|||
146690827|NCT05104567|529044891|FG001|Overall Study|Other|1|||
146690828|NCT05104567|529044892|FG002|Overall Study|Other|1|||
146690829|NCT05104567|529044893|FG003|Overall Study|Other|0|||
146690830|NCT05104567|529044894|FG004|Overall Study|Other|0|||
146690831|NCT05104567|529044895|FG005|Overall Study|Other|0|||
146690832|NCT05104567|529044896|FG006|Overall Study|Other|0|||
146690833|NCT01464346|529044900|FG000|Overall Study|Withdrawal by Subject|0|||
146690834|NCT01464346|529044901|FG001|Overall Study|Withdrawal by Subject|0|||
146690835|NCT01464346|529044902|FG002|Overall Study|Withdrawal by Subject|1|||
146690836|NCT02295995|529044903|FG000|Overall Study|Lost to Follow-up|5|||
146690837|NCT02295995|529044904|FG001|Overall Study|Lost to Follow-up|1|||
146690838|NCT01498458|529044906|FG000|Overall Study|Adverse Event|4|||
146690839|NCT01498458|529044906|FG000|Overall Study|Physician Decision|3|||
146690840|NCT02005250|529044907|FG000|Overall Study|Lost to Follow-up|15|||
146690841|NCT02005250|529044908|FG001|Overall Study|Lost to Follow-up|5|||
146690842|NCT00378209|529044911|FG000|Overall Study|Progressive disease|11|||
146690843|NCT00378209|529044911|FG000|Overall Study|Adverse Event|3|||
146690844|NCT00378209|529044911|FG000|Overall Study|Initiation of non-protocol therapy|3|||
146690845|NCT00378209|529044911|FG000|Overall Study|Physician Decision|3|||
146690846|NCT00378209|529044911|FG000|Overall Study|Death|1|||
146690847|NCT00378209|529044911|FG000|Overall Study|Treatment delay|1|||
146690848|NCT01252940|529044912|FG000|Main Study Phase|Randomized but not treated|4|||
146690849|NCT01252940|529044913|FG001|Main Study Phase|Randomized but not treated|2|||
146690850|NCT01252940|529044912|FG000|Main Study Phase|Adverse Event|3|||
146690851|NCT01252940|529044913|FG001|Main Study Phase|Adverse Event|1|||
146690852|NCT01252940|529044912|FG000|Main Study Phase|Lack of Efficacy|1|||
146690853|NCT01252940|529044913|FG001|Main Study Phase|Lack of Efficacy|0|||
146690854|NCT01252940|529044912|FG000|Main Study Phase|Lost to Follow-up|6|||
146690855|NCT01252940|529044913|FG001|Main Study Phase|Lost to Follow-up|1|||
146690856|NCT01252940|529044912|FG000|Main Study Phase|Physician Decision|1|||
146690857|NCT01252940|529044913|FG001|Main Study Phase|Physician Decision|0|||
146690858|NCT01252940|529044912|FG000|Main Study Phase|Protocol Violation|4|||
146690859|NCT01252940|529044913|FG001|Main Study Phase|Protocol Violation|2|||
146690860|NCT01252940|529044912|FG000|Main Study Phase|Withdrawal by Subject|6|||
146690861|NCT01252940|529044913|FG001|Main Study Phase|Withdrawal by Subject|5|||
146690862|NCT01252940|529044912|FG000|Main Study Phase|Subject Non-compliance|1|||
146690863|NCT01252940|529044913|FG001|Main Study Phase|Subject Non-compliance|1|||
146690864|NCT01252940|529044912|FG000|Extension Phase|Adverse Event|2|||
146690865|NCT01252940|529044913|FG001|Extension Phase|Adverse Event|1|||
146690866|NCT01252940|529044912|FG000|Extension Phase|Lack of Efficacy|1|||
146690867|NCT01252940|529044913|FG001|Extension Phase|Lack of Efficacy|0|||
146690868|NCT01252940|529044912|FG000|Extension Phase|Lost to Follow-up|5|||
146690869|NCT01252940|529044913|FG001|Extension Phase|Lost to Follow-up|0|||
146690870|NCT01252940|529044912|FG000|Extension Phase|Physician Decision|0|||
146690871|NCT01252940|529044913|FG001|Extension Phase|Physician Decision|1|||
146690872|NCT01252940|529044912|FG000|Extension Phase|Subject Non-compliance|1|||
146690873|NCT01252940|529044913|FG001|Extension Phase|Subject Non-compliance|0|||
146690874|NCT01252940|529044912|FG000|Extension Phase|Withdrawal by Subject|1|||
146690875|NCT01252940|529044913|FG001|Extension Phase|Withdrawal by Subject|1|||
146690876|NCT00939809|529046907|FG000|Overall Study|Adverse Event|2|||
146690877|NCT00939809|529046907|FG000|Overall Study|Death|1|||
146690878|NCT00858442|529046912|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
146929710|NCT02062463|529900843|FG002|Stage 2|Lack of Efficacy|3|||
146929711|NCT02062463|529900844|FG003|Stage 2|Lack of Efficacy|4|||
146929712|NCT02062463|529900841|FG000|Stage 2|Lost to Follow-up|0|||
146929713|NCT02062463|529900842|FG001|Stage 2|Lost to Follow-up|0|||
146929714|NCT02062463|529900843|FG002|Stage 2|Lost to Follow-up|20|||
146929715|NCT02062463|529900844|FG003|Stage 2|Lost to Follow-up|20|||
146929716|NCT02062463|529900841|FG000|Stage 2|Non-Compliance|0|||
146929717|NCT02062463|529900842|FG001|Stage 2|Non-Compliance|0|||
146929718|NCT02062463|529900843|FG002|Stage 2|Non-Compliance|0|||
146929719|NCT02062463|529900844|FG003|Stage 2|Non-Compliance|1|||
146929720|NCT02062463|529900841|FG000|Stage 2|Other than specified|0|||
146690879|NCT00858442|529046913|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
146690880|NCT02016625|529046916|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
146690881|NCT02016625|529046917|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
146690882|NCT02016625|529046916|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
146690883|NCT02016625|529046917|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
146929721|NCT02062463|529900842|FG001|Stage 2|Other than specified|0|||
146929722|NCT02062463|529900843|FG002|Stage 2|Other than specified|3|||
146929723|NCT02062463|529900844|FG003|Stage 2|Other than specified|1|||
146929724|NCT02062463|529900841|FG000|Stage 2|Withdrawal by Subject|0|||
146775467|NCT00402246|529349519|FG000|Overall Study|Heart Transplant|0|||
146690884|NCT02016625|529046916|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
146690885|NCT02016625|529046917|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
146690886|NCT02155738|529046918|FG000|Overall Study|Missing critical information|1|||
146690887|NCT02155738|529046919|FG001|Overall Study|Missing critical information|0|||
146690888|NCT02155738|529046920|FG002|Overall Study|Missing critical information|0|||
146690889|NCT02155738|529046921|FG003|Overall Study|Missing critical information|1|||
146690890|NCT00380978|529046923|FG000|Overall Study|Refused allocated intervention|0|||
146690891|NCT00380978|529046924|FG001|Overall Study|Refused allocated intervention|6|||
146690892|NCT00380978|529046923|FG000|Overall Study|Wrong study envelope|0|||
146690893|NCT00380978|529046924|FG001|Overall Study|Wrong study envelope|2|||
146690894|NCT00380978|529046923|FG000|Overall Study|Allocation prior to analgesia request|1|||
146690895|NCT00380978|529046924|FG001|Overall Study|Allocation prior to analgesia request|2|||
146690896|NCT00380978|529046923|FG000|Overall Study|Parous patient|1|||
146690897|NCT00380978|529046924|FG001|Overall Study|Parous patient|0|||
146690898|NCT00887354|529046925|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
146690899|NCT00887354|529046926|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
146690900|NCT00887354|529046925|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
146690901|NCT00887354|529046926|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
146690902|NCT00887354|529046925|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
146690903|NCT00887354|529046926|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
146775468|NCT00402246|529349520|FG001|Overall Study|Heart Transplant|1|||
146775469|NCT00402246|529349519|FG000|Overall Study|Patient's device explanted|6|||
146775470|NCT00402246|529349520|FG001|Overall Study|Patient's device explanted|2|||
146775471|NCT00402246|529349519|FG000|Overall Study|Center Closure|5|||
146775472|NCT00402246|529349520|FG001|Overall Study|Center Closure|3|||
146775473|NCT00402246|529349519|FG000|Overall Study|Deterioriating Condition|3|||
146775474|NCT00402246|529349520|FG001|Overall Study|Deterioriating Condition|2|||
146775475|NCT01808339|529349526|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
146775476|NCT01808339|529349527|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
146775477|NCT01808339|529349528|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
146775478|NCT01808339|529349529|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
146775479|NCT01808339|529349530|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
146775480|NCT01808339|529349531|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
146775481|NCT01808339|529349526|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146775482|NCT01808339|529349527|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
146775483|NCT01808339|529349528|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146775484|NCT01808339|529349529|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
146775485|NCT01808339|529349530|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146775486|NCT01808339|529349531|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146775487|NCT01808339|529349526|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
146775488|NCT01808339|529349527|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
146775489|NCT01808339|529349528|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
146775490|NCT01808339|529349529|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
146775491|NCT01808339|529349530|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
146775492|NCT01808339|529349531|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
146775493|NCT02932579|529349533|FG000|Overall Study|Withdrawal by Subject|4|||
146775494|NCT02932579|529349534|FG001|Overall Study|Withdrawal by Subject|1|||
146775495|NCT00111813|529349535|FG000|Overall Study|Adverse Event|1|||
146775496|NCT00111813|529349536|FG001|Overall Study|Adverse Event|2|||
146775497|NCT00111813|529349537|FG002|Overall Study|Adverse Event|4|||
146775498|NCT00111813|529349538|FG003|Overall Study|Adverse Event|2|||
146775499|NCT00111813|529349539|FG004|Overall Study|Adverse Event|2|||
146775500|NCT00111813|529349540|FG005|Overall Study|Adverse Event|2|||
146775501|NCT00111813|529349535|FG000|Overall Study|Progressive disease|2|||
146775502|NCT00111813|529349536|FG001|Overall Study|Progressive disease|1|||
146775503|NCT00111813|529349537|FG002|Overall Study|Progressive disease|5|||
146775504|NCT00111813|529349538|FG003|Overall Study|Progressive disease|3|||
146775505|NCT00111813|529349539|FG004|Overall Study|Progressive disease|4|||
146775506|NCT00111813|529349540|FG005|Overall Study|Progressive disease|3|||
146775507|NCT00111813|529349535|FG000|Overall Study|Lack of Efficacy|0|||
146775508|NCT00111813|529349536|FG001|Overall Study|Lack of Efficacy|0|||
146690904|NCT00887354|529046925|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
146690905|NCT00887354|529046926|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
146775509|NCT00111813|529349537|FG002|Overall Study|Lack of Efficacy|0|||
146775510|NCT00111813|529349538|FG003|Overall Study|Lack of Efficacy|0|||
146775511|NCT00111813|529349539|FG004|Overall Study|Lack of Efficacy|0|||
146775512|NCT00111813|529349540|FG005|Overall Study|Lack of Efficacy|1|||
146775513|NCT00111813|529349535|FG000|Overall Study|Other|0|||
146775514|NCT00111813|529349536|FG001|Overall Study|Other|0|||
146690906|NCT00887354|529046925|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
146979753|NCT03565211|530089446|FG000|Overall Study|Withdrawal by Subject|2|||
146979754|NCT03565211|530089446|FG000|Overall Study|Lost to Follow-up|1|||
146979755|NCT03565211|530089446|FG000|Overall Study|Adverse Event|44|||
146979756|NCT03565211|530089446|FG000|Overall Study|Personal issues|1|||
146979757|NCT00950599|530089448|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146979758|NCT00950599|530089449|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146979759|NCT00950599|530089450|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146979760|NCT00950599|530089451|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
146979761|NCT00950599|530089452|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146979762|NCT00950599|530089453|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146979763|NCT00950599|530089454|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146979764|NCT00950599|530089455|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146979765|NCT00950599|530089456|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146979766|NCT00950599|530089457|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146979767|NCT00950599|530089448|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146979768|NCT00950599|530089449|FG001|Double-Blind Treatment Period|Adverse Event|1|||
146979769|NCT00950599|530089450|FG002|Double-Blind Treatment Period|Adverse Event|1|||
146979770|NCT00950599|530089451|FG003|Double-Blind Treatment Period|Adverse Event|1|||
146979771|NCT00950599|530089452|FG004|Double-Blind Treatment Period|Adverse Event|1|||
146979772|NCT00950599|530089453|FG005|Double-Blind Treatment Period|Adverse Event|1|||
146979773|NCT00950599|530089454|FG006|Double-Blind Treatment Period|Adverse Event|0|||
146979774|NCT00950599|530089455|FG007|Double-Blind Treatment Period|Adverse Event|0|||
146979775|NCT00950599|530089456|FG008|Double-Blind Treatment Period|Adverse Event|0|||
146979776|NCT00950599|530089457|FG009|Double-Blind Treatment Period|Adverse Event|0|||
146690907|NCT00887354|529046926|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
146690908|NCT00887354|529046925|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
146690909|NCT00887354|529046926|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
146690910|NCT00887354|529046925|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
146690911|NCT00887354|529046926|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
146690912|NCT00887354|529046925|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
146690913|NCT00887354|529046926|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
146690914|NCT00887354|529046925|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
146690915|NCT00887354|529046926|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
146690916|NCT00887354|529046925|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
146690917|NCT00887354|529046926|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
146690918|NCT00887354|529046925|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
146690919|NCT00887354|529046926|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
146690920|NCT00887354|529046925|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
146690921|NCT00887354|529046926|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
146690922|NCT00887354|529046925|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
146690923|NCT00887354|529046926|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
146690924|NCT00887354|529046925|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
146690925|NCT00887354|529046926|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
146690926|NCT00887354|529046925|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
146690927|NCT00887354|529046926|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
146690928|NCT01466348|529046929|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
146690929|NCT01466348|529046930|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
146690930|NCT03970733|529046931|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
146690931|NCT03970733|529046932|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
146690932|NCT03970733|529046933|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
146690933|NCT03970733|529046934|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
146690934|NCT03970733|529046935|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
146690935|NCT03970733|529046931|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
146690936|NCT03970733|529046932|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
146690937|NCT03970733|529046933|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
146690938|NCT03970733|529046934|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
146690939|NCT03970733|529046935|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
146690940|NCT03970733|529046931|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
146690941|NCT03970733|529046932|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
146690942|NCT03970733|529046933|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
146690943|NCT03970733|529046934|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
146690944|NCT03970733|529046935|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
146690945|NCT03970733|529046931|FG000|Main Study Phase (18 Months)|Other|1|||
146690946|NCT03970733|529046932|FG001|Main Study Phase (18 Months)|Other|1|||
146690947|NCT03970733|529046933|FG002|Main Study Phase (18 Months)|Other|0|||
146690948|NCT03970733|529046934|FG003|Main Study Phase (18 Months)|Other|0|||
146690949|NCT03970733|529046935|FG004|Main Study Phase (18 Months)|Other|0|||
146979777|NCT00950599|530089448|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
146979778|NCT00950599|530089449|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
146979779|NCT00950599|530089450|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
146979780|NCT00950599|530089451|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
146979781|NCT00950599|530089452|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
146979782|NCT00950599|530089453|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
146979783|NCT00950599|530089454|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
146979784|NCT00950599|530089455|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
146979785|NCT00950599|530089456|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
146979786|NCT00950599|530089457|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
146979787|NCT00950599|530089448|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146979788|NCT00950599|530089449|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
146979789|NCT00950599|530089450|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
146979790|NCT00950599|530089451|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
146979791|NCT00950599|530089452|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
146979792|NCT00950599|530089453|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
146979793|NCT00950599|530089454|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
146979794|NCT00950599|530089455|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
146690950|NCT03970733|529046931|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
146690951|NCT03970733|529046932|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
146690952|NCT03970733|529046933|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
146690953|NCT03970733|529046934|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
146775515|NCT00111813|529349537|FG002|Overall Study|Other|1|||
146690954|NCT03970733|529046935|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
146690955|NCT01955161|529046939|FG000|Overall Study|Withdrawal before treatment|2|||
146690956|NCT01955161|529046940|FG001|Overall Study|Withdrawal before treatment|0|||
146690957|NCT01955161|529046941|FG002|Overall Study|Withdrawal before treatment|1|||
146690958|NCT01955161|529046939|FG000|Overall Study|Adverse Event|10|||
146690959|NCT01955161|529046940|FG001|Overall Study|Adverse Event|14|||
146690960|NCT01955161|529046941|FG002|Overall Study|Adverse Event|15|||
146690961|NCT01955161|529046939|FG000|Overall Study|Death|1|||
146690962|NCT01955161|529046940|FG001|Overall Study|Death|1|||
146690963|NCT01955161|529046941|FG002|Overall Study|Death|3|||
146690964|NCT01955161|529046939|FG000|Overall Study|Withdrawal by Subject|9|||
146690965|NCT01955161|529046940|FG001|Overall Study|Withdrawal by Subject|8|||
146690966|NCT01955161|529046941|FG002|Overall Study|Withdrawal by Subject|12|||
146690967|NCT01955161|529046939|FG000|Overall Study|Protocol Violation|2|||
146690968|NCT01955161|529046940|FG001|Overall Study|Protocol Violation|0|||
146690969|NCT01955161|529046941|FG002|Overall Study|Protocol Violation|0|||
146690970|NCT01955161|529046939|FG000|Overall Study|Other reason: physician decision|0|||
146690971|NCT01955161|529046940|FG001|Overall Study|Other reason: physician decision|1|||
146690972|NCT01955161|529046941|FG002|Overall Study|Other reason: physician decision|1|||
146690973|NCT01955161|529046939|FG000|Overall Study|Other reason: disallowed medication|1|||
146690974|NCT01955161|529046940|FG001|Overall Study|Other reason: disallowed medication|0|||
146690975|NCT01955161|529046941|FG002|Overall Study|Other reason: disallowed medication|1|||
146690976|NCT01955161|529046939|FG000|Overall Study|Other reason: caregiver unavailable|1|||
146690977|NCT01955161|529046940|FG001|Overall Study|Other reason: caregiver unavailable|0|||
146690978|NCT01955161|529046941|FG002|Overall Study|Other reason: caregiver unavailable|0|||
146690979|NCT01955161|529046939|FG000|Overall Study|Other reason: moved to nursing home|0|||
146690980|NCT01955161|529046940|FG001|Overall Study|Other reason: moved to nursing home|1|||
146690981|NCT01955161|529046941|FG002|Overall Study|Other reason: moved to nursing home|0|||
146690982|NCT01955161|529046939|FG000|Overall Study|Other reason: insufficient compliance|0|||
146690983|NCT01955161|529046940|FG001|Overall Study|Other reason: insufficient compliance|0|||
146690984|NCT01955161|529046941|FG002|Overall Study|Other reason: insufficient compliance|1|||
146690985|NCT01955161|529046939|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
146690986|NCT01955161|529046940|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
146690987|NCT01955161|529046941|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
146690988|NCT01955161|529046939|FG000|Overall Study|Other reason: patient's will|0|||
146775516|NCT00111813|529349538|FG003|Overall Study|Other|0|||
146929725|NCT02062463|529900842|FG001|Stage 2|Withdrawal by Subject|0|||
146929726|NCT02062463|529900843|FG002|Stage 2|Withdrawal by Subject|15|||
146929727|NCT02062463|529900844|FG003|Stage 2|Withdrawal by Subject|10|||
146929728|NCT02716194|529900858|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
146929729|NCT02716194|529900859|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
146929730|NCT02716194|529900860|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
146929731|NCT00363051|529900861|FG000|Overall Study|Adminstrative problems|1|||
146929732|NCT00363051|529900862|FG001|Overall Study|Adminstrative problems|1|||
146929733|NCT00363051|529900861|FG000|Overall Study|Adverse Event|21|||
146929734|NCT00363051|529900862|FG001|Overall Study|Adverse Event|12|||
146929735|NCT00363051|529900861|FG000|Overall Study|New Cancer Therapy|2|||
146929736|NCT00363051|529900862|FG001|Overall Study|New Cancer Therapy|1|||
146929737|NCT00363051|529900861|FG000|Overall Study|Withdrawal by Subject|11|||
146979795|NCT00950599|530089456|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
146775517|NCT00111813|529349539|FG004|Overall Study|Other|0|||
146775518|NCT00111813|529349540|FG005|Overall Study|Other|0|||
146775519|NCT00818246|529349542|FG000|Overall Study|Impossible to match pictures|5|||
146775520|NCT02121002|529349546|FG000|Overall Study|Physician Decision|2|||
146775521|NCT02121002|529349547|FG001|Overall Study|Physician Decision|0|||
146775522|NCT02121002|529349548|FG002|Overall Study|Physician Decision|0|||
146775523|NCT02121002|529349546|FG000|Overall Study|Withdrawal by Subject|3|||
146775524|NCT02121002|529349547|FG001|Overall Study|Withdrawal by Subject|1|||
146775525|NCT02121002|529349548|FG002|Overall Study|Withdrawal by Subject|4|||
146775526|NCT02121002|529349546|FG000|Overall Study|Protocol Violation|1|||
146775527|NCT02121002|529349547|FG001|Overall Study|Protocol Violation|2|||
146775528|NCT02121002|529349548|FG002|Overall Study|Protocol Violation|4|||
146775529|NCT02121002|529349546|FG000|Overall Study|Concomitant therapy|0|||
146775530|NCT02121002|529349547|FG001|Overall Study|Concomitant therapy|1|||
146775531|NCT02121002|529349548|FG002|Overall Study|Concomitant therapy|1|||
146775532|NCT02121002|529349546|FG000|Overall Study|Others|1|||
146775533|NCT02121002|529349547|FG001|Overall Study|Others|0|||
146775534|NCT02121002|529349548|FG002|Overall Study|Others|1|||
146775535|NCT01007396|529349549|FG000|Overall Study|Lost to Follow-up|47|||
146775536|NCT00409838|529349550|FG000|Short-term Period|Adverse Event|0|||
146775537|NCT00409838|529349551|FG001|Short-term Period|Adverse Event|1|||
146775538|NCT00409838|529349550|FG000|Short-term Period|Lost to Follow-up|0|||
146775539|NCT00409838|529349551|FG001|Short-term Period|Lost to Follow-up|1|||
146775540|NCT00409838|529349550|FG000|Short-term Period|Withdrawal by Subject|2|||
146775541|NCT00409838|529349551|FG001|Short-term Period|Withdrawal by Subject|3|||
146775542|NCT00409838|529349550|FG000|Short-term Period|Never Treated|1|||
146775543|NCT00409838|529349551|FG001|Short-term Period|Never Treated|0|||
146775544|NCT00409838|529349550|FG000|Long-term Extension Period|Adverse Event|10|||
146775545|NCT00409838|529349551|FG001|Long-term Extension Period|Adverse Event|0|||
146775546|NCT00409838|529349550|FG000|Long-term Extension Period|Death|1|||
146775547|NCT00409838|529349551|FG001|Long-term Extension Period|Death|0|||
146775548|NCT00409838|529349550|FG000|Long-term Extension Period|Lack of Efficacy|2|||
146775549|NCT00409838|529349551|FG001|Long-term Extension Period|Lack of Efficacy|0|||
146775550|NCT00409838|529349550|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
146775551|NCT00409838|529349551|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
146775552|NCT00409838|529349550|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
146775553|NCT00409838|529349551|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
146775554|NCT00409838|529349550|FG000|Long-term Extension Period|Pregnancy|1|||
146775555|NCT00409838|529349551|FG001|Long-term Extension Period|Pregnancy|0|||
146775556|NCT04788641|529349552|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
146690989|NCT01955161|529046940|FG001|Overall Study|Other reason: patient's will|0|||
146690990|NCT01955161|529046941|FG002|Overall Study|Other reason: patient's will|1|||
146690991|NCT02784821|529046942|FG000|Overall Study|Death|0|||
146690992|NCT02784821|529046943|FG001|Overall Study|Death|5|||
146690993|NCT02784821|529046944|FG002|Overall Study|Death|4|||
146690994|NCT02784821|529046945|FG003|Overall Study|Death|5|||
146690995|NCT02794103|529046946|FG000|Overall Study|Loss to follow up due to high sedation|3|||
146690996|NCT01139450|529046947|FG000|Overall Study|Withdrawal by Subject|7|||
146690997|NCT01139450|529046948|FG001|Overall Study|Withdrawal by Subject|10|||
146690998|NCT01139450|529046949|FG002|Overall Study|Withdrawal by Subject|13|||
146690999|NCT01139450|529046947|FG000|Overall Study|Lack of Efficacy|3|||
146691000|NCT01139450|529046948|FG001|Overall Study|Lack of Efficacy|1|||
146691001|NCT01139450|529046949|FG002|Overall Study|Lack of Efficacy|8|||
146691002|NCT01139450|529046947|FG000|Overall Study|Protocol Violation|6|||
146691003|NCT01139450|529046948|FG001|Overall Study|Protocol Violation|5|||
146691004|NCT01139450|529046949|FG002|Overall Study|Protocol Violation|2|||
146775557|NCT04788641|529349553|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
146775558|NCT04788641|529349554|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
146979796|NCT00950599|530089457|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
146691005|NCT01139450|529046947|FG000|Overall Study|Lost to Follow-up|9|||
146691006|NCT01139450|529046948|FG001|Overall Study|Lost to Follow-up|7|||
146691007|NCT01139450|529046949|FG002|Overall Study|Lost to Follow-up|11|||
146691008|NCT01139450|529046947|FG000|Overall Study|Administrative|0|||
146691009|NCT01139450|529046948|FG001|Overall Study|Administrative|0|||
146691010|NCT01139450|529046949|FG002|Overall Study|Administrative|1|||
146691011|NCT01139450|529046947|FG000|Overall Study|Adverse Event|2|||
146775559|NCT04788641|529349555|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
146775560|NCT04788641|529349552|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
146775561|NCT04788641|529349553|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
146775562|NCT04788641|529349554|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
146691012|NCT01139450|529046948|FG001|Overall Study|Adverse Event|2|||
146775563|NCT04788641|529349555|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
146775564|NCT04788641|529349552|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
146775565|NCT04788641|529349553|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
146775566|NCT04788641|529349554|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
146691013|NCT01139450|529046949|FG002|Overall Study|Adverse Event|3|||
146691014|NCT02608268|529046961|FG000|Overall Study|Adverse Event|0|||
146691015|NCT02608268|529046962|FG001|Overall Study|Adverse Event|0|||
146691016|NCT02608268|529046963|FG002|Overall Study|Adverse Event|1|||
146691017|NCT02608268|529046964|FG003|Overall Study|Adverse Event|0|||
146691018|NCT02608268|529046965|FG004|Overall Study|Adverse Event|0|||
146691019|NCT02608268|529046966|FG005|Overall Study|Adverse Event|0|||
146691020|NCT02608268|529046967|FG006|Overall Study|Adverse Event|0|||
146691021|NCT02608268|529046968|FG007|Overall Study|Adverse Event|0|||
146691022|NCT02608268|529046969|FG008|Overall Study|Adverse Event|0|||
146691023|NCT02608268|529046970|FG009|Overall Study|Adverse Event|0|||
146691024|NCT02608268|529046971|FG010|Overall Study|Adverse Event|0|||
146691025|NCT02608268|529046972|FG011|Overall Study|Adverse Event|0|||
146691026|NCT02608268|529046973|FG012|Overall Study|Adverse Event|2|||
146691027|NCT02608268|529046974|FG013|Overall Study|Adverse Event|0|||
146691028|NCT02608268|529046975|FG014|Overall Study|Adverse Event|0|||
146691029|NCT02608268|529046976|FG015|Overall Study|Adverse Event|0|||
146691030|NCT02608268|529046977|FG016|Overall Study|Adverse Event|0|||
146691031|NCT02608268|529046978|FG017|Overall Study|Adverse Event|0|||
146691032|NCT02608268|529046979|FG018|Overall Study|Adverse Event|0|||
146691033|NCT02608268|529046980|FG019|Overall Study|Adverse Event|0|||
146691034|NCT02608268|529046981|FG020|Overall Study|Adverse Event|1|||
146691035|NCT02608268|529046982|FG021|Overall Study|Adverse Event|1|||
146691036|NCT02608268|529046983|FG022|Overall Study|Adverse Event|0|||
146691037|NCT02608268|529046984|FG023|Overall Study|Adverse Event|0|||
146691038|NCT02608268|529046985|FG024|Overall Study|Adverse Event|1|||
146691039|NCT02608268|529046986|FG025|Overall Study|Adverse Event|0|||
146691040|NCT02608268|529046987|FG026|Overall Study|Adverse Event|0|||
146691041|NCT02608268|529046988|FG027|Overall Study|Adverse Event|0|||
146691042|NCT02608268|529046989|FG028|Overall Study|Adverse Event|1|||
146691043|NCT02608268|529046990|FG029|Overall Study|Adverse Event|0|||
146691044|NCT02608268|529046961|FG000|Overall Study|Death|1|||
146691045|NCT02608268|529046962|FG001|Overall Study|Death|0|||
146691046|NCT02608268|529046963|FG002|Overall Study|Death|0|||
146691047|NCT02608268|529046964|FG003|Overall Study|Death|0|||
146691048|NCT02608268|529046965|FG004|Overall Study|Death|0|||
146691049|NCT02608268|529046966|FG005|Overall Study|Death|0|||
146691050|NCT02608268|529046967|FG006|Overall Study|Death|0|||
146691051|NCT02608268|529046968|FG007|Overall Study|Death|0|||
146691052|NCT02608268|529046969|FG008|Overall Study|Death|1|||
146691053|NCT02608268|529046970|FG009|Overall Study|Death|1|||
146691054|NCT02608268|529046971|FG010|Overall Study|Death|0|||
146691055|NCT02608268|529046972|FG011|Overall Study|Death|0|||
146691056|NCT02608268|529046973|FG012|Overall Study|Death|0|||
146691057|NCT02608268|529046974|FG013|Overall Study|Death|0|||
146691058|NCT02608268|529046975|FG014|Overall Study|Death|0|||
146691059|NCT02608268|529046976|FG015|Overall Study|Death|1|||
146691060|NCT02608268|529046977|FG016|Overall Study|Death|0|||
146691061|NCT02608268|529046978|FG017|Overall Study|Death|1|||
146691062|NCT02608268|529046979|FG018|Overall Study|Death|0|||
146691063|NCT02608268|529046980|FG019|Overall Study|Death|1|||
146691064|NCT02608268|529046981|FG020|Overall Study|Death|1|||
146691065|NCT02608268|529046982|FG021|Overall Study|Death|0|||
146691066|NCT02608268|529046983|FG022|Overall Study|Death|0|||
146691067|NCT02608268|529046984|FG023|Overall Study|Death|0|||
146691068|NCT02608268|529046985|FG024|Overall Study|Death|1|||
146691069|NCT02608268|529046986|FG025|Overall Study|Death|2|||
146691070|NCT02608268|529046987|FG026|Overall Study|Death|0|||
146691071|NCT02608268|529046988|FG027|Overall Study|Death|1|||
146691072|NCT02608268|529046989|FG028|Overall Study|Death|4|||
146691073|NCT02608268|529046990|FG029|Overall Study|Death|0|||
146929738|NCT00363051|529900862|FG001|Overall Study|Withdrawal by Subject|3|||
146691074|NCT02608268|529046961|FG000|Overall Study|Physician Decision|0|||
146691075|NCT02608268|529046962|FG001|Overall Study|Physician Decision|0|||
146691076|NCT02608268|529046963|FG002|Overall Study|Physician Decision|0|||
146691077|NCT02608268|529046964|FG003|Overall Study|Physician Decision|0|||
146691078|NCT02608268|529046965|FG004|Overall Study|Physician Decision|0|||
146691079|NCT02608268|529046966|FG005|Overall Study|Physician Decision|0|||
146691080|NCT02608268|529046967|FG006|Overall Study|Physician Decision|0|||
146691081|NCT02608268|529046968|FG007|Overall Study|Physician Decision|0|||
146691082|NCT02608268|529046969|FG008|Overall Study|Physician Decision|0|||
146691083|NCT02608268|529046970|FG009|Overall Study|Physician Decision|0|||
146691084|NCT02608268|529046971|FG010|Overall Study|Physician Decision|1|||
146691085|NCT02608268|529046972|FG011|Overall Study|Physician Decision|0|||
146691086|NCT02608268|529046973|FG012|Overall Study|Physician Decision|0|||
146691087|NCT02608268|529046974|FG013|Overall Study|Physician Decision|1|||
146691088|NCT02608268|529046975|FG014|Overall Study|Physician Decision|0|||
146691089|NCT02608268|529046976|FG015|Overall Study|Physician Decision|0|||
146929739|NCT00363051|529900861|FG000|Overall Study|Lost to Follow-up|0|||
146691090|NCT02608268|529046977|FG016|Overall Study|Physician Decision|0|||
146691091|NCT02608268|529046978|FG017|Overall Study|Physician Decision|0|||
146691092|NCT02608268|529046979|FG018|Overall Study|Physician Decision|0|||
146691093|NCT02608268|529046980|FG019|Overall Study|Physician Decision|0|||
146929740|NCT00363051|529900862|FG001|Overall Study|Lost to Follow-up|1|||
146691094|NCT02608268|529046981|FG020|Overall Study|Physician Decision|0|||
146691095|NCT02608268|529046982|FG021|Overall Study|Physician Decision|0|||
146691096|NCT02608268|529046983|FG022|Overall Study|Physician Decision|1|||
146691097|NCT02608268|529046984|FG023|Overall Study|Physician Decision|1|||
146691098|NCT02608268|529046985|FG024|Overall Study|Physician Decision|1|||
146691099|NCT02608268|529046986|FG025|Overall Study|Physician Decision|0|||
146691100|NCT02608268|529046987|FG026|Overall Study|Physician Decision|0|||
146691101|NCT02608268|529046988|FG027|Overall Study|Physician Decision|2|||
146691102|NCT02608268|529046989|FG028|Overall Study|Physician Decision|1|||
146691103|NCT02608268|529046990|FG029|Overall Study|Physician Decision|1|||
146691104|NCT02608268|529046961|FG000|Overall Study|Progressive disease|12|||
146691105|NCT02608268|529046962|FG001|Overall Study|Progressive disease|8|||
146691106|NCT02608268|529046963|FG002|Overall Study|Progressive disease|13|||
146691107|NCT02608268|529046964|FG003|Overall Study|Progressive disease|5|||
146691108|NCT02608268|529046965|FG004|Overall Study|Progressive disease|2|||
146691109|NCT02608268|529046966|FG005|Overall Study|Progressive disease|4|||
146691110|NCT02608268|529046967|FG006|Overall Study|Progressive disease|6|||
146691111|NCT02608268|529046968|FG007|Overall Study|Progressive disease|2|||
146691112|NCT02608268|529046969|FG008|Overall Study|Progressive disease|5|||
146691113|NCT02608268|529046970|FG009|Overall Study|Progressive disease|6|||
146691114|NCT02608268|529046971|FG010|Overall Study|Progressive disease|5|||
146691115|NCT02608268|529046972|FG011|Overall Study|Progressive disease|5|||
146691116|NCT02608268|529046973|FG012|Overall Study|Progressive disease|4|||
146691117|NCT02608268|529046974|FG013|Overall Study|Progressive disease|11|||
146691118|NCT02608268|529046975|FG014|Overall Study|Progressive disease|6|||
146691119|NCT02608268|529046976|FG015|Overall Study|Progressive disease|3|||
146691120|NCT02608268|529046977|FG016|Overall Study|Progressive disease|5|||
146691121|NCT02608268|529046978|FG017|Overall Study|Progressive disease|5|||
146691122|NCT02608268|529046979|FG018|Overall Study|Progressive disease|5|||
146691123|NCT02608268|529046980|FG019|Overall Study|Progressive disease|2|||
146691124|NCT02608268|529046981|FG020|Overall Study|Progressive disease|10|||
146691125|NCT02608268|529046982|FG021|Overall Study|Progressive disease|4|||
146691126|NCT02608268|529046983|FG022|Overall Study|Progressive disease|5|||
146691127|NCT02608268|529046984|FG023|Overall Study|Progressive disease|5|||
146691128|NCT02608268|529046985|FG024|Overall Study|Progressive disease|3|||
146691129|NCT02608268|529046986|FG025|Overall Study|Progressive disease|11|||
146691130|NCT02608268|529046987|FG026|Overall Study|Progressive disease|16|||
146691131|NCT02608268|529046988|FG027|Overall Study|Progressive disease|11|||
146691132|NCT02608268|529046989|FG028|Overall Study|Progressive disease|10|||
146691133|NCT02608268|529046990|FG029|Overall Study|Progressive disease|15|||
146691134|NCT02608268|529046961|FG000|Overall Study|Subject/guardian decision|1|||
146691135|NCT02608268|529046962|FG001|Overall Study|Subject/guardian decision|1|||
146691136|NCT02608268|529046963|FG002|Overall Study|Subject/guardian decision|2|||
146691137|NCT02608268|529046964|FG003|Overall Study|Subject/guardian decision|0|||
146691138|NCT02608268|529046965|FG004|Overall Study|Subject/guardian decision|0|||
146691139|NCT02608268|529046966|FG005|Overall Study|Subject/guardian decision|0|||
146691140|NCT02608268|529046967|FG006|Overall Study|Subject/guardian decision|0|||
146691141|NCT02608268|529046968|FG007|Overall Study|Subject/guardian decision|0|||
146691142|NCT02608268|529046969|FG008|Overall Study|Subject/guardian decision|2|||
146691143|NCT02608268|529046970|FG009|Overall Study|Subject/guardian decision|2|||
146691144|NCT02608268|529046971|FG010|Overall Study|Subject/guardian decision|0|||
146691145|NCT02608268|529046972|FG011|Overall Study|Subject/guardian decision|1|||
146691146|NCT02608268|529046973|FG012|Overall Study|Subject/guardian decision|0|||
146691147|NCT02608268|529046974|FG013|Overall Study|Subject/guardian decision|1|||
146691148|NCT02608268|529046975|FG014|Overall Study|Subject/guardian decision|0|||
146691149|NCT02608268|529046976|FG015|Overall Study|Subject/guardian decision|1|||
146691150|NCT02608268|529046977|FG016|Overall Study|Subject/guardian decision|0|||
146691151|NCT02608268|529046978|FG017|Overall Study|Subject/guardian decision|0|||
146691152|NCT02608268|529046979|FG018|Overall Study|Subject/guardian decision|1|||
146691153|NCT02608268|529046980|FG019|Overall Study|Subject/guardian decision|0|||
146691154|NCT02608268|529046981|FG020|Overall Study|Subject/guardian decision|0|||
146691155|NCT02608268|529046982|FG021|Overall Study|Subject/guardian decision|0|||
146691156|NCT02608268|529046983|FG022|Overall Study|Subject/guardian decision|1|||
146691157|NCT02608268|529046984|FG023|Overall Study|Subject/guardian decision|0|||
146691158|NCT02608268|529046985|FG024|Overall Study|Subject/guardian decision|0|||
146691159|NCT02608268|529046986|FG025|Overall Study|Subject/guardian decision|1|||
146691160|NCT02608268|529046987|FG026|Overall Study|Subject/guardian decision|1|||
146691161|NCT02608268|529046988|FG027|Overall Study|Subject/guardian decision|1|||
146691162|NCT02608268|529046989|FG028|Overall Study|Subject/guardian decision|1|||
146691163|NCT02608268|529046990|FG029|Overall Study|Subject/guardian decision|0|||
146691164|NCT01030523|529046991|FG000|Initial Study (5 Years)|Death|1|||
146691165|NCT01030523|529046992|FG001|Initial Study (5 Years)|Death|0|||
146691166|NCT01030523|529046991|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
146691167|NCT01030523|529046992|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
146691168|NCT01030523|529046991|FG000|Initial Study (5 Years)|Implant failure|1|||
146691169|NCT01030523|529046992|FG001|Initial Study (5 Years)|Implant failure|0|||
146691170|NCT01030523|529046991|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
146691171|NCT01030523|529046992|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
146691172|NCT01030523|529046991|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
146691173|NCT01030523|529046992|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
146691174|NCT01030523|529046991|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
146691175|NCT01030523|529046992|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
146691176|NCT01454570|529047003|FG000|Overall Study|Withdrawal by Subject|2|||
146691177|NCT01454570|529047003|FG000|Overall Study|Screen Failure|7|||
146691178|NCT04351087|529047013|FG000|Overall Study|Lost to Follow-up|7|||
146691179|NCT04351087|529047014|FG001|Overall Study|Lost to Follow-up|3|||
146691180|NCT04351087|529047013|FG000|Overall Study|Withdrawal by Subject|3|||
146691181|NCT04351087|529047014|FG001|Overall Study|Withdrawal by Subject|4|||
146691182|NCT04351087|529047013|FG000|Overall Study|Lack of Efficacy|3|||
146691183|NCT04351087|529047014|FG001|Overall Study|Lack of Efficacy|2|||
146691184|NCT05517382|529047015|FG000|Overall Study|Lost to Follow-up|0|||
146691185|NCT05517382|529047016|FG001|Overall Study|Lost to Follow-up|1|||
146691186|NCT01374087|529047021|FG000|Overall Study|Adverse Event|1|||
146691187|NCT01374087|529047022|FG001|Overall Study|Adverse Event|0|||
146691188|NCT01374087|529047021|FG000|Overall Study|Disease progression|2|||
146691189|NCT01374087|529047022|FG001|Overall Study|Disease progression|2|||
146691190|NCT01374087|529047021|FG000|Overall Study|Study discontinued|13|||
146691191|NCT01374087|529047022|FG001|Overall Study|Study discontinued|13|||
146691192|NCT00271947|529047025|FG000|Overall Study|Lost to Follow-up|1|||
146691193|NCT01522365|529047028|FG000|Overall Study|Withdrawal by Subject|1|||
146691194|NCT01522365|529047029|FG001|Overall Study|Withdrawal by Subject|1|||
146691195|NCT01522365|529047028|FG000|Overall Study|Lost to Follow-up|1|||
146691196|NCT01522365|529047029|FG001|Overall Study|Lost to Follow-up|1|||
146691197|NCT00651755|529047030|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
146691198|NCT00651755|529047031|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
146691199|NCT00651755|529047030|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
146691200|NCT00651755|529047031|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
146691201|NCT03188094|529047038|FG000|Overall Study|Screen failure|1|||
146691202|NCT03188094|529047039|FG001|Overall Study|Screen failure|0|||
146691203|NCT03188094|529047040|FG002|Overall Study|Screen failure|0|||
146691204|NCT03188094|529047038|FG000|Overall Study|Pregnancy|3|||
146691205|NCT03188094|529047039|FG001|Overall Study|Pregnancy|0|||
146691206|NCT03188094|529047040|FG002|Overall Study|Pregnancy|0|||
146691207|NCT03188094|529047038|FG000|Overall Study|Ineligible|1|||
146691208|NCT03188094|529047039|FG001|Overall Study|Ineligible|0|||
146691209|NCT03188094|529047040|FG002|Overall Study|Ineligible|0|||
146691210|NCT03188094|529047038|FG000|Overall Study|Lost to Follow-up|0|||
146691211|NCT03188094|529047039|FG001|Overall Study|Lost to Follow-up|0|||
146691212|NCT03188094|529047040|FG002|Overall Study|Lost to Follow-up|17|||
146691213|NCT04007094|529047041|FG000|Overall Study|Lost to Follow-up|1|||
146691214|NCT04007094|529047042|FG001|Overall Study|Lost to Follow-up|1|||
146691215|NCT04350788|529047048|FG000|Overall Study|Lost to Follow-up|6|||
146691216|NCT04350788|529047049|FG001|Overall Study|Lost to Follow-up|2|||
146691217|NCT04350788|529047048|FG000|Overall Study|Withdrawal by Subject|2|||
146691218|NCT04350788|529047049|FG001|Overall Study|Withdrawal by Subject|4|||
146691219|NCT04350788|529047048|FG000|Overall Study|Protocol Violation|4|||
146691220|NCT04350788|529047049|FG001|Overall Study|Protocol Violation|0|||
146691221|NCT01581307|529047050|FG000|Overall Study|Withdrawal by Subject|1|||
146691222|NCT02070744|529047053|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
146691223|NCT02070744|529047054|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
146691224|NCT02070744|529047055|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
146691225|NCT02070744|529047056|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
146691226|NCT02070744|529047057|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
146691227|NCT02070744|529047053|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
146691228|NCT02070744|529047054|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
146691229|NCT02070744|529047055|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
146691230|NCT02070744|529047056|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
146691231|NCT02070744|529047057|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
146691232|NCT02070744|529047053|FG000|OLE Phase (48 Weeks)|Other|0|||
146691233|NCT02070744|529047054|FG001|OLE Phase (48 Weeks)|Other|0|||
146691234|NCT02070744|529047055|FG002|OLE Phase (48 Weeks)|Other|0|||
146691235|NCT02070744|529047056|FG003|OLE Phase (48 Weeks)|Other|0|||
146691236|NCT02070744|529047057|FG004|OLE Phase (48 Weeks)|Other|1|||
146691237|NCT01894581|529047058|FG000|Overall Study|Withdrawal by Subject|2|||
146691238|NCT01894581|529047059|FG001|Overall Study|Withdrawal by Subject|3|||
146691239|NCT01894581|529047058|FG000|Overall Study|Screen Failure|3|||
146691240|NCT01894581|529047059|FG001|Overall Study|Screen Failure|4|||
146691241|NCT03795298|529047063|FG000|Overall Study|Death|34|||
146691242|NCT03795298|529047064|FG001|Overall Study|Death|29|||
146691243|NCT03795298|529047063|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
146691244|NCT03795298|529047064|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
146691245|NCT03795298|529047063|FG000|Overall Study|Lost to Follow-up|28|||
146691246|NCT03795298|529047064|FG001|Overall Study|Lost to Follow-up|17|||
146691247|NCT03795298|529047063|FG000|Overall Study|Physician Decision|5|||
146691248|NCT03795298|529047064|FG001|Overall Study|Physician Decision|4|||
146691249|NCT03795298|529047063|FG000|Overall Study|Withdrawal by Subject|43|||
146691250|NCT03795298|529047064|FG001|Overall Study|Withdrawal by Subject|28|||
146691251|NCT03795298|529047063|FG000|Overall Study|Reason not reported|7|||
146691252|NCT03795298|529047064|FG001|Overall Study|Reason not reported|9|||
146691253|NCT04383743|529047065|FG000|Overall Study|Withdrawal by Subject|1|||
146691254|NCT04383743|529047065|FG000|Overall Study|Adverse Event|1|||
146691255|NCT05478252|529047068|FG000|Overall Study|Withdrawal by Subject|2|||
146691256|NCT05478252|529047069|FG001|Overall Study|Withdrawal by Subject|3|||
146691257|NCT05478252|529047068|FG000|Overall Study|Lost to Follow-up|4|||
146691258|NCT05478252|529047069|FG001|Overall Study|Lost to Follow-up|2|||
146691259|NCT05478252|529047068|FG000|Overall Study|Physician Decision|1|||
146691260|NCT05478252|529047069|FG001|Overall Study|Physician Decision|1|||
146691261|NCT05478252|529047068|FG000|Overall Study|Death|1|||
146691262|NCT05478252|529047069|FG001|Overall Study|Death|0|||
146691263|NCT03482791|529047074|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
146691264|NCT03482791|529047075|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
146691265|NCT01816893|529047076|FG000|Washout Period|Withdrawal by Subject|2|||
146691266|NCT01816893|529047077|FG001|Washout Period|Withdrawal by Subject|0|||
146691267|NCT01239368|529048611|FG000|Overall Study|Principal investigator discretion|1|||
146691268|NCT01239368|529048612|FG001|Overall Study|Principal investigator discretion|0|||
146691269|NCT01239368|529048613|FG002|Overall Study|Principal investigator discretion|0|||
146691270|NCT01239368|529048614|FG003|Overall Study|Principal investigator discretion|0|||
146691271|NCT01239368|529048615|FG004|Overall Study|Principal investigator discretion|1|||
146691272|NCT01239368|529048616|FG005|Overall Study|Principal investigator discretion|2|||
146691273|NCT01239368|529048617|FG006|Overall Study|Principal investigator discretion|0|||
146691274|NCT01239368|529048618|FG007|Overall Study|Principal investigator discretion|0|||
146691275|NCT01239368|529048619|FG008|Overall Study|Principal investigator discretion|0|||
146691276|NCT01239368|529048620|FG009|Overall Study|Principal investigator discretion|1|||
146691277|NCT01239368|529048611|FG000|Overall Study|Disease progression on study|1|||
146691278|NCT01239368|529048612|FG001|Overall Study|Disease progression on study|1|||
146691279|NCT01239368|529048613|FG002|Overall Study|Disease progression on study|1|||
146691280|NCT01239368|529048614|FG003|Overall Study|Disease progression on study|1|||
146691281|NCT01239368|529048615|FG004|Overall Study|Disease progression on study|4|||
146691282|NCT01239368|529048616|FG005|Overall Study|Disease progression on study|2|||
146691283|NCT01239368|529048617|FG006|Overall Study|Disease progression on study|5|||
146691284|NCT01239368|529048618|FG007|Overall Study|Disease progression on study|0|||
146691285|NCT01239368|529048619|FG008|Overall Study|Disease progression on study|0|||
146691286|NCT01239368|529048620|FG009|Overall Study|Disease progression on study|2|||
146691287|NCT01239368|529048611|FG000|Overall Study|Refused further treatment|0|||
146691288|NCT01239368|529048612|FG001|Overall Study|Refused further treatment|0|||
146691289|NCT01239368|529048613|FG002|Overall Study|Refused further treatment|0|||
146691290|NCT01239368|529048614|FG003|Overall Study|Refused further treatment|0|||
146691291|NCT01239368|529048615|FG004|Overall Study|Refused further treatment|0|||
146691292|NCT01239368|529048616|FG005|Overall Study|Refused further treatment|0|||
146691293|NCT01239368|529048617|FG006|Overall Study|Refused further treatment|0|||
146691294|NCT01239368|529048618|FG007|Overall Study|Refused further treatment|0|||
146691295|NCT01239368|529048619|FG008|Overall Study|Refused further treatment|0|||
146691296|NCT01239368|529048620|FG009|Overall Study|Refused further treatment|1|||
146691297|NCT01239368|529048611|FG000|Overall Study|Death|0|||
146691298|NCT01239368|529048612|FG001|Overall Study|Death|0|||
146691299|NCT01239368|529048613|FG002|Overall Study|Death|0|||
146691300|NCT01239368|529048614|FG003|Overall Study|Death|0|||
146691301|NCT01239368|529048615|FG004|Overall Study|Death|0|||
146691302|NCT01239368|529048616|FG005|Overall Study|Death|0|||
146691303|NCT01239368|529048617|FG006|Overall Study|Death|1|||
146691304|NCT01239368|529048618|FG007|Overall Study|Death|0|||
146691305|NCT01239368|529048619|FG008|Overall Study|Death|0|||
146691306|NCT01239368|529048620|FG009|Overall Study|Death|0|||
146691307|NCT04709575|529048621|FG000|Overall Study|Withdrawal by Subject|6|||
146691308|NCT04709575|529048622|FG001|Overall Study|Withdrawal by Subject|2|||
146691309|NCT04709575|529048621|FG000|Overall Study|Lost to Follow-up|2|||
146691310|NCT04709575|529048622|FG001|Overall Study|Lost to Follow-up|2|||
146691311|NCT04709575|529048621|FG000|Overall Study|Adverse Event|1|||
146691312|NCT04709575|529048622|FG001|Overall Study|Adverse Event|0|||
146929741|NCT00363051|529900861|FG000|Overall Study|Protocol Violation|0|||
146929742|NCT00363051|529900862|FG001|Overall Study|Protocol Violation|2|||
146929743|NCT00363051|529900861|FG000|Overall Study|Death|3|||
146929744|NCT00363051|529900862|FG001|Overall Study|Death|2|||
146929745|NCT00830115|529900865|FG000|Overall Study|Adverse Event|2|||
146929746|NCT00830115|529900865|FG000|Overall Study|Improvement/recovery|1|||
146979797|NCT00950599|530089448|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
146691313|NCT04709575|529048621|FG000|Overall Study|Protocol Violation|1|||
146691314|NCT04709575|529048622|FG001|Overall Study|Protocol Violation|1|||
146929747|NCT01925612|529900873|FG000|Overall Study|Progressive Disease|1|||
146929748|NCT01925612|529900874|FG001|Overall Study|Progressive Disease|1|||
146929749|NCT01925612|529900875|FG002|Overall Study|Progressive Disease|1|||
146691315|NCT03181399|529048624|FG000|6 Months on Treatment|Protocol non-compliance|7|||
146691316|NCT03181399|529048624|FG000|6 Months on Treatment|Adverse Event|4|||
146691317|NCT03181399|529048624|FG000|6 Months on Treatment|Tried alternative treatment|2|||
146691318|NCT03181399|529048624|FG000|6 Months on Treatment|Lost to Follow-up|2|||
146691319|NCT03181399|529048624|FG000|6 Months on Treatment|Personal reasons|1|||
146691320|NCT03181399|529048624|FG000|3 Months Off-treatment|Parent unable to travel|1|||
146691321|NCT01536379|529048625|FG000|Overall Study|Adverse Event|1|||
146691322|NCT01536379|529048626|FG001|Overall Study|Adverse Event|2|||
146691323|NCT01536379|529048625|FG000|Overall Study|Withdrawal by Subject|1|||
146691324|NCT01536379|529048626|FG001|Overall Study|Withdrawal by Subject|1|||
146691325|NCT04439253|529048632|FG000|Overall Study|Adverse Event|1|||
146691326|NCT04439253|529048632|FG000|Overall Study|Disease progression|2|||
146691327|NCT04439253|529048632|FG000|Overall Study|Complicating disease|1|||
146691328|NCT03971695|529048633|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
146691329|NCT03971695|529048634|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
146691330|NCT03971695|529048635|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
146691331|NCT03971695|529048636|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
146691332|NCT03971695|529048637|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
146691333|NCT03971695|529048638|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
146691334|NCT03971695|529048639|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
146691335|NCT03971695|529048640|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
146691336|NCT03971695|529048641|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
146691337|NCT03971695|529048642|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
146691338|NCT03971695|529048643|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
146691339|NCT03971695|529048644|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
146691340|NCT03971695|529048645|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
146691341|NCT04447417|529048646|FG000|Overall Study|Withdrawal by Subject|1|||
146691342|NCT04447417|529048647|FG001|Overall Study|Withdrawal by Subject|0|||
146691343|NCT04447417|529048646|FG000|Overall Study|Failure to meet inclusion criteria|1|||
146691344|NCT04447417|529048647|FG001|Overall Study|Failure to meet inclusion criteria|0|||
146691345|NCT04447417|529048646|FG000|Overall Study|Lost to Follow-up|1|||
146691346|NCT04447417|529048647|FG001|Overall Study|Lost to Follow-up|0|||
146691347|NCT00702403|529048648|FG000|From Consent to Engraftment|Progressive leukemia|6|||
146691348|NCT00702403|529048648|FG000|From Consent to Engraftment|Critically ill|2|||
146691349|NCT00702403|529048648|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
146691350|NCT00702403|529048648|FG000|From Consent to Engraftment|Myocardial infarction|1|||
146691351|NCT00702403|529048648|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
146691352|NCT00702403|529048648|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
146691353|NCT00702403|529048648|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
146691354|NCT00702403|529048648|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
146691355|NCT00702403|529048648|FG000|From Engraftment to Study Completion|Non-compliance|2|||
146691356|NCT00702403|529048648|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
146691357|NCT00702403|529048648|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
146691358|NCT00702403|529048648|FG000|From Engraftment to Study Completion|Suicide|1|||
146691359|NCT00702403|529048648|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
146691360|NCT00702403|529048648|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
146691361|NCT00702403|529048648|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
146691362|NCT02356783|529048650|FG000|Overall Study|Lost to Follow-up|1|||
146691363|NCT02356783|529048651|FG001|Overall Study|Lost to Follow-up|3|||
146691364|NCT02603809|529048652|FG000|Overall Study|Withdrawal by Subject|4|||
146691365|NCT02603809|529048653|FG001|Overall Study|Withdrawal by Subject|1|||
146691366|NCT02603809|529048654|FG002|Overall Study|Withdrawal by Subject|2|||
146691367|NCT02603809|529048655|FG003|Overall Study|Withdrawal by Subject|3|||
146691368|NCT02603809|529048656|FG004|Overall Study|Withdrawal by Subject|3|||
146691369|NCT02603809|529048657|FG005|Overall Study|Withdrawal by Subject|4|||
146691370|NCT02603809|529048652|FG000|Overall Study|Lost to Follow-up|2|||
146691371|NCT02603809|529048653|FG001|Overall Study|Lost to Follow-up|3|||
146691372|NCT02603809|529048654|FG002|Overall Study|Lost to Follow-up|1|||
146691373|NCT02603809|529048655|FG003|Overall Study|Lost to Follow-up|4|||
146691374|NCT02603809|529048656|FG004|Overall Study|Lost to Follow-up|2|||
146691375|NCT02603809|529048657|FG005|Overall Study|Lost to Follow-up|2|||
146691376|NCT02603809|529048652|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
146691377|NCT02603809|529048653|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
146691378|NCT02603809|529048654|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
146691379|NCT02603809|529048655|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
146691380|NCT02603809|529048656|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
146979798|NCT00950599|530089449|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
146979799|NCT00950599|530089450|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
146979800|NCT00950599|530089451|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
146979801|NCT00950599|530089452|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
146979802|NCT00950599|530089453|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
146979803|NCT00950599|530089454|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
146979804|NCT00950599|530089455|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
146979805|NCT00950599|530089456|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
146979806|NCT00950599|530089457|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
146979807|NCT00950599|530089448|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
146979808|NCT00950599|530089449|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
146979809|NCT00950599|530089450|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
146979810|NCT00950599|530089451|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
146979811|NCT00950599|530089452|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
146979812|NCT00950599|530089453|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
146979813|NCT00950599|530089454|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
146979814|NCT00950599|530089455|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
146979815|NCT00950599|530089456|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
146979816|NCT00950599|530089457|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
146979817|NCT00950599|530089448|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
146979818|NCT00950599|530089449|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
146979819|NCT00950599|530089450|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
146979820|NCT00950599|530089451|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
146979821|NCT00950599|530089452|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
146979822|NCT00950599|530089453|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
146979823|NCT00950599|530089454|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
146979824|NCT00950599|530089455|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
146979825|NCT00950599|530089456|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
146979826|NCT00950599|530089457|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
146979827|NCT00950599|530089448|FG000|Follow-Up Period|Adverse Event|0|||
146979828|NCT00950599|530089449|FG001|Follow-Up Period|Adverse Event|0|||
146979829|NCT00950599|530089450|FG002|Follow-Up Period|Adverse Event|0|||
146979830|NCT00950599|530089451|FG003|Follow-Up Period|Adverse Event|0|||
146979831|NCT00950599|530089452|FG004|Follow-Up Period|Adverse Event|0|||
146979832|NCT00950599|530089453|FG005|Follow-Up Period|Adverse Event|0|||
146979833|NCT00950599|530089454|FG006|Follow-Up Period|Adverse Event|0|||
146979834|NCT00950599|530089455|FG007|Follow-Up Period|Adverse Event|0|||
146979835|NCT00950599|530089456|FG008|Follow-Up Period|Adverse Event|1|||
146979836|NCT00950599|530089457|FG009|Follow-Up Period|Adverse Event|0|||
146979837|NCT00950599|530089448|FG000|Follow-Up Period|Lack of Efficacy|0|||
146979838|NCT00950599|530089449|FG001|Follow-Up Period|Lack of Efficacy|0|||
146979839|NCT00950599|530089450|FG002|Follow-Up Period|Lack of Efficacy|0|||
146979840|NCT00950599|530089451|FG003|Follow-Up Period|Lack of Efficacy|0|||
146979841|NCT00950599|530089452|FG004|Follow-Up Period|Lack of Efficacy|0|||
146979842|NCT00950599|530089453|FG005|Follow-Up Period|Lack of Efficacy|0|||
146979843|NCT00950599|530089454|FG006|Follow-Up Period|Lack of Efficacy|0|||
146979844|NCT00950599|530089455|FG007|Follow-Up Period|Lack of Efficacy|0|||
146979845|NCT00950599|530089456|FG008|Follow-Up Period|Lack of Efficacy|3|||
146979846|NCT00950599|530089457|FG009|Follow-Up Period|Lack of Efficacy|0|||
146979847|NCT00950599|530089448|FG000|Follow-Up Period|Lost to Follow-up|0|||
146979848|NCT00950599|530089449|FG001|Follow-Up Period|Lost to Follow-up|0|||
146979849|NCT00950599|530089450|FG002|Follow-Up Period|Lost to Follow-up|0|||
146979850|NCT00950599|530089451|FG003|Follow-Up Period|Lost to Follow-up|0|||
146979851|NCT00950599|530089452|FG004|Follow-Up Period|Lost to Follow-up|0|||
146979852|NCT00950599|530089453|FG005|Follow-Up Period|Lost to Follow-up|0|||
146979853|NCT00950599|530089454|FG006|Follow-Up Period|Lost to Follow-up|0|||
146979854|NCT00950599|530089455|FG007|Follow-Up Period|Lost to Follow-up|0|||
146979855|NCT00950599|530089456|FG008|Follow-Up Period|Lost to Follow-up|5|||
146979856|NCT00950599|530089457|FG009|Follow-Up Period|Lost to Follow-up|1|||
146691381|NCT02603809|529048657|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
146691382|NCT02603809|529048652|FG000|Overall Study|Physician Decision|0|||
146691383|NCT02603809|529048653|FG001|Overall Study|Physician Decision|0|||
146691384|NCT02603809|529048654|FG002|Overall Study|Physician Decision|0|||
146979857|NCT00950599|530089448|FG000|Follow-Up Period|Physician Decision|0|||
146979858|NCT00950599|530089449|FG001|Follow-Up Period|Physician Decision|0|||
146979859|NCT00950599|530089450|FG002|Follow-Up Period|Physician Decision|0|||
146979860|NCT00950599|530089451|FG003|Follow-Up Period|Physician Decision|0|||
146979861|NCT00950599|530089452|FG004|Follow-Up Period|Physician Decision|0|||
146979862|NCT00950599|530089453|FG005|Follow-Up Period|Physician Decision|0|||
146979863|NCT00950599|530089454|FG006|Follow-Up Period|Physician Decision|0|||
146979864|NCT00950599|530089455|FG007|Follow-Up Period|Physician Decision|0|||
146691385|NCT02603809|529048655|FG003|Overall Study|Physician Decision|1|||
146979865|NCT00950599|530089456|FG008|Follow-Up Period|Physician Decision|1|||
146691386|NCT02603809|529048656|FG004|Overall Study|Physician Decision|2|||
146691387|NCT02603809|529048657|FG005|Overall Study|Physician Decision|1|||
146691388|NCT02603809|529048652|FG000|Overall Study|Adverse Event|3|||
146691389|NCT02603809|529048653|FG001|Overall Study|Adverse Event|0|||
146691390|NCT02603809|529048654|FG002|Overall Study|Adverse Event|2|||
146691391|NCT02603809|529048655|FG003|Overall Study|Adverse Event|2|||
146691392|NCT02603809|529048656|FG004|Overall Study|Adverse Event|1|||
146691393|NCT02603809|529048657|FG005|Overall Study|Adverse Event|1|||
146691394|NCT02603809|529048652|FG000|Overall Study|Lack of Efficacy|0|||
146691395|NCT02603809|529048653|FG001|Overall Study|Lack of Efficacy|1|||
146691396|NCT02603809|529048654|FG002|Overall Study|Lack of Efficacy|0|||
146691397|NCT02603809|529048655|FG003|Overall Study|Lack of Efficacy|0|||
146691398|NCT02603809|529048656|FG004|Overall Study|Lack of Efficacy|0|||
146691399|NCT02603809|529048657|FG005|Overall Study|Lack of Efficacy|1|||
146691400|NCT01254227|529048658|FG000|Overall Study|Withdrawal by Subject|6|||
146691401|NCT01254227|529048658|FG000|Overall Study|Lost to Follow-up|6|||
146691402|NCT01254227|529048658|FG000|Overall Study|Adverse Event|5|||
146691403|NCT01254227|529048658|FG000|Overall Study|Abnormal test procedure result|5|||
146691404|NCT01254227|529048658|FG000|Overall Study|Administrative problems|2|||
146691405|NCT01254227|529048658|FG000|Overall Study|Death|1|||
146691406|NCT01254227|529048658|FG000|Overall Study|Protocol deviation|1|||
146691407|NCT00192504|529048661|FG000|Overall Study|Lost to Follow-up|1|||
146691408|NCT00192504|529048662|FG001|Overall Study|Lost to Follow-up|0|||
146691409|NCT00192504|529048663|FG002|Overall Study|Lost to Follow-up|0|||
146691410|NCT00192504|529048664|FG003|Overall Study|Lost to Follow-up|0|||
146691411|NCT00192504|529048661|FG000|Overall Study|Dosing window missed|0|||
146691412|NCT00192504|529048662|FG001|Overall Study|Dosing window missed|0|||
146691413|NCT00192504|529048663|FG002|Overall Study|Dosing window missed|1|||
146691414|NCT00192504|529048664|FG003|Overall Study|Dosing window missed|0|||
146691415|NCT03989440|529048665|FG000|Overall Study|COVID-19 travel restrictions|0|||
146691416|NCT03989440|529048666|FG001|Overall Study|COVID-19 travel restrictions|0|||
146691417|NCT03989440|529048667|FG002|Overall Study|COVID-19 travel restrictions|1|||
146691418|NCT03989440|529048668|FG003|Overall Study|COVID-19 travel restrictions|0|||
146691419|NCT03989440|529048669|FG004|Overall Study|COVID-19 travel restrictions|0|||
146691420|NCT03989440|529048670|FG005|Overall Study|COVID-19 travel restrictions|0|||
146691421|NCT03989440|529048665|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
146691422|NCT03989440|529048666|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
146691423|NCT03989440|529048667|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
146691424|NCT03989440|529048668|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
146691425|NCT03989440|529048669|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
146691426|NCT03989440|529048670|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
146691427|NCT02189473|529048673|FG000|Overall Study|Death|22|||
146691428|NCT02189473|529048674|FG001|Overall Study|Death|23|||
146691429|NCT02189473|529048673|FG000|Overall Study|Lost to Follow-up|1|||
146691430|NCT02189473|529048674|FG001|Overall Study|Lost to Follow-up|2|||
146691431|NCT04608500|529048675|FG000|Overall Study|Adverse Event|2|||
146691432|NCT04608500|529048676|FG001|Overall Study|Adverse Event|0|||
146691433|NCT04608500|529048675|FG000|Overall Study|Lost to Follow-up|15|||
146691434|NCT04608500|529048676|FG001|Overall Study|Lost to Follow-up|9|||
146691435|NCT04608500|529048675|FG000|Overall Study|Participant request|11|||
146691436|NCT04608500|529048676|FG001|Overall Study|Participant request|7|||
146691437|NCT04608500|529048675|FG000|Overall Study|Protocol Violation|1|||
146691438|NCT04608500|529048676|FG001|Overall Study|Protocol Violation|0|||
146691439|NCT04608500|529048675|FG000|Overall Study|Other|6|||
146691440|NCT04608500|529048676|FG001|Overall Study|Other|2|||
146691441|NCT01881230|529048677|FG000|Overall Study|Death|2|||
146691442|NCT01881230|529048678|FG001|Overall Study|Death|0|||
146691443|NCT01881230|529048679|FG002|Overall Study|Death|1|||
146691444|NCT01881230|529048677|FG000|Overall Study|Adverse Event|9|||
146691445|NCT01881230|529048678|FG001|Overall Study|Adverse Event|13|||
146691446|NCT01881230|529048679|FG002|Overall Study|Adverse Event|12|||
146691447|NCT01881230|529048677|FG000|Overall Study|Progressive Disease|31|||
146691448|NCT01881230|529048678|FG001|Overall Study|Progressive Disease|35|||
146691449|NCT01881230|529048679|FG002|Overall Study|Progressive Disease|36|||
146691450|NCT01881230|529048677|FG000|Overall Study|Symptomatic Deterioration|3|||
146691451|NCT01881230|529048678|FG001|Overall Study|Symptomatic Deterioration|3|||
146691452|NCT01881230|529048679|FG002|Overall Study|Symptomatic Deterioration|1|||
146691453|NCT01881230|529048677|FG000|Overall Study|Withdrawal by Subject|6|||
146691454|NCT01881230|529048678|FG001|Overall Study|Withdrawal by Subject|4|||
146691455|NCT01881230|529048679|FG002|Overall Study|Withdrawal by Subject|6|||
146691456|NCT01881230|529048677|FG000|Overall Study|Physician Decision|4|||
146691457|NCT01881230|529048678|FG001|Overall Study|Physician Decision|3|||
146691458|NCT01881230|529048679|FG002|Overall Study|Physician Decision|6|||
146691459|NCT01881230|529048677|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146691460|NCT01881230|529048678|FG001|Overall Study|Non-Compliance with Study Drug|2|||
146691461|NCT01881230|529048679|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146691462|NCT01881230|529048677|FG000|Overall Study|Given Commercially Available Drug|0|||
146691463|NCT01881230|529048678|FG001|Overall Study|Given Commercially Available Drug|0|||
146691464|NCT01881230|529048679|FG002|Overall Study|Given Commercially Available Drug|2|||
146691465|NCT01881230|529048677|FG000|Overall Study|Protocol Violation|1|||
146691466|NCT01881230|529048678|FG001|Overall Study|Protocol Violation|1|||
146691467|NCT01881230|529048679|FG002|Overall Study|Protocol Violation|0|||
146691468|NCT01881230|529048677|FG000|Overall Study|Miscellaneous|3|||
146691469|NCT01881230|529048678|FG001|Overall Study|Miscellaneous|3|||
146691470|NCT01881230|529048679|FG002|Overall Study|Miscellaneous|0|||
146691471|NCT01881230|529048677|FG000|Overall Study|Untreated: Other|0|||
146691472|NCT01881230|529048678|FG001|Overall Study|Untreated: Other|0|||
146691473|NCT01881230|529048679|FG002|Overall Study|Untreated: Other|1|||
146691474|NCT01881230|529048677|FG000|Overall Study|Untreated: Death|0|||
146691475|NCT01881230|529048678|FG001|Overall Study|Untreated: Death|0|||
146691476|NCT01881230|529048679|FG002|Overall Study|Untreated: Death|1|||
146691477|NCT01881230|529048677|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
146691478|NCT01881230|529048678|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
146691479|NCT01881230|529048679|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
146691480|NCT05123222|529048680|FG000|Overall Study|Lost to Follow-up|2|||
146691481|NCT05123222|529048681|FG001|Overall Study|Lost to Follow-up|0|||
146691482|NCT05123222|529048682|FG002|Overall Study|Lost to Follow-up|0|||
146691483|NCT05123222|529048683|FG003|Overall Study|Lost to Follow-up|0|||
146691484|NCT05123222|529048680|FG000|Overall Study|Protocol Violation|0|||
146691485|NCT05123222|529048681|FG001|Overall Study|Protocol Violation|0|||
146691486|NCT05123222|529048682|FG002|Overall Study|Protocol Violation|1|||
146691487|NCT05123222|529048683|FG003|Overall Study|Protocol Violation|0|||
146691488|NCT00112502|529048684|FG000|Overall Study|Withdrawal by Subject|0|||
146691489|NCT00112502|529048685|FG001|Overall Study|Withdrawal by Subject|1|||
146691490|NCT00112502|529048686|FG002|Overall Study|Withdrawal by Subject|1|||
146691491|NCT00112502|529048687|FG003|Overall Study|Withdrawal by Subject|4|||
146691492|NCT00112502|529048688|FG004|Overall Study|Withdrawal by Subject|2|||
146691493|NCT00112502|529048689|FG005|Overall Study|Withdrawal by Subject|5|||
146691494|NCT00112502|529048690|FG006|Overall Study|Withdrawal by Subject|3|||
146691495|NCT00112502|529048691|FG007|Overall Study|Withdrawal by Subject|7|||
146691496|NCT00914810|529048694|FG000|Overall Study|Withdrawal by Subject|1|||
146691497|NCT00914810|529048695|FG001|Overall Study|Withdrawal by Subject|0|||
146691498|NCT00914810|529048694|FG000|Overall Study|Relocated out of state|1|||
146691499|NCT00914810|529048695|FG001|Overall Study|Relocated out of state|0|||
146691500|NCT00914810|529048694|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
146691501|NCT00914810|529048695|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
146691502|NCT02747420|529048696|FG000|Overall Study|Lost to Follow-up|4|||
146691503|NCT02747420|529048697|FG001|Overall Study|Lost to Follow-up|2|||
146691504|NCT02747420|529048696|FG000|Overall Study|Withdrawal by Subject|3|||
146691505|NCT02747420|529048697|FG001|Overall Study|Withdrawal by Subject|2|||
146691506|NCT05129488|529048698|FG000|Overall Study|Protocol Violation|3|||
146691507|NCT00265343|529048699|FG000|Overall Study|Adverse Event|10|||
146691508|NCT00265343|529048700|FG001|Overall Study|Adverse Event|7|||
146691509|NCT00265343|529048699|FG000|Overall Study|Withdrawal by Subject|3|||
146691510|NCT00265343|529048700|FG001|Overall Study|Withdrawal by Subject|9|||
146691511|NCT00265343|529048699|FG000|Overall Study|Other|8|||
146691512|NCT00265343|529048700|FG001|Overall Study|Other|3|||
146691513|NCT00706641|529048705|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
146691514|NCT00706641|529048705|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
146691515|NCT00706641|529048705|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
146691516|NCT04782856|529048709|FG000|Overall Study|Withdrawal by Subject|0|||
146691517|NCT04782856|529048710|FG001|Overall Study|Withdrawal by Subject|1|||
146691518|NCT02535741|529048711|FG000|Overall Study|Adverse Event|3|||
146691519|NCT02535741|529048711|FG000|Overall Study|Withdrawal by Subject|9|||
146691520|NCT02535741|529048711|FG000|Overall Study|Lost to Follow-up|10|||
146691521|NCT02535741|529048711|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
146691522|NCT02535741|529048711|FG000|Overall Study|Missing data|6|||
146691523|NCT00798369|529048714|FG000|Overall Study|Subject withdrew consent|0|||
146691524|NCT00798369|529048715|FG001|Overall Study|Subject withdrew consent|0|||
146691525|NCT00798369|529048716|FG002|Overall Study|Subject withdrew consent|1|||
146691526|NCT00798369|529048717|FG003|Overall Study|Subject withdrew consent|1|||
146691527|NCT00798369|529048718|FG004|Overall Study|Subject withdrew consent|0|||
146691528|NCT00798369|529048719|FG005|Overall Study|Subject withdrew consent|2|||
146691529|NCT00798369|529048714|FG000|Overall Study|Lost to Follow-up|1|||
146691530|NCT00798369|529048715|FG001|Overall Study|Lost to Follow-up|1|||
146691531|NCT00798369|529048716|FG002|Overall Study|Lost to Follow-up|1|||
146691532|NCT00798369|529048717|FG003|Overall Study|Lost to Follow-up|0|||
146691533|NCT00798369|529048718|FG004|Overall Study|Lost to Follow-up|1|||
146691534|NCT00798369|529048719|FG005|Overall Study|Lost to Follow-up|0|||
146691535|NCT00798369|529048714|FG000|Overall Study|Adminstrative problems|0|||
146691536|NCT00798369|529048715|FG001|Overall Study|Adminstrative problems|0|||
146691537|NCT00798369|529048716|FG002|Overall Study|Adminstrative problems|0|||
146691538|NCT00798369|529048717|FG003|Overall Study|Adminstrative problems|0|||
146691539|NCT00798369|529048718|FG004|Overall Study|Adminstrative problems|0|||
146691540|NCT00798369|529048719|FG005|Overall Study|Adminstrative problems|1|||
146691541|NCT01290666|529048721|FG000|Overall Study|Lost to Follow-up|11|||
146691542|NCT01290666|529048721|FG000|Overall Study|Withdrawal by Subject|23|||
146691543|NCT01290666|529048721|FG000|Overall Study|Early Termination of Study|4|||
146691544|NCT01652664|529048722|FG000|Overall Study|Treatment Failure|5|||
146691545|NCT01652664|529048723|FG001|Overall Study|Treatment Failure|1|||
146691546|NCT01652664|529048722|FG000|Overall Study|Inadequate IOP control|1|||
146979866|NCT00950599|530089457|FG009|Follow-Up Period|Physician Decision|0|||
146979867|NCT00950599|530089448|FG000|Follow-Up Period|Poor/Noncompliance|0|||
146979868|NCT00950599|530089449|FG001|Follow-Up Period|Poor/Noncompliance|0|||
146979869|NCT00950599|530089450|FG002|Follow-Up Period|Poor/Noncompliance|0|||
146979870|NCT00950599|530089451|FG003|Follow-Up Period|Poor/Noncompliance|0|||
146691547|NCT01652664|529048723|FG001|Overall Study|Inadequate IOP control|0|||
146691548|NCT03538158|529048724|FG000|Overall Study|Lost to Follow-up|13|||
146691549|NCT03538158|529048725|FG001|Overall Study|Lost to Follow-up|7|||
146691550|NCT03538158|529048724|FG000|Overall Study|Withdrawal by Subject|2|||
146691551|NCT03538158|529048725|FG001|Overall Study|Withdrawal by Subject|1|||
146691552|NCT02418468|529048729|FG000|Overall Study|Adverse Event|1|||
146691553|NCT02418468|529048730|FG001|Overall Study|Adverse Event|0|||
146691554|NCT02418468|529048729|FG000|Overall Study|Withdrawal of informed consent|1|||
146691555|NCT02418468|529048730|FG001|Overall Study|Withdrawal of informed consent|1|||
146691556|NCT02914769|529048731|FG000|Overall Study|Protocol Violation|3|||
146691557|NCT02914769|529048732|FG001|Overall Study|Protocol Violation|2|||
146691558|NCT02914769|529048731|FG000|Overall Study|Withdrawal by Subject|0|||
146691559|NCT02914769|529048732|FG001|Overall Study|Withdrawal by Subject|1|||
146691560|NCT04356963|529048736|FG000|First Session|Withdrawal by Subject|1|||
146691561|NCT04356963|529048736|FG000|Second Session|Withdrawal by Subject|3|||
146691562|NCT04356963|529048736|FG000|Second Session|Lost to Follow-up|1|||
146691563|NCT04356963|529048736|FG000|Third Session|Lost to Follow-up|6|||
146691564|NCT04356963|529048736|FG000|Third Session|Withdrawal by Subject|1|||
146691565|NCT00099437|529048737|FG000|Overall Study|Lost to Follow-up|30|||
146691566|NCT00099437|529048738|FG001|Overall Study|Lost to Follow-up|33|||
146691567|NCT00099437|529048737|FG000|Overall Study|Death|293|||
146691568|NCT00099437|529048738|FG001|Overall Study|Death|261|||
146691569|NCT00099437|529048737|FG000|Overall Study|Withdrawal by Subject|6|||
146691570|NCT00099437|529048738|FG001|Overall Study|Withdrawal by Subject|10|||
146691571|NCT00099437|529048737|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
146691572|NCT00099437|529048738|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
146691573|NCT02410954|529048739|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
146691574|NCT02410954|529048740|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
146691575|NCT02410954|529048739|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
146691576|NCT02410954|529048740|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
146691577|NCT02738333|529048741|FG000|Overall Study|Death|1|||
146691578|NCT02738333|529048742|FG001|Overall Study|Death|0|||
146691579|NCT02738333|529048743|FG002|Overall Study|Death|0|||
146691580|NCT02738333|529048741|FG000|Overall Study|Lost to Follow-up|1|||
146691581|NCT02738333|529048742|FG001|Overall Study|Lost to Follow-up|0|||
146691582|NCT02738333|529048743|FG002|Overall Study|Lost to Follow-up|0|||
146691583|NCT00791518|529048744|FG000|Overall Study|Protocol Violation|93|||
146691584|NCT02809677|529048746|FG000|Overall Study|Withdrawal by Subject|8|||
146691585|NCT04969224|529048751|FG000|Overall Study|Adverse Event|1|||
146691586|NCT04969224|529048751|FG000|Overall Study|Enrolled but never dosed|1|||
146691587|NCT01498952|529048752|FG000|Overall Study|Death|2|||
146691588|NCT01498952|529048753|FG001|Overall Study|Death|2|||
146691589|NCT01498952|529048754|FG002|Overall Study|Death|0|||
146691590|NCT01498952|529048755|FG003|Overall Study|Death|0|||
146691591|NCT01498952|529048756|FG004|Overall Study|Death|0|||
146691592|NCT02726074|529048757|FG000|Overall Study|Withdrawal by Subject|4|||
146691593|NCT02726074|529048757|FG000|Overall Study|Adverse Event|14|||
146691594|NCT02726074|529048757|FG000|Overall Study|Protocol Violation|3|||
146691595|NCT02726074|529048757|FG000|Overall Study|Lost to Follow-up|2|||
146691596|NCT02726074|529048757|FG000|Overall Study|Others|3|||
146691597|NCT01679002|529048758|FG000|Overall Study|Adverse Event|1|||
146691598|NCT01679002|529048759|FG001|Overall Study|Adverse Event|1|||
146979871|NCT00950599|530089452|FG004|Follow-Up Period|Poor/Noncompliance|0|||
146691599|NCT01679002|529048760|FG002|Overall Study|Adverse Event|0|||
146691600|NCT05172544|529048761|FG000|Overall Study|Withdrawal by Subject|1|||
146691601|NCT05172544|529048762|FG001|Overall Study|Withdrawal by Subject|0|||
146691602|NCT05172544|529048763|FG002|Overall Study|Withdrawal by Subject|0|||
146691603|NCT05172544|529048761|FG000|Overall Study|Physician Decision|0|||
146691604|NCT05172544|529048762|FG001|Overall Study|Physician Decision|0|||
146691605|NCT05172544|529048763|FG002|Overall Study|Physician Decision|1|||
146691606|NCT00454987|529048764|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
146691607|NCT00454987|529048765|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
146691608|NCT00454987|529048766|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
146691609|NCT00454987|529048764|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
146691610|NCT00454987|529048765|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
146691611|NCT00454987|529048766|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
146691612|NCT00454987|529048764|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
146691613|NCT00454987|529048765|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
146691614|NCT00454987|529048766|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
146691615|NCT01176266|529048767|FG000|Overall Study|Death|6|||
146691616|NCT01176266|529048767|FG000|Overall Study|Withdrawal by Subject|3|||
146691617|NCT02642432|529048768|FG000|Overall Study|Adverse Event|2|||
146691618|NCT02642432|529048768|FG000|Overall Study|Withdrew Consent|1|||
146691619|NCT02642432|529048768|FG000|Overall Study|Lost to Follow-up|2|||
146691620|NCT02642432|529048768|FG000|Overall Study|Other|3|||
146691621|NCT03999892|529048769|FG000|Overall Study|Lost to Follow-up|1|||
146691622|NCT01848756|529048770|FG000|Overall Study|Adverse Event|1|||
146691623|NCT01848756|529048770|FG000|Overall Study|Withdrawal by Subject|1|||
146691624|NCT01848756|529048770|FG000|Overall Study|Enrolled in Error|1|||
146691625|NCT03245008|529048771|FG000|Overall Study|Adverse Event|15|||
146691626|NCT03245008|529048772|FG001|Overall Study|Adverse Event|18|||
146691627|NCT03245008|529048773|FG002|Overall Study|Adverse Event|15|||
146691628|NCT03245008|529048774|FG003|Overall Study|Adverse Event|0|||
146691629|NCT03245008|529048775|FG004|Overall Study|Adverse Event|1|||
146691630|NCT03245008|529048771|FG000|Overall Study|Lack of Efficacy|0|||
146691631|NCT03245008|529048772|FG001|Overall Study|Lack of Efficacy|1|||
146691632|NCT03245008|529048773|FG002|Overall Study|Lack of Efficacy|0|||
146691633|NCT03245008|529048774|FG003|Overall Study|Lack of Efficacy|0|||
146691634|NCT03245008|529048775|FG004|Overall Study|Lack of Efficacy|0|||
146691635|NCT03245008|529048771|FG000|Overall Study|Lost to Follow-up|4|||
146691636|NCT03245008|529048772|FG001|Overall Study|Lost to Follow-up|1|||
146691637|NCT03245008|529048773|FG002|Overall Study|Lost to Follow-up|0|||
146691638|NCT03245008|529048774|FG003|Overall Study|Lost to Follow-up|0|||
146691639|NCT03245008|529048775|FG004|Overall Study|Lost to Follow-up|1|||
146691640|NCT03245008|529048771|FG000|Overall Study|Physician Decision|1|||
146691641|NCT03245008|529048772|FG001|Overall Study|Physician Decision|3|||
146691642|NCT03245008|529048773|FG002|Overall Study|Physician Decision|4|||
146691643|NCT03245008|529048774|FG003|Overall Study|Physician Decision|0|||
146691644|NCT03245008|529048775|FG004|Overall Study|Physician Decision|0|||
146691645|NCT03245008|529048771|FG000|Overall Study|Protocol Violation|0|||
146691646|NCT03245008|529048772|FG001|Overall Study|Protocol Violation|1|||
146691647|NCT03245008|529048773|FG002|Overall Study|Protocol Violation|0|||
146691648|NCT03245008|529048774|FG003|Overall Study|Protocol Violation|0|||
146691649|NCT03245008|529048775|FG004|Overall Study|Protocol Violation|0|||
146691650|NCT03245008|529048771|FG000|Overall Study|Withdrawal by Subject|20|||
146691651|NCT03245008|529048772|FG001|Overall Study|Withdrawal by Subject|19|||
146691652|NCT03245008|529048773|FG002|Overall Study|Withdrawal by Subject|11|||
146691653|NCT03245008|529048774|FG003|Overall Study|Withdrawal by Subject|0|||
146691654|NCT03245008|529048775|FG004|Overall Study|Withdrawal by Subject|0|||
146691655|NCT03245008|529048771|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
146691656|NCT03245008|529048772|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
146691657|NCT03245008|529048773|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
146691658|NCT03245008|529048774|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
146691659|NCT03245008|529048775|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
146691660|NCT03245008|529048771|FG000|Overall Study|Failure to meet randomization criteria|0|||
146691661|NCT03245008|529048772|FG001|Overall Study|Failure to meet randomization criteria|1|||
146691662|NCT03245008|529048773|FG002|Overall Study|Failure to meet randomization criteria|0|||
146691663|NCT03245008|529048774|FG003|Overall Study|Failure to meet randomization criteria|1|||
146691664|NCT03245008|529048775|FG004|Overall Study|Failure to meet randomization criteria|0|||
146691665|NCT02075658|529048776|FG000|Overall Study|Physician Decision|2|||
146691666|NCT02075658|529048777|FG001|Overall Study|Physician Decision|2|||
146691667|NCT01286012|529048778|FG000|Overall Study|Adverse Event|3|||
146691668|NCT01286012|529048779|FG001|Overall Study|Adverse Event|3|||
146691669|NCT01286012|529048778|FG000|Overall Study|Death|2|||
146691670|NCT01286012|529048779|FG001|Overall Study|Death|3|||
146691671|NCT01286012|529048778|FG000|Overall Study|Protocol Violation|1|||
146691672|NCT01286012|529048779|FG001|Overall Study|Protocol Violation|1|||
146691673|NCT01286012|529048778|FG000|Overall Study|Withdrawal by Subject|4|||
146691674|NCT01286012|529048779|FG001|Overall Study|Withdrawal by Subject|4|||
146691675|NCT01286012|529048778|FG000|Overall Study|Physician Decision|2|||
146691676|NCT01286012|529048779|FG001|Overall Study|Physician Decision|0|||
146691677|NCT01286012|529048778|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
146691678|NCT01286012|529048779|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
146691679|NCT01602380|529048783|FG000|Overall Study|Death|147|||
146691680|NCT01602380|529048784|FG001|Overall Study|Death|145|||
146691681|NCT01602380|529048783|FG000|Overall Study|Withdrawal by Subject|39|||
146691682|NCT01602380|529048784|FG001|Overall Study|Withdrawal by Subject|41|||
146691683|NCT01602380|529048783|FG000|Overall Study|Lost to Follow-up|15|||
146691684|NCT01602380|529048784|FG001|Overall Study|Lost to Follow-up|12|||
146691685|NCT01602380|529048783|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
146691686|NCT01602380|529048784|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
146691687|NCT01602380|529048783|FG000|Overall Study|Other|2|||
146691688|NCT01602380|529048784|FG001|Overall Study|Other|0|||
146691689|NCT04475588|529050720|FG000|Overall Study|Adverse Event|2|||
146691690|NCT04475588|529050721|FG001|Overall Study|Adverse Event|0|||
146691691|NCT01327300|529050722|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
146691692|NCT01327300|529050723|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
146691693|NCT03020823|529050724|FG000|Overall Study|Physician Decision|4|||
146691694|NCT03020823|529050724|FG000|Overall Study|Lack of Efficacy|4|||
146691695|NCT03020823|529050724|FG000|Overall Study|Adverse Event|2|||
146691696|NCT03739112|529050726|FG000|Overall Study|Adverse Event|2|||
146691697|NCT03739112|529050727|FG001|Overall Study|Adverse Event|2|||
146691698|NCT03739112|529050726|FG000|Overall Study|Withdrawal by Subject|38|||
146691699|NCT03739112|529050727|FG001|Overall Study|Withdrawal by Subject|19|||
146691700|NCT03739112|529050726|FG000|Overall Study|Lost to Follow-up|31|||
146691701|NCT03739112|529050727|FG001|Overall Study|Lost to Follow-up|33|||
146691702|NCT03739112|529050726|FG000|Overall Study|Protocol Deviation|12|||
146691703|NCT03739112|529050727|FG001|Overall Study|Protocol Deviation|9|||
146691704|NCT03739112|529050726|FG000|Overall Study|Physician Decision|1|||
146691705|NCT03739112|529050727|FG001|Overall Study|Physician Decision|0|||
146691706|NCT03739112|529050726|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
146691707|NCT03739112|529050727|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
146691708|NCT03739112|529050726|FG000|Overall Study|Site went on hold|65|||
146691709|NCT03739112|529050727|FG001|Overall Study|Site went on hold|67|||
146691710|NCT03739112|529050726|FG000|Overall Study|Other than specified|8|||
146691711|NCT03739112|529050727|FG001|Overall Study|Other than specified|5|||
146691712|NCT03739112|529050726|FG000|Overall Study|Randomized but not vaccinated|31|||
146691713|NCT03739112|529050727|FG001|Overall Study|Randomized but not vaccinated|25|||
146691714|NCT00588822|529050728|FG000|Overall Study|progression of disease|8|||
146691715|NCT04762680|529050730|FG000|Phase 2|Adverse Event|0|||
146691716|NCT04762680|529050731|FG001|Phase 2|Adverse Event|1|||
146691717|NCT04762680|529050732|FG002|Phase 2|Adverse Event|0|||
146691718|NCT04762680|529050733|FG003|Phase 2|Adverse Event|0|||
146691719|NCT04762680|529050734|FG004|Phase 2|Adverse Event|0|||
146691720|NCT04762680|529050735|FG005|Phase 2|Adverse Event|0|||
146691721|NCT04762680|529050736|FG006|Phase 2|Adverse Event|0|||
146691722|NCT04762680|529050737|FG007|Phase 2|Adverse Event|0|||
146691723|NCT04762680|529050738|FG008|Phase 2|Adverse Event|0|||
146691724|NCT04762680|529050739|FG009|Phase 2|Adverse Event|0|||
146691725|NCT04762680|529050740|FG010|Phase 2|Adverse Event|0|||
146691726|NCT04762680|529050741|FG011|Phase 2|Adverse Event|0|||
146691727|NCT04762680|529050742|FG012|Phase 2|Adverse Event|0|||
146691728|NCT04762680|529050743|FG013|Phase 2|Adverse Event|0|||
146691729|NCT04762680|529050744|FG014|Phase 2|Adverse Event|0|||
146691730|NCT04762680|529050745|FG015|Phase 2|Adverse Event|0|||
146691731|NCT04762680|529050746|FG016|Phase 2|Adverse Event|0|||
146691732|NCT04762680|529050747|FG017|Phase 2|Adverse Event|0|||
146691733|NCT04762680|529050748|FG018|Phase 2|Adverse Event|0|||
146691734|NCT04762680|529050749|FG019|Phase 2|Adverse Event|0|||
146691735|NCT04762680|529050750|FG020|Phase 2|Adverse Event|0|||
146691736|NCT04762680|529050751|FG021|Phase 2|Adverse Event|0|||
146691737|NCT04762680|529050730|FG000|Phase 2|Protocol Violation|5|||
146691738|NCT04762680|529050731|FG001|Phase 2|Protocol Violation|5|||
146691739|NCT04762680|529050732|FG002|Phase 2|Protocol Violation|1|||
146691740|NCT04762680|529050733|FG003|Phase 2|Protocol Violation|0|||
146691741|NCT04762680|529050734|FG004|Phase 2|Protocol Violation|0|||
146691742|NCT04762680|529050735|FG005|Phase 2|Protocol Violation|0|||
146691743|NCT04762680|529050736|FG006|Phase 2|Protocol Violation|0|||
146691744|NCT04762680|529050737|FG007|Phase 2|Protocol Violation|0|||
146691745|NCT04762680|529050738|FG008|Phase 2|Protocol Violation|0|||
146691746|NCT04762680|529050739|FG009|Phase 2|Protocol Violation|0|||
146691747|NCT04762680|529050740|FG010|Phase 2|Protocol Violation|0|||
146691748|NCT04762680|529050741|FG011|Phase 2|Protocol Violation|0|||
146691749|NCT04762680|529050742|FG012|Phase 2|Protocol Violation|0|||
146775567|NCT04788641|529349555|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
146775568|NCT01250769|529349556|FG000|Overall Study|Withdrawal by Subject|0|||
146691750|NCT04762680|529050743|FG013|Phase 2|Protocol Violation|0|||
146691751|NCT04762680|529050744|FG014|Phase 2|Protocol Violation|0|||
146691752|NCT04762680|529050745|FG015|Phase 2|Protocol Violation|0|||
146691753|NCT04762680|529050746|FG016|Phase 2|Protocol Violation|0|||
146691754|NCT04762680|529050747|FG017|Phase 2|Protocol Violation|0|||
146691755|NCT04762680|529050748|FG018|Phase 2|Protocol Violation|0|||
146775569|NCT01250769|529349557|FG001|Overall Study|Withdrawal by Subject|1|||
146691756|NCT04762680|529050749|FG019|Phase 2|Protocol Violation|0|||
146691757|NCT04762680|529050750|FG020|Phase 2|Protocol Violation|0|||
146691758|NCT04762680|529050751|FG021|Phase 2|Protocol Violation|0|||
146691759|NCT04762680|529050730|FG000|Phase 2|Withdrawal by Subject|23|||
146691760|NCT04762680|529050731|FG001|Phase 2|Withdrawal by Subject|21|||
146691761|NCT04762680|529050732|FG002|Phase 2|Withdrawal by Subject|28|||
146691762|NCT04762680|529050733|FG003|Phase 2|Withdrawal by Subject|0|||
146691763|NCT04762680|529050734|FG004|Phase 2|Withdrawal by Subject|0|||
146691764|NCT04762680|529050735|FG005|Phase 2|Withdrawal by Subject|0|||
146691765|NCT04762680|529050736|FG006|Phase 2|Withdrawal by Subject|0|||
146691766|NCT04762680|529050737|FG007|Phase 2|Withdrawal by Subject|0|||
146691767|NCT04762680|529050738|FG008|Phase 2|Withdrawal by Subject|0|||
146691768|NCT04762680|529050739|FG009|Phase 2|Withdrawal by Subject|0|||
146691769|NCT04762680|529050740|FG010|Phase 2|Withdrawal by Subject|0|||
146691770|NCT04762680|529050741|FG011|Phase 2|Withdrawal by Subject|0|||
146691771|NCT04762680|529050742|FG012|Phase 2|Withdrawal by Subject|0|||
146691772|NCT04762680|529050743|FG013|Phase 2|Withdrawal by Subject|0|||
146691773|NCT04762680|529050744|FG014|Phase 2|Withdrawal by Subject|0|||
146691774|NCT04762680|529050745|FG015|Phase 2|Withdrawal by Subject|0|||
146691775|NCT04762680|529050746|FG016|Phase 2|Withdrawal by Subject|0|||
146691776|NCT04762680|529050747|FG017|Phase 2|Withdrawal by Subject|0|||
146691777|NCT04762680|529050748|FG018|Phase 2|Withdrawal by Subject|0|||
146691778|NCT04762680|529050749|FG019|Phase 2|Withdrawal by Subject|0|||
146691779|NCT04762680|529050750|FG020|Phase 2|Withdrawal by Subject|0|||
146691780|NCT04762680|529050751|FG021|Phase 2|Withdrawal by Subject|0|||
146691781|NCT04762680|529050730|FG000|Phase 2|Lost to Follow-up|14|||
146691782|NCT04762680|529050731|FG001|Phase 2|Lost to Follow-up|8|||
146691783|NCT04762680|529050732|FG002|Phase 2|Lost to Follow-up|9|||
146691784|NCT04762680|529050733|FG003|Phase 2|Lost to Follow-up|0|||
146691785|NCT04762680|529050734|FG004|Phase 2|Lost to Follow-up|0|||
146691786|NCT04762680|529050735|FG005|Phase 2|Lost to Follow-up|0|||
146691787|NCT04762680|529050736|FG006|Phase 2|Lost to Follow-up|0|||
146691788|NCT04762680|529050737|FG007|Phase 2|Lost to Follow-up|0|||
146691789|NCT04762680|529050738|FG008|Phase 2|Lost to Follow-up|0|||
146691790|NCT04762680|529050739|FG009|Phase 2|Lost to Follow-up|0|||
146691791|NCT04762680|529050740|FG010|Phase 2|Lost to Follow-up|0|||
146691792|NCT04762680|529050741|FG011|Phase 2|Lost to Follow-up|0|||
146691793|NCT04762680|529050742|FG012|Phase 2|Lost to Follow-up|0|||
146691794|NCT04762680|529050743|FG013|Phase 2|Lost to Follow-up|0|||
146691795|NCT04762680|529050744|FG014|Phase 2|Lost to Follow-up|0|||
146691796|NCT04762680|529050745|FG015|Phase 2|Lost to Follow-up|0|||
146691797|NCT04762680|529050746|FG016|Phase 2|Lost to Follow-up|0|||
146691798|NCT04762680|529050747|FG017|Phase 2|Lost to Follow-up|0|||
146691799|NCT04762680|529050748|FG018|Phase 2|Lost to Follow-up|0|||
146691800|NCT04762680|529050749|FG019|Phase 2|Lost to Follow-up|0|||
146691801|NCT04762680|529050750|FG020|Phase 2|Lost to Follow-up|0|||
146691802|NCT04762680|529050751|FG021|Phase 2|Lost to Follow-up|0|||
146691803|NCT04762680|529050730|FG000|Phase 3|Adverse Event|0|||
146691804|NCT04762680|529050731|FG001|Phase 3|Adverse Event|0|||
146691805|NCT04762680|529050732|FG002|Phase 3|Adverse Event|0|||
146691806|NCT04762680|529050733|FG003|Phase 3|Adverse Event|1|||
146691807|NCT04762680|529050734|FG004|Phase 3|Adverse Event|0|||
146691808|NCT04762680|529050735|FG005|Phase 3|Adverse Event|0|||
146691809|NCT04762680|529050736|FG006|Phase 3|Adverse Event|0|||
146691810|NCT04762680|529050737|FG007|Phase 3|Adverse Event|0|||
146691811|NCT04762680|529050738|FG008|Phase 3|Adverse Event|0|||
146691812|NCT04762680|529050739|FG009|Phase 3|Adverse Event|0|||
146691813|NCT04762680|529050740|FG010|Phase 3|Adverse Event|0|||
146691814|NCT04762680|529050741|FG011|Phase 3|Adverse Event|0|||
146691815|NCT04762680|529050742|FG012|Phase 3|Adverse Event|0|||
146691816|NCT04762680|529050743|FG013|Phase 3|Adverse Event|0|||
146691817|NCT04762680|529050744|FG014|Phase 3|Adverse Event|0|||
146691818|NCT04762680|529050745|FG015|Phase 3|Adverse Event|0|||
146691819|NCT04762680|529050746|FG016|Phase 3|Adverse Event|0|||
146691820|NCT04762680|529050747|FG017|Phase 3|Adverse Event|3|||
146691821|NCT04762680|529050748|FG018|Phase 3|Adverse Event|0|||
146691822|NCT04762680|529050749|FG019|Phase 3|Adverse Event|0|||
146691823|NCT04762680|529050750|FG020|Phase 3|Adverse Event|0|||
146691824|NCT04762680|529050751|FG021|Phase 3|Adverse Event|0|||
146691825|NCT04762680|529050730|FG000|Phase 3|Protocol Violation|0|||
146691826|NCT04762680|529050731|FG001|Phase 3|Protocol Violation|0|||
146691827|NCT04762680|529050732|FG002|Phase 3|Protocol Violation|0|||
146691828|NCT04762680|529050733|FG003|Phase 3|Protocol Violation|4|||
146691829|NCT04762680|529050734|FG004|Phase 3|Protocol Violation|1|||
146691830|NCT04762680|529050735|FG005|Phase 3|Protocol Violation|5|||
146691831|NCT04762680|529050736|FG006|Phase 3|Protocol Violation|1|||
146691832|NCT04762680|529050737|FG007|Phase 3|Protocol Violation|0|||
146691833|NCT04762680|529050738|FG008|Phase 3|Protocol Violation|0|||
146691834|NCT04762680|529050739|FG009|Phase 3|Protocol Violation|0|||
146691835|NCT04762680|529050740|FG010|Phase 3|Protocol Violation|0|||
146691836|NCT04762680|529050741|FG011|Phase 3|Protocol Violation|2|||
146691837|NCT04762680|529050742|FG012|Phase 3|Protocol Violation|3|||
146691838|NCT04762680|529050743|FG013|Phase 3|Protocol Violation|0|||
146691839|NCT04762680|529050744|FG014|Phase 3|Protocol Violation|0|||
146691840|NCT04762680|529050745|FG015|Phase 3|Protocol Violation|1|||
146691841|NCT04762680|529050746|FG016|Phase 3|Protocol Violation|0|||
146691842|NCT04762680|529050747|FG017|Phase 3|Protocol Violation|10|||
146691843|NCT04762680|529050748|FG018|Phase 3|Protocol Violation|0|||
146691844|NCT04762680|529050749|FG019|Phase 3|Protocol Violation|0|||
146691845|NCT04762680|529050750|FG020|Phase 3|Protocol Violation|0|||
146691846|NCT04762680|529050751|FG021|Phase 3|Protocol Violation|0|||
146691847|NCT04762680|529050730|FG000|Phase 3|Withdrawal by Subject|0|||
146691848|NCT04762680|529050731|FG001|Phase 3|Withdrawal by Subject|0|||
146691849|NCT04762680|529050732|FG002|Phase 3|Withdrawal by Subject|0|||
146691850|NCT04762680|529050733|FG003|Phase 3|Withdrawal by Subject|13|||
146979872|NCT00950599|530089453|FG005|Follow-Up Period|Poor/Noncompliance|0|||
146979873|NCT00950599|530089454|FG006|Follow-Up Period|Poor/Noncompliance|0|||
146979874|NCT00950599|530089455|FG007|Follow-Up Period|Poor/Noncompliance|0|||
146979875|NCT00950599|530089456|FG008|Follow-Up Period|Poor/Noncompliance|1|||
146979876|NCT00950599|530089457|FG009|Follow-Up Period|Poor/Noncompliance|0|||
146979877|NCT00950599|530089448|FG000|Follow-Up Period|Subject withdrew Consent|0|||
146979878|NCT00950599|530089449|FG001|Follow-Up Period|Subject withdrew Consent|0|||
146979879|NCT00950599|530089450|FG002|Follow-Up Period|Subject withdrew Consent|0|||
146979880|NCT00950599|530089451|FG003|Follow-Up Period|Subject withdrew Consent|0|||
146979881|NCT00950599|530089452|FG004|Follow-Up Period|Subject withdrew Consent|0|||
146979882|NCT00950599|530089453|FG005|Follow-Up Period|Subject withdrew Consent|0|||
146979883|NCT00950599|530089454|FG006|Follow-Up Period|Subject withdrew Consent|0|||
146979884|NCT00950599|530089455|FG007|Follow-Up Period|Subject withdrew Consent|0|||
146979885|NCT00950599|530089456|FG008|Follow-Up Period|Subject withdrew Consent|2|||
146979886|NCT00950599|530089457|FG009|Follow-Up Period|Subject withdrew Consent|1|||
146979887|NCT01684722|530089458|FG000|Overall Study|Lost to Follow-up|78|||
146979888|NCT01684722|530089459|FG001|Overall Study|Lost to Follow-up|56|||
146979889|NCT01684722|530089460|FG002|Overall Study|Lost to Follow-up|75|||
146979890|NCT01684722|530089461|FG003|Overall Study|Lost to Follow-up|89|||
146979891|NCT01684722|530089458|FG000|Overall Study|Death|19|||
146979892|NCT01684722|530089459|FG001|Overall Study|Death|21|||
146979893|NCT01684722|530089460|FG002|Overall Study|Death|19|||
146979894|NCT01684722|530089461|FG003|Overall Study|Death|21|||
146979895|NCT02741271|530089470|FG000|Overall Study|Lost to Follow-up|2|||
146979896|NCT02741271|530089471|FG001|Overall Study|Lost to Follow-up|0|||
146979897|NCT02741271|530089470|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146979898|NCT02741271|530089471|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
146979899|NCT03652961|530089472|FG000|Overall Study|Lost to Follow-up|3|||
146979900|NCT03652961|530089472|FG000|Overall Study|Screen Failure|1|||
146979901|NCT00410410|530089473|FG000|Induction Period (IP)|Death|1|||
146979902|NCT00410410|530089474|FG001|Induction Period (IP)|Death|0|||
146979903|NCT00410410|530089475|FG002|Induction Period (IP)|Death|0|||
146979904|NCT00410410|530089476|FG003|Induction Period (IP)|Death|0|||
146979905|NCT00410410|530089477|FG004|Induction Period (IP)|Death|0|||
146979906|NCT00410410|530089478|FG005|Induction Period (IP)|Death|0|||
146979907|NCT00410410|530089479|FG006|Induction Period (IP)|Death|0|||
146979908|NCT00410410|530089480|FG007|Induction Period (IP)|Death|0|||
146979909|NCT00410410|530089481|FG008|Induction Period (IP)|Death|0|||
146979910|NCT00410410|530089473|FG000|Induction Period (IP)|Adverse Event|3|||
146979911|NCT00410410|530089474|FG001|Induction Period (IP)|Adverse Event|4|||
146979912|NCT00410410|530089475|FG002|Induction Period (IP)|Adverse Event|2|||
146979913|NCT00410410|530089476|FG003|Induction Period (IP)|Adverse Event|4|||
146691851|NCT04762680|529050734|FG004|Phase 3|Withdrawal by Subject|17|||
146691852|NCT04762680|529050735|FG005|Phase 3|Withdrawal by Subject|12|||
146691853|NCT04762680|529050736|FG006|Phase 3|Withdrawal by Subject|8|||
146691854|NCT04762680|529050737|FG007|Phase 3|Withdrawal by Subject|3|||
146691855|NCT04762680|529050738|FG008|Phase 3|Withdrawal by Subject|2|||
146691856|NCT04762680|529050739|FG009|Phase 3|Withdrawal by Subject|4|||
146691857|NCT04762680|529050740|FG010|Phase 3|Withdrawal by Subject|3|||
146691858|NCT04762680|529050741|FG011|Phase 3|Withdrawal by Subject|1|||
146691859|NCT04762680|529050742|FG012|Phase 3|Withdrawal by Subject|3|||
146691860|NCT04762680|529050743|FG013|Phase 3|Withdrawal by Subject|2|||
146691861|NCT04762680|529050744|FG014|Phase 3|Withdrawal by Subject|1|||
146691862|NCT04762680|529050745|FG015|Phase 3|Withdrawal by Subject|4|||
146691863|NCT04762680|529050746|FG016|Phase 3|Withdrawal by Subject|6|||
146691864|NCT04762680|529050747|FG017|Phase 3|Withdrawal by Subject|32|||
146691865|NCT04762680|529050748|FG018|Phase 3|Withdrawal by Subject|0|||
146691866|NCT04762680|529050749|FG019|Phase 3|Withdrawal by Subject|0|||
146691867|NCT04762680|529050750|FG020|Phase 3|Withdrawal by Subject|0|||
146691868|NCT04762680|529050751|FG021|Phase 3|Withdrawal by Subject|0|||
146691869|NCT04762680|529050730|FG000|Phase 3|Lost to Follow-up|0|||
146979914|NCT00410410|530089477|FG004|Induction Period (IP)|Adverse Event|1|||
146979915|NCT00410410|530089478|FG005|Induction Period (IP)|Adverse Event|0|||
146979916|NCT00410410|530089479|FG006|Induction Period (IP)|Adverse Event|0|||
146979917|NCT00410410|530089480|FG007|Induction Period (IP)|Adverse Event|0|||
146979918|NCT00410410|530089481|FG008|Induction Period (IP)|Adverse Event|0|||
146979919|NCT00410410|530089473|FG000|Induction Period (IP)|Lack of Efficacy|26|||
146979920|NCT00410410|530089474|FG001|Induction Period (IP)|Lack of Efficacy|24|||
146691870|NCT04762680|529050731|FG001|Phase 3|Lost to Follow-up|0|||
146691871|NCT04762680|529050732|FG002|Phase 3|Lost to Follow-up|0|||
146691872|NCT04762680|529050733|FG003|Phase 3|Lost to Follow-up|9|||
146691873|NCT04762680|529050734|FG004|Phase 3|Lost to Follow-up|22|||
146979921|NCT00410410|530089475|FG002|Induction Period (IP)|Lack of Efficacy|8|||
146979922|NCT00410410|530089476|FG003|Induction Period (IP)|Lack of Efficacy|8|||
146979923|NCT00410410|530089477|FG004|Induction Period (IP)|Lack of Efficacy|7|||
146691874|NCT04762680|529050735|FG005|Phase 3|Lost to Follow-up|24|||
146979924|NCT00410410|530089478|FG005|Induction Period (IP)|Lack of Efficacy|7|||
146979925|NCT00410410|530089479|FG006|Induction Period (IP)|Lack of Efficacy|0|||
146979926|NCT00410410|530089480|FG007|Induction Period (IP)|Lack of Efficacy|0|||
146691875|NCT04762680|529050736|FG006|Phase 3|Lost to Follow-up|2|||
146691876|NCT04762680|529050737|FG007|Phase 3|Lost to Follow-up|4|||
146691877|NCT04762680|529050738|FG008|Phase 3|Lost to Follow-up|6|||
146691878|NCT04762680|529050739|FG009|Phase 3|Lost to Follow-up|4|||
146691879|NCT04762680|529050740|FG010|Phase 3|Lost to Follow-up|3|||
146691880|NCT04762680|529050741|FG011|Phase 3|Lost to Follow-up|0|||
146691881|NCT04762680|529050742|FG012|Phase 3|Lost to Follow-up|5|||
146691882|NCT04762680|529050743|FG013|Phase 3|Lost to Follow-up|4|||
146691883|NCT04762680|529050744|FG014|Phase 3|Lost to Follow-up|6|||
146691884|NCT04762680|529050745|FG015|Phase 3|Lost to Follow-up|1|||
146691885|NCT04762680|529050746|FG016|Phase 3|Lost to Follow-up|1|||
146691886|NCT04762680|529050747|FG017|Phase 3|Lost to Follow-up|66|||
146691887|NCT04762680|529050748|FG018|Phase 3|Lost to Follow-up|0|||
146691888|NCT04762680|529050749|FG019|Phase 3|Lost to Follow-up|0|||
146691889|NCT04762680|529050750|FG020|Phase 3|Lost to Follow-up|0|||
146691890|NCT04762680|529050751|FG021|Phase 3|Lost to Follow-up|0|||
146691891|NCT04762680|529050730|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146775570|NCT01250769|529349558|FG002|Overall Study|Withdrawal by Subject|1|||
146775571|NCT01250769|529349559|FG003|Overall Study|Withdrawal by Subject|0|||
146775572|NCT01250769|529349556|FG000|Overall Study|Adverse Event|0|||
146775573|NCT01250769|529349557|FG001|Overall Study|Adverse Event|0|||
146775574|NCT01250769|529349558|FG002|Overall Study|Adverse Event|1|||
146775575|NCT01250769|529349559|FG003|Overall Study|Adverse Event|0|||
146775576|NCT03283371|529349560|FG000|Placebo-controlled|Adverse Event|1|||
146775577|NCT03283371|529349561|FG001|Placebo-controlled|Adverse Event|1|||
146775578|NCT03283371|529349562|FG002|Placebo-controlled|Adverse Event|0|||
146775579|NCT03283371|529349563|FG003|Placebo-controlled|Adverse Event|0|||
146691892|NCT04762680|529050731|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691893|NCT04762680|529050732|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691894|NCT04762680|529050733|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691895|NCT04762680|529050734|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146775580|NCT03283371|529349560|FG000|Placebo-controlled|Lack of Efficacy|1|||
146775581|NCT03283371|529349561|FG001|Placebo-controlled|Lack of Efficacy|0|||
146691896|NCT04762680|529050735|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691897|NCT04762680|529050736|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691898|NCT04762680|529050737|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691899|NCT04762680|529050738|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691900|NCT04762680|529050739|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691901|NCT04762680|529050740|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691902|NCT04762680|529050741|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691903|NCT04762680|529050742|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691904|NCT04762680|529050743|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691905|NCT04762680|529050744|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691906|NCT04762680|529050745|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691907|NCT04762680|529050746|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691908|NCT04762680|529050747|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691909|NCT04762680|529050748|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691910|NCT04762680|529050749|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691911|NCT04762680|529050750|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146691912|NCT04762680|529050751|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
146691913|NCT04762680|529050730|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691914|NCT04762680|529050731|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691915|NCT04762680|529050732|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
146775582|NCT03283371|529349562|FG002|Placebo-controlled|Lack of Efficacy|0|||
146775583|NCT03283371|529349563|FG003|Placebo-controlled|Lack of Efficacy|0|||
146775584|NCT03283371|529349560|FG000|Placebo-controlled|Withdrawal by Subject|1|||
146775585|NCT03283371|529349561|FG001|Placebo-controlled|Withdrawal by Subject|1|||
146775586|NCT03283371|529349562|FG002|Placebo-controlled|Withdrawal by Subject|0|||
146775587|NCT03283371|529349563|FG003|Placebo-controlled|Withdrawal by Subject|0|||
146775588|NCT03283371|529349560|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
146775589|NCT03283371|529349561|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
146775590|NCT03283371|529349562|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
146775591|NCT03283371|529349563|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
146691916|NCT04762680|529050733|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691917|NCT04762680|529050734|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691918|NCT04762680|529050735|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691919|NCT04762680|529050736|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691920|NCT04762680|529050737|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691921|NCT04762680|529050738|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691922|NCT04762680|529050739|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691923|NCT04762680|529050740|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691924|NCT04762680|529050741|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
146775592|NCT03283371|529349560|FG000|Open-label Phase|Adverse Event|0|||
146775593|NCT03283371|529349561|FG001|Open-label Phase|Adverse Event|0|||
146775594|NCT03283371|529349562|FG002|Open-label Phase|Adverse Event|2|||
146775595|NCT03283371|529349563|FG003|Open-label Phase|Adverse Event|0|||
146775596|NCT03283371|529349560|FG000|Open-label Phase|Withdrawal by Subject|0|||
146979927|NCT00410410|530089481|FG008|Induction Period (IP)|Lack of Efficacy|0|||
146979928|NCT00410410|530089473|FG000|Induction Period (IP)|Lost to Follow-up|2|||
146691925|NCT04762680|529050742|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691926|NCT04762680|529050743|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691927|NCT04762680|529050744|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691928|NCT04762680|529050745|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691929|NCT04762680|529050746|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691930|NCT04762680|529050747|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691931|NCT04762680|529050748|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
146691932|NCT04762680|529050749|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
146691933|NCT04762680|529050750|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
146775597|NCT03283371|529349561|FG001|Open-label Phase|Withdrawal by Subject|0|||
146775598|NCT03283371|529349562|FG002|Open-label Phase|Withdrawal by Subject|1|||
146929750|NCT01925612|529900876|FG003|Overall Study|Progressive Disease|0|||
146929751|NCT01925612|529900877|FG004|Overall Study|Progressive Disease|0|||
146929752|NCT01925612|529900873|FG000|Overall Study|Adverse Event|3|||
146929753|NCT01925612|529900874|FG001|Overall Study|Adverse Event|3|||
146929754|NCT01925612|529900875|FG002|Overall Study|Adverse Event|0|||
146929755|NCT01925612|529900876|FG003|Overall Study|Adverse Event|1|||
146929756|NCT01925612|529900877|FG004|Overall Study|Adverse Event|2|||
146929757|NCT01610076|529900878|FG000|Overall Study|Technical issue with video|0|||
146929758|NCT01610076|529900879|FG001|Overall Study|Technical issue with video|1|||
146929759|NCT01610076|529900878|FG000|Overall Study|Lost to Follow-up|3|||
146929760|NCT01610076|529900879|FG001|Overall Study|Lost to Follow-up|4|||
146929761|NCT01895452|529900883|FG000|Overall Study|Adverse Event|1|||
146929762|NCT01895452|529900884|FG001|Overall Study|Adverse Event|4|||
146929763|NCT01895452|529900883|FG000|Overall Study|Lost to Follow-up|1|||
146929764|NCT01895452|529900884|FG001|Overall Study|Lost to Follow-up|5|||
146929765|NCT01895452|529900883|FG000|Overall Study|Pregnancy|0|||
146929766|NCT01895452|529900884|FG001|Overall Study|Pregnancy|1|||
146929767|NCT01895452|529900883|FG000|Overall Study|Withdrawal by Subject|2|||
146929768|NCT01895452|529900884|FG001|Overall Study|Withdrawal by Subject|14|||
146929769|NCT01895452|529900883|FG000|Overall Study|Underlying disease|0|||
146929770|NCT01895452|529900884|FG001|Overall Study|Underlying disease|3|||
146929771|NCT01895452|529900883|FG000|Overall Study|Noncompliance with study drug|0|||
146929772|NCT01895452|529900884|FG001|Overall Study|Noncompliance with study drug|1|||
146929773|NCT01653158|529900885|FG000|Overall Study|Death|0|||
146929774|NCT01653158|529900886|FG001|Overall Study|Death|0|||
146929775|NCT01653158|529900887|FG002|Overall Study|Death|0|||
146929776|NCT01653158|529900888|FG003|Overall Study|Death|1|||
146929777|NCT01653158|529900889|FG004|Overall Study|Death|0|||
146929778|NCT01653158|529900890|FG005|Overall Study|Death|0|||
146929779|NCT01653158|529900891|FG006|Overall Study|Death|0|||
146929780|NCT01653158|529900892|FG007|Overall Study|Death|2|||
146929781|NCT01653158|529900885|FG000|Overall Study|Adverse Event|0|||
146929782|NCT01653158|529900886|FG001|Overall Study|Adverse Event|0|||
146929783|NCT01653158|529900887|FG002|Overall Study|Adverse Event|0|||
146929784|NCT01653158|529900888|FG003|Overall Study|Adverse Event|1|||
146929785|NCT01653158|529900889|FG004|Overall Study|Adverse Event|0|||
146929786|NCT01653158|529900890|FG005|Overall Study|Adverse Event|0|||
146929787|NCT01653158|529900891|FG006|Overall Study|Adverse Event|0|||
146929788|NCT01653158|529900892|FG007|Overall Study|Adverse Event|3|||
146929789|NCT01653158|529900885|FG000|Overall Study|Other|0|||
146929790|NCT01653158|529900886|FG001|Overall Study|Other|0|||
146929791|NCT01653158|529900887|FG002|Overall Study|Other|0|||
146929792|NCT01653158|529900888|FG003|Overall Study|Other|0|||
146929793|NCT01653158|529900889|FG004|Overall Study|Other|0|||
146929794|NCT01653158|529900890|FG005|Overall Study|Other|0|||
146929795|NCT01653158|529900891|FG006|Overall Study|Other|0|||
146979929|NCT00410410|530089474|FG001|Induction Period (IP)|Lost to Follow-up|2|||
146691934|NCT04762680|529050751|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
146929796|NCT01653158|529900892|FG007|Overall Study|Other|1|||
146929797|NCT01653158|529900885|FG000|Overall Study|Progressive disease|0|||
146929798|NCT01653158|529900886|FG001|Overall Study|Progressive disease|0|||
146929799|NCT01653158|529900887|FG002|Overall Study|Progressive disease|0|||
146929800|NCT01653158|529900888|FG003|Overall Study|Progressive disease|0|||
146929801|NCT01653158|529900889|FG004|Overall Study|Progressive disease|1|||
146929802|NCT01653158|529900890|FG005|Overall Study|Progressive disease|1|||
146929803|NCT01653158|529900891|FG006|Overall Study|Progressive disease|2|||
146929804|NCT01653158|529900892|FG007|Overall Study|Progressive disease|9|||
146929805|NCT01653158|529900885|FG000|Overall Study|Withdrawal by Subject|1|||
146929806|NCT01653158|529900886|FG001|Overall Study|Withdrawal by Subject|0|||
146929807|NCT01653158|529900887|FG002|Overall Study|Withdrawal by Subject|0|||
146929808|NCT01653158|529900888|FG003|Overall Study|Withdrawal by Subject|0|||
146929809|NCT01653158|529900889|FG004|Overall Study|Withdrawal by Subject|0|||
146929810|NCT01653158|529900890|FG005|Overall Study|Withdrawal by Subject|0|||
146929811|NCT01653158|529900891|FG006|Overall Study|Withdrawal by Subject|0|||
146691935|NCT02082210|529050752|FG000|Overall Study|Death|0|||
146929812|NCT01653158|529900892|FG007|Overall Study|Withdrawal by Subject|0|||
146691936|NCT02082210|529050753|FG001|Overall Study|Death|0|||
146691937|NCT02082210|529050754|FG002|Overall Study|Death|1|||
146691938|NCT02082210|529050755|FG003|Overall Study|Death|1|||
146691939|NCT02082210|529050756|FG004|Overall Study|Death|1|||
146691940|NCT02082210|529050757|FG005|Overall Study|Death|0|||
146691941|NCT02082210|529050752|FG000|Overall Study|Withdrawal by Subject|0|||
146691942|NCT02082210|529050753|FG001|Overall Study|Withdrawal by Subject|0|||
146691943|NCT02082210|529050754|FG002|Overall Study|Withdrawal by Subject|0|||
146691944|NCT02082210|529050755|FG003|Overall Study|Withdrawal by Subject|1|||
146691945|NCT02082210|529050756|FG004|Overall Study|Withdrawal by Subject|2|||
146691946|NCT02082210|529050757|FG005|Overall Study|Withdrawal by Subject|2|||
146691947|NCT02082210|529050752|FG000|Overall Study|Clinical Progression|0|||
146691948|NCT02082210|529050753|FG001|Overall Study|Clinical Progression|0|||
146691949|NCT02082210|529050754|FG002|Overall Study|Clinical Progression|0|||
146691950|NCT02082210|529050755|FG003|Overall Study|Clinical Progression|1|||
146691951|NCT02082210|529050756|FG004|Overall Study|Clinical Progression|0|||
146691952|NCT02082210|529050757|FG005|Overall Study|Clinical Progression|0|||
146691953|NCT02082210|529050752|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
146691954|NCT02082210|529050753|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
146691955|NCT02082210|529050754|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
146691956|NCT02082210|529050755|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
146691957|NCT02082210|529050756|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
146691958|NCT02082210|529050757|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
146691959|NCT02082210|529050752|FG000|Overall Study|Physician Decision|0|||
146691960|NCT02082210|529050753|FG001|Overall Study|Physician Decision|0|||
146691961|NCT02082210|529050754|FG002|Overall Study|Physician Decision|1|||
146691962|NCT02082210|529050755|FG003|Overall Study|Physician Decision|1|||
146691963|NCT02082210|529050756|FG004|Overall Study|Physician Decision|0|||
146691964|NCT02082210|529050757|FG005|Overall Study|Physician Decision|0|||
146691965|NCT02436759|529050762|FG000|Overall Study|Adverse Event|3|||
146691966|NCT02436759|529050763|FG001|Overall Study|Adverse Event|0|||
146691967|NCT02436759|529050762|FG000|Overall Study|Protocol Violation|1|||
146691968|NCT02436759|529050763|FG001|Overall Study|Protocol Violation|0|||
146691969|NCT02436759|529050762|FG000|Overall Study|Withdrawal by Subject|0|||
146691970|NCT02436759|529050763|FG001|Overall Study|Withdrawal by Subject|1|||
146691971|NCT01727141|529050764|FG000|Overall Study|Physician Decision|0|||
146691972|NCT01727141|529050765|FG001|Overall Study|Physician Decision|1|||
146691973|NCT01727141|529050766|FG002|Overall Study|Physician Decision|0|||
146691974|NCT01727141|529050767|FG003|Overall Study|Physician Decision|2|||
146691975|NCT01727141|529050764|FG000|Overall Study|Lost to Follow-up|0|||
146691976|NCT01727141|529050765|FG001|Overall Study|Lost to Follow-up|2|||
146691977|NCT01727141|529050766|FG002|Overall Study|Lost to Follow-up|0|||
146691978|NCT01727141|529050767|FG003|Overall Study|Lost to Follow-up|0|||
146691979|NCT01727141|529050764|FG000|Overall Study|Death|0|||
146775599|NCT03283371|529349563|FG003|Open-label Phase|Withdrawal by Subject|0|||
146775600|NCT03283371|529349560|FG000|Open-label Phase|Other|0|||
146775601|NCT03283371|529349561|FG001|Open-label Phase|Other|0|||
146775602|NCT03283371|529349562|FG002|Open-label Phase|Other|1|||
146775603|NCT03283371|529349563|FG003|Open-label Phase|Other|1|||
146775604|NCT00243503|529349564|FG000|Overall Study|Adverse Event|11|||
146775605|NCT00243503|529349564|FG000|Overall Study|Withdrawal by Subject|1|||
146775606|NCT00243503|529349564|FG000|Overall Study|Lack of Efficacy|44|||
146775607|NCT00243503|529349564|FG000|Overall Study|Death|1|||
146775608|NCT00243503|529349564|FG000|Overall Study|Other|1|||
146775609|NCT00914589|529349565|FG000|Overall Study|Adverse Event|1|||
146775610|NCT00914589|529349566|FG001|Overall Study|Adverse Event|0|||
146775611|NCT00914589|529349567|FG002|Overall Study|Adverse Event|1|||
146775612|NCT00914589|529349565|FG000|Overall Study|Protocol Violation|8|||
146775613|NCT00914589|529349566|FG001|Overall Study|Protocol Violation|6|||
146775614|NCT00914589|529349567|FG002|Overall Study|Protocol Violation|3|||
146775615|NCT00914589|529349565|FG000|Overall Study|unclassified|16|||
146775616|NCT00914589|529349566|FG001|Overall Study|unclassified|9|||
146775617|NCT00914589|529349567|FG002|Overall Study|unclassified|7|||
146775618|NCT00914589|529349565|FG000|Overall Study|Death|0|||
146775619|NCT00914589|529349566|FG001|Overall Study|Death|1|||
146775620|NCT00914589|529349567|FG002|Overall Study|Death|1|||
146775621|NCT00093015|529349572|FG000|Overall Study|Withdrawal by Subject|194|||
146775622|NCT00093015|529349573|FG001|Overall Study|Withdrawal by Subject|171|||
146775623|NCT00093015|529349572|FG000|Overall Study|Lost to Follow-up|96|||
146775624|NCT00093015|529349573|FG001|Overall Study|Lost to Follow-up|108|||
146775625|NCT00093015|529349572|FG000|Overall Study|Death|375|||
146929813|NCT00980343|529900893|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
146929814|NCT00980343|529900894|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
146691980|NCT01727141|529050765|FG001|Overall Study|Death|1|||
146691981|NCT01727141|529050766|FG002|Overall Study|Death|1|||
146691982|NCT01727141|529050767|FG003|Overall Study|Death|1|||
146691983|NCT01727141|529050764|FG000|Overall Study|Protocol deviation|1|||
146691984|NCT01727141|529050765|FG001|Overall Study|Protocol deviation|1|||
146775626|NCT00093015|529349573|FG001|Overall Study|Death|385|||
146775627|NCT00296036|529349574|FG000|Overall Study|Withdrawal by Subject|1|||
146691985|NCT01727141|529050766|FG002|Overall Study|Protocol deviation|0|||
146691986|NCT01727141|529050767|FG003|Overall Study|Protocol deviation|1|||
146691987|NCT01727141|529050764|FG000|Overall Study|Withdrawal by Subject|4|||
146691988|NCT01727141|529050765|FG001|Overall Study|Withdrawal by Subject|4|||
146691989|NCT01727141|529050766|FG002|Overall Study|Withdrawal by Subject|2|||
146691990|NCT01727141|529050767|FG003|Overall Study|Withdrawal by Subject|11|||
146691991|NCT02584504|529050768|FG000|Double-blind Treatment|Participant withdrew consent|0|||
146691992|NCT02584504|529050769|FG001|Double-blind Treatment|Participant withdrew consent|0|||
146691993|NCT02584504|529050770|FG002|Double-blind Treatment|Participant withdrew consent|1|||
146691994|NCT02584504|529050768|FG000|Double-blind Treatment|Adverse Event|0|||
146691995|NCT02584504|529050769|FG001|Double-blind Treatment|Adverse Event|1|||
146691996|NCT02584504|529050770|FG002|Double-blind Treatment|Adverse Event|0|||
146691997|NCT02584504|529050768|FG000|Double-blind Treatment|Family Matter|0|||
146691998|NCT02584504|529050769|FG001|Double-blind Treatment|Family Matter|1|||
146691999|NCT02584504|529050770|FG002|Double-blind Treatment|Family Matter|0|||
146692000|NCT02584504|529050768|FG000|Open-label Treatment|Participant withdrew consent|0|||
146692001|NCT02584504|529050769|FG001|Open-label Treatment|Participant withdrew consent|0|||
146692002|NCT02584504|529050770|FG002|Open-label Treatment|Participant withdrew consent|4|||
146692003|NCT02584504|529050768|FG000|Open-label Treatment|Adverse Event|2|||
146692004|NCT02584504|529050769|FG001|Open-label Treatment|Adverse Event|2|||
146692005|NCT02584504|529050770|FG002|Open-label Treatment|Adverse Event|3|||
146692006|NCT02584504|529050768|FG000|Open-label Treatment|Physician Decision|0|||
146692007|NCT02584504|529050769|FG001|Open-label Treatment|Physician Decision|1|||
146692008|NCT02584504|529050770|FG002|Open-label Treatment|Physician Decision|0|||
146692009|NCT02584504|529050768|FG000|Open-label Treatment|Entered but not treated|0|||
146692010|NCT02584504|529050769|FG001|Open-label Treatment|Entered but not treated|1|||
146692011|NCT02584504|529050770|FG002|Open-label Treatment|Entered but not treated|1|||
146692012|NCT00297037|529050773|FG000|Overall Study|Withdrawal by Subject|2|||
146692013|NCT00297037|529050774|FG001|Overall Study|Withdrawal by Subject|0|||
146692014|NCT00581776|529050775|FG000|Overall Study|Disease progression or no response|3|||
146692015|NCT03425331|529050776|FG000|Overall Study|Withdrawal by Subject|1|||
146692016|NCT03425331|529050776|FG000|Overall Study|Death|1|||
146692017|NCT03425331|529050776|FG000|Overall Study|Adverse Event|1|||
146692018|NCT03425331|529050776|FG000|Overall Study|Disease Progression|2|||
146692019|NCT01413360|529050779|FG000|Overall Study|Lost to Follow-up|2|||
146692020|NCT01413360|529050779|FG000|Overall Study|Adverse Event|1|||
146692021|NCT02246673|529050780|FG000|Overall Study|Sponsor Decision|1|||
146692022|NCT02246673|529050781|FG001|Overall Study|Sponsor Decision|0|||
146692023|NCT02246673|529050782|FG002|Overall Study|Sponsor Decision|0|||
146692024|NCT02246673|529050783|FG003|Overall Study|Sponsor Decision|0|||
146692025|NCT02246673|529050784|FG004|Overall Study|Sponsor Decision|0|||
146692026|NCT02246673|529050780|FG000|Overall Study|Withdrawal by Subject|0|||
146692027|NCT02246673|529050781|FG001|Overall Study|Withdrawal by Subject|0|||
146692028|NCT02246673|529050782|FG002|Overall Study|Withdrawal by Subject|0|||
146692029|NCT02246673|529050783|FG003|Overall Study|Withdrawal by Subject|0|||
146692030|NCT02246673|529050784|FG004|Overall Study|Withdrawal by Subject|1|||
146692031|NCT02246673|529050780|FG000|Overall Study|Lost to Follow-up|0|||
146692032|NCT02246673|529050781|FG001|Overall Study|Lost to Follow-up|0|||
146692033|NCT02246673|529050782|FG002|Overall Study|Lost to Follow-up|0|||
146692034|NCT02246673|529050783|FG003|Overall Study|Lost to Follow-up|1|||
146692035|NCT02246673|529050784|FG004|Overall Study|Lost to Follow-up|0|||
146692036|NCT02246673|529050780|FG000|Overall Study|Protocol Violation|0|||
146692037|NCT02246673|529050781|FG001|Overall Study|Protocol Violation|0|||
146692038|NCT02246673|529050782|FG002|Overall Study|Protocol Violation|0|||
146692039|NCT02246673|529050783|FG003|Overall Study|Protocol Violation|1|||
146692040|NCT02246673|529050784|FG004|Overall Study|Protocol Violation|0|||
146692041|NCT02488681|529050786|FG000|Overall Study|Implant unsuccessful|7|||
146692042|NCT05413369|529050787|FG000|Overall Study|Adverse Event|1|||
146692043|NCT05413369|529050788|FG001|Overall Study|Adverse Event|1|||
146692044|NCT05413369|529050787|FG000|Overall Study|Withdrawal by Subject|13|||
146692045|NCT05413369|529050788|FG001|Overall Study|Withdrawal by Subject|4|||
146692046|NCT05413369|529050787|FG000|Overall Study|Non-compliance with study schedule|2|||
146692047|NCT05413369|529050788|FG001|Overall Study|Non-compliance with study schedule|1|||
146692048|NCT05413369|529050787|FG000|Overall Study|Other|1|||
146692049|NCT05413369|529050788|FG001|Overall Study|Other|1|||
146929815|NCT01840228|529900913|FG000|Overall Study|Lost to Follow-up|1|||
146692050|NCT00720057|529050789|FG000|Overall Study|Lost to Follow-up|0|||
146692051|NCT00720057|529050790|FG001|Overall Study|Lost to Follow-up|2|||
146692052|NCT00720057|529050789|FG000|Overall Study|Protocol Violation|1|||
146692053|NCT00720057|529050790|FG001|Overall Study|Protocol Violation|0|||
146692054|NCT00720057|529050789|FG000|Overall Study|Withdrawal by Subject|0|||
146692055|NCT00720057|529050790|FG001|Overall Study|Withdrawal by Subject|1|||
146692056|NCT00579826|529050795|FG000|Overall Study|Withdrawal by Subject|5|||
146692057|NCT00579826|529050796|FG001|Overall Study|Withdrawal by Subject|3|||
146692058|NCT00304356|529050798|FG000|Nitazoxanide|Physician Decision|5|||
146692059|NCT00304356|529050798|FG000|Nitazoxanide|Physician Decision|1|||
146692060|NCT00304356|529050798|FG000|Nitazoxanide|number is 0|1|||
146979930|NCT00410410|530089475|FG002|Induction Period (IP)|Lost to Follow-up|2|||
146979931|NCT00410410|530089476|FG003|Induction Period (IP)|Lost to Follow-up|3|||
146979932|NCT00410410|530089477|FG004|Induction Period (IP)|Lost to Follow-up|0|||
146979933|NCT00410410|530089478|FG005|Induction Period (IP)|Lost to Follow-up|1|||
146979934|NCT00410410|530089479|FG006|Induction Period (IP)|Lost to Follow-up|0|||
146979935|NCT00410410|530089480|FG007|Induction Period (IP)|Lost to Follow-up|0|||
146979936|NCT00410410|530089481|FG008|Induction Period (IP)|Lost to Follow-up|0|||
146979937|NCT00410410|530089473|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
146979938|NCT00410410|530089474|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
146979939|NCT00410410|530089475|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
146979940|NCT00410410|530089476|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
146979941|NCT00410410|530089477|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
146979942|NCT00410410|530089478|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
146979943|NCT00410410|530089479|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
146979944|NCT00410410|530089480|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
146979945|NCT00410410|530089481|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
146979946|NCT00410410|530089473|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
146979947|NCT00410410|530089474|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
146979948|NCT00410410|530089475|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
146979949|NCT00410410|530089476|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
146979950|NCT00410410|530089477|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
146979951|NCT00410410|530089478|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
146979952|NCT00410410|530089479|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
146979953|NCT00410410|530089480|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
146979954|NCT00410410|530089481|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
146979955|NCT00410410|530089473|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
146979956|NCT00410410|530089474|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
146979957|NCT00410410|530089475|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
146979958|NCT00410410|530089476|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
146979959|NCT00410410|530089477|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
146979960|NCT00410410|530089478|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
146979961|NCT00410410|530089479|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
146979962|NCT00410410|530089480|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
146979963|NCT00410410|530089481|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
146692061|NCT00304356|529050798|FG000|Nitazoxanide|Physician Decision|1|||
146692062|NCT00304356|529050798|FG000|Nitazoxanide|Physician Decision|1|||
146692063|NCT00304356|529050798|FG000|Nitazoxanide|Physician Decision|1|||
146692064|NCT04120974|529050802|FG000|Overall Study|Death|1|||
146692065|NCT04120974|529050802|FG000|Overall Study|Physician Decision|1|||
146692066|NCT04120974|529050802|FG000|Overall Study|Lost to Follow-up|6|||
146692067|NCT00973479|529050805|FG000|Overall Study|Lost to Follow-up|0|||
146692068|NCT00973479|529050806|FG001|Overall Study|Lost to Follow-up|3|||
146692069|NCT00973479|529050805|FG000|Overall Study|Death|2|||
146692070|NCT00973479|529050806|FG001|Overall Study|Death|2|||
146692071|NCT00973479|529050805|FG000|Overall Study|Withdrawal by Subject|15|||
146692072|NCT00973479|529050806|FG001|Overall Study|Withdrawal by Subject|16|||
146692073|NCT00973479|529050805|FG000|Overall Study|Lack of Efficacy|5|||
146692074|NCT00973479|529050806|FG001|Overall Study|Lack of Efficacy|7|||
146692075|NCT00973479|529050805|FG000|Overall Study|Adverse Event|12|||
146692076|NCT00973479|529050806|FG001|Overall Study|Adverse Event|32|||
146692077|NCT00973479|529050805|FG000|Overall Study|Protocol Violation|2|||
146692078|NCT00973479|529050806|FG001|Overall Study|Protocol Violation|2|||
146692079|NCT00973479|529050805|FG000|Overall Study|Other|1|||
146692080|NCT00973479|529050806|FG001|Overall Study|Other|7|||
146692081|NCT05075850|529050807|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
146692082|NCT04256785|529050808|FG000|Overall Study|Adverse Event|8|||
146692083|NCT04256785|529050809|FG001|Overall Study|Adverse Event|6|||
146692084|NCT04256785|529050808|FG000|Overall Study|Lack of Efficacy|3|||
146692085|NCT04256785|529050809|FG001|Overall Study|Lack of Efficacy|4|||
146979964|NCT00410410|530089473|FG000|Induction Period (IP)|Other|0|||
146979965|NCT00410410|530089474|FG001|Induction Period (IP)|Other|0|||
146979966|NCT00410410|530089475|FG002|Induction Period (IP)|Other|1|||
146692086|NCT04256785|529050808|FG000|Overall Study|Lost to Follow-up|7|||
146692087|NCT04256785|529050809|FG001|Overall Study|Lost to Follow-up|7|||
146692088|NCT04256785|529050808|FG000|Overall Study|Protocol Violation|1|||
146692089|NCT04256785|529050809|FG001|Overall Study|Protocol Violation|0|||
146692090|NCT04256785|529050808|FG000|Overall Study|Withdrawal by Subject|4|||
146692091|NCT04256785|529050809|FG001|Overall Study|Withdrawal by Subject|1|||
146692092|NCT04256785|529050808|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
146692093|NCT04256785|529050809|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
146692094|NCT01265849|529050810|FG000|Overall Study|Randomized//Treatment not initiated|1|||
146692095|NCT01265849|529050811|FG001|Overall Study|Randomized//Treatment not initiated|4|||
146692096|NCT01265849|529050812|FG002|Overall Study|Randomized//Treatment not initiated|0|||
146692097|NCT01265849|529050810|FG000|Overall Study|Physician Decision|1|||
146692098|NCT01265849|529050811|FG001|Overall Study|Physician Decision|2|||
146692099|NCT01265849|529050812|FG002|Overall Study|Physician Decision|0|||
146692100|NCT01265849|529050810|FG000|Overall Study|Lost to Follow-up|18|||
146692101|NCT01265849|529050811|FG001|Overall Study|Lost to Follow-up|15|||
146692102|NCT01265849|529050812|FG002|Overall Study|Lost to Follow-up|5|||
146692103|NCT01265849|529050810|FG000|Overall Study|Not otherwise specified|1|||
146692104|NCT01265849|529050811|FG001|Overall Study|Not otherwise specified|6|||
146692105|NCT01265849|529050812|FG002|Overall Study|Not otherwise specified|1|||
146692106|NCT01265849|529050810|FG000|Overall Study|Withdrawal by Subject|25|||
146692107|NCT01265849|529050811|FG001|Overall Study|Withdrawal by Subject|34|||
146692108|NCT01265849|529050812|FG002|Overall Study|Withdrawal by Subject|13|||
146692109|NCT01170091|529050814|FG000|Overall Study|Missing efficacy evaluation|3|||
146692110|NCT01170091|529050814|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
146692111|NCT03194321|529050815|FG000|Overall Study|Withdrawal by Subject|1|||
146692112|NCT03194321|529050815|FG000|Overall Study|Lost to Follow-up|1|||
146692113|NCT03194321|529050815|FG000|Overall Study|Travel for Follow-up|1|||
146692114|NCT00271609|529050816|FG000|Overall Study|Adverse Event|11|||
146692115|NCT00271609|529050817|FG001|Overall Study|Adverse Event|3|||
146692116|NCT00271609|529050816|FG000|Overall Study|Withdrawal by Subject|2|||
146692117|NCT00271609|529050817|FG001|Overall Study|Withdrawal by Subject|0|||
146692118|NCT02188589|529050818|FG000|Overall Study|Withdrawal by Subject|5|||
146692119|NCT03341533|529050819|FG000|Overall Study|Withdrawal by Subject|1|||
146692120|NCT03341533|529050820|FG001|Overall Study|Withdrawal by Subject|1|||
146692121|NCT03341533|529050819|FG000|Overall Study|Not eligible after randomization|2|||
146692122|NCT03341533|529050820|FG001|Overall Study|Not eligible after randomization|1|||
146692123|NCT01675128|529050821|FG000|Overall Study|Disease progression on study|1|||
146692124|NCT01675128|529050822|FG001|Overall Study|Disease progression on study|1|||
146692125|NCT01675128|529050823|FG002|Overall Study|Disease progression on study|1|||
146692126|NCT01675128|529050821|FG000|Overall Study|Refused further treatment|1|||
146692127|NCT01675128|529050822|FG001|Overall Study|Refused further treatment|0|||
146692128|NCT01675128|529050823|FG002|Overall Study|Refused further treatment|0|||
146692129|NCT01675128|529050821|FG000|Overall Study|Pulmonary complication; off study|0|||
146692130|NCT01675128|529050822|FG001|Overall Study|Pulmonary complication; off study|1|||
146692131|NCT01675128|529050823|FG002|Overall Study|Pulmonary complication; off study|0|||
146692132|NCT03526458|529050824|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
146692133|NCT03526458|529050825|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
146692134|NCT03526458|529050824|FG000|Overall Study|Stone passed, surgery cancelled|2|||
146692135|NCT03526458|529050825|FG001|Overall Study|Stone passed, surgery cancelled|1|||
146692136|NCT03526458|529050824|FG000|Overall Study|Withdrawal by Subject|1|||
146692137|NCT03526458|529050825|FG001|Overall Study|Withdrawal by Subject|0|||
146692138|NCT03526458|529050824|FG000|Overall Study|Physician Decision|2|||
146692139|NCT03526458|529050825|FG001|Overall Study|Physician Decision|1|||
146692140|NCT03526458|529050824|FG000|Overall Study|Lack of equipment|1|||
146692141|NCT03526458|529050825|FG001|Overall Study|Lack of equipment|1|||
146692142|NCT03011307|529050826|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
146692143|NCT03011307|529050827|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
146692144|NCT03011307|529050826|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
146692145|NCT03011307|529050827|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
146692146|NCT03011307|529050826|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
146692147|NCT03011307|529050827|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
146692148|NCT01782664|529050828|FG000|Overall Study|Adverse Event|2|||
146692149|NCT01782664|529050829|FG001|Overall Study|Adverse Event|2|||
146692150|NCT01782664|529050830|FG002|Overall Study|Adverse Event|2|||
146692151|NCT01782664|529050831|FG003|Overall Study|Adverse Event|2|||
146692152|NCT01782664|529050832|FG004|Overall Study|Adverse Event|0|||
146692153|NCT01782664|529050833|FG005|Overall Study|Adverse Event|0|||
146692154|NCT01782664|529050828|FG000|Overall Study|Lack of Efficacy|2|||
146692155|NCT01782664|529050829|FG001|Overall Study|Lack of Efficacy|0|||
146692156|NCT01782664|529050830|FG002|Overall Study|Lack of Efficacy|2|||
146692157|NCT01782664|529050831|FG003|Overall Study|Lack of Efficacy|2|||
146929816|NCT01840228|529900914|FG001|Overall Study|Lost to Follow-up|1|||
146929817|NCT01103778|529900919|FG000|Overall Study|Lost to Follow-up|1|||
146929818|NCT01103778|529900919|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
146929819|NCT01103778|529900919|FG000|Overall Study|Screen failure|1|||
146692158|NCT01782664|529050832|FG004|Overall Study|Lack of Efficacy|0|||
146929820|NCT01658579|529900920|FG000|Treatment Period A|Other|0|||
146692159|NCT01782664|529050833|FG005|Overall Study|Lack of Efficacy|0|||
146692160|NCT01782664|529050828|FG000|Overall Study|Protocol Violation|0|||
146692161|NCT01782664|529050829|FG001|Overall Study|Protocol Violation|1|||
146692162|NCT01782664|529050830|FG002|Overall Study|Protocol Violation|0|||
146692163|NCT01782664|529050831|FG003|Overall Study|Protocol Violation|1|||
146929821|NCT01658579|529900921|FG001|Treatment Period A|Other|0|||
146929822|NCT01658579|529900922|FG002|Treatment Period A|Other|1|||
146692164|NCT01782664|529050832|FG004|Overall Study|Protocol Violation|0|||
146692165|NCT01782664|529050833|FG005|Overall Study|Protocol Violation|0|||
146692166|NCT01782664|529050828|FG000|Overall Study|Withdrawal by Subject|2|||
146692167|NCT01782664|529050829|FG001|Overall Study|Withdrawal by Subject|2|||
146692168|NCT01782664|529050830|FG002|Overall Study|Withdrawal by Subject|0|||
146692169|NCT01782664|529050831|FG003|Overall Study|Withdrawal by Subject|0|||
146692170|NCT01782664|529050832|FG004|Overall Study|Withdrawal by Subject|0|||
146692171|NCT01782664|529050833|FG005|Overall Study|Withdrawal by Subject|0|||
146692172|NCT00698581|529050836|FG000|Overall Study|Lack of Efficacy|23|||
146692173|NCT00698581|529050837|FG001|Overall Study|Lack of Efficacy|11|||
146692174|NCT00698581|529050836|FG000|Overall Study|Withdrawal by Subject|6|||
146692175|NCT00698581|529050837|FG001|Overall Study|Withdrawal by Subject|0|||
146692176|NCT00698581|529050836|FG000|Overall Study|Other reason|9|||
146692177|NCT00698581|529050837|FG001|Overall Study|Other reason|1|||
146692178|NCT00698581|529050836|FG000|Overall Study|SAE, non-fatal|1|||
146692179|NCT00698581|529050837|FG001|Overall Study|SAE, non-fatal|0|||
146692180|NCT00698581|529050836|FG000|Overall Study|AE, non-serious non-fatal|4|||
146692181|NCT00698581|529050837|FG001|Overall Study|AE, non-serious non-fatal|0|||
146692182|NCT00698581|529050836|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
146692183|NCT00698581|529050837|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
146692184|NCT00698581|529050836|FG000|Overall Study|AE of unknown type|1|||
146692185|NCT00698581|529050837|FG001|Overall Study|AE of unknown type|0|||
146692186|NCT03760146|529050838|FG000|Overall Study|Adverse Event|11|||
146692187|NCT03760146|529050839|FG001|Overall Study|Adverse Event|8|||
146692188|NCT03760146|529050840|FG002|Overall Study|Adverse Event|0|||
146692189|NCT03760146|529050841|FG003|Overall Study|Adverse Event|0|||
146692190|NCT03760146|529050842|FG004|Overall Study|Adverse Event|0|||
146692191|NCT03760146|529050843|FG005|Overall Study|Adverse Event|0|||
146692192|NCT03760146|529050838|FG000|Overall Study|Death|1|||
146692193|NCT03760146|529050839|FG001|Overall Study|Death|0|||
146692194|NCT03760146|529050840|FG002|Overall Study|Death|0|||
146692195|NCT03760146|529050841|FG003|Overall Study|Death|0|||
146692196|NCT03760146|529050842|FG004|Overall Study|Death|0|||
146692197|NCT03760146|529050843|FG005|Overall Study|Death|0|||
146692198|NCT03760146|529050838|FG000|Overall Study|Lost to Follow-up|41|||
146692199|NCT03760146|529050839|FG001|Overall Study|Lost to Follow-up|28|||
146692200|NCT03760146|529050840|FG002|Overall Study|Lost to Follow-up|9|||
146692201|NCT03760146|529050841|FG003|Overall Study|Lost to Follow-up|2|||
146775628|NCT00296036|529349575|FG001|Overall Study|Withdrawal by Subject|0|||
146775629|NCT00296036|529349576|FG002|Overall Study|Withdrawal by Subject|2|||
146775630|NCT00296036|529349577|FG003|Overall Study|Withdrawal by Subject|1|||
146775631|NCT00296036|529349578|FG004|Overall Study|Withdrawal by Subject|2|||
146775632|NCT00296036|529349579|FG005|Overall Study|Withdrawal by Subject|1|||
146775633|NCT00296036|529349574|FG000|Overall Study|Protocol Violation|0|||
146775634|NCT00296036|529349575|FG001|Overall Study|Protocol Violation|0|||
146775635|NCT00296036|529349576|FG002|Overall Study|Protocol Violation|0|||
146775636|NCT00296036|529349577|FG003|Overall Study|Protocol Violation|0|||
146775637|NCT00296036|529349578|FG004|Overall Study|Protocol Violation|0|||
146775638|NCT00296036|529349579|FG005|Overall Study|Protocol Violation|3|||
146775639|NCT03403413|529349580|FG000|Overall Study|Lack of Efficacy|2|||
146775640|NCT05052996|529349584|FG000|Overall Study|Still on study|0|||
146692202|NCT03760146|529050842|FG004|Overall Study|Lost to Follow-up|14|||
146692203|NCT03760146|529050843|FG005|Overall Study|Lost to Follow-up|8|||
146692204|NCT03760146|529050838|FG000|Overall Study|No longer met eligibility criteria|3|||
146692205|NCT03760146|529050839|FG001|Overall Study|No longer met eligibility criteria|9|||
146692206|NCT03760146|529050840|FG002|Overall Study|No longer met eligibility criteria|0|||
146692207|NCT03760146|529050841|FG003|Overall Study|No longer met eligibility criteria|0|||
146692208|NCT03760146|529050842|FG004|Overall Study|No longer met eligibility criteria|1|||
146775641|NCT05052996|529349585|FG001|Overall Study|Still on study|0|||
146775642|NCT05052996|529349586|FG002|Overall Study|Still on study|47|||
146775643|NCT05052996|529349587|FG003|Overall Study|Still on study|44|||
146692209|NCT03760146|529050843|FG005|Overall Study|No longer met eligibility criteria|0|||
146692210|NCT03760146|529050838|FG000|Overall Study|Protocol Violation|21|||
146692211|NCT03760146|529050839|FG001|Overall Study|Protocol Violation|13|||
146692212|NCT03760146|529050840|FG002|Overall Study|Protocol Violation|1|||
146692213|NCT03760146|529050841|FG003|Overall Study|Protocol Violation|0|||
146692214|NCT03760146|529050842|FG004|Overall Study|Protocol Violation|1|||
146692215|NCT03760146|529050843|FG005|Overall Study|Protocol Violation|0|||
146692216|NCT03760146|529050838|FG000|Overall Study|Withdrawal by Subject|19|||
146692217|NCT03760146|529050839|FG001|Overall Study|Withdrawal by Subject|20|||
146692218|NCT03760146|529050840|FG002|Overall Study|Withdrawal by Subject|1|||
146692219|NCT03760146|529050841|FG003|Overall Study|Withdrawal by Subject|0|||
146692220|NCT03760146|529050842|FG004|Overall Study|Withdrawal by Subject|1|||
146692221|NCT03760146|529050843|FG005|Overall Study|Withdrawal by Subject|0|||
146692222|NCT01082965|529050844|FG000|Overall Study|Protocol Violation|0|||
146775644|NCT05052996|529349584|FG000|Overall Study|Cohort terminated by sponsor|21|||
146775645|NCT05052996|529349585|FG001|Overall Study|Cohort terminated by sponsor|12|||
146775646|NCT05052996|529349586|FG002|Overall Study|Cohort terminated by sponsor|0|||
146692223|NCT01082965|529050845|FG001|Overall Study|Protocol Violation|1|||
146692224|NCT01082965|529050844|FG000|Overall Study|Other|1|||
146692225|NCT01082965|529050845|FG001|Overall Study|Other|1|||
146692226|NCT02587065|529050846|FG000|Overall Study|Adverse Event|14|||
146692227|NCT02587065|529050846|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
146692228|NCT02587065|529050846|FG000|Overall Study|Non-adherence to the Protocol|3|||
146692229|NCT02587065|529050846|FG000|Overall Study|Discontinuation of Study Medication|2|||
146692230|NCT02587065|529050846|FG000|Overall Study|Reason not Specified|3|||
146692231|NCT04056195|529050849|FG000|Overall Study|Adverse Event|1|||
146692232|NCT04056195|529050850|FG001|Overall Study|Adverse Event|0|||
146692233|NCT04056195|529050851|FG002|Overall Study|Adverse Event|0|||
146692234|NCT04056195|529050849|FG000|Overall Study|Withdrawal by Subject|0|||
146692235|NCT04056195|529050850|FG001|Overall Study|Withdrawal by Subject|1|||
146692236|NCT04056195|529050851|FG002|Overall Study|Withdrawal by Subject|1|||
146692237|NCT04056195|529050849|FG000|Overall Study|Physician Decision|1|||
146692238|NCT04056195|529050850|FG001|Overall Study|Physician Decision|1|||
146692239|NCT04056195|529050851|FG002|Overall Study|Physician Decision|1|||
146692240|NCT02406651|529050852|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
146692241|NCT00718328|529050857|FG000|Overall Study|Lost to Follow-up|1|||
146692242|NCT00718328|529050858|FG001|Overall Study|Lost to Follow-up|0|||
146692243|NCT02865915|529050859|FG000|Overall Study|Pregnancy|1|||
146692244|NCT02865915|529050860|FG001|Overall Study|Pregnancy|0|||
146692245|NCT02865915|529050859|FG000|Overall Study|Withdrawal by Subject|1|||
146692246|NCT02865915|529050860|FG001|Overall Study|Withdrawal by Subject|1|||
146692247|NCT02865915|529050859|FG000|Overall Study|Adverse Event|0|||
146692248|NCT02865915|529050860|FG001|Overall Study|Adverse Event|4|||
146692249|NCT02865915|529050859|FG000|Overall Study|Lost to Follow-up|0|||
146692250|NCT02865915|529050860|FG001|Overall Study|Lost to Follow-up|1|||
146692251|NCT02865915|529050859|FG000|Overall Study|Protocol Violation|0|||
146692252|NCT02865915|529050860|FG001|Overall Study|Protocol Violation|1|||
146692253|NCT02865915|529050859|FG000|Overall Study|Study terminated by sponsor|23|||
146692254|NCT02865915|529050860|FG001|Overall Study|Study terminated by sponsor|18|||
146692255|NCT02865915|529050859|FG000|Overall Study|Dosing group discontinued|0|||
146692256|NCT02865915|529050860|FG001|Overall Study|Dosing group discontinued|5|||
146692257|NCT00663052|529050861|FG000|Overall Study|Adverse Event|6|||
146692258|NCT00663052|529050862|FG001|Overall Study|Adverse Event|3|||
146692259|NCT00663052|529050861|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
146692260|NCT00663052|529050862|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
146692261|NCT00663052|529050861|FG000|Overall Study|Protocol Violation|1|||
146692262|NCT00663052|529050862|FG001|Overall Study|Protocol Violation|0|||
146692263|NCT00663052|529050861|FG000|Overall Study|Withdrawal by Subject|2|||
146692264|NCT00663052|529050862|FG001|Overall Study|Withdrawal by Subject|5|||
146692265|NCT00663052|529050861|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
146692266|NCT00663052|529050862|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
146692267|NCT00663052|529050861|FG000|Overall Study|Other|0|||
146692268|NCT00663052|529050862|FG001|Overall Study|Other|1|||
146692269|NCT05497284|529050867|FG000|Overall Study|Adverse Event|1|||
146692270|NCT05497284|529050868|FG001|Overall Study|Adverse Event|0|||
146692271|NCT05497284|529050867|FG000|Overall Study|Physician Decision|0|||
146692272|NCT05497284|529050868|FG001|Overall Study|Physician Decision|1|||
146692273|NCT05497284|529050867|FG000|Overall Study|Study terminated by sponsor|7|||
146692274|NCT05497284|529050868|FG001|Overall Study|Study terminated by sponsor|4|||
146692275|NCT05497284|529050867|FG000|Overall Study|Subject Decision|0|||
146692276|NCT05497284|529050868|FG001|Overall Study|Subject Decision|1|||
146692277|NCT05760300|529050869|FG000|Overall Study|Adverse Event|0|||
146692278|NCT05760300|529050870|FG001|Overall Study|Adverse Event|0|||
146692279|NCT05760300|529050871|FG002|Overall Study|Adverse Event|1|||
146692280|NCT05760300|529050872|FG003|Overall Study|Adverse Event|0|||
146692281|NCT05760300|529050869|FG000|Overall Study|Participant Decision|1|||
146692282|NCT05760300|529050870|FG001|Overall Study|Participant Decision|0|||
146692283|NCT05760300|529050871|FG002|Overall Study|Participant Decision|0|||
146692284|NCT05760300|529050872|FG003|Overall Study|Participant Decision|0|||
146692285|NCT03878446|529050873|FG000|Overall Study|Withdrawn by parent or guardian|1|||
146692286|NCT03878446|529050874|FG001|Overall Study|Withdrawn by parent or guardian|0|||
146692287|NCT03878446|529050875|FG002|Overall Study|Withdrawn by parent or guardian|0|||
146692288|NCT03878446|529050876|FG003|Overall Study|Withdrawn by parent or guardian|0|||
146692289|NCT03878446|529050877|FG004|Overall Study|Withdrawn by parent or guardian|0|||
146692290|NCT05041322|529050878|FG000|Baseline|Withdrawal by Subject|1|||
146692291|NCT05041322|529050879|FG001|Baseline|Withdrawal by Subject|0|||
146692292|NCT05041322|529050878|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
146692293|NCT05041322|529050879|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
146692294|NCT05041322|529050878|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
146692295|NCT05041322|529050879|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
146692296|NCT04814433|529050880|FG000|Overall Study|Survey not returned|4|||
146692297|NCT04814433|529050881|FG001|Overall Study|Survey not returned|8|||
146692298|NCT04814433|529050882|FG002|Overall Study|Survey not returned|4|||
146692299|NCT04814433|529050883|FG003|Overall Study|Survey not returned|5|||
146692300|NCT04307446|529052948|FG000|Overall Study|Lost to Follow-up|2|||
146692301|NCT04307446|529052949|FG001|Overall Study|Lost to Follow-up|0|||
146692302|NCT01063764|529052953|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
146692303|NCT01063764|529052953|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
146692304|NCT01063764|529052953|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
146692305|NCT01063764|529052953|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
146692306|NCT01063764|529052953|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
146692307|NCT01063764|529052953|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
146692308|NCT01063764|529052953|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
146692309|NCT00697515|529052954|FG000|Dose Optimization Period|Adverse Event|4|||
146692310|NCT00697515|529052955|FG001|Dose Optimization Period|Adverse Event|0|||
146692311|NCT00697515|529052954|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
146692312|NCT00697515|529052955|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
146692313|NCT00697515|529052954|FG000|Dose Optimization Period|Lost to Follow-up|2|||
146692314|NCT00697515|529052955|FG001|Dose Optimization Period|Lost to Follow-up|0|||
146692315|NCT00697515|529052954|FG000|Dose Optimization Period|sponsor request|2|||
146692316|NCT00697515|529052955|FG001|Dose Optimization Period|sponsor request|0|||
146692317|NCT00697515|529052954|FG000|Dose Optimization Period|called to active duty|1|||
146692318|NCT00697515|529052955|FG001|Dose Optimization Period|called to active duty|0|||
146692319|NCT00697515|529052954|FG000|Dose Optimization Period|elevated QTc|1|||
146692320|NCT00697515|529052955|FG001|Dose Optimization Period|elevated QTc|0|||
146692321|NCT00697515|529052954|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
146692322|NCT00697515|529052955|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
146692323|NCT00697515|529052954|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
146692324|NCT00697515|529052955|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
146692325|NCT00697515|529052954|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
146692326|NCT00697515|529052955|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
146692327|NCT00697515|529052954|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
146692328|NCT00697515|529052955|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
146692329|NCT02603432|529052958|FG000|Overall Study|Adverse Event|1|||
146692330|NCT02603432|529052959|FG001|Overall Study|Adverse Event|0|||
146692331|NCT02603432|529052958|FG000|Overall Study|Death|221|||
146692332|NCT02603432|529052959|FG001|Overall Study|Death|242|||
146692333|NCT02603432|529052958|FG000|Overall Study|Lost to Follow-up|3|||
146692334|NCT02603432|529052959|FG001|Overall Study|Lost to Follow-up|9|||
146692335|NCT02603432|529052958|FG000|Overall Study|Progressive Disease|7|||
146692336|NCT02603432|529052959|FG001|Overall Study|Progressive Disease|5|||
146692337|NCT02603432|529052958|FG000|Overall Study|Withdrawal by Subject|12|||
146692338|NCT02603432|529052959|FG001|Overall Study|Withdrawal by Subject|18|||
146692339|NCT02603432|529052958|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
146692340|NCT02603432|529052959|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146692341|NCT02603432|529052958|FG000|Overall Study|Study terminated by sponsor|74|||
146692342|NCT02603432|529052959|FG001|Overall Study|Study terminated by sponsor|75|||
146692343|NCT02603432|529052958|FG000|Overall Study|Other|13|||
146692344|NCT02603432|529052959|FG001|Overall Study|Other|0|||
146692353|NCT02759120|529052970|FG000|Overall Study|Death|34|||
146692354|NCT02759120|529052971|FG001|Overall Study|Death|36|||
146692355|NCT02759120|529052970|FG000|Overall Study|Lost to Follow-up|4|||
146692356|NCT02759120|529052971|FG001|Overall Study|Lost to Follow-up|7|||
146692357|NCT02759120|529052970|FG000|Overall Study|Physician Decision|3|||
146775647|NCT05052996|529349587|FG003|Overall Study|Cohort terminated by sponsor|0|||
146775648|NCT05052996|529349584|FG000|Overall Study|Withdrew consent|1|||
146692358|NCT02759120|529052971|FG001|Overall Study|Physician Decision|0|||
146692359|NCT02759120|529052970|FG000|Overall Study|Withdrawal by Subject|28|||
146692360|NCT02759120|529052971|FG001|Overall Study|Withdrawal by Subject|15|||
146692361|NCT02759120|529052970|FG000|Overall Study|Moved out of area|3|||
146692362|NCT02759120|529052971|FG001|Overall Study|Moved out of area|4|||
146692363|NCT02759120|529052970|FG000|Overall Study|Lung transplant|3|||
146692364|NCT02759120|529052971|FG001|Overall Study|Lung transplant|5|||
146692365|NCT02759120|529052970|FG000|Overall Study|Other reason not completed|10|||
146692366|NCT02759120|529052971|FG001|Overall Study|Other reason not completed|12|||
146692367|NCT02063854|529052973|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
146692368|NCT02063854|529052974|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
146692369|NCT02063854|529052975|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
146692370|NCT02063854|529052976|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
146692371|NCT02063854|529052977|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
146979967|NCT00410410|530089476|FG003|Induction Period (IP)|Other|0|||
146979968|NCT00410410|530089477|FG004|Induction Period (IP)|Other|0|||
146979969|NCT00410410|530089478|FG005|Induction Period (IP)|Other|0|||
146979970|NCT00410410|530089479|FG006|Induction Period (IP)|Other|0|||
146979971|NCT00410410|530089480|FG007|Induction Period (IP)|Other|0|||
146979972|NCT00410410|530089481|FG008|Induction Period (IP)|Other|0|||
146979973|NCT00410410|530089473|FG000|Maintenance Period (MP)|Death|0|||
146979974|NCT00410410|530089474|FG001|Maintenance Period (MP)|Death|0|||
146979975|NCT00410410|530089475|FG002|Maintenance Period (MP)|Death|0|||
146979976|NCT00410410|530089476|FG003|Maintenance Period (MP)|Death|0|||
146979977|NCT00410410|530089477|FG004|Maintenance Period (MP)|Death|0|||
146979978|NCT00410410|530089478|FG005|Maintenance Period (MP)|Death|0|||
146979979|NCT00410410|530089479|FG006|Maintenance Period (MP)|Death|1|||
146979980|NCT00410410|530089480|FG007|Maintenance Period (MP)|Death|0|||
146979981|NCT00410410|530089481|FG008|Maintenance Period (MP)|Death|0|||
146979982|NCT00410410|530089473|FG000|Maintenance Period (MP)|Adverse Event|0|||
146979983|NCT00410410|530089474|FG001|Maintenance Period (MP)|Adverse Event|0|||
146979984|NCT00410410|530089475|FG002|Maintenance Period (MP)|Adverse Event|0|||
146692372|NCT02063854|529052978|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
146692373|NCT02063854|529052979|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
146692374|NCT02063854|529052973|FG000|Overall Study|Major Protocol Deviation|0|||
146692375|NCT02063854|529052974|FG001|Overall Study|Major Protocol Deviation|0|||
146692376|NCT02063854|529052975|FG002|Overall Study|Major Protocol Deviation|3|||
146692377|NCT02063854|529052976|FG003|Overall Study|Major Protocol Deviation|0|||
146692378|NCT02063854|529052977|FG004|Overall Study|Major Protocol Deviation|0|||
146692379|NCT02063854|529052978|FG005|Overall Study|Major Protocol Deviation|0|||
146692380|NCT02063854|529052979|FG006|Overall Study|Major Protocol Deviation|0|||
146692381|NCT02063854|529052973|FG000|Overall Study|Voluntary Withdrawal|2|||
146692382|NCT02063854|529052974|FG001|Overall Study|Voluntary Withdrawal|0|||
146692383|NCT02063854|529052975|FG002|Overall Study|Voluntary Withdrawal|8|||
146692384|NCT02063854|529052976|FG003|Overall Study|Voluntary Withdrawal|1|||
146692385|NCT02063854|529052977|FG004|Overall Study|Voluntary Withdrawal|3|||
146692386|NCT02063854|529052978|FG005|Overall Study|Voluntary Withdrawal|6|||
146692387|NCT02063854|529052979|FG006|Overall Study|Voluntary Withdrawal|1|||
146692388|NCT02063854|529052973|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
146692389|NCT02063854|529052974|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
146692390|NCT02063854|529052975|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
146692391|NCT02063854|529052976|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
146692392|NCT02063854|529052977|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
146692393|NCT02063854|529052978|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
146692394|NCT02063854|529052979|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
146692395|NCT02063854|529052973|FG000|Overall Study|Reason Not Specified|1|||
146692396|NCT02063854|529052974|FG001|Overall Study|Reason Not Specified|0|||
146692397|NCT02063854|529052975|FG002|Overall Study|Reason Not Specified|0|||
146692398|NCT02063854|529052976|FG003|Overall Study|Reason Not Specified|0|||
146692399|NCT02063854|529052977|FG004|Overall Study|Reason Not Specified|0|||
146692400|NCT02063854|529052978|FG005|Overall Study|Reason Not Specified|0|||
146692401|NCT02063854|529052979|FG006|Overall Study|Reason Not Specified|0|||
146692402|NCT02063854|529052973|FG000|Overall Study|Did Not Receive Study Drug|0|||
146692403|NCT02063854|529052974|FG001|Overall Study|Did Not Receive Study Drug|0|||
146692404|NCT02063854|529052975|FG002|Overall Study|Did Not Receive Study Drug|0|||
146692405|NCT02063854|529052976|FG003|Overall Study|Did Not Receive Study Drug|0|||
146692406|NCT02063854|529052977|FG004|Overall Study|Did Not Receive Study Drug|0|||
146692407|NCT02063854|529052978|FG005|Overall Study|Did Not Receive Study Drug|1|||
146692408|NCT02063854|529052979|FG006|Overall Study|Did Not Receive Study Drug|0|||
146692409|NCT00930579|529052982|FG000|Overall Study|Withdrawal by Subject|1|||
146692410|NCT00930579|529052982|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
146979985|NCT00410410|530089476|FG003|Maintenance Period (MP)|Adverse Event|0|||
146979986|NCT00410410|530089477|FG004|Maintenance Period (MP)|Adverse Event|0|||
146979987|NCT00410410|530089478|FG005|Maintenance Period (MP)|Adverse Event|0|||
146979988|NCT00410410|530089479|FG006|Maintenance Period (MP)|Adverse Event|1|||
146979989|NCT00410410|530089480|FG007|Maintenance Period (MP)|Adverse Event|3|||
146979990|NCT00410410|530089481|FG008|Maintenance Period (MP)|Adverse Event|0|||
146979991|NCT00410410|530089473|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
146692411|NCT02255981|529052983|FG000|Overall Study|Lost to Follow-up|3|||
146692412|NCT02255981|529052983|FG000|Overall Study|Withdrawal by Subject|1|||
146692413|NCT01046682|529052984|FG000|Overall Study|Adverse Event|2|||
146692414|NCT01046682|529052985|FG001|Overall Study|Adverse Event|0|||
146692415|NCT00107198|529052991|FG000|Overall Study|Lack of Efficacy|28|||
146692416|NCT00107198|529052991|FG000|Overall Study|Lost to Follow-up|12|||
146979992|NCT00410410|530089474|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
146979993|NCT00410410|530089475|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
146979994|NCT00410410|530089476|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
146979995|NCT00410410|530089477|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
146979996|NCT00410410|530089478|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
146692417|NCT00107198|529052991|FG000|Overall Study|Protocol Violation|1|||
146692418|NCT00107198|529052991|FG000|Overall Study|Withdrawal by Subject|6|||
146692419|NCT00107198|529052991|FG000|Overall Study|Ineligible|5|||
146692420|NCT00949325|529052992|FG000|Overall Study|Adverse Event|0|||
146692421|NCT00949325|529052993|FG001|Overall Study|Adverse Event|2|||
146692422|NCT00949325|529052994|FG002|Overall Study|Adverse Event|0|||
146692423|NCT00751348|529052995|FG000|Overall Study|Withdrawal by Subject|5|||
146692424|NCT00751348|529052996|FG001|Overall Study|Withdrawal by Subject|2|||
146692425|NCT00751348|529052995|FG000|Overall Study|Migration from study area|1|||
146692426|NCT00751348|529052996|FG001|Overall Study|Migration from study area|0|||
146692427|NCT05533632|529052997|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
146692428|NCT05533632|529052997|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
146692429|NCT05533632|529052997|FG000|Overall Study|Lost to Follow-up|1|||
146692430|NCT05533632|529052997|FG000|Overall Study|Withdrawal by Subject|4|||
146692431|NCT05533632|529052997|FG000|Overall Study|Adverse Event|4|||
146692432|NCT02205333|529053003|FG000|Overall Study|Death|5|||
146692433|NCT02205333|529053004|FG001|Overall Study|Death|6|||
146692434|NCT02205333|529053005|FG002|Overall Study|Death|2|||
146692435|NCT02205333|529053006|FG003|Overall Study|Death|6|||
146692436|NCT02205333|529053007|FG004|Overall Study|Death|5|||
146692437|NCT02205333|529053008|FG005|Overall Study|Death|3|||
146692438|NCT02205333|529053009|FG006|Overall Study|Death|3|||
146692439|NCT02205333|529053010|FG007|Overall Study|Death|2|||
146692440|NCT02205333|529053011|FG008|Overall Study|Death|0|||
146692441|NCT02205333|529053003|FG000|Overall Study|Withdrawal by Subject|1|||
146692442|NCT02205333|529053004|FG001|Overall Study|Withdrawal by Subject|0|||
146692443|NCT02205333|529053005|FG002|Overall Study|Withdrawal by Subject|0|||
146692444|NCT02205333|529053006|FG003|Overall Study|Withdrawal by Subject|1|||
146692445|NCT02205333|529053007|FG004|Overall Study|Withdrawal by Subject|0|||
146692446|NCT02205333|529053008|FG005|Overall Study|Withdrawal by Subject|0|||
146692447|NCT02205333|529053009|FG006|Overall Study|Withdrawal by Subject|2|||
146692448|NCT02205333|529053010|FG007|Overall Study|Withdrawal by Subject|0|||
146692449|NCT02205333|529053011|FG008|Overall Study|Withdrawal by Subject|0|||
146692450|NCT03054870|529053013|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
146692451|NCT03054870|529053013|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
146692452|NCT02009046|529053014|FG000|Overall Study|Lost to Follow-up|256|||
146692453|NCT02009046|529053015|FG001|Overall Study|Lost to Follow-up|206|||
146692454|NCT01154218|529053016|FG000|Third Intervention Period|Adverse Event|0|||
146692455|NCT01154218|529053017|FG001|Third Intervention Period|Adverse Event|1|||
146692456|NCT01154218|529053018|FG002|Third Intervention Period|Adverse Event|0|||
146692457|NCT01154218|529053019|FG003|Third Intervention Period|Adverse Event|0|||
146692458|NCT01154218|529053016|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
146692459|NCT01154218|529053017|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
146692460|NCT01154218|529053018|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
146692461|NCT01154218|529053019|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
146692462|NCT01154218|529053016|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
146692463|NCT01154218|529053017|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
146692464|NCT01154218|529053018|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
146692465|NCT01154218|529053019|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
146692466|NCT00362115|529053020|FG000|Overall Study|Adverse Event|0|||
146692467|NCT00362115|529053021|FG001|Overall Study|Adverse Event|1|||
146692468|NCT00362115|529053022|FG002|Overall Study|Adverse Event|1|||
146692469|NCT00362115|529053023|FG003|Overall Study|Adverse Event|1|||
146692470|NCT00362115|529053024|FG004|Overall Study|Adverse Event|2|||
146692471|NCT00362115|529053025|FG005|Overall Study|Adverse Event|2|||
146692472|NCT00362115|529053026|FG006|Overall Study|Adverse Event|1|||
146692473|NCT00362115|529053020|FG000|Overall Study|Protocol Violation|0|||
146692474|NCT00362115|529053021|FG001|Overall Study|Protocol Violation|0|||
146692475|NCT00362115|529053022|FG002|Overall Study|Protocol Violation|0|||
146692476|NCT00362115|529053023|FG003|Overall Study|Protocol Violation|0|||
146692477|NCT00362115|529053024|FG004|Overall Study|Protocol Violation|0|||
146692478|NCT00362115|529053025|FG005|Overall Study|Protocol Violation|1|||
146692479|NCT00362115|529053026|FG006|Overall Study|Protocol Violation|0|||
146692480|NCT00362115|529053020|FG000|Overall Study|Lost to Follow-up|0|||
146692481|NCT00362115|529053021|FG001|Overall Study|Lost to Follow-up|1|||
146692482|NCT00362115|529053022|FG002|Overall Study|Lost to Follow-up|0|||
146692483|NCT00362115|529053023|FG003|Overall Study|Lost to Follow-up|0|||
146692484|NCT00362115|529053024|FG004|Overall Study|Lost to Follow-up|2|||
146692485|NCT00362115|529053025|FG005|Overall Study|Lost to Follow-up|0|||
146692486|NCT00362115|529053026|FG006|Overall Study|Lost to Follow-up|1|||
146692487|NCT00362115|529053020|FG000|Overall Study|Withdrawal by Subject|1|||
146692488|NCT00362115|529053021|FG001|Overall Study|Withdrawal by Subject|3|||
146692489|NCT00362115|529053022|FG002|Overall Study|Withdrawal by Subject|1|||
146692490|NCT00362115|529053023|FG003|Overall Study|Withdrawal by Subject|0|||
146692491|NCT00362115|529053024|FG004|Overall Study|Withdrawal by Subject|1|||
146692492|NCT00362115|529053025|FG005|Overall Study|Withdrawal by Subject|3|||
146692493|NCT00362115|529053026|FG006|Overall Study|Withdrawal by Subject|4|||
146692494|NCT00362115|529053020|FG000|Overall Study|Lack of Efficacy|1|||
146692495|NCT00362115|529053021|FG001|Overall Study|Lack of Efficacy|0|||
146692496|NCT00362115|529053022|FG002|Overall Study|Lack of Efficacy|5|||
146692497|NCT00362115|529053023|FG003|Overall Study|Lack of Efficacy|2|||
146692498|NCT00362115|529053024|FG004|Overall Study|Lack of Efficacy|2|||
146692499|NCT00362115|529053025|FG005|Overall Study|Lack of Efficacy|0|||
146692500|NCT00362115|529053026|FG006|Overall Study|Lack of Efficacy|3|||
146692501|NCT00362115|529053020|FG000|Overall Study|Physician Decision|0|||
146692502|NCT00362115|529053021|FG001|Overall Study|Physician Decision|0|||
146692503|NCT00362115|529053022|FG002|Overall Study|Physician Decision|0|||
146692504|NCT00362115|529053023|FG003|Overall Study|Physician Decision|0|||
146692505|NCT00362115|529053024|FG004|Overall Study|Physician Decision|0|||
146692506|NCT00362115|529053025|FG005|Overall Study|Physician Decision|0|||
146692507|NCT00362115|529053026|FG006|Overall Study|Physician Decision|3|||
146692508|NCT00362115|529053020|FG000|Overall Study|Other|0|||
146692509|NCT00362115|529053021|FG001|Overall Study|Other|1|||
146692510|NCT00362115|529053022|FG002|Overall Study|Other|0|||
146692511|NCT00362115|529053023|FG003|Overall Study|Other|1|||
146692512|NCT00362115|529053024|FG004|Overall Study|Other|0|||
146692513|NCT00362115|529053025|FG005|Overall Study|Other|1|||
146692514|NCT00362115|529053026|FG006|Overall Study|Other|0|||
146692515|NCT00643682|529053029|FG000|Overall Study|did not keep appointment|522|||
146692516|NCT00643682|529053030|FG001|Overall Study|did not keep appointment|509|||
146692517|NCT03755414|529053032|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
146692518|NCT03755414|529053033|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
146692519|NCT03755414|529053034|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
146692520|NCT03755414|529053032|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
146692521|NCT03755414|529053033|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
146692522|NCT03755414|529053034|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
146692523|NCT03755414|529053032|FG000|Overall Study|Non-compliance|0|||
146692524|NCT03755414|529053033|FG001|Overall Study|Non-compliance|1|||
146692525|NCT03755414|529053034|FG002|Overall Study|Non-compliance|0|||
146692526|NCT02153112|529053035|FG000|Overall Study|Adverse Event|0|||
146692527|NCT02153112|529053036|FG001|Overall Study|Adverse Event|0|||
146692528|NCT02153112|529053037|FG002|Overall Study|Adverse Event|1|||
146692529|NCT02153112|529053038|FG003|Overall Study|Adverse Event|0|||
146692530|NCT02153112|529053039|FG004|Overall Study|Adverse Event|0|||
146692531|NCT02153112|529053040|FG005|Overall Study|Adverse Event|0|||
146692532|NCT02153112|529053041|FG006|Overall Study|Adverse Event|0|||
146692533|NCT02153112|529053042|FG007|Overall Study|Adverse Event|0|||
146692534|NCT02153112|529053043|FG008|Overall Study|Adverse Event|0|||
146692535|NCT02153112|529053044|FG009|Overall Study|Adverse Event|0|||
146692536|NCT02153112|529053035|FG000|Overall Study|Lost to Follow-up|1|||
146692537|NCT02153112|529053036|FG001|Overall Study|Lost to Follow-up|1|||
146692538|NCT02153112|529053037|FG002|Overall Study|Lost to Follow-up|0|||
146692539|NCT02153112|529053038|FG003|Overall Study|Lost to Follow-up|0|||
146692540|NCT02153112|529053039|FG004|Overall Study|Lost to Follow-up|2|||
146692541|NCT02153112|529053040|FG005|Overall Study|Lost to Follow-up|1|||
146692542|NCT02153112|529053041|FG006|Overall Study|Lost to Follow-up|1|||
146692543|NCT02153112|529053042|FG007|Overall Study|Lost to Follow-up|0|||
146692544|NCT02153112|529053043|FG008|Overall Study|Lost to Follow-up|1|||
146692545|NCT02153112|529053044|FG009|Overall Study|Lost to Follow-up|1|||
146692546|NCT02153112|529053035|FG000|Overall Study|Withdrawal by Subject|3|||
146692547|NCT02153112|529053036|FG001|Overall Study|Withdrawal by Subject|1|||
146692548|NCT02153112|529053037|FG002|Overall Study|Withdrawal by Subject|2|||
146929823|NCT01658579|529900923|FG003|Treatment Period A|Other|1|||
146929824|NCT01658579|529900920|FG000|Treatment Period A|Adverse Event|1|||
146929825|NCT01658579|529900921|FG001|Treatment Period A|Adverse Event|0|||
146929826|NCT01658579|529900922|FG002|Treatment Period A|Adverse Event|0|||
146929827|NCT01658579|529900923|FG003|Treatment Period A|Adverse Event|0|||
146929828|NCT01658579|529900920|FG000|Treatment Period B|Other|0|||
146692549|NCT02153112|529053038|FG003|Overall Study|Withdrawal by Subject|2|||
146692550|NCT02153112|529053039|FG004|Overall Study|Withdrawal by Subject|1|||
146692551|NCT02153112|529053040|FG005|Overall Study|Withdrawal by Subject|1|||
146692552|NCT02153112|529053041|FG006|Overall Study|Withdrawal by Subject|7|||
146692553|NCT02153112|529053042|FG007|Overall Study|Withdrawal by Subject|2|||
146692554|NCT02153112|529053043|FG008|Overall Study|Withdrawal by Subject|13|||
146929829|NCT01658579|529900921|FG001|Treatment Period B|Other|0|||
146929830|NCT01658579|529900922|FG002|Treatment Period B|Other|0|||
146692555|NCT02153112|529053044|FG009|Overall Study|Withdrawal by Subject|12|||
146692556|NCT02153112|529053035|FG000|Overall Study|Reason not Specified|0|||
146692557|NCT02153112|529053036|FG001|Overall Study|Reason not Specified|0|||
146692558|NCT02153112|529053037|FG002|Overall Study|Reason not Specified|0|||
146692559|NCT02153112|529053038|FG003|Overall Study|Reason not Specified|0|||
146692560|NCT02153112|529053039|FG004|Overall Study|Reason not Specified|0|||
146692561|NCT02153112|529053040|FG005|Overall Study|Reason not Specified|0|||
146692562|NCT02153112|529053041|FG006|Overall Study|Reason not Specified|0|||
146692563|NCT02153112|529053042|FG007|Overall Study|Reason not Specified|0|||
146692564|NCT02153112|529053043|FG008|Overall Study|Reason not Specified|1|||
146692565|NCT02153112|529053044|FG009|Overall Study|Reason not Specified|1|||
146692566|NCT00003641|529053050|FG000|Overall Study|Withdrawal by Subject|0|||
146692567|NCT00003641|529053051|FG001|Overall Study|Withdrawal by Subject|100|||
146692568|NCT00003641|529053050|FG000|Overall Study|Adverse Event|0|||
146692569|NCT00003641|529053051|FG001|Overall Study|Adverse Event|38|||
146692570|NCT00003641|529053050|FG000|Overall Study|Disease progression|0|||
146692571|NCT00003641|529053051|FG001|Overall Study|Disease progression|2|||
146692572|NCT00003641|529053050|FG000|Overall Study|Unknown/missing|0|||
146692573|NCT00003641|529053051|FG001|Overall Study|Unknown/missing|22|||
146692574|NCT00003641|529053050|FG000|Overall Study|Should not receive interferon therapy|2|||
146692575|NCT00003641|529053051|FG001|Overall Study|Should not receive interferon therapy|0|||
146692576|NCT00003641|529053050|FG000|Overall Study|Never started interferon|567|||
146692577|NCT00003641|529053051|FG001|Overall Study|Never started interferon|12|||
146692578|NCT02154581|529053055|FG000|Overall Study|Lost to Follow-up|7|||
146692579|NCT02154581|529053056|FG001|Overall Study|Lost to Follow-up|8|||
146692580|NCT00878709|529053057|FG000|Overall Study|Withdrawal by Subject|197|||
146692581|NCT00878709|529053058|FG001|Overall Study|Withdrawal by Subject|120|||
146692582|NCT00878709|529053057|FG000|Overall Study|Lost to Follow-up|35|||
146692583|NCT00878709|529053058|FG001|Overall Study|Lost to Follow-up|33|||
146692584|NCT00878709|529053057|FG000|Overall Study|Other Reasons|93|||
146692585|NCT00878709|529053058|FG001|Overall Study|Other Reasons|84|||
146692586|NCT02225743|529053059|FG000|Overall Study|Withdrawal by Subject|18|||
146692587|NCT00768300|529053064|FG000|Overall Study|Randomized but not treated|1|||
146692588|NCT00768300|529053065|FG001|Overall Study|Randomized but not treated|1|||
146692589|NCT00768300|529053064|FG000|Overall Study|Adverse Event|10|||
146692590|NCT00768300|529053065|FG001|Overall Study|Adverse Event|2|||
146692591|NCT00768300|529053064|FG000|Overall Study|Protocol Violation|6|||
146692592|NCT00768300|529053065|FG001|Overall Study|Protocol Violation|1|||
146692593|NCT00768300|529053064|FG000|Overall Study|Withdrawal by Subject|13|||
146692594|NCT00768300|529053065|FG001|Overall Study|Withdrawal by Subject|7|||
146692595|NCT00768300|529053064|FG000|Overall Study|Physician Decision|2|||
146692596|NCT00768300|529053065|FG001|Overall Study|Physician Decision|3|||
146692597|NCT00768300|529053064|FG000|Overall Study|Study discontinued by Sponsor|271|||
146692598|NCT00768300|529053065|FG001|Overall Study|Study discontinued by Sponsor|140|||
146692599|NCT00768300|529053064|FG000|Overall Study|Death|21|||
146692600|NCT00768300|529053065|FG001|Overall Study|Death|5|||
146692601|NCT00768300|529053064|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
146692602|NCT00768300|529053065|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
146692603|NCT00768300|529053064|FG000|Overall Study|Screen failure following randomization|1|||
146692604|NCT00768300|529053065|FG001|Overall Study|Screen failure following randomization|0|||
146692605|NCT00768300|529053064|FG000|Overall Study|Received lung transplant|1|||
146692606|NCT00768300|529053065|FG001|Overall Study|Received lung transplant|1|||
146692607|NCT00768300|529053064|FG000|Overall Study|Lost to Follow-up|0|||
146692608|NCT00768300|529053065|FG001|Overall Study|Lost to Follow-up|1|||
146692609|NCT00768300|529053064|FG000|Overall Study|Began prohibited concomitant medication|0|||
146692610|NCT00768300|529053065|FG001|Overall Study|Began prohibited concomitant medication|1|||
146692611|NCT00768300|529053064|FG000|Overall Study|Treated but never dosed with Study drug|1|||
146692612|NCT00768300|529053065|FG001|Overall Study|Treated but never dosed with Study drug|0|||
146692613|NCT00768300|529053064|FG000|Overall Study|Missing data|1|||
146692614|NCT00768300|529053065|FG001|Overall Study|Missing data|0|||
146692615|NCT02068222|529053068|FG000|Overall Study|Lost to Follow-up|1|||
146692616|NCT00281684|529053073|FG000|Overall Study|Lost to Follow-up|0|||
146692617|NCT00281684|529053074|FG001|Overall Study|Lost to Follow-up|0|||
146692618|NCT00281684|529053075|FG002|Overall Study|Lost to Follow-up|1|||
146692619|NCT00281684|529053076|FG003|Overall Study|Lost to Follow-up|0|||
146692620|NCT00281684|529053073|FG000|Overall Study|Withdrawal by Subject|1|||
146692621|NCT00281684|529053074|FG001|Overall Study|Withdrawal by Subject|0|||
146692622|NCT00281684|529053075|FG002|Overall Study|Withdrawal by Subject|0|||
146692623|NCT00281684|529053076|FG003|Overall Study|Withdrawal by Subject|0|||
146692624|NCT03642717|529053079|FG000|Overall Study|Lost to Follow-up|2|||
146692625|NCT03642717|529053079|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
146692626|NCT03642717|529053079|FG000|Overall Study|Taken study drug prior to contract date|3|||
146692627|NCT01559012|529053080|FG000|Overall Study|Withdrawal by Subject|0|||
146692628|NCT01559012|529053081|FG001|Overall Study|Withdrawal by Subject|1|||
146692629|NCT00302458|529053082|FG000|Overall Study|Lost to Follow-up|1|||
146692630|NCT00302458|529053082|FG000|Overall Study|Ineligible after screening|1|||
146692631|NCT00302458|529053082|FG000|Overall Study|Withdrawal by Subject|1|||
146692632|NCT00853723|529053086|FG000|Overall Study|Adverse Event|3|||
146692633|NCT00853723|529053087|FG001|Overall Study|Adverse Event|4|||
146692634|NCT00853723|529053088|FG002|Overall Study|Adverse Event|1|||
146692635|NCT00853723|529053086|FG000|Overall Study|Withdrawal by Subject|2|||
146692636|NCT00853723|529053087|FG001|Overall Study|Withdrawal by Subject|1|||
146692637|NCT00853723|529053088|FG002|Overall Study|Withdrawal by Subject|0|||
146692638|NCT00853723|529053086|FG000|Overall Study|Protocol Violation|1|||
146692639|NCT00853723|529053087|FG001|Overall Study|Protocol Violation|2|||
146775649|NCT05052996|529349585|FG001|Overall Study|Withdrew consent|0|||
146692640|NCT00853723|529053088|FG002|Overall Study|Protocol Violation|1|||
146692641|NCT00445965|529053089|FG000|Overall Study|Adverse Event|2|||
146692642|NCT00445965|529053089|FG000|Overall Study|Physician Decision|1|||
146692643|NCT00445965|529053089|FG000|Overall Study|Enrolled but not treated|1|||
146692644|NCT00445965|529053089|FG000|Overall Study|Removed due to progressive disease|29|||
146692645|NCT02447081|529053090|FG000|Overall Study|Death|161|||
146692646|NCT02447081|529053090|FG000|Overall Study|Lost to Follow-up|36|||
146692647|NCT02447081|529053090|FG000|Overall Study|Visit not completed|17|||
146692648|NCT02447081|529053090|FG000|Overall Study|unsuccessful implant procedure|10|||
146692649|NCT05778786|529053091|FG000|Period 1|COVID-19 Related|3|||
146692650|NCT05778786|529053092|FG001|Period 1|COVID-19 Related|3|||
146692651|NCT05778786|529053091|FG000|Period 1|Withdrew Consent during Study|1|||
146692652|NCT05778786|529053092|FG001|Period 1|Withdrew Consent during Study|0|||
146692653|NCT05778786|529053091|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
146692654|NCT05778786|529053092|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
146692655|NCT05778786|529053091|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
146692656|NCT05778786|529053092|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
146692657|NCT02867709|529053095|FG000|Treatment Period|Adverse Event|1|||
146692658|NCT02867709|529053096|FG001|Treatment Period|Adverse Event|1|||
146692659|NCT02867709|529053097|FG002|Treatment Period|Adverse Event|2|||
146692660|NCT02867709|529053095|FG000|Treatment Period|Withdrawal of Consent|7|||
146692661|NCT02867709|529053096|FG001|Treatment Period|Withdrawal of Consent|9|||
146692662|NCT02867709|529053097|FG002|Treatment Period|Withdrawal of Consent|8|||
146692663|NCT02867709|529053095|FG000|Treatment Period|Lost to Follow-up|17|||
146692664|NCT02867709|529053096|FG001|Treatment Period|Lost to Follow-up|20|||
146692665|NCT02867709|529053097|FG002|Treatment Period|Lost to Follow-up|20|||
146692666|NCT02867709|529053095|FG000|Treatment Period|Lack of Qualifying Event|42|||
146692667|NCT02867709|529053096|FG001|Treatment Period|Lack of Qualifying Event|55|||
146692668|NCT02867709|529053097|FG002|Treatment Period|Lack of Qualifying Event|42|||
146692669|NCT02867709|529053095|FG000|Treatment Period|Protocol Violation|3|||
146692670|NCT02867709|529053096|FG001|Treatment Period|Protocol Violation|2|||
146692671|NCT02867709|529053097|FG002|Treatment Period|Protocol Violation|3|||
146692672|NCT02867709|529053095|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
146692673|NCT02867709|529053096|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
146692674|NCT02867709|529053097|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
146692675|NCT02867709|529053095|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
146692676|NCT02867709|529053096|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
146692677|NCT02867709|529053097|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
146692678|NCT02867709|529053095|FG000|Safety Follow-up Period|Pregnancy|0|||
146692679|NCT02867709|529053096|FG001|Safety Follow-up Period|Pregnancy|1|||
146692680|NCT02867709|529053097|FG002|Safety Follow-up Period|Pregnancy|0|||
146692681|NCT02867709|529053095|FG000|Safety Follow-up Period|Protocol Violation|0|||
146692682|NCT02867709|529053096|FG001|Safety Follow-up Period|Protocol Violation|1|||
146692683|NCT02867709|529053097|FG002|Safety Follow-up Period|Protocol Violation|1|||
146692684|NCT03615105|529053100|FG000|Overall Study|Protocol Violation|1|||
146692685|NCT03615105|529053101|FG001|Overall Study|Protocol Violation|0|||
146692686|NCT03615105|529053102|FG002|Overall Study|Protocol Violation|0|||
146692687|NCT03615105|529053100|FG000|Overall Study|Death|0|||
146692688|NCT03615105|529053101|FG001|Overall Study|Death|2|||
146692689|NCT03615105|529053102|FG002|Overall Study|Death|0|||
146692690|NCT03313804|529053103|FG000|Treatment|Death|5|||
146692691|NCT03313804|529053103|FG000|Treatment|still on treatment|2|||
146692692|NCT03313804|529053103|FG000|Follow Up|still on follow up|3|||
146692693|NCT01502423|529053104|FG000|Overall Study|Withdrawal by Subject|0|||
146692694|NCT01502423|529053105|FG001|Overall Study|Withdrawal by Subject|1|||
146692695|NCT01545817|529054335|FG000|Pazopanib|Disease progression|51|||
146692696|NCT01545817|529054336|FG001|Pazopanib|Disease progression|0|||
146692697|NCT01545817|529054335|FG000|Pazopanib|Adverse Event|19|||
146692698|NCT01545817|529054336|FG001|Pazopanib|Adverse Event|0|||
146775650|NCT05052996|529349586|FG002|Overall Study|Withdrew consent|1|||
146775651|NCT05052996|529349587|FG003|Overall Study|Withdrew consent|2|||
146775652|NCT05052996|529349584|FG000|Overall Study|Lost to Follow-up|1|||
146692699|NCT01545817|529054335|FG000|Pazopanib|Other reason|4|||
146692700|NCT01545817|529054336|FG001|Pazopanib|Other reason|0|||
146692701|NCT01545817|529054335|FG000|Everolimus|Other reason|0|||
146692702|NCT01545817|529054336|FG001|Everolimus|Other reason|7|||
146692703|NCT01545817|529054335|FG000|Everolimus|Disease progression|0|||
146692704|NCT01545817|529054336|FG001|Everolimus|Disease progression|25|||
146692705|NCT01545817|529054335|FG000|Everolimus|Adverse Event|0|||
146692706|NCT01545817|529054336|FG001|Everolimus|Adverse Event|6|||
146692707|NCT02967692|529054337|FG000|Overall Study|Progressive disease|3|||
146692708|NCT02967692|529054338|FG001|Overall Study|Progressive disease|15|||
146692709|NCT02967692|529054339|FG002|Overall Study|Progressive disease|114|||
146692710|NCT02967692|529054340|FG003|Overall Study|Progressive disease|151|||
146692711|NCT02967692|529054337|FG000|Overall Study|Subject/guardian decision|1|||
146692712|NCT02967692|529054338|FG001|Overall Study|Subject/guardian decision|1|||
146775653|NCT05052996|529349585|FG001|Overall Study|Lost to Follow-up|0|||
146775654|NCT05052996|529349586|FG002|Overall Study|Lost to Follow-up|0|||
146692713|NCT02967692|529054339|FG002|Overall Study|Subject/guardian decision|14|||
146692714|NCT02967692|529054340|FG003|Overall Study|Subject/guardian decision|22|||
146692715|NCT02967692|529054337|FG000|Overall Study|Death|0|||
146692716|NCT02967692|529054338|FG001|Overall Study|Death|1|||
146692717|NCT02967692|529054339|FG002|Overall Study|Death|13|||
146692718|NCT02967692|529054340|FG003|Overall Study|Death|13|||
146692719|NCT02967692|529054337|FG000|Overall Study|Protocol deviation|1|||
146692720|NCT02967692|529054338|FG001|Overall Study|Protocol deviation|0|||
146692721|NCT02967692|529054339|FG002|Overall Study|Protocol deviation|1|||
146692722|NCT02967692|529054340|FG003|Overall Study|Protocol deviation|1|||
146692723|NCT02967692|529054337|FG000|Overall Study|Lost to Follow-up|0|||
146692724|NCT02967692|529054338|FG001|Overall Study|Lost to Follow-up|0|||
146692725|NCT02967692|529054339|FG002|Overall Study|Lost to Follow-up|1|||
146692726|NCT02967692|529054340|FG003|Overall Study|Lost to Follow-up|0|||
146692727|NCT02967692|529054337|FG000|Overall Study|Physician Decision|0|||
146692728|NCT02967692|529054338|FG001|Overall Study|Physician Decision|0|||
146692729|NCT02967692|529054339|FG002|Overall Study|Physician Decision|22|||
146692730|NCT02967692|529054340|FG003|Overall Study|Physician Decision|13|||
146692731|NCT02967692|529054337|FG000|Overall Study|Adverse Event|2|||
146692732|NCT02967692|529054338|FG001|Overall Study|Adverse Event|9|||
146692733|NCT02967692|529054339|FG002|Overall Study|Adverse Event|60|||
146692734|NCT02967692|529054340|FG003|Overall Study|Adverse Event|28|||
146692735|NCT02967692|529054337|FG000|Overall Study|Study terminated by sponsor|2|||
146692736|NCT02967692|529054338|FG001|Overall Study|Study terminated by sponsor|1|||
146692737|NCT02967692|529054339|FG002|Overall Study|Study terminated by sponsor|42|||
146692738|NCT02967692|529054340|FG003|Overall Study|Study terminated by sponsor|37|||
146692739|NCT00066066|529054343|FG000|Overall Study|Lost to Follow-up|6|||
146692740|NCT00066066|529054344|FG001|Overall Study|Lost to Follow-up|4|||
146692741|NCT00066066|529054345|FG002|Overall Study|Lost to Follow-up|7|||
146692742|NCT00066066|529054346|FG003|Overall Study|Lost to Follow-up|4|||
146692743|NCT00066066|529054347|FG004|Overall Study|Lost to Follow-up|3|||
146692744|NCT00066066|529054348|FG005|Overall Study|Lost to Follow-up|5|||
146692745|NCT03257631|529054357|FG000|Overall Study|Death|1|||
146692746|NCT03257631|529054358|FG001|Overall Study|Death|0|||
146692747|NCT03257631|529054359|FG002|Overall Study|Death|1|||
146692748|NCT03257631|529054360|FG003|Overall Study|Death|1|||
146692749|NCT03257631|529054357|FG000|Overall Study|Progressive Disease|10|||
146692750|NCT03257631|529054358|FG001|Overall Study|Progressive Disease|9|||
146692751|NCT03257631|529054359|FG002|Overall Study|Progressive Disease|17|||
146692752|NCT03257631|529054360|FG003|Overall Study|Progressive Disease|8|||
146692753|NCT03257631|529054357|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146692754|NCT03257631|529054358|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146692755|NCT03257631|529054359|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
146692756|NCT03257631|529054360|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
146692757|NCT03257631|529054357|FG000|Overall Study|Adverse Event|0|||
146692758|NCT03257631|529054358|FG001|Overall Study|Adverse Event|0|||
146692759|NCT03257631|529054359|FG002|Overall Study|Adverse Event|2|||
146692760|NCT03257631|529054360|FG003|Overall Study|Adverse Event|0|||
146692761|NCT02529137|529054361|FG000|Overall Study|Discontinuation for different reasons|8|||
146692762|NCT01649375|529054362|FG000|Up to Week 16|Adverse Event|2|||
146692763|NCT01649375|529054363|FG001|Up to Week 16|Adverse Event|5|||
146775655|NCT05052996|529349587|FG003|Overall Study|Lost to Follow-up|2|||
146775656|NCT05052996|529349584|FG000|Overall Study|Adverse Event|0|||
146775657|NCT05052996|529349585|FG001|Overall Study|Adverse Event|0|||
146775658|NCT05052996|529349586|FG002|Overall Study|Adverse Event|2|||
146775659|NCT05052996|529349587|FG003|Overall Study|Adverse Event|0|||
146775660|NCT05052996|529349584|FG000|Overall Study|Randomized but never treated|0|||
146775661|NCT05052996|529349585|FG001|Overall Study|Randomized but never treated|0|||
146692764|NCT01649375|529054364|FG002|Up to Week 16|Adverse Event|4|||
146692765|NCT01649375|529054365|FG003|Up to Week 16|Adverse Event|0|||
146692766|NCT01649375|529054366|FG004|Up to Week 16|Adverse Event|0|||
146692767|NCT01649375|529054362|FG000|Up to Week 16|Lack of Efficacy|0|||
146692768|NCT01649375|529054363|FG001|Up to Week 16|Lack of Efficacy|0|||
146775662|NCT05052996|529349586|FG002|Overall Study|Randomized but never treated|1|||
146929831|NCT01658579|529900923|FG003|Treatment Period B|Other|1|||
146692769|NCT01649375|529054364|FG002|Up to Week 16|Lack of Efficacy|1|||
146692770|NCT01649375|529054365|FG003|Up to Week 16|Lack of Efficacy|0|||
146692771|NCT01649375|529054366|FG004|Up to Week 16|Lack of Efficacy|0|||
146692772|NCT01649375|529054362|FG000|Up to Week 16|Physician Decision|0|||
146692773|NCT01649375|529054363|FG001|Up to Week 16|Physician Decision|0|||
146692774|NCT01649375|529054364|FG002|Up to Week 16|Physician Decision|1|||
146692775|NCT01649375|529054365|FG003|Up to Week 16|Physician Decision|0|||
146692776|NCT01649375|529054366|FG004|Up to Week 16|Physician Decision|0|||
146692777|NCT01649375|529054362|FG000|Up to Week 16|Withdrawal by Subject|2|||
146692778|NCT01649375|529054363|FG001|Up to Week 16|Withdrawal by Subject|1|||
146692779|NCT01649375|529054364|FG002|Up to Week 16|Withdrawal by Subject|2|||
146692780|NCT01649375|529054365|FG003|Up to Week 16|Withdrawal by Subject|0|||
146692781|NCT01649375|529054366|FG004|Up to Week 16|Withdrawal by Subject|0|||
146775663|NCT05052996|529349587|FG003|Overall Study|Randomized but never treated|1|||
146692782|NCT01649375|529054362|FG000|Up to Week 16|Death|1|||
146692783|NCT01649375|529054363|FG001|Up to Week 16|Death|0|||
146692784|NCT01649375|529054364|FG002|Up to Week 16|Death|0|||
146692785|NCT01649375|529054365|FG003|Up to Week 16|Death|0|||
146692786|NCT01649375|529054366|FG004|Up to Week 16|Death|0|||
146692787|NCT01649375|529054362|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
146692788|NCT01649375|529054363|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
146692789|NCT01649375|529054364|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
146692790|NCT01649375|529054365|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
146692791|NCT01649375|529054366|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
146692792|NCT01649375|529054362|FG000|Week 16 up to Week 260|Non-compliance|0|||
146692793|NCT01649375|529054363|FG001|Week 16 up to Week 260|Non-compliance|1|||
146692794|NCT01649375|529054364|FG002|Week 16 up to Week 260|Non-compliance|0|||
146692795|NCT01649375|529054365|FG003|Week 16 up to Week 260|Non-compliance|1|||
146692796|NCT01649375|529054366|FG004|Week 16 up to Week 260|Non-compliance|0|||
146692797|NCT01649375|529054362|FG000|Week 16 up to Week 260|Physician Decision|0|||
146692798|NCT01649375|529054363|FG001|Week 16 up to Week 260|Physician Decision|2|||
146692799|NCT01649375|529054364|FG002|Week 16 up to Week 260|Physician Decision|0|||
146692800|NCT01649375|529054365|FG003|Week 16 up to Week 260|Physician Decision|0|||
146692801|NCT01649375|529054366|FG004|Week 16 up to Week 260|Physician Decision|0|||
146692802|NCT01649375|529054362|FG000|Week 16 up to Week 260|Technical issues|0|||
146692803|NCT01649375|529054363|FG001|Week 16 up to Week 260|Technical issues|1|||
146692804|NCT01649375|529054364|FG002|Week 16 up to Week 260|Technical issues|0|||
146692805|NCT01649375|529054365|FG003|Week 16 up to Week 260|Technical issues|1|||
146692806|NCT01649375|529054366|FG004|Week 16 up to Week 260|Technical issues|0|||
146692807|NCT01649375|529054362|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
146692808|NCT01649375|529054363|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
146692809|NCT01649375|529054364|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
146692810|NCT01649375|529054365|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
146692811|NCT01649375|529054366|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
146692812|NCT01649375|529054362|FG000|Week 16 up to Week 260|Death|1|||
146692813|NCT01649375|529054363|FG001|Week 16 up to Week 260|Death|1|||
146692814|NCT01649375|529054364|FG002|Week 16 up to Week 260|Death|0|||
146692815|NCT01649375|529054365|FG003|Week 16 up to Week 260|Death|0|||
146692816|NCT01649375|529054366|FG004|Week 16 up to Week 260|Death|0|||
146692817|NCT01649375|529054362|FG000|Week 16 up to Week 260|Adverse Event|5|||
146692818|NCT01649375|529054363|FG001|Week 16 up to Week 260|Adverse Event|2|||
146692819|NCT01649375|529054364|FG002|Week 16 up to Week 260|Adverse Event|0|||
146692820|NCT01649375|529054365|FG003|Week 16 up to Week 260|Adverse Event|3|||
146692821|NCT01649375|529054366|FG004|Week 16 up to Week 260|Adverse Event|2|||
146692822|NCT01124604|529054367|FG000|Overall Study|Adverse Event|10|||
146692823|NCT01124604|529054368|FG001|Overall Study|Adverse Event|1|||
146692824|NCT01124604|529054367|FG000|Overall Study|Lack of Efficacy|1|||
146692825|NCT01124604|529054368|FG001|Overall Study|Lack of Efficacy|0|||
146692826|NCT01124604|529054367|FG000|Overall Study|Withdrawal by Subject|4|||
146692827|NCT01124604|529054368|FG001|Overall Study|Withdrawal by Subject|0|||
146692828|NCT01124604|529054367|FG000|Overall Study|Disease Progression|0|||
146692829|NCT01124604|529054368|FG001|Overall Study|Disease Progression|1|||
146692830|NCT03102918|529054369|FG000|Overall Study|Protocol Violation|1|||
146692831|NCT03102918|529054370|FG001|Overall Study|Protocol Violation|0|||
146692832|NCT00952341|529054372|FG000|Cycle 1|Adverse Event|4|||
146692833|NCT00952341|529054373|FG001|Cycle 1|Adverse Event|1|||
146692834|NCT00952341|529054372|FG000|Cycle 1|Withdrawal by Subject|3|||
146692835|NCT00952341|529054373|FG001|Cycle 1|Withdrawal by Subject|8|||
146692836|NCT00952341|529054372|FG000|Cycle 1|Protocol Violation|2|||
146692837|NCT00952341|529054373|FG001|Cycle 1|Protocol Violation|1|||
146692838|NCT00952341|529054372|FG000|Cycle 1|Lost to Follow-up|11|||
146692839|NCT00952341|529054373|FG001|Cycle 1|Lost to Follow-up|2|||
146692840|NCT00952341|529054372|FG000|Cycle 1|Physician Decision|0|||
146692841|NCT00952341|529054373|FG001|Cycle 1|Physician Decision|1|||
146692842|NCT00952341|529054372|FG000|Cycle 2|Withdrawal by Subject|1|||
146929832|NCT04580394|529900924|FG000|First Intervention|Incorrectly Randomized|1|||
146929833|NCT04580394|529900924|FG000|First Intervention|Physician Decision|1|||
146692843|NCT00952341|529054373|FG001|Cycle 2|Withdrawal by Subject|1|||
146692844|NCT00952341|529054372|FG000|Cycle 2|Protocol Violation|1|||
146929834|NCT04580394|529900924|FG000|First Intervention|Lost to Follow-up|1|||
146692845|NCT00952341|529054373|FG001|Cycle 2|Protocol Violation|0|||
146692846|NCT00952341|529054372|FG000|Cycle 2|Lost to Follow-up|6|||
146692847|NCT00952341|529054373|FG001|Cycle 2|Lost to Follow-up|9|||
146692848|NCT00952341|529054372|FG000|Cycle 2|Physician Decision|1|||
146692849|NCT00952341|529054373|FG001|Cycle 2|Physician Decision|1|||
146692850|NCT00952341|529054372|FG000|Cycle 2|Progressive Disease|0|||
146692851|NCT00952341|529054373|FG001|Cycle 2|Progressive Disease|1|||
146692852|NCT02066467|529054376|FG000|Overall Study|Did not undergo implant procedure|24|||
146692853|NCT02066467|529054376|FG000|Overall Study|Attempted to implant withoput success|43|||
146692854|NCT02066467|529054376|FG000|Overall Study|Consent ineligible|1|||
146692855|NCT02066467|529054376|FG000|Overall Study|Death|54|||
146692856|NCT02066467|529054376|FG000|Overall Study|Lost to Follow-up|51|||
146692857|NCT02066467|529054376|FG000|Overall Study|Adverse Event|20|||
146929835|NCT04580394|529900924|FG000|Washout (One Week)|Withdrawal by Subject|1|||
146929836|NCT04580394|529900924|FG000|Washout (One Week)|Adverse Event|1|||
146692858|NCT02066467|529054376|FG000|Overall Study|Withdrawal by Subject|16|||
146692859|NCT02066467|529054376|FG000|Overall Study|Physician Decision|2|||
146692860|NCT02066467|529054376|FG000|Overall Study|Not defined|4|||
146692861|NCT03056755|529054377|FG000|Treatment- Core Phase|Progressive disease|89|||
146692862|NCT03056755|529054378|FG001|Treatment- Core Phase|Progressive disease|88|||
146692863|NCT03056755|529054379|FG002|Treatment- Core Phase|Progressive disease|90|||
146692864|NCT03056755|529054377|FG000|Treatment- Core Phase|Adverse Event|20|||
146692865|NCT03056755|529054378|FG001|Treatment- Core Phase|Adverse Event|14|||
146692866|NCT03056755|529054379|FG002|Treatment- Core Phase|Adverse Event|13|||
146692867|NCT03056755|529054377|FG000|Treatment- Core Phase|Physician Decision|7|||
146692868|NCT03056755|529054378|FG001|Treatment- Core Phase|Physician Decision|13|||
146692869|NCT03056755|529054379|FG002|Treatment- Core Phase|Physician Decision|5|||
146692870|NCT03056755|529054377|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
146692871|NCT03056755|529054378|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
146692872|NCT03056755|529054379|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
146692873|NCT03056755|529054377|FG000|Treatment- Core Phase|Death|3|||
146692874|NCT03056755|529054378|FG001|Treatment- Core Phase|Death|2|||
146692875|NCT03056755|529054379|FG002|Treatment- Core Phase|Death|4|||
146692876|NCT03056755|529054377|FG000|Treatment- Core Phase|Protocol deviation|1|||
146692877|NCT03056755|529054378|FG001|Treatment- Core Phase|Protocol deviation|1|||
146692878|NCT03056755|529054379|FG002|Treatment- Core Phase|Protocol deviation|0|||
146692879|NCT03056755|529054377|FG000|Treatment- Core Phase|Technical problems|1|||
146692880|NCT03056755|529054378|FG001|Treatment- Core Phase|Technical problems|0|||
146692881|NCT03056755|529054379|FG002|Treatment- Core Phase|Technical problems|0|||
146692882|NCT03056755|529054377|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
146692883|NCT03056755|529054378|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
146692884|NCT03056755|529054379|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
146692885|NCT03056755|529054377|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
146692886|NCT03056755|529054378|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
146692887|NCT03056755|529054379|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
146692888|NCT03056755|529054377|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
146692889|NCT03056755|529054378|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
146692890|NCT03056755|529054379|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
146692891|NCT03056755|529054377|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
146692892|NCT03056755|529054378|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
146692893|NCT03056755|529054379|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
146692894|NCT04461015|529054382|FG000|Overall Study|IV access lost during the study|0|||
146692895|NCT04461015|529054383|FG001|Overall Study|IV access lost during the study|1|||
146692896|NCT04461015|529054382|FG000|Overall Study|Withdrawal by Subject|0|||
146692897|NCT04461015|529054383|FG001|Overall Study|Withdrawal by Subject|1|||
146692898|NCT00464568|529054384|FG000|Overall Study|Adverse Event|2|||
146692899|NCT02864251|529054398|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
146692900|NCT02864251|529054399|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
146692901|NCT02864251|529054400|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
146692902|NCT02864251|529054398|FG000|Pre-Treatment|Withdrawal by Participant|0|||
146692903|NCT02864251|529054399|FG001|Pre-Treatment|Withdrawal by Participant|0|||
146692904|NCT02864251|529054400|FG002|Pre-Treatment|Withdrawal by Participant|4|||
146692905|NCT02864251|529054398|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
146692906|NCT02864251|529054399|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
146692907|NCT02864251|529054400|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
146692908|NCT02864251|529054398|FG000|Pre-Treatment|Other Reasons|0|||
146692909|NCT02864251|529054399|FG001|Pre-Treatment|Other Reasons|1|||
146692910|NCT02864251|529054400|FG002|Pre-Treatment|Other Reasons|1|||
146692911|NCT02864251|529054398|FG000|Treatment|Disease Progression|109|||
146692912|NCT02864251|529054399|FG001|Treatment|Disease Progression|52|||
146692913|NCT02864251|529054400|FG002|Treatment|Disease Progression|101|||
146692914|NCT02864251|529054398|FG000|Treatment|Study Drug Toxicity|9|||
146692915|NCT02864251|529054399|FG001|Treatment|Study Drug Toxicity|4|||
146692916|NCT02864251|529054400|FG002|Treatment|Study Drug Toxicity|10|||
146692917|NCT02864251|529054398|FG000|Treatment|Death|0|||
146692918|NCT02864251|529054399|FG001|Treatment|Death|2|||
146692919|NCT02864251|529054400|FG002|Treatment|Death|3|||
146692920|NCT02864251|529054398|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
146929837|NCT04580394|529900924|FG000|Washout (One Week)|Withdrawal by Subject|2|||
146692921|NCT02864251|529054399|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
146692922|NCT02864251|529054400|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
146692923|NCT02864251|529054398|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
146692924|NCT02864251|529054399|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
146692925|NCT02864251|529054400|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
146692926|NCT02864251|529054398|FG000|Treatment|Withdrawal by Participant|8|||
146979997|NCT00410410|530089479|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
146979998|NCT00410410|530089480|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
146979999|NCT00410410|530089481|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
146980000|NCT00410410|530089473|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
146980001|NCT00410410|530089474|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
146980002|NCT00410410|530089475|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
146980003|NCT00410410|530089476|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
146980004|NCT00410410|530089477|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
146980005|NCT00410410|530089478|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
146980006|NCT00410410|530089479|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
146980007|NCT00410410|530089480|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
146980008|NCT00410410|530089481|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
146980009|NCT00410410|530089473|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
146980010|NCT00410410|530089474|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
146980011|NCT00410410|530089475|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
146980012|NCT00410410|530089476|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
146980013|NCT00410410|530089477|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
146980014|NCT00410410|530089478|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
146980015|NCT00410410|530089479|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
146980016|NCT00410410|530089480|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
146980017|NCT00410410|530089481|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
146980018|NCT00410410|530089473|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
146980019|NCT00410410|530089474|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
146980020|NCT00410410|530089475|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
146980021|NCT00410410|530089476|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
146980022|NCT00410410|530089477|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
146980023|NCT00410410|530089478|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
146980024|NCT00410410|530089479|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
146980025|NCT00410410|530089480|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
146980026|NCT00410410|530089481|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
146980027|NCT00410410|530089473|FG000|Open-Label Period (OL)|Death|0|||
146980028|NCT00410410|530089474|FG001|Open-Label Period (OL)|Death|0|||
146980029|NCT00410410|530089475|FG002|Open-Label Period (OL)|Death|0|||
146980030|NCT00410410|530089476|FG003|Open-Label Period (OL)|Death|0|||
146980031|NCT00410410|530089477|FG004|Open-Label Period (OL)|Death|0|||
146980032|NCT00410410|530089478|FG005|Open-Label Period (OL)|Death|0|||
146980033|NCT00410410|530089479|FG006|Open-Label Period (OL)|Death|0|||
146980034|NCT00410410|530089480|FG007|Open-Label Period (OL)|Death|0|||
146980035|NCT00410410|530089481|FG008|Open-Label Period (OL)|Death|1|||
146980036|NCT00410410|530089473|FG000|Open-Label Period (OL)|Adverse Event|0|||
146692927|NCT02864251|529054399|FG001|Treatment|Withdrawal by Participant|5|||
146692928|NCT02864251|529054400|FG002|Treatment|Withdrawal by Participant|13|||
146692929|NCT02864251|529054398|FG000|Treatment|Maximum Clinical Benefit|1|||
146692930|NCT02864251|529054399|FG001|Treatment|Maximum Clinical Benefit|0|||
146692931|NCT02864251|529054400|FG002|Treatment|Maximum Clinical Benefit|1|||
146692932|NCT02864251|529054398|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
146692933|NCT02864251|529054399|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
146692934|NCT02864251|529054400|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
146692935|NCT02864251|529054398|FG000|Treatment|Other Reasons|1|||
146692936|NCT02864251|529054399|FG001|Treatment|Other Reasons|1|||
146692937|NCT02864251|529054400|FG002|Treatment|Other Reasons|4|||
146692938|NCT02864251|529054398|FG000|Treatment|Administrative Reason by Sponsor|1|||
146692939|NCT02864251|529054399|FG001|Treatment|Administrative Reason by Sponsor|0|||
146692940|NCT02864251|529054400|FG002|Treatment|Administrative Reason by Sponsor|0|||
146692941|NCT03506373|529054401|FG000|Overall Study|Adverse Event|6|||
146692942|NCT03506373|529054401|FG000|Overall Study|Withdrawal by Subject|2|||
146692943|NCT03506373|529054401|FG000|Overall Study|Disease progression|5|||
146692944|NCT03506373|529054401|FG000|Overall Study|Other|3|||
146980037|NCT00410410|530089474|FG001|Open-Label Period (OL)|Adverse Event|0|||
146980038|NCT00410410|530089475|FG002|Open-Label Period (OL)|Adverse Event|0|||
146980039|NCT00410410|530089476|FG003|Open-Label Period (OL)|Adverse Event|0|||
146980040|NCT00410410|530089477|FG004|Open-Label Period (OL)|Adverse Event|0|||
146980041|NCT00410410|530089478|FG005|Open-Label Period (OL)|Adverse Event|0|||
146980042|NCT00410410|530089479|FG006|Open-Label Period (OL)|Adverse Event|0|||
146980043|NCT00410410|530089480|FG007|Open-Label Period (OL)|Adverse Event|0|||
146980044|NCT00410410|530089481|FG008|Open-Label Period (OL)|Adverse Event|10|||
146980045|NCT00410410|530089473|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
146980046|NCT00410410|530089474|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
146980047|NCT00410410|530089475|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
146980048|NCT00410410|530089476|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
146980049|NCT00410410|530089477|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
146692945|NCT00885755|529054402|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
146692946|NCT00885755|529054403|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
146692947|NCT00885755|529054404|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
146692948|NCT00885755|529054402|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
146692949|NCT00885755|529054403|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
146692950|NCT00885755|529054404|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
146692951|NCT00885755|529054402|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
146692952|NCT00885755|529054403|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
146692953|NCT00885755|529054404|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
146692954|NCT00885755|529054402|FG000|Part I: Trastuzumab+Taxane|Death|0|||
146692955|NCT00885755|529054403|FG001|Part I: Trastuzumab+Taxane|Death|0|||
146775664|NCT05052996|529349584|FG000|Overall Study|Protocol Violation|1|||
146775665|NCT05052996|529349585|FG001|Overall Study|Protocol Violation|0|||
146775666|NCT05052996|529349586|FG002|Overall Study|Protocol Violation|0|||
146775667|NCT05052996|529349587|FG003|Overall Study|Protocol Violation|0|||
146775668|NCT03951805|529349588|FG000|Overall Study|Adverse Event|1|||
146775669|NCT03951805|529349589|FG001|Overall Study|Adverse Event|0|||
146775670|NCT03951805|529349590|FG002|Overall Study|Adverse Event|0|||
146775671|NCT03951805|529349591|FG003|Overall Study|Adverse Event|0|||
146775672|NCT05782231|529349593|FG000|Overall Study|Withdrawal by Subject|1|||
146775673|NCT01198145|529349594|FG000|Overall Study|Withdrawal by Subject|1|||
146775674|NCT01198145|529349595|FG001|Overall Study|Withdrawal by Subject|1|||
146775675|NCT03830866|529349596|FG000|Overall Study|Death|90|||
146775676|NCT03830866|529349597|FG001|Overall Study|Death|111|||
146775677|NCT03830866|529349596|FG000|Overall Study|Lost to Follow-up|7|||
146775678|NCT03830866|529349597|FG001|Overall Study|Lost to Follow-up|7|||
146775679|NCT03830866|529349596|FG000|Overall Study|Withdrawal by Subject|19|||
146775680|NCT03830866|529349597|FG001|Overall Study|Withdrawal by Subject|16|||
146775681|NCT03830866|529349596|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
146775682|NCT03830866|529349597|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
146775683|NCT03830866|529349596|FG000|Overall Study|Other|1|||
146775684|NCT03830866|529349597|FG001|Overall Study|Other|1|||
146775685|NCT00510887|529349599|FG000|Overall Study|Lost to Follow-up|1|||
146775686|NCT02692417|529349608|FG000|Overall Study|Withdrawal by Subject|5|||
146775687|NCT02692417|529349609|FG001|Overall Study|Withdrawal by Subject|1|||
146775688|NCT02692417|529349608|FG000|Overall Study|Adverse Event|1|||
146775689|NCT02692417|529349609|FG001|Overall Study|Adverse Event|0|||
146775690|NCT01803555|529349614|FG000|Overall Study|Adverse Event|3|||
146775691|NCT01803555|529349615|FG001|Overall Study|Adverse Event|2|||
146775692|NCT01803555|529349614|FG000|Overall Study|Withdrawal by Subject|3|||
146775693|NCT01803555|529349615|FG001|Overall Study|Withdrawal by Subject|3|||
146775694|NCT01803555|529349614|FG000|Overall Study|Non-compliance|1|||
146775695|NCT01803555|529349615|FG001|Overall Study|Non-compliance|1|||
146775696|NCT01803555|529349614|FG000|Overall Study|Protocol Violation|3|||
146775697|NCT01803555|529349615|FG001|Overall Study|Protocol Violation|5|||
146775698|NCT01803555|529349614|FG000|Overall Study|Lost to Follow-up|0|||
146775699|NCT01803555|529349615|FG001|Overall Study|Lost to Follow-up|2|||
146775700|NCT01803555|529349614|FG000|Overall Study|Other than specified|3|||
146775701|NCT01803555|529349615|FG001|Overall Study|Other than specified|5|||
146775702|NCT01551355|529349616|FG000|Overall Study|Lost to Follow-up|51|||
146775703|NCT01551355|529349617|FG001|Overall Study|Lost to Follow-up|49|||
146775704|NCT01551355|529349618|FG002|Overall Study|Lost to Follow-up|34|||
146775705|NCT01551355|529349619|FG003|Overall Study|Lost to Follow-up|24|||
146775706|NCT01551355|529349620|FG004|Overall Study|Lost to Follow-up|9|||
146775707|NCT01551355|529349621|FG005|Overall Study|Lost to Follow-up|6|||
146775708|NCT02409667|529349622|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
146775709|NCT02409667|529349623|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
146775710|NCT02409667|529349624|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
146775711|NCT02409667|529349625|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
146775712|NCT02409667|529349626|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
146775713|NCT02409667|529349622|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
146775714|NCT02409667|529349623|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
146775715|NCT02409667|529349624|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
146775716|NCT02409667|529349625|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
146775717|NCT02409667|529349626|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
146775718|NCT02409667|529349622|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
146692956|NCT00885755|529054404|FG002|Part I: Trastuzumab+Taxane|Death|1|||
146692957|NCT00885755|529054402|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
146775719|NCT02409667|529349623|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
146692958|NCT00885755|529054403|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
146775720|NCT02409667|529349624|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
146692959|NCT00885755|529054404|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
146775721|NCT02409667|529349625|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
146775722|NCT02409667|529349626|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
146775723|NCT02409667|529349622|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
146775724|NCT02409667|529349623|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
146692960|NCT02120950|529054410|FG000|Overall Study|Adverse Event|5|||
146775725|NCT02409667|529349624|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
146775726|NCT02409667|529349625|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
146775727|NCT02409667|529349626|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
146775728|NCT02409667|529349622|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
146775729|NCT02409667|529349623|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
146775730|NCT02409667|529349624|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
146775731|NCT02409667|529349625|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
146775732|NCT02409667|529349626|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
146692961|NCT02120950|529054411|FG001|Overall Study|Adverse Event|4|||
146692962|NCT02120950|529054412|FG002|Overall Study|Adverse Event|3|||
146692963|NCT02120950|529054410|FG000|Overall Study|Death|3|||
146692964|NCT02120950|529054411|FG001|Overall Study|Death|0|||
146692965|NCT02120950|529054412|FG002|Overall Study|Death|1|||
146692966|NCT02120950|529054410|FG000|Overall Study|Withdrawal by Subject|6|||
146692967|NCT02120950|529054411|FG001|Overall Study|Withdrawal by Subject|3|||
146692968|NCT02120950|529054412|FG002|Overall Study|Withdrawal by Subject|2|||
146692969|NCT02120950|529054410|FG000|Overall Study|Protocol Violation|1|||
146692970|NCT02120950|529054411|FG001|Overall Study|Protocol Violation|1|||
146692971|NCT02120950|529054412|FG002|Overall Study|Protocol Violation|7|||
146692972|NCT02120950|529054410|FG000|Overall Study|Other reasons|5|||
146692973|NCT02120950|529054411|FG001|Overall Study|Other reasons|4|||
146775733|NCT02409667|529349622|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
146775734|NCT02409667|529349623|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
146775735|NCT02409667|529349624|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
146775736|NCT02409667|529349625|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
146929838|NCT04580394|529900924|FG000|Third Intervention|Adverse Event|1|||
146929839|NCT04580394|529900924|FG000|Third Intervention|Withdrawal by Subject|1|||
146929840|NCT04580394|529900924|FG000|Washout (One Week)|Withdrawal by Subject|2|||
146929841|NCT01464788|529900925|FG000|Overall Study|Lost to Follow-up|0|||
146929842|NCT01464788|529900926|FG001|Overall Study|Lost to Follow-up|1|||
146929843|NCT01464788|529900927|FG002|Overall Study|Lost to Follow-up|0|||
146929844|NCT01464788|529900925|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
146929845|NCT01464788|529900926|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
146929846|NCT01464788|529900927|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
146929847|NCT04397718|529900930|FG000|Overall Study|Death|7|||
146929848|NCT04397718|529900931|FG001|Overall Study|Death|11|||
146929849|NCT04397718|529900930|FG000|Overall Study|Lost to Follow-up|0|||
146929850|NCT04397718|529900931|FG001|Overall Study|Lost to Follow-up|4|||
146929851|NCT01153893|529900932|FG000|Overall Study|Adverse Event|1|||
146929852|NCT01153893|529900933|FG001|Overall Study|Adverse Event|0|||
146929853|NCT02128763|529900938|FG000|Overall Study|Death|1|||
146929854|NCT02128763|529900939|FG001|Overall Study|Death|0|||
146929855|NCT02128763|529900938|FG000|Overall Study|Lost to Follow-up|19|||
146929856|NCT02128763|529900939|FG001|Overall Study|Lost to Follow-up|16|||
146929857|NCT03722784|529900942|FG000|Overall Study|Withdrawal by Subject|1|||
146929858|NCT03722784|529900943|FG001|Overall Study|Withdrawal by Subject|0|||
146929859|NCT03722784|529900942|FG000|Overall Study|Physician Decision|1|||
146929860|NCT03722784|529900943|FG001|Overall Study|Physician Decision|1|||
146929861|NCT03722784|529900942|FG000|Overall Study|Protocol Violation|0|||
146929862|NCT03722784|529900943|FG001|Overall Study|Protocol Violation|1|||
146929863|NCT00910429|529900946|FG000|Overall Study|Death|18|||
146929864|NCT00910429|529900947|FG001|Overall Study|Death|12|||
146929865|NCT00910429|529900946|FG000|Overall Study|Withdrawal by Subject|3|||
146929866|NCT00910429|529900947|FG001|Overall Study|Withdrawal by Subject|2|||
146929867|NCT00910429|529900946|FG000|Overall Study|Protocol Violation|1|||
146929868|NCT00910429|529900947|FG001|Overall Study|Protocol Violation|0|||
146929869|NCT00910429|529900946|FG000|Overall Study|Lost to Follow-up|2|||
146929870|NCT00910429|529900947|FG001|Overall Study|Lost to Follow-up|1|||
146929871|NCT00910429|529900946|FG000|Overall Study|Adverse Event|10|||
146929872|NCT00910429|529900947|FG001|Overall Study|Adverse Event|5|||
146929873|NCT00910429|529900946|FG000|Overall Study|Drug non-compliance|1|||
146929874|NCT00910429|529900947|FG001|Overall Study|Drug non-compliance|0|||
146692974|NCT02120950|529054412|FG002|Overall Study|Other reasons|1|||
146692975|NCT02120950|529054410|FG000|Overall Study|Lost to Follow-up|0|||
146929875|NCT00910429|529900946|FG000|Overall Study|Lack of Efficacy|4|||
146929876|NCT00910429|529900947|FG001|Overall Study|Lack of Efficacy|1|||
146929877|NCT01317615|529900948|FG000|Overall Study|Disease progression|25|||
146929878|NCT01317615|529900948|FG000|Overall Study|New cancer therapy|5|||
146929879|NCT01317615|529900948|FG000|Overall Study|Death|6|||
146929880|NCT01317615|529900948|FG000|Overall Study|Withdrawal by Subject|5|||
146929881|NCT01317615|529900948|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146692976|NCT02120950|529054411|FG001|Overall Study|Lost to Follow-up|2|||
146692977|NCT02120950|529054412|FG002|Overall Study|Lost to Follow-up|1|||
146692978|NCT02625090|529054415|FG000|Overall Study|Participant wants to be pregnant|2|||
146692979|NCT02625090|529054415|FG000|Overall Study|For the Promoter|1|||
146929882|NCT01317615|529900948|FG000|Overall Study|Adverse Event|7|||
146929883|NCT04465396|529900951|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
146929884|NCT04465396|529900952|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
146929885|NCT04465396|529900953|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
146929886|NCT04465396|529900954|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
146929887|NCT00438399|529900955|FG000|Overall Study|Lost to Follow-up|2|||
146929888|NCT00438399|529900956|FG001|Overall Study|Lost to Follow-up|2|||
146929889|NCT00438399|529900957|FG002|Overall Study|Lost to Follow-up|1|||
146929890|NCT00438399|529900958|FG003|Overall Study|Lost to Follow-up|1|||
146929891|NCT00438399|529900959|FG004|Overall Study|Lost to Follow-up|1|||
146929892|NCT00438399|529900960|FG005|Overall Study|Lost to Follow-up|1|||
146929893|NCT00438399|529900955|FG000|Overall Study|Adverse Event|0|||
146929894|NCT00438399|529900956|FG001|Overall Study|Adverse Event|0|||
146929895|NCT00438399|529900957|FG002|Overall Study|Adverse Event|1|||
146929896|NCT00438399|529900958|FG003|Overall Study|Adverse Event|1|||
146929897|NCT00438399|529900959|FG004|Overall Study|Adverse Event|0|||
146929898|NCT00438399|529900960|FG005|Overall Study|Adverse Event|1|||
146929899|NCT00438399|529900955|FG000|Overall Study|Withdrawal by Subject|5|||
146929900|NCT00438399|529900956|FG001|Overall Study|Withdrawal by Subject|6|||
146929901|NCT00438399|529900957|FG002|Overall Study|Withdrawal by Subject|3|||
146929902|NCT00438399|529900958|FG003|Overall Study|Withdrawal by Subject|2|||
146929903|NCT00438399|529900959|FG004|Overall Study|Withdrawal by Subject|2|||
146929904|NCT00438399|529900960|FG005|Overall Study|Withdrawal by Subject|2|||
146929905|NCT00438399|529900955|FG000|Overall Study|Protocol Violation|0|||
146929906|NCT00438399|529900956|FG001|Overall Study|Protocol Violation|0|||
146929907|NCT00438399|529900957|FG002|Overall Study|Protocol Violation|1|||
146929908|NCT00438399|529900958|FG003|Overall Study|Protocol Violation|0|||
146929909|NCT00438399|529900959|FG004|Overall Study|Protocol Violation|0|||
146929910|NCT00438399|529900960|FG005|Overall Study|Protocol Violation|1|||
146929911|NCT00438399|529900955|FG000|Overall Study|Subje stopped study|0|||
146929912|NCT00438399|529900956|FG001|Overall Study|Subje stopped study|0|||
146929913|NCT00438399|529900957|FG002|Overall Study|Subje stopped study|1|||
146929914|NCT00438399|529900958|FG003|Overall Study|Subje stopped study|0|||
146929915|NCT00438399|529900959|FG004|Overall Study|Subje stopped study|0|||
146929916|NCT00438399|529900960|FG005|Overall Study|Subje stopped study|0|||
146929917|NCT00438399|529900955|FG000|Overall Study|Pregnancy|0|||
146929918|NCT00438399|529900956|FG001|Overall Study|Pregnancy|0|||
146929919|NCT00438399|529900957|FG002|Overall Study|Pregnancy|0|||
146929920|NCT00438399|529900958|FG003|Overall Study|Pregnancy|0|||
146929921|NCT00438399|529900959|FG004|Overall Study|Pregnancy|0|||
146929922|NCT00438399|529900960|FG005|Overall Study|Pregnancy|1|||
146929923|NCT00438399|529900955|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
146929924|NCT00438399|529900956|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
146929925|NCT00438399|529900957|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
146929926|NCT00438399|529900958|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
146929927|NCT00438399|529900959|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
146929928|NCT00438399|529900960|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
146929929|NCT01364233|529900961|FG000|Overall Study|Lost to Follow-up|1|||
146929930|NCT03730194|529900965|FG000|First Stage Treatment|Withdrawal by Subject|1|||
146692980|NCT02625090|529054415|FG000|Overall Study|Sponsor's Decision|9|||
146692981|NCT02625090|529054415|FG000|Overall Study|Somnolence|1|||
146692982|NCT02625090|529054415|FG000|Overall Study|Study terminated by Sponsor|7|||
146692983|NCT02625090|529054415|FG000|Overall Study|Negative Benefit/Risk|1|||
146692984|NCT02625090|529054415|FG000|Overall Study|Protocol Deviation|2|||
146692985|NCT02625090|529054415|FG000|Overall Study|Lack of Efficacy|16|||
146692986|NCT02625090|529054415|FG000|Overall Study|Adverse Event|3|||
146692987|NCT02250443|529054416|FG000|Overall Study|Administrative problems|7|||
146692988|NCT02250443|529054416|FG000|Overall Study|Adverse Event|3|||
146692989|NCT01549964|529054417|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
146692990|NCT01549964|529054418|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
146692991|NCT01549964|529054419|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
146692992|NCT01549964|529054420|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
146692993|NCT01549964|529054417|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
146929931|NCT03730194|529900966|FG001|First Stage Treatment|Withdrawal by Subject|1|||
146929932|NCT03730194|529900967|FG002|First Stage Treatment|Withdrawal by Subject|0|||
146929933|NCT03730194|529900968|FG003|First Stage Treatment|Withdrawal by Subject|0|||
146929934|NCT03730194|529900969|FG004|First Stage Treatment|Withdrawal by Subject|0|||
146929935|NCT03730194|529900970|FG005|First Stage Treatment|Withdrawal by Subject|0|||
146929936|NCT03730194|529900965|FG000|First Stage Treatment|Protocol Violation|3|||
146929937|NCT03730194|529900966|FG001|First Stage Treatment|Protocol Violation|3|||
146929938|NCT03730194|529900967|FG002|First Stage Treatment|Protocol Violation|0|||
146929939|NCT03730194|529900968|FG003|First Stage Treatment|Protocol Violation|0|||
146929940|NCT03730194|529900969|FG004|First Stage Treatment|Protocol Violation|0|||
146929941|NCT03730194|529900970|FG005|First Stage Treatment|Protocol Violation|0|||
146929942|NCT01766817|529900974|FG000|Overall Study|Drug-related adverse event|1|||
146692994|NCT01549964|529054418|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
146980050|NCT00410410|530089478|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
146980051|NCT00410410|530089479|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
146980052|NCT00410410|530089480|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
146980053|NCT00410410|530089481|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
146980054|NCT00410410|530089473|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
146980055|NCT00410410|530089474|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
146980056|NCT00410410|530089475|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
146980057|NCT00410410|530089476|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
146980058|NCT00410410|530089477|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
146980059|NCT00410410|530089478|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
146980060|NCT00410410|530089479|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
146980061|NCT00410410|530089480|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
146980062|NCT00410410|530089481|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
146980063|NCT00410410|530089473|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
146980064|NCT00410410|530089474|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
146980065|NCT00410410|530089475|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
146980066|NCT00410410|530089476|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
146980067|NCT00410410|530089477|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
146980068|NCT00410410|530089478|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
146980069|NCT00410410|530089479|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
146980070|NCT00410410|530089480|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
146980071|NCT00410410|530089481|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
146980072|NCT00410410|530089473|FG000|Open-Label Period (OL)|Pregnancy|0|||
146980073|NCT00410410|530089474|FG001|Open-Label Period (OL)|Pregnancy|0|||
146980074|NCT00410410|530089475|FG002|Open-Label Period (OL)|Pregnancy|0|||
146980075|NCT00410410|530089476|FG003|Open-Label Period (OL)|Pregnancy|0|||
146980076|NCT00410410|530089477|FG004|Open-Label Period (OL)|Pregnancy|0|||
146980077|NCT00410410|530089478|FG005|Open-Label Period (OL)|Pregnancy|0|||
146980078|NCT00410410|530089479|FG006|Open-Label Period (OL)|Pregnancy|0|||
146980079|NCT00410410|530089480|FG007|Open-Label Period (OL)|Pregnancy|0|||
146980080|NCT00410410|530089481|FG008|Open-Label Period (OL)|Pregnancy|1|||
146980081|NCT00410410|530089473|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
146980082|NCT00410410|530089474|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
146980083|NCT00410410|530089475|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
146980084|NCT00410410|530089476|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
146980085|NCT00410410|530089477|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
146980086|NCT00410410|530089478|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
146980087|NCT00410410|530089479|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
146980088|NCT00410410|530089480|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
146980089|NCT00410410|530089481|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
146980090|NCT00410410|530089473|FG000|Open-Label Period (OL)|Other|0|||
146980091|NCT00410410|530089474|FG001|Open-Label Period (OL)|Other|0|||
146980092|NCT00410410|530089475|FG002|Open-Label Period (OL)|Other|0|||
146980093|NCT00410410|530089476|FG003|Open-Label Period (OL)|Other|0|||
146980094|NCT00410410|530089477|FG004|Open-Label Period (OL)|Other|0|||
146980095|NCT00410410|530089478|FG005|Open-Label Period (OL)|Other|0|||
146980096|NCT00410410|530089479|FG006|Open-Label Period (OL)|Other|0|||
146980097|NCT00410410|530089480|FG007|Open-Label Period (OL)|Other|0|||
146980098|NCT00410410|530089481|FG008|Open-Label Period (OL)|Other|7|||
146980099|NCT01783496|530089482|FG000|Overall Study|Lost to Follow-up|0|||
146980100|NCT01783496|530089483|FG001|Overall Study|Lost to Follow-up|0|||
146980101|NCT01783496|530089484|FG002|Overall Study|Lost to Follow-up|0|||
146980102|NCT01783496|530089485|FG003|Overall Study|Lost to Follow-up|2|||
146692995|NCT01549964|529054419|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
146692996|NCT01549964|529054420|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
146692997|NCT01549964|529054417|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
146692998|NCT01549964|529054418|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
146692999|NCT01549964|529054419|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
146693000|NCT01549964|529054420|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
146693001|NCT01549964|529054417|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
146693002|NCT01549964|529054418|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
146693003|NCT01549964|529054419|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
146693004|NCT01549964|529054420|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
146693005|NCT01549964|529054417|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
146693006|NCT01549964|529054418|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
146980103|NCT01783496|530089486|FG004|Overall Study|Lost to Follow-up|0|||
146980104|NCT01783496|530089487|FG005|Overall Study|Lost to Follow-up|1|||
146980105|NCT01783496|530089482|FG000|Overall Study|Withdrawal by Subject|1|||
146980106|NCT01783496|530089483|FG001|Overall Study|Withdrawal by Subject|0|||
146693007|NCT01549964|529054419|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
146693008|NCT01549964|529054420|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
146980107|NCT01783496|530089484|FG002|Overall Study|Withdrawal by Subject|0|||
146980108|NCT01783496|530089485|FG003|Overall Study|Withdrawal by Subject|0|||
146980109|NCT01783496|530089486|FG004|Overall Study|Withdrawal by Subject|0|||
146980110|NCT01783496|530089487|FG005|Overall Study|Withdrawal by Subject|0|||
146980111|NCT01023269|530089488|FG000|Overall Study|early termination of the study|2|||
146980112|NCT01023269|530089489|FG001|Overall Study|early termination of the study|0|||
146980113|NCT01953783|530089490|FG000|Overall Study|Progressive disease|2|||
146980114|NCT01789281|530089491|FG000|Overall Study|Disease progression|15|||
146980115|NCT01789281|530089492|FG001|Overall Study|Disease progression|4|||
146980116|NCT01789281|530089491|FG000|Overall Study|Adverse Event|5|||
146980117|NCT01789281|530089492|FG001|Overall Study|Adverse Event|5|||
146980118|NCT01789281|530089491|FG000|Overall Study|Withdrawal by Subject|1|||
146980119|NCT01789281|530089492|FG001|Overall Study|Withdrawal by Subject|0|||
146980120|NCT01789281|530089491|FG000|Overall Study|Lost to Follow-up|1|||
146980121|NCT01789281|530089492|FG001|Overall Study|Lost to Follow-up|0|||
146980122|NCT01789281|530089491|FG000|Overall Study|Administrative problems|0|||
146980123|NCT01789281|530089492|FG001|Overall Study|Administrative problems|1|||
146980124|NCT00686920|530089493|FG000|Overall Study|Death|45|||
146980125|NCT00686920|530089494|FG001|Overall Study|Death|14|||
146980126|NCT00686920|530089493|FG000|Overall Study|Liver Transplant|23|||
146980127|NCT00686920|530089494|FG001|Overall Study|Liver Transplant|8|||
146980128|NCT00686920|530089493|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
146980129|NCT00686920|530089494|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
146980130|NCT00686920|530089493|FG000|Overall Study|Withdrawal by Subject|23|||
146980131|NCT00686920|530089494|FG001|Overall Study|Withdrawal by Subject|5|||
146980132|NCT00686920|530089493|FG000|Overall Study|Protocol Violation|2|||
146693009|NCT01549964|529054417|FG000|24-Week Treatment Period|Other|1|||
146693010|NCT01549964|529054418|FG001|24-Week Treatment Period|Other|0|||
146693011|NCT01549964|529054419|FG002|24-Week Treatment Period|Other|1|||
146693012|NCT01549964|529054420|FG003|24-Week Treatment Period|Other|0|||
146693013|NCT01549964|529054417|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
146693014|NCT01549964|529054418|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
146693015|NCT01549964|529054419|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
146693016|NCT01549964|529054420|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
146693017|NCT01549964|529054417|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
146693018|NCT01549964|529054418|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
146693019|NCT01549964|529054419|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
146693020|NCT01549964|529054420|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
146693021|NCT01549964|529054417|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
146693022|NCT01549964|529054418|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
146693023|NCT01549964|529054419|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
146693024|NCT01549964|529054420|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
146693025|NCT01549964|529054417|FG000|80-Week Extension Period|Pregnancy|0|||
146693026|NCT01549964|529054418|FG001|80-Week Extension Period|Pregnancy|0|||
146693027|NCT01549964|529054419|FG002|80-Week Extension Period|Pregnancy|1|||
146693028|NCT01549964|529054420|FG003|80-Week Extension Period|Pregnancy|0|||
146693029|NCT01549964|529054417|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
146693030|NCT01549964|529054418|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
146693031|NCT01549964|529054419|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
146693032|NCT01549964|529054420|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
146693033|NCT01549964|529054417|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
146693034|NCT01549964|529054418|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
146693035|NCT01549964|529054419|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
146693036|NCT01549964|529054420|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
146693037|NCT01549964|529054417|FG000|80-Week Extension Period|Lost to Follow-up|1|||
146693038|NCT01549964|529054418|FG001|80-Week Extension Period|Lost to Follow-up|0|||
146693039|NCT01549964|529054419|FG002|80-Week Extension Period|Lost to Follow-up|2|||
146693040|NCT01549964|529054420|FG003|80-Week Extension Period|Lost to Follow-up|1|||
146693041|NCT01549964|529054417|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
146693042|NCT01549964|529054418|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
146693043|NCT01549964|529054419|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
146693044|NCT01549964|529054420|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
146693045|NCT01520363|529054426|FG000|Overall Study|Withdrawal by Subject|2|||
146693046|NCT01520363|529054427|FG001|Overall Study|Withdrawal by Subject|0|||
146693047|NCT04191382|529054434|FG000|Overall Study|Withdrawal by Subject|1|||
146980133|NCT00686920|530089494|FG001|Overall Study|Protocol Violation|1|||
146980134|NCT00686920|530089493|FG000|Overall Study|Adverse Event|10|||
146980135|NCT00686920|530089494|FG001|Overall Study|Adverse Event|2|||
146980136|NCT00686920|530089493|FG000|Overall Study|Personal Reason|0|||
146980137|NCT00686920|530089494|FG001|Overall Study|Personal Reason|1|||
146980138|NCT00686920|530089493|FG000|Overall Study|Lost to Follow-up|15|||
146980139|NCT00686920|530089494|FG001|Overall Study|Lost to Follow-up|3|||
146980140|NCT00686920|530089493|FG000|Overall Study|Moved to Another State|1|||
146980141|NCT00686920|530089494|FG001|Overall Study|Moved to Another State|0|||
146693048|NCT04191382|529054435|FG001|Overall Study|Withdrawal by Subject|0|||
146980142|NCT00686920|530089493|FG000|Overall Study|Transferred to Nursing Home|1|||
146693049|NCT04191382|529054436|FG002|Overall Study|Withdrawal by Subject|0|||
146693050|NCT05237206|529054437|FG000|Overall Study|screen failure-did not receive treatment|8|||
146693051|NCT05237206|529054437|FG000|Overall Study|did not receive treatment|3|||
146693052|NCT01476696|529054440|FG000|Overall Study|Sponsor decision|2|||
146693053|NCT01476696|529054441|FG001|Overall Study|Sponsor decision|1|||
146693054|NCT01476696|529054442|FG002|Overall Study|Sponsor decision|0|||
146693055|NCT01476696|529054440|FG000|Overall Study|Withdrawal by Subject|1|||
146693056|NCT01476696|529054441|FG001|Overall Study|Withdrawal by Subject|0|||
146693057|NCT01476696|529054442|FG002|Overall Study|Withdrawal by Subject|0|||
146693058|NCT03965962|529054448|FG000|Overall Study|Adverse Event|1|||
146693059|NCT03965962|529054449|FG001|Overall Study|Adverse Event|0|||
146693060|NCT03965962|529054450|FG002|Overall Study|Adverse Event|0|||
146693061|NCT03965962|529054451|FG003|Overall Study|Adverse Event|0|||
146693062|NCT03965962|529054448|FG000|Overall Study|Protocol Violation|21|||
146693063|NCT03965962|529054449|FG001|Overall Study|Protocol Violation|4|||
146693064|NCT03965962|529054450|FG002|Overall Study|Protocol Violation|10|||
146693065|NCT03965962|529054451|FG003|Overall Study|Protocol Violation|5|||
146693066|NCT03965962|529054448|FG000|Overall Study|Lost to Follow-up|0|||
146693067|NCT03965962|529054449|FG001|Overall Study|Lost to Follow-up|1|||
146693068|NCT03965962|529054450|FG002|Overall Study|Lost to Follow-up|0|||
146693069|NCT03965962|529054451|FG003|Overall Study|Lost to Follow-up|0|||
146693070|NCT03965962|529054448|FG000|Overall Study|Withdrawal by Subject|3|||
146693071|NCT03965962|529054449|FG001|Overall Study|Withdrawal by Subject|0|||
146693072|NCT03965962|529054450|FG002|Overall Study|Withdrawal by Subject|0|||
146693073|NCT03965962|529054451|FG003|Overall Study|Withdrawal by Subject|1|||
146693074|NCT00741039|529054452|FG000|Overall Study|Patient non-compliance|2|||
146693075|NCT00741039|529054453|FG001|Overall Study|Patient non-compliance|0|||
146693076|NCT01712854|529054454|FG000|Overall Study|Physician Decision|1|||
146693077|NCT03886220|529054455|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
146693078|NCT03886220|529054456|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
146693079|NCT03886220|529054455|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
146693080|NCT03886220|529054456|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146693081|NCT03886220|529054455|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
146693082|NCT03886220|529054456|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
146693083|NCT00322842|529054457|FG000|Overall Study|Withdrawal by Subject|0|||
146693084|NCT00322842|529054458|FG001|Overall Study|Withdrawal by Subject|1|||
146693085|NCT00322842|529054457|FG000|Overall Study|Lost to Follow-up|0|||
146693086|NCT00322842|529054458|FG001|Overall Study|Lost to Follow-up|1|||
146693087|NCT00322842|529054457|FG000|Overall Study|Refused transplant|1|||
146693088|NCT00322842|529054458|FG001|Overall Study|Refused transplant|0|||
146693089|NCT00322842|529054457|FG000|Overall Study|Death|1|||
146693090|NCT00322842|529054458|FG001|Overall Study|Death|0|||
146693091|NCT03082599|529054459|FG000|Overall Study|Lost to Follow-up|1|||
146693092|NCT03082599|529054460|FG001|Overall Study|Lost to Follow-up|0|||
146693093|NCT00946712|529054469|FG000|Overall Study|Adverse Event|118|||
146693094|NCT00946712|529054470|FG001|Overall Study|Adverse Event|124|||
146693095|NCT00946712|529054469|FG000|Overall Study|Disease progression|308|||
146693096|NCT00946712|529054470|FG001|Overall Study|Disease progression|404|||
146693097|NCT00946712|529054469|FG000|Overall Study|Death|21|||
146693098|NCT00946712|529054470|FG001|Overall Study|Death|22|||
146693099|NCT00946712|529054469|FG000|Overall Study|No treatment given|25|||
146693100|NCT00946712|529054470|FG001|Overall Study|No treatment given|29|||
146693101|NCT00946712|529054469|FG000|Overall Study|Other reasons|61|||
146693102|NCT00946712|529054470|FG001|Overall Study|Other reasons|73|||
146693103|NCT00946712|529054469|FG000|Overall Study|On Treatment|0|||
146693104|NCT00946712|529054470|FG001|Overall Study|On Treatment|4|||
146693105|NCT00946712|529054469|FG000|Overall Study|Ineligible|14|||
146693106|NCT00946712|529054470|FG001|Overall Study|Ineligible|6|||
146693107|NCT00567892|529054471|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
146693108|NCT00567892|529054472|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
146693109|NCT00567892|529054473|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
146693110|NCT00567892|529054474|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
146693111|NCT00567892|529054471|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
146693112|NCT00567892|529054472|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
146693113|NCT00567892|529054473|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
146693114|NCT00567892|529054474|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
146693115|NCT04690751|529054476|FG000|Overall Study|Protocol Violation|0|||
146693116|NCT04690751|529054477|FG001|Overall Study|Protocol Violation|1|||
146693117|NCT04690751|529054478|FG002|Overall Study|Protocol Violation|0|||
146693118|NCT04690751|529054479|FG003|Overall Study|Protocol Violation|1|||
146693119|NCT04690751|529054480|FG004|Overall Study|Protocol Violation|2|||
146693120|NCT04690751|529054481|FG005|Overall Study|Protocol Violation|0|||
146693121|NCT04690751|529054476|FG000|Overall Study|Adverse Event|0|||
146693122|NCT04690751|529054477|FG001|Overall Study|Adverse Event|0|||
146693123|NCT04690751|529054478|FG002|Overall Study|Adverse Event|1|||
146693124|NCT04690751|529054479|FG003|Overall Study|Adverse Event|0|||
146693125|NCT04690751|529054480|FG004|Overall Study|Adverse Event|0|||
146693126|NCT04690751|529054481|FG005|Overall Study|Adverse Event|0|||
146693127|NCT04690751|529054476|FG000|Overall Study|Positive urine drug screen test|0|||
146693128|NCT04690751|529054477|FG001|Overall Study|Positive urine drug screen test|0|||
146693129|NCT04690751|529054478|FG002|Overall Study|Positive urine drug screen test|0|||
146693130|NCT04690751|529054479|FG003|Overall Study|Positive urine drug screen test|0|||
146693131|NCT04690751|529054480|FG004|Overall Study|Positive urine drug screen test|1|||
146693132|NCT04690751|529054481|FG005|Overall Study|Positive urine drug screen test|0|||
146693133|NCT01344161|529054482|FG000|Overall Study|Lost to Follow-up|4|||
146693134|NCT01344161|529054483|FG001|Overall Study|Lost to Follow-up|1|||
146693135|NCT01344161|529054482|FG000|Overall Study|Pregnancy|0|||
146693136|NCT01344161|529054483|FG001|Overall Study|Pregnancy|1|||
146693137|NCT01344161|529054482|FG000|Overall Study|Protocol Violation|1|||
146693138|NCT01344161|529054483|FG001|Overall Study|Protocol Violation|1|||
146693139|NCT04364620|529054484|FG000|Overall Study|Disease Progression|20|||
146693140|NCT04364620|529054484|FG000|Overall Study|Adverse Event|5|||
146693141|NCT04364620|529054484|FG000|Overall Study|Physician Decision|4|||
146693142|NCT04364620|529054484|FG000|Overall Study|Death|3|||
146693143|NCT04364620|529054484|FG000|Overall Study|Other|2|||
146693144|NCT04364620|529054484|FG000|Overall Study|Withdrawal by Subject|1|||
146693145|NCT00156533|529055881|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
146693146|NCT00156533|529055882|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
146693147|NCT00156533|529055883|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
146693148|NCT00156533|529055884|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
146693149|NCT00156533|529055881|FG000|Overall Study|Withdrawal by Subject|1|||
146693150|NCT00156533|529055882|FG001|Overall Study|Withdrawal by Subject|0|||
146693151|NCT00156533|529055883|FG002|Overall Study|Withdrawal by Subject|0|||
146693152|NCT00156533|529055884|FG003|Overall Study|Withdrawal by Subject|1|||
146693153|NCT00156533|529055881|FG000|Overall Study|Failed Screening|1|||
146693154|NCT00156533|529055882|FG001|Overall Study|Failed Screening|0|||
146693155|NCT00156533|529055883|FG002|Overall Study|Failed Screening|1|||
146693156|NCT00156533|529055884|FG003|Overall Study|Failed Screening|1|||
146693157|NCT01541969|529055887|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
146693158|NCT01541969|529055888|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
146693159|NCT01541969|529055887|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
146693160|NCT01541969|529055888|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
146693161|NCT01541969|529055887|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
146693162|NCT01541969|529055888|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
146693163|NCT01541969|529055887|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
146693164|NCT01541969|529055888|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
146693165|NCT01541969|529055887|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
146693166|NCT01541969|529055888|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
146693167|NCT01541969|529055887|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
146693168|NCT01541969|529055888|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
146693169|NCT01541969|529055887|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
146693170|NCT01541969|529055888|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
146693171|NCT01541969|529055887|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
146693172|NCT01541969|529055888|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
146693173|NCT01541969|529055887|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
146693174|NCT01541969|529055888|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
146693175|NCT01541969|529055887|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
146693176|NCT01541969|529055888|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
146693177|NCT01365507|529055889|FG000|Overall Study|Withdrawal Criteria|8|||
146693178|NCT01365507|529055890|FG001|Overall Study|Withdrawal Criteria|5|||
146693179|NCT01365507|529055889|FG000|Overall Study|Unclassified|1|||
146693180|NCT01365507|529055890|FG001|Overall Study|Unclassified|4|||
146693181|NCT03265249|529055893|FG000|Overall Study|Withdrawal by Subject|0|||
146693182|NCT03265249|529055894|FG001|Overall Study|Withdrawal by Subject|1|||
146693183|NCT01614990|529055895|FG000|Overall Study|Protocol Violation|1|||
146693184|NCT01614990|529055896|FG001|Overall Study|Protocol Violation|1|||
146693185|NCT02255500|529055903|FG000|Overall Study|Withdrawal by Subject|1|||
146693186|NCT02255500|529055904|FG001|Overall Study|Withdrawal by Subject|0|||
146693187|NCT01012622|529055905|FG000|Overall Study|Withdrawal by Subject|6|||
146693188|NCT01012622|529055905|FG000|Overall Study|Lost to Follow-up|5|||
146693189|NCT01012622|529055905|FG000|Overall Study|Adverse Event|7|||
146693190|NCT01012622|529055905|FG000|Overall Study|non-compliance with the drug|9|||
146693191|NCT01012622|529055905|FG000|Overall Study|Other|1|||
146693192|NCT01012622|529055905|FG000|Overall Study|screening failure|1|||
146929943|NCT01766817|529900975|FG001|Overall Study|Drug-related adverse event|2|||
146929944|NCT01766817|529900976|FG002|Overall Study|Drug-related adverse event|1|||
146693193|NCT01012622|529055905|FG000|Overall Study|withdrawal of consent by a parent|2|||
146693194|NCT04254978|529055906|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
146693195|NCT04254978|529055906|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
146929945|NCT01766817|529900974|FG000|Overall Study|Drug-unrelated adverse event|3|||
146980143|NCT00686920|530089494|FG001|Overall Study|Transferred to Nursing Home|0|||
146980144|NCT00686920|530089493|FG000|Overall Study|Noncompliance|9|||
146980145|NCT00686920|530089494|FG001|Overall Study|Noncompliance|0|||
146980146|NCT00686920|530089493|FG000|Overall Study|Principal Investigator Decision|2|||
146980147|NCT00686920|530089494|FG001|Overall Study|Principal Investigator Decision|0|||
146980148|NCT00449930|530089497|FG000|Overall Study|Adverse Event|9|||
146980149|NCT00449930|530089498|FG001|Overall Study|Adverse Event|19|||
146980150|NCT00449930|530089497|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
146980151|NCT00449930|530089498|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
146980152|NCT00449930|530089497|FG000|Overall Study|Lack of Efficacy|10|||
146980153|NCT00449930|530089498|FG001|Overall Study|Lack of Efficacy|1|||
146980154|NCT00449930|530089497|FG000|Overall Study|Lost to Follow-up|9|||
146980155|NCT00449930|530089498|FG001|Overall Study|Lost to Follow-up|14|||
146980156|NCT00449930|530089497|FG000|Overall Study|Physician Decision|1|||
146980157|NCT00449930|530089498|FG001|Overall Study|Physician Decision|2|||
146980158|NCT00449930|530089497|FG000|Overall Study|Protocol Violation|14|||
146980159|NCT00449930|530089498|FG001|Overall Study|Protocol Violation|15|||
146980160|NCT00449930|530089497|FG000|Overall Study|Withdrawal by Subject|16|||
146980161|NCT00449930|530089498|FG001|Overall Study|Withdrawal by Subject|23|||
146980162|NCT00449930|530089497|FG000|Overall Study|Glycemic discontinuation criteria|1|||
146980163|NCT00449930|530089498|FG001|Overall Study|Glycemic discontinuation criteria|1|||
146980164|NCT03124381|530089504|FG000|Overall Study|Lost to Follow-up|1|||
146980165|NCT03124381|530089505|FG001|Overall Study|Lost to Follow-up|1|||
146980166|NCT03124381|530089504|FG000|Overall Study|Withdrawal by Subject|6|||
146980167|NCT03124381|530089505|FG001|Overall Study|Withdrawal by Subject|3|||
146980168|NCT03124381|530089504|FG000|Overall Study|Protocol Violation|0|||
146980169|NCT03124381|530089505|FG001|Overall Study|Protocol Violation|1|||
146980170|NCT03124381|530089504|FG000|Overall Study|Adverse Event|1|||
146980171|NCT03124381|530089505|FG001|Overall Study|Adverse Event|1|||
146980172|NCT03124381|530089504|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
146980173|NCT03124381|530089505|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
146980174|NCT05017493|530089511|FG000|Overall Study|Withdrawal by Subject|26|||
146980175|NCT05017493|530089512|FG001|Overall Study|Withdrawal by Subject|0|||
146980176|NCT05017493|530089511|FG000|Overall Study|Physician Decision|15|||
146980177|NCT05017493|530089512|FG001|Overall Study|Physician Decision|0|||
146980178|NCT05017493|530089511|FG000|Overall Study|Protocol Violation|81|||
146980179|NCT05017493|530089512|FG001|Overall Study|Protocol Violation|0|||
146980180|NCT02473510|530089513|FG000|Overall Study|Lost to Follow-up|1|||
146980181|NCT02473510|530089514|FG001|Overall Study|Lost to Follow-up|2|||
146693196|NCT04254978|529055906|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
146693197|NCT04254978|529055906|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
146693198|NCT04254978|529055906|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
146693199|NCT04254978|529055906|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
146693200|NCT02515942|529055907|FG000|Overall Study|Adverse Event|5|||
146693201|NCT02515942|529055908|FG001|Overall Study|Adverse Event|0|||
146693202|NCT02515942|529055909|FG002|Overall Study|Adverse Event|0|||
146693203|NCT02515942|529055907|FG000|Overall Study|Death|0|||
146693204|NCT02515942|529055908|FG001|Overall Study|Death|0|||
146693205|NCT02515942|529055909|FG002|Overall Study|Death|1|||
146693206|NCT02515942|529055907|FG000|Overall Study|Lack of Efficacy|0|||
146693207|NCT02515942|529055908|FG001|Overall Study|Lack of Efficacy|0|||
146693208|NCT02515942|529055909|FG002|Overall Study|Lack of Efficacy|1|||
146693209|NCT02515942|529055907|FG000|Overall Study|Lost to Follow-up|2|||
146693210|NCT02515942|529055908|FG001|Overall Study|Lost to Follow-up|0|||
146693211|NCT02515942|529055909|FG002|Overall Study|Lost to Follow-up|0|||
146693212|NCT02515942|529055907|FG000|Overall Study|Withdrawal by Subject|0|||
146693213|NCT02515942|529055908|FG001|Overall Study|Withdrawal by Subject|3|||
146693214|NCT02515942|529055909|FG002|Overall Study|Withdrawal by Subject|2|||
146693215|NCT00666757|529055912|FG000|Overall Study|Lost to Follow-up|39|||
146693216|NCT00666757|529055913|FG001|Overall Study|Lost to Follow-up|35|||
146693217|NCT00666757|529055912|FG000|Overall Study|Protocol Violation|23|||
146693218|NCT00666757|529055913|FG001|Overall Study|Protocol Violation|24|||
146693219|NCT00666757|529055912|FG000|Overall Study|Adverse Event|22|||
146693220|NCT00666757|529055913|FG001|Overall Study|Adverse Event|12|||
146693221|NCT00666757|529055912|FG000|Overall Study|Withdrawal by Subject|13|||
146775737|NCT02409667|529349626|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
146775738|NCT02409667|529349622|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
146980182|NCT00345683|530089522|FG000|Overall Study|Lost to Follow-up|19|||
146693222|NCT00666757|529055913|FG001|Overall Study|Withdrawal by Subject|17|||
146693223|NCT00666757|529055912|FG000|Overall Study|Lack of Efficacy|3|||
146693224|NCT00666757|529055913|FG001|Overall Study|Lack of Efficacy|6|||
146980183|NCT00345683|530089523|FG001|Overall Study|Lost to Follow-up|7|||
146980184|NCT00345683|530089522|FG000|Overall Study|Other|6|||
146980185|NCT00345683|530089523|FG001|Overall Study|Other|2|||
146980186|NCT03182686|530089526|FG000|Overall Study|Lost to Follow-up|2|||
146980187|NCT03182686|530089527|FG001|Overall Study|Lost to Follow-up|0|||
146980188|NCT03182686|530089526|FG000|Overall Study|Adverse Event|2|||
146980189|NCT03182686|530089527|FG001|Overall Study|Adverse Event|0|||
146693225|NCT00666757|529055912|FG000|Overall Study|Physician Decision|0|||
146693226|NCT00666757|529055913|FG001|Overall Study|Physician Decision|2|||
146693227|NCT00666757|529055912|FG000|Overall Study|Sponsor decision|0|||
146693228|NCT00666757|529055913|FG001|Overall Study|Sponsor decision|1|||
146693229|NCT04765358|529055914|FG000|Overall Study|Withdrawal by Subject|1|||
146693230|NCT01660711|529055915|FG000|Overall Study|Adverse Event|7|||
146693231|NCT01660711|529055915|FG000|Overall Study|Withdrawal by Subject|1|||
146693232|NCT01316276|529055916|FG000|Overall Study|Death|1|||
146693233|NCT01316276|529055916|FG000|Overall Study|Adverse Event|19|||
146693234|NCT01316276|529055916|FG000|Overall Study|Withdrawal of consent|24|||
146693235|NCT01316276|529055916|FG000|Overall Study|Lost to Follow-up|1|||
146693236|NCT01316276|529055916|FG000|Overall Study|Other|22|||
146693237|NCT00405587|529055918|FG000|Overall Study|Death|0|||
146693238|NCT00405587|529055919|FG001|Overall Study|Death|0|||
146693239|NCT00405587|529055920|FG002|Overall Study|Death|0|||
146693240|NCT00405587|529055921|FG003|Overall Study|Death|1|||
146693241|NCT00405587|529055918|FG000|Overall Study|Disease Progression|22|||
146693242|NCT00405587|529055919|FG001|Overall Study|Disease Progression|23|||
146693243|NCT00405587|529055920|FG002|Overall Study|Disease Progression|21|||
146693244|NCT00405587|529055921|FG003|Overall Study|Disease Progression|17|||
146693245|NCT00405587|529055918|FG000|Overall Study|Physician Decision|3|||
146693246|NCT00405587|529055919|FG001|Overall Study|Physician Decision|2|||
146693247|NCT00405587|529055920|FG002|Overall Study|Physician Decision|0|||
146693248|NCT00405587|529055921|FG003|Overall Study|Physician Decision|0|||
146693249|NCT00405587|529055918|FG000|Overall Study|Adverse Event|1|||
146693250|NCT00405587|529055919|FG001|Overall Study|Adverse Event|0|||
146693251|NCT00405587|529055920|FG002|Overall Study|Adverse Event|0|||
146693252|NCT00405587|529055921|FG003|Overall Study|Adverse Event|0|||
146693253|NCT00405587|529055918|FG000|Overall Study|Lost to Follow-up|0|||
146693254|NCT00405587|529055919|FG001|Overall Study|Lost to Follow-up|1|||
146693255|NCT00405587|529055920|FG002|Overall Study|Lost to Follow-up|1|||
146693256|NCT00405587|529055921|FG003|Overall Study|Lost to Follow-up|0|||
146693257|NCT00405587|529055918|FG000|Overall Study|Radiation induced necrosis|0|||
146693258|NCT00405587|529055919|FG001|Overall Study|Radiation induced necrosis|1|||
146693259|NCT00405587|529055920|FG002|Overall Study|Radiation induced necrosis|0|||
146693260|NCT00405587|529055921|FG003|Overall Study|Radiation induced necrosis|0|||
146693261|NCT00405587|529055918|FG000|Overall Study|Withdrawal by Subject|0|||
146693262|NCT00405587|529055919|FG001|Overall Study|Withdrawal by Subject|0|||
146693263|NCT00405587|529055920|FG002|Overall Study|Withdrawal by Subject|0|||
146693264|NCT00405587|529055921|FG003|Overall Study|Withdrawal by Subject|2|||
146693265|NCT00405587|529055918|FG000|Overall Study|Participant not dosed|0|||
146693266|NCT00405587|529055919|FG001|Overall Study|Participant not dosed|1|||
146693267|NCT00405587|529055920|FG002|Overall Study|Participant not dosed|0|||
146693268|NCT00405587|529055921|FG003|Overall Study|Participant not dosed|0|||
146693269|NCT03406858|529055922|FG000|Overall Study|Failure to receive treatment drug.|1|||
146693270|NCT03406858|529055922|FG000|Overall Study|ineligible|1|||
146693271|NCT02419742|529055923|FG000|Overall Study|Adverse Event|2|||
146693272|NCT02419742|529055924|FG001|Overall Study|Adverse Event|0|||
146693273|NCT02419742|529055923|FG000|Overall Study|Disease Progression|0|||
146693274|NCT02419742|529055924|FG001|Overall Study|Disease Progression|1|||
146693275|NCT02419742|529055923|FG000|Overall Study|Withdrew Consent|2|||
146693276|NCT02419742|529055924|FG001|Overall Study|Withdrew Consent|1|||
146693277|NCT02419742|529055923|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
146693278|NCT02419742|529055924|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
146693279|NCT00507442|529055929|FG000|Overall Study|Adverse Event|8|||
146693280|NCT00507442|529055930|FG001|Overall Study|Adverse Event|11|||
146693281|NCT00507442|529055931|FG002|Overall Study|Adverse Event|4|||
146693282|NCT00507442|529055932|FG003|Overall Study|Adverse Event|1|||
146693283|NCT00507442|529055929|FG000|Overall Study|Protocol Violation|0|||
146693284|NCT00507442|529055930|FG001|Overall Study|Protocol Violation|1|||
146980190|NCT03182686|530089526|FG000|Overall Study|Withdrawal by Subject|3|||
146693285|NCT00507442|529055931|FG002|Overall Study|Protocol Violation|0|||
146980191|NCT03182686|530089527|FG001|Overall Study|Withdrawal by Subject|0|||
146980192|NCT01154127|530089528|FG000|Period 1 (21 Days)|Adverse Event|3|||
146980193|NCT01154127|530089529|FG001|Period 1 (21 Days)|Adverse Event|4|||
146693286|NCT00507442|529055932|FG003|Overall Study|Protocol Violation|0|||
146693287|NCT00507442|529055929|FG000|Overall Study|Lost to Follow-up|0|||
146693288|NCT00507442|529055930|FG001|Overall Study|Lost to Follow-up|0|||
146693289|NCT00507442|529055931|FG002|Overall Study|Lost to Follow-up|1|||
146693290|NCT00507442|529055932|FG003|Overall Study|Lost to Follow-up|0|||
146693291|NCT00507442|529055929|FG000|Overall Study|Physician Decision|0|||
146693292|NCT00507442|529055930|FG001|Overall Study|Physician Decision|2|||
146693293|NCT00507442|529055931|FG002|Overall Study|Physician Decision|4|||
146693294|NCT00507442|529055932|FG003|Overall Study|Physician Decision|1|||
146693295|NCT00507442|529055929|FG000|Overall Study|Progressive Disease|2|||
146693296|NCT00507442|529055930|FG001|Overall Study|Progressive Disease|4|||
146693297|NCT00507442|529055931|FG002|Overall Study|Progressive Disease|2|||
146693298|NCT00507442|529055932|FG003|Overall Study|Progressive Disease|0|||
146693299|NCT00507442|529055929|FG000|Overall Study|Withdrawal by Subject|4|||
146693300|NCT00507442|529055930|FG001|Overall Study|Withdrawal by Subject|4|||
146693301|NCT00507442|529055931|FG002|Overall Study|Withdrawal by Subject|2|||
146693302|NCT00507442|529055932|FG003|Overall Study|Withdrawal by Subject|1|||
146693303|NCT00507442|529055929|FG000|Overall Study|Other|2|||
146693304|NCT00507442|529055930|FG001|Overall Study|Other|5|||
146693305|NCT00507442|529055931|FG002|Overall Study|Other|2|||
146693306|NCT00507442|529055932|FG003|Overall Study|Other|2|||
146693307|NCT02672423|529055934|FG000|Period 1|Adverse Event|0|||
146693308|NCT02672423|529055935|FG001|Period 1|Adverse Event|0|||
146693309|NCT02672423|529055936|FG002|Period 1|Adverse Event|0|||
146693310|NCT02672423|529055937|FG003|Period 1|Adverse Event|0|||
146693311|NCT02672423|529055938|FG004|Period 1|Adverse Event|1|||
146693312|NCT02672423|529055939|FG005|Period 1|Adverse Event|0|||
146693313|NCT02672423|529055940|FG006|Period 1|Adverse Event|0|||
146693314|NCT02672423|529055941|FG007|Period 1|Adverse Event|0|||
146693315|NCT02672423|529055942|FG008|Period 1|Adverse Event|0|||
146693316|NCT02672423|529055943|FG009|Period 1|Adverse Event|0|||
146693317|NCT02672423|529055934|FG000|Period 2|Withdrawal by Subject|0|||
146693318|NCT02672423|529055935|FG001|Period 2|Withdrawal by Subject|0|||
146693319|NCT02672423|529055936|FG002|Period 2|Withdrawal by Subject|1|||
146693320|NCT02672423|529055937|FG003|Period 2|Withdrawal by Subject|0|||
146693321|NCT02672423|529055938|FG004|Period 2|Withdrawal by Subject|0|||
146693322|NCT02672423|529055939|FG005|Period 2|Withdrawal by Subject|0|||
146693323|NCT02672423|529055940|FG006|Period 2|Withdrawal by Subject|0|||
146693324|NCT02672423|529055941|FG007|Period 2|Withdrawal by Subject|0|||
146693325|NCT02672423|529055942|FG008|Period 2|Withdrawal by Subject|0|||
146693326|NCT02672423|529055943|FG009|Period 2|Withdrawal by Subject|0|||
146693327|NCT02672423|529055934|FG000|Period 3|Withdrawal by Subject|0|||
146693328|NCT02672423|529055935|FG001|Period 3|Withdrawal by Subject|0|||
146693329|NCT02672423|529055936|FG002|Period 3|Withdrawal by Subject|0|||
146693330|NCT02672423|529055937|FG003|Period 3|Withdrawal by Subject|0|||
146693331|NCT02672423|529055938|FG004|Period 3|Withdrawal by Subject|0|||
146693332|NCT02672423|529055939|FG005|Period 3|Withdrawal by Subject|0|||
146693333|NCT02672423|529055940|FG006|Period 3|Withdrawal by Subject|0|||
146693334|NCT02672423|529055941|FG007|Period 3|Withdrawal by Subject|1|||
146693335|NCT02672423|529055942|FG008|Period 3|Withdrawal by Subject|0|||
146693336|NCT02672423|529055943|FG009|Period 3|Withdrawal by Subject|0|||
146693337|NCT02672423|529055934|FG000|Period 3|Physician Decision|0|||
146693338|NCT02672423|529055935|FG001|Period 3|Physician Decision|0|||
146693339|NCT02672423|529055936|FG002|Period 3|Physician Decision|0|||
146693340|NCT02672423|529055937|FG003|Period 3|Physician Decision|0|||
146693341|NCT02672423|529055938|FG004|Period 3|Physician Decision|0|||
146693342|NCT02672423|529055939|FG005|Period 3|Physician Decision|1|||
146693343|NCT02672423|529055940|FG006|Period 3|Physician Decision|0|||
146693344|NCT02672423|529055941|FG007|Period 3|Physician Decision|0|||
146693345|NCT02672423|529055942|FG008|Period 3|Physician Decision|0|||
146693346|NCT02672423|529055943|FG009|Period 3|Physician Decision|0|||
146693347|NCT01852812|529055950|FG000|Overall Study|Adverse Event|0|||
146693348|NCT01852812|529055951|FG001|Overall Study|Adverse Event|0|||
146693349|NCT01852812|529055952|FG002|Overall Study|Adverse Event|1|||
146693350|NCT01852812|529055950|FG000|Overall Study|Non-compliance With Study Drug|0|||
146693351|NCT01852812|529055951|FG001|Overall Study|Non-compliance With Study Drug|1|||
146693352|NCT01852812|529055952|FG002|Overall Study|Non-compliance With Study Drug|0|||
146693353|NCT02290821|529055954|FG000|Overall Study|Withdrawal by Subject|1|||
146693354|NCT02290821|529055955|FG001|Overall Study|Withdrawal by Subject|1|||
146693355|NCT02290821|529055954|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
146693356|NCT02290821|529055955|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
146693357|NCT02290821|529055954|FG000|Overall Study|Lost to Follow-up|3|||
146693358|NCT02290821|529055955|FG001|Overall Study|Lost to Follow-up|2|||
146693359|NCT02438722|529055956|FG000|Overall Study|Adverse Event|12|||
146693360|NCT02438722|529055957|FG001|Overall Study|Adverse Event|9|||
146693361|NCT02438722|529055956|FG000|Overall Study|Refusal unrelated to AE|2|||
146693362|NCT02438722|529055957|FG001|Overall Study|Refusal unrelated to AE|5|||
146693363|NCT02438722|529055956|FG000|Overall Study|Disease progression/relapse|46|||
146693364|NCT02438722|529055957|FG001|Overall Study|Disease progression/relapse|51|||
146693365|NCT02438722|529055956|FG000|Overall Study|Death|0|||
146693366|NCT02438722|529055957|FG001|Overall Study|Death|3|||
146693367|NCT02438722|529055956|FG000|Overall Study|Physician Decision|2|||
146693368|NCT02438722|529055957|FG001|Overall Study|Physician Decision|2|||
146693369|NCT02438722|529055956|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
146693370|NCT02438722|529055957|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
146693371|NCT02438722|529055956|FG000|Overall Study|Withdrawal by Subject|0|||
146693372|NCT02438722|529055957|FG001|Overall Study|Withdrawal by Subject|1|||
146693373|NCT02438722|529055956|FG000|Overall Study|On protocol treatment|15|||
146693374|NCT02438722|529055957|FG001|Overall Study|On protocol treatment|14|||
146693375|NCT02438722|529055956|FG000|Overall Study|Did not receive protocol treatment|5|||
146693376|NCT02438722|529055957|FG001|Overall Study|Did not receive protocol treatment|0|||
146693377|NCT00768144|529055961|FG000|Overall Study|Adverse Event|13|||
146693378|NCT00768144|529055961|FG000|Overall Study|Progressive Disease|21|||
146693379|NCT00768144|529055961|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
146693380|NCT00768144|529055961|FG000|Overall Study|Pt Withdrew Consent|1|||
146693381|NCT01150123|529055962|FG000|Overall Study|Withdrawal by Subject|1|||
146693382|NCT01150123|529055963|FG001|Overall Study|Withdrawal by Subject|1|||
146693383|NCT01150123|529055964|FG002|Overall Study|Withdrawal by Subject|2|||
146693384|NCT01150123|529055965|FG003|Overall Study|Withdrawal by Subject|1|||
146693385|NCT01150123|529055966|FG004|Overall Study|Withdrawal by Subject|1|||
146693386|NCT01150123|529055967|FG005|Overall Study|Withdrawal by Subject|1|||
146693387|NCT01150123|529055968|FG006|Overall Study|Withdrawal by Subject|0|||
146693388|NCT01150123|529055969|FG007|Overall Study|Withdrawal by Subject|3|||
146693389|NCT01150123|529055970|FG008|Overall Study|Withdrawal by Subject|2|||
146693390|NCT01150123|529055971|FG009|Overall Study|Withdrawal by Subject|0|||
146693391|NCT01150123|529055972|FG010|Overall Study|Withdrawal by Subject|1|||
146693392|NCT01150123|529055973|FG011|Overall Study|Withdrawal by Subject|0|||
146693393|NCT01150123|529055974|FG012|Overall Study|Withdrawal by Subject|1|||
146693394|NCT01150123|529055975|FG013|Overall Study|Withdrawal by Subject|0|||
146693395|NCT01150123|529055976|FG014|Overall Study|Withdrawal by Subject|0|||
146693396|NCT01150123|529055977|FG015|Overall Study|Withdrawal by Subject|1|||
146693397|NCT01150123|529055978|FG016|Overall Study|Withdrawal by Subject|0|||
146693398|NCT01150123|529055979|FG017|Overall Study|Withdrawal by Subject|1|||
146693399|NCT01150123|529055962|FG000|Overall Study|Lost to Follow-up|2|||
146693400|NCT01150123|529055963|FG001|Overall Study|Lost to Follow-up|1|||
146693401|NCT01150123|529055964|FG002|Overall Study|Lost to Follow-up|2|||
146693402|NCT01150123|529055965|FG003|Overall Study|Lost to Follow-up|2|||
146693403|NCT01150123|529055966|FG004|Overall Study|Lost to Follow-up|2|||
146693404|NCT01150123|529055967|FG005|Overall Study|Lost to Follow-up|5|||
146693405|NCT01150123|529055968|FG006|Overall Study|Lost to Follow-up|0|||
146693406|NCT01150123|529055969|FG007|Overall Study|Lost to Follow-up|0|||
146693407|NCT01150123|529055970|FG008|Overall Study|Lost to Follow-up|3|||
146693408|NCT01150123|529055971|FG009|Overall Study|Lost to Follow-up|1|||
146693409|NCT01150123|529055972|FG010|Overall Study|Lost to Follow-up|1|||
146693410|NCT01150123|529055973|FG011|Overall Study|Lost to Follow-up|1|||
146693411|NCT01150123|529055974|FG012|Overall Study|Lost to Follow-up|2|||
146693412|NCT01150123|529055975|FG013|Overall Study|Lost to Follow-up|0|||
146693413|NCT01150123|529055976|FG014|Overall Study|Lost to Follow-up|0|||
146693414|NCT01150123|529055977|FG015|Overall Study|Lost to Follow-up|0|||
146693415|NCT01150123|529055978|FG016|Overall Study|Lost to Follow-up|0|||
146693416|NCT01150123|529055979|FG017|Overall Study|Lost to Follow-up|0|||
146693417|NCT01466387|529055982|FG000|Overall Study|Adverse Event|0|||
146693418|NCT01466387|529055983|FG001|Overall Study|Adverse Event|0|||
146693419|NCT01466387|529055984|FG002|Overall Study|Adverse Event|1|||
146693420|NCT01466387|529055985|FG003|Overall Study|Adverse Event|1|||
146693421|NCT01466387|529055986|FG004|Overall Study|Adverse Event|0|||
146693422|NCT01466387|529055987|FG005|Overall Study|Adverse Event|0|||
146693423|NCT01466387|529055982|FG000|Overall Study|Lost to Follow-up|0|||
146693424|NCT01466387|529055983|FG001|Overall Study|Lost to Follow-up|0|||
146693425|NCT01466387|529055984|FG002|Overall Study|Lost to Follow-up|0|||
146693426|NCT01466387|529055985|FG003|Overall Study|Lost to Follow-up|0|||
146693427|NCT01466387|529055986|FG004|Overall Study|Lost to Follow-up|0|||
146693428|NCT01466387|529055987|FG005|Overall Study|Lost to Follow-up|1|||
146693429|NCT01466387|529055982|FG000|Overall Study|Protocol Violation|1|||
146693430|NCT01466387|529055983|FG001|Overall Study|Protocol Violation|0|||
146693431|NCT01466387|529055984|FG002|Overall Study|Protocol Violation|0|||
146693432|NCT01466387|529055985|FG003|Overall Study|Protocol Violation|1|||
146693433|NCT01466387|529055986|FG004|Overall Study|Protocol Violation|0|||
146693434|NCT01466387|529055987|FG005|Overall Study|Protocol Violation|0|||
146693435|NCT01319877|529055990|FG000|Overall Study|Lost to Follow-up|100|||
146693436|NCT01319877|529055991|FG001|Overall Study|Lost to Follow-up|37|||
146693437|NCT01319877|529055990|FG000|Overall Study|Physician Decision|2|||
146693438|NCT01319877|529055991|FG001|Overall Study|Physician Decision|0|||
146693439|NCT01319877|529055990|FG000|Overall Study|Disease Progression|2|||
146693440|NCT01319877|529055991|FG001|Overall Study|Disease Progression|2|||
146693441|NCT01319877|529055990|FG000|Overall Study|Withdrawal by Subject|0|||
146693442|NCT01319877|529055991|FG001|Overall Study|Withdrawal by Subject|1|||
146693443|NCT01319877|529055990|FG000|Overall Study|Reason Not Specified|4|||
146693444|NCT01319877|529055991|FG001|Overall Study|Reason Not Specified|5|||
146693445|NCT00832585|529055993|FG000|Overall Study|Withdrawal by Subject|1|||
146693446|NCT00832585|529055993|FG000|Overall Study|Lost to Follow-up|1|||
146693447|NCT02347189|529055994|FG000|Overall Study|No implant attempted of study device|9|||
146693448|NCT02347189|529055994|FG000|Overall Study|No primary outcome data available|2|||
146693449|NCT02677987|529055995|FG000|Overall Study|Withdrawal by Subject|3|||
146693450|NCT02677987|529055996|FG001|Overall Study|Withdrawal by Subject|0|||
146693451|NCT02677987|529055995|FG000|Overall Study|Lost to Follow-up|1|||
146693452|NCT02677987|529055996|FG001|Overall Study|Lost to Follow-up|0|||
146693453|NCT04404855|529055998|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
146693454|NCT04404855|529055999|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
146693455|NCT00735878|529056000|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
146693456|NCT00735878|529056001|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
146693457|NCT00735878|529056002|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
146693458|NCT00673179|529056003|FG000|Overall Study|Toxicity/Complications|3|||
146693459|NCT00673179|529056004|FG001|Overall Study|Toxicity/Complications|0|||
146693460|NCT01531387|529056007|FG000|Overall Study|Early termination of study|11|||
146693461|NCT01531387|529056008|FG001|Overall Study|Early termination of study|11|||
146693462|NCT04248933|529056009|FG000|Overall Study|Lost to Follow-up|9|||
146693463|NCT04248933|529056009|FG000|Overall Study|Withdrawal by Subject|2|||
146693464|NCT00578942|529056010|FG000|Overall Study|Lost to Follow-up|1|||
146693465|NCT03200899|529056011|FG000|Overall Study|Lost to Follow-up|10|||
146693466|NCT03200899|529056012|FG001|Overall Study|Lost to Follow-up|23|||
146693467|NCT01400516|529056015|FG000|Primary Trial|Withdrawal by Subject|0|||
146693468|NCT01400516|529056016|FG001|Primary Trial|Withdrawal by Subject|2|||
146693469|NCT04439318|529056017|FG000|Overall Study|Ineligible|1|||
146693470|NCT04439318|529056017|FG000|Overall Study|Never Started Treatment|3|||
146693471|NCT04439318|529056017|FG000|Overall Study|Adverse Event|10|||
146693472|NCT04439318|529056017|FG000|Overall Study|Death|2|||
146693473|NCT04439318|529056017|FG000|Overall Study|Disease Progression|25|||
146693474|NCT04439318|529056017|FG000|Overall Study|Other Complicating Disease|2|||
146693475|NCT04439318|529056017|FG000|Overall Study|Withdrawal by Subject|4|||
146693476|NCT04439318|529056017|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
146693477|NCT04439318|529056017|FG000|Overall Study|Non-Compliance|1|||
146693478|NCT04439318|529056017|FG000|Overall Study|Still on Treatment|1|||
146693479|NCT00699972|529057633|FG000|Overall Study|Adverse Event|7|||
146693480|NCT00699972|529057634|FG001|Overall Study|Adverse Event|9|||
146693481|NCT00699972|529057635|FG002|Overall Study|Adverse Event|24|||
146693482|NCT00699972|529057633|FG000|Overall Study|Lost to Follow-up|0|||
146693483|NCT00699972|529057634|FG001|Overall Study|Lost to Follow-up|2|||
146693484|NCT00699972|529057635|FG002|Overall Study|Lost to Follow-up|0|||
146693485|NCT00699972|529057633|FG000|Overall Study|Withdrawal by Subject|3|||
146693486|NCT00699972|529057634|FG001|Overall Study|Withdrawal by Subject|7|||
146693487|NCT00699972|529057635|FG002|Overall Study|Withdrawal by Subject|4|||
146693488|NCT00699972|529057633|FG000|Overall Study|Lack of Efficacy|2|||
146693489|NCT00699972|529057634|FG001|Overall Study|Lack of Efficacy|0|||
146693490|NCT00699972|529057635|FG002|Overall Study|Lack of Efficacy|2|||
146693491|NCT00699972|529057633|FG000|Overall Study|Administrative/Other|3|||
146693492|NCT00699972|529057634|FG001|Overall Study|Administrative/Other|1|||
146693493|NCT00699972|529057635|FG002|Overall Study|Administrative/Other|4|||
146693494|NCT00699972|529057633|FG000|Overall Study|Randomized, Not Treated|1|||
146693495|NCT00699972|529057634|FG001|Overall Study|Randomized, Not Treated|0|||
146693496|NCT00699972|529057635|FG002|Overall Study|Randomized, Not Treated|1|||
146693497|NCT00277212|529057637|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
146693498|NCT00277212|529057638|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
146693499|NCT00277212|529057639|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
146693500|NCT00277212|529057637|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
146693501|NCT00277212|529057638|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
146693502|NCT00277212|529057639|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
146693503|NCT00277212|529057637|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
146693504|NCT00277212|529057638|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
146693505|NCT00277212|529057639|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
146693506|NCT00277212|529057637|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
146693507|NCT00277212|529057638|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
146693508|NCT00277212|529057639|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
146693509|NCT00277212|529057637|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
146693510|NCT00277212|529057638|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
146693511|NCT00277212|529057639|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
146693512|NCT00277212|529057637|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
146693513|NCT00277212|529057638|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
146693514|NCT00277212|529057639|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
146693515|NCT00277212|529057637|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
146693516|NCT00277212|529057638|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
146693517|NCT00277212|529057639|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
146693518|NCT00277212|529057637|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
146693519|NCT00277212|529057638|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
146775739|NCT02409667|529349623|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
146693520|NCT00277212|529057639|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
146693521|NCT00277212|529057637|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
146693522|NCT00277212|529057638|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
146693523|NCT00277212|529057639|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
146693524|NCT00277212|529057637|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
146929946|NCT01766817|529900975|FG001|Overall Study|Drug-unrelated adverse event|3|||
146929947|NCT01766817|529900976|FG002|Overall Study|Drug-unrelated adverse event|3|||
146775740|NCT02409667|529349624|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
146775741|NCT02409667|529349625|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
146775742|NCT02409667|529349626|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
146775743|NCT02409667|529349622|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
146775744|NCT02409667|529349623|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
146775745|NCT02409667|529349624|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
146775746|NCT02409667|529349625|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
146775747|NCT02409667|529349626|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
146775748|NCT02409667|529349622|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
146775749|NCT02409667|529349623|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
146775750|NCT02409667|529349624|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
146775751|NCT02409667|529349625|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
146775752|NCT02409667|529349626|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
146775753|NCT02409667|529349622|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
146980194|NCT01154127|530089528|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
146693525|NCT00277212|529057638|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
146693526|NCT00277212|529057639|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
146693527|NCT00277212|529057637|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
146693528|NCT00277212|529057638|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
146693529|NCT00277212|529057639|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
146693530|NCT00277212|529057637|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
146693531|NCT00277212|529057638|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
146693532|NCT00277212|529057639|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
146693533|NCT00277212|529057637|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
146693534|NCT00277212|529057638|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
146693535|NCT00277212|529057639|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
146693536|NCT00277212|529057637|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
146693537|NCT00277212|529057638|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
146693538|NCT00277212|529057639|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
146693539|NCT00277212|529057637|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
146693540|NCT00277212|529057638|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
146693541|NCT00277212|529057639|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
146693542|NCT00277212|529057637|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
146693543|NCT00277212|529057638|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
146693544|NCT00277212|529057639|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
146693545|NCT00277212|529057637|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
146693546|NCT00277212|529057638|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
146693547|NCT00277212|529057639|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
146693548|NCT00277212|529057637|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
146693549|NCT00277212|529057638|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
146693550|NCT00277212|529057639|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
146693551|NCT00902564|529057640|FG000|Overall Study|Withdrawal by Subject|2|||
146693552|NCT03336216|529057641|FG000|Randomization|Not reported|2|||
146693553|NCT03336216|529057642|FG001|Randomization|Not reported|0|||
146693554|NCT03336216|529057643|FG002|Randomization|Not reported|1|||
146693555|NCT03336216|529057644|FG003|Randomization|Not reported|0|||
146693556|NCT03336216|529057641|FG000|Randomization|Other reasons|1|||
146693557|NCT03336216|529057642|FG001|Randomization|Other reasons|1|||
146693558|NCT03336216|529057643|FG002|Randomization|Other reasons|1|||
146693559|NCT03336216|529057644|FG003|Randomization|Other reasons|0|||
146693560|NCT03336216|529057641|FG000|Randomization|Participant no longer meets study criteria|0|||
146693561|NCT03336216|529057642|FG001|Randomization|Participant no longer meets study criteria|2|||
146693562|NCT03336216|529057643|FG002|Randomization|Participant no longer meets study criteria|4|||
146693563|NCT03336216|529057644|FG003|Randomization|Participant no longer meets study criteria|1|||
146693564|NCT03336216|529057641|FG000|Randomization|Lost to Follow-up|1|||
146693565|NCT03336216|529057642|FG001|Randomization|Lost to Follow-up|0|||
146693566|NCT03336216|529057643|FG002|Randomization|Lost to Follow-up|0|||
146693567|NCT03336216|529057644|FG003|Randomization|Lost to Follow-up|0|||
146693568|NCT03336216|529057641|FG000|Randomization|Participant withdrew consent|9|||
146693569|NCT03336216|529057642|FG001|Randomization|Participant withdrew consent|1|||
146693570|NCT03336216|529057643|FG002|Randomization|Participant withdrew consent|0|||
146693571|NCT03336216|529057644|FG003|Randomization|Participant withdrew consent|0|||
146693572|NCT03336216|529057641|FG000|Randomization|Adverse Event|1|||
146693573|NCT03336216|529057642|FG001|Randomization|Adverse Event|1|||
146693574|NCT03336216|529057643|FG002|Randomization|Adverse Event|0|||
146775754|NCT02409667|529349623|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
146775755|NCT02409667|529349624|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
146775756|NCT02409667|529349625|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
146775757|NCT02409667|529349626|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
146929948|NCT01766817|529900974|FG000|Overall Study|Death|1|||
146693575|NCT03336216|529057644|FG003|Randomization|Adverse Event|0|||
146693576|NCT03336216|529057641|FG000|Treatment|Adverse Event|2|||
146693577|NCT03336216|529057642|FG001|Treatment|Adverse Event|3|||
146693578|NCT03336216|529057643|FG002|Treatment|Adverse Event|4|||
146693579|NCT03336216|529057644|FG003|Treatment|Adverse Event|4|||
146693580|NCT03336216|529057641|FG000|Treatment|Participant request to discontinue treatment|2|||
146693581|NCT03336216|529057642|FG001|Treatment|Participant request to discontinue treatment|1|||
146693582|NCT03336216|529057643|FG002|Treatment|Participant request to discontinue treatment|2|||
146693583|NCT03336216|529057644|FG003|Treatment|Participant request to discontinue treatment|2|||
146693584|NCT03336216|529057641|FG000|Treatment|Participant withdrew consent|7|||
146693585|NCT03336216|529057642|FG001|Treatment|Participant withdrew consent|2|||
146693586|NCT03336216|529057643|FG002|Treatment|Participant withdrew consent|3|||
146693587|NCT03336216|529057644|FG003|Treatment|Participant withdrew consent|2|||
146693588|NCT03336216|529057641|FG000|Treatment|Death|2|||
146693589|NCT03336216|529057642|FG001|Treatment|Death|3|||
146693590|NCT03336216|529057643|FG002|Treatment|Death|3|||
146693591|NCT03336216|529057644|FG003|Treatment|Death|4|||
146693592|NCT03336216|529057641|FG000|Treatment|Participant no longer meets study criteria|0|||
146693593|NCT03336216|529057642|FG001|Treatment|Participant no longer meets study criteria|1|||
146693594|NCT03336216|529057643|FG002|Treatment|Participant no longer meets study criteria|0|||
146693595|NCT03336216|529057644|FG003|Treatment|Participant no longer meets study criteria|0|||
146693596|NCT03336216|529057641|FG000|Treatment|Other reasons|2|||
146693597|NCT03336216|529057642|FG001|Treatment|Other reasons|0|||
146693598|NCT03336216|529057643|FG002|Treatment|Other reasons|0|||
146693599|NCT03336216|529057644|FG003|Treatment|Other reasons|3|||
146693600|NCT03336216|529057641|FG000|Treatment|Disease progression|23|||
146693601|NCT03336216|529057642|FG001|Treatment|Disease progression|34|||
146693602|NCT03336216|529057643|FG002|Treatment|Disease progression|33|||
146693603|NCT03336216|529057644|FG003|Treatment|Disease progression|26|||
146693604|NCT03336216|529057641|FG000|Treatment|Study drug toxicity|0|||
146693605|NCT03336216|529057642|FG001|Treatment|Study drug toxicity|3|||
146693606|NCT03336216|529057643|FG002|Treatment|Study drug toxicity|2|||
146693607|NCT03336216|529057644|FG003|Treatment|Study drug toxicity|0|||
146693608|NCT03336216|529057641|FG000|Treatment|Adverse Event unrelated to study drug|1|||
146693609|NCT03336216|529057642|FG001|Treatment|Adverse Event unrelated to study drug|1|||
146693610|NCT03336216|529057643|FG002|Treatment|Adverse Event unrelated to study drug|1|||
146693611|NCT03336216|529057644|FG003|Treatment|Adverse Event unrelated to study drug|0|||
146693612|NCT03336216|529057641|FG000|Treatment|Disease Recurrence|1|||
146693613|NCT03336216|529057642|FG001|Treatment|Disease Recurrence|0|||
146693614|NCT03336216|529057643|FG002|Treatment|Disease Recurrence|0|||
146693615|NCT03336216|529057644|FG003|Treatment|Disease Recurrence|0|||
146693616|NCT00922766|529057650|FG000|Overall Study|Death|3|||
146693617|NCT00922766|529057650|FG000|Overall Study|Withdrawal by Subject|2|||
146693618|NCT00922766|529057650|FG000|Overall Study|Other|1|||
146693619|NCT00922766|529057650|FG000|Overall Study|Adverse Event|1|||
146693620|NCT01231581|529057656|FG000|Overall Study|Lost to Follow-up|2|||
146929949|NCT01766817|529900975|FG001|Overall Study|Death|1|||
146929950|NCT01766817|529900976|FG002|Overall Study|Death|0|||
146929951|NCT01766817|529900974|FG000|Overall Study|Unable to take study drug|0|||
146929952|NCT01766817|529900975|FG001|Overall Study|Unable to take study drug|1|||
146929953|NCT01766817|529900976|FG002|Overall Study|Unable to take study drug|0|||
146929954|NCT01766817|529900974|FG000|Overall Study|Withdrawal by Subject|2|||
146929955|NCT01766817|529900975|FG001|Overall Study|Withdrawal by Subject|0|||
146929956|NCT01766817|529900976|FG002|Overall Study|Withdrawal by Subject|3|||
146929957|NCT01766817|529900974|FG000|Overall Study|Subject non-compliance|0|||
146929958|NCT01766817|529900975|FG001|Overall Study|Subject non-compliance|1|||
146929959|NCT01766817|529900976|FG002|Overall Study|Subject non-compliance|2|||
146929960|NCT01766817|529900974|FG000|Overall Study|Physician Decision|3|||
146929961|NCT01766817|529900975|FG001|Overall Study|Physician Decision|3|||
146929962|NCT01766817|529900976|FG002|Overall Study|Physician Decision|4|||
146929963|NCT01766817|529900974|FG000|Overall Study|Other|1|||
146929964|NCT01766817|529900975|FG001|Overall Study|Other|0|||
146693621|NCT01231581|529057657|FG001|Overall Study|Lost to Follow-up|2|||
146693622|NCT01231581|529057656|FG000|Overall Study|Withdrawal by Subject|6|||
146693623|NCT01231581|529057657|FG001|Overall Study|Withdrawal by Subject|9|||
146693624|NCT01231581|529057656|FG000|Overall Study|Study Closed/Terminated|6|||
146693625|NCT01231581|529057657|FG001|Overall Study|Study Closed/Terminated|5|||
146693626|NCT01231581|529057656|FG000|Overall Study|Death|65|||
146693627|NCT01231581|529057657|FG001|Overall Study|Death|64|||
146693628|NCT01231581|529057656|FG000|Overall Study|Ongoing|1|||
146693629|NCT01231581|529057657|FG001|Overall Study|Ongoing|0|||
146693630|NCT01957462|529057658|FG000|Test Period 1|Withdrawal by Subject|1|||
146693631|NCT01957462|529057659|FG001|Test Period 1|Withdrawal by Subject|0|||
146929965|NCT01766817|529900976|FG002|Overall Study|Other|0|||
146929966|NCT01255306|529903418|FG000|Overall Study|Physician Decision|1|||
146929967|NCT01255306|529903419|FG001|Overall Study|Physician Decision|1|||
146929968|NCT01179347|529903420|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
146929969|NCT01179347|529903421|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
146980195|NCT01154127|530089529|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
146980196|NCT01154127|530089528|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
146980197|NCT01154127|530089529|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
146980198|NCT01154127|530089528|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
146980199|NCT01154127|530089529|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
146980200|NCT01154127|530089528|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
146980201|NCT01154127|530089529|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
146980202|NCT01697449|530089536|FG000|Overall Study|Disease progression|47|||
146980203|NCT01697449|530089536|FG000|Overall Study|Adverse Event|7|||
146980204|NCT01697449|530089536|FG000|Overall Study|Lost to Follow-up|5|||
146980205|NCT01697449|530089536|FG000|Overall Study|Withdrawal by Subject|2|||
146980206|NCT01697449|530089536|FG000|Overall Study|Physician Decision|1|||
146980207|NCT01697449|530089536|FG000|Overall Study|Death|2|||
146980208|NCT01697449|530089536|FG000|Overall Study|Other|1|||
146980209|NCT01697449|530089536|FG000|Overall Study|Missing|25|||
146980210|NCT01169844|530089537|FG000|Overall Study|Adverse Event|0|||
146980211|NCT01169844|530089538|FG001|Overall Study|Adverse Event|1|||
146980212|NCT01169844|530089537|FG000|Overall Study|Patient withdrew consent|4|||
146980213|NCT01169844|530089538|FG001|Overall Study|Patient withdrew consent|0|||
146980214|NCT01169844|530089537|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146980215|NCT01169844|530089538|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146980216|NCT01337050|530089539|FG000|Overall Study|Death|0|||
146980217|NCT01337050|530089540|FG001|Overall Study|Death|0|||
146980218|NCT01337050|530089541|FG002|Overall Study|Death|4|||
146980219|NCT01337050|530089539|FG000|Overall Study|Other|4|||
146980220|NCT01337050|530089540|FG001|Overall Study|Other|6|||
146980221|NCT01337050|530089541|FG002|Overall Study|Other|8|||
146980222|NCT01337050|530089539|FG000|Overall Study|Participants refused further follow-up|0|||
146980223|NCT01337050|530089540|FG001|Overall Study|Participants refused further follow-up|7|||
146980224|NCT01337050|530089541|FG002|Overall Study|Participants refused further follow-up|7|||
146980225|NCT00003102|530089542|FG000|Overall Study|Physician Decision|1|||
146980226|NCT00003102|530089543|FG001|Overall Study|Physician Decision|1|||
146693632|NCT01957462|529057658|FG000|Test Period 1|Adverse Event|1|||
146693633|NCT01957462|529057659|FG001|Test Period 1|Adverse Event|0|||
146693634|NCT05954052|529057660|FG000|Overall Study|Adverse Event|1|||
146693635|NCT03616912|529057661|FG000|Overall Study|Adverse Event|17|||
146693636|NCT03616912|529057662|FG001|Overall Study|Adverse Event|21|||
146980227|NCT00003102|530089544|FG002|Overall Study|Physician Decision|0|||
146980228|NCT00003102|530089542|FG000|Overall Study|Progressive Disease|0|||
146980229|NCT00003102|530089543|FG001|Overall Study|Progressive Disease|1|||
146980230|NCT00003102|530089544|FG002|Overall Study|Progressive Disease|0|||
146980231|NCT00003102|530089542|FG000|Overall Study|Adverse Event|0|||
146693637|NCT03616912|529057663|FG002|Overall Study|Adverse Event|9|||
146693638|NCT03616912|529057664|FG003|Overall Study|Adverse Event|0|||
146693639|NCT03616912|529057665|FG004|Overall Study|Adverse Event|0|||
146693640|NCT03616912|529057666|FG005|Overall Study|Adverse Event|0|||
146693641|NCT03616912|529057661|FG000|Overall Study|Death|1|||
146693642|NCT03616912|529057662|FG001|Overall Study|Death|1|||
146693643|NCT03616912|529057663|FG002|Overall Study|Death|0|||
146693644|NCT03616912|529057664|FG003|Overall Study|Death|0|||
146693645|NCT03616912|529057665|FG004|Overall Study|Death|0|||
146693646|NCT03616912|529057666|FG005|Overall Study|Death|0|||
146693647|NCT03616912|529057661|FG000|Overall Study|Lack of Efficacy|13|||
146693648|NCT03616912|529057662|FG001|Overall Study|Lack of Efficacy|6|||
146693649|NCT03616912|529057663|FG002|Overall Study|Lack of Efficacy|8|||
146693650|NCT03616912|529057664|FG003|Overall Study|Lack of Efficacy|4|||
146693651|NCT03616912|529057665|FG004|Overall Study|Lack of Efficacy|5|||
146693652|NCT03616912|529057666|FG005|Overall Study|Lack of Efficacy|1|||
146693653|NCT03616912|529057661|FG000|Overall Study|Lost to Follow-up|1|||
146693654|NCT03616912|529057662|FG001|Overall Study|Lost to Follow-up|2|||
146693655|NCT03616912|529057663|FG002|Overall Study|Lost to Follow-up|3|||
146693656|NCT03616912|529057664|FG003|Overall Study|Lost to Follow-up|0|||
146693657|NCT03616912|529057665|FG004|Overall Study|Lost to Follow-up|0|||
146693658|NCT03616912|529057666|FG005|Overall Study|Lost to Follow-up|0|||
146980232|NCT00003102|530089543|FG001|Overall Study|Adverse Event|1|||
146980233|NCT00003102|530089544|FG002|Overall Study|Adverse Event|1|||
146980234|NCT00003102|530089542|FG000|Overall Study|Death|0|||
146980235|NCT00003102|530089543|FG001|Overall Study|Death|0|||
146980236|NCT00003102|530089544|FG002|Overall Study|Death|1|||
146980237|NCT01559818|530089545|FG000|Overall Study|Physician Decision|1|||
146980238|NCT01559818|530089545|FG000|Overall Study|Pregnancy|1|||
146980239|NCT01559818|530089545|FG000|Overall Study|Study terminated by Sponsor|4|||
146980240|NCT01559818|530089545|FG000|Overall Study|Withdrawal by Subject|1|||
146693659|NCT03616912|529057661|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
146693660|NCT03616912|529057662|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
146693661|NCT03616912|529057663|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
146693662|NCT03616912|529057664|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
146775758|NCT02409667|529349622|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
146980241|NCT04071626|530089546|FG000|Overall Study|Withdrawal by Subject|1|||
146980242|NCT04071626|530089547|FG001|Overall Study|Withdrawal by Subject|1|||
146980243|NCT04071626|530089546|FG000|Overall Study|Protocol Violation|0|||
146980244|NCT04071626|530089547|FG001|Overall Study|Protocol Violation|1|||
146980245|NCT00931385|530089548|FG000|Overall Study|Adverse Event|2|||
146980246|NCT00931385|530089549|FG001|Overall Study|Adverse Event|1|||
146980247|NCT00931385|530089550|FG002|Overall Study|Adverse Event|0|||
146980248|NCT00931385|530089551|FG003|Overall Study|Adverse Event|3|||
146980249|NCT00931385|530089548|FG000|Overall Study|Protocol Violation|0|||
146980250|NCT00931385|530089549|FG001|Overall Study|Protocol Violation|0|||
146980251|NCT00931385|530089550|FG002|Overall Study|Protocol Violation|1|||
146980252|NCT00931385|530089551|FG003|Overall Study|Protocol Violation|0|||
146980253|NCT00931385|530089548|FG000|Overall Study|Withdrawal by Subject|0|||
146980254|NCT00931385|530089549|FG001|Overall Study|Withdrawal by Subject|1|||
146980255|NCT00931385|530089550|FG002|Overall Study|Withdrawal by Subject|0|||
146980256|NCT00931385|530089551|FG003|Overall Study|Withdrawal by Subject|1|||
146980257|NCT00931385|530089548|FG000|Overall Study|Lost to Follow-up|0|||
146980258|NCT00931385|530089549|FG001|Overall Study|Lost to Follow-up|0|||
146980259|NCT00931385|530089550|FG002|Overall Study|Lost to Follow-up|0|||
146980260|NCT00931385|530089551|FG003|Overall Study|Lost to Follow-up|1|||
146980261|NCT00665626|530089556|FG000|Overall Study|Lack of Efficacy|8|||
146980262|NCT00665626|530089557|FG001|Overall Study|Lack of Efficacy|5|||
146980263|NCT00665626|530089556|FG000|Overall Study|Lost to Follow-up|0|||
146980264|NCT00665626|530089557|FG001|Overall Study|Lost to Follow-up|2|||
146693663|NCT03616912|529057665|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
146693664|NCT03616912|529057666|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
146693665|NCT03616912|529057661|FG000|Overall Study|Withdrawal by Subject|12|||
146693666|NCT03616912|529057662|FG001|Overall Study|Withdrawal by Subject|12|||
146693667|NCT03616912|529057663|FG002|Overall Study|Withdrawal by Subject|15|||
146693668|NCT03616912|529057664|FG003|Overall Study|Withdrawal by Subject|2|||
146693669|NCT03616912|529057665|FG004|Overall Study|Withdrawal by Subject|0|||
146693670|NCT03616912|529057666|FG005|Overall Study|Withdrawal by Subject|2|||
146693671|NCT03616912|529057661|FG000|Overall Study|Study Terminated by Sponsor|0|||
146693672|NCT03616912|529057662|FG001|Overall Study|Study Terminated by Sponsor|0|||
146693673|NCT03616912|529057663|FG002|Overall Study|Study Terminated by Sponsor|0|||
146693674|NCT03616912|529057664|FG003|Overall Study|Study Terminated by Sponsor|10|||
146693675|NCT03616912|529057665|FG004|Overall Study|Study Terminated by Sponsor|9|||
146693676|NCT03616912|529057666|FG005|Overall Study|Study Terminated by Sponsor|11|||
146693677|NCT03616912|529057661|FG000|Overall Study|Protocol Deviation|1|||
146693678|NCT03616912|529057662|FG001|Overall Study|Protocol Deviation|1|||
146693679|NCT03616912|529057663|FG002|Overall Study|Protocol Deviation|0|||
146693680|NCT03616912|529057664|FG003|Overall Study|Protocol Deviation|0|||
146693681|NCT03616912|529057665|FG004|Overall Study|Protocol Deviation|0|||
146693682|NCT03616912|529057666|FG005|Overall Study|Protocol Deviation|0|||
146693683|NCT03616912|529057661|FG000|Overall Study|Pregnancy|1|||
146693684|NCT03616912|529057662|FG001|Overall Study|Pregnancy|0|||
146693685|NCT03616912|529057663|FG002|Overall Study|Pregnancy|4|||
146693686|NCT03616912|529057664|FG003|Overall Study|Pregnancy|0|||
146693687|NCT03616912|529057665|FG004|Overall Study|Pregnancy|0|||
146693688|NCT03616912|529057666|FG005|Overall Study|Pregnancy|0|||
146693689|NCT03616912|529057661|FG000|Overall Study|Protocol Violation|1|||
146693690|NCT03616912|529057662|FG001|Overall Study|Protocol Violation|0|||
146693691|NCT03616912|529057663|FG002|Overall Study|Protocol Violation|2|||
146693692|NCT03616912|529057664|FG003|Overall Study|Protocol Violation|0|||
146693693|NCT03616912|529057665|FG004|Overall Study|Protocol Violation|0|||
146693694|NCT03616912|529057666|FG005|Overall Study|Protocol Violation|0|||
146775759|NCT02409667|529349623|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
146775760|NCT02409667|529349624|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
146775761|NCT02409667|529349625|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
146775762|NCT02409667|529349626|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
146775763|NCT02409667|529349622|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
146693695|NCT03616912|529057661|FG000|Overall Study|Physician Decision|2|||
146693696|NCT03616912|529057662|FG001|Overall Study|Physician Decision|0|||
146693697|NCT03616912|529057663|FG002|Overall Study|Physician Decision|0|||
146775764|NCT02409667|529349623|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
146775765|NCT02409667|529349624|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
146775766|NCT02409667|529349625|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
146980265|NCT00665626|530089556|FG000|Overall Study|Withdrawal by Subject|0|||
146980266|NCT00665626|530089557|FG001|Overall Study|Withdrawal by Subject|1|||
146980267|NCT00665626|530089556|FG000|Overall Study|Protocol Violation|0|||
146980268|NCT00665626|530089557|FG001|Overall Study|Protocol Violation|2|||
146980269|NCT00665626|530089556|FG000|Overall Study|Adverse Event|1|||
146980270|NCT00665626|530089557|FG001|Overall Study|Adverse Event|9|||
146980271|NCT00665626|530089556|FG000|Overall Study|Due to exclusion criteria|0|||
146980272|NCT00665626|530089557|FG001|Overall Study|Due to exclusion criteria|1|||
146693698|NCT03616912|529057664|FG003|Overall Study|Physician Decision|0|||
146693699|NCT03616912|529057665|FG004|Overall Study|Physician Decision|1|||
146693700|NCT03616912|529057666|FG005|Overall Study|Physician Decision|0|||
146980273|NCT00665626|530089556|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
146980274|NCT00665626|530089557|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
146693701|NCT03616912|529057661|FG000|Overall Study|Randomized But Never Treated|0|||
146693702|NCT03616912|529057662|FG001|Overall Study|Randomized But Never Treated|2|||
146693703|NCT03616912|529057663|FG002|Overall Study|Randomized But Never Treated|0|||
146693704|NCT03616912|529057664|FG003|Overall Study|Randomized But Never Treated|0|||
146693705|NCT03616912|529057665|FG004|Overall Study|Randomized But Never Treated|0|||
146693706|NCT03616912|529057666|FG005|Overall Study|Randomized But Never Treated|0|||
146693707|NCT01723163|529057669|FG000|Treatment Phase|Withdrawal by Subject|14|||
146693708|NCT01723163|529057670|FG001|Treatment Phase|Withdrawal by Subject|6|||
146693709|NCT01723163|529057669|FG000|Treatment Phase|Withdrawal by PI|5|||
146693710|NCT01723163|529057670|FG001|Treatment Phase|Withdrawal by PI|1|||
146693711|NCT01723163|529057669|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
146775767|NCT02409667|529349626|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
146775768|NCT02409667|529349622|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
146929970|NCT01179347|529903420|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
146693712|NCT01723163|529057670|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
146693713|NCT01723163|529057669|FG000|3-Month Follow-up|Unable to Contact|12|||
146693714|NCT01723163|529057670|FG001|3-Month Follow-up|Unable to Contact|19|||
146693715|NCT01723163|529057669|FG000|6-Month Follow-up|Death|1|||
146693716|NCT01723163|529057670|FG001|6-Month Follow-up|Death|0|||
146693717|NCT01723163|529057669|FG000|6-Month Follow-up|Unable to Contact|17|||
146693718|NCT01723163|529057670|FG001|6-Month Follow-up|Unable to Contact|15|||
146693719|NCT01723163|529057669|FG000|12-Month Follow-up|Death|1|||
146693720|NCT01723163|529057670|FG001|12-Month Follow-up|Death|0|||
146693721|NCT01723163|529057669|FG000|12-Month Follow-up|Unable to Contact|23|||
146693722|NCT01723163|529057670|FG001|12-Month Follow-up|Unable to Contact|28|||
146693723|NCT02510794|529057671|FG000|Overall Study|Adverse Event|0|||
146693724|NCT02510794|529057672|FG001|Overall Study|Adverse Event|1|||
146693725|NCT02510794|529057673|FG002|Overall Study|Adverse Event|0|||
146693726|NCT02510794|529057674|FG003|Overall Study|Adverse Event|0|||
146693727|NCT02510794|529057671|FG000|Overall Study|Death|1|||
146693728|NCT02510794|529057672|FG001|Overall Study|Death|2|||
146693729|NCT02510794|529057673|FG002|Overall Study|Death|1|||
146693730|NCT02510794|529057674|FG003|Overall Study|Death|1|||
146693731|NCT02510794|529057671|FG000|Overall Study|Lack of Efficacy|3|||
146693732|NCT02510794|529057672|FG001|Overall Study|Lack of Efficacy|1|||
146693733|NCT02510794|529057673|FG002|Overall Study|Lack of Efficacy|1|||
146693734|NCT02510794|529057674|FG003|Overall Study|Lack of Efficacy|0|||
146693735|NCT02510794|529057671|FG000|Overall Study|Participant moved out of the area|0|||
146693736|NCT02510794|529057672|FG001|Overall Study|Participant moved out of the area|0|||
146693737|NCT02510794|529057673|FG002|Overall Study|Participant moved out of the area|0|||
146693738|NCT02510794|529057674|FG003|Overall Study|Participant moved out of the area|1|||
146693739|NCT02510794|529057671|FG000|Overall Study|Physician Decision|3|||
146693740|NCT02510794|529057672|FG001|Overall Study|Physician Decision|0|||
146693741|NCT02510794|529057673|FG002|Overall Study|Physician Decision|0|||
146693742|NCT02510794|529057674|FG003|Overall Study|Physician Decision|0|||
146693743|NCT02510794|529057671|FG000|Overall Study|Protocol Violation|0|||
146693744|NCT02510794|529057672|FG001|Overall Study|Protocol Violation|0|||
146693745|NCT02510794|529057673|FG002|Overall Study|Protocol Violation|1|||
146693746|NCT02510794|529057674|FG003|Overall Study|Protocol Violation|0|||
146693747|NCT02510794|529057671|FG000|Overall Study|Withdrawal by Subject|1|||
146693748|NCT02510794|529057672|FG001|Overall Study|Withdrawal by Subject|2|||
146693749|NCT02510794|529057673|FG002|Overall Study|Withdrawal by Subject|4|||
146693750|NCT02510794|529057674|FG003|Overall Study|Withdrawal by Subject|3|||
146693751|NCT01856790|529057677|FG000|Closed Loop Control|Withdrawal by Subject|2|||
146693752|NCT01856790|529057677|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
146693753|NCT02731729|529057678|FG000|Overall Study|Death|2|||
146693754|NCT02731729|529057679|FG001|Overall Study|Death|2|||
146693755|NCT02731729|529057678|FG000|Overall Study|Study terminated by Sponsor|6|||
146929971|NCT01179347|529903421|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
146929972|NCT01179347|529903420|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
146693756|NCT02731729|529057679|FG001|Overall Study|Study terminated by Sponsor|6|||
146693757|NCT02731729|529057678|FG000|Overall Study|Withdrawal by Subject|1|||
146693758|NCT02731729|529057679|FG001|Overall Study|Withdrawal by Subject|0|||
146693759|NCT01344447|529057680|FG000|Overall Study|Adverse Event|1|||
146693760|NCT01344447|529057680|FG000|Overall Study|Protocol Violation|1|||
146693761|NCT01344447|529057680|FG000|Overall Study|Withdrawal by Subject|1|||
146693762|NCT01344447|529057680|FG000|Overall Study|The contrast was not seen|1|||
146693763|NCT01344447|529057680|FG000|Overall Study|Physician Decision|1|||
146693764|NCT01344447|529057680|FG000|Overall Study|MRA unsuccessful|1|||
146693765|NCT01344447|529057680|FG000|Overall Study|Bolus tracking failed|1|||
146693766|NCT01344447|529057680|FG000|Overall Study|Error of power injector|1|||
146693767|NCT03446040|529057681|FG000|Overall Study|Disease progression|3|||
146693768|NCT03446040|529057682|FG001|Overall Study|Disease progression|3|||
146693769|NCT03446040|529057683|FG002|Overall Study|Disease progression|3|||
146693770|NCT03446040|529057684|FG003|Overall Study|Disease progression|4|||
146693771|NCT03446040|529057685|FG004|Overall Study|Disease progression|4|||
146693772|NCT03446040|529057686|FG005|Overall Study|Disease progression|6|||
146693773|NCT03446040|529057687|FG006|Overall Study|Disease progression|3|||
146693774|NCT03446040|529057688|FG007|Overall Study|Disease progression|4|||
146693775|NCT03446040|529057689|FG008|Overall Study|Disease progression|2|||
146693776|NCT03446040|529057690|FG009|Overall Study|Disease progression|4|||
146693777|NCT03446040|529057691|FG010|Overall Study|Disease progression|9|||
146693778|NCT03446040|529057692|FG011|Overall Study|Disease progression|3|||
146693779|NCT03446040|529057693|FG012|Overall Study|Disease progression|7|||
146693780|NCT03446040|529057694|FG013|Overall Study|Disease progression|7|||
146693781|NCT03446040|529057681|FG000|Overall Study|Study drug toxicity|0|||
146693782|NCT03446040|529057682|FG001|Overall Study|Study drug toxicity|0|||
146693783|NCT03446040|529057683|FG002|Overall Study|Study drug toxicity|0|||
146693784|NCT03446040|529057684|FG003|Overall Study|Study drug toxicity|0|||
146693785|NCT03446040|529057685|FG004|Overall Study|Study drug toxicity|0|||
146693786|NCT03446040|529057686|FG005|Overall Study|Study drug toxicity|0|||
146693787|NCT03446040|529057687|FG006|Overall Study|Study drug toxicity|0|||
146693788|NCT03446040|529057688|FG007|Overall Study|Study drug toxicity|0|||
146693789|NCT03446040|529057689|FG008|Overall Study|Study drug toxicity|1|||
146693790|NCT03446040|529057690|FG009|Overall Study|Study drug toxicity|0|||
146693791|NCT03446040|529057691|FG010|Overall Study|Study drug toxicity|0|||
146693792|NCT03446040|529057692|FG011|Overall Study|Study drug toxicity|0|||
146693793|NCT03446040|529057693|FG012|Overall Study|Study drug toxicity|0|||
146693794|NCT03446040|529057694|FG013|Overall Study|Study drug toxicity|0|||
146693795|NCT03446040|529057681|FG000|Overall Study|Adverse Event|0|||
146693796|NCT03446040|529057682|FG001|Overall Study|Adverse Event|0|||
146693797|NCT03446040|529057683|FG002|Overall Study|Adverse Event|0|||
146693798|NCT03446040|529057684|FG003|Overall Study|Adverse Event|0|||
146693799|NCT03446040|529057685|FG004|Overall Study|Adverse Event|0|||
146693800|NCT03446040|529057686|FG005|Overall Study|Adverse Event|2|||
146693801|NCT03446040|529057687|FG006|Overall Study|Adverse Event|0|||
146693802|NCT03446040|529057688|FG007|Overall Study|Adverse Event|0|||
146693803|NCT03446040|529057689|FG008|Overall Study|Adverse Event|1|||
146693804|NCT03446040|529057690|FG009|Overall Study|Adverse Event|0|||
146693805|NCT03446040|529057691|FG010|Overall Study|Adverse Event|0|||
146693806|NCT03446040|529057692|FG011|Overall Study|Adverse Event|0|||
146693807|NCT03446040|529057693|FG012|Overall Study|Adverse Event|0|||
146693808|NCT03446040|529057694|FG013|Overall Study|Adverse Event|0|||
146693809|NCT03446040|529057681|FG000|Overall Study|Death|0|||
146693810|NCT03446040|529057682|FG001|Overall Study|Death|0|||
146693811|NCT03446040|529057683|FG002|Overall Study|Death|0|||
146693812|NCT03446040|529057684|FG003|Overall Study|Death|0|||
146693813|NCT03446040|529057685|FG004|Overall Study|Death|0|||
146693814|NCT03446040|529057686|FG005|Overall Study|Death|0|||
146693815|NCT03446040|529057687|FG006|Overall Study|Death|0|||
146693816|NCT03446040|529057688|FG007|Overall Study|Death|0|||
146693817|NCT03446040|529057689|FG008|Overall Study|Death|0|||
146693818|NCT03446040|529057690|FG009|Overall Study|Death|0|||
146693819|NCT03446040|529057691|FG010|Overall Study|Death|1|||
146693820|NCT03446040|529057692|FG011|Overall Study|Death|0|||
146693821|NCT03446040|529057693|FG012|Overall Study|Death|0|||
146693822|NCT03446040|529057694|FG013|Overall Study|Death|2|||
146693823|NCT03446040|529057681|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
146693824|NCT03446040|529057682|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
146693825|NCT03446040|529057683|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
146693826|NCT03446040|529057684|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
146693827|NCT03446040|529057685|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
146693828|NCT03446040|529057686|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
146693829|NCT03446040|529057687|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
146693830|NCT03446040|529057688|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
146693831|NCT03446040|529057689|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
146693832|NCT03446040|529057690|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
146929973|NCT01179347|529903421|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
146929974|NCT01179347|529903420|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
146929975|NCT01179347|529903421|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
146693833|NCT03446040|529057691|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
146693834|NCT03446040|529057692|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
146693835|NCT03446040|529057693|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
146693836|NCT03446040|529057694|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
146693837|NCT03446040|529057681|FG000|Overall Study|Participant withdrew consent|0|||
146693838|NCT03446040|529057682|FG001|Overall Study|Participant withdrew consent|0|||
146693839|NCT03446040|529057683|FG002|Overall Study|Participant withdrew consent|0|||
146693840|NCT03446040|529057684|FG003|Overall Study|Participant withdrew consent|0|||
146693841|NCT03446040|529057685|FG004|Overall Study|Participant withdrew consent|0|||
146693842|NCT03446040|529057686|FG005|Overall Study|Participant withdrew consent|1|||
146929976|NCT01179347|529903420|FG000|Double-blind Period (12 Weeks)|Other|2|||
146929977|NCT01179347|529903421|FG001|Double-blind Period (12 Weeks)|Other|4|||
146980275|NCT00665626|530089556|FG000|Overall Study|Unably to comply with dosing regimen|0|||
146980276|NCT00665626|530089557|FG001|Overall Study|Unably to comply with dosing regimen|1|||
146980277|NCT00665626|530089556|FG000|Overall Study|Death|1|||
146980278|NCT00665626|530089557|FG001|Overall Study|Death|0|||
146980279|NCT00530439|530089558|FG000|Overall Study|GDM|9|||
146980280|NCT00530439|530089559|FG001|Overall Study|GDM|3|||
146980281|NCT00530439|530089558|FG000|Overall Study|Withdraw|18|||
146693843|NCT03446040|529057687|FG006|Overall Study|Participant withdrew consent|0|||
146693844|NCT03446040|529057688|FG007|Overall Study|Participant withdrew consent|1|||
146693845|NCT03446040|529057689|FG008|Overall Study|Participant withdrew consent|0|||
146693846|NCT03446040|529057690|FG009|Overall Study|Participant withdrew consent|0|||
146693847|NCT03446040|529057691|FG010|Overall Study|Participant withdrew consent|0|||
146693848|NCT03446040|529057692|FG011|Overall Study|Participant withdrew consent|0|||
146693849|NCT03446040|529057693|FG012|Overall Study|Participant withdrew consent|0|||
146693850|NCT03446040|529057694|FG013|Overall Study|Participant withdrew consent|0|||
146693851|NCT03446040|529057681|FG000|Overall Study|Not reported|0|||
146693852|NCT03446040|529057682|FG001|Overall Study|Not reported|0|||
146693853|NCT03446040|529057683|FG002|Overall Study|Not reported|1|||
146693854|NCT03446040|529057684|FG003|Overall Study|Not reported|0|||
146693855|NCT03446040|529057685|FG004|Overall Study|Not reported|0|||
146693856|NCT03446040|529057686|FG005|Overall Study|Not reported|0|||
146693857|NCT03446040|529057687|FG006|Overall Study|Not reported|0|||
146693858|NCT03446040|529057688|FG007|Overall Study|Not reported|0|||
146693859|NCT03446040|529057689|FG008|Overall Study|Not reported|0|||
146693860|NCT03446040|529057690|FG009|Overall Study|Not reported|0|||
146693861|NCT03446040|529057691|FG010|Overall Study|Not reported|0|||
146693862|NCT03446040|529057692|FG011|Overall Study|Not reported|0|||
146693863|NCT03446040|529057693|FG012|Overall Study|Not reported|0|||
146693864|NCT03446040|529057694|FG013|Overall Study|Not reported|0|||
146693865|NCT00456521|529057695|FG000|Overall Study|Adverse Event|150|||
146693866|NCT00456521|529057696|FG001|Overall Study|Adverse Event|25|||
146693867|NCT00456521|529057695|FG000|Overall Study|Withdrawal by Subject|43|||
146693868|NCT00456521|529057696|FG001|Overall Study|Withdrawal by Subject|24|||
146693869|NCT00456521|529057695|FG000|Overall Study|Lost to Follow-up|22|||
146693870|NCT00456521|529057696|FG001|Overall Study|Lost to Follow-up|17|||
146693871|NCT00456521|529057695|FG000|Overall Study|Lack of Efficacy|3|||
146693872|NCT00456521|529057696|FG001|Overall Study|Lack of Efficacy|6|||
146693873|NCT00456521|529057695|FG000|Overall Study|Protocol Violation|4|||
146693874|NCT00456521|529057696|FG001|Overall Study|Protocol Violation|0|||
146693875|NCT00456521|529057695|FG000|Overall Study|Pregnancy|1|||
146693876|NCT00456521|529057696|FG001|Overall Study|Pregnancy|1|||
146693877|NCT00456521|529057695|FG000|Overall Study|Drug non-compliance, moved, other|26|||
146693878|NCT00456521|529057696|FG001|Overall Study|Drug non-compliance, moved, other|11|||
146693879|NCT00076011|529057700|FG000|Overall Study|Death|1|||
146693880|NCT00076011|529057700|FG000|Overall Study|Adverse Event|10|||
146693881|NCT00076011|529057700|FG000|Overall Study|Lack of Efficacy|25|||
146693882|NCT00076011|529057700|FG000|Overall Study|Withdrawal by Subject|1|||
146693883|NCT00076011|529057700|FG000|Overall Study|Study terminated by sponsor|3|||
146693884|NCT00076011|529057700|FG000|Overall Study|Other|11|||
146693885|NCT00076011|529057700|FG000|Overall Study|Ongoing|1|||
146693886|NCT06027866|529057705|FG000|Overall Study|Withdrawal by Subject|2|||
146693887|NCT04343521|529057706|FG000|Overall Study|Adverse Event|0|||
146693888|NCT04343521|529057707|FG001|Overall Study|Adverse Event|2|||
146693889|NCT04343521|529057706|FG000|Overall Study|Death|1|||
146693890|NCT04343521|529057707|FG001|Overall Study|Death|2|||
146693891|NCT04343521|529057706|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
146693892|NCT04343521|529057707|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
146693893|NCT04343521|529057706|FG000|Overall Study|Withdrawal by Subject|70|||
146693894|NCT04343521|529057707|FG001|Overall Study|Withdrawal by Subject|95|||
146693895|NCT04343521|529057706|FG000|Overall Study|Withdrawal by study team|6|||
146693896|NCT04343521|529057707|FG001|Overall Study|Withdrawal by study team|12|||
146693897|NCT02939560|529057708|FG000|Overall Study|Withdrawal by Subject|2|||
146693898|NCT02939560|529057708|FG000|Overall Study|Protocol Violation|1|||
146693899|NCT03340025|529057709|FG000|Overall Study|Lost to Follow-up|2|||
146693900|NCT03340025|529057710|FG001|Overall Study|Lost to Follow-up|2|||
146693901|NCT02420691|529057713|FG000|Overall Study|Adverse Event|3|||
146693902|NCT02420691|529057713|FG000|Overall Study|Withdrawal by Subject|3|||
146693903|NCT03897179|529057716|FG000|Overall Study|Withdrawal by Subject|1|||
146693904|NCT00704535|529057717|FG000|Overall Study|Adverse Event|2|||
146693905|NCT00704535|529057717|FG000|Overall Study|Death|2|||
146980282|NCT00530439|530089559|FG001|Overall Study|Withdraw|14|||
146693906|NCT00704535|529057717|FG000|Overall Study|Lost to Follow-up|8|||
146693907|NCT00704535|529057717|FG000|Overall Study|Protocol Violation|10|||
146693908|NCT00704535|529057717|FG000|Overall Study|Completed status not on Case Report Form|124|||
146693909|NCT05694546|529057721|FG000|Overall Study|Lost to Follow-up|11|||
146693910|NCT02424383|529057722|FG000|Overall Study|Withdrawal by Subject|32|||
146693911|NCT02424383|529057722|FG000|Overall Study|Death|170|||
146980283|NCT00530439|530089558|FG000|Overall Study|Missed abortion|1|||
146980284|NCT00530439|530089559|FG001|Overall Study|Missed abortion|4|||
146980285|NCT00530439|530089558|FG000|Overall Study|Misclassification|2|||
146980286|NCT00530439|530089559|FG001|Overall Study|Misclassification|0|||
146980287|NCT00530439|530089558|FG000|Overall Study|Twin pregnancy|0|||
146980288|NCT00530439|530089559|FG001|Overall Study|Twin pregnancy|2|||
146980289|NCT00530439|530089558|FG000|Overall Study|Severe malformation/abortion|0|||
146980290|NCT00530439|530089559|FG001|Overall Study|Severe malformation/abortion|3|||
146980291|NCT01629693|530089562|FG000|Overall Study|Lost to Follow-up|2|||
146980292|NCT01629693|530089563|FG001|Overall Study|Lost to Follow-up|4|||
146980293|NCT01629693|530089562|FG000|Overall Study|Withdrawal by Subject|2|||
146980294|NCT01629693|530089563|FG001|Overall Study|Withdrawal by Subject|2|||
146980295|NCT01629693|530089562|FG000|Overall Study|Adverse Event|1|||
146980296|NCT01629693|530089563|FG001|Overall Study|Adverse Event|0|||
146980297|NCT01629693|530089562|FG000|Overall Study|Investigator decision|0|||
146980298|NCT01629693|530089563|FG001|Overall Study|Investigator decision|1|||
146980299|NCT01629693|530089562|FG000|Overall Study|Poor comfort of study lenses|0|||
146980300|NCT01629693|530089563|FG001|Overall Study|Poor comfort of study lenses|2|||
146980301|NCT01629693|530089562|FG000|Overall Study|Subject decision unrelated to AE|0|||
146980302|NCT01629693|530089563|FG001|Overall Study|Subject decision unrelated to AE|1|||
146980303|NCT04385199|530089564|FG000|Overall Study|Withdrawal by Subject|1|||
146980304|NCT04385199|530089565|FG001|Overall Study|Withdrawal by Subject|0|||
146980305|NCT01025193|530089567|FG000|Overall Study|Protocol Violation|1|||
146980306|NCT01025193|530089567|FG000|Overall Study|Adverse Event|3|||
146980307|NCT04079842|530089568|FG000|Overall Study|Request of subject|2|||
146980308|NCT04079842|530089568|FG000|Overall Study|Unable to draw Arterial samples|1|||
146980309|NCT02904200|530089569|FG000|Overall Study|Withdrawal by Subject|1|||
146980310|NCT02904200|530089570|FG001|Overall Study|Withdrawal by Subject|0|||
146980311|NCT02133352|530089573|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
146980312|NCT03705169|530089574|FG000|Overall Study|Lost to Follow-up|0|||
146980313|NCT03705169|530089575|FG001|Overall Study|Lost to Follow-up|0|||
146980314|NCT03705169|530089576|FG002|Overall Study|Lost to Follow-up|0|||
146980315|NCT03705169|530089577|FG003|Overall Study|Lost to Follow-up|2|||
146980316|NCT03705169|530089578|FG004|Overall Study|Lost to Follow-up|0|||
146693912|NCT02424383|529057722|FG000|Overall Study|Sponsor's decision|3|||
146693913|NCT02424383|529057722|FG000|Overall Study|Investigator's decision|44|||
146693914|NCT02424383|529057722|FG000|Overall Study|Lost to Follow-up|81|||
146693915|NCT02424383|529057722|FG000|Overall Study|Other|7|||
146693916|NCT02424383|529057722|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
146693917|NCT01251380|529057728|FG000|Overall Study|Other (Not otherwise specified)|12|||
146693918|NCT01251380|529057728|FG000|Overall Study|Withdrawal by Subject|6|||
146693919|NCT01251380|529057728|FG000|Overall Study|Lack of Efficacy|1|||
146693920|NCT01251380|529057728|FG000|Overall Study|Adverse Event|1|||
146693921|NCT01251380|529057728|FG000|Overall Study|Lost to Follow-up|2|||
146693922|NCT02063737|529057729|FG000|Overall Study|Lost to Follow-up|11|||
146693923|NCT02063737|529057730|FG001|Overall Study|Lost to Follow-up|4|||
146693924|NCT00439556|529057731|FG000|Overall Study|Patient was taken off study for non-comp|0|||
146693925|NCT00439556|529057732|FG001|Overall Study|Patient was taken off study for non-comp|1|||
146693926|NCT00439556|529057733|FG002|Overall Study|Patient was taken off study for non-comp|0|||
146693927|NCT01826487|529057740|FG000|Overall Study|Adverse Event|1|||
146693928|NCT01826487|529057741|FG001|Overall Study|Adverse Event|1|||
146693929|NCT01826487|529057740|FG000|Overall Study|Lost to Follow-up|1|||
146693930|NCT01826487|529057741|FG001|Overall Study|Lost to Follow-up|0|||
146693931|NCT01826487|529057740|FG000|Overall Study|Withdrawal by Subject|1|||
146693932|NCT01826487|529057741|FG001|Overall Study|Withdrawal by Subject|3|||
146693933|NCT01826487|529057740|FG000|Overall Study|Protocol Violation|1|||
146693934|NCT01826487|529057741|FG001|Overall Study|Protocol Violation|1|||
146693935|NCT01358357|529057742|FG000|Open Label Phase|Adverse Event|0|||
146693936|NCT01358357|529057743|FG001|Open Label Phase|Adverse Event|0|||
146693937|NCT01358357|529057744|FG002|Open Label Phase|Adverse Event|59|||
146693938|NCT01358357|529057742|FG000|Open Label Phase|Lack of Efficacy|0|||
146693939|NCT01358357|529057743|FG001|Open Label Phase|Lack of Efficacy|0|||
146693940|NCT01358357|529057744|FG002|Open Label Phase|Lack of Efficacy|107|||
146693941|NCT01358357|529057742|FG000|Open Label Phase|Lost to Follow-up|0|||
146693942|NCT01358357|529057743|FG001|Open Label Phase|Lost to Follow-up|0|||
146693943|NCT01358357|529057744|FG002|Open Label Phase|Lost to Follow-up|76|||
146693944|NCT01358357|529057742|FG000|Open Label Phase|Protocol Violation|0|||
146693945|NCT01358357|529057743|FG001|Open Label Phase|Protocol Violation|0|||
146693946|NCT01358357|529057744|FG002|Open Label Phase|Protocol Violation|45|||
146693947|NCT01358357|529057742|FG000|Open Label Phase|Withdrawal by Subject|0|||
146693948|NCT01358357|529057743|FG001|Open Label Phase|Withdrawal by Subject|0|||
146693949|NCT01358357|529057744|FG002|Open Label Phase|Withdrawal by Subject|112|||
146693950|NCT01358357|529057742|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
146693951|NCT01358357|529057743|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
146693952|NCT01358357|529057744|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
146693953|NCT01358357|529057742|FG000|Open Label Phase|Terminated at study completion|0|||
146775769|NCT02409667|529349623|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
146980317|NCT03705169|530089579|FG005|Overall Study|Lost to Follow-up|2|||
146775770|NCT02409667|529349624|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
146775771|NCT02409667|529349625|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
146775772|NCT02409667|529349626|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
146775773|NCT02409667|529349622|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
146775774|NCT02409667|529349623|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
146775775|NCT02409667|529349624|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
146775776|NCT02409667|529349625|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
146775777|NCT02409667|529349626|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
146775778|NCT02409667|529349622|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
146775779|NCT02409667|529349623|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
146775780|NCT02409667|529349624|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
146775781|NCT02409667|529349625|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
146775782|NCT02409667|529349626|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
146775783|NCT02409667|529349622|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
146775784|NCT02409667|529349623|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
146775785|NCT02409667|529349624|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
146775786|NCT02409667|529349625|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
146775787|NCT02409667|529349626|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
146775788|NCT01255670|529349627|FG000|Overall Study|Adverse Event|10|||
146775789|NCT01255670|529349628|FG001|Overall Study|Adverse Event|10|||
146929978|NCT01179347|529903420|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
146929979|NCT01179347|529903421|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
146929980|NCT01179347|529903420|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
146693954|NCT01358357|529057743|FG001|Open Label Phase|Terminated at study completion|0|||
146693955|NCT01358357|529057744|FG002|Open Label Phase|Terminated at study completion|5|||
146693956|NCT01358357|529057742|FG000|Open Label Phase|Mood episode|0|||
146693957|NCT01358357|529057743|FG001|Open Label Phase|Mood episode|0|||
146693958|NCT01358357|529057744|FG002|Open Label Phase|Mood episode|42|||
146693959|NCT01358357|529057742|FG000|Double-Blind Phase|Adverse Event|8|||
146693960|NCT01358357|529057743|FG001|Double-Blind Phase|Adverse Event|5|||
146693961|NCT01358357|529057744|FG002|Double-Blind Phase|Adverse Event|0|||
146693962|NCT01358357|529057742|FG000|Double-Blind Phase|Lost to Follow-up|5|||
146693963|NCT01358357|529057743|FG001|Double-Blind Phase|Lost to Follow-up|7|||
146693964|NCT01358357|529057744|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146693965|NCT01358357|529057742|FG000|Double-Blind Phase|Protocol Violation|1|||
146693966|NCT01358357|529057743|FG001|Double-Blind Phase|Protocol Violation|11|||
146693967|NCT01358357|529057744|FG002|Double-Blind Phase|Protocol Violation|0|||
146693968|NCT01358357|529057742|FG000|Double-Blind Phase|Protocol Violation|16|||
146693969|NCT01358357|529057743|FG001|Double-Blind Phase|Protocol Violation|12|||
146693970|NCT01358357|529057744|FG002|Double-Blind Phase|Protocol Violation|0|||
146693971|NCT01358357|529057742|FG000|Double-Blind Phase|Terminated at study completion|2|||
146693972|NCT01358357|529057743|FG001|Double-Blind Phase|Terminated at study completion|0|||
146693973|NCT01358357|529057744|FG002|Double-Blind Phase|Terminated at study completion|0|||
146693974|NCT01358357|529057742|FG000|Double-Blind Phase|Recurrence of mood event|48|||
146775790|NCT01255670|529349627|FG000|Overall Study|Lost to Follow-up|16|||
146775791|NCT01255670|529349628|FG001|Overall Study|Lost to Follow-up|10|||
146775792|NCT03664960|529349629|FG000|Overall Study|Adverse Event|0|||
146775793|NCT03664960|529349630|FG001|Overall Study|Adverse Event|3|||
146929981|NCT01179347|529903421|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
146929982|NCT01179347|529903420|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
146929983|NCT01179347|529903421|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
146929984|NCT01179347|529903420|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
146929985|NCT01179347|529903421|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
146929986|NCT01179347|529903420|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
146929987|NCT01179347|529903421|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
146929988|NCT01179347|529903420|FG000|Open-label Period (12 Weeks)|Other|7|||
146929989|NCT01179347|529903421|FG001|Open-label Period (12 Weeks)|Other|4|||
146929990|NCT01337167|529903425|FG000|Infant Series|Adverse Event|1|||
146929991|NCT01337167|529903426|FG001|Infant Series|Adverse Event|1|||
146929992|NCT01337167|529903425|FG000|Infant Series|Death|1|||
146929993|NCT01337167|529903426|FG001|Infant Series|Death|1|||
146693975|NCT01358357|529057743|FG001|Double-Blind Phase|Recurrence of mood event|64|||
146693976|NCT01358357|529057744|FG002|Double-Blind Phase|Recurrence of mood event|0|||
146775794|NCT03664960|529349629|FG000|Overall Study|Lost to Follow-up|3|||
146775795|NCT03664960|529349630|FG001|Overall Study|Lost to Follow-up|2|||
146775796|NCT03664960|529349629|FG000|Overall Study|Physician Decision|1|||
146929994|NCT01337167|529903425|FG000|Infant Series|Lost to Follow-up|13|||
146929995|NCT01337167|529903426|FG001|Infant Series|Lost to Follow-up|7|||
146929996|NCT01337167|529903425|FG000|Infant Series|Non-compliance with study drug|2|||
146693977|NCT01358357|529057742|FG000|Double-Blind Phase|Administrative|0|||
146693978|NCT01358357|529057743|FG001|Double-Blind Phase|Administrative|1|||
146929997|NCT01337167|529903426|FG001|Infant Series|Non-compliance with study drug|1|||
146693979|NCT01358357|529057744|FG002|Double-Blind Phase|Administrative|0|||
146693980|NCT02171260|529057749|FG000|Overall Study|Death|0|||
146693981|NCT02171260|529057750|FG001|Overall Study|Death|0|||
146693982|NCT02171260|529057751|FG002|Overall Study|Death|0|||
146693983|NCT02171260|529057752|FG003|Overall Study|Death|1|||
146693984|NCT02171260|529057749|FG000|Overall Study|Physician Decision|1|||
146693985|NCT02171260|529057750|FG001|Overall Study|Physician Decision|0|||
146693986|NCT02171260|529057751|FG002|Overall Study|Physician Decision|1|||
146693987|NCT02171260|529057752|FG003|Overall Study|Physician Decision|0|||
146693988|NCT02171260|529057749|FG000|Overall Study|Withdrawal by Subject|1|||
146693989|NCT02171260|529057750|FG001|Overall Study|Withdrawal by Subject|0|||
146693990|NCT02171260|529057751|FG002|Overall Study|Withdrawal by Subject|0|||
146693991|NCT02171260|529057752|FG003|Overall Study|Withdrawal by Subject|0|||
146693992|NCT02171260|529057749|FG000|Overall Study|Evidence of progressive disease|4|||
146693993|NCT02171260|529057750|FG001|Overall Study|Evidence of progressive disease|6|||
146693994|NCT02171260|529057751|FG002|Overall Study|Evidence of progressive disease|4|||
146693995|NCT02171260|529057752|FG003|Overall Study|Evidence of progressive disease|4|||
146693996|NCT00323492|529057757|FG000|Study Phase 1|Adverse Event|2|||
146693997|NCT00323492|529057758|FG001|Study Phase 1|Adverse Event|0|||
146693998|NCT00323492|529057759|FG002|Study Phase 1|Adverse Event|0|||
146693999|NCT00323492|529057757|FG000|Study Phase 2|Adverse Event|1|||
146694000|NCT00323492|529057758|FG001|Study Phase 2|Adverse Event|0|||
146694001|NCT00323492|529057759|FG002|Study Phase 2|Adverse Event|0|||
146694002|NCT00323492|529057757|FG000|Study Phase 2|Physician Decision|1|||
146694003|NCT00323492|529057758|FG001|Study Phase 2|Physician Decision|0|||
146694004|NCT00323492|529057759|FG002|Study Phase 2|Physician Decision|0|||
146694005|NCT00323492|529057757|FG000|Study Phase 2|Lost to Follow-up|1|||
146694006|NCT00323492|529057758|FG001|Study Phase 2|Lost to Follow-up|0|||
146694007|NCT00323492|529057759|FG002|Study Phase 2|Lost to Follow-up|0|||
146694008|NCT00323492|529057757|FG000|Study Phase 2|Withdrawal by Subject|0|||
146694009|NCT00323492|529057758|FG001|Study Phase 2|Withdrawal by Subject|1|||
146694010|NCT00323492|529057759|FG002|Study Phase 2|Withdrawal by Subject|0|||
146694011|NCT00323492|529057757|FG000|Study Phase 2|Noncompliance with study schedule|0|||
146694012|NCT00323492|529057758|FG001|Study Phase 2|Noncompliance with study schedule|0|||
146694013|NCT00323492|529057759|FG002|Study Phase 2|Noncompliance with study schedule|1|||
146694014|NCT00323492|529057757|FG000|Study Phase 2|Protocol Violation|1|||
146694015|NCT00323492|529057758|FG001|Study Phase 2|Protocol Violation|0|||
146694016|NCT00323492|529057759|FG002|Study Phase 2|Protocol Violation|0|||
146694017|NCT02486042|529057760|FG000|Overall Study|Physician Decision|1|||
146694018|NCT02486042|529057761|FG001|Overall Study|Physician Decision|7|||
146694019|NCT02486042|529057760|FG000|Overall Study|Hospital transfer|2|||
146694020|NCT02486042|529057761|FG001|Overall Study|Hospital transfer|2|||
146694021|NCT02486042|529057760|FG000|Overall Study|Withdrawal by Subject|0|||
146694022|NCT02486042|529057761|FG001|Overall Study|Withdrawal by Subject|2|||
146694023|NCT03320564|529057764|FG000|Overall Study|Protocol Violation|1|||
146694024|NCT04668950|529057768|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
146694025|NCT04668950|529057769|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
146694026|NCT04668950|529057768|FG000|Overall Study|Could not confirm started study medication|15|||
146694027|NCT04668950|529057769|FG001|Overall Study|Could not confirm started study medication|15|||
146694028|NCT04668950|529057768|FG000|Overall Study|Could not confirm baseline status|6|||
146694029|NCT04668950|529057769|FG001|Overall Study|Could not confirm baseline status|2|||
146694030|NCT04668950|529057768|FG000|Overall Study|Drop out and did not start medication|15|||
146694031|NCT04668950|529057769|FG001|Overall Study|Drop out and did not start medication|17|||
146694032|NCT04668950|529057768|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
146694033|NCT04668950|529057769|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
146694034|NCT04668950|529057768|FG000|Overall Study|Other|2|||
146694035|NCT04668950|529057769|FG001|Overall Study|Other|4|||
146694036|NCT03979638|529057770|FG000|Period 1|Physician Decision|1|||
146694037|NCT03979638|529057771|FG001|Period 1|Physician Decision|1|||
146694038|NCT03979638|529057770|FG000|Period 1|Withdrawal by Subject|4|||
146694039|NCT03979638|529057771|FG001|Period 1|Withdrawal by Subject|3|||
146929998|NCT01337167|529903425|FG000|Infant Series|Physician Decision|3|||
146929999|NCT01337167|529903426|FG001|Infant Series|Physician Decision|1|||
146694040|NCT03979638|529057770|FG000|Period 1|Study terminated by Sponsor|1|||
146694041|NCT03979638|529057771|FG001|Period 1|Study terminated by Sponsor|3|||
146694042|NCT03979638|529057770|FG000|Period 1|Protocol Violation|1|||
146694043|NCT03979638|529057771|FG001|Period 1|Protocol Violation|0|||
146694044|NCT03979638|529057770|FG000|Period 2|Study terminated by Sponsor|1|||
146694045|NCT03979638|529057771|FG001|Period 2|Study terminated by Sponsor|1|||
146694046|NCT00600938|529057776|FG000|Core Study|Abnormal test procedure result(s)|3|||
146694047|NCT00600938|529057777|FG001|Core Study|Abnormal test procedure result(s)|2|||
146694048|NCT00600938|529057778|FG002|Core Study|Abnormal test procedure result(s)|0|||
146694049|NCT00600938|529057779|FG003|Core Study|Abnormal test procedure result(s)|0|||
146694050|NCT00600938|529057776|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
146694051|NCT00600938|529057777|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
146930000|NCT01337167|529903425|FG000|Infant Series|Protocol Violation|22|||
146694052|NCT00600938|529057778|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
146694053|NCT00600938|529057779|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
146694054|NCT00600938|529057776|FG000|Core Study|Patient withdrew consent|7|||
146694055|NCT00600938|529057777|FG001|Core Study|Patient withdrew consent|12|||
146694056|NCT00600938|529057778|FG002|Core Study|Patient withdrew consent|0|||
146694057|NCT00600938|529057779|FG003|Core Study|Patient withdrew consent|0|||
146694058|NCT00600938|529057776|FG000|Core Study|Lost to Follow-up|3|||
146694059|NCT00600938|529057777|FG001|Core Study|Lost to Follow-up|2|||
146930001|NCT01337167|529903426|FG001|Infant Series|Protocol Violation|9|||
146694060|NCT00600938|529057778|FG002|Core Study|Lost to Follow-up|0|||
146694061|NCT00600938|529057779|FG003|Core Study|Lost to Follow-up|0|||
146694062|NCT00600938|529057776|FG000|Core Study|Death|1|||
146694063|NCT00600938|529057777|FG001|Core Study|Death|1|||
146694064|NCT00600938|529057778|FG002|Core Study|Death|0|||
146694065|NCT00600938|529057779|FG003|Core Study|Death|0|||
146694066|NCT00600938|529057776|FG000|Core Study|Protocol Violation|1|||
146694067|NCT00600938|529057777|FG001|Core Study|Protocol Violation|2|||
146694068|NCT00600938|529057778|FG002|Core Study|Protocol Violation|0|||
146694069|NCT00600938|529057779|FG003|Core Study|Protocol Violation|0|||
146694070|NCT00600938|529057776|FG000|Extension Study|Adverse Event|1|||
146694071|NCT00600938|529057777|FG001|Extension Study|Adverse Event|0|||
146694072|NCT00600938|529057778|FG002|Extension Study|Adverse Event|2|||
146694073|NCT00600938|529057779|FG003|Extension Study|Adverse Event|0|||
146694074|NCT00600938|529057776|FG000|Extension Study|Abnormal test procedure results|0|||
146694075|NCT00600938|529057777|FG001|Extension Study|Abnormal test procedure results|1|||
146694076|NCT00600938|529057778|FG002|Extension Study|Abnormal test procedure results|1|||
146694077|NCT00600938|529057779|FG003|Extension Study|Abnormal test procedure results|1|||
146694078|NCT00600938|529057776|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
146694079|NCT00600938|529057777|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
146694080|NCT00600938|529057778|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
146694081|NCT00600938|529057779|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
146694082|NCT00600938|529057776|FG000|Extension Study|Withdrawal by Subject|2|||
146694083|NCT00600938|529057777|FG001|Extension Study|Withdrawal by Subject|2|||
146694084|NCT00600938|529057778|FG002|Extension Study|Withdrawal by Subject|3|||
146694085|NCT00600938|529057779|FG003|Extension Study|Withdrawal by Subject|0|||
146694086|NCT00600938|529057776|FG000|Extension Study|Lost to Follow-up|1|||
146694087|NCT00600938|529057777|FG001|Extension Study|Lost to Follow-up|1|||
146694088|NCT00600938|529057778|FG002|Extension Study|Lost to Follow-up|2|||
146694089|NCT00600938|529057779|FG003|Extension Study|Lost to Follow-up|0|||
146694090|NCT00600938|529057776|FG000|Extension Study|Death|1|||
146694091|NCT00600938|529057777|FG001|Extension Study|Death|0|||
146694092|NCT00600938|529057778|FG002|Extension Study|Death|0|||
146694093|NCT00600938|529057779|FG003|Extension Study|Death|0|||
146694094|NCT04220411|529057780|FG000|Overall Study|Adverse Event|0|||
146694095|NCT04220411|529057781|FG001|Overall Study|Adverse Event|0|||
146694096|NCT04220411|529057782|FG002|Overall Study|Adverse Event|0|||
146694097|NCT04220411|529057783|FG003|Overall Study|Adverse Event|1|||
146694098|NCT02680639|529057784|FG000|Screening Period|Screen Failure|7|||
146694099|NCT02680639|529057785|FG001|Screening Period|Screen Failure|0|||
146694100|NCT02680639|529057786|FG002|Screening Period|Screen Failure|0|||
146694101|NCT00549562|529057801|FG000|Overall Study|Adverse Event|1|||
146694102|NCT00549562|529057801|FG000|Overall Study|Lack of Efficacy|1|||
146694103|NCT00323115|529057805|FG000|Vaccine Administration|Adverse Event|1|||
146694104|NCT00323115|529057805|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
146694105|NCT02946047|529057806|FG000|Overall Study|Adverse Event|1|||
146694106|NCT02946047|529057807|FG001|Overall Study|Adverse Event|0|||
146694107|NCT02946047|529057808|FG002|Overall Study|Adverse Event|0|||
146694108|NCT02946047|529057809|FG003|Overall Study|Adverse Event|0|||
146694109|NCT02496533|529057810|FG000|Overall Study|Lack of data on outcome|3|||
146694110|NCT02496533|529057811|FG001|Overall Study|Lack of data on outcome|0|||
146694111|NCT02496533|529057810|FG000|Overall Study|Patient did not complete all measures|0|||
146694112|NCT02496533|529057811|FG001|Overall Study|Patient did not complete all measures|4|||
146694113|NCT02496533|529057810|FG000|Overall Study|Late for radiologic testing|0|||
146694114|NCT02496533|529057811|FG001|Overall Study|Late for radiologic testing|2|||
146694115|NCT02268409|529059808|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
146694116|NCT02268409|529059808|FG000|Overall Study|Death|1|||
146694117|NCT02268409|529059808|FG000|Overall Study|Lost to Follow-up|1|||
146694118|NCT02268409|529059808|FG000|Overall Study|Protocol Violation|3|||
146694119|NCT02268409|529059808|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
146694120|NCT02268409|529059808|FG000|Overall Study|Withdrawal by Subject|5|||
146694121|NCT00489853|529059809|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
146694122|NCT00489853|529059810|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
146694123|NCT00489853|529059811|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
146694124|NCT00489853|529059809|FG000|Wash-out Period 1|Adverse Event|0|||
146694125|NCT00489853|529059810|FG001|Wash-out Period 1|Adverse Event|1|||
146694126|NCT00489853|529059811|FG002|Wash-out Period 1|Adverse Event|1|||
146694127|NCT00489853|529059809|FG000|Wash-out Period 1|Protocol Violation|0|||
146694128|NCT00489853|529059810|FG001|Wash-out Period 1|Protocol Violation|1|||
146694129|NCT00489853|529059811|FG002|Wash-out Period 1|Protocol Violation|1|||
146694130|NCT00489853|529059809|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
146694131|NCT00489853|529059810|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
146694132|NCT00489853|529059811|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
146694133|NCT00489853|529059809|FG000|Wash-out Period 2|Adverse Event|1|||
146694134|NCT00489853|529059810|FG001|Wash-out Period 2|Adverse Event|1|||
146694135|NCT00489853|529059811|FG002|Wash-out Period 2|Adverse Event|0|||
146694136|NCT00489853|529059809|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
146694137|NCT00489853|529059810|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
146694138|NCT00489853|529059811|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
146694139|NCT00489853|529059809|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
146694140|NCT00489853|529059810|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
146694141|NCT00489853|529059811|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
146694142|NCT04865354|529059812|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
146694143|NCT04865354|529059813|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
146694144|NCT04865354|529059812|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
146694145|NCT04865354|529059813|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
146694146|NCT04865354|529059812|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
146694147|NCT04865354|529059813|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
146694148|NCT03873987|529059814|FG000|Overall Study|Adverse Event|1|||
146694149|NCT03873987|529059815|FG001|Overall Study|Adverse Event|0|||
146694150|NCT03873987|529059814|FG000|Overall Study|staff was unable to start a new IV line|1|||
146694151|NCT03873987|529059815|FG001|Overall Study|staff was unable to start a new IV line|0|||
146694152|NCT03873987|529059814|FG000|Overall Study|Lost to Follow-up|0|||
146694153|NCT03873987|529059815|FG001|Overall Study|Lost to Follow-up|1|||
146694154|NCT01465022|529059816|FG000|Overall Study|Lost to Follow-up|15|||
146694155|NCT01465022|529059817|FG001|Overall Study|Lost to Follow-up|14|||
146694156|NCT01465022|529059818|FG002|Overall Study|Lost to Follow-up|0|||
146694157|NCT01465022|529059816|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
146694158|NCT01465022|529059817|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
146694159|NCT01465022|529059818|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
146694160|NCT01465022|529059816|FG000|Overall Study|Not Randomized|0|||
146694161|NCT01465022|529059817|FG001|Overall Study|Not Randomized|0|||
146694162|NCT01465022|529059818|FG002|Overall Study|Not Randomized|70|||
146694163|NCT00004888|529059819|FG000|Overall Study|Adverse Event|5|||
146694164|NCT00004888|529059820|FG001|Overall Study|Adverse Event|10|||
146694165|NCT00004888|529059819|FG000|Overall Study|Withdrawal by Subject|0|||
146694166|NCT00004888|529059820|FG001|Overall Study|Withdrawal by Subject|3|||
146775797|NCT03664960|529349630|FG001|Overall Study|Physician Decision|0|||
146930002|NCT01337167|529903425|FG000|Infant Series|Withdrawal by Subject|15|||
146930003|NCT01337167|529903426|FG001|Infant Series|Withdrawal by Subject|4|||
146930004|NCT01337167|529903425|FG000|Infant Series|Randomized but not vaccinated|5|||
146930005|NCT01337167|529903426|FG001|Infant Series|Randomized but not vaccinated|3|||
146930006|NCT01337167|529903425|FG000|Interim Period|Lost to Follow-up|51|||
146930007|NCT01337167|529903426|FG001|Interim Period|Lost to Follow-up|23|||
146930008|NCT01337167|529903425|FG000|Interim Period|Non-compliance with study drug|1|||
146930009|NCT01337167|529903426|FG001|Interim Period|Non-compliance with study drug|0|||
146930010|NCT01337167|529903425|FG000|Interim Period|Physician Decision|6|||
146930011|NCT01337167|529903426|FG001|Interim Period|Physician Decision|3|||
146930012|NCT01337167|529903425|FG000|Interim Period|Protocol Violation|5|||
146930013|NCT01337167|529903426|FG001|Interim Period|Protocol Violation|3|||
146930014|NCT01337167|529903425|FG000|Interim Period|Withdrawal by Subject|18|||
146930015|NCT01337167|529903426|FG001|Interim Period|Withdrawal by Subject|10|||
146930016|NCT01337167|529903425|FG000|Interim Period|Other protocol criterion not met|0|||
146930017|NCT01337167|529903426|FG001|Interim Period|Other protocol criterion not met|1|||
146930018|NCT01337167|529903425|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
146930019|NCT01337167|529903426|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
146930020|NCT01337167|529903425|FG000|Toddler Vaccinations|Protocol Violation|0|||
146930021|NCT01337167|529903426|FG001|Toddler Vaccinations|Protocol Violation|1|||
146694167|NCT00004888|529059819|FG000|Overall Study|Physician Decision|1|||
146694168|NCT00004888|529059820|FG001|Overall Study|Physician Decision|1|||
146694169|NCT00004888|529059819|FG000|Overall Study|Progressive Disease|4|||
146694170|NCT00004888|529059820|FG001|Overall Study|Progressive Disease|9|||
146694171|NCT00004888|529059819|FG000|Overall Study|Death without progressive disease|0|||
146694172|NCT00004888|529059820|FG001|Overall Study|Death without progressive disease|1|||
146694173|NCT00004888|529059819|FG000|Overall Study|Toxic death|1|||
146694174|NCT00004888|529059820|FG001|Overall Study|Toxic death|0|||
146930022|NCT01337167|529903425|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
146930023|NCT01337167|529903426|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
146930024|NCT03833817|529903431|FG000|Overall Study|Withdrawal by Subject|3|||
146930025|NCT03833817|529903432|FG001|Overall Study|Withdrawal by Subject|3|||
146930026|NCT03833817|529903431|FG000|Overall Study|Lost to Follow-up|3|||
146694175|NCT00136084|529059821|FG000|Overall Study|Death|12|||
146694176|NCT00136084|529059822|FG001|Overall Study|Death|5|||
146694177|NCT00136084|529059821|FG000|Overall Study|Unacceptable toxicity|8|||
146694178|NCT00136084|529059822|FG001|Overall Study|Unacceptable toxicity|11|||
146775798|NCT03664960|529349629|FG000|Overall Study|Withdrawal by Subject|3|||
146775799|NCT03664960|529349630|FG001|Overall Study|Withdrawal by Subject|14|||
146775800|NCT03664960|529349629|FG000|Overall Study|Sponsor Decision|1|||
146694179|NCT00136084|529059821|FG000|Overall Study|Relapse|20|||
146694180|NCT00136084|529059822|FG001|Overall Study|Relapse|23|||
146694181|NCT00136084|529059821|FG000|Overall Study|Lost to Follow-up|2|||
146694182|NCT00136084|529059822|FG001|Overall Study|Lost to Follow-up|0|||
146694183|NCT00136084|529059821|FG000|Overall Study|No Response|1|||
146694184|NCT00136084|529059822|FG001|Overall Study|No Response|2|||
146694185|NCT00136084|529059821|FG000|Overall Study|Withdrawal by Subject|5|||
146694186|NCT00136084|529059822|FG001|Overall Study|Withdrawal by Subject|1|||
146694187|NCT02520011|529059823|FG000|Overall Study|Adverse Event|0|||
146694188|NCT02520011|529059824|FG001|Overall Study|Adverse Event|1|||
146694189|NCT02520011|529059825|FG002|Overall Study|Adverse Event|2|||
146694190|NCT02520011|529059823|FG000|Overall Study|Death|0|||
146775801|NCT03664960|529349630|FG001|Overall Study|Sponsor Decision|1|||
146775802|NCT03664960|529349629|FG000|Overall Study|Other|1|||
146775803|NCT03664960|529349630|FG001|Overall Study|Other|2|||
146775804|NCT00823472|529349631|FG000|Overall Study|Physician Decision|24|||
146775805|NCT00823472|529349632|FG001|Overall Study|Physician Decision|28|||
146775806|NCT04019444|529349633|FG000|Overall Study|Withdrawal by Subject|0|||
146775807|NCT04019444|529349634|FG001|Overall Study|Withdrawal by Subject|1|||
146775808|NCT04019444|529349635|FG002|Overall Study|Withdrawal by Subject|0|||
146775809|NCT04019444|529349636|FG003|Overall Study|Withdrawal by Subject|1|||
146775810|NCT04019444|529349633|FG000|Overall Study|Solicited Event|0|||
146694191|NCT02520011|529059824|FG001|Overall Study|Death|8|||
146694192|NCT02520011|529059825|FG002|Overall Study|Death|1|||
146694193|NCT02520011|529059823|FG000|Overall Study|Lack of Efficacy|4|||
146694194|NCT02520011|529059824|FG001|Overall Study|Lack of Efficacy|26|||
146694195|NCT02520011|529059825|FG002|Overall Study|Lack of Efficacy|4|||
146694196|NCT02520011|529059823|FG000|Overall Study|Physician Decision|0|||
146694197|NCT02520011|529059824|FG001|Overall Study|Physician Decision|2|||
146694198|NCT02520011|529059825|FG002|Overall Study|Physician Decision|0|||
146694199|NCT02520011|529059823|FG000|Overall Study|Withdrawal by Subject|1|||
146694200|NCT02520011|529059824|FG001|Overall Study|Withdrawal by Subject|3|||
146694201|NCT02520011|529059825|FG002|Overall Study|Withdrawal by Subject|0|||
146694202|NCT02520011|529059823|FG000|Overall Study|Protocol Deviation|0|||
146694203|NCT02520011|529059824|FG001|Overall Study|Protocol Deviation|1|||
146694204|NCT02520011|529059825|FG002|Overall Study|Protocol Deviation|0|||
146694205|NCT02520011|529059823|FG000|Overall Study|Patient went to hospice|0|||
146694206|NCT02520011|529059824|FG001|Overall Study|Patient went to hospice|1|||
146694207|NCT02520011|529059825|FG002|Overall Study|Patient went to hospice|0|||
146694208|NCT02520011|529059823|FG000|Overall Study|Progressive disease following response|0|||
146694209|NCT02520011|529059824|FG001|Overall Study|Progressive disease following response|4|||
146694210|NCT02520011|529059825|FG002|Overall Study|Progressive disease following response|2|||
146694211|NCT03239470|529059828|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
146694212|NCT03239470|529059829|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
146694213|NCT01921829|529059830|FG000|Overall Study|Withdrawal by Subject|0|||
146694214|NCT01921829|529059831|FG001|Overall Study|Withdrawal by Subject|1|||
146694215|NCT01762943|529059833|FG000|Overall Study|Physician Decision|1|||
146694216|NCT01762943|529059834|FG001|Overall Study|Physician Decision|1|||
146694217|NCT01762943|529059833|FG000|Overall Study|Protocol Violation|1|||
146694218|NCT01762943|529059834|FG001|Overall Study|Protocol Violation|0|||
146694219|NCT01762943|529059833|FG000|Overall Study|Withdrawal by Subject|2|||
146694220|NCT01762943|529059834|FG001|Overall Study|Withdrawal by Subject|1|||
146694221|NCT00539838|529059835|FG000|Overall Study|Fail to return|2|||
146694222|NCT00539838|529059836|FG001|Overall Study|Fail to return|0|||
146694223|NCT00539838|529059837|FG002|Overall Study|Fail to return|0|||
146775811|NCT04019444|529349634|FG001|Overall Study|Solicited Event|0|||
146775812|NCT04019444|529349635|FG002|Overall Study|Solicited Event|2|||
146775813|NCT04019444|529349636|FG003|Overall Study|Solicited Event|0|||
146775814|NCT03807778|529349642|FG000|Overall Study|Adverse Event|0|||
146980318|NCT03705169|530089580|FG006|Overall Study|Lost to Follow-up|1|||
146694224|NCT00539838|529059835|FG000|Overall Study|Withdrawal by Subject|0|||
146694225|NCT00539838|529059836|FG001|Overall Study|Withdrawal by Subject|4|||
146694226|NCT00539838|529059837|FG002|Overall Study|Withdrawal by Subject|0|||
146694227|NCT00539838|529059835|FG000|Overall Study|Death|0|||
146694228|NCT00539838|529059836|FG001|Overall Study|Death|2|||
146694229|NCT00539838|529059837|FG002|Overall Study|Death|0|||
146694230|NCT00539838|529059835|FG000|Overall Study|Did not cooperate|1|||
146694231|NCT00539838|529059836|FG001|Overall Study|Did not cooperate|0|||
146694232|NCT00539838|529059837|FG002|Overall Study|Did not cooperate|1|||
146775815|NCT03807778|529349643|FG001|Overall Study|Adverse Event|0|||
146775816|NCT03807778|529349644|FG002|Overall Study|Adverse Event|3|||
146775817|NCT03807778|529349645|FG003|Overall Study|Adverse Event|5|||
146694233|NCT00539838|529059835|FG000|Overall Study|Administrative|4|||
146694234|NCT00539838|529059836|FG001|Overall Study|Administrative|0|||
146694235|NCT00539838|529059837|FG002|Overall Study|Administrative|8|||
146694236|NCT02658890|529059843|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694237|NCT02658890|529059844|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694238|NCT02658890|529059845|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694239|NCT02658890|529059846|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694240|NCT02658890|529059847|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146930027|NCT03833817|529903432|FG001|Overall Study|Lost to Follow-up|3|||
146694241|NCT02658890|529059848|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694242|NCT02658890|529059849|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694243|NCT02658890|529059850|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694244|NCT02658890|529059851|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
146694245|NCT02658890|529059852|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694246|NCT02658890|529059853|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694247|NCT02658890|529059854|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694248|NCT02658890|529059855|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694249|NCT02658890|529059856|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694250|NCT02658890|529059857|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694251|NCT02658890|529059858|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694252|NCT02658890|529059859|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694253|NCT02658890|529059860|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694254|NCT02658890|529059861|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146775818|NCT03807778|529349642|FG000|Overall Study|Progressive Disease|4|||
146930028|NCT00884221|529903433|FG000|Overall Study|Withdrawal by Subject|0|||
146930029|NCT00884221|529903434|FG001|Overall Study|Withdrawal by Subject|3|||
146930030|NCT00884221|529903433|FG000|Overall Study|Adverse Event|6|||
146930031|NCT00884221|529903434|FG001|Overall Study|Adverse Event|3|||
146930032|NCT00884221|529903433|FG000|Overall Study|Protocol Violation|16|||
146930033|NCT00884221|529903434|FG001|Overall Study|Protocol Violation|13|||
146930034|NCT00884221|529903433|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
146930035|NCT00884221|529903434|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
146930036|NCT02126670|529903437|FG000|Overall Study|Withdrawal by Subject|1|||
146930037|NCT02126670|529903438|FG001|Overall Study|Withdrawal by Subject|0|||
146930038|NCT02126670|529903439|FG002|Overall Study|Withdrawal by Subject|0|||
146930039|NCT02126670|529903440|FG003|Overall Study|Withdrawal by Subject|1|||
146930040|NCT01827319|529903443|FG000|Overall Study|Lost to Follow-up|3|||
146930041|NCT03947255|529903445|FG000|Overall Study|Study Closure by Sponsor|2|||
146930042|NCT03947255|529903446|FG001|Overall Study|Study Closure by Sponsor|2|||
146930043|NCT03947255|529903445|FG000|Overall Study|Withdrawal by Subject|2|||
146930044|NCT03947255|529903446|FG001|Overall Study|Withdrawal by Subject|2|||
146930045|NCT03947255|529903445|FG000|Overall Study|Lost to Follow-up|2|||
146930046|NCT03947255|529903446|FG001|Overall Study|Lost to Follow-up|0|||
146930047|NCT03947255|529903445|FG000|Overall Study|Death|0|||
146930048|NCT03947255|529903446|FG001|Overall Study|Death|2|||
146930049|NCT00574119|529903447|FG000|Overall Study|Adverse Event|1|||
146930050|NCT00574119|529903447|FG000|Overall Study|Protocol Violation|1|||
146930051|NCT00574119|529903447|FG000|Overall Study|Withdrawal by Subject|1|||
146930052|NCT00574119|529903447|FG000|Overall Study|Physician Decision|1|||
146930053|NCT00600028|529903453|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
146930054|NCT00600028|529903454|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
146930055|NCT00600028|529903453|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
146930056|NCT00600028|529903454|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
146930057|NCT00600028|529903453|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
146930058|NCT00600028|529903454|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
146930059|NCT03172481|529903455|FG000|Double-blind|Withdrawal by Subject|1|||
146930060|NCT03172481|529903456|FG001|Double-blind|Withdrawal by Subject|0|||
146930061|NCT01107405|529903461|FG000|Overall Study|Adverse Event|1|||
146930062|NCT01107405|529903462|FG001|Overall Study|Adverse Event|1|||
146930063|NCT01107405|529903463|FG002|Overall Study|Adverse Event|0|||
146930064|NCT01107405|529903464|FG003|Overall Study|Adverse Event|0|||
146930065|NCT01107405|529903465|FG004|Overall Study|Adverse Event|2|||
146930066|NCT01107405|529903461|FG000|Overall Study|Withdrawal by Subject|1|||
146930067|NCT01107405|529903462|FG001|Overall Study|Withdrawal by Subject|0|||
146930068|NCT01107405|529903463|FG002|Overall Study|Withdrawal by Subject|1|||
146930069|NCT01107405|529903464|FG003|Overall Study|Withdrawal by Subject|2|||
146930070|NCT01107405|529903465|FG004|Overall Study|Withdrawal by Subject|1|||
146930071|NCT01107405|529903461|FG000|Overall Study|Protocol Violation|0|||
146694255|NCT02658890|529059862|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146930072|NCT01107405|529903462|FG001|Overall Study|Protocol Violation|0|||
146930073|NCT01107405|529903463|FG002|Overall Study|Protocol Violation|1|||
146930074|NCT01107405|529903464|FG003|Overall Study|Protocol Violation|1|||
146694256|NCT02658890|529059863|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694257|NCT02658890|529059864|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694258|NCT02658890|529059865|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694259|NCT02658890|529059866|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694260|NCT02658890|529059867|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694261|NCT02658890|529059868|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694262|NCT02658890|529059869|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694263|NCT02658890|529059843|FG000|Treatment Phase|Adverse Event|0|||
146694264|NCT02658890|529059844|FG001|Treatment Phase|Adverse Event|1|||
146694265|NCT02658890|529059845|FG002|Treatment Phase|Adverse Event|2|||
146694266|NCT02658890|529059846|FG003|Treatment Phase|Adverse Event|2|||
146694267|NCT02658890|529059847|FG004|Treatment Phase|Adverse Event|1|||
146694268|NCT02658890|529059848|FG005|Treatment Phase|Adverse Event|0|||
146694269|NCT02658890|529059849|FG006|Treatment Phase|Adverse Event|0|||
146694270|NCT02658890|529059850|FG007|Treatment Phase|Adverse Event|2|||
146694271|NCT02658890|529059851|FG008|Treatment Phase|Adverse Event|1|||
146694272|NCT02658890|529059852|FG009|Treatment Phase|Adverse Event|2|||
146694273|NCT02658890|529059853|FG010|Treatment Phase|Adverse Event|3|||
146694274|NCT02658890|529059854|FG011|Treatment Phase|Adverse Event|0|||
146694275|NCT02658890|529059855|FG012|Treatment Phase|Adverse Event|1|||
146694276|NCT02658890|529059856|FG013|Treatment Phase|Adverse Event|4|||
146694277|NCT02658890|529059857|FG014|Treatment Phase|Adverse Event|0|||
146694278|NCT02658890|529059858|FG015|Treatment Phase|Adverse Event|0|||
146694279|NCT02658890|529059859|FG016|Treatment Phase|Adverse Event|0|||
146694280|NCT02658890|529059860|FG017|Treatment Phase|Adverse Event|0|||
146694281|NCT02658890|529059861|FG018|Treatment Phase|Adverse Event|5|||
146694282|NCT02658890|529059862|FG019|Treatment Phase|Adverse Event|1|||
146694283|NCT02658890|529059863|FG020|Treatment Phase|Adverse Event|3|||
146694284|NCT02658890|529059864|FG021|Treatment Phase|Adverse Event|0|||
146694285|NCT02658890|529059865|FG022|Treatment Phase|Adverse Event|5|||
146694286|NCT02658890|529059866|FG023|Treatment Phase|Adverse Event|0|||
146694287|NCT02658890|529059867|FG024|Treatment Phase|Adverse Event|0|||
146694288|NCT02658890|529059868|FG025|Treatment Phase|Adverse Event|2|||
146694289|NCT02658890|529059869|FG026|Treatment Phase|Adverse Event|1|||
146694290|NCT02658890|529059843|FG000|Treatment Phase|Death|0|||
146694291|NCT02658890|529059844|FG001|Treatment Phase|Death|0|||
146694292|NCT02658890|529059845|FG002|Treatment Phase|Death|0|||
146694293|NCT02658890|529059846|FG003|Treatment Phase|Death|0|||
146694294|NCT02658890|529059847|FG004|Treatment Phase|Death|0|||
146694295|NCT02658890|529059848|FG005|Treatment Phase|Death|0|||
146694296|NCT02658890|529059849|FG006|Treatment Phase|Death|0|||
146694297|NCT02658890|529059850|FG007|Treatment Phase|Death|0|||
146694298|NCT02658890|529059851|FG008|Treatment Phase|Death|0|||
146694299|NCT02658890|529059852|FG009|Treatment Phase|Death|0|||
146694300|NCT02658890|529059853|FG010|Treatment Phase|Death|0|||
146694301|NCT02658890|529059854|FG011|Treatment Phase|Death|0|||
146694302|NCT02658890|529059855|FG012|Treatment Phase|Death|0|||
146694303|NCT02658890|529059856|FG013|Treatment Phase|Death|0|||
146694304|NCT02658890|529059857|FG014|Treatment Phase|Death|0|||
146694305|NCT02658890|529059858|FG015|Treatment Phase|Death|0|||
146694306|NCT02658890|529059859|FG016|Treatment Phase|Death|0|||
146694307|NCT02658890|529059860|FG017|Treatment Phase|Death|0|||
146694308|NCT02658890|529059861|FG018|Treatment Phase|Death|1|||
146694309|NCT02658890|529059862|FG019|Treatment Phase|Death|0|||
146694310|NCT02658890|529059863|FG020|Treatment Phase|Death|0|||
146694311|NCT02658890|529059864|FG021|Treatment Phase|Death|0|||
146694312|NCT02658890|529059865|FG022|Treatment Phase|Death|0|||
146694313|NCT02658890|529059866|FG023|Treatment Phase|Death|0|||
146694314|NCT02658890|529059867|FG024|Treatment Phase|Death|0|||
146980319|NCT03705169|530089581|FG007|Overall Study|Lost to Follow-up|0|||
146694315|NCT02658890|529059868|FG025|Treatment Phase|Death|0|||
146694316|NCT02658890|529059869|FG026|Treatment Phase|Death|0|||
146694317|NCT02658890|529059843|FG000|Treatment Phase|Lost to Follow-up|0|||
146694318|NCT02658890|529059844|FG001|Treatment Phase|Lost to Follow-up|0|||
146694319|NCT02658890|529059845|FG002|Treatment Phase|Lost to Follow-up|0|||
146694320|NCT02658890|529059846|FG003|Treatment Phase|Lost to Follow-up|0|||
146694321|NCT02658890|529059847|FG004|Treatment Phase|Lost to Follow-up|0|||
146694322|NCT02658890|529059848|FG005|Treatment Phase|Lost to Follow-up|0|||
146694323|NCT02658890|529059849|FG006|Treatment Phase|Lost to Follow-up|1|||
146694324|NCT02658890|529059850|FG007|Treatment Phase|Lost to Follow-up|0|||
146694325|NCT02658890|529059851|FG008|Treatment Phase|Lost to Follow-up|0|||
146980320|NCT03705169|530089582|FG008|Overall Study|Lost to Follow-up|0|||
146694326|NCT02658890|529059852|FG009|Treatment Phase|Lost to Follow-up|0|||
146694327|NCT02658890|529059853|FG010|Treatment Phase|Lost to Follow-up|0|||
146694328|NCT02658890|529059854|FG011|Treatment Phase|Lost to Follow-up|0|||
146694329|NCT02658890|529059855|FG012|Treatment Phase|Lost to Follow-up|0|||
146694330|NCT02658890|529059856|FG013|Treatment Phase|Lost to Follow-up|0|||
146694331|NCT02658890|529059857|FG014|Treatment Phase|Lost to Follow-up|0|||
146694332|NCT02658890|529059858|FG015|Treatment Phase|Lost to Follow-up|0|||
146694333|NCT02658890|529059859|FG016|Treatment Phase|Lost to Follow-up|0|||
146694334|NCT02658890|529059860|FG017|Treatment Phase|Lost to Follow-up|0|||
146980321|NCT03705169|530089583|FG009|Overall Study|Lost to Follow-up|1|||
146980322|NCT03705169|530089574|FG000|Overall Study|Adverse Event|0|||
146980323|NCT03705169|530089575|FG001|Overall Study|Adverse Event|0|||
146980324|NCT03705169|530089576|FG002|Overall Study|Adverse Event|0|||
146980325|NCT03705169|530089577|FG003|Overall Study|Adverse Event|1|||
146980326|NCT03705169|530089578|FG004|Overall Study|Adverse Event|0|||
146980327|NCT03705169|530089579|FG005|Overall Study|Adverse Event|0|||
146980328|NCT03705169|530089580|FG006|Overall Study|Adverse Event|0|||
146980329|NCT03705169|530089581|FG007|Overall Study|Adverse Event|0|||
146980330|NCT03705169|530089582|FG008|Overall Study|Adverse Event|0|||
146980331|NCT03705169|530089583|FG009|Overall Study|Adverse Event|0|||
146980332|NCT03705169|530089574|FG000|Overall Study|Site Closure|0|||
146980333|NCT03705169|530089575|FG001|Overall Study|Site Closure|0|||
146980334|NCT03705169|530089576|FG002|Overall Study|Site Closure|0|||
146980335|NCT03705169|530089577|FG003|Overall Study|Site Closure|1|||
146980336|NCT03705169|530089578|FG004|Overall Study|Site Closure|0|||
146980337|NCT03705169|530089579|FG005|Overall Study|Site Closure|0|||
146980338|NCT03705169|530089580|FG006|Overall Study|Site Closure|0|||
146980339|NCT03705169|530089581|FG007|Overall Study|Site Closure|0|||
146980340|NCT03705169|530089582|FG008|Overall Study|Site Closure|0|||
146980341|NCT03705169|530089583|FG009|Overall Study|Site Closure|0|||
146980342|NCT03705169|530089574|FG000|Overall Study|Did not receive study treatment|0|||
146980343|NCT03705169|530089575|FG001|Overall Study|Did not receive study treatment|0|||
146980344|NCT03705169|530089576|FG002|Overall Study|Did not receive study treatment|0|||
146980345|NCT03705169|530089577|FG003|Overall Study|Did not receive study treatment|1|||
146980346|NCT03705169|530089578|FG004|Overall Study|Did not receive study treatment|0|||
146980347|NCT03705169|530089579|FG005|Overall Study|Did not receive study treatment|0|||
146980348|NCT03705169|530089580|FG006|Overall Study|Did not receive study treatment|0|||
146980349|NCT03705169|530089581|FG007|Overall Study|Did not receive study treatment|0|||
146980350|NCT03705169|530089582|FG008|Overall Study|Did not receive study treatment|0|||
146980351|NCT03705169|530089583|FG009|Overall Study|Did not receive study treatment|0|||
146980352|NCT03705169|530089574|FG000|Overall Study|Concerns about study visit compliance|0|||
146980353|NCT03705169|530089575|FG001|Overall Study|Concerns about study visit compliance|0|||
146980354|NCT03705169|530089576|FG002|Overall Study|Concerns about study visit compliance|0|||
146980355|NCT03705169|530089577|FG003|Overall Study|Concerns about study visit compliance|1|||
146980356|NCT03705169|530089578|FG004|Overall Study|Concerns about study visit compliance|0|||
146980357|NCT03705169|530089579|FG005|Overall Study|Concerns about study visit compliance|0|||
146980358|NCT03705169|530089580|FG006|Overall Study|Concerns about study visit compliance|0|||
146980359|NCT03705169|530089581|FG007|Overall Study|Concerns about study visit compliance|0|||
146980360|NCT03705169|530089582|FG008|Overall Study|Concerns about study visit compliance|0|||
146980361|NCT03705169|530089583|FG009|Overall Study|Concerns about study visit compliance|0|||
146980362|NCT00185211|530089584|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
146980363|NCT00185211|530089585|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
146980364|NCT00185211|530089584|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
146980365|NCT00185211|530089585|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
146980366|NCT00185211|530089584|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
146980367|NCT00185211|530089585|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
146980368|NCT00185211|530089584|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
146980369|NCT00185211|530089585|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
146980370|NCT00185211|530089584|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
146980371|NCT00185211|530089585|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
146980372|NCT00185211|530089584|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
146980373|NCT00185211|530089585|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
146980374|NCT00185211|530089584|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
146980375|NCT00185211|530089585|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
146980376|NCT00185211|530089584|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
146775819|NCT03807778|529349643|FG001|Overall Study|Progressive Disease|2|||
146775820|NCT03807778|529349644|FG002|Overall Study|Progressive Disease|8|||
146775821|NCT03807778|529349645|FG003|Overall Study|Progressive Disease|15|||
146980377|NCT00185211|530089585|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
146980378|NCT00185211|530089584|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
146980379|NCT00185211|530089585|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
146980380|NCT00185211|530089584|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
146980381|NCT00185211|530089585|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
146980382|NCT00185211|530089584|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
146775822|NCT03807778|529349642|FG000|Overall Study|Symptomatic Deterioration|0|||
146775823|NCT03807778|529349643|FG001|Overall Study|Symptomatic Deterioration|1|||
146980383|NCT00185211|530089585|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
146980384|NCT00185211|530089584|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
146775824|NCT03807778|529349644|FG002|Overall Study|Symptomatic Deterioration|0|||
146775825|NCT03807778|529349645|FG003|Overall Study|Symptomatic Deterioration|1|||
146775826|NCT03807778|529349642|FG000|Overall Study|Withdrawal by Subject|0|||
146775827|NCT03807778|529349643|FG001|Overall Study|Withdrawal by Subject|1|||
146775828|NCT03807778|529349644|FG002|Overall Study|Withdrawal by Subject|0|||
146775829|NCT03807778|529349645|FG003|Overall Study|Withdrawal by Subject|1|||
146775830|NCT03807778|529349642|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
146775831|NCT03807778|529349643|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
146775832|NCT03807778|529349644|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
146775833|NCT03807778|529349645|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
146775834|NCT03783026|529351197|FG000|Treatment Phase|Adverse Event|15|||
146775835|NCT03783026|529351197|FG000|Treatment Phase|Lack of Efficacy|11|||
146775836|NCT03783026|529351197|FG000|Treatment Phase|Withdrawal by Subject|6|||
146775837|NCT03783026|529351197|FG000|Treatment Phase|Lost to Follow-up|2|||
146775838|NCT03783026|529351197|FG000|Treatment Phase|Protocol Deviation|8|||
146775839|NCT03783026|529351197|FG000|Treatment Phase|Did Not Receive Treatment|1|||
146775840|NCT03783026|529351197|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
146775841|NCT04814186|529351198|FG000|Treatment Phase|Adverse Event|1|||
146775842|NCT04814186|529351198|FG000|Treatment Phase|Death|6|||
146775843|NCT04814186|529351198|FG000|Treatment Phase|Withdrawal by Subject|2|||
146775844|NCT04814186|529351198|FG000|Treatment Phase|Other|1|||
146775845|NCT04814186|529351198|FG000|Follow-Up Phase|Adverse Event|1|||
146775846|NCT04814186|529351198|FG000|Follow-Up Phase|Death|6|||
146775847|NCT04814186|529351198|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
146775848|NCT04814186|529351198|FG000|Follow-Up Phase|Other|1|||
146775849|NCT01853748|529351202|FG000|Allocation|Withdrawal by Subject|1|||
146775850|NCT01853748|529351203|FG001|Allocation|Withdrawal by Subject|13|||
146775851|NCT01853748|529351202|FG000|Allocation|not sufficient to receive intervention|0|||
146775852|NCT01853748|529351203|FG001|Allocation|not sufficient to receive intervention|1|||
146775853|NCT01853748|529351202|FG000|Follow-Up|Withdrawal by Subject|7|||
146775854|NCT01853748|529351203|FG001|Follow-Up|Withdrawal by Subject|6|||
146775855|NCT01853748|529351202|FG000|Follow-Up|Adverse Event|67|||
146775856|NCT01853748|529351203|FG001|Follow-Up|Adverse Event|7|||
146775857|NCT01853748|529351202|FG000|Follow-Up|not available for data collection|16|||
146775858|NCT01853748|529351203|FG001|Follow-Up|not available for data collection|4|||
146775859|NCT01643070|529351210|FG000|Overall Study|Withdrawal by Subject|3|||
146775860|NCT01643070|529351211|FG001|Overall Study|Withdrawal by Subject|1|||
146775861|NCT01643070|529351210|FG000|Overall Study|Death|1|||
146775862|NCT01643070|529351211|FG001|Overall Study|Death|0|||
146775863|NCT01643070|529351210|FG000|Overall Study|Pregressive disease|0|||
146775864|NCT01643070|529351211|FG001|Overall Study|Pregressive disease|2|||
146775865|NCT04941287|529351212|FG000|Overall Study|Rapid decline before starting treatment|3|||
146775866|NCT04941287|529351213|FG001|Overall Study|Rapid decline before starting treatment|1|||
146775867|NCT02980276|529351214|FG000|Overall Study|Withdrawal by Subject|4|||
146775868|NCT02980276|529351215|FG001|Overall Study|Withdrawal by Subject|4|||
146775869|NCT02980276|529351214|FG000|Overall Study|Physician Decision|0|||
146775870|NCT02980276|529351215|FG001|Overall Study|Physician Decision|1|||
146775871|NCT02980276|529351214|FG000|Overall Study|Lost to Follow-up|18|||
146775872|NCT02980276|529351215|FG001|Overall Study|Lost to Follow-up|18|||
146775873|NCT02980276|529351214|FG000|Overall Study|Death|1|||
146775874|NCT02980276|529351215|FG001|Overall Study|Death|0|||
146775875|NCT02980276|529351214|FG000|Overall Study|Miscellaneous other|10|||
146775876|NCT02980276|529351215|FG001|Overall Study|Miscellaneous other|4|||
146775877|NCT03990649|529351220|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
146775878|NCT03990649|529351221|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
146775879|NCT03990649|529351222|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
146775880|NCT03990649|529351220|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
146775881|NCT03990649|529351221|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
146775882|NCT03990649|529351222|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
146775883|NCT03990649|529351220|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
146775884|NCT03990649|529351221|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
146775885|NCT03990649|529351222|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
146775886|NCT03990649|529351220|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
146775887|NCT03990649|529351221|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
146775888|NCT03990649|529351222|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
146775889|NCT03990649|529351220|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
146775890|NCT03990649|529351221|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
146775891|NCT03990649|529351222|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
146775892|NCT03990649|529351220|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
146775893|NCT03990649|529351221|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
146775894|NCT03990649|529351222|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
146775895|NCT03990649|529351220|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
146775896|NCT03990649|529351221|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
146930075|NCT01107405|529903465|FG004|Overall Study|Protocol Violation|0|||
146775897|NCT03990649|529351222|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
146775898|NCT05773313|529351223|FG000|Overall Study|Lost to Follow-up|3|||
146775899|NCT03050814|529351224|FG000|Overall Study|Screen failures|0|||
146775900|NCT03050814|529351225|FG001|Overall Study|Screen failures|0|||
146775901|NCT03050814|529351226|FG002|Overall Study|Screen failures|4|||
146775902|NCT01443845|529351230|FG000|Overall Study|Protocol Violation|43|||
146775903|NCT01443845|529351231|FG001|Overall Study|Protocol Violation|45|||
146775904|NCT01443845|529351230|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
146775905|NCT01443845|529351231|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
146775906|NCT01443845|529351230|FG000|Overall Study|Deterioration in pulmonary function|1|||
146775907|NCT01443845|529351231|FG001|Overall Study|Deterioration in pulmonary function|4|||
146775908|NCT01443845|529351230|FG000|Overall Study|Lack of Efficacy|10|||
146775909|NCT01443845|529351231|FG001|Overall Study|Lack of Efficacy|5|||
146775910|NCT01443845|529351230|FG000|Overall Study|Adverse Event|64|||
146775911|NCT01443845|529351231|FG001|Overall Study|Adverse Event|138|||
146775912|NCT01443845|529351230|FG000|Overall Study|Withdrawal by Subject|63|||
146775913|NCT01443845|529351231|FG001|Overall Study|Withdrawal by Subject|67|||
146775914|NCT01443845|529351230|FG000|Overall Study|Military Conflict - Site Terminated|20|||
146775915|NCT01443845|529351231|FG001|Overall Study|Military Conflict - Site Terminated|21|||
146775916|NCT01443845|529351230|FG000|Overall Study|Lost to Follow-up|9|||
146775917|NCT01443845|529351231|FG001|Overall Study|Lost to Follow-up|13|||
146775918|NCT01471691|529351232|FG000|Overall Study|Lack of Efficacy|0|||
146775919|NCT01471691|529351233|FG001|Overall Study|Lack of Efficacy|1|||
146775920|NCT01854385|529351234|FG000|Pre-Treatment|Withdrawal by Subject|4|||
146775921|NCT01854385|529351234|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
146775922|NCT01854385|529351234|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
146775923|NCT01854385|529351234|FG000|Pre-Treatment|Unable to come for study visits|1|||
146694335|NCT02658890|529059861|FG018|Treatment Phase|Lost to Follow-up|0|||
146694336|NCT02658890|529059862|FG019|Treatment Phase|Lost to Follow-up|0|||
146694337|NCT02658890|529059863|FG020|Treatment Phase|Lost to Follow-up|0|||
146694338|NCT02658890|529059864|FG021|Treatment Phase|Lost to Follow-up|0|||
146694339|NCT02658890|529059865|FG022|Treatment Phase|Lost to Follow-up|0|||
146694340|NCT02658890|529059866|FG023|Treatment Phase|Lost to Follow-up|0|||
146694341|NCT02658890|529059867|FG024|Treatment Phase|Lost to Follow-up|0|||
146694342|NCT02658890|529059868|FG025|Treatment Phase|Lost to Follow-up|0|||
146694343|NCT02658890|529059869|FG026|Treatment Phase|Lost to Follow-up|0|||
146694344|NCT02658890|529059843|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
146694345|NCT02658890|529059844|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
146694346|NCT02658890|529059845|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
146694347|NCT02658890|529059846|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
146694348|NCT02658890|529059847|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
146694349|NCT02658890|529059848|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
146694350|NCT02658890|529059849|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
146694351|NCT02658890|529059850|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
146694352|NCT02658890|529059851|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
146694353|NCT02658890|529059852|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
146694354|NCT02658890|529059853|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
146694355|NCT02658890|529059854|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
146694356|NCT02658890|529059855|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
146694357|NCT02658890|529059856|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
146694358|NCT02658890|529059857|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
146694359|NCT02658890|529059858|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
146694360|NCT02658890|529059859|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
146694361|NCT02658890|529059860|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
146694362|NCT02658890|529059861|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
146694363|NCT02658890|529059862|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
146694364|NCT02658890|529059863|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
146694365|NCT02658890|529059864|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
146694366|NCT02658890|529059865|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
146694367|NCT02658890|529059866|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
146694368|NCT02658890|529059867|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
146694369|NCT02658890|529059868|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
146694370|NCT02658890|529059869|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
146694371|NCT02658890|529059843|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
146775924|NCT01854385|529351234|FG000|Treatment|Lost to Follow-up|1|||
146775925|NCT01610297|529351235|FG000|Overall Study|Lost to Follow-up|1|||
146775926|NCT01121991|529351237|FG000|Overall Study|Lack of Ovarian Response|2|||
146694372|NCT02658890|529059844|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
146694373|NCT02658890|529059845|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
146694374|NCT02658890|529059846|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
146694375|NCT02658890|529059847|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
146694376|NCT02658890|529059848|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
146694377|NCT02658890|529059849|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
146694378|NCT02658890|529059850|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
146694379|NCT02658890|529059851|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
146694380|NCT02658890|529059852|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
146694381|NCT02658890|529059853|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
146694382|NCT02658890|529059854|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
146694383|NCT02658890|529059855|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
146694384|NCT02658890|529059856|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
146694385|NCT02658890|529059857|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
146694386|NCT02658890|529059858|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
146694387|NCT02658890|529059859|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
146694388|NCT02658890|529059860|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
146694389|NCT02658890|529059861|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
146694390|NCT02658890|529059862|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
146694391|NCT02658890|529059863|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
146694392|NCT02658890|529059864|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
146694393|NCT02658890|529059865|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
146694394|NCT02658890|529059866|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
146694395|NCT02658890|529059867|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
146694396|NCT02658890|529059868|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
146694397|NCT02658890|529059869|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
146694398|NCT02658890|529059843|FG000|Treatment Phase|Other Reasons|0|||
146694399|NCT02658890|529059844|FG001|Treatment Phase|Other Reasons|0|||
146694400|NCT02658890|529059845|FG002|Treatment Phase|Other Reasons|0|||
146694401|NCT02658890|529059846|FG003|Treatment Phase|Other Reasons|0|||
146694402|NCT02658890|529059847|FG004|Treatment Phase|Other Reasons|0|||
146694403|NCT02658890|529059848|FG005|Treatment Phase|Other Reasons|0|||
146694404|NCT02658890|529059849|FG006|Treatment Phase|Other Reasons|1|||
146694405|NCT02658890|529059850|FG007|Treatment Phase|Other Reasons|0|||
146694406|NCT02658890|529059851|FG008|Treatment Phase|Other Reasons|1|||
146694407|NCT02658890|529059852|FG009|Treatment Phase|Other Reasons|0|||
146694408|NCT02658890|529059853|FG010|Treatment Phase|Other Reasons|0|||
146694409|NCT02658890|529059854|FG011|Treatment Phase|Other Reasons|0|||
146694410|NCT02658890|529059855|FG012|Treatment Phase|Other Reasons|0|||
146694411|NCT02658890|529059856|FG013|Treatment Phase|Other Reasons|2|||
146930076|NCT03495453|529903466|FG000|Overall Study|Withdrawal by Subject|0|||
146930077|NCT03495453|529903467|FG001|Overall Study|Withdrawal by Subject|1|||
146930078|NCT00085917|529903468|FG000|Overall Study|Adverse Event|4|||
146930079|NCT00085917|529903469|FG001|Overall Study|Adverse Event|3|||
146930080|NCT01360762|529903472|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
146930081|NCT01360762|529903472|FG000|Main Study Period (12-month Treatment)|Death|5|||
146930082|NCT01360762|529903472|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
146930083|NCT01360762|529903472|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
146930084|NCT01360762|529903472|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
146930085|NCT01360762|529903472|FG000|Whole Study Period|Lost to Follow-up|10|||
146930086|NCT01360762|529903472|FG000|Whole Study Period|Death|7|||
146930087|NCT01360762|529903472|FG000|Whole Study Period|Patient relapsed|18|||
146930088|NCT01360762|529903472|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
146930089|NCT00865189|529903473|FG000|Overall Study|Other|1|||
146930090|NCT00865189|529903474|FG001|Overall Study|Other|2|||
146930091|NCT00865189|529903473|FG000|Overall Study|Death|4|||
146930092|NCT00865189|529903474|FG001|Overall Study|Death|11|||
146930093|NCT00865189|529903473|FG000|Overall Study|Lost to Follow-up|6|||
146930094|NCT00865189|529903474|FG001|Overall Study|Lost to Follow-up|6|||
146930095|NCT00865189|529903473|FG000|Overall Study|Withdrawal by Subject|1|||
146930096|NCT00865189|529903474|FG001|Overall Study|Withdrawal by Subject|0|||
146930097|NCT05590767|529903479|FG000|Overall Study|Protocol Violation|1|||
146930098|NCT05590767|529903479|FG000|Overall Study|surgery canceled|1|||
146930099|NCT05590767|529903479|FG000|Overall Study|interscalene brachial block not performed|1|||
146930100|NCT00084929|529903480|FG000|Overall Study|ineligible - medical contraindication|1|||
146930101|NCT00084929|529903480|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
146930102|NCT00084929|529903480|FG000|Overall Study|Ineligible - Medical history|6|||
146930103|NCT00084929|529903480|FG000|Overall Study|Withdrawal by Subject|10|||
146930104|NCT00084929|529903480|FG000|Overall Study|Missing/incomplete CTC exam|9|||
146930105|NCT00084929|529903480|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
146930106|NCT00973921|529903482|FG000|Overall Study|IVUS results were not available|9|||
146930107|NCT02120157|529903493|FG000|Overall Study|Death|8|||
146930108|NCT01354431|529903499|FG000|Pre-Treatment Period|Not reported|1|||
146930109|NCT01354431|529903500|FG001|Pre-Treatment Period|Not reported|0|||
146930110|NCT01354431|529903501|FG002|Pre-Treatment Period|Not reported|0|||
146694412|NCT02658890|529059857|FG014|Treatment Phase|Other Reasons|0|||
146694413|NCT02658890|529059858|FG015|Treatment Phase|Other Reasons|0|||
146694414|NCT02658890|529059859|FG016|Treatment Phase|Other Reasons|0|||
146694415|NCT02658890|529059860|FG017|Treatment Phase|Other Reasons|0|||
146694416|NCT02658890|529059861|FG018|Treatment Phase|Other Reasons|1|||
146775927|NCT01121991|529351237|FG000|Overall Study|No Oocytes Retrieved|3|||
146694417|NCT02658890|529059862|FG019|Treatment Phase|Other Reasons|0|||
146930111|NCT01354431|529903499|FG000|Treatment Period|Disease Progression|50|||
146694418|NCT02658890|529059863|FG020|Treatment Phase|Other Reasons|0|||
146694419|NCT02658890|529059864|FG021|Treatment Phase|Other Reasons|0|||
146694420|NCT02658890|529059865|FG022|Treatment Phase|Other Reasons|0|||
146694421|NCT02658890|529059866|FG023|Treatment Phase|Other Reasons|0|||
146694422|NCT02658890|529059867|FG024|Treatment Phase|Other Reasons|1|||
146694423|NCT02658890|529059868|FG025|Treatment Phase|Other Reasons|0|||
146694424|NCT02658890|529059869|FG026|Treatment Phase|Other Reasons|1|||
146694425|NCT02658890|529059843|FG000|Treatment Phase|Progressive Disease|6|||
146694426|NCT02658890|529059844|FG001|Treatment Phase|Progressive Disease|7|||
146694427|NCT02658890|529059845|FG002|Treatment Phase|Progressive Disease|6|||
146694428|NCT02658890|529059846|FG003|Treatment Phase|Progressive Disease|12|||
146694429|NCT02658890|529059847|FG004|Treatment Phase|Progressive Disease|6|||
146694430|NCT02658890|529059848|FG005|Treatment Phase|Progressive Disease|18|||
146694431|NCT02658890|529059849|FG006|Treatment Phase|Progressive Disease|12|||
146694432|NCT02658890|529059850|FG007|Treatment Phase|Progressive Disease|19|||
146694433|NCT02658890|529059851|FG008|Treatment Phase|Progressive Disease|26|||
146694434|NCT02658890|529059852|FG009|Treatment Phase|Progressive Disease|8|||
146694435|NCT02658890|529059853|FG010|Treatment Phase|Progressive Disease|7|||
146694436|NCT02658890|529059854|FG011|Treatment Phase|Progressive Disease|9|||
146694437|NCT02658890|529059855|FG012|Treatment Phase|Progressive Disease|8|||
146694438|NCT02658890|529059856|FG013|Treatment Phase|Progressive Disease|29|||
146694439|NCT02658890|529059857|FG014|Treatment Phase|Progressive Disease|6|||
146694440|NCT02658890|529059858|FG015|Treatment Phase|Progressive Disease|2|||
146694441|NCT02658890|529059859|FG016|Treatment Phase|Progressive Disease|32|||
146694442|NCT02658890|529059860|FG017|Treatment Phase|Progressive Disease|14|||
146694443|NCT02658890|529059861|FG018|Treatment Phase|Progressive Disease|40|||
146694444|NCT02658890|529059862|FG019|Treatment Phase|Progressive Disease|32|||
146694445|NCT02658890|529059863|FG020|Treatment Phase|Progressive Disease|19|||
146694446|NCT02658890|529059864|FG021|Treatment Phase|Progressive Disease|30|||
146694447|NCT02658890|529059865|FG022|Treatment Phase|Progressive Disease|15|||
146694448|NCT02658890|529059866|FG023|Treatment Phase|Progressive Disease|0|||
146694449|NCT02658890|529059867|FG024|Treatment Phase|Progressive Disease|0|||
146694450|NCT02658890|529059868|FG025|Treatment Phase|Progressive Disease|14|||
146694451|NCT02658890|529059869|FG026|Treatment Phase|Progressive Disease|11|||
146694452|NCT02658890|529059843|FG000|Treatment Phase|Study Drug Toxicity|0|||
146694453|NCT02658890|529059844|FG001|Treatment Phase|Study Drug Toxicity|0|||
146694454|NCT02658890|529059845|FG002|Treatment Phase|Study Drug Toxicity|2|||
146694455|NCT02658890|529059846|FG003|Treatment Phase|Study Drug Toxicity|0|||
146694456|NCT02658890|529059847|FG004|Treatment Phase|Study Drug Toxicity|0|||
146694457|NCT02658890|529059848|FG005|Treatment Phase|Study Drug Toxicity|0|||
146694458|NCT02658890|529059849|FG006|Treatment Phase|Study Drug Toxicity|0|||
146694459|NCT02658890|529059850|FG007|Treatment Phase|Study Drug Toxicity|0|||
146694460|NCT02658890|529059851|FG008|Treatment Phase|Study Drug Toxicity|3|||
146694461|NCT02658890|529059852|FG009|Treatment Phase|Study Drug Toxicity|0|||
146694462|NCT02658890|529059853|FG010|Treatment Phase|Study Drug Toxicity|1|||
146694463|NCT02658890|529059854|FG011|Treatment Phase|Study Drug Toxicity|1|||
146694464|NCT02658890|529059855|FG012|Treatment Phase|Study Drug Toxicity|2|||
146694465|NCT02658890|529059856|FG013|Treatment Phase|Study Drug Toxicity|9|||
146694466|NCT02658890|529059857|FG014|Treatment Phase|Study Drug Toxicity|0|||
146694467|NCT02658890|529059858|FG015|Treatment Phase|Study Drug Toxicity|1|||
146694468|NCT02658890|529059859|FG016|Treatment Phase|Study Drug Toxicity|1|||
146694469|NCT02658890|529059860|FG017|Treatment Phase|Study Drug Toxicity|0|||
146694470|NCT02658890|529059861|FG018|Treatment Phase|Study Drug Toxicity|8|||
146694471|NCT02658890|529059862|FG019|Treatment Phase|Study Drug Toxicity|3|||
146694472|NCT02658890|529059863|FG020|Treatment Phase|Study Drug Toxicity|2|||
146694473|NCT02658890|529059864|FG021|Treatment Phase|Study Drug Toxicity|0|||
146694474|NCT02658890|529059865|FG022|Treatment Phase|Study Drug Toxicity|8|||
146694475|NCT02658890|529059866|FG023|Treatment Phase|Study Drug Toxicity|0|||
146694476|NCT02658890|529059867|FG024|Treatment Phase|Study Drug Toxicity|0|||
146694477|NCT02658890|529059868|FG025|Treatment Phase|Study Drug Toxicity|2|||
146694478|NCT02658890|529059869|FG026|Treatment Phase|Study Drug Toxicity|0|||
146694479|NCT02658890|529059843|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146775928|NCT01121991|529351237|FG000|Overall Study|No Fertilization|1|||
146775929|NCT02590432|529351238|FG000|Open-label Treatment Period|Adverse Event|97|||
146694480|NCT02658890|529059844|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694481|NCT02658890|529059845|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694482|NCT02658890|529059846|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
146775930|NCT02590432|529351239|FG001|Open-label Treatment Period|Adverse Event|79|||
146775931|NCT02590432|529351240|FG002|Open-label Treatment Period|Adverse Event|0|||
146694483|NCT02658890|529059847|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694484|NCT02658890|529059848|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694485|NCT02658890|529059849|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694486|NCT02658890|529059850|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694487|NCT02658890|529059851|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694488|NCT02658890|529059852|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
146694489|NCT02658890|529059853|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694490|NCT02658890|529059854|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694491|NCT02658890|529059855|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694492|NCT02658890|529059856|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694493|NCT02658890|529059857|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694494|NCT02658890|529059858|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694495|NCT02658890|529059859|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694496|NCT02658890|529059860|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694497|NCT02658890|529059861|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
146694498|NCT02658890|529059862|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694499|NCT02658890|529059863|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694500|NCT02658890|529059864|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694501|NCT02658890|529059865|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
146694502|NCT02658890|529059866|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694503|NCT02658890|529059867|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694504|NCT02658890|529059868|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694505|NCT02658890|529059869|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146694506|NCT02658890|529059843|FG000|Treatment Phase|Withdrawal by Subject|0|||
146694507|NCT02658890|529059844|FG001|Treatment Phase|Withdrawal by Subject|1|||
146694508|NCT02658890|529059845|FG002|Treatment Phase|Withdrawal by Subject|0|||
146694509|NCT02658890|529059846|FG003|Treatment Phase|Withdrawal by Subject|0|||
146694510|NCT02658890|529059847|FG004|Treatment Phase|Withdrawal by Subject|0|||
146694511|NCT02658890|529059848|FG005|Treatment Phase|Withdrawal by Subject|0|||
146694512|NCT02658890|529059849|FG006|Treatment Phase|Withdrawal by Subject|1|||
146694513|NCT02658890|529059850|FG007|Treatment Phase|Withdrawal by Subject|0|||
146694514|NCT02658890|529059851|FG008|Treatment Phase|Withdrawal by Subject|0|||
146694515|NCT02658890|529059852|FG009|Treatment Phase|Withdrawal by Subject|1|||
146694516|NCT02658890|529059853|FG010|Treatment Phase|Withdrawal by Subject|0|||
146694517|NCT02658890|529059854|FG011|Treatment Phase|Withdrawal by Subject|0|||
146694518|NCT02658890|529059855|FG012|Treatment Phase|Withdrawal by Subject|1|||
146694519|NCT02658890|529059856|FG013|Treatment Phase|Withdrawal by Subject|3|||
146694520|NCT02658890|529059857|FG014|Treatment Phase|Withdrawal by Subject|0|||
146694521|NCT02658890|529059858|FG015|Treatment Phase|Withdrawal by Subject|0|||
146694522|NCT02658890|529059859|FG016|Treatment Phase|Withdrawal by Subject|1|||
146694523|NCT02658890|529059860|FG017|Treatment Phase|Withdrawal by Subject|0|||
146694524|NCT02658890|529059861|FG018|Treatment Phase|Withdrawal by Subject|4|||
146694525|NCT02658890|529059862|FG019|Treatment Phase|Withdrawal by Subject|3|||
146694526|NCT02658890|529059863|FG020|Treatment Phase|Withdrawal by Subject|0|||
146694527|NCT02658890|529059864|FG021|Treatment Phase|Withdrawal by Subject|4|||
146694528|NCT02658890|529059865|FG022|Treatment Phase|Withdrawal by Subject|1|||
146694529|NCT02658890|529059866|FG023|Treatment Phase|Withdrawal by Subject|1|||
146694530|NCT02658890|529059867|FG024|Treatment Phase|Withdrawal by Subject|0|||
146694531|NCT02658890|529059868|FG025|Treatment Phase|Withdrawal by Subject|0|||
146694532|NCT02658890|529059869|FG026|Treatment Phase|Withdrawal by Subject|0|||
146694533|NCT02474199|529059870|FG000|Overall Study|Lost to Follow-up|1|||
146694534|NCT02474199|529059871|FG001|Overall Study|Lost to Follow-up|0|||
146694535|NCT02474199|529059872|FG002|Overall Study|Lost to Follow-up|0|||
146694536|NCT02474199|529059873|FG003|Overall Study|Lost to Follow-up|0|||
146694537|NCT02474199|529059870|FG000|Overall Study|Withdrawal by Subject|1|||
146694538|NCT02474199|529059871|FG001|Overall Study|Withdrawal by Subject|2|||
146694539|NCT02474199|529059872|FG002|Overall Study|Withdrawal by Subject|0|||
146694540|NCT02474199|529059873|FG003|Overall Study|Withdrawal by Subject|1|||
146694541|NCT02474199|529059870|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
146694542|NCT02474199|529059871|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
146694543|NCT02474199|529059872|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
146694544|NCT02474199|529059873|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
146694545|NCT02474199|529059870|FG000|Overall Study|Did not meet eligibility criteria|0|||
146694546|NCT02474199|529059871|FG001|Overall Study|Did not meet eligibility criteria|0|||
146694547|NCT02474199|529059872|FG002|Overall Study|Did not meet eligibility criteria|2|||
146694548|NCT02474199|529059873|FG003|Overall Study|Did not meet eligibility criteria|2|||
146694549|NCT03090100|529059874|FG000|Overall Study|Adverse Event|9|||
146694550|NCT03090100|529059875|FG001|Overall Study|Adverse Event|11|||
146694551|NCT03090100|529059874|FG000|Overall Study|Pregnancy|1|||
146694552|NCT03090100|529059875|FG001|Overall Study|Pregnancy|1|||
146694553|NCT03090100|529059874|FG000|Overall Study|Lack of Efficacy|2|||
146694554|NCT03090100|529059875|FG001|Overall Study|Lack of Efficacy|7|||
146694555|NCT03090100|529059874|FG000|Overall Study|Lost to Follow-up|2|||
146694556|NCT03090100|529059875|FG001|Overall Study|Lost to Follow-up|2|||
146694557|NCT03090100|529059874|FG000|Overall Study|Withdrawal by Subject|7|||
146694558|NCT03090100|529059875|FG001|Overall Study|Withdrawal by Subject|19|||
146980385|NCT00185211|530089585|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
146980386|NCT01759537|530089586|FG000|Overall Study|Death|1|||
146980387|NCT01759537|530089587|FG001|Overall Study|Death|1|||
146980388|NCT01759537|530089586|FG000|Overall Study|Pregnancy|1|||
146980389|NCT01759537|530089587|FG001|Overall Study|Pregnancy|1|||
146980390|NCT01759537|530089586|FG000|Overall Study|Lost to Follow-up|9|||
146980391|NCT01759537|530089587|FG001|Overall Study|Lost to Follow-up|9|||
146980392|NCT01759537|530089586|FG000|Overall Study|Accident involving jaw fracture|1|||
146980393|NCT01759537|530089587|FG001|Overall Study|Accident involving jaw fracture|1|||
146980394|NCT01759537|530089586|FG000|Overall Study|Subcrestal implant too coronal|1|||
146980395|NCT01759537|530089587|FG001|Overall Study|Subcrestal implant too coronal|1|||
146980396|NCT00420290|530089588|FG000|Overall Study|Adverse Event|3|||
146980397|NCT00420290|530089589|FG001|Overall Study|Adverse Event|1|||
146980398|NCT00420290|530089588|FG000|Overall Study|Withdrawal by Subject|0|||
146980399|NCT00420290|530089589|FG001|Overall Study|Withdrawal by Subject|2|||
146980400|NCT00420290|530089588|FG000|Overall Study|did not meet inclusion/exclusion|1|||
146980401|NCT00420290|530089589|FG001|Overall Study|did not meet inclusion/exclusion|1|||
146694559|NCT03090100|529059874|FG000|Overall Study|Protocol Violation|2|||
146694560|NCT03090100|529059875|FG001|Overall Study|Protocol Violation|6|||
146694561|NCT03090100|529059874|FG000|Overall Study|Non-compliance|2|||
146694562|NCT03090100|529059875|FG001|Overall Study|Non-compliance|0|||
146694563|NCT03090100|529059874|FG000|Overall Study|Other|2|||
146694564|NCT03090100|529059875|FG001|Overall Study|Other|2|||
146694565|NCT00159588|529059876|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
146694566|NCT00159588|529059877|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
146694567|NCT00159588|529059878|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
146694568|NCT00605475|529059879|FG000|Overall Study|Abnormal Laboratory Values|0|||
146694569|NCT00605475|529059880|FG001|Overall Study|Abnormal Laboratory Values|0|||
146694570|NCT00605475|529059881|FG002|Overall Study|Abnormal Laboratory Values|0|||
146694571|NCT00605475|529059882|FG003|Overall Study|Abnormal Laboratory Values|0|||
146694572|NCT00605475|529059883|FG004|Overall Study|Abnormal Laboratory Values|0|||
146694573|NCT00605475|529059884|FG005|Overall Study|Abnormal Laboratory Values|0|||
146694574|NCT00605475|529059885|FG006|Overall Study|Abnormal Laboratory Values|0|||
146694575|NCT00605475|529059886|FG007|Overall Study|Abnormal Laboratory Values|0|||
146694576|NCT00605475|529059887|FG008|Overall Study|Abnormal Laboratory Values|1|||
146694577|NCT00605475|529059888|FG009|Overall Study|Abnormal Laboratory Values|0|||
146694578|NCT00605475|529059879|FG000|Overall Study|Administrative problems|0|||
146694579|NCT00605475|529059880|FG001|Overall Study|Administrative problems|0|||
146694580|NCT00605475|529059881|FG002|Overall Study|Administrative problems|0|||
146694581|NCT00605475|529059882|FG003|Overall Study|Administrative problems|0|||
146694582|NCT00605475|529059883|FG004|Overall Study|Administrative problems|0|||
146694583|NCT00605475|529059884|FG005|Overall Study|Administrative problems|0|||
146694584|NCT00605475|529059885|FG006|Overall Study|Administrative problems|1|||
146694585|NCT00605475|529059886|FG007|Overall Study|Administrative problems|0|||
146694586|NCT00605475|529059887|FG008|Overall Study|Administrative problems|0|||
146694587|NCT00605475|529059888|FG009|Overall Study|Administrative problems|0|||
146694588|NCT00605475|529059879|FG000|Overall Study|Lost to Follow-up|0|||
146694589|NCT00605475|529059880|FG001|Overall Study|Lost to Follow-up|0|||
146694590|NCT00605475|529059881|FG002|Overall Study|Lost to Follow-up|0|||
146694591|NCT00605475|529059882|FG003|Overall Study|Lost to Follow-up|0|||
146694592|NCT00605475|529059883|FG004|Overall Study|Lost to Follow-up|0|||
146694593|NCT00605475|529059884|FG005|Overall Study|Lost to Follow-up|0|||
146694594|NCT00605475|529059885|FG006|Overall Study|Lost to Follow-up|0|||
146694595|NCT00605475|529059886|FG007|Overall Study|Lost to Follow-up|0|||
146694596|NCT00605475|529059887|FG008|Overall Study|Lost to Follow-up|1|||
146694597|NCT00605475|529059888|FG009|Overall Study|Lost to Follow-up|1|||
146694598|NCT00605475|529059879|FG000|Overall Study|Protocol Violation|0|||
146694599|NCT00605475|529059880|FG001|Overall Study|Protocol Violation|0|||
146694600|NCT00605475|529059881|FG002|Overall Study|Protocol Violation|0|||
146980402|NCT00606684|530091178|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
146980403|NCT00606684|530091179|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
146980404|NCT00606684|530091180|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
146694601|NCT00605475|529059882|FG003|Overall Study|Protocol Violation|0|||
146694602|NCT00605475|529059883|FG004|Overall Study|Protocol Violation|1|||
146694603|NCT00605475|529059884|FG005|Overall Study|Protocol Violation|0|||
146694604|NCT00605475|529059885|FG006|Overall Study|Protocol Violation|0|||
146694605|NCT00605475|529059886|FG007|Overall Study|Protocol Violation|0|||
146694606|NCT00605475|529059887|FG008|Overall Study|Protocol Violation|0|||
146980405|NCT00606684|530091181|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
146694607|NCT00605475|529059888|FG009|Overall Study|Protocol Violation|0|||
146694608|NCT00605475|529059879|FG000|Overall Study|Withdrawal by Subject|0|||
146694609|NCT00605475|529059880|FG001|Overall Study|Withdrawal by Subject|0|||
146694610|NCT00605475|529059881|FG002|Overall Study|Withdrawal by Subject|0|||
146694611|NCT00605475|529059882|FG003|Overall Study|Withdrawal by Subject|0|||
146694612|NCT00605475|529059883|FG004|Overall Study|Withdrawal by Subject|0|||
146694613|NCT00605475|529059884|FG005|Overall Study|Withdrawal by Subject|2|||
146930112|NCT01354431|529903500|FG001|Treatment Period|Disease Progression|40|||
146930113|NCT01354431|529903501|FG002|Treatment Period|Disease Progression|44|||
146930114|NCT01354431|529903499|FG000|Treatment Period|Study Drug Toxicity|5|||
146930115|NCT01354431|529903500|FG001|Treatment Period|Study Drug Toxicity|8|||
146930116|NCT01354431|529903501|FG002|Treatment Period|Study Drug Toxicity|4|||
146930117|NCT01354431|529903499|FG000|Treatment Period|Death|0|||
146930118|NCT01354431|529903500|FG001|Treatment Period|Death|1|||
146930119|NCT01354431|529903501|FG002|Treatment Period|Death|0|||
146930120|NCT01354431|529903499|FG000|Treatment Period|AE unrelated to study drug|1|||
146930121|NCT01354431|529903500|FG001|Treatment Period|AE unrelated to study drug|2|||
146930122|NCT01354431|529903501|FG002|Treatment Period|AE unrelated to study drug|5|||
146930123|NCT01354431|529903499|FG000|Treatment Period|Participant request to discontinue|2|||
146930124|NCT01354431|529903500|FG001|Treatment Period|Participant request to discontinue|2|||
146930125|NCT01354431|529903501|FG002|Treatment Period|Participant request to discontinue|1|||
146694614|NCT00605475|529059885|FG006|Overall Study|Withdrawal by Subject|0|||
146694615|NCT00605475|529059886|FG007|Overall Study|Withdrawal by Subject|0|||
146694616|NCT00605475|529059887|FG008|Overall Study|Withdrawal by Subject|0|||
146694617|NCT00605475|529059888|FG009|Overall Study|Withdrawal by Subject|1|||
146694618|NCT02596854|529059889|FG000|Overall Study|Withdrawn|8|||
146694619|NCT03615326|529059897|FG000|Overall Study|Death|266|||
146694620|NCT03615326|529059898|FG001|Overall Study|Death|286|||
146694621|NCT03615326|529059899|FG002|Overall Study|Death|14|||
146694622|NCT03615326|529059900|FG003|Overall Study|Death|17|||
146694623|NCT03615326|529059897|FG000|Overall Study|Lost to Follow-up|0|||
146694624|NCT03615326|529059898|FG001|Overall Study|Lost to Follow-up|1|||
146694625|NCT03615326|529059899|FG002|Overall Study|Lost to Follow-up|0|||
146694626|NCT03615326|529059900|FG003|Overall Study|Lost to Follow-up|0|||
146694627|NCT03615326|529059897|FG000|Overall Study|Withdrawal by Subject|1|||
146694628|NCT03615326|529059898|FG001|Overall Study|Withdrawal by Subject|3|||
146694629|NCT03615326|529059899|FG002|Overall Study|Withdrawal by Subject|0|||
146694630|NCT03615326|529059900|FG003|Overall Study|Withdrawal by Subject|0|||
146694631|NCT03615326|529059897|FG000|Overall Study|Participants Ongoing|83|||
146694632|NCT03615326|529059898|FG001|Overall Study|Participants Ongoing|58|||
146694633|NCT03615326|529059899|FG002|Overall Study|Participants Ongoing|6|||
146694634|NCT03615326|529059900|FG003|Overall Study|Participants Ongoing|3|||
146694635|NCT05071183|529059901|FG000|Overall Study|Death|1|||
146694636|NCT05071183|529059902|FG001|Overall Study|Death|2|||
146694637|NCT05071183|529059903|FG002|Overall Study|Death|0|||
146694638|NCT05071183|529059901|FG000|Overall Study|Other Reasons|1|||
146617830|NCT03493945|528773121|FG001|Phase II Dose Expansion|Refused further treatment|0|||
146617831|NCT03493945|528773122|FG002|Phase II Dose Expansion|Refused further treatment|0|||
146617832|NCT03493945|528773123|FG003|Phase II Dose Expansion|Refused further treatment|0|||
146617833|NCT03493945|528773124|FG004|Phase II Dose Expansion|Refused further treatment|1|||
146617834|NCT03493945|528773125|FG005|Phase II Dose Expansion|Refused further treatment|1|||
146617835|NCT03493945|528773126|FG006|Phase II Dose Expansion|Refused further treatment|0|||
146617836|NCT03493945|528773120|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
146617837|NCT03493945|528773121|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
146694639|NCT05071183|529059902|FG001|Overall Study|Other Reasons|3|||
146694640|NCT05071183|529059903|FG002|Overall Study|Other Reasons|2|||
146694641|NCT02046148|529059904|FG000|Overall Study|Lost to Follow-up|1|||
146694642|NCT02046148|529059905|FG001|Overall Study|Lost to Follow-up|1|||
146694643|NCT02046148|529059904|FG000|Overall Study|Withdrawal by Subject|0|||
146694644|NCT02046148|529059905|FG001|Overall Study|Withdrawal by Subject|2|||
146694645|NCT02532647|529059908|FG000|Overall Study|Did not receive trial medication|1|||
146694646|NCT02532647|529059909|FG001|Overall Study|Did not receive trial medication|0|||
146694647|NCT02532647|529059910|FG002|Overall Study|Did not receive trial medication|1|||
146694648|NCT01480076|529059911|FG000|Overall Study|Run-in Failure|52|||
146694649|NCT01480076|529059911|FG000|Overall Study|Adverse Event|39|||
146694650|NCT01480076|529059911|FG000|Overall Study|Death|2|||
146694651|NCT01480076|529059911|FG000|Overall Study|Disease Progression|5|||
146694652|NCT01480076|529059911|FG000|Overall Study|Non-compliance With Study Protocol|15|||
146930126|NCT01354431|529903499|FG000|Treatment Period|Participant withdrew consent|0|||
146930127|NCT01354431|529903500|FG001|Treatment Period|Participant withdrew consent|1|||
146930128|NCT01354431|529903501|FG002|Treatment Period|Participant withdrew consent|0|||
146980406|NCT00606684|530091182|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
146980407|NCT00606684|530091183|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
147013207|NCT02048813|530210053|FG001|Overall Study|Withdrawal by Subject|8|||
146694653|NCT01480076|529059911|FG000|Overall Study|Withdrawal by Subject|105|||
146694654|NCT01480076|529059911|FG000|Overall Study|Lost to Follow-up|7|||
146694655|NCT01480076|529059911|FG000|Overall Study|Investigator Decision|13|||
146694656|NCT01480076|529059911|FG000|Overall Study|Other|52|||
146694657|NCT02503332|529059912|FG000|Overall Study|Adverse Event|17|||
146694658|NCT02503332|529059913|FG001|Overall Study|Adverse Event|5|||
146694659|NCT02503332|529059914|FG002|Overall Study|Adverse Event|3|||
146694660|NCT02503332|529059915|FG003|Overall Study|Adverse Event|1|||
146694661|NCT02503332|529059912|FG000|Overall Study|Investigator's Decision|5|||
146980408|NCT00606684|530091184|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
146980409|NCT00606684|530091178|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
146980410|NCT00606684|530091179|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
146980411|NCT00606684|530091180|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
146980412|NCT00606684|530091181|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
146980413|NCT00606684|530091182|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
146980414|NCT00606684|530091183|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
146980415|NCT00606684|530091184|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
146980416|NCT00606684|530091178|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
146980417|NCT00606684|530091179|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
146980418|NCT00606684|530091180|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
146980419|NCT00606684|530091181|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
146980420|NCT00606684|530091182|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
146980421|NCT00606684|530091183|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
146980422|NCT00606684|530091184|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
146980423|NCT00606684|530091178|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
146980424|NCT00606684|530091179|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
146980425|NCT00606684|530091180|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
146980426|NCT00606684|530091181|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
146980427|NCT00606684|530091182|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
146980428|NCT00606684|530091183|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
146980429|NCT00606684|530091184|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
146980430|NCT00606684|530091178|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
146980431|NCT00606684|530091179|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
146980432|NCT00606684|530091180|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
146980433|NCT00606684|530091181|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
146980434|NCT00606684|530091182|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
146980435|NCT00606684|530091183|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
146980436|NCT00606684|530091184|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
146980437|NCT00606684|530091178|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
146980438|NCT00606684|530091179|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
146980439|NCT00606684|530091180|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
146980440|NCT00606684|530091181|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
146980441|NCT00606684|530091182|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
146980442|NCT00606684|530091183|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
146980443|NCT00606684|530091184|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
146980444|NCT00606684|530091178|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
146980445|NCT00606684|530091179|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
146980446|NCT00606684|530091180|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
146980447|NCT00606684|530091181|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
146980448|NCT00606684|530091182|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
146980449|NCT00606684|530091183|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
146980450|NCT00606684|530091184|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
146980451|NCT00606684|530091178|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146980452|NCT00606684|530091179|FG001|Double-Blind Treatment Period|Adverse Event|3|||
146980453|NCT00606684|530091180|FG002|Double-Blind Treatment Period|Adverse Event|2|||
146980454|NCT00606684|530091181|FG003|Double-Blind Treatment Period|Adverse Event|4|||
146980455|NCT00606684|530091182|FG004|Double-Blind Treatment Period|Adverse Event|2|||
146980456|NCT00606684|530091183|FG005|Double-Blind Treatment Period|Adverse Event|0|||
146980457|NCT00606684|530091184|FG006|Double-Blind Treatment Period|Adverse Event|1|||
146980458|NCT00606684|530091178|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
146980459|NCT00606684|530091179|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
146980460|NCT00606684|530091180|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
146980461|NCT00606684|530091181|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
146980462|NCT00606684|530091182|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
146980463|NCT00606684|530091183|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
146980464|NCT00606684|530091184|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
146980465|NCT00606684|530091178|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
146980466|NCT00606684|530091179|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
146980467|NCT00606684|530091180|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
146980468|NCT00606684|530091181|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
146980469|NCT00606684|530091182|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
146980470|NCT00606684|530091183|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
146617838|NCT03493945|528773122|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
146617839|NCT03493945|528773123|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
146617840|NCT03493945|528773124|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
146694662|NCT02503332|529059913|FG001|Overall Study|Investigator's Decision|1|||
146694663|NCT02503332|529059914|FG002|Overall Study|Investigator's Decision|0|||
146694664|NCT02503332|529059915|FG003|Overall Study|Investigator's Decision|0|||
146694665|NCT02503332|529059912|FG000|Overall Study|Sponsor's Decision|1|||
146694666|NCT02503332|529059913|FG001|Overall Study|Sponsor's Decision|0|||
146694667|NCT02503332|529059914|FG002|Overall Study|Sponsor's Decision|0|||
146694668|NCT02503332|529059915|FG003|Overall Study|Sponsor's Decision|1|||
146694669|NCT02503332|529059912|FG000|Overall Study|Subject Request|6|||
146694670|NCT02503332|529059913|FG001|Overall Study|Subject Request|5|||
146694671|NCT02503332|529059914|FG002|Overall Study|Subject Request|2|||
146694672|NCT02503332|529059915|FG003|Overall Study|Subject Request|1|||
146694673|NCT02503332|529059912|FG000|Overall Study|Death|0|||
146694674|NCT02503332|529059913|FG001|Overall Study|Death|2|||
146694675|NCT02503332|529059914|FG002|Overall Study|Death|2|||
146694676|NCT02503332|529059915|FG003|Overall Study|Death|0|||
146694677|NCT02503332|529059912|FG000|Overall Study|Other|5|||
146694678|NCT02503332|529059913|FG001|Overall Study|Other|6|||
146694679|NCT02503332|529059914|FG002|Overall Study|Other|1|||
146694680|NCT02503332|529059915|FG003|Overall Study|Other|1|||
146694681|NCT01589445|529059916|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
146694682|NCT01589445|529059916|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
146694683|NCT01589445|529059916|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
146694684|NCT01589445|529059916|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
146694685|NCT01589445|529059916|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
146694686|NCT01589445|529059916|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
146694687|NCT01589445|529059916|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
146694688|NCT01589445|529059916|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
146694689|NCT01589445|529059916|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
146694690|NCT01589445|529059916|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
146694691|NCT00325754|529059917|FG000|Overall Study|Adverse Event|4|||
146694692|NCT00325754|529059918|FG001|Overall Study|Adverse Event|1|||
146694693|NCT03168464|529059923|FG000|Overall Study|Death|9|||
146694694|NCT03168464|529059923|FG000|Overall Study|Progression of disease|6|||
146694695|NCT04649164|529059924|FG000|Overall Study|Withdrawal by Subject|1|||
146694696|NCT04649164|529059925|FG001|Overall Study|Withdrawal by Subject|1|||
146694697|NCT04649164|529059926|FG002|Overall Study|Withdrawal by Subject|2|||
146694698|NCT04649164|529059924|FG000|Overall Study|Participant's care recipient expired|0|||
146694699|NCT04649164|529059925|FG001|Overall Study|Participant's care recipient expired|0|||
146694700|NCT04649164|529059926|FG002|Overall Study|Participant's care recipient expired|2|||
146694701|NCT00634088|529059931|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
146694702|NCT00634088|529059932|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
146694703|NCT00634088|529059933|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
146617841|NCT03493945|528773125|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
146617842|NCT03493945|528773126|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
146617843|NCT01517750|528773127|FG000|Overall Study|Lost to Follow-up|1|||
146617844|NCT01517750|528773128|FG001|Overall Study|Lost to Follow-up|2|||
146617845|NCT01517750|528773129|FG002|Overall Study|Lost to Follow-up|4|||
146617846|NCT01517750|528773130|FG003|Overall Study|Lost to Follow-up|1|||
146617847|NCT01307319|528773131|FG000|Overall Study|Adverse Event|2|||
146617848|NCT01307319|528773132|FG001|Overall Study|Adverse Event|2|||
146617849|NCT01307319|528773133|FG002|Overall Study|Adverse Event|1|||
146617850|NCT01307319|528773131|FG000|Overall Study|Lost to Follow-up|1|||
146617851|NCT01307319|528773132|FG001|Overall Study|Lost to Follow-up|0|||
146617852|NCT01307319|528773133|FG002|Overall Study|Lost to Follow-up|1|||
146617853|NCT01307319|528773131|FG000|Overall Study|Protocol Violation|1|||
146617854|NCT01307319|528773132|FG001|Overall Study|Protocol Violation|1|||
146617855|NCT01307319|528773133|FG002|Overall Study|Protocol Violation|0|||
146617856|NCT01307319|528773131|FG000|Overall Study|Withdrawal by Subject|0|||
146617857|NCT01307319|528773132|FG001|Overall Study|Withdrawal by Subject|1|||
146617858|NCT01307319|528773133|FG002|Overall Study|Withdrawal by Subject|2|||
146617859|NCT01307319|528773131|FG000|Overall Study|Other|0|||
146617860|NCT01307319|528773132|FG001|Overall Study|Other|4|||
146617861|NCT01307319|528773133|FG002|Overall Study|Other|3|||
146617862|NCT02735239|528773134|FG000|Overall Study|Adverse Event|0|||
146617863|NCT02735239|528773135|FG001|Overall Study|Adverse Event|0|||
146617864|NCT02735239|528773136|FG002|Overall Study|Adverse Event|4|||
146617865|NCT02735239|528773137|FG003|Overall Study|Adverse Event|0|||
146617866|NCT02735239|528773138|FG004|Overall Study|Adverse Event|0|||
146617867|NCT02735239|528773139|FG005|Overall Study|Adverse Event|0|||
146617868|NCT02735239|528773134|FG000|Overall Study|Death|1|||
146617869|NCT02735239|528773135|FG001|Overall Study|Death|1|||
146617870|NCT02735239|528773136|FG002|Overall Study|Death|0|||
146617871|NCT02735239|528773137|FG003|Overall Study|Death|0|||
146617872|NCT02735239|528773138|FG004|Overall Study|Death|0|||
146617873|NCT02735239|528773139|FG005|Overall Study|Death|0|||
146617874|NCT02735239|528773134|FG000|Overall Study|Physician Decision|0|||
146617875|NCT02735239|528773135|FG001|Overall Study|Physician Decision|0|||
146617876|NCT02735239|528773136|FG002|Overall Study|Physician Decision|1|||
146694704|NCT00634088|529059934|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
146694705|NCT00634088|529059931|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
146694706|NCT00634088|529059932|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
146694707|NCT00634088|529059933|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
146694708|NCT00634088|529059934|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
146694709|NCT00634088|529059931|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
146694710|NCT00634088|529059932|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
146694711|NCT00634088|529059933|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
146694712|NCT00634088|529059934|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
146694713|NCT00634088|529059931|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
146694714|NCT00634088|529059932|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
146694715|NCT00634088|529059933|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
146694716|NCT00634088|529059934|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
146694717|NCT00634088|529059931|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
146694718|NCT00634088|529059932|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
146694719|NCT00634088|529059933|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
146694720|NCT00634088|529059934|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
146694721|NCT00634088|529059931|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
146694722|NCT00634088|529059932|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
146694723|NCT00634088|529059933|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
146694724|NCT00634088|529059934|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
146694725|NCT00600756|529059939|FG000|Analysis After 6 Months|Adverse Event|43|||
146694726|NCT00600756|529059940|FG001|Analysis After 6 Months|Adverse Event|33|||
146694727|NCT00600756|529059939|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
146694728|NCT00600756|529059940|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
146694729|NCT00600756|529059939|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
146694730|NCT00600756|529059940|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
146694731|NCT00600756|529059939|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
146694732|NCT00600756|529059940|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
146694733|NCT00600756|529059939|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
146694734|NCT00600756|529059940|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
146694735|NCT00600756|529059939|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
146694736|NCT00600756|529059940|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
146694737|NCT00600756|529059939|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
146694738|NCT00600756|529059940|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
146694739|NCT00600756|529059939|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
146694740|NCT00600756|529059940|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
146694741|NCT00600756|529059939|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
146694742|NCT00600756|529059940|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
146694743|NCT00600756|529059939|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
146694744|NCT00600756|529059940|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
146694745|NCT00600756|529059939|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
146694746|NCT00600756|529059940|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
146694747|NCT00600756|529059939|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
146694748|NCT00600756|529059940|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
146694749|NCT00600756|529059939|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
146694750|NCT00600756|529059940|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
146694751|NCT00600756|529059939|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
146694752|NCT00600756|529059940|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
146694753|NCT02802592|529059943|FG000|Overall Study|Study terminated due to loss of funding|4|||
146694754|NCT00352846|529059950|FG000|Overall Study|Disease progression|0|||
146694755|NCT00352846|529059951|FG001|Overall Study|Disease progression|2|||
146694756|NCT00352846|529059950|FG000|Overall Study|Withdrawal by Subject|3|||
146694757|NCT00352846|529059951|FG001|Overall Study|Withdrawal by Subject|8|||
146694758|NCT00352846|529059950|FG000|Overall Study|Ineligible|3|||
146694759|NCT00352846|529059951|FG001|Overall Study|Ineligible|2|||
146694760|NCT00352846|529059950|FG000|Overall Study|Non-compliance|2|||
146694761|NCT00352846|529059951|FG001|Overall Study|Non-compliance|0|||
146694762|NCT00352846|529059950|FG000|Overall Study|Death|0|||
146775932|NCT02590432|529351241|FG003|Open-label Treatment Period|Adverse Event|0|||
146775933|NCT02590432|529351242|FG004|Open-label Treatment Period|Adverse Event|0|||
146775934|NCT02590432|529351243|FG005|Open-label Treatment Period|Adverse Event|0|||
146694763|NCT00352846|529059951|FG001|Overall Study|Death|1|||
146694764|NCT00788827|529059952|FG000|Overall Study|Lack of Efficacy|2|||
146775935|NCT02590432|529351244|FG006|Open-label Treatment Period|Adverse Event|0|||
146694765|NCT01527682|529059953|FG000|Overall Study|Protocol Violation|8|||
146694766|NCT04837131|529059957|FG000|Overall Study|Death|1|||
146694767|NCT04837131|529059957|FG000|Overall Study|Withdrawal by Subject|1|||
146775936|NCT02590432|529351245|FG007|Open-label Treatment Period|Adverse Event|0|||
146775937|NCT02590432|529351246|FG008|Open-label Treatment Period|Adverse Event|0|||
146694768|NCT04837131|529059957|FG000|Overall Study|Adverse Event|1|||
146694769|NCT04837131|529059957|FG000|Overall Study|Protocol Violation|1|||
146694770|NCT00502697|529061523|FG000|Overall Study|Withdrawal by Subject|3|||
146694771|NCT00502697|529061524|FG001|Overall Study|Withdrawal by Subject|1|||
146694772|NCT00502697|529061523|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
146694773|NCT00502697|529061524|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
146694774|NCT00502697|529061523|FG000|Overall Study|found not to meet eligibility criteria|3|||
146694775|NCT00502697|529061524|FG001|Overall Study|found not to meet eligibility criteria|4|||
146694776|NCT00502697|529061523|FG000|Overall Study|did not meet assignment criteria|4|||
146694777|NCT00502697|529061524|FG001|Overall Study|did not meet assignment criteria|2|||
146694778|NCT02579265|529061533|FG000|Overall Study|Weaned off earlier than 28 days|44|||
146694779|NCT02579265|529061534|FG001|Overall Study|Weaned off earlier than 28 days|43|||
146694780|NCT02579265|529061533|FG000|Overall Study|Adverse Event|2|||
146694781|NCT02579265|529061534|FG001|Overall Study|Adverse Event|0|||
146694782|NCT02579265|529061533|FG000|Overall Study|Any other reason not specified|0|||
146694783|NCT02579265|529061534|FG001|Overall Study|Any other reason not specified|2|||
146694784|NCT02579265|529061533|FG000|Overall Study|Withdrawal by Subject|2|||
146694785|NCT02579265|529061534|FG001|Overall Study|Withdrawal by Subject|0|||
146694786|NCT02579265|529061533|FG000|Overall Study|Physician Decision|1|||
146694787|NCT02579265|529061534|FG001|Overall Study|Physician Decision|0|||
146694788|NCT02579265|529061533|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
146694789|NCT02579265|529061534|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
146694790|NCT02174848|529061535|FG000|Overall Study|Adverse Event|2|||
146694791|NCT02174848|529061536|FG001|Overall Study|Adverse Event|1|||
146694792|NCT02174848|529061535|FG000|Overall Study|Withdrawal by Subject|3|||
146694793|NCT02174848|529061536|FG001|Overall Study|Withdrawal by Subject|3|||
146694794|NCT02174848|529061535|FG000|Overall Study|Lost to Follow-up|0|||
146694795|NCT02174848|529061536|FG001|Overall Study|Lost to Follow-up|1|||
146694796|NCT02174848|529061535|FG000|Overall Study|Worsening of disease|1|||
146694797|NCT02174848|529061536|FG001|Overall Study|Worsening of disease|1|||
146694798|NCT02174848|529061535|FG000|Overall Study|Unable to comply with study requirements|1|||
146694799|NCT02174848|529061536|FG001|Overall Study|Unable to comply with study requirements|0|||
146694800|NCT00644969|529061540|FG000|Treatment Phase|Randomized, not treated|1|||
146694801|NCT00644969|529061541|FG001|Treatment Phase|Randomized, not treated|0|||
146694802|NCT00644969|529061540|FG000|Treatment Phase|Adverse Event|3|||
146694803|NCT00644969|529061541|FG001|Treatment Phase|Adverse Event|0|||
146694804|NCT00644969|529061540|FG000|Treatment Phase|Withdrawal by Subject|4|||
146694805|NCT00644969|529061541|FG001|Treatment Phase|Withdrawal by Subject|0|||
146694806|NCT00644969|529061540|FG000|Treatment Phase|Lost to Follow-up|2|||
146694807|NCT00644969|529061541|FG001|Treatment Phase|Lost to Follow-up|2|||
146694808|NCT00644969|529061540|FG000|Treatment Phase|Other|4|||
146694809|NCT00644969|529061541|FG001|Treatment Phase|Other|1|||
146694810|NCT00644969|529061540|FG000|Post Treatment Phase|Death|1|||
146694811|NCT00644969|529061541|FG001|Post Treatment Phase|Death|0|||
146694812|NCT00644969|529061540|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
146694813|NCT00644969|529061541|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
146694814|NCT00644969|529061540|FG000|Post Treatment Phase|Lost to Follow-up|4|||
146694815|NCT00644969|529061541|FG001|Post Treatment Phase|Lost to Follow-up|1|||
146694816|NCT00644969|529061540|FG000|Post Treatment Phase|Other|1|||
146694817|NCT00644969|529061541|FG001|Post Treatment Phase|Other|0|||
146694818|NCT02449239|529061542|FG000|Induction Phase|Lack of Efficacy|64|||
146694819|NCT02449239|529061542|FG000|Induction Phase|Adverse Event|1|||
146694820|NCT02449239|529061542|FG000|Induction Phase|Lost to Follow-up|1|||
146694821|NCT02449239|529061542|FG000|Induction Phase|Protocol Violation|1|||
146694822|NCT02449239|529061542|FG000|Induction Phase|Physician Decision|1|||
146694823|NCT02449239|529061542|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
146694824|NCT02449239|529061542|FG000|Induction Phase|Withdrawal by Subject|1|||
146694825|NCT02449239|529061542|FG000|Maintenance Month 3|Lack of Efficacy|14|||
146694826|NCT02449239|529061542|FG000|Maintenance Month 6|Lack of Efficacy|10|||
146694827|NCT02449239|529061542|FG000|Maintenance Month 6|Adverse Event|2|||
146694828|NCT02449239|529061542|FG000|Maintenance Month 6|Physician Decision|1|||
146694829|NCT02449239|529061542|FG000|Maintenance Month 9|Lack of Efficacy|2|||
146930129|NCT01354431|529903499|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
146930130|NCT01354431|529903500|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
146930131|NCT01354431|529903501|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
146930132|NCT04685499|529903502|FG000|Overall Study|Study Terminated Early|1|||
146930133|NCT00634114|529903503|FG000|Overall Study|Adverse Event|6|||
146930134|NCT00634114|529903504|FG001|Overall Study|Adverse Event|8|||
146694830|NCT02449239|529061542|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
146694831|NCT02449239|529061542|FG000|Maintenance Month 12|Lack of Efficacy|5|||
146694832|NCT02449239|529061542|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
146694833|NCT02449239|529061542|FG000|Maintenance Month 12|Subject moved from area|1|||
146694834|NCT02449239|529061542|FG000|Maintenance Month 15|Lack of Efficacy|1|||
146694835|NCT02449239|529061542|FG000|Maintenance Month 21|Lack of Efficacy|1|||
146694836|NCT02449239|529061542|FG000|Maintenance Month 21|Sponsor decision|1|||
146694837|NCT03509675|529061543|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
146694838|NCT03509675|529061544|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
146694839|NCT03509675|529061543|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
146694840|NCT03509675|529061544|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
146694841|NCT03509675|529061543|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
146694842|NCT03509675|529061544|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
146694843|NCT03509675|529061543|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
146694844|NCT03509675|529061544|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
146694845|NCT05620576|529061547|FG000|Overall Study|Adverse Event|1|||
146694846|NCT05620576|529061548|FG001|Overall Study|Adverse Event|1|||
146694847|NCT05620576|529061547|FG000|Overall Study|Lost to Follow-up|3|||
146694848|NCT05620576|529061548|FG001|Overall Study|Lost to Follow-up|1|||
146694849|NCT05620576|529061547|FG000|Overall Study|Physician Decision|0|||
146694850|NCT05620576|529061548|FG001|Overall Study|Physician Decision|1|||
146694851|NCT05620576|529061547|FG000|Overall Study|Protocol Deviation|1|||
146694852|NCT05620576|529061548|FG001|Overall Study|Protocol Deviation|1|||
146694853|NCT05620576|529061547|FG000|Overall Study|Withdrawal by Subject|2|||
146694854|NCT05620576|529061548|FG001|Overall Study|Withdrawal by Subject|3|||
146694855|NCT02622828|529061549|FG000|Overall Study|participant withdrew|3|||
146694856|NCT04091646|529061550|FG000|Overall Study|Adverse Event|2|||
146694857|NCT04091646|529061551|FG001|Overall Study|Adverse Event|1|||
146694858|NCT04091646|529061550|FG000|Overall Study|Lost to Follow-up|6|||
146694859|NCT04091646|529061551|FG001|Overall Study|Lost to Follow-up|2|||
146694860|NCT04091646|529061550|FG000|Overall Study|Protocol Violation|0|||
146694861|NCT04091646|529061551|FG001|Overall Study|Protocol Violation|1|||
146694862|NCT04091646|529061550|FG000|Overall Study|Withdrawal by Subject|4|||
146694863|NCT04091646|529061551|FG001|Overall Study|Withdrawal by Subject|1|||
146694864|NCT04091646|529061550|FG000|Overall Study|Participant Incarcerated|1|||
146694865|NCT04091646|529061551|FG001|Overall Study|Participant Incarcerated|0|||
146694866|NCT03314584|529061556|FG000|Overall Study|Withdrawal by Subject|3|||
146694867|NCT03314584|529061557|FG001|Overall Study|Withdrawal by Subject|3|||
146694868|NCT03314584|529061556|FG000|Overall Study|Lost to Follow-up|4|||
146694869|NCT03314584|529061557|FG001|Overall Study|Lost to Follow-up|0|||
146694870|NCT01752855|529061562|FG000|Overall Study|Adverse Event|1|||
146694871|NCT01752855|529061563|FG001|Overall Study|Adverse Event|0|||
146694872|NCT01752855|529061562|FG000|Overall Study|Withdrew Consent|0|||
146694873|NCT01752855|529061563|FG001|Overall Study|Withdrew Consent|2|||
146694874|NCT01752855|529061562|FG000|Overall Study|Lack of Efficacy|0|||
146694875|NCT01752855|529061563|FG001|Overall Study|Lack of Efficacy|2|||
146694876|NCT02439320|529061567|FG000|Overall Study|Adverse Event|0|||
146694877|NCT02439320|529061568|FG001|Overall Study|Adverse Event|2|||
146694878|NCT02439320|529061569|FG002|Overall Study|Adverse Event|0|||
146694879|NCT02439320|529061567|FG000|Overall Study|Lost to Follow-up|37|||
146694880|NCT02439320|529061568|FG001|Overall Study|Lost to Follow-up|34|||
146694881|NCT02439320|529061569|FG002|Overall Study|Lost to Follow-up|42|||
146694882|NCT02439320|529061567|FG000|Overall Study|Death|0|||
146694883|NCT02439320|529061568|FG001|Overall Study|Death|1|||
146694884|NCT02439320|529061569|FG002|Overall Study|Death|0|||
146694885|NCT02439320|529061567|FG000|Overall Study|Noncompliance with Protocol|10|||
146694886|NCT02439320|529061568|FG001|Overall Study|Noncompliance with Protocol|11|||
146694887|NCT02439320|529061569|FG002|Overall Study|Noncompliance with Protocol|7|||
146694888|NCT02439320|529061567|FG000|Overall Study|Pregnancy|0|||
146694889|NCT02439320|529061568|FG001|Overall Study|Pregnancy|1|||
146694890|NCT02439320|529061569|FG002|Overall Study|Pregnancy|1|||
146694891|NCT02439320|529061567|FG000|Overall Study|Withdrawal by Subject|12|||
146694892|NCT02439320|529061568|FG001|Overall Study|Withdrawal by Subject|16|||
146694893|NCT02439320|529061569|FG002|Overall Study|Withdrawal by Subject|14|||
146694894|NCT02439320|529061567|FG000|Overall Study|Physician Decision|2|||
146694895|NCT02439320|529061568|FG001|Overall Study|Physician Decision|1|||
146694896|NCT02439320|529061569|FG002|Overall Study|Physician Decision|0|||
146694897|NCT02439320|529061567|FG000|Overall Study|Sponsor Request|0|||
146694898|NCT02439320|529061568|FG001|Overall Study|Sponsor Request|2|||
146694899|NCT02439320|529061569|FG002|Overall Study|Sponsor Request|1|||
146694900|NCT02439320|529061567|FG000|Overall Study|Randomization Failure|35|||
146694901|NCT02439320|529061568|FG001|Overall Study|Randomization Failure|46|||
146694902|NCT02439320|529061569|FG002|Overall Study|Randomization Failure|34|||
146694903|NCT03343483|529061575|FG000|Overall Study|Death|0|||
146694904|NCT03343483|529061576|FG001|Overall Study|Death|3|||
146694905|NCT03343483|529061575|FG000|Overall Study|Lost to Follow-up|9|||
146694906|NCT03343483|529061576|FG001|Overall Study|Lost to Follow-up|13|||
146694907|NCT03343483|529061575|FG000|Overall Study|Withdrawal by Subject|8|||
146694908|NCT03343483|529061576|FG001|Overall Study|Withdrawal by Subject|17|||
146694909|NCT01505608|529061577|FG000|Phase I|Lack of Efficacy|0|||
146694910|NCT01505608|529061578|FG001|Phase I|Lack of Efficacy|4|||
146694911|NCT01505608|529061577|FG000|Phase I|Adverse Event|0|||
146694912|NCT01505608|529061578|FG001|Phase I|Adverse Event|1|||
146694913|NCT01505608|529061577|FG000|Phase I|Withdrawal by Subject|0|||
146694914|NCT01505608|529061578|FG001|Phase I|Withdrawal by Subject|1|||
146930135|NCT00634114|529903505|FG002|Overall Study|Adverse Event|3|||
146930136|NCT00634114|529903503|FG000|Overall Study|Withdrawal by Subject|9|||
146930137|NCT00634114|529903504|FG001|Overall Study|Withdrawal by Subject|6|||
146930138|NCT00634114|529903505|FG002|Overall Study|Withdrawal by Subject|11|||
146930139|NCT00634114|529903503|FG000|Overall Study|Lost to Follow-up|0|||
146930140|NCT00634114|529903504|FG001|Overall Study|Lost to Follow-up|0|||
146930141|NCT00634114|529903505|FG002|Overall Study|Lost to Follow-up|1|||
146930142|NCT00634114|529903503|FG000|Overall Study|Protocol Violation|3|||
146930143|NCT00634114|529903504|FG001|Overall Study|Protocol Violation|3|||
146930144|NCT00634114|529903505|FG002|Overall Study|Protocol Violation|1|||
146930145|NCT00634114|529903503|FG000|Overall Study|Pregnancy|1|||
146930146|NCT00634114|529903504|FG001|Overall Study|Pregnancy|0|||
146930147|NCT00634114|529903505|FG002|Overall Study|Pregnancy|0|||
146930148|NCT00634114|529903503|FG000|Overall Study|Incorrect enrolment|0|||
146930149|NCT00634114|529903504|FG001|Overall Study|Incorrect enrolment|1|||
146930150|NCT00634114|529903505|FG002|Overall Study|Incorrect enrolment|0|||
146930151|NCT00634114|529903503|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
146930152|NCT00634114|529903504|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
146930153|NCT00634114|529903505|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
146930154|NCT00634114|529903503|FG000|Overall Study|Difficult to continue|3|||
146930155|NCT00634114|529903504|FG001|Overall Study|Difficult to continue|1|||
146930156|NCT00634114|529903505|FG002|Overall Study|Difficult to continue|1|||
146930157|NCT00634114|529903503|FG000|Overall Study|Other reason|1|||
146930158|NCT00634114|529903504|FG001|Overall Study|Other reason|1|||
146930159|NCT00634114|529903505|FG002|Overall Study|Other reason|1|||
146930160|NCT02802878|529903506|FG000|Overall Study|Withdrawal by Subject|3|||
146930161|NCT02802878|529903507|FG001|Overall Study|Withdrawal by Subject|3|||
146930162|NCT02802878|529903506|FG000|Overall Study|Protocol Violation|1|||
146930163|NCT02802878|529903507|FG001|Overall Study|Protocol Violation|0|||
146930164|NCT01599754|529903508|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
146930165|NCT01599754|529903509|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
146930166|NCT01599754|529903508|FG000|Overall Study|Participant noncompliance|4|||
146930167|NCT01599754|529903509|FG001|Overall Study|Participant noncompliance|4|||
146930168|NCT01599754|529903508|FG000|Overall Study|Lost to Follow-up|13|||
146930169|NCT01599754|529903509|FG001|Overall Study|Lost to Follow-up|6|||
146930170|NCT01599754|529903508|FG000|Overall Study|Death|31|||
146930171|NCT01599754|529903509|FG001|Overall Study|Death|33|||
146930172|NCT01599754|529903508|FG000|Overall Study|Adverse Event|3|||
146930173|NCT01599754|529903509|FG001|Overall Study|Adverse Event|2|||
146930174|NCT01599754|529903508|FG000|Overall Study|Investigator decision|1|||
146930175|NCT01599754|529903509|FG001|Overall Study|Investigator decision|3|||
146930176|NCT01599754|529903508|FG000|Overall Study|Withdrawal by Subject|24|||
146930177|NCT01599754|529903509|FG001|Overall Study|Withdrawal by Subject|25|||
146930178|NCT01599754|529903508|FG000|Overall Study|Study terminated by sponsor|282|||
146930179|NCT01599754|529903509|FG001|Overall Study|Study terminated by sponsor|285|||
146930180|NCT00702052|529903510|FG000|Overall Study|Adverse Event|23|||
146930181|NCT00702052|529903510|FG000|Overall Study|Disease Progression|30|||
146930182|NCT00702052|529903510|FG000|Overall Study|Withdrawal by Subject|5|||
146930183|NCT01577160|529903511|FG000|Overall Study|Adverse Event|9|||
146930184|NCT01577160|529903511|FG000|Overall Study|Lack of Efficacy|15|||
146930185|NCT01577160|529903511|FG000|Overall Study|Lost to Follow-up|40|||
146930186|NCT01577160|529903511|FG000|Overall Study|Withdrawal by Subject|18|||
146980471|NCT00606684|530091184|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
146980472|NCT00606684|530091178|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
146980473|NCT00606684|530091179|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
146694915|NCT01505608|529061577|FG000|Phase II|Lack of Efficacy|2|||
146930187|NCT01577160|529903511|FG000|Overall Study|Subject Uncooperative|7|||
146930188|NCT01577160|529903511|FG000|Overall Study|Other|9|||
146694916|NCT01505608|529061578|FG001|Phase II|Lack of Efficacy|1|||
146694917|NCT01505608|529061577|FG000|Phase II|Protocol Violation|0|||
146694918|NCT01505608|529061578|FG001|Phase II|Protocol Violation|1|||
146694919|NCT01488097|529061579|FG000|Overall Study|Lost to Follow-up|1|||
146694920|NCT01577758|529061580|FG000|Dose Escalation Phase|Adverse Event|0|||
146694921|NCT01577758|529061581|FG001|Dose Escalation Phase|Adverse Event|0|||
146694922|NCT01577758|529061582|FG002|Dose Escalation Phase|Adverse Event|0|||
146694923|NCT01577758|529061583|FG003|Dose Escalation Phase|Adverse Event|0|||
146694924|NCT01577758|529061584|FG004|Dose Escalation Phase|Adverse Event|0|||
146694925|NCT01577758|529061585|FG005|Dose Escalation Phase|Adverse Event|2|||
146694926|NCT01577758|529061586|FG006|Dose Escalation Phase|Adverse Event|1|||
146694927|NCT01577758|529061587|FG007|Dose Escalation Phase|Adverse Event|0|||
146694928|NCT01577758|529061580|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
146694929|NCT01577758|529061581|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
146694930|NCT01577758|529061582|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
146694931|NCT01577758|529061583|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
146694932|NCT01577758|529061584|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
146694933|NCT01577758|529061585|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
146694934|NCT01577758|529061586|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
146694935|NCT01577758|529061587|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
146694936|NCT01577758|529061580|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
146694937|NCT01577758|529061581|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
146694938|NCT01577758|529061582|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
146694939|NCT01577758|529061583|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
146694940|NCT01577758|529061584|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
146694941|NCT01577758|529061585|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
146694942|NCT01577758|529061586|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
146694943|NCT01577758|529061587|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
146694944|NCT01577758|529061580|FG000|Dose Escalation Phase|Progression Disease|2|||
146694945|NCT01577758|529061581|FG001|Dose Escalation Phase|Progression Disease|2|||
146694946|NCT01577758|529061582|FG002|Dose Escalation Phase|Progression Disease|1|||
146694947|NCT01577758|529061583|FG003|Dose Escalation Phase|Progression Disease|2|||
146694948|NCT01577758|529061584|FG004|Dose Escalation Phase|Progression Disease|5|||
146694949|NCT01577758|529061585|FG005|Dose Escalation Phase|Progression Disease|0|||
146694950|NCT01577758|529061586|FG006|Dose Escalation Phase|Progression Disease|0|||
146694951|NCT01577758|529061587|FG007|Dose Escalation Phase|Progression Disease|0|||
146694952|NCT01577758|529061580|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
146694953|NCT01577758|529061581|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
146694954|NCT01577758|529061582|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
146694955|NCT01577758|529061583|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
146694956|NCT01577758|529061584|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
146694957|NCT01577758|529061585|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
146694958|NCT01577758|529061586|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
146694959|NCT01577758|529061587|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
146694960|NCT01577758|529061580|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
146694961|NCT01577758|529061581|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
146694962|NCT01577758|529061582|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
146694963|NCT01577758|529061583|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
146694964|NCT01577758|529061584|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
146694965|NCT01577758|529061585|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
146694966|NCT01577758|529061586|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
146694967|NCT01577758|529061587|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
146694968|NCT01577758|529061580|FG000|mCRC Expansion Phase|Progression Disease|0|||
146694969|NCT01577758|529061581|FG001|mCRC Expansion Phase|Progression Disease|0|||
146694970|NCT01577758|529061582|FG002|mCRC Expansion Phase|Progression Disease|0|||
146694971|NCT01577758|529061583|FG003|mCRC Expansion Phase|Progression Disease|0|||
146694972|NCT01577758|529061584|FG004|mCRC Expansion Phase|Progression Disease|0|||
146694973|NCT01577758|529061585|FG005|mCRC Expansion Phase|Progression Disease|0|||
146694974|NCT01577758|529061586|FG006|mCRC Expansion Phase|Progression Disease|0|||
146694975|NCT01577758|529061587|FG007|mCRC Expansion Phase|Progression Disease|19|||
146694976|NCT01293240|529061588|FG000|Overall Study|Noncompliance|2|||
146694977|NCT02404350|529061595|FG000|Overall Study|Adverse Event|2|||
146694978|NCT02404350|529061596|FG001|Overall Study|Adverse Event|2|||
146694979|NCT02404350|529061597|FG002|Overall Study|Adverse Event|3|||
146694980|NCT02404350|529061598|FG003|Overall Study|Adverse Event|9|||
146694981|NCT02404350|529061595|FG000|Overall Study|Lack of Efficacy|3|||
146694982|NCT02404350|529061596|FG001|Overall Study|Lack of Efficacy|1|||
146694983|NCT02404350|529061597|FG002|Overall Study|Lack of Efficacy|0|||
146694984|NCT02404350|529061598|FG003|Overall Study|Lack of Efficacy|3|||
146694985|NCT02404350|529061595|FG000|Overall Study|Lost to Follow-up|2|||
146694986|NCT02404350|529061596|FG001|Overall Study|Lost to Follow-up|0|||
146694987|NCT02404350|529061597|FG002|Overall Study|Lost to Follow-up|0|||
146694988|NCT02404350|529061598|FG003|Overall Study|Lost to Follow-up|1|||
146694989|NCT02404350|529061595|FG000|Overall Study|Physician Decision|1|||
146694990|NCT02404350|529061596|FG001|Overall Study|Physician Decision|0|||
146694991|NCT02404350|529061597|FG002|Overall Study|Physician Decision|0|||
146694992|NCT02404350|529061598|FG003|Overall Study|Physician Decision|2|||
146694993|NCT02404350|529061595|FG000|Overall Study|Pregnancy|0|||
146694994|NCT02404350|529061596|FG001|Overall Study|Pregnancy|0|||
146930189|NCT00101192|529903512|FG000|Overall Study|Ineligible|6|||
146930190|NCT00101192|529903512|FG000|Overall Study|Inevaluable|1|||
146930191|NCT03670641|529903513|FG000|Overall Study|Lost to Follow-up|3|||
146694995|NCT02404350|529061597|FG002|Overall Study|Pregnancy|0|||
146694996|NCT02404350|529061598|FG003|Overall Study|Pregnancy|1|||
146694997|NCT02404350|529061595|FG000|Overall Study|Withdrawal by Subject|7|||
146694998|NCT02404350|529061596|FG001|Overall Study|Withdrawal by Subject|3|||
146694999|NCT02404350|529061597|FG002|Overall Study|Withdrawal by Subject|3|||
146695000|NCT02404350|529061598|FG003|Overall Study|Withdrawal by Subject|19|||
146695001|NCT02404350|529061595|FG000|Overall Study|Due to Non-compliance with treatment|0|||
146695002|NCT02404350|529061596|FG001|Overall Study|Due to Non-compliance with treatment|0|||
146930192|NCT03691610|529903514|FG000|Overall Study|Adverse Event|0|||
146930193|NCT03691610|529903515|FG001|Overall Study|Adverse Event|1|||
146930194|NCT03691610|529903516|FG002|Overall Study|Adverse Event|0|||
146695003|NCT02404350|529061597|FG002|Overall Study|Due to Non-compliance with treatment|0|||
146695004|NCT02404350|529061598|FG003|Overall Study|Due to Non-compliance with treatment|1|||
146695005|NCT02404350|529061595|FG000|Overall Study|Due to Technical problems|0|||
146695006|NCT02404350|529061596|FG001|Overall Study|Due to Technical problems|0|||
146695007|NCT02404350|529061597|FG002|Overall Study|Due to Technical problems|0|||
146695008|NCT02404350|529061598|FG003|Overall Study|Due to Technical problems|1|||
146695009|NCT05389657|529061599|FG000|Overall Study|Lost to Follow-up|7|||
146695010|NCT05389657|529061600|FG001|Overall Study|Lost to Follow-up|8|||
146695011|NCT03261947|529061602|FG000|Overall Study|Death|10|||
146695012|NCT03261947|529061603|FG001|Overall Study|Death|13|||
146695013|NCT03261947|529061604|FG002|Overall Study|Death|17|||
146695014|NCT03261947|529061605|FG003|Overall Study|Death|12|||
146695015|NCT03261947|529061606|FG004|Overall Study|Death|8|||
146695016|NCT03261947|529061602|FG000|Overall Study|Lost to Follow-up|0|||
146695017|NCT03261947|529061603|FG001|Overall Study|Lost to Follow-up|0|||
146695018|NCT03261947|529061604|FG002|Overall Study|Lost to Follow-up|2|||
146695019|NCT03261947|529061605|FG003|Overall Study|Lost to Follow-up|1|||
146695020|NCT03261947|529061606|FG004|Overall Study|Lost to Follow-up|0|||
146695021|NCT03261947|529061602|FG000|Overall Study|Withdrawal by Subject|0|||
146695022|NCT03261947|529061603|FG001|Overall Study|Withdrawal by Subject|0|||
146695023|NCT03261947|529061604|FG002|Overall Study|Withdrawal by Subject|3|||
146695024|NCT03261947|529061605|FG003|Overall Study|Withdrawal by Subject|0|||
146695025|NCT03261947|529061606|FG004|Overall Study|Withdrawal by Subject|1|||
146695026|NCT03261947|529061602|FG000|Overall Study|Site Terminated by Sponsor|0|||
146695027|NCT03261947|529061603|FG001|Overall Study|Site Terminated by Sponsor|0|||
146695028|NCT03261947|529061604|FG002|Overall Study|Site Terminated by Sponsor|4|||
146695029|NCT03261947|529061605|FG003|Overall Study|Site Terminated by Sponsor|7|||
146695030|NCT03261947|529061606|FG004|Overall Study|Site Terminated by Sponsor|5|||
146695031|NCT03261947|529061602|FG000|Overall Study|Reason not Specified|2|||
146695032|NCT03261947|529061603|FG001|Overall Study|Reason not Specified|0|||
146695033|NCT03261947|529061604|FG002|Overall Study|Reason not Specified|4|||
146695034|NCT03261947|529061605|FG003|Overall Study|Reason not Specified|1|||
146695035|NCT03261947|529061606|FG004|Overall Study|Reason not Specified|3|||
146695036|NCT03969992|529061607|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
146695037|NCT03969992|529061608|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
146695038|NCT03969992|529061609|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
146695039|NCT03969992|529061607|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
146695040|NCT03969992|529061608|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
146695041|NCT03969992|529061609|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
146695042|NCT03969992|529061607|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
146695043|NCT03969992|529061608|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
146695044|NCT03969992|529061609|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
146695045|NCT03969992|529061607|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
146695046|NCT03969992|529061608|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
146695047|NCT03969992|529061609|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
146695048|NCT03969992|529061607|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
146695049|NCT03969992|529061608|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
146695050|NCT03969992|529061609|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
146695051|NCT01324388|529061610|FG000|Part 1 of Study|Adverse Event|2|||
146695052|NCT01324388|529061611|FG001|Part 1 of Study|Adverse Event|0|||
146695053|NCT01324388|529061612|FG002|Part 1 of Study|Adverse Event|0|||
146695054|NCT01324388|529061613|FG003|Part 1 of Study|Adverse Event|0|||
146695055|NCT01324388|529061610|FG000|Part 1 of Study|Protocol Violation|1|||
146695056|NCT01324388|529061611|FG001|Part 1 of Study|Protocol Violation|2|||
146695057|NCT01324388|529061612|FG002|Part 1 of Study|Protocol Violation|0|||
146695058|NCT01324388|529061613|FG003|Part 1 of Study|Protocol Violation|0|||
146695059|NCT01324388|529061610|FG000|Part 1 of Study|Physician Decision|1|||
146695060|NCT01324388|529061611|FG001|Part 1 of Study|Physician Decision|0|||
146695061|NCT01324388|529061612|FG002|Part 1 of Study|Physician Decision|0|||
146695062|NCT01324388|529061613|FG003|Part 1 of Study|Physician Decision|0|||
146695063|NCT01324388|529061610|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
146930195|NCT03691610|529903517|FG003|Overall Study|Adverse Event|0|||
146930196|NCT03691610|529903514|FG000|Overall Study|Protocol Deviation|15|||
146930197|NCT03691610|529903515|FG001|Overall Study|Protocol Deviation|8|||
146930198|NCT03691610|529903516|FG002|Overall Study|Protocol Deviation|1|||
146695064|NCT01324388|529061611|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
146695065|NCT01324388|529061612|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
146695066|NCT01324388|529061613|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
146695067|NCT01324388|529061610|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
146695068|NCT01324388|529061611|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
146695069|NCT01324388|529061612|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
146695070|NCT01324388|529061613|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
146695071|NCT01405963|529061614|FG000|Overall Study|Moved Away|2|||
146695072|NCT01405963|529061615|FG001|Overall Study|Moved Away|0|||
146930199|NCT03691610|529903517|FG003|Overall Study|Protocol Deviation|2|||
146930200|NCT03691610|529903514|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
146930201|NCT03691610|529903515|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
146695073|NCT01405963|529061614|FG000|Overall Study|Adverse Event|0|||
146695074|NCT01405963|529061615|FG001|Overall Study|Adverse Event|1|||
146695075|NCT01405963|529061614|FG000|Overall Study|Lost to Follow-up|0|||
146695076|NCT01405963|529061615|FG001|Overall Study|Lost to Follow-up|1|||
146695077|NCT01498640|529061616|FG000|Overall Study|Lost to Follow-up|1|||
146695078|NCT01498640|529061616|FG000|Overall Study|Death|1|||
146695079|NCT01498640|529061616|FG000|Overall Study|Other|3|||
146695080|NCT01737047|529061617|FG000|Overall Study|Death|10|||
146695081|NCT01737047|529061618|FG001|Overall Study|Death|0|||
146695082|NCT01737047|529061619|FG002|Overall Study|Death|1|||
146695083|NCT01737047|529061617|FG000|Overall Study|Withdrawal by Subject|17|||
146695084|NCT01737047|529061618|FG001|Overall Study|Withdrawal by Subject|11|||
146695085|NCT01737047|529061619|FG002|Overall Study|Withdrawal by Subject|4|||
146695086|NCT00129129|529061620|FG000|Primary Phase|Adverse Event|2|||
146695087|NCT00129129|529061621|FG001|Primary Phase|Adverse Event|1|||
146695088|NCT00129129|529061622|FG002|Primary Phase|Adverse Event|0|||
146695089|NCT00129129|529061623|FG003|Primary Phase|Adverse Event|0|||
146695090|NCT00129129|529061624|FG004|Primary Phase|Adverse Event|0|||
146695091|NCT00129129|529061620|FG000|Primary Phase|Withdrawal by Subject|12|||
146695092|NCT00129129|529061621|FG001|Primary Phase|Withdrawal by Subject|10|||
146695093|NCT00129129|529061622|FG002|Primary Phase|Withdrawal by Subject|0|||
146695094|NCT00129129|529061623|FG003|Primary Phase|Withdrawal by Subject|0|||
146695095|NCT00129129|529061624|FG004|Primary Phase|Withdrawal by Subject|0|||
146695096|NCT00129129|529061620|FG000|Primary Phase|Migration from study area|1|||
146695097|NCT00129129|529061621|FG001|Primary Phase|Migration from study area|3|||
146695098|NCT00129129|529061622|FG002|Primary Phase|Migration from study area|0|||
146695099|NCT00129129|529061623|FG003|Primary Phase|Migration from study area|0|||
146695100|NCT00129129|529061624|FG004|Primary Phase|Migration from study area|0|||
146695101|NCT00129129|529061620|FG000|Primary Phase|Lost to Follow-up|8|||
146695102|NCT00129129|529061621|FG001|Primary Phase|Lost to Follow-up|6|||
146695103|NCT00129129|529061622|FG002|Primary Phase|Lost to Follow-up|0|||
146695104|NCT00129129|529061623|FG003|Primary Phase|Lost to Follow-up|0|||
146695105|NCT00129129|529061624|FG004|Primary Phase|Lost to Follow-up|0|||
146695106|NCT00129129|529061620|FG000|Primary Phase|Other|2|||
146695107|NCT00129129|529061621|FG001|Primary Phase|Other|5|||
146695108|NCT00129129|529061622|FG002|Primary Phase|Other|0|||
146695109|NCT00129129|529061623|FG003|Primary Phase|Other|0|||
146695110|NCT00129129|529061624|FG004|Primary Phase|Other|0|||
146695111|NCT00129129|529061620|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
146695112|NCT00129129|529061621|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
146695113|NCT00129129|529061622|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
146695114|NCT00129129|529061623|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
146695115|NCT00129129|529061624|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
146695116|NCT00129129|529061620|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
146695117|NCT00129129|529061621|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
146695118|NCT00129129|529061622|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
146695119|NCT00129129|529061623|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
146695120|NCT00129129|529061624|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
146695121|NCT00129129|529061620|FG000|Fourth Dose Phase|Migration from study area|0|||
146695122|NCT00129129|529061621|FG001|Fourth Dose Phase|Migration from study area|0|||
146695123|NCT00129129|529061622|FG002|Fourth Dose Phase|Migration from study area|0|||
146695124|NCT00129129|529061623|FG003|Fourth Dose Phase|Migration from study area|0|||
146695125|NCT00129129|529061624|FG004|Fourth Dose Phase|Migration from study area|2|||
146695126|NCT00129129|529061620|FG000|Fourth Dose Phase|Other|0|||
146695127|NCT00129129|529061621|FG001|Fourth Dose Phase|Other|0|||
146695128|NCT00129129|529061622|FG002|Fourth Dose Phase|Other|0|||
146695129|NCT00129129|529061623|FG003|Fourth Dose Phase|Other|1|||
146695130|NCT00129129|529061624|FG004|Fourth Dose Phase|Other|1|||
146695131|NCT00129129|529061620|FG000|Fourth Dose Phase|Protocol Violation|0|||
146695132|NCT00129129|529061621|FG001|Fourth Dose Phase|Protocol Violation|0|||
146695133|NCT00129129|529061622|FG002|Fourth Dose Phase|Protocol Violation|0|||
146695134|NCT00129129|529061623|FG003|Fourth Dose Phase|Protocol Violation|1|||
146930202|NCT03691610|529903516|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
146930203|NCT03691610|529903517|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
146695135|NCT00129129|529061624|FG004|Fourth Dose Phase|Protocol Violation|0|||
146695136|NCT03089606|529061625|FG000|Overall Study|Progression after Cycle 1|1|||
146695137|NCT00335972|529061626|FG000|Overall Study|not given treatments|0|||
146695138|NCT00335972|529061627|FG001|Overall Study|not given treatments|3|||
146695139|NCT02140567|529061631|FG000|Overall Study|Problems with recording equipment|6|||
146695140|NCT02882854|529061633|FG000|Overall Study|Lost to Follow-up|1|||
146695141|NCT02882854|529061634|FG001|Overall Study|Lost to Follow-up|2|||
146695142|NCT02882854|529061633|FG000|Overall Study|Physician Decision|0|||
146695143|NCT02882854|529061634|FG001|Overall Study|Physician Decision|1|||
146695144|NCT02039674|529061635|FG000|Overall Study|Adverse Event|0|||
146695145|NCT02039674|529061636|FG001|Overall Study|Adverse Event|0|||
146695146|NCT02039674|529061637|FG002|Overall Study|Adverse Event|0|||
146695147|NCT02039674|529061638|FG003|Overall Study|Adverse Event|1|||
146695148|NCT02039674|529061639|FG004|Overall Study|Adverse Event|0|||
146695149|NCT02039674|529061640|FG005|Overall Study|Adverse Event|0|||
146695150|NCT02039674|529061641|FG006|Overall Study|Adverse Event|0|||
146695151|NCT02039674|529061642|FG007|Overall Study|Adverse Event|0|||
146695152|NCT02039674|529061643|FG008|Overall Study|Adverse Event|2|||
146695153|NCT02039674|529061644|FG009|Overall Study|Adverse Event|1|||
146695154|NCT02039674|529061645|FG010|Overall Study|Adverse Event|0|||
146695155|NCT02039674|529061646|FG011|Overall Study|Adverse Event|2|||
146695156|NCT02039674|529061647|FG012|Overall Study|Adverse Event|3|||
146695157|NCT02039674|529061648|FG013|Overall Study|Adverse Event|1|||
146695158|NCT02039674|529061635|FG000|Overall Study|Death|2|||
146695159|NCT02039674|529061636|FG001|Overall Study|Death|0|||
146695160|NCT02039674|529061637|FG002|Overall Study|Death|2|||
146695161|NCT02039674|529061638|FG003|Overall Study|Death|3|||
146695162|NCT02039674|529061639|FG004|Overall Study|Death|0|||
146695163|NCT02039674|529061640|FG005|Overall Study|Death|0|||
146695164|NCT02039674|529061641|FG006|Overall Study|Death|1|||
146695165|NCT02039674|529061642|FG007|Overall Study|Death|0|||
146695166|NCT02039674|529061643|FG008|Overall Study|Death|2|||
146695167|NCT02039674|529061644|FG009|Overall Study|Death|0|||
146695168|NCT02039674|529061645|FG010|Overall Study|Death|1|||
146695169|NCT02039674|529061646|FG011|Overall Study|Death|3|||
146695170|NCT02039674|529061647|FG012|Overall Study|Death|2|||
146695171|NCT02039674|529061648|FG013|Overall Study|Death|8|||
146695172|NCT02039674|529061635|FG000|Overall Study|Excluded Medication|1|||
146695173|NCT02039674|529061636|FG001|Overall Study|Excluded Medication|1|||
146695174|NCT02039674|529061637|FG002|Overall Study|Excluded Medication|0|||
146695175|NCT02039674|529061638|FG003|Overall Study|Excluded Medication|1|||
146695176|NCT02039674|529061639|FG004|Overall Study|Excluded Medication|0|||
146695177|NCT02039674|529061640|FG005|Overall Study|Excluded Medication|1|||
146695178|NCT02039674|529061641|FG006|Overall Study|Excluded Medication|0|||
146695179|NCT02039674|529061642|FG007|Overall Study|Excluded Medication|0|||
146695180|NCT02039674|529061643|FG008|Overall Study|Excluded Medication|2|||
146695181|NCT02039674|529061644|FG009|Overall Study|Excluded Medication|3|||
146695182|NCT02039674|529061645|FG010|Overall Study|Excluded Medication|5|||
146695183|NCT02039674|529061646|FG011|Overall Study|Excluded Medication|6|||
146695184|NCT02039674|529061647|FG012|Overall Study|Excluded Medication|8|||
146695185|NCT02039674|529061648|FG013|Overall Study|Excluded Medication|3|||
146695186|NCT02039674|529061635|FG000|Overall Study|Lost to Follow-up|0|||
146695187|NCT02039674|529061636|FG001|Overall Study|Lost to Follow-up|0|||
146695188|NCT02039674|529061637|FG002|Overall Study|Lost to Follow-up|0|||
146695189|NCT02039674|529061638|FG003|Overall Study|Lost to Follow-up|0|||
146695190|NCT02039674|529061639|FG004|Overall Study|Lost to Follow-up|1|||
146695191|NCT02039674|529061640|FG005|Overall Study|Lost to Follow-up|1|||
146695192|NCT02039674|529061641|FG006|Overall Study|Lost to Follow-up|0|||
146695193|NCT02039674|529061642|FG007|Overall Study|Lost to Follow-up|0|||
146695194|NCT02039674|529061643|FG008|Overall Study|Lost to Follow-up|0|||
146695195|NCT02039674|529061644|FG009|Overall Study|Lost to Follow-up|0|||
146695196|NCT02039674|529061645|FG010|Overall Study|Lost to Follow-up|0|||
146695197|NCT02039674|529061646|FG011|Overall Study|Lost to Follow-up|2|||
146695198|NCT02039674|529061647|FG012|Overall Study|Lost to Follow-up|2|||
146695199|NCT02039674|529061648|FG013|Overall Study|Lost to Follow-up|1|||
146695200|NCT02039674|529061635|FG000|Overall Study|Physician Decision|0|||
146695201|NCT02039674|529061636|FG001|Overall Study|Physician Decision|0|||
146695202|NCT02039674|529061637|FG002|Overall Study|Physician Decision|0|||
146695203|NCT02039674|529061638|FG003|Overall Study|Physician Decision|0|||
146695204|NCT02039674|529061639|FG004|Overall Study|Physician Decision|0|||
146695205|NCT02039674|529061640|FG005|Overall Study|Physician Decision|0|||
146695206|NCT02039674|529061641|FG006|Overall Study|Physician Decision|0|||
146695207|NCT02039674|529061642|FG007|Overall Study|Physician Decision|0|||
146695208|NCT02039674|529061643|FG008|Overall Study|Physician Decision|0|||
146695209|NCT02039674|529061644|FG009|Overall Study|Physician Decision|0|||
146695210|NCT02039674|529061645|FG010|Overall Study|Physician Decision|0|||
146695211|NCT02039674|529061646|FG011|Overall Study|Physician Decision|1|||
146695212|NCT02039674|529061647|FG012|Overall Study|Physician Decision|1|||
146695213|NCT02039674|529061648|FG013|Overall Study|Physician Decision|0|||
146695214|NCT02039674|529061635|FG000|Overall Study|Progressive Disease|8|||
146695215|NCT02039674|529061636|FG001|Overall Study|Progressive Disease|8|||
146695216|NCT02039674|529061637|FG002|Overall Study|Progressive Disease|6|||
146695217|NCT02039674|529061638|FG003|Overall Study|Progressive Disease|7|||
146695218|NCT02039674|529061639|FG004|Overall Study|Progressive Disease|9|||
146695219|NCT02039674|529061640|FG005|Overall Study|Progressive Disease|10|||
146695220|NCT02039674|529061641|FG006|Overall Study|Progressive Disease|1|||
146695221|NCT02039674|529061642|FG007|Overall Study|Progressive Disease|3|||
146695222|NCT02039674|529061643|FG008|Overall Study|Progressive Disease|6|||
146695223|NCT02039674|529061644|FG009|Overall Study|Progressive Disease|4|||
146695224|NCT02039674|529061645|FG010|Overall Study|Progressive Disease|0|||
146695225|NCT02039674|529061646|FG011|Overall Study|Progressive Disease|34|||
146695226|NCT02039674|529061647|FG012|Overall Study|Progressive Disease|34|||
146695227|NCT02039674|529061648|FG013|Overall Study|Progressive Disease|18|||
146695228|NCT02039674|529061635|FG000|Overall Study|Withdrawal by Subject|1|||
146695229|NCT02039674|529061636|FG001|Overall Study|Withdrawal by Subject|2|||
146695230|NCT02039674|529061637|FG002|Overall Study|Withdrawal by Subject|3|||
146695231|NCT02039674|529061638|FG003|Overall Study|Withdrawal by Subject|0|||
146695232|NCT02039674|529061639|FG004|Overall Study|Withdrawal by Subject|1|||
146695233|NCT02039674|529061640|FG005|Overall Study|Withdrawal by Subject|0|||
146695234|NCT02039674|529061641|FG006|Overall Study|Withdrawal by Subject|0|||
146695235|NCT02039674|529061642|FG007|Overall Study|Withdrawal by Subject|0|||
146695236|NCT02039674|529061643|FG008|Overall Study|Withdrawal by Subject|0|||
146695237|NCT02039674|529061644|FG009|Overall Study|Withdrawal by Subject|1|||
146695238|NCT02039674|529061645|FG010|Overall Study|Withdrawal by Subject|1|||
146695239|NCT02039674|529061646|FG011|Overall Study|Withdrawal by Subject|4|||
146695240|NCT02039674|529061647|FG012|Overall Study|Withdrawal by Subject|6|||
146695241|NCT02039674|529061648|FG013|Overall Study|Withdrawal by Subject|2|||
146695242|NCT02039674|529061635|FG000|Overall Study|Clinical Progression|0|||
146695243|NCT02039674|529061636|FG001|Overall Study|Clinical Progression|0|||
146695244|NCT02039674|529061637|FG002|Overall Study|Clinical Progression|0|||
146695245|NCT02039674|529061638|FG003|Overall Study|Clinical Progression|0|||
146695246|NCT02039674|529061639|FG004|Overall Study|Clinical Progression|0|||
146695247|NCT02039674|529061640|FG005|Overall Study|Clinical Progression|0|||
146695248|NCT02039674|529061641|FG006|Overall Study|Clinical Progression|1|||
146695249|NCT02039674|529061642|FG007|Overall Study|Clinical Progression|0|||
146695250|NCT02039674|529061643|FG008|Overall Study|Clinical Progression|0|||
146695251|NCT02039674|529061644|FG009|Overall Study|Clinical Progression|0|||
146695252|NCT02039674|529061645|FG010|Overall Study|Clinical Progression|0|||
146695253|NCT02039674|529061646|FG011|Overall Study|Clinical Progression|0|||
146695254|NCT02039674|529061647|FG012|Overall Study|Clinical Progression|1|||
146695255|NCT02039674|529061648|FG013|Overall Study|Clinical Progression|0|||
146695256|NCT02039674|529061635|FG000|Overall Study|Sponsor Decision|1|||
146695257|NCT02039674|529061636|FG001|Overall Study|Sponsor Decision|1|||
146695258|NCT02039674|529061637|FG002|Overall Study|Sponsor Decision|1|||
146695259|NCT02039674|529061638|FG003|Overall Study|Sponsor Decision|1|||
146695260|NCT02039674|529061639|FG004|Overall Study|Sponsor Decision|1|||
146695261|NCT02039674|529061640|FG005|Overall Study|Sponsor Decision|0|||
146695262|NCT02039674|529061641|FG006|Overall Study|Sponsor Decision|0|||
146695263|NCT02039674|529061642|FG007|Overall Study|Sponsor Decision|0|||
146695264|NCT02039674|529061643|FG008|Overall Study|Sponsor Decision|0|||
146695265|NCT02039674|529061644|FG009|Overall Study|Sponsor Decision|3|||
146695266|NCT02039674|529061645|FG010|Overall Study|Sponsor Decision|0|||
146695267|NCT02039674|529061646|FG011|Overall Study|Sponsor Decision|8|||
146695268|NCT02039674|529061647|FG012|Overall Study|Sponsor Decision|5|||
146695269|NCT02039674|529061648|FG013|Overall Study|Sponsor Decision|0|||
146695270|NCT02039674|529061635|FG000|Overall Study|Other|0|||
146695271|NCT02039674|529061636|FG001|Overall Study|Other|0|||
146695272|NCT02039674|529061637|FG002|Overall Study|Other|0|||
146695273|NCT02039674|529061638|FG003|Overall Study|Other|0|||
146695274|NCT02039674|529061639|FG004|Overall Study|Other|0|||
146695275|NCT02039674|529061640|FG005|Overall Study|Other|0|||
146695276|NCT02039674|529061641|FG006|Overall Study|Other|0|||
146695277|NCT02039674|529061642|FG007|Overall Study|Other|0|||
146695278|NCT02039674|529061643|FG008|Overall Study|Other|0|||
146695279|NCT02039674|529061644|FG009|Overall Study|Other|0|||
146695280|NCT02039674|529061645|FG010|Overall Study|Other|0|||
146695281|NCT02039674|529061646|FG011|Overall Study|Other|0|||
146695282|NCT02039674|529061647|FG012|Overall Study|Other|1|||
146695283|NCT02039674|529061648|FG013|Overall Study|Other|0|||
146695284|NCT01408030|529061650|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
146695285|NCT01408030|529061651|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
146695286|NCT01408030|529061652|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
146695287|NCT01408030|529061653|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
146695288|NCT01408030|529061650|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
146695289|NCT01408030|529061651|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
146695290|NCT01408030|529061652|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
146695291|NCT01408030|529061653|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
146695292|NCT01408030|529061650|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
146695293|NCT01408030|529061651|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
146695294|NCT01408030|529061652|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
146695295|NCT01408030|529061653|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
146695296|NCT01408030|529061650|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
146695297|NCT01408030|529061651|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
146695298|NCT01408030|529061652|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
146695299|NCT01408030|529061653|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
146695300|NCT01408030|529061650|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
146695301|NCT01408030|529061651|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
146695302|NCT01408030|529061652|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
146695303|NCT01408030|529061653|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
146930204|NCT03691610|529903514|FG000|Overall Study|Lost to Follow-up|20|||
146617877|NCT02735239|528773137|FG003|Overall Study|Physician Decision|0|||
146775938|NCT02590432|529351238|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
146930205|NCT03691610|529903515|FG001|Overall Study|Lost to Follow-up|11|||
146930206|NCT03691610|529903516|FG002|Overall Study|Lost to Follow-up|5|||
146930207|NCT03691610|529903517|FG003|Overall Study|Lost to Follow-up|2|||
146930208|NCT00242580|529903521|FG000|Overall Study|Adverse Event|3|||
146930209|NCT00242580|529903522|FG001|Overall Study|Adverse Event|0|||
146930210|NCT00242580|529903523|FG002|Overall Study|Adverse Event|2|||
146930211|NCT00242580|529903521|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146930212|NCT00242580|529903522|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
146930213|NCT00242580|529903523|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
146930214|NCT00242580|529903521|FG000|Overall Study|Protocol Violation|0|||
146930215|NCT00242580|529903522|FG001|Overall Study|Protocol Violation|0|||
146930216|NCT00242580|529903523|FG002|Overall Study|Protocol Violation|1|||
146930217|NCT00242580|529903521|FG000|Overall Study|Subject withdrew consent|2|||
146930218|NCT00242580|529903522|FG001|Overall Study|Subject withdrew consent|2|||
146930219|NCT00242580|529903523|FG002|Overall Study|Subject withdrew consent|5|||
146930220|NCT00242580|529903521|FG000|Overall Study|Lost to Follow-up|0|||
146930221|NCT00242580|529903522|FG001|Overall Study|Lost to Follow-up|3|||
146930222|NCT00242580|529903523|FG002|Overall Study|Lost to Follow-up|0|||
146930223|NCT00242580|529903521|FG000|Overall Study|Death|1|||
146930224|NCT00242580|529903522|FG001|Overall Study|Death|2|||
146930225|NCT00242580|529903523|FG002|Overall Study|Death|1|||
146930226|NCT01232894|529903524|FG000|Overall Study|Lost to Follow-up|0|||
146930227|NCT01232894|529903525|FG001|Overall Study|Lost to Follow-up|1|||
146930228|NCT01232894|529903524|FG000|Overall Study|Death|1|||
146930229|NCT01232894|529903525|FG001|Overall Study|Death|0|||
146930230|NCT01232894|529903524|FG000|Overall Study|Protocol Violation|1|||
146930231|NCT01232894|529903525|FG001|Overall Study|Protocol Violation|1|||
146930232|NCT01232894|529903524|FG000|Overall Study|Withdrawal by Subject|8|||
146930233|NCT01232894|529903525|FG001|Overall Study|Withdrawal by Subject|5|||
146930234|NCT01232894|529903524|FG000|Overall Study|Physician Decision|2|||
146930235|NCT01232894|529903525|FG001|Overall Study|Physician Decision|1|||
146930236|NCT03970395|529903530|FG000|Overall Study|Withdrawal by Subject|3|||
146617878|NCT02735239|528773138|FG004|Overall Study|Physician Decision|0|||
146617879|NCT02735239|528773139|FG005|Overall Study|Physician Decision|0|||
146617880|NCT02735239|528773134|FG000|Overall Study|Progressive disease|3|||
146617881|NCT02735239|528773135|FG001|Overall Study|Progressive disease|1|||
146617882|NCT02735239|528773136|FG002|Overall Study|Progressive disease|3|||
146617883|NCT02735239|528773137|FG003|Overall Study|Progressive disease|0|||
146617884|NCT02735239|528773138|FG004|Overall Study|Progressive disease|0|||
146617885|NCT02735239|528773139|FG005|Overall Study|Progressive disease|2|||
146617886|NCT02735239|528773134|FG000|Overall Study|Withdrawal by Subject|0|||
146617887|NCT02735239|528773135|FG001|Overall Study|Withdrawal by Subject|1|||
146617888|NCT02735239|528773136|FG002|Overall Study|Withdrawal by Subject|0|||
146617889|NCT02735239|528773137|FG003|Overall Study|Withdrawal by Subject|0|||
146617890|NCT02735239|528773138|FG004|Overall Study|Withdrawal by Subject|0|||
146617891|NCT02735239|528773139|FG005|Overall Study|Withdrawal by Subject|0|||
146617892|NCT02152631|528773141|FG000|Overall Study|Adverse Event|32|||
146617893|NCT02152631|528773142|FG001|Overall Study|Adverse Event|4|||
146617894|NCT02152631|528773141|FG000|Overall Study|Withdrawal by Subject|13|||
146617895|NCT02152631|528773142|FG001|Overall Study|Withdrawal by Subject|16|||
146617896|NCT02152631|528773141|FG000|Overall Study|Noncompliance with study drug|1|||
146617897|NCT02152631|528773142|FG001|Overall Study|Noncompliance with study drug|0|||
146617898|NCT02152631|528773141|FG000|Overall Study|Physician Decision|1|||
146617899|NCT02152631|528773142|FG001|Overall Study|Physician Decision|2|||
146617900|NCT02152631|528773141|FG000|Overall Study|Lost to Follow-up|0|||
146617901|NCT02152631|528773142|FG001|Overall Study|Lost to Follow-up|1|||
146617902|NCT02152631|528773141|FG000|Overall Study|On Treatment|19|||
146617903|NCT02152631|528773142|FG001|Overall Study|On Treatment|3|||
146617904|NCT00527735|528773143|FG000|Overall Study|Disease progression|47|||
146617905|NCT00527735|528773144|FG001|Overall Study|Disease progression|61|||
146617906|NCT00527735|528773145|FG002|Overall Study|Disease progression|53|||
146617907|NCT00527735|528773143|FG000|Overall Study|Death|23|||
146617908|NCT00527735|528773144|FG001|Overall Study|Death|13|||
146617909|NCT00527735|528773145|FG002|Overall Study|Death|15|||
146617910|NCT00527735|528773143|FG000|Overall Study|Completed treatment in treatment phase|14|||
146617911|NCT00527735|528773144|FG001|Overall Study|Completed treatment in treatment phase|13|||
146617912|NCT00527735|528773145|FG002|Overall Study|Completed treatment in treatment phase|18|||
146617913|NCT00527735|528773143|FG000|Overall Study|Adverse Event|10|||
146617914|NCT00527735|528773144|FG001|Overall Study|Adverse Event|6|||
146617915|NCT00527735|528773145|FG002|Overall Study|Adverse Event|7|||
146617916|NCT00527735|528773143|FG000|Overall Study|Not identified|5|||
146617917|NCT00527735|528773144|FG001|Overall Study|Not identified|5|||
146617918|NCT00527735|528773145|FG002|Overall Study|Not identified|5|||
146617919|NCT00527735|528773143|FG000|Overall Study|Withdrawal by Subject|5|||
146617920|NCT00527735|528773144|FG001|Overall Study|Withdrawal by Subject|4|||
146980474|NCT00606684|530091180|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
146775939|NCT02590432|529351239|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
146775940|NCT02590432|529351240|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
146775941|NCT02590432|529351241|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
146775942|NCT02590432|529351242|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
146775943|NCT02590432|529351243|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
146775944|NCT02590432|529351244|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
146775945|NCT02590432|529351245|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
146775946|NCT02590432|529351246|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
146775947|NCT02590432|529351238|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
146775948|NCT02590432|529351239|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
146775949|NCT02590432|529351240|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
146775950|NCT02590432|529351241|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
146775951|NCT02590432|529351242|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
146775952|NCT02590432|529351243|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
146775953|NCT02590432|529351244|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
146775954|NCT02590432|529351245|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
146775955|NCT02590432|529351246|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
146775956|NCT02590432|529351238|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
146775957|NCT02590432|529351239|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
146775958|NCT02590432|529351240|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
146775959|NCT02590432|529351241|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
146775960|NCT02590432|529351242|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
146775961|NCT02590432|529351243|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
146775962|NCT02590432|529351244|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
146775963|NCT02590432|529351245|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
146775964|NCT02590432|529351246|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
146775965|NCT02590432|529351238|FG000|Open-label Treatment Period|Protocol Violation|10|||
146775966|NCT02590432|529351239|FG001|Open-label Treatment Period|Protocol Violation|4|||
146775967|NCT02590432|529351240|FG002|Open-label Treatment Period|Protocol Violation|0|||
146775968|NCT02590432|529351241|FG003|Open-label Treatment Period|Protocol Violation|0|||
146775969|NCT02590432|529351242|FG004|Open-label Treatment Period|Protocol Violation|0|||
146775970|NCT02590432|529351243|FG005|Open-label Treatment Period|Protocol Violation|0|||
146775971|NCT02590432|529351244|FG006|Open-label Treatment Period|Protocol Violation|0|||
146775972|NCT02590432|529351245|FG007|Open-label Treatment Period|Protocol Violation|0|||
146775973|NCT02590432|529351246|FG008|Open-label Treatment Period|Protocol Violation|0|||
146775974|NCT02590432|529351238|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
146775975|NCT02590432|529351239|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
146775976|NCT02590432|529351240|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
146775977|NCT02590432|529351241|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
146775978|NCT02590432|529351242|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
146775979|NCT02590432|529351243|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
146775980|NCT02590432|529351244|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
146775981|NCT02590432|529351245|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
146775982|NCT02590432|529351246|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
146775983|NCT02590432|529351238|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
146775984|NCT02590432|529351239|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
146775985|NCT02590432|529351240|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
146775986|NCT02590432|529351241|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
146775987|NCT02590432|529351242|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
146775988|NCT02590432|529351243|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
146775989|NCT02590432|529351244|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
146775990|NCT02590432|529351245|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
146775991|NCT02590432|529351246|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
146775992|NCT02590432|529351238|FG000|Double-blind Treatment Period|Adverse Event|0|||
146775993|NCT02590432|529351239|FG001|Double-blind Treatment Period|Adverse Event|0|||
146775994|NCT02590432|529351240|FG002|Double-blind Treatment Period|Adverse Event|14|||
146775995|NCT02590432|529351241|FG003|Double-blind Treatment Period|Adverse Event|12|||
146775996|NCT02590432|529351242|FG004|Double-blind Treatment Period|Adverse Event|6|||
146775997|NCT02590432|529351243|FG005|Double-blind Treatment Period|Adverse Event|22|||
146775998|NCT02590432|529351244|FG006|Double-blind Treatment Period|Adverse Event|20|||
146775999|NCT02590432|529351245|FG007|Double-blind Treatment Period|Adverse Event|0|||
146776000|NCT02590432|529351246|FG008|Double-blind Treatment Period|Adverse Event|0|||
146776001|NCT02590432|529351238|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
146776002|NCT02590432|529351239|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
146776003|NCT02590432|529351240|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
146776004|NCT02590432|529351241|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
146980475|NCT00606684|530091181|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
146695304|NCT01408030|529061650|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
146695305|NCT01408030|529061651|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
146695306|NCT01408030|529061652|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
146695307|NCT01408030|529061653|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
146695308|NCT01408030|529061650|FG000|Observation Phase (Off Drug)|Other|1|||
146695309|NCT01408030|529061651|FG001|Observation Phase (Off Drug)|Other|1|||
146695310|NCT01408030|529061652|FG002|Observation Phase (Off Drug)|Other|1|||
146695311|NCT01408030|529061653|FG003|Observation Phase (Off Drug)|Other|1|||
146695312|NCT02590939|529061654|FG000|Overall Study|Withdrawal by Subject|3|||
146695313|NCT02590939|529061655|FG001|Overall Study|Withdrawal by Subject|1|||
146695314|NCT02590939|529061654|FG000|Overall Study|Failed the nociceptive test|2|||
146695315|NCT02590939|529061655|FG001|Overall Study|Failed the nociceptive test|1|||
146695316|NCT03774433|529061656|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
146695317|NCT00108160|529061657|FG000|Overall Study|Lost to Follow-up|25|||
146695318|NCT00108160|529061658|FG001|Overall Study|Lost to Follow-up|12|||
146695319|NCT00108160|529061657|FG000|Overall Study|Death|1|||
146695320|NCT00108160|529061658|FG001|Overall Study|Death|2|||
146695321|NCT00108160|529061657|FG000|Overall Study|Withdrawal by Subject|4|||
146695322|NCT00108160|529061658|FG001|Overall Study|Withdrawal by Subject|2|||
146695323|NCT00108160|529061657|FG000|Overall Study|Protocol Violation|9|||
146695324|NCT00108160|529061658|FG001|Overall Study|Protocol Violation|5|||
146695325|NCT05045144|529061659|FG000|Overall Study|Lost to Follow-up|3|||
146695326|NCT05045144|529061660|FG001|Overall Study|Lost to Follow-up|2|||
146695327|NCT05045144|529061661|FG002|Overall Study|Lost to Follow-up|3|||
146695328|NCT05045144|529061662|FG003|Overall Study|Lost to Follow-up|5|||
146695329|NCT05045144|529061663|FG004|Overall Study|Lost to Follow-up|13|||
146695330|NCT05045144|529061659|FG000|Overall Study|Withdrawal by Subject|0|||
146695331|NCT05045144|529061660|FG001|Overall Study|Withdrawal by Subject|1|||
146695332|NCT05045144|529061661|FG002|Overall Study|Withdrawal by Subject|0|||
146695333|NCT05045144|529061662|FG003|Overall Study|Withdrawal by Subject|0|||
146695334|NCT05045144|529061663|FG004|Overall Study|Withdrawal by Subject|0|||
146695335|NCT05045144|529061659|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146695336|NCT05045144|529061660|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146695337|NCT05045144|529061661|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146695338|NCT05045144|529061662|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146695339|NCT05045144|529061663|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146695340|NCT02385084|529061664|FG000|Period 2|Protocol Violation|0|||
146695341|NCT02385084|529061665|FG001|Period 2|Protocol Violation|0|||
146695342|NCT02385084|529061666|FG002|Period 2|Protocol Violation|1|||
146695343|NCT02385084|529061667|FG003|Period 2|Protocol Violation|0|||
146695344|NCT02385084|529061668|FG004|Period 2|Protocol Violation|0|||
146695345|NCT02385084|529061669|FG005|Period 2|Protocol Violation|0|||
146695346|NCT02081079|529061671|FG000|Overall Study|Lack of Efficacy|3|||
146695347|NCT02081079|529061672|FG001|Overall Study|Lack of Efficacy|2|||
146695348|NCT02081079|529061671|FG000|Overall Study|Lost to Follow-up|1|||
146695349|NCT02081079|529061672|FG001|Overall Study|Lost to Follow-up|0|||
146695350|NCT02968979|529061673|FG000|Overall Study|Protocol Violation|7|||
146695351|NCT02968979|529061673|FG000|Overall Study|Withdrawal by Subject|1|||
146695352|NCT00729183|529061674|FG000|Overall Study|Adverse Event|11|||
146695353|NCT00729183|529061675|FG001|Overall Study|Adverse Event|5|||
146695354|NCT00729183|529061674|FG000|Overall Study|Lack of Efficacy|0|||
146695355|NCT00729183|529061675|FG001|Overall Study|Lack of Efficacy|1|||
146695356|NCT00729183|529061674|FG000|Overall Study|Lost to Follow-up|3|||
146695357|NCT00729183|529061675|FG001|Overall Study|Lost to Follow-up|1|||
146695358|NCT00729183|529061674|FG000|Overall Study|Physician Decision|1|||
146695359|NCT00729183|529061675|FG001|Overall Study|Physician Decision|1|||
146695360|NCT00729183|529061674|FG000|Overall Study|Protocol Violation|1|||
146695361|NCT00729183|529061675|FG001|Overall Study|Protocol Violation|0|||
146695362|NCT00729183|529061674|FG000|Overall Study|Withdrawal by Subject|9|||
146776005|NCT02590432|529351242|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
146776006|NCT02590432|529351243|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
146776007|NCT02590432|529351244|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
146776008|NCT02590432|529351245|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
147013208|NCT02048813|530210052|FG000|Overall Study|Death|2|||
146695363|NCT00729183|529061675|FG001|Overall Study|Withdrawal by Subject|7|||
146695364|NCT01359254|529061682|FG000|Overall Study|Death|1|||
146695365|NCT01359254|529061683|FG001|Overall Study|Death|0|||
146695366|NCT00851799|529061686|FG000|Overall Study|Death|1|||
146695367|NCT00851799|529061687|FG001|Overall Study|Death|0|||
146695368|NCT00851799|529061688|FG002|Overall Study|Death|1|||
146695369|NCT00851799|529061686|FG000|Overall Study|Lost to Follow-up|5|||
146695370|NCT00851799|529061687|FG001|Overall Study|Lost to Follow-up|3|||
146695371|NCT00851799|529061688|FG002|Overall Study|Lost to Follow-up|10|||
146695372|NCT00851799|529061686|FG000|Overall Study|Not able to get to clinic|8|||
146695373|NCT00851799|529061687|FG001|Overall Study|Not able to get to clinic|5|||
146695374|NCT00851799|529061688|FG002|Overall Study|Not able to get to clinic|9|||
146776009|NCT02590432|529351246|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
146695375|NCT00851799|529061686|FG000|Overall Study|Not willing to adhere to requirements|1|||
146695376|NCT00851799|529061687|FG001|Overall Study|Not willing to adhere to requirements|2|||
146695377|NCT00851799|529061688|FG002|Overall Study|Not willing to adhere to requirements|2|||
146695378|NCT00851799|529061686|FG000|Overall Study|Withdrew consent prior study completion|1|||
146695379|NCT00851799|529061687|FG001|Overall Study|Withdrew consent prior study completion|2|||
146695380|NCT00851799|529061688|FG002|Overall Study|Withdrew consent prior study completion|1|||
146695381|NCT00851799|529061686|FG000|Overall Study|Severe Debilitation|0|||
146695382|NCT00851799|529061687|FG001|Overall Study|Severe Debilitation|1|||
146695383|NCT00851799|529061688|FG002|Overall Study|Severe Debilitation|0|||
146695384|NCT00851799|529061686|FG000|Overall Study|Completed protocol due to pregnancy|0|||
146695385|NCT00851799|529061687|FG001|Overall Study|Completed protocol due to pregnancy|0|||
146695386|NCT00851799|529061688|FG002|Overall Study|Completed protocol due to pregnancy|1|||
146695387|NCT01449526|529061689|FG000|Overall Study|Lost to Follow-up|1|||
146695388|NCT01449526|529061690|FG001|Overall Study|Lost to Follow-up|2|||
146695389|NCT01449526|529061689|FG000|Overall Study|Withdrawal by Subject|1|||
146695390|NCT01449526|529061690|FG001|Overall Study|Withdrawal by Subject|1|||
146695391|NCT01449526|529061689|FG000|Overall Study|Symptoms/complaints|0|||
146695392|NCT01449526|529061690|FG001|Overall Study|Symptoms/complaints|1|||
146695393|NCT01449526|529061689|FG000|Overall Study|Lack of Motivation|0|||
146695394|NCT01449526|529061690|FG001|Overall Study|Lack of Motivation|1|||
146695395|NCT01449526|529061689|FG000|Overall Study|Cannot maintain visits|0|||
146695396|NCT01449526|529061690|FG001|Overall Study|Cannot maintain visits|1|||
146695397|NCT04365556|529061691|FG000|Overall Study|No longer eligible due to treatment plan|1|||
146695398|NCT04365556|529061692|FG001|Overall Study|No longer eligible due to treatment plan|0|||
146695399|NCT04365556|529061691|FG000|Overall Study|Lost to Follow-up|3|||
146695400|NCT04365556|529061692|FG001|Overall Study|Lost to Follow-up|2|||
146695401|NCT00589108|529063115|FG000|Overall Study|Lost to Follow-up|1|||
146695402|NCT00589108|529063116|FG001|Overall Study|Lost to Follow-up|1|||
146695403|NCT00589108|529063117|FG002|Overall Study|Lost to Follow-up|1|||
146695404|NCT00589108|529063115|FG000|Overall Study|Death|3|||
146695405|NCT00589108|529063116|FG001|Overall Study|Death|3|||
146695406|NCT00589108|529063117|FG002|Overall Study|Death|4|||
146695407|NCT03256552|529063118|FG000|Overall Study|Protocol Violation|1|||
146695408|NCT03256552|529063118|FG000|Overall Study|Physician Decision|1|||
146695409|NCT03256552|529063118|FG000|Overall Study|Adverse Event|1|||
146695410|NCT03256552|529063118|FG000|Overall Study|Withdrawal by Subject|2|||
146695411|NCT05083442|529063123|FG000|Overall Study|Lost to Follow-up|1|||
146695412|NCT05083442|529063124|FG001|Overall Study|Lost to Follow-up|0|||
146695413|NCT05083442|529063123|FG000|Overall Study|Lack of Efficacy|0|||
146695414|NCT05083442|529063124|FG001|Overall Study|Lack of Efficacy|1|||
146695415|NCT05083442|529063123|FG000|Overall Study|Withdrawal by Subject|1|||
146695416|NCT05083442|529063124|FG001|Overall Study|Withdrawal by Subject|3|||
146695417|NCT05083442|529063123|FG000|Overall Study|scheduling difficulties|1|||
146695418|NCT05083442|529063124|FG001|Overall Study|scheduling difficulties|2|||
146695419|NCT01933048|529063131|FG000|Overall Study|Lost to Follow-up|15|||
146695420|NCT01933048|529063132|FG001|Overall Study|Lost to Follow-up|18|||
146695421|NCT01933048|529063131|FG000|Overall Study|personal reasons|1|||
146695422|NCT01933048|529063132|FG001|Overall Study|personal reasons|1|||
146695423|NCT01933048|529063131|FG000|Overall Study|Protocol Violation|7|||
146695424|NCT01933048|529063132|FG001|Overall Study|Protocol Violation|8|||
146695425|NCT01933048|529063131|FG000|Overall Study|Physician Decision|1|||
146695426|NCT01933048|529063132|FG001|Overall Study|Physician Decision|0|||
146695427|NCT01933048|529063131|FG000|Overall Study|unknown reasons|1|||
146695428|NCT01933048|529063132|FG001|Overall Study|unknown reasons|1|||
146695429|NCT02780804|529063133|FG000|Overall Study|Death|1|||
146695430|NCT02780804|529063134|FG001|Overall Study|Death|0|||
146695431|NCT02780804|529063135|FG002|Overall Study|Death|0|||
146695432|NCT02780804|529063133|FG000|Overall Study|Lack of Efficacy|5|||
146695433|NCT02780804|529063134|FG001|Overall Study|Lack of Efficacy|8|||
146695434|NCT02780804|529063135|FG002|Overall Study|Lack of Efficacy|4|||
146930237|NCT03970395|529903531|FG001|Overall Study|Withdrawal by Subject|4|||
146930238|NCT03970395|529903530|FG000|Overall Study|Lost to Follow-up|4|||
146695435|NCT02780804|529063133|FG000|Overall Study|Physician Decision|0|||
146695436|NCT02780804|529063134|FG001|Overall Study|Physician Decision|0|||
146695437|NCT02780804|529063135|FG002|Overall Study|Physician Decision|2|||
146695438|NCT02780804|529063133|FG000|Overall Study|Withdrawal by Subject|0|||
146695439|NCT02780804|529063134|FG001|Overall Study|Withdrawal by Subject|1|||
146695440|NCT02780804|529063135|FG002|Overall Study|Withdrawal by Subject|0|||
146695441|NCT02476968|529063136|FG000|Overall Study|Other|0|||
146695442|NCT02476968|529063137|FG001|Overall Study|Other|2|||
146695443|NCT02476968|529063138|FG002|Overall Study|Other|0|||
146695444|NCT02476968|529063136|FG000|Overall Study|Lost to Follow-up|10|||
146695445|NCT02476968|529063137|FG001|Overall Study|Lost to Follow-up|0|||
146695446|NCT02476968|529063138|FG002|Overall Study|Lost to Follow-up|1|||
146695447|NCT02476968|529063136|FG000|Overall Study|Death|48|||
146695448|NCT02476968|529063137|FG001|Overall Study|Death|8|||
146695449|NCT02476968|529063138|FG002|Overall Study|Death|1|||
146695450|NCT02476968|529063136|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146930239|NCT03970395|529903531|FG001|Overall Study|Lost to Follow-up|8|||
146930240|NCT00916370|529903532|FG000|Overall Study|Death|3|||
146930241|NCT00916370|529903533|FG001|Overall Study|Death|1|||
146930242|NCT00916370|529903532|FG000|Overall Study|Withdrawal by Subject|2|||
146930243|NCT00916370|529903533|FG001|Overall Study|Withdrawal by Subject|0|||
146930244|NCT00916370|529903532|FG000|Overall Study|Physician Decision|0|||
146930245|NCT00916370|529903533|FG001|Overall Study|Physician Decision|1|||
146930246|NCT00929734|529903534|FG000|Overall Study|Lost to Follow-up|2|||
146930247|NCT00929734|529903535|FG001|Overall Study|Lost to Follow-up|1|||
146930248|NCT00929734|529903534|FG000|Overall Study|Withdrawal by Subject|0|||
146930249|NCT00929734|529903535|FG001|Overall Study|Withdrawal by Subject|2|||
146930250|NCT00980980|529903536|FG000|Overall Study|Withdrawal by Hospital|0|||
146930251|NCT00980980|529903537|FG001|Overall Study|Withdrawal by Hospital|1|||
146930252|NCT00980980|529903538|FG002|Overall Study|Withdrawal by Hospital|0|||
146930253|NCT02921919|529903540|FG000|Overall Study|Other|5|||
146930254|NCT02921919|529903541|FG001|Overall Study|Other|6|||
146930255|NCT02921919|529903540|FG000|Overall Study|Lost to Follow-up|0|||
146930256|NCT02921919|529903541|FG001|Overall Study|Lost to Follow-up|1|||
146930257|NCT02921919|529903540|FG000|Overall Study|Withdrawal by Subject|5|||
146930258|NCT02921919|529903541|FG001|Overall Study|Withdrawal by Subject|1|||
146930259|NCT02921919|529903540|FG000|Overall Study|Disease Progression|47|||
146930260|NCT02921919|529903541|FG001|Overall Study|Disease Progression|38|||
146930261|NCT02921919|529903540|FG000|Overall Study|Physician Decision|3|||
146930262|NCT02921919|529903541|FG001|Overall Study|Physician Decision|2|||
146930263|NCT02921919|529903540|FG000|Overall Study|Adverse Event|6|||
146930264|NCT02921919|529903541|FG001|Overall Study|Adverse Event|4|||
146930265|NCT02756650|529903542|FG000|Overall Study|Physician Decision|1|||
146930266|NCT02756650|529903542|FG000|Overall Study|Adverse Event|1|||
146930267|NCT01553916|529903543|FG000|Overall Study|Withdrawal by Subject|2|||
146930268|NCT01553916|529903543|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
146930269|NCT04348591|529903546|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
146930270|NCT04348591|529903547|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
146930271|NCT04348591|529903546|FG000|Imaging Session (120 Min)|Physician Decision|0|||
146930272|NCT04348591|529903547|FG001|Imaging Session (120 Min)|Physician Decision|1|||
146930273|NCT04348591|529903546|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
146930274|NCT04348591|529903547|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
146930275|NCT00645567|529903551|FG000|Overall Study|Adverse Event|1|||
146930276|NCT02648724|529903552|FG000|Overall Study|Withdrawal by Subject|0|||
146930277|NCT02648724|529903553|FG001|Overall Study|Withdrawal by Subject|1|||
146930278|NCT02648724|529903554|FG002|Overall Study|Withdrawal by Subject|1|||
146930279|NCT02648724|529903555|FG003|Overall Study|Withdrawal by Subject|0|||
146930280|NCT02648724|529903556|FG004|Overall Study|Withdrawal by Subject|1|||
146930281|NCT02648724|529903557|FG005|Overall Study|Withdrawal by Subject|0|||
146930282|NCT02648724|529903558|FG006|Overall Study|Withdrawal by Subject|0|||
146930283|NCT02648724|529903552|FG000|Overall Study|Progressive disease|2|||
146930284|NCT02648724|529903553|FG001|Overall Study|Progressive disease|2|||
146930285|NCT02648724|529903554|FG002|Overall Study|Progressive disease|2|||
146930286|NCT02648724|529903555|FG003|Overall Study|Progressive disease|3|||
146930287|NCT02648724|529903556|FG004|Overall Study|Progressive disease|22|||
146930288|NCT02648724|529903557|FG005|Overall Study|Progressive disease|7|||
146930289|NCT02648724|529903558|FG006|Overall Study|Progressive disease|8|||
146930290|NCT02648724|529903552|FG000|Overall Study|Other reason (unknown)|1|||
146930291|NCT02648724|529903553|FG001|Overall Study|Other reason (unknown)|0|||
146930292|NCT02648724|529903554|FG002|Overall Study|Other reason (unknown)|0|||
146930293|NCT02648724|529903555|FG003|Overall Study|Other reason (unknown)|0|||
146930294|NCT02648724|529903556|FG004|Overall Study|Other reason (unknown)|0|||
146930295|NCT02648724|529903557|FG005|Overall Study|Other reason (unknown)|0|||
146930296|NCT02648724|529903558|FG006|Overall Study|Other reason (unknown)|0|||
146930297|NCT02648724|529903552|FG000|Overall Study|Protocol Violation|0|||
146930298|NCT02648724|529903553|FG001|Overall Study|Protocol Violation|0|||
146930299|NCT02648724|529903554|FG002|Overall Study|Protocol Violation|0|||
146930300|NCT02648724|529903555|FG003|Overall Study|Protocol Violation|0|||
146930301|NCT02648724|529903556|FG004|Overall Study|Protocol Violation|1|||
146930302|NCT02648724|529903557|FG005|Overall Study|Protocol Violation|0|||
146930303|NCT02648724|529903558|FG006|Overall Study|Protocol Violation|0|||
146930304|NCT02648724|529903552|FG000|Overall Study|Death|0|||
146930305|NCT02648724|529903553|FG001|Overall Study|Death|0|||
146930306|NCT02648724|529903554|FG002|Overall Study|Death|0|||
146930307|NCT02648724|529903555|FG003|Overall Study|Death|0|||
146930308|NCT02648724|529903556|FG004|Overall Study|Death|0|||
146930309|NCT02648724|529903557|FG005|Overall Study|Death|0|||
146930310|NCT02648724|529903558|FG006|Overall Study|Death|3|||
146930311|NCT02648724|529903552|FG000|Overall Study|Physician Decision|0|||
146930312|NCT02648724|529903553|FG001|Overall Study|Physician Decision|0|||
146930313|NCT02648724|529903554|FG002|Overall Study|Physician Decision|0|||
146930314|NCT02648724|529903555|FG003|Overall Study|Physician Decision|0|||
146930315|NCT02648724|529903556|FG004|Overall Study|Physician Decision|1|||
146930316|NCT02648724|529903557|FG005|Overall Study|Physician Decision|0|||
146930317|NCT02648724|529903558|FG006|Overall Study|Physician Decision|1|||
146930318|NCT02648724|529903552|FG000|Overall Study|Transferred to named patient program|0|||
146980476|NCT00606684|530091182|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
146980477|NCT00606684|530091183|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
146980478|NCT00606684|530091184|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
146980479|NCT00606684|530091178|FG000|Double-Blind Treatment Period|Physician Decision|0|||
146980480|NCT00606684|530091179|FG001|Double-Blind Treatment Period|Physician Decision|5|||
146980481|NCT00606684|530091180|FG002|Double-Blind Treatment Period|Physician Decision|1|||
146980482|NCT00606684|530091181|FG003|Double-Blind Treatment Period|Physician Decision|0|||
146980483|NCT00606684|530091182|FG004|Double-Blind Treatment Period|Physician Decision|3|||
146980484|NCT00606684|530091183|FG005|Double-Blind Treatment Period|Physician Decision|1|||
146980485|NCT00606684|530091184|FG006|Double-Blind Treatment Period|Physician Decision|2|||
146980486|NCT00606684|530091178|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146980487|NCT00606684|530091179|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146980488|NCT00606684|530091180|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146980489|NCT00606684|530091181|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
146980490|NCT00606684|530091182|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146980491|NCT00606684|530091183|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
146980492|NCT00606684|530091184|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146980493|NCT01759381|530091187|FG000|Overall Study|Death|1|||
146980494|NCT01759381|530091188|FG001|Overall Study|Death|0|||
146980495|NCT01907737|530091196|FG000|Overall Study|Withdrawal by Subject|1|||
146980496|NCT00909727|530091201|FG000|Overall Study|Adverse Event|1|||
146980497|NCT00909727|530091202|FG001|Overall Study|Adverse Event|0|||
146980498|NCT00909727|530091201|FG000|Overall Study|Wrong Genotype|1|||
146980499|NCT00909727|530091202|FG001|Overall Study|Wrong Genotype|0|||
146980500|NCT00909727|530091201|FG000|Overall Study|Withdrawal of Consent|1|||
146980501|NCT00909727|530091202|FG001|Overall Study|Withdrawal of Consent|0|||
146980502|NCT00909727|530091201|FG000|Overall Study|Prohibited Medication|1|||
146980503|NCT00909727|530091202|FG001|Overall Study|Prohibited Medication|0|||
146980504|NCT00829413|530091207|FG000|Overall Study|No study drug admimnistered|13|||
146980505|NCT00829413|530091207|FG000|Overall Study|Training Patients|67|||
146980506|NCT00829413|530091207|FG000|Overall Study|No truth standard procedure available|9|||
146980507|NCT00829413|530091207|FG000|Overall Study|Technically inadequate truth standard|2|||
146980508|NCT00829413|530091207|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
146695451|NCT02476968|529063137|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146695452|NCT02476968|529063138|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
146695453|NCT02476968|529063136|FG000|Overall Study|Patient decision|37|||
146695454|NCT02476968|529063137|FG001|Overall Study|Patient decision|8|||
146695455|NCT02476968|529063138|FG002|Overall Study|Patient decision|0|||
146695456|NCT01859507|529063139|FG000|Overall Study|left the country|4|||
146695457|NCT04476030|529063140|FG000|Overall Study|Withdrawal by Subject|20|||
146695458|NCT04476030|529063141|FG001|Overall Study|Withdrawal by Subject|16|||
146695459|NCT04476030|529063140|FG000|Overall Study|Adverse Event|10|||
146695460|NCT04476030|529063141|FG001|Overall Study|Adverse Event|11|||
146695461|NCT04476030|529063140|FG000|Overall Study|Lost to Follow-up|7|||
146695462|NCT04476030|529063141|FG001|Overall Study|Lost to Follow-up|4|||
146695463|NCT04476030|529063140|FG000|Overall Study|Physician Decision|1|||
146695464|NCT04476030|529063141|FG001|Overall Study|Physician Decision|1|||
146695465|NCT04476030|529063140|FG000|Overall Study|Protocol Deviation|2|||
146695466|NCT04476030|529063141|FG001|Overall Study|Protocol Deviation|0|||
146695467|NCT04476030|529063140|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
146695468|NCT04476030|529063141|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
146695469|NCT04476030|529063140|FG000|Overall Study|Randomized but not Dosed|2|||
146695470|NCT04476030|529063141|FG001|Overall Study|Randomized but not Dosed|8|||
146695471|NCT02404311|529063142|FG000|Part A: Month 0-18|Death|2|||
146695472|NCT02404311|529063143|FG001|Part A: Month 0-18|Death|0|||
146695473|NCT02404311|529063144|FG002|Part A: Month 0-18|Death|0|||
146695474|NCT02404311|529063145|FG003|Part A: Month 0-18|Death|0|||
146695475|NCT02404311|529063146|FG004|Part A: Month 0-18|Death|0|||
146695476|NCT02404311|529063142|FG000|Part A: Month 0-18|Physician Decision|1|||
146695477|NCT02404311|529063143|FG001|Part A: Month 0-18|Physician Decision|0|||
146695478|NCT02404311|529063144|FG002|Part A: Month 0-18|Physician Decision|0|||
146695479|NCT02404311|529063145|FG003|Part A: Month 0-18|Physician Decision|0|||
146980509|NCT04272775|530091209|FG000|Overall Study|Study Terminated by Sponsor|1|||
146695480|NCT02404311|529063146|FG004|Part A: Month 0-18|Physician Decision|0|||
146695481|NCT02404311|529063142|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
146695482|NCT02404311|529063143|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
146695483|NCT02404311|529063144|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
146695484|NCT02404311|529063145|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
146695485|NCT02404311|529063146|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
146695486|NCT02404311|529063142|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
146980510|NCT04272775|530091210|FG001|Overall Study|Study Terminated by Sponsor|0|||
146980511|NCT04272775|530091209|FG000|Overall Study|Protocol Violation|0|||
146980512|NCT04272775|530091210|FG001|Overall Study|Protocol Violation|1|||
146980513|NCT04272775|530091209|FG000|Overall Study|Symptomatic Deterioration|1|||
146980514|NCT04272775|530091210|FG001|Overall Study|Symptomatic Deterioration|1|||
146980515|NCT04272775|530091209|FG000|Overall Study|Withdrawal by Subject|1|||
146980516|NCT04272775|530091210|FG001|Overall Study|Withdrawal by Subject|2|||
146980517|NCT04272775|530091209|FG000|Overall Study|Adverse Event|1|||
146980518|NCT04272775|530091210|FG001|Overall Study|Adverse Event|2|||
146980519|NCT04272775|530091209|FG000|Overall Study|Progressive Disease|3|||
146980520|NCT04272775|530091210|FG001|Overall Study|Progressive Disease|1|||
146980521|NCT01967888|530091211|FG000|Overall Study|Lost to Follow-up|6|||
146980522|NCT01967888|530091212|FG001|Overall Study|Lost to Follow-up|4|||
146980523|NCT01967888|530091211|FG000|Overall Study|Withdrawal by Subject|1|||
146980524|NCT01967888|530091212|FG001|Overall Study|Withdrawal by Subject|1|||
146980525|NCT01967888|530091211|FG000|Overall Study|Did Not Have Transplant|1|||
146980526|NCT01967888|530091212|FG001|Overall Study|Did Not Have Transplant|0|||
146980527|NCT01967888|530091211|FG000|Overall Study|Research visit not done, data recorded|1|||
146980528|NCT01967888|530091212|FG001|Overall Study|Research visit not done, data recorded|0|||
146980529|NCT01967888|530091211|FG000|Overall Study|Subject excluded after randomization|1|||
146980530|NCT01967888|530091212|FG001|Overall Study|Subject excluded after randomization|0|||
146980531|NCT01967888|530091211|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
146980532|NCT01967888|530091212|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
146980533|NCT01967888|530091211|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
146980534|NCT01967888|530091212|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
146980535|NCT00891774|530091213|FG000|Overall Study|Lost to Follow-up|5|||
146980536|NCT00891774|530091213|FG000|Overall Study|Illness (Self/Mother)|3|||
146980537|NCT00891774|530091213|FG000|Overall Study|Withdrawal by Subject|2|||
146980538|NCT00891774|530091213|FG000|Overall Study|Protocol Violation|4|||
146980539|NCT03175120|530091215|FG000|Overall Study|Adverse Event|2|||
146980540|NCT03175120|530091216|FG001|Overall Study|Adverse Event|2|||
146980541|NCT03175120|530091215|FG000|Overall Study|Protocol Violation|5|||
146980542|NCT03175120|530091216|FG001|Overall Study|Protocol Violation|2|||
146980543|NCT03175120|530091215|FG000|Overall Study|Lost to Follow-up|1|||
146980544|NCT03175120|530091216|FG001|Overall Study|Lost to Follow-up|0|||
146980545|NCT03175120|530091215|FG000|Overall Study|Withdrawal by Subject|2|||
146980546|NCT03175120|530091216|FG001|Overall Study|Withdrawal by Subject|5|||
146980547|NCT03175120|530091215|FG000|Overall Study|Other|2|||
146980548|NCT03175120|530091216|FG001|Overall Study|Other|3|||
146980549|NCT01894984|530091220|FG000|Overall Study|Other|314|||
146980550|NCT01894984|530091221|FG001|Overall Study|Other|175|||
146980551|NCT00827359|530091222|FG000|Overall Study|Progressive Diseas|19|||
146980552|NCT00827359|530091222|FG000|Overall Study|Unacceptable Toxicity|5|||
146980553|NCT00827359|530091222|FG000|Overall Study|Ineligible|1|||
146980554|NCT00323609|530091223|FG000|Overall Study|Death|16|||
146980555|NCT00323609|530091224|FG001|Overall Study|Death|21|||
146980556|NCT00323609|530091225|FG002|Overall Study|Death|0|||
146980557|NCT00323609|530091226|FG003|Overall Study|Death|0|||
146980558|NCT00323609|530091223|FG000|Overall Study|Lost to Follow-up|9|||
146980559|NCT00323609|530091224|FG001|Overall Study|Lost to Follow-up|10|||
146980560|NCT00323609|530091225|FG002|Overall Study|Lost to Follow-up|0|||
146980561|NCT00323609|530091226|FG003|Overall Study|Lost to Follow-up|0|||
146980562|NCT00323609|530091223|FG000|Overall Study|Physician Decision|2|||
146980563|NCT00323609|530091224|FG001|Overall Study|Physician Decision|0|||
146980564|NCT00323609|530091225|FG002|Overall Study|Physician Decision|0|||
146980565|NCT00323609|530091226|FG003|Overall Study|Physician Decision|1|||
146980566|NCT00323609|530091223|FG000|Overall Study|Withdrawal by Subject|11|||
146980567|NCT00323609|530091224|FG001|Overall Study|Withdrawal by Subject|23|||
146980568|NCT00323609|530091225|FG002|Overall Study|Withdrawal by Subject|4|||
146980569|NCT00323609|530091226|FG003|Overall Study|Withdrawal by Subject|4|||
146980570|NCT00323609|530091223|FG000|Overall Study|Other non-VCF-related medical condition|3|||
146980571|NCT00323609|530091224|FG001|Overall Study|Other non-VCF-related medical condition|2|||
146980572|NCT00323609|530091225|FG002|Overall Study|Other non-VCF-related medical condition|0|||
146980573|NCT00323609|530091226|FG003|Overall Study|Other non-VCF-related medical condition|0|||
146695487|NCT02404311|529063143|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
146695488|NCT02404311|529063144|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
146695489|NCT02404311|529063145|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
146695490|NCT02404311|529063146|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
146695491|NCT02404311|529063142|FG000|Part A: Month 0-18|HIV Infection|6|||
146980574|NCT00323609|530091223|FG000|Overall Study|Sponsor discontinued trial|29|||
146980575|NCT00323609|530091224|FG001|Overall Study|Sponsor discontinued trial|29|||
146980576|NCT00323609|530091225|FG002|Overall Study|Sponsor discontinued trial|0|||
146980577|NCT00323609|530091226|FG003|Overall Study|Sponsor discontinued trial|0|||
146980578|NCT00323609|530091223|FG000|Overall Study|Unrelenting or severe back pain|1|||
146980579|NCT00323609|530091224|FG001|Overall Study|Unrelenting or severe back pain|1|||
146980580|NCT00323609|530091225|FG002|Overall Study|Unrelenting or severe back pain|0|||
146980581|NCT00323609|530091226|FG003|Overall Study|Unrelenting or severe back pain|0|||
146980582|NCT00323609|530091223|FG000|Overall Study|Logistical withdrawal|9|||
146980583|NCT00323609|530091224|FG001|Overall Study|Logistical withdrawal|5|||
146695492|NCT02404311|529063143|FG001|Part A: Month 0-18|HIV Infection|2|||
146695493|NCT02404311|529063144|FG002|Part A: Month 0-18|HIV Infection|0|||
146695494|NCT02404311|529063145|FG003|Part A: Month 0-18|HIV Infection|0|||
146695495|NCT02404311|529063146|FG004|Part A: Month 0-18|HIV Infection|0|||
146695496|NCT02404311|529063142|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
146930319|NCT02648724|529903553|FG001|Overall Study|Transferred to named patient program|0|||
146930320|NCT02648724|529903554|FG002|Overall Study|Transferred to named patient program|0|||
146930321|NCT02648724|529903555|FG003|Overall Study|Transferred to named patient program|0|||
146930322|NCT02648724|529903556|FG004|Overall Study|Transferred to named patient program|0|||
146930323|NCT02648724|529903557|FG005|Overall Study|Transferred to named patient program|1|||
146930324|NCT02648724|529903558|FG006|Overall Study|Transferred to named patient program|0|||
146930325|NCT00302718|529903559|FG000|Overall Study|Participant left the hospital|1|||
146930326|NCT00302718|529903560|FG001|Overall Study|Participant left the hospital|0|||
146930327|NCT00302718|529903561|FG002|Overall Study|Participant left the hospital|0|||
146930328|NCT00302718|529903562|FG003|Overall Study|Participant left the hospital|1|||
146930329|NCT00302718|529903559|FG000|Overall Study|Withdrawal by Subject|0|||
146930330|NCT00302718|529903560|FG001|Overall Study|Withdrawal by Subject|1|||
146930331|NCT00302718|529903561|FG002|Overall Study|Withdrawal by Subject|0|||
146930332|NCT00302718|529903562|FG003|Overall Study|Withdrawal by Subject|0|||
146930333|NCT00302718|529903559|FG000|Overall Study|Participant left primary care setting|0|||
146930334|NCT00302718|529903560|FG001|Overall Study|Participant left primary care setting|0|||
146930335|NCT00302718|529903561|FG002|Overall Study|Participant left primary care setting|2|||
146930336|NCT00302718|529903562|FG003|Overall Study|Participant left primary care setting|1|||
146930337|NCT00349752|529903563|FG000|Overall Study|Adverse Event|8|||
146930338|NCT00349752|529903564|FG001|Overall Study|Adverse Event|12|||
146930339|NCT00349752|529903563|FG000|Overall Study|Lack of Efficacy|37|||
146930340|NCT00349752|529903564|FG001|Overall Study|Lack of Efficacy|42|||
146930341|NCT00349752|529903563|FG000|Overall Study|Lost to Follow-up|4|||
146930342|NCT00349752|529903564|FG001|Overall Study|Lost to Follow-up|2|||
146930343|NCT00349752|529903563|FG000|Overall Study|Personal reasons|6|||
146930344|NCT00349752|529903564|FG001|Overall Study|Personal reasons|5|||
146930345|NCT00349752|529903563|FG000|Overall Study|Other: Required exclusionary medication|0|||
146930346|NCT00349752|529903564|FG001|Overall Study|Other: Required exclusionary medication|1|||
146930347|NCT00349752|529903563|FG000|Overall Study|Other: Non compliance|0|||
146930348|NCT00349752|529903564|FG001|Overall Study|Other: Non compliance|1|||
146930349|NCT00349752|529903563|FG000|Overall Study|Other: Patient stopped steroids|0|||
146930350|NCT00349752|529903564|FG001|Overall Study|Other: Patient stopped steroids|1|||
146930351|NCT00349752|529903563|FG000|Overall Study|Other: Patient's steroid use|1|||
146930352|NCT00349752|529903564|FG001|Overall Study|Other: Patient's steroid use|0|||
146930353|NCT00349752|529903563|FG000|Overall Study|Other: Ineligible|1|||
146930354|NCT00349752|529903564|FG001|Overall Study|Other: Ineligible|0|||
146930355|NCT00349752|529903563|FG000|Overall Study|Other: Inadvertently unblinded|1|||
146930356|NCT00349752|529903564|FG001|Overall Study|Other: Inadvertently unblinded|0|||
146930357|NCT00349752|529903563|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
146930358|NCT00349752|529903564|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
146930359|NCT00819585|529903565|FG000|Core Study|Adverse Event|2|||
146930360|NCT00819585|529903566|FG001|Core Study|Adverse Event|1|||
146930361|NCT00819585|529903567|FG002|Core Study|Adverse Event|1|||
146930362|NCT00819585|529903568|FG003|Core Study|Adverse Event|4|||
146930363|NCT00819585|529903569|FG004|Core Study|Adverse Event|1|||
146930364|NCT00819585|529903570|FG005|Core Study|Adverse Event|0|||
146930365|NCT00819585|529903571|FG006|Core Study|Adverse Event|2|||
146930366|NCT00819585|529903572|FG007|Core Study|Adverse Event|0|||
146930367|NCT00819585|529903573|FG008|Core Study|Adverse Event|0|||
146930368|NCT00819585|529903574|FG009|Core Study|Adverse Event|0|||
146930369|NCT00819585|529903575|FG010|Core Study|Adverse Event|0|||
146930370|NCT00819585|529903565|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
146930371|NCT00819585|529903566|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
146930372|NCT00819585|529903567|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
146930373|NCT00819585|529903568|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
146930374|NCT00819585|529903569|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
146930375|NCT00819585|529903570|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
146695497|NCT02404311|529063143|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
146695498|NCT02404311|529063144|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
146930376|NCT00819585|529903571|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
146930377|NCT00819585|529903572|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
146930378|NCT00819585|529903573|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
146930379|NCT00819585|529903574|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
146930380|NCT00819585|529903575|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
146930381|NCT00819585|529903565|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
146930382|NCT00819585|529903566|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
146930383|NCT00819585|529903567|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
146930384|NCT00819585|529903568|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
146930385|NCT00819585|529903569|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
146695499|NCT02404311|529063145|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
146695500|NCT02404311|529063146|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
146695501|NCT02256891|529063151|FG000|Overall Study|Death|0|||
146695502|NCT02256891|529063152|FG001|Overall Study|Death|2|||
146695503|NCT02256891|529063151|FG000|Overall Study|Lost to Follow-up|0|||
146695504|NCT02256891|529063152|FG001|Overall Study|Lost to Follow-up|3|||
146695505|NCT02256891|529063151|FG000|Overall Study|Physician Decision|7|||
146695506|NCT02256891|529063152|FG001|Overall Study|Physician Decision|3|||
146695507|NCT02256891|529063151|FG000|Overall Study|Screen Fail|5|||
146695508|NCT02256891|529063152|FG001|Overall Study|Screen Fail|4|||
146695509|NCT02256891|529063151|FG000|Overall Study|Equipment Malfunction|0|||
146695510|NCT02256891|529063152|FG001|Overall Study|Equipment Malfunction|1|||
146695511|NCT04171414|529063161|FG000|Overall Study|Death|1|||
146695512|NCT04171414|529063161|FG000|Overall Study|Withdrawal by Subject|1|||
146695513|NCT04920123|529063166|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
146695514|NCT04920123|529063167|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
146695515|NCT04920123|529063168|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
146695516|NCT00218296|529063174|FG000|Overall Study|Lost to Follow-up|9|||
146695517|NCT00218296|529063175|FG001|Overall Study|Lost to Follow-up|7|||
146695518|NCT00218296|529063174|FG000|Overall Study|Withdrawal by Subject|36|||
146695519|NCT00218296|529063175|FG001|Overall Study|Withdrawal by Subject|47|||
146695520|NCT00218296|529063174|FG000|Overall Study|Randomized but did not enter treatment|66|||
146695521|NCT00218296|529063175|FG001|Overall Study|Randomized but did not enter treatment|67|||
146695522|NCT02586493|529063180|FG000|Overall Study|Adverse Event|4|||
146695523|NCT02586493|529063180|FG000|Overall Study|Protocol Violation|6|||
146695524|NCT02586493|529063180|FG000|Overall Study|Lost to Follow-up|1|||
146695525|NCT02586493|529063180|FG000|Overall Study|Withdrawal by Subject|1|||
146695526|NCT06134817|529063187|FG000|Overall Study|Physician Departure - termination of study|1|||
146695527|NCT00278954|529063188|FG000|Overall Study|Adverse Event|3|||
146695528|NCT00278954|529063188|FG000|Overall Study|Lost to Follow-up|1|||
146695529|NCT00278954|529063188|FG000|Overall Study|Withdrawal by Subject|1|||
146695530|NCT02211131|529063204|FG000|Overall Study|Death|26|||
146695531|NCT02211131|529063205|FG001|Overall Study|Death|16|||
146695532|NCT02211131|529063204|FG000|Overall Study|Lost to Follow-up|4|||
146695533|NCT02211131|529063205|FG001|Overall Study|Lost to Follow-up|3|||
146695534|NCT02211131|529063204|FG000|Overall Study|Decision by Sponsor|1|||
146695535|NCT02211131|529063205|FG001|Overall Study|Decision by Sponsor|1|||
146695536|NCT02211131|529063204|FG000|Overall Study|Withdrawal by Subject|3|||
146695537|NCT02211131|529063205|FG001|Overall Study|Withdrawal by Subject|8|||
146695538|NCT05664490|529063207|FG000|Overall Study|Withdrawal by Subject|0|||
146695539|NCT05664490|529063208|FG001|Overall Study|Withdrawal by Subject|1|||
146695540|NCT05664490|529063207|FG000|Overall Study|Lost to Follow-up|14|||
146695541|NCT05664490|529063208|FG001|Overall Study|Lost to Follow-up|22|||
146695542|NCT05442554|529063209|FG000|Overall Study|Adverse Event|1|||
146695543|NCT01990495|529063217|FG000|Overall Study|Physician Decision|5|||
146695544|NCT01990495|529063218|FG001|Overall Study|Physician Decision|4|||
146695545|NCT01478321|529063219|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
146695546|NCT01478321|529063219|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
146695547|NCT01478321|529063219|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
146695548|NCT01478321|529063219|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
146695549|NCT01478321|529063219|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
146695550|NCT01478321|529063219|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
146695551|NCT01478321|529063219|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
146695552|NCT01478321|529063219|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
146695553|NCT02965703|529063229|FG000|Overall Study|Withdrawal by Subject|6|||
146695554|NCT02965703|529063230|FG001|Overall Study|Withdrawal by Subject|3|||
146695555|NCT02965703|529063231|FG002|Overall Study|Withdrawal by Subject|1|||
146695556|NCT02965703|529063229|FG000|Overall Study|Protocol Violation|1|||
146695557|NCT02965703|529063230|FG001|Overall Study|Protocol Violation|0|||
146695558|NCT02965703|529063231|FG002|Overall Study|Protocol Violation|0|||
146695559|NCT02965703|529063229|FG000|Overall Study|Adverse Event|1|||
146695560|NCT02965703|529063230|FG001|Overall Study|Adverse Event|1|||
146695561|NCT02965703|529063231|FG002|Overall Study|Adverse Event|0|||
146695562|NCT02965703|529063229|FG000|Overall Study|Lost to Follow-up|2|||
146695563|NCT02965703|529063230|FG001|Overall Study|Lost to Follow-up|1|||
146776010|NCT02590432|529351238|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
146695564|NCT02965703|529063231|FG002|Overall Study|Lost to Follow-up|1|||
146695565|NCT01471379|529063232|FG000|Overall Study|Adverse Event|1|||
146776011|NCT02590432|529351239|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
146695566|NCT01471379|529063233|FG001|Overall Study|Adverse Event|0|||
146695567|NCT01471379|529063234|FG002|Overall Study|Adverse Event|0|||
146695568|NCT01471379|529063232|FG000|Overall Study|Study terminated|0|||
146695569|NCT01471379|529063233|FG001|Overall Study|Study terminated|1|||
146695570|NCT01471379|529063234|FG002|Overall Study|Study terminated|0|||
146695571|NCT03745144|529063235|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
146695572|NCT03745144|529063236|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
146695573|NCT03745144|529063237|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
146695574|NCT03745144|529063235|FG000|Period 1|Other|0|||
146695575|NCT03745144|529063236|FG001|Period 1|Other|0|||
146695576|NCT03745144|529063237|FG002|Period 1|Other|1|||
146695577|NCT01124643|529063248|FG000|Overall Study|Death|1|||
146695578|NCT02678676|529063249|FG000|Overall Study|Death|619|||
146695579|NCT02678676|529063250|FG001|Overall Study|Death|649|||
146695580|NCT02678676|529063249|FG000|Overall Study|Withdrawal by Subject|13|||
146695581|NCT02678676|529063250|FG001|Overall Study|Withdrawal by Subject|5|||
146695582|NCT02678676|529063249|FG000|Overall Study|Lost to Follow-up|171|||
146695583|NCT02678676|529063250|FG001|Overall Study|Lost to Follow-up|151|||
146695584|NCT02678676|529063249|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
146695585|NCT02678676|529063250|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
146695586|NCT01342510|529063251|FG000|Overall Study|Protocol Violation|12|||
146695587|NCT01342510|529063252|FG001|Overall Study|Protocol Violation|6|||
146695588|NCT01342510|529063253|FG002|Overall Study|Protocol Violation|13|||
146695589|NCT01342510|529063254|FG003|Overall Study|Protocol Violation|11|||
146695590|NCT05756790|529063255|FG000|Overall Study|Withdrawal by Subject|1|||
146695591|NCT05756790|529063256|FG001|Overall Study|Withdrawal by Subject|1|||
146695592|NCT05756790|529063257|FG002|Overall Study|Withdrawal by Subject|1|||
146695593|NCT05756790|529063258|FG003|Overall Study|Withdrawal by Subject|1|||
146695594|NCT05756790|529063259|FG004|Overall Study|Withdrawal by Subject|0|||
146695595|NCT05756790|529063260|FG005|Overall Study|Withdrawal by Subject|0|||
146695596|NCT05756790|529063255|FG000|Overall Study|Protocol Violation|0|||
146695597|NCT05756790|529063256|FG001|Overall Study|Protocol Violation|0|||
146695598|NCT05756790|529063257|FG002|Overall Study|Protocol Violation|1|||
146695599|NCT05756790|529063258|FG003|Overall Study|Protocol Violation|1|||
146695600|NCT05756790|529063259|FG004|Overall Study|Protocol Violation|0|||
146695601|NCT05756790|529063260|FG005|Overall Study|Protocol Violation|0|||
146695602|NCT05756790|529063255|FG000|Overall Study|Ineligible|0|||
146695603|NCT05756790|529063256|FG001|Overall Study|Ineligible|0|||
146695604|NCT05756790|529063257|FG002|Overall Study|Ineligible|0|||
146695605|NCT05756790|529063258|FG003|Overall Study|Ineligible|0|||
146695606|NCT05756790|529063259|FG004|Overall Study|Ineligible|2|||
146695607|NCT05756790|529063260|FG005|Overall Study|Ineligible|2|||
146695608|NCT02181556|529065130|FG000|Overall Study|Withdrawal by Subject|1|||
146695609|NCT01023581|529065135|FG000|Overall Study|Adverse Event|4|||
146695610|NCT01023581|529065136|FG001|Overall Study|Adverse Event|4|||
146695611|NCT01023581|529065137|FG002|Overall Study|Adverse Event|7|||
146695612|NCT01023581|529065138|FG003|Overall Study|Adverse Event|3|||
146695613|NCT01023581|529065139|FG004|Overall Study|Adverse Event|2|||
146695614|NCT01023581|529065140|FG005|Overall Study|Adverse Event|5|||
146695615|NCT01023581|529065141|FG006|Overall Study|Adverse Event|11|||
146695616|NCT01023581|529065135|FG000|Overall Study|Major protocol deviation|2|||
146695617|NCT01023581|529065136|FG001|Overall Study|Major protocol deviation|0|||
146695618|NCT01023581|529065137|FG002|Overall Study|Major protocol deviation|3|||
146695619|NCT01023581|529065138|FG003|Overall Study|Major protocol deviation|0|||
146695620|NCT01023581|529065139|FG004|Overall Study|Major protocol deviation|0|||
146695621|NCT01023581|529065140|FG005|Overall Study|Major protocol deviation|0|||
146930386|NCT00819585|529903570|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
146930387|NCT00819585|529903571|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
146930388|NCT00819585|529903572|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
146930389|NCT00819585|529903573|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
146930390|NCT00819585|529903574|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
146930391|NCT00819585|529903575|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
146930392|NCT00819585|529903565|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
146930393|NCT00819585|529903566|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
146930394|NCT00819585|529903567|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
146930395|NCT00819585|529903568|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
146930396|NCT00819585|529903569|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
146930397|NCT00819585|529903570|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
146930398|NCT00819585|529903571|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
146930399|NCT00819585|529903572|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
146930400|NCT00819585|529903573|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
146930401|NCT00819585|529903574|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
146930402|NCT00819585|529903575|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
146930403|NCT00819585|529903565|FG000|Core Study|Subject Withdrew Consent|0|||
146695622|NCT01023581|529065141|FG006|Overall Study|Major protocol deviation|0|||
146695623|NCT01023581|529065135|FG000|Overall Study|Lost to Follow-up|4|||
146695624|NCT01023581|529065136|FG001|Overall Study|Lost to Follow-up|8|||
146930404|NCT00819585|529903566|FG001|Core Study|Subject Withdrew Consent|3|||
146930405|NCT00819585|529903567|FG002|Core Study|Subject Withdrew Consent|2|||
146930406|NCT00819585|529903568|FG003|Core Study|Subject Withdrew Consent|1|||
146695625|NCT01023581|529065137|FG002|Overall Study|Lost to Follow-up|7|||
146695626|NCT01023581|529065138|FG003|Overall Study|Lost to Follow-up|2|||
146695627|NCT01023581|529065139|FG004|Overall Study|Lost to Follow-up|5|||
146695628|NCT01023581|529065140|FG005|Overall Study|Lost to Follow-up|2|||
146695629|NCT01023581|529065141|FG006|Overall Study|Lost to Follow-up|2|||
146695630|NCT01023581|529065135|FG000|Overall Study|Withdrawal by Subject|13|||
146695631|NCT01023581|529065136|FG001|Overall Study|Withdrawal by Subject|8|||
146695632|NCT01023581|529065137|FG002|Overall Study|Withdrawal by Subject|16|||
146695633|NCT01023581|529065138|FG003|Overall Study|Withdrawal by Subject|10|||
146695634|NCT01023581|529065139|FG004|Overall Study|Withdrawal by Subject|6|||
146695635|NCT01023581|529065140|FG005|Overall Study|Withdrawal by Subject|8|||
146695636|NCT01023581|529065141|FG006|Overall Study|Withdrawal by Subject|5|||
146695637|NCT01023581|529065135|FG000|Overall Study|Pregnancy|0|||
146695638|NCT01023581|529065136|FG001|Overall Study|Pregnancy|0|||
146695639|NCT01023581|529065137|FG002|Overall Study|Pregnancy|0|||
146695640|NCT01023581|529065138|FG003|Overall Study|Pregnancy|2|||
146930407|NCT00819585|529903569|FG004|Core Study|Subject Withdrew Consent|0|||
146930408|NCT00819585|529903570|FG005|Core Study|Subject Withdrew Consent|0|||
146930409|NCT00819585|529903571|FG006|Core Study|Subject Withdrew Consent|3|||
146930410|NCT00819585|529903572|FG007|Core Study|Subject Withdrew Consent|0|||
146695641|NCT01023581|529065139|FG004|Overall Study|Pregnancy|0|||
146695642|NCT01023581|529065140|FG005|Overall Study|Pregnancy|1|||
146695643|NCT01023581|529065141|FG006|Overall Study|Pregnancy|0|||
146695644|NCT01023581|529065135|FG000|Overall Study|Lack of Efficacy|9|||
146695645|NCT01023581|529065136|FG001|Overall Study|Lack of Efficacy|3|||
146695646|NCT01023581|529065137|FG002|Overall Study|Lack of Efficacy|6|||
146695647|NCT01023581|529065138|FG003|Overall Study|Lack of Efficacy|2|||
146695648|NCT01023581|529065139|FG004|Overall Study|Lack of Efficacy|1|||
146695649|NCT01023581|529065140|FG005|Overall Study|Lack of Efficacy|2|||
146695650|NCT01023581|529065141|FG006|Overall Study|Lack of Efficacy|1|||
146695651|NCT01023581|529065135|FG000|Overall Study|Physician Decision|2|||
146695652|NCT01023581|529065136|FG001|Overall Study|Physician Decision|0|||
146695653|NCT01023581|529065137|FG002|Overall Study|Physician Decision|2|||
146695654|NCT01023581|529065138|FG003|Overall Study|Physician Decision|1|||
146695655|NCT01023581|529065139|FG004|Overall Study|Physician Decision|1|||
146695656|NCT01023581|529065140|FG005|Overall Study|Physician Decision|1|||
146695657|NCT01023581|529065141|FG006|Overall Study|Physician Decision|1|||
146695658|NCT01023581|529065135|FG000|Overall Study|Other|1|||
146695659|NCT01023581|529065136|FG001|Overall Study|Other|0|||
146695660|NCT01023581|529065137|FG002|Overall Study|Other|1|||
146695661|NCT01023581|529065138|FG003|Overall Study|Other|0|||
146695662|NCT01023581|529065139|FG004|Overall Study|Other|1|||
146695663|NCT01023581|529065140|FG005|Overall Study|Other|0|||
146695664|NCT01023581|529065141|FG006|Overall Study|Other|0|||
146695665|NCT01176292|529065142|FG000|Overall Study|Lost to Follow-up|2|||
146695666|NCT01176292|529065143|FG001|Overall Study|Lost to Follow-up|4|||
146695667|NCT01176292|529065142|FG000|Overall Study|Adverse Event|1|||
146695668|NCT01176292|529065143|FG001|Overall Study|Adverse Event|1|||
146695669|NCT01176292|529065142|FG000|Overall Study|Physician Decision|0|||
146695670|NCT01176292|529065143|FG001|Overall Study|Physician Decision|2|||
146695671|NCT01176292|529065142|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
146695672|NCT01176292|529065143|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
146695673|NCT00997503|529065144|FG000|Overall Study|Death|53|||
146695674|NCT00997503|529065144|FG000|Overall Study|Withdrawal by Subject|76|||
146695675|NCT00997503|529065144|FG000|Overall Study|Lost to Follow-up|33|||
146776012|NCT02590432|529351240|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
146930411|NCT00819585|529903573|FG008|Core Study|Subject Withdrew Consent|0|||
146930412|NCT00819585|529903574|FG009|Core Study|Subject Withdrew Consent|0|||
146930413|NCT00819585|529903575|FG010|Core Study|Subject Withdrew Consent|0|||
146930414|NCT00819585|529903565|FG000|Core Study|Lost to Follow-up|2|||
146930415|NCT00819585|529903566|FG001|Core Study|Lost to Follow-up|1|||
146930416|NCT00819585|529903567|FG002|Core Study|Lost to Follow-up|2|||
146930417|NCT00819585|529903568|FG003|Core Study|Lost to Follow-up|0|||
146930418|NCT00819585|529903569|FG004|Core Study|Lost to Follow-up|1|||
146930419|NCT00819585|529903570|FG005|Core Study|Lost to Follow-up|1|||
146930420|NCT00819585|529903571|FG006|Core Study|Lost to Follow-up|1|||
146695676|NCT00997503|529065144|FG000|Overall Study|Adverse Event|3|||
146695677|NCT00997503|529065144|FG000|Overall Study|Physician Decision|10|||
146695678|NCT00997503|529065144|FG000|Overall Study|Missed 12-month follow-up|85|||
146695679|NCT00997503|529065144|FG000|Overall Study|Other reason|13|||
146695680|NCT00380393|529065145|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
146695681|NCT00380393|529065146|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
146695682|NCT00380393|529065145|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
146695683|NCT00380393|529065146|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
146695684|NCT00380393|529065145|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
146695685|NCT00380393|529065146|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
146695686|NCT00380393|529065145|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
146695687|NCT00380393|529065146|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
146695688|NCT00380393|529065145|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
146695689|NCT00380393|529065146|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
146930421|NCT00819585|529903572|FG007|Core Study|Lost to Follow-up|0|||
146930422|NCT00819585|529903573|FG008|Core Study|Lost to Follow-up|0|||
146930423|NCT00819585|529903574|FG009|Core Study|Lost to Follow-up|0|||
146930424|NCT00819585|529903575|FG010|Core Study|Lost to Follow-up|0|||
146695690|NCT00380393|529065145|FG000|Month 14|Withdrawal by Subject|9|||
146695691|NCT00380393|529065146|FG001|Month 14|Withdrawal by Subject|7|||
146695692|NCT00380393|529065145|FG000|Month 14|Death|1|||
146695693|NCT00380393|529065146|FG001|Month 14|Death|0|||
146930425|NCT00819585|529903565|FG000|Core Study|Administrative Problems|0|||
146930426|NCT00819585|529903566|FG001|Core Study|Administrative Problems|0|||
146930427|NCT00819585|529903567|FG002|Core Study|Administrative Problems|0|||
146930428|NCT00819585|529903568|FG003|Core Study|Administrative Problems|0|||
146930429|NCT00819585|529903569|FG004|Core Study|Administrative Problems|0|||
146930430|NCT00819585|529903570|FG005|Core Study|Administrative Problems|0|||
146930431|NCT00819585|529903571|FG006|Core Study|Administrative Problems|2|||
146930432|NCT00819585|529903572|FG007|Core Study|Administrative Problems|0|||
146930433|NCT00819585|529903573|FG008|Core Study|Administrative Problems|0|||
146930434|NCT00819585|529903574|FG009|Core Study|Administrative Problems|0|||
146930435|NCT00819585|529903575|FG010|Core Study|Administrative Problems|0|||
146930436|NCT00819585|529903565|FG000|Core Study|Death|0|||
146930437|NCT00819585|529903566|FG001|Core Study|Death|0|||
146930438|NCT00819585|529903567|FG002|Core Study|Death|0|||
146930439|NCT00819585|529903568|FG003|Core Study|Death|0|||
146930440|NCT00819585|529903569|FG004|Core Study|Death|0|||
146930441|NCT00819585|529903570|FG005|Core Study|Death|0|||
146930442|NCT00819585|529903571|FG006|Core Study|Death|1|||
146930443|NCT00819585|529903572|FG007|Core Study|Death|0|||
146930444|NCT00819585|529903573|FG008|Core Study|Death|0|||
146930445|NCT00819585|529903574|FG009|Core Study|Death|0|||
146930446|NCT00819585|529903575|FG010|Core Study|Death|0|||
146930447|NCT00819585|529903565|FG000|Core Study|Protocol Violation|0|||
146930448|NCT00819585|529903566|FG001|Core Study|Protocol Violation|0|||
146930449|NCT00819585|529903567|FG002|Core Study|Protocol Violation|1|||
146930450|NCT00819585|529903568|FG003|Core Study|Protocol Violation|0|||
146930451|NCT00819585|529903569|FG004|Core Study|Protocol Violation|0|||
146930452|NCT00819585|529903570|FG005|Core Study|Protocol Violation|1|||
146930453|NCT00819585|529903571|FG006|Core Study|Protocol Violation|3|||
146930454|NCT00819585|529903572|FG007|Core Study|Protocol Violation|0|||
146930455|NCT00819585|529903573|FG008|Core Study|Protocol Violation|0|||
146930456|NCT00819585|529903574|FG009|Core Study|Protocol Violation|0|||
146930457|NCT00819585|529903575|FG010|Core Study|Protocol Violation|0|||
146930458|NCT00819585|529903565|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
146930459|NCT00819585|529903566|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
146930460|NCT00819585|529903567|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
146930461|NCT00819585|529903568|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
146930462|NCT00819585|529903569|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
146930463|NCT00819585|529903570|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
146930464|NCT00819585|529903571|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
146930465|NCT00819585|529903572|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
146930466|NCT00819585|529903573|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
146930467|NCT00819585|529903574|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
146930468|NCT00819585|529903575|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
146930469|NCT00819585|529903565|FG000|Extension Study|Subject Withdrew Consent|0|||
146930470|NCT00819585|529903566|FG001|Extension Study|Subject Withdrew Consent|0|||
146930471|NCT00819585|529903567|FG002|Extension Study|Subject Withdrew Consent|0|||
146930472|NCT00819585|529903568|FG003|Extension Study|Subject Withdrew Consent|0|||
146930473|NCT00819585|529903569|FG004|Extension Study|Subject Withdrew Consent|0|||
146930474|NCT00819585|529903570|FG005|Extension Study|Subject Withdrew Consent|0|||
146930475|NCT00819585|529903571|FG006|Extension Study|Subject Withdrew Consent|0|||
146695694|NCT00380393|529065145|FG000|Month 14|Lost to Follow-up|0|||
146695695|NCT00380393|529065146|FG001|Month 14|Lost to Follow-up|1|||
146695696|NCT00380393|529065145|FG000|Month 14|Migrated/moved from study area|39|||
146930476|NCT00819585|529903572|FG007|Extension Study|Subject Withdrew Consent|0|||
146930477|NCT00819585|529903573|FG008|Extension Study|Subject Withdrew Consent|3|||
146930478|NCT00819585|529903574|FG009|Extension Study|Subject Withdrew Consent|0|||
146930479|NCT00819585|529903575|FG010|Extension Study|Subject Withdrew Consent|1|||
146930480|NCT00819585|529903565|FG000|Extension Study|Lost to Follow-up|0|||
146930481|NCT00819585|529903566|FG001|Extension Study|Lost to Follow-up|0|||
146930482|NCT00819585|529903567|FG002|Extension Study|Lost to Follow-up|0|||
146930483|NCT00819585|529903568|FG003|Extension Study|Lost to Follow-up|0|||
146930484|NCT00819585|529903569|FG004|Extension Study|Lost to Follow-up|0|||
146930485|NCT00819585|529903570|FG005|Extension Study|Lost to Follow-up|0|||
146930486|NCT00819585|529903571|FG006|Extension Study|Lost to Follow-up|0|||
146930487|NCT00819585|529903572|FG007|Extension Study|Lost to Follow-up|0|||
146930488|NCT00819585|529903573|FG008|Extension Study|Lost to Follow-up|2|||
146930489|NCT00819585|529903574|FG009|Extension Study|Lost to Follow-up|1|||
146930490|NCT00819585|529903575|FG010|Extension Study|Lost to Follow-up|1|||
146930491|NCT00819585|529903565|FG000|Extension Study|Death|0|||
146930492|NCT00819585|529903566|FG001|Extension Study|Death|0|||
146930493|NCT00819585|529903567|FG002|Extension Study|Death|0|||
146930494|NCT00819585|529903568|FG003|Extension Study|Death|0|||
146930495|NCT00819585|529903569|FG004|Extension Study|Death|0|||
146695697|NCT00380393|529065146|FG001|Month 14|Migrated/moved from study area|42|||
146930496|NCT00819585|529903570|FG005|Extension Study|Death|0|||
146695698|NCT00380393|529065145|FG000|Month 14|Protocol Violation|2|||
146695699|NCT00380393|529065146|FG001|Month 14|Protocol Violation|0|||
146695700|NCT00380393|529065145|FG000|Month 14|Others|6|||
146695701|NCT00380393|529065146|FG001|Month 14|Others|6|||
146695702|NCT03412084|529065147|FG000|Overall Study|Withdrawal by Subject|2|||
146695703|NCT03412084|529065148|FG001|Overall Study|Withdrawal by Subject|0|||
146695704|NCT03412084|529065147|FG000|Overall Study|Participant moved|1|||
146695705|NCT03412084|529065148|FG001|Overall Study|Participant moved|0|||
146695706|NCT03412084|529065147|FG000|Overall Study|Lost to Follow-up|1|||
146695707|NCT03412084|529065148|FG001|Overall Study|Lost to Follow-up|1|||
146695708|NCT01928862|529065149|FG000|Overall Study|Lost to Follow-up|1|||
146695709|NCT01928862|529065150|FG001|Overall Study|Lost to Follow-up|0|||
146695710|NCT01928862|529065151|FG002|Overall Study|Lost to Follow-up|0|||
146695711|NCT01928862|529065152|FG003|Overall Study|Lost to Follow-up|0|||
146695712|NCT01928862|529065153|FG004|Overall Study|Lost to Follow-up|1|||
146695713|NCT02053753|529065157|FG000|Overall Study|Withdrawal by Subject|2|||
146695714|NCT02053753|529065158|FG001|Overall Study|Withdrawal by Subject|4|||
146695715|NCT02053753|529065157|FG000|Overall Study|Decision by Sponsor|1|||
146695716|NCT02053753|529065158|FG001|Overall Study|Decision by Sponsor|1|||
146695717|NCT02053753|529065157|FG000|Overall Study|Lost to Follow-up|4|||
146695718|NCT02053753|529065158|FG001|Overall Study|Lost to Follow-up|3|||
146695719|NCT02972632|529065159|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
146695720|NCT02972632|529065159|FG000|Overall Study|Lost to Follow-up|4|||
146695721|NCT02972632|529065159|FG000|Overall Study|Voluntary Withdrawal|10|||
146695722|NCT02023151|529065160|FG000|Overall Study|Lost to Follow-up|4|||
146695723|NCT04064294|529065161|FG000|Overall Study|Adverse Event|1|||
146695724|NCT04064294|529065162|FG001|Overall Study|Adverse Event|0|||
146695725|NCT04064294|529065163|FG002|Overall Study|Adverse Event|0|||
146695726|NCT03450707|529065164|FG000|Overall Study|Outside enrollment window|4|||
146695727|NCT03450707|529065165|FG001|Overall Study|Outside enrollment window|1|||
146695728|NCT03450707|529065164|FG000|Overall Study|Death|1|||
146695729|NCT03450707|529065165|FG001|Overall Study|Death|0|||
146695730|NCT03450707|529065164|FG000|Overall Study|Indication for thiamine|1|||
146695731|NCT03450707|529065165|FG001|Overall Study|Indication for thiamine|1|||
146695732|NCT03450707|529065164|FG000|Overall Study|Evidence of traumatic brain injury|1|||
146695733|NCT03450707|529065165|FG001|Overall Study|Evidence of traumatic brain injury|0|||
146695734|NCT03450707|529065164|FG000|Overall Study|Following commands|0|||
146695735|NCT03450707|529065165|FG001|Overall Study|Following commands|3|||
146695736|NCT03450707|529065164|FG000|Overall Study|Lactate < 3.5|0|||
146695737|NCT03450707|529065165|FG001|Overall Study|Lactate < 3.5|2|||
146695738|NCT03450707|529065164|FG000|Overall Study|Rearrest with ECMO|0|||
146695739|NCT03450707|529065165|FG001|Overall Study|Rearrest with ECMO|1|||
146695740|NCT03450707|529065164|FG000|Overall Study|Indication for thiamine + head CT results|0|||
146695741|NCT03450707|529065165|FG001|Overall Study|Indication for thiamine + head CT results|1|||
146695742|NCT03450707|529065164|FG000|Overall Study|Family/patient goals of care|0|||
146695743|NCT03450707|529065165|FG001|Overall Study|Family/patient goals of care|1|||
146695744|NCT00481195|529065166|FG000|Overall Study|Adverse Event|16|||
146695745|NCT00481195|529065167|FG001|Overall Study|Adverse Event|11|||
146695746|NCT00481195|529065166|FG000|Overall Study|Lack of Efficacy|1|||
146695747|NCT00481195|529065167|FG001|Overall Study|Lack of Efficacy|3|||
146695748|NCT00481195|529065166|FG000|Overall Study|Lost to Follow-up|4|||
146695749|NCT00481195|529065167|FG001|Overall Study|Lost to Follow-up|6|||
146695750|NCT00481195|529065166|FG000|Overall Study|Physician Decision|3|||
146695751|NCT00481195|529065167|FG001|Overall Study|Physician Decision|1|||
146695752|NCT00481195|529065166|FG000|Overall Study|Protocol Violation|10|||
146695753|NCT00481195|529065167|FG001|Overall Study|Protocol Violation|7|||
146695754|NCT00481195|529065166|FG000|Overall Study|Withdrawal by Subject|3|||
146695755|NCT00481195|529065167|FG001|Overall Study|Withdrawal by Subject|9|||
146695756|NCT00481195|529065166|FG000|Overall Study|Miscellaneous|2|||
146695757|NCT00481195|529065167|FG001|Overall Study|Miscellaneous|2|||
146695758|NCT02932904|529065174|FG000|Overall Study|Reason not Specified|1|||
146695759|NCT02932904|529065175|FG001|Overall Study|Reason not Specified|0|||
146695760|NCT02932904|529065176|FG002|Overall Study|Reason not Specified|2|||
146695761|NCT02932904|529065177|FG003|Overall Study|Reason not Specified|2|||
146695762|NCT02932904|529065174|FG000|Overall Study|Noncompliance with Study Drug|2|||
146695763|NCT02932904|529065175|FG001|Overall Study|Noncompliance with Study Drug|3|||
146695764|NCT02932904|529065176|FG002|Overall Study|Noncompliance with Study Drug|3|||
146695765|NCT02932904|529065177|FG003|Overall Study|Noncompliance with Study Drug|4|||
146695766|NCT02932904|529065174|FG000|Overall Study|Pregnancy|0|||
146695767|NCT02932904|529065175|FG001|Overall Study|Pregnancy|1|||
146695768|NCT02932904|529065176|FG002|Overall Study|Pregnancy|1|||
146695769|NCT02932904|529065177|FG003|Overall Study|Pregnancy|0|||
146695770|NCT02932904|529065174|FG000|Overall Study|Study Termination|0|||
146695771|NCT02932904|529065175|FG001|Overall Study|Study Termination|1|||
146695772|NCT02932904|529065176|FG002|Overall Study|Study Termination|0|||
146695773|NCT02932904|529065177|FG003|Overall Study|Study Termination|0|||
146695774|NCT02932904|529065174|FG000|Overall Study|Voluntary Withdrawal|2|||
146695775|NCT02932904|529065175|FG001|Overall Study|Voluntary Withdrawal|1|||
146695776|NCT02932904|529065176|FG002|Overall Study|Voluntary Withdrawal|4|||
146930497|NCT00819585|529903571|FG006|Extension Study|Death|0|||
146930498|NCT00819585|529903572|FG007|Extension Study|Death|0|||
146930499|NCT00819585|529903573|FG008|Extension Study|Death|2|||
146930500|NCT00819585|529903574|FG009|Extension Study|Death|0|||
146930501|NCT00819585|529903575|FG010|Extension Study|Death|0|||
146930502|NCT00738374|529903576|FG000|Induction Treatment Phase|Adverse Event|14|||
146930503|NCT00738374|529903577|FG001|Induction Treatment Phase|Adverse Event|0|||
146930504|NCT00738374|529903578|FG002|Induction Treatment Phase|Adverse Event|0|||
146930505|NCT00738374|529903579|FG003|Induction Treatment Phase|Adverse Event|0|||
146930506|NCT00738374|529903576|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
146930507|NCT00738374|529903577|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
146930508|NCT00738374|529903578|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
146930509|NCT00738374|529903579|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
146930510|NCT00738374|529903576|FG000|Induction Treatment Phase|Physician Decision|2|||
146930511|NCT00738374|529903577|FG001|Induction Treatment Phase|Physician Decision|0|||
146930512|NCT00738374|529903578|FG002|Induction Treatment Phase|Physician Decision|0|||
146930513|NCT00738374|529903579|FG003|Induction Treatment Phase|Physician Decision|0|||
146930514|NCT00738374|529903576|FG000|Induction Treatment Phase|Protocol Violation|2|||
146930515|NCT00738374|529903577|FG001|Induction Treatment Phase|Protocol Violation|0|||
146695777|NCT02932904|529065177|FG003|Overall Study|Voluntary Withdrawal|2|||
146695778|NCT02932904|529065174|FG000|Overall Study|Lost to Follow-up|5|||
146695779|NCT02932904|529065175|FG001|Overall Study|Lost to Follow-up|3|||
146695780|NCT02932904|529065176|FG002|Overall Study|Lost to Follow-up|6|||
146695781|NCT02932904|529065177|FG003|Overall Study|Lost to Follow-up|0|||
146695782|NCT02932904|529065174|FG000|Overall Study|Significant Protocol Deviation|2|||
146695783|NCT02932904|529065175|FG001|Overall Study|Significant Protocol Deviation|3|||
146695784|NCT02932904|529065176|FG002|Overall Study|Significant Protocol Deviation|6|||
146695785|NCT02932904|529065177|FG003|Overall Study|Significant Protocol Deviation|1|||
146695786|NCT02932904|529065174|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
146695787|NCT02932904|529065175|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
146695788|NCT02932904|529065176|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
146695789|NCT02932904|529065177|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
146695790|NCT02932904|529065174|FG000|Overall Study|Randomized But Not Treated|1|||
146695791|NCT02932904|529065175|FG001|Overall Study|Randomized But Not Treated|1|||
146695792|NCT02932904|529065176|FG002|Overall Study|Randomized But Not Treated|0|||
146695793|NCT02932904|529065177|FG003|Overall Study|Randomized But Not Treated|2|||
146695794|NCT00337103|529065181|FG000|Overall Study|Progressive Disease|414|||
146695795|NCT00337103|529065182|FG001|Overall Study|Progressive Disease|410|||
146695796|NCT00337103|529065181|FG000|Overall Study|Adverse Event|45|||
146695797|NCT00337103|529065182|FG001|Overall Study|Adverse Event|59|||
146695798|NCT00337103|529065181|FG000|Overall Study|Subject Choice|34|||
146695799|NCT00337103|529065182|FG001|Overall Study|Subject Choice|27|||
146695800|NCT00337103|529065181|FG000|Overall Study|Clinical Progression|27|||
146695801|NCT00337103|529065182|FG001|Overall Study|Clinical Progression|24|||
146695802|NCT00337103|529065181|FG000|Overall Study|Physician Decision|15|||
146695803|NCT00337103|529065182|FG001|Overall Study|Physician Decision|14|||
146695804|NCT00337103|529065181|FG000|Overall Study|Withdrawal by Subject|8|||
146695805|NCT00337103|529065182|FG001|Overall Study|Withdrawal by Subject|5|||
146695806|NCT00337103|529065181|FG000|Overall Study|Other|5|||
146695807|NCT00337103|529065182|FG001|Overall Study|Other|6|||
146695808|NCT00337103|529065181|FG000|Overall Study|Entry Criteria Not Met|4|||
146695809|NCT00337103|529065182|FG001|Overall Study|Entry Criteria Not Met|1|||
146695810|NCT00337103|529065181|FG000|Overall Study|Lost to Follow-up|1|||
146695811|NCT00337103|529065182|FG001|Overall Study|Lost to Follow-up|2|||
146695812|NCT00337103|529065181|FG000|Overall Study|Death|1|||
146695813|NCT00337103|529065182|FG001|Overall Study|Death|0|||
146695814|NCT02016482|529065183|FG000|Period A|Adverse Event|3|||
146695815|NCT02016482|529065184|FG001|Period A|Adverse Event|5|||
146695816|NCT02016482|529065183|FG000|Period A|Withdrawal by Subject|3|||
146695817|NCT02016482|529065184|FG001|Period A|Withdrawal by Subject|4|||
146695818|NCT02016482|529065183|FG000|Period A|Lost to Follow-up|3|||
146695819|NCT02016482|529065184|FG001|Period A|Lost to Follow-up|3|||
146776013|NCT02590432|529351241|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
146695820|NCT02016482|529065183|FG000|Period A|Lack of Efficacy|2|||
146695821|NCT02016482|529065184|FG001|Period A|Lack of Efficacy|1|||
146695822|NCT02016482|529065183|FG000|Period A|Other|3|||
146695823|NCT02016482|529065184|FG001|Period A|Other|0|||
146695824|NCT02016482|529065183|FG000|Period A|Protocol Violation|0|||
146695825|NCT02016482|529065184|FG001|Period A|Protocol Violation|1|||
146930516|NCT00738374|529903578|FG002|Induction Treatment Phase|Protocol Violation|0|||
146930517|NCT00738374|529903579|FG003|Induction Treatment Phase|Protocol Violation|0|||
146930518|NCT00738374|529903576|FG000|Induction Treatment Phase|Non-compliance|1|||
146930519|NCT00738374|529903577|FG001|Induction Treatment Phase|Non-compliance|0|||
146695826|NCT02016482|529065183|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
146695827|NCT02016482|529065184|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
146695828|NCT02016482|529065183|FG000|Period B|Withdrawal by Subject|1|||
146930520|NCT00738374|529903578|FG002|Induction Treatment Phase|Non-compliance|0|||
146930521|NCT00738374|529903579|FG003|Induction Treatment Phase|Non-compliance|0|||
146930522|NCT00738374|529903576|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
146695829|NCT02016482|529065184|FG001|Period B|Withdrawal by Subject|1|||
146695830|NCT02016482|529065183|FG000|Period B|Lost to Follow-up|2|||
146695831|NCT02016482|529065184|FG001|Period B|Lost to Follow-up|0|||
146695832|NCT02016482|529065183|FG000|Period B|Lack of Efficacy|6|||
146695833|NCT02016482|529065184|FG001|Period B|Lack of Efficacy|4|||
146695834|NCT02016482|529065183|FG000|Period B|Other|4|||
146695835|NCT02016482|529065184|FG001|Period B|Other|0|||
146695836|NCT02016482|529065183|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
146695837|NCT02016482|529065184|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
146695838|NCT01289847|529065185|FG000|Overall Study|Patient could not comply with visits|1|||
146695839|NCT03975647|529065198|FG000|Overall Study|Death|71|||
146695840|NCT03975647|529065199|FG001|Overall Study|Death|63|||
146695841|NCT03975647|529065198|FG000|Overall Study|Lost to Follow-up|2|||
146695842|NCT03975647|529065199|FG001|Overall Study|Lost to Follow-up|2|||
146695843|NCT03975647|529065198|FG000|Overall Study|Subject withdrawal of consent|7|||
146695844|NCT03975647|529065199|FG001|Overall Study|Subject withdrawal of consent|11|||
146695845|NCT00228917|529065209|FG000|Overall Study|Migrated/moved from study area|0|||
146695846|NCT00228917|529065210|FG001|Overall Study|Migrated/moved from study area|0|||
146695847|NCT00228917|529065211|FG002|Overall Study|Migrated/moved from study area|0|||
146695848|NCT00228917|529065212|FG003|Overall Study|Migrated/moved from study area|0|||
146695849|NCT00228917|529065213|FG004|Overall Study|Migrated/moved from study area|0|||
146695850|NCT00228917|529065214|FG005|Overall Study|Migrated/moved from study area|2|||
146695851|NCT00228917|529065215|FG006|Overall Study|Migrated/moved from study area|0|||
146695852|NCT00228917|529065216|FG007|Overall Study|Migrated/moved from study area|0|||
146695853|NCT00409617|529065217|FG000|Overall Study|Adverse Event|57|||
146695854|NCT00409617|529065217|FG000|Overall Study|Lack of Efficacy|54|||
146695855|NCT00409617|529065217|FG000|Overall Study|Lost to Follow-up|2|||
146695856|NCT00409617|529065217|FG000|Overall Study|Protocol Violation|24|||
146695857|NCT00409617|529065217|FG000|Overall Study|Withdrawal by Subject|8|||
146695858|NCT00409617|529065217|FG000|Overall Study|Administrative reasons|1|||
146695859|NCT00409617|529065217|FG000|Overall Study|Not described|14|||
146695860|NCT01354496|529065233|FG000|Period 1|Adverse Event|0|||
146695861|NCT01354496|529065234|FG001|Period 1|Adverse Event|0|||
146695862|NCT01354496|529065235|FG002|Period 1|Adverse Event|1|||
146695863|NCT01354496|529065236|FG003|Period 1|Adverse Event|0|||
146695864|NCT01354496|529065237|FG004|Period 1|Adverse Event|0|||
146695865|NCT01354496|529065238|FG005|Period 1|Adverse Event|0|||
146695866|NCT01354496|529065233|FG000|Period 1|Physician Decision|0|||
146695867|NCT01354496|529065234|FG001|Period 1|Physician Decision|0|||
146695868|NCT01354496|529065235|FG002|Period 1|Physician Decision|1|||
146695869|NCT01354496|529065236|FG003|Period 1|Physician Decision|0|||
146695870|NCT01354496|529065237|FG004|Period 1|Physician Decision|0|||
146695871|NCT01354496|529065238|FG005|Period 1|Physician Decision|0|||
146695872|NCT01354496|529065233|FG000|Period 2|Adverse Event|0|||
146695873|NCT01354496|529065234|FG001|Period 2|Adverse Event|0|||
146695874|NCT01354496|529065235|FG002|Period 2|Adverse Event|0|||
146695875|NCT01354496|529065236|FG003|Period 2|Adverse Event|1|||
146695876|NCT01354496|529065237|FG004|Period 2|Adverse Event|0|||
146695877|NCT01354496|529065238|FG005|Period 2|Adverse Event|0|||
146695878|NCT01354496|529065233|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
146695879|NCT01354496|529065234|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
146695880|NCT01354496|529065235|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
146695881|NCT01354496|529065236|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
146695882|NCT01354496|529065237|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
146695883|NCT01354496|529065238|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
146695884|NCT01524692|529065239|FG000|Overall Study|Withdrawal by Subject|3|||
146695885|NCT03190889|529065240|FG000|Overall Study|Lost to Follow-up|7|||
146695886|NCT03190889|529065241|FG001|Overall Study|Lost to Follow-up|7|||
146695887|NCT03190889|529065242|FG002|Overall Study|Lost to Follow-up|3|||
146695888|NCT03190889|529065240|FG000|Overall Study|Withdrawal by Subject|1|||
146695889|NCT03190889|529065241|FG001|Overall Study|Withdrawal by Subject|1|||
146695890|NCT03190889|529065242|FG002|Overall Study|Withdrawal by Subject|2|||
146695891|NCT03190889|529065240|FG000|Overall Study|Did not complete protocol|4|||
146695892|NCT03190889|529065241|FG001|Overall Study|Did not complete protocol|9|||
146695893|NCT03190889|529065242|FG002|Overall Study|Did not complete protocol|0|||
146695894|NCT03190889|529065240|FG000|Overall Study|COVID-19|1|||
146695895|NCT03190889|529065241|FG001|Overall Study|COVID-19|0|||
146695896|NCT03190889|529065242|FG002|Overall Study|COVID-19|2|||
146695897|NCT04007523|529065243|FG000|Overall Study|Withdrawal by Subject|0|||
146695898|NCT04007523|529065244|FG001|Overall Study|Withdrawal by Subject|1|||
146695899|NCT04007523|529065245|FG002|Overall Study|Withdrawal by Subject|1|||
146695900|NCT04007523|529065246|FG003|Overall Study|Withdrawal by Subject|0|||
146695901|NCT04007523|529065243|FG000|Overall Study|ICU Transfer|0|||
147013209|NCT02048813|530210053|FG001|Overall Study|Death|1|||
146695902|NCT04007523|529065244|FG001|Overall Study|ICU Transfer|1|||
146695903|NCT04007523|529065245|FG002|Overall Study|ICU Transfer|0|||
146695904|NCT04007523|529065246|FG003|Overall Study|ICU Transfer|0|||
146695905|NCT04007523|529065243|FG000|Overall Study|COVID hospital closure|0|||
146695906|NCT04007523|529065244|FG001|Overall Study|COVID hospital closure|0|||
146695907|NCT04007523|529065245|FG002|Overall Study|COVID hospital closure|1|||
146695908|NCT04007523|529065246|FG003|Overall Study|COVID hospital closure|2|||
146695909|NCT04007523|529065243|FG000|Overall Study|Surgery cancelled|0|||
146695910|NCT04007523|529065244|FG001|Overall Study|Surgery cancelled|0|||
146695911|NCT04007523|529065245|FG002|Overall Study|Surgery cancelled|1|||
146695912|NCT04007523|529065246|FG003|Overall Study|Surgery cancelled|1|||
146695913|NCT02136576|529065247|FG000|Overall Study|Lost to Follow-up|2|||
146695914|NCT02136576|529065248|FG001|Overall Study|Lost to Follow-up|0|||
146695915|NCT02136576|529065249|FG002|Overall Study|Lost to Follow-up|0|||
146695916|NCT02197806|529065251|FG000|Overall Study|Adverse Event|0|||
146695917|NCT02197806|529065252|FG001|Overall Study|Adverse Event|1|||
146695918|NCT02197806|529065253|FG002|Overall Study|Adverse Event|0|||
146695919|NCT02197806|529065254|FG003|Overall Study|Adverse Event|1|||
146695920|NCT00537381|529065255|FG000|Overall Study|Adverse Event|13|||
146695921|NCT00537381|529065256|FG001|Overall Study|Adverse Event|9|||
146695922|NCT00537381|529065255|FG000|Overall Study|Death|3|||
146695923|NCT00537381|529065256|FG001|Overall Study|Death|3|||
146695924|NCT00537381|529065255|FG000|Overall Study|Withdrawal by Subject|5|||
146695925|NCT00537381|529065256|FG001|Overall Study|Withdrawal by Subject|14|||
146695926|NCT00537381|529065255|FG000|Overall Study|Physician Decision|7|||
146695927|NCT00537381|529065256|FG001|Overall Study|Physician Decision|6|||
146695928|NCT00537381|529065255|FG000|Overall Study|Disease Progression|9|||
146695929|NCT00537381|529065256|FG001|Overall Study|Disease Progression|18|||
146695930|NCT00537381|529065255|FG000|Overall Study|Sponsor decision|14|||
146695931|NCT00537381|529065256|FG001|Overall Study|Sponsor decision|9|||
146695932|NCT00537381|529065255|FG000|Overall Study|Other|5|||
146695933|NCT00537381|529065256|FG001|Overall Study|Other|3|||
146695934|NCT00500292|529065263|FG000|Overall Study|Adverse Event|3|||
146695935|NCT00500292|529065264|FG001|Overall Study|Adverse Event|6|||
146695936|NCT00500292|529065265|FG002|Overall Study|Adverse Event|4|||
146695937|NCT00500292|529065263|FG000|Overall Study|Condition under investigation worsened|21|||
146695938|NCT00500292|529065264|FG001|Overall Study|Condition under investigation worsened|23|||
146695939|NCT00500292|529065265|FG002|Overall Study|Condition under investigation worsened|19|||
146695940|NCT00500292|529065263|FG000|Overall Study|Withdrawal by Subject|0|||
146695941|NCT00500292|529065264|FG001|Overall Study|Withdrawal by Subject|1|||
146695942|NCT00500292|529065265|FG002|Overall Study|Withdrawal by Subject|0|||
146695943|NCT00500292|529065263|FG000|Overall Study|Other|1|||
146695944|NCT00500292|529065264|FG001|Overall Study|Other|1|||
146695945|NCT00500292|529065265|FG002|Overall Study|Other|4|||
146695946|NCT03065244|529065266|FG000|Overall Study|Lost to Follow-up|1|||
146695947|NCT03065244|529065267|FG001|Overall Study|Lost to Follow-up|1|||
146695948|NCT03065244|529065266|FG000|Overall Study|Diagnosed with a different disease|1|||
146695949|NCT03065244|529065267|FG001|Overall Study|Diagnosed with a different disease|1|||
146695950|NCT03065244|529065266|FG000|Overall Study|Protocol Violation|0|||
146695951|NCT03065244|529065267|FG001|Overall Study|Protocol Violation|1|||
146695952|NCT03065244|529065266|FG000|Overall Study|Withdrawal by Subject|1|||
146695953|NCT03065244|529065267|FG001|Overall Study|Withdrawal by Subject|1|||
146695954|NCT03717480|529065268|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
146695955|NCT01708174|529065269|FG000|Treatment Period|Withdrawal by Subject|1|||
146695956|NCT01708174|529065270|FG001|Treatment Period|Withdrawal by Subject|0|||
146695957|NCT01708174|529065271|FG002|Treatment Period|Withdrawal by Subject|0|||
146695958|NCT01708174|529065269|FG000|Treatment Period|Progressive disease|0|||
146695959|NCT01708174|529065270|FG001|Treatment Period|Progressive disease|1|||
146695960|NCT01708174|529065271|FG002|Treatment Period|Progressive disease|0|||
146695961|NCT01708174|529065269|FG000|Treatment Period|Death|0|||
146695962|NCT01708174|529065270|FG001|Treatment Period|Death|0|||
146695963|NCT01708174|529065271|FG002|Treatment Period|Death|1|||
146695964|NCT01708174|529065269|FG000|Treatment Period|Adverse Event|0|||
146695965|NCT01708174|529065270|FG001|Treatment Period|Adverse Event|1|||
146695966|NCT01708174|529065271|FG002|Treatment Period|Adverse Event|0|||
146695967|NCT01894152|529065272|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
146695968|NCT00923559|529065273|FG000|Overall Study|Lost to Follow-up|2|||
146695969|NCT00923559|529065274|FG001|Overall Study|Lost to Follow-up|3|||
146695970|NCT00744627|529065279|FG000|Overall Study|Adverse Event|6|||
146695971|NCT00744627|529065280|FG001|Overall Study|Adverse Event|9|||
146695972|NCT00744627|529065279|FG000|Overall Study|Lack of Efficacy|7|||
146695973|NCT00744627|529065280|FG001|Overall Study|Lack of Efficacy|3|||
146695974|NCT00744627|529065279|FG000|Overall Study|Noncompliance|0|||
146695975|NCT00744627|529065280|FG001|Overall Study|Noncompliance|1|||
146695976|NCT00744627|529065279|FG000|Overall Study|Protocol Deviations|0|||
146930523|NCT00738374|529903577|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
146930524|NCT00738374|529903578|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
146930525|NCT00738374|529903579|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
146930526|NCT00738374|529903576|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
146695977|NCT00744627|529065280|FG001|Overall Study|Protocol Deviations|2|||
146695978|NCT00744627|529065279|FG000|Overall Study|Voluntary Withdrawal|9|||
146695979|NCT00744627|529065280|FG001|Overall Study|Voluntary Withdrawal|6|||
146695980|NCT00744627|529065279|FG000|Overall Study|Lost to Follow-up|2|||
146695981|NCT00744627|529065280|FG001|Overall Study|Lost to Follow-up|1|||
146695982|NCT00744627|529065279|FG000|Overall Study|Other|1|||
146695983|NCT00744627|529065280|FG001|Overall Study|Other|0|||
146695984|NCT01062555|529065282|FG000|Phase 1|Death|10|||
146695985|NCT01062555|529065283|FG001|Phase 1|Death|17|||
146695986|NCT01062555|529065284|FG002|Phase 1|Death|0|||
146695987|NCT01062555|529065285|FG003|Phase 1|Death|0|||
146695988|NCT01062555|529065282|FG000|Phase 1|Graft Failure|12|||
146695989|NCT01062555|529065283|FG001|Phase 1|Graft Failure|8|||
146695990|NCT01062555|529065284|FG002|Phase 1|Graft Failure|0|||
146695991|NCT01062555|529065285|FG003|Phase 1|Graft Failure|0|||
146695992|NCT01062555|529065282|FG000|Phase 1|Withdrawal by Subject|1|||
146695993|NCT01062555|529065283|FG001|Phase 1|Withdrawal by Subject|1|||
146695994|NCT01062555|529065284|FG002|Phase 1|Withdrawal by Subject|0|||
146695995|NCT01062555|529065285|FG003|Phase 1|Withdrawal by Subject|0|||
146695996|NCT01062555|529065282|FG000|Phase 2|Death|0|||
146695997|NCT01062555|529065283|FG001|Phase 2|Death|0|||
146695998|NCT01062555|529065284|FG002|Phase 2|Death|8|||
146695999|NCT01062555|529065285|FG003|Phase 2|Death|3|||
146696000|NCT01062555|529065282|FG000|Phase 2|Graft failure|0|||
146696001|NCT01062555|529065283|FG001|Phase 2|Graft failure|0|||
146696002|NCT01062555|529065284|FG002|Phase 2|Graft failure|7|||
146696003|NCT01062555|529065285|FG003|Phase 2|Graft failure|4|||
146696004|NCT01062555|529065282|FG000|Phase 2|Withdrawal by Subject|0|||
146696005|NCT01062555|529065283|FG001|Phase 2|Withdrawal by Subject|0|||
146696006|NCT01062555|529065284|FG002|Phase 2|Withdrawal by Subject|0|||
146696007|NCT01062555|529065285|FG003|Phase 2|Withdrawal by Subject|7|||
146696008|NCT01062555|529065282|FG000|Phase 2|Protocol Violation|0|||
146696009|NCT01062555|529065283|FG001|Phase 2|Protocol Violation|0|||
146696010|NCT01062555|529065284|FG002|Phase 2|Protocol Violation|0|||
146696011|NCT01062555|529065285|FG003|Phase 2|Protocol Violation|3|||
146696012|NCT01062555|529065282|FG000|Phase 2|Physician Decision|0|||
146696013|NCT01062555|529065283|FG001|Phase 2|Physician Decision|0|||
146696014|NCT01062555|529065284|FG002|Phase 2|Physician Decision|0|||
146696015|NCT01062555|529065285|FG003|Phase 2|Physician Decision|17|||
146696016|NCT03560531|529065286|FG000|Overall Study|Death|4|||
146696017|NCT03560531|529065287|FG001|Overall Study|Death|1|||
146696018|NCT03560531|529065288|FG002|Overall Study|Death|1|||
146696019|NCT03560531|529065289|FG003|Overall Study|Death|2|||
146696020|NCT03560531|529065290|FG004|Overall Study|Death|6|||
146696021|NCT03560531|529065291|FG005|Overall Study|Death|1|||
146696022|NCT03560531|529065292|FG006|Overall Study|Death|4|||
146696023|NCT03560531|529065293|FG007|Overall Study|Death|8|||
146696024|NCT03560531|529065294|FG008|Overall Study|Death|1|||
146696025|NCT03560531|529065295|FG009|Overall Study|Death|3|||
146696026|NCT03560531|529065296|FG010|Overall Study|Death|2|||
146696027|NCT03560531|529065297|FG011|Overall Study|Death|0|||
146696028|NCT03560531|529065298|FG012|Overall Study|Death|4|||
146696029|NCT03560531|529065299|FG013|Overall Study|Death|1|||
146696030|NCT03560531|529065286|FG000|Overall Study|Lost to Follow-up|1|||
146696031|NCT03560531|529065287|FG001|Overall Study|Lost to Follow-up|1|||
146696032|NCT03560531|529065288|FG002|Overall Study|Lost to Follow-up|0|||
146696033|NCT03560531|529065289|FG003|Overall Study|Lost to Follow-up|0|||
146696034|NCT03560531|529065290|FG004|Overall Study|Lost to Follow-up|0|||
146696035|NCT03560531|529065291|FG005|Overall Study|Lost to Follow-up|0|||
146696036|NCT03560531|529065292|FG006|Overall Study|Lost to Follow-up|1|||
146696037|NCT03560531|529065293|FG007|Overall Study|Lost to Follow-up|0|||
146696038|NCT03560531|529065294|FG008|Overall Study|Lost to Follow-up|0|||
146696039|NCT03560531|529065295|FG009|Overall Study|Lost to Follow-up|0|||
146696040|NCT03560531|529065296|FG010|Overall Study|Lost to Follow-up|0|||
146696041|NCT03560531|529065297|FG011|Overall Study|Lost to Follow-up|0|||
146696042|NCT03560531|529065298|FG012|Overall Study|Lost to Follow-up|0|||
146696043|NCT03560531|529065299|FG013|Overall Study|Lost to Follow-up|0|||
146696044|NCT03560531|529065286|FG000|Overall Study|Withdrawal by Subject|1|||
146696045|NCT03560531|529065287|FG001|Overall Study|Withdrawal by Subject|0|||
146696046|NCT03560531|529065288|FG002|Overall Study|Withdrawal by Subject|0|||
146980584|NCT00323609|530091225|FG002|Overall Study|Logistical withdrawal|0|||
146980585|NCT00323609|530091226|FG003|Overall Study|Logistical withdrawal|1|||
146696047|NCT03560531|529065289|FG003|Overall Study|Withdrawal by Subject|0|||
146696048|NCT03560531|529065290|FG004|Overall Study|Withdrawal by Subject|0|||
146696049|NCT03560531|529065291|FG005|Overall Study|Withdrawal by Subject|0|||
146980586|NCT00323609|530091223|FG000|Overall Study|Other reason|11|||
146696050|NCT03560531|529065292|FG006|Overall Study|Withdrawal by Subject|0|||
146696051|NCT03560531|529065293|FG007|Overall Study|Withdrawal by Subject|3|||
146696052|NCT03560531|529065294|FG008|Overall Study|Withdrawal by Subject|2|||
146696053|NCT03560531|529065295|FG009|Overall Study|Withdrawal by Subject|0|||
146696054|NCT03560531|529065296|FG010|Overall Study|Withdrawal by Subject|0|||
146696055|NCT03560531|529065297|FG011|Overall Study|Withdrawal by Subject|0|||
146696056|NCT03560531|529065298|FG012|Overall Study|Withdrawal by Subject|2|||
146696057|NCT03560531|529065299|FG013|Overall Study|Withdrawal by Subject|0|||
146696058|NCT03560531|529065286|FG000|Overall Study|Study end per-protocol|1|||
146696059|NCT03560531|529065287|FG001|Overall Study|Study end per-protocol|1|||
146696060|NCT03560531|529065288|FG002|Overall Study|Study end per-protocol|2|||
146696061|NCT03560531|529065289|FG003|Overall Study|Study end per-protocol|0|||
146696062|NCT03560531|529065290|FG004|Overall Study|Study end per-protocol|1|||
146696063|NCT03560531|529065291|FG005|Overall Study|Study end per-protocol|0|||
146696064|NCT03560531|529065292|FG006|Overall Study|Study end per-protocol|0|||
146696065|NCT03560531|529065293|FG007|Overall Study|Study end per-protocol|0|||
146696066|NCT03560531|529065294|FG008|Overall Study|Study end per-protocol|0|||
146696067|NCT03560531|529065295|FG009|Overall Study|Study end per-protocol|0|||
146696068|NCT03560531|529065296|FG010|Overall Study|Study end per-protocol|0|||
146696069|NCT03560531|529065297|FG011|Overall Study|Study end per-protocol|0|||
146696070|NCT03560531|529065298|FG012|Overall Study|Study end per-protocol|0|||
146696071|NCT03560531|529065299|FG013|Overall Study|Study end per-protocol|0|||
146696072|NCT03560531|529065286|FG000|Overall Study|Early study termination by sponsor|9|||
146696073|NCT03560531|529065287|FG001|Overall Study|Early study termination by sponsor|0|||
146696074|NCT03560531|529065288|FG002|Overall Study|Early study termination by sponsor|0|||
146696075|NCT03560531|529065289|FG003|Overall Study|Early study termination by sponsor|4|||
146696076|NCT03560531|529065290|FG004|Overall Study|Early study termination by sponsor|8|||
146696077|NCT03560531|529065291|FG005|Overall Study|Early study termination by sponsor|2|||
146696078|NCT03560531|529065292|FG006|Overall Study|Early study termination by sponsor|5|||
146696079|NCT03560531|529065293|FG007|Overall Study|Early study termination by sponsor|64|||
146696080|NCT03560531|529065294|FG008|Overall Study|Early study termination by sponsor|7|||
146696081|NCT03560531|529065295|FG009|Overall Study|Early study termination by sponsor|2|||
146696082|NCT03560531|529065296|FG010|Overall Study|Early study termination by sponsor|16|||
146696083|NCT03560531|529065297|FG011|Overall Study|Early study termination by sponsor|2|||
146696084|NCT03560531|529065298|FG012|Overall Study|Early study termination by sponsor|6|||
146696085|NCT03560531|529065299|FG013|Overall Study|Early study termination by sponsor|2|||
146696086|NCT02028988|529065300|FG000|Overall Study|Withdrawal by Subject|2|||
146696087|NCT01063595|529065301|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
146696088|NCT01063595|529065302|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
146696089|NCT01063595|529065301|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
146696090|NCT01063595|529065302|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
146696091|NCT01063595|529065301|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
146696092|NCT01063595|529065302|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
146696093|NCT01063595|529065301|FG000|First Intervention|Adverse Event|1|||
146696094|NCT01063595|529065302|FG001|First Intervention|Adverse Event|4|||
146696095|NCT01063595|529065301|FG000|First Intervention|Withdrawal by Subject|1|||
146696096|NCT01063595|529065302|FG001|First Intervention|Withdrawal by Subject|0|||
146696097|NCT01063595|529065301|FG000|First Intervention|Reason not Specified|0|||
146696098|NCT01063595|529065302|FG001|First Intervention|Reason not Specified|1|||
146696099|NCT00747435|529065303|FG000|Overall Study|Lost to Follow-up|2|||
146696100|NCT00747435|529065303|FG000|Overall Study|Withdrawal by Subject|3|||
146696101|NCT00747435|529065303|FG000|Overall Study|Still undergoing follow up|1|||
146696102|NCT03161483|529066252|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
146696103|NCT03161483|529066253|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
146696104|NCT03161483|529066254|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
146696105|NCT03161483|529066255|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
146696106|NCT03161483|529066252|FG000|Treatment Period|Death|1|||
146696107|NCT03161483|529066253|FG001|Treatment Period|Death|0|||
146696108|NCT03161483|529066254|FG002|Treatment Period|Death|0|||
146696109|NCT03161483|529066255|FG003|Treatment Period|Death|0|||
146696110|NCT03161483|529066252|FG000|Treatment Period|Adverse Event|5|||
146696111|NCT03161483|529066253|FG001|Treatment Period|Adverse Event|2|||
146696112|NCT03161483|529066254|FG002|Treatment Period|Adverse Event|1|||
146696113|NCT03161483|529066255|FG003|Treatment Period|Adverse Event|11|||
146696114|NCT03161483|529066252|FG000|Treatment Period|Pregnancy|1|||
146696115|NCT03161483|529066253|FG001|Treatment Period|Pregnancy|0|||
146696116|NCT03161483|529066254|FG002|Treatment Period|Pregnancy|0|||
146696117|NCT03161483|529066255|FG003|Treatment Period|Pregnancy|0|||
146696118|NCT03161483|529066252|FG000|Treatment Period|Lack of Efficacy|0|||
146696119|NCT03161483|529066253|FG001|Treatment Period|Lack of Efficacy|0|||
146696120|NCT03161483|529066254|FG002|Treatment Period|Lack of Efficacy|0|||
146696121|NCT03161483|529066255|FG003|Treatment Period|Lack of Efficacy|1|||
146696122|NCT03161483|529066252|FG000|Treatment Period|Withdrawal by Subject|2|||
146696123|NCT03161483|529066253|FG001|Treatment Period|Withdrawal by Subject|5|||
146696124|NCT03161483|529066254|FG002|Treatment Period|Withdrawal by Subject|2|||
146696125|NCT03161483|529066255|FG003|Treatment Period|Withdrawal by Subject|6|||
146696126|NCT03161483|529066252|FG000|Treatment Period|Lost to Follow-up|0|||
146696127|NCT03161483|529066253|FG001|Treatment Period|Lost to Follow-up|0|||
146696128|NCT03161483|529066254|FG002|Treatment Period|Lost to Follow-up|0|||
146696129|NCT03161483|529066255|FG003|Treatment Period|Lost to Follow-up|1|||
146696130|NCT03161483|529066252|FG000|Treatment Period|Protocol Violation|0|||
146696131|NCT03161483|529066253|FG001|Treatment Period|Protocol Violation|0|||
146696132|NCT03161483|529066254|FG002|Treatment Period|Protocol Violation|0|||
146980587|NCT00323609|530091224|FG001|Overall Study|Other reason|8|||
146980588|NCT00323609|530091225|FG002|Overall Study|Other reason|4|||
146980589|NCT00323609|530091226|FG003|Overall Study|Other reason|9|||
146980590|NCT01612156|530091233|FG000|Overall Study|Protocol Violation|2|||
146980591|NCT01612156|530091234|FG001|Overall Study|Protocol Violation|0|||
146980592|NCT01141283|530091235|FG000|Overall Study|Adverse Event|56|||
146980593|NCT01141283|530091235|FG000|Overall Study|Lost to Follow-up|4|||
146980594|NCT01141283|530091235|FG000|Overall Study|Withdrawal by Subject|14|||
146980595|NCT01141283|530091235|FG000|Overall Study|Administrative|4|||
146980596|NCT01141283|530091235|FG000|Overall Study|Lack of Efficacy|10|||
146980597|NCT02124746|530091238|FG000|Overall Study|Adverse Event|2|||
146980598|NCT02124746|530091239|FG001|Overall Study|Adverse Event|1|||
146980599|NCT02124746|530091240|FG002|Overall Study|Adverse Event|2|||
146980600|NCT02124746|530091238|FG000|Overall Study|Death|2|||
146980601|NCT02124746|530091239|FG001|Overall Study|Death|1|||
146980602|NCT02124746|530091240|FG002|Overall Study|Death|3|||
146980603|NCT02124746|530091238|FG000|Overall Study|Lack of Efficacy|3|||
146980604|NCT02124746|530091239|FG001|Overall Study|Lack of Efficacy|2|||
146980605|NCT02124746|530091240|FG002|Overall Study|Lack of Efficacy|2|||
146980606|NCT02124746|530091238|FG000|Overall Study|Physician Decision|6|||
146980607|NCT02124746|530091239|FG001|Overall Study|Physician Decision|4|||
146980608|NCT02124746|530091240|FG002|Overall Study|Physician Decision|5|||
146980609|NCT02124746|530091238|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146980610|NCT02124746|530091239|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146980611|NCT02124746|530091240|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146980612|NCT02124746|530091238|FG000|Overall Study|Withdrawal by Subject|3|||
146980613|NCT02124746|530091239|FG001|Overall Study|Withdrawal by Subject|3|||
146980614|NCT02124746|530091240|FG002|Overall Study|Withdrawal by Subject|0|||
146980615|NCT02124746|530091238|FG000|Overall Study|Study Terminated by Sponsor|0|||
146980616|NCT02124746|530091239|FG001|Overall Study|Study Terminated by Sponsor|0|||
146980617|NCT02124746|530091240|FG002|Overall Study|Study Terminated by Sponsor|6|||
146980618|NCT02124746|530091238|FG000|Overall Study|Disease Progression|3|||
146980619|NCT02124746|530091239|FG001|Overall Study|Disease Progression|6|||
146980620|NCT02124746|530091240|FG002|Overall Study|Disease Progression|4|||
146980621|NCT02868281|530091243|FG000|Overall Study|Adverse Event|2|||
146980622|NCT02868281|530091244|FG001|Overall Study|Adverse Event|2|||
146980623|NCT02868281|530091243|FG000|Overall Study|Protocol Violation|13|||
146980624|NCT02868281|530091244|FG001|Overall Study|Protocol Violation|10|||
146980625|NCT02868281|530091243|FG000|Overall Study|Lost to Follow-up|3|||
146980626|NCT02868281|530091244|FG001|Overall Study|Lost to Follow-up|6|||
146980627|NCT02868281|530091243|FG000|Overall Study|Withdrawal by Subject|11|||
146980628|NCT02868281|530091244|FG001|Overall Study|Withdrawal by Subject|15|||
146980629|NCT02868281|530091243|FG000|Overall Study|Physician Decision|2|||
146980630|NCT02868281|530091244|FG001|Overall Study|Physician Decision|0|||
146980631|NCT02868281|530091243|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
146980632|NCT02868281|530091244|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
146980633|NCT02868281|530091243|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
146980634|NCT02868281|530091244|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
146930527|NCT00738374|529903577|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
146930528|NCT00738374|529903578|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
146930529|NCT00738374|529903579|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
146930530|NCT00738374|529903576|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
146930531|NCT00738374|529903577|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
146930532|NCT00738374|529903578|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
146930533|NCT00738374|529903579|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
146930534|NCT00738374|529903576|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
146930535|NCT00738374|529903577|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
146930536|NCT00738374|529903578|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
146930537|NCT00738374|529903579|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
146980635|NCT02868281|530091243|FG000|Overall Study|Long journey/moving away|1|||
146980636|NCT02868281|530091244|FG001|Overall Study|Long journey/moving away|1|||
146980637|NCT01722266|530091245|FG000|Overall Study|Withdrawal by Subject|1|||
146980638|NCT01722266|530091246|FG001|Overall Study|Withdrawal by Subject|2|||
146980639|NCT01722266|530091247|FG002|Overall Study|Withdrawal by Subject|0|||
146980640|NCT01722266|530091248|FG003|Overall Study|Withdrawal by Subject|0|||
146980641|NCT01722266|530091245|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
146980642|NCT01722266|530091246|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
146980643|NCT01722266|530091247|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
146980644|NCT01722266|530091248|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
146980645|NCT01722266|530091245|FG000|Overall Study|Dropped out due to Nausea|0|||
146980646|NCT01722266|530091246|FG001|Overall Study|Dropped out due to Nausea|0|||
146980647|NCT01722266|530091247|FG002|Overall Study|Dropped out due to Nausea|2|||
146980648|NCT01722266|530091248|FG003|Overall Study|Dropped out due to Nausea|0|||
146980649|NCT03811249|530091249|FG000|Overall Study|Withdrawal by Subject|44|||
146696133|NCT03161483|529066255|FG003|Treatment Period|Protocol Violation|1|||
146696134|NCT03161483|529066252|FG000|Treatment Period|Other reasons|1|||
146696135|NCT03161483|529066253|FG001|Treatment Period|Other reasons|1|||
146696136|NCT03161483|529066254|FG002|Treatment Period|Other reasons|0|||
146696137|NCT03161483|529066255|FG003|Treatment Period|Other reasons|0|||
146696138|NCT03925324|529066259|FG000|Overall Study|Death|1|||
146696139|NCT03925324|529066260|FG001|Overall Study|Death|1|||
146696140|NCT00794196|529066261|FG000|Overall Study|Lost to Follow-up|5|||
146696141|NCT00794196|529066262|FG001|Overall Study|Lost to Follow-up|23|||
146696142|NCT02129803|529066266|FG000|Overall Study|Protocol Violation|4|||
146696143|NCT02129803|529066267|FG001|Overall Study|Protocol Violation|0|||
146696144|NCT02129803|529066266|FG000|Overall Study|Physician Decision|0|||
146696145|NCT02129803|529066267|FG001|Overall Study|Physician Decision|1|||
146696146|NCT02129803|529066266|FG000|Overall Study|Difficulty sleeping|1|||
146696147|NCT02129803|529066267|FG001|Overall Study|Difficulty sleeping|0|||
146696148|NCT02129803|529066266|FG000|Overall Study|Morning headache|0|||
146696149|NCT02129803|529066267|FG001|Overall Study|Morning headache|1|||
146696150|NCT02129803|529066266|FG000|Overall Study|Withdrawal by Subject|1|||
146696151|NCT02129803|529066267|FG001|Overall Study|Withdrawal by Subject|1|||
146696152|NCT00149747|529066274|FG000|Overall Study|Death|1|||
146696153|NCT00149747|529066275|FG001|Overall Study|Death|0|||
146696154|NCT00149747|529066274|FG000|Overall Study|Withdrawal by Subject|3|||
146696155|NCT00149747|529066275|FG001|Overall Study|Withdrawal by Subject|3|||
146696156|NCT02871739|529066276|FG000|Overall Study|Lost to Follow-up|3|||
146696157|NCT02871739|529066277|FG001|Overall Study|Lost to Follow-up|2|||
146696158|NCT02871739|529066278|FG002|Overall Study|Lost to Follow-up|0|||
146696159|NCT02871739|529066279|FG003|Overall Study|Lost to Follow-up|2|||
146696160|NCT03818516|529066280|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
146696161|NCT04372602|529066281|FG000|Overall Study|Withdrawal by Subject|1|||
146696162|NCT04372602|529066282|FG001|Overall Study|Withdrawal by Subject|1|||
146696163|NCT04372602|529066281|FG000|Overall Study|Adverse Event|0|||
146696164|NCT04372602|529066282|FG001|Overall Study|Adverse Event|1|||
146696165|NCT04372602|529066281|FG000|Overall Study|Transitioned to comfort care|0|||
146696166|NCT04372602|529066282|FG001|Overall Study|Transitioned to comfort care|1|||
146696167|NCT00594464|529066283|FG000|Overall Study|Withdrawal by Subject|1|||
146696168|NCT00594464|529066283|FG000|Overall Study|Delay in operation|2|||
146696169|NCT02907359|529066284|FG000|Overall Study|Death|234|||
146696170|NCT02907359|529066285|FG001|Overall Study|Death|117|||
146696171|NCT02907359|529066284|FG000|Overall Study|Withdrawal by Subject|6|||
146696172|NCT02907359|529066285|FG001|Overall Study|Withdrawal by Subject|11|||
146696173|NCT02907359|529066284|FG000|Overall Study|Lost to Follow-up|1|||
146696174|NCT02907359|529066285|FG001|Overall Study|Lost to Follow-up|0|||
146696175|NCT01085097|529066290|FG000|Overall Study|Adverse Event|0|||
146696176|NCT01085097|529066291|FG001|Overall Study|Adverse Event|0|||
146696177|NCT01085097|529066292|FG002|Overall Study|Adverse Event|2|||
146696178|NCT01085097|529066290|FG000|Overall Study|Treatment failure|2|||
146696179|NCT01085097|529066291|FG001|Overall Study|Treatment failure|0|||
146696180|NCT01085097|529066292|FG002|Overall Study|Treatment failure|0|||
146696181|NCT03742141|529066297|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
146696182|NCT00850395|529066302|FG000|Overall Study|Death|1|||
146696183|NCT00850395|529066302|FG000|Overall Study|Adverse Event|1|||
146696184|NCT00850395|529066302|FG000|Overall Study|Insufficient clinical response|3|||
146696185|NCT00850395|529066302|FG000|Overall Study|Other|5|||
146696186|NCT06049043|529066303|FG000|Overall Study|Lost to Follow-up|11|||
146696187|NCT06049043|529066304|FG001|Overall Study|Lost to Follow-up|9|||
146696188|NCT02741700|529066306|FG000|Overall Study|Lost to Follow-up|17|||
146696189|NCT02741700|529066307|FG001|Overall Study|Lost to Follow-up|8|||
146696190|NCT02741700|529066306|FG000|Overall Study|Withdrawal by Subject|2|||
146696191|NCT02741700|529066307|FG001|Overall Study|Withdrawal by Subject|5|||
146696192|NCT02741700|529066306|FG000|Overall Study|Physician Decision|3|||
146696193|NCT02741700|529066307|FG001|Overall Study|Physician Decision|0|||
146696194|NCT02741700|529066306|FG000|Overall Study|Moved out of State|0|||
146696195|NCT02741700|529066307|FG001|Overall Study|Moved out of State|1|||
146696196|NCT02741700|529066306|FG000|Overall Study|Death|4|||
146696197|NCT02741700|529066307|FG001|Overall Study|Death|5|||
146696198|NCT01774786|529066308|FG000|Overall Study|Death|300|||
146696199|NCT01774786|529066309|FG001|Overall Study|Death|319|||
146696200|NCT01774786|529066308|FG000|Overall Study|Lost to Follow-up|6|||
146696201|NCT01774786|529066309|FG001|Overall Study|Lost to Follow-up|7|||
146696202|NCT01774786|529066308|FG000|Overall Study|Withdrawal by Subject|18|||
146696203|NCT01774786|529066309|FG001|Overall Study|Withdrawal by Subject|14|||
146696204|NCT01774786|529066308|FG000|Overall Study|Physician Decision|2|||
146696205|NCT01774786|529066309|FG001|Overall Study|Physician Decision|0|||
146696206|NCT01774786|529066308|FG000|Overall Study|Non-compliance|0|||
146696207|NCT01774786|529066309|FG001|Overall Study|Non-compliance|1|||
146696208|NCT01774786|529066308|FG000|Overall Study|Reason Not Specified|2|||
146696209|NCT01774786|529066309|FG001|Overall Study|Reason Not Specified|5|||
146696210|NCT02268812|529066310|FG000|Overall Study|Adverse Event|8|||
146696211|NCT02268812|529066311|FG001|Overall Study|Adverse Event|26|||
146696212|NCT02268812|529066312|FG002|Overall Study|Adverse Event|7|||
146930538|NCT00738374|529903576|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
146930539|NCT00738374|529903577|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
146930540|NCT00738374|529903578|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
146930541|NCT00738374|529903579|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
146930542|NCT00738374|529903576|FG000|Maintenance Treatment/Observation Phase|Other|0|||
146930543|NCT00738374|529903577|FG001|Maintenance Treatment/Observation Phase|Other|1|||
146930544|NCT00738374|529903578|FG002|Maintenance Treatment/Observation Phase|Other|0|||
146930545|NCT00738374|529903579|FG003|Maintenance Treatment/Observation Phase|Other|0|||
146930546|NCT00632541|529903580|FG000|Overall Study|Adverse Event|7|||
146930547|NCT03334396|529903581|FG000|Overall Study|Adverse Event|1|||
146930548|NCT03334396|529903582|FG001|Overall Study|Adverse Event|0|||
146930549|NCT03334396|529903583|FG002|Overall Study|Adverse Event|1|||
146930550|NCT03334396|529903584|FG003|Overall Study|Adverse Event|0|||
146930551|NCT03334396|529903585|FG004|Overall Study|Adverse Event|0|||
146930552|NCT03334396|529903586|FG005|Overall Study|Adverse Event|0|||
146930553|NCT03334396|529903587|FG006|Overall Study|Adverse Event|0|||
146930554|NCT03334396|529903588|FG007|Overall Study|Adverse Event|0|||
146930555|NCT03334396|529903581|FG000|Overall Study|Lack of Efficacy|10|||
146930556|NCT03334396|529903582|FG001|Overall Study|Lack of Efficacy|4|||
146930557|NCT03334396|529903583|FG002|Overall Study|Lack of Efficacy|1|||
146930558|NCT03334396|529903584|FG003|Overall Study|Lack of Efficacy|3|||
146930559|NCT03334396|529903585|FG004|Overall Study|Lack of Efficacy|1|||
146930560|NCT03334396|529903586|FG005|Overall Study|Lack of Efficacy|0|||
146930561|NCT03334396|529903587|FG006|Overall Study|Lack of Efficacy|0|||
146930562|NCT03334396|529903588|FG007|Overall Study|Lack of Efficacy|1|||
146930563|NCT03334396|529903581|FG000|Overall Study|Lost to Follow-up|0|||
146930564|NCT03334396|529903582|FG001|Overall Study|Lost to Follow-up|0|||
146930565|NCT03334396|529903583|FG002|Overall Study|Lost to Follow-up|1|||
146930566|NCT03334396|529903584|FG003|Overall Study|Lost to Follow-up|0|||
146930567|NCT03334396|529903585|FG004|Overall Study|Lost to Follow-up|0|||
146930568|NCT03334396|529903586|FG005|Overall Study|Lost to Follow-up|0|||
146930569|NCT03334396|529903587|FG006|Overall Study|Lost to Follow-up|1|||
146930570|NCT03334396|529903588|FG007|Overall Study|Lost to Follow-up|0|||
146930571|NCT03334396|529903581|FG000|Overall Study|Physician Decision|1|||
146930572|NCT03334396|529903582|FG001|Overall Study|Physician Decision|0|||
146930573|NCT03334396|529903583|FG002|Overall Study|Physician Decision|0|||
146930574|NCT03334396|529903584|FG003|Overall Study|Physician Decision|0|||
146930575|NCT03334396|529903585|FG004|Overall Study|Physician Decision|0|||
146930576|NCT03334396|529903586|FG005|Overall Study|Physician Decision|0|||
146930577|NCT03334396|529903587|FG006|Overall Study|Physician Decision|0|||
146930578|NCT03334396|529903588|FG007|Overall Study|Physician Decision|0|||
146930579|NCT03334396|529903581|FG000|Overall Study|Withdrawal by Subject|10|||
146930580|NCT03334396|529903582|FG001|Overall Study|Withdrawal by Subject|5|||
146930581|NCT03334396|529903583|FG002|Overall Study|Withdrawal by Subject|7|||
146930582|NCT03334396|529903584|FG003|Overall Study|Withdrawal by Subject|2|||
146930583|NCT03334396|529903585|FG004|Overall Study|Withdrawal by Subject|2|||
146930584|NCT03334396|529903586|FG005|Overall Study|Withdrawal by Subject|1|||
146930585|NCT03334396|529903587|FG006|Overall Study|Withdrawal by Subject|2|||
146930586|NCT03334396|529903588|FG007|Overall Study|Withdrawal by Subject|0|||
146930587|NCT03334396|529903581|FG000|Overall Study|Pregnancy|0|||
146930588|NCT03334396|529903582|FG001|Overall Study|Pregnancy|1|||
146930589|NCT03334396|529903583|FG002|Overall Study|Pregnancy|0|||
146930590|NCT03334396|529903584|FG003|Overall Study|Pregnancy|0|||
146930591|NCT03334396|529903585|FG004|Overall Study|Pregnancy|0|||
146930592|NCT03334396|529903586|FG005|Overall Study|Pregnancy|0|||
146930593|NCT03334396|529903587|FG006|Overall Study|Pregnancy|0|||
146930594|NCT03334396|529903588|FG007|Overall Study|Pregnancy|0|||
146930595|NCT03334396|529903581|FG000|Overall Study|Ineligible|0|||
146930596|NCT03334396|529903582|FG001|Overall Study|Ineligible|1|||
146930597|NCT03334396|529903583|FG002|Overall Study|Ineligible|0|||
146930598|NCT03334396|529903584|FG003|Overall Study|Ineligible|0|||
146696213|NCT02268812|529066313|FG003|Overall Study|Adverse Event|10|||
146696214|NCT02268812|529066310|FG000|Overall Study|Protocol deviation|0|||
146696215|NCT02268812|529066311|FG001|Overall Study|Protocol deviation|0|||
146696216|NCT02268812|529066312|FG002|Overall Study|Protocol deviation|1|||
146930599|NCT03334396|529903585|FG004|Overall Study|Ineligible|0|||
146930600|NCT03334396|529903586|FG005|Overall Study|Ineligible|0|||
146980650|NCT03811249|530091249|FG000|Overall Study|Missed Visit|24|||
146980651|NCT01504867|530091253|FG000|Overall Study|Inclusion criteria not met|2|||
146696217|NCT02268812|529066313|FG003|Overall Study|Protocol deviation|0|||
146930601|NCT03334396|529903587|FG006|Overall Study|Ineligible|0|||
146930602|NCT03334396|529903588|FG007|Overall Study|Ineligible|0|||
146696218|NCT02268812|529066310|FG000|Overall Study|Withdrawal by Subject|0|||
146930603|NCT03334396|529903581|FG000|Overall Study|Started New Job|1|||
146930604|NCT03334396|529903582|FG001|Overall Study|Started New Job|0|||
146930605|NCT03334396|529903583|FG002|Overall Study|Started New Job|0|||
146930606|NCT03334396|529903584|FG003|Overall Study|Started New Job|0|||
146930607|NCT03334396|529903585|FG004|Overall Study|Started New Job|0|||
146930608|NCT03334396|529903586|FG005|Overall Study|Started New Job|0|||
146930609|NCT03334396|529903587|FG006|Overall Study|Started New Job|0|||
146930610|NCT03334396|529903588|FG007|Overall Study|Started New Job|0|||
146930611|NCT02927873|529903592|FG000|Overall Study|Lost to Follow-up|0|||
146930612|NCT02927873|529903593|FG001|Overall Study|Lost to Follow-up|1|||
146930613|NCT02927873|529903594|FG002|Overall Study|Lost to Follow-up|0|||
146930614|NCT02927873|529903595|FG003|Overall Study|Lost to Follow-up|0|||
146930615|NCT02927873|529903596|FG004|Overall Study|Lost to Follow-up|0|||
146930616|NCT02927873|529903597|FG005|Overall Study|Lost to Follow-up|0|||
146930617|NCT02927873|529903592|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
146930618|NCT02927873|529903593|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
146930619|NCT02927873|529903594|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
146930620|NCT02927873|529903595|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
146930621|NCT02927873|529903596|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
146930622|NCT02927873|529903597|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
146930623|NCT02927873|529903592|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146930624|NCT02927873|529903593|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146930625|NCT02927873|529903594|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146930626|NCT02927873|529903595|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146930627|NCT02927873|529903596|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146930628|NCT02927873|529903597|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146930629|NCT02927873|529903592|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
146930630|NCT02927873|529903593|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
146930631|NCT02927873|529903594|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
146930632|NCT02927873|529903595|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
146930633|NCT02927873|529903596|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
146930634|NCT02927873|529903597|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
146930635|NCT02927873|529903592|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
146930636|NCT02927873|529903593|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
146930637|NCT02927873|529903594|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
146930638|NCT02927873|529903595|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
146930639|NCT02927873|529903596|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
146930640|NCT02927873|529903597|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
146930641|NCT02927873|529903592|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
146930642|NCT02927873|529903593|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
146930643|NCT02927873|529903594|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
146930644|NCT02927873|529903595|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
146930645|NCT02927873|529903596|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
146930646|NCT02927873|529903597|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
146930647|NCT00383721|529903598|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
146930648|NCT00383721|529903599|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
146930649|NCT00383721|529903600|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
146930650|NCT00383721|529903601|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
146930651|NCT00383721|529903602|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
146930652|NCT00383721|529903598|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
146930653|NCT00383721|529903599|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
146930654|NCT00383721|529903600|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
146930655|NCT00383721|529903601|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
146930656|NCT00383721|529903602|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
146930657|NCT00383721|529903598|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
146696219|NCT02268812|529066311|FG001|Overall Study|Withdrawal by Subject|1|||
146696220|NCT02268812|529066312|FG002|Overall Study|Withdrawal by Subject|0|||
146696221|NCT02268812|529066313|FG003|Overall Study|Withdrawal by Subject|0|||
146696222|NCT02268812|529066310|FG000|Overall Study|Physician Decision|3|||
146696223|NCT02268812|529066311|FG001|Overall Study|Physician Decision|1|||
146696224|NCT02268812|529066312|FG002|Overall Study|Physician Decision|0|||
146696225|NCT02268812|529066313|FG003|Overall Study|Physician Decision|1|||
146696226|NCT02268812|529066310|FG000|Overall Study|Other|5|||
146696227|NCT02268812|529066311|FG001|Overall Study|Other|4|||
146696228|NCT02268812|529066312|FG002|Overall Study|Other|1|||
146696229|NCT02268812|529066313|FG003|Overall Study|Other|3|||
146696230|NCT04544293|529066314|FG000|Double-blind|Adverse Event|2|||
146696231|NCT04544293|529066315|FG001|Double-blind|Adverse Event|1|||
146696232|NCT04544293|529066314|FG000|Double-blind|Pregnancy|0|||
146696233|NCT04544293|529066315|FG001|Double-blind|Pregnancy|1|||
146696234|NCT04544293|529066314|FG000|Double-blind|Lost to Follow-up|0|||
146696235|NCT04544293|529066315|FG001|Double-blind|Lost to Follow-up|1|||
146696236|NCT04544293|529066314|FG000|Open-Label Extension|Study ongoing|79|||
146696237|NCT04544293|529066315|FG001|Open-Label Extension|Study ongoing|81|||
146696238|NCT01951157|529066316|FG000|Overall Study|Progressive Disease|12|||
146696239|NCT01951157|529066317|FG001|Overall Study|Progressive Disease|13|||
146930658|NCT00383721|529903599|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
146930659|NCT00383721|529903600|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
146930660|NCT00383721|529903601|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
146930661|NCT00383721|529903602|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
146930662|NCT00383721|529903598|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
146930663|NCT00383721|529903599|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
146930664|NCT00383721|529903600|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
146930665|NCT00383721|529903601|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
146930666|NCT00383721|529903602|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
146930667|NCT00383721|529903598|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
146930668|NCT00383721|529903599|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
146930669|NCT00383721|529903600|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
146930670|NCT00383721|529903601|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
146930671|NCT00383721|529903602|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
146930672|NCT00383721|529903598|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
146930673|NCT00383721|529903599|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
146930674|NCT00383721|529903600|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
146930675|NCT00383721|529903601|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
146930676|NCT00383721|529903602|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
146930677|NCT00383721|529903598|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
146930678|NCT00383721|529903599|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
146930679|NCT00383721|529903600|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
146930680|NCT00383721|529903601|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
146930681|NCT00383721|529903602|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
146930682|NCT00383721|529903598|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
146930683|NCT00383721|529903599|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
146930684|NCT00383721|529903600|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
146930685|NCT00383721|529903601|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
146930686|NCT00383721|529903602|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
146930687|NCT00383721|529903598|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
146930688|NCT00383721|529903599|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
146930689|NCT00383721|529903600|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
146930690|NCT00383721|529903601|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
146930691|NCT00383721|529903602|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
146930692|NCT00383721|529903598|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
146930693|NCT00383721|529903599|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
146930694|NCT00383721|529903600|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
146930695|NCT00383721|529903601|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
146930696|NCT00383721|529903602|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
146930697|NCT00383721|529903598|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
146930698|NCT00383721|529903599|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
146930699|NCT00383721|529903600|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
146930700|NCT00383721|529903601|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
146930701|NCT00383721|529903602|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
146930702|NCT00383721|529903598|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
146930703|NCT00383721|529903599|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
146930704|NCT00383721|529903600|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
146930705|NCT00383721|529903601|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
146930706|NCT00383721|529903602|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
146930707|NCT00383721|529903598|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
146930708|NCT00383721|529903599|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
146930709|NCT00383721|529903600|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
146930710|NCT00383721|529903601|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
146930711|NCT00383721|529903602|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
146930712|NCT00383721|529903598|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
146930713|NCT00383721|529903599|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
146696240|NCT01951157|529066318|FG002|Overall Study|Progressive Disease|10|||
146696241|NCT01951157|529066316|FG000|Overall Study|Treatment-unrelated AE|1|||
146696242|NCT01951157|529066317|FG001|Overall Study|Treatment-unrelated AE|0|||
146696243|NCT01951157|529066318|FG002|Overall Study|Treatment-unrelated AE|3|||
146696244|NCT01951157|529066316|FG000|Overall Study|Study Termination|0|||
146696245|NCT01951157|529066317|FG001|Overall Study|Study Termination|0|||
146696246|NCT01951157|529066318|FG002|Overall Study|Study Termination|1|||
146696247|NCT01951157|529066316|FG000|Overall Study|Physician Decision|5|||
146696248|NCT01951157|529066317|FG001|Overall Study|Physician Decision|3|||
146696249|NCT01951157|529066318|FG002|Overall Study|Physician Decision|2|||
146696250|NCT01951157|529066316|FG000|Overall Study|Non-treatmentrelated death|2|||
146696251|NCT01951157|529066317|FG001|Overall Study|Non-treatmentrelated death|2|||
146696252|NCT01951157|529066318|FG002|Overall Study|Non-treatmentrelated death|2|||
146696253|NCT01951157|529066316|FG000|Overall Study|No treated|0|||
146696254|NCT01951157|529066317|FG001|Overall Study|No treated|1|||
146696255|NCT01951157|529066318|FG002|Overall Study|No treated|0|||
146696256|NCT01951157|529066316|FG000|Overall Study|Treatment-related AE|2|||
146696257|NCT01951157|529066317|FG001|Overall Study|Treatment-related AE|0|||
146696258|NCT01951157|529066318|FG002|Overall Study|Treatment-related AE|4|||
146696259|NCT01951157|529066316|FG000|Overall Study|Consent withdrawn by subject|0|||
146696260|NCT01951157|529066317|FG001|Overall Study|Consent withdrawn by subject|1|||
146696261|NCT01951157|529066318|FG002|Overall Study|Consent withdrawn by subject|3|||
146696262|NCT01951157|529066316|FG000|Overall Study|Treatment-related death|0|||
146696263|NCT01951157|529066317|FG001|Overall Study|Treatment-related death|2|||
146696264|NCT01951157|529066318|FG002|Overall Study|Treatment-related death|0|||
146696265|NCT02268786|529066320|FG000|Overall Study|No Euploid Embryos available|42|||
146696266|NCT02268786|529066321|FG001|Overall Study|No Euploid Embryos available|0|||
146696267|NCT02268786|529066320|FG000|Overall Study|Withdrawal by Subject|7|||
146696268|NCT02268786|529066321|FG001|Overall Study|Withdrawal by Subject|14|||
146696269|NCT02268786|529066320|FG000|Overall Study|Thaw Failure|6|||
146696270|NCT02268786|529066321|FG001|Overall Study|Thaw Failure|4|||
146696271|NCT02268786|529066320|FG000|Overall Study|Protocol Violation|1|||
146696272|NCT02268786|529066321|FG001|Overall Study|Protocol Violation|0|||
146696273|NCT04809220|529066324|FG000|Overall Study|Adverse Event|4|||
146696274|NCT04809220|529066325|FG001|Overall Study|Adverse Event|0|||
146696275|NCT04809220|529066324|FG000|Overall Study|Death|1|||
146696276|NCT04809220|529066325|FG001|Overall Study|Death|0|||
146696277|NCT04809220|529066324|FG000|Overall Study|Lost to Follow-up|3|||
146696278|NCT04809220|529066325|FG001|Overall Study|Lost to Follow-up|0|||
146696279|NCT04809220|529066324|FG000|Overall Study|Physician Decision|0|||
146696280|NCT04809220|529066325|FG001|Overall Study|Physician Decision|1|||
146696281|NCT04809220|529066324|FG000|Overall Study|Withdrawal by Subject|9|||
146696282|NCT04809220|529066325|FG001|Overall Study|Withdrawal by Subject|5|||
146696283|NCT04809220|529066324|FG000|Overall Study|Due to long-term overseas business trips|1|||
146696284|NCT04809220|529066325|FG001|Overall Study|Due to long-term overseas business trips|0|||
146696285|NCT02120794|529066329|FG000|Overall Study|Withdrawal by Subject|43|||
146696286|NCT02120794|529066329|FG000|Overall Study|Adverse Event|10|||
146696287|NCT02120794|529066329|FG000|Overall Study|Physician Decision|4|||
146696288|NCT02120794|529066329|FG000|Overall Study|Due to insurance coverage|1|||
146696289|NCT00994240|529066331|FG000|Overall Study|Lost to Follow-up|3|||
146696290|NCT00994240|529066332|FG001|Overall Study|Lost to Follow-up|2|||
146696291|NCT00994240|529066331|FG000|Overall Study|Withdrawal by Subject|1|||
146696292|NCT00994240|529066332|FG001|Overall Study|Withdrawal by Subject|0|||
146696293|NCT00994240|529066331|FG000|Overall Study|study termination|2|||
146696294|NCT00994240|529066332|FG001|Overall Study|study termination|3|||
146696295|NCT01200797|529066333|FG000|Overall Study|symptomatic deterioration|2|||
146696296|NCT01200797|529066333|FG000|Overall Study|Adverse Event|4|||
146696297|NCT01200797|529066333|FG000|Overall Study|Disease Progression|13|||
146696298|NCT03608774|529066338|FG000|Overall Study|Lost to Follow-up|5|||
146696299|NCT03608774|529066339|FG001|Overall Study|Lost to Follow-up|5|||
146696300|NCT03608774|529066338|FG000|Overall Study|Withdrawal by Subject|1|||
146696301|NCT03608774|529066339|FG001|Overall Study|Withdrawal by Subject|0|||
146696302|NCT03608774|529066338|FG000|Overall Study|Protocol Violation|1|||
146696303|NCT03608774|529066339|FG001|Overall Study|Protocol Violation|0|||
146696304|NCT03608774|529066338|FG000|Overall Study|Not eligible at enrollment|0|||
146696305|NCT03608774|529066339|FG001|Overall Study|Not eligible at enrollment|1|||
146696306|NCT03608774|529066338|FG000|Overall Study|Health related event|0|||
146696307|NCT03608774|529066339|FG001|Overall Study|Health related event|1|||
146696308|NCT00642668|529066340|FG000|Overall Study|Lost to Follow-up|1|||
146696309|NCT00642668|529066340|FG000|Overall Study|Adverse Event|2|||
146696310|NCT00642668|529066340|FG000|Overall Study|Death|2|||
146696311|NCT00642668|529066340|FG000|Overall Study|Insufficient Therapeutic Response|1|||
146696312|NCT00642668|529066340|FG000|Overall Study|Failure to Return|1|||
146696313|NCT00642668|529066340|FG000|Overall Study|Dialysis Initiation|5|||
146696314|NCT00642668|529066340|FG000|Overall Study|Blood Transfusion|2|||
146696315|NCT00896337|529066341|FG000|Overall Study|Death|7|||
146696316|NCT00896337|529066341|FG000|Overall Study|Withdrawal by Subject|7|||
146696317|NCT00896337|529066341|FG000|Overall Study|Lost to Follow-up|11|||
146696318|NCT01586819|529066342|FG000|Overall Study|Withdrawal by Subject|1|||
146696319|NCT01586819|529066343|FG001|Overall Study|Withdrawal by Subject|0|||
146696320|NCT02910167|529066354|FG000|Overall Study|Adverse Event|1|||
146696321|NCT02910167|529066354|FG000|Overall Study|Lost to Follow-up|18|||
146696322|NCT01418937|529066355|FG000|Overall Study|Lost to Follow-up|5|||
146696323|NCT01418937|529066355|FG000|Overall Study|Protocol Violation|1|||
146696324|NCT01418937|529066355|FG000|Overall Study|Pregnancy|1|||
146696325|NCT01418937|529066355|FG000|Overall Study|Withdrawal by Subject|1|||
146696326|NCT01623596|529066356|FG000|Overall Study|Abnormal laboratory values|2|||
146696327|NCT01623596|529066357|FG001|Overall Study|Abnormal laboratory values|0|||
146696328|NCT01623596|529066356|FG000|Overall Study|Administrative problems|9|||
146696329|NCT01623596|529066357|FG001|Overall Study|Administrative problems|13|||
146696330|NCT01623596|529066356|FG000|Overall Study|Adverse Event|20|||
146930714|NCT00383721|529903600|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
146930715|NCT00383721|529903601|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
146930716|NCT00383721|529903602|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
146930717|NCT00383721|529903598|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
146930718|NCT00383721|529903599|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
146930719|NCT00383721|529903600|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
146930720|NCT00383721|529903601|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
146930721|NCT00383721|529903602|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
146930722|NCT00383721|529903598|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
146930723|NCT00383721|529903599|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
146930724|NCT00383721|529903600|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
146930725|NCT00383721|529903601|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
146930726|NCT00383721|529903602|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
146930727|NCT00383721|529903598|FG000|26-Week Treatment Safety Extension|Administrative|1|||
146930728|NCT00383721|529903599|FG001|26-Week Treatment Safety Extension|Administrative|2|||
146930729|NCT00383721|529903600|FG002|26-Week Treatment Safety Extension|Administrative|3|||
146930730|NCT00383721|529903601|FG003|26-Week Treatment Safety Extension|Administrative|1|||
146930731|NCT00383721|529903602|FG004|26-Week Treatment Safety Extension|Administrative|0|||
146930732|NCT03814590|529903603|FG000|Overall Study|Adverse Event|0|||
146930733|NCT03814590|529903604|FG001|Overall Study|Adverse Event|0|||
146930734|NCT03814590|529903605|FG002|Overall Study|Adverse Event|0|||
146930735|NCT03814590|529903606|FG003|Overall Study|Adverse Event|0|||
146930736|NCT03814590|529903607|FG004|Overall Study|Adverse Event|0|||
146930737|NCT03814590|529903608|FG005|Overall Study|Adverse Event|1|||
146930738|NCT03814590|529903609|FG006|Overall Study|Adverse Event|1|||
146930739|NCT03814590|529903610|FG007|Overall Study|Adverse Event|1|||
146930740|NCT03814590|529903611|FG008|Overall Study|Adverse Event|0|||
146930741|NCT03814590|529903612|FG009|Overall Study|Adverse Event|0|||
146930742|NCT03814590|529903613|FG010|Overall Study|Adverse Event|1|||
146930743|NCT03814590|529903614|FG011|Overall Study|Adverse Event|0|||
146930744|NCT03814590|529903615|FG012|Overall Study|Adverse Event|3|||
146930745|NCT03814590|529903616|FG013|Overall Study|Adverse Event|0|||
146930746|NCT03814590|529903603|FG000|Overall Study|Lost to Follow-up|0|||
146930747|NCT03814590|529903604|FG001|Overall Study|Lost to Follow-up|2|||
146930748|NCT03814590|529903605|FG002|Overall Study|Lost to Follow-up|1|||
146930749|NCT03814590|529903606|FG003|Overall Study|Lost to Follow-up|0|||
146930750|NCT03814590|529903607|FG004|Overall Study|Lost to Follow-up|1|||
146930751|NCT03814590|529903608|FG005|Overall Study|Lost to Follow-up|1|||
146930752|NCT03814590|529903609|FG006|Overall Study|Lost to Follow-up|1|||
146930753|NCT03814590|529903610|FG007|Overall Study|Lost to Follow-up|1|||
146930754|NCT03814590|529903611|FG008|Overall Study|Lost to Follow-up|0|||
146930755|NCT03814590|529903612|FG009|Overall Study|Lost to Follow-up|0|||
146930756|NCT03814590|529903613|FG010|Overall Study|Lost to Follow-up|1|||
146930757|NCT03814590|529903614|FG011|Overall Study|Lost to Follow-up|0|||
146930758|NCT03814590|529903615|FG012|Overall Study|Lost to Follow-up|0|||
146930759|NCT03814590|529903616|FG013|Overall Study|Lost to Follow-up|1|||
146930760|NCT03814590|529903603|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146930761|NCT03814590|529903604|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146930762|NCT03814590|529903605|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146930763|NCT03814590|529903606|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146930764|NCT03814590|529903607|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146930765|NCT03814590|529903608|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146930766|NCT03814590|529903609|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146930767|NCT03814590|529903610|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146930768|NCT03814590|529903611|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146930769|NCT03814590|529903612|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
146930770|NCT03814590|529903613|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146930771|NCT03814590|529903614|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146930772|NCT03814590|529903615|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146930773|NCT03814590|529903616|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146930774|NCT03814590|529903603|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
146930775|NCT03814590|529903604|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
147013210|NCT02048813|530210052|FG000|Overall Study|Complication|2|||
146930776|NCT03814590|529903605|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
146930777|NCT03814590|529903606|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
146930778|NCT03814590|529903607|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
146930779|NCT03814590|529903608|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
146930780|NCT03814590|529903609|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
146930781|NCT03814590|529903610|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
146930782|NCT03814590|529903611|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
146930783|NCT03814590|529903612|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
146930784|NCT03814590|529903613|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
146930785|NCT03814590|529903614|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
146930786|NCT03814590|529903615|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
146930787|NCT03814590|529903616|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
146930788|NCT03814590|529903603|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146930789|NCT03814590|529903604|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146930790|NCT03814590|529903605|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146930791|NCT03814590|529903606|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146930792|NCT03814590|529903607|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146930793|NCT03814590|529903608|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146930794|NCT03814590|529903609|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146930795|NCT03814590|529903610|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146696331|NCT01623596|529066357|FG001|Overall Study|Adverse Event|29|||
146696332|NCT01623596|529066356|FG000|Overall Study|Death|0|||
146696333|NCT01623596|529066357|FG001|Overall Study|Death|2|||
146696334|NCT01623596|529066356|FG000|Overall Study|Lost to Follow-up|12|||
146696335|NCT01623596|529066357|FG001|Overall Study|Lost to Follow-up|16|||
146696336|NCT01623596|529066356|FG000|Overall Study|Withdrawal by Subject|13|||
146696337|NCT01623596|529066357|FG001|Overall Study|Withdrawal by Subject|31|||
146696338|NCT01623596|529066356|FG000|Overall Study|Patient no longer requires study drug|1|||
146696339|NCT01623596|529066357|FG001|Overall Study|Patient no longer requires study drug|0|||
146696340|NCT01623596|529066356|FG000|Overall Study|Protocol Violation|0|||
146696341|NCT01623596|529066357|FG001|Overall Study|Protocol Violation|6|||
146696342|NCT01623596|529066356|FG000|Overall Study|Lack of Efficacy|5|||
146696343|NCT01623596|529066357|FG001|Overall Study|Lack of Efficacy|3|||
146696344|NCT04059146|529066358|FG000|Overall Study|Withdrawal by Subject|0|||
146696345|NCT04059146|529066359|FG001|Overall Study|Withdrawal by Subject|1|||
146696346|NCT01324349|529066360|FG000|Overall Study|Death|1|||
146696347|NCT01324349|529066361|FG001|Overall Study|Death|1|||
146696348|NCT01324349|529066360|FG000|Overall Study|Withdrawal by Subject|0|||
146696349|NCT01324349|529066361|FG001|Overall Study|Withdrawal by Subject|1|||
146696350|NCT00748215|529066362|FG000|Overall Study|Withdrawal by Subject|7|||
146696351|NCT00748215|529066363|FG001|Overall Study|Withdrawal by Subject|7|||
146696352|NCT00748215|529066362|FG000|Overall Study|Treatment change|2|||
146696353|NCT00748215|529066363|FG001|Overall Study|Treatment change|1|||
146696354|NCT00748215|529066362|FG000|Overall Study|Change in patient condition|0|||
146696355|NCT00748215|529066363|FG001|Overall Study|Change in patient condition|3|||
146696356|NCT00748215|529066362|FG000|Overall Study|Non-compliant|0|||
146696357|NCT00748215|529066363|FG001|Overall Study|Non-compliant|2|||
146696358|NCT00748215|529066362|FG000|Overall Study|Adverse Event|0|||
146696359|NCT00748215|529066363|FG001|Overall Study|Adverse Event|5|||
146696360|NCT00574405|529068219|FG000|Overall Study|Withdrawal by Subject|3|||
146696361|NCT00574405|529068220|FG001|Overall Study|Withdrawal by Subject|2|||
146696362|NCT03026257|529068222|FG000|Overall Study|Adverse Event|3|||
146696363|NCT03026257|529068223|FG001|Overall Study|Adverse Event|0|||
146696364|NCT03026257|529068224|FG002|Overall Study|Adverse Event|0|||
146696365|NCT03026257|529068225|FG003|Overall Study|Adverse Event|0|||
146696366|NCT03026257|529068226|FG004|Overall Study|Adverse Event|0|||
146696367|NCT03026257|529068227|FG005|Overall Study|Adverse Event|0|||
146696368|NCT03026257|529068222|FG000|Overall Study|Lost to Follow-up|1|||
146696369|NCT03026257|529068223|FG001|Overall Study|Lost to Follow-up|0|||
146696370|NCT03026257|529068224|FG002|Overall Study|Lost to Follow-up|0|||
146696371|NCT03026257|529068225|FG003|Overall Study|Lost to Follow-up|0|||
146696372|NCT03026257|529068226|FG004|Overall Study|Lost to Follow-up|0|||
146696373|NCT03026257|529068227|FG005|Overall Study|Lost to Follow-up|0|||
146696374|NCT03026257|529068222|FG000|Overall Study|Protocol Violation|1|||
146696375|NCT03026257|529068223|FG001|Overall Study|Protocol Violation|0|||
146696376|NCT03026257|529068224|FG002|Overall Study|Protocol Violation|0|||
146696377|NCT03026257|529068225|FG003|Overall Study|Protocol Violation|1|||
146696378|NCT03026257|529068226|FG004|Overall Study|Protocol Violation|1|||
146696379|NCT03026257|529068227|FG005|Overall Study|Protocol Violation|0|||
146696380|NCT03026257|529068222|FG000|Overall Study|Withdrawal by Subject|1|||
146696381|NCT03026257|529068223|FG001|Overall Study|Withdrawal by Subject|1|||
146696382|NCT03026257|529068224|FG002|Overall Study|Withdrawal by Subject|0|||
146696383|NCT03026257|529068225|FG003|Overall Study|Withdrawal by Subject|0|||
146696384|NCT03026257|529068226|FG004|Overall Study|Withdrawal by Subject|0|||
146696385|NCT03026257|529068227|FG005|Overall Study|Withdrawal by Subject|0|||
146696386|NCT04380857|529068228|FG000|Overall Study|Lost to Follow-up|3|||
146696387|NCT04380857|529068229|FG001|Overall Study|Lost to Follow-up|3|||
146696388|NCT00427635|529068230|FG000|Treatment Phase|Withdrawal by Subject|1|||
146696389|NCT00427635|529068231|FG001|Treatment Phase|Withdrawal by Subject|0|||
146696390|NCT00427635|529068230|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
146696391|NCT00427635|529068231|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
146696392|NCT02558790|529068232|FG000|Overall Study|Lost to Follow-up|2|||
146696393|NCT02558790|529068232|FG000|Overall Study|Physician Decision|1|||
146696394|NCT02558790|529068232|FG000|Overall Study|Withdrawal by Subject|1|||
146696395|NCT02558790|529068232|FG000|Overall Study|Screen Fail|3|||
146696396|NCT00838201|529068233|FG000|Overall Study|Investigator decision, or other reasons|2|||
146696397|NCT00838201|529068234|FG001|Overall Study|Investigator decision, or other reasons|3|||
146696398|NCT00838201|529068233|FG000|Overall Study|Noncompliance|0|||
146696399|NCT00838201|529068234|FG001|Overall Study|Noncompliance|1|||
146696400|NCT00838201|529068233|FG000|Overall Study|Administrative decision|1|||
146696401|NCT00838201|529068234|FG001|Overall Study|Administrative decision|2|||
146696402|NCT00838201|529068233|FG000|Overall Study|Disease progression|3|||
146696403|NCT00838201|529068234|FG001|Overall Study|Disease progression|3|||
146696404|NCT00838201|529068233|FG000|Overall Study|Consent withdrawn|16|||
146696405|NCT00838201|529068234|FG001|Overall Study|Consent withdrawn|19|||
146696406|NCT00838201|529068233|FG000|Overall Study|Lost to Follow-up|4|||
146696407|NCT00838201|529068234|FG001|Overall Study|Lost to Follow-up|3|||
146696408|NCT00838201|529068233|FG000|Overall Study|Adverse Event|5|||
146696409|NCT00838201|529068234|FG001|Overall Study|Adverse Event|9|||
146696410|NCT00838201|529068233|FG000|Overall Study|Death|11|||
146696411|NCT00838201|529068234|FG001|Overall Study|Death|13|||
146696412|NCT02042924|529068238|FG000|Overall Study|Early Death|1|||
146696413|NCT04033003|529068239|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
146696414|NCT04033003|529068240|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
146696415|NCT04033003|529068239|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
146696416|NCT04033003|529068240|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
146696417|NCT04033003|529068239|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
146696418|NCT04033003|529068240|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
146696419|NCT04033003|529068239|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
146696420|NCT04033003|529068240|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
146696421|NCT04033003|529068239|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
146696422|NCT04033003|529068240|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
146696423|NCT04033003|529068239|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
146696424|NCT04033003|529068240|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
146696425|NCT04033003|529068239|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
146696426|NCT04033003|529068240|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
146696427|NCT04033003|529068239|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
146696428|NCT04033003|529068240|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
146696429|NCT04033003|529068239|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
146696430|NCT04033003|529068240|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
146696431|NCT04033003|529068239|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
146696432|NCT04033003|529068240|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
146696433|NCT04033003|529068239|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
146696434|NCT04033003|529068240|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
146696435|NCT04033003|529068239|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
146696436|NCT04033003|529068240|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
146696437|NCT04033003|529068239|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
146696438|NCT04033003|529068240|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
146696439|NCT01714310|529068241|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
146696440|NCT01714310|529068242|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
146696441|NCT01714310|529068243|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
146696442|NCT01714310|529068241|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
146696443|NCT01714310|529068242|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
146930796|NCT03814590|529903611|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146930797|NCT03814590|529903612|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146930798|NCT03814590|529903613|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146696444|NCT01714310|529068243|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
146696445|NCT01714310|529068241|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
146696446|NCT01714310|529068242|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
146696447|NCT01714310|529068243|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
146696448|NCT01714310|529068241|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
146696449|NCT01714310|529068242|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
146696450|NCT01714310|529068243|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
146696451|NCT02487394|529068244|FG000|Phase 1|Withdrawal by Subject|0|||
146696452|NCT02487394|529068245|FG001|Phase 1|Withdrawal by Subject|1|||
146696453|NCT00826267|529068250|FG000|Overall Study|Other Adverse Event|1|||
146696454|NCT00826267|529068251|FG001|Overall Study|Other Adverse Event|0|||
146696455|NCT00826267|529068252|FG002|Overall Study|Other Adverse Event|0|||
146696456|NCT01675882|529068269|FG000|Overall Study|Adverse Event|0|||
146696457|NCT01675882|529068270|FG001|Overall Study|Adverse Event|2|||
146696458|NCT01675882|529068271|FG002|Overall Study|Adverse Event|1|||
146696459|NCT01675882|529068272|FG003|Overall Study|Adverse Event|0|||
146696460|NCT01675882|529068269|FG000|Overall Study|Participant unwilling to continue|2|||
146696461|NCT01675882|529068270|FG001|Overall Study|Participant unwilling to continue|4|||
146696462|NCT01675882|529068271|FG002|Overall Study|Participant unwilling to continue|2|||
146696463|NCT01675882|529068272|FG003|Overall Study|Participant unwilling to continue|1|||
146696464|NCT01675882|529068269|FG000|Overall Study|Lost to Follow-up|0|||
146696465|NCT01675882|529068270|FG001|Overall Study|Lost to Follow-up|1|||
146696466|NCT01675882|529068271|FG002|Overall Study|Lost to Follow-up|0|||
146696467|NCT01675882|529068272|FG003|Overall Study|Lost to Follow-up|0|||
146696468|NCT01675882|529068269|FG000|Overall Study|Non-compliance|0|||
146696469|NCT01675882|529068270|FG001|Overall Study|Non-compliance|0|||
146696470|NCT01675882|529068271|FG002|Overall Study|Non-compliance|0|||
146696471|NCT01675882|529068272|FG003|Overall Study|Non-compliance|1|||
146696472|NCT02711800|529068276|FG000|Overall Study|Lost to Follow-up|1|||
146696473|NCT02711800|529068276|FG000|Overall Study|Withdrawal by Subject|1|||
146696474|NCT00314574|529068289|FG000|Overall Study|Death|3|||
146696475|NCT00314574|529068290|FG001|Overall Study|Death|0|||
146696476|NCT00314574|529068289|FG000|Overall Study|Adverse Event|11|||
146696477|NCT00314574|529068290|FG001|Overall Study|Adverse Event|16|||
146696478|NCT00314574|529068289|FG000|Overall Study|Lost to Follow-up|19|||
146696479|NCT00314574|529068290|FG001|Overall Study|Lost to Follow-up|25|||
146696480|NCT00314574|529068289|FG000|Overall Study|Withdrawal by Subject|33|||
146696481|NCT00314574|529068290|FG001|Overall Study|Withdrawal by Subject|22|||
146696482|NCT00314574|529068289|FG000|Overall Study|Physician Decision|22|||
146696483|NCT00314574|529068290|FG001|Overall Study|Physician Decision|15|||
146696484|NCT00314574|529068289|FG000|Overall Study|Pregnancy|6|||
146696485|NCT00314574|529068290|FG001|Overall Study|Pregnancy|4|||
146696486|NCT00314574|529068289|FG000|Overall Study|Data unknown at database lock|0|||
146696487|NCT00314574|529068290|FG001|Overall Study|Data unknown at database lock|1|||
146696488|NCT00449956|529068291|FG000|Overall Study|Adverse Event|7|||
146696489|NCT00449956|529068292|FG001|Overall Study|Adverse Event|1|||
146696490|NCT00449956|529068293|FG002|Overall Study|Adverse Event|6|||
146696491|NCT00449956|529068291|FG000|Overall Study|Lack of Efficacy|0|||
146696492|NCT00449956|529068292|FG001|Overall Study|Lack of Efficacy|0|||
146696493|NCT00449956|529068293|FG002|Overall Study|Lack of Efficacy|1|||
146696494|NCT00449956|529068291|FG000|Overall Study|Protocol Violation|1|||
146696495|NCT00449956|529068292|FG001|Overall Study|Protocol Violation|1|||
146696496|NCT00449956|529068293|FG002|Overall Study|Protocol Violation|1|||
146696497|NCT00449956|529068291|FG000|Overall Study|Withdrawal by Subject|0|||
146696498|NCT00449956|529068292|FG001|Overall Study|Withdrawal by Subject|1|||
146696499|NCT00449956|529068293|FG002|Overall Study|Withdrawal by Subject|0|||
146696500|NCT00449956|529068291|FG000|Overall Study|Physician Decision|2|||
146696501|NCT00449956|529068292|FG001|Overall Study|Physician Decision|1|||
146696502|NCT00449956|529068293|FG002|Overall Study|Physician Decision|1|||
146696503|NCT01446965|529068298|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
146696504|NCT01446965|529068299|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
146696505|NCT01446965|529068298|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
146696506|NCT01446965|529068299|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
146696507|NCT00004412|529068300|FG000|Randomized Period|Moved to Crossover Period|3|||
146696508|NCT00004412|529068301|FG001|Randomized Period|Moved to Crossover Period|0|||
146696509|NCT00004412|529068302|FG002|Randomized Period|Moved to Crossover Period|0|||
146696510|NCT03144180|529068308|FG000|Overall Study|STAT Delivery|1|||
146696511|NCT03144180|529068309|FG001|Overall Study|STAT Delivery|1|||
146696512|NCT03144180|529068308|FG000|Overall Study|Provider forgot to fill out forms|1|||
146696513|NCT03144180|529068309|FG001|Overall Study|Provider forgot to fill out forms|3|||
146696514|NCT03144180|529068308|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
146696515|NCT03144180|529068309|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
146696516|NCT03144180|529068308|FG000|Overall Study|Scrub tech removed tube cap|0|||
146696517|NCT03144180|529068309|FG001|Overall Study|Scrub tech removed tube cap|1|||
146696518|NCT03387813|529068312|FG000|Overall Study|Death|40|||
146696519|NCT03387813|529068313|FG001|Overall Study|Death|37|||
146696520|NCT03387813|529068314|FG002|Overall Study|Death|190|||
146696521|NCT03387813|529068312|FG000|Overall Study|Withdrawal by Subject|9|||
146696522|NCT03387813|529068313|FG001|Overall Study|Withdrawal by Subject|19|||
146696523|NCT03387813|529068314|FG002|Overall Study|Withdrawal by Subject|32|||
146696524|NCT03387813|529068312|FG000|Overall Study|Lost to Follow-up|3|||
146696525|NCT03387813|529068313|FG001|Overall Study|Lost to Follow-up|9|||
146696526|NCT03387813|529068314|FG002|Overall Study|Lost to Follow-up|15|||
146930799|NCT03814590|529903614|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146930800|NCT03814590|529903615|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146930801|NCT03814590|529903616|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146930802|NCT03814590|529903603|FG000|Overall Study|UNKNOWN REASON|0|||
146930803|NCT03814590|529903604|FG001|Overall Study|UNKNOWN REASON|0|||
146930804|NCT03814590|529903605|FG002|Overall Study|UNKNOWN REASON|0|||
146930805|NCT03814590|529903606|FG003|Overall Study|UNKNOWN REASON|0|||
146930806|NCT03814590|529903607|FG004|Overall Study|UNKNOWN REASON|0|||
146930807|NCT03814590|529903608|FG005|Overall Study|UNKNOWN REASON|0|||
146930808|NCT03814590|529903609|FG006|Overall Study|UNKNOWN REASON|0|||
146930809|NCT03814590|529903610|FG007|Overall Study|UNKNOWN REASON|1|||
146930810|NCT03814590|529903611|FG008|Overall Study|UNKNOWN REASON|0|||
146930811|NCT03814590|529903612|FG009|Overall Study|UNKNOWN REASON|0|||
146930812|NCT03814590|529903613|FG010|Overall Study|UNKNOWN REASON|0|||
146930813|NCT03814590|529903614|FG011|Overall Study|UNKNOWN REASON|0|||
146930814|NCT03814590|529903615|FG012|Overall Study|UNKNOWN REASON|0|||
146930815|NCT03814590|529903616|FG013|Overall Study|UNKNOWN REASON|0|||
146930816|NCT03519516|529903622|FG000|Overall Study|Adverse Event|0|||
146930817|NCT03519516|529903623|FG001|Overall Study|Adverse Event|1|||
146930818|NCT01975246|529905281|FG000|Overall Study|Adverse Event|2|||
146930819|NCT01975246|529905282|FG001|Overall Study|Adverse Event|1|||
146930820|NCT01975246|529905281|FG000|Overall Study|Lack of Efficacy|1|||
146930821|NCT01975246|529905282|FG001|Overall Study|Lack of Efficacy|0|||
146930822|NCT01975246|529905281|FG000|Overall Study|Protocol Violation|1|||
146930823|NCT01975246|529905282|FG001|Overall Study|Protocol Violation|0|||
146930824|NCT01975246|529905281|FG000|Overall Study|Other than stated|0|||
146930825|NCT01975246|529905282|FG001|Overall Study|Other than stated|1|||
146930826|NCT00255034|529905283|FG000|Overall Study|Withdrawal by Subject|15|||
146930827|NCT00255034|529905284|FG001|Overall Study|Withdrawal by Subject|38|||
146930828|NCT01263093|529905285|FG000|Washout|Physician Decision|1|||
146930829|NCT01263093|529905286|FG001|Washout|Physician Decision|0|||
146930830|NCT01263093|529905285|FG000|Period 2|Adverse Event|1|||
146930831|NCT01263093|529905286|FG001|Period 2|Adverse Event|0|||
146930832|NCT00424346|529905287|FG000|Core Study|Adverse Event|5|||
146930833|NCT00424346|529905288|FG001|Core Study|Adverse Event|3|||
146930834|NCT00424346|529905289|FG002|Core Study|Adverse Event|1|||
146930835|NCT00424346|529905290|FG003|Core Study|Adverse Event|1|||
146930836|NCT00424346|529905287|FG000|Core Study|Abnormal Laboratory Values|0|||
146930837|NCT00424346|529905288|FG001|Core Study|Abnormal Laboratory Values|1|||
146930838|NCT00424346|529905289|FG002|Core Study|Abnormal Laboratory Values|0|||
146930839|NCT00424346|529905290|FG003|Core Study|Abnormal Laboratory Values|0|||
146930840|NCT00424346|529905287|FG000|Core Study|Lack of Efficacy|1|||
146930841|NCT00424346|529905288|FG001|Core Study|Lack of Efficacy|3|||
146930842|NCT00424346|529905289|FG002|Core Study|Lack of Efficacy|0|||
146930843|NCT00424346|529905290|FG003|Core Study|Lack of Efficacy|4|||
146930844|NCT00424346|529905287|FG000|Core Study|Withdrawal by Subject|1|||
146930845|NCT00424346|529905288|FG001|Core Study|Withdrawal by Subject|0|||
146930846|NCT00424346|529905289|FG002|Core Study|Withdrawal by Subject|0|||
146930847|NCT00424346|529905290|FG003|Core Study|Withdrawal by Subject|2|||
146696527|NCT03387813|529068312|FG000|Overall Study|Non-Compliance|6|||
146696528|NCT03387813|529068313|FG001|Overall Study|Non-Compliance|6|||
146696529|NCT03387813|529068314|FG002|Overall Study|Non-Compliance|31|||
146696530|NCT03387813|529068312|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
146696531|NCT03387813|529068313|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
146696532|NCT03387813|529068314|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
146696533|NCT00743652|529068315|FG000|Overall Study|Parent/Legal Guardian Request|3|||
146696534|NCT00743652|529068316|FG001|Overall Study|Parent/Legal Guardian Request|2|||
146696535|NCT00743652|529068317|FG002|Overall Study|Parent/Legal Guardian Request|2|||
146696536|NCT00743652|529068318|FG003|Overall Study|Parent/Legal Guardian Request|2|||
146696537|NCT00743652|529068319|FG004|Overall Study|Parent/Legal Guardian Request|0|||
146696538|NCT00743652|529068315|FG000|Overall Study|Adverse Event|3|||
146696539|NCT00743652|529068316|FG001|Overall Study|Adverse Event|0|||
146696540|NCT00743652|529068317|FG002|Overall Study|Adverse Event|0|||
146696541|NCT00743652|529068318|FG003|Overall Study|Adverse Event|0|||
146696542|NCT00743652|529068319|FG004|Overall Study|Adverse Event|0|||
146696543|NCT00743652|529068315|FG000|Overall Study|Death|2|||
146696544|NCT00743652|529068316|FG001|Overall Study|Death|0|||
146696545|NCT00743652|529068317|FG002|Overall Study|Death|0|||
146696546|NCT00743652|529068318|FG003|Overall Study|Death|0|||
146696547|NCT00743652|529068319|FG004|Overall Study|Death|0|||
146696548|NCT00743652|529068315|FG000|Overall Study|Investigator Request|0|||
146696549|NCT00743652|529068316|FG001|Overall Study|Investigator Request|0|||
146696550|NCT00743652|529068317|FG002|Overall Study|Investigator Request|0|||
146696551|NCT00743652|529068318|FG003|Overall Study|Investigator Request|2|||
146696552|NCT00743652|529068319|FG004|Overall Study|Investigator Request|0|||
146696553|NCT00743652|529068315|FG000|Overall Study|Other|1|||
146930848|NCT00424346|529905287|FG000|Core Study|Lost to Follow-up|1|||
146930849|NCT00424346|529905288|FG001|Core Study|Lost to Follow-up|1|||
146696554|NCT00743652|529068316|FG001|Overall Study|Other|1|||
146696555|NCT00743652|529068317|FG002|Overall Study|Other|0|||
146696556|NCT00743652|529068318|FG003|Overall Study|Other|0|||
146696557|NCT00743652|529068319|FG004|Overall Study|Other|0|||
146696558|NCT00743652|529068315|FG000|Overall Study|Lost to Follow-up|1|||
146696559|NCT00743652|529068316|FG001|Overall Study|Lost to Follow-up|0|||
146696560|NCT00743652|529068317|FG002|Overall Study|Lost to Follow-up|0|||
146696561|NCT00743652|529068318|FG003|Overall Study|Lost to Follow-up|0|||
146696562|NCT00743652|529068319|FG004|Overall Study|Lost to Follow-up|0|||
146696563|NCT02547129|529068320|FG000|Overall Study|Difficulty with ongoing infection|1|||
146696564|NCT02547129|529068321|FG001|Overall Study|Difficulty with ongoing infection|0|||
146696565|NCT00805766|529068322|FG000|Screening Period|Adverse Event|1|||
146696566|NCT00805766|529068322|FG000|Screening Period|Lack of Efficacy|2|||
146696567|NCT00805766|529068322|FG000|Screening Period|Pregnancy|1|||
146696568|NCT00805766|529068322|FG000|Screening Period|Responder|2|||
146696569|NCT00805766|529068322|FG000|Increased Dose Period|Adverse Event|4|||
146696570|NCT00805766|529068322|FG000|Increased Dose Period|Lack of Efficacy|7|||
146696571|NCT00805766|529068322|FG000|Increased Dose Period|Pregnancy|1|||
146696572|NCT00805766|529068322|FG000|Increased Dose Period|Withdrawal by Subject|1|||
146696573|NCT04371380|529068323|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
146696574|NCT04371380|529068324|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
146696575|NCT04371380|529068325|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
146696576|NCT01640366|529068326|FG000|Overall Study|Withdrawal by Subject|1|||
146696577|NCT01640366|529068326|FG000|Overall Study|Protocol Violation|16|||
146696578|NCT01640366|529068326|FG000|Overall Study|Lost to Follow-up|5|||
146696579|NCT02739269|529068327|FG000|Overall Study|Protocol Violation|5|||
146696580|NCT02739269|529068328|FG001|Overall Study|Protocol Violation|0|||
146696581|NCT02739269|529068327|FG000|Overall Study|Cycle cancellation|2|||
146696582|NCT02739269|529068328|FG001|Overall Study|Cycle cancellation|2|||
146696583|NCT02739269|529068327|FG000|Overall Study|Withdrawal by Subject|0|||
146696584|NCT02739269|529068328|FG001|Overall Study|Withdrawal by Subject|2|||
146696585|NCT00405548|529068331|FG000|Overall Study|Cognitive Memory problems on study day|1|||
146696586|NCT00405548|529068332|FG001|Overall Study|Cognitive Memory problems on study day|0|||
146696587|NCT00405548|529068331|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
146696588|NCT00405548|529068332|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
146696589|NCT00405548|529068331|FG000|Overall Study|Unable to self-administer shots|1|||
146696590|NCT00405548|529068332|FG001|Overall Study|Unable to self-administer shots|0|||
146696591|NCT00405548|529068331|FG000|Overall Study|Venous access failed during study day|1|||
146696592|NCT00405548|529068332|FG001|Overall Study|Venous access failed during study day|0|||
146696593|NCT00405548|529068331|FG000|Overall Study|Withdrawal by Subject|1|||
146696594|NCT00405548|529068332|FG001|Overall Study|Withdrawal by Subject|0|||
146696595|NCT01709695|529068333|FG000|Overall Study|Withdrawal by Subject|1|||
146696596|NCT01709695|529068334|FG001|Overall Study|Withdrawal by Subject|1|||
146696597|NCT00680901|529068338|FG000|Overall Study|Ongoing: On Study Treatment|1|||
146696598|NCT00680901|529068339|FG001|Overall Study|Ongoing: On Study Treatment|0|||
146696599|NCT00680901|529068338|FG000|Overall Study|Ongoing: In Follow Up|1|||
146696600|NCT00680901|529068339|FG001|Overall Study|Ongoing: In Follow Up|0|||
146696601|NCT00680901|529068338|FG000|Overall Study|Adverse Event|1|||
146696602|NCT00680901|529068339|FG001|Overall Study|Adverse Event|1|||
146696603|NCT00680901|529068338|FG000|Overall Study|Lost to Follow-up|3|||
146696604|NCT00680901|529068339|FG001|Overall Study|Lost to Follow-up|5|||
146696605|NCT00680901|529068338|FG000|Overall Study|Subject decided to withdraw from the study|4|||
146696606|NCT00680901|529068339|FG001|Overall Study|Subject decided to withdraw from the study|15|||
146696607|NCT00680901|529068338|FG000|Overall Study|Sponsor decision|1|||
146696608|NCT00680901|529068339|FG001|Overall Study|Sponsor decision|0|||
146696609|NCT00680901|529068338|FG000|Overall Study|Physician Decision|0|||
146696610|NCT00680901|529068339|FG001|Overall Study|Physician Decision|2|||
146696611|NCT00680901|529068338|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
146696612|NCT00680901|529068339|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
146696613|NCT00680901|529068338|FG000|Overall Study|Other protocol defined stopping criteria|17|||
146696614|NCT00680901|529068339|FG001|Overall Study|Other protocol defined stopping criteria|17|||
146930850|NCT00424346|529905289|FG002|Core Study|Lost to Follow-up|0|||
146696615|NCT00075582|529068340|FG000|Overall Study|Adverse Event|3|||
146696616|NCT00075582|529068341|FG001|Overall Study|Adverse Event|1|||
146696617|NCT00075582|529068340|FG000|Overall Study|Lack of Efficacy|4|||
146696618|NCT00075582|529068341|FG001|Overall Study|Lack of Efficacy|8|||
146696619|NCT00075582|529068340|FG000|Overall Study|Physician Decision|5|||
146930851|NCT00424346|529905290|FG003|Core Study|Lost to Follow-up|0|||
146696620|NCT00075582|529068341|FG001|Overall Study|Physician Decision|8|||
146696621|NCT00075582|529068340|FG000|Overall Study|Withdrawal by Subject|2|||
146696622|NCT00075582|529068341|FG001|Overall Study|Withdrawal by Subject|2|||
146696623|NCT00075582|529068340|FG000|Overall Study|Ineligible for study|36|||
146696624|NCT00075582|529068341|FG001|Overall Study|Ineligible for study|16|||
146696625|NCT01177540|529068342|FG000|Overall Study|Adverse Event|1|||
146696626|NCT01177540|529068343|FG001|Overall Study|Adverse Event|0|||
146930852|NCT00424346|529905287|FG000|Core Study|Administrative Problems|1|||
146980652|NCT01504867|530091254|FG001|Overall Study|Inclusion criteria not met|2|||
146980653|NCT01504867|530091253|FG000|Overall Study|Consent revoked|5|||
146980654|NCT01504867|530091254|FG001|Overall Study|Consent revoked|1|||
146980655|NCT00571922|530091255|FG000|Overall Study|Completion unknown|36|||
146980656|NCT00571922|530091256|FG001|Overall Study|Completion unknown|36|||
146980657|NCT01783730|530091263|FG000|Overall Study|Failed to meet inclusion criteria|6|||
146980658|NCT02533999|530091264|FG000|Overall Study|Lost to Follow-up|3|||
146980659|NCT02533999|530091265|FG001|Overall Study|Lost to Follow-up|5|||
146980660|NCT02533999|530091264|FG000|Overall Study|Protocol Violation|3|||
146980661|NCT02533999|530091265|FG001|Overall Study|Protocol Violation|0|||
146980662|NCT02533999|530091264|FG000|Overall Study|Adverse Event|0|||
146980663|NCT02533999|530091265|FG001|Overall Study|Adverse Event|1|||
146980664|NCT02533999|530091264|FG000|Overall Study|Randomized but intervention not received|0|||
146980665|NCT02533999|530091265|FG001|Overall Study|Randomized but intervention not received|1|||
146980666|NCT03210259|530091266|FG000|12-Week Run-in Period|Adverse Event|1|||
146980667|NCT03210259|530091267|FG001|12-Week Run-in Period|Adverse Event|0|||
146980668|NCT03210259|530091268|FG002|12-Week Run-in Period|Adverse Event|0|||
146980669|NCT03210259|530091266|FG000|12-Week Run-in Period|Death|1|||
146980670|NCT03210259|530091267|FG001|12-Week Run-in Period|Death|0|||
146980671|NCT03210259|530091268|FG002|12-Week Run-in Period|Death|0|||
146980672|NCT03210259|530091266|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
146980673|NCT03210259|530091267|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
146980674|NCT03210259|530091268|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
146980675|NCT03210259|530091266|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
146980676|NCT03210259|530091267|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
146980677|NCT03210259|530091268|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
146980678|NCT03210259|530091266|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
146980679|NCT03210259|530091267|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
146980680|NCT03210259|530091268|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
146980681|NCT03210259|530091266|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
146980682|NCT03210259|530091267|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
146980683|NCT03210259|530091268|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
146980684|NCT03210259|530091266|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
146980685|NCT03210259|530091267|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
146980686|NCT03210259|530091268|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
146980687|NCT03210259|530091266|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
146980688|NCT03210259|530091267|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
146980689|NCT03210259|530091268|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
146980690|NCT03210259|530091266|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
146980691|NCT03210259|530091267|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
146980692|NCT03210259|530091268|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
146980693|NCT03210259|530091266|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
146980694|NCT03210259|530091267|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
146980695|NCT03210259|530091268|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
146980696|NCT03210259|530091266|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
146980697|NCT03210259|530091267|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
146980698|NCT03210259|530091268|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
146980699|NCT01154153|530091271|FG000|Overall Study|Poor compliance to protocol|2|||
146980700|NCT01154153|530091272|FG001|Overall Study|Poor compliance to protocol|0|||
146980701|NCT01154153|530091271|FG000|Overall Study|Unable to use labs|2|||
146980702|NCT01154153|530091272|FG001|Overall Study|Unable to use labs|3|||
146980703|NCT01154153|530091271|FG000|Overall Study|Withdrew consent|1|||
146980704|NCT01154153|530091272|FG001|Overall Study|Withdrew consent|0|||
146980705|NCT00964223|530091279|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
146980706|NCT04304950|530091280|FG000|Overall Study|Lost to Follow-up|1|||
146980707|NCT04304950|530091281|FG001|Overall Study|Lost to Follow-up|1|||
146980708|NCT00408876|530091282|FG000|Overall Study|Adverse Event|9|||
146980709|NCT00408876|530091283|FG001|Overall Study|Adverse Event|17|||
146980710|NCT00408876|530091284|FG002|Overall Study|Adverse Event|27|||
146980711|NCT00408876|530091285|FG003|Overall Study|Adverse Event|10|||
146980712|NCT00408876|530091282|FG000|Overall Study|Withdrawal by Subject|3|||
146980713|NCT00408876|530091283|FG001|Overall Study|Withdrawal by Subject|6|||
146980714|NCT00408876|530091284|FG002|Overall Study|Withdrawal by Subject|6|||
146980715|NCT00408876|530091285|FG003|Overall Study|Withdrawal by Subject|14|||
146980716|NCT00408876|530091282|FG000|Overall Study|Lack of Efficacy|2|||
146980717|NCT00408876|530091283|FG001|Overall Study|Lack of Efficacy|4|||
146980718|NCT00408876|530091284|FG002|Overall Study|Lack of Efficacy|5|||
146980719|NCT00408876|530091285|FG003|Overall Study|Lack of Efficacy|6|||
146980720|NCT00408876|530091282|FG000|Overall Study|Lost to Follow-up|1|||
146980721|NCT00408876|530091283|FG001|Overall Study|Lost to Follow-up|6|||
146980722|NCT00408876|530091284|FG002|Overall Study|Lost to Follow-up|5|||
146980723|NCT00408876|530091285|FG003|Overall Study|Lost to Follow-up|2|||
146980724|NCT00408876|530091282|FG000|Overall Study|Protocol Violation|0|||
146980725|NCT00408876|530091283|FG001|Overall Study|Protocol Violation|3|||
146980726|NCT00408876|530091284|FG002|Overall Study|Protocol Violation|4|||
146696627|NCT00856908|529068364|FG000|Overall Study|Lost to Follow-up|1|||
146696628|NCT00856908|529068365|FG001|Overall Study|Lost to Follow-up|0|||
146696629|NCT01070316|529068368|FG000|Extension Phase|Lack of Efficacy|3|||
146696630|NCT01070316|529068368|FG000|Extension Phase|Withdrawal by Subject|1|||
146696631|NCT02013167|529068372|FG000|Overall Study|Withdrawal by Subject|15|||
146696632|NCT02013167|529068373|FG001|Overall Study|Withdrawal by Subject|14|||
146696633|NCT02013167|529068372|FG000|Overall Study|Sponsor Decision|1|||
146696634|NCT02013167|529068373|FG001|Overall Study|Sponsor Decision|3|||
146696635|NCT02013167|529068372|FG000|Overall Study|Lost to Follow-up|0|||
146696636|NCT02013167|529068373|FG001|Overall Study|Lost to Follow-up|1|||
146696637|NCT02013167|529068372|FG000|Overall Study|Death|85|||
146696638|NCT02013167|529068373|FG001|Overall Study|Death|160|||
146696639|NCT00842348|529068376|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
146696640|NCT00842348|529068377|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
146696641|NCT00842348|529068376|FG000|Study 729|Disease progression/death|19|||
146696642|NCT00842348|529068377|FG001|Study 729|Disease progression/death|30|||
146696643|NCT00842348|529068376|FG000|Study 729|Adverse Event|1|||
146696644|NCT00842348|529068377|FG001|Study 729|Adverse Event|1|||
146696645|NCT00842348|529068376|FG000|Study 729|Protocol Violation|1|||
146696646|NCT00842348|529068377|FG001|Study 729|Protocol Violation|1|||
146696647|NCT00842348|529068376|FG000|Study 729|Withdrawal by Subject|2|||
146696648|NCT00842348|529068377|FG001|Study 729|Withdrawal by Subject|4|||
146696649|NCT00842348|529068376|FG000|Study 729|Due to Sponsor stopping the study|1|||
146696650|NCT00842348|529068377|FG001|Study 729|Due to Sponsor stopping the study|1|||
146696651|NCT00842348|529068376|FG000|Study 729|Due to non-availability of IP|0|||
146696652|NCT00842348|529068377|FG001|Study 729|Due to non-availability of IP|1|||
146696653|NCT00842348|529068376|FG000|Study 729|Sponsor's decision|1|||
146696654|NCT00842348|529068377|FG001|Study 729|Sponsor's decision|0|||
146696655|NCT00842348|529068376|FG000|Study 729|Surgical resection|1|||
146696656|NCT00842348|529068377|FG001|Study 729|Surgical resection|0|||
146696657|NCT01113879|529068380|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
146696658|NCT01113879|529068381|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
146696659|NCT00026793|529068382|FG000|Overall Study|Death on study due to underlying disease|4|||
146696660|NCT00026793|529068382|FG000|Overall Study|Physician Decision|2|||
146696661|NCT00026793|529068382|FG000|Overall Study|Off study|2|||
146696662|NCT04151290|529068383|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
146696663|NCT01132495|529068384|FG000|Overall Study|Various reasons|40|||
146696664|NCT01132495|529068385|FG001|Overall Study|Various reasons|38|||
146696665|NCT01132495|529068386|FG002|Overall Study|Various reasons|20|||
146696666|NCT01132495|529068387|FG003|Overall Study|Various reasons|12|||
146696667|NCT00082433|529068390|FG000|Overall Study|Adverse Event|12|||
146696668|NCT00082433|529068391|FG001|Overall Study|Adverse Event|17|||
146696669|NCT00082433|529068390|FG000|Overall Study|Death|8|||
146696670|NCT00082433|529068391|FG001|Overall Study|Death|18|||
146696671|NCT00082433|529068390|FG000|Overall Study|Disease Progression/Relapse|270|||
146696672|NCT00082433|529068391|FG001|Overall Study|Disease Progression/Relapse|388|||
146696673|NCT00082433|529068390|FG000|Overall Study|Physician Decision|50|||
146696674|NCT00082433|529068391|FG001|Overall Study|Physician Decision|61|||
146696675|NCT00082433|529068390|FG000|Overall Study|Lost to Follow-up|1|||
146696676|NCT00082433|529068391|FG001|Overall Study|Lost to Follow-up|2|||
146696677|NCT00082433|529068390|FG000|Overall Study|Study Drug Toxicity|179|||
146696678|NCT00082433|529068391|FG001|Overall Study|Study Drug Toxicity|66|||
146696679|NCT00082433|529068390|FG000|Overall Study|Withdrawal by Subject|55|||
146696680|NCT00082433|529068391|FG001|Overall Study|Withdrawal by Subject|30|||
146696681|NCT00082433|529068390|FG000|Overall Study|Still On Treatment|2|||
146696682|NCT00082433|529068391|FG001|Overall Study|Still On Treatment|1|||
146696683|NCT00082433|529068390|FG000|Overall Study|Not Treated|12|||
146696684|NCT00082433|529068391|FG001|Overall Study|Not Treated|11|||
146696685|NCT00082433|529068390|FG000|Overall Study|Ineligible|2|||
146696686|NCT00082433|529068391|FG001|Overall Study|Ineligible|1|||
146696687|NCT00082433|529068390|FG000|Overall Study|Noncompliance|2|||
146696688|NCT00082433|529068391|FG001|Overall Study|Noncompliance|1|||
146696689|NCT00082433|529068390|FG000|Overall Study|New primary cancer|1|||
146696690|NCT00082433|529068391|FG001|Overall Study|New primary cancer|0|||
146696691|NCT00082433|529068390|FG000|Overall Study|Impending surgery|0|||
146696692|NCT00082433|529068391|FG001|Overall Study|Impending surgery|1|||
146696693|NCT02276612|529068394|FG000|Overall Study|Death|1|||
146696694|NCT02276612|529068395|FG001|Overall Study|Death|0|||
146696695|NCT02276612|529068394|FG000|Overall Study|Pregnancy|1|||
146696696|NCT02276612|529068395|FG001|Overall Study|Pregnancy|0|||
146696697|NCT02276612|529068394|FG000|Overall Study|Withdrew Consent|1|||
146696698|NCT02276612|529068395|FG001|Overall Study|Withdrew Consent|0|||
146696699|NCT02276612|529068394|FG000|Overall Study|Lost to Follow-up|1|||
146696700|NCT02276612|529068395|FG001|Overall Study|Lost to Follow-up|0|||
146696701|NCT01796197|529068396|FG000|Overall Study|Lost to Follow-up|1|||
146696702|NCT01796197|529068396|FG000|Overall Study|Lack of Efficacy|1|||
146696703|NCT04097821|529068397|FG000|Overall Study|Subject Decision|0|||
146696704|NCT04097821|529068398|FG001|Overall Study|Subject Decision|0|||
146696705|NCT04097821|529068399|FG002|Overall Study|Subject Decision|0|||
146696706|NCT04097821|529068400|FG003|Overall Study|Subject Decision|1|||
146696707|NCT04097821|529068401|FG004|Overall Study|Subject Decision|2|||
146696708|NCT04097821|529068402|FG005|Overall Study|Subject Decision|2|||
146696709|NCT04097821|529068403|FG006|Overall Study|Subject Decision|0|||
146696710|NCT04097821|529068404|FG007|Overall Study|Subject Decision|1|||
146696711|NCT04097821|529068397|FG000|Overall Study|Death|0|||
146696712|NCT04097821|529068398|FG001|Overall Study|Death|0|||
146696713|NCT04097821|529068399|FG002|Overall Study|Death|3|||
146696714|NCT04097821|529068400|FG003|Overall Study|Death|1|||
146696715|NCT04097821|529068401|FG004|Overall Study|Death|0|||
146696716|NCT04097821|529068402|FG005|Overall Study|Death|0|||
146696717|NCT04097821|529068403|FG006|Overall Study|Death|0|||
146696718|NCT04097821|529068404|FG007|Overall Study|Death|0|||
146696719|NCT04097821|529068397|FG000|Overall Study|Physician Decision|1|||
146696720|NCT04097821|529068398|FG001|Overall Study|Physician Decision|2|||
146696721|NCT04097821|529068399|FG002|Overall Study|Physician Decision|0|||
146696722|NCT04097821|529068400|FG003|Overall Study|Physician Decision|0|||
146696723|NCT04097821|529068401|FG004|Overall Study|Physician Decision|0|||
146696724|NCT04097821|529068402|FG005|Overall Study|Physician Decision|0|||
146696725|NCT04097821|529068403|FG006|Overall Study|Physician Decision|0|||
146696726|NCT04097821|529068404|FG007|Overall Study|Physician Decision|0|||
146696727|NCT04097821|529068397|FG000|Overall Study|Adverse Event|0|||
146696728|NCT04097821|529068398|FG001|Overall Study|Adverse Event|0|||
146696729|NCT04097821|529068399|FG002|Overall Study|Adverse Event|1|||
146696730|NCT04097821|529068400|FG003|Overall Study|Adverse Event|1|||
146696731|NCT04097821|529068401|FG004|Overall Study|Adverse Event|0|||
146696732|NCT04097821|529068402|FG005|Overall Study|Adverse Event|0|||
146696733|NCT04097821|529068403|FG006|Overall Study|Adverse Event|0|||
146696734|NCT04097821|529068404|FG007|Overall Study|Adverse Event|0|||
146696735|NCT04097821|529068397|FG000|Overall Study|New Therapy For Study Indication|0|||
146696736|NCT04097821|529068398|FG001|Overall Study|New Therapy For Study Indication|0|||
146696737|NCT04097821|529068399|FG002|Overall Study|New Therapy For Study Indication|0|||
146696738|NCT04097821|529068400|FG003|Overall Study|New Therapy For Study Indication|0|||
146696739|NCT04097821|529068401|FG004|Overall Study|New Therapy For Study Indication|0|||
146696740|NCT04097821|529068402|FG005|Overall Study|New Therapy For Study Indication|0|||
146696741|NCT04097821|529068403|FG006|Overall Study|New Therapy For Study Indication|1|||
146696742|NCT04097821|529068404|FG007|Overall Study|New Therapy For Study Indication|0|||
146696743|NCT00244712|529068405|FG000|Overall Study|Adverse Event|20|||
146696744|NCT00244712|529068406|FG001|Overall Study|Adverse Event|21|||
146696745|NCT00244712|529068405|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
146696746|NCT00244712|529068406|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
146696747|NCT00244712|529068405|FG000|Overall Study|Lack of Compliance|10|||
146696748|NCT00244712|529068406|FG001|Overall Study|Lack of Compliance|11|||
146696749|NCT00244712|529068405|FG000|Overall Study|Lost to Follow-up|45|||
146696750|NCT00244712|529068406|FG001|Overall Study|Lost to Follow-up|52|||
146696751|NCT00244712|529068405|FG000|Overall Study|Withdrawal by Subject|13|||
146696752|NCT00244712|529068406|FG001|Overall Study|Withdrawal by Subject|23|||
146696753|NCT00244712|529068405|FG000|Overall Study|Protocol Violation, disease progression|13|||
146696754|NCT00244712|529068406|FG001|Overall Study|Protocol Violation, disease progression|11|||
146696755|NCT01572038|529070127|FG000|Overall Study|Death|648|||
146696756|NCT01572038|529070127|FG000|Overall Study|Withdrawal by Subject|204|||
146696757|NCT01572038|529070127|FG000|Overall Study|Lost to Follow-up|81|||
146696758|NCT01572038|529070127|FG000|Overall Study|Physician Decision|20|||
146696759|NCT01572038|529070127|FG000|Overall Study|Patient Decision|14|||
146696760|NCT01572038|529070127|FG000|Overall Study|Progressive Disease|8|||
146696761|NCT01572038|529070127|FG000|Overall Study|Site Closed Before Completing Form|6|||
146696762|NCT01572038|529070127|FG000|Overall Study|Enrolled into Another Trial|3|||
146696763|NCT01572038|529070127|FG000|Overall Study|Participated in Another Trial|3|||
146696764|NCT01572038|529070127|FG000|Overall Study|Termination by Sponsor|2|||
146696765|NCT01572038|529070127|FG000|Overall Study|Patient Deterioration|1|||
146696766|NCT01572038|529070127|FG000|Overall Study|Sponsor Decision|1|||
146696767|NCT01888497|529070128|FG000|Washout Period 1|Withdrawal by Subject|0|||
146696768|NCT01888497|529070129|FG001|Washout Period 1|Withdrawal by Subject|0|||
146696769|NCT01888497|529070130|FG002|Washout Period 1|Withdrawal by Subject|1|||
146696770|NCT01888497|529070131|FG003|Washout Period 1|Withdrawal by Subject|1|||
146696771|NCT01888497|529070128|FG000|Washout Period 2|Adverse Event|0|||
146696772|NCT01888497|529070129|FG001|Washout Period 2|Adverse Event|0|||
146696773|NCT01888497|529070130|FG002|Washout Period 2|Adverse Event|0|||
146696774|NCT01888497|529070131|FG003|Washout Period 2|Adverse Event|1|||
146696775|NCT01888497|529070128|FG000|Washout Period 2|Withdrawal by Subject|0|||
146980727|NCT00408876|530091285|FG003|Overall Study|Protocol Violation|3|||
146980728|NCT00408876|530091282|FG000|Overall Study|Physician Decision|1|||
146696776|NCT01888497|529070129|FG001|Washout Period 2|Withdrawal by Subject|0|||
146696777|NCT01888497|529070130|FG002|Washout Period 2|Withdrawal by Subject|0|||
146696778|NCT01888497|529070131|FG003|Washout Period 2|Withdrawal by Subject|1|||
146696779|NCT04152447|529070132|FG000|Overall Study|Lost to Follow-up|1|||
146696780|NCT04152447|529070133|FG001|Overall Study|Lost to Follow-up|0|||
146696781|NCT04152447|529070132|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
146696782|NCT04152447|529070133|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
146776014|NCT02590432|529351242|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
146776015|NCT02590432|529351243|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
146776016|NCT02590432|529351244|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
146776017|NCT02590432|529351245|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
146776018|NCT02590432|529351246|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
146776019|NCT02590432|529351238|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
146776020|NCT02590432|529351239|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
146776021|NCT02590432|529351240|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
146776022|NCT02590432|529351241|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
146776023|NCT02590432|529351242|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
146776024|NCT02590432|529351243|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
146776025|NCT02590432|529351244|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
146776026|NCT02590432|529351245|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
146776027|NCT02590432|529351246|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
146776028|NCT02590432|529351238|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
146776029|NCT02590432|529351239|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
146776030|NCT02590432|529351240|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
146776031|NCT02590432|529351241|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
146776032|NCT02590432|529351242|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
146776033|NCT02590432|529351243|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
146776034|NCT02590432|529351244|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
146776035|NCT02590432|529351245|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
146930853|NCT00424346|529905288|FG001|Core Study|Administrative Problems|0|||
146930854|NCT00424346|529905289|FG002|Core Study|Administrative Problems|1|||
146930855|NCT00424346|529905290|FG003|Core Study|Administrative Problems|0|||
146930856|NCT00424346|529905287|FG000|Core Study|Protocol Violation|0|||
146930857|NCT00424346|529905288|FG001|Core Study|Protocol Violation|0|||
146930858|NCT00424346|529905289|FG002|Core Study|Protocol Violation|2|||
146930859|NCT00424346|529905290|FG003|Core Study|Protocol Violation|0|||
146930860|NCT00424346|529905287|FG000|Extension Phase|Adverse Event|0|||
146930861|NCT00424346|529905288|FG001|Extension Phase|Adverse Event|9|||
146930862|NCT00424346|529905289|FG002|Extension Phase|Adverse Event|5|||
146930863|NCT00424346|529905290|FG003|Extension Phase|Adverse Event|4|||
146930864|NCT00424346|529905287|FG000|Extension Phase|Lack of Efficacy|0|||
146930865|NCT00424346|529905288|FG001|Extension Phase|Lack of Efficacy|16|||
146930866|NCT00424346|529905289|FG002|Extension Phase|Lack of Efficacy|14|||
146930867|NCT00424346|529905290|FG003|Extension Phase|Lack of Efficacy|11|||
146930868|NCT00424346|529905287|FG000|Extension Phase|Withdrawal by Subject|0|||
146930869|NCT00424346|529905288|FG001|Extension Phase|Withdrawal by Subject|5|||
146930870|NCT00424346|529905289|FG002|Extension Phase|Withdrawal by Subject|3|||
146776036|NCT02590432|529351246|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
146776037|NCT02590432|529351238|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
146776038|NCT02590432|529351239|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
146776039|NCT02590432|529351240|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
146776040|NCT02590432|529351241|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
146776041|NCT02590432|529351242|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
146776042|NCT02590432|529351243|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
146776043|NCT02590432|529351244|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
146776044|NCT02590432|529351245|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
146776045|NCT02590432|529351246|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
146930871|NCT00424346|529905290|FG003|Extension Phase|Withdrawal by Subject|4|||
146930872|NCT00424346|529905287|FG000|Extension Phase|Lost to Follow-up|0|||
146930873|NCT00424346|529905288|FG001|Extension Phase|Lost to Follow-up|2|||
146930874|NCT00424346|529905289|FG002|Extension Phase|Lost to Follow-up|0|||
146930875|NCT00424346|529905290|FG003|Extension Phase|Lost to Follow-up|0|||
146930876|NCT00424346|529905287|FG000|Extension Phase|Administrative Problems|0|||
146930877|NCT00424346|529905288|FG001|Extension Phase|Administrative Problems|69|||
146930878|NCT00424346|529905289|FG002|Extension Phase|Administrative Problems|32|||
146930879|NCT00424346|529905290|FG003|Extension Phase|Administrative Problems|35|||
146930880|NCT00424346|529905287|FG000|Extension Phase|Death|0|||
146930881|NCT00424346|529905288|FG001|Extension Phase|Death|0|||
146930882|NCT00424346|529905289|FG002|Extension Phase|Death|0|||
146930883|NCT00424346|529905290|FG003|Extension Phase|Death|1|||
146930884|NCT00424346|529905287|FG000|Extension Phase|Protocol Violation|0|||
146930885|NCT00424346|529905288|FG001|Extension Phase|Protocol Violation|1|||
146930886|NCT00424346|529905289|FG002|Extension Phase|Protocol Violation|1|||
146930887|NCT00424346|529905290|FG003|Extension Phase|Protocol Violation|0|||
146930888|NCT03287245|529905291|FG000|Overall Study|Study terminated by sponsor|3|||
146930889|NCT03287245|529905292|FG001|Overall Study|Study terminated by sponsor|0|||
146930890|NCT03287245|529905293|FG002|Overall Study|Study terminated by sponsor|3|||
146930891|NCT03287245|529905294|FG003|Overall Study|Study terminated by sponsor|1|||
146930892|NCT03287245|529905291|FG000|Overall Study|Adverse Event|1|||
146696783|NCT04152447|529070132|FG000|Overall Study|Withdrawal by Subject|0|||
146696784|NCT04152447|529070133|FG001|Overall Study|Withdrawal by Subject|1|||
146696785|NCT04152447|529070132|FG000|Overall Study|Found ineligible after enrolling|1|||
146696786|NCT04152447|529070133|FG001|Overall Study|Found ineligible after enrolling|1|||
146696787|NCT04152447|529070132|FG000|Overall Study|Did not receive VR headset in time.|0|||
146696788|NCT04152447|529070133|FG001|Overall Study|Did not receive VR headset in time.|2|||
146696789|NCT01275066|529070138|FG000|Overall Study|Withdrawal by Subject|0|||
146696790|NCT01275066|529070139|FG001|Overall Study|Withdrawal by Subject|0|||
146696791|NCT01275066|529070140|FG002|Overall Study|Withdrawal by Subject|1|||
146696792|NCT01275066|529070138|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
146696793|NCT01275066|529070139|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
146696794|NCT01275066|529070140|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
146696795|NCT00394212|529070143|FG000|Overall Study|Lost to Follow-up|3|||
146696796|NCT00394212|529070144|FG001|Overall Study|Lost to Follow-up|0|||
146696797|NCT00394212|529070143|FG000|Overall Study|Withdrawal by Subject|4|||
146696798|NCT00394212|529070144|FG001|Overall Study|Withdrawal by Subject|1|||
146696799|NCT00588445|529070145|FG000|Overall Study|Protocol Violation|1|||
146696800|NCT00588445|529070145|FG000|Overall Study|Withdrawal by Subject|3|||
146696801|NCT00588445|529070145|FG000|Overall Study|Disease Progression|1|||
146696802|NCT00588445|529070145|FG000|Overall Study|Not Treated|10|||
146696803|NCT03240133|529070146|FG000|Overall Study|Withdrawal by Subject|0|||
146696804|NCT03240133|529070147|FG001|Overall Study|Withdrawal by Subject|1|||
146696805|NCT03240133|529070148|FG002|Overall Study|Withdrawal by Subject|0|||
146696806|NCT03240133|529070146|FG000|Overall Study|Adverse Event|1|||
146696807|NCT03240133|529070147|FG001|Overall Study|Adverse Event|1|||
146696808|NCT03240133|529070148|FG002|Overall Study|Adverse Event|0|||
146696809|NCT03240133|529070146|FG000|Overall Study|Rash|1|||
146696810|NCT03240133|529070147|FG001|Overall Study|Rash|0|||
146696811|NCT03240133|529070148|FG002|Overall Study|Rash|0|||
146696812|NCT03240133|529070146|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
146696813|NCT03240133|529070147|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
146696814|NCT03240133|529070148|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
146696815|NCT03240133|529070146|FG000|Overall Study|Intercurrent illness.|0|||
146696816|NCT03240133|529070147|FG001|Overall Study|Intercurrent illness.|1|||
146696817|NCT03240133|529070148|FG002|Overall Study|Intercurrent illness.|0|||
146696818|NCT03240133|529070146|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
146696819|NCT03240133|529070147|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
146696820|NCT03240133|529070148|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
146696821|NCT00116831|529070149|FG000|Overall Study|Adverse Event|14|||
146696822|NCT00116831|529070150|FG001|Overall Study|Adverse Event|16|||
146696823|NCT00116831|529070149|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
146696824|NCT00116831|529070150|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
146696825|NCT00116831|529070149|FG000|Overall Study|Lost to Follow-up|8|||
146696826|NCT00116831|529070150|FG001|Overall Study|Lost to Follow-up|6|||
146696827|NCT00116831|529070149|FG000|Overall Study|Protocol Violation|3|||
146696828|NCT00116831|529070150|FG001|Overall Study|Protocol Violation|6|||
146696829|NCT00116831|529070149|FG000|Overall Study|Hypoglycaemic events|1|||
146696830|NCT00116831|529070150|FG001|Overall Study|Hypoglycaemic events|0|||
146696831|NCT00116831|529070149|FG000|Overall Study|Low haemoglobin on screening|1|||
146696832|NCT00116831|529070150|FG001|Overall Study|Low haemoglobin on screening|0|||
146696833|NCT00116831|529070149|FG000|Overall Study|Withdrawn investigational product|1|||
146696834|NCT00116831|529070150|FG001|Overall Study|Withdrawn investigational product|0|||
146696835|NCT00116831|529070149|FG000|Overall Study|Withdrawal by Subject|32|||
146696836|NCT00116831|529070150|FG001|Overall Study|Withdrawal by Subject|32|||
146696837|NCT00116831|529070149|FG000|Overall Study|Insufficient therapeutic effect|0|||
146696838|NCT00116831|529070150|FG001|Overall Study|Insufficient therapeutic effect|1|||
146696839|NCT00116831|529070149|FG000|Overall Study|Missing data for participant|1|||
146696840|NCT00116831|529070150|FG001|Overall Study|Missing data for participant|0|||
146696841|NCT02945410|529070151|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
146696842|NCT02945410|529070152|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
146696843|NCT02945410|529070153|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
146696844|NCT02945410|529070154|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
146696845|NCT02945410|529070155|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
146696846|NCT02945410|529070156|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
146696847|NCT02945410|529070151|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
146696848|NCT02945410|529070152|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
146696849|NCT02945410|529070153|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
146696850|NCT02945410|529070154|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
146696851|NCT02945410|529070155|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
146696852|NCT02945410|529070156|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
146696853|NCT02945410|529070151|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
146696854|NCT02945410|529070152|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
146696855|NCT02945410|529070153|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
146696856|NCT02945410|529070154|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
146980729|NCT00408876|530091283|FG001|Overall Study|Physician Decision|0|||
146930893|NCT03287245|529905292|FG001|Overall Study|Adverse Event|0|||
146980730|NCT00408876|530091284|FG002|Overall Study|Physician Decision|3|||
146980731|NCT00408876|530091285|FG003|Overall Study|Physician Decision|0|||
146980732|NCT03404206|530091288|FG000|Overall Study|Withdrawal by Subject|1|||
146980733|NCT03404206|530091289|FG001|Overall Study|Withdrawal by Subject|1|||
146980734|NCT03404206|530091290|FG002|Overall Study|Withdrawal by Subject|0|||
146980735|NCT03404206|530091288|FG000|Overall Study|Lost to Follow-up|3|||
146980736|NCT03404206|530091289|FG001|Overall Study|Lost to Follow-up|1|||
146980737|NCT03404206|530091290|FG002|Overall Study|Lost to Follow-up|0|||
146980738|NCT05478603|530091291|FG000|Overall Study|Withdrawal by Subject|0|||
146980739|NCT05478603|530091292|FG001|Overall Study|Withdrawal by Subject|1|||
146980740|NCT05478603|530091293|FG002|Overall Study|Withdrawal by Subject|0|||
146696857|NCT02945410|529070155|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
146696858|NCT02945410|529070156|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
146696859|NCT00735371|529070159|FG000|Overall Study|Adverse Event|3|||
146696860|NCT00735371|529070160|FG001|Overall Study|Adverse Event|3|||
146696861|NCT00735371|529070161|FG002|Overall Study|Adverse Event|4|||
146696862|NCT00735371|529070162|FG003|Overall Study|Adverse Event|1|||
146696863|NCT00735371|529070159|FG000|Overall Study|Protocol Violation|2|||
146696864|NCT00735371|529070160|FG001|Overall Study|Protocol Violation|2|||
146696865|NCT00735371|529070161|FG002|Overall Study|Protocol Violation|0|||
146696866|NCT00735371|529070162|FG003|Overall Study|Protocol Violation|3|||
146696867|NCT00735371|529070159|FG000|Overall Study|Withdrawal by Subject|0|||
146696868|NCT00735371|529070160|FG001|Overall Study|Withdrawal by Subject|2|||
146696869|NCT00735371|529070161|FG002|Overall Study|Withdrawal by Subject|2|||
146696870|NCT00735371|529070162|FG003|Overall Study|Withdrawal by Subject|0|||
146696871|NCT00735371|529070159|FG000|Overall Study|Lost to Follow-up|1|||
146696872|NCT00735371|529070160|FG001|Overall Study|Lost to Follow-up|1|||
146696873|NCT00735371|529070161|FG002|Overall Study|Lost to Follow-up|3|||
146696874|NCT00735371|529070162|FG003|Overall Study|Lost to Follow-up|1|||
146696875|NCT00735371|529070159|FG000|Overall Study|Lack of Efficacy|4|||
146696876|NCT00735371|529070160|FG001|Overall Study|Lack of Efficacy|2|||
146696877|NCT00735371|529070161|FG002|Overall Study|Lack of Efficacy|0|||
146696878|NCT00735371|529070162|FG003|Overall Study|Lack of Efficacy|4|||
146696879|NCT00735371|529070159|FG000|Overall Study|Sponsor Decision|3|||
146696880|NCT00735371|529070160|FG001|Overall Study|Sponsor Decision|1|||
146696881|NCT00735371|529070161|FG002|Overall Study|Sponsor Decision|0|||
146696882|NCT00735371|529070162|FG003|Overall Study|Sponsor Decision|1|||
146696883|NCT00735371|529070159|FG000|Overall Study|Protocol Violation|0|||
146696884|NCT00735371|529070160|FG001|Overall Study|Protocol Violation|1|||
146696885|NCT00735371|529070161|FG002|Overall Study|Protocol Violation|2|||
146696886|NCT00735371|529070162|FG003|Overall Study|Protocol Violation|0|||
146696887|NCT00735371|529070159|FG000|Overall Study|Prior Vyvanse Exposure|1|||
146696888|NCT00735371|529070160|FG001|Overall Study|Prior Vyvanse Exposure|1|||
146696889|NCT00735371|529070161|FG002|Overall Study|Prior Vyvanse Exposure|0|||
146696890|NCT00735371|529070162|FG003|Overall Study|Prior Vyvanse Exposure|0|||
146696891|NCT00735371|529070159|FG000|Overall Study|Exclusion criteria|1|||
146696892|NCT00735371|529070160|FG001|Overall Study|Exclusion criteria|0|||
146696893|NCT00735371|529070161|FG002|Overall Study|Exclusion criteria|0|||
146696894|NCT00735371|529070162|FG003|Overall Study|Exclusion criteria|0|||
146696895|NCT00097721|529070163|FG000|Overall Study|Adverse Event|8|||
146696896|NCT00097721|529070164|FG001|Overall Study|Adverse Event|1|||
146696897|NCT00097721|529070163|FG000|Overall Study|Withdrawal by Subject|6|||
146696898|NCT00097721|529070164|FG001|Overall Study|Withdrawal by Subject|1|||
146696899|NCT00097721|529070163|FG000|Overall Study|Progressive Disease|55|||
146696900|NCT00097721|529070164|FG001|Overall Study|Progressive Disease|27|||
146696901|NCT00097721|529070163|FG000|Overall Study|Physician Decision|1|||
146696902|NCT00097721|529070164|FG001|Overall Study|Physician Decision|3|||
146930894|NCT03287245|529905293|FG002|Overall Study|Adverse Event|0|||
146930895|NCT03287245|529905294|FG003|Overall Study|Adverse Event|0|||
146930896|NCT03287245|529905291|FG000|Overall Study|Withdrawal by Subject|8|||
146930897|NCT03287245|529905292|FG001|Overall Study|Withdrawal by Subject|3|||
146930898|NCT03287245|529905293|FG002|Overall Study|Withdrawal by Subject|3|||
146930899|NCT03287245|529905294|FG003|Overall Study|Withdrawal by Subject|0|||
146930900|NCT03287245|529905291|FG000|Overall Study|Physician Decision|3|||
146980741|NCT05478603|530091294|FG003|Overall Study|Withdrawal by Subject|0|||
146696903|NCT00097721|529070163|FG000|Overall Study|Reason not given|1|||
146980742|NCT03634488|530091295|FG000|Overall Study|Death|1|||
146980743|NCT03634488|530091296|FG001|Overall Study|Death|0|||
146980744|NCT03634488|530091297|FG002|Overall Study|Death|0|||
146696904|NCT00097721|529070164|FG001|Overall Study|Reason not given|1|||
146696905|NCT01828034|529070168|FG000|Overall Study|Withdrawal by Subject|0|||
146696906|NCT01828034|529070169|FG001|Overall Study|Withdrawal by Subject|0|||
146696907|NCT01828034|529070170|FG002|Overall Study|Withdrawal by Subject|0|||
146696908|NCT01828034|529070171|FG003|Overall Study|Withdrawal by Subject|1|||
146696909|NCT04327999|529070178|FG000|Overall Study|Protocol Violation|1|||
146696910|NCT02872116|529070183|FG000|Pre-Treatment|Disease Progression|0|||
146696911|NCT02872116|529070184|FG001|Pre-Treatment|Disease Progression|1|||
146930901|NCT03287245|529905292|FG001|Overall Study|Physician Decision|2|||
146930902|NCT03287245|529905293|FG002|Overall Study|Physician Decision|0|||
146930903|NCT03287245|529905294|FG003|Overall Study|Physician Decision|0|||
146930904|NCT02701192|529905295|FG000|Overall Study|Protocol Violation|2|||
146930905|NCT02701192|529905295|FG000|Overall Study|Lost to Follow-up|4|||
146930906|NCT02862548|529905296|FG000|Randomized Phase (Up to Week 48)|Death|0|||
146930907|NCT02862548|529905297|FG001|Randomized Phase (Up to Week 48)|Death|1|||
146930908|NCT02862548|529905296|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
146930909|NCT02862548|529905297|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
146930910|NCT02862548|529905296|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
146930911|NCT02862548|529905297|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
146930912|NCT02862548|529905296|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
146930913|NCT02862548|529905297|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
146930914|NCT00880763|529905298|FG000|Extension Period (Part 2)|Adverse Event|0|||
146930915|NCT00880763|529905299|FG001|Extension Period (Part 2)|Adverse Event|0|||
146930916|NCT00880763|529905300|FG002|Extension Period (Part 2)|Adverse Event|1|||
146930917|NCT00880763|529905301|FG003|Extension Period (Part 2)|Adverse Event|1|||
146930918|NCT00880763|529905298|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
146930919|NCT00880763|529905299|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
146930920|NCT00880763|529905300|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
146930921|NCT00880763|529905301|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
146930922|NCT00880763|529905298|FG000|Extension Period (Part 2)|Physician Decision|0|||
146930923|NCT00880763|529905299|FG001|Extension Period (Part 2)|Physician Decision|1|||
146930924|NCT00880763|529905300|FG002|Extension Period (Part 2)|Physician Decision|1|||
146930925|NCT00880763|529905301|FG003|Extension Period (Part 2)|Physician Decision|0|||
146930926|NCT00880763|529905298|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
146930927|NCT00880763|529905299|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
146930928|NCT00880763|529905300|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
146930929|NCT00880763|529905301|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
146930930|NCT02667457|529905303|FG000|Overall Study|Withdrawal by Subject|1|||
146930931|NCT02667457|529905304|FG001|Overall Study|Withdrawal by Subject|0|||
146930932|NCT02667457|529905303|FG000|Overall Study|Other Reason|0|||
146930933|NCT02667457|529905304|FG001|Overall Study|Other Reason|2|||
146930934|NCT00603733|529905307|FG000|Active Phase ITT|Adverse Event|8|||
146930935|NCT00603733|529905308|FG001|Active Phase ITT|Adverse Event|7|||
146930936|NCT00603733|529905307|FG000|Active Phase ITT|Withdrawal by Subject|0|||
146930937|NCT00603733|529905308|FG001|Active Phase ITT|Withdrawal by Subject|3|||
146930938|NCT00603733|529905307|FG000|Active Phase ITT|Lost to Follow-up|0|||
146930939|NCT00603733|529905308|FG001|Active Phase ITT|Lost to Follow-up|1|||
146930940|NCT00603733|529905307|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
146930941|NCT00603733|529905308|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
146930942|NCT00603733|529905307|FG000|Active Phase ITT|Lack of Efficacy|1|||
146930943|NCT00603733|529905308|FG001|Active Phase ITT|Lack of Efficacy|2|||
146930944|NCT00603733|529905307|FG000|Active Phase ITT|Subject moved, site closed|1|||
146930945|NCT00603733|529905308|FG001|Active Phase ITT|Subject moved, site closed|1|||
146930946|NCT00603733|529905307|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
146930947|NCT00603733|529905308|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
146930948|NCT00603733|529905307|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
146930949|NCT00603733|529905308|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
146930950|NCT00603733|529905307|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
146930951|NCT00603733|529905308|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
146930952|NCT00603733|529905307|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
147013211|NCT02048813|530210053|FG001|Overall Study|Complication|2|||
146696912|NCT02872116|529070185|FG002|Pre-Treatment|Disease Progression|0|||
146696913|NCT02872116|529070183|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
146696914|NCT02872116|529070184|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
146696915|NCT02872116|529070185|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
146696916|NCT02872116|529070183|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
146696917|NCT02872116|529070184|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
146696918|NCT02872116|529070185|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
146696919|NCT02872116|529070183|FG000|Pre-Treatment|Participant withdrew consent|2|||
146696920|NCT02872116|529070184|FG001|Pre-Treatment|Participant withdrew consent|20|||
146696921|NCT02872116|529070185|FG002|Pre-Treatment|Participant withdrew consent|3|||
146696922|NCT02872116|529070183|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
146696923|NCT02872116|529070184|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
146696924|NCT02872116|529070185|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
146696925|NCT02872116|529070183|FG000|Pre-Treatment|Other reasons|1|||
146696926|NCT02872116|529070184|FG001|Pre-Treatment|Other reasons|2|||
146696927|NCT02872116|529070185|FG002|Pre-Treatment|Other reasons|2|||
146696928|NCT02872116|529070183|FG000|Treatment|Death|121|||
146696929|NCT02872116|529070184|FG001|Treatment|Death|94|||
146696930|NCT02872116|529070185|FG002|Treatment|Death|68|||
146696931|NCT02872116|529070183|FG000|Treatment|Lost to Follow-up|5|||
146696932|NCT02872116|529070184|FG001|Treatment|Lost to Follow-up|7|||
146696933|NCT02872116|529070185|FG002|Treatment|Lost to Follow-up|3|||
146696934|NCT02872116|529070183|FG000|Treatment|Participant withdrew consent|20|||
146696935|NCT02872116|529070184|FG001|Treatment|Participant withdrew consent|40|||
146696936|NCT02872116|529070185|FG002|Treatment|Participant withdrew consent|8|||
146696937|NCT02872116|529070183|FG000|Treatment|Other reasons|13|||
146696938|NCT02872116|529070184|FG001|Treatment|Other reasons|12|||
146696939|NCT02872116|529070185|FG002|Treatment|Other reasons|5|||
146696940|NCT02346136|529070186|FG000|Overall Study|Withdrawal by Subject|7|||
146696941|NCT02346136|529070187|FG001|Overall Study|Withdrawal by Subject|5|||
146696942|NCT02346136|529070186|FG000|Overall Study|Death|1|||
146696943|NCT02346136|529070187|FG001|Overall Study|Death|0|||
146696944|NCT02346136|529070186|FG000|Overall Study|Study termination|14|||
146696945|NCT02346136|529070187|FG001|Overall Study|Study termination|18|||
146696946|NCT03735667|529070188|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
146696947|NCT03735667|529070189|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
146696948|NCT03735667|529070190|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
146696949|NCT03735667|529070188|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
146696950|NCT03735667|529070189|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
146696951|NCT03735667|529070190|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
146696952|NCT03735667|529070188|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
146696953|NCT03735667|529070189|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
146696954|NCT03735667|529070190|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
146696955|NCT03735667|529070188|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
146696956|NCT03735667|529070189|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
146696957|NCT03735667|529070190|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
146696958|NCT03735667|529070188|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
146696959|NCT03735667|529070189|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
146696960|NCT03735667|529070190|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
146696961|NCT03735667|529070188|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
146696962|NCT03735667|529070189|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
146696963|NCT03735667|529070190|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
146696964|NCT03735667|529070188|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
146696965|NCT03735667|529070189|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
146696966|NCT03735667|529070190|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
146696967|NCT03735667|529070188|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
146696968|NCT03735667|529070189|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
146696969|NCT03735667|529070190|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
146696970|NCT03735667|529070188|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
146696971|NCT03735667|529070189|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
146696972|NCT03735667|529070190|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
146696973|NCT03735667|529070188|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
146696974|NCT03735667|529070189|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
146696975|NCT03735667|529070190|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
146696976|NCT03735667|529070188|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
146696977|NCT03735667|529070189|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
146696978|NCT03735667|529070190|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
146696979|NCT03735667|529070188|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
146696980|NCT03735667|529070189|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
146696981|NCT03735667|529070190|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
146696982|NCT02308735|529070191|FG000|Overall Study|Physician Decision|2|||
146696983|NCT02308735|529070192|FG001|Overall Study|Physician Decision|0|||
146696984|NCT02308735|529070193|FG002|Overall Study|Physician Decision|0|||
146696985|NCT02308735|529070194|FG003|Overall Study|Physician Decision|2|||
146696986|NCT00006478|529070202|FG000|Overall Study|Vaccine could not be produced|1|||
146696987|NCT00006478|529070202|FG000|Overall Study|Physician Decision|6|||
146696988|NCT04238728|529070208|FG000|Overall Study|Withdrawal by Subject|1|||
146696989|NCT04238728|529070208|FG000|Overall Study|Lost to Follow-up|2|||
146696990|NCT01907828|529070209|FG000|Overall Study|Exclusion criteria not met|0|||
146696991|NCT01907828|529070210|FG001|Overall Study|Exclusion criteria not met|1|||
146696992|NCT01907828|529070209|FG000|Overall Study|Withdrawal by Subject|3|||
146696993|NCT01907828|529070210|FG001|Overall Study|Withdrawal by Subject|4|||
146696994|NCT01907828|529070209|FG000|Overall Study|Lost to Follow-up|3|||
146696995|NCT01907828|529070210|FG001|Overall Study|Lost to Follow-up|0|||
146696996|NCT01907828|529070209|FG000|Overall Study|Participant refused 24-month follow-up|1|||
146696997|NCT01907828|529070210|FG001|Overall Study|Participant refused 24-month follow-up|0|||
146696998|NCT01907828|529070209|FG000|Overall Study|Participant met exclusion criteria|0|||
146696999|NCT01907828|529070210|FG001|Overall Study|Participant met exclusion criteria|1|||
146697000|NCT04960228|529070215|FG000|Overall Study|Withdrawal by Subject|216|||
146697001|NCT04960228|529070216|FG001|Overall Study|Withdrawal by Subject|35|||
146697002|NCT04960228|529070215|FG000|Overall Study|Failed attention check|69|||
146697003|NCT04960228|529070216|FG001|Overall Study|Failed attention check|148|||
146776046|NCT02590432|529351238|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
146697004|NCT04960228|529070215|FG000|Overall Study|Flagged for response quality by Dynata|3|||
146697005|NCT04960228|529070216|FG001|Overall Study|Flagged for response quality by Dynata|3|||
146697006|NCT01364428|529070217|FG000|Overall Study|Adverse Event|1|||
146697007|NCT01364428|529070218|FG001|Overall Study|Adverse Event|2|||
146697008|NCT01364428|529070217|FG000|Overall Study|Protocol Violation|2|||
146697009|NCT01364428|529070218|FG001|Overall Study|Protocol Violation|0|||
146697010|NCT01364428|529070217|FG000|Overall Study|Withdrawal Criteria|14|||
146697011|NCT01364428|529070218|FG001|Overall Study|Withdrawal Criteria|10|||
146697012|NCT01364428|529070217|FG000|Overall Study|Other|3|||
146697013|NCT01364428|529070218|FG001|Overall Study|Other|3|||
146697014|NCT01987427|529070219|FG000|Overall Study|Adverse Event|4|||
146697015|NCT01987427|529070220|FG001|Overall Study|Adverse Event|2|||
146697016|NCT01987427|529070221|FG002|Overall Study|Adverse Event|8|||
146697017|NCT01987427|529070219|FG000|Overall Study|Lost to Follow-up|6|||
146697018|NCT01987427|529070220|FG001|Overall Study|Lost to Follow-up|6|||
146697019|NCT01987427|529070221|FG002|Overall Study|Lost to Follow-up|9|||
146697020|NCT01987427|529070219|FG000|Overall Study|Withdrawal by Subject|2|||
146697021|NCT01987427|529070220|FG001|Overall Study|Withdrawal by Subject|1|||
146697022|NCT01987427|529070221|FG002|Overall Study|Withdrawal by Subject|3|||
146697023|NCT01987427|529070219|FG000|Overall Study|Lack of Efficacy|1|||
146697024|NCT01987427|529070220|FG001|Overall Study|Lack of Efficacy|0|||
146697025|NCT01987427|529070221|FG002|Overall Study|Lack of Efficacy|0|||
146697026|NCT01987427|529070219|FG000|Overall Study|Other|1|||
146697027|NCT01987427|529070220|FG001|Overall Study|Other|1|||
146697028|NCT01987427|529070221|FG002|Overall Study|Other|0|||
146697029|NCT01073865|529070222|FG000|Overall Study|Reasons other than below|19|||
146697030|NCT01073865|529070223|FG001|Overall Study|Reasons other than below|31|||
146697031|NCT01073865|529070222|FG000|Overall Study|Lost to Follow-up|1|||
146697032|NCT01073865|529070223|FG001|Overall Study|Lost to Follow-up|1|||
146697033|NCT01073865|529070222|FG000|Overall Study|Death|3|||
146697034|NCT01073865|529070223|FG001|Overall Study|Death|2|||
146697035|NCT01073865|529070222|FG000|Overall Study|Withdrawal by Subject|5|||
146697036|NCT01073865|529070223|FG001|Overall Study|Withdrawal by Subject|5|||
146697037|NCT01256593|529070228|FG000|Overall Study|Protocol Violation|26|||
146930953|NCT00603733|529905308|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
146930954|NCT00603733|529905307|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
146930955|NCT00603733|529905308|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
146697038|NCT01256593|529070228|FG000|Overall Study|No Drug Administration Information|2|||
146697039|NCT01256593|529070228|FG000|Overall Study|No Visit After Treatment|186|||
146930956|NCT00603733|529905307|FG000|Maintenance Phase ITT|Adverse Event|3|||
146930957|NCT00603733|529905308|FG001|Maintenance Phase ITT|Adverse Event|6|||
146697040|NCT04414553|529070229|FG000|Overall Study|Lost to Follow-up|20|||
146697041|NCT03373383|529070232|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
146697042|NCT03373383|529070233|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
146697043|NCT03373383|529070234|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
146697044|NCT03373383|529070235|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
146697045|NCT03373383|529070236|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
146697046|NCT03373383|529070232|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
146697047|NCT03373383|529070233|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
146697048|NCT03373383|529070234|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
146697049|NCT03373383|529070235|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
146697050|NCT03373383|529070236|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
146697051|NCT03373383|529070232|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
146697052|NCT03373383|529070233|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
146697053|NCT03373383|529070234|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
146697054|NCT03373383|529070235|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
146697055|NCT03373383|529070236|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
146697056|NCT03373383|529070232|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
146697057|NCT03373383|529070233|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
146697058|NCT03373383|529070234|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
146930958|NCT00603733|529905307|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
146930959|NCT00603733|529905308|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
146930960|NCT00603733|529905307|FG000|Maintenance Phase ITT|Protocol Violation|1|||
146930961|NCT00603733|529905308|FG001|Maintenance Phase ITT|Protocol Violation|1|||
146930962|NCT00603733|529905307|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
146930963|NCT00603733|529905308|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
146930964|NCT00603733|529905307|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
146930965|NCT00603733|529905308|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
146930966|NCT00603733|529905307|FG000|Maintenance Phase ITT|Physician Decision|0|||
146930967|NCT00603733|529905308|FG001|Maintenance Phase ITT|Physician Decision|1|||
146930968|NCT00603733|529905307|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
146697059|NCT03373383|529070235|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
146930969|NCT00603733|529905308|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
146930970|NCT01253187|529905319|FG000|Period 2|Withdrawal by Subject|0|||
146697060|NCT03373383|529070236|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
146697061|NCT03373383|529070232|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
146697062|NCT03373383|529070233|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
146697063|NCT03373383|529070234|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
146697064|NCT03373383|529070235|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
146697065|NCT03373383|529070236|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
146697066|NCT03373383|529070232|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
146697067|NCT03373383|529070233|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
146697068|NCT03373383|529070234|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
146697069|NCT03373383|529070235|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
146697070|NCT03373383|529070236|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
146697071|NCT03373383|529070232|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
146697072|NCT03373383|529070233|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
146697073|NCT03373383|529070234|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
146697074|NCT03373383|529070235|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
146697075|NCT03373383|529070236|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
146697076|NCT03373383|529070232|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
146697077|NCT03373383|529070233|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
146697078|NCT03373383|529070234|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
146697079|NCT03373383|529070235|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
146697080|NCT03373383|529070236|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
146697081|NCT03373383|529070232|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
146697082|NCT03373383|529070233|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
146697083|NCT03373383|529070234|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
146697084|NCT03373383|529070235|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
146697085|NCT03373383|529070236|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
146697086|NCT02159521|529070237|FG000|Overall Study|Enrolled but not treated|3|||
146697087|NCT02159521|529070237|FG000|Overall Study|Withdrawal by Subject|7|||
146697088|NCT02159521|529070237|FG000|Overall Study|Lost to Follow-up|6|||
146697089|NCT02159521|529070237|FG000|Overall Study|Death|1|||
146697090|NCT02159521|529070237|FG000|Overall Study|Other than specified|1|||
146697091|NCT00694369|529070238|FG000|Overall Study|Adverse Event|0|||
146697092|NCT00694369|529070239|FG001|Overall Study|Adverse Event|1|||
146697093|NCT00694369|529070240|FG002|Overall Study|Adverse Event|0|||
146697094|NCT00694369|529070241|FG003|Overall Study|Adverse Event|1|||
146697095|NCT00694369|529070242|FG004|Overall Study|Adverse Event|3|||
146697096|NCT00694369|529070238|FG000|Overall Study|Lost to Follow-up|0|||
146697097|NCT00694369|529070239|FG001|Overall Study|Lost to Follow-up|0|||
146697098|NCT00694369|529070240|FG002|Overall Study|Lost to Follow-up|1|||
146697099|NCT00694369|529070241|FG003|Overall Study|Lost to Follow-up|1|||
146697100|NCT00694369|529070242|FG004|Overall Study|Lost to Follow-up|0|||
146697101|NCT00694369|529070238|FG000|Overall Study|Physician Decision|0|||
146697102|NCT00694369|529070239|FG001|Overall Study|Physician Decision|0|||
146697103|NCT00694369|529070240|FG002|Overall Study|Physician Decision|0|||
146697104|NCT00694369|529070241|FG003|Overall Study|Physician Decision|0|||
146697105|NCT00694369|529070242|FG004|Overall Study|Physician Decision|1|||
146697106|NCT00694369|529070238|FG000|Overall Study|Protocol Violation|0|||
146697107|NCT00694369|529070239|FG001|Overall Study|Protocol Violation|1|||
146697108|NCT00694369|529070240|FG002|Overall Study|Protocol Violation|0|||
146697109|NCT00694369|529070241|FG003|Overall Study|Protocol Violation|0|||
146697110|NCT00694369|529070242|FG004|Overall Study|Protocol Violation|0|||
146697111|NCT00694369|529070238|FG000|Overall Study|Withdrawal by Subject|1|||
146697112|NCT00694369|529070239|FG001|Overall Study|Withdrawal by Subject|1|||
146697113|NCT00694369|529070240|FG002|Overall Study|Withdrawal by Subject|1|||
146697114|NCT00694369|529070241|FG003|Overall Study|Withdrawal by Subject|1|||
146697115|NCT00694369|529070242|FG004|Overall Study|Withdrawal by Subject|2|||
146697116|NCT00907374|529070243|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
146697117|NCT00907374|529070244|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
146697118|NCT03131440|529070249|FG000|Overall Study|Withdrawal by Subject|1|||
146697119|NCT03131440|529070250|FG001|Overall Study|Withdrawal by Subject|3|||
146697120|NCT03131440|529070251|FG002|Overall Study|Withdrawal by Subject|0|||
146697121|NCT03131440|529070252|FG003|Overall Study|Withdrawal by Subject|0|||
146697122|NCT03131440|529070253|FG004|Overall Study|Withdrawal by Subject|1|||
146697123|NCT03131440|529070254|FG005|Overall Study|Withdrawal by Subject|0|||
146776047|NCT02590432|529351239|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
146776048|NCT02590432|529351240|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
146697124|NCT03131440|529070255|FG006|Overall Study|Withdrawal by Subject|0|||
146697125|NCT03131440|529070256|FG007|Overall Study|Withdrawal by Subject|1|||
146697126|NCT03131440|529070257|FG008|Overall Study|Withdrawal by Subject|1|||
146697127|NCT03131440|529070258|FG009|Overall Study|Withdrawal by Subject|1|||
146697128|NCT03131440|529070259|FG010|Overall Study|Withdrawal by Subject|0|||
146776049|NCT02590432|529351241|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
146776050|NCT02590432|529351242|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
146776051|NCT02590432|529351243|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
146930971|NCT01253187|529905320|FG001|Period 2|Withdrawal by Subject|0|||
146776052|NCT02590432|529351244|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
146776053|NCT02590432|529351245|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
146776054|NCT02590432|529351246|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
146776055|NCT02590432|529351238|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
146776056|NCT02590432|529351239|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
146776057|NCT02590432|529351240|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
146776058|NCT02590432|529351241|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
146776059|NCT02590432|529351242|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
146776060|NCT02590432|529351243|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
146776061|NCT02590432|529351244|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
146776062|NCT02590432|529351245|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
146776063|NCT02590432|529351246|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
146776064|NCT02590432|529351238|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
146776065|NCT02590432|529351239|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
146776066|NCT02590432|529351240|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
146930972|NCT01253187|529905321|FG002|Period 2|Withdrawal by Subject|0|||
146930973|NCT01253187|529905322|FG003|Period 2|Withdrawal by Subject|0|||
146930974|NCT01253187|529905323|FG004|Period 2|Withdrawal by Subject|1|||
146697129|NCT03131440|529070260|FG011|Overall Study|Withdrawal by Subject|1|||
146697130|NCT03131440|529070261|FG012|Overall Study|Withdrawal by Subject|1|||
146697131|NCT03131440|529070262|FG013|Overall Study|Withdrawal by Subject|0|||
146697132|NCT03131440|529070263|FG014|Overall Study|Withdrawal by Subject|1|||
146697133|NCT03131440|529070264|FG015|Overall Study|Withdrawal by Subject|0|||
146697134|NCT03131440|529070265|FG016|Overall Study|Withdrawal by Subject|0|||
146697135|NCT03131440|529070266|FG017|Overall Study|Withdrawal by Subject|0|||
146697136|NCT03131440|529070267|FG018|Overall Study|Withdrawal by Subject|1|||
146697137|NCT03131440|529070268|FG019|Overall Study|Withdrawal by Subject|0|||
146697138|NCT03131440|529070269|FG020|Overall Study|Withdrawal by Subject|1|||
146697139|NCT03131440|529070270|FG021|Overall Study|Withdrawal by Subject|1|||
146697140|NCT03131440|529070271|FG022|Overall Study|Withdrawal by Subject|1|||
146697141|NCT03131440|529070272|FG023|Overall Study|Withdrawal by Subject|0|||
146697142|NCT03131440|529070273|FG024|Overall Study|Withdrawal by Subject|0|||
146697143|NCT03131440|529070274|FG025|Overall Study|Withdrawal by Subject|0|||
146697144|NCT03131440|529070275|FG026|Overall Study|Withdrawal by Subject|0|||
146697145|NCT03131440|529070276|FG027|Overall Study|Withdrawal by Subject|0|||
146697146|NCT03131440|529070277|FG028|Overall Study|Withdrawal by Subject|0|||
146697147|NCT03131440|529070278|FG029|Overall Study|Withdrawal by Subject|0|||
146697148|NCT03131440|529070279|FG030|Overall Study|Withdrawal by Subject|1|||
146697149|NCT03131440|529070280|FG031|Overall Study|Withdrawal by Subject|0|||
146697150|NCT03131440|529070249|FG000|Overall Study|Lost to Follow-up|0|||
146697151|NCT03131440|529070250|FG001|Overall Study|Lost to Follow-up|0|||
146697152|NCT03131440|529070251|FG002|Overall Study|Lost to Follow-up|0|||
146697153|NCT03131440|529070252|FG003|Overall Study|Lost to Follow-up|0|||
146697154|NCT03131440|529070253|FG004|Overall Study|Lost to Follow-up|0|||
146697155|NCT03131440|529070254|FG005|Overall Study|Lost to Follow-up|1|||
146697156|NCT03131440|529070255|FG006|Overall Study|Lost to Follow-up|0|||
146697157|NCT03131440|529070256|FG007|Overall Study|Lost to Follow-up|0|||
146697158|NCT03131440|529070257|FG008|Overall Study|Lost to Follow-up|0|||
146697159|NCT03131440|529070258|FG009|Overall Study|Lost to Follow-up|0|||
146697160|NCT03131440|529070259|FG010|Overall Study|Lost to Follow-up|0|||
146697161|NCT03131440|529070260|FG011|Overall Study|Lost to Follow-up|0|||
146697162|NCT03131440|529070261|FG012|Overall Study|Lost to Follow-up|0|||
146930975|NCT01253187|529905324|FG005|Period 2|Withdrawal by Subject|0|||
146930976|NCT01253187|529905319|FG000|Period 3|Pregnancy|1|||
146930977|NCT01253187|529905320|FG001|Period 3|Pregnancy|0|||
146930978|NCT01253187|529905321|FG002|Period 3|Pregnancy|0|||
146930979|NCT01253187|529905322|FG003|Period 3|Pregnancy|0|||
146930980|NCT01253187|529905323|FG004|Period 3|Pregnancy|0|||
146930981|NCT01253187|529905324|FG005|Period 3|Pregnancy|0|||
146930982|NCT01253187|529905319|FG000|Period 3|difficulty with blood sampling|0|||
146930983|NCT01253187|529905320|FG001|Period 3|difficulty with blood sampling|1|||
146930984|NCT01253187|529905321|FG002|Period 3|difficulty with blood sampling|0|||
146930985|NCT01253187|529905322|FG003|Period 3|difficulty with blood sampling|0|||
146930986|NCT01253187|529905323|FG004|Period 3|difficulty with blood sampling|0|||
146930987|NCT01253187|529905324|FG005|Period 3|difficulty with blood sampling|0|||
146930988|NCT01253187|529905319|FG000|Period 3|non-compliance|0|||
146930989|NCT01253187|529905320|FG001|Period 3|non-compliance|0|||
146930990|NCT01253187|529905321|FG002|Period 3|non-compliance|0|||
146930991|NCT01253187|529905322|FG003|Period 3|non-compliance|0|||
146930992|NCT01253187|529905323|FG004|Period 3|non-compliance|1|||
146697163|NCT03131440|529070262|FG013|Overall Study|Lost to Follow-up|0|||
146697164|NCT03131440|529070263|FG014|Overall Study|Lost to Follow-up|0|||
146697165|NCT03131440|529070264|FG015|Overall Study|Lost to Follow-up|0|||
146697166|NCT03131440|529070265|FG016|Overall Study|Lost to Follow-up|0|||
146697167|NCT03131440|529070266|FG017|Overall Study|Lost to Follow-up|0|||
146776067|NCT02590432|529351241|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
146776068|NCT02590432|529351242|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
146776069|NCT02590432|529351243|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
146776070|NCT02590432|529351244|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
146776071|NCT02590432|529351245|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
146776072|NCT02590432|529351246|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
146776073|NCT02590432|529351238|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
146776074|NCT02590432|529351239|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
146776075|NCT02590432|529351240|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
146776076|NCT02590432|529351241|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
146776077|NCT02590432|529351242|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
146776078|NCT02590432|529351243|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
146776079|NCT02590432|529351244|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
146776080|NCT02590432|529351245|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
146776081|NCT02590432|529351246|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
146776082|NCT02590432|529351238|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
146776083|NCT02590432|529351239|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
146776084|NCT02590432|529351240|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
146776085|NCT02590432|529351241|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
146776086|NCT02590432|529351242|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
146776087|NCT02590432|529351243|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
146776088|NCT02590432|529351244|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
146776089|NCT02590432|529351245|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
146776090|NCT02590432|529351246|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
146776091|NCT02590432|529351238|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
146776092|NCT02590432|529351239|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
146776093|NCT02590432|529351240|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
146776094|NCT02590432|529351241|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
146776095|NCT02590432|529351242|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
146776096|NCT02590432|529351243|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
146776097|NCT02590432|529351244|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
146776098|NCT02590432|529351245|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
146776099|NCT02590432|529351246|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
146776100|NCT03655262|529351248|FG000|Overall Study|Withdrawal by Subject|0|||
146776101|NCT03655262|529351249|FG001|Overall Study|Withdrawal by Subject|0|||
146776102|NCT03655262|529351250|FG002|Overall Study|Withdrawal by Subject|1|||
146776103|NCT04583423|529351253|FG000|Overall Study|Lost to Follow-up|0|||
146776104|NCT04583423|529351254|FG001|Overall Study|Lost to Follow-up|1|||
146697168|NCT03131440|529070267|FG018|Overall Study|Lost to Follow-up|0|||
146697169|NCT03131440|529070268|FG019|Overall Study|Lost to Follow-up|2|||
146697170|NCT03131440|529070269|FG020|Overall Study|Lost to Follow-up|1|||
146697171|NCT03131440|529070270|FG021|Overall Study|Lost to Follow-up|0|||
146697172|NCT03131440|529070271|FG022|Overall Study|Lost to Follow-up|1|||
146697173|NCT03131440|529070272|FG023|Overall Study|Lost to Follow-up|0|||
146697174|NCT03131440|529070273|FG024|Overall Study|Lost to Follow-up|1|||
146697175|NCT03131440|529070274|FG025|Overall Study|Lost to Follow-up|0|||
146697176|NCT03131440|529070275|FG026|Overall Study|Lost to Follow-up|0|||
146697177|NCT03131440|529070276|FG027|Overall Study|Lost to Follow-up|2|||
146697178|NCT03131440|529070277|FG028|Overall Study|Lost to Follow-up|0|||
146697179|NCT03131440|529070278|FG029|Overall Study|Lost to Follow-up|2|||
146697180|NCT03131440|529070279|FG030|Overall Study|Lost to Follow-up|0|||
146697181|NCT03131440|529070280|FG031|Overall Study|Lost to Follow-up|0|||
146697182|NCT03131440|529070249|FG000|Overall Study|Death|0|||
146697183|NCT03131440|529070250|FG001|Overall Study|Death|0|||
146697184|NCT03131440|529070251|FG002|Overall Study|Death|0|||
146697185|NCT03131440|529070252|FG003|Overall Study|Death|0|||
146697186|NCT03131440|529070253|FG004|Overall Study|Death|0|||
146697187|NCT03131440|529070254|FG005|Overall Study|Death|0|||
146697188|NCT03131440|529070255|FG006|Overall Study|Death|0|||
146697189|NCT03131440|529070256|FG007|Overall Study|Death|0|||
146697190|NCT03131440|529070257|FG008|Overall Study|Death|0|||
146697191|NCT03131440|529070258|FG009|Overall Study|Death|0|||
146697192|NCT03131440|529070259|FG010|Overall Study|Death|0|||
146697193|NCT03131440|529070260|FG011|Overall Study|Death|0|||
146697194|NCT03131440|529070261|FG012|Overall Study|Death|0|||
146697195|NCT03131440|529070262|FG013|Overall Study|Death|0|||
146697196|NCT03131440|529070263|FG014|Overall Study|Death|0|||
146697197|NCT03131440|529070264|FG015|Overall Study|Death|0|||
146697198|NCT03131440|529070265|FG016|Overall Study|Death|0|||
146697199|NCT03131440|529070266|FG017|Overall Study|Death|0|||
146697200|NCT03131440|529070267|FG018|Overall Study|Death|0|||
146697201|NCT03131440|529070268|FG019|Overall Study|Death|0|||
146697202|NCT03131440|529070269|FG020|Overall Study|Death|0|||
146697203|NCT03131440|529070270|FG021|Overall Study|Death|0|||
146697204|NCT03131440|529070271|FG022|Overall Study|Death|0|||
146980745|NCT03634488|530091295|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
146980746|NCT03634488|530091296|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
146980747|NCT03634488|530091297|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
146980748|NCT00096486|530091301|FG000|Overall Study|Withdrawal by Subject|0|||
146980749|NCT00096486|530091302|FG001|Overall Study|Withdrawal by Subject|0|||
146980750|NCT00096486|530091303|FG002|Overall Study|Withdrawal by Subject|1|||
146980751|NCT00096486|530091304|FG003|Overall Study|Withdrawal by Subject|1|||
146980752|NCT00096486|530091301|FG000|Overall Study|Not Treated|0|||
146980753|NCT00096486|530091302|FG001|Overall Study|Not Treated|0|||
146697205|NCT03131440|529070272|FG023|Overall Study|Death|0|||
146697206|NCT03131440|529070273|FG024|Overall Study|Death|0|||
146697207|NCT03131440|529070274|FG025|Overall Study|Death|1|||
146697208|NCT03131440|529070275|FG026|Overall Study|Death|0|||
146697209|NCT03131440|529070276|FG027|Overall Study|Death|0|||
146697210|NCT03131440|529070277|FG028|Overall Study|Death|0|||
146697211|NCT03131440|529070278|FG029|Overall Study|Death|0|||
146697212|NCT03131440|529070279|FG030|Overall Study|Death|0|||
146697213|NCT03131440|529070280|FG031|Overall Study|Death|0|||
146697214|NCT00746941|529070283|FG000|Overall Study|Death|2|||
146697215|NCT00746941|529070284|FG001|Overall Study|Death|0|||
146697216|NCT00746941|529070285|FG002|Overall Study|Death|0|||
146697217|NCT00746941|529070286|FG003|Overall Study|Death|6|||
146697218|NCT00746941|529070283|FG000|Overall Study|Physician Decision|0|||
146697219|NCT00746941|529070284|FG001|Overall Study|Physician Decision|0|||
146697220|NCT00746941|529070285|FG002|Overall Study|Physician Decision|2|||
146697221|NCT00746941|529070286|FG003|Overall Study|Physician Decision|0|||
146697222|NCT00746941|529070283|FG000|Overall Study|Withdrawal by Subject|3|||
146697223|NCT00746941|529070284|FG001|Overall Study|Withdrawal by Subject|0|||
146697224|NCT00746941|529070285|FG002|Overall Study|Withdrawal by Subject|0|||
146697225|NCT00746941|529070286|FG003|Overall Study|Withdrawal by Subject|2|||
146697226|NCT00746941|529070283|FG000|Overall Study|Other, reason not provided|2|||
146697227|NCT00746941|529070284|FG001|Overall Study|Other, reason not provided|4|||
146697228|NCT00746941|529070285|FG002|Overall Study|Other, reason not provided|0|||
146697229|NCT00746941|529070286|FG003|Overall Study|Other, reason not provided|4|||
146697230|NCT00746941|529070283|FG000|Overall Study|Adverse Event|0|||
146697231|NCT00746941|529070284|FG001|Overall Study|Adverse Event|0|||
146697232|NCT00746941|529070285|FG002|Overall Study|Adverse Event|0|||
146697233|NCT00746941|529070286|FG003|Overall Study|Adverse Event|1|||
146697234|NCT01148511|529070294|FG000|Exposed to Study Drug|Protocol Violation|2|||
146697235|NCT01148511|529070295|FG001|Exposed to Study Drug|Protocol Violation|0|||
146697236|NCT01148511|529070296|FG002|Exposed to Study Drug|Protocol Violation|0|||
146697237|NCT01148511|529070294|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
146697238|NCT01148511|529070295|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
146697239|NCT01148511|529070296|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
146697240|NCT01148511|529070294|FG000|Randomized|Adverse Event|0|||
146697241|NCT01148511|529070295|FG001|Randomized|Adverse Event|1|||
146697242|NCT01148511|529070296|FG002|Randomized|Adverse Event|0|||
146697243|NCT01148511|529070294|FG000|Randomized|Protocol Violation|0|||
146697244|NCT01148511|529070295|FG001|Randomized|Protocol Violation|2|||
146697245|NCT01148511|529070296|FG002|Randomized|Protocol Violation|1|||
146697246|NCT01148511|529070294|FG000|Randomized|Lost to Follow-up|0|||
146697247|NCT01148511|529070295|FG001|Randomized|Lost to Follow-up|1|||
146697248|NCT01148511|529070296|FG002|Randomized|Lost to Follow-up|1|||
146697249|NCT01148511|529070294|FG000|Randomized|Consent withdrawal|0|||
146697250|NCT01148511|529070295|FG001|Randomized|Consent withdrawal|5|||
146697251|NCT01148511|529070296|FG002|Randomized|Consent withdrawal|3|||
146697252|NCT01148511|529070294|FG000|Randomized|Other|0|||
146697253|NCT01148511|529070295|FG001|Randomized|Other|1|||
146697254|NCT01148511|529070296|FG002|Randomized|Other|1|||
146697255|NCT01644175|529070297|FG000|Overall Study|Randomized But Not Treated|0|||
146697256|NCT01644175|529070298|FG001|Overall Study|Randomized But Not Treated|2|||
146697257|NCT01644175|529070297|FG000|Overall Study|Adverse Event|8|||
146697258|NCT01644175|529070298|FG001|Overall Study|Adverse Event|13|||
146697259|NCT01644175|529070297|FG000|Overall Study|Death|1|||
146697260|NCT01644175|529070298|FG001|Overall Study|Death|2|||
146697261|NCT01644175|529070297|FG000|Overall Study|Poor compliance to protocol|9|||
146697262|NCT01644175|529070298|FG001|Overall Study|Poor compliance to protocol|10|||
146697263|NCT01644175|529070297|FG000|Overall Study|Physician Decision|1|||
146697264|NCT01644175|529070298|FG001|Overall Study|Physician Decision|2|||
146697265|NCT01644175|529070297|FG000|Overall Study|Participant Moved|1|||
146697266|NCT01644175|529070298|FG001|Overall Study|Participant Moved|2|||
146697267|NCT01644175|529070297|FG000|Overall Study|Consent withdrawn by participant|3|||
146697268|NCT01644175|529070298|FG001|Overall Study|Consent withdrawn by participant|4|||
146697269|NCT01644175|529070297|FG000|Overall Study|Related to Autoinjector Administration|2|||
146697270|NCT01644175|529070298|FG001|Overall Study|Related to Autoinjector Administration|1|||
146697271|NCT01644175|529070297|FG000|Overall Study|Last visit outside protocol visit window|4|||
146697272|NCT01644175|529070298|FG001|Overall Study|Last visit outside protocol visit window|11|||
146697273|NCT01644175|529070297|FG000|Overall Study|Selection criteria finally not met|0|||
146697274|NCT01644175|529070298|FG001|Overall Study|Selection criteria finally not met|1|||
146697275|NCT01644175|529070297|FG000|Overall Study|Site closure|2|||
146697276|NCT01644175|529070298|FG001|Overall Study|Site closure|2|||
146697277|NCT01644175|529070297|FG000|Overall Study|Lost to Follow-up|1|||
146697278|NCT01644175|529070298|FG001|Overall Study|Lost to Follow-up|0|||
146697279|NCT01644175|529070297|FG000|Overall Study|Other than specified above|0|||
146697280|NCT01644175|529070298|FG001|Overall Study|Other than specified above|3|||
146697281|NCT04258605|529070300|FG000|Overall Study|Death|1|||
146697282|NCT04258605|529070301|FG001|Overall Study|Death|0|||
146697283|NCT04258605|529070300|FG000|Overall Study|Early study termination|21|||
146697284|NCT04258605|529070301|FG001|Overall Study|Early study termination|2|||
146697285|NCT02818777|529070306|FG000|Overall Study|Adverse Event|3|||
146697286|NCT01712256|529070316|FG000|Overall Study|Lost to Follow-up|1|||
146697287|NCT00962104|529070317|FG000|Overall Study|Adverse Event|10|||
146697288|NCT00962104|529070318|FG001|Overall Study|Adverse Event|3|||
146697289|NCT00962104|529070317|FG000|Overall Study|Entry Criteria Not Met|1|||
146697290|NCT00962104|529070318|FG001|Overall Study|Entry Criteria Not Met|2|||
146697291|NCT00962104|529070317|FG000|Overall Study|Lack of Efficacy|0|||
146697292|NCT00962104|529070318|FG001|Overall Study|Lack of Efficacy|1|||
146697293|NCT00962104|529070317|FG000|Overall Study|Lost to Follow-up|10|||
146697294|NCT00962104|529070318|FG001|Overall Study|Lost to Follow-up|4|||
146697295|NCT00962104|529070317|FG000|Overall Study|Physician Decision|1|||
146697296|NCT00962104|529070318|FG001|Overall Study|Physician Decision|0|||
146697297|NCT00962104|529070317|FG000|Overall Study|Protocol Violation|6|||
146697298|NCT00962104|529070318|FG001|Overall Study|Protocol Violation|8|||
146697299|NCT00962104|529070317|FG000|Overall Study|Sponsor Decision|0|||
146697300|NCT00962104|529070318|FG001|Overall Study|Sponsor Decision|1|||
146697301|NCT00962104|529070317|FG000|Overall Study|Withdrawal by Subject|10|||
146697302|NCT00962104|529070318|FG001|Overall Study|Withdrawal by Subject|6|||
146697303|NCT00962104|529070317|FG000|Overall Study|Other|2|||
146697304|NCT00962104|529070318|FG001|Overall Study|Other|0|||
146697305|NCT01077804|529070322|FG000|Overall Study|Unreachable|102|||
146697306|NCT01077804|529070322|FG000|Overall Study|Refused to continue|79|||
146697307|NCT01077804|529070322|FG000|Overall Study|Other|18|||
146697308|NCT02776917|529070323|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
146697309|NCT02620046|529070324|FG000|Overall Study|Adverse Event|22|||
146697310|NCT02620046|529070325|FG001|Overall Study|Adverse Event|42|||
146697311|NCT02620046|529070324|FG000|Overall Study|Lost to Follow-up|4|||
146697312|NCT02620046|529070325|FG001|Overall Study|Lost to Follow-up|10|||
146697313|NCT02620046|529070324|FG000|Overall Study|Withdrawal by Subject|36|||
146697314|NCT02620046|529070325|FG001|Overall Study|Withdrawal by Subject|66|||
146697315|NCT02620046|529070324|FG000|Overall Study|Site Termination|3|||
146697316|NCT02620046|529070325|FG001|Overall Study|Site Termination|3|||
146697317|NCT02620046|529070324|FG000|Overall Study|Pregnancy|3|||
146697318|NCT02620046|529070325|FG001|Overall Study|Pregnancy|7|||
146697319|NCT02620046|529070324|FG000|Overall Study|Lack of Efficacy|81|||
146697320|NCT02620046|529070325|FG001|Overall Study|Lack of Efficacy|146|||
146697321|NCT02620046|529070324|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
146697322|NCT02620046|529070325|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
146697323|NCT02620046|529070324|FG000|Overall Study|Reason Not Specified|13|||
146697324|NCT02620046|529070325|FG001|Overall Study|Reason Not Specified|21|||
146697325|NCT02620046|529070324|FG000|Overall Study|Significant Protocol Deviation|0|||
146697326|NCT02620046|529070325|FG001|Overall Study|Significant Protocol Deviation|1|||
146697327|NCT00403273|529072338|FG000|Overall Study|Lost to Follow-up|3|||
146697328|NCT00403273|529072339|FG001|Overall Study|Lost to Follow-up|2|||
146697329|NCT00403273|529072338|FG000|Overall Study|Physician Decision|0|||
146697330|NCT00403273|529072339|FG001|Overall Study|Physician Decision|1|||
146697331|NCT00403273|529072338|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
146697332|NCT00403273|529072339|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
146697333|NCT01336738|529072341|FG000|Overall Study|Adverse Event|0|||
146697334|NCT01336738|529072342|FG001|Overall Study|Adverse Event|3|||
146697335|NCT01336738|529072343|FG002|Overall Study|Adverse Event|2|||
146697336|NCT01336738|529072344|FG003|Overall Study|Adverse Event|1|||
146776105|NCT04583423|529351255|FG002|Overall Study|Lost to Follow-up|0|||
146776106|NCT04583423|529351256|FG003|Overall Study|Lost to Follow-up|2|||
146776107|NCT04583423|529351253|FG000|Overall Study|Study Terminated by Sponsor|32|||
146697337|NCT01336738|529072345|FG004|Overall Study|Adverse Event|3|||
146697338|NCT01336738|529072341|FG000|Overall Study|Lost to Follow-up|2|||
146697339|NCT01336738|529072342|FG001|Overall Study|Lost to Follow-up|1|||
146697340|NCT01336738|529072343|FG002|Overall Study|Lost to Follow-up|2|||
146697341|NCT01336738|529072344|FG003|Overall Study|Lost to Follow-up|2|||
146697342|NCT01336738|529072345|FG004|Overall Study|Lost to Follow-up|2|||
146697343|NCT01336738|529072341|FG000|Overall Study|Did not meet entrance criteria|0|||
146776108|NCT04583423|529351254|FG001|Overall Study|Study Terminated by Sponsor|35|||
146697344|NCT01336738|529072342|FG001|Overall Study|Did not meet entrance criteria|1|||
146697345|NCT01336738|529072343|FG002|Overall Study|Did not meet entrance criteria|0|||
146697346|NCT01336738|529072344|FG003|Overall Study|Did not meet entrance criteria|0|||
146697347|NCT01336738|529072345|FG004|Overall Study|Did not meet entrance criteria|0|||
146697348|NCT01336738|529072341|FG000|Overall Study|Protocol Violation|0|||
146697349|NCT01336738|529072342|FG001|Overall Study|Protocol Violation|1|||
146697350|NCT01336738|529072343|FG002|Overall Study|Protocol Violation|0|||
146697351|NCT01336738|529072344|FG003|Overall Study|Protocol Violation|0|||
146697352|NCT01336738|529072345|FG004|Overall Study|Protocol Violation|0|||
146980754|NCT00096486|530091303|FG002|Overall Study|Not Treated|1|||
146980755|NCT00096486|530091304|FG003|Overall Study|Not Treated|1|||
146980756|NCT01512979|530091305|FG000|Overall Study|Adverse Event|2|||
146697353|NCT01336738|529072341|FG000|Overall Study|Withdrawal by Subject|2|||
146697354|NCT01336738|529072342|FG001|Overall Study|Withdrawal by Subject|0|||
146697355|NCT01336738|529072343|FG002|Overall Study|Withdrawal by Subject|2|||
146697356|NCT01336738|529072344|FG003|Overall Study|Withdrawal by Subject|1|||
146697357|NCT01336738|529072345|FG004|Overall Study|Withdrawal by Subject|1|||
146697358|NCT01336738|529072341|FG000|Overall Study|Other|3|||
146697359|NCT01336738|529072342|FG001|Overall Study|Other|3|||
146697360|NCT01336738|529072343|FG002|Overall Study|Other|2|||
146697361|NCT01336738|529072344|FG003|Overall Study|Other|3|||
146697362|NCT01336738|529072345|FG004|Overall Study|Other|4|||
146697363|NCT01083433|529072346|FG000|Overall Study|Lost to Follow-up|2|||
146697364|NCT01083433|529072347|FG001|Overall Study|Lost to Follow-up|1|||
146697365|NCT01083433|529072348|FG002|Overall Study|Lost to Follow-up|1|||
146697366|NCT01083433|529072346|FG000|Overall Study|Withdrawal by Subject|0|||
146697367|NCT01083433|529072347|FG001|Overall Study|Withdrawal by Subject|5|||
146697368|NCT01083433|529072348|FG002|Overall Study|Withdrawal by Subject|3|||
146697369|NCT01083433|529072346|FG000|Overall Study|Pregnancy|0|||
146697370|NCT01083433|529072347|FG001|Overall Study|Pregnancy|0|||
146697371|NCT01083433|529072348|FG002|Overall Study|Pregnancy|1|||
146697372|NCT01332149|529072350|FG000|Overall Study|Adverse Event|11|||
146697373|NCT01332149|529072351|FG001|Overall Study|Adverse Event|9|||
146697374|NCT01332149|529072350|FG000|Overall Study|Other unspecified|5|||
146697375|NCT01332149|529072351|FG001|Overall Study|Other unspecified|7|||
146697376|NCT01332149|529072350|FG000|Overall Study|Protocol Violation|1|||
146697377|NCT01332149|529072351|FG001|Overall Study|Protocol Violation|3|||
146697378|NCT01332149|529072350|FG000|Overall Study|Withdrawal by Subject|4|||
146697379|NCT01332149|529072351|FG001|Overall Study|Withdrawal by Subject|5|||
146697380|NCT01332149|529072350|FG000|Overall Study|Lost to Follow-up|1|||
146697381|NCT01332149|529072351|FG001|Overall Study|Lost to Follow-up|1|||
146697382|NCT01332149|529072350|FG000|Overall Study|Insufficient clinical response|4|||
146697383|NCT01332149|529072351|FG001|Overall Study|Insufficient clinical response|7|||
146697384|NCT01332149|529072350|FG000|Overall Study|Did not meet entrance criteria|3|||
146697385|NCT01332149|529072351|FG001|Overall Study|Did not meet entrance criteria|4|||
146697386|NCT01332149|529072350|FG000|Overall Study|Randomized but not treated|1|||
146697387|NCT01332149|529072351|FG001|Overall Study|Randomized but not treated|2|||
146697388|NCT04615949|529072356|FG000|Overall Study|Withdrawal by Subject|2|||
146697389|NCT04615949|529072357|FG001|Overall Study|Withdrawal by Subject|4|||
146697390|NCT04615949|529072356|FG000|Overall Study|Lost to Follow-up|2|||
146697391|NCT04615949|529072357|FG001|Overall Study|Lost to Follow-up|2|||
146697392|NCT04615949|529072356|FG000|Overall Study|Death|0|||
146697393|NCT04615949|529072357|FG001|Overall Study|Death|2|||
146697394|NCT03036566|529072358|FG000|Overall Study|Lost to Follow-up|3|||
146697395|NCT05458856|529072359|FG000|Overall Study|Withdrawal by Subject|5|||
146697396|NCT05458856|529072359|FG000|Overall Study|Death|4|||
146697397|NCT05458856|529072359|FG000|Overall Study|Protocol Deviation|3|||
146697398|NCT05458856|529072359|FG000|Overall Study|Physician Decision|1|||
146697399|NCT01852292|529072360|FG000|Overall Study|Untreated - did not receive study drug|3|||
146697400|NCT01852292|529072361|FG001|Overall Study|Untreated - did not receive study drug|1|||
146697401|NCT01852292|529072360|FG000|Overall Study|Death|9|||
146697402|NCT01852292|529072361|FG001|Overall Study|Death|8|||
146697403|NCT01852292|529072360|FG000|Overall Study|Patient/guardian decision|8|||
146697404|NCT01852292|529072361|FG001|Overall Study|Patient/guardian decision|4|||
146697405|NCT01852292|529072360|FG000|Overall Study|Adverse Event|8|||
146697406|NCT01852292|529072361|FG001|Overall Study|Adverse Event|11|||
146697407|NCT01852292|529072360|FG000|Overall Study|Physician Decision|6|||
146697408|NCT01852292|529072361|FG001|Overall Study|Physician Decision|2|||
146697409|NCT01852292|529072360|FG000|Overall Study|Protocol Violation|2|||
146697410|NCT01852292|529072361|FG001|Overall Study|Protocol Violation|0|||
146697411|NCT01852292|529072360|FG000|Overall Study|Non-compliance with study treatment|1|||
146697412|NCT01852292|529072361|FG001|Overall Study|Non-compliance with study treatment|0|||
146697413|NCT01852292|529072360|FG000|Overall Study|Study terminated by Sponsor|0|||
146697414|NCT01852292|529072361|FG001|Overall Study|Study terminated by Sponsor|1|||
146697415|NCT01852292|529072360|FG000|Overall Study|Progressive disease|42|||
146697416|NCT01852292|529072361|FG001|Overall Study|Progressive disease|52|||
146697417|NCT04013191|529072364|FG000|Overall Study|Adverse Event|1|||
146697418|NCT04013191|529072365|FG001|Overall Study|Adverse Event|0|||
146980757|NCT01512979|530091306|FG001|Overall Study|Adverse Event|2|||
146776109|NCT04583423|529351255|FG002|Overall Study|Study Terminated by Sponsor|36|||
146776110|NCT04583423|529351256|FG003|Overall Study|Study Terminated by Sponsor|33|||
146776111|NCT04583423|529351253|FG000|Overall Study|Withdrawal by Subject|3|||
146776112|NCT04583423|529351254|FG001|Overall Study|Withdrawal by Subject|1|||
146776113|NCT04583423|529351255|FG002|Overall Study|Withdrawal by Subject|2|||
146776114|NCT04583423|529351256|FG003|Overall Study|Withdrawal by Subject|1|||
146776115|NCT01561989|529351257|FG000|Overall Study|accural target not met.|5|||
146776116|NCT01561989|529351258|FG001|Overall Study|accural target not met.|6|||
146776117|NCT01736215|529351259|FG000|Overall Study|Early termination of erythropoietin use|1|||
146776118|NCT01736215|529351259|FG000|Overall Study|Adverse Event|4|||
146776119|NCT01736215|529351259|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
146776120|NCT01736215|529351259|FG000|Overall Study|Insufficient data to perform analysis|8|||
146776121|NCT03447249|529351260|FG000|Overall Study|Adverse Event|1|||
146776122|NCT03447249|529351261|FG001|Overall Study|Adverse Event|0|||
146776123|NCT03447249|529351260|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
146776124|NCT03447249|529351261|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
146776125|NCT03447249|529351260|FG000|Overall Study|Other|3|||
146776126|NCT03447249|529351261|FG001|Overall Study|Other|0|||
146776127|NCT01248936|529351262|FG000|Overall Study|Sponsor Decision|259|||
146776128|NCT01248936|529351262|FG000|Overall Study|Progression of Disease|50|||
146776129|NCT01248936|529351262|FG000|Overall Study|Death|26|||
146776130|NCT01248936|529351262|FG000|Overall Study|Withdrawal of Consent|20|||
146776131|NCT01248936|529351262|FG000|Overall Study|Adverse Event|8|||
146776132|NCT01248936|529351262|FG000|Overall Study|Lost to Follow-up|7|||
146776133|NCT01248936|529351262|FG000|Overall Study|Refused Treatment|1|||
146776134|NCT01248936|529351262|FG000|Overall Study|Other reason|3|||
146776135|NCT03485950|529351263|FG000|Overall Study|Adverse Event|1|||
146776136|NCT03485950|529351264|FG001|Overall Study|Adverse Event|0|||
146776137|NCT03485950|529351263|FG000|Overall Study|Death|3|||
146776138|NCT03485950|529351264|FG001|Overall Study|Death|2|||
146776139|NCT03485950|529351263|FG000|Overall Study|Withdrawal by Subject|3|||
146776140|NCT03485950|529351264|FG001|Overall Study|Withdrawal by Subject|0|||
146776141|NCT00988858|529351265|FG000|Overall Study|Adverse Event|7|||
146776142|NCT00988858|529351265|FG000|Overall Study|Death|1|||
146776143|NCT00988858|529351265|FG000|Overall Study|Physician Decision|1|||
146776144|NCT00988858|529351265|FG000|Overall Study|Sponsor Decision|1|||
146776145|NCT02238483|529351266|FG000|Overall Study|Withdrawal by Subject|2|||
146776146|NCT02238483|529351267|FG001|Overall Study|Withdrawal by Subject|7|||
146776147|NCT02238483|529351266|FG000|Overall Study|Lost to Follow-up|1|||
146776148|NCT02238483|529351267|FG001|Overall Study|Lost to Follow-up|1|||
146776149|NCT02238483|529351266|FG000|Overall Study|Protocol Violation|1|||
146776150|NCT02238483|529351267|FG001|Overall Study|Protocol Violation|2|||
146776151|NCT02238483|529351266|FG000|Overall Study|Death|1|||
146776152|NCT02238483|529351267|FG001|Overall Study|Death|0|||
146776153|NCT02238483|529351266|FG000|Overall Study|Adverse Event|7|||
146776154|NCT02238483|529351267|FG001|Overall Study|Adverse Event|3|||
146776155|NCT02238483|529351266|FG000|Overall Study|Withdrawn due to physician decision|1|||
146776156|NCT02238483|529351267|FG001|Overall Study|Withdrawn due to physician decision|0|||
146776157|NCT02238483|529351266|FG000|Overall Study|Completion status not recorded|1|||
146776158|NCT02238483|529351267|FG001|Overall Study|Completion status not recorded|1|||
146776159|NCT02238483|529351266|FG000|Overall Study|Illness in family member|1|||
146776160|NCT02238483|529351267|FG001|Overall Study|Illness in family member|0|||
146776161|NCT00567489|529351268|FG000|Overall Study|Adverse Event|6|||
146776162|NCT00567489|529351269|FG001|Overall Study|Adverse Event|14|||
146776163|NCT00567489|529351268|FG000|Overall Study|Physician Decision|0|||
146776164|NCT00567489|529351269|FG001|Overall Study|Physician Decision|4|||
146697419|NCT03711162|529072372|FG000|Overall Study|Adverse Event|5|||
146697420|NCT03711162|529072373|FG001|Overall Study|Adverse Event|2|||
146697421|NCT03711162|529072374|FG002|Overall Study|Adverse Event|4|||
146697422|NCT03711162|529072372|FG000|Overall Study|Death|11|||
146697423|NCT03711162|529072373|FG001|Overall Study|Death|7|||
146697424|NCT03711162|529072374|FG002|Overall Study|Death|8|||
146697425|NCT03711162|529072372|FG000|Overall Study|Lost to Follow-up|1|||
146697426|NCT03711162|529072373|FG001|Overall Study|Lost to Follow-up|0|||
146697427|NCT03711162|529072374|FG002|Overall Study|Lost to Follow-up|1|||
146697428|NCT03711162|529072372|FG000|Overall Study|Study Terminated by Sponsor|139|||
146697429|NCT03711162|529072373|FG001|Overall Study|Study Terminated by Sponsor|152|||
146697430|NCT03711162|529072374|FG002|Overall Study|Study Terminated by Sponsor|146|||
146776165|NCT00567489|529351268|FG000|Overall Study|Withdrawal by Subject|0|||
146776166|NCT00567489|529351269|FG001|Overall Study|Withdrawal by Subject|2|||
146776167|NCT00567489|529351268|FG000|Overall Study|Renal Transplantation|0|||
146776168|NCT00567489|529351269|FG001|Overall Study|Renal Transplantation|3|||
146776169|NCT00567489|529351268|FG000|Overall Study|Other|1|||
146776170|NCT00567489|529351269|FG001|Overall Study|Other|0|||
146776171|NCT00390299|529351270|FG000|Overall Study|Cancellation|1|||
146776172|NCT00390299|529351271|FG001|Overall Study|Cancellation|0|||
146776173|NCT00390299|529351272|FG002|Overall Study|Cancellation|0|||
146776174|NCT00390299|529351273|FG003|Overall Study|Cancellation|0|||
146776175|NCT00390299|529351274|FG004|Overall Study|Cancellation|0|||
146697431|NCT03711162|529072372|FG000|Overall Study|Withdrawal by Subject|17|||
146697432|NCT03711162|529072373|FG001|Overall Study|Withdrawal by Subject|10|||
146697433|NCT03711162|529072374|FG002|Overall Study|Withdrawal by Subject|10|||
146697434|NCT03711162|529072372|FG000|Overall Study|Miscellaneous|1|||
146697435|NCT03711162|529072373|FG001|Overall Study|Miscellaneous|2|||
146697436|NCT03711162|529072374|FG002|Overall Study|Miscellaneous|2|||
146697437|NCT03711162|529072372|FG000|Overall Study|Not Treated|1|||
146697438|NCT03711162|529072373|FG001|Overall Study|Not Treated|0|||
146697439|NCT03711162|529072374|FG002|Overall Study|Not Treated|1|||
146980758|NCT01512979|530091305|FG000|Overall Study|Protocol Violation|1|||
146617921|NCT00527735|528773145|FG002|Overall Study|Withdrawal by Subject|3|||
146617922|NCT00527735|528773143|FG000|Overall Study|No longer met study criteria|2|||
146617923|NCT00527735|528773144|FG001|Overall Study|No longer met study criteria|2|||
146617924|NCT00527735|528773145|FG002|Overall Study|No longer met study criteria|1|||
146617925|NCT00527735|528773143|FG000|Overall Study|Lost to Follow-up|0|||
146617926|NCT00527735|528773144|FG001|Overall Study|Lost to Follow-up|0|||
146617927|NCT00527735|528773145|FG002|Overall Study|Lost to Follow-up|3|||
146617928|NCT00527735|528773143|FG000|Overall Study|Poor compliance or noncompliance|0|||
146617929|NCT00527735|528773144|FG001|Overall Study|Poor compliance or noncompliance|1|||
146617930|NCT00527735|528773145|FG002|Overall Study|Poor compliance or noncompliance|1|||
146617931|NCT00527735|528773143|FG000|Overall Study|Completed treatment during maintenance|2|||
146617932|NCT00527735|528773144|FG001|Overall Study|Completed treatment during maintenance|2|||
146617933|NCT00527735|528773145|FG002|Overall Study|Completed treatment during maintenance|1|||
146617934|NCT01855412|528773146|FG000|Overall Study|Death|77|||
146617935|NCT01855412|528773147|FG001|Overall Study|Death|123|||
146617936|NCT01855412|528773148|FG002|Overall Study|Death|30|||
146617937|NCT01855412|528773146|FG000|Overall Study|Lost to Follow-up|28|||
146617938|NCT01855412|528773147|FG001|Overall Study|Lost to Follow-up|46|||
146617939|NCT01855412|528773148|FG002|Overall Study|Lost to Follow-up|15|||
146617940|NCT01855412|528773146|FG000|Overall Study|Withdrawal by Subject|77|||
146617941|NCT01855412|528773147|FG001|Overall Study|Withdrawal by Subject|123|||
146617942|NCT01855412|528773148|FG002|Overall Study|Withdrawal by Subject|24|||
146617943|NCT01855412|528773146|FG000|Overall Study|Physician Decision|25|||
146617944|NCT01855412|528773147|FG001|Overall Study|Physician Decision|31|||
146617945|NCT01855412|528773148|FG002|Overall Study|Physician Decision|3|||
146617946|NCT01855412|528773146|FG000|Overall Study|Site Closure|4|||
146617947|NCT01855412|528773147|FG001|Overall Study|Site Closure|18|||
146617948|NCT01855412|528773148|FG002|Overall Study|Site Closure|1|||
146617949|NCT01855412|528773146|FG000|Overall Study|Reason not Specified|1|||
146617950|NCT01855412|528773147|FG001|Overall Study|Reason not Specified|2|||
146617951|NCT01855412|528773148|FG002|Overall Study|Reason not Specified|3|||
146617952|NCT00346216|528773150|FG000|Overall Study|Other|181|||
146617953|NCT00346216|528773151|FG001|Overall Study|Other|231|||
146617954|NCT00346216|528773152|FG002|Overall Study|Other|205|||
146617955|NCT00346216|528773150|FG000|Overall Study|No longer willing to participate|600|||
146617956|NCT00346216|528773151|FG001|Overall Study|No longer willing to participate|606|||
146617957|NCT00346216|528773152|FG002|Overall Study|No longer willing to participate|585|||
146617958|NCT00346216|528773150|FG000|Overall Study|Withdrawal by Subject|661|||
146617959|NCT00346216|528773151|FG001|Overall Study|Withdrawal by Subject|692|||
146617960|NCT00346216|528773152|FG002|Overall Study|Withdrawal by Subject|651|||
146617961|NCT00346216|528773150|FG000|Overall Study|Lost to Follow-up|611|||
146617962|NCT00346216|528773151|FG001|Overall Study|Lost to Follow-up|588|||
146617963|NCT00346216|528773152|FG002|Overall Study|Lost to Follow-up|542|||
146617964|NCT00346216|528773150|FG000|Overall Study|Physician Decision|80|||
146617965|NCT00346216|528773151|FG001|Overall Study|Physician Decision|76|||
146617966|NCT00346216|528773152|FG002|Overall Study|Physician Decision|59|||
146617967|NCT00346216|528773150|FG000|Overall Study|Does not meet entrance criteria|13|||
146617968|NCT00346216|528773151|FG001|Overall Study|Does not meet entrance criteria|10|||
146617969|NCT00346216|528773152|FG002|Overall Study|Does not meet entrance criteria|8|||
146617970|NCT00346216|528773150|FG000|Overall Study|Death|189|||
146617971|NCT00346216|528773151|FG001|Overall Study|Death|192|||
146617972|NCT00346216|528773152|FG002|Overall Study|Death|228|||
146617973|NCT00346216|528773150|FG000|Overall Study|Study terminated by sponsor|11|||
146617974|NCT00346216|528773151|FG001|Overall Study|Study terminated by sponsor|4|||
146617975|NCT00346216|528773152|FG002|Overall Study|Study terminated by sponsor|8|||
146617976|NCT00346216|528773150|FG000|Overall Study|Missing Subject Summary Status|62|||
146617977|NCT00346216|528773151|FG001|Overall Study|Missing Subject Summary Status|61|||
146617978|NCT00346216|528773152|FG002|Overall Study|Missing Subject Summary Status|62|||
146617979|NCT01132807|528773153|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
146617980|NCT01132807|528773154|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
146617981|NCT01132807|528773155|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
146617982|NCT01132807|528773153|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
146617983|NCT01132807|528773154|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
146617984|NCT01132807|528773155|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
146776176|NCT04732338|529351283|FG000|Overall Study|Lost to Follow-up|3|||
146776177|NCT04732338|529351284|FG001|Overall Study|Lost to Follow-up|3|||
146776178|NCT02372253|529351285|FG000|Overall Study|Non Compliance|2|||
146776179|NCT02372253|529351286|FG001|Overall Study|Non Compliance|0|||
146776180|NCT03750968|529351289|FG000|Overall Study|Adverse Event|2|||
146776181|NCT03750968|529351290|FG001|Overall Study|Adverse Event|0|||
146776182|NCT03750968|529351289|FG000|Overall Study|Lost to Follow-up|1|||
146776183|NCT03750968|529351290|FG001|Overall Study|Lost to Follow-up|3|||
146776184|NCT02178098|529351291|FG000|Overall Study|Withdrawal by Subject|0|||
146776185|NCT02178098|529351292|FG001|Overall Study|Withdrawal by Subject|6|||
146776186|NCT02178098|529351291|FG000|Overall Study|Adverse Event|1|||
146776187|NCT02178098|529351292|FG001|Overall Study|Adverse Event|2|||
146776188|NCT02178098|529351291|FG000|Overall Study|Protocol Violation|1|||
146776189|NCT02178098|529351292|FG001|Overall Study|Protocol Violation|1|||
146776190|NCT02178098|529351291|FG000|Overall Study|Lost to Follow-up|0|||
146776191|NCT02178098|529351292|FG001|Overall Study|Lost to Follow-up|1|||
146776192|NCT02178098|529351291|FG000|Overall Study|Sponsor Request|1|||
146776193|NCT02178098|529351292|FG001|Overall Study|Sponsor Request|0|||
146776194|NCT02178098|529351291|FG000|Overall Study|Other|2|||
146776195|NCT02178098|529351292|FG001|Overall Study|Other|2|||
146776196|NCT03101371|529351295|FG000|Overall Study|Physician Decision|0|||
146776197|NCT03101371|529351296|FG001|Overall Study|Physician Decision|1|||
146776198|NCT03101371|529351295|FG000|Overall Study|Lost to Follow-up|1|||
146776199|NCT03101371|529351296|FG001|Overall Study|Lost to Follow-up|4|||
146776200|NCT03101371|529351295|FG000|Overall Study|Did not meet eligibility criteria|2|||
146776201|NCT03101371|529351296|FG001|Overall Study|Did not meet eligibility criteria|1|||
146776202|NCT01094184|529351303|FG000|Overall Study|Death|35|||
146776203|NCT01094184|529351304|FG001|Overall Study|Death|11|||
146776204|NCT04766034|529351305|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
146776205|NCT04766034|529351306|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
146776206|NCT04766034|529351307|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
146776207|NCT04766034|529351308|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
146776208|NCT04766034|529351309|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
146776209|NCT04766034|529351305|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
146776210|NCT04766034|529351306|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
146776211|NCT04766034|529351307|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
146776212|NCT04766034|529351308|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
146776213|NCT04766034|529351309|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
146776214|NCT04766034|529351305|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
146776215|NCT04766034|529351306|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
146697440|NCT03711162|529072372|FG000|Overall Study|Physician Decision|0|||
146697441|NCT03711162|529072373|FG001|Overall Study|Physician Decision|2|||
146697442|NCT03711162|529072374|FG002|Overall Study|Physician Decision|0|||
146697443|NCT03711162|529072372|FG000|Overall Study|Lack of Efficacy|0|||
146697444|NCT03711162|529072373|FG001|Overall Study|Lack of Efficacy|0|||
146697445|NCT03711162|529072374|FG002|Overall Study|Lack of Efficacy|2|||
146697446|NCT03711162|529072372|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
146697447|NCT03711162|529072373|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
146697448|NCT03711162|529072374|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
146697449|NCT03034954|529072375|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
146697450|NCT03034954|529072376|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
146697451|NCT04904185|529072383|FG000|Overall Study|Expansion failure|1|||
146697452|NCT04904185|529072384|FG001|Overall Study|Expansion failure|0|||
146697453|NCT04904185|529072383|FG000|Overall Study|Late response on prior treatment|1|||
146697454|NCT04904185|529072384|FG001|Overall Study|Late response on prior treatment|0|||
146697455|NCT00110812|529072387|FG000|Main Study|Death|0|||
146697456|NCT00110812|529072388|FG001|Main Study|Death|0|||
146697457|NCT00110812|529072389|FG002|Main Study|Death|2|||
146697458|NCT00110812|529072387|FG000|Main Study|Withdrawal by Subject|0|||
146697459|NCT00110812|529072388|FG001|Main Study|Withdrawal by Subject|0|||
146697460|NCT00110812|529072389|FG002|Main Study|Withdrawal by Subject|1|||
146697461|NCT00110812|529072387|FG000|Main Study|Lost to Follow-up|8|||
146776216|NCT04766034|529351307|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
146776217|NCT04766034|529351308|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
146697462|NCT00110812|529072388|FG001|Main Study|Lost to Follow-up|11|||
146697463|NCT00110812|529072389|FG002|Main Study|Lost to Follow-up|10|||
146697464|NCT00110812|529072387|FG000|Extended Follow-up|Death|1|||
146930993|NCT01253187|529905324|FG005|Period 3|non-compliance|0|||
146697465|NCT00110812|529072388|FG001|Extended Follow-up|Death|0|||
146930994|NCT01293006|529905326|FG000|Period 2|Lost to Follow-up|1|||
146697466|NCT00110812|529072389|FG002|Extended Follow-up|Death|3|||
146697467|NCT00110812|529072387|FG000|Extended Follow-up|Withdrawal by Subject|0|||
146697468|NCT00110812|529072388|FG001|Extended Follow-up|Withdrawal by Subject|1|||
146697469|NCT00110812|529072389|FG002|Extended Follow-up|Withdrawal by Subject|0|||
146697470|NCT00110812|529072387|FG000|Extended Follow-up|Lost to Follow-up|1|||
146697471|NCT00110812|529072388|FG001|Extended Follow-up|Lost to Follow-up|3|||
146697472|NCT00110812|529072389|FG002|Extended Follow-up|Lost to Follow-up|1|||
146697473|NCT01604343|529072390|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
146697474|NCT01604343|529072391|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
146697475|NCT01604343|529072392|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
146697476|NCT01604343|529072393|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
146697477|NCT01604343|529072394|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
146697478|NCT01604343|529072390|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
146697479|NCT01604343|529072391|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
146697480|NCT01604343|529072392|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
146697481|NCT01604343|529072393|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
146697482|NCT01604343|529072394|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
146697483|NCT01604343|529072390|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
146697484|NCT01604343|529072391|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
146697485|NCT01604343|529072392|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
146697486|NCT01604343|529072393|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
146697487|NCT01604343|529072394|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
146697488|NCT01604343|529072390|FG000|Prior to W52 Administration(Through W52)|Death|5|||
146697489|NCT01604343|529072391|FG001|Prior to W52 Administration(Through W52)|Death|0|||
146697490|NCT01604343|529072392|FG002|Prior to W52 Administration(Through W52)|Death|2|||
146697491|NCT01604343|529072393|FG003|Prior to W52 Administration(Through W52)|Death|0|||
146697492|NCT01604343|529072394|FG004|Prior to W52 Administration(Through W52)|Death|4|||
146697493|NCT01604343|529072390|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
146697494|NCT01604343|529072391|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
146697495|NCT01604343|529072392|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
146697496|NCT01604343|529072393|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
146697497|NCT01604343|529072394|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
146697498|NCT01604343|529072390|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
146697499|NCT01604343|529072391|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
146697500|NCT01604343|529072392|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
146697501|NCT01604343|529072393|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
146697502|NCT01604343|529072394|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
146697503|NCT01604343|529072390|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
146697504|NCT01604343|529072391|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
146697505|NCT01604343|529072392|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
146697506|NCT01604343|529072393|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
146697507|NCT01604343|529072394|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
146697508|NCT01604343|529072390|FG000|Prior to W52 Administration(Through W52)|Other|15|||
146697509|NCT01604343|529072391|FG001|Prior to W52 Administration(Through W52)|Other|0|||
146697510|NCT01604343|529072392|FG002|Prior to W52 Administration(Through W52)|Other|10|||
146697511|NCT01604343|529072393|FG003|Prior to W52 Administration(Through W52)|Other|0|||
146697512|NCT01604343|529072394|FG004|Prior to W52 Administration(Through W52)|Other|6|||
146697513|NCT01604343|529072390|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
146697514|NCT01604343|529072391|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
146697515|NCT01604343|529072392|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
146697516|NCT01604343|529072393|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
146697517|NCT01604343|529072394|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
146697518|NCT01604343|529072390|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
146697519|NCT01604343|529072391|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
146697520|NCT01604343|529072392|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
146697521|NCT01604343|529072393|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
146697522|NCT01604343|529072394|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
146697523|NCT01604343|529072390|FG000|Week 52 to Week 104|Adverse Event|0|||
146697524|NCT01604343|529072391|FG001|Week 52 to Week 104|Adverse Event|12|||
146697525|NCT01604343|529072392|FG002|Week 52 to Week 104|Adverse Event|26|||
146697526|NCT01604343|529072393|FG003|Week 52 to Week 104|Adverse Event|21|||
146697527|NCT01604343|529072394|FG004|Week 52 to Week 104|Adverse Event|27|||
146697528|NCT01604343|529072390|FG000|Week 52 to Week 104|Death|0|||
146697529|NCT01604343|529072391|FG001|Week 52 to Week 104|Death|4|||
146697530|NCT01604343|529072392|FG002|Week 52 to Week 104|Death|2|||
146697531|NCT01604343|529072393|FG003|Week 52 to Week 104|Death|5|||
146697532|NCT01604343|529072394|FG004|Week 52 to Week 104|Death|0|||
146697533|NCT01604343|529072390|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
146697534|NCT01604343|529072391|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
146697535|NCT01604343|529072392|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
146697536|NCT01604343|529072393|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
146697537|NCT01604343|529072394|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
146697538|NCT01604343|529072390|FG000|Week 52 to Week 104|Physician Decision|0|||
146697539|NCT01604343|529072391|FG001|Week 52 to Week 104|Physician Decision|1|||
146697540|NCT01604343|529072392|FG002|Week 52 to Week 104|Physician Decision|0|||
146697541|NCT01604343|529072393|FG003|Week 52 to Week 104|Physician Decision|0|||
146697542|NCT01604343|529072394|FG004|Week 52 to Week 104|Physician Decision|2|||
146697543|NCT01604343|529072390|FG000|Week 52 to Week 104|Pregnancy|0|||
146697544|NCT01604343|529072391|FG001|Week 52 to Week 104|Pregnancy|0|||
146697545|NCT01604343|529072392|FG002|Week 52 to Week 104|Pregnancy|1|||
146697546|NCT01604343|529072393|FG003|Week 52 to Week 104|Pregnancy|2|||
146697547|NCT01604343|529072394|FG004|Week 52 to Week 104|Pregnancy|1|||
146697548|NCT01604343|529072390|FG000|Week 52 to Week 104|Other|0|||
146697549|NCT01604343|529072391|FG001|Week 52 to Week 104|Other|11|||
146697550|NCT01604343|529072392|FG002|Week 52 to Week 104|Other|11|||
146697551|NCT01604343|529072393|FG003|Week 52 to Week 104|Other|6|||
146697552|NCT01604343|529072394|FG004|Week 52 to Week 104|Other|3|||
146697553|NCT01604343|529072390|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
146697554|NCT01604343|529072391|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
146697555|NCT01604343|529072392|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
146697556|NCT01604343|529072393|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
146697557|NCT01604343|529072394|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
146697558|NCT01604343|529072390|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
146697559|NCT01604343|529072391|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
146697560|NCT01604343|529072392|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
146697561|NCT01604343|529072393|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
146697562|NCT01604343|529072394|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
146697563|NCT01604343|529072390|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
146697564|NCT01604343|529072391|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
146697565|NCT01604343|529072392|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
146697566|NCT01604343|529072393|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
146697567|NCT01604343|529072394|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
146697568|NCT02871375|529072395|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
146697569|NCT02871375|529072396|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
146697570|NCT01988571|529072397|FG000|Overall Study|Death|3|||
146697571|NCT01988571|529072398|FG001|Overall Study|Death|1|||
146697572|NCT01988571|529072397|FG000|Overall Study|Physician Decision|2|||
146697573|NCT01988571|529072398|FG001|Overall Study|Physician Decision|1|||
146697574|NCT01988571|529072397|FG000|Overall Study|Lost to Follow-up|3|||
146697575|NCT01988571|529072398|FG001|Overall Study|Lost to Follow-up|0|||
146697576|NCT01988571|529072397|FG000|Overall Study|Withdrawal by Subject|31|||
146697577|NCT01988571|529072398|FG001|Overall Study|Withdrawal by Subject|33|||
146697578|NCT03792672|529072402|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
146697579|NCT03792672|529072403|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
146697580|NCT03792672|529072404|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
146697581|NCT03792672|529072405|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
146697582|NCT03792672|529072406|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
146697583|NCT03792672|529072407|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
146697584|NCT03792672|529072402|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
146697585|NCT03792672|529072403|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
146697586|NCT03792672|529072404|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
146697587|NCT03792672|529072405|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
146697588|NCT03792672|529072406|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
146697589|NCT03792672|529072407|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
146697590|NCT03792672|529072402|FG000|Treatment Period 4 (2 Days)|Other|1|||
146697591|NCT03792672|529072403|FG001|Treatment Period 4 (2 Days)|Other|0|||
146697592|NCT03792672|529072404|FG002|Treatment Period 4 (2 Days)|Other|0|||
146697593|NCT03792672|529072405|FG003|Treatment Period 4 (2 Days)|Other|0|||
146697594|NCT03792672|529072406|FG004|Treatment Period 4 (2 Days)|Other|0|||
146697595|NCT03792672|529072407|FG005|Treatment Period 4 (2 Days)|Other|0|||
146697596|NCT00453999|529072408|FG000|Overall Study|Adverse Event|1|||
146697597|NCT00453999|529072409|FG001|Overall Study|Adverse Event|2|||
146697598|NCT00453999|529072410|FG002|Overall Study|Adverse Event|1|||
146697599|NCT00453999|529072408|FG000|Overall Study|Lost to Follow-up|0|||
146697600|NCT00453999|529072409|FG001|Overall Study|Lost to Follow-up|1|||
146697601|NCT00453999|529072410|FG002|Overall Study|Lost to Follow-up|1|||
146697602|NCT00453999|529072408|FG000|Overall Study|Withdrawal by Subject|2|||
146697603|NCT00453999|529072409|FG001|Overall Study|Withdrawal by Subject|1|||
146980759|NCT01512979|530091306|FG001|Overall Study|Protocol Violation|4|||
146697604|NCT00453999|529072410|FG002|Overall Study|Withdrawal by Subject|1|||
146697605|NCT00453999|529072408|FG000|Overall Study|Subject Request|2|||
146697606|NCT00453999|529072409|FG001|Overall Study|Subject Request|1|||
146697607|NCT00453999|529072410|FG002|Overall Study|Subject Request|0|||
146697608|NCT01417481|529072420|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
146697609|NCT01417481|529072421|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
146697610|NCT00829296|529072427|FG000|Overall Study|Adverse Event|5|||
146697611|NCT00829296|529072428|FG001|Overall Study|Adverse Event|4|||
146697612|NCT03029624|529072429|FG000|Overall Study|Adverse Event|1|||
146697613|NCT03029624|529072429|FG000|Overall Study|Withdrawal by Subject|1|||
146697614|NCT03029624|529072429|FG000|Overall Study|Lack of Efficacy|1|||
146697615|NCT03029624|529072429|FG000|Overall Study|MRI need|2|||
146697616|NCT02689258|529072430|FG000|Overall Study|Subject Non-Compliance|0|||
146697617|NCT02689258|529072431|FG001|Overall Study|Subject Non-Compliance|1|||
146697618|NCT02689258|529072432|FG002|Overall Study|Subject Non-Compliance|0|||
146697619|NCT02689258|529072433|FG003|Overall Study|Subject Non-Compliance|0|||
146697620|NCT02689258|529072434|FG004|Overall Study|Subject Non-Compliance|0|||
146697621|NCT02689258|529072435|FG005|Overall Study|Subject Non-Compliance|0|||
146697622|NCT02689258|529072436|FG006|Overall Study|Subject Non-Compliance|0|||
146697623|NCT02689258|529072437|FG007|Overall Study|Subject Non-Compliance|0|||
146697624|NCT02689258|529072438|FG008|Overall Study|Subject Non-Compliance|0|||
146697625|NCT02689258|529072439|FG009|Overall Study|Subject Non-Compliance|0|||
146697626|NCT02689258|529072440|FG010|Overall Study|Subject Non-Compliance|0|||
146697627|NCT02689258|529072441|FG011|Overall Study|Subject Non-Compliance|0|||
146697628|NCT02689258|529072430|FG000|Overall Study|Subject Refusal to Continue|0|||
146697629|NCT02689258|529072431|FG001|Overall Study|Subject Refusal to Continue|1|||
146697630|NCT02689258|529072432|FG002|Overall Study|Subject Refusal to Continue|0|||
146697631|NCT02689258|529072433|FG003|Overall Study|Subject Refusal to Continue|0|||
146697632|NCT02689258|529072434|FG004|Overall Study|Subject Refusal to Continue|0|||
146697633|NCT02689258|529072435|FG005|Overall Study|Subject Refusal to Continue|0|||
146697634|NCT02689258|529072436|FG006|Overall Study|Subject Refusal to Continue|0|||
146697635|NCT02689258|529072437|FG007|Overall Study|Subject Refusal to Continue|0|||
146697636|NCT02689258|529072438|FG008|Overall Study|Subject Refusal to Continue|1|||
146697637|NCT02689258|529072439|FG009|Overall Study|Subject Refusal to Continue|0|||
146697638|NCT02689258|529072440|FG010|Overall Study|Subject Refusal to Continue|0|||
146697639|NCT02689258|529072441|FG011|Overall Study|Subject Refusal to Continue|1|||
146697640|NCT02689258|529072430|FG000|Overall Study|Other|0|||
146697641|NCT02689258|529072431|FG001|Overall Study|Other|2|||
146697642|NCT02689258|529072432|FG002|Overall Study|Other|0|||
146697643|NCT02689258|529072433|FG003|Overall Study|Other|0|||
146697644|NCT02689258|529072434|FG004|Overall Study|Other|1|||
146697645|NCT02689258|529072435|FG005|Overall Study|Other|0|||
146697646|NCT02689258|529072436|FG006|Overall Study|Other|0|||
146697647|NCT02689258|529072437|FG007|Overall Study|Other|0|||
146697648|NCT02689258|529072438|FG008|Overall Study|Other|1|||
146697649|NCT02689258|529072439|FG009|Overall Study|Other|0|||
146697650|NCT02689258|529072440|FG010|Overall Study|Other|0|||
146697651|NCT02689258|529072441|FG011|Overall Study|Other|0|||
146697652|NCT04753164|529072445|FG000|Overall Study|Adverse Event|0|||
146697653|NCT04753164|529072446|FG001|Overall Study|Adverse Event|2|||
146697654|NCT04753164|529072445|FG000|Overall Study|Withdrawal by Subject|9|||
146697655|NCT04753164|529072446|FG001|Overall Study|Withdrawal by Subject|7|||
146697656|NCT04753164|529072445|FG000|Overall Study|Lost to Follow-up|6|||
146697657|NCT04753164|529072446|FG001|Overall Study|Lost to Follow-up|6|||
146697658|NCT04753164|529072445|FG000|Overall Study|Other|12|||
146697659|NCT04753164|529072446|FG001|Overall Study|Other|5|||
146697660|NCT00696137|529072448|FG000|Overall Study|Withdrawal by Subject|2|||
146697661|NCT01371656|529072449|FG000|Overall Study|Death|7|||
146697662|NCT01371656|529072450|FG001|Overall Study|Death|4|||
146697663|NCT01371656|529072449|FG000|Overall Study|Physician Decision|46|||
146697664|NCT01371656|529072450|FG001|Overall Study|Physician Decision|7|||
146697665|NCT01371656|529072449|FG000|Overall Study|Withdrawal by Subject|7|||
146697666|NCT01371656|529072450|FG001|Overall Study|Withdrawal by Subject|0|||
146697667|NCT01371656|529072449|FG000|Overall Study|Ineligible|4|||
146697668|NCT01371656|529072450|FG001|Overall Study|Ineligible|3|||
146697669|NCT01465464|529072462|FG000|Overall Study|Adverse Event|96|||
146697670|NCT01465464|529072463|FG001|Overall Study|Adverse Event|49|||
146697671|NCT01465464|529072462|FG000|Overall Study|Lack of Efficacy|139|||
146697672|NCT01465464|529072463|FG001|Overall Study|Lack of Efficacy|190|||
146697673|NCT01465464|529072462|FG000|Overall Study|Physician Decision|13|||
146697674|NCT01465464|529072463|FG001|Overall Study|Physician Decision|5|||
146697675|NCT01465464|529072462|FG000|Overall Study|Protocol Violation|1|||
146697676|NCT01465464|529072463|FG001|Overall Study|Protocol Violation|1|||
146697677|NCT01465464|529072462|FG000|Overall Study|Withdrawal by Subject|46|||
146697678|NCT01465464|529072463|FG001|Overall Study|Withdrawal by Subject|30|||
146980760|NCT01512979|530091305|FG000|Overall Study|Lost to Follow-up|2|||
146697679|NCT01465464|529072462|FG000|Overall Study|Other|9|||
146697680|NCT01465464|529072463|FG001|Overall Study|Other|3|||
146697681|NCT01465464|529072462|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
146697682|NCT01465464|529072463|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
146697683|NCT00785486|529072464|FG000|Midazolam Alone|Withdrawal by Subject|1|||
146697684|NCT00775437|529072465|FG000|Overall Study|Loss of efficacy|2|||
146697685|NCT00775437|529072465|FG000|Overall Study|Withdrawal by Subject|3|||
146697686|NCT00775437|529072465|FG000|Overall Study|Lost to Follow-up|1|||
146697687|NCT03316885|529072466|FG000|Overall Study|Adverse Event|1|||
146697688|NCT03316885|529072466|FG000|Overall Study|Death|10|||
146980761|NCT01512979|530091306|FG001|Overall Study|Lost to Follow-up|5|||
146980762|NCT01512979|530091305|FG000|Overall Study|Withdrawal by Subject|1|||
146980763|NCT01512979|530091306|FG001|Overall Study|Withdrawal by Subject|2|||
146980764|NCT01512979|530091305|FG000|Overall Study|Reason other than stated above|13|||
146980765|NCT01512979|530091306|FG001|Overall Study|Reason other than stated above|9|||
146980766|NCT00529568|530091307|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
146980767|NCT00529568|530091308|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
146980768|NCT00529568|530091309|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
146980769|NCT00529568|530091307|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
146980770|NCT00529568|530091308|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
146980771|NCT00529568|530091309|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
146980772|NCT00529568|530091307|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
146980773|NCT00529568|530091308|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
146980774|NCT00529568|530091309|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
146980775|NCT00529568|530091307|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
146980776|NCT00529568|530091308|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
146980777|NCT00529568|530091309|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
146980778|NCT00529568|530091307|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
146697689|NCT03316885|529072466|FG000|Overall Study|Lost to Follow-up|4|||
146697690|NCT03316885|529072466|FG000|Overall Study|Withdrawal by Subject|9|||
146697691|NCT03316885|529072466|FG000|Overall Study|COVID related|8|||
146697692|NCT04251221|529072467|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
146697693|NCT04251221|529072468|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
146697694|NCT00329407|529072469|FG000|Overall Study|Withdrawal by Subject|1|||
146697695|NCT02357940|529072470|FG000|Overall Study|Adverse Event|0|||
146697696|NCT02357940|529072471|FG001|Overall Study|Adverse Event|1|||
146697697|NCT02357940|529072470|FG000|Overall Study|Investigator's judgement|0|||
146697698|NCT02357940|529072471|FG001|Overall Study|Investigator's judgement|1|||
146697699|NCT02442778|529072472|FG000|Overall Study|Adverse Event|2|||
146697700|NCT02442778|529072473|FG001|Overall Study|Adverse Event|6|||
146697701|NCT02442778|529072474|FG002|Overall Study|Adverse Event|6|||
146697702|NCT02442778|529072472|FG000|Overall Study|Death|0|||
146697703|NCT02442778|529072473|FG001|Overall Study|Death|2|||
146697704|NCT02442778|529072474|FG002|Overall Study|Death|0|||
146697705|NCT02442778|529072472|FG000|Overall Study|Lack of Efficacy|1|||
146697706|NCT02442778|529072473|FG001|Overall Study|Lack of Efficacy|0|||
146697707|NCT02442778|529072474|FG002|Overall Study|Lack of Efficacy|0|||
146697708|NCT02442778|529072472|FG000|Overall Study|Lost to Follow-up|1|||
146697709|NCT02442778|529072473|FG001|Overall Study|Lost to Follow-up|1|||
146697710|NCT02442778|529072474|FG002|Overall Study|Lost to Follow-up|1|||
146930995|NCT01293006|529905327|FG001|Period 2|Lost to Follow-up|0|||
146930996|NCT01293006|529905328|FG002|Period 2|Lost to Follow-up|0|||
146930997|NCT01293006|529905329|FG003|Period 2|Lost to Follow-up|0|||
146930998|NCT01494987|529905330|FG000|Overall Study|Adverse Event|6|||
146930999|NCT01494987|529905331|FG001|Overall Study|Adverse Event|5|||
146931000|NCT01494987|529905330|FG000|Overall Study|Hyperglycemia|6|||
146931001|NCT01494987|529905331|FG001|Overall Study|Hyperglycemia|4|||
146931002|NCT01494987|529905330|FG000|Overall Study|Investigator's Discretion|1|||
146931003|NCT01494987|529905331|FG001|Overall Study|Investigator's Discretion|2|||
146931004|NCT01494987|529905330|FG000|Overall Study|Lost to Follow-up|1|||
146931005|NCT01494987|529905331|FG001|Overall Study|Lost to Follow-up|1|||
146931006|NCT01494987|529905330|FG000|Overall Study|Protocol Violation|3|||
146931007|NCT01494987|529905331|FG001|Overall Study|Protocol Violation|3|||
146931008|NCT01494987|529905330|FG000|Overall Study|Subject Non-Compliance|9|||
146931009|NCT01494987|529905331|FG001|Overall Study|Subject Non-Compliance|10|||
146931010|NCT01494987|529905330|FG000|Overall Study|Subject Withdrew Consent|2|||
146931011|NCT01494987|529905331|FG001|Overall Study|Subject Withdrew Consent|3|||
146931012|NCT02254551|529905332|FG000|Dose Escalation|Physician Decision|1|||
146931013|NCT02254551|529905332|FG000|Dose Escalation|Dose-limiting toxicity|2|||
146931014|NCT01061736|529905333|FG000|Overall Study|Dose regimen not selected|0|||
146931015|NCT01061736|529905334|FG001|Overall Study|Dose regimen not selected|0|||
146931016|NCT01061736|529905335|FG002|Overall Study|Dose regimen not selected|0|||
146931017|NCT01061736|529905336|FG003|Overall Study|Dose regimen not selected|0|||
146931018|NCT01061736|529905337|FG004|Overall Study|Dose regimen not selected|0|||
146931019|NCT01061736|529905338|FG005|Overall Study|Dose regimen not selected|0|||
146931020|NCT01061736|529905339|FG006|Overall Study|Dose regimen not selected|79|||
146931021|NCT01061736|529905340|FG007|Overall Study|Dose regimen not selected|0|||
146931022|NCT01061736|529905341|FG008|Overall Study|Dose regimen not selected|0|||
146931023|NCT01061736|529905342|FG009|Overall Study|Dose regimen not selected|0|||
146931024|NCT01061736|529905333|FG000|Overall Study|Adverse Event|13|||
146931025|NCT01061736|529905334|FG001|Overall Study|Adverse Event|1|||
146931026|NCT01061736|529905335|FG002|Overall Study|Adverse Event|3|||
146931027|NCT01061736|529905336|FG003|Overall Study|Adverse Event|2|||
146697711|NCT02442778|529072472|FG000|Overall Study|Non-compliance with study drug|2|||
146697712|NCT02442778|529072473|FG001|Overall Study|Non-compliance with study drug|0|||
146697713|NCT02442778|529072474|FG002|Overall Study|Non-compliance with study drug|1|||
146697714|NCT02442778|529072472|FG000|Overall Study|Physician Decision|1|||
146697715|NCT02442778|529072473|FG001|Overall Study|Physician Decision|1|||
146697716|NCT02442778|529072474|FG002|Overall Study|Physician Decision|1|||
146697717|NCT02442778|529072472|FG000|Overall Study|Protocol Deviation|3|||
146697718|NCT02442778|529072473|FG001|Overall Study|Protocol Deviation|0|||
146697719|NCT02442778|529072474|FG002|Overall Study|Protocol Deviation|1|||
146697720|NCT02442778|529072472|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
146697721|NCT02442778|529072473|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
146697722|NCT02442778|529072474|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
146697723|NCT02442778|529072472|FG000|Overall Study|Withdrawal by Subject|4|||
146697724|NCT02442778|529072473|FG001|Overall Study|Withdrawal by Subject|4|||
146697725|NCT02442778|529072474|FG002|Overall Study|Withdrawal by Subject|3|||
146697726|NCT02442778|529072472|FG000|Overall Study|Reason not specified|1|||
146697727|NCT02442778|529072473|FG001|Overall Study|Reason not specified|4|||
146697728|NCT02442778|529072474|FG002|Overall Study|Reason not specified|0|||
146697729|NCT00978068|529072475|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
146697730|NCT00978068|529072476|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
146697731|NCT00978068|529072475|FG000|Overall Study|Death|1|||
146697732|NCT00978068|529072476|FG001|Overall Study|Death|2|||
146776218|NCT04766034|529351309|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
146776219|NCT04766034|529351305|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
146776220|NCT04766034|529351306|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
146776221|NCT04766034|529351307|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
146776222|NCT04766034|529351308|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
146776223|NCT04766034|529351309|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
146776224|NCT04992390|529351315|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
146776225|NCT04992390|529351316|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
146776226|NCT04992390|529351317|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
146776227|NCT04992390|529351315|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
146776228|NCT04992390|529351316|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
146776229|NCT04992390|529351317|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
146776230|NCT04992390|529351315|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
146776231|NCT04992390|529351316|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
146776232|NCT04992390|529351317|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
146776233|NCT04992390|529351315|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
146776234|NCT04992390|529351316|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
146776235|NCT04992390|529351317|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
146776236|NCT04992390|529351315|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
146776237|NCT04992390|529351316|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
146776238|NCT04992390|529351317|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
146776239|NCT04992390|529351315|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
146776240|NCT04992390|529351316|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
146776241|NCT04992390|529351317|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
146776242|NCT04992390|529351315|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
146776243|NCT04992390|529351316|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
146776244|NCT04992390|529351317|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
146776245|NCT04992390|529351315|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
146776246|NCT04992390|529351316|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
146776247|NCT04992390|529351317|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
146776248|NCT04992390|529351315|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
146776249|NCT04992390|529351316|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
146776250|NCT04992390|529351317|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
146776251|NCT04992390|529351315|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
146776252|NCT04992390|529351316|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
146776253|NCT04992390|529351317|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
146776254|NCT04992390|529351315|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
146776255|NCT04992390|529351316|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
146776256|NCT04992390|529351317|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
146776257|NCT04992390|529351315|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
146776258|NCT04992390|529351316|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
146776259|NCT04992390|529351317|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
146776260|NCT04992390|529351315|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
146931028|NCT01061736|529905337|FG004|Overall Study|Adverse Event|4|||
146697733|NCT00978068|529072475|FG000|Overall Study|Lost to Follow-up|1|||
146697734|NCT00978068|529072476|FG001|Overall Study|Lost to Follow-up|2|||
146697735|NCT00978068|529072475|FG000|Overall Study|Physician Decision|0|||
146697736|NCT00978068|529072476|FG001|Overall Study|Physician Decision|1|||
146697737|NCT00978068|529072475|FG000|Overall Study|Unable to Comply with Study|0|||
146697738|NCT00978068|529072476|FG001|Overall Study|Unable to Comply with Study|2|||
146697739|NCT04964128|529072479|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
146697740|NCT04964128|529072479|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
146697741|NCT03913091|529072484|FG000|Overall Study|Lost to Follow-up|18|||
146697742|NCT03913091|529072485|FG001|Overall Study|Lost to Follow-up|11|||
146697743|NCT03913091|529072484|FG000|Overall Study|Required additional meds/surgery|1|||
146697744|NCT03913091|529072485|FG001|Overall Study|Required additional meds/surgery|2|||
146697745|NCT03913091|529072484|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
146697746|NCT03913091|529072485|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
146697747|NCT02196324|529072487|FG000|Overall Study|Withdrawal by Subject|8|||
146697748|NCT02196324|529072488|FG001|Overall Study|Withdrawal by Subject|4|||
146697749|NCT02196324|529072487|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
146697750|NCT02196324|529072488|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
146697751|NCT02196324|529072487|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
146697752|NCT02196324|529072488|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
146697753|NCT02196324|529072487|FG000|Overall Study|Other|1|||
146697754|NCT02196324|529072488|FG001|Overall Study|Other|0|||
146697755|NCT01380184|529072489|FG000|Part 1 (19 Days)|Adverse Event|1|||
146697756|NCT01380184|529072489|FG000|Part 2|Adverse Event|5|||
146697757|NCT01380184|529072489|FG000|Part 2|Disease Progression|8|||
146697758|NCT01380184|529072489|FG000|Part 2|Lost to Follow-up|1|||
146697759|NCT04243538|529072490|FG000|Overall Study|Withdrawal by Subject|0|||
146697760|NCT04243538|529072491|FG001|Overall Study|Withdrawal by Subject|2|||
146697761|NCT04243538|529072490|FG000|Overall Study|Lost to Follow-up|0|||
146697762|NCT04243538|529072491|FG001|Overall Study|Lost to Follow-up|3|||
146697763|NCT00655564|529072492|FG000|Overall Study|Adverse Event|1|||
146697764|NCT00655564|529072492|FG000|Overall Study|Lost to Follow-up|1|||
146697765|NCT00655564|529072492|FG000|Overall Study|Desired Alternate Therapy|1|||
146697766|NCT00344773|529072497|FG000|Overall Study|Adverse Event|2|||
146697767|NCT00344773|529072497|FG000|Overall Study|Objective Disease Progression|16|||
146697768|NCT00344773|529072497|FG000|Overall Study|Withdrawal by Subject|1|||
146697769|NCT00344773|529072497|FG000|Overall Study|Not Eligible for the study|2|||
146697770|NCT00500370|529072504|FG000|Overall Study|Adverse Event|9|||
146776261|NCT04992390|529351316|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
146697771|NCT00500370|529072505|FG001|Overall Study|Adverse Event|3|||
146697772|NCT00500370|529072504|FG000|Overall Study|Lost to Follow-up|10|||
146776262|NCT04992390|529351317|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
146776263|NCT04992390|529351315|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
146776264|NCT04992390|529351316|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
146776265|NCT04992390|529351317|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
146776266|NCT04992390|529351315|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
146776267|NCT04992390|529351316|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
146776268|NCT04992390|529351317|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
146776269|NCT04992390|529351315|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
146776270|NCT04992390|529351316|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
146776271|NCT04992390|529351317|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
146776272|NCT05094141|529351318|FG000|Overall Study|Death|0|||
146776273|NCT05094141|529351319|FG001|Overall Study|Death|0|||
146776274|NCT05094141|529351320|FG002|Overall Study|Death|1|||
146776275|NCT05094141|529351318|FG000|Overall Study|Withdrawal by Subject|0|||
146776276|NCT05094141|529351319|FG001|Overall Study|Withdrawal by Subject|0|||
146776277|NCT05094141|529351320|FG002|Overall Study|Withdrawal by Subject|1|||
146776278|NCT05094141|529351318|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
146776279|NCT05094141|529351319|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
146697773|NCT00500370|529072505|FG001|Overall Study|Lost to Follow-up|10|||
146697774|NCT00500370|529072504|FG000|Overall Study|Protocol Violation|2|||
146697775|NCT00500370|529072505|FG001|Overall Study|Protocol Violation|4|||
146697776|NCT00500370|529072504|FG000|Overall Study|Sponsor Decision|2|||
146697777|NCT00500370|529072505|FG001|Overall Study|Sponsor Decision|0|||
146697778|NCT00500370|529072504|FG000|Overall Study|Subject Decision|10|||
146697779|NCT00500370|529072505|FG001|Overall Study|Subject Decision|17|||
146697780|NCT04804813|529072506|FG000|Overall Study|Protocol Violation|2|||
146697781|NCT04804813|529072507|FG001|Overall Study|Protocol Violation|0|||
146697782|NCT04804813|529072506|FG000|Overall Study|Withdrawal by Subject|1|||
146776280|NCT05094141|529351320|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
146697783|NCT04804813|529072507|FG001|Overall Study|Withdrawal by Subject|0|||
146697784|NCT05627518|529072508|FG000|Treatment Period 1|Adverse Event|0|||
146697785|NCT05627518|529072509|FG001|Treatment Period 1|Adverse Event|0|||
146697786|NCT05627518|529072510|FG002|Treatment Period 1|Adverse Event|1|||
146697787|NCT05627518|529072511|FG003|Treatment Period 1|Adverse Event|0|||
146697788|NCT05627518|529072512|FG004|Treatment Period 1|Adverse Event|0|||
146697789|NCT05627518|529072513|FG005|Treatment Period 1|Adverse Event|0|||
146697790|NCT05627518|529072514|FG006|Treatment Period 1|Adverse Event|0|||
146697791|NCT05627518|529072515|FG007|Treatment Period 1|Adverse Event|1|||
146697792|NCT05627518|529072508|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146697793|NCT05627518|529072509|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146697794|NCT05627518|529072510|FG002|Treatment Period 1|Withdrawal by Subject|1|||
146697795|NCT05627518|529072511|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146697796|NCT05627518|529072512|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146697797|NCT05627518|529072513|FG005|Treatment Period 1|Withdrawal by Subject|1|||
146697798|NCT05627518|529072514|FG006|Treatment Period 1|Withdrawal by Subject|0|||
146697799|NCT05627518|529072515|FG007|Treatment Period 1|Withdrawal by Subject|0|||
146697800|NCT05627518|529072508|FG000|Treatment Period 1|Protocol Violation|0|||
146697801|NCT05627518|529072509|FG001|Treatment Period 1|Protocol Violation|0|||
146697802|NCT05627518|529072510|FG002|Treatment Period 1|Protocol Violation|0|||
146697803|NCT05627518|529072511|FG003|Treatment Period 1|Protocol Violation|0|||
146697804|NCT05627518|529072512|FG004|Treatment Period 1|Protocol Violation|0|||
146697805|NCT05627518|529072513|FG005|Treatment Period 1|Protocol Violation|0|||
146697806|NCT05627518|529072514|FG006|Treatment Period 1|Protocol Violation|6|||
146697807|NCT05627518|529072515|FG007|Treatment Period 1|Protocol Violation|6|||
146697808|NCT05627518|529072508|FG000|Treatment Period 2|Adverse Event|1|||
146697809|NCT05627518|529072509|FG001|Treatment Period 2|Adverse Event|0|||
146697810|NCT05627518|529072510|FG002|Treatment Period 2|Adverse Event|0|||
146697811|NCT05627518|529072511|FG003|Treatment Period 2|Adverse Event|0|||
146697812|NCT05627518|529072512|FG004|Treatment Period 2|Adverse Event|0|||
146697813|NCT05627518|529072513|FG005|Treatment Period 2|Adverse Event|0|||
146697814|NCT05627518|529072514|FG006|Treatment Period 2|Adverse Event|0|||
146697815|NCT05627518|529072515|FG007|Treatment Period 2|Adverse Event|0|||
146697816|NCT05627518|529072508|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146697817|NCT05627518|529072509|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146697818|NCT05627518|529072510|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146697819|NCT05627518|529072511|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146697820|NCT05627518|529072512|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146697821|NCT05627518|529072513|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146697822|NCT05627518|529072514|FG006|Treatment Period 2|Withdrawal by Subject|0|||
146697823|NCT05627518|529072515|FG007|Treatment Period 2|Withdrawal by Subject|0|||
146697824|NCT02917031|529072519|FG000|Overall Study|Reason not specified|7|||
146697825|NCT02917031|529072520|FG001|Overall Study|Reason not specified|5|||
146697826|NCT02917031|529072521|FG002|Overall Study|Reason not specified|6|||
146697827|NCT02917031|529072519|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
146697828|NCT02917031|529072520|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
146697829|NCT02917031|529072521|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
146697830|NCT02917031|529072519|FG000|Overall Study|Withdrawal by Subject|3|||
146697831|NCT02917031|529072520|FG001|Overall Study|Withdrawal by Subject|3|||
146697832|NCT02917031|529072521|FG002|Overall Study|Withdrawal by Subject|0|||
146697833|NCT02917031|529072519|FG000|Overall Study|Physician Decision|1|||
146697834|NCT02917031|529072520|FG001|Overall Study|Physician Decision|0|||
146697835|NCT02917031|529072521|FG002|Overall Study|Physician Decision|0|||
146697836|NCT02917031|529072519|FG000|Overall Study|Adverse Event|4|||
146697837|NCT02917031|529072520|FG001|Overall Study|Adverse Event|1|||
146697838|NCT02917031|529072521|FG002|Overall Study|Adverse Event|5|||
146697839|NCT02917031|529072519|FG000|Overall Study|Death|2|||
146697840|NCT02917031|529072520|FG001|Overall Study|Death|3|||
146697841|NCT02917031|529072521|FG002|Overall Study|Death|4|||
146697842|NCT01581593|529074449|FG000|Overall Study|Withdrawal by Subject|1|||
146697843|NCT04982029|529074450|FG000|Overall Study|Lost to Follow-up|2|||
146697844|NCT04982029|529074451|FG001|Overall Study|Lost to Follow-up|3|||
146697845|NCT03264404|529074452|FG000|Overall Study|Death|2|||
146697846|NCT03264404|529074452|FG000|Overall Study|Physician Decision|1|||
146697847|NCT03264404|529074452|FG000|Overall Study|Disease Progression|28|||
146697848|NCT03264404|529074452|FG000|Overall Study|Adverse Event|1|||
146697849|NCT03264404|529074452|FG000|Overall Study|Off study prior to treatment|2|||
146697850|NCT02586012|529074453|FG000|Overall Study|Withdrawal by Subject|1|||
146697851|NCT02586012|529074454|FG001|Overall Study|Withdrawal by Subject|1|||
146697852|NCT02586012|529074455|FG002|Overall Study|Withdrawal by Subject|0|||
146697853|NCT02586012|529074456|FG003|Overall Study|Withdrawal by Subject|1|||
146697854|NCT02586012|529074457|FG004|Overall Study|Withdrawal by Subject|0|||
146697855|NCT02586012|529074458|FG005|Overall Study|Withdrawal by Subject|2|||
146697856|NCT02586012|529074453|FG000|Overall Study|Protocol Violation|0|||
146697857|NCT02586012|529074454|FG001|Overall Study|Protocol Violation|0|||
146697858|NCT02586012|529074455|FG002|Overall Study|Protocol Violation|0|||
146697859|NCT02586012|529074456|FG003|Overall Study|Protocol Violation|0|||
146697860|NCT02586012|529074457|FG004|Overall Study|Protocol Violation|0|||
146697861|NCT02586012|529074458|FG005|Overall Study|Protocol Violation|1|||
146697862|NCT02586012|529074453|FG000|Overall Study|study terminated|0|||
146697863|NCT02586012|529074454|FG001|Overall Study|study terminated|2|||
146697864|NCT02586012|529074455|FG002|Overall Study|study terminated|1|||
146697865|NCT02586012|529074456|FG003|Overall Study|study terminated|1|||
146776281|NCT05094141|529351318|FG000|Overall Study|Did not participate in randomization|0|||
146776282|NCT05094141|529351319|FG001|Overall Study|Did not participate in randomization|0|||
146776283|NCT05094141|529351320|FG002|Overall Study|Did not participate in randomization|33|||
146697866|NCT02586012|529074457|FG004|Overall Study|study terminated|1|||
146697867|NCT02586012|529074458|FG005|Overall Study|study terminated|0|||
146697868|NCT02388737|529074460|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
146697869|NCT02388737|529074461|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
146697870|NCT02388737|529074462|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
146697871|NCT02388737|529074460|FG000|Overall Study|Major Protocol Deviation|18|||
146697872|NCT02388737|529074461|FG001|Overall Study|Major Protocol Deviation|25|||
146697873|NCT02388737|529074462|FG002|Overall Study|Major Protocol Deviation|22|||
146697874|NCT02388737|529074460|FG000|Overall Study|Lost to Follow-up|5|||
146697875|NCT02388737|529074461|FG001|Overall Study|Lost to Follow-up|1|||
146697876|NCT02388737|529074462|FG002|Overall Study|Lost to Follow-up|4|||
146697877|NCT02388737|529074460|FG000|Overall Study|Voluntary Withdrawal|10|||
146697878|NCT02388737|529074461|FG001|Overall Study|Voluntary Withdrawal|18|||
146697879|NCT02388737|529074462|FG002|Overall Study|Voluntary Withdrawal|17|||
146697880|NCT02388737|529074460|FG000|Overall Study|Lack of Efficacy|3|||
146697881|NCT02388737|529074461|FG001|Overall Study|Lack of Efficacy|0|||
146697882|NCT02388737|529074462|FG002|Overall Study|Lack of Efficacy|3|||
146697883|NCT02388737|529074460|FG000|Overall Study|Reason Not Specified|5|||
146697884|NCT02388737|529074461|FG001|Overall Study|Reason Not Specified|5|||
146697885|NCT02388737|529074462|FG002|Overall Study|Reason Not Specified|4|||
146697888|NCT03299842|529074464|FG000|Overall Study|Caregiver withdrew consent|2|||
146697889|NCT03299842|529074464|FG000|Overall Study|Child would not keep the watch on|3|||
146697890|NCT00071812|529074465|FG000|24-Week Double-Blind Period|Adverse Event|2|||
146697891|NCT00071812|529074466|FG001|24-Week Double-Blind Period|Adverse Event|3|||
146697892|NCT00071812|529074467|FG002|24-Week Double-Blind Period|Adverse Event|4|||
146697893|NCT00071812|529074468|FG003|24-Week Double-Blind Period|Adverse Event|4|||
146697894|NCT00071812|529074465|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
146697895|NCT00071812|529074466|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
146697896|NCT00071812|529074467|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
146697897|NCT00071812|529074468|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
146697898|NCT00071812|529074465|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
146697899|NCT00071812|529074466|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
146697900|NCT00071812|529074467|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
146697901|NCT00071812|529074468|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
146697902|NCT00071812|529074465|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
146697903|NCT00071812|529074466|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
146697904|NCT00071812|529074467|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
146697905|NCT00071812|529074468|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
146697906|NCT00071812|529074465|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
146697907|NCT00071812|529074466|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
146697908|NCT00071812|529074467|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
146697909|NCT00071812|529074468|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
146697910|NCT00071812|529074465|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
146697911|NCT00071812|529074466|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
146697912|NCT00071812|529074467|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
146697913|NCT00071812|529074468|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
146697914|NCT00071812|529074465|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
146697915|NCT00071812|529074466|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
146697916|NCT00071812|529074467|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
146697917|NCT00071812|529074468|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
146697918|NCT00071812|529074465|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
146697919|NCT00071812|529074466|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
146697920|NCT00071812|529074467|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
146697921|NCT00071812|529074468|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
146697922|NCT00071812|529074465|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146697923|NCT00071812|529074466|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146697924|NCT00071812|529074467|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146697925|NCT00071812|529074468|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
146697926|NCT00071812|529074465|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
146697927|NCT00071812|529074466|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
146697928|NCT00071812|529074467|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
146697929|NCT00071812|529074468|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
146776284|NCT02576509|529353571|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
146776285|NCT02576509|529353572|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
146697930|NCT01816139|529074469|FG000|Overall Study|Adverse Event|6|||
146697931|NCT01816139|529074470|FG001|Overall Study|Adverse Event|8|||
146776286|NCT02576509|529353571|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
146776287|NCT02576509|529353572|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
146776288|NCT02576509|529353571|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
146776289|NCT02576509|529353572|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
146776290|NCT02576509|529353571|FG000|Treatment Period|Disease progression|263|||
146776291|NCT02576509|529353572|FG001|Treatment Period|Disease progression|244|||
146776292|NCT02576509|529353571|FG000|Treatment Period|Study drug toxicity|37|||
146776293|NCT02576509|529353572|FG001|Treatment Period|Study drug toxicity|41|||
146776294|NCT02576509|529353571|FG000|Treatment Period|Death|1|||
146776295|NCT02576509|529353572|FG001|Treatment Period|Death|1|||
146776296|NCT02576509|529353571|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
146776297|NCT02576509|529353572|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
146776298|NCT02576509|529353571|FG000|Treatment Period|Participant request to stop treatment|8|||
146776299|NCT02576509|529353572|FG001|Treatment Period|Participant request to stop treatment|18|||
146776300|NCT02576509|529353571|FG000|Treatment Period|Participant withdrew consent|3|||
146776301|NCT02576509|529353572|FG001|Treatment Period|Participant withdrew consent|7|||
146776302|NCT02576509|529353571|FG000|Treatment Period|Lost to Follow-up|0|||
146776303|NCT02576509|529353572|FG001|Treatment Period|Lost to Follow-up|1|||
146776304|NCT02576509|529353571|FG000|Treatment Period|Maximum clinical benefit|1|||
146776305|NCT02576509|529353572|FG001|Treatment Period|Maximum clinical benefit|0|||
146776306|NCT02576509|529353571|FG000|Treatment Period|Poor/non-compliance|1|||
146776307|NCT02576509|529353572|FG001|Treatment Period|Poor/non-compliance|1|||
146776308|NCT02576509|529353571|FG000|Treatment Period|Participant no longer meets criteria|1|||
146776309|NCT02576509|529353572|FG001|Treatment Period|Participant no longer meets criteria|0|||
146776310|NCT02576509|529353571|FG000|Treatment Period|Other reason|12|||
146776311|NCT02576509|529353572|FG001|Treatment Period|Other reason|8|||
146776312|NCT02576509|529353571|FG000|Treatment Period|NOT REPORTED|1|||
146776313|NCT02576509|529353572|FG001|Treatment Period|NOT REPORTED|0|||
146776314|NCT02576509|529353571|FG000|Treatment Period|Administrative reason by sponsor|0|||
146776315|NCT02576509|529353572|FG001|Treatment Period|Administrative reason by sponsor|1|||
146776316|NCT01216176|529353576|FG000|Overall Study|Adverse Event|0|||
146776317|NCT01216176|529353577|FG001|Overall Study|Adverse Event|8|||
146776318|NCT01216176|529353578|FG002|Overall Study|Adverse Event|0|||
146776319|NCT01216176|529353576|FG000|Overall Study|Physician Decision|0|||
146776320|NCT01216176|529353577|FG001|Overall Study|Physician Decision|0|||
146776321|NCT01216176|529353578|FG002|Overall Study|Physician Decision|1|||
146776322|NCT01600014|529353581|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
146776323|NCT01600014|529353582|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
146776324|NCT01600014|529353581|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
146776325|NCT01600014|529353582|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
146776326|NCT01600014|529353581|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
146776327|NCT01600014|529353582|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
146776328|NCT01600014|529353581|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
146776329|NCT01600014|529353582|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
146776330|NCT01600014|529353581|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
146776331|NCT01600014|529353582|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
146776332|NCT01600014|529353581|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
146776333|NCT01600014|529353582|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
146776334|NCT01600014|529353581|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
146776335|NCT01600014|529353582|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
146776336|NCT01600014|529353581|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
146776337|NCT01600014|529353582|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
146776338|NCT01600014|529353581|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
146776339|NCT01600014|529353582|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
146776340|NCT01600014|529353581|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
146776341|NCT01600014|529353582|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
146776342|NCT01600014|529353581|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
146776343|NCT01600014|529353582|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
146776344|NCT01600014|529353581|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
146776345|NCT01600014|529353582|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
146931029|NCT01061736|529905338|FG005|Overall Study|Adverse Event|1|||
146931030|NCT01061736|529905339|FG006|Overall Study|Adverse Event|4|||
146931031|NCT01061736|529905340|FG007|Overall Study|Adverse Event|63|||
146931032|NCT01061736|529905341|FG008|Overall Study|Adverse Event|67|||
146931033|NCT01061736|529905342|FG009|Overall Study|Adverse Event|34|||
146776346|NCT01600014|529353581|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
146776347|NCT01600014|529353582|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
146776348|NCT01600014|529353581|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
146931034|NCT01061736|529905333|FG000|Overall Study|Lack of Efficacy|0|||
146931035|NCT01061736|529905334|FG001|Overall Study|Lack of Efficacy|2|||
146931036|NCT01061736|529905335|FG002|Overall Study|Lack of Efficacy|1|||
146931037|NCT01061736|529905336|FG003|Overall Study|Lack of Efficacy|1|||
146980779|NCT00529568|530091308|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
146697932|NCT01816139|529074469|FG000|Overall Study|Lack of Efficacy|1|||
146697933|NCT01816139|529074470|FG001|Overall Study|Lack of Efficacy|2|||
146697934|NCT01816139|529074469|FG000|Overall Study|Lost to Follow-up|5|||
146697935|NCT01816139|529074470|FG001|Overall Study|Lost to Follow-up|3|||
146697936|NCT01816139|529074469|FG000|Overall Study|Withdrew Consent|6|||
146697937|NCT01816139|529074470|FG001|Overall Study|Withdrew Consent|4|||
146697938|NCT01816139|529074469|FG000|Overall Study|Protocol Violation|6|||
146697939|NCT01816139|529074470|FG001|Overall Study|Protocol Violation|3|||
146697940|NCT01816139|529074469|FG000|Overall Study|Reason not Specified|4|||
146697941|NCT01816139|529074470|FG001|Overall Study|Reason not Specified|2|||
146697942|NCT00358527|529074471|FG000|Overall Study|Adverse Event|4|||
146697943|NCT00358527|529074472|FG001|Overall Study|Adverse Event|0|||
146697944|NCT00358527|529074471|FG000|Overall Study|Withdrawal by Subject|1|||
146697945|NCT00358527|529074472|FG001|Overall Study|Withdrawal by Subject|1|||
146980780|NCT00529568|530091309|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
146980781|NCT00529568|530091307|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
146980782|NCT00529568|530091308|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
146980783|NCT00529568|530091309|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
146980784|NCT00529568|530091307|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
146980785|NCT00529568|530091308|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
146980786|NCT00529568|530091309|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
146980787|NCT00529568|530091307|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
146980788|NCT00529568|530091308|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
146980789|NCT00529568|530091309|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
146980790|NCT00529568|530091307|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
146980791|NCT00529568|530091308|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
146980792|NCT00529568|530091309|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
146980793|NCT00529568|530091307|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
146980794|NCT00529568|530091308|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
146980795|NCT00529568|530091309|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
146980796|NCT00529568|530091307|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
146980797|NCT00529568|530091308|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
146980798|NCT00529568|530091309|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
146697946|NCT00358527|529074471|FG000|Overall Study|Non-compliance with protocol|6|||
146697947|NCT00358527|529074472|FG001|Overall Study|Non-compliance with protocol|1|||
146697948|NCT00358527|529074471|FG000|Overall Study|Administrative|2|||
146697949|NCT00358527|529074472|FG001|Overall Study|Administrative|1|||
146697950|NCT00749463|529074473|FG000|Overall Study|Adverse Event|0|||
146697951|NCT00749463|529074474|FG001|Overall Study|Adverse Event|4|||
146697952|NCT00749463|529074475|FG002|Overall Study|Adverse Event|1|||
146697953|NCT00749463|529074473|FG000|Overall Study|Withdrawal by Subject|1|||
146697954|NCT00749463|529074474|FG001|Overall Study|Withdrawal by Subject|0|||
146697955|NCT00749463|529074475|FG002|Overall Study|Withdrawal by Subject|0|||
146697956|NCT00913744|529074478|FG000|Overall Study|Adverse Event|2|||
146697957|NCT00913744|529074479|FG001|Overall Study|Adverse Event|0|||
146697958|NCT00913744|529074478|FG000|Overall Study|Withdrawal by Subject|2|||
146697959|NCT00913744|529074479|FG001|Overall Study|Withdrawal by Subject|1|||
146697960|NCT00913744|529074478|FG000|Overall Study|Death|1|||
146697961|NCT00913744|529074479|FG001|Overall Study|Death|0|||
146697962|NCT01344369|529074480|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
146697963|NCT01344369|529074481|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
146697964|NCT01344369|529074480|FG000|Washout of 28 Days|Physician Decision|0|||
146697965|NCT01344369|529074481|FG001|Washout of 28 Days|Physician Decision|1|||
146697966|NCT01344369|529074480|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
146697967|NCT01344369|529074481|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
146697968|NCT01886833|529074486|FG000|Overall Study|IgA not available from both periods|204|||
146697969|NCT01454726|529074487|FG000|Overall Study|Withdrawal by Subject|0|||
146697970|NCT01454726|529074488|FG001|Overall Study|Withdrawal by Subject|1|||
146697971|NCT04200248|529074489|FG000|Overall Study|Personal reasons|0|||
146697972|NCT04200248|529074490|FG001|Overall Study|Personal reasons|0|||
146697973|NCT04200248|529074491|FG002|Overall Study|Personal reasons|1|||
146980799|NCT04049552|530091310|FG000|Overall Study|Lost to Follow-up|1|||
146980800|NCT01201356|530091311|FG000|Overall Study|Adverse Event|170|||
146697974|NCT04200248|529074489|FG000|Overall Study|Discontinued prior to treatment|3|||
146697975|NCT04200248|529074490|FG001|Overall Study|Discontinued prior to treatment|3|||
146697976|NCT04200248|529074491|FG002|Overall Study|Discontinued prior to treatment|2|||
146697977|NCT02342704|529074494|FG000|Overall Study|Physician Decision|0|||
146697978|NCT02342704|529074495|FG001|Overall Study|Physician Decision|3|||
146697979|NCT02342704|529074494|FG000|Overall Study|Sponsor Termination|49|||
146697980|NCT02342704|529074495|FG001|Overall Study|Sponsor Termination|43|||
146697981|NCT02342704|529074494|FG000|Overall Study|Other|0|||
146697982|NCT02342704|529074495|FG001|Overall Study|Other|1|||
146931038|NCT01061736|529905337|FG004|Overall Study|Lack of Efficacy|1|||
146931039|NCT01061736|529905338|FG005|Overall Study|Lack of Efficacy|2|||
146931040|NCT01061736|529905339|FG006|Overall Study|Lack of Efficacy|1|||
146931041|NCT01061736|529905340|FG007|Overall Study|Lack of Efficacy|9|||
146931042|NCT01061736|529905341|FG008|Overall Study|Lack of Efficacy|9|||
146931043|NCT01061736|529905342|FG009|Overall Study|Lack of Efficacy|10|||
146697983|NCT02342704|529074494|FG000|Overall Study|Withdrawal by Subject|1|||
146697984|NCT02342704|529074495|FG001|Overall Study|Withdrawal by Subject|0|||
146697985|NCT02342704|529074494|FG000|Overall Study|Lost to Follow-up|2|||
146697986|NCT02342704|529074495|FG001|Overall Study|Lost to Follow-up|1|||
146697987|NCT02342704|529074494|FG000|Overall Study|Adverse Event|1|||
146697988|NCT02342704|529074495|FG001|Overall Study|Adverse Event|3|||
146697989|NCT00302003|529074497|FG000|Overall Study|Lack of Efficacy|62|||
146697990|NCT00302003|529074497|FG000|Overall Study|Lost to Follow-up|1|||
146697991|NCT00302003|529074497|FG000|Overall Study|Physician Decision|2|||
146697992|NCT00302003|529074497|FG000|Overall Study|Withdrawal by Subject|5|||
146697993|NCT00302003|529074497|FG000|Overall Study|Ineligible|9|||
146697994|NCT00302003|529074497|FG000|Overall Study|Protocol Violation|1|||
146697995|NCT01218516|529074498|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
146697996|NCT01218516|529074499|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
146697997|NCT01218516|529074500|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
146697998|NCT01218516|529074501|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
146697999|NCT01218516|529074498|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
146698000|NCT01218516|529074499|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
146698001|NCT01218516|529074500|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
146698002|NCT01218516|529074501|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
146698003|NCT01218516|529074498|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
146698004|NCT01218516|529074499|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
146698005|NCT01218516|529074500|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
146698006|NCT01218516|529074501|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
146698007|NCT01218516|529074498|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
146698008|NCT01218516|529074499|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
146698009|NCT01218516|529074500|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
146698010|NCT01218516|529074501|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
146698011|NCT01218516|529074498|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
146698012|NCT01218516|529074499|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
146698013|NCT01218516|529074500|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
146698014|NCT01218516|529074501|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
146698015|NCT01218516|529074498|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
146698016|NCT01218516|529074499|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
146698017|NCT01218516|529074500|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
146698018|NCT01218516|529074501|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
146698019|NCT01218516|529074498|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
146698020|NCT01218516|529074499|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
146698021|NCT01218516|529074500|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
146698022|NCT01218516|529074501|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
146698023|NCT01218516|529074498|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
146698024|NCT01218516|529074499|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
146698025|NCT01218516|529074500|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
146698026|NCT01218516|529074501|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
146698027|NCT01218516|529074498|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
146698028|NCT01218516|529074499|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
146698029|NCT01218516|529074500|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
146698030|NCT01218516|529074501|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
146698031|NCT01218516|529074498|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
146698032|NCT01218516|529074499|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
146698033|NCT01218516|529074500|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
146698034|NCT01218516|529074501|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
146698035|NCT01218516|529074498|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
146698036|NCT01218516|529074499|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
146698037|NCT01218516|529074500|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
146698038|NCT01218516|529074501|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
146698039|NCT01218516|529074498|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
146736342|NCT00787319|529206817|FG000|Overall Study|Withdrawal by Subject|15|||
146931044|NCT01061736|529905333|FG000|Overall Study|Poor compliance to protocol|0|||
146931045|NCT01061736|529905334|FG001|Overall Study|Poor compliance to protocol|0|||
146980801|NCT01201356|530091311|FG000|Overall Study|Abnormal laboratory value(s)|51|||
146980802|NCT01201356|530091311|FG000|Overall Study|Abnormal test procedure result(s)|3|||
146980803|NCT01201356|530091311|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
146980804|NCT01201356|530091311|FG000|Overall Study|Condition no longer requires study drug|12|||
146980805|NCT01201356|530091311|FG000|Overall Study|Withdrawal by Subject|144|||
146980806|NCT01201356|530091311|FG000|Overall Study|Lost to Follow-up|50|||
146980807|NCT01201356|530091311|FG000|Overall Study|administrative problems|74|||
146980808|NCT01201356|530091311|FG000|Overall Study|Death|16|||
146980809|NCT01201356|530091311|FG000|Overall Study|Protocol Violation|12|||
146980810|NCT00738920|530091314|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
146980811|NCT00738920|530091315|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
146980812|NCT00738920|530091316|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
146980813|NCT00738920|530091314|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
146980814|NCT00738920|530091315|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
146980815|NCT00738920|530091316|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
146980816|NCT00738920|530091314|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
146980817|NCT00738920|530091315|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
146980818|NCT00738920|530091316|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
146980819|NCT00738920|530091314|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
146980820|NCT00738920|530091315|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
146980821|NCT00738920|530091316|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
146980822|NCT00738920|530091314|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
146980823|NCT00738920|530091315|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
146980824|NCT00738920|530091316|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
146980825|NCT00738920|530091314|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
146980826|NCT00738920|530091315|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
146980827|NCT00738920|530091316|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
146698040|NCT01218516|529074499|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
146698041|NCT01218516|529074500|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
146931046|NCT01061736|529905335|FG002|Overall Study|Poor compliance to protocol|0|||
146931047|NCT01061736|529905336|FG003|Overall Study|Poor compliance to protocol|0|||
146931048|NCT01061736|529905337|FG004|Overall Study|Poor compliance to protocol|0|||
146931049|NCT01061736|529905338|FG005|Overall Study|Poor compliance to protocol|0|||
146931050|NCT01061736|529905339|FG006|Overall Study|Poor compliance to protocol|0|||
146931051|NCT01061736|529905340|FG007|Overall Study|Poor compliance to protocol|2|||
146931052|NCT01061736|529905341|FG008|Overall Study|Poor compliance to protocol|5|||
146931053|NCT01061736|529905342|FG009|Overall Study|Poor compliance to protocol|9|||
146931054|NCT01061736|529905333|FG000|Overall Study|Not treated|0|||
146931055|NCT01061736|529905334|FG001|Overall Study|Not treated|0|||
146931056|NCT01061736|529905335|FG002|Overall Study|Not treated|0|||
146931057|NCT01061736|529905336|FG003|Overall Study|Not treated|0|||
146931058|NCT01061736|529905337|FG004|Overall Study|Not treated|1|||
146931059|NCT01061736|529905338|FG005|Overall Study|Not treated|0|||
146931060|NCT01061736|529905339|FG006|Overall Study|Not treated|0|||
146931061|NCT01061736|529905340|FG007|Overall Study|Not treated|2|||
146931062|NCT01061736|529905341|FG008|Overall Study|Not treated|1|||
146931063|NCT01061736|529905342|FG009|Overall Study|Not treated|0|||
146931064|NCT01061736|529905333|FG000|Overall Study|Other than specified above|0|||
146931065|NCT01061736|529905334|FG001|Overall Study|Other than specified above|1|||
146931066|NCT01061736|529905335|FG002|Overall Study|Other than specified above|2|||
146931067|NCT01061736|529905336|FG003|Overall Study|Other than specified above|0|||
146931068|NCT01061736|529905337|FG004|Overall Study|Other than specified above|1|||
146931069|NCT01061736|529905338|FG005|Overall Study|Other than specified above|0|||
146931070|NCT01061736|529905339|FG006|Overall Study|Other than specified above|0|||
146931071|NCT01061736|529905340|FG007|Overall Study|Other than specified above|18|||
146931072|NCT01061736|529905341|FG008|Overall Study|Other than specified above|15|||
146931073|NCT01061736|529905342|FG009|Overall Study|Other than specified above|21|||
146698042|NCT01218516|529074501|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
146698043|NCT01539226|529074502|FG000|Overall Study|Withdrawal by Subject|24|||
146698044|NCT01539226|529074503|FG001|Overall Study|Withdrawal by Subject|54|||
146698045|NCT01539226|529074502|FG000|Overall Study|Lost to Follow-up|20|||
146698046|NCT01539226|529074503|FG001|Overall Study|Lost to Follow-up|54|||
146698047|NCT01539226|529074502|FG000|Overall Study|Death|1|||
146931074|NCT01093755|529905344|FG000|Overall Study|Withdrawal by Subject|3|||
146931075|NCT01093755|529905345|FG001|Overall Study|Withdrawal by Subject|4|||
146931076|NCT04019795|529905346|FG000|Overall Study|Withdrawal by Subject|1|||
146931077|NCT04019795|529905347|FG001|Overall Study|Withdrawal by Subject|2|||
146931078|NCT04019795|529905348|FG002|Overall Study|Withdrawal by Subject|2|||
146931079|NCT04019795|529905349|FG003|Overall Study|Withdrawal by Subject|1|||
146931080|NCT04019795|529905346|FG000|Overall Study|Lost to Follow-up|0|||
146931081|NCT04019795|529905347|FG001|Overall Study|Lost to Follow-up|1|||
146931082|NCT04019795|529905348|FG002|Overall Study|Lost to Follow-up|1|||
146931083|NCT04019795|529905349|FG003|Overall Study|Lost to Follow-up|2|||
146698048|NCT01539226|529074503|FG001|Overall Study|Death|2|||
146698049|NCT01539226|529074502|FG000|Overall Study|Adverse Event|2|||
146698050|NCT01539226|529074503|FG001|Overall Study|Adverse Event|0|||
146698051|NCT01539226|529074502|FG000|Overall Study|Pregnancy|13|||
146698052|NCT01539226|529074503|FG001|Overall Study|Pregnancy|29|||
146698053|NCT01539226|529074502|FG000|Overall Study|inappropriate enrollment|0|||
146698054|NCT01539226|529074503|FG001|Overall Study|inappropriate enrollment|1|||
146698055|NCT01539226|529074502|FG000|Overall Study|Multiple Reasons|3|||
146698056|NCT01539226|529074503|FG001|Overall Study|Multiple Reasons|1|||
146698057|NCT01539226|529074502|FG000|Overall Study|not HIV seroconversion-related|93|||
146698058|NCT01539226|529074503|FG001|Overall Study|not HIV seroconversion-related|176|||
146698059|NCT01539226|529074502|FG000|Overall Study|HIV seroconversion-related|55|||
146698060|NCT01539226|529074503|FG001|Overall Study|HIV seroconversion-related|80|||
146698061|NCT01539226|529074502|FG000|Overall Study|Non-compliance|6|||
146698062|NCT01539226|529074503|FG001|Overall Study|Non-compliance|8|||
146698063|NCT02919670|529074504|FG000|Overall Study|Only 17 participants met compliance|43|||
146698064|NCT02919670|529074505|FG001|Overall Study|Only 17 participants met compliance|39|||
146698065|NCT02118428|529074512|FG000|Overall Study|Physician Decision|0|||
146698066|NCT02118428|529074513|FG001|Overall Study|Physician Decision|1|||
146698067|NCT02118428|529074514|FG002|Overall Study|Physician Decision|0|||
146698068|NCT02118428|529074512|FG000|Overall Study|Withdrawal by Subject|2|||
146698069|NCT02118428|529074513|FG001|Overall Study|Withdrawal by Subject|2|||
146698070|NCT02118428|529074514|FG002|Overall Study|Withdrawal by Subject|0|||
146698071|NCT02118428|529074512|FG000|Overall Study|Death|7|||
146698072|NCT02118428|529074513|FG001|Overall Study|Death|5|||
146698073|NCT02118428|529074514|FG002|Overall Study|Death|0|||
146698074|NCT02118428|529074512|FG000|Overall Study|Lost to Follow-up|3|||
146698075|NCT02118428|529074513|FG001|Overall Study|Lost to Follow-up|1|||
146698076|NCT02118428|529074514|FG002|Overall Study|Lost to Follow-up|0|||
146698077|NCT02118428|529074512|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
146698078|NCT02118428|529074513|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
146698079|NCT02118428|529074514|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
146698080|NCT00782210|529074523|FG000|Overall Study|Adverse Event|21|||
146698081|NCT00782210|529074524|FG001|Overall Study|Adverse Event|17|||
146698082|NCT00782210|529074525|FG002|Overall Study|Adverse Event|16|||
146698083|NCT00782210|529074523|FG000|Overall Study|Lost to Follow-up|2|||
146698084|NCT00782210|529074524|FG001|Overall Study|Lost to Follow-up|1|||
146698085|NCT00782210|529074525|FG002|Overall Study|Lost to Follow-up|2|||
146698086|NCT00782210|529074523|FG000|Overall Study|Withdrawal by Subject|11|||
146698087|NCT00782210|529074524|FG001|Overall Study|Withdrawal by Subject|8|||
146698088|NCT00782210|529074525|FG002|Overall Study|Withdrawal by Subject|11|||
146698089|NCT00782210|529074523|FG000|Overall Study|Non compliance with protocol|0|||
146698090|NCT00782210|529074524|FG001|Overall Study|Non compliance with protocol|3|||
146698091|NCT00782210|529074525|FG002|Overall Study|Non compliance with protocol|2|||
146698092|NCT00782210|529074523|FG000|Overall Study|Lack of Efficacy|13|||
146698093|NCT00782210|529074524|FG001|Overall Study|Lack of Efficacy|4|||
146698094|NCT00782210|529074525|FG002|Overall Study|Lack of Efficacy|1|||
146698095|NCT00782210|529074523|FG000|Overall Study|Other reason not described above|3|||
146698096|NCT00782210|529074524|FG001|Overall Study|Other reason not described above|2|||
146698097|NCT00782210|529074525|FG002|Overall Study|Other reason not described above|3|||
146698098|NCT01641367|529074526|FG000|Cohorts|Death|18|||
146698099|NCT01641367|529074527|FG001|Cohorts|Death|1|||
146698100|NCT01641367|529074528|FG002|Cohorts|Death|2|||
146698101|NCT01641367|529074529|FG003|Cohorts|Death|0|||
146698102|NCT01641367|529074530|FG004|Cohorts|Death|1|||
146698103|NCT01641367|529074531|FG005|Cohorts|Death|1|||
146698104|NCT01641367|529074532|FG006|Cohorts|Death|0|||
146698105|NCT01641367|529074533|FG007|Cohorts|Death|0|||
146698106|NCT01641367|529074526|FG000|Cohorts|Lost to Follow-up|16|||
146698107|NCT01641367|529074527|FG001|Cohorts|Lost to Follow-up|0|||
146698108|NCT01641367|529074528|FG002|Cohorts|Lost to Follow-up|2|||
146698109|NCT01641367|529074529|FG003|Cohorts|Lost to Follow-up|0|||
146698110|NCT01641367|529074530|FG004|Cohorts|Lost to Follow-up|2|||
146698111|NCT01641367|529074531|FG005|Cohorts|Lost to Follow-up|0|||
146698112|NCT01641367|529074532|FG006|Cohorts|Lost to Follow-up|0|||
146698113|NCT01641367|529074533|FG007|Cohorts|Lost to Follow-up|0|||
146698114|NCT01641367|529074526|FG000|Randomized Adherence Intervention|Death|0|||
146698115|NCT01641367|529074527|FG001|Randomized Adherence Intervention|Death|0|||
146698116|NCT01641367|529074528|FG002|Randomized Adherence Intervention|Death|0|||
146698117|NCT01641367|529074529|FG003|Randomized Adherence Intervention|Death|0|||
146698118|NCT01641367|529074530|FG004|Randomized Adherence Intervention|Death|0|||
146698119|NCT01641367|529074531|FG005|Randomized Adherence Intervention|Death|0|||
146698120|NCT01641367|529074532|FG006|Randomized Adherence Intervention|Death|11|||
146698121|NCT01641367|529074533|FG007|Randomized Adherence Intervention|Death|12|||
146698122|NCT01641367|529074526|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
146698123|NCT01641367|529074527|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
146698124|NCT01641367|529074528|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
146698125|NCT01641367|529074529|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
146698126|NCT01641367|529074530|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
146698127|NCT01641367|529074531|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
146698128|NCT01641367|529074532|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
146698129|NCT01641367|529074533|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
146698130|NCT00436748|529074538|FG000|Overall Study|Ineligibility Determined|1|||
146698131|NCT00436748|529074539|FG001|Overall Study|Ineligibility Determined|1|||
146698132|NCT00436748|529074538|FG000|Overall Study|Adverse Event|0|||
146698133|NCT00436748|529074539|FG001|Overall Study|Adverse Event|2|||
146698134|NCT00436748|529074538|FG000|Overall Study|Consent Withdrawn|1|||
146698135|NCT00436748|529074539|FG001|Overall Study|Consent Withdrawn|4|||
146698136|NCT00436748|529074538|FG000|Overall Study|Administrative Decision|1|||
146698137|NCT00436748|529074539|FG001|Overall Study|Administrative Decision|0|||
146698138|NCT00436748|529074538|FG000|Overall Study|Lost to Follow-up|0|||
146698139|NCT00436748|529074539|FG001|Overall Study|Lost to Follow-up|1|||
146698140|NCT00436748|529074538|FG000|Overall Study|Protocol-specified Criteria|5|||
146698141|NCT00436748|529074539|FG001|Overall Study|Protocol-specified Criteria|4|||
146698142|NCT00436748|529074538|FG000|Overall Study|Other|3|||
146698143|NCT00436748|529074539|FG001|Overall Study|Other|0|||
146698144|NCT01610791|529074540|FG000|Overall Study|Lost to Follow-up|7|||
146698145|NCT01610791|529074540|FG000|Overall Study|Adverse Event|6|||
146698146|NCT01610791|529074540|FG000|Overall Study|Physician Decision|1|||
146698147|NCT01610791|529074540|FG000|Overall Study|Adverse event and Investigator decision|1|||
146698148|NCT01610791|529074540|FG000|Overall Study|Death|1|||
146698149|NCT01610791|529074540|FG000|Overall Study|Not determined|5|||
146698150|NCT00850200|529074543|FG000|Overall Study|Physician Decision|2|||
146698151|NCT00850200|529074543|FG000|Overall Study|Did not recieve treatment|2|||
146698152|NCT00850200|529074543|FG000|Overall Study|Withdrawal by Subject|1|||
146698153|NCT02086110|529074555|FG000|Overall Study|Withdrawal by Subject|1|||
146698154|NCT02086110|529074556|FG001|Overall Study|Withdrawal by Subject|1|||
146698155|NCT01869192|529074557|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
146698156|NCT01869192|529074558|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
146698157|NCT01869192|529074557|FG000|Postoperative Chemotherapy|Physician Decision|0|||
146698158|NCT01869192|529074558|FG001|Postoperative Chemotherapy|Physician Decision|2|||
146698159|NCT01203072|529074559|FG000|Overall Study|Adverse Event|5|||
146698160|NCT01203072|529074560|FG001|Overall Study|Adverse Event|3|||
146698161|NCT01203072|529074561|FG002|Overall Study|Adverse Event|2|||
146698162|NCT01203072|529074562|FG003|Overall Study|Adverse Event|4|||
146698163|NCT01203072|529074563|FG004|Overall Study|Adverse Event|2|||
146698164|NCT01203072|529074559|FG000|Overall Study|Lack of Efficacy|1|||
146698165|NCT01203072|529074560|FG001|Overall Study|Lack of Efficacy|0|||
146698166|NCT01203072|529074561|FG002|Overall Study|Lack of Efficacy|0|||
146698167|NCT01203072|529074562|FG003|Overall Study|Lack of Efficacy|0|||
146698168|NCT01203072|529074563|FG004|Overall Study|Lack of Efficacy|0|||
146698169|NCT01203072|529074559|FG000|Overall Study|Lost to Follow-up|0|||
146698170|NCT01203072|529074560|FG001|Overall Study|Lost to Follow-up|1|||
146698171|NCT01203072|529074561|FG002|Overall Study|Lost to Follow-up|0|||
146698172|NCT01203072|529074562|FG003|Overall Study|Lost to Follow-up|0|||
146698173|NCT01203072|529074563|FG004|Overall Study|Lost to Follow-up|0|||
146698174|NCT01203072|529074559|FG000|Overall Study|Protocol Violation|2|||
146698175|NCT01203072|529074560|FG001|Overall Study|Protocol Violation|0|||
146698176|NCT01203072|529074561|FG002|Overall Study|Protocol Violation|0|||
146698177|NCT01203072|529074562|FG003|Overall Study|Protocol Violation|0|||
146698178|NCT01203072|529074563|FG004|Overall Study|Protocol Violation|1|||
146698179|NCT01203072|529074559|FG000|Overall Study|Withdrawal by Subject|2|||
146698180|NCT01203072|529074560|FG001|Overall Study|Withdrawal by Subject|2|||
146698181|NCT01203072|529074561|FG002|Overall Study|Withdrawal by Subject|1|||
146698182|NCT01203072|529074562|FG003|Overall Study|Withdrawal by Subject|2|||
146698183|NCT01203072|529074563|FG004|Overall Study|Withdrawal by Subject|3|||
146698184|NCT02272413|529074565|FG000|Randomized Through Treatment Start|Not treated|3|||
146698185|NCT02272413|529074566|FG001|Randomized Through Treatment Start|Not treated|5|||
146698186|NCT02272413|529074565|FG000|Pre-switch Period|Adverse Event|38|||
146698187|NCT02272413|529074566|FG001|Pre-switch Period|Adverse Event|37|||
146698188|NCT02272413|529074565|FG000|Pre-switch Period|Death|26|||
146698189|NCT02272413|529074566|FG001|Pre-switch Period|Death|26|||
146698190|NCT02272413|529074565|FG000|Pre-switch Period|Withdrawal by Subject|27|||
146698191|NCT02272413|529074566|FG001|Pre-switch Period|Withdrawal by Subject|15|||
146698192|NCT02272413|529074565|FG000|Pre-switch Period|Physician Decision|6|||
146698193|NCT02272413|529074566|FG001|Pre-switch Period|Physician Decision|18|||
146698194|NCT02272413|529074565|FG000|Pre-switch Period|Progressive disease|185|||
146698195|NCT02272413|529074566|FG001|Pre-switch Period|Progressive disease|173|||
146698196|NCT02272413|529074565|FG000|Pre-switch Period|Lost to Follow-up|0|||
146698197|NCT02272413|529074566|FG001|Pre-switch Period|Lost to Follow-up|2|||
146698198|NCT02272413|529074565|FG000|Pre-switch Period|Protocol Violation|1|||
146698199|NCT02272413|529074566|FG001|Pre-switch Period|Protocol Violation|0|||
146698200|NCT02272413|529074565|FG000|Pre-switch Period|Other than listed|10|||
146698201|NCT02272413|529074566|FG001|Pre-switch Period|Other than listed|11|||
146698202|NCT02272413|529074565|FG000|Post-switch Period|Adverse Event|4|||
146698203|NCT02272413|529074566|FG001|Post-switch Period|Adverse Event|4|||
146931084|NCT04019795|529905346|FG000|Overall Study|Treatment non-compliance|3|||
146931085|NCT04019795|529905347|FG001|Overall Study|Treatment non-compliance|1|||
146931086|NCT04019795|529905348|FG002|Overall Study|Treatment non-compliance|2|||
146931087|NCT04019795|529905349|FG003|Overall Study|Treatment non-compliance|0|||
146776349|NCT01600014|529353582|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
146776350|NCT01600014|529353581|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
146776351|NCT01600014|529353582|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
146776352|NCT01600014|529353581|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
146776353|NCT01600014|529353582|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
146776354|NCT01600014|529353581|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
146776355|NCT01600014|529353582|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
146776356|NCT04278586|529353585|FG000|Overall Study|Withdrawal by Subject|13|||
146776357|NCT04278586|529353586|FG001|Overall Study|Withdrawal by Subject|6|||
146776358|NCT04278586|529353585|FG000|Overall Study|Lost to Follow-up|37|||
146776359|NCT04278586|529353586|FG001|Overall Study|Lost to Follow-up|24|||
146931088|NCT04019795|529905346|FG000|Overall Study|Physician Decision|0|||
146931089|NCT04019795|529905347|FG001|Overall Study|Physician Decision|0|||
146698204|NCT02272413|529074565|FG000|Post-switch Period|Death|3|||
146698205|NCT02272413|529074566|FG001|Post-switch Period|Death|2|||
146698206|NCT02272413|529074565|FG000|Post-switch Period|Withdrawal by Subject|1|||
146698207|NCT02272413|529074566|FG001|Post-switch Period|Withdrawal by Subject|2|||
146698208|NCT02272413|529074565|FG000|Post-switch Period|Physician Decision|1|||
146698209|NCT02272413|529074566|FG001|Post-switch Period|Physician Decision|1|||
146698210|NCT02272413|529074565|FG000|Post-switch Period|Progressive disease|21|||
146698211|NCT02272413|529074566|FG001|Post-switch Period|Progressive disease|21|||
146698212|NCT02272413|529074565|FG000|Post-switch Period|Study terminated by sponsor|8|||
146698213|NCT02272413|529074566|FG001|Post-switch Period|Study terminated by sponsor|11|||
146698214|NCT02272413|529074565|FG000|Post-switch Period|Other than listed|4|||
146698215|NCT02272413|529074566|FG001|Post-switch Period|Other than listed|5|||
146698216|NCT02286193|529074569|FG000|Overall Study|Referred: CRS unable to make contact|62|||
146698217|NCT02286193|529074569|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
146698218|NCT02286193|529074569|FG000|Overall Study|Referred: Declined service|38|||
146698219|NCT00423891|529074570|FG000|Enrolled|Withdrawal by Subject|0|||
146698220|NCT00423891|529074571|FG001|Enrolled|Withdrawal by Subject|0|||
146698221|NCT00423891|529074572|FG002|Enrolled|Withdrawal by Subject|1|||
146698222|NCT00423891|529074570|FG000|Enrolled|Lost to Follow-up|0|||
146698223|NCT00423891|529074571|FG001|Enrolled|Lost to Follow-up|0|||
146698224|NCT00423891|529074572|FG002|Enrolled|Lost to Follow-up|1|||
146698225|NCT00423891|529074570|FG000|Enrolled|No longer met criteria|11|||
146698226|NCT00423891|529074571|FG001|Enrolled|No longer met criteria|2|||
146698227|NCT00423891|529074572|FG002|Enrolled|No longer met criteria|1|||
146698228|NCT00423891|529074570|FG000|Treatment|Withdrawal by Subject|1|||
146698229|NCT00423891|529074571|FG001|Treatment|Withdrawal by Subject|0|||
146698230|NCT00423891|529074572|FG002|Treatment|Withdrawal by Subject|0|||
146698231|NCT00423891|529074570|FG000|Treatment|Lost to Follow-up|1|||
146698232|NCT00423891|529074571|FG001|Treatment|Lost to Follow-up|0|||
146698233|NCT00423891|529074572|FG002|Treatment|Lost to Follow-up|0|||
146698234|NCT00423891|529074570|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
146698235|NCT00423891|529074571|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
146698236|NCT00423891|529074572|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
146698237|NCT00423891|529074570|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
146698238|NCT00423891|529074571|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
146698239|NCT00423891|529074572|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
146698240|NCT02852265|529074573|FG000|3-month Follow-up|Lost to Follow-up|1|||
146698241|NCT02852265|529074574|FG001|3-month Follow-up|Lost to Follow-up|1|||
146698242|NCT01585766|529074581|FG000|Overall Study|Withdrawal by Subject|0|||
146698243|NCT01585766|529074582|FG001|Overall Study|Withdrawal by Subject|1|||
146698244|NCT01585766|529074583|FG002|Overall Study|Withdrawal by Subject|1|||
146698245|NCT01585766|529074584|FG003|Overall Study|Withdrawal by Subject|0|||
146698246|NCT01585766|529074585|FG004|Overall Study|Withdrawal by Subject|0|||
146698247|NCT01585766|529074586|FG005|Overall Study|Withdrawal by Subject|0|||
146776360|NCT02791230|529353587|FG000|Overall Study|Adverse Event|10|||
146931090|NCT04019795|529905348|FG002|Overall Study|Physician Decision|1|||
146931091|NCT04019795|529905349|FG003|Overall Study|Physician Decision|0|||
146931092|NCT04019795|529905346|FG000|Overall Study|Adverse Event|1|||
146698248|NCT01585766|529074581|FG000|Overall Study|Death|0|||
146931093|NCT04019795|529905347|FG001|Overall Study|Adverse Event|0|||
146931094|NCT04019795|529905348|FG002|Overall Study|Adverse Event|0|||
146931095|NCT04019795|529905349|FG003|Overall Study|Adverse Event|0|||
146698249|NCT01585766|529074582|FG001|Overall Study|Death|1|||
146698250|NCT01585766|529074583|FG002|Overall Study|Death|0|||
146698251|NCT01585766|529074584|FG003|Overall Study|Death|0|||
146698252|NCT01585766|529074585|FG004|Overall Study|Death|0|||
146698253|NCT01585766|529074586|FG005|Overall Study|Death|0|||
146698254|NCT01585766|529074581|FG000|Overall Study|Physician Decision|0|||
146698255|NCT01585766|529074582|FG001|Overall Study|Physician Decision|0|||
146698256|NCT01585766|529074583|FG002|Overall Study|Physician Decision|1|||
146698257|NCT01585766|529074584|FG003|Overall Study|Physician Decision|0|||
146698258|NCT01585766|529074585|FG004|Overall Study|Physician Decision|0|||
146698259|NCT01585766|529074586|FG005|Overall Study|Physician Decision|0|||
146698260|NCT04116710|529074587|FG000|Overall Study|Death|4|||
146698261|NCT04116710|529074588|FG001|Overall Study|Death|6|||
146698262|NCT04116710|529074589|FG002|Overall Study|Death|3|||
146698263|NCT04116710|529074590|FG003|Overall Study|Death|1|||
146698264|NCT04116710|529074587|FG000|Overall Study|Withdrawal by Subject|0|||
146698265|NCT04116710|529074588|FG001|Overall Study|Withdrawal by Subject|0|||
146698266|NCT04116710|529074589|FG002|Overall Study|Withdrawal by Subject|0|||
146698267|NCT04116710|529074590|FG003|Overall Study|Withdrawal by Subject|1|||
146698268|NCT00582933|529074591|FG000|Overall Study|Physician Decision|3|||
146698269|NCT02319031|529074592|FG000|Treatment Period|Death|1|||
146698270|NCT02319031|529074593|FG001|Treatment Period|Death|0|||
146698271|NCT01183975|529074604|FG000|Overall Study|Lost to Follow-up|73|||
146698272|NCT02376166|529074607|FG000|Overall Study|Adverse Event|1|||
146698273|NCT02376166|529074607|FG000|Overall Study|Discontinued metformin early|2|||
146698274|NCT04180020|529074608|FG000|Overall Study|missed visit|18|||
146698275|NCT04180020|529074609|FG001|Overall Study|missed visit|16|||
146698276|NCT04180020|529074608|FG000|Overall Study|Death|2|||
146698277|NCT04180020|529074609|FG001|Overall Study|Death|3|||
146698278|NCT04180020|529074608|FG000|Overall Study|Withdrawal by Subject|1|||
146698279|NCT04180020|529074609|FG001|Overall Study|Withdrawal by Subject|5|||
146698280|NCT04180020|529074608|FG000|Overall Study|incarcerated|1|||
146698281|NCT04180020|529074609|FG001|Overall Study|incarcerated|1|||
146698282|NCT04180020|529074608|FG000|Overall Study|Physician Decision|0|||
146698283|NCT04180020|529074609|FG001|Overall Study|Physician Decision|2|||
146698284|NCT02244580|529074616|FG000|Overall Study|No cancer tissues available|241|||
146698285|NCT00811577|529074619|FG000|Overall Study|Lost to Follow-up|7|||
146698286|NCT00811577|529074620|FG001|Overall Study|Lost to Follow-up|1|||
146698287|NCT00811577|529074619|FG000|Overall Study|Withdrawal by Subject|3|||
146698288|NCT00811577|529074620|FG001|Overall Study|Withdrawal by Subject|0|||
146698289|NCT03003520|529076721|FG000|Overall Study|Adverse Event|9|||
146698290|NCT03003520|529076722|FG001|Overall Study|Adverse Event|0|||
146698291|NCT03003520|529076721|FG000|Overall Study|Death|1|||
146698292|NCT03003520|529076722|FG001|Overall Study|Death|0|||
146698293|NCT03003520|529076721|FG000|Overall Study|Other reasons|4|||
146698294|NCT03003520|529076722|FG001|Overall Study|Other reasons|0|||
146698295|NCT03003520|529076721|FG000|Overall Study|Withdrawal by Subject|6|||
146698296|NCT03003520|529076722|FG001|Overall Study|Withdrawal by Subject|0|||
146698297|NCT03003520|529076721|FG000|Overall Study|Progressive disease|9|||
146698298|NCT03003520|529076722|FG001|Overall Study|Progressive disease|1|||
146698299|NCT02565381|529076723|FG000|Overall Study|Lost to Follow-up|1|||
146698300|NCT02565381|529076724|FG001|Overall Study|Lost to Follow-up|0|||
146698301|NCT02565381|529076725|FG002|Overall Study|Lost to Follow-up|1|||
146698302|NCT01914666|529076731|FG000|Treatment Period|Lack of Efficacy|0|||
146698303|NCT01914666|529076732|FG001|Treatment Period|Lack of Efficacy|0|||
146698304|NCT01914666|529076733|FG002|Treatment Period|Lack of Efficacy|2|||
146698305|NCT01914666|529076731|FG000|Treatment Period|Adverse Event|10|||
146698306|NCT01914666|529076732|FG001|Treatment Period|Adverse Event|4|||
146698307|NCT01914666|529076733|FG002|Treatment Period|Adverse Event|2|||
146698308|NCT01914666|529076731|FG000|Treatment Period|Withdrawal by Subject|3|||
146698309|NCT01914666|529076732|FG001|Treatment Period|Withdrawal by Subject|2|||
146698310|NCT01914666|529076733|FG002|Treatment Period|Withdrawal by Subject|2|||
146698311|NCT01914666|529076731|FG000|Treatment Period|Physician Decision|0|||
146698312|NCT01914666|529076732|FG001|Treatment Period|Physician Decision|0|||
146698313|NCT01914666|529076733|FG002|Treatment Period|Physician Decision|2|||
146698314|NCT03252522|529076734|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
146698315|NCT03252522|529076735|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
146698316|NCT03252522|529076736|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
146698317|NCT03252522|529076734|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
146698318|NCT03252522|529076735|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
146698319|NCT03252522|529076736|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
146698320|NCT03252522|529076734|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
146698321|NCT03252522|529076735|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
146698322|NCT03252522|529076736|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
146931096|NCT02022033|529905353|FG000|Overall Study|Physician Decision|1|||
146931097|NCT01429077|529905354|FG000|Overall Study|Lost to Follow-up|0|||
146698323|NCT03252522|529076734|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
146698324|NCT03252522|529076735|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
146698325|NCT03252522|529076736|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
146698326|NCT03252522|529076734|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
146698327|NCT03252522|529076735|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
146698328|NCT03252522|529076736|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
146698329|NCT03252522|529076734|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
146931098|NCT01429077|529905355|FG001|Overall Study|Lost to Follow-up|3|||
146931099|NCT01413542|529905357|FG000|Overall Study|Physician Decision|1|||
146931100|NCT01413542|529905358|FG001|Overall Study|Physician Decision|0|||
146931101|NCT01413542|529905359|FG002|Overall Study|Physician Decision|3|||
146931102|NCT01413542|529905360|FG003|Overall Study|Physician Decision|0|||
146931103|NCT01413542|529905357|FG000|Overall Study|Adverse Event|0|||
146931104|NCT01413542|529905358|FG001|Overall Study|Adverse Event|0|||
146931105|NCT01413542|529905359|FG002|Overall Study|Adverse Event|0|||
146931106|NCT01413542|529905360|FG003|Overall Study|Adverse Event|1|||
146931107|NCT03084718|529905361|FG000|Overall Study|Withdrawal by Subject|4|||
146931108|NCT03084718|529905362|FG001|Overall Study|Withdrawal by Subject|3|||
146931109|NCT03084718|529905363|FG002|Overall Study|Withdrawal by Subject|4|||
146931110|NCT03084718|529905364|FG003|Overall Study|Withdrawal by Subject|0|||
146931111|NCT03084718|529905365|FG004|Overall Study|Withdrawal by Subject|0|||
146931112|NCT03084718|529905361|FG000|Overall Study|Physician Decision|1|||
146931113|NCT03084718|529905362|FG001|Overall Study|Physician Decision|0|||
146931114|NCT03084718|529905363|FG002|Overall Study|Physician Decision|0|||
146931115|NCT03084718|529905364|FG003|Overall Study|Physician Decision|0|||
146931116|NCT03084718|529905365|FG004|Overall Study|Physician Decision|0|||
146931117|NCT03084718|529905361|FG000|Overall Study|Adverse Event|3|||
146931118|NCT03084718|529905362|FG001|Overall Study|Adverse Event|5|||
146931119|NCT03084718|529905363|FG002|Overall Study|Adverse Event|5|||
146931120|NCT03084718|529905364|FG003|Overall Study|Adverse Event|8|||
146931121|NCT03084718|529905365|FG004|Overall Study|Adverse Event|2|||
146931122|NCT03084718|529905361|FG000|Overall Study|Lack of Efficacy|2|||
146931123|NCT03084718|529905362|FG001|Overall Study|Lack of Efficacy|0|||
146931124|NCT03084718|529905363|FG002|Overall Study|Lack of Efficacy|1|||
146931125|NCT03084718|529905364|FG003|Overall Study|Lack of Efficacy|4|||
146931126|NCT03084718|529905365|FG004|Overall Study|Lack of Efficacy|0|||
146931127|NCT03084718|529905361|FG000|Overall Study|Lost to Follow-up|0|||
146931128|NCT03084718|529905362|FG001|Overall Study|Lost to Follow-up|1|||
146931129|NCT03084718|529905363|FG002|Overall Study|Lost to Follow-up|0|||
146931130|NCT03084718|529905364|FG003|Overall Study|Lost to Follow-up|0|||
146931131|NCT03084718|529905365|FG004|Overall Study|Lost to Follow-up|2|||
146931132|NCT03084718|529905361|FG000|Overall Study|Protocol Violation|0|||
146931133|NCT03084718|529905362|FG001|Overall Study|Protocol Violation|0|||
146931134|NCT03084718|529905363|FG002|Overall Study|Protocol Violation|1|||
146931135|NCT03084718|529905364|FG003|Overall Study|Protocol Violation|0|||
146931136|NCT03084718|529905365|FG004|Overall Study|Protocol Violation|0|||
146931137|NCT03084718|529905361|FG000|Overall Study|Death|0|||
146931138|NCT03084718|529905362|FG001|Overall Study|Death|1|||
146931139|NCT03084718|529905363|FG002|Overall Study|Death|0|||
146931140|NCT03084718|529905364|FG003|Overall Study|Death|0|||
146931141|NCT03084718|529905365|FG004|Overall Study|Death|0|||
146931142|NCT03084718|529905361|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
146931143|NCT03084718|529905362|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
146931144|NCT03084718|529905363|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
146931145|NCT03084718|529905364|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
146931146|NCT03084718|529905365|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
146931147|NCT03341923|529905366|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
146931148|NCT03341923|529905367|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
146931149|NCT03986190|529905368|FG000|Overall Study|Withdrawal by Subject|12|||
146931150|NCT03986190|529905369|FG001|Overall Study|Withdrawal by Subject|0|||
146931151|NCT02806947|529905370|FG000|Overall Study|Withdrawal by Subject|5|||
146931152|NCT02806947|529905371|FG001|Overall Study|Withdrawal by Subject|1|||
146931153|NCT04511819|529905372|FG000|Overall Study|Non-compliance with study drug|5|||
146931154|NCT04511819|529905373|FG001|Overall Study|Non-compliance with study drug|1|||
146931155|NCT04511819|529905372|FG000|Overall Study|Withdrawal by Subject|0|||
146931156|NCT04511819|529905373|FG001|Overall Study|Withdrawal by Subject|3|||
146931157|NCT04511819|529905372|FG000|Overall Study|Adverse Event|0|||
146931158|NCT04511819|529905373|FG001|Overall Study|Adverse Event|1|||
146931159|NCT04511819|529905372|FG000|Overall Study|Protocol deviation|1|||
146931160|NCT04511819|529905373|FG001|Overall Study|Protocol deviation|0|||
146931161|NCT00844649|529905374|FG000|Overall Study|Progressive Disease|196|||
146931162|NCT00844649|529905375|FG001|Overall Study|Progressive Disease|245|||
146931163|NCT00844649|529905374|FG000|Overall Study|Adverse Event|128|||
146931164|NCT00844649|529905375|FG001|Overall Study|Adverse Event|73|||
146931165|NCT00844649|529905374|FG000|Overall Study|Physician Decision|25|||
146931166|NCT00844649|529905375|FG001|Overall Study|Physician Decision|18|||
146931167|NCT00844649|529905374|FG000|Overall Study|Protocol Violation|10|||
146931168|NCT00844649|529905375|FG001|Overall Study|Protocol Violation|6|||
146931169|NCT00844649|529905374|FG000|Overall Study|Withdrawal by Subject|28|||
146931170|NCT00844649|529905375|FG001|Overall Study|Withdrawal by Subject|39|||
146931171|NCT00844649|529905374|FG000|Overall Study|Other|7|||
146931172|NCT00844649|529905375|FG001|Overall Study|Other|10|||
146931173|NCT00844649|529905374|FG000|Overall Study|Withdrew prior to starting treatment|11|||
146931174|NCT00844649|529905375|FG001|Overall Study|Withdrew prior to starting treatment|27|||
146931175|NCT02767856|529905386|FG000|Overall Study|Lost to Follow-up|9|||
146980828|NCT00738920|530091314|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
146980829|NCT00738920|530091315|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
146980830|NCT00738920|530091316|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
146980831|NCT00738920|530091314|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
146980832|NCT00738920|530091315|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
146980833|NCT00738920|530091316|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
146980834|NCT00738920|530091314|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
146980835|NCT00738920|530091315|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
146980836|NCT00738920|530091316|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
146980837|NCT00738920|530091314|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
146980838|NCT00738920|530091315|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
146980839|NCT00738920|530091316|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
146776361|NCT02791230|529353588|FG001|Overall Study|Adverse Event|9|||
146776362|NCT02791230|529353589|FG002|Overall Study|Adverse Event|66|||
146931176|NCT02767856|529905387|FG001|Overall Study|Lost to Follow-up|1|||
146931177|NCT02767856|529905386|FG000|Overall Study|Withdrawal by Subject|2|||
146931178|NCT02767856|529905387|FG001|Overall Study|Withdrawal by Subject|1|||
146931179|NCT00091026|529905390|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
146931180|NCT00091026|529905391|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
146931181|NCT00091026|529905390|FG000|Overall Study|Patient withdrew and never received trea|0|||
146931182|NCT00091026|529905391|FG001|Overall Study|Patient withdrew and never received trea|2|||
146931183|NCT00091026|529905390|FG000|Overall Study|Unknown-never received treatment|0|||
146931184|NCT00091026|529905391|FG001|Overall Study|Unknown-never received treatment|1|||
146931185|NCT00065442|529905394|FG000|Overall Study|Lost to Follow-up|1|||
146980840|NCT02046369|530091317|FG000|Overall Study|Adverse Event|3|||
146980841|NCT02046369|530091318|FG001|Overall Study|Adverse Event|3|||
146776363|NCT02791230|529353587|FG000|Overall Study|Death|38|||
146776364|NCT02791230|529353588|FG001|Overall Study|Death|25|||
146776365|NCT02791230|529353589|FG002|Overall Study|Death|184|||
146776366|NCT02791230|529353587|FG000|Overall Study|Lack of Efficacy|1|||
146776367|NCT02791230|529353588|FG001|Overall Study|Lack of Efficacy|0|||
146776368|NCT02791230|529353589|FG002|Overall Study|Lack of Efficacy|3|||
146980842|NCT02046369|530091317|FG000|Overall Study|Lack of Efficacy|3|||
146698330|NCT03252522|529076735|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
146776369|NCT02791230|529353587|FG000|Overall Study|Lost to Follow-up|0|||
146776370|NCT02791230|529353588|FG001|Overall Study|Lost to Follow-up|0|||
146776371|NCT02791230|529353589|FG002|Overall Study|Lost to Follow-up|10|||
146776372|NCT02791230|529353587|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
146776373|NCT02791230|529353588|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
146980843|NCT02046369|530091318|FG001|Overall Study|Lack of Efficacy|3|||
146980844|NCT02046369|530091317|FG000|Overall Study|Lost to Follow-up|3|||
146698331|NCT03252522|529076736|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
146698332|NCT03252522|529076734|FG000|Phase 2: Open Label|Adverse Event|0|||
146698333|NCT03252522|529076735|FG001|Phase 2: Open Label|Adverse Event|0|||
146698334|NCT03252522|529076736|FG002|Phase 2: Open Label|Adverse Event|2|||
146698335|NCT03252522|529076734|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
146698336|NCT03252522|529076735|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
146698337|NCT03252522|529076736|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
146698338|NCT01940120|529076740|FG000|Overall Study|Death|40|||
146698339|NCT01940120|529076740|FG000|Overall Study|Withdrawal by Subject|8|||
146698340|NCT02554656|529076741|FG000|Overall Study|Protocol Violation|3|||
146698341|NCT03568942|529076746|FG000|Overall Study|Family emergency|1|||
146698342|NCT03568942|529076746|FG000|Overall Study|Lost to Follow-up|1|||
146698343|NCT01945489|529076747|FG000|Cycle 1|Adverse Event|2|||
146698344|NCT01945489|529076748|FG001|Cycle 1|Adverse Event|0|||
146698345|NCT01945489|529076747|FG000|Cycle 1|Lost to Follow-up|4|||
146698346|NCT01945489|529076748|FG001|Cycle 1|Lost to Follow-up|0|||
146698347|NCT01945489|529076747|FG000|Cycle 1|Personal Reasons|4|||
146698348|NCT01945489|529076748|FG001|Cycle 1|Personal Reasons|2|||
146698349|NCT01945489|529076747|FG000|Cycle 1|Protocol Violation|0|||
146698350|NCT01945489|529076748|FG001|Cycle 1|Protocol Violation|1|||
146698351|NCT01945489|529076747|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
146698352|NCT01945489|529076748|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
146698353|NCT01945489|529076747|FG000|Cycle 2|Adverse Event|1|||
146698354|NCT01945489|529076748|FG001|Cycle 2|Adverse Event|0|||
146698355|NCT01945489|529076747|FG000|Cycle 2|Lost to Follow-up|0|||
146776374|NCT02791230|529353589|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
146776375|NCT02791230|529353587|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
146776376|NCT02791230|529353588|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
146698356|NCT01945489|529076748|FG001|Cycle 2|Lost to Follow-up|1|||
146698357|NCT04144166|529076749|FG000|Overall Study|Discharged before study start|1|||
146698358|NCT04144166|529076749|FG000|Overall Study|Pregnancy|1|||
146698359|NCT04144166|529076749|FG000|Overall Study|Nail polish could not be removed from finger|1|||
146698360|NCT02433834|529076755|FG000|Overall Study|Protocol-specified criteria|7|||
146698361|NCT02433834|529076755|FG000|Overall Study|Protocol Violation|3|||
146931186|NCT00065442|529905395|FG001|Overall Study|Lost to Follow-up|1|||
146931187|NCT00065442|529905394|FG000|Overall Study|Death|121|||
146931188|NCT00065442|529905395|FG001|Overall Study|Death|210|||
146931189|NCT00065442|529905394|FG000|Overall Study|Withdrawal by Subject|3|||
146931190|NCT00065442|529905395|FG001|Overall Study|Withdrawal by Subject|9|||
146931191|NCT01594333|529905396|FG000|Overall Study|Death|96|||
146931192|NCT01594333|529905397|FG001|Overall Study|Death|83|||
146931193|NCT01594333|529905396|FG000|Overall Study|Lost to Follow-up|5|||
146931194|NCT01594333|529905397|FG001|Overall Study|Lost to Follow-up|5|||
146931195|NCT01594333|529905396|FG000|Overall Study|Withdrawal by Subject|60|||
146931196|NCT01594333|529905397|FG001|Overall Study|Withdrawal by Subject|63|||
146931197|NCT01797965|529905398|FG000|Overall Study|Adverse Event|104|||
146931198|NCT01797965|529905399|FG001|Overall Study|Adverse Event|129|||
146931199|NCT01797965|529905400|FG002|Overall Study|Adverse Event|4|||
146931200|NCT01797965|529905401|FG003|Overall Study|Adverse Event|21|||
146931201|NCT01797965|529905398|FG000|Overall Study|Lost to Follow-up|9|||
146931202|NCT01797965|529905399|FG001|Overall Study|Lost to Follow-up|8|||
146931203|NCT01797965|529905400|FG002|Overall Study|Lost to Follow-up|1|||
146931204|NCT01797965|529905401|FG003|Overall Study|Lost to Follow-up|2|||
146931205|NCT01797965|529905398|FG000|Overall Study|Consent withdrawn|130|||
146931206|NCT01797965|529905399|FG001|Overall Study|Consent withdrawn|117|||
146931207|NCT01797965|529905400|FG002|Overall Study|Consent withdrawn|3|||
146931208|NCT01797965|529905401|FG003|Overall Study|Consent withdrawn|35|||
146931209|NCT01797965|529905398|FG000|Overall Study|Investigator decision|21|||
146931210|NCT01797965|529905399|FG001|Overall Study|Investigator decision|15|||
146931211|NCT01797965|529905400|FG002|Overall Study|Investigator decision|0|||
146931212|NCT01797965|529905401|FG003|Overall Study|Investigator decision|0|||
146931213|NCT01797965|529905398|FG000|Overall Study|Death|2|||
146931214|NCT01797965|529905399|FG001|Overall Study|Death|4|||
146931215|NCT01797965|529905400|FG002|Overall Study|Death|0|||
146931216|NCT01797965|529905401|FG003|Overall Study|Death|0|||
146931217|NCT01797965|529905398|FG000|Overall Study|Disease progression, defined by protocol|3|||
146931218|NCT01797965|529905399|FG001|Overall Study|Disease progression, defined by protocol|1|||
146931219|NCT01797965|529905400|FG002|Overall Study|Disease progression, defined by protocol|0|||
146931220|NCT01797965|529905401|FG003|Overall Study|Disease progression, defined by protocol|0|||
146931221|NCT01797965|529905398|FG000|Overall Study|Reason Not Specified|280|||
146931222|NCT01797965|529905399|FG001|Overall Study|Reason Not Specified|295|||
146931223|NCT01797965|529905400|FG002|Overall Study|Reason Not Specified|0|||
146931224|NCT01797965|529905401|FG003|Overall Study|Reason Not Specified|15|||
146931225|NCT00304915|529905402|FG000|Overall Study|Lost to Follow-up|11|||
146931226|NCT00304915|529905403|FG001|Overall Study|Lost to Follow-up|11|||
146931227|NCT00304915|529905402|FG000|Overall Study|Death|4|||
146931228|NCT00304915|529905403|FG001|Overall Study|Death|5|||
146931229|NCT00304915|529905402|FG000|Overall Study|Withdrawal by Subject|3|||
146931230|NCT00304915|529905403|FG001|Overall Study|Withdrawal by Subject|0|||
146931231|NCT00712322|529905404|FG000|Overall Study|Protocol deviation|0|||
146931232|NCT00712322|529905405|FG001|Overall Study|Protocol deviation|1|||
146931233|NCT00712322|529905406|FG002|Overall Study|Protocol deviation|0|||
146931234|NCT02670330|529905409|FG000|Overall Study|Protocol Deviation|1|||
146931235|NCT02670330|529905410|FG001|Overall Study|Protocol Deviation|0|||
146931236|NCT02670330|529905409|FG000|Overall Study|Study Terminated By Sponsor|36|||
146931237|NCT02670330|529905410|FG001|Overall Study|Study Terminated By Sponsor|43|||
146931238|NCT02670330|529905409|FG000|Overall Study|Adverse Event|1|||
146931239|NCT02670330|529905410|FG001|Overall Study|Adverse Event|3|||
146931240|NCT02670330|529905409|FG000|Overall Study|Withdrawal by Subject|34|||
146931241|NCT02670330|529905410|FG001|Overall Study|Withdrawal by Subject|29|||
146931242|NCT02670330|529905409|FG000|Overall Study|Lost to Follow-up|3|||
146931243|NCT02670330|529905410|FG001|Overall Study|Lost to Follow-up|2|||
146931244|NCT04404010|529905411|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
146980845|NCT02046369|530091318|FG001|Overall Study|Lost to Follow-up|3|||
146980846|NCT02046369|530091317|FG000|Overall Study|Protocol Violation|1|||
146698362|NCT02433834|529076755|FG000|Overall Study|Lost to Follow-up|6|||
146698363|NCT02433834|529076755|FG000|Overall Study|Withdrawal by Subject|14|||
146931245|NCT04404010|529905412|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
146931246|NCT03176277|529905413|FG000|Part A Dose Escalation Study|Adverse Event|1|||
146931247|NCT03176277|529905414|FG001|Part A Dose Escalation Study|Adverse Event|0|||
146931248|NCT03176277|529905415|FG002|Part A Dose Escalation Study|Adverse Event|1|||
146931249|NCT03176277|529905416|FG003|Part A Dose Escalation Study|Adverse Event|0|||
146931250|NCT03176277|529905413|FG000|Part A Dose Escalation Study|Physician Decision|1|||
146931251|NCT03176277|529905414|FG001|Part A Dose Escalation Study|Physician Decision|1|||
146931252|NCT03176277|529905415|FG002|Part A Dose Escalation Study|Physician Decision|2|||
146931253|NCT03176277|529905416|FG003|Part A Dose Escalation Study|Physician Decision|0|||
146931254|NCT03176277|529905413|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
146931255|NCT03176277|529905414|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
146931256|NCT03176277|529905415|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
146931257|NCT03176277|529905416|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
146980847|NCT02046369|530091318|FG001|Overall Study|Protocol Violation|2|||
146980848|NCT02046369|530091317|FG000|Overall Study|Withdrawal by Subject|3|||
146980849|NCT02046369|530091318|FG001|Overall Study|Withdrawal by Subject|6|||
146980850|NCT02046369|530091317|FG000|Overall Study|never received study drug|0|||
146980851|NCT02046369|530091318|FG001|Overall Study|never received study drug|1|||
146980852|NCT02046369|530091317|FG000|Overall Study|non compliance|1|||
146980853|NCT02046369|530091318|FG001|Overall Study|non compliance|0|||
146980854|NCT02196506|530091319|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
146980855|NCT02196506|530091320|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
146980856|NCT02196506|530091321|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
146980857|NCT02196506|530091322|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
146980858|NCT02196506|530091319|FG000|Phase A|Withdrawal by Subject|34|||
146980859|NCT02196506|530091320|FG001|Phase A|Withdrawal by Subject|0|||
146980860|NCT02196506|530091321|FG002|Phase A|Withdrawal by Subject|0|||
146980861|NCT02196506|530091322|FG003|Phase A|Withdrawal by Subject|0|||
146980862|NCT02196506|530091319|FG000|Phase A|Adverse Event|22|||
146980863|NCT02196506|530091320|FG001|Phase A|Adverse Event|0|||
146980864|NCT02196506|530091321|FG002|Phase A|Adverse Event|0|||
146980865|NCT02196506|530091322|FG003|Phase A|Adverse Event|0|||
146980866|NCT02196506|530091319|FG000|Phase A|Lost to Follow-up|9|||
146980867|NCT02196506|530091320|FG001|Phase A|Lost to Follow-up|0|||
146980868|NCT02196506|530091321|FG002|Phase A|Lost to Follow-up|0|||
146980869|NCT02196506|530091322|FG003|Phase A|Lost to Follow-up|0|||
146980870|NCT02196506|530091319|FG000|Phase A|Protocol deviation|12|||
146980871|NCT02196506|530091320|FG001|Phase A|Protocol deviation|0|||
146980872|NCT02196506|530091321|FG002|Phase A|Protocol deviation|0|||
146980873|NCT02196506|530091322|FG003|Phase A|Protocol deviation|0|||
146980874|NCT02196506|530091319|FG000|Phase A|Participant withdrawn by investigator|10|||
146980875|NCT02196506|530091320|FG001|Phase A|Participant withdrawn by investigator|0|||
146980876|NCT02196506|530091321|FG002|Phase A|Participant withdrawn by investigator|0|||
146980877|NCT02196506|530091322|FG003|Phase A|Participant withdrawn by investigator|0|||
146980878|NCT02196506|530091319|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
146980879|NCT02196506|530091320|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
146980880|NCT02196506|530091321|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
146980881|NCT02196506|530091322|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
146980882|NCT02196506|530091319|FG000|Phase B|Lack of Efficacy|0|||
146980883|NCT02196506|530091320|FG001|Phase B|Lack of Efficacy|1|||
146980884|NCT02196506|530091321|FG002|Phase B|Lack of Efficacy|2|||
146980885|NCT02196506|530091322|FG003|Phase B|Lack of Efficacy|0|||
146980886|NCT02196506|530091319|FG000|Phase B|Withdrawal by Participant|0|||
146980887|NCT02196506|530091320|FG001|Phase B|Withdrawal by Participant|8|||
146980888|NCT02196506|530091321|FG002|Phase B|Withdrawal by Participant|1|||
146980889|NCT02196506|530091322|FG003|Phase B|Withdrawal by Participant|0|||
146980890|NCT02196506|530091319|FG000|Phase B|Adverse Event|0|||
146980891|NCT02196506|530091320|FG001|Phase B|Adverse Event|4|||
146980892|NCT02196506|530091321|FG002|Phase B|Adverse Event|1|||
146980893|NCT02196506|530091322|FG003|Phase B|Adverse Event|0|||
146980894|NCT02196506|530091319|FG000|Phase B|Lost to Follow-up|0|||
146931258|NCT03176277|529905413|FG000|Part A Dose Escalation Study|Progressive disease|3|||
146931259|NCT03176277|529905414|FG001|Part A Dose Escalation Study|Progressive disease|1|||
146931260|NCT03176277|529905415|FG002|Part A Dose Escalation Study|Progressive disease|3|||
146931261|NCT03176277|529905416|FG003|Part A Dose Escalation Study|Progressive disease|0|||
146931262|NCT03282357|529905417|FG000|Overall Study|Lost to Follow-up|3|||
146931263|NCT03282357|529905417|FG000|Overall Study|Withdrawal by Subject|4|||
146931264|NCT03282357|529905417|FG000|Overall Study|Adverse Event|1|||
146931265|NCT03282357|529905417|FG000|Overall Study|Other|9|||
146931266|NCT03550131|529905418|FG000|Overall Study|Lost to Follow-up|16|||
146980895|NCT02196506|530091320|FG001|Phase B|Lost to Follow-up|2|||
146980896|NCT02196506|530091321|FG002|Phase B|Lost to Follow-up|1|||
146980897|NCT02196506|530091322|FG003|Phase B|Lost to Follow-up|0|||
146980898|NCT02196506|530091319|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
146980899|NCT02196506|530091320|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
146698364|NCT02433834|529076755|FG000|Overall Study|Adverse Event|6|||
146698365|NCT02433834|529076755|FG000|Overall Study|Physician Decision|1|||
146931267|NCT03550131|529905419|FG001|Overall Study|Lost to Follow-up|24|||
146698366|NCT00934544|529076756|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
146931268|NCT03550131|529905418|FG000|Overall Study|Withdrawal by Subject|36|||
146931269|NCT03550131|529905419|FG001|Overall Study|Withdrawal by Subject|28|||
146931270|NCT03550131|529905418|FG000|Overall Study|Illness of dyad member|10|||
146931271|NCT03550131|529905419|FG001|Overall Study|Illness of dyad member|2|||
146980900|NCT02196506|530091321|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
146980901|NCT02196506|530091322|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
146980902|NCT02196506|530091319|FG000|Phase A+|Withdrawal by Participant|0|||
146980903|NCT02196506|530091320|FG001|Phase A+|Withdrawal by Participant|0|||
146980904|NCT02196506|530091321|FG002|Phase A+|Withdrawal by Participant|0|||
146980905|NCT02196506|530091322|FG003|Phase A+|Withdrawal by Participant|5|||
146980906|NCT02196506|530091319|FG000|Phase A+|Adverse Event|0|||
146980907|NCT02196506|530091320|FG001|Phase A+|Adverse Event|0|||
146980908|NCT02196506|530091321|FG002|Phase A+|Adverse Event|0|||
146698367|NCT00934544|529076757|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
146698368|NCT00934544|529076758|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
146698369|NCT00934544|529076756|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
146698370|NCT00934544|529076757|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
146698371|NCT00934544|529076758|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
146698372|NCT00934544|529076756|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
146698373|NCT00934544|529076757|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
146698374|NCT00934544|529076758|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
146698375|NCT00934544|529076756|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
146698376|NCT00934544|529076757|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
146698377|NCT00934544|529076758|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
146698378|NCT00934544|529076756|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
146698379|NCT00934544|529076757|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
146698380|NCT00934544|529076758|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
146698381|NCT00934544|529076756|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
146698382|NCT00934544|529076757|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
146698383|NCT00934544|529076758|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
146698384|NCT00934544|529076756|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
146698385|NCT00934544|529076757|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
146698386|NCT00934544|529076758|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
146698387|NCT00934544|529076756|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
146698388|NCT00934544|529076757|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
146698389|NCT00934544|529076758|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
146698390|NCT00934544|529076756|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
146698391|NCT00934544|529076757|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
146698392|NCT00934544|529076758|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
146698393|NCT00934544|529076756|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
146698394|NCT00934544|529076757|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
146698395|NCT00934544|529076758|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
146698396|NCT00934544|529076756|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
146698397|NCT00934544|529076757|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
146698398|NCT00934544|529076758|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
146698399|NCT00934544|529076756|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
146698400|NCT00934544|529076757|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
146698401|NCT00934544|529076758|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
146698402|NCT00934544|529076756|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
146698403|NCT00934544|529076757|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
146698404|NCT00934544|529076758|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
146698405|NCT00934544|529076756|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
146698406|NCT00934544|529076757|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
146698407|NCT00934544|529076758|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
146698408|NCT00934544|529076756|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
146698409|NCT00934544|529076757|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
146698410|NCT00934544|529076758|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
146698411|NCT00934544|529076756|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
146698412|NCT00934544|529076757|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
146698413|NCT00934544|529076758|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
146698414|NCT00283439|529076759|FG000|Overall Study|Adverse Event|0|||
146698415|NCT00283439|529076760|FG001|Overall Study|Adverse Event|0|||
146698416|NCT00283439|529076761|FG002|Overall Study|Adverse Event|0|||
146698417|NCT00283439|529076762|FG003|Overall Study|Adverse Event|1|||
146698418|NCT00283439|529076759|FG000|Overall Study|Death|0|||
146698419|NCT00283439|529076760|FG001|Overall Study|Death|0|||
146698420|NCT00283439|529076761|FG002|Overall Study|Death|1|||
146698421|NCT00283439|529076762|FG003|Overall Study|Death|0|||
146698422|NCT00283439|529076759|FG000|Overall Study|Disease progression|0|||
146698423|NCT00283439|529076760|FG001|Overall Study|Disease progression|1|||
146698424|NCT00283439|529076761|FG002|Overall Study|Disease progression|0|||
146698425|NCT00283439|529076762|FG003|Overall Study|Disease progression|0|||
146698426|NCT00283439|529076759|FG000|Overall Study|Requirement for alternative therapy|1|||
146698427|NCT00283439|529076760|FG001|Overall Study|Requirement for alternative therapy|2|||
146698428|NCT00283439|529076761|FG002|Overall Study|Requirement for alternative therapy|5|||
146698429|NCT00283439|529076762|FG003|Overall Study|Requirement for alternative therapy|2|||
146698430|NCT00283439|529076759|FG000|Overall Study|Stem cell transplant|6|||
146698431|NCT00283439|529076760|FG001|Overall Study|Stem cell transplant|6|||
146698432|NCT00283439|529076761|FG002|Overall Study|Stem cell transplant|4|||
146698433|NCT00283439|529076762|FG003|Overall Study|Stem cell transplant|3|||
146698434|NCT00283439|529076759|FG000|Overall Study|Treatment discontinued|0|||
146698435|NCT00283439|529076760|FG001|Overall Study|Treatment discontinued|2|||
146698436|NCT00283439|529076761|FG002|Overall Study|Treatment discontinued|1|||
146698437|NCT00283439|529076762|FG003|Overall Study|Treatment discontinued|3|||
146698438|NCT00283439|529076759|FG000|Overall Study|Other|1|||
146698439|NCT00283439|529076760|FG001|Overall Study|Other|0|||
146698440|NCT00283439|529076761|FG002|Overall Study|Other|0|||
146698441|NCT00283439|529076762|FG003|Overall Study|Other|0|||
146698442|NCT01632891|529076763|FG000|Overall Study|Lost to Follow-up|0|||
146698443|NCT01632891|529076764|FG001|Overall Study|Lost to Follow-up|1|||
146698444|NCT01632891|529076763|FG000|Overall Study|Withdrawal by Subject|1|||
146698445|NCT01632891|529076764|FG001|Overall Study|Withdrawal by Subject|0|||
146698446|NCT00333229|529076767|FG000|Overall Study|Lack of Efficacy|0|||
146698447|NCT00333229|529076768|FG001|Overall Study|Lack of Efficacy|1|||
146698448|NCT00240071|529076770|FG000|Overall Study|Withdrawal by Subject|3|||
146698449|NCT00654381|529076780|FG000|1st Stage|Adverse Event|3|||
146698450|NCT00654381|529076781|FG001|1st Stage|Adverse Event|3|||
146698451|NCT00654381|529076782|FG002|1st Stage|Adverse Event|3|||
146698452|NCT00654381|529076783|FG003|1st Stage|Adverse Event|3|||
146698453|NCT00654381|529076784|FG004|1st Stage|Adverse Event|2|||
146698454|NCT00654381|529076785|FG005|1st Stage|Adverse Event|1|||
146698455|NCT00654381|529076780|FG000|1st Stage|Withdrawal by Subject|0|||
146698456|NCT00654381|529076781|FG001|1st Stage|Withdrawal by Subject|0|||
146698457|NCT00654381|529076782|FG002|1st Stage|Withdrawal by Subject|0|||
146698458|NCT00654381|529076783|FG003|1st Stage|Withdrawal by Subject|1|||
146698459|NCT00654381|529076784|FG004|1st Stage|Withdrawal by Subject|0|||
146698460|NCT00654381|529076785|FG005|1st Stage|Withdrawal by Subject|1|||
146698461|NCT00654381|529076780|FG000|1st Stage|Investigator's decision|0|||
146698462|NCT00654381|529076781|FG001|1st Stage|Investigator's decision|0|||
146698463|NCT00654381|529076782|FG002|1st Stage|Investigator's decision|0|||
146698464|NCT00654381|529076783|FG003|1st Stage|Investigator's decision|1|||
146698465|NCT00654381|529076784|FG004|1st Stage|Investigator's decision|0|||
146698466|NCT00654381|529076785|FG005|1st Stage|Investigator's decision|0|||
146698467|NCT00654381|529076780|FG000|2nd Stage|Adverse Event|2|||
146698468|NCT00654381|529076781|FG001|2nd Stage|Adverse Event|0|||
146698469|NCT00654381|529076782|FG002|2nd Stage|Adverse Event|2|||
146698470|NCT00654381|529076783|FG003|2nd Stage|Adverse Event|3|||
146698471|NCT00654381|529076784|FG004|2nd Stage|Adverse Event|7|||
146698472|NCT00654381|529076785|FG005|2nd Stage|Adverse Event|2|||
146698473|NCT00654381|529076780|FG000|2nd Stage|Withdrawal by Subject|0|||
146698474|NCT00654381|529076781|FG001|2nd Stage|Withdrawal by Subject|0|||
146698475|NCT00654381|529076782|FG002|2nd Stage|Withdrawal by Subject|0|||
146698476|NCT00654381|529076783|FG003|2nd Stage|Withdrawal by Subject|0|||
146698477|NCT00654381|529076784|FG004|2nd Stage|Withdrawal by Subject|1|||
146698478|NCT00654381|529076785|FG005|2nd Stage|Withdrawal by Subject|1|||
146698479|NCT00654381|529076780|FG000|2nd Stage|Investigator's decision|0|||
146698480|NCT00654381|529076781|FG001|2nd Stage|Investigator's decision|0|||
146698481|NCT00654381|529076782|FG002|2nd Stage|Investigator's decision|1|||
146698482|NCT00654381|529076783|FG003|2nd Stage|Investigator's decision|1|||
146698483|NCT00654381|529076784|FG004|2nd Stage|Investigator's decision|0|||
146698484|NCT00654381|529076785|FG005|2nd Stage|Investigator's decision|0|||
146698485|NCT00654381|529076780|FG000|Extension Stage|Adverse Event|1|||
146698486|NCT00654381|529076781|FG001|Extension Stage|Adverse Event|2|||
146698487|NCT00654381|529076782|FG002|Extension Stage|Adverse Event|9|||
146698488|NCT00654381|529076783|FG003|Extension Stage|Adverse Event|7|||
146931272|NCT03550131|529905418|FG000|Overall Study|Death of person with dementia|4|||
146931273|NCT03550131|529905419|FG001|Overall Study|Death of person with dementia|8|||
146931274|NCT01318512|529905420|FG000|Maintenance Period (6 Months)|Death|2|||
146931275|NCT01318512|529905420|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
146931276|NCT01822691|529905425|FG000|Overall Study|Withdrawal by Subject|2|||
146931277|NCT02379390|529905426|FG000|Overall Study|Adverse Event|1|||
146931278|NCT02379390|529905427|FG001|Overall Study|Adverse Event|1|||
146931279|NCT02379390|529905426|FG000|Overall Study|Investigator's decision|1|||
146931280|NCT02379390|529905427|FG001|Overall Study|Investigator's decision|0|||
146931281|NCT02379390|529905426|FG000|Overall Study|Study Termination|0|||
146931282|NCT02379390|529905427|FG001|Overall Study|Study Termination|1|||
146698489|NCT00654381|529076784|FG004|Extension Stage|Adverse Event|1|||
146698490|NCT00654381|529076785|FG005|Extension Stage|Adverse Event|1|||
146698491|NCT00654381|529076780|FG000|Extension Stage|Protocol Violation|0|||
146698492|NCT00654381|529076781|FG001|Extension Stage|Protocol Violation|0|||
146698493|NCT00654381|529076782|FG002|Extension Stage|Protocol Violation|0|||
146698494|NCT00654381|529076783|FG003|Extension Stage|Protocol Violation|1|||
146698495|NCT00654381|529076784|FG004|Extension Stage|Protocol Violation|0|||
146698496|NCT00654381|529076785|FG005|Extension Stage|Protocol Violation|0|||
146698497|NCT00654381|529076780|FG000|Extension Stage|Lack of Efficacy|0|||
146698498|NCT00654381|529076781|FG001|Extension Stage|Lack of Efficacy|0|||
146698499|NCT00654381|529076782|FG002|Extension Stage|Lack of Efficacy|1|||
146698500|NCT00654381|529076783|FG003|Extension Stage|Lack of Efficacy|0|||
146698501|NCT00654381|529076784|FG004|Extension Stage|Lack of Efficacy|0|||
146698502|NCT00654381|529076785|FG005|Extension Stage|Lack of Efficacy|0|||
146931283|NCT03245723|529905436|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
146931284|NCT03245723|529905437|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
146931285|NCT03245723|529905436|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
146931286|NCT03245723|529905437|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
146931287|NCT03245723|529905436|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
146931288|NCT03245723|529905437|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
146931289|NCT03245723|529905436|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
146931290|NCT03245723|529905437|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
146931291|NCT00077376|529905438|FG000|Overall Study|Adverse Event|8|||
146931292|NCT00077376|529905438|FG000|Overall Study|Withdrawal by Subject|2|||
146931293|NCT00077376|529905438|FG000|Overall Study|Death|1|||
146931294|NCT00077376|529905438|FG000|Overall Study|Physician Decision|1|||
146931295|NCT00077376|529905438|FG000|Overall Study|Alternative therapy|5|||
146931296|NCT00077376|529905438|FG000|Overall Study|Complicating disease|1|||
146931297|NCT00077376|529905438|FG000|Overall Study|Still on treatment|1|||
146931298|NCT00077376|529905438|FG000|Overall Study|Symptomatic deterioration|1|||
146931299|NCT00077376|529905438|FG000|Overall Study|Surgery|1|||
146931300|NCT00077376|529905438|FG000|Overall Study|Insurance ran out|1|||
146931301|NCT03784027|529905439|FG000|Period 1|Withdrawal by Subject|0|||
146931302|NCT03784027|529905440|FG001|Period 1|Withdrawal by Subject|1|||
146931303|NCT01283997|529906657|FG000|Overall Study|Physician Decision|8|||
146931304|NCT01283997|529906658|FG001|Overall Study|Physician Decision|10|||
146931305|NCT01283997|529906657|FG000|Overall Study|Withdrawal by Subject|3|||
146931306|NCT01283997|529906658|FG001|Overall Study|Withdrawal by Subject|2|||
146931307|NCT01283997|529906657|FG000|Overall Study|Physically unable to continue|0|||
146931308|NCT01283997|529906658|FG001|Overall Study|Physically unable to continue|1|||
146931309|NCT01283997|529906657|FG000|Overall Study|Progressive disease|1|||
146931310|NCT01283997|529906658|FG001|Overall Study|Progressive disease|0|||
146931311|NCT01283997|529906657|FG000|Overall Study|Other|4|||
146931312|NCT01283997|529906658|FG001|Overall Study|Other|4|||
146931313|NCT02658968|529906659|FG000|Received Rituximab|Adverse Event|0|||
146931314|NCT02658968|529906660|FG001|Received Rituximab|Adverse Event|0|||
146931315|NCT02658968|529906661|FG002|Received Rituximab|Adverse Event|0|||
146931316|NCT02658968|529906662|FG003|Received Rituximab|Adverse Event|0|||
146931317|NCT02658968|529906663|FG004|Received Rituximab|Adverse Event|1|||
146931318|NCT02658968|529906659|FG000|Received Rituximab|Progressive disease|0|||
146931319|NCT02658968|529906660|FG001|Received Rituximab|Progressive disease|0|||
146931320|NCT02658968|529906661|FG002|Received Rituximab|Progressive disease|0|||
146931321|NCT02658968|529906662|FG003|Received Rituximab|Progressive disease|0|||
146931322|NCT02658968|529906663|FG004|Received Rituximab|Progressive disease|1|||
146931323|NCT02658968|529906659|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
146931324|NCT02658968|529906660|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
146931325|NCT02658968|529906661|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
146698503|NCT00654381|529076780|FG000|Extension Stage|Withdrawal by Subject|0|||
146698504|NCT00654381|529076781|FG001|Extension Stage|Withdrawal by Subject|0|||
146698505|NCT00654381|529076782|FG002|Extension Stage|Withdrawal by Subject|1|||
146698506|NCT00654381|529076783|FG003|Extension Stage|Withdrawal by Subject|1|||
146698507|NCT00654381|529076784|FG004|Extension Stage|Withdrawal by Subject|1|||
146698508|NCT00654381|529076785|FG005|Extension Stage|Withdrawal by Subject|1|||
146698509|NCT00654381|529076780|FG000|Extension Stage|Closure of the trial site|0|||
146698510|NCT00654381|529076781|FG001|Extension Stage|Closure of the trial site|0|||
146698511|NCT00654381|529076782|FG002|Extension Stage|Closure of the trial site|0|||
146698512|NCT00654381|529076783|FG003|Extension Stage|Closure of the trial site|0|||
146698513|NCT00654381|529076784|FG004|Extension Stage|Closure of the trial site|1|||
146698514|NCT00654381|529076785|FG005|Extension Stage|Closure of the trial site|1|||
146698515|NCT03100825|529076786|FG000|Overall Study|Participant/Guardian Decision|7|||
146698516|NCT03100825|529076786|FG000|Overall Study|Physician Decision|1|||
146931326|NCT02658968|529906662|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
146931327|NCT02658968|529906663|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
146931328|NCT02658968|529906659|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
146931329|NCT02658968|529906660|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
146931330|NCT02658968|529906661|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
146931331|NCT02658968|529906662|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
146931332|NCT02658968|529906663|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
146931333|NCT02658968|529906659|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
146931334|NCT02658968|529906660|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
146931335|NCT02658968|529906661|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
146698517|NCT00994448|529076788|FG000|Overall Study|Adverse Event|1|||
146698518|NCT00994448|529076789|FG001|Overall Study|Adverse Event|0|||
146698519|NCT00994448|529076788|FG000|Overall Study|Lost to Follow-up|5|||
146698520|NCT00994448|529076789|FG001|Overall Study|Lost to Follow-up|1|||
146980909|NCT02196506|530091322|FG003|Phase A+|Adverse Event|1|||
146980910|NCT02196506|530091319|FG000|Phase A+|Lost to Follow-up|0|||
146980911|NCT02196506|530091320|FG001|Phase A+|Lost to Follow-up|0|||
146980912|NCT02196506|530091321|FG002|Phase A+|Lost to Follow-up|0|||
146980913|NCT02196506|530091322|FG003|Phase A+|Lost to Follow-up|6|||
146980914|NCT02196506|530091319|FG000|Phase A+|Participant withdrawn by investigator|0|||
146980915|NCT02196506|530091320|FG001|Phase A+|Participant withdrawn by investigator|0|||
146980916|NCT02196506|530091321|FG002|Phase A+|Participant withdrawn by investigator|0|||
146698521|NCT00994448|529076788|FG000|Overall Study|Withdrawal by Subject|1|||
146931336|NCT02658968|529906662|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
146931337|NCT02658968|529906663|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
146931338|NCT02658968|529906659|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
146931339|NCT02658968|529906660|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
146931340|NCT02658968|529906661|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
146931341|NCT02658968|529906662|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
146931342|NCT02658968|529906663|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
146931343|NCT02658968|529906659|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
146931344|NCT02658968|529906660|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
146931345|NCT02658968|529906661|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
146931346|NCT02658968|529906662|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
146931347|NCT02658968|529906663|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
146931348|NCT00436982|529906664|FG000|Overall Study|Withdrawal by Subject|3|||
146931349|NCT00436982|529906665|FG001|Overall Study|Withdrawal by Subject|1|||
146931350|NCT00436982|529906664|FG000|Overall Study|Did not receive allocated intervention|0|||
146931351|NCT00436982|529906665|FG001|Overall Study|Did not receive allocated intervention|1|||
146931352|NCT00436982|529906664|FG000|Overall Study|no RSA data|1|||
146931353|NCT00436982|529906665|FG001|Overall Study|no RSA data|2|||
146931354|NCT00953225|529906669|FG000|Overall Study|Withdrawal by Subject|2|||
146931355|NCT00953225|529906670|FG001|Overall Study|Withdrawal by Subject|0|||
146931356|NCT02215616|529906673|FG000|Overall Study|Sponsor requested to stop study drug|0|||
146931357|NCT02215616|529906674|FG001|Overall Study|Sponsor requested to stop study drug|0|||
146931358|NCT02215616|529906675|FG002|Overall Study|Sponsor requested to stop study drug|1|||
146931359|NCT02215616|529906676|FG003|Overall Study|Sponsor requested to stop study drug|4|||
146931360|NCT02215616|529906673|FG000|Overall Study|Death|1|||
146931361|NCT02215616|529906674|FG001|Overall Study|Death|0|||
146980917|NCT02196506|530091322|FG003|Phase A+|Participant withdrawn by investigator|1|||
146698522|NCT00994448|529076789|FG001|Overall Study|Withdrawal by Subject|1|||
146698523|NCT00994448|529076788|FG000|Overall Study|Physician Decision|1|||
146698524|NCT00994448|529076789|FG001|Overall Study|Physician Decision|0|||
146698525|NCT04164901|529076792|FG000|Overall Study|Withdrawal by Subject|4|||
146698526|NCT04164901|529076793|FG001|Overall Study|Withdrawal by Subject|4|||
146698527|NCT05358821|529076796|FG000|Overall Study|Withdrawal by Subject|0|||
146698528|NCT05358821|529076797|FG001|Overall Study|Withdrawal by Subject|1|||
146698529|NCT05358821|529076798|FG002|Overall Study|Withdrawal by Subject|0|||
146698530|NCT05358821|529076796|FG000|Overall Study|Withdrawal of Consent|0|||
146698531|NCT05358821|529076797|FG001|Overall Study|Withdrawal of Consent|0|||
146698532|NCT05358821|529076798|FG002|Overall Study|Withdrawal of Consent|1|||
146698533|NCT00048542|529076800|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
146698534|NCT00048542|529076801|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
146698535|NCT00048542|529076802|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
146698536|NCT00048542|529076803|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
146698537|NCT00048542|529076804|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
146698538|NCT00048542|529076805|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
146698539|NCT00048542|529076806|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
146698540|NCT00048542|529076807|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
146698541|NCT00048542|529076800|FG000|Double-Blind Phase|Protocol Violation|0|||
146698542|NCT00048542|529076801|FG001|Double-Blind Phase|Protocol Violation|0|||
146698543|NCT00048542|529076802|FG002|Double-Blind Phase|Protocol Violation|1|||
146980918|NCT02257632|530093678|FG000|Overall Study|Withdrawal by Subject|0|||
146980919|NCT02257632|530093679|FG001|Overall Study|Withdrawal by Subject|1|||
146698544|NCT00048542|529076803|FG003|Double-Blind Phase|Protocol Violation|0|||
146931362|NCT02215616|529906675|FG002|Overall Study|Death|0|||
146931363|NCT02215616|529906676|FG003|Overall Study|Death|0|||
146931364|NCT02215616|529906673|FG000|Overall Study|Adverse Event|7|||
146931365|NCT02215616|529906674|FG001|Overall Study|Adverse Event|4|||
146931366|NCT02215616|529906675|FG002|Overall Study|Adverse Event|9|||
146931367|NCT02215616|529906676|FG003|Overall Study|Adverse Event|2|||
146931368|NCT02215616|529906673|FG000|Overall Study|Withdrawal by Subject|1|||
146931369|NCT02215616|529906674|FG001|Overall Study|Withdrawal by Subject|8|||
146931370|NCT02215616|529906675|FG002|Overall Study|Withdrawal by Subject|2|||
146980920|NCT02257632|530093678|FG000|Overall Study|Adverse Event|1|||
146698545|NCT00048542|529076804|FG004|Double-Blind Phase|Protocol Violation|0|||
146698546|NCT00048542|529076805|FG005|Double-Blind Phase|Protocol Violation|0|||
146698547|NCT00048542|529076806|FG006|Double-Blind Phase|Protocol Violation|0|||
146980921|NCT02257632|530093679|FG001|Overall Study|Adverse Event|2|||
146980922|NCT02468557|530093680|FG000|Overall Study|Adverse Event|1|||
146980923|NCT02468557|530093680|FG000|Overall Study|Death|1|||
146980924|NCT02468557|530093680|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
146980925|NCT02468557|530093680|FG000|Overall Study|All Enrolled but Never Dosed|4|||
146980926|NCT03322462|530093684|FG000|Overall Study|Technical difficulties|2|||
146980927|NCT03322462|530093684|FG000|Overall Study|Other|1|||
146980928|NCT01393990|530093685|FG000|Overall Study|Adverse Event|0|||
146980929|NCT01393990|530093686|FG001|Overall Study|Adverse Event|0|||
146980930|NCT01393990|530093687|FG002|Overall Study|Adverse Event|0|||
146980931|NCT01393990|530093688|FG003|Overall Study|Adverse Event|0|||
146980932|NCT01393990|530093689|FG004|Overall Study|Adverse Event|0|||
146980933|NCT01393990|530093690|FG005|Overall Study|Adverse Event|0|||
146980934|NCT01393990|530093691|FG006|Overall Study|Adverse Event|0|||
146980935|NCT01393990|530093692|FG007|Overall Study|Adverse Event|0|||
146980936|NCT01393990|530093693|FG008|Overall Study|Adverse Event|0|||
146980937|NCT01393990|530093694|FG009|Overall Study|Adverse Event|0|||
146980938|NCT01393990|530093695|FG010|Overall Study|Adverse Event|0|||
146980939|NCT01393990|530093696|FG011|Overall Study|Adverse Event|0|||
146980940|NCT01393990|530093697|FG012|Overall Study|Adverse Event|0|||
146980941|NCT01393990|530093698|FG013|Overall Study|Adverse Event|0|||
146980942|NCT01393990|530093699|FG014|Overall Study|Adverse Event|1|||
146980943|NCT01393990|530093700|FG015|Overall Study|Adverse Event|1|||
146980944|NCT01393990|530093701|FG016|Overall Study|Adverse Event|0|||
146980945|NCT01393990|530093702|FG017|Overall Study|Adverse Event|0|||
146980946|NCT01393990|530093685|FG000|Overall Study|Progressive Disease|1|||
146980947|NCT01393990|530093686|FG001|Overall Study|Progressive Disease|0|||
146980948|NCT01393990|530093687|FG002|Overall Study|Progressive Disease|0|||
146980949|NCT01393990|530093688|FG003|Overall Study|Progressive Disease|1|||
146980950|NCT01393990|530093689|FG004|Overall Study|Progressive Disease|1|||
146980951|NCT01393990|530093690|FG005|Overall Study|Progressive Disease|1|||
146980952|NCT01393990|530093691|FG006|Overall Study|Progressive Disease|1|||
146980953|NCT01393990|530093692|FG007|Overall Study|Progressive Disease|1|||
146980954|NCT01393990|530093693|FG008|Overall Study|Progressive Disease|3|||
146980955|NCT01393990|530093694|FG009|Overall Study|Progressive Disease|1|||
146980956|NCT01393990|530093695|FG010|Overall Study|Progressive Disease|0|||
146980957|NCT01393990|530093696|FG011|Overall Study|Progressive Disease|0|||
146980958|NCT01393990|530093697|FG012|Overall Study|Progressive Disease|0|||
146980959|NCT01393990|530093698|FG013|Overall Study|Progressive Disease|1|||
146698548|NCT00048542|529076807|FG007|Double-Blind Phase|Protocol Violation|0|||
146698549|NCT00048542|529076800|FG000|Double-Blind Phase|Sponsor request or decision|2|||
146698550|NCT00048542|529076801|FG001|Double-Blind Phase|Sponsor request or decision|0|||
146698551|NCT00048542|529076802|FG002|Double-Blind Phase|Sponsor request or decision|0|||
146698552|NCT00048542|529076803|FG003|Double-Blind Phase|Sponsor request or decision|0|||
146698553|NCT00048542|529076804|FG004|Double-Blind Phase|Sponsor request or decision|0|||
146698554|NCT00048542|529076805|FG005|Double-Blind Phase|Sponsor request or decision|0|||
146698555|NCT00048542|529076806|FG006|Double-Blind Phase|Sponsor request or decision|0|||
146698556|NCT00048542|529076807|FG007|Double-Blind Phase|Sponsor request or decision|0|||
146698557|NCT00048542|529076800|FG000|Double-Blind Phase|Randomized in error|1|||
146698558|NCT00048542|529076801|FG001|Double-Blind Phase|Randomized in error|0|||
146698559|NCT00048542|529076802|FG002|Double-Blind Phase|Randomized in error|0|||
146698560|NCT00048542|529076803|FG003|Double-Blind Phase|Randomized in error|0|||
146698561|NCT00048542|529076804|FG004|Double-Blind Phase|Randomized in error|0|||
146698562|NCT00048542|529076805|FG005|Double-Blind Phase|Randomized in error|0|||
146698563|NCT00048542|529076806|FG006|Double-Blind Phase|Randomized in error|0|||
146698564|NCT00048542|529076807|FG007|Double-Blind Phase|Randomized in error|0|||
146698565|NCT00048542|529076800|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
146698566|NCT00048542|529076801|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
146698567|NCT00048542|529076802|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
146698568|NCT00048542|529076803|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
146698569|NCT00048542|529076804|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
146698570|NCT00048542|529076805|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
146698571|NCT00048542|529076806|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
146698572|NCT00048542|529076807|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
146698573|NCT00048542|529076800|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
146980960|NCT01393990|530093699|FG014|Overall Study|Progressive Disease|6|||
146980961|NCT01393990|530093700|FG015|Overall Study|Progressive Disease|1|||
146980962|NCT01393990|530093701|FG016|Overall Study|Progressive Disease|0|||
146980963|NCT01393990|530093702|FG017|Overall Study|Progressive Disease|0|||
146980964|NCT01393990|530093685|FG000|Overall Study|Death|0|||
146980965|NCT01393990|530093686|FG001|Overall Study|Death|0|||
146980966|NCT01393990|530093687|FG002|Overall Study|Death|0|||
146980967|NCT01393990|530093688|FG003|Overall Study|Death|0|||
146980968|NCT01393990|530093689|FG004|Overall Study|Death|1|||
146980969|NCT01393990|530093690|FG005|Overall Study|Death|0|||
146980970|NCT01393990|530093691|FG006|Overall Study|Death|0|||
146980971|NCT01393990|530093692|FG007|Overall Study|Death|0|||
146698574|NCT00048542|529076801|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
146698575|NCT00048542|529076802|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
146698576|NCT00048542|529076803|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
146698577|NCT00048542|529076804|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
146698578|NCT00048542|529076805|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
146698579|NCT00048542|529076806|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
146698580|NCT00048542|529076807|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
146698581|NCT00048542|529076800|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
146698582|NCT00048542|529076801|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
146931371|NCT02215616|529906676|FG003|Overall Study|Withdrawal by Subject|5|||
146931372|NCT02215616|529906673|FG000|Overall Study|Non-compliance|0|||
146931373|NCT02215616|529906674|FG001|Overall Study|Non-compliance|2|||
146931374|NCT02215616|529906675|FG002|Overall Study|Non-compliance|1|||
146931375|NCT02215616|529906676|FG003|Overall Study|Non-compliance|0|||
146931376|NCT02215616|529906673|FG000|Overall Study|Protocol Violation|0|||
146931377|NCT02215616|529906674|FG001|Overall Study|Protocol Violation|2|||
146931378|NCT02215616|529906675|FG002|Overall Study|Protocol Violation|0|||
146931379|NCT02215616|529906676|FG003|Overall Study|Protocol Violation|0|||
146931380|NCT02215616|529906673|FG000|Overall Study|Lost to Follow-up|1|||
146931381|NCT02215616|529906674|FG001|Overall Study|Lost to Follow-up|1|||
146931382|NCT02215616|529906675|FG002|Overall Study|Lost to Follow-up|0|||
146931383|NCT02215616|529906676|FG003|Overall Study|Lost to Follow-up|1|||
146931384|NCT02215616|529906673|FG000|Overall Study|Other than specified|1|||
146931385|NCT02215616|529906674|FG001|Overall Study|Other than specified|0|||
146931386|NCT02215616|529906675|FG002|Overall Study|Other than specified|1|||
146931387|NCT02215616|529906676|FG003|Overall Study|Other than specified|1|||
146931388|NCT04058158|529906677|FG000|Period 1|Death|1|||
146931389|NCT04058158|529906678|FG001|Period 1|Death|0|||
146698583|NCT00048542|529076802|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
146698584|NCT00048542|529076803|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
146698585|NCT00048542|529076804|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
146698586|NCT00048542|529076805|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
146698587|NCT00048542|529076806|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
146698588|NCT00048542|529076807|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
146698589|NCT00048542|529076800|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
146698590|NCT00048542|529076801|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
146698591|NCT00048542|529076802|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
146698592|NCT00048542|529076803|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
146698593|NCT00048542|529076804|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
146698594|NCT00048542|529076805|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
146698595|NCT00048542|529076806|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
146698596|NCT00048542|529076807|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
146698597|NCT00048542|529076800|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
146698598|NCT00048542|529076801|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
146698599|NCT00048542|529076802|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
146698600|NCT00048542|529076803|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
146698601|NCT00048542|529076804|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
146698602|NCT00048542|529076805|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
146698603|NCT00048542|529076806|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
146698604|NCT00048542|529076807|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
146698605|NCT00048542|529076800|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
146698606|NCT00048542|529076801|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
146698607|NCT00048542|529076802|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
146698608|NCT00048542|529076803|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
146698609|NCT00048542|529076804|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
146698610|NCT00048542|529076805|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
146698611|NCT00048542|529076806|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
146698612|NCT00048542|529076807|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
146698613|NCT00048542|529076800|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
146698614|NCT00048542|529076801|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
146698615|NCT00048542|529076802|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
146776377|NCT02791230|529353589|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
146931390|NCT04058158|529906677|FG000|Period 1|Adverse Event|1|||
146931391|NCT04058158|529906678|FG001|Period 1|Adverse Event|1|||
146931392|NCT04058158|529906677|FG000|Period 1|Pregnancy|0|||
146931393|NCT04058158|529906678|FG001|Period 1|Pregnancy|1|||
146931394|NCT01634113|529906679|FG000|Overall Study|Not treated|0|||
146931395|NCT01634113|529906680|FG001|Overall Study|Not treated|0|||
146931396|NCT01634113|529906681|FG002|Overall Study|Not treated|1|||
146931397|NCT01352845|529906684|FG000|Overall Study|Lost to Follow-up|313|||
146931398|NCT01352845|529906685|FG001|Overall Study|Lost to Follow-up|92|||
146931399|NCT01352845|529906684|FG000|Overall Study|No Longer Willing to Participate|205|||
146698616|NCT00048542|529076803|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
146698617|NCT00048542|529076804|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
146698618|NCT00048542|529076805|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
146931400|NCT01352845|529906685|FG001|Overall Study|No Longer Willing to Participate|58|||
146931401|NCT01352845|529906684|FG000|Overall Study|Withdrawal by Subject|48|||
146931402|NCT01352845|529906685|FG001|Overall Study|Withdrawal by Subject|16|||
146698619|NCT00048542|529076806|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
146698620|NCT00048542|529076807|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
146698621|NCT00048542|529076800|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
146698622|NCT00048542|529076801|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
146698623|NCT00048542|529076802|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
146931403|NCT01352845|529906684|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
146931404|NCT01352845|529906685|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
146931405|NCT01352845|529906684|FG000|Overall Study|Pregnancy|27|||
146931406|NCT01352845|529906685|FG001|Overall Study|Pregnancy|7|||
146698624|NCT00048542|529076803|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
146698625|NCT00048542|529076804|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
146698626|NCT00048542|529076805|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
146698627|NCT00048542|529076806|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
146698628|NCT00048542|529076807|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
146698629|NCT00048542|529076800|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
146698630|NCT00048542|529076801|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
146931407|NCT01352845|529906684|FG000|Overall Study|Adverse Event|22|||
146931408|NCT01352845|529906685|FG001|Overall Study|Adverse Event|6|||
146931409|NCT01352845|529906684|FG000|Overall Study|Other|17|||
146931410|NCT01352845|529906685|FG001|Overall Study|Other|7|||
146931411|NCT01352845|529906684|FG000|Overall Study|Protocol Violation|12|||
146931412|NCT01352845|529906685|FG001|Overall Study|Protocol Violation|6|||
146931413|NCT01352845|529906684|FG000|Overall Study|Death|3|||
146931414|NCT01352845|529906685|FG001|Overall Study|Death|0|||
146931415|NCT01956240|529906686|FG000|Overall Study|Lost to Follow-up|6|||
146931416|NCT01956240|529906687|FG001|Overall Study|Lost to Follow-up|20|||
146931417|NCT01956240|529906686|FG000|Overall Study|Adverse Event|17|||
146931418|NCT01956240|529906687|FG001|Overall Study|Adverse Event|4|||
146931419|NCT02759562|529906691|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
146931420|NCT02759562|529906692|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
146931421|NCT02759562|529906691|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
146931422|NCT02759562|529906692|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
146931423|NCT02293993|529906693|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
146931424|NCT02293993|529906694|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
146698631|NCT00048542|529076802|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
146698632|NCT00048542|529076803|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
146698633|NCT00048542|529076804|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
146698634|NCT00048542|529076805|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
146698635|NCT00048542|529076806|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
146698636|NCT00048542|529076807|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
146698637|NCT00048542|529076800|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
146698638|NCT00048542|529076801|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
146776378|NCT02791230|529353587|FG000|Overall Study|Study sites terminated by sponsor|1|||
146776379|NCT02791230|529353588|FG001|Overall Study|Study sites terminated by sponsor|0|||
146776380|NCT02791230|529353589|FG002|Overall Study|Study sites terminated by sponsor|5|||
146776381|NCT02791230|529353587|FG000|Overall Study|Other|9|||
146776382|NCT02791230|529353588|FG001|Overall Study|Other|1|||
146776383|NCT02791230|529353589|FG002|Overall Study|Other|28|||
146776384|NCT02791230|529353587|FG000|Overall Study|Protocol Violation|0|||
146776385|NCT02791230|529353588|FG001|Overall Study|Protocol Violation|0|||
146776386|NCT02791230|529353589|FG002|Overall Study|Protocol Violation|4|||
146776387|NCT02791230|529353587|FG000|Overall Study|Withdrawal by Subject|24|||
146776388|NCT02791230|529353588|FG001|Overall Study|Withdrawal by Subject|13|||
146776389|NCT02791230|529353589|FG002|Overall Study|Withdrawal by Subject|172|||
146776390|NCT02791230|529353587|FG000|Overall Study|Enrolled but not treated|0|||
146776391|NCT02791230|529353588|FG001|Overall Study|Enrolled but not treated|0|||
146931425|NCT02293993|529906695|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
146931426|NCT02293993|529906696|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
146931427|NCT02293993|529906693|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
146931428|NCT02293993|529906694|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
146931429|NCT02293993|529906695|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
146931430|NCT02293993|529906696|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
146931431|NCT02293993|529906693|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
146698639|NCT00048542|529076802|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
146698640|NCT00048542|529076803|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
146698641|NCT00048542|529076804|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
146698642|NCT00048542|529076805|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
146698643|NCT00048542|529076806|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
146698644|NCT00048542|529076807|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
146698645|NCT00048542|529076800|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
146698646|NCT00048542|529076801|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
146698647|NCT00048542|529076802|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
146698648|NCT00048542|529076803|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
146698649|NCT00048542|529076804|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
146698650|NCT00048542|529076805|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
146698651|NCT00048542|529076806|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
146698652|NCT00048542|529076807|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
146698653|NCT04476017|529076810|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
146698654|NCT04476017|529076811|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
146698655|NCT00846742|529076812|FG000|Overall Study|Withdrawal by Subject|1|||
146698656|NCT02775344|529076813|FG000|Overall Study|No ovarian cyst identified|3|||
146698657|NCT02775344|529076814|FG001|Overall Study|No ovarian cyst identified|2|||
146698658|NCT04098458|529076818|FG000|Overall Study|Death|1|||
146698659|NCT04098458|529076818|FG000|Overall Study|did not meet study inclusion criteria|3|||
146698660|NCT00006489|529076819|FG000|Overall Study|Adverse Event|3|||
146698661|NCT00006489|529076820|FG001|Overall Study|Adverse Event|2|||
146698662|NCT00006489|529076821|FG002|Overall Study|Adverse Event|4|||
146698663|NCT00006489|529076822|FG003|Overall Study|Adverse Event|3|||
146698664|NCT00006489|529076819|FG000|Overall Study|Withdrawal by Subject|10|||
146698665|NCT00006489|529076820|FG001|Overall Study|Withdrawal by Subject|9|||
146698666|NCT00006489|529076821|FG002|Overall Study|Withdrawal by Subject|9|||
146698667|NCT00006489|529076822|FG003|Overall Study|Withdrawal by Subject|6|||
146698668|NCT00006489|529076819|FG000|Overall Study|Scheduling Conflict|0|||
146698669|NCT00006489|529076820|FG001|Overall Study|Scheduling Conflict|3|||
146698670|NCT00006489|529076821|FG002|Overall Study|Scheduling Conflict|2|||
146698671|NCT00006489|529076822|FG003|Overall Study|Scheduling Conflict|1|||
146698672|NCT00006489|529076819|FG000|Overall Study|Death|0|||
146698673|NCT00006489|529076820|FG001|Overall Study|Death|0|||
146698674|NCT00006489|529076821|FG002|Overall Study|Death|0|||
146698675|NCT00006489|529076822|FG003|Overall Study|Death|1|||
146698676|NCT00578175|529076823|FG000|Overall Study|Adverse Event|0|||
146698677|NCT00578175|529076824|FG001|Overall Study|Adverse Event|1|||
146698678|NCT00578175|529076825|FG002|Overall Study|Adverse Event|1|||
146698679|NCT00578175|529076823|FG000|Overall Study|Other reasons|70|||
146698680|NCT00578175|529076824|FG001|Overall Study|Other reasons|42|||
146698681|NCT00578175|529076825|FG002|Overall Study|Other reasons|23|||
146698682|NCT00235872|529076826|FG000|Overall Study|Adverse Event|34|||
146698683|NCT00235872|529076826|FG000|Overall Study|Death|1|||
146698684|NCT00235872|529076826|FG000|Overall Study|Lost to Follow-up|1|||
146698685|NCT00235872|529076826|FG000|Overall Study|Withdrawal by Subject|50|||
146698686|NCT00235872|529076826|FG000|Overall Study|Administrative reason|61|||
146698687|NCT02126969|529076827|FG000|Overall Study|Withdrawal by Subject|1|||
146698688|NCT02126969|529076828|FG001|Overall Study|Withdrawal by Subject|2|||
146698689|NCT01533246|529076836|FG000|Overall Study|Adverse Event|1|||
146698690|NCT01533246|529076836|FG000|Overall Study|Withdrawal by Subject|1|||
146698691|NCT00354172|529076837|FG000|Overall Study|Did not receive transplant|1|||
146698692|NCT01800916|529076838|FG000|Test Period 1 (1 Week)|Convex product user|0|||
146698693|NCT01800916|529076839|FG001|Test Period 1 (1 Week)|Convex product user|0|||
146698694|NCT01800916|529076840|FG002|Test Period 1 (1 Week)|Convex product user|0|||
146698695|NCT01800916|529076841|FG003|Test Period 1 (1 Week)|Convex product user|1|||
146698696|NCT01800916|529076842|FG004|Test Period 1 (1 Week)|Convex product user|0|||
146698697|NCT01800916|529076843|FG005|Test Period 1 (1 Week)|Convex product user|0|||
146698698|NCT01800916|529076844|FG006|Test Period 1 (1 Week)|Convex product user|0|||
146698699|NCT01800916|529076845|FG007|Test Period 1 (1 Week)|Convex product user|0|||
146698700|NCT01800916|529076846|FG008|Test Period 1 (1 Week)|Convex product user|0|||
146698701|NCT01800916|529076838|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
146698702|NCT01800916|529076839|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
146698703|NCT01800916|529076840|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
146698704|NCT01800916|529076841|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
146698705|NCT01800916|529076842|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
146698706|NCT01800916|529076843|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
146698707|NCT01800916|529076844|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
146980972|NCT01393990|530093693|FG008|Overall Study|Death|0|||
146698708|NCT01800916|529076845|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
146698709|NCT01800916|529076846|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
146698710|NCT01461096|529076853|FG000|Overall Study|Death|3|||
146698711|NCT01461096|529076854|FG001|Overall Study|Death|6|||
146736343|NCT00787319|529206817|FG000|Overall Study|Adverse Event|3|||
146698712|NCT01461096|529076853|FG000|Overall Study|Severe debilitation, unable to continue|1|||
146698713|NCT01461096|529076854|FG001|Overall Study|Severe debilitation, unable to continue|1|||
146698714|NCT01461096|529076853|FG000|Overall Study|Subj not able to get to clinic|15|||
146698715|NCT01461096|529076854|FG001|Overall Study|Subj not able to get to clinic|13|||
146698716|NCT01461096|529076853|FG000|Overall Study|Site is closing|27|||
146698717|NCT01461096|529076854|FG001|Overall Study|Site is closing|30|||
146698718|NCT01461096|529076853|FG000|Overall Study|Withdrawal by Subject|5|||
146698719|NCT01461096|529076854|FG001|Overall Study|Withdrawal by Subject|3|||
146698720|NCT01461096|529076853|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
146698721|NCT01461096|529076854|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
146698722|NCT01461096|529076853|FG000|Overall Study|Lost to Follow-up|8|||
146698723|NCT01461096|529076854|FG001|Overall Study|Lost to Follow-up|4|||
146698724|NCT01479621|529076855|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
146698725|NCT01479621|529076856|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146698726|NCT01479621|529076857|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146698727|NCT01479621|529076858|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146698728|NCT01479621|529076859|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146698729|NCT01479621|529076860|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146698730|NCT01479621|529076861|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146698731|NCT01479621|529076855|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
146698732|NCT01479621|529076856|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146698733|NCT01479621|529076857|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146698734|NCT01479621|529076858|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146698735|NCT01479621|529076859|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146698736|NCT01479621|529076860|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146698737|NCT01479621|529076861|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146698738|NCT01479621|529076855|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
146698739|NCT01479621|529076856|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146698740|NCT01479621|529076857|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146698741|NCT01479621|529076858|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146698742|NCT01479621|529076859|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146698743|NCT01479621|529076860|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146698744|NCT01479621|529076861|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146698745|NCT01479621|529076855|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
146698746|NCT01479621|529076856|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146698747|NCT01479621|529076857|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146698748|NCT01479621|529076858|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146698749|NCT01479621|529076859|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146698750|NCT01479621|529076860|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146698751|NCT01479621|529076861|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146698752|NCT01479621|529076855|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
146698753|NCT01479621|529076856|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146698754|NCT01479621|529076857|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146698755|NCT01479621|529076858|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146698756|NCT01479621|529076859|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146698757|NCT01479621|529076860|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146698758|NCT01479621|529076861|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146776392|NCT02791230|529353589|FG002|Overall Study|Enrolled but not treated|5|||
146776393|NCT04201834|529353597|FG000|Overall Study|Screen fail|1|||
146776394|NCT04104321|529353600|FG000|Overall Study|didn't take the study drug|3|||
146776395|NCT04038957|529353601|FG000|Overall Study|Withdrawal by Subject|1|||
146776396|NCT04038957|529353601|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
146776397|NCT04065048|529353602|FG000|Overall Study|Withdrawal by Subject|1|||
146776398|NCT04065048|529353603|FG001|Overall Study|Withdrawal by Subject|2|||
146776399|NCT04065048|529353604|FG002|Overall Study|Withdrawal by Subject|1|||
146776400|NCT04065048|529353605|FG003|Overall Study|Withdrawal by Subject|1|||
146776401|NCT04065048|529353602|FG000|Overall Study|Adverse Event|1|||
146776402|NCT04065048|529353603|FG001|Overall Study|Adverse Event|0|||
146776403|NCT04065048|529353604|FG002|Overall Study|Adverse Event|1|||
146698759|NCT01479621|529076855|FG000|Treatment Period|Adverse Event|0|||
146698760|NCT01479621|529076856|FG001|Treatment Period|Adverse Event|0|||
146698761|NCT01479621|529076857|FG002|Treatment Period|Adverse Event|0|||
146698762|NCT01479621|529076858|FG003|Treatment Period|Adverse Event|0|||
146776404|NCT04065048|529353605|FG003|Overall Study|Adverse Event|0|||
146776405|NCT03554265|529353607|FG000|Overall Study|Withdrawal by Subject|2|||
146776406|NCT03554265|529353608|FG001|Overall Study|Withdrawal by Subject|2|||
146776407|NCT03554265|529353609|FG002|Overall Study|Withdrawal by Subject|3|||
146980973|NCT01393990|530093694|FG009|Overall Study|Death|0|||
146698763|NCT01479621|529076859|FG004|Treatment Period|Adverse Event|1|||
146698764|NCT01479621|529076860|FG005|Treatment Period|Adverse Event|2|||
146698765|NCT01479621|529076861|FG006|Treatment Period|Adverse Event|2|||
146698766|NCT01479621|529076855|FG000|Treatment Period|Withdrawal by Subject|0|||
146698767|NCT01479621|529076856|FG001|Treatment Period|Withdrawal by Subject|4|||
146698768|NCT01479621|529076857|FG002|Treatment Period|Withdrawal by Subject|2|||
146698769|NCT01479621|529076858|FG003|Treatment Period|Withdrawal by Subject|2|||
146698770|NCT01479621|529076859|FG004|Treatment Period|Withdrawal by Subject|5|||
146698771|NCT01479621|529076860|FG005|Treatment Period|Withdrawal by Subject|5|||
146698772|NCT01479621|529076861|FG006|Treatment Period|Withdrawal by Subject|1|||
146698773|NCT01479621|529076855|FG000|Treatment Period|Physician Decision|0|||
146698774|NCT01479621|529076856|FG001|Treatment Period|Physician Decision|0|||
146698775|NCT01479621|529076857|FG002|Treatment Period|Physician Decision|0|||
146698776|NCT01479621|529076858|FG003|Treatment Period|Physician Decision|0|||
146698777|NCT01479621|529076859|FG004|Treatment Period|Physician Decision|1|||
146698778|NCT01479621|529076860|FG005|Treatment Period|Physician Decision|1|||
146698779|NCT01479621|529076861|FG006|Treatment Period|Physician Decision|0|||
146698780|NCT01479621|529076855|FG000|Treatment Period|Non-compliance to study drug|0|||
146698781|NCT01479621|529076856|FG001|Treatment Period|Non-compliance to study drug|1|||
146698782|NCT01479621|529076857|FG002|Treatment Period|Non-compliance to study drug|0|||
146698783|NCT01479621|529076858|FG003|Treatment Period|Non-compliance to study drug|0|||
146698784|NCT01479621|529076859|FG004|Treatment Period|Non-compliance to study drug|0|||
146698785|NCT01479621|529076860|FG005|Treatment Period|Non-compliance to study drug|0|||
146698786|NCT01479621|529076861|FG006|Treatment Period|Non-compliance to study drug|1|||
146698787|NCT01479621|529076855|FG000|Treatment Period|Protocol Violation|0|||
146698788|NCT01479621|529076856|FG001|Treatment Period|Protocol Violation|9|||
146698789|NCT01479621|529076857|FG002|Treatment Period|Protocol Violation|6|||
146698790|NCT01479621|529076858|FG003|Treatment Period|Protocol Violation|5|||
146698791|NCT01479621|529076859|FG004|Treatment Period|Protocol Violation|2|||
146698792|NCT01479621|529076860|FG005|Treatment Period|Protocol Violation|10|||
146698793|NCT01479621|529076861|FG006|Treatment Period|Protocol Violation|6|||
146698794|NCT01479621|529076855|FG000|Treatment Period|Pregnancy|0|||
146698795|NCT01479621|529076856|FG001|Treatment Period|Pregnancy|0|||
146698796|NCT01479621|529076857|FG002|Treatment Period|Pregnancy|2|||
146698797|NCT01479621|529076858|FG003|Treatment Period|Pregnancy|0|||
146698798|NCT01479621|529076859|FG004|Treatment Period|Pregnancy|0|||
146698799|NCT01479621|529076860|FG005|Treatment Period|Pregnancy|0|||
146698800|NCT01479621|529076861|FG006|Treatment Period|Pregnancy|0|||
146698801|NCT01479621|529076855|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
146698802|NCT01479621|529076856|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
146698803|NCT01479621|529076857|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
146698804|NCT01479621|529076858|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
146698805|NCT01479621|529076859|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
146698806|NCT01479621|529076860|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
146698807|NCT01479621|529076861|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
146698808|NCT01479621|529076855|FG000|Treatment Period|Lost to Follow-up|0|||
146698809|NCT01479621|529076856|FG001|Treatment Period|Lost to Follow-up|0|||
146698810|NCT01479621|529076857|FG002|Treatment Period|Lost to Follow-up|1|||
146698811|NCT01479621|529076858|FG003|Treatment Period|Lost to Follow-up|0|||
146698812|NCT01479621|529076859|FG004|Treatment Period|Lost to Follow-up|2|||
146698813|NCT01479621|529076860|FG005|Treatment Period|Lost to Follow-up|2|||
146698814|NCT01479621|529076861|FG006|Treatment Period|Lost to Follow-up|1|||
146698815|NCT01479621|529076855|FG000|Treatment Period|Met stopping criteria|0|||
146698816|NCT01479621|529076856|FG001|Treatment Period|Met stopping criteria|8|||
146698817|NCT01479621|529076857|FG002|Treatment Period|Met stopping criteria|7|||
146698818|NCT01479621|529076858|FG003|Treatment Period|Met stopping criteria|4|||
146698819|NCT01479621|529076859|FG004|Treatment Period|Met stopping criteria|9|||
146698820|NCT01479621|529076860|FG005|Treatment Period|Met stopping criteria|20|||
146698821|NCT01479621|529076861|FG006|Treatment Period|Met stopping criteria|6|||
146698822|NCT04225923|529076862|FG000|Overall Study|Protocol Violation|1|||
146698823|NCT04225923|529076863|FG001|Overall Study|Protocol Violation|0|||
146698824|NCT04225923|529076864|FG002|Overall Study|Protocol Violation|1|||
146698825|NCT04225923|529076862|FG000|Overall Study|Withdrawal by Subject|4|||
146698826|NCT04225923|529076863|FG001|Overall Study|Withdrawal by Subject|1|||
146698827|NCT04225923|529076864|FG002|Overall Study|Withdrawal by Subject|3|||
146698828|NCT04225923|529076862|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
146698829|NCT04225923|529076863|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
146698830|NCT04225923|529076864|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
146698831|NCT00855309|529076865|FG000|Overall Study|patient never recieved drug|1|||
146698832|NCT00855309|529076866|FG001|Overall Study|patient never recieved drug|0|||
146698833|NCT01228747|529076871|FG000|Overall Study|Adverse Event|8|||
146698834|NCT01228747|529076872|FG001|Overall Study|Adverse Event|4|||
146698835|NCT01228747|529076871|FG000|Overall Study|Lack of Efficacy|40|||
146698836|NCT01228747|529076872|FG001|Overall Study|Lack of Efficacy|27|||
146698837|NCT01228747|529076871|FG000|Overall Study|Protocol Violation|6|||
146698838|NCT01228747|529076872|FG001|Overall Study|Protocol Violation|5|||
146698839|NCT01228747|529076871|FG000|Overall Study|Lost to Follow-up|4|||
146698840|NCT01228747|529076872|FG001|Overall Study|Lost to Follow-up|3|||
146698841|NCT01228747|529076871|FG000|Overall Study|Withdrawal by Subject|5|||
146698842|NCT01228747|529076872|FG001|Overall Study|Withdrawal by Subject|1|||
146698843|NCT01228747|529076871|FG000|Overall Study|Other Reason|2|||
146698844|NCT01228747|529076872|FG001|Overall Study|Other Reason|5|||
146698845|NCT02036502|529076873|FG000|Part 1:Dose Determination/Escalation|Death|3|||
146698846|NCT02036502|529076874|FG001|Part 1:Dose Determination/Escalation|Death|2|||
146698847|NCT02036502|529076875|FG002|Part 1:Dose Determination/Escalation|Death|0|||
146698848|NCT02036502|529076876|FG003|Part 1:Dose Determination/Escalation|Death|0|||
146698849|NCT02036502|529076877|FG004|Part 1:Dose Determination/Escalation|Death|0|||
146698850|NCT02036502|529076878|FG005|Part 1:Dose Determination/Escalation|Death|0|||
146698851|NCT02036502|529076879|FG006|Part 1:Dose Determination/Escalation|Death|0|||
146698852|NCT02036502|529076880|FG007|Part 1:Dose Determination/Escalation|Death|0|||
146698853|NCT02036502|529076873|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
146698854|NCT02036502|529076874|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
146698855|NCT02036502|529076875|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
146698856|NCT02036502|529076876|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
146698857|NCT02036502|529076877|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
146698858|NCT02036502|529076878|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
146698859|NCT02036502|529076879|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
146698860|NCT02036502|529076880|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
146698861|NCT02036502|529076873|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
146698862|NCT02036502|529076874|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
146698863|NCT02036502|529076875|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
146698864|NCT02036502|529076876|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
146698865|NCT02036502|529076877|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
146698866|NCT02036502|529076878|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
146698867|NCT02036502|529076879|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
146698868|NCT02036502|529076880|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
146698869|NCT02036502|529076873|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
146698870|NCT02036502|529076874|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
146698871|NCT02036502|529076875|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
146698872|NCT02036502|529076876|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
146698873|NCT02036502|529076877|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
146698874|NCT02036502|529076878|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
146698875|NCT02036502|529076879|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
146698876|NCT02036502|529076880|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
146698877|NCT02036502|529076873|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
146698878|NCT02036502|529076874|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
146698879|NCT02036502|529076875|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
146698880|NCT02036502|529076876|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
146698881|NCT02036502|529076877|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
146698882|NCT02036502|529076878|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
146698883|NCT02036502|529076879|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
146698884|NCT02036502|529076880|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
146698885|NCT02036502|529076873|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
146698886|NCT02036502|529076874|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
146698887|NCT02036502|529076875|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
146698888|NCT02036502|529076876|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
146698889|NCT02036502|529076877|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
146698890|NCT02036502|529076878|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
146698891|NCT02036502|529076879|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
146698892|NCT02036502|529076880|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
146698893|NCT02036502|529076873|FG000|Part 2:Dose Confirmation|Death|0|||
146698894|NCT02036502|529076874|FG001|Part 2:Dose Confirmation|Death|0|||
146698895|NCT02036502|529076875|FG002|Part 2:Dose Confirmation|Death|1|||
146698896|NCT02036502|529076876|FG003|Part 2:Dose Confirmation|Death|0|||
146698897|NCT02036502|529076877|FG004|Part 2:Dose Confirmation|Death|0|||
146698898|NCT02036502|529076878|FG005|Part 2:Dose Confirmation|Death|0|||
146698899|NCT02036502|529076879|FG006|Part 2:Dose Confirmation|Death|0|||
146698900|NCT02036502|529076880|FG007|Part 2:Dose Confirmation|Death|0|||
146698901|NCT02036502|529076873|FG000|Part 2:Dose Confirmation|Not treated|0|||
146698902|NCT02036502|529076874|FG001|Part 2:Dose Confirmation|Not treated|0|||
146698903|NCT02036502|529076875|FG002|Part 2:Dose Confirmation|Not treated|0|||
146698904|NCT02036502|529076876|FG003|Part 2:Dose Confirmation|Not treated|1|||
146698905|NCT02036502|529076877|FG004|Part 2:Dose Confirmation|Not treated|0|||
146698906|NCT02036502|529076878|FG005|Part 2:Dose Confirmation|Not treated|0|||
146698907|NCT02036502|529076879|FG006|Part 2:Dose Confirmation|Not treated|0|||
146698908|NCT02036502|529076880|FG007|Part 2:Dose Confirmation|Not treated|0|||
146698909|NCT02036502|529076873|FG000|Part 3:Dose Expansion|Adverse Event|0|||
146698910|NCT02036502|529076874|FG001|Part 3:Dose Expansion|Adverse Event|0|||
146698911|NCT02036502|529076875|FG002|Part 3:Dose Expansion|Adverse Event|0|||
146698912|NCT02036502|529076876|FG003|Part 3:Dose Expansion|Adverse Event|0|||
146698913|NCT02036502|529076877|FG004|Part 3:Dose Expansion|Adverse Event|0|||
146698914|NCT02036502|529076878|FG005|Part 3:Dose Expansion|Adverse Event|4|||
146698915|NCT02036502|529076879|FG006|Part 3:Dose Expansion|Adverse Event|0|||
146698916|NCT02036502|529076880|FG007|Part 3:Dose Expansion|Adverse Event|2|||
146698917|NCT02036502|529076873|FG000|Part 3:Dose Expansion|Death|0|||
146698918|NCT02036502|529076874|FG001|Part 3:Dose Expansion|Death|0|||
146698919|NCT02036502|529076875|FG002|Part 3:Dose Expansion|Death|0|||
146698920|NCT02036502|529076876|FG003|Part 3:Dose Expansion|Death|0|||
146698921|NCT02036502|529076877|FG004|Part 3:Dose Expansion|Death|0|||
146776408|NCT03554265|529353607|FG000|Overall Study|Physician Decision|0|||
146931432|NCT02293993|529906694|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
146931433|NCT02293993|529906695|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
146931434|NCT02293993|529906696|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
146931435|NCT02293993|529906693|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
146931436|NCT02293993|529906694|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
146931437|NCT02293993|529906695|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
146931438|NCT02293993|529906696|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
146931439|NCT02293993|529906693|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
146931440|NCT02293993|529906694|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
146931441|NCT02293993|529906695|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
146931442|NCT02293993|529906696|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
146931443|NCT01957709|529906697|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
146931444|NCT03587584|529906698|FG000|Overall Study|SOC deviations|4|||
146931445|NCT03587584|529906699|FG001|Overall Study|SOC deviations|6|||
146931446|NCT03587584|529906698|FG000|Overall Study|Incomplete data|0|||
146931447|NCT03587584|529906699|FG001|Overall Study|Incomplete data|3|||
146931448|NCT03115112|529906707|FG000|Overall Study|Adverse Event|5|||
146931449|NCT03115112|529906708|FG001|Overall Study|Adverse Event|1|||
146931450|NCT03115112|529906707|FG000|Overall Study|Withdrawal by Subject|4|||
146931451|NCT03115112|529906708|FG001|Overall Study|Withdrawal by Subject|2|||
146931452|NCT03115112|529906707|FG000|Overall Study|Lost to Follow-up|0|||
146931453|NCT03115112|529906708|FG001|Overall Study|Lost to Follow-up|1|||
146931454|NCT03115112|529906707|FG000|Overall Study|Death|1|||
146931455|NCT03115112|529906708|FG001|Overall Study|Death|0|||
146931456|NCT03115112|529906707|FG000|Overall Study|Pregnancy|1|||
146931457|NCT03115112|529906708|FG001|Overall Study|Pregnancy|0|||
146931458|NCT03115112|529906707|FG000|Overall Study|Site closure|1|||
146931459|NCT03115112|529906708|FG001|Overall Study|Site closure|1|||
146931460|NCT01170702|529906716|FG000|Overall Study|Exclusion criteria met after consent|1|||
146931461|NCT01170702|529906717|FG001|Overall Study|Exclusion criteria met after consent|2|||
146931462|NCT01170702|529906718|FG002|Overall Study|Exclusion criteria met after consent|0|||
146931463|NCT01170702|529906719|FG003|Overall Study|Exclusion criteria met after consent|2|||
146931464|NCT00098020|529906722|FG000|Overall Study|Adverse Event|2|||
146931465|NCT00098020|529906722|FG000|Overall Study|Lost to Follow-up|1|||
146931466|NCT00098020|529906722|FG000|Overall Study|elevated liver enzymes|1|||
146931467|NCT00098020|529906722|FG000|Overall Study|Low urine PCR|1|||
146931468|NCT00098020|529906722|FG000|Overall Study|Low epidermal growth factor receptor|1|||
146931469|NCT01453998|529906723|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
146931470|NCT01453998|529906724|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
146931471|NCT01453998|529906725|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
146931472|NCT00712933|529906728|FG000|Overall Study|Adverse Event|69|||
146931473|NCT00712933|529906728|FG000|Overall Study|Lack of Efficacy|6|||
146931474|NCT00712933|529906728|FG000|Overall Study|Lost to Follow-up|22|||
146931475|NCT00712933|529906728|FG000|Overall Study|Non-compliance with study drug|13|||
146931476|NCT00712933|529906728|FG000|Overall Study|Other Pregnancy|37|||
146931477|NCT00712933|529906728|FG000|Overall Study|Sponsor decision|14|||
146931478|NCT00712933|529906728|FG000|Overall Study|Withdrew consent|4|||
146931479|NCT00712933|529906728|FG000|Overall Study|Hip replacement surgery|1|||
146931480|NCT00712933|529906728|FG000|Overall Study|Involved in Clinical research|3|||
146931481|NCT00712933|529906728|FG000|Overall Study|Participant hospitalized|1|||
146931482|NCT00712933|529906728|FG000|Overall Study|Participant travelled overseas|2|||
146931483|NCT00712933|529906728|FG000|Overall Study|Death of patient|1|||
146931484|NCT00712933|529906728|FG000|Overall Study|Other Physician decision|1|||
146931485|NCT00712933|529906728|FG000|Overall Study|Not committed to contraception|1|||
146698922|NCT02036502|529076878|FG005|Part 3:Dose Expansion|Death|24|||
146698923|NCT02036502|529076879|FG006|Part 3:Dose Expansion|Death|0|||
146698924|NCT02036502|529076880|FG007|Part 3:Dose Expansion|Death|3|||
146698925|NCT02036502|529076873|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
146698926|NCT02036502|529076874|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
146698927|NCT02036502|529076875|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
146698928|NCT02036502|529076876|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
146698929|NCT02036502|529076877|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
146698930|NCT02036502|529076878|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
146698931|NCT02036502|529076879|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
146698932|NCT02036502|529076880|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
146698933|NCT02036502|529076873|FG000|Part 3:Dose Expansion|Physician Decision|0|||
146698934|NCT02036502|529076874|FG001|Part 3:Dose Expansion|Physician Decision|0|||
146698935|NCT02036502|529076875|FG002|Part 3:Dose Expansion|Physician Decision|0|||
146698936|NCT02036502|529076876|FG003|Part 3:Dose Expansion|Physician Decision|0|||
146698937|NCT02036502|529076877|FG004|Part 3:Dose Expansion|Physician Decision|0|||
146698938|NCT02036502|529076878|FG005|Part 3:Dose Expansion|Physician Decision|1|||
146698939|NCT02036502|529076879|FG006|Part 3:Dose Expansion|Physician Decision|0|||
146698940|NCT02036502|529076880|FG007|Part 3:Dose Expansion|Physician Decision|0|||
146698941|NCT02036502|529076873|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
146698942|NCT02036502|529076874|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
146698943|NCT02036502|529076875|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
146698944|NCT02036502|529076876|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
146698945|NCT02036502|529076877|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
146698946|NCT02036502|529076878|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
146698947|NCT02036502|529076879|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
146698948|NCT02036502|529076880|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
146698949|NCT02036502|529076873|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
146698950|NCT02036502|529076874|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
146698951|NCT02036502|529076875|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
146698952|NCT02036502|529076876|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
146698953|NCT02036502|529076877|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
146698954|NCT02036502|529076878|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
146698955|NCT02036502|529076879|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
146698956|NCT02036502|529076880|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
146698957|NCT02036502|529076873|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
146698958|NCT02036502|529076874|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
146698959|NCT02036502|529076875|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
146698960|NCT02036502|529076876|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
146698961|NCT02036502|529076877|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
146698962|NCT02036502|529076878|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
146698963|NCT02036502|529076879|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
146698964|NCT02036502|529076880|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
146698965|NCT02036502|529076873|FG000|Part 3:Dose Expansion|Not Treated|0|||
146698966|NCT02036502|529076874|FG001|Part 3:Dose Expansion|Not Treated|0|||
146698967|NCT02036502|529076875|FG002|Part 3:Dose Expansion|Not Treated|0|||
146698968|NCT02036502|529076876|FG003|Part 3:Dose Expansion|Not Treated|0|||
146698969|NCT02036502|529076877|FG004|Part 3:Dose Expansion|Not Treated|0|||
146698970|NCT02036502|529076878|FG005|Part 3:Dose Expansion|Not Treated|2|||
146698971|NCT02036502|529076879|FG006|Part 3:Dose Expansion|Not Treated|0|||
146698972|NCT02036502|529076880|FG007|Part 3:Dose Expansion|Not Treated|0|||
146698973|NCT01068509|529076883|FG000|Overall Study|Death|0|||
146698974|NCT01068509|529076884|FG001|Overall Study|Death|0|||
146698975|NCT01068509|529076885|FG002|Overall Study|Death|1|||
146698976|NCT01068509|529076883|FG000|Overall Study|Disease Progression|5|||
146698977|NCT01068509|529076884|FG001|Overall Study|Disease Progression|20|||
146698978|NCT01068509|529076885|FG002|Overall Study|Disease Progression|18|||
146698979|NCT01068509|529076883|FG000|Overall Study|Lost to Follow-up|1|||
146698980|NCT01068509|529076884|FG001|Overall Study|Lost to Follow-up|0|||
146698981|NCT01068509|529076885|FG002|Overall Study|Lost to Follow-up|0|||
146698982|NCT01068509|529076883|FG000|Overall Study|Withdrew Consent|0|||
146698983|NCT01068509|529076884|FG001|Overall Study|Withdrew Consent|1|||
146698984|NCT01068509|529076885|FG002|Overall Study|Withdrew Consent|2|||
146698985|NCT01068509|529076883|FG000|Overall Study|Reason Not Specified|0|||
146698986|NCT01068509|529076884|FG001|Overall Study|Reason Not Specified|1|||
146698987|NCT01068509|529076885|FG002|Overall Study|Reason Not Specified|0|||
146698988|NCT01165138|529076890|FG000|Overall Study|Adverse Event|0|||
146698989|NCT01165138|529076891|FG001|Overall Study|Adverse Event|1|||
146698990|NCT01165138|529076892|FG002|Overall Study|Adverse Event|0|||
146698991|NCT01165138|529076893|FG003|Overall Study|Adverse Event|2|||
146698992|NCT01165138|529076890|FG000|Overall Study|Lack of Efficacy|0|||
146698993|NCT01165138|529076891|FG001|Overall Study|Lack of Efficacy|32|||
146698994|NCT01165138|529076892|FG002|Overall Study|Lack of Efficacy|6|||
146698995|NCT01165138|529076893|FG003|Overall Study|Lack of Efficacy|7|||
146698996|NCT01165138|529076890|FG000|Overall Study|Protocol Violation|0|||
146698997|NCT01165138|529076891|FG001|Overall Study|Protocol Violation|7|||
146698998|NCT01165138|529076892|FG002|Overall Study|Protocol Violation|0|||
146931486|NCT00712933|529906728|FG000|Overall Study|Participant received medication|1|||
146931487|NCT00712933|529906728|FG000|Overall Study|Physician Decision|36|||
146931488|NCT00712933|529906728|FG000|Overall Study|Protocol Violation|4|||
146931489|NCT00712933|529906728|FG000|Overall Study|Withdrawal by Subject|151|||
146931490|NCT01879319|529906731|FG000|Overall Study|Withdrawal by Subject|1|||
146931491|NCT01879319|529906732|FG001|Overall Study|Withdrawal by Subject|0|||
146931492|NCT01879319|529906731|FG000|Overall Study|Lost to Follow-up|1|||
146931493|NCT01879319|529906732|FG001|Overall Study|Lost to Follow-up|5|||
146931494|NCT00589979|529906734|FG000|Run-In Period|Adverse Event|5|||
146931495|NCT00589979|529906735|FG001|Run-In Period|Adverse Event|0|||
146931496|NCT00589979|529906736|FG002|Run-In Period|Adverse Event|0|||
146931497|NCT00589979|529906734|FG000|Run-In Period|Protocol Violation|3|||
146931498|NCT00589979|529906735|FG001|Run-In Period|Protocol Violation|0|||
146931499|NCT00589979|529906736|FG002|Run-In Period|Protocol Violation|0|||
146931500|NCT00589979|529906734|FG000|Run-In Period|Did not qualify for randomization|54|||
146931501|NCT00589979|529906735|FG001|Run-In Period|Did not qualify for randomization|0|||
146931502|NCT00589979|529906736|FG002|Run-In Period|Did not qualify for randomization|0|||
146931503|NCT00589979|529906734|FG000|Run-In Period|Withdrawal by Subject|10|||
146931504|NCT00589979|529906735|FG001|Run-In Period|Withdrawal by Subject|0|||
146931505|NCT00589979|529906736|FG002|Run-In Period|Withdrawal by Subject|0|||
146931506|NCT00589979|529906734|FG000|Run-In Period|Informed Consent Withdrawn|4|||
146931507|NCT00589979|529906735|FG001|Run-In Period|Informed Consent Withdrawn|0|||
146931508|NCT00589979|529906736|FG002|Run-In Period|Informed Consent Withdrawn|0|||
146931509|NCT00589979|529906734|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
146931510|NCT00589979|529906735|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
146931511|NCT00589979|529906736|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
146931512|NCT00589979|529906734|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
146931513|NCT00589979|529906735|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
146931514|NCT00589979|529906736|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
146931515|NCT00589979|529906734|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
146931516|NCT00589979|529906735|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
146931517|NCT00589979|529906736|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
146931518|NCT00589979|529906734|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
146931519|NCT00589979|529906735|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
146931520|NCT00589979|529906736|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
146931521|NCT00589979|529906734|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
146931522|NCT00589979|529906735|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
146931523|NCT00589979|529906736|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
146931524|NCT00589979|529906734|FG000|Double-Blind Treatment Period 2|Other|0|||
146931525|NCT00589979|529906735|FG001|Double-Blind Treatment Period 2|Other|0|||
146931526|NCT00589979|529906736|FG002|Double-Blind Treatment Period 2|Other|1|||
146931527|NCT00589979|529906734|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
146931528|NCT00589979|529906735|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
146931529|NCT00589979|529906736|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
146931530|NCT00589979|529906734|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
146931531|NCT00589979|529906735|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
146931532|NCT00589979|529906736|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
146931533|NCT00239837|529906740|FG000|Overall Study|Lost to Follow-up|3|||
146931534|NCT00239837|529906741|FG001|Overall Study|Lost to Follow-up|7|||
146980974|NCT01393990|530093695|FG010|Overall Study|Death|0|||
146980975|NCT01393990|530093696|FG011|Overall Study|Death|0|||
146980976|NCT01393990|530093697|FG012|Overall Study|Death|0|||
146980977|NCT01393990|530093698|FG013|Overall Study|Death|1|||
146980978|NCT01393990|530093699|FG014|Overall Study|Death|1|||
146980979|NCT01393990|530093700|FG015|Overall Study|Death|0|||
146980980|NCT01393990|530093701|FG016|Overall Study|Death|0|||
146980981|NCT01393990|530093702|FG017|Overall Study|Death|0|||
146698999|NCT01165138|529076893|FG003|Overall Study|Protocol Violation|2|||
146931535|NCT01838590|529906742|FG000|Overall Study|Lack of Efficacy|12|||
146931536|NCT01838590|529906743|FG001|Overall Study|Lack of Efficacy|4|||
146931537|NCT01838590|529906742|FG000|Overall Study|Lost to Follow-up|0|||
146931538|NCT01838590|529906743|FG001|Overall Study|Lost to Follow-up|1|||
146931539|NCT00536978|529906744|FG000|Overall Study|Not eligible for Adback Infusion|22|||
146931540|NCT00622869|529906748|FG000|Overall Study|Subject Withdrew Consent|13|||
146931541|NCT00622869|529906749|FG001|Overall Study|Subject Withdrew Consent|17|||
146931542|NCT00622869|529906750|FG002|Overall Study|Subject Withdrew Consent|11|||
146931543|NCT00622869|529906748|FG000|Overall Study|Administrative Problems|11|||
146931544|NCT00622869|529906749|FG001|Overall Study|Administrative Problems|17|||
146931545|NCT00622869|529906750|FG002|Overall Study|Administrative Problems|13|||
146931546|NCT00622869|529906748|FG000|Overall Study|Death|12|||
146931547|NCT00622869|529906749|FG001|Overall Study|Death|15|||
146931548|NCT00622869|529906750|FG002|Overall Study|Death|10|||
146980982|NCT01393990|530093685|FG000|Overall Study|Withdrawal by Subject|0|||
146980983|NCT01393990|530093686|FG001|Overall Study|Withdrawal by Subject|0|||
146980984|NCT01393990|530093687|FG002|Overall Study|Withdrawal by Subject|0|||
146931549|NCT00622869|529906748|FG000|Overall Study|Lost to Follow-up|2|||
146931550|NCT00622869|529906749|FG001|Overall Study|Lost to Follow-up|4|||
146931551|NCT00622869|529906750|FG002|Overall Study|Lost to Follow-up|2|||
146931552|NCT00622869|529906748|FG000|Overall Study|Graft Loss|5|||
146931553|NCT00622869|529906749|FG001|Overall Study|Graft Loss|3|||
146931554|NCT00622869|529906750|FG002|Overall Study|Graft Loss|2|||
146931555|NCT00622869|529906748|FG000|Overall Study|Missing|0|||
146931556|NCT00622869|529906749|FG001|Overall Study|Missing|1|||
146931557|NCT00622869|529906750|FG002|Overall Study|Missing|1|||
146931558|NCT04664855|529906751|FG000|Overall Study|Withdrawal by Subject|0|||
146931559|NCT04664855|529906752|FG001|Overall Study|Withdrawal by Subject|2|||
146931560|NCT03076190|529906754|FG000|Overall Study|Lost to Follow-up|9|||
146931561|NCT03076190|529906755|FG001|Overall Study|Lost to Follow-up|34|||
146931562|NCT03076190|529906754|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
146931563|NCT03076190|529906755|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
146931564|NCT00393913|529906757|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
146931565|NCT00393913|529906757|FG000|Initial Assessment|Withdrawal by Subject|16|||
146931566|NCT00393913|529906757|FG000|CPAP|Withdrawal by Subject|3|||
146931567|NCT00393913|529906757|FG000|CPAP|Physician Decision|1|||
146931568|NCT00393913|529906757|FG000|CPAP|TEchnical problem with CPAP|3|||
146931569|NCT01518244|529906758|FG000|Overall Study|Adverse Event|3|||
146931570|NCT00870818|529906759|FG000|Overall Study|Lost to Follow-up|3|||
146931571|NCT00870818|529906760|FG001|Overall Study|Lost to Follow-up|2|||
146931572|NCT00870818|529906761|FG002|Overall Study|Lost to Follow-up|1|||
146931573|NCT00870818|529906762|FG003|Overall Study|Lost to Follow-up|0|||
146931574|NCT00870818|529906763|FG004|Overall Study|Lost to Follow-up|0|||
146931575|NCT00870818|529906759|FG000|Overall Study|Withdrawal by Subject|0|||
146931576|NCT00870818|529906760|FG001|Overall Study|Withdrawal by Subject|0|||
146931577|NCT00870818|529906761|FG002|Overall Study|Withdrawal by Subject|1|||
146931578|NCT00870818|529906762|FG003|Overall Study|Withdrawal by Subject|2|||
146931579|NCT00870818|529906763|FG004|Overall Study|Withdrawal by Subject|0|||
146931580|NCT00870818|529906759|FG000|Overall Study|Terminated by sponsor|29|||
146931581|NCT00870818|529906760|FG001|Overall Study|Terminated by sponsor|70|||
146931582|NCT00870818|529906761|FG002|Overall Study|Terminated by sponsor|36|||
146931583|NCT00870818|529906762|FG003|Overall Study|Terminated by sponsor|36|||
146931584|NCT00870818|529906763|FG004|Overall Study|Terminated by sponsor|38|||
146931585|NCT00870818|529906759|FG000|Overall Study|Other|0|||
146931586|NCT00870818|529906760|FG001|Overall Study|Other|1|||
146931587|NCT00870818|529906761|FG002|Overall Study|Other|0|||
146931588|NCT00870818|529906762|FG003|Overall Study|Other|0|||
146931589|NCT00870818|529906763|FG004|Overall Study|Other|0|||
146931590|NCT04900038|529906764|FG000|Overall Study|Adverse Event|1|||
146931591|NCT04900038|529906765|FG001|Overall Study|Adverse Event|0|||
146931592|NCT04900038|529906766|FG002|Overall Study|Adverse Event|1|||
146931593|NCT04900038|529906767|FG003|Overall Study|Adverse Event|1|||
146931594|NCT04900038|529906764|FG000|Overall Study|Withdrawal by Subject|0|||
146931595|NCT04900038|529906765|FG001|Overall Study|Withdrawal by Subject|1|||
146931596|NCT04900038|529906766|FG002|Overall Study|Withdrawal by Subject|0|||
146931597|NCT04900038|529906767|FG003|Overall Study|Withdrawal by Subject|0|||
146931598|NCT04900038|529906764|FG000|Overall Study|Study terminated by sponsor|18|||
146776409|NCT03554265|529353608|FG001|Overall Study|Physician Decision|0|||
146776410|NCT03554265|529353609|FG002|Overall Study|Physician Decision|1|||
146931599|NCT04900038|529906765|FG001|Overall Study|Study terminated by sponsor|15|||
146931600|NCT04900038|529906766|FG002|Overall Study|Study terminated by sponsor|17|||
146931601|NCT04900038|529906767|FG003|Overall Study|Study terminated by sponsor|14|||
146931602|NCT04900038|529906764|FG000|Overall Study|Protocol Deviation|1|||
146931603|NCT04900038|529906765|FG001|Overall Study|Protocol Deviation|1|||
146931604|NCT04900038|529906766|FG002|Overall Study|Protocol Deviation|0|||
146931605|NCT04900038|529906767|FG003|Overall Study|Protocol Deviation|0|||
146931606|NCT04900038|529906764|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
146931607|NCT04900038|529906765|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
146931608|NCT04900038|529906766|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
146931609|NCT04900038|529906767|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
146931610|NCT04900038|529906764|FG000|Overall Study|Lost to Follow-up|0|||
146931611|NCT04900038|529906765|FG001|Overall Study|Lost to Follow-up|0|||
146931612|NCT04900038|529906766|FG002|Overall Study|Lost to Follow-up|0|||
146931613|NCT04900038|529906767|FG003|Overall Study|Lost to Follow-up|1|||
146931614|NCT04093258|529906771|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
146931615|NCT04093258|529906772|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
146931616|NCT00986427|529906773|FG000|Overall Study|Lost to Follow-up|2|||
146931617|NCT00986427|529906774|FG001|Overall Study|Lost to Follow-up|0|||
146931618|NCT00986427|529906773|FG000|Overall Study|Lack of Efficacy|1|||
146931619|NCT00986427|529906774|FG001|Overall Study|Lack of Efficacy|0|||
146931620|NCT00986427|529906773|FG000|Overall Study|Withdrawal by Subject|1|||
146931621|NCT00986427|529906774|FG001|Overall Study|Withdrawal by Subject|0|||
146931622|NCT02109744|529908102|FG000|Overall Study|Death|1|||
146931623|NCT02109744|529908103|FG001|Overall Study|Death|1|||
146931624|NCT02109744|529908102|FG000|Overall Study|no marrow exam|1|||
146699000|NCT01165138|529076890|FG000|Overall Study|Lost to Follow-up|0|||
146699001|NCT01165138|529076891|FG001|Overall Study|Lost to Follow-up|0|||
146699002|NCT01165138|529076892|FG002|Overall Study|Lost to Follow-up|1|||
146699003|NCT01165138|529076893|FG003|Overall Study|Lost to Follow-up|2|||
146699004|NCT01165138|529076890|FG000|Overall Study|Physician Decision|0|||
146699005|NCT01165138|529076891|FG001|Overall Study|Physician Decision|6|||
146699006|NCT01165138|529076892|FG002|Overall Study|Physician Decision|7|||
146699007|NCT01165138|529076893|FG003|Overall Study|Physician Decision|6|||
146699008|NCT01165138|529076890|FG000|Overall Study|Withdrawal by Subject|0|||
146699009|NCT01165138|529076891|FG001|Overall Study|Withdrawal by Subject|6|||
146699010|NCT01165138|529076892|FG002|Overall Study|Withdrawal by Subject|6|||
146699011|NCT01165138|529076893|FG003|Overall Study|Withdrawal by Subject|3|||
146699012|NCT02641379|529076894|FG000|Overall Study|Exclusion criterion during screening|1|||
146699013|NCT02641379|529076895|FG001|Overall Study|Exclusion criterion during screening|0|||
146699014|NCT02641379|529076896|FG002|Overall Study|Exclusion criterion during screening|0|||
146699015|NCT02641379|529076897|FG003|Overall Study|Exclusion criterion during screening|1|||
146699016|NCT02641379|529076898|FG004|Overall Study|Exclusion criterion during screening|2|||
146699017|NCT02641379|529076899|FG005|Overall Study|Exclusion criterion during screening|0|||
146699018|NCT02641379|529076900|FG006|Overall Study|Exclusion criterion during screening|0|||
146699019|NCT02641379|529076901|FG007|Overall Study|Exclusion criterion during screening|0|||
146699020|NCT02641379|529076902|FG008|Overall Study|Exclusion criterion during screening|0|||
146699021|NCT02641379|529076903|FG009|Overall Study|Exclusion criterion during screening|0|||
146699022|NCT02641379|529076904|FG010|Overall Study|Exclusion criterion during screening|0|||
146699023|NCT02641379|529076894|FG000|Overall Study|Withdrawal of informed consent|0|||
146699024|NCT02641379|529076895|FG001|Overall Study|Withdrawal of informed consent|1|||
146699025|NCT02641379|529076896|FG002|Overall Study|Withdrawal of informed consent|0|||
146699026|NCT02641379|529076897|FG003|Overall Study|Withdrawal of informed consent|0|||
146699027|NCT02641379|529076898|FG004|Overall Study|Withdrawal of informed consent|0|||
146699028|NCT02641379|529076899|FG005|Overall Study|Withdrawal of informed consent|0|||
146699029|NCT02641379|529076900|FG006|Overall Study|Withdrawal of informed consent|0|||
146699030|NCT02641379|529076901|FG007|Overall Study|Withdrawal of informed consent|1|||
146699031|NCT02641379|529076902|FG008|Overall Study|Withdrawal of informed consent|0|||
146699032|NCT02641379|529076903|FG009|Overall Study|Withdrawal of informed consent|0|||
146699033|NCT02641379|529076904|FG010|Overall Study|Withdrawal of informed consent|0|||
146699034|NCT02641379|529076894|FG000|Overall Study|Adverse Event|7|||
146699035|NCT02641379|529076895|FG001|Overall Study|Adverse Event|8|||
146699036|NCT02641379|529076896|FG002|Overall Study|Adverse Event|2|||
146699037|NCT02641379|529076897|FG003|Overall Study|Adverse Event|2|||
146699038|NCT02641379|529076898|FG004|Overall Study|Adverse Event|5|||
146699039|NCT02641379|529076899|FG005|Overall Study|Adverse Event|1|||
146699040|NCT02641379|529076900|FG006|Overall Study|Adverse Event|5|||
146699041|NCT02641379|529076901|FG007|Overall Study|Adverse Event|0|||
146699042|NCT02641379|529076902|FG008|Overall Study|Adverse Event|1|||
146699043|NCT02641379|529076903|FG009|Overall Study|Adverse Event|1|||
146699044|NCT02641379|529076904|FG010|Overall Study|Adverse Event|5|||
146699045|NCT02641379|529076894|FG000|Overall Study|Lack of Efficacy|0|||
146699046|NCT02641379|529076895|FG001|Overall Study|Lack of Efficacy|0|||
146699047|NCT02641379|529076896|FG002|Overall Study|Lack of Efficacy|2|||
146699048|NCT02641379|529076897|FG003|Overall Study|Lack of Efficacy|0|||
146931625|NCT02109744|529908103|FG001|Overall Study|no marrow exam|0|||
146931626|NCT04095442|529908104|FG000|Overall Study|Lost to Follow-up|0|||
146931627|NCT04095442|529908105|FG001|Overall Study|Lost to Follow-up|1|||
146931628|NCT04095442|529908104|FG000|Overall Study|Screen failure|1|||
146931629|NCT04095442|529908105|FG001|Overall Study|Screen failure|0|||
146699049|NCT02641379|529076898|FG004|Overall Study|Lack of Efficacy|0|||
146699050|NCT02641379|529076899|FG005|Overall Study|Lack of Efficacy|2|||
146699051|NCT02641379|529076900|FG006|Overall Study|Lack of Efficacy|0|||
146699052|NCT02641379|529076901|FG007|Overall Study|Lack of Efficacy|5|||
146699053|NCT02641379|529076902|FG008|Overall Study|Lack of Efficacy|0|||
146699054|NCT02641379|529076903|FG009|Overall Study|Lack of Efficacy|0|||
146776411|NCT02652260|529353610|FG000|Base Study|Pregnancy|0|||
146776412|NCT02652260|529353611|FG001|Base Study|Pregnancy|1|||
146776413|NCT02652260|529353610|FG000|Base Study|Withdrawal by Subject|0|||
146931630|NCT01677624|529908106|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
146931631|NCT03097614|529908110|FG000|Overall Study|Adverse Event|3|||
146931632|NCT00520299|529908111|FG000|Overall Study|Withdrawal by Subject|0|||
146699055|NCT02641379|529076904|FG010|Overall Study|Lack of Efficacy|0|||
146699056|NCT02641379|529076894|FG000|Overall Study|Participant unable to attend study visit|4|||
146699057|NCT02641379|529076895|FG001|Overall Study|Participant unable to attend study visit|10|||
146699058|NCT02641379|529076896|FG002|Overall Study|Participant unable to attend study visit|1|||
146699059|NCT02641379|529076897|FG003|Overall Study|Participant unable to attend study visit|2|||
146699060|NCT02641379|529076898|FG004|Overall Study|Participant unable to attend study visit|5|||
146699061|NCT02641379|529076899|FG005|Overall Study|Participant unable to attend study visit|1|||
146699062|NCT02641379|529076900|FG006|Overall Study|Participant unable to attend study visit|1|||
146776414|NCT02652260|529353611|FG001|Base Study|Withdrawal by Subject|1|||
146931633|NCT00520299|529908112|FG001|Overall Study|Withdrawal by Subject|0|||
146931634|NCT00520299|529908113|FG002|Overall Study|Withdrawal by Subject|2|||
146931635|NCT00520299|529908111|FG000|Overall Study|Progressive disease|0|||
146931636|NCT00520299|529908112|FG001|Overall Study|Progressive disease|3|||
146931637|NCT00520299|529908113|FG002|Overall Study|Progressive disease|4|||
146931638|NCT02310906|529908114|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
146931639|NCT02310906|529908115|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
146931640|NCT02310906|529908116|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
146931641|NCT02310906|529908117|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
146931642|NCT02310906|529908114|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
146931643|NCT02310906|529908115|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
146931644|NCT02310906|529908116|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
146931645|NCT02310906|529908117|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
146931646|NCT02310906|529908114|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
146931647|NCT02310906|529908115|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
146931648|NCT02310906|529908116|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
146931649|NCT02310906|529908117|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
146931650|NCT02310906|529908114|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
146931651|NCT02310906|529908115|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
146931652|NCT02310906|529908116|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
146931653|NCT02310906|529908117|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
146931654|NCT03819218|529908120|FG000|Overall Study|Protocol Violation|1|||
146931655|NCT00433446|529908121|FG000|Overall Study|Adverse Event|4|||
146931656|NCT00433446|529908121|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
146931657|NCT00433446|529908121|FG000|Overall Study|Progression|44|||
146931658|NCT00433446|529908121|FG000|Overall Study|Other - Not Protocol specified|3|||
146931659|NCT00433446|529908121|FG000|Overall Study|Ineligible|9|||
146931660|NCT01188538|529908122|FG000|Overall Study|Lost to Follow-up|0|||
146931661|NCT01188538|529908123|FG001|Overall Study|Lost to Follow-up|1|||
146931662|NCT02267278|529908124|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
146931663|NCT02267278|529908124|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
146931664|NCT02267278|529908124|FG000|Overall Study|Developed new cancer diagnoses|2|||
146931665|NCT02267278|529908124|FG000|Overall Study|prescribed prohibited medication|1|||
146931666|NCT02513771|529908125|FG000|Overall Study|Lost to Follow-up|1|||
146931667|NCT02513771|529908126|FG001|Overall Study|Lost to Follow-up|1|||
146931668|NCT02513771|529908125|FG000|Overall Study|Not being able to get to clinic|1|||
146931669|NCT02513771|529908126|FG001|Overall Study|Not being able to get to clinic|0|||
146931670|NCT01797445|529908127|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
146931671|NCT01797445|529908128|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
146931672|NCT01797445|529908127|FG000|Double-Blind Phase|Adverse Event|3|||
146931673|NCT01797445|529908128|FG001|Double-Blind Phase|Adverse Event|0|||
146931674|NCT01797445|529908127|FG000|Double-Blind Phase|Death|5|||
146931675|NCT01797445|529908128|FG001|Double-Blind Phase|Death|4|||
146931676|NCT01797445|529908127|FG000|Double-Blind Phase|Pregnancy|0|||
146931677|NCT01797445|529908128|FG001|Double-Blind Phase|Pregnancy|1|||
146931678|NCT01797445|529908127|FG000|Double-Blind Phase|Lack of Efficacy|1|||
146931679|NCT01797445|529908128|FG001|Double-Blind Phase|Lack of Efficacy|2|||
146931680|NCT01797445|529908127|FG000|Double-Blind Phase|Investigator's Discretion|15|||
146931681|NCT01797445|529908128|FG001|Double-Blind Phase|Investigator's Discretion|17|||
146931682|NCT01797445|529908127|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
146980985|NCT01393990|530093688|FG003|Overall Study|Withdrawal by Subject|0|||
146980986|NCT01393990|530093689|FG004|Overall Study|Withdrawal by Subject|0|||
146980987|NCT01393990|530093690|FG005|Overall Study|Withdrawal by Subject|0|||
146699063|NCT02641379|529076901|FG007|Overall Study|Participant unable to attend study visit|1|||
146980988|NCT01393990|530093691|FG006|Overall Study|Withdrawal by Subject|0|||
146699064|NCT02641379|529076902|FG008|Overall Study|Participant unable to attend study visit|0|||
146699065|NCT02641379|529076903|FG009|Overall Study|Participant unable to attend study visit|2|||
146699066|NCT02641379|529076904|FG010|Overall Study|Participant unable to attend study visit|0|||
146699067|NCT02641379|529076894|FG000|Overall Study|Participant's compliance|0|||
146699068|NCT02641379|529076895|FG001|Overall Study|Participant's compliance|1|||
146699069|NCT02641379|529076896|FG002|Overall Study|Participant's compliance|0|||
146699070|NCT02641379|529076897|FG003|Overall Study|Participant's compliance|1|||
146699071|NCT02641379|529076898|FG004|Overall Study|Participant's compliance|0|||
146699072|NCT02641379|529076899|FG005|Overall Study|Participant's compliance|2|||
146699073|NCT02641379|529076900|FG006|Overall Study|Participant's compliance|0|||
146699074|NCT02641379|529076901|FG007|Overall Study|Participant's compliance|0|||
146699075|NCT02641379|529076902|FG008|Overall Study|Participant's compliance|1|||
146776415|NCT02652260|529353610|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
146699076|NCT02641379|529076903|FG009|Overall Study|Participant's compliance|1|||
146931683|NCT01797445|529908128|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
146699077|NCT02641379|529076904|FG010|Overall Study|Participant's compliance|1|||
146699078|NCT02641379|529076894|FG000|Overall Study|Participant cannot be reached|4|||
146699079|NCT02641379|529076895|FG001|Overall Study|Participant cannot be reached|4|||
146699080|NCT02641379|529076896|FG002|Overall Study|Participant cannot be reached|0|||
146699081|NCT02641379|529076897|FG003|Overall Study|Participant cannot be reached|8|||
146699082|NCT02641379|529076898|FG004|Overall Study|Participant cannot be reached|2|||
146699083|NCT02641379|529076899|FG005|Overall Study|Participant cannot be reached|1|||
146699084|NCT02641379|529076900|FG006|Overall Study|Participant cannot be reached|0|||
146699085|NCT02641379|529076901|FG007|Overall Study|Participant cannot be reached|1|||
146699086|NCT02641379|529076902|FG008|Overall Study|Participant cannot be reached|0|||
146699087|NCT02641379|529076903|FG009|Overall Study|Participant cannot be reached|2|||
146699088|NCT02641379|529076904|FG010|Overall Study|Participant cannot be reached|1|||
146699089|NCT02641379|529076894|FG000|Overall Study|PCR positive at Week 24|15|||
146699090|NCT02641379|529076895|FG001|Overall Study|PCR positive at Week 24|21|||
146699091|NCT02641379|529076896|FG002|Overall Study|PCR positive at Week 24|62|||
146699092|NCT02641379|529076897|FG003|Overall Study|PCR positive at Week 24|0|||
146699093|NCT02641379|529076898|FG004|Overall Study|PCR positive at Week 24|0|||
146699094|NCT02641379|529076899|FG005|Overall Study|PCR positive at Week 24|6|||
146699095|NCT02641379|529076900|FG006|Overall Study|PCR positive at Week 24|3|||
146699096|NCT02641379|529076901|FG007|Overall Study|PCR positive at Week 24|8|||
146699097|NCT02641379|529076902|FG008|Overall Study|PCR positive at Week 24|0|||
146699098|NCT02641379|529076903|FG009|Overall Study|PCR positive at Week 24|1|||
146699099|NCT02641379|529076904|FG010|Overall Study|PCR positive at Week 24|0|||
146699100|NCT02641379|529076894|FG000|Overall Study|PCR positive at follow up 2|1|||
146699101|NCT02641379|529076895|FG001|Overall Study|PCR positive at follow up 2|0|||
146699102|NCT02641379|529076896|FG002|Overall Study|PCR positive at follow up 2|0|||
146699103|NCT02641379|529076897|FG003|Overall Study|PCR positive at follow up 2|0|||
146699104|NCT02641379|529076898|FG004|Overall Study|PCR positive at follow up 2|0|||
146699105|NCT02641379|529076899|FG005|Overall Study|PCR positive at follow up 2|0|||
146699106|NCT02641379|529076900|FG006|Overall Study|PCR positive at follow up 2|0|||
146699107|NCT02641379|529076901|FG007|Overall Study|PCR positive at follow up 2|0|||
146699108|NCT02641379|529076902|FG008|Overall Study|PCR positive at follow up 2|0|||
146699109|NCT02641379|529076903|FG009|Overall Study|PCR positive at follow up 2|0|||
146699110|NCT02641379|529076904|FG010|Overall Study|PCR positive at follow up 2|0|||
146699111|NCT02641379|529076894|FG000|Overall Study|Participant showed relapse|1|||
146699112|NCT02641379|529076895|FG001|Overall Study|Participant showed relapse|0|||
146699113|NCT02641379|529076896|FG002|Overall Study|Participant showed relapse|0|||
146699114|NCT02641379|529076897|FG003|Overall Study|Participant showed relapse|0|||
146699115|NCT02641379|529076898|FG004|Overall Study|Participant showed relapse|0|||
146699116|NCT02641379|529076899|FG005|Overall Study|Participant showed relapse|0|||
146699117|NCT02641379|529076900|FG006|Overall Study|Participant showed relapse|1|||
146699118|NCT02641379|529076901|FG007|Overall Study|Participant showed relapse|0|||
146699119|NCT02641379|529076902|FG008|Overall Study|Participant showed relapse|0|||
146699120|NCT02641379|529076903|FG009|Overall Study|Participant showed relapse|0|||
146699121|NCT02641379|529076904|FG010|Overall Study|Participant showed relapse|0|||
146699122|NCT02641379|529076894|FG000|Overall Study|Participant stopped study/treatment|1|||
146699123|NCT02641379|529076895|FG001|Overall Study|Participant stopped study/treatment|3|||
146699124|NCT02641379|529076896|FG002|Overall Study|Participant stopped study/treatment|1|||
146699125|NCT02641379|529076897|FG003|Overall Study|Participant stopped study/treatment|0|||
146699126|NCT02641379|529076898|FG004|Overall Study|Participant stopped study/treatment|0|||
146699127|NCT02641379|529076899|FG005|Overall Study|Participant stopped study/treatment|1|||
146699128|NCT02641379|529076900|FG006|Overall Study|Participant stopped study/treatment|2|||
146699129|NCT02641379|529076901|FG007|Overall Study|Participant stopped study/treatment|0|||
146699130|NCT02641379|529076902|FG008|Overall Study|Participant stopped study/treatment|1|||
146699131|NCT02641379|529076903|FG009|Overall Study|Participant stopped study/treatment|0|||
146699132|NCT02641379|529076904|FG010|Overall Study|Participant stopped study/treatment|0|||
146699133|NCT02641379|529076894|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
146699134|NCT02641379|529076895|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
146699135|NCT02641379|529076896|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
146699136|NCT02641379|529076897|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
146699137|NCT02641379|529076898|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
146699138|NCT02641379|529076899|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
146699139|NCT02641379|529076900|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
146699140|NCT02641379|529076901|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
146699141|NCT02641379|529076902|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
146699142|NCT02641379|529076903|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
146931684|NCT01797445|529908127|FG000|Double-Blind Phase|Protocol Violation|0|||
146699143|NCT02641379|529076904|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
146699144|NCT02641379|529076894|FG000|Overall Study|Financial problems|0|||
146699145|NCT02641379|529076895|FG001|Overall Study|Financial problems|1|||
146699146|NCT02641379|529076896|FG002|Overall Study|Financial problems|0|||
146931685|NCT01797445|529908128|FG001|Double-Blind Phase|Protocol Violation|1|||
146931686|NCT01797445|529908127|FG000|Double-Blind Phase|Withdrew Consent|20|||
146699147|NCT02641379|529076897|FG003|Overall Study|Financial problems|0|||
146699148|NCT02641379|529076898|FG004|Overall Study|Financial problems|0|||
146699149|NCT02641379|529076899|FG005|Overall Study|Financial problems|0|||
146699150|NCT02641379|529076900|FG006|Overall Study|Financial problems|0|||
146699151|NCT02641379|529076901|FG007|Overall Study|Financial problems|0|||
146931687|NCT01797445|529908128|FG001|Double-Blind Phase|Withdrew Consent|35|||
146931688|NCT01797445|529908127|FG000|Double-Blind Phase|Lost to Follow-up|34|||
146931689|NCT01797445|529908128|FG001|Double-Blind Phase|Lost to Follow-up|26|||
146931690|NCT01797445|529908127|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
146931691|NCT01797445|529908128|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
146931692|NCT01595438|529908129|FG000|Overall Study|Lost to Follow-up|20|||
146931693|NCT01595438|529908130|FG001|Overall Study|Lost to Follow-up|20|||
146931694|NCT01595438|529908129|FG000|Overall Study|Withdrawal by Subject|12|||
146931695|NCT01595438|529908130|FG001|Overall Study|Withdrawal by Subject|12|||
146931696|NCT01595438|529908129|FG000|Overall Study|Other Eligibility criteria|11|||
146931697|NCT01595438|529908130|FG001|Overall Study|Other Eligibility criteria|9|||
146931698|NCT00650091|529908132|FG000|Amended Study Design|Withdrawal by Subject|12|||
146931699|NCT00650091|529908133|FG001|Amended Study Design|Withdrawal by Subject|11|||
146931700|NCT00650091|529908134|FG002|Amended Study Design|Withdrawal by Subject|0|||
146931701|NCT00650091|529908132|FG000|Amended Study Design|Physician Decision|5|||
146931702|NCT00650091|529908133|FG001|Amended Study Design|Physician Decision|0|||
146931703|NCT00650091|529908134|FG002|Amended Study Design|Physician Decision|0|||
146931704|NCT00650091|529908132|FG000|Amended Study Design|Adverse Event|1|||
146931705|NCT00650091|529908133|FG001|Amended Study Design|Adverse Event|4|||
146931706|NCT00650091|529908134|FG002|Amended Study Design|Adverse Event|0|||
146931707|NCT00650091|529908132|FG000|Amended Study Design|Lung transplantation|4|||
146931708|NCT00650091|529908133|FG001|Amended Study Design|Lung transplantation|2|||
146931709|NCT00650091|529908134|FG002|Amended Study Design|Lung transplantation|0|||
146931710|NCT00650091|529908132|FG000|Amended Study Design|Other|1|||
146931711|NCT00650091|529908133|FG001|Amended Study Design|Other|3|||
146931712|NCT00650091|529908134|FG002|Amended Study Design|Other|0|||
146931713|NCT01204697|529908135|FG000|Overall Study|Death|26|||
146931714|NCT01204697|529908136|FG001|Overall Study|Death|27|||
146931715|NCT01204697|529908135|FG000|Overall Study|Lost to Follow-up|3|||
146931716|NCT01204697|529908136|FG001|Overall Study|Lost to Follow-up|4|||
146931717|NCT01204697|529908135|FG000|Overall Study|Withdrawal by Subject|2|||
146931718|NCT01204697|529908136|FG001|Overall Study|Withdrawal by Subject|4|||
146931719|NCT01204697|529908135|FG000|Overall Study|Randomized, but not treated|0|||
146931720|NCT01204697|529908136|FG001|Overall Study|Randomized, but not treated|1|||
146931721|NCT01280266|529908143|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
146931722|NCT01280266|529908144|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
146931723|NCT01280266|529908143|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
146931724|NCT01280266|529908144|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
146931725|NCT00469209|529908151|FG000|Overall Study|Adverse Event|1|||
146931726|NCT00469209|529908152|FG001|Overall Study|Adverse Event|0|||
146931727|NCT00469209|529908153|FG002|Overall Study|Adverse Event|1|||
146931728|NCT04268004|529908156|FG000|Overall Study|Excluded from analyses|0|||
146931729|NCT04268004|529908157|FG001|Overall Study|Excluded from analyses|1|||
146931730|NCT01082367|529908158|FG000|Double-blind Period|Administrative problems|0|||
146931731|NCT01082367|529908159|FG001|Double-blind Period|Administrative problems|1|||
146931732|NCT01082367|529908158|FG000|Double-blind Period|Lack of Efficacy|5|||
146931733|NCT01082367|529908159|FG001|Double-blind Period|Lack of Efficacy|11|||
146931734|NCT01082367|529908158|FG000|Double-blind Period|Adverse Event|0|||
146931735|NCT01082367|529908159|FG001|Double-blind Period|Adverse Event|1|||
146931736|NCT01082367|529908158|FG000|Follow-up (F-U) Period|Administrative problems|1|||
146931737|NCT01082367|529908159|FG001|Follow-up (F-U) Period|Administrative problems|0|||
146931738|NCT01082367|529908158|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
146931739|NCT01082367|529908159|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
146931740|NCT01082367|529908158|FG000|Follow-up (F-U) Period|Adverse Event|0|||
146931741|NCT01082367|529908159|FG001|Follow-up (F-U) Period|Adverse Event|1|||
146931742|NCT04724733|529908165|FG000|Overall Study|Lost to Follow-up|1|||
146931743|NCT04724733|529908166|FG001|Overall Study|Lost to Follow-up|1|||
146931744|NCT04724733|529908167|FG002|Overall Study|Lost to Follow-up|1|||
146931745|NCT03067129|529908168|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
146931746|NCT03067129|529908169|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
146931747|NCT03067129|529908170|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
146931748|NCT03067129|529908171|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
146931749|NCT03067129|529908168|FG000|Overall Study|Withdrawal by Subject|0|||
146931750|NCT03067129|529908169|FG001|Overall Study|Withdrawal by Subject|0|||
146931751|NCT03067129|529908170|FG002|Overall Study|Withdrawal by Subject|1|||
146931752|NCT03067129|529908171|FG003|Overall Study|Withdrawal by Subject|2|||
146931753|NCT03067129|529908168|FG000|Overall Study|Lost to Follow-up|5|||
146931754|NCT03067129|529908169|FG001|Overall Study|Lost to Follow-up|5|||
146931755|NCT03067129|529908170|FG002|Overall Study|Lost to Follow-up|4|||
146931756|NCT03067129|529908171|FG003|Overall Study|Lost to Follow-up|3|||
146776416|NCT02652260|529353611|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
146699152|NCT02641379|529076902|FG008|Overall Study|Financial problems|0|||
146699153|NCT02641379|529076903|FG009|Overall Study|Financial problems|0|||
146699154|NCT02641379|529076904|FG010|Overall Study|Financial problems|0|||
146699155|NCT02641379|529076894|FG000|Overall Study|PCR positive at Week 68|0|||
146699156|NCT02641379|529076895|FG001|Overall Study|PCR positive at Week 68|1|||
146699157|NCT02641379|529076896|FG002|Overall Study|PCR positive at Week 68|0|||
146699158|NCT02641379|529076897|FG003|Overall Study|PCR positive at Week 68|0|||
146699159|NCT02641379|529076898|FG004|Overall Study|PCR positive at Week 68|0|||
146699160|NCT02641379|529076899|FG005|Overall Study|PCR positive at Week 68|0|||
146699161|NCT02641379|529076900|FG006|Overall Study|PCR positive at Week 68|0|||
146699162|NCT02641379|529076901|FG007|Overall Study|PCR positive at Week 68|0|||
146699163|NCT02641379|529076902|FG008|Overall Study|PCR positive at Week 68|0|||
146699164|NCT02641379|529076903|FG009|Overall Study|PCR positive at Week 68|0|||
146699165|NCT02641379|529076904|FG010|Overall Study|PCR positive at Week 68|0|||
146699166|NCT02641379|529076894|FG000|Overall Study|PCR positive at Week 48|0|||
146699167|NCT02641379|529076895|FG001|Overall Study|PCR positive at Week 48|1|||
146699168|NCT02641379|529076896|FG002|Overall Study|PCR positive at Week 48|0|||
146699169|NCT02641379|529076897|FG003|Overall Study|PCR positive at Week 48|0|||
146699170|NCT02641379|529076898|FG004|Overall Study|PCR positive at Week 48|0|||
146699171|NCT02641379|529076899|FG005|Overall Study|PCR positive at Week 48|0|||
146699172|NCT02641379|529076900|FG006|Overall Study|PCR positive at Week 48|0|||
146699173|NCT02641379|529076901|FG007|Overall Study|PCR positive at Week 48|0|||
146699174|NCT02641379|529076902|FG008|Overall Study|PCR positive at Week 48|0|||
146699175|NCT02641379|529076903|FG009|Overall Study|PCR positive at Week 48|0|||
146699176|NCT02641379|529076904|FG010|Overall Study|PCR positive at Week 48|0|||
146699177|NCT02641379|529076894|FG000|Overall Study|PCR not performed at Week 12|0|||
146699178|NCT02641379|529076895|FG001|Overall Study|PCR not performed at Week 12|0|||
146699179|NCT02641379|529076896|FG002|Overall Study|PCR not performed at Week 12|1|||
146699180|NCT02641379|529076897|FG003|Overall Study|PCR not performed at Week 12|0|||
146699181|NCT02641379|529076898|FG004|Overall Study|PCR not performed at Week 12|0|||
146776417|NCT02652260|529353610|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
146776418|NCT02652260|529353611|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
146776419|NCT02652260|529353610|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
146699182|NCT02641379|529076899|FG005|Overall Study|PCR not performed at Week 12|0|||
146699183|NCT02641379|529076900|FG006|Overall Study|PCR not performed at Week 12|0|||
146699184|NCT02641379|529076901|FG007|Overall Study|PCR not performed at Week 12|0|||
146699185|NCT02641379|529076902|FG008|Overall Study|PCR not performed at Week 12|0|||
146776420|NCT02652260|529353611|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
146776421|NCT02652260|529353610|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
146931757|NCT03372603|529908172|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
146931758|NCT03372603|529908173|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
146931759|NCT03372603|529908172|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
146931760|NCT03372603|529908173|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
146931761|NCT04929613|529908174|FG000|Overall Study|Withdrawal by Subject|12|||
146931762|NCT00664209|529908180|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
146931763|NCT00664209|529908180|FG000|Study Treatment Period|Physician Decision|4|||
146931764|NCT00664209|529908180|FG000|Study Treatment Period|Withdrawal by Subject|2|||
146931765|NCT00418379|529908181|FG000|Year 1|Adverse Event|9|||
146931766|NCT00418379|529908182|FG001|Year 1|Adverse Event|15|||
146931767|NCT00418379|529908183|FG002|Year 1|Adverse Event|3|||
146931768|NCT00418379|529908181|FG000|Year 1|Withdrawal by Subject|7|||
146931769|NCT00418379|529908182|FG001|Year 1|Withdrawal by Subject|8|||
146931770|NCT00418379|529908183|FG002|Year 1|Withdrawal by Subject|5|||
146931771|NCT00418379|529908181|FG000|Year 1|Any other reason not above-mentioned|2|||
146931772|NCT00418379|529908182|FG001|Year 1|Any other reason not above-mentioned|5|||
146931773|NCT00418379|529908183|FG002|Year 1|Any other reason not above-mentioned|7|||
146931774|NCT00418379|529908181|FG000|Year 2|Adverse Event|5|||
146931775|NCT00418379|529908182|FG001|Year 2|Adverse Event|2|||
146931776|NCT00418379|529908183|FG002|Year 2|Adverse Event|1|||
146931777|NCT00418379|529908181|FG000|Year 2|Withdrawal by Subject|1|||
146931778|NCT00418379|529908182|FG001|Year 2|Withdrawal by Subject|1|||
146931779|NCT00418379|529908183|FG002|Year 2|Withdrawal by Subject|3|||
146931780|NCT00418379|529908181|FG000|Year 2|Any other reason not above-mentioned|2|||
146931781|NCT00418379|529908182|FG001|Year 2|Any other reason not above-mentioned|1|||
146931782|NCT00418379|529908183|FG002|Year 2|Any other reason not above-mentioned|6|||
146931783|NCT00418379|529908181|FG000|Year 3|Withdrawal by Subject|1|||
146931784|NCT00418379|529908182|FG001|Year 3|Withdrawal by Subject|1|||
146931785|NCT00418379|529908183|FG002|Year 3|Withdrawal by Subject|2|||
146931786|NCT00418379|529908181|FG000|Year 3|Any other reason not above-mentioned|2|||
146931787|NCT00418379|529908182|FG001|Year 3|Any other reason not above-mentioned|1|||
146931788|NCT00418379|529908183|FG002|Year 3|Any other reason not above-mentioned|1|||
146931789|NCT00418379|529908181|FG000|Year 4|Adverse Event|0|||
146931790|NCT00418379|529908182|FG001|Year 4|Adverse Event|1|||
146931791|NCT00418379|529908183|FG002|Year 4|Adverse Event|0|||
146699186|NCT02641379|529076903|FG009|Overall Study|PCR not performed at Week 12|0|||
146699187|NCT02641379|529076904|FG010|Overall Study|PCR not performed at Week 12|0|||
146699188|NCT02641379|529076894|FG000|Overall Study|No PCR at baseline|0|||
146699189|NCT02641379|529076895|FG001|Overall Study|No PCR at baseline|0|||
146699190|NCT02641379|529076896|FG002|Overall Study|No PCR at baseline|1|||
146699191|NCT02641379|529076897|FG003|Overall Study|No PCR at baseline|0|||
146699192|NCT02641379|529076898|FG004|Overall Study|No PCR at baseline|0|||
146699193|NCT02641379|529076899|FG005|Overall Study|No PCR at baseline|0|||
146699194|NCT02641379|529076900|FG006|Overall Study|No PCR at baseline|0|||
146699195|NCT02641379|529076901|FG007|Overall Study|No PCR at baseline|0|||
146699196|NCT02641379|529076902|FG008|Overall Study|No PCR at baseline|0|||
146699197|NCT02641379|529076903|FG009|Overall Study|No PCR at baseline|0|||
146699198|NCT02641379|529076904|FG010|Overall Study|No PCR at baseline|0|||
146699199|NCT02641379|529076894|FG000|Overall Study|PCR positive at Week 28|0|||
146699200|NCT02641379|529076895|FG001|Overall Study|PCR positive at Week 28|0|||
146699201|NCT02641379|529076896|FG002|Overall Study|PCR positive at Week 28|1|||
146699202|NCT02641379|529076897|FG003|Overall Study|PCR positive at Week 28|0|||
146699203|NCT02641379|529076898|FG004|Overall Study|PCR positive at Week 28|0|||
146699204|NCT02641379|529076899|FG005|Overall Study|PCR positive at Week 28|0|||
146699205|NCT02641379|529076900|FG006|Overall Study|PCR positive at Week 28|0|||
146699206|NCT02641379|529076901|FG007|Overall Study|PCR positive at Week 28|0|||
146699207|NCT02641379|529076902|FG008|Overall Study|PCR positive at Week 28|0|||
146699208|NCT02641379|529076903|FG009|Overall Study|PCR positive at Week 28|0|||
146699209|NCT02641379|529076904|FG010|Overall Study|PCR positive at Week 28|0|||
146699210|NCT02641379|529076894|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
146699211|NCT02641379|529076895|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
146699212|NCT02641379|529076896|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
146699213|NCT02641379|529076897|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
146699214|NCT02641379|529076898|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
146699215|NCT02641379|529076899|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
146699216|NCT02641379|529076900|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
146699217|NCT02641379|529076901|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
146699218|NCT02641379|529076902|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
146699219|NCT02641379|529076903|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
146699220|NCT02641379|529076904|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
146699221|NCT02641379|529076894|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
146699222|NCT02641379|529076895|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
146699223|NCT02641379|529076896|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
146699224|NCT02641379|529076897|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
146699225|NCT02641379|529076898|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
146699226|NCT02641379|529076899|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
146699227|NCT02641379|529076900|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
146699228|NCT02641379|529076901|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
146699229|NCT02641379|529076902|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
146931792|NCT00418379|529908181|FG000|Year 4|Withdrawal by Subject|2|||
146931793|NCT00418379|529908182|FG001|Year 4|Withdrawal by Subject|3|||
146931794|NCT00418379|529908183|FG002|Year 4|Withdrawal by Subject|2|||
146931795|NCT00418379|529908181|FG000|Year 4|Any other reason not above-mentioned|1|||
146931796|NCT00418379|529908182|FG001|Year 4|Any other reason not above-mentioned|1|||
146931797|NCT00418379|529908183|FG002|Year 4|Any other reason not above-mentioned|0|||
146931798|NCT00418379|529908181|FG000|Year 5|Adverse Event|0|||
146931799|NCT00418379|529908182|FG001|Year 5|Adverse Event|1|||
146931800|NCT00418379|529908183|FG002|Year 5|Adverse Event|0|||
146931801|NCT00418379|529908181|FG000|Year 5|Any other reason not above-mentioned|2|||
146931802|NCT00418379|529908182|FG001|Year 5|Any other reason not above-mentioned|4|||
146931803|NCT00418379|529908183|FG002|Year 5|Any other reason not above-mentioned|3|||
146931804|NCT00843843|529908184|FG000|Overall Study|Physician Decision|1|||
146931805|NCT00843843|529908185|FG001|Overall Study|Physician Decision|1|||
146931806|NCT00843843|529908184|FG000|Overall Study|Protocol Violation|1|||
146931807|NCT00843843|529908185|FG001|Overall Study|Protocol Violation|1|||
146931808|NCT01764256|529908186|FG000|Received All Vaccinations|Adverse Event|1|||
146699230|NCT02641379|529076903|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
146699231|NCT02641379|529076904|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
146931809|NCT01764256|529908187|FG001|Received All Vaccinations|Adverse Event|1|||
146931810|NCT01764256|529908188|FG002|Received All Vaccinations|Adverse Event|0|||
146699232|NCT02641379|529076894|FG000|Overall Study|Baseline viral load unavailable|0|||
146699233|NCT02641379|529076895|FG001|Overall Study|Baseline viral load unavailable|0|||
146699234|NCT02641379|529076896|FG002|Overall Study|Baseline viral load unavailable|0|||
146699235|NCT02641379|529076897|FG003|Overall Study|Baseline viral load unavailable|1|||
146699236|NCT02641379|529076898|FG004|Overall Study|Baseline viral load unavailable|0|||
146931811|NCT01764256|529908189|FG003|Received All Vaccinations|Adverse Event|0|||
146931812|NCT01764256|529908186|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
146931813|NCT01764256|529908187|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
146931814|NCT01764256|529908188|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
146699237|NCT02641379|529076899|FG005|Overall Study|Baseline viral load unavailable|0|||
146699238|NCT02641379|529076900|FG006|Overall Study|Baseline viral load unavailable|0|||
146699239|NCT02641379|529076901|FG007|Overall Study|Baseline viral load unavailable|0|||
146699240|NCT02641379|529076902|FG008|Overall Study|Baseline viral load unavailable|0|||
146699241|NCT02641379|529076903|FG009|Overall Study|Baseline viral load unavailable|0|||
146699242|NCT02641379|529076904|FG010|Overall Study|Baseline viral load unavailable|0|||
146699243|NCT02641379|529076894|FG000|Overall Study|Blood could not be drawn|0|||
146699244|NCT02641379|529076895|FG001|Overall Study|Blood could not be drawn|0|||
146699245|NCT02641379|529076896|FG002|Overall Study|Blood could not be drawn|0|||
146699246|NCT02641379|529076897|FG003|Overall Study|Blood could not be drawn|0|||
146699247|NCT02641379|529076898|FG004|Overall Study|Blood could not be drawn|1|||
146699248|NCT02641379|529076899|FG005|Overall Study|Blood could not be drawn|0|||
146699249|NCT02641379|529076900|FG006|Overall Study|Blood could not be drawn|0|||
146699250|NCT02641379|529076901|FG007|Overall Study|Blood could not be drawn|0|||
146699251|NCT02641379|529076902|FG008|Overall Study|Blood could not be drawn|0|||
146699252|NCT02641379|529076903|FG009|Overall Study|Blood could not be drawn|0|||
146699253|NCT02641379|529076904|FG010|Overall Study|Blood could not be drawn|0|||
146699254|NCT02641379|529076894|FG000|Overall Study|Protocol Violation|0|||
146699255|NCT02641379|529076895|FG001|Overall Study|Protocol Violation|0|||
146699256|NCT02641379|529076896|FG002|Overall Study|Protocol Violation|0|||
146699257|NCT02641379|529076897|FG003|Overall Study|Protocol Violation|0|||
146699258|NCT02641379|529076898|FG004|Overall Study|Protocol Violation|2|||
146699259|NCT02641379|529076899|FG005|Overall Study|Protocol Violation|0|||
146699260|NCT02641379|529076900|FG006|Overall Study|Protocol Violation|0|||
146699261|NCT02641379|529076901|FG007|Overall Study|Protocol Violation|0|||
146699262|NCT02641379|529076902|FG008|Overall Study|Protocol Violation|1|||
146699263|NCT02641379|529076903|FG009|Overall Study|Protocol Violation|0|||
146699264|NCT02641379|529076904|FG010|Overall Study|Protocol Violation|0|||
146699265|NCT02641379|529076894|FG000|Overall Study|Participation in sili rescue study|0|||
146699266|NCT02641379|529076895|FG001|Overall Study|Participation in sili rescue study|0|||
146699267|NCT02641379|529076896|FG002|Overall Study|Participation in sili rescue study|0|||
146699268|NCT02641379|529076897|FG003|Overall Study|Participation in sili rescue study|0|||
146699269|NCT02641379|529076898|FG004|Overall Study|Participation in sili rescue study|0|||
146699270|NCT02641379|529076899|FG005|Overall Study|Participation in sili rescue study|1|||
146699271|NCT02641379|529076900|FG006|Overall Study|Participation in sili rescue study|0|||
146699272|NCT02641379|529076901|FG007|Overall Study|Participation in sili rescue study|0|||
146699273|NCT02641379|529076902|FG008|Overall Study|Participation in sili rescue study|0|||
146699274|NCT02641379|529076903|FG009|Overall Study|Participation in sili rescue study|0|||
146699275|NCT02641379|529076904|FG010|Overall Study|Participation in sili rescue study|0|||
146699276|NCT02641379|529076894|FG000|Overall Study|Lost to Follow-up|0|||
146699277|NCT02641379|529076895|FG001|Overall Study|Lost to Follow-up|0|||
146699278|NCT02641379|529076896|FG002|Overall Study|Lost to Follow-up|0|||
146699279|NCT02641379|529076897|FG003|Overall Study|Lost to Follow-up|0|||
146699280|NCT02641379|529076898|FG004|Overall Study|Lost to Follow-up|0|||
146699281|NCT02641379|529076899|FG005|Overall Study|Lost to Follow-up|0|||
146699282|NCT02641379|529076900|FG006|Overall Study|Lost to Follow-up|0|||
146699283|NCT02641379|529076901|FG007|Overall Study|Lost to Follow-up|0|||
146699284|NCT02641379|529076902|FG008|Overall Study|Lost to Follow-up|1|||
146699285|NCT02641379|529076903|FG009|Overall Study|Lost to Follow-up|0|||
146699286|NCT02641379|529076904|FG010|Overall Study|Lost to Follow-up|0|||
146699287|NCT02641379|529076894|FG000|Overall Study|Source data not found|0|||
146699288|NCT02641379|529076895|FG001|Overall Study|Source data not found|0|||
146699289|NCT02641379|529076896|FG002|Overall Study|Source data not found|0|||
146699290|NCT02641379|529076897|FG003|Overall Study|Source data not found|0|||
146699291|NCT02641379|529076898|FG004|Overall Study|Source data not found|0|||
146699292|NCT02641379|529076899|FG005|Overall Study|Source data not found|1|||
146699293|NCT02641379|529076900|FG006|Overall Study|Source data not found|0|||
146699294|NCT02641379|529076901|FG007|Overall Study|Source data not found|0|||
146699295|NCT02641379|529076902|FG008|Overall Study|Source data not found|0|||
146699296|NCT02641379|529076903|FG009|Overall Study|Source data not found|0|||
146699297|NCT02641379|529076904|FG010|Overall Study|Source data not found|0|||
146699298|NCT02641379|529076894|FG000|Overall Study|Participant showed weight reduction|0|||
146699299|NCT02641379|529076895|FG001|Overall Study|Participant showed weight reduction|0|||
146699300|NCT02641379|529076896|FG002|Overall Study|Participant showed weight reduction|0|||
146699301|NCT02641379|529076897|FG003|Overall Study|Participant showed weight reduction|0|||
146699302|NCT02641379|529076898|FG004|Overall Study|Participant showed weight reduction|0|||
146699303|NCT02641379|529076899|FG005|Overall Study|Participant showed weight reduction|0|||
146699304|NCT02641379|529076900|FG006|Overall Study|Participant showed weight reduction|0|||
146699305|NCT02641379|529076901|FG007|Overall Study|Participant showed weight reduction|1|||
146699306|NCT02641379|529076902|FG008|Overall Study|Participant showed weight reduction|0|||
146699307|NCT02641379|529076903|FG009|Overall Study|Participant showed weight reduction|0|||
146699308|NCT02641379|529076904|FG010|Overall Study|Participant showed weight reduction|0|||
146699309|NCT02641379|529076894|FG000|Overall Study|Non-response Week 12|0|||
146699310|NCT02641379|529076895|FG001|Overall Study|Non-response Week 12|0|||
146699311|NCT02641379|529076896|FG002|Overall Study|Non-response Week 12|0|||
146699312|NCT02641379|529076897|FG003|Overall Study|Non-response Week 12|0|||
146699313|NCT02641379|529076898|FG004|Overall Study|Non-response Week 12|0|||
146699314|NCT02641379|529076899|FG005|Overall Study|Non-response Week 12|0|||
146699315|NCT02641379|529076900|FG006|Overall Study|Non-response Week 12|0|||
146699316|NCT02641379|529076901|FG007|Overall Study|Non-response Week 12|1|||
146699317|NCT02641379|529076902|FG008|Overall Study|Non-response Week 12|0|||
146699318|NCT02641379|529076903|FG009|Overall Study|Non-response Week 12|0|||
146699319|NCT02641379|529076904|FG010|Overall Study|Non-response Week 12|0|||
146699320|NCT02641379|529076894|FG000|Overall Study|No 2 Log drop at Week 12|0|||
146699321|NCT02641379|529076895|FG001|Overall Study|No 2 Log drop at Week 12|0|||
146699322|NCT02641379|529076896|FG002|Overall Study|No 2 Log drop at Week 12|0|||
146699323|NCT02641379|529076897|FG003|Overall Study|No 2 Log drop at Week 12|0|||
146699324|NCT02641379|529076898|FG004|Overall Study|No 2 Log drop at Week 12|0|||
146699325|NCT02641379|529076899|FG005|Overall Study|No 2 Log drop at Week 12|0|||
146699326|NCT02641379|529076900|FG006|Overall Study|No 2 Log drop at Week 12|0|||
146699327|NCT02641379|529076901|FG007|Overall Study|No 2 Log drop at Week 12|0|||
146699328|NCT02641379|529076902|FG008|Overall Study|No 2 Log drop at Week 12|0|||
146699329|NCT02641379|529076903|FG009|Overall Study|No 2 Log drop at Week 12|0|||
146699330|NCT02641379|529076904|FG010|Overall Study|No 2 Log drop at Week 12|1|||
146699331|NCT02641379|529076894|FG000|Overall Study|Negative PCR result|0|||
146699332|NCT02641379|529076895|FG001|Overall Study|Negative PCR result|0|||
146699333|NCT02641379|529076896|FG002|Overall Study|Negative PCR result|0|||
146699334|NCT02641379|529076897|FG003|Overall Study|Negative PCR result|0|||
146699335|NCT02641379|529076898|FG004|Overall Study|Negative PCR result|0|||
146699336|NCT02641379|529076899|FG005|Overall Study|Negative PCR result|0|||
146699337|NCT02641379|529076900|FG006|Overall Study|Negative PCR result|0|||
146699338|NCT02641379|529076901|FG007|Overall Study|Negative PCR result|0|||
146931815|NCT01764256|529908189|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
146931816|NCT01764256|529908186|FG000|Received All Vaccinations|Lost to Follow-up|1|||
146931817|NCT01764256|529908187|FG001|Received All Vaccinations|Lost to Follow-up|0|||
146931818|NCT01764256|529908188|FG002|Received All Vaccinations|Lost to Follow-up|0|||
146931819|NCT01764256|529908189|FG003|Received All Vaccinations|Lost to Follow-up|0|||
146931820|NCT01764256|529908186|FG000|Completed Study|Lost to Follow-up|0|||
146931821|NCT01764256|529908187|FG001|Completed Study|Lost to Follow-up|0|||
146931822|NCT01764256|529908188|FG002|Completed Study|Lost to Follow-up|0|||
146931823|NCT01764256|529908189|FG003|Completed Study|Lost to Follow-up|1|||
146931824|NCT02029638|529908190|FG000|Overall Study|Death|0|||
146931825|NCT02029638|529908191|FG001|Overall Study|Death|0|||
146931826|NCT02029638|529908192|FG002|Overall Study|Death|1|||
146931827|NCT02029638|529908190|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
146931828|NCT02029638|529908191|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
146931829|NCT02029638|529908192|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
146931830|NCT01153841|529908193|FG000|Overall Study|Adverse Event|1|||
146931831|NCT01153841|529908194|FG001|Overall Study|Adverse Event|0|||
146931832|NCT01153841|529908193|FG000|Overall Study|Withdrawal by Subject|1|||
146931833|NCT01153841|529908194|FG001|Overall Study|Withdrawal by Subject|0|||
146931834|NCT01153841|529908193|FG000|Overall Study|Protocol Violation|2|||
146931835|NCT01153841|529908194|FG001|Overall Study|Protocol Violation|0|||
146931836|NCT01153841|529908193|FG000|Overall Study|Lost to Follow-up|2|||
146931837|NCT01153841|529908194|FG001|Overall Study|Lost to Follow-up|0|||
146931838|NCT00830804|529908197|FG000|Overall Study|Lost to Follow-up|4|||
146931839|NCT00830804|529908197|FG000|Overall Study|Death|1|||
146931840|NCT00830804|529908197|FG000|Overall Study|Unable to get to clinic|7|||
146931841|NCT00830804|529908197|FG000|Overall Study|Consent withdrawn|2|||
146931842|NCT00830804|529908197|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
146931843|NCT03428997|529908203|FG000|Overall Study|Sponsor decision.|1|||
146931844|NCT03428997|529908203|FG000|Overall Study|Withdrawal by Subject|3|||
146931845|NCT03428997|529908203|FG000|Overall Study|Lost to Follow-up|4|||
146931846|NCT00510068|529908210|FG000|Double-blind Period|Disease progression|98|||
146931847|NCT00510068|529908211|FG001|Double-blind Period|Disease progression|169|||
146931848|NCT00510068|529908210|FG000|Double-blind Period|Final primary analysis|52|||
146931849|NCT00510068|529908211|FG001|Double-blind Period|Final primary analysis|18|||
146931850|NCT00510068|529908210|FG000|Double-blind Period|Adverse Event|37|||
146931851|NCT00510068|529908211|FG001|Double-blind Period|Adverse Event|7|||
146931852|NCT00510068|529908210|FG000|Double-blind Period|Withdrawal by Subject|8|||
146931853|NCT00510068|529908211|FG001|Double-blind Period|Withdrawal by Subject|6|||
146699339|NCT02641379|529076902|FG008|Overall Study|Negative PCR result|0|||
146699340|NCT02641379|529076903|FG009|Overall Study|Negative PCR result|1|||
146699341|NCT02641379|529076904|FG010|Overall Study|Negative PCR result|0|||
146699342|NCT02641379|529076894|FG000|Overall Study|Participant's PCR high|0|||
146699343|NCT02641379|529076895|FG001|Overall Study|Participant's PCR high|0|||
146931854|NCT00510068|529908210|FG000|Double-blind Period|Death|4|||
146931855|NCT00510068|529908211|FG001|Double-blind Period|Death|3|||
146931856|NCT00510068|529908210|FG000|Double-blind Period|Abnormal test result (s)|1|||
146931857|NCT00510068|529908211|FG001|Double-blind Period|Abnormal test result (s)|0|||
146931858|NCT00510068|529908210|FG000|Double-blind Period|Lost to Follow-up|1|||
146931859|NCT00510068|529908211|FG001|Double-blind Period|Lost to Follow-up|0|||
146931860|NCT00510068|529908210|FG000|Double-blind Period|Protocol Violation|6|||
146931861|NCT00510068|529908211|FG001|Double-blind Period|Protocol Violation|0|||
146931862|NCT00510068|529908210|FG000|Open-label Period|Disease Progression|124|||
146931863|NCT00510068|529908211|FG001|Open-label Period|Disease Progression|0|||
146931864|NCT00510068|529908210|FG000|Open-label Period|Adverse Event|46|||
146931865|NCT00510068|529908211|FG001|Open-label Period|Adverse Event|0|||
146931866|NCT00510068|529908210|FG000|Open-label Period|Withdrawal by Subject|21|||
146931867|NCT00510068|529908211|FG001|Open-label Period|Withdrawal by Subject|0|||
146931868|NCT00510068|529908210|FG000|Open-label Period|Administrative problems|17|||
146931869|NCT00510068|529908211|FG001|Open-label Period|Administrative problems|0|||
146931870|NCT00510068|529908210|FG000|Open-label Period|Death|7|||
146931871|NCT00510068|529908211|FG001|Open-label Period|Death|0|||
146931872|NCT00510068|529908210|FG000|Open-label Period|New cancer therapy|7|||
146931873|NCT00510068|529908211|FG001|Open-label Period|New cancer therapy|0|||
146931874|NCT00510068|529908210|FG000|Open-label Period|Protocol Violation|2|||
146931875|NCT00510068|529908211|FG001|Open-label Period|Protocol Violation|0|||
146931876|NCT00510068|529908210|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
146931877|NCT00510068|529908211|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
146931878|NCT01397448|529908213|FG000|Overall Study|Adverse Event|4|||
146931879|NCT01397448|529908214|FG001|Overall Study|Adverse Event|4|||
146931880|NCT01397448|529908215|FG002|Overall Study|Adverse Event|6|||
146931881|NCT01397448|529908213|FG000|Overall Study|Withdrawal by Subject|4|||
146931882|NCT01397448|529908214|FG001|Overall Study|Withdrawal by Subject|4|||
146931883|NCT01397448|529908215|FG002|Overall Study|Withdrawal by Subject|3|||
146931884|NCT01397448|529908213|FG000|Overall Study|Lack of Efficacy|2|||
146931885|NCT01397448|529908214|FG001|Overall Study|Lack of Efficacy|0|||
146931886|NCT01397448|529908215|FG002|Overall Study|Lack of Efficacy|5|||
146931887|NCT01397448|529908213|FG000|Overall Study|Other|8|||
146931888|NCT01397448|529908214|FG001|Overall Study|Other|7|||
146931889|NCT01397448|529908215|FG002|Overall Study|Other|4|||
146931890|NCT02180217|529908222|FG000|Overall Study|Adverse Event|3|||
146931891|NCT02180217|529908223|FG001|Overall Study|Adverse Event|2|||
146931892|NCT02180217|529908224|FG002|Overall Study|Adverse Event|22|||
146931893|NCT02180217|529908222|FG000|Overall Study|Death|1|||
146931894|NCT02180217|529908223|FG001|Overall Study|Death|1|||
146931895|NCT02180217|529908224|FG002|Overall Study|Death|0|||
146931896|NCT02180217|529908222|FG000|Overall Study|Withdrawal by Subject|1|||
146931897|NCT02180217|529908223|FG001|Overall Study|Withdrawal by Subject|1|||
146931898|NCT02180217|529908224|FG002|Overall Study|Withdrawal by Subject|4|||
146931899|NCT02180217|529908222|FG000|Overall Study|Subject/Guardian decision|5|||
146931900|NCT02180217|529908223|FG001|Overall Study|Subject/Guardian decision|3|||
146931901|NCT02180217|529908224|FG002|Overall Study|Subject/Guardian decision|6|||
146931902|NCT02180217|529908222|FG000|Overall Study|Physician Decision|1|||
146931903|NCT02180217|529908223|FG001|Overall Study|Physician Decision|1|||
146931904|NCT02180217|529908224|FG002|Overall Study|Physician Decision|6|||
146931905|NCT02180217|529908222|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146931906|NCT02180217|529908223|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146931907|NCT02180217|529908224|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146931908|NCT00776555|529908225|FG000|Overall Study|Study terminated|3|||
146931909|NCT00776555|529908226|FG001|Overall Study|Study terminated|0|||
146931910|NCT02553317|529908227|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
146931911|NCT02553317|529908228|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
146931912|NCT02553317|529908227|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
146931913|NCT02553317|529908228|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
146931914|NCT02553317|529908227|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
146931915|NCT02553317|529908228|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
146931916|NCT02553317|529908227|FG000|Overall Treatment Period + Follow-up|Death|1|||
146931917|NCT02553317|529908228|FG001|Overall Treatment Period + Follow-up|Death|3|||
146931918|NCT02553317|529908227|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
146931919|NCT02553317|529908228|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
146931920|NCT02553317|529908227|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
146931921|NCT02553317|529908228|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
146931922|NCT02553317|529908227|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
146931923|NCT02553317|529908228|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
146931924|NCT02553317|529908227|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
146931925|NCT02553317|529908228|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
146931926|NCT02553317|529908227|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
146931927|NCT02553317|529908228|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
146931928|NCT02553317|529908227|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
146931929|NCT02553317|529908228|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
146931930|NCT03483116|529908230|FG000|Overall Study|Adverse Event|0|||
146931931|NCT03483116|529908231|FG001|Overall Study|Adverse Event|1|||
146931932|NCT03483116|529908232|FG002|Overall Study|Adverse Event|0|||
146699344|NCT02641379|529076896|FG002|Overall Study|Participant's PCR high|0|||
146699345|NCT02641379|529076897|FG003|Overall Study|Participant's PCR high|0|||
146699346|NCT02641379|529076898|FG004|Overall Study|Participant's PCR high|0|||
146699347|NCT02641379|529076899|FG005|Overall Study|Participant's PCR high|0|||
146699348|NCT02641379|529076900|FG006|Overall Study|Participant's PCR high|0|||
146699349|NCT02641379|529076901|FG007|Overall Study|Participant's PCR high|1|||
146699350|NCT02641379|529076902|FG008|Overall Study|Participant's PCR high|0|||
146699351|NCT02641379|529076903|FG009|Overall Study|Participant's PCR high|0|||
146699352|NCT02641379|529076904|FG010|Overall Study|Participant's PCR high|0|||
146699353|NCT02641379|529076894|FG000|Overall Study|Participant treated after Week 24|0|||
146699354|NCT02641379|529076895|FG001|Overall Study|Participant treated after Week 24|0|||
146931933|NCT03483116|529908233|FG003|Overall Study|Adverse Event|1|||
146931934|NCT03483116|529908230|FG000|Overall Study|Protocol Violation|1|||
146931935|NCT03483116|529908231|FG001|Overall Study|Protocol Violation|0|||
146931936|NCT03483116|529908232|FG002|Overall Study|Protocol Violation|0|||
146931937|NCT03483116|529908233|FG003|Overall Study|Protocol Violation|7|||
146931938|NCT03483116|529908230|FG000|Overall Study|Lost to Follow-up|9|||
146931939|NCT03483116|529908231|FG001|Overall Study|Lost to Follow-up|4|||
146931940|NCT03483116|529908232|FG002|Overall Study|Lost to Follow-up|9|||
146931941|NCT03483116|529908233|FG003|Overall Study|Lost to Follow-up|5|||
146931942|NCT03483116|529908230|FG000|Overall Study|Death|1|||
146931943|NCT03483116|529908231|FG001|Overall Study|Death|0|||
146931944|NCT03483116|529908232|FG002|Overall Study|Death|2|||
146931945|NCT03483116|529908233|FG003|Overall Study|Death|1|||
146931946|NCT03483116|529908230|FG000|Overall Study|Withdrawal by Subject|14|||
146931947|NCT03483116|529908231|FG001|Overall Study|Withdrawal by Subject|16|||
146931948|NCT03483116|529908232|FG002|Overall Study|Withdrawal by Subject|14|||
146931949|NCT03483116|529908233|FG003|Overall Study|Withdrawal by Subject|16|||
146931950|NCT03483116|529908230|FG000|Overall Study|Unknown other reason|3|||
146931951|NCT03483116|529908231|FG001|Overall Study|Unknown other reason|2|||
146931952|NCT03483116|529908232|FG002|Overall Study|Unknown other reason|1|||
146931953|NCT03483116|529908233|FG003|Overall Study|Unknown other reason|1|||
146931954|NCT02475395|529908236|FG000|Overall Study|Protocol Violation|30|||
146931955|NCT02475395|529908237|FG001|Overall Study|Protocol Violation|3|||
146931956|NCT01512108|529911074|FG000|Overall Study|Adverse Event|9|||
146931957|NCT01512108|529911075|FG001|Overall Study|Adverse Event|4|||
146931958|NCT01512108|529911074|FG000|Overall Study|Protocol Violation|1|||
146931959|NCT01512108|529911075|FG001|Overall Study|Protocol Violation|2|||
146699355|NCT02641379|529076896|FG002|Overall Study|Participant treated after Week 24|0|||
146699356|NCT02641379|529076897|FG003|Overall Study|Participant treated after Week 24|0|||
146699357|NCT02641379|529076898|FG004|Overall Study|Participant treated after Week 24|0|||
146931960|NCT01512108|529911074|FG000|Overall Study|Withdrawal Criteria|1|||
146931961|NCT01512108|529911075|FG001|Overall Study|Withdrawal Criteria|0|||
146931962|NCT01512108|529911074|FG000|Overall Study|Unclassified|11|||
146931963|NCT01512108|529911075|FG001|Overall Study|Unclassified|3|||
146931964|NCT02017899|529911078|FG000|Overall Study|Withdrawal by Subject|0|||
146931965|NCT02017899|529911079|FG001|Overall Study|Withdrawal by Subject|0|||
146931966|NCT02017899|529911080|FG002|Overall Study|Withdrawal by Subject|0|||
146699358|NCT02641379|529076899|FG005|Overall Study|Participant treated after Week 24|0|||
146699359|NCT02641379|529076900|FG006|Overall Study|Participant treated after Week 24|0|||
146699360|NCT02641379|529076901|FG007|Overall Study|Participant treated after Week 24|0|||
146699361|NCT02641379|529076902|FG008|Overall Study|Participant treated after Week 24|1|||
146699362|NCT02641379|529076903|FG009|Overall Study|Participant treated after Week 24|0|||
146699363|NCT02641379|529076904|FG010|Overall Study|Participant treated after Week 24|0|||
146699364|NCT02641379|529076894|FG000|Overall Study|Missing PCR result at Week 8|0|||
146699365|NCT02641379|529076895|FG001|Overall Study|Missing PCR result at Week 8|0|||
146699366|NCT02641379|529076896|FG002|Overall Study|Missing PCR result at Week 8|0|||
146931967|NCT02017899|529911081|FG003|Overall Study|Withdrawal by Subject|1|||
146931968|NCT02017899|529911082|FG004|Overall Study|Withdrawal by Subject|1|||
146931969|NCT02017899|529911083|FG005|Overall Study|Withdrawal by Subject|0|||
146931970|NCT02843178|529911086|FG000|Overall Study|Lost to Follow-up|8|||
146699367|NCT02641379|529076897|FG003|Overall Study|Missing PCR result at Week 8|0|||
146699368|NCT02641379|529076898|FG004|Overall Study|Missing PCR result at Week 8|0|||
146699369|NCT02641379|529076899|FG005|Overall Study|Missing PCR result at Week 8|0|||
146699370|NCT02641379|529076900|FG006|Overall Study|Missing PCR result at Week 8|0|||
146931971|NCT02843178|529911087|FG001|Overall Study|Lost to Follow-up|8|||
146931972|NCT02843178|529911088|FG002|Overall Study|Lost to Follow-up|6|||
146931973|NCT02843178|529911089|FG003|Overall Study|Lost to Follow-up|3|||
146931974|NCT02843178|529911086|FG000|Overall Study|Withdrawal by Subject|0|||
146931975|NCT02843178|529911087|FG001|Overall Study|Withdrawal by Subject|0|||
146931976|NCT02843178|529911088|FG002|Overall Study|Withdrawal by Subject|1|||
146931977|NCT02843178|529911089|FG003|Overall Study|Withdrawal by Subject|1|||
146931978|NCT02420795|529911099|FG000|Overall Study|Withdrawal by Subject|1|||
146931979|NCT02420795|529911100|FG001|Overall Study|Withdrawal by Subject|0|||
146931980|NCT02420795|529911101|FG002|Overall Study|Withdrawal by Subject|0|||
146931981|NCT02420795|529911099|FG000|Overall Study|Adverse Event|1|||
146699371|NCT02641379|529076901|FG007|Overall Study|Missing PCR result at Week 8|0|||
146699372|NCT02641379|529076902|FG008|Overall Study|Missing PCR result at Week 8|0|||
146699373|NCT02641379|529076903|FG009|Overall Study|Missing PCR result at Week 8|1|||
146699374|NCT02641379|529076904|FG010|Overall Study|Missing PCR result at Week 8|0|||
146699375|NCT02641379|529076894|FG000|Overall Study|PCR positive|0|||
146699376|NCT02641379|529076895|FG001|Overall Study|PCR positive|0|||
146699377|NCT02641379|529076896|FG002|Overall Study|PCR positive|0|||
146699378|NCT02641379|529076897|FG003|Overall Study|PCR positive|0|||
146699379|NCT02641379|529076898|FG004|Overall Study|PCR positive|0|||
146699380|NCT02641379|529076899|FG005|Overall Study|PCR positive|0|||
146699381|NCT02641379|529076900|FG006|Overall Study|PCR positive|1|||
146699382|NCT02641379|529076901|FG007|Overall Study|PCR positive|0|||
146699383|NCT02641379|529076902|FG008|Overall Study|PCR positive|0|||
146699384|NCT02641379|529076903|FG009|Overall Study|PCR positive|0|||
146699385|NCT02641379|529076904|FG010|Overall Study|PCR positive|0|||
146699386|NCT03323658|529076907|FG000|Overall Study|Adverse Event|0|||
146699387|NCT03323658|529076908|FG001|Overall Study|Adverse Event|1|||
146699388|NCT03323658|529076909|FG002|Overall Study|Adverse Event|0|||
146699389|NCT00615056|529076910|FG000|Overall Study|Death|31|||
146699390|NCT00615056|529076911|FG001|Overall Study|Death|31|||
146699391|NCT00615056|529076912|FG002|Overall Study|Death|21|||
146699392|NCT00615056|529076913|FG003|Overall Study|Death|23|||
146699393|NCT00615056|529076910|FG000|Overall Study|Lost to Follow-up|1|||
146699394|NCT00615056|529076911|FG001|Overall Study|Lost to Follow-up|2|||
146699395|NCT00615056|529076912|FG002|Overall Study|Lost to Follow-up|4|||
146699396|NCT00615056|529076913|FG003|Overall Study|Lost to Follow-up|5|||
146699397|NCT00615056|529076910|FG000|Overall Study|Other|13|||
146699398|NCT00615056|529076911|FG001|Overall Study|Other|15|||
146699399|NCT00615056|529076912|FG002|Overall Study|Other|10|||
146699400|NCT00615056|529076913|FG003|Overall Study|Other|7|||
146699401|NCT00615056|529076910|FG000|Overall Study|Objective progression or relapse|0|||
146699402|NCT00615056|529076911|FG001|Overall Study|Objective progression or relapse|2|||
146699403|NCT00615056|529076912|FG002|Overall Study|Objective progression or relapse|0|||
146699404|NCT00615056|529076913|FG003|Overall Study|Objective progression or relapse|0|||
146699405|NCT00615056|529076910|FG000|Overall Study|Withdrawal by Subject|0|||
146699406|NCT00615056|529076911|FG001|Overall Study|Withdrawal by Subject|1|||
146699407|NCT00615056|529076912|FG002|Overall Study|Withdrawal by Subject|1|||
146699408|NCT00615056|529076913|FG003|Overall Study|Withdrawal by Subject|0|||
146699409|NCT00615056|529076910|FG000|Overall Study|Discontinued by Sponsor|1|||
146699410|NCT00615056|529076911|FG001|Overall Study|Discontinued by Sponsor|0|||
146699411|NCT00615056|529076912|FG002|Overall Study|Discontinued by Sponsor|0|||
146699412|NCT00615056|529076913|FG003|Overall Study|Discontinued by Sponsor|0|||
146699413|NCT00615056|529076910|FG000|Overall Study|Randomized but not treated|3|||
146699414|NCT00615056|529076911|FG001|Overall Study|Randomized but not treated|0|||
146699415|NCT00615056|529076912|FG002|Overall Study|Randomized but not treated|0|||
146699416|NCT00615056|529076913|FG003|Overall Study|Randomized but not treated|0|||
146699417|NCT04536727|529076914|FG000|Overall Study|Lost to Follow-up|1|||
146931982|NCT02420795|529911100|FG001|Overall Study|Adverse Event|0|||
146699418|NCT04536727|529076915|FG001|Overall Study|Lost to Follow-up|1|||
146699419|NCT04536727|529076914|FG000|Overall Study|Death|0|||
146699420|NCT04536727|529076915|FG001|Overall Study|Death|1|||
146699421|NCT00560950|529076918|FG000|Overall Study|Lost to Follow-up|1|||
146699422|NCT00560950|529076919|FG001|Overall Study|Lost to Follow-up|0|||
146699423|NCT05308901|529078169|FG000|Overall Study|Death|6|||
146699424|NCT03277846|529078170|FG000|Overall Study|Inpatient stay too brief|12|||
146699425|NCT03277846|529078171|FG001|Overall Study|Inpatient stay too brief|11|||
146699426|NCT03240575|529078172|FG000|Overall Study|Adverse Event|0|||
146699427|NCT03240575|529078173|FG001|Overall Study|Adverse Event|2|||
146699428|NCT03240575|529078174|FG002|Overall Study|Adverse Event|0|||
146699429|NCT03240575|529078175|FG003|Overall Study|Adverse Event|1|||
146699430|NCT03240575|529078172|FG000|Overall Study|Withdrawal by Subject|2|||
146699431|NCT03240575|529078173|FG001|Overall Study|Withdrawal by Subject|11|||
146699432|NCT03240575|529078174|FG002|Overall Study|Withdrawal by Subject|0|||
146699433|NCT03240575|529078175|FG003|Overall Study|Withdrawal by Subject|1|||
146931983|NCT02420795|529911101|FG002|Overall Study|Adverse Event|0|||
146699434|NCT03240575|529078172|FG000|Overall Study|Other|0|||
146699435|NCT03240575|529078173|FG001|Overall Study|Other|1|||
146699436|NCT03240575|529078174|FG002|Overall Study|Other|0|||
146699437|NCT03240575|529078175|FG003|Overall Study|Other|0|||
146699438|NCT02223767|529078180|FG000|Overall Study|Withdrawal by Subject|4|||
146699439|NCT02223767|529078181|FG001|Overall Study|Withdrawal by Subject|4|||
146699440|NCT02643251|529078183|FG000|Overall Study|Adverse Event|3|||
146699441|NCT02643251|529078184|FG001|Overall Study|Adverse Event|1|||
146699442|NCT02643251|529078183|FG000|Overall Study|Withdrawal by Subject|2|||
146699443|NCT02643251|529078184|FG001|Overall Study|Withdrawal by Subject|0|||
146699444|NCT02643251|529078183|FG000|Overall Study|Lost to Follow-up|4|||
146699445|NCT02643251|529078184|FG001|Overall Study|Lost to Follow-up|1|||
146931984|NCT02420795|529911099|FG000|Overall Study|Progressive disease|2|||
146931985|NCT02420795|529911100|FG001|Overall Study|Progressive disease|2|||
146699446|NCT02643251|529078183|FG000|Overall Study|Protocol Violation|1|||
146699447|NCT02643251|529078184|FG001|Overall Study|Protocol Violation|0|||
146699448|NCT02643251|529078183|FG000|Overall Study|PI Decision to terminate patient|1|||
146699449|NCT02643251|529078184|FG001|Overall Study|PI Decision to terminate patient|0|||
146699450|NCT01466270|529078185|FG000|Overall Study|Withdrawal by Subject|4|||
146699451|NCT01466270|529078186|FG001|Overall Study|Withdrawal by Subject|1|||
146699452|NCT01466270|529078185|FG000|Overall Study|Physician Decision|1|||
146699453|NCT01466270|529078186|FG001|Overall Study|Physician Decision|0|||
146699454|NCT01466270|529078185|FG000|Overall Study|Lost to Follow-up|1|||
146699455|NCT01466270|529078186|FG001|Overall Study|Lost to Follow-up|3|||
146699456|NCT01466270|529078185|FG000|Overall Study|Progression|1|||
146699457|NCT01466270|529078186|FG001|Overall Study|Progression|0|||
146699458|NCT01466270|529078185|FG000|Overall Study|Toxicity|4|||
146699459|NCT01466270|529078186|FG001|Overall Study|Toxicity|1|||
146699460|NCT01466270|529078185|FG000|Overall Study|Multiple|1|||
146699461|NCT01466270|529078186|FG001|Overall Study|Multiple|1|||
146699462|NCT02821962|529078187|FG000|Overall Study|Lost to Follow-up|2|||
146699463|NCT02821962|529078188|FG001|Overall Study|Lost to Follow-up|0|||
146699464|NCT02704364|529078189|FG000|Overall Study|Adverse Event|1|||
146699465|NCT02704364|529078190|FG001|Overall Study|Adverse Event|1|||
146699466|NCT02704364|529078191|FG002|Overall Study|Adverse Event|0|||
146699467|NCT02704364|529078189|FG000|Overall Study|Noncompliance with study drug|1|||
146699468|NCT02704364|529078190|FG001|Overall Study|Noncompliance with study drug|1|||
146699469|NCT02704364|529078191|FG002|Overall Study|Noncompliance with study drug|0|||
146699470|NCT02704364|529078189|FG000|Overall Study|Other|0|||
146699471|NCT02704364|529078190|FG001|Overall Study|Other|1|||
146699472|NCT02704364|529078191|FG002|Overall Study|Other|1|||
146699473|NCT04627064|529078193|FG000|Overall Study|Progressive disease|8|||
146699474|NCT04627064|529078194|FG001|Overall Study|Progressive disease|0|||
146699475|NCT04627064|529078193|FG000|Overall Study|Withdrawal by Subject|2|||
146699476|NCT04627064|529078194|FG001|Overall Study|Withdrawal by Subject|0|||
146699477|NCT04627064|529078193|FG000|Overall Study|Physician Decision|1|||
146699478|NCT04627064|529078194|FG001|Overall Study|Physician Decision|0|||
146699479|NCT01232296|529078195|FG000|Overall Study|Adverse Event|24|||
146699480|NCT01232296|529078196|FG001|Overall Study|Adverse Event|12|||
146699481|NCT01232296|529078195|FG000|Overall Study|Physician Decision|1|||
146699482|NCT01232296|529078196|FG001|Overall Study|Physician Decision|1|||
146699483|NCT01232296|529078195|FG000|Overall Study|Progressive disease|43|||
146699484|NCT01232296|529078196|FG001|Overall Study|Progressive disease|61|||
146699485|NCT01232296|529078195|FG000|Overall Study|Study terminated by sponsor|0|||
146699486|NCT01232296|529078196|FG001|Overall Study|Study terminated by sponsor|1|||
146699487|NCT01232296|529078195|FG000|Overall Study|Technical problems|3|||
146699488|NCT01232296|529078196|FG001|Overall Study|Technical problems|0|||
146699489|NCT01232296|529078195|FG000|Overall Study|Subject/guardian decision|10|||
146699490|NCT01232296|529078196|FG001|Overall Study|Subject/guardian decision|2|||
146699491|NCT01232296|529078195|FG000|Overall Study|Death|1|||
146699492|NCT01232296|529078196|FG001|Overall Study|Death|6|||
146699493|NCT00937547|529078198|FG000|Overall Study|misdiagnosis|1|||
146699494|NCT00937547|529078199|FG001|Overall Study|misdiagnosis|6|||
146699495|NCT00937547|529078200|FG002|Overall Study|misdiagnosis|7|||
146699496|NCT01234467|529078201|FG000|Overall Study|Adverse Event|3|||
146699497|NCT01234467|529078201|FG000|Overall Study|Death|2|||
146699498|NCT01234467|529078201|FG000|Overall Study|Withdrawal by Subject|2|||
146699499|NCT01234467|529078201|FG000|Overall Study|Disease Progression|2|||
146699500|NCT01234467|529078201|FG000|Overall Study|Clinical deterioration|1|||
146699501|NCT01234467|529078201|FG000|Overall Study|Physician Decision|1|||
146699502|NCT01234467|529078201|FG000|Overall Study|Other complicating disease (stroke)|1|||
146699503|NCT04889625|529078202|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
146699504|NCT04889625|529078203|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
146699505|NCT04889625|529078202|FG000|Period 1|Subject out of window|0|||
146699506|NCT04889625|529078203|FG001|Period 1|Subject out of window|1|||
146699507|NCT04889625|529078202|FG000|Period 1|Wrong add power dispensed|0|||
146776422|NCT02652260|529353611|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
146776423|NCT02652260|529353610|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
146776424|NCT02652260|529353611|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
146699508|NCT04889625|529078203|FG001|Period 1|Wrong add power dispensed|1|||
146699509|NCT04889625|529078202|FG000|Period 1|Discontinued due to fitting guide error|1|||
146699510|NCT04889625|529078203|FG001|Period 1|Discontinued due to fitting guide error|1|||
146699511|NCT04889625|529078202|FG000|Period 2|Test article no longer available|1|||
146699512|NCT04889625|529078203|FG001|Period 2|Test article no longer available|0|||
146776425|NCT02652260|529353610|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
146776426|NCT02652260|529353611|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
146776427|NCT02652260|529353610|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
146699513|NCT04889625|529078202|FG000|Period 2|Incorrect lens dispensed|1|||
146699514|NCT04889625|529078203|FG001|Period 2|Incorrect lens dispensed|0|||
146699515|NCT04889625|529078202|FG000|Period 2|Wrong add power dispensed|0|||
146699516|NCT04889625|529078203|FG001|Period 2|Wrong add power dispensed|1|||
146931986|NCT02420795|529911101|FG002|Overall Study|Progressive disease|4|||
146931987|NCT02420795|529911099|FG000|Overall Study|Death|0|||
146931988|NCT02420795|529911100|FG001|Overall Study|Death|0|||
146931989|NCT02420795|529911101|FG002|Overall Study|Death|1|||
146931990|NCT00949910|529911102|FG000|Overall Study|Progressive Disease|3750|||
146931991|NCT00949910|529911102|FG000|Overall Study|Symptomatic Deterioration|1088|||
146931992|NCT00949910|529911102|FG000|Overall Study|Lost to Follow-up|100|||
146931993|NCT00949910|529911102|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
146931994|NCT00949910|529911102|FG000|Overall Study|Participant Refusal|390|||
146931995|NCT00949910|529911102|FG000|Overall Study|Death Due to Malignant Disease|456|||
146931996|NCT00949910|529911102|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
146931997|NCT00949910|529911102|FG000|Overall Study|Death Due to Adverse Event|115|||
146931998|NCT00949910|529911102|FG000|Overall Study|Death Due to Toxicity|3|||
146931999|NCT00949910|529911102|FG000|Overall Study|Death from Unknown Cause|5|||
146932000|NCT00949910|529911102|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
146932001|NCT00949910|529911102|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
146932002|NCT00949910|529911102|FG000|Overall Study|Switched to Commercial Treatment|4|||
146932003|NCT00949910|529911102|FG000|Overall Study|Violation of Eligibility|23|||
146932004|NCT00949910|529911102|FG000|Overall Study|Logistical Reasons|13|||
146932005|NCT00949910|529911102|FG000|Overall Study|Non-Compliance|10|||
146932006|NCT00949910|529911102|FG000|Overall Study|Prolonged Dosing Interruption|4|||
146932007|NCT00949910|529911102|FG000|Overall Study|Adverse Event|83|||
146932008|NCT00949910|529911102|FG000|Overall Study|Serious Adverse Event|6|||
146932009|NCT00949910|529911102|FG000|Overall Study|Physician/Participant Decision|7|||
146932010|NCT00949910|529911102|FG000|Overall Study|Other|4|||
146932011|NCT00949910|529911102|FG000|Overall Study|No Data|9|||
146932012|NCT03287869|529911103|FG000|Overall Study|Adverse Event|14|||
146932013|NCT03287869|529911104|FG001|Overall Study|Adverse Event|12|||
146932014|NCT03287869|529911103|FG000|Overall Study|Lack of Efficacy|1|||
146932015|NCT03287869|529911104|FG001|Overall Study|Lack of Efficacy|0|||
146932016|NCT03287869|529911103|FG000|Overall Study|Lost to Follow-up|13|||
146932017|NCT03287869|529911104|FG001|Overall Study|Lost to Follow-up|19|||
146932018|NCT03287869|529911103|FG000|Overall Study|Non-Compliance With Study Drug|5|||
146932019|NCT03287869|529911104|FG001|Overall Study|Non-Compliance With Study Drug|9|||
146932020|NCT03287869|529911103|FG000|Overall Study|Progressive Disease|1|||
146932021|NCT03287869|529911104|FG001|Overall Study|Progressive Disease|0|||
146932022|NCT03287869|529911103|FG000|Overall Study|Protocol Deviation|2|||
146932023|NCT03287869|529911104|FG001|Overall Study|Protocol Deviation|1|||
146932024|NCT03287869|529911103|FG000|Overall Study|Withdrawal by Subject|36|||
146932025|NCT03287869|529911104|FG001|Overall Study|Withdrawal by Subject|43|||
146932026|NCT03287869|529911103|FG000|Overall Study|Early Closure of the Site|0|||
146932027|NCT03287869|529911104|FG001|Overall Study|Early Closure of the Site|1|||
146932028|NCT03287869|529911103|FG000|Overall Study|Physician Decision|5|||
146932029|NCT03287869|529911104|FG001|Overall Study|Physician Decision|5|||
146932030|NCT03287869|529911103|FG000|Overall Study|Reason not Specified|6|||
146932031|NCT03287869|529911104|FG001|Overall Study|Reason not Specified|3|||
146932032|NCT02455388|529911105|FG000|Overall Study|Protocol Violation|1|||
146699517|NCT00404352|529078213|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
146699518|NCT00404352|529078214|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
146699519|NCT00404352|529078215|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
146699520|NCT00404352|529078216|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
146699521|NCT00404352|529078217|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
146699522|NCT00404352|529078218|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
146699523|NCT00404352|529078219|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
146699524|NCT00404352|529078220|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
146699525|NCT00404352|529078221|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
146699526|NCT00404352|529078213|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
146699527|NCT00404352|529078214|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
146699528|NCT00404352|529078215|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
146699529|NCT00404352|529078216|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
146699530|NCT00404352|529078217|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
146699531|NCT00404352|529078218|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
146699532|NCT00404352|529078219|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
146932033|NCT02455388|529911106|FG001|Overall Study|Protocol Violation|0|||
146932034|NCT02455388|529911107|FG002|Overall Study|Protocol Violation|4|||
146932035|NCT02455388|529911105|FG000|Overall Study|Withdrawal by Subject|0|||
146932036|NCT02455388|529911106|FG001|Overall Study|Withdrawal by Subject|0|||
146932037|NCT02455388|529911107|FG002|Overall Study|Withdrawal by Subject|7|||
146932038|NCT04847141|529911108|FG000|Overall Study|Adverse Event|1|||
146932039|NCT04847141|529911109|FG001|Overall Study|Adverse Event|0|||
146932040|NCT04847141|529911110|FG002|Overall Study|Adverse Event|1|||
146932041|NCT04847141|529911108|FG000|Overall Study|Withdrawal by Subject|2|||
146932042|NCT04847141|529911109|FG001|Overall Study|Withdrawal by Subject|4|||
146932043|NCT04847141|529911110|FG002|Overall Study|Withdrawal by Subject|3|||
146932044|NCT04847141|529911108|FG000|Overall Study|Lost to Follow-up|7|||
146932045|NCT04847141|529911109|FG001|Overall Study|Lost to Follow-up|5|||
146699533|NCT00404352|529078220|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
146699534|NCT00404352|529078221|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
146699535|NCT00404352|529078213|FG000|Double Blind (up to 24 Month)|Death|0|||
146699536|NCT00404352|529078214|FG001|Double Blind (up to 24 Month)|Death|0|||
146699537|NCT00404352|529078215|FG002|Double Blind (up to 24 Month)|Death|1|||
146699538|NCT00404352|529078216|FG003|Double Blind (up to 24 Month)|Death|0|||
146699539|NCT00404352|529078217|FG004|Double Blind (up to 24 Month)|Death|0|||
146699540|NCT00404352|529078218|FG005|Double Blind (up to 24 Month)|Death|0|||
146699541|NCT00404352|529078219|FG006|Double Blind (up to 24 Month)|Death|0|||
146699542|NCT00404352|529078220|FG007|Double Blind (up to 24 Month)|Death|0|||
146699543|NCT00404352|529078221|FG008|Double Blind (up to 24 Month)|Death|0|||
146699544|NCT00404352|529078213|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
146699545|NCT00404352|529078214|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
146699546|NCT00404352|529078215|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
146699547|NCT00404352|529078216|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
146699548|NCT00404352|529078217|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
146699549|NCT00404352|529078218|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
146699550|NCT00404352|529078219|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
146699551|NCT00404352|529078220|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
146699552|NCT00404352|529078221|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
146699553|NCT00404352|529078213|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
146699554|NCT00404352|529078214|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
146699555|NCT00404352|529078215|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
146699556|NCT00404352|529078216|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
146699557|NCT00404352|529078217|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
146699558|NCT00404352|529078218|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
146699559|NCT00404352|529078219|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
146699560|NCT00404352|529078220|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
146699561|NCT00404352|529078221|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
146699562|NCT00404352|529078213|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
146699563|NCT00404352|529078214|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
146699564|NCT00404352|529078215|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
146699565|NCT00404352|529078216|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
146699566|NCT00404352|529078217|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
146699567|NCT00404352|529078218|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
146699568|NCT00404352|529078219|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
146699569|NCT00404352|529078220|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
146699570|NCT00404352|529078221|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
146699571|NCT00404352|529078213|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
146699572|NCT00404352|529078214|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
146699573|NCT00404352|529078215|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
146699574|NCT00404352|529078216|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
146699575|NCT00404352|529078217|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
146699576|NCT00404352|529078218|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
146699577|NCT00404352|529078219|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
146699578|NCT00404352|529078220|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
146699579|NCT00404352|529078221|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
146699580|NCT00404352|529078213|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
146699581|NCT00404352|529078214|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
146932046|NCT04847141|529911110|FG002|Overall Study|Lost to Follow-up|7|||
146932047|NCT04847141|529911108|FG000|Overall Study|Reason not Specified|0|||
146932048|NCT04847141|529911109|FG001|Overall Study|Reason not Specified|1|||
146932049|NCT04847141|529911110|FG002|Overall Study|Reason not Specified|0|||
146932050|NCT00324740|529911111|FG000|Overall Study|Withdrawal by Subject|1|||
146699582|NCT00404352|529078215|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
146699583|NCT00404352|529078216|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
146699584|NCT00404352|529078217|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
146699585|NCT00404352|529078218|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
146699586|NCT00404352|529078219|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
146699587|NCT00404352|529078220|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
146699588|NCT00404352|529078221|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
146699589|NCT00404352|529078213|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
146699590|NCT00404352|529078214|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
146699591|NCT00404352|529078215|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
146699592|NCT00404352|529078216|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
146699593|NCT00404352|529078217|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
146699594|NCT00404352|529078218|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
146776428|NCT02652260|529353611|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
146932051|NCT00324740|529911112|FG001|Overall Study|Withdrawal by Subject|0|||
146699595|NCT00404352|529078219|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
146699596|NCT00404352|529078220|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
146699597|NCT00404352|529078221|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
146699598|NCT00404352|529078213|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
146699599|NCT00404352|529078214|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
146699600|NCT00404352|529078215|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
146699601|NCT00404352|529078216|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
146932052|NCT00324740|529911113|FG002|Overall Study|Withdrawal by Subject|1|||
146932053|NCT00971425|529911118|FG000|Overall Study|Adverse Event|1|||
146932054|NCT00971425|529911119|FG001|Overall Study|Adverse Event|1|||
146932055|NCT00971425|529911118|FG000|Overall Study|Withdrawal by Subject|0|||
146932056|NCT00971425|529911119|FG001|Overall Study|Withdrawal by Subject|1|||
146932057|NCT01357980|529911120|FG000|Overall Study|Lack of Efficacy|0|||
146932058|NCT01357980|529911121|FG001|Overall Study|Lack of Efficacy|1|||
146932059|NCT01357980|529911122|FG002|Overall Study|Lack of Efficacy|0|||
146932060|NCT01357980|529911123|FG003|Overall Study|Lack of Efficacy|0|||
146932061|NCT01357980|529911120|FG000|Overall Study|Consent withdrawn|0|||
146932062|NCT01357980|529911121|FG001|Overall Study|Consent withdrawn|0|||
146932063|NCT01357980|529911122|FG002|Overall Study|Consent withdrawn|1|||
146932064|NCT01357980|529911123|FG003|Overall Study|Consent withdrawn|0|||
146932065|NCT02528253|529911124|FG000|Overall Study|Adverse Event|3|||
146932066|NCT02528253|529911125|FG001|Overall Study|Adverse Event|4|||
146932067|NCT02528253|529911126|FG002|Overall Study|Adverse Event|4|||
146932068|NCT02528253|529911127|FG003|Overall Study|Adverse Event|8|||
146932069|NCT02528253|529911128|FG004|Overall Study|Adverse Event|18|||
146932070|NCT02528253|529911124|FG000|Overall Study|Death|2|||
146932071|NCT02528253|529911125|FG001|Overall Study|Death|2|||
146932072|NCT02528253|529911126|FG002|Overall Study|Death|1|||
146932073|NCT02528253|529911127|FG003|Overall Study|Death|0|||
146932074|NCT02528253|529911128|FG004|Overall Study|Death|1|||
146932075|NCT02528253|529911124|FG000|Overall Study|Insufficient clinical response|7|||
146932076|NCT02528253|529911125|FG001|Overall Study|Insufficient clinical response|10|||
146932077|NCT02528253|529911126|FG002|Overall Study|Insufficient clinical response|13|||
146932078|NCT02528253|529911127|FG003|Overall Study|Insufficient clinical response|12|||
146932079|NCT02528253|529911128|FG004|Overall Study|Insufficient clinical response|16|||
146932080|NCT02528253|529911124|FG000|Overall Study|Lost to Follow-up|16|||
146932081|NCT02528253|529911125|FG001|Overall Study|Lost to Follow-up|9|||
146932082|NCT02528253|529911126|FG002|Overall Study|Lost to Follow-up|31|||
146932083|NCT02528253|529911127|FG003|Overall Study|Lost to Follow-up|16|||
146932084|NCT02528253|529911128|FG004|Overall Study|Lost to Follow-up|34|||
146932085|NCT02528253|529911124|FG000|Overall Study|Other|21|||
146932086|NCT02528253|529911125|FG001|Overall Study|Other|22|||
146932087|NCT02528253|529911126|FG002|Overall Study|Other|58|||
146932088|NCT02528253|529911127|FG003|Overall Study|Other|52|||
146932089|NCT02528253|529911128|FG004|Overall Study|Other|76|||
146932090|NCT02528253|529911124|FG000|Overall Study|Withdrawal by Subject|25|||
146932091|NCT02528253|529911125|FG001|Overall Study|Withdrawal by Subject|20|||
146932092|NCT02528253|529911126|FG002|Overall Study|Withdrawal by Subject|29|||
146932093|NCT02528253|529911127|FG003|Overall Study|Withdrawal by Subject|48|||
146932094|NCT02528253|529911128|FG004|Overall Study|Withdrawal by Subject|73|||
146932095|NCT02528253|529911124|FG000|Overall Study|Protocol Violation|1|||
146932096|NCT02528253|529911125|FG001|Overall Study|Protocol Violation|2|||
146932097|NCT02528253|529911126|FG002|Overall Study|Protocol Violation|4|||
146932098|NCT02528253|529911127|FG003|Overall Study|Protocol Violation|0|||
146932099|NCT02528253|529911128|FG004|Overall Study|Protocol Violation|4|||
146932100|NCT02528253|529911124|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
146932101|NCT02528253|529911125|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
146932102|NCT02528253|529911126|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
146699602|NCT00404352|529078217|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
146776429|NCT02652260|529353610|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
146776430|NCT02652260|529353611|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
146699603|NCT00404352|529078218|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
146932103|NCT02528253|529911127|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
146932104|NCT02528253|529911128|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
146932105|NCT00094835|529911131|FG000|Overall Study|Physician Decision|1|||
146932106|NCT00094835|529911132|FG001|Overall Study|Physician Decision|0|||
146932107|NCT00094835|529911133|FG002|Overall Study|Physician Decision|0|||
146932108|NCT00094835|529911134|FG003|Overall Study|Physician Decision|0|||
146932109|NCT00094835|529911135|FG004|Overall Study|Physician Decision|0|||
146932110|NCT00094835|529911136|FG005|Overall Study|Physician Decision|1|||
146932111|NCT00094835|529911137|FG006|Overall Study|Physician Decision|0|||
146932112|NCT00094835|529911131|FG000|Overall Study|Withdrawal by Subject|0|||
146932113|NCT00094835|529911132|FG001|Overall Study|Withdrawal by Subject|0|||
146932114|NCT00094835|529911133|FG002|Overall Study|Withdrawal by Subject|0|||
146932115|NCT00094835|529911134|FG003|Overall Study|Withdrawal by Subject|0|||
146932116|NCT00094835|529911135|FG004|Overall Study|Withdrawal by Subject|0|||
146932117|NCT00094835|529911136|FG005|Overall Study|Withdrawal by Subject|0|||
146932118|NCT00094835|529911137|FG006|Overall Study|Withdrawal by Subject|1|||
146932119|NCT00094835|529911131|FG000|Overall Study|Lost to Follow-up|0|||
146932120|NCT00094835|529911132|FG001|Overall Study|Lost to Follow-up|0|||
146699604|NCT00404352|529078219|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
146699605|NCT00404352|529078220|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
146699606|NCT00404352|529078221|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
146699607|NCT00404352|529078213|FG000|Double Blind (up to 24 Month)|Other|0|||
146699608|NCT00404352|529078214|FG001|Double Blind (up to 24 Month)|Other|1|||
146699609|NCT00404352|529078215|FG002|Double Blind (up to 24 Month)|Other|0|||
146699610|NCT00404352|529078216|FG003|Double Blind (up to 24 Month)|Other|0|||
146699611|NCT00404352|529078217|FG004|Double Blind (up to 24 Month)|Other|0|||
146699612|NCT00404352|529078218|FG005|Double Blind (up to 24 Month)|Other|0|||
146699613|NCT00404352|529078219|FG006|Double Blind (up to 24 Month)|Other|0|||
146699614|NCT00404352|529078220|FG007|Double Blind (up to 24 Month)|Other|0|||
146699615|NCT00404352|529078221|FG008|Double Blind (up to 24 Month)|Other|0|||
146699616|NCT00404352|529078213|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
146699617|NCT00404352|529078214|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
146699618|NCT00404352|529078215|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
146699619|NCT00404352|529078216|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
146699620|NCT00404352|529078217|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
146699621|NCT00404352|529078218|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
146699622|NCT00404352|529078219|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
146699623|NCT00404352|529078220|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
146699624|NCT00404352|529078221|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
146699625|NCT00404352|529078213|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
146699626|NCT00404352|529078214|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
146699627|NCT00404352|529078215|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
146699628|NCT00404352|529078216|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
146699629|NCT00404352|529078217|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
146699630|NCT00404352|529078218|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
146699631|NCT00404352|529078219|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
146699632|NCT00404352|529078220|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
146699633|NCT00404352|529078221|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
146699634|NCT00404352|529078213|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
146699635|NCT00404352|529078214|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
146699636|NCT00404352|529078215|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
146699637|NCT00404352|529078216|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
146699638|NCT00404352|529078217|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
146699639|NCT00404352|529078218|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
146699640|NCT00404352|529078219|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
146699641|NCT00404352|529078220|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
146699642|NCT00404352|529078221|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
146699643|NCT00404352|529078213|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
146699644|NCT00404352|529078214|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
146699645|NCT00404352|529078215|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
146699646|NCT00404352|529078216|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
146699647|NCT00404352|529078217|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
146699648|NCT00404352|529078218|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
146699649|NCT00404352|529078219|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
146699650|NCT00404352|529078220|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
146699651|NCT00404352|529078221|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
146699652|NCT00404352|529078213|FG000|Open Label (up to 24 Month)|Disease progression|0|||
146699653|NCT00404352|529078214|FG001|Open Label (up to 24 Month)|Disease progression|0|||
146699654|NCT00404352|529078215|FG002|Open Label (up to 24 Month)|Disease progression|0|||
146699655|NCT00404352|529078216|FG003|Open Label (up to 24 Month)|Disease progression|1|||
146699656|NCT00404352|529078217|FG004|Open Label (up to 24 Month)|Disease progression|0|||
146699657|NCT00404352|529078218|FG005|Open Label (up to 24 Month)|Disease progression|0|||
146699658|NCT00404352|529078219|FG006|Open Label (up to 24 Month)|Disease progression|0|||
146699659|NCT00404352|529078220|FG007|Open Label (up to 24 Month)|Disease progression|0|||
146699660|NCT00404352|529078221|FG008|Open Label (up to 24 Month)|Disease progression|0|||
146932121|NCT00094835|529911133|FG002|Overall Study|Lost to Follow-up|0|||
146932122|NCT00094835|529911134|FG003|Overall Study|Lost to Follow-up|0|||
146932123|NCT00094835|529911135|FG004|Overall Study|Lost to Follow-up|1|||
146932124|NCT00094835|529911136|FG005|Overall Study|Lost to Follow-up|0|||
146932125|NCT00094835|529911137|FG006|Overall Study|Lost to Follow-up|0|||
146699661|NCT00404352|529078213|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
146699662|NCT00404352|529078214|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
146699663|NCT00404352|529078215|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
146699664|NCT00404352|529078216|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
146699665|NCT00404352|529078217|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
146699666|NCT00404352|529078218|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
146932126|NCT00094835|529911131|FG000|Overall Study|Death|1|||
146932127|NCT00094835|529911132|FG001|Overall Study|Death|0|||
146932128|NCT00094835|529911133|FG002|Overall Study|Death|0|||
146699667|NCT00404352|529078219|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
146699668|NCT00404352|529078220|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
146699669|NCT00404352|529078221|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
146699670|NCT00404352|529078213|FG000|Open Label Extension (up to 36 Months)|Other|0|||
146699671|NCT00404352|529078214|FG001|Open Label Extension (up to 36 Months)|Other|0|||
146699672|NCT00404352|529078215|FG002|Open Label Extension (up to 36 Months)|Other|0|||
146699673|NCT00404352|529078216|FG003|Open Label Extension (up to 36 Months)|Other|0|||
146699674|NCT00404352|529078217|FG004|Open Label Extension (up to 36 Months)|Other|0|||
146699675|NCT00404352|529078218|FG005|Open Label Extension (up to 36 Months)|Other|0|||
146699676|NCT00404352|529078219|FG006|Open Label Extension (up to 36 Months)|Other|0|||
146699677|NCT00404352|529078220|FG007|Open Label Extension (up to 36 Months)|Other|0|||
146699678|NCT00404352|529078221|FG008|Open Label Extension (up to 36 Months)|Other|2|||
146699679|NCT04370691|529078224|FG000|Overall Study|Pending visit|48|||
146699680|NCT04370691|529078224|FG000|Overall Study|Have Not Reached Lower Window|15|||
146699681|NCT04370691|529078224|FG000|Overall Study|Termination|14|||
146699682|NCT04370691|529078224|FG000|Overall Study|Missed or Overdue|10|||
146699683|NCT00606892|529078230|FG000|First Intervention|Protocol Violation|1|||
146699684|NCT00606892|529078231|FG001|First Intervention|Protocol Violation|4|||
146699685|NCT04334460|529078244|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
146699686|NCT04334460|529078245|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
146699687|NCT04334460|529078244|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
146699688|NCT04334460|529078245|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
146699689|NCT03778931|529078246|FG000|Overall Study|Withdrawal by Subject|12|||
146699690|NCT03778931|529078247|FG001|Overall Study|Withdrawal by Subject|25|||
146699691|NCT03778931|529078246|FG000|Overall Study|Physician Decision|1|||
146699692|NCT03778931|529078247|FG001|Overall Study|Physician Decision|3|||
146699693|NCT03778931|529078246|FG000|Overall Study|Participant Noncompliance|1|||
146699694|NCT03778931|529078247|FG001|Overall Study|Participant Noncompliance|1|||
146699695|NCT03778931|529078246|FG000|Overall Study|Lost to Follow-up|4|||
146699696|NCT03778931|529078247|FG001|Overall Study|Lost to Follow-up|1|||
146699697|NCT03778931|529078246|FG000|Overall Study|Death|69|||
146699698|NCT03778931|529078247|FG001|Overall Study|Death|79|||
146699699|NCT02130765|529078250|FG000|Overall Study|Did not receive treatment|4|||
146699700|NCT02130765|529078251|FG001|Overall Study|Did not receive treatment|0|||
146699701|NCT02130765|529078252|FG002|Overall Study|Did not receive treatment|0|||
146699702|NCT02130765|529078253|FG003|Overall Study|Did not receive treatment|0|||
146699703|NCT03216850|529078261|FG000|Overall Study|Pre-analytical error|6|||
146699704|NCT01116232|529078262|FG000|Overall Study|Progressive diease|4|||
146699705|NCT03554291|529078263|FG000|Overall Study|Death|2|||
146699706|NCT03554291|529078264|FG001|Overall Study|Death|1|||
146699707|NCT03554291|529078263|FG000|Overall Study|Lost to Follow-up|1|||
146699708|NCT03554291|529078264|FG001|Overall Study|Lost to Follow-up|0|||
146699709|NCT03554291|529078263|FG000|Overall Study|Withdrawal by Subject|1|||
146699710|NCT03554291|529078264|FG001|Overall Study|Withdrawal by Subject|0|||
146699711|NCT03554291|529078263|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
146699712|NCT03554291|529078264|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
146699713|NCT01398956|529078270|FG000|Overall Study|Withdrawal by Subject|4|||
146699714|NCT01398956|529078270|FG000|Overall Study|AE, non-serious non-fatal|4|||
146699715|NCT01398956|529078270|FG000|Overall Study|Withdrawal Criteria No.3|1|||
146699716|NCT01398956|529078270|FG000|Overall Study|Subject moved a long distance|1|||
146699717|NCT00451035|529078271|FG000|Overall Study|Disease progression|11|||
146699718|NCT00451035|529078271|FG000|Overall Study|Death|3|||
146699719|NCT00451035|529078271|FG000|Overall Study|New anti-neoplastic therapy|3|||
146699720|NCT03274986|529078272|FG000|Overall Study|Withdrawal by Subject|0|||
146776431|NCT02652260|529353610|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
146699721|NCT03274986|529078273|FG001|Overall Study|Withdrawal by Subject|1|||
146776432|NCT02652260|529353611|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
146776433|NCT02652260|529353610|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
146776434|NCT02652260|529353611|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
146776435|NCT02652260|529353610|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
146776436|NCT02652260|529353611|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
146932129|NCT00094835|529911134|FG003|Overall Study|Death|0|||
146699722|NCT03274986|529078272|FG000|Overall Study|Lost to Follow-up|0|||
146699723|NCT03274986|529078273|FG001|Overall Study|Lost to Follow-up|1|||
146699724|NCT00603746|529078274|FG000|Overall Study|Adverse Event|2|||
146699725|NCT00603746|529078275|FG001|Overall Study|Adverse Event|3|||
146699726|NCT00603746|529078276|FG002|Overall Study|Adverse Event|0|||
146699727|NCT00603746|529078277|FG003|Overall Study|Adverse Event|1|||
146699728|NCT00603746|529078278|FG004|Overall Study|Adverse Event|0|||
146699729|NCT00603746|529078279|FG005|Overall Study|Adverse Event|4|||
146699730|NCT00603746|529078274|FG000|Overall Study|Lack of Efficacy|34|||
146699731|NCT00603746|529078275|FG001|Overall Study|Lack of Efficacy|11|||
146699732|NCT00603746|529078276|FG002|Overall Study|Lack of Efficacy|6|||
146699733|NCT00603746|529078277|FG003|Overall Study|Lack of Efficacy|11|||
146699734|NCT00603746|529078278|FG004|Overall Study|Lack of Efficacy|12|||
146699735|NCT00603746|529078279|FG005|Overall Study|Lack of Efficacy|8|||
146699736|NCT00603746|529078274|FG000|Overall Study|Protocol Violation|0|||
146699737|NCT00603746|529078275|FG001|Overall Study|Protocol Violation|3|||
146699738|NCT00603746|529078276|FG002|Overall Study|Protocol Violation|1|||
146699739|NCT00603746|529078277|FG003|Overall Study|Protocol Violation|0|||
146699740|NCT00603746|529078278|FG004|Overall Study|Protocol Violation|1|||
146699741|NCT00603746|529078279|FG005|Overall Study|Protocol Violation|0|||
146699742|NCT00603746|529078274|FG000|Overall Study|Lost to Follow-up|0|||
146699743|NCT00603746|529078275|FG001|Overall Study|Lost to Follow-up|1|||
146699744|NCT00603746|529078276|FG002|Overall Study|Lost to Follow-up|1|||
146699745|NCT00603746|529078277|FG003|Overall Study|Lost to Follow-up|0|||
146699746|NCT00603746|529078278|FG004|Overall Study|Lost to Follow-up|0|||
146699747|NCT00603746|529078279|FG005|Overall Study|Lost to Follow-up|0|||
146699748|NCT00603746|529078274|FG000|Overall Study|Physician Decision|1|||
146699749|NCT00603746|529078275|FG001|Overall Study|Physician Decision|0|||
146699750|NCT00603746|529078276|FG002|Overall Study|Physician Decision|0|||
146699751|NCT00603746|529078277|FG003|Overall Study|Physician Decision|0|||
146699752|NCT00603746|529078278|FG004|Overall Study|Physician Decision|1|||
146699753|NCT00603746|529078279|FG005|Overall Study|Physician Decision|0|||
146699754|NCT00603746|529078274|FG000|Overall Study|Withdrawal by Subject|1|||
146699755|NCT00603746|529078275|FG001|Overall Study|Withdrawal by Subject|0|||
146699756|NCT00603746|529078276|FG002|Overall Study|Withdrawal by Subject|0|||
146699757|NCT00603746|529078277|FG003|Overall Study|Withdrawal by Subject|1|||
146699758|NCT00603746|529078278|FG004|Overall Study|Withdrawal by Subject|3|||
146699759|NCT00603746|529078279|FG005|Overall Study|Withdrawal by Subject|1|||
146699760|NCT01524627|529078282|FG000|Overall Study|Physician Decision|0|||
146699761|NCT01524627|529078283|FG001|Overall Study|Physician Decision|1|||
146699762|NCT01524627|529078282|FG000|Overall Study|Lost to Follow-up|1|||
146699763|NCT01524627|529078283|FG001|Overall Study|Lost to Follow-up|1|||
146699764|NCT00717769|529078284|FG000|Overall Study|Adverse Event|9|||
146699765|NCT00717769|529078285|FG001|Overall Study|Adverse Event|6|||
146699766|NCT00717769|529078286|FG002|Overall Study|Adverse Event|1|||
146699767|NCT00717769|529078284|FG000|Overall Study|Lack of compliance|0|||
146699768|NCT00717769|529078285|FG001|Overall Study|Lack of compliance|2|||
146699769|NCT00717769|529078286|FG002|Overall Study|Lack of compliance|0|||
146699770|NCT00717769|529078284|FG000|Overall Study|Lost to Follow-up|3|||
146699771|NCT00717769|529078285|FG001|Overall Study|Lost to Follow-up|4|||
146699772|NCT00717769|529078286|FG002|Overall Study|Lost to Follow-up|0|||
146699773|NCT00717769|529078284|FG000|Overall Study|Lack of Efficacy|1|||
146699774|NCT00717769|529078285|FG001|Overall Study|Lack of Efficacy|2|||
146699775|NCT00717769|529078286|FG002|Overall Study|Lack of Efficacy|0|||
146699776|NCT00717769|529078284|FG000|Overall Study|Protocol Violation|0|||
146699777|NCT00717769|529078285|FG001|Overall Study|Protocol Violation|2|||
146699778|NCT00717769|529078286|FG002|Overall Study|Protocol Violation|0|||
146699779|NCT00717769|529078284|FG000|Overall Study|Sponsor decision|1|||
146699780|NCT00717769|529078285|FG001|Overall Study|Sponsor decision|0|||
146699781|NCT00717769|529078286|FG002|Overall Study|Sponsor decision|10|||
146699782|NCT00717769|529078284|FG000|Overall Study|Withdrew consent|2|||
146699783|NCT00717769|529078285|FG001|Overall Study|Withdrew consent|2|||
146699784|NCT00717769|529078286|FG002|Overall Study|Withdrew consent|0|||
146699785|NCT03350503|529078290|FG000|Overall Study|Adverse Event|5|||
146699786|NCT03350503|529078290|FG000|Overall Study|Withdrawal by Subject|5|||
146699787|NCT03350503|529078290|FG000|Overall Study|Continuation impossible due to move|4|||
146699788|NCT03350503|529078290|FG000|Overall Study|Physician Decision|3|||
146699789|NCT01399593|529078292|FG000|Overall Study|Physician Decision|1|||
146699790|NCT01399593|529078293|FG001|Overall Study|Physician Decision|0|||
146699791|NCT01399593|529078292|FG000|Overall Study|Adverse Event|1|||
146699792|NCT01399593|529078293|FG001|Overall Study|Adverse Event|0|||
146699793|NCT01399593|529078292|FG000|Overall Study|Death|1|||
146699794|NCT01399593|529078293|FG001|Overall Study|Death|1|||
146699795|NCT01399593|529078292|FG000|Overall Study|Transplantectomy|0|||
146699796|NCT01399593|529078293|FG001|Overall Study|Transplantectomy|1|||
146699797|NCT02357147|529078296|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
146699798|NCT02357147|529078297|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
146699799|NCT02357147|529078296|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
146699800|NCT02357147|529078297|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
146699801|NCT02357147|529078296|FG000|Combination Treatment Phase|Investigator Discretion|1|||
146699802|NCT02357147|529078297|FG001|Combination Treatment Phase|Investigator Discretion|1|||
146699803|NCT02357147|529078296|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
146699804|NCT02357147|529078297|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
146699805|NCT02357147|529078296|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
146699806|NCT02357147|529078297|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
146699807|NCT02357147|529078296|FG000|Combination Treatment Phase|Adverse Event|12|||
146699808|NCT02357147|529078297|FG001|Combination Treatment Phase|Adverse Event|4|||
146699809|NCT02357147|529078296|FG000|Combination Treatment Phase|Death|1|||
146932130|NCT00094835|529911135|FG004|Overall Study|Death|1|||
146932131|NCT00094835|529911136|FG005|Overall Study|Death|0|||
146932132|NCT00094835|529911137|FG006|Overall Study|Death|0|||
146932133|NCT00094835|529911131|FG000|Overall Study|Non-compliance|1|||
146932134|NCT00094835|529911132|FG001|Overall Study|Non-compliance|2|||
146932135|NCT00094835|529911133|FG002|Overall Study|Non-compliance|2|||
146932136|NCT00094835|529911134|FG003|Overall Study|Non-compliance|0|||
146932137|NCT00094835|529911135|FG004|Overall Study|Non-compliance|2|||
146932138|NCT00094835|529911136|FG005|Overall Study|Non-compliance|2|||
146932139|NCT00094835|529911137|FG006|Overall Study|Non-compliance|1|||
146932140|NCT00094835|529911131|FG000|Overall Study|Other|1|||
146932141|NCT00094835|529911132|FG001|Overall Study|Other|1|||
146932142|NCT00094835|529911133|FG002|Overall Study|Other|1|||
146699810|NCT02357147|529078297|FG001|Combination Treatment Phase|Death|1|||
146699811|NCT02357147|529078296|FG000|Combination Treatment Phase|Sponsor Decision|0|||
146699812|NCT02357147|529078297|FG001|Combination Treatment Phase|Sponsor Decision|12|||
146699813|NCT02357147|529078296|FG000|Combination Treatment Phase|Other|1|||
146699814|NCT02357147|529078297|FG001|Combination Treatment Phase|Other|0|||
146699815|NCT02357147|529078296|FG000|Combination Treatment Phase|Not treated|0|||
146699816|NCT02357147|529078297|FG001|Combination Treatment Phase|Not treated|2|||
146699817|NCT02357147|529078296|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
146699818|NCT02357147|529078297|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
146699819|NCT02357147|529078296|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146699820|NCT02357147|529078297|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
146699821|NCT02357147|529078296|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
146699822|NCT02357147|529078297|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
146699823|NCT02357147|529078296|FG000|Maintenance Treatment Phase|Adverse Event|0|||
146699824|NCT02357147|529078297|FG001|Maintenance Treatment Phase|Adverse Event|3|||
146699825|NCT02357147|529078296|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
146699826|NCT02357147|529078297|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
146699827|NCT02357147|529078296|FG000|Maintenance Treatment Phase|Not Treated|1|||
146699828|NCT02357147|529078297|FG001|Maintenance Treatment Phase|Not Treated|0|||
146699829|NCT03962543|529078300|FG000|Treatment Phase|Death|0|||
146699830|NCT03962543|529078301|FG001|Treatment Phase|Death|1|||
146699831|NCT03962543|529078300|FG000|Treatment Phase|Withdrawal by Subject|3|||
146699832|NCT03962543|529078301|FG001|Treatment Phase|Withdrawal by Subject|0|||
146699833|NCT03962543|529078300|FG000|Treatment Phase|Adverse Event|3|||
146699834|NCT03962543|529078301|FG001|Treatment Phase|Adverse Event|12|||
146699835|NCT03962543|529078300|FG000|Treatment Phase|Lost to Follow-up|1|||
146699836|NCT03962543|529078301|FG001|Treatment Phase|Lost to Follow-up|2|||
146699837|NCT03962543|529078300|FG000|Treatment Phase|Radiographic PD|9|||
146699838|NCT03962543|529078301|FG001|Treatment Phase|Radiographic PD|3|||
146699839|NCT03962543|529078300|FG000|Treatment Phase|Participant Decision|3|||
146699840|NCT03962543|529078301|FG001|Treatment Phase|Participant Decision|8|||
146699841|NCT03962543|529078300|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
146699842|NCT03962543|529078301|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
146699843|NCT03962543|529078300|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
146699844|NCT03962543|529078301|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
146699845|NCT03962543|529078300|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
146699846|NCT03962543|529078301|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
146699847|NCT03962543|529078300|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
146699848|NCT03962543|529078301|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
146699849|NCT03962543|529078300|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
146932143|NCT00094835|529911134|FG003|Overall Study|Other|1|||
146932144|NCT00094835|529911135|FG004|Overall Study|Other|0|||
146932145|NCT00094835|529911136|FG005|Overall Study|Other|0|||
146932146|NCT00094835|529911137|FG006|Overall Study|Other|0|||
146699850|NCT03962543|529078301|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
146699851|NCT03962543|529078300|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
146699852|NCT03962543|529078301|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
146699853|NCT03962543|529078300|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
146699854|NCT03962543|529078301|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
146699855|NCT03962543|529078300|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
146699856|NCT03962543|529078301|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
146699857|NCT03962543|529078300|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
146699858|NCT03962543|529078301|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
146932147|NCT00387348|529911138|FG000|Overall Study|Death|1|||
146932148|NCT00387348|529911139|FG001|Overall Study|Death|1|||
146932149|NCT00387348|529911140|FG002|Overall Study|Death|0|||
146699859|NCT03962543|529078300|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
146699860|NCT03962543|529078301|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
146699861|NCT02970968|529079772|FG000|Overall Study|Withdrawal by Subject|3|||
146699862|NCT02970968|529079773|FG001|Overall Study|Withdrawal by Subject|3|||
146932150|NCT00387348|529911138|FG000|Overall Study|Physician Decision|1|||
146932151|NCT00387348|529911139|FG001|Overall Study|Physician Decision|0|||
146932152|NCT00387348|529911140|FG002|Overall Study|Physician Decision|1|||
146932153|NCT00387348|529911138|FG000|Overall Study|Withdrawal by Subject|0|||
146932154|NCT00387348|529911139|FG001|Overall Study|Withdrawal by Subject|2|||
146932155|NCT00387348|529911140|FG002|Overall Study|Withdrawal by Subject|2|||
146699863|NCT02970968|529079772|FG000|Overall Study|Adverse Event|1|||
146699864|NCT02970968|529079773|FG001|Overall Study|Adverse Event|2|||
146699865|NCT02970968|529079772|FG000|Overall Study|Lost to Follow-up|1|||
146699866|NCT02970968|529079773|FG001|Overall Study|Lost to Follow-up|1|||
146932156|NCT00387348|529911138|FG000|Overall Study|Adverse Event|1|||
146932157|NCT00387348|529911139|FG001|Overall Study|Adverse Event|0|||
146932158|NCT00387348|529911140|FG002|Overall Study|Adverse Event|1|||
146932159|NCT00505752|529911141|FG000|Overall Study|Adverse Event|1|||
146932160|NCT00505752|529911142|FG001|Overall Study|Adverse Event|0|||
146932161|NCT00505752|529911143|FG002|Overall Study|Adverse Event|1|||
146932162|NCT00505752|529911144|FG003|Overall Study|Adverse Event|0|||
146932163|NCT00505752|529911141|FG000|Overall Study|Lost to Follow-up|1|||
146932164|NCT00505752|529911142|FG001|Overall Study|Lost to Follow-up|0|||
146932165|NCT00505752|529911143|FG002|Overall Study|Lost to Follow-up|0|||
146932166|NCT00505752|529911144|FG003|Overall Study|Lost to Follow-up|0|||
146932167|NCT00505752|529911141|FG000|Overall Study|Lack of ovarian response|1|||
146932168|NCT00505752|529911142|FG001|Overall Study|Lack of ovarian response|3|||
146932169|NCT00505752|529911143|FG002|Overall Study|Lack of ovarian response|0|||
146932170|NCT00505752|529911144|FG003|Overall Study|Lack of ovarian response|0|||
146932171|NCT00505752|529911141|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
146932172|NCT00505752|529911142|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
146932173|NCT00505752|529911143|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
146932174|NCT00505752|529911144|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
146932175|NCT00505752|529911141|FG000|Overall Study|No oocytes retrieved|0|||
146932176|NCT00505752|529911142|FG001|Overall Study|No oocytes retrieved|2|||
146932177|NCT00505752|529911143|FG002|Overall Study|No oocytes retrieved|0|||
146932178|NCT00505752|529911144|FG003|Overall Study|No oocytes retrieved|1|||
146932179|NCT00505752|529911141|FG000|Overall Study|No Fertilization|1|||
146932180|NCT00505752|529911142|FG001|Overall Study|No Fertilization|1|||
146932181|NCT00505752|529911143|FG002|Overall Study|No Fertilization|2|||
146932182|NCT00505752|529911144|FG003|Overall Study|No Fertilization|1|||
146932183|NCT00505752|529911141|FG000|Overall Study|All embryos/blastocysts discarded|0|||
146932184|NCT00505752|529911142|FG001|Overall Study|All embryos/blastocysts discarded|0|||
146932185|NCT00505752|529911143|FG002|Overall Study|All embryos/blastocysts discarded|1|||
146932186|NCT00505752|529911144|FG003|Overall Study|All embryos/blastocysts discarded|1|||
146932187|NCT00505752|529911141|FG000|Overall Study|Other|1|||
146699867|NCT02970968|529079772|FG000|Overall Study|Non-Compliance|0|||
146699868|NCT02970968|529079773|FG001|Overall Study|Non-Compliance|1|||
146699869|NCT01904604|529079776|FG000|Overall Study|Withdrew before receiving dosing|0|||
146699870|NCT01904604|529079777|FG001|Overall Study|Withdrew before receiving dosing|1|||
146699871|NCT01904604|529079778|FG002|Overall Study|Withdrew before receiving dosing|0|||
146699872|NCT01904604|529079776|FG000|Overall Study|Non-compliance|1|||
146699873|NCT01904604|529079777|FG001|Overall Study|Non-compliance|0|||
146699874|NCT01904604|529079778|FG002|Overall Study|Non-compliance|0|||
146699875|NCT01904604|529079776|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
146699876|NCT01904604|529079777|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
146699877|NCT01904604|529079778|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
146699878|NCT01904604|529079776|FG000|Overall Study|Patch site reactions|1|||
146699879|NCT01904604|529079777|FG001|Overall Study|Patch site reactions|1|||
146932188|NCT00505752|529911142|FG001|Overall Study|Other|2|||
146932189|NCT00505752|529911143|FG002|Overall Study|Other|1|||
146932190|NCT00505752|529911144|FG003|Overall Study|Other|2|||
146932191|NCT01149343|529911145|FG000|Overall Study|Withdrawal by Subject|1|||
146932192|NCT01149343|529911146|FG001|Overall Study|Withdrawal by Subject|1|||
146699880|NCT01904604|529079778|FG002|Overall Study|Patch site reactions|0|||
146699881|NCT01904604|529079776|FG000|Overall Study|Increased syncope|0|||
146776437|NCT02652260|529353610|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
146776438|NCT02652260|529353611|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
146776439|NCT02723955|529353612|FG000|Escalation Phase|Death|1|||
146932193|NCT01149343|529911147|FG002|Overall Study|Withdrawal by Subject|1|||
146932194|NCT01149343|529911148|FG003|Overall Study|Withdrawal by Subject|5|||
146932195|NCT01149343|529911145|FG000|Overall Study|Death|10|||
146932196|NCT01149343|529911146|FG001|Overall Study|Death|13|||
146699882|NCT01904604|529079777|FG001|Overall Study|Increased syncope|1|||
146699883|NCT01904604|529079778|FG002|Overall Study|Increased syncope|0|||
146776440|NCT02723955|529353613|FG001|Escalation Phase|Death|1|||
146932197|NCT01149343|529911147|FG002|Overall Study|Death|18|||
146932198|NCT01149343|529911148|FG003|Overall Study|Death|18|||
146932199|NCT01149343|529911145|FG000|Overall Study|Lost to Follow-up|1|||
146932200|NCT01149343|529911146|FG001|Overall Study|Lost to Follow-up|0|||
146699884|NCT01904604|529079776|FG000|Overall Study|Unrelated illness|0|||
146699885|NCT01904604|529079777|FG001|Overall Study|Unrelated illness|1|||
146776441|NCT02723955|529353614|FG002|Escalation Phase|Death|2|||
146932201|NCT01149343|529911147|FG002|Overall Study|Lost to Follow-up|0|||
146699886|NCT01904604|529079778|FG002|Overall Study|Unrelated illness|0|||
146699887|NCT01904604|529079776|FG000|Overall Study|Passed Week 52 OFC|1|||
146699888|NCT01904604|529079777|FG001|Overall Study|Passed Week 52 OFC|0|||
146699889|NCT01904604|529079778|FG002|Overall Study|Passed Week 52 OFC|0|||
146699890|NCT01904604|529079776|FG000|Overall Study|Withdrawal by Subject|1|||
146699891|NCT01904604|529079777|FG001|Overall Study|Withdrawal by Subject|2|||
146699892|NCT01904604|529079778|FG002|Overall Study|Withdrawal by Subject|0|||
146699893|NCT01904604|529079776|FG000|Overall Study|Participant Relocated|1|||
146699894|NCT01904604|529079777|FG001|Overall Study|Participant Relocated|1|||
146699895|NCT01904604|529079778|FG002|Overall Study|Participant Relocated|1|||
146699896|NCT01904604|529079776|FG000|Overall Study|Lost to Follow-up|0|||
146699897|NCT01904604|529079777|FG001|Overall Study|Lost to Follow-up|0|||
146699898|NCT01904604|529079778|FG002|Overall Study|Lost to Follow-up|1|||
146699899|NCT00697346|529079781|FG000|Overall Study|Adverse Event|4|||
146699900|NCT00697346|529079782|FG001|Overall Study|Adverse Event|5|||
146699901|NCT00697346|529079783|FG002|Overall Study|Adverse Event|0|||
146699902|NCT00697346|529079781|FG000|Overall Study|Progressive Disease|19|||
146699903|NCT00697346|529079782|FG001|Overall Study|Progressive Disease|18|||
146699904|NCT00697346|529079783|FG002|Overall Study|Progressive Disease|0|||
146699905|NCT00697346|529079781|FG000|Overall Study|Symptomatic Deterioration|0|||
146699906|NCT00697346|529079782|FG001|Overall Study|Symptomatic Deterioration|1|||
146699907|NCT00697346|529079783|FG002|Overall Study|Symptomatic Deterioration|0|||
146699908|NCT00697346|529079781|FG000|Overall Study|Withdrawal by Subject|2|||
146699909|NCT00697346|529079782|FG001|Overall Study|Withdrawal by Subject|2|||
146699910|NCT00697346|529079783|FG002|Overall Study|Withdrawal by Subject|0|||
146699911|NCT00697346|529079781|FG000|Overall Study|Reason not Specified|3|||
146699912|NCT00697346|529079782|FG001|Overall Study|Reason not Specified|0|||
146699913|NCT00697346|529079783|FG002|Overall Study|Reason not Specified|1|||
146699914|NCT03569371|529079784|FG000|Overall Study|Lack of Efficacy|1|||
146699915|NCT03569371|529079784|FG000|Overall Study|Lost to Follow-up|1|||
146699916|NCT03569371|529079784|FG000|Overall Study|Adverse Event|1|||
146699917|NCT03643562|529079785|FG000|Overall Study|Adverse Event|1|||
146699918|NCT03643562|529079786|FG001|Overall Study|Adverse Event|0|||
146699919|NCT03643562|529079785|FG000|Overall Study|Lack of Efficacy|0|||
146699920|NCT03643562|529079786|FG001|Overall Study|Lack of Efficacy|1|||
146699921|NCT03643562|529079785|FG000|Overall Study|Physician Decision|0|||
146699922|NCT03643562|529079786|FG001|Overall Study|Physician Decision|1|||
146699923|NCT03643562|529079785|FG000|Overall Study|Study Terminated by Sponsor|2|||
146699924|NCT03643562|529079786|FG001|Overall Study|Study Terminated by Sponsor|10|||
146699925|NCT03643562|529079785|FG000|Overall Study|Withdrawal by Subject|2|||
146699926|NCT03643562|529079786|FG001|Overall Study|Withdrawal by Subject|2|||
146699927|NCT03643562|529079785|FG000|Overall Study|Other than specified|3|||
146699928|NCT03643562|529079786|FG001|Overall Study|Other than specified|2|||
146699929|NCT04145895|529079787|FG000|Overall Study|Physician Decision|2|||
146699930|NCT04145895|529079788|FG001|Overall Study|Physician Decision|0|||
146699931|NCT04145895|529079787|FG000|Overall Study|Withdrawal by Subject|0|||
146699932|NCT04145895|529079788|FG001|Overall Study|Withdrawal by Subject|2|||
146699933|NCT01236755|529079789|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
146699934|NCT01236755|529079789|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
146699935|NCT01236755|529079789|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
146699936|NCT01236755|529079789|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
146699937|NCT01481116|529079790|FG000|Overall Study|Adverse Event|26|||
146699938|NCT01481116|529079791|FG001|Overall Study|Adverse Event|26|||
146699939|NCT01481116|529079792|FG002|Overall Study|Adverse Event|42|||
146699940|NCT01481116|529079790|FG000|Overall Study|Major Protocol Deviation|3|||
146699941|NCT01481116|529079791|FG001|Overall Study|Major Protocol Deviation|7|||
146699942|NCT01481116|529079792|FG002|Overall Study|Major Protocol Deviation|1|||
146699943|NCT01481116|529079790|FG000|Overall Study|Lost to Follow-up|8|||
146699944|NCT01481116|529079791|FG001|Overall Study|Lost to Follow-up|12|||
146699945|NCT01481116|529079792|FG002|Overall Study|Lost to Follow-up|11|||
146699946|NCT01481116|529079790|FG000|Overall Study|Withdrawal by Subject|37|||
146699947|NCT01481116|529079791|FG001|Overall Study|Withdrawal by Subject|33|||
146699948|NCT01481116|529079792|FG002|Overall Study|Withdrawal by Subject|37|||
146699949|NCT01481116|529079790|FG000|Overall Study|Study Termination|730|||
146699950|NCT01481116|529079791|FG001|Overall Study|Study Termination|729|||
146699951|NCT01481116|529079792|FG002|Overall Study|Study Termination|713|||
146699952|NCT01481116|529079790|FG000|Overall Study|Pregnancy|0|||
146699953|NCT01481116|529079791|FG001|Overall Study|Pregnancy|0|||
146699954|NCT01481116|529079792|FG002|Overall Study|Pregnancy|1|||
146699955|NCT01481116|529079790|FG000|Overall Study|Lack of Efficacy|3|||
146699956|NCT01481116|529079791|FG001|Overall Study|Lack of Efficacy|3|||
146699957|NCT01481116|529079792|FG002|Overall Study|Lack of Efficacy|1|||
146699958|NCT01481116|529079790|FG000|Overall Study|Contraindications|1|||
146699959|NCT01481116|529079791|FG001|Overall Study|Contraindications|1|||
146699960|NCT01481116|529079792|FG002|Overall Study|Contraindications|0|||
146699961|NCT01481116|529079790|FG000|Overall Study|Other|1|||
146699962|NCT01481116|529079791|FG001|Overall Study|Other|1|||
146699963|NCT01481116|529079792|FG002|Overall Study|Other|0|||
146699964|NCT01481116|529079790|FG000|Overall Study|Participant Started Taking Glipizide|1|||
146699965|NCT01481116|529079791|FG001|Overall Study|Participant Started Taking Glipizide|0|||
146699966|NCT01481116|529079792|FG002|Overall Study|Participant Started Taking Glipizide|0|||
146699967|NCT01481116|529079790|FG000|Overall Study|Participant Moved Out of Area|2|||
146699968|NCT01481116|529079791|FG001|Overall Study|Participant Moved Out of Area|0|||
146699969|NCT01481116|529079792|FG002|Overall Study|Participant Moved Out of Area|1|||
146699970|NCT01481116|529079790|FG000|Overall Study|Participant Moved Out of Country|1|||
146699971|NCT01481116|529079791|FG001|Overall Study|Participant Moved Out of Country|0|||
146699972|NCT01481116|529079792|FG002|Overall Study|Participant Moved Out of Country|1|||
146699973|NCT01481116|529079790|FG000|Overall Study|Investigator Decision|3|||
146699974|NCT01481116|529079791|FG001|Overall Study|Investigator Decision|2|||
146699975|NCT01481116|529079792|FG002|Overall Study|Investigator Decision|1|||
146699976|NCT01481116|529079790|FG000|Overall Study|Sponsor Decision|0|||
146699977|NCT01481116|529079791|FG001|Overall Study|Sponsor Decision|1|||
146699978|NCT01481116|529079792|FG002|Overall Study|Sponsor Decision|3|||
146699979|NCT01481116|529079790|FG000|Overall Study|Non-Compliant With Study Drug|0|||
146699980|NCT01481116|529079791|FG001|Overall Study|Non-Compliant With Study Drug|1|||
146699981|NCT01481116|529079792|FG002|Overall Study|Non-Compliant With Study Drug|1|||
146699982|NCT01481116|529079790|FG000|Overall Study|Investigator's Discretion|2|||
146699983|NCT01481116|529079791|FG001|Overall Study|Investigator's Discretion|0|||
146699984|NCT01481116|529079792|FG002|Overall Study|Investigator's Discretion|0|||
146699985|NCT01481116|529079790|FG000|Overall Study|Death|2|||
146699986|NCT01481116|529079791|FG001|Overall Study|Death|1|||
146699987|NCT01481116|529079792|FG002|Overall Study|Death|0|||
146699988|NCT01481116|529079790|FG000|Overall Study|Hypoglycemic Event|4|||
146699989|NCT01481116|529079791|FG001|Overall Study|Hypoglycemic Event|0|||
146699990|NCT01481116|529079792|FG002|Overall Study|Hypoglycemic Event|0|||
146699991|NCT00805935|529079793|FG000|Overall Study|Stimulation Failure|1|||
146699992|NCT00805935|529079794|FG001|Overall Study|Stimulation Failure|5|||
146699993|NCT00805935|529079795|FG002|Overall Study|Stimulation Failure|2|||
146699994|NCT00805935|529079796|FG003|Overall Study|Stimulation Failure|2|||
146699995|NCT00805935|529079793|FG000|Overall Study|Cycle cancelled|0|||
146699996|NCT00805935|529079794|FG001|Overall Study|Cycle cancelled|0|||
146699997|NCT00805935|529079795|FG002|Overall Study|Cycle cancelled|2|||
146699998|NCT00805935|529079796|FG003|Overall Study|Cycle cancelled|0|||
146699999|NCT00805935|529079793|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
146700000|NCT00805935|529079794|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
146700001|NCT00805935|529079795|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
146700002|NCT00805935|529079796|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
146700003|NCT00805935|529079793|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
146700004|NCT00805935|529079794|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
146700005|NCT00805935|529079795|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
146700006|NCT00805935|529079796|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
146700007|NCT00805935|529079793|FG000|Overall Study|Lost to Follow-up|1|||
146700008|NCT00805935|529079794|FG001|Overall Study|Lost to Follow-up|0|||
146700009|NCT00805935|529079795|FG002|Overall Study|Lost to Follow-up|0|||
146700010|NCT00805935|529079796|FG003|Overall Study|Lost to Follow-up|0|||
146700011|NCT00805935|529079793|FG000|Overall Study|No positive serum pregnancy|8|||
146700012|NCT00805935|529079794|FG001|Overall Study|No positive serum pregnancy|7|||
146700013|NCT00805935|529079795|FG002|Overall Study|No positive serum pregnancy|6|||
146700014|NCT00805935|529079796|FG003|Overall Study|No positive serum pregnancy|5|||
146700015|NCT00805935|529079793|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
146700016|NCT00805935|529079794|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
146700017|NCT00805935|529079795|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
146700018|NCT00805935|529079796|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
146700019|NCT00805935|529079793|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
146700020|NCT00805935|529079794|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
146700021|NCT00805935|529079795|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
146700022|NCT00805935|529079796|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
146700023|NCT00805935|529079793|FG000|Overall Study|Biochemical pregnancy|0|||
146700024|NCT00805935|529079794|FG001|Overall Study|Biochemical pregnancy|1|||
146700025|NCT00805935|529079795|FG002|Overall Study|Biochemical pregnancy|0|||
146700026|NCT00805935|529079796|FG003|Overall Study|Biochemical pregnancy|0|||
146700027|NCT00805935|529079793|FG000|Overall Study|Chemical pregnancy|0|||
146700028|NCT00805935|529079794|FG001|Overall Study|Chemical pregnancy|5|||
146700029|NCT00805935|529079795|FG002|Overall Study|Chemical pregnancy|3|||
146776442|NCT02723955|529353615|FG003|Escalation Phase|Death|7|||
146700030|NCT00805935|529079796|FG003|Overall Study|Chemical pregnancy|2|||
146700031|NCT00805935|529079793|FG000|Overall Study|Ectopic pregnancy|0|||
146700032|NCT00805935|529079794|FG001|Overall Study|Ectopic pregnancy|0|||
146700033|NCT00805935|529079795|FG002|Overall Study|Ectopic pregnancy|1|||
146700034|NCT00805935|529079796|FG003|Overall Study|Ectopic pregnancy|0|||
146700035|NCT00805935|529079793|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
146700036|NCT00805935|529079794|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
146700037|NCT00805935|529079795|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
146700038|NCT00805935|529079796|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
146700039|NCT02789176|529079797|FG000|Overall Study|Death|0|||
146700040|NCT02789176|529079798|FG001|Overall Study|Death|0|||
146700041|NCT02789176|529079799|FG002|Overall Study|Death|3|||
146700042|NCT02789176|529079800|FG003|Overall Study|Death|0|||
146700043|NCT02789176|529079797|FG000|Overall Study|Withdrawal by Subject|0|||
146700044|NCT02789176|529079798|FG001|Overall Study|Withdrawal by Subject|0|||
146700045|NCT02789176|529079799|FG002|Overall Study|Withdrawal by Subject|1|||
146700046|NCT02789176|529079800|FG003|Overall Study|Withdrawal by Subject|0|||
146700047|NCT02789176|529079797|FG000|Overall Study|Lost to Follow-up|8|||
146700048|NCT02789176|529079798|FG001|Overall Study|Lost to Follow-up|2|||
146700049|NCT02789176|529079799|FG002|Overall Study|Lost to Follow-up|6|||
146700050|NCT02789176|529079800|FG003|Overall Study|Lost to Follow-up|1|||
146700051|NCT00596011|529079802|FG000|Overall Study|Withdrawal by Subject|2|||
146700052|NCT00596011|529079803|FG001|Overall Study|Withdrawal by Subject|3|||
146700053|NCT00596011|529079802|FG000|Overall Study|Adverse Event|11|||
146700054|NCT00596011|529079803|FG001|Overall Study|Adverse Event|7|||
146700055|NCT02347527|529079804|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
146700056|NCT02347527|529079805|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
146700057|NCT02347527|529079806|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
146700058|NCT02347527|529079807|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
146700059|NCT02347527|529079804|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
146700060|NCT02347527|529079805|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
146700061|NCT02347527|529079806|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
146700062|NCT02347527|529079807|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
146700063|NCT02347527|529079804|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
146700064|NCT02347527|529079805|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
146700065|NCT02347527|529079806|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
146700066|NCT02347527|529079807|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
146700067|NCT02347527|529079804|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
146700068|NCT02347527|529079805|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
146700069|NCT02347527|529079806|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
146700070|NCT02347527|529079807|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
146700071|NCT02347527|529079804|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
146700072|NCT02347527|529079805|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
146700073|NCT02347527|529079806|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
146700074|NCT02347527|529079807|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
146700075|NCT00348556|529079808|FG000|Overall Study|Adverse Event|1|||
146700076|NCT00192075|529079809|FG000|Overall Study|Disease Progression|23|||
146700077|NCT00192075|529079810|FG001|Overall Study|Disease Progression|6|||
146700078|NCT00192075|529079809|FG000|Overall Study|Adverse Event|1|||
146700079|NCT00192075|529079810|FG001|Overall Study|Adverse Event|3|||
146700080|NCT00192075|529079809|FG000|Overall Study|Death|0|||
146700081|NCT00192075|529079810|FG001|Overall Study|Death|1|||
146700082|NCT00192075|529079809|FG000|Overall Study|Lack of Efficacy|0|||
146700083|NCT00192075|529079810|FG001|Overall Study|Lack of Efficacy|0|||
146700084|NCT00192075|529079809|FG000|Overall Study|Physician Decision|3|||
146700085|NCT00192075|529079810|FG001|Overall Study|Physician Decision|0|||
146700086|NCT00192075|529079809|FG000|Overall Study|Withdrawal by Subject|5|||
146700087|NCT00192075|529079810|FG001|Overall Study|Withdrawal by Subject|5|||
146700088|NCT00192075|529079809|FG000|Overall Study|Patient Non-Compliance|0|||
146700089|NCT00192075|529079810|FG001|Overall Study|Patient Non-Compliance|1|||
146700090|NCT00192075|529079809|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
146700091|NCT00192075|529079810|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
146700092|NCT00192075|529079809|FG000|Overall Study|Other|5|||
146700093|NCT00192075|529079810|FG001|Overall Study|Other|2|||
146700094|NCT01944059|529079811|FG000|Overall Study|Lost to Follow-up|1|||
146700095|NCT01944059|529079811|FG000|Overall Study|Physician Decision|3|||
146700096|NCT01944059|529079811|FG000|Overall Study|Withdrawal by Subject|1|||
146700097|NCT01944059|529079811|FG000|Overall Study|Adverse Event|2|||
146700098|NCT04206293|529079823|FG000|Overall Study|Consent withdrawal|1|||
146700099|NCT00430092|529079825|FG000|Overall Study|Adverse Event|0|||
146700100|NCT00430092|529079826|FG001|Overall Study|Adverse Event|0|||
146700101|NCT00430092|529079827|FG002|Overall Study|Adverse Event|1|||
146700102|NCT00430092|529079825|FG000|Overall Study|Lack of Efficacy|5|||
146700103|NCT00430092|529079826|FG001|Overall Study|Lack of Efficacy|2|||
146700104|NCT00430092|529079827|FG002|Overall Study|Lack of Efficacy|54|||
146700105|NCT00430092|529079825|FG000|Overall Study|Lost to Follow-up|1|||
146700106|NCT00430092|529079826|FG001|Overall Study|Lost to Follow-up|0|||
146700107|NCT00430092|529079827|FG002|Overall Study|Lost to Follow-up|0|||
146700108|NCT00430092|529079825|FG000|Overall Study|Protocol Violation|0|||
146700109|NCT00430092|529079826|FG001|Overall Study|Protocol Violation|1|||
146700110|NCT00430092|529079827|FG002|Overall Study|Protocol Violation|1|||
146700111|NCT00430092|529079825|FG000|Overall Study|Withdrawal by Subject|0|||
146700112|NCT00430092|529079826|FG001|Overall Study|Withdrawal by Subject|1|||
146700113|NCT00430092|529079827|FG002|Overall Study|Withdrawal by Subject|1|||
146700114|NCT00706966|529079830|FG000|Overall Study|Adverse Event|1|||
146700115|NCT03752619|529079838|FG000|Overall Study|Lost to Follow-up|2|||
146700116|NCT03752619|529079839|FG001|Overall Study|Lost to Follow-up|1|||
146700117|NCT03752619|529079838|FG000|Overall Study|Withdrawal by Subject|1|||
146700118|NCT03752619|529079839|FG001|Overall Study|Withdrawal by Subject|1|||
146700119|NCT03752619|529079838|FG000|Overall Study|Adverse Event|0|||
146700120|NCT03752619|529079839|FG001|Overall Study|Adverse Event|1|||
146700121|NCT05040152|529079840|FG000|Overall Study|Withdrawal by Subject|5|||
146700122|NCT05040152|529079841|FG001|Overall Study|Withdrawal by Subject|0|||
146700123|NCT05040152|529079840|FG000|Overall Study|Lost to Follow-up|0|||
146700124|NCT05040152|529079841|FG001|Overall Study|Lost to Follow-up|2|||
146700125|NCT03907683|529079842|FG000|Overall Study|Pregnancy|1|||
146700126|NCT03907683|529079842|FG000|Overall Study|Withdrawal by Subject|1|||
146700127|NCT03400332|529079843|FG000|Pre-Treatment|Other reasons|0|||
146700128|NCT03400332|529079844|FG001|Pre-Treatment|Other reasons|0|||
146700129|NCT03400332|529079845|FG002|Pre-Treatment|Other reasons|0|||
146700130|NCT03400332|529079846|FG003|Pre-Treatment|Other reasons|0|||
146700131|NCT03400332|529079847|FG004|Pre-Treatment|Other reasons|0|||
146700132|NCT03400332|529079848|FG005|Pre-Treatment|Other reasons|0|||
146700133|NCT03400332|529079849|FG006|Pre-Treatment|Other reasons|0|||
146700134|NCT03400332|529079850|FG007|Pre-Treatment|Other reasons|0|||
146700135|NCT03400332|529079851|FG008|Pre-Treatment|Other reasons|1|||
146700136|NCT03400332|529079843|FG000|Pre-Treatment|No longer met study criteria|0|||
146700137|NCT03400332|529079844|FG001|Pre-Treatment|No longer met study criteria|0|||
146700138|NCT03400332|529079845|FG002|Pre-Treatment|No longer met study criteria|0|||
146700139|NCT03400332|529079846|FG003|Pre-Treatment|No longer met study criteria|0|||
146700140|NCT03400332|529079847|FG004|Pre-Treatment|No longer met study criteria|0|||
146700141|NCT03400332|529079848|FG005|Pre-Treatment|No longer met study criteria|0|||
146700142|NCT03400332|529079849|FG006|Pre-Treatment|No longer met study criteria|0|||
146700143|NCT03400332|529079850|FG007|Pre-Treatment|No longer met study criteria|0|||
146700144|NCT03400332|529079851|FG008|Pre-Treatment|No longer met study criteria|1|||
146700145|NCT03400332|529079843|FG000|Pre-Treatment|Withdrawal by Subject|0|||
146700146|NCT03400332|529079844|FG001|Pre-Treatment|Withdrawal by Subject|0|||
146700147|NCT03400332|529079845|FG002|Pre-Treatment|Withdrawal by Subject|0|||
146700148|NCT03400332|529079846|FG003|Pre-Treatment|Withdrawal by Subject|0|||
146700149|NCT03400332|529079847|FG004|Pre-Treatment|Withdrawal by Subject|0|||
146700150|NCT03400332|529079848|FG005|Pre-Treatment|Withdrawal by Subject|0|||
146700151|NCT03400332|529079849|FG006|Pre-Treatment|Withdrawal by Subject|0|||
146700152|NCT03400332|529079850|FG007|Pre-Treatment|Withdrawal by Subject|0|||
146700153|NCT03400332|529079851|FG008|Pre-Treatment|Withdrawal by Subject|1|||
146700154|NCT03400332|529079843|FG000|Treatment|Participant withdrew consent|2|||
146700155|NCT03400332|529079844|FG001|Treatment|Participant withdrew consent|2|||
146700156|NCT03400332|529079845|FG002|Treatment|Participant withdrew consent|0|||
146700157|NCT03400332|529079846|FG003|Treatment|Participant withdrew consent|0|||
146700158|NCT03400332|529079847|FG004|Treatment|Participant withdrew consent|3|||
146700159|NCT03400332|529079848|FG005|Treatment|Participant withdrew consent|3|||
146700160|NCT03400332|529079849|FG006|Treatment|Participant withdrew consent|1|||
146700161|NCT03400332|529079850|FG007|Treatment|Participant withdrew consent|1|||
146700162|NCT03400332|529079851|FG008|Treatment|Participant withdrew consent|1|||
146700163|NCT03400332|529079843|FG000|Treatment|Other reasons|0|||
146700164|NCT03400332|529079844|FG001|Treatment|Other reasons|1|||
146700165|NCT03400332|529079845|FG002|Treatment|Other reasons|1|||
146700166|NCT03400332|529079846|FG003|Treatment|Other reasons|0|||
146700167|NCT03400332|529079847|FG004|Treatment|Other reasons|3|||
146700168|NCT03400332|529079848|FG005|Treatment|Other reasons|1|||
146700169|NCT03400332|529079849|FG006|Treatment|Other reasons|2|||
146700170|NCT03400332|529079850|FG007|Treatment|Other reasons|0|||
146700171|NCT03400332|529079851|FG008|Treatment|Other reasons|1|||
146932202|NCT01149343|529911148|FG003|Overall Study|Lost to Follow-up|1|||
146700172|NCT03400332|529079843|FG000|Treatment|Lost to Follow-up|0|||
146700173|NCT03400332|529079844|FG001|Treatment|Lost to Follow-up|1|||
146932203|NCT01149343|529911145|FG000|Overall Study|Other|8|||
146932204|NCT01149343|529911146|FG001|Overall Study|Other|10|||
146700174|NCT03400332|529079845|FG002|Treatment|Lost to Follow-up|0|||
146700175|NCT03400332|529079846|FG003|Treatment|Lost to Follow-up|0|||
146700176|NCT03400332|529079847|FG004|Treatment|Lost to Follow-up|0|||
146700177|NCT03400332|529079848|FG005|Treatment|Lost to Follow-up|0|||
146700178|NCT03400332|529079849|FG006|Treatment|Lost to Follow-up|0|||
146700179|NCT03400332|529079850|FG007|Treatment|Lost to Follow-up|0|||
146932205|NCT01149343|529911147|FG002|Overall Study|Other|2|||
146700180|NCT03400332|529079851|FG008|Treatment|Lost to Follow-up|0|||
146700181|NCT03400332|529079843|FG000|Treatment|Death|3|||
146700182|NCT03400332|529079844|FG001|Treatment|Death|1|||
146700183|NCT03400332|529079845|FG002|Treatment|Death|2|||
146700184|NCT03400332|529079846|FG003|Treatment|Death|3|||
146700185|NCT03400332|529079847|FG004|Treatment|Death|6|||
146700186|NCT03400332|529079848|FG005|Treatment|Death|2|||
146700187|NCT03400332|529079849|FG006|Treatment|Death|1|||
146700188|NCT03400332|529079850|FG007|Treatment|Death|3|||
146700189|NCT03400332|529079851|FG008|Treatment|Death|6|||
146700190|NCT02075840|529079854|FG000|Overall Study|Withdrawal by Subject|13|||
146700191|NCT02075840|529079855|FG001|Overall Study|Withdrawal by Subject|22|||
146700192|NCT02075840|529079854|FG000|Overall Study|Reason not specified|1|||
146700193|NCT02075840|529079855|FG001|Overall Study|Reason not specified|0|||
146700194|NCT02075840|529079854|FG000|Overall Study|Adverse Event|0|||
146700195|NCT02075840|529079855|FG001|Overall Study|Adverse Event|2|||
146700196|NCT02075840|529079854|FG000|Overall Study|Death|35|||
146700197|NCT02075840|529079855|FG001|Overall Study|Death|40|||
146700198|NCT02075840|529079854|FG000|Overall Study|Lost to Follow-up|3|||
146700199|NCT02075840|529079855|FG001|Overall Study|Lost to Follow-up|2|||
146700200|NCT02075840|529079854|FG000|Overall Study|Physician Decision|1|||
146700201|NCT02075840|529079855|FG001|Overall Study|Physician Decision|3|||
146700202|NCT02075840|529079854|FG000|Overall Study|Ongoing at CCOD|99|||
146700203|NCT02075840|529079855|FG001|Overall Study|Ongoing at CCOD|82|||
146700204|NCT03909165|529079858|FG000|Overall Study|Physician Decision|0|||
146700205|NCT03909165|529079859|FG001|Overall Study|Physician Decision|1|||
146700206|NCT03909165|529079860|FG002|Overall Study|Physician Decision|0|||
146700207|NCT03909165|529079861|FG003|Overall Study|Physician Decision|0|||
146700208|NCT03909165|529079862|FG004|Overall Study|Physician Decision|0|||
146700209|NCT03909165|529079858|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146700210|NCT03909165|529079859|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146700211|NCT03909165|529079860|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146700212|NCT03909165|529079861|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146700213|NCT03909165|529079862|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
146700214|NCT03909165|529079858|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
146700215|NCT03909165|529079859|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
146700216|NCT03909165|529079860|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
146700217|NCT03909165|529079861|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
146700218|NCT03909165|529079862|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
146700219|NCT03909165|529079858|FG000|Overall Study|Previous Drug Exposure|0|||
146700220|NCT03909165|529079859|FG001|Overall Study|Previous Drug Exposure|0|||
146700221|NCT03909165|529079860|FG002|Overall Study|Previous Drug Exposure|1|||
146700222|NCT03909165|529079861|FG003|Overall Study|Previous Drug Exposure|0|||
146700223|NCT03909165|529079862|FG004|Overall Study|Previous Drug Exposure|0|||
146700224|NCT03909165|529079858|FG000|Overall Study|Early Discharge|1|||
146700225|NCT03909165|529079859|FG001|Overall Study|Early Discharge|0|||
146700226|NCT03909165|529079860|FG002|Overall Study|Early Discharge|0|||
146700227|NCT03909165|529079861|FG003|Overall Study|Early Discharge|0|||
146700228|NCT03909165|529079862|FG004|Overall Study|Early Discharge|0|||
146700229|NCT00414661|529079866|FG000|Overall Study|Death|2|||
146700230|NCT00414661|529079867|FG001|Overall Study|Death|5|||
146700231|NCT00414661|529079868|FG002|Overall Study|Death|0|||
146700232|NCT00414661|529079869|FG003|Overall Study|Death|0|||
146700233|NCT00414661|529079866|FG000|Overall Study|Lost to Follow-up|1|||
146700234|NCT00414661|529079867|FG001|Overall Study|Lost to Follow-up|4|||
146700235|NCT00414661|529079868|FG002|Overall Study|Lost to Follow-up|0|||
146700236|NCT00414661|529079869|FG003|Overall Study|Lost to Follow-up|1|||
146700237|NCT00414661|529079866|FG000|Overall Study|Withdrawal by Subject|5|||
146700238|NCT00414661|529079867|FG001|Overall Study|Withdrawal by Subject|2|||
146700239|NCT00414661|529079868|FG002|Overall Study|Withdrawal by Subject|2|||
146700240|NCT00414661|529079869|FG003|Overall Study|Withdrawal by Subject|2|||
146700241|NCT00414661|529079866|FG000|Overall Study|Other|6|||
146700242|NCT00414661|529079867|FG001|Overall Study|Other|3|||
146700243|NCT00414661|529079868|FG002|Overall Study|Other|0|||
146700244|NCT00414661|529079869|FG003|Overall Study|Other|0|||
146700245|NCT00559962|529079870|FG000|Overall Study|Adverse Event|1|||
146700246|NCT00559962|529079871|FG001|Overall Study|Adverse Event|7|||
146700247|NCT00559962|529079872|FG002|Overall Study|Adverse Event|8|||
146700248|NCT00559962|529079873|FG003|Overall Study|Adverse Event|5|||
146700249|NCT00559962|529079874|FG004|Overall Study|Adverse Event|11|||
146700250|NCT00559962|529079875|FG005|Overall Study|Adverse Event|4|||
146700251|NCT00559962|529079876|FG006|Overall Study|Adverse Event|4|||
146700252|NCT00559962|529079877|FG007|Overall Study|Adverse Event|2|||
146700253|NCT00559962|529079870|FG000|Overall Study|Lost to Follow-up|0|||
146700254|NCT00559962|529079871|FG001|Overall Study|Lost to Follow-up|1|||
146700255|NCT00559962|529079872|FG002|Overall Study|Lost to Follow-up|0|||
146700256|NCT00559962|529079873|FG003|Overall Study|Lost to Follow-up|0|||
146700257|NCT00559962|529079874|FG004|Overall Study|Lost to Follow-up|0|||
146700258|NCT00559962|529079875|FG005|Overall Study|Lost to Follow-up|0|||
146700259|NCT00559962|529079876|FG006|Overall Study|Lost to Follow-up|0|||
146700260|NCT00559962|529079877|FG007|Overall Study|Lost to Follow-up|0|||
146700261|NCT00559962|529079870|FG000|Overall Study|Withdrawal by Subject|1|||
146700262|NCT00559962|529079871|FG001|Overall Study|Withdrawal by Subject|1|||
146700263|NCT00559962|529079872|FG002|Overall Study|Withdrawal by Subject|2|||
146700264|NCT00559962|529079873|FG003|Overall Study|Withdrawal by Subject|0|||
146700265|NCT00559962|529079874|FG004|Overall Study|Withdrawal by Subject|3|||
146700266|NCT00559962|529079875|FG005|Overall Study|Withdrawal by Subject|1|||
146700267|NCT00559962|529079876|FG006|Overall Study|Withdrawal by Subject|0|||
146700268|NCT00559962|529079877|FG007|Overall Study|Withdrawal by Subject|2|||
146700269|NCT00559962|529079870|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
146700270|NCT00559962|529079871|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
146700271|NCT00559962|529079872|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
146700272|NCT00559962|529079873|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
146700273|NCT00559962|529079874|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
146700274|NCT00559962|529079875|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
146700275|NCT00559962|529079876|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
146700276|NCT00559962|529079877|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
146700277|NCT03047135|529079878|FG000|Overall Study|Still being treated|3|||
146700278|NCT00323414|529079879|FG000|Overall Study|Withdrawal by Subject|0|||
146700279|NCT00323414|529079880|FG001|Overall Study|Withdrawal by Subject|1|||
146700280|NCT01077960|529079881|FG000|Overall Study|Adverse Event|6|||
146700281|NCT01077960|529079881|FG000|Overall Study|Protocol Violation|3|||
146700282|NCT01077960|529079881|FG000|Overall Study|Lost to Follow-up|5|||
146700283|NCT01077960|529079881|FG000|Overall Study|Subject decision|1|||
146700284|NCT01077960|529079881|FG000|Overall Study|Reason unspecified|1|||
146700285|NCT05619692|529079882|FG000|Overall Study|Adverse Event|2|||
146700286|NCT05619692|529079883|FG001|Overall Study|Adverse Event|2|||
146700287|NCT05619692|529079882|FG000|Overall Study|Withdrawal by Participant|3|||
146700288|NCT05619692|529079883|FG001|Overall Study|Withdrawal by Participant|4|||
146700289|NCT05619692|529079882|FG000|Overall Study|Lost to Follow-up|2|||
146700290|NCT05619692|529079883|FG001|Overall Study|Lost to Follow-up|1|||
146700291|NCT05619692|529079882|FG000|Overall Study|Randomized but not treated|1|||
146700292|NCT05619692|529079883|FG001|Overall Study|Randomized but not treated|3|||
146700293|NCT02703636|529079885|FG000|Overall Study|Adverse Event|14|||
146700294|NCT02703636|529079885|FG000|Overall Study|Study stopped by sponsor|1|||
146700295|NCT02703636|529079885|FG000|Overall Study|Withdrawal by Subject|1|||
146700296|NCT00969553|529079893|FG000|Overall Study|Progressive disease (PD)|2|||
146700297|NCT00969553|529079894|FG001|Overall Study|Progressive disease (PD)|2|||
146700298|NCT00969553|529079895|FG002|Overall Study|Progressive disease (PD)|6|||
146700299|NCT00969553|529079896|FG003|Overall Study|Progressive disease (PD)|9|||
146700300|NCT00969553|529079897|FG004|Overall Study|Progressive disease (PD)|2|||
146700301|NCT00969553|529079898|FG005|Overall Study|Progressive disease (PD)|4|||
146700302|NCT00969553|529079899|FG006|Overall Study|Progressive disease (PD)|2|||
146700303|NCT00969553|529079900|FG007|Overall Study|Progressive disease (PD)|12|||
146700304|NCT00969553|529079901|FG008|Overall Study|Progressive disease (PD)|3|||
146700305|NCT00969553|529079893|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
146700306|NCT00969553|529079894|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
146700307|NCT00969553|529079895|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
146700308|NCT00969553|529079896|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
146700309|NCT00969553|529079897|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
146700310|NCT00969553|529079898|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
146700311|NCT00969553|529079899|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
146700312|NCT00969553|529079900|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
146700313|NCT00969553|529079901|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
146700314|NCT00969553|529079893|FG000|Overall Study|Other Adverse Event|0|||
146700315|NCT00969553|529079894|FG001|Overall Study|Other Adverse Event|0|||
146700316|NCT00969553|529079895|FG002|Overall Study|Other Adverse Event|0|||
146700317|NCT00969553|529079896|FG003|Overall Study|Other Adverse Event|1|||
146776443|NCT02723955|529353616|FG004|Escalation Phase|Death|18|||
146776444|NCT02723955|529353617|FG005|Escalation Phase|Death|17|||
146776445|NCT02723955|529353618|FG006|Escalation Phase|Death|11|||
146776446|NCT02723955|529353619|FG007|Escalation Phase|Death|21|||
146776447|NCT02723955|529353620|FG008|Escalation Phase|Death|3|||
146776448|NCT02723955|529353621|FG009|Escalation Phase|Death|0|||
146700318|NCT00969553|529079897|FG004|Overall Study|Other Adverse Event|0|||
146700319|NCT00969553|529079898|FG005|Overall Study|Other Adverse Event|0|||
146700320|NCT00969553|529079899|FG006|Overall Study|Other Adverse Event|1|||
146700321|NCT00969553|529079900|FG007|Overall Study|Other Adverse Event|0|||
146700322|NCT00969553|529079901|FG008|Overall Study|Other Adverse Event|0|||
146700323|NCT00969553|529079893|FG000|Overall Study|Refused cont. medication|1|||
146700324|NCT00969553|529079894|FG001|Overall Study|Refused cont. medication|1|||
146700325|NCT00969553|529079895|FG002|Overall Study|Refused cont. medication|0|||
146700326|NCT00969553|529079896|FG003|Overall Study|Refused cont. medication|2|||
146700327|NCT00969553|529079897|FG004|Overall Study|Refused cont. medication|0|||
146700328|NCT00969553|529079898|FG005|Overall Study|Refused cont. medication|0|||
146700329|NCT00969553|529079899|FG006|Overall Study|Refused cont. medication|0|||
146700330|NCT00969553|529079900|FG007|Overall Study|Refused cont. medication|1|||
146700331|NCT00969553|529079901|FG008|Overall Study|Refused cont. medication|0|||
146700332|NCT00969553|529079893|FG000|Overall Study|Not specified above|0|||
146776449|NCT02723955|529353622|FG010|Escalation Phase|Death|0|||
146700333|NCT00969553|529079894|FG001|Overall Study|Not specified above|0|||
146700334|NCT00969553|529079895|FG002|Overall Study|Not specified above|0|||
146700335|NCT00969553|529079896|FG003|Overall Study|Not specified above|4|||
146700336|NCT00969553|529079897|FG004|Overall Study|Not specified above|0|||
146700337|NCT00969553|529079898|FG005|Overall Study|Not specified above|0|||
146700338|NCT00969553|529079899|FG006|Overall Study|Not specified above|1|||
146700339|NCT00969553|529079900|FG007|Overall Study|Not specified above|1|||
146700340|NCT00969553|529079901|FG008|Overall Study|Not specified above|0|||
146700341|NCT02321462|529079903|FG000|Overall Study|Withdrawal by Subject|5|||
146700342|NCT02321462|529079904|FG001|Overall Study|Withdrawal by Subject|2|||
146700343|NCT02321462|529079903|FG000|Overall Study|Subject withdrawn before any treatment|1|||
146700344|NCT02321462|529079904|FG001|Overall Study|Subject withdrawn before any treatment|1|||
146700345|NCT04327986|529079906|FG000|Overall Study|Physician Decision|2|||
146700346|NCT04327986|529079907|FG001|Overall Study|Physician Decision|0|||
146700347|NCT04327986|529079908|FG002|Overall Study|Physician Decision|0|||
146700348|NCT04327986|529079906|FG000|Overall Study|Death|1|||
146700349|NCT04327986|529079907|FG001|Overall Study|Death|0|||
146700350|NCT04327986|529079908|FG002|Overall Study|Death|0|||
146700351|NCT04248816|529079909|FG000|Overall Study|Ineligible post-randomization|7|||
146700352|NCT04248816|529079910|FG001|Overall Study|Ineligible post-randomization|21|||
146700353|NCT04248816|529079911|FG002|Overall Study|Ineligible post-randomization|25|||
146700354|NCT03829046|529079915|FG000|Overall Study|Withdrawal by Subject|1|||
146700355|NCT03829046|529079916|FG001|Overall Study|Withdrawal by Subject|0|||
146700356|NCT04477304|529079918|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
146700357|NCT04477304|529079919|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
146700358|NCT04482179|529081658|FG000|Overall Study|Death|1|||
146700359|NCT04482179|529081659|FG001|Overall Study|Death|0|||
146700360|NCT04482179|529081658|FG000|Overall Study|Withdrawal by Subject|1|||
146700361|NCT04482179|529081659|FG001|Overall Study|Withdrawal by Subject|0|||
146700362|NCT01302964|529081660|FG000|Overall Study|Adverse Event|1|||
146700363|NCT01302964|529081661|FG001|Overall Study|Adverse Event|0|||
146700364|NCT04127786|529081662|FG000|Primary Series|Adverse Event|1|||
146700365|NCT04127786|529081663|FG001|Primary Series|Adverse Event|0|||
146700366|NCT04127786|529081664|FG002|Primary Series|Adverse Event|0|||
146700367|NCT04127786|529081665|FG003|Primary Series|Adverse Event|1|||
146700368|NCT04127786|529081666|FG004|Primary Series|Adverse Event|0|||
146700369|NCT04127786|529081667|FG005|Primary Series|Adverse Event|1|||
146700370|NCT04127786|529081662|FG000|Primary Series|Protocol Violation|5|||
146700371|NCT04127786|529081663|FG001|Primary Series|Protocol Violation|3|||
146700372|NCT04127786|529081664|FG002|Primary Series|Protocol Violation|4|||
146700373|NCT04127786|529081665|FG003|Primary Series|Protocol Violation|3|||
146700374|NCT04127786|529081666|FG004|Primary Series|Protocol Violation|2|||
146700375|NCT04127786|529081667|FG005|Primary Series|Protocol Violation|0|||
146700376|NCT04127786|529081662|FG000|Primary Series|Withdrawal by Subject|0|||
146700377|NCT04127786|529081663|FG001|Primary Series|Withdrawal by Subject|0|||
146700378|NCT04127786|529081664|FG002|Primary Series|Withdrawal by Subject|0|||
146776450|NCT02723955|529353623|FG011|Escalation Phase|Death|0|||
146776451|NCT02723955|529353624|FG012|Escalation Phase|Death|2|||
146776452|NCT02723955|529353625|FG013|Escalation Phase|Death|4|||
146776453|NCT02723955|529353626|FG014|Escalation Phase|Death|5|||
146776454|NCT02723955|529353627|FG015|Escalation Phase|Death|6|||
146776455|NCT02723955|529353628|FG016|Escalation Phase|Death|6|||
146776456|NCT02723955|529353629|FG017|Escalation Phase|Death|7|||
146700379|NCT04127786|529081665|FG003|Primary Series|Withdrawal by Subject|1|||
146700380|NCT04127786|529081666|FG004|Primary Series|Withdrawal by Subject|0|||
146700381|NCT04127786|529081667|FG005|Primary Series|Withdrawal by Subject|0|||
146700382|NCT04127786|529081662|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
146700383|NCT04127786|529081663|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
146700384|NCT04127786|529081664|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
146700385|NCT04127786|529081665|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
146700386|NCT04127786|529081666|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
146700387|NCT04127786|529081667|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
146700388|NCT04127786|529081662|FG000|Booster Phase|Withdrawal by Subject|2|||
146700389|NCT04127786|529081663|FG001|Booster Phase|Withdrawal by Subject|0|||
146700390|NCT04127786|529081664|FG002|Booster Phase|Withdrawal by Subject|0|||
146700391|NCT04127786|529081665|FG003|Booster Phase|Withdrawal by Subject|0|||
146700392|NCT04127786|529081666|FG004|Booster Phase|Withdrawal by Subject|0|||
146700393|NCT04127786|529081667|FG005|Booster Phase|Withdrawal by Subject|0|||
146700394|NCT03848845|529081677|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
146700395|NCT03848845|529081678|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
146700396|NCT03848845|529081679|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
146700397|NCT03848845|529081680|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
146700398|NCT03848845|529081677|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
146700399|NCT03848845|529081678|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
146700400|NCT03848845|529081679|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
146776457|NCT02723955|529353630|FG018|Escalation Phase|Death|1|||
146776458|NCT02723955|529353631|FG019|Escalation Phase|Death|3|||
146776459|NCT02723955|529353632|FG020|Escalation Phase|Death|13|||
146776460|NCT02723955|529353633|FG021|Escalation Phase|Death|3|||
146776461|NCT02723955|529353634|FG022|Escalation Phase|Death|2|||
146776462|NCT02723955|529353635|FG023|Escalation Phase|Death|4|||
146776463|NCT02723955|529353636|FG024|Escalation Phase|Death|31|||
146776464|NCT02723955|529353637|FG025|Escalation Phase|Death|7|||
146776465|NCT02723955|529353638|FG026|Escalation Phase|Death|13|||
146776466|NCT02723955|529353639|FG027|Escalation Phase|Death|0|||
146776467|NCT02723955|529353640|FG028|Escalation Phase|Death|1|||
146776468|NCT02723955|529353641|FG029|Escalation Phase|Death|0|||
146776469|NCT02723955|529353642|FG030|Escalation Phase|Death|0|||
146776470|NCT02723955|529353643|FG031|Escalation Phase|Death|0|||
146776471|NCT02723955|529353644|FG032|Escalation Phase|Death|0|||
146776472|NCT02723955|529353645|FG033|Escalation Phase|Death|0|||
146776473|NCT02723955|529353646|FG034|Escalation Phase|Death|0|||
146932206|NCT01149343|529911148|FG003|Overall Study|Other|14|||
146932207|NCT01149343|529911145|FG000|Overall Study|Sponsor study termination|0|||
146932208|NCT01149343|529911146|FG001|Overall Study|Sponsor study termination|0|||
146932209|NCT01149343|529911147|FG002|Overall Study|Sponsor study termination|0|||
146932210|NCT01149343|529911148|FG003|Overall Study|Sponsor study termination|2|||
146932211|NCT01149343|529911145|FG000|Overall Study|Recurrence / Progressive disease|0|||
146932212|NCT01149343|529911146|FG001|Overall Study|Recurrence / Progressive disease|0|||
146932213|NCT01149343|529911147|FG002|Overall Study|Recurrence / Progressive disease|1|||
146932214|NCT01149343|529911148|FG003|Overall Study|Recurrence / Progressive disease|0|||
146932215|NCT04624672|529911152|FG000|Overall Study|Early Study Closure|2|||
146932216|NCT04624672|529911153|FG001|Overall Study|Early Study Closure|1|||
146932217|NCT03472040|529911154|FG000|Overall Study|Physician Decision|0|||
146932218|NCT03472040|529911155|FG001|Overall Study|Physician Decision|3|||
146932219|NCT03472040|529911154|FG000|Overall Study|Withdrawal by Subject|10|||
146932220|NCT03472040|529911155|FG001|Overall Study|Withdrawal by Subject|23|||
146932221|NCT03472040|529911154|FG000|Overall Study|Perceived Lack of Efficacy|29|||
146932222|NCT03472040|529911155|FG001|Overall Study|Perceived Lack of Efficacy|30|||
146932223|NCT03472040|529911154|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
146932224|NCT03472040|529911155|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
146932225|NCT03472040|529911154|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
146700401|NCT03848845|529081680|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
146700402|NCT03848845|529081677|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
146700403|NCT03848845|529081678|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
146700404|NCT03848845|529081679|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
146700405|NCT03848845|529081680|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
146700406|NCT03848845|529081677|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
146700407|NCT03848845|529081678|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
146700408|NCT03848845|529081679|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
146700409|NCT03848845|529081680|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
146700410|NCT02365636|529081681|FG000|Overall Study|Adverse Event|3|||
146700411|NCT02365636|529081682|FG001|Overall Study|Adverse Event|3|||
146700412|NCT02365636|529081683|FG002|Overall Study|Adverse Event|2|||
146700413|NCT02365636|529081681|FG000|Overall Study|Protocol Violation|1|||
146700414|NCT02365636|529081682|FG001|Overall Study|Protocol Violation|4|||
146700415|NCT02365636|529081683|FG002|Overall Study|Protocol Violation|0|||
146700416|NCT02365636|529081681|FG000|Overall Study|Lost to Follow-up|0|||
146700417|NCT02365636|529081682|FG001|Overall Study|Lost to Follow-up|0|||
146700418|NCT02365636|529081683|FG002|Overall Study|Lost to Follow-up|1|||
146700419|NCT02365636|529081681|FG000|Overall Study|Other|2|||
146700420|NCT02365636|529081682|FG001|Overall Study|Other|0|||
146700421|NCT02365636|529081683|FG002|Overall Study|Other|0|||
146776474|NCT02723955|529353647|FG035|Escalation Phase|Death|0|||
146776475|NCT02723955|529353648|FG036|Escalation Phase|Death|0|||
146776476|NCT02723955|529353649|FG037|Escalation Phase|Death|0|||
146932226|NCT03472040|529911155|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
146932227|NCT03472040|529911154|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
146932228|NCT03472040|529911155|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
146932229|NCT03472040|529911154|FG000|Overall Study|Subject Non-compliance|2|||
146700422|NCT01454934|529081684|FG000|Overall Study|Clinical progression|28|||
146700423|NCT01454934|529081685|FG001|Overall Study|Clinical progression|25|||
146700424|NCT01454934|529081684|FG000|Overall Study|Other|6|||
146700425|NCT01454934|529081685|FG001|Overall Study|Other|17|||
146776477|NCT02723955|529353650|FG038|Escalation Phase|Death|0|||
146932230|NCT03472040|529911155|FG001|Overall Study|Subject Non-compliance|5|||
146932231|NCT03472040|529911154|FG000|Overall Study|Discontinuation due to Rash|0|||
146932232|NCT03472040|529911155|FG001|Overall Study|Discontinuation due to Rash|1|||
146700426|NCT01454934|529081684|FG000|Overall Study|Adverse Event|28|||
146700427|NCT01454934|529081685|FG001|Overall Study|Adverse Event|24|||
146776478|NCT02723955|529353651|FG039|Escalation Phase|Death|0|||
146776479|NCT02723955|529353652|FG040|Escalation Phase|Death|0|||
146776480|NCT02723955|529353653|FG041|Escalation Phase|Death|0|||
146776481|NCT02723955|529353654|FG042|Escalation Phase|Death|0|||
146700428|NCT01454934|529081684|FG000|Overall Study|Withdrawn consent|2|||
146700429|NCT01454934|529081685|FG001|Overall Study|Withdrawn consent|5|||
146700430|NCT01454934|529081684|FG000|Overall Study|Withdrawal by Subject|11|||
146700431|NCT01454934|529081685|FG001|Overall Study|Withdrawal by Subject|15|||
146700432|NCT01454934|529081684|FG000|Overall Study|Disease progression|194|||
146700433|NCT01454934|529081685|FG001|Overall Study|Disease progression|181|||
146700434|NCT01454934|529081684|FG000|Overall Study|Lost to Follow-up|0|||
146700435|NCT01454934|529081685|FG001|Overall Study|Lost to Follow-up|1|||
146700436|NCT01454934|529081684|FG000|Overall Study|Not treated|1|||
146700437|NCT01454934|529081685|FG001|Overall Study|Not treated|2|||
146700438|NCT02884089|529081688|FG000|Period 1|Dosing error|2|||
146700439|NCT02884089|529081689|FG001|Period 1|Dosing error|2|||
146700440|NCT02884089|529081690|FG002|Period 1|Dosing error|0|||
146700441|NCT02884089|529081691|FG003|Period 1|Dosing error|0|||
146700442|NCT02884089|529081688|FG000|Washout Period 1|Lost to Follow-up|0|||
146700443|NCT02884089|529081689|FG001|Washout Period 1|Lost to Follow-up|1|||
146700444|NCT02884089|529081690|FG002|Washout Period 1|Lost to Follow-up|0|||
146700445|NCT02884089|529081691|FG003|Washout Period 1|Lost to Follow-up|1|||
146700446|NCT02884089|529081688|FG000|Washout Period 1|Withdrawal by Subject|0|||
146700447|NCT02884089|529081689|FG001|Washout Period 1|Withdrawal by Subject|1|||
146700448|NCT02884089|529081690|FG002|Washout Period 1|Withdrawal by Subject|0|||
146700449|NCT02884089|529081691|FG003|Washout Period 1|Withdrawal by Subject|0|||
146700450|NCT02884089|529081688|FG000|Period 2|Adverse Event|1|||
146700451|NCT02884089|529081689|FG001|Period 2|Adverse Event|0|||
146700452|NCT02884089|529081690|FG002|Period 2|Adverse Event|0|||
146700453|NCT02884089|529081691|FG003|Period 2|Adverse Event|0|||
146700454|NCT02884089|529081688|FG000|Period 3|Withdrawal by Subject|0|||
146700455|NCT02884089|529081689|FG001|Period 3|Withdrawal by Subject|0|||
146700456|NCT02884089|529081690|FG002|Period 3|Withdrawal by Subject|1|||
146700457|NCT02884089|529081691|FG003|Period 3|Withdrawal by Subject|0|||
146700458|NCT02884089|529081688|FG000|Washout Period 3|Withdrawal by Subject|0|||
146700459|NCT02884089|529081689|FG001|Washout Period 3|Withdrawal by Subject|0|||
146700460|NCT02884089|529081690|FG002|Washout Period 3|Withdrawal by Subject|1|||
146700461|NCT02884089|529081691|FG003|Washout Period 3|Withdrawal by Subject|0|||
146700462|NCT02884089|529081688|FG000|Washout Period 3|Lost to Follow-up|0|||
146700463|NCT02884089|529081689|FG001|Washout Period 3|Lost to Follow-up|0|||
146700464|NCT02884089|529081690|FG002|Washout Period 3|Lost to Follow-up|0|||
146700465|NCT02884089|529081691|FG003|Washout Period 3|Lost to Follow-up|1|||
146700466|NCT02884089|529081688|FG000|Period 4|Withdrawal by Subject|0|||
146700467|NCT02884089|529081689|FG001|Period 4|Withdrawal by Subject|1|||
146700468|NCT02884089|529081690|FG002|Period 4|Withdrawal by Subject|0|||
146700469|NCT02884089|529081691|FG003|Period 4|Withdrawal by Subject|0|||
146700470|NCT02884089|529081688|FG000|Period 4|Lost to Follow-up|1|||
146700471|NCT02884089|529081689|FG001|Period 4|Lost to Follow-up|0|||
146700472|NCT02884089|529081690|FG002|Period 4|Lost to Follow-up|0|||
146700473|NCT02884089|529081691|FG003|Period 4|Lost to Follow-up|0|||
146700474|NCT02884089|529081688|FG000|Follow-up Visit|Withdrawal by Subject|1|||
146700475|NCT02884089|529081689|FG001|Follow-up Visit|Withdrawal by Subject|0|||
146700476|NCT02884089|529081690|FG002|Follow-up Visit|Withdrawal by Subject|0|||
146700477|NCT02884089|529081691|FG003|Follow-up Visit|Withdrawal by Subject|1|||
146700478|NCT01631474|529081692|FG000|Overall Study|Lost to Follow-up|8|||
146700479|NCT01631474|529081693|FG001|Overall Study|Lost to Follow-up|5|||
146700480|NCT01631474|529081694|FG002|Overall Study|Lost to Follow-up|7|||
146776482|NCT02723955|529353612|FG000|Escalation Phase|Lost to Follow-up|0|||
146776483|NCT02723955|529353613|FG001|Escalation Phase|Lost to Follow-up|0|||
146776484|NCT02723955|529353614|FG002|Escalation Phase|Lost to Follow-up|0|||
146776485|NCT02723955|529353615|FG003|Escalation Phase|Lost to Follow-up|0|||
146776486|NCT02723955|529353616|FG004|Escalation Phase|Lost to Follow-up|0|||
146776487|NCT02723955|529353617|FG005|Escalation Phase|Lost to Follow-up|2|||
146776488|NCT02723955|529353618|FG006|Escalation Phase|Lost to Follow-up|1|||
146776489|NCT02723955|529353619|FG007|Escalation Phase|Lost to Follow-up|1|||
146776490|NCT02723955|529353620|FG008|Escalation Phase|Lost to Follow-up|1|||
146776491|NCT02723955|529353621|FG009|Escalation Phase|Lost to Follow-up|0|||
146776492|NCT02723955|529353622|FG010|Escalation Phase|Lost to Follow-up|0|||
146776493|NCT02723955|529353623|FG011|Escalation Phase|Lost to Follow-up|0|||
146776494|NCT02723955|529353624|FG012|Escalation Phase|Lost to Follow-up|1|||
146700481|NCT01631474|529081695|FG003|Overall Study|Lost to Follow-up|5|||
146700482|NCT01631474|529081696|FG004|Overall Study|Lost to Follow-up|5|||
146700483|NCT01631474|529081692|FG000|Overall Study|Withdrawal by Subject|4|||
146700484|NCT01631474|529081693|FG001|Overall Study|Withdrawal by Subject|4|||
146700485|NCT01631474|529081694|FG002|Overall Study|Withdrawal by Subject|2|||
146700486|NCT01631474|529081695|FG003|Overall Study|Withdrawal by Subject|6|||
146700487|NCT01631474|529081696|FG004|Overall Study|Withdrawal by Subject|5|||
146700488|NCT01631474|529081692|FG000|Overall Study|Lack of Efficacy|2|||
146700489|NCT01631474|529081693|FG001|Overall Study|Lack of Efficacy|2|||
146700490|NCT01631474|529081694|FG002|Overall Study|Lack of Efficacy|0|||
146776495|NCT02723955|529353625|FG013|Escalation Phase|Lost to Follow-up|0|||
146776496|NCT02723955|529353626|FG014|Escalation Phase|Lost to Follow-up|0|||
146776497|NCT02723955|529353627|FG015|Escalation Phase|Lost to Follow-up|0|||
146932233|NCT03472040|529911154|FG000|Overall Study|Subsequent Ineligibility|0|||
146932234|NCT03472040|529911155|FG001|Overall Study|Subsequent Ineligibility|2|||
146932235|NCT03472040|529911154|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
146932236|NCT03472040|529911155|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
146932237|NCT02769832|529911156|FG000|Overall Study|Death|30|||
146932238|NCT00225147|529911165|FG000|Open-label Phase|Lost to Follow-up|0|||
146932239|NCT00225147|529911166|FG001|Open-label Phase|Lost to Follow-up|0|||
146932240|NCT00225147|529911167|FG002|Open-label Phase|Lost to Follow-up|0|||
146932241|NCT00225147|529911168|FG003|Open-label Phase|Lost to Follow-up|4|||
146932242|NCT00225147|529911165|FG000|Open-label Phase|Withdrawal by Subject|0|||
146932243|NCT00225147|529911166|FG001|Open-label Phase|Withdrawal by Subject|0|||
146932244|NCT00225147|529911167|FG002|Open-label Phase|Withdrawal by Subject|0|||
146932245|NCT00225147|529911168|FG003|Open-label Phase|Withdrawal by Subject|6|||
146932246|NCT02685995|529911174|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
146932247|NCT02685995|529911175|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
146932248|NCT03625141|529911176|FG000|Overall Study|Adverse Event|0|||
146932249|NCT03625141|529911177|FG001|Overall Study|Adverse Event|2|||
146932250|NCT03625141|529911176|FG000|Overall Study|Study Terminated By Sponsor|1|||
146932251|NCT03625141|529911177|FG001|Overall Study|Study Terminated By Sponsor|13|||
146932252|NCT03625141|529911176|FG000|Overall Study|Withdrawal by Subject|3|||
146932253|NCT03625141|529911177|FG001|Overall Study|Withdrawal by Subject|0|||
146932254|NCT03625141|529911176|FG000|Overall Study|Withdrawal Of Consent|0|||
146932255|NCT03625141|529911177|FG001|Overall Study|Withdrawal Of Consent|1|||
146932256|NCT03625141|529911176|FG000|Overall Study|Death|11|||
146932257|NCT03625141|529911177|FG001|Overall Study|Death|47|||
146932258|NCT03625141|529911176|FG000|Overall Study|Progressive Disease|0|||
146932259|NCT03625141|529911177|FG001|Overall Study|Progressive Disease|2|||
146932260|NCT03250377|529911178|FG000|Overall Study|Adverse Event|2|||
146932261|NCT03250377|529911179|FG001|Overall Study|Adverse Event|4|||
146932262|NCT03250377|529911180|FG002|Overall Study|Adverse Event|0|||
146932263|NCT03250377|529911181|FG003|Overall Study|Adverse Event|4|||
146932264|NCT03250377|529911178|FG000|Overall Study|Lack of Efficacy|5|||
146932265|NCT03250377|529911179|FG001|Overall Study|Lack of Efficacy|14|||
146932266|NCT03250377|529911180|FG002|Overall Study|Lack of Efficacy|1|||
146932267|NCT03250377|529911181|FG003|Overall Study|Lack of Efficacy|3|||
146932268|NCT03250377|529911178|FG000|Overall Study|Protocol Violation|0|||
146932269|NCT03250377|529911179|FG001|Overall Study|Protocol Violation|2|||
146932270|NCT03250377|529911180|FG002|Overall Study|Protocol Violation|0|||
146932271|NCT03250377|529911181|FG003|Overall Study|Protocol Violation|1|||
146932272|NCT03250377|529911178|FG000|Overall Study|Lost to Follow-up|0|||
146700491|NCT01631474|529081695|FG003|Overall Study|Lack of Efficacy|0|||
146700492|NCT01631474|529081696|FG004|Overall Study|Lack of Efficacy|2|||
146700493|NCT01631474|529081692|FG000|Overall Study|Noncompliance with Study Drug|0|||
146700494|NCT01631474|529081693|FG001|Overall Study|Noncompliance with Study Drug|0|||
146700495|NCT01631474|529081694|FG002|Overall Study|Noncompliance with Study Drug|0|||
146700496|NCT01631474|529081695|FG003|Overall Study|Noncompliance with Study Drug|0|||
146700497|NCT01631474|529081696|FG004|Overall Study|Noncompliance with Study Drug|1|||
146700498|NCT01631474|529081692|FG000|Overall Study|Adverse Event|0|||
146700499|NCT01631474|529081693|FG001|Overall Study|Adverse Event|1|||
146700500|NCT01631474|529081694|FG002|Overall Study|Adverse Event|0|||
146700501|NCT01631474|529081695|FG003|Overall Study|Adverse Event|0|||
146700502|NCT01631474|529081696|FG004|Overall Study|Adverse Event|0|||
146700503|NCT01467076|529081697|FG000|Overall Study|Lost to Follow-up|1|||
146700504|NCT01467076|529081698|FG001|Overall Study|Lost to Follow-up|0|||
146932273|NCT03250377|529911179|FG001|Overall Study|Lost to Follow-up|1|||
146932274|NCT03250377|529911180|FG002|Overall Study|Lost to Follow-up|0|||
146932275|NCT03250377|529911181|FG003|Overall Study|Lost to Follow-up|0|||
146932276|NCT03250377|529911178|FG000|Overall Study|Withdrawal by Subject|7|||
146932277|NCT03250377|529911179|FG001|Overall Study|Withdrawal by Subject|7|||
146932278|NCT03250377|529911180|FG002|Overall Study|Withdrawal by Subject|0|||
146932279|NCT03250377|529911181|FG003|Overall Study|Withdrawal by Subject|4|||
146932280|NCT03250377|529911178|FG000|Overall Study|Investigator's Judgment|1|||
146932281|NCT03250377|529911179|FG001|Overall Study|Investigator's Judgment|0|||
146932282|NCT03250377|529911180|FG002|Overall Study|Investigator's Judgment|0|||
146932283|NCT03250377|529911181|FG003|Overall Study|Investigator's Judgment|0|||
146932284|NCT03250377|529911178|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
146932285|NCT03250377|529911179|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
146932286|NCT03250377|529911180|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
146932287|NCT03250377|529911181|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
146700505|NCT01467076|529081699|FG002|Overall Study|Lost to Follow-up|0|||
146700506|NCT03354429|529081700|FG000|Overall Study|Withdrawal by Subject|8|||
146700507|NCT03354429|529081701|FG001|Overall Study|Withdrawal by Subject|7|||
146932288|NCT03250377|529911178|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
146932289|NCT03250377|529911179|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
146700508|NCT03354429|529081700|FG000|Overall Study|Lost to Follow-up|1|||
146700509|NCT03354429|529081701|FG001|Overall Study|Lost to Follow-up|0|||
146700510|NCT05923229|529081702|FG000|Overall Study|Withdrawal by Subject|3|||
146700511|NCT05923229|529081703|FG001|Overall Study|Withdrawal by Subject|0|||
146700512|NCT05923229|529081702|FG000|Overall Study|Health related|2|||
146700513|NCT05923229|529081703|FG001|Overall Study|Health related|1|||
146700514|NCT03064126|529081704|FG000|Overall Study|Death|40|||
146700515|NCT03064126|529081705|FG001|Overall Study|Death|16|||
146700516|NCT03064126|529081706|FG002|Overall Study|Death|4|||
146700517|NCT03064126|529081707|FG003|Overall Study|Death|2|||
146700518|NCT03064126|529081704|FG000|Overall Study|Withdrawal by Subject|17|||
146700519|NCT03064126|529081705|FG001|Overall Study|Withdrawal by Subject|9|||
146700520|NCT03064126|529081706|FG002|Overall Study|Withdrawal by Subject|0|||
146700521|NCT03064126|529081707|FG003|Overall Study|Withdrawal by Subject|2|||
146700522|NCT03064126|529081704|FG000|Overall Study|Lost to Follow-up|7|||
146700523|NCT03064126|529081705|FG001|Overall Study|Lost to Follow-up|3|||
146700524|NCT03064126|529081706|FG002|Overall Study|Lost to Follow-up|0|||
146932290|NCT03250377|529911180|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
146932291|NCT03250377|529911181|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
146932292|NCT03250377|529911178|FG000|Overall Study|Epilepsy Surgery|0|||
146932293|NCT03250377|529911179|FG001|Overall Study|Epilepsy Surgery|1|||
146932294|NCT03250377|529911180|FG002|Overall Study|Epilepsy Surgery|2|||
146932295|NCT03250377|529911181|FG003|Overall Study|Epilepsy Surgery|0|||
146932296|NCT03250377|529911178|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
146932297|NCT03250377|529911179|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
146932298|NCT03250377|529911180|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
146932299|NCT03250377|529911181|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
146932300|NCT03250377|529911178|FG000|Overall Study|Request From The Sponsor|0|||
146932301|NCT03250377|529911179|FG001|Overall Study|Request From The Sponsor|1|||
146932302|NCT03250377|529911180|FG002|Overall Study|Request From The Sponsor|0|||
146932303|NCT03250377|529911181|FG003|Overall Study|Request From The Sponsor|0|||
146932304|NCT03250377|529911178|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
146932305|NCT03250377|529911179|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
146932306|NCT03250377|529911180|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
146932307|NCT03250377|529911181|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
146932308|NCT03250377|529911178|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
146932309|NCT03250377|529911179|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
146932310|NCT03250377|529911180|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
146932311|NCT03250377|529911181|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
146932312|NCT03250377|529911178|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
146932313|NCT03250377|529911179|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
146932314|NCT03250377|529911180|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
146932315|NCT03250377|529911181|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
146932316|NCT03250377|529911178|FG000|Overall Study|Pregnancy Event|0|||
146932317|NCT03250377|529911179|FG001|Overall Study|Pregnancy Event|1|||
146932318|NCT03250377|529911180|FG002|Overall Study|Pregnancy Event|0|||
146932319|NCT03250377|529911181|FG003|Overall Study|Pregnancy Event|0|||
146932320|NCT03250377|529911178|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
146932321|NCT03250377|529911179|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
146932322|NCT03250377|529911180|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
146932323|NCT03250377|529911181|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
146932324|NCT03250377|529911178|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
146932325|NCT03250377|529911179|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
146932326|NCT03250377|529911180|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
146932327|NCT03250377|529911181|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
146932328|NCT03250377|529911178|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
146932329|NCT03250377|529911179|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
146932330|NCT03250377|529911180|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
146700525|NCT03064126|529081707|FG003|Overall Study|Lost to Follow-up|0|||
146700526|NCT03064126|529081704|FG000|Overall Study|Adverse Event|2|||
146932331|NCT03250377|529911181|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
146932332|NCT03250377|529911178|FG000|Overall Study|Patient requested to change hospital|0|||
146932333|NCT03250377|529911179|FG001|Overall Study|Patient requested to change hospital|0|||
146932334|NCT03250377|529911180|FG002|Overall Study|Patient requested to change hospital|0|||
146932335|NCT03250377|529911181|FG003|Overall Study|Patient requested to change hospital|1|||
146932336|NCT03250377|529911178|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
146700527|NCT03064126|529081705|FG001|Overall Study|Adverse Event|0|||
146700528|NCT03064126|529081706|FG002|Overall Study|Adverse Event|0|||
146700529|NCT03064126|529081707|FG003|Overall Study|Adverse Event|0|||
146700530|NCT03064126|529081704|FG000|Overall Study|Physician Decision|3|||
146932337|NCT03250377|529911179|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
146700531|NCT03064126|529081705|FG001|Overall Study|Physician Decision|0|||
146700532|NCT03064126|529081706|FG002|Overall Study|Physician Decision|0|||
146700533|NCT03064126|529081707|FG003|Overall Study|Physician Decision|0|||
146700534|NCT03064126|529081704|FG000|Overall Study|Other reason for early termination|3|||
146700535|NCT03064126|529081705|FG001|Overall Study|Other reason for early termination|2|||
146700536|NCT03064126|529081706|FG002|Overall Study|Other reason for early termination|0|||
146700537|NCT03064126|529081707|FG003|Overall Study|Other reason for early termination|0|||
146700538|NCT03064126|529081704|FG000|Overall Study|Missed Visit|3|||
146700539|NCT03064126|529081705|FG001|Overall Study|Missed Visit|1|||
146700540|NCT03064126|529081706|FG002|Overall Study|Missed Visit|0|||
146700541|NCT03064126|529081707|FG003|Overall Study|Missed Visit|0|||
146700542|NCT05288556|529081711|FG000|Overall Study|Protocol Violation|1|||
146700543|NCT05288556|529081711|FG000|Overall Study|Withdrawal by Subject|1|||
146700544|NCT02465528|529081712|FG000|Overall Study|Progressive disease|0|||
146700545|NCT02465528|529081713|FG001|Overall Study|Progressive disease|2|||
146700546|NCT02465528|529081714|FG002|Overall Study|Progressive disease|9|||
146700547|NCT02465528|529081715|FG003|Overall Study|Progressive disease|4|||
146700548|NCT02465528|529081712|FG000|Overall Study|Study terminated by sponsor|1|||
146700549|NCT02465528|529081713|FG001|Overall Study|Study terminated by sponsor|2|||
146700550|NCT02465528|529081714|FG002|Overall Study|Study terminated by sponsor|0|||
146700551|NCT02465528|529081715|FG003|Overall Study|Study terminated by sponsor|0|||
146700552|NCT02465528|529081712|FG000|Overall Study|Withdrawal by Subject|0|||
146700553|NCT02465528|529081713|FG001|Overall Study|Withdrawal by Subject|0|||
146700554|NCT02465528|529081714|FG002|Overall Study|Withdrawal by Subject|2|||
146700555|NCT02465528|529081715|FG003|Overall Study|Withdrawal by Subject|0|||
146700556|NCT02465528|529081712|FG000|Overall Study|Adverse Event|0|||
146700557|NCT02465528|529081713|FG001|Overall Study|Adverse Event|0|||
146700558|NCT02465528|529081714|FG002|Overall Study|Adverse Event|0|||
146700559|NCT02465528|529081715|FG003|Overall Study|Adverse Event|1|||
146700560|NCT02465528|529081712|FG000|Overall Study|Physician Decision|0|||
146700561|NCT02465528|529081713|FG001|Overall Study|Physician Decision|0|||
146700562|NCT02465528|529081714|FG002|Overall Study|Physician Decision|1|||
146700563|NCT02465528|529081715|FG003|Overall Study|Physician Decision|0|||
146700564|NCT03795610|529081716|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
146700565|NCT03795610|529081716|FG000|Overall Study|Withdrawal by Subject|1|||
146700566|NCT03795610|529081716|FG000|Overall Study|Screen Failure (Unknown)|1|||
146700567|NCT01428193|529081727|FG000|Overall Study|Physician Decision|1|||
146700568|NCT01428193|529081727|FG000|Overall Study|Elevated screening liver enzymes|1|||
146700569|NCT03762083|529081728|FG000|Overall Study|Withdrawal by Subject|2|||
146700570|NCT03762083|529081728|FG000|Overall Study|Physician Decision|1|||
146700571|NCT02027844|529081729|FG000|Overall Study|Withdrawal by Subject|3|||
146700572|NCT02027844|529081730|FG001|Overall Study|Withdrawal by Subject|2|||
146700573|NCT02027844|529081731|FG002|Overall Study|Withdrawal by Subject|1|||
146700574|NCT02027844|529081729|FG000|Overall Study|Lost to Follow-up|0|||
146700575|NCT02027844|529081730|FG001|Overall Study|Lost to Follow-up|2|||
146700576|NCT02027844|529081731|FG002|Overall Study|Lost to Follow-up|1|||
146700577|NCT02027844|529081729|FG000|Overall Study|Protocol Violation|0|||
146700578|NCT02027844|529081730|FG001|Overall Study|Protocol Violation|2|||
146700579|NCT02027844|529081731|FG002|Overall Study|Protocol Violation|0|||
146700580|NCT02027844|529081729|FG000|Overall Study|Incomlete data|2|||
146700581|NCT02027844|529081730|FG001|Overall Study|Incomlete data|0|||
146700582|NCT02027844|529081731|FG002|Overall Study|Incomlete data|0|||
146700583|NCT02659020|529081732|FG000|Overall Study|Adverse Event|0|||
146700584|NCT02659020|529081733|FG001|Overall Study|Adverse Event|0|||
146700585|NCT02659020|529081734|FG002|Overall Study|Adverse Event|0|||
146700586|NCT02659020|529081735|FG003|Overall Study|Adverse Event|2|||
146932338|NCT03250377|529911180|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
146932339|NCT03250377|529911181|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
146932340|NCT02168803|529911182|FG000|Overall Study|Lost to Follow-up|1|||
146932341|NCT02168803|529911183|FG001|Overall Study|Lost to Follow-up|0|||
146932342|NCT02168803|529911184|FG002|Overall Study|Lost to Follow-up|1|||
146932343|NCT02168803|529911182|FG000|Overall Study|Withdrawal by Subject|1|||
146932344|NCT02168803|529911183|FG001|Overall Study|Withdrawal by Subject|1|||
146932345|NCT02168803|529911184|FG002|Overall Study|Withdrawal by Subject|2|||
146700587|NCT02659020|529081736|FG004|Overall Study|Adverse Event|0|||
146700588|NCT02659020|529081737|FG005|Overall Study|Adverse Event|0|||
146700589|NCT02659020|529081738|FG006|Overall Study|Adverse Event|2|||
146700590|NCT02659020|529081732|FG000|Overall Study|Lost to Follow-up|1|||
146700591|NCT02659020|529081733|FG001|Overall Study|Lost to Follow-up|2|||
146700592|NCT02659020|529081734|FG002|Overall Study|Lost to Follow-up|1|||
146700593|NCT02659020|529081735|FG003|Overall Study|Lost to Follow-up|6|||
146700594|NCT02659020|529081736|FG004|Overall Study|Lost to Follow-up|1|||
146700595|NCT02659020|529081737|FG005|Overall Study|Lost to Follow-up|5|||
146700596|NCT02659020|529081738|FG006|Overall Study|Lost to Follow-up|0|||
146700597|NCT02659020|529081732|FG000|Overall Study|Physician Decision|0|||
146700598|NCT02659020|529081733|FG001|Overall Study|Physician Decision|0|||
146700599|NCT02659020|529081734|FG002|Overall Study|Physician Decision|0|||
146700600|NCT02659020|529081735|FG003|Overall Study|Physician Decision|1|||
146700601|NCT02659020|529081736|FG004|Overall Study|Physician Decision|1|||
146700602|NCT02659020|529081737|FG005|Overall Study|Physician Decision|0|||
146700603|NCT02659020|529081738|FG006|Overall Study|Physician Decision|1|||
146700604|NCT02659020|529081732|FG000|Overall Study|Withdrawal by Subject|2|||
146700605|NCT02659020|529081733|FG001|Overall Study|Withdrawal by Subject|1|||
146700606|NCT02659020|529081734|FG002|Overall Study|Withdrawal by Subject|0|||
146700607|NCT02659020|529081735|FG003|Overall Study|Withdrawal by Subject|3|||
146700608|NCT02659020|529081736|FG004|Overall Study|Withdrawal by Subject|3|||
146700609|NCT02659020|529081737|FG005|Overall Study|Withdrawal by Subject|6|||
146700610|NCT02659020|529081738|FG006|Overall Study|Withdrawal by Subject|3|||
146700611|NCT02659020|529081732|FG000|Overall Study|Progressive Disease|0|||
146700612|NCT02659020|529081733|FG001|Overall Study|Progressive Disease|0|||
146700613|NCT02659020|529081734|FG002|Overall Study|Progressive Disease|0|||
146700614|NCT02659020|529081735|FG003|Overall Study|Progressive Disease|4|||
146700615|NCT02659020|529081736|FG004|Overall Study|Progressive Disease|1|||
146700616|NCT02659020|529081737|FG005|Overall Study|Progressive Disease|0|||
146700617|NCT02659020|529081738|FG006|Overall Study|Progressive Disease|2|||
146700618|NCT04049760|529081740|FG000|Overall Study|Withdrawal by Subject|1|||
146700619|NCT02457598|529081741|FG000|Overall Study|Progressive Disease|2|||
146700620|NCT02457598|529081742|FG001|Overall Study|Progressive Disease|2|||
146700621|NCT02457598|529081743|FG002|Overall Study|Progressive Disease|1|||
146700622|NCT02457598|529081744|FG003|Overall Study|Progressive Disease|11|||
146700623|NCT02457598|529081745|FG004|Overall Study|Progressive Disease|7|||
146700624|NCT02457598|529081746|FG005|Overall Study|Progressive Disease|3|||
146700625|NCT02457598|529081747|FG006|Overall Study|Progressive Disease|2|||
146700626|NCT02457598|529081748|FG007|Overall Study|Progressive Disease|1|||
146700627|NCT02457598|529081749|FG008|Overall Study|Progressive Disease|1|||
146700628|NCT02457598|529081750|FG009|Overall Study|Progressive Disease|2|||
146700629|NCT02457598|529081751|FG010|Overall Study|Progressive Disease|45|||
146700630|NCT02457598|529081752|FG011|Overall Study|Progressive Disease|6|||
146700631|NCT02457598|529081753|FG012|Overall Study|Progressive Disease|2|||
146700632|NCT02457598|529081754|FG013|Overall Study|Progressive Disease|2|||
146700633|NCT02457598|529081755|FG014|Overall Study|Progressive Disease|10|||
146700634|NCT02457598|529081756|FG015|Overall Study|Progressive Disease|1|||
146700635|NCT02457598|529081757|FG016|Overall Study|Progressive Disease|1|||
146700636|NCT02457598|529081741|FG000|Overall Study|Investigator's Discretion|0|||
146700637|NCT02457598|529081742|FG001|Overall Study|Investigator's Discretion|2|||
146700638|NCT02457598|529081743|FG002|Overall Study|Investigator's Discretion|2|||
146700639|NCT02457598|529081744|FG003|Overall Study|Investigator's Discretion|2|||
146700640|NCT02457598|529081745|FG004|Overall Study|Investigator's Discretion|0|||
146700641|NCT02457598|529081746|FG005|Overall Study|Investigator's Discretion|0|||
146700642|NCT02457598|529081747|FG006|Overall Study|Investigator's Discretion|0|||
146700643|NCT02457598|529081748|FG007|Overall Study|Investigator's Discretion|1|||
146700644|NCT02457598|529081749|FG008|Overall Study|Investigator's Discretion|2|||
146700645|NCT02457598|529081750|FG009|Overall Study|Investigator's Discretion|0|||
146700646|NCT02457598|529081751|FG010|Overall Study|Investigator's Discretion|10|||
146700647|NCT02457598|529081752|FG011|Overall Study|Investigator's Discretion|2|||
146700648|NCT02457598|529081753|FG012|Overall Study|Investigator's Discretion|2|||
146700649|NCT02457598|529081754|FG013|Overall Study|Investigator's Discretion|1|||
146700650|NCT02457598|529081755|FG014|Overall Study|Investigator's Discretion|5|||
146700651|NCT02457598|529081756|FG015|Overall Study|Investigator's Discretion|0|||
146700652|NCT02457598|529081757|FG016|Overall Study|Investigator's Discretion|0|||
146700653|NCT02457598|529081741|FG000|Overall Study|Study Terminated by Sponsor|0|||
146700654|NCT02457598|529081742|FG001|Overall Study|Study Terminated by Sponsor|1|||
146700655|NCT02457598|529081743|FG002|Overall Study|Study Terminated by Sponsor|0|||
146700656|NCT02457598|529081744|FG003|Overall Study|Study Terminated by Sponsor|4|||
146700657|NCT02457598|529081745|FG004|Overall Study|Study Terminated by Sponsor|1|||
146700658|NCT02457598|529081746|FG005|Overall Study|Study Terminated by Sponsor|0|||
146700659|NCT02457598|529081747|FG006|Overall Study|Study Terminated by Sponsor|1|||
146700660|NCT02457598|529081748|FG007|Overall Study|Study Terminated by Sponsor|0|||
146776498|NCT02723955|529353628|FG016|Escalation Phase|Lost to Follow-up|1|||
146700661|NCT02457598|529081749|FG008|Overall Study|Study Terminated by Sponsor|0|||
146776499|NCT02723955|529353629|FG017|Escalation Phase|Lost to Follow-up|2|||
146776500|NCT02723955|529353630|FG018|Escalation Phase|Lost to Follow-up|0|||
146700662|NCT02457598|529081750|FG009|Overall Study|Study Terminated by Sponsor|0|||
146700663|NCT02457598|529081751|FG010|Overall Study|Study Terminated by Sponsor|4|||
146700664|NCT02457598|529081752|FG011|Overall Study|Study Terminated by Sponsor|0|||
146700665|NCT02457598|529081753|FG012|Overall Study|Study Terminated by Sponsor|1|||
146700666|NCT02457598|529081754|FG013|Overall Study|Study Terminated by Sponsor|0|||
146700667|NCT02457598|529081755|FG014|Overall Study|Study Terminated by Sponsor|8|||
146700668|NCT02457598|529081756|FG015|Overall Study|Study Terminated by Sponsor|1|||
146700669|NCT02457598|529081757|FG016|Overall Study|Study Terminated by Sponsor|0|||
146700670|NCT02457598|529081741|FG000|Overall Study|Adverse Event|0|||
146700671|NCT02457598|529081742|FG001|Overall Study|Adverse Event|1|||
146700672|NCT02457598|529081743|FG002|Overall Study|Adverse Event|1|||
146776501|NCT02723955|529353631|FG019|Escalation Phase|Lost to Follow-up|1|||
146700673|NCT02457598|529081744|FG003|Overall Study|Adverse Event|4|||
146700674|NCT02457598|529081745|FG004|Overall Study|Adverse Event|1|||
146700675|NCT02457598|529081746|FG005|Overall Study|Adverse Event|0|||
146700676|NCT02457598|529081747|FG006|Overall Study|Adverse Event|0|||
146700677|NCT02457598|529081748|FG007|Overall Study|Adverse Event|1|||
146700678|NCT02457598|529081749|FG008|Overall Study|Adverse Event|0|||
146700679|NCT02457598|529081750|FG009|Overall Study|Adverse Event|1|||
146700680|NCT02457598|529081751|FG010|Overall Study|Adverse Event|6|||
146700681|NCT02457598|529081752|FG011|Overall Study|Adverse Event|0|||
146700682|NCT02457598|529081753|FG012|Overall Study|Adverse Event|0|||
146700683|NCT02457598|529081754|FG013|Overall Study|Adverse Event|1|||
146700684|NCT02457598|529081755|FG014|Overall Study|Adverse Event|2|||
146700685|NCT02457598|529081756|FG015|Overall Study|Adverse Event|0|||
146700686|NCT02457598|529081757|FG016|Overall Study|Adverse Event|0|||
146700687|NCT02457598|529081741|FG000|Overall Study|Death|0|||
146700688|NCT02457598|529081742|FG001|Overall Study|Death|0|||
146700689|NCT02457598|529081743|FG002|Overall Study|Death|0|||
146700690|NCT02457598|529081744|FG003|Overall Study|Death|3|||
146700691|NCT02457598|529081745|FG004|Overall Study|Death|0|||
146700692|NCT02457598|529081746|FG005|Overall Study|Death|1|||
146700693|NCT02457598|529081747|FG006|Overall Study|Death|0|||
146700694|NCT02457598|529081748|FG007|Overall Study|Death|0|||
146776502|NCT02723955|529353632|FG020|Escalation Phase|Lost to Follow-up|2|||
146776503|NCT02723955|529353633|FG021|Escalation Phase|Lost to Follow-up|1|||
146776504|NCT02723955|529353634|FG022|Escalation Phase|Lost to Follow-up|0|||
146776505|NCT02723955|529353635|FG023|Escalation Phase|Lost to Follow-up|0|||
146776506|NCT02723955|529353636|FG024|Escalation Phase|Lost to Follow-up|1|||
146776507|NCT02723955|529353637|FG025|Escalation Phase|Lost to Follow-up|1|||
146776508|NCT02723955|529353638|FG026|Escalation Phase|Lost to Follow-up|3|||
146776509|NCT02723955|529353639|FG027|Escalation Phase|Lost to Follow-up|0|||
146776510|NCT02723955|529353640|FG028|Escalation Phase|Lost to Follow-up|1|||
146776511|NCT02723955|529353641|FG029|Escalation Phase|Lost to Follow-up|0|||
146776512|NCT02723955|529353642|FG030|Escalation Phase|Lost to Follow-up|0|||
146776513|NCT02723955|529353643|FG031|Escalation Phase|Lost to Follow-up|0|||
146776514|NCT02723955|529353644|FG032|Escalation Phase|Lost to Follow-up|0|||
146776515|NCT02723955|529353645|FG033|Escalation Phase|Lost to Follow-up|0|||
146776516|NCT02723955|529353646|FG034|Escalation Phase|Lost to Follow-up|0|||
146776517|NCT02723955|529353647|FG035|Escalation Phase|Lost to Follow-up|0|||
146776518|NCT02723955|529353648|FG036|Escalation Phase|Lost to Follow-up|0|||
146776519|NCT02723955|529353649|FG037|Escalation Phase|Lost to Follow-up|0|||
146776520|NCT02723955|529353650|FG038|Escalation Phase|Lost to Follow-up|0|||
146776521|NCT02723955|529353651|FG039|Escalation Phase|Lost to Follow-up|0|||
146776522|NCT02723955|529353652|FG040|Escalation Phase|Lost to Follow-up|0|||
146776523|NCT02723955|529353653|FG041|Escalation Phase|Lost to Follow-up|0|||
146776524|NCT02723955|529353654|FG042|Escalation Phase|Lost to Follow-up|0|||
146776525|NCT02723955|529353612|FG000|Escalation Phase|Physician Decision|0|||
146776526|NCT02723955|529353613|FG001|Escalation Phase|Physician Decision|0|||
146776527|NCT02723955|529353614|FG002|Escalation Phase|Physician Decision|0|||
146776528|NCT02723955|529353615|FG003|Escalation Phase|Physician Decision|0|||
146776529|NCT02723955|529353616|FG004|Escalation Phase|Physician Decision|0|||
146776530|NCT02723955|529353617|FG005|Escalation Phase|Physician Decision|2|||
146776531|NCT02723955|529353618|FG006|Escalation Phase|Physician Decision|0|||
146776532|NCT02723955|529353619|FG007|Escalation Phase|Physician Decision|0|||
146776533|NCT02723955|529353620|FG008|Escalation Phase|Physician Decision|0|||
146776534|NCT02723955|529353621|FG009|Escalation Phase|Physician Decision|0|||
146776535|NCT02723955|529353622|FG010|Escalation Phase|Physician Decision|0|||
146776536|NCT02723955|529353623|FG011|Escalation Phase|Physician Decision|0|||
146776537|NCT02723955|529353624|FG012|Escalation Phase|Physician Decision|0|||
146776538|NCT02723955|529353625|FG013|Escalation Phase|Physician Decision|0|||
146700695|NCT02457598|529081749|FG008|Overall Study|Death|0|||
146700696|NCT02457598|529081750|FG009|Overall Study|Death|0|||
146776539|NCT02723955|529353626|FG014|Escalation Phase|Physician Decision|0|||
146776540|NCT02723955|529353627|FG015|Escalation Phase|Physician Decision|0|||
146776541|NCT02723955|529353628|FG016|Escalation Phase|Physician Decision|0|||
146776542|NCT02723955|529353629|FG017|Escalation Phase|Physician Decision|0|||
146776543|NCT02723955|529353630|FG018|Escalation Phase|Physician Decision|0|||
146932346|NCT02168803|529911182|FG000|Overall Study|Physician Decision|0|||
146700697|NCT02457598|529081751|FG010|Overall Study|Death|3|||
146700698|NCT02457598|529081752|FG011|Overall Study|Death|0|||
146700699|NCT02457598|529081753|FG012|Overall Study|Death|0|||
146700700|NCT02457598|529081754|FG013|Overall Study|Death|1|||
146700701|NCT02457598|529081755|FG014|Overall Study|Death|2|||
146776544|NCT02723955|529353631|FG019|Escalation Phase|Physician Decision|0|||
146776545|NCT02723955|529353632|FG020|Escalation Phase|Physician Decision|0|||
146776546|NCT02723955|529353633|FG021|Escalation Phase|Physician Decision|0|||
146776547|NCT02723955|529353634|FG022|Escalation Phase|Physician Decision|0|||
146776548|NCT02723955|529353635|FG023|Escalation Phase|Physician Decision|0|||
146776549|NCT02723955|529353636|FG024|Escalation Phase|Physician Decision|0|||
146932347|NCT02168803|529911183|FG001|Overall Study|Physician Decision|1|||
146700702|NCT02457598|529081756|FG015|Overall Study|Death|0|||
146700703|NCT02457598|529081757|FG016|Overall Study|Death|1|||
146700704|NCT02457598|529081741|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
146700705|NCT02457598|529081742|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
146700706|NCT02457598|529081743|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
146700707|NCT02457598|529081744|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
146700708|NCT02457598|529081745|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
146700709|NCT02457598|529081746|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
146700710|NCT02457598|529081747|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
146700711|NCT02457598|529081748|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
146700712|NCT02457598|529081749|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
146700713|NCT02457598|529081750|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
146700714|NCT02457598|529081751|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
146700715|NCT02457598|529081752|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
146700716|NCT02457598|529081753|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
146700717|NCT02457598|529081754|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
146700718|NCT02457598|529081755|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
146700719|NCT02457598|529081756|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
146700720|NCT02457598|529081757|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
146932348|NCT02168803|529911184|FG002|Overall Study|Physician Decision|0|||
146700721|NCT02457598|529081741|FG000|Overall Study|Withdrew Consent|0|||
146700722|NCT02457598|529081742|FG001|Overall Study|Withdrew Consent|0|||
146700723|NCT02457598|529081743|FG002|Overall Study|Withdrew Consent|0|||
146700724|NCT02457598|529081744|FG003|Overall Study|Withdrew Consent|0|||
146700725|NCT02457598|529081745|FG004|Overall Study|Withdrew Consent|0|||
146700726|NCT02457598|529081746|FG005|Overall Study|Withdrew Consent|0|||
146700727|NCT02457598|529081747|FG006|Overall Study|Withdrew Consent|0|||
146700728|NCT02457598|529081748|FG007|Overall Study|Withdrew Consent|2|||
146700729|NCT02457598|529081749|FG008|Overall Study|Withdrew Consent|0|||
146700730|NCT02457598|529081750|FG009|Overall Study|Withdrew Consent|0|||
146700731|NCT02457598|529081751|FG010|Overall Study|Withdrew Consent|3|||
146700732|NCT02457598|529081752|FG011|Overall Study|Withdrew Consent|0|||
146700733|NCT02457598|529081753|FG012|Overall Study|Withdrew Consent|0|||
146700734|NCT02457598|529081754|FG013|Overall Study|Withdrew Consent|1|||
146700735|NCT02457598|529081755|FG014|Overall Study|Withdrew Consent|0|||
146932349|NCT02168803|529911182|FG000|Overall Study|Adverse Event|0|||
146776550|NCT02723955|529353637|FG025|Escalation Phase|Physician Decision|0|||
146776551|NCT02723955|529353638|FG026|Escalation Phase|Physician Decision|2|||
146932350|NCT02168803|529911183|FG001|Overall Study|Adverse Event|1|||
146932351|NCT02168803|529911184|FG002|Overall Study|Adverse Event|1|||
146932352|NCT02168803|529911182|FG000|Overall Study|Death|0|||
146932353|NCT02168803|529911183|FG001|Overall Study|Death|0|||
146932354|NCT02168803|529911184|FG002|Overall Study|Death|1|||
146932355|NCT02168803|529911182|FG000|Overall Study|Sponsor Decision|0|||
146700736|NCT02457598|529081756|FG015|Overall Study|Withdrew Consent|0|||
146700737|NCT02457598|529081757|FG016|Overall Study|Withdrew Consent|0|||
146700738|NCT02457598|529081741|FG000|Overall Study|Unacceptable Toxicity|0|||
146700739|NCT02457598|529081742|FG001|Overall Study|Unacceptable Toxicity|0|||
146700740|NCT02457598|529081743|FG002|Overall Study|Unacceptable Toxicity|0|||
146700741|NCT02457598|529081744|FG003|Overall Study|Unacceptable Toxicity|0|||
146700742|NCT02457598|529081745|FG004|Overall Study|Unacceptable Toxicity|0|||
146700743|NCT02457598|529081746|FG005|Overall Study|Unacceptable Toxicity|0|||
146700744|NCT02457598|529081747|FG006|Overall Study|Unacceptable Toxicity|0|||
146932356|NCT02168803|529911183|FG001|Overall Study|Sponsor Decision|0|||
146932357|NCT02168803|529911184|FG002|Overall Study|Sponsor Decision|1|||
146932358|NCT01114373|529911186|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
146700745|NCT02457598|529081748|FG007|Overall Study|Unacceptable Toxicity|0|||
146700746|NCT02457598|529081749|FG008|Overall Study|Unacceptable Toxicity|0|||
146700747|NCT02457598|529081750|FG009|Overall Study|Unacceptable Toxicity|0|||
146700748|NCT02457598|529081751|FG010|Overall Study|Unacceptable Toxicity|1|||
146700749|NCT02457598|529081752|FG011|Overall Study|Unacceptable Toxicity|0|||
146700750|NCT02457598|529081753|FG012|Overall Study|Unacceptable Toxicity|1|||
146932359|NCT01114373|529911187|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
146932360|NCT01114373|529911186|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
146932361|NCT01114373|529911187|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
146932362|NCT01114373|529911186|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
146932363|NCT01114373|529911187|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
146932364|NCT01114373|529911186|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
146700751|NCT02457598|529081754|FG013|Overall Study|Unacceptable Toxicity|1|||
146700752|NCT02457598|529081755|FG014|Overall Study|Unacceptable Toxicity|1|||
146700753|NCT02457598|529081756|FG015|Overall Study|Unacceptable Toxicity|0|||
146700754|NCT02457598|529081757|FG016|Overall Study|Unacceptable Toxicity|0|||
146700755|NCT02457598|529081741|FG000|Overall Study|Intercurrent Illness|0|||
146700756|NCT02457598|529081742|FG001|Overall Study|Intercurrent Illness|0|||
146700757|NCT02457598|529081743|FG002|Overall Study|Intercurrent Illness|0|||
146700758|NCT02457598|529081744|FG003|Overall Study|Intercurrent Illness|0|||
146700759|NCT02457598|529081745|FG004|Overall Study|Intercurrent Illness|0|||
146700760|NCT02457598|529081746|FG005|Overall Study|Intercurrent Illness|0|||
146700761|NCT02457598|529081747|FG006|Overall Study|Intercurrent Illness|0|||
146700762|NCT02457598|529081748|FG007|Overall Study|Intercurrent Illness|0|||
146700763|NCT02457598|529081749|FG008|Overall Study|Intercurrent Illness|0|||
146700764|NCT02457598|529081750|FG009|Overall Study|Intercurrent Illness|0|||
146700765|NCT02457598|529081751|FG010|Overall Study|Intercurrent Illness|1|||
146700766|NCT02457598|529081752|FG011|Overall Study|Intercurrent Illness|0|||
146700767|NCT02457598|529081753|FG012|Overall Study|Intercurrent Illness|0|||
146700768|NCT02457598|529081754|FG013|Overall Study|Intercurrent Illness|0|||
146700769|NCT02457598|529081755|FG014|Overall Study|Intercurrent Illness|0|||
146700770|NCT02457598|529081756|FG015|Overall Study|Intercurrent Illness|0|||
146700771|NCT02457598|529081757|FG016|Overall Study|Intercurrent Illness|0|||
146700772|NCT02457598|529081741|FG000|Overall Study|Protocol Violation|0|||
146700773|NCT02457598|529081742|FG001|Overall Study|Protocol Violation|0|||
146700774|NCT02457598|529081743|FG002|Overall Study|Protocol Violation|0|||
146700775|NCT02457598|529081744|FG003|Overall Study|Protocol Violation|0|||
146700776|NCT02457598|529081745|FG004|Overall Study|Protocol Violation|0|||
146700777|NCT02457598|529081746|FG005|Overall Study|Protocol Violation|0|||
146700778|NCT02457598|529081747|FG006|Overall Study|Protocol Violation|0|||
146700779|NCT02457598|529081748|FG007|Overall Study|Protocol Violation|0|||
146700780|NCT02457598|529081749|FG008|Overall Study|Protocol Violation|0|||
146700781|NCT02457598|529081750|FG009|Overall Study|Protocol Violation|0|||
146700782|NCT02457598|529081751|FG010|Overall Study|Protocol Violation|1|||
146700783|NCT02457598|529081752|FG011|Overall Study|Protocol Violation|0|||
146700784|NCT02457598|529081753|FG012|Overall Study|Protocol Violation|0|||
146700785|NCT02457598|529081754|FG013|Overall Study|Protocol Violation|0|||
146700786|NCT02457598|529081755|FG014|Overall Study|Protocol Violation|0|||
146700787|NCT02457598|529081756|FG015|Overall Study|Protocol Violation|0|||
146700788|NCT02457598|529081757|FG016|Overall Study|Protocol Violation|0|||
146700789|NCT03837899|529081758|FG000|Overall Study|Death|6|||
146700790|NCT03837899|529081759|FG001|Overall Study|Death|8|||
146700791|NCT03837899|529081760|FG002|Overall Study|Death|3|||
146700792|NCT03837899|529081761|FG003|Overall Study|Death|7|||
146700793|NCT03837899|529081762|FG004|Overall Study|Death|8|||
146700794|NCT03837899|529081763|FG005|Overall Study|Death|7|||
146700795|NCT03837899|529081758|FG000|Overall Study|Moved to post-trial access program|0|||
146700796|NCT03837899|529081759|FG001|Overall Study|Moved to post-trial access program|1|||
146700797|NCT03837899|529081760|FG002|Overall Study|Moved to post-trial access program|0|||
146700798|NCT03837899|529081761|FG003|Overall Study|Moved to post-trial access program|0|||
146700799|NCT03837899|529081762|FG004|Overall Study|Moved to post-trial access program|0|||
146700800|NCT03837899|529081763|FG005|Overall Study|Moved to post-trial access program|0|||
146700801|NCT03837899|529081758|FG000|Overall Study|Other|0|||
146700802|NCT03837899|529081759|FG001|Overall Study|Other|0|||
146700803|NCT03837899|529081760|FG002|Overall Study|Other|0|||
146700804|NCT03837899|529081761|FG003|Overall Study|Other|0|||
146700805|NCT03837899|529081762|FG004|Overall Study|Other|0|||
146700806|NCT03837899|529081763|FG005|Overall Study|Other|2|||
146700807|NCT03837899|529081758|FG000|Overall Study|Lost to Follow-up|0|||
146700808|NCT03837899|529081759|FG001|Overall Study|Lost to Follow-up|1|||
146700809|NCT03837899|529081760|FG002|Overall Study|Lost to Follow-up|0|||
146700810|NCT03837899|529081761|FG003|Overall Study|Lost to Follow-up|0|||
146700811|NCT03837899|529081762|FG004|Overall Study|Lost to Follow-up|0|||
146700812|NCT03837899|529081763|FG005|Overall Study|Lost to Follow-up|0|||
146700813|NCT03837899|529081758|FG000|Overall Study|Withdrawal by Subject|0|||
146700814|NCT03837899|529081759|FG001|Overall Study|Withdrawal by Subject|0|||
146700815|NCT03837899|529081760|FG002|Overall Study|Withdrawal by Subject|0|||
146700816|NCT03837899|529081761|FG003|Overall Study|Withdrawal by Subject|1|||
146700817|NCT03837899|529081762|FG004|Overall Study|Withdrawal by Subject|0|||
146700818|NCT03837899|529081763|FG005|Overall Study|Withdrawal by Subject|0|||
146700819|NCT03837899|529081758|FG000|Overall Study|Study specific discontinuation criteria|0|||
146700820|NCT03837899|529081759|FG001|Overall Study|Study specific discontinuation criteria|1|||
146700821|NCT03837899|529081760|FG002|Overall Study|Study specific discontinuation criteria|0|||
146700822|NCT03837899|529081761|FG003|Overall Study|Study specific discontinuation criteria|0|||
146700823|NCT03837899|529081762|FG004|Overall Study|Study specific discontinuation criteria|3|||
146700824|NCT03837899|529081763|FG005|Overall Study|Study specific discontinuation criteria|1|||
146700825|NCT01537783|529081772|FG000|Overall Study|Lost to Follow-up|11|||
146700826|NCT01537783|529081773|FG001|Overall Study|Lost to Follow-up|2|||
146700827|NCT01554618|529081774|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
146700828|NCT01554618|529081775|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
146700829|NCT01554618|529081774|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
146700830|NCT01554618|529081775|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
146700831|NCT01554618|529081774|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
146700832|NCT01554618|529081775|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
146700833|NCT01554618|529081774|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
146700834|NCT01554618|529081775|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
146700835|NCT01554618|529081774|FG000|Open-Label Extension Period|Physician Decision|0|||
146700836|NCT01554618|529081775|FG001|Open-Label Extension Period|Physician Decision|1|||
146700837|NCT01554618|529081774|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
146700838|NCT01554618|529081775|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
146700839|NCT00477672|529081776|FG000|Overall Study|Adverse Event|3|||
146700840|NCT00477672|529081777|FG001|Overall Study|Adverse Event|5|||
146700841|NCT00477672|529081778|FG002|Overall Study|Adverse Event|6|||
146700842|NCT00477672|529081776|FG000|Overall Study|Death|0|||
146700843|NCT00477672|529081777|FG001|Overall Study|Death|1|||
146700844|NCT00477672|529081778|FG002|Overall Study|Death|0|||
146700845|NCT00477672|529081776|FG000|Overall Study|Disease progression|0|||
146700846|NCT00477672|529081777|FG001|Overall Study|Disease progression|1|||
146700847|NCT00477672|529081778|FG002|Overall Study|Disease progression|0|||
146700848|NCT00477672|529081776|FG000|Overall Study|Physician Decision|1|||
146700849|NCT00477672|529081777|FG001|Overall Study|Physician Decision|0|||
146700850|NCT00477672|529081778|FG002|Overall Study|Physician Decision|0|||
146700851|NCT00477672|529081776|FG000|Overall Study|Protocol noncompliance|0|||
146700852|NCT00477672|529081777|FG001|Overall Study|Protocol noncompliance|2|||
146700853|NCT00477672|529081778|FG002|Overall Study|Protocol noncompliance|0|||
146700854|NCT00477672|529081776|FG000|Overall Study|Consent withdrawn|2|||
146700855|NCT00477672|529081777|FG001|Overall Study|Consent withdrawn|5|||
146700856|NCT00477672|529081778|FG002|Overall Study|Consent withdrawn|10|||
146700857|NCT00477672|529081776|FG000|Overall Study|Discretion of Sponsor|1|||
146700858|NCT00477672|529081777|FG001|Overall Study|Discretion of Sponsor|2|||
146700859|NCT00477672|529081778|FG002|Overall Study|Discretion of Sponsor|0|||
146700860|NCT02722928|529081781|FG000|Overall Study|Standard CT was not as required per prot|5|||
146700861|NCT02722928|529081782|FG001|Overall Study|Standard CT was not as required per prot|13|||
146700862|NCT02722928|529081781|FG000|Overall Study|Required Intraoperative MRI|5|||
146700863|NCT02722928|529081782|FG001|Overall Study|Required Intraoperative MRI|7|||
146700864|NCT04011410|529081783|FG000|Overall Study|Withdrawal by Subject|1|||
146700865|NCT01557400|529081784|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
146700866|NCT01557400|529081784|FG000|Overall Study|Adverse Event|3|||
146700867|NCT01557400|529081784|FG000|Overall Study|Lost to Follow-up|5|||
146700868|NCT01557400|529081784|FG000|Overall Study|Withdrawal by Subject|9|||
146700869|NCT01393405|529081787|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
146700870|NCT01393405|529081788|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
146700871|NCT01393405|529081789|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
146700872|NCT01393405|529081787|FG000|Induction Period (week1-16)|Adverse Event|16|||
146700873|NCT01393405|529081788|FG001|Induction Period (week1-16)|Adverse Event|0|||
146700874|NCT01393405|529081789|FG002|Induction Period (week1-16)|Adverse Event|0|||
146700875|NCT01393405|529081787|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
146700876|NCT01393405|529081788|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
146700877|NCT01393405|529081789|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
146700878|NCT01393405|529081787|FG000|Maintenance Period Week|Lack of Efficacy|0|||
146700879|NCT01393405|529081788|FG001|Maintenance Period Week|Lack of Efficacy|22|||
146700880|NCT01393405|529081789|FG002|Maintenance Period Week|Lack of Efficacy|22|||
146700881|NCT01393405|529081787|FG000|Maintenance Period Week|Adverse Event|0|||
146700882|NCT01393405|529081788|FG001|Maintenance Period Week|Adverse Event|5|||
146700883|NCT01393405|529081789|FG002|Maintenance Period Week|Adverse Event|2|||
146700884|NCT01393405|529081787|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
146700885|NCT01393405|529081788|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
146700886|NCT01393405|529081789|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
146700887|NCT01393405|529081787|FG000|Maintenance Period Week|Lost to Follow-up|0|||
146700888|NCT01393405|529081788|FG001|Maintenance Period Week|Lost to Follow-up|1|||
146700889|NCT01393405|529081789|FG002|Maintenance Period Week|Lost to Follow-up|0|||
146700890|NCT04365699|529081790|FG000|Overall Study|Death|2|||
146700891|NCT04365699|529081791|FG001|Overall Study|Death|5|||
146700892|NCT04365699|529081792|FG002|Overall Study|Death|15|||
146700893|NCT03925727|529081793|FG000|Overall Study|Adverse Event|4|||
146700894|NCT03925727|529081794|FG001|Overall Study|Adverse Event|0|||
146700895|NCT03925727|529081795|FG002|Overall Study|Adverse Event|3|||
146700896|NCT03925727|529081793|FG000|Overall Study|Protocol Violation|1|||
146700897|NCT03925727|529081794|FG001|Overall Study|Protocol Violation|2|||
146700898|NCT03925727|529081795|FG002|Overall Study|Protocol Violation|2|||
146700899|NCT03925727|529081793|FG000|Overall Study|Withdrawal by Subject|3|||
146700900|NCT03925727|529081794|FG001|Overall Study|Withdrawal by Subject|2|||
146700901|NCT03925727|529081795|FG002|Overall Study|Withdrawal by Subject|4|||
146700902|NCT03925727|529081793|FG000|Overall Study|Administrative Reasons|3|||
146700903|NCT03925727|529081794|FG001|Overall Study|Administrative Reasons|1|||
146700904|NCT03925727|529081795|FG002|Overall Study|Administrative Reasons|2|||
146700905|NCT03925727|529081793|FG000|Overall Study|Randomized in error or Disqualified|8|||
146700906|NCT03925727|529081794|FG001|Overall Study|Randomized in error or Disqualified|1|||
146700907|NCT03925727|529081795|FG002|Overall Study|Randomized in error or Disqualified|7|||
146700908|NCT00692770|529081808|FG000|Overall Study|Protocol Violation|2|||
146700909|NCT00692770|529081809|FG001|Overall Study|Protocol Violation|7|||
146700910|NCT00692770|529081808|FG000|Overall Study|Withdrawal by Subject|97|||
146700911|NCT00692770|529081809|FG001|Overall Study|Withdrawal by Subject|36|||
146700912|NCT00692770|529081808|FG000|Overall Study|Adverse Event|136|||
146700913|NCT00692770|529081809|FG001|Overall Study|Adverse Event|41|||
146700914|NCT00692770|529081808|FG000|Overall Study|Death|10|||
146700915|NCT00692770|529081809|FG001|Overall Study|Death|5|||
146700916|NCT00692770|529081808|FG000|Overall Study|Lost to Follow-up|7|||
146932365|NCT01114373|529911187|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
146932366|NCT03444870|529911188|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
146932367|NCT03444870|529911189|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
146932368|NCT03444870|529911190|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
146700917|NCT00692770|529081809|FG001|Overall Study|Lost to Follow-up|3|||
146700918|NCT00692770|529081808|FG000|Overall Study|Non-compliant with study medication|11|||
146700919|NCT00692770|529081809|FG001|Overall Study|Non-compliant with study medication|5|||
146700920|NCT00692770|529081808|FG000|Overall Study|Progression by clinical judgment|2|||
146700921|NCT00692770|529081809|FG001|Overall Study|Progression by clinical judgment|3|||
146700922|NCT00692770|529081808|FG000|Overall Study|Physician decision not protocol driven|10|||
146700923|NCT00692770|529081809|FG001|Overall Study|Physician decision not protocol driven|14|||
146700924|NCT00692770|529081808|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
146700925|NCT00692770|529081809|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
146700926|NCT00692770|529081808|FG000|Overall Study|Protocol driven decision point|3|||
146700927|NCT00692770|529081809|FG001|Overall Study|Protocol driven decision point|7|||
146700928|NCT00692770|529081808|FG000|Overall Study|Completed all planned assessments|79|||
146700929|NCT00692770|529081809|FG001|Overall Study|Completed all planned assessments|101|||
146700930|NCT00692770|529081808|FG000|Overall Study|Radiological and clinical progression|8|||
146700931|NCT00692770|529081809|FG001|Overall Study|Radiological and clinical progression|8|||
146700932|NCT00692770|529081808|FG000|Overall Study|Clinical endpoint reached|16|||
146700933|NCT00692770|529081809|FG001|Overall Study|Clinical endpoint reached|43|||
146700934|NCT00692770|529081808|FG000|Overall Study|Study terminated by sponsor|2|||
146700935|NCT00692770|529081809|FG001|Overall Study|Study terminated by sponsor|2|||
146700936|NCT00692770|529081808|FG000|Overall Study|Randomized but not treated|3|||
146700937|NCT00692770|529081809|FG001|Overall Study|Randomized but not treated|4|||
146700938|NCT00834912|529081810|FG000|Treatment Period 1|Adverse Event|0|||
146700939|NCT00834912|529081811|FG001|Treatment Period 1|Adverse Event|1|||
146700940|NCT00834912|529081812|FG002|Treatment Period 1|Adverse Event|0|||
146700941|NCT00834912|529081813|FG003|Treatment Period 1|Adverse Event|1|||
146700942|NCT00834912|529081814|FG004|Treatment Period 1|Adverse Event|0|||
146700943|NCT00834912|529081815|FG005|Treatment Period 1|Adverse Event|0|||
146700944|NCT00834912|529081810|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146700945|NCT00834912|529081811|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146700946|NCT00834912|529081812|FG002|Treatment Period 2|Withdrawal by Subject|1|||
146700947|NCT00834912|529081813|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146700948|NCT00834912|529081814|FG004|Treatment Period 2|Withdrawal by Subject|1|||
146700949|NCT00834912|529081815|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146700950|NCT03044197|529081816|FG000|Overall Study|Withdrawal by Subject|3|||
146700951|NCT03044197|529081817|FG001|Overall Study|Withdrawal by Subject|1|||
146700952|NCT00262067|529081823|FG000|Overall Study|Death|190|||
146700953|NCT00262067|529081824|FG001|Overall Study|Death|89|||
146700954|NCT00262067|529081825|FG002|Overall Study|Death|186|||
146932369|NCT03444870|529911191|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
146932370|NCT03444870|529911192|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
146932371|NCT03444870|529911193|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
146932372|NCT03444870|529911188|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
146932373|NCT03444870|529911189|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
146932374|NCT03444870|529911190|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
146932375|NCT03444870|529911191|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
146700955|NCT00262067|529081826|FG003|Overall Study|Death|99|||
146700956|NCT00262067|529081823|FG000|Overall Study|Lost to Follow-up|5|||
146700957|NCT00262067|529081824|FG001|Overall Study|Lost to Follow-up|4|||
146700958|NCT00262067|529081825|FG002|Overall Study|Lost to Follow-up|7|||
146700959|NCT00262067|529081826|FG003|Overall Study|Lost to Follow-up|5|||
146932376|NCT03444870|529911192|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
146932377|NCT03444870|529911193|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
146932378|NCT03444870|529911188|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
146700960|NCT00262067|529081823|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
146700961|NCT00262067|529081824|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
146700962|NCT00262067|529081825|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
146700963|NCT00262067|529081826|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
146700964|NCT00262067|529081823|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
146700965|NCT00262067|529081824|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
146700966|NCT00262067|529081825|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
146700967|NCT00262067|529081826|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
146700968|NCT01574352|529081829|FG000|Overall Study|Withdrawal by Subject|6|||
146700969|NCT01574352|529081830|FG001|Overall Study|Withdrawal by Subject|13|||
146700970|NCT01574352|529081829|FG000|Overall Study|Injury in non-camp related sport|1|||
146700971|NCT01574352|529081830|FG001|Overall Study|Injury in non-camp related sport|0|||
146700972|NCT02849548|529081831|FG000|Overall Study|Lost to Follow-up|1|||
146700973|NCT02849548|529081832|FG001|Overall Study|Lost to Follow-up|2|||
146700974|NCT02849548|529081831|FG000|Overall Study|Protocol Violation|1|||
146700975|NCT02849548|529081832|FG001|Overall Study|Protocol Violation|0|||
146700976|NCT00714259|529081833|FG000|Overall Study|Death|2|||
146700977|NCT00256698|529081836|FG000|Overall Study|Withdrawal by Subject|7|||
146700978|NCT00256698|529081837|FG001|Overall Study|Withdrawal by Subject|7|||
146700979|NCT00256698|529081836|FG000|Overall Study|Adverse Event|13|||
146700980|NCT00256698|529081837|FG001|Overall Study|Adverse Event|6|||
146700981|NCT00256698|529081836|FG000|Overall Study|Protocol Violation|6|||
146700982|NCT00256698|529081837|FG001|Overall Study|Protocol Violation|5|||
146700983|NCT00256698|529081836|FG000|Overall Study|Lost to Follow-up|1|||
146700984|NCT00256698|529081837|FG001|Overall Study|Lost to Follow-up|3|||
146700985|NCT00256698|529081836|FG000|Overall Study|disease progression|97|||
146700986|NCT00256698|529081837|FG001|Overall Study|disease progression|105|||
146700987|NCT00256698|529081836|FG000|Overall Study|still ongoing at data cut-off|41|||
146700988|NCT00256698|529081837|FG001|Overall Study|still ongoing at data cut-off|46|||
146700989|NCT00256698|529081836|FG000|Overall Study|withdrawn due to osteoporosis|1|||
146700990|NCT00256698|529081837|FG001|Overall Study|withdrawn due to osteoporosis|0|||
146700991|NCT00256698|529081836|FG000|Overall Study|Prematurely Discontinued|1|||
146700992|NCT00256698|529081837|FG001|Overall Study|Prematurely Discontinued|0|||
146700993|NCT02777125|529081838|FG000|Overall Study|Consent form violation|14|||
146700994|NCT02777125|529081839|FG001|Overall Study|Consent form violation|12|||
146700995|NCT02777125|529081838|FG000|Overall Study|Assent form violation|21|||
146700996|NCT02777125|529081839|FG001|Overall Study|Assent form violation|23|||
146700997|NCT02777125|529081838|FG000|Overall Study|Protocol Violation|8|||
146700998|NCT02777125|529081839|FG001|Overall Study|Protocol Violation|12|||
146700999|NCT02283788|529081841|FG000|Overall Study|Adverse Event|1|||
146701000|NCT02283788|529081842|FG001|Overall Study|Adverse Event|3|||
146701001|NCT02283788|529081843|FG002|Overall Study|Adverse Event|5|||
146701002|NCT02283788|529081844|FG003|Overall Study|Adverse Event|1|||
146701003|NCT02283788|529081841|FG000|Overall Study|Withdrawal by Subject|0|||
146701004|NCT02283788|529081842|FG001|Overall Study|Withdrawal by Subject|1|||
146701005|NCT02283788|529081843|FG002|Overall Study|Withdrawal by Subject|0|||
146701006|NCT02283788|529081844|FG003|Overall Study|Withdrawal by Subject|1|||
146701007|NCT05168475|529083907|FG000|Period 1|Protocol Violation|1|||
146701008|NCT05168475|529083907|FG000|Period 1|IMP shortage|2|||
146701009|NCT05168475|529083907|FG000|Period 1|Not randomised|2|||
146701010|NCT05168475|529083907|FG000|Period 2|IMP shortage|1|||
146701011|NCT01589822|529083908|FG000|Overall Study|Withdrawal by Subject|1|||
146701012|NCT01589822|529083909|FG001|Overall Study|Withdrawal by Subject|2|||
146701013|NCT01589822|529083910|FG002|Overall Study|Withdrawal by Subject|0|||
146701014|NCT01589822|529083908|FG000|Overall Study|Death|1|||
146701015|NCT01589822|529083909|FG001|Overall Study|Death|0|||
146701016|NCT01589822|529083910|FG002|Overall Study|Death|0|||
146701017|NCT01589822|529083908|FG000|Overall Study|Missed 90 day visit|2|||
146701018|NCT01589822|529083909|FG001|Overall Study|Missed 90 day visit|1|||
146701019|NCT01589822|529083910|FG002|Overall Study|Missed 90 day visit|1|||
146701020|NCT01140477|529083911|FG000|Overall Study|Lost to Follow-up|4|||
146701021|NCT01140477|529083912|FG001|Overall Study|Lost to Follow-up|0|||
146701022|NCT01140477|529083911|FG000|Overall Study|Withdrawal by Subject|1|||
146701023|NCT01140477|529083912|FG001|Overall Study|Withdrawal by Subject|4|||
146701024|NCT01140477|529083911|FG000|Overall Study|Surgical complication preventing implant|2|||
146701025|NCT01140477|529083912|FG001|Overall Study|Surgical complication preventing implant|0|||
146701026|NCT01140477|529083911|FG000|Overall Study|Death|1|||
146701027|NCT01140477|529083912|FG001|Overall Study|Death|1|||
146701028|NCT01140477|529083911|FG000|Overall Study|Subject explanted|0|||
146701029|NCT01140477|529083912|FG001|Overall Study|Subject explanted|1|||
146701030|NCT05723770|529083913|FG000|Overall Study|Lost to Follow-up|4|||
146701031|NCT05723770|529083913|FG000|Overall Study|Withdrawal by Subject|2|||
146701032|NCT01982253|529083914|FG000|Overall Study|Withdrawal by Subject|1|||
146701033|NCT01982253|529083915|FG001|Overall Study|Withdrawal by Subject|0|||
146701034|NCT01982253|529083916|FG002|Overall Study|Withdrawal by Subject|0|||
146701035|NCT01982253|529083914|FG000|Overall Study|Study terminated by sponsor|1|||
146701036|NCT01982253|529083915|FG001|Overall Study|Study terminated by sponsor|4|||
146701037|NCT01982253|529083916|FG002|Overall Study|Study terminated by sponsor|4|||
146701038|NCT00779675|529083917|FG000|Treatment Period|Adverse Event|87|||
146701039|NCT00779675|529083917|FG000|Treatment Period|Treatment Failure|80|||
146701040|NCT00779675|529083917|FG000|Treatment Period|Transferred to Another Study|38|||
146701041|NCT00779675|529083917|FG000|Treatment Period|Lost to Follow-up|23|||
146701042|NCT00779675|529083917|FG000|Treatment Period|Withdrawal by Subject|46|||
146701043|NCT00779675|529083917|FG000|Treatment Period|Protocol Violation|54|||
146701044|NCT00779675|529083917|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
146701045|NCT00779675|529083917|FG000|Treatment Period|Administrative|3|||
146701046|NCT00779675|529083917|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
146701047|NCT00779675|529083917|FG000|Extended Treatment Period|Protocol Violation|13|||
146701048|NCT00779675|529083917|FG000|Extended Treatment Period|Adverse Event|6|||
146701049|NCT00779675|529083917|FG000|Extended Treatment Period|Treatment Failure|11|||
146701050|NCT00779675|529083917|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
146701051|NCT00779675|529083917|FG000|Extended Treatment Period|Lost to Follow-up|6|||
146701052|NCT00355238|529083927|FG000|Overall Study|Adverse event unrelated to study drug|2|||
146701053|NCT00355238|529083928|FG001|Overall Study|Adverse event unrelated to study drug|2|||
146701054|NCT00355238|529083929|FG002|Overall Study|Adverse event unrelated to study drug|0|||
146701055|NCT00355238|529083930|FG003|Overall Study|Adverse event unrelated to study drug|1|||
146701056|NCT00355238|529083927|FG000|Overall Study|Death|1|||
146701057|NCT00355238|529083928|FG001|Overall Study|Death|0|||
146701058|NCT00355238|529083929|FG002|Overall Study|Death|0|||
146701059|NCT00355238|529083930|FG003|Overall Study|Death|0|||
146701060|NCT00355238|529083927|FG000|Overall Study|Disease progression|37|||
146701061|NCT00355238|529083928|FG001|Overall Study|Disease progression|36|||
146701062|NCT00355238|529083929|FG002|Overall Study|Disease progression|16|||
146701063|NCT00355238|529083930|FG003|Overall Study|Disease progression|11|||
146701064|NCT00355238|529083927|FG000|Overall Study|Study drug toxicity|11|||
146701065|NCT00355238|529083928|FG001|Overall Study|Study drug toxicity|7|||
146701066|NCT00355238|529083929|FG002|Overall Study|Study drug toxicity|5|||
146701067|NCT00355238|529083930|FG003|Overall Study|Study drug toxicity|2|||
146701068|NCT00355238|529083927|FG000|Overall Study|Participant withdrew consent|3|||
146701069|NCT00355238|529083928|FG001|Overall Study|Participant withdrew consent|1|||
146701070|NCT00355238|529083929|FG002|Overall Study|Participant withdrew consent|0|||
146701071|NCT00355238|529083930|FG003|Overall Study|Participant withdrew consent|0|||
146701072|NCT00355238|529083927|FG000|Overall Study|Participant request to discontinue study treatment|1|||
146701073|NCT00355238|529083928|FG001|Overall Study|Participant request to discontinue study treatment|0|||
146701074|NCT00355238|529083929|FG002|Overall Study|Participant request to discontinue study treatment|1|||
146701075|NCT00355238|529083930|FG003|Overall Study|Participant request to discontinue study treatment|0|||
146701076|NCT01956110|529083931|FG000|Overall Study|Protocol Violation|25|||
146701077|NCT01956110|529083932|FG001|Overall Study|Protocol Violation|11|||
146701078|NCT01956110|529083931|FG000|Overall Study|Adverse Event|9|||
146701079|NCT01956110|529083932|FG001|Overall Study|Adverse Event|10|||
146701080|NCT01956110|529083931|FG000|Overall Study|Personal reasons|1|||
146701081|NCT01956110|529083932|FG001|Overall Study|Personal reasons|1|||
146701082|NCT03325166|529083939|FG000|Overall Study|Adverse Event|1|||
146701083|NCT01633944|529083940|FG000|Open-label Titration Phase|Adverse Event|109|||
146701084|NCT01633944|529083941|FG001|Open-label Titration Phase|Adverse Event|0|||
146701085|NCT01633944|529083942|FG002|Open-label Titration Phase|Adverse Event|0|||
146701086|NCT01633944|529083940|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
146701087|NCT01633944|529083941|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
146701088|NCT01633944|529083942|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
146701089|NCT01633944|529083940|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
146701090|NCT01633944|529083941|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
146701091|NCT01633944|529083942|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
146701092|NCT01633944|529083940|FG000|Open-label Titration Phase|Protocol Violation|24|||
146701093|NCT01633944|529083941|FG001|Open-label Titration Phase|Protocol Violation|0|||
146701094|NCT01633944|529083942|FG002|Open-label Titration Phase|Protocol Violation|0|||
146701095|NCT01633944|529083940|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
146701096|NCT01633944|529083941|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
146701097|NCT01633944|529083942|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
146701098|NCT01633944|529083940|FG000|Open-label Titration Phase|Other|68|||
146701099|NCT01633944|529083941|FG001|Open-label Titration Phase|Other|0|||
146701100|NCT01633944|529083942|FG002|Open-label Titration Phase|Other|0|||
146701101|NCT01633944|529083940|FG000|Double-blind Treatment Phase|Adverse Event|0|||
146701102|NCT01633944|529083941|FG001|Double-blind Treatment Phase|Adverse Event|13|||
146701103|NCT01633944|529083942|FG002|Double-blind Treatment Phase|Adverse Event|7|||
146701104|NCT01633944|529083940|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
146701105|NCT01633944|529083941|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
146701106|NCT01633944|529083942|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
146701107|NCT01633944|529083940|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146701108|NCT01633944|529083941|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
146701109|NCT01633944|529083942|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
146701110|NCT01633944|529083940|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
146701111|NCT01633944|529083941|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
146701112|NCT01633944|529083942|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
146701113|NCT01633944|529083940|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
146701114|NCT01633944|529083941|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
146701115|NCT01633944|529083942|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
146701116|NCT01633944|529083940|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
146932379|NCT03444870|529911189|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
146932380|NCT03444870|529911190|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
146932381|NCT03444870|529911191|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
146932382|NCT03444870|529911192|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
146932383|NCT03444870|529911193|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
146932384|NCT03444870|529911188|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
146932385|NCT03444870|529911189|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
146932386|NCT03444870|529911190|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
146932387|NCT03444870|529911191|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
146932388|NCT03444870|529911192|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
146932389|NCT03444870|529911193|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
146932390|NCT03444870|529911188|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
146932391|NCT03444870|529911189|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
146932392|NCT03444870|529911190|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
146932393|NCT03444870|529911191|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
146932394|NCT03444870|529911192|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
146932395|NCT03444870|529911193|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
146932396|NCT03444870|529911188|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
146932397|NCT03444870|529911189|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
146932398|NCT03444870|529911190|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
146932399|NCT03444870|529911191|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
146932400|NCT03444870|529911192|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
146932401|NCT03444870|529911193|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
146932402|NCT03444870|529911188|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
146932403|NCT03444870|529911189|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
146932404|NCT03444870|529911190|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
146932405|NCT03444870|529911191|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
146932406|NCT03444870|529911192|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
146932407|NCT03444870|529911193|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
146932408|NCT03444870|529911188|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
146932409|NCT03444870|529911189|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
146932410|NCT03444870|529911190|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
146776552|NCT02723955|529353639|FG027|Escalation Phase|Physician Decision|0|||
146776553|NCT02723955|529353640|FG028|Escalation Phase|Physician Decision|0|||
146776554|NCT02723955|529353641|FG029|Escalation Phase|Physician Decision|0|||
146776555|NCT02723955|529353642|FG030|Escalation Phase|Physician Decision|0|||
146776556|NCT02723955|529353643|FG031|Escalation Phase|Physician Decision|0|||
146776557|NCT02723955|529353644|FG032|Escalation Phase|Physician Decision|0|||
146932411|NCT03444870|529911191|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
146932412|NCT03444870|529911192|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
146932413|NCT03444870|529911193|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
146932414|NCT03444870|529911188|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
146932415|NCT03444870|529911189|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
146932416|NCT03444870|529911190|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
146932417|NCT03444870|529911191|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
146932418|NCT03444870|529911192|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
146932419|NCT03444870|529911193|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
146932420|NCT03444870|529911188|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
146932421|NCT03444870|529911189|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
146932422|NCT03444870|529911190|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
146932423|NCT03444870|529911191|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
146932424|NCT03444870|529911192|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
146932425|NCT03444870|529911193|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
146932426|NCT03444870|529911188|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
146932427|NCT03444870|529911189|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
146932428|NCT03444870|529911190|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
146932429|NCT03444870|529911191|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
146932430|NCT03444870|529911192|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
146932431|NCT03444870|529911193|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
146932432|NCT03444870|529911188|FG000|Open-Label Extension (OLE) Period|Death|0|||
146932433|NCT03444870|529911189|FG001|Open-Label Extension (OLE) Period|Death|0|||
146932434|NCT03444870|529911190|FG002|Open-Label Extension (OLE) Period|Death|0|||
146776558|NCT02723955|529353645|FG033|Escalation Phase|Physician Decision|0|||
146776559|NCT02723955|529353646|FG034|Escalation Phase|Physician Decision|0|||
146776560|NCT02723955|529353647|FG035|Escalation Phase|Physician Decision|0|||
146776561|NCT02723955|529353648|FG036|Escalation Phase|Physician Decision|0|||
146776562|NCT02723955|529353649|FG037|Escalation Phase|Physician Decision|0|||
146932435|NCT03444870|529911191|FG003|Open-Label Extension (OLE) Period|Death|0|||
146932436|NCT03444870|529911192|FG004|Open-Label Extension (OLE) Period|Death|1|||
146932437|NCT03444870|529911193|FG005|Open-Label Extension (OLE) Period|Death|0|||
146932438|NCT00868166|529911194|FG000|Overall Study|Death|58|||
146932439|NCT00868166|529911195|FG001|Overall Study|Death|65|||
146932440|NCT00868166|529911194|FG000|Overall Study|Withdrawal by Subject|33|||
146932441|NCT00868166|529911195|FG001|Overall Study|Withdrawal by Subject|25|||
146932442|NCT00868166|529911194|FG000|Overall Study|Protocol Violation|1|||
146932443|NCT00868166|529911195|FG001|Overall Study|Protocol Violation|0|||
146932444|NCT00868166|529911194|FG000|Overall Study|Lost to Follow-up|1|||
146932445|NCT00868166|529911195|FG001|Overall Study|Lost to Follow-up|3|||
146932446|NCT00868166|529911194|FG000|Overall Study|Adverse Event|9|||
146932447|NCT00868166|529911195|FG001|Overall Study|Adverse Event|10|||
146932448|NCT00868166|529911194|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
146932449|NCT00868166|529911195|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
146932450|NCT00868166|529911194|FG000|Overall Study|Non-compliance with IMP|1|||
146932451|NCT00868166|529911195|FG001|Overall Study|Non-compliance with IMP|1|||
146932452|NCT02034552|529911200|FG000|Overall Study|Never treated|3|||
146932453|NCT02034552|529911201|FG001|Overall Study|Never treated|2|||
146932454|NCT02034552|529911202|FG002|Overall Study|Never treated|0|||
146932455|NCT02034552|529911200|FG000|Overall Study|Radiological progression|3|||
146932456|NCT02034552|529911201|FG001|Overall Study|Radiological progression|5|||
146932457|NCT02034552|529911202|FG002|Overall Study|Radiological progression|4|||
146932458|NCT02034552|529911200|FG000|Overall Study|AE not assoc. with disease progression|1|||
146701117|NCT01633944|529083941|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
146701118|NCT01633944|529083942|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
146701119|NCT01633944|529083940|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
146701120|NCT01633944|529083941|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
146701121|NCT01633944|529083942|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
146701122|NCT01633944|529083940|FG000|Double-blind Treatment Phase|Other|0|||
146701123|NCT01633944|529083941|FG001|Double-blind Treatment Phase|Other|7|||
146701124|NCT01633944|529083942|FG002|Double-blind Treatment Phase|Other|0|||
146701125|NCT00463060|529083946|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
146701126|NCT00463060|529083946|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
146701127|NCT00701129|529083947|FG000|Overall Study|Death|2|||
146701128|NCT01400841|529083948|FG000|Initial Study Phase (6 Months)|Death|1|||
146701129|NCT01400841|529083948|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
146701130|NCT00910715|529083949|FG000|Overall Study|Lost to Follow-up|22|||
146701131|NCT00910715|529083950|FG001|Overall Study|Lost to Follow-up|26|||
146701132|NCT00910715|529083951|FG002|Overall Study|Lost to Follow-up|0|||
146701133|NCT02624284|529083952|FG000|Overall Study|Withdrawal by Subject|3|||
146701134|NCT02624284|529083953|FG001|Overall Study|Withdrawal by Subject|6|||
146701135|NCT02624284|529083954|FG002|Overall Study|Withdrawal by Subject|3|||
146701136|NCT02624284|529083952|FG000|Overall Study|Protocol Violation|9|||
146701137|NCT02624284|529083953|FG001|Overall Study|Protocol Violation|10|||
146701138|NCT02624284|529083954|FG002|Overall Study|Protocol Violation|7|||
146701139|NCT02624284|529083952|FG000|Overall Study|Revealed exclusionary condition|2|||
146701140|NCT02624284|529083953|FG001|Overall Study|Revealed exclusionary condition|2|||
146701141|NCT02624284|529083954|FG002|Overall Study|Revealed exclusionary condition|0|||
146701142|NCT02624284|529083952|FG000|Overall Study|Adverse Event|0|||
146701143|NCT02624284|529083953|FG001|Overall Study|Adverse Event|0|||
146701144|NCT02624284|529083954|FG002|Overall Study|Adverse Event|1|||
146701145|NCT02018458|529083957|FG000|Overall Study|Death|4|||
146701146|NCT00378014|529083958|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
146701147|NCT00378014|529083959|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
146701148|NCT00378014|529083958|FG000|Core (Randomization to Month 11)|Graft loss|1|||
146701149|NCT00378014|529083959|FG001|Core (Randomization to Month 11)|Graft loss|2|||
146701150|NCT00378014|529083958|FG000|Core (Randomization to Month 11)|Death|5|||
146701151|NCT00378014|529083959|FG001|Core (Randomization to Month 11)|Death|3|||
146701152|NCT00378014|529083958|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
146701153|NCT00378014|529083959|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
146701154|NCT00378014|529083958|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
146932459|NCT02034552|529911201|FG001|Overall Study|AE not assoc. with disease progression|4|||
146932460|NCT02034552|529911202|FG002|Overall Study|AE not assoc. with disease progression|2|||
146932461|NCT02034552|529911200|FG000|Overall Study|AE associated with disease progression|0|||
146980989|NCT01393990|530093692|FG007|Overall Study|Withdrawal by Subject|0|||
146701155|NCT00378014|529083959|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
146701156|NCT00378014|529083958|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
146701157|NCT00378014|529083959|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
146701158|NCT00378014|529083958|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
146701159|NCT00378014|529083959|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
146932462|NCT02034552|529911201|FG001|Overall Study|AE associated with disease progression|1|||
146932463|NCT02034552|529911202|FG002|Overall Study|AE associated with disease progression|0|||
146932464|NCT02034552|529911200|FG000|Overall Study|Withdrawal by Subject|2|||
146932465|NCT02034552|529911201|FG001|Overall Study|Withdrawal by Subject|1|||
146701160|NCT00378014|529083958|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
146701161|NCT00378014|529083959|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
146701162|NCT00378014|529083958|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
146701163|NCT00378014|529083959|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
146701164|NCT00378014|529083958|FG000|Extension (Month 12 to Month 59)|Death|1|||
146701165|NCT00378014|529083959|FG001|Extension (Month 12 to Month 59)|Death|2|||
146701166|NCT00378014|529083958|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
146701167|NCT00378014|529083959|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
146701168|NCT00378014|529083958|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
146701169|NCT00378014|529083959|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
146701170|NCT00378014|529083958|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
146701171|NCT00378014|529083959|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
146701172|NCT00378014|529083958|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
146701173|NCT00378014|529083959|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
146701174|NCT00357370|529083960|FG000|Cohort 2|Lack of Efficacy|0|||
146701175|NCT00357370|529083961|FG001|Cohort 2|Lack of Efficacy|2|||
146701176|NCT00357370|529083962|FG002|Cohort 2|Lack of Efficacy|1|||
146776563|NCT02723955|529353650|FG038|Escalation Phase|Physician Decision|0|||
146776564|NCT02723955|529353651|FG039|Escalation Phase|Physician Decision|0|||
146776565|NCT02723955|529353652|FG040|Escalation Phase|Physician Decision|0|||
146776566|NCT02723955|529353653|FG041|Escalation Phase|Physician Decision|0|||
146776567|NCT02723955|529353654|FG042|Escalation Phase|Physician Decision|0|||
146932466|NCT02034552|529911202|FG002|Overall Study|Withdrawal by Subject|1|||
146932467|NCT02034552|529911200|FG000|Overall Study|Non-compliance with study drug|0|||
146932468|NCT02034552|529911201|FG001|Overall Study|Non-compliance with study drug|0|||
146932469|NCT02034552|529911202|FG002|Overall Study|Non-compliance with study drug|1|||
146932470|NCT02034552|529911200|FG000|Overall Study|Clinical progression|5|||
146932471|NCT02034552|529911201|FG001|Overall Study|Clinical progression|7|||
146932472|NCT02034552|529911202|FG002|Overall Study|Clinical progression|9|||
146932473|NCT02501902|529911206|FG000|Overall Study|Subject Refused Further Follow-up|0|||
146932474|NCT02501902|529911207|FG001|Overall Study|Subject Refused Further Follow-up|0|||
146932475|NCT02501902|529911208|FG002|Overall Study|Subject Refused Further Follow-up|0|||
146932476|NCT02501902|529911209|FG003|Overall Study|Subject Refused Further Follow-up|0|||
146932477|NCT02501902|529911210|FG004|Overall Study|Subject Refused Further Follow-up|0|||
146932478|NCT02501902|529911211|FG005|Overall Study|Subject Refused Further Follow-up|0|||
146932479|NCT02501902|529911212|FG006|Overall Study|Subject Refused Further Follow-up|0|||
146932480|NCT02501902|529911213|FG007|Overall Study|Subject Refused Further Follow-up|1|||
146932481|NCT02501902|529911206|FG000|Overall Study|Study Terminated by Sponsor|0|||
146932482|NCT02501902|529911207|FG001|Overall Study|Study Terminated by Sponsor|3|||
146932483|NCT02501902|529911208|FG002|Overall Study|Study Terminated by Sponsor|0|||
146932484|NCT02501902|529911209|FG003|Overall Study|Study Terminated by Sponsor|1|||
146932485|NCT02501902|529911210|FG004|Overall Study|Study Terminated by Sponsor|1|||
146932486|NCT02501902|529911211|FG005|Overall Study|Study Terminated by Sponsor|0|||
146932487|NCT02501902|529911212|FG006|Overall Study|Study Terminated by Sponsor|2|||
146932488|NCT02501902|529911213|FG007|Overall Study|Study Terminated by Sponsor|4|||
146932489|NCT02501902|529911206|FG000|Overall Study|Death|3|||
146776568|NCT02723955|529353612|FG000|Escalation Phase|Withdrawal by Subject|0|||
146776569|NCT02723955|529353613|FG001|Escalation Phase|Withdrawal by Subject|0|||
146776570|NCT02723955|529353614|FG002|Escalation Phase|Withdrawal by Subject|0|||
146776571|NCT02723955|529353615|FG003|Escalation Phase|Withdrawal by Subject|0|||
146776572|NCT02723955|529353616|FG004|Escalation Phase|Withdrawal by Subject|1|||
146776573|NCT02723955|529353617|FG005|Escalation Phase|Withdrawal by Subject|1|||
146776574|NCT02723955|529353618|FG006|Escalation Phase|Withdrawal by Subject|1|||
146776575|NCT02723955|529353619|FG007|Escalation Phase|Withdrawal by Subject|1|||
146776576|NCT02723955|529353620|FG008|Escalation Phase|Withdrawal by Subject|0|||
146932490|NCT02501902|529911207|FG001|Overall Study|Death|4|||
146701177|NCT00357370|529083960|FG000|Cohort 2|Adverse Event|1|||
146701178|NCT00357370|529083961|FG001|Cohort 2|Adverse Event|1|||
146776577|NCT02723955|529353621|FG009|Escalation Phase|Withdrawal by Subject|0|||
146776578|NCT02723955|529353622|FG010|Escalation Phase|Withdrawal by Subject|0|||
146776579|NCT02723955|529353623|FG011|Escalation Phase|Withdrawal by Subject|0|||
146776580|NCT02723955|529353624|FG012|Escalation Phase|Withdrawal by Subject|1|||
146776581|NCT02723955|529353625|FG013|Escalation Phase|Withdrawal by Subject|0|||
146776582|NCT02723955|529353626|FG014|Escalation Phase|Withdrawal by Subject|0|||
146932491|NCT02501902|529911208|FG002|Overall Study|Death|4|||
146932492|NCT02501902|529911209|FG003|Overall Study|Death|10|||
146932493|NCT02501902|529911210|FG004|Overall Study|Death|10|||
146932494|NCT02501902|529911211|FG005|Overall Study|Death|11|||
146932495|NCT02501902|529911212|FG006|Overall Study|Death|7|||
146932496|NCT02501902|529911213|FG007|Overall Study|Death|15|||
146980990|NCT01393990|530093693|FG008|Overall Study|Withdrawal by Subject|0|||
146980991|NCT01393990|530093694|FG009|Overall Study|Withdrawal by Subject|0|||
146776583|NCT02723955|529353627|FG015|Escalation Phase|Withdrawal by Subject|0|||
146932497|NCT01878097|529911216|FG000|Baseline|Surveys not fully completed|2497|||
146932498|NCT01878097|529911217|FG001|Baseline|Surveys not fully completed|1800|||
146701179|NCT00357370|529083962|FG002|Cohort 2|Adverse Event|1|||
146701180|NCT00357370|529083960|FG000|Cohort 2|Lost to Follow-up|0|||
146701181|NCT00357370|529083961|FG001|Cohort 2|Lost to Follow-up|1|||
146701182|NCT00357370|529083962|FG002|Cohort 2|Lost to Follow-up|0|||
146701183|NCT00357370|529083960|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
146701184|NCT00357370|529083961|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
146701185|NCT00357370|529083962|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
146701186|NCT00357370|529083960|FG000|Cohort 2|Withdrawal by Subject|0|||
146701187|NCT00357370|529083961|FG001|Cohort 2|Withdrawal by Subject|2|||
146701188|NCT00357370|529083962|FG002|Cohort 2|Withdrawal by Subject|0|||
146701189|NCT02644967|529083974|FG000|Overall Study|Death|26|||
146701190|NCT02644967|529083974|FG000|Overall Study|Physician Decision|1|||
146701191|NCT02644967|529083974|FG000|Overall Study|Withdrawal by Subject|2|||
146701192|NCT02644967|529083974|FG000|Overall Study|Protocol Violation|1|||
146701193|NCT02644967|529083974|FG000|Overall Study|Progressive Disease|1|||
146701194|NCT02644967|529083974|FG000|Overall Study|Study Terminated by Sponsor|4|||
146701195|NCT02287896|529083975|FG000|Second Injection Visit|Withdrawal by Subject|0|||
146701196|NCT02287896|529083976|FG001|Second Injection Visit|Withdrawal by Subject|1|||
146701197|NCT03746522|529083977|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
146701198|NCT03746522|529083978|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
146701199|NCT03746522|529083979|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
146701200|NCT03746522|529083977|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
146701201|NCT03746522|529083978|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
146701202|NCT03746522|529083979|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
146701203|NCT03746522|529083977|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
146701204|NCT03746522|529083978|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
146701205|NCT03746522|529083979|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
146701206|NCT03746522|529083977|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
146701207|NCT03746522|529083978|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
146701208|NCT03746522|529083979|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
146701209|NCT03746522|529083977|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
146701210|NCT03746522|529083978|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
146701211|NCT03746522|529083979|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
146701212|NCT01639040|529083980|FG000|Overall Study|Adverse Event|1|||
146701213|NCT01639040|529083981|FG001|Overall Study|Adverse Event|0|||
146701214|NCT00486265|529083985|FG000|Overall Study|Adverse Event|1|||
146701215|NCT00486265|529083985|FG000|Overall Study|Lack of Efficacy|8|||
146701216|NCT01452412|529083986|FG000|Overall Study|Withdrawal by Subject|15|||
146701217|NCT01452412|529083987|FG001|Overall Study|Withdrawal by Subject|11|||
146701218|NCT01452412|529083986|FG000|Overall Study|Adverse Event|4|||
146701219|NCT01452412|529083987|FG001|Overall Study|Adverse Event|3|||
146701220|NCT01452412|529083986|FG000|Overall Study|Lost to Follow-up|5|||
146701221|NCT01452412|529083987|FG001|Overall Study|Lost to Follow-up|3|||
146701222|NCT01452412|529083986|FG000|Overall Study|Death|1|||
146701223|NCT01452412|529083987|FG001|Overall Study|Death|0|||
146701224|NCT01452412|529083986|FG000|Overall Study|Initiated dialysis|1|||
146701225|NCT01452412|529083987|FG001|Overall Study|Initiated dialysis|0|||
146701226|NCT01452412|529083986|FG000|Overall Study|Other|2|||
146701227|NCT01452412|529083987|FG001|Overall Study|Other|0|||
146701228|NCT05132127|529083988|FG000|Overall Study|Adverse Event|1|||
146701229|NCT03013543|529083989|FG000|Overall Study|Withdrawal by Subject|0|||
146701230|NCT03013543|529083990|FG001|Overall Study|Withdrawal by Subject|2|||
146701231|NCT03013543|529083991|FG002|Overall Study|Withdrawal by Subject|0|||
146701232|NCT03013543|529083992|FG003|Overall Study|Withdrawal by Subject|5|||
146701233|NCT03013543|529083993|FG004|Overall Study|Withdrawal by Subject|6|||
146701234|NCT03013543|529083994|FG005|Overall Study|Withdrawal by Subject|2|||
146701235|NCT03013543|529083995|FG006|Overall Study|Withdrawal by Subject|3|||
146701236|NCT03013543|529083996|FG007|Overall Study|Withdrawal by Subject|1|||
146701237|NCT03013543|529083997|FG008|Overall Study|Withdrawal by Subject|0|||
146701238|NCT03013543|529083998|FG009|Overall Study|Withdrawal by Subject|4|||
146701239|NCT03013543|529083989|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
146701240|NCT03013543|529083990|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
146701241|NCT03013543|529083991|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
146701242|NCT03013543|529083992|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
146701243|NCT03013543|529083993|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
146701244|NCT03013543|529083994|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
146701245|NCT03013543|529083995|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
146701246|NCT03013543|529083996|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
146701247|NCT03013543|529083997|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
146701248|NCT03013543|529083998|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
146701249|NCT03013543|529083989|FG000|Overall Study|Other|0|||
146701250|NCT03013543|529083990|FG001|Overall Study|Other|0|||
146701251|NCT03013543|529083991|FG002|Overall Study|Other|2|||
146701252|NCT03013543|529083992|FG003|Overall Study|Other|0|||
146701253|NCT03013543|529083993|FG004|Overall Study|Other|2|||
146701254|NCT03013543|529083994|FG005|Overall Study|Other|0|||
146776584|NCT02723955|529353628|FG016|Escalation Phase|Withdrawal by Subject|1|||
146776585|NCT02723955|529353629|FG017|Escalation Phase|Withdrawal by Subject|0|||
146776586|NCT02723955|529353630|FG018|Escalation Phase|Withdrawal by Subject|0|||
146776587|NCT02723955|529353631|FG019|Escalation Phase|Withdrawal by Subject|0|||
146776588|NCT02723955|529353632|FG020|Escalation Phase|Withdrawal by Subject|0|||
146776589|NCT02723955|529353633|FG021|Escalation Phase|Withdrawal by Subject|0|||
146776590|NCT02723955|529353634|FG022|Escalation Phase|Withdrawal by Subject|0|||
146776591|NCT02723955|529353635|FG023|Escalation Phase|Withdrawal by Subject|2|||
146776592|NCT02723955|529353636|FG024|Escalation Phase|Withdrawal by Subject|0|||
146776593|NCT02723955|529353637|FG025|Escalation Phase|Withdrawal by Subject|1|||
146776594|NCT02723955|529353638|FG026|Escalation Phase|Withdrawal by Subject|0|||
146776595|NCT02723955|529353639|FG027|Escalation Phase|Withdrawal by Subject|0|||
146776596|NCT02723955|529353640|FG028|Escalation Phase|Withdrawal by Subject|1|||
146776597|NCT02723955|529353641|FG029|Escalation Phase|Withdrawal by Subject|0|||
146776598|NCT02723955|529353642|FG030|Escalation Phase|Withdrawal by Subject|0|||
146776599|NCT02723955|529353643|FG031|Escalation Phase|Withdrawal by Subject|0|||
146776600|NCT02723955|529353644|FG032|Escalation Phase|Withdrawal by Subject|0|||
146776601|NCT02723955|529353645|FG033|Escalation Phase|Withdrawal by Subject|0|||
146776602|NCT02723955|529353646|FG034|Escalation Phase|Withdrawal by Subject|0|||
146776603|NCT02723955|529353647|FG035|Escalation Phase|Withdrawal by Subject|0|||
146776604|NCT02723955|529353648|FG036|Escalation Phase|Withdrawal by Subject|0|||
146776605|NCT02723955|529353649|FG037|Escalation Phase|Withdrawal by Subject|0|||
146776606|NCT02723955|529353650|FG038|Escalation Phase|Withdrawal by Subject|0|||
146701255|NCT03013543|529083995|FG006|Overall Study|Other|0|||
146701256|NCT03013543|529083996|FG007|Overall Study|Other|0|||
146701257|NCT03013543|529083997|FG008|Overall Study|Other|1|||
146701258|NCT03013543|529083998|FG009|Overall Study|Other|0|||
146701259|NCT03013543|529083989|FG000|Overall Study|Adverse Event|0|||
146701260|NCT03013543|529083990|FG001|Overall Study|Adverse Event|0|||
146701261|NCT03013543|529083991|FG002|Overall Study|Adverse Event|0|||
146701262|NCT03013543|529083992|FG003|Overall Study|Adverse Event|3|||
146701263|NCT03013543|529083993|FG004|Overall Study|Adverse Event|2|||
146701264|NCT03013543|529083994|FG005|Overall Study|Adverse Event|1|||
146701265|NCT03013543|529083995|FG006|Overall Study|Adverse Event|3|||
146701266|NCT03013543|529083996|FG007|Overall Study|Adverse Event|8|||
146701267|NCT03013543|529083997|FG008|Overall Study|Adverse Event|0|||
146701268|NCT03013543|529083998|FG009|Overall Study|Adverse Event|2|||
146701269|NCT03013543|529083989|FG000|Overall Study|Death|0|||
146701270|NCT03013543|529083990|FG001|Overall Study|Death|0|||
146701271|NCT03013543|529083991|FG002|Overall Study|Death|0|||
146701272|NCT03013543|529083992|FG003|Overall Study|Death|1|||
146701273|NCT03013543|529083993|FG004|Overall Study|Death|0|||
146701274|NCT03013543|529083994|FG005|Overall Study|Death|0|||
146701275|NCT03013543|529083995|FG006|Overall Study|Death|0|||
146701276|NCT03013543|529083996|FG007|Overall Study|Death|0|||
146701277|NCT03013543|529083997|FG008|Overall Study|Death|0|||
146701278|NCT03013543|529083998|FG009|Overall Study|Death|0|||
146701279|NCT03013543|529083989|FG000|Overall Study|Lack of Efficacy|0|||
146701280|NCT03013543|529083990|FG001|Overall Study|Lack of Efficacy|0|||
146701281|NCT03013543|529083991|FG002|Overall Study|Lack of Efficacy|0|||
146701282|NCT03013543|529083992|FG003|Overall Study|Lack of Efficacy|1|||
146701283|NCT03013543|529083993|FG004|Overall Study|Lack of Efficacy|0|||
146701284|NCT03013543|529083994|FG005|Overall Study|Lack of Efficacy|0|||
146701285|NCT03013543|529083995|FG006|Overall Study|Lack of Efficacy|0|||
146701286|NCT03013543|529083996|FG007|Overall Study|Lack of Efficacy|0|||
146701287|NCT03013543|529083997|FG008|Overall Study|Lack of Efficacy|0|||
146701288|NCT03013543|529083998|FG009|Overall Study|Lack of Efficacy|0|||
146701289|NCT03013543|529083989|FG000|Overall Study|Lost to Follow-up|0|||
146701290|NCT03013543|529083990|FG001|Overall Study|Lost to Follow-up|0|||
146701291|NCT03013543|529083991|FG002|Overall Study|Lost to Follow-up|0|||
146701292|NCT03013543|529083992|FG003|Overall Study|Lost to Follow-up|1|||
146701293|NCT03013543|529083993|FG004|Overall Study|Lost to Follow-up|0|||
146701294|NCT03013543|529083994|FG005|Overall Study|Lost to Follow-up|0|||
146701295|NCT03013543|529083995|FG006|Overall Study|Lost to Follow-up|1|||
146701296|NCT03013543|529083996|FG007|Overall Study|Lost to Follow-up|0|||
146776607|NCT02723955|529353651|FG039|Escalation Phase|Withdrawal by Subject|0|||
146776608|NCT02723955|529353652|FG040|Escalation Phase|Withdrawal by Subject|0|||
146776609|NCT02723955|529353653|FG041|Escalation Phase|Withdrawal by Subject|0|||
146776610|NCT02723955|529353654|FG042|Escalation Phase|Withdrawal by Subject|0|||
146776611|NCT02723955|529353612|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776612|NCT02723955|529353613|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776613|NCT02723955|529353614|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146701297|NCT03013543|529083997|FG008|Overall Study|Lost to Follow-up|0|||
146701298|NCT03013543|529083998|FG009|Overall Study|Lost to Follow-up|2|||
146701299|NCT03013543|529083989|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146701300|NCT03013543|529083990|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146701301|NCT03013543|529083991|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146701302|NCT03013543|529083992|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146776614|NCT02723955|529353615|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776615|NCT02723955|529353616|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
146776616|NCT02723955|529353617|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
146776617|NCT02723955|529353618|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
146776618|NCT02723955|529353619|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
146776619|NCT02723955|529353620|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
146776620|NCT02723955|529353621|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776621|NCT02723955|529353622|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776622|NCT02723955|529353623|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776623|NCT02723955|529353624|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776624|NCT02723955|529353625|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776625|NCT02723955|529353626|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776626|NCT02723955|529353627|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146701303|NCT03013543|529083993|FG004|Overall Study|Non-Compliance With Study Drug|0|||
146701304|NCT03013543|529083994|FG005|Overall Study|Non-Compliance With Study Drug|0|||
146701305|NCT03013543|529083995|FG006|Overall Study|Non-Compliance With Study Drug|0|||
146701306|NCT03013543|529083996|FG007|Overall Study|Non-Compliance With Study Drug|0|||
146701307|NCT03013543|529083997|FG008|Overall Study|Non-Compliance With Study Drug|1|||
146701308|NCT03013543|529083998|FG009|Overall Study|Non-Compliance With Study Drug|0|||
146701309|NCT03013543|529083989|FG000|Overall Study|Physician Decision|0|||
146701310|NCT03013543|529083990|FG001|Overall Study|Physician Decision|0|||
146701311|NCT03013543|529083991|FG002|Overall Study|Physician Decision|0|||
146701312|NCT03013543|529083992|FG003|Overall Study|Physician Decision|0|||
146701313|NCT03013543|529083993|FG004|Overall Study|Physician Decision|1|||
146701314|NCT03013543|529083994|FG005|Overall Study|Physician Decision|0|||
146701315|NCT03013543|529083995|FG006|Overall Study|Physician Decision|0|||
146701316|NCT03013543|529083996|FG007|Overall Study|Physician Decision|0|||
146701317|NCT03013543|529083997|FG008|Overall Study|Physician Decision|0|||
146701318|NCT03013543|529083998|FG009|Overall Study|Physician Decision|0|||
146701319|NCT03013543|529083989|FG000|Overall Study|Protocol Violation|0|||
146776627|NCT02723955|529353628|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776628|NCT02723955|529353629|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776629|NCT02723955|529353630|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776630|NCT02723955|529353631|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776631|NCT02723955|529353632|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776632|NCT02723955|529353633|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776633|NCT02723955|529353634|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776634|NCT02723955|529353635|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776635|NCT02723955|529353636|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776636|NCT02723955|529353637|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776637|NCT02723955|529353638|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776638|NCT02723955|529353639|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776639|NCT02723955|529353640|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776640|NCT02723955|529353641|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776641|NCT02723955|529353642|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776642|NCT02723955|529353643|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776643|NCT02723955|529353644|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776644|NCT02723955|529353645|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776645|NCT02723955|529353646|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776646|NCT02723955|529353647|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776647|NCT02723955|529353648|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776648|NCT02723955|529353649|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776649|NCT02723955|529353650|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146932499|NCT01878097|529911216|FG000|Implementation Year 1|Surveys not fully completed|3202|||
146932500|NCT01878097|529911217|FG001|Implementation Year 1|Surveys not fully completed|2549|||
146701320|NCT03013543|529083990|FG001|Overall Study|Protocol Violation|0|||
146701321|NCT03013543|529083991|FG002|Overall Study|Protocol Violation|0|||
146701322|NCT03013543|529083992|FG003|Overall Study|Protocol Violation|0|||
146701323|NCT03013543|529083993|FG004|Overall Study|Protocol Violation|0|||
146932501|NCT01878097|529911216|FG000|Implementation Year 2|Surveys not fully completed|3281|||
146932502|NCT01878097|529911217|FG001|Implementation Year 2|Surveys not fully completed|2841|||
146932503|NCT01878097|529911216|FG000|Implementation Year 3|Surveys not fully completed|3494|||
146932504|NCT01878097|529911217|FG001|Implementation Year 3|Surveys not fully completed|2980|||
146932505|NCT01878097|529911216|FG000|Implementation Year 4|Surveys not fully completed|3604|||
146932506|NCT01878097|529911217|FG001|Implementation Year 4|Surveys not fully completed|3007|||
146932507|NCT00565058|529911220|FG000|Overall Study|Adverse Event|1|||
146932508|NCT00565058|529911221|FG001|Overall Study|Adverse Event|0|||
146932509|NCT02227108|529911222|FG000|Overall Study|Did not receive treatment|2|||
146932510|NCT02227108|529911222|FG000|Overall Study|Other|3|||
146932511|NCT02227108|529911222|FG000|Overall Study|Progressive disease|17|||
146932512|NCT02227108|529911222|FG000|Overall Study|Initiation of alternative therapy|2|||
146932513|NCT02227108|529911222|FG000|Overall Study|Investigator discretion|1|||
146932514|NCT02227108|529911222|FG000|Overall Study|Adverse Event|6|||
146932515|NCT02486952|529911223|FG000|Overall Study|Not Started Induction Therapy|3|||
146932516|NCT02486952|529911223|FG000|Overall Study|Adverse Event|1|||
146701324|NCT03013543|529083994|FG005|Overall Study|Protocol Violation|0|||
146701325|NCT03013543|529083995|FG006|Overall Study|Protocol Violation|0|||
146701326|NCT03013543|529083996|FG007|Overall Study|Protocol Violation|0|||
146701327|NCT03013543|529083997|FG008|Overall Study|Protocol Violation|0|||
146701328|NCT03013543|529083998|FG009|Overall Study|Protocol Violation|1|||
146701329|NCT02552316|529084000|FG000|Overall Study|Withdrawal by Subject|1|||
146701330|NCT02552316|529084000|FG000|Overall Study|Withdrawal due to non-compliance|1|||
146701331|NCT04382911|529084001|FG000|Overall Study|unable to be imaged prior to surgery|2|||
146701332|NCT01120210|529084007|FG000|MAIN INFUSION|Adverse Event|1|||
146701333|NCT01120210|529084008|FG001|MAIN INFUSION|Adverse Event|0|||
146701334|NCT01120210|529084007|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
146701335|NCT01120210|529084008|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
146701336|NCT04697628|529084019|FG000|Overall Study|Withdrawal by Subject|17|||
146701337|NCT04697628|529084020|FG001|Overall Study|Withdrawal by Subject|23|||
146701338|NCT04697628|529084019|FG000|Overall Study|Lost to Follow-up|0|||
146701339|NCT04697628|529084020|FG001|Overall Study|Lost to Follow-up|4|||
146701340|NCT04697628|529084019|FG000|Overall Study|On-going in study|122|||
146701341|NCT04697628|529084020|FG001|Overall Study|On-going in study|91|||
146701342|NCT00974571|529084021|FG000|Overall Study|Adverse Event|31|||
146701343|NCT00974571|529084022|FG001|Overall Study|Adverse Event|4|||
146701344|NCT00974571|529084023|FG002|Overall Study|Adverse Event|27|||
146701345|NCT00974571|529084021|FG000|Overall Study|Lack of Efficacy|3|||
146701346|NCT00974571|529084022|FG001|Overall Study|Lack of Efficacy|2|||
146701347|NCT00974571|529084023|FG002|Overall Study|Lack of Efficacy|9|||
146701348|NCT00974571|529084021|FG000|Overall Study|Lost to Follow-up|2|||
146701349|NCT00974571|529084022|FG001|Overall Study|Lost to Follow-up|1|||
146701350|NCT00974571|529084023|FG002|Overall Study|Lost to Follow-up|2|||
146701351|NCT00974571|529084021|FG000|Overall Study|Protocol Violation|13|||
146701352|NCT00974571|529084022|FG001|Overall Study|Protocol Violation|4|||
146701353|NCT00974571|529084023|FG002|Overall Study|Protocol Violation|18|||
146701354|NCT00974571|529084021|FG000|Overall Study|Withdrawal by Subject|14|||
146701355|NCT00974571|529084022|FG001|Overall Study|Withdrawal by Subject|5|||
146701356|NCT00974571|529084023|FG002|Overall Study|Withdrawal by Subject|16|||
146701357|NCT00974571|529084021|FG000|Overall Study|Patient Moved|1|||
146701358|NCT00974571|529084022|FG001|Overall Study|Patient Moved|0|||
146701359|NCT00974571|529084023|FG002|Overall Study|Patient Moved|1|||
146701360|NCT00974571|529084021|FG000|Overall Study|Other|4|||
146701361|NCT00974571|529084022|FG001|Overall Study|Other|0|||
146701362|NCT00974571|529084023|FG002|Overall Study|Other|10|||
146701363|NCT00393939|529084024|FG000|Overall Study|Protocol Violation|1|||
146701364|NCT00393939|529084025|FG001|Overall Study|Protocol Violation|1|||
146701365|NCT00393939|529084024|FG000|Overall Study|Lost to Follow-up|2|||
146701366|NCT00393939|529084025|FG001|Overall Study|Lost to Follow-up|4|||
146701367|NCT00393939|529084024|FG000|Overall Study|Death|10|||
146701368|NCT00393939|529084025|FG001|Overall Study|Death|4|||
146701369|NCT00393939|529084024|FG000|Overall Study|Sponsor|5|||
146701370|NCT00393939|529084025|FG001|Overall Study|Sponsor|13|||
146701371|NCT00393939|529084024|FG000|Overall Study|Objective progression or relapse|239|||
146701372|NCT00393939|529084025|FG001|Overall Study|Objective progression or relapse|223|||
146701373|NCT00393939|529084024|FG000|Overall Study|Withdrawal by Subject|2|||
146932517|NCT02486952|529911223|FG000|Overall Study|Death|15|||
146932518|NCT02486952|529911223|FG000|Overall Study|Lack of Efficacy|3|||
146932519|NCT02486952|529911223|FG000|Overall Study|Lost to Follow-up|26|||
146701374|NCT00393939|529084025|FG001|Overall Study|Withdrawal by Subject|7|||
146701375|NCT00393939|529084024|FG000|Overall Study|Other|37|||
146701376|NCT00393939|529084025|FG001|Overall Study|Other|45|||
146701377|NCT02385799|529084026|FG000|Overall Study|Lost to Follow-up|1|||
146932520|NCT02486952|529911223|FG000|Overall Study|Other|2|||
146932521|NCT04111107|529911224|FG000|Overall Study|Withdrawal by Subject|6|||
146932522|NCT04111107|529911224|FG000|Overall Study|Declining Health|5|||
146932523|NCT00594204|529911225|FG000|Overall Study|Adverse Event|15|||
146701378|NCT02385799|529084027|FG001|Overall Study|Lost to Follow-up|2|||
146701379|NCT02385799|529084026|FG000|Overall Study|Adverse Event|4|||
146932524|NCT00594204|529911226|FG001|Overall Study|Adverse Event|3|||
146932525|NCT00594204|529911225|FG000|Overall Study|Lost to Follow-up|9|||
146932526|NCT00594204|529911226|FG001|Overall Study|Lost to Follow-up|5|||
146701380|NCT02385799|529084027|FG001|Overall Study|Adverse Event|2|||
146701381|NCT02385799|529084026|FG000|Overall Study|Withdrawal by Subject|0|||
146701382|NCT02385799|529084027|FG001|Overall Study|Withdrawal by Subject|4|||
146701383|NCT00547703|529084028|FG000|Overall Study|Lost to Follow-up|1|||
146701384|NCT00547703|529084029|FG001|Overall Study|Lost to Follow-up|0|||
146701385|NCT01736696|529084030|FG000|Overall Study|Withdrawal by Subject|0|||
146701386|NCT01736696|529084031|FG001|Overall Study|Withdrawal by Subject|0|||
146701387|NCT01736696|529084032|FG002|Overall Study|Withdrawal by Subject|1|||
146701388|NCT01736696|529084033|FG003|Overall Study|Withdrawal by Subject|0|||
146701389|NCT01736696|529084034|FG004|Overall Study|Withdrawal by Subject|0|||
146701390|NCT01736696|529084035|FG005|Overall Study|Withdrawal by Subject|0|||
146701391|NCT01736696|529084036|FG006|Overall Study|Withdrawal by Subject|0|||
146701392|NCT00838565|529084037|FG000|Overall Study|Withdrawal by Subject|0|||
146701393|NCT00838565|529084038|FG001|Overall Study|Withdrawal by Subject|0|||
146701394|NCT00838565|529084039|FG002|Overall Study|Withdrawal by Subject|1|||
146701395|NCT00838565|529084040|FG003|Overall Study|Withdrawal by Subject|0|||
146701396|NCT00838565|529084041|FG004|Overall Study|Withdrawal by Subject|0|||
146701397|NCT00838565|529084042|FG005|Overall Study|Withdrawal by Subject|2|||
146701398|NCT00838565|529084037|FG000|Overall Study|Other|0|||
146701399|NCT00838565|529084038|FG001|Overall Study|Other|2|||
146701400|NCT00838565|529084039|FG002|Overall Study|Other|0|||
146701401|NCT00838565|529084040|FG003|Overall Study|Other|0|||
146701402|NCT00838565|529084041|FG004|Overall Study|Other|0|||
146701403|NCT00838565|529084042|FG005|Overall Study|Other|0|||
146701404|NCT00838565|529084037|FG000|Overall Study|Randomized but not Treated|0|||
146701405|NCT00838565|529084038|FG001|Overall Study|Randomized but not Treated|1|||
146701406|NCT00838565|529084039|FG002|Overall Study|Randomized but not Treated|0|||
146701407|NCT00838565|529084040|FG003|Overall Study|Randomized but not Treated|0|||
146701408|NCT00838565|529084041|FG004|Overall Study|Randomized but not Treated|0|||
146701409|NCT00838565|529084042|FG005|Overall Study|Randomized but not Treated|0|||
146701410|NCT00458484|529084043|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
146701411|NCT00458484|529084044|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
146701412|NCT00458484|529084045|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
146701413|NCT00458484|529084046|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
146701414|NCT00458484|529084047|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
146701415|NCT00458484|529084048|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
146701416|NCT00458484|529084049|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
146701417|NCT03571516|529084050|FG000|Overall Study|Severe diarrhea|1|||
146701418|NCT03571516|529084051|FG001|Overall Study|Severe diarrhea|0|||
146701419|NCT03571516|529084050|FG000|Overall Study|Withdrawal by Subject|0|||
146701420|NCT03571516|529084051|FG001|Overall Study|Withdrawal by Subject|1|||
146701421|NCT02275481|529084052|FG000|Overall Study|Death|2|||
146701422|NCT02275481|529084053|FG001|Overall Study|Death|1|||
146701423|NCT02275481|529084052|FG000|Overall Study|Lost to Follow-up|2|||
146701424|NCT02275481|529084053|FG001|Overall Study|Lost to Follow-up|0|||
146701425|NCT02275481|529084052|FG000|Overall Study|Withdrawal by Subject|3|||
146701426|NCT02275481|529084053|FG001|Overall Study|Withdrawal by Subject|0|||
146701427|NCT02275481|529084052|FG000|Overall Study|all other reasons combined|2|||
146701428|NCT02275481|529084053|FG001|Overall Study|all other reasons combined|1|||
146701429|NCT02275481|529084052|FG000|Overall Study|Physician Decision|0|||
146701430|NCT02275481|529084053|FG001|Overall Study|Physician Decision|1|||
146701431|NCT01838642|529084055|FG000|Overall Study|Died on study|1|||
146701432|NCT01215227|529084059|FG000|Overall Study|Adverse Event|11|||
146701433|NCT01215227|529084060|FG001|Overall Study|Adverse Event|11|||
146701434|NCT01215227|529084061|FG002|Overall Study|Adverse Event|4|||
146701435|NCT01215227|529084062|FG003|Overall Study|Adverse Event|8|||
146701436|NCT01215227|529084063|FG004|Overall Study|Adverse Event|7|||
146701437|NCT01215227|529084064|FG005|Overall Study|Adverse Event|6|||
146701438|NCT01215227|529084059|FG000|Overall Study|Treatment Failure|8|||
146701439|NCT01215227|529084060|FG001|Overall Study|Treatment Failure|4|||
146701440|NCT01215227|529084061|FG002|Overall Study|Treatment Failure|1|||
146701441|NCT01215227|529084062|FG003|Overall Study|Treatment Failure|5|||
146701442|NCT01215227|529084063|FG004|Overall Study|Treatment Failure|1|||
146701443|NCT01215227|529084064|FG005|Overall Study|Treatment Failure|1|||
146701444|NCT01215227|529084059|FG000|Overall Study|Lost to Follow-up|1|||
146701445|NCT01215227|529084060|FG001|Overall Study|Lost to Follow-up|4|||
146701446|NCT01215227|529084061|FG002|Overall Study|Lost to Follow-up|1|||
146701447|NCT01215227|529084062|FG003|Overall Study|Lost to Follow-up|1|||
146932527|NCT00594204|529911225|FG000|Overall Study|Withdrawal by Subject|23|||
146932528|NCT00594204|529911226|FG001|Overall Study|Withdrawal by Subject|29|||
146701448|NCT01215227|529084063|FG004|Overall Study|Lost to Follow-up|1|||
146701449|NCT01215227|529084064|FG005|Overall Study|Lost to Follow-up|2|||
146701450|NCT01215227|529084059|FG000|Overall Study|Subject Withdrew Consent|16|||
146701451|NCT01215227|529084060|FG001|Overall Study|Subject Withdrew Consent|20|||
146701452|NCT01215227|529084061|FG002|Overall Study|Subject Withdrew Consent|7|||
146701453|NCT01215227|529084062|FG003|Overall Study|Subject Withdrew Consent|10|||
146701454|NCT01215227|529084063|FG004|Overall Study|Subject Withdrew Consent|11|||
146701455|NCT01215227|529084064|FG005|Overall Study|Subject Withdrew Consent|8|||
146701456|NCT01215227|529084059|FG000|Overall Study|Non-Compliance With Protocol|2|||
146701457|NCT01215227|529084060|FG001|Overall Study|Non-Compliance With Protocol|6|||
146701458|NCT01215227|529084061|FG002|Overall Study|Non-Compliance With Protocol|1|||
146701459|NCT01215227|529084062|FG003|Overall Study|Non-Compliance With Protocol|0|||
146701460|NCT01215227|529084063|FG004|Overall Study|Non-Compliance With Protocol|0|||
146701461|NCT01215227|529084064|FG005|Overall Study|Non-Compliance With Protocol|0|||
146701462|NCT01215227|529084059|FG000|Overall Study|Administrative|83|||
146701463|NCT01215227|529084060|FG001|Overall Study|Administrative|73|||
146932529|NCT00594204|529911225|FG000|Overall Study|Other|4|||
146932530|NCT00594204|529911226|FG001|Overall Study|Other|3|||
146932531|NCT00594204|529911225|FG000|Overall Study|Lack of Efficacy|3|||
146932532|NCT00594204|529911226|FG001|Overall Study|Lack of Efficacy|4|||
146932533|NCT00594204|529911225|FG000|Overall Study|Randomized but not treated|4|||
146932534|NCT00594204|529911226|FG001|Overall Study|Randomized but not treated|1|||
146932535|NCT00567541|529911227|FG000|Overall Study|Adverse Event|0|||
146932536|NCT00567541|529911228|FG001|Overall Study|Adverse Event|1|||
146932537|NCT01890512|529911231|FG000|Overall Study|Physician Decision|1|||
146932538|NCT01890512|529911231|FG000|Overall Study|Withdrawal by Subject|1|||
146932539|NCT01890512|529911231|FG000|Overall Study|Protocol Violation|1|||
146932540|NCT01529385|529911232|FG000|Overall Study|Lost to Follow-up|2|||
146932541|NCT01529385|529911233|FG001|Overall Study|Lost to Follow-up|1|||
146932542|NCT01401465|529911234|FG000|Treatment Period 1|Adverse Event|4|||
146932543|NCT01401465|529911235|FG001|Treatment Period 1|Adverse Event|1|||
146932544|NCT01401465|529911234|FG000|Treatment Period 1|Pregnancy|0|||
146932545|NCT01401465|529911235|FG001|Treatment Period 1|Pregnancy|1|||
146932546|NCT01401465|529911234|FG000|Treatment Period 1|Protocol Violation|5|||
146932547|NCT01401465|529911235|FG001|Treatment Period 1|Protocol Violation|0|||
146932548|NCT01401465|529911234|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146932549|NCT01401465|529911235|FG001|Treatment Period 1|Withdrawal by Subject|4|||
146932550|NCT01401465|529911234|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
146932551|NCT01401465|529911235|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
146932552|NCT01401465|529911234|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
146932553|NCT01401465|529911235|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
146932554|NCT01401465|529911234|FG000|Treatment Period 1|Scheduling Difficulties|1|||
146932555|NCT01401465|529911235|FG001|Treatment Period 1|Scheduling Difficulties|1|||
146932556|NCT01401465|529911234|FG000|Treatment Period 2|Lost to Follow-up|0|||
146932557|NCT01401465|529911235|FG001|Treatment Period 2|Lost to Follow-up|1|||
146932558|NCT01401465|529911234|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146932559|NCT01401465|529911235|FG001|Treatment Period 2|Withdrawal by Subject|1|||
146932560|NCT01115738|529911236|FG000|Overall Study|Death|1|||
146932561|NCT01115738|529911237|FG001|Overall Study|Death|0|||
146932562|NCT01115738|529911238|FG002|Overall Study|Death|0|||
146932563|NCT01115738|529911236|FG000|Overall Study|Lost to Follow-up|0|||
146932564|NCT01115738|529911237|FG001|Overall Study|Lost to Follow-up|0|||
146701464|NCT01215227|529084061|FG002|Overall Study|Administrative|42|||
146701465|NCT01215227|529084062|FG003|Overall Study|Administrative|24|||
146701466|NCT01215227|529084063|FG004|Overall Study|Administrative|28|||
146701467|NCT01215227|529084064|FG005|Overall Study|Administrative|40|||
146701468|NCT01215227|529084059|FG000|Overall Study|Missing Status|0|||
146701469|NCT01215227|529084060|FG001|Overall Study|Missing Status|1|||
146701470|NCT01215227|529084061|FG002|Overall Study|Missing Status|0|||
146701471|NCT01215227|529084062|FG003|Overall Study|Missing Status|0|||
146701472|NCT01215227|529084063|FG004|Overall Study|Missing Status|0|||
146701473|NCT01215227|529084064|FG005|Overall Study|Missing Status|0|||
146701474|NCT01215227|529084059|FG000|Overall Study|Randomized but not treated|0|||
146701475|NCT01215227|529084060|FG001|Overall Study|Randomized but not treated|0|||
146701476|NCT01215227|529084061|FG002|Overall Study|Randomized but not treated|1|||
146701477|NCT01215227|529084062|FG003|Overall Study|Randomized but not treated|1|||
146932565|NCT01115738|529911238|FG002|Overall Study|Lost to Follow-up|1|||
146932566|NCT01115738|529911236|FG000|Overall Study|Physician Decision|18|||
146932567|NCT01115738|529911237|FG001|Overall Study|Physician Decision|15|||
146932568|NCT01115738|529911238|FG002|Overall Study|Physician Decision|17|||
146932569|NCT01115738|529911236|FG000|Overall Study|Withdrawal by Subject|6|||
146932570|NCT01115738|529911237|FG001|Overall Study|Withdrawal by Subject|6|||
146932571|NCT01115738|529911238|FG002|Overall Study|Withdrawal by Subject|9|||
146932572|NCT00575094|529911241|FG000|Overall Study|Adverse Event|2|||
146932573|NCT00575094|529911241|FG000|Overall Study|Withdrawal by Subject|1|||
146932574|NCT00772382|529911242|FG000|Overall Study|Adverse Event|19|||
146932575|NCT00772382|529911242|FG000|Overall Study|Death|6|||
146932576|NCT00772382|529911242|FG000|Overall Study|Lack of Efficacy|4|||
146932577|NCT00772382|529911242|FG000|Overall Study|Physician Decision|5|||
146701478|NCT01215227|529084063|FG004|Overall Study|Randomized but not treated|0|||
146701479|NCT01215227|529084064|FG005|Overall Study|Randomized but not treated|1|||
146701480|NCT00291668|529084065|FG000|Overall Study|Lack of Efficacy|1|||
146932578|NCT00772382|529911242|FG000|Overall Study|Protocol Violation|1|||
146701481|NCT00291668|529084066|FG001|Overall Study|Lack of Efficacy|0|||
146701482|NCT00291668|529084067|FG002|Overall Study|Lack of Efficacy|0|||
146701483|NCT00291668|529084065|FG000|Overall Study|SAE, non-fatal|1|||
146701484|NCT00291668|529084066|FG001|Overall Study|SAE, non-fatal|1|||
146701485|NCT00291668|529084067|FG002|Overall Study|SAE, non-fatal|1|||
146701486|NCT00291668|529084065|FG000|Overall Study|AE, non-serious non-fatal|1|||
146701487|NCT00291668|529084066|FG001|Overall Study|AE, non-serious non-fatal|0|||
146701488|NCT00291668|529084067|FG002|Overall Study|AE, non-serious non-fatal|0|||
146701489|NCT00291668|529084065|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
146701490|NCT00291668|529084066|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
146701491|NCT00291668|529084067|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
146701492|NCT00313612|529084070|FG000|Overall Study|Patient never received treatment|0|||
146701493|NCT00313612|529084071|FG001|Overall Study|Patient never received treatment|1|||
146701494|NCT02281552|529084078|FG000|Overall Study|Medication error|1|||
146701495|NCT02281552|529084079|FG001|Overall Study|Medication error|0|||
146701496|NCT02281552|529084078|FG000|Overall Study|Insufficient clinical response|0|||
146701497|NCT02281552|529084079|FG001|Overall Study|Insufficient clinical response|1|||
146701498|NCT02281552|529084078|FG000|Overall Study|Adverse Event|3|||
146701499|NCT02281552|529084079|FG001|Overall Study|Adverse Event|9|||
146701500|NCT01434290|529084080|FG000|Overall Study|Protocol Violation|6|||
146701501|NCT01434290|529084081|FG001|Overall Study|Protocol Violation|3|||
146701502|NCT01434290|529084080|FG000|Overall Study|No protocol treatment|2|||
146701503|NCT01434290|529084081|FG001|Overall Study|No protocol treatment|4|||
146701504|NCT01224639|529084082|FG000|Overall Study|Withdrawal by Subject|0|||
146701505|NCT01224639|529084083|FG001|Overall Study|Withdrawal by Subject|0|||
146701506|NCT01224639|529084084|FG002|Overall Study|Withdrawal by Subject|0|||
146701507|NCT01224639|529084085|FG003|Overall Study|Withdrawal by Subject|0|||
146701508|NCT01224639|529084086|FG004|Overall Study|Withdrawal by Subject|2|||
146701509|NCT01224639|529084087|FG005|Overall Study|Withdrawal by Subject|0|||
146701510|NCT01224639|529084088|FG006|Overall Study|Withdrawal by Subject|1|||
146701511|NCT01224639|529084089|FG007|Overall Study|Withdrawal by Subject|1|||
146701512|NCT01224639|529084082|FG000|Overall Study|Adverse Event|0|||
146701513|NCT01224639|529084083|FG001|Overall Study|Adverse Event|0|||
146701514|NCT01224639|529084084|FG002|Overall Study|Adverse Event|0|||
146701515|NCT01224639|529084085|FG003|Overall Study|Adverse Event|0|||
146701516|NCT01224639|529084086|FG004|Overall Study|Adverse Event|0|||
146701517|NCT01224639|529084087|FG005|Overall Study|Adverse Event|0|||
146701518|NCT01224639|529084088|FG006|Overall Study|Adverse Event|0|||
146701519|NCT01224639|529084089|FG007|Overall Study|Adverse Event|1|||
146701520|NCT00653224|529086011|FG000|Overall Study|Adverse Event|2|||
146701521|NCT00653224|529086012|FG001|Overall Study|Adverse Event|1|||
146701522|NCT00653224|529086011|FG000|Overall Study|Lack of Efficacy|1|||
146701523|NCT00653224|529086012|FG001|Overall Study|Lack of Efficacy|2|||
146701524|NCT00653224|529086011|FG000|Overall Study|Loss of efficacy|1|||
146701525|NCT00653224|529086012|FG001|Overall Study|Loss of efficacy|0|||
146701526|NCT00653224|529086011|FG000|Overall Study|Lost to Follow-up|1|||
146701527|NCT00653224|529086012|FG001|Overall Study|Lost to Follow-up|0|||
146701528|NCT00653224|529086011|FG000|Overall Study|Other|2|||
146701529|NCT00653224|529086012|FG001|Overall Study|Other|4|||
146701530|NCT00773175|529086013|FG000|Overall Study|Adverse Event|2|||
146701531|NCT00773175|529086014|FG001|Overall Study|Adverse Event|0|||
146701532|NCT00773175|529086013|FG000|Overall Study|Consent Withdrawn|0|||
146701533|NCT00773175|529086014|FG001|Overall Study|Consent Withdrawn|2|||
146701534|NCT00503841|529086015|FG000|Overall Study|All screen failures|44|||
146701535|NCT00326612|529086020|FG000|Overall Study|They did not have a seizure requiring tx|129|||
146701536|NCT00326612|529086021|FG001|Overall Study|They did not have a seizure requiring tx|137|||
146701537|NCT00419562|529086022|FG000|Overall Study|Lost to Follow-up|12|||
146701538|NCT00419562|529086023|FG001|Overall Study|Lost to Follow-up|13|||
146701539|NCT00419562|529086022|FG000|Overall Study|Withdrawal by Subject|20|||
146701540|NCT00419562|529086023|FG001|Overall Study|Withdrawal by Subject|18|||
146701541|NCT00419562|529086022|FG000|Overall Study|Participant Institutionalized|1|||
146701542|NCT00419562|529086023|FG001|Overall Study|Participant Institutionalized|0|||
146701543|NCT00640510|529086024|FG000|Overall Study|Lack of Efficacy|0|||
146701544|NCT00640510|529086025|FG001|Overall Study|Lack of Efficacy|1|||
146701545|NCT00640510|529086024|FG000|Overall Study|Protocol Violation|1|||
146701546|NCT00640510|529086025|FG001|Overall Study|Protocol Violation|0|||
146701547|NCT00640510|529086024|FG000|Overall Study|Physician Decision|0|||
146701548|NCT00640510|529086025|FG001|Overall Study|Physician Decision|1|||
146701549|NCT01440322|529086026|FG000|Overall Study|Discomfort|2|||
146701550|NCT01440322|529086027|FG001|Overall Study|Discomfort|0|||
146701551|NCT01440322|529086026|FG000|Overall Study|Biomicroscopy|1|||
146701552|NCT01440322|529086027|FG001|Overall Study|Biomicroscopy|0|||
146701553|NCT01440322|529086026|FG000|Overall Study|Symptoms and Problems|1|||
146701554|NCT01440322|529086027|FG001|Overall Study|Symptoms and Problems|0|||
146701555|NCT01440322|529086026|FG000|Overall Study|Unacceptable Subjective Vision|1|||
146701556|NCT01440322|529086027|FG001|Overall Study|Unacceptable Subjective Vision|0|||
146701557|NCT01440322|529086026|FG000|Overall Study|Other Product Related|1|||
146701558|NCT01440322|529086027|FG001|Overall Study|Other Product Related|0|||
146932579|NCT00772382|529911242|FG000|Overall Study|Withdrawal by Subject|10|||
146932580|NCT00772382|529911242|FG000|Overall Study|Other Reasons|10|||
146932581|NCT02721251|529911243|FG000|Overall Study|Withdrawal by Subject|8|||
146932582|NCT02721251|529911244|FG001|Overall Study|Withdrawal by Subject|7|||
146932583|NCT02721251|529911245|FG002|Overall Study|Withdrawal by Subject|9|||
146932584|NCT02721251|529911243|FG000|Overall Study|poor adherence|2|||
146932585|NCT02721251|529911244|FG001|Overall Study|poor adherence|2|||
146932586|NCT02721251|529911245|FG002|Overall Study|poor adherence|2|||
146932587|NCT02921763|529911246|FG000|Overall Study|Adverse Event|4|||
146932588|NCT02921763|529911246|FG000|Overall Study|Lost to Follow-up|4|||
146932589|NCT02921763|529911246|FG000|Overall Study|Lack of Efficacy|3|||
146932590|NCT02921763|529911246|FG000|Overall Study|Protocol Violation|2|||
146932591|NCT02921763|529911246|FG000|Overall Study|Withdrawal by Subject|2|||
146932592|NCT02921763|529911246|FG000|Overall Study|Physician Decision|1|||
146932593|NCT02921763|529911246|FG000|Overall Study|No data obtained|2|||
146932594|NCT00862121|529911251|FG000|Overall Study|Adverse Event|1|||
146932595|NCT00862121|529911252|FG001|Overall Study|Adverse Event|2|||
146932596|NCT00862121|529911251|FG000|Overall Study|Lack of Efficacy|0|||
146932597|NCT00862121|529911252|FG001|Overall Study|Lack of Efficacy|3|||
146932598|NCT00862121|529911251|FG000|Overall Study|Protocol Violation|0|||
146932599|NCT00862121|529911252|FG001|Overall Study|Protocol Violation|1|||
146932600|NCT00862121|529911251|FG000|Overall Study|Exclusion criterion violation|0|||
146932601|NCT00862121|529911252|FG001|Overall Study|Exclusion criterion violation|1|||
146932602|NCT00862121|529911251|FG000|Overall Study|Incorrect randomisation|0|||
146932603|NCT00862121|529911252|FG001|Overall Study|Incorrect randomisation|1|||
146932604|NCT01582971|529911253|FG000|Overall Study|Death|2|||
146701559|NCT01440322|529086026|FG000|Overall Study|Unrelated Medical Problem|0|||
146701560|NCT01440322|529086027|FG001|Overall Study|Unrelated Medical Problem|1|||
146701561|NCT01440322|529086026|FG000|Overall Study|Other Non-Product Related|1|||
146701562|NCT01440322|529086027|FG001|Overall Study|Other Non-Product Related|0|||
146701563|NCT00770120|529086030|FG000|Overall Study|Progression|31|||
146701564|NCT00770120|529086030|FG000|Overall Study|Adverse Event|11|||
146701565|NCT00770120|529086030|FG000|Overall Study|Not Protocol Specified|11|||
146701566|NCT00770120|529086030|FG000|Overall Study|Death|3|||
146701567|NCT00770120|529086030|FG000|Overall Study|Withdrawal by Subject|2|||
146701568|NCT00770120|529086030|FG000|Overall Study|Ineligible|1|||
146701569|NCT00770120|529086030|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
146701570|NCT00770120|529086030|FG000|Overall Study|Reason under Review|1|||
146701571|NCT02412631|529086031|FG000|Overall Study|Adverse Event|1|||
146701572|NCT02412631|529086032|FG001|Overall Study|Adverse Event|2|||
146701573|NCT02412631|529086031|FG000|Overall Study|Lost to Follow-up|5|||
146701574|NCT02412631|529086032|FG001|Overall Study|Lost to Follow-up|9|||
146701575|NCT02412631|529086031|FG000|Overall Study|Withdrawal by Subject|9|||
146701576|NCT02412631|529086032|FG001|Overall Study|Withdrawal by Subject|3|||
146701577|NCT02412631|529086031|FG000|Overall Study|Early stop by FDA|5|||
146701578|NCT02412631|529086032|FG001|Overall Study|Early stop by FDA|2|||
146701579|NCT02412631|529086031|FG000|Overall Study|Unspecified reason|6|||
146701580|NCT02412631|529086032|FG001|Overall Study|Unspecified reason|8|||
146701581|NCT01782313|529086040|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
146701582|NCT01782313|529086040|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
146701583|NCT01782313|529086040|FG000|Treated Cycle 3|Progressive Disease|21|||
146701584|NCT01782313|529086040|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
146701585|NCT01782313|529086040|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
146701586|NCT01782313|529086040|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
146701587|NCT01782313|529086040|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
146701588|NCT01782313|529086040|FG000|Survival Follow up|Lost to Follow-up|1|||
146701589|NCT00958776|529086041|FG000|Overall Study|Adverse Event|0|||
146701590|NCT00958776|529086042|FG001|Overall Study|Adverse Event|1|||
146701591|NCT00958776|529086041|FG000|Overall Study|Physician Decision|1|||
146701592|NCT00958776|529086042|FG001|Overall Study|Physician Decision|0|||
146701593|NCT00958776|529086041|FG000|Overall Study|Lost to Follow-up|2|||
146701594|NCT00958776|529086042|FG001|Overall Study|Lost to Follow-up|6|||
146932605|NCT01582971|529911254|FG001|Overall Study|Death|1|||
146932606|NCT01582971|529911253|FG000|Overall Study|Lost to Follow-up|18|||
146932607|NCT01582971|529911254|FG001|Overall Study|Lost to Follow-up|21|||
146932608|NCT01582971|529911253|FG000|Overall Study|Withdrawal by Subject|4|||
146932609|NCT01582971|529911254|FG001|Overall Study|Withdrawal by Subject|2|||
146932610|NCT01582971|529911253|FG000|Overall Study|Other|15|||
146932611|NCT01582971|529911254|FG001|Overall Study|Other|13|||
146932612|NCT02007954|529911255|FG000|Overall Study|Received liver transplant|3|||
146932613|NCT02007954|529911255|FG000|Overall Study|Switch in treatment modality|2|||
146932614|NCT02007954|529911255|FG000|Overall Study|Disease progression and unrelated AE|1|||
146701595|NCT00958776|529086041|FG000|Overall Study|Withdrawal by Subject|7|||
146701596|NCT00958776|529086042|FG001|Overall Study|Withdrawal by Subject|16|||
146701597|NCT00958776|529086041|FG000|Overall Study|Protocol Violation|1|||
146701598|NCT00958776|529086042|FG001|Overall Study|Protocol Violation|1|||
146701599|NCT00958776|529086041|FG000|Overall Study|Death|2|||
146932615|NCT02007954|529911255|FG000|Overall Study|Death|1|||
146701600|NCT00958776|529086042|FG001|Overall Study|Death|1|||
146701601|NCT00958776|529086041|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
146701602|NCT00958776|529086042|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
146701603|NCT00958776|529086041|FG000|Overall Study|Missing|1|||
146701604|NCT00958776|529086042|FG001|Overall Study|Missing|1|||
146701605|NCT00480636|529086043|FG000|Overall Study|Death|12|||
146701606|NCT00480636|529086043|FG000|Overall Study|Lost to Follow-up|4|||
146701607|NCT00480636|529086043|FG000|Overall Study|Other|2|||
146701608|NCT00480636|529086043|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
146701609|NCT02583256|529086044|FG000|Overall Study|Withdrawal by Subject|0|||
146701610|NCT02583256|529086045|FG001|Overall Study|Withdrawal by Subject|1|||
146701611|NCT02583256|529086046|FG002|Overall Study|Withdrawal by Subject|1|||
146701612|NCT02583256|529086047|FG003|Overall Study|Withdrawal by Subject|0|||
146701613|NCT02583256|529086044|FG000|Overall Study|Lost to Follow-up|1|||
146701614|NCT02583256|529086045|FG001|Overall Study|Lost to Follow-up|1|||
146701615|NCT02583256|529086046|FG002|Overall Study|Lost to Follow-up|0|||
146701616|NCT02583256|529086047|FG003|Overall Study|Lost to Follow-up|1|||
146701617|NCT02583256|529086044|FG000|Overall Study|Administrative/Other|2|||
146701618|NCT02583256|529086045|FG001|Overall Study|Administrative/Other|0|||
146701619|NCT02583256|529086046|FG002|Overall Study|Administrative/Other|1|||
146701620|NCT02583256|529086047|FG003|Overall Study|Administrative/Other|2|||
146701621|NCT03364049|529086054|FG000|Overall Study|Death|6|||
146701622|NCT03364049|529086055|FG001|Overall Study|Death|4|||
146701623|NCT03364049|529086056|FG002|Overall Study|Death|5|||
146701624|NCT03364049|529086057|FG003|Overall Study|Death|14|||
146701625|NCT03364049|529086054|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
146701626|NCT03364049|529086055|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
146701627|NCT03364049|529086056|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
146701628|NCT03364049|529086057|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
146701629|NCT03364049|529086054|FG000|Overall Study|Withdrawal by Subject|0|||
146701630|NCT03364049|529086055|FG001|Overall Study|Withdrawal by Subject|1|||
146701631|NCT03364049|529086056|FG002|Overall Study|Withdrawal by Subject|1|||
146701632|NCT03364049|529086057|FG003|Overall Study|Withdrawal by Subject|1|||
146701633|NCT00418691|529086058|FG000|Overall Study|Lost to Follow-up|1|||
146701634|NCT00418691|529086059|FG001|Overall Study|Lost to Follow-up|2|||
146701635|NCT00418691|529086060|FG002|Overall Study|Lost to Follow-up|3|||
146701636|NCT00418691|529086058|FG000|Overall Study|Started new medication voiding entry|0|||
146701637|NCT00418691|529086059|FG001|Overall Study|Started new medication voiding entry|0|||
146701638|NCT00418691|529086060|FG002|Overall Study|Started new medication voiding entry|1|||
146701639|NCT00418691|529086058|FG000|Overall Study|Progressive Disease|1|||
146701640|NCT00418691|529086059|FG001|Overall Study|Progressive Disease|0|||
146701641|NCT00418691|529086060|FG002|Overall Study|Progressive Disease|1|||
146701642|NCT01096784|529086061|FG000|Overall Study|Withdrawal by Subject|2|||
146701643|NCT01096784|529086062|FG001|Overall Study|Withdrawal by Subject|1|||
146701644|NCT01096784|529086061|FG000|Overall Study|Adverse Event|11|||
146701645|NCT01096784|529086062|FG001|Overall Study|Adverse Event|9|||
146701646|NCT01096784|529086061|FG000|Overall Study|Protocol Deviation|2|||
146701647|NCT01096784|529086062|FG001|Overall Study|Protocol Deviation|2|||
146701648|NCT01096784|529086061|FG000|Overall Study|Administrative Decision|0|||
146701649|NCT01096784|529086062|FG001|Overall Study|Administrative Decision|1|||
146701650|NCT01096784|529086061|FG000|Overall Study|Other Unspecified|0|||
146701651|NCT01096784|529086062|FG001|Overall Study|Other Unspecified|1|||
146701652|NCT02975934|529086063|FG000|Treatment Phase|Never initiated study drug|0|||
146701653|NCT02975934|529086064|FG001|Treatment Phase|Never initiated study drug|5|||
146701654|NCT02975934|529086065|FG002|Treatment Phase|Never initiated study drug|0|||
146701655|NCT03362502|529086066|FG000|Overall Study|Death|0|||
146701656|NCT03362502|529086067|FG001|Overall Study|Death|0|||
146701657|NCT03362502|529086068|FG002|Overall Study|Death|1|||
146701658|NCT06034496|529086071|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
146701659|NCT06034496|529086072|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
146701660|NCT06034496|529086071|FG000|Overall Study|Withdrawal by Subject|5|||
146701661|NCT06034496|529086072|FG001|Overall Study|Withdrawal by Subject|4|||
146701662|NCT00116558|529086073|FG000|Overall Study|Death|11|||
146701663|NCT00116558|529086074|FG001|Overall Study|Death|5|||
146701664|NCT00116558|529086075|FG002|Overall Study|Death|3|||
146701665|NCT00116558|529086073|FG000|Overall Study|Withdrawal by Subject|17|||
146701666|NCT00116558|529086074|FG001|Overall Study|Withdrawal by Subject|3|||
146701667|NCT00116558|529086075|FG002|Overall Study|Withdrawal by Subject|12|||
146701668|NCT00116558|529086073|FG000|Overall Study|disease progression|3|||
146701669|NCT00116558|529086074|FG001|Overall Study|disease progression|7|||
146776650|NCT02723955|529353651|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146701670|NCT00116558|529086075|FG002|Overall Study|disease progression|18|||
146701671|NCT01143090|529086076|FG000|Overall Study|Lack of Efficacy|2|||
146701672|NCT01143090|529086076|FG000|Overall Study|Adverse Event|17|||
146701673|NCT01143090|529086076|FG000|Overall Study|Lost to Follow-up|9|||
146701674|NCT01143090|529086076|FG000|Overall Study|Protocol Violation|2|||
146701675|NCT01143090|529086076|FG000|Overall Study|Withdrawal by Subject|18|||
146701676|NCT01143090|529086076|FG000|Overall Study|Non-compliance with study drug|1|||
146701677|NCT01143090|529086076|FG000|Overall Study|Failure to meet eligibility criteria|1|||
146701678|NCT01143090|529086076|FG000|Overall Study|Administrative|1|||
146701679|NCT03491150|529086077|FG000|Overall Study|Adverse Event|1|||
146701680|NCT03491150|529086078|FG001|Overall Study|Adverse Event|0|||
146701681|NCT03491150|529086077|FG000|Overall Study|Study Terminated by Sponsor|74|||
146701682|NCT03491150|529086078|FG001|Overall Study|Study Terminated by Sponsor|70|||
146701683|NCT03491150|529086077|FG000|Overall Study|Other|0|||
146701684|NCT03491150|529086078|FG001|Overall Study|Other|1|||
146701685|NCT03491150|529086077|FG000|Overall Study|Withdrawal by Subject|1|||
146701686|NCT03491150|529086078|FG001|Overall Study|Withdrawal by Subject|2|||
146701687|NCT00727714|529086082|FG000|Overall Study|Lost to Follow-up|2|||
146701688|NCT00325234|529086085|FG000|Overall Study|Adverse Event|10|||
146701689|NCT00325234|529086086|FG001|Overall Study|Adverse Event|7|||
146701690|NCT00325234|529086085|FG000|Overall Study|Death due to Study Disease|1|||
146701691|NCT00325234|529086086|FG001|Overall Study|Death due to Study Disease|0|||
146701692|NCT00325234|529086085|FG000|Overall Study|Entry Criteria Not Met|1|||
146701693|NCT00325234|529086086|FG001|Overall Study|Entry Criteria Not Met|2|||
146701694|NCT00325234|529086085|FG000|Overall Study|Subject Decision|6|||
146701695|NCT00325234|529086086|FG001|Overall Study|Subject Decision|8|||
146701696|NCT00325234|529086085|FG000|Overall Study|Physician Decision|17|||
146701697|NCT00325234|529086086|FG001|Overall Study|Physician Decision|12|||
146701698|NCT00325234|529086085|FG000|Overall Study|Progressive Disease|34|||
146701699|NCT00325234|529086086|FG001|Overall Study|Progressive Disease|37|||
146701700|NCT05179421|529086087|FG000|First Infusion Day|Adverse Event|1|||
146701701|NCT05179421|529086088|FG001|First Infusion Day|Adverse Event|0|||
146701702|NCT02043015|529086089|FG000|Overall Study|Lost to Follow-up|4|||
146701703|NCT02043015|529086089|FG000|Overall Study|Withdrawal by Subject|4|||
146701704|NCT02043015|529086089|FG000|Overall Study|Removed once target enrollment reached|15|||
146701705|NCT02043015|529086089|FG000|Overall Study|Participant moved away from study city|4|||
146701706|NCT02043015|529086089|FG000|Overall Study|Incarceration|1|||
146701707|NCT01403974|529086090|FG000|Overall Study|Progressive disease according to RECIST|3|||
146701708|NCT01403974|529086091|FG001|Overall Study|Progressive disease according to RECIST|3|||
146701709|NCT01403974|529086092|FG002|Overall Study|Progressive disease according to RECIST|2|||
146701710|NCT01403974|529086093|FG003|Overall Study|Progressive disease according to RECIST|3|||
146701711|NCT01403974|529086094|FG004|Overall Study|Progressive disease according to RECIST|3|||
146701712|NCT01403974|529086095|FG005|Overall Study|Progressive disease according to RECIST|2|||
146701713|NCT01403974|529086096|FG006|Overall Study|Progressive disease according to RECIST|3|||
146701714|NCT01403974|529086097|FG007|Overall Study|Progressive disease according to RECIST|2|||
146701715|NCT01403974|529086098|FG008|Overall Study|Progressive disease according to RECIST|6|||
146701716|NCT01403974|529086099|FG009|Overall Study|Progressive disease according to RECIST|2|||
146701717|NCT01403974|529086100|FG010|Overall Study|Progressive disease according to RECIST|3|||
146701718|NCT01403974|529086101|FG011|Overall Study|Progressive disease according to RECIST|2|||
146701719|NCT01403974|529086102|FG012|Overall Study|Progressive disease according to RECIST|2|||
146701720|NCT01403974|529086103|FG013|Overall Study|Progressive disease according to RECIST|3|||
146701721|NCT01403974|529086104|FG014|Overall Study|Progressive disease according to RECIST|1|||
146701722|NCT01403974|529086105|FG015|Overall Study|Progressive disease according to RECIST|8|||
146701723|NCT01403974|529086090|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
146701724|NCT01403974|529086091|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
146701725|NCT01403974|529086092|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
146701726|NCT01403974|529086093|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
146701727|NCT01403974|529086094|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
146701728|NCT01403974|529086095|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
146701729|NCT01403974|529086096|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
146701730|NCT01403974|529086097|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
146932616|NCT01195363|529911259|FG000|Overall Study|Lost to Follow-up|7|||
146932617|NCT01195363|529911260|FG001|Overall Study|Lost to Follow-up|4|||
146932618|NCT01195363|529911259|FG000|Overall Study|Adverse Event|3|||
146932619|NCT01195363|529911260|FG001|Overall Study|Adverse Event|1|||
146701731|NCT01403974|529086098|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
146701732|NCT01403974|529086099|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
146701733|NCT01403974|529086100|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
146701734|NCT01403974|529086101|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
146932620|NCT01195363|529911259|FG000|Overall Study|Lack of Efficacy|0|||
146932621|NCT01195363|529911260|FG001|Overall Study|Lack of Efficacy|4|||
146932622|NCT01195363|529911259|FG000|Overall Study|incarceration|1|||
146776651|NCT02723955|529353652|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146932623|NCT01195363|529911260|FG001|Overall Study|incarceration|0|||
146701735|NCT01403974|529086102|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
146701736|NCT01403974|529086103|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
146932624|NCT01763866|529911262|FG000|Overall Study|Withdrawal by Subject|2|||
146701737|NCT01403974|529086104|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
146701738|NCT01403974|529086105|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
146701739|NCT01403974|529086090|FG000|Overall Study|Refused to continue study medication|0|||
146701740|NCT01403974|529086091|FG001|Overall Study|Refused to continue study medication|0|||
146701741|NCT01403974|529086092|FG002|Overall Study|Refused to continue study medication|0|||
146701742|NCT01403974|529086093|FG003|Overall Study|Refused to continue study medication|0|||
146701743|NCT01403974|529086094|FG004|Overall Study|Refused to continue study medication|0|||
146701744|NCT01403974|529086095|FG005|Overall Study|Refused to continue study medication|1|||
146701745|NCT01403974|529086096|FG006|Overall Study|Refused to continue study medication|0|||
146701746|NCT01403974|529086097|FG007|Overall Study|Refused to continue study medication|0|||
146701747|NCT01403974|529086098|FG008|Overall Study|Refused to continue study medication|1|||
146701748|NCT01403974|529086099|FG009|Overall Study|Refused to continue study medication|0|||
146701749|NCT01403974|529086100|FG010|Overall Study|Refused to continue study medication|1|||
146701750|NCT01403974|529086101|FG011|Overall Study|Refused to continue study medication|0|||
146701751|NCT01403974|529086102|FG012|Overall Study|Refused to continue study medication|0|||
146701752|NCT01403974|529086103|FG013|Overall Study|Refused to continue study medication|0|||
146701753|NCT01403974|529086104|FG014|Overall Study|Refused to continue study medication|0|||
146701754|NCT01403974|529086105|FG015|Overall Study|Refused to continue study medication|4|||
146701755|NCT01403974|529086090|FG000|Overall Study|Adverse Event|0|||
146701756|NCT01403974|529086091|FG001|Overall Study|Adverse Event|0|||
146701757|NCT01403974|529086092|FG002|Overall Study|Adverse Event|1|||
146701758|NCT01403974|529086093|FG003|Overall Study|Adverse Event|0|||
146701759|NCT01403974|529086094|FG004|Overall Study|Adverse Event|0|||
146701760|NCT01403974|529086095|FG005|Overall Study|Adverse Event|0|||
146701761|NCT01403974|529086096|FG006|Overall Study|Adverse Event|0|||
146701762|NCT01403974|529086097|FG007|Overall Study|Adverse Event|1|||
146701763|NCT01403974|529086098|FG008|Overall Study|Adverse Event|0|||
146701764|NCT01403974|529086099|FG009|Overall Study|Adverse Event|0|||
146701765|NCT01403974|529086100|FG010|Overall Study|Adverse Event|0|||
146701766|NCT01403974|529086101|FG011|Overall Study|Adverse Event|0|||
146701767|NCT01403974|529086102|FG012|Overall Study|Adverse Event|1|||
146701768|NCT01403974|529086103|FG013|Overall Study|Adverse Event|0|||
146701769|NCT01403974|529086104|FG014|Overall Study|Adverse Event|0|||
146701770|NCT01403974|529086105|FG015|Overall Study|Adverse Event|0|||
146701771|NCT01403974|529086090|FG000|Overall Study|Other than specified|0|||
146701772|NCT01403974|529086091|FG001|Overall Study|Other than specified|0|||
146932625|NCT01763866|529911263|FG001|Overall Study|Withdrawal by Subject|1|||
146932626|NCT01763866|529911264|FG002|Overall Study|Withdrawal by Subject|4|||
146701773|NCT01403974|529086092|FG002|Overall Study|Other than specified|0|||
146701774|NCT01403974|529086093|FG003|Overall Study|Other than specified|0|||
146701775|NCT01403974|529086094|FG004|Overall Study|Other than specified|0|||
146932627|NCT01763866|529911265|FG003|Overall Study|Withdrawal by Subject|0|||
146932628|NCT01763866|529911266|FG004|Overall Study|Withdrawal by Subject|0|||
146932629|NCT01763866|529911267|FG005|Overall Study|Withdrawal by Subject|3|||
146932630|NCT01763866|529911268|FG006|Overall Study|Withdrawal by Subject|4|||
146932631|NCT01763866|529911269|FG007|Overall Study|Withdrawal by Subject|0|||
146932632|NCT01763866|529911270|FG008|Overall Study|Withdrawal by Subject|1|||
146932633|NCT01763866|529911271|FG009|Overall Study|Withdrawal by Subject|1|||
146932634|NCT01763866|529911272|FG010|Overall Study|Withdrawal by Subject|2|||
146932635|NCT01763866|529911273|FG011|Overall Study|Withdrawal by Subject|2|||
146932636|NCT01763866|529911274|FG012|Overall Study|Withdrawal by Subject|2|||
146701776|NCT01403974|529086095|FG005|Overall Study|Other than specified|0|||
146701777|NCT01403974|529086096|FG006|Overall Study|Other than specified|0|||
146701778|NCT01403974|529086097|FG007|Overall Study|Other than specified|0|||
146701779|NCT01403974|529086098|FG008|Overall Study|Other than specified|0|||
146701780|NCT01403974|529086099|FG009|Overall Study|Other than specified|1|||
146701781|NCT01403974|529086100|FG010|Overall Study|Other than specified|0|||
146701782|NCT01403974|529086101|FG011|Overall Study|Other than specified|1|||
146932637|NCT01763866|529911275|FG013|Overall Study|Withdrawal by Subject|0|||
146932638|NCT01763866|529911276|FG014|Overall Study|Withdrawal by Subject|6|||
146932639|NCT01763866|529911277|FG015|Overall Study|Withdrawal by Subject|3|||
146932640|NCT01763866|529911278|FG016|Overall Study|Withdrawal by Subject|0|||
146932641|NCT01763866|529911279|FG017|Overall Study|Withdrawal by Subject|1|||
146932642|NCT01763866|529911280|FG018|Overall Study|Withdrawal by Subject|1|||
146932643|NCT01763866|529911281|FG019|Overall Study|Withdrawal by Subject|1|||
146932644|NCT01763866|529911282|FG020|Overall Study|Withdrawal by Subject|2|||
146932645|NCT01763866|529911283|FG021|Overall Study|Withdrawal by Subject|1|||
146932646|NCT01763866|529911284|FG022|Overall Study|Withdrawal by Subject|2|||
146701783|NCT01403974|529086102|FG012|Overall Study|Other than specified|0|||
146701784|NCT01403974|529086103|FG013|Overall Study|Other than specified|0|||
146932647|NCT01763866|529911285|FG023|Overall Study|Withdrawal by Subject|1|||
146701785|NCT01403974|529086104|FG014|Overall Study|Other than specified|0|||
146701786|NCT01403974|529086105|FG015|Overall Study|Other than specified|0|||
146701787|NCT01494610|529086108|FG000|Period 1|Withdrawal by Subject|1|||
146701788|NCT01494610|529086109|FG001|Period 1|Withdrawal by Subject|1|||
146701789|NCT01494610|529086108|FG000|Period 3|Adverse Event|1|||
146701790|NCT01494610|529086109|FG001|Period 3|Adverse Event|0|||
146701791|NCT01494610|529086108|FG000|Period 3|Withdrawal by Subject|1|||
146701792|NCT01494610|529086109|FG001|Period 3|Withdrawal by Subject|0|||
146701793|NCT01494610|529086108|FG000|Period 4|Protocol Violation|1|||
146701794|NCT01494610|529086109|FG001|Period 4|Protocol Violation|0|||
146701795|NCT03995953|529086112|FG000|Overall Study|Death|3|||
146701796|NCT03995953|529086113|FG001|Overall Study|Death|0|||
146701797|NCT03995953|529086114|FG002|Overall Study|Death|3|||
146701798|NCT03995953|529086115|FG003|Overall Study|Death|0|||
146701799|NCT03995953|529086116|FG004|Overall Study|Death|3|||
146701800|NCT03995953|529086117|FG005|Overall Study|Death|0|||
146701801|NCT03995953|529086118|FG006|Overall Study|Death|0|||
146701802|NCT03995953|529086119|FG007|Overall Study|Death|0|||
146701803|NCT03995953|529086120|FG008|Overall Study|Death|1|||
146701804|NCT03995953|529086121|FG009|Overall Study|Death|0|||
146701805|NCT03995953|529086122|FG010|Overall Study|Death|0|||
146701806|NCT03995953|529086123|FG011|Overall Study|Death|0|||
146701807|NCT03995953|529086112|FG000|Overall Study|Lost to Follow-up|6|||
146701808|NCT03995953|529086113|FG001|Overall Study|Lost to Follow-up|54|||
146701809|NCT03995953|529086114|FG002|Overall Study|Lost to Follow-up|3|||
146701810|NCT03995953|529086115|FG003|Overall Study|Lost to Follow-up|32|||
146701811|NCT03995953|529086116|FG004|Overall Study|Lost to Follow-up|5|||
146701812|NCT03995953|529086117|FG005|Overall Study|Lost to Follow-up|44|||
146701813|NCT03995953|529086118|FG006|Overall Study|Lost to Follow-up|0|||
146701814|NCT03995953|529086119|FG007|Overall Study|Lost to Follow-up|31|||
146701815|NCT03995953|529086120|FG008|Overall Study|Lost to Follow-up|8|||
146701816|NCT03995953|529086121|FG009|Overall Study|Lost to Follow-up|36|||
146701817|NCT03995953|529086122|FG010|Overall Study|Lost to Follow-up|5|||
146701818|NCT03995953|529086123|FG011|Overall Study|Lost to Follow-up|41|||
146701819|NCT03995953|529086112|FG000|Overall Study|Withdrawal by Subject|4|||
146701820|NCT03995953|529086113|FG001|Overall Study|Withdrawal by Subject|0|||
146701821|NCT03995953|529086114|FG002|Overall Study|Withdrawal by Subject|1|||
146701822|NCT03995953|529086115|FG003|Overall Study|Withdrawal by Subject|0|||
146701823|NCT03995953|529086116|FG004|Overall Study|Withdrawal by Subject|1|||
146701824|NCT03995953|529086117|FG005|Overall Study|Withdrawal by Subject|0|||
146701825|NCT03995953|529086118|FG006|Overall Study|Withdrawal by Subject|1|||
146701826|NCT03995953|529086119|FG007|Overall Study|Withdrawal by Subject|0|||
146701827|NCT03995953|529086120|FG008|Overall Study|Withdrawal by Subject|3|||
146701828|NCT03995953|529086121|FG009|Overall Study|Withdrawal by Subject|0|||
146701829|NCT03995953|529086122|FG010|Overall Study|Withdrawal by Subject|3|||
146701830|NCT03995953|529086123|FG011|Overall Study|Withdrawal by Subject|0|||
146701831|NCT03995953|529086112|FG000|Overall Study|Health Issues|0|||
146701832|NCT03995953|529086113|FG001|Overall Study|Health Issues|0|||
146701833|NCT03995953|529086114|FG002|Overall Study|Health Issues|0|||
146701834|NCT03995953|529086115|FG003|Overall Study|Health Issues|0|||
146701835|NCT03995953|529086116|FG004|Overall Study|Health Issues|1|||
146701836|NCT03995953|529086117|FG005|Overall Study|Health Issues|0|||
146701837|NCT03995953|529086118|FG006|Overall Study|Health Issues|0|||
146701838|NCT03995953|529086119|FG007|Overall Study|Health Issues|0|||
146701839|NCT03995953|529086120|FG008|Overall Study|Health Issues|4|||
146701840|NCT03995953|529086121|FG009|Overall Study|Health Issues|0|||
146701841|NCT03995953|529086122|FG010|Overall Study|Health Issues|0|||
146701842|NCT03995953|529086123|FG011|Overall Study|Health Issues|0|||
146701843|NCT03995953|529086112|FG000|Overall Study|Relocated|11|||
146701844|NCT03995953|529086113|FG001|Overall Study|Relocated|0|||
146701845|NCT03995953|529086114|FG002|Overall Study|Relocated|16|||
146701846|NCT03995953|529086115|FG003|Overall Study|Relocated|0|||
146701847|NCT03995953|529086116|FG004|Overall Study|Relocated|14|||
146701848|NCT03995953|529086117|FG005|Overall Study|Relocated|0|||
146701849|NCT03995953|529086118|FG006|Overall Study|Relocated|16|||
146701850|NCT03995953|529086119|FG007|Overall Study|Relocated|0|||
146701851|NCT03995953|529086120|FG008|Overall Study|Relocated|14|||
146701852|NCT03995953|529086121|FG009|Overall Study|Relocated|0|||
146776652|NCT02723955|529353653|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146701853|NCT03995953|529086122|FG010|Overall Study|Relocated|15|||
146701854|NCT03995953|529086123|FG011|Overall Study|Relocated|0|||
146701855|NCT02161718|529086126|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
146701856|NCT02161718|529086127|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
146701857|NCT02161718|529086128|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
146701858|NCT02161718|529086126|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
146701859|NCT02161718|529086127|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
146701860|NCT02161718|529086128|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
146701861|NCT02161718|529086126|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
146701862|NCT02161718|529086127|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
146701863|NCT02161718|529086128|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
146701864|NCT02161718|529086126|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
146701865|NCT02161718|529086127|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
146701866|NCT02161718|529086128|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
146932648|NCT01763866|529911262|FG000|Overall Study|Decision by sponsor|0|||
146932649|NCT01763866|529911263|FG001|Overall Study|Decision by sponsor|0|||
146932650|NCT01763866|529911264|FG002|Overall Study|Decision by sponsor|1|||
146932651|NCT01763866|529911265|FG003|Overall Study|Decision by sponsor|0|||
146932652|NCT01763866|529911266|FG004|Overall Study|Decision by sponsor|2|||
146932653|NCT01763866|529911267|FG005|Overall Study|Decision by sponsor|0|||
146932654|NCT01763866|529911268|FG006|Overall Study|Decision by sponsor|2|||
146932655|NCT01763866|529911269|FG007|Overall Study|Decision by sponsor|0|||
146932656|NCT01763866|529911270|FG008|Overall Study|Decision by sponsor|2|||
146932657|NCT01763866|529911271|FG009|Overall Study|Decision by sponsor|0|||
146932658|NCT01763866|529911272|FG010|Overall Study|Decision by sponsor|6|||
146932659|NCT01763866|529911273|FG011|Overall Study|Decision by sponsor|0|||
146932660|NCT01763866|529911274|FG012|Overall Study|Decision by sponsor|1|||
146932661|NCT01763866|529911275|FG013|Overall Study|Decision by sponsor|0|||
146932662|NCT01763866|529911276|FG014|Overall Study|Decision by sponsor|5|||
146932663|NCT01763866|529911277|FG015|Overall Study|Decision by sponsor|0|||
146932664|NCT01763866|529911278|FG016|Overall Study|Decision by sponsor|0|||
146932665|NCT01763866|529911279|FG017|Overall Study|Decision by sponsor|0|||
146932666|NCT01763866|529911280|FG018|Overall Study|Decision by sponsor|4|||
146932667|NCT01763866|529911281|FG019|Overall Study|Decision by sponsor|0|||
146980992|NCT01393990|530093695|FG010|Overall Study|Withdrawal by Subject|0|||
146701867|NCT02161718|529086126|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
146701868|NCT02161718|529086127|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
146701869|NCT02161718|529086128|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
146701870|NCT02161718|529086126|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
146701871|NCT02161718|529086127|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
146701872|NCT02161718|529086128|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
146701873|NCT02161718|529086126|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
146932668|NCT01763866|529911282|FG020|Overall Study|Decision by sponsor|2|||
146932669|NCT01763866|529911283|FG021|Overall Study|Decision by sponsor|0|||
146932670|NCT01763866|529911284|FG022|Overall Study|Decision by sponsor|1|||
146932671|NCT01763866|529911285|FG023|Overall Study|Decision by sponsor|0|||
146932672|NCT01763866|529911262|FG000|Overall Study|Lost to Follow-up|0|||
146932673|NCT01763866|529911263|FG001|Overall Study|Lost to Follow-up|0|||
146932674|NCT01763866|529911264|FG002|Overall Study|Lost to Follow-up|0|||
146932675|NCT01763866|529911265|FG003|Overall Study|Lost to Follow-up|0|||
146932676|NCT01763866|529911266|FG004|Overall Study|Lost to Follow-up|0|||
146932677|NCT01763866|529911267|FG005|Overall Study|Lost to Follow-up|0|||
146701874|NCT02161718|529086127|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
146701875|NCT02161718|529086128|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
146701876|NCT02161718|529086126|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
146701877|NCT02161718|529086127|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
146701878|NCT02161718|529086128|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
146701879|NCT02161718|529086126|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
146701880|NCT02161718|529086127|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
146701881|NCT02161718|529086128|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
146701882|NCT02161718|529086126|FG000|Post- Randomization Period|Lost to Follow-up|0|||
146701883|NCT02161718|529086127|FG001|Post- Randomization Period|Lost to Follow-up|9|||
146701884|NCT02161718|529086128|FG002|Post- Randomization Period|Lost to Follow-up|15|||
146701885|NCT02161718|529086126|FG000|Post- Randomization Period|Adverse Event|0|||
146701886|NCT02161718|529086127|FG001|Post- Randomization Period|Adverse Event|9|||
146701887|NCT02161718|529086128|FG002|Post- Randomization Period|Adverse Event|10|||
146701888|NCT02161718|529086126|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
146701889|NCT02161718|529086127|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
146701890|NCT02161718|529086128|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
146701891|NCT02161718|529086126|FG000|Post- Randomization Period|Physician Decision|0|||
146701892|NCT02161718|529086127|FG001|Post- Randomization Period|Physician Decision|2|||
146932678|NCT01763866|529911268|FG006|Overall Study|Lost to Follow-up|1|||
146932679|NCT01763866|529911269|FG007|Overall Study|Lost to Follow-up|0|||
146932680|NCT01763866|529911270|FG008|Overall Study|Lost to Follow-up|0|||
146932681|NCT01763866|529911271|FG009|Overall Study|Lost to Follow-up|0|||
146932682|NCT01763866|529911272|FG010|Overall Study|Lost to Follow-up|0|||
146932683|NCT01763866|529911273|FG011|Overall Study|Lost to Follow-up|0|||
146932684|NCT01763866|529911274|FG012|Overall Study|Lost to Follow-up|1|||
146980993|NCT01393990|530093696|FG011|Overall Study|Withdrawal by Subject|0|||
146701893|NCT02161718|529086128|FG002|Post- Randomization Period|Physician Decision|4|||
146701894|NCT02161718|529086126|FG000|Post- Randomization Period|Protocol Violation|0|||
146932685|NCT01763866|529911275|FG013|Overall Study|Lost to Follow-up|0|||
146932686|NCT01763866|529911276|FG014|Overall Study|Lost to Follow-up|1|||
146932687|NCT01763866|529911277|FG015|Overall Study|Lost to Follow-up|0|||
146932688|NCT01763866|529911278|FG016|Overall Study|Lost to Follow-up|0|||
146932689|NCT01763866|529911279|FG017|Overall Study|Lost to Follow-up|0|||
146932690|NCT01763866|529911280|FG018|Overall Study|Lost to Follow-up|1|||
146932691|NCT01763866|529911281|FG019|Overall Study|Lost to Follow-up|1|||
146980994|NCT01393990|530093697|FG012|Overall Study|Withdrawal by Subject|0|||
146701895|NCT02161718|529086127|FG001|Post- Randomization Period|Protocol Violation|2|||
146701896|NCT02161718|529086128|FG002|Post- Randomization Period|Protocol Violation|3|||
146701897|NCT02161718|529086126|FG000|Post- Randomization Period|Lack of Efficacy|0|||
146701898|NCT02161718|529086127|FG001|Post- Randomization Period|Lack of Efficacy|0|||
146701899|NCT02161718|529086128|FG002|Post- Randomization Period|Lack of Efficacy|1|||
146701900|NCT02161718|529086126|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
146701901|NCT02161718|529086127|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
146701902|NCT02161718|529086128|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
146701903|NCT02161718|529086126|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
146701904|NCT02161718|529086127|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
146701905|NCT02161718|529086128|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
146701906|NCT02161718|529086126|FG000|Post- Randomization Period|Relocation|0|||
146701907|NCT02161718|529086127|FG001|Post- Randomization Period|Relocation|3|||
146701908|NCT02161718|529086128|FG002|Post- Randomization Period|Relocation|0|||
146701909|NCT02350309|529086133|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
146701910|NCT02350309|529086134|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
146701911|NCT02350309|529086135|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
146701912|NCT02350309|529086136|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
146701913|NCT02350309|529086137|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
146701914|NCT02350309|529086138|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
146701915|NCT02350309|529086133|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
146701916|NCT02350309|529086134|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
146701917|NCT02350309|529086135|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
146701918|NCT02350309|529086136|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
146701919|NCT02350309|529086137|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
146701920|NCT02350309|529086138|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
146701921|NCT01256710|529086139|FG000|Overall Study|Death|449|||
146701922|NCT01256710|529086139|FG000|Overall Study|System Explant|67|||
146701923|NCT01256710|529086139|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
146701924|NCT01256710|529086139|FG000|Overall Study|Lost to Follow-up|67|||
146701925|NCT01256710|529086139|FG000|Overall Study|Withdrawal by Subject|29|||
146701926|NCT01256710|529086139|FG000|Overall Study|Physician Decision|9|||
146701927|NCT01256710|529086139|FG000|Overall Study|Subject Noncompliance|2|||
146701928|NCT01256710|529086139|FG000|Overall Study|Study Terminated by Sponsor|273|||
146701929|NCT01205165|529086141|FG000|Overall Study|Lost to Follow-up|2|||
146701930|NCT02681302|529086144|FG000|Overall Study|Withdrawal by Subject|1|||
146701931|NCT02681302|529086145|FG001|Overall Study|Withdrawal by Subject|1|||
146701932|NCT02681302|529086146|FG002|Overall Study|Withdrawal by Subject|0|||
146701933|NCT02681302|529086147|FG003|Overall Study|Withdrawal by Subject|0|||
146701934|NCT02681302|529086148|FG004|Overall Study|Withdrawal by Subject|1|||
146701935|NCT02681302|529086149|FG005|Overall Study|Withdrawal by Subject|0|||
146701936|NCT02681302|529086144|FG000|Overall Study|Screen Failure|2|||
146701937|NCT02681302|529086145|FG001|Overall Study|Screen Failure|4|||
146701938|NCT02681302|529086146|FG002|Overall Study|Screen Failure|2|||
146701939|NCT02681302|529086147|FG003|Overall Study|Screen Failure|0|||
146701940|NCT02681302|529086148|FG004|Overall Study|Screen Failure|1|||
146701941|NCT02681302|529086149|FG005|Overall Study|Screen Failure|1|||
146701942|NCT02681302|529086144|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
146701943|NCT02681302|529086145|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
146701944|NCT02681302|529086146|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
146701945|NCT02681302|529086147|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
146701946|NCT02681302|529086148|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
146701947|NCT02681302|529086149|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
146701948|NCT02942017|529086150|FG000|Overall Study|Adverse Event|0|||
146701949|NCT02942017|529086151|FG001|Overall Study|Adverse Event|1|||
146701950|NCT02942017|529086150|FG000|Overall Study|Withdrawal by Subject|0|||
146701951|NCT02942017|529086151|FG001|Overall Study|Withdrawal by Subject|1|||
146701952|NCT02942017|529086150|FG000|Overall Study|Lost to Follow-up|1|||
146701953|NCT02942017|529086151|FG001|Overall Study|Lost to Follow-up|1|||
146701954|NCT02942017|529086150|FG000|Overall Study|Randomized but not dosed|1|||
146701955|NCT02942017|529086151|FG001|Overall Study|Randomized but not dosed|3|||
146701956|NCT04399161|529086152|FG000|Overall Study|Withdrawal by Subject|1|||
146701957|NCT04399161|529086153|FG001|Overall Study|Withdrawal by Subject|0|||
146701958|NCT04399161|529086154|FG002|Overall Study|Withdrawal by Subject|2|||
146701959|NCT04399161|529086152|FG000|Overall Study|Protocol Violation|1|||
146701960|NCT04399161|529086153|FG001|Overall Study|Protocol Violation|2|||
146701961|NCT04399161|529086154|FG002|Overall Study|Protocol Violation|0|||
146701962|NCT03417141|529086155|FG000|Overall Study|Withdrawal by Subject|1|||
146701963|NCT03417141|529086155|FG000|Overall Study|Protocol Violation|3|||
146701964|NCT02253810|529086156|FG000|Overall Study|Withdrawal by Subject|2|||
146701965|NCT02253810|529086157|FG001|Overall Study|Withdrawal by Subject|1|||
146701966|NCT02253810|529086156|FG000|Overall Study|Unknown concomitant procedure|3|||
146701967|NCT02253810|529086157|FG001|Overall Study|Unknown concomitant procedure|2|||
146701968|NCT03465878|529086161|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
146701969|NCT03465878|529086162|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
146701970|NCT03465878|529086163|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
146701971|NCT03465878|529086164|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
146701972|NCT03465878|529086161|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
146701973|NCT03465878|529086162|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
146701974|NCT03465878|529086163|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
146701975|NCT03465878|529086164|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
146701976|NCT03465878|529086161|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
146701977|NCT03465878|529086162|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
146701978|NCT03465878|529086163|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
146701979|NCT03465878|529086164|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
146701980|NCT04656132|529086165|FG000|Overall Study|Lost to Follow-up|4|||
146701981|NCT04656132|529086165|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
146701982|NCT04019041|529086166|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
146701983|NCT04019041|529086167|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
146701984|NCT04019041|529086168|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
146701985|NCT04019041|529086169|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
146701986|NCT04019041|529086170|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
146701987|NCT04019041|529086171|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
146701988|NCT04019041|529086166|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
146701989|NCT04019041|529086167|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
146932692|NCT01763866|529911282|FG020|Overall Study|Lost to Follow-up|0|||
146701990|NCT04019041|529086168|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
146701991|NCT04019041|529086169|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
146701992|NCT04019041|529086170|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
146701993|NCT04019041|529086171|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
146701994|NCT04019041|529086166|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
146701995|NCT04019041|529086167|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
146701996|NCT04019041|529086168|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
146701997|NCT04019041|529086169|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
146701998|NCT04019041|529086170|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
146701999|NCT04019041|529086171|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
146702000|NCT04019041|529086166|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
146702001|NCT04019041|529086167|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
146702002|NCT04019041|529086168|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
146702003|NCT04019041|529086169|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
146702004|NCT04019041|529086170|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
146702005|NCT04019041|529086171|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
146702006|NCT04019041|529086166|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
146702007|NCT04019041|529086167|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
146702008|NCT04019041|529086168|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
146702009|NCT04019041|529086169|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
146702010|NCT04019041|529086170|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
146932693|NCT01763866|529911283|FG021|Overall Study|Lost to Follow-up|0|||
146932694|NCT01763866|529911284|FG022|Overall Study|Lost to Follow-up|0|||
146932695|NCT01763866|529911285|FG023|Overall Study|Lost to Follow-up|1|||
146932696|NCT01763866|529911262|FG000|Overall Study|Death|0|||
146932697|NCT01763866|529911263|FG001|Overall Study|Death|0|||
146932698|NCT01763866|529911264|FG002|Overall Study|Death|0|||
146932699|NCT01763866|529911265|FG003|Overall Study|Death|0|||
146932700|NCT01763866|529911266|FG004|Overall Study|Death|0|||
146932701|NCT01763866|529911267|FG005|Overall Study|Death|0|||
146932702|NCT01763866|529911268|FG006|Overall Study|Death|0|||
146932703|NCT01763866|529911269|FG007|Overall Study|Death|0|||
146932704|NCT01763866|529911270|FG008|Overall Study|Death|0|||
146932705|NCT01763866|529911271|FG009|Overall Study|Death|0|||
146932706|NCT01763866|529911272|FG010|Overall Study|Death|0|||
146932707|NCT01763866|529911273|FG011|Overall Study|Death|0|||
146932708|NCT01763866|529911274|FG012|Overall Study|Death|0|||
146932709|NCT01763866|529911275|FG013|Overall Study|Death|0|||
146932710|NCT01763866|529911276|FG014|Overall Study|Death|0|||
146932711|NCT01763866|529911277|FG015|Overall Study|Death|0|||
146932712|NCT01763866|529911278|FG016|Overall Study|Death|1|||
146932713|NCT01763866|529911279|FG017|Overall Study|Death|0|||
146932714|NCT01763866|529911280|FG018|Overall Study|Death|0|||
146932715|NCT01763866|529911281|FG019|Overall Study|Death|0|||
146932716|NCT01763866|529911282|FG020|Overall Study|Death|0|||
146932717|NCT01763866|529911283|FG021|Overall Study|Death|0|||
146932718|NCT01763866|529911284|FG022|Overall Study|Death|0|||
146932719|NCT01763866|529911285|FG023|Overall Study|Death|0|||
146702011|NCT04019041|529086171|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
146702012|NCT04019041|529086166|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
146702013|NCT04019041|529086167|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
146702014|NCT04019041|529086168|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
146702015|NCT04019041|529086169|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
146702016|NCT04019041|529086170|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
146702017|NCT04019041|529086171|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
146702018|NCT04019041|529086166|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
146702019|NCT04019041|529086167|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
146702020|NCT04019041|529086168|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
146702021|NCT04019041|529086169|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
146702022|NCT04019041|529086170|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
146702023|NCT04019041|529086171|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
146702024|NCT04019041|529086166|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
146702025|NCT04019041|529086167|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
146702026|NCT04019041|529086168|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
146702027|NCT04019041|529086169|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
146702028|NCT04019041|529086170|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
146702029|NCT04019041|529086171|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
146702030|NCT04019041|529086166|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
146702031|NCT04019041|529086167|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
146702032|NCT04019041|529086168|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
146702033|NCT04019041|529086169|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
146702034|NCT04019041|529086170|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
146702035|NCT04019041|529086171|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
146702036|NCT02540954|529086172|FG000|Overall Study|Physician Decision|3|||
146702037|NCT02540954|529086173|FG001|Overall Study|Physician Decision|1|||
146702038|NCT02540954|529086172|FG000|Overall Study|Withdrawal by Subject|6|||
146776653|NCT02723955|529353654|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146776654|NCT02723955|529353612|FG000|Escalation Phase|Site Closed|0|||
146776655|NCT02723955|529353613|FG001|Escalation Phase|Site Closed|0|||
146776656|NCT02723955|529353614|FG002|Escalation Phase|Site Closed|0|||
146776657|NCT02723955|529353615|FG003|Escalation Phase|Site Closed|0|||
146776658|NCT02723955|529353616|FG004|Escalation Phase|Site Closed|0|||
146776659|NCT02723955|529353617|FG005|Escalation Phase|Site Closed|0|||
146776660|NCT02723955|529353618|FG006|Escalation Phase|Site Closed|0|||
146776661|NCT02723955|529353619|FG007|Escalation Phase|Site Closed|0|||
146776662|NCT02723955|529353620|FG008|Escalation Phase|Site Closed|0|||
146776663|NCT02723955|529353621|FG009|Escalation Phase|Site Closed|0|||
146776664|NCT02723955|529353622|FG010|Escalation Phase|Site Closed|0|||
146776665|NCT02723955|529353623|FG011|Escalation Phase|Site Closed|0|||
146776666|NCT02723955|529353624|FG012|Escalation Phase|Site Closed|0|||
146776667|NCT02723955|529353625|FG013|Escalation Phase|Site Closed|0|||
146776668|NCT02723955|529353626|FG014|Escalation Phase|Site Closed|0|||
146776669|NCT02723955|529353627|FG015|Escalation Phase|Site Closed|1|||
146776670|NCT02723955|529353628|FG016|Escalation Phase|Site Closed|0|||
146776671|NCT02723955|529353629|FG017|Escalation Phase|Site Closed|2|||
146776672|NCT02723955|529353630|FG018|Escalation Phase|Site Closed|0|||
146776673|NCT02723955|529353631|FG019|Escalation Phase|Site Closed|0|||
146776674|NCT02723955|529353632|FG020|Escalation Phase|Site Closed|1|||
146776675|NCT02723955|529353633|FG021|Escalation Phase|Site Closed|0|||
146776676|NCT02723955|529353634|FG022|Escalation Phase|Site Closed|0|||
146776677|NCT02723955|529353635|FG023|Escalation Phase|Site Closed|0|||
146776678|NCT02723955|529353636|FG024|Escalation Phase|Site Closed|3|||
146776679|NCT02723955|529353637|FG025|Escalation Phase|Site Closed|1|||
146776680|NCT02723955|529353638|FG026|Escalation Phase|Site Closed|3|||
146776681|NCT02723955|529353639|FG027|Escalation Phase|Site Closed|1|||
146776682|NCT02723955|529353640|FG028|Escalation Phase|Site Closed|1|||
146776683|NCT02723955|529353641|FG029|Escalation Phase|Site Closed|0|||
146776684|NCT02723955|529353642|FG030|Escalation Phase|Site Closed|0|||
146776685|NCT02723955|529353643|FG031|Escalation Phase|Site Closed|0|||
146776686|NCT02723955|529353644|FG032|Escalation Phase|Site Closed|0|||
146776687|NCT02723955|529353645|FG033|Escalation Phase|Site Closed|0|||
146932720|NCT03337139|529911289|FG000|Phase I|Withdrawal by Subject|10|||
146932721|NCT03337139|529911290|FG001|Phase I|Withdrawal by Subject|0|||
146702039|NCT02540954|529086173|FG001|Overall Study|Withdrawal by Subject|5|||
146702040|NCT02540954|529086172|FG000|Overall Study|Lost to Follow-up|1|||
146776688|NCT02723955|529353646|FG034|Escalation Phase|Site Closed|0|||
146776689|NCT02723955|529353647|FG035|Escalation Phase|Site Closed|0|||
146776690|NCT02723955|529353648|FG036|Escalation Phase|Site Closed|0|||
146776691|NCT02723955|529353649|FG037|Escalation Phase|Site Closed|0|||
146776692|NCT02723955|529353650|FG038|Escalation Phase|Site Closed|0|||
146776693|NCT02723955|529353651|FG039|Escalation Phase|Site Closed|0|||
146776694|NCT02723955|529353652|FG040|Escalation Phase|Site Closed|0|||
146932722|NCT03288493|529911291|FG000|Overall Study|Withdrawal by Subject|4|||
146776695|NCT02723955|529353653|FG041|Escalation Phase|Site Closed|0|||
146702041|NCT02540954|529086173|FG001|Overall Study|Lost to Follow-up|1|||
146702042|NCT02540954|529086172|FG000|Overall Study|Adverse Event|4|||
146702043|NCT02540954|529086173|FG001|Overall Study|Adverse Event|2|||
146702044|NCT02540954|529086172|FG000|Overall Study|Death|0|||
146702045|NCT02540954|529086173|FG001|Overall Study|Death|3|||
146702046|NCT02540954|529086172|FG000|Overall Study|Treatment failure|1|||
146702047|NCT02540954|529086173|FG001|Overall Study|Treatment failure|0|||
146702048|NCT02540954|529086172|FG000|Overall Study|Other reason|4|||
146702049|NCT02540954|529086173|FG001|Overall Study|Other reason|2|||
146702050|NCT00213148|529086174|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
146702051|NCT00213148|529086175|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
146702052|NCT00213148|529086176|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
146702053|NCT00213148|529086177|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
146702054|NCT00213148|529086178|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
146702055|NCT00213148|529086174|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
146702056|NCT00213148|529086175|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
146702057|NCT00213148|529086176|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
146702058|NCT00213148|529086177|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
146702059|NCT00213148|529086178|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
146702060|NCT00213148|529086174|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
146702061|NCT00213148|529086175|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
146702062|NCT00213148|529086176|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
146702063|NCT00213148|529086177|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
146702064|NCT00213148|529086178|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
146702065|NCT00213148|529086174|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
146776696|NCT02723955|529353654|FG042|Escalation Phase|Site Closed|0|||
146776697|NCT02723955|529353612|FG000|Expansion Phase|Death|0|||
146776698|NCT02723955|529353613|FG001|Expansion Phase|Death|0|||
146776699|NCT02723955|529353614|FG002|Expansion Phase|Death|0|||
146776700|NCT02723955|529353615|FG003|Expansion Phase|Death|0|||
146776701|NCT02723955|529353616|FG004|Expansion Phase|Death|0|||
146776702|NCT02723955|529353617|FG005|Expansion Phase|Death|0|||
146776703|NCT02723955|529353618|FG006|Expansion Phase|Death|0|||
146776704|NCT02723955|529353619|FG007|Expansion Phase|Death|0|||
146776705|NCT02723955|529353620|FG008|Expansion Phase|Death|0|||
146776706|NCT02723955|529353621|FG009|Expansion Phase|Death|25|||
146776707|NCT02723955|529353622|FG010|Expansion Phase|Death|69|||
146776708|NCT02723955|529353623|FG011|Expansion Phase|Death|48|||
146776709|NCT02723955|529353624|FG012|Expansion Phase|Death|0|||
146776710|NCT02723955|529353625|FG013|Expansion Phase|Death|0|||
146776711|NCT02723955|529353626|FG014|Expansion Phase|Death|0|||
146776712|NCT02723955|529353627|FG015|Expansion Phase|Death|0|||
146776713|NCT02723955|529353628|FG016|Expansion Phase|Death|0|||
146776714|NCT02723955|529353629|FG017|Expansion Phase|Death|0|||
146776715|NCT02723955|529353630|FG018|Expansion Phase|Death|0|||
146776716|NCT02723955|529353631|FG019|Expansion Phase|Death|0|||
146776717|NCT02723955|529353632|FG020|Expansion Phase|Death|0|||
146776718|NCT02723955|529353633|FG021|Expansion Phase|Death|0|||
146776719|NCT02723955|529353634|FG022|Expansion Phase|Death|0|||
146776720|NCT02723955|529353635|FG023|Expansion Phase|Death|0|||
146776721|NCT02723955|529353636|FG024|Expansion Phase|Death|0|||
146776722|NCT02723955|529353637|FG025|Expansion Phase|Death|0|||
146776723|NCT02723955|529353638|FG026|Expansion Phase|Death|0|||
146776724|NCT02723955|529353639|FG027|Expansion Phase|Death|0|||
146776725|NCT02723955|529353640|FG028|Expansion Phase|Death|0|||
146776726|NCT02723955|529353641|FG029|Expansion Phase|Death|12|||
146776727|NCT02723955|529353642|FG030|Expansion Phase|Death|202|||
146776728|NCT02723955|529353643|FG031|Expansion Phase|Death|31|||
146776729|NCT02723955|529353644|FG032|Expansion Phase|Death|17|||
146702066|NCT00213148|529086175|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
146702067|NCT00213148|529086176|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
146702068|NCT00213148|529086177|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
146702069|NCT00213148|529086178|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
146702070|NCT00213148|529086174|FG000|Cycle 1 (1 Month)|Other|3|||
146702071|NCT00213148|529086175|FG001|Cycle 1 (1 Month)|Other|0|||
146776730|NCT02723955|529353645|FG033|Expansion Phase|Death|2|||
146776731|NCT02723955|529353646|FG034|Expansion Phase|Death|3|||
146702072|NCT00213148|529086176|FG002|Cycle 1 (1 Month)|Other|2|||
146702073|NCT00213148|529086177|FG003|Cycle 1 (1 Month)|Other|2|||
146702074|NCT00213148|529086178|FG004|Cycle 1 (1 Month)|Other|7|||
146702075|NCT00213148|529086174|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
146776732|NCT02723955|529353647|FG035|Expansion Phase|Death|3|||
146776733|NCT02723955|529353648|FG036|Expansion Phase|Death|1|||
146776734|NCT02723955|529353649|FG037|Expansion Phase|Death|0|||
146776735|NCT02723955|529353650|FG038|Expansion Phase|Death|0|||
146776736|NCT02723955|529353651|FG039|Expansion Phase|Death|0|||
146776737|NCT02723955|529353652|FG040|Expansion Phase|Death|0|||
146776738|NCT02723955|529353653|FG041|Expansion Phase|Death|0|||
146776739|NCT02723955|529353654|FG042|Expansion Phase|Death|0|||
146776740|NCT02723955|529353612|FG000|Expansion Phase|Lost to Follow-up|0|||
146776741|NCT02723955|529353613|FG001|Expansion Phase|Lost to Follow-up|0|||
146776742|NCT02723955|529353614|FG002|Expansion Phase|Lost to Follow-up|0|||
146932723|NCT03288493|529911292|FG001|Overall Study|Withdrawal by Subject|0|||
146932724|NCT03288493|529911293|FG002|Overall Study|Withdrawal by Subject|0|||
146932725|NCT03288493|529911294|FG003|Overall Study|Withdrawal by Subject|0|||
146932726|NCT03288493|529911295|FG004|Overall Study|Withdrawal by Subject|0|||
146932727|NCT03288493|529911296|FG005|Overall Study|Withdrawal by Subject|2|||
146932728|NCT03288493|529911297|FG006|Overall Study|Withdrawal by Subject|0|||
146932729|NCT03288493|529911291|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
146932730|NCT03288493|529911292|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
146932731|NCT03288493|529911293|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
146932732|NCT03288493|529911294|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
146932733|NCT03288493|529911295|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
146932734|NCT03288493|529911296|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
146932735|NCT03288493|529911297|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
146932736|NCT03288493|529911291|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
146932737|NCT03288493|529911292|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
146932738|NCT03288493|529911293|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
146932739|NCT03288493|529911294|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
146932740|NCT03288493|529911295|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
146932741|NCT03288493|529911296|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
146932742|NCT03288493|529911297|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
146932743|NCT03288493|529911291|FG000|Overall Study|Death|2|||
146932744|NCT03288493|529911292|FG001|Overall Study|Death|0|||
146932745|NCT03288493|529911293|FG002|Overall Study|Death|0|||
146932746|NCT03288493|529911294|FG003|Overall Study|Death|0|||
146932747|NCT03288493|529911295|FG004|Overall Study|Death|0|||
146932748|NCT03288493|529911296|FG005|Overall Study|Death|0|||
146932749|NCT03288493|529911297|FG006|Overall Study|Death|0|||
146932750|NCT03288493|529911291|FG000|Overall Study|other reason not listed above|2|||
146932751|NCT03288493|529911292|FG001|Overall Study|other reason not listed above|0|||
146932752|NCT03288493|529911293|FG002|Overall Study|other reason not listed above|0|||
146932753|NCT03288493|529911294|FG003|Overall Study|other reason not listed above|0|||
146932754|NCT03288493|529911295|FG004|Overall Study|other reason not listed above|0|||
146932755|NCT03288493|529911296|FG005|Overall Study|other reason not listed above|0|||
146932756|NCT03288493|529911297|FG006|Overall Study|other reason not listed above|0|||
146932757|NCT06025396|529912495|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
146932758|NCT06025396|529912496|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
146932759|NCT06025396|529912497|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
146932760|NCT06025396|529912498|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
146932761|NCT06025396|529912499|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
146932762|NCT06025396|529912495|FG000|Overall Study|Withdrawal by Subject|0|||
146932763|NCT06025396|529912496|FG001|Overall Study|Withdrawal by Subject|1|||
146932764|NCT06025396|529912497|FG002|Overall Study|Withdrawal by Subject|1|||
146932765|NCT06025396|529912498|FG003|Overall Study|Withdrawal by Subject|0|||
146932766|NCT06025396|529912499|FG004|Overall Study|Withdrawal by Subject|0|||
146932767|NCT06422377|529912502|FG000|Overall Study|Study Terminated by Sponsor|1|||
146932768|NCT00646113|529912503|FG000|Overall Study|Lost to Follow-up|5|||
146932769|NCT00646113|529912503|FG000|Overall Study|Adverse Event|3|||
146932770|NCT00804843|529912504|FG000|Overall Study|Protocol Violation|1|||
146932771|NCT00804843|529912505|FG001|Overall Study|Protocol Violation|0|||
146932772|NCT00804843|529912504|FG000|Overall Study|Adverse Event|8|||
146932773|NCT00804843|529912505|FG001|Overall Study|Adverse Event|5|||
146702076|NCT00213148|529086175|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
146702077|NCT00213148|529086176|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
146702078|NCT00213148|529086177|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
146702079|NCT00213148|529086178|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
146702080|NCT00213148|529086174|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
146702081|NCT00213148|529086175|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
146702082|NCT00213148|529086176|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
146702083|NCT00213148|529086177|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
146702084|NCT00213148|529086178|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
146702085|NCT00213148|529086174|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
146702086|NCT00213148|529086175|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
146702087|NCT00213148|529086176|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
146776743|NCT02723955|529353615|FG003|Expansion Phase|Lost to Follow-up|0|||
146776744|NCT02723955|529353616|FG004|Expansion Phase|Lost to Follow-up|0|||
146702088|NCT00213148|529086177|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
146702089|NCT00213148|529086178|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
146702090|NCT00213148|529086174|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
146702091|NCT00213148|529086175|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
146702092|NCT00213148|529086176|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
146702093|NCT00213148|529086177|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
146702094|NCT00213148|529086178|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
146702095|NCT00213148|529086174|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
146702096|NCT00213148|529086175|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
146702097|NCT00213148|529086176|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
146702098|NCT00213148|529086177|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
146702099|NCT00213148|529086178|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
146702100|NCT00213148|529086174|FG000|Cycle 2 (1 Month)|Other|2|||
146702101|NCT00213148|529086175|FG001|Cycle 2 (1 Month)|Other|1|||
146702102|NCT00213148|529086176|FG002|Cycle 2 (1 Month)|Other|2|||
146702103|NCT00213148|529086177|FG003|Cycle 2 (1 Month)|Other|8|||
146702104|NCT00213148|529086178|FG004|Cycle 2 (1 Month)|Other|7|||
146702105|NCT00213148|529086174|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
146702106|NCT00213148|529086175|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
146702107|NCT00213148|529086176|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
146702108|NCT00213148|529086177|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
146702109|NCT00213148|529086178|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
146702110|NCT00213148|529086174|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
146702111|NCT00213148|529086175|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
146702112|NCT00213148|529086176|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
146702113|NCT00213148|529086177|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
146702114|NCT00213148|529086178|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
146702115|NCT00213148|529086174|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
146702116|NCT00213148|529086175|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
146702117|NCT00213148|529086176|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
146702118|NCT00213148|529086177|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
146702119|NCT00213148|529086178|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
146702120|NCT00213148|529086174|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
146702121|NCT00213148|529086175|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
146702122|NCT00213148|529086176|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
146702123|NCT00213148|529086177|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
146702124|NCT00213148|529086178|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
146702125|NCT00213148|529086174|FG000|Cycle 3 (1 Month)|Other|0|||
146702126|NCT00213148|529086175|FG001|Cycle 3 (1 Month)|Other|0|||
146702127|NCT00213148|529086176|FG002|Cycle 3 (1 Month)|Other|1|||
146702128|NCT00213148|529086177|FG003|Cycle 3 (1 Month)|Other|1|||
146702129|NCT00213148|529086178|FG004|Cycle 3 (1 Month)|Other|0|||
146702130|NCT03080961|529086180|FG000|Overall Study|Withdrawal by Subject|3|||
146702131|NCT00245765|529086181|FG000|Overall Study|Adverse Event|1|||
146702132|NCT00245765|529086182|FG001|Overall Study|Adverse Event|1|||
146702133|NCT00245765|529086183|FG002|Overall Study|Adverse Event|0|||
146702134|NCT00245765|529086181|FG000|Overall Study|Lack of Efficacy|14|||
146702135|NCT00245765|529086182|FG001|Overall Study|Lack of Efficacy|7|||
146702136|NCT00245765|529086183|FG002|Overall Study|Lack of Efficacy|0|||
146702137|NCT00245765|529086181|FG000|Overall Study|Lost to Follow-up|1|||
146702138|NCT00245765|529086182|FG001|Overall Study|Lost to Follow-up|2|||
146702139|NCT00245765|529086183|FG002|Overall Study|Lost to Follow-up|0|||
146702140|NCT00245765|529086181|FG000|Overall Study|Withdrawal by Subject|1|||
146702141|NCT00245765|529086182|FG001|Overall Study|Withdrawal by Subject|0|||
146932774|NCT00804843|529912504|FG000|Overall Study|Withdrawal by Subject|1|||
146932775|NCT00804843|529912505|FG001|Overall Study|Withdrawal by Subject|2|||
146932776|NCT02150213|529912509|FG000|Overall Study|Lost to Follow-up|1|||
146932777|NCT02150213|529912509|FG000|Overall Study|Withdrawal by Subject|1|||
146702142|NCT00245765|529086183|FG002|Overall Study|Withdrawal by Subject|3|||
146702143|NCT00245765|529086181|FG000|Overall Study|Other reason|2|||
146702144|NCT00245765|529086182|FG001|Overall Study|Other reason|0|||
146702145|NCT00245765|529086183|FG002|Overall Study|Other reason|1|||
146702146|NCT00245765|529086181|FG000|Overall Study|Other|13|||
146702147|NCT00245765|529086182|FG001|Overall Study|Other|4|||
146702148|NCT00245765|529086183|FG002|Overall Study|Other|4|||
146702149|NCT02741115|529086184|FG000|Overall Study|Adverse Event|1|||
146702150|NCT02741115|529086185|FG001|Overall Study|Adverse Event|0|||
146702151|NCT02741115|529086184|FG000|Overall Study|Lost to Follow-up|7|||
146702152|NCT02741115|529086185|FG001|Overall Study|Lost to Follow-up|4|||
146702153|NCT02741115|529086184|FG000|Overall Study|Withdrawal by Subject|4|||
146702154|NCT02741115|529086185|FG001|Overall Study|Withdrawal by Subject|2|||
146702155|NCT04602624|529086188|FG000|Overall Study|Protocol Deviation|1|||
146932778|NCT01297309|529912511|FG000|Overall Study|Eligibility failure|2|||
146932779|NCT01297309|529912511|FG000|Overall Study|Screen failure|2|||
146702156|NCT04602624|529086188|FG000|Overall Study|Withdrawal by Participant|1|||
146702157|NCT06425458|529086189|FG000|Overall Study|Removed by study team|2|||
146932780|NCT01297309|529912511|FG000|Overall Study|Withdrawal by Subject|5|||
146932781|NCT01297309|529912511|FG000|Overall Study|Adverse Event|1|||
146932782|NCT01297309|529912511|FG000|Overall Study|Investigator Decision|2|||
146932783|NCT01297309|529912511|FG000|Overall Study|Death|1|||
146932784|NCT01297309|529912511|FG000|Overall Study|Participant not entering extensionperiod|1|||
146932785|NCT00640146|529912515|FG000|Overall Study|Adverse Event|2|||
146932786|NCT00640146|529912516|FG001|Overall Study|Adverse Event|0|||
146932787|NCT00640146|529912515|FG000|Overall Study|Lost to Follow-up|0|||
146932788|NCT00640146|529912516|FG001|Overall Study|Lost to Follow-up|1|||
146932789|NCT00640146|529912515|FG000|Overall Study|Lack of Efficacy|0|||
146932790|NCT00640146|529912516|FG001|Overall Study|Lack of Efficacy|1|||
146932791|NCT00640146|529912515|FG000|Overall Study|Withdrawal by Subject|1|||
146932792|NCT00640146|529912516|FG001|Overall Study|Withdrawal by Subject|1|||
146932793|NCT00640146|529912515|FG000|Overall Study|Randomized but not treated|1|||
146932794|NCT00640146|529912516|FG001|Overall Study|Randomized but not treated|3|||
146932795|NCT03024255|529912520|FG000|Overall Study|Adverse Event|1|||
146932796|NCT03024255|529912521|FG001|Overall Study|Adverse Event|4|||
146932797|NCT03024255|529912522|FG002|Overall Study|Adverse Event|8|||
146932798|NCT03024255|529912523|FG003|Overall Study|Adverse Event|0|||
146932799|NCT03024255|529912520|FG000|Overall Study|Withdrawal by Subject|3|||
146932800|NCT03024255|529912521|FG001|Overall Study|Withdrawal by Subject|1|||
146932801|NCT03024255|529912522|FG002|Overall Study|Withdrawal by Subject|0|||
146932802|NCT03024255|529912523|FG003|Overall Study|Withdrawal by Subject|3|||
146932803|NCT03024255|529912520|FG000|Overall Study|Protocol Violation|0|||
146932804|NCT03024255|529912521|FG001|Overall Study|Protocol Violation|0|||
146932805|NCT03024255|529912522|FG002|Overall Study|Protocol Violation|2|||
146932806|NCT03024255|529912523|FG003|Overall Study|Protocol Violation|0|||
146932807|NCT03024255|529912520|FG000|Overall Study|Lost to Follow-up|1|||
146932808|NCT03024255|529912521|FG001|Overall Study|Lost to Follow-up|2|||
146932809|NCT03024255|529912522|FG002|Overall Study|Lost to Follow-up|1|||
146932810|NCT03024255|529912523|FG003|Overall Study|Lost to Follow-up|1|||
146932811|NCT03024255|529912520|FG000|Overall Study|Lack of Efficacy|1|||
146932812|NCT03024255|529912521|FG001|Overall Study|Lack of Efficacy|0|||
146932813|NCT03024255|529912522|FG002|Overall Study|Lack of Efficacy|0|||
146932814|NCT03024255|529912523|FG003|Overall Study|Lack of Efficacy|0|||
146932815|NCT03024255|529912520|FG000|Overall Study|Protocol Noncompliance|1|||
146932816|NCT03024255|529912521|FG001|Overall Study|Protocol Noncompliance|1|||
146932817|NCT03024255|529912522|FG002|Overall Study|Protocol Noncompliance|0|||
146932818|NCT03024255|529912523|FG003|Overall Study|Protocol Noncompliance|1|||
146932819|NCT01415908|529912524|FG000|Overall Study|Withdrawal by Subject|1|||
146932820|NCT01415908|529912525|FG001|Overall Study|Withdrawal by Subject|0|||
146932821|NCT02197897|529912528|FG000|Overall Study|not eligible|1|||
146932822|NCT00688545|529912529|FG000|Overall Study|Lost to Follow-up|1|||
146932823|NCT00688545|529912530|FG001|Overall Study|Lost to Follow-up|4|||
146932824|NCT00688545|529912529|FG000|Overall Study|Insurance/cost of drug|0|||
146932825|NCT00688545|529912530|FG001|Overall Study|Insurance/cost of drug|1|||
146932826|NCT00688545|529912529|FG000|Overall Study|Withdrawal by Subject|2|||
146932827|NCT00688545|529912530|FG001|Overall Study|Withdrawal by Subject|3|||
146932828|NCT00688545|529912529|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
146932829|NCT00688545|529912530|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
146932830|NCT04295356|529912531|FG000|Overall Study|Physician Decision|1|||
146932831|NCT04295356|529912532|FG001|Overall Study|Physician Decision|0|||
146932832|NCT04295356|529912531|FG000|Overall Study|Lost to Follow-up|0|||
146932833|NCT04295356|529912532|FG001|Overall Study|Lost to Follow-up|3|||
146932834|NCT04295356|529912531|FG000|Overall Study|Protocol Violation|0|||
146932835|NCT04295356|529912532|FG001|Overall Study|Protocol Violation|1|||
146932836|NCT04116073|529912539|FG000|Overall Study|Withdrawal by Subject|2|||
146932837|NCT04116073|529912539|FG000|Overall Study|failed to maintained eligibility|1|||
146702158|NCT06425458|529086189|FG000|Overall Study|Lost to Follow-up|5|||
146702159|NCT03945981|529086192|FG000|Overall Study|Lost to Follow-up|12|||
146702160|NCT03945981|529086192|FG000|Overall Study|Physician Decision|4|||
146932838|NCT03783442|529912544|FG000|Overall Study|Death|252|||
146932839|NCT03783442|529912545|FG001|Overall Study|Death|268|||
146702161|NCT03945981|529086192|FG000|Overall Study|Withdrawal by Subject|6|||
146702162|NCT03945981|529086192|FG000|Overall Study|Protocol Violation|1|||
146932840|NCT03783442|529912544|FG000|Overall Study|Withdrawal by Subject|19|||
146932841|NCT03783442|529912545|FG001|Overall Study|Withdrawal by Subject|21|||
146932842|NCT03783442|529912544|FG000|Overall Study|Lost to Follow-up|7|||
146932843|NCT03783442|529912545|FG001|Overall Study|Lost to Follow-up|6|||
146932844|NCT03783442|529912544|FG000|Overall Study|Sponsor Ended Study|48|||
146932845|NCT03783442|529912545|FG001|Overall Study|Sponsor Ended Study|28|||
146932846|NCT01381718|529912546|FG000|Overall Study|Withdrawal by Subject|2|||
146932847|NCT01381718|529912547|FG001|Overall Study|Withdrawal by Subject|5|||
146932848|NCT01381718|529912546|FG000|Overall Study|Lost to Follow-up|3|||
146932849|NCT01381718|529912547|FG001|Overall Study|Lost to Follow-up|5|||
146702163|NCT02177266|529087373|FG000|Overall Study|Adverse Event|0|||
146932850|NCT01381718|529912546|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
146932851|NCT01381718|529912547|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
146932852|NCT02505542|529912548|FG000|Part A: Open-Label Period|Adverse Event|31|||
146702164|NCT02177266|529087374|FG001|Overall Study|Adverse Event|1|||
146702165|NCT02177266|529087373|FG000|Overall Study|Withdrawal by Subject|1|||
146702166|NCT02177266|529087374|FG001|Overall Study|Withdrawal by Subject|0|||
146702167|NCT00546715|529087376|FG000|Overall Study|Withdrawal by Subject|0|||
146702168|NCT00546715|529087377|FG001|Overall Study|Withdrawal by Subject|1|||
146702169|NCT00546715|529087378|FG002|Overall Study|Withdrawal by Subject|0|||
146702170|NCT00546715|529087379|FG003|Overall Study|Withdrawal by Subject|0|||
146702171|NCT01802775|529087380|FG000|Overall Study|Death|0|||
146702172|NCT01802775|529087381|FG001|Overall Study|Death|3|||
146702173|NCT01802775|529087380|FG000|Overall Study|Reason not provided|0|||
146702174|NCT01802775|529087381|FG001|Overall Study|Reason not provided|1|||
146702175|NCT01802775|529087380|FG000|Overall Study|Physician Decision|1|||
146702176|NCT01802775|529087381|FG001|Overall Study|Physician Decision|0|||
146702177|NCT01802775|529087380|FG000|Overall Study|Adverse Event|1|||
146702178|NCT01802775|529087381|FG001|Overall Study|Adverse Event|1|||
146702179|NCT01802775|529087380|FG000|Overall Study|Withdrawal by Subject|3|||
146702180|NCT01802775|529087381|FG001|Overall Study|Withdrawal by Subject|5|||
146702181|NCT01802775|529087380|FG000|Overall Study|Lost to Follow-up|1|||
146702182|NCT01802775|529087381|FG001|Overall Study|Lost to Follow-up|2|||
146702183|NCT03761628|529087382|FG000|Overall Study|Withdrawal by Subject|3|||
146702184|NCT03761628|529087382|FG000|Overall Study|Physician Decision|1|||
146702185|NCT03761628|529087382|FG000|Overall Study|Pregnancy|1|||
146702186|NCT03761628|529087382|FG000|Overall Study|Lost to Follow-up|1|||
146702187|NCT04649151|529087385|FG000|Overall Study|Pregnancy|0|||
146702188|NCT04649151|529087386|FG001|Overall Study|Pregnancy|0|||
146702189|NCT04649151|529087387|FG002|Overall Study|Pregnancy|0|||
146702190|NCT04649151|529087388|FG003|Overall Study|Pregnancy|0|||
146702191|NCT04649151|529087389|FG004|Overall Study|Pregnancy|3|||
146702192|NCT04649151|529087385|FG000|Overall Study|Physician Decision|10|||
146702193|NCT04649151|529087386|FG001|Overall Study|Physician Decision|0|||
146702194|NCT04649151|529087387|FG002|Overall Study|Physician Decision|0|||
146702195|NCT04649151|529087388|FG003|Overall Study|Physician Decision|1|||
146702196|NCT04649151|529087389|FG004|Overall Study|Physician Decision|1|||
146702197|NCT04649151|529087385|FG000|Overall Study|Protocol Deviation|25|||
146702198|NCT04649151|529087386|FG001|Overall Study|Protocol Deviation|3|||
146702199|NCT04649151|529087387|FG002|Overall Study|Protocol Deviation|0|||
146702200|NCT04649151|529087388|FG003|Overall Study|Protocol Deviation|0|||
146702201|NCT04649151|529087389|FG004|Overall Study|Protocol Deviation|0|||
146702202|NCT04649151|529087385|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
146702203|NCT04649151|529087386|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
146702204|NCT04649151|529087387|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
146702205|NCT04649151|529087388|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
146702206|NCT04649151|529087389|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
146702207|NCT04649151|529087385|FG000|Overall Study|Withdrawal by Subject|370|||
146702208|NCT04649151|529087386|FG001|Overall Study|Withdrawal by Subject|113|||
146702209|NCT04649151|529087387|FG002|Overall Study|Withdrawal by Subject|2|||
146702210|NCT04649151|529087388|FG003|Overall Study|Withdrawal by Subject|7|||
146702211|NCT04649151|529087389|FG004|Overall Study|Withdrawal by Subject|15|||
146702212|NCT04649151|529087385|FG000|Overall Study|Adverse Event|1|||
146702213|NCT04649151|529087386|FG001|Overall Study|Adverse Event|0|||
146702214|NCT04649151|529087387|FG002|Overall Study|Adverse Event|0|||
146702215|NCT04649151|529087388|FG003|Overall Study|Adverse Event|0|||
146702216|NCT04649151|529087389|FG004|Overall Study|Adverse Event|0|||
146702217|NCT04649151|529087385|FG000|Overall Study|Lost to Follow-up|256|||
146702218|NCT04649151|529087386|FG001|Overall Study|Lost to Follow-up|29|||
146702219|NCT04649151|529087387|FG002|Overall Study|Lost to Follow-up|10|||
146776745|NCT02723955|529353617|FG005|Expansion Phase|Lost to Follow-up|0|||
146932853|NCT02505542|529912549|FG001|Part A: Open-Label Period|Adverse Event|0|||
146702220|NCT04649151|529087388|FG003|Overall Study|Lost to Follow-up|3|||
146702221|NCT04649151|529087389|FG004|Overall Study|Lost to Follow-up|6|||
146702222|NCT04649151|529087385|FG000|Overall Study|Other than specified|59|||
146702223|NCT04649151|529087386|FG001|Overall Study|Other than specified|294|||
146702224|NCT04649151|529087387|FG002|Overall Study|Other than specified|0|||
146702225|NCT04649151|529087388|FG003|Overall Study|Other than specified|0|||
146702226|NCT04649151|529087389|FG004|Overall Study|Other than specified|4|||
146702227|NCT04649151|529087385|FG000|Overall Study|Death|0|||
146702228|NCT04649151|529087386|FG001|Overall Study|Death|0|||
146702229|NCT04649151|529087387|FG002|Overall Study|Death|0|||
146702230|NCT04649151|529087388|FG003|Overall Study|Death|0|||
146702231|NCT04649151|529087389|FG004|Overall Study|Death|1|||
146702232|NCT00433654|529087390|FG000|Overall Study|Death|4|||
146702233|NCT00433654|529087391|FG001|Overall Study|Death|0|||
146702234|NCT00433654|529087390|FG000|Overall Study|Missed visit|6|||
146702235|NCT00433654|529087391|FG001|Overall Study|Missed visit|3|||
146702236|NCT00433654|529087390|FG000|Overall Study|Subject not yet due for visit|4|||
146702237|NCT00433654|529087391|FG001|Overall Study|Subject not yet due for visit|0|||
146702238|NCT00433654|529087390|FG000|Overall Study|Withdrawal by Subject|1|||
146702239|NCT00433654|529087391|FG001|Overall Study|Withdrawal by Subject|2|||
146702240|NCT03277261|529087392|FG000|Overall Study|Adverse Event|17|||
146702241|NCT03277261|529087393|FG001|Overall Study|Adverse Event|1|||
146702242|NCT03277261|529087392|FG000|Overall Study|Participant Withdrawal of Consent|6|||
146702243|NCT03277261|529087393|FG001|Overall Study|Participant Withdrawal of Consent|15|||
146702244|NCT03277261|529087392|FG000|Overall Study|Investigator / Sponsor Decision|4|||
146702245|NCT03277261|529087393|FG001|Overall Study|Investigator / Sponsor Decision|2|||
146702246|NCT03277261|529087392|FG000|Overall Study|Pregnancy|2|||
146702247|NCT03277261|529087393|FG001|Overall Study|Pregnancy|0|||
146702248|NCT03277261|529087392|FG000|Overall Study|Lost to Follow-up|2|||
146702249|NCT03277261|529087393|FG001|Overall Study|Lost to Follow-up|2|||
146702250|NCT03277261|529087392|FG000|Overall Study|Lack of Efficacy|2|||
146702251|NCT03277261|529087393|FG001|Overall Study|Lack of Efficacy|2|||
146702252|NCT03277261|529087392|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
146702253|NCT03277261|529087393|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
146702254|NCT02388997|529087394|FG000|Overall Study|Adverse Event|1|||
146702255|NCT02388997|529087395|FG001|Overall Study|Adverse Event|2|||
146702256|NCT02388997|529087394|FG000|Overall Study|Withdrawal by Subject|2|||
146702257|NCT02388997|529087395|FG001|Overall Study|Withdrawal by Subject|1|||
146702258|NCT02388997|529087394|FG000|Overall Study|Lung function exclusion criteria|0|||
146702259|NCT02388997|529087395|FG001|Overall Study|Lung function exclusion criteria|2|||
146702260|NCT02388997|529087394|FG000|Overall Study|Tested positive for virus during run-in|0|||
146702261|NCT02388997|529087395|FG001|Overall Study|Tested positive for virus during run-in|1|||
146702262|NCT00006184|529087396|FG000|Overall Study|Death|1|||
146702263|NCT00006184|529087397|FG001|Overall Study|Death|0|||
146702264|NCT01110915|529087404|FG000|Overall Study|Death|2|||
146702265|NCT01110915|529087405|FG001|Overall Study|Death|1|||
146702266|NCT01110915|529087404|FG000|Overall Study|Lost to Follow-up|1|||
146702267|NCT01110915|529087405|FG001|Overall Study|Lost to Follow-up|0|||
146702268|NCT01110915|529087404|FG000|Overall Study|Withdrawal by Subject|7|||
146702269|NCT01110915|529087405|FG001|Overall Study|Withdrawal by Subject|1|||
146702270|NCT02948842|529087411|FG000|Overall Study|Withdrawal by Subject|4|||
146702271|NCT00207142|529087414|FG000|Induction Phase|Adverse Event|9|||
146702272|NCT00207142|529087415|FG001|Induction Phase|Adverse Event|0|||
146702273|NCT00207142|529087416|FG002|Induction Phase|Adverse Event|0|||
146702274|NCT00207142|529087417|FG003|Induction Phase|Adverse Event|0|||
146702275|NCT00207142|529087414|FG000|Induction Phase|Death|1|||
146702276|NCT00207142|529087415|FG001|Induction Phase|Death|0|||
146702277|NCT00207142|529087416|FG002|Induction Phase|Death|0|||
146702278|NCT00207142|529087417|FG003|Induction Phase|Death|0|||
146702279|NCT00207142|529087414|FG000|Induction Phase|Lack of Efficacy|1|||
146702280|NCT00207142|529087415|FG001|Induction Phase|Lack of Efficacy|0|||
146702281|NCT00207142|529087416|FG002|Induction Phase|Lack of Efficacy|0|||
146702282|NCT00207142|529087417|FG003|Induction Phase|Lack of Efficacy|0|||
146702283|NCT00207142|529087414|FG000|Induction Phase|Lost to Follow-up|5|||
146702284|NCT00207142|529087415|FG001|Induction Phase|Lost to Follow-up|0|||
146702285|NCT00207142|529087416|FG002|Induction Phase|Lost to Follow-up|0|||
146702286|NCT00207142|529087417|FG003|Induction Phase|Lost to Follow-up|0|||
146702287|NCT00207142|529087414|FG000|Induction Phase|Physician Decision|2|||
146702288|NCT00207142|529087415|FG001|Induction Phase|Physician Decision|0|||
146702289|NCT00207142|529087416|FG002|Induction Phase|Physician Decision|0|||
146702290|NCT00207142|529087417|FG003|Induction Phase|Physician Decision|0|||
146702291|NCT00207142|529087414|FG000|Induction Phase|Poor/noncompliance|2|||
146702292|NCT00207142|529087415|FG001|Induction Phase|Poor/noncompliance|0|||
146702293|NCT00207142|529087416|FG002|Induction Phase|Poor/noncompliance|0|||
146702294|NCT00207142|529087417|FG003|Induction Phase|Poor/noncompliance|0|||
146702295|NCT00207142|529087414|FG000|Induction Phase|Pregnancy|1|||
146702296|NCT00207142|529087415|FG001|Induction Phase|Pregnancy|0|||
146702297|NCT00207142|529087416|FG002|Induction Phase|Pregnancy|0|||
146702298|NCT00207142|529087417|FG003|Induction Phase|Pregnancy|0|||
146702299|NCT00207142|529087414|FG000|Induction Phase|Subject no longer meets study criteria|3|||
146702300|NCT00207142|529087415|FG001|Induction Phase|Subject no longer meets study criteria|0|||
146702301|NCT00207142|529087416|FG002|Induction Phase|Subject no longer meets study criteria|0|||
146702302|NCT00207142|529087417|FG003|Induction Phase|Subject no longer meets study criteria|0|||
146702303|NCT00207142|529087414|FG000|Induction Phase|Withdrawal by Subject|4|||
146702304|NCT00207142|529087415|FG001|Induction Phase|Withdrawal by Subject|0|||
146776746|NCT02723955|529353618|FG006|Expansion Phase|Lost to Follow-up|0|||
146702305|NCT00207142|529087416|FG002|Induction Phase|Withdrawal by Subject|0|||
146702306|NCT00207142|529087417|FG003|Induction Phase|Withdrawal by Subject|0|||
146702307|NCT00207142|529087414|FG000|Induction Phase|Incarceration|1|||
146702308|NCT00207142|529087415|FG001|Induction Phase|Incarceration|0|||
146702309|NCT00207142|529087416|FG002|Induction Phase|Incarceration|0|||
146702310|NCT00207142|529087417|FG003|Induction Phase|Incarceration|0|||
146702311|NCT00207142|529087414|FG000|Induction Phase|Missing lab data|1|||
146702312|NCT00207142|529087415|FG001|Induction Phase|Missing lab data|0|||
146702313|NCT00207142|529087416|FG002|Induction Phase|Missing lab data|0|||
146702314|NCT00207142|529087417|FG003|Induction Phase|Missing lab data|0|||
146702315|NCT00207142|529087414|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
146776747|NCT02723955|529353619|FG007|Expansion Phase|Lost to Follow-up|0|||
146932854|NCT02505542|529912550|FG002|Part A: Open-Label Period|Adverse Event|0|||
146932855|NCT02505542|529912551|FG003|Part A: Open-Label Period|Adverse Event|0|||
146932856|NCT02505542|529912548|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
146932857|NCT02505542|529912549|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
146932858|NCT02505542|529912550|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
146932859|NCT02505542|529912551|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
146932860|NCT02505542|529912548|FG000|Part A: Open-Label Period|Protocol Violation|1|||
146932861|NCT02505542|529912549|FG001|Part A: Open-Label Period|Protocol Violation|0|||
146932862|NCT02505542|529912550|FG002|Part A: Open-Label Period|Protocol Violation|0|||
146932863|NCT02505542|529912551|FG003|Part A: Open-Label Period|Protocol Violation|0|||
146932864|NCT02505542|529912548|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
146932865|NCT02505542|529912549|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
146932866|NCT02505542|529912550|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
146932867|NCT02505542|529912551|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
146932868|NCT02505542|529912548|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
146932869|NCT02505542|529912549|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
146932870|NCT02505542|529912550|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
146932871|NCT02505542|529912551|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
146932872|NCT02505542|529912548|FG000|Part A: Open-Label Period|New medical history available|1|||
146932873|NCT02505542|529912549|FG001|Part A: Open-Label Period|New medical history available|0|||
146932874|NCT02505542|529912550|FG002|Part A: Open-Label Period|New medical history available|0|||
146932875|NCT02505542|529912551|FG003|Part A: Open-Label Period|New medical history available|0|||
146932876|NCT02505542|529912548|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
146932877|NCT02505542|529912549|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
146932878|NCT02505542|529912550|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
146932879|NCT02505542|529912551|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
146932880|NCT02505542|529912548|FG000|Part A: Open-Label Period|Pregnancy|2|||
146932881|NCT02505542|529912549|FG001|Part A: Open-Label Period|Pregnancy|0|||
146932882|NCT02505542|529912550|FG002|Part A: Open-Label Period|Pregnancy|0|||
146932883|NCT02505542|529912551|FG003|Part A: Open-Label Period|Pregnancy|0|||
146932884|NCT02505542|529912548|FG000|Part A: Open-Label Period|Sponsor directive|1|||
146932885|NCT02505542|529912549|FG001|Part A: Open-Label Period|Sponsor directive|0|||
146932886|NCT02505542|529912550|FG002|Part A: Open-Label Period|Sponsor directive|0|||
146932887|NCT02505542|529912551|FG003|Part A: Open-Label Period|Sponsor directive|0|||
146932888|NCT02505542|529912548|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
146932889|NCT02505542|529912549|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
146932890|NCT02505542|529912550|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
146932891|NCT02505542|529912551|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
146932892|NCT02505542|529912548|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
146932893|NCT02505542|529912549|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
146932894|NCT02505542|529912550|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
146932895|NCT02505542|529912551|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
146932896|NCT02505542|529912548|FG000|Part A: Open-Label Period|Non-compliance|1|||
146932897|NCT02505542|529912549|FG001|Part A: Open-Label Period|Non-compliance|0|||
146932898|NCT02505542|529912550|FG002|Part A: Open-Label Period|Non-compliance|0|||
146932899|NCT02505542|529912551|FG003|Part A: Open-Label Period|Non-compliance|0|||
146932900|NCT02505542|529912548|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
146702316|NCT00207142|529087415|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
146702317|NCT00207142|529087416|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
146702318|NCT00207142|529087417|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
146702319|NCT00207142|529087414|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
146702320|NCT00207142|529087415|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
146702321|NCT00207142|529087416|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
146702322|NCT00207142|529087417|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
146702323|NCT00207142|529087414|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
146702324|NCT00207142|529087415|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
146702325|NCT00207142|529087416|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
146702326|NCT00207142|529087417|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
146702327|NCT00207142|529087414|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
146702328|NCT00207142|529087415|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
146702329|NCT00207142|529087416|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
146702330|NCT00207142|529087417|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
146702331|NCT00207142|529087414|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
146932901|NCT02505542|529912549|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
146932902|NCT02505542|529912550|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
146932903|NCT02505542|529912551|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
146932904|NCT02505542|529912548|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
146702332|NCT00207142|529087415|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
146932905|NCT02505542|529912549|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
146932906|NCT02505542|529912550|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
146932907|NCT02505542|529912551|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
146932908|NCT02505542|529912548|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
146932909|NCT02505542|529912549|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
146932910|NCT02505542|529912550|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
146932911|NCT02505542|529912551|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
146932912|NCT02505542|529912548|FG000|Part B: Double-Blind Period|Adverse Event|0|||
146932913|NCT02505542|529912549|FG001|Part B: Double-Blind Period|Adverse Event|0|||
146932914|NCT02505542|529912550|FG002|Part B: Double-Blind Period|Adverse Event|1|||
146932915|NCT02505542|529912551|FG003|Part B: Double-Blind Period|Adverse Event|3|||
146932916|NCT02505542|529912548|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
146932917|NCT02505542|529912549|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
146932918|NCT02505542|529912550|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
146932919|NCT02505542|529912551|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
146932920|NCT02505542|529912548|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
146932921|NCT02505542|529912549|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
146932922|NCT02505542|529912550|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
146932923|NCT02505542|529912551|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
146932924|NCT02505542|529912548|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
146932925|NCT02505542|529912549|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
146932926|NCT02505542|529912550|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
146932927|NCT02505542|529912551|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
146932928|NCT02505542|529912548|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
146932929|NCT02505542|529912549|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
146932930|NCT02505542|529912550|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
146932931|NCT02505542|529912551|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
146932932|NCT02505542|529912548|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
146932933|NCT02505542|529912549|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
146932934|NCT02505542|529912550|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
146932935|NCT02505542|529912551|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
146932936|NCT02505542|529912548|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
146932937|NCT02505542|529912549|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
146932938|NCT02505542|529912550|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
146932939|NCT02505542|529912551|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
146932940|NCT02505542|529912548|FG000|Part B: Double-Blind Period|Miscalculation|0|||
146932941|NCT02505542|529912549|FG001|Part B: Double-Blind Period|Miscalculation|1|||
146932942|NCT02505542|529912550|FG002|Part B: Double-Blind Period|Miscalculation|0|||
146932943|NCT02505542|529912551|FG003|Part B: Double-Blind Period|Miscalculation|0|||
146702333|NCT00207142|529087416|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
146702334|NCT00207142|529087417|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
146702335|NCT00207142|529087414|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
146702336|NCT00207142|529087415|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
146702337|NCT00207142|529087416|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
146702338|NCT00207142|529087417|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
146702339|NCT00207142|529087414|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
146702340|NCT00207142|529087415|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
146702341|NCT00207142|529087416|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
146702342|NCT00207142|529087417|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
146932944|NCT02505542|529912548|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
146932945|NCT02505542|529912549|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
146932946|NCT02505542|529912550|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
146932947|NCT02505542|529912551|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
146932948|NCT00168064|529912552|FG000|Overall Study|Adverse Event|26|||
146932949|NCT00168064|529912553|FG001|Overall Study|Adverse Event|22|||
146932950|NCT00168064|529912552|FG000|Overall Study|Withdrawal by Subject|3|||
146932951|NCT00168064|529912553|FG001|Overall Study|Withdrawal by Subject|4|||
146932952|NCT00168064|529912552|FG000|Overall Study|Lack of Efficacy|4|||
146932953|NCT00168064|529912553|FG001|Overall Study|Lack of Efficacy|4|||
146932954|NCT00168064|529912552|FG000|Overall Study|Lost to Follow-up|4|||
146932955|NCT00168064|529912553|FG001|Overall Study|Lost to Follow-up|3|||
146932956|NCT00168064|529912552|FG000|Overall Study|Non-compliance|2|||
146932957|NCT00168064|529912553|FG001|Overall Study|Non-compliance|3|||
146932958|NCT00168064|529912552|FG000|Overall Study|Concurrent Illness|4|||
146702343|NCT00207142|529087414|FG000|Maintenance Phase/Rescue Phase|Death|0|||
146702344|NCT00207142|529087415|FG001|Maintenance Phase/Rescue Phase|Death|0|||
146702345|NCT00207142|529087416|FG002|Maintenance Phase/Rescue Phase|Death|0|||
146702346|NCT00207142|529087417|FG003|Maintenance Phase/Rescue Phase|Death|1|||
146932959|NCT00168064|529912553|FG001|Overall Study|Concurrent Illness|3|||
146932960|NCT00168064|529912552|FG000|Overall Study|Subject's Best interest|2|||
146932961|NCT00168064|529912553|FG001|Overall Study|Subject's Best interest|2|||
146932962|NCT00168064|529912552|FG000|Overall Study|Various|4|||
146932963|NCT00168064|529912553|FG001|Overall Study|Various|3|||
146932964|NCT05489081|529912558|FG000|Overall Study|student left classroom|0|||
146932965|NCT05489081|529912559|FG001|Overall Study|student left classroom|1|||
146932966|NCT05489081|529912558|FG000|Overall Study|teacher left school|0|||
146932967|NCT05489081|529912559|FG001|Overall Study|teacher left school|2|||
146932968|NCT00400712|529912560|FG000|Overall Study|Death|1|||
146932969|NCT00400712|529912561|FG001|Overall Study|Death|0|||
146932970|NCT00400712|529912560|FG000|Overall Study|Withdrawal by Subject|11|||
146932971|NCT00400712|529912561|FG001|Overall Study|Withdrawal by Subject|12|||
146932972|NCT00400712|529912560|FG000|Overall Study|Physician Decision|5|||
146932973|NCT00400712|529912561|FG001|Overall Study|Physician Decision|4|||
146932974|NCT01181102|529912562|FG000|Overall Study|Adverse Event|28|||
146932975|NCT01181102|529912563|FG001|Overall Study|Adverse Event|26|||
146932976|NCT01181102|529912562|FG000|Overall Study|Lack of Efficacy|3|||
146932977|NCT01181102|529912563|FG001|Overall Study|Lack of Efficacy|1|||
146932978|NCT01181102|529912562|FG000|Overall Study|Lost to Follow-up|2|||
146932979|NCT01181102|529912563|FG001|Overall Study|Lost to Follow-up|0|||
146932980|NCT01181102|529912562|FG000|Overall Study|Physician Decision|3|||
146932981|NCT01181102|529912563|FG001|Overall Study|Physician Decision|1|||
146932982|NCT01181102|529912562|FG000|Overall Study|Protocol Violation|5|||
146932983|NCT01181102|529912563|FG001|Overall Study|Protocol Violation|6|||
146932984|NCT01181102|529912562|FG000|Overall Study|Withdrawal by Subject|10|||
146932985|NCT01181102|529912563|FG001|Overall Study|Withdrawal by Subject|12|||
146932986|NCT01309841|529912566|FG000|Overall Study|Other|0|||
146932987|NCT01309841|529912567|FG001|Overall Study|Other|1|||
146932988|NCT01309841|529912568|FG002|Overall Study|Other|1|||
146932989|NCT01309841|529912566|FG000|Overall Study|Lost to Follow-up|7|||
146932990|NCT01309841|529912567|FG001|Overall Study|Lost to Follow-up|6|||
146932991|NCT01309841|529912568|FG002|Overall Study|Lost to Follow-up|4|||
146702347|NCT00207142|529087414|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
146702348|NCT00207142|529087415|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
146702349|NCT00207142|529087416|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
146702350|NCT00207142|529087417|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
146702351|NCT01857063|529087418|FG000|Period 1 (7 Days)|Adverse Event|0|||
146702352|NCT01857063|529087419|FG001|Period 1 (7 Days)|Adverse Event|1|||
146702353|NCT01857063|529087418|FG000|Period 1 (7 Days)|Physician Decision|1|||
146702354|NCT01857063|529087419|FG001|Period 1 (7 Days)|Physician Decision|0|||
146702355|NCT01857063|529087418|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
146702356|NCT01857063|529087419|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
146702357|NCT01857063|529087418|FG000|Period 2 (7 Days)|Adverse Event|2|||
146702358|NCT01857063|529087419|FG001|Period 2 (7 Days)|Adverse Event|1|||
146702359|NCT01857063|529087418|FG000|Period 2 (7 Days)|Physician Decision|1|||
146702360|NCT01857063|529087419|FG001|Period 2 (7 Days)|Physician Decision|1|||
146702361|NCT01857063|529087418|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
146702362|NCT01857063|529087419|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
146702363|NCT04958109|529087420|FG000|Overall Study|Withdrawal by Subject|0|||
146702364|NCT04958109|529087421|FG001|Overall Study|Withdrawal by Subject|1|||
146702365|NCT04958109|529087420|FG000|Overall Study|Lost to Follow-up|0|||
146776748|NCT02723955|529353620|FG008|Expansion Phase|Lost to Follow-up|0|||
146776749|NCT02723955|529353621|FG009|Expansion Phase|Lost to Follow-up|0|||
146932992|NCT01309841|529912566|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
146932993|NCT01309841|529912567|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
146932994|NCT01309841|529912568|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
146932995|NCT01309841|529912566|FG000|Overall Study|Lack of Efficacy|0|||
146932996|NCT01309841|529912567|FG001|Overall Study|Lack of Efficacy|0|||
146932997|NCT01309841|529912568|FG002|Overall Study|Lack of Efficacy|2|||
146932998|NCT01309841|529912566|FG000|Overall Study|Adverse Event|9|||
146932999|NCT01309841|529912567|FG001|Overall Study|Adverse Event|22|||
146933000|NCT01309841|529912568|FG002|Overall Study|Adverse Event|11|||
146933001|NCT01309841|529912566|FG000|Overall Study|Death|1|||
146933002|NCT01309841|529912567|FG001|Overall Study|Death|0|||
146702366|NCT04958109|529087421|FG001|Overall Study|Lost to Follow-up|1|||
146702367|NCT00715793|529087424|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
146702368|NCT00715793|529087425|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
146702369|NCT00715793|529087424|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
146702370|NCT00715793|529087425|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
146933003|NCT01309841|529912568|FG002|Overall Study|Death|0|||
146776750|NCT02723955|529353622|FG010|Expansion Phase|Lost to Follow-up|4|||
146933004|NCT01309841|529912566|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
146933005|NCT01309841|529912567|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
146933006|NCT01309841|529912568|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
146933007|NCT01309841|529912566|FG000|Overall Study|Withdrawal by Subject|17|||
146933008|NCT01309841|529912567|FG001|Overall Study|Withdrawal by Subject|6|||
146933009|NCT01309841|529912568|FG002|Overall Study|Withdrawal by Subject|13|||
146933010|NCT01309841|529912566|FG000|Overall Study|Did Not Receive Treatment|2|||
146933011|NCT01309841|529912567|FG001|Overall Study|Did Not Receive Treatment|0|||
146933012|NCT01309841|529912568|FG002|Overall Study|Did Not Receive Treatment|1|||
146933013|NCT01309841|529912566|FG000|Overall Study|Severe non-compliance with protocol|0|||
146933014|NCT01309841|529912567|FG001|Overall Study|Severe non-compliance with protocol|5|||
146933015|NCT01309841|529912568|FG002|Overall Study|Severe non-compliance with protocol|2|||
146933016|NCT05127421|529912570|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
146933017|NCT05127421|529912571|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
146933018|NCT05127421|529912572|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
146933019|NCT05127421|529912573|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
146933020|NCT05127421|529912570|FG000|4-Week Double-Blind Period|Physician Decision|1|||
146933021|NCT05127421|529912571|FG001|4-Week Double-Blind Period|Physician Decision|0|||
146933022|NCT05127421|529912572|FG002|4-Week Double-Blind Period|Physician Decision|0|||
146933023|NCT05127421|529912573|FG003|4-Week Double-Blind Period|Physician Decision|0|||
146933024|NCT05127421|529912570|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
146933025|NCT05127421|529912571|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
146933026|NCT05127421|529912572|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
146933027|NCT05127421|529912573|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
146933028|NCT05127421|529912570|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
146933029|NCT05127421|529912571|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
146933030|NCT05127421|529912572|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
146933031|NCT05127421|529912573|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
146933032|NCT05127421|529912570|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
146933033|NCT05127421|529912571|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
146933034|NCT05127421|529912572|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
146933035|NCT05127421|529912573|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
146933036|NCT05127421|529912570|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
146933037|NCT05127421|529912571|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
146933038|NCT05127421|529912572|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
146933039|NCT05127421|529912573|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
146933040|NCT05127421|529912570|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
146933041|NCT05127421|529912571|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
146933042|NCT05127421|529912572|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
146933043|NCT05127421|529912573|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
146933044|NCT05127421|529912570|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
146933045|NCT05127421|529912571|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
146933046|NCT05127421|529912572|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
146933047|NCT05127421|529912573|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
146933048|NCT01441115|529912574|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
146933049|NCT00878215|529912578|FG000|Overall Study|Determined to be ineligible|0|||
146933050|NCT00878215|529912579|FG001|Overall Study|Determined to be ineligible|10|||
146933051|NCT00878215|529912580|FG002|Overall Study|Determined to be ineligible|0|||
146933052|NCT00878215|529912581|FG003|Overall Study|Determined to be ineligible|0|||
146933053|NCT00574496|529912586|FG000|Overall Study|Withdrawal by Subject|1|||
146933054|NCT01969799|529912587|FG000|Overall Study|Adverse Event|0|||
146933055|NCT01969799|529912588|FG001|Overall Study|Adverse Event|1|||
146933056|NCT01969799|529912587|FG000|Overall Study|Death|16|||
146702371|NCT00058825|529087426|FG000|Overall Study|Relapse|9|||
146702372|NCT00058825|529087426|FG000|Overall Study|Progressive Disease|5|||
146702373|NCT00058825|529087426|FG000|Overall Study|Graft Failure|5|||
146702374|NCT00058825|529087426|FG000|Overall Study|Death|3|||
146702375|NCT04115358|529087427|FG000|Overall Study|exfoliation|0|||
146702376|NCT04115358|529087428|FG001|Overall Study|exfoliation|0|||
146702377|NCT04115358|529087429|FG002|Overall Study|exfoliation|1|||
146702378|NCT02346240|529087430|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702379|NCT02346240|529087431|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
146702380|NCT02346240|529087432|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
146702381|NCT02346240|529087433|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
146702382|NCT02346240|529087434|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702383|NCT02346240|529087435|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702384|NCT02346240|529087436|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702385|NCT02346240|529087437|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702386|NCT02346240|529087438|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702387|NCT02346240|529087439|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702388|NCT02346240|529087440|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702389|NCT02346240|529087441|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702390|NCT02346240|529087442|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702391|NCT02346240|529087443|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702392|NCT02346240|529087444|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146933057|NCT01969799|529912588|FG001|Overall Study|Death|11|||
146702393|NCT02346240|529087445|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702394|NCT02346240|529087446|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702395|NCT02346240|529087447|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702396|NCT02346240|529087448|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702397|NCT02346240|529087449|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702398|NCT02346240|529087450|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702399|NCT02346240|529087451|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702400|NCT02346240|529087452|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702401|NCT02346240|529087453|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146702402|NCT02346240|529087430|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146933058|NCT01969799|529912587|FG000|Overall Study|Lost to Follow-up|0|||
146933059|NCT01969799|529912588|FG001|Overall Study|Lost to Follow-up|2|||
146933060|NCT01969799|529912587|FG000|Overall Study|Physician Decision|1|||
146933061|NCT01969799|529912588|FG001|Overall Study|Physician Decision|0|||
146702403|NCT02346240|529087431|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
146702404|NCT02346240|529087432|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702405|NCT02346240|529087433|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702406|NCT02346240|529087434|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702407|NCT02346240|529087435|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702408|NCT02346240|529087436|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702409|NCT02346240|529087437|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702410|NCT02346240|529087438|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702411|NCT02346240|529087439|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702412|NCT02346240|529087440|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702413|NCT02346240|529087441|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702414|NCT02346240|529087442|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702415|NCT02346240|529087443|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702416|NCT02346240|529087444|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702417|NCT02346240|529087445|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702418|NCT02346240|529087446|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702419|NCT02346240|529087447|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702420|NCT02346240|529087448|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702421|NCT02346240|529087449|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702422|NCT02346240|529087450|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702423|NCT02346240|529087451|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702424|NCT02346240|529087452|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702425|NCT02346240|529087453|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146702426|NCT02346240|529087430|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702427|NCT02346240|529087431|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
146702428|NCT02346240|529087432|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702429|NCT02346240|529087433|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702430|NCT02346240|529087434|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702431|NCT02346240|529087435|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702432|NCT02346240|529087436|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702433|NCT02346240|529087437|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702434|NCT02346240|529087438|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702435|NCT02346240|529087439|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702436|NCT02346240|529087440|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702437|NCT02346240|529087441|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702438|NCT02346240|529087442|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702439|NCT02346240|529087443|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702440|NCT02346240|529087444|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702441|NCT02346240|529087445|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702442|NCT02346240|529087446|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702443|NCT02346240|529087447|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702444|NCT02346240|529087448|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702445|NCT02346240|529087449|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702446|NCT02346240|529087450|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702447|NCT02346240|529087451|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702448|NCT02346240|529087452|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702449|NCT02346240|529087453|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146702450|NCT02346240|529087430|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
146933062|NCT01361919|529912589|FG000|Overall Study|technical issues|10|||
146933063|NCT01361919|529912590|FG001|Overall Study|technical issues|12|||
146933064|NCT01361919|529912591|FG002|Overall Study|technical issues|10|||
146702451|NCT02346240|529087431|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
146702452|NCT02346240|529087432|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
146933065|NCT01681576|529912594|FG000|Period 1|Adverse Event|1|||
146702453|NCT02346240|529087433|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
146702454|NCT02346240|529087434|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702455|NCT02346240|529087435|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702456|NCT02346240|529087436|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702457|NCT02346240|529087437|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702458|NCT02346240|529087438|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702459|NCT02346240|529087439|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702460|NCT02346240|529087440|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702461|NCT02346240|529087441|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702462|NCT02346240|529087442|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702463|NCT02346240|529087443|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702464|NCT02346240|529087444|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702465|NCT02346240|529087445|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702466|NCT02346240|529087446|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702467|NCT02346240|529087447|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702468|NCT02346240|529087448|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702469|NCT02346240|529087449|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702470|NCT02346240|529087450|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702471|NCT02346240|529087451|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702472|NCT02346240|529087452|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702473|NCT02346240|529087453|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146702474|NCT02346240|529087430|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
146702475|NCT02346240|529087431|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
146702476|NCT02346240|529087432|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
146702477|NCT02346240|529087433|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
146702478|NCT02346240|529087434|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702479|NCT02346240|529087435|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702480|NCT02346240|529087436|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702481|NCT02346240|529087437|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702482|NCT02346240|529087438|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702483|NCT02346240|529087439|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702484|NCT02346240|529087440|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702485|NCT02346240|529087441|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702486|NCT02346240|529087442|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702487|NCT02346240|529087443|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702488|NCT02346240|529087444|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702489|NCT02346240|529087445|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702490|NCT02346240|529087446|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702491|NCT02346240|529087447|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702492|NCT02346240|529087448|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702493|NCT02346240|529087449|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702494|NCT02346240|529087450|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702495|NCT02346240|529087451|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702496|NCT02346240|529087452|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702497|NCT02346240|529087453|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146702498|NCT02346240|529087430|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702499|NCT02346240|529087431|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
146702500|NCT02346240|529087432|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702501|NCT02346240|529087433|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
146702502|NCT02346240|529087434|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702503|NCT02346240|529087435|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702504|NCT02346240|529087436|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702505|NCT02346240|529087437|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702506|NCT02346240|529087438|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702507|NCT02346240|529087439|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702508|NCT02346240|529087440|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702509|NCT02346240|529087441|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702510|NCT02346240|529087442|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702511|NCT02346240|529087443|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702512|NCT02346240|529087444|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702513|NCT02346240|529087445|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702514|NCT02346240|529087446|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702515|NCT02346240|529087447|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702516|NCT02346240|529087448|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702517|NCT02346240|529087449|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702518|NCT02346240|529087450|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702519|NCT02346240|529087451|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702520|NCT02346240|529087452|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702521|NCT02346240|529087453|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146702522|NCT02346240|529087430|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702523|NCT02346240|529087431|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702524|NCT02346240|529087432|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
146702525|NCT02346240|529087433|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702526|NCT02346240|529087434|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702527|NCT02346240|529087435|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702528|NCT02346240|529087436|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702529|NCT02346240|529087437|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702530|NCT02346240|529087438|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702531|NCT02346240|529087439|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702532|NCT02346240|529087440|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702533|NCT02346240|529087441|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702534|NCT02346240|529087442|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702535|NCT02346240|529087443|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702536|NCT02346240|529087444|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702537|NCT02346240|529087445|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702538|NCT02346240|529087446|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702539|NCT02346240|529087447|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702540|NCT02346240|529087448|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702541|NCT02346240|529087449|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702542|NCT02346240|529087450|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702543|NCT02346240|529087451|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702544|NCT02346240|529087452|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702545|NCT02346240|529087453|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146702546|NCT02346240|529087430|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702547|NCT02346240|529087431|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702548|NCT02346240|529087432|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702549|NCT02346240|529087433|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702550|NCT02346240|529087434|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702551|NCT02346240|529087435|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702552|NCT02346240|529087436|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702553|NCT02346240|529087437|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
146702554|NCT02346240|529087438|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
146702555|NCT02346240|529087439|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702556|NCT02346240|529087440|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702557|NCT02346240|529087441|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702558|NCT02346240|529087442|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702559|NCT02346240|529087443|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
146702560|NCT02346240|529087444|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
146702561|NCT02346240|529087445|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
146702562|NCT02346240|529087446|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
146702563|NCT02346240|529087447|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702564|NCT02346240|529087448|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702565|NCT02346240|529087449|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702566|NCT02346240|529087450|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702567|NCT02346240|529087451|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702568|NCT02346240|529087452|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702569|NCT02346240|529087453|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146702570|NCT02346240|529087430|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702571|NCT02346240|529087431|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702572|NCT02346240|529087432|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702573|NCT02346240|529087433|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702574|NCT02346240|529087434|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702575|NCT02346240|529087435|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702576|NCT02346240|529087436|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702577|NCT02346240|529087437|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702578|NCT02346240|529087438|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702579|NCT02346240|529087439|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702580|NCT02346240|529087440|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146933066|NCT01681576|529912595|FG001|Period 1|Adverse Event|0|||
146702581|NCT02346240|529087441|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702582|NCT02346240|529087442|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702583|NCT02346240|529087443|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
146702584|NCT02346240|529087444|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702585|NCT02346240|529087445|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
146702586|NCT02346240|529087446|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702587|NCT02346240|529087447|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702588|NCT02346240|529087448|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702589|NCT02346240|529087449|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702590|NCT02346240|529087450|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702591|NCT02346240|529087451|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702592|NCT02346240|529087452|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702593|NCT02346240|529087453|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146702594|NCT02346240|529087430|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702595|NCT02346240|529087431|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702596|NCT02346240|529087432|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702597|NCT02346240|529087433|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702598|NCT02346240|529087434|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702599|NCT02346240|529087435|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702600|NCT02346240|529087436|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702601|NCT02346240|529087437|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702602|NCT02346240|529087438|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702603|NCT02346240|529087439|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702604|NCT02346240|529087440|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702605|NCT02346240|529087441|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702606|NCT02346240|529087442|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702607|NCT02346240|529087443|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702608|NCT02346240|529087444|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
146702609|NCT02346240|529087445|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702610|NCT02346240|529087446|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702611|NCT02346240|529087447|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702612|NCT02346240|529087448|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702613|NCT02346240|529087449|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702614|NCT02346240|529087450|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702615|NCT02346240|529087451|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702616|NCT02346240|529087452|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702617|NCT02346240|529087453|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146702618|NCT02346240|529087430|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146702619|NCT02346240|529087431|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146702620|NCT02346240|529087432|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146702621|NCT02346240|529087433|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146702622|NCT02346240|529087434|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146702623|NCT02346240|529087435|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146702624|NCT02346240|529087436|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146702625|NCT02346240|529087437|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146702626|NCT02346240|529087438|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146702627|NCT02346240|529087439|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146702628|NCT02346240|529087440|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146702629|NCT02346240|529087441|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
146702630|NCT02346240|529087442|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146702631|NCT02346240|529087443|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
146702632|NCT02346240|529087444|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
146702633|NCT02346240|529087445|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
146702634|NCT02346240|529087446|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146702635|NCT02346240|529087447|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146933067|NCT01681576|529912594|FG000|Period 1|Protocol Deviation|1|||
146933068|NCT01681576|529912595|FG001|Period 1|Protocol Deviation|0|||
146933069|NCT01681576|529912594|FG000|Period 2|subject/guardian decision|3|||
146933070|NCT01681576|529912595|FG001|Period 2|subject/guardian decision|1|||
146702636|NCT02346240|529087448|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146702637|NCT02346240|529087449|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146702638|NCT02346240|529087450|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146702639|NCT02346240|529087451|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146702640|NCT02346240|529087452|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146776751|NCT02723955|529353623|FG011|Expansion Phase|Lost to Follow-up|1|||
146776752|NCT02723955|529353624|FG012|Expansion Phase|Lost to Follow-up|0|||
146776753|NCT02723955|529353625|FG013|Expansion Phase|Lost to Follow-up|0|||
146776754|NCT02723955|529353626|FG014|Expansion Phase|Lost to Follow-up|0|||
146776755|NCT02723955|529353627|FG015|Expansion Phase|Lost to Follow-up|0|||
146776756|NCT02723955|529353628|FG016|Expansion Phase|Lost to Follow-up|0|||
146776757|NCT02723955|529353629|FG017|Expansion Phase|Lost to Follow-up|0|||
146776758|NCT02723955|529353630|FG018|Expansion Phase|Lost to Follow-up|0|||
146776759|NCT02723955|529353631|FG019|Expansion Phase|Lost to Follow-up|0|||
146776760|NCT02723955|529353632|FG020|Expansion Phase|Lost to Follow-up|0|||
146776761|NCT02723955|529353633|FG021|Expansion Phase|Lost to Follow-up|0|||
146776762|NCT02723955|529353634|FG022|Expansion Phase|Lost to Follow-up|0|||
146776763|NCT02723955|529353635|FG023|Expansion Phase|Lost to Follow-up|0|||
146776764|NCT02723955|529353636|FG024|Expansion Phase|Lost to Follow-up|0|||
146776765|NCT02723955|529353637|FG025|Expansion Phase|Lost to Follow-up|0|||
146776766|NCT02723955|529353638|FG026|Expansion Phase|Lost to Follow-up|0|||
146776767|NCT02723955|529353639|FG027|Expansion Phase|Lost to Follow-up|0|||
146776768|NCT02723955|529353640|FG028|Expansion Phase|Lost to Follow-up|0|||
146776769|NCT02723955|529353641|FG029|Expansion Phase|Lost to Follow-up|1|||
146776770|NCT02723955|529353642|FG030|Expansion Phase|Lost to Follow-up|19|||
146776771|NCT02723955|529353643|FG031|Expansion Phase|Lost to Follow-up|2|||
146776772|NCT02723955|529353644|FG032|Expansion Phase|Lost to Follow-up|1|||
146776773|NCT02723955|529353645|FG033|Expansion Phase|Lost to Follow-up|0|||
146776774|NCT02723955|529353646|FG034|Expansion Phase|Lost to Follow-up|0|||
146776775|NCT02723955|529353647|FG035|Expansion Phase|Lost to Follow-up|0|||
146776776|NCT02723955|529353648|FG036|Expansion Phase|Lost to Follow-up|0|||
146776777|NCT02723955|529353649|FG037|Expansion Phase|Lost to Follow-up|0|||
146776778|NCT02723955|529353650|FG038|Expansion Phase|Lost to Follow-up|0|||
146776779|NCT02723955|529353651|FG039|Expansion Phase|Lost to Follow-up|0|||
146776780|NCT02723955|529353652|FG040|Expansion Phase|Lost to Follow-up|0|||
146776781|NCT02723955|529353653|FG041|Expansion Phase|Lost to Follow-up|0|||
146776782|NCT02723955|529353654|FG042|Expansion Phase|Lost to Follow-up|0|||
146776783|NCT02723955|529353612|FG000|Expansion Phase|Physician Decision|0|||
146776784|NCT02723955|529353613|FG001|Expansion Phase|Physician Decision|0|||
146776785|NCT02723955|529353614|FG002|Expansion Phase|Physician Decision|0|||
146776786|NCT02723955|529353615|FG003|Expansion Phase|Physician Decision|0|||
146776787|NCT02723955|529353616|FG004|Expansion Phase|Physician Decision|0|||
146702641|NCT02346240|529087453|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146702642|NCT02346240|529087430|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702643|NCT02346240|529087431|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702644|NCT02346240|529087432|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702645|NCT02346240|529087433|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702646|NCT02346240|529087434|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702647|NCT02346240|529087435|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146776788|NCT02723955|529353617|FG005|Expansion Phase|Physician Decision|0|||
146776789|NCT02723955|529353618|FG006|Expansion Phase|Physician Decision|0|||
146776790|NCT02723955|529353619|FG007|Expansion Phase|Physician Decision|0|||
146776791|NCT02723955|529353620|FG008|Expansion Phase|Physician Decision|0|||
146776792|NCT02723955|529353621|FG009|Expansion Phase|Physician Decision|0|||
146776793|NCT02723955|529353622|FG010|Expansion Phase|Physician Decision|0|||
146776794|NCT02723955|529353623|FG011|Expansion Phase|Physician Decision|0|||
146776795|NCT02723955|529353624|FG012|Expansion Phase|Physician Decision|0|||
146776796|NCT02723955|529353625|FG013|Expansion Phase|Physician Decision|0|||
146776797|NCT02723955|529353626|FG014|Expansion Phase|Physician Decision|0|||
146776798|NCT02723955|529353627|FG015|Expansion Phase|Physician Decision|0|||
146776799|NCT02723955|529353628|FG016|Expansion Phase|Physician Decision|0|||
146776800|NCT02723955|529353629|FG017|Expansion Phase|Physician Decision|0|||
146776801|NCT02723955|529353630|FG018|Expansion Phase|Physician Decision|0|||
146776802|NCT02723955|529353631|FG019|Expansion Phase|Physician Decision|0|||
146776803|NCT02723955|529353632|FG020|Expansion Phase|Physician Decision|0|||
146776804|NCT02723955|529353633|FG021|Expansion Phase|Physician Decision|0|||
146776805|NCT02723955|529353634|FG022|Expansion Phase|Physician Decision|0|||
146776806|NCT02723955|529353635|FG023|Expansion Phase|Physician Decision|0|||
146776807|NCT02723955|529353636|FG024|Expansion Phase|Physician Decision|0|||
146776808|NCT02723955|529353637|FG025|Expansion Phase|Physician Decision|0|||
146776809|NCT02723955|529353638|FG026|Expansion Phase|Physician Decision|0|||
146776810|NCT02723955|529353639|FG027|Expansion Phase|Physician Decision|0|||
146776811|NCT02723955|529353640|FG028|Expansion Phase|Physician Decision|0|||
146776812|NCT02723955|529353641|FG029|Expansion Phase|Physician Decision|0|||
146776813|NCT02723955|529353642|FG030|Expansion Phase|Physician Decision|1|||
146776814|NCT02723955|529353643|FG031|Expansion Phase|Physician Decision|1|||
146776815|NCT02723955|529353644|FG032|Expansion Phase|Physician Decision|0|||
146776816|NCT02723955|529353645|FG033|Expansion Phase|Physician Decision|0|||
146776817|NCT02723955|529353646|FG034|Expansion Phase|Physician Decision|0|||
146776818|NCT02723955|529353647|FG035|Expansion Phase|Physician Decision|0|||
146702648|NCT02346240|529087436|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702649|NCT02346240|529087437|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702650|NCT02346240|529087438|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702651|NCT02346240|529087439|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702652|NCT02346240|529087440|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702653|NCT02346240|529087441|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702654|NCT02346240|529087442|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702655|NCT02346240|529087443|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
146933071|NCT01681576|529912594|FG000|Period 2|Non-compliance with study treatment|1|||
146933072|NCT01681576|529912595|FG001|Period 2|Non-compliance with study treatment|0|||
146933073|NCT00178464|529912597|FG000|Overall Study|Withdrawal by Subject|1|||
146933074|NCT00178464|529912597|FG000|Overall Study|Physician Decision|1|||
146933075|NCT02260648|529912598|FG000|Overall Study|Adverse Event|3|||
146933076|NCT02260648|529912599|FG001|Overall Study|Adverse Event|0|||
146933077|NCT02260648|529912600|FG002|Overall Study|Adverse Event|1|||
146933078|NCT02260648|529912598|FG000|Overall Study|Withdrawal by Subject|1|||
146933079|NCT02260648|529912599|FG001|Overall Study|Withdrawal by Subject|1|||
146933080|NCT02260648|529912600|FG002|Overall Study|Withdrawal by Subject|0|||
146933081|NCT02260648|529912598|FG000|Overall Study|Protocol Violation|1|||
146933082|NCT02260648|529912599|FG001|Overall Study|Protocol Violation|0|||
146933083|NCT02260648|529912600|FG002|Overall Study|Protocol Violation|0|||
146933084|NCT02260648|529912598|FG000|Overall Study|Discontinue Due to Study Termination|13|||
146933085|NCT02260648|529912599|FG001|Overall Study|Discontinue Due to Study Termination|12|||
146933086|NCT02260648|529912600|FG002|Overall Study|Discontinue Due to Study Termination|7|||
146702656|NCT02346240|529087444|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
146702657|NCT02346240|529087445|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
146702658|NCT02346240|529087446|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
146702659|NCT02346240|529087447|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702660|NCT02346240|529087448|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702661|NCT02346240|529087449|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702662|NCT02346240|529087450|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702663|NCT02346240|529087451|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702664|NCT02346240|529087452|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702665|NCT02346240|529087453|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146702666|NCT02346240|529087430|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702667|NCT02346240|529087431|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702668|NCT02346240|529087432|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702669|NCT02346240|529087433|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702670|NCT02346240|529087434|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702671|NCT02346240|529087435|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702672|NCT02346240|529087436|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
146702673|NCT02346240|529087437|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702674|NCT02346240|529087438|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702675|NCT02346240|529087439|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702676|NCT02346240|529087440|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702677|NCT02346240|529087441|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702678|NCT02346240|529087442|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702679|NCT02346240|529087443|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702680|NCT02346240|529087444|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702681|NCT02346240|529087445|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702682|NCT02346240|529087446|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702683|NCT02346240|529087447|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702684|NCT02346240|529087448|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702685|NCT02346240|529087449|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702686|NCT02346240|529087450|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702687|NCT02346240|529087451|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702688|NCT02346240|529087452|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146702689|NCT02346240|529087453|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146933087|NCT03956225|529912601|FG000|Overall Study|Lack of Efficacy|1|||
146933088|NCT03956225|529912602|FG001|Overall Study|Lack of Efficacy|1|||
146933089|NCT03956225|529912601|FG000|Overall Study|Lost to Follow-up|0|||
146933090|NCT03956225|529912602|FG001|Overall Study|Lost to Follow-up|1|||
146702690|NCT02346240|529087430|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702691|NCT02346240|529087431|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702692|NCT02346240|529087432|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146933091|NCT03956225|529912601|FG000|Overall Study|Withdrawal by Subject|2|||
146702693|NCT02346240|529087433|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702694|NCT02346240|529087434|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702695|NCT02346240|529087435|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702696|NCT02346240|529087436|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702697|NCT02346240|529087437|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702698|NCT02346240|529087438|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
146702699|NCT02346240|529087439|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702700|NCT02346240|529087440|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702701|NCT02346240|529087441|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
146702702|NCT02346240|529087442|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702703|NCT02346240|529087443|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
146702704|NCT02346240|529087444|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
146702705|NCT02346240|529087445|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702706|NCT02346240|529087446|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702707|NCT02346240|529087447|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702708|NCT02346240|529087448|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702709|NCT02346240|529087449|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146776819|NCT02723955|529353648|FG036|Expansion Phase|Physician Decision|0|||
146776820|NCT02723955|529353649|FG037|Expansion Phase|Physician Decision|0|||
146776821|NCT02723955|529353650|FG038|Expansion Phase|Physician Decision|0|||
146776822|NCT02723955|529353651|FG039|Expansion Phase|Physician Decision|0|||
146776823|NCT02723955|529353652|FG040|Expansion Phase|Physician Decision|0|||
146776824|NCT02723955|529353653|FG041|Expansion Phase|Physician Decision|0|||
146776825|NCT02723955|529353654|FG042|Expansion Phase|Physician Decision|0|||
146776826|NCT02723955|529353612|FG000|Expansion Phase|Withdrawal by Subject|0|||
146776827|NCT02723955|529353613|FG001|Expansion Phase|Withdrawal by Subject|0|||
146776828|NCT02723955|529353614|FG002|Expansion Phase|Withdrawal by Subject|0|||
146776829|NCT02723955|529353615|FG003|Expansion Phase|Withdrawal by Subject|0|||
146776830|NCT02723955|529353616|FG004|Expansion Phase|Withdrawal by Subject|0|||
146776831|NCT02723955|529353617|FG005|Expansion Phase|Withdrawal by Subject|0|||
146776832|NCT02723955|529353618|FG006|Expansion Phase|Withdrawal by Subject|0|||
146776833|NCT02723955|529353619|FG007|Expansion Phase|Withdrawal by Subject|0|||
146702710|NCT02346240|529087450|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702711|NCT02346240|529087451|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702712|NCT02346240|529087452|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702713|NCT02346240|529087453|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146702714|NCT02346240|529087430|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702715|NCT02346240|529087431|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702716|NCT02346240|529087432|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702717|NCT02346240|529087433|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702718|NCT02346240|529087434|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702719|NCT02346240|529087435|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702720|NCT02346240|529087436|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702721|NCT02346240|529087437|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702722|NCT02346240|529087438|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702723|NCT02346240|529087439|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
146702724|NCT02346240|529087440|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702725|NCT02346240|529087441|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702726|NCT02346240|529087442|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702727|NCT02346240|529087443|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702728|NCT02346240|529087444|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702729|NCT02346240|529087445|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702730|NCT02346240|529087446|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702731|NCT02346240|529087447|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702732|NCT02346240|529087448|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702733|NCT02346240|529087449|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702734|NCT02346240|529087450|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146776834|NCT02723955|529353620|FG008|Expansion Phase|Withdrawal by Subject|0|||
146776835|NCT02723955|529353621|FG009|Expansion Phase|Withdrawal by Subject|2|||
146933092|NCT03956225|529912602|FG001|Overall Study|Withdrawal by Subject|1|||
146933093|NCT03956225|529912601|FG000|Overall Study|Other Reasons|2|||
146933094|NCT03956225|529912602|FG001|Overall Study|Other Reasons|1|||
146933095|NCT00805545|529912603|FG000|Overall Study|Protocol Violation|3|||
146933096|NCT00805545|529912604|FG001|Overall Study|Protocol Violation|2|||
146933097|NCT00805545|529912603|FG000|Overall Study|Protocol Violation|3|||
146933098|NCT00805545|529912604|FG001|Overall Study|Protocol Violation|1|||
146933099|NCT00643604|529912613|FG000|Overall Study|Death|1|||
146933100|NCT01054976|529912620|FG000|Overall Study|Adverse Event|16|||
146933101|NCT01054976|529912620|FG000|Overall Study|Uncooperative participations to study|7|||
146933102|NCT01054976|529912620|FG000|Overall Study|Withdrawal by Subject|4|||
146933103|NCT01054976|529912620|FG000|Overall Study|Other|8|||
146933104|NCT00377429|529912621|FG000|Overall Study|Withdrawal by Subject|5|||
146933105|NCT00377429|529912621|FG000|Overall Study|Adverse Event|8|||
146933106|NCT00377429|529912621|FG000|Overall Study|Physician Decision|1|||
146933107|NCT00377429|529912621|FG000|Overall Study|Patient non-compliance|1|||
146933108|NCT01871896|529912622|FG000|Overall Study|Lost to Follow-up|1|||
146933109|NCT05691829|529913882|FG000|Overall Study|Physician Decision|2|||
146933110|NCT05691829|529913882|FG000|Overall Study|Eligibility criteria not met|3|||
146933111|NCT00453180|529913883|FG000|Overall Study|Lost to Follow-up|2|||
146933112|NCT00453180|529913884|FG001|Overall Study|Lost to Follow-up|1|||
146933113|NCT00453180|529913883|FG000|Overall Study|Adverse Event|1|||
146933114|NCT00453180|529913884|FG001|Overall Study|Adverse Event|2|||
146933115|NCT03326869|529913889|FG000|Overall Study|Study data has been lost to natural disa|1|||
146933116|NCT03326869|529913890|FG001|Overall Study|Study data has been lost to natural disa|1|||
146933117|NCT01002742|529913893|FG000|Overall Study|Determined to be ineligible|0|||
146933118|NCT01002742|529913894|FG001|Overall Study|Determined to be ineligible|1|||
146933119|NCT03927911|529913895|FG000|Overall Study|problems with eDiary|0|||
146933120|NCT03927911|529913896|FG001|Overall Study|problems with eDiary|1|||
146933121|NCT03927911|529913897|FG002|Overall Study|problems with eDiary|0|||
146933122|NCT03927911|529913898|FG003|Overall Study|problems with eDiary|1|||
146933123|NCT03927911|529913899|FG004|Overall Study|problems with eDiary|0|||
146933124|NCT03927911|529913900|FG005|Overall Study|problems with eDiary|4|||
146933125|NCT03927911|529913895|FG000|Overall Study|Adverse Event|0|||
146933126|NCT03927911|529913896|FG001|Overall Study|Adverse Event|0|||
146933127|NCT03927911|529913897|FG002|Overall Study|Adverse Event|0|||
146933128|NCT03927911|529913898|FG003|Overall Study|Adverse Event|0|||
146933129|NCT03927911|529913899|FG004|Overall Study|Adverse Event|0|||
146933130|NCT03927911|529913900|FG005|Overall Study|Adverse Event|1|||
146933131|NCT03927911|529913895|FG000|Overall Study|not treated -study terminated by sponsor|0|||
146933132|NCT03927911|529913896|FG001|Overall Study|not treated -study terminated by sponsor|1|||
146933133|NCT03927911|529913897|FG002|Overall Study|not treated -study terminated by sponsor|0|||
146702735|NCT02346240|529087451|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702736|NCT02346240|529087452|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146702737|NCT02346240|529087453|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146933134|NCT03927911|529913898|FG003|Overall Study|not treated -study terminated by sponsor|0|||
146933135|NCT03927911|529913899|FG004|Overall Study|not treated -study terminated by sponsor|0|||
146933136|NCT03927911|529913900|FG005|Overall Study|not treated -study terminated by sponsor|0|||
146702738|NCT02346240|529087430|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702739|NCT02346240|529087431|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702740|NCT02346240|529087432|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702741|NCT02346240|529087433|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702742|NCT02346240|529087434|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702743|NCT02346240|529087435|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702744|NCT02346240|529087436|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702745|NCT02346240|529087437|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702746|NCT02346240|529087438|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702747|NCT02346240|529087439|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702748|NCT02346240|529087440|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
146933137|NCT03927911|529913895|FG000|Overall Study|Surgery cancelled|0|||
146933138|NCT03927911|529913896|FG001|Overall Study|Surgery cancelled|0|||
146933139|NCT03927911|529913897|FG002|Overall Study|Surgery cancelled|0|||
146933140|NCT03927911|529913898|FG003|Overall Study|Surgery cancelled|1|||
146933141|NCT03927911|529913899|FG004|Overall Study|Surgery cancelled|0|||
146980995|NCT01393990|530093698|FG013|Overall Study|Withdrawal by Subject|0|||
146980996|NCT01393990|530093699|FG014|Overall Study|Withdrawal by Subject|1|||
146702749|NCT02346240|529087441|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702750|NCT02346240|529087442|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146933142|NCT03927911|529913900|FG005|Overall Study|Surgery cancelled|1|||
146933143|NCT03927911|529913895|FG000|Overall Study|Protocol Violation|0|||
146933144|NCT03927911|529913896|FG001|Overall Study|Protocol Violation|0|||
146933145|NCT03927911|529913897|FG002|Overall Study|Protocol Violation|0|||
146702751|NCT02346240|529087443|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702752|NCT02346240|529087444|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702753|NCT02346240|529087445|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702754|NCT02346240|529087446|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702755|NCT02346240|529087447|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702756|NCT02346240|529087448|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702757|NCT02346240|529087449|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702758|NCT02346240|529087450|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702759|NCT02346240|529087451|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702760|NCT02346240|529087452|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702761|NCT02346240|529087453|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146702762|NCT02346240|529087430|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702763|NCT02346240|529087431|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702764|NCT02346240|529087432|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702765|NCT02346240|529087433|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702766|NCT02346240|529087434|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702767|NCT02346240|529087435|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702768|NCT02346240|529087436|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702769|NCT02346240|529087437|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702770|NCT02346240|529087438|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702771|NCT02346240|529087439|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702772|NCT02346240|529087440|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702773|NCT02346240|529087441|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702774|NCT02346240|529087442|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702775|NCT02346240|529087443|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702776|NCT02346240|529087444|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
146702777|NCT02346240|529087445|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702778|NCT02346240|529087446|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702779|NCT02346240|529087447|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702780|NCT02346240|529087448|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702781|NCT02346240|529087449|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702782|NCT02346240|529087450|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702783|NCT02346240|529087451|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702784|NCT02346240|529087452|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702785|NCT02346240|529087453|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146702786|NCT02346240|529087430|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702787|NCT02346240|529087431|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702788|NCT02346240|529087432|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702789|NCT02346240|529087433|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702790|NCT02346240|529087434|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702791|NCT02346240|529087435|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702792|NCT02346240|529087436|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702793|NCT02346240|529087437|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702794|NCT02346240|529087438|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702795|NCT02346240|529087439|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702796|NCT02346240|529087440|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702797|NCT02346240|529087441|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702798|NCT02346240|529087442|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702799|NCT02346240|529087443|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702800|NCT02346240|529087444|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
146702801|NCT02346240|529087445|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702802|NCT02346240|529087446|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702803|NCT02346240|529087447|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702804|NCT02346240|529087448|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702805|NCT02346240|529087449|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702806|NCT02346240|529087450|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702807|NCT02346240|529087451|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702808|NCT02346240|529087452|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146933146|NCT03927911|529913898|FG003|Overall Study|Protocol Violation|0|||
146702809|NCT02346240|529087453|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146702810|NCT02346240|529087430|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702811|NCT02346240|529087431|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702812|NCT02346240|529087432|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702813|NCT02346240|529087433|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702814|NCT02346240|529087434|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702815|NCT02346240|529087435|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702816|NCT02346240|529087436|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702817|NCT02346240|529087437|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702818|NCT02346240|529087438|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702819|NCT02346240|529087439|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702820|NCT02346240|529087440|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702821|NCT02346240|529087441|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702822|NCT02346240|529087442|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702823|NCT02346240|529087443|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702824|NCT02346240|529087444|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
146702825|NCT02346240|529087445|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702826|NCT02346240|529087446|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702827|NCT02346240|529087447|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702828|NCT02346240|529087448|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702829|NCT02346240|529087449|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702830|NCT02346240|529087450|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702831|NCT02346240|529087451|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702832|NCT02346240|529087452|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702833|NCT02346240|529087453|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146702834|NCT02346240|529087430|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702835|NCT02346240|529087431|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702836|NCT02346240|529087432|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702837|NCT02346240|529087433|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702838|NCT02346240|529087434|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702839|NCT02346240|529087435|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702840|NCT02346240|529087436|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702841|NCT02346240|529087437|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702842|NCT02346240|529087438|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702843|NCT02346240|529087439|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702844|NCT02346240|529087440|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702845|NCT02346240|529087441|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702846|NCT02346240|529087442|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702847|NCT02346240|529087443|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702848|NCT02346240|529087444|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702849|NCT02346240|529087445|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702850|NCT02346240|529087446|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146702851|NCT02346240|529087447|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
146702852|NCT02346240|529087448|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
146702853|NCT02346240|529087449|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
146702854|NCT02346240|529087450|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
146702855|NCT02346240|529087451|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
146702856|NCT02346240|529087452|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
146702857|NCT02346240|529087453|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
146702858|NCT02346240|529087430|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702859|NCT02346240|529087431|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702860|NCT02346240|529087432|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702861|NCT02346240|529087433|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702862|NCT02346240|529087434|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702863|NCT02346240|529087435|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702864|NCT02346240|529087436|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702865|NCT02346240|529087437|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702866|NCT02346240|529087438|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
146933147|NCT03927911|529913899|FG004|Overall Study|Protocol Violation|0|||
146933148|NCT03927911|529913900|FG005|Overall Study|Protocol Violation|1|||
146933149|NCT00562640|529913901|FG000|Overall Study|Death|0|||
146933150|NCT00562640|529913902|FG001|Overall Study|Death|1|||
146702867|NCT02346240|529087439|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702868|NCT02346240|529087440|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702869|NCT02346240|529087441|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702870|NCT02346240|529087442|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702871|NCT02346240|529087443|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702872|NCT02346240|529087444|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702873|NCT02346240|529087445|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702874|NCT02346240|529087446|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702875|NCT02346240|529087447|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702876|NCT02346240|529087448|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
146702877|NCT02346240|529087449|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
146776836|NCT02723955|529353622|FG010|Expansion Phase|Withdrawal by Subject|1|||
146776837|NCT02723955|529353623|FG011|Expansion Phase|Withdrawal by Subject|0|||
146776838|NCT02723955|529353624|FG012|Expansion Phase|Withdrawal by Subject|0|||
146933151|NCT00562640|529913903|FG002|Overall Study|Death|1|||
146933152|NCT00562640|529913904|FG003|Overall Study|Death|0|||
146933153|NCT01412151|529913905|FG000|Week 0 - 306 - Treatment Period|Death|1|||
146933154|NCT01412151|529913905|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
146933155|NCT01412151|529913905|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
146933156|NCT01412151|529913905|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
146933157|NCT03127852|529913906|FG000|Overall Study|Withdrawal by Subject|4|||
146933158|NCT03127852|529913907|FG001|Overall Study|Withdrawal by Subject|1|||
146933159|NCT03127852|529913906|FG000|Overall Study|Death|1|||
146933160|NCT03127852|529913907|FG001|Overall Study|Death|1|||
146933161|NCT01824693|529913908|FG000|Overall Study|Death|0|||
146933162|NCT01824693|529913909|FG001|Overall Study|Death|1|||
146933163|NCT01824693|529913910|FG002|Overall Study|Death|0|||
146933164|NCT01824693|529913908|FG000|Overall Study|Physician Decision|1|||
146933165|NCT01824693|529913909|FG001|Overall Study|Physician Decision|1|||
146933166|NCT01824693|529913910|FG002|Overall Study|Physician Decision|1|||
146933167|NCT01824693|529913908|FG000|Overall Study|Withdrawal by Subject|0|||
146933168|NCT01824693|529913909|FG001|Overall Study|Withdrawal by Subject|0|||
146933169|NCT01824693|529913910|FG002|Overall Study|Withdrawal by Subject|1|||
146933170|NCT01824693|529913908|FG000|Overall Study|Progressive Disease|0|||
146776839|NCT02723955|529353625|FG013|Expansion Phase|Withdrawal by Subject|0|||
146776840|NCT02723955|529353626|FG014|Expansion Phase|Withdrawal by Subject|0|||
146776841|NCT02723955|529353627|FG015|Expansion Phase|Withdrawal by Subject|0|||
146933171|NCT01824693|529913909|FG001|Overall Study|Progressive Disease|5|||
146933172|NCT01824693|529913910|FG002|Overall Study|Progressive Disease|0|||
146933173|NCT01824693|529913908|FG000|Overall Study|Ineligible|0|||
146933174|NCT01824693|529913909|FG001|Overall Study|Ineligible|0|||
146933175|NCT01824693|529913910|FG002|Overall Study|Ineligible|3|||
146933176|NCT01824693|529913908|FG000|Overall Study|No Transplant Planned|0|||
146933177|NCT01824693|529913909|FG001|Overall Study|No Transplant Planned|0|||
146933178|NCT01824693|529913910|FG002|Overall Study|No Transplant Planned|10|||
146933179|NCT02678312|529913911|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
146933180|NCT02678312|529913912|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
146933181|NCT02678312|529913913|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
146933182|NCT02678312|529913914|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
146933183|NCT02678312|529913915|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
146933184|NCT02678312|529913911|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
146933185|NCT02678312|529913912|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
146933186|NCT02678312|529913913|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
146933187|NCT02678312|529913914|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
146933188|NCT02678312|529913915|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
146933189|NCT02678312|529913911|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
146933190|NCT02678312|529913912|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
146933191|NCT02678312|529913913|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
146933192|NCT02678312|529913914|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
146933193|NCT02678312|529913915|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
146933194|NCT02678312|529913911|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
146933195|NCT02678312|529913912|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
146702878|NCT02346240|529087450|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
146776842|NCT02723955|529353628|FG016|Expansion Phase|Withdrawal by Subject|0|||
146776843|NCT02723955|529353629|FG017|Expansion Phase|Withdrawal by Subject|0|||
146933196|NCT02678312|529913913|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
146933197|NCT02678312|529913914|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
146933198|NCT02678312|529913915|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
146933199|NCT02678312|529913911|FG000|Part 2 Double Blind Epoch|Death|0|||
146702879|NCT02346240|529087451|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
146776844|NCT02723955|529353630|FG018|Expansion Phase|Withdrawal by Subject|0|||
146933200|NCT02678312|529913912|FG001|Part 2 Double Blind Epoch|Death|0|||
146933201|NCT02678312|529913913|FG002|Part 2 Double Blind Epoch|Death|0|||
146933202|NCT02678312|529913914|FG003|Part 2 Double Blind Epoch|Death|8|||
146702880|NCT02346240|529087452|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702881|NCT02346240|529087453|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
146702882|NCT02346240|529087430|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702883|NCT02346240|529087431|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702884|NCT02346240|529087432|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702885|NCT02346240|529087433|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702886|NCT02346240|529087434|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702887|NCT02346240|529087435|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702888|NCT02346240|529087436|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702889|NCT02346240|529087437|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702890|NCT02346240|529087438|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702891|NCT02346240|529087439|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702892|NCT02346240|529087440|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702893|NCT02346240|529087441|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702894|NCT02346240|529087442|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702895|NCT02346240|529087443|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702896|NCT02346240|529087444|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702897|NCT02346240|529087445|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702898|NCT02346240|529087446|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702899|NCT02346240|529087447|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702900|NCT02346240|529087448|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
146702901|NCT02346240|529087449|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702902|NCT02346240|529087450|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702903|NCT02346240|529087451|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
146702904|NCT02346240|529087452|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702905|NCT02346240|529087453|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146702906|NCT02346240|529087430|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702907|NCT02346240|529087431|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702908|NCT02346240|529087432|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702909|NCT02346240|529087433|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702910|NCT02346240|529087434|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702911|NCT02346240|529087435|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702912|NCT02346240|529087436|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702913|NCT02346240|529087437|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702914|NCT02346240|529087438|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702915|NCT02346240|529087439|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702916|NCT02346240|529087440|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702917|NCT02346240|529087441|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702918|NCT02346240|529087442|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702919|NCT02346240|529087443|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702920|NCT02346240|529087444|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702921|NCT02346240|529087445|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702922|NCT02346240|529087446|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702923|NCT02346240|529087447|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702924|NCT02346240|529087448|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146933203|NCT02678312|529913915|FG004|Part 2 Double Blind Epoch|Death|12|||
146933204|NCT02678312|529913911|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
146933205|NCT02678312|529913912|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
146933206|NCT02678312|529913913|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
146933207|NCT02678312|529913914|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
146933208|NCT02678312|529913915|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
146933209|NCT02678312|529913911|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
146933210|NCT02678312|529913912|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
146933211|NCT02678312|529913913|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
146933212|NCT02678312|529913914|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
146933213|NCT02678312|529913915|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
146933214|NCT02678312|529913911|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
146933215|NCT02678312|529913912|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
146933216|NCT02678312|529913913|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
146933217|NCT02678312|529913914|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
146933218|NCT02678312|529913915|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
146933219|NCT02591238|529913916|FG000|Overall Study|Pregnancy|1|||
146933220|NCT02591238|529913917|FG001|Overall Study|Pregnancy|0|||
146933221|NCT02591238|529913918|FG002|Overall Study|Pregnancy|0|||
146933222|NCT02591238|529913919|FG003|Overall Study|Pregnancy|0|||
146702925|NCT02346240|529087449|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702926|NCT02346240|529087450|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702927|NCT02346240|529087451|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
146702928|NCT02346240|529087452|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702929|NCT02346240|529087453|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146702930|NCT02346240|529087430|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702931|NCT02346240|529087431|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702932|NCT02346240|529087432|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702933|NCT02346240|529087433|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702934|NCT02346240|529087434|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702935|NCT02346240|529087435|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702936|NCT02346240|529087436|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702937|NCT02346240|529087437|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702938|NCT02346240|529087438|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702939|NCT02346240|529087439|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702940|NCT02346240|529087440|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702941|NCT02346240|529087441|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702942|NCT02346240|529087442|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702943|NCT02346240|529087443|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702944|NCT02346240|529087444|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702945|NCT02346240|529087445|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702946|NCT02346240|529087446|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702947|NCT02346240|529087447|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
146702948|NCT02346240|529087448|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
146702949|NCT02346240|529087449|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
146702950|NCT02346240|529087450|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146702951|NCT02346240|529087451|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
146702952|NCT02346240|529087452|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
146702953|NCT02346240|529087453|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
146702954|NCT02346240|529087430|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702955|NCT02346240|529087431|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702956|NCT02346240|529087432|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702957|NCT02346240|529087433|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702958|NCT02346240|529087434|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702959|NCT02346240|529087435|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702960|NCT02346240|529087436|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702961|NCT02346240|529087437|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702962|NCT02346240|529087438|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702963|NCT02346240|529087439|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702964|NCT02346240|529087440|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702965|NCT02346240|529087441|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702966|NCT02346240|529087442|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702967|NCT02346240|529087443|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702968|NCT02346240|529087444|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702969|NCT02346240|529087445|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702970|NCT02346240|529087446|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702971|NCT02346240|529087447|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702972|NCT02346240|529087448|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
146702973|NCT02346240|529087449|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
146702974|NCT02346240|529087450|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146702975|NCT02346240|529087451|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
146702976|NCT02346240|529087452|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
146702977|NCT02346240|529087453|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
146702978|NCT02346240|529087430|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702979|NCT02346240|529087431|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702980|NCT02346240|529087432|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146776845|NCT02723955|529353631|FG019|Expansion Phase|Withdrawal by Subject|0|||
146776846|NCT02723955|529353632|FG020|Expansion Phase|Withdrawal by Subject|0|||
146933223|NCT02591238|529913916|FG000|Overall Study|Withdrawal by Subject|0|||
146933224|NCT02591238|529913917|FG001|Overall Study|Withdrawal by Subject|0|||
146933225|NCT02591238|529913918|FG002|Overall Study|Withdrawal by Subject|0|||
146933226|NCT02591238|529913919|FG003|Overall Study|Withdrawal by Subject|1|||
146702981|NCT02346240|529087433|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702982|NCT02346240|529087434|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146933227|NCT02591238|529913916|FG000|Overall Study|influenza|0|||
146933228|NCT02591238|529913917|FG001|Overall Study|influenza|0|||
146702983|NCT02346240|529087435|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702984|NCT02346240|529087436|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702985|NCT02346240|529087437|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702986|NCT02346240|529087438|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702987|NCT02346240|529087439|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702988|NCT02346240|529087440|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702989|NCT02346240|529087441|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702990|NCT02346240|529087442|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702991|NCT02346240|529087443|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702992|NCT02346240|529087444|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702993|NCT02346240|529087445|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702994|NCT02346240|529087446|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702995|NCT02346240|529087447|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702996|NCT02346240|529087448|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
146702997|NCT02346240|529087449|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702998|NCT02346240|529087450|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146702999|NCT02346240|529087451|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
146703000|NCT02346240|529087452|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
146703001|NCT02346240|529087453|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
146933229|NCT02591238|529913918|FG002|Overall Study|influenza|0|||
146703002|NCT02346240|529087430|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703003|NCT02346240|529087431|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703004|NCT02346240|529087432|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703005|NCT02346240|529087433|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703006|NCT02346240|529087434|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146933230|NCT02591238|529913919|FG003|Overall Study|influenza|1|||
146933231|NCT02591238|529913916|FG000|Overall Study|personal circumstances|0|||
146933232|NCT02591238|529913917|FG001|Overall Study|personal circumstances|0|||
146933233|NCT02591238|529913918|FG002|Overall Study|personal circumstances|0|||
146933234|NCT02591238|529913919|FG003|Overall Study|personal circumstances|1|||
146933235|NCT02591238|529913916|FG000|Overall Study|personal circumstances|0|||
146933236|NCT02591238|529913917|FG001|Overall Study|personal circumstances|1|||
146703007|NCT02346240|529087435|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703008|NCT02346240|529087436|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703009|NCT02346240|529087437|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703010|NCT02346240|529087438|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703011|NCT02346240|529087439|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703012|NCT02346240|529087440|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703013|NCT02346240|529087441|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703014|NCT02346240|529087442|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703015|NCT02346240|529087443|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703016|NCT02346240|529087444|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703017|NCT02346240|529087445|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703018|NCT02346240|529087446|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703019|NCT02346240|529087447|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703020|NCT02346240|529087448|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
146703021|NCT02346240|529087449|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703022|NCT02346240|529087450|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703023|NCT02346240|529087451|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703024|NCT02346240|529087452|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703025|NCT02346240|529087453|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146703026|NCT01455012|529087457|FG000|Overall Study|Adverse Event|0|||
146703027|NCT01455012|529087458|FG001|Overall Study|Adverse Event|2|||
146703028|NCT01455012|529087457|FG000|Overall Study|Lack of Efficacy|6|||
146703029|NCT01455012|529087458|FG001|Overall Study|Lack of Efficacy|1|||
146703030|NCT01455012|529087457|FG000|Overall Study|Withdrawal by Subject|3|||
146703031|NCT01455012|529087458|FG001|Overall Study|Withdrawal by Subject|1|||
146703032|NCT01455012|529087457|FG000|Overall Study|Unknown reason|2|||
146933237|NCT02591238|529913918|FG002|Overall Study|personal circumstances|0|||
146933238|NCT02591238|529913919|FG003|Overall Study|personal circumstances|0|||
146933239|NCT00656084|529913920|FG000|Overall Study|Adverse Event|4|||
146933240|NCT00656084|529913920|FG000|Overall Study|Withdrawal by Subject|1|||
146980997|NCT01393990|530093700|FG015|Overall Study|Withdrawal by Subject|1|||
146933241|NCT00656084|529913920|FG000|Overall Study|Patient Request|1|||
146980998|NCT01393990|530093701|FG016|Overall Study|Withdrawal by Subject|0|||
146933242|NCT00656084|529913920|FG000|Overall Study|Investigator Request|1|||
146933243|NCT00525785|529913924|FG000|Overall Study|Withdrawal by Subject|1|||
146933244|NCT00525785|529913924|FG000|Overall Study|Lack of Efficacy|1|||
146933245|NCT00525785|529913924|FG000|Overall Study|Physician Decision|1|||
146933246|NCT03628599|529913925|FG000|Overall Study|Adverse Event|0|||
146933247|NCT03628599|529913926|FG001|Overall Study|Adverse Event|1|||
146933248|NCT01624506|529913927|FG000|Overall Study|Lost to Follow-up|29|||
146933249|NCT01624506|529913928|FG001|Overall Study|Lost to Follow-up|15|||
146933250|NCT01624506|529913927|FG000|Overall Study|Withdrawal by Subject|9|||
146933251|NCT01624506|529913928|FG001|Overall Study|Withdrawal by Subject|2|||
146933252|NCT01624506|529913927|FG000|Overall Study|Death|1|||
146933253|NCT01624506|529913928|FG001|Overall Study|Death|0|||
146933254|NCT01624506|529913927|FG000|Overall Study|LINX explants|23|||
146933255|NCT01624506|529913928|FG001|Overall Study|LINX explants|0|||
146933256|NCT01624506|529913927|FG000|Overall Study|Adverse Event|3|||
146933257|NCT01624506|529913928|FG001|Overall Study|Adverse Event|0|||
146933258|NCT00132314|529913934|FG000|Overall Study|Lost to Follow-up|70|||
146933259|NCT00132314|529913935|FG001|Overall Study|Lost to Follow-up|62|||
146933260|NCT00132314|529913934|FG000|Overall Study|Lacked SSN|1|||
146933261|NCT00132314|529913935|FG001|Overall Study|Lacked SSN|3|||
146933262|NCT00132314|529913934|FG000|Overall Study|Refused intervention at baseline|2|||
146933263|NCT00132314|529913935|FG001|Overall Study|Refused intervention at baseline|7|||
146933264|NCT03939637|529913947|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
146933265|NCT03939637|529913948|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
146933266|NCT03939637|529913947|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
146933267|NCT03939637|529913948|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
146933268|NCT04325906|529913949|FG000|Overall Study|Withdrawal by Subject|2|||
146933269|NCT04325906|529913950|FG001|Overall Study|Withdrawal by Subject|0|||
146933270|NCT02016898|529913951|FG000|Overall Study|Death|1|||
146933271|NCT02016898|529913952|FG001|Overall Study|Death|1|||
146933272|NCT02016898|529913951|FG000|Overall Study|Lost to Follow-up|4|||
146933273|NCT02016898|529913952|FG001|Overall Study|Lost to Follow-up|4|||
146933274|NCT00992186|529913957|FG000|Overall Study|Withdrawal by Subject|2|||
146933275|NCT00992186|529913957|FG000|Overall Study|Protocol Violation|1|||
146933276|NCT00992186|529913957|FG000|Overall Study|Physician Decision|1|||
146933277|NCT00992186|529913957|FG000|Overall Study|Adverse Event|9|||
146933278|NCT00992186|529913957|FG000|Overall Study|Progressive Disease|30|||
146933279|NCT00992186|529913957|FG000|Overall Study|Refusal To Receive Study Agent|3|||
146933280|NCT00973622|529913960|FG000|Overall Study|did not attend MRI|14|||
146933281|NCT00973622|529913961|FG001|Overall Study|did not attend MRI|3|||
146933282|NCT00973622|529913960|FG000|Overall Study|did not pass MRI screen|6|||
146933283|NCT00973622|529913961|FG001|Overall Study|did not pass MRI screen|0|||
146933284|NCT00973622|529913960|FG000|Overall Study|did not complete rTMS sessions|11|||
146933285|NCT00973622|529913961|FG001|Overall Study|did not complete rTMS sessions|2|||
146933286|NCT03074149|529913966|FG000|Overall Study|Reason unknown|22|||
146933287|NCT03074149|529913967|FG001|Overall Study|Reason unknown|35|||
146933288|NCT03074149|529913966|FG000|Overall Study|Death|10|||
146933289|NCT03074149|529913967|FG001|Overall Study|Death|45|||
146933290|NCT02855450|529913970|FG000|Overall Study|Adverse Event|1|||
146933291|NCT02855450|529913971|FG001|Overall Study|Adverse Event|0|||
146933292|NCT02855450|529913970|FG000|Overall Study|Lost to Follow-up|4|||
146933293|NCT02855450|529913971|FG001|Overall Study|Lost to Follow-up|0|||
146933294|NCT05159362|529913972|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
146933295|NCT05159362|529913973|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
146980999|NCT01393990|530093702|FG017|Overall Study|Withdrawal by Subject|0|||
146703033|NCT01455012|529087458|FG001|Overall Study|Unknown reason|0|||
146703034|NCT04552587|529087459|FG000|Overall Study|Lost to Follow-up|4|||
146703035|NCT01822132|529087460|FG000|Overall Study|Lost to Follow-up|4|||
146703036|NCT01822132|529087461|FG001|Overall Study|Lost to Follow-up|2|||
146703037|NCT01393743|529087462|FG000|Core Study|Adverse Event|5|||
146703038|NCT01393743|529087463|FG001|Core Study|Adverse Event|9|||
146703039|NCT01393743|529087464|FG002|Core Study|Adverse Event|0|||
146703040|NCT01393743|529087462|FG000|Core Study|Lost to Follow-up|1|||
146933296|NCT05159362|529913974|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
146933297|NCT01324622|529913975|FG000|Overall Study|Lost to Follow-up|7|||
146933298|NCT01324622|529913976|FG001|Overall Study|Lost to Follow-up|7|||
146933299|NCT01324622|529913975|FG000|Overall Study|Death|1|||
146933300|NCT01324622|529913976|FG001|Overall Study|Death|0|||
146933301|NCT01324622|529913975|FG000|Overall Study|Lack of Efficacy|1|||
146933302|NCT01324622|529913976|FG001|Overall Study|Lack of Efficacy|0|||
146933303|NCT00618449|529913977|FG000|Overall Study|Lost to Follow-up|98|||
146933304|NCT00618449|529913978|FG001|Overall Study|Lost to Follow-up|110|||
146933305|NCT02219087|529913979|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
146933306|NCT02219087|529913980|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
146933307|NCT02815293|529913983|FG000|Overall Study|Study termination by sponsor|10|||
146703041|NCT01393743|529087463|FG001|Core Study|Lost to Follow-up|1|||
146933308|NCT02815293|529913984|FG001|Overall Study|Study termination by sponsor|7|||
146933309|NCT02815293|529913985|FG002|Overall Study|Study termination by sponsor|0|||
146933310|NCT02815293|529913983|FG000|Overall Study|Participants not randomized|0|||
146933311|NCT02815293|529913984|FG001|Overall Study|Participants not randomized|0|||
146703042|NCT01393743|529087464|FG002|Core Study|Lost to Follow-up|0|||
146703043|NCT01393743|529087462|FG000|Core Study|Participant's Choice|2|||
146703044|NCT01393743|529087463|FG001|Core Study|Participant's Choice|3|||
146703045|NCT01393743|529087464|FG002|Core Study|Participant's Choice|0|||
146703046|NCT01393743|529087462|FG000|Core Study|Inadequate therapeutic effect|2|||
146703047|NCT01393743|529087463|FG001|Core Study|Inadequate therapeutic effect|0|||
146703048|NCT01393743|529087464|FG002|Core Study|Inadequate therapeutic effect|0|||
146703049|NCT01393743|529087462|FG000|Extension Phase|Adverse Event|0|||
146703050|NCT01393743|529087463|FG001|Extension Phase|Adverse Event|0|||
146703051|NCT01393743|529087464|FG002|Extension Phase|Adverse Event|12|||
146703052|NCT01393743|529087462|FG000|Extension Phase|Lost to Follow-up|0|||
146703053|NCT01393743|529087463|FG001|Extension Phase|Lost to Follow-up|0|||
146703054|NCT01393743|529087464|FG002|Extension Phase|Lost to Follow-up|2|||
146703055|NCT01393743|529087462|FG000|Extension Phase|Participant choice|0|||
146703056|NCT01393743|529087463|FG001|Extension Phase|Participant choice|0|||
146703057|NCT01393743|529087464|FG002|Extension Phase|Participant choice|16|||
146703058|NCT01393743|529087462|FG000|Extension Phase|Inadequate therapeutic effect|0|||
146703059|NCT01393743|529087463|FG001|Extension Phase|Inadequate therapeutic effect|0|||
146703060|NCT01393743|529087464|FG002|Extension Phase|Inadequate therapeutic effect|7|||
146703061|NCT01393743|529087462|FG000|Extension Phase|Withdrawal by Subject|0|||
146703062|NCT01393743|529087463|FG001|Extension Phase|Withdrawal by Subject|0|||
146703063|NCT01393743|529087464|FG002|Extension Phase|Withdrawal by Subject|8|||
146703064|NCT01393743|529087462|FG000|Extension Phase|Pregnancy|0|||
146703065|NCT01393743|529087463|FG001|Extension Phase|Pregnancy|0|||
146703066|NCT01393743|529087464|FG002|Extension Phase|Pregnancy|1|||
146703067|NCT01393743|529087462|FG000|Extension Phase|Other|0|||
146703068|NCT01393743|529087463|FG001|Extension Phase|Other|0|||
146703069|NCT01393743|529087464|FG002|Extension Phase|Other|14|||
146703070|NCT01723228|529087466|FG000|Overall Study|Adverse Event|2|||
146703071|NCT01723228|529087467|FG001|Overall Study|Adverse Event|6|||
146703072|NCT01723228|529087466|FG000|Overall Study|Withdrawal by Subject|2|||
146703073|NCT01723228|529087467|FG001|Overall Study|Withdrawal by Subject|1|||
146703074|NCT01723228|529087466|FG000|Overall Study|Protocol Violation|0|||
146703075|NCT01723228|529087467|FG001|Overall Study|Protocol Violation|2|||
146703076|NCT01723228|529087466|FG000|Overall Study|Lost to Follow-up|2|||
146703077|NCT01723228|529087467|FG001|Overall Study|Lost to Follow-up|1|||
146703078|NCT01723228|529087466|FG000|Overall Study|Other|2|||
146703079|NCT01723228|529087467|FG001|Overall Study|Other|1|||
146703080|NCT01806896|529087468|FG000|Overall Study|Adverse Event|2|||
146703081|NCT01806896|529087469|FG001|Overall Study|Adverse Event|0|||
146703082|NCT01806896|529087468|FG000|Overall Study|Other|1|||
146703083|NCT01806896|529087469|FG001|Overall Study|Other|0|||
146703084|NCT02434770|529087470|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
146703085|NCT02434770|529087471|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
146703086|NCT02434770|529087472|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
146703087|NCT02434770|529087470|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
146703088|NCT02434770|529087471|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
146703089|NCT02434770|529087472|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
146703090|NCT02434770|529087470|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
146703091|NCT02434770|529087471|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
146703092|NCT02434770|529087472|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
146703093|NCT02434770|529087470|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
146703094|NCT02434770|529087471|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
146703095|NCT02434770|529087472|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
146703096|NCT02434770|529087470|FG000|Week 1 to Week 18|Death|1|||
146703097|NCT02434770|529087471|FG001|Week 1 to Week 18|Death|0|||
146703098|NCT02434770|529087472|FG002|Week 1 to Week 18|Death|0|||
146703099|NCT02434770|529087470|FG000|Week 18 to Week|Lost to Follow-up|2|||
146703100|NCT02434770|529087471|FG001|Week 18 to Week|Lost to Follow-up|2|||
146703101|NCT02434770|529087472|FG002|Week 18 to Week|Lost to Follow-up|1|||
146703102|NCT02434770|529087470|FG000|Week 18 to Week|Withdrawal by Subject|0|||
146703103|NCT02434770|529087471|FG001|Week 18 to Week|Withdrawal by Subject|0|||
146703104|NCT02434770|529087472|FG002|Week 18 to Week|Withdrawal by Subject|2|||
146703105|NCT02434770|529087470|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
146776847|NCT02723955|529353633|FG021|Expansion Phase|Withdrawal by Subject|0|||
146703106|NCT02434770|529087471|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
146703107|NCT02434770|529087472|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
146703108|NCT00660348|529087473|FG000|Overall Study|Withdrawal by Subject|1|||
146776848|NCT02723955|529353634|FG022|Expansion Phase|Withdrawal by Subject|0|||
146933312|NCT02815293|529913985|FG002|Overall Study|Participants not randomized|18|||
146703109|NCT00660348|529087474|FG001|Overall Study|Withdrawal by Subject|0|||
146703110|NCT01282424|529087480|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
146703111|NCT01282424|529087480|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
146703112|NCT01282424|529087480|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
146933313|NCT02815293|529913983|FG000|Overall Study|Adverse Event|0|||
146933314|NCT02815293|529913984|FG001|Overall Study|Adverse Event|1|||
146933315|NCT02815293|529913985|FG002|Overall Study|Adverse Event|0|||
146933316|NCT02431468|529913986|FG000|Overall Study|Adverse Event|2|||
146933317|NCT02431468|529913987|FG001|Overall Study|Adverse Event|4|||
146933318|NCT02431468|529913988|FG002|Overall Study|Adverse Event|5|||
146933319|NCT02431468|529913986|FG000|Overall Study|Withdrawal by Subject|4|||
146933320|NCT02431468|529913987|FG001|Overall Study|Withdrawal by Subject|12|||
146933321|NCT02431468|529913988|FG002|Overall Study|Withdrawal by Subject|2|||
146933322|NCT02431468|529913986|FG000|Overall Study|noncompliance, investigator termination,|2|||
146933323|NCT02431468|529913987|FG001|Overall Study|noncompliance, investigator termination,|2|||
146933324|NCT02431468|529913988|FG002|Overall Study|noncompliance, investigator termination,|2|||
146776849|NCT02723955|529353635|FG023|Expansion Phase|Withdrawal by Subject|0|||
146776850|NCT02723955|529353636|FG024|Expansion Phase|Withdrawal by Subject|0|||
146776851|NCT02723955|529353637|FG025|Expansion Phase|Withdrawal by Subject|0|||
146703113|NCT01282424|529087480|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
146776852|NCT02723955|529353638|FG026|Expansion Phase|Withdrawal by Subject|0|||
146776853|NCT02723955|529353639|FG027|Expansion Phase|Withdrawal by Subject|0|||
146776854|NCT02723955|529353640|FG028|Expansion Phase|Withdrawal by Subject|0|||
146776855|NCT02723955|529353641|FG029|Expansion Phase|Withdrawal by Subject|0|||
146776856|NCT02723955|529353642|FG030|Expansion Phase|Withdrawal by Subject|8|||
146776857|NCT02723955|529353643|FG031|Expansion Phase|Withdrawal by Subject|4|||
146776858|NCT02723955|529353644|FG032|Expansion Phase|Withdrawal by Subject|0|||
146933325|NCT00006604|529913991|FG000|Overall Study|Met study objective - no further FU|1|||
146703114|NCT01282424|529087480|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
146703115|NCT01282424|529087480|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
146703116|NCT01282424|529087480|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
146933326|NCT00006604|529913992|FG001|Overall Study|Met study objective - no further FU|0|||
146933327|NCT00006604|529913993|FG002|Overall Study|Met study objective - no further FU|0|||
146933328|NCT00006604|529913994|FG003|Overall Study|Met study objective - no further FU|0|||
146933329|NCT00006604|529913995|FG004|Overall Study|Met study objective - no further FU|0|||
146933330|NCT00006604|529913996|FG005|Overall Study|Met study objective - no further FU|0|||
146933331|NCT00006604|529913997|FG006|Overall Study|Met study objective - no further FU|0|||
146933332|NCT00006604|529913998|FG007|Overall Study|Met study objective - no further FU|0|||
146933333|NCT00006604|529913999|FG008|Overall Study|Met study objective - no further FU|0|||
146933334|NCT00006604|529914000|FG009|Overall Study|Met study objective - no further FU|0|||
146933335|NCT00006604|529914001|FG010|Overall Study|Met study objective - no further FU|0|||
146933336|NCT00006604|529914002|FG011|Overall Study|Met study objective - no further FU|0|||
146933337|NCT00006604|529914003|FG012|Overall Study|Met study objective - no further FU|0|||
146933338|NCT00006604|529914004|FG013|Overall Study|Met study objective - no further FU|0|||
146933339|NCT00006604|529914005|FG014|Overall Study|Met study objective - no further FU|1|||
146933340|NCT00006604|529914006|FG015|Overall Study|Met study objective - no further FU|1|||
146933341|NCT00006604|529914007|FG016|Overall Study|Met study objective - no further FU|0|||
146933342|NCT00006604|529913991|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
146933343|NCT00006604|529913992|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
146933344|NCT00006604|529913993|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
146703117|NCT01282424|529087480|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
146703118|NCT00528528|529087481|FG000|Overall Study|Lost to Follow-up|0|||
146703119|NCT00528528|529087482|FG001|Overall Study|Lost to Follow-up|0|||
146703120|NCT00528528|529087483|FG002|Overall Study|Lost to Follow-up|1|||
146703121|NCT00528528|529087484|FG003|Overall Study|Lost to Follow-up|1|||
146703122|NCT00528528|529087481|FG000|Overall Study|Ineligible to continue the trial|0|||
146703123|NCT00528528|529087482|FG001|Overall Study|Ineligible to continue the trial|0|||
146703124|NCT00528528|529087483|FG002|Overall Study|Ineligible to continue the trial|0|||
146703125|NCT00528528|529087484|FG003|Overall Study|Ineligible to continue the trial|1|||
146933345|NCT00006604|529913994|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
146933346|NCT00006604|529913995|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
146933347|NCT00006604|529913996|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
146933348|NCT00006604|529913997|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
146933349|NCT00006604|529913998|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
146933350|NCT00006604|529913999|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
146933351|NCT00006604|529914000|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
146933352|NCT00006604|529914001|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
146776859|NCT02723955|529353645|FG033|Expansion Phase|Withdrawal by Subject|0|||
146776860|NCT02723955|529353646|FG034|Expansion Phase|Withdrawal by Subject|0|||
146776861|NCT02723955|529353647|FG035|Expansion Phase|Withdrawal by Subject|1|||
146933353|NCT00006604|529914002|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
146933354|NCT00006604|529914003|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
146933355|NCT00006604|529914004|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
146703126|NCT00528528|529087481|FG000|Overall Study|Other|0|||
146703127|NCT00528528|529087482|FG001|Overall Study|Other|1|||
146703128|NCT00528528|529087483|FG002|Overall Study|Other|0|||
146703129|NCT00528528|529087484|FG003|Overall Study|Other|0|||
146703130|NCT00528528|529087481|FG000|Overall Study|Withdrawal by Subject|3|||
146703131|NCT00528528|529087482|FG001|Overall Study|Withdrawal by Subject|2|||
146703132|NCT00528528|529087483|FG002|Overall Study|Withdrawal by Subject|1|||
146703133|NCT00528528|529087484|FG003|Overall Study|Withdrawal by Subject|1|||
146703134|NCT00528528|529087481|FG000|Overall Study|Ongoing participant|0|||
146703135|NCT00528528|529087482|FG001|Overall Study|Ongoing participant|0|||
146703136|NCT00528528|529087483|FG002|Overall Study|Ongoing participant|1|||
146703137|NCT00528528|529087484|FG003|Overall Study|Ongoing participant|0|||
146703138|NCT03508219|529087485|FG000|Overall Study|Death|2|||
146703139|NCT03508219|529087485|FG000|Overall Study|Withdrawal by Subject|1|||
146703140|NCT03508219|529087485|FG000|Overall Study|Lost to Follow-up|4|||
146703141|NCT03508219|529087485|FG000|Overall Study|Missed visit|2|||
146703142|NCT04466891|529087486|FG000|Overall Study|Death|60|||
146703143|NCT04466891|529087487|FG001|Overall Study|Death|6|||
146703144|NCT04466891|529087486|FG000|Overall Study|Withdrawal by Subject|8|||
146703145|NCT04466891|529087487|FG001|Overall Study|Withdrawal by Subject|1|||
146703146|NCT04466891|529087486|FG000|Overall Study|Study terminated by sponsor|5|||
146703147|NCT04466891|529087487|FG001|Overall Study|Study terminated by sponsor|0|||
146703148|NCT04466891|529087486|FG000|Overall Study|Lost to Follow-up|2|||
146703149|NCT04466891|529087487|FG001|Overall Study|Lost to Follow-up|0|||
146703150|NCT04466891|529087486|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
146703151|NCT04466891|529087487|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
146703152|NCT00445328|529087488|FG000|Overall Study|Death|0|||
146703153|NCT00445328|529087489|FG001|Overall Study|Death|1|||
146703154|NCT00445328|529087488|FG000|Overall Study|Adverse Event|0|||
146703155|NCT00445328|529087489|FG001|Overall Study|Adverse Event|3|||
146703156|NCT00445328|529087488|FG000|Overall Study|Other|0|||
146703157|NCT00445328|529087489|FG001|Overall Study|Other|2|||
146703158|NCT00445328|529087488|FG000|Overall Study|Withdrawal by Subject|2|||
146703159|NCT00445328|529087489|FG001|Overall Study|Withdrawal by Subject|0|||
146703160|NCT00445328|529087488|FG000|Overall Study|Protocol Violation|1|||
146703161|NCT00445328|529087489|FG001|Overall Study|Protocol Violation|0|||
146703162|NCT00316199|529087490|FG000|Overall Study|Adverse Event|2|||
146703163|NCT00316199|529087490|FG000|Overall Study|Death|8|||
146703164|NCT00316199|529087490|FG000|Overall Study|Lost to Follow-up|2|||
146703165|NCT00590954|529087491|FG000|Overall Study|Inevaluable|2|||
146703166|NCT02782949|529087493|FG000|Overall Study|Protocol Violation|1|||
146703167|NCT02782949|529087494|FG001|Overall Study|Protocol Violation|0|||
146703168|NCT02782949|529087493|FG000|Overall Study|Withdrawal by Subject|0|||
146703169|NCT02782949|529087494|FG001|Overall Study|Withdrawal by Subject|1|||
146703170|NCT03316872|529087495|FG000|Overall Study|Death|1|||
146703171|NCT04074317|529087498|FG000|Third Period|Withdrawal by Subject|0|||
146703172|NCT04074317|529087499|FG001|Third Period|Withdrawal by Subject|0|||
146703173|NCT04074317|529087500|FG002|Third Period|Withdrawal by Subject|0|||
146703174|NCT04074317|529087501|FG003|Third Period|Withdrawal by Subject|1|||
146703175|NCT04074317|529087502|FG004|Third Period|Withdrawal by Subject|0|||
146933356|NCT00006604|529914005|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
146933357|NCT00006604|529914006|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
146933358|NCT00006604|529914007|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
146933359|NCT00006604|529913991|FG000|Overall Study|Death|0|||
146933360|NCT00006604|529913992|FG001|Overall Study|Death|0|||
146933361|NCT00006604|529913993|FG002|Overall Study|Death|0|||
146933362|NCT00006604|529913994|FG003|Overall Study|Death|0|||
146933363|NCT00006604|529913995|FG004|Overall Study|Death|0|||
146933364|NCT00006604|529913996|FG005|Overall Study|Death|0|||
146933365|NCT00006604|529913997|FG006|Overall Study|Death|0|||
146933366|NCT00006604|529913998|FG007|Overall Study|Death|0|||
146933367|NCT00006604|529913999|FG008|Overall Study|Death|0|||
146933368|NCT00006604|529914000|FG009|Overall Study|Death|1|||
146703176|NCT04074317|529087503|FG005|Third Period|Withdrawal by Subject|0|||
146703177|NCT06023394|529087504|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
146703178|NCT06023394|529087505|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
146703179|NCT06023394|529087504|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
146703180|NCT06023394|529087505|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
146703181|NCT06023394|529087504|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
146703182|NCT06023394|529087505|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
146703183|NCT06023394|529087504|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
146703184|NCT06023394|529087505|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
146933369|NCT00006604|529914001|FG010|Overall Study|Death|1|||
146933370|NCT00006604|529914002|FG011|Overall Study|Death|1|||
146933371|NCT00006604|529914003|FG012|Overall Study|Death|0|||
146703185|NCT01101841|529089073|FG000|Overall Study|Adverse Event|15|||
146703186|NCT01101841|529089074|FG001|Overall Study|Adverse Event|15|||
146933372|NCT00006604|529914004|FG013|Overall Study|Death|0|||
146703187|NCT01101841|529089073|FG000|Overall Study|Lost to Follow-up|9|||
146703188|NCT01101841|529089074|FG001|Overall Study|Lost to Follow-up|3|||
146703189|NCT01101841|529089073|FG000|Overall Study|Withdrawal by Subject|21|||
146703190|NCT01101841|529089074|FG001|Overall Study|Withdrawal by Subject|40|||
146703191|NCT01101841|529089073|FG000|Overall Study|Protocol Violation|1|||
146703192|NCT01101841|529089074|FG001|Overall Study|Protocol Violation|1|||
146703193|NCT01101841|529089073|FG000|Overall Study|Physician Decision|0|||
146703194|NCT01101841|529089074|FG001|Overall Study|Physician Decision|2|||
146703195|NCT01101841|529089073|FG000|Overall Study|Lack of Efficacy|0|||
146933373|NCT00006604|529914005|FG014|Overall Study|Death|0|||
146933374|NCT00006604|529914006|FG015|Overall Study|Death|0|||
146933375|NCT00006604|529914007|FG016|Overall Study|Death|0|||
146933376|NCT00006604|529913991|FG000|Overall Study|Severe debilitation, unable to continue|0|||
146933377|NCT00006604|529913992|FG001|Overall Study|Severe debilitation, unable to continue|0|||
146933378|NCT00006604|529913993|FG002|Overall Study|Severe debilitation, unable to continue|0|||
146933379|NCT00006604|529913994|FG003|Overall Study|Severe debilitation, unable to continue|0|||
146933380|NCT00006604|529913995|FG004|Overall Study|Severe debilitation, unable to continue|0|||
146933381|NCT00006604|529913996|FG005|Overall Study|Severe debilitation, unable to continue|0|||
146933382|NCT00006604|529913997|FG006|Overall Study|Severe debilitation, unable to continue|3|||
146933383|NCT00006604|529913998|FG007|Overall Study|Severe debilitation, unable to continue|0|||
146933384|NCT00006604|529913999|FG008|Overall Study|Severe debilitation, unable to continue|0|||
146933385|NCT00006604|529914000|FG009|Overall Study|Severe debilitation, unable to continue|5|||
146933386|NCT00006604|529914001|FG010|Overall Study|Severe debilitation, unable to continue|0|||
146933387|NCT00006604|529914002|FG011|Overall Study|Severe debilitation, unable to continue|2|||
146933388|NCT00006604|529914003|FG012|Overall Study|Severe debilitation, unable to continue|1|||
146933389|NCT00006604|529914004|FG013|Overall Study|Severe debilitation, unable to continue|0|||
146933390|NCT00006604|529914005|FG014|Overall Study|Severe debilitation, unable to continue|2|||
146933391|NCT00006604|529914006|FG015|Overall Study|Severe debilitation, unable to continue|0|||
146933392|NCT00006604|529914007|FG016|Overall Study|Severe debilitation, unable to continue|0|||
146933393|NCT00006604|529913991|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
146933394|NCT00006604|529913992|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
146933395|NCT00006604|529913993|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
146933396|NCT00006604|529913994|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
146933397|NCT00006604|529913995|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
146933398|NCT00006604|529913996|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
146933399|NCT00006604|529913997|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
146933400|NCT00006604|529913998|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
146933401|NCT00006604|529913999|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
146933402|NCT00006604|529914000|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
146933403|NCT00006604|529914001|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
146933404|NCT00006604|529914002|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
146933405|NCT00006604|529914003|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
146933406|NCT00006604|529914004|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
146933407|NCT00006604|529914005|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
146933408|NCT00006604|529914006|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
146703196|NCT01101841|529089074|FG001|Overall Study|Lack of Efficacy|2|||
146703197|NCT01101841|529089073|FG000|Overall Study|Other|0|||
146703198|NCT01101841|529089074|FG001|Overall Study|Other|1|||
146703199|NCT01101841|529089073|FG000|Overall Study|Suicidality Tracking Scale|3|||
146703200|NCT01101841|529089074|FG001|Overall Study|Suicidality Tracking Scale|1|||
146703201|NCT01101841|529089073|FG000|Overall Study|Eligibility Criteria|1|||
146703202|NCT01101841|529089074|FG001|Overall Study|Eligibility Criteria|2|||
146703203|NCT03756558|529089077|FG000|Overall Study|Death|1|||
146703204|NCT03756558|529089077|FG000|Overall Study|Lost to Follow-up|2|||
146703205|NCT03756558|529089077|FG000|Overall Study|Withdrawal by Subject|2|||
146703206|NCT02896400|529089079|FG000|1 Month Follow-up|Lost to Follow-up|7|||
146703207|NCT02896400|529089080|FG001|1 Month Follow-up|Lost to Follow-up|7|||
146703208|NCT02896400|529089081|FG002|1 Month Follow-up|Lost to Follow-up|5|||
146703209|NCT02896400|529089082|FG003|1 Month Follow-up|Lost to Follow-up|8|||
146703210|NCT02896400|529089083|FG004|1 Month Follow-up|Lost to Follow-up|9|||
146703211|NCT02896400|529089084|FG005|1 Month Follow-up|Lost to Follow-up|6|||
146703212|NCT02896400|529089085|FG006|1 Month Follow-up|Lost to Follow-up|5|||
146933409|NCT00006604|529914007|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
146933410|NCT00006604|529913991|FG000|Overall Study|Site closing|0|||
146703213|NCT02896400|529089086|FG007|1 Month Follow-up|Lost to Follow-up|6|||
146703214|NCT02896400|529089087|FG008|1 Month Follow-up|Lost to Follow-up|4|||
146933411|NCT00006604|529913992|FG001|Overall Study|Site closing|0|||
146703215|NCT02896400|529089088|FG009|1 Month Follow-up|Lost to Follow-up|7|||
146703216|NCT02896400|529089089|FG010|1 Month Follow-up|Lost to Follow-up|5|||
146703217|NCT02896400|529089090|FG011|1 Month Follow-up|Lost to Follow-up|5|||
146703218|NCT02896400|529089091|FG012|1 Month Follow-up|Lost to Follow-up|3|||
146703219|NCT02896400|529089092|FG013|1 Month Follow-up|Lost to Follow-up|4|||
146703220|NCT02896400|529089093|FG014|1 Month Follow-up|Lost to Follow-up|1|||
146703221|NCT02896400|529089094|FG015|1 Month Follow-up|Lost to Follow-up|2|||
146703222|NCT02896400|529089079|FG000|1 Month Follow-up|Death|0|||
146703223|NCT02896400|529089080|FG001|1 Month Follow-up|Death|0|||
146703224|NCT02896400|529089081|FG002|1 Month Follow-up|Death|0|||
146703225|NCT02896400|529089082|FG003|1 Month Follow-up|Death|0|||
146703226|NCT02896400|529089083|FG004|1 Month Follow-up|Death|0|||
146703227|NCT02896400|529089084|FG005|1 Month Follow-up|Death|0|||
146703228|NCT02896400|529089085|FG006|1 Month Follow-up|Death|0|||
146703229|NCT02896400|529089086|FG007|1 Month Follow-up|Death|0|||
146703230|NCT02896400|529089087|FG008|1 Month Follow-up|Death|0|||
146703231|NCT02896400|529089088|FG009|1 Month Follow-up|Death|0|||
146703232|NCT02896400|529089089|FG010|1 Month Follow-up|Death|0|||
146703233|NCT02896400|529089090|FG011|1 Month Follow-up|Death|0|||
146703234|NCT02896400|529089091|FG012|1 Month Follow-up|Death|0|||
146703235|NCT02896400|529089092|FG013|1 Month Follow-up|Death|0|||
146703236|NCT02896400|529089093|FG014|1 Month Follow-up|Death|0|||
146703237|NCT02896400|529089094|FG015|1 Month Follow-up|Death|1|||
146703238|NCT02896400|529089079|FG000|3 Month Follow-up|Lost to Follow-up|6|||
146703239|NCT02896400|529089080|FG001|3 Month Follow-up|Lost to Follow-up|3|||
146703240|NCT02896400|529089081|FG002|3 Month Follow-up|Lost to Follow-up|6|||
146703241|NCT02896400|529089082|FG003|3 Month Follow-up|Lost to Follow-up|11|||
146703242|NCT02896400|529089083|FG004|3 Month Follow-up|Lost to Follow-up|12|||
146703243|NCT02896400|529089084|FG005|3 Month Follow-up|Lost to Follow-up|6|||
146703244|NCT02896400|529089085|FG006|3 Month Follow-up|Lost to Follow-up|4|||
146703245|NCT02896400|529089086|FG007|3 Month Follow-up|Lost to Follow-up|3|||
146703246|NCT02896400|529089087|FG008|3 Month Follow-up|Lost to Follow-up|6|||
146703247|NCT02896400|529089088|FG009|3 Month Follow-up|Lost to Follow-up|5|||
146703248|NCT02896400|529089089|FG010|3 Month Follow-up|Lost to Follow-up|6|||
146703249|NCT02896400|529089090|FG011|3 Month Follow-up|Lost to Follow-up|6|||
146703250|NCT02896400|529089091|FG012|3 Month Follow-up|Lost to Follow-up|3|||
146703251|NCT02896400|529089092|FG013|3 Month Follow-up|Lost to Follow-up|5|||
146703252|NCT02896400|529089093|FG014|3 Month Follow-up|Lost to Follow-up|3|||
146703253|NCT02896400|529089094|FG015|3 Month Follow-up|Lost to Follow-up|2|||
146703254|NCT02896400|529089079|FG000|3 Month Follow-up|Death|0|||
146703255|NCT02896400|529089080|FG001|3 Month Follow-up|Death|0|||
146703256|NCT02896400|529089081|FG002|3 Month Follow-up|Death|0|||
146703257|NCT02896400|529089082|FG003|3 Month Follow-up|Death|0|||
146703258|NCT02896400|529089083|FG004|3 Month Follow-up|Death|0|||
146703259|NCT02896400|529089084|FG005|3 Month Follow-up|Death|0|||
146703260|NCT02896400|529089085|FG006|3 Month Follow-up|Death|0|||
146703261|NCT02896400|529089086|FG007|3 Month Follow-up|Death|0|||
146703262|NCT02896400|529089087|FG008|3 Month Follow-up|Death|0|||
146703263|NCT02896400|529089088|FG009|3 Month Follow-up|Death|0|||
146703264|NCT02896400|529089089|FG010|3 Month Follow-up|Death|0|||
146703265|NCT02896400|529089090|FG011|3 Month Follow-up|Death|0|||
146703266|NCT02896400|529089091|FG012|3 Month Follow-up|Death|0|||
146703267|NCT02896400|529089092|FG013|3 Month Follow-up|Death|1|||
146703268|NCT02896400|529089093|FG014|3 Month Follow-up|Death|1|||
146703269|NCT02896400|529089094|FG015|3 Month Follow-up|Death|0|||
146703270|NCT02896400|529089079|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
146703271|NCT02896400|529089080|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
146703272|NCT02896400|529089081|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
146703273|NCT02896400|529089082|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
146703274|NCT02896400|529089083|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
146703275|NCT02896400|529089084|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
146703276|NCT02896400|529089085|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
146703277|NCT02896400|529089086|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
146703278|NCT02896400|529089087|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
146703279|NCT02896400|529089088|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
146703280|NCT02896400|529089089|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
146703281|NCT02896400|529089090|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
146933412|NCT00006604|529913993|FG002|Overall Study|Site closing|1|||
146703282|NCT02896400|529089091|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
146703283|NCT02896400|529089092|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
146703284|NCT02896400|529089093|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
146703285|NCT02896400|529089094|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
146933413|NCT00006604|529913994|FG003|Overall Study|Site closing|1|||
146933414|NCT00006604|529913995|FG004|Overall Study|Site closing|0|||
146933415|NCT00006604|529913996|FG005|Overall Study|Site closing|0|||
146703286|NCT02896400|529089079|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
146703287|NCT02896400|529089080|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
146703288|NCT02896400|529089081|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
146703289|NCT02896400|529089082|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
146703290|NCT02896400|529089083|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
146933416|NCT00006604|529913997|FG006|Overall Study|Site closing|0|||
146703291|NCT02896400|529089084|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
146703292|NCT02896400|529089085|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
146703293|NCT02896400|529089086|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
146703294|NCT02896400|529089087|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
146703295|NCT02896400|529089088|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
146703296|NCT02896400|529089089|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
146703297|NCT02896400|529089090|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
146703298|NCT02896400|529089091|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
146703299|NCT02896400|529089092|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
146703300|NCT02896400|529089093|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
146703301|NCT02896400|529089094|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
146703302|NCT00634647|529089097|FG000|Overall Study|death on study|3|||
146703303|NCT00634647|529089097|FG000|Overall Study|refused further treatment|3|||
146703304|NCT00634647|529089097|FG000|Overall Study|declined to participate before treatment|1|||
146703305|NCT02984020|529089098|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
146703306|NCT02984020|529089098|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
146703307|NCT02984020|529089098|FG000|Overall Study|Other significant protocol violation|2|||
146703308|NCT01700179|529089099|FG000|Overall Study|Physician Decision|2|||
146703309|NCT01896895|529089100|FG000|Double-blind MP|Physician Decision|0|||
146703310|NCT01896895|529089101|FG001|Double-blind MP|Physician Decision|0|||
146703311|NCT01896895|529089102|FG002|Double-blind MP|Physician Decision|1|||
146703312|NCT01896895|529089103|FG003|Double-blind MP|Physician Decision|0|||
146703313|NCT01896895|529089100|FG000|Double-blind MP|Withdrawal by Subject|0|||
146703314|NCT01896895|529089101|FG001|Double-blind MP|Withdrawal by Subject|2|||
146703315|NCT01896895|529089102|FG002|Double-blind MP|Withdrawal by Subject|1|||
146703316|NCT01896895|529089103|FG003|Double-blind MP|Withdrawal by Subject|0|||
146703317|NCT01896895|529089100|FG000|Double-blind MP|Lost to Follow-up|1|||
146703318|NCT01896895|529089101|FG001|Double-blind MP|Lost to Follow-up|0|||
146703319|NCT01896895|529089102|FG002|Double-blind MP|Lost to Follow-up|1|||
146703320|NCT01896895|529089103|FG003|Double-blind MP|Lost to Follow-up|0|||
146703321|NCT00667342|529089104|FG000|Overall Study|Protocol Violation|1|||
146703322|NCT00667342|529089105|FG001|Overall Study|Protocol Violation|0|||
146703323|NCT00667342|529089106|FG002|Overall Study|Protocol Violation|0|||
146703324|NCT00667342|529089104|FG000|Overall Study|Withdrawal by Subject|1|||
146703325|NCT00667342|529089105|FG001|Overall Study|Withdrawal by Subject|0|||
146703326|NCT00667342|529089106|FG002|Overall Study|Withdrawal by Subject|0|||
146703327|NCT00667342|529089104|FG000|Overall Study|Physician Decision|3|||
146703328|NCT00667342|529089105|FG001|Overall Study|Physician Decision|0|||
146703329|NCT00667342|529089106|FG002|Overall Study|Physician Decision|0|||
146703330|NCT00667342|529089104|FG000|Overall Study|Relapse or tumor progression|9|||
146703331|NCT00667342|529089105|FG001|Overall Study|Relapse or tumor progression|0|||
146703332|NCT00667342|529089106|FG002|Overall Study|Relapse or tumor progression|7|||
146703333|NCT00667342|529089104|FG000|Overall Study|Adverse Event|0|||
146703334|NCT00667342|529089105|FG001|Overall Study|Adverse Event|0|||
146703335|NCT00667342|529089106|FG002|Overall Study|Adverse Event|1|||
146703336|NCT00667342|529089104|FG000|Overall Study|Ineligible|0|||
146703337|NCT00667342|529089105|FG001|Overall Study|Ineligible|0|||
146703338|NCT00667342|529089106|FG002|Overall Study|Ineligible|1|||
146703339|NCT01207778|529089107|FG000|Overall Study|Lost to Follow-up|0|||
146703340|NCT01207778|529089108|FG001|Overall Study|Lost to Follow-up|3|||
146703341|NCT01207778|529089109|FG002|Overall Study|Lost to Follow-up|3|||
146703342|NCT01433263|529089112|FG000|Overall Study|Adverse Event|3|||
146703343|NCT01433263|529089113|FG001|Overall Study|Adverse Event|1|||
146703344|NCT01433263|529089112|FG000|Overall Study|Death|5|||
146703345|NCT01433263|529089113|FG001|Overall Study|Death|3|||
146703346|NCT01433263|529089112|FG000|Overall Study|Lost to Follow-up|0|||
146703347|NCT01433263|529089113|FG001|Overall Study|Lost to Follow-up|1|||
146703348|NCT01433263|529089112|FG000|Overall Study|Protocol Deviation|1|||
146703349|NCT01433263|529089113|FG001|Overall Study|Protocol Deviation|0|||
146703350|NCT01433263|529089112|FG000|Overall Study|Withdrawal by Subject|10|||
146981000|NCT00720798|530093709|FG000|Overall Study|Adverse Event|304|||
146703351|NCT01433263|529089113|FG001|Overall Study|Withdrawal by Subject|7|||
146703352|NCT00646204|529089114|FG000|Overall Study|Adverse Event|3|||
146703353|NCT00646204|529089115|FG001|Overall Study|Adverse Event|0|||
146703354|NCT00646204|529089114|FG000|Overall Study|Withdrawal by Subject|1|||
146703355|NCT00646204|529089115|FG001|Overall Study|Withdrawal by Subject|0|||
146703356|NCT03107988|529089121|FG000|Overall Study|Adverse Event|0|||
146703357|NCT03107988|529089122|FG001|Overall Study|Adverse Event|0|||
146703358|NCT03107988|529089123|FG002|Overall Study|Adverse Event|0|||
146703359|NCT03107988|529089124|FG003|Overall Study|Adverse Event|1|||
146703360|NCT03107988|529089125|FG004|Overall Study|Adverse Event|0|||
146703361|NCT03107988|529089126|FG005|Overall Study|Adverse Event|1|||
146703362|NCT03107988|529089127|FG006|Overall Study|Adverse Event|0|||
146703363|NCT03107988|529089128|FG007|Overall Study|Adverse Event|1|||
146703364|NCT03107988|529089129|FG008|Overall Study|Adverse Event|0|||
146703365|NCT03107988|529089130|FG009|Overall Study|Adverse Event|0|||
146703366|NCT03107988|529089131|FG010|Overall Study|Adverse Event|0|||
146703367|NCT03107988|529089132|FG011|Overall Study|Adverse Event|0|||
146703368|NCT03107988|529089133|FG012|Overall Study|Adverse Event|0|||
146703369|NCT03107988|529089121|FG000|Overall Study|Disease Progression or Relapse|1|||
146703370|NCT03107988|529089122|FG001|Overall Study|Disease Progression or Relapse|2|||
146703371|NCT03107988|529089123|FG002|Overall Study|Disease Progression or Relapse|2|||
146703372|NCT03107988|529089124|FG003|Overall Study|Disease Progression or Relapse|5|||
146703373|NCT03107988|529089125|FG004|Overall Study|Disease Progression or Relapse|1|||
146703374|NCT03107988|529089126|FG005|Overall Study|Disease Progression or Relapse|1|||
146703375|NCT03107988|529089127|FG006|Overall Study|Disease Progression or Relapse|0|||
146703376|NCT03107988|529089128|FG007|Overall Study|Disease Progression or Relapse|0|||
146703377|NCT03107988|529089129|FG008|Overall Study|Disease Progression or Relapse|0|||
146703378|NCT03107988|529089130|FG009|Overall Study|Disease Progression or Relapse|1|||
146703379|NCT03107988|529089131|FG010|Overall Study|Disease Progression or Relapse|4|||
146703380|NCT03107988|529089132|FG011|Overall Study|Disease Progression or Relapse|0|||
146703381|NCT03107988|529089133|FG012|Overall Study|Disease Progression or Relapse|0|||
146703382|NCT03107988|529089121|FG000|Overall Study|Ineligible|0|||
146703383|NCT03107988|529089122|FG001|Overall Study|Ineligible|0|||
146703384|NCT03107988|529089123|FG002|Overall Study|Ineligible|0|||
146703385|NCT03107988|529089124|FG003|Overall Study|Ineligible|0|||
146703386|NCT03107988|529089125|FG004|Overall Study|Ineligible|0|||
146703387|NCT03107988|529089126|FG005|Overall Study|Ineligible|0|||
146703388|NCT03107988|529089127|FG006|Overall Study|Ineligible|0|||
146703389|NCT03107988|529089128|FG007|Overall Study|Ineligible|0|||
146703390|NCT03107988|529089129|FG008|Overall Study|Ineligible|1|||
146703391|NCT03107988|529089130|FG009|Overall Study|Ineligible|0|||
146703392|NCT03107988|529089131|FG010|Overall Study|Ineligible|0|||
146703393|NCT03107988|529089132|FG011|Overall Study|Ineligible|0|||
146703394|NCT03107988|529089133|FG012|Overall Study|Ineligible|0|||
146703395|NCT04709237|529089135|FG000|Overall Study|Lost to Follow-up|1|||
146703396|NCT04709237|529089136|FG001|Overall Study|Lost to Follow-up|0|||
146703397|NCT04709237|529089137|FG002|Overall Study|Lost to Follow-up|0|||
146703398|NCT02610192|529089138|FG000|Overall Study|Received other treatment|8|||
146703399|NCT02610192|529089138|FG000|Overall Study|Physician Decision|1|||
146703400|NCT01344057|529089140|FG000|Overall Study|Premature Withdrawal|1|||
146703401|NCT00145509|529089141|FG000|Overall Study|Adverse Event|10|||
146703402|NCT00145509|529089142|FG001|Overall Study|Adverse Event|3|||
146703403|NCT00145509|529089141|FG000|Overall Study|Lack of Efficacy|3|||
146703404|NCT00145509|529089142|FG001|Overall Study|Lack of Efficacy|1|||
146703405|NCT00145509|529089141|FG000|Overall Study|Lost to Follow-up|5|||
146703406|NCT00145509|529089142|FG001|Overall Study|Lost to Follow-up|9|||
146703407|NCT00145509|529089141|FG000|Overall Study|Withdrew Consent|2|||
146703408|NCT00145509|529089142|FG001|Overall Study|Withdrew Consent|7|||
146703409|NCT00145509|529089141|FG000|Overall Study|Reason not provided|2|||
146703410|NCT00145509|529089142|FG001|Overall Study|Reason not provided|1|||
146703411|NCT01359592|529089143|FG000|Initial Registration|Adverse Event|1|||
146703412|NCT01359592|529089144|FG001|Initial Registration|Adverse Event|0|||
146703413|NCT01359592|529089145|FG002|Initial Registration|Adverse Event|0|||
146703414|NCT01359592|529089146|FG003|Initial Registration|Adverse Event|0|||
146703415|NCT01359592|529089143|FG000|Initial Registration|Death|1|||
146703416|NCT01359592|529089144|FG001|Initial Registration|Death|0|||
146703417|NCT01359592|529089145|FG002|Initial Registration|Death|0|||
146703418|NCT01359592|529089146|FG003|Initial Registration|Death|0|||
146703419|NCT01359592|529089143|FG000|Initial Registration|Other reason not protocol specified|1|||
146703420|NCT01359592|529089144|FG001|Initial Registration|Other reason not protocol specified|0|||
146776862|NCT02723955|529353648|FG036|Expansion Phase|Withdrawal by Subject|0|||
146776863|NCT02723955|529353649|FG037|Expansion Phase|Withdrawal by Subject|0|||
146776864|NCT02723955|529353650|FG038|Expansion Phase|Withdrawal by Subject|0|||
146933417|NCT00006604|529913998|FG007|Overall Study|Site closing|1|||
146703421|NCT01359592|529089145|FG002|Initial Registration|Other reason not protocol specified|0|||
146703422|NCT01359592|529089146|FG003|Initial Registration|Other reason not protocol specified|0|||
146703423|NCT01359592|529089143|FG000|Initial Registration|Ineligible|26|||
146703424|NCT01359592|529089144|FG001|Initial Registration|Ineligible|0|||
146703425|NCT01359592|529089145|FG002|Initial Registration|Ineligible|0|||
146703426|NCT01359592|529089146|FG003|Initial Registration|Ineligible|0|||
146703427|NCT01359592|529089143|FG000|PET-Directed Therapy|Adverse Event|0|||
146933418|NCT00006604|529913999|FG008|Overall Study|Site closing|0|||
146703428|NCT01359592|529089144|FG001|PET-Directed Therapy|Adverse Event|0|||
146703429|NCT01359592|529089145|FG002|PET-Directed Therapy|Adverse Event|1|||
146703430|NCT01359592|529089146|FG003|PET-Directed Therapy|Adverse Event|0|||
146703431|NCT01359592|529089143|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
146703432|NCT01359592|529089144|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
146703433|NCT01359592|529089145|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
146703434|NCT01359592|529089146|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
146703435|NCT01359592|529089143|FG000|PET-Directed Therapy|Ineligible|0|||
146703436|NCT01359592|529089144|FG001|PET-Directed Therapy|Ineligible|0|||
146703437|NCT01359592|529089145|FG002|PET-Directed Therapy|Ineligible|24|||
146703438|NCT01359592|529089146|FG003|PET-Directed Therapy|Ineligible|0|||
146703439|NCT00749775|529089153|FG000|Overall Study|Protocol Violation|24|||
146703440|NCT00749775|529089153|FG000|Overall Study|Lost to Follow-up|36|||
146703441|NCT00749775|529089153|FG000|Overall Study|No visit after first day of treatment|44|||
146703442|NCT00749775|529089153|FG000|Overall Study|No drug administration|3|||
146703443|NCT02506816|529089158|FG000|Overall Study|Adverse Event|3|||
146703444|NCT03019627|529089159|FG000|Overall Study|Adverse Event|8|||
146703445|NCT03019627|529089160|FG001|Overall Study|Adverse Event|0|||
146703446|NCT03019627|529089159|FG000|Overall Study|Unrelated to adverse event|1|||
146703447|NCT03019627|529089160|FG001|Overall Study|Unrelated to adverse event|3|||
146703448|NCT03019627|529089159|FG000|Overall Study|Lost to Follow-up|2|||
146703449|NCT03019627|529089160|FG001|Overall Study|Lost to Follow-up|1|||
146703450|NCT03019627|529089159|FG000|Overall Study|not compliance|2|||
146703451|NCT03019627|529089160|FG001|Overall Study|not compliance|2|||
146703452|NCT03019627|529089159|FG000|Overall Study|Other|2|||
146703453|NCT03019627|529089160|FG001|Overall Study|Other|2|||
146703454|NCT01340976|529089163|FG000|Overall Study|Physician Decision|2|||
146703455|NCT01340976|529089164|FG001|Overall Study|Physician Decision|0|||
146703456|NCT01340976|529089165|FG002|Overall Study|Physician Decision|1|||
146703457|NCT01340976|529089166|FG003|Overall Study|Physician Decision|1|||
146703458|NCT01340976|529089167|FG004|Overall Study|Physician Decision|1|||
146703459|NCT01340976|529089168|FG005|Overall Study|Physician Decision|0|||
146703460|NCT01340976|529089163|FG000|Overall Study|Death|0|||
146703461|NCT01340976|529089164|FG001|Overall Study|Death|1|||
146703462|NCT01340976|529089165|FG002|Overall Study|Death|0|||
146703463|NCT01340976|529089166|FG003|Overall Study|Death|0|||
146703464|NCT01340976|529089167|FG004|Overall Study|Death|0|||
146703465|NCT01340976|529089168|FG005|Overall Study|Death|0|||
146703466|NCT01340976|529089163|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
146703467|NCT01340976|529089164|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
146703468|NCT01340976|529089165|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
146703469|NCT01340976|529089166|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
146703470|NCT01340976|529089167|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
146703471|NCT01340976|529089168|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
146703472|NCT01340976|529089163|FG000|Overall Study|Withdrawal by Subject|0|||
146703473|NCT01340976|529089164|FG001|Overall Study|Withdrawal by Subject|0|||
146703474|NCT01340976|529089165|FG002|Overall Study|Withdrawal by Subject|0|||
146703475|NCT01340976|529089166|FG003|Overall Study|Withdrawal by Subject|1|||
146703476|NCT01340976|529089167|FG004|Overall Study|Withdrawal by Subject|1|||
146776865|NCT02723955|529353651|FG039|Expansion Phase|Withdrawal by Subject|0|||
146776866|NCT02723955|529353652|FG040|Expansion Phase|Withdrawal by Subject|0|||
146776867|NCT02723955|529353653|FG041|Expansion Phase|Withdrawal by Subject|0|||
146776868|NCT02723955|529353654|FG042|Expansion Phase|Withdrawal by Subject|0|||
146776869|NCT02723955|529353612|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146703477|NCT01340976|529089168|FG005|Overall Study|Withdrawal by Subject|0|||
146703478|NCT01340976|529089163|FG000|Overall Study|Other anemia treatment|1|||
146703479|NCT01340976|529089164|FG001|Overall Study|Other anemia treatment|0|||
146703480|NCT01340976|529089165|FG002|Overall Study|Other anemia treatment|2|||
146703481|NCT01340976|529089166|FG003|Overall Study|Other anemia treatment|1|||
146703482|NCT01340976|529089167|FG004|Overall Study|Other anemia treatment|0|||
146703483|NCT01340976|529089168|FG005|Overall Study|Other anemia treatment|1|||
146703484|NCT01340976|529089163|FG000|Overall Study|Adverse Event|0|||
146848374|NCT03900416|529615663|FG000|Twelve Week Follow-up|Adverse Event|1|||
146848375|NCT03900416|529615664|FG001|Twelve Week Follow-up|Adverse Event|1|||
146703485|NCT01340976|529089164|FG001|Overall Study|Adverse Event|1|||
146848376|NCT03900416|529615663|FG000|Six Month Follow-up|Lost to Follow-up|4|||
146848377|NCT03900416|529615664|FG001|Six Month Follow-up|Lost to Follow-up|3|||
146848378|NCT03900416|529615663|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
146848379|NCT03900416|529615664|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
146848380|NCT03507777|529615665|FG000|Overall Study|Lost to Follow-up|5|||
146848381|NCT03507777|529615666|FG001|Overall Study|Lost to Follow-up|7|||
146848382|NCT03507777|529615665|FG000|Overall Study|Withdrawal by Subject|6|||
146848383|NCT03507777|529615666|FG001|Overall Study|Withdrawal by Subject|11|||
146848384|NCT03507777|529615665|FG000|Overall Study|Death|30|||
146848385|NCT03507777|529615666|FG001|Overall Study|Death|44|||
146848386|NCT03507777|529615665|FG000|Overall Study|Other Reasons|3|||
146848387|NCT03507777|529615666|FG001|Overall Study|Other Reasons|8|||
146848388|NCT02245737|529615667|FG000|Overall Study|Adverse Event|23|||
146848389|NCT02245737|529615668|FG001|Overall Study|Adverse Event|26|||
146848390|NCT02245737|529615669|FG002|Overall Study|Adverse Event|33|||
146848391|NCT02245737|529615667|FG000|Overall Study|Condition Worsened|9|||
146848392|NCT02245737|529615668|FG001|Overall Study|Condition Worsened|10|||
146848393|NCT02245737|529615669|FG002|Overall Study|Condition Worsened|9|||
146848394|NCT02245737|529615667|FG000|Overall Study|Death|2|||
146703486|NCT01340976|529089165|FG002|Overall Study|Adverse Event|0|||
146703487|NCT01340976|529089166|FG003|Overall Study|Adverse Event|0|||
146703488|NCT01340976|529089167|FG004|Overall Study|Adverse Event|0|||
146703489|NCT01340976|529089168|FG005|Overall Study|Adverse Event|0|||
146703490|NCT02953821|529089169|FG000|Overall Study|Adverse Event|0|||
146703491|NCT02953821|529089170|FG001|Overall Study|Adverse Event|4|||
146703492|NCT02953821|529089169|FG000|Overall Study|Death|1|||
146703493|NCT02953821|529089170|FG001|Overall Study|Death|0|||
146703494|NCT02953821|529089169|FG000|Overall Study|Progressive Disease|5|||
146703495|NCT02953821|529089170|FG001|Overall Study|Progressive Disease|1|||
146703496|NCT02953821|529089169|FG000|Overall Study|Lost to Follow-up|2|||
146703497|NCT02953821|529089170|FG001|Overall Study|Lost to Follow-up|0|||
146703498|NCT02953821|529089169|FG000|Overall Study|Physician Decision|1|||
146703499|NCT02953821|529089170|FG001|Overall Study|Physician Decision|1|||
146703500|NCT02953821|529089169|FG000|Overall Study|Withdrawal by Subject|3|||
146703501|NCT02953821|529089170|FG001|Overall Study|Withdrawal by Subject|3|||
146703502|NCT02953821|529089169|FG000|Overall Study|Change of address|0|||
146703503|NCT02953821|529089170|FG001|Overall Study|Change of address|1|||
146703504|NCT02953821|529089169|FG000|Overall Study|Lack of Efficacy|1|||
146703505|NCT02953821|529089170|FG001|Overall Study|Lack of Efficacy|0|||
146703506|NCT02953821|529089169|FG000|Overall Study|Out of state for indeterminate time|0|||
146703507|NCT02953821|529089170|FG001|Overall Study|Out of state for indeterminate time|1|||
146703508|NCT02953821|529089169|FG000|Overall Study|No improvement|0|||
146703509|NCT02953821|529089170|FG001|Overall Study|No improvement|1|||
146703510|NCT02953821|529089169|FG000|Overall Study|Refused follow-up visit|2|||
146703511|NCT02953821|529089170|FG001|Overall Study|Refused follow-up visit|1|||
146703512|NCT01067352|529089171|FG000|Overall Study|Withdrawal by Subject|1|||
146703513|NCT01067352|529089172|FG001|Overall Study|Withdrawal by Subject|2|||
146703514|NCT01067352|529089173|FG002|Overall Study|Withdrawal by Subject|1|||
146703515|NCT01067352|529089171|FG000|Overall Study|Physician Decision|0|||
146703516|NCT01067352|529089172|FG001|Overall Study|Physician Decision|1|||
146703517|NCT01067352|529089173|FG002|Overall Study|Physician Decision|0|||
146703518|NCT02103478|529089174|FG000|Overall Study|Adverse Event|0|||
146703519|NCT02103478|529089175|FG001|Overall Study|Adverse Event|0|||
146703520|NCT02103478|529089176|FG002|Overall Study|Adverse Event|1|||
146703521|NCT02103478|529089177|FG003|Overall Study|Adverse Event|1|||
146703522|NCT02103478|529089178|FG004|Overall Study|Adverse Event|2|||
146703523|NCT02103478|529089179|FG005|Overall Study|Adverse Event|1|||
146703524|NCT02103478|529089180|FG006|Overall Study|Adverse Event|0|||
146703525|NCT02103478|529089181|FG007|Overall Study|Adverse Event|0|||
146703526|NCT02103478|529089182|FG008|Overall Study|Adverse Event|0|||
146703527|NCT02103478|529089174|FG000|Overall Study|Death|2|||
146703528|NCT02103478|529089175|FG001|Overall Study|Death|2|||
146703529|NCT02103478|529089176|FG002|Overall Study|Death|1|||
146703530|NCT02103478|529089177|FG003|Overall Study|Death|1|||
146703531|NCT02103478|529089178|FG004|Overall Study|Death|5|||
146703532|NCT02103478|529089179|FG005|Overall Study|Death|15|||
146703533|NCT02103478|529089180|FG006|Overall Study|Death|14|||
146703534|NCT02103478|529089181|FG007|Overall Study|Death|10|||
146703535|NCT02103478|529089182|FG008|Overall Study|Death|11|||
146703536|NCT02103478|529089174|FG000|Overall Study|Progressive Disease|2|||
146703537|NCT02103478|529089175|FG001|Overall Study|Progressive Disease|1|||
146703538|NCT02103478|529089176|FG002|Overall Study|Progressive Disease|2|||
146703539|NCT02103478|529089177|FG003|Overall Study|Progressive Disease|0|||
146703540|NCT02103478|529089178|FG004|Overall Study|Progressive Disease|9|||
146703541|NCT02103478|529089179|FG005|Overall Study|Progressive Disease|1|||
146703542|NCT02103478|529089180|FG006|Overall Study|Progressive Disease|2|||
146703543|NCT02103478|529089181|FG007|Overall Study|Progressive Disease|0|||
146703544|NCT02103478|529089182|FG008|Overall Study|Progressive Disease|1|||
146848395|NCT02245737|529615668|FG001|Overall Study|Death|4|||
146703545|NCT02103478|529089174|FG000|Overall Study|Withdrawal by Subject|2|||
146703546|NCT02103478|529089175|FG001|Overall Study|Withdrawal by Subject|0|||
146703547|NCT02103478|529089176|FG002|Overall Study|Withdrawal by Subject|0|||
146703548|NCT02103478|529089177|FG003|Overall Study|Withdrawal by Subject|4|||
146703549|NCT02103478|529089178|FG004|Overall Study|Withdrawal by Subject|0|||
146703550|NCT02103478|529089179|FG005|Overall Study|Withdrawal by Subject|0|||
146703551|NCT02103478|529089180|FG006|Overall Study|Withdrawal by Subject|1|||
146703552|NCT02103478|529089181|FG007|Overall Study|Withdrawal by Subject|1|||
146703553|NCT02103478|529089182|FG008|Overall Study|Withdrawal by Subject|0|||
146703554|NCT02103478|529089174|FG000|Overall Study|Lost to Follow-up|0|||
146703555|NCT02103478|529089175|FG001|Overall Study|Lost to Follow-up|0|||
146703556|NCT02103478|529089176|FG002|Overall Study|Lost to Follow-up|0|||
146703557|NCT02103478|529089177|FG003|Overall Study|Lost to Follow-up|0|||
146703558|NCT02103478|529089178|FG004|Overall Study|Lost to Follow-up|0|||
146703559|NCT02103478|529089179|FG005|Overall Study|Lost to Follow-up|0|||
146703560|NCT02103478|529089180|FG006|Overall Study|Lost to Follow-up|0|||
146703561|NCT02103478|529089181|FG007|Overall Study|Lost to Follow-up|1|||
146703562|NCT02103478|529089182|FG008|Overall Study|Lost to Follow-up|0|||
146703563|NCT02103478|529089174|FG000|Overall Study|Other|1|||
146703564|NCT02103478|529089175|FG001|Overall Study|Other|3|||
146703565|NCT02103478|529089176|FG002|Overall Study|Other|2|||
146703566|NCT02103478|529089177|FG003|Overall Study|Other|0|||
146703567|NCT02103478|529089178|FG004|Overall Study|Other|3|||
146703568|NCT02103478|529089179|FG005|Overall Study|Other|8|||
146703569|NCT02103478|529089180|FG006|Overall Study|Other|8|||
146703570|NCT02103478|529089181|FG007|Overall Study|Other|4|||
146703571|NCT02103478|529089182|FG008|Overall Study|Other|2|||
146703572|NCT00723606|529089183|FG000|Overall Study|Adverse Event|2|||
146703573|NCT00723606|529089184|FG001|Overall Study|Adverse Event|5|||
146703574|NCT00723606|529089183|FG000|Overall Study|Other|2|||
146703575|NCT00723606|529089184|FG001|Overall Study|Other|0|||
146703576|NCT00723606|529089183|FG000|Overall Study|Withdrawal by Subject|0|||
146703577|NCT00723606|529089184|FG001|Overall Study|Withdrawal by Subject|2|||
146703578|NCT02566759|529089185|FG000|All Parts|Withdrawal by Subject|0|||
146703579|NCT02566759|529089186|FG001|All Parts|Withdrawal by Subject|1|||
146703580|NCT02566759|529089187|FG002|All Parts|Withdrawal by Subject|0|||
146703581|NCT02566759|529089188|FG003|All Parts|Withdrawal by Subject|0|||
146703582|NCT02566759|529089189|FG004|All Parts|Withdrawal by Subject|0|||
146703583|NCT02566759|529089190|FG005|All Parts|Withdrawal by Subject|0|||
146703584|NCT02566759|529089191|FG006|All Parts|Withdrawal by Subject|0|||
146703585|NCT02566759|529089192|FG007|All Parts|Withdrawal by Subject|0|||
146703586|NCT02566759|529089193|FG008|All Parts|Withdrawal by Subject|0|||
146703587|NCT02566759|529089194|FG009|All Parts|Withdrawal by Subject|0|||
146703588|NCT02566759|529089195|FG010|All Parts|Withdrawal by Subject|0|||
146703589|NCT02566759|529089196|FG011|All Parts|Withdrawal by Subject|0|||
146703590|NCT02566759|529089197|FG012|All Parts|Withdrawal by Subject|0|||
146703591|NCT02566759|529089198|FG013|All Parts|Withdrawal by Subject|0|||
146703592|NCT02566759|529089199|FG014|All Parts|Withdrawal by Subject|0|||
146703593|NCT02566759|529089200|FG015|All Parts|Withdrawal by Subject|0|||
146703594|NCT02566759|529089201|FG016|All Parts|Withdrawal by Subject|0|||
146703595|NCT02566759|529089185|FG000|All Parts|Adverse Event|0|||
146703596|NCT02566759|529089186|FG001|All Parts|Adverse Event|0|||
146703597|NCT02566759|529089187|FG002|All Parts|Adverse Event|0|||
146703598|NCT02566759|529089188|FG003|All Parts|Adverse Event|0|||
146703599|NCT02566759|529089189|FG004|All Parts|Adverse Event|0|||
146703600|NCT02566759|529089190|FG005|All Parts|Adverse Event|0|||
146703601|NCT02566759|529089191|FG006|All Parts|Adverse Event|0|||
146703602|NCT02566759|529089192|FG007|All Parts|Adverse Event|0|||
146703603|NCT02566759|529089193|FG008|All Parts|Adverse Event|0|||
146703604|NCT02566759|529089194|FG009|All Parts|Adverse Event|0|||
146703605|NCT02566759|529089195|FG010|All Parts|Adverse Event|0|||
146703606|NCT02566759|529089196|FG011|All Parts|Adverse Event|0|||
146703607|NCT02566759|529089197|FG012|All Parts|Adverse Event|1|||
146703608|NCT02566759|529089198|FG013|All Parts|Adverse Event|3|||
146703609|NCT02566759|529089199|FG014|All Parts|Adverse Event|0|||
146703610|NCT02566759|529089200|FG015|All Parts|Adverse Event|0|||
146703611|NCT02566759|529089201|FG016|All Parts|Adverse Event|0|||
146703612|NCT02566759|529089185|FG000|All Parts|Other|0|||
146703613|NCT02566759|529089186|FG001|All Parts|Other|0|||
146703614|NCT02566759|529089187|FG002|All Parts|Other|0|||
146703615|NCT02566759|529089188|FG003|All Parts|Other|0|||
146703616|NCT02566759|529089189|FG004|All Parts|Other|0|||
146703617|NCT02566759|529089190|FG005|All Parts|Other|0|||
146703618|NCT02566759|529089191|FG006|All Parts|Other|0|||
146703619|NCT02566759|529089192|FG007|All Parts|Other|0|||
146703620|NCT02566759|529089193|FG008|All Parts|Other|0|||
146703621|NCT02566759|529089194|FG009|All Parts|Other|0|||
146703622|NCT02566759|529089195|FG010|All Parts|Other|0|||
146703623|NCT02566759|529089196|FG011|All Parts|Other|0|||
146703624|NCT02566759|529089197|FG012|All Parts|Other|0|||
146703625|NCT02566759|529089198|FG013|All Parts|Other|2|||
146703626|NCT02566759|529089199|FG014|All Parts|Other|0|||
146703627|NCT02566759|529089200|FG015|All Parts|Other|0|||
146703628|NCT02566759|529089201|FG016|All Parts|Other|0|||
146703629|NCT02566759|529089185|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146703630|NCT02566759|529089186|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146703631|NCT02566759|529089187|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146703632|NCT02566759|529089188|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146703633|NCT02566759|529089189|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146933419|NCT00006604|529914000|FG009|Overall Study|Site closing|0|||
146703634|NCT02566759|529089190|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146703635|NCT02566759|529089191|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146703636|NCT02566759|529089192|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146703637|NCT02566759|529089193|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146703638|NCT02566759|529089194|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146703639|NCT02566759|529089195|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146703640|NCT02566759|529089196|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146703641|NCT02566759|529089197|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146703642|NCT02566759|529089198|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146703643|NCT02566759|529089199|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146703644|NCT02566759|529089200|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146703645|NCT02566759|529089201|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
146703646|NCT00976898|529089202|FG000|Overall Study|Protocol Violation|1|||
146703647|NCT00976898|529089202|FG000|Overall Study|Adverse Event|1|||
146703648|NCT00976898|529089202|FG000|Overall Study|Physician Decision|1|||
146703649|NCT00976898|529089202|FG000|Overall Study|Liver Transplant|1|||
146703650|NCT00976898|529089202|FG000|Overall Study|Progressive Disease|1|||
146703651|NCT05107128|529089203|FG000|Overall Study|Adverse Event|2|||
146703652|NCT05107128|529089204|FG001|Overall Study|Adverse Event|0|||
146703653|NCT05107128|529089203|FG000|Overall Study|Withdrawal by Subject|3|||
146703654|NCT05107128|529089204|FG001|Overall Study|Withdrawal by Subject|3|||
146703655|NCT05107128|529089203|FG000|Overall Study|Withdrawal of Consent|0|||
146703656|NCT05107128|529089204|FG001|Overall Study|Withdrawal of Consent|1|||
146703657|NCT05107128|529089203|FG000|Overall Study|Reason Not Specified|2|||
146703658|NCT05107128|529089204|FG001|Overall Study|Reason Not Specified|0|||
146703659|NCT05459129|529089207|FG000|Overall Study|Death|1|||
146703660|NCT05459129|529089208|FG001|Overall Study|Death|0|||
146703661|NCT05459129|529089207|FG000|Overall Study|Study Terminated By Sponsor|5|||
146703662|NCT05459129|529089208|FG001|Overall Study|Study Terminated By Sponsor|6|||
146703663|NCT04033159|529089235|FG000|Washout Period|Physician Decision|0|||
146703664|NCT04033159|529089236|FG001|Washout Period|Physician Decision|1|||
146703665|NCT04033159|529089237|FG002|Washout Period|Physician Decision|0|||
146703666|NCT04033159|529089235|FG000|Washout Period|Study terminated by Sponsor|0|||
146703667|NCT04033159|529089236|FG001|Washout Period|Study terminated by Sponsor|7|||
146703668|NCT04033159|529089237|FG002|Washout Period|Study terminated by Sponsor|0|||
146703669|NCT04033159|529089235|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
146703670|NCT04033159|529089236|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
146703671|NCT04033159|529089237|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
146703672|NCT00499603|529089244|FG000|Overall Study|Adverse Event|0|||
146703673|NCT00499603|529089245|FG001|Overall Study|Adverse Event|1|||
146703674|NCT03323099|529089246|FG000|Overall Study|Withdrawal by Subject|6|||
146703675|NCT03323099|529089247|FG001|Overall Study|Withdrawal by Subject|12|||
146703676|NCT03323099|529089246|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
146703677|NCT03323099|529089247|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
146703678|NCT01502644|529089248|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
146703679|NCT01502644|529089249|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
146703680|NCT01502644|529089250|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
146703681|NCT01502644|529089251|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
146703682|NCT01502644|529089248|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
146703683|NCT01502644|529089249|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
146703684|NCT01502644|529089250|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
146703685|NCT01502644|529089251|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
146703686|NCT01502644|529089248|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
146703687|NCT01502644|529089249|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
146703688|NCT01502644|529089250|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
146703689|NCT01502644|529089251|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
146703690|NCT01502644|529089248|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
146703691|NCT01502644|529089249|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
146703692|NCT01502644|529089250|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
146703693|NCT01502644|529089251|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
146703694|NCT01502644|529089248|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
146703695|NCT01502644|529089249|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
146703696|NCT01502644|529089250|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
146703697|NCT01502644|529089251|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
146703698|NCT01526889|529089252|FG000|Treatment Period|Adverse Event|2|||
146703699|NCT01526889|529089253|FG001|Treatment Period|Adverse Event|0|||
146703700|NCT01526889|529089252|FG000|Treatment Extension Period|Administrative problems|1|||
146703701|NCT01526889|529089253|FG001|Treatment Extension Period|Administrative problems|0|||
146703702|NCT00613509|529089254|FG000|Cycle 1|Adverse Event|2|||
146703703|NCT00613509|529089255|FG001|Cycle 1|Adverse Event|1|||
146933420|NCT00006604|529914001|FG010|Overall Study|Site closing|0|||
146933421|NCT00006604|529914002|FG011|Overall Study|Site closing|1|||
146933422|NCT00006604|529914003|FG012|Overall Study|Site closing|1|||
146933423|NCT00006604|529914004|FG013|Overall Study|Site closing|1|||
146933424|NCT00006604|529914005|FG014|Overall Study|Site closing|0|||
146703704|NCT00613509|529089254|FG000|Cycle 1|Disease Progression|2|||
146703705|NCT00613509|529089255|FG001|Cycle 1|Disease Progression|6|||
146703706|NCT00613509|529089254|FG000|Cycle 1|Unacceptable Toxicity|1|||
146703707|NCT00613509|529089255|FG001|Cycle 1|Unacceptable Toxicity|0|||
146703708|NCT00613509|529089254|FG000|Cycle 1|Other administrative reason|0|||
146703709|NCT00613509|529089255|FG001|Cycle 1|Other administrative reason|1|||
146703710|NCT00314366|529089256|FG000|Overall Study|not treated due to patient medical condi|1|||
146703711|NCT00314366|529089257|FG001|Overall Study|not treated due to patient medical condi|0|||
146703712|NCT03400033|529089258|FG000|Overall Study|Withdrawal by Subject|1|||
146703713|NCT03400033|529089259|FG001|Overall Study|Withdrawal by Subject|2|||
146703714|NCT02469610|529089269|FG000|Overall Study|Death|1|||
146703715|NCT02469610|529089270|FG001|Overall Study|Death|0|||
146703716|NCT02469610|529089269|FG000|Overall Study|Lost to Follow-up|1|||
146703717|NCT02469610|529089270|FG001|Overall Study|Lost to Follow-up|0|||
146703718|NCT02469610|529089269|FG000|Overall Study|exclusion criteria|2|||
146703719|NCT02469610|529089270|FG001|Overall Study|exclusion criteria|1|||
146703720|NCT01387607|529089273|FG000|Overall Study|Adverse Event|23|||
146703721|NCT01387607|529089274|FG001|Overall Study|Adverse Event|11|||
146703722|NCT01387607|529089273|FG000|Overall Study|Lack of Efficacy|8|||
146703723|NCT01387607|529089274|FG001|Overall Study|Lack of Efficacy|6|||
146703724|NCT01387607|529089273|FG000|Overall Study|Lost to Follow-up|2|||
146703725|NCT01387607|529089274|FG001|Overall Study|Lost to Follow-up|1|||
146703726|NCT01387607|529089273|FG000|Overall Study|No longer meets eligibility criteria|0|||
146703727|NCT01387607|529089274|FG001|Overall Study|No longer meets eligibility criteria|1|||
146703728|NCT01387607|529089273|FG000|Overall Study|Protocol Violation|1|||
146703729|NCT01387607|529089274|FG001|Overall Study|Protocol Violation|5|||
146703730|NCT01387607|529089273|FG000|Overall Study|Withdrawal by Subject|13|||
146703731|NCT01387607|529089274|FG001|Overall Study|Withdrawal by Subject|14|||
146703732|NCT01387607|529089273|FG000|Overall Study|Other|1|||
146703733|NCT01387607|529089274|FG001|Overall Study|Other|1|||
146703734|NCT01387607|529089273|FG000|Overall Study|Randomized, not treated|3|||
146703735|NCT01387607|529089274|FG001|Overall Study|Randomized, not treated|6|||
146703736|NCT03548584|529091020|FG000|Overall Study|Lost to Follow-up|0|||
146703737|NCT03548584|529091021|FG001|Overall Study|Lost to Follow-up|0|||
146703738|NCT03548584|529091022|FG002|Overall Study|Lost to Follow-up|1|||
146703739|NCT03548584|529091020|FG000|Overall Study|Adverse Event|1|||
146703740|NCT03548584|529091021|FG001|Overall Study|Adverse Event|11|||
146703741|NCT03548584|529091022|FG002|Overall Study|Adverse Event|5|||
146703742|NCT03548584|529091020|FG000|Overall Study|Site Terminated by Sponsor|1|||
146703743|NCT03548584|529091021|FG001|Overall Study|Site Terminated by Sponsor|3|||
146703744|NCT03548584|529091022|FG002|Overall Study|Site Terminated by Sponsor|2|||
146703745|NCT03548584|529091020|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
146703746|NCT03548584|529091021|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
146703747|NCT03548584|529091022|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
146703748|NCT03548584|529091020|FG000|Overall Study|Lack of Efficacy|0|||
146703749|NCT03548584|529091021|FG001|Overall Study|Lack of Efficacy|1|||
146703750|NCT03548584|529091022|FG002|Overall Study|Lack of Efficacy|0|||
146703751|NCT03548584|529091020|FG000|Overall Study|Non-compliance with Study Drug|0|||
146703752|NCT03548584|529091021|FG001|Overall Study|Non-compliance with Study Drug|1|||
146703753|NCT03548584|529091022|FG002|Overall Study|Non-compliance with Study Drug|0|||
146703754|NCT03548584|529091020|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
146703755|NCT03548584|529091021|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
146776870|NCT02723955|529353613|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146933425|NCT00006604|529914006|FG015|Overall Study|Site closing|0|||
146933426|NCT00006604|529914007|FG016|Overall Study|Site closing|1|||
146933427|NCT00006604|529913991|FG000|Overall Study|Withdrawal by Subject|1|||
146933428|NCT00006604|529913992|FG001|Overall Study|Withdrawal by Subject|0|||
146933429|NCT00006604|529913993|FG002|Overall Study|Withdrawal by Subject|2|||
146933430|NCT00006604|529913994|FG003|Overall Study|Withdrawal by Subject|0|||
146933431|NCT00006604|529913995|FG004|Overall Study|Withdrawal by Subject|1|||
146933432|NCT00006604|529913996|FG005|Overall Study|Withdrawal by Subject|2|||
146933433|NCT00006604|529913997|FG006|Overall Study|Withdrawal by Subject|2|||
146933434|NCT00006604|529913998|FG007|Overall Study|Withdrawal by Subject|0|||
146933435|NCT00006604|529913999|FG008|Overall Study|Withdrawal by Subject|1|||
146933436|NCT00006604|529914000|FG009|Overall Study|Withdrawal by Subject|3|||
146933437|NCT00006604|529914001|FG010|Overall Study|Withdrawal by Subject|2|||
146933438|NCT00006604|529914002|FG011|Overall Study|Withdrawal by Subject|0|||
146933439|NCT00006604|529914003|FG012|Overall Study|Withdrawal by Subject|1|||
146933440|NCT00006604|529914004|FG013|Overall Study|Withdrawal by Subject|2|||
146933441|NCT00006604|529914005|FG014|Overall Study|Withdrawal by Subject|1|||
146933442|NCT00006604|529914006|FG015|Overall Study|Withdrawal by Subject|0|||
146933443|NCT00006604|529914007|FG016|Overall Study|Withdrawal by Subject|1|||
146703756|NCT03548584|529091022|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
146703757|NCT00533949|529091023|FG000|Overall Study|Protocol Violation|12|||
146703758|NCT00533949|529091024|FG001|Overall Study|Protocol Violation|12|||
146703759|NCT00533949|529091025|FG002|Overall Study|Protocol Violation|9|||
146703760|NCT00533949|529091026|FG003|Overall Study|Protocol Violation|9|||
146703761|NCT00533949|529091023|FG000|Overall Study|Withdrawal by Subject|3|||
146703762|NCT00533949|529091024|FG001|Overall Study|Withdrawal by Subject|2|||
146703763|NCT00533949|529091025|FG002|Overall Study|Withdrawal by Subject|1|||
146703764|NCT00533949|529091026|FG003|Overall Study|Withdrawal by Subject|1|||
146703765|NCT00727194|529091027|FG000|Screening Period|Low QMG scores|0|||
146703766|NCT00727194|529091028|FG001|Screening Period|Low QMG scores|0|||
146703767|NCT00727194|529091029|FG002|Screening Period|Low QMG scores|6|||
146703768|NCT00727194|529091027|FG000|Screening Period|Lacked AChR antibodies|0|||
146703769|NCT00727194|529091028|FG001|Screening Period|Lacked AChR antibodies|0|||
146703770|NCT00727194|529091029|FG002|Screening Period|Lacked AChR antibodies|5|||
146703771|NCT00727194|529091027|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
146703772|NCT00727194|529091028|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
146703773|NCT00727194|529091029|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
146703774|NCT00727194|529091027|FG000|Screening Period|Severe infections|0|||
146703775|NCT00727194|529091028|FG001|Screening Period|Severe infections|0|||
146703776|NCT00727194|529091029|FG002|Screening Period|Severe infections|2|||
146703777|NCT00727194|529091027|FG000|Screening Period|History of thymoma|0|||
146703778|NCT00727194|529091028|FG001|Screening Period|History of thymoma|0|||
146703779|NCT00727194|529091029|FG002|Screening Period|History of thymoma|1|||
146703780|NCT00727194|529091027|FG000|Treatment Period 2|Lack of Efficacy|0|||
146703781|NCT00727194|529091028|FG001|Treatment Period 2|Lack of Efficacy|1|||
146703782|NCT00727194|529091029|FG002|Treatment Period 2|Lack of Efficacy|0|||
146703783|NCT04269161|529091030|FG000|Overall Study|Change of modality and no longer eligible|3|||
146703784|NCT04269161|529091031|FG001|Overall Study|Change of modality and no longer eligible|3|||
146703785|NCT04269161|529091030|FG000|Overall Study|Required procedure outside of NICU|1|||
146703786|NCT04269161|529091031|FG001|Overall Study|Required procedure outside of NICU|0|||
146703787|NCT04269161|529091030|FG000|Overall Study|Equipment issue|1|||
146703788|NCT04269161|529091031|FG001|Overall Study|Equipment issue|1|||
146703789|NCT01677195|529091032|FG000|Overall Study|Lost to Follow-up|14|||
146703790|NCT01677195|529091033|FG001|Overall Study|Lost to Follow-up|22|||
146703791|NCT01677195|529091034|FG002|Overall Study|Lost to Follow-up|22|||
146703792|NCT01677195|529091032|FG000|Overall Study|Withdrawal by Subject|1|||
146703793|NCT01677195|529091033|FG001|Overall Study|Withdrawal by Subject|0|||
146703794|NCT01677195|529091034|FG002|Overall Study|Withdrawal by Subject|1|||
146703795|NCT01677195|529091032|FG000|Overall Study|Adverse Event|6|||
146703796|NCT01677195|529091033|FG001|Overall Study|Adverse Event|4|||
146703797|NCT01677195|529091034|FG002|Overall Study|Adverse Event|1|||
146703798|NCT01677195|529091032|FG000|Overall Study|Physician Decision|1|||
146703799|NCT01677195|529091033|FG001|Overall Study|Physician Decision|2|||
146703800|NCT01677195|529091034|FG002|Overall Study|Physician Decision|2|||
146703801|NCT01677195|529091032|FG000|Overall Study|Pregnancy|0|||
146703802|NCT01677195|529091033|FG001|Overall Study|Pregnancy|1|||
146703803|NCT01677195|529091034|FG002|Overall Study|Pregnancy|0|||
146703804|NCT01677195|529091032|FG000|Overall Study|Protocol Violation|7|||
146703805|NCT01677195|529091033|FG001|Overall Study|Protocol Violation|3|||
146703806|NCT01677195|529091034|FG002|Overall Study|Protocol Violation|4|||
146703807|NCT04368429|529091035|FG000|Overall Study|Adverse Event|1|||
146703808|NCT04368429|529091036|FG001|Overall Study|Adverse Event|0|||
146703809|NCT03633396|529091039|FG000|Overall Study|Withdrawal by Subject|4|||
146703810|NCT03633396|529091040|FG001|Overall Study|Withdrawal by Subject|4|||
146703811|NCT03633396|529091039|FG000|Overall Study|Adverse Event|1|||
146703812|NCT03633396|529091040|FG001|Overall Study|Adverse Event|1|||
146703813|NCT03633396|529091039|FG000|Overall Study|Lack of Efficacy|1|||
146703814|NCT03633396|529091040|FG001|Overall Study|Lack of Efficacy|0|||
146703815|NCT03633396|529091039|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
146703816|NCT03633396|529091040|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
146703817|NCT01012817|529091041|FG000|Overall Study|Withdrawal by Subject|0|||
146703818|NCT01012817|529091042|FG001|Overall Study|Withdrawal by Subject|0|||
146703819|NCT01012817|529091043|FG002|Overall Study|Withdrawal by Subject|0|||
146703820|NCT01012817|529091044|FG003|Overall Study|Withdrawal by Subject|1|||
146703821|NCT01012817|529091045|FG004|Overall Study|Withdrawal by Subject|0|||
146703822|NCT01012817|529091046|FG005|Overall Study|Withdrawal by Subject|0|||
146703823|NCT01012817|529091047|FG006|Overall Study|Withdrawal by Subject|0|||
146703824|NCT01012817|529091048|FG007|Overall Study|Withdrawal by Subject|1|||
146703825|NCT01012817|529091049|FG008|Overall Study|Withdrawal by Subject|0|||
146703826|NCT01012817|529091050|FG009|Overall Study|Withdrawal by Subject|0|||
146703827|NCT01012817|529091051|FG010|Overall Study|Withdrawal by Subject|1|||
146703828|NCT01012817|529091052|FG011|Overall Study|Withdrawal by Subject|1|||
146703829|NCT01012817|529091053|FG012|Overall Study|Withdrawal by Subject|0|||
146703830|NCT01012817|529091054|FG013|Overall Study|Withdrawal by Subject|1|||
146703831|NCT01012817|529091041|FG000|Overall Study|Adverse Event|0|||
146703832|NCT01012817|529091042|FG001|Overall Study|Adverse Event|0|||
146703833|NCT01012817|529091043|FG002|Overall Study|Adverse Event|0|||
146703834|NCT01012817|529091044|FG003|Overall Study|Adverse Event|0|||
146703835|NCT01012817|529091045|FG004|Overall Study|Adverse Event|0|||
146703836|NCT01012817|529091046|FG005|Overall Study|Adverse Event|1|||
146703837|NCT01012817|529091047|FG006|Overall Study|Adverse Event|0|||
146703838|NCT01012817|529091048|FG007|Overall Study|Adverse Event|0|||
146703839|NCT01012817|529091049|FG008|Overall Study|Adverse Event|0|||
146703840|NCT01012817|529091050|FG009|Overall Study|Adverse Event|0|||
146703841|NCT01012817|529091051|FG010|Overall Study|Adverse Event|1|||
146703842|NCT01012817|529091052|FG011|Overall Study|Adverse Event|0|||
146703843|NCT01012817|529091053|FG012|Overall Study|Adverse Event|0|||
146703844|NCT01012817|529091054|FG013|Overall Study|Adverse Event|1|||
146703845|NCT02472756|529091055|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
146703846|NCT02472756|529091055|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
146703847|NCT02472756|529091055|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
146703848|NCT02472756|529091055|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
146703849|NCT02472756|529091055|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
146703850|NCT02143414|529091056|FG000|Induction|Adverse Event|1|||
146703851|NCT02143414|529091057|FG001|Induction|Adverse Event|2|||
146703852|NCT02143414|529091056|FG000|Induction|Death|1|||
146703853|NCT02143414|529091057|FG001|Induction|Death|2|||
146703854|NCT02143414|529091056|FG000|Induction|Patient refusal|1|||
146703855|NCT02143414|529091057|FG001|Induction|Patient refusal|1|||
146703856|NCT02143414|529091056|FG000|Induction|Refractory|1|||
146703857|NCT02143414|529091057|FG001|Induction|Refractory|0|||
146703858|NCT02143414|529091056|FG000|Induction|Began alternative treatment|1|||
146703859|NCT02143414|529091057|FG001|Induction|Began alternative treatment|0|||
146703860|NCT02143414|529091056|FG000|Induction|Ineligible for postremission|5|||
146703861|NCT02143414|529091057|FG001|Induction|Ineligible for postremission|1|||
146981001|NCT00720798|530093709|FG000|Overall Study|Death|39|||
146981002|NCT00720798|530093709|FG000|Overall Study|Insufficient Therapeutic Response|129|||
146981003|NCT00720798|530093709|FG000|Overall Study|Protocol Violation|4|||
146981004|NCT00720798|530093709|FG000|Overall Study|Refused Treatment|151|||
146981005|NCT00720798|530093709|FG000|Overall Study|Failure to Return|46|||
146981006|NCT00720798|530093709|FG000|Overall Study|Reason not Specified|83|||
146981007|NCT00433381|530093710|FG000|Overall Study|Ineligible / no protocol treatment|3|||
146981008|NCT00433381|530093711|FG001|Overall Study|Ineligible / no protocol treatment|3|||
146703862|NCT02143414|529091056|FG000|Post-remission|Adverse Event|0|||
146703863|NCT02143414|529091057|FG001|Post-remission|Adverse Event|2|||
146703864|NCT02143414|529091056|FG000|Post-remission|Disease progression/relapse|5|||
146703865|NCT02143414|529091057|FG001|Post-remission|Disease progression/relapse|0|||
146703866|NCT02143414|529091056|FG000|Maintenance|Adverse Event|4|||
146703867|NCT02143414|529091057|FG001|Maintenance|Adverse Event|6|||
146703868|NCT02143414|529091056|FG000|Maintenance|Disease progression/relapse|3|||
146703869|NCT02143414|529091057|FG001|Maintenance|Disease progression/relapse|2|||
146703870|NCT02143414|529091056|FG000|Maintenance|Patient refusal|2|||
146703871|NCT02143414|529091057|FG001|Maintenance|Patient refusal|1|||
146703872|NCT02143414|529091056|FG000|Maintenance|Physician Decision|1|||
146703873|NCT02143414|529091057|FG001|Maintenance|Physician Decision|0|||
146703874|NCT02143414|529091056|FG000|Maintenance|Death|0|||
146703875|NCT02143414|529091057|FG001|Maintenance|Death|1|||
146703876|NCT02143414|529091056|FG000|Maintenance|On protocol treatment|0|||
146703877|NCT02143414|529091057|FG001|Maintenance|On protocol treatment|6|||
146703878|NCT00978731|529091061|FG000|Overall Study|Death|4|||
146703879|NCT00978731|529091062|FG001|Overall Study|Death|1|||
146703880|NCT00978731|529091063|FG002|Overall Study|Death|1|||
146703881|NCT00978731|529091064|FG003|Overall Study|Death|0|||
146703882|NCT00978731|529091061|FG000|Overall Study|Lost to Follow-up|0|||
146703883|NCT00978731|529091062|FG001|Overall Study|Lost to Follow-up|0|||
146703884|NCT00978731|529091063|FG002|Overall Study|Lost to Follow-up|0|||
146703885|NCT00978731|529091064|FG003|Overall Study|Lost to Follow-up|1|||
146703886|NCT00978731|529091061|FG000|Overall Study|Adverse Event|5|||
146703887|NCT00978731|529091062|FG001|Overall Study|Adverse Event|2|||
146703888|NCT00978731|529091063|FG002|Overall Study|Adverse Event|0|||
146703889|NCT00978731|529091064|FG003|Overall Study|Adverse Event|0|||
146981009|NCT00434161|530093712|FG000|Overall Study|Adverse Event|5|||
146981010|NCT00434161|530093713|FG001|Overall Study|Adverse Event|1|||
146981011|NCT00434161|530093714|FG002|Overall Study|Adverse Event|4|||
146981012|NCT00434161|530093712|FG000|Overall Study|Lost to Follow-up|0|||
146703890|NCT00978731|529091061|FG000|Overall Study|Participant's request|1|||
146703891|NCT00978731|529091062|FG001|Overall Study|Participant's request|0|||
146703892|NCT00978731|529091063|FG002|Overall Study|Participant's request|0|||
146703893|NCT00978731|529091064|FG003|Overall Study|Participant's request|0|||
146703894|NCT00978731|529091061|FG000|Overall Study|Administrative reason|3|||
146703895|NCT00978731|529091062|FG001|Overall Study|Administrative reason|3|||
146703896|NCT00978731|529091063|FG002|Overall Study|Administrative reason|1|||
146703897|NCT00978731|529091064|FG003|Overall Study|Administrative reason|0|||
146703898|NCT00978731|529091061|FG000|Overall Study|Deterioration without progression|0|||
146703899|NCT00978731|529091062|FG001|Overall Study|Deterioration without progression|1|||
146703900|NCT00978731|529091063|FG002|Overall Study|Deterioration without progression|0|||
146848396|NCT02245737|529615669|FG002|Overall Study|Death|4|||
146848397|NCT02245737|529615667|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
146848398|NCT02245737|529615668|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
146848399|NCT02245737|529615669|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
146848400|NCT02245737|529615667|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
146848401|NCT02245737|529615668|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
146848402|NCT02245737|529615669|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
146848403|NCT02245737|529615667|FG000|Overall Study|Lost to Follow-up|2|||
146848404|NCT02245737|529615668|FG001|Overall Study|Lost to Follow-up|5|||
146703901|NCT00978731|529091064|FG003|Overall Study|Deterioration without progression|0|||
146703902|NCT00978731|529091061|FG000|Overall Study|Disease progression/relapse|5|||
146703903|NCT00978731|529091062|FG001|Overall Study|Disease progression/relapse|4|||
146703904|NCT00978731|529091063|FG002|Overall Study|Disease progression/relapse|2|||
146703905|NCT00978731|529091064|FG003|Overall Study|Disease progression/relapse|2|||
146703906|NCT00978731|529091061|FG000|Overall Study|Study closure|3|||
146703907|NCT00978731|529091062|FG001|Overall Study|Study closure|4|||
146703908|NCT00978731|529091063|FG002|Overall Study|Study closure|1|||
146703909|NCT00978731|529091064|FG003|Overall Study|Study closure|1|||
146703910|NCT00978731|529091061|FG000|Overall Study|No response|1|||
146703911|NCT00978731|529091062|FG001|Overall Study|No response|0|||
146703912|NCT00978731|529091063|FG002|Overall Study|No response|0|||
146703913|NCT00978731|529091064|FG003|Overall Study|No response|0|||
146703914|NCT00110266|529091065|FG000|Overall Study|Adverse Event|27|||
146703915|NCT00110266|529091065|FG000|Overall Study|Abnormal laboratory value|15|||
146703916|NCT00110266|529091065|FG000|Overall Study|Withdrawal by Subject|16|||
146703917|NCT00110266|529091065|FG000|Overall Study|Death|17|||
146703918|NCT00110266|529091065|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146703919|NCT00110266|529091065|FG000|Overall Study|Participant condition no longer requires study drug|1|||
146703920|NCT00293384|529091066|FG000|Overall Study|Non-compliance|2|||
146703921|NCT00293384|529091066|FG000|Overall Study|Missed dosage/study drug|1|||
146703922|NCT00293384|529091066|FG000|Overall Study|Ineligible|2|||
146703923|NCT03285646|529091081|FG000|Overall Study|Adverse Event|1|||
146703924|NCT03285646|529091082|FG001|Overall Study|Adverse Event|0|||
146703925|NCT03285646|529091081|FG000|Overall Study|Withdrawal by Subject|10|||
146703926|NCT03285646|529091082|FG001|Overall Study|Withdrawal by Subject|2|||
146703927|NCT03285646|529091081|FG000|Overall Study|Lost to Follow-up|2|||
146703928|NCT03285646|529091082|FG001|Overall Study|Lost to Follow-up|1|||
146703929|NCT03285646|529091081|FG000|Overall Study|Investigator/Sponsor Decision|0|||
146703930|NCT03285646|529091082|FG001|Overall Study|Investigator/Sponsor Decision|1|||
146703931|NCT00548808|529091086|FG000|Overall Study|Lost to Follow-up|9|||
146703932|NCT00548808|529091087|FG001|Overall Study|Lost to Follow-up|3|||
146703933|NCT00548808|529091086|FG000|Overall Study|Protocol Violation|8|||
146703934|NCT00548808|529091087|FG001|Overall Study|Protocol Violation|8|||
146703935|NCT00548808|529091086|FG000|Overall Study|Withdrawal by Subject|8|||
146703936|NCT00548808|529091087|FG001|Overall Study|Withdrawal by Subject|4|||
146703937|NCT00548808|529091086|FG000|Overall Study|Physician Decision|6|||
146703938|NCT00548808|529091087|FG001|Overall Study|Physician Decision|3|||
146703939|NCT00548808|529091086|FG000|Overall Study|Adverse Event|4|||
146703940|NCT00548808|529091087|FG001|Overall Study|Adverse Event|5|||
146703941|NCT00548808|529091086|FG000|Overall Study|Death|2|||
146703942|NCT00548808|529091087|FG001|Overall Study|Death|0|||
146703943|NCT00548808|529091086|FG000|Overall Study|Entry Criteria Not Met|2|||
146703944|NCT00548808|529091087|FG001|Overall Study|Entry Criteria Not Met|2|||
146703945|NCT00548808|529091086|FG000|Overall Study|Lack of Efficacy|2|||
146703946|NCT00548808|529091087|FG001|Overall Study|Lack of Efficacy|0|||
146703947|NCT00548808|529091086|FG000|Overall Study|Sponsor Decision|1|||
146703948|NCT00548808|529091087|FG001|Overall Study|Sponsor Decision|1|||
146703949|NCT04300296|529091088|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
146703950|NCT04300296|529091089|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
146703951|NCT04300296|529091090|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
146703952|NCT04300296|529091091|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
146703953|NCT04300296|529091092|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
146703954|NCT04300296|529091093|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
146703955|NCT04300296|529091088|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
146703956|NCT04300296|529091089|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
146703957|NCT04300296|529091090|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
146703958|NCT04300296|529091091|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
146703959|NCT04300296|529091092|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
146703960|NCT04300296|529091093|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
146703961|NCT04300296|529091088|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
146703962|NCT04300296|529091089|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
146703963|NCT04300296|529091090|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
146703964|NCT04300296|529091091|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
146703965|NCT04300296|529091092|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
146703966|NCT04300296|529091093|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
146703967|NCT04300296|529091088|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
146703968|NCT04300296|529091089|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
146703969|NCT04300296|529091090|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
146703970|NCT04300296|529091091|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
146703971|NCT04300296|529091092|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
146703972|NCT04300296|529091093|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
146703973|NCT04300296|529091088|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
146703974|NCT04300296|529091089|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
146703975|NCT04300296|529091090|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
146703976|NCT04300296|529091091|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
146703977|NCT04300296|529091092|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
146703978|NCT04300296|529091093|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
146703979|NCT04300296|529091088|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
146703980|NCT04300296|529091089|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
146703981|NCT04300296|529091090|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
146703982|NCT04300296|529091091|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
146703983|NCT04300296|529091092|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
146703984|NCT04300296|529091093|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
146981013|NCT00434161|530093713|FG001|Overall Study|Lost to Follow-up|1|||
146776871|NCT02723955|529353614|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776872|NCT02723955|529353615|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776873|NCT02723955|529353616|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146703985|NCT04300296|529091088|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
146703986|NCT04300296|529091089|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
146703987|NCT04300296|529091090|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
146703988|NCT04300296|529091091|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
146703989|NCT04300296|529091092|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
146703990|NCT04300296|529091093|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
146703991|NCT05044234|529091097|FG000|Overall Study|Lost to Follow-up|2|||
146703992|NCT05044234|529091098|FG001|Overall Study|Lost to Follow-up|1|||
146703993|NCT05044234|529091099|FG002|Overall Study|Lost to Follow-up|1|||
146703994|NCT05044234|529091100|FG003|Overall Study|Lost to Follow-up|2|||
146703995|NCT05044234|529091097|FG000|Overall Study|Withdrawal by Subject|6|||
146703996|NCT05044234|529091098|FG001|Overall Study|Withdrawal by Subject|4|||
146703997|NCT05044234|529091099|FG002|Overall Study|Withdrawal by Subject|5|||
146703998|NCT05044234|529091100|FG003|Overall Study|Withdrawal by Subject|8|||
146703999|NCT05044234|529091097|FG000|Overall Study|Study terminated by Sponsor|21|||
146704000|NCT05044234|529091098|FG001|Overall Study|Study terminated by Sponsor|21|||
146704001|NCT05044234|529091099|FG002|Overall Study|Study terminated by Sponsor|20|||
146704002|NCT05044234|529091100|FG003|Overall Study|Study terminated by Sponsor|14|||
146704003|NCT05044234|529091097|FG000|Overall Study|Other, not specified|0|||
146704004|NCT05044234|529091098|FG001|Overall Study|Other, not specified|0|||
146704005|NCT05044234|529091099|FG002|Overall Study|Other, not specified|1|||
146704006|NCT05044234|529091100|FG003|Overall Study|Other, not specified|2|||
146704007|NCT05044234|529091097|FG000|Overall Study|Delayed data entry|0|||
146704008|NCT05044234|529091098|FG001|Overall Study|Delayed data entry|0|||
146704009|NCT05044234|529091099|FG002|Overall Study|Delayed data entry|0|||
146704010|NCT05044234|529091100|FG003|Overall Study|Delayed data entry|1|||
146704011|NCT00279708|529091101|FG000|Overall Study|Withdrawal by Subject|2|||
146776874|NCT02723955|529353617|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776875|NCT02723955|529353618|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776876|NCT02723955|529353619|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776877|NCT02723955|529353620|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776878|NCT02723955|529353621|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
146776879|NCT02723955|529353622|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
146776880|NCT02723955|529353623|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
146848405|NCT02245737|529615669|FG002|Overall Study|Lost to Follow-up|4|||
146848406|NCT02245737|529615667|FG000|Overall Study|Other-determined by Investigator|9|||
146848407|NCT02245737|529615668|FG001|Overall Study|Other-determined by Investigator|10|||
146848408|NCT02245737|529615669|FG002|Overall Study|Other-determined by Investigator|10|||
146848409|NCT02245737|529615667|FG000|Overall Study|Physician Decision|6|||
146848410|NCT02245737|529615668|FG001|Overall Study|Physician Decision|3|||
146704012|NCT00279708|529091102|FG001|Overall Study|Withdrawal by Subject|3|||
146704013|NCT00279708|529091101|FG000|Overall Study|Adverse Event|1|||
146848411|NCT02245737|529615669|FG002|Overall Study|Physician Decision|6|||
146848412|NCT02245737|529615667|FG000|Overall Study|Protocol Violation|3|||
146848413|NCT02245737|529615668|FG001|Overall Study|Protocol Violation|2|||
146848414|NCT02245737|529615669|FG002|Overall Study|Protocol Violation|3|||
146848415|NCT02245737|529615667|FG000|Overall Study|Withdrawal by Subject|40|||
146848416|NCT02245737|529615668|FG001|Overall Study|Withdrawal by Subject|41|||
146848417|NCT02245737|529615669|FG002|Overall Study|Withdrawal by Subject|44|||
146848418|NCT02245737|529615667|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
146848419|NCT02245737|529615668|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
146848420|NCT02245737|529615669|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
146848421|NCT02245737|529615667|FG000|Overall Study|Sponsor Decision|445|||
146704014|NCT00279708|529091102|FG001|Overall Study|Adverse Event|1|||
146704015|NCT02896127|529091103|FG000|COMPLETED WEEK 52|Adverse Event|9|||
146704016|NCT02896127|529091104|FG001|COMPLETED WEEK 52|Adverse Event|2|||
146704017|NCT02896127|529091103|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
146704018|NCT02896127|529091104|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
146704019|NCT02896127|529091103|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
146704020|NCT02896127|529091104|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
146704021|NCT02896127|529091103|FG000|COMPLETED WEEK 52|Physician Decision|1|||
146704022|NCT02896127|529091104|FG001|COMPLETED WEEK 52|Physician Decision|1|||
146704023|NCT02896127|529091103|FG000|COMPLETED WEEK 52|Pregnancy|2|||
146704024|NCT02896127|529091104|FG001|COMPLETED WEEK 52|Pregnancy|0|||
146704025|NCT02896127|529091103|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
146704026|NCT02896127|529091104|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
146704027|NCT02896127|529091103|FG000|COMPLETED WEEK 52|Technical problems|1|||
146704028|NCT02896127|529091104|FG001|COMPLETED WEEK 52|Technical problems|0|||
146704029|NCT02896127|529091103|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
146704030|NCT02896127|529091104|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
146704031|NCT02896127|529091103|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
146704032|NCT02896127|529091104|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
146704033|NCT02896127|529091103|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
146704034|NCT02896127|529091104|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
146704035|NCT02896127|529091103|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
146704036|NCT02896127|529091104|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
146704037|NCT02896127|529091103|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
146704038|NCT02896127|529091104|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
146704039|NCT02940691|529091105|FG000|Overall Study|Lost to Follow-up|5|||
146704040|NCT02940691|529091105|FG000|Overall Study|Incarceration|1|||
146704041|NCT03912233|529091106|FG000|Overall Study|Adverse Event|1|||
146704042|NCT03912233|529091107|FG001|Overall Study|Adverse Event|0|||
146704043|NCT03912233|529091108|FG002|Overall Study|Adverse Event|0|||
146704044|NCT03912233|529091109|FG003|Overall Study|Adverse Event|0|||
146704045|NCT03912233|529091110|FG004|Overall Study|Adverse Event|0|||
146704046|NCT03912233|529091111|FG005|Overall Study|Adverse Event|0|||
146704047|NCT03912233|529091106|FG000|Overall Study|Physician Decision|1|||
146704048|NCT03912233|529091107|FG001|Overall Study|Physician Decision|0|||
146704049|NCT03912233|529091108|FG002|Overall Study|Physician Decision|0|||
146704050|NCT03912233|529091109|FG003|Overall Study|Physician Decision|0|||
146704051|NCT03912233|529091110|FG004|Overall Study|Physician Decision|0|||
146704052|NCT03912233|529091111|FG005|Overall Study|Physician Decision|0|||
146704053|NCT03912233|529091106|FG000|Overall Study|Other|0|||
146704054|NCT03912233|529091107|FG001|Overall Study|Other|0|||
146704055|NCT03912233|529091108|FG002|Overall Study|Other|0|||
146704056|NCT03912233|529091109|FG003|Overall Study|Other|0|||
146704057|NCT03912233|529091110|FG004|Overall Study|Other|7|||
146704058|NCT03912233|529091111|FG005|Overall Study|Other|12|||
146704059|NCT00326911|529091112|FG000|Overall Study|Hospitalization prior to treatment|0|||
146704060|NCT00326911|529091113|FG001|Overall Study|Hospitalization prior to treatment|1|||
146704061|NCT00326911|529091112|FG000|Overall Study|Physician decision prior to treatment|1|||
146704062|NCT00326911|529091113|FG001|Overall Study|Physician decision prior to treatment|0|||
146704063|NCT00326911|529091112|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
146704064|NCT00326911|529091113|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
146704065|NCT04537806|529091122|FG000|Overall Study|Randomized but not treated|1|||
146704066|NCT04537806|529091123|FG001|Overall Study|Randomized but not treated|0|||
146704067|NCT04537806|529091122|FG000|Overall Study|Adverse Event|1|||
146704068|NCT04537806|529091123|FG001|Overall Study|Adverse Event|1|||
146704069|NCT02477020|529091126|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
146704070|NCT02477020|529091127|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
146704071|NCT02477020|529091126|FG000|Overall Study|Voluntary Withdrawal|7|||
146704072|NCT02477020|529091127|FG001|Overall Study|Voluntary Withdrawal|16|||
146704073|NCT02477020|529091126|FG000|Overall Study|Reason not Specified|3|||
146704074|NCT02477020|529091127|FG001|Overall Study|Reason not Specified|1|||
146704075|NCT02477020|529091126|FG000|Overall Study|Lack of Efficacy|14|||
146704076|NCT02477020|529091127|FG001|Overall Study|Lack of Efficacy|5|||
146704077|NCT00501540|529091131|FG000|Overall Study|Death|5|||
146704078|NCT00519649|529091132|FG000|Overall Study|Withdrawal by Subject|1|||
146704079|NCT01465802|529091133|FG000|Overall Study|Study terminated by sponsor|1|||
146704080|NCT01465802|529091134|FG001|Overall Study|Study terminated by sponsor|0|||
146933444|NCT00006604|529913991|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
146704081|NCT01465802|529091135|FG002|Overall Study|Study terminated by sponsor|0|||
146704082|NCT01465802|529091136|FG003|Overall Study|Study terminated by sponsor|1|||
146704083|NCT01465802|529091137|FG004|Overall Study|Study terminated by sponsor|7|||
146704084|NCT01465802|529091133|FG000|Overall Study|Withdrawal by Subject|7|||
146704085|NCT01465802|529091134|FG001|Overall Study|Withdrawal by Subject|7|||
146704086|NCT01465802|529091135|FG002|Overall Study|Withdrawal by Subject|0|||
146933445|NCT00006604|529913992|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
146704087|NCT01465802|529091136|FG003|Overall Study|Withdrawal by Subject|8|||
146704088|NCT01465802|529091137|FG004|Overall Study|Withdrawal by Subject|1|||
146704089|NCT01465802|529091133|FG000|Overall Study|Lost to Follow-up|1|||
146704090|NCT01465802|529091134|FG001|Overall Study|Lost to Follow-up|1|||
146704091|NCT01465802|529091135|FG002|Overall Study|Lost to Follow-up|0|||
146704092|NCT01465802|529091136|FG003|Overall Study|Lost to Follow-up|0|||
146704093|NCT01465802|529091137|FG004|Overall Study|Lost to Follow-up|0|||
146704094|NCT01465802|529091133|FG000|Overall Study|Reason not specified|9|||
146704095|NCT01465802|529091134|FG001|Overall Study|Reason not specified|4|||
146704096|NCT01465802|529091135|FG002|Overall Study|Reason not specified|0|||
146704097|NCT01465802|529091136|FG003|Overall Study|Reason not specified|10|||
146704098|NCT01465802|529091137|FG004|Overall Study|Reason not specified|2|||
146704099|NCT01465802|529091133|FG000|Overall Study|Death|15|||
146704100|NCT01465802|529091134|FG001|Overall Study|Death|12|||
146704101|NCT01465802|529091135|FG002|Overall Study|Death|0|||
146704102|NCT01465802|529091136|FG003|Overall Study|Death|10|||
146704103|NCT01465802|529091137|FG004|Overall Study|Death|2|||
146704104|NCT03219333|529091138|FG000|Overall Study|Withdrawal by Subject|9|||
146704105|NCT03219333|529091139|FG001|Overall Study|Withdrawal by Subject|4|||
146704106|NCT03219333|529091138|FG000|Overall Study|Lost to Follow-up|1|||
146704107|NCT03219333|529091139|FG001|Overall Study|Lost to Follow-up|1|||
146704108|NCT03219333|529091138|FG000|Overall Study|Death|104|||
146704109|NCT03219333|529091139|FG001|Overall Study|Death|72|||
146704110|NCT03219333|529091138|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
146704111|NCT03219333|529091139|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
146704112|NCT03219333|529091138|FG000|Overall Study|Other|2|||
146704113|NCT03219333|529091139|FG001|Overall Study|Other|2|||
146704114|NCT04304001|529091142|FG000|Overall Study|Lost to Follow-up|13|||
146704115|NCT04304001|529091143|FG001|Overall Study|Lost to Follow-up|9|||
146704116|NCT05220397|529091144|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
146704117|NCT05220397|529091145|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
146704118|NCT05220397|529091146|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
146704119|NCT05220397|529091147|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
146704120|NCT05220397|529091148|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
146704121|NCT02052739|529091151|FG000|Overall Study|Withdrew due to Adverse Event|3|||
146704122|NCT02052739|529091152|FG001|Overall Study|Withdrew due to Adverse Event|0|||
146704123|NCT02052739|529091151|FG000|Overall Study|Participant Died|2|||
146704124|NCT02052739|529091152|FG001|Overall Study|Participant Died|1|||
146704125|NCT01573624|529091153|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
146704126|NCT01573624|529091154|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
146704127|NCT01573624|529091155|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
146704128|NCT01573624|529091156|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
146704129|NCT01573624|529091157|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
146704130|NCT01573624|529091158|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
146704131|NCT01573624|529091159|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
146704132|NCT01573624|529091153|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
146704133|NCT01573624|529091154|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
146704134|NCT01573624|529091155|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
146933446|NCT00006604|529913993|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
146933447|NCT00006604|529913994|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
146933448|NCT00006604|529913995|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
146704135|NCT01573624|529091156|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
146704136|NCT01573624|529091157|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
146704137|NCT01573624|529091158|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
146704138|NCT01573624|529091159|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
146704139|NCT01573624|529091153|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
146704140|NCT01573624|529091154|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
146704141|NCT01573624|529091155|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
146704142|NCT01573624|529091156|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
146704143|NCT01573624|529091157|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
146704144|NCT01573624|529091158|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
146704145|NCT01573624|529091159|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
146704146|NCT01573624|529091153|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
146704147|NCT01573624|529091154|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146704148|NCT01573624|529091155|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
146704149|NCT01573624|529091156|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146704150|NCT01573624|529091157|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146704151|NCT01573624|529091158|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
146933449|NCT00006604|529913996|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
146704152|NCT01573624|529091159|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146704153|NCT01573624|529091153|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
146704154|NCT01573624|529091154|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
146704155|NCT01573624|529091155|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
146704156|NCT01573624|529091156|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
146704157|NCT01573624|529091157|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
146704158|NCT01573624|529091158|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
146704159|NCT01573624|529091159|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
146704160|NCT01573624|529091153|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
146704161|NCT01573624|529091154|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
146704162|NCT01573624|529091155|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
146704163|NCT01573624|529091156|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
146704164|NCT01573624|529091157|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
146704165|NCT01573624|529091158|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
146704166|NCT01573624|529091159|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
146704167|NCT01573624|529091153|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
146704168|NCT01573624|529091154|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
146704169|NCT01573624|529091155|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
146704170|NCT01573624|529091156|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
146704171|NCT01573624|529091157|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
146704172|NCT01573624|529091158|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
146704173|NCT01573624|529091159|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
146704174|NCT01573624|529091153|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
146704175|NCT01573624|529091154|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146704176|NCT01573624|529091155|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
146704177|NCT01573624|529091156|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
146704178|NCT01573624|529091157|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146704179|NCT01573624|529091158|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146704180|NCT01573624|529091159|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146704181|NCT01573624|529091153|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
146704182|NCT01573624|529091154|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
146704183|NCT01573624|529091155|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
146704184|NCT01573624|529091156|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
146704185|NCT01573624|529091157|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
146704186|NCT01573624|529091158|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
146704187|NCT01573624|529091159|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
146704188|NCT01573624|529091153|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
146704189|NCT01573624|529091154|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
146704190|NCT01573624|529091155|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
146704191|NCT01573624|529091156|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
146704192|NCT01573624|529091157|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
146704193|NCT01573624|529091158|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
146704194|NCT01573624|529091159|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
146933450|NCT00006604|529913997|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
146933451|NCT00006604|529913998|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
146933452|NCT00006604|529913999|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
146933453|NCT00006604|529914000|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
146933454|NCT00006604|529914001|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
146933455|NCT00006604|529914002|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
146933456|NCT00006604|529914003|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
146933457|NCT00006604|529914004|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
146933458|NCT00006604|529914005|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
146933459|NCT00006604|529914006|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
146704195|NCT01573624|529091153|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
146704196|NCT01573624|529091154|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
146704197|NCT01573624|529091155|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
146704198|NCT01573624|529091156|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
146704199|NCT01573624|529091157|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
146704200|NCT01573624|529091158|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
146776881|NCT02723955|529353624|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146933460|NCT00006604|529914007|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
146704201|NCT01573624|529091159|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
146704202|NCT01573624|529091153|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
146704203|NCT01573624|529091154|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
146704204|NCT01573624|529091155|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
146704205|NCT01573624|529091156|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
146704206|NCT01573624|529091157|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
146704207|NCT01573624|529091158|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
146704208|NCT01573624|529091159|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
146704209|NCT01573624|529091153|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
146704210|NCT01573624|529091154|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
146704211|NCT01573624|529091155|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
146704212|NCT01573624|529091156|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
146704213|NCT01573624|529091157|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
146704214|NCT01573624|529091158|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
146704215|NCT01573624|529091159|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
146704216|NCT01573624|529091153|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
146704217|NCT01573624|529091154|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
146704218|NCT01573624|529091155|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
146704219|NCT01573624|529091156|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
146704220|NCT01573624|529091157|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
146704221|NCT01573624|529091158|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
146704222|NCT01573624|529091159|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
146704223|NCT01573624|529091153|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
146704224|NCT01573624|529091154|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
146704225|NCT01573624|529091155|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
146704226|NCT01573624|529091156|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
146704227|NCT01573624|529091157|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
146704228|NCT01573624|529091158|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
146704229|NCT01573624|529091159|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
146704230|NCT01573624|529091153|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
146704231|NCT01573624|529091154|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
146704232|NCT01573624|529091155|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
146704233|NCT01573624|529091156|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
146704234|NCT01573624|529091157|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
146704235|NCT01573624|529091158|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
146704236|NCT01573624|529091159|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
146704237|NCT01573624|529091153|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
146704238|NCT01573624|529091154|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
146704239|NCT01573624|529091155|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
146704240|NCT01573624|529091156|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
146704241|NCT01573624|529091157|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
146704242|NCT01573624|529091158|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
146704243|NCT01573624|529091159|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
146704244|NCT01573624|529091153|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
146704245|NCT01573624|529091154|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
146704246|NCT01573624|529091155|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
146704247|NCT01573624|529091156|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
146704248|NCT01573624|529091157|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
146704249|NCT01573624|529091158|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
146704250|NCT01573624|529091159|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
146704251|NCT01573624|529091153|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
146704252|NCT01573624|529091154|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
146848422|NCT02245737|529615668|FG001|Overall Study|Sponsor Decision|430|||
146704253|NCT01573624|529091155|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
146704254|NCT01573624|529091156|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
146704255|NCT01573624|529091157|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
146704256|NCT01573624|529091158|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
146704257|NCT01573624|529091159|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
146704258|NCT01573624|529091153|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
146704259|NCT01573624|529091154|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
146704260|NCT01573624|529091155|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
146704261|NCT01573624|529091156|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
146704262|NCT01573624|529091157|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
146704263|NCT01573624|529091158|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
146704264|NCT01573624|529091159|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
146704265|NCT01573624|529091153|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146704266|NCT01573624|529091154|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146704267|NCT01573624|529091155|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146704268|NCT01573624|529091156|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146704269|NCT01573624|529091157|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146704270|NCT01573624|529091158|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
146704271|NCT01573624|529091159|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
146704272|NCT01573624|529091153|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
146704273|NCT01573624|529091154|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
146704274|NCT01573624|529091155|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
146704275|NCT01573624|529091156|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
146704276|NCT01573624|529091157|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
146704277|NCT01573624|529091158|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
146704278|NCT01573624|529091159|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
146704279|NCT01573624|529091153|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
146704280|NCT01573624|529091154|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146704281|NCT01573624|529091155|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146704282|NCT01573624|529091156|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146704283|NCT01573624|529091157|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
146704284|NCT01573624|529091158|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
146704285|NCT01573624|529091159|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
146704286|NCT01573624|529091153|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
146704287|NCT01573624|529091154|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
146704288|NCT01573624|529091155|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
146704289|NCT01573624|529091156|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
146704290|NCT01573624|529091157|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
146704291|NCT01573624|529091158|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
146704292|NCT01573624|529091159|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
146704293|NCT01573624|529091153|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
146704294|NCT01573624|529091154|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
146704295|NCT01573624|529091155|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
146704296|NCT01573624|529091156|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
146704297|NCT01573624|529091157|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
146704298|NCT01573624|529091158|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
146704299|NCT01573624|529091159|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
146704300|NCT01573624|529091153|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
146704301|NCT01573624|529091154|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
146704302|NCT01573624|529091155|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
146704303|NCT01573624|529091156|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
146704304|NCT01573624|529091157|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
146704305|NCT01573624|529091158|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
146704306|NCT01573624|529091159|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
146704307|NCT01573624|529091153|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
146704308|NCT01573624|529091154|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
146704309|NCT01573624|529091155|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
146704310|NCT01573624|529091156|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
146704311|NCT01573624|529091157|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
146704312|NCT01573624|529091158|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
146704313|NCT01573624|529091159|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
146704314|NCT05059600|529091160|FG000|Overall Study|Enrolled but not Treated|10|||
146704315|NCT04907032|529091162|FG000|Overall Study|Withdrawal by Subject|7|||
146704316|NCT04907032|529091163|FG001|Overall Study|Withdrawal by Subject|1|||
146704317|NCT02519712|529091165|FG000|Overall Study|Disease Relapse|1|||
146704318|NCT02519712|529091165|FG000|Overall Study|Disease Progression|1|||
146704319|NCT02519712|529091165|FG000|Overall Study|Accruals are donors|2|||
146704320|NCT04847674|529091174|FG000|Overall Study|Withdrawal by Subject|0|||
146704321|NCT04847674|529091175|FG001|Overall Study|Withdrawal by Subject|1|||
146704322|NCT04847674|529091176|FG002|Overall Study|Withdrawal by Subject|0|||
146704323|NCT04847674|529091174|FG000|Overall Study|Lost to Follow-up|0|||
146704324|NCT04847674|529091175|FG001|Overall Study|Lost to Follow-up|0|||
146704325|NCT04847674|529091176|FG002|Overall Study|Lost to Follow-up|2|||
146704326|NCT04847674|529091174|FG000|Overall Study|Other than specified|21|||
146704327|NCT04847674|529091175|FG001|Overall Study|Other than specified|20|||
146704328|NCT04847674|529091176|FG002|Overall Study|Other than specified|20|||
146704329|NCT02705820|529091177|FG000|Overall Study|Death|2|||
146704330|NCT02705820|529091177|FG000|Overall Study|Disease Progression|34|||
146704331|NCT02705820|529091177|FG000|Overall Study|Clinical Deterioration|3|||
146704332|NCT00677807|529091179|FG000|Overall Study|Adverse Event|4|||
146704333|NCT00677807|529091180|FG001|Overall Study|Adverse Event|1|||
146704334|NCT00677807|529091181|FG002|Overall Study|Adverse Event|6|||
146704335|NCT00677807|529091179|FG000|Overall Study|Lack of Efficacy|0|||
146704336|NCT00677807|529091180|FG001|Overall Study|Lack of Efficacy|0|||
146704337|NCT00677807|529091181|FG002|Overall Study|Lack of Efficacy|2|||
146704338|NCT00677807|529091179|FG000|Overall Study|Participant no longer needs study drug|0|||
146704339|NCT00677807|529091180|FG001|Overall Study|Participant no longer needs study drug|0|||
146704340|NCT00677807|529091181|FG002|Overall Study|Participant no longer needs study drug|1|||
146704341|NCT00677807|529091179|FG000|Overall Study|Withdrawal by Subject|10|||
146704342|NCT00677807|529091180|FG001|Overall Study|Withdrawal by Subject|3|||
146704343|NCT00677807|529091181|FG002|Overall Study|Withdrawal by Subject|6|||
146704344|NCT00677807|529091179|FG000|Overall Study|Lost to Follow-up|2|||
146704345|NCT00677807|529091180|FG001|Overall Study|Lost to Follow-up|2|||
146704346|NCT00677807|529091181|FG002|Overall Study|Lost to Follow-up|2|||
146704347|NCT00677807|529091179|FG000|Overall Study|Administrative problems|1|||
146704348|NCT00677807|529091180|FG001|Overall Study|Administrative problems|1|||
146704349|NCT00677807|529091181|FG002|Overall Study|Administrative problems|2|||
146704350|NCT00677807|529091179|FG000|Overall Study|Death|0|||
146704351|NCT00677807|529091180|FG001|Overall Study|Death|1|||
146704352|NCT00677807|529091181|FG002|Overall Study|Death|1|||
146704353|NCT00677807|529091179|FG000|Overall Study|Protocol Deviation|1|||
146704354|NCT00677807|529091180|FG001|Overall Study|Protocol Deviation|3|||
146704355|NCT00677807|529091181|FG002|Overall Study|Protocol Deviation|0|||
146704356|NCT01524770|529091187|FG000|First Intervention|Withdrawal by Subject|1|||
146704357|NCT01524770|529091188|FG001|First Intervention|Withdrawal by Subject|0|||
146704358|NCT01524770|529091187|FG000|First Intervention|Adverse Event|1|||
146704359|NCT01524770|529091188|FG001|First Intervention|Adverse Event|1|||
146704360|NCT01524770|529091187|FG000|First Intervention|Protocol Violation|1|||
146704361|NCT01524770|529091188|FG001|First Intervention|Protocol Violation|0|||
146704362|NCT00989833|529091190|FG000|Overall Study|Lost to Follow-up|0|||
146704363|NCT00989833|529091191|FG001|Overall Study|Lost to Follow-up|1|||
146704364|NCT00989833|529091192|FG002|Overall Study|Lost to Follow-up|0|||
146704365|NCT00989833|529091190|FG000|Overall Study|Protocol Violation|1|||
146704366|NCT00989833|529091191|FG001|Overall Study|Protocol Violation|2|||
146704367|NCT00989833|529091192|FG002|Overall Study|Protocol Violation|1|||
146704368|NCT00989833|529091190|FG000|Overall Study|Withdrawal by Subject|0|||
146704369|NCT00989833|529091191|FG001|Overall Study|Withdrawal by Subject|0|||
146704370|NCT00989833|529091192|FG002|Overall Study|Withdrawal by Subject|1|||
146704371|NCT00989833|529091190|FG000|Overall Study|Incorrectly randomized|1|||
146704372|NCT00989833|529091191|FG001|Overall Study|Incorrectly randomized|0|||
146704373|NCT00989833|529091192|FG002|Overall Study|Incorrectly randomized|0|||
146704374|NCT02167256|529091193|FG000|Overall Study|Adverse Event|13|||
146704375|NCT02167256|529091194|FG001|Overall Study|Adverse Event|6|||
146704376|NCT02167256|529091193|FG000|Overall Study|Withdrawal by Subject|4|||
146704377|NCT02167256|529091194|FG001|Overall Study|Withdrawal by Subject|4|||
146704378|NCT02167256|529091193|FG000|Overall Study|non-compliance|3|||
146704379|NCT02167256|529091194|FG001|Overall Study|non-compliance|0|||
146704380|NCT02167256|529091193|FG000|Overall Study|Study partner unable to participate|1|||
146704381|NCT02167256|529091194|FG001|Overall Study|Study partner unable to participate|0|||
146704382|NCT00414388|529091195|FG000|Overall Study|Adverse Event|1|||
146704383|NCT03467425|529091196|FG000|Overall Study|Adverse Event|9|||
146704384|NCT03467425|529091197|FG001|Overall Study|Adverse Event|9|||
146704385|NCT03467425|529091196|FG000|Overall Study|Lack of Efficacy|3|||
146704386|NCT03467425|529091197|FG001|Overall Study|Lack of Efficacy|1|||
146704387|NCT03467425|529091196|FG000|Overall Study|Protocol Violation|0|||
146704388|NCT03467425|529091197|FG001|Overall Study|Protocol Violation|1|||
146704389|NCT03467425|529091196|FG000|Overall Study|Lost to Follow-up|18|||
146704390|NCT03467425|529091197|FG001|Overall Study|Lost to Follow-up|25|||
146704391|NCT03467425|529091196|FG000|Overall Study|Physician Decision|2|||
146704392|NCT03467425|529091197|FG001|Overall Study|Physician Decision|1|||
146704393|NCT03467425|529091196|FG000|Overall Study|Withdrawal by Subject|15|||
146704394|NCT03467425|529091197|FG001|Overall Study|Withdrawal by Subject|17|||
146704395|NCT01864291|529091198|FG000|Overall Study|need for revision surgery|2|||
146704396|NCT03091192|529091205|FG000|Overall Study|Study terminated by sponsor|21|||
146704397|NCT03091192|529091206|FG001|Overall Study|Study terminated by sponsor|14|||
146704398|NCT03091192|529091205|FG000|Overall Study|Death|9|||
146704399|NCT03091192|529091206|FG001|Overall Study|Death|13|||
146704400|NCT03091192|529091205|FG000|Overall Study|Withdrawal by Subject|2|||
146704401|NCT03091192|529091206|FG001|Overall Study|Withdrawal by Subject|0|||
146704402|NCT03091192|529091205|FG000|Overall Study|Lost to Follow-up|1|||
146704403|NCT03091192|529091206|FG001|Overall Study|Lost to Follow-up|0|||
146704404|NCT02349711|529092363|FG000|Overall Study|Withdrawal by Subject|2|||
146704405|NCT02349711|529092364|FG001|Overall Study|Withdrawal by Subject|1|||
146704406|NCT02349711|529092363|FG000|Overall Study|Lost to Follow-up|1|||
146704407|NCT02349711|529092364|FG001|Overall Study|Lost to Follow-up|1|||
146704408|NCT02096835|529092370|FG000|Overall Study|Withdrawal by Subject|1|||
146704409|NCT02096835|529092371|FG001|Overall Study|Withdrawal by Subject|0|||
146704410|NCT02096835|529092372|FG002|Overall Study|Withdrawal by Subject|0|||
146704411|NCT02096835|529092370|FG000|Overall Study|converted to open procedures|1|||
146704412|NCT02096835|529092371|FG001|Overall Study|converted to open procedures|0|||
146704413|NCT02096835|529092372|FG002|Overall Study|converted to open procedures|0|||
146704414|NCT02096835|529092370|FG000|Overall Study|Lost to Follow-up|1|||
146704415|NCT02096835|529092371|FG001|Overall Study|Lost to Follow-up|0|||
146704416|NCT02096835|529092372|FG002|Overall Study|Lost to Follow-up|1|||
146704417|NCT00023673|529092374|FG000|Overall Study|Ineligible / no protocol treatment|0|||
146704418|NCT00023673|529092375|FG001|Overall Study|Ineligible / no protocol treatment|0|||
146704419|NCT00023673|529092376|FG002|Overall Study|Ineligible / no protocol treatment|0|||
146704420|NCT00023673|529092377|FG003|Overall Study|Ineligible / no protocol treatment|1|||
146704421|NCT00023673|529092374|FG000|Overall Study|Patient withdrew consent|0|||
146704422|NCT00023673|529092375|FG001|Overall Study|Patient withdrew consent|0|||
146704423|NCT00023673|529092376|FG002|Overall Study|Patient withdrew consent|0|||
146704424|NCT00023673|529092377|FG003|Overall Study|Patient withdrew consent|1|||
146704425|NCT02453594|529092378|FG000|Overall Study|Protocol Violation|0|||
146704426|NCT02453594|529092379|FG001|Overall Study|Protocol Violation|0|||
146704427|NCT02453594|529092380|FG002|Overall Study|Protocol Violation|1|||
146704428|NCT02453594|529092378|FG000|Overall Study|Cohort Was Closed|17|||
146704429|NCT02453594|529092379|FG001|Overall Study|Cohort Was Closed|21|||
146704430|NCT02453594|529092380|FG002|Overall Study|Cohort Was Closed|14|||
146704431|NCT02453594|529092378|FG000|Overall Study|Death|20|||
146704432|NCT02453594|529092379|FG001|Overall Study|Death|24|||
146704433|NCT02453594|529092380|FG002|Overall Study|Death|16|||
146704434|NCT02453594|529092378|FG000|Overall Study|Lost to Follow-up|6|||
146704435|NCT02453594|529092379|FG001|Overall Study|Lost to Follow-up|14|||
146704436|NCT02453594|529092380|FG002|Overall Study|Lost to Follow-up|2|||
146704437|NCT02453594|529092378|FG000|Overall Study|Physician Decision|2|||
146704438|NCT02453594|529092379|FG001|Overall Study|Physician Decision|4|||
146704439|NCT02453594|529092380|FG002|Overall Study|Physician Decision|0|||
146704440|NCT02453594|529092378|FG000|Overall Study|Site Terminated by Sponsor|1|||
146704441|NCT02453594|529092379|FG001|Overall Study|Site Terminated by Sponsor|0|||
146704442|NCT02453594|529092380|FG002|Overall Study|Site Terminated by Sponsor|1|||
146704443|NCT02453594|529092378|FG000|Overall Study|Transitioned to Extension Study|16|||
146704444|NCT02453594|529092379|FG001|Overall Study|Transitioned to Extension Study|9|||
146704445|NCT02453594|529092380|FG002|Overall Study|Transitioned to Extension Study|16|||
146704446|NCT02453594|529092378|FG000|Overall Study|Withdrawal by Subject|7|||
146704447|NCT02453594|529092379|FG001|Overall Study|Withdrawal by Subject|9|||
146704448|NCT02453594|529092380|FG002|Overall Study|Withdrawal by Subject|11|||
146704449|NCT02097134|529092381|FG000|Overall Study|Physician Decision|4|||
146704450|NCT02097134|529092381|FG000|Overall Study|Non-Protocol Therapy|1|||
146704451|NCT02097134|529092381|FG000|Overall Study|Progressive Disease|3|||
146704452|NCT02097134|529092381|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
146704453|NCT01023659|529092389|FG000|Overall Study|Lost to Follow-up|73|||
146704454|NCT01023659|529092390|FG001|Overall Study|Lost to Follow-up|228|||
146704455|NCT01023659|529092391|FG002|Overall Study|Lost to Follow-up|99|||
146704456|NCT01434823|529092392|FG000|Overall Study|Incomplete data in medical record|4|||
146704457|NCT01434823|529092393|FG001|Overall Study|Incomplete data in medical record|7|||
146704458|NCT02331446|529092394|FG000|Overall Study|Lost to Follow-up|2|||
146776882|NCT02723955|529353625|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146981014|NCT00434161|530093714|FG002|Overall Study|Lost to Follow-up|0|||
146704459|NCT02331446|529092395|FG001|Overall Study|Lost to Follow-up|1|||
146704460|NCT02331446|529092396|FG002|Overall Study|Lost to Follow-up|0|||
146704461|NCT02331446|529092397|FG003|Overall Study|Lost to Follow-up|1|||
146704462|NCT02331446|529092394|FG000|Overall Study|Personal Problem|2|||
146704463|NCT02331446|529092395|FG001|Overall Study|Personal Problem|0|||
146704464|NCT02331446|529092396|FG002|Overall Study|Personal Problem|0|||
146704465|NCT02331446|529092397|FG003|Overall Study|Personal Problem|0|||
146704466|NCT02331446|529092394|FG000|Overall Study|Disease|0|||
146704467|NCT02331446|529092395|FG001|Overall Study|Disease|2|||
146704468|NCT02331446|529092396|FG002|Overall Study|Disease|2|||
146704469|NCT02331446|529092397|FG003|Overall Study|Disease|1|||
146704470|NCT02331446|529092394|FG000|Overall Study|Physician Decision|0|||
146704471|NCT02331446|529092395|FG001|Overall Study|Physician Decision|1|||
146704472|NCT02331446|529092396|FG002|Overall Study|Physician Decision|0|||
146704473|NCT02331446|529092397|FG003|Overall Study|Physician Decision|1|||
146704474|NCT02331446|529092394|FG000|Overall Study|Lost before baseline analysis|0|||
146704475|NCT02331446|529092395|FG001|Overall Study|Lost before baseline analysis|1|||
146704476|NCT02331446|529092396|FG002|Overall Study|Lost before baseline analysis|1|||
146704477|NCT02331446|529092397|FG003|Overall Study|Lost before baseline analysis|0|||
146704478|NCT04879745|529092398|FG000|Overall Study|Lost to Follow-up|4|||
146704479|NCT04879745|529092399|FG001|Overall Study|Lost to Follow-up|1|||
146704480|NCT00120042|529092400|FG000|Overall Study|all completed protocl|0|||
146704481|NCT00120042|529092401|FG001|Overall Study|all completed protocl|0|||
146704482|NCT00120042|529092402|FG002|Overall Study|all completed protocl|0|||
146704483|NCT03852316|529092403|FG000|Overall Study|Protocol Violation|1|||
146704484|NCT03852316|529092403|FG000|Overall Study|Withdrawal by Subject|2|||
146704485|NCT03852316|529092403|FG000|Overall Study|Enrolled but Device not Utilized|1|||
146704486|NCT04532112|529092404|FG000|Overall Study|Adverse Event|3|||
146704487|NCT04532112|529092405|FG001|Overall Study|Adverse Event|0|||
146704488|NCT03592641|529092406|FG000|Overall Study|Withdrawal by Subject|1|||
146704489|NCT01126541|529092408|FG000|Overall Study|Adverse Event|0|||
146704490|NCT01126541|529092409|FG001|Overall Study|Adverse Event|2|||
146704491|NCT01126541|529092410|FG002|Overall Study|Adverse Event|4|||
146704492|NCT01126541|529092408|FG000|Overall Study|Death|0|||
146704493|NCT01126541|529092409|FG001|Overall Study|Death|1|||
146704494|NCT01126541|529092410|FG002|Overall Study|Death|0|||
146704495|NCT01126541|529092408|FG000|Overall Study|Lack of Efficacy|6|||
146704496|NCT01126541|529092409|FG001|Overall Study|Lack of Efficacy|1|||
146704497|NCT01126541|529092410|FG002|Overall Study|Lack of Efficacy|11|||
146704498|NCT01126541|529092408|FG000|Overall Study|Lost to Follow-up|1|||
146704499|NCT01126541|529092409|FG001|Overall Study|Lost to Follow-up|2|||
146704500|NCT01126541|529092410|FG002|Overall Study|Lost to Follow-up|2|||
146704501|NCT01126541|529092408|FG000|Overall Study|Withdrawal by Subject|2|||
146704502|NCT01126541|529092409|FG001|Overall Study|Withdrawal by Subject|5|||
146704503|NCT01126541|529092410|FG002|Overall Study|Withdrawal by Subject|6|||
146704504|NCT01126541|529092408|FG000|Overall Study|Protocol Violation|0|||
146704505|NCT01126541|529092409|FG001|Overall Study|Protocol Violation|0|||
146704506|NCT01126541|529092410|FG002|Overall Study|Protocol Violation|1|||
146704507|NCT01126541|529092408|FG000|Overall Study|Administrative reason or other|1|||
146704508|NCT01126541|529092409|FG001|Overall Study|Administrative reason or other|1|||
146704509|NCT01126541|529092410|FG002|Overall Study|Administrative reason or other|2|||
146704510|NCT01470469|529092411|FG000|Overall Study|Withdrawal by Subject|4|||
146704511|NCT01470469|529092412|FG001|Overall Study|Withdrawal by Subject|6|||
146704512|NCT01470469|529092411|FG000|Overall Study|Lack of Efficacy|1|||
146704513|NCT01470469|529092412|FG001|Overall Study|Lack of Efficacy|7|||
146704514|NCT01470469|529092411|FG000|Overall Study|Adverse Event|0|||
146704515|NCT01470469|529092412|FG001|Overall Study|Adverse Event|7|||
146704516|NCT01470469|529092411|FG000|Overall Study|Lost to Follow-up|2|||
146704517|NCT01470469|529092412|FG001|Overall Study|Lost to Follow-up|2|||
146704518|NCT01470469|529092411|FG000|Overall Study|Protocol Violation|1|||
146704519|NCT01470469|529092412|FG001|Overall Study|Protocol Violation|1|||
146704520|NCT01470469|529092411|FG000|Overall Study|Other|2|||
146704521|NCT01470469|529092412|FG001|Overall Study|Other|1|||
146704522|NCT03670810|529092413|FG000|Main Study|Adverse Event|37|||
146704523|NCT03670810|529092414|FG001|Main Study|Adverse Event|38|||
146704524|NCT03670810|529092415|FG002|Main Study|Adverse Event|3|||
146704525|NCT03670810|529092416|FG003|Main Study|Adverse Event|4|||
146704526|NCT03670810|529092417|FG004|Main Study|Adverse Event|4|||
146704527|NCT03670810|529092418|FG005|Main Study|Adverse Event|5|||
146704528|NCT03670810|529092419|FG006|Main Study|Adverse Event|0|||
146704529|NCT03670810|529092420|FG007|Main Study|Adverse Event|0|||
146704530|NCT03670810|529092421|FG008|Main Study|Adverse Event|0|||
146704531|NCT03670810|529092413|FG000|Main Study|Lack of Efficacy|8|||
146704532|NCT03670810|529092414|FG001|Main Study|Lack of Efficacy|9|||
146704533|NCT03670810|529092415|FG002|Main Study|Lack of Efficacy|3|||
146704534|NCT03670810|529092416|FG003|Main Study|Lack of Efficacy|4|||
146704535|NCT03670810|529092417|FG004|Main Study|Lack of Efficacy|0|||
146704536|NCT03670810|529092418|FG005|Main Study|Lack of Efficacy|0|||
146704537|NCT03670810|529092419|FG006|Main Study|Lack of Efficacy|0|||
146704538|NCT03670810|529092420|FG007|Main Study|Lack of Efficacy|0|||
146704539|NCT03670810|529092421|FG008|Main Study|Lack of Efficacy|0|||
146704540|NCT03670810|529092413|FG000|Main Study|Lost to Follow-up|9|||
146704541|NCT03670810|529092414|FG001|Main Study|Lost to Follow-up|7|||
146704542|NCT03670810|529092415|FG002|Main Study|Lost to Follow-up|4|||
146704543|NCT03670810|529092416|FG003|Main Study|Lost to Follow-up|6|||
146704544|NCT03670810|529092417|FG004|Main Study|Lost to Follow-up|1|||
146704545|NCT03670810|529092418|FG005|Main Study|Lost to Follow-up|0|||
146704546|NCT03670810|529092419|FG006|Main Study|Lost to Follow-up|0|||
146704547|NCT03670810|529092420|FG007|Main Study|Lost to Follow-up|0|||
146704548|NCT03670810|529092421|FG008|Main Study|Lost to Follow-up|0|||
146704549|NCT03670810|529092413|FG000|Main Study|Non-compliance with Study Drug|0|||
146704550|NCT03670810|529092414|FG001|Main Study|Non-compliance with Study Drug|2|||
146704551|NCT03670810|529092415|FG002|Main Study|Non-compliance with Study Drug|3|||
146704552|NCT03670810|529092416|FG003|Main Study|Non-compliance with Study Drug|0|||
146704553|NCT03670810|529092417|FG004|Main Study|Non-compliance with Study Drug|0|||
146704554|NCT03670810|529092418|FG005|Main Study|Non-compliance with Study Drug|0|||
146704555|NCT03670810|529092419|FG006|Main Study|Non-compliance with Study Drug|0|||
146704556|NCT03670810|529092420|FG007|Main Study|Non-compliance with Study Drug|1|||
146704557|NCT03670810|529092421|FG008|Main Study|Non-compliance with Study Drug|0|||
146704558|NCT03670810|529092413|FG000|Main Study|Physician Decision|3|||
146704559|NCT03670810|529092414|FG001|Main Study|Physician Decision|0|||
146704560|NCT03670810|529092415|FG002|Main Study|Physician Decision|1|||
146704561|NCT03670810|529092416|FG003|Main Study|Physician Decision|0|||
146704562|NCT03670810|529092417|FG004|Main Study|Physician Decision|0|||
146704563|NCT03670810|529092418|FG005|Main Study|Physician Decision|0|||
146704564|NCT03670810|529092419|FG006|Main Study|Physician Decision|1|||
146704565|NCT03670810|529092420|FG007|Main Study|Physician Decision|1|||
146704566|NCT03670810|529092421|FG008|Main Study|Physician Decision|0|||
146704567|NCT03670810|529092413|FG000|Main Study|Pregnancy|1|||
146704568|NCT03670810|529092414|FG001|Main Study|Pregnancy|2|||
146704569|NCT03670810|529092415|FG002|Main Study|Pregnancy|0|||
146704570|NCT03670810|529092416|FG003|Main Study|Pregnancy|0|||
146704571|NCT03670810|529092417|FG004|Main Study|Pregnancy|0|||
146704572|NCT03670810|529092418|FG005|Main Study|Pregnancy|0|||
146704573|NCT03670810|529092419|FG006|Main Study|Pregnancy|0|||
146704574|NCT03670810|529092420|FG007|Main Study|Pregnancy|0|||
146704575|NCT03670810|529092421|FG008|Main Study|Pregnancy|0|||
146704576|NCT03670810|529092413|FG000|Main Study|Protocol Deviation|2|||
146704577|NCT03670810|529092414|FG001|Main Study|Protocol Deviation|12|||
146704578|NCT03670810|529092415|FG002|Main Study|Protocol Deviation|8|||
146704579|NCT03670810|529092416|FG003|Main Study|Protocol Deviation|4|||
146704580|NCT03670810|529092417|FG004|Main Study|Protocol Deviation|0|||
146704581|NCT03670810|529092418|FG005|Main Study|Protocol Deviation|0|||
146704582|NCT03670810|529092419|FG006|Main Study|Protocol Deviation|0|||
146704583|NCT03670810|529092420|FG007|Main Study|Protocol Deviation|0|||
146704584|NCT03670810|529092421|FG008|Main Study|Protocol Deviation|0|||
146704585|NCT03670810|529092413|FG000|Main Study|Withdrawal by Subject|21|||
146704586|NCT03670810|529092414|FG001|Main Study|Withdrawal by Subject|21|||
146704587|NCT03670810|529092415|FG002|Main Study|Withdrawal by Subject|8|||
146704588|NCT03670810|529092416|FG003|Main Study|Withdrawal by Subject|9|||
146704589|NCT03670810|529092417|FG004|Main Study|Withdrawal by Subject|5|||
146704590|NCT03670810|529092418|FG005|Main Study|Withdrawal by Subject|2|||
146704591|NCT03670810|529092419|FG006|Main Study|Withdrawal by Subject|1|||
146704592|NCT03670810|529092420|FG007|Main Study|Withdrawal by Subject|1|||
146704593|NCT03670810|529092421|FG008|Main Study|Withdrawal by Subject|0|||
146704594|NCT03670810|529092413|FG000|Main Study|Participant did not want to take the three other treatments|1|||
146704595|NCT03670810|529092414|FG001|Main Study|Participant did not want to take the three other treatments|0|||
146704596|NCT03670810|529092415|FG002|Main Study|Participant did not want to take the three other treatments|0|||
146704597|NCT03670810|529092416|FG003|Main Study|Participant did not want to take the three other treatments|0|||
146704598|NCT03670810|529092417|FG004|Main Study|Participant did not want to take the three other treatments|0|||
146704599|NCT03670810|529092418|FG005|Main Study|Participant did not want to take the three other treatments|0|||
146704600|NCT03670810|529092419|FG006|Main Study|Participant did not want to take the three other treatments|0|||
146704601|NCT03670810|529092420|FG007|Main Study|Participant did not want to take the three other treatments|0|||
146704602|NCT03670810|529092421|FG008|Main Study|Participant did not want to take the three other treatments|0|||
146704603|NCT03670810|529092413|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
146704604|NCT03670810|529092414|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
146704605|NCT03670810|529092415|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
146704606|NCT03670810|529092416|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
146704607|NCT03670810|529092417|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
146704608|NCT03670810|529092418|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
146704609|NCT03670810|529092419|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
146704610|NCT03670810|529092420|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
146704611|NCT03670810|529092421|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
146704612|NCT03670810|529092413|FG000|Main Study|Travel and Coronavirus issues|0|||
146704613|NCT03670810|529092414|FG001|Main Study|Travel and Coronavirus issues|0|||
146704614|NCT03670810|529092415|FG002|Main Study|Travel and Coronavirus issues|0|||
146704615|NCT03670810|529092416|FG003|Main Study|Travel and Coronavirus issues|1|||
146704616|NCT03670810|529092417|FG004|Main Study|Travel and Coronavirus issues|0|||
146704617|NCT03670810|529092418|FG005|Main Study|Travel and Coronavirus issues|0|||
146704618|NCT03670810|529092419|FG006|Main Study|Travel and Coronavirus issues|0|||
146704619|NCT03670810|529092420|FG007|Main Study|Travel and Coronavirus issues|0|||
146704620|NCT03670810|529092421|FG008|Main Study|Travel and Coronavirus issues|0|||
146704621|NCT03670810|529092413|FG000|Open Label Extension|Protocol Deviation|0|||
146704622|NCT03670810|529092414|FG001|Open Label Extension|Protocol Deviation|0|||
146704623|NCT03670810|529092415|FG002|Open Label Extension|Protocol Deviation|0|||
146704624|NCT03670810|529092416|FG003|Open Label Extension|Protocol Deviation|0|||
146704625|NCT03670810|529092417|FG004|Open Label Extension|Protocol Deviation|0|||
146704626|NCT03670810|529092418|FG005|Open Label Extension|Protocol Deviation|0|||
146704627|NCT03670810|529092419|FG006|Open Label Extension|Protocol Deviation|0|||
146704628|NCT03670810|529092420|FG007|Open Label Extension|Protocol Deviation|0|||
146704629|NCT03670810|529092421|FG008|Open Label Extension|Protocol Deviation|5|||
146704630|NCT03670810|529092413|FG000|Open Label Extension|Death|0|||
146704631|NCT03670810|529092414|FG001|Open Label Extension|Death|0|||
146704632|NCT03670810|529092415|FG002|Open Label Extension|Death|0|||
146704633|NCT03670810|529092416|FG003|Open Label Extension|Death|0|||
146704634|NCT03670810|529092417|FG004|Open Label Extension|Death|0|||
146704635|NCT03670810|529092418|FG005|Open Label Extension|Death|0|||
146704636|NCT03670810|529092419|FG006|Open Label Extension|Death|0|||
146704637|NCT03670810|529092420|FG007|Open Label Extension|Death|0|||
146704638|NCT03670810|529092421|FG008|Open Label Extension|Death|1|||
146704639|NCT03670810|529092413|FG000|Open Label Extension|COVID-19|0|||
146704640|NCT03670810|529092414|FG001|Open Label Extension|COVID-19|0|||
146704641|NCT03670810|529092415|FG002|Open Label Extension|COVID-19|0|||
146704642|NCT03670810|529092416|FG003|Open Label Extension|COVID-19|0|||
146704643|NCT03670810|529092417|FG004|Open Label Extension|COVID-19|0|||
146704644|NCT03670810|529092418|FG005|Open Label Extension|COVID-19|0|||
146704645|NCT03670810|529092419|FG006|Open Label Extension|COVID-19|0|||
146704646|NCT03670810|529092420|FG007|Open Label Extension|COVID-19|0|||
146704647|NCT03670810|529092421|FG008|Open Label Extension|COVID-19|1|||
146704648|NCT03670810|529092413|FG000|Open Label Extension|Lack of Efficacy|0|||
146704649|NCT03670810|529092414|FG001|Open Label Extension|Lack of Efficacy|0|||
146704650|NCT03670810|529092415|FG002|Open Label Extension|Lack of Efficacy|0|||
146704651|NCT03670810|529092416|FG003|Open Label Extension|Lack of Efficacy|0|||
146704652|NCT03670810|529092417|FG004|Open Label Extension|Lack of Efficacy|0|||
146704653|NCT03670810|529092418|FG005|Open Label Extension|Lack of Efficacy|0|||
146704654|NCT03670810|529092419|FG006|Open Label Extension|Lack of Efficacy|0|||
146704655|NCT03670810|529092420|FG007|Open Label Extension|Lack of Efficacy|0|||
146704656|NCT03670810|529092421|FG008|Open Label Extension|Lack of Efficacy|39|||
146704657|NCT03670810|529092413|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
146704658|NCT03670810|529092414|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
146704659|NCT03670810|529092415|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
146704660|NCT03670810|529092416|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
146704661|NCT03670810|529092417|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
146704662|NCT03670810|529092418|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
146704663|NCT03670810|529092419|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
146704664|NCT03670810|529092420|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
146704665|NCT03670810|529092421|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
146704666|NCT03670810|529092413|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
146704667|NCT03670810|529092414|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
146704668|NCT03670810|529092415|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
146704669|NCT03670810|529092416|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
146704670|NCT03670810|529092417|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
146704671|NCT03670810|529092418|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
146704672|NCT03670810|529092419|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
146704673|NCT03670810|529092420|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
146704674|NCT03670810|529092421|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
146704675|NCT03670810|529092413|FG000|Open Label Extension|Withdrawal by Subject|0|||
146704676|NCT03670810|529092414|FG001|Open Label Extension|Withdrawal by Subject|0|||
146704677|NCT03670810|529092415|FG002|Open Label Extension|Withdrawal by Subject|0|||
146704678|NCT03670810|529092416|FG003|Open Label Extension|Withdrawal by Subject|0|||
146704679|NCT03670810|529092417|FG004|Open Label Extension|Withdrawal by Subject|0|||
146704680|NCT03670810|529092418|FG005|Open Label Extension|Withdrawal by Subject|0|||
146704681|NCT03670810|529092419|FG006|Open Label Extension|Withdrawal by Subject|0|||
146704682|NCT03670810|529092420|FG007|Open Label Extension|Withdrawal by Subject|0|||
146704683|NCT03670810|529092421|FG008|Open Label Extension|Withdrawal by Subject|46|||
146704684|NCT03670810|529092413|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
146704685|NCT03670810|529092414|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
146704686|NCT03670810|529092415|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
146704687|NCT03670810|529092416|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
146704688|NCT03670810|529092417|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
146704689|NCT03670810|529092418|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
146704690|NCT03670810|529092419|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
146704691|NCT03670810|529092420|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
146704692|NCT03670810|529092421|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
146704693|NCT03670810|529092413|FG000|Open Label Extension|Physician Decision|0|||
146704694|NCT03670810|529092414|FG001|Open Label Extension|Physician Decision|0|||
146704695|NCT03670810|529092415|FG002|Open Label Extension|Physician Decision|0|||
146704696|NCT03670810|529092416|FG003|Open Label Extension|Physician Decision|0|||
146704697|NCT03670810|529092417|FG004|Open Label Extension|Physician Decision|0|||
146704698|NCT03670810|529092418|FG005|Open Label Extension|Physician Decision|0|||
146704699|NCT03670810|529092419|FG006|Open Label Extension|Physician Decision|0|||
146704700|NCT03670810|529092420|FG007|Open Label Extension|Physician Decision|0|||
146704701|NCT03670810|529092421|FG008|Open Label Extension|Physician Decision|2|||
146704702|NCT03670810|529092413|FG000|Open Label Extension|Non-compliance with study drug|0|||
146704703|NCT03670810|529092414|FG001|Open Label Extension|Non-compliance with study drug|0|||
146704704|NCT03670810|529092415|FG002|Open Label Extension|Non-compliance with study drug|0|||
146704705|NCT03670810|529092416|FG003|Open Label Extension|Non-compliance with study drug|0|||
146704706|NCT03670810|529092417|FG004|Open Label Extension|Non-compliance with study drug|0|||
146704707|NCT03670810|529092418|FG005|Open Label Extension|Non-compliance with study drug|0|||
146704708|NCT03670810|529092419|FG006|Open Label Extension|Non-compliance with study drug|0|||
146704709|NCT03670810|529092420|FG007|Open Label Extension|Non-compliance with study drug|0|||
146704710|NCT03670810|529092421|FG008|Open Label Extension|Non-compliance with study drug|5|||
146704711|NCT03670810|529092413|FG000|Open Label Extension|Pregnancy|0|||
146704712|NCT03670810|529092414|FG001|Open Label Extension|Pregnancy|0|||
146704713|NCT03670810|529092415|FG002|Open Label Extension|Pregnancy|0|||
146704714|NCT03670810|529092416|FG003|Open Label Extension|Pregnancy|0|||
146704715|NCT03670810|529092417|FG004|Open Label Extension|Pregnancy|0|||
146704716|NCT03670810|529092418|FG005|Open Label Extension|Pregnancy|0|||
146704717|NCT03670810|529092419|FG006|Open Label Extension|Pregnancy|0|||
146704718|NCT03670810|529092420|FG007|Open Label Extension|Pregnancy|0|||
146704719|NCT03670810|529092421|FG008|Open Label Extension|Pregnancy|3|||
146704720|NCT03670810|529092413|FG000|Open Label Extension|Adverse Event|0|||
146704721|NCT03670810|529092414|FG001|Open Label Extension|Adverse Event|0|||
146704722|NCT03670810|529092415|FG002|Open Label Extension|Adverse Event|0|||
146704723|NCT03670810|529092416|FG003|Open Label Extension|Adverse Event|0|||
146704724|NCT03670810|529092417|FG004|Open Label Extension|Adverse Event|0|||
146704725|NCT03670810|529092418|FG005|Open Label Extension|Adverse Event|0|||
146704726|NCT03670810|529092419|FG006|Open Label Extension|Adverse Event|0|||
146704727|NCT03670810|529092420|FG007|Open Label Extension|Adverse Event|0|||
146704728|NCT03670810|529092421|FG008|Open Label Extension|Adverse Event|24|||
146704729|NCT03670810|529092413|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
146704730|NCT03670810|529092414|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
146704731|NCT03670810|529092415|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
146704732|NCT03670810|529092416|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
146704733|NCT03670810|529092417|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
146704734|NCT03670810|529092418|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
146704735|NCT03670810|529092419|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
146704736|NCT03670810|529092420|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
146704737|NCT03670810|529092421|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
146704738|NCT03670810|529092413|FG000|Open Label Extension|Lost to Follow-up|0|||
146704739|NCT03670810|529092414|FG001|Open Label Extension|Lost to Follow-up|0|||
146704740|NCT03670810|529092415|FG002|Open Label Extension|Lost to Follow-up|0|||
146704741|NCT03670810|529092416|FG003|Open Label Extension|Lost to Follow-up|0|||
146704742|NCT03670810|529092417|FG004|Open Label Extension|Lost to Follow-up|0|||
146704743|NCT03670810|529092418|FG005|Open Label Extension|Lost to Follow-up|0|||
146704744|NCT03670810|529092419|FG006|Open Label Extension|Lost to Follow-up|0|||
146704745|NCT03670810|529092420|FG007|Open Label Extension|Lost to Follow-up|0|||
146704746|NCT03670810|529092421|FG008|Open Label Extension|Lost to Follow-up|23|||
146704747|NCT04182100|529092422|FG000|Overall Study|Adverse Event|1|||
146704748|NCT04182100|529092422|FG000|Overall Study|Withdrawal by Subject|1|||
146704749|NCT02504372|529092424|FG000|Overall Study|Death|136|||
146704750|NCT02504372|529092425|FG001|Overall Study|Death|154|||
146704751|NCT02504372|529092424|FG000|Overall Study|Lost to Follow-up|0|||
146704752|NCT02504372|529092425|FG001|Overall Study|Lost to Follow-up|2|||
146704753|NCT02504372|529092424|FG000|Overall Study|Withdrawal of consent|25|||
146704754|NCT02504372|529092425|FG001|Overall Study|Withdrawal of consent|16|||
146704755|NCT02504372|529092424|FG000|Overall Study|Participants ongoing|429|||
146704756|NCT02504372|529092425|FG001|Overall Study|Participants ongoing|415|||
146704757|NCT00376168|529092431|FG000|Overall Study|Adverse Event|1|||
146704758|NCT00376168|529092432|FG001|Overall Study|Adverse Event|1|||
146704759|NCT00376168|529092431|FG000|Overall Study|Pregnancy|1|||
146704760|NCT00376168|529092432|FG001|Overall Study|Pregnancy|0|||
146704761|NCT02214121|529092433|FG000|Part A|Patient decision|2|||
146704762|NCT02214121|529092434|FG001|Part A|Patient decision|0|||
146704763|NCT02214121|529092435|FG002|Part A|Patient decision|0|||
146704764|NCT02214121|529092433|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
146704765|NCT02214121|529092434|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
146704766|NCT02214121|529092435|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
146776883|NCT02723955|529353626|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146848423|NCT02245737|529615669|FG002|Overall Study|Sponsor Decision|432|||
146704767|NCT02214121|529092433|FG000|Part A|Other|1|||
146848424|NCT03122223|529615679|FG000|Overall Study|Withdrawal by Subject|2|||
146848425|NCT03122223|529615680|FG001|Overall Study|Withdrawal by Subject|2|||
146848426|NCT03122223|529615681|FG002|Overall Study|Withdrawal by Subject|1|||
146848427|NCT03122223|529615682|FG003|Overall Study|Withdrawal by Subject|0|||
146933461|NCT00006604|529913991|FG000|Overall Study|Lost to Follow-up|0|||
146933462|NCT00006604|529913992|FG001|Overall Study|Lost to Follow-up|0|||
146933463|NCT00006604|529913993|FG002|Overall Study|Lost to Follow-up|0|||
146933464|NCT00006604|529913994|FG003|Overall Study|Lost to Follow-up|0|||
146933465|NCT00006604|529913995|FG004|Overall Study|Lost to Follow-up|0|||
146933466|NCT00006604|529913996|FG005|Overall Study|Lost to Follow-up|0|||
146933467|NCT00006604|529913997|FG006|Overall Study|Lost to Follow-up|0|||
146933468|NCT00006604|529913998|FG007|Overall Study|Lost to Follow-up|1|||
146933469|NCT00006604|529913999|FG008|Overall Study|Lost to Follow-up|0|||
146933470|NCT00006604|529914000|FG009|Overall Study|Lost to Follow-up|2|||
146933471|NCT00006604|529914001|FG010|Overall Study|Lost to Follow-up|0|||
146933472|NCT00006604|529914002|FG011|Overall Study|Lost to Follow-up|0|||
146933473|NCT00006604|529914003|FG012|Overall Study|Lost to Follow-up|0|||
146933474|NCT00006604|529914004|FG013|Overall Study|Lost to Follow-up|0|||
146933475|NCT00006604|529914005|FG014|Overall Study|Lost to Follow-up|0|||
146933476|NCT00006604|529914006|FG015|Overall Study|Lost to Follow-up|1|||
146933477|NCT00006604|529914007|FG016|Overall Study|Lost to Follow-up|3|||
146933478|NCT00006604|529913991|FG000|Overall Study|Other Reason|0|||
146933479|NCT00006604|529913992|FG001|Overall Study|Other Reason|0|||
146933480|NCT00006604|529913993|FG002|Overall Study|Other Reason|0|||
146933481|NCT00006604|529913994|FG003|Overall Study|Other Reason|0|||
146933482|NCT00006604|529913995|FG004|Overall Study|Other Reason|0|||
146933483|NCT00006604|529913996|FG005|Overall Study|Other Reason|1|||
146933484|NCT00006604|529913997|FG006|Overall Study|Other Reason|0|||
146933485|NCT00006604|529913998|FG007|Overall Study|Other Reason|0|||
146933486|NCT00006604|529913999|FG008|Overall Study|Other Reason|0|||
146933487|NCT00006604|529914000|FG009|Overall Study|Other Reason|1|||
146933488|NCT00006604|529914001|FG010|Overall Study|Other Reason|0|||
146933489|NCT00006604|529914002|FG011|Overall Study|Other Reason|0|||
146933490|NCT00006604|529914003|FG012|Overall Study|Other Reason|0|||
146933491|NCT00006604|529914004|FG013|Overall Study|Other Reason|0|||
146933492|NCT00006604|529914005|FG014|Overall Study|Other Reason|0|||
146933493|NCT00006604|529914006|FG015|Overall Study|Other Reason|0|||
146933494|NCT00006604|529914007|FG016|Overall Study|Other Reason|0|||
146933495|NCT01056341|529914008|FG000|Overall Study|Treatment Intolerance|0|||
146933496|NCT01056341|529914009|FG001|Overall Study|Treatment Intolerance|2|||
146933497|NCT01056341|529914010|FG002|Overall Study|Treatment Intolerance|0|||
146933498|NCT01056341|529914011|FG003|Overall Study|Treatment Intolerance|2|||
146933499|NCT01056341|529914012|FG004|Overall Study|Treatment Intolerance|0|||
146933500|NCT01056341|529914008|FG000|Overall Study|Lack of Efficacy|32|||
146933501|NCT01056341|529914009|FG001|Overall Study|Lack of Efficacy|30|||
146933502|NCT01056341|529914010|FG002|Overall Study|Lack of Efficacy|7|||
146933503|NCT01056341|529914011|FG003|Overall Study|Lack of Efficacy|25|||
146933504|NCT01056341|529914012|FG004|Overall Study|Lack of Efficacy|9|||
146933505|NCT01056341|529914008|FG000|Overall Study|Other reasons|4|||
146933506|NCT01056341|529914009|FG001|Overall Study|Other reasons|4|||
146933507|NCT01056341|529914010|FG002|Overall Study|Other reasons|8|||
146933508|NCT01056341|529914011|FG003|Overall Study|Other reasons|9|||
146933509|NCT01056341|529914012|FG004|Overall Study|Other reasons|5|||
146933510|NCT01086150|529914013|FG000|Overall Study|Withdrawal by Subject|0|||
146933511|NCT01086150|529914014|FG001|Overall Study|Withdrawal by Subject|4|||
146933512|NCT01086150|529914015|FG002|Overall Study|Withdrawal by Subject|1|||
146933513|NCT01086150|529914013|FG000|Overall Study|Lost to Follow-up|0|||
146933514|NCT01086150|529914014|FG001|Overall Study|Lost to Follow-up|1|||
146933515|NCT01086150|529914015|FG002|Overall Study|Lost to Follow-up|0|||
146933516|NCT01086150|529914013|FG000|Overall Study|Screen Failure|0|||
146933517|NCT01086150|529914014|FG001|Overall Study|Screen Failure|1|||
146933518|NCT01086150|529914015|FG002|Overall Study|Screen Failure|0|||
146933519|NCT03543358|529914018|FG000|Overall Study|Death|1|||
146933520|NCT03543358|529914019|FG001|Overall Study|Death|0|||
146933521|NCT03543358|529914018|FG000|Overall Study|Disease Progression|1|||
146933522|NCT03543358|529914019|FG001|Overall Study|Disease Progression|0|||
146981015|NCT00434161|530093712|FG000|Overall Study|Death|1|||
146933523|NCT03543358|529914018|FG000|Overall Study|Parent Study Closure|1|||
146933524|NCT03543358|529914019|FG001|Overall Study|Parent Study Closure|0|||
146933525|NCT02157506|529914022|FG000|Overall Study|Adverse Event|0|||
146981016|NCT00434161|530093713|FG001|Overall Study|Death|0|||
146981017|NCT00434161|530093714|FG002|Overall Study|Death|1|||
146981018|NCT00434161|530093712|FG000|Overall Study|Non-Compliance|1|||
146933526|NCT02157506|529914023|FG001|Overall Study|Adverse Event|1|||
146933527|NCT02157506|529914024|FG002|Overall Study|Adverse Event|0|||
146933528|NCT02157506|529914025|FG003|Overall Study|Adverse Event|0|||
146933529|NCT02157506|529914026|FG004|Overall Study|Adverse Event|0|||
146933530|NCT02157506|529914022|FG000|Overall Study|Lost to Follow-up|0|||
146933531|NCT02157506|529914023|FG001|Overall Study|Lost to Follow-up|0|||
146933532|NCT02157506|529914024|FG002|Overall Study|Lost to Follow-up|1|||
146933533|NCT02157506|529914025|FG003|Overall Study|Lost to Follow-up|0|||
146933534|NCT02157506|529914026|FG004|Overall Study|Lost to Follow-up|0|||
146933535|NCT02702011|529914027|FG000|Overall Study|Withdrawal by Subject|0|||
146933536|NCT02702011|529914028|FG001|Overall Study|Withdrawal by Subject|1|||
146981019|NCT00434161|530093713|FG001|Overall Study|Non-Compliance|1|||
146933537|NCT02702011|529914029|FG002|Overall Study|Withdrawal by Subject|0|||
146933538|NCT02702011|529914030|FG003|Overall Study|Withdrawal by Subject|0|||
146933539|NCT01578785|529914040|FG000|Overall Study|Withdrawal by Subject|0|||
146933540|NCT01578785|529914041|FG001|Overall Study|Withdrawal by Subject|1|||
146933541|NCT01578785|529914040|FG000|Overall Study|Study terminated by sponsor|59|||
146933542|NCT01578785|529914041|FG001|Overall Study|Study terminated by sponsor|118|||
146933543|NCT01164865|529914042|FG000|Overall Study|Lost to Follow-up|2|||
146933544|NCT01164865|529914043|FG001|Overall Study|Lost to Follow-up|1|||
146933545|NCT00171314|529914044|FG000|Overall Study|Adverse Event|44|||
146933546|NCT00171314|529914045|FG001|Overall Study|Adverse Event|41|||
146933547|NCT00171314|529914044|FG000|Overall Study|Lack of Efficacy|19|||
146933548|NCT00171314|529914045|FG001|Overall Study|Lack of Efficacy|14|||
146933549|NCT00171314|529914044|FG000|Overall Study|Withdrawal by Subject|9|||
146933550|NCT00171314|529914045|FG001|Overall Study|Withdrawal by Subject|6|||
146933551|NCT00171314|529914044|FG000|Overall Study|Abnormal Test Procedure Results|9|||
146933552|NCT00171314|529914045|FG001|Overall Study|Abnormal Test Procedure Results|3|||
146933553|NCT00171314|529914044|FG000|Overall Study|Protocol Violation|3|||
146933554|NCT00171314|529914045|FG001|Overall Study|Protocol Violation|7|||
146933555|NCT00171314|529914044|FG000|Overall Study|Administrative Problems|4|||
146933556|NCT00171314|529914045|FG001|Overall Study|Administrative Problems|3|||
146933557|NCT00171314|529914044|FG000|Overall Study|Lost to Follow-up|1|||
146933558|NCT00171314|529914045|FG001|Overall Study|Lost to Follow-up|3|||
146933559|NCT00171314|529914044|FG000|Overall Study|Death|2|||
146933560|NCT00171314|529914045|FG001|Overall Study|Death|1|||
146933561|NCT02394795|529914048|FG000|Overall Study|Adverse Event|92|||
146933562|NCT02394795|529914049|FG001|Overall Study|Adverse Event|70|||
146933563|NCT02394795|529914048|FG000|Overall Study|Lost to Follow-up|0|||
146933564|NCT02394795|529914049|FG001|Overall Study|Lost to Follow-up|1|||
146704768|NCT02214121|529092434|FG001|Part A|Other|0|||
146704769|NCT02214121|529092435|FG002|Part A|Other|0|||
146704770|NCT02214121|529092433|FG000|Part B|Patient decision|0|||
146704771|NCT02214121|529092434|FG001|Part B|Patient decision|1|||
146704772|NCT02214121|529092435|FG002|Part B|Patient decision|0|||
146704773|NCT02214121|529092433|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
146704774|NCT02214121|529092434|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
146704775|NCT02214121|529092435|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
146704776|NCT02214121|529092433|FG000|Part B|Lost to Follow-up|0|||
146704777|NCT02214121|529092434|FG001|Part B|Lost to Follow-up|0|||
146704778|NCT02214121|529092435|FG002|Part B|Lost to Follow-up|1|||
146704779|NCT02114879|529092440|FG000|Overall Study|Withdrawal by Subject|9|||
146704780|NCT02114879|529092441|FG001|Overall Study|Withdrawal by Subject|5|||
146704781|NCT02114879|529092440|FG000|Overall Study|Death|6|||
146704782|NCT02114879|529092441|FG001|Overall Study|Death|11|||
146704783|NCT02114879|529092440|FG000|Overall Study|Lost to Follow-up|4|||
146704784|NCT02114879|529092441|FG001|Overall Study|Lost to Follow-up|6|||
146704785|NCT02114879|529092440|FG000|Overall Study|Physician Decision|0|||
146704786|NCT02114879|529092441|FG001|Overall Study|Physician Decision|2|||
146704787|NCT02152995|529092442|FG000|Overall Study|Withdrawal by Subject|1|||
146704788|NCT02152995|529092443|FG001|Overall Study|Withdrawal by Subject|0|||
146704789|NCT01365273|529092444|FG000|Overall Study|Lost to Follow-up|1|||
146704790|NCT01365273|529092445|FG001|Overall Study|Lost to Follow-up|0|||
146704791|NCT01365273|529092444|FG000|Overall Study|Protocol Violation|0|||
146704792|NCT01365273|529092445|FG001|Overall Study|Protocol Violation|1|||
146704793|NCT01365273|529092444|FG000|Overall Study|Physician Decision|1|||
146704794|NCT01365273|529092445|FG001|Overall Study|Physician Decision|0|||
146704795|NCT00308711|529092447|FG000|Overall Study|Withdrawal by Subject|1|||
146704796|NCT00308711|529092448|FG001|Overall Study|Withdrawal by Subject|0|||
146704797|NCT00308711|529092449|FG002|Overall Study|Withdrawal by Subject|1|||
146933565|NCT02394795|529914048|FG000|Overall Study|Withdrawal by Subject|17|||
146933566|NCT02394795|529914049|FG001|Overall Study|Withdrawal by Subject|26|||
146933567|NCT02394795|529914048|FG000|Overall Study|Lack of Efficacy|181|||
146933568|NCT02394795|529914049|FG001|Overall Study|Lack of Efficacy|211|||
146933569|NCT02394795|529914048|FG000|Overall Study|Death|4|||
146933570|NCT02394795|529914049|FG001|Overall Study|Death|5|||
146933571|NCT02394795|529914048|FG000|Overall Study|Physician Decision|109|||
146704798|NCT00308711|529092447|FG000|Overall Study|Protocol Violation|0|||
146704799|NCT00308711|529092448|FG001|Overall Study|Protocol Violation|1|||
146933572|NCT02394795|529914049|FG001|Overall Study|Physician Decision|93|||
146933573|NCT02939599|529914051|FG000|Overall Study|Adverse Event|1|||
146933574|NCT02939599|529914052|FG001|Overall Study|Adverse Event|0|||
146933575|NCT02939599|529914051|FG000|Overall Study|Study Terminated By Sponsor|2|||
146704800|NCT00308711|529092449|FG002|Overall Study|Protocol Violation|1|||
146704801|NCT00308711|529092447|FG000|Overall Study|Lost to Follow-up|0|||
146704802|NCT00308711|529092448|FG001|Overall Study|Lost to Follow-up|1|||
146704803|NCT00308711|529092449|FG002|Overall Study|Lost to Follow-up|0|||
146704804|NCT00308711|529092447|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
146704805|NCT00308711|529092448|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
146933576|NCT02939599|529914052|FG001|Overall Study|Study Terminated By Sponsor|2|||
146933577|NCT01669811|529914053|FG000|Overall Study|Investigator decision|0|||
146704806|NCT00308711|529092449|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
146704807|NCT00308711|529092447|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
146704808|NCT00308711|529092448|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
146704809|NCT00308711|529092449|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
146704810|NCT02318693|529092451|FG000|Overall Study|Protocol Violation|0|||
146704811|NCT02318693|529092452|FG001|Overall Study|Protocol Violation|1|||
146704812|NCT00689481|529092453|FG000|Overall Study|Adverse Event|7|||
146704813|NCT00689481|529092454|FG001|Overall Study|Adverse Event|1|||
146704814|NCT00689481|529092453|FG000|Overall Study|Lost to Follow-up|4|||
146704815|NCT00689481|529092454|FG001|Overall Study|Lost to Follow-up|3|||
146704816|NCT00689481|529092453|FG000|Overall Study|Lack of Efficacy|4|||
146704817|NCT00689481|529092454|FG001|Overall Study|Lack of Efficacy|3|||
146704818|NCT00689481|529092453|FG000|Overall Study|Non-compliance with study treatment|1|||
146704819|NCT00689481|529092454|FG001|Overall Study|Non-compliance with study treatment|1|||
146704820|NCT00689481|529092453|FG000|Overall Study|Withdrawal by Subject|8|||
146704821|NCT00689481|529092454|FG001|Overall Study|Withdrawal by Subject|4|||
146704822|NCT00689481|529092453|FG000|Overall Study|Excluded medication started during study|0|||
146704823|NCT00689481|529092454|FG001|Overall Study|Excluded medication started during study|1|||
146704824|NCT00689481|529092453|FG000|Overall Study|Subject early term, left on vacation|0|||
146704825|NCT00689481|529092454|FG001|Overall Study|Subject early term, left on vacation|1|||
146704826|NCT05645432|529092459|FG000|Overall Study|Withdrawal by Subject|1|||
146704827|NCT03195478|529092460|FG000|Overall Study|Disease Progression|5|||
146704828|NCT03195478|529092461|FG001|Overall Study|Disease Progression|4|||
146704829|NCT03195478|529092462|FG002|Overall Study|Disease Progression|6|||
146704830|NCT03195478|529092463|FG003|Overall Study|Disease Progression|1|||
146704831|NCT03195478|529092460|FG000|Overall Study|Study Drug Toxicity|2|||
146704832|NCT03195478|529092461|FG001|Overall Study|Study Drug Toxicity|0|||
146704833|NCT03195478|529092462|FG002|Overall Study|Study Drug Toxicity|0|||
146704834|NCT03195478|529092463|FG003|Overall Study|Study Drug Toxicity|1|||
146704835|NCT03195478|529092460|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
146704836|NCT03195478|529092461|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
146704837|NCT03195478|529092462|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
146704838|NCT03195478|529092463|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
146704839|NCT03195478|529092460|FG000|Overall Study|Participant Withdrew Consent|1|||
146704840|NCT03195478|529092461|FG001|Overall Study|Participant Withdrew Consent|0|||
146704841|NCT03195478|529092462|FG002|Overall Study|Participant Withdrew Consent|0|||
146704842|NCT03195478|529092463|FG003|Overall Study|Participant Withdrew Consent|0|||
146704843|NCT03195478|529092460|FG000|Overall Study|Maximum Clinical benefit|0|||
146704844|NCT03195478|529092461|FG001|Overall Study|Maximum Clinical benefit|0|||
146704845|NCT03195478|529092462|FG002|Overall Study|Maximum Clinical benefit|1|||
146704846|NCT03195478|529092463|FG003|Overall Study|Maximum Clinical benefit|0|||
146704847|NCT03195478|529092460|FG000|Overall Study|Other Reasons|0|||
146704848|NCT03195478|529092461|FG001|Overall Study|Other Reasons|0|||
146704849|NCT03195478|529092462|FG002|Overall Study|Other Reasons|1|||
146704850|NCT03195478|529092463|FG003|Overall Study|Other Reasons|0|||
146704851|NCT02742103|529094370|FG000|Overall Study|Protocol Violation|1|||
146704852|NCT02742103|529094371|FG001|Overall Study|Protocol Violation|0|||
146704853|NCT02742103|529094370|FG000|Overall Study|Death|2|||
146704854|NCT02742103|529094371|FG001|Overall Study|Death|2|||
146704855|NCT02742103|529094370|FG000|Overall Study|Adverse Event|1|||
146704856|NCT02742103|529094371|FG001|Overall Study|Adverse Event|0|||
146704857|NCT02742103|529094370|FG000|Overall Study|Moved to another town|0|||
146704858|NCT02742103|529094371|FG001|Overall Study|Moved to another town|1|||
146704859|NCT02742103|529094370|FG000|Overall Study|Withdrawal by Subject|5|||
146704860|NCT02742103|529094371|FG001|Overall Study|Withdrawal by Subject|2|||
146704861|NCT04346615|529094374|FG000|Overall Study|Lost to Follow-up|0|||
146704862|NCT04346615|529094375|FG001|Overall Study|Lost to Follow-up|2|||
146704863|NCT04346615|529094374|FG000|Overall Study|Withdrawal by Subject|1|||
146704864|NCT04346615|529094375|FG001|Overall Study|Withdrawal by Subject|0|||
146704865|NCT04346615|529094374|FG000|Overall Study|Death|5|||
146704866|NCT04346615|529094375|FG001|Overall Study|Death|1|||
146704867|NCT04346615|529094374|FG000|Overall Study|Other|0|||
146704868|NCT04346615|529094375|FG001|Overall Study|Other|2|||
146704869|NCT04346615|529094374|FG000|Overall Study|Randomized not treated|1|||
146704870|NCT04346615|529094375|FG001|Overall Study|Randomized not treated|0|||
146704871|NCT01105533|529094385|FG000|Overall Study|Death|0|||
146933578|NCT01669811|529914054|FG001|Overall Study|Investigator decision|1|||
146933579|NCT01669811|529914053|FG000|Overall Study|Withdrawal by Subject|1|||
146933580|NCT01669811|529914054|FG001|Overall Study|Withdrawal by Subject|2|||
146704872|NCT01105533|529094386|FG001|Overall Study|Death|0|||
146704873|NCT01105533|529094387|FG002|Overall Study|Death|0|||
146704874|NCT01105533|529094388|FG003|Overall Study|Death|0|||
146704875|NCT01105533|529094389|FG004|Overall Study|Death|1|||
146704876|NCT01105533|529094390|FG005|Overall Study|Death|0|||
146704877|NCT01105533|529094391|FG006|Overall Study|Death|0|||
146704878|NCT01105533|529094392|FG007|Overall Study|Death|0|||
146704879|NCT01105533|529094393|FG008|Overall Study|Death|0|||
146704880|NCT01105533|529094385|FG000|Overall Study|Lack of Efficacy|1|||
146704881|NCT01105533|529094386|FG001|Overall Study|Lack of Efficacy|1|||
146704882|NCT01105533|529094387|FG002|Overall Study|Lack of Efficacy|3|||
146704883|NCT01105533|529094388|FG003|Overall Study|Lack of Efficacy|3|||
146704884|NCT01105533|529094389|FG004|Overall Study|Lack of Efficacy|4|||
146704885|NCT01105533|529094390|FG005|Overall Study|Lack of Efficacy|5|||
146704886|NCT01105533|529094391|FG006|Overall Study|Lack of Efficacy|3|||
146704887|NCT01105533|529094392|FG007|Overall Study|Lack of Efficacy|2|||
146704888|NCT01105533|529094393|FG008|Overall Study|Lack of Efficacy|9|||
146704889|NCT01105533|529094385|FG000|Overall Study|Adverse Event|0|||
146704890|NCT01105533|529094386|FG001|Overall Study|Adverse Event|0|||
146704891|NCT01105533|529094387|FG002|Overall Study|Adverse Event|0|||
146704892|NCT01105533|529094388|FG003|Overall Study|Adverse Event|0|||
146704893|NCT01105533|529094389|FG004|Overall Study|Adverse Event|1|||
146704894|NCT01105533|529094390|FG005|Overall Study|Adverse Event|2|||
146704895|NCT01105533|529094391|FG006|Overall Study|Adverse Event|2|||
146704896|NCT01105533|529094392|FG007|Overall Study|Adverse Event|0|||
146704897|NCT01105533|529094393|FG008|Overall Study|Adverse Event|1|||
146704898|NCT01105533|529094385|FG000|Overall Study|Other|0|||
146704899|NCT01105533|529094386|FG001|Overall Study|Other|0|||
146704900|NCT01105533|529094387|FG002|Overall Study|Other|0|||
146704901|NCT01105533|529094388|FG003|Overall Study|Other|0|||
146704902|NCT01105533|529094389|FG004|Overall Study|Other|1|||
146704903|NCT01105533|529094390|FG005|Overall Study|Other|0|||
146704904|NCT01105533|529094391|FG006|Overall Study|Other|3|||
146704905|NCT01105533|529094392|FG007|Overall Study|Other|1|||
146704906|NCT01105533|529094393|FG008|Overall Study|Other|2|||
146704907|NCT01105533|529094385|FG000|Overall Study|Physician Decision|0|||
146704908|NCT01105533|529094386|FG001|Overall Study|Physician Decision|0|||
146704909|NCT01105533|529094387|FG002|Overall Study|Physician Decision|0|||
146704910|NCT01105533|529094388|FG003|Overall Study|Physician Decision|0|||
146704911|NCT01105533|529094389|FG004|Overall Study|Physician Decision|0|||
146704912|NCT01105533|529094390|FG005|Overall Study|Physician Decision|0|||
146704913|NCT01105533|529094391|FG006|Overall Study|Physician Decision|0|||
146704914|NCT01105533|529094392|FG007|Overall Study|Physician Decision|1|||
146704915|NCT01105533|529094393|FG008|Overall Study|Physician Decision|0|||
146704916|NCT00306592|529094394|FG000|Overall Study|Adverse Event|8|||
146704917|NCT00306592|529094395|FG001|Overall Study|Adverse Event|15|||
146704918|NCT00306592|529094394|FG000|Overall Study|Lost to Follow-up|1|||
146704919|NCT00306592|529094395|FG001|Overall Study|Lost to Follow-up|0|||
146704920|NCT00306592|529094394|FG000|Overall Study|Noncompliance|0|||
146704921|NCT00306592|529094395|FG001|Overall Study|Noncompliance|2|||
146704922|NCT00306592|529094394|FG000|Overall Study|Persistent Antibodies|6|||
146704923|NCT00306592|529094395|FG001|Overall Study|Persistent Antibodies|3|||
146704924|NCT00306592|529094394|FG000|Overall Study|Voluntary|10|||
146704925|NCT00306592|529094395|FG001|Overall Study|Voluntary|6|||
146704926|NCT00306592|529094394|FG000|Overall Study|Other|5|||
146704927|NCT00306592|529094395|FG001|Overall Study|Other|10|||
146704928|NCT00306592|529094394|FG000|Overall Study|Other|1|||
146704929|NCT00306592|529094395|FG001|Overall Study|Other|2|||
146704930|NCT00306592|529094394|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
146704931|NCT00306592|529094395|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
146704932|NCT04101526|529094396|FG000|Overall Study|Did not complete all sleep diary entries|0|||
146704933|NCT04101526|529094397|FG001|Overall Study|Did not complete all sleep diary entries|1|||
146704934|NCT02488629|529094398|FG000|Overall Study|Lack of Efficacy|3|||
146704935|NCT02488629|529094399|FG001|Overall Study|Lack of Efficacy|1|||
146704936|NCT02488629|529094400|FG002|Overall Study|Lack of Efficacy|0|||
146704937|NCT02488629|529094401|FG003|Overall Study|Lack of Efficacy|0|||
146704938|NCT02488629|529094398|FG000|Overall Study|Withdrawal by Subject|0|||
146704939|NCT02488629|529094399|FG001|Overall Study|Withdrawal by Subject|1|||
146704940|NCT02488629|529094400|FG002|Overall Study|Withdrawal by Subject|0|||
146704941|NCT02488629|529094401|FG003|Overall Study|Withdrawal by Subject|0|||
146704942|NCT00796861|529094402|FG000|Overall Study|Withdrawal by Subject|2|||
146704943|NCT00796861|529094402|FG000|Overall Study|Death|2|||
146704944|NCT00529386|529094411|FG000|Overall Study|Lost to Follow-up|1|||
146704945|NCT01049919|529094413|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
146704946|NCT01049919|529094414|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
146704947|NCT01049919|529094413|FG000|Overall Study|Withdrawal by Subject|5|||
146704948|NCT01049919|529094414|FG001|Overall Study|Withdrawal by Subject|0|||
146981020|NCT00434161|530093714|FG002|Overall Study|Non-Compliance|0|||
146704949|NCT01049919|529094413|FG000|Overall Study|Lost to Follow-up|6|||
146704950|NCT01049919|529094414|FG001|Overall Study|Lost to Follow-up|1|||
146704951|NCT01049919|529094413|FG000|Overall Study|Physician Decision|2|||
146704952|NCT01049919|529094414|FG001|Overall Study|Physician Decision|0|||
146704953|NCT01049919|529094413|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
146704954|NCT01049919|529094414|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
146704955|NCT01049919|529094413|FG000|Overall Study|Early study termination by sponsor.|2|||
146704956|NCT01049919|529094414|FG001|Overall Study|Early study termination by sponsor.|0|||
146933581|NCT01669811|529914053|FG000|Overall Study|Adverse Event|2|||
146704957|NCT02039427|529094418|FG000|Overall Study|Duration of surgery > 3h|1|||
146704958|NCT02039427|529094419|FG001|Overall Study|Duration of surgery > 3h|1|||
146704959|NCT02039427|529094420|FG002|Overall Study|Duration of surgery > 3h|0|||
146704960|NCT02039427|529094421|FG003|Overall Study|Duration of surgery > 3h|0|||
146704961|NCT02039427|529094418|FG000|Overall Study|Withdrawal on concent|0|||
146704962|NCT02039427|529094419|FG001|Overall Study|Withdrawal on concent|0|||
146704963|NCT02039427|529094420|FG002|Overall Study|Withdrawal on concent|0|||
146704964|NCT02039427|529094421|FG003|Overall Study|Withdrawal on concent|1|||
146704965|NCT02039427|529094418|FG000|Overall Study|Cancellation of surgery|0|||
146704966|NCT02039427|529094419|FG001|Overall Study|Cancellation of surgery|0|||
146704967|NCT02039427|529094420|FG002|Overall Study|Cancellation of surgery|1|||
146704968|NCT02039427|529094421|FG003|Overall Study|Cancellation of surgery|0|||
146704969|NCT02039427|529094418|FG000|Overall Study|Loss of follow - up|1|||
146704970|NCT02039427|529094419|FG001|Overall Study|Loss of follow - up|0|||
146704971|NCT02039427|529094420|FG002|Overall Study|Loss of follow - up|2|||
146704972|NCT02039427|529094421|FG003|Overall Study|Loss of follow - up|4|||
146704973|NCT02039427|529094418|FG000|Overall Study|Steroid Use|1|||
146704974|NCT02039427|529094419|FG001|Overall Study|Steroid Use|0|||
146704975|NCT02039427|529094420|FG002|Overall Study|Steroid Use|0|||
146704976|NCT02039427|529094421|FG003|Overall Study|Steroid Use|0|||
146704977|NCT00844545|529094422|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
146704978|NCT00844545|529094422|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
146704979|NCT00844545|529094422|FG000|Extension Treatment Period|Adverse Event|2|||
146704980|NCT00844545|529094422|FG000|Post Treatment Period|Withdrawal by Subject|1|||
146704981|NCT02984995|529094423|FG000|Overall Study|Required stem cell transplant|13|||
146704982|NCT02984995|529094424|FG001|Overall Study|Required stem cell transplant|2|||
146704983|NCT02984995|529094423|FG000|Overall Study|Progressive disease|11|||
146704984|NCT02984995|529094424|FG001|Overall Study|Progressive disease|1|||
146704985|NCT02984995|529094423|FG000|Overall Study|Adverse Event|1|||
146704986|NCT02984995|529094424|FG001|Overall Study|Adverse Event|0|||
146704987|NCT01401530|529094425|FG000|Overall Study|Disease Progression|1|||
146704988|NCT01401530|529094426|FG001|Overall Study|Disease Progression|2|||
146704989|NCT01401530|529094427|FG002|Overall Study|Disease Progression|1|||
146704990|NCT01401530|529094425|FG000|Overall Study|Adverse Event|1|||
146704991|NCT01401530|529094426|FG001|Overall Study|Adverse Event|1|||
146704992|NCT01401530|529094427|FG002|Overall Study|Adverse Event|1|||
146704993|NCT01401530|529094425|FG000|Overall Study|Participant Choice|1|||
146704994|NCT01401530|529094426|FG001|Overall Study|Participant Choice|2|||
146704995|NCT01401530|529094427|FG002|Overall Study|Participant Choice|1|||
146704996|NCT01401530|529094425|FG000|Overall Study|Physician Decision|0|||
146704997|NCT01401530|529094426|FG001|Overall Study|Physician Decision|1|||
146704998|NCT01401530|529094427|FG002|Overall Study|Physician Decision|0|||
146704999|NCT00813124|529094433|FG000|Overall Study|Death|2|||
146705000|NCT00813124|529094433|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
146705001|NCT00813124|529094433|FG000|Overall Study|Withdrawal by Subject|1|||
146705002|NCT00767676|529094434|FG000|Overall Study|Investigator error|54|||
146705003|NCT00079274|529094437|FG000|Overall Study|Withdrawal by Subject|111|||
146705004|NCT00079274|529094438|FG001|Overall Study|Withdrawal by Subject|10|||
146705005|NCT00079274|529094439|FG002|Overall Study|Withdrawal by Subject|12|||
146705006|NCT00079274|529094440|FG003|Overall Study|Withdrawal by Subject|163|||
146705007|NCT00079274|529094441|FG004|Overall Study|Withdrawal by Subject|7|||
146705008|NCT00079274|529094442|FG005|Overall Study|Withdrawal by Subject|8|||
146933582|NCT01669811|529914054|FG001|Overall Study|Adverse Event|6|||
146933583|NCT01669811|529914053|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
146933584|NCT01669811|529914054|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
146933585|NCT02559206|529914058|FG000|Overall Study|Adverse Event|0|||
146933586|NCT02559206|529914059|FG001|Overall Study|Adverse Event|4|||
146933587|NCT02559206|529914060|FG002|Overall Study|Adverse Event|1|||
146933588|NCT02559206|529914061|FG003|Overall Study|Adverse Event|5|||
146933589|NCT02559206|529914062|FG004|Overall Study|Adverse Event|3|||
146933590|NCT02559206|529914063|FG005|Overall Study|Adverse Event|0|||
146933591|NCT02559206|529914064|FG006|Overall Study|Adverse Event|1|||
146933592|NCT02559206|529914065|FG007|Overall Study|Adverse Event|0|||
146933593|NCT02559206|529914058|FG000|Overall Study|Protocol Violation|1|||
146705009|NCT00079274|529094443|FG006|Overall Study|Withdrawal by Subject|0|||
146705010|NCT00079274|529094437|FG000|Overall Study|Adverse Event|130|||
146705011|NCT00079274|529094438|FG001|Overall Study|Adverse Event|8|||
146705012|NCT00079274|529094439|FG002|Overall Study|Adverse Event|8|||
146705013|NCT00079274|529094440|FG003|Overall Study|Adverse Event|184|||
146705014|NCT00079274|529094441|FG004|Overall Study|Adverse Event|7|||
146705015|NCT00079274|529094442|FG005|Overall Study|Adverse Event|8|||
146705016|NCT00079274|529094443|FG006|Overall Study|Adverse Event|0|||
146705017|NCT00079274|529094437|FG000|Overall Study|Recurrence|21|||
146705018|NCT00079274|529094438|FG001|Overall Study|Recurrence|0|||
146933594|NCT02559206|529914059|FG001|Overall Study|Protocol Violation|0|||
146705019|NCT00079274|529094439|FG002|Overall Study|Recurrence|1|||
146705020|NCT00079274|529094440|FG003|Overall Study|Recurrence|15|||
146933595|NCT02559206|529914060|FG002|Overall Study|Protocol Violation|1|||
146705021|NCT00079274|529094441|FG004|Overall Study|Recurrence|0|||
146933596|NCT02559206|529914061|FG003|Overall Study|Protocol Violation|0|||
146933597|NCT02559206|529914062|FG004|Overall Study|Protocol Violation|0|||
146933598|NCT02559206|529914063|FG005|Overall Study|Protocol Violation|2|||
146933599|NCT02559206|529914064|FG006|Overall Study|Protocol Violation|0|||
146933600|NCT02559206|529914065|FG007|Overall Study|Protocol Violation|0|||
146933601|NCT02559206|529914058|FG000|Overall Study|Withdrawal by Subject|3|||
146933602|NCT02559206|529914059|FG001|Overall Study|Withdrawal by Subject|3|||
146776884|NCT02723955|529353627|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776885|NCT02723955|529353628|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776886|NCT02723955|529353629|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776887|NCT02723955|529353630|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776888|NCT02723955|529353631|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146933603|NCT02559206|529914060|FG002|Overall Study|Withdrawal by Subject|1|||
146933604|NCT02559206|529914061|FG003|Overall Study|Withdrawal by Subject|3|||
146933605|NCT02559206|529914062|FG004|Overall Study|Withdrawal by Subject|5|||
146933606|NCT02559206|529914063|FG005|Overall Study|Withdrawal by Subject|4|||
146933607|NCT02559206|529914064|FG006|Overall Study|Withdrawal by Subject|1|||
146933608|NCT02559206|529914065|FG007|Overall Study|Withdrawal by Subject|2|||
146933609|NCT02559206|529914058|FG000|Overall Study|Lost to Follow-up|3|||
146933610|NCT02559206|529914059|FG001|Overall Study|Lost to Follow-up|5|||
146933611|NCT02559206|529914060|FG002|Overall Study|Lost to Follow-up|3|||
146933612|NCT02559206|529914061|FG003|Overall Study|Lost to Follow-up|3|||
146933613|NCT02559206|529914062|FG004|Overall Study|Lost to Follow-up|2|||
146933614|NCT02559206|529914063|FG005|Overall Study|Lost to Follow-up|5|||
146933615|NCT02559206|529914064|FG006|Overall Study|Lost to Follow-up|1|||
146933616|NCT02559206|529914065|FG007|Overall Study|Lost to Follow-up|4|||
146933617|NCT02559206|529914058|FG000|Overall Study|Lack of Efficacy|1|||
146933618|NCT02559206|529914059|FG001|Overall Study|Lack of Efficacy|0|||
146933619|NCT02559206|529914060|FG002|Overall Study|Lack of Efficacy|3|||
146933620|NCT02559206|529914061|FG003|Overall Study|Lack of Efficacy|2|||
146933621|NCT02559206|529914062|FG004|Overall Study|Lack of Efficacy|2|||
146933622|NCT02559206|529914063|FG005|Overall Study|Lack of Efficacy|3|||
146933623|NCT02559206|529914064|FG006|Overall Study|Lack of Efficacy|3|||
146933624|NCT02559206|529914065|FG007|Overall Study|Lack of Efficacy|3|||
146705022|NCT00079274|529094442|FG005|Overall Study|Recurrence|2|||
146705023|NCT00079274|529094443|FG006|Overall Study|Recurrence|0|||
146705024|NCT00079274|529094437|FG000|Overall Study|Alternate Treatment|6|||
146705025|NCT00079274|529094438|FG001|Overall Study|Alternate Treatment|1|||
146705026|NCT00079274|529094439|FG002|Overall Study|Alternate Treatment|0|||
146705027|NCT00079274|529094440|FG003|Overall Study|Alternate Treatment|3|||
146705028|NCT00079274|529094441|FG004|Overall Study|Alternate Treatment|0|||
146705029|NCT00079274|529094442|FG005|Overall Study|Alternate Treatment|0|||
146705030|NCT00079274|529094443|FG006|Overall Study|Alternate Treatment|0|||
146705031|NCT00079274|529094437|FG000|Overall Study|Other Medical Problems|6|||
146705032|NCT00079274|529094438|FG001|Overall Study|Other Medical Problems|1|||
146705033|NCT00079274|529094439|FG002|Overall Study|Other Medical Problems|0|||
146705034|NCT00079274|529094440|FG003|Overall Study|Other Medical Problems|7|||
146705035|NCT00079274|529094441|FG004|Overall Study|Other Medical Problems|0|||
146705036|NCT00079274|529094442|FG005|Overall Study|Other Medical Problems|0|||
146705037|NCT00079274|529094443|FG006|Overall Study|Other Medical Problems|0|||
146705038|NCT00079274|529094437|FG000|Overall Study|Death|4|||
146705039|NCT00079274|529094438|FG001|Overall Study|Death|0|||
146705040|NCT00079274|529094439|FG002|Overall Study|Death|1|||
146705041|NCT00079274|529094440|FG003|Overall Study|Death|15|||
146705042|NCT00079274|529094441|FG004|Overall Study|Death|0|||
146705043|NCT00079274|529094442|FG005|Overall Study|Death|0|||
146705044|NCT00079274|529094443|FG006|Overall Study|Death|0|||
146705045|NCT00079274|529094437|FG000|Overall Study|Cytogenetic resistance|0|||
146705046|NCT00079274|529094438|FG001|Overall Study|Cytogenetic resistance|0|||
146705047|NCT00079274|529094439|FG002|Overall Study|Cytogenetic resistance|0|||
146705048|NCT00079274|529094440|FG003|Overall Study|Cytogenetic resistance|2|||
146933625|NCT02559206|529914058|FG000|Overall Study|Other Not Specified|0|||
146933626|NCT02559206|529914059|FG001|Overall Study|Other Not Specified|0|||
146981021|NCT00434161|530093712|FG000|Overall Study|Withdrawal by Subject|2|||
146705049|NCT00079274|529094441|FG004|Overall Study|Cytogenetic resistance|0|||
146705050|NCT00079274|529094442|FG005|Overall Study|Cytogenetic resistance|0|||
146705051|NCT00079274|529094443|FG006|Overall Study|Cytogenetic resistance|0|||
146705052|NCT00079274|529094437|FG000|Overall Study|Other|43|||
146705053|NCT00079274|529094438|FG001|Overall Study|Other|7|||
146705054|NCT00079274|529094439|FG002|Overall Study|Other|5|||
146705055|NCT00079274|529094440|FG003|Overall Study|Other|55|||
146705056|NCT00079274|529094441|FG004|Overall Study|Other|1|||
146705057|NCT00079274|529094442|FG005|Overall Study|Other|2|||
146933627|NCT02559206|529914060|FG002|Overall Study|Other Not Specified|0|||
146933628|NCT02559206|529914061|FG003|Overall Study|Other Not Specified|1|||
146933629|NCT02559206|529914062|FG004|Overall Study|Other Not Specified|0|||
146705058|NCT00079274|529094443|FG006|Overall Study|Other|0|||
146933630|NCT02559206|529914063|FG005|Overall Study|Other Not Specified|0|||
146933631|NCT02559206|529914064|FG006|Overall Study|Other Not Specified|0|||
146933632|NCT02559206|529914065|FG007|Overall Study|Other Not Specified|0|||
146933633|NCT05263921|529915938|FG000|Overall Study|Other: family emergency.|0|||
146933634|NCT05263921|529915939|FG001|Overall Study|Other: family emergency.|0|||
146933635|NCT05263921|529915940|FG002|Overall Study|Other: family emergency.|1|||
146933636|NCT05263921|529915941|FG003|Overall Study|Other: family emergency.|0|||
146933637|NCT02670928|529915942|FG000|Overall Study|Adverse Event|3|||
146933638|NCT02670928|529915943|FG001|Overall Study|Adverse Event|1|||
146933639|NCT02670928|529915942|FG000|Overall Study|Withdrawal by Subject|4|||
146933640|NCT02670928|529915943|FG001|Overall Study|Withdrawal by Subject|0|||
146933641|NCT02670928|529915942|FG000|Overall Study|Lost to Follow-up|1|||
146933642|NCT02670928|529915943|FG001|Overall Study|Lost to Follow-up|0|||
146933643|NCT02670928|529915942|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
146933644|NCT02670928|529915943|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
146933645|NCT02966353|529915954|FG000|Overall Study|Withdrawal by Subject|7|||
146933646|NCT02966353|529915954|FG000|Overall Study|Adverse Event|4|||
146933647|NCT02966353|529915954|FG000|Overall Study|Death|4|||
146933648|NCT02966353|529915954|FG000|Overall Study|Physician Decision|3|||
146933649|NCT02966353|529915954|FG000|Overall Study|Progressive disease|2|||
146933650|NCT02966353|529915954|FG000|Overall Study|Protocol deviation|2|||
146933651|NCT00093470|529915960|FG000|Overall Study|Disease progression|39|||
146933652|NCT00093470|529915961|FG001|Overall Study|Disease progression|0|||
146933653|NCT00093470|529915960|FG000|Overall Study|Adverse Event|15|||
146933654|NCT00093470|529915961|FG001|Overall Study|Adverse Event|0|||
146933655|NCT00093470|529915960|FG000|Overall Study|Death|2|||
146933656|NCT00093470|529915961|FG001|Overall Study|Death|0|||
146933657|NCT00093470|529915960|FG000|Overall Study|Withdrawal by Subject|8|||
146933658|NCT00093470|529915961|FG001|Overall Study|Withdrawal by Subject|0|||
146933659|NCT00093470|529915960|FG000|Overall Study|Alternative therapy|2|||
146933660|NCT00093470|529915961|FG001|Overall Study|Alternative therapy|0|||
146933661|NCT00093470|529915960|FG000|Overall Study|Other complicating disease|3|||
146933662|NCT00093470|529915961|FG001|Overall Study|Other complicating disease|0|||
146933663|NCT00093470|529915960|FG000|Overall Study|Physician Decision|2|||
146933664|NCT00093470|529915961|FG001|Overall Study|Physician Decision|0|||
146933665|NCT00093470|529915960|FG000|Overall Study|Never started treatment|1|||
146933666|NCT00093470|529915961|FG001|Overall Study|Never started treatment|0|||
146933667|NCT00093470|529915960|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
146933668|NCT00093470|529915961|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
146933669|NCT02514772|529915962|FG000|Overall Study|Adverse Event|1|||
146933670|NCT02514772|529915963|FG001|Overall Study|Adverse Event|0|||
146933671|NCT02514772|529915962|FG000|Overall Study|Death|0|||
146933672|NCT02514772|529915963|FG001|Overall Study|Death|1|||
146933673|NCT02514772|529915962|FG000|Overall Study|Withdrawal by Subject|2|||
146933674|NCT02514772|529915963|FG001|Overall Study|Withdrawal by Subject|1|||
146933675|NCT00877006|529915964|FG000|Treatment Period|Death|2|||
146705059|NCT00617240|529094446|FG000|Overall Study|Lack of Efficacy|1|||
146705060|NCT00617240|529094447|FG001|Overall Study|Lack of Efficacy|0|||
146705061|NCT01611259|529094448|FG000|Overall Study|Physician Decision|1|||
146705062|NCT01611259|529094448|FG000|Overall Study|Lack of Efficacy|2|||
146705063|NCT01611259|529094448|FG000|Overall Study|Adverse Event|4|||
146705064|NCT01611259|529094448|FG000|Overall Study|Withdrawal by Subject|7|||
146933676|NCT00877006|529915965|FG001|Treatment Period|Death|1|||
146933677|NCT00877006|529915964|FG000|Treatment Period|Adverse Event|10|||
146933678|NCT00877006|529915965|FG001|Treatment Period|Adverse Event|3|||
146933679|NCT00877006|529915964|FG000|Treatment Period|Withdrawal by Subject|2|||
146933680|NCT00877006|529915965|FG001|Treatment Period|Withdrawal by Subject|3|||
146933681|NCT00877006|529915964|FG000|Treatment Period|Protocol Violation|1|||
146933682|NCT00877006|529915965|FG001|Treatment Period|Protocol Violation|0|||
146933683|NCT00877006|529915964|FG000|Treatment Period|Lost to Follow-up|0|||
146933684|NCT00877006|529915965|FG001|Treatment Period|Lost to Follow-up|1|||
146933685|NCT00877006|529915964|FG000|Treatment Period|Disease Progression|1|||
146933686|NCT00877006|529915965|FG001|Treatment Period|Disease Progression|2|||
146705065|NCT03969212|529094449|FG000|Overall Study|Adverse Event|1|||
146933687|NCT00877006|529915964|FG000|Treatment Period|Started New Treatment Regimen|2|||
146933688|NCT00877006|529915965|FG001|Treatment Period|Started New Treatment Regimen|5|||
146933689|NCT00877006|529915964|FG000|Treatment Period|Other|4|||
146933690|NCT00877006|529915965|FG001|Treatment Period|Other|4|||
146933691|NCT00877006|529915964|FG000|Treatment Period|Randomized but Not Treated|3|||
146933692|NCT00877006|529915965|FG001|Treatment Period|Randomized but Not Treated|8|||
146933693|NCT00877006|529915964|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
146933694|NCT00877006|529915965|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
146933695|NCT00877006|529915964|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
146933696|NCT00877006|529915965|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
146933697|NCT00877006|529915964|FG000|Long-Term Follow-up Period|Death|26|||
146933698|NCT00877006|529915965|FG001|Long-Term Follow-up Period|Death|18|||
146933699|NCT00877006|529915964|FG000|Long-Term Follow-up Period|Other|7|||
146933700|NCT00877006|529915965|FG001|Long-Term Follow-up Period|Other|9|||
146705066|NCT03969212|529094450|FG001|Overall Study|Adverse Event|0|||
146705067|NCT03969212|529094451|FG002|Overall Study|Adverse Event|0|||
146705068|NCT03969212|529094452|FG003|Overall Study|Adverse Event|0|||
146705069|NCT03969212|529094449|FG000|Overall Study|Lost to Follow-up|2|||
146705070|NCT03969212|529094450|FG001|Overall Study|Lost to Follow-up|2|||
146705071|NCT03969212|529094451|FG002|Overall Study|Lost to Follow-up|2|||
146705072|NCT03969212|529094452|FG003|Overall Study|Lost to Follow-up|2|||
146705073|NCT03969212|529094449|FG000|Overall Study|Protocol Violation|0|||
146705074|NCT03969212|529094450|FG001|Overall Study|Protocol Violation|0|||
146705075|NCT03969212|529094451|FG002|Overall Study|Protocol Violation|0|||
146705076|NCT03969212|529094452|FG003|Overall Study|Protocol Violation|1|||
146705077|NCT03969212|529094449|FG000|Overall Study|Withdrawal by Subject|7|||
146705078|NCT03969212|529094450|FG001|Overall Study|Withdrawal by Subject|13|||
146705079|NCT03969212|529094451|FG002|Overall Study|Withdrawal by Subject|5|||
146705080|NCT03969212|529094452|FG003|Overall Study|Withdrawal by Subject|11|||
146705081|NCT03969212|529094449|FG000|Overall Study|Physician Decision|0|||
146705082|NCT03969212|529094450|FG001|Overall Study|Physician Decision|0|||
146705083|NCT03969212|529094451|FG002|Overall Study|Physician Decision|1|||
146705084|NCT03969212|529094452|FG003|Overall Study|Physician Decision|0|||
146705085|NCT03969212|529094449|FG000|Overall Study|Reason not Specified|22|||
146705086|NCT03969212|529094450|FG001|Overall Study|Reason not Specified|23|||
146705087|NCT03969212|529094451|FG002|Overall Study|Reason not Specified|28|||
146705088|NCT03969212|529094452|FG003|Overall Study|Reason not Specified|26|||
146705089|NCT01147653|529094456|FG000|Year 2|Withdrawal by Subject|2|||
146705090|NCT01147653|529094457|FG001|Year 2|Withdrawal by Subject|3|||
146705091|NCT00280566|529094458|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
146705092|NCT00280566|529094459|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
146705093|NCT00280566|529094460|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
146705094|NCT00280566|529094458|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
146705095|NCT00280566|529094459|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
146705096|NCT00280566|529094460|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
146705097|NCT00280566|529094458|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
146705098|NCT00280566|529094459|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
146705099|NCT00280566|529094460|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
146705100|NCT00280566|529094458|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
146705101|NCT00280566|529094459|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
146705102|NCT00280566|529094460|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
146705103|NCT00280566|529094458|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
146705104|NCT00280566|529094459|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
146705105|NCT00280566|529094460|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
146705106|NCT00280566|529094458|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
146705107|NCT00280566|529094459|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
146705108|NCT00280566|529094460|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
146705109|NCT00280566|529094458|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
146705110|NCT00280566|529094459|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
146705111|NCT00280566|529094460|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
146705112|NCT00280566|529094458|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
146705113|NCT00280566|529094459|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
146705114|NCT00280566|529094460|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
146705115|NCT00280566|529094458|FG000|Period 2 Double Blind|Adverse Event|0|||
146705116|NCT00280566|529094459|FG001|Period 2 Double Blind|Adverse Event|11|||
146705117|NCT00280566|529094460|FG002|Period 2 Double Blind|Adverse Event|15|||
146705118|NCT00280566|529094458|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
146705119|NCT00280566|529094459|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
146705120|NCT00280566|529094460|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
146705121|NCT00280566|529094458|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
146705122|NCT00280566|529094459|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
146705123|NCT00280566|529094460|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
146705124|NCT00280566|529094458|FG000|Period 2 Double Blind|miscellaneous|0|||
146705125|NCT00280566|529094459|FG001|Period 2 Double Blind|miscellaneous|10|||
146705126|NCT00280566|529094460|FG002|Period 2 Double Blind|miscellaneous|5|||
146705127|NCT00353366|529094461|FG000|Overall Study|Adverse Event|8|||
146705128|NCT00353366|529094461|FG000|Overall Study|Protocol Violation|12|||
146705129|NCT00353366|529094461|FG000|Overall Study|Withdrawal by Subject|12|||
146705130|NCT00353366|529094461|FG000|Overall Study|Lost to Follow-up|92|||
146705131|NCT00353366|529094461|FG000|Overall Study|Other|19|||
146705132|NCT01302392|529094462|FG000|Overall Study|Lost to Follow-up|1|||
146705133|NCT01302392|529094463|FG001|Overall Study|Lost to Follow-up|0|||
146705134|NCT01302392|529094462|FG000|Overall Study|Withdrawal by Subject|6|||
146705135|NCT01302392|529094463|FG001|Overall Study|Withdrawal by Subject|1|||
146705136|NCT00259857|529094464|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
146705137|NCT00259857|529094465|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
146705138|NCT00259857|529094464|FG000|24 Months Treatment|Lost to Follow-up|0|||
146705139|NCT00259857|529094465|FG001|24 Months Treatment|Lost to Follow-up|3|||
146705140|NCT00670228|529094466|FG000|Overall Study|Adverse Event|1|||
146705141|NCT00670228|529094467|FG001|Overall Study|Adverse Event|0|||
146705142|NCT00670228|529094466|FG000|Overall Study|Death or MACE|0|||
146705143|NCT00670228|529094467|FG001|Overall Study|Death or MACE|1|||
146705144|NCT00670228|529094466|FG000|Overall Study|Not treated|2|||
146705145|NCT00670228|529094467|FG001|Overall Study|Not treated|2|||
146705146|NCT00670228|529094466|FG000|Overall Study|Not meeting the selection criteria|2|||
146705147|NCT00670228|529094467|FG001|Overall Study|Not meeting the selection criteria|0|||
146705148|NCT05267054|529094468|FG000|Overall Study|Death|13|||
146705149|NCT05267054|529094469|FG001|Overall Study|Death|14|||
146705150|NCT05267054|529094468|FG000|Overall Study|Study Ended by Sponsor|9|||
146705151|NCT05267054|529094469|FG001|Overall Study|Study Ended by Sponsor|13|||
146705152|NCT05267054|529094468|FG000|Overall Study|Lost to Follow-up|1|||
146705153|NCT05267054|529094469|FG001|Overall Study|Lost to Follow-up|1|||
146705154|NCT05267054|529094468|FG000|Overall Study|Withdrawal by Subject|1|||
146705155|NCT05267054|529094469|FG001|Overall Study|Withdrawal by Subject|1|||
146705156|NCT01552226|529094473|FG000|Overall Study|Withdrawal by Subject|4|||
146705157|NCT01552226|529094474|FG001|Overall Study|Withdrawal by Subject|4|||
146705158|NCT03604692|529094475|FG000|Overall Study|Investigator's Decision|0|||
146705159|NCT03604692|529094476|FG001|Overall Study|Investigator's Decision|0|||
146705160|NCT03604692|529094477|FG002|Overall Study|Investigator's Decision|0|||
146705161|NCT03604692|529094478|FG003|Overall Study|Investigator's Decision|1|||
146705162|NCT03604692|529094479|FG004|Overall Study|Investigator's Decision|0|||
146705163|NCT03604692|529094480|FG005|Overall Study|Investigator's Decision|7|||
146705164|NCT03604692|529094475|FG000|Overall Study|Withdrawal by Subject|0|||
146705165|NCT03604692|529094476|FG001|Overall Study|Withdrawal by Subject|0|||
146705166|NCT03604692|529094477|FG002|Overall Study|Withdrawal by Subject|0|||
146705167|NCT03604692|529094478|FG003|Overall Study|Withdrawal by Subject|0|||
146705168|NCT03604692|529094479|FG004|Overall Study|Withdrawal by Subject|0|||
146705169|NCT03604692|529094480|FG005|Overall Study|Withdrawal by Subject|2|||
146705170|NCT03604692|529094475|FG000|Overall Study|Progressive Disease|1|||
146705171|NCT03604692|529094476|FG001|Overall Study|Progressive Disease|0|||
146705172|NCT03604692|529094477|FG002|Overall Study|Progressive Disease|1|||
146705173|NCT03604692|529094478|FG003|Overall Study|Progressive Disease|0|||
146705174|NCT03604692|529094479|FG004|Overall Study|Progressive Disease|3|||
146705175|NCT03604692|529094480|FG005|Overall Study|Progressive Disease|4|||
146705176|NCT03604692|529094475|FG000|Overall Study|Difficulty Coming into Site|0|||
146705177|NCT03604692|529094476|FG001|Overall Study|Difficulty Coming into Site|0|||
146705178|NCT03604692|529094477|FG002|Overall Study|Difficulty Coming into Site|0|||
146705179|NCT03604692|529094478|FG003|Overall Study|Difficulty Coming into Site|0|||
146705180|NCT03604692|529094479|FG004|Overall Study|Difficulty Coming into Site|0|||
146705181|NCT03604692|529094480|FG005|Overall Study|Difficulty Coming into Site|1|||
146705182|NCT03604692|529094475|FG000|Overall Study|Death|0|||
146705183|NCT03604692|529094476|FG001|Overall Study|Death|0|||
146705184|NCT03604692|529094477|FG002|Overall Study|Death|1|||
146705185|NCT03604692|529094478|FG003|Overall Study|Death|0|||
146705186|NCT03604692|529094479|FG004|Overall Study|Death|0|||
146705187|NCT03604692|529094480|FG005|Overall Study|Death|0|||
146705188|NCT03604692|529094475|FG000|Overall Study|Drug Intolerance|0|||
146705189|NCT03604692|529094476|FG001|Overall Study|Drug Intolerance|0|||
146705190|NCT03604692|529094477|FG002|Overall Study|Drug Intolerance|0|||
146705191|NCT03604692|529094478|FG003|Overall Study|Drug Intolerance|1|||
146705192|NCT03604692|529094479|FG004|Overall Study|Drug Intolerance|0|||
146705193|NCT03604692|529094480|FG005|Overall Study|Drug Intolerance|0|||
146705194|NCT03604692|529094475|FG000|Overall Study|Noncompliance with follow-up visit|0|||
146705195|NCT03604692|529094476|FG001|Overall Study|Noncompliance with follow-up visit|0|||
146705196|NCT03604692|529094477|FG002|Overall Study|Noncompliance with follow-up visit|0|||
146705197|NCT03604692|529094478|FG003|Overall Study|Noncompliance with follow-up visit|1|||
146705198|NCT03604692|529094479|FG004|Overall Study|Noncompliance with follow-up visit|0|||
146705199|NCT03604692|529094480|FG005|Overall Study|Noncompliance with follow-up visit|0|||
146705200|NCT03604692|529094475|FG000|Overall Study|Not Treated|0|||
146705201|NCT03604692|529094476|FG001|Overall Study|Not Treated|0|||
146705202|NCT03604692|529094477|FG002|Overall Study|Not Treated|0|||
146705203|NCT03604692|529094478|FG003|Overall Study|Not Treated|0|||
146705204|NCT03604692|529094479|FG004|Overall Study|Not Treated|1|||
146705205|NCT03604692|529094480|FG005|Overall Study|Not Treated|0|||
146705206|NCT00637195|529094484|FG000|Overall Study|Lost to Follow-up|1|||
146705207|NCT00637195|529094485|FG001|Overall Study|Lost to Follow-up|0|||
146705208|NCT00637195|529094484|FG000|Overall Study|Other|2|||
146705209|NCT00637195|529094485|FG001|Overall Study|Other|0|||
146705210|NCT00637195|529094484|FG000|Overall Study|Withdrawal by Subject|0|||
146705211|NCT00637195|529094485|FG001|Overall Study|Withdrawal by Subject|1|||
146705212|NCT01469065|529094486|FG000|Overall Study|Lack of Efficacy|0|||
146705213|NCT01469065|529094487|FG001|Overall Study|Lack of Efficacy|0|||
146705214|NCT01469065|529094488|FG002|Overall Study|Lack of Efficacy|0|||
146705215|NCT01469065|529094489|FG003|Overall Study|Lack of Efficacy|0|||
146705216|NCT01469065|529094490|FG004|Overall Study|Lack of Efficacy|1|||
146705217|NCT01469065|529094486|FG000|Overall Study|Other|0|||
146705218|NCT01469065|529094487|FG001|Overall Study|Other|1|||
146705219|NCT01469065|529094488|FG002|Overall Study|Other|0|||
146933701|NCT00817206|529915966|FG000|Overall Study|Adverse Event|10|||
146933702|NCT00817206|529915967|FG001|Overall Study|Adverse Event|3|||
146933703|NCT00817206|529915966|FG000|Overall Study|Protocol Violation|0|||
146933704|NCT00817206|529915967|FG001|Overall Study|Protocol Violation|2|||
146933705|NCT00817206|529915966|FG000|Overall Study|Lost to Follow-up|0|||
146933706|NCT00817206|529915967|FG001|Overall Study|Lost to Follow-up|1|||
146933707|NCT00817206|529915966|FG000|Overall Study|Death|2|||
146933708|NCT00817206|529915967|FG001|Overall Study|Death|0|||
146933709|NCT00817206|529915966|FG000|Overall Study|Withdrawal by Subject|7|||
146933710|NCT00817206|529915967|FG001|Overall Study|Withdrawal by Subject|3|||
146933711|NCT00817206|529915966|FG000|Overall Study|Physician Decision|2|||
146933712|NCT00817206|529915967|FG001|Overall Study|Physician Decision|0|||
146933713|NCT00126581|529915968|FG000|Overall Study|Adverse Event|3|||
146933714|NCT00126581|529915969|FG001|Overall Study|Adverse Event|7|||
146933715|NCT00126581|529915968|FG000|Overall Study|Death|3|||
146933716|NCT00126581|529915969|FG001|Overall Study|Death|2|||
146933717|NCT00126581|529915968|FG000|Overall Study|Withdrawal by Subject|1|||
146933718|NCT00126581|529915969|FG001|Overall Study|Withdrawal by Subject|4|||
146933719|NCT00126581|529915968|FG000|Overall Study|Alternative therapy|3|||
146933720|NCT00126581|529915969|FG001|Overall Study|Alternative therapy|3|||
146705220|NCT01469065|529094489|FG003|Overall Study|Other|0|||
146705221|NCT01469065|529094490|FG004|Overall Study|Other|0|||
146705222|NCT01020019|529094496|FG000|Overall Study|Lost to Follow-up|21|||
146705223|NCT01020019|529094497|FG001|Overall Study|Lost to Follow-up|18|||
146705224|NCT01020019|529094496|FG000|Overall Study|Adverse Event|1|||
146705225|NCT01020019|529094497|FG001|Overall Study|Adverse Event|5|||
146705226|NCT01020019|529094496|FG000|Overall Study|not interested in treatment|4|||
146705227|NCT01020019|529094497|FG001|Overall Study|not interested in treatment|4|||
146705228|NCT01020019|529094496|FG000|Overall Study|moving|0|||
146705229|NCT01020019|529094497|FG001|Overall Study|moving|2|||
146705230|NCT05091528|529094498|FG000|Overall Study|Study Termination by Sponsor|0|||
146705231|NCT05091528|529094499|FG001|Overall Study|Study Termination by Sponsor|1|||
146705232|NCT05091528|529094500|FG002|Overall Study|Study Termination by Sponsor|0|||
146705233|NCT05091528|529094501|FG003|Overall Study|Study Termination by Sponsor|1|||
146705234|NCT02375672|529094502|FG000|Overall Study|remain on follow up|20|||
146705235|NCT00094653|529094505|FG000|Overall Study|Death|306|||
146705236|NCT00094653|529094506|FG001|Overall Study|Death|100|||
146705237|NCT00094653|529094507|FG002|Overall Study|Death|119|||
146705238|NCT00094653|529094505|FG000|Overall Study|Subject Withdrew Consent|10|||
146705239|NCT00094653|529094506|FG001|Overall Study|Subject Withdrew Consent|2|||
146705240|NCT00094653|529094507|FG002|Overall Study|Subject Withdrew Consent|3|||
146705241|NCT00094653|529094505|FG000|Overall Study|Other|2|||
146705242|NCT00094653|529094506|FG001|Overall Study|Other|2|||
146705243|NCT00094653|529094507|FG002|Overall Study|Other|2|||
146705244|NCT00094653|529094505|FG000|Overall Study|Lost to Follow-up|3|||
146705245|NCT00094653|529094506|FG001|Overall Study|Lost to Follow-up|2|||
146705246|NCT00094653|529094507|FG002|Overall Study|Lost to Follow-up|1|||
146705247|NCT00094653|529094505|FG000|Overall Study|Protocol Violation|0|||
146705248|NCT00094653|529094506|FG001|Overall Study|Protocol Violation|0|||
146776889|NCT02723955|529353632|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776890|NCT02723955|529353633|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776891|NCT02723955|529353634|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776892|NCT02723955|529353635|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776893|NCT02723955|529353636|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776894|NCT02723955|529353637|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776895|NCT02723955|529353638|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776896|NCT02723955|529353639|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776897|NCT02723955|529353640|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776898|NCT02723955|529353641|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146933721|NCT00126581|529915968|FG000|Overall Study|Other illness/MD discretion|3|||
146933722|NCT00126581|529915969|FG001|Overall Study|Other illness/MD discretion|4|||
146933723|NCT03728140|529915971|FG000|Overall Study|Abnormal embryo transfer operation|10|||
146776899|NCT02723955|529353642|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
146776900|NCT02723955|529353643|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776901|NCT02723955|529353644|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776902|NCT02723955|529353645|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146933724|NCT03728140|529915972|FG001|Overall Study|Abnormal embryo transfer operation|7|||
146933725|NCT01188096|529915973|FG000|Overall Study|progression of disease|4|||
146933726|NCT01188096|529915973|FG000|Overall Study|Withdrawal by Subject|2|||
146933727|NCT02384395|529915974|FG000|Overall Study|Physician Decision|4|||
146933728|NCT02384395|529915974|FG000|Overall Study|Withdrawal by Subject|3|||
146705249|NCT00094653|529094507|FG002|Overall Study|Protocol Violation|1|||
146776903|NCT02723955|529353646|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776904|NCT02723955|529353647|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776905|NCT02723955|529353648|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776906|NCT02723955|529353649|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776907|NCT02723955|529353650|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776908|NCT02723955|529353651|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776909|NCT02723955|529353652|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776910|NCT02723955|529353653|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776911|NCT02723955|529353654|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146776912|NCT02723955|529353612|FG000|Expansion Phase|Site Closed|0|||
146776913|NCT02723955|529353613|FG001|Expansion Phase|Site Closed|0|||
146776914|NCT02723955|529353614|FG002|Expansion Phase|Site Closed|0|||
146776915|NCT02723955|529353615|FG003|Expansion Phase|Site Closed|0|||
146776916|NCT02723955|529353616|FG004|Expansion Phase|Site Closed|0|||
146776917|NCT02723955|529353617|FG005|Expansion Phase|Site Closed|0|||
146776918|NCT02723955|529353618|FG006|Expansion Phase|Site Closed|0|||
146776919|NCT02723955|529353619|FG007|Expansion Phase|Site Closed|0|||
146776920|NCT02723955|529353620|FG008|Expansion Phase|Site Closed|0|||
146776921|NCT02723955|529353621|FG009|Expansion Phase|Site Closed|1|||
146776922|NCT02723955|529353622|FG010|Expansion Phase|Site Closed|2|||
146776923|NCT02723955|529353623|FG011|Expansion Phase|Site Closed|6|||
146776924|NCT02723955|529353624|FG012|Expansion Phase|Site Closed|0|||
146776925|NCT02723955|529353625|FG013|Expansion Phase|Site Closed|0|||
146776926|NCT02723955|529353626|FG014|Expansion Phase|Site Closed|0|||
146776927|NCT02723955|529353627|FG015|Expansion Phase|Site Closed|0|||
146776928|NCT02723955|529353628|FG016|Expansion Phase|Site Closed|0|||
146776929|NCT02723955|529353629|FG017|Expansion Phase|Site Closed|0|||
146776930|NCT02723955|529353630|FG018|Expansion Phase|Site Closed|0|||
146776931|NCT02723955|529353631|FG019|Expansion Phase|Site Closed|0|||
146776932|NCT02723955|529353632|FG020|Expansion Phase|Site Closed|0|||
146776933|NCT02723955|529353633|FG021|Expansion Phase|Site Closed|0|||
146776934|NCT02723955|529353634|FG022|Expansion Phase|Site Closed|0|||
146776935|NCT02723955|529353635|FG023|Expansion Phase|Site Closed|0|||
146776936|NCT02723955|529353636|FG024|Expansion Phase|Site Closed|0|||
146776937|NCT02723955|529353637|FG025|Expansion Phase|Site Closed|0|||
146776938|NCT02723955|529353638|FG026|Expansion Phase|Site Closed|0|||
146776939|NCT02723955|529353639|FG027|Expansion Phase|Site Closed|0|||
146776940|NCT02723955|529353640|FG028|Expansion Phase|Site Closed|0|||
146776941|NCT02723955|529353641|FG029|Expansion Phase|Site Closed|0|||
146776942|NCT02723955|529353642|FG030|Expansion Phase|Site Closed|8|||
146776943|NCT02723955|529353643|FG031|Expansion Phase|Site Closed|4|||
146776944|NCT02723955|529353644|FG032|Expansion Phase|Site Closed|2|||
146776945|NCT02723955|529353645|FG033|Expansion Phase|Site Closed|2|||
146776946|NCT02723955|529353646|FG034|Expansion Phase|Site Closed|0|||
146776947|NCT02723955|529353647|FG035|Expansion Phase|Site Closed|0|||
146776948|NCT02723955|529353648|FG036|Expansion Phase|Site Closed|0|||
146776949|NCT02723955|529353649|FG037|Expansion Phase|Site Closed|0|||
146776950|NCT02723955|529353650|FG038|Expansion Phase|Site Closed|0|||
146776951|NCT02723955|529353651|FG039|Expansion Phase|Site Closed|0|||
146776952|NCT02723955|529353652|FG040|Expansion Phase|Site Closed|0|||
146776953|NCT02723955|529353653|FG041|Expansion Phase|Site Closed|0|||
146776954|NCT02723955|529353654|FG042|Expansion Phase|Site Closed|0|||
146776955|NCT02723955|529353612|FG000|Crossover/ Re-treatment Phase|Death|0|||
146776956|NCT02723955|529353613|FG001|Crossover/ Re-treatment Phase|Death|0|||
146776957|NCT02723955|529353614|FG002|Crossover/ Re-treatment Phase|Death|0|||
146776958|NCT02723955|529353615|FG003|Crossover/ Re-treatment Phase|Death|0|||
146705250|NCT03921411|529094508|FG000|Overall Study|Withdrawal by Subject|1|||
146705251|NCT03921411|529094508|FG000|Overall Study|Protocol Deviation|2|||
146705252|NCT03921411|529094508|FG000|Overall Study|Enrolled, but never treated|2|||
146705253|NCT00006916|529094509|FG000|Overall Study|Device not inserted|4|||
146705254|NCT00006916|529094509|FG000|Overall Study|Complication of device insertion|1|||
146705255|NCT00558103|529094510|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
146705256|NCT00558103|529094511|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
146705257|NCT00558103|529094512|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
146705258|NCT00558103|529094513|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
146705259|NCT00558103|529094514|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
146776959|NCT02723955|529353616|FG004|Crossover/ Re-treatment Phase|Death|0|||
146776960|NCT02723955|529353617|FG005|Crossover/ Re-treatment Phase|Death|0|||
146776961|NCT02723955|529353618|FG006|Crossover/ Re-treatment Phase|Death|0|||
146981022|NCT00434161|530093713|FG001|Overall Study|Withdrawal by Subject|0|||
146776962|NCT02723955|529353619|FG007|Crossover/ Re-treatment Phase|Death|0|||
146776963|NCT02723955|529353620|FG008|Crossover/ Re-treatment Phase|Death|0|||
146776964|NCT02723955|529353621|FG009|Crossover/ Re-treatment Phase|Death|0|||
146776965|NCT02723955|529353622|FG010|Crossover/ Re-treatment Phase|Death|0|||
146705260|NCT00558103|529094515|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
146705261|NCT00558103|529094510|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
146705262|NCT00558103|529094511|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
146705263|NCT00558103|529094512|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
146705264|NCT00558103|529094513|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
146705265|NCT00558103|529094514|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
146705266|NCT00558103|529094515|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
146705267|NCT00558103|529094510|FG000|Randomized Treatment Phase|Disease Progression|1|||
146705268|NCT00558103|529094511|FG001|Randomized Treatment Phase|Disease Progression|0|||
146705269|NCT00558103|529094512|FG002|Randomized Treatment Phase|Disease Progression|1|||
146705270|NCT00558103|529094513|FG003|Randomized Treatment Phase|Disease Progression|0|||
146705271|NCT00558103|529094514|FG004|Randomized Treatment Phase|Disease Progression|0|||
146705272|NCT00558103|529094515|FG005|Randomized Treatment Phase|Disease Progression|0|||
146705273|NCT00558103|529094510|FG000|Randomized Treatment Phase|Adverse Event|0|||
146705274|NCT00558103|529094511|FG001|Randomized Treatment Phase|Adverse Event|0|||
146705275|NCT00558103|529094512|FG002|Randomized Treatment Phase|Adverse Event|0|||
146705276|NCT00558103|529094513|FG003|Randomized Treatment Phase|Adverse Event|1|||
146705277|NCT00558103|529094514|FG004|Randomized Treatment Phase|Adverse Event|1|||
146705278|NCT00558103|529094515|FG005|Randomized Treatment Phase|Adverse Event|0|||
146705279|NCT00558103|529094510|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
146705280|NCT00558103|529094511|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
146705281|NCT00558103|529094512|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
146705282|NCT00558103|529094513|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
146705283|NCT00558103|529094514|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
146776966|NCT02723955|529353623|FG011|Crossover/ Re-treatment Phase|Death|0|||
146776967|NCT02723955|529353624|FG012|Crossover/ Re-treatment Phase|Death|0|||
146776968|NCT02723955|529353625|FG013|Crossover/ Re-treatment Phase|Death|0|||
146776969|NCT02723955|529353626|FG014|Crossover/ Re-treatment Phase|Death|0|||
146776970|NCT02723955|529353627|FG015|Crossover/ Re-treatment Phase|Death|0|||
146776971|NCT02723955|529353628|FG016|Crossover/ Re-treatment Phase|Death|0|||
146776972|NCT02723955|529353629|FG017|Crossover/ Re-treatment Phase|Death|0|||
146776973|NCT02723955|529353630|FG018|Crossover/ Re-treatment Phase|Death|0|||
146776974|NCT02723955|529353631|FG019|Crossover/ Re-treatment Phase|Death|0|||
146776975|NCT02723955|529353632|FG020|Crossover/ Re-treatment Phase|Death|0|||
146776976|NCT02723955|529353633|FG021|Crossover/ Re-treatment Phase|Death|0|||
146776977|NCT02723955|529353634|FG022|Crossover/ Re-treatment Phase|Death|0|||
146776978|NCT02723955|529353635|FG023|Crossover/ Re-treatment Phase|Death|0|||
146705284|NCT00558103|529094515|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
146705285|NCT00558103|529094510|FG000|Monotherapy Extension Phase|Disease Progression|0|||
146705286|NCT00558103|529094511|FG001|Monotherapy Extension Phase|Disease Progression|0|||
146705287|NCT00558103|529094512|FG002|Monotherapy Extension Phase|Disease Progression|0|||
146705288|NCT00558103|529094513|FG003|Monotherapy Extension Phase|Disease Progression|0|||
146705289|NCT00558103|529094514|FG004|Monotherapy Extension Phase|Disease Progression|0|||
146705290|NCT00558103|529094515|FG005|Monotherapy Extension Phase|Disease Progression|8|||
146705291|NCT02751983|529094517|FG000|Treatment|Stopped ACT, but Remained in study|2|||
146705292|NCT02751983|529094518|FG001|Treatment|Stopped ACT, but Remained in study|0|||
146705293|NCT02751983|529094517|FG000|Treatment|Discharged prior to beginning ACT|2|||
146705294|NCT02751983|529094518|FG001|Treatment|Discharged prior to beginning ACT|0|||
146705295|NCT02751983|529094517|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
146705296|NCT02751983|529094518|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
146705297|NCT02751983|529094517|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
146705298|NCT02751983|529094518|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
146705299|NCT02751983|529094517|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
146705300|NCT02751983|529094518|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
146705301|NCT03139916|529094521|FG000|Overall Study|Withdrawal by Subject|2|||
146705302|NCT03139916|529094521|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
146705303|NCT01420081|529094522|FG000|Overall Study|Death|1|||
146705304|NCT01420081|529094523|FG001|Overall Study|Death|0|||
146705305|NCT01420081|529094524|FG002|Overall Study|Death|8|||
146705306|NCT01420081|529094525|FG003|Overall Study|Death|0|||
146705307|NCT01420081|529094526|FG004|Overall Study|Death|7|||
146705308|NCT01420081|529094527|FG005|Overall Study|Death|12|||
146705309|NCT01420081|529094528|FG006|Overall Study|Death|0|||
146705310|NCT01420081|529094529|FG007|Overall Study|Death|1|||
146705311|NCT01420081|529094530|FG008|Overall Study|Death|1|||
146705312|NCT01420081|529094522|FG000|Overall Study|Lost to Follow-up|0|||
146705313|NCT01420081|529094523|FG001|Overall Study|Lost to Follow-up|0|||
146705314|NCT01420081|529094524|FG002|Overall Study|Lost to Follow-up|0|||
146705315|NCT01420081|529094525|FG003|Overall Study|Lost to Follow-up|0|||
146705316|NCT01420081|529094526|FG004|Overall Study|Lost to Follow-up|1|||
146705317|NCT01420081|529094527|FG005|Overall Study|Lost to Follow-up|1|||
146776979|NCT02723955|529353636|FG024|Crossover/ Re-treatment Phase|Death|0|||
146776980|NCT02723955|529353637|FG025|Crossover/ Re-treatment Phase|Death|0|||
146776981|NCT02723955|529353638|FG026|Crossover/ Re-treatment Phase|Death|0|||
146705318|NCT01420081|529094528|FG006|Overall Study|Lost to Follow-up|0|||
146705319|NCT01420081|529094529|FG007|Overall Study|Lost to Follow-up|0|||
146705320|NCT01420081|529094530|FG008|Overall Study|Lost to Follow-up|0|||
146705321|NCT01420081|529094522|FG000|Overall Study|Study Terminated by Sponsor|2|||
146705322|NCT01420081|529094523|FG001|Overall Study|Study Terminated by Sponsor|1|||
146705323|NCT01420081|529094524|FG002|Overall Study|Study Terminated by Sponsor|1|||
146776982|NCT02723955|529353639|FG027|Crossover/ Re-treatment Phase|Death|0|||
146776983|NCT02723955|529353640|FG028|Crossover/ Re-treatment Phase|Death|0|||
146776984|NCT02723955|529353641|FG029|Crossover/ Re-treatment Phase|Death|0|||
146776985|NCT02723955|529353642|FG030|Crossover/ Re-treatment Phase|Death|0|||
146776986|NCT02723955|529353643|FG031|Crossover/ Re-treatment Phase|Death|0|||
146776987|NCT02723955|529353644|FG032|Crossover/ Re-treatment Phase|Death|0|||
146776988|NCT02723955|529353645|FG033|Crossover/ Re-treatment Phase|Death|0|||
146776989|NCT02723955|529353646|FG034|Crossover/ Re-treatment Phase|Death|0|||
146776990|NCT02723955|529353647|FG035|Crossover/ Re-treatment Phase|Death|0|||
146776991|NCT02723955|529353648|FG036|Crossover/ Re-treatment Phase|Death|0|||
146776992|NCT02723955|529353649|FG037|Crossover/ Re-treatment Phase|Death|1|||
146776993|NCT02723955|529353650|FG038|Crossover/ Re-treatment Phase|Death|14|||
146776994|NCT02723955|529353651|FG039|Crossover/ Re-treatment Phase|Death|32|||
146776995|NCT02723955|529353652|FG040|Crossover/ Re-treatment Phase|Death|2|||
146776996|NCT02723955|529353653|FG041|Crossover/ Re-treatment Phase|Death|1|||
146776997|NCT02723955|529353654|FG042|Crossover/ Re-treatment Phase|Death|0|||
146776998|NCT02723955|529353612|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146776999|NCT02723955|529353613|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777000|NCT02723955|529353614|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777001|NCT02723955|529353615|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777002|NCT02723955|529353616|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777003|NCT02723955|529353617|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146981023|NCT00434161|530093714|FG002|Overall Study|Withdrawal by Subject|3|||
146981024|NCT00434161|530093712|FG000|Overall Study|Logistical error study assessments|1|||
146981025|NCT00434161|530093713|FG001|Overall Study|Logistical error study assessments|0|||
146981026|NCT00434161|530093714|FG002|Overall Study|Logistical error study assessments|3|||
146981027|NCT00549198|530093718|FG000|Overall Study|Adverse Event|28|||
146981028|NCT00549198|530093719|FG001|Overall Study|Adverse Event|26|||
146981029|NCT00549198|530093718|FG000|Overall Study|Insufficient Viral Load Response|4|||
146981030|NCT00549198|530093719|FG001|Overall Study|Insufficient Viral Load Response|2|||
146981031|NCT00549198|530093718|FG000|Overall Study|Protocol-defined Virological Failure|7|||
146981032|NCT00549198|530093719|FG001|Overall Study|Protocol-defined Virological Failure|0|||
146981033|NCT00549198|530093718|FG000|Overall Study|Non-compliance|2|||
146981034|NCT00549198|530093719|FG001|Overall Study|Non-compliance|4|||
146981035|NCT00549198|530093718|FG000|Overall Study|Lost to Follow-up|7|||
146981036|NCT00549198|530093719|FG001|Overall Study|Lost to Follow-up|8|||
146705324|NCT01420081|529094525|FG003|Overall Study|Study Terminated by Sponsor|3|||
146705325|NCT01420081|529094526|FG004|Overall Study|Study Terminated by Sponsor|11|||
146705326|NCT01420081|529094527|FG005|Overall Study|Study Terminated by Sponsor|7|||
146705327|NCT01420081|529094528|FG006|Overall Study|Study Terminated by Sponsor|3|||
146705328|NCT01420081|529094529|FG007|Overall Study|Study Terminated by Sponsor|2|||
146705329|NCT01420081|529094530|FG008|Overall Study|Study Terminated by Sponsor|2|||
146705330|NCT01420081|529094522|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
146705331|NCT01420081|529094523|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
146705332|NCT01420081|529094524|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
146705333|NCT01420081|529094525|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
146705334|NCT01420081|529094526|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
146705335|NCT01420081|529094527|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
146705336|NCT01420081|529094528|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
146705337|NCT01420081|529094529|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
146705338|NCT01420081|529094530|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
146705339|NCT01420081|529094522|FG000|Overall Study|Other Reasons|0|||
146705340|NCT01420081|529094523|FG001|Overall Study|Other Reasons|0|||
146705341|NCT01420081|529094524|FG002|Overall Study|Other Reasons|1|||
146705342|NCT01420081|529094525|FG003|Overall Study|Other Reasons|0|||
146777004|NCT02723955|529353618|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777005|NCT02723955|529353619|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146981037|NCT00549198|530093718|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
146981038|NCT00549198|530093719|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
146777006|NCT02723955|529353620|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777007|NCT02723955|529353621|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146981039|NCT00549198|530093718|FG000|Overall Study|Protocol Violation|7|||
146981040|NCT00549198|530093719|FG001|Overall Study|Protocol Violation|2|||
146705343|NCT01420081|529094526|FG004|Overall Study|Other Reasons|0|||
146705344|NCT01420081|529094527|FG005|Overall Study|Other Reasons|0|||
146705345|NCT01420081|529094528|FG006|Overall Study|Other Reasons|0|||
146705346|NCT01420081|529094529|FG007|Overall Study|Other Reasons|0|||
146777008|NCT02723955|529353622|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777009|NCT02723955|529353623|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777010|NCT02723955|529353624|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777011|NCT02723955|529353625|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777012|NCT02723955|529353626|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777013|NCT02723955|529353627|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777014|NCT02723955|529353628|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777015|NCT02723955|529353629|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777016|NCT02723955|529353630|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777017|NCT02723955|529353631|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777018|NCT02723955|529353632|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777019|NCT02723955|529353633|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777020|NCT02723955|529353634|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777021|NCT02723955|529353635|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777022|NCT02723955|529353636|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777023|NCT02723955|529353637|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777024|NCT02723955|529353638|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777025|NCT02723955|529353639|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777026|NCT02723955|529353640|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777027|NCT02723955|529353641|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777028|NCT02723955|529353642|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777029|NCT02723955|529353643|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777030|NCT02723955|529353644|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777031|NCT02723955|529353645|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777032|NCT02723955|529353646|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777033|NCT02723955|529353647|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777034|NCT02723955|529353648|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777035|NCT02723955|529353649|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777036|NCT02723955|529353650|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777037|NCT02723955|529353651|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
146777038|NCT02723955|529353652|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777039|NCT02723955|529353653|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777040|NCT02723955|529353654|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146777041|NCT02723955|529353612|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777042|NCT02723955|529353613|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777043|NCT02723955|529353614|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777044|NCT02723955|529353615|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777045|NCT02723955|529353616|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777046|NCT02723955|529353617|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777047|NCT02723955|529353618|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777048|NCT02723955|529353619|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777049|NCT02723955|529353620|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777050|NCT02723955|529353621|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777051|NCT02723955|529353622|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777052|NCT02723955|529353623|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777053|NCT02723955|529353624|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777054|NCT02723955|529353625|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777055|NCT02723955|529353626|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777056|NCT02723955|529353627|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777057|NCT02723955|529353628|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777058|NCT02723955|529353629|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777059|NCT02723955|529353630|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777060|NCT02723955|529353631|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777061|NCT02723955|529353632|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777062|NCT02723955|529353633|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777063|NCT02723955|529353634|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777064|NCT02723955|529353635|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777065|NCT02723955|529353636|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777066|NCT02723955|529353637|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777067|NCT02723955|529353638|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777068|NCT02723955|529353639|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777069|NCT02723955|529353640|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
146933729|NCT02384395|529915974|FG000|Overall Study|Lost to Follow-up|3|||
146933730|NCT03485222|529915975|FG000|Overall Study|Death|0|||
146933731|NCT03485222|529915976|FG001|Overall Study|Death|1|||
146933732|NCT03485222|529915975|FG000|Overall Study|Lost to Follow-up|2|||
146933733|NCT03485222|529915976|FG001|Overall Study|Lost to Follow-up|1|||
146777070|NCT02723955|529353641|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777071|NCT02723955|529353642|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777072|NCT02723955|529353643|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
146933734|NCT03004976|529915981|FG000|Overall Study|Lost to Follow-up|7|||
146933735|NCT03004976|529915982|FG001|Overall Study|Lost to Follow-up|5|||
146705347|NCT01420081|529094530|FG008|Overall Study|Other Reasons|0|||
146705348|NCT00025883|529094531|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
146705349|NCT00025883|529094531|FG000|Overall Study|no baseline data|1|||
146705350|NCT00025883|529094531|FG000|Overall Study|Death|1|||
146777073|NCT02723955|529353644|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777074|NCT02723955|529353645|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777075|NCT02723955|529353646|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777076|NCT02723955|529353647|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777077|NCT02723955|529353648|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777078|NCT02723955|529353649|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777079|NCT02723955|529353650|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
146777080|NCT02723955|529353651|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
146777081|NCT02723955|529353652|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777082|NCT02723955|529353653|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
146777083|NCT02723955|529353654|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
146777084|NCT02723955|529353612|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
146777085|NCT02723955|529353613|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
146777086|NCT02723955|529353614|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
146777087|NCT02723955|529353615|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
146777088|NCT02723955|529353616|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
146777089|NCT02723955|529353617|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
146777090|NCT02723955|529353618|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
146777091|NCT02723955|529353619|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
146777092|NCT02723955|529353620|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
146777093|NCT02723955|529353621|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
146777094|NCT02723955|529353622|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
146777095|NCT02723955|529353623|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
146777096|NCT02723955|529353624|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
146777097|NCT02723955|529353625|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
146777098|NCT02723955|529353626|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
146777099|NCT02723955|529353627|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
146777100|NCT02723955|529353628|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
146777101|NCT02723955|529353629|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
146705351|NCT00025883|529094531|FG000|Overall Study|Adverse Event|1|||
146705352|NCT00025883|529094531|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
146705353|NCT00218543|529094532|FG000|Overall Study|Lost to Follow-up|8|||
146705354|NCT00218543|529094532|FG000|Overall Study|relocated|1|||
146705355|NCT00218543|529094532|FG000|Overall Study|Withdrawal by Subject|1|||
146705356|NCT00218543|529094532|FG000|Overall Study|Physician Decision|3|||
146705357|NCT00218543|529094532|FG000|Overall Study|Adverse Event|2|||
146705358|NCT01282216|529094533|FG000|Overall Study|Graft failure|0|||
146705359|NCT01282216|529094534|FG001|Overall Study|Graft failure|0|||
146705360|NCT01282216|529094535|FG002|Overall Study|Graft failure|3|||
146705361|NCT01282216|529094536|FG003|Overall Study|Graft failure|2|||
146705362|NCT01282216|529094533|FG000|Overall Study|Physician Decision|0|||
146705363|NCT01282216|529094534|FG001|Overall Study|Physician Decision|0|||
146705364|NCT01282216|529094535|FG002|Overall Study|Physician Decision|11|||
146705365|NCT01282216|529094536|FG003|Overall Study|Physician Decision|0|||
146705366|NCT01282216|529094533|FG000|Overall Study|Relapse|0|||
146705367|NCT01282216|529094534|FG001|Overall Study|Relapse|0|||
146705368|NCT01282216|529094535|FG002|Overall Study|Relapse|17|||
146705369|NCT01282216|529094536|FG003|Overall Study|Relapse|6|||
146705370|NCT01282216|529094533|FG000|Overall Study|Death|0|||
146705371|NCT01282216|529094534|FG001|Overall Study|Death|0|||
146705372|NCT01282216|529094535|FG002|Overall Study|Death|2|||
146705373|NCT01282216|529094536|FG003|Overall Study|Death|0|||
146705374|NCT02448875|529094537|FG000|Overall Study|Adverse Event|2|||
146705375|NCT02448875|529094538|FG001|Overall Study|Adverse Event|1|||
146705376|NCT02448875|529094539|FG002|Overall Study|Adverse Event|0|||
146705377|NCT02448875|529094537|FG000|Overall Study|Lost to Follow-up|1|||
146933736|NCT03004976|529915981|FG000|Overall Study|Physician Decision|1|||
146933737|NCT03004976|529915982|FG001|Overall Study|Physician Decision|0|||
146933738|NCT03004976|529915981|FG000|Overall Study|Withdrawal by Subject|1|||
146705378|NCT02448875|529094538|FG001|Overall Study|Lost to Follow-up|0|||
146705379|NCT02448875|529094539|FG002|Overall Study|Lost to Follow-up|0|||
146777102|NCT02723955|529353630|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
146777103|NCT02723955|529353631|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
146777104|NCT02723955|529353632|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
146933739|NCT03004976|529915982|FG001|Overall Study|Withdrawal by Subject|0|||
146705380|NCT02448875|529094537|FG000|Overall Study|Investigator Decision|3|||
146705381|NCT02448875|529094538|FG001|Overall Study|Investigator Decision|0|||
146705382|NCT02448875|529094539|FG002|Overall Study|Investigator Decision|1|||
146705383|NCT02448875|529094537|FG000|Overall Study|Withdrawal by Subject|1|||
146705384|NCT02448875|529094538|FG001|Overall Study|Withdrawal by Subject|0|||
146705385|NCT02448875|529094539|FG002|Overall Study|Withdrawal by Subject|0|||
146705386|NCT03337724|529094544|FG000|Overall Study|Reason not Specified|12|||
146705387|NCT03337724|529094545|FG001|Overall Study|Reason not Specified|21|||
146705388|NCT03337724|529094546|FG002|Overall Study|Reason not Specified|9|||
146705389|NCT03337724|529094547|FG003|Overall Study|Reason not Specified|9|||
146705390|NCT03337724|529094548|FG004|Overall Study|Reason not Specified|29|||
146705391|NCT03337724|529094544|FG000|Overall Study|Withdrawal by Subject|13|||
146705392|NCT03337724|529094545|FG001|Overall Study|Withdrawal by Subject|15|||
146705393|NCT03337724|529094546|FG002|Overall Study|Withdrawal by Subject|4|||
146705394|NCT03337724|529094547|FG003|Overall Study|Withdrawal by Subject|15|||
146705395|NCT03337724|529094548|FG004|Overall Study|Withdrawal by Subject|6|||
146705396|NCT03337724|529094544|FG000|Overall Study|Protocol Deviation|0|||
146705397|NCT03337724|529094545|FG001|Overall Study|Protocol Deviation|1|||
146705398|NCT03337724|529094546|FG002|Overall Study|Protocol Deviation|1|||
146705399|NCT03337724|529094547|FG003|Overall Study|Protocol Deviation|1|||
146705400|NCT03337724|529094548|FG004|Overall Study|Protocol Deviation|0|||
146705401|NCT03337724|529094544|FG000|Overall Study|Adverse Event|1|||
146705402|NCT03337724|529094545|FG001|Overall Study|Adverse Event|1|||
146705403|NCT03337724|529094546|FG002|Overall Study|Adverse Event|0|||
146705404|NCT03337724|529094547|FG003|Overall Study|Adverse Event|1|||
146705405|NCT03337724|529094548|FG004|Overall Study|Adverse Event|0|||
146705406|NCT03337724|529094544|FG000|Overall Study|Death|40|||
146705407|NCT03337724|529094545|FG001|Overall Study|Death|89|||
146705408|NCT03337724|529094546|FG002|Overall Study|Death|43|||
146705409|NCT03337724|529094547|FG003|Overall Study|Death|76|||
146705410|NCT03337724|529094548|FG004|Overall Study|Death|50|||
146705411|NCT03337724|529094544|FG000|Overall Study|Lost to Follow-up|5|||
146705412|NCT03337724|529094545|FG001|Overall Study|Lost to Follow-up|5|||
146705413|NCT03337724|529094546|FG002|Overall Study|Lost to Follow-up|4|||
146705414|NCT03337724|529094547|FG003|Overall Study|Lost to Follow-up|7|||
146705415|NCT03337724|529094548|FG004|Overall Study|Lost to Follow-up|4|||
146705416|NCT03337724|529094544|FG000|Overall Study|Physician Decision|16|||
146705417|NCT03337724|529094545|FG001|Overall Study|Physician Decision|34|||
146705418|NCT03337724|529094546|FG002|Overall Study|Physician Decision|14|||
146705419|NCT03337724|529094547|FG003|Overall Study|Physician Decision|34|||
146705420|NCT03337724|529094548|FG004|Overall Study|Physician Decision|13|||
146705421|NCT03337724|529094544|FG000|Overall Study|Progressive Disease|0|||
146705422|NCT03337724|529094545|FG001|Overall Study|Progressive Disease|2|||
146705423|NCT03337724|529094546|FG002|Overall Study|Progressive Disease|1|||
146705424|NCT03337724|529094547|FG003|Overall Study|Progressive Disease|2|||
146705425|NCT03337724|529094548|FG004|Overall Study|Progressive Disease|0|||
146705426|NCT03337724|529094544|FG000|Overall Study|Symptomatic Deterioration|0|||
146705427|NCT03337724|529094545|FG001|Overall Study|Symptomatic Deterioration|0|||
146777105|NCT02723955|529353633|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
146777106|NCT02723955|529353634|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
146777107|NCT02723955|529353635|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
146777108|NCT02723955|529353636|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
146777109|NCT02723955|529353637|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
146777110|NCT02723955|529353638|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
146777111|NCT02723955|529353639|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
146777112|NCT02723955|529353640|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
146777113|NCT02723955|529353641|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
146777114|NCT02723955|529353642|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
146777115|NCT02723955|529353643|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
146777116|NCT02723955|529353644|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
146777117|NCT02723955|529353645|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
146777118|NCT02723955|529353646|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
146777119|NCT02723955|529353647|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
146777120|NCT02723955|529353648|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
146777121|NCT02723955|529353649|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
146705428|NCT03337724|529094546|FG002|Overall Study|Symptomatic Deterioration|0|||
146705429|NCT03337724|529094547|FG003|Overall Study|Symptomatic Deterioration|1|||
146777122|NCT02723955|529353650|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
146705430|NCT03337724|529094548|FG004|Overall Study|Symptomatic Deterioration|0|||
146705431|NCT00773097|529094549|FG000|Overall Study|Withdrawal by Subject|1|||
146705432|NCT00773097|529094549|FG000|Overall Study|Physician Decision|6|||
146705433|NCT03238911|529094550|FG000|Overall Study|Withdrawal by Subject|1|||
146705434|NCT03238911|529094551|FG001|Overall Study|Withdrawal by Subject|2|||
146777123|NCT02723955|529353651|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
146777124|NCT02723955|529353652|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
146777125|NCT02723955|529353653|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
146933740|NCT03004976|529915981|FG000|Overall Study|Death|4|||
146933741|NCT03004976|529915982|FG001|Overall Study|Death|1|||
146933742|NCT01143714|529915983|FG000|Overall Study|Adverse Event|4|||
146705435|NCT03238911|529094550|FG000|Overall Study|Lost to Follow-up|2|||
146705436|NCT03238911|529094551|FG001|Overall Study|Lost to Follow-up|1|||
146705437|NCT02239536|529094552|FG000|Overall Study|Non-neoplastic polyp|23|||
146777126|NCT02723955|529353654|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
146777127|NCT04999085|529353655|FG000|Overall Study|Death|1|||
146705438|NCT02239536|529094553|FG001|Overall Study|Non-neoplastic polyp|17|||
146705439|NCT01038778|529094559|FG000|Overall Study|Withdrawal by Subject|0|||
146933743|NCT01143714|529915984|FG001|Overall Study|Adverse Event|2|||
146705440|NCT01038778|529094560|FG001|Overall Study|Withdrawal by Subject|2|||
146705441|NCT01038778|529094561|FG002|Overall Study|Withdrawal by Subject|3|||
146705442|NCT04740034|529094562|FG000|Overall Study|Death|0|||
146705443|NCT04740034|529094563|FG001|Overall Study|Death|1|||
146705444|NCT04740034|529094564|FG002|Overall Study|Death|2|||
146705445|NCT04740034|529094565|FG003|Overall Study|Death|3|||
146705446|NCT04740034|529094566|FG004|Overall Study|Death|4|||
146705447|NCT04740034|529094567|FG005|Overall Study|Death|4|||
146705448|NCT04740034|529094568|FG006|Overall Study|Death|2|||
146705449|NCT04740034|529094569|FG007|Overall Study|Death|2|||
146705450|NCT04740034|529094570|FG008|Overall Study|Death|2|||
146705451|NCT04740034|529094571|FG009|Overall Study|Death|4|||
146705452|NCT04740034|529094572|FG010|Overall Study|Death|0|||
146705453|NCT04740034|529094562|FG000|Overall Study|Lost to Follow-up|0|||
146705454|NCT04740034|529094563|FG001|Overall Study|Lost to Follow-up|0|||
146705455|NCT04740034|529094564|FG002|Overall Study|Lost to Follow-up|0|||
146705456|NCT04740034|529094565|FG003|Overall Study|Lost to Follow-up|1|||
146705457|NCT04740034|529094566|FG004|Overall Study|Lost to Follow-up|2|||
146705458|NCT04740034|529094567|FG005|Overall Study|Lost to Follow-up|2|||
146705459|NCT04740034|529094568|FG006|Overall Study|Lost to Follow-up|0|||
146705460|NCT04740034|529094569|FG007|Overall Study|Lost to Follow-up|0|||
146705461|NCT04740034|529094570|FG008|Overall Study|Lost to Follow-up|0|||
146705462|NCT04740034|529094571|FG009|Overall Study|Lost to Follow-up|1|||
146705463|NCT04740034|529094572|FG010|Overall Study|Lost to Follow-up|0|||
146705464|NCT04740034|529094562|FG000|Overall Study|Withdrawal by Subject|1|||
146705465|NCT04740034|529094563|FG001|Overall Study|Withdrawal by Subject|0|||
146705466|NCT04740034|529094564|FG002|Overall Study|Withdrawal by Subject|0|||
146705467|NCT04740034|529094565|FG003|Overall Study|Withdrawal by Subject|0|||
146705468|NCT04740034|529094566|FG004|Overall Study|Withdrawal by Subject|0|||
146705469|NCT04740034|529094567|FG005|Overall Study|Withdrawal by Subject|0|||
146705470|NCT04740034|529094568|FG006|Overall Study|Withdrawal by Subject|0|||
146705471|NCT04740034|529094569|FG007|Overall Study|Withdrawal by Subject|1|||
146705472|NCT04740034|529094570|FG008|Overall Study|Withdrawal by Subject|0|||
146705473|NCT04740034|529094571|FG009|Overall Study|Withdrawal by Subject|1|||
146705474|NCT04740034|529094572|FG010|Overall Study|Withdrawal by Subject|0|||
146705475|NCT04740034|529094562|FG000|Overall Study|Decision by sponsor|0|||
146705476|NCT04740034|529094563|FG001|Overall Study|Decision by sponsor|0|||
146705477|NCT04740034|529094564|FG002|Overall Study|Decision by sponsor|1|||
146705478|NCT04740034|529094565|FG003|Overall Study|Decision by sponsor|0|||
146705479|NCT04740034|529094566|FG004|Overall Study|Decision by sponsor|0|||
146705480|NCT04740034|529094567|FG005|Overall Study|Decision by sponsor|0|||
146705481|NCT04740034|529094568|FG006|Overall Study|Decision by sponsor|1|||
146705482|NCT04740034|529094569|FG007|Overall Study|Decision by sponsor|2|||
146705483|NCT04740034|529094570|FG008|Overall Study|Decision by sponsor|1|||
146705484|NCT04740034|529094571|FG009|Overall Study|Decision by sponsor|1|||
146705485|NCT04740034|529094572|FG010|Overall Study|Decision by sponsor|2|||
146705486|NCT03892889|529096167|FG000|Overall Study|Adverse Event|17|||
146705487|NCT03892889|529096167|FG000|Overall Study|Lack of Efficacy|1|||
146705488|NCT03892889|529096167|FG000|Overall Study|Lost to Follow-up|46|||
146705489|NCT03892889|529096167|FG000|Overall Study|Non-compliance with study drug|22|||
146705490|NCT03892889|529096167|FG000|Overall Study|Pregnancy|1|||
146705491|NCT03892889|529096167|FG000|Overall Study|Protocol Deviation|3|||
146705492|NCT03892889|529096167|FG000|Overall Study|Withdrawal by Subject|50|||
146705493|NCT03892889|529096167|FG000|Overall Study|Withdrawal by Caregiver|1|||
146705494|NCT03892889|529096167|FG000|Overall Study|Study Terminated by Sponsor|50|||
146705495|NCT03892889|529096167|FG000|Overall Study|Physician Decision|8|||
146705496|NCT03892889|529096167|FG000|Overall Study|Reason not Specified|5|||
146705497|NCT01610700|529096168|FG000|Overall Study|Adverse Event|3|||
146705498|NCT01610700|529096169|FG001|Overall Study|Adverse Event|1|||
146705499|NCT01610700|529096168|FG000|Overall Study|Withdrawal by Subject|0|||
146705500|NCT01610700|529096169|FG001|Overall Study|Withdrawal by Subject|1|||
146705501|NCT01610700|529096168|FG000|Overall Study|subject took one dose of street cannabis|0|||
146705502|NCT01610700|529096169|FG001|Overall Study|subject took one dose of street cannabis|1|||
146705503|NCT00679341|529096171|FG000|Overall Study|Disease progression|42|||
146705504|NCT00679341|529096172|FG001|Overall Study|Disease progression|36|||
146705505|NCT00679341|529096171|FG000|Overall Study|Adverse Event|5|||
146705506|NCT00679341|529096172|FG001|Overall Study|Adverse Event|6|||
146705507|NCT00679341|529096171|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
146705508|NCT00679341|529096172|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
146705509|NCT00679341|529096171|FG000|Overall Study|Death|1|||
146705510|NCT00679341|529096172|FG001|Overall Study|Death|1|||
146705511|NCT00679341|529096171|FG000|Overall Study|Other|1|||
146705512|NCT00679341|529096172|FG001|Overall Study|Other|0|||
146705513|NCT00679341|529096171|FG000|Overall Study|Physician Decision|1|||
146705514|NCT00679341|529096172|FG001|Overall Study|Physician Decision|0|||
146705515|NCT00679341|529096171|FG000|Overall Study|Not treated|0|||
146705516|NCT00679341|529096172|FG001|Overall Study|Not treated|2|||
146705517|NCT00679341|529096171|FG000|Overall Study|Physician/patient decision to withdraw|0|||
146705518|NCT00679341|529096172|FG001|Overall Study|Physician/patient decision to withdraw|6|||
146705519|NCT02652624|529096175|FG000|Randomized Phase|Pregnancy|3|||
146705520|NCT02652624|529096176|FG001|Randomized Phase|Pregnancy|1|||
146705521|NCT02652624|529096175|FG000|Randomized Phase|Investigator's Discretion|0|||
146705522|NCT02652624|529096176|FG001|Randomized Phase|Investigator's Discretion|2|||
146705523|NCT02652624|529096175|FG000|Randomized Phase|Death|0|||
146705524|NCT02652624|529096176|FG001|Randomized Phase|Death|1|||
146705525|NCT02652624|529096175|FG000|Randomized Phase|Lost to Follow-up|0|||
146705526|NCT02652624|529096176|FG001|Randomized Phase|Lost to Follow-up|1|||
146705527|NCT02652624|529096175|FG000|Extension Phase|Lost to Follow-up|3|||
146705528|NCT02652624|529096176|FG001|Extension Phase|Lost to Follow-up|1|||
146705529|NCT02652624|529096175|FG000|Extension Phase|Pregnancy|1|||
146705530|NCT02652624|529096176|FG001|Extension Phase|Pregnancy|1|||
146705531|NCT02652624|529096175|FG000|Extension Phase|Adverse Event|0|||
146705532|NCT02652624|529096176|FG001|Extension Phase|Adverse Event|1|||
146705533|NCT02652624|529096175|FG000|Extension Phase|Withdrew Consent|0|||
146705534|NCT02652624|529096176|FG001|Extension Phase|Withdrew Consent|1|||
146705535|NCT00654628|529096177|FG000|6-week Active Treatment Period|Adverse Event|9|||
146705536|NCT00654628|529096177|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
146705537|NCT00654628|529096177|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
146705538|NCT00654628|529096177|FG000|6-week Active Treatment Period|Out of window period|1|||
146705539|NCT00654628|529096177|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
146705540|NCT00654628|529096177|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
146705541|NCT00953329|529096178|FG000|Overall Study|Lack of Efficacy|1|||
146705542|NCT01797536|529096179|FG000|Overall Study|Adverse Event|0|||
146705543|NCT01797536|529096180|FG001|Overall Study|Adverse Event|1|||
146705544|NCT01797536|529096181|FG002|Overall Study|Adverse Event|0|||
146705545|NCT01797536|529096182|FG003|Overall Study|Adverse Event|0|||
146705546|NCT01532687|529096189|FG000|Overall Study|Death|2|||
146705547|NCT01532687|529096190|FG001|Overall Study|Death|0|||
146705548|NCT01532687|529096189|FG000|Overall Study|Adverse Event|6|||
146705549|NCT01532687|529096190|FG001|Overall Study|Adverse Event|1|||
146705550|NCT01532687|529096189|FG000|Overall Study|Withdrawal by Subject|1|||
146705551|NCT01532687|529096190|FG001|Overall Study|Withdrawal by Subject|0|||
146705552|NCT01532687|529096189|FG000|Overall Study|Physician Decision|2|||
146705553|NCT01532687|529096190|FG001|Overall Study|Physician Decision|1|||
146705554|NCT01532687|529096189|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
146705555|NCT01532687|529096190|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
146705556|NCT04354831|529096191|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
146705557|NCT04354831|529096192|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
146705558|NCT02732847|529096193|FG000|Overall Study|some filled early|42|||
146705559|NCT02732847|529096194|FG001|Overall Study|some filled early|42|||
146705560|NCT01018264|529096195|FG000|Overall Study|Withdrawal by Subject|1|||
146705561|NCT01018264|529096196|FG001|Overall Study|Withdrawal by Subject|0|||
146705562|NCT01018264|529096195|FG000|Overall Study|Lost to Follow-up|0|||
146705563|NCT01018264|529096196|FG001|Overall Study|Lost to Follow-up|1|||
146705564|NCT03217136|529096198|FG000|Overall Study|Lost to Follow-up|2|||
146705565|NCT03217136|529096199|FG001|Overall Study|Lost to Follow-up|1|||
146705566|NCT03217136|529096198|FG000|Overall Study|Site Randomized Participant in Error|0|||
146705567|NCT03217136|529096199|FG001|Overall Study|Site Randomized Participant in Error|1|||
146705568|NCT03217136|529096198|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
146777128|NCT05056246|529353658|FG000|Overall Study|Adverse Event|0|||
146777129|NCT05056246|529353659|FG001|Overall Study|Adverse Event|0|||
146705569|NCT03217136|529096199|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
146705570|NCT03217136|529096198|FG000|Overall Study|Dispensing Error|1|||
146705571|NCT03217136|529096199|FG001|Overall Study|Dispensing Error|0|||
146705572|NCT03217136|529096198|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146705573|NCT03217136|529096199|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146705574|NCT02939404|529096200|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
146705575|NCT02939404|529096201|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
146705576|NCT02939404|529096200|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
146705577|NCT02939404|529096201|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
146705578|NCT06640829|529096203|FG000|Overall Study|Withdrawal by Subject|1|||
146705579|NCT06640829|529096203|FG000|Overall Study|Lost to Follow-up|1|||
146705580|NCT01350128|529096204|FG000|Overall Study|Withdrawal by Subject|3|||
146705581|NCT01350128|529096204|FG000|Overall Study|Protocol discontinuation criteria|8|||
146705582|NCT01350128|529096204|FG000|Overall Study|Physician Decision|1|||
146705583|NCT01350128|529096204|FG000|Overall Study|Lost to Follow-up|2|||
146705584|NCT01252290|529096207|FG000|Overall Study|Withdrawal by Subject|1|||
146705585|NCT02075437|529096208|FG000|Overall Study|Withdrawal by Subject|5|||
146705586|NCT02075437|529096208|FG000|Overall Study|Lost to Follow-up|1|||
146705587|NCT04439240|529096209|FG000|Overall Study|Ineligible|2|||
146705588|NCT04439240|529096209|FG000|Overall Study|Never started treatment|2|||
146705589|NCT04439240|529096209|FG000|Overall Study|Adverse Event|12|||
146705590|NCT04439240|529096209|FG000|Overall Study|Death|2|||
146705591|NCT04439240|529096209|FG000|Overall Study|Disease progression|25|||
146705592|NCT04439240|529096209|FG000|Overall Study|Other diseases|2|||
146777130|NCT05056246|529353660|FG002|Overall Study|Adverse Event|0|||
146705593|NCT04439240|529096209|FG000|Overall Study|Withdrawal by Subject|3|||
146705594|NCT04439240|529096209|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
146705595|NCT04439240|529096209|FG000|Overall Study|Symptomatic decline|1|||
146705596|NCT04439240|529096209|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
146705597|NCT04439240|529096209|FG000|Overall Study|Clinical progression|1|||
146705598|NCT03120013|529096213|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146705599|NCT03120013|529096214|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
146705600|NCT02098109|529096215|FG000|Overall Study|Protocol Violation|3|||
146705601|NCT02098109|529096216|FG001|Overall Study|Protocol Violation|0|||
146705602|NCT01541826|529096217|FG000|Overall Study|Lost to Follow-up|2|||
146705603|NCT01541826|529096218|FG001|Overall Study|Lost to Follow-up|3|||
146705604|NCT01541826|529096219|FG002|Overall Study|Lost to Follow-up|0|||
146705605|NCT01541826|529096217|FG000|Overall Study|Withdrawal by Subject|2|||
146705606|NCT01541826|529096218|FG001|Overall Study|Withdrawal by Subject|0|||
146705607|NCT01541826|529096219|FG002|Overall Study|Withdrawal by Subject|0|||
146705608|NCT01565291|529096220|FG000|Overall Study|Withdrawal by Subject|1|||
146705609|NCT01565291|529096221|FG001|Overall Study|Withdrawal by Subject|0|||
146705610|NCT02143843|529096222|FG000|Overall Study|Adverse Event|8|||
146705611|NCT02143843|529096222|FG000|Overall Study|Lack of Efficacy|2|||
146705612|NCT02143843|529096222|FG000|Overall Study|Withdrawal by Subject|2|||
146705613|NCT02702401|529096227|FG000|Overall Study|Death|242|||
146705614|NCT02702401|529096228|FG001|Overall Study|Death|125|||
146705615|NCT02702401|529096227|FG000|Overall Study|Withdrawal by Subject|15|||
146705616|NCT02702401|529096228|FG001|Overall Study|Withdrawal by Subject|5|||
146705617|NCT02702401|529096227|FG000|Overall Study|Sponsor Decision|19|||
146705618|NCT02702401|529096228|FG001|Overall Study|Sponsor Decision|3|||
146705619|NCT02702401|529096227|FG000|Overall Study|Physician Decision|1|||
146705620|NCT02702401|529096228|FG001|Overall Study|Physician Decision|2|||
146705621|NCT02702401|529096227|FG000|Overall Study|Lost to Follow-up|1|||
146705622|NCT02702401|529096228|FG001|Overall Study|Lost to Follow-up|0|||
146705623|NCT01462357|529096233|FG000|Overall Study|Death|0|||
146705624|NCT01462357|529096234|FG001|Overall Study|Death|0|||
146705625|NCT01462357|529096235|FG002|Overall Study|Death|1|||
146705626|NCT01462357|529096233|FG000|Overall Study|Withdrawal by Subject|3|||
146705627|NCT01462357|529096234|FG001|Overall Study|Withdrawal by Subject|11|||
146705628|NCT01462357|529096235|FG002|Overall Study|Withdrawal by Subject|3|||
146705629|NCT01462357|529096233|FG000|Overall Study|Migrated/moved from study area|2|||
146705630|NCT01462357|529096234|FG001|Overall Study|Migrated/moved from study area|3|||
146705631|NCT01462357|529096235|FG002|Overall Study|Migrated/moved from study area|1|||
146705632|NCT01462357|529096233|FG000|Overall Study|Lost to Follow-up|3|||
146705633|NCT01462357|529096234|FG001|Overall Study|Lost to Follow-up|5|||
146705634|NCT01462357|529096235|FG002|Overall Study|Lost to Follow-up|7|||
146705635|NCT04292730|529096236|FG000|Overall Study|Lost to Follow-up|8|||
146705636|NCT04292730|529096237|FG001|Overall Study|Lost to Follow-up|12|||
146705637|NCT04292730|529096238|FG002|Overall Study|Lost to Follow-up|12|||
146705638|NCT04292730|529096239|FG003|Overall Study|Lost to Follow-up|48|||
146705639|NCT04292730|529096236|FG000|Overall Study|Death|2|||
146705640|NCT04292730|529096237|FG001|Overall Study|Death|2|||
146705641|NCT04292730|529096238|FG002|Overall Study|Death|4|||
146705642|NCT04292730|529096239|FG003|Overall Study|Death|12|||
146705643|NCT04292730|529096236|FG000|Overall Study|Withdrew Consent|2|||
146777131|NCT05056246|529353661|FG003|Overall Study|Adverse Event|0|||
146777132|NCT05056246|529353662|FG004|Overall Study|Adverse Event|1|||
146777133|NCT05056246|529353658|FG000|Overall Study|Lost to Follow-up|0|||
146777134|NCT05056246|529353659|FG001|Overall Study|Lost to Follow-up|0|||
146777135|NCT05056246|529353660|FG002|Overall Study|Lost to Follow-up|0|||
146777136|NCT05056246|529353661|FG003|Overall Study|Lost to Follow-up|2|||
146705644|NCT04292730|529096237|FG001|Overall Study|Withdrew Consent|2|||
146705645|NCT04292730|529096238|FG002|Overall Study|Withdrew Consent|5|||
146705646|NCT04292730|529096239|FG003|Overall Study|Withdrew Consent|6|||
146705647|NCT04292730|529096236|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146705648|NCT04292730|529096237|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146705649|NCT04292730|529096238|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146705650|NCT04292730|529096239|FG003|Overall Study|Non-Compliance with Study Drug|0|||
146705651|NCT04292730|529096236|FG000|Overall Study|Protocol Violation|0|||
146705652|NCT04292730|529096237|FG001|Overall Study|Protocol Violation|0|||
146705653|NCT04292730|529096238|FG002|Overall Study|Protocol Violation|1|||
146705654|NCT04292730|529096239|FG003|Overall Study|Protocol Violation|0|||
146705655|NCT04292730|529096236|FG000|Overall Study|Randomized but not Treated|8|||
146705656|NCT04292730|529096237|FG001|Overall Study|Randomized but not Treated|4|||
146705657|NCT04292730|529096238|FG002|Overall Study|Randomized but not Treated|0|||
146705658|NCT04292730|529096239|FG003|Overall Study|Randomized but not Treated|14|||
146705659|NCT01527292|529096241|FG000|Overall Study|Physician Decision|0|||
146705660|NCT01527292|529096242|FG001|Overall Study|Physician Decision|3|||
146705661|NCT01482767|529096245|FG000|Overall Study|Death|1|||
146705662|NCT01482767|529096246|FG001|Overall Study|Death|1|||
146705663|NCT01482767|529096245|FG000|Overall Study|Withdrawal by Subject|7|||
146705664|NCT01482767|529096246|FG001|Overall Study|Withdrawal by Subject|5|||
146705665|NCT01482767|529096245|FG000|Overall Study|Lost to Follow-up|12|||
146705666|NCT01482767|529096246|FG001|Overall Study|Lost to Follow-up|6|||
146705667|NCT01482767|529096245|FG000|Overall Study|Adverse Event|0|||
146705668|NCT01482767|529096246|FG001|Overall Study|Adverse Event|3|||
146705669|NCT01482767|529096245|FG000|Overall Study|Site closure|22|||
146705670|NCT01482767|529096246|FG001|Overall Study|Site closure|14|||
146705671|NCT01482767|529096245|FG000|Overall Study|Non-adherence to study requirements|4|||
146705672|NCT01482767|529096246|FG001|Overall Study|Non-adherence to study requirements|7|||
146705673|NCT01482767|529096245|FG000|Overall Study|Alternate HCV treatment|7|||
146705674|NCT01482767|529096246|FG001|Overall Study|Alternate HCV treatment|8|||
146705675|NCT01482767|529096245|FG000|Overall Study|Ineligible|0|||
146705676|NCT01482767|529096246|FG001|Overall Study|Ineligible|5|||
146705677|NCT01482767|529096245|FG000|Overall Study|Nurse error|1|||
146705678|NCT01482767|529096246|FG001|Overall Study|Nurse error|0|||
146705679|NCT01247090|529096249|FG000|Overall Study|Physician Decision|1|||
146705680|NCT01247090|529096250|FG001|Overall Study|Physician Decision|0|||
146705681|NCT01247090|529096251|FG002|Overall Study|Physician Decision|0|||
146705682|NCT01247090|529096249|FG000|Overall Study|Withdrawal by Subject|0|||
146705683|NCT01247090|529096250|FG001|Overall Study|Withdrawal by Subject|1|||
146705684|NCT01247090|529096251|FG002|Overall Study|Withdrawal by Subject|0|||
146705685|NCT02457325|529096255|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
146705686|NCT02457325|529096256|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
146705687|NCT03385239|529096259|FG000|Overall Study|Voluntary Withdrawal|2|||
146705688|NCT03385239|529096260|FG001|Overall Study|Voluntary Withdrawal|3|||
146705689|NCT03385239|529096261|FG002|Overall Study|Voluntary Withdrawal|2|||
146705690|NCT03385239|529096262|FG003|Overall Study|Voluntary Withdrawal|3|||
146705691|NCT03385239|529096263|FG004|Overall Study|Voluntary Withdrawal|0|||
146705692|NCT03385239|529096259|FG000|Overall Study|Adverse Event|0|||
146705693|NCT03385239|529096260|FG001|Overall Study|Adverse Event|0|||
146705694|NCT03385239|529096261|FG002|Overall Study|Adverse Event|1|||
146705695|NCT03385239|529096262|FG003|Overall Study|Adverse Event|0|||
146705696|NCT03385239|529096263|FG004|Overall Study|Adverse Event|0|||
146705697|NCT03385239|529096259|FG000|Overall Study|Other|0|||
146705698|NCT03385239|529096260|FG001|Overall Study|Other|0|||
146705699|NCT03385239|529096261|FG002|Overall Study|Other|0|||
146705700|NCT03385239|529096262|FG003|Overall Study|Other|1|||
146705701|NCT03385239|529096263|FG004|Overall Study|Other|0|||
146705702|NCT01574703|529096264|FG000|Overall Study|Adverse Event|0|||
146705703|NCT01574703|529096265|FG001|Overall Study|Adverse Event|2|||
146705704|NCT01574703|529096266|FG002|Overall Study|Adverse Event|1|||
146705705|NCT01574703|529096267|FG003|Overall Study|Adverse Event|1|||
146705706|NCT01574703|529096264|FG000|Overall Study|Protocol Violation|0|||
146705707|NCT01574703|529096265|FG001|Overall Study|Protocol Violation|0|||
146705708|NCT01574703|529096266|FG002|Overall Study|Protocol Violation|0|||
146705709|NCT01574703|529096267|FG003|Overall Study|Protocol Violation|1|||
146705710|NCT01574703|529096264|FG000|Overall Study|Unspecified Reason|27|||
146705711|NCT01574703|529096265|FG001|Overall Study|Unspecified Reason|15|||
146705712|NCT01574703|529096266|FG002|Overall Study|Unspecified Reason|20|||
146705713|NCT01574703|529096267|FG003|Overall Study|Unspecified Reason|16|||
146705714|NCT01574703|529096264|FG000|Overall Study|Withdrawal by Subject|53|||
146705715|NCT01574703|529096265|FG001|Overall Study|Withdrawal by Subject|52|||
146705716|NCT01574703|529096266|FG002|Overall Study|Withdrawal by Subject|36|||
146705717|NCT01574703|529096267|FG003|Overall Study|Withdrawal by Subject|61|||
146705718|NCT01574703|529096264|FG000|Overall Study|Met Withdrawal Criteria|0|||
146705719|NCT01574703|529096265|FG001|Overall Study|Met Withdrawal Criteria|1|||
146705720|NCT01574703|529096266|FG002|Overall Study|Met Withdrawal Criteria|1|||
146705721|NCT01574703|529096267|FG003|Overall Study|Met Withdrawal Criteria|0|||
146705722|NCT01574703|529096264|FG000|Overall Study|Lost to Follow-up|43|||
146705723|NCT01574703|529096265|FG001|Overall Study|Lost to Follow-up|41|||
146705724|NCT01574703|529096266|FG002|Overall Study|Lost to Follow-up|46|||
146705725|NCT01574703|529096267|FG003|Overall Study|Lost to Follow-up|35|||
146705726|NCT01574703|529096264|FG000|Overall Study|Death|2|||
146705727|NCT01574703|529096265|FG001|Overall Study|Death|1|||
146705728|NCT01574703|529096266|FG002|Overall Study|Death|1|||
146705729|NCT01574703|529096267|FG003|Overall Study|Death|0|||
146705730|NCT03591575|529096268|FG000|Overall Study|Adverse Event|2|||
146705731|NCT03591575|529096269|FG001|Overall Study|Adverse Event|0|||
146777137|NCT05056246|529353662|FG004|Overall Study|Lost to Follow-up|0|||
146777138|NCT05056246|529353658|FG000|Overall Study|Withdrawal by Subject|0|||
146933744|NCT01143714|529915983|FG000|Overall Study|Withdrawal by Subject|1|||
146933745|NCT01143714|529915984|FG001|Overall Study|Withdrawal by Subject|0|||
146705732|NCT03591575|529096268|FG000|Overall Study|Withdrawal by Subject|4|||
146705733|NCT03591575|529096269|FG001|Overall Study|Withdrawal by Subject|1|||
146705734|NCT00700011|529096271|FG000|Overall Study|Death|0|||
146705735|NCT00700011|529096272|FG001|Overall Study|Death|1|||
146705736|NCT00678561|529096273|FG000|Overall Study|Adverse Event|0|||
146705737|NCT00678561|529096274|FG001|Overall Study|Adverse Event|1|||
146705738|NCT00678561|529096275|FG002|Overall Study|Adverse Event|1|||
146705739|NCT00678561|529096276|FG003|Overall Study|Adverse Event|0|||
146705740|NCT00678561|529096277|FG004|Overall Study|Adverse Event|1|||
146705741|NCT00678561|529096278|FG005|Overall Study|Adverse Event|0|||
146705742|NCT00678561|529096279|FG006|Overall Study|Adverse Event|0|||
146705743|NCT00678561|529096280|FG007|Overall Study|Adverse Event|0|||
146705744|NCT00678561|529096273|FG000|Overall Study|Protocol Violation|0|||
146705745|NCT00678561|529096274|FG001|Overall Study|Protocol Violation|0|||
146705746|NCT00678561|529096275|FG002|Overall Study|Protocol Violation|0|||
146705747|NCT00678561|529096276|FG003|Overall Study|Protocol Violation|0|||
146705748|NCT00678561|529096277|FG004|Overall Study|Protocol Violation|1|||
146705749|NCT00678561|529096278|FG005|Overall Study|Protocol Violation|1|||
146705750|NCT00678561|529096279|FG006|Overall Study|Protocol Violation|0|||
146705751|NCT00678561|529096280|FG007|Overall Study|Protocol Violation|0|||
146705752|NCT00678561|529096273|FG000|Overall Study|Withdrawal by Subject|0|||
146705753|NCT00678561|529096274|FG001|Overall Study|Withdrawal by Subject|0|||
146705754|NCT00678561|529096275|FG002|Overall Study|Withdrawal by Subject|0|||
146705755|NCT00678561|529096276|FG003|Overall Study|Withdrawal by Subject|0|||
146705756|NCT00678561|529096277|FG004|Overall Study|Withdrawal by Subject|0|||
146705757|NCT00678561|529096278|FG005|Overall Study|Withdrawal by Subject|0|||
146705758|NCT00678561|529096279|FG006|Overall Study|Withdrawal by Subject|0|||
146705759|NCT00678561|529096280|FG007|Overall Study|Withdrawal by Subject|1|||
146705760|NCT00004031|529096281|FG000|Overall Study|Adverse Event|5|||
146705761|NCT00004031|529096282|FG001|Overall Study|Adverse Event|0|||
146705762|NCT00004031|529096281|FG000|Overall Study|Refusal unrelated to adverse events|2|||
146705763|NCT00004031|529096282|FG001|Overall Study|Refusal unrelated to adverse events|11|||
146705764|NCT00004031|529096281|FG000|Overall Study|Progression/relapse|9|||
146705765|NCT00004031|529096282|FG001|Overall Study|Progression/relapse|4|||
146705766|NCT00004031|529096281|FG000|Overall Study|Death|3|||
146705767|NCT00004031|529096282|FG001|Overall Study|Death|1|||
146705768|NCT00004031|529096281|FG000|Overall Study|Other- not protocol specified|3|||
146705769|NCT00004031|529096282|FG001|Overall Study|Other- not protocol specified|3|||
146705770|NCT00004031|529096281|FG000|Overall Study|Reason under review|3|||
146705771|NCT00004031|529096282|FG001|Overall Study|Reason under review|2|||
146705772|NCT02920983|529096283|FG000|Dispense 1|Unacceptable Lens Fit|0|||
146705773|NCT02920983|529096284|FG001|Dispense 1|Unacceptable Lens Fit|0|||
146705774|NCT02920983|529096285|FG002|Dispense 1|Unacceptable Lens Fit|0|||
146705775|NCT02920983|529096286|FG003|Dispense 1|Unacceptable Lens Fit|0|||
146705776|NCT02920983|529096287|FG004|Dispense 1|Unacceptable Lens Fit|1|||
146705777|NCT02920983|529096288|FG005|Dispense 1|Unacceptable Lens Fit|0|||
146705778|NCT02920983|529096283|FG000|Dispense 2|Unscceptable lens fit|1|||
146705779|NCT02920983|529096284|FG001|Dispense 2|Unscceptable lens fit|0|||
146705780|NCT02920983|529096285|FG002|Dispense 2|Unscceptable lens fit|0|||
146705781|NCT02920983|529096286|FG003|Dispense 2|Unscceptable lens fit|0|||
146705782|NCT02920983|529096287|FG004|Dispense 2|Unscceptable lens fit|1|||
146705783|NCT02920983|529096288|FG005|Dispense 2|Unscceptable lens fit|0|||
146705784|NCT02920983|529096283|FG000|Dispense 3|Unacceptable Lens Fit|1|||
146705785|NCT02920983|529096284|FG001|Dispense 3|Unacceptable Lens Fit|1|||
146705786|NCT02920983|529096285|FG002|Dispense 3|Unacceptable Lens Fit|0|||
146705787|NCT02920983|529096286|FG003|Dispense 3|Unacceptable Lens Fit|0|||
146705788|NCT02920983|529096287|FG004|Dispense 3|Unacceptable Lens Fit|1|||
146705789|NCT02920983|529096288|FG005|Dispense 3|Unacceptable Lens Fit|0|||
146705790|NCT01451424|529096289|FG000|Overall Study|Withdrawal by Subject|1|||
146705791|NCT01451424|529096290|FG001|Overall Study|Withdrawal by Subject|1|||
146777139|NCT05056246|529353659|FG001|Overall Study|Withdrawal by Subject|1|||
146777140|NCT05056246|529353660|FG002|Overall Study|Withdrawal by Subject|0|||
146777141|NCT05056246|529353661|FG003|Overall Study|Withdrawal by Subject|0|||
146933746|NCT01143714|529915983|FG000|Overall Study|Subject non-compliance|0|||
146933747|NCT01143714|529915984|FG001|Overall Study|Subject non-compliance|1|||
146933748|NCT01143714|529915983|FG000|Overall Study|wound closed = deemed healed|1|||
146705792|NCT01451424|529096291|FG002|Overall Study|Withdrawal by Subject|0|||
146705793|NCT01451424|529096292|FG003|Overall Study|Withdrawal by Subject|2|||
146705794|NCT01451424|529096289|FG000|Overall Study|Lost to Follow-up|0|||
146705795|NCT01451424|529096290|FG001|Overall Study|Lost to Follow-up|1|||
146705796|NCT01451424|529096291|FG002|Overall Study|Lost to Follow-up|0|||
146705797|NCT01451424|529096292|FG003|Overall Study|Lost to Follow-up|1|||
146705798|NCT01451424|529096289|FG000|Overall Study|Physician Decision|0|||
146705799|NCT01451424|529096290|FG001|Overall Study|Physician Decision|0|||
146705800|NCT01451424|529096291|FG002|Overall Study|Physician Decision|1|||
146705801|NCT01451424|529096292|FG003|Overall Study|Physician Decision|1|||
146705802|NCT01451424|529096289|FG000|Overall Study|Adverse Event|0|||
146705803|NCT01451424|529096290|FG001|Overall Study|Adverse Event|0|||
146705804|NCT01451424|529096291|FG002|Overall Study|Adverse Event|0|||
146705805|NCT01451424|529096292|FG003|Overall Study|Adverse Event|1|||
146705806|NCT02908529|529096293|FG000|Overall Study|Lost to Follow-up|0|||
146705807|NCT02908529|529096294|FG001|Overall Study|Lost to Follow-up|2|||
146705808|NCT02553421|529096297|FG000|Overall Study|Lost to Follow-up|21|||
146705809|NCT02553421|529096298|FG001|Overall Study|Lost to Follow-up|1|||
146705810|NCT02553421|529096297|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
146705811|NCT02553421|529096298|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
146705812|NCT02553421|529096297|FG000|Overall Study|Improper Device Placement|3|||
146705813|NCT02553421|529096298|FG001|Overall Study|Improper Device Placement|0|||
146705814|NCT04084769|529096307|FG000|Overall Study|Protocol Violation|1|||
146705815|NCT04084769|529096308|FG001|Overall Study|Protocol Violation|3|||
146705816|NCT04084769|529096309|FG002|Overall Study|Protocol Violation|0|||
146705817|NCT04084769|529096310|FG003|Overall Study|Protocol Violation|1|||
146705818|NCT04084769|529096307|FG000|Overall Study|Withdrawal by Subject|0|||
146705819|NCT04084769|529096308|FG001|Overall Study|Withdrawal by Subject|1|||
146705820|NCT04084769|529096309|FG002|Overall Study|Withdrawal by Subject|0|||
146705821|NCT04084769|529096310|FG003|Overall Study|Withdrawal by Subject|0|||
146705822|NCT04084769|529096307|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146705823|NCT04084769|529096308|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146705824|NCT04084769|529096309|FG002|Overall Study|Withdrawal by parent/guardian|0|||
146705825|NCT04084769|529096310|FG003|Overall Study|Withdrawal by parent/guardian|1|||
146705826|NCT04084769|529096307|FG000|Overall Study|Lost to Follow-up|2|||
146705827|NCT04084769|529096308|FG001|Overall Study|Lost to Follow-up|0|||
146705828|NCT04084769|529096309|FG002|Overall Study|Lost to Follow-up|0|||
146705829|NCT04084769|529096310|FG003|Overall Study|Lost to Follow-up|0|||
146705830|NCT01660412|529096311|FG000|Overall Study|Protocol Violation|0|||
146705831|NCT01660412|529096312|FG001|Overall Study|Protocol Violation|3|||
146705832|NCT03551210|529096313|FG000|Overall Study|Adverse Event|5|||
146705833|NCT03551210|529096314|FG001|Overall Study|Adverse Event|6|||
146705834|NCT03551210|529096313|FG000|Overall Study|Withdrawal by Subject|1|||
146705835|NCT03551210|529096314|FG001|Overall Study|Withdrawal by Subject|7|||
146705836|NCT03551210|529096313|FG000|Overall Study|Needed in other antibiotic treatment|2|||
146705837|NCT03551210|529096314|FG001|Overall Study|Needed in other antibiotic treatment|5|||
146705838|NCT03551210|529096313|FG000|Overall Study|Lost to Follow-up|1|||
146705839|NCT03551210|529096314|FG001|Overall Study|Lost to Follow-up|1|||
146705840|NCT03551210|529096313|FG000|Overall Study|Absence of visit 4 and 5|1|||
146705841|NCT03551210|529096314|FG001|Overall Study|Absence of visit 4 and 5|0|||
146705842|NCT03551210|529096313|FG000|Overall Study|No drug for dispensing|0|||
146705843|NCT03551210|529096314|FG001|Overall Study|No drug for dispensing|1|||
146705844|NCT03013491|529096315|FG000|Main Study|Death|2|||
146705845|NCT03013491|529096316|FG001|Main Study|Death|2|||
146705846|NCT03013491|529096317|FG002|Main Study|Death|5|||
146705847|NCT03013491|529096318|FG003|Main Study|Death|3|||
146705848|NCT03013491|529096319|FG004|Main Study|Death|9|||
146705849|NCT03013491|529096320|FG005|Main Study|Death|12|||
146705850|NCT03013491|529096321|FG006|Main Study|Death|3|||
146705851|NCT03013491|529096322|FG007|Main Study|Death|5|||
146705852|NCT03013491|529096323|FG008|Main Study|Death|1|||
146705853|NCT03013491|529096324|FG009|Main Study|Death|2|||
146705854|NCT03013491|529096325|FG010|Main Study|Death|4|||
146705855|NCT03013491|529096326|FG011|Main Study|Death|1|||
146705856|NCT03013491|529096327|FG012|Main Study|Death|1|||
146705857|NCT03013491|529096328|FG013|Main Study|Death|4|||
146705858|NCT03013491|529096329|FG014|Main Study|Death|0|||
146705859|NCT03013491|529096330|FG015|Main Study|Death|3|||
146705860|NCT03013491|529096331|FG016|Main Study|Death|5|||
146705861|NCT03013491|529096332|FG017|Main Study|Death|1|||
146705862|NCT03013491|529096333|FG018|Main Study|Death|47|||
146705863|NCT03013491|529096315|FG000|Main Study|Lost to Follow-up|0|||
146705864|NCT03013491|529096316|FG001|Main Study|Lost to Follow-up|0|||
146705865|NCT03013491|529096317|FG002|Main Study|Lost to Follow-up|1|||
146705866|NCT03013491|529096318|FG003|Main Study|Lost to Follow-up|0|||
146705867|NCT03013491|529096319|FG004|Main Study|Lost to Follow-up|1|||
146705868|NCT03013491|529096320|FG005|Main Study|Lost to Follow-up|0|||
146777142|NCT05056246|529353662|FG004|Overall Study|Withdrawal by Subject|0|||
146705869|NCT03013491|529096321|FG006|Main Study|Lost to Follow-up|0|||
146705870|NCT03013491|529096322|FG007|Main Study|Lost to Follow-up|0|||
146705871|NCT03013491|529096323|FG008|Main Study|Lost to Follow-up|0|||
146705872|NCT03013491|529096324|FG009|Main Study|Lost to Follow-up|0|||
146705873|NCT03013491|529096325|FG010|Main Study|Lost to Follow-up|0|||
146705874|NCT03013491|529096326|FG011|Main Study|Lost to Follow-up|0|||
146705875|NCT03013491|529096327|FG012|Main Study|Lost to Follow-up|0|||
146705876|NCT03013491|529096328|FG013|Main Study|Lost to Follow-up|0|||
146705877|NCT03013491|529096329|FG014|Main Study|Lost to Follow-up|0|||
146705878|NCT03013491|529096330|FG015|Main Study|Lost to Follow-up|0|||
146705879|NCT03013491|529096331|FG016|Main Study|Lost to Follow-up|0|||
146705880|NCT03013491|529096332|FG017|Main Study|Lost to Follow-up|0|||
146705881|NCT03013491|529096333|FG018|Main Study|Lost to Follow-up|3|||
146705882|NCT03013491|529096315|FG000|Main Study|Termination of the study by Sponsor|0|||
146705883|NCT03013491|529096316|FG001|Main Study|Termination of the study by Sponsor|0|||
146705884|NCT03013491|529096317|FG002|Main Study|Termination of the study by Sponsor|2|||
146705885|NCT03013491|529096318|FG003|Main Study|Termination of the study by Sponsor|0|||
146705886|NCT03013491|529096319|FG004|Main Study|Termination of the study by Sponsor|1|||
146705887|NCT03013491|529096320|FG005|Main Study|Termination of the study by Sponsor|2|||
146705888|NCT03013491|529096321|FG006|Main Study|Termination of the study by Sponsor|0|||
146705889|NCT03013491|529096322|FG007|Main Study|Termination of the study by Sponsor|0|||
146705890|NCT03013491|529096323|FG008|Main Study|Termination of the study by Sponsor|1|||
146705891|NCT03013491|529096324|FG009|Main Study|Termination of the study by Sponsor|1|||
146705892|NCT03013491|529096325|FG010|Main Study|Termination of the study by Sponsor|1|||
146777143|NCT05096819|529353667|FG000|Overall Study|Withdrawal by Subject|3|||
146777144|NCT05096819|529353668|FG001|Overall Study|Withdrawal by Subject|0|||
146777145|NCT03324984|529353669|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
146777146|NCT03324984|529353670|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
146705893|NCT03013491|529096326|FG011|Main Study|Termination of the study by Sponsor|2|||
146705894|NCT03013491|529096327|FG012|Main Study|Termination of the study by Sponsor|0|||
146705895|NCT03013491|529096328|FG013|Main Study|Termination of the study by Sponsor|0|||
146705896|NCT03013491|529096329|FG014|Main Study|Termination of the study by Sponsor|0|||
146705897|NCT03013491|529096330|FG015|Main Study|Termination of the study by Sponsor|0|||
146705898|NCT03013491|529096331|FG016|Main Study|Termination of the study by Sponsor|0|||
146705899|NCT03013491|529096332|FG017|Main Study|Termination of the study by Sponsor|1|||
146705900|NCT03013491|529096333|FG018|Main Study|Termination of the study by Sponsor|13|||
146705901|NCT03013491|529096315|FG000|Main Study|Withdrawal by Subject|0|||
146705902|NCT03013491|529096316|FG001|Main Study|Withdrawal by Subject|0|||
146705903|NCT03013491|529096317|FG002|Main Study|Withdrawal by Subject|0|||
146705904|NCT03013491|529096318|FG003|Main Study|Withdrawal by Subject|4|||
146705905|NCT03013491|529096319|FG004|Main Study|Withdrawal by Subject|2|||
146705906|NCT03013491|529096320|FG005|Main Study|Withdrawal by Subject|1|||
146705907|NCT03013491|529096321|FG006|Main Study|Withdrawal by Subject|0|||
146705908|NCT03013491|529096322|FG007|Main Study|Withdrawal by Subject|0|||
146705909|NCT03013491|529096323|FG008|Main Study|Withdrawal by Subject|0|||
146705910|NCT03013491|529096324|FG009|Main Study|Withdrawal by Subject|0|||
146705911|NCT03013491|529096325|FG010|Main Study|Withdrawal by Subject|1|||
146705912|NCT03013491|529096326|FG011|Main Study|Withdrawal by Subject|2|||
146705913|NCT03013491|529096327|FG012|Main Study|Withdrawal by Subject|0|||
146705914|NCT03013491|529096328|FG013|Main Study|Withdrawal by Subject|2|||
146705915|NCT03013491|529096329|FG014|Main Study|Withdrawal by Subject|0|||
146705916|NCT03013491|529096330|FG015|Main Study|Withdrawal by Subject|0|||
146705917|NCT03013491|529096331|FG016|Main Study|Withdrawal by Subject|0|||
146705918|NCT03013491|529096332|FG017|Main Study|Withdrawal by Subject|0|||
146705919|NCT03013491|529096333|FG018|Main Study|Withdrawal by Subject|18|||
146705920|NCT03013491|529096315|FG000|Main Study|Disease progression|0|||
146705921|NCT03013491|529096316|FG001|Main Study|Disease progression|0|||
146705922|NCT03013491|529096317|FG002|Main Study|Disease progression|0|||
146705923|NCT03013491|529096318|FG003|Main Study|Disease progression|1|||
146705924|NCT03013491|529096319|FG004|Main Study|Disease progression|0|||
146705925|NCT03013491|529096320|FG005|Main Study|Disease progression|0|||
146705926|NCT03013491|529096321|FG006|Main Study|Disease progression|0|||
146705927|NCT03013491|529096322|FG007|Main Study|Disease progression|0|||
146705928|NCT03013491|529096323|FG008|Main Study|Disease progression|1|||
146705929|NCT03013491|529096324|FG009|Main Study|Disease progression|0|||
146705930|NCT03013491|529096325|FG010|Main Study|Disease progression|1|||
146705931|NCT03013491|529096326|FG011|Main Study|Disease progression|0|||
146705932|NCT03013491|529096327|FG012|Main Study|Disease progression|0|||
146705933|NCT03013491|529096328|FG013|Main Study|Disease progression|0|||
146705934|NCT03013491|529096329|FG014|Main Study|Disease progression|0|||
146705935|NCT03013491|529096330|FG015|Main Study|Disease progression|0|||
146705936|NCT03013491|529096331|FG016|Main Study|Disease progression|0|||
146705937|NCT03013491|529096332|FG017|Main Study|Disease progression|0|||
146705938|NCT03013491|529096333|FG018|Main Study|Disease progression|4|||
146705939|NCT03013491|529096315|FG000|Main Study|Symptomatic deterioration|0|||
146705940|NCT03013491|529096316|FG001|Main Study|Symptomatic deterioration|0|||
146705941|NCT03013491|529096317|FG002|Main Study|Symptomatic deterioration|0|||
146777147|NCT02152137|529353672|FG000|Overall Study|Withdrawal by Subject|1|||
146933749|NCT01143714|529915984|FG001|Overall Study|wound closed = deemed healed|0|||
146705942|NCT03013491|529096318|FG003|Main Study|Symptomatic deterioration|0|||
146705943|NCT03013491|529096319|FG004|Main Study|Symptomatic deterioration|0|||
146705944|NCT03013491|529096320|FG005|Main Study|Symptomatic deterioration|1|||
146705945|NCT03013491|529096321|FG006|Main Study|Symptomatic deterioration|0|||
146705946|NCT03013491|529096322|FG007|Main Study|Symptomatic deterioration|0|||
146705947|NCT03013491|529096323|FG008|Main Study|Symptomatic deterioration|0|||
146705948|NCT03013491|529096324|FG009|Main Study|Symptomatic deterioration|0|||
146933750|NCT01143714|529915983|FG000|Overall Study|wound size increased|1|||
146705949|NCT03013491|529096325|FG010|Main Study|Symptomatic deterioration|0|||
146705950|NCT03013491|529096326|FG011|Main Study|Symptomatic deterioration|0|||
146705951|NCT03013491|529096327|FG012|Main Study|Symptomatic deterioration|0|||
146705952|NCT03013491|529096328|FG013|Main Study|Symptomatic deterioration|0|||
146705953|NCT03013491|529096329|FG014|Main Study|Symptomatic deterioration|0|||
146705954|NCT03013491|529096330|FG015|Main Study|Symptomatic deterioration|0|||
146705955|NCT03013491|529096331|FG016|Main Study|Symptomatic deterioration|0|||
146705956|NCT03013491|529096332|FG017|Main Study|Symptomatic deterioration|0|||
146705957|NCT03013491|529096333|FG018|Main Study|Symptomatic deterioration|0|||
146705958|NCT03013491|529096315|FG000|Main Study|Protocol version 8.0 approval|0|||
146705959|NCT03013491|529096316|FG001|Main Study|Protocol version 8.0 approval|0|||
146705960|NCT03013491|529096317|FG002|Main Study|Protocol version 8.0 approval|0|||
146705961|NCT03013491|529096318|FG003|Main Study|Protocol version 8.0 approval|0|||
146777148|NCT02152137|529353672|FG000|Overall Study|Originally assigned to Arm B|3|||
146777149|NCT04878354|529353673|FG000|Overall Study|Adverse Event|4|||
146777150|NCT04878354|529353674|FG001|Overall Study|Adverse Event|13|||
146777151|NCT04878354|529353673|FG000|Overall Study|Withdrawal by Subject|14|||
146777152|NCT04878354|529353674|FG001|Overall Study|Withdrawal by Subject|12|||
146777153|NCT04878354|529353673|FG000|Overall Study|Lost to Follow-up|4|||
146777154|NCT04878354|529353674|FG001|Overall Study|Lost to Follow-up|1|||
146777155|NCT04878354|529353673|FG000|Overall Study|Lack of Efficacy|1|||
146777156|NCT04878354|529353674|FG001|Overall Study|Lack of Efficacy|0|||
146777157|NCT04878354|529353673|FG000|Overall Study|Protocol Violation|0|||
146777158|NCT04878354|529353674|FG001|Overall Study|Protocol Violation|1|||
146777159|NCT04878354|529353673|FG000|Overall Study|"Reason stated as other in CRF"|2|||
146777160|NCT04878354|529353674|FG001|Overall Study|"Reason stated as other in CRF"|3|||
146777161|NCT03358875|529353675|FG000|Overall Study|Death|409|||
146777162|NCT03358875|529353676|FG001|Overall Study|Death|223|||
146777163|NCT03358875|529353675|FG000|Overall Study|Study Closed by Sponsor|66|||
146777164|NCT03358875|529353676|FG001|Overall Study|Study Closed by Sponsor|29|||
146777165|NCT03358875|529353675|FG000|Overall Study|Withdrawal by Subject|13|||
146777166|NCT03358875|529353676|FG001|Overall Study|Withdrawal by Subject|16|||
146777167|NCT03358875|529353675|FG000|Overall Study|Lost to Follow-up|13|||
146777168|NCT03358875|529353676|FG001|Overall Study|Lost to Follow-up|2|||
146777169|NCT03358875|529353675|FG000|Overall Study|Miscellaneous|33|||
146777170|NCT03358875|529353676|FG001|Overall Study|Miscellaneous|0|||
146777171|NCT03358875|529353675|FG000|Overall Study|Remained on Study|1|||
146777172|NCT03358875|529353676|FG001|Overall Study|Remained on Study|0|||
146777173|NCT06194214|529353691|FG000|Overall Study|Adverse Event|1|||
146777174|NCT05687903|529353692|FG000|Overall Study|Protocol Deviation|1|||
146777175|NCT05687903|529353693|FG001|Overall Study|Protocol Deviation|1|||
146777176|NCT05687903|529353694|FG002|Overall Study|Protocol Deviation|0|||
146777177|NCT05687903|529353695|FG003|Overall Study|Protocol Deviation|1|||
146777178|NCT05687903|529353696|FG004|Overall Study|Protocol Deviation|0|||
146777179|NCT04847999|529353697|FG000|Overall Study|Lost to Follow-up|0|||
146777180|NCT04847999|529353698|FG001|Overall Study|Lost to Follow-up|1|||
146777181|NCT02879448|529353699|FG000|Overall Study|Death|251|||
146777182|NCT02879448|529353700|FG001|Overall Study|Death|263|||
146777183|NCT02879448|529353699|FG000|Overall Study|Lost to Follow-up|23|||
146777184|NCT02879448|529353700|FG001|Overall Study|Lost to Follow-up|28|||
146777185|NCT02879448|529353699|FG000|Overall Study|Withdrawal by Subject|42|||
146777186|NCT02879448|529353700|FG001|Overall Study|Withdrawal by Subject|79|||
146777187|NCT02879448|529353699|FG000|Overall Study|Other Reasons|8|||
146777188|NCT02879448|529353700|FG001|Overall Study|Other Reasons|12|||
146777189|NCT04300231|529353710|FG000|Overall Study|Protocol Violation|4|||
146777190|NCT04300231|529353711|FG001|Overall Study|Protocol Violation|3|||
146777191|NCT04300231|529353712|FG002|Overall Study|Protocol Violation|0|||
146777192|NCT04300231|529353713|FG003|Overall Study|Protocol Violation|2|||
146777193|NCT02386553|529353715|FG000|Overall Study|Reason Not Specified|1|||
146777194|NCT02386553|529353716|FG001|Overall Study|Reason Not Specified|1|||
146777195|NCT02386553|529353715|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
146777196|NCT02386553|529353716|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
146777197|NCT02006758|529353720|FG000|Overall Study|Protocol Violation|1|||
146777198|NCT02006758|529353720|FG000|Overall Study|Death|1|||
146777199|NCT02006758|529353720|FG000|Overall Study|Lost to Follow-up|4|||
146777200|NCT02006758|529353720|FG000|Overall Study|Withdrawal by Subject|4|||
146777201|NCT02006758|529353720|FG000|Overall Study|Procedurally excluded|1|||
146777202|NCT02006758|529353720|FG000|Overall Study|Other|2|||
146777203|NCT02740231|529353721|FG000|Overall Study|Withdrawal by Subject|1|||
146777204|NCT02740231|529353722|FG001|Overall Study|Withdrawal by Subject|1|||
146777205|NCT02740231|529353723|FG002|Overall Study|Withdrawal by Subject|1|||
146777206|NCT02740231|529353724|FG003|Overall Study|Withdrawal by Subject|0|||
146777207|NCT02740231|529353721|FG000|Overall Study|Lack of Efficacy|0|||
146777208|NCT02740231|529353722|FG001|Overall Study|Lack of Efficacy|1|||
146777209|NCT02740231|529353723|FG002|Overall Study|Lack of Efficacy|0|||
146777210|NCT02740231|529353724|FG003|Overall Study|Lack of Efficacy|4|||
146777211|NCT02740231|529353721|FG000|Overall Study|Lost to Follow-up|1|||
146777212|NCT02740231|529353722|FG001|Overall Study|Lost to Follow-up|3|||
146933751|NCT01143714|529915984|FG001|Overall Study|wound size increased|0|||
146777213|NCT02740231|529353723|FG002|Overall Study|Lost to Follow-up|0|||
146777214|NCT02740231|529353724|FG003|Overall Study|Lost to Follow-up|3|||
146777215|NCT02740231|529353721|FG000|Overall Study|Adverse Event|0|||
146777216|NCT02740231|529353722|FG001|Overall Study|Adverse Event|1|||
146777217|NCT02740231|529353723|FG002|Overall Study|Adverse Event|0|||
146777218|NCT02740231|529353724|FG003|Overall Study|Adverse Event|1|||
146777219|NCT04328727|529353725|FG000|Overall Study|Guardian Decision|1|||
146777220|NCT04328727|529353725|FG000|Overall Study|Participant decision|4|||
146777221|NCT04328727|529353725|FG000|Overall Study|Death|3|||
146777222|NCT04149002|529353726|FG000|Overall Study|Lost to Follow-up|1|||
146777223|NCT04149002|529353727|FG001|Overall Study|Lost to Follow-up|0|||
146777224|NCT04149002|529353726|FG000|Overall Study|Withdrawal by Subject|1|||
146777225|NCT04149002|529353727|FG001|Overall Study|Withdrawal by Subject|0|||
146705962|NCT03013491|529096319|FG004|Main Study|Protocol version 8.0 approval|0|||
146705963|NCT03013491|529096320|FG005|Main Study|Protocol version 8.0 approval|0|||
146705964|NCT03013491|529096321|FG006|Main Study|Protocol version 8.0 approval|0|||
146705965|NCT03013491|529096322|FG007|Main Study|Protocol version 8.0 approval|0|||
146705966|NCT03013491|529096323|FG008|Main Study|Protocol version 8.0 approval|0|||
146705967|NCT03013491|529096324|FG009|Main Study|Protocol version 8.0 approval|0|||
146705968|NCT03013491|529096325|FG010|Main Study|Protocol version 8.0 approval|1|||
146705969|NCT03013491|529096326|FG011|Main Study|Protocol version 8.0 approval|0|||
146705970|NCT03013491|529096327|FG012|Main Study|Protocol version 8.0 approval|0|||
146705971|NCT03013491|529096328|FG013|Main Study|Protocol version 8.0 approval|0|||
146705972|NCT03013491|529096329|FG014|Main Study|Protocol version 8.0 approval|0|||
146705973|NCT03013491|529096330|FG015|Main Study|Protocol version 8.0 approval|0|||
146705974|NCT03013491|529096331|FG016|Main Study|Protocol version 8.0 approval|0|||
146705975|NCT03013491|529096332|FG017|Main Study|Protocol version 8.0 approval|0|||
146705976|NCT03013491|529096333|FG018|Main Study|Protocol version 8.0 approval|0|||
146705977|NCT03013491|529096315|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
146705978|NCT03013491|529096316|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
146705979|NCT03013491|529096317|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
146705980|NCT03013491|529096318|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
146705981|NCT03013491|529096319|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
146705982|NCT03013491|529096320|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
146705983|NCT03013491|529096321|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
146705984|NCT03013491|529096322|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
146705985|NCT03013491|529096323|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
146705986|NCT03013491|529096324|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
146705987|NCT03013491|529096325|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
146705988|NCT03013491|529096326|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
146705989|NCT03013491|529096327|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
146705990|NCT03013491|529096328|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
146705991|NCT03013491|529096329|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
146705992|NCT03013491|529096330|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
146705993|NCT03013491|529096331|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
146705994|NCT03013491|529096332|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
146705995|NCT03013491|529096333|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
146705996|NCT03013491|529096315|FG000|Main Study|Start of new anticancer therapy|0|||
146705997|NCT03013491|529096316|FG001|Main Study|Start of new anticancer therapy|0|||
146705998|NCT03013491|529096317|FG002|Main Study|Start of new anticancer therapy|0|||
146705999|NCT03013491|529096318|FG003|Main Study|Start of new anticancer therapy|0|||
146706000|NCT03013491|529096319|FG004|Main Study|Start of new anticancer therapy|0|||
146706001|NCT03013491|529096320|FG005|Main Study|Start of new anticancer therapy|0|||
146706002|NCT03013491|529096321|FG006|Main Study|Start of new anticancer therapy|0|||
146706003|NCT03013491|529096322|FG007|Main Study|Start of new anticancer therapy|0|||
146706004|NCT03013491|529096323|FG008|Main Study|Start of new anticancer therapy|0|||
146706005|NCT03013491|529096324|FG009|Main Study|Start of new anticancer therapy|0|||
146706006|NCT03013491|529096325|FG010|Main Study|Start of new anticancer therapy|0|||
146706007|NCT03013491|529096326|FG011|Main Study|Start of new anticancer therapy|0|||
146706008|NCT03013491|529096327|FG012|Main Study|Start of new anticancer therapy|0|||
146706009|NCT03013491|529096328|FG013|Main Study|Start of new anticancer therapy|0|||
146706010|NCT03013491|529096329|FG014|Main Study|Start of new anticancer therapy|0|||
146706011|NCT03013491|529096330|FG015|Main Study|Start of new anticancer therapy|0|||
146706012|NCT03013491|529096331|FG016|Main Study|Start of new anticancer therapy|0|||
146706013|NCT03013491|529096332|FG017|Main Study|Start of new anticancer therapy|0|||
146706014|NCT03013491|529096333|FG018|Main Study|Start of new anticancer therapy|2|||
146706015|NCT03013491|529096315|FG000|Long-term Extension|Disease progression|0|||
146706016|NCT03013491|529096316|FG001|Long-term Extension|Disease progression|0|||
146706017|NCT03013491|529096317|FG002|Long-term Extension|Disease progression|0|||
146706018|NCT03013491|529096318|FG003|Long-term Extension|Disease progression|1|||
146706019|NCT03013491|529096319|FG004|Long-term Extension|Disease progression|0|||
146706020|NCT03013491|529096320|FG005|Long-term Extension|Disease progression|0|||
146706021|NCT03013491|529096321|FG006|Long-term Extension|Disease progression|0|||
146706022|NCT03013491|529096322|FG007|Long-term Extension|Disease progression|0|||
146706023|NCT03013491|529096323|FG008|Long-term Extension|Disease progression|0|||
146706024|NCT03013491|529096324|FG009|Long-term Extension|Disease progression|0|||
146706025|NCT03013491|529096325|FG010|Long-term Extension|Disease progression|0|||
146706026|NCT03013491|529096326|FG011|Long-term Extension|Disease progression|0|||
146706027|NCT03013491|529096327|FG012|Long-term Extension|Disease progression|0|||
146706028|NCT03013491|529096328|FG013|Long-term Extension|Disease progression|0|||
146706029|NCT03013491|529096329|FG014|Long-term Extension|Disease progression|0|||
146848428|NCT03122223|529615679|FG000|Overall Study|Lost to Follow-up|0|||
146848429|NCT03122223|529615680|FG001|Overall Study|Lost to Follow-up|2|||
146706030|NCT03013491|529096330|FG015|Long-term Extension|Disease progression|0|||
146706031|NCT03013491|529096331|FG016|Long-term Extension|Disease progression|0|||
146706032|NCT03013491|529096332|FG017|Long-term Extension|Disease progression|0|||
146706033|NCT03013491|529096333|FG018|Long-term Extension|Disease progression|1|||
146706034|NCT03013491|529096315|FG000|Long-term Extension|Withdrawal by Subject|0|||
146706035|NCT03013491|529096316|FG001|Long-term Extension|Withdrawal by Subject|0|||
146706036|NCT03013491|529096317|FG002|Long-term Extension|Withdrawal by Subject|0|||
146706037|NCT03013491|529096318|FG003|Long-term Extension|Withdrawal by Subject|0|||
146706038|NCT03013491|529096319|FG004|Long-term Extension|Withdrawal by Subject|0|||
146706039|NCT03013491|529096320|FG005|Long-term Extension|Withdrawal by Subject|0|||
146706040|NCT03013491|529096321|FG006|Long-term Extension|Withdrawal by Subject|0|||
146706041|NCT03013491|529096322|FG007|Long-term Extension|Withdrawal by Subject|1|||
146706042|NCT03013491|529096323|FG008|Long-term Extension|Withdrawal by Subject|0|||
146706043|NCT03013491|529096324|FG009|Long-term Extension|Withdrawal by Subject|0|||
146706044|NCT03013491|529096325|FG010|Long-term Extension|Withdrawal by Subject|0|||
146706045|NCT03013491|529096326|FG011|Long-term Extension|Withdrawal by Subject|0|||
146706046|NCT03013491|529096327|FG012|Long-term Extension|Withdrawal by Subject|0|||
146706047|NCT03013491|529096328|FG013|Long-term Extension|Withdrawal by Subject|0|||
146706048|NCT03013491|529096329|FG014|Long-term Extension|Withdrawal by Subject|0|||
146706049|NCT03013491|529096330|FG015|Long-term Extension|Withdrawal by Subject|0|||
146706050|NCT03013491|529096331|FG016|Long-term Extension|Withdrawal by Subject|0|||
146706051|NCT03013491|529096332|FG017|Long-term Extension|Withdrawal by Subject|0|||
146706052|NCT03013491|529096333|FG018|Long-term Extension|Withdrawal by Subject|0|||
146706053|NCT03013491|529096315|FG000|Long-term Extension|Adverse Event|0|||
146706054|NCT03013491|529096316|FG001|Long-term Extension|Adverse Event|0|||
146706055|NCT03013491|529096317|FG002|Long-term Extension|Adverse Event|0|||
146706056|NCT03013491|529096318|FG003|Long-term Extension|Adverse Event|0|||
146706057|NCT03013491|529096319|FG004|Long-term Extension|Adverse Event|0|||
146706058|NCT03013491|529096320|FG005|Long-term Extension|Adverse Event|0|||
146706059|NCT03013491|529096321|FG006|Long-term Extension|Adverse Event|0|||
146706060|NCT03013491|529096322|FG007|Long-term Extension|Adverse Event|0|||
146706061|NCT03013491|529096323|FG008|Long-term Extension|Adverse Event|0|||
146706062|NCT03013491|529096324|FG009|Long-term Extension|Adverse Event|0|||
146706063|NCT03013491|529096325|FG010|Long-term Extension|Adverse Event|0|||
146706064|NCT03013491|529096326|FG011|Long-term Extension|Adverse Event|0|||
146706065|NCT03013491|529096327|FG012|Long-term Extension|Adverse Event|0|||
146706066|NCT03013491|529096328|FG013|Long-term Extension|Adverse Event|0|||
146706067|NCT03013491|529096329|FG014|Long-term Extension|Adverse Event|0|||
146706068|NCT03013491|529096330|FG015|Long-term Extension|Adverse Event|0|||
146706069|NCT03013491|529096331|FG016|Long-term Extension|Adverse Event|0|||
146706070|NCT03013491|529096332|FG017|Long-term Extension|Adverse Event|0|||
146706071|NCT03013491|529096333|FG018|Long-term Extension|Adverse Event|1|||
146706072|NCT03013491|529096315|FG000|Long-term Extension|Death|0|||
146706073|NCT03013491|529096316|FG001|Long-term Extension|Death|0|||
146706074|NCT03013491|529096317|FG002|Long-term Extension|Death|0|||
146706075|NCT03013491|529096318|FG003|Long-term Extension|Death|0|||
146706076|NCT03013491|529096319|FG004|Long-term Extension|Death|0|||
146706077|NCT03013491|529096320|FG005|Long-term Extension|Death|0|||
146706078|NCT03013491|529096321|FG006|Long-term Extension|Death|0|||
146706079|NCT03013491|529096322|FG007|Long-term Extension|Death|0|||
146706080|NCT03013491|529096323|FG008|Long-term Extension|Death|0|||
146706081|NCT03013491|529096324|FG009|Long-term Extension|Death|0|||
146706082|NCT03013491|529096325|FG010|Long-term Extension|Death|0|||
146706083|NCT03013491|529096326|FG011|Long-term Extension|Death|0|||
146706084|NCT03013491|529096327|FG012|Long-term Extension|Death|0|||
146706085|NCT03013491|529096328|FG013|Long-term Extension|Death|0|||
146706086|NCT03013491|529096329|FG014|Long-term Extension|Death|0|||
146706087|NCT03013491|529096330|FG015|Long-term Extension|Death|0|||
146706088|NCT03013491|529096331|FG016|Long-term Extension|Death|0|||
146706089|NCT03013491|529096332|FG017|Long-term Extension|Death|0|||
146706090|NCT03013491|529096333|FG018|Long-term Extension|Death|1|||
146706091|NCT03265119|529096334|FG000|Overall Study|Adverse Event|2|||
146706092|NCT03265119|529096335|FG001|Overall Study|Adverse Event|1|||
146706093|NCT03265119|529096334|FG000|Overall Study|Lack of Efficacy|3|||
146706094|NCT03265119|529096335|FG001|Overall Study|Lack of Efficacy|0|||
146706095|NCT03265119|529096334|FG000|Overall Study|Protocol Violation|1|||
146706096|NCT03265119|529096335|FG001|Overall Study|Protocol Violation|2|||
146706097|NCT03265119|529096334|FG000|Overall Study|Withdrawal by Subject|2|||
146706098|NCT03265119|529096335|FG001|Overall Study|Withdrawal by Subject|4|||
146706099|NCT03265119|529096334|FG000|Overall Study|Lost to Follow-up|1|||
146706100|NCT03265119|529096335|FG001|Overall Study|Lost to Follow-up|0|||
146706101|NCT03265119|529096334|FG000|Overall Study|Lack of Compliance|1|||
146706102|NCT03265119|529096335|FG001|Overall Study|Lack of Compliance|0|||
146706103|NCT04579679|529096338|FG000|Overall Study|New Antitumor Therapy|6|||
146706104|NCT04579679|529096339|FG001|Overall Study|New Antitumor Therapy|4|||
146706105|NCT04579679|529096340|FG002|Overall Study|New Antitumor Therapy|7|||
146777226|NCT04704284|529353728|FG000|Overall Study|Withdrawal by Subject|1|||
146706106|NCT04579679|529096341|FG003|Overall Study|New Antitumor Therapy|0|||
146706107|NCT04579679|529096338|FG000|Overall Study|Withdrawal of Consent|1|||
146706108|NCT04579679|529096339|FG001|Overall Study|Withdrawal of Consent|1|||
146706109|NCT04579679|529096340|FG002|Overall Study|Withdrawal of Consent|2|||
146706110|NCT04579679|529096341|FG003|Overall Study|Withdrawal of Consent|4|||
146706111|NCT04579679|529096338|FG000|Overall Study|Death|2|||
146706112|NCT04579679|529096339|FG001|Overall Study|Death|2|||
146706113|NCT04579679|529096340|FG002|Overall Study|Death|2|||
146706114|NCT04579679|529096341|FG003|Overall Study|Death|0|||
146706115|NCT04579679|529096338|FG000|Overall Study|Adverse Event|0|||
146706116|NCT04579679|529096339|FG001|Overall Study|Adverse Event|4|||
146706117|NCT04579679|529096340|FG002|Overall Study|Adverse Event|0|||
146706118|NCT04579679|529096341|FG003|Overall Study|Adverse Event|0|||
146706119|NCT04579679|529096338|FG000|Overall Study|Disease Progression|9|||
146706120|NCT04579679|529096339|FG001|Overall Study|Disease Progression|13|||
146706121|NCT04579679|529096340|FG002|Overall Study|Disease Progression|7|||
146706122|NCT04579679|529096341|FG003|Overall Study|Disease Progression|0|||
146706123|NCT04579679|529096338|FG000|Overall Study|Physician Decision|0|||
146706124|NCT04579679|529096339|FG001|Overall Study|Physician Decision|0|||
146706125|NCT04579679|529096340|FG002|Overall Study|Physician Decision|1|||
146706126|NCT04579679|529096341|FG003|Overall Study|Physician Decision|0|||
146706127|NCT04579679|529096338|FG000|Overall Study|Study Terminated by Sponsor|2|||
146706128|NCT04579679|529096339|FG001|Overall Study|Study Terminated by Sponsor|7|||
146706129|NCT04579679|529096340|FG002|Overall Study|Study Terminated by Sponsor|1|||
146706130|NCT04579679|529096341|FG003|Overall Study|Study Terminated by Sponsor|0|||
146706131|NCT00991302|529098258|FG000|Overall Study|Death|0|||
146706132|NCT00991302|529098259|FG001|Overall Study|Death|1|||
146706133|NCT00991302|529098258|FG000|Overall Study|Lost to Follow-up|14|||
146706134|NCT00991302|529098259|FG001|Overall Study|Lost to Follow-up|12|||
146706135|NCT01709318|529098260|FG000|Overall Study|Adverse Event|3|||
146706136|NCT01709318|529098261|FG001|Overall Study|Adverse Event|4|||
146706137|NCT01709318|529098262|FG002|Overall Study|Adverse Event|2|||
146706138|NCT01709318|529098263|FG003|Overall Study|Adverse Event|2|||
146706139|NCT01709318|529098264|FG004|Overall Study|Adverse Event|0|||
146706140|NCT01709318|529098265|FG005|Overall Study|Adverse Event|1|||
146706141|NCT01709318|529098266|FG006|Overall Study|Adverse Event|2|||
146706142|NCT01709318|529098260|FG000|Overall Study|Lost to Follow-up|2|||
146706143|NCT01709318|529098261|FG001|Overall Study|Lost to Follow-up|0|||
146706144|NCT01709318|529098262|FG002|Overall Study|Lost to Follow-up|0|||
146706145|NCT01709318|529098263|FG003|Overall Study|Lost to Follow-up|0|||
146706146|NCT01709318|529098264|FG004|Overall Study|Lost to Follow-up|1|||
146706147|NCT01709318|529098265|FG005|Overall Study|Lost to Follow-up|1|||
146706148|NCT01709318|529098266|FG006|Overall Study|Lost to Follow-up|1|||
146706149|NCT01709318|529098260|FG000|Overall Study|Non-compliance with Study Drug|0|||
146706150|NCT01709318|529098261|FG001|Overall Study|Non-compliance with Study Drug|2|||
146706151|NCT01709318|529098262|FG002|Overall Study|Non-compliance with Study Drug|1|||
146706152|NCT01709318|529098263|FG003|Overall Study|Non-compliance with Study Drug|1|||
146706153|NCT01709318|529098264|FG004|Overall Study|Non-compliance with Study Drug|0|||
146706154|NCT01709318|529098265|FG005|Overall Study|Non-compliance with Study Drug|0|||
146706155|NCT01709318|529098266|FG006|Overall Study|Non-compliance with Study Drug|2|||
146706156|NCT01709318|529098260|FG000|Overall Study|Physician Decision|0|||
146706157|NCT01709318|529098261|FG001|Overall Study|Physician Decision|0|||
146706158|NCT01709318|529098262|FG002|Overall Study|Physician Decision|0|||
146706159|NCT01709318|529098263|FG003|Overall Study|Physician Decision|0|||
146706160|NCT01709318|529098264|FG004|Overall Study|Physician Decision|0|||
146706161|NCT01709318|529098265|FG005|Overall Study|Physician Decision|0|||
146706162|NCT01709318|529098266|FG006|Overall Study|Physician Decision|1|||
146706163|NCT01709318|529098260|FG000|Overall Study|Pregnancy|0|||
146706164|NCT01709318|529098261|FG001|Overall Study|Pregnancy|0|||
146706165|NCT01709318|529098262|FG002|Overall Study|Pregnancy|0|||
146706166|NCT01709318|529098263|FG003|Overall Study|Pregnancy|0|||
146706167|NCT01709318|529098264|FG004|Overall Study|Pregnancy|1|||
146706168|NCT01709318|529098265|FG005|Overall Study|Pregnancy|0|||
146706169|NCT01709318|529098266|FG006|Overall Study|Pregnancy|0|||
146706170|NCT01709318|529098260|FG000|Overall Study|Protocol Violation|0|||
146706171|NCT01709318|529098261|FG001|Overall Study|Protocol Violation|0|||
146706172|NCT01709318|529098262|FG002|Overall Study|Protocol Violation|0|||
146706173|NCT01709318|529098263|FG003|Overall Study|Protocol Violation|0|||
146706174|NCT01709318|529098264|FG004|Overall Study|Protocol Violation|2|||
146706175|NCT01709318|529098265|FG005|Overall Study|Protocol Violation|0|||
146706176|NCT01709318|529098266|FG006|Overall Study|Protocol Violation|1|||
146706177|NCT01709318|529098260|FG000|Overall Study|Technical Problems|1|||
146706178|NCT01709318|529098261|FG001|Overall Study|Technical Problems|0|||
146706179|NCT01709318|529098262|FG002|Overall Study|Technical Problems|0|||
146706180|NCT01709318|529098263|FG003|Overall Study|Technical Problems|0|||
146706181|NCT01709318|529098264|FG004|Overall Study|Technical Problems|0|||
146706182|NCT01709318|529098265|FG005|Overall Study|Technical Problems|0|||
146706183|NCT01709318|529098266|FG006|Overall Study|Technical Problems|0|||
146706184|NCT01709318|529098260|FG000|Overall Study|Withdrawal by Subject|3|||
146706185|NCT01709318|529098261|FG001|Overall Study|Withdrawal by Subject|0|||
146706186|NCT01709318|529098262|FG002|Overall Study|Withdrawal by Subject|3|||
146706187|NCT01709318|529098263|FG003|Overall Study|Withdrawal by Subject|3|||
146706188|NCT01709318|529098264|FG004|Overall Study|Withdrawal by Subject|0|||
146706189|NCT01709318|529098265|FG005|Overall Study|Withdrawal by Subject|2|||
146706190|NCT01709318|529098266|FG006|Overall Study|Withdrawal by Subject|4|||
146706191|NCT01709318|529098260|FG000|Overall Study|Other Protocol Specified Criteria|0|||
146706192|NCT01709318|529098261|FG001|Overall Study|Other Protocol Specified Criteria|1|||
146706193|NCT01709318|529098262|FG002|Overall Study|Other Protocol Specified Criteria|0|||
146706194|NCT01709318|529098263|FG003|Overall Study|Other Protocol Specified Criteria|0|||
146706195|NCT01709318|529098264|FG004|Overall Study|Other Protocol Specified Criteria|0|||
146706196|NCT01709318|529098265|FG005|Overall Study|Other Protocol Specified Criteria|0|||
146706197|NCT01709318|529098266|FG006|Overall Study|Other Protocol Specified Criteria|0|||
146706198|NCT03370341|529098267|FG000|Overall Study|Lost to Follow-up|0|||
146706199|NCT03370341|529098268|FG001|Overall Study|Lost to Follow-up|1|||
146706200|NCT01707004|529098269|FG000|Overall Study|Physician Decision|3|||
146706201|NCT03085927|529098273|FG000|Overall Study|Withdrawal by Subject|1|||
146706202|NCT03085927|529098274|FG001|Overall Study|Withdrawal by Subject|4|||
146706203|NCT03085927|529098273|FG000|Overall Study|Lost to Follow-up|3|||
146706204|NCT03085927|529098274|FG001|Overall Study|Lost to Follow-up|1|||
146706205|NCT03085927|529098273|FG000|Overall Study|Death|1|||
146706206|NCT03085927|529098274|FG001|Overall Study|Death|0|||
146706207|NCT03085927|529098273|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
146706208|NCT03085927|529098274|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
146706209|NCT03085927|529098273|FG000|Overall Study|Dyad Became Ineligible|0|||
146706210|NCT03085927|529098274|FG001|Overall Study|Dyad Became Ineligible|1|||
146706211|NCT02573324|529098275|FG000|Overall Study|Withdrawal by Subject|26|||
146706212|NCT02573324|529098276|FG001|Overall Study|Withdrawal by Subject|23|||
146706213|NCT02573324|529098277|FG002|Overall Study|Withdrawal by Subject|3|||
146706214|NCT02573324|529098275|FG000|Overall Study|Lost to Follow-up|4|||
146706215|NCT02573324|529098276|FG001|Overall Study|Lost to Follow-up|5|||
146706216|NCT02573324|529098277|FG002|Overall Study|Lost to Follow-up|0|||
146706217|NCT02573324|529098275|FG000|Overall Study|Study Terminated by Sponsor|107|||
146706218|NCT02573324|529098276|FG001|Overall Study|Study Terminated by Sponsor|89|||
146706219|NCT02573324|529098277|FG002|Overall Study|Study Terminated by Sponsor|2|||
146706220|NCT02573324|529098275|FG000|Overall Study|Death|182|||
146706221|NCT02573324|529098276|FG001|Overall Study|Death|200|||
146706222|NCT02573324|529098277|FG002|Overall Study|Death|1|||
146706223|NCT02573324|529098275|FG000|Overall Study|Other, Not Specified|20|||
146706224|NCT02573324|529098276|FG001|Overall Study|Other, Not Specified|27|||
146706225|NCT02573324|529098277|FG002|Overall Study|Other, Not Specified|0|||
146706226|NCT02573324|529098275|FG000|Overall Study|Unknown Reason|2|||
146706227|NCT02573324|529098276|FG001|Overall Study|Unknown Reason|0|||
146706228|NCT02573324|529098277|FG002|Overall Study|Unknown Reason|0|||
146706229|NCT00600821|529098278|FG000|Overall Study|Death|45|||
146706230|NCT00600821|529098279|FG001|Overall Study|Death|46|||
146706231|NCT00600821|529098278|FG000|Overall Study|Lost to Follow-up|2|||
146706232|NCT00600821|529098279|FG001|Overall Study|Lost to Follow-up|2|||
146706233|NCT00600821|529098278|FG000|Overall Study|Withdrawal by Subject|1|||
146706234|NCT00600821|529098279|FG001|Overall Study|Withdrawal by Subject|1|||
146706235|NCT00600821|529098278|FG000|Overall Study|Terminated by sponsor|8|||
146706236|NCT00600821|529098279|FG001|Overall Study|Terminated by sponsor|6|||
146706237|NCT00600821|529098278|FG000|Overall Study|Objective progression or relapse|0|||
146706238|NCT00600821|529098279|FG001|Overall Study|Objective progression or relapse|1|||
146706239|NCT00600821|529098278|FG000|Overall Study|Randomized but not treated|0|||
146706240|NCT00600821|529098279|FG001|Overall Study|Randomized but not treated|1|||
146706241|NCT00600821|529098278|FG000|Overall Study|Other|2|||
146706242|NCT00600821|529098279|FG001|Overall Study|Other|3|||
146706243|NCT01607905|529098280|FG000|Overall Study|Withdrawal by participant|7|||
146706244|NCT01607905|529098281|FG001|Overall Study|Withdrawal by participant|2|||
146706245|NCT01607905|529098282|FG002|Overall Study|Withdrawal by participant|4|||
146706246|NCT01607905|529098283|FG003|Overall Study|Withdrawal by participant|6|||
146706247|NCT01607905|529098284|FG004|Overall Study|Withdrawal by participant|0|||
146706248|NCT01607905|529098285|FG005|Overall Study|Withdrawal by participant|4|||
146706249|NCT01607905|529098286|FG006|Overall Study|Withdrawal by participant|12|||
146706250|NCT01607905|529098280|FG000|Overall Study|Incidence or severity of AEs|5|||
146706251|NCT01607905|529098281|FG001|Overall Study|Incidence or severity of AEs|1|||
146706252|NCT01607905|529098282|FG002|Overall Study|Incidence or severity of AEs|1|||
146706253|NCT01607905|529098283|FG003|Overall Study|Incidence or severity of AEs|3|||
146706254|NCT01607905|529098284|FG004|Overall Study|Incidence or severity of AEs|0|||
146706255|NCT01607905|529098285|FG005|Overall Study|Incidence or severity of AEs|2|||
146706256|NCT01607905|529098286|FG006|Overall Study|Incidence or severity of AEs|8|||
146706257|NCT01607905|529098280|FG000|Overall Study|Disease progression|44|||
146706258|NCT01607905|529098281|FG001|Overall Study|Disease progression|16|||
146706259|NCT01607905|529098282|FG002|Overall Study|Disease progression|15|||
146706260|NCT01607905|529098283|FG003|Overall Study|Disease progression|11|||
146706261|NCT01607905|529098284|FG004|Overall Study|Disease progression|6|||
146706262|NCT01607905|529098285|FG005|Overall Study|Disease progression|7|||
146706263|NCT01607905|529098286|FG006|Overall Study|Disease progression|21|||
146706264|NCT01607905|529098280|FG000|Overall Study|Non-compliance with study procedures|0|||
146777227|NCT03930420|529353732|FG000|Overall Study|Withdrawal by Subject|7|||
146777228|NCT03930420|529353733|FG001|Overall Study|Withdrawal by Subject|9|||
146933752|NCT01106391|529915985|FG000|Overall Study|Death|12|||
146706265|NCT01607905|529098281|FG001|Overall Study|Non-compliance with study procedures|0|||
146706266|NCT01607905|529098282|FG002|Overall Study|Non-compliance with study procedures|0|||
146706267|NCT01607905|529098283|FG003|Overall Study|Non-compliance with study procedures|0|||
146706268|NCT01607905|529098284|FG004|Overall Study|Non-compliance with study procedures|0|||
146706269|NCT01607905|529098285|FG005|Overall Study|Non-compliance with study procedures|0|||
146706270|NCT01607905|529098286|FG006|Overall Study|Non-compliance with study procedures|1|||
146706271|NCT01607905|529098280|FG000|Overall Study|Death|1|||
146706272|NCT01607905|529098281|FG001|Overall Study|Death|1|||
146706273|NCT01607905|529098282|FG002|Overall Study|Death|1|||
146706274|NCT01607905|529098283|FG003|Overall Study|Death|1|||
146706275|NCT01607905|529098284|FG004|Overall Study|Death|0|||
146706276|NCT01607905|529098285|FG005|Overall Study|Death|0|||
146706277|NCT01607905|529098286|FG006|Overall Study|Death|3|||
146706278|NCT01607905|529098280|FG000|Overall Study|Other treatments become available|1|||
146706279|NCT01607905|529098281|FG001|Overall Study|Other treatments become available|0|||
146706280|NCT01607905|529098282|FG002|Overall Study|Other treatments become available|0|||
146706281|NCT01607905|529098283|FG003|Overall Study|Other treatments become available|0|||
146706282|NCT01607905|529098284|FG004|Overall Study|Other treatments become available|0|||
146706283|NCT01607905|529098285|FG005|Overall Study|Other treatments become available|0|||
146706284|NCT01607905|529098286|FG006|Overall Study|Other treatments become available|1|||
146706285|NCT01607905|529098280|FG000|Overall Study|Investigator discretion|0|||
146706286|NCT01607905|529098281|FG001|Overall Study|Investigator discretion|0|||
146706287|NCT01607905|529098282|FG002|Overall Study|Investigator discretion|0|||
146706288|NCT01607905|529098283|FG003|Overall Study|Investigator discretion|0|||
146706289|NCT01607905|529098284|FG004|Overall Study|Investigator discretion|0|||
146706290|NCT01607905|529098285|FG005|Overall Study|Investigator discretion|1|||
146706291|NCT01607905|529098286|FG006|Overall Study|Investigator discretion|0|||
146706292|NCT01607905|529098280|FG000|Overall Study|Other|1|||
146706293|NCT01607905|529098281|FG001|Overall Study|Other|0|||
146706294|NCT01607905|529098282|FG002|Overall Study|Other|0|||
146706295|NCT01607905|529098283|FG003|Overall Study|Other|0|||
146706296|NCT01607905|529098284|FG004|Overall Study|Other|0|||
146706297|NCT01607905|529098285|FG005|Overall Study|Other|0|||
146706298|NCT01607905|529098286|FG006|Overall Study|Other|1|||
146706299|NCT01607905|529098280|FG000|Overall Study|Randomized but not treated|1|||
146706300|NCT01607905|529098281|FG001|Overall Study|Randomized but not treated|0|||
146706301|NCT01607905|529098282|FG002|Overall Study|Randomized but not treated|0|||
146706302|NCT01607905|529098283|FG003|Overall Study|Randomized but not treated|0|||
146706303|NCT01607905|529098284|FG004|Overall Study|Randomized but not treated|1|||
146706304|NCT01607905|529098285|FG005|Overall Study|Randomized but not treated|1|||
146706305|NCT01607905|529098286|FG006|Overall Study|Randomized but not treated|0|||
146706306|NCT00912405|529098289|FG000|Overall Study|Lost to Follow-up|5|||
146706307|NCT00403455|529098290|FG000|Overall Study|Withdrawal by Subject|1|||
146706308|NCT03160703|529098291|FG000|Overall Study|Withdrawal by Subject|0|||
146706309|NCT03160703|529098292|FG001|Overall Study|Withdrawal by Subject|0|||
146706310|NCT03160703|529098293|FG002|Overall Study|Withdrawal by Subject|0|||
146706311|NCT03160703|529098294|FG003|Overall Study|Withdrawal by Subject|1|||
146706312|NCT00226941|529098301|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
146706313|NCT00226941|529098302|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
146706314|NCT00226941|529098303|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
146706315|NCT00226941|529098304|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
146706316|NCT00226941|529098301|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
146706317|NCT00226941|529098302|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
146706318|NCT00226941|529098303|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
146706319|NCT00226941|529098304|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
146706320|NCT01513291|529098305|FG000|Treatment Period|Adverse Event|8|||
146706321|NCT01513291|529098306|FG001|Treatment Period|Adverse Event|4|||
146706322|NCT01513291|529098307|FG002|Treatment Period|Adverse Event|0|||
146706323|NCT01513291|529098308|FG003|Treatment Period|Adverse Event|0|||
146706324|NCT01513291|529098309|FG004|Treatment Period|Adverse Event|0|||
146706325|NCT01513291|529098305|FG000|Treatment Period|Lack of Efficacy|3|||
146706326|NCT01513291|529098306|FG001|Treatment Period|Lack of Efficacy|0|||
146706327|NCT01513291|529098307|FG002|Treatment Period|Lack of Efficacy|0|||
146706328|NCT01513291|529098308|FG003|Treatment Period|Lack of Efficacy|0|||
146706329|NCT01513291|529098309|FG004|Treatment Period|Lack of Efficacy|0|||
146706330|NCT01513291|529098305|FG000|Treatment Period|Lost to Follow-up|2|||
146706331|NCT01513291|529098306|FG001|Treatment Period|Lost to Follow-up|3|||
146706332|NCT01513291|529098307|FG002|Treatment Period|Lost to Follow-up|0|||
146706333|NCT01513291|529098308|FG003|Treatment Period|Lost to Follow-up|0|||
146706334|NCT01513291|529098309|FG004|Treatment Period|Lost to Follow-up|0|||
146706335|NCT01513291|529098305|FG000|Treatment Period|Physician Decision|1|||
146706336|NCT01513291|529098306|FG001|Treatment Period|Physician Decision|0|||
146777229|NCT02538341|529353736|FG000|Overall Study|Lost to Follow-up|51|||
146706337|NCT01513291|529098307|FG002|Treatment Period|Physician Decision|0|||
146706338|NCT01513291|529098308|FG003|Treatment Period|Physician Decision|0|||
146706339|NCT01513291|529098309|FG004|Treatment Period|Physician Decision|0|||
146706340|NCT01513291|529098305|FG000|Treatment Period|Protocol Violation|1|||
146706341|NCT01513291|529098306|FG001|Treatment Period|Protocol Violation|2|||
146706342|NCT01513291|529098307|FG002|Treatment Period|Protocol Violation|0|||
146706343|NCT01513291|529098308|FG003|Treatment Period|Protocol Violation|0|||
146706344|NCT01513291|529098309|FG004|Treatment Period|Protocol Violation|0|||
146706345|NCT01513291|529098305|FG000|Treatment Period|Withdrawal by Subject|8|||
146706346|NCT01513291|529098306|FG001|Treatment Period|Withdrawal by Subject|5|||
146706347|NCT01513291|529098307|FG002|Treatment Period|Withdrawal by Subject|0|||
146706348|NCT01513291|529098308|FG003|Treatment Period|Withdrawal by Subject|0|||
146706349|NCT01513291|529098309|FG004|Treatment Period|Withdrawal by Subject|0|||
146706350|NCT01513291|529098305|FG000|Treatment Period|Randomized not treated|0|||
146706351|NCT01513291|529098306|FG001|Treatment Period|Randomized not treated|2|||
146706352|NCT01513291|529098307|FG002|Treatment Period|Randomized not treated|0|||
146706353|NCT01513291|529098308|FG003|Treatment Period|Randomized not treated|0|||
146706354|NCT01513291|529098309|FG004|Treatment Period|Randomized not treated|0|||
146706355|NCT01513291|529098305|FG000|Run-out Period|Lost to Follow-up|0|||
146706356|NCT01513291|529098306|FG001|Run-out Period|Lost to Follow-up|0|||
146706357|NCT01513291|529098307|FG002|Run-out Period|Lost to Follow-up|0|||
146706358|NCT01513291|529098308|FG003|Run-out Period|Lost to Follow-up|1|||
146706359|NCT01513291|529098309|FG004|Run-out Period|Lost to Follow-up|0|||
146706360|NCT01513291|529098305|FG000|Run-out Period|Withdrawal by Subject|0|||
146706361|NCT01513291|529098306|FG001|Run-out Period|Withdrawal by Subject|0|||
146706362|NCT01513291|529098307|FG002|Run-out Period|Withdrawal by Subject|0|||
146706363|NCT01513291|529098308|FG003|Run-out Period|Withdrawal by Subject|1|||
146706364|NCT01513291|529098309|FG004|Run-out Period|Withdrawal by Subject|0|||
146706365|NCT03732638|529098310|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
146706366|NCT03732638|529098311|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
146706367|NCT03732638|529098310|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
146706368|NCT03732638|529098311|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
146706369|NCT03732638|529098310|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
146706370|NCT03732638|529098311|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
146706371|NCT03732638|529098310|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
146706372|NCT03732638|529098311|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
146706373|NCT03732638|529098310|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
146706374|NCT03732638|529098311|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
146706375|NCT03732638|529098310|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
146706376|NCT03732638|529098311|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
146706377|NCT03732638|529098310|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
146706378|NCT03732638|529098311|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
146706379|NCT03732638|529098310|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
146706380|NCT03732638|529098311|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
146706381|NCT03732638|529098310|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
146706382|NCT03732638|529098311|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
146706383|NCT03732638|529098310|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
146706384|NCT03732638|529098311|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
146706385|NCT03732638|529098310|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
146706386|NCT03732638|529098311|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
146706387|NCT03732638|529098310|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
146706388|NCT03732638|529098311|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
146706389|NCT03732638|529098310|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
146706390|NCT03732638|529098311|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
146706391|NCT03732638|529098310|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
146706392|NCT03732638|529098311|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
146706393|NCT03732638|529098310|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
146706394|NCT03732638|529098311|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
146706395|NCT03732638|529098310|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
146706396|NCT03732638|529098311|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
146706397|NCT03732638|529098310|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
146706398|NCT03732638|529098311|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
146706399|NCT03732638|529098310|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
146706400|NCT03732638|529098311|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
146706401|NCT03732638|529098310|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
146706402|NCT03732638|529098311|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
146706403|NCT03732638|529098310|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
146706404|NCT03732638|529098311|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
146706405|NCT03732638|529098310|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
146706406|NCT03732638|529098311|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
146706407|NCT03732638|529098310|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
146706408|NCT03732638|529098311|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
146777230|NCT02538341|529353737|FG001|Overall Study|Lost to Follow-up|46|||
146777231|NCT02538341|529353736|FG000|Overall Study|Withdrawal by Subject|3|||
146777232|NCT02538341|529353737|FG001|Overall Study|Withdrawal by Subject|1|||
146777233|NCT02538341|529353736|FG000|Overall Study|Death|2|||
146777234|NCT02538341|529353737|FG001|Overall Study|Death|0|||
146777235|NCT00331136|529353738|FG000|Overall Study|Adverse Event|3|||
146777236|NCT00331136|529353739|FG001|Overall Study|Adverse Event|5|||
146777237|NCT00331136|529353740|FG002|Overall Study|Adverse Event|0|||
146777238|NCT00331136|529353741|FG003|Overall Study|Adverse Event|1|||
146777239|NCT00331136|529353738|FG000|Overall Study|Withdrawal by Subject|0|||
146777240|NCT00331136|529353739|FG001|Overall Study|Withdrawal by Subject|1|||
146777241|NCT00331136|529353740|FG002|Overall Study|Withdrawal by Subject|0|||
146777242|NCT00331136|529353741|FG003|Overall Study|Withdrawal by Subject|0|||
146777243|NCT00331136|529353738|FG000|Overall Study|Lost to Follow-up|0|||
146777244|NCT00331136|529353739|FG001|Overall Study|Lost to Follow-up|1|||
146777245|NCT00331136|529353740|FG002|Overall Study|Lost to Follow-up|0|||
146777246|NCT00331136|529353741|FG003|Overall Study|Lost to Follow-up|0|||
146777247|NCT00331136|529353738|FG000|Overall Study|Protocol Violation|1|||
146777248|NCT00331136|529353739|FG001|Overall Study|Protocol Violation|0|||
146777249|NCT00331136|529353740|FG002|Overall Study|Protocol Violation|0|||
146777250|NCT00331136|529353741|FG003|Overall Study|Protocol Violation|0|||
146777251|NCT00331136|529353738|FG000|Overall Study|Not treated|1|||
146777252|NCT00331136|529353739|FG001|Overall Study|Not treated|0|||
146777253|NCT00331136|529353740|FG002|Overall Study|Not treated|0|||
146777254|NCT00331136|529353741|FG003|Overall Study|Not treated|0|||
146777255|NCT00393484|529353747|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
146777256|NCT00393484|529353748|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
146777257|NCT00393484|529353747|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
146777258|NCT00393484|529353748|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
146777259|NCT00393484|529353747|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
146777260|NCT00393484|529353748|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
146777261|NCT00393484|529353747|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
146777262|NCT00393484|529353748|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
146777263|NCT00393484|529353747|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
146777264|NCT00393484|529353748|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
146777265|NCT00393484|529353747|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
146777266|NCT00393484|529353748|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
146777267|NCT00393484|529353747|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
146777268|NCT00393484|529353748|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
146777269|NCT00393484|529353747|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
146777270|NCT00393484|529353748|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
146777271|NCT00393484|529353747|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
146777272|NCT00393484|529353748|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
146777273|NCT00393484|529353747|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
146777274|NCT00393484|529353748|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
146777275|NCT00088413|529353754|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
146777276|NCT00088413|529353755|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
146777277|NCT00088413|529353756|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
146777278|NCT00088413|529353757|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
146777279|NCT00088413|529353754|FG000|Overall Study|Adverse Events/Side Effects|0|||
146777280|NCT00088413|529353755|FG001|Overall Study|Adverse Events/Side Effects|1|||
146777281|NCT00088413|529353756|FG002|Overall Study|Adverse Events/Side Effects|1|||
146777282|NCT00088413|529353757|FG003|Overall Study|Adverse Events/Side Effects|0|||
146777283|NCT00088413|529353754|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
146777284|NCT00088413|529353755|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
146777285|NCT00088413|529353756|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
146777286|NCT00088413|529353757|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
146777287|NCT00088413|529353754|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
146777288|NCT00088413|529353755|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
146777289|NCT00088413|529353756|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
146777290|NCT00088413|529353757|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
146777291|NCT00088413|529353754|FG000|Overall Study|Death|0|||
146777292|NCT00088413|529353755|FG001|Overall Study|Death|1|||
146777293|NCT00088413|529353756|FG002|Overall Study|Death|0|||
146777294|NCT00088413|529353757|FG003|Overall Study|Death|0|||
146777295|NCT00088413|529353754|FG000|Overall Study|Progressive disease|9|||
146777296|NCT00088413|529353755|FG001|Overall Study|Progressive disease|11|||
146777297|NCT00088413|529353756|FG002|Overall Study|Progressive disease|8|||
146777298|NCT00088413|529353757|FG003|Overall Study|Progressive disease|14|||
146777299|NCT00088413|529353754|FG000|Overall Study|Other|0|||
146777300|NCT00088413|529353755|FG001|Overall Study|Other|1|||
146777301|NCT00088413|529353756|FG002|Overall Study|Other|0|||
146777302|NCT00088413|529353757|FG003|Overall Study|Other|0|||
146777303|NCT00088413|529353754|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
146777304|NCT00088413|529353755|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
146777305|NCT00088413|529353756|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
146777306|NCT00088413|529353757|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
146777307|NCT05028582|529353761|FG000|Overall Study|Lost to Follow-up|11|||
146777308|NCT05028582|529353762|FG001|Overall Study|Lost to Follow-up|9|||
146777309|NCT05028582|529353761|FG000|Overall Study|Withdrawal by Subject|9|||
146777310|NCT05028582|529353762|FG001|Overall Study|Withdrawal by Subject|10|||
146777311|NCT05028582|529353761|FG000|Overall Study|Adverse Event|5|||
146777312|NCT05028582|529353762|FG001|Overall Study|Adverse Event|2|||
146777313|NCT05028582|529353761|FG000|Overall Study|Miscellaneous|3|||
146777314|NCT05028582|529353762|FG001|Overall Study|Miscellaneous|2|||
146777315|NCT05028582|529353761|FG000|Overall Study|Lack of Efficacy|3|||
146777316|NCT05028582|529353762|FG001|Overall Study|Lack of Efficacy|1|||
146777317|NCT05028582|529353761|FG000|Overall Study|Physician Decision|0|||
146777318|NCT05028582|529353762|FG001|Overall Study|Physician Decision|1|||
146777319|NCT04939246|529353763|FG000|After Treatment|Death|4|||
146777320|NCT04939246|529353763|FG000|After Treatment|Lost to Follow-up|1|||
146777321|NCT04939246|529353763|FG000|After Treatment|Discharged to hospice|2|||
146777322|NCT03398148|529355258|FG000|Substudy 1 Period 1|Adverse Event|5|||
146777323|NCT03398148|529355259|FG001|Substudy 1 Period 1|Adverse Event|2|||
146777324|NCT03398148|529355260|FG002|Substudy 1 Period 1|Adverse Event|2|||
146777325|NCT03398148|529355261|FG003|Substudy 1 Period 1|Adverse Event|0|||
146777326|NCT03398148|529355262|FG004|Substudy 1 Period 1|Adverse Event|8|||
146777327|NCT03398148|529355263|FG005|Substudy 1 Period 1|Adverse Event|0|||
146777328|NCT03398148|529355264|FG006|Substudy 1 Period 1|Adverse Event|0|||
146777329|NCT03398148|529355265|FG007|Substudy 1 Period 1|Adverse Event|0|||
146777330|NCT03398148|529355266|FG008|Substudy 1 Period 1|Adverse Event|0|||
146777331|NCT03398148|529355267|FG009|Substudy 1 Period 1|Adverse Event|0|||
146777332|NCT03398148|529355268|FG010|Substudy 1 Period 1|Adverse Event|0|||
146777333|NCT03398148|529355269|FG011|Substudy 1 Period 1|Adverse Event|0|||
146777334|NCT03398148|529355270|FG012|Substudy 1 Period 1|Adverse Event|0|||
146777335|NCT03398148|529355271|FG013|Substudy 1 Period 1|Adverse Event|0|||
146777336|NCT03398148|529355272|FG014|Substudy 1 Period 1|Adverse Event|0|||
146777337|NCT03398148|529355258|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
146777338|NCT03398148|529355259|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
146777339|NCT03398148|529355260|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146777340|NCT03398148|529355261|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
146777341|NCT03398148|529355262|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
146777342|NCT03398148|529355263|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146777343|NCT03398148|529355264|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146777344|NCT03398148|529355265|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146777345|NCT03398148|529355266|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146777346|NCT03398148|529355267|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146777347|NCT03398148|529355268|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146777348|NCT03398148|529355269|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146777349|NCT03398148|529355270|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146777350|NCT03398148|529355271|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146777351|NCT03398148|529355272|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146777352|NCT03398148|529355258|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
146777353|NCT03398148|529355259|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
146777354|NCT03398148|529355260|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
146777355|NCT03398148|529355261|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
146777356|NCT03398148|529355262|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
146777357|NCT03398148|529355263|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
146777358|NCT03398148|529355264|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
146777359|NCT03398148|529355265|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
146777360|NCT03398148|529355266|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
146777361|NCT03398148|529355267|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
146777362|NCT03398148|529355268|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
146777363|NCT03398148|529355269|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
146777364|NCT03398148|529355270|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
146777365|NCT03398148|529355271|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
146777366|NCT03398148|529355272|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
146777367|NCT03398148|529355258|FG000|Substudy 1 Period 1|Other|0|||
146777368|NCT03398148|529355259|FG001|Substudy 1 Period 1|Other|1|||
146933753|NCT01106391|529915985|FG000|Overall Study|Withdrawal by Subject|7|||
146933754|NCT00150345|529915986|FG000|Overall Study|Death|5|||
146777369|NCT03398148|529355260|FG002|Substudy 1 Period 1|Other|0|||
146777370|NCT03398148|529355261|FG003|Substudy 1 Period 1|Other|0|||
146777371|NCT03398148|529355262|FG004|Substudy 1 Period 1|Other|3|||
146777372|NCT03398148|529355263|FG005|Substudy 1 Period 1|Other|0|||
146777373|NCT03398148|529355264|FG006|Substudy 1 Period 1|Other|0|||
146777374|NCT03398148|529355265|FG007|Substudy 1 Period 1|Other|0|||
146777375|NCT03398148|529355266|FG008|Substudy 1 Period 1|Other|0|||
146777376|NCT03398148|529355267|FG009|Substudy 1 Period 1|Other|0|||
146777377|NCT03398148|529355268|FG010|Substudy 1 Period 1|Other|0|||
146777378|NCT03398148|529355269|FG011|Substudy 1 Period 1|Other|0|||
146777379|NCT03398148|529355270|FG012|Substudy 1 Period 1|Other|0|||
146706409|NCT03732638|529098310|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
146706410|NCT03732638|529098311|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
146706411|NCT03732638|529098310|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
146706412|NCT03732638|529098311|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
146706413|NCT01358981|529098312|FG000|Period 1|Withdrawal by Subject|0|||
146706414|NCT01358981|529098313|FG001|Period 1|Withdrawal by Subject|0|||
146706415|NCT01358981|529098314|FG002|Period 1|Withdrawal by Subject|0|||
146706416|NCT01358981|529098315|FG003|Period 1|Withdrawal by Subject|1|||
146706417|NCT01358981|529098316|FG004|Period 1|Withdrawal by Subject|0|||
146706418|NCT01358981|529098317|FG005|Period 1|Withdrawal by Subject|0|||
146706419|NCT01358981|529098318|FG006|Period 1|Withdrawal by Subject|0|||
146706420|NCT03728582|529098319|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
146706421|NCT03728582|529098320|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
146706422|NCT03728582|529098319|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
146706423|NCT03728582|529098320|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
146706424|NCT02738775|529098321|FG000|Overall Study|Withdrawal by Subject|0|||
146706425|NCT02738775|529098322|FG001|Overall Study|Withdrawal by Subject|1|||
146706426|NCT02738775|529098323|FG002|Overall Study|Withdrawal by Subject|0|||
146706427|NCT02738775|529098324|FG003|Overall Study|Withdrawal by Subject|0|||
146706428|NCT02738775|529098325|FG004|Overall Study|Withdrawal by Subject|0|||
146706429|NCT02738775|529098326|FG005|Overall Study|Withdrawal by Subject|0|||
146706430|NCT02738775|529098321|FG000|Overall Study|Adverse Event|0|||
146706431|NCT02738775|529098322|FG001|Overall Study|Adverse Event|0|||
146706432|NCT02738775|529098323|FG002|Overall Study|Adverse Event|0|||
146706433|NCT02738775|529098324|FG003|Overall Study|Adverse Event|1|||
146706434|NCT02738775|529098325|FG004|Overall Study|Adverse Event|0|||
146706435|NCT02738775|529098326|FG005|Overall Study|Adverse Event|0|||
146706436|NCT02738775|529098321|FG000|Overall Study|Pregnancy|0|||
146706437|NCT02738775|529098322|FG001|Overall Study|Pregnancy|1|||
146706438|NCT02738775|529098323|FG002|Overall Study|Pregnancy|0|||
146706439|NCT02738775|529098324|FG003|Overall Study|Pregnancy|0|||
146706440|NCT02738775|529098325|FG004|Overall Study|Pregnancy|0|||
146706441|NCT02738775|529098326|FG005|Overall Study|Pregnancy|0|||
146706442|NCT02738775|529098321|FG000|Overall Study|Missing|0|||
146706443|NCT02738775|529098322|FG001|Overall Study|Missing|0|||
146706444|NCT02738775|529098323|FG002|Overall Study|Missing|0|||
146706445|NCT02738775|529098324|FG003|Overall Study|Missing|0|||
146706446|NCT02738775|529098325|FG004|Overall Study|Missing|0|||
146706447|NCT02738775|529098326|FG005|Overall Study|Missing|1|||
146706448|NCT01785524|529098327|FG000|Overall Study|Withdrawal by Subject|2|||
146706449|NCT01785524|529098328|FG001|Overall Study|Withdrawal by Subject|2|||
146706450|NCT01060384|529098329|FG000|Overall Study|Withdrawal by Subject|0|||
146706451|NCT01060384|529098330|FG001|Overall Study|Withdrawal by Subject|1|||
146706452|NCT01060384|529098331|FG002|Overall Study|Withdrawal by Subject|0|||
146706453|NCT01060384|529098332|FG003|Overall Study|Withdrawal by Subject|0|||
146706454|NCT01060384|529098333|FG004|Overall Study|Withdrawal by Subject|0|||
146706455|NCT01060384|529098329|FG000|Overall Study|Death|0|||
146706456|NCT01060384|529098330|FG001|Overall Study|Death|0|||
146706457|NCT01060384|529098331|FG002|Overall Study|Death|0|||
146706458|NCT01060384|529098332|FG003|Overall Study|Death|0|||
146706459|NCT01060384|529098333|FG004|Overall Study|Death|1|||
146706460|NCT01060384|529098329|FG000|Overall Study|Intercurrent illness|0|||
146706461|NCT01060384|529098330|FG001|Overall Study|Intercurrent illness|0|||
146706462|NCT01060384|529098331|FG002|Overall Study|Intercurrent illness|0|||
146706463|NCT01060384|529098332|FG003|Overall Study|Intercurrent illness|0|||
146706464|NCT01060384|529098333|FG004|Overall Study|Intercurrent illness|1|||
146706465|NCT00812929|529098336|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
146706466|NCT00812929|529098337|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
146706467|NCT00812929|529098338|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
146706468|NCT00812929|529098339|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
146706469|NCT00812929|529098340|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
146706470|NCT00812929|529098341|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
146706471|NCT00812929|529098342|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
146706472|NCT00812929|529098343|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
146706473|NCT00812929|529098344|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
146706474|NCT00812929|529098345|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
146706475|NCT00812929|529098336|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
146706476|NCT00812929|529098337|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
146706477|NCT00812929|529098338|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
146706478|NCT00812929|529098339|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
146706479|NCT00812929|529098340|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
146706480|NCT00812929|529098341|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
146706481|NCT00812929|529098342|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
146706482|NCT00812929|529098343|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
146706483|NCT00812929|529098344|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
146706484|NCT00812929|529098345|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
146777380|NCT03398148|529355271|FG013|Substudy 1 Period 1|Other|0|||
146777381|NCT03398148|529355272|FG014|Substudy 1 Period 1|Other|0|||
146777382|NCT03398148|529355258|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
146777383|NCT03398148|529355259|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
146777384|NCT03398148|529355260|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
146706485|NCT00812929|529098336|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
146706486|NCT00812929|529098337|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
146706487|NCT00812929|529098338|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
146706488|NCT00812929|529098339|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
146706489|NCT00812929|529098340|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
146706490|NCT00812929|529098341|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
146706491|NCT00812929|529098342|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
146706492|NCT00812929|529098343|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
146706493|NCT00812929|529098344|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
146706494|NCT00812929|529098345|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
146706495|NCT00678691|529098352|FG000|Overall Study|Adverse Event|6|||
146706496|NCT00678691|529098353|FG001|Overall Study|Adverse Event|4|||
146706497|NCT01859715|529098365|FG000|Overall Study|No 2nd VAS|16|||
146706498|NCT01859715|529098366|FG001|Overall Study|No 2nd VAS|8|||
146706499|NCT01859715|529098367|FG002|Overall Study|No 2nd VAS|23|||
146706500|NCT04936685|529098368|FG000|Overall Study|Protocol Violation|1|||
146706501|NCT04936685|529098369|FG001|Overall Study|Protocol Violation|0|||
146706502|NCT04542070|529098372|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
146706503|NCT04542070|529098373|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
146706504|NCT04542070|529098374|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
146706505|NCT04542070|529098375|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
146706506|NCT04542070|529098372|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
146706507|NCT04542070|529098373|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
146706508|NCT04542070|529098374|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
146706509|NCT04542070|529098375|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
146706510|NCT04542070|529098372|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
146706511|NCT04542070|529098373|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
146706512|NCT04542070|529098374|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
146706513|NCT04542070|529098375|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
146706514|NCT04542070|529098372|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
146706515|NCT04542070|529098373|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
146706516|NCT04542070|529098374|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
146706517|NCT04542070|529098375|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
146706518|NCT04542070|529098372|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
146706519|NCT04542070|529098373|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
146706520|NCT04542070|529098374|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
146706521|NCT04542070|529098375|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
146706522|NCT04542070|529098372|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
146706523|NCT04542070|529098373|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
146706524|NCT04542070|529098374|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
146706525|NCT04542070|529098375|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
146706526|NCT04542070|529098372|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
146706527|NCT04542070|529098373|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
146706528|NCT04542070|529098374|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
146706529|NCT04542070|529098375|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
146706530|NCT04542070|529098372|FG000|Maintenance + Extension Period|Adverse Event|10|||
146706531|NCT04542070|529098373|FG001|Maintenance + Extension Period|Adverse Event|2|||
146706532|NCT04542070|529098374|FG002|Maintenance + Extension Period|Adverse Event|0|||
146706533|NCT04542070|529098375|FG003|Maintenance + Extension Period|Adverse Event|0|||
146706534|NCT04542070|529098372|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
146706535|NCT04542070|529098373|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
146706536|NCT04542070|529098374|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
146706537|NCT04542070|529098375|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
146777385|NCT03398148|529355261|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
146777386|NCT03398148|529355262|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
146777387|NCT03398148|529355263|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
146777388|NCT03398148|529355264|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
146933755|NCT00150345|529915987|FG001|Overall Study|Death|2|||
146933756|NCT00150345|529915986|FG000|Overall Study|Adverse Event|8|||
146933757|NCT00150345|529915987|FG001|Overall Study|Adverse Event|6|||
146933758|NCT00150345|529915986|FG000|Overall Study|Lack of Efficacy|5|||
146933759|NCT00150345|529915987|FG001|Overall Study|Lack of Efficacy|4|||
146706538|NCT04542070|529098372|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
146706539|NCT04542070|529098373|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
146777389|NCT03398148|529355265|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
146777390|NCT03398148|529355266|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
146777391|NCT03398148|529355267|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
146777392|NCT03398148|529355268|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
146777393|NCT03398148|529355269|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
146777394|NCT03398148|529355270|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
146777395|NCT03398148|529355271|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
146706540|NCT04542070|529098374|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
146706541|NCT04542070|529098375|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
146706542|NCT04542070|529098372|FG000|Maintenance + Extension Period|Physician Decision|1|||
146706543|NCT04542070|529098373|FG001|Maintenance + Extension Period|Physician Decision|1|||
146706544|NCT04542070|529098374|FG002|Maintenance + Extension Period|Physician Decision|0|||
146706545|NCT04542070|529098375|FG003|Maintenance + Extension Period|Physician Decision|0|||
146706546|NCT04542070|529098372|FG000|Maintenance + Extension Period|Protocol Violation|2|||
146706547|NCT04542070|529098373|FG001|Maintenance + Extension Period|Protocol Violation|5|||
146706548|NCT04542070|529098374|FG002|Maintenance + Extension Period|Protocol Violation|0|||
146706549|NCT04542070|529098375|FG003|Maintenance + Extension Period|Protocol Violation|0|||
146706550|NCT04542070|529098372|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
146706551|NCT04542070|529098373|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
146706552|NCT04542070|529098374|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
146706553|NCT04542070|529098375|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
146706554|NCT04542070|529098372|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
146706555|NCT04542070|529098373|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
146706556|NCT04542070|529098374|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
146706557|NCT04542070|529098375|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
146706558|NCT04542070|529098372|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
146706559|NCT04542070|529098373|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
146706560|NCT04542070|529098374|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
146706561|NCT04542070|529098375|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
146706562|NCT04542070|529098372|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
146706563|NCT04542070|529098373|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
146706564|NCT04542070|529098374|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
146706565|NCT04542070|529098375|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
146706566|NCT04542070|529098372|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
146706567|NCT04542070|529098373|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
146706568|NCT04542070|529098374|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
146706569|NCT04542070|529098375|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
146706570|NCT04542070|529098372|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
146706571|NCT04542070|529098373|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
146706572|NCT04542070|529098374|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
146777396|NCT03398148|529355272|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
146777397|NCT03398148|529355258|FG000|Substudy 1 Period 2|Adverse Event|0|||
146777398|NCT03398148|529355259|FG001|Substudy 1 Period 2|Adverse Event|0|||
146777399|NCT03398148|529355260|FG002|Substudy 1 Period 2|Adverse Event|0|||
146777400|NCT03398148|529355261|FG003|Substudy 1 Period 2|Adverse Event|0|||
146777401|NCT03398148|529355262|FG004|Substudy 1 Period 2|Adverse Event|0|||
146777402|NCT03398148|529355263|FG005|Substudy 1 Period 2|Adverse Event|2|||
146777403|NCT03398148|529355264|FG006|Substudy 1 Period 2|Adverse Event|4|||
146777404|NCT03398148|529355265|FG007|Substudy 1 Period 2|Adverse Event|0|||
146777405|NCT03398148|529355266|FG008|Substudy 1 Period 2|Adverse Event|0|||
146777406|NCT03398148|529355267|FG009|Substudy 1 Period 2|Adverse Event|0|||
146777407|NCT03398148|529355268|FG010|Substudy 1 Period 2|Adverse Event|0|||
146777408|NCT03398148|529355269|FG011|Substudy 1 Period 2|Adverse Event|0|||
146777409|NCT03398148|529355270|FG012|Substudy 1 Period 2|Adverse Event|0|||
146777410|NCT03398148|529355271|FG013|Substudy 1 Period 2|Adverse Event|0|||
146777411|NCT03398148|529355272|FG014|Substudy 1 Period 2|Adverse Event|0|||
146777412|NCT03398148|529355258|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146777413|NCT03398148|529355259|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146777414|NCT03398148|529355260|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146777415|NCT03398148|529355261|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146777416|NCT03398148|529355262|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146777417|NCT03398148|529355263|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146777418|NCT03398148|529355264|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
146777419|NCT03398148|529355265|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
146777420|NCT03398148|529355266|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146777421|NCT03398148|529355267|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146777422|NCT03398148|529355268|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146777423|NCT03398148|529355269|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146777424|NCT03398148|529355270|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146777425|NCT03398148|529355271|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146848430|NCT03122223|529615681|FG002|Overall Study|Lost to Follow-up|2|||
146848431|NCT03122223|529615682|FG003|Overall Study|Lost to Follow-up|0|||
146777426|NCT03398148|529355272|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146777427|NCT03398148|529355258|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
146777428|NCT03398148|529355259|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
146777429|NCT03398148|529355260|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
146777430|NCT03398148|529355261|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
146777431|NCT03398148|529355262|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
146777432|NCT03398148|529355263|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
146777433|NCT03398148|529355264|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
146777434|NCT03398148|529355265|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
146777435|NCT03398148|529355266|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
146777436|NCT03398148|529355267|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
146777437|NCT03398148|529355268|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
146777438|NCT03398148|529355269|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
146777439|NCT03398148|529355270|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
146777440|NCT03398148|529355271|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
146777441|NCT03398148|529355272|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
146777442|NCT03398148|529355258|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777443|NCT03398148|529355259|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777444|NCT03398148|529355260|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777445|NCT03398148|529355261|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777446|NCT03398148|529355262|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777447|NCT03398148|529355263|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777448|NCT03398148|529355264|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
146777449|NCT03398148|529355265|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777450|NCT03398148|529355266|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777451|NCT03398148|529355267|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777452|NCT03398148|529355268|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777453|NCT03398148|529355269|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777454|NCT03398148|529355270|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777455|NCT03398148|529355271|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777456|NCT03398148|529355272|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777457|NCT03398148|529355258|FG000|Substudy 1 Period 2|Other|0|||
146777458|NCT03398148|529355259|FG001|Substudy 1 Period 2|Other|0|||
146777459|NCT03398148|529355260|FG002|Substudy 1 Period 2|Other|0|||
146777460|NCT03398148|529355261|FG003|Substudy 1 Period 2|Other|0|||
146777461|NCT03398148|529355262|FG004|Substudy 1 Period 2|Other|0|||
146777462|NCT03398148|529355263|FG005|Substudy 1 Period 2|Other|0|||
146777463|NCT03398148|529355264|FG006|Substudy 1 Period 2|Other|1|||
146777464|NCT03398148|529355265|FG007|Substudy 1 Period 2|Other|0|||
146777465|NCT03398148|529355266|FG008|Substudy 1 Period 2|Other|0|||
146777466|NCT03398148|529355267|FG009|Substudy 1 Period 2|Other|0|||
146777467|NCT03398148|529355268|FG010|Substudy 1 Period 2|Other|0|||
146777468|NCT03398148|529355269|FG011|Substudy 1 Period 2|Other|0|||
146706573|NCT04542070|529098375|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
146706574|NCT04542070|529098372|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
146706575|NCT04542070|529098373|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
146706576|NCT04542070|529098374|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
146706577|NCT04542070|529098375|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
146706578|NCT03049813|529098378|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
146706579|NCT03049813|529098379|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
146706580|NCT03049813|529098380|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
146706581|NCT03049813|529098381|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
146706582|NCT03049813|529098378|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
146706583|NCT03049813|529098379|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
146706584|NCT03049813|529098380|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
146706585|NCT03049813|529098381|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
146706586|NCT03049813|529098378|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
146706587|NCT03049813|529098379|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
146706588|NCT03049813|529098380|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
146706589|NCT03049813|529098381|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
146777469|NCT03398148|529355270|FG012|Substudy 1 Period 2|Other|0|||
146777470|NCT03398148|529355271|FG013|Substudy 1 Period 2|Other|0|||
146777471|NCT03398148|529355272|FG014|Substudy 1 Period 2|Other|0|||
146777472|NCT03398148|529355258|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
146777473|NCT03398148|529355259|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
146777474|NCT03398148|529355260|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
146777475|NCT03398148|529355261|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
146777476|NCT03398148|529355262|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
146777477|NCT03398148|529355263|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
146933760|NCT00150345|529915986|FG000|Overall Study|Withdrawal by Subject|3|||
146933761|NCT00150345|529915987|FG001|Overall Study|Withdrawal by Subject|4|||
146706590|NCT03049813|529098378|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
146706591|NCT03049813|529098379|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
146706592|NCT03049813|529098380|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
146706593|NCT03049813|529098381|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
146706594|NCT01813019|529098382|FG000|Overall Study|Adverse Event|0|||
146706595|NCT01813019|529098383|FG001|Overall Study|Adverse Event|3|||
146706596|NCT01813019|529098382|FG000|Overall Study|Withdrawal by Subject|3|||
146706597|NCT01813019|529098383|FG001|Overall Study|Withdrawal by Subject|2|||
146706598|NCT01813019|529098382|FG000|Overall Study|administrative problems|2|||
146706599|NCT01813019|529098383|FG001|Overall Study|administrative problems|0|||
146706600|NCT01813019|529098382|FG000|Overall Study|Protocol Deviation|2|||
146706601|NCT01813019|529098383|FG001|Overall Study|Protocol Deviation|1|||
146706602|NCT01193556|529098389|FG000|Overall Study|Study termination|26|||
146706603|NCT01193556|529098390|FG001|Overall Study|Study termination|25|||
146706604|NCT01696032|529098392|FG000|Overall Study|Withdrawal by Subject|0|||
146706605|NCT01696032|529098393|FG001|Overall Study|Withdrawal by Subject|0|||
146706606|NCT01696032|529098394|FG002|Overall Study|Withdrawal by Subject|1|||
146706607|NCT01696032|529098395|FG003|Overall Study|Withdrawal by Subject|2|||
146706608|NCT01696032|529098392|FG000|Overall Study|Death|14|||
146706609|NCT01696032|529098393|FG001|Overall Study|Death|4|||
146706610|NCT01696032|529098394|FG002|Overall Study|Death|43|||
146706611|NCT01696032|529098395|FG003|Overall Study|Death|18|||
146706612|NCT01696032|529098392|FG000|Overall Study|Lost to Follow-up|0|||
146706613|NCT01696032|529098393|FG001|Overall Study|Lost to Follow-up|1|||
146706614|NCT01696032|529098394|FG002|Overall Study|Lost to Follow-up|0|||
146706615|NCT01696032|529098395|FG003|Overall Study|Lost to Follow-up|0|||
146706616|NCT01696032|529098392|FG000|Overall Study|Database lock|0|||
146706617|NCT01696032|529098393|FG001|Overall Study|Database lock|1|||
146706618|NCT01696032|529098394|FG002|Overall Study|Database lock|7|||
146706619|NCT01696032|529098395|FG003|Overall Study|Database lock|2|||
146706620|NCT03025828|529098398|FG000|Overall Study|Lost to Follow-up|1|||
146706621|NCT02203591|529098399|FG000|Overall Study|Did not meet treatment day baseline|147|||
146706622|NCT02203591|529098400|FG001|Overall Study|Did not meet treatment day baseline|141|||
146706623|NCT02203591|529098401|FG002|Overall Study|Did not meet treatment day baseline|150|||
146706624|NCT02203591|529098402|FG003|Overall Study|Did not meet treatment day baseline|45|||
146706625|NCT02203591|529098403|FG004|Overall Study|Did not meet treatment day baseline|33|||
146706626|NCT02203591|529098404|FG005|Overall Study|Did not meet treatment day baseline|35|||
146706627|NCT02203591|529098405|FG006|Overall Study|Did not meet treatment day baseline|29|||
146706628|NCT02203591|529098406|FG007|Overall Study|Did not meet treatment day baseline|12|||
146706629|NCT02203591|529098399|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
146706630|NCT02203591|529098400|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
146706631|NCT02203591|529098401|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
146706632|NCT02203591|529098402|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
146706633|NCT02203591|529098403|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
146706634|NCT02203591|529098404|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
146706635|NCT02203591|529098405|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
146706636|NCT02203591|529098406|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
146706637|NCT03306264|529098409|FG000|Overall Study|Death|33|||
146706638|NCT03306264|529098410|FG001|Overall Study|Death|25|||
146706639|NCT03306264|529098411|FG002|Overall Study|Death|34|||
146706640|NCT03306264|529098412|FG003|Overall Study|Death|34|||
146706641|NCT03306264|529098409|FG000|Overall Study|Complete Consent Withdrawal|4|||
146706642|NCT03306264|529098410|FG001|Overall Study|Complete Consent Withdrawal|4|||
146706643|NCT03306264|529098411|FG002|Overall Study|Complete Consent Withdrawal|1|||
146706644|NCT03306264|529098412|FG003|Overall Study|Complete Consent Withdrawal|8|||
146706645|NCT03306264|529098409|FG000|Overall Study|Lost to Follow-up|1|||
146706646|NCT03306264|529098410|FG001|Overall Study|Lost to Follow-up|0|||
146706647|NCT03306264|529098411|FG002|Overall Study|Lost to Follow-up|1|||
146706648|NCT03306264|529098412|FG003|Overall Study|Lost to Follow-up|0|||
146706649|NCT03306264|529098409|FG000|Overall Study|Rollover to ASTX727-06|10|||
146706650|NCT03306264|529098410|FG001|Overall Study|Rollover to ASTX727-06|18|||
146706651|NCT03306264|529098411|FG002|Overall Study|Rollover to ASTX727-06|4|||
146706652|NCT03306264|529098412|FG003|Overall Study|Rollover to ASTX727-06|2|||
146706653|NCT03306264|529098409|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
146706654|NCT03306264|529098410|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
146706655|NCT03306264|529098411|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
146706656|NCT03306264|529098412|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
146706657|NCT00806546|529098429|FG000|Overall Study|Enrolled, not treated|35|||
146706658|NCT00806546|529098429|FG000|Overall Study|Lost to Follow-up|32|||
146706659|NCT00806546|529098429|FG000|Overall Study|Adverse Event|74|||
146706660|NCT00806546|529098429|FG000|Overall Study|Withdrawal by Subject|75|||
146706661|NCT00806546|529098429|FG000|Overall Study|Protocol Violation|49|||
146706662|NCT00806546|529098429|FG000|Overall Study|Various|42|||
146706663|NCT01466192|529098434|FG000|Overall Study|Physician Decision|1|||
146706664|NCT01466192|529098434|FG000|Overall Study|Withdrawal by Subject|3|||
146706665|NCT04524403|529100095|FG000|Overall Study|Withdrawal by Subject|10|||
146706666|NCT04524403|529100096|FG001|Overall Study|Withdrawal by Subject|3|||
146706667|NCT04524403|529100097|FG002|Overall Study|Withdrawal by Subject|8|||
146706668|NCT04524403|529100095|FG000|Overall Study|Lost to Follow-up|3|||
146706669|NCT04524403|529100096|FG001|Overall Study|Lost to Follow-up|4|||
146706670|NCT04524403|529100097|FG002|Overall Study|Lost to Follow-up|3|||
146706671|NCT04524403|529100095|FG000|Overall Study|Adverse Event|3|||
146706672|NCT04524403|529100096|FG001|Overall Study|Adverse Event|1|||
146706673|NCT04524403|529100097|FG002|Overall Study|Adverse Event|4|||
146706674|NCT04524403|529100095|FG000|Overall Study|Non-compliant with study drug|1|||
146706675|NCT04524403|529100096|FG001|Overall Study|Non-compliant with study drug|2|||
146706676|NCT04524403|529100097|FG002|Overall Study|Non-compliant with study drug|3|||
146706677|NCT04524403|529100095|FG000|Overall Study|Moved|0|||
146706678|NCT04524403|529100096|FG001|Overall Study|Moved|1|||
146706679|NCT04524403|529100097|FG002|Overall Study|Moved|0|||
146706680|NCT02383758|529100098|FG000|Overall Study|Withdrawal by Subject|0|||
146706681|NCT02383758|529100099|FG001|Overall Study|Withdrawal by Subject|2|||
146706682|NCT00646958|529100102|FG000|Overall Study|Lack of Efficacy|1|||
146706683|NCT00646958|529100103|FG001|Overall Study|Lack of Efficacy|0|||
146706684|NCT00646958|529100104|FG002|Overall Study|Lack of Efficacy|0|||
146706685|NCT00646958|529100102|FG000|Overall Study|Adverse Event|4|||
146706686|NCT00646958|529100103|FG001|Overall Study|Adverse Event|0|||
146706687|NCT00646958|529100104|FG002|Overall Study|Adverse Event|0|||
146706688|NCT00646958|529100102|FG000|Overall Study|Lost to Follow-up|1|||
146706689|NCT00646958|529100103|FG001|Overall Study|Lost to Follow-up|5|||
146706690|NCT00646958|529100104|FG002|Overall Study|Lost to Follow-up|7|||
146706691|NCT00646958|529100102|FG000|Overall Study|Protocol Violation|1|||
146706692|NCT00646958|529100103|FG001|Overall Study|Protocol Violation|1|||
146706693|NCT00646958|529100104|FG002|Overall Study|Protocol Violation|0|||
146706694|NCT00646958|529100102|FG000|Overall Study|Abnormal screening lab tests|1|||
146706695|NCT00646958|529100103|FG001|Overall Study|Abnormal screening lab tests|1|||
146706696|NCT00646958|529100104|FG002|Overall Study|Abnormal screening lab tests|0|||
146706697|NCT00646958|529100102|FG000|Overall Study|Withdrawal by Subject|1|||
146706698|NCT00646958|529100103|FG001|Overall Study|Withdrawal by Subject|2|||
146706699|NCT00646958|529100104|FG002|Overall Study|Withdrawal by Subject|0|||
146706700|NCT00646958|529100102|FG000|Overall Study|Did not receive study drug|2|||
146706701|NCT00646958|529100103|FG001|Overall Study|Did not receive study drug|0|||
146706702|NCT00646958|529100104|FG002|Overall Study|Did not receive study drug|2|||
146706703|NCT02602288|529100105|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
146706704|NCT02602288|529100106|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
146706705|NCT02602288|529100105|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
146706706|NCT02602288|529100106|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
146706707|NCT02602288|529100105|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
146777478|NCT03398148|529355264|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
146777479|NCT03398148|529355265|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
146777480|NCT03398148|529355266|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
146777481|NCT03398148|529355267|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
146777482|NCT03398148|529355268|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
146777483|NCT03398148|529355269|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
146777484|NCT03398148|529355270|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
146777485|NCT03398148|529355271|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
146777486|NCT03398148|529355272|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
146777487|NCT03398148|529355258|FG000|Substudy 2 Period 1|Adverse Event|0|||
146777488|NCT03398148|529355259|FG001|Substudy 2 Period 1|Adverse Event|0|||
146777489|NCT03398148|529355260|FG002|Substudy 2 Period 1|Adverse Event|0|||
146777490|NCT03398148|529355261|FG003|Substudy 2 Period 1|Adverse Event|0|||
146777491|NCT03398148|529355262|FG004|Substudy 2 Period 1|Adverse Event|0|||
146777492|NCT03398148|529355263|FG005|Substudy 2 Period 1|Adverse Event|0|||
146777493|NCT03398148|529355264|FG006|Substudy 2 Period 1|Adverse Event|0|||
146777494|NCT03398148|529355265|FG007|Substudy 2 Period 1|Adverse Event|0|||
146777495|NCT03398148|529355266|FG008|Substudy 2 Period 1|Adverse Event|0|||
146777496|NCT03398148|529355267|FG009|Substudy 2 Period 1|Adverse Event|12|||
146777497|NCT03398148|529355268|FG010|Substudy 2 Period 1|Adverse Event|2|||
146933762|NCT00150345|529915986|FG000|Overall Study|Laboratory abnormality|1|||
146933763|NCT00150345|529915987|FG001|Overall Study|Laboratory abnormality|2|||
146706708|NCT02602288|529100106|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
146706709|NCT02602288|529100105|FG000|12 Month Follow-up|Lost to Follow-up|0|||
146706710|NCT02602288|529100106|FG001|12 Month Follow-up|Lost to Follow-up|4|||
146706711|NCT02602288|529100105|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
146777498|NCT03398148|529355269|FG011|Substudy 2 Period 1|Adverse Event|0|||
146777499|NCT03398148|529355270|FG012|Substudy 2 Period 1|Adverse Event|0|||
146777500|NCT03398148|529355271|FG013|Substudy 2 Period 1|Adverse Event|0|||
146777501|NCT03398148|529355272|FG014|Substudy 2 Period 1|Adverse Event|0|||
146777502|NCT03398148|529355258|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146777503|NCT03398148|529355259|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146933764|NCT00150345|529915986|FG000|Overall Study|Other|12|||
146706712|NCT02602288|529100106|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
146706713|NCT00194012|529100107|FG000|Randomized Phase|Lack of Efficacy|8|||
146706714|NCT00194012|529100108|FG001|Randomized Phase|Lack of Efficacy|18|||
146706715|NCT00194012|529100107|FG000|Randomized Phase|Study nonadherence|2|||
146706716|NCT00194012|529100108|FG001|Randomized Phase|Study nonadherence|1|||
146706717|NCT00194012|529100107|FG000|Randomized Phase|Withdrawal by Subject|3|||
146706718|NCT00194012|529100108|FG001|Randomized Phase|Withdrawal by Subject|3|||
146706719|NCT00194012|529100107|FG000|Randomized Phase|Adverse Event|2|||
146706720|NCT00194012|529100108|FG001|Randomized Phase|Adverse Event|1|||
146706721|NCT00194012|529100107|FG000|Randomized Phase|Participant reported having a rash|1|||
146706722|NCT00194012|529100108|FG001|Randomized Phase|Participant reported having a rash|0|||
146706723|NCT00194012|529100107|FG000|Randomized Phase|Emesis and enuresis|0|||
146706724|NCT00194012|529100108|FG001|Randomized Phase|Emesis and enuresis|1|||
146706725|NCT00194012|529100107|FG000|Randomized Phase|Oral/nasal twitching|0|||
146706726|NCT00194012|529100108|FG001|Randomized Phase|Oral/nasal twitching|1|||
146706727|NCT00194012|529100107|FG000|Open Label Extension (OLE)|Weight Gain|1|||
146706728|NCT00194012|529100108|FG001|Open Label Extension (OLE)|Weight Gain|0|||
146706729|NCT00194012|529100107|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
146706730|NCT00194012|529100108|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
146706731|NCT00194012|529100107|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
146706732|NCT00194012|529100108|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
146706733|NCT00194012|529100107|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
146706734|NCT00194012|529100108|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
146706735|NCT02066298|529100114|FG000|Overall Study|Lost to Follow-up|3|||
146706736|NCT02066298|529100115|FG001|Overall Study|Lost to Follow-up|2|||
146706737|NCT02066298|529100116|FG002|Overall Study|Lost to Follow-up|3|||
146706738|NCT02066298|529100117|FG003|Overall Study|Lost to Follow-up|2|||
146706739|NCT02066298|529100118|FG004|Overall Study|Lost to Follow-up|3|||
146706740|NCT02066298|529100119|FG005|Overall Study|Lost to Follow-up|4|||
146706741|NCT02066298|529100114|FG000|Overall Study|Withdrawal by Subject|6|||
146706742|NCT02066298|529100115|FG001|Overall Study|Withdrawal by Subject|6|||
146706743|NCT02066298|529100116|FG002|Overall Study|Withdrawal by Subject|6|||
146706744|NCT02066298|529100117|FG003|Overall Study|Withdrawal by Subject|4|||
146706745|NCT02066298|529100118|FG004|Overall Study|Withdrawal by Subject|5|||
146706746|NCT02066298|529100119|FG005|Overall Study|Withdrawal by Subject|8|||
146706747|NCT02066298|529100114|FG000|Overall Study|Physician Decision|0|||
146706748|NCT02066298|529100115|FG001|Overall Study|Physician Decision|0|||
146706749|NCT02066298|529100116|FG002|Overall Study|Physician Decision|1|||
146706750|NCT02066298|529100117|FG003|Overall Study|Physician Decision|0|||
146706751|NCT02066298|529100118|FG004|Overall Study|Physician Decision|1|||
146706752|NCT02066298|529100119|FG005|Overall Study|Physician Decision|0|||
146706753|NCT00630877|529100122|FG000|Overall Study|Adverse Event|11|||
146706754|NCT00630877|529100123|FG001|Overall Study|Adverse Event|8|||
146706755|NCT00630877|529100124|FG002|Overall Study|Adverse Event|7|||
146706756|NCT00630877|529100122|FG000|Overall Study|Withdrawal by Subject|3|||
146706757|NCT00630877|529100123|FG001|Overall Study|Withdrawal by Subject|4|||
146706758|NCT00630877|529100124|FG002|Overall Study|Withdrawal by Subject|0|||
146706759|NCT00630877|529100122|FG000|Overall Study|Lost to Follow-up|2|||
146706760|NCT00630877|529100123|FG001|Overall Study|Lost to Follow-up|0|||
146706761|NCT00630877|529100124|FG002|Overall Study|Lost to Follow-up|0|||
146706762|NCT00630877|529100122|FG000|Overall Study|Noncompliance|2|||
146706763|NCT00630877|529100123|FG001|Overall Study|Noncompliance|3|||
146706764|NCT00630877|529100124|FG002|Overall Study|Noncompliance|1|||
146706765|NCT00630877|529100122|FG000|Overall Study|Protocol violation|1|||
146706766|NCT00630877|529100123|FG001|Overall Study|Protocol violation|0|||
146706767|NCT00630877|529100124|FG002|Overall Study|Protocol violation|1|||
146706768|NCT00630877|529100122|FG000|Overall Study|Personal reasons|0|||
146706769|NCT00630877|529100123|FG001|Overall Study|Personal reasons|0|||
146706770|NCT00630877|529100124|FG002|Overall Study|Personal reasons|1|||
146706771|NCT02564198|529100126|FG000|Overall Study|Withdrawal by Subject|2|||
146706772|NCT02564198|529100127|FG001|Overall Study|Withdrawal by Subject|4|||
146706773|NCT02564198|529100128|FG002|Overall Study|Withdrawal by Subject|0|||
146706774|NCT02564198|529100126|FG000|Overall Study|Adverse Event|0|||
146706775|NCT02564198|529100127|FG001|Overall Study|Adverse Event|1|||
146706776|NCT02564198|529100128|FG002|Overall Study|Adverse Event|0|||
146706777|NCT01639001|529100134|FG000|Overall Study|Refused further follow-up|9|||
146706778|NCT01639001|529100135|FG001|Overall Study|Refused further follow-up|12|||
146706779|NCT01639001|529100134|FG000|Overall Study|Lost to Follow-up|3|||
146706780|NCT01639001|529100135|FG001|Overall Study|Lost to Follow-up|0|||
146706781|NCT01639001|529100134|FG000|Overall Study|Death|62|||
146706782|NCT01639001|529100135|FG001|Overall Study|Death|61|||
146706783|NCT01639001|529100134|FG000|Overall Study|Randomized but not treated|0|||
146706784|NCT01639001|529100135|FG001|Overall Study|Randomized but not treated|2|||
146706785|NCT01639001|529100134|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
146706786|NCT01639001|529100135|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
146706787|NCT02649972|529100136|FG000|Overall Study|Not treated|1|||
146706788|NCT00424372|529100137|FG000|Overall Study|Death|1|||
146706789|NCT00424372|529100137|FG000|Overall Study|Adverse Event|18|||
146706790|NCT00424372|529100137|FG000|Overall Study|Lack of Efficacy|6|||
146706791|NCT00424372|529100137|FG000|Overall Study|Withdrawal by Subject|4|||
146706792|NCT00424372|529100137|FG000|Overall Study|Protocol Violation|1|||
146706793|NCT00424372|529100137|FG000|Overall Study|Health deterioration|1|||
146706794|NCT00098839|529100138|FG000|Overall Study|Adverse Event|5|||
146706795|NCT00098839|529100139|FG001|Overall Study|Adverse Event|2|||
146706796|NCT00098839|529100138|FG000|Overall Study|Death|1|||
146706797|NCT00098839|529100139|FG001|Overall Study|Death|2|||
146706798|NCT00098839|529100138|FG000|Overall Study|Physician Decision|4|||
146706799|NCT00098839|529100139|FG001|Overall Study|Physician Decision|14|||
146706800|NCT00098839|529100138|FG000|Overall Study|Withdrawal by Subject|1|||
146706801|NCT00098839|529100139|FG001|Overall Study|Withdrawal by Subject|0|||
146706802|NCT00098839|529100138|FG000|Overall Study|Refusal of further protocol therapy|3|||
146706803|NCT00098839|529100139|FG001|Overall Study|Refusal of further protocol therapy|1|||
146706804|NCT00098839|529100138|FG000|Overall Study|Relapse|6|||
146706805|NCT00098839|529100139|FG001|Overall Study|Relapse|3|||
146706806|NCT00098839|529100138|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
146706807|NCT00098839|529100139|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
146706808|NCT00098839|529100138|FG000|Overall Study|Ineligible|2|||
146706809|NCT00098839|529100139|FG001|Overall Study|Ineligible|0|||
146706810|NCT02148003|529100141|FG000|Overall Study|Failed inclusion criteria|1|||
146706811|NCT02148003|529100142|FG001|Overall Study|Failed inclusion criteria|0|||
146706812|NCT02148003|529100141|FG000|Overall Study|Met exclusion criteria|0|||
146706813|NCT02148003|529100142|FG001|Overall Study|Met exclusion criteria|1|||
146706814|NCT02148003|529100141|FG000|Overall Study|Withdrawal by Subject|0|||
146706815|NCT02148003|529100142|FG001|Overall Study|Withdrawal by Subject|1|||
146706816|NCT03348904|529100145|FG000|Overall Study|Administrative reason by the sponsor|0|||
146706817|NCT03348904|529100146|FG001|Overall Study|Administrative reason by the sponsor|1|||
146706818|NCT03348904|529100147|FG002|Overall Study|Administrative reason by the sponsor|0|||
146706819|NCT00436280|529100148|FG000|Period 1: Induction|Adverse Event|8|||
146706820|NCT00436280|529100148|FG000|Period 1: Induction|Progressive Disease|12|||
146706821|NCT00436280|529100148|FG000|Period 1: Induction|Stable Disease|6|||
146706822|NCT00436280|529100148|FG000|Period 1: Induction|Withdrawal by Subject|1|||
146706823|NCT00436280|529100148|FG000|Period 1: Induction|Death|1|||
146706824|NCT00436280|529100148|FG000|Period 2: Consolidation|Adverse Event|1|||
146706825|NCT00436280|529100148|FG000|Period 2: Consolidation|Progressive Disease|10|||
146706826|NCT00436280|529100148|FG000|Period 2: Consolidation|Stable Disease|1|||
146706827|NCT00436280|529100148|FG000|Period 2: Consolidation|Physician Decision|2|||
146706828|NCT00436280|529100148|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
146706829|NCT00436280|529100148|FG000|Period 2: Consolidation|Death|1|||
146706830|NCT00436280|529100148|FG000|Period 3: Maintenance|Adverse Event|6|||
146706831|NCT00436280|529100148|FG000|Period 3: Maintenance|Progressive Disease|12|||
146706832|NCT03586869|529100150|FG000|Overall Study|Progressive Disease|3|||
146706833|NCT00087568|529100151|FG000|Overall Study|Adverse Event|4|||
146706834|NCT00087568|529100152|FG001|Overall Study|Adverse Event|0|||
146706835|NCT00087568|529100151|FG000|Overall Study|Withdrawal by Subject|1|||
146706836|NCT00087568|529100152|FG001|Overall Study|Withdrawal by Subject|1|||
146706837|NCT00087568|529100151|FG000|Overall Study|Lost to Follow-up|1|||
146706838|NCT00087568|529100152|FG001|Overall Study|Lost to Follow-up|0|||
146706839|NCT00087568|529100151|FG000|Overall Study|Lack of Efficacy|24|||
146706840|NCT00087568|529100152|FG001|Overall Study|Lack of Efficacy|1|||
146706841|NCT01034397|529100153|FG000|Overall Study|Lack of compliance|0|||
146706842|NCT01034397|529100154|FG001|Overall Study|Lack of compliance|1|||
146706843|NCT01034397|529100153|FG000|Overall Study|Lack of Efficacy|3|||
146706844|NCT01034397|529100154|FG001|Overall Study|Lack of Efficacy|0|||
146706845|NCT01034397|529100153|FG000|Overall Study|Adverse Event|4|||
146706846|NCT01034397|529100154|FG001|Overall Study|Adverse Event|0|||
146706847|NCT01034397|529100153|FG000|Overall Study|Other|0|||
146706848|NCT01034397|529100154|FG001|Overall Study|Other|1|||
146706849|NCT04027686|529100155|FG000|Overall Study|Lost to Follow-up|2|||
146706850|NCT04027686|529100156|FG001|Overall Study|Lost to Follow-up|0|||
146706851|NCT04027686|529100155|FG000|Overall Study|Withdrawal by Subject|0|||
146706852|NCT04027686|529100156|FG001|Overall Study|Withdrawal by Subject|1|||
146706853|NCT01263873|529100157|FG000|Overall Study|One provider unable to complete numbers|1|||
146777504|NCT03398148|529355260|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146706854|NCT01263873|529100158|FG001|Overall Study|One provider unable to complete numbers|1|||
146706855|NCT03296696|529100169|FG000|Overall Study|Started Other Antitumor Therapy|1|||
146706856|NCT03296696|529100170|FG001|Overall Study|Started Other Antitumor Therapy|2|||
146706857|NCT03296696|529100171|FG002|Overall Study|Started Other Antitumor Therapy|1|||
146706858|NCT03296696|529100172|FG003|Overall Study|Started Other Antitumor Therapy|2|||
146706859|NCT03296696|529100173|FG004|Overall Study|Started Other Antitumor Therapy|1|||
146706860|NCT03296696|529100174|FG005|Overall Study|Started Other Antitumor Therapy|1|||
146706861|NCT03296696|529100175|FG006|Overall Study|Started Other Antitumor Therapy|2|||
146706862|NCT03296696|529100176|FG007|Overall Study|Started Other Antitumor Therapy|3|||
146777505|NCT03398148|529355261|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146706863|NCT03296696|529100177|FG008|Overall Study|Started Other Antitumor Therapy|1|||
146706864|NCT03296696|529100178|FG009|Overall Study|Started Other Antitumor Therapy|0|||
146706865|NCT03296696|529100169|FG000|Overall Study|Death|0|||
146706866|NCT03296696|529100170|FG001|Overall Study|Death|1|||
146706867|NCT03296696|529100171|FG002|Overall Study|Death|1|||
146706868|NCT03296696|529100172|FG003|Overall Study|Death|2|||
146706869|NCT03296696|529100173|FG004|Overall Study|Death|2|||
146706870|NCT03296696|529100174|FG005|Overall Study|Death|3|||
146706871|NCT03296696|529100175|FG006|Overall Study|Death|1|||
146706872|NCT03296696|529100176|FG007|Overall Study|Death|2|||
146706873|NCT03296696|529100177|FG008|Overall Study|Death|0|||
146706874|NCT03296696|529100178|FG009|Overall Study|Death|0|||
146706875|NCT03296696|529100169|FG000|Overall Study|Withdrawal by Subject|0|||
146706876|NCT03296696|529100170|FG001|Overall Study|Withdrawal by Subject|0|||
146706877|NCT03296696|529100171|FG002|Overall Study|Withdrawal by Subject|1|||
146706878|NCT03296696|529100172|FG003|Overall Study|Withdrawal by Subject|0|||
146706879|NCT03296696|529100173|FG004|Overall Study|Withdrawal by Subject|1|||
146706880|NCT03296696|529100174|FG005|Overall Study|Withdrawal by Subject|0|||
146706881|NCT03296696|529100175|FG006|Overall Study|Withdrawal by Subject|0|||
146706882|NCT03296696|529100176|FG007|Overall Study|Withdrawal by Subject|0|||
146706883|NCT03296696|529100177|FG008|Overall Study|Withdrawal by Subject|0|||
146706884|NCT03296696|529100178|FG009|Overall Study|Withdrawal by Subject|1|||
146706885|NCT04694131|529100181|FG000|Overall Study|Withdrawal by Subject|7|||
146706886|NCT04694131|529100181|FG000|Overall Study|Screen Failure|1|||
146706887|NCT04694131|529100181|FG000|Overall Study|High stimulation threshold|3|||
146706888|NCT04456699|529100182|FG000|Overall Study|Death|48|||
146706889|NCT04456699|529100183|FG001|Overall Study|Death|50|||
146706890|NCT04456699|529100184|FG002|Overall Study|Death|52|||
146706891|NCT04456699|529100182|FG000|Overall Study|Physician Decision|0|||
146706892|NCT04456699|529100183|FG001|Overall Study|Physician Decision|0|||
146706893|NCT04456699|529100184|FG002|Overall Study|Physician Decision|2|||
146706894|NCT04456699|529100182|FG000|Overall Study|Sponsor Decision|55|||
146706895|NCT04456699|529100183|FG001|Overall Study|Sponsor Decision|61|||
146706896|NCT04456699|529100184|FG002|Overall Study|Sponsor Decision|50|||
146706897|NCT04456699|529100182|FG000|Overall Study|Withdrawal by Subject|8|||
146706898|NCT04456699|529100183|FG001|Overall Study|Withdrawal by Subject|4|||
146706899|NCT04456699|529100184|FG002|Overall Study|Withdrawal by Subject|5|||
146706900|NCT00261716|529100190|FG000|Overall Study|Withdrawal by Subject|6|||
146706901|NCT00261716|529100191|FG001|Overall Study|Withdrawal by Subject|8|||
146706902|NCT00261716|529100190|FG000|Overall Study|Lost to Follow-up|0|||
146706903|NCT00261716|529100191|FG001|Overall Study|Lost to Follow-up|2|||
146706904|NCT02047110|529100194|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
146706905|NCT02047110|529100195|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
146706906|NCT02047110|529100196|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
146706907|NCT02047110|529100197|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
146706908|NCT02047110|529100194|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
146706909|NCT02047110|529100195|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
146706910|NCT02047110|529100196|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
146706911|NCT02047110|529100197|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
146706912|NCT02047110|529100194|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
146706913|NCT02047110|529100195|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
146706914|NCT02047110|529100196|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
146706915|NCT02047110|529100197|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
146706916|NCT02047110|529100194|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
146706917|NCT02047110|529100195|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
146706918|NCT02047110|529100196|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
146706919|NCT02047110|529100197|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
146706920|NCT02047110|529100194|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
146706921|NCT02047110|529100195|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
146706922|NCT02047110|529100196|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
146706923|NCT02047110|529100197|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
146706924|NCT02047110|529100194|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
146706925|NCT02047110|529100195|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
146706926|NCT02047110|529100196|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
146706927|NCT02047110|529100197|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
146706928|NCT02047110|529100194|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
146777506|NCT03398148|529355262|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146706929|NCT02047110|529100195|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
146706930|NCT02047110|529100196|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
146706931|NCT02047110|529100197|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
146706932|NCT02047110|529100194|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
146706933|NCT02047110|529100195|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
146706934|NCT02047110|529100196|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
146706935|NCT02047110|529100197|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
146706936|NCT02047110|529100194|FG000|Escape Treatment Period|Adverse Event|1|||
146706937|NCT02047110|529100195|FG001|Escape Treatment Period|Adverse Event|2|||
146706938|NCT02047110|529100196|FG002|Escape Treatment Period|Adverse Event|2|||
146706939|NCT02047110|529100197|FG003|Escape Treatment Period|Adverse Event|0|||
146706940|NCT02047110|529100194|FG000|Escape Treatment Period|Other than specified|1|||
146706941|NCT02047110|529100195|FG001|Escape Treatment Period|Other than specified|2|||
146706942|NCT02047110|529100196|FG002|Escape Treatment Period|Other than specified|0|||
146706943|NCT02047110|529100197|FG003|Escape Treatment Period|Other than specified|1|||
146706944|NCT02047110|529100194|FG000|OLE Treatment Period|Other than specified|0|||
146706945|NCT02047110|529100195|FG001|OLE Treatment Period|Other than specified|0|||
146706946|NCT02047110|529100196|FG002|OLE Treatment Period|Other than specified|1|||
146706947|NCT02047110|529100197|FG003|OLE Treatment Period|Other than specified|0|||
146706948|NCT01632800|529100200|FG000|Overall Study|Subject did not fit in apparatus|1|||
146706949|NCT01000051|529100201|FG000|Overall Study|Withdrawal by Subject|1|||
146706950|NCT01000051|529100202|FG001|Overall Study|Withdrawal by Subject|1|||
146706951|NCT01000051|529100201|FG000|Overall Study|Disease Progression|1|||
146706952|NCT01000051|529100202|FG001|Overall Study|Disease Progression|0|||
146706953|NCT01000051|529100201|FG000|Overall Study|Serious noncompliance|1|||
146706954|NCT01000051|529100202|FG001|Overall Study|Serious noncompliance|0|||
146706955|NCT02247349|529100203|FG000|Overall Study|Disease Progression|7|||
146706956|NCT02247349|529100204|FG001|Overall Study|Disease Progression|4|||
146706957|NCT02247349|529100205|FG002|Overall Study|Disease Progression|26|||
146706958|NCT02247349|529100206|FG003|Overall Study|Disease Progression|31|||
146706959|NCT02247349|529100207|FG004|Overall Study|Disease Progression|16|||
146706960|NCT02247349|529100208|FG005|Overall Study|Disease Progression|6|||
146706961|NCT02247349|529100203|FG000|Overall Study|Study drug toxicity|0|||
146706962|NCT02247349|529100204|FG001|Overall Study|Study drug toxicity|1|||
146706963|NCT02247349|529100205|FG002|Overall Study|Study drug toxicity|1|||
146706964|NCT02247349|529100206|FG003|Overall Study|Study drug toxicity|1|||
146706965|NCT02247349|529100207|FG004|Overall Study|Study drug toxicity|2|||
146706966|NCT02247349|529100208|FG005|Overall Study|Study drug toxicity|2|||
146706967|NCT02247349|529100203|FG000|Overall Study|Death|0|||
146706968|NCT02247349|529100204|FG001|Overall Study|Death|0|||
146706969|NCT02247349|529100205|FG002|Overall Study|Death|0|||
146706970|NCT02247349|529100206|FG003|Overall Study|Death|1|||
146706971|NCT02247349|529100207|FG004|Overall Study|Death|0|||
146706972|NCT02247349|529100208|FG005|Overall Study|Death|0|||
146706973|NCT02247349|529100203|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
146706974|NCT02247349|529100204|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
146706975|NCT02247349|529100205|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
146706976|NCT02247349|529100206|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
146706977|NCT02247349|529100207|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
146706978|NCT02247349|529100208|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
146706979|NCT02247349|529100203|FG000|Overall Study|Participant request to discontinue study treatment|0|||
146706980|NCT02247349|529100204|FG001|Overall Study|Participant request to discontinue study treatment|0|||
146706981|NCT02247349|529100205|FG002|Overall Study|Participant request to discontinue study treatment|1|||
146706982|NCT02247349|529100206|FG003|Overall Study|Participant request to discontinue study treatment|2|||
146706983|NCT02247349|529100207|FG004|Overall Study|Participant request to discontinue study treatment|1|||
146706984|NCT02247349|529100208|FG005|Overall Study|Participant request to discontinue study treatment|0|||
146706985|NCT02247349|529100203|FG000|Overall Study|Withdrawal by Subject|0|||
146706986|NCT02247349|529100204|FG001|Overall Study|Withdrawal by Subject|1|||
146706987|NCT02247349|529100205|FG002|Overall Study|Withdrawal by Subject|0|||
146706988|NCT02247349|529100206|FG003|Overall Study|Withdrawal by Subject|0|||
146706989|NCT02247349|529100207|FG004|Overall Study|Withdrawal by Subject|0|||
146706990|NCT02247349|529100208|FG005|Overall Study|Withdrawal by Subject|0|||
146706991|NCT02247349|529100203|FG000|Overall Study|Administrative reason by sponsor|0|||
146706992|NCT02247349|529100204|FG001|Overall Study|Administrative reason by sponsor|0|||
146706993|NCT02247349|529100205|FG002|Overall Study|Administrative reason by sponsor|0|||
146706994|NCT02247349|529100206|FG003|Overall Study|Administrative reason by sponsor|0|||
146706995|NCT02247349|529100207|FG004|Overall Study|Administrative reason by sponsor|1|||
146706996|NCT02247349|529100208|FG005|Overall Study|Administrative reason by sponsor|0|||
146706997|NCT02247349|529100203|FG000|Overall Study|Other reasons|0|||
146706998|NCT02247349|529100204|FG001|Overall Study|Other reasons|0|||
146706999|NCT02247349|529100205|FG002|Overall Study|Other reasons|1|||
146707000|NCT02247349|529100206|FG003|Overall Study|Other reasons|0|||
146707001|NCT02247349|529100207|FG004|Overall Study|Other reasons|0|||
146707002|NCT02247349|529100208|FG005|Overall Study|Other reasons|0|||
146707003|NCT00673452|529100209|FG000|Acute Double-Blind Phase|Adverse Event|41|||
146707004|NCT00673452|529100210|FG001|Acute Double-Blind Phase|Adverse Event|24|||
146707005|NCT00673452|529100209|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
146707006|NCT00673452|529100210|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
146707007|NCT00673452|529100209|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
146707008|NCT00673452|529100210|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
146707009|NCT00673452|529100209|FG000|Acute Double-Blind Phase|Physician Decision|0|||
146707010|NCT00673452|529100210|FG001|Acute Double-Blind Phase|Physician Decision|6|||
146707011|NCT00673452|529100209|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
146707012|NCT00673452|529100210|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
146707013|NCT00673452|529100209|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
146707014|NCT00673452|529100210|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
146707015|NCT00673452|529100209|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
146707016|NCT00673452|529100210|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
146707017|NCT00673452|529100209|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
146707018|NCT00673452|529100210|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
146707019|NCT00673452|529100209|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
146707020|NCT00673452|529100210|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
146707021|NCT00673452|529100209|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
146707022|NCT00673452|529100210|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
146707023|NCT00673452|529100209|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
146707024|NCT00673452|529100210|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
146707025|NCT00673452|529100209|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
146707026|NCT00673452|529100210|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
146707027|NCT00673452|529100209|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
146707028|NCT00673452|529100210|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
146707029|NCT00673452|529100209|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
146707030|NCT00673452|529100210|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
146707031|NCT00673452|529100209|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
146707032|NCT00673452|529100210|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
146707033|NCT03495908|529100217|FG000|Overall Study|Withdrawal by Subject|3|||
146707034|NCT03495908|529100218|FG001|Overall Study|Withdrawal by Subject|1|||
146707035|NCT03495908|529100217|FG000|Overall Study|Lost to Follow-up|1|||
146707036|NCT03495908|529100218|FG001|Overall Study|Lost to Follow-up|4|||
146707037|NCT03495908|529100217|FG000|Overall Study|Adverse Event|0|||
146707038|NCT03495908|529100218|FG001|Overall Study|Adverse Event|2|||
146707039|NCT03495908|529100217|FG000|Overall Study|Death|1|||
146707040|NCT03495908|529100218|FG001|Overall Study|Death|0|||
146707041|NCT03495908|529100217|FG000|Overall Study|Physician Decision|5|||
146707042|NCT03495908|529100218|FG001|Overall Study|Physician Decision|4|||
146707043|NCT03495908|529100217|FG000|Overall Study|No documented reason|0|||
146707044|NCT03495908|529100218|FG001|Overall Study|No documented reason|2|||
146707045|NCT02410811|529100219|FG000|Overall Study|Withdrawal by Subject|0|||
146707046|NCT02410811|529100220|FG001|Overall Study|Withdrawal by Subject|0|||
146707047|NCT02410811|529100221|FG002|Overall Study|Withdrawal by Subject|1|||
146707048|NCT02410811|529100222|FG003|Overall Study|Withdrawal by Subject|0|||
146707049|NCT00480779|529100228|FG000|Overall Study|Other|2|||
146707050|NCT00480779|529100229|FG001|Overall Study|Other|0|||
146707051|NCT00480779|529100228|FG000|Overall Study|Job and Health-related|0|||
146707052|NCT00480779|529100229|FG001|Overall Study|Job and Health-related|3|||
146707053|NCT00854581|529100234|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
146707054|NCT00854581|529100234|FG000|Induction (Up to Day 21)|Death|1|||
146707055|NCT00854581|529100234|FG000|Induction (Up to Day 21)|Physician Decision|1|||
146707056|NCT00854581|529100234|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
146707057|NCT01339390|529100235|FG000|Overall Study|Death|32|||
146707058|NCT01339390|529100236|FG001|Overall Study|Death|29|||
146707059|NCT01339390|529100235|FG000|Overall Study|Lost to Follow-up|125|||
146707060|NCT01339390|529100236|FG001|Overall Study|Lost to Follow-up|127|||
146707061|NCT00378703|529100239|FG000|Overall Study|Disease progression|59|||
146707062|NCT00378703|529100240|FG001|Overall Study|Disease progression|43|||
146707063|NCT00378703|529100241|FG002|Overall Study|Disease progression|48|||
146707064|NCT00378703|529100242|FG003|Overall Study|Disease progression|49|||
146707065|NCT00378703|529100239|FG000|Overall Study|Adverse Event|11|||
146707066|NCT00378703|529100240|FG001|Overall Study|Adverse Event|17|||
146707067|NCT00378703|529100241|FG002|Overall Study|Adverse Event|20|||
146707068|NCT00378703|529100242|FG003|Overall Study|Adverse Event|18|||
146777507|NCT03398148|529355263|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146777508|NCT03398148|529355264|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146777509|NCT03398148|529355265|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146777510|NCT03398148|529355266|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146933765|NCT00150345|529915987|FG001|Overall Study|Other|14|||
146933766|NCT05224076|529915989|FG000|Overall Study|Lost to Follow-up|24|||
146933767|NCT01807949|529915990|FG000|Overall Study|Adverse Event|1|||
146707069|NCT00378703|529100239|FG000|Overall Study|Death|2|||
146707070|NCT00378703|529100240|FG001|Overall Study|Death|2|||
146707071|NCT00378703|529100241|FG002|Overall Study|Death|4|||
146707072|NCT00378703|529100242|FG003|Overall Study|Death|3|||
146707073|NCT00378703|529100239|FG000|Overall Study|Withdrawal by Subject|4|||
146707074|NCT00378703|529100240|FG001|Overall Study|Withdrawal by Subject|8|||
146707075|NCT00378703|529100241|FG002|Overall Study|Withdrawal by Subject|5|||
146707076|NCT00378703|529100242|FG003|Overall Study|Withdrawal by Subject|7|||
146707077|NCT00378703|529100239|FG000|Overall Study|Physician Decision|1|||
146707078|NCT00378703|529100240|FG001|Overall Study|Physician Decision|4|||
146707079|NCT00378703|529100241|FG002|Overall Study|Physician Decision|1|||
146707080|NCT00378703|529100242|FG003|Overall Study|Physician Decision|0|||
146707081|NCT00378703|529100239|FG000|Overall Study|Alternative therapy|4|||
146707082|NCT00378703|529100240|FG001|Overall Study|Alternative therapy|2|||
146707083|NCT00378703|529100241|FG002|Overall Study|Alternative therapy|0|||
146707084|NCT00378703|529100242|FG003|Overall Study|Alternative therapy|0|||
146707085|NCT00378703|529100239|FG000|Overall Study|Other complicated disease|0|||
146707086|NCT00378703|529100240|FG001|Overall Study|Other complicated disease|2|||
146707087|NCT00378703|529100241|FG002|Overall Study|Other complicated disease|2|||
146707088|NCT00378703|529100242|FG003|Overall Study|Other complicated disease|0|||
146707089|NCT00378703|529100239|FG000|Overall Study|Symptomatic deterioration|0|||
146707090|NCT00378703|529100240|FG001|Overall Study|Symptomatic deterioration|1|||
146707091|NCT00378703|529100241|FG002|Overall Study|Symptomatic deterioration|0|||
146707092|NCT00378703|529100242|FG003|Overall Study|Symptomatic deterioration|2|||
146707093|NCT00378703|529100239|FG000|Overall Study|Surgery|1|||
146707094|NCT00378703|529100240|FG001|Overall Study|Surgery|0|||
146707095|NCT00378703|529100241|FG002|Overall Study|Surgery|0|||
146707096|NCT00378703|529100242|FG003|Overall Study|Surgery|1|||
146707097|NCT00378703|529100239|FG000|Overall Study|Joint decision of physician and patient|1|||
146707098|NCT00378703|529100240|FG001|Overall Study|Joint decision of physician and patient|0|||
146707099|NCT00378703|529100241|FG002|Overall Study|Joint decision of physician and patient|0|||
146707100|NCT00378703|529100242|FG003|Overall Study|Joint decision of physician and patient|0|||
146707101|NCT00378703|529100239|FG000|Overall Study|Adverse events and progressive disease|0|||
146707102|NCT00378703|529100240|FG001|Overall Study|Adverse events and progressive disease|0|||
146707103|NCT00378703|529100241|FG002|Overall Study|Adverse events and progressive disease|0|||
146707104|NCT00378703|529100242|FG003|Overall Study|Adverse events and progressive disease|1|||
146707105|NCT00378703|529100239|FG000|Overall Study|Relocation|0|||
146707106|NCT00378703|529100240|FG001|Overall Study|Relocation|0|||
146707107|NCT00378703|529100241|FG002|Overall Study|Relocation|1|||
146707108|NCT00378703|529100242|FG003|Overall Study|Relocation|0|||
146707109|NCT00378703|529100239|FG000|Overall Study|Ineligible|4|||
146707110|NCT00378703|529100240|FG001|Overall Study|Ineligible|7|||
146707111|NCT00378703|529100241|FG002|Overall Study|Ineligible|7|||
146707112|NCT00378703|529100242|FG003|Overall Study|Ineligible|7|||
146707113|NCT00378703|529100239|FG000|Overall Study|Never started treatment|1|||
146707114|NCT00378703|529100240|FG001|Overall Study|Never started treatment|4|||
146707115|NCT00378703|529100241|FG002|Overall Study|Never started treatment|0|||
146707116|NCT00378703|529100242|FG003|Overall Study|Never started treatment|0|||
146707117|NCT00378703|529100239|FG000|Overall Study|Other|1|||
146707118|NCT00378703|529100240|FG001|Overall Study|Other|1|||
146707119|NCT00378703|529100241|FG002|Overall Study|Other|2|||
146707120|NCT00378703|529100242|FG003|Overall Study|Other|3|||
146707121|NCT01541930|529100250|FG000|Overall Study|Withdrawal by Subject|1|||
146707122|NCT01957475|529100251|FG000|Test Period 1|Withdrawal by Subject|1|||
146707123|NCT01957475|529100252|FG001|Test Period 1|Withdrawal by Subject|0|||
146707124|NCT01957475|529100251|FG000|Test Period 1|Other|1|||
146707125|NCT01957475|529100252|FG001|Test Period 1|Other|0|||
146707126|NCT01957475|529100251|FG000|Test Period 1|Lack of Efficacy|0|||
146707127|NCT01957475|529100252|FG001|Test Period 1|Lack of Efficacy|1|||
146707128|NCT01957475|529100251|FG000|Test Period 2|Adverse Event|1|||
146707129|NCT01957475|529100252|FG001|Test Period 2|Adverse Event|0|||
146707130|NCT00813358|529100255|FG000|Overall Study|Death|32|||
146707131|NCT00813358|529100255|FG000|Overall Study|Lost to Follow-up|12|||
146707132|NCT00813358|529100255|FG000|Overall Study|other endpoints|5|||
146707133|NCT00813358|529100255|FG000|Overall Study|Withdrawal by Subject|20|||
146707134|NCT04497987|529100256|FG000|Overall Study|Adverse Event|1|||
146707135|NCT04497987|529100257|FG001|Overall Study|Adverse Event|0|||
146707136|NCT04497987|529100256|FG000|Overall Study|Death|21|||
146707137|NCT04497987|529100257|FG001|Overall Study|Death|13|||
146707138|NCT04497987|529100256|FG000|Overall Study|Lost to Follow-up|19|||
146707139|NCT04497987|529100257|FG001|Overall Study|Lost to Follow-up|17|||
146707140|NCT04497987|529100256|FG000|Overall Study|Other - as reported by the investigator|22|||
146707141|NCT04497987|529100257|FG001|Overall Study|Other - as reported by the investigator|16|||
146707142|NCT04497987|529100256|FG000|Overall Study|Physician Decision|1|||
146707143|NCT04497987|529100257|FG001|Overall Study|Physician Decision|0|||
146707144|NCT04497987|529100256|FG000|Overall Study|Withdrawal by Subject|35|||
146707145|NCT04497987|529100257|FG001|Overall Study|Withdrawal by Subject|21|||
146707146|NCT03665038|529100258|FG000|Overall Study|Lost to Follow-up|0|||
146707147|NCT03665038|529100259|FG001|Overall Study|Lost to Follow-up|0|||
146707148|NCT03665038|529100260|FG002|Overall Study|Lost to Follow-up|1|||
146707149|NCT03890367|529100265|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146707150|NCT03890367|529100266|FG001|Overall Study|Withdrawal by parent/guardian|3|||
146707151|NCT03890367|529100267|FG002|Overall Study|Withdrawal by parent/guardian|0|||
146933768|NCT01807949|529915991|FG001|Overall Study|Adverse Event|2|||
146707152|NCT03890367|529100265|FG000|Overall Study|Protocol deviation|2|||
146707153|NCT03890367|529100266|FG001|Overall Study|Protocol deviation|2|||
146707154|NCT03890367|529100267|FG002|Overall Study|Protocol deviation|1|||
146707155|NCT03890367|529100265|FG000|Overall Study|Lost to Follow-up|1|||
146933769|NCT01807949|529915992|FG002|Overall Study|Adverse Event|2|||
146707156|NCT03890367|529100266|FG001|Overall Study|Lost to Follow-up|1|||
146707157|NCT03890367|529100267|FG002|Overall Study|Lost to Follow-up|0|||
146707158|NCT04260191|529101995|FG000|Overall Study|Decision by Sponsor|0|||
146707159|NCT04260191|529101996|FG001|Overall Study|Decision by Sponsor|1|||
146707160|NCT04260191|529101997|FG002|Overall Study|Decision by Sponsor|0|||
146707161|NCT04260191|529101995|FG000|Overall Study|Withdrawal by Subject|1|||
146707162|NCT04260191|529101996|FG001|Overall Study|Withdrawal by Subject|0|||
146707163|NCT04260191|529101997|FG002|Overall Study|Withdrawal by Subject|3|||
146707164|NCT04260191|529101995|FG000|Overall Study|Death|4|||
146707165|NCT04260191|529101996|FG001|Overall Study|Death|3|||
146707166|NCT04260191|529101997|FG002|Overall Study|Death|2|||
146707167|NCT01643473|529101998|FG000|Overall Study|Lost to Follow-up|1|||
146707168|NCT01643473|529101999|FG001|Overall Study|Lost to Follow-up|0|||
146707169|NCT01519518|529102000|FG000|Overall Study|Consent not available|7|||
146707170|NCT01519518|529102001|FG001|Overall Study|Consent not available|10|||
146707171|NCT02033889|529102002|FG000|Overall Study|Adverse Event|3|||
146707172|NCT02033889|529102003|FG001|Overall Study|Adverse Event|1|||
146707173|NCT02033889|529102004|FG002|Overall Study|Adverse Event|3|||
146707174|NCT02033889|529102002|FG000|Overall Study|Death|3|||
146707175|NCT02033889|529102003|FG001|Overall Study|Death|1|||
146707176|NCT02033889|529102004|FG002|Overall Study|Death|2|||
146707177|NCT02033889|529102002|FG000|Overall Study|Excluded Medication|1|||
146707178|NCT02033889|529102003|FG001|Overall Study|Excluded Medication|1|||
146707179|NCT02033889|529102004|FG002|Overall Study|Excluded Medication|0|||
146707180|NCT02033889|529102002|FG000|Overall Study|Lost to Follow-up|8|||
146707181|NCT02033889|529102003|FG001|Overall Study|Lost to Follow-up|5|||
146707182|NCT02033889|529102004|FG002|Overall Study|Lost to Follow-up|6|||
146707183|NCT02033889|529102002|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146707184|NCT02033889|529102003|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146707185|NCT02033889|529102004|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146707186|NCT02033889|529102002|FG000|Overall Study|Physician Decision|0|||
146707187|NCT02033889|529102003|FG001|Overall Study|Physician Decision|1|||
146707188|NCT02033889|529102004|FG002|Overall Study|Physician Decision|1|||
146707189|NCT02033889|529102002|FG000|Overall Study|Participant moved|0|||
146707190|NCT02033889|529102003|FG001|Overall Study|Participant moved|1|||
146707191|NCT02033889|529102004|FG002|Overall Study|Participant moved|0|||
146707192|NCT02033889|529102002|FG000|Overall Study|Withdrawal by Subject|18|||
146707193|NCT02033889|529102003|FG001|Overall Study|Withdrawal by Subject|10|||
146707194|NCT02033889|529102004|FG002|Overall Study|Withdrawal by Subject|13|||
146707195|NCT02343458|529102008|FG000|Overall Study|Adverse Event|15|||
146707196|NCT02343458|529102009|FG001|Overall Study|Adverse Event|14|||
146707197|NCT02343458|529102010|FG002|Overall Study|Adverse Event|15|||
146707198|NCT02343458|529102011|FG003|Overall Study|Adverse Event|3|||
146707199|NCT02343458|529102008|FG000|Overall Study|Lack of Efficacy|3|||
146707200|NCT02343458|529102009|FG001|Overall Study|Lack of Efficacy|8|||
146707201|NCT02343458|529102010|FG002|Overall Study|Lack of Efficacy|4|||
146707202|NCT02343458|529102011|FG003|Overall Study|Lack of Efficacy|8|||
146707203|NCT02343458|529102008|FG000|Overall Study|Withdrawal by Subject|18|||
146707204|NCT02343458|529102009|FG001|Overall Study|Withdrawal by Subject|17|||
146707205|NCT02343458|529102010|FG002|Overall Study|Withdrawal by Subject|23|||
146707206|NCT02343458|529102011|FG003|Overall Study|Withdrawal by Subject|14|||
146707207|NCT02343458|529102008|FG000|Overall Study|Physician Decision|1|||
146707208|NCT02343458|529102009|FG001|Overall Study|Physician Decision|4|||
146707209|NCT02343458|529102010|FG002|Overall Study|Physician Decision|2|||
146707210|NCT02343458|529102011|FG003|Overall Study|Physician Decision|2|||
146707211|NCT02343458|529102008|FG000|Overall Study|Lost to Follow-up|5|||
146707212|NCT02343458|529102009|FG001|Overall Study|Lost to Follow-up|5|||
146707213|NCT02343458|529102010|FG002|Overall Study|Lost to Follow-up|3|||
146707214|NCT02343458|529102011|FG003|Overall Study|Lost to Follow-up|1|||
146707215|NCT02343458|529102008|FG000|Overall Study|Protocol Violation|2|||
146707216|NCT02343458|529102009|FG001|Overall Study|Protocol Violation|5|||
146707217|NCT02343458|529102010|FG002|Overall Study|Protocol Violation|2|||
146707218|NCT02343458|529102011|FG003|Overall Study|Protocol Violation|2|||
146707219|NCT02343458|529102008|FG000|Overall Study|Protocol Specified Criteria|17|||
146707220|NCT02343458|529102009|FG001|Overall Study|Protocol Specified Criteria|13|||
146707221|NCT02343458|529102010|FG002|Overall Study|Protocol Specified Criteria|14|||
146707222|NCT02343458|529102011|FG003|Overall Study|Protocol Specified Criteria|8|||
146707223|NCT01312909|529102012|FG000|Overall Study|Randomized but not treated|1|||
146707224|NCT01312909|529102013|FG001|Overall Study|Randomized but not treated|3|||
146707225|NCT01312909|529102014|FG002|Overall Study|Randomized but not treated|1|||
146707226|NCT01312909|529102012|FG000|Overall Study|Adverse Event|1|||
146707227|NCT01312909|529102013|FG001|Overall Study|Adverse Event|0|||
146707228|NCT01312909|529102014|FG002|Overall Study|Adverse Event|3|||
146707229|NCT01312909|529102012|FG000|Overall Study|Protocol Violation|2|||
146707230|NCT01312909|529102013|FG001|Overall Study|Protocol Violation|0|||
146707231|NCT01312909|529102014|FG002|Overall Study|Protocol Violation|2|||
146707232|NCT01312909|529102012|FG000|Overall Study|Other|9|||
146707233|NCT01312909|529102013|FG001|Overall Study|Other|6|||
146707234|NCT01312909|529102014|FG002|Overall Study|Other|11|||
146707235|NCT01312909|529102012|FG000|Overall Study|Withdrawal by Subject|8|||
146707236|NCT01312909|529102013|FG001|Overall Study|Withdrawal by Subject|10|||
146707237|NCT01312909|529102014|FG002|Overall Study|Withdrawal by Subject|7|||
146707238|NCT01312909|529102012|FG000|Overall Study|Lost to Follow-up|21|||
146707239|NCT01312909|529102013|FG001|Overall Study|Lost to Follow-up|17|||
146707240|NCT01312909|529102014|FG002|Overall Study|Lost to Follow-up|20|||
146707241|NCT01312909|529102012|FG000|Overall Study|Insufficient clinical response|0|||
146707242|NCT01312909|529102013|FG001|Overall Study|Insufficient clinical response|0|||
146707243|NCT01312909|529102014|FG002|Overall Study|Insufficient clinical response|1|||
146707244|NCT01312909|529102012|FG000|Overall Study|Entrance criteria not met|0|||
146707245|NCT01312909|529102013|FG001|Overall Study|Entrance criteria not met|0|||
146707246|NCT01312909|529102014|FG002|Overall Study|Entrance criteria not met|2|||
146707247|NCT01913041|529102015|FG000|Overall Study|Protocol Violation|35|||
146707248|NCT01913041|529102015|FG000|Overall Study|Withdrawal by Subject|3|||
146707249|NCT01913041|529102015|FG000|Overall Study|Physician Decision|1|||
146707250|NCT01513317|529102016|FG000|Overall Study|Withdrawal by Subject|15|||
146707251|NCT01513317|529102017|FG001|Overall Study|Withdrawal by Subject|4|||
146707252|NCT01513317|529102016|FG000|Overall Study|Death|1|||
146707253|NCT01513317|529102017|FG001|Overall Study|Death|1|||
146707254|NCT01513317|529102016|FG000|Overall Study|Study terminated by sponsor|18|||
146707255|NCT01513317|529102017|FG001|Overall Study|Study terminated by sponsor|18|||
146707256|NCT01513317|529102016|FG000|Overall Study|Other|0|||
146707257|NCT01513317|529102017|FG001|Overall Study|Other|1|||
146707258|NCT02660359|529102020|FG000|Overall Study|Protocol Deviation|0|||
146707259|NCT02660359|529102021|FG001|Overall Study|Protocol Deviation|0|||
146707260|NCT02660359|529102022|FG002|Overall Study|Protocol Deviation|1|||
146707261|NCT02660359|529102020|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
146707262|NCT02660359|529102021|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
146707263|NCT02660359|529102022|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
146707264|NCT02660359|529102020|FG000|Overall Study|Lack of Efficacy|1|||
146707265|NCT02660359|529102021|FG001|Overall Study|Lack of Efficacy|1|||
146707266|NCT02660359|529102022|FG002|Overall Study|Lack of Efficacy|1|||
146707267|NCT02660359|529102020|FG000|Overall Study|Adverse Event|0|||
146707268|NCT02660359|529102021|FG001|Overall Study|Adverse Event|1|||
146707269|NCT02660359|529102022|FG002|Overall Study|Adverse Event|0|||
146707270|NCT02660359|529102020|FG000|Overall Study|Other|2|||
146707271|NCT02660359|529102021|FG001|Overall Study|Other|1|||
146707272|NCT02660359|529102022|FG002|Overall Study|Other|3|||
146707273|NCT02660359|529102020|FG000|Overall Study|Withdrawal by Subject|7|||
146707274|NCT02660359|529102021|FG001|Overall Study|Withdrawal by Subject|5|||
146707275|NCT02660359|529102022|FG002|Overall Study|Withdrawal by Subject|8|||
146707276|NCT02660359|529102020|FG000|Overall Study|Lost to Follow-up|3|||
146707277|NCT02660359|529102021|FG001|Overall Study|Lost to Follow-up|3|||
146707278|NCT02660359|529102022|FG002|Overall Study|Lost to Follow-up|0|||
146707279|NCT04622254|529102026|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
146707280|NCT04622254|529102027|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
146707281|NCT04622254|529102028|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
146707282|NCT04622254|529102029|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
146707283|NCT04622254|529102030|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
146707284|NCT04622254|529102031|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
146707285|NCT04622254|529102026|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
146707286|NCT04622254|529102027|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
146707287|NCT04622254|529102028|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
146707288|NCT04622254|529102029|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
146707289|NCT04622254|529102030|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
146707290|NCT04622254|529102031|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
146707291|NCT04622254|529102026|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
146707292|NCT04622254|529102027|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
146707293|NCT04622254|529102028|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
146707294|NCT04622254|529102029|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
146707295|NCT04622254|529102030|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
146707296|NCT04622254|529102031|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
146707297|NCT04622254|529102026|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
146707298|NCT04622254|529102027|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
146707299|NCT04622254|529102028|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
146707300|NCT04622254|529102029|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
146933770|NCT01807949|529915990|FG000|Overall Study|Withdrawal by Subject|1|||
146933771|NCT01807949|529915991|FG001|Overall Study|Withdrawal by Subject|2|||
146707301|NCT04622254|529102030|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
146707302|NCT04622254|529102031|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
146707303|NCT04622254|529102026|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146707304|NCT04622254|529102027|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146933772|NCT01807949|529915992|FG002|Overall Study|Withdrawal by Subject|2|||
146707305|NCT04622254|529102028|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146707306|NCT04622254|529102029|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
146933773|NCT01807949|529915990|FG000|Overall Study|Non-Compliance|0|||
146707307|NCT04622254|529102030|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146707308|NCT04622254|529102031|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146707309|NCT04622254|529102026|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
146707310|NCT04622254|529102027|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
146707311|NCT04622254|529102028|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
146707312|NCT04622254|529102029|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
146707313|NCT04622254|529102030|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
146707314|NCT04622254|529102031|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
146707315|NCT04622254|529102026|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146707316|NCT04622254|529102027|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146707317|NCT04622254|529102028|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146707318|NCT04622254|529102029|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
146707319|NCT04622254|529102030|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146707320|NCT04622254|529102031|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146707321|NCT04622254|529102026|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146707322|NCT04622254|529102027|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146707323|NCT04622254|529102028|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146707324|NCT04622254|529102029|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
146707325|NCT04622254|529102030|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146707326|NCT04622254|529102031|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146707327|NCT04622254|529102026|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
146707328|NCT04622254|529102027|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
146707329|NCT04622254|529102028|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
146707330|NCT04622254|529102029|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
146707331|NCT04622254|529102030|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
146707332|NCT04622254|529102031|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
146707333|NCT04622254|529102026|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
146707334|NCT04622254|529102027|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
146707335|NCT04622254|529102028|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
146707336|NCT04622254|529102029|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
146707337|NCT04622254|529102030|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
146707338|NCT04622254|529102031|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
146707339|NCT04622254|529102026|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
146707340|NCT04622254|529102027|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
146707341|NCT04622254|529102028|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
146707342|NCT04622254|529102029|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
146707343|NCT04622254|529102030|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
146707344|NCT04622254|529102031|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
146707345|NCT03228680|529102032|FG000|Overall Study|Adverse Event|13|||
146707346|NCT03228680|529102033|FG001|Overall Study|Adverse Event|18|||
146707347|NCT03228680|529102032|FG000|Overall Study|Randomization failure|0|||
146707348|NCT03228680|529102033|FG001|Overall Study|Randomization failure|1|||
146707349|NCT03228680|529102032|FG000|Overall Study|Withdrawal by Subject|1|||
146707350|NCT03228680|529102033|FG001|Overall Study|Withdrawal by Subject|0|||
146707351|NCT03228680|529102032|FG000|Overall Study|Other|9|||
146707352|NCT03228680|529102033|FG001|Overall Study|Other|16|||
146707353|NCT02167035|529102034|FG000|Overall Study|Adverse Event|2|||
146707354|NCT02167035|529102035|FG001|Overall Study|Adverse Event|2|||
146707355|NCT02167035|529102034|FG000|Overall Study|Lost to Follow-up|3|||
146707356|NCT02167035|529102035|FG001|Overall Study|Lost to Follow-up|3|||
146707357|NCT02167035|529102034|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
146707358|NCT02167035|529102035|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
146707359|NCT02489981|529102036|FG000|Overall Study|Adverse Event|21|||
146707360|NCT02489981|529102036|FG000|Overall Study|Insufficient effectiveness|16|||
146707361|NCT02489981|529102036|FG000|Overall Study|Improved|31|||
146707362|NCT02489981|529102036|FG000|Overall Study|Lost to Follow-up|31|||
146707363|NCT02489981|529102036|FG000|Overall Study|Other than listed|28|||
146707364|NCT01743092|529102037|FG000|Overall Study|Lost to Follow-up|14|||
146707365|NCT01743092|529102038|FG001|Overall Study|Lost to Follow-up|15|||
146707366|NCT02992899|529102043|FG000|Overall Study|Withdrawal by Subject|1|||
146707367|NCT02992899|529102044|FG001|Overall Study|Withdrawal by Subject|0|||
146707368|NCT02992899|529102043|FG000|Overall Study|Lost to Follow-up|1|||
146777511|NCT03398148|529355267|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
146777512|NCT03398148|529355268|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
146777513|NCT03398148|529355269|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146707369|NCT02992899|529102044|FG001|Overall Study|Lost to Follow-up|3|||
146707370|NCT02370888|529102045|FG000|Overall Study|disease progression|2|||
146707371|NCT02370888|529102045|FG000|Overall Study|did not meet chimerism criteria|6|||
146777514|NCT03398148|529355270|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146777515|NCT03398148|529355271|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146707372|NCT01332305|529102046|FG000|Overall Study|Adverse Event|1|||
146707373|NCT01332305|529102047|FG001|Overall Study|Adverse Event|4|||
146707374|NCT01332305|529102048|FG002|Overall Study|Adverse Event|6|||
146707375|NCT01332305|529102049|FG003|Overall Study|Adverse Event|3|||
146707376|NCT01332305|529102050|FG004|Overall Study|Adverse Event|5|||
146707377|NCT01332305|529102046|FG000|Overall Study|Withdrawal by Subject|6|||
146707378|NCT01332305|529102047|FG001|Overall Study|Withdrawal by Subject|5|||
146707379|NCT01332305|529102048|FG002|Overall Study|Withdrawal by Subject|4|||
146707380|NCT01332305|529102049|FG003|Overall Study|Withdrawal by Subject|1|||
146707381|NCT01332305|529102050|FG004|Overall Study|Withdrawal by Subject|0|||
146707382|NCT01332305|529102046|FG000|Overall Study|Lost to Follow-up|0|||
146707383|NCT01332305|529102047|FG001|Overall Study|Lost to Follow-up|2|||
146707384|NCT01332305|529102048|FG002|Overall Study|Lost to Follow-up|3|||
146707385|NCT01332305|529102049|FG003|Overall Study|Lost to Follow-up|2|||
146707386|NCT01332305|529102050|FG004|Overall Study|Lost to Follow-up|3|||
146707387|NCT01332305|529102046|FG000|Overall Study|Protocol Violation|1|||
146707388|NCT01332305|529102047|FG001|Overall Study|Protocol Violation|2|||
146707389|NCT01332305|529102048|FG002|Overall Study|Protocol Violation|1|||
146707390|NCT01332305|529102049|FG003|Overall Study|Protocol Violation|0|||
146707391|NCT01332305|529102050|FG004|Overall Study|Protocol Violation|3|||
146707392|NCT01332305|529102046|FG000|Overall Study|Withdrawal by Sponsor|1|||
146707393|NCT01332305|529102047|FG001|Overall Study|Withdrawal by Sponsor|0|||
146707394|NCT01332305|529102048|FG002|Overall Study|Withdrawal by Sponsor|0|||
146707395|NCT01332305|529102049|FG003|Overall Study|Withdrawal by Sponsor|1|||
146707396|NCT01332305|529102050|FG004|Overall Study|Withdrawal by Sponsor|1|||
146707397|NCT01332305|529102046|FG000|Overall Study|Treatment Failure|1|||
146707398|NCT01332305|529102047|FG001|Overall Study|Treatment Failure|1|||
146707399|NCT01332305|529102048|FG002|Overall Study|Treatment Failure|0|||
146707400|NCT01332305|529102049|FG003|Overall Study|Treatment Failure|0|||
146707401|NCT01332305|529102050|FG004|Overall Study|Treatment Failure|0|||
146707402|NCT01332305|529102046|FG000|Overall Study|Physician Decision|0|||
146707403|NCT01332305|529102047|FG001|Overall Study|Physician Decision|0|||
146707404|NCT01332305|529102048|FG002|Overall Study|Physician Decision|0|||
146707405|NCT01332305|529102049|FG003|Overall Study|Physician Decision|1|||
146707406|NCT01332305|529102050|FG004|Overall Study|Physician Decision|0|||
146707407|NCT03192150|529102051|FG000|Overall Study|Adverse Event|14|||
146707408|NCT03192150|529102052|FG001|Overall Study|Adverse Event|12|||
146707409|NCT03192150|529102051|FG000|Overall Study|Lack of Efficacy|23|||
146707410|NCT03192150|529102052|FG001|Overall Study|Lack of Efficacy|30|||
146707411|NCT03192150|529102051|FG000|Overall Study|Lost to Follow-up|1|||
146707412|NCT03192150|529102052|FG001|Overall Study|Lost to Follow-up|1|||
146707413|NCT03192150|529102051|FG000|Overall Study|Withdrawal by Subject|4|||
146707414|NCT03192150|529102052|FG001|Overall Study|Withdrawal by Subject|2|||
146707415|NCT03192150|529102051|FG000|Overall Study|Protocol Violation|5|||
146707416|NCT03192150|529102052|FG001|Overall Study|Protocol Violation|2|||
146707417|NCT03192150|529102051|FG000|Overall Study|Surgery Canceled|6|||
146707418|NCT03192150|529102052|FG001|Overall Study|Surgery Canceled|2|||
146707419|NCT03192150|529102051|FG000|Overall Study|Other-Various Administrative Reasons|2|||
146707420|NCT03192150|529102052|FG001|Overall Study|Other-Various Administrative Reasons|5|||
146707421|NCT02579616|529102053|FG000|Overall Study|Participants did not receive treatment|3|||
146707422|NCT00482391|529102054|FG000|Overall Study|Withdrawal by Subject|1|||
146707423|NCT00482391|529102054|FG000|Overall Study|Adverse Event|1|||
146707424|NCT00482391|529102054|FG000|Overall Study|Death|1|||
146707425|NCT01448850|529102055|FG000|Overall Study|Death|3|||
146707426|NCT01448850|529102056|FG001|Overall Study|Death|6|||
146707427|NCT01448850|529102055|FG000|Overall Study|Withdrawal by Subject|13|||
146707428|NCT01448850|529102056|FG001|Overall Study|Withdrawal by Subject|21|||
146707429|NCT01448850|529102055|FG000|Overall Study|Lost to Follow-up|3|||
146707430|NCT01448850|529102056|FG001|Overall Study|Lost to Follow-up|1|||
146707431|NCT01448850|529102055|FG000|Overall Study|Other|15|||
146707432|NCT01448850|529102056|FG001|Overall Study|Other|12|||
146707433|NCT02664038|529102059|FG000|13 Week|Lost to Follow-up|7|||
146707434|NCT02664038|529102060|FG001|13 Week|Lost to Follow-up|14|||
146707435|NCT02664038|529102059|FG000|13 Week|Withdrawal by Subject|1|||
146707436|NCT02664038|529102060|FG001|13 Week|Withdrawal by Subject|0|||
146707437|NCT02664038|529102059|FG000|26 Week|Lost to Follow-up|5|||
146707438|NCT02664038|529102060|FG001|26 Week|Lost to Follow-up|4|||
146707439|NCT02606136|529102063|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
146707440|NCT02606136|529102063|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
146707441|NCT02606136|529102063|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
146707442|NCT02606136|529102063|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
146707443|NCT00086580|529102067|FG000|Treatment Period|Disease progression|9|||
146707444|NCT00086580|529102068|FG001|Treatment Period|Disease progression|8|||
146707445|NCT00086580|529102067|FG000|Treatment Period|Unable to comply with protocol|3|||
146707446|NCT00086580|529102068|FG001|Treatment Period|Unable to comply with protocol|1|||
146707447|NCT00086580|529102067|FG000|Treatment Period|Withdrawal by Subject|7|||
146707448|NCT00086580|529102068|FG001|Treatment Period|Withdrawal by Subject|8|||
146707449|NCT00086580|529102067|FG000|Treatment Period|Physician Decision|13|||
146707450|NCT00086580|529102068|FG001|Treatment Period|Physician Decision|7|||
146707451|NCT00086580|529102067|FG000|Treatment Period|AE - not treatment related|7|||
146933774|NCT01807949|529915991|FG001|Overall Study|Non-Compliance|0|||
146933775|NCT01807949|529915992|FG002|Overall Study|Non-Compliance|1|||
146933776|NCT01807949|529915990|FG000|Overall Study|Undefined|0|||
146933777|NCT01807949|529915991|FG001|Overall Study|Undefined|1|||
146933778|NCT01807949|529915992|FG002|Overall Study|Undefined|2|||
146707452|NCT00086580|529102068|FG001|Treatment Period|AE - not treatment related|7|||
146707453|NCT00086580|529102067|FG000|Treatment Period|Toxicity - treatment related|15|||
146707454|NCT00086580|529102068|FG001|Treatment Period|Toxicity - treatment related|15|||
146707455|NCT00086580|529102067|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
146707456|NCT00086580|529102068|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
146707457|NCT00086580|529102067|FG000|Treatment Period|Death|5|||
146707458|NCT00086580|529102068|FG001|Treatment Period|Death|7|||
146707459|NCT00086580|529102067|FG000|Treatment Period|Other|5|||
146707460|NCT00086580|529102068|FG001|Treatment Period|Other|3|||
146707461|NCT00086580|529102067|FG000|Follow-up Period|Disease progression|72|||
146777516|NCT03398148|529355272|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146777517|NCT03398148|529355258|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
146777518|NCT03398148|529355259|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
146777519|NCT03398148|529355260|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
146777520|NCT03398148|529355261|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
146777521|NCT03398148|529355262|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
146777522|NCT03398148|529355263|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
146777523|NCT03398148|529355264|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
146777524|NCT03398148|529355265|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
146777525|NCT03398148|529355266|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
146777526|NCT03398148|529355267|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
146777527|NCT03398148|529355268|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
146777528|NCT03398148|529355269|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
146777529|NCT03398148|529355270|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
146777530|NCT03398148|529355271|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
146777531|NCT03398148|529355272|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
146777532|NCT03398148|529355258|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146777533|NCT03398148|529355259|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146777534|NCT03398148|529355260|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146777535|NCT03398148|529355261|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146777536|NCT03398148|529355262|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146777537|NCT03398148|529355263|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146777538|NCT03398148|529355264|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146777539|NCT03398148|529355265|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146777540|NCT03398148|529355266|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146777541|NCT03398148|529355267|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146777542|NCT03398148|529355268|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
146777543|NCT03398148|529355269|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146777544|NCT03398148|529355270|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146777545|NCT03398148|529355271|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146777546|NCT03398148|529355272|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146777547|NCT03398148|529355258|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777548|NCT03398148|529355259|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777549|NCT03398148|529355260|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777550|NCT03398148|529355261|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777551|NCT03398148|529355262|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777552|NCT03398148|529355263|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777553|NCT03398148|529355264|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777554|NCT03398148|529355265|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777555|NCT03398148|529355266|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777556|NCT03398148|529355267|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777557|NCT03398148|529355268|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
146777558|NCT03398148|529355269|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777559|NCT03398148|529355270|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777560|NCT03398148|529355271|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777561|NCT03398148|529355272|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146777562|NCT03398148|529355258|FG000|Substudy 2 Period 1|Other|0|||
146777563|NCT03398148|529355259|FG001|Substudy 2 Period 1|Other|0|||
146777564|NCT03398148|529355260|FG002|Substudy 2 Period 1|Other|0|||
146933779|NCT01807949|529915990|FG000|Overall Study|Randomized But Not Treated|0|||
146707462|NCT00086580|529102068|FG001|Follow-up Period|Disease progression|99|||
146707463|NCT00086580|529102067|FG000|Follow-up Period|Unable to comply with protocol|5|||
146777565|NCT03398148|529355261|FG003|Substudy 2 Period 1|Other|0|||
146777566|NCT03398148|529355262|FG004|Substudy 2 Period 1|Other|0|||
146777567|NCT03398148|529355263|FG005|Substudy 2 Period 1|Other|0|||
146777568|NCT03398148|529355264|FG006|Substudy 2 Period 1|Other|0|||
146777569|NCT03398148|529355265|FG007|Substudy 2 Period 1|Other|0|||
146933780|NCT01807949|529915991|FG001|Overall Study|Randomized But Not Treated|2|||
146933781|NCT01807949|529915992|FG002|Overall Study|Randomized But Not Treated|2|||
146777570|NCT03398148|529355266|FG008|Substudy 2 Period 1|Other|0|||
146777571|NCT03398148|529355267|FG009|Substudy 2 Period 1|Other|4|||
146777572|NCT03398148|529355268|FG010|Substudy 2 Period 1|Other|4|||
146777573|NCT03398148|529355269|FG011|Substudy 2 Period 1|Other|0|||
146777574|NCT03398148|529355270|FG012|Substudy 2 Period 1|Other|0|||
146777575|NCT03398148|529355271|FG013|Substudy 2 Period 1|Other|0|||
146777576|NCT03398148|529355272|FG014|Substudy 2 Period 1|Other|0|||
146777577|NCT03398148|529355258|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
146777578|NCT03398148|529355259|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
146777579|NCT03398148|529355260|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
146777580|NCT03398148|529355261|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
146777581|NCT03398148|529355262|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
146777582|NCT03398148|529355263|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
146777583|NCT03398148|529355264|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
146777584|NCT03398148|529355265|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
146777585|NCT03398148|529355266|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
146777586|NCT03398148|529355267|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
146777587|NCT03398148|529355268|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
146777588|NCT03398148|529355269|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
146777589|NCT03398148|529355270|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
146777590|NCT03398148|529355271|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
146777591|NCT03398148|529355272|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
146777592|NCT03398148|529355258|FG000|Substudy 2 Period 2|Adverse Event|0|||
146777593|NCT03398148|529355259|FG001|Substudy 2 Period 2|Adverse Event|0|||
146777594|NCT03398148|529355260|FG002|Substudy 2 Period 2|Adverse Event|0|||
146777595|NCT03398148|529355261|FG003|Substudy 2 Period 2|Adverse Event|0|||
146777596|NCT03398148|529355262|FG004|Substudy 2 Period 2|Adverse Event|0|||
146777597|NCT03398148|529355263|FG005|Substudy 2 Period 2|Adverse Event|0|||
146777598|NCT03398148|529355264|FG006|Substudy 2 Period 2|Adverse Event|0|||
146777599|NCT03398148|529355265|FG007|Substudy 2 Period 2|Adverse Event|0|||
146777600|NCT03398148|529355266|FG008|Substudy 2 Period 2|Adverse Event|0|||
146777601|NCT03398148|529355267|FG009|Substudy 2 Period 2|Adverse Event|0|||
146777602|NCT03398148|529355268|FG010|Substudy 2 Period 2|Adverse Event|0|||
146777603|NCT03398148|529355269|FG011|Substudy 2 Period 2|Adverse Event|0|||
146777604|NCT03398148|529355270|FG012|Substudy 2 Period 2|Adverse Event|0|||
146777605|NCT03398148|529355271|FG013|Substudy 2 Period 2|Adverse Event|1|||
146777606|NCT03398148|529355272|FG014|Substudy 2 Period 2|Adverse Event|3|||
146777607|NCT03398148|529355258|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
146777608|NCT03398148|529355259|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
146777609|NCT03398148|529355260|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
146777610|NCT03398148|529355261|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
146777611|NCT03398148|529355262|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
146777612|NCT03398148|529355263|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
146777613|NCT03398148|529355264|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
146777614|NCT03398148|529355265|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
146777615|NCT03398148|529355266|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
146777616|NCT03398148|529355267|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
146777617|NCT03398148|529355268|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
146777618|NCT03398148|529355269|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
146777619|NCT03398148|529355270|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
146777620|NCT03398148|529355271|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
146777621|NCT03398148|529355272|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
146777622|NCT03398148|529355258|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146777623|NCT03398148|529355259|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146777624|NCT03398148|529355260|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146777625|NCT03398148|529355261|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146777626|NCT03398148|529355262|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146777627|NCT03398148|529355263|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146777628|NCT03398148|529355264|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146777629|NCT03398148|529355265|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146777630|NCT03398148|529355266|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146933782|NCT00830960|529915995|FG000|Overall Study|Death|5|||
146933783|NCT00830960|529915996|FG001|Overall Study|Death|4|||
146777631|NCT03398148|529355267|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146777632|NCT03398148|529355268|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146777633|NCT03398148|529355269|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
146777634|NCT03398148|529355270|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146777635|NCT03398148|529355271|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
146933784|NCT00830960|529915997|FG002|Overall Study|Death|3|||
146777636|NCT03398148|529355272|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
146777637|NCT03398148|529355258|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
146777638|NCT03398148|529355259|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
146777639|NCT03398148|529355260|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
146777640|NCT03398148|529355261|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
146933785|NCT00830960|529915998|FG003|Overall Study|Death|2|||
146933786|NCT00830960|529915999|FG004|Overall Study|Death|6|||
146777641|NCT03398148|529355262|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
146933787|NCT00830960|529916000|FG005|Overall Study|Death|1|||
146777642|NCT03398148|529355263|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
146777643|NCT03398148|529355264|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
146777644|NCT03398148|529355265|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
146777645|NCT03398148|529355266|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
146777646|NCT03398148|529355267|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
146777647|NCT03398148|529355268|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
146777648|NCT03398148|529355269|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
146777649|NCT03398148|529355270|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
146777650|NCT03398148|529355271|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
146777651|NCT03398148|529355272|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
146777652|NCT03398148|529355258|FG000|Substudy 2 Period 2|Other|0|||
146777653|NCT03398148|529355259|FG001|Substudy 2 Period 2|Other|0|||
146777654|NCT03398148|529355260|FG002|Substudy 2 Period 2|Other|0|||
146777655|NCT03398148|529355261|FG003|Substudy 2 Period 2|Other|0|||
146777656|NCT03398148|529355262|FG004|Substudy 2 Period 2|Other|0|||
146777657|NCT03398148|529355263|FG005|Substudy 2 Period 2|Other|0|||
146777658|NCT03398148|529355264|FG006|Substudy 2 Period 2|Other|0|||
146777659|NCT03398148|529355265|FG007|Substudy 2 Period 2|Other|0|||
146777660|NCT03398148|529355266|FG008|Substudy 2 Period 2|Other|0|||
146707464|NCT00086580|529102068|FG001|Follow-up Period|Unable to comply with protocol|0|||
146707465|NCT00086580|529102067|FG000|Follow-up Period|Withdrawal by Subject|6|||
146707466|NCT00086580|529102068|FG001|Follow-up Period|Withdrawal by Subject|6|||
146707467|NCT00086580|529102067|FG000|Follow-up Period|Physician Decision|0|||
146707468|NCT00086580|529102068|FG001|Follow-up Period|Physician Decision|1|||
146707469|NCT00086580|529102067|FG000|Follow-up Period|AE - not related|1|||
146707470|NCT00086580|529102068|FG001|Follow-up Period|AE - not related|0|||
146707471|NCT00086580|529102067|FG000|Follow-up Period|Death|13|||
146707472|NCT00086580|529102068|FG001|Follow-up Period|Death|7|||
146707473|NCT00086580|529102067|FG000|Follow-up Period|Other|7|||
146707474|NCT00086580|529102068|FG001|Follow-up Period|Other|6|||
146707475|NCT00086580|529102067|FG000|Observation Period|Unable to comply with protocol|1|||
146707476|NCT00086580|529102068|FG001|Observation Period|Unable to comply with protocol|1|||
146707477|NCT00086580|529102067|FG000|Observation Period|Withdrawal by Subject|4|||
146707478|NCT00086580|529102068|FG001|Observation Period|Withdrawal by Subject|2|||
146707479|NCT00086580|529102067|FG000|Observation Period|Death|33|||
146707480|NCT00086580|529102068|FG001|Observation Period|Death|55|||
146707481|NCT00086580|529102067|FG000|Observation Period|Other|8|||
146707482|NCT00086580|529102068|FG001|Observation Period|Other|7|||
146707483|NCT03235024|529102069|FG000|Overall Study|Adverse Event|2|||
146707484|NCT03235024|529102070|FG001|Overall Study|Adverse Event|2|||
146707485|NCT03235024|529102069|FG000|Overall Study|Death|1|||
146707486|NCT03235024|529102070|FG001|Overall Study|Death|0|||
146707487|NCT03235024|529102069|FG000|Overall Study|Lost to Follow-up|2|||
146707488|NCT03235024|529102070|FG001|Overall Study|Lost to Follow-up|5|||
146707489|NCT03235024|529102069|FG000|Overall Study|Protocol Violation|1|||
146707490|NCT03235024|529102070|FG001|Overall Study|Protocol Violation|0|||
146707491|NCT03235024|529102069|FG000|Overall Study|Withdrawal by Subject|0|||
146707492|NCT03235024|529102070|FG001|Overall Study|Withdrawal by Subject|3|||
146707493|NCT02357576|529102071|FG000|Treatment Period|Withdrawal by Subject|0|||
146707494|NCT02357576|529102072|FG001|Treatment Period|Withdrawal by Subject|1|||
146707495|NCT02357576|529102071|FG000|Treatment Period|Physician Decision|0|||
146707496|NCT02357576|529102072|FG001|Treatment Period|Physician Decision|1|||
146707497|NCT02357576|529102071|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
146707498|NCT02357576|529102072|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
146707499|NCT02357576|529102071|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
146707500|NCT02357576|529102072|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
146707501|NCT02357576|529102071|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
146707502|NCT02357576|529102072|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
146707503|NCT02357576|529102071|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
146707504|NCT02357576|529102072|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
146707505|NCT00699699|529102073|FG000|Overall Study|Adverse Event|36|||
146707506|NCT00699699|529102073|FG000|Overall Study|Individual different reasons|21|||
146707507|NCT00705575|529102074|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146707508|NCT00705575|529102075|FG001|Overall Study|Abnormal laboratory value(s)|3|||
146707509|NCT00705575|529102074|FG000|Overall Study|Abnormal test procedure result(s)|2|||
146707510|NCT00705575|529102075|FG001|Overall Study|Abnormal test procedure result(s)|12|||
146707511|NCT00705575|529102074|FG000|Overall Study|Adverse Event|11|||
146707512|NCT00705575|529102075|FG001|Overall Study|Adverse Event|15|||
146707513|NCT00705575|529102074|FG000|Overall Study|Lost to Follow-up|3|||
146707514|NCT00705575|529102075|FG001|Overall Study|Lost to Follow-up|4|||
146707515|NCT00705575|529102074|FG000|Overall Study|Protocol Violation|2|||
146777661|NCT03398148|529355267|FG009|Substudy 2 Period 2|Other|0|||
146777662|NCT03398148|529355268|FG010|Substudy 2 Period 2|Other|0|||
146707516|NCT00705575|529102075|FG001|Overall Study|Protocol Violation|2|||
146707517|NCT00705575|529102074|FG000|Overall Study|Withdrawal by Subject|5|||
146707518|NCT00705575|529102075|FG001|Overall Study|Withdrawal by Subject|10|||
146707519|NCT01959581|529102079|FG000|Overall Study|Lost to Follow-up|5|||
146777663|NCT03398148|529355269|FG011|Substudy 2 Period 2|Other|0|||
146777664|NCT03398148|529355270|FG012|Substudy 2 Period 2|Other|0|||
146777665|NCT03398148|529355271|FG013|Substudy 2 Period 2|Other|1|||
146777666|NCT03398148|529355272|FG014|Substudy 2 Period 2|Other|1|||
146777667|NCT03398148|529355258|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
146777668|NCT03398148|529355259|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
146777669|NCT03398148|529355260|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
146777670|NCT03398148|529355261|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
146777671|NCT03398148|529355262|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
146777672|NCT03398148|529355263|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
146777673|NCT03398148|529355264|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
146777674|NCT03398148|529355265|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
146777675|NCT03398148|529355266|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
146777676|NCT03398148|529355267|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
146777677|NCT03398148|529355268|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
146777678|NCT03398148|529355269|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
146777679|NCT03398148|529355270|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
146777680|NCT03398148|529355271|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
146777681|NCT03398148|529355272|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
146777682|NCT00212355|529355273|FG000|Overall Study|Adverse Event|1|||
146777683|NCT00212355|529355273|FG000|Overall Study|Withdrawal by Subject|1|||
146777684|NCT00212355|529355273|FG000|Overall Study|A change of address|1|||
146777685|NCT03012841|529355279|FG000|Overall Study|Protocol Violation|0|||
146777686|NCT03012841|529355280|FG001|Overall Study|Protocol Violation|10|||
146777687|NCT03012841|529355279|FG000|Overall Study|Lost to Follow-up|6|||
146777688|NCT03012841|529355280|FG001|Overall Study|Lost to Follow-up|1|||
146777689|NCT03012841|529355279|FG000|Overall Study|Withdrawal by Subject|6|||
146777690|NCT03012841|529355280|FG001|Overall Study|Withdrawal by Subject|0|||
146777691|NCT03012841|529355279|FG000|Overall Study|Unable to complete 12 month visit|6|||
146707520|NCT02075320|529102082|FG000|Overall Study|Withdrawal by Subject|2|||
146707521|NCT03773757|529102084|FG000|Overall Study|Withdrawal by Subject|2|||
146707522|NCT03773757|529102085|FG001|Overall Study|Withdrawal by Subject|4|||
146707523|NCT02985736|529102092|FG000|Overall Study|Lost to Follow-up|3|||
146707524|NCT00382733|529102093|FG000|Overall Study|Withdrawal by Subject|0|||
146707525|NCT00382733|529102094|FG001|Overall Study|Withdrawal by Subject|1|||
146707526|NCT00382733|529102095|FG002|Overall Study|Withdrawal by Subject|0|||
146707527|NCT00382733|529102096|FG003|Overall Study|Withdrawal by Subject|0|||
146707528|NCT00382733|529102097|FG004|Overall Study|Withdrawal by Subject|0|||
146707529|NCT00179413|529102098|FG000|Overall Study|Adverse Event|38|||
146777692|NCT03012841|529355280|FG001|Overall Study|Unable to complete 12 month visit|0|||
146777693|NCT03012841|529355279|FG000|Overall Study|Subject relocation|1|||
146777694|NCT03012841|529355280|FG001|Overall Study|Subject relocation|0|||
146777695|NCT03012841|529355279|FG000|Overall Study|Seasonal winter travel|1|||
146777696|NCT03012841|529355280|FG001|Overall Study|Seasonal winter travel|0|||
146777697|NCT03012841|529355279|FG000|Overall Study|Physician Decision|0|||
146777698|NCT03012841|529355280|FG001|Overall Study|Physician Decision|2|||
146777699|NCT03012841|529355279|FG000|Overall Study|No ablation performed|0|||
146777700|NCT03012841|529355280|FG001|Overall Study|No ablation performed|2|||
146777701|NCT03012841|529355279|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
146777702|NCT03012841|529355280|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
146777703|NCT03012841|529355279|FG000|Overall Study|Insurance change|0|||
146777704|NCT03012841|529355280|FG001|Overall Study|Insurance change|1|||
146777705|NCT03954184|529355281|FG000|Overall Study|Lost to Follow-up|500|||
146777706|NCT03954184|529355282|FG001|Overall Study|Lost to Follow-up|0|||
146777707|NCT03397108|529355283|FG000|Overall Study|Lost to Follow-up|15|||
146777708|NCT03397108|529355284|FG001|Overall Study|Lost to Follow-up|0|||
146777709|NCT03397108|529355283|FG000|Overall Study|Insufficient milk production|3|||
146777710|NCT03397108|529355284|FG001|Overall Study|Insufficient milk production|2|||
146777711|NCT03397108|529355283|FG000|Overall Study|Withdrawal by Subject|2|||
146777712|NCT03397108|529355284|FG001|Overall Study|Withdrawal by Subject|0|||
146777713|NCT05104697|529355285|FG000|Overall Study|Withdrawal by Subject|0|||
146777714|NCT05104697|529355286|FG001|Overall Study|Withdrawal by Subject|1|||
146777715|NCT04468776|529355287|FG000|Overall Study|Lost to Follow-up|4|||
146777716|NCT04468776|529355288|FG001|Overall Study|Lost to Follow-up|3|||
146777717|NCT04468776|529355289|FG002|Overall Study|Lost to Follow-up|4|||
146777718|NCT04468776|529355287|FG000|Overall Study|Withdrawal by Subject|1|||
146981041|NCT00549198|530093718|FG000|Overall Study|Investigator Decision|4|||
146707530|NCT00179413|529102099|FG001|Overall Study|Adverse Event|20|||
146777719|NCT04468776|529355288|FG001|Overall Study|Withdrawal by Subject|10|||
146777720|NCT04468776|529355289|FG002|Overall Study|Withdrawal by Subject|4|||
146777721|NCT04468776|529355287|FG000|Overall Study|Physician Decision|0|||
146777722|NCT04468776|529355288|FG001|Overall Study|Physician Decision|1|||
146777723|NCT04468776|529355289|FG002|Overall Study|Physician Decision|1|||
146777724|NCT05613205|529355290|FG000|Overall Study|Lost to Follow-up|0|||
146777725|NCT05613205|529355291|FG001|Overall Study|Lost to Follow-up|0|||
146777726|NCT05613205|529355292|FG002|Overall Study|Lost to Follow-up|1|||
146707531|NCT00179413|529102098|FG000|Overall Study|Withdrawal by Subject|87|||
146707532|NCT00179413|529102099|FG001|Overall Study|Withdrawal by Subject|95|||
146707533|NCT00550836|529102100|FG000|Overall Study|Withdrawal by Subject|3|||
146707534|NCT00550836|529102101|FG001|Overall Study|Withdrawal by Subject|9|||
146707535|NCT00439140|529102104|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
146707536|NCT00439140|529102105|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
146707537|NCT00439140|529102106|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
146707538|NCT00439140|529102104|FG000|Treatment Cycle 1|Personal reasons|0|||
146707539|NCT00439140|529102105|FG001|Treatment Cycle 1|Personal reasons|2|||
146707540|NCT00439140|529102106|FG002|Treatment Cycle 1|Personal reasons|0|||
146707541|NCT00439140|529102104|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
146707542|NCT00439140|529102105|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
146707543|NCT00439140|529102106|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
146707544|NCT00439140|529102104|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
146707545|NCT00439140|529102105|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
146777727|NCT05613205|529355293|FG003|Overall Study|Lost to Follow-up|1|||
146777728|NCT05613205|529355294|FG004|Overall Study|Lost to Follow-up|0|||
146777729|NCT05613205|529355290|FG000|Overall Study|Withdrawal by Subject|0|||
146777730|NCT05613205|529355291|FG001|Overall Study|Withdrawal by Subject|0|||
146777731|NCT05613205|529355292|FG002|Overall Study|Withdrawal by Subject|1|||
146777732|NCT05613205|529355293|FG003|Overall Study|Withdrawal by Subject|1|||
146777733|NCT05613205|529355294|FG004|Overall Study|Withdrawal by Subject|0|||
146777734|NCT03103321|529355297|FG000|Overall Study|Protocol Violation|1|||
146777735|NCT03103321|529355298|FG001|Overall Study|Protocol Violation|1|||
146777736|NCT03103321|529355299|FG002|Overall Study|Protocol Violation|1|||
146777737|NCT03103321|529355300|FG003|Overall Study|Protocol Violation|0|||
146777738|NCT06629454|529355304|FG000|Overall Study|Withdraw by Clinician Decision|1|||
146777739|NCT01704079|529355305|FG000|Overall Study|Withdrawal by Subject|5|||
146777740|NCT01704079|529355306|FG001|Overall Study|Withdrawal by Subject|7|||
146777741|NCT01704079|529355305|FG000|Overall Study|Lost to Follow-up|2|||
146777742|NCT01704079|529355306|FG001|Overall Study|Lost to Follow-up|5|||
146777743|NCT01704079|529355305|FG000|Overall Study|Adverse Event|4|||
146777744|NCT01704079|529355306|FG001|Overall Study|Adverse Event|7|||
146777745|NCT01704079|529355305|FG000|Overall Study|Protocol Violation|1|||
146777746|NCT01704079|529355306|FG001|Overall Study|Protocol Violation|0|||
146777747|NCT01704079|529355305|FG000|Overall Study|Subject noncompliance|2|||
146777748|NCT01704079|529355306|FG001|Overall Study|Subject noncompliance|3|||
146777749|NCT01704079|529355305|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
146777750|NCT01704079|529355306|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
146777751|NCT05846646|529355312|FG000|Overall Study|Physician Decision|1|||
146777752|NCT05846646|529355313|FG001|Overall Study|Physician Decision|0|||
146777753|NCT05846646|529355314|FG002|Overall Study|Physician Decision|0|||
146777754|NCT05846646|529355312|FG000|Overall Study|Lack of Efficacy|1|||
146777755|NCT05846646|529355313|FG001|Overall Study|Lack of Efficacy|1|||
146777756|NCT05846646|529355314|FG002|Overall Study|Lack of Efficacy|0|||
146777757|NCT05846646|529355312|FG000|Overall Study|Early Study Termination|1|||
146777758|NCT05846646|529355313|FG001|Overall Study|Early Study Termination|2|||
146777759|NCT05846646|529355314|FG002|Overall Study|Early Study Termination|0|||
146777760|NCT00505934|529355315|FG000|Overall Study|Adverse Event|1|||
146777761|NCT00505934|529355315|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
146777762|NCT00505934|529355315|FG000|Overall Study|Other: IV dose needed to be changed|1|||
146777763|NCT02461628|529355320|FG000|Overall Study|Refused to complete survey|4|||
146777764|NCT02461628|529355321|FG001|Overall Study|Refused to complete survey|7|||
146777765|NCT02015520|529355322|FG000|Overall Study|Lack of Efficacy|1|||
146777766|NCT02015520|529355323|FG001|Overall Study|Lack of Efficacy|0|||
146777767|NCT02015520|529355324|FG002|Overall Study|Lack of Efficacy|3|||
146777768|NCT02015520|529355325|FG003|Overall Study|Lack of Efficacy|2|||
146777769|NCT02015520|529355322|FG000|Overall Study|Adverse Event|0|||
146777770|NCT02015520|529355323|FG001|Overall Study|Adverse Event|0|||
146777771|NCT02015520|529355324|FG002|Overall Study|Adverse Event|0|||
146777772|NCT02015520|529355325|FG003|Overall Study|Adverse Event|1|||
146777773|NCT02015520|529355322|FG000|Overall Study|Withdrawal by Subject|2|||
146777774|NCT02015520|529355323|FG001|Overall Study|Withdrawal by Subject|2|||
146777775|NCT02015520|529355324|FG002|Overall Study|Withdrawal by Subject|1|||
146777776|NCT02015520|529355325|FG003|Overall Study|Withdrawal by Subject|0|||
146777777|NCT02015520|529355322|FG000|Overall Study|Death|1|||
146777778|NCT02015520|529355323|FG001|Overall Study|Death|0|||
146777779|NCT02015520|529355324|FG002|Overall Study|Death|0|||
146777780|NCT02015520|529355325|FG003|Overall Study|Death|0|||
146777781|NCT02015520|529355322|FG000|Overall Study|Lost to Follow-up|0|||
146777782|NCT02015520|529355323|FG001|Overall Study|Lost to Follow-up|0|||
146777783|NCT02015520|529355324|FG002|Overall Study|Lost to Follow-up|1|||
146777784|NCT02015520|529355325|FG003|Overall Study|Lost to Follow-up|0|||
146777785|NCT02015520|529355322|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
146777786|NCT02015520|529355323|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
146777787|NCT02015520|529355324|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
146777788|NCT02015520|529355325|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
146707546|NCT00439140|529102106|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
146707547|NCT00439140|529102104|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
146707548|NCT00439140|529102105|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
146707549|NCT00439140|529102106|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
146707550|NCT01458171|529102107|FG000|Overall Study|Adverse Event|1|||
146707551|NCT00578565|529102111|FG000|Overall Study|Adverse Event|3|||
146707552|NCT01192152|529102112|FG000|Period 1|left prematurely (while on treatment B)|0|||
146707553|NCT01192152|529102113|FG001|Period 1|left prematurely (while on treatment B)|1|||
146707554|NCT01192152|529102112|FG000|Period 3|family emergency|1|||
146707555|NCT01192152|529102113|FG001|Period 3|family emergency|0|||
146707556|NCT01559311|529102115|FG000|Overall Study|Protocol Violation|0|||
146707557|NCT01559311|529102116|FG001|Overall Study|Protocol Violation|0|||
146707558|NCT01559311|529102117|FG002|Overall Study|Protocol Violation|2|||
146707559|NCT01559311|529102115|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
146707560|NCT01559311|529102116|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
146707561|NCT01559311|529102117|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
146707562|NCT01559311|529102115|FG000|Overall Study|Withdrawal by Subject|2|||
146707563|NCT01559311|529102116|FG001|Overall Study|Withdrawal by Subject|1|||
146707564|NCT01559311|529102117|FG002|Overall Study|Withdrawal by Subject|0|||
146707565|NCT01559311|529102115|FG000|Overall Study|Death|0|||
146707566|NCT01559311|529102116|FG001|Overall Study|Death|2|||
146707567|NCT01559311|529102117|FG002|Overall Study|Death|3|||
146707568|NCT01559311|529102115|FG000|Overall Study|Lost to Follow-up|0|||
146707569|NCT01559311|529102116|FG001|Overall Study|Lost to Follow-up|3|||
146707570|NCT01559311|529102117|FG002|Overall Study|Lost to Follow-up|2|||
146707571|NCT01559311|529102115|FG000|Overall Study|Adverse Event|0|||
146707572|NCT01559311|529102116|FG001|Overall Study|Adverse Event|0|||
146707573|NCT01559311|529102117|FG002|Overall Study|Adverse Event|1|||
146707574|NCT05013905|529102118|FG000|Overall Study|Adverse Event|1|||
146707575|NCT05013905|529102118|FG000|Overall Study|Lack of Efficacy|1|||
146707576|NCT01849588|529102119|FG000|Overall Study|Lack of Efficacy|3|||
146707577|NCT00515827|529102120|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
146707578|NCT00515827|529102121|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
146707579|NCT00515827|529102120|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
146707580|NCT00515827|529102121|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
146707581|NCT03181542|529102122|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
146707582|NCT03181542|529102123|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
146707583|NCT01009099|529102124|FG000|Overall Study|Lost to Follow-up|1|||
146707584|NCT01009099|529102125|FG001|Overall Study|Lost to Follow-up|0|||
146707585|NCT01009099|529102124|FG000|Overall Study|Physician Decision|3|||
146707586|NCT01009099|529102125|FG001|Overall Study|Physician Decision|2|||
146707587|NCT01009099|529102124|FG000|Overall Study|Withdrawal by Subject|1|||
146707588|NCT01009099|529102125|FG001|Overall Study|Withdrawal by Subject|1|||
146707589|NCT01009099|529102124|FG000|Overall Study|Death|0|||
146707590|NCT01009099|529102125|FG001|Overall Study|Death|1|||
146707591|NCT01856543|529102126|FG000|Overall Study|Treatment discontinued|6|||
146707592|NCT01856543|529102127|FG001|Overall Study|Treatment discontinued|3|||
146707593|NCT01856543|529102126|FG000|Overall Study|Withdrawn before start|7|||
146707594|NCT01856543|529102127|FG001|Overall Study|Withdrawn before start|3|||
146707595|NCT01712984|529102128|FG000|Overall Study|Adverse Event|0|||
146707596|NCT01712984|529102129|FG001|Overall Study|Adverse Event|0|||
146707597|NCT01712984|529102130|FG002|Overall Study|Adverse Event|1|||
146707598|NCT01712984|529102128|FG000|Overall Study|Protocol Violation|2|||
146707599|NCT01712984|529102129|FG001|Overall Study|Protocol Violation|0|||
146707600|NCT01712984|529102130|FG002|Overall Study|Protocol Violation|1|||
146707601|NCT01712984|529102128|FG000|Overall Study|Lost to Follow-up|8|||
146707602|NCT01712984|529102129|FG001|Overall Study|Lost to Follow-up|10|||
146707603|NCT01712984|529102130|FG002|Overall Study|Lost to Follow-up|1|||
146707604|NCT01712984|529102128|FG000|Overall Study|Withdrawal by Subject|6|||
146707605|NCT01712984|529102129|FG001|Overall Study|Withdrawal by Subject|6|||
146707606|NCT01712984|529102130|FG002|Overall Study|Withdrawal by Subject|7|||
146707607|NCT01310413|529104050|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
146707608|NCT01310413|529104051|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
146707609|NCT01310413|529104052|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
146777789|NCT02015520|529355322|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
146707610|NCT01310413|529104053|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
146707611|NCT01310413|529104054|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
146707612|NCT01310413|529104055|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
146707613|NCT01310413|529104056|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
146707614|NCT01310413|529104050|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
146707615|NCT01310413|529104051|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
146707616|NCT01310413|529104052|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
146933788|NCT00830960|529915995|FG000|Overall Study|Lost to Follow-up|1|||
146707617|NCT01310413|529104053|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
146707618|NCT01310413|529104054|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
146933789|NCT00830960|529915996|FG001|Overall Study|Lost to Follow-up|1|||
146933790|NCT00830960|529915997|FG002|Overall Study|Lost to Follow-up|1|||
146933791|NCT00830960|529915998|FG003|Overall Study|Lost to Follow-up|0|||
146933792|NCT00830960|529915999|FG004|Overall Study|Lost to Follow-up|0|||
146933793|NCT00830960|529916000|FG005|Overall Study|Lost to Follow-up|1|||
146933794|NCT00830960|529915995|FG000|Overall Study|Withdrawal by Subject|19|||
146707619|NCT01310413|529104055|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
146707620|NCT01310413|529104056|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
146707621|NCT01310413|529104050|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
146707622|NCT01310413|529104051|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
146707623|NCT01310413|529104052|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
146707624|NCT01310413|529104053|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
146707625|NCT01310413|529104054|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
146707626|NCT01310413|529104055|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
146707627|NCT01310413|529104056|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
146707628|NCT01310413|529104050|FG000|Day 0 to Day 385|Other|1|||
146707629|NCT01310413|529104051|FG001|Day 0 to Day 385|Other|0|||
146707630|NCT01310413|529104052|FG002|Day 0 to Day 385|Other|3|||
146707631|NCT01310413|529104053|FG003|Day 0 to Day 385|Other|0|||
146707632|NCT01310413|529104054|FG004|Day 0 to Day 385|Other|0|||
146707633|NCT01310413|529104055|FG005|Day 0 to Day 385|Other|0|||
146707634|NCT01310413|529104056|FG006|Day 0 to Day 385|Other|0|||
146707635|NCT01310413|529104050|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
146707636|NCT01310413|529104051|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
146707637|NCT01310413|529104052|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
146707638|NCT01310413|529104053|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
146707639|NCT01310413|529104054|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
146707640|NCT01310413|529104055|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
146707641|NCT01310413|529104056|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
146707642|NCT01310413|529104050|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
146707643|NCT01310413|529104051|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
146707644|NCT01310413|529104052|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
146707645|NCT01310413|529104053|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
146707646|NCT01310413|529104054|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
146707647|NCT01310413|529104055|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
146707648|NCT01310413|529104056|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
146707649|NCT02564471|529104057|FG000|Overall Study|Adverse Event|1|||
146707650|NCT02564471|529104058|FG001|Overall Study|Adverse Event|0|||
146707651|NCT02564471|529104059|FG002|Overall Study|Adverse Event|0|||
146707652|NCT02564471|529104060|FG003|Overall Study|Adverse Event|0|||
146707653|NCT02564471|529104057|FG000|Overall Study|Withdrawal by Subject|2|||
146707654|NCT02564471|529104058|FG001|Overall Study|Withdrawal by Subject|1|||
146707655|NCT02564471|529104059|FG002|Overall Study|Withdrawal by Subject|3|||
146707656|NCT02564471|529104060|FG003|Overall Study|Withdrawal by Subject|0|||
146707657|NCT02564471|529104057|FG000|Overall Study|Lost to Follow-up|0|||
146707658|NCT02564471|529104058|FG001|Overall Study|Lost to Follow-up|2|||
146707659|NCT02564471|529104059|FG002|Overall Study|Lost to Follow-up|0|||
146707660|NCT02564471|529104060|FG003|Overall Study|Lost to Follow-up|0|||
146707661|NCT00941733|529104061|FG000|Overall Study|Death|24|||
146707662|NCT00941733|529104062|FG001|Overall Study|Death|10|||
146707663|NCT00941733|529104061|FG000|Overall Study|Withdrawal by Subject|14|||
146707664|NCT00941733|529104062|FG001|Overall Study|Withdrawal by Subject|6|||
146707665|NCT00941733|529104061|FG000|Overall Study|Adverse Event|20|||
146707666|NCT00941733|529104062|FG001|Overall Study|Adverse Event|4|||
146707667|NCT00941733|529104061|FG000|Overall Study|Lost to Follow-up|1|||
146707668|NCT00941733|529104062|FG001|Overall Study|Lost to Follow-up|2|||
146707669|NCT00941733|529104061|FG000|Overall Study|Protocol Violation|15|||
146707670|NCT00941733|529104062|FG001|Overall Study|Protocol Violation|6|||
146707671|NCT03019536|529104065|FG000|Overall Study|Withdrawal by Subject|1|||
146707672|NCT03019536|529104066|FG001|Overall Study|Withdrawal by Subject|1|||
146707673|NCT03019536|529104067|FG002|Overall Study|Withdrawal by Subject|0|||
146707674|NCT03019536|529104065|FG000|Overall Study|Adverse Event|0|||
146707675|NCT03019536|529104066|FG001|Overall Study|Adverse Event|0|||
146707676|NCT03019536|529104067|FG002|Overall Study|Adverse Event|2|||
146707677|NCT00182689|529104073|FG000|Overall Study|Adverse Event|8|||
146707678|NCT00182689|529104074|FG001|Overall Study|Adverse Event|11|||
146707679|NCT00182689|529104073|FG000|Overall Study|Withdrawal by Subject|2|||
146707680|NCT00182689|529104074|FG001|Overall Study|Withdrawal by Subject|2|||
146707681|NCT00182689|529104073|FG000|Overall Study|Progression|27|||
146707682|NCT00182689|529104074|FG001|Overall Study|Progression|29|||
146707683|NCT00182689|529104073|FG000|Overall Study|Death|1|||
146707684|NCT00182689|529104074|FG001|Overall Study|Death|0|||
146707685|NCT00182689|529104073|FG000|Overall Study|not protocol specified|0|||
146707686|NCT00182689|529104074|FG001|Overall Study|not protocol specified|3|||
146707687|NCT00182689|529104073|FG000|Overall Study|Ineligible|1|||
146707688|NCT00182689|529104074|FG001|Overall Study|Ineligible|4|||
146707689|NCT00182689|529104073|FG000|Overall Study|Never received treatment|1|||
146707690|NCT00182689|529104074|FG001|Overall Study|Never received treatment|0|||
146707691|NCT01640301|529104075|FG000|Overall Study|Death|0|||
146777790|NCT02015520|529355323|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
146777791|NCT02015520|529355324|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
146777792|NCT02015520|529355325|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
146777793|NCT00998881|529355329|FG000|Overall Study|Adverse Event|2|||
146777794|NCT00998881|529355330|FG001|Overall Study|Adverse Event|2|||
146777795|NCT00998881|529355329|FG000|Overall Study|Lack of Efficacy|1|||
146777796|NCT00998881|529355330|FG001|Overall Study|Lack of Efficacy|0|||
146777797|NCT00998881|529355329|FG000|Overall Study|Physician Decision|3|||
146777798|NCT00998881|529355330|FG001|Overall Study|Physician Decision|0|||
146777799|NCT00998881|529355329|FG000|Overall Study|Withdrawal by Subject|1|||
146777800|NCT00998881|529355330|FG001|Overall Study|Withdrawal by Subject|0|||
146777801|NCT00998881|529355329|FG000|Overall Study|Personal matter|1|||
146777802|NCT00998881|529355330|FG001|Overall Study|Personal matter|0|||
146777803|NCT01619410|529355331|FG000|Overall Study|Lost to Follow-up|7|||
146777804|NCT01619410|529355332|FG001|Overall Study|Lost to Follow-up|4|||
146777805|NCT02462759|529355337|FG000|Part 1: Double Blind|Death|1|||
146777806|NCT02462759|529355338|FG001|Part 1: Double Blind|Death|0|||
146777807|NCT02462759|529355339|FG002|Part 1: Double Blind|Death|0|||
146777808|NCT04110054|529355340|FG000|Overall Study|COVID-19 reason other than AE|0|||
146777809|NCT04110054|529355341|FG001|Overall Study|COVID-19 reason other than AE|0|||
146777810|NCT04110054|529355342|FG002|Overall Study|COVID-19 reason other than AE|2|||
146777811|NCT04110054|529355343|FG003|Overall Study|COVID-19 reason other than AE|0|||
146777812|NCT04110054|529355340|FG000|Overall Study|Withdrawal by Subject|0|||
146777813|NCT04110054|529355341|FG001|Overall Study|Withdrawal by Subject|3|||
146777814|NCT04110054|529355342|FG002|Overall Study|Withdrawal by Subject|2|||
146777815|NCT04110054|529355343|FG003|Overall Study|Withdrawal by Subject|0|||
146777816|NCT04110054|529355340|FG000|Overall Study|Adverse Event|1|||
146777817|NCT04110054|529355341|FG001|Overall Study|Adverse Event|1|||
146777818|NCT04110054|529355342|FG002|Overall Study|Adverse Event|4|||
146777819|NCT04110054|529355343|FG003|Overall Study|Adverse Event|3|||
146777820|NCT01000480|529355345|FG000|Induction Phase|Adverse Event|2|||
146777821|NCT01000480|529355345|FG000|Induction Phase|Lost to Follow-up|1|||
146777822|NCT01000480|529355345|FG000|Induction Phase|Physician Decision|1|||
146777823|NCT01000480|529355345|FG000|Induction Phase|Entry Criteria Not Met|3|||
146777824|NCT01000480|529355345|FG000|Concurrent Therapy Phase|Adverse Event|4|||
146777825|NCT01000480|529355345|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
146777826|NCT01000480|529355345|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
146777827|NCT01000480|529355345|FG000|Concurrent Therapy Phase|Physician Decision|1|||
146777828|NCT02321514|529355350|FG000|Overall Study|Death|15|||
146777829|NCT02321514|529355350|FG000|Overall Study|Missed Visit|7|||
146777830|NCT02321514|529355350|FG000|Overall Study|Study Exit|3|||
146777831|NCT02539225|529355358|FG000|Part A|Adverse Event|13|||
146777832|NCT02539225|529355359|FG001|Part A|Adverse Event|4|||
146777833|NCT02539225|529355358|FG000|Part A|Withdrawal by Subject|2|||
146777834|NCT02539225|529355359|FG001|Part A|Withdrawal by Subject|4|||
146777835|NCT02539225|529355358|FG000|Part A|Physician Decision|4|||
146777836|NCT02539225|529355359|FG001|Part A|Physician Decision|7|||
146777837|NCT02539225|529355358|FG000|Part A|Did Not Receive study Drug|1|||
146777838|NCT02539225|529355359|FG001|Part A|Did Not Receive study Drug|1|||
146777839|NCT02539225|529355358|FG000|Pre Treatment for Part B|Progressive disease|1|||
146777840|NCT02539225|529355359|FG001|Pre Treatment for Part B|Progressive disease|1|||
146777841|NCT02539225|529355358|FG000|Pre Treatment for Part B|Adverse Event|1|||
146777842|NCT02539225|529355359|FG001|Pre Treatment for Part B|Adverse Event|1|||
146777843|NCT02539225|529355358|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
146777844|NCT02539225|529355359|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
146777845|NCT02539225|529355358|FG000|Pre Treatment for Part B|Physician Decision|2|||
146777846|NCT02539225|529355359|FG001|Pre Treatment for Part B|Physician Decision|0|||
146777847|NCT02539225|529355358|FG000|Part B|Adverse Event|4|||
146777848|NCT02539225|529355359|FG001|Part B|Adverse Event|4|||
146777849|NCT02539225|529355358|FG000|Part B|Withdrawal by Subject|0|||
146777850|NCT02539225|529355359|FG001|Part B|Withdrawal by Subject|3|||
146777851|NCT02539225|529355358|FG000|Part B|Physician Decision|0|||
146777852|NCT02539225|529355359|FG001|Part B|Physician Decision|9|||
146777853|NCT01044303|529355360|FG000|Overall Study|Lost to Follow-up|2|||
146777854|NCT01109524|529355363|FG000|Overall Study|Disease Progression|29|||
146777855|NCT01109524|529355363|FG000|Overall Study|Study Drug toxicity|6|||
146777856|NCT01109524|529355363|FG000|Overall Study|Adverse Event|4|||
146777857|NCT01109524|529355363|FG000|Overall Study|Withdrawal by Subject|2|||
146777858|NCT01109524|529355363|FG000|Overall Study|Maximum clinical benefit|3|||
146777859|NCT01109524|529355363|FG000|Overall Study|Death|2|||
146777860|NCT01109524|529355363|FG000|Overall Study|No longer meets criteria|2|||
146777861|NCT01109524|529355363|FG000|Overall Study|Participant requested to end treatment|4|||
146777862|NCT01109524|529355363|FG000|Overall Study|Other|5|||
146777863|NCT02318134|529355369|FG000|Overall Study|Withdrawal by Subject|2|||
146777864|NCT02318134|529355370|FG001|Overall Study|Withdrawal by Subject|1|||
146777865|NCT00031694|529355371|FG000|Overall Study|Adverse Event|12|||
146777866|NCT00031694|529355371|FG000|Overall Study|Death|2|||
146777867|NCT00031694|529355371|FG000|Overall Study|Withdrawal by Subject|5|||
146933795|NCT00830960|529915996|FG001|Overall Study|Withdrawal by Subject|19|||
146933796|NCT00830960|529915997|FG002|Overall Study|Withdrawal by Subject|18|||
146707692|NCT01640301|529104076|FG001|Overall Study|Death|8|||
146707693|NCT00659646|529104077|FG000|Overall Study|Protocol Violation|12|||
146707694|NCT00659646|529104078|FG001|Overall Study|Protocol Violation|8|||
146707695|NCT00659646|529104077|FG000|Overall Study|Adverse Event|1|||
146707696|NCT00659646|529104078|FG001|Overall Study|Adverse Event|0|||
146707697|NCT00659646|529104077|FG000|Overall Study|Lost to Follow-up|1|||
146707698|NCT00659646|529104078|FG001|Overall Study|Lost to Follow-up|0|||
146707699|NCT00659646|529104077|FG000|Overall Study|protocol noncompliance after randomized|1|||
146707700|NCT00659646|529104078|FG001|Overall Study|protocol noncompliance after randomized|0|||
146707701|NCT02200042|529104081|FG000|Overall Study|Withdrawal by Subject|0|||
146707702|NCT02200042|529104082|FG001|Overall Study|Withdrawal by Subject|1|||
146707703|NCT01969838|529104083|FG000|Double-blind Phase|Adverse Event|10|||
146707704|NCT01969838|529104084|FG001|Double-blind Phase|Adverse Event|4|||
146707705|NCT01969838|529104085|FG002|Double-blind Phase|Adverse Event|0|||
146707706|NCT01969838|529104086|FG003|Double-blind Phase|Adverse Event|0|||
146707707|NCT01969838|529104083|FG000|Double-blind Phase|Death|5|||
146707708|NCT01969838|529104084|FG001|Double-blind Phase|Death|2|||
146707709|NCT01969838|529104085|FG002|Double-blind Phase|Death|0|||
146707710|NCT01969838|529104086|FG003|Double-blind Phase|Death|0|||
146707711|NCT01969838|529104083|FG000|Double-blind Phase|Physician Decision|5|||
146707712|NCT01969838|529104084|FG001|Double-blind Phase|Physician Decision|1|||
146707713|NCT01969838|529104085|FG002|Double-blind Phase|Physician Decision|0|||
146707714|NCT01969838|529104086|FG003|Double-blind Phase|Physician Decision|0|||
146707715|NCT01969838|529104083|FG000|Double-blind Phase|Subject Decision|4|||
146707716|NCT01969838|529104084|FG001|Double-blind Phase|Subject Decision|2|||
146707717|NCT01969838|529104085|FG002|Double-blind Phase|Subject Decision|0|||
146707718|NCT01969838|529104086|FG003|Double-blind Phase|Subject Decision|0|||
146707719|NCT01969838|529104083|FG000|Double-blind Phase|Disease Progression|2|||
146707720|NCT01969838|529104084|FG001|Double-blind Phase|Disease Progression|0|||
146707721|NCT01969838|529104085|FG002|Double-blind Phase|Disease Progression|0|||
146707722|NCT01969838|529104086|FG003|Double-blind Phase|Disease Progression|0|||
146707723|NCT01969838|529104083|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
146707724|NCT01969838|529104084|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
146707725|NCT01969838|529104085|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
146707726|NCT01969838|529104086|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
146707727|NCT01969838|529104083|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
146707728|NCT01969838|529104084|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
146707729|NCT01969838|529104085|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
146707730|NCT01969838|529104086|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
146707731|NCT01969838|529104083|FG000|Open-label Phase|Adverse Event|0|||
146707732|NCT01969838|529104084|FG001|Open-label Phase|Adverse Event|0|||
146707733|NCT01969838|529104085|FG002|Open-label Phase|Adverse Event|37|||
146707734|NCT01969838|529104086|FG003|Open-label Phase|Adverse Event|49|||
146707735|NCT01969838|529104083|FG000|Open-label Phase|Disease Progression|0|||
146707736|NCT01969838|529104084|FG001|Open-label Phase|Disease Progression|0|||
146707737|NCT01969838|529104085|FG002|Open-label Phase|Disease Progression|26|||
146707738|NCT01969838|529104086|FG003|Open-label Phase|Disease Progression|27|||
146707739|NCT01969838|529104083|FG000|Open-label Phase|Lack of Efficacy|0|||
146707740|NCT01969838|529104084|FG001|Open-label Phase|Lack of Efficacy|0|||
146707741|NCT01969838|529104085|FG002|Open-label Phase|Lack of Efficacy|17|||
146707742|NCT01969838|529104086|FG003|Open-label Phase|Lack of Efficacy|19|||
146707743|NCT01969838|529104083|FG000|Open-label Phase|Subject Decision|0|||
146707744|NCT01969838|529104084|FG001|Open-label Phase|Subject Decision|0|||
146707745|NCT01969838|529104085|FG002|Open-label Phase|Subject Decision|14|||
146707746|NCT01969838|529104086|FG003|Open-label Phase|Subject Decision|15|||
146707747|NCT01969838|529104083|FG000|Open-label Phase|Death|0|||
146707748|NCT01969838|529104084|FG001|Open-label Phase|Death|0|||
146707749|NCT01969838|529104085|FG002|Open-label Phase|Death|13|||
146707750|NCT01969838|529104086|FG003|Open-label Phase|Death|11|||
146707751|NCT01969838|529104083|FG000|Open-label Phase|Physician Decision|0|||
146707752|NCT01969838|529104084|FG001|Open-label Phase|Physician Decision|0|||
146707753|NCT01969838|529104085|FG002|Open-label Phase|Physician Decision|9|||
146707754|NCT01969838|529104086|FG003|Open-label Phase|Physician Decision|14|||
146707755|NCT01969838|529104083|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
146707756|NCT01969838|529104084|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
146707757|NCT01969838|529104085|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
146707758|NCT01969838|529104086|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
146707759|NCT00408993|529104087|FG000|Overall Study|Adverse Event|15|||
146707760|NCT00408993|529104088|FG001|Overall Study|Adverse Event|4|||
146707761|NCT00408993|529104087|FG000|Overall Study|Protocol Violation|1|||
146707762|NCT00408993|529104088|FG001|Overall Study|Protocol Violation|6|||
146707763|NCT00408993|529104087|FG000|Overall Study|Lack of Efficacy|1|||
146707764|NCT00408993|529104088|FG001|Overall Study|Lack of Efficacy|4|||
146707765|NCT00408993|529104087|FG000|Overall Study|Withdrawal by Subject|2|||
146707766|NCT00408993|529104088|FG001|Overall Study|Withdrawal by Subject|3|||
146707767|NCT00298896|529104089|FG000|Overall Study|Death|3|||
146707768|NCT00298896|529104089|FG000|Overall Study|Physician Decision|2|||
146707769|NCT00298896|529104089|FG000|Overall Study|Intercurrent Illness|1|||
146707770|NCT00298896|529104089|FG000|Overall Study|Disease Progression|41|||
146707771|NCT00298896|529104089|FG000|Overall Study|Withdrawal by Subject|2|||
146707772|NCT00298896|529104089|FG000|Overall Study|Assigned to treatment in error|1|||
146707773|NCT02880371|529104090|FG000|Phase 1b|Lost to Follow-up|1|||
146707774|NCT02880371|529104091|FG001|Phase 1b|Lost to Follow-up|0|||
146707775|NCT02880371|529104092|FG002|Phase 1b|Lost to Follow-up|0|||
146707776|NCT02880371|529104093|FG003|Phase 1b|Lost to Follow-up|0|||
146707777|NCT02880371|529104094|FG004|Phase 1b|Lost to Follow-up|0|||
146707778|NCT02880371|529104095|FG005|Phase 1b|Lost to Follow-up|0|||
146707779|NCT02880371|529104096|FG006|Phase 1b|Lost to Follow-up|0|||
146707780|NCT02880371|529104097|FG007|Phase 1b|Lost to Follow-up|0|||
146707781|NCT02880371|529104090|FG000|Phase 1b|Participants terminated by Sponsor|1|||
146707782|NCT02880371|529104091|FG001|Phase 1b|Participants terminated by Sponsor|0|||
146707783|NCT02880371|529104092|FG002|Phase 1b|Participants terminated by Sponsor|0|||
146707784|NCT02880371|529104093|FG003|Phase 1b|Participants terminated by Sponsor|0|||
146707785|NCT02880371|529104094|FG004|Phase 1b|Participants terminated by Sponsor|0|||
146707786|NCT02880371|529104095|FG005|Phase 1b|Participants terminated by Sponsor|0|||
146707787|NCT02880371|529104096|FG006|Phase 1b|Participants terminated by Sponsor|0|||
146707788|NCT02880371|529104097|FG007|Phase 1b|Participants terminated by Sponsor|0|||
146707789|NCT02880371|529104090|FG000|Phase 1b|Withdrawal by Subject|0|||
146707790|NCT02880371|529104091|FG001|Phase 1b|Withdrawal by Subject|0|||
146707791|NCT02880371|529104092|FG002|Phase 1b|Withdrawal by Subject|1|||
146707792|NCT02880371|529104093|FG003|Phase 1b|Withdrawal by Subject|0|||
146707793|NCT02880371|529104094|FG004|Phase 1b|Withdrawal by Subject|0|||
146707794|NCT02880371|529104095|FG005|Phase 1b|Withdrawal by Subject|0|||
146707795|NCT02880371|529104096|FG006|Phase 1b|Withdrawal by Subject|0|||
146707796|NCT02880371|529104097|FG007|Phase 1b|Withdrawal by Subject|0|||
146707797|NCT02880371|529104090|FG000|Phase 1b|Death|4|||
146707798|NCT02880371|529104091|FG001|Phase 1b|Death|6|||
146707799|NCT02880371|529104092|FG002|Phase 1b|Death|5|||
146707800|NCT02880371|529104093|FG003|Phase 1b|Death|1|||
146707801|NCT02880371|529104094|FG004|Phase 1b|Death|0|||
146707802|NCT02880371|529104095|FG005|Phase 1b|Death|0|||
146707803|NCT02880371|529104096|FG006|Phase 1b|Death|0|||
146707804|NCT02880371|529104097|FG007|Phase 1b|Death|0|||
146707805|NCT02880371|529104090|FG000|Phase 1b|Enrolled but not Treated|0|||
146707806|NCT02880371|529104091|FG001|Phase 1b|Enrolled but not Treated|1|||
146707807|NCT02880371|529104092|FG002|Phase 1b|Enrolled but not Treated|0|||
146707808|NCT02880371|529104093|FG003|Phase 1b|Enrolled but not Treated|0|||
146707809|NCT02880371|529104094|FG004|Phase 1b|Enrolled but not Treated|0|||
146707810|NCT02880371|529104095|FG005|Phase 1b|Enrolled but not Treated|0|||
146707811|NCT02880371|529104096|FG006|Phase 1b|Enrolled but not Treated|0|||
146707812|NCT02880371|529104097|FG007|Phase 1b|Enrolled but not Treated|0|||
146707813|NCT02880371|529104090|FG000|Phase 2|Enrolled but not Treated|0|||
146707814|NCT02880371|529104091|FG001|Phase 2|Enrolled but not Treated|0|||
146707815|NCT02880371|529104092|FG002|Phase 2|Enrolled but not Treated|0|||
146707816|NCT02880371|529104093|FG003|Phase 2|Enrolled but not Treated|0|||
146707817|NCT02880371|529104094|FG004|Phase 2|Enrolled but not Treated|0|||
146707818|NCT02880371|529104095|FG005|Phase 2|Enrolled but not Treated|1|||
146707819|NCT02880371|529104096|FG006|Phase 2|Enrolled but not Treated|1|||
146777868|NCT01976312|529355376|FG000|Overall Study|Pregnancy|0|||
146777869|NCT01976312|529355377|FG001|Overall Study|Pregnancy|1|||
146777870|NCT01976312|529355376|FG000|Overall Study|Lost to Follow-up|2|||
146777871|NCT01976312|529355377|FG001|Overall Study|Lost to Follow-up|0|||
146777872|NCT01976312|529355376|FG000|Overall Study|Withdrawal by Subject|7|||
146777873|NCT01976312|529355377|FG001|Overall Study|Withdrawal by Subject|2|||
146707820|NCT02880371|529104097|FG007|Phase 2|Enrolled but not Treated|0|||
146707821|NCT02880371|529104090|FG000|Phase 2|Other|0|||
146707822|NCT02880371|529104091|FG001|Phase 2|Other|0|||
146707823|NCT02880371|529104092|FG002|Phase 2|Other|0|||
146707824|NCT02880371|529104093|FG003|Phase 2|Other|0|||
146707825|NCT02880371|529104094|FG004|Phase 2|Other|0|||
146707826|NCT02880371|529104095|FG005|Phase 2|Other|1|||
146707827|NCT02880371|529104096|FG006|Phase 2|Other|2|||
146707828|NCT02880371|529104097|FG007|Phase 2|Other|1|||
146707829|NCT02880371|529104090|FG000|Phase 2|Participants terminated by Sponsor|0|||
146707830|NCT02880371|529104091|FG001|Phase 2|Participants terminated by Sponsor|0|||
146707831|NCT02880371|529104092|FG002|Phase 2|Participants terminated by Sponsor|0|||
146707832|NCT02880371|529104093|FG003|Phase 2|Participants terminated by Sponsor|0|||
146707833|NCT02880371|529104094|FG004|Phase 2|Participants terminated by Sponsor|1|||
146707834|NCT02880371|529104095|FG005|Phase 2|Participants terminated by Sponsor|6|||
146707835|NCT02880371|529104096|FG006|Phase 2|Participants terminated by Sponsor|1|||
146707836|NCT02880371|529104097|FG007|Phase 2|Participants terminated by Sponsor|5|||
146707837|NCT02880371|529104090|FG000|Phase 2|Death|0|||
146707838|NCT02880371|529104091|FG001|Phase 2|Death|0|||
146707839|NCT02880371|529104092|FG002|Phase 2|Death|0|||
146707840|NCT02880371|529104093|FG003|Phase 2|Death|0|||
146777874|NCT01976312|529355376|FG000|Overall Study|Adverse Event|6|||
146777875|NCT01976312|529355377|FG001|Overall Study|Adverse Event|6|||
146777876|NCT01976312|529355376|FG000|Overall Study|Protocol Violation|2|||
146777877|NCT01976312|529355377|FG001|Overall Study|Protocol Violation|0|||
146777878|NCT01538719|529355378|FG000|Overall Study|Lost to Follow-up|2|||
146777879|NCT01538719|529355379|FG001|Overall Study|Lost to Follow-up|0|||
146777880|NCT02556138|529355384|FG000|Overall Study|Withdrawal by Subject|1|||
146777881|NCT01037985|529355387|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
146777882|NCT01037985|529355388|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
146777883|NCT01037985|529355387|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
146777884|NCT01037985|529355388|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
146777885|NCT01037985|529355387|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
146777886|NCT01037985|529355388|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
146777887|NCT01037985|529355387|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
146777888|NCT01037985|529355388|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
146777889|NCT01609218|529355390|FG000|Period 1|Adverse Event|3|||
146777890|NCT01609218|529355391|FG001|Period 1|Adverse Event|5|||
146777891|NCT01609218|529355390|FG000|Period 1|Sponsor Decision|0|||
146777892|NCT01609218|529355391|FG001|Period 1|Sponsor Decision|1|||
146777893|NCT01609218|529355390|FG000|Period 2|Adverse Event|1|||
146777894|NCT01609218|529355391|FG001|Period 2|Adverse Event|0|||
146777895|NCT00774852|529355394|FG000|Overall Study|Adverse Event|9|||
146777896|NCT00774852|529355395|FG001|Overall Study|Adverse Event|6|||
146777897|NCT00774852|529355394|FG000|Overall Study|Death|2|||
146777898|NCT00774852|529355395|FG001|Overall Study|Death|1|||
146777899|NCT00774852|529355394|FG000|Overall Study|Lack of Efficacy|3|||
146777900|NCT00774852|529355395|FG001|Overall Study|Lack of Efficacy|7|||
146777901|NCT00774852|529355394|FG000|Overall Study|Lost to Follow-up|9|||
146777902|NCT00774852|529355395|FG001|Overall Study|Lost to Follow-up|5|||
146777903|NCT00774852|529355394|FG000|Overall Study|Physician Decision|2|||
146777904|NCT00774852|529355395|FG001|Overall Study|Physician Decision|6|||
146777905|NCT00774852|529355394|FG000|Overall Study|Pregnancy|1|||
146777906|NCT00774852|529355395|FG001|Overall Study|Pregnancy|2|||
146777907|NCT00774852|529355394|FG000|Overall Study|Withdrawal by Subject|2|||
146777908|NCT00774852|529355395|FG001|Overall Study|Withdrawal by Subject|2|||
146777909|NCT00774852|529355394|FG000|Overall Study|Non-responder|15|||
146777910|NCT00774852|529355395|FG001|Overall Study|Non-responder|11|||
146777911|NCT00774852|529355394|FG000|Overall Study|Subject non-compliance|0|||
146777912|NCT00774852|529355395|FG001|Overall Study|Subject non-compliance|1|||
146777913|NCT00774852|529355394|FG000|Overall Study|Protocol Violation|1|||
146777914|NCT00774852|529355395|FG001|Overall Study|Protocol Violation|0|||
146777915|NCT00774852|529355394|FG000|Overall Study|Subject received prohibited medication|1|||
146777916|NCT00774852|529355395|FG001|Overall Study|Subject received prohibited medication|0|||
146777917|NCT04428112|529355396|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
146777918|NCT04428112|529355397|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
146777919|NCT04428112|529355396|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
146777920|NCT04428112|529355397|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
146777921|NCT04428112|529355396|FG000|Overall Study|Withdrawal by Subject|9|||
146777922|NCT04428112|529355397|FG001|Overall Study|Withdrawal by Subject|4|||
146777923|NCT04428112|529355396|FG000|Overall Study|Lost to Follow-up|27|||
146777924|NCT04428112|529355397|FG001|Overall Study|Lost to Follow-up|7|||
146777925|NCT02807779|529355399|FG000|Overall Study|Lost to Follow-up|1|||
146777926|NCT02807779|529355400|FG001|Overall Study|Lost to Follow-up|0|||
146777927|NCT02807779|529355401|FG002|Overall Study|Lost to Follow-up|0|||
146777928|NCT02807779|529355399|FG000|Overall Study|Physician Decision|2|||
146777929|NCT02807779|529355400|FG001|Overall Study|Physician Decision|0|||
146777930|NCT02807779|529355401|FG002|Overall Study|Physician Decision|1|||
146777931|NCT02807779|529355399|FG000|Overall Study|Death|1|||
146777932|NCT02807779|529355400|FG001|Overall Study|Death|1|||
146777933|NCT02807779|529355401|FG002|Overall Study|Death|0|||
146777934|NCT06024174|529355402|FG000|Overall Study|Other Reasons|1|||
146777935|NCT06024174|529355402|FG000|Overall Study|Study terminated by Sponsor|4|||
146777936|NCT03725722|529357399|FG000|Overall Study|Lack of Efficacy|2|||
146777937|NCT03725722|529357400|FG001|Overall Study|Lack of Efficacy|1|||
146777938|NCT03725722|529357401|FG002|Overall Study|Lack of Efficacy|2|||
146777939|NCT03725722|529357402|FG003|Overall Study|Lack of Efficacy|0|||
146777940|NCT03725722|529357403|FG004|Overall Study|Lack of Efficacy|2|||
146777941|NCT03725722|529357399|FG000|Overall Study|Adverse Event|2|||
146777942|NCT03725722|529357400|FG001|Overall Study|Adverse Event|2|||
146933797|NCT00830960|529915998|FG003|Overall Study|Withdrawal by Subject|23|||
146777943|NCT03725722|529357401|FG002|Overall Study|Adverse Event|1|||
146777944|NCT03725722|529357402|FG003|Overall Study|Adverse Event|0|||
146777945|NCT03725722|529357403|FG004|Overall Study|Adverse Event|6|||
146777946|NCT03725722|529357399|FG000|Overall Study|Withdrawal by Subject|4|||
146777947|NCT03725722|529357400|FG001|Overall Study|Withdrawal by Subject|1|||
146777948|NCT03725722|529357401|FG002|Overall Study|Withdrawal by Subject|0|||
146777949|NCT03725722|529357402|FG003|Overall Study|Withdrawal by Subject|4|||
146777950|NCT03725722|529357403|FG004|Overall Study|Withdrawal by Subject|4|||
146777951|NCT03725722|529357399|FG000|Overall Study|Lost to Follow-up|3|||
146777952|NCT03725722|529357400|FG001|Overall Study|Lost to Follow-up|1|||
146777953|NCT03725722|529357401|FG002|Overall Study|Lost to Follow-up|2|||
146777954|NCT03725722|529357402|FG003|Overall Study|Lost to Follow-up|2|||
146777955|NCT03725722|529357403|FG004|Overall Study|Lost to Follow-up|1|||
146777956|NCT03725722|529357399|FG000|Overall Study|Personal reasons|0|||
146777957|NCT03725722|529357400|FG001|Overall Study|Personal reasons|0|||
146777958|NCT03725722|529357401|FG002|Overall Study|Personal reasons|1|||
146777959|NCT03725722|529357402|FG003|Overall Study|Personal reasons|0|||
146777960|NCT03725722|529357403|FG004|Overall Study|Personal reasons|1|||
146777961|NCT03725722|529357399|FG000|Overall Study|COVID-19 situation|0|||
146777962|NCT03725722|529357400|FG001|Overall Study|COVID-19 situation|1|||
146777963|NCT03725722|529357401|FG002|Overall Study|COVID-19 situation|0|||
146777964|NCT03725722|529357402|FG003|Overall Study|COVID-19 situation|0|||
146777965|NCT03725722|529357403|FG004|Overall Study|COVID-19 situation|0|||
146777966|NCT04310735|529357407|FG000|Overall Study|Withdrawal by Subject|1|||
146777967|NCT04310735|529357408|FG001|Overall Study|Withdrawal by Subject|3|||
146777968|NCT04310735|529357409|FG002|Overall Study|Withdrawal by Subject|8|||
146777969|NCT04310735|529357407|FG000|Overall Study|Equipment malfunction|0|||
146777970|NCT04310735|529357408|FG001|Overall Study|Equipment malfunction|1|||
146777971|NCT04310735|529357409|FG002|Overall Study|Equipment malfunction|0|||
146777972|NCT03398200|529357410|FG000|Overall Study|Withdrawal by Subject|0|||
146777973|NCT03398200|529357411|FG001|Overall Study|Withdrawal by Subject|1|||
146777974|NCT01649271|529357412|FG000|Overall Study|Progressive disease|4|||
146777975|NCT01649271|529357413|FG001|Overall Study|Progressive disease|5|||
146777976|NCT01649271|529357412|FG000|Overall Study|Other Adverse Event|0|||
146777977|NCT01649271|529357413|FG001|Overall Study|Other Adverse Event|2|||
146777978|NCT01649271|529357412|FG000|Overall Study|Withdrawal by Subject|1|||
146777979|NCT01649271|529357413|FG001|Overall Study|Withdrawal by Subject|0|||
146777980|NCT01649271|529357412|FG000|Overall Study|Other than stated above|1|||
146777981|NCT01649271|529357413|FG001|Overall Study|Other than stated above|0|||
146777982|NCT05644002|529357416|FG000|Overall Study|Lost to Follow-up|1|||
146777983|NCT05644002|529357417|FG001|Overall Study|Lost to Follow-up|2|||
146777984|NCT05644002|529357416|FG000|Overall Study|Withdrawal by Subject|0|||
146777985|NCT05644002|529357417|FG001|Overall Study|Withdrawal by Subject|1|||
146777986|NCT04842500|529357418|FG000|Overall Study|Withdrawal by Subject|4|||
146777987|NCT04842500|529357419|FG001|Overall Study|Withdrawal by Subject|1|||
146777988|NCT04842500|529357420|FG002|Overall Study|Withdrawal by Subject|2|||
146777989|NCT04842500|529357421|FG003|Overall Study|Withdrawal by Subject|3|||
146777990|NCT04842500|529357418|FG000|Overall Study|Protocol Violation|1|||
146777991|NCT04842500|529357419|FG001|Overall Study|Protocol Violation|0|||
146777992|NCT04842500|529357420|FG002|Overall Study|Protocol Violation|0|||
146777993|NCT04842500|529357421|FG003|Overall Study|Protocol Violation|1|||
146777994|NCT05756075|529357424|FG000|Overall Study|Withdrawal by Subject|16|||
146777995|NCT05756075|529357425|FG001|Overall Study|Withdrawal by Subject|9|||
146777996|NCT02605837|529357430|FG000|Overall Study|Adverse Event|3|||
146777997|NCT02605837|529357431|FG001|Overall Study|Adverse Event|1|||
146777998|NCT02605837|529357430|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146777999|NCT02605837|529357431|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146778000|NCT02605837|529357430|FG000|Overall Study|Withdrawal by Subject|8|||
146778001|NCT02605837|529357431|FG001|Overall Study|Withdrawal by Subject|8|||
146778002|NCT02605837|529357430|FG000|Overall Study|Physician Decision|0|||
146778003|NCT02605837|529357431|FG001|Overall Study|Physician Decision|1|||
146778004|NCT03845465|529357432|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
146778005|NCT03845465|529357433|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
146778006|NCT03845465|529357432|FG000|6-month Data Collection|Withdrawal by Subject|0|||
146778007|NCT03845465|529357433|FG001|6-month Data Collection|Withdrawal by Subject|2|||
146778008|NCT03845465|529357432|FG000|12-month Data Collection|Withdrawal by Subject|0|||
146933798|NCT00830960|529915999|FG004|Overall Study|Withdrawal by Subject|16|||
146933799|NCT00830960|529916000|FG005|Overall Study|Withdrawal by Subject|21|||
146933800|NCT00830960|529915995|FG000|Overall Study|Sponsor Decision|1|||
146933801|NCT00830960|529915996|FG001|Overall Study|Sponsor Decision|2|||
146933802|NCT00830960|529915997|FG002|Overall Study|Sponsor Decision|3|||
146933803|NCT00830960|529915998|FG003|Overall Study|Sponsor Decision|4|||
146933804|NCT00830960|529915999|FG004|Overall Study|Sponsor Decision|5|||
146778009|NCT03845465|529357433|FG001|12-month Data Collection|Withdrawal by Subject|2|||
146778010|NCT05656911|529357434|FG000|Treatment Phase|Physician Decision|2|||
146778011|NCT05656911|529357435|FG001|Treatment Phase|Physician Decision|0|||
146778012|NCT05656911|529357434|FG000|Treatment Phase|Lack of Efficacy|6|||
146778013|NCT05656911|529357435|FG001|Treatment Phase|Lack of Efficacy|3|||
146778014|NCT05656911|529357434|FG000|Treatment Phase|Subject Decision|4|||
146778015|NCT05656911|529357435|FG001|Treatment Phase|Subject Decision|2|||
146778016|NCT05656911|529357434|FG000|Treatment Phase|Other Reasons|1|||
146778017|NCT05656911|529357435|FG001|Treatment Phase|Other Reasons|0|||
146778018|NCT05656911|529357434|FG000|Treatment Phase|Adverse Event|3|||
146933805|NCT00830960|529916000|FG005|Overall Study|Sponsor Decision|7|||
146933806|NCT00830960|529915995|FG000|Overall Study|No study drug received|7|||
146981042|NCT00549198|530093719|FG001|Overall Study|Investigator Decision|3|||
146981043|NCT00549198|530093718|FG000|Overall Study|Withdrawal by Subject|7|||
146981044|NCT00549198|530093719|FG001|Overall Study|Withdrawal by Subject|7|||
146981045|NCT00549198|530093718|FG000|Overall Study|Disease Progression|1|||
146981046|NCT00549198|530093719|FG001|Overall Study|Disease Progression|0|||
146707841|NCT02880371|529104094|FG004|Phase 2|Death|1|||
146707842|NCT02880371|529104095|FG005|Phase 2|Death|10|||
146707843|NCT02880371|529104096|FG006|Phase 2|Death|20|||
146707844|NCT02880371|529104097|FG007|Phase 2|Death|5|||
146707845|NCT02880371|529104090|FG000|Phase 2|Lost to Follow-up|0|||
146707846|NCT02880371|529104091|FG001|Phase 2|Lost to Follow-up|0|||
146707847|NCT02880371|529104092|FG002|Phase 2|Lost to Follow-up|0|||
146707848|NCT02880371|529104093|FG003|Phase 2|Lost to Follow-up|0|||
146707849|NCT02880371|529104094|FG004|Phase 2|Lost to Follow-up|0|||
146707850|NCT02880371|529104095|FG005|Phase 2|Lost to Follow-up|0|||
146707851|NCT02880371|529104096|FG006|Phase 2|Lost to Follow-up|3|||
146707852|NCT02880371|529104097|FG007|Phase 2|Lost to Follow-up|0|||
146707853|NCT02880371|529104090|FG000|Phase 2|Withdrawal by Subject|0|||
146707854|NCT02880371|529104091|FG001|Phase 2|Withdrawal by Subject|0|||
146707855|NCT02880371|529104092|FG002|Phase 2|Withdrawal by Subject|0|||
146707856|NCT02880371|529104093|FG003|Phase 2|Withdrawal by Subject|0|||
146707857|NCT02880371|529104094|FG004|Phase 2|Withdrawal by Subject|0|||
146707858|NCT02880371|529104095|FG005|Phase 2|Withdrawal by Subject|1|||
146707859|NCT02880371|529104096|FG006|Phase 2|Withdrawal by Subject|1|||
146707860|NCT02880371|529104097|FG007|Phase 2|Withdrawal by Subject|0|||
146707861|NCT02880371|529104090|FG000|Phase 2|End of Study page not completed by error|0|||
146707862|NCT02880371|529104091|FG001|Phase 2|End of Study page not completed by error|0|||
146707863|NCT02880371|529104092|FG002|Phase 2|End of Study page not completed by error|0|||
146707864|NCT02880371|529104093|FG003|Phase 2|End of Study page not completed by error|0|||
146707865|NCT02880371|529104094|FG004|Phase 2|End of Study page not completed by error|0|||
146707866|NCT02880371|529104095|FG005|Phase 2|End of Study page not completed by error|1|||
146707867|NCT02880371|529104096|FG006|Phase 2|End of Study page not completed by error|0|||
146707868|NCT02880371|529104097|FG007|Phase 2|End of Study page not completed by error|0|||
146707869|NCT03394391|529104098|FG000|Overall Study|Lost to Follow-up|1|||
146707870|NCT03394391|529104099|FG001|Overall Study|Lost to Follow-up|2|||
146707871|NCT00451282|529104102|FG000|Overall Study|Lost to Follow-up|6|||
146707872|NCT00451282|529104103|FG001|Overall Study|Lost to Follow-up|5|||
146707873|NCT01565993|529104104|FG000|Overall Study|Physician Decision|0|||
146707874|NCT01565993|529104105|FG001|Overall Study|Physician Decision|3|||
146707875|NCT04086472|529104106|FG000|Overall Study|Lost to Follow-up|1|||
146707876|NCT04086472|529104107|FG001|Overall Study|Lost to Follow-up|0|||
146707877|NCT04086472|529104108|FG002|Overall Study|Lost to Follow-up|0|||
146707878|NCT04086472|529104109|FG003|Overall Study|Lost to Follow-up|0|||
146707879|NCT04086472|529104110|FG004|Overall Study|Lost to Follow-up|1|||
146707880|NCT04086472|529104106|FG000|Overall Study|Physician Decision|0|||
146707881|NCT04086472|529104107|FG001|Overall Study|Physician Decision|1|||
146707882|NCT04086472|529104108|FG002|Overall Study|Physician Decision|1|||
146707883|NCT04086472|529104109|FG003|Overall Study|Physician Decision|0|||
146707884|NCT04086472|529104110|FG004|Overall Study|Physician Decision|0|||
146707885|NCT04086472|529104106|FG000|Overall Study|Withdrawal by Subject|1|||
146707886|NCT04086472|529104107|FG001|Overall Study|Withdrawal by Subject|1|||
146707887|NCT04086472|529104108|FG002|Overall Study|Withdrawal by Subject|1|||
146707888|NCT04086472|529104109|FG003|Overall Study|Withdrawal by Subject|0|||
146707889|NCT04086472|529104110|FG004|Overall Study|Withdrawal by Subject|0|||
146707890|NCT04086472|529104106|FG000|Overall Study|Various reasons|2|||
146707891|NCT04086472|529104107|FG001|Overall Study|Various reasons|0|||
146707892|NCT04086472|529104108|FG002|Overall Study|Various reasons|0|||
146707893|NCT04086472|529104109|FG003|Overall Study|Various reasons|3|||
146707894|NCT04086472|529104110|FG004|Overall Study|Various reasons|1|||
146707895|NCT02252081|529104111|FG000|Overall Study|Withdrawal by Subject|2|||
146707896|NCT02252081|529104112|FG001|Overall Study|Withdrawal by Subject|1|||
146707897|NCT02252081|529104111|FG000|Overall Study|Adverse Event|4|||
146707898|NCT02252081|529104112|FG001|Overall Study|Adverse Event|1|||
146707899|NCT02252081|529104111|FG000|Overall Study|non compliance & others|0|||
146707900|NCT02252081|529104112|FG001|Overall Study|non compliance & others|2|||
146707901|NCT00048724|529104118|FG000|Overall Study|Adverse Event|53|||
146707902|NCT00048724|529104119|FG001|Overall Study|Adverse Event|12|||
146707903|NCT00048724|529104118|FG000|Overall Study|Withdrawal by Subject|34|||
146707904|NCT00048724|529104119|FG001|Overall Study|Withdrawal by Subject|54|||
146707905|NCT00048724|529104118|FG000|Overall Study|Lost to Follow-up|5|||
146707906|NCT00048724|529104119|FG001|Overall Study|Lost to Follow-up|5|||
146981047|NCT00549198|530093718|FG000|Overall Study|Participant Moved|2|||
146707907|NCT00048724|529104118|FG000|Overall Study|Protocol-defined Clinical Event|17|||
146707908|NCT00048724|529104119|FG001|Overall Study|Protocol-defined Clinical Event|32|||
146707909|NCT00048724|529104118|FG000|Overall Study|Noncompliance With Protocol|4|||
146707910|NCT00048724|529104119|FG001|Overall Study|Noncompliance With Protocol|12|||
146707911|NCT00048724|529104118|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
146707912|NCT00048724|529104119|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
146707913|NCT00048724|529104118|FG000|Overall Study|Administrative|1|||
146707914|NCT00048724|529104119|FG001|Overall Study|Administrative|1|||
146707915|NCT04116229|529104120|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
146707916|NCT04116229|529104121|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
146707917|NCT04116229|529104120|FG000|Overall Study|Scheduling not possible.|0|||
146707918|NCT04116229|529104121|FG001|Overall Study|Scheduling not possible.|1|||
146707919|NCT04574362|529104124|FG000|Overall Study|Other|0|||
146707920|NCT04574362|529104125|FG001|Overall Study|Other|5|||
146707921|NCT04574362|529104124|FG000|Overall Study|COVID-19|0|||
146707922|NCT04574362|529104125|FG001|Overall Study|COVID-19|1|||
146707923|NCT04574362|529104124|FG000|Overall Study|Adverse Event|1|||
146707924|NCT04574362|529104125|FG001|Overall Study|Adverse Event|1|||
146707925|NCT04574362|529104124|FG000|Overall Study|Withdrawal by Subject|2|||
146707926|NCT04574362|529104125|FG001|Overall Study|Withdrawal by Subject|4|||
146707927|NCT04574362|529104124|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
146707928|NCT04574362|529104125|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
146707929|NCT04574362|529104124|FG000|Overall Study|Participant refused to come to the hospital|1|||
146707930|NCT04574362|529104125|FG001|Overall Study|Participant refused to come to the hospital|0|||
146707931|NCT04574362|529104124|FG000|Overall Study|Participant refused the visit|1|||
146707932|NCT04574362|529104125|FG001|Overall Study|Participant refused the visit|0|||
146707933|NCT04574362|529104124|FG000|Overall Study|Participant quit early because of business trip|1|||
146707934|NCT04574362|529104125|FG001|Overall Study|Participant quit early because of business trip|0|||
146707935|NCT00642304|529104126|FG000|Overall Study|Adverse Event|1|||
146707936|NCT00642304|529104126|FG000|Overall Study|Death|1|||
146707937|NCT00642304|529104126|FG000|Overall Study|Blood transfusion|2|||
146707938|NCT00642304|529104126|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
146707939|NCT00642304|529104126|FG000|Overall Study|Transplantation|1|||
146707940|NCT02178475|529104130|FG000|Overall Study|Withdrawal by Subject|7|||
146707941|NCT02178475|529104130|FG000|Overall Study|Lost to Follow-up|10|||
146707942|NCT02178475|529104130|FG000|Overall Study|Death|13|||
146707943|NCT02178475|529104130|FG000|Overall Study|Protocol-specified Criteria|99|||
146707944|NCT01430585|529104131|FG000|Overall Study|Death|1|||
146707945|NCT01430585|529104131|FG000|Overall Study|Objective Progression or Relapse|3|||
146707946|NCT01430585|529104131|FG000|Overall Study|Study Terminated by Sponsor|3|||
146707947|NCT01430585|529104131|FG000|Overall Study|Other|7|||
146707948|NCT00779766|529104132|FG000|Month 24|Serious Adverse Event|2|||
146707949|NCT00779766|529104133|FG001|Month 24|Serious Adverse Event|3|||
146707950|NCT00779766|529104132|FG000|Month 24|Adverse Event|3|||
146707951|NCT00779766|529104133|FG001|Month 24|Adverse Event|3|||
146707952|NCT00779766|529104132|FG000|Month 24|Protocol Violation|3|||
146707953|NCT00779766|529104133|FG001|Month 24|Protocol Violation|1|||
146707954|NCT00779766|529104132|FG000|Month 24|Withdrawal by Subject|159|||
146707955|NCT00779766|529104133|FG001|Month 24|Withdrawal by Subject|127|||
146707956|NCT00779766|529104132|FG000|Month 24|Migrated/moved from study area|138|||
146707957|NCT00779766|529104133|FG001|Month 24|Migrated/moved from study area|162|||
146707958|NCT00779766|529104132|FG000|Month 24|Lost to Follow-up|9|||
146707959|NCT00779766|529104133|FG001|Month 24|Lost to Follow-up|9|||
146707960|NCT00779766|529104132|FG000|Month 24|Other|18|||
146707961|NCT00779766|529104133|FG001|Month 24|Other|27|||
146707962|NCT00779766|529104132|FG000|Month 48|Withdrawal by Subject|68|||
146707963|NCT00779766|529104133|FG001|Month 48|Withdrawal by Subject|63|||
146707964|NCT00779766|529104132|FG000|Month 48|Migrated/moved from study area|76|||
146707965|NCT00779766|529104133|FG001|Month 48|Migrated/moved from study area|75|||
146707966|NCT00779766|529104132|FG000|Month 48|Lost to Follow-up|29|||
146707967|NCT00779766|529104133|FG001|Month 48|Lost to Follow-up|30|||
146707968|NCT00779766|529104132|FG000|Month 48|Other|1|||
146707969|NCT00779766|529104133|FG001|Month 48|Other|0|||
146707970|NCT00779766|529104132|FG000|Month 72|Withdrawal by Subject|55|||
146707971|NCT00779766|529104133|FG001|Month 72|Withdrawal by Subject|71|||
146707972|NCT00779766|529104132|FG000|Month 72|Migrated/moved from study area|124|||
146707973|NCT00779766|529104133|FG001|Month 72|Migrated/moved from study area|109|||
146707974|NCT00779766|529104132|FG000|Month 72|Lost to Follow-up|6|||
146707975|NCT00779766|529104133|FG001|Month 72|Lost to Follow-up|8|||
146707976|NCT00779766|529104132|FG000|Month 72|Other|0|||
146707977|NCT00779766|529104133|FG001|Month 72|Other|1|||
146707978|NCT01412424|529104138|FG000|Core Treatment Period|Treatment Failure|24|||
146707979|NCT01412424|529104138|FG000|Core Treatment Period|Adverse Event|21|||
146707980|NCT01412424|529104138|FG000|Core Treatment Period|Patient Request|5|||
146707981|NCT01412424|529104138|FG000|Core Treatment Period|Lost to Follow-up|2|||
146707982|NCT01412424|529104138|FG000|Core Treatment Period|Sponsor Request|1|||
146707983|NCT01412424|529104138|FG000|Extension Treatment Period|Adverse Event|2|||
146707984|NCT01412424|529104138|FG000|Extension Treatment Period|Treatment Failure|2|||
146707985|NCT01412424|529104138|FG000|Extension Treatment Period|Patient Request|2|||
146707986|NCT01274637|529104141|FG000|Overall Study|Withdrawal by Subject|0|||
146707987|NCT01274637|529104142|FG001|Overall Study|Withdrawal by Subject|1|||
146707988|NCT01274637|529104141|FG000|Overall Study|Lost to Follow-up|0|||
146707989|NCT01274637|529104142|FG001|Overall Study|Lost to Follow-up|1|||
146707990|NCT01824303|529104145|FG000|Randomized Study|Withdrawal by Subject|1|||
146707991|NCT01824303|529104146|FG001|Randomized Study|Withdrawal by Subject|1|||
146707992|NCT01824303|529104145|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
146707993|NCT01824303|529104146|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
146707994|NCT02170727|529104157|FG000|Overall Study|Lost to Follow-up|1|||
146707995|NCT02170727|529104158|FG001|Overall Study|Lost to Follow-up|0|||
146707996|NCT02170727|529104157|FG000|Overall Study|Withdrawal by Subject|2|||
146707997|NCT02170727|529104158|FG001|Overall Study|Withdrawal by Subject|0|||
146707998|NCT00414050|529104159|FG000|Overall Study|Adverse Event|1|||
146707999|NCT00414050|529104160|FG001|Overall Study|Adverse Event|1|||
146708000|NCT00414050|529104161|FG002|Overall Study|Adverse Event|1|||
146708001|NCT00414050|529104162|FG003|Overall Study|Adverse Event|1|||
146708002|NCT00414050|529104159|FG000|Overall Study|Lost to Follow-up|2|||
146708003|NCT00414050|529104160|FG001|Overall Study|Lost to Follow-up|2|||
146708004|NCT00414050|529104161|FG002|Overall Study|Lost to Follow-up|1|||
146708005|NCT00414050|529104162|FG003|Overall Study|Lost to Follow-up|1|||
146708006|NCT00414050|529104159|FG000|Overall Study|Withdrawal by Subject|5|||
146708007|NCT00414050|529104160|FG001|Overall Study|Withdrawal by Subject|3|||
146708008|NCT00414050|529104161|FG002|Overall Study|Withdrawal by Subject|2|||
146708009|NCT00414050|529104162|FG003|Overall Study|Withdrawal by Subject|4|||
146708010|NCT00414050|529104159|FG000|Overall Study|Subject discontinued for other reason|1|||
146708011|NCT00414050|529104160|FG001|Overall Study|Subject discontinued for other reason|2|||
146708012|NCT00414050|529104161|FG002|Overall Study|Subject discontinued for other reason|2|||
146708013|NCT00414050|529104162|FG003|Overall Study|Subject discontinued for other reason|1|||
146708014|NCT00414050|529104159|FG000|Overall Study|Subject Moved|0|||
146708015|NCT00414050|529104160|FG001|Overall Study|Subject Moved|0|||
146708016|NCT00414050|529104161|FG002|Overall Study|Subject Moved|0|||
146708017|NCT00414050|529104162|FG003|Overall Study|Subject Moved|1|||
146708018|NCT00057746|529104164|FG000|Overall Study|Withdrawal by Subject|0|||
146708019|NCT00057746|529104165|FG001|Overall Study|Withdrawal by Subject|0|||
146708020|NCT00057746|529104166|FG002|Overall Study|Withdrawal by Subject|1|||
146708021|NCT01109316|529104167|FG000|Study Period 1|Adverse Event|0|||
146708022|NCT01109316|529104168|FG001|Study Period 1|Adverse Event|0|||
146708023|NCT01109316|529104169|FG002|Study Period 1|Adverse Event|1|||
146708024|NCT01109316|529104170|FG003|Study Period 1|Adverse Event|0|||
146708025|NCT01109316|529104171|FG004|Study Period 1|Adverse Event|0|||
146708026|NCT01109316|529104172|FG005|Study Period 1|Adverse Event|0|||
146708027|NCT01109316|529104167|FG000|Study Period 1|Lost to Follow-up|0|||
146708028|NCT01109316|529104168|FG001|Study Period 1|Lost to Follow-up|0|||
146708029|NCT01109316|529104169|FG002|Study Period 1|Lost to Follow-up|1|||
146708030|NCT01109316|529104170|FG003|Study Period 1|Lost to Follow-up|1|||
146708031|NCT01109316|529104171|FG004|Study Period 1|Lost to Follow-up|0|||
146708032|NCT01109316|529104172|FG005|Study Period 1|Lost to Follow-up|0|||
146708033|NCT01109316|529104167|FG000|Study Period 1|Withdrawal by Subject|0|||
146708034|NCT01109316|529104168|FG001|Study Period 1|Withdrawal by Subject|0|||
146708035|NCT01109316|529104169|FG002|Study Period 1|Withdrawal by Subject|1|||
146708036|NCT01109316|529104170|FG003|Study Period 1|Withdrawal by Subject|0|||
146708037|NCT01109316|529104171|FG004|Study Period 1|Withdrawal by Subject|2|||
146708038|NCT01109316|529104172|FG005|Study Period 1|Withdrawal by Subject|0|||
146708039|NCT01109316|529104167|FG000|Study Period 1|Sponsor Decision|0|||
146708040|NCT01109316|529104168|FG001|Study Period 1|Sponsor Decision|0|||
146708041|NCT01109316|529104169|FG002|Study Period 1|Sponsor Decision|0|||
146708042|NCT01109316|529104170|FG003|Study Period 1|Sponsor Decision|0|||
146708043|NCT01109316|529104171|FG004|Study Period 1|Sponsor Decision|0|||
146708044|NCT01109316|529104172|FG005|Study Period 1|Sponsor Decision|2|||
146981048|NCT00549198|530093719|FG001|Overall Study|Participant Moved|0|||
146708045|NCT01109316|529104167|FG000|Study Period 2|Entry Criteria Not Met|0|||
146708046|NCT01109316|529104168|FG001|Study Period 2|Entry Criteria Not Met|1|||
146708047|NCT01109316|529104169|FG002|Study Period 2|Entry Criteria Not Met|0|||
146708048|NCT01109316|529104170|FG003|Study Period 2|Entry Criteria Not Met|0|||
146708049|NCT01109316|529104171|FG004|Study Period 2|Entry Criteria Not Met|0|||
146708050|NCT01109316|529104172|FG005|Study Period 2|Entry Criteria Not Met|0|||
146708051|NCT01109316|529104167|FG000|Study Period 2|Physician Decision|0|||
146708052|NCT01109316|529104168|FG001|Study Period 2|Physician Decision|0|||
146708053|NCT01109316|529104169|FG002|Study Period 2|Physician Decision|0|||
146708054|NCT01109316|529104170|FG003|Study Period 2|Physician Decision|1|||
146708055|NCT01109316|529104171|FG004|Study Period 2|Physician Decision|0|||
146708056|NCT01109316|529104172|FG005|Study Period 2|Physician Decision|0|||
146708057|NCT01109316|529104167|FG000|Study Period 2|Protocol Violation|1|||
146708058|NCT01109316|529104168|FG001|Study Period 2|Protocol Violation|0|||
146708059|NCT01109316|529104169|FG002|Study Period 2|Protocol Violation|0|||
146708060|NCT01109316|529104170|FG003|Study Period 2|Protocol Violation|0|||
146708061|NCT01109316|529104171|FG004|Study Period 2|Protocol Violation|0|||
146708062|NCT01109316|529104172|FG005|Study Period 2|Protocol Violation|0|||
146708063|NCT01109316|529104167|FG000|Study Period 2|Withdrawal by Subject|0|||
146708064|NCT01109316|529104168|FG001|Study Period 2|Withdrawal by Subject|0|||
146708065|NCT01109316|529104169|FG002|Study Period 2|Withdrawal by Subject|1|||
146708066|NCT01109316|529104170|FG003|Study Period 2|Withdrawal by Subject|0|||
146708067|NCT01109316|529104171|FG004|Study Period 2|Withdrawal by Subject|0|||
146778019|NCT05656911|529357435|FG001|Treatment Phase|Adverse Event|1|||
146778020|NCT05656911|529357434|FG000|Follow-up Phase|Subject Decision|0|||
146708068|NCT01109316|529104172|FG005|Study Period 2|Withdrawal by Subject|1|||
146708069|NCT01109316|529104167|FG000|Study Period 3|Lost to Follow-up|0|||
146708070|NCT01109316|529104168|FG001|Study Period 3|Lost to Follow-up|0|||
146708071|NCT01109316|529104169|FG002|Study Period 3|Lost to Follow-up|0|||
146708072|NCT01109316|529104170|FG003|Study Period 3|Lost to Follow-up|0|||
146708073|NCT01109316|529104171|FG004|Study Period 3|Lost to Follow-up|1|||
146708074|NCT01109316|529104172|FG005|Study Period 3|Lost to Follow-up|0|||
146708075|NCT01109316|529104167|FG000|Study Period 3|Withdrawal by Subject|1|||
146708076|NCT01109316|529104168|FG001|Study Period 3|Withdrawal by Subject|0|||
146708077|NCT01109316|529104169|FG002|Study Period 3|Withdrawal by Subject|0|||
146708078|NCT01109316|529104170|FG003|Study Period 3|Withdrawal by Subject|0|||
146708079|NCT01109316|529104171|FG004|Study Period 3|Withdrawal by Subject|1|||
146708080|NCT01109316|529104172|FG005|Study Period 3|Withdrawal by Subject|0|||
146708081|NCT03511560|529104180|FG000|Overall Study|Death|0|||
146708082|NCT03511560|529104181|FG001|Overall Study|Death|1|||
146708083|NCT03511560|529104180|FG000|Overall Study|Adverse Event|0|||
146708084|NCT03511560|529104181|FG001|Overall Study|Adverse Event|2|||
146708085|NCT03511560|529104180|FG000|Overall Study|Transplant cancelled|0|||
146708086|NCT03511560|529104181|FG001|Overall Study|Transplant cancelled|1|||
146708087|NCT03511560|529104180|FG000|Overall Study|Patient switched to another drug|1|||
146708088|NCT03511560|529104181|FG001|Overall Study|Patient switched to another drug|0|||
146708089|NCT04545515|529104183|FG000|Overall Study|Adverse Event|1|||
146708090|NCT04545515|529104183|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
146708091|NCT04545515|529104183|FG000|Overall Study|Commercial drug is available for participant|7|||
146708092|NCT01848990|529104184|FG000|Overall Study|Adverse Event|6|||
146708093|NCT01848990|529104185|FG001|Overall Study|Adverse Event|2|||
146708094|NCT01848990|529104186|FG002|Overall Study|Adverse Event|0|||
146708095|NCT01848990|529104184|FG000|Overall Study|Lost to Follow-up|6|||
146708096|NCT01848990|529104185|FG001|Overall Study|Lost to Follow-up|2|||
146708097|NCT01848990|529104186|FG002|Overall Study|Lost to Follow-up|2|||
146708098|NCT01848990|529104184|FG000|Overall Study|Protocol Violation|1|||
146708099|NCT01848990|529104185|FG001|Overall Study|Protocol Violation|1|||
146708100|NCT01848990|529104186|FG002|Overall Study|Protocol Violation|0|||
146708101|NCT01848990|529104184|FG000|Overall Study|Withdrawal by Subject|29|||
146708102|NCT01848990|529104185|FG001|Overall Study|Withdrawal by Subject|10|||
146708103|NCT01848990|529104186|FG002|Overall Study|Withdrawal by Subject|11|||
146708104|NCT01848990|529104184|FG000|Overall Study|Physician Decision|1|||
146708105|NCT01848990|529104185|FG001|Overall Study|Physician Decision|1|||
146708106|NCT01848990|529104186|FG002|Overall Study|Physician Decision|0|||
146708107|NCT01848990|529104184|FG000|Overall Study|Non Compliance|1|||
146708108|NCT01848990|529104185|FG001|Overall Study|Non Compliance|0|||
146708109|NCT01848990|529104186|FG002|Overall Study|Non Compliance|0|||
146708110|NCT01848990|529104184|FG000|Overall Study|Death|1|||
146778021|NCT05656911|529357435|FG001|Follow-up Phase|Subject Decision|1|||
146778022|NCT05656911|529357434|FG000|Follow-up Phase|Missing|1|||
146778023|NCT05656911|529357435|FG001|Follow-up Phase|Missing|0|||
146778024|NCT03547908|529357436|FG000|Blinded Phase|Lost to Follow-up|3|||
146778025|NCT03547908|529357437|FG001|Blinded Phase|Lost to Follow-up|3|||
146778026|NCT03547908|529357438|FG002|Blinded Phase|Lost to Follow-up|0|||
146778027|NCT03547908|529357439|FG003|Blinded Phase|Lost to Follow-up|0|||
146778028|NCT03547908|529357436|FG000|Blinded Phase|Withdrew Consent|2|||
146778029|NCT03547908|529357437|FG001|Blinded Phase|Withdrew Consent|3|||
146778030|NCT03547908|529357438|FG002|Blinded Phase|Withdrew Consent|0|||
146778031|NCT03547908|529357439|FG003|Blinded Phase|Withdrew Consent|0|||
146778032|NCT03547908|529357436|FG000|Blinded Phase|Investigator's Discretion|2|||
146933807|NCT00830960|529915996|FG001|Overall Study|No study drug received|2|||
146933808|NCT00830960|529915997|FG002|Overall Study|No study drug received|4|||
146933809|NCT00830960|529915998|FG003|Overall Study|No study drug received|3|||
146933810|NCT00830960|529915999|FG004|Overall Study|No study drug received|5|||
146933811|NCT00830960|529916000|FG005|Overall Study|No study drug received|7|||
146708111|NCT01848990|529104185|FG001|Overall Study|Death|0|||
146708112|NCT01848990|529104186|FG002|Overall Study|Death|1|||
146708113|NCT01848990|529104184|FG000|Overall Study|Other|1|||
146708114|NCT01848990|529104185|FG001|Overall Study|Other|4|||
146708115|NCT01848990|529104186|FG002|Overall Study|Other|2|||
146708116|NCT00096044|529104187|FG000|Overall Study|Withdrawal by Subject|9|||
146708117|NCT00096044|529104187|FG000|Overall Study|Adverse Event|21|||
146708118|NCT00096044|529104187|FG000|Overall Study|Disease Progression|4|||
146708119|NCT01552772|529104188|FG000|Overall Study|Lost to Follow-up|2|||
146708120|NCT01552772|529104188|FG000|Overall Study|Adverse Event|1|||
146778033|NCT03547908|529357437|FG001|Blinded Phase|Investigator's Discretion|1|||
146778034|NCT03547908|529357438|FG002|Blinded Phase|Investigator's Discretion|0|||
146778035|NCT03547908|529357439|FG003|Blinded Phase|Investigator's Discretion|0|||
146962304|NCT01049360|530021576|FG002|Period 1|Did not meet inc/exc criteria|0|||
146708121|NCT01552772|529104188|FG000|Overall Study|Protocol Deviation|1|||
146708122|NCT03851016|529104191|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
146708123|NCT03851016|529104192|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
146708124|NCT03878134|529104193|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
146708125|NCT00853658|529104194|FG000|Overall Study|Death|713|||
146708126|NCT00853658|529104195|FG001|Overall Study|Death|768|||
146708127|NCT00853658|529104196|FG002|Overall Study|Death|753|||
146708128|NCT00853658|529104194|FG000|Overall Study|Lost to Follow-up|11|||
146708129|NCT00853658|529104195|FG001|Overall Study|Lost to Follow-up|6|||
146708130|NCT00853658|529104196|FG002|Overall Study|Lost to Follow-up|11|||
146708131|NCT00853658|529104194|FG000|Overall Study|H.A. Request|26|||
146708132|NCT00853658|529104195|FG001|Overall Study|H.A. Request|23|||
146708133|NCT00853658|529104196|FG002|Overall Study|H.A. Request|19|||
146708134|NCT00853658|529104194|FG000|Overall Study|IRB request|0|||
146708135|NCT00853658|529104195|FG001|Overall Study|IRB request|0|||
146708136|NCT00853658|529104196|FG002|Overall Study|IRB request|2|||
146708137|NCT00853658|529104194|FG000|Overall Study|Vital Status known (alive) at study end|2|||
146708138|NCT00853658|529104195|FG001|Overall Study|Vital Status known (alive) at study end|3|||
146708139|NCT00853658|529104196|FG002|Overall Study|Vital Status known (alive) at study end|3|||
146708140|NCT00853658|529104194|FG000|Overall Study|Vital Status unknown at study end|1|||
146708141|NCT00853658|529104195|FG001|Overall Study|Vital Status unknown at study end|1|||
146708142|NCT00853658|529104196|FG002|Overall Study|Vital Status unknown at study end|0|||
146708143|NCT00853658|529104194|FG000|Overall Study|Vital Status at study end N/A|8|||
146708144|NCT00853658|529104195|FG001|Overall Study|Vital Status at study end N/A|10|||
146708145|NCT00853658|529104196|FG002|Overall Study|Vital Status at study end N/A|10|||
146708146|NCT00853658|529104194|FG000|Overall Study|Patient's request|21|||
146708147|NCT00853658|529104195|FG001|Overall Study|Patient's request|17|||
146708148|NCT00853658|529104196|FG002|Overall Study|Patient's request|11|||
146778036|NCT03547908|529357436|FG000|Blinded Phase|Death|2|||
146778037|NCT03547908|529357437|FG001|Blinded Phase|Death|0|||
146778038|NCT03547908|529357438|FG002|Blinded Phase|Death|0|||
146778039|NCT03547908|529357439|FG003|Blinded Phase|Death|0|||
146778040|NCT03547908|529357436|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
146778041|NCT03547908|529357437|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
146778042|NCT03547908|529357438|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
146778043|NCT03547908|529357439|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
146778044|NCT03547908|529357436|FG000|Blinded Phase|Adverse Event|1|||
146778045|NCT03547908|529357437|FG001|Blinded Phase|Adverse Event|0|||
146778046|NCT03547908|529357438|FG002|Blinded Phase|Adverse Event|0|||
146778047|NCT03547908|529357439|FG003|Blinded Phase|Adverse Event|0|||
146778048|NCT03547908|529357436|FG000|Blinded Phase|Randomized But Never Treated|1|||
146778049|NCT03547908|529357437|FG001|Blinded Phase|Randomized But Never Treated|0|||
146778050|NCT03547908|529357438|FG002|Blinded Phase|Randomized But Never Treated|0|||
146778051|NCT03547908|529357439|FG003|Blinded Phase|Randomized But Never Treated|0|||
146778052|NCT03547908|529357436|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
146778053|NCT03547908|529357437|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
146778054|NCT03547908|529357438|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
146778055|NCT03547908|529357439|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
146778056|NCT03547908|529357436|FG000|Open-label Extension Phase|Death|0|||
146778057|NCT03547908|529357437|FG001|Open-label Extension Phase|Death|0|||
146778058|NCT03547908|529357438|FG002|Open-label Extension Phase|Death|1|||
146778059|NCT03547908|529357439|FG003|Open-label Extension Phase|Death|0|||
146778060|NCT04607044|529357446|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
146778061|NCT04607044|529357446|FG000|Overall Study|Adverse Event|1|||
146778062|NCT04607044|529357446|FG000|Overall Study|Did not receive study device|3|||
146778063|NCT04607044|529357446|FG000|Overall Study|Death|1|||
146778064|NCT05403801|529357447|FG000|Overall Study|Withdrawal by Subject|2|||
146778065|NCT05075408|529357448|FG000|Overall Study|Withdrawal by Subject|5|||
146933812|NCT01376245|529916007|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
146933813|NCT01376245|529916008|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
146708149|NCT00853658|529104194|FG000|Overall Study|Missing study completion information|5|||
146708150|NCT00853658|529104195|FG001|Overall Study|Missing study completion information|4|||
146708151|NCT00853658|529104196|FG002|Overall Study|Missing study completion information|6|||
146708152|NCT00586469|529104197|FG000|Overall Study|Adverse Event|0|||
146708153|NCT00586469|529104198|FG001|Overall Study|Adverse Event|1|||
146708154|NCT01227512|529104200|FG000|Overall Study|Physician Decision|6|||
146708155|NCT01227512|529104201|FG001|Overall Study|Physician Decision|6|||
146708156|NCT01227512|529104200|FG000|Overall Study|Adverse Event|4|||
146708157|NCT01227512|529104201|FG001|Overall Study|Adverse Event|3|||
146708158|NCT01227512|529104200|FG000|Overall Study|Withdrawal by Subject|3|||
146708159|NCT01227512|529104201|FG001|Overall Study|Withdrawal by Subject|0|||
146708160|NCT01227512|529104200|FG000|Overall Study|Participant met withdrawal criteria|0|||
146708161|NCT01227512|529104201|FG001|Overall Study|Participant met withdrawal criteria|1|||
146778066|NCT05075408|529357449|FG001|Overall Study|Withdrawal by Subject|3|||
146778067|NCT05075408|529357450|FG002|Overall Study|Withdrawal by Subject|4|||
146778068|NCT05075408|529357448|FG000|Overall Study|Adverse Event|5|||
146778069|NCT05075408|529357449|FG001|Overall Study|Adverse Event|7|||
146778070|NCT05075408|529357450|FG002|Overall Study|Adverse Event|8|||
146778071|NCT05075408|529357448|FG000|Overall Study|Protocol Violation|0|||
146778072|NCT05075408|529357449|FG001|Overall Study|Protocol Violation|1|||
146778073|NCT05075408|529357450|FG002|Overall Study|Protocol Violation|0|||
146778074|NCT05075408|529357448|FG000|Overall Study|Lost to Follow-up|2|||
146778075|NCT05075408|529357449|FG001|Overall Study|Lost to Follow-up|1|||
146778076|NCT05075408|529357450|FG002|Overall Study|Lost to Follow-up|1|||
146778077|NCT05075408|529357448|FG000|Overall Study|Physician Decision|1|||
146933814|NCT01376245|529916009|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
146933815|NCT01376245|529916010|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
146933816|NCT01376245|529916011|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
146708162|NCT04055116|529104202|FG000|First Intervention|Physician Decision|2|||
146708163|NCT04055116|529104203|FG001|First Intervention|Physician Decision|7|||
146708164|NCT02774681|529104210|FG000|Treatment on Study|Progressive Disease|7|||
146708165|NCT02774681|529104210|FG000|Follow-Up for 3 Years|Death|11|||
146708166|NCT02774681|529104210|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
146708167|NCT00512096|529104212|FG000|Overall Study|Adverse Event|2|||
146708168|NCT00512096|529104212|FG000|Overall Study|Withdrawal by Subject|2|||
146708169|NCT00512096|529104212|FG000|Overall Study|Lack of Efficacy|3|||
146708170|NCT01069289|529104219|FG000|Overall Study|Withdrawal by Subject|15|||
146708171|NCT01069289|529104220|FG001|Overall Study|Withdrawal by Subject|26|||
146708172|NCT01069289|529104219|FG000|Overall Study|Adverse Event|21|||
146708173|NCT01069289|529104220|FG001|Overall Study|Adverse Event|28|||
146708174|NCT01069289|529104219|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
146708175|NCT01069289|529104220|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146708176|NCT01069289|529104219|FG000|Overall Study|Severe non-compliance to protocol|3|||
146708177|NCT01069289|529104220|FG001|Overall Study|Severe non-compliance to protocol|2|||
146708178|NCT01069289|529104219|FG000|Overall Study|Due to deteriorating health condition|1|||
146708179|NCT01069289|529104220|FG001|Overall Study|Due to deteriorating health condition|0|||
146708180|NCT01265953|529105618|FG000|Overall Study|Non compliance|5|||
146708181|NCT01265953|529105619|FG001|Overall Study|Non compliance|3|||
146708182|NCT02391948|529105624|FG000|6-month Assessment|Death|0|||
146708183|NCT02391948|529105625|FG001|6-month Assessment|Death|0|||
146708184|NCT02391948|529105626|FG002|6-month Assessment|Death|0|||
146708185|NCT02391948|529105627|FG003|6-month Assessment|Death|0|||
146708186|NCT02391948|529105628|FG004|6-month Assessment|Death|1|||
146708187|NCT02391948|529105624|FG000|6-month Assessment|Withdrawal by Subject|0|||
146708188|NCT02391948|529105625|FG001|6-month Assessment|Withdrawal by Subject|0|||
146708189|NCT02391948|529105626|FG002|6-month Assessment|Withdrawal by Subject|1|||
146708190|NCT02391948|529105627|FG003|6-month Assessment|Withdrawal by Subject|2|||
146708191|NCT02391948|529105628|FG004|6-month Assessment|Withdrawal by Subject|0|||
146708192|NCT02391948|529105624|FG000|6-month Assessment|Lost to Follow-up|4|||
146708193|NCT02391948|529105625|FG001|6-month Assessment|Lost to Follow-up|5|||
146708194|NCT02391948|529105626|FG002|6-month Assessment|Lost to Follow-up|2|||
146708195|NCT02391948|529105627|FG003|6-month Assessment|Lost to Follow-up|3|||
146708196|NCT02391948|529105628|FG004|6-month Assessment|Lost to Follow-up|1|||
146708197|NCT02391948|529105624|FG000|6-month Assessment|Medical issue/illness|1|||
146708198|NCT02391948|529105625|FG001|6-month Assessment|Medical issue/illness|1|||
146708199|NCT02391948|529105626|FG002|6-month Assessment|Medical issue/illness|0|||
146708200|NCT02391948|529105627|FG003|6-month Assessment|Medical issue/illness|0|||
146708201|NCT02391948|529105628|FG004|6-month Assessment|Medical issue/illness|0|||
146708202|NCT02391948|529105624|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
146708203|NCT02391948|529105625|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
146708204|NCT02391948|529105626|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
146708205|NCT02391948|529105627|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
146708206|NCT02391948|529105628|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
146708207|NCT02391948|529105624|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
146708208|NCT02391948|529105625|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
146708209|NCT02391948|529105626|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
146708210|NCT02391948|529105627|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
146708211|NCT02391948|529105628|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
146708212|NCT02391948|529105624|FG000|12-month Assessment|Death|0|||
146708213|NCT02391948|529105625|FG001|12-month Assessment|Death|0|||
146708214|NCT02391948|529105626|FG002|12-month Assessment|Death|0|||
146708215|NCT02391948|529105627|FG003|12-month Assessment|Death|1|||
146708216|NCT02391948|529105628|FG004|12-month Assessment|Death|0|||
146708217|NCT02391948|529105624|FG000|12-month Assessment|Withdrawal by Subject|1|||
146708218|NCT02391948|529105625|FG001|12-month Assessment|Withdrawal by Subject|0|||
146708219|NCT02391948|529105626|FG002|12-month Assessment|Withdrawal by Subject|0|||
146708220|NCT02391948|529105627|FG003|12-month Assessment|Withdrawal by Subject|1|||
146708221|NCT02391948|529105628|FG004|12-month Assessment|Withdrawal by Subject|0|||
146708222|NCT02391948|529105624|FG000|12-month Assessment|Lost to Follow-up|5|||
146708223|NCT02391948|529105625|FG001|12-month Assessment|Lost to Follow-up|4|||
146778078|NCT05075408|529357449|FG001|Overall Study|Physician Decision|0|||
146778079|NCT05075408|529357450|FG002|Overall Study|Physician Decision|0|||
146778080|NCT05075408|529357448|FG000|Overall Study|Other-unspecified|3|||
146778081|NCT05075408|529357449|FG001|Overall Study|Other-unspecified|2|||
146778082|NCT05075408|529357450|FG002|Overall Study|Other-unspecified|0|||
146778083|NCT05419505|529357452|FG000|Overall Study|Adverse Event|0|||
146778084|NCT05419505|529357453|FG001|Overall Study|Adverse Event|0|||
146778085|NCT05419505|529357454|FG002|Overall Study|Adverse Event|0|||
146778086|NCT05419505|529357455|FG003|Overall Study|Adverse Event|1|||
146778087|NCT05419505|529357456|FG004|Overall Study|Adverse Event|0|||
146778088|NCT05419505|529357457|FG005|Overall Study|Adverse Event|0|||
146778089|NCT05419505|529357458|FG006|Overall Study|Adverse Event|0|||
146778090|NCT05419505|529357459|FG007|Overall Study|Adverse Event|0|||
146778091|NCT05419505|529357452|FG000|Overall Study|Withdrawal by Subject|1|||
146778092|NCT05419505|529357453|FG001|Overall Study|Withdrawal by Subject|2|||
146778093|NCT05419505|529357454|FG002|Overall Study|Withdrawal by Subject|0|||
146778094|NCT05419505|529357455|FG003|Overall Study|Withdrawal by Subject|0|||
146778095|NCT05419505|529357456|FG004|Overall Study|Withdrawal by Subject|0|||
146778096|NCT05419505|529357457|FG005|Overall Study|Withdrawal by Subject|0|||
146778097|NCT05419505|529357458|FG006|Overall Study|Withdrawal by Subject|1|||
146778098|NCT05419505|529357459|FG007|Overall Study|Withdrawal by Subject|0|||
146778099|NCT05419505|529357452|FG000|Overall Study|Lost to Follow-up|2|||
146778100|NCT05419505|529357453|FG001|Overall Study|Lost to Follow-up|1|||
146778101|NCT05419505|529357454|FG002|Overall Study|Lost to Follow-up|0|||
146778102|NCT05419505|529357455|FG003|Overall Study|Lost to Follow-up|0|||
146778103|NCT05419505|529357456|FG004|Overall Study|Lost to Follow-up|1|||
146778104|NCT05419505|529357457|FG005|Overall Study|Lost to Follow-up|2|||
146778105|NCT05419505|529357458|FG006|Overall Study|Lost to Follow-up|0|||
146778106|NCT05419505|529357459|FG007|Overall Study|Lost to Follow-up|1|||
146778107|NCT02780388|529357462|FG000|Overall Study|Lost to Follow-up|0|||
146778108|NCT02780388|529357463|FG001|Overall Study|Lost to Follow-up|1|||
146778109|NCT02780388|529357464|FG002|Overall Study|Lost to Follow-up|0|||
146778110|NCT02780388|529357465|FG003|Overall Study|Lost to Follow-up|0|||
146778111|NCT02780388|529357466|FG004|Overall Study|Lost to Follow-up|0|||
146778112|NCT02780388|529357462|FG000|Overall Study|Withdrawal by Subject|1|||
146778113|NCT02780388|529357463|FG001|Overall Study|Withdrawal by Subject|1|||
146778114|NCT02780388|529357464|FG002|Overall Study|Withdrawal by Subject|0|||
146778115|NCT02780388|529357465|FG003|Overall Study|Withdrawal by Subject|0|||
146778116|NCT02780388|529357466|FG004|Overall Study|Withdrawal by Subject|0|||
146778117|NCT04527146|529357467|FG000|Overall Study|Withdrawal by Subject|12|||
146778118|NCT04527146|529357468|FG001|Overall Study|Withdrawal by Subject|15|||
146933817|NCT01376245|529916007|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
146708224|NCT02391948|529105626|FG002|12-month Assessment|Lost to Follow-up|4|||
146708225|NCT02391948|529105627|FG003|12-month Assessment|Lost to Follow-up|4|||
146708226|NCT02391948|529105628|FG004|12-month Assessment|Lost to Follow-up|5|||
146708227|NCT02391948|529105624|FG000|12-month Assessment|Medical issue/illness|0|||
146708228|NCT02391948|529105625|FG001|12-month Assessment|Medical issue/illness|1|||
146708229|NCT02391948|529105626|FG002|12-month Assessment|Medical issue/illness|0|||
146708230|NCT02391948|529105627|FG003|12-month Assessment|Medical issue/illness|1|||
146708231|NCT02391948|529105628|FG004|12-month Assessment|Medical issue/illness|0|||
146708232|NCT02391948|529105624|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
146708233|NCT02391948|529105625|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
146708234|NCT02391948|529105626|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
146708235|NCT02391948|529105627|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
146708236|NCT02391948|529105628|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
146708237|NCT02391948|529105624|FG000|18-month Assessment|Death|0|||
146708238|NCT02391948|529105625|FG001|18-month Assessment|Death|0|||
146708239|NCT02391948|529105626|FG002|18-month Assessment|Death|0|||
146708240|NCT02391948|529105627|FG003|18-month Assessment|Death|1|||
146708241|NCT02391948|529105628|FG004|18-month Assessment|Death|1|||
146708242|NCT02391948|529105624|FG000|18-month Assessment|Withdrawal by Subject|1|||
146708243|NCT02391948|529105625|FG001|18-month Assessment|Withdrawal by Subject|0|||
146708244|NCT02391948|529105626|FG002|18-month Assessment|Withdrawal by Subject|0|||
146708245|NCT02391948|529105627|FG003|18-month Assessment|Withdrawal by Subject|1|||
146708246|NCT02391948|529105628|FG004|18-month Assessment|Withdrawal by Subject|0|||
146708247|NCT02391948|529105624|FG000|18-month Assessment|Lost to Follow-up|2|||
146708248|NCT02391948|529105625|FG001|18-month Assessment|Lost to Follow-up|6|||
146708249|NCT02391948|529105626|FG002|18-month Assessment|Lost to Follow-up|2|||
146708250|NCT02391948|529105627|FG003|18-month Assessment|Lost to Follow-up|2|||
146708251|NCT02391948|529105628|FG004|18-month Assessment|Lost to Follow-up|3|||
146708252|NCT02391948|529105624|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
146778119|NCT04527146|529357469|FG002|Overall Study|Withdrawal by Subject|7|||
146778120|NCT04527146|529357470|FG003|Overall Study|Withdrawal by Subject|16|||
146778121|NCT04527146|529357467|FG000|Overall Study|Lost to Follow-up|13|||
146778122|NCT04527146|529357468|FG001|Overall Study|Lost to Follow-up|9|||
146778123|NCT04527146|529357469|FG002|Overall Study|Lost to Follow-up|16|||
146778124|NCT04527146|529357470|FG003|Overall Study|Lost to Follow-up|13|||
146778125|NCT04527146|529357467|FG000|Overall Study|Death|0|||
146778126|NCT04527146|529357468|FG001|Overall Study|Death|1|||
146708253|NCT02391948|529105625|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
146708254|NCT02391948|529105626|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
146708255|NCT02391948|529105627|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
146708256|NCT02391948|529105628|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
146708257|NCT02391948|529105624|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
146708258|NCT02391948|529105625|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
146708259|NCT02391948|529105626|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
146708260|NCT02391948|529105627|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
146708261|NCT02391948|529105628|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
146708262|NCT02391948|529105624|FG000|24-month Assessment|Death|0|||
146708263|NCT02391948|529105625|FG001|24-month Assessment|Death|0|||
146708264|NCT02391948|529105626|FG002|24-month Assessment|Death|0|||
146708265|NCT02391948|529105627|FG003|24-month Assessment|Death|0|||
146708266|NCT02391948|529105628|FG004|24-month Assessment|Death|1|||
146708267|NCT02391948|529105624|FG000|24-month Assessment|Withdrawal by Subject|1|||
146708268|NCT02391948|529105625|FG001|24-month Assessment|Withdrawal by Subject|1|||
146708269|NCT02391948|529105626|FG002|24-month Assessment|Withdrawal by Subject|0|||
146708270|NCT02391948|529105627|FG003|24-month Assessment|Withdrawal by Subject|0|||
146708271|NCT02391948|529105628|FG004|24-month Assessment|Withdrawal by Subject|1|||
146708272|NCT02391948|529105624|FG000|24-month Assessment|Lost to Follow-up|5|||
146708273|NCT02391948|529105625|FG001|24-month Assessment|Lost to Follow-up|4|||
146708274|NCT02391948|529105626|FG002|24-month Assessment|Lost to Follow-up|0|||
146708275|NCT02391948|529105627|FG003|24-month Assessment|Lost to Follow-up|0|||
146708276|NCT02391948|529105628|FG004|24-month Assessment|Lost to Follow-up|0|||
146708277|NCT02391948|529105624|FG000|24-month Assessment|Medical issue/illness|0|||
146708278|NCT02391948|529105625|FG001|24-month Assessment|Medical issue/illness|0|||
146708279|NCT02391948|529105626|FG002|24-month Assessment|Medical issue/illness|1|||
146708280|NCT02391948|529105627|FG003|24-month Assessment|Medical issue/illness|0|||
146708281|NCT02391948|529105628|FG004|24-month Assessment|Medical issue/illness|0|||
146708282|NCT02391948|529105624|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
146708283|NCT02391948|529105625|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
146708284|NCT02391948|529105626|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
146708285|NCT02391948|529105627|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
146708286|NCT02391948|529105628|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
146708287|NCT02348489|529105631|FG000|Overall Study|Death|336|||
146708288|NCT02348489|529105632|FG001|Overall Study|Death|335|||
146708289|NCT02348489|529105631|FG000|Overall Study|Withdrawal by Subject|14|||
146708290|NCT02348489|529105632|FG001|Overall Study|Withdrawal by Subject|27|||
146708291|NCT02348489|529105631|FG000|Overall Study|Lost to Follow-up|3|||
146708292|NCT02348489|529105632|FG001|Overall Study|Lost to Follow-up|5|||
146708293|NCT02866682|529105633|FG000|Overall Study|Death|0|||
146708294|NCT02866682|529105634|FG001|Overall Study|Death|1|||
146708295|NCT02866682|529105633|FG000|Overall Study|Lost to Follow-up|0|||
146708296|NCT02866682|529105634|FG001|Overall Study|Lost to Follow-up|4|||
146708297|NCT02866682|529105633|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
146708298|NCT02866682|529105634|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
146708299|NCT02866682|529105633|FG000|Overall Study|Other|0|||
146708300|NCT02866682|529105634|FG001|Overall Study|Other|1|||
146708301|NCT00201006|529105635|FG000|Overall Study|Withdrawal by Subject|7|||
146708302|NCT00201006|529105636|FG001|Overall Study|Withdrawal by Subject|2|||
146708303|NCT00201006|529105637|FG002|Overall Study|Withdrawal by Subject|3|||
146708304|NCT00201006|529105635|FG000|Overall Study|Adverse Event|1|||
146708305|NCT00201006|529105636|FG001|Overall Study|Adverse Event|0|||
146708306|NCT00201006|529105637|FG002|Overall Study|Adverse Event|1|||
146708307|NCT01750268|529105639|FG000|Overall Study|Lost to Follow-up|0|||
146708308|NCT01750268|529105640|FG001|Overall Study|Lost to Follow-up|2|||
146708309|NCT01750268|529105639|FG000|Overall Study|Physician Decision|0|||
146708310|NCT01750268|529105640|FG001|Overall Study|Physician Decision|3|||
146708311|NCT01750268|529105639|FG000|Overall Study|Withdrawal by Subject|2|||
146708312|NCT01750268|529105640|FG001|Overall Study|Withdrawal by Subject|0|||
146708313|NCT00938431|529105644|FG000|Overall Study|Adverse Event|5|||
146708314|NCT00938431|529105645|FG001|Overall Study|Adverse Event|8|||
146708315|NCT00938431|529105646|FG002|Overall Study|Adverse Event|6|||
146708316|NCT00938431|529105644|FG000|Overall Study|Lack of Efficacy|0|||
146708317|NCT00938431|529105645|FG001|Overall Study|Lack of Efficacy|1|||
146708318|NCT00938431|529105646|FG002|Overall Study|Lack of Efficacy|0|||
146708319|NCT00938431|529105644|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
146708320|NCT00938431|529105645|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
146708321|NCT00938431|529105646|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
146708322|NCT00938431|529105644|FG000|Overall Study|Dosing compliance issue|0|||
146708323|NCT00938431|529105645|FG001|Overall Study|Dosing compliance issue|0|||
146708324|NCT00938431|529105646|FG002|Overall Study|Dosing compliance issue|1|||
146708325|NCT00938431|529105644|FG000|Overall Study|Reached maximum dose early|0|||
146708326|NCT00938431|529105645|FG001|Overall Study|Reached maximum dose early|0|||
146933818|NCT01376245|529916008|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
146933819|NCT01376245|529916009|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
146708327|NCT00938431|529105646|FG002|Overall Study|Reached maximum dose early|1|||
146708328|NCT02086591|529105647|FG000|Overall Study|Adverse Event|1|||
146708329|NCT02086591|529105647|FG000|Overall Study|Withdrawal by Subject|1|||
146708330|NCT02086591|529105647|FG000|Overall Study|protocol terminated|3|||
146708331|NCT03738865|529105650|FG000|Overall Study|Withdrawal by Subject|3|||
146708332|NCT03738865|529105651|FG001|Overall Study|Withdrawal by Subject|3|||
146708333|NCT03738865|529105650|FG000|Overall Study|Adverse Event|2|||
146708334|NCT03738865|529105651|FG001|Overall Study|Adverse Event|0|||
146708335|NCT03738865|529105650|FG000|Overall Study|Physician Decision|0|||
146708336|NCT03738865|529105651|FG001|Overall Study|Physician Decision|1|||
146708337|NCT01923181|529105652|FG000|Overall Study|Protocol Violation|2|||
146708338|NCT01923181|529105653|FG001|Overall Study|Protocol Violation|2|||
146708339|NCT01923181|529105654|FG002|Overall Study|Protocol Violation|0|||
146708340|NCT01923181|529105655|FG003|Overall Study|Protocol Violation|2|||
146708341|NCT01923181|529105656|FG004|Overall Study|Protocol Violation|2|||
146708342|NCT01923181|529105657|FG005|Overall Study|Protocol Violation|1|||
146708343|NCT01923181|529105658|FG006|Overall Study|Protocol Violation|1|||
146708344|NCT01923181|529105659|FG007|Overall Study|Protocol Violation|2|||
146708345|NCT01923181|529105660|FG008|Overall Study|Protocol Violation|1|||
146708346|NCT01923181|529105652|FG000|Overall Study|Withdrawal by Subject|0|||
146708347|NCT01923181|529105653|FG001|Overall Study|Withdrawal by Subject|1|||
146708348|NCT01923181|529105654|FG002|Overall Study|Withdrawal by Subject|0|||
146708349|NCT01923181|529105655|FG003|Overall Study|Withdrawal by Subject|1|||
146708350|NCT01923181|529105656|FG004|Overall Study|Withdrawal by Subject|4|||
146708351|NCT01923181|529105657|FG005|Overall Study|Withdrawal by Subject|2|||
146708352|NCT01923181|529105658|FG006|Overall Study|Withdrawal by Subject|4|||
146708353|NCT01923181|529105659|FG007|Overall Study|Withdrawal by Subject|3|||
146708354|NCT01923181|529105660|FG008|Overall Study|Withdrawal by Subject|1|||
146708355|NCT01923181|529105652|FG000|Overall Study|Other|1|||
146708356|NCT01923181|529105653|FG001|Overall Study|Other|0|||
146708357|NCT01923181|529105654|FG002|Overall Study|Other|0|||
146708358|NCT01923181|529105655|FG003|Overall Study|Other|1|||
146708359|NCT01923181|529105656|FG004|Overall Study|Other|0|||
146708360|NCT01923181|529105657|FG005|Overall Study|Other|0|||
146708361|NCT01923181|529105658|FG006|Overall Study|Other|0|||
146708362|NCT01923181|529105659|FG007|Overall Study|Other|0|||
146708363|NCT01923181|529105660|FG008|Overall Study|Other|0|||
146708364|NCT01923181|529105652|FG000|Overall Study|Lost to Follow-up|0|||
146708365|NCT01923181|529105653|FG001|Overall Study|Lost to Follow-up|3|||
146708366|NCT01923181|529105654|FG002|Overall Study|Lost to Follow-up|2|||
146708367|NCT01923181|529105655|FG003|Overall Study|Lost to Follow-up|1|||
146708368|NCT01923181|529105656|FG004|Overall Study|Lost to Follow-up|2|||
146708369|NCT01923181|529105657|FG005|Overall Study|Lost to Follow-up|1|||
146708370|NCT01923181|529105658|FG006|Overall Study|Lost to Follow-up|3|||
146708371|NCT01923181|529105659|FG007|Overall Study|Lost to Follow-up|3|||
146708372|NCT01923181|529105660|FG008|Overall Study|Lost to Follow-up|1|||
146708373|NCT02944578|529105661|FG000|Overall Study|Physician Decision|1|||
146708374|NCT02944578|529105662|FG001|Overall Study|Physician Decision|0|||
146708375|NCT02932891|529105664|FG000|Overall Study|Lost to Follow-up|2|||
146708376|NCT02932891|529105664|FG000|Overall Study|HPA Suppress|2|||
146708377|NCT00577122|529105667|FG000|Overall Study|Adverse Event|0|||
146708378|NCT00577122|529105668|FG001|Overall Study|Adverse Event|2|||
146708379|NCT00577122|529105667|FG000|Overall Study|Progression, relapse during active trt|6|||
146708380|NCT00577122|529105668|FG001|Overall Study|Progression, relapse during active trt|8|||
146708381|NCT00577122|529105667|FG000|Overall Study|Prog, refract disease during active trt|8|||
146708382|NCT00577122|529105668|FG001|Overall Study|Prog, refract disease during active trt|5|||
146708383|NCT00577122|529105667|FG000|Overall Study|Alternative Therapy|0|||
146708384|NCT00577122|529105668|FG001|Overall Study|Alternative Therapy|1|||
146708385|NCT00440271|529105670|FG000|Overall Study|Protocol Violation|1|||
146933820|NCT01376245|529916010|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
146933821|NCT01376245|529916011|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
146933822|NCT01376245|529916007|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
146708386|NCT00440271|529105671|FG001|Overall Study|Protocol Violation|1|||
146708387|NCT00440271|529105670|FG000|Overall Study|Adverse Event|0|||
146708388|NCT00440271|529105671|FG001|Overall Study|Adverse Event|1|||
146708389|NCT00440271|529105670|FG000|Overall Study|Lost to Follow-up|1|||
146708390|NCT00440271|529105671|FG001|Overall Study|Lost to Follow-up|0|||
146708391|NCT00440271|529105670|FG000|Overall Study|Withdrawal by Subject|0|||
146708392|NCT00440271|529105671|FG001|Overall Study|Withdrawal by Subject|2|||
146708393|NCT00440271|529105670|FG000|Overall Study|Lack of Efficacy|0|||
146933823|NCT01376245|529916008|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
146708394|NCT00440271|529105671|FG001|Overall Study|Lack of Efficacy|1|||
146708395|NCT00440271|529105670|FG000|Overall Study|Due to closure of trial|8|||
146708396|NCT00440271|529105671|FG001|Overall Study|Due to closure of trial|10|||
146708397|NCT00440271|529105670|FG000|Overall Study|Other|2|||
146933824|NCT01376245|529916009|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
146933825|NCT01376245|529916010|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
146708398|NCT00440271|529105671|FG001|Overall Study|Other|0|||
146708399|NCT00456092|529105672|FG000|Extension Phase|Grade 2 or Greater AE|2|||
146708400|NCT00456092|529105673|FG001|Extension Phase|Grade 2 or Greater AE|2|||
146708401|NCT00456092|529105674|FG002|Extension Phase|Grade 2 or Greater AE|0|||
146708402|NCT00456092|529105675|FG003|Extension Phase|Grade 2 or Greater AE|0|||
146708403|NCT00456092|529105676|FG004|Extension Phase|Grade 2 or Greater AE|2|||
146708404|NCT00456092|529105672|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
146708405|NCT00456092|529105673|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
146708406|NCT00456092|529105674|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
146708407|NCT00456092|529105675|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
146708408|NCT00456092|529105676|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
146708409|NCT00456092|529105672|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
146708410|NCT00456092|529105673|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
146708411|NCT00456092|529105674|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
146708412|NCT00456092|529105675|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
146708413|NCT00456092|529105676|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
146708414|NCT00456092|529105672|FG000|Extension Phase|Withdrew Consent|2|||
146708415|NCT00456092|529105673|FG001|Extension Phase|Withdrew Consent|0|||
146708416|NCT00456092|529105674|FG002|Extension Phase|Withdrew Consent|0|||
146708417|NCT00456092|529105675|FG003|Extension Phase|Withdrew Consent|0|||
146708418|NCT00456092|529105676|FG004|Extension Phase|Withdrew Consent|0|||
146708419|NCT00456092|529105672|FG000|Extension Phase|Lost to Follow-up|1|||
146708420|NCT00456092|529105673|FG001|Extension Phase|Lost to Follow-up|1|||
146708421|NCT00456092|529105674|FG002|Extension Phase|Lost to Follow-up|0|||
146708422|NCT00456092|529105675|FG003|Extension Phase|Lost to Follow-up|0|||
146708423|NCT00456092|529105676|FG004|Extension Phase|Lost to Follow-up|1|||
146708424|NCT00456092|529105672|FG000|Extension Phase|Other|2|||
146708425|NCT00456092|529105673|FG001|Extension Phase|Other|0|||
146708426|NCT00456092|529105674|FG002|Extension Phase|Other|0|||
146708427|NCT00456092|529105675|FG003|Extension Phase|Other|1|||
146708428|NCT00456092|529105676|FG004|Extension Phase|Other|1|||
146708429|NCT00456092|529105672|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
146708430|NCT00456092|529105673|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
146708431|NCT00456092|529105674|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
146708432|NCT00456092|529105675|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
146708433|NCT00456092|529105676|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
146708434|NCT00456092|529105672|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
146708435|NCT00456092|529105673|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
146708436|NCT00456092|529105674|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
146708437|NCT00456092|529105675|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
146708438|NCT00456092|529105676|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
146708439|NCT00456092|529105672|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
146708440|NCT00456092|529105673|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
146708441|NCT00456092|529105674|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
146708442|NCT00456092|529105675|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
146708443|NCT00456092|529105676|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
146708444|NCT00456092|529105672|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
146708445|NCT00456092|529105673|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
146708446|NCT00456092|529105674|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
146708447|NCT00456092|529105675|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
146708448|NCT00456092|529105676|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
146708449|NCT00456092|529105672|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
146708450|NCT00456092|529105673|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
146708451|NCT00456092|529105674|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
146708452|NCT00456092|529105675|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
146708453|NCT00456092|529105676|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
146708454|NCT00456092|529105672|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
146708455|NCT00456092|529105673|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
146708456|NCT00456092|529105674|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
146933826|NCT01376245|529916011|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
146933827|NCT01376245|529916007|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
146708457|NCT00456092|529105675|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
146708458|NCT00456092|529105676|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
146708459|NCT00456092|529105672|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
146708460|NCT00456092|529105673|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
146778127|NCT04527146|529357469|FG002|Overall Study|Death|1|||
146778128|NCT04527146|529357470|FG003|Overall Study|Death|0|||
146778129|NCT04527146|529357467|FG000|Overall Study|Adverse Event|0|||
146778130|NCT04527146|529357468|FG001|Overall Study|Adverse Event|0|||
146778131|NCT04527146|529357469|FG002|Overall Study|Adverse Event|1|||
146778132|NCT04527146|529357470|FG003|Overall Study|Adverse Event|0|||
146778133|NCT04527146|529357467|FG000|Overall Study|Ineligible after randomization|2|||
146778134|NCT04527146|529357468|FG001|Overall Study|Ineligible after randomization|0|||
146778135|NCT04527146|529357469|FG002|Overall Study|Ineligible after randomization|2|||
146778136|NCT04527146|529357470|FG003|Overall Study|Ineligible after randomization|2|||
146778137|NCT04527146|529357467|FG000|Overall Study|Moved to a different group|6|||
146778138|NCT04527146|529357468|FG001|Overall Study|Moved to a different group|3|||
146778139|NCT04527146|529357469|FG002|Overall Study|Moved to a different group|0|||
146778140|NCT04527146|529357470|FG003|Overall Study|Moved to a different group|2|||
146778141|NCT05107401|529357471|FG000|Overall Study|Lost to Follow-up|13|||
146778142|NCT05107401|529357472|FG001|Overall Study|Lost to Follow-up|12|||
146778143|NCT04337372|529357474|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
146778144|NCT04337372|529357475|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
146778145|NCT04337372|529357476|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
146778146|NCT04337372|529357477|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
146778147|NCT04337372|529357474|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
146778148|NCT04337372|529357475|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
146778149|NCT04337372|529357476|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
146778150|NCT04337372|529357477|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
146778151|NCT04337372|529357474|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
146778152|NCT04337372|529357475|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
146778153|NCT04337372|529357476|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
146778154|NCT04337372|529357477|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
146778155|NCT04337372|529357474|FG000|Day 2: EEG Measures|Protocol Violation|6|||
146778156|NCT04337372|529357475|FG001|Day 2: EEG Measures|Protocol Violation|6|||
146778157|NCT04337372|529357476|FG002|Day 2: EEG Measures|Protocol Violation|5|||
146778158|NCT04337372|529357477|FG003|Day 2: EEG Measures|Protocol Violation|17|||
146778159|NCT05307783|529357478|FG000|Overall Study|Death|7|||
146778160|NCT05307783|529357478|FG000|Overall Study|Lost to Follow-up|4|||
146778161|NCT04883645|529357479|FG000|Overall Study|Death|1|||
146778162|NCT03460236|529357483|FG000|Overall Study|failed radiographic screening|16|||
146778163|NCT03460236|529357483|FG000|Overall Study|Withdrawal by Subject|11|||
146778164|NCT04869982|529357493|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
146778165|NCT04869982|529357494|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
146778166|NCT04869982|529357493|FG000|Overall Study|Migrated / moved from the study area|1|||
146778167|NCT04869982|529357494|FG001|Overall Study|Migrated / moved from the study area|1|||
146778168|NCT04869982|529357493|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
146778169|NCT04869982|529357494|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
146778170|NCT04869982|529357493|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
146778171|NCT04869982|529357494|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
146778172|NCT04869982|529357493|FG000|Overall Study|Solicited adverse event|2|||
146778173|NCT04869982|529357494|FG001|Overall Study|Solicited adverse event|1|||
146778174|NCT04608045|529357495|FG000|Overall Study|Physician Decision|1|||
146778175|NCT02473250|529357497|FG000|Overall Study|Lost to Follow-up|10|||
146981049|NCT00549198|530093718|FG000|Overall Study|Participant not able to perform Week 96|1|||
146981050|NCT00549198|530093719|FG001|Overall Study|Participant not able to perform Week 96|0|||
146778176|NCT02473250|529357497|FG000|Overall Study|Physician Decision|5|||
146778177|NCT02473250|529357497|FG000|Overall Study|Did not tolerate medication washout|3|||
146778178|NCT02473250|529357497|FG000|Overall Study|Antidepressant effect of divalproex|2|||
146778179|NCT06023082|529357498|FG000|Overall Study|Withdrawal by Subject|2|||
146778180|NCT06023082|529357498|FG000|Overall Study|Lost to Follow-up|15|||
146778181|NCT06023082|529357498|FG000|Overall Study|Side effects|5|||
146778182|NCT03584516|529357499|FG000|Part 1|Death|2|||
146778183|NCT03584516|529357500|FG001|Part 1|Death|3|||
146778184|NCT03584516|529357501|FG002|Part 1|Death|0|||
146778185|NCT03584516|529357502|FG003|Part 1|Death|0|||
146778186|NCT03584516|529357503|FG004|Part 1|Death|0|||
146778187|NCT03584516|529357504|FG005|Part 1|Death|0|||
146778188|NCT03584516|529357499|FG000|Part 1|Withdrawal by Subject|2|||
146981051|NCT00549198|530093718|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
146981052|NCT00549198|530093719|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
146981053|NCT00549198|530093718|FG000|Overall Study|Prohibited Medication|1|||
146778189|NCT03584516|529357500|FG001|Part 1|Withdrawal by Subject|0|||
146778190|NCT03584516|529357501|FG002|Part 1|Withdrawal by Subject|0|||
146778191|NCT03584516|529357502|FG003|Part 1|Withdrawal by Subject|0|||
146778192|NCT03584516|529357503|FG004|Part 1|Withdrawal by Subject|0|||
146778193|NCT03584516|529357504|FG005|Part 1|Withdrawal by Subject|0|||
146778194|NCT03584516|529357499|FG000|Part 1|Lost to Follow-up|1|||
146778195|NCT03584516|529357500|FG001|Part 1|Lost to Follow-up|0|||
146778196|NCT03584516|529357501|FG002|Part 1|Lost to Follow-up|0|||
146778197|NCT03584516|529357502|FG003|Part 1|Lost to Follow-up|0|||
146778198|NCT03584516|529357503|FG004|Part 1|Lost to Follow-up|0|||
146778199|NCT03584516|529357504|FG005|Part 1|Lost to Follow-up|0|||
146778200|NCT03584516|529357499|FG000|Part 1|Study Terminated by Sponsor|0|||
146778201|NCT03584516|529357500|FG001|Part 1|Study Terminated by Sponsor|2|||
146778202|NCT03584516|529357501|FG002|Part 1|Study Terminated by Sponsor|0|||
146778203|NCT03584516|529357502|FG003|Part 1|Study Terminated by Sponsor|0|||
146778204|NCT03584516|529357503|FG004|Part 1|Study Terminated by Sponsor|0|||
146778205|NCT03584516|529357504|FG005|Part 1|Study Terminated by Sponsor|0|||
146778206|NCT03584516|529357499|FG000|Part 1 Expansion|Death|0|||
146778207|NCT03584516|529357500|FG001|Part 1 Expansion|Death|0|||
146778208|NCT03584516|529357501|FG002|Part 1 Expansion|Death|9|||
146778209|NCT03584516|529357502|FG003|Part 1 Expansion|Death|8|||
146778210|NCT03584516|529357503|FG004|Part 1 Expansion|Death|4|||
146778211|NCT03584516|529357504|FG005|Part 1 Expansion|Death|5|||
146778212|NCT03584516|529357499|FG000|Part 1 Expansion|Lost to Follow-up|0|||
146778213|NCT03584516|529357500|FG001|Part 1 Expansion|Lost to Follow-up|0|||
146778214|NCT03584516|529357501|FG002|Part 1 Expansion|Lost to Follow-up|0|||
146778215|NCT03584516|529357502|FG003|Part 1 Expansion|Lost to Follow-up|1|||
146778216|NCT03584516|529357503|FG004|Part 1 Expansion|Lost to Follow-up|0|||
146778217|NCT03584516|529357504|FG005|Part 1 Expansion|Lost to Follow-up|0|||
146778218|NCT03584516|529357499|FG000|Part 1 Expansion|Physician Decision|0|||
146778219|NCT03584516|529357500|FG001|Part 1 Expansion|Physician Decision|0|||
146778220|NCT03584516|529357501|FG002|Part 1 Expansion|Physician Decision|4|||
146778221|NCT03584516|529357502|FG003|Part 1 Expansion|Physician Decision|3|||
146778222|NCT03584516|529357503|FG004|Part 1 Expansion|Physician Decision|2|||
146778223|NCT03584516|529357504|FG005|Part 1 Expansion|Physician Decision|3|||
146778224|NCT03584516|529357499|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
146778225|NCT03584516|529357500|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
146778226|NCT03584516|529357501|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
146778227|NCT03584516|529357502|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
146778228|NCT03584516|529357503|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
146778229|NCT03584516|529357504|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
146778230|NCT03584516|529357499|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
146778231|NCT03584516|529357500|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
146708461|NCT00456092|529105674|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
146708462|NCT00456092|529105675|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
146708463|NCT00456092|529105676|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
146708464|NCT00456092|529105672|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
146708465|NCT00456092|529105673|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
146708466|NCT00456092|529105674|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
146708467|NCT00456092|529105675|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
146708468|NCT00456092|529105676|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
146708469|NCT00456092|529105672|FG000|Treatment Phase (12 Weeks)|Other|1|||
146708470|NCT00456092|529105673|FG001|Treatment Phase (12 Weeks)|Other|0|||
146708471|NCT00456092|529105674|FG002|Treatment Phase (12 Weeks)|Other|1|||
146708472|NCT00456092|529105675|FG003|Treatment Phase (12 Weeks)|Other|0|||
146708473|NCT00456092|529105676|FG004|Treatment Phase (12 Weeks)|Other|0|||
146708474|NCT00723801|529105679|FG000|Overall Study|Lost to Follow-up|1|||
146708475|NCT00723801|529105680|FG001|Overall Study|Lost to Follow-up|2|||
146708476|NCT00723801|529105679|FG000|Overall Study|Protocol Violation|2|||
146708477|NCT00723801|529105680|FG001|Overall Study|Protocol Violation|1|||
146708478|NCT01600040|529105682|FG000|Overall Study|Withdrawal by Subject|1|||
146708479|NCT00047463|529105683|FG000|Overall Study|Withdrawal by Subject|0|||
146708480|NCT00047463|529105684|FG001|Overall Study|Withdrawal by Subject|3|||
146708481|NCT00113516|529105685|FG000|Part 1|Adverse Event|6|||
146708482|NCT00113516|529105686|FG001|Part 1|Adverse Event|0|||
146708483|NCT00113516|529105685|FG000|Part 1|Death|3|||
146708484|NCT00113516|529105686|FG001|Part 1|Death|0|||
146708485|NCT00113516|529105685|FG000|Part 1|Other|3|||
146708486|NCT00113516|529105686|FG001|Part 1|Other|0|||
146708487|NCT00113516|529105685|FG000|Part 1|Withdrawal by Subject|2|||
146708488|NCT00113516|529105686|FG001|Part 1|Withdrawal by Subject|0|||
146708489|NCT00113516|529105685|FG000|Part 1|Lack of Efficacy|2|||
146708490|NCT00113516|529105686|FG001|Part 1|Lack of Efficacy|0|||
146778232|NCT03584516|529357501|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
146778233|NCT03584516|529357502|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
146778234|NCT03584516|529357503|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
146778235|NCT03584516|529357504|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
146778236|NCT03584516|529357499|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
146778237|NCT03584516|529357500|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
146778238|NCT03584516|529357501|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
146778239|NCT03584516|529357502|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
146708491|NCT00113516|529105685|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
146708492|NCT00113516|529105686|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
146708493|NCT00113516|529105685|FG000|Part 1|Laboratory Abnormality|1|||
146708494|NCT00113516|529105686|FG001|Part 1|Laboratory Abnormality|0|||
146708495|NCT00113516|529105685|FG000|Part 1|Ongoing|1|||
146708496|NCT00113516|529105686|FG001|Part 1|Ongoing|0|||
146708497|NCT00113516|529105685|FG000|Part 1|Missing|65|||
146708498|NCT00113516|529105686|FG001|Part 1|Missing|0|||
146778240|NCT03584516|529357503|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
146778241|NCT03584516|529357504|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
146778242|NCT03584516|529357499|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
146778243|NCT03584516|529357500|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
146778244|NCT03584516|529357501|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
146778245|NCT03584516|529357502|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
146778246|NCT03584516|529357503|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
146778247|NCT03584516|529357504|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
146778248|NCT05986565|529357505|FG000|Overall Study|Lost to Follow-up|8|||
146778249|NCT05986565|529357506|FG001|Overall Study|Lost to Follow-up|3|||
146778250|NCT05986565|529357505|FG000|Overall Study|Withdrawal by Subject|0|||
146778251|NCT05986565|529357506|FG001|Overall Study|Withdrawal by Subject|1|||
146778252|NCT00670046|529357509|FG000|Overall Study|Lost to Follow-up|1|||
146778253|NCT00670046|529357510|FG001|Overall Study|Lost to Follow-up|1|||
146778254|NCT00670046|529357509|FG000|Overall Study|Withdrawal by Subject|0|||
146778255|NCT00670046|529357510|FG001|Overall Study|Withdrawal by Subject|1|||
146778256|NCT04759833|529357519|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
146778257|NCT04759833|529357520|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
146778258|NCT04759833|529357521|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
146778259|NCT04759833|529357522|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
146778260|NCT04759833|529357523|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
146778261|NCT04759833|529357519|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
146778262|NCT04759833|529357520|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
146778263|NCT04759833|529357521|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
146778264|NCT04759833|529357522|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
146778265|NCT04759833|529357523|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
146778266|NCT04759833|529357519|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
146778267|NCT04759833|529357520|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
146778268|NCT04759833|529357521|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
146778269|NCT04759833|529357522|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
146778270|NCT04759833|529357523|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
146778271|NCT04759833|529357519|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
146778272|NCT04759833|529357520|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
146778273|NCT04759833|529357521|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
146778274|NCT04759833|529357522|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
146778275|NCT04759833|529357523|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
146778276|NCT04759833|529357519|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
146778277|NCT04759833|529357520|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
146778278|NCT04759833|529357521|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
146778279|NCT04759833|529357522|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
146778280|NCT04759833|529357523|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
146778281|NCT04759833|529357519|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
146778282|NCT04759833|529357520|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
146778283|NCT04759833|529357521|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
146778284|NCT04759833|529357522|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
146778285|NCT04759833|529357523|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
146778286|NCT04759833|529357519|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
146778287|NCT04759833|529357520|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
146778288|NCT04759833|529357521|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
146778289|NCT04759833|529357522|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
146708499|NCT00113516|529105685|FG000|Part 2|Adverse Event|0|||
146708500|NCT00113516|529105686|FG001|Part 2|Adverse Event|16|||
146708501|NCT00113516|529105685|FG000|Part 2|Death|0|||
146708502|NCT00113516|529105686|FG001|Part 2|Death|5|||
146708503|NCT00113516|529105685|FG000|Part 2|Lack of Efficacy|0|||
146708504|NCT00113516|529105686|FG001|Part 2|Lack of Efficacy|37|||
146708505|NCT00113516|529105685|FG000|Part 2|Withdrawal by Subject|0|||
146708506|NCT00113516|529105686|FG001|Part 2|Withdrawal by Subject|3|||
146708507|NCT00113516|529105685|FG000|Part 2|Other|0|||
146708508|NCT00113516|529105686|FG001|Part 2|Other|3|||
146708509|NCT00113516|529105685|FG000|Part 2|Laboratory Abnormality|0|||
146708510|NCT00113516|529105686|FG001|Part 2|Laboratory Abnormality|1|||
146708511|NCT00113516|529105685|FG000|Part 2|Ongoing|0|||
146708512|NCT00113516|529105686|FG001|Part 2|Ongoing|1|||
146708513|NCT02802345|529105697|FG000|Overall Study|Not Treated|0|||
146708514|NCT02802345|529105698|FG001|Overall Study|Not Treated|1|||
146708515|NCT02802345|529105697|FG000|Overall Study|Adverse Event|28|||
146708516|NCT02802345|529105698|FG001|Overall Study|Adverse Event|20|||
146708517|NCT02802345|529105697|FG000|Overall Study|Withdrawal by Subject|3|||
146708518|NCT02802345|529105698|FG001|Overall Study|Withdrawal by Subject|3|||
146708519|NCT02802345|529105697|FG000|Overall Study|Protocol Violation|0|||
146708520|NCT02802345|529105698|FG001|Overall Study|Protocol Violation|1|||
146708521|NCT02802345|529105697|FG000|Overall Study|Other than listed|1|||
146708522|NCT02802345|529105698|FG001|Overall Study|Other than listed|5|||
146708523|NCT03075644|529105699|FG000|Overall Study|Withdrawal by Subject|1|||
146708524|NCT03075644|529105700|FG001|Overall Study|Withdrawal by Subject|1|||
146708525|NCT01706250|529105709|FG000|Overall Study|Lost to Follow-up|2|||
146708526|NCT03286140|529105710|FG000|Overall Study|Withdrawal by Subject|10|||
146708527|NCT03286140|529105711|FG001|Overall Study|Withdrawal by Subject|5|||
146708528|NCT03286140|529105710|FG000|Overall Study|Lost to Follow-up|5|||
146708529|NCT03286140|529105711|FG001|Overall Study|Lost to Follow-up|10|||
146708530|NCT03286140|529105710|FG000|Overall Study|Failure to comply|0|||
146708531|NCT03286140|529105711|FG001|Overall Study|Failure to comply|1|||
146708532|NCT01826825|529105712|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
146708533|NCT01826825|529105713|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
146708534|NCT03254134|529105714|FG000|Overall Study|Not eligible patients|599|||
146708535|NCT03254134|529105715|FG001|Overall Study|Not eligible patients|3630|||
146708536|NCT02563028|529105716|FG000|Overall Study|Lack of equipment|1|||
146708537|NCT02563028|529105716|FG000|Overall Study|Unable to elicit VEP post induction|1|||
146933828|NCT01376245|529916008|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
146933829|NCT01376245|529916009|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
146933830|NCT01376245|529916010|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
146933831|NCT01376245|529916011|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
146933832|NCT01376245|529916007|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
146933833|NCT01376245|529916008|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
146933834|NCT01376245|529916009|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
146933835|NCT01376245|529916010|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
146933836|NCT01376245|529916011|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
146933837|NCT01376245|529916007|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
146933838|NCT01376245|529916008|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
146933839|NCT01376245|529916009|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
146933840|NCT01376245|529916010|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
146933841|NCT01376245|529916011|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
146933842|NCT01376245|529916007|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
146981054|NCT00549198|530093719|FG001|Overall Study|Prohibited Medication|2|||
146708556|NCT00799617|529105724|FG000|Main Testosterone Trial|Randomized in error|1|||
146708557|NCT00799617|529105725|FG001|Main Testosterone Trial|Randomized in error|1|||
146708558|NCT00799617|529105724|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
146708559|NCT00799617|529105725|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
146708560|NCT00799617|529105724|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
146708561|NCT00799617|529105725|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
146708562|NCT00799617|529105724|FG000|Sexual Funtion Trial|No Baseline Data|4|||
146708563|NCT00799617|529105725|FG001|Sexual Funtion Trial|No Baseline Data|7|||
146708564|NCT00799617|529105724|FG000|Physical Function Trial|Lost to Follow-up|6|||
146708565|NCT00799617|529105725|FG001|Physical Function Trial|Lost to Follow-up|11|||
146708566|NCT00799617|529105724|FG000|Vitality Trial|Lost to Follow-up|7|||
146708567|NCT00799617|529105725|FG001|Vitality Trial|Lost to Follow-up|22|||
146708568|NCT00799617|529105724|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
146708569|NCT00799617|529105725|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
146708570|NCT00799617|529105724|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
146708571|NCT00799617|529105725|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
146708572|NCT00799617|529105724|FG000|Bone Trial|Month 12 scan not available|6|||
146708573|NCT00799617|529105725|FG001|Bone Trial|Month 12 scan not available|16|||
146708574|NCT00799617|529105724|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
146708575|NCT00799617|529105725|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
146708576|NCT00799617|529105724|FG000|Anemia Trial|Withdrawal by Subject|3|||
146708577|NCT00799617|529105725|FG001|Anemia Trial|Withdrawal by Subject|3|||
146708578|NCT02501096|529105726|FG000|Overall Study|Lost to Follow-up|0|||
146708579|NCT02501096|529105727|FG001|Overall Study|Lost to Follow-up|0|||
146708580|NCT02501096|529105728|FG002|Overall Study|Lost to Follow-up|0|||
146708581|NCT02501096|529105729|FG003|Overall Study|Lost to Follow-up|0|||
146708582|NCT02501096|529105730|FG004|Overall Study|Lost to Follow-up|1|||
146708583|NCT02501096|529105731|FG005|Overall Study|Lost to Follow-up|1|||
146708584|NCT02501096|529105732|FG006|Overall Study|Lost to Follow-up|3|||
146708585|NCT02501096|529105733|FG007|Overall Study|Lost to Follow-up|0|||
146708586|NCT02501096|529105734|FG008|Overall Study|Lost to Follow-up|0|||
146708587|NCT02501096|529105726|FG000|Overall Study|Withdrawal by Subject|1|||
146708588|NCT02501096|529105727|FG001|Overall Study|Withdrawal by Subject|0|||
146708589|NCT02501096|529105728|FG002|Overall Study|Withdrawal by Subject|7|||
146708590|NCT02501096|529105729|FG003|Overall Study|Withdrawal by Subject|13|||
146708591|NCT02501096|529105730|FG004|Overall Study|Withdrawal by Subject|2|||
146708592|NCT02501096|529105731|FG005|Overall Study|Withdrawal by Subject|2|||
146708593|NCT02501096|529105732|FG006|Overall Study|Withdrawal by Subject|2|||
146708594|NCT02501096|529105733|FG007|Overall Study|Withdrawal by Subject|3|||
146708595|NCT02501096|529105734|FG008|Overall Study|Withdrawal by Subject|0|||
146708596|NCT02501096|529105726|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
146708597|NCT02501096|529105727|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
146708598|NCT02501096|529105728|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
146708599|NCT02501096|529105729|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
146708600|NCT02501096|529105730|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
146708601|NCT02501096|529105731|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
146708602|NCT02501096|529105732|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
146708603|NCT02501096|529105733|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
146708604|NCT02501096|529105734|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
146708605|NCT02501096|529105726|FG000|Overall Study|Death|1|||
146708606|NCT02501096|529105727|FG001|Overall Study|Death|1|||
146708607|NCT02501096|529105728|FG002|Overall Study|Death|88|||
146708608|NCT02501096|529105729|FG003|Overall Study|Death|74|||
146708609|NCT02501096|529105730|FG004|Overall Study|Death|15|||
146708610|NCT02501096|529105731|FG005|Overall Study|Death|16|||
146708611|NCT02501096|529105732|FG006|Overall Study|Death|15|||
146708612|NCT02501096|529105733|FG007|Overall Study|Death|16|||
146708613|NCT02501096|529105734|FG008|Overall Study|Death|1|||
146708614|NCT02442830|529105737|FG000|Overall Study|Technical Failure|0|||
146708615|NCT02442830|529105738|FG001|Overall Study|Technical Failure|1|||
146708616|NCT04587193|529105739|FG000|Overall Study|Screen failure after consent|3|||
146708617|NCT04587193|529105740|FG001|Overall Study|Screen failure after consent|0|||
146708618|NCT04587193|529105739|FG000|Overall Study|Device broke during study|3|||
146708619|NCT04587193|529105740|FG001|Overall Study|Device broke during study|2|||
146708620|NCT00298038|529105743|FG000|Overall Study|Lost to Follow-up|0|||
146708621|NCT00298038|529105744|FG001|Overall Study|Lost to Follow-up|1|||
146708622|NCT00298038|529105743|FG000|Overall Study|Liver Transplant|0|||
146708623|NCT00298038|529105744|FG001|Overall Study|Liver Transplant|1|||
146708624|NCT00298038|529105743|FG000|Overall Study|Protocol Violation|1|||
146708625|NCT00298038|529105744|FG001|Overall Study|Protocol Violation|3|||
146708626|NCT00298038|529105743|FG000|Overall Study|Death|6|||
146708627|NCT00298038|529105744|FG001|Overall Study|Death|3|||
146708628|NCT00298038|529105743|FG000|Overall Study|Withdrawal by Subject|6|||
146708629|NCT00298038|529105744|FG001|Overall Study|Withdrawal by Subject|9|||
146708630|NCT00298038|529105743|FG000|Overall Study|Adverse Event|8|||
146708631|NCT00298038|529105744|FG001|Overall Study|Adverse Event|7|||
146708632|NCT00298038|529105743|FG000|Overall Study|Breakthrough overt HE episode|28|||
146708633|NCT00298038|529105744|FG001|Overall Study|Breakthrough overt HE episode|69|||
146708634|NCT00298038|529105743|FG000|Overall Study|Noncompliance|1|||
146708635|NCT00298038|529105744|FG001|Overall Study|Noncompliance|0|||
146708636|NCT00298038|529105743|FG000|Overall Study|Cocaine Abuse|1|||
146708637|NCT00298038|529105744|FG001|Overall Study|Cocaine Abuse|0|||
146708638|NCT00298038|529105743|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
146708639|NCT00298038|529105744|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
146708640|NCT02696096|529105745|FG000|Overall Study|ruled out at screening|1|||
146708641|NCT02696096|529105745|FG000|Overall Study|did not attend second fMRI|1|||
146708642|NCT02707640|529105746|FG000|Overall Study|Adverse Event|4|||
146708643|NCT02707640|529105747|FG001|Overall Study|Adverse Event|2|||
146708644|NCT02707640|529105746|FG000|Overall Study|Death|1|||
146708645|NCT02707640|529105747|FG001|Overall Study|Death|2|||
146708646|NCT02707640|529105746|FG000|Overall Study|Physician Decision|2|||
146708647|NCT02707640|529105747|FG001|Overall Study|Physician Decision|0|||
146708648|NCT02707640|529105746|FG000|Overall Study|Withdrawal by Subject|0|||
146708649|NCT02707640|529105747|FG001|Overall Study|Withdrawal by Subject|1|||
146708650|NCT02707640|529105746|FG000|Overall Study|Participant's Personal Decision|1|||
146708651|NCT02707640|529105747|FG001|Overall Study|Participant's Personal Decision|2|||
146708652|NCT02707640|529105746|FG000|Overall Study|Sponsor Discretion|1|||
146708653|NCT02707640|529105747|FG001|Overall Study|Sponsor Discretion|0|||
146736344|NCT00787319|529206817|FG000|Overall Study|Objective progression or relapse|30|||
146736345|NCT00787319|529206817|FG000|Overall Study|Lack of Efficacy|1|||
146736346|NCT00787319|529206817|FG000|Overall Study|Budget exhausted/exceeded|1|||
146736347|NCT00787319|529206817|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
146736348|NCT00787319|529206817|FG000|Overall Study|No health insurance reimbursement|2|||
146736349|NCT00787319|529206817|FG000|Overall Study|Stabilized disease findings|3|||
146736350|NCT00787319|529206817|FG000|Overall Study|Inactive disease|5|||
146736351|NCT03075904|529206818|FG000|Overall Study|Physician Decision|3|||
146736352|NCT03075904|529206818|FG000|Overall Study|Need for Medication not Permitted|1|||
146736353|NCT02228395|529206819|FG000|First Intervention Period|No longer willing to participate|1|||
146736354|NCT02228395|529206820|FG001|First Intervention Period|No longer willing to participate|0|||
146736355|NCT02228395|529206821|FG002|First Intervention Period|No longer willing to participate|0|||
146736356|NCT02228395|529206819|FG000|First Intervention Period|Unable to comply with study dates|0|||
146708654|NCT02556710|529107580|FG000|Overall Study|Surgical treatment|3|||
146708655|NCT02556710|529107581|FG001|Overall Study|Surgical treatment|0|||
146708656|NCT02556710|529107580|FG000|Overall Study|Required proscribed pain medication|2|||
146708657|NCT02556710|529107581|FG001|Overall Study|Required proscribed pain medication|1|||
146708658|NCT02556710|529107580|FG000|Overall Study|Lack of Efficacy|1|||
146708659|NCT02556710|529107581|FG001|Overall Study|Lack of Efficacy|0|||
146708660|NCT02556710|529107580|FG000|Overall Study|Worsening osteoarthritis|1|||
146708661|NCT02556710|529107581|FG001|Overall Study|Worsening osteoarthritis|0|||
146708662|NCT02556710|529107580|FG000|Overall Study|Moved out of state|1|||
146708663|NCT02556710|529107581|FG001|Overall Study|Moved out of state|0|||
146708664|NCT02556710|529107580|FG000|Overall Study|Missing reason|3|||
146708665|NCT02556710|529107581|FG001|Overall Study|Missing reason|1|||
146708666|NCT02556710|529107580|FG000|Overall Study|Pain as lack of efficacy|0|||
146708667|NCT02556710|529107581|FG001|Overall Study|Pain as lack of efficacy|4|||
146708668|NCT00827372|529107582|FG000|Overall Study|Adverse Event|5|||
146708669|NCT00827372|529107582|FG000|Overall Study|Lack of Efficacy|3|||
146708670|NCT02139644|529107583|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
146708671|NCT02139644|529107584|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146708672|NCT02139644|529107585|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146708673|NCT02139644|529107586|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146708674|NCT02139644|529107587|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146708675|NCT02139644|529107588|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146708676|NCT02139644|529107583|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
146708677|NCT02139644|529107584|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146708678|NCT02139644|529107585|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146708679|NCT02139644|529107586|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146708680|NCT02139644|529107587|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146708681|NCT02139644|529107588|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146708682|NCT02139644|529107583|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
146708683|NCT02139644|529107584|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146708684|NCT02139644|529107585|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146708685|NCT02139644|529107586|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146708686|NCT02139644|529107587|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146708687|NCT02139644|529107588|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146708688|NCT02139644|529107583|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
146708689|NCT02139644|529107584|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146708690|NCT02139644|529107585|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146708691|NCT02139644|529107586|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146708692|NCT02139644|529107587|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146708693|NCT02139644|529107588|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146708694|NCT02139644|529107583|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
146708695|NCT02139644|529107584|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146778290|NCT04759833|529357523|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
146778291|NCT04759833|529357519|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
146778292|NCT04759833|529357520|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
146778293|NCT04759833|529357521|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
146778294|NCT04759833|529357522|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
146778295|NCT04759833|529357523|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
146778296|NCT04759833|529357519|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
146778297|NCT04759833|529357520|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
146778298|NCT04759833|529357521|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
146778299|NCT04759833|529357522|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
146778300|NCT04759833|529357523|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
146778301|NCT04759833|529357519|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
146778302|NCT04759833|529357520|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
146778303|NCT04759833|529357521|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
146778304|NCT04759833|529357522|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
146778305|NCT04759833|529357523|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
146778306|NCT04759833|529357519|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
146778307|NCT04759833|529357520|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
146778308|NCT04759833|529357521|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
146778309|NCT04759833|529357522|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
146778310|NCT04759833|529357523|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
146778311|NCT04759833|529357519|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
146778312|NCT04759833|529357520|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
146778313|NCT04759833|529357521|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
146708696|NCT02139644|529107585|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146708697|NCT02139644|529107586|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146708698|NCT02139644|529107587|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146708699|NCT02139644|529107588|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146708700|NCT02139644|529107583|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
146708701|NCT02139644|529107584|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
146708702|NCT02139644|529107585|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
146708703|NCT02139644|529107586|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
146708704|NCT02139644|529107587|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
146708705|NCT02139644|529107588|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
146708706|NCT02139644|529107583|FG000|Run-In Period (Pre-assignment)|Other|6|||
146708707|NCT02139644|529107584|FG001|Run-In Period (Pre-assignment)|Other|0|||
146708708|NCT02139644|529107585|FG002|Run-In Period (Pre-assignment)|Other|0|||
146708709|NCT02139644|529107586|FG003|Run-In Period (Pre-assignment)|Other|0|||
146708710|NCT02139644|529107587|FG004|Run-In Period (Pre-assignment)|Other|0|||
146708711|NCT02139644|529107588|FG005|Run-In Period (Pre-assignment)|Other|0|||
146708712|NCT02139644|529107583|FG000|Treatment Period|Adverse Event|0|||
146708713|NCT02139644|529107584|FG001|Treatment Period|Adverse Event|0|||
146708714|NCT02139644|529107585|FG002|Treatment Period|Adverse Event|3|||
146708715|NCT02139644|529107586|FG003|Treatment Period|Adverse Event|2|||
146708716|NCT02139644|529107587|FG004|Treatment Period|Adverse Event|1|||
146708717|NCT02139644|529107588|FG005|Treatment Period|Adverse Event|6|||
146708718|NCT02139644|529107583|FG000|Treatment Period|Withdrawal by Subject|0|||
146708719|NCT02139644|529107584|FG001|Treatment Period|Withdrawal by Subject|0|||
146708720|NCT02139644|529107585|FG002|Treatment Period|Withdrawal by Subject|2|||
146708721|NCT02139644|529107586|FG003|Treatment Period|Withdrawal by Subject|2|||
146708722|NCT02139644|529107587|FG004|Treatment Period|Withdrawal by Subject|3|||
146708723|NCT02139644|529107588|FG005|Treatment Period|Withdrawal by Subject|2|||
146708724|NCT02139644|529107583|FG000|Treatment Period|Non-compliance|0|||
146708725|NCT02139644|529107584|FG001|Treatment Period|Non-compliance|0|||
146708726|NCT02139644|529107585|FG002|Treatment Period|Non-compliance|0|||
146708727|NCT02139644|529107586|FG003|Treatment Period|Non-compliance|1|||
146708728|NCT02139644|529107587|FG004|Treatment Period|Non-compliance|0|||
146708729|NCT02139644|529107588|FG005|Treatment Period|Non-compliance|0|||
146708730|NCT02139644|529107583|FG000|Treatment Period|Protocol Violation|0|||
146708731|NCT02139644|529107584|FG001|Treatment Period|Protocol Violation|0|||
146708732|NCT02139644|529107585|FG002|Treatment Period|Protocol Violation|0|||
146708733|NCT02139644|529107586|FG003|Treatment Period|Protocol Violation|1|||
146708734|NCT02139644|529107587|FG004|Treatment Period|Protocol Violation|1|||
146708735|NCT02139644|529107588|FG005|Treatment Period|Protocol Violation|1|||
146708736|NCT02139644|529107583|FG000|Treatment Period|Disease progression|0|||
146708737|NCT02139644|529107584|FG001|Treatment Period|Disease progression|0|||
146708738|NCT02139644|529107585|FG002|Treatment Period|Disease progression|0|||
146708739|NCT02139644|529107586|FG003|Treatment Period|Disease progression|1|||
146708740|NCT02139644|529107587|FG004|Treatment Period|Disease progression|1|||
146708741|NCT02139644|529107588|FG005|Treatment Period|Disease progression|2|||
146708742|NCT02139644|529107583|FG000|Treatment Period|Lost to Follow-up|0|||
146708743|NCT02139644|529107584|FG001|Treatment Period|Lost to Follow-up|0|||
146708744|NCT02139644|529107585|FG002|Treatment Period|Lost to Follow-up|1|||
146708745|NCT02139644|529107586|FG003|Treatment Period|Lost to Follow-up|1|||
146708746|NCT02139644|529107587|FG004|Treatment Period|Lost to Follow-up|1|||
146708747|NCT02139644|529107588|FG005|Treatment Period|Lost to Follow-up|1|||
146708748|NCT02139644|529107583|FG000|Treatment Period|Lack of Efficacy|0|||
146708749|NCT02139644|529107584|FG001|Treatment Period|Lack of Efficacy|0|||
146708750|NCT02139644|529107585|FG002|Treatment Period|Lack of Efficacy|1|||
146708751|NCT02139644|529107586|FG003|Treatment Period|Lack of Efficacy|0|||
146708752|NCT02139644|529107587|FG004|Treatment Period|Lack of Efficacy|1|||
146708753|NCT02139644|529107588|FG005|Treatment Period|Lack of Efficacy|4|||
146708754|NCT02139644|529107583|FG000|Treatment Period|Other|0|||
146708755|NCT02139644|529107584|FG001|Treatment Period|Other|3|||
146708756|NCT02139644|529107585|FG002|Treatment Period|Other|1|||
146708757|NCT02139644|529107586|FG003|Treatment Period|Other|1|||
146708758|NCT02139644|529107587|FG004|Treatment Period|Other|0|||
146708759|NCT02139644|529107588|FG005|Treatment Period|Other|1|||
146708760|NCT01076400|529107590|FG000|Overall Study|Adverse Event|2|||
146708761|NCT01076400|529107591|FG001|Overall Study|Adverse Event|0|||
146708762|NCT01076400|529107592|FG002|Overall Study|Adverse Event|0|||
146708763|NCT01076400|529107590|FG000|Overall Study|Progressive Disease|5|||
146708764|NCT01076400|529107591|FG001|Overall Study|Progressive Disease|0|||
146708765|NCT01076400|529107592|FG002|Overall Study|Progressive Disease|0|||
146708766|NCT02766608|529107595|FG000|Overall Study|Adverse Event|27|||
146708767|NCT02766608|529107596|FG001|Overall Study|Adverse Event|22|||
146708768|NCT02766608|529107597|FG002|Overall Study|Adverse Event|17|||
146708769|NCT02766608|529107598|FG003|Overall Study|Adverse Event|13|||
146708770|NCT02766608|529107599|FG004|Overall Study|Adverse Event|12|||
146708771|NCT02766608|529107595|FG000|Overall Study|Withdrawal by Subject|21|||
146708772|NCT02766608|529107596|FG001|Overall Study|Withdrawal by Subject|20|||
146708773|NCT02766608|529107597|FG002|Overall Study|Withdrawal by Subject|24|||
146708774|NCT02766608|529107598|FG003|Overall Study|Withdrawal by Subject|13|||
146708775|NCT02766608|529107599|FG004|Overall Study|Withdrawal by Subject|10|||
146708776|NCT02766608|529107595|FG000|Overall Study|Lack of Efficacy|16|||
146708777|NCT02766608|529107596|FG001|Overall Study|Lack of Efficacy|15|||
146708778|NCT02766608|529107597|FG002|Overall Study|Lack of Efficacy|32|||
146708779|NCT02766608|529107598|FG003|Overall Study|Lack of Efficacy|8|||
146708780|NCT02766608|529107599|FG004|Overall Study|Lack of Efficacy|2|||
146708781|NCT02766608|529107595|FG000|Overall Study|Lost to Follow-up|6|||
146708782|NCT02766608|529107596|FG001|Overall Study|Lost to Follow-up|3|||
146708783|NCT02766608|529107597|FG002|Overall Study|Lost to Follow-up|5|||
146708784|NCT02766608|529107598|FG003|Overall Study|Lost to Follow-up|2|||
146708785|NCT02766608|529107599|FG004|Overall Study|Lost to Follow-up|2|||
146708786|NCT02766608|529107595|FG000|Overall Study|Physician Decision|3|||
146708787|NCT02766608|529107596|FG001|Overall Study|Physician Decision|2|||
146708788|NCT02766608|529107597|FG002|Overall Study|Physician Decision|3|||
146708789|NCT02766608|529107598|FG003|Overall Study|Physician Decision|1|||
146708790|NCT02766608|529107599|FG004|Overall Study|Physician Decision|2|||
146708791|NCT02766608|529107595|FG000|Overall Study|Protocol disc criteria|3|||
146708792|NCT02766608|529107596|FG001|Overall Study|Protocol disc criteria|3|||
146708793|NCT02766608|529107597|FG002|Overall Study|Protocol disc criteria|4|||
146708794|NCT02766608|529107598|FG003|Overall Study|Protocol disc criteria|0|||
146708795|NCT02766608|529107599|FG004|Overall Study|Protocol disc criteria|0|||
146708796|NCT02766608|529107595|FG000|Overall Study|Protocol Violation|0|||
146708797|NCT02766608|529107596|FG001|Overall Study|Protocol Violation|4|||
146708798|NCT02766608|529107597|FG002|Overall Study|Protocol Violation|4|||
146708799|NCT02766608|529107598|FG003|Overall Study|Protocol Violation|0|||
146708800|NCT02766608|529107599|FG004|Overall Study|Protocol Violation|1|||
146708801|NCT02766608|529107595|FG000|Overall Study|Administrative Reasons|3|||
146708802|NCT02766608|529107596|FG001|Overall Study|Administrative Reasons|1|||
146708803|NCT02766608|529107597|FG002|Overall Study|Administrative Reasons|1|||
146708804|NCT02766608|529107598|FG003|Overall Study|Administrative Reasons|0|||
146708805|NCT02766608|529107599|FG004|Overall Study|Administrative Reasons|0|||
146708806|NCT02080091|529107600|FG000|Overall Study|Study Terminated|22|||
146708807|NCT02080091|529107600|FG000|Overall Study|Death|1|||
146708808|NCT02080091|529107600|FG000|Overall Study|Withdrawal by Subject|1|||
146708809|NCT02080091|529107600|FG000|Overall Study|Other|1|||
146708810|NCT01529645|529107605|FG000|Overall Study|Lost to Follow-up|0|||
146708811|NCT01529645|529107606|FG001|Overall Study|Lost to Follow-up|1|||
146708812|NCT01529645|529107607|FG002|Overall Study|Lost to Follow-up|1|||
146708813|NCT01529645|529107608|FG003|Overall Study|Lost to Follow-up|1|||
146708814|NCT01529645|529107609|FG004|Overall Study|Lost to Follow-up|1|||
146708815|NCT01529645|529107610|FG005|Overall Study|Lost to Follow-up|0|||
146708816|NCT01529645|529107611|FG006|Overall Study|Lost to Follow-up|2|||
146708817|NCT01529645|529107612|FG007|Overall Study|Lost to Follow-up|0|||
146708818|NCT01529645|529107613|FG008|Overall Study|Lost to Follow-up|1|||
146708819|NCT01529645|529107614|FG009|Overall Study|Lost to Follow-up|0|||
146708820|NCT01529645|529107605|FG000|Overall Study|SAE - Premature contractions|0|||
146708821|NCT01529645|529107606|FG001|Overall Study|SAE - Premature contractions|0|||
146708822|NCT01529645|529107607|FG002|Overall Study|SAE - Premature contractions|1|||
146708823|NCT01529645|529107608|FG003|Overall Study|SAE - Premature contractions|0|||
146708824|NCT01529645|529107609|FG004|Overall Study|SAE - Premature contractions|0|||
146708825|NCT01529645|529107610|FG005|Overall Study|SAE - Premature contractions|0|||
146708826|NCT01529645|529107611|FG006|Overall Study|SAE - Premature contractions|0|||
146708827|NCT01529645|529107612|FG007|Overall Study|SAE - Premature contractions|0|||
146708828|NCT01529645|529107613|FG008|Overall Study|SAE - Premature contractions|0|||
146708829|NCT01529645|529107614|FG009|Overall Study|SAE - Premature contractions|0|||
146708830|NCT01529645|529107605|FG000|Overall Study|Withdrawal by Subject|2|||
146708831|NCT01529645|529107606|FG001|Overall Study|Withdrawal by Subject|0|||
146708832|NCT01529645|529107607|FG002|Overall Study|Withdrawal by Subject|0|||
146708833|NCT01529645|529107608|FG003|Overall Study|Withdrawal by Subject|1|||
146708834|NCT01529645|529107609|FG004|Overall Study|Withdrawal by Subject|1|||
146933843|NCT01376245|529916008|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
146708835|NCT01529645|529107610|FG005|Overall Study|Withdrawal by Subject|1|||
146708836|NCT01529645|529107611|FG006|Overall Study|Withdrawal by Subject|0|||
146708837|NCT01529645|529107612|FG007|Overall Study|Withdrawal by Subject|0|||
146708838|NCT01529645|529107613|FG008|Overall Study|Withdrawal by Subject|0|||
146708839|NCT01529645|529107614|FG009|Overall Study|Withdrawal by Subject|0|||
146708840|NCT00274716|529107615|FG000|Phase A|Other non-reported reason|4|||
146708841|NCT00274716|529107616|FG001|Phase A|Other non-reported reason|2|||
146708842|NCT00274716|529107617|FG002|Phase A|Other non-reported reason|1|||
146933844|NCT01376245|529916009|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
146708843|NCT00274716|529107618|FG003|Phase A|Other non-reported reason|2|||
146708844|NCT00274716|529107619|FG004|Phase A|Other non-reported reason|0|||
146708845|NCT00274716|529107620|FG005|Phase A|Other non-reported reason|1|||
146708846|NCT00274716|529107615|FG000|Phase A|Participant moved|0|||
146708847|NCT00274716|529107616|FG001|Phase A|Participant moved|0|||
146708848|NCT00274716|529107617|FG002|Phase A|Participant moved|1|||
146708849|NCT00274716|529107618|FG003|Phase A|Participant moved|0|||
146708850|NCT00274716|529107619|FG004|Phase A|Participant moved|0|||
146708851|NCT00274716|529107620|FG005|Phase A|Participant moved|1|||
146708852|NCT00274716|529107615|FG000|Phase A|Site Terminated|0|||
146708853|NCT00274716|529107616|FG001|Phase A|Site Terminated|0|||
146708854|NCT00274716|529107617|FG002|Phase A|Site Terminated|0|||
146708855|NCT00274716|529107618|FG003|Phase A|Site Terminated|1|||
146708856|NCT00274716|529107619|FG004|Phase A|Site Terminated|0|||
146708857|NCT00274716|529107620|FG005|Phase A|Site Terminated|0|||
146708858|NCT00274716|529107615|FG000|Phase A|Protocol Violation|1|||
146708859|NCT00274716|529107616|FG001|Phase A|Protocol Violation|0|||
146708860|NCT00274716|529107617|FG002|Phase A|Protocol Violation|0|||
146708861|NCT00274716|529107618|FG003|Phase A|Protocol Violation|1|||
146708862|NCT00274716|529107619|FG004|Phase A|Protocol Violation|0|||
146708863|NCT00274716|529107620|FG005|Phase A|Protocol Violation|0|||
146708864|NCT00274716|529107615|FG000|Phase A|Met criteria for discontinuation|1|||
146708865|NCT00274716|529107616|FG001|Phase A|Met criteria for discontinuation|1|||
146708866|NCT00274716|529107617|FG002|Phase A|Met criteria for discontinuation|0|||
146708867|NCT00274716|529107618|FG003|Phase A|Met criteria for discontinuation|0|||
146708868|NCT00274716|529107619|FG004|Phase A|Met criteria for discontinuation|0|||
146708869|NCT00274716|529107620|FG005|Phase A|Met criteria for discontinuation|0|||
146708870|NCT00274716|529107615|FG000|Phase A|Withdrawal by Subject|2|||
146708871|NCT00274716|529107616|FG001|Phase A|Withdrawal by Subject|2|||
146708872|NCT00274716|529107617|FG002|Phase A|Withdrawal by Subject|1|||
146708873|NCT00274716|529107618|FG003|Phase A|Withdrawal by Subject|3|||
146708874|NCT00274716|529107619|FG004|Phase A|Withdrawal by Subject|0|||
146708875|NCT00274716|529107620|FG005|Phase A|Withdrawal by Subject|1|||
146708876|NCT00274716|529107615|FG000|Phase A|Adverse Event|2|||
146708877|NCT00274716|529107616|FG001|Phase A|Adverse Event|3|||
146708878|NCT00274716|529107617|FG002|Phase A|Adverse Event|3|||
146708879|NCT00274716|529107618|FG003|Phase A|Adverse Event|0|||
146708880|NCT00274716|529107619|FG004|Phase A|Adverse Event|2|||
146708881|NCT00274716|529107620|FG005|Phase A|Adverse Event|0|||
146708882|NCT00274716|529107615|FG000|Phase A|Completed but did not enter Phase B|1|||
146708883|NCT00274716|529107616|FG001|Phase A|Completed but did not enter Phase B|2|||
146708884|NCT00274716|529107617|FG002|Phase A|Completed but did not enter Phase B|2|||
146708885|NCT00274716|529107618|FG003|Phase A|Completed but did not enter Phase B|2|||
146708886|NCT00274716|529107619|FG004|Phase A|Completed but did not enter Phase B|1|||
146708887|NCT00274716|529107620|FG005|Phase A|Completed but did not enter Phase B|1|||
146708888|NCT00274716|529107615|FG000|Phase B|Adverse Event|0|||
146708889|NCT00274716|529107616|FG001|Phase B|Adverse Event|0|||
146708890|NCT00274716|529107617|FG002|Phase B|Adverse Event|2|||
146708891|NCT00274716|529107618|FG003|Phase B|Adverse Event|0|||
146708892|NCT00274716|529107619|FG004|Phase B|Adverse Event|0|||
146708893|NCT00274716|529107620|FG005|Phase B|Adverse Event|1|||
146708894|NCT00274716|529107615|FG000|Phase B|Protocol Violation|0|||
146708895|NCT00274716|529107616|FG001|Phase B|Protocol Violation|2|||
146708896|NCT00274716|529107617|FG002|Phase B|Protocol Violation|0|||
146708897|NCT00274716|529107618|FG003|Phase B|Protocol Violation|0|||
146708898|NCT00274716|529107619|FG004|Phase B|Protocol Violation|0|||
146708899|NCT00274716|529107620|FG005|Phase B|Protocol Violation|0|||
146708900|NCT00274716|529107615|FG000|Phase B|Withdrawal by Subject|0|||
146708901|NCT00274716|529107616|FG001|Phase B|Withdrawal by Subject|1|||
146708902|NCT00274716|529107617|FG002|Phase B|Withdrawal by Subject|0|||
146708903|NCT00274716|529107618|FG003|Phase B|Withdrawal by Subject|0|||
146708904|NCT00274716|529107619|FG004|Phase B|Withdrawal by Subject|0|||
146708905|NCT00274716|529107620|FG005|Phase B|Withdrawal by Subject|0|||
146708906|NCT00274716|529107615|FG000|Phase B|Participant moved|1|||
146708907|NCT00274716|529107616|FG001|Phase B|Participant moved|0|||
146708908|NCT00274716|529107617|FG002|Phase B|Participant moved|0|||
146708909|NCT00274716|529107618|FG003|Phase B|Participant moved|0|||
146708910|NCT00274716|529107619|FG004|Phase B|Participant moved|0|||
146708911|NCT00274716|529107620|FG005|Phase B|Participant moved|0|||
146708912|NCT00274716|529107615|FG000|Phase B|Other non-reported reason|0|||
146708913|NCT00274716|529107616|FG001|Phase B|Other non-reported reason|0|||
146708914|NCT00274716|529107617|FG002|Phase B|Other non-reported reason|1|||
146708915|NCT00274716|529107618|FG003|Phase B|Other non-reported reason|1|||
146708916|NCT00274716|529107619|FG004|Phase B|Other non-reported reason|0|||
146708917|NCT00274716|529107620|FG005|Phase B|Other non-reported reason|0|||
146708918|NCT00274716|529107615|FG000|Phase B|Lost to Follow-up|0|||
146708919|NCT00274716|529107616|FG001|Phase B|Lost to Follow-up|1|||
146708920|NCT00274716|529107617|FG002|Phase B|Lost to Follow-up|0|||
146708921|NCT00274716|529107618|FG003|Phase B|Lost to Follow-up|0|||
146708922|NCT00274716|529107619|FG004|Phase B|Lost to Follow-up|0|||
146708923|NCT00274716|529107620|FG005|Phase B|Lost to Follow-up|0|||
146708924|NCT04193202|529107621|FG000|Overall Study|Adverse Event|2|||
146708925|NCT04193202|529107622|FG001|Overall Study|Adverse Event|1|||
146708926|NCT04193202|529107621|FG000|Overall Study|Death|0|||
146708927|NCT04193202|529107622|FG001|Overall Study|Death|1|||
146708928|NCT04193202|529107621|FG000|Overall Study|Physician Decision|1|||
146708929|NCT04193202|529107622|FG001|Overall Study|Physician Decision|1|||
146708930|NCT04193202|529107621|FG000|Overall Study|Protocol Violation|2|||
146708931|NCT04193202|529107622|FG001|Overall Study|Protocol Violation|2|||
146778314|NCT04759833|529357522|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
146708932|NCT04193202|529107621|FG000|Overall Study|Withdrawal by Subject|11|||
146708933|NCT04193202|529107622|FG001|Overall Study|Withdrawal by Subject|5|||
146708934|NCT02212730|529107623|FG000|Overall Study|Tumor not of the required cell histology|1|||
146708935|NCT02212730|529107624|FG001|Overall Study|Tumor not of the required cell histology|0|||
146708936|NCT02212730|529107623|FG000|Overall Study|Withdrawal by Subject|1|||
146708937|NCT02212730|529107624|FG001|Overall Study|Withdrawal by Subject|0|||
146708938|NCT02212730|529107623|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
146708939|NCT02212730|529107624|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
146708940|NCT01777997|529107627|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
146708941|NCT01777997|529107627|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
146708942|NCT01777997|529107627|FG000|Weeks 48 to 72/96 on ART|Death|1|||
146708943|NCT01777997|529107627|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
146708944|NCT01694706|529107628|FG000|Overall Study|Adverse Event|0|||
146708945|NCT01694706|529107629|FG001|Overall Study|Adverse Event|1|||
146708946|NCT01694706|529107630|FG002|Overall Study|Adverse Event|0|||
146708947|NCT01694706|529107628|FG000|Overall Study|other reason not defined above|1|||
146708948|NCT01694706|529107629|FG001|Overall Study|other reason not defined above|0|||
146708949|NCT01694706|529107630|FG002|Overall Study|other reason not defined above|0|||
146708950|NCT00975975|529107631|FG000|Overall Study|Death|6|||
146708951|NCT00563797|529107645|FG000|Overall Study|Lost to Follow-up|7|||
146708952|NCT00563797|529107646|FG001|Overall Study|Lost to Follow-up|2|||
146708953|NCT02809976|529107647|FG000|Overall Study|Lost to Follow-up|1|||
146708954|NCT02809976|529107647|FG000|Overall Study|Withdrawal by Subject|1|||
146708955|NCT00211081|529107648|FG000|Overall Study|Withdrawal by Subject|2|||
146708956|NCT03755765|529107653|FG000|Overall Study|Withdrawal by Subject|2|||
146708957|NCT03755765|529107654|FG001|Overall Study|Withdrawal by Subject|4|||
146708958|NCT03755765|529107655|FG002|Overall Study|Withdrawal by Subject|4|||
146708959|NCT02104557|529107656|FG000|Overall Study|Adverse Event|24|||
146708960|NCT02104557|529107656|FG000|Overall Study|Lost to Follow-up|34|||
146708961|NCT02104557|529107656|FG000|Overall Study|Violated the usage and dosage|14|||
146708962|NCT02104557|529107656|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
146708963|NCT02104557|529107656|FG000|Overall Study|Administered Sayana prior to the contract|1|||
146708964|NCT02104557|529107656|FG000|Overall Study|Other|17|||
146708965|NCT02104557|529107656|FG000|Overall Study|Change to other contraception methods|5|||
146708966|NCT02104557|529107656|FG000|Overall Study|Discontinuation due to no pain|1|||
146708967|NCT02104557|529107656|FG000|Overall Study|Withdrawal consent|2|||
146708968|NCT02104557|529107656|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
146708969|NCT02104557|529107656|FG000|Overall Study|Discontinuation of contraception|9|||
146708970|NCT01490060|529107662|FG000|Cycle 1|Change of Treatment|0|||
146708971|NCT01490060|529107663|FG001|Cycle 1|Change of Treatment|1|||
146708972|NCT01490060|529107664|FG002|Cycle 1|Change of Treatment|1|||
146708973|NCT01490060|529107665|FG003|Cycle 1|Change of Treatment|1|||
146708974|NCT01490060|529107662|FG000|Cycle 1|Insurance Denied|0|||
146708975|NCT01490060|529107663|FG001|Cycle 1|Insurance Denied|0|||
146708976|NCT01490060|529107664|FG002|Cycle 1|Insurance Denied|2|||
146708977|NCT01490060|529107665|FG003|Cycle 1|Insurance Denied|0|||
146708978|NCT01490060|529107662|FG000|Cycle 1|Withdrawal by Subject|0|||
146708979|NCT01490060|529107663|FG001|Cycle 1|Withdrawal by Subject|0|||
146708980|NCT01490060|529107664|FG002|Cycle 1|Withdrawal by Subject|0|||
146708981|NCT01490060|529107665|FG003|Cycle 1|Withdrawal by Subject|1|||
146708982|NCT01490060|529107662|FG000|Cycle 1|Treatment at Another Facility|0|||
146708983|NCT01490060|529107663|FG001|Cycle 1|Treatment at Another Facility|0|||
146708984|NCT01490060|529107664|FG002|Cycle 1|Treatment at Another Facility|0|||
146708985|NCT01490060|529107665|FG003|Cycle 1|Treatment at Another Facility|1|||
146708986|NCT01490060|529107662|FG000|Cycle 2|Change of Treatment|1|||
146708987|NCT01490060|529107663|FG001|Cycle 2|Change of Treatment|1|||
146778315|NCT04759833|529357523|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
146778316|NCT04759833|529357519|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
146778317|NCT04759833|529357520|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
146708988|NCT01490060|529107664|FG002|Cycle 2|Change of Treatment|0|||
146708989|NCT01490060|529107665|FG003|Cycle 2|Change of Treatment|0|||
146708990|NCT01490060|529107662|FG000|Cycle 2|Non-Compliance|0|||
146708991|NCT01490060|529107663|FG001|Cycle 2|Non-Compliance|0|||
146778318|NCT04759833|529357521|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
146708992|NCT01490060|529107664|FG002|Cycle 2|Non-Compliance|1|||
146708993|NCT01490060|529107665|FG003|Cycle 2|Non-Compliance|0|||
146708994|NCT01490060|529107662|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
146708995|NCT01490060|529107663|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
146708996|NCT01490060|529107664|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
146778319|NCT04759833|529357522|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
146708997|NCT01490060|529107665|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
146708998|NCT02464969|529107668|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
146708999|NCT02464969|529107669|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
146981055|NCT00549198|530093718|FG000|Overall Study|Participant planning pregnancy|1|||
146981056|NCT00549198|530093719|FG001|Overall Study|Participant planning pregnancy|0|||
146981057|NCT00549198|530093718|FG000|Overall Study|Participant overweight, no scan possible|1|||
146981058|NCT00549198|530093719|FG001|Overall Study|Participant overweight, no scan possible|0|||
146709000|NCT02464969|529107668|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
146709001|NCT02464969|529107669|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
146709002|NCT02464969|529107668|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
146709003|NCT02464969|529107669|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
146709004|NCT02464969|529107668|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
146709005|NCT02464969|529107669|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
146709006|NCT02464969|529107668|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
146709007|NCT02464969|529107669|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
146709008|NCT02464969|529107668|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
146709009|NCT02464969|529107669|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
146709010|NCT02464969|529107668|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
146709011|NCT02464969|529107669|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
146709012|NCT02464969|529107668|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
146709013|NCT02464969|529107669|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
146709014|NCT02464969|529107668|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
146709015|NCT02464969|529107669|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
146709016|NCT02464969|529107668|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
146709017|NCT02464969|529107669|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
146709018|NCT02464969|529107668|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
146709019|NCT02464969|529107669|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
146709020|NCT02863354|529107670|FG000|Year 1|Lost to Follow-up|1|||
146709021|NCT02863354|529107671|FG001|Year 1|Lost to Follow-up|1|||
146709022|NCT02863354|529107670|FG000|Year 1|Withdrawal by Subject|3|||
146709023|NCT02863354|529107671|FG001|Year 1|Withdrawal by Subject|0|||
146709024|NCT02863354|529107670|FG000|Year 1|Death|0|||
146709025|NCT02863354|529107671|FG001|Year 1|Death|1|||
146709026|NCT02863354|529107670|FG000|Year 2|Lost to Follow-up|2|||
146709027|NCT02863354|529107671|FG001|Year 2|Lost to Follow-up|2|||
146709028|NCT03698773|529107672|FG000|Overall Study|Lost to Follow-up|2|||
146709029|NCT03698773|529107673|FG001|Overall Study|Lost to Follow-up|1|||
146709030|NCT02399085|529107674|FG000|Overall Study|Adverse Event|16|||
146709031|NCT02399085|529107674|FG000|Overall Study|Death|2|||
146709032|NCT02399085|529107674|FG000|Overall Study|Withdrawal by Subject|8|||
146709033|NCT02399085|529107674|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
146709034|NCT02399085|529107674|FG000|Overall Study|Physician Decision|5|||
146709035|NCT00724451|529107678|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
146709036|NCT00724451|529107678|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
146709037|NCT00724451|529107678|FG000|Overall Study|Not Eligible for Treatment|431|||
146709038|NCT00724451|529107678|FG000|Overall Study|Participant Refused Treatment|89|||
146709039|NCT00724451|529107678|FG000|Overall Study|Never Started Treatment|89|||
146709040|NCT00724451|529107678|FG000|Overall Study|Unknown; No Data Sources Available|9|||
146709041|NCT00724451|529107678|FG000|Overall Study|Physician Decision|116|||
146709042|NCT00724451|529107678|FG000|Overall Study|Withdrawal by Subject|45|||
146709043|NCT00724451|529107678|FG000|Overall Study|Investigator + Participant Decision|13|||
146709044|NCT01599650|529107679|FG000|Overall Study|Administrative issue|1|||
146709045|NCT01599650|529107680|FG001|Overall Study|Administrative issue|0|||
146709046|NCT01599650|529107681|FG002|Overall Study|Administrative issue|1|||
146709047|NCT01599650|529107679|FG000|Overall Study|Physician Decision|2|||
146709048|NCT01599650|529107680|FG001|Overall Study|Physician Decision|0|||
146709049|NCT01599650|529107681|FG002|Overall Study|Physician Decision|7|||
146709050|NCT01599650|529107679|FG000|Overall Study|Protocol Violation|0|||
146981059|NCT00549198|530093718|FG000|Overall Study|No scan facilities|0|||
146709051|NCT01599650|529107680|FG001|Overall Study|Protocol Violation|3|||
146709052|NCT01599650|529107681|FG002|Overall Study|Protocol Violation|0|||
146981060|NCT00549198|530093719|FG001|Overall Study|No scan facilities|2|||
146981061|NCT00549198|530093718|FG000|Overall Study|Pregnancy|0|||
146709053|NCT01599650|529107679|FG000|Overall Study|Death|2|||
146709054|NCT01599650|529107680|FG001|Overall Study|Death|1|||
146709055|NCT01599650|529107681|FG002|Overall Study|Death|2|||
146709056|NCT01599650|529107679|FG000|Overall Study|Lost to Follow-up|3|||
146709057|NCT01599650|529107680|FG001|Overall Study|Lost to Follow-up|3|||
146709058|NCT01599650|529107681|FG002|Overall Study|Lost to Follow-up|3|||
146709059|NCT01599650|529107679|FG000|Overall Study|Withdrawal by Subject|11|||
146709060|NCT01599650|529107680|FG001|Overall Study|Withdrawal by Subject|11|||
146709061|NCT01599650|529107681|FG002|Overall Study|Withdrawal by Subject|10|||
146709062|NCT01599650|529107679|FG000|Overall Study|Adverse Event|3|||
146709063|NCT01599650|529107680|FG001|Overall Study|Adverse Event|8|||
146709064|NCT01599650|529107681|FG002|Overall Study|Adverse Event|4|||
146709065|NCT00720876|529107682|FG000|Overall Study|found to be ineligible after starting tx|2|||
146709066|NCT03304379|529107684|FG000|Overall Study|Protocol Violation|8|||
146709067|NCT03304379|529107685|FG001|Overall Study|Protocol Violation|10|||
146933845|NCT01376245|529916010|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
146933846|NCT01376245|529916011|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
146933847|NCT01376245|529916007|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
146933848|NCT01376245|529916008|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
146933849|NCT01376245|529916009|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
146933850|NCT01376245|529916010|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
146933851|NCT01376245|529916011|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
146709068|NCT03304379|529107686|FG002|Overall Study|Protocol Violation|5|||
146709069|NCT03304379|529107687|FG003|Overall Study|Protocol Violation|0|||
146709070|NCT03304379|529107688|FG004|Overall Study|Protocol Violation|2|||
146709071|NCT03304379|529107684|FG000|Overall Study|Adverse Event|4|||
146709072|NCT03304379|529107685|FG001|Overall Study|Adverse Event|20|||
146709073|NCT03304379|529107686|FG002|Overall Study|Adverse Event|17|||
146709074|NCT03304379|529107687|FG003|Overall Study|Adverse Event|1|||
146709075|NCT03304379|529107688|FG004|Overall Study|Adverse Event|0|||
146709076|NCT03304379|529107684|FG000|Overall Study|Lack of Efficacy|17|||
146709077|NCT03304379|529107685|FG001|Overall Study|Lack of Efficacy|16|||
146709078|NCT03304379|529107686|FG002|Overall Study|Lack of Efficacy|20|||
146709079|NCT03304379|529107687|FG003|Overall Study|Lack of Efficacy|0|||
146709080|NCT03304379|529107688|FG004|Overall Study|Lack of Efficacy|0|||
146709081|NCT03304379|529107684|FG000|Overall Study|Physician Decision|6|||
146709082|NCT03304379|529107685|FG001|Overall Study|Physician Decision|10|||
146709083|NCT03304379|529107686|FG002|Overall Study|Physician Decision|6|||
146709084|NCT03304379|529107687|FG003|Overall Study|Physician Decision|9|||
146709085|NCT03304379|529107688|FG004|Overall Study|Physician Decision|10|||
146709086|NCT03304379|529107684|FG000|Overall Study|Withdrawal by Subject|26|||
146709087|NCT03304379|529107685|FG001|Overall Study|Withdrawal by Subject|58|||
146709088|NCT03304379|529107686|FG002|Overall Study|Withdrawal by Subject|66|||
146709089|NCT03304379|529107687|FG003|Overall Study|Withdrawal by Subject|3|||
146709090|NCT03304379|529107688|FG004|Overall Study|Withdrawal by Subject|5|||
146709091|NCT03304379|529107684|FG000|Overall Study|Lost to Follow-up|8|||
146709092|NCT03304379|529107685|FG001|Overall Study|Lost to Follow-up|24|||
146709093|NCT03304379|529107686|FG002|Overall Study|Lost to Follow-up|35|||
146709094|NCT03304379|529107687|FG003|Overall Study|Lost to Follow-up|4|||
146709095|NCT03304379|529107688|FG004|Overall Study|Lost to Follow-up|0|||
146709096|NCT03304379|529107684|FG000|Overall Study|Death|1|||
146709097|NCT03304379|529107685|FG001|Overall Study|Death|2|||
146709098|NCT03304379|529107686|FG002|Overall Study|Death|0|||
146709099|NCT03304379|529107687|FG003|Overall Study|Death|0|||
146709100|NCT03304379|529107688|FG004|Overall Study|Death|0|||
146709101|NCT03304379|529107684|FG000|Overall Study|Other|0|||
146709102|NCT03304379|529107685|FG001|Overall Study|Other|1|||
146709103|NCT03304379|529107686|FG002|Overall Study|Other|0|||
146709104|NCT03304379|529107687|FG003|Overall Study|Other|0|||
146709105|NCT03304379|529107688|FG004|Overall Study|Other|0|||
146709106|NCT01752933|529107698|FG000|Treatment|Disease Progression|3|||
146709107|NCT01752933|529107699|FG001|Treatment|Disease Progression|29|||
146709108|NCT01752933|529107698|FG000|Treatment|Withdrawal by Subject|0|||
146709109|NCT01752933|529107699|FG001|Treatment|Withdrawal by Subject|5|||
146709110|NCT01752933|529107698|FG000|Treatment|Adverse Event|1|||
146709111|NCT01752933|529107699|FG001|Treatment|Adverse Event|4|||
146709112|NCT01752933|529107698|FG000|Treatment|Physician Decision|0|||
146709113|NCT01752933|529107699|FG001|Treatment|Physician Decision|3|||
146709114|NCT01752933|529107698|FG000|Treatment|Death|0|||
146709115|NCT01752933|529107699|FG001|Treatment|Death|2|||
146709116|NCT01752933|529107698|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
146709117|NCT01752933|529107699|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
146709118|NCT01752933|529107698|FG000|Treatment|Patient noncompliant|0|||
146709119|NCT01752933|529107699|FG001|Treatment|Patient noncompliant|1|||
146709120|NCT01752933|529107698|FG000|Treatment|Patient unable to travel to appointments|0|||
146709121|NCT01752933|529107699|FG001|Treatment|Patient unable to travel to appointments|1|||
146709122|NCT01752933|529107698|FG000|Overall Study and Follow-up|Death|4|||
146709123|NCT01752933|529107699|FG001|Overall Study and Follow-up|Death|34|||
146709124|NCT01752933|529107698|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
146709125|NCT01752933|529107699|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
146709126|NCT01752933|529107698|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
146933852|NCT01376245|529916007|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
146709127|NCT01752933|529107699|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
146709128|NCT01752933|529107698|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
146709129|NCT01752933|529107699|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
146709130|NCT00179647|529107704|FG000|Overall Study|Adverse Event|294|||
146709131|NCT00179647|529107704|FG000|Overall Study|Lack of Efficacy|478|||
146709132|NCT00179647|529107704|FG000|Overall Study|Withdrawal by Subject|83|||
146709133|NCT00179647|529107704|FG000|Overall Study|Lost to Follow-up|4|||
146709134|NCT00179647|529107704|FG000|Overall Study|Death|94|||
146709135|NCT00179647|529107704|FG000|Overall Study|Other|960|||
146709136|NCT00622635|529107705|FG000|Treatment Period 1|Adverse Event|0|||
146709137|NCT00622635|529107706|FG001|Treatment Period 1|Adverse Event|0|||
146709138|NCT00622635|529107707|FG002|Treatment Period 1|Adverse Event|1|||
146709139|NCT00622635|529107708|FG003|Treatment Period 1|Adverse Event|0|||
146709140|NCT00622635|529107709|FG004|Treatment Period 1|Adverse Event|0|||
146709141|NCT00622635|529107710|FG005|Treatment Period 1|Adverse Event|0|||
146709142|NCT00622635|529107705|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146709143|NCT00622635|529107706|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146709144|NCT00622635|529107707|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146709145|NCT00622635|529107708|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146709146|NCT00622635|529107709|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146709147|NCT00622635|529107710|FG005|Treatment Period 1|Withdrawal by Subject|0|||
146709148|NCT00622635|529107705|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
146709149|NCT00622635|529107706|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
146709150|NCT00622635|529107707|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
146709151|NCT00622635|529107708|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
146709152|NCT00622635|529107709|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
146709153|NCT00622635|529107710|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
146709154|NCT00622635|529107705|FG000|Treatment Period 2|Adverse Event|1|||
146709155|NCT00622635|529107706|FG001|Treatment Period 2|Adverse Event|0|||
146709156|NCT00622635|529107707|FG002|Treatment Period 2|Adverse Event|0|||
146709157|NCT00622635|529107708|FG003|Treatment Period 2|Adverse Event|0|||
146709158|NCT00622635|529107709|FG004|Treatment Period 2|Adverse Event|0|||
146709159|NCT00622635|529107710|FG005|Treatment Period 2|Adverse Event|0|||
146709160|NCT00622635|529107705|FG000|Treatment Period 3|Adverse Event|0|||
146709161|NCT00622635|529107706|FG001|Treatment Period 3|Adverse Event|0|||
146709162|NCT00622635|529107707|FG002|Treatment Period 3|Adverse Event|0|||
146709163|NCT00622635|529107708|FG003|Treatment Period 3|Adverse Event|2|||
146709164|NCT00622635|529107709|FG004|Treatment Period 3|Adverse Event|0|||
146709165|NCT00622635|529107710|FG005|Treatment Period 3|Adverse Event|0|||
146709166|NCT00622635|529107705|FG000|Treatment Period 3|Withdrawal by Subject|0|||
146709167|NCT00622635|529107706|FG001|Treatment Period 3|Withdrawal by Subject|0|||
146709168|NCT00622635|529107707|FG002|Treatment Period 3|Withdrawal by Subject|0|||
146709169|NCT00622635|529107708|FG003|Treatment Period 3|Withdrawal by Subject|1|||
146709170|NCT00622635|529107709|FG004|Treatment Period 3|Withdrawal by Subject|0|||
146709171|NCT00622635|529107710|FG005|Treatment Period 3|Withdrawal by Subject|0|||
146709172|NCT00281840|529107711|FG000|Overall Study|Adverse Event|12|||
146709173|NCT00281840|529107711|FG000|Overall Study|Physician Decision|6|||
146709174|NCT00281840|529107711|FG000|Overall Study|Withdrawal by Subject|3|||
146709175|NCT00281840|529107711|FG000|Overall Study|Disease Progression|2|||
146709176|NCT00281840|529107711|FG000|Overall Study|exceed maximum delay in treatment|1|||
146709177|NCT00281840|529107711|FG000|Overall Study|Complicating Disease|1|||
146709178|NCT00835406|529107712|FG000|Period: First Intervention|Adverse Event|0|||
146709179|NCT00835406|529107713|FG001|Period: First Intervention|Adverse Event|1|||
146709180|NCT00835406|529107712|FG000|Period: First Intervention|Withdrawal by Subject|2|||
146709181|NCT00835406|529107713|FG001|Period: First Intervention|Withdrawal by Subject|0|||
146709182|NCT00835406|529107712|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
146709183|NCT00835406|529107713|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
146709184|NCT02185768|529107716|FG000|Overall Study|Patients were not treated|2|||
146709185|NCT02550652|529107720|FG000|Overall Study|Death|1|||
146709186|NCT02550652|529107721|FG001|Overall Study|Death|4|||
146709187|NCT02550652|529107720|FG000|Overall Study|Lack of Efficacy|1|||
146709188|NCT02550652|529107721|FG001|Overall Study|Lack of Efficacy|0|||
146709189|NCT02550652|529107720|FG000|Overall Study|Withdrawal by Subject|4|||
146709190|NCT02550652|529107721|FG001|Overall Study|Withdrawal by Subject|7|||
146709191|NCT02550652|529107720|FG000|Overall Study|Post Trial Access|1|||
146709192|NCT02550652|529107721|FG001|Overall Study|Post Trial Access|0|||
146709193|NCT02550652|529107720|FG000|Overall Study|Lost to Follow-up|1|||
146709194|NCT02550652|529107721|FG001|Overall Study|Lost to Follow-up|3|||
146709195|NCT02550652|529107720|FG000|Overall Study|Physician Decision|0|||
146709196|NCT02550652|529107721|FG001|Overall Study|Physician Decision|2|||
146709197|NCT02550652|529107720|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
146709198|NCT02550652|529107721|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
146709199|NCT03027466|529107722|FG000|Overall Study|Opting out of the app|1869|||
146709200|NCT03027466|529107723|FG001|Overall Study|Opting out of the app|1819|||
146709201|NCT03027466|529107724|FG002|Overall Study|Opting out of the app|1743|||
146709202|NCT03027466|529107725|FG003|Overall Study|Opting out of the app|1821|||
146933853|NCT01376245|529916008|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
146933854|NCT01376245|529916009|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
146933855|NCT01376245|529916010|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
146709203|NCT02486406|529107726|FG000|Overall Study|Withdrew consent|1|||
146709204|NCT02486406|529107727|FG001|Overall Study|Withdrew consent|0|||
146709205|NCT02486406|529107728|FG002|Overall Study|Withdrew consent|0|||
146709206|NCT02486406|529107729|FG003|Overall Study|Withdrew consent|1|||
146709207|NCT02486406|529107726|FG000|Overall Study|Lost to Follow-up|1|||
146709208|NCT02486406|529107727|FG001|Overall Study|Lost to Follow-up|3|||
146709209|NCT02486406|529107728|FG002|Overall Study|Lost to Follow-up|1|||
146709210|NCT02486406|529107729|FG003|Overall Study|Lost to Follow-up|3|||
146709211|NCT02486406|529107726|FG000|Overall Study|Other, not specified|0|||
146709212|NCT02486406|529107727|FG001|Overall Study|Other, not specified|0|||
146709213|NCT02486406|529107728|FG002|Overall Study|Other, not specified|1|||
146709214|NCT02486406|529107729|FG003|Overall Study|Other, not specified|0|||
146709215|NCT01858194|529107730|FG000|Overall Study|Total Artificial Heart Implant|0|||
146709216|NCT01858194|529107731|FG001|Overall Study|Total Artificial Heart Implant|1|||
146709217|NCT01858194|529107730|FG000|Overall Study|Lost to Follow-up|0|||
146709218|NCT01858194|529107731|FG001|Overall Study|Lost to Follow-up|1|||
146709219|NCT02158039|529107732|FG000|Overall Study|Withdrawal by Subject|1|||
146709220|NCT02158039|529107732|FG000|Overall Study|Screen Failure|9|||
146709221|NCT03062891|529107744|FG000|Overall Study|Withdrawal by Subject|2|||
146709222|NCT03062891|529107745|FG001|Overall Study|Withdrawal by Subject|0|||
146709223|NCT03062891|529107744|FG000|Overall Study|Lost to Follow-up|50|||
146709224|NCT03062891|529107745|FG001|Overall Study|Lost to Follow-up|38|||
146709225|NCT01079234|529107756|FG000|Main: Week 0 to 26|Adverse Event|5|||
146709226|NCT01079234|529107757|FG001|Main: Week 0 to 26|Adverse Event|4|||
146709227|NCT01079234|529107758|FG002|Main: Week 0 to 26|Adverse Event|1|||
146709228|NCT01079234|529107759|FG003|Main: Week 0 to 26|Adverse Event|0|||
146709229|NCT01079234|529107756|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
146709230|NCT01079234|529107757|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
146709231|NCT01079234|529107758|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
146709232|NCT01079234|529107759|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
146709233|NCT01079234|529107756|FG000|Main: Week 0 to 26|Protocol Violation|6|||
146709234|NCT01079234|529107757|FG001|Main: Week 0 to 26|Protocol Violation|2|||
146709235|NCT01079234|529107758|FG002|Main: Week 0 to 26|Protocol Violation|4|||
146709236|NCT01079234|529107759|FG003|Main: Week 0 to 26|Protocol Violation|0|||
146709237|NCT01079234|529107756|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
146709238|NCT01079234|529107757|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
146709239|NCT01079234|529107758|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
146709240|NCT01079234|529107759|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
146709241|NCT01079234|529107756|FG000|Main: Week 0 to 26|Unclassified|7|||
146709242|NCT01079234|529107757|FG001|Main: Week 0 to 26|Unclassified|13|||
146709243|NCT01079234|529107758|FG002|Main: Week 0 to 26|Unclassified|4|||
146709244|NCT01079234|529107759|FG003|Main: Week 0 to 26|Unclassified|0|||
146709245|NCT01079234|529107756|FG000|Extension: Week 27 to 52|Adverse Event|0|||
146709246|NCT01079234|529107757|FG001|Extension: Week 27 to 52|Adverse Event|0|||
146709247|NCT01079234|529107758|FG002|Extension: Week 27 to 52|Adverse Event|1|||
146709248|NCT01079234|529107759|FG003|Extension: Week 27 to 52|Adverse Event|0|||
146709249|NCT01079234|529107756|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
146709250|NCT01079234|529107757|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
146709251|NCT01079234|529107758|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
146709252|NCT01079234|529107759|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
146709253|NCT01079234|529107756|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
146709254|NCT01079234|529107757|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
146709255|NCT01079234|529107758|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
146709256|NCT01079234|529107759|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
146709257|NCT01079234|529107756|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
146709258|NCT01079234|529107757|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
146709259|NCT01079234|529107758|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
146778320|NCT04759833|529357523|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
146778321|NCT03446157|529357524|FG000|Overall Study|Death|11|||
146778322|NCT03446157|529357525|FG001|Overall Study|Death|9|||
146933856|NCT01376245|529916011|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
146933857|NCT01376245|529916007|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146933858|NCT01376245|529916008|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
146933859|NCT01376245|529916009|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146933860|NCT01376245|529916010|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
146933861|NCT01376245|529916011|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
146933862|NCT01376245|529916007|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
146933863|NCT01376245|529916008|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
146933864|NCT01376245|529916009|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
146933865|NCT01376245|529916010|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
146709260|NCT01079234|529107759|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
146709261|NCT01079234|529107756|FG000|Extension: Week 27 to 52|Unclassified|0|||
146709262|NCT01079234|529107757|FG001|Extension: Week 27 to 52|Unclassified|0|||
146709263|NCT01079234|529107758|FG002|Extension: Week 27 to 52|Unclassified|4|||
146709264|NCT01079234|529107759|FG003|Extension: Week 27 to 52|Unclassified|7|||
146709265|NCT03509948|529107764|FG000|Overall Study|Protocol Violation|0|||
146709266|NCT03509948|529107765|FG001|Overall Study|Protocol Violation|1|||
146709267|NCT03221257|529107766|FG000|Overall Study|Lost to Follow-up|0|||
146778323|NCT03446157|529357524|FG000|Overall Study|Lost to Follow-up|0|||
146709268|NCT03221257|529107767|FG001|Overall Study|Lost to Follow-up|1|||
146709269|NCT03221257|529107766|FG000|Overall Study|Withdrawal by Subject|1|||
146709270|NCT03221257|529107767|FG001|Overall Study|Withdrawal by Subject|1|||
146709271|NCT05402995|529107770|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
146709272|NCT05402995|529107771|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
146709273|NCT05402995|529107772|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
146709274|NCT05402995|529107773|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
146709275|NCT00205712|529107774|FG000|Overall Study|Lost to Follow-up|0|||
146709276|NCT00205712|529107775|FG001|Overall Study|Lost to Follow-up|1|||
146709277|NCT01071512|529107776|FG000|Overall Study|Adverse Event|1|||
146709278|NCT01071512|529107776|FG000|Overall Study|Development of antibodies to drug|2|||
146709279|NCT01071512|529107776|FG000|Overall Study|positive anti-JC virus antibody test|2|||
146709280|NCT02188485|529107777|FG000|Overall Study|Withdrawal by Subject|2|||
146709281|NCT02188485|529107778|FG001|Overall Study|Withdrawal by Subject|1|||
146709282|NCT02188485|529107777|FG000|Overall Study|PI withdrew, lack of capacity|0|||
146709283|NCT02188485|529107778|FG001|Overall Study|PI withdrew, lack of capacity|2|||
146709284|NCT03149237|529107779|FG000|Overall Study|Withdrawal by Subject|4|||
146709285|NCT03149237|529107780|FG001|Overall Study|Withdrawal by Subject|5|||
146709286|NCT00437034|529107781|FG000|Overall Study|Adverse Event|1|||
146709287|NCT00437034|529107781|FG000|Overall Study|Disease progression during treatment|5|||
146709288|NCT01976845|529107784|FG000|Overall Study|Physician Decision|8|||
146709289|NCT01976845|529107785|FG001|Overall Study|Physician Decision|8|||
146709290|NCT01976845|529107786|FG002|Overall Study|Physician Decision|3|||
146709291|NCT04258839|529109977|FG000|Overall Study|Adverse Event|2|||
146709292|NCT04258839|529109978|FG001|Overall Study|Adverse Event|4|||
146709293|NCT04258839|529109977|FG000|Overall Study|Lack of Efficacy|0|||
146709294|NCT04258839|529109978|FG001|Overall Study|Lack of Efficacy|2|||
146709295|NCT04258839|529109977|FG000|Overall Study|Lost to Follow-up|2|||
146709296|NCT04258839|529109978|FG001|Overall Study|Lost to Follow-up|0|||
146709297|NCT04258839|529109977|FG000|Overall Study|Withdrawal by Subject|1|||
146709298|NCT04258839|529109978|FG001|Overall Study|Withdrawal by Subject|2|||
146709299|NCT04258839|529109977|FG000|Overall Study|Withdrawal by Caregiver|5|||
146709300|NCT04258839|529109978|FG001|Overall Study|Withdrawal by Caregiver|6|||
146709301|NCT04258839|529109977|FG000|Overall Study|Reason not Specified|0|||
146709302|NCT04258839|529109978|FG001|Overall Study|Reason not Specified|1|||
146709303|NCT02293005|529109979|FG000|Overall Study|Adverse Event|2|||
146709304|NCT02293005|529109979|FG000|Overall Study|Death|4|||
146709305|NCT02293005|529109979|FG000|Overall Study|Lost to Follow-up|1|||
146709306|NCT02293005|529109979|FG000|Overall Study|Withdrawal by Subject|2|||
146709307|NCT02293005|529109979|FG000|Overall Study|Progression|17|||
146709308|NCT03328897|529109980|FG000|Randomized-treatment Epoch|Adverse Event|4|||
146709309|NCT03328897|529109981|FG001|Randomized-treatment Epoch|Adverse Event|1|||
146709310|NCT03328897|529109982|FG002|Randomized-treatment Epoch|Adverse Event|1|||
146709311|NCT03328897|529109980|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
146709312|NCT03328897|529109981|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
146709313|NCT03328897|529109982|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
146709314|NCT03328897|529109980|FG000|Randomized-treatment Epoch|Pregnancy|3|||
146709315|NCT03328897|529109981|FG001|Randomized-treatment Epoch|Pregnancy|0|||
146709316|NCT03328897|529109982|FG002|Randomized-treatment Epoch|Pregnancy|0|||
146709317|NCT03328897|529109980|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
146709318|NCT03328897|529109981|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
146709319|NCT03328897|529109982|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
146709320|NCT03328897|529109980|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
146709321|NCT03328897|529109981|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
146709322|NCT03328897|529109982|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
146709323|NCT03328897|529109980|FG000|Follow-up Epoch|Adverse Event|4|||
146709324|NCT03328897|529109981|FG001|Follow-up Epoch|Adverse Event|0|||
146709325|NCT03328897|529109982|FG002|Follow-up Epoch|Adverse Event|1|||
146709326|NCT03328897|529109980|FG000|Follow-up Epoch|Lack of Efficacy|1|||
146709327|NCT03328897|529109981|FG001|Follow-up Epoch|Lack of Efficacy|1|||
146709328|NCT03328897|529109982|FG002|Follow-up Epoch|Lack of Efficacy|1|||
146709329|NCT03328897|529109980|FG000|Follow-up Epoch|Lost to Follow-up|0|||
146709330|NCT03328897|529109981|FG001|Follow-up Epoch|Lost to Follow-up|1|||
146709331|NCT03328897|529109982|FG002|Follow-up Epoch|Lost to Follow-up|0|||
146709332|NCT03328897|529109980|FG000|Follow-up Epoch|Pregnancy|1|||
146709333|NCT03328897|529109981|FG001|Follow-up Epoch|Pregnancy|0|||
146709334|NCT03328897|529109982|FG002|Follow-up Epoch|Pregnancy|0|||
146709335|NCT03328897|529109980|FG000|Follow-up Epoch|Patient/guardian decision|2|||
146709336|NCT03328897|529109981|FG001|Follow-up Epoch|Patient/guardian decision|1|||
146709337|NCT03328897|529109982|FG002|Follow-up Epoch|Patient/guardian decision|0|||
146709338|NCT00608829|529109983|FG000|Overall Study|Death|6|||
146709339|NCT00608829|529109983|FG000|Overall Study|Withdrawal by Subject|4|||
146709340|NCT00608829|529109983|FG000|Overall Study|Subject refuses to follow up or return.|5|||
146709341|NCT00612066|529109984|FG000|Overall Study|Adverse Event|1|||
146709342|NCT02648698|529109987|FG000|Overall Study|Protocol Violation|1|||
146709343|NCT02648698|529109988|FG001|Overall Study|Protocol Violation|5|||
146709344|NCT03143829|529109989|FG000|Overall Study|Withdrawal by Subject|2|||
146709345|NCT03143829|529109990|FG001|Overall Study|Withdrawal by Subject|5|||
146709346|NCT03143829|529109989|FG000|Overall Study|Lost to Follow-up|0|||
146709347|NCT03143829|529109990|FG001|Overall Study|Lost to Follow-up|2|||
146709348|NCT03143829|529109989|FG000|Overall Study|Death|1|||
146709349|NCT03143829|529109990|FG001|Overall Study|Death|1|||
146709350|NCT03143829|529109989|FG000|Overall Study|changed treatment, no longer eligible|2|||
146709351|NCT03143829|529109990|FG001|Overall Study|changed treatment, no longer eligible|2|||
146709352|NCT00966940|529109992|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
146709353|NCT00966940|529109993|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
146709354|NCT00966940|529109992|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
146709355|NCT00966940|529109993|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
146709356|NCT01774903|529109998|FG000|Overall Study|Adverse Event|7|||
146709357|NCT01774903|529109998|FG000|Overall Study|Withdrawal by Subject|2|||
146709358|NCT01774903|529109998|FG000|Overall Study|Lack of Efficacy|1|||
146709359|NCT01774903|529109998|FG000|Overall Study|Ineligible to continue the trial|1|||
146709360|NCT00924950|529109999|FG000|Overall Study|Lost to Follow-up|2|||
146709361|NCT01602315|529110000|FG000|Overall Study|Protocol Violation|0|||
146709362|NCT01602315|529110001|FG001|Overall Study|Protocol Violation|0|||
146709363|NCT01602315|529110002|FG002|Overall Study|Protocol Violation|0|||
146709364|NCT01602315|529110003|FG003|Overall Study|Protocol Violation|0|||
146709365|NCT01602315|529110004|FG004|Overall Study|Protocol Violation|0|||
146709366|NCT01602315|529110005|FG005|Overall Study|Protocol Violation|1|||
146709367|NCT01602315|529110006|FG006|Overall Study|Protocol Violation|0|||
146709368|NCT01602315|529110000|FG000|Overall Study|Physician Decision|2|||
146709369|NCT01602315|529110001|FG001|Overall Study|Physician Decision|0|||
146709370|NCT01602315|529110002|FG002|Overall Study|Physician Decision|0|||
146709371|NCT01602315|529110003|FG003|Overall Study|Physician Decision|0|||
146709372|NCT01602315|529110004|FG004|Overall Study|Physician Decision|2|||
146709373|NCT01602315|529110005|FG005|Overall Study|Physician Decision|1|||
146709374|NCT01602315|529110006|FG006|Overall Study|Physician Decision|1|||
146709375|NCT01602315|529110000|FG000|Overall Study|Disease progression|6|||
146709376|NCT01602315|529110001|FG001|Overall Study|Disease progression|3|||
146709377|NCT01602315|529110002|FG002|Overall Study|Disease progression|10|||
146709378|NCT01602315|529110003|FG003|Overall Study|Disease progression|1|||
146709379|NCT01602315|529110004|FG004|Overall Study|Disease progression|41|||
146709380|NCT01602315|529110005|FG005|Overall Study|Disease progression|12|||
146709381|NCT01602315|529110006|FG006|Overall Study|Disease progression|15|||
146709382|NCT01602315|529110000|FG000|Overall Study|Death|1|||
146709383|NCT01602315|529110001|FG001|Overall Study|Death|1|||
146709384|NCT01602315|529110002|FG002|Overall Study|Death|1|||
146709385|NCT01602315|529110003|FG003|Overall Study|Death|1|||
146709386|NCT01602315|529110004|FG004|Overall Study|Death|7|||
146709387|NCT01602315|529110005|FG005|Overall Study|Death|2|||
146709388|NCT01602315|529110006|FG006|Overall Study|Death|2|||
146709389|NCT01602315|529110000|FG000|Overall Study|Withdrawal by Subject|2|||
146709390|NCT01602315|529110001|FG001|Overall Study|Withdrawal by Subject|0|||
146709391|NCT01602315|529110002|FG002|Overall Study|Withdrawal by Subject|2|||
146709392|NCT01602315|529110003|FG003|Overall Study|Withdrawal by Subject|0|||
146709393|NCT01602315|529110004|FG004|Overall Study|Withdrawal by Subject|6|||
146709394|NCT01602315|529110005|FG005|Overall Study|Withdrawal by Subject|0|||
146709395|NCT01602315|529110006|FG006|Overall Study|Withdrawal by Subject|1|||
146709396|NCT01602315|529110000|FG000|Overall Study|Adverse Event|5|||
146709397|NCT01602315|529110001|FG001|Overall Study|Adverse Event|1|||
146709398|NCT01602315|529110002|FG002|Overall Study|Adverse Event|5|||
146709399|NCT01602315|529110003|FG003|Overall Study|Adverse Event|4|||
146933866|NCT01376245|529916011|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
146709400|NCT01602315|529110004|FG004|Overall Study|Adverse Event|15|||
146709401|NCT01602315|529110005|FG005|Overall Study|Adverse Event|3|||
146709402|NCT01602315|529110006|FG006|Overall Study|Adverse Event|9|||
146709403|NCT01602315|529110000|FG000|Overall Study|Subject/guardian decision|0|||
146709404|NCT01602315|529110001|FG001|Overall Study|Subject/guardian decision|0|||
146709405|NCT01602315|529110002|FG002|Overall Study|Subject/guardian decision|0|||
146709406|NCT01602315|529110003|FG003|Overall Study|Subject/guardian decision|0|||
146709407|NCT01602315|529110004|FG004|Overall Study|Subject/guardian decision|0|||
146709408|NCT01602315|529110005|FG005|Overall Study|Subject/guardian decision|0|||
146709409|NCT01602315|529110006|FG006|Overall Study|Subject/guardian decision|1|||
146709410|NCT01602315|529110000|FG000|Overall Study|Cross-over patients to combo treatment|0|||
146709411|NCT01602315|529110001|FG001|Overall Study|Cross-over patients to combo treatment|0|||
146709412|NCT01602315|529110002|FG002|Overall Study|Cross-over patients to combo treatment|0|||
146709413|NCT01602315|529110003|FG003|Overall Study|Cross-over patients to combo treatment|0|||
146709414|NCT01602315|529110004|FG004|Overall Study|Cross-over patients to combo treatment|0|||
146709415|NCT01602315|529110005|FG005|Overall Study|Cross-over patients to combo treatment|16|||
146709416|NCT01602315|529110006|FG006|Overall Study|Cross-over patients to combo treatment|0|||
146709417|NCT00961259|529110013|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
146709418|NCT00961259|529110014|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
146709419|NCT00961259|529110015|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
146709420|NCT01252251|529110018|FG000|Overall Study|Withdrawal by Subject|1|||
146709421|NCT01324024|529110019|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
146709422|NCT01324024|529110020|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
146709423|NCT02691455|529110023|FG000|Overall Study|Withdrawal by Subject|1|||
146709424|NCT02691455|529110024|FG001|Overall Study|Withdrawal by Subject|2|||
146709425|NCT02691455|529110023|FG000|Overall Study|Lost to Follow-up|15|||
146709426|NCT02691455|529110024|FG001|Overall Study|Lost to Follow-up|15|||
146709427|NCT01257204|529110025|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
146709428|NCT01257204|529110026|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
146709429|NCT01257204|529110027|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
146709430|NCT01257204|529110025|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
146709431|NCT01257204|529110026|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
146709432|NCT01257204|529110027|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
146709433|NCT01257204|529110025|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
146709434|NCT01257204|529110026|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
146709435|NCT01257204|529110027|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
146709436|NCT01257204|529110025|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
146709437|NCT01257204|529110026|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
146709438|NCT01257204|529110027|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
146709439|NCT01257204|529110025|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
146709440|NCT01257204|529110026|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
146709441|NCT01257204|529110027|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
146709442|NCT01257204|529110025|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
146709443|NCT01257204|529110026|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
146709444|NCT01257204|529110027|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
146709445|NCT01257204|529110025|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
146709446|NCT01257204|529110026|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
146709447|NCT01257204|529110027|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
146709448|NCT01257204|529110025|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
146709449|NCT01257204|529110026|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
146709450|NCT01257204|529110027|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
146709451|NCT01257204|529110025|FG000|Follow-up Period (up to Week 48)|Other|0|||
146709452|NCT01257204|529110026|FG001|Follow-up Period (up to Week 48)|Other|0|||
146709453|NCT01257204|529110027|FG002|Follow-up Period (up to Week 48)|Other|5|||
146709454|NCT02057757|529110028|FG000|Overall Study|Withdrawal by Subject|3|||
146709455|NCT02057757|529110029|FG001|Overall Study|Withdrawal by Subject|5|||
146709456|NCT02057757|529110028|FG000|Overall Study|Death|2|||
146709457|NCT02057757|529110029|FG001|Overall Study|Death|0|||
146709458|NCT02057757|529110028|FG000|Overall Study|Lost to Follow-up|8|||
146709459|NCT02057757|529110029|FG001|Overall Study|Lost to Follow-up|3|||
146709460|NCT02057757|529110028|FG000|Overall Study|Non-compliance|1|||
146709461|NCT02057757|529110029|FG001|Overall Study|Non-compliance|0|||
146709462|NCT00530023|529110030|FG000|Overall Study|Withdrawal by Subject|0|||
146709463|NCT00530023|529110031|FG001|Overall Study|Withdrawal by Subject|1|||
146709464|NCT01158222|529110032|FG000|Overall Study|Not eligible for intermediate phase|17|||
146709465|NCT00111228|529110033|FG000|Overall Study|Withdrawal by Subject|5|||
146709466|NCT00111228|529110034|FG001|Overall Study|Withdrawal by Subject|1|||
146709467|NCT00111228|529110035|FG002|Overall Study|Withdrawal by Subject|0|||
146709468|NCT02480621|529110038|FG000|Randomization|Withdrawal by Subject|1|||
146709469|NCT02480621|529110039|FG001|Randomization|Withdrawal by Subject|0|||
146709470|NCT02480621|529110038|FG000|Randomization|Surgeon did not give intervention|0|||
146709471|NCT02480621|529110039|FG001|Randomization|Surgeon did not give intervention|1|||
146709472|NCT02480621|529110038|FG000|Follow Up|Lost to Follow-up|4|||
146709473|NCT02480621|529110039|FG001|Follow Up|Lost to Follow-up|2|||
146709474|NCT04632940|529110042|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
146709475|NCT04632940|529110043|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
146709476|NCT04632940|529110042|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
146709477|NCT04632940|529110043|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
146709478|NCT04632940|529110042|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
146709479|NCT04632940|529110043|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
146709480|NCT04632940|529110042|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
146709481|NCT04632940|529110043|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
146709482|NCT04632940|529110042|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
146709483|NCT04632940|529110043|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
146709484|NCT04632940|529110042|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
146709485|NCT04632940|529110043|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
146709486|NCT04632940|529110042|FG000|OLE Period (52 Weeks)|Other than specified|0|||
146709487|NCT04632940|529110043|FG001|OLE Period (52 Weeks)|Other than specified|1|||
146709488|NCT04632940|529110042|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
146709489|NCT04632940|529110043|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
146709490|NCT00684424|529110044|FG000|Overall Study|Adverse Event|1|||
146709491|NCT00684424|529110044|FG000|Overall Study|Lost to Follow-up|2|||
146709492|NCT00684424|529110044|FG000|Overall Study|Other|2|||
146709493|NCT02520531|529110047|FG000|Overall Study|Revision of study device components|2|||
146709494|NCT02520531|529110048|FG001|Overall Study|Revision of study device components|2|||
146709495|NCT02520531|529110047|FG000|Overall Study|Death|1|||
146709496|NCT02520531|529110048|FG001|Overall Study|Death|2|||
146709497|NCT02520531|529110047|FG000|Overall Study|Lost to Follow-up|1|||
146709498|NCT02520531|529110048|FG001|Overall Study|Lost to Follow-up|1|||
146709499|NCT02520531|529110047|FG000|Overall Study|Meet exclusion criterion|0|||
146709500|NCT02520531|529110048|FG001|Overall Study|Meet exclusion criterion|1|||
146709501|NCT02520531|529110047|FG000|Overall Study|Withdrawal by Subject|1|||
146709502|NCT02520531|529110048|FG001|Overall Study|Withdrawal by Subject|0|||
146709503|NCT02520531|529110047|FG000|Overall Study|Not study device|1|||
146709504|NCT02520531|529110048|FG001|Overall Study|Not study device|0|||
146709505|NCT00958880|529110064|FG000|Overall Study|Lost to Follow-up|2|||
146709506|NCT00958880|529110065|FG001|Overall Study|Lost to Follow-up|2|||
146709507|NCT01971346|529110066|FG000|Overall Study|Protocol Violation|3|||
146709508|NCT01971346|529110066|FG000|Overall Study|Lost to Follow-up|2|||
146709509|NCT01971346|529110066|FG000|Overall Study|Withdrawal by Subject|2|||
146709510|NCT01971346|529110066|FG000|Overall Study|Physician Decision|1|||
146709511|NCT01687166|529110071|FG000|Overall Study|Attempt subject|2|||
146709512|NCT01687166|529110072|FG001|Overall Study|Attempt subject|3|||
146709513|NCT01687166|529110073|FG002|Overall Study|Attempt subject|2|||
146709514|NCT01687166|529110074|FG003|Overall Study|Attempt subject|0|||
146709515|NCT01687166|529110071|FG000|Overall Study|Did not meet eligibility criteria|4|||
146709516|NCT01687166|529110072|FG001|Overall Study|Did not meet eligibility criteria|6|||
146709517|NCT01687166|529110073|FG002|Overall Study|Did not meet eligibility criteria|1|||
146709518|NCT01687166|529110074|FG003|Overall Study|Did not meet eligibility criteria|1|||
146709519|NCT01687166|529110071|FG000|Overall Study|Adverse Event|2|||
146709520|NCT01687166|529110072|FG001|Overall Study|Adverse Event|1|||
146709521|NCT01687166|529110073|FG002|Overall Study|Adverse Event|0|||
146709522|NCT01687166|529110074|FG003|Overall Study|Adverse Event|0|||
146709523|NCT01687166|529110071|FG000|Overall Study|Physician Decision|3|||
146709524|NCT01687166|529110072|FG001|Overall Study|Physician Decision|2|||
146709525|NCT01687166|529110073|FG002|Overall Study|Physician Decision|1|||
146709526|NCT01687166|529110074|FG003|Overall Study|Physician Decision|0|||
146709527|NCT01687166|529110071|FG000|Overall Study|Withdrawal by Subject|11|||
146709528|NCT01687166|529110072|FG001|Overall Study|Withdrawal by Subject|4|||
146709529|NCT01687166|529110073|FG002|Overall Study|Withdrawal by Subject|3|||
146709530|NCT01687166|529110074|FG003|Overall Study|Withdrawal by Subject|0|||
146709531|NCT01687166|529110071|FG000|Overall Study|Lost to Follow-up|2|||
146709532|NCT01687166|529110072|FG001|Overall Study|Lost to Follow-up|5|||
146709533|NCT01687166|529110073|FG002|Overall Study|Lost to Follow-up|1|||
146709534|NCT01687166|529110074|FG003|Overall Study|Lost to Follow-up|0|||
146709535|NCT01687166|529110071|FG000|Overall Study|Equipment/Device Availability|0|||
146709536|NCT01687166|529110072|FG001|Overall Study|Equipment/Device Availability|1|||
146709537|NCT01687166|529110073|FG002|Overall Study|Equipment/Device Availability|0|||
146709538|NCT01687166|529110074|FG003|Overall Study|Equipment/Device Availability|0|||
146709539|NCT01687166|529110071|FG000|Overall Study|Death|1|||
146709540|NCT01687166|529110072|FG001|Overall Study|Death|1|||
146709541|NCT01687166|529110073|FG002|Overall Study|Death|0|||
146709542|NCT01687166|529110074|FG003|Overall Study|Death|0|||
146709543|NCT01687166|529110071|FG000|Overall Study|Protocol Violation|1|||
146709544|NCT01687166|529110072|FG001|Overall Study|Protocol Violation|1|||
146709545|NCT01687166|529110073|FG002|Overall Study|Protocol Violation|1|||
146709546|NCT01687166|529110074|FG003|Overall Study|Protocol Violation|0|||
146709547|NCT01687166|529110071|FG000|Overall Study|Subject moved out of state|0|||
146709548|NCT01687166|529110072|FG001|Overall Study|Subject moved out of state|1|||
146709549|NCT01687166|529110073|FG002|Overall Study|Subject moved out of state|0|||
146709550|NCT01687166|529110074|FG003|Overall Study|Subject moved out of state|0|||
146709551|NCT01687166|529110071|FG000|Overall Study|Patient unable to be compliant|1|||
146709552|NCT01687166|529110072|FG001|Overall Study|Patient unable to be compliant|0|||
146709553|NCT01687166|529110073|FG002|Overall Study|Patient unable to be compliant|0|||
146709554|NCT01687166|529110074|FG003|Overall Study|Patient unable to be compliant|0|||
146709555|NCT01687166|529110071|FG000|Overall Study|Physician choice to use different device|1|||
146709556|NCT01687166|529110072|FG001|Overall Study|Physician choice to use different device|2|||
146709557|NCT01687166|529110073|FG002|Overall Study|Physician choice to use different device|4|||
146709558|NCT01687166|529110074|FG003|Overall Study|Physician choice to use different device|0|||
146709559|NCT01687166|529110071|FG000|Overall Study|Insurance|0|||
146709560|NCT01687166|529110072|FG001|Overall Study|Insurance|0|||
146709561|NCT01687166|529110073|FG002|Overall Study|Insurance|1|||
146709562|NCT01687166|529110074|FG003|Overall Study|Insurance|1|||
146709563|NCT02755831|529110075|FG000|Overall Study|Lost to Follow-up|3|||
146709564|NCT02755831|529110076|FG001|Overall Study|Lost to Follow-up|3|||
146709565|NCT02316717|529110077|FG000|Overall Study|Adverse Event|2|||
146709566|NCT02316717|529110078|FG001|Overall Study|Adverse Event|2|||
146709567|NCT02316717|529110079|FG002|Overall Study|Adverse Event|0|||
146778324|NCT03446157|529357525|FG001|Overall Study|Lost to Follow-up|1|||
146778325|NCT03446157|529357524|FG000|Overall Study|Withdrawal by Subject|2|||
146778326|NCT03446157|529357525|FG001|Overall Study|Withdrawal by Subject|1|||
146778327|NCT02374307|529357529|FG000|3-months Follow-up|Lost to Follow-up|1|||
146778328|NCT02374307|529357530|FG001|3-months Follow-up|Lost to Follow-up|2|||
146778329|NCT02374307|529357529|FG000|3-months Follow-up|Withdrawal by Subject|1|||
146778330|NCT02374307|529357530|FG001|3-months Follow-up|Withdrawal by Subject|4|||
146778331|NCT02374307|529357529|FG000|3-months Follow-up|Death|1|||
146778332|NCT02374307|529357530|FG001|3-months Follow-up|Death|2|||
146778333|NCT02374307|529357529|FG000|3-months Follow-up|Missed first follow-up|5|||
146778334|NCT02374307|529357530|FG001|3-months Follow-up|Missed first follow-up|1|||
146778335|NCT02374307|529357529|FG000|6-months Follow-up|Lost to Follow-up|1|||
146778336|NCT02374307|529357530|FG001|6-months Follow-up|Lost to Follow-up|2|||
146778337|NCT02374307|529357529|FG000|6-months Follow-up|Death|2|||
146778338|NCT02374307|529357530|FG001|6-months Follow-up|Death|1|||
146778339|NCT02374307|529357529|FG000|6-months Follow-up|Withdrawal by Subject|0|||
146778340|NCT02374307|529357530|FG001|6-months Follow-up|Withdrawal by Subject|3|||
146778341|NCT00632203|529357531|FG000|Overall Study|Did not start study treatment|1|||
146778342|NCT00632203|529357532|FG001|Overall Study|Did not start study treatment|0|||
146778343|NCT04452318|529357535|FG000|Overall Study|Physician Decision|1|||
146778344|NCT04452318|529357536|FG001|Overall Study|Physician Decision|2|||
146778345|NCT04452318|529357537|FG002|Overall Study|Physician Decision|0|||
146778346|NCT04452318|529357538|FG003|Overall Study|Physician Decision|2|||
146778347|NCT04452318|529357539|FG004|Overall Study|Physician Decision|0|||
146778348|NCT04452318|529357540|FG005|Overall Study|Physician Decision|2|||
146778349|NCT04452318|529357541|FG006|Overall Study|Physician Decision|5|||
146778350|NCT04452318|529357535|FG000|Overall Study|Death|2|||
146778351|NCT04452318|529357536|FG001|Overall Study|Death|3|||
146778352|NCT04452318|529357537|FG002|Overall Study|Death|0|||
146778353|NCT04452318|529357538|FG003|Overall Study|Death|0|||
146778354|NCT04452318|529357539|FG004|Overall Study|Death|0|||
146778355|NCT04452318|529357540|FG005|Overall Study|Death|0|||
146778356|NCT04452318|529357541|FG006|Overall Study|Death|0|||
146778357|NCT04452318|529357535|FG000|Overall Study|Lost to Follow-up|38|||
146778358|NCT04452318|529357536|FG001|Overall Study|Lost to Follow-up|28|||
146778359|NCT04452318|529357537|FG002|Overall Study|Lost to Follow-up|0|||
146778360|NCT04452318|529357538|FG003|Overall Study|Lost to Follow-up|3|||
146778361|NCT04452318|529357539|FG004|Overall Study|Lost to Follow-up|3|||
146778362|NCT04452318|529357540|FG005|Overall Study|Lost to Follow-up|2|||
146778363|NCT04452318|529357541|FG006|Overall Study|Lost to Follow-up|1|||
146778364|NCT04452318|529357535|FG000|Overall Study|Withdrawal by Subject|46|||
146778365|NCT04452318|529357536|FG001|Overall Study|Withdrawal by Subject|40|||
146778366|NCT04452318|529357537|FG002|Overall Study|Withdrawal by Subject|0|||
146778367|NCT04452318|529357538|FG003|Overall Study|Withdrawal by Subject|18|||
146778368|NCT04452318|529357539|FG004|Overall Study|Withdrawal by Subject|6|||
146778369|NCT04452318|529357540|FG005|Overall Study|Withdrawal by Subject|8|||
146778370|NCT04452318|529357541|FG006|Overall Study|Withdrawal by Subject|6|||
146778371|NCT02554786|529357542|FG000|Overall Study|Subject/guardian decision|29|||
146778372|NCT02554786|529357543|FG001|Overall Study|Subject/guardian decision|17|||
146778373|NCT02554786|529357544|FG002|Overall Study|Subject/guardian decision|18|||
146778374|NCT02554786|529357545|FG003|Overall Study|Subject/guardian decision|30|||
146778375|NCT02554786|529357546|FG004|Overall Study|Subject/guardian decision|20|||
146778376|NCT02554786|529357542|FG000|Overall Study|Lost to Follow-up|4|||
146778377|NCT02554786|529357543|FG001|Overall Study|Lost to Follow-up|3|||
146778378|NCT02554786|529357544|FG002|Overall Study|Lost to Follow-up|4|||
146778379|NCT02554786|529357545|FG003|Overall Study|Lost to Follow-up|2|||
146778380|NCT02554786|529357546|FG004|Overall Study|Lost to Follow-up|2|||
146778381|NCT02554786|529357542|FG000|Overall Study|Protocol deviation|1|||
146778382|NCT02554786|529357543|FG001|Overall Study|Protocol deviation|3|||
146778383|NCT02554786|529357544|FG002|Overall Study|Protocol deviation|3|||
146778384|NCT02554786|529357545|FG003|Overall Study|Protocol deviation|4|||
146981062|NCT00549198|530093719|FG001|Overall Study|Pregnancy|3|||
146981063|NCT00549198|530093718|FG000|Overall Study|Not Exposed to Study Drug|3|||
146778385|NCT02554786|529357546|FG004|Overall Study|Protocol deviation|2|||
146778386|NCT02554786|529357542|FG000|Overall Study|Technical problems|1|||
146778387|NCT02554786|529357543|FG001|Overall Study|Technical problems|1|||
146778388|NCT02554786|529357544|FG002|Overall Study|Technical problems|0|||
146778389|NCT02554786|529357545|FG003|Overall Study|Technical problems|2|||
146778390|NCT02554786|529357546|FG004|Overall Study|Technical problems|1|||
146778391|NCT02554786|529357542|FG000|Overall Study|Adverse Event|0|||
146778392|NCT02554786|529357543|FG001|Overall Study|Adverse Event|0|||
146778393|NCT02554786|529357544|FG002|Overall Study|Adverse Event|0|||
146778394|NCT02554786|529357545|FG003|Overall Study|Adverse Event|0|||
146778395|NCT02554786|529357546|FG004|Overall Study|Adverse Event|2|||
146778396|NCT02554786|529357542|FG000|Overall Study|Death|0|||
146778397|NCT02554786|529357543|FG001|Overall Study|Death|0|||
146778398|NCT02554786|529357544|FG002|Overall Study|Death|0|||
146778399|NCT02554786|529357545|FG003|Overall Study|Death|1|||
146778400|NCT02554786|529357546|FG004|Overall Study|Death|0|||
146778401|NCT02554786|529357542|FG000|Overall Study|Non-compliance with study treatment|0|||
146778402|NCT02554786|529357543|FG001|Overall Study|Non-compliance with study treatment|1|||
146778403|NCT02554786|529357544|FG002|Overall Study|Non-compliance with study treatment|1|||
146709568|NCT02316717|529110077|FG000|Overall Study|Lost to Follow-up|1|||
146709569|NCT02316717|529110078|FG001|Overall Study|Lost to Follow-up|2|||
146709570|NCT02316717|529110079|FG002|Overall Study|Lost to Follow-up|1|||
146709571|NCT02316717|529110077|FG000|Overall Study|Non compliance|3|||
146709572|NCT02316717|529110078|FG001|Overall Study|Non compliance|1|||
146709573|NCT02316717|529110079|FG002|Overall Study|Non compliance|0|||
146709574|NCT02316717|529110077|FG000|Overall Study|Protocol Violation|2|||
146709575|NCT02316717|529110078|FG001|Overall Study|Protocol Violation|0|||
146709576|NCT02316717|529110079|FG002|Overall Study|Protocol Violation|0|||
146709577|NCT02316717|529110077|FG000|Overall Study|Withdrawal by Subject|2|||
146709578|NCT02316717|529110078|FG001|Overall Study|Withdrawal by Subject|1|||
146709579|NCT02316717|529110079|FG002|Overall Study|Withdrawal by Subject|1|||
146709580|NCT02316717|529110077|FG000|Overall Study|Death|0|||
146709581|NCT02316717|529110078|FG001|Overall Study|Death|0|||
146709582|NCT02316717|529110079|FG002|Overall Study|Death|1|||
146709583|NCT02316717|529110077|FG000|Overall Study|Physician Decision|0|||
146709584|NCT02316717|529110078|FG001|Overall Study|Physician Decision|1|||
146709585|NCT02316717|529110079|FG002|Overall Study|Physician Decision|0|||
146709586|NCT02316717|529110077|FG000|Overall Study|TBC|1|||
146709587|NCT02316717|529110078|FG001|Overall Study|TBC|0|||
146709588|NCT02316717|529110079|FG002|Overall Study|TBC|0|||
146709589|NCT02296112|529110080|FG000|Overall Study|Disease progression|7|||
146709590|NCT02296112|529110080|FG000|Overall Study|Toxicity|1|||
146709591|NCT02296112|529110080|FG000|Overall Study|Began an alternate therapy|1|||
146709592|NCT00298831|529110081|FG000|Overall Study|Adverse Event|1|||
146709593|NCT00298831|529110081|FG000|Overall Study|Lost to Follow-up|3|||
146709594|NCT00298831|529110081|FG000|Overall Study|Withdrawal by Subject|1|||
146709595|NCT00298831|529110081|FG000|Overall Study|Participants did not receive treatment|27|||
146709596|NCT02052466|529110082|FG000|Overall Study|Withdrawal by Subject|1|||
146709597|NCT02052466|529110082|FG000|Overall Study|Acromial fracture|1|||
146709598|NCT01720069|529110083|FG000|Overall Study|Could not use e-diary correctly|0|||
146709599|NCT01720069|529110084|FG001|Overall Study|Could not use e-diary correctly|1|||
146709600|NCT01720069|529110085|FG002|Overall Study|Could not use e-diary correctly|1|||
146709601|NCT01720069|529110083|FG000|Overall Study|Randomised without baseline values|0|||
146709602|NCT01720069|529110084|FG001|Overall Study|Randomised without baseline values|0|||
146709603|NCT01720069|529110085|FG002|Overall Study|Randomised without baseline values|1|||
146709604|NCT01720069|529110083|FG000|Overall Study|Adverse Event|0|||
146709605|NCT01720069|529110084|FG001|Overall Study|Adverse Event|0|||
146709606|NCT01720069|529110085|FG002|Overall Study|Adverse Event|1|||
146709607|NCT01720069|529110083|FG000|Overall Study|Lack of Efficacy|0|||
146709608|NCT01720069|529110084|FG001|Overall Study|Lack of Efficacy|4|||
146709609|NCT01720069|529110085|FG002|Overall Study|Lack of Efficacy|0|||
146709610|NCT01720069|529110083|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
146709611|NCT01720069|529110084|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
146709612|NCT01720069|529110085|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
146709613|NCT01720069|529110083|FG000|Overall Study|Withdrawal by Subject|0|||
146709614|NCT01720069|529110084|FG001|Overall Study|Withdrawal by Subject|2|||
146709615|NCT01720069|529110085|FG002|Overall Study|Withdrawal by Subject|1|||
146709616|NCT01720069|529110083|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
146709617|NCT01720069|529110084|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
146709618|NCT01720069|529110085|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
146709619|NCT01720069|529110083|FG000|Overall Study|Non-compliance on using e-diary|0|||
146709620|NCT01720069|529110084|FG001|Overall Study|Non-compliance on using e-diary|0|||
146709621|NCT01720069|529110085|FG002|Overall Study|Non-compliance on using e-diary|1|||
146709622|NCT01720069|529110083|FG000|Overall Study|Lost to Follow-up|0|||
146709623|NCT01720069|529110084|FG001|Overall Study|Lost to Follow-up|0|||
146709624|NCT01720069|529110085|FG002|Overall Study|Lost to Follow-up|1|||
146709625|NCT00508742|529110086|FG000|Period 1: Infant Series|Adverse Event|5|||
146709626|NCT00508742|529110087|FG001|Period 1: Infant Series|Adverse Event|4|||
146709627|NCT00508742|529110086|FG000|Period 1: Infant Series|Protocol Violation|1|||
146709628|NCT00508742|529110087|FG001|Period 1: Infant Series|Protocol Violation|0|||
146709629|NCT00508742|529110086|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
146709630|NCT00508742|529110087|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
146709631|NCT00508742|529110086|FG000|Period 1: Infant Series|Physician Decision|1|||
146709632|NCT00508742|529110087|FG001|Period 1: Infant Series|Physician Decision|0|||
146709633|NCT00508742|529110086|FG000|Period 1: Infant Series|Other|4|||
146709634|NCT00508742|529110087|FG001|Period 1: Infant Series|Other|1|||
146709635|NCT00508742|529110086|FG000|Period 2: After Infant Series|Adverse Event|2|||
146709636|NCT00508742|529110087|FG001|Period 2: After Infant Series|Adverse Event|6|||
146709637|NCT00508742|529110086|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
146709638|NCT00508742|529110087|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
146709639|NCT00508742|529110086|FG000|Period 2: After Infant Series|Protocol Violation|1|||
146778404|NCT02554786|529357545|FG003|Overall Study|Non-compliance with study treatment|0|||
146778405|NCT02554786|529357546|FG004|Overall Study|Non-compliance with study treatment|1|||
146709640|NCT00508742|529110087|FG001|Period 2: After Infant Series|Protocol Violation|0|||
146709641|NCT00508742|529110086|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
146709642|NCT00508742|529110087|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
146709643|NCT00508742|529110086|FG000|Period 2: After Infant Series|Failed to Return|1|||
146709644|NCT00508742|529110087|FG001|Period 2: After Infant Series|Failed to Return|0|||
146709645|NCT00508742|529110086|FG000|Period 2: After Infant Series|Other|2|||
146709646|NCT00508742|529110087|FG001|Period 2: After Infant Series|Other|1|||
146709647|NCT00508742|529110086|FG000|Period 3: Toddler Dose|Adverse Event|1|||
146709648|NCT00508742|529110087|FG001|Period 3: Toddler Dose|Adverse Event|0|||
146709649|NCT00508742|529110086|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
146709650|NCT00508742|529110087|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
146709651|NCT00508742|529110086|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
146709652|NCT00508742|529110087|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
146709653|NCT00508742|529110086|FG000|Period 3: Toddler Dose|Other|5|||
146709654|NCT00508742|529110087|FG001|Period 3: Toddler Dose|Other|4|||
146709655|NCT02460224|529110095|FG000|Overall Study|Adverse Event|0|||
146709656|NCT02460224|529110096|FG001|Overall Study|Adverse Event|0|||
146709657|NCT02460224|529110097|FG002|Overall Study|Adverse Event|0|||
146709658|NCT02460224|529110098|FG003|Overall Study|Adverse Event|0|||
146709659|NCT02460224|529110099|FG004|Overall Study|Adverse Event|0|||
146709660|NCT02460224|529110100|FG005|Overall Study|Adverse Event|0|||
146709661|NCT02460224|529110101|FG006|Overall Study|Adverse Event|1|||
146709662|NCT02460224|529110102|FG007|Overall Study|Adverse Event|0|||
146709663|NCT02460224|529110103|FG008|Overall Study|Adverse Event|0|||
146709664|NCT02460224|529110104|FG009|Overall Study|Adverse Event|0|||
146709665|NCT02460224|529110105|FG010|Overall Study|Adverse Event|0|||
146709666|NCT02460224|529110106|FG011|Overall Study|Adverse Event|0|||
146709667|NCT02460224|529110107|FG012|Overall Study|Adverse Event|1|||
146709668|NCT02460224|529110108|FG013|Overall Study|Adverse Event|0|||
146709669|NCT02460224|529110109|FG014|Overall Study|Adverse Event|0|||
146709670|NCT02460224|529110110|FG015|Overall Study|Adverse Event|0|||
146709671|NCT02460224|529110111|FG016|Overall Study|Adverse Event|1|||
146709672|NCT02460224|529110112|FG017|Overall Study|Adverse Event|0|||
146709673|NCT02460224|529110113|FG018|Overall Study|Adverse Event|1|||
146709674|NCT02460224|529110114|FG019|Overall Study|Adverse Event|0|||
146709675|NCT02460224|529110115|FG020|Overall Study|Adverse Event|1|||
146709676|NCT02460224|529110116|FG021|Overall Study|Adverse Event|1|||
146709677|NCT02460224|529110117|FG022|Overall Study|Adverse Event|1|||
146709678|NCT02460224|529110118|FG023|Overall Study|Adverse Event|0|||
146709679|NCT02460224|529110119|FG024|Overall Study|Adverse Event|0|||
146709680|NCT02460224|529110120|FG025|Overall Study|Adverse Event|0|||
146709681|NCT02460224|529110121|FG026|Overall Study|Adverse Event|11|||
146709682|NCT02460224|529110122|FG027|Overall Study|Adverse Event|1|||
146709683|NCT02460224|529110123|FG028|Overall Study|Adverse Event|6|||
146709684|NCT02460224|529110095|FG000|Overall Study|Death|0|||
146709685|NCT02460224|529110096|FG001|Overall Study|Death|0|||
146709686|NCT02460224|529110097|FG002|Overall Study|Death|0|||
146709687|NCT02460224|529110098|FG003|Overall Study|Death|0|||
146709688|NCT02460224|529110099|FG004|Overall Study|Death|0|||
146709689|NCT02460224|529110100|FG005|Overall Study|Death|2|||
146709690|NCT02460224|529110101|FG006|Overall Study|Death|1|||
146709691|NCT02460224|529110102|FG007|Overall Study|Death|0|||
146709692|NCT02460224|529110103|FG008|Overall Study|Death|0|||
146709693|NCT02460224|529110104|FG009|Overall Study|Death|1|||
146709694|NCT02460224|529110105|FG010|Overall Study|Death|0|||
146709695|NCT02460224|529110106|FG011|Overall Study|Death|0|||
146709696|NCT02460224|529110107|FG012|Overall Study|Death|0|||
146709697|NCT02460224|529110108|FG013|Overall Study|Death|1|||
146709698|NCT02460224|529110109|FG014|Overall Study|Death|0|||
146709699|NCT02460224|529110110|FG015|Overall Study|Death|0|||
146709700|NCT02460224|529110111|FG016|Overall Study|Death|2|||
146709701|NCT02460224|529110112|FG017|Overall Study|Death|1|||
146709702|NCT02460224|529110113|FG018|Overall Study|Death|0|||
146709703|NCT02460224|529110114|FG019|Overall Study|Death|2|||
146709704|NCT02460224|529110115|FG020|Overall Study|Death|0|||
146709705|NCT02460224|529110116|FG021|Overall Study|Death|0|||
146709706|NCT02460224|529110117|FG022|Overall Study|Death|0|||
146709707|NCT02460224|529110118|FG023|Overall Study|Death|0|||
146709708|NCT02460224|529110119|FG024|Overall Study|Death|1|||
146709709|NCT02460224|529110120|FG025|Overall Study|Death|1|||
146709710|NCT02460224|529110121|FG026|Overall Study|Death|5|||
146709711|NCT02460224|529110122|FG027|Overall Study|Death|0|||
146709712|NCT02460224|529110123|FG028|Overall Study|Death|1|||
146709713|NCT02460224|529110095|FG000|Overall Study|Lost to Follow-up|0|||
146709714|NCT02460224|529110096|FG001|Overall Study|Lost to Follow-up|0|||
146709715|NCT02460224|529110097|FG002|Overall Study|Lost to Follow-up|0|||
146709716|NCT02460224|529110098|FG003|Overall Study|Lost to Follow-up|0|||
146709717|NCT02460224|529110099|FG004|Overall Study|Lost to Follow-up|0|||
146709718|NCT02460224|529110100|FG005|Overall Study|Lost to Follow-up|0|||
146709719|NCT02460224|529110101|FG006|Overall Study|Lost to Follow-up|0|||
146778406|NCT02554786|529357542|FG000|Overall Study|Physician Decision|0|||
146778407|NCT02554786|529357543|FG001|Overall Study|Physician Decision|1|||
146778408|NCT02554786|529357544|FG002|Overall Study|Physician Decision|4|||
146778409|NCT02554786|529357545|FG003|Overall Study|Physician Decision|1|||
146778410|NCT02554786|529357546|FG004|Overall Study|Physician Decision|1|||
146778411|NCT02554786|529357542|FG000|Overall Study|Pregnancy|0|||
146778412|NCT02554786|529357543|FG001|Overall Study|Pregnancy|0|||
146778413|NCT02554786|529357544|FG002|Overall Study|Pregnancy|0|||
146778414|NCT02554786|529357545|FG003|Overall Study|Pregnancy|1|||
146778415|NCT02554786|529357546|FG004|Overall Study|Pregnancy|1|||
146778416|NCT00604669|529357547|FG000|Overall Study|lack of information in chart|7|||
146778417|NCT01695954|529357548|FG000|Overall Study|Withdrawal by Subject|4|||
146778418|NCT01695954|529357549|FG001|Overall Study|Withdrawal by Subject|0|||
146778419|NCT01695954|529357548|FG000|Overall Study|Adverse Event|0|||
146778420|NCT01695954|529357549|FG001|Overall Study|Adverse Event|2|||
146778421|NCT03330795|529357568|FG000|Overall Study|Death|3|||
146778422|NCT03330795|529357568|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
146778423|NCT00539734|529357570|FG000|Overall Study|Protocol Violation|1|||
146778424|NCT01070069|529357571|FG000|Overall Study|Death|1|||
146778425|NCT01070069|529357572|FG001|Overall Study|Death|0|||
146778426|NCT01070069|529357573|FG002|Overall Study|Death|2|||
146778427|NCT01070069|529357574|FG003|Overall Study|Death|0|||
146778428|NCT01070069|529357575|FG004|Overall Study|Death|1|||
146778429|NCT01070069|529357571|FG000|Overall Study|Withdrawal by Subject|1|||
146778430|NCT01070069|529357572|FG001|Overall Study|Withdrawal by Subject|1|||
146778431|NCT01070069|529357573|FG002|Overall Study|Withdrawal by Subject|4|||
146778432|NCT01070069|529357574|FG003|Overall Study|Withdrawal by Subject|0|||
146778433|NCT01070069|529357575|FG004|Overall Study|Withdrawal by Subject|0|||
146778434|NCT01070069|529357571|FG000|Overall Study|Lost to Follow-up|4|||
146778435|NCT01070069|529357572|FG001|Overall Study|Lost to Follow-up|1|||
146778436|NCT01070069|529357573|FG002|Overall Study|Lost to Follow-up|0|||
146778437|NCT01070069|529357574|FG003|Overall Study|Lost to Follow-up|0|||
146778438|NCT01070069|529357575|FG004|Overall Study|Lost to Follow-up|3|||
146778439|NCT01771731|529357576|FG000|Overall Study|Physician Decision|1|||
146778440|NCT01771731|529357577|FG001|Overall Study|Physician Decision|0|||
146709720|NCT02460224|529110102|FG007|Overall Study|Lost to Follow-up|0|||
146709721|NCT02460224|529110103|FG008|Overall Study|Lost to Follow-up|0|||
146709722|NCT02460224|529110104|FG009|Overall Study|Lost to Follow-up|0|||
146709723|NCT02460224|529110105|FG010|Overall Study|Lost to Follow-up|0|||
146709724|NCT02460224|529110106|FG011|Overall Study|Lost to Follow-up|0|||
146709725|NCT02460224|529110107|FG012|Overall Study|Lost to Follow-up|0|||
146709726|NCT02460224|529110108|FG013|Overall Study|Lost to Follow-up|0|||
146709727|NCT02460224|529110109|FG014|Overall Study|Lost to Follow-up|0|||
146709728|NCT02460224|529110110|FG015|Overall Study|Lost to Follow-up|0|||
146709729|NCT02460224|529110111|FG016|Overall Study|Lost to Follow-up|0|||
146709730|NCT02460224|529110112|FG017|Overall Study|Lost to Follow-up|0|||
146709731|NCT02460224|529110113|FG018|Overall Study|Lost to Follow-up|0|||
146709732|NCT02460224|529110114|FG019|Overall Study|Lost to Follow-up|0|||
146709733|NCT02460224|529110115|FG020|Overall Study|Lost to Follow-up|0|||
146709734|NCT02460224|529110116|FG021|Overall Study|Lost to Follow-up|0|||
146709735|NCT02460224|529110117|FG022|Overall Study|Lost to Follow-up|1|||
146709736|NCT02460224|529110118|FG023|Overall Study|Lost to Follow-up|0|||
146709737|NCT02460224|529110119|FG024|Overall Study|Lost to Follow-up|0|||
146778441|NCT01771731|529357576|FG000|Overall Study|Protocol Violation|0|||
146778442|NCT01771731|529357577|FG001|Overall Study|Protocol Violation|1|||
146778443|NCT01771731|529357576|FG000|Overall Study|Adverse event: Pain Crisis|1|||
146778444|NCT01771731|529357577|FG001|Overall Study|Adverse event: Pain Crisis|1|||
146778445|NCT03201562|529357578|FG000|Overall Study|Physician Decision|0|||
146933867|NCT01376245|529916007|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
146933868|NCT01376245|529916008|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
146933869|NCT01376245|529916009|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
146709738|NCT02460224|529110120|FG025|Overall Study|Lost to Follow-up|0|||
146709739|NCT02460224|529110121|FG026|Overall Study|Lost to Follow-up|0|||
146709740|NCT02460224|529110122|FG027|Overall Study|Lost to Follow-up|0|||
146709741|NCT02460224|529110123|FG028|Overall Study|Lost to Follow-up|0|||
146709742|NCT02460224|529110095|FG000|Overall Study|Physician Decision|0|||
146933870|NCT01376245|529916010|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
146709743|NCT02460224|529110096|FG001|Overall Study|Physician Decision|1|||
146709744|NCT02460224|529110097|FG002|Overall Study|Physician Decision|0|||
146778446|NCT03201562|529357579|FG001|Overall Study|Physician Decision|0|||
146778447|NCT03201562|529357580|FG002|Overall Study|Physician Decision|1|||
146778448|NCT03201562|529357578|FG000|Overall Study|Adverse Event|0|||
146778449|NCT03201562|529357579|FG001|Overall Study|Adverse Event|0|||
146778450|NCT03201562|529357580|FG002|Overall Study|Adverse Event|1|||
146778451|NCT03201562|529357578|FG000|Overall Study|Lost to Follow-up|0|||
146778452|NCT03201562|529357579|FG001|Overall Study|Lost to Follow-up|1|||
146778453|NCT03201562|529357580|FG002|Overall Study|Lost to Follow-up|2|||
146709745|NCT02460224|529110098|FG003|Overall Study|Physician Decision|0|||
146778454|NCT00065260|529357581|FG000|Overall Study|Death|0|||
146709746|NCT02460224|529110099|FG004|Overall Study|Physician Decision|1|||
146709747|NCT02460224|529110100|FG005|Overall Study|Physician Decision|0|||
146709748|NCT02460224|529110101|FG006|Overall Study|Physician Decision|0|||
146709749|NCT02460224|529110102|FG007|Overall Study|Physician Decision|1|||
146709750|NCT02460224|529110103|FG008|Overall Study|Physician Decision|0|||
146709751|NCT02460224|529110104|FG009|Overall Study|Physician Decision|0|||
146709752|NCT02460224|529110105|FG010|Overall Study|Physician Decision|0|||
146709753|NCT02460224|529110106|FG011|Overall Study|Physician Decision|1|||
146709754|NCT02460224|529110107|FG012|Overall Study|Physician Decision|0|||
146709755|NCT02460224|529110108|FG013|Overall Study|Physician Decision|1|||
146709756|NCT02460224|529110109|FG014|Overall Study|Physician Decision|0|||
146709757|NCT02460224|529110110|FG015|Overall Study|Physician Decision|0|||
146709758|NCT02460224|529110111|FG016|Overall Study|Physician Decision|2|||
146709759|NCT02460224|529110112|FG017|Overall Study|Physician Decision|1|||
146709760|NCT02460224|529110113|FG018|Overall Study|Physician Decision|1|||
146709761|NCT02460224|529110114|FG019|Overall Study|Physician Decision|2|||
146709762|NCT02460224|529110115|FG020|Overall Study|Physician Decision|1|||
146709763|NCT02460224|529110116|FG021|Overall Study|Physician Decision|1|||
146709764|NCT02460224|529110117|FG022|Overall Study|Physician Decision|0|||
146709765|NCT02460224|529110118|FG023|Overall Study|Physician Decision|0|||
146709766|NCT02460224|529110119|FG024|Overall Study|Physician Decision|1|||
146709767|NCT02460224|529110120|FG025|Overall Study|Physician Decision|0|||
146709768|NCT02460224|529110121|FG026|Overall Study|Physician Decision|14|||
146709769|NCT02460224|529110122|FG027|Overall Study|Physician Decision|1|||
146709770|NCT02460224|529110123|FG028|Overall Study|Physician Decision|6|||
146709771|NCT02460224|529110095|FG000|Overall Study|Progressive disease|15|||
146709772|NCT02460224|529110096|FG001|Overall Study|Progressive disease|11|||
146709773|NCT02460224|529110097|FG002|Overall Study|Progressive disease|5|||
146709774|NCT02460224|529110098|FG003|Overall Study|Progressive disease|6|||
146709775|NCT02460224|529110099|FG004|Overall Study|Progressive disease|3|||
146709776|NCT02460224|529110100|FG005|Overall Study|Progressive disease|26|||
146709777|NCT02460224|529110101|FG006|Overall Study|Progressive disease|28|||
146709778|NCT02460224|529110102|FG007|Overall Study|Progressive disease|4|||
146709779|NCT02460224|529110103|FG008|Overall Study|Progressive disease|5|||
146709780|NCT02460224|529110104|FG009|Overall Study|Progressive disease|9|||
146709781|NCT02460224|529110105|FG010|Overall Study|Progressive disease|5|||
146709782|NCT02460224|529110106|FG011|Overall Study|Progressive disease|4|||
146709783|NCT02460224|529110107|FG012|Overall Study|Progressive disease|5|||
146709784|NCT02460224|529110108|FG013|Overall Study|Progressive disease|4|||
146709785|NCT02460224|529110109|FG014|Overall Study|Progressive disease|5|||
146709786|NCT02460224|529110110|FG015|Overall Study|Progressive disease|5|||
146709787|NCT02460224|529110111|FG016|Overall Study|Progressive disease|15|||
146709788|NCT02460224|529110112|FG017|Overall Study|Progressive disease|3|||
146709789|NCT02460224|529110113|FG018|Overall Study|Progressive disease|8|||
146709790|NCT02460224|529110114|FG019|Overall Study|Progressive disease|3|||
146709791|NCT02460224|529110115|FG020|Overall Study|Progressive disease|4|||
146709792|NCT02460224|529110116|FG021|Overall Study|Progressive disease|9|||
146709793|NCT02460224|529110117|FG022|Overall Study|Progressive disease|4|||
146709794|NCT02460224|529110118|FG023|Overall Study|Progressive disease|11|||
146709795|NCT02460224|529110119|FG024|Overall Study|Progressive disease|4|||
146709796|NCT02460224|529110120|FG025|Overall Study|Progressive disease|5|||
146709797|NCT02460224|529110121|FG026|Overall Study|Progressive disease|85|||
146709798|NCT02460224|529110122|FG027|Overall Study|Progressive disease|17|||
146709799|NCT02460224|529110123|FG028|Overall Study|Progressive disease|77|||
146709800|NCT02460224|529110095|FG000|Overall Study|Subject/guardian decision|2|||
146709801|NCT02460224|529110096|FG001|Overall Study|Subject/guardian decision|0|||
146709802|NCT02460224|529110097|FG002|Overall Study|Subject/guardian decision|1|||
146709803|NCT02460224|529110098|FG003|Overall Study|Subject/guardian decision|0|||
146709804|NCT02460224|529110099|FG004|Overall Study|Subject/guardian decision|2|||
146709805|NCT02460224|529110100|FG005|Overall Study|Subject/guardian decision|2|||
146709806|NCT02460224|529110101|FG006|Overall Study|Subject/guardian decision|0|||
146709807|NCT02460224|529110102|FG007|Overall Study|Subject/guardian decision|0|||
146709808|NCT02460224|529110103|FG008|Overall Study|Subject/guardian decision|1|||
146709809|NCT02460224|529110104|FG009|Overall Study|Subject/guardian decision|1|||
146709810|NCT02460224|529110105|FG010|Overall Study|Subject/guardian decision|0|||
146709811|NCT02460224|529110106|FG011|Overall Study|Subject/guardian decision|1|||
146709812|NCT02460224|529110107|FG012|Overall Study|Subject/guardian decision|0|||
146709813|NCT02460224|529110108|FG013|Overall Study|Subject/guardian decision|0|||
146709814|NCT02460224|529110109|FG014|Overall Study|Subject/guardian decision|0|||
146709815|NCT02460224|529110110|FG015|Overall Study|Subject/guardian decision|1|||
146709816|NCT02460224|529110111|FG016|Overall Study|Subject/guardian decision|0|||
146709817|NCT02460224|529110112|FG017|Overall Study|Subject/guardian decision|1|||
146709818|NCT02460224|529110113|FG018|Overall Study|Subject/guardian decision|2|||
146709819|NCT02460224|529110114|FG019|Overall Study|Subject/guardian decision|0|||
146709820|NCT02460224|529110115|FG020|Overall Study|Subject/guardian decision|0|||
146709821|NCT02460224|529110116|FG021|Overall Study|Subject/guardian decision|1|||
146709822|NCT02460224|529110117|FG022|Overall Study|Subject/guardian decision|0|||
146709823|NCT02460224|529110118|FG023|Overall Study|Subject/guardian decision|0|||
146709824|NCT02460224|529110119|FG024|Overall Study|Subject/guardian decision|0|||
146709825|NCT02460224|529110120|FG025|Overall Study|Subject/guardian decision|0|||
146709826|NCT02460224|529110121|FG026|Overall Study|Subject/guardian decision|6|||
146709827|NCT02460224|529110122|FG027|Overall Study|Subject/guardian decision|2|||
146709828|NCT02460224|529110123|FG028|Overall Study|Subject/guardian decision|3|||
146709829|NCT03146650|529110125|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
146709830|NCT03146650|529110125|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
146709831|NCT03146650|529110125|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
146709832|NCT03146650|529110125|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
146709833|NCT03146650|529110125|FG000|2 Year Follow-up|Death|11|||
146709834|NCT03146650|529110125|FG000|2 Year Follow-up|Still in follow-up|7|||
146709835|NCT03146650|529110125|FG000|2 Year Follow-up|Lost to Follow-up|1|||
146709836|NCT02047604|529110130|FG000|Overall Study|Withdrawal by Subject|0|||
146709837|NCT02047604|529110131|FG001|Overall Study|Withdrawal by Subject|0|||
146709838|NCT02047604|529110132|FG002|Overall Study|Withdrawal by Subject|0|||
146709839|NCT02047604|529110133|FG003|Overall Study|Withdrawal by Subject|0|||
146709840|NCT02047604|529110134|FG004|Overall Study|Withdrawal by Subject|1|||
146709841|NCT02047604|529110135|FG005|Overall Study|Withdrawal by Subject|1|||
146709842|NCT00983814|529110136|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
146709843|NCT00983814|529110137|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
146709844|NCT00983814|529110138|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
146709845|NCT00983814|529110136|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
146709846|NCT00983814|529110137|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
146709847|NCT00983814|529110138|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
146709848|NCT00983814|529110136|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
146709849|NCT00983814|529110137|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
146709850|NCT00983814|529110138|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
146709851|NCT00983814|529110136|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
146709852|NCT00983814|529110137|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
146709853|NCT00983814|529110138|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
146709854|NCT00983814|529110136|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
146709855|NCT00983814|529110137|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
146709856|NCT00983814|529110138|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
146709857|NCT02517905|529110139|FG000|Overall Study|Lost to Follow-up|4|||
146709858|NCT02517905|529110140|FG001|Overall Study|Lost to Follow-up|0|||
146709859|NCT02517905|529110139|FG000|Overall Study|Withdrawal by Subject|4|||
146709860|NCT02517905|529110140|FG001|Overall Study|Withdrawal by Subject|0|||
146709861|NCT02517905|529110139|FG000|Overall Study|Screen failure|2|||
146709862|NCT02517905|529110140|FG001|Overall Study|Screen failure|2|||
146709863|NCT01994395|529110146|FG000|Overall Study|Withdrawal by Subject|1|||
146709864|NCT01994395|529110147|FG001|Overall Study|Withdrawal by Subject|2|||
146709865|NCT00459134|529110148|FG000|Overall Study|Physician Decision|1|||
146709866|NCT00459134|529110149|FG001|Overall Study|Physician Decision|1|||
146709867|NCT00459134|529110148|FG000|Overall Study|Withdrawal by Subject|8|||
146709868|NCT00459134|529110149|FG001|Overall Study|Withdrawal by Subject|7|||
146709869|NCT00459134|529110148|FG000|Overall Study|Lost to Follow-up|6|||
146709870|NCT00459134|529110149|FG001|Overall Study|Lost to Follow-up|7|||
146709871|NCT00459134|529110148|FG000|Overall Study|Surgery|1|||
146709872|NCT00459134|529110149|FG001|Overall Study|Surgery|2|||
146709873|NCT00459134|529110148|FG000|Overall Study|Toxicity|4|||
146709874|NCT00459134|529110149|FG001|Overall Study|Toxicity|5|||
146709875|NCT00459134|529110148|FG000|Overall Study|Progression|1|||
146709876|NCT00459134|529110149|FG001|Overall Study|Progression|0|||
146709877|NCT00459134|529110148|FG000|Overall Study|Multiple Reasons|2|||
146709878|NCT00459134|529110149|FG001|Overall Study|Multiple Reasons|3|||
146709879|NCT00829621|529110150|FG000|Overall Study|Death|1|||
146709880|NCT00829621|529110151|FG001|Overall Study|Death|0|||
146709881|NCT00829621|529110150|FG000|Overall Study|Lost to Follow-up|3|||
146709882|NCT00829621|529110151|FG001|Overall Study|Lost to Follow-up|4|||
146709883|NCT01755416|529110152|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
146709884|NCT01755416|529110153|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
146709885|NCT00441337|529110154|FG000|Overall Study|Disease Progression|6|||
146709886|NCT00441337|529110155|FG001|Overall Study|Disease Progression|6|||
146709887|NCT00441337|529110156|FG002|Overall Study|Disease Progression|4|||
146709888|NCT00441337|529110157|FG003|Overall Study|Disease Progression|18|||
146709889|NCT00441337|529110154|FG000|Overall Study|Lost to Follow-up|0|||
146709890|NCT00441337|529110155|FG001|Overall Study|Lost to Follow-up|0|||
146709891|NCT00441337|529110156|FG002|Overall Study|Lost to Follow-up|0|||
146709892|NCT00441337|529110157|FG003|Overall Study|Lost to Follow-up|1|||
146709893|NCT00441337|529110154|FG000|Overall Study|Sponsor Decision|0|||
146709894|NCT00441337|529110155|FG001|Overall Study|Sponsor Decision|0|||
146709895|NCT00441337|529110156|FG002|Overall Study|Sponsor Decision|1|||
146709896|NCT00441337|529110157|FG003|Overall Study|Sponsor Decision|2|||
146709897|NCT00441337|529110154|FG000|Overall Study|Did not meet inclusion criteria|0|||
146709898|NCT00441337|529110155|FG001|Overall Study|Did not meet inclusion criteria|0|||
146709899|NCT00441337|529110156|FG002|Overall Study|Did not meet inclusion criteria|1|||
146709900|NCT00441337|529110157|FG003|Overall Study|Did not meet inclusion criteria|0|||
146778455|NCT00065260|529357582|FG001|Overall Study|Death|1|||
146778456|NCT00001277|529357583|FG000|Overall Study|Adverse Event|0|||
146778457|NCT00001277|529357584|FG001|Overall Study|Adverse Event|0|||
146778458|NCT00001277|529357585|FG002|Overall Study|Adverse Event|1|||
146778459|NCT00001277|529357583|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
146778460|NCT00001277|529357584|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
146778461|NCT00001277|529357585|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
146778462|NCT04484935|529357587|FG000|Overall Study|Other|0|||
146778463|NCT04484935|529357588|FG001|Overall Study|Other|1|||
146778464|NCT04484935|529357587|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146778465|NCT04484935|529357588|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146778466|NCT04484935|529357587|FG000|Overall Study|Lost to Follow-up|1|||
146778467|NCT04484935|529357588|FG001|Overall Study|Lost to Follow-up|0|||
146778468|NCT04484935|529357587|FG000|Overall Study|Death|2|||
146778469|NCT04484935|529357588|FG001|Overall Study|Death|1|||
146778470|NCT05134337|529359493|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
146778471|NCT05134337|529359494|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
146778472|NCT03481660|529359495|FG000|Overall Study|Adverse Event|5|||
146778473|NCT03481660|529359496|FG001|Overall Study|Adverse Event|4|||
146778474|NCT03481660|529359495|FG000|Overall Study|Death|13|||
146778475|NCT03481660|529359496|FG001|Overall Study|Death|9|||
146778476|NCT03481660|529359495|FG000|Overall Study|Lost to Follow-up|2|||
146778477|NCT03481660|529359496|FG001|Overall Study|Lost to Follow-up|2|||
146778478|NCT03481660|529359495|FG000|Overall Study|Physician Decision|2|||
146778479|NCT03481660|529359496|FG001|Overall Study|Physician Decision|3|||
146778480|NCT03481660|529359495|FG000|Overall Study|Withdrawal by Subject|14|||
146778481|NCT03481660|529359496|FG001|Overall Study|Withdrawal by Subject|7|||
146778482|NCT01259401|529359497|FG000|4-month Follow-up|Death|0|||
146778483|NCT01259401|529359498|FG001|4-month Follow-up|Death|1|||
146778484|NCT01259401|529359497|FG000|4-month Follow-up|Lost to Follow-up|0|||
146778485|NCT01259401|529359498|FG001|4-month Follow-up|Lost to Follow-up|1|||
146778486|NCT00186992|529359499|FG000|Overall Study|Withdrawal by Subject|5|||
146778487|NCT00186992|529359499|FG000|Overall Study|Physician's discretion|13|||
146778488|NCT00186992|529359499|FG000|Overall Study|PI Discretion|4|||
146778489|NCT00186992|529359499|FG000|Overall Study|Ineligible|2|||
146778490|NCT00186992|529359499|FG000|Overall Study|Lost to Follow-up|2|||
146778491|NCT00186992|529359499|FG000|Overall Study|Still on Study|9|||
146778492|NCT03683069|529359500|FG000|Overall Study|see limitations|12|||
146778493|NCT03683069|529359501|FG001|Overall Study|see limitations|13|||
146778494|NCT05696080|529359502|FG000|Overall Study|Lost to Follow-up|2|||
146778495|NCT05696080|529359503|FG001|Overall Study|Lost to Follow-up|1|||
146778496|NCT05696080|529359502|FG000|Overall Study|Physician Decision|1|||
146778497|NCT05696080|529359503|FG001|Overall Study|Physician Decision|0|||
146778498|NCT05696080|529359502|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146778499|NCT05696080|529359503|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
146778500|NCT05696080|529359502|FG000|Overall Study|Withdrawal by Subject|12|||
146778501|NCT05696080|529359503|FG001|Overall Study|Withdrawal by Subject|0|||
146778502|NCT05478525|529359506|FG000|Overall Study|Withdrawal by Subject|0|||
146778503|NCT05478525|529359507|FG001|Overall Study|Withdrawal by Subject|1|||
146778504|NCT05478525|529359508|FG002|Overall Study|Withdrawal by Subject|2|||
146778505|NCT05478525|529359509|FG003|Overall Study|Withdrawal by Subject|0|||
146778506|NCT05478525|529359506|FG000|Overall Study|COVID-19 Infection|2|||
146778507|NCT05478525|529359507|FG001|Overall Study|COVID-19 Infection|0|||
146778508|NCT05478525|529359508|FG002|Overall Study|COVID-19 Infection|1|||
146778509|NCT05478525|529359509|FG003|Overall Study|COVID-19 Infection|1|||
146778510|NCT01991977|529359510|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
146778511|NCT01991977|529359510|FG000|Overall Study|Withdrew after start of treatment|5|||
146778512|NCT03416023|529359511|FG000|Overall Study|Exclusion criteria failure|1|||
146778513|NCT03416023|529359511|FG000|Overall Study|Withdrawal by Subject|6|||
146778514|NCT03416023|529359511|FG000|Overall Study|Explanted|7|||
146778515|NCT03416023|529359511|FG000|Overall Study|Physician Decision|1|||
146778516|NCT03416023|529359511|FG000|Overall Study|Lost to Follow-up|1|||
146778517|NCT03416023|529359511|FG000|Overall Study|Death|1|||
146778518|NCT03651895|529359512|FG000|First Drug Assignment|Adverse Event|4|||
146778519|NCT03651895|529359513|FG001|First Drug Assignment|Adverse Event|5|||
146778520|NCT03651895|529359512|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
146778521|NCT03651895|529359513|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
146778522|NCT02837510|529359514|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
146778523|NCT02837510|529359515|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
146778524|NCT02837510|529359514|FG000|Washout (2 Weeks)|Adverse Event|0|||
146778525|NCT02837510|529359515|FG001|Washout (2 Weeks)|Adverse Event|1|||
146778526|NCT02837510|529359514|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
146778527|NCT02837510|529359515|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
146981064|NCT00549198|530093719|FG001|Overall Study|Not Exposed to Study Drug|4|||
146778528|NCT02837510|529359514|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
146778529|NCT02837510|529359515|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
146981065|NCT01473758|530093720|FG000|Cycle 1|Adverse Event|10|||
146981066|NCT01473758|530093721|FG001|Cycle 1|Adverse Event|2|||
146981067|NCT01473758|530093722|FG002|Cycle 1|Adverse Event|0|||
146981068|NCT01473758|530093723|FG003|Cycle 1|Adverse Event|0|||
146981069|NCT01473758|530093720|FG000|Cycle 1|Withdrawal by Subject|1|||
146981070|NCT01473758|530093721|FG001|Cycle 1|Withdrawal by Subject|1|||
146981071|NCT01473758|530093722|FG002|Cycle 1|Withdrawal by Subject|0|||
146981072|NCT01473758|530093723|FG003|Cycle 1|Withdrawal by Subject|0|||
146981073|NCT01473758|530093720|FG000|Cycle 2|Adverse Event|0|||
146981074|NCT01473758|530093721|FG001|Cycle 2|Adverse Event|0|||
146709901|NCT03655236|529110158|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
146709902|NCT03655236|529110159|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
146709903|NCT03655236|529110160|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
146709904|NCT03655236|529110158|FG000|Subject Disposition in Part 1 Period|Death|1|||
146709905|NCT03655236|529110159|FG001|Subject Disposition in Part 1 Period|Death|0|||
146709906|NCT03655236|529110160|FG002|Subject Disposition in Part 1 Period|Death|0|||
146709907|NCT03655236|529110158|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
146709908|NCT03655236|529110159|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
146709909|NCT03655236|529110160|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
146709910|NCT03655236|529110158|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
146709911|NCT03655236|529110159|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
146709912|NCT03655236|529110160|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
146709913|NCT03655236|529110158|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
146709914|NCT03655236|529110159|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
146709915|NCT03655236|529110160|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
146709916|NCT03655236|529110158|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
146709917|NCT03655236|529110159|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
146709918|NCT03655236|529110160|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
146709919|NCT03655236|529110158|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
146709920|NCT03655236|529110159|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
146709921|NCT03655236|529110160|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
146709922|NCT03655236|529110158|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
146709923|NCT03655236|529110159|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
146709924|NCT03655236|529110160|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
146709925|NCT03655236|529110158|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
146709926|NCT03655236|529110159|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
146709927|NCT03655236|529110160|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
146709928|NCT03655236|529110158|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
146709929|NCT03655236|529110159|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
146709930|NCT03655236|529110160|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
146709931|NCT03655236|529110158|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
146709932|NCT03655236|529110159|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
146709933|NCT03655236|529110160|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
146709934|NCT03655236|529110158|FG000|Subject Disposition in Part 1 Period|Other|0|||
146709935|NCT03655236|529110159|FG001|Subject Disposition in Part 1 Period|Other|2|||
146709936|NCT03655236|529110160|FG002|Subject Disposition in Part 1 Period|Other|2|||
146709937|NCT03655236|529110158|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
146709938|NCT03655236|529110159|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
146709939|NCT03655236|529110160|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
146709940|NCT03655236|529110158|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
146709941|NCT03655236|529110159|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
146709942|NCT03655236|529110160|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
146709943|NCT03655236|529110158|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
146709944|NCT03655236|529110159|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
146709945|NCT03655236|529110160|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
146709946|NCT03655236|529110158|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
146709947|NCT03655236|529110159|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
146709948|NCT03655236|529110160|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
146709949|NCT03655236|529110158|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
146709950|NCT03655236|529110159|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
146709951|NCT03655236|529110160|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
146709952|NCT03655236|529110158|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
146709953|NCT03655236|529110159|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
146981075|NCT01473758|530093722|FG002|Cycle 2|Adverse Event|5|||
146981076|NCT01473758|530093723|FG003|Cycle 2|Adverse Event|0|||
146981077|NCT02480010|530093724|FG000|Overall Study|Adverse Event|3|||
146981078|NCT02480010|530093725|FG001|Overall Study|Adverse Event|1|||
146778530|NCT02837510|529359514|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
146778531|NCT02837510|529359515|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
146778532|NCT02837510|529359514|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
146778533|NCT02837510|529359515|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
146778534|NCT03857620|529359516|FG000|Overall Study|Death|4|||
146778535|NCT03857620|529359517|FG001|Overall Study|Death|5|||
146778536|NCT03857620|529359518|FG002|Overall Study|Death|7|||
146778537|NCT03857620|529359516|FG000|Overall Study|Lost to Follow-up|2|||
146778538|NCT03857620|529359517|FG001|Overall Study|Lost to Follow-up|5|||
146778539|NCT03857620|529359518|FG002|Overall Study|Lost to Follow-up|3|||
146778540|NCT03857620|529359516|FG000|Overall Study|Disease progression or relapse after study registration|1|||
146778541|NCT03857620|529359517|FG001|Overall Study|Disease progression or relapse after study registration|5|||
146778542|NCT03857620|529359518|FG002|Overall Study|Disease progression or relapse after study registration|1|||
146778543|NCT03857620|529359516|FG000|Overall Study|Ineligible|5|||
146778544|NCT03857620|529359517|FG001|Overall Study|Ineligible|0|||
146778545|NCT03857620|529359518|FG002|Overall Study|Ineligible|2|||
146778546|NCT03857620|529359516|FG000|Overall Study|No malignancy|1|||
146778547|NCT03857620|529359517|FG001|Overall Study|No malignancy|0|||
146778548|NCT03857620|529359518|FG002|Overall Study|No malignancy|1|||
146778549|NCT03857620|529359516|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
146778550|NCT03857620|529359517|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
146778551|NCT03857620|529359518|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
146778552|NCT03857620|529359516|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
146778553|NCT03857620|529359517|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
146778554|NCT03857620|529359518|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
146778555|NCT03857620|529359516|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
146778556|NCT03857620|529359517|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
146778557|NCT03857620|529359518|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
146778558|NCT03857620|529359516|FG000|Overall Study|Surgery not performed, patient decision|0|||
146778559|NCT03857620|529359517|FG001|Overall Study|Surgery not performed, patient decision|3|||
146778560|NCT03857620|529359518|FG002|Overall Study|Surgery not performed, patient decision|1|||
146778561|NCT03857620|529359516|FG000|Overall Study|Surgery not performed, other reason|3|||
146778562|NCT03857620|529359517|FG001|Overall Study|Surgery not performed, other reason|1|||
146778563|NCT03857620|529359518|FG002|Overall Study|Surgery not performed, other reason|4|||
146778564|NCT03857620|529359516|FG000|Overall Study|Worsening performance status after surgery performed|0|||
146778565|NCT03857620|529359517|FG001|Overall Study|Worsening performance status after surgery performed|1|||
146778566|NCT03857620|529359518|FG002|Overall Study|Worsening performance status after surgery performed|1|||
146778567|NCT03271151|529359519|FG000|Overall Study|Lost to Follow-up|1|||
146709954|NCT03655236|529110160|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
146709955|NCT03655236|529110158|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
146709956|NCT03655236|529110159|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
146709957|NCT03655236|529110160|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
146709958|NCT03655236|529110158|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
146709959|NCT03655236|529110159|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
146709960|NCT03655236|529110160|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
146709961|NCT03655236|529110158|FG000|Subject Disposition in Part 2 Period|Other|1|||
146709962|NCT03655236|529110159|FG001|Subject Disposition in Part 2 Period|Other|0|||
146709963|NCT03655236|529110160|FG002|Subject Disposition in Part 2 Period|Other|0|||
146709964|NCT01818336|529111302|FG000|Overall Study|Declined retest visit|0|||
146709965|NCT01818336|529111303|FG001|Overall Study|Declined retest visit|11|||
146709966|NCT01818336|529111302|FG000|Overall Study|Lost to Follow-up|0|||
146709967|NCT01818336|529111303|FG001|Overall Study|Lost to Follow-up|1|||
146709968|NCT00672477|529111308|FG000|Overall Study|Adverse Event|10|||
146709969|NCT00672477|529111309|FG001|Overall Study|Adverse Event|7|||
146709970|NCT00672477|529111308|FG000|Overall Study|Death|7|||
146709971|NCT00672477|529111309|FG001|Overall Study|Death|11|||
146709972|NCT00672477|529111308|FG000|Overall Study|Physician Decision|2|||
146709973|NCT00672477|529111309|FG001|Overall Study|Physician Decision|0|||
146709974|NCT00672477|529111308|FG000|Overall Study|Protocol Violation|1|||
146709975|NCT00672477|529111309|FG001|Overall Study|Protocol Violation|1|||
146778568|NCT03271151|529359520|FG001|Overall Study|Lost to Follow-up|3|||
146778569|NCT03271151|529359519|FG000|Overall Study|Withdrawal by Subject|1|||
146709976|NCT00672477|529111308|FG000|Overall Study|Withdrawal by Subject|5|||
146709977|NCT00672477|529111309|FG001|Overall Study|Withdrawal by Subject|3|||
146709978|NCT00672477|529111308|FG000|Overall Study|Lack of Efficacy|1|||
146778570|NCT03271151|529359520|FG001|Overall Study|Withdrawal by Subject|0|||
146778571|NCT04118452|529359521|FG000|Overall Study|Lost to Follow-up|5|||
146778572|NCT04118452|529359522|FG001|Overall Study|Lost to Follow-up|5|||
146778573|NCT04118452|529359521|FG000|Overall Study|Withdrawal by Subject|17|||
146778574|NCT04118452|529359522|FG001|Overall Study|Withdrawal by Subject|17|||
146709979|NCT00672477|529111309|FG001|Overall Study|Lack of Efficacy|1|||
146778575|NCT03215030|529359523|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
146778576|NCT03215030|529359524|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
146778577|NCT03215030|529359525|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
146778578|NCT03215030|529359526|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
146778579|NCT03215030|529359527|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
146778580|NCT03215030|529359528|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
146778581|NCT03215030|529359529|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
146778582|NCT03215030|529359530|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
146778583|NCT03215030|529359531|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
146778584|NCT03215030|529359532|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
146778585|NCT03215030|529359533|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
146778586|NCT03215030|529359534|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
146778587|NCT03215030|529359523|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
146778588|NCT03215030|529359524|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146778589|NCT03215030|529359525|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146778590|NCT03215030|529359526|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
146778591|NCT03215030|529359527|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146778592|NCT03215030|529359528|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146778593|NCT03215030|529359529|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146778594|NCT03215030|529359530|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146778595|NCT03215030|529359531|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146778596|NCT03215030|529359532|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146778597|NCT03215030|529359533|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146778598|NCT03215030|529359534|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146778599|NCT03215030|529359523|FG000|Part 1: Dose Escalation|Death|15|||
146778600|NCT03215030|529359524|FG001|Part 1: Dose Escalation|Death|6|||
146778601|NCT03215030|529359525|FG002|Part 1: Dose Escalation|Death|6|||
146778602|NCT03215030|529359526|FG003|Part 1: Dose Escalation|Death|8|||
146778603|NCT03215030|529359527|FG004|Part 1: Dose Escalation|Death|0|||
146778604|NCT03215030|529359528|FG005|Part 1: Dose Escalation|Death|0|||
146778605|NCT03215030|529359529|FG006|Part 1: Dose Escalation|Death|0|||
146778606|NCT03215030|529359530|FG007|Part 1: Dose Escalation|Death|0|||
146778607|NCT03215030|529359531|FG008|Part 1: Dose Escalation|Death|0|||
146778608|NCT03215030|529359532|FG009|Part 1: Dose Escalation|Death|0|||
146778609|NCT03215030|529359533|FG010|Part 1: Dose Escalation|Death|0|||
146778610|NCT03215030|529359534|FG011|Part 1: Dose Escalation|Death|0|||
146778611|NCT03215030|529359523|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
146778612|NCT03215030|529359524|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
146778613|NCT03215030|529359525|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
146778614|NCT03215030|529359526|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
146778615|NCT03215030|529359527|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
146778616|NCT03215030|529359528|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
146778617|NCT03215030|529359529|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
146778618|NCT03215030|529359530|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
146981079|NCT02480010|530093724|FG000|Overall Study|Death|1|||
146709980|NCT00672477|529111308|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
146709981|NCT00672477|529111309|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
146709982|NCT02886572|529111310|FG000|Overall Study|Death|8|||
146709983|NCT03087591|529111313|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
146709984|NCT03087591|529111313|FG000|Overall Study|Withdrawal by Subject|1|||
146709985|NCT00982319|529111320|FG000|Overall Study|Surgery date change|1|||
146709986|NCT00982319|529111321|FG001|Overall Study|Surgery date change|0|||
146709987|NCT00982319|529111320|FG000|Overall Study|Preop values out of acceptable range|1|||
146709988|NCT00982319|529111321|FG001|Overall Study|Preop values out of acceptable range|1|||
146709989|NCT00982319|529111320|FG000|Overall Study|Pregnancy|0|||
146709990|NCT00982319|529111321|FG001|Overall Study|Pregnancy|1|||
146709991|NCT01933334|529111322|FG000|Overall Study|Adverse Event|5|||
146709992|NCT01933334|529111323|FG001|Overall Study|Adverse Event|1|||
146709993|NCT01933334|529111322|FG000|Overall Study|Withdrawal by Subject|0|||
146709994|NCT01933334|529111323|FG001|Overall Study|Withdrawal by Subject|1|||
146709995|NCT02082522|529111326|FG000|Overall Study|Sponsor termination|5|||
146709996|NCT02082522|529111327|FG001|Overall Study|Sponsor termination|3|||
146709997|NCT02082522|529111326|FG000|Overall Study|Withdrawal by Subject|2|||
146709998|NCT02082522|529111327|FG001|Overall Study|Withdrawal by Subject|4|||
146709999|NCT02082522|529111326|FG000|Overall Study|Death|1|||
146778619|NCT03215030|529359531|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
146778620|NCT03215030|529359532|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
146778621|NCT03215030|529359533|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
146778622|NCT03215030|529359534|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
146778623|NCT03215030|529359523|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146778624|NCT03215030|529359524|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146778625|NCT03215030|529359525|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146710000|NCT02082522|529111327|FG001|Overall Study|Death|0|||
146710001|NCT02082522|529111326|FG000|Overall Study|Lost to Follow-up|1|||
146710002|NCT02082522|529111327|FG001|Overall Study|Lost to Follow-up|0|||
146710003|NCT02082522|529111326|FG000|Overall Study|Physician Decision|3|||
146710004|NCT02082522|529111327|FG001|Overall Study|Physician Decision|1|||
146710005|NCT02082522|529111326|FG000|Overall Study|Disease progression|2|||
146710006|NCT02082522|529111327|FG001|Overall Study|Disease progression|2|||
146710007|NCT02082522|529111326|FG000|Overall Study|Chemotherapy change|1|||
146710008|NCT02082522|529111327|FG001|Overall Study|Chemotherapy change|3|||
146710009|NCT01863446|529111328|FG000|Overall Study|Withdrawal by Subject|1|||
146710010|NCT01863446|529111329|FG001|Overall Study|Withdrawal by Subject|0|||
146710011|NCT01863446|529111330|FG002|Overall Study|Withdrawal by Subject|1|||
146710012|NCT01863446|529111331|FG003|Overall Study|Withdrawal by Subject|2|||
146710013|NCT01863446|529111328|FG000|Overall Study|Physician Decision|0|||
146710014|NCT01863446|529111329|FG001|Overall Study|Physician Decision|0|||
146710015|NCT01863446|529111330|FG002|Overall Study|Physician Decision|1|||
146710016|NCT01863446|529111331|FG003|Overall Study|Physician Decision|0|||
146710017|NCT03603964|529111334|FG000|Overall Study|Death|9|||
146710018|NCT03603964|529111334|FG000|Overall Study|Withdrawal by participant|7|||
146710019|NCT03603964|529111334|FG000|Overall Study|Study terminated by Sponsor|19|||
146710020|NCT03095417|529111337|FG000|Overall Study|missed|1|||
146710021|NCT03095417|529111338|FG001|Overall Study|missed|2|||
146710022|NCT03095417|529111339|FG002|Overall Study|missed|0|||
146710023|NCT03095417|529111340|FG003|Overall Study|missed|1|||
146710024|NCT03095417|529111337|FG000|Overall Study|Lost to Follow-up|2|||
146710025|NCT03095417|529111338|FG001|Overall Study|Lost to Follow-up|2|||
146710026|NCT03095417|529111339|FG002|Overall Study|Lost to Follow-up|1|||
146710027|NCT03095417|529111340|FG003|Overall Study|Lost to Follow-up|0|||
146710028|NCT03095417|529111337|FG000|Overall Study|refusal|0|||
146710029|NCT03095417|529111338|FG001|Overall Study|refusal|1|||
146710030|NCT03095417|529111339|FG002|Overall Study|refusal|0|||
146710031|NCT03095417|529111340|FG003|Overall Study|refusal|1|||
146710032|NCT03095417|529111337|FG000|Overall Study|Withdrawal by Subject|8|||
146710033|NCT03095417|529111338|FG001|Overall Study|Withdrawal by Subject|2|||
146710034|NCT03095417|529111339|FG002|Overall Study|Withdrawal by Subject|5|||
146710035|NCT03095417|529111340|FG003|Overall Study|Withdrawal by Subject|4|||
146710036|NCT03095417|529111337|FG000|Overall Study|Physician Decision|1|||
146710037|NCT03095417|529111338|FG001|Overall Study|Physician Decision|2|||
146710038|NCT03095417|529111339|FG002|Overall Study|Physician Decision|2|||
146710039|NCT03095417|529111340|FG003|Overall Study|Physician Decision|2|||
146710040|NCT03095417|529111337|FG000|Overall Study|Death|1|||
146710041|NCT03095417|529111338|FG001|Overall Study|Death|2|||
146710042|NCT03095417|529111339|FG002|Overall Study|Death|1|||
146710043|NCT03095417|529111340|FG003|Overall Study|Death|3|||
146710044|NCT02571452|529111341|FG000|Overall Study Treatment|Protocol Violation|0|||
146710045|NCT02571452|529111342|FG001|Overall Study Treatment|Protocol Violation|1|||
146710046|NCT02571452|529111341|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
146710047|NCT02571452|529111342|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
146710048|NCT02571452|529111341|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
146710049|NCT02571452|529111342|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
146710050|NCT03795922|529111346|FG000|Overall Study|Adverse Event|2|||
146710051|NCT03795922|529111347|FG001|Overall Study|Adverse Event|1|||
146710052|NCT03795922|529111346|FG000|Overall Study|Withdrawal by Subject|5|||
146710053|NCT03795922|529111347|FG001|Overall Study|Withdrawal by Subject|13|||
146710054|NCT03795922|529111346|FG000|Overall Study|Lost to Follow-up|2|||
146710055|NCT03795922|529111347|FG001|Overall Study|Lost to Follow-up|3|||
146710056|NCT03795922|529111346|FG000|Overall Study|Pregnancy|0|||
146710057|NCT03795922|529111347|FG001|Overall Study|Pregnancy|1|||
146710058|NCT03795922|529111346|FG000|Overall Study|Physician Decision|1|||
146710059|NCT03795922|529111347|FG001|Overall Study|Physician Decision|2|||
146710060|NCT03795922|529111346|FG000|Overall Study|Protocol Violation|0|||
146710061|NCT03795922|529111347|FG001|Overall Study|Protocol Violation|1|||
146710062|NCT03795922|529111346|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
146710063|NCT03795922|529111347|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
146710064|NCT01416805|529111360|FG000|Overall Study|Lost to Follow-up|4|||
146710065|NCT01416805|529111361|FG001|Overall Study|Lost to Follow-up|4|||
146710066|NCT01723904|529111363|FG000|Overall Study|Noncompliant|3|||
146710067|NCT01723904|529111363|FG000|Overall Study|Adverse Event|5|||
146778626|NCT03215030|529359526|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146710068|NCT01723904|529111363|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
146710069|NCT00887341|529111374|FG000|Overall Study|Refused treatment|1|||
146710070|NCT00887341|529111375|FG001|Overall Study|Refused treatment|0|||
146710071|NCT00887341|529111374|FG000|Overall Study|Withdrawal by Subject|1|||
146710072|NCT00887341|529111375|FG001|Overall Study|Withdrawal by Subject|1|||
146710073|NCT00887341|529111374|FG000|Overall Study|Adverse Event|0|||
146710074|NCT00887341|529111375|FG001|Overall Study|Adverse Event|1|||
146710075|NCT00887341|529111374|FG000|Overall Study|Lost to Follow-up|0|||
146778627|NCT03215030|529359527|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146710076|NCT00887341|529111375|FG001|Overall Study|Lost to Follow-up|1|||
146778628|NCT03215030|529359528|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146981080|NCT02480010|530093725|FG001|Overall Study|Death|0|||
146778629|NCT03215030|529359529|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146778630|NCT03215030|529359530|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
146778631|NCT03215030|529359531|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146778632|NCT03215030|529359532|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146778633|NCT03215030|529359533|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146778634|NCT03215030|529359534|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146778635|NCT03215030|529359523|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146778636|NCT03215030|529359524|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146778637|NCT03215030|529359525|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146778638|NCT03215030|529359526|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146778639|NCT03215030|529359527|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
146778640|NCT03215030|529359528|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
146778641|NCT03215030|529359529|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
146778642|NCT03215030|529359530|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
146778643|NCT03215030|529359531|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146778644|NCT03215030|529359532|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146778645|NCT03215030|529359533|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146778646|NCT03215030|529359534|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146778647|NCT03215030|529359523|FG000|Part 2: Dose Expansion|Death|0|||
146778648|NCT03215030|529359524|FG001|Part 2: Dose Expansion|Death|0|||
146778649|NCT03215030|529359525|FG002|Part 2: Dose Expansion|Death|0|||
146778650|NCT03215030|529359526|FG003|Part 2: Dose Expansion|Death|0|||
146778651|NCT03215030|529359527|FG004|Part 2: Dose Expansion|Death|3|||
146778652|NCT03215030|529359528|FG005|Part 2: Dose Expansion|Death|1|||
146778653|NCT03215030|529359529|FG006|Part 2: Dose Expansion|Death|5|||
146778654|NCT03215030|529359530|FG007|Part 2: Dose Expansion|Death|4|||
146778655|NCT03215030|529359531|FG008|Part 2: Dose Expansion|Death|0|||
146778656|NCT03215030|529359532|FG009|Part 2: Dose Expansion|Death|0|||
146778657|NCT03215030|529359533|FG010|Part 2: Dose Expansion|Death|0|||
146778658|NCT03215030|529359534|FG011|Part 2: Dose Expansion|Death|0|||
146778659|NCT03215030|529359523|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
146778660|NCT03215030|529359524|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
146778661|NCT03215030|529359525|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
146778662|NCT03215030|529359526|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
146778663|NCT03215030|529359527|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
146778664|NCT03215030|529359528|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
146778665|NCT03215030|529359529|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
146778666|NCT03215030|529359530|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
146778667|NCT03215030|529359531|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
146710077|NCT01591681|529111378|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
146710078|NCT01591681|529111378|FG000|Overall Study|Failed to use system during run-in|1|||
146710079|NCT01649856|529111379|FG000|Overall Study|Withdrawal by Subject|14|||
146710080|NCT01649856|529111380|FG001|Overall Study|Withdrawal by Subject|14|||
146710081|NCT01649856|529111379|FG000|Overall Study|Protocol Violation|4|||
146710082|NCT01649856|529111380|FG001|Overall Study|Protocol Violation|4|||
146710083|NCT01649856|529111379|FG000|Overall Study|Treatment Failure|1|||
146710084|NCT01649856|529111380|FG001|Overall Study|Treatment Failure|1|||
146710085|NCT01649856|529111379|FG000|Overall Study|Death|69|||
146710086|NCT01649856|529111380|FG001|Overall Study|Death|34|||
146710087|NCT01649856|529111379|FG000|Overall Study|Stable or Progressed Disease|5|||
146710088|NCT01649856|529111380|FG001|Overall Study|Stable or Progressed Disease|3|||
146710089|NCT01649856|529111379|FG000|Overall Study|Lost to Follow-up|20|||
146710090|NCT01649856|529111380|FG001|Overall Study|Lost to Follow-up|16|||
146710091|NCT01649856|529111379|FG000|Overall Study|Lack of Compliance|6|||
146710092|NCT01649856|529111380|FG001|Overall Study|Lack of Compliance|1|||
146710093|NCT01649856|529111379|FG000|Overall Study|Other|20|||
146710094|NCT01649856|529111380|FG001|Overall Study|Other|5|||
146710095|NCT02138214|529111381|FG000|Overall Study|Withdrawal by Subject|0|||
146710096|NCT02138214|529111382|FG001|Overall Study|Withdrawal by Subject|1|||
146710097|NCT02138214|529111383|FG002|Overall Study|Withdrawal by Subject|0|||
146710098|NCT02138214|529111381|FG000|Overall Study|Lost to Follow-up|0|||
146710099|NCT02138214|529111382|FG001|Overall Study|Lost to Follow-up|2|||
146710100|NCT02138214|529111383|FG002|Overall Study|Lost to Follow-up|4|||
146710101|NCT02138214|529111381|FG000|Overall Study|Screen Failure|0|||
146710102|NCT02138214|529111382|FG001|Overall Study|Screen Failure|1|||
146710103|NCT02138214|529111383|FG002|Overall Study|Screen Failure|0|||
146710104|NCT00235989|529111389|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
146778668|NCT03215030|529359532|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
146778669|NCT03215030|529359533|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
146778670|NCT03215030|529359534|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
146778671|NCT03215030|529359523|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
146778672|NCT03215030|529359524|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
146710105|NCT00235989|529111390|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
146710106|NCT00235989|529111391|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
146778673|NCT03215030|529359525|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
146778674|NCT03215030|529359526|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
146778675|NCT03215030|529359527|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
146778676|NCT03215030|529359528|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
146778677|NCT03215030|529359529|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
146778678|NCT03215030|529359530|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
146778679|NCT03215030|529359531|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
146778680|NCT03215030|529359532|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
146778681|NCT03215030|529359533|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
146778682|NCT03215030|529359534|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
146778683|NCT03215030|529359523|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146778684|NCT03215030|529359524|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146778685|NCT03215030|529359525|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146778686|NCT03215030|529359526|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146778687|NCT03215030|529359527|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146778688|NCT03215030|529359528|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146778689|NCT03215030|529359529|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146778690|NCT03215030|529359530|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146778691|NCT03215030|529359531|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
146778692|NCT03215030|529359532|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
146710107|NCT00235989|529111392|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
146710108|NCT00235989|529111393|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
146710109|NCT00235989|529111394|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
146710110|NCT00235989|529111389|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
146710111|NCT00235989|529111390|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
146710112|NCT00235989|529111391|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
146710113|NCT00235989|529111392|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
146710114|NCT00235989|529111393|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
146710115|NCT00235989|529111394|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
146710116|NCT00235989|529111389|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
146710117|NCT00235989|529111390|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
146710118|NCT00235989|529111391|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
146710119|NCT00235989|529111392|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
146710120|NCT00235989|529111393|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
146710121|NCT00235989|529111394|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
146710122|NCT00235989|529111389|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
146710123|NCT00235989|529111390|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
146710124|NCT00235989|529111391|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
146710125|NCT00235989|529111392|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
146710126|NCT00235989|529111393|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
146710127|NCT00235989|529111394|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
146710128|NCT00235989|529111389|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
146710129|NCT00235989|529111390|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
146710130|NCT00235989|529111391|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
146710131|NCT00235989|529111392|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
146710132|NCT00235989|529111393|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
146710133|NCT00235989|529111394|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
146710134|NCT01334866|529111403|FG000|Overall Study|Withdrawal by Subject|10|||
146710135|NCT01334866|529111403|FG000|Overall Study|Lost to Follow-up|3|||
146710136|NCT01334866|529111403|FG000|Overall Study|Physician Decision|3|||
146710137|NCT01334866|529111403|FG000|Overall Study|medically necessary prior to procedure|2|||
146710138|NCT01334866|529111403|FG000|Overall Study|medically necessary post-procedure|1|||
146710139|NCT01516879|529111407|FG000|Overall Study|Withdrawal by Subject|9|||
146710140|NCT01516879|529111408|FG001|Overall Study|Withdrawal by Subject|11|||
146710141|NCT01516879|529111407|FG000|Overall Study|Death|0|||
146710142|NCT01516879|529111408|FG001|Overall Study|Death|2|||
146710143|NCT01516879|529111407|FG000|Overall Study|Lost to Follow-up|2|||
146710144|NCT01516879|529111408|FG001|Overall Study|Lost to Follow-up|11|||
146710145|NCT01516879|529111407|FG000|Overall Study|Other|5|||
146710146|NCT01516879|529111408|FG001|Overall Study|Other|10|||
146778693|NCT03215030|529359533|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146778694|NCT03215030|529359534|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146778695|NCT03215030|529359523|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
146778696|NCT03215030|529359524|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
146778697|NCT03215030|529359525|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
146710147|NCT04568122|529111409|FG000|Overall Study|Lost to Follow-up|48|||
146710148|NCT04568122|529111410|FG001|Overall Study|Lost to Follow-up|44|||
146710149|NCT04568122|529111411|FG002|Overall Study|Lost to Follow-up|4|||
146778698|NCT03215030|529359526|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
146778699|NCT03215030|529359527|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
146933871|NCT01376245|529916011|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
146710150|NCT04568122|529111412|FG003|Overall Study|Lost to Follow-up|0|||
146710151|NCT04568122|529111413|FG004|Overall Study|Lost to Follow-up|0|||
146710152|NCT00965848|529111420|FG000|Overall Study|Protocol Violation|3|||
146710153|NCT00965848|529111421|FG001|Overall Study|Protocol Violation|0|||
146710154|NCT00965848|529111422|FG002|Overall Study|Protocol Violation|1|||
146710155|NCT00965848|529111420|FG000|Overall Study|Death|11|||
146710156|NCT00965848|529111421|FG001|Overall Study|Death|1|||
146710157|NCT00965848|529111422|FG002|Overall Study|Death|5|||
146710158|NCT00965848|529111420|FG000|Overall Study|Lost to Follow-up|0|||
146933872|NCT01335698|529916012|FG000|Treatment Stage 1|Lack of Efficacy|3|||
146710159|NCT00965848|529111421|FG001|Overall Study|Lost to Follow-up|0|||
146710160|NCT00965848|529111422|FG002|Overall Study|Lost to Follow-up|1|||
146710161|NCT00965848|529111420|FG000|Overall Study|Withdrawal by Subject|1|||
146710162|NCT00965848|529111421|FG001|Overall Study|Withdrawal by Subject|0|||
146710163|NCT00965848|529111422|FG002|Overall Study|Withdrawal by Subject|0|||
146710164|NCT00965848|529111420|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
146710165|NCT00965848|529111421|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
146710166|NCT00965848|529111422|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
146710167|NCT00965848|529111420|FG000|Overall Study|Not Clinically Evaluable|7|||
146710168|NCT00965848|529111421|FG001|Overall Study|Not Clinically Evaluable|1|||
146710169|NCT00965848|529111422|FG002|Overall Study|Not Clinically Evaluable|1|||
146710170|NCT00965848|529111420|FG000|Overall Study|Other|5|||
146710171|NCT00965848|529111421|FG001|Overall Study|Other|0|||
146710172|NCT00965848|529111422|FG002|Overall Study|Other|1|||
146710173|NCT00813761|529111423|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
146710174|NCT00813761|529111424|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
146710175|NCT00813761|529111425|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
146710176|NCT00813761|529111426|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
146710177|NCT00813761|529111423|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
146710178|NCT00813761|529111424|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
146710179|NCT00813761|529111425|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
146710180|NCT00813761|529111426|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
146710181|NCT00813761|529111423|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
146710182|NCT00813761|529111424|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
146710183|NCT00813761|529111425|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
146710184|NCT00813761|529111426|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
146710185|NCT00813761|529111423|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
146710186|NCT00813761|529111424|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
146710187|NCT00813761|529111425|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
146710188|NCT00813761|529111426|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
146710189|NCT00813761|529111423|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
146710190|NCT00813761|529111424|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
146710191|NCT00813761|529111425|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
146710192|NCT00813761|529111426|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
146710193|NCT00813761|529111423|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
146710194|NCT00813761|529111424|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
146710195|NCT00813761|529111425|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
146710196|NCT00813761|529111426|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
146710197|NCT00813761|529111423|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
146710198|NCT00813761|529111424|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
146710199|NCT00813761|529111425|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
146710200|NCT00813761|529111426|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
146710201|NCT00813761|529111423|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
146710202|NCT00813761|529111424|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
146710203|NCT00813761|529111425|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
146710204|NCT00813761|529111426|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
146710205|NCT00813761|529111423|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
146710206|NCT00813761|529111424|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
146710207|NCT00813761|529111425|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
146710208|NCT00813761|529111426|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
146710209|NCT00813761|529111423|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
146710210|NCT00813761|529111424|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
146710211|NCT00813761|529111425|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
146710212|NCT00813761|529111426|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
146710213|NCT00813761|529111423|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
146710214|NCT00813761|529111424|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
146710215|NCT00813761|529111425|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
146710216|NCT00813761|529111426|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
146710217|NCT00813761|529111423|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
146710218|NCT00813761|529111424|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
146933873|NCT01335698|529916013|FG001|Treatment Stage 1|Lack of Efficacy|1|||
146933874|NCT01335698|529916014|FG002|Treatment Stage 1|Lack of Efficacy|3|||
146710219|NCT00813761|529111425|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
146710220|NCT00813761|529111426|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
146710221|NCT05789875|529111430|FG000|Overall Study|Lost to Follow-up|6|||
146710222|NCT03333486|529111433|FG000|Overall Study|Withdrawal by Subject|1|||
146710223|NCT03333486|529111433|FG000|Overall Study|Lost to Follow-up|1|||
146710224|NCT03246529|529111442|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
146710225|NCT03246529|529111443|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
146710226|NCT03246529|529111444|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
146710227|NCT03246529|529111442|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
146710228|NCT03246529|529111443|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
146710229|NCT03246529|529111444|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
146710230|NCT03246529|529111442|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
146710231|NCT03246529|529111443|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
146710232|NCT03246529|529111444|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
146710233|NCT03246529|529111442|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
146710234|NCT03246529|529111443|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
146710235|NCT03246529|529111444|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
146710236|NCT03246529|529111442|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
146710237|NCT03246529|529111443|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
146710238|NCT03246529|529111444|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
146710239|NCT03246529|529111442|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
146710240|NCT03246529|529111443|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
146710241|NCT03246529|529111444|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
146710242|NCT03246529|529111442|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
146710243|NCT03246529|529111443|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
146710244|NCT03246529|529111444|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
146710245|NCT03246529|529111442|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
146710246|NCT03246529|529111443|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
146710247|NCT03246529|529111444|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
146710248|NCT03246529|529111442|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
146710249|NCT03246529|529111443|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
146710250|NCT03246529|529111444|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
146710251|NCT03042312|529113125|FG000|Overall Study|Administrative Reason|1|||
146710252|NCT03042312|529113126|FG001|Overall Study|Administrative Reason|1|||
146710253|NCT03042312|529113125|FG000|Overall Study|Adverse Event|0|||
146710254|NCT03042312|529113126|FG001|Overall Study|Adverse Event|1|||
146710255|NCT03042312|529113125|FG000|Overall Study|Lost to Follow-up|1|||
146710256|NCT03042312|529113126|FG001|Overall Study|Lost to Follow-up|3|||
146710257|NCT03042312|529113125|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
146710258|NCT03042312|529113126|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
146710259|NCT03042312|529113125|FG000|Overall Study|Withdrawal by Subject|4|||
146710260|NCT03042312|529113126|FG001|Overall Study|Withdrawal by Subject|5|||
146710261|NCT02805257|529113129|FG000|Overall Study|Lost to Follow-up|7|||
146710262|NCT02805257|529113130|FG001|Overall Study|Lost to Follow-up|6|||
146710263|NCT02805257|529113129|FG000|Overall Study|Death|0|||
146710264|NCT02805257|529113130|FG001|Overall Study|Death|1|||
146710265|NCT01043874|529113132|FG000|Overall Study|Adverse Event|3|||
146710266|NCT01043874|529113132|FG000|Overall Study|Withdrawal by Subject|1|||
146710267|NCT01043874|529113132|FG000|Overall Study|Lack of Efficacy|1|||
146710268|NCT01043874|529113132|FG000|Overall Study|Administrative Problems|1|||
146710269|NCT01627249|529113138|FG000|Overall Study|Death|3|||
146710270|NCT01627249|529113139|FG001|Overall Study|Death|5|||
146710271|NCT01627249|529113140|FG002|Overall Study|Death|3|||
146710272|NCT01627249|529113138|FG000|Overall Study|Withdrawal by Subject|12|||
146710273|NCT01627249|529113139|FG001|Overall Study|Withdrawal by Subject|6|||
146710274|NCT01627249|529113140|FG002|Overall Study|Withdrawal by Subject|9|||
146710275|NCT01627249|529113138|FG000|Overall Study|Missed Visit|1|||
146710276|NCT01627249|529113139|FG001|Overall Study|Missed Visit|1|||
146710277|NCT01627249|529113140|FG002|Overall Study|Missed Visit|0|||
146710278|NCT03266588|529113141|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
146710279|NCT03266588|529113142|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
146710280|NCT03266588|529113143|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
146710281|NCT03266588|529113141|FG000|Observational Period|Withdrawal by Subject|44|||
146710282|NCT03266588|529113142|FG001|Observational Period|Withdrawal by Subject|22|||
146710283|NCT03266588|529113143|FG002|Observational Period|Withdrawal by Subject|13|||
146710284|NCT03266588|529113141|FG000|Observational Period|Non-compliance|18|||
146710285|NCT03266588|529113142|FG001|Observational Period|Non-compliance|12|||
146710286|NCT03266588|529113143|FG002|Observational Period|Non-compliance|10|||
146710287|NCT03266588|529113141|FG000|Observational Period|Lost to Follow-up|8|||
146710288|NCT03266588|529113142|FG001|Observational Period|Lost to Follow-up|12|||
146778700|NCT03215030|529359528|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
146778701|NCT03215030|529359529|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
146778702|NCT03215030|529359530|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
146778703|NCT03215030|529359531|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
146778704|NCT03215030|529359532|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
146778705|NCT03215030|529359533|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
146778706|NCT03215030|529359534|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
146778707|NCT03215030|529359523|FG000|Part 3: Dose Extension|Death|0|||
146778708|NCT03215030|529359524|FG001|Part 3: Dose Extension|Death|0|||
146778709|NCT03215030|529359525|FG002|Part 3: Dose Extension|Death|0|||
146778710|NCT03215030|529359526|FG003|Part 3: Dose Extension|Death|0|||
146778711|NCT03215030|529359527|FG004|Part 3: Dose Extension|Death|0|||
146778712|NCT03215030|529359528|FG005|Part 3: Dose Extension|Death|0|||
146778713|NCT03215030|529359529|FG006|Part 3: Dose Extension|Death|0|||
146778714|NCT03215030|529359530|FG007|Part 3: Dose Extension|Death|0|||
146778715|NCT03215030|529359531|FG008|Part 3: Dose Extension|Death|19|||
146778716|NCT03215030|529359532|FG009|Part 3: Dose Extension|Death|20|||
146778717|NCT03215030|529359533|FG010|Part 3: Dose Extension|Death|0|||
146778718|NCT03215030|529359534|FG011|Part 3: Dose Extension|Death|0|||
146778719|NCT03215030|529359523|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
146778720|NCT03215030|529359524|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
146778721|NCT03215030|529359525|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
146778722|NCT03215030|529359526|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
146778723|NCT03215030|529359527|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
146778724|NCT03215030|529359528|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
146778725|NCT03215030|529359529|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
146778726|NCT03215030|529359530|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
146778727|NCT03215030|529359531|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
146778728|NCT03215030|529359532|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
146778729|NCT03215030|529359533|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
146778730|NCT03215030|529359534|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
146778731|NCT03215030|529359523|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146778732|NCT03215030|529359524|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146778733|NCT03215030|529359525|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146778734|NCT03215030|529359526|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146778735|NCT03215030|529359527|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146778736|NCT03215030|529359528|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146778737|NCT03215030|529359529|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146778738|NCT03215030|529359530|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146778739|NCT03215030|529359531|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146778740|NCT03215030|529359532|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146778741|NCT03215030|529359533|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
146778742|NCT03215030|529359534|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
146778743|NCT03438188|529359535|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
146778744|NCT03438188|529359536|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
146778745|NCT03438188|529359537|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
146778746|NCT03438188|529359535|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
146778747|NCT03438188|529359536|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
146778748|NCT03438188|529359537|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
146778749|NCT03438188|529359535|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
146778750|NCT03438188|529359536|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
146778751|NCT03438188|529359537|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
146778752|NCT03438188|529359535|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
146778753|NCT03438188|529359536|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
146778754|NCT03438188|529359537|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
146778755|NCT03438188|529359535|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
146778756|NCT03438188|529359536|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
146778757|NCT03438188|529359537|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
146778758|NCT05215847|529359538|FG000|Overall Study|Lost to Follow-up|1|||
146778759|NCT03433339|529359539|FG000|Overall Study|Lost to Follow-up|2|||
146778760|NCT03433339|529359540|FG001|Overall Study|Lost to Follow-up|0|||
146778761|NCT03433339|529359539|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
146778762|NCT03433339|529359540|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
146778763|NCT03433339|529359539|FG000|Overall Study|Withdrawal by Subject|0|||
146778764|NCT03433339|529359540|FG001|Overall Study|Withdrawal by Subject|2|||
146778765|NCT05952076|529359541|FG000|Overall Study|Death|1|||
146778766|NCT05952076|529359542|FG001|Overall Study|Death|1|||
146778767|NCT05952076|529359541|FG000|Overall Study|Lost to Follow-up|0|||
146778768|NCT05952076|529359542|FG001|Overall Study|Lost to Follow-up|1|||
146778769|NCT04143061|529359544|FG000|Overall Study|Protocol Deviation|0|||
146710289|NCT03266588|529113143|FG002|Observational Period|Lost to Follow-up|4|||
146710290|NCT03266588|529113141|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
146710291|NCT03266588|529113142|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
146710292|NCT03266588|529113143|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
146710293|NCT03266588|529113141|FG000|Observational Period|Protocol Deviation|1|||
146710294|NCT03266588|529113142|FG001|Observational Period|Protocol Deviation|0|||
146710295|NCT03266588|529113143|FG002|Observational Period|Protocol Deviation|0|||
146710296|NCT03266588|529113141|FG000|Observational Period|Other Reasons|3|||
146710297|NCT03266588|529113142|FG001|Observational Period|Other Reasons|0|||
146710298|NCT03266588|529113143|FG002|Observational Period|Other Reasons|1|||
146710299|NCT03266588|529113141|FG000|Long-term Treatment Period|Adverse Event|33|||
146710300|NCT03266588|529113142|FG001|Long-term Treatment Period|Adverse Event|17|||
146710301|NCT03266588|529113143|FG002|Long-term Treatment Period|Adverse Event|8|||
146710302|NCT03266588|529113141|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
146710303|NCT03266588|529113142|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
146710304|NCT03266588|529113143|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
146710305|NCT03266588|529113141|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
146710306|NCT03266588|529113142|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
146710307|NCT03266588|529113143|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
146710308|NCT03266588|529113141|FG000|Long-term Treatment Period|Non-Compliance|126|||
146710309|NCT03266588|529113142|FG001|Long-term Treatment Period|Non-Compliance|57|||
146710310|NCT03266588|529113143|FG002|Long-term Treatment Period|Non-Compliance|7|||
146710311|NCT03266588|529113141|FG000|Long-term Treatment Period|Pregnancy|11|||
146710312|NCT03266588|529113142|FG001|Long-term Treatment Period|Pregnancy|5|||
146710313|NCT03266588|529113143|FG002|Long-term Treatment Period|Pregnancy|0|||
146710314|NCT03266588|529113141|FG000|Long-term Treatment Period|Protocol Deviation|17|||
146710315|NCT03266588|529113142|FG001|Long-term Treatment Period|Protocol Deviation|10|||
146710316|NCT03266588|529113143|FG002|Long-term Treatment Period|Protocol Deviation|4|||
146710317|NCT03266588|529113141|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
146710318|NCT03266588|529113142|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
146710319|NCT03266588|529113143|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
146710320|NCT03266588|529113141|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
146710321|NCT03266588|529113142|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
146710322|NCT03266588|529113143|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
146710323|NCT03266588|529113141|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
146710324|NCT03266588|529113142|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
146710325|NCT03266588|529113143|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
146710326|NCT03266588|529113141|FG000|Long-term Treatment Period|Other Reasons|5|||
146710327|NCT03266588|529113142|FG001|Long-term Treatment Period|Other Reasons|0|||
146710328|NCT03266588|529113143|FG002|Long-term Treatment Period|Other Reasons|0|||
146710329|NCT03266588|529113141|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
146710330|NCT03266588|529113142|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
146710331|NCT03266588|529113143|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
146710332|NCT00767000|529113151|FG000|54-week Study|Adverse Event|4|||
146710333|NCT00767000|529113152|FG001|54-week Study|Adverse Event|6|||
146710334|NCT00767000|529113153|FG002|54-week Study|Adverse Event|6|||
146710335|NCT00767000|529113154|FG003|54-week Study|Adverse Event|8|||
146710336|NCT00767000|529113155|FG004|54-week Study|Adverse Event|4|||
146710337|NCT00767000|529113151|FG000|54-week Study|Creaninine/creatinine clearance|2|||
146710338|NCT00767000|529113152|FG001|54-week Study|Creaninine/creatinine clearance|1|||
146710339|NCT00767000|529113153|FG002|54-week Study|Creaninine/creatinine clearance|2|||
146710340|NCT00767000|529113154|FG003|54-week Study|Creaninine/creatinine clearance|2|||
146710341|NCT00767000|529113155|FG004|54-week Study|Creaninine/creatinine clearance|4|||
146710342|NCT00767000|529113151|FG000|54-week Study|Hyperglycemia|0|||
146710343|NCT00767000|529113152|FG001|54-week Study|Hyperglycemia|0|||
146710344|NCT00767000|529113153|FG002|54-week Study|Hyperglycemia|1|||
146710345|NCT00767000|529113154|FG003|54-week Study|Hyperglycemia|0|||
146710346|NCT00767000|529113155|FG004|54-week Study|Hyperglycemia|1|||
146710347|NCT00767000|529113151|FG000|54-week Study|Hypoglycemia|0|||
146710348|NCT00767000|529113152|FG001|54-week Study|Hypoglycemia|1|||
146710349|NCT00767000|529113153|FG002|54-week Study|Hypoglycemia|0|||
146710350|NCT00767000|529113154|FG003|54-week Study|Hypoglycemia|0|||
146710351|NCT00767000|529113155|FG004|54-week Study|Hypoglycemia|0|||
146710352|NCT00767000|529113151|FG000|54-week Study|Interruption of study medication|0|||
146778770|NCT04143061|529359545|FG001|Overall Study|Protocol Deviation|0|||
146710353|NCT00767000|529113152|FG001|54-week Study|Interruption of study medication|0|||
146710354|NCT00767000|529113153|FG002|54-week Study|Interruption of study medication|1|||
146710355|NCT00767000|529113154|FG003|54-week Study|Interruption of study medication|0|||
146710356|NCT00767000|529113155|FG004|54-week Study|Interruption of study medication|0|||
146710357|NCT00767000|529113151|FG000|54-week Study|Lack of Efficacy|2|||
146710358|NCT00767000|529113152|FG001|54-week Study|Lack of Efficacy|0|||
146710359|NCT00767000|529113153|FG002|54-week Study|Lack of Efficacy|1|||
146710360|NCT00767000|529113154|FG003|54-week Study|Lack of Efficacy|0|||
146710361|NCT00767000|529113155|FG004|54-week Study|Lack of Efficacy|5|||
146710362|NCT00767000|529113151|FG000|54-week Study|Lost to Follow-up|4|||
146710363|NCT00767000|529113152|FG001|54-week Study|Lost to Follow-up|0|||
146710364|NCT00767000|529113153|FG002|54-week Study|Lost to Follow-up|1|||
146710365|NCT00767000|529113154|FG003|54-week Study|Lost to Follow-up|4|||
146710366|NCT00767000|529113155|FG004|54-week Study|Lost to Follow-up|2|||
146710367|NCT00767000|529113151|FG000|54-week Study|Physician Decision|4|||
146710368|NCT00767000|529113152|FG001|54-week Study|Physician Decision|0|||
146710369|NCT00767000|529113153|FG002|54-week Study|Physician Decision|1|||
146710370|NCT00767000|529113154|FG003|54-week Study|Physician Decision|1|||
146710371|NCT00767000|529113155|FG004|54-week Study|Physician Decision|1|||
146710372|NCT00767000|529113151|FG000|54-week Study|Progressive disease|0|||
146710373|NCT00767000|529113152|FG001|54-week Study|Progressive disease|0|||
146710374|NCT00767000|529113153|FG002|54-week Study|Progressive disease|1|||
146710375|NCT00767000|529113154|FG003|54-week Study|Progressive disease|0|||
146710376|NCT00767000|529113155|FG004|54-week Study|Progressive disease|0|||
146710377|NCT00767000|529113151|FG000|54-week Study|Protocol Violation|0|||
146710378|NCT00767000|529113152|FG001|54-week Study|Protocol Violation|0|||
146710379|NCT00767000|529113153|FG002|54-week Study|Protocol Violation|1|||
146710380|NCT00767000|529113154|FG003|54-week Study|Protocol Violation|2|||
146710381|NCT00767000|529113155|FG004|54-week Study|Protocol Violation|0|||
146710382|NCT00767000|529113151|FG000|54-week Study|Withdrawal by Subject|2|||
146710383|NCT00767000|529113152|FG001|54-week Study|Withdrawal by Subject|3|||
146710384|NCT00767000|529113153|FG002|54-week Study|Withdrawal by Subject|5|||
146710385|NCT00767000|529113154|FG003|54-week Study|Withdrawal by Subject|11|||
146710386|NCT00767000|529113155|FG004|54-week Study|Withdrawal by Subject|13|||
146710387|NCT00767000|529113151|FG000|54-week Study|Study terminated by sponsor|90|||
146710388|NCT00767000|529113152|FG001|54-week Study|Study terminated by sponsor|102|||
146710389|NCT00767000|529113153|FG002|54-week Study|Study terminated by sponsor|89|||
146710390|NCT00767000|529113154|FG003|54-week Study|Study terminated by sponsor|196|||
146710391|NCT00767000|529113155|FG004|54-week Study|Study terminated by sponsor|194|||
146710392|NCT00767000|529113151|FG000|54-week Study|Reason not reported|0|||
146710393|NCT00767000|529113152|FG001|54-week Study|Reason not reported|0|||
146710394|NCT00767000|529113153|FG002|54-week Study|Reason not reported|0|||
146710395|NCT00767000|529113154|FG003|54-week Study|Reason not reported|1|||
146710396|NCT00767000|529113155|FG004|54-week Study|Reason not reported|0|||
146710397|NCT00767000|529113151|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
146710398|NCT00767000|529113152|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
146710399|NCT00767000|529113153|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
146710400|NCT00767000|529113154|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
146710401|NCT00767000|529113155|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
146710402|NCT03614793|529113157|FG000|Overall Study|Lost to Follow-up|1|||
146710403|NCT03614793|529113158|FG001|Overall Study|Lost to Follow-up|2|||
146710404|NCT03614793|529113157|FG000|Overall Study|Lack of Efficacy|0|||
146710405|NCT03614793|529113158|FG001|Overall Study|Lack of Efficacy|5|||
146710406|NCT03614793|529113157|FG000|Overall Study|Withdrawal by Subject|0|||
146710407|NCT03614793|529113158|FG001|Overall Study|Withdrawal by Subject|1|||
146710408|NCT03614793|529113157|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
146710409|NCT03614793|529113158|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
146710410|NCT02496884|529113159|FG000|Overall Study|Counted twice as enrolled|2|||
146710411|NCT02496884|529113160|FG001|Overall Study|Counted twice as enrolled|0|||
146710412|NCT02496884|529113161|FG002|Overall Study|Counted twice as enrolled|0|||
146710413|NCT02496884|529113162|FG003|Overall Study|Counted twice as enrolled|0|||
146710414|NCT02496884|529113159|FG000|Overall Study|Withdrawal by Subject|0|||
146710415|NCT02496884|529113160|FG001|Overall Study|Withdrawal by Subject|3|||
146710416|NCT02496884|529113161|FG002|Overall Study|Withdrawal by Subject|0|||
146710417|NCT02496884|529113162|FG003|Overall Study|Withdrawal by Subject|0|||
146710418|NCT00097591|529113163|FG000|Overall Study|Withdrawal of consent|342|||
146710419|NCT00097591|529113164|FG001|Overall Study|Withdrawal of consent|323|||
146710420|NCT00097591|529113163|FG000|Overall Study|Less than 6 months on study drug|9|||
146710421|NCT00097591|529113164|FG001|Overall Study|Less than 6 months on study drug|7|||
146710422|NCT00097591|529113163|FG000|Overall Study|Unable to attend termination visit|53|||
146710423|NCT00097591|529113164|FG001|Overall Study|Unable to attend termination visit|51|||
146710424|NCT00097591|529113163|FG000|Overall Study|Lost to follow up|6|||
146710425|NCT00097591|529113164|FG001|Overall Study|Lost to follow up|10|||
146710426|NCT00097591|529113163|FG000|Overall Study|Other|0|||
146710427|NCT00097591|529113164|FG001|Overall Study|Other|3|||
146710428|NCT01168999|529113169|FG000|Overall Study|Lost to Follow-up|2|||
146710429|NCT01168999|529113170|FG001|Overall Study|Lost to Follow-up|1|||
146710430|NCT01168999|529113171|FG002|Overall Study|Lost to Follow-up|0|||
146710431|NCT01168999|529113172|FG003|Overall Study|Lost to Follow-up|0|||
146710432|NCT04317586|529113173|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
146710433|NCT04317586|529113173|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
146710434|NCT01276327|529113174|FG000|Overall Study|Adverse Event|1|||
146710435|NCT01276327|529113175|FG001|Overall Study|Adverse Event|3|||
146710436|NCT01276327|529113174|FG000|Overall Study|Withdrawal by Subject|1|||
146778771|NCT04143061|529359546|FG002|Overall Study|Protocol Deviation|0|||
146778772|NCT04143061|529359547|FG003|Overall Study|Protocol Deviation|0|||
146778773|NCT04143061|529359548|FG004|Overall Study|Protocol Deviation|0|||
146778774|NCT04143061|529359549|FG005|Overall Study|Protocol Deviation|0|||
146778775|NCT04143061|529359550|FG006|Overall Study|Protocol Deviation|5|||
146778776|NCT04143061|529359551|FG007|Overall Study|Protocol Deviation|5|||
146778777|NCT04143061|529359544|FG000|Overall Study|Withdrawal by Subject|2|||
146778778|NCT04143061|529359545|FG001|Overall Study|Withdrawal by Subject|0|||
146778779|NCT04143061|529359546|FG002|Overall Study|Withdrawal by Subject|0|||
146778780|NCT04143061|529359547|FG003|Overall Study|Withdrawal by Subject|0|||
146778781|NCT04143061|529359548|FG004|Overall Study|Withdrawal by Subject|0|||
146778782|NCT04143061|529359549|FG005|Overall Study|Withdrawal by Subject|1|||
146778783|NCT04143061|529359550|FG006|Overall Study|Withdrawal by Subject|0|||
146778784|NCT04143061|529359551|FG007|Overall Study|Withdrawal by Subject|0|||
146778785|NCT04143061|529359544|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146778786|NCT04143061|529359545|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146778787|NCT04143061|529359546|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146778788|NCT04143061|529359547|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146778789|NCT04143061|529359548|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
146778790|NCT04143061|529359549|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
146778791|NCT04143061|529359550|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
146778792|NCT04143061|529359551|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
146778793|NCT03602014|529359558|FG000|Overall Study|Lost to Follow-up|2|||
146778794|NCT03602014|529359559|FG001|Overall Study|Lost to Follow-up|0|||
146778795|NCT03602014|529359560|FG002|Overall Study|Lost to Follow-up|0|||
146778796|NCT01898494|529359564|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
146778797|NCT01898494|529359565|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
146710437|NCT01276327|529113175|FG001|Overall Study|Withdrawal by Subject|0|||
146710438|NCT00807092|529113176|FG000|Overall Study|Adverse Event|0|||
146710439|NCT00807092|529113177|FG001|Overall Study|Adverse Event|1|||
146710440|NCT00807092|529113176|FG000|Overall Study|Protocol Violation|0|||
146710441|NCT00807092|529113177|FG001|Overall Study|Protocol Violation|2|||
146710442|NCT00807092|529113176|FG000|Overall Study|Withdrawal by Subject|1|||
146710443|NCT00807092|529113177|FG001|Overall Study|Withdrawal by Subject|0|||
146710444|NCT00807092|529113176|FG000|Overall Study|CGMS data collection failed|0|||
146710445|NCT00807092|529113177|FG001|Overall Study|CGMS data collection failed|1|||
146710446|NCT01794949|529113178|FG000|Overall Study|Lost to Follow-up|1|||
146710447|NCT01794949|529113179|FG001|Overall Study|Lost to Follow-up|0|||
146710448|NCT03003676|529113180|FG000|Overall Study|Lack of Efficacy|5|||
146710449|NCT03003676|529113181|FG001|Overall Study|Lack of Efficacy|7|||
146710450|NCT03003676|529113180|FG000|Overall Study|Withdrawal by Subject|0|||
146778798|NCT01898494|529359566|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
146778799|NCT01898494|529359567|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
146778800|NCT01898494|529359568|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
146778801|NCT01898494|529359564|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
146778802|NCT01898494|529359565|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
146778803|NCT01898494|529359566|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
146778804|NCT01898494|529359567|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
146778805|NCT01898494|529359568|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
146778806|NCT01898494|529359564|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
146778807|NCT01898494|529359565|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
146778808|NCT01898494|529359566|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
146778809|NCT01898494|529359567|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
146778810|NCT01898494|529359568|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
146778811|NCT01898494|529359564|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
146778812|NCT01898494|529359565|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
146778813|NCT01898494|529359566|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
146778814|NCT01898494|529359567|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
146778815|NCT01898494|529359568|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
146778816|NCT01898494|529359564|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
146778817|NCT01898494|529359565|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
146778818|NCT01898494|529359566|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
146778819|NCT01898494|529359567|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
146778820|NCT01898494|529359568|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
146778821|NCT01898494|529359564|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
146710451|NCT03003676|529113181|FG001|Overall Study|Withdrawal by Subject|1|||
146778822|NCT01898494|529359565|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
146778823|NCT01898494|529359566|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
146778824|NCT01898494|529359567|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
146933875|NCT01335698|529916015|FG003|Treatment Stage 1|Lack of Efficacy|3|||
146933876|NCT01335698|529916016|FG004|Treatment Stage 1|Lack of Efficacy|1|||
146710452|NCT03003676|529113180|FG000|Overall Study|Hepatitis B infection|1|||
146710453|NCT03003676|529113181|FG001|Overall Study|Hepatitis B infection|0|||
146710454|NCT03766646|529113187|FG000|Overall Study|Withdrawal by Subject|1|||
146710455|NCT03766646|529113188|FG001|Overall Study|Withdrawal by Subject|0|||
146710456|NCT03766646|529113187|FG000|Overall Study|Protocol Violation|0|||
146710457|NCT03766646|529113188|FG001|Overall Study|Protocol Violation|3|||
146710458|NCT01931839|529113193|FG000|Overall Study|Death|0|||
146710459|NCT01931839|529113194|FG001|Overall Study|Death|1|||
146710460|NCT01931839|529113195|FG002|Overall Study|Death|2|||
146710461|NCT01931839|529113196|FG003|Overall Study|Death|0|||
146710462|NCT01931839|529113197|FG004|Overall Study|Death|0|||
146710463|NCT01931839|529113198|FG005|Overall Study|Death|0|||
146710464|NCT01931839|529113199|FG006|Overall Study|Death|0|||
146710465|NCT01931839|529113193|FG000|Overall Study|Physician Decision|1|||
146710466|NCT01931839|529113194|FG001|Overall Study|Physician Decision|0|||
146710467|NCT01931839|529113195|FG002|Overall Study|Physician Decision|1|||
146710468|NCT01931839|529113196|FG003|Overall Study|Physician Decision|0|||
146710469|NCT01931839|529113197|FG004|Overall Study|Physician Decision|0|||
146710470|NCT01931839|529113198|FG005|Overall Study|Physician Decision|0|||
146710471|NCT01931839|529113199|FG006|Overall Study|Physician Decision|1|||
146710472|NCT01931839|529113193|FG000|Overall Study|Withdrawal of consent|0|||
146710473|NCT01931839|529113194|FG001|Overall Study|Withdrawal of consent|0|||
146710474|NCT01931839|529113195|FG002|Overall Study|Withdrawal of consent|0|||
146710475|NCT01931839|529113196|FG003|Overall Study|Withdrawal of consent|0|||
146710476|NCT01931839|529113197|FG004|Overall Study|Withdrawal of consent|1|||
146710477|NCT01931839|529113198|FG005|Overall Study|Withdrawal of consent|0|||
146710478|NCT01931839|529113199|FG006|Overall Study|Withdrawal of consent|0|||
146710479|NCT01931839|529113193|FG000|Overall Study|Adverse Event|9|||
146710480|NCT01931839|529113194|FG001|Overall Study|Adverse Event|4|||
146710481|NCT01931839|529113195|FG002|Overall Study|Adverse Event|1|||
146710482|NCT01931839|529113196|FG003|Overall Study|Adverse Event|3|||
146710483|NCT01931839|529113197|FG004|Overall Study|Adverse Event|0|||
146710484|NCT01931839|529113198|FG005|Overall Study|Adverse Event|0|||
146710485|NCT01931839|529113199|FG006|Overall Study|Adverse Event|1|||
146710486|NCT01931839|529113193|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
146710487|NCT01931839|529113194|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
146710488|NCT01931839|529113195|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
146710489|NCT01931839|529113196|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
146710490|NCT01931839|529113197|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
146710491|NCT01931839|529113198|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
146710492|NCT01931839|529113199|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
146710493|NCT01931839|529113193|FG000|Overall Study|Other non-compliance|15|||
146710494|NCT01931839|529113194|FG001|Overall Study|Other non-compliance|9|||
146710495|NCT01931839|529113195|FG002|Overall Study|Other non-compliance|12|||
146710496|NCT01931839|529113196|FG003|Overall Study|Other non-compliance|3|||
146710497|NCT01931839|529113197|FG004|Overall Study|Other non-compliance|0|||
146710498|NCT01931839|529113198|FG005|Overall Study|Other non-compliance|3|||
146710499|NCT01931839|529113199|FG006|Overall Study|Other non-compliance|0|||
146710500|NCT01931839|529113193|FG000|Overall Study|Lost to Follow-up|1|||
146710501|NCT01931839|529113194|FG001|Overall Study|Lost to Follow-up|2|||
146710502|NCT01931839|529113195|FG002|Overall Study|Lost to Follow-up|4|||
146710503|NCT01931839|529113196|FG003|Overall Study|Lost to Follow-up|5|||
146710504|NCT01931839|529113197|FG004|Overall Study|Lost to Follow-up|0|||
146710505|NCT01931839|529113198|FG005|Overall Study|Lost to Follow-up|0|||
146710506|NCT01931839|529113199|FG006|Overall Study|Lost to Follow-up|0|||
146710507|NCT01931839|529113193|FG000|Overall Study|Other|4|||
146710508|NCT01931839|529113194|FG001|Overall Study|Other|2|||
146710509|NCT01931839|529113195|FG002|Overall Study|Other|6|||
146710510|NCT01931839|529113196|FG003|Overall Study|Other|0|||
146710511|NCT01931839|529113197|FG004|Overall Study|Other|0|||
146710512|NCT01931839|529113198|FG005|Overall Study|Other|0|||
146710513|NCT01931839|529113199|FG006|Overall Study|Other|0|||
146710514|NCT03224468|529113205|FG000|Overall Study|Did not obtain MM card|53|||
146710515|NCT03224468|529113206|FG001|Overall Study|Did not obtain MM card|0|||
146710516|NCT03224468|529113205|FG000|Overall Study|Lost to Follow-up|4|||
146710517|NCT03224468|529113206|FG001|Overall Study|Lost to Follow-up|11|||
146710518|NCT03224468|529113205|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
146710519|NCT03224468|529113206|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
146710520|NCT01978119|529113207|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
146710521|NCT01978119|529113208|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
146710522|NCT01978119|529113207|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
146710523|NCT01978119|529113208|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146710524|NCT01978119|529113207|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146710525|NCT01978119|529113208|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
146710526|NCT00812812|529113209|FG000|Overall Study|Adverse Event|2|||
146710527|NCT00812812|529113210|FG001|Overall Study|Adverse Event|1|||
146710528|NCT00812812|529113209|FG000|Overall Study|Lack of Efficacy|1|||
146710529|NCT00812812|529113210|FG001|Overall Study|Lack of Efficacy|0|||
146710530|NCT00812812|529113209|FG000|Overall Study|Lost to Follow-up|0|||
146710531|NCT00812812|529113210|FG001|Overall Study|Lost to Follow-up|1|||
146710532|NCT00812812|529113209|FG000|Overall Study|Withdrawal by Subject|0|||
146710533|NCT00812812|529113210|FG001|Overall Study|Withdrawal by Subject|2|||
146710534|NCT01877421|529113211|FG000|Phase 2|Lost to Follow-up|0|||
146710535|NCT01877421|529113212|FG001|Phase 2|Lost to Follow-up|0|||
146710536|NCT01877421|529113213|FG002|Phase 2|Lost to Follow-up|0|||
146710537|NCT01877421|529113214|FG003|Phase 2|Lost to Follow-up|0|||
146710538|NCT01877421|529113215|FG004|Phase 2|Lost to Follow-up|0|||
146710539|NCT01877421|529113216|FG005|Phase 2|Lost to Follow-up|0|||
146710540|NCT01877421|529113217|FG006|Phase 2|Lost to Follow-up|1|||
146710541|NCT01877421|529113218|FG007|Phase 2|Lost to Follow-up|0|||
146710542|NCT01877421|529113219|FG008|Phase 2|Lost to Follow-up|0|||
146710543|NCT01877421|529113220|FG009|Phase 2|Lost to Follow-up|0|||
146710544|NCT01877421|529113221|FG010|Phase 2|Lost to Follow-up|0|||
146710545|NCT01877421|529113222|FG011|Phase 2|Lost to Follow-up|0|||
146710546|NCT01877421|529113223|FG012|Phase 2|Lost to Follow-up|0|||
146710547|NCT01877421|529113224|FG013|Phase 2|Lost to Follow-up|0|||
146710548|NCT01877421|529113225|FG014|Phase 2|Lost to Follow-up|0|||
146710549|NCT01877421|529113226|FG015|Phase 2|Lost to Follow-up|0|||
146710550|NCT01877421|529113227|FG016|Phase 2|Lost to Follow-up|0|||
146710551|NCT01877421|529113228|FG017|Phase 2|Lost to Follow-up|0|||
146710552|NCT01877421|529113211|FG000|Phase 2|Withdrawal by Subject|0|||
146710553|NCT01877421|529113212|FG001|Phase 2|Withdrawal by Subject|0|||
146710554|NCT01877421|529113213|FG002|Phase 2|Withdrawal by Subject|0|||
146710555|NCT01877421|529113214|FG003|Phase 2|Withdrawal by Subject|0|||
146710556|NCT01877421|529113215|FG004|Phase 2|Withdrawal by Subject|0|||
146710557|NCT01877421|529113216|FG005|Phase 2|Withdrawal by Subject|0|||
146710558|NCT01877421|529113217|FG006|Phase 2|Withdrawal by Subject|0|||
146710559|NCT01877421|529113218|FG007|Phase 2|Withdrawal by Subject|0|||
146710560|NCT01877421|529113219|FG008|Phase 2|Withdrawal by Subject|1|||
146710561|NCT01877421|529113220|FG009|Phase 2|Withdrawal by Subject|0|||
146710562|NCT01877421|529113221|FG010|Phase 2|Withdrawal by Subject|1|||
146710563|NCT01877421|529113222|FG011|Phase 2|Withdrawal by Subject|0|||
146710564|NCT01877421|529113223|FG012|Phase 2|Withdrawal by Subject|1|||
146710565|NCT01877421|529113224|FG013|Phase 2|Withdrawal by Subject|0|||
146710566|NCT01877421|529113225|FG014|Phase 2|Withdrawal by Subject|0|||
146710567|NCT01877421|529113226|FG015|Phase 2|Withdrawal by Subject|1|||
146710568|NCT01877421|529113227|FG016|Phase 2|Withdrawal by Subject|0|||
146710569|NCT01877421|529113228|FG017|Phase 2|Withdrawal by Subject|0|||
146710570|NCT01877421|529113211|FG000|Phase 2|Protocol Violation|0|||
146710571|NCT01877421|529113212|FG001|Phase 2|Protocol Violation|0|||
146710572|NCT01877421|529113213|FG002|Phase 2|Protocol Violation|0|||
146710573|NCT01877421|529113214|FG003|Phase 2|Protocol Violation|0|||
146710574|NCT01877421|529113215|FG004|Phase 2|Protocol Violation|0|||
146710575|NCT01877421|529113216|FG005|Phase 2|Protocol Violation|0|||
146710576|NCT01877421|529113217|FG006|Phase 2|Protocol Violation|0|||
146710577|NCT01877421|529113218|FG007|Phase 2|Protocol Violation|0|||
146710578|NCT01877421|529113219|FG008|Phase 2|Protocol Violation|0|||
146710579|NCT01877421|529113220|FG009|Phase 2|Protocol Violation|0|||
146710580|NCT01877421|529113221|FG010|Phase 2|Protocol Violation|1|||
146710581|NCT01877421|529113222|FG011|Phase 2|Protocol Violation|0|||
146710582|NCT01877421|529113223|FG012|Phase 2|Protocol Violation|0|||
146710583|NCT01877421|529113224|FG013|Phase 2|Protocol Violation|0|||
146710584|NCT01877421|529113225|FG014|Phase 2|Protocol Violation|0|||
146710585|NCT01877421|529113226|FG015|Phase 2|Protocol Violation|0|||
146710586|NCT01877421|529113227|FG016|Phase 2|Protocol Violation|0|||
146710587|NCT01877421|529113228|FG017|Phase 2|Protocol Violation|0|||
146710588|NCT00908960|529113229|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
146710589|NCT00908960|529113230|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
146710590|NCT00908960|529113231|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
146710591|NCT01158924|529113232|FG000|Overall Study|Withdrawal by Subject|1|||
146710592|NCT01158924|529113233|FG001|Overall Study|Withdrawal by Subject|2|||
146710593|NCT01158924|529113232|FG000|Overall Study|Lost to Follow-up|0|||
146710594|NCT01158924|529113233|FG001|Overall Study|Lost to Follow-up|1|||
146710595|NCT03653429|529113236|FG000|Overall Study|Physician Decision|4|||
146710596|NCT03653429|529113237|FG001|Overall Study|Physician Decision|10|||
146710597|NCT01700946|529113244|FG000|Overall Study|Lost to Follow-up|1|||
146710598|NCT01700946|529113245|FG001|Overall Study|Lost to Follow-up|0|||
146710599|NCT01700946|529113244|FG000|Overall Study|Physician Decision|7|||
146710600|NCT01700946|529113245|FG001|Overall Study|Physician Decision|12|||
146710601|NCT01700946|529113244|FG000|Overall Study|Withdrawal by Subject|0|||
146710602|NCT01700946|529113245|FG001|Overall Study|Withdrawal by Subject|2|||
146710603|NCT01700946|529113244|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
146710604|NCT01700946|529113245|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
146710605|NCT01700946|529113244|FG000|Overall Study|Relapse|2|||
146710606|NCT01700946|529113245|FG001|Overall Study|Relapse|1|||
146710607|NCT01700946|529113244|FG000|Overall Study|Unacceptable toxicity|1|||
146710608|NCT01700946|529113245|FG001|Overall Study|Unacceptable toxicity|0|||
146710609|NCT03056690|529113248|FG000|Overall Study|Adverse Event|3|||
146710610|NCT03056690|529113249|FG001|Overall Study|Adverse Event|2|||
146710611|NCT03056690|529113248|FG000|Overall Study|Lack of Efficacy|1|||
146778825|NCT01898494|529359568|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
146778826|NCT01898494|529359564|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
146778827|NCT01898494|529359565|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
146778828|NCT01898494|529359566|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
146778829|NCT01898494|529359567|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
146778830|NCT01898494|529359568|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
146778831|NCT01898494|529359564|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
146778832|NCT01898494|529359565|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
146778833|NCT01898494|529359566|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
146778834|NCT01898494|529359567|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
146778835|NCT01898494|529359568|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
146778836|NCT01898494|529359564|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
146778837|NCT01898494|529359565|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
146778838|NCT01898494|529359566|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
146778839|NCT01898494|529359567|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
146778840|NCT01898494|529359568|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
146778841|NCT01898494|529359564|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
146778842|NCT01898494|529359565|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
146778843|NCT01898494|529359566|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
146778844|NCT01898494|529359567|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
146778845|NCT01898494|529359568|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
146778846|NCT01898494|529359564|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
146778847|NCT01898494|529359565|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
146778848|NCT01898494|529359566|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
146778849|NCT01898494|529359567|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
146778850|NCT01898494|529359568|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
146778851|NCT01898494|529359564|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
146778852|NCT01898494|529359565|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
146778853|NCT01898494|529359566|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
146778854|NCT01898494|529359567|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
146778855|NCT01898494|529359568|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
146778856|NCT01898494|529359564|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
146778857|NCT01898494|529359565|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
146778858|NCT01898494|529359566|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
146778859|NCT01898494|529359567|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
146778860|NCT01898494|529359568|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
146778861|NCT01898494|529359564|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
146778862|NCT01898494|529359565|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
146778863|NCT01898494|529359566|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
146778864|NCT01898494|529359567|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
146778865|NCT01898494|529359568|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
146778866|NCT03289039|529359571|FG000|Overall Study|Withdrawal by Subject|0|||
146778867|NCT03289039|529359572|FG001|Overall Study|Withdrawal by Subject|1|||
146778868|NCT03289039|529359571|FG000|Overall Study|Became ineligible prior to treatment start|0|||
146778869|NCT03289039|529359572|FG001|Overall Study|Became ineligible prior to treatment start|1|||
146778870|NCT03289039|529359571|FG000|Overall Study|progressed before treatment start|1|||
146778871|NCT03289039|529359572|FG001|Overall Study|progressed before treatment start|0|||
146778872|NCT02819843|529359573|FG000|Overall Study|Disease progression before RT|0|||
146778873|NCT02819843|529359574|FG001|Overall Study|Disease progression before RT|1|||
146778874|NCT04732494|529359575|FG000|Overall Study|Death|39|||
146778875|NCT04732494|529359576|FG001|Overall Study|Death|36|||
146778876|NCT04732494|529359575|FG000|Overall Study|Study Closed by Sponsor|20|||
146778877|NCT04732494|529359576|FG001|Overall Study|Study Closed by Sponsor|15|||
146778878|NCT04732494|529359575|FG000|Overall Study|Withdrawal by Subject|2|||
146778879|NCT04732494|529359576|FG001|Overall Study|Withdrawal by Subject|7|||
146778880|NCT04732494|529359575|FG000|Overall Study|Lost to Follow-up|1|||
146778881|NCT04732494|529359576|FG001|Overall Study|Lost to Follow-up|5|||
146778882|NCT03055858|529359577|FG000|Overall Study|Death|9|||
146778883|NCT03055858|529359577|FG000|Overall Study|Withdrawal by Subject|11|||
146778884|NCT03055858|529359577|FG000|Overall Study|Lost to Follow-up|6|||
146778885|NCT03055858|529359577|FG000|Overall Study|Missed Follow-Up Visits|18|||
146778886|NCT04586920|529359578|FG000|Overall Study|Lost to Follow-up|0|||
146778887|NCT04586920|529359579|FG001|Overall Study|Lost to Follow-up|0|||
146778888|NCT04586920|529359580|FG002|Overall Study|Lost to Follow-up|0|||
146778889|NCT04586920|529359581|FG003|Overall Study|Lost to Follow-up|0|||
146778890|NCT04586920|529359582|FG004|Overall Study|Lost to Follow-up|0|||
146778891|NCT04586920|529359583|FG005|Overall Study|Lost to Follow-up|0|||
146778892|NCT04586920|529359584|FG006|Overall Study|Lost to Follow-up|1|||
146778893|NCT04586920|529359585|FG007|Overall Study|Lost to Follow-up|1|||
146933877|NCT01335698|529916012|FG000|Treatment Stage 1|Adverse Event|1|||
146933878|NCT01335698|529916013|FG001|Treatment Stage 1|Adverse Event|2|||
146933879|NCT01335698|529916014|FG002|Treatment Stage 1|Adverse Event|2|||
146778894|NCT04586920|529359586|FG008|Overall Study|Lost to Follow-up|0|||
146778895|NCT04586920|529359587|FG009|Overall Study|Lost to Follow-up|1|||
146778896|NCT04586920|529359588|FG010|Overall Study|Lost to Follow-up|0|||
146778897|NCT04586920|529359589|FG011|Overall Study|Lost to Follow-up|0|||
146778898|NCT04586920|529359590|FG012|Overall Study|Lost to Follow-up|0|||
146778899|NCT04586920|529359591|FG013|Overall Study|Lost to Follow-up|1|||
146778900|NCT04586920|529359592|FG014|Overall Study|Lost to Follow-up|0|||
146778901|NCT04586920|529359593|FG015|Overall Study|Lost to Follow-up|0|||
146778902|NCT04586920|529359594|FG016|Overall Study|Lost to Follow-up|0|||
146778903|NCT04586920|529359595|FG017|Overall Study|Lost to Follow-up|0|||
146778904|NCT04586920|529359578|FG000|Overall Study|Withdrawal by Subject|0|||
146710612|NCT03056690|529113249|FG001|Overall Study|Lack of Efficacy|2|||
146710613|NCT03056690|529113248|FG000|Overall Study|Lost to Follow-up|3|||
146710614|NCT03056690|529113249|FG001|Overall Study|Lost to Follow-up|2|||
146710615|NCT03056690|529113248|FG000|Overall Study|Protocol Violation|2|||
146710616|NCT03056690|529113249|FG001|Overall Study|Protocol Violation|2|||
146710617|NCT03056690|529113248|FG000|Overall Study|Withdrawal by Subject|3|||
146710618|NCT03056690|529113249|FG001|Overall Study|Withdrawal by Subject|6|||
146710619|NCT03056690|529113248|FG000|Overall Study|Non-compliance with Study Drug|1|||
146710620|NCT03056690|529113249|FG001|Overall Study|Non-compliance with Study Drug|0|||
146710621|NCT03056690|529113248|FG000|Overall Study|Miscellaneous|1|||
146710622|NCT03056690|529113249|FG001|Overall Study|Miscellaneous|2|||
146710623|NCT02617589|529113253|FG000|Randomization|Request to Discontinue Study Treatment|1|||
146778905|NCT04586920|529359579|FG001|Overall Study|Withdrawal by Subject|0|||
146778906|NCT04586920|529359580|FG002|Overall Study|Withdrawal by Subject|0|||
146778907|NCT04586920|529359581|FG003|Overall Study|Withdrawal by Subject|0|||
146778908|NCT04586920|529359582|FG004|Overall Study|Withdrawal by Subject|0|||
146778909|NCT04586920|529359583|FG005|Overall Study|Withdrawal by Subject|0|||
146778910|NCT04586920|529359584|FG006|Overall Study|Withdrawal by Subject|0|||
146778911|NCT04586920|529359585|FG007|Overall Study|Withdrawal by Subject|1|||
146778912|NCT04586920|529359586|FG008|Overall Study|Withdrawal by Subject|0|||
146778913|NCT04586920|529359587|FG009|Overall Study|Withdrawal by Subject|1|||
146710624|NCT02617589|529113254|FG001|Randomization|Request to Discontinue Study Treatment|3|||
146710625|NCT02617589|529113253|FG000|Randomization|Participant Withdrew Consent|1|||
146710626|NCT02617589|529113254|FG001|Randomization|Participant Withdrew Consent|2|||
146710627|NCT02617589|529113253|FG000|Treatment|Other Reasons|3|||
146710628|NCT02617589|529113254|FG001|Treatment|Other Reasons|3|||
146710629|NCT02617589|529113253|FG000|Treatment|Poor/Non Compliance|1|||
146710630|NCT02617589|529113254|FG001|Treatment|Poor/Non Compliance|1|||
146710631|NCT02617589|529113253|FG000|Treatment|Maximum Clinical Benefit|0|||
146710632|NCT02617589|529113254|FG001|Treatment|Maximum Clinical Benefit|2|||
146710633|NCT02617589|529113253|FG000|Treatment|Participant Withdrew Consent|2|||
146710634|NCT02617589|529113254|FG001|Treatment|Participant Withdrew Consent|6|||
146710635|NCT02617589|529113253|FG000|Treatment|Participant Request to Discontinue|12|||
146710636|NCT02617589|529113254|FG001|Treatment|Participant Request to Discontinue|21|||
146710637|NCT02617589|529113253|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
146710638|NCT02617589|529113254|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
146710639|NCT02617589|529113253|FG000|Treatment|Death|1|||
146710640|NCT02617589|529113254|FG001|Treatment|Death|1|||
146710641|NCT02617589|529113253|FG000|Treatment|Study Drug Toxicity|27|||
146710642|NCT02617589|529113254|FG001|Treatment|Study Drug Toxicity|20|||
146710643|NCT02617589|529113253|FG000|Treatment|Disease Progression|216|||
146710644|NCT02617589|529113254|FG001|Treatment|Disease Progression|136|||
146710645|NCT01975389|529113255|FG000|Overall Study|Adverse Event|10|||
146710646|NCT01975389|529113256|FG001|Overall Study|Adverse Event|6|||
146778914|NCT04586920|529359588|FG010|Overall Study|Withdrawal by Subject|0|||
146778915|NCT04586920|529359589|FG011|Overall Study|Withdrawal by Subject|1|||
146778916|NCT04586920|529359590|FG012|Overall Study|Withdrawal by Subject|0|||
146778917|NCT04586920|529359591|FG013|Overall Study|Withdrawal by Subject|0|||
146778918|NCT04586920|529359592|FG014|Overall Study|Withdrawal by Subject|0|||
146778919|NCT04586920|529359593|FG015|Overall Study|Withdrawal by Subject|0|||
146778920|NCT04586920|529359594|FG016|Overall Study|Withdrawal by Subject|0|||
146778921|NCT04586920|529359595|FG017|Overall Study|Withdrawal by Subject|0|||
146778922|NCT01718743|529359600|FG000|Overall Study|Physician Decision|7|||
146778923|NCT01718743|529359600|FG000|Overall Study|Withdrawal by Subject|14|||
146778924|NCT01718743|529359600|FG000|Overall Study|Progressive Disease|22|||
146778925|NCT01718743|529359600|FG000|Overall Study|Toxicity|1|||
146778926|NCT01718743|529359600|FG000|Overall Study|Malignancy|1|||
146710647|NCT01975389|529113255|FG000|Overall Study|Death|61|||
146710648|NCT01975389|529113256|FG001|Overall Study|Death|54|||
146710649|NCT01975389|529113255|FG000|Overall Study|Lost to Follow-up|81|||
146710650|NCT01975389|529113256|FG001|Overall Study|Lost to Follow-up|86|||
146710651|NCT01975389|529113255|FG000|Overall Study|Withdrawal by Subject|90|||
146710652|NCT01975389|529113256|FG001|Overall Study|Withdrawal by Subject|76|||
146710653|NCT01975389|529113255|FG000|Overall Study|Other|6|||
146778927|NCT02728557|529359601|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
146778928|NCT02728557|529359602|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
146710654|NCT01975389|529113256|FG001|Overall Study|Other|9|||
146778929|NCT02728557|529359601|FG000|Overall Study|Dissatisfaction with research tasks|0|||
146778930|NCT02728557|529359602|FG001|Overall Study|Dissatisfaction with research tasks|1|||
146778931|NCT02728557|529359601|FG000|Overall Study|Scheduling or change in availability|1|||
146778932|NCT02728557|529359602|FG001|Overall Study|Scheduling or change in availability|1|||
146778933|NCT03416010|529359603|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
146778934|NCT03416010|529359604|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
146778935|NCT03416010|529359603|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
146778936|NCT03416010|529359604|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
146778937|NCT03416010|529359603|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
146778938|NCT03416010|529359604|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
146778939|NCT03416010|529359603|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
146778940|NCT03416010|529359604|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
146778941|NCT03416010|529359603|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
146778942|NCT03416010|529359604|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
146778943|NCT03416010|529359603|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
146778944|NCT03416010|529359604|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
146778945|NCT03416010|529359603|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
146778946|NCT03416010|529359604|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
146778947|NCT03948763|529359608|FG000|Overall Study|Sponsor's decision|0|||
146778948|NCT03948763|529359609|FG001|Overall Study|Sponsor's decision|2|||
146778949|NCT03948763|529359610|FG002|Overall Study|Sponsor's decision|6|||
146778950|NCT03948763|529359611|FG003|Overall Study|Sponsor's decision|4|||
146778951|NCT03948763|529359612|FG004|Overall Study|Sponsor's decision|0|||
146778952|NCT03948763|529359608|FG000|Overall Study|Physician Decision|0|||
146778953|NCT03948763|529359609|FG001|Overall Study|Physician Decision|0|||
146778954|NCT03948763|529359610|FG002|Overall Study|Physician Decision|1|||
146778955|NCT03948763|529359611|FG003|Overall Study|Physician Decision|0|||
146778956|NCT03948763|529359612|FG004|Overall Study|Physician Decision|0|||
146778957|NCT03948763|529359608|FG000|Overall Study|Lost to Follow-up|0|||
146778958|NCT03948763|529359609|FG001|Overall Study|Lost to Follow-up|0|||
146778959|NCT03948763|529359610|FG002|Overall Study|Lost to Follow-up|0|||
146778960|NCT03948763|529359611|FG003|Overall Study|Lost to Follow-up|0|||
146778961|NCT03948763|529359612|FG004|Overall Study|Lost to Follow-up|1|||
146778962|NCT03948763|529359608|FG000|Overall Study|Death|2|||
146778963|NCT03948763|529359609|FG001|Overall Study|Death|12|||
146778964|NCT03948763|529359610|FG002|Overall Study|Death|13|||
146778965|NCT03948763|529359611|FG003|Overall Study|Death|10|||
146778966|NCT03948763|529359612|FG004|Overall Study|Death|11|||
146778967|NCT03948763|529359608|FG000|Overall Study|Withdrawal by Subject|1|||
146778968|NCT03948763|529359609|FG001|Overall Study|Withdrawal by Subject|1|||
146778969|NCT03948763|529359610|FG002|Overall Study|Withdrawal by Subject|0|||
146778970|NCT03948763|529359611|FG003|Overall Study|Withdrawal by Subject|2|||
146778971|NCT03948763|529359612|FG004|Overall Study|Withdrawal by Subject|4|||
146778972|NCT05136404|529359614|FG000|Period 1|Adverse Event|0|||
146778973|NCT05136404|529359615|FG001|Period 1|Adverse Event|1|||
146778974|NCT05136404|529359616|FG002|Period 1|Adverse Event|1|||
146778975|NCT05136404|529359614|FG000|Period 2|Inappropriate Behavior|0|||
146778976|NCT05136404|529359615|FG001|Period 2|Inappropriate Behavior|0|||
146778977|NCT05136404|529359616|FG002|Period 2|Inappropriate Behavior|1|||
146778978|NCT05136404|529359614|FG000|Period 3|Adverse Event|0|||
146778979|NCT05136404|529359615|FG001|Period 3|Adverse Event|0|||
146778980|NCT05136404|529359616|FG002|Period 3|Adverse Event|1|||
146778981|NCT01426412|529359619|FG000|Overall Study|Withdrawal by Subject|1|||
146778982|NCT01426412|529359620|FG001|Overall Study|Withdrawal by Subject|0|||
146778983|NCT01426412|529359621|FG002|Overall Study|Withdrawal by Subject|0|||
146778984|NCT01426412|529359622|FG003|Overall Study|Withdrawal by Subject|0|||
146778985|NCT01426412|529359623|FG004|Overall Study|Withdrawal by Subject|1|||
146778986|NCT01426412|529359624|FG005|Overall Study|Withdrawal by Subject|0|||
146778987|NCT01426412|529359625|FG006|Overall Study|Withdrawal by Subject|0|||
146778988|NCT01426412|529359626|FG007|Overall Study|Withdrawal by Subject|3|||
146778989|NCT01426412|529359627|FG008|Overall Study|Withdrawal by Subject|1|||
146778990|NCT02376790|529359629|FG000|Overall Study|Withdrawal by Subject|43|||
146778991|NCT02376790|529359630|FG001|Overall Study|Withdrawal by Subject|36|||
146778992|NCT02376790|529359631|FG002|Overall Study|Withdrawal by Subject|37|||
146778993|NCT02376790|529359629|FG000|Overall Study|Decision by Sponsor|2|||
146778994|NCT02376790|529359630|FG001|Overall Study|Decision by Sponsor|1|||
146778995|NCT02376790|529359631|FG002|Overall Study|Decision by Sponsor|4|||
146778996|NCT02376790|529359629|FG000|Overall Study|Lost to Follow-up|15|||
146778997|NCT02376790|529359630|FG001|Overall Study|Lost to Follow-up|10|||
146778998|NCT02376790|529359631|FG002|Overall Study|Lost to Follow-up|12|||
146778999|NCT03014453|529359632|FG000|Overall Study|Lost to Follow-up|12|||
146779000|NCT03014453|529359632|FG000|Overall Study|Discontinued GER|3|||
146779001|NCT03014453|529359632|FG000|Overall Study|Excluded|19|||
146779002|NCT03014453|529359632|FG000|Overall Study|Refused to take part in|37|||
146779003|NCT05450458|529359633|FG000|Overall Study|Lost to Follow-up|4|||
146779004|NCT02141074|529359638|FG000|Pre-prophylaxis|Adverse Event|3|||
146779005|NCT02141074|529359639|FG001|Pre-prophylaxis|Adverse Event|0|||
146779006|NCT02141074|529359638|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
146779007|NCT02141074|529359639|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
146779008|NCT02141074|529359638|FG000|Prophylaxis|Adverse Event|0|||
146779009|NCT02141074|529359639|FG001|Prophylaxis|Adverse Event|4|||
146779010|NCT02141074|529359638|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
146779011|NCT02141074|529359639|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
146779012|NCT02141074|529359638|FG000|Prophylaxis|Withdrawal by Subject|0|||
146779013|NCT02141074|529359639|FG001|Prophylaxis|Withdrawal by Subject|1|||
146779014|NCT03101930|529359642|FG000|Overall Study|Withdrawal by Subject|2|||
146779015|NCT03101930|529359643|FG001|Overall Study|Withdrawal by Subject|1|||
146779016|NCT03101930|529359644|FG002|Overall Study|Withdrawal by Subject|2|||
146779017|NCT00262301|529359645|FG000|Double-blind Phase|Lost to Follow-up|1|||
146779018|NCT00262301|529359646|FG001|Double-blind Phase|Lost to Follow-up|0|||
146779019|NCT00262301|529359647|FG002|Double-blind Phase|Lost to Follow-up|0|||
146779020|NCT00262301|529359645|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
146779021|NCT00262301|529359646|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
146779022|NCT00262301|529359647|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
146779023|NCT01017146|529359648|FG000|Overall Study|Adverse Event|11|||
146779024|NCT01017146|529359649|FG001|Overall Study|Adverse Event|1|||
146779025|NCT01017146|529359648|FG000|Overall Study|Lost to Follow-up|14|||
146779026|NCT01017146|529359649|FG001|Overall Study|Lost to Follow-up|14|||
146779027|NCT01017146|529359648|FG000|Overall Study|Noncompliance with Study Product|1|||
146779028|NCT01017146|529359649|FG001|Overall Study|Noncompliance with Study Product|1|||
146779029|NCT01017146|529359648|FG000|Overall Study|Withdrawal by Subject|32|||
146779030|NCT01017146|529359649|FG001|Overall Study|Withdrawal by Subject|16|||
146779031|NCT01017146|529359648|FG000|Overall Study|Relocation|0|||
146779032|NCT01017146|529359649|FG001|Overall Study|Relocation|4|||
146779033|NCT01017146|529359648|FG000|Overall Study|Pregnancy|2|||
146779034|NCT01017146|529359649|FG001|Overall Study|Pregnancy|1|||
146779035|NCT01017146|529359648|FG000|Overall Study|Protocol Violation|2|||
146779036|NCT01017146|529359649|FG001|Overall Study|Protocol Violation|0|||
146779037|NCT01017146|529359648|FG000|Overall Study|Took Excluded Medication|2|||
146779038|NCT01017146|529359649|FG001|Overall Study|Took Excluded Medication|0|||
146779039|NCT01017146|529359648|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
146779040|NCT01017146|529359649|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
146779041|NCT01017146|529359648|FG000|Overall Study|Change in Work Situation|1|||
146779042|NCT01017146|529359649|FG001|Overall Study|Change in Work Situation|0|||
146779043|NCT04048382|529359655|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
146779044|NCT04048382|529359656|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
146779045|NCT04048382|529359655|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
146779046|NCT04048382|529359656|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
146779047|NCT04048382|529359655|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
146779048|NCT04048382|529359656|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
146779049|NCT01227265|529359657|FG000|Overall Study|Did Not Receive Treatment|1|||
146779050|NCT01227265|529359658|FG001|Overall Study|Did Not Receive Treatment|2|||
146779051|NCT01227265|529359659|FG002|Overall Study|Did Not Receive Treatment|0|||
146779052|NCT01227265|529359657|FG000|Overall Study|Administrative|1|||
146779053|NCT01227265|529359658|FG001|Overall Study|Administrative|0|||
146779054|NCT01227265|529359659|FG002|Overall Study|Administrative|2|||
146779055|NCT01227265|529359657|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
146779056|NCT01227265|529359658|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
146779057|NCT01227265|529359659|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
146779058|NCT01227265|529359657|FG000|Overall Study|Protocol Violation|2|||
146779059|NCT01227265|529359658|FG001|Overall Study|Protocol Violation|1|||
146779060|NCT01227265|529359659|FG002|Overall Study|Protocol Violation|0|||
146779061|NCT01227265|529359657|FG000|Overall Study|Withdrawal by Subject|7|||
146779062|NCT01227265|529359658|FG001|Overall Study|Withdrawal by Subject|7|||
146779063|NCT01227265|529359659|FG002|Overall Study|Withdrawal by Subject|3|||
146779064|NCT01227265|529359657|FG000|Overall Study|Lost to Follow-up|2|||
146779065|NCT01227265|529359658|FG001|Overall Study|Lost to Follow-up|0|||
146779066|NCT01227265|529359659|FG002|Overall Study|Lost to Follow-up|3|||
146779067|NCT01227265|529359657|FG000|Overall Study|Adverse Event|6|||
146779068|NCT01227265|529359658|FG001|Overall Study|Adverse Event|10|||
146779069|NCT01227265|529359659|FG002|Overall Study|Adverse Event|5|||
146779070|NCT03481816|529359661|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
146779071|NCT03481816|529359662|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
146779072|NCT03481816|529359661|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
146779073|NCT03481816|529359662|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
146779074|NCT03481816|529359661|FG000|Dose Expansion|Withdrawal by Subject|0|||
146779075|NCT03481816|529359662|FG001|Dose Expansion|Withdrawal by Subject|2|||
146779076|NCT03481816|529359661|FG000|Dose Expansion|Physician Decision|0|||
146779077|NCT03481816|529359662|FG001|Dose Expansion|Physician Decision|5|||
146779078|NCT02269475|529359663|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
146779079|NCT02269475|529359664|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
146779080|NCT02269475|529359663|FG000|Overall Study|Withdrawal by Subject|0|||
146779081|NCT02269475|529359664|FG001|Overall Study|Withdrawal by Subject|1|||
146779082|NCT05368558|529359669|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
146779083|NCT05368558|529359670|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
146779084|NCT05368558|529359671|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
146779085|NCT05368558|529359672|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146779086|NCT05368558|529359673|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146779087|NCT05368558|529359674|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146779088|NCT05368558|529359675|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146779089|NCT05368558|529359676|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146779090|NCT05368558|529359677|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146779091|NCT05368558|529359678|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146710655|NCT01975389|529113255|FG000|Overall Study|Randomized, not treated|4|||
146710656|NCT01975389|529113256|FG001|Overall Study|Randomized, not treated|5|||
146710657|NCT02127307|529113257|FG000|Overall Study|Protocol Violation|36|||
146710658|NCT02127307|529113257|FG000|Overall Study|Lost to Follow-up|2|||
146710659|NCT02127307|529113257|FG000|Overall Study|Death|101|||
146710660|NCT02127307|529113257|FG000|Overall Study|Other than specified above|169|||
146710661|NCT01312961|529113258|FG000|Overall Study|Adverse Event|3|||
146710662|NCT01312961|529113259|FG001|Overall Study|Adverse Event|3|||
146710663|NCT01312961|529113258|FG000|Overall Study|Lack of Efficacy|11|||
146710664|NCT01312961|529113259|FG001|Overall Study|Lack of Efficacy|1|||
146710665|NCT01312961|529113258|FG000|Overall Study|Poor compliance to protocol|1|||
146710666|NCT01312961|529113259|FG001|Overall Study|Poor compliance to protocol|0|||
146710667|NCT01312961|529113258|FG000|Overall Study|Other than specified above|2|||
146710668|NCT01312961|529113259|FG001|Overall Study|Other than specified above|3|||
146710669|NCT04187196|529113262|FG000|Overall Study|Screen Failure|2|||
146710670|NCT04187196|529113263|FG001|Overall Study|Screen Failure|0|||
146710671|NCT00183872|529113264|FG000|Overall Study|Death|3|||
146710672|NCT00183872|529113264|FG000|Overall Study|Adverse Event|9|||
146710673|NCT00183872|529113264|FG000|Overall Study|Withdrawal by Subject|2|||
146710674|NCT00183872|529113264|FG000|Overall Study|Drug delayed more than 28 days|2|||
146710675|NCT00595582|529113265|FG000|Overall Study|Pilot study that PI terminated|2|||
146710676|NCT00595582|529113265|FG000|Overall Study|Lost to Follow-up|1|||
146710677|NCT00595582|529113265|FG000|Overall Study|Adverse Event|2|||
146710678|NCT00595582|529113265|FG000|Overall Study|Physician Decision|5|||
146710679|NCT02797262|529113266|FG000|Overall Study|Withdrawal by Subject|5|||
146710680|NCT02797262|529113267|FG001|Overall Study|Withdrawal by Subject|1|||
146710681|NCT02797262|529113266|FG000|Overall Study|Lost to Follow-up|10|||
146710682|NCT02797262|529113267|FG001|Overall Study|Lost to Follow-up|7|||
146710683|NCT02797262|529113266|FG000|Overall Study|Death|1|||
146710684|NCT02797262|529113267|FG001|Overall Study|Death|2|||
146710685|NCT02797262|529113266|FG000|Overall Study|Adverse Event|1|||
146710686|NCT02797262|529113267|FG001|Overall Study|Adverse Event|0|||
146710687|NCT02797262|529113266|FG000|Overall Study|COVID-19|2|||
146710688|NCT02797262|529113267|FG001|Overall Study|COVID-19|1|||
146710689|NCT02797262|529113266|FG000|Overall Study|Out-of-country|1|||
146710690|NCT02797262|529113267|FG001|Overall Study|Out-of-country|0|||
146710691|NCT01600586|529113268|FG000|Overall Study|Physician Decision|3|||
146710692|NCT01600586|529113269|FG001|Overall Study|Physician Decision|3|||
146710693|NCT01978184|529113271|FG000|Overall Study|Progressive disease|5|||
146710694|NCT01978184|529113272|FG001|Overall Study|Progressive disease|5|||
146710695|NCT01978184|529113271|FG000|Overall Study|Other than PDA|2|||
146710696|NCT01978184|529113272|FG001|Overall Study|Other than PDA|2|||
146710697|NCT01978184|529113271|FG000|Overall Study|Physician Decision|0|||
146710698|NCT01978184|529113272|FG001|Overall Study|Physician Decision|3|||
146710699|NCT01978184|529113271|FG000|Overall Study|Noncompliance|1|||
146710700|NCT01978184|529113272|FG001|Overall Study|Noncompliance|2|||
146710701|NCT01978184|529113271|FG000|Overall Study|Death|1|||
146710702|NCT01978184|529113272|FG001|Overall Study|Death|0|||
146779092|NCT05368558|529359679|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146779093|NCT05368558|529359680|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146779094|NCT05368558|529359669|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146779095|NCT05368558|529359670|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146779096|NCT05368558|529359671|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146779097|NCT05368558|529359672|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
146779098|NCT05368558|529359673|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146710703|NCT01978184|529113271|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
146710704|NCT01978184|529113272|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
146710705|NCT02460198|529113273|FG000|Overall Study|Adverse Event|1|||
146710706|NCT02460198|529113274|FG001|Overall Study|Adverse Event|3|||
146710707|NCT02460198|529113273|FG000|Overall Study|Death|36|||
146710708|NCT02460198|529113274|FG001|Overall Study|Death|28|||
146710709|NCT02460198|529113273|FG000|Overall Study|Lost to Follow-up|1|||
146710710|NCT02460198|529113274|FG001|Overall Study|Lost to Follow-up|1|||
146710711|NCT02460198|529113273|FG000|Overall Study|Transferred to Extension Study|15|||
146710712|NCT02460198|529113274|FG001|Overall Study|Transferred to Extension Study|15|||
146710713|NCT02460198|529113273|FG000|Overall Study|Withdrawal by Subject|2|||
146710714|NCT02460198|529113274|FG001|Overall Study|Withdrawal by Subject|4|||
146710715|NCT02460198|529113273|FG000|Overall Study|Site Terminated By Sponsor|0|||
146710716|NCT02460198|529113274|FG001|Overall Study|Site Terminated By Sponsor|1|||
146710717|NCT02460198|529113273|FG000|Overall Study|Did Not Continue on Extension Study|6|||
146710718|NCT02460198|529113274|FG001|Overall Study|Did Not Continue on Extension Study|11|||
146710719|NCT00931307|529113275|FG000|Overall Study|Lack of Efficacy|12|||
146710720|NCT00931307|529113275|FG000|Overall Study|Biomicroscopy|1|||
146710721|NCT00691210|529113276|FG000|Overall Study|Progression of Disease|0|||
146710722|NCT00691210|529113277|FG001|Overall Study|Progression of Disease|0|||
146710723|NCT00691210|529113278|FG002|Overall Study|Progression of Disease|0|||
146710724|NCT00691210|529113279|FG003|Overall Study|Progression of Disease|2|||
146710725|NCT00691210|529113280|FG004|Overall Study|Progression of Disease|0|||
146710726|NCT00691210|529113281|FG005|Overall Study|Progression of Disease|0|||
146710727|NCT00691210|529113282|FG006|Overall Study|Progression of Disease|0|||
146710728|NCT00691210|529113283|FG007|Overall Study|Progression of Disease|0|||
146710729|NCT00691210|529113276|FG000|Overall Study|Lack of Efficacy|0|||
146710730|NCT00691210|529113277|FG001|Overall Study|Lack of Efficacy|0|||
146710731|NCT00691210|529113278|FG002|Overall Study|Lack of Efficacy|0|||
146710732|NCT00691210|529113279|FG003|Overall Study|Lack of Efficacy|1|||
146710733|NCT00691210|529113280|FG004|Overall Study|Lack of Efficacy|0|||
146710734|NCT00691210|529113281|FG005|Overall Study|Lack of Efficacy|1|||
146710735|NCT00691210|529113282|FG006|Overall Study|Lack of Efficacy|0|||
146710736|NCT00691210|529113283|FG007|Overall Study|Lack of Efficacy|0|||
146710737|NCT01208233|529113284|FG000|Overall Study|Adverse Event|0|||
146710738|NCT01208233|529113285|FG001|Overall Study|Adverse Event|1|||
146710739|NCT01208233|529113286|FG002|Overall Study|Adverse Event|2|||
146710740|NCT01208233|529113287|FG003|Overall Study|Adverse Event|0|||
146710741|NCT01208233|529113288|FG004|Overall Study|Adverse Event|3|||
146710742|NCT01208233|529113289|FG005|Overall Study|Adverse Event|5|||
146710743|NCT01208233|529113284|FG000|Overall Study|Death|0|||
146710744|NCT01208233|529113285|FG001|Overall Study|Death|0|||
146710745|NCT01208233|529113286|FG002|Overall Study|Death|0|||
146710746|NCT01208233|529113287|FG003|Overall Study|Death|0|||
146710747|NCT01208233|529113288|FG004|Overall Study|Death|3|||
146710748|NCT01208233|529113289|FG005|Overall Study|Death|5|||
146710749|NCT01208233|529113284|FG000|Overall Study|Did not meet entrance criteria|2|||
146710750|NCT01208233|529113285|FG001|Overall Study|Did not meet entrance criteria|1|||
146710751|NCT01208233|529113286|FG002|Overall Study|Did not meet entrance criteria|1|||
146710752|NCT01208233|529113287|FG003|Overall Study|Did not meet entrance criteria|0|||
146710753|NCT01208233|529113288|FG004|Overall Study|Did not meet entrance criteria|1|||
146710754|NCT01208233|529113289|FG005|Overall Study|Did not meet entrance criteria|0|||
146710755|NCT01208233|529113284|FG000|Overall Study|Medication error without adverse event|0|||
146710756|NCT01208233|529113285|FG001|Overall Study|Medication error without adverse event|0|||
146710757|NCT01208233|529113286|FG002|Overall Study|Medication error without adverse event|0|||
146710758|NCT01208233|529113287|FG003|Overall Study|Medication error without adverse event|0|||
146710759|NCT01208233|529113288|FG004|Overall Study|Medication error without adverse event|0|||
146710760|NCT01208233|529113289|FG005|Overall Study|Medication error without adverse event|1|||
146710761|NCT01208233|529113284|FG000|Overall Study|Study terminated by sponsor|0|||
146710762|NCT01208233|529113285|FG001|Overall Study|Study terminated by sponsor|0|||
146710763|NCT01208233|529113286|FG002|Overall Study|Study terminated by sponsor|0|||
146710764|NCT01208233|529113287|FG003|Overall Study|Study terminated by sponsor|0|||
146710765|NCT01208233|529113288|FG004|Overall Study|Study terminated by sponsor|10|||
146710766|NCT01208233|529113289|FG005|Overall Study|Study terminated by sponsor|7|||
146710767|NCT01208233|529113284|FG000|Overall Study|Protocol Violation|0|||
146710768|NCT01208233|529113285|FG001|Overall Study|Protocol Violation|0|||
146710769|NCT01208233|529113286|FG002|Overall Study|Protocol Violation|0|||
146710770|NCT01208233|529113287|FG003|Overall Study|Protocol Violation|0|||
146710771|NCT01208233|529113288|FG004|Overall Study|Protocol Violation|3|||
146710772|NCT01208233|529113289|FG005|Overall Study|Protocol Violation|0|||
146710773|NCT01208233|529113284|FG000|Overall Study|Other|2|||
146710774|NCT01208233|529113285|FG001|Overall Study|Other|1|||
146710775|NCT01208233|529113286|FG002|Overall Study|Other|0|||
146710776|NCT01208233|529113287|FG003|Overall Study|Other|0|||
146710777|NCT01208233|529113288|FG004|Overall Study|Other|0|||
146710778|NCT01208233|529113289|FG005|Overall Study|Other|1|||
146710779|NCT01208233|529113284|FG000|Overall Study|Withdrawal by Subject|1|||
146779099|NCT05368558|529359674|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
146933880|NCT01335698|529916015|FG003|Treatment Stage 1|Adverse Event|1|||
146710780|NCT01208233|529113285|FG001|Overall Study|Withdrawal by Subject|0|||
146710781|NCT01208233|529113286|FG002|Overall Study|Withdrawal by Subject|1|||
146710782|NCT01208233|529113287|FG003|Overall Study|Withdrawal by Subject|1|||
146710783|NCT01208233|529113288|FG004|Overall Study|Withdrawal by Subject|4|||
146710784|NCT01208233|529113289|FG005|Overall Study|Withdrawal by Subject|2|||
146710785|NCT01181895|529113290|FG000|Overall Study|Adverse Event|3|||
146710786|NCT01181895|529113291|FG001|Overall Study|Adverse Event|1|||
146710787|NCT01181895|529113292|FG002|Overall Study|Adverse Event|1|||
146710788|NCT01181895|529113290|FG000|Overall Study|Lack of Efficacy|8|||
146779100|NCT05368558|529359675|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146779101|NCT05368558|529359676|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146779102|NCT05368558|529359677|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146779103|NCT05368558|529359678|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146779104|NCT05368558|529359679|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146779105|NCT05368558|529359680|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146779106|NCT05368558|529359669|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146779107|NCT05368558|529359670|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146779108|NCT05368558|529359671|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146779109|NCT05368558|529359672|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
146779110|NCT05368558|529359673|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146779111|NCT05368558|529359674|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146779112|NCT05368558|529359675|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146779113|NCT05368558|529359676|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146779114|NCT05368558|529359677|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146779115|NCT05368558|529359678|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146779116|NCT05368558|529359679|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146779117|NCT05368558|529359680|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146779118|NCT05368558|529359669|FG000|Blinded Extension Period (BEP)|other|0|||
146779119|NCT05368558|529359670|FG001|Blinded Extension Period (BEP)|other|0|||
146779120|NCT05368558|529359671|FG002|Blinded Extension Period (BEP)|other|0|||
146779121|NCT05368558|529359672|FG003|Blinded Extension Period (BEP)|other|0|||
146779122|NCT05368558|529359673|FG004|Blinded Extension Period (BEP)|other|0|||
146779123|NCT05368558|529359674|FG005|Blinded Extension Period (BEP)|other|1|||
146779124|NCT05368558|529359675|FG006|Blinded Extension Period (BEP)|other|0|||
146779125|NCT05368558|529359676|FG007|Blinded Extension Period (BEP)|other|0|||
146779126|NCT05368558|529359677|FG008|Blinded Extension Period (BEP)|other|0|||
146779127|NCT05368558|529359678|FG009|Blinded Extension Period (BEP)|other|0|||
146779128|NCT05368558|529359679|FG010|Blinded Extension Period (BEP)|other|0|||
146779129|NCT05368558|529359680|FG011|Blinded Extension Period (BEP)|other|0|||
146779130|NCT04994509|529359681|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
146779131|NCT04994509|529359682|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
146779132|NCT04994509|529359683|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
146779133|NCT04994509|529359681|FG000|Overall Study|Withdrew Consent|73|||
146779134|NCT04994509|529359682|FG001|Overall Study|Withdrew Consent|72|||
146779135|NCT04994509|529359683|FG002|Overall Study|Withdrew Consent|46|||
146779136|NCT04994509|529359681|FG000|Overall Study|Lost to Follow-up|39|||
146779137|NCT04994509|529359682|FG001|Overall Study|Lost to Follow-up|36|||
146779138|NCT04994509|529359683|FG002|Overall Study|Lost to Follow-up|26|||
146779139|NCT04994509|529359681|FG000|Overall Study|HIV-1 Infection|4|||
146779140|NCT04994509|529359682|FG001|Overall Study|HIV-1 Infection|20|||
146779141|NCT04994509|529359683|FG002|Overall Study|HIV-1 Infection|12|||
146779142|NCT04994509|529359681|FG000|Overall Study|Investigator's Discretion|9|||
146779143|NCT04994509|529359682|FG001|Overall Study|Investigator's Discretion|8|||
146779144|NCT04994509|529359683|FG002|Overall Study|Investigator's Discretion|11|||
146779145|NCT04994509|529359681|FG000|Overall Study|Randomized but Never Treated|10|||
146779146|NCT04994509|529359682|FG001|Overall Study|Randomized but Never Treated|10|||
146779147|NCT04994509|529359683|FG002|Overall Study|Randomized but Never Treated|3|||
146779148|NCT04994509|529359681|FG000|Overall Study|Pregnancy|5|||
146779149|NCT04994509|529359682|FG001|Overall Study|Pregnancy|5|||
146779150|NCT04994509|529359683|FG002|Overall Study|Pregnancy|0|||
146779151|NCT04994509|529359681|FG000|Overall Study|Death|0|||
146779152|NCT04994509|529359682|FG001|Overall Study|Death|5|||
146779153|NCT04994509|529359683|FG002|Overall Study|Death|0|||
146779154|NCT04994509|529359681|FG000|Overall Study|Adverse Event|2|||
146779155|NCT04994509|529359682|FG001|Overall Study|Adverse Event|1|||
146779156|NCT04994509|529359683|FG002|Overall Study|Adverse Event|0|||
146779157|NCT04994509|529359681|FG000|Overall Study|Non-compliance With Study Drug|1|||
146779158|NCT04994509|529359682|FG001|Overall Study|Non-compliance With Study Drug|1|||
146779159|NCT04994509|529359683|FG002|Overall Study|Non-compliance With Study Drug|1|||
146779160|NCT04994509|529359681|FG000|Overall Study|Withdrew Assent|3|||
146779161|NCT04994509|529359682|FG001|Overall Study|Withdrew Assent|0|||
146779162|NCT04994509|529359683|FG002|Overall Study|Withdrew Assent|0|||
146779163|NCT04994509|529359681|FG000|Overall Study|Protocol Violation|1|||
146779164|NCT04994509|529359682|FG001|Overall Study|Protocol Violation|0|||
146779165|NCT04994509|529359683|FG002|Overall Study|Protocol Violation|0|||
146779166|NCT04402294|529359685|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
146779167|NCT04402294|529359686|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
146779168|NCT04402294|529359685|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
146779169|NCT04402294|529359686|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
146779170|NCT04459416|529361503|FG000|Overall Study|Lost to Follow-up|2|||
146710789|NCT01181895|529113291|FG001|Overall Study|Lack of Efficacy|9|||
146710790|NCT01181895|529113292|FG002|Overall Study|Lack of Efficacy|9|||
146710791|NCT01181895|529113290|FG000|Overall Study|Protocol Violation|2|||
146710792|NCT01181895|529113291|FG001|Overall Study|Protocol Violation|1|||
146710793|NCT01181895|529113292|FG002|Overall Study|Protocol Violation|0|||
146710794|NCT01181895|529113290|FG000|Overall Study|Lost to Follow-up|0|||
146710795|NCT01181895|529113291|FG001|Overall Study|Lost to Follow-up|1|||
146710796|NCT01181895|529113292|FG002|Overall Study|Lost to Follow-up|2|||
146710797|NCT01181895|529113290|FG000|Overall Study|Investigator Discretion|1|||
146710798|NCT01181895|529113291|FG001|Overall Study|Investigator Discretion|2|||
146710799|NCT01181895|529113292|FG002|Overall Study|Investigator Discretion|1|||
146710800|NCT01181895|529113290|FG000|Overall Study|Withdrawal by Subject|3|||
146710801|NCT01181895|529113291|FG001|Overall Study|Withdrawal by Subject|0|||
146710802|NCT01181895|529113292|FG002|Overall Study|Withdrawal by Subject|5|||
146710803|NCT00555438|529113293|FG000|10 Days Post-operative|Death|4|||
146710804|NCT00555438|529113293|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
146710805|NCT02758236|529113296|FG000|Overall Study|Investigator discretion|43|||
146710806|NCT00023452|529113297|FG000|Overall Study|Ineligible for Study|163|||
146710807|NCT00023452|529113298|FG001|Overall Study|Ineligible for Study|159|||
146710808|NCT00023452|529113297|FG000|Overall Study|Out of Window|129|||
146710809|NCT00023452|529113298|FG001|Overall Study|Out of Window|69|||
146710810|NCT00023452|529113297|FG000|Overall Study|Death|2|||
146710811|NCT00023452|529113298|FG001|Overall Study|Death|0|||
146710812|NCT00023452|529113297|FG000|Overall Study|Withdrawal by Subject|66|||
146710813|NCT00023452|529113298|FG001|Overall Study|Withdrawal by Subject|54|||
146710814|NCT00023452|529113297|FG000|Overall Study|Adverse Event|139|||
146710815|NCT00023452|529113298|FG001|Overall Study|Adverse Event|196|||
146710816|NCT00023452|529113297|FG000|Overall Study|Lost to Follow-up|293|||
146710817|NCT00023452|529113298|FG001|Overall Study|Lost to Follow-up|60|||
146710818|NCT00023452|529113297|FG000|Overall Study|Physician Decision|49|||
146710819|NCT00023452|529113298|FG001|Overall Study|Physician Decision|21|||
146710820|NCT00023452|529113297|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
146710821|NCT00023452|529113298|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
146710822|NCT00023452|529113297|FG000|Overall Study|Pregnant|53|||
146710823|NCT00023452|529113298|FG001|Overall Study|Pregnant|20|||
146710824|NCT00023452|529113297|FG000|Overall Study|Other|204|||
146710825|NCT00023452|529113298|FG001|Overall Study|Other|69|||
146710826|NCT01940705|529113300|FG000|Overall Study|Lost to Follow-up|1|||
146710827|NCT01940705|529113301|FG001|Overall Study|Lost to Follow-up|3|||
146710828|NCT01940705|529113302|FG002|Overall Study|Lost to Follow-up|2|||
146710829|NCT01940705|529113303|FG003|Overall Study|Lost to Follow-up|2|||
146710830|NCT01940705|529113300|FG000|Overall Study|Withdrawal by Subject|2|||
146710831|NCT01940705|529113301|FG001|Overall Study|Withdrawal by Subject|2|||
146710832|NCT01940705|529113302|FG002|Overall Study|Withdrawal by Subject|3|||
146710833|NCT01940705|529113303|FG003|Overall Study|Withdrawal by Subject|2|||
146710834|NCT01940705|529113300|FG000|Overall Study|Intervention not given|0|||
146710835|NCT01940705|529113301|FG001|Overall Study|Intervention not given|3|||
146710836|NCT01940705|529113302|FG002|Overall Study|Intervention not given|3|||
146710837|NCT01940705|529113303|FG003|Overall Study|Intervention not given|0|||
146710838|NCT01940705|529113300|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
146710839|NCT01940705|529113301|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
146710840|NCT01940705|529113302|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
146710841|NCT01940705|529113303|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
146710842|NCT02447991|529113304|FG000|Overall Study|Withdrawn by subject - no data|0|||
146710843|NCT02447991|529113305|FG001|Overall Study|Withdrawn by subject - no data|2|||
146710844|NCT02447991|529113304|FG000|Overall Study|Withdrawn by Subject - with data|4|||
146710845|NCT02447991|529113305|FG001|Overall Study|Withdrawn by Subject - with data|4|||
146710846|NCT02447991|529113304|FG000|Overall Study|Lost to Follow-up - no data|3|||
146710847|NCT02447991|529113305|FG001|Overall Study|Lost to Follow-up - no data|6|||
146710848|NCT02447991|529113304|FG000|Overall Study|Lost to follow-up - with data|0|||
146933881|NCT01335698|529916016|FG004|Treatment Stage 1|Adverse Event|1|||
146933882|NCT01335698|529916012|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
146933883|NCT01335698|529916013|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
146710849|NCT02447991|529113305|FG001|Overall Study|Lost to follow-up - with data|3|||
146710850|NCT02447991|529113304|FG000|Overall Study|End of study - no treatment results|3|||
146710851|NCT02447991|529113305|FG001|Overall Study|End of study - no treatment results|6|||
146710852|NCT02447991|529113304|FG000|Overall Study|End of study - partial treatment results|0|||
146710853|NCT02447991|529113305|FG001|Overall Study|End of study - partial treatment results|9|||
146710854|NCT02770391|529113312|FG000|Overall Study|Lost to Follow-up|2|||
146710855|NCT02770391|529113312|FG000|Overall Study|Withdrawal by Subject|1|||
146710856|NCT02770391|529113312|FG000|Overall Study|Surgery delayed unevaluable|2|||
146710857|NCT02770391|529113312|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
146710858|NCT03136068|529115151|FG000|Overall Study|Lost to Follow-up|1|||
146710859|NCT03136068|529115152|FG001|Overall Study|Lost to Follow-up|1|||
146710860|NCT03136068|529115151|FG000|Overall Study|Protocol Violation|1|||
146933884|NCT01335698|529916014|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
146779171|NCT04459416|529361504|FG001|Overall Study|Lost to Follow-up|0|||
146779172|NCT04459416|529361503|FG000|Overall Study|Withdrawal by Subject|8|||
146779173|NCT04459416|529361504|FG001|Overall Study|Withdrawal by Subject|10|||
146779174|NCT04459416|529361503|FG000|Overall Study|Disease progression|0|||
146779175|NCT04459416|529361504|FG001|Overall Study|Disease progression|3|||
146779176|NCT03744312|529361505|FG000|Overall Study|Withdrawal by Subject|0|||
146779177|NCT03744312|529361506|FG001|Overall Study|Withdrawal by Subject|1|||
146779178|NCT03744312|529361505|FG000|Overall Study|Screen fail|0|||
146779179|NCT03744312|529361506|FG001|Overall Study|Screen fail|1|||
146779180|NCT04579380|529361507|FG000|Overall Study|Death|9|||
146779181|NCT04579380|529361508|FG001|Overall Study|Death|22|||
146779182|NCT04579380|529361509|FG002|Overall Study|Death|22|||
146779183|NCT04579380|529361510|FG003|Overall Study|Death|17|||
146779184|NCT04579380|529361511|FG004|Overall Study|Death|6|||
146779185|NCT04579380|529361512|FG005|Overall Study|Death|21|||
146779186|NCT04579380|529361513|FG006|Overall Study|Death|10|||
146779187|NCT04579380|529361514|FG007|Overall Study|Death|11|||
146779188|NCT04579380|529361515|FG008|Overall Study|Death|25|||
146779189|NCT04579380|529361507|FG000|Overall Study|Withdrawal by Subject|0|||
146779190|NCT04579380|529361508|FG001|Overall Study|Withdrawal by Subject|3|||
146779191|NCT04579380|529361509|FG002|Overall Study|Withdrawal by Subject|4|||
146779192|NCT04579380|529361510|FG003|Overall Study|Withdrawal by Subject|0|||
146779193|NCT04579380|529361511|FG004|Overall Study|Withdrawal by Subject|1|||
146779194|NCT04579380|529361512|FG005|Overall Study|Withdrawal by Subject|2|||
146779195|NCT04579380|529361513|FG006|Overall Study|Withdrawal by Subject|0|||
146779196|NCT04579380|529361514|FG007|Overall Study|Withdrawal by Subject|1|||
146779197|NCT04579380|529361515|FG008|Overall Study|Withdrawal by Subject|2|||
146779198|NCT04579380|529361507|FG000|Overall Study|Ongoing|2|||
146779199|NCT04579380|529361508|FG001|Overall Study|Ongoing|6|||
146779200|NCT04579380|529361509|FG002|Overall Study|Ongoing|4|||
146779201|NCT04579380|529361510|FG003|Overall Study|Ongoing|8|||
146779202|NCT04579380|529361511|FG004|Overall Study|Ongoing|5|||
146779203|NCT04579380|529361512|FG005|Overall Study|Ongoing|8|||
146779204|NCT04579380|529361513|FG006|Overall Study|Ongoing|3|||
146779205|NCT04579380|529361514|FG007|Overall Study|Ongoing|19|||
146779206|NCT04579380|529361515|FG008|Overall Study|Ongoing|6|||
146779207|NCT03821844|529361516|FG000|Overall Study|Death|37|||
146779208|NCT03821844|529361517|FG001|Overall Study|Death|31|||
146779209|NCT03821844|529361516|FG000|Overall Study|Discharged|10|||
146779210|NCT03821844|529361517|FG001|Overall Study|Discharged|14|||
146779211|NCT03821844|529361516|FG000|Overall Study|Not present in facility at followup|2|||
146779212|NCT03821844|529361517|FG001|Overall Study|Not present in facility at followup|3|||
146779213|NCT03913195|529361518|FG000|Overall Study|Adverse Event|0|||
146779214|NCT03913195|529361519|FG001|Overall Study|Adverse Event|0|||
146779215|NCT03913195|529361520|FG002|Overall Study|Adverse Event|1|||
146779216|NCT03913195|529361521|FG003|Overall Study|Adverse Event|1|||
146779217|NCT03913195|529361522|FG004|Overall Study|Adverse Event|0|||
146779218|NCT03913195|529361518|FG000|Overall Study|Withdrawal by Subject|0|||
146779219|NCT03913195|529361519|FG001|Overall Study|Withdrawal by Subject|0|||
146779220|NCT03913195|529361520|FG002|Overall Study|Withdrawal by Subject|1|||
146779221|NCT03913195|529361521|FG003|Overall Study|Withdrawal by Subject|0|||
146779222|NCT03913195|529361522|FG004|Overall Study|Withdrawal by Subject|1|||
146779223|NCT03913195|529361518|FG000|Overall Study|non adherence to study|0|||
146779224|NCT03913195|529361519|FG001|Overall Study|non adherence to study|0|||
146779225|NCT03913195|529361520|FG002|Overall Study|non adherence to study|1|||
146779226|NCT03913195|529361521|FG003|Overall Study|non adherence to study|0|||
146779227|NCT03913195|529361522|FG004|Overall Study|non adherence to study|0|||
146779228|NCT05307978|529361523|FG000|Overall Study|Lost to Follow-up|0|||
146779229|NCT05307978|529361524|FG001|Overall Study|Lost to Follow-up|1|||
146933885|NCT01335698|529916015|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
146933886|NCT01335698|529916016|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
146933887|NCT01335698|529916012|FG000|Treatment Stage 1|Lost to Follow-up|1|||
146933888|NCT01335698|529916013|FG001|Treatment Stage 1|Lost to Follow-up|1|||
146933889|NCT01335698|529916014|FG002|Treatment Stage 1|Lost to Follow-up|0|||
146933890|NCT01335698|529916015|FG003|Treatment Stage 1|Lost to Follow-up|0|||
146933891|NCT01335698|529916016|FG004|Treatment Stage 1|Lost to Follow-up|0|||
146933892|NCT01335698|529916012|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
146779230|NCT05307978|529361525|FG002|Overall Study|Lost to Follow-up|0|||
146779231|NCT05307978|529361526|FG003|Overall Study|Lost to Follow-up|4|||
146779232|NCT05307978|529361527|FG004|Overall Study|Lost to Follow-up|0|||
146779233|NCT05307978|529361528|FG005|Overall Study|Lost to Follow-up|0|||
146779234|NCT05307978|529361529|FG006|Overall Study|Lost to Follow-up|1|||
146779235|NCT04855760|529361532|FG000|Overall Study|Adverse Event|21|||
146779236|NCT04855760|529361532|FG000|Overall Study|Withdrawal by Subject|116|||
146779237|NCT04855760|529361532|FG000|Overall Study|Lack of Efficacy|21|||
146779238|NCT04855760|529361532|FG000|Overall Study|Lost to Follow-up|49|||
146779239|NCT04855760|529361532|FG000|Overall Study|Protocol Violation|2|||
146779240|NCT04855760|529361532|FG000|Overall Study|Physician Decision|5|||
146779241|NCT04855760|529361532|FG000|Overall Study|Pregnancy|1|||
146779242|NCT04855760|529361532|FG000|Overall Study|Non-Compliance with Study Drug|11|||
146710861|NCT03136068|529115152|FG001|Overall Study|Protocol Violation|0|||
146710862|NCT01337089|529115155|FG000|Overall Study|Adverse Event|237|||
146710863|NCT01337089|529115155|FG000|Overall Study|Withdrawal by Subject|129|||
146710864|NCT01337089|529115155|FG000|Overall Study|Withdrawal by Investigator|33|||
146710865|NCT01337089|529115155|FG000|Overall Study|Met Withdrawal Criteria|3|||
146710866|NCT01337089|529115155|FG000|Overall Study|Lost to Follow-up|2|||
146710867|NCT04419493|529115156|FG000|Wash-out After Period 1|Adverse Event|1|||
146710868|NCT04419493|529115157|FG001|Wash-out After Period 1|Adverse Event|2|||
146710869|NCT04419493|529115158|FG002|Wash-out After Period 1|Adverse Event|1|||
146710870|NCT04419493|529115159|FG003|Wash-out After Period 1|Adverse Event|0|||
146710871|NCT00524134|529115160|FG000|Overall Study|Withdrawal by Subject|1|||
146710872|NCT00524134|529115160|FG000|Overall Study|Physician Decision|1|||
146710873|NCT01782131|529115161|FG000|Overall Study|Death|93|||
146710874|NCT01782131|529115162|FG001|Overall Study|Death|96|||
146710875|NCT01782131|529115161|FG000|Overall Study|Lost to Follow-up|1|||
146710876|NCT01782131|529115162|FG001|Overall Study|Lost to Follow-up|3|||
146710877|NCT01782131|529115161|FG000|Overall Study|Withdrawal by Subject|10|||
146710878|NCT01782131|529115162|FG001|Overall Study|Withdrawal by Subject|10|||
146710879|NCT01782131|529115161|FG000|Overall Study|Randomized but not treated|5|||
146710880|NCT01782131|529115162|FG001|Overall Study|Randomized but not treated|5|||
146710881|NCT01782131|529115161|FG000|Overall Study|Reason not provided|0|||
146710882|NCT01782131|529115162|FG001|Overall Study|Reason not provided|1|||
146710883|NCT00796718|529115163|FG000|Overall Study|Adverse Event|2|||
146710884|NCT00796718|529115163|FG000|Overall Study|Exclusion Criteria|1|||
146710885|NCT00796718|529115163|FG000|Overall Study|Lost to Follow-up|5|||
146710886|NCT00796718|529115163|FG000|Overall Study|Withdrawal by Informed Consent|1|||
146710887|NCT02627677|529115165|FG000|Overall Study|Adverse event (not progressive disease)|1|||
146710888|NCT02627677|529115166|FG001|Overall Study|Adverse event (not progressive disease)|4|||
146710889|NCT02627677|529115167|FG002|Overall Study|Adverse event (not progressive disease)|1|||
146710890|NCT02627677|529115165|FG000|Overall Study|Progressive disease|1|||
146710891|NCT02627677|529115166|FG001|Overall Study|Progressive disease|3|||
146710892|NCT02627677|529115167|FG002|Overall Study|Progressive disease|0|||
146710893|NCT02627677|529115165|FG000|Overall Study|Lack of Efficacy|1|||
146710894|NCT02627677|529115166|FG001|Overall Study|Lack of Efficacy|2|||
146710895|NCT02627677|529115167|FG002|Overall Study|Lack of Efficacy|0|||
146710896|NCT02627677|529115165|FG000|Overall Study|Lost to Follow-up|0|||
146710897|NCT02627677|529115166|FG001|Overall Study|Lost to Follow-up|0|||
146710898|NCT02627677|529115167|FG002|Overall Study|Lost to Follow-up|1|||
146710899|NCT02627677|529115165|FG000|Overall Study|Pregnancy|0|||
146710900|NCT02627677|529115166|FG001|Overall Study|Pregnancy|1|||
146710901|NCT02627677|529115167|FG002|Overall Study|Pregnancy|0|||
146710902|NCT02627677|529115165|FG000|Overall Study|Study Terminated by Sponsor|5|||
146710903|NCT02627677|529115166|FG001|Overall Study|Study Terminated by Sponsor|10|||
146710904|NCT02627677|529115167|FG002|Overall Study|Study Terminated by Sponsor|6|||
146710905|NCT02627677|529115165|FG000|Overall Study|Physician Decision|0|||
146710906|NCT02627677|529115166|FG001|Overall Study|Physician Decision|0|||
146710907|NCT02627677|529115167|FG002|Overall Study|Physician Decision|2|||
146710908|NCT02627677|529115165|FG000|Overall Study|Withdrawal by Subject|2|||
146710909|NCT02627677|529115166|FG001|Overall Study|Withdrawal by Subject|1|||
146710910|NCT02627677|529115167|FG002|Overall Study|Withdrawal by Subject|1|||
146710911|NCT02627677|529115165|FG000|Overall Study|Reason not Specified|0|||
146710912|NCT02627677|529115166|FG001|Overall Study|Reason not Specified|0|||
146710913|NCT02627677|529115167|FG002|Overall Study|Reason not Specified|1|||
146710914|NCT02627677|529115165|FG000|Overall Study|Randomized but not Treated|1|||
146710915|NCT02627677|529115166|FG001|Overall Study|Randomized but not Treated|0|||
146710916|NCT02627677|529115167|FG002|Overall Study|Randomized but not Treated|0|||
146710917|NCT00317772|529115168|FG000|Overall Study|Adverse Event|0|||
146710918|NCT00317772|529115169|FG001|Overall Study|Adverse Event|0|||
146710919|NCT00317772|529115170|FG002|Overall Study|Adverse Event|0|||
146710920|NCT00317772|529115171|FG003|Overall Study|Adverse Event|2|||
146710921|NCT00317772|529115168|FG000|Overall Study|Disease Progression|2|||
146710922|NCT00317772|529115169|FG001|Overall Study|Disease Progression|2|||
146710923|NCT00317772|529115170|FG002|Overall Study|Disease Progression|1|||
146710924|NCT00317772|529115171|FG003|Overall Study|Disease Progression|7|||
146710925|NCT01040871|529115172|FG000|Overall Study|Adverse Event|6|||
146710926|NCT01040871|529115173|FG001|Overall Study|Adverse Event|2|||
146710927|NCT01040871|529115172|FG000|Overall Study|Withdrawal by Subject|2|||
146710928|NCT01040871|529115173|FG001|Overall Study|Withdrawal by Subject|0|||
146710929|NCT01040871|529115172|FG000|Overall Study|Death|1|||
146710930|NCT01040871|529115173|FG001|Overall Study|Death|3|||
146710931|NCT01040871|529115172|FG000|Overall Study|Lack of Efficacy|1|||
146710932|NCT01040871|529115173|FG001|Overall Study|Lack of Efficacy|1|||
146710933|NCT01040871|529115172|FG000|Overall Study|drug supply issue|1|||
146710934|NCT01040871|529115173|FG001|Overall Study|drug supply issue|0|||
146710935|NCT01040871|529115172|FG000|Overall Study|Randomized and Not Treated|2|||
146710936|NCT01040871|529115173|FG001|Overall Study|Randomized and Not Treated|1|||
146710937|NCT01073618|529115175|FG000|Overall Study|Death|208|||
146710938|NCT01073618|529115175|FG000|Overall Study|Adverse Event|19|||
146710939|NCT01073618|529115175|FG000|Overall Study|Other|80|||
146710940|NCT02696850|529115176|FG000|Overall Study|Withdrawal by Subject|3|||
146710941|NCT02696850|529115177|FG001|Overall Study|Withdrawal by Subject|3|||
146710942|NCT02696850|529115176|FG000|Overall Study|Lost to Follow-up|8|||
146710943|NCT02696850|529115177|FG001|Overall Study|Lost to Follow-up|5|||
146710944|NCT00673049|529115180|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
146710945|NCT00673049|529115181|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
146710946|NCT00673049|529115182|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
146710947|NCT00673049|529115183|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
146710948|NCT00673049|529115180|FG000|Before Progression on Erlotinib|Death|235|||
146710949|NCT00673049|529115181|FG001|Before Progression on Erlotinib|Death|167|||
146710950|NCT00673049|529115182|FG002|Before Progression on Erlotinib|Death|1|||
146710951|NCT00673049|529115183|FG003|Before Progression on Erlotinib|Death|0|||
146710952|NCT00673049|529115180|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
146710953|NCT00673049|529115181|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
146710954|NCT00673049|529115182|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
146710955|NCT00673049|529115183|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
146710956|NCT00673049|529115180|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
146710957|NCT00673049|529115181|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
146710958|NCT00673049|529115182|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
146710959|NCT00673049|529115183|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
146710960|NCT00673049|529115180|FG000|Before Progression on Erlotinib|Other|1|||
146710961|NCT00673049|529115181|FG001|Before Progression on Erlotinib|Other|2|||
146710962|NCT00673049|529115182|FG002|Before Progression on Erlotinib|Other|0|||
146710963|NCT00673049|529115183|FG003|Before Progression on Erlotinib|Other|0|||
146710964|NCT00673049|529115180|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
146710965|NCT00673049|529115181|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
146710966|NCT00673049|529115182|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
146710967|NCT00673049|529115183|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
146710968|NCT00673049|529115180|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
146710969|NCT00673049|529115181|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
146710970|NCT00673049|529115182|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
146710971|NCT00673049|529115183|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
146710972|NCT00673049|529115180|FG000|After Progression on Erlotinib|Death|0|||
146710973|NCT00673049|529115181|FG001|After Progression on Erlotinib|Death|0|||
146710974|NCT00673049|529115182|FG002|After Progression on Erlotinib|Death|0|||
146710975|NCT00673049|529115183|FG003|After Progression on Erlotinib|Death|71|||
146710976|NCT00673049|529115180|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
146710977|NCT00673049|529115181|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
146710978|NCT00673049|529115182|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
146710979|NCT00673049|529115183|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
146710980|NCT00673049|529115180|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
146710981|NCT00673049|529115181|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
146710982|NCT00673049|529115182|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
146710983|NCT00673049|529115183|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
146710984|NCT00673049|529115180|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
146710985|NCT00673049|529115181|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
146710986|NCT00673049|529115182|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
146710987|NCT00673049|529115183|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
146710988|NCT02621606|529115184|FG000|Overall Study|Withdrawal by Subject|0|||
146710989|NCT02621606|529115185|FG001|Overall Study|Withdrawal by Subject|1|||
146710990|NCT02621606|529115186|FG002|Overall Study|Withdrawal by Subject|0|||
146710991|NCT02044510|529115187|FG000|Overall Study|Adverse Event|1|||
146710992|NCT02044510|529115188|FG001|Overall Study|Adverse Event|2|||
146710993|NCT01175824|529115189|FG000|Overall Study|Adverse Event|2|||
146710994|NCT01175824|529115190|FG001|Overall Study|Adverse Event|1|||
146710995|NCT01175824|529115189|FG000|Overall Study|Lack of Efficacy|2|||
146710996|NCT01175824|529115190|FG001|Overall Study|Lack of Efficacy|0|||
146710997|NCT01175824|529115189|FG000|Overall Study|Lost to Follow-up|0|||
146710998|NCT01175824|529115190|FG001|Overall Study|Lost to Follow-up|1|||
146710999|NCT01175824|529115189|FG000|Overall Study|Physician Decision|0|||
146711000|NCT01175824|529115190|FG001|Overall Study|Physician Decision|4|||
146711001|NCT01175824|529115189|FG000|Overall Study|Protocol Violation|2|||
146711002|NCT01175824|529115190|FG001|Overall Study|Protocol Violation|5|||
146933893|NCT01335698|529916013|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
146933894|NCT01335698|529916014|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
146711003|NCT01175824|529115189|FG000|Overall Study|Withdrawal by Subject|3|||
146711004|NCT01175824|529115190|FG001|Overall Study|Withdrawal by Subject|7|||
146711005|NCT01175824|529115189|FG000|Overall Study|Sponsor Decision|1|||
146711006|NCT01175824|529115190|FG001|Overall Study|Sponsor Decision|0|||
146711007|NCT01175824|529115189|FG000|Overall Study|Entry Criteria Not Met|6|||
146711008|NCT01175824|529115190|FG001|Overall Study|Entry Criteria Not Met|4|||
146711009|NCT03455855|529115191|FG000|Overall Study|Lost to Follow-up|4|||
146711010|NCT03455855|529115192|FG001|Overall Study|Lost to Follow-up|2|||
146711011|NCT02979535|529115193|FG000|Overall Study|Non compliance with the protocol|78|||
146711012|NCT02979535|529115194|FG001|Overall Study|Non compliance with the protocol|82|||
146711013|NCT02979535|529115193|FG000|Overall Study|Consent withdrawn by participant|11|||
146711014|NCT02979535|529115194|FG001|Overall Study|Consent withdrawn by participant|18|||
146711015|NCT02979535|529115193|FG000|Overall Study|Lost to Follow-up|6|||
146711016|NCT02979535|529115194|FG001|Overall Study|Lost to Follow-up|1|||
146711017|NCT04820673|529115195|FG000|Overall Study|Adverse Event|6|||
146711018|NCT04820673|529115195|FG000|Overall Study|Due to Lack of Effectiveness|1|||
146711019|NCT04820673|529115195|FG000|Overall Study|Pregnancy|1|||
146711020|NCT04820673|529115195|FG000|Overall Study|Voluntary Withdrawal|20|||
146711021|NCT04820673|529115195|FG000|Overall Study|Lost to Follow-up|10|||
146711022|NCT00587587|529115196|FG000|Overall Study|Lost to Follow-up|6|||
146711023|NCT00587587|529115197|FG001|Overall Study|Lost to Follow-up|1|||
146711024|NCT02039505|529115199|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
146711025|NCT02039505|529115200|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
146711026|NCT02039505|529115201|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
146711027|NCT02039505|529115202|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
146711028|NCT02039505|529115203|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
146711029|NCT02039505|529115204|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
146711030|NCT02039505|529115205|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
146711031|NCT02039505|529115199|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
146711032|NCT02039505|529115200|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
146711033|NCT02039505|529115201|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
146711034|NCT02039505|529115202|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
146711035|NCT02039505|529115203|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
146711036|NCT02039505|529115204|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
146711037|NCT02039505|529115205|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
146711038|NCT02039505|529115199|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
146711039|NCT02039505|529115200|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
146711040|NCT02039505|529115201|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
146711041|NCT02039505|529115202|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
146711042|NCT02039505|529115203|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
146711043|NCT02039505|529115204|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
146711044|NCT02039505|529115205|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
146711045|NCT02039505|529115199|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
146711046|NCT02039505|529115200|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
146711047|NCT02039505|529115201|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
146711048|NCT02039505|529115202|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
146711049|NCT02039505|529115203|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
146711050|NCT02039505|529115204|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
146711051|NCT02039505|529115205|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
146711052|NCT02039505|529115199|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
146711053|NCT02039505|529115200|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
146711054|NCT02039505|529115201|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
146711055|NCT02039505|529115202|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
146711056|NCT02039505|529115203|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
146711057|NCT02039505|529115204|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
146711058|NCT02039505|529115205|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
146711059|NCT02039505|529115199|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
146711060|NCT02039505|529115200|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
146711061|NCT02039505|529115201|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
146711062|NCT02039505|529115202|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
146711063|NCT02039505|529115203|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
146711064|NCT02039505|529115204|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
146711065|NCT02039505|529115205|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
146711066|NCT02039505|529115199|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
146711067|NCT02039505|529115200|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
146711068|NCT02039505|529115201|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
146711069|NCT02039505|529115202|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
146711070|NCT02039505|529115203|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
146711071|NCT02039505|529115204|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
146981081|NCT02480010|530093724|FG000|Overall Study|Insufficient therapeutic response|31|||
146981082|NCT02480010|530093725|FG001|Overall Study|Insufficient therapeutic response|29|||
146981083|NCT02480010|530093724|FG000|Overall Study|Refused Treatment|0|||
146711072|NCT02039505|529115205|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
146711073|NCT02039505|529115199|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
146711074|NCT02039505|529115200|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
146711075|NCT02039505|529115201|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
146711076|NCT02039505|529115202|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
146711077|NCT02039505|529115203|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
146711078|NCT02039505|529115204|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
146711079|NCT02039505|529115205|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
146711080|NCT02039505|529115199|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
146711081|NCT02039505|529115200|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
146711082|NCT02039505|529115201|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
146711083|NCT02039505|529115202|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
146711084|NCT02039505|529115203|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
146711085|NCT02039505|529115204|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
146711086|NCT02039505|529115205|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
146711087|NCT02039505|529115199|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
146711088|NCT02039505|529115200|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
146711089|NCT02039505|529115201|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
146711090|NCT02039505|529115202|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
146711091|NCT02039505|529115203|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
146711092|NCT02039505|529115204|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
146711093|NCT02039505|529115205|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
146711094|NCT02039505|529115199|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
146711095|NCT02039505|529115200|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
146711096|NCT02039505|529115201|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
146711097|NCT02039505|529115202|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
146711098|NCT02039505|529115203|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
146711099|NCT02039505|529115204|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
146711100|NCT02039505|529115205|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
146711101|NCT01343082|529115208|FG000|The run-in Period|Not meeting criteria|3|||
146711102|NCT01343082|529115209|FG001|The run-in Period|Not meeting criteria|4|||
146711103|NCT01343082|529115210|FG002|The run-in Period|Not meeting criteria|5|||
146711104|NCT01343082|529115208|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
146711105|NCT01343082|529115209|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
146711106|NCT01343082|529115210|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
146711107|NCT01343082|529115208|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
146711108|NCT01343082|529115209|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
146711109|NCT01343082|529115210|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
146711110|NCT01343082|529115208|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
146711111|NCT01343082|529115209|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
146711112|NCT01343082|529115210|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
146711113|NCT01343082|529115208|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
146711114|NCT01343082|529115209|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
146711115|NCT01343082|529115210|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
146711116|NCT00633984|529115211|FG000|Overall Study|Lost to Follow-up|0|||
146711117|NCT00633984|529115212|FG001|Overall Study|Lost to Follow-up|6|||
146711118|NCT00633984|529115211|FG000|Overall Study|Withdrawal by Subject|8|||
146711119|NCT00633984|529115212|FG001|Overall Study|Withdrawal by Subject|7|||
146711120|NCT00633984|529115211|FG000|Overall Study|Hospitalized|1|||
146711121|NCT00633984|529115212|FG001|Overall Study|Hospitalized|0|||
146711122|NCT02554773|529115213|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
146711123|NCT02554773|529115214|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
146711124|NCT02554773|529115213|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
146711125|NCT02554773|529115214|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
146711126|NCT02554773|529115213|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
146711127|NCT02554773|529115214|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
146711128|NCT02554773|529115213|FG000|Original Dose Regimen (SAS 1)|Death|1|||
146711129|NCT02554773|529115214|FG001|Original Dose Regimen (SAS 1)|Death|0|||
146711130|NCT02554773|529115213|FG000|Original Dose Regimen (SAS 1)|Other|4|||
146711131|NCT02554773|529115214|FG001|Original Dose Regimen (SAS 1)|Other|0|||
146711132|NCT02554773|529115213|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
146711133|NCT02554773|529115214|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
146711134|NCT02554773|529115213|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
146711135|NCT02554773|529115214|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
146779243|NCT04855760|529361532|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
146779244|NCT04855760|529361532|FG000|Overall Study|Study Completed by Sponsor|202|||
146779245|NCT04855760|529361532|FG000|Overall Study|Other|13|||
146779246|NCT04840199|529361533|FG000|Overall Study|Study Terminated by Sponsor|8|||
146779247|NCT04840199|529361534|FG001|Overall Study|Study Terminated by Sponsor|9|||
146779248|NCT04840199|529361533|FG000|Overall Study|Lost to Follow-up|0|||
146779249|NCT04840199|529361534|FG001|Overall Study|Lost to Follow-up|2|||
146779250|NCT04840199|529361533|FG000|Overall Study|Withdrawal by Subject|2|||
146779251|NCT04840199|529361534|FG001|Overall Study|Withdrawal by Subject|0|||
146779252|NCT04840199|529361533|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
146779253|NCT04840199|529361534|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
146779254|NCT03424811|529361541|FG000|Overall Study|Lost to Follow-up|9|||
146779255|NCT03424811|529361542|FG001|Overall Study|Lost to Follow-up|0|||
146779256|NCT00567398|529361544|FG000|Overall Study|Adverse Event|6|||
146779257|NCT00567398|529361545|FG001|Overall Study|Adverse Event|14|||
146779258|NCT00567398|529361544|FG000|Overall Study|Physician Decision|0|||
146779259|NCT00567398|529361545|FG001|Overall Study|Physician Decision|4|||
146779260|NCT00567398|529361544|FG000|Overall Study|Withdrawal by Subject|0|||
146711136|NCT02554773|529115213|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
146711137|NCT02554773|529115214|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
146711138|NCT02554773|529115213|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
146711139|NCT02554773|529115214|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
146779261|NCT00567398|529361545|FG001|Overall Study|Withdrawal by Subject|2|||
146779262|NCT00567398|529361544|FG000|Overall Study|Renal Transplantation|0|||
146779263|NCT00567398|529361545|FG001|Overall Study|Renal Transplantation|3|||
146779264|NCT00567398|529361544|FG000|Overall Study|Other|1|||
146779265|NCT00567398|529361545|FG001|Overall Study|Other|0|||
146779266|NCT03517553|529361546|FG000|Overall Study|Withdrawal by Subject|2|||
146779267|NCT04247542|529361551|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
146779268|NCT04247542|529361552|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
146779269|NCT04247542|529361553|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
146779270|NCT04247542|529361551|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
146779271|NCT04247542|529361552|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
146779272|NCT04247542|529361553|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
146779273|NCT02201108|529361554|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
146779274|NCT02201108|529361555|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
146779275|NCT02201108|529361556|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
146779276|NCT02201108|529361554|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
146779277|NCT02201108|529361555|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
146779278|NCT02201108|529361556|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
146779279|NCT02201108|529361554|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
146779280|NCT02201108|529361555|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
146779281|NCT02201108|529361556|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
146779282|NCT02201108|529361554|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
146779283|NCT02201108|529361555|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
146779284|NCT02201108|529361556|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
146779285|NCT02201108|529361554|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
146779286|NCT02201108|529361555|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
146779287|NCT02201108|529361556|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
146779288|NCT02201108|529361554|FG000|Open Label Period (up to Week 192)|Other reason|4|||
146779289|NCT02201108|529361555|FG001|Open Label Period (up to Week 192)|Other reason|7|||
146779290|NCT02201108|529361556|FG002|Open Label Period (up to Week 192)|Other reason|0|||
146779291|NCT02201108|529361554|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
146779292|NCT02201108|529361555|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
146933895|NCT01335698|529916015|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
146933896|NCT01335698|529916016|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
146933897|NCT01335698|529916012|FG000|Treatment Stage 1|No longer meets study criteria|1|||
146711140|NCT00009737|529115218|FG000|Overall Study|Adverse Event|112|||
146711141|NCT00009737|529115219|FG001|Overall Study|Adverse Event|75|||
146711142|NCT00009737|529115218|FG000|Overall Study|Death|4|||
146711143|NCT00009737|529115219|FG001|Overall Study|Death|6|||
146711144|NCT00009737|529115218|FG000|Overall Study|Lack of Efficacy|17|||
146711145|NCT00009737|529115219|FG001|Overall Study|Lack of Efficacy|15|||
146711146|NCT00009737|529115218|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
146711147|NCT00009737|529115219|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
146711148|NCT00009737|529115218|FG000|Overall Study|Other Protocol Violation|1|||
146711149|NCT00009737|529115219|FG001|Overall Study|Other Protocol Violation|0|||
146711150|NCT00009737|529115218|FG000|Overall Study|Refused Treatment|15|||
146711151|NCT00009737|529115219|FG001|Overall Study|Refused Treatment|16|||
146711152|NCT00009737|529115218|FG000|Overall Study|Lost to Follow-up|1|||
146711153|NCT00009737|529115219|FG001|Overall Study|Lost to Follow-up|1|||
146711154|NCT00009737|529115218|FG000|Overall Study|Administrative/Other Reasons|7|||
146711155|NCT00009737|529115219|FG001|Overall Study|Administrative/Other Reasons|1|||
146711156|NCT01163682|529115220|FG000|Overall Study|Lost to Follow-up|6|||
146711157|NCT01163682|529115221|FG001|Overall Study|Lost to Follow-up|9|||
146711158|NCT01172938|529115223|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
146711159|NCT01172938|529115224|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
146711160|NCT01172938|529115225|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
146711161|NCT01172938|529115226|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146711162|NCT01172938|529115227|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146711163|NCT01172938|529115228|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146711164|NCT01172938|529115229|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146711165|NCT01172938|529115230|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146711166|NCT01172938|529115231|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146711167|NCT01172938|529115223|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
146711168|NCT01172938|529115224|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
146711169|NCT01172938|529115225|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
146711170|NCT01172938|529115226|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146711171|NCT01172938|529115227|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146711172|NCT01172938|529115228|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146711173|NCT01172938|529115229|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146711174|NCT01172938|529115230|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146711175|NCT01172938|529115231|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146711176|NCT01172938|529115223|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146711177|NCT01172938|529115224|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
146711178|NCT01172938|529115225|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
146711179|NCT01172938|529115226|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146711180|NCT01172938|529115227|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146711181|NCT01172938|529115228|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146711182|NCT01172938|529115229|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146711183|NCT01172938|529115230|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146711184|NCT01172938|529115231|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146711185|NCT01172938|529115223|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
146711186|NCT01172938|529115224|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
146711187|NCT01172938|529115225|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
146711188|NCT01172938|529115226|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146711189|NCT01172938|529115227|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146711190|NCT01172938|529115228|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146711191|NCT01172938|529115229|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146711192|NCT01172938|529115230|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146711193|NCT01172938|529115231|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146711194|NCT01172938|529115223|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
146711195|NCT01172938|529115224|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
146711196|NCT01172938|529115225|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
146711197|NCT01172938|529115226|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
146711198|NCT01172938|529115227|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
146711199|NCT01172938|529115228|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
146711200|NCT01172938|529115229|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
146711201|NCT01172938|529115230|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
146711202|NCT01172938|529115231|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
146711203|NCT01172938|529115223|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
146711204|NCT01172938|529115224|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146711205|NCT01172938|529115225|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146711206|NCT01172938|529115226|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146711207|NCT01172938|529115227|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146711208|NCT01172938|529115228|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146711209|NCT01172938|529115229|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146711210|NCT01172938|529115230|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146711211|NCT01172938|529115231|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146711212|NCT01172938|529115223|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
146711213|NCT01172938|529115224|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
146711214|NCT01172938|529115225|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
146711215|NCT01172938|529115226|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
146711216|NCT01172938|529115227|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
146711217|NCT01172938|529115228|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
146711218|NCT01172938|529115229|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
146711219|NCT01172938|529115230|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
146711220|NCT01172938|529115231|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
146711221|NCT01172938|529115223|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
146711222|NCT01172938|529115224|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
146711223|NCT01172938|529115225|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
146711224|NCT01172938|529115226|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
146711225|NCT01172938|529115227|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
146711226|NCT01172938|529115228|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
146711227|NCT01172938|529115229|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
146711228|NCT01172938|529115230|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
146711229|NCT01172938|529115231|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
146711230|NCT01172938|529115223|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
146711231|NCT01172938|529115224|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
146711232|NCT01172938|529115225|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
146711233|NCT01172938|529115226|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
146711234|NCT01172938|529115227|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
146711235|NCT01172938|529115228|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
146711236|NCT01172938|529115229|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
146711237|NCT01172938|529115230|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
146711238|NCT01172938|529115231|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
146711239|NCT01172938|529115223|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
146711240|NCT01172938|529115224|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
146711241|NCT01172938|529115225|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
146711242|NCT01172938|529115226|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
146711243|NCT01172938|529115227|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
146711244|NCT01172938|529115228|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
146711245|NCT01172938|529115229|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
146711246|NCT01172938|529115230|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
146711247|NCT01172938|529115231|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
146711248|NCT01172938|529115223|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
146711249|NCT01172938|529115224|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
146711250|NCT01172938|529115225|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
146711251|NCT01172938|529115226|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
146711252|NCT01172938|529115227|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
146711253|NCT01172938|529115228|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
146711254|NCT01172938|529115229|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
146711255|NCT01172938|529115230|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
146711256|NCT01172938|529115231|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
146711257|NCT01172938|529115223|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
146711258|NCT01172938|529115224|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
146711259|NCT01172938|529115225|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
146711260|NCT01172938|529115226|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
146711261|NCT01172938|529115227|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
146711262|NCT01172938|529115228|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
146711263|NCT01172938|529115229|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
146711264|NCT01172938|529115230|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
146711265|NCT01172938|529115231|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
146711266|NCT01172938|529115223|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
146711267|NCT01172938|529115224|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
146711268|NCT01172938|529115225|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
146711269|NCT01172938|529115226|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
146711270|NCT01172938|529115227|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
146711271|NCT01172938|529115228|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
146711272|NCT01172938|529115229|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
146711273|NCT01172938|529115230|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
146711274|NCT01172938|529115231|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
146711275|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
146711276|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
146711277|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
146711278|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
146711279|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
146711280|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
146711281|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
146711282|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
146711283|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
146779293|NCT02201108|529361556|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
146779294|NCT02201108|529361554|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
146779295|NCT02201108|529361555|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
146779296|NCT02201108|529361556|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
146779297|NCT02201108|529361554|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
146779298|NCT02201108|529361555|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
146779299|NCT02201108|529361556|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
146779300|NCT02553642|529361558|FG000|Overall Study|Withdrawal by Subject|0|||
146779301|NCT02553642|529361559|FG001|Overall Study|Withdrawal by Subject|3|||
146779302|NCT02553642|529361558|FG000|Overall Study|Physician Decision|0|||
146779303|NCT02553642|529361559|FG001|Overall Study|Physician Decision|1|||
146779304|NCT02553642|529361558|FG000|Overall Study|Additional cancer dx|0|||
146779305|NCT02553642|529361559|FG001|Overall Study|Additional cancer dx|1|||
146779306|NCT02553642|529361558|FG000|Overall Study|Never started treatment|0|||
146779307|NCT02553642|529361559|FG001|Overall Study|Never started treatment|1|||
146779308|NCT04600752|529361560|FG000|Overall Study|Physician Decision|0|||
146779309|NCT04600752|529361561|FG001|Overall Study|Physician Decision|0|||
146779310|NCT04600752|529361562|FG002|Overall Study|Physician Decision|1|||
146779311|NCT04600752|529361560|FG000|Overall Study|Adverse Event|0|||
146779312|NCT04600752|529361561|FG001|Overall Study|Adverse Event|1|||
146779313|NCT04600752|529361562|FG002|Overall Study|Adverse Event|0|||
146779314|NCT04600752|529361560|FG000|Overall Study|Withdrawal by Subject|2|||
146779315|NCT04600752|529361561|FG001|Overall Study|Withdrawal by Subject|1|||
146779316|NCT04600752|529361562|FG002|Overall Study|Withdrawal by Subject|0|||
146779317|NCT04600752|529361560|FG000|Overall Study|Lack of Efficacy|1|||
146779318|NCT04600752|529361561|FG001|Overall Study|Lack of Efficacy|0|||
146779319|NCT04600752|529361562|FG002|Overall Study|Lack of Efficacy|0|||
146779320|NCT03732820|529361563|FG000|Overall Study|Death|168|||
146779321|NCT03732820|529361564|FG001|Overall Study|Death|203|||
146779322|NCT03732820|529361563|FG000|Overall Study|Other|2|||
146779323|NCT03732820|529361564|FG001|Overall Study|Other|2|||
146779324|NCT03732820|529361563|FG000|Overall Study|Failure to meet randomisation criteria|1|||
146779325|NCT03732820|529361564|FG001|Overall Study|Failure to meet randomisation criteria|1|||
146779326|NCT03732820|529361563|FG000|Overall Study|Patient decision|14|||
146779327|NCT03732820|529361564|FG001|Overall Study|Patient decision|10|||
146779328|NCT03732820|529361563|FG000|Overall Study|Screen failure|0|||
146779329|NCT03732820|529361564|FG001|Overall Study|Screen failure|1|||
146779330|NCT03732820|529361563|FG000|Overall Study|Patients ongoing study at data cut off|210|||
146779331|NCT03732820|529361564|FG001|Overall Study|Patients ongoing study at data cut off|178|||
146779332|NCT03732820|529361563|FG000|Overall Study|Lost to Follow-up|4|||
146779333|NCT03732820|529361564|FG001|Overall Study|Lost to Follow-up|2|||
146779334|NCT04287985|529361572|FG000|Overall Study|Adverse Event|1|||
146779335|NCT04287985|529361573|FG001|Overall Study|Adverse Event|0|||
146779336|NCT04287985|529361574|FG002|Overall Study|Adverse Event|0|||
146779337|NCT04287985|529361575|FG003|Overall Study|Adverse Event|0|||
146779338|NCT04287985|529361572|FG000|Overall Study|Protocol Violation|0|||
146779339|NCT04287985|529361573|FG001|Overall Study|Protocol Violation|1|||
146779340|NCT04287985|529361574|FG002|Overall Study|Protocol Violation|0|||
146779341|NCT04287985|529361575|FG003|Overall Study|Protocol Violation|0|||
146779342|NCT04287985|529361572|FG000|Overall Study|Physician Decision|0|||
146779343|NCT04287985|529361573|FG001|Overall Study|Physician Decision|0|||
146779344|NCT04287985|529361574|FG002|Overall Study|Physician Decision|0|||
146779345|NCT04287985|529361575|FG003|Overall Study|Physician Decision|1|||
146779346|NCT04287985|529361572|FG000|Overall Study|Withdrawal by Subject|2|||
146779347|NCT04287985|529361573|FG001|Overall Study|Withdrawal by Subject|1|||
146779348|NCT04287985|529361574|FG002|Overall Study|Withdrawal by Subject|1|||
146779349|NCT04287985|529361575|FG003|Overall Study|Withdrawal by Subject|2|||
146779350|NCT01340066|529361576|FG000|Placebo Run in Period|Screen Failures|27|||
146779351|NCT01340066|529361577|FG001|Placebo Run in Period|Screen Failures|0|||
146779352|NCT01340066|529361578|FG002|Placebo Run in Period|Screen Failures|0|||
146779353|NCT01340066|529361576|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
146779354|NCT01340066|529361577|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
146779355|NCT01340066|529361578|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
146779356|NCT01340066|529361576|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
146779357|NCT01340066|529361577|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
146779358|NCT01340066|529361578|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
146779359|NCT01340066|529361576|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
146779360|NCT01340066|529361577|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
146779361|NCT01340066|529361578|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
146779362|NCT02789020|529361579|FG000|Overall Study|Withdrawal by Subject|6|||
146779363|NCT02789020|529361580|FG001|Overall Study|Withdrawal by Subject|5|||
146779364|NCT03771352|529361586|FG000|Overall Study|Screen failure|2|||
146779365|NCT03771352|529361586|FG000|Overall Study|Withdrawal by Subject|2|||
146779366|NCT03338816|529361601|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
146981084|NCT02480010|530093725|FG001|Overall Study|Refused Treatment|3|||
146779367|NCT03338816|529361602|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
146779368|NCT03338816|529361603|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
146779369|NCT03338816|529361604|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
146779370|NCT03338816|529361601|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
146779371|NCT03338816|529361602|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
146779372|NCT03338816|529361603|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
146779373|NCT03338816|529361604|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
146779374|NCT03338816|529361601|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
146779375|NCT03338816|529361602|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
146779376|NCT03338816|529361603|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
146779377|NCT03338816|529361604|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
146779378|NCT03338816|529361601|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
146779379|NCT03338816|529361602|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
146779380|NCT03338816|529361603|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
146779381|NCT03338816|529361604|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
146779382|NCT03338816|529361601|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
146779383|NCT03338816|529361602|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
146779384|NCT03338816|529361603|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
146779385|NCT03338816|529361604|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
146779386|NCT03338816|529361601|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
146779387|NCT03338816|529361602|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
146779388|NCT03338816|529361603|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
146779389|NCT03338816|529361604|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
146779390|NCT03338816|529361601|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
146779391|NCT03338816|529361602|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
146779392|NCT03338816|529361603|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
146779393|NCT03338816|529361604|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
146779394|NCT04238247|529361605|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
146779395|NCT04238247|529361606|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
146779396|NCT04238247|529361607|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
146779397|NCT04238247|529361608|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
146779398|NCT04238247|529361605|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
146779399|NCT04238247|529361606|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
146779400|NCT04238247|529361607|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
146779401|NCT04238247|529361608|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
146779402|NCT04238247|529361605|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
146779403|NCT04238247|529361606|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
146779404|NCT04238247|529361607|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
146779405|NCT04238247|529361608|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
146779406|NCT04238247|529361605|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
146779407|NCT04238247|529361606|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
146779408|NCT04238247|529361607|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
146779409|NCT04238247|529361608|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
146779410|NCT01948661|529361610|FG000|Overall Study|Withdrawal by Subject|2|||
146779411|NCT01948661|529361611|FG001|Overall Study|Withdrawal by Subject|4|||
146779412|NCT03271489|529361612|FG000|Double-Blind (DB) Period|Adverse Event|4|||
146779413|NCT03271489|529361613|FG001|Double-Blind (DB) Period|Adverse Event|1|||
146779414|NCT03271489|529361612|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
146779415|NCT03271489|529361613|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
146779416|NCT03271489|529361612|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
146779417|NCT03271489|529361613|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
146779418|NCT03271489|529361612|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
146779419|NCT03271489|529361613|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
146779420|NCT03271489|529361612|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
146779421|NCT03271489|529361613|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
146779422|NCT03271489|529361612|FG000|Double-Blind (DB) Period|Other|6|||
146779423|NCT03271489|529361613|FG001|Double-Blind (DB) Period|Other|1|||
146779424|NCT03271489|529361612|FG000|Double-Blind (DB) Period|Missing|1|||
146779425|NCT03271489|529361613|FG001|Double-Blind (DB) Period|Missing|0|||
146779426|NCT03271489|529361612|FG000|Open-Label (OL) Period|Adverse Event|2|||
146779427|NCT03271489|529361613|FG001|Open-Label (OL) Period|Adverse Event|0|||
146779428|NCT03271489|529361612|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
146779429|NCT03271489|529361613|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
146981085|NCT01764854|530093735|FG000|Overall Study|Adverse Event|0|||
146779430|NCT03271489|529361612|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
146981086|NCT01764854|530093736|FG001|Overall Study|Adverse Event|0|||
146933898|NCT01335698|529916013|FG001|Treatment Stage 1|No longer meets study criteria|1|||
146933899|NCT01335698|529916014|FG002|Treatment Stage 1|No longer meets study criteria|0|||
146933900|NCT01335698|529916015|FG003|Treatment Stage 1|No longer meets study criteria|1|||
146711284|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
146711285|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
146711286|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
146711287|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
146711288|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
146711289|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
146711290|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
146711291|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
146711292|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
146711293|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
146711294|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
146711295|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
146711296|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
146711297|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
146736357|NCT02228395|529206820|FG001|First Intervention Period|Unable to comply with study dates|1|||
146736358|NCT02228395|529206821|FG002|First Intervention Period|Unable to comply with study dates|1|||
146736359|NCT02569437|529206825|FG000|Overall Study|Lost to Follow-up|12|||
146736360|NCT02569437|529206826|FG001|Overall Study|Lost to Follow-up|14|||
146736361|NCT02255357|529206827|FG000|Overall Study|Physician Decision|10|||
146736362|NCT02255357|529206828|FG001|Overall Study|Physician Decision|24|||
146736363|NCT01641926|529206829|FG000|Overall Study|Adverse Event|5|||
146736364|NCT01641926|529206830|FG001|Overall Study|Adverse Event|2|||
146736365|NCT01641926|529206831|FG002|Overall Study|Adverse Event|3|||
146736366|NCT01641926|529206832|FG003|Overall Study|Adverse Event|1|||
146736367|NCT01641926|529206829|FG000|Overall Study|Lost to Follow-up|2|||
146736368|NCT01641926|529206830|FG001|Overall Study|Lost to Follow-up|2|||
146736369|NCT01641926|529206831|FG002|Overall Study|Lost to Follow-up|1|||
146736370|NCT01641926|529206832|FG003|Overall Study|Lost to Follow-up|0|||
146736371|NCT01641926|529206829|FG000|Overall Study|Physician Decision|6|||
146736372|NCT01641926|529206830|FG001|Overall Study|Physician Decision|5|||
146736373|NCT01641926|529206831|FG002|Overall Study|Physician Decision|0|||
146736374|NCT01641926|529206832|FG003|Overall Study|Physician Decision|1|||
146736375|NCT01641926|529206829|FG000|Overall Study|Protocol Violation|1|||
146736376|NCT01641926|529206830|FG001|Overall Study|Protocol Violation|0|||
146736377|NCT01641926|529206831|FG002|Overall Study|Protocol Violation|0|||
146736378|NCT01641926|529206832|FG003|Overall Study|Protocol Violation|1|||
146736379|NCT01641926|529206829|FG000|Overall Study|Withdrawal by Subject|13|||
146736380|NCT01641926|529206830|FG001|Overall Study|Withdrawal by Subject|5|||
146736381|NCT01641926|529206831|FG002|Overall Study|Withdrawal by Subject|6|||
146736382|NCT01641926|529206832|FG003|Overall Study|Withdrawal by Subject|1|||
146736383|NCT01641926|529206829|FG000|Overall Study|Not Treated|1|||
146736384|NCT01641926|529206830|FG001|Overall Study|Not Treated|1|||
146736385|NCT01641926|529206831|FG002|Overall Study|Not Treated|1|||
146736386|NCT01641926|529206832|FG003|Overall Study|Not Treated|0|||
146736387|NCT01691521|529206833|FG000|Overall Study|Adverse Event|4|||
146736388|NCT01691521|529206834|FG001|Overall Study|Adverse Event|0|||
146736389|NCT01691521|529206835|FG002|Overall Study|Adverse Event|1|||
146736390|NCT01691521|529206833|FG000|Overall Study|Lack of Efficacy|1|||
146736391|NCT01691521|529206834|FG001|Overall Study|Lack of Efficacy|1|||
146736392|NCT01691521|529206835|FG002|Overall Study|Lack of Efficacy|2|||
146736393|NCT01691521|529206833|FG000|Overall Study|Protocol Violation|0|||
146736394|NCT01691521|529206834|FG001|Overall Study|Protocol Violation|3|||
146736395|NCT01691521|529206835|FG002|Overall Study|Protocol Violation|0|||
146736396|NCT01691521|529206833|FG000|Overall Study|Lost to Follow-up|0|||
146736397|NCT01691521|529206834|FG001|Overall Study|Lost to Follow-up|2|||
146736398|NCT01691521|529206835|FG002|Overall Study|Lost to Follow-up|2|||
146736399|NCT01691521|529206833|FG000|Overall Study|Physician Decision|2|||
146736400|NCT01691521|529206834|FG001|Overall Study|Physician Decision|1|||
146736401|NCT01691521|529206835|FG002|Overall Study|Physician Decision|0|||
146736402|NCT01691521|529206833|FG000|Overall Study|Withdrawal by Subject|5|||
146736403|NCT01691521|529206834|FG001|Overall Study|Withdrawal by Subject|9|||
146736404|NCT01691521|529206835|FG002|Overall Study|Withdrawal by Subject|4|||
146736405|NCT02343003|529206836|FG000|Overall Study|Withdrawal by Subject|9|||
146736406|NCT02343003|529206837|FG001|Overall Study|Withdrawal by Subject|4|||
146736407|NCT02343003|529206836|FG000|Overall Study|Lost to Follow-up|5|||
146736408|NCT02343003|529206837|FG001|Overall Study|Lost to Follow-up|1|||
146736409|NCT02343003|529206836|FG000|Overall Study|Protocol Violation|1|||
146736410|NCT02343003|529206837|FG001|Overall Study|Protocol Violation|0|||
146736411|NCT02343003|529206836|FG000|Overall Study|Death|0|||
146736412|NCT02343003|529206837|FG001|Overall Study|Death|1|||
146711298|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
146711299|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
146711300|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
146711301|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
146711302|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
146711303|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
146711304|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
146711305|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
146711306|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
146711307|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
146711308|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
146711309|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
146779431|NCT03271489|529361613|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
146779432|NCT03271489|529361612|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
146779433|NCT03271489|529361613|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
146779434|NCT03271489|529361612|FG000|Open-Label (OL) Period|No Specified|2|||
146779435|NCT03271489|529361613|FG001|Open-Label (OL) Period|No Specified|2|||
146779436|NCT03271489|529361612|FG000|Open-Label (OL) Period|Missing|2|||
146779437|NCT03271489|529361613|FG001|Open-Label (OL) Period|Missing|0|||
146779438|NCT03271489|529361612|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
146779439|NCT03271489|529361613|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
146779440|NCT03271489|529361612|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
146779441|NCT03271489|529361613|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
146779442|NCT03271489|529361612|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
146779443|NCT03271489|529361613|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
146779444|NCT03271489|529361612|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
146779445|NCT03271489|529361613|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
146779446|NCT03271489|529361612|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
146779447|NCT03271489|529361613|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
146779448|NCT03271489|529361612|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
146779449|NCT03271489|529361613|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
146779450|NCT03271489|529361612|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
146779451|NCT03271489|529361613|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
146779452|NCT03271489|529361612|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
146779453|NCT03271489|529361613|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
146779454|NCT06061081|529361614|FG000|Overall Study|Withdrawal by Subject|1|||
146779455|NCT06061081|529361615|FG001|Overall Study|Withdrawal by Subject|0|||
146779456|NCT06061081|529361616|FG002|Overall Study|Withdrawal by Subject|0|||
146779457|NCT06061081|529361617|FG003|Overall Study|Withdrawal by Subject|0|||
146779458|NCT06061081|529361618|FG004|Overall Study|Withdrawal by Subject|0|||
146779459|NCT02252172|529361619|FG000|Overall Study|Lost to Follow-up|9|||
146779460|NCT02252172|529361620|FG001|Overall Study|Lost to Follow-up|6|||
146779461|NCT02252172|529361619|FG000|Overall Study|Death|218|||
146779462|NCT02252172|529361620|FG001|Overall Study|Death|175|||
146779463|NCT02252172|529361619|FG000|Overall Study|Withdrawal by Subject|20|||
146779464|NCT02252172|529361620|FG001|Overall Study|Withdrawal by Subject|15|||
146779465|NCT02252172|529361619|FG000|Overall Study|Physician Decision|0|||
146779466|NCT02252172|529361620|FG001|Overall Study|Physician Decision|1|||
146779467|NCT02252172|529361619|FG000|Overall Study|End of data collection|122|||
146779468|NCT02252172|529361620|FG001|Overall Study|End of data collection|170|||
146779469|NCT02252172|529361619|FG000|Overall Study|Site closure|0|||
146779470|NCT02252172|529361620|FG001|Overall Study|Site closure|1|||
146779471|NCT05575076|529361621|FG000|Overall Study|Adverse Event|24|||
146779472|NCT05575076|529361621|FG000|Overall Study|Death|7|||
146779473|NCT05575076|529361621|FG000|Overall Study|Lost to Follow-up|16|||
146779474|NCT05575076|529361621|FG000|Overall Study|Non-Compliance|3|||
146779475|NCT05575076|529361621|FG000|Overall Study|Physician Decision|6|||
146779476|NCT05575076|529361621|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
146779477|NCT05575076|529361621|FG000|Overall Study|Withdrawal by Subject|71|||
146981087|NCT01764854|530093737|FG002|Overall Study|Adverse Event|2|||
146981088|NCT01764854|530093738|FG003|Overall Study|Adverse Event|0|||
146711310|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
146711311|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
146711312|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
146779478|NCT05575076|529361621|FG000|Overall Study|Study Terminated by Sponsor|630|||
146981089|NCT01764854|530093735|FG000|Overall Study|Withdrawal by Subject|0|||
146779479|NCT05575076|529361621|FG000|Overall Study|Other|17|||
146779480|NCT03380390|529361622|FG000|Overall Study|Adverse Event|3|||
146981090|NCT01764854|530093736|FG001|Overall Study|Withdrawal by Subject|0|||
146779481|NCT02886286|529361623|FG000|Overall Study|pump motor stall|0|||
146779482|NCT02886286|529361624|FG001|Overall Study|pump motor stall|1|||
146779483|NCT01127373|529361625|FG000|Overall Study|Not Treated|3|||
146779484|NCT01127373|529361625|FG000|Overall Study|Lost to Follow-up|7|||
146779485|NCT01127373|529361625|FG000|Overall Study|Withdrawal by Subject|1|||
146779486|NCT01127373|529361625|FG000|Overall Study|Disease progression|1|||
146779487|NCT00522951|529361630|FG000|Period 1|body motion|0|||
146779488|NCT00522951|529361631|FG001|Period 1|body motion|1|||
146779489|NCT00522951|529361630|FG000|Washout Period|Adverse Event|0|||
146779490|NCT00522951|529361631|FG001|Washout Period|Adverse Event|1|||
146779491|NCT00522951|529361630|FG000|Washout Period|Death|0|||
146779492|NCT00522951|529361631|FG001|Washout Period|Death|1|||
146779493|NCT00522951|529361630|FG000|Period 2|Withdrawal by Subject|1|||
146779494|NCT00522951|529361631|FG001|Period 2|Withdrawal by Subject|0|||
146779495|NCT00522951|529361630|FG000|Period 2|residual contrast medium|1|||
146779496|NCT00522951|529361631|FG001|Period 2|residual contrast medium|1|||
146779497|NCT01084707|529361637|FG000|Overall Study|Withdrawal by Subject|6|||
146779498|NCT01747486|529361638|FG000|Stage 1|Physician Decision|3|||
146779499|NCT01747486|529361639|FG001|Stage 1|Physician Decision|0|||
146779500|NCT01747486|529361638|FG000|Stage 1|Withdrawal by Subject|4|||
146779501|NCT01747486|529361639|FG001|Stage 1|Withdrawal by Subject|3|||
146779502|NCT01747486|529361638|FG000|Stage 1|Disease progression|4|||
146779503|NCT01747486|529361639|FG001|Stage 1|Disease progression|9|||
146779504|NCT01747486|529361638|FG000|Stage 1|Death|1|||
146779505|NCT01747486|529361639|FG001|Stage 1|Death|1|||
146779506|NCT01747486|529361638|FG000|Stage 2|Physician Decision|2|||
146779507|NCT01747486|529361639|FG001|Stage 2|Physician Decision|0|||
146779508|NCT01747486|529361638|FG000|Stage 2|Withdrawal by Subject|1|||
146779509|NCT01747486|529361639|FG001|Stage 2|Withdrawal by Subject|0|||
146779510|NCT01747486|529361638|FG000|Stage 2|New Cancer Therapy|3|||
146779511|NCT01747486|529361639|FG001|Stage 2|New Cancer Therapy|0|||
146779512|NCT01747486|529361638|FG000|Stage 2|Disease Progression|3|||
146779513|NCT01747486|529361639|FG001|Stage 2|Disease Progression|0|||
146779514|NCT00087139|529361640|FG000|Overall Study|Adverse Event|18|||
146779515|NCT00087139|529361641|FG001|Overall Study|Adverse Event|17|||
146779516|NCT00087139|529361642|FG002|Overall Study|Adverse Event|13|||
146779517|NCT00087139|529361640|FG000|Overall Study|Death|2|||
146779518|NCT00087139|529361641|FG001|Overall Study|Death|1|||
146779519|NCT00087139|529361642|FG002|Overall Study|Death|0|||
146779520|NCT00087139|529361640|FG000|Overall Study|Withdrawal by Subject|3|||
146779521|NCT00087139|529361641|FG001|Overall Study|Withdrawal by Subject|2|||
146779522|NCT00087139|529361642|FG002|Overall Study|Withdrawal by Subject|2|||
146779523|NCT00087139|529361640|FG000|Overall Study|Physician Decision|1|||
146779524|NCT00087139|529361641|FG001|Overall Study|Physician Decision|1|||
146779525|NCT00087139|529361642|FG002|Overall Study|Physician Decision|1|||
146779526|NCT00087139|529361640|FG000|Overall Study|Disease progression|9|||
146981091|NCT01764854|530093737|FG002|Overall Study|Withdrawal by Subject|1|||
146981092|NCT01764854|530093738|FG003|Overall Study|Withdrawal by Subject|0|||
146981093|NCT01764854|530093735|FG000|Overall Study|relocation|0|||
146981094|NCT01764854|530093736|FG001|Overall Study|relocation|0|||
146981095|NCT01764854|530093737|FG002|Overall Study|relocation|2|||
146981096|NCT01764854|530093738|FG003|Overall Study|relocation|0|||
146981097|NCT01764854|530093735|FG000|Overall Study|Protocol Violation|0|||
146981098|NCT01764854|530093736|FG001|Overall Study|Protocol Violation|0|||
146981099|NCT01764854|530093737|FG002|Overall Study|Protocol Violation|1|||
146981100|NCT01764854|530093738|FG003|Overall Study|Protocol Violation|2|||
146981101|NCT00910858|530093747|FG000|Pharmacokinetic Phase|Adverse Event|1|||
146981102|NCT00910858|530093748|FG001|Pharmacokinetic Phase|Adverse Event|0|||
146981103|NCT00910858|530093749|FG002|Pharmacokinetic Phase|Adverse Event|0|||
146981104|NCT00910858|530093747|FG000|Monotherapy Phase|Adverse Event|3|||
146981105|NCT00910858|530093748|FG001|Monotherapy Phase|Adverse Event|2|||
146981106|NCT00910858|530093749|FG002|Monotherapy Phase|Adverse Event|0|||
146981107|NCT00910858|530093747|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
146779527|NCT00087139|529361641|FG001|Overall Study|Disease progression|19|||
146779528|NCT00087139|529361642|FG002|Overall Study|Disease progression|12|||
146779529|NCT00087139|529361640|FG000|Overall Study|Ineligible|4|||
146779530|NCT00087139|529361641|FG001|Overall Study|Ineligible|7|||
146779531|NCT00087139|529361642|FG002|Overall Study|Ineligible|4|||
146779532|NCT00087139|529361640|FG000|Overall Study|Symptomatic deterioration|1|||
146779533|NCT00087139|529361641|FG001|Overall Study|Symptomatic deterioration|1|||
146779534|NCT00087139|529361642|FG002|Overall Study|Symptomatic deterioration|3|||
146981108|NCT00910858|530093748|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
146779535|NCT00087139|529361640|FG000|Overall Study|Use of coumadin|1|||
146779536|NCT00087139|529361641|FG001|Overall Study|Use of coumadin|0|||
146779537|NCT00087139|529361642|FG002|Overall Study|Use of coumadin|0|||
146779538|NCT00087139|529361640|FG000|Overall Study|Response achieved|0|||
146779539|NCT00087139|529361641|FG001|Overall Study|Response achieved|1|||
146981109|NCT00910858|530093749|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
146779540|NCT00087139|529361642|FG002|Overall Study|Response achieved|0|||
146779541|NCT00087139|529361640|FG000|Overall Study|Extradural disease|0|||
146779542|NCT00087139|529361641|FG001|Overall Study|Extradural disease|0|||
146711313|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
146711314|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
146711315|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
146711316|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
146711317|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
146711318|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
146711319|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
146711320|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
146711321|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
146711322|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
146711323|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
146711324|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
146711325|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
146711326|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
146711327|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
146711328|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
146711329|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
146711330|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
146711331|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
146711332|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
146711333|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
146711334|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
146711335|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
146711336|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
146711337|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
146711338|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
146711339|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
146711340|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
146711341|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
146711342|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
146711343|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
146711344|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
146711345|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
146711346|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
146711347|NCT01172938|529115223|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
146711348|NCT01172938|529115224|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
146711349|NCT01172938|529115225|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
146711350|NCT01172938|529115226|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
146711351|NCT01172938|529115227|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
146711352|NCT01172938|529115228|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
146711353|NCT01172938|529115229|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
146711354|NCT01172938|529115230|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
146711355|NCT01172938|529115231|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
146711356|NCT01172938|529115223|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
146711357|NCT01172938|529115224|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
146711358|NCT01172938|529115225|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
146711359|NCT01172938|529115226|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
146711360|NCT01172938|529115227|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
146711361|NCT01172938|529115228|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
146711362|NCT01172938|529115229|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
146711363|NCT01172938|529115230|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
146711364|NCT01172938|529115231|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
146711365|NCT01172938|529115223|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
146711366|NCT01172938|529115224|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
146711367|NCT01172938|529115225|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
146711368|NCT01172938|529115226|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
146711369|NCT01172938|529115227|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
146711370|NCT01172938|529115228|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
146711371|NCT01172938|529115229|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
146711372|NCT01172938|529115230|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
146711373|NCT01172938|529115231|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
146711374|NCT01172938|529115223|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
146711375|NCT01172938|529115224|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
146711376|NCT01172938|529115225|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
146779543|NCT00087139|529361642|FG002|Overall Study|Extradural disease|1|||
146779544|NCT00976495|529361643|FG000|Overall Study|Withdrawal by Subject|0|||
146711377|NCT01172938|529115226|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
146711378|NCT01172938|529115227|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
146711379|NCT01172938|529115228|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
146711380|NCT01172938|529115229|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
146711381|NCT01172938|529115230|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
146711382|NCT01172938|529115231|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
146711383|NCT01172938|529115223|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
146711384|NCT01172938|529115224|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
146711385|NCT01172938|529115225|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
146711386|NCT01172938|529115226|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
146711387|NCT01172938|529115227|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
146711388|NCT01172938|529115228|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
146711389|NCT01172938|529115229|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
146711390|NCT01172938|529115230|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
146711391|NCT01172938|529115231|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
146711392|NCT01172938|529115223|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
146711393|NCT01172938|529115224|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
146711394|NCT01172938|529115225|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
146711395|NCT01172938|529115226|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
146711396|NCT01172938|529115227|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
146711397|NCT01172938|529115228|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
146711398|NCT01172938|529115229|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
146711399|NCT01172938|529115230|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
146711400|NCT01172938|529115231|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
146711401|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
146711402|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
146711403|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
146711404|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
146711405|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
146711406|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
146711407|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
146711408|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
146711409|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
146711410|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
146711411|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
146711412|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
146711413|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
146711414|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
146711415|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
146711416|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
146711417|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
146711418|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
146711419|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
146711420|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
146711421|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
146711422|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
146711423|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
146711424|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
146711425|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
146711426|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
146711427|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
146711428|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
146711429|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
146711430|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
146711431|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
146711432|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
146711433|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
146711434|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
146711435|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
146711436|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
146711437|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
146711438|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
146711439|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
146711440|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
146981110|NCT00910858|530093747|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
146711441|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
146711442|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
146711443|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
146711444|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
146711445|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
146711446|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
146711447|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
146711448|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
146711449|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
146711450|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
146711451|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
146711452|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
146711453|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
146711454|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
146711455|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
146711456|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
146711457|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
146711458|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
146711459|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
146711460|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
146711461|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
146711462|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
146711463|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
146711464|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
146711465|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
146711466|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
146711467|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
146711468|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
146711469|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
146711470|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
146711471|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
146711472|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
146711473|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
146711474|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
146711475|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
146711476|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
146711477|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
146711478|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
146711479|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
146711480|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
146711481|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
146711482|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
146711483|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
146711484|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
146711485|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
146711486|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
146711487|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
146711488|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
146711489|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
146711490|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
146711491|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
146711492|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
146711493|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
146711494|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
146711495|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
146711496|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
146711497|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
146711498|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
146711499|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
146711500|NCT01172938|529115223|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
146711501|NCT01172938|529115224|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
146711502|NCT01172938|529115225|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
146711503|NCT01172938|529115226|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
146711504|NCT01172938|529115227|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
146779545|NCT00976495|529361644|FG001|Overall Study|Withdrawal by Subject|1|||
146779546|NCT00976495|529361645|FG002|Overall Study|Withdrawal by Subject|0|||
146779547|NCT02272816|529361646|FG000|Overall Study|Adverse Event|1|||
146779548|NCT05171777|529361647|FG000|Treatment Crossover Period|Adverse Event|9|||
146779549|NCT05171777|529361648|FG001|Treatment Crossover Period|Adverse Event|6|||
146779550|NCT05171777|529361649|FG002|Treatment Crossover Period|Adverse Event|0|||
146779551|NCT05171777|529361650|FG003|Treatment Crossover Period|Adverse Event|0|||
146779552|NCT05171777|529361647|FG000|Treatment Crossover Period|Death|5|||
146779553|NCT05171777|529361648|FG001|Treatment Crossover Period|Death|5|||
146779554|NCT05171777|529361649|FG002|Treatment Crossover Period|Death|0|||
146779555|NCT05171777|529361650|FG003|Treatment Crossover Period|Death|0|||
146779556|NCT05171777|529361647|FG000|Treatment Crossover Period|Disease Relapse|0|||
146779557|NCT05171777|529361648|FG001|Treatment Crossover Period|Disease Relapse|1|||
146779558|NCT05171777|529361649|FG002|Treatment Crossover Period|Disease Relapse|0|||
146779559|NCT05171777|529361650|FG003|Treatment Crossover Period|Disease Relapse|0|||
146779560|NCT05171777|529361647|FG000|Treatment Crossover Period|Reason not Specified|2|||
146779561|NCT05171777|529361648|FG001|Treatment Crossover Period|Reason not Specified|1|||
146779562|NCT05171777|529361649|FG002|Treatment Crossover Period|Reason not Specified|0|||
146779563|NCT05171777|529361650|FG003|Treatment Crossover Period|Reason not Specified|0|||
146779564|NCT05171777|529361647|FG000|Treatment Crossover Period|Physician Decision|0|||
146779565|NCT05171777|529361648|FG001|Treatment Crossover Period|Physician Decision|1|||
146779566|NCT05171777|529361649|FG002|Treatment Crossover Period|Physician Decision|0|||
146779567|NCT05171777|529361650|FG003|Treatment Crossover Period|Physician Decision|0|||
146779568|NCT05171777|529361647|FG000|Treatment Crossover Period|Progressive Disease|13|||
146779569|NCT05171777|529361648|FG001|Treatment Crossover Period|Progressive Disease|9|||
146779570|NCT05171777|529361649|FG002|Treatment Crossover Period|Progressive Disease|0|||
146779571|NCT05171777|529361650|FG003|Treatment Crossover Period|Progressive Disease|0|||
146779572|NCT05171777|529361647|FG000|Treatment Crossover Period|Protocol Violation|0|||
146779573|NCT05171777|529361648|FG001|Treatment Crossover Period|Protocol Violation|2|||
146779574|NCT05171777|529361649|FG002|Treatment Crossover Period|Protocol Violation|0|||
146779575|NCT05171777|529361650|FG003|Treatment Crossover Period|Protocol Violation|0|||
146779576|NCT05171777|529361647|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
146779577|NCT05171777|529361648|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
146779578|NCT05171777|529361649|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
146779579|NCT05171777|529361650|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
146779580|NCT05171777|529361647|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
146779581|NCT05171777|529361648|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
146779582|NCT05171777|529361649|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
146779583|NCT05171777|529361650|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
146779584|NCT05171777|529361647|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
146779585|NCT05171777|529361648|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
146779586|NCT05171777|529361649|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
146779587|NCT05171777|529361650|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
146779588|NCT05171777|529361647|FG000|Treatment Continuation Period|Death|0|||
146779589|NCT05171777|529361648|FG001|Treatment Continuation Period|Death|0|||
146779590|NCT05171777|529361649|FG002|Treatment Continuation Period|Death|1|||
146779591|NCT05171777|529361650|FG003|Treatment Continuation Period|Death|6|||
146779592|NCT05171777|529361647|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
146779593|NCT05171777|529361648|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
146779594|NCT05171777|529361649|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
146779595|NCT05171777|529361650|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
146779596|NCT04154384|529361651|FG000|Overall Study|Lost to Follow-up|24|||
146779597|NCT04154384|529361652|FG001|Overall Study|Lost to Follow-up|33|||
146779598|NCT04154384|529361653|FG002|Overall Study|Lost to Follow-up|0|||
146779599|NCT04154384|529361651|FG000|Overall Study|Withdrawal by Subject|7|||
146779600|NCT04154384|529361652|FG001|Overall Study|Withdrawal by Subject|18|||
146779601|NCT04154384|529361653|FG002|Overall Study|Withdrawal by Subject|0|||
146779602|NCT04154384|529361651|FG000|Overall Study|Missing outcome data|1|||
146779603|NCT04154384|529361652|FG001|Overall Study|Missing outcome data|0|||
146779604|NCT04154384|529361653|FG002|Overall Study|Missing outcome data|0|||
146779605|NCT01136876|529361654|FG000|Overall Study|Lost to Follow-up|0|||
146779606|NCT01136876|529361655|FG001|Overall Study|Lost to Follow-up|1|||
146779607|NCT01136876|529361654|FG000|Overall Study|Physician Decision|3|||
146779608|NCT01136876|529361655|FG001|Overall Study|Physician Decision|5|||
146779609|NCT01136876|529361654|FG000|Overall Study|Missing NGAL measurement|2|||
146779610|NCT01136876|529361655|FG001|Overall Study|Missing NGAL measurement|5|||
146779611|NCT05321069|529361656|FG000|Overall Study|Adverse Event|52|||
146779612|NCT05321069|529361657|FG001|Overall Study|Adverse Event|52|||
146933901|NCT01335698|529916016|FG004|Treatment Stage 1|No longer meets study criteria|0|||
146933902|NCT01335698|529916012|FG000|Treatment Stage 1|Other|1|||
146933903|NCT01335698|529916013|FG001|Treatment Stage 1|Other|0|||
146933904|NCT01335698|529916014|FG002|Treatment Stage 1|Other|0|||
146933905|NCT01335698|529916015|FG003|Treatment Stage 1|Other|1|||
146711505|NCT01172938|529115228|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
146711506|NCT01172938|529115229|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
146711507|NCT01172938|529115230|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
146711508|NCT01172938|529115231|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
146711509|NCT02956629|529115232|FG000|Overall Study|Adverse Event|0|||
146711510|NCT02956629|529115233|FG001|Overall Study|Adverse Event|0|||
146711511|NCT02956629|529115234|FG002|Overall Study|Adverse Event|1|||
146711512|NCT02956629|529115235|FG003|Overall Study|Adverse Event|0|||
146711513|NCT02956629|529115236|FG004|Overall Study|Adverse Event|0|||
146711514|NCT02956629|529115237|FG005|Overall Study|Adverse Event|0|||
146711515|NCT02956629|529115232|FG000|Overall Study|Lost to Follow-up|2|||
146711516|NCT02956629|529115233|FG001|Overall Study|Lost to Follow-up|5|||
146711517|NCT02956629|529115234|FG002|Overall Study|Lost to Follow-up|3|||
146711518|NCT02956629|529115235|FG003|Overall Study|Lost to Follow-up|1|||
146711519|NCT02956629|529115236|FG004|Overall Study|Lost to Follow-up|0|||
146711520|NCT02956629|529115237|FG005|Overall Study|Lost to Follow-up|1|||
146711521|NCT02956629|529115232|FG000|Overall Study|Withdrawal by Subject|3|||
146711522|NCT02956629|529115233|FG001|Overall Study|Withdrawal by Subject|1|||
146711523|NCT02956629|529115234|FG002|Overall Study|Withdrawal by Subject|0|||
146711524|NCT02956629|529115235|FG003|Overall Study|Withdrawal by Subject|0|||
146711525|NCT02956629|529115236|FG004|Overall Study|Withdrawal by Subject|0|||
146711526|NCT02956629|529115237|FG005|Overall Study|Withdrawal by Subject|0|||
146711527|NCT00003498|529115238|FG000|Overall Study|Not evaluable.|4|||
146711528|NCT05282004|529115246|FG000|Overall Study|Adverse Event|2|||
146711529|NCT04808609|529115247|FG000|Overall Study|Lost to Follow-up|0|||
146711530|NCT04808609|529115248|FG001|Overall Study|Lost to Follow-up|2|||
146711531|NCT04808609|529115247|FG000|Overall Study|Administrative Withdrawal|0|||
146711532|NCT04808609|529115248|FG001|Overall Study|Administrative Withdrawal|1|||
146711533|NCT01993719|529115249|FG000|First Drug Administration|Not treated|1|||
146711534|NCT01993719|529115250|FG001|First Drug Administration|Not treated|0|||
146711535|NCT01993719|529115251|FG002|First Drug Administration|Not treated|0|||
146711536|NCT01993719|529115252|FG003|First Drug Administration|Not treated|0|||
146711537|NCT01993719|529115253|FG004|First Drug Administration|Not treated|0|||
146711538|NCT04713748|529115260|FG000|Overall Study|Not enough kits allocated|35|||
146711539|NCT02461589|529115261|FG000|Overall Study|Withdrawal by Subject|5|||
146711540|NCT02461589|529115262|FG001|Overall Study|Withdrawal by Subject|1|||
146711541|NCT02461589|529115263|FG002|Overall Study|Withdrawal by Subject|3|||
146711542|NCT02461589|529115264|FG003|Overall Study|Withdrawal by Subject|2|||
146711543|NCT02461589|529115265|FG004|Overall Study|Withdrawal by Subject|1|||
146711544|NCT02461589|529115266|FG005|Overall Study|Withdrawal by Subject|2|||
146711545|NCT02461589|529115267|FG006|Overall Study|Withdrawal by Subject|1|||
146711546|NCT02461589|529115268|FG007|Overall Study|Withdrawal by Subject|3|||
146711547|NCT02461589|529115269|FG008|Overall Study|Withdrawal by Subject|3|||
146711548|NCT02461589|529115270|FG009|Overall Study|Withdrawal by Subject|1|||
146711549|NCT02461589|529115261|FG000|Overall Study|Lost to Follow-up|0|||
146711550|NCT02461589|529115262|FG001|Overall Study|Lost to Follow-up|0|||
146711551|NCT02461589|529115263|FG002|Overall Study|Lost to Follow-up|2|||
146711552|NCT02461589|529115264|FG003|Overall Study|Lost to Follow-up|3|||
146711553|NCT02461589|529115265|FG004|Overall Study|Lost to Follow-up|1|||
146711554|NCT02461589|529115266|FG005|Overall Study|Lost to Follow-up|1|||
146711555|NCT02461589|529115267|FG006|Overall Study|Lost to Follow-up|3|||
146711556|NCT02461589|529115268|FG007|Overall Study|Lost to Follow-up|1|||
146711557|NCT02461589|529115269|FG008|Overall Study|Lost to Follow-up|3|||
146711558|NCT02461589|529115270|FG009|Overall Study|Lost to Follow-up|1|||
146711559|NCT02461589|529115261|FG000|Overall Study|Death|0|||
146711560|NCT02461589|529115262|FG001|Overall Study|Death|0|||
146711561|NCT02461589|529115263|FG002|Overall Study|Death|0|||
146711562|NCT02461589|529115264|FG003|Overall Study|Death|0|||
146711563|NCT02461589|529115265|FG004|Overall Study|Death|0|||
146711564|NCT02461589|529115266|FG005|Overall Study|Death|0|||
146711565|NCT02461589|529115267|FG006|Overall Study|Death|0|||
146779613|NCT05321069|529361658|FG002|Overall Study|Adverse Event|64|||
146779614|NCT05321069|529361656|FG000|Overall Study|Protocol Violation|1|||
146711566|NCT02461589|529115268|FG007|Overall Study|Death|1|||
146711567|NCT02461589|529115269|FG008|Overall Study|Death|0|||
146711568|NCT02461589|529115270|FG009|Overall Study|Death|0|||
146711569|NCT02461589|529115261|FG000|Overall Study|Unclassified|0|||
146711570|NCT02461589|529115262|FG001|Overall Study|Unclassified|0|||
146711571|NCT02461589|529115263|FG002|Overall Study|Unclassified|0|||
146711572|NCT02461589|529115264|FG003|Overall Study|Unclassified|0|||
146711573|NCT02461589|529115265|FG004|Overall Study|Unclassified|0|||
146711574|NCT02461589|529115266|FG005|Overall Study|Unclassified|0|||
146711575|NCT02461589|529115267|FG006|Overall Study|Unclassified|1|||
146711576|NCT02461589|529115268|FG007|Overall Study|Unclassified|0|||
146779615|NCT05321069|529361657|FG001|Overall Study|Protocol Violation|1|||
146933906|NCT01335698|529916016|FG004|Treatment Stage 1|Other|0|||
146711577|NCT02461589|529115269|FG008|Overall Study|Unclassified|0|||
146711578|NCT02461589|529115270|FG009|Overall Study|Unclassified|2|||
146711579|NCT02461589|529115261|FG000|Overall Study|Missing follow-up information|1|||
146779616|NCT05321069|529361658|FG002|Overall Study|Protocol Violation|0|||
146779617|NCT05321069|529361656|FG000|Overall Study|Withdrawal by Subject|23|||
146779618|NCT05321069|529361657|FG001|Overall Study|Withdrawal by Subject|18|||
146779619|NCT05321069|529361658|FG002|Overall Study|Withdrawal by Subject|12|||
146779620|NCT05321069|529361656|FG000|Overall Study|Lost to Follow-up|1|||
146779621|NCT05321069|529361657|FG001|Overall Study|Lost to Follow-up|0|||
146779622|NCT05321069|529361658|FG002|Overall Study|Lost to Follow-up|1|||
146779623|NCT05321069|529361656|FG000|Overall Study|No reason stated by the participants|23|||
146779624|NCT05321069|529361657|FG001|Overall Study|No reason stated by the participants|22|||
146779625|NCT05321069|529361658|FG002|Overall Study|No reason stated by the participants|16|||
146779626|NCT05321069|529361656|FG000|Overall Study|Lack of Efficacy|1|||
146779627|NCT05321069|529361657|FG001|Overall Study|Lack of Efficacy|1|||
146779628|NCT05321069|529361658|FG002|Overall Study|Lack of Efficacy|0|||
146779629|NCT02412748|529361661|FG000|Overall Study|Lost to Follow-up|38|||
146779630|NCT02412748|529361662|FG001|Overall Study|Lost to Follow-up|39|||
146779631|NCT04128319|529361663|FG000|Overall Study|Death|3|||
146779632|NCT03582722|529361668|FG000|Overall Study|Lost to Follow-up|1|||
146779633|NCT03582722|529361669|FG001|Overall Study|Lost to Follow-up|4|||
146779634|NCT03582722|529361668|FG000|Overall Study|Withdrawal by Subject|3|||
146779635|NCT03582722|529361669|FG001|Overall Study|Withdrawal by Subject|3|||
146779636|NCT01959698|529361670|FG000|Overall Study|Adverse Event|0|||
146779637|NCT01959698|529361671|FG001|Overall Study|Adverse Event|0|||
146779638|NCT01959698|529361672|FG002|Overall Study|Adverse Event|0|||
146779639|NCT01959698|529361673|FG003|Overall Study|Adverse Event|0|||
146779640|NCT01959698|529361674|FG004|Overall Study|Adverse Event|0|||
146779641|NCT01959698|529361675|FG005|Overall Study|Adverse Event|0|||
146779642|NCT01959698|529361676|FG006|Overall Study|Adverse Event|1|||
146779643|NCT01959698|529361670|FG000|Overall Study|Physician Decision|1|||
146779644|NCT01959698|529361671|FG001|Overall Study|Physician Decision|0|||
146779645|NCT01959698|529361672|FG002|Overall Study|Physician Decision|1|||
146779646|NCT01959698|529361673|FG003|Overall Study|Physician Decision|2|||
146779647|NCT01959698|529361674|FG004|Overall Study|Physician Decision|0|||
146779648|NCT01959698|529361675|FG005|Overall Study|Physician Decision|3|||
146779649|NCT01959698|529361676|FG006|Overall Study|Physician Decision|3|||
146779650|NCT02525692|529363950|FG000|Overall Study|Withdrawal by Subject|1|||
146779651|NCT02525692|529363951|FG001|Overall Study|Withdrawal by Subject|1|||
146779652|NCT02525692|529363952|FG002|Overall Study|Withdrawal by Subject|0|||
146779653|NCT02525692|529363953|FG003|Overall Study|Withdrawal by Subject|5|||
146779654|NCT02525692|529363954|FG004|Overall Study|Withdrawal by Subject|0|||
146779655|NCT02525692|529363955|FG005|Overall Study|Withdrawal by Subject|1|||
146779656|NCT02525692|529363950|FG000|Overall Study|Death|16|||
146779657|NCT02525692|529363951|FG001|Overall Study|Death|18|||
146779658|NCT02525692|529363952|FG002|Overall Study|Death|7|||
146779659|NCT02525692|529363953|FG003|Overall Study|Death|20|||
146779660|NCT02525692|529363954|FG004|Overall Study|Death|3|||
146779661|NCT02525692|529363955|FG005|Overall Study|Death|6|||
146779662|NCT02525692|529363950|FG000|Overall Study|Lost to Follow-up|0|||
146779663|NCT02525692|529363951|FG001|Overall Study|Lost to Follow-up|0|||
146779664|NCT02525692|529363952|FG002|Overall Study|Lost to Follow-up|1|||
146779665|NCT02525692|529363953|FG003|Overall Study|Lost to Follow-up|5|||
146779666|NCT02525692|529363954|FG004|Overall Study|Lost to Follow-up|0|||
146779667|NCT02525692|529363955|FG005|Overall Study|Lost to Follow-up|0|||
146779668|NCT05510232|529363956|FG000|Overall Study|Withdrawal by Subject|2|||
146779669|NCT05510232|529363957|FG001|Overall Study|Withdrawal by Subject|7|||
146779670|NCT05510232|529363958|FG002|Overall Study|Withdrawal by Subject|6|||
146779671|NCT00979576|529363968|FG000|Combination Treatment Phase|Progressive disease|3|||
146779672|NCT00979576|529363969|FG001|Combination Treatment Phase|Progressive disease|1|||
146779673|NCT00979576|529363970|FG002|Combination Treatment Phase|Progressive disease|5|||
146779674|NCT00979576|529363968|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
146779675|NCT00979576|529363969|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
146779676|NCT00979576|529363970|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
146779677|NCT00979576|529363968|FG000|Combination Treatment Phase|Adverse Event|0|||
146779678|NCT00979576|529363969|FG001|Combination Treatment Phase|Adverse Event|2|||
146779679|NCT00979576|529363970|FG002|Combination Treatment Phase|Adverse Event|2|||
146779680|NCT00979576|529363968|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
146779681|NCT00979576|529363969|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
146779682|NCT00979576|529363970|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
146779683|NCT04905407|529363972|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
146779684|NCT04905407|529363973|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
146779685|NCT04905407|529363974|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
146779686|NCT04905407|529363975|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
146779687|NCT04905407|529363972|FG000|Part 1 and Part 2|Death|7|||
146779688|NCT04905407|529363973|FG001|Part 1 and Part 2|Death|7|||
146779689|NCT04905407|529363974|FG002|Part 1 and Part 2|Death|7|||
146779690|NCT04905407|529363975|FG003|Part 1 and Part 2|Death|0|||
146779691|NCT04905407|529363972|FG000|Part 1 and Part 2|Other than specified|0|||
146779692|NCT04905407|529363973|FG001|Part 1 and Part 2|Other than specified|0|||
146779693|NCT04905407|529363974|FG002|Part 1 and Part 2|Other than specified|1|||
146711580|NCT02461589|529115262|FG001|Overall Study|Missing follow-up information|1|||
146933907|NCT01335698|529916012|FG000|Treatment Stage 2|Lack of Efficacy|2|||
146933908|NCT01335698|529916013|FG001|Treatment Stage 2|Lack of Efficacy|1|||
146711581|NCT02461589|529115263|FG002|Overall Study|Missing follow-up information|0|||
146711582|NCT02461589|529115264|FG003|Overall Study|Missing follow-up information|0|||
146711583|NCT02461589|529115265|FG004|Overall Study|Missing follow-up information|0|||
146711584|NCT02461589|529115266|FG005|Overall Study|Missing follow-up information|0|||
146711585|NCT02461589|529115267|FG006|Overall Study|Missing follow-up information|1|||
146711586|NCT02461589|529115268|FG007|Overall Study|Missing follow-up information|0|||
146711587|NCT02461589|529115269|FG008|Overall Study|Missing follow-up information|0|||
146711588|NCT02461589|529115270|FG009|Overall Study|Missing follow-up information|0|||
146711589|NCT02461589|529115261|FG000|Overall Study|Withdrawal from trial before exposure|0|||
146711590|NCT02461589|529115262|FG001|Overall Study|Withdrawal from trial before exposure|0|||
146711591|NCT02461589|529115263|FG002|Overall Study|Withdrawal from trial before exposure|0|||
146711592|NCT02461589|529115264|FG003|Overall Study|Withdrawal from trial before exposure|0|||
146711593|NCT02461589|529115265|FG004|Overall Study|Withdrawal from trial before exposure|0|||
146711594|NCT02461589|529115266|FG005|Overall Study|Withdrawal from trial before exposure|0|||
146711595|NCT02461589|529115267|FG006|Overall Study|Withdrawal from trial before exposure|0|||
146711596|NCT02461589|529115268|FG007|Overall Study|Withdrawal from trial before exposure|0|||
146711597|NCT02461589|529115269|FG008|Overall Study|Withdrawal from trial before exposure|0|||
146711598|NCT02461589|529115270|FG009|Overall Study|Withdrawal from trial before exposure|1|||
146711599|NCT01557946|529115271|FG000|Overall Study|Adverse Event|3|||
146711600|NCT01557946|529115272|FG001|Overall Study|Adverse Event|0|||
146711601|NCT04067141|529115273|FG000|First Intervention|Withdrawal by Subject|0|||
146711602|NCT04067141|529115274|FG001|First Intervention|Withdrawal by Subject|1|||
146711603|NCT04067141|529115273|FG000|Second Intervention|Adverse Event|0|||
146711604|NCT04067141|529115274|FG001|Second Intervention|Adverse Event|2|||
146711605|NCT03295201|529115275|FG000|Overall Study|Lost to Follow-up|1|||
146711606|NCT03295201|529115276|FG001|Overall Study|Lost to Follow-up|1|||
146711607|NCT03295201|529115275|FG000|Overall Study|Hospital admission|0|||
146711608|NCT03295201|529115276|FG001|Overall Study|Hospital admission|1|||
146711609|NCT00572572|529115277|FG000|Overall Study|Withdrawal by Subject|3|||
146711610|NCT00572572|529115278|FG001|Overall Study|Withdrawal by Subject|6|||
146711611|NCT00889421|529115279|FG000|Overall Study|Lack of Efficacy|3|||
146711612|NCT01958918|529115280|FG000|Overall Study|Death|1|||
146711613|NCT01958918|529115281|FG001|Overall Study|Death|3|||
146711614|NCT01958918|529115280|FG000|Overall Study|Lost to Follow-up|4|||
146711615|NCT01958918|529115281|FG001|Overall Study|Lost to Follow-up|7|||
146711616|NCT01958918|529115280|FG000|Overall Study|Withdrawal by Subject|13|||
146711617|NCT01958918|529115281|FG001|Overall Study|Withdrawal by Subject|8|||
146711618|NCT01958918|529115280|FG000|Overall Study|Lack of Efficacy|13|||
146711619|NCT01958918|529115281|FG001|Overall Study|Lack of Efficacy|10|||
146711620|NCT01958918|529115280|FG000|Overall Study|Adverse Event|12|||
146711621|NCT01958918|529115281|FG001|Overall Study|Adverse Event|12|||
146711622|NCT01958918|529115280|FG000|Overall Study|administrative problems|0|||
146711623|NCT01958918|529115281|FG001|Overall Study|administrative problems|2|||
146711624|NCT02114892|529115285|FG000|Overall Study|Lost to Follow-up|1|||
146711625|NCT02114892|529115286|FG001|Overall Study|Lost to Follow-up|2|||
146711626|NCT00659269|529115290|FG000|Overall Study|Physician Decision|1|||
146711627|NCT00659269|529115291|FG001|Overall Study|Physician Decision|1|||
146711628|NCT00718042|529115293|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
146711629|NCT00718042|529115294|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
146711630|NCT00718042|529115295|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
146711631|NCT00718042|529115296|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
146711632|NCT00718042|529115297|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
146711633|NCT00718042|529115298|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
146711634|NCT00718042|529115293|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
146711635|NCT00718042|529115294|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
146711636|NCT00718042|529115295|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
146711637|NCT00718042|529115296|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
146711638|NCT00718042|529115297|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
146711639|NCT00718042|529115298|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
146711640|NCT00718042|529115293|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
146933909|NCT01335698|529916014|FG002|Treatment Stage 2|Lack of Efficacy|3|||
146711641|NCT00718042|529115294|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
146711642|NCT00718042|529115295|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
146711643|NCT00718042|529115296|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
146711644|NCT00718042|529115297|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
146711645|NCT00718042|529115298|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
146711646|NCT00718042|529115293|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
146711647|NCT00718042|529115294|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
146711648|NCT00718042|529115295|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
146933910|NCT01335698|529916015|FG003|Treatment Stage 2|Lack of Efficacy|1|||
146779694|NCT04905407|529363975|FG003|Part 1 and Part 2|Other than specified|0|||
146779695|NCT04905407|529363972|FG000|Part 3|Death|0|||
146779696|NCT04905407|529363973|FG001|Part 3|Death|0|||
146779697|NCT04905407|529363974|FG002|Part 3|Death|0|||
146779698|NCT04905407|529363975|FG003|Part 3|Death|2|||
146779699|NCT05444192|529363983|FG000|Overall Study|Lost to Follow-up|1|||
146779700|NCT05444192|529363984|FG001|Overall Study|Lost to Follow-up|0|||
146779701|NCT04424927|529363986|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
146779702|NCT04424927|529363987|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
146779703|NCT04424927|529363988|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
146779704|NCT04424927|529363989|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
146779705|NCT04424927|529363990|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
146779706|NCT04424927|529363986|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
146779707|NCT04424927|529363987|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
146779708|NCT04424927|529363988|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
146779709|NCT04424927|529363989|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
146779710|NCT04424927|529363990|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
146779711|NCT04424927|529363986|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
146779712|NCT04424927|529363987|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
146779713|NCT04424927|529363988|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
146779714|NCT04424927|529363989|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
146779715|NCT04424927|529363990|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
146779716|NCT04424927|529363986|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
146779717|NCT04424927|529363987|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
146779718|NCT04424927|529363988|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
146779719|NCT04424927|529363989|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
146779720|NCT04424927|529363990|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
146779721|NCT04424927|529363986|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
146779722|NCT04424927|529363987|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
146779723|NCT04424927|529363988|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
146779724|NCT04424927|529363989|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
146779725|NCT04424927|529363990|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
146779726|NCT04424927|529363986|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
146779727|NCT04424927|529363987|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
146779728|NCT04424927|529363988|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
146779729|NCT04424927|529363989|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
146779730|NCT04424927|529363990|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
146779731|NCT04424927|529363986|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
146779732|NCT04424927|529363987|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
146779733|NCT04424927|529363988|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
146779734|NCT04424927|529363989|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
146779735|NCT04424927|529363990|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
146779736|NCT04424927|529363986|FG000|Double-blind Period (24 Weeks)|Other|0|||
146779737|NCT04424927|529363987|FG001|Double-blind Period (24 Weeks)|Other|1|||
146779738|NCT04424927|529363988|FG002|Double-blind Period (24 Weeks)|Other|3|||
146779739|NCT04424927|529363989|FG003|Double-blind Period (24 Weeks)|Other|1|||
146779740|NCT04424927|529363990|FG004|Double-blind Period (24 Weeks)|Other|0|||
146779741|NCT04791709|529363994|FG000|Overall Study|Withdrawal by Subject|3|||
146779742|NCT02724956|529363995|FG000|Overall Study|Physician Decision|1|||
146779743|NCT02724956|529363996|FG001|Overall Study|Physician Decision|0|||
146779744|NCT02724956|529363995|FG000|Overall Study|Lack of Efficacy|0|||
146779745|NCT02724956|529363996|FG001|Overall Study|Lack of Efficacy|1|||
146779746|NCT02724956|529363995|FG000|Overall Study|Withdrawal by Subject|0|||
146779747|NCT02724956|529363996|FG001|Overall Study|Withdrawal by Subject|1|||
146779748|NCT01532388|529363997|FG000|3-month Follow-up|Lost to Follow-up|68|||
146779749|NCT01532388|529363998|FG001|3-month Follow-up|Lost to Follow-up|68|||
146779750|NCT01532388|529363997|FG000|6-month Follow-up|Lost to Follow-up|74|||
146779751|NCT01532388|529363998|FG001|6-month Follow-up|Lost to Follow-up|66|||
146779752|NCT01532388|529363997|FG000|12-month Follow-up|Lost to Follow-up|69|||
146779753|NCT01532388|529363998|FG001|12-month Follow-up|Lost to Follow-up|67|||
146779754|NCT00792636|529363999|FG000|Overall Study|Protocol Violation|17|||
146779755|NCT00792636|529364000|FG001|Overall Study|Protocol Violation|23|||
146779756|NCT00792636|529364001|FG002|Overall Study|Protocol Violation|20|||
146779757|NCT00792636|529363999|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
146779758|NCT00792636|529364000|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
146779759|NCT00792636|529364001|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
146933911|NCT01335698|529916016|FG004|Treatment Stage 2|Lack of Efficacy|0|||
146779760|NCT00792636|529363999|FG000|Overall Study|Lost to Follow-up|13|||
146779761|NCT00792636|529364000|FG001|Overall Study|Lost to Follow-up|19|||
146779762|NCT00792636|529364001|FG002|Overall Study|Lost to Follow-up|14|||
146779763|NCT00792636|529363999|FG000|Overall Study|Withdrew Consent|10|||
146933912|NCT01335698|529916012|FG000|Treatment Stage 2|Adverse Event|2|||
146711649|NCT00718042|529115296|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
146711650|NCT00718042|529115297|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
146711651|NCT00718042|529115298|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
146711652|NCT00718042|529115293|FG000|Donor Follow-up|Lost to Follow-up|13|||
146711653|NCT00718042|529115294|FG001|Donor Follow-up|Lost to Follow-up|0|||
146711654|NCT00718042|529115295|FG002|Donor Follow-up|Lost to Follow-up|0|||
146711655|NCT00718042|529115296|FG003|Donor Follow-up|Lost to Follow-up|0|||
146711656|NCT00718042|529115297|FG004|Donor Follow-up|Lost to Follow-up|19|||
146711657|NCT00718042|529115298|FG005|Donor Follow-up|Lost to Follow-up|0|||
146711658|NCT04327934|529115299|FG000|Overall Study|Did not qualify|7|||
146711659|NCT04327934|529115300|FG001|Overall Study|Did not qualify|4|||
146711660|NCT04327934|529115299|FG000|Overall Study|Physician Decision|0|||
146711661|NCT04327934|529115300|FG001|Overall Study|Physician Decision|1|||
146711662|NCT02822794|529115302|FG000|Overall Study|Withdrew Consent|1|||
146711663|NCT02822794|529115303|FG001|Overall Study|Withdrew Consent|0|||
146711664|NCT03732248|529115304|FG000|Overall Study|Withdrawal by Subject|1|||
146711665|NCT03732248|529115305|FG001|Overall Study|Withdrawal by Subject|0|||
146711666|NCT02266381|529115306|FG000|Overall Study|Physician Decision|3|||
146711667|NCT02266381|529115307|FG001|Overall Study|Physician Decision|5|||
146711668|NCT02266381|529115308|FG002|Overall Study|Physician Decision|4|||
146711669|NCT00403546|529115312|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
146711670|NCT00403546|529115313|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
146711671|NCT00403546|529115314|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
146711672|NCT00403546|529115312|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
146711673|NCT00403546|529115313|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
146711674|NCT00403546|529115314|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
146711675|NCT00403546|529115312|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
146711676|NCT00403546|529115313|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
146711677|NCT00403546|529115314|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
146711678|NCT00403546|529115312|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
146711679|NCT00403546|529115313|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
146711680|NCT00403546|529115314|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
146711681|NCT00403546|529115312|FG000|Screening Phase|Screening Failure|22|||
146711682|NCT00403546|529115313|FG001|Screening Phase|Screening Failure|0|||
146711683|NCT00403546|529115314|FG002|Screening Phase|Screening Failure|0|||
146711684|NCT00403546|529115312|FG000|Screening Phase|Adverse Event|1|||
146711685|NCT00403546|529115313|FG001|Screening Phase|Adverse Event|0|||
146711686|NCT00403546|529115314|FG002|Screening Phase|Adverse Event|0|||
146711687|NCT00403546|529115312|FG000|Screening Phase|Terminated Prior to Randomization|5|||
146711688|NCT00403546|529115313|FG001|Screening Phase|Terminated Prior to Randomization|0|||
146711689|NCT00403546|529115314|FG002|Screening Phase|Terminated Prior to Randomization|0|||
146711690|NCT00403546|529115312|FG000|Randomized Trial|Early Terminations|0|||
146711691|NCT00403546|529115313|FG001|Randomized Trial|Early Terminations|17|||
146711692|NCT00403546|529115314|FG002|Randomized Trial|Early Terminations|16|||
146711693|NCT02604589|529115315|FG000|Overall Study|catheter dislodgement|0|||
146711694|NCT02604589|529115316|FG001|Overall Study|catheter dislodgement|0|||
146711695|NCT02604589|529115317|FG002|Overall Study|catheter dislodgement|1|||
146711696|NCT00793910|529115318|FG000|Overall Study|discarded study pills|0|||
146711697|NCT00793910|529115319|FG001|Overall Study|discarded study pills|1|||
146711698|NCT00793910|529115318|FG000|Overall Study|did not pick up medications|1|||
146711699|NCT00793910|529115319|FG001|Overall Study|did not pick up medications|1|||
146711700|NCT00793910|529115318|FG000|Overall Study|ineligible based on entry criteria|2|||
146711701|NCT00793910|529115319|FG001|Overall Study|ineligible based on entry criteria|3|||
146711702|NCT00793910|529115318|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
146711703|NCT00793910|529115319|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
146711704|NCT00793910|529115318|FG000|Overall Study|Withdrawal by Subject|0|||
146711705|NCT00793910|529115319|FG001|Overall Study|Withdrawal by Subject|1|||
146711706|NCT02610140|529115322|FG000|Randomization and Treatment Period|Radiological progression|23|||
146711707|NCT02610140|529115323|FG001|Randomization and Treatment Period|Radiological progression|15|||
146711708|NCT02610140|529115322|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
146711709|NCT02610140|529115323|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
146711710|NCT02610140|529115322|FG000|Randomization and Treatment Period|Protocol Violation|1|||
146711711|NCT02610140|529115323|FG001|Randomization and Treatment Period|Protocol Violation|0|||
146711712|NCT02610140|529115322|FG000|Randomization and Treatment Period|Physician Decision|0|||
146711713|NCT02610140|529115323|FG001|Randomization and Treatment Period|Physician Decision|1|||
146711714|NCT02610140|529115322|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
146711715|NCT02610140|529115323|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
146711716|NCT02610140|529115322|FG000|Randomization and Treatment Period|Death|7|||
146711717|NCT02610140|529115323|FG001|Randomization and Treatment Period|Death|1|||
146711718|NCT02610140|529115322|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
146711719|NCT02610140|529115323|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
146711720|NCT02610140|529115322|FG000|Randomization and Treatment Period|Adverse Event|44|||
146779764|NCT00792636|529364000|FG001|Overall Study|Withdrew Consent|13|||
146779765|NCT00792636|529364001|FG002|Overall Study|Withdrew Consent|9|||
146779766|NCT00792636|529363999|FG000|Overall Study|Lack of Efficacy|3|||
146711721|NCT02610140|529115323|FG001|Randomization and Treatment Period|Adverse Event|13|||
146711722|NCT02610140|529115322|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
146779767|NCT00792636|529364000|FG001|Overall Study|Lack of Efficacy|4|||
146779768|NCT00792636|529364001|FG002|Overall Study|Lack of Efficacy|13|||
146779769|NCT00792636|529363999|FG000|Overall Study|Adverse Event|4|||
146779770|NCT00792636|529364000|FG001|Overall Study|Adverse Event|2|||
146779771|NCT00792636|529364001|FG002|Overall Study|Adverse Event|3|||
146779772|NCT00792636|529363999|FG000|Overall Study|Investigator Discretion|2|||
146779773|NCT00792636|529364000|FG001|Overall Study|Investigator Discretion|0|||
146779774|NCT00792636|529364001|FG002|Overall Study|Investigator Discretion|2|||
146779775|NCT01046136|529364002|FG000|Overall Study|Withdrawal by Subject|0|||
146779776|NCT01046136|529364003|FG001|Overall Study|Withdrawal by Subject|4|||
146779777|NCT01046136|529364002|FG000|Overall Study|Physician Decision|1|||
146779778|NCT01046136|529364003|FG001|Overall Study|Physician Decision|1|||
146779779|NCT01046136|529364002|FG000|Overall Study|Lost to Follow-up|3|||
146779780|NCT01046136|529364003|FG001|Overall Study|Lost to Follow-up|3|||
146779781|NCT04579250|529364004|FG000|Overall Study|Withdrawal by Subject|1|||
146779782|NCT04579250|529364005|FG001|Overall Study|Withdrawal by Subject|1|||
146779783|NCT04579250|529364006|FG002|Overall Study|Withdrawal by Subject|0|||
146779784|NCT04579250|529364004|FG000|Overall Study|Lost to Follow-up|1|||
146779785|NCT04579250|529364005|FG001|Overall Study|Lost to Follow-up|1|||
146779786|NCT04579250|529364006|FG002|Overall Study|Lost to Follow-up|0|||
146779787|NCT04579250|529364004|FG000|Overall Study|Moved from area|0|||
146779788|NCT04579250|529364005|FG001|Overall Study|Moved from area|1|||
146779789|NCT04579250|529364006|FG002|Overall Study|Moved from area|2|||
146779790|NCT02058108|529364007|FG000|Overall Study|Abnormal Laboratory Values|0|||
146779791|NCT02058108|529364008|FG001|Overall Study|Abnormal Laboratory Values|1|||
146779792|NCT02058108|529364007|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
146779793|NCT02058108|529364008|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
146779794|NCT02058108|529364007|FG000|Overall Study|No longer requires study drug|0|||
146779795|NCT02058108|529364008|FG001|Overall Study|No longer requires study drug|1|||
146779796|NCT02058108|529364007|FG000|Overall Study|Withdrawal by Subject|1|||
146779797|NCT02058108|529364008|FG001|Overall Study|Withdrawal by Subject|0|||
146779798|NCT02058108|529364007|FG000|Overall Study|Administrative problems|3|||
146779799|NCT02058108|529364008|FG001|Overall Study|Administrative problems|3|||
146711723|NCT02610140|529115323|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
146711724|NCT02610140|529115322|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
146711725|NCT02610140|529115323|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
146711726|NCT02610140|529115322|FG000|Randomization and Treatment Period|Not treated|3|||
146711727|NCT02610140|529115323|FG001|Randomization and Treatment Period|Not treated|10|||
146711728|NCT02610140|529115322|FG000|Safety Follow-up|Other|0|||
146711729|NCT02610140|529115323|FG001|Safety Follow-up|Other|2|||
146711730|NCT02610140|529115322|FG000|Safety Follow-up|Lost to Follow-up|1|||
146711731|NCT02610140|529115323|FG001|Safety Follow-up|Lost to Follow-up|0|||
146711732|NCT02610140|529115322|FG000|Safety Follow-up|No follow-up|5|||
146711733|NCT02610140|529115323|FG001|Safety Follow-up|No follow-up|3|||
146711734|NCT02610140|529115322|FG000|Safety Follow-up|Death|12|||
146711735|NCT02610140|529115323|FG001|Safety Follow-up|Death|2|||
146711736|NCT02610140|529115322|FG000|Safety Follow-up|Deterioration of general conditions|15|||
146711737|NCT02610140|529115323|FG001|Safety Follow-up|Deterioration of general conditions|5|||
146711738|NCT02610140|529115322|FG000|Safety Follow-up|Withdrawal by Subject|12|||
146779800|NCT02058108|529364007|FG000|Overall Study|Protocol Violation|0|||
146779801|NCT02058108|529364008|FG001|Overall Study|Protocol Violation|1|||
146779802|NCT01376700|529364012|FG000|Overall Study|Sponsor terminated study early|8|||
146779803|NCT01376700|529364012|FG000|Overall Study|Low or high titer inhibitor|8|||
146779804|NCT00727909|529364013|FG000|Overall Study|Withdrawal by Subject|5|||
146779805|NCT00727909|529364014|FG001|Overall Study|Withdrawal by Subject|11|||
146779806|NCT00727909|529364015|FG002|Overall Study|Withdrawal by Subject|8|||
146779807|NCT00727909|529364016|FG003|Overall Study|Withdrawal by Subject|5|||
146779808|NCT00727909|529364013|FG000|Overall Study|Death|0|||
146711739|NCT02610140|529115323|FG001|Safety Follow-up|Withdrawal by Subject|12|||
146779809|NCT00727909|529364014|FG001|Overall Study|Death|0|||
146779810|NCT00727909|529364015|FG002|Overall Study|Death|1|||
146779811|NCT00727909|529364016|FG003|Overall Study|Death|0|||
146779812|NCT01696773|529364017|FG000|Days 15-27, Washout|Adverse Event|1|||
146779813|NCT01696773|529364018|FG001|Days 15-27, Washout|Adverse Event|0|||
146779814|NCT05623345|529364027|FG000|Overall Study|Withdrawal by Subject|14|||
146779815|NCT05623345|529364028|FG001|Overall Study|Withdrawal by Subject|0|||
146779816|NCT05623345|529364029|FG002|Overall Study|Withdrawal by Subject|9|||
146779817|NCT05623345|529364030|FG003|Overall Study|Withdrawal by Subject|20|||
146779818|NCT05623345|529364027|FG000|Overall Study|Lost to Follow-up|3|||
146711740|NCT02610140|529115322|FG000|Active Follow-up|Progressive disease - radiological|30|||
146711741|NCT02610140|529115323|FG001|Active Follow-up|Progressive disease - radiological|22|||
146779819|NCT05623345|529364028|FG001|Overall Study|Lost to Follow-up|0|||
146779820|NCT05623345|529364029|FG002|Overall Study|Lost to Follow-up|7|||
146779821|NCT05623345|529364030|FG003|Overall Study|Lost to Follow-up|2|||
146779822|NCT05623345|529364027|FG000|Overall Study|Termination of Study By Sponsor|37|||
146779823|NCT05623345|529364028|FG001|Overall Study|Termination of Study By Sponsor|4|||
146779824|NCT05623345|529364029|FG002|Overall Study|Termination of Study By Sponsor|40|||
146779825|NCT05623345|529364030|FG003|Overall Study|Termination of Study By Sponsor|38|||
146779826|NCT05384730|529364031|FG000|Overall Study|Adverse Event|1|||
146779827|NCT05384730|529364032|FG001|Overall Study|Adverse Event|0|||
146779828|NCT05384730|529364031|FG000|Overall Study|Lack of social support|2|||
146779829|NCT05384730|529364032|FG001|Overall Study|Lack of social support|0|||
146779830|NCT05384730|529364031|FG000|Overall Study|Hospital readmission|2|||
146779831|NCT05384730|529364032|FG001|Overall Study|Hospital readmission|0|||
146779832|NCT05384730|529364031|FG000|Overall Study|Disease progression|5|||
146779833|NCT05384730|529364032|FG001|Overall Study|Disease progression|0|||
146779834|NCT05384730|529364031|FG000|Overall Study|Overwhelmed with College commitments|0|||
146779835|NCT05384730|529364032|FG001|Overall Study|Overwhelmed with College commitments|2|||
146779836|NCT00411151|529364033|FG000|Overall Study|Death|38|||
146779837|NCT00411151|529364033|FG000|Overall Study|Withdrawal by Subject|2|||
146779838|NCT00411151|529364033|FG000|Overall Study|Lost to Follow-up|2|||
146779839|NCT00411151|529364033|FG000|Overall Study|Protocol Violation|1|||
146779840|NCT00411151|529364033|FG000|Overall Study|Trial prematurely closed|4|||
146779841|NCT01989455|529364040|FG000|Overall Study|Adverse Event|0|||
146779842|NCT01989455|529364041|FG001|Overall Study|Adverse Event|1|||
146779843|NCT01989455|529364042|FG002|Overall Study|Adverse Event|0|||
146779844|NCT01989455|529364043|FG003|Overall Study|Adverse Event|0|||
146779845|NCT01989455|529364044|FG004|Overall Study|Adverse Event|0|||
146779846|NCT01989455|529364040|FG000|Overall Study|Withdrawal by Subject|0|||
146779847|NCT01989455|529364041|FG001|Overall Study|Withdrawal by Subject|1|||
146779848|NCT01989455|529364042|FG002|Overall Study|Withdrawal by Subject|0|||
146779849|NCT01989455|529364043|FG003|Overall Study|Withdrawal by Subject|0|||
146779850|NCT01989455|529364044|FG004|Overall Study|Withdrawal by Subject|0|||
146779851|NCT01989455|529364040|FG000|Overall Study|Technical problems with infusion|0|||
146779852|NCT01989455|529364041|FG001|Overall Study|Technical problems with infusion|0|||
146779853|NCT01989455|529364042|FG002|Overall Study|Technical problems with infusion|1|||
146779854|NCT01989455|529364043|FG003|Overall Study|Technical problems with infusion|0|||
146779855|NCT01989455|529364044|FG004|Overall Study|Technical problems with infusion|1|||
146779856|NCT00999167|529364045|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
146779857|NCT00999167|529364046|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
146779858|NCT00999167|529364047|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
146779859|NCT00999167|529364045|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
146779860|NCT00999167|529364046|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
146779861|NCT00999167|529364047|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
146779862|NCT00999167|529364045|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
146779863|NCT00999167|529364046|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
146933913|NCT01335698|529916013|FG001|Treatment Stage 2|Adverse Event|0|||
146933914|NCT01335698|529916014|FG002|Treatment Stage 2|Adverse Event|0|||
146933915|NCT01335698|529916015|FG003|Treatment Stage 2|Adverse Event|3|||
146933916|NCT01335698|529916016|FG004|Treatment Stage 2|Adverse Event|0|||
146933917|NCT01335698|529916012|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
146933918|NCT01335698|529916013|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
146933919|NCT01335698|529916014|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
146779864|NCT00999167|529364047|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
146779865|NCT00999167|529364045|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
146779866|NCT00999167|529364046|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
146779867|NCT00999167|529364047|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
146779868|NCT00999167|529364045|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
146779869|NCT00999167|529364046|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
146779870|NCT00999167|529364047|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
146779871|NCT00999167|529364045|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
146779872|NCT00999167|529364046|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
146779873|NCT00999167|529364047|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
146779874|NCT00999167|529364045|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
146933920|NCT01335698|529916015|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
146933921|NCT01335698|529916016|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
146779875|NCT00999167|529364046|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
146779876|NCT00999167|529364047|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
146779877|NCT00999167|529364045|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
146779878|NCT00999167|529364046|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
146933922|NCT01335698|529916012|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
146933923|NCT01335698|529916013|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
146711742|NCT02610140|529115322|FG000|Active Follow-up|Death|8|||
146711743|NCT02610140|529115323|FG001|Active Follow-up|Death|1|||
146711744|NCT02610140|529115322|FG000|Active Follow-up|Withdrawal by Subject|4|||
146711745|NCT02610140|529115323|FG001|Active Follow-up|Withdrawal by Subject|0|||
146711746|NCT02610140|529115322|FG000|Active Follow-up|Progressive disease - clinical|1|||
146711747|NCT02610140|529115323|FG001|Active Follow-up|Progressive disease - clinical|2|||
146711748|NCT02610140|529115322|FG000|Active Follow-up|Deterioration of general conditions|1|||
146711749|NCT02610140|529115323|FG001|Active Follow-up|Deterioration of general conditions|0|||
146711750|NCT02610140|529115322|FG000|Active Follow-up|Ongoing but not completed|4|||
146711751|NCT02610140|529115323|FG001|Active Follow-up|Ongoing but not completed|1|||
146711752|NCT02610140|529115322|FG000|Long-term Follow-up|Death|86|||
146711753|NCT02610140|529115323|FG001|Long-term Follow-up|Death|44|||
146711754|NCT02610140|529115322|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
146711755|NCT02610140|529115323|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
146711756|NCT02610140|529115322|FG000|Long-term Follow-up|Lost to Follow-up|1|||
146711757|NCT02610140|529115323|FG001|Long-term Follow-up|Lost to Follow-up|2|||
146711758|NCT02610140|529115322|FG000|Long-term Follow-up|Ongoing but not completed|30|||
146711759|NCT02610140|529115323|FG001|Long-term Follow-up|Ongoing but not completed|17|||
146711760|NCT06748040|529115328|FG000|Overall Study|Death|3|||
146711761|NCT06748040|529115329|FG001|Overall Study|Death|4|||
146711762|NCT06748040|529115328|FG000|Overall Study|Lost to Follow-up|134|||
146711763|NCT06748040|529115329|FG001|Overall Study|Lost to Follow-up|132|||
146711764|NCT06748040|529115328|FG000|Overall Study|Withdrawal by Subject|3|||
146711765|NCT06748040|529115329|FG001|Overall Study|Withdrawal by Subject|5|||
146711766|NCT00432380|529116886|FG000|Overall Study|Migrated/moved from study area|3|||
146711767|NCT00432380|529116887|FG001|Overall Study|Migrated/moved from study area|4|||
146711768|NCT00432380|529116888|FG002|Overall Study|Migrated/moved from study area|1|||
146711769|NCT00432380|529116886|FG000|Overall Study|Adverse Event|1|||
146711770|NCT00432380|529116887|FG001|Overall Study|Adverse Event|0|||
146711771|NCT00432380|529116888|FG002|Overall Study|Adverse Event|0|||
146711772|NCT01071395|529116889|FG000|Overall Study|Withdrawal by Subject|2|||
146711773|NCT01071395|529116890|FG001|Overall Study|Withdrawal by Subject|1|||
146711774|NCT01071395|529116889|FG000|Overall Study|Adverse Event|3|||
146711775|NCT01071395|529116890|FG001|Overall Study|Adverse Event|1|||
146711776|NCT03422003|529116894|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
146711777|NCT03422003|529116895|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
146711778|NCT03422003|529116894|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
146711779|NCT03422003|529116895|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
146711780|NCT01404312|529116896|FG000|Overall Study|Death|21|||
146711781|NCT01404312|529116897|FG001|Overall Study|Death|27|||
146711782|NCT01404312|529116896|FG000|Overall Study|Withdrawal by Subject|15|||
146711783|NCT01404312|529116897|FG001|Overall Study|Withdrawal by Subject|18|||
146711784|NCT01404312|529116896|FG000|Overall Study|Participant Unable to get to clinic|93|||
146711785|NCT01404312|529116897|FG001|Overall Study|Participant Unable to get to clinic|103|||
146711786|NCT01404312|529116896|FG000|Overall Study|Lost to Follow-up|115|||
146711787|NCT01404312|529116897|FG001|Overall Study|Lost to Follow-up|111|||
146711788|NCT01404312|529116896|FG000|Overall Study|Site closed|22|||
146711789|NCT01404312|529116897|FG001|Overall Study|Site closed|21|||
146711790|NCT01404312|529116896|FG000|Overall Study|Participant not willing to adhere to req|31|||
146711791|NCT01404312|529116897|FG001|Overall Study|Participant not willing to adhere to req|29|||
146711792|NCT01404312|529116896|FG000|Overall Study|Severe debilitation, unable to continue|1|||
146711793|NCT01404312|529116897|FG001|Overall Study|Severe debilitation, unable to continue|2|||
146711794|NCT01722331|529116898|FG000|Part 1|Adverse Event|5|||
146711795|NCT01722331|529116899|FG001|Part 1|Adverse Event|0|||
146711796|NCT01722331|529116900|FG002|Part 1|Adverse Event|0|||
146711797|NCT01722331|529116901|FG003|Part 1|Adverse Event|0|||
146711798|NCT01722331|529116902|FG004|Part 1|Adverse Event|0|||
146711799|NCT01722331|529116903|FG005|Part 1|Adverse Event|0|||
146711800|NCT01722331|529116904|FG006|Part 1|Adverse Event|0|||
146779879|NCT00999167|529364047|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
146981111|NCT00910858|530093748|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
146981112|NCT00910858|530093749|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
146981113|NCT00910858|530093747|FG000|Monotherapy Phase|Protocol Violation|1|||
146981114|NCT00910858|530093748|FG001|Monotherapy Phase|Protocol Violation|0|||
146711801|NCT01722331|529116898|FG000|Part 1|Lack of Efficacy|0|||
146711802|NCT01722331|529116899|FG001|Part 1|Lack of Efficacy|0|||
146711803|NCT01722331|529116900|FG002|Part 1|Lack of Efficacy|1|||
146711804|NCT01722331|529116901|FG003|Part 1|Lack of Efficacy|0|||
146711805|NCT01722331|529116902|FG004|Part 1|Lack of Efficacy|2|||
146711806|NCT01722331|529116903|FG005|Part 1|Lack of Efficacy|0|||
146711807|NCT01722331|529116904|FG006|Part 1|Lack of Efficacy|0|||
146711808|NCT01722331|529116898|FG000|Part 1|Lost to Follow-up|1|||
146711809|NCT01722331|529116899|FG001|Part 1|Lost to Follow-up|0|||
146711810|NCT01722331|529116900|FG002|Part 1|Lost to Follow-up|2|||
146711811|NCT01722331|529116901|FG003|Part 1|Lost to Follow-up|0|||
146711812|NCT01722331|529116902|FG004|Part 1|Lost to Follow-up|1|||
146711813|NCT01722331|529116903|FG005|Part 1|Lost to Follow-up|0|||
146779880|NCT00448669|529364048|FG000|Overall Study|Lost to Follow-up|52|||
146779881|NCT00448669|529364049|FG001|Overall Study|Lost to Follow-up|63|||
146779882|NCT00448669|529364048|FG000|Overall Study|Withdrawal by Subject|90|||
146779883|NCT00448669|529364049|FG001|Overall Study|Withdrawal by Subject|74|||
146779884|NCT00448669|529364048|FG000|Overall Study|Relocated|49|||
146779885|NCT00448669|529364049|FG001|Overall Study|Relocated|36|||
146779886|NCT00448669|529364048|FG000|Overall Study|Were withdrawn by investigator|10|||
146779887|NCT00448669|529364049|FG001|Overall Study|Were withdrawn by investigator|6|||
146779888|NCT00448669|529364048|FG000|Overall Study|Death|2|||
146779889|NCT00448669|529364049|FG001|Overall Study|Death|4|||
146779890|NCT00448669|529364048|FG000|Overall Study|Had other reasons|5|||
146779891|NCT00448669|529364049|FG001|Overall Study|Had other reasons|6|||
146779892|NCT00448669|529364048|FG000|Overall Study|HIV-infected at enrollment|1|||
146779893|NCT00448669|529364049|FG001|Overall Study|HIV-infected at enrollment|2|||
146779894|NCT00448669|529364048|FG000|Overall Study|Never started drug|9|||
146779895|NCT00448669|529364049|FG001|Overall Study|Never started drug|7|||
146711814|NCT01722331|529116904|FG006|Part 1|Lost to Follow-up|0|||
146711815|NCT01722331|529116898|FG000|Part 1|Physician Decision|0|||
146711816|NCT01722331|529116899|FG001|Part 1|Physician Decision|0|||
146711817|NCT01722331|529116900|FG002|Part 1|Physician Decision|3|||
146711818|NCT01722331|529116901|FG003|Part 1|Physician Decision|0|||
146711819|NCT01722331|529116902|FG004|Part 1|Physician Decision|1|||
146711820|NCT01722331|529116903|FG005|Part 1|Physician Decision|0|||
146711821|NCT01722331|529116904|FG006|Part 1|Physician Decision|0|||
146711822|NCT01722331|529116898|FG000|Part 1|Pregnancy|1|||
146711823|NCT01722331|529116899|FG001|Part 1|Pregnancy|0|||
146711824|NCT01722331|529116900|FG002|Part 1|Pregnancy|0|||
146711825|NCT01722331|529116901|FG003|Part 1|Pregnancy|0|||
146711826|NCT01722331|529116902|FG004|Part 1|Pregnancy|0|||
146711827|NCT01722331|529116903|FG005|Part 1|Pregnancy|0|||
146711828|NCT01722331|529116904|FG006|Part 1|Pregnancy|0|||
146711829|NCT01722331|529116898|FG000|Part 1|Progressive Disease|0|||
146711830|NCT01722331|529116899|FG001|Part 1|Progressive Disease|0|||
146711831|NCT01722331|529116900|FG002|Part 1|Progressive Disease|0|||
146711832|NCT01722331|529116901|FG003|Part 1|Progressive Disease|0|||
146711833|NCT01722331|529116902|FG004|Part 1|Progressive Disease|1|||
146711834|NCT01722331|529116903|FG005|Part 1|Progressive Disease|0|||
146711835|NCT01722331|529116904|FG006|Part 1|Progressive Disease|0|||
146711836|NCT01722331|529116898|FG000|Part 1|Protocol Violation|1|||
146711837|NCT01722331|529116899|FG001|Part 1|Protocol Violation|0|||
146711838|NCT01722331|529116900|FG002|Part 1|Protocol Violation|0|||
146711839|NCT01722331|529116901|FG003|Part 1|Protocol Violation|0|||
146711840|NCT01722331|529116902|FG004|Part 1|Protocol Violation|1|||
146711841|NCT01722331|529116903|FG005|Part 1|Protocol Violation|0|||
146711842|NCT01722331|529116904|FG006|Part 1|Protocol Violation|0|||
146711843|NCT01722331|529116898|FG000|Part 1|Withdrawal by Subject|2|||
146711844|NCT01722331|529116899|FG001|Part 1|Withdrawal by Subject|0|||
146711845|NCT01722331|529116900|FG002|Part 1|Withdrawal by Subject|3|||
146711846|NCT01722331|529116901|FG003|Part 1|Withdrawal by Subject|0|||
146711847|NCT01722331|529116902|FG004|Part 1|Withdrawal by Subject|3|||
146711848|NCT01722331|529116903|FG005|Part 1|Withdrawal by Subject|0|||
146711849|NCT01722331|529116904|FG006|Part 1|Withdrawal by Subject|0|||
146711850|NCT01722331|529116898|FG000|Part 2|Adverse Event|3|||
146711851|NCT01722331|529116899|FG001|Part 2|Adverse Event|0|||
146711852|NCT01722331|529116900|FG002|Part 2|Adverse Event|0|||
146711853|NCT01722331|529116901|FG003|Part 2|Adverse Event|0|||
146711854|NCT01722331|529116902|FG004|Part 2|Adverse Event|0|||
146711855|NCT01722331|529116903|FG005|Part 2|Adverse Event|1|||
146711856|NCT01722331|529116904|FG006|Part 2|Adverse Event|0|||
146711857|NCT01722331|529116898|FG000|Part 2|Lack of Efficacy|3|||
146779896|NCT02638337|529364054|FG000|Overall Study|Adverse Event|6|||
146779897|NCT02638337|529364055|FG001|Overall Study|Adverse Event|10|||
146779898|NCT02638337|529364054|FG000|Overall Study|Protocol Violation|3|||
146981115|NCT00910858|530093749|FG002|Monotherapy Phase|Protocol Violation|0|||
146981116|NCT00910858|530093747|FG000|Monotherapy Phase|Other|3|||
146981117|NCT00910858|530093748|FG001|Monotherapy Phase|Other|4|||
146711858|NCT01722331|529116899|FG001|Part 2|Lack of Efficacy|0|||
146711859|NCT01722331|529116900|FG002|Part 2|Lack of Efficacy|11|||
146711860|NCT01722331|529116901|FG003|Part 2|Lack of Efficacy|0|||
146711861|NCT01722331|529116902|FG004|Part 2|Lack of Efficacy|0|||
146711862|NCT01722331|529116903|FG005|Part 2|Lack of Efficacy|3|||
146711863|NCT01722331|529116904|FG006|Part 2|Lack of Efficacy|3|||
146711864|NCT01722331|529116898|FG000|Part 2|Lost to Follow-up|0|||
146779899|NCT02638337|529364055|FG001|Overall Study|Protocol Violation|0|||
146711865|NCT01722331|529116899|FG001|Part 2|Lost to Follow-up|0|||
146711866|NCT01722331|529116900|FG002|Part 2|Lost to Follow-up|3|||
146711867|NCT01722331|529116901|FG003|Part 2|Lost to Follow-up|0|||
146711868|NCT01722331|529116902|FG004|Part 2|Lost to Follow-up|0|||
146711869|NCT01722331|529116903|FG005|Part 2|Lost to Follow-up|1|||
146711870|NCT01722331|529116904|FG006|Part 2|Lost to Follow-up|1|||
146711871|NCT01722331|529116898|FG000|Part 2|Non-Compliance with Study Drug|1|||
146711872|NCT01722331|529116899|FG001|Part 2|Non-Compliance with Study Drug|0|||
146711873|NCT01722331|529116900|FG002|Part 2|Non-Compliance with Study Drug|1|||
146779900|NCT02638337|529364054|FG000|Overall Study|Withdrawal by Subject|13|||
146981118|NCT00910858|530093749|FG002|Monotherapy Phase|Other|2|||
146933924|NCT01335698|529916014|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
146933925|NCT01335698|529916015|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
146711874|NCT01722331|529116901|FG003|Part 2|Non-Compliance with Study Drug|0|||
146711875|NCT01722331|529116902|FG004|Part 2|Non-Compliance with Study Drug|0|||
146711876|NCT01722331|529116903|FG005|Part 2|Non-Compliance with Study Drug|0|||
146711877|NCT01722331|529116904|FG006|Part 2|Non-Compliance with Study Drug|0|||
146711878|NCT01722331|529116898|FG000|Part 2|Physician Decision|0|||
146711879|NCT01722331|529116899|FG001|Part 2|Physician Decision|0|||
146711880|NCT01722331|529116900|FG002|Part 2|Physician Decision|2|||
146711881|NCT01722331|529116901|FG003|Part 2|Physician Decision|0|||
146711882|NCT01722331|529116902|FG004|Part 2|Physician Decision|0|||
146711883|NCT01722331|529116903|FG005|Part 2|Physician Decision|0|||
146711884|NCT01722331|529116904|FG006|Part 2|Physician Decision|0|||
146711885|NCT01722331|529116898|FG000|Part 2|Pregnancy|0|||
146711886|NCT01722331|529116899|FG001|Part 2|Pregnancy|0|||
146711887|NCT01722331|529116900|FG002|Part 2|Pregnancy|0|||
146711888|NCT01722331|529116901|FG003|Part 2|Pregnancy|0|||
146711889|NCT01722331|529116902|FG004|Part 2|Pregnancy|0|||
146711890|NCT01722331|529116903|FG005|Part 2|Pregnancy|1|||
146711891|NCT01722331|529116904|FG006|Part 2|Pregnancy|0|||
146711892|NCT01722331|529116898|FG000|Part 2|Progressive Disease|0|||
146711893|NCT01722331|529116899|FG001|Part 2|Progressive Disease|0|||
146711894|NCT01722331|529116900|FG002|Part 2|Progressive Disease|1|||
146711895|NCT01722331|529116901|FG003|Part 2|Progressive Disease|0|||
146711896|NCT01722331|529116902|FG004|Part 2|Progressive Disease|0|||
146711897|NCT01722331|529116903|FG005|Part 2|Progressive Disease|0|||
146711898|NCT01722331|529116904|FG006|Part 2|Progressive Disease|0|||
146711899|NCT01722331|529116898|FG000|Part 2|Protocol Violation|1|||
146711900|NCT01722331|529116899|FG001|Part 2|Protocol Violation|0|||
146711901|NCT01722331|529116900|FG002|Part 2|Protocol Violation|0|||
146711902|NCT01722331|529116901|FG003|Part 2|Protocol Violation|0|||
146711903|NCT01722331|529116902|FG004|Part 2|Protocol Violation|0|||
146711904|NCT01722331|529116903|FG005|Part 2|Protocol Violation|0|||
146711905|NCT01722331|529116904|FG006|Part 2|Protocol Violation|0|||
146711906|NCT01722331|529116898|FG000|Part 2|Withdrawal by Subject|5|||
146711907|NCT01722331|529116899|FG001|Part 2|Withdrawal by Subject|0|||
146711908|NCT01722331|529116900|FG002|Part 2|Withdrawal by Subject|3|||
146711909|NCT01722331|529116901|FG003|Part 2|Withdrawal by Subject|0|||
146711910|NCT01722331|529116902|FG004|Part 2|Withdrawal by Subject|0|||
146711911|NCT01722331|529116903|FG005|Part 2|Withdrawal by Subject|2|||
146711912|NCT01722331|529116904|FG006|Part 2|Withdrawal by Subject|2|||
146711913|NCT01722331|529116898|FG000|Part 2|Other Protocol Specified Criteria|6|||
146711914|NCT01722331|529116899|FG001|Part 2|Other Protocol Specified Criteria|0|||
146711915|NCT01722331|529116900|FG002|Part 2|Other Protocol Specified Criteria|10|||
146711916|NCT01722331|529116901|FG003|Part 2|Other Protocol Specified Criteria|0|||
146711917|NCT01722331|529116902|FG004|Part 2|Other Protocol Specified Criteria|0|||
146711918|NCT01722331|529116903|FG005|Part 2|Other Protocol Specified Criteria|2|||
146711919|NCT01722331|529116904|FG006|Part 2|Other Protocol Specified Criteria|1|||
146711920|NCT01722331|529116898|FG000|Part 3|Adverse Event|2|||
146711921|NCT01722331|529116899|FG001|Part 3|Adverse Event|2|||
146711922|NCT01722331|529116900|FG002|Part 3|Adverse Event|0|||
146711923|NCT01722331|529116901|FG003|Part 3|Adverse Event|1|||
146711924|NCT01722331|529116902|FG004|Part 3|Adverse Event|0|||
146711925|NCT01722331|529116903|FG005|Part 3|Adverse Event|0|||
146711926|NCT01722331|529116904|FG006|Part 3|Adverse Event|0|||
146711927|NCT01722331|529116898|FG000|Part 3|Death|1|||
146711928|NCT01722331|529116899|FG001|Part 3|Death|0|||
146711929|NCT01722331|529116900|FG002|Part 3|Death|0|||
146711930|NCT01722331|529116901|FG003|Part 3|Death|0|||
146711931|NCT01722331|529116902|FG004|Part 3|Death|0|||
146711932|NCT01722331|529116903|FG005|Part 3|Death|0|||
146711933|NCT01722331|529116904|FG006|Part 3|Death|0|||
146711934|NCT01722331|529116898|FG000|Part 3|Lack of Efficacy|1|||
146711935|NCT01722331|529116899|FG001|Part 3|Lack of Efficacy|0|||
146711936|NCT01722331|529116900|FG002|Part 3|Lack of Efficacy|0|||
146711937|NCT01722331|529116901|FG003|Part 3|Lack of Efficacy|0|||
146711938|NCT01722331|529116902|FG004|Part 3|Lack of Efficacy|0|||
146711939|NCT01722331|529116903|FG005|Part 3|Lack of Efficacy|0|||
146711940|NCT01722331|529116904|FG006|Part 3|Lack of Efficacy|0|||
146711941|NCT01722331|529116898|FG000|Part 3|Lost to Follow-up|3|||
146711942|NCT01722331|529116899|FG001|Part 3|Lost to Follow-up|4|||
146711943|NCT01722331|529116900|FG002|Part 3|Lost to Follow-up|0|||
146711944|NCT01722331|529116901|FG003|Part 3|Lost to Follow-up|0|||
146711945|NCT01722331|529116902|FG004|Part 3|Lost to Follow-up|0|||
146711946|NCT01722331|529116903|FG005|Part 3|Lost to Follow-up|1|||
146711947|NCT01722331|529116904|FG006|Part 3|Lost to Follow-up|0|||
146711948|NCT01722331|529116898|FG000|Part 3|Non-Compliance with Study Drug|0|||
146711949|NCT01722331|529116899|FG001|Part 3|Non-Compliance with Study Drug|1|||
146711950|NCT01722331|529116900|FG002|Part 3|Non-Compliance with Study Drug|0|||
146711951|NCT01722331|529116901|FG003|Part 3|Non-Compliance with Study Drug|0|||
146711952|NCT01722331|529116902|FG004|Part 3|Non-Compliance with Study Drug|0|||
146711953|NCT01722331|529116903|FG005|Part 3|Non-Compliance with Study Drug|0|||
146711954|NCT01722331|529116904|FG006|Part 3|Non-Compliance with Study Drug|0|||
146711955|NCT01722331|529116898|FG000|Part 3|Physician Decision|1|||
146711956|NCT01722331|529116899|FG001|Part 3|Physician Decision|1|||
146711957|NCT01722331|529116900|FG002|Part 3|Physician Decision|0|||
146711958|NCT01722331|529116901|FG003|Part 3|Physician Decision|0|||
146711959|NCT01722331|529116902|FG004|Part 3|Physician Decision|0|||
146711960|NCT01722331|529116903|FG005|Part 3|Physician Decision|0|||
146711961|NCT01722331|529116904|FG006|Part 3|Physician Decision|1|||
146711962|NCT01722331|529116898|FG000|Part 3|Protocol Violation|2|||
146711963|NCT01722331|529116899|FG001|Part 3|Protocol Violation|1|||
146711964|NCT01722331|529116900|FG002|Part 3|Protocol Violation|0|||
146711965|NCT01722331|529116901|FG003|Part 3|Protocol Violation|0|||
146711966|NCT01722331|529116902|FG004|Part 3|Protocol Violation|0|||
146711967|NCT01722331|529116903|FG005|Part 3|Protocol Violation|0|||
146711968|NCT01722331|529116904|FG006|Part 3|Protocol Violation|0|||
146711969|NCT01722331|529116898|FG000|Part 3|Withdrawal by Subject|4|||
146711970|NCT01722331|529116899|FG001|Part 3|Withdrawal by Subject|7|||
146711971|NCT01722331|529116900|FG002|Part 3|Withdrawal by Subject|0|||
146711972|NCT01722331|529116901|FG003|Part 3|Withdrawal by Subject|0|||
146711973|NCT01722331|529116902|FG004|Part 3|Withdrawal by Subject|0|||
146711974|NCT01722331|529116903|FG005|Part 3|Withdrawal by Subject|2|||
146711975|NCT01722331|529116904|FG006|Part 3|Withdrawal by Subject|1|||
146711976|NCT01722331|529116898|FG000|Part 3|Other Protocol Specified Criteria|1|||
146711977|NCT01722331|529116899|FG001|Part 3|Other Protocol Specified Criteria|1|||
146711978|NCT01722331|529116900|FG002|Part 3|Other Protocol Specified Criteria|0|||
146711979|NCT01722331|529116901|FG003|Part 3|Other Protocol Specified Criteria|0|||
146711980|NCT01722331|529116902|FG004|Part 3|Other Protocol Specified Criteria|0|||
146711981|NCT01722331|529116903|FG005|Part 3|Other Protocol Specified Criteria|0|||
146711982|NCT01722331|529116904|FG006|Part 3|Other Protocol Specified Criteria|0|||
146711983|NCT01154166|529116905|FG000|Overall Study|Adverse Event|14|||
146711984|NCT01154166|529116906|FG001|Overall Study|Adverse Event|9|||
146711985|NCT01154166|529116905|FG000|Overall Study|Lost to Follow-up|1|||
146711986|NCT01154166|529116906|FG001|Overall Study|Lost to Follow-up|1|||
146711987|NCT01154166|529116905|FG000|Overall Study|Protocol Violation|4|||
146711988|NCT01154166|529116906|FG001|Overall Study|Protocol Violation|1|||
146711989|NCT01154166|529116905|FG000|Overall Study|Withdrawal by Subject|10|||
146711990|NCT01154166|529116906|FG001|Overall Study|Withdrawal by Subject|1|||
146711991|NCT01154166|529116905|FG000|Overall Study|Lack of Efficacy|3|||
146711992|NCT01154166|529116906|FG001|Overall Study|Lack of Efficacy|0|||
146711993|NCT01154166|529116905|FG000|Overall Study|Disease Progression|1|||
146711994|NCT01154166|529116906|FG001|Overall Study|Disease Progression|0|||
146711995|NCT01154166|529116905|FG000|Overall Study|Poor Compliance|1|||
146711996|NCT01154166|529116906|FG001|Overall Study|Poor Compliance|0|||
146711997|NCT04265755|529116907|FG000|Overall Study|Withdrawal by Subject|39|||
146711998|NCT04265755|529116907|FG000|Overall Study|Decision by sponsor|2|||
146711999|NCT04265755|529116907|FG000|Overall Study|Lost to Follow-up|11|||
146712000|NCT04265755|529116907|FG000|Overall Study|Death|1|||
146712001|NCT01375049|529116908|FG000|Overall Study|Adverse Event|2|||
146712002|NCT01375049|529116908|FG000|Overall Study|Lost to Follow-up|1|||
146712003|NCT01375049|529116908|FG000|Overall Study|Withdrawal by Subject|2|||
146712004|NCT01375049|529116908|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
146712005|NCT01575561|529116909|FG000|Overall Study|Adverse Event|9|||
146712006|NCT01575561|529116909|FG000|Overall Study|Lack of Efficacy|8|||
146712007|NCT01575561|529116909|FG000|Overall Study|Lost to Follow-up|6|||
146712008|NCT01575561|529116909|FG000|Overall Study|Protocol Violation|4|||
146712009|NCT01575561|529116909|FG000|Overall Study|Withdrawal by Subject|11|||
146712010|NCT01575561|529116909|FG000|Overall Study|administration|1|||
146712011|NCT02840877|529116910|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
146712012|NCT02840877|529116910|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
146712013|NCT02840877|529116910|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
146712014|NCT02840877|529116910|FG000|Baseline to 12 Weeks|Death|1|||
146712015|NCT02840877|529116910|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
146933926|NCT01335698|529916016|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
146933927|NCT01335698|529916012|FG000|Treatment Stage 2|Lost to Follow-up|1|||
146712016|NCT02840877|529116910|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
146712017|NCT02840877|529116910|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
146712018|NCT02840877|529116910|FG000|12 Weeks to 6 Months|Treatment failure|1|||
146712019|NCT02840877|529116910|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
146712020|NCT02840877|529116910|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
146712021|NCT02840877|529116910|FG000|12 Weeks to 6 Months|Death|1|||
146712022|NCT02840877|529116910|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
146712023|NCT02840877|529116910|FG000|6 Months to 18 Months|Treatment failure|7|||
146712024|NCT02840877|529116910|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
146712025|NCT02840877|529116910|FG000|6 Months to 18 Months|Moved/transferred out|6|||
146712026|NCT02840877|529116910|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
146712027|NCT02840877|529116910|FG000|6 Months to 18 Months|Death|4|||
146712028|NCT02840877|529116910|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
146712029|NCT02840877|529116910|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
146712030|NCT02840877|529116910|FG000|6 Months to 18 Months|Still in study.|14|||
146712031|NCT00406029|529116911|FG000|Overall Study|Adverse Event|12|||
146779901|NCT02638337|529364055|FG001|Overall Study|Withdrawal by Subject|16|||
146779902|NCT02638337|529364054|FG000|Overall Study|Lost to Follow-up|7|||
146779903|NCT02638337|529364055|FG001|Overall Study|Lost to Follow-up|7|||
146779904|NCT02638337|529364054|FG000|Overall Study|Other - Miscellaneous|4|||
146779905|NCT02638337|529364055|FG001|Overall Study|Other - Miscellaneous|3|||
146779906|NCT00274469|529364056|FG000|Overall Study|Death|63|||
146779907|NCT00274469|529364057|FG001|Overall Study|Death|74|||
146779908|NCT00274469|529364056|FG000|Overall Study|Did not consent to OS follow-up|16|||
146779909|NCT00274469|529364057|FG001|Overall Study|Did not consent to OS follow-up|19|||
146779910|NCT05512962|529364058|FG000|Overall Study|Withdrawal by Subject|1|||
146779911|NCT05512962|529364059|FG001|Overall Study|Withdrawal by Subject|0|||
146779912|NCT04950127|529364060|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
146779913|NCT04950127|529364061|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
146779914|NCT04950127|529364062|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
146779915|NCT04950127|529364063|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
146779916|NCT04950127|529364064|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
146779917|NCT04950127|529364065|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
146779918|NCT04950127|529364060|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
146779919|NCT04950127|529364061|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
146779920|NCT04950127|529364062|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
146779921|NCT04950127|529364063|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
146779922|NCT04950127|529364064|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
146779923|NCT04950127|529364065|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
146779924|NCT04950127|529364060|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
146779925|NCT04950127|529364061|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
146779926|NCT04950127|529364062|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
146779927|NCT04950127|529364063|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
146779928|NCT04950127|529364064|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
146779929|NCT04950127|529364065|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
146779930|NCT04950127|529364060|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
146779931|NCT04950127|529364061|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
146933928|NCT01335698|529916013|FG001|Treatment Stage 2|Lost to Follow-up|0|||
146933929|NCT01335698|529916014|FG002|Treatment Stage 2|Lost to Follow-up|0|||
146933930|NCT01335698|529916015|FG003|Treatment Stage 2|Lost to Follow-up|0|||
146933931|NCT01335698|529916016|FG004|Treatment Stage 2|Lost to Follow-up|0|||
146712032|NCT00406029|529116912|FG001|Overall Study|Adverse Event|2|||
146712033|NCT00406029|529116913|FG002|Overall Study|Adverse Event|5|||
146712034|NCT00406029|529116914|FG003|Overall Study|Adverse Event|10|||
146712035|NCT00406029|529116915|FG004|Overall Study|Adverse Event|7|||
146712036|NCT00406029|529116911|FG000|Overall Study|Withdrawal by Subject|3|||
146712037|NCT00406029|529116912|FG001|Overall Study|Withdrawal by Subject|4|||
146712038|NCT00406029|529116913|FG002|Overall Study|Withdrawal by Subject|2|||
146712039|NCT00406029|529116914|FG003|Overall Study|Withdrawal by Subject|2|||
146712040|NCT00406029|529116915|FG004|Overall Study|Withdrawal by Subject|0|||
146712041|NCT00406029|529116911|FG000|Overall Study|Protocol Violation|1|||
146712042|NCT00406029|529116912|FG001|Overall Study|Protocol Violation|2|||
146712043|NCT00406029|529116913|FG002|Overall Study|Protocol Violation|0|||
146712044|NCT00406029|529116914|FG003|Overall Study|Protocol Violation|2|||
146712045|NCT00406029|529116915|FG004|Overall Study|Protocol Violation|0|||
146712046|NCT00406029|529116911|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
146712047|NCT00406029|529116912|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
146712048|NCT00406029|529116913|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
146712049|NCT00406029|529116914|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
146712050|NCT00406029|529116915|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
146712051|NCT00406029|529116911|FG000|Overall Study|Randomized in Error|0|||
146712052|NCT00406029|529116912|FG001|Overall Study|Randomized in Error|0|||
146712053|NCT00406029|529116913|FG002|Overall Study|Randomized in Error|2|||
146712054|NCT00406029|529116914|FG003|Overall Study|Randomized in Error|3|||
146779932|NCT04950127|529364062|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
146779933|NCT04950127|529364063|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
146779934|NCT04950127|529364064|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
146779935|NCT04950127|529364065|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
146779936|NCT04950127|529364060|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
146779937|NCT04950127|529364061|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
146779938|NCT04950127|529364062|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
146779939|NCT04950127|529364063|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
146779940|NCT04950127|529364064|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
146712055|NCT00406029|529116915|FG004|Overall Study|Randomized in Error|1|||
146712056|NCT01038921|529116917|FG000|Overall Study|Withdrawal by Subject|1|||
146712057|NCT01038921|529116918|FG001|Overall Study|Withdrawal by Subject|0|||
146712058|NCT01038921|529116917|FG000|Overall Study|Physician Decision|1|||
146779941|NCT04950127|529364065|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
146779942|NCT01711632|529364066|FG000|Overall Study|Adverse Event|4|||
146779943|NCT01711632|529364066|FG000|Overall Study|Death|3|||
146779944|NCT01711632|529364066|FG000|Overall Study|Lost to Follow-up|3|||
146779945|NCT01711632|529364066|FG000|Overall Study|Withdrawal by Subject|4|||
146712059|NCT01038921|529116918|FG001|Overall Study|Physician Decision|0|||
146712060|NCT01709227|529116919|FG000|Overall Study|Physician Decision|1|||
146712061|NCT01709227|529116920|FG001|Overall Study|Physician Decision|0|||
146712062|NCT01709227|529116919|FG000|Overall Study|Pleural Peritoneal communication|0|||
146712063|NCT01709227|529116920|FG001|Overall Study|Pleural Peritoneal communication|9|||
146712064|NCT01831089|529116924|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
146712065|NCT01831089|529116925|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
146712066|NCT01831089|529116926|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
146712067|NCT01831089|529116927|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
146712068|NCT01831089|529116928|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
146712069|NCT01831089|529116929|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
146712070|NCT01831089|529116924|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
146712071|NCT01831089|529116925|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
146712072|NCT01831089|529116926|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
146712073|NCT01831089|529116927|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
146712074|NCT01831089|529116928|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
146712075|NCT01831089|529116929|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
146712076|NCT01831089|529116924|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
146712077|NCT01831089|529116925|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
146712078|NCT01831089|529116926|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
146712079|NCT01831089|529116927|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
146712080|NCT01831089|529116928|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
146712081|NCT01831089|529116929|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
146712082|NCT01831089|529116924|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
146712083|NCT01831089|529116925|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
146712084|NCT01831089|529116926|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
146712085|NCT01831089|529116927|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
146712086|NCT01831089|529116928|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
146712087|NCT01831089|529116929|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
146712088|NCT01831089|529116924|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
146712089|NCT01831089|529116925|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
146712090|NCT01831089|529116926|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
146712091|NCT01831089|529116927|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
146712092|NCT01831089|529116928|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
146712093|NCT01831089|529116929|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
146712094|NCT01831089|529116924|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
146712095|NCT01831089|529116925|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
146712096|NCT01831089|529116926|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
146712097|NCT01831089|529116927|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
146712098|NCT01831089|529116928|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
146712099|NCT01831089|529116929|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
146712100|NCT01831089|529116924|FG000|Cohort III: Dose Level 3|Global end of study|0|||
146712101|NCT01831089|529116925|FG001|Cohort III: Dose Level 3|Global end of study|0|||
146712102|NCT01831089|529116926|FG002|Cohort III: Dose Level 3|Global end of study|1|||
146712103|NCT01831089|529116927|FG003|Cohort III: Dose Level 3|Global end of study|0|||
146712104|NCT01831089|529116928|FG004|Cohort III: Dose Level 3|Global end of study|0|||
146712105|NCT01831089|529116929|FG005|Cohort III: Dose Level 3|Global end of study|0|||
146712106|NCT01831089|529116924|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
146712107|NCT01831089|529116925|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
146712108|NCT01831089|529116926|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
146712109|NCT01831089|529116927|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
146712110|NCT01831089|529116928|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
146712111|NCT01831089|529116929|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
146712112|NCT01831089|529116924|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
146712113|NCT01831089|529116925|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
146712114|NCT01831089|529116926|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
146712115|NCT01831089|529116927|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
146712116|NCT01831089|529116928|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
146779946|NCT01711632|529364066|FG000|Overall Study|Progressive disease|2|||
146779947|NCT01711632|529364066|FG000|Overall Study|No follow up required in re-treatment|3|||
146779948|NCT01711632|529364066|FG000|Overall Study|No follow up required in re-treatment|3|||
146712117|NCT01831089|529116929|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
146712118|NCT01831089|529116924|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
146712119|NCT01831089|529116925|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
146712120|NCT01831089|529116926|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
146712121|NCT01831089|529116927|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
146779949|NCT04315181|529364067|FG000|Overall Study|Non-responsive to drug conditions.|1|||
146779950|NCT03833167|529364068|FG000|Overall Study|Withdrawal by Subject|4|||
146712122|NCT01831089|529116928|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
146779951|NCT03833167|529364069|FG001|Overall Study|Withdrawal by Subject|6|||
146981119|NCT00910858|530093747|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
146712123|NCT01831089|529116929|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
146712124|NCT01831089|529116924|FG000|Cohort V: Dose Level 5|Death|0|||
146712125|NCT01831089|529116925|FG001|Cohort V: Dose Level 5|Death|0|||
146712126|NCT01831089|529116926|FG002|Cohort V: Dose Level 5|Death|0|||
146712127|NCT01831089|529116927|FG003|Cohort V: Dose Level 5|Death|0|||
146712128|NCT01831089|529116928|FG004|Cohort V: Dose Level 5|Death|1|||
146712129|NCT01831089|529116929|FG005|Cohort V: Dose Level 5|Death|0|||
146712130|NCT01831089|529116924|FG000|Cohort V: Dose Level 5|Global end of study|0|||
146712131|NCT01831089|529116925|FG001|Cohort V: Dose Level 5|Global end of study|0|||
146712132|NCT01831089|529116926|FG002|Cohort V: Dose Level 5|Global end of study|0|||
146712133|NCT01831089|529116927|FG003|Cohort V: Dose Level 5|Global end of study|0|||
146712134|NCT01831089|529116928|FG004|Cohort V: Dose Level 5|Global end of study|2|||
146712135|NCT01831089|529116929|FG005|Cohort V: Dose Level 5|Global end of study|0|||
146712136|NCT01831089|529116924|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
146712137|NCT01831089|529116925|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
146712138|NCT01831089|529116926|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
146712139|NCT01831089|529116927|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
146712140|NCT01831089|529116928|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
146712141|NCT01831089|529116929|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
146712142|NCT01831089|529116924|FG000|Cohort B: Arm B|Progressive disease|0|||
146712143|NCT01831089|529116925|FG001|Cohort B: Arm B|Progressive disease|0|||
146712144|NCT01831089|529116926|FG002|Cohort B: Arm B|Progressive disease|0|||
146712145|NCT01831089|529116927|FG003|Cohort B: Arm B|Progressive disease|0|||
146712146|NCT01831089|529116928|FG004|Cohort B: Arm B|Progressive disease|0|||
146712147|NCT01831089|529116929|FG005|Cohort B: Arm B|Progressive disease|8|||
146712148|NCT01831089|529116924|FG000|Cohort B: Arm B|Physician Decision|0|||
146712149|NCT01831089|529116925|FG001|Cohort B: Arm B|Physician Decision|0|||
146712150|NCT01831089|529116926|FG002|Cohort B: Arm B|Physician Decision|0|||
146712151|NCT01831089|529116927|FG003|Cohort B: Arm B|Physician Decision|0|||
146712152|NCT01831089|529116928|FG004|Cohort B: Arm B|Physician Decision|0|||
146712153|NCT01831089|529116929|FG005|Cohort B: Arm B|Physician Decision|2|||
146712154|NCT01831089|529116924|FG000|Cohort B: Arm B|Never treated|0|||
146712155|NCT01831089|529116925|FG001|Cohort B: Arm B|Never treated|0|||
146712156|NCT01831089|529116926|FG002|Cohort B: Arm B|Never treated|0|||
146712157|NCT01831089|529116927|FG003|Cohort B: Arm B|Never treated|0|||
146712158|NCT01831089|529116928|FG004|Cohort B: Arm B|Never treated|0|||
146712159|NCT01831089|529116929|FG005|Cohort B: Arm B|Never treated|2|||
146712160|NCT01831089|529116924|FG000|Cohort B: Arm B|Adverse Event|0|||
146712161|NCT01831089|529116925|FG001|Cohort B: Arm B|Adverse Event|0|||
146712162|NCT01831089|529116926|FG002|Cohort B: Arm B|Adverse Event|0|||
146712163|NCT01831089|529116927|FG003|Cohort B: Arm B|Adverse Event|0|||
146712164|NCT01831089|529116928|FG004|Cohort B: Arm B|Adverse Event|0|||
146712165|NCT01831089|529116929|FG005|Cohort B: Arm B|Adverse Event|1|||
146712166|NCT01831089|529116924|FG000|Cohort B: Arm B|Global end of study|0|||
146712167|NCT01831089|529116925|FG001|Cohort B: Arm B|Global end of study|0|||
146712168|NCT01831089|529116926|FG002|Cohort B: Arm B|Global end of study|0|||
146712169|NCT01831089|529116927|FG003|Cohort B: Arm B|Global end of study|0|||
146712170|NCT01831089|529116928|FG004|Cohort B: Arm B|Global end of study|0|||
146712171|NCT01831089|529116929|FG005|Cohort B: Arm B|Global end of study|1|||
146712172|NCT02013765|529116930|FG000|Overall Study|Trial was terminated by sponsor|1|||
146712173|NCT04479618|529116931|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
146981120|NCT00910858|530093748|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
146981121|NCT00910858|530093749|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
146981122|NCT00910858|530093747|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
146981123|NCT00910858|530093748|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
146981124|NCT00910858|530093749|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
146981125|NCT00910858|530093747|FG000|Combined Treatment Phase|Protocol Violation|1|||
146981126|NCT00910858|530093748|FG001|Combined Treatment Phase|Protocol Violation|0|||
146981127|NCT00910858|530093749|FG002|Combined Treatment Phase|Protocol Violation|0|||
146981128|NCT00910858|530093747|FG000|Combined Treatment Phase|Other|0|||
146981129|NCT00910858|530093748|FG001|Combined Treatment Phase|Other|2|||
146981130|NCT00910858|530093749|FG002|Combined Treatment Phase|Other|1|||
146981131|NCT00827827|530093750|FG000|Overall Study|Lost to Follow-up|3|||
146712174|NCT04479618|529116932|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
146712175|NCT04479618|529116933|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
146981132|NCT00827827|530093751|FG001|Overall Study|Lost to Follow-up|0|||
146981133|NCT00827827|530093750|FG000|Overall Study|Fall at home- hospitalization|1|||
146981134|NCT00827827|530093751|FG001|Overall Study|Fall at home- hospitalization|0|||
146712176|NCT04479618|529116931|FG000|Overall Study|Lack of Efficacy|1|||
146981135|NCT00827827|530093750|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
146712177|NCT04479618|529116932|FG001|Overall Study|Lack of Efficacy|0|||
146712178|NCT04479618|529116933|FG002|Overall Study|Lack of Efficacy|0|||
146981136|NCT00827827|530093751|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
146712179|NCT04479618|529116931|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
146712180|NCT04479618|529116932|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
146712181|NCT04479618|529116933|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
146712182|NCT04479618|529116931|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
146712183|NCT04479618|529116932|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
146712184|NCT04479618|529116933|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
146712185|NCT04479618|529116931|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
146712186|NCT04479618|529116932|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
146712187|NCT04479618|529116933|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
146712188|NCT04479618|529116931|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
146712189|NCT04479618|529116932|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
146712190|NCT04479618|529116933|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
146712191|NCT02443298|529116940|FG000|Overall Study|Adverse Event|3|||
146712192|NCT02443298|529116941|FG001|Overall Study|Adverse Event|3|||
146712193|NCT02443298|529116940|FG000|Overall Study|Withdrawal by Subject|1|||
146712194|NCT02443298|529116941|FG001|Overall Study|Withdrawal by Subject|2|||
146712195|NCT01047683|529116942|FG000|Overall Study|Adverse Event|3|||
146712196|NCT01047683|529116943|FG001|Overall Study|Adverse Event|1|||
146712197|NCT01047683|529116944|FG002|Overall Study|Adverse Event|0|||
146712198|NCT01047683|529116942|FG000|Overall Study|Withdrew Consent|1|||
146712199|NCT01047683|529116943|FG001|Overall Study|Withdrew Consent|4|||
146712200|NCT01047683|529116944|FG002|Overall Study|Withdrew Consent|2|||
146712201|NCT01047683|529116942|FG000|Overall Study|Lost to Follow-up|0|||
146712202|NCT01047683|529116943|FG001|Overall Study|Lost to Follow-up|1|||
146712203|NCT01047683|529116944|FG002|Overall Study|Lost to Follow-up|0|||
146712204|NCT01047683|529116942|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
146712205|NCT01047683|529116943|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
146712206|NCT01047683|529116944|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
146712207|NCT00833924|529116959|FG000|Overall Study|Death|21|||
146712208|NCT00833924|529116959|FG000|Overall Study|Conversion|2|||
146712209|NCT00833924|529116959|FG000|Overall Study|Lost to Follow-up|2|||
146712210|NCT00833924|529116959|FG000|Overall Study|Withdrawal by Subject|13|||
146712211|NCT00833924|529116959|FG000|Overall Study|In study follow-up|71|||
146712212|NCT01485861|529116960|FG000|Phase Ib|Death|1|||
146712213|NCT01485861|529116961|FG001|Phase Ib|Death|0|||
146712214|NCT01485861|529116962|FG002|Phase Ib|Death|0|||
146712215|NCT01485861|529116963|FG003|Phase Ib|Death|0|||
146712216|NCT01485861|529116964|FG004|Phase Ib|Death|0|||
146712217|NCT01485861|529116965|FG005|Phase Ib|Death|0|||
146712218|NCT01485861|529116960|FG000|Phase Ib|Physician Decision|1|||
146712219|NCT01485861|529116961|FG001|Phase Ib|Physician Decision|1|||
146712220|NCT01485861|529116962|FG002|Phase Ib|Physician Decision|0|||
146712221|NCT01485861|529116963|FG003|Phase Ib|Physician Decision|0|||
146712222|NCT01485861|529116964|FG004|Phase Ib|Physician Decision|0|||
146712223|NCT01485861|529116965|FG005|Phase Ib|Physician Decision|0|||
146712224|NCT01485861|529116960|FG000|Phase Ib|Adverse Event|0|||
146712225|NCT01485861|529116961|FG001|Phase Ib|Adverse Event|4|||
146712226|NCT01485861|529116962|FG002|Phase Ib|Adverse Event|0|||
146712227|NCT01485861|529116963|FG003|Phase Ib|Adverse Event|0|||
146712228|NCT01485861|529116964|FG004|Phase Ib|Adverse Event|0|||
146712229|NCT01485861|529116965|FG005|Phase Ib|Adverse Event|0|||
146712230|NCT01485861|529116960|FG000|Phase Ib|Progression of disease|5|||
146712231|NCT01485861|529116961|FG001|Phase Ib|Progression of disease|0|||
146712232|NCT01485861|529116962|FG002|Phase Ib|Progression of disease|0|||
146712233|NCT01485861|529116963|FG003|Phase Ib|Progression of disease|0|||
146712234|NCT01485861|529116964|FG004|Phase Ib|Progression of disease|0|||
146712235|NCT01485861|529116965|FG005|Phase Ib|Progression of disease|0|||
146712236|NCT01485861|529116960|FG000|Phase Ib|Other|3|||
146712237|NCT01485861|529116961|FG001|Phase Ib|Other|0|||
146712238|NCT01485861|529116962|FG002|Phase Ib|Other|0|||
146712239|NCT01485861|529116963|FG003|Phase Ib|Other|0|||
146712240|NCT01485861|529116964|FG004|Phase Ib|Other|0|||
146712241|NCT01485861|529116965|FG005|Phase Ib|Other|0|||
146712242|NCT01485861|529116960|FG000|Phase Ib|Withdrawal by Subject|4|||
146712243|NCT01485861|529116961|FG001|Phase Ib|Withdrawal by Subject|1|||
146712244|NCT01485861|529116962|FG002|Phase Ib|Withdrawal by Subject|0|||
146712245|NCT01485861|529116963|FG003|Phase Ib|Withdrawal by Subject|0|||
146712246|NCT01485861|529116964|FG004|Phase Ib|Withdrawal by Subject|0|||
146779952|NCT03833167|529364068|FG000|Overall Study|Ongoing|186|||
146712247|NCT01485861|529116965|FG005|Phase Ib|Withdrawal by Subject|0|||
146712248|NCT01485861|529116960|FG000|Phase II|Death|0|||
146712249|NCT01485861|529116961|FG001|Phase II|Death|0|||
146712250|NCT01485861|529116962|FG002|Phase II|Death|67|||
146712251|NCT01485861|529116963|FG003|Phase II|Death|71|||
146712252|NCT01485861|529116964|FG004|Phase II|Death|68|||
146712253|NCT01485861|529116965|FG005|Phase II|Death|0|||
146712254|NCT01485861|529116960|FG000|Phase II|Progression of Disease|0|||
146712255|NCT01485861|529116961|FG001|Phase II|Progression of Disease|0|||
146712256|NCT01485861|529116962|FG002|Phase II|Progression of Disease|1|||
146712257|NCT01485861|529116963|FG003|Phase II|Progression of Disease|0|||
146712258|NCT01485861|529116964|FG004|Phase II|Progression of Disease|0|||
146712259|NCT01485861|529116965|FG005|Phase II|Progression of Disease|0|||
146712260|NCT01485861|529116960|FG000|Phase II|Other|0|||
146712261|NCT01485861|529116961|FG001|Phase II|Other|0|||
146712262|NCT01485861|529116962|FG002|Phase II|Other|0|||
146712263|NCT01485861|529116963|FG003|Phase II|Other|1|||
146712264|NCT01485861|529116964|FG004|Phase II|Other|0|||
146712265|NCT01485861|529116965|FG005|Phase II|Other|0|||
146712266|NCT01485861|529116960|FG000|Phase II|Withdrawal by Subject|0|||
146712267|NCT01485861|529116961|FG001|Phase II|Withdrawal by Subject|0|||
146712268|NCT01485861|529116962|FG002|Phase II|Withdrawal by Subject|6|||
146712269|NCT01485861|529116963|FG003|Phase II|Withdrawal by Subject|3|||
146712270|NCT01485861|529116964|FG004|Phase II|Withdrawal by Subject|4|||
146712271|NCT01485861|529116965|FG005|Phase II|Withdrawal by Subject|0|||
146712272|NCT01485861|529116960|FG000|Phase II|Lost to Follow-up|0|||
146712273|NCT01485861|529116961|FG001|Phase II|Lost to Follow-up|0|||
146712274|NCT01485861|529116962|FG002|Phase II|Lost to Follow-up|2|||
146712275|NCT01485861|529116963|FG003|Phase II|Lost to Follow-up|3|||
146712276|NCT01485861|529116964|FG004|Phase II|Lost to Follow-up|5|||
146712277|NCT01485861|529116965|FG005|Phase II|Lost to Follow-up|0|||
146712278|NCT01485861|529116960|FG000|Phase II|Study Ended|0|||
146712279|NCT01485861|529116961|FG001|Phase II|Study Ended|0|||
146712280|NCT01485861|529116962|FG002|Phase II|Study Ended|7|||
146712281|NCT01485861|529116963|FG003|Phase II|Study Ended|8|||
146712282|NCT01485861|529116964|FG004|Phase II|Study Ended|6|||
146712283|NCT01485861|529116965|FG005|Phase II|Study Ended|0|||
146712284|NCT01485861|529116960|FG000|Safety Phase|Death|0|||
146712285|NCT01485861|529116961|FG001|Safety Phase|Death|0|||
146712286|NCT01485861|529116962|FG002|Safety Phase|Death|0|||
146712287|NCT01485861|529116963|FG003|Safety Phase|Death|0|||
146712288|NCT01485861|529116964|FG004|Safety Phase|Death|0|||
146712289|NCT01485861|529116965|FG005|Safety Phase|Death|2|||
146712290|NCT01485861|529116960|FG000|Safety Phase|Adverse Event|0|||
146712291|NCT01485861|529116961|FG001|Safety Phase|Adverse Event|0|||
146712292|NCT01485861|529116962|FG002|Safety Phase|Adverse Event|0|||
146712293|NCT01485861|529116963|FG003|Safety Phase|Adverse Event|0|||
146712294|NCT01485861|529116964|FG004|Safety Phase|Adverse Event|0|||
146712295|NCT01485861|529116965|FG005|Safety Phase|Adverse Event|1|||
146712296|NCT01485861|529116960|FG000|Safety Phase|Other|0|||
146712297|NCT01485861|529116961|FG001|Safety Phase|Other|0|||
146712298|NCT01485861|529116962|FG002|Safety Phase|Other|0|||
146712299|NCT01485861|529116963|FG003|Safety Phase|Other|0|||
146712300|NCT01485861|529116964|FG004|Safety Phase|Other|0|||
146712301|NCT01485861|529116965|FG005|Safety Phase|Other|5|||
146712302|NCT01485861|529116960|FG000|Safety Phase|Progression of Disease|0|||
146712303|NCT01485861|529116961|FG001|Safety Phase|Progression of Disease|0|||
146712304|NCT01485861|529116962|FG002|Safety Phase|Progression of Disease|0|||
146712305|NCT01485861|529116963|FG003|Safety Phase|Progression of Disease|0|||
146712306|NCT01485861|529116964|FG004|Safety Phase|Progression of Disease|0|||
146712307|NCT01485861|529116965|FG005|Safety Phase|Progression of Disease|9|||
146712308|NCT01485861|529116960|FG000|Safety Phase|Withdrawal by Subject|0|||
146712309|NCT01485861|529116961|FG001|Safety Phase|Withdrawal by Subject|0|||
146712310|NCT01485861|529116962|FG002|Safety Phase|Withdrawal by Subject|0|||
146712311|NCT01485861|529116963|FG003|Safety Phase|Withdrawal by Subject|0|||
146712312|NCT01485861|529116964|FG004|Safety Phase|Withdrawal by Subject|0|||
146712313|NCT01485861|529116965|FG005|Safety Phase|Withdrawal by Subject|6|||
146712314|NCT01485861|529116960|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
146712315|NCT01485861|529116961|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
146712316|NCT01485861|529116962|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
146712317|NCT01485861|529116963|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
146712318|NCT01485861|529116964|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
146712319|NCT01485861|529116965|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
146712320|NCT01260922|529116966|FG000|First Intervention|Withdrawal by Subject|0|||
146712321|NCT01260922|529116967|FG001|First Intervention|Withdrawal by Subject|1|||
146712322|NCT01260922|529116966|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
146712323|NCT01260922|529116967|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
146712324|NCT01260922|529116966|FG000|Second Intervention|Emesis|0|||
146712325|NCT01260922|529116967|FG001|Second Intervention|Emesis|2|||
146712326|NCT05101252|529116970|FG000|Overall Study|Unsatisfactory Test Article|1|||
146712327|NCT05101252|529116971|FG001|Overall Study|Unsatisfactory Test Article|0|||
146712328|NCT05101252|529116970|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
146712329|NCT05101252|529116971|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
146712330|NCT05101252|529116970|FG000|Overall Study|Withdrew Consent during study|0|||
146712331|NCT05101252|529116971|FG001|Overall Study|Withdrew Consent during study|1|||
146712332|NCT05101252|529116970|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
146712333|NCT05101252|529116971|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
146779953|NCT03833167|529364069|FG001|Overall Study|Ongoing|194|||
146779954|NCT03833167|529364068|FG000|Overall Study|Lost to Follow-up|1|||
146779955|NCT03833167|529364069|FG001|Overall Study|Lost to Follow-up|1|||
146779956|NCT03833167|529364068|FG000|Overall Study|Physician Decision|0|||
146779957|NCT03833167|529364069|FG001|Overall Study|Physician Decision|2|||
146779958|NCT03833167|529364068|FG000|Overall Study|Death|34|||
146779959|NCT03833167|529364069|FG001|Overall Study|Death|22|||
146779960|NCT02860130|529364070|FG000|Overall Study|Adverse Event|2|||
146779961|NCT02860130|529364071|FG001|Overall Study|Adverse Event|3|||
146779962|NCT02860130|529364070|FG000|Overall Study|Protocol Violation|1|||
146779963|NCT02860130|529364071|FG001|Overall Study|Protocol Violation|1|||
146779964|NCT02860130|529364070|FG000|Overall Study|Withdrawal by Subject|0|||
146779965|NCT02860130|529364071|FG001|Overall Study|Withdrawal by Subject|2|||
146779966|NCT02860130|529364070|FG000|Overall Study|Physician Decision|2|||
146779967|NCT02860130|529364071|FG001|Overall Study|Physician Decision|2|||
146779968|NCT02860130|529364070|FG000|Overall Study|Other|2|||
146779969|NCT02860130|529364071|FG001|Overall Study|Other|1|||
146779970|NCT01467427|529364072|FG000|Overall Study|Withdrawal by Subject|1|||
146779971|NCT01467427|529364073|FG001|Overall Study|Withdrawal by Subject|0|||
146779972|NCT01467427|529364072|FG000|Overall Study|Not continuing in extension phase|0|||
146779973|NCT01467427|529364073|FG001|Overall Study|Not continuing in extension phase|2|||
146779974|NCT01467427|529364072|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
146779975|NCT01467427|529364073|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
146779976|NCT01467427|529364072|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
146779977|NCT01467427|529364073|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
146779978|NCT01467427|529364072|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
146779979|NCT01467427|529364073|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
146779980|NCT01467427|529364072|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
146779981|NCT01467427|529364073|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
146779982|NCT05494788|529364077|FG000|Initial Treatment Period|Adverse Event|2|||
146779983|NCT05494788|529364077|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
146779984|NCT05494788|529364077|FG000|Extension Period|Adverse Event|1|||
146779985|NCT05494788|529364077|FG000|Extension Period|Withdrawal by Subject|1|||
146779986|NCT05480943|529364078|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
146779987|NCT05480943|529364078|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
146779988|NCT05480943|529364078|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
146779989|NCT05480943|529364078|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
146779990|NCT00976937|529364080|FG000|Overall Study|Adverse Event|4|||
146779991|NCT00976937|529364081|FG001|Overall Study|Adverse Event|5|||
146779992|NCT00976937|529364080|FG000|Overall Study|Lost to Follow-up|2|||
146779993|NCT00976937|529364081|FG001|Overall Study|Lost to Follow-up|1|||
146779994|NCT00976937|529364080|FG000|Overall Study|Withdrawal by Subject|5|||
146779995|NCT00976937|529364081|FG001|Overall Study|Withdrawal by Subject|3|||
146779996|NCT00976937|529364080|FG000|Overall Study|Poor compliance to protocol|3|||
146779997|NCT00976937|529364081|FG001|Overall Study|Poor compliance to protocol|0|||
146779998|NCT00976937|529364080|FG000|Overall Study|Personal and Familial Reason|2|||
146779999|NCT00976937|529364081|FG001|Overall Study|Personal and Familial Reason|2|||
146780000|NCT03069313|529364082|FG000|Overall Study|Adverse Event|5|||
146780001|NCT04218266|529364083|FG000|Overall Study|Death|1|||
146780002|NCT04218266|529364084|FG001|Overall Study|Death|2|||
146780003|NCT04218266|529364085|FG002|Overall Study|Death|3|||
146780004|NCT04218266|529364083|FG000|Overall Study|Adverse Event|13|||
146780005|NCT04218266|529364084|FG001|Overall Study|Adverse Event|14|||
146780006|NCT04218266|529364085|FG002|Overall Study|Adverse Event|11|||
146780007|NCT04218266|529364083|FG000|Overall Study|Other|7|||
146780008|NCT04218266|529364084|FG001|Overall Study|Other|5|||
146780009|NCT04218266|529364085|FG002|Overall Study|Other|14|||
146780010|NCT04218266|529364083|FG000|Overall Study|Physician Decision|1|||
146780011|NCT04218266|529364084|FG001|Overall Study|Physician Decision|3|||
146780012|NCT04218266|529364085|FG002|Overall Study|Physician Decision|2|||
146712334|NCT00733824|529116972|FG000|Phase I|Withdrawal by Subject|1|||
146712335|NCT00733824|529116973|FG001|Phase I|Withdrawal by Subject|0|||
146712336|NCT00733824|529116974|FG002|Phase I|Withdrawal by Subject|0|||
146712337|NCT00733824|529116975|FG003|Phase I|Withdrawal by Subject|0|||
146712338|NCT00733824|529116976|FG004|Phase I|Withdrawal by Subject|0|||
146712339|NCT01243944|529116984|FG000|Overall Study|Adverse Event|15|||
146712340|NCT01243944|529116985|FG001|Overall Study|Adverse Event|13|||
146712341|NCT01243944|529116984|FG000|Overall Study|Lost to Follow-up|2|||
146712342|NCT01243944|529116985|FG001|Overall Study|Lost to Follow-up|1|||
146712343|NCT01243944|529116984|FG000|Overall Study|Physician Decision|2|||
146712344|NCT01243944|529116985|FG001|Overall Study|Physician Decision|7|||
146712345|NCT01243944|529116984|FG000|Overall Study|Disease progression|12|||
146712346|NCT01243944|529116985|FG001|Overall Study|Disease progression|11|||
146712347|NCT01243944|529116984|FG000|Overall Study|Protocol deviation|1|||
146712348|NCT01243944|529116985|FG001|Overall Study|Protocol deviation|1|||
146712349|NCT01243944|529116984|FG000|Overall Study|Participant decision|10|||
146712350|NCT01243944|529116985|FG001|Overall Study|Participant decision|15|||
146712351|NCT01243944|529116984|FG000|Overall Study|Death|2|||
146712352|NCT01243944|529116985|FG001|Overall Study|Death|3|||
146712353|NCT01243944|529116984|FG000|Overall Study|Non-compliance with study treatment|1|||
146712354|NCT01243944|529116985|FG001|Overall Study|Non-compliance with study treatment|0|||
146712355|NCT01731171|529116989|FG000|Overall Study|Withdrawal by Subject|4|||
146712356|NCT01731171|529116990|FG001|Overall Study|Withdrawal by Subject|1|||
146712357|NCT01731171|529116989|FG000|Overall Study|Lost to Follow-up|3|||
146712358|NCT01731171|529116990|FG001|Overall Study|Lost to Follow-up|2|||
146712359|NCT01731171|529116989|FG000|Overall Study|Moved out of Area|0|||
146712360|NCT01731171|529116990|FG001|Overall Study|Moved out of Area|2|||
146712361|NCT01731171|529116989|FG000|Overall Study|Terminated for Lack of Adherence|0|||
146712362|NCT01731171|529116990|FG001|Overall Study|Terminated for Lack of Adherence|1|||
146712363|NCT01731171|529116989|FG000|Overall Study|Terminated for Safety Reasons|0|||
146712364|NCT01731171|529116990|FG001|Overall Study|Terminated for Safety Reasons|1|||
146712365|NCT01410110|529116991|FG000|Overall Study|Withdrawal by Subject|4|||
146712366|NCT01410110|529116992|FG001|Overall Study|Withdrawal by Subject|2|||
146712367|NCT05061446|529117001|FG000|Overall Study|Adverse Event|2|||
146712368|NCT05061446|529117002|FG001|Overall Study|Adverse Event|0|||
146712369|NCT05061446|529117003|FG002|Overall Study|Adverse Event|0|||
146712370|NCT05061446|529117001|FG000|Overall Study|Participant no longer available due to personal reason|0|||
146712371|NCT05061446|529117002|FG001|Overall Study|Participant no longer available due to personal reason|1|||
146712372|NCT05061446|529117003|FG002|Overall Study|Participant no longer available due to personal reason|0|||
146712373|NCT02799082|529117006|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
146712374|NCT02799082|529117007|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
146712375|NCT02799082|529117006|FG000|Overall Study|Protocol Violation|0|||
146712376|NCT02799082|529117007|FG001|Overall Study|Protocol Violation|1|||
146712377|NCT04496258|529117008|FG000|Overall Study|Withdrawal by Subject|2|||
146712378|NCT04496258|529117009|FG001|Overall Study|Withdrawal by Subject|1|||
146712379|NCT00861341|529117012|FG000|Overall Study|Withdrawal by Subject|2|||
146712380|NCT04382612|529117021|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
146712381|NCT03149328|529117022|FG000|Overall Study|Withdrawal by Subject|30|||
146712382|NCT03149328|529117023|FG001|Overall Study|Withdrawal by Subject|26|||
146712383|NCT03149328|529117022|FG000|Overall Study|Changed Dialysis Modality|18|||
146712384|NCT03149328|529117023|FG001|Overall Study|Changed Dialysis Modality|1|||
146712385|NCT03149328|529117022|FG000|Overall Study|Transplant|9|||
146712386|NCT03149328|529117023|FG001|Overall Study|Transplant|1|||
146712387|NCT03149328|529117022|FG000|Overall Study|Lost to Follow-up|25|||
146712388|NCT03149328|529117023|FG001|Overall Study|Lost to Follow-up|16|||
146712389|NCT03149328|529117022|FG000|Overall Study|Left Study Site|1|||
146712390|NCT03149328|529117023|FG001|Overall Study|Left Study Site|2|||
146712391|NCT03149328|529117022|FG000|Overall Study|Language Barrier|1|||
146712392|NCT03149328|529117023|FG001|Overall Study|Language Barrier|0|||
146712393|NCT01328002|529117024|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
146712394|NCT01328002|529117025|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
146712395|NCT01328002|529117024|FG000|Open-Label Period|Adverse Event|8|||
146712396|NCT01328002|529117025|FG001|Open-Label Period|Adverse Event|0|||
146712397|NCT01328002|529117024|FG000|Open-Label Period|Lack of Efficacy|3|||
146712398|NCT01328002|529117025|FG001|Open-Label Period|Lack of Efficacy|0|||
146712399|NCT01328002|529117024|FG000|Open-Label Period|Protocol Violation|2|||
146712400|NCT01328002|529117025|FG001|Open-Label Period|Protocol Violation|0|||
146712401|NCT01328002|529117024|FG000|Open-Label Period|Withdrawal by Subject|9|||
146712402|NCT01328002|529117025|FG001|Open-Label Period|Withdrawal by Subject|0|||
146712403|NCT01328002|529117024|FG000|Open-Label Period|Lost to Follow-up|6|||
146712404|NCT01328002|529117025|FG001|Open-Label Period|Lost to Follow-up|0|||
146712405|NCT01328002|529117024|FG000|Open-Label Period|Other Reason|2|||
146712406|NCT01328002|529117025|FG001|Open-Label Period|Other Reason|0|||
146712407|NCT01328002|529117024|FG000|Double-Blind Period|Adverse Event|1|||
146780013|NCT04218266|529364083|FG000|Overall Study|Non-compliance with study drug|0|||
146780014|NCT04218266|529364084|FG001|Overall Study|Non-compliance with study drug|0|||
146780015|NCT04218266|529364085|FG002|Overall Study|Non-compliance with study drug|1|||
146780016|NCT04218266|529364083|FG000|Overall Study|Withdrawal by Subject|1|||
146780017|NCT04218266|529364084|FG001|Overall Study|Withdrawal by Subject|3|||
146780018|NCT04218266|529364085|FG002|Overall Study|Withdrawal by Subject|1|||
146712408|NCT01328002|529117025|FG001|Double-Blind Period|Adverse Event|0|||
146712409|NCT01328002|529117024|FG000|Double-Blind Period|Lack of Efficacy|1|||
146712410|NCT01328002|529117025|FG001|Double-Blind Period|Lack of Efficacy|0|||
146712411|NCT01306617|529117029|FG000|Overall Study|Adverse Event|1|||
146712412|NCT01306617|529117030|FG001|Overall Study|Adverse Event|0|||
146712413|NCT01306617|529117031|FG002|Overall Study|Adverse Event|0|||
146712414|NCT01306617|529117029|FG000|Overall Study|Virologic Failure|0|||
146712415|NCT01306617|529117030|FG001|Overall Study|Virologic Failure|0|||
146712416|NCT01306617|529117031|FG002|Overall Study|Virologic Failure|5|||
146712417|NCT01306617|529117029|FG000|Overall Study|Non-compliance|0|||
146712418|NCT01306617|529117030|FG001|Overall Study|Non-compliance|1|||
146981137|NCT00827827|530093750|FG000|Overall Study|Gout|1|||
146712419|NCT01306617|529117031|FG002|Overall Study|Non-compliance|0|||
146712420|NCT00766415|529117038|FG000|Overall Study|Withdrawal by Subject|0|||
146712421|NCT00766415|529117039|FG001|Overall Study|Withdrawal by Subject|1|||
146712422|NCT00061048|529117040|FG000|Overall Study|Adverse Event|2|||
146712423|NCT00061048|529117040|FG000|Overall Study|disease progression|20|||
146712424|NCT01114516|529117041|FG000|Overall Study|Lost to Follow-up|2|||
146712425|NCT01114516|529117042|FG001|Overall Study|Lost to Follow-up|1|||
146712426|NCT03779841|529117044|FG000|Randomized Population|Did Not Receive Treatment|3|||
146712427|NCT03779841|529117045|FG001|Randomized Population|Did Not Receive Treatment|1|||
146712428|NCT03779841|529117046|FG002|Randomized Population|Did Not Receive Treatment|0|||
146712429|NCT03779841|529117044|FG000|Treated (Safety) Population|Adverse Event|1|||
146712430|NCT03779841|529117045|FG001|Treated (Safety) Population|Adverse Event|1|||
146712431|NCT03779841|529117046|FG002|Treated (Safety) Population|Adverse Event|0|||
146712432|NCT03779841|529117044|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
146712433|NCT03779841|529117045|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
146712434|NCT03779841|529117046|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
146712435|NCT03779841|529117044|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
146712436|NCT03779841|529117045|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
146712437|NCT03779841|529117046|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
146712438|NCT03779841|529117044|FG000|Treated (Safety) Population|Death|1|||
146712439|NCT03779841|529117045|FG001|Treated (Safety) Population|Death|0|||
146712440|NCT03779841|529117046|FG002|Treated (Safety) Population|Death|2|||
146712441|NCT01632579|529117047|FG000|Washout Period|Adverse Event|1|||
146712442|NCT01632579|529117048|FG001|Washout Period|Adverse Event|0|||
146712443|NCT01632579|529117049|FG002|Washout Period|Adverse Event|0|||
146712444|NCT01632579|529117050|FG003|Washout Period|Adverse Event|0|||
146712445|NCT01632579|529117051|FG004|Washout Period|Adverse Event|0|||
146933932|NCT01335698|529916012|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
146933933|NCT01335698|529916013|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
146933934|NCT01335698|529916014|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
146933935|NCT01335698|529916015|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
146933936|NCT01335698|529916016|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
146712446|NCT01632579|529117052|FG005|Washout Period|Adverse Event|0|||
146712447|NCT01632579|529117053|FG006|Washout Period|Adverse Event|0|||
146712448|NCT01632579|529117054|FG007|Washout Period|Adverse Event|0|||
146712449|NCT01632579|529117055|FG008|Washout Period|Adverse Event|0|||
146712450|NCT01632579|529117047|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
146712451|NCT01632579|529117048|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
146712452|NCT01632579|529117049|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
146712453|NCT01632579|529117050|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
146712454|NCT01632579|529117051|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
146712455|NCT01632579|529117052|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
146712456|NCT01632579|529117053|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
146712457|NCT01632579|529117054|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
146712458|NCT01632579|529117055|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
146712459|NCT00898677|529117056|FG000|Overall Study|Adverse Event|0|||
146712460|NCT00898677|529117057|FG001|Overall Study|Adverse Event|0|||
146712461|NCT00898677|529117058|FG002|Overall Study|Adverse Event|1|||
146933937|NCT01335698|529916012|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
146933938|NCT01335698|529916013|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
146933939|NCT01335698|529916014|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
146933940|NCT01335698|529916015|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
146933941|NCT01335698|529916016|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
146933942|NCT01335698|529916012|FG000|Treatment Stage 2|Switched to another formulation|1|||
146933943|NCT01335698|529916013|FG001|Treatment Stage 2|Switched to another formulation|1|||
146712462|NCT00898677|529117059|FG003|Overall Study|Adverse Event|0|||
146712463|NCT00898677|529117056|FG000|Overall Study|Lost to Follow-up|0|||
146712464|NCT00898677|529117057|FG001|Overall Study|Lost to Follow-up|0|||
146712465|NCT00898677|529117058|FG002|Overall Study|Lost to Follow-up|2|||
146933944|NCT01335698|529916014|FG002|Treatment Stage 2|Switched to another formulation|0|||
146712466|NCT00898677|529117059|FG003|Overall Study|Lost to Follow-up|0|||
146712467|NCT00898677|529117056|FG000|Overall Study|Protocol Violation|1|||
146933945|NCT01335698|529916015|FG003|Treatment Stage 2|Switched to another formulation|0|||
146933946|NCT01335698|529916016|FG004|Treatment Stage 2|Switched to another formulation|0|||
146933947|NCT01170221|529916017|FG000|Overall Study|Lost to Follow-up|22|||
146933948|NCT01170221|529916018|FG001|Overall Study|Lost to Follow-up|21|||
146933949|NCT01170221|529916017|FG000|Overall Study|Withdrawal by Subject|9|||
146712468|NCT00898677|529117057|FG001|Overall Study|Protocol Violation|1|||
146712469|NCT00898677|529117058|FG002|Overall Study|Protocol Violation|2|||
146712470|NCT00898677|529117059|FG003|Overall Study|Protocol Violation|0|||
146933950|NCT01170221|529916018|FG001|Overall Study|Withdrawal by Subject|7|||
146712471|NCT00898677|529117056|FG000|Overall Study|Withdrawal by Subject|0|||
146712472|NCT00898677|529117057|FG001|Overall Study|Withdrawal by Subject|0|||
146712473|NCT00898677|529117058|FG002|Overall Study|Withdrawal by Subject|0|||
146780019|NCT04218266|529364083|FG000|Overall Study|Study drug never administered|2|||
146780020|NCT04218266|529364084|FG001|Overall Study|Study drug never administered|0|||
146780021|NCT04218266|529364085|FG002|Overall Study|Study drug never administered|0|||
146780022|NCT03432858|529364088|FG000|Overall Study|Protocol Violation|2|||
146780023|NCT03432858|529364089|FG001|Overall Study|Protocol Violation|1|||
146780024|NCT03432858|529364090|FG002|Overall Study|Protocol Violation|9|||
146780025|NCT03432858|529364088|FG000|Overall Study|Withdrawal by Subject|0|||
146780026|NCT03432858|529364089|FG001|Overall Study|Withdrawal by Subject|1|||
146780027|NCT03432858|529364090|FG002|Overall Study|Withdrawal by Subject|1|||
146780028|NCT03432858|529364088|FG000|Overall Study|Procedure canceled/rescheduled|0|||
146780029|NCT03432858|529364089|FG001|Overall Study|Procedure canceled/rescheduled|9|||
146780030|NCT03432858|529364090|FG002|Overall Study|Procedure canceled/rescheduled|6|||
146780031|NCT03432858|529364088|FG000|Overall Study|Required postop mobilization with splinting|0|||
146780032|NCT03432858|529364089|FG001|Overall Study|Required postop mobilization with splinting|0|||
146780033|NCT03432858|529364090|FG002|Overall Study|Required postop mobilization with splinting|1|||
146780034|NCT01011946|529364091|FG000|Overall Study|Transferred to another hospital|2|||
146780035|NCT01011946|529364091|FG000|Overall Study|No pathological lab value|1|||
146780036|NCT04820686|529364092|FG000|Overall Study|Withdrawal by Subject|5|||
146780037|NCT04820686|529364093|FG001|Overall Study|Withdrawal by Subject|2|||
146780038|NCT04820686|529364094|FG002|Overall Study|Withdrawal by Subject|3|||
146780039|NCT04820686|529364092|FG000|Overall Study|Study Termination|25|||
146780040|NCT04820686|529364093|FG001|Overall Study|Study Termination|13|||
146780041|NCT04820686|529364094|FG002|Overall Study|Study Termination|14|||
146780042|NCT04820686|529364092|FG000|Overall Study|Adverse Event|0|||
146780043|NCT04820686|529364093|FG001|Overall Study|Adverse Event|1|||
146780044|NCT04820686|529364094|FG002|Overall Study|Adverse Event|0|||
146780045|NCT01424670|529364095|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
146780046|NCT01424670|529364096|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
146780047|NCT01424670|529364095|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
146780048|NCT01424670|529364096|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
146780049|NCT01424670|529364095|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
146780050|NCT01424670|529364096|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
146780051|NCT01424670|529364095|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
146780052|NCT01424670|529364096|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
146780053|NCT01424670|529364095|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
146780054|NCT01424670|529364096|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
146780055|NCT01424670|529364095|FG000|Continuation Period|Adverse Event|13|||
146780056|NCT01424670|529364096|FG001|Continuation Period|Adverse Event|5|||
146780057|NCT01424670|529364095|FG000|Continuation Period|Lost to Follow-up|2|||
146780058|NCT01424670|529364096|FG001|Continuation Period|Lost to Follow-up|0|||
146780059|NCT01424670|529364095|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
146780060|NCT01424670|529364096|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
146780061|NCT01424670|529364095|FG000|Continuation Period|Physician Decision|5|||
146780062|NCT01424670|529364096|FG001|Continuation Period|Physician Decision|4|||
146780063|NCT01424670|529364095|FG000|Continuation Period|Withdrawal by Subject|13|||
146780064|NCT01424670|529364096|FG001|Continuation Period|Withdrawal by Subject|4|||
146780065|NCT00761189|529364097|FG000|Overall Study|Adverse Event|42|||
146780066|NCT00761189|529364097|FG000|Overall Study|Lack of Efficacy|45|||
146780067|NCT00761189|529364097|FG000|Overall Study|Lost to Follow-up|36|||
146780068|NCT00761189|529364097|FG000|Overall Study|Withdrawal by Subject|49|||
146780069|NCT00761189|529364097|FG000|Overall Study|Other|13|||
146780070|NCT01494922|529364098|FG000|Overall Study|Adverse Event|1|||
146780071|NCT04377308|529364099|FG000|Overall Study|Withdrawal by Subject|0|||
146780072|NCT04377308|529364100|FG001|Overall Study|Withdrawal by Subject|1|||
146780073|NCT02759016|529364101|FG000|Overall Study|Not treated with BI 836826|1|||
146780074|NCT02759016|529364102|FG001|Overall Study|Not treated with BI 836826|0|||
146780075|NCT02759016|529364101|FG000|Overall Study|Progressive disease|1|||
146780076|NCT02759016|529364102|FG001|Overall Study|Progressive disease|0|||
146780077|NCT02759016|529364101|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
146780078|NCT02759016|529364102|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
146933951|NCT01170221|529916017|FG000|Overall Study|Subject completed only screening and LFU|1|||
146933952|NCT01170221|529916018|FG001|Overall Study|Subject completed only screening and LFU|0|||
146933953|NCT01170221|529916017|FG000|Overall Study|Randomized but not treated|1|||
146780079|NCT02759016|529364101|FG000|Overall Study|Other not defined above|2|||
146780080|NCT02759016|529364102|FG001|Overall Study|Other not defined above|1|||
146780081|NCT03988842|529364103|FG000|Overall Study|Death|1|||
146780082|NCT02891915|529364106|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
146780083|NCT02891915|529364107|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
146780084|NCT02891915|529364106|FG000|Overall Study|Withdrawal by Subject|3|||
146780085|NCT02891915|529364107|FG001|Overall Study|Withdrawal by Subject|3|||
146780086|NCT02891915|529364106|FG000|Overall Study|Became Ineligible After Enrollment|2|||
146780087|NCT02891915|529364107|FG001|Overall Study|Became Ineligible After Enrollment|1|||
146780088|NCT02891915|529364106|FG000|Overall Study|Lost to Follow-up|1|||
146981138|NCT00827827|530093751|FG001|Overall Study|Gout|0|||
146981139|NCT00827827|530093750|FG000|Overall Study|Transportation issues|1|||
146712474|NCT00898677|529117059|FG003|Overall Study|Withdrawal by Subject|1|||
146712475|NCT00898677|529117056|FG000|Overall Study|Not Treated: Adverse Event|0|||
146712476|NCT00898677|529117057|FG001|Overall Study|Not Treated: Adverse Event|2|||
146712477|NCT00898677|529117058|FG002|Overall Study|Not Treated: Adverse Event|1|||
146712478|NCT00898677|529117059|FG003|Overall Study|Not Treated: Adverse Event|0|||
146712479|NCT00898677|529117056|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
146712480|NCT00898677|529117057|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
146712481|NCT00898677|529117058|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
146712482|NCT00898677|529117059|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
146712483|NCT00898677|529117056|FG000|Overall Study|Not Treated: Pregnancy|0|||
146712484|NCT00898677|529117057|FG001|Overall Study|Not Treated: Pregnancy|0|||
146712485|NCT00898677|529117058|FG002|Overall Study|Not Treated: Pregnancy|1|||
146712486|NCT00898677|529117059|FG003|Overall Study|Not Treated: Pregnancy|0|||
146712487|NCT00898677|529117056|FG000|Overall Study|Not Treated: Protocol Violation|2|||
146712488|NCT00898677|529117057|FG001|Overall Study|Not Treated: Protocol Violation|0|||
146712489|NCT00898677|529117058|FG002|Overall Study|Not Treated: Protocol Violation|2|||
146712490|NCT00898677|529117059|FG003|Overall Study|Not Treated: Protocol Violation|0|||
146712491|NCT00898677|529117056|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
146712492|NCT00898677|529117057|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
146712493|NCT00898677|529117058|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
146712494|NCT00898677|529117059|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
146712495|NCT00898677|529117056|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
146712496|NCT00898677|529117057|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
146712497|NCT00898677|529117058|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
146712498|NCT00898677|529117059|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
146712499|NCT00898677|529117056|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
146712500|NCT00898677|529117057|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
146712501|NCT00898677|529117058|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
146712502|NCT00898677|529117059|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
146712503|NCT00898677|529117056|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
146712504|NCT00898677|529117057|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
146712505|NCT00898677|529117058|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
146712506|NCT00898677|529117059|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
146712507|NCT00898677|529117056|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
146712508|NCT00898677|529117057|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
146712509|NCT00898677|529117058|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
146712510|NCT00898677|529117059|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
146712511|NCT00898677|529117056|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
146712512|NCT00898677|529117057|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
146712513|NCT00898677|529117058|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
146712514|NCT00898677|529117059|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
146712515|NCT00898677|529117056|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
146712516|NCT00898677|529117057|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
146712517|NCT00898677|529117058|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
146712518|NCT00898677|529117059|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
146712519|NCT00836875|529117062|FG000|Overall Study|Death|3|||
146712520|NCT00836875|529117063|FG001|Overall Study|Death|2|||
146712521|NCT00836875|529117062|FG000|Overall Study|Withdrawal by Subject|0|||
146712522|NCT00836875|529117063|FG001|Overall Study|Withdrawal by Subject|1|||
146712523|NCT03794089|529119315|FG000|Overall Study|Lost to Follow-up|4|||
146712524|NCT03794089|529119316|FG001|Overall Study|Lost to Follow-up|1|||
146712525|NCT03794089|529119315|FG000|Overall Study|Withdrawal by Subject|2|||
146712526|NCT03794089|529119316|FG001|Overall Study|Withdrawal by Subject|0|||
146712527|NCT00116805|529119317|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
146712528|NCT00116805|529119318|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
146712529|NCT00116805|529119317|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
146712530|NCT00116805|529119318|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
146712531|NCT00116805|529119317|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
146712532|NCT00116805|529119318|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
146712533|NCT00116805|529119317|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
146712534|NCT00116805|529119318|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
146712535|NCT00116805|529119317|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
146712536|NCT00116805|529119318|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
146712537|NCT00116805|529119317|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
146712538|NCT00116805|529119318|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
146712539|NCT00116805|529119317|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
146712540|NCT00116805|529119318|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
146712541|NCT00116805|529119317|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
146933954|NCT01170221|529916018|FG001|Overall Study|Randomized but not treated|0|||
146933955|NCT00050960|529916020|FG000|Overall Study|Progressive Disease|137|||
146712542|NCT00116805|529119318|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
146712543|NCT00116805|529119317|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
146712544|NCT00116805|529119318|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
146712545|NCT00116805|529119317|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
146712546|NCT00116805|529119318|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
146712547|NCT00116805|529119317|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
146712548|NCT00116805|529119318|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
146712549|NCT00116805|529119317|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
146712550|NCT00116805|529119318|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
146712551|NCT00116805|529119317|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
146712552|NCT00116805|529119318|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
146712553|NCT00116805|529119317|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
146712554|NCT00116805|529119318|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
146712555|NCT00116805|529119317|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
146712556|NCT00116805|529119318|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
146712557|NCT00116805|529119317|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
146712558|NCT00116805|529119318|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
146712559|NCT00116805|529119317|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
146712560|NCT00116805|529119318|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
146712561|NCT00116805|529119317|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
146712562|NCT00116805|529119318|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
146712563|NCT00116805|529119317|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
146712564|NCT00116805|529119318|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
146712565|NCT00116805|529119317|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
146712566|NCT00116805|529119318|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
146712567|NCT00116805|529119317|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
146712568|NCT00116805|529119318|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
146712569|NCT00116805|529119317|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
146712570|NCT00116805|529119318|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
146712571|NCT00116805|529119317|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
146712572|NCT00116805|529119318|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
146712573|NCT00116805|529119317|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
146712574|NCT00116805|529119318|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
146712575|NCT00116805|529119317|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
146712576|NCT00116805|529119318|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
146712577|NCT00116805|529119317|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
146712578|NCT00116805|529119318|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
146712579|NCT00116805|529119317|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
146712580|NCT00116805|529119318|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
146712581|NCT00116805|529119317|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
146712582|NCT00116805|529119318|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
146712583|NCT00116805|529119317|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
146712584|NCT00116805|529119318|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
146712585|NCT00116805|529119317|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
146712586|NCT00116805|529119318|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
146712587|NCT00116805|529119317|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
146712588|NCT00116805|529119318|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
146712589|NCT00116805|529119317|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
146712590|NCT00116805|529119318|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
146712591|NCT00116805|529119317|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
146712592|NCT00116805|529119318|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
146712593|NCT00116805|529119317|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
146712594|NCT00116805|529119318|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
146712595|NCT00116805|529119317|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
146712596|NCT00116805|529119318|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
146712597|NCT00116805|529119317|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
146712598|NCT00116805|529119318|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
146712599|NCT00116805|529119317|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
146712600|NCT00116805|529119318|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
146712601|NCT00116805|529119317|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
146712602|NCT00116805|529119318|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
146712603|NCT00116805|529119317|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
146712604|NCT00116805|529119318|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
146712605|NCT00116805|529119317|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
146712606|NCT00116805|529119318|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
146712607|NCT00116805|529119317|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
146712608|NCT00116805|529119318|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
146712609|NCT00116805|529119317|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
146712610|NCT00116805|529119318|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
146712611|NCT00116805|529119317|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
146712612|NCT00116805|529119318|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
146712613|NCT00116805|529119317|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
146712614|NCT00116805|529119318|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
146712615|NCT00116805|529119317|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
146712616|NCT00116805|529119318|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
146712617|NCT01760954|529119319|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
146712618|NCT01760954|529119320|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
146712619|NCT01760954|529119321|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
146712620|NCT01760954|529119322|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
146712621|NCT01760954|529119319|FG000|Treatment Period (6 Months)|Adverse Event|5|||
146712622|NCT01760954|529119320|FG001|Treatment Period (6 Months)|Adverse Event|3|||
146712623|NCT01760954|529119321|FG002|Treatment Period (6 Months)|Adverse Event|4|||
146712624|NCT01760954|529119322|FG003|Treatment Period (6 Months)|Adverse Event|10|||
146712625|NCT01760954|529119319|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
146712626|NCT01760954|529119320|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
146712627|NCT01760954|529119321|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
146712628|NCT01760954|529119322|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
146712629|NCT01760954|529119319|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
146712630|NCT01760954|529119320|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
146712631|NCT01760954|529119321|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
146712632|NCT01760954|529119322|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
146712633|NCT01760954|529119319|FG000|Treatment Period (6 Months)|Pregnancy|5|||
146712634|NCT01760954|529119320|FG001|Treatment Period (6 Months)|Pregnancy|0|||
146712635|NCT01760954|529119321|FG002|Treatment Period (6 Months)|Pregnancy|3|||
146712636|NCT01760954|529119322|FG003|Treatment Period (6 Months)|Pregnancy|2|||
146712637|NCT01760954|529119319|FG000|Treatment Period (6 Months)|Non-compliance|1|||
146712638|NCT01760954|529119320|FG001|Treatment Period (6 Months)|Non-compliance|4|||
146712639|NCT01760954|529119321|FG002|Treatment Period (6 Months)|Non-compliance|0|||
146712640|NCT01760954|529119322|FG003|Treatment Period (6 Months)|Non-compliance|3|||
146712641|NCT01760954|529119319|FG000|Treatment Period (6 Months)|Other|0|||
146712642|NCT01760954|529119320|FG001|Treatment Period (6 Months)|Other|3|||
146712643|NCT01760954|529119321|FG002|Treatment Period (6 Months)|Other|3|||
146712644|NCT01760954|529119322|FG003|Treatment Period (6 Months)|Other|1|||
146712645|NCT01760954|529119319|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
146712646|NCT01760954|529119320|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
146712647|NCT01760954|529119321|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
146712648|NCT01760954|529119322|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
146712649|NCT01760954|529119319|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
146712650|NCT01760954|529119320|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
146712651|NCT01760954|529119321|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
146712652|NCT01760954|529119322|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
146712653|NCT01760954|529119319|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
146712654|NCT01760954|529119320|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
146712655|NCT01760954|529119321|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
146712656|NCT01760954|529119322|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
146712657|NCT01760954|529119319|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
146712658|NCT01760954|529119320|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
146712659|NCT01760954|529119321|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
146712660|NCT01760954|529119322|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
146712661|NCT01760954|529119319|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
146712662|NCT01760954|529119320|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
146712663|NCT01760954|529119321|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
146712664|NCT01760954|529119322|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
146712665|NCT01760954|529119319|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
146712666|NCT01760954|529119320|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
146712667|NCT01760954|529119321|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
146712668|NCT01760954|529119322|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
146736413|NCT02343003|529206836|FG000|Overall Study|exclusion criteria met|1|||
146736414|NCT02343003|529206837|FG001|Overall Study|exclusion criteria met|1|||
146712669|NCT01760954|529119319|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
146712670|NCT01760954|529119320|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
146712671|NCT01760954|529119321|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
146712672|NCT01760954|529119322|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
146712673|NCT01760954|529119319|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
146712674|NCT01760954|529119320|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
146712675|NCT01760954|529119321|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
146712676|NCT01760954|529119322|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
146712677|NCT00071487|529119328|FG000|52-Week Double-Blind Period|Adverse Event|5|||
146712678|NCT00071487|529119329|FG001|52-Week Double-Blind Period|Adverse Event|8|||
146712679|NCT00071487|529119330|FG002|52-Week Double-Blind Period|Adverse Event|4|||
146712680|NCT00071487|529119331|FG003|52-Week Double-Blind Period|Adverse Event|8|||
146712681|NCT00071487|529119328|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
146712682|NCT00071487|529119329|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
146712683|NCT00071487|529119330|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
146712684|NCT00071487|529119331|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
146712685|NCT00071487|529119328|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
146712686|NCT00071487|529119329|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
146712687|NCT00071487|529119330|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
146712688|NCT00071487|529119331|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
146712689|NCT00071487|529119328|FG000|52-Week Double-Blind Period|Physician Decision|1|||
146712690|NCT00071487|529119329|FG001|52-Week Double-Blind Period|Physician Decision|0|||
146712691|NCT00071487|529119330|FG002|52-Week Double-Blind Period|Physician Decision|0|||
146712692|NCT00071487|529119331|FG003|52-Week Double-Blind Period|Physician Decision|0|||
146712693|NCT00071487|529119328|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
146712694|NCT00071487|529119329|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
146712695|NCT00071487|529119330|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
146712696|NCT00071487|529119331|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
146712697|NCT00071487|529119328|FG000|52-Week Double-Blind Period|Pregnancy|0|||
146712698|NCT00071487|529119329|FG001|52-Week Double-Blind Period|Pregnancy|1|||
146712699|NCT00071487|529119330|FG002|52-Week Double-Blind Period|Pregnancy|0|||
146712700|NCT00071487|529119331|FG003|52-Week Double-Blind Period|Pregnancy|0|||
146712701|NCT00071487|529119328|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
146712702|NCT00071487|529119329|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
146712703|NCT00071487|529119330|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
146712704|NCT00071487|529119331|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
146712705|NCT00071487|529119328|FG000|52-Week Double-Blind Period|Death|0|||
146712706|NCT00071487|529119329|FG001|52-Week Double-Blind Period|Death|1|||
146712707|NCT00071487|529119330|FG002|52-Week Double-Blind Period|Death|0|||
146712708|NCT00071487|529119331|FG003|52-Week Double-Blind Period|Death|0|||
146712709|NCT00071487|529119328|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
146712710|NCT00071487|529119329|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
146712711|NCT00071487|529119330|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
146712712|NCT00071487|529119331|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
146712713|NCT00071487|529119328|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
146712714|NCT00071487|529119329|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
146712715|NCT00071487|529119330|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
146712716|NCT00071487|529119331|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
146712717|NCT00071487|529119328|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
146712718|NCT00071487|529119329|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
146712719|NCT00071487|529119330|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
146712720|NCT00071487|529119331|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
146712721|NCT00071487|529119328|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146712722|NCT00071487|529119329|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146712723|NCT00071487|529119330|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146712724|NCT00071487|529119331|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
146712725|NCT00071487|529119328|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
146712726|NCT00071487|529119329|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
146712727|NCT00071487|529119330|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
146712728|NCT00071487|529119331|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
146712729|NCT00071487|529119328|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
146712730|NCT00071487|529119329|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
146712731|NCT00071487|529119330|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
146712732|NCT00071487|529119331|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
146712733|NCT00071487|529119328|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
146712734|NCT00071487|529119329|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
146712735|NCT00071487|529119330|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
146780089|NCT02891915|529364107|FG001|Overall Study|Lost to Follow-up|4|||
146780090|NCT02891915|529364106|FG000|Overall Study|Physician Decision|1|||
146780091|NCT02891915|529364107|FG001|Overall Study|Physician Decision|0|||
146933956|NCT00050960|529916021|FG001|Overall Study|Progressive Disease|93|||
146933957|NCT00050960|529916020|FG000|Overall Study|Stable Disease|19|||
146933958|NCT00050960|529916021|FG001|Overall Study|Stable Disease|48|||
146933959|NCT00050960|529916020|FG000|Overall Study|Partial Response|14|||
146933960|NCT00050960|529916021|FG001|Overall Study|Partial Response|19|||
146712736|NCT00071487|529119331|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
146712737|NCT02318329|529119334|FG000|Overall Study|Progressive Disease|2|||
146712738|NCT02318329|529119335|FG001|Overall Study|Progressive Disease|3|||
146712739|NCT02318329|529119336|FG002|Overall Study|Progressive Disease|2|||
146712740|NCT02318329|529119337|FG003|Overall Study|Progressive Disease|3|||
146712741|NCT02318329|529119338|FG004|Overall Study|Progressive Disease|3|||
146712742|NCT02318329|529119339|FG005|Overall Study|Progressive Disease|3|||
146712743|NCT02318329|529119340|FG006|Overall Study|Progressive Disease|1|||
146712744|NCT02318329|529119341|FG007|Overall Study|Progressive Disease|1|||
146712745|NCT02318329|529119342|FG008|Overall Study|Progressive Disease|5|||
146712746|NCT02318329|529119343|FG009|Overall Study|Progressive Disease|39|||
146712747|NCT02318329|529119334|FG000|Overall Study|Death|0|||
146712748|NCT02318329|529119335|FG001|Overall Study|Death|0|||
146712749|NCT02318329|529119336|FG002|Overall Study|Death|0|||
146712750|NCT02318329|529119337|FG003|Overall Study|Death|0|||
146712751|NCT02318329|529119338|FG004|Overall Study|Death|0|||
146712752|NCT02318329|529119339|FG005|Overall Study|Death|0|||
146712753|NCT02318329|529119340|FG006|Overall Study|Death|0|||
146712754|NCT02318329|529119341|FG007|Overall Study|Death|0|||
146712755|NCT02318329|529119342|FG008|Overall Study|Death|0|||
146712756|NCT02318329|529119343|FG009|Overall Study|Death|5|||
146712757|NCT02318329|529119334|FG000|Overall Study|Lost to Follow-up|0|||
146712758|NCT02318329|529119335|FG001|Overall Study|Lost to Follow-up|0|||
146712759|NCT02318329|529119336|FG002|Overall Study|Lost to Follow-up|0|||
146712760|NCT02318329|529119337|FG003|Overall Study|Lost to Follow-up|0|||
146712761|NCT02318329|529119338|FG004|Overall Study|Lost to Follow-up|0|||
146712762|NCT02318329|529119339|FG005|Overall Study|Lost to Follow-up|0|||
146712763|NCT02318329|529119340|FG006|Overall Study|Lost to Follow-up|0|||
146712764|NCT02318329|529119341|FG007|Overall Study|Lost to Follow-up|0|||
146712765|NCT02318329|529119342|FG008|Overall Study|Lost to Follow-up|0|||
146712766|NCT02318329|529119343|FG009|Overall Study|Lost to Follow-up|1|||
146712767|NCT02318329|529119334|FG000|Overall Study|Withdrawal by Subject|0|||
146712768|NCT02318329|529119335|FG001|Overall Study|Withdrawal by Subject|0|||
146712769|NCT02318329|529119336|FG002|Overall Study|Withdrawal by Subject|0|||
146712770|NCT02318329|529119337|FG003|Overall Study|Withdrawal by Subject|0|||
146712771|NCT02318329|529119338|FG004|Overall Study|Withdrawal by Subject|0|||
146712772|NCT02318329|529119339|FG005|Overall Study|Withdrawal by Subject|0|||
146712773|NCT02318329|529119340|FG006|Overall Study|Withdrawal by Subject|0|||
146712774|NCT02318329|529119341|FG007|Overall Study|Withdrawal by Subject|0|||
146712775|NCT02318329|529119342|FG008|Overall Study|Withdrawal by Subject|0|||
146712776|NCT02318329|529119343|FG009|Overall Study|Withdrawal by Subject|6|||
146712777|NCT02318329|529119334|FG000|Overall Study|Other|1|||
146712778|NCT02318329|529119335|FG001|Overall Study|Other|1|||
146712779|NCT02318329|529119336|FG002|Overall Study|Other|1|||
146712780|NCT02318329|529119337|FG003|Overall Study|Other|0|||
146712781|NCT02318329|529119338|FG004|Overall Study|Other|0|||
146712782|NCT02318329|529119339|FG005|Overall Study|Other|0|||
146712783|NCT02318329|529119340|FG006|Overall Study|Other|0|||
146712784|NCT02318329|529119341|FG007|Overall Study|Other|0|||
146712785|NCT02318329|529119342|FG008|Overall Study|Other|1|||
146712786|NCT02318329|529119343|FG009|Overall Study|Other|1|||
146712787|NCT02032901|529119346|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
146712788|NCT02032901|529119347|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
146712789|NCT02032901|529119346|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
146712790|NCT02032901|529119347|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
146712791|NCT00353704|529119360|FG000|Overall Study|Protocol Violation|3|||
146712792|NCT00353704|529119361|FG001|Overall Study|Protocol Violation|1|||
146712793|NCT02530619|529119371|FG000|Registered for Study|Withdrawal by Subject|2|||
146933961|NCT00050960|529916020|FG000|Overall Study|Complete Response|0|||
146933962|NCT00050960|529916021|FG001|Overall Study|Complete Response|2|||
146933963|NCT00050960|529916020|FG000|Overall Study|Adverse Event|62|||
146712794|NCT02530619|529119371|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
146712795|NCT02530619|529119371|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
146712796|NCT02530619|529119371|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
146712797|NCT02530619|529119371|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
146712798|NCT02530619|529119371|FG000|Follow-up Period (6 Months)|Death|4|||
146712799|NCT02530619|529119371|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
146712800|NCT02530619|529119371|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
146712801|NCT01854554|529119382|FG000|Overall Study|Denial of Insurance Coverage|12|||
146712802|NCT01854554|529119383|FG001|Overall Study|Denial of Insurance Coverage|0|||
146712803|NCT01854554|529119382|FG000|Overall Study|Decided to get treatment locally|1|||
146712804|NCT01854554|529119383|FG001|Overall Study|Decided to get treatment locally|5|||
146933964|NCT00050960|529916021|FG001|Overall Study|Adverse Event|61|||
146933965|NCT00050960|529916020|FG000|Overall Study|Lost to Follow-up|0|||
146981140|NCT00827827|530093751|FG001|Overall Study|Transportation issues|0|||
146981141|NCT00827827|530093750|FG000|Overall Study|Burned with water at home|1|||
146981142|NCT00827827|530093751|FG001|Overall Study|Burned with water at home|0|||
146712805|NCT01854554|529119382|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
146712806|NCT01854554|529119383|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
146712807|NCT01854554|529119382|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
146712808|NCT01854554|529119383|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
146712809|NCT01854554|529119382|FG000|Overall Study|Progression|0|||
146712810|NCT01854554|529119383|FG001|Overall Study|Progression|1|||
146712811|NCT01854554|529119382|FG000|Overall Study|Lost to Follow-up|0|||
146712812|NCT01854554|529119383|FG001|Overall Study|Lost to Follow-up|1|||
146712813|NCT00359762|529119386|FG000|Period II|Adverse Event|17|||
146712814|NCT00359762|529119387|FG001|Period II|Adverse Event|0|||
146712815|NCT00359762|529119388|FG002|Period II|Adverse Event|0|||
146712816|NCT00359762|529119389|FG003|Period II|Adverse Event|0|||
146712817|NCT00359762|529119390|FG004|Period II|Adverse Event|49|||
146712818|NCT00359762|529119386|FG000|Period II|Protocol Violation|18|||
146712819|NCT00359762|529119387|FG001|Period II|Protocol Violation|0|||
146712820|NCT00359762|529119388|FG002|Period II|Protocol Violation|0|||
146712821|NCT00359762|529119389|FG003|Period II|Protocol Violation|0|||
146712822|NCT00359762|529119390|FG004|Period II|Protocol Violation|11|||
146712823|NCT00359762|529119386|FG000|Period II|Physician Decision|17|||
146712824|NCT00359762|529119387|FG001|Period II|Physician Decision|0|||
146712825|NCT00359762|529119388|FG002|Period II|Physician Decision|0|||
146712826|NCT00359762|529119389|FG003|Period II|Physician Decision|0|||
146712827|NCT00359762|529119390|FG004|Period II|Physician Decision|23|||
146712828|NCT00359762|529119386|FG000|Period II|Death|2|||
146712829|NCT00359762|529119387|FG001|Period II|Death|0|||
146712830|NCT00359762|529119388|FG002|Period II|Death|0|||
146712831|NCT00359762|529119389|FG003|Period II|Death|0|||
146712832|NCT00359762|529119390|FG004|Period II|Death|4|||
146712833|NCT00359762|529119386|FG000|Period II|Lack of Efficacy|11|||
146712834|NCT00359762|529119387|FG001|Period II|Lack of Efficacy|0|||
146712835|NCT00359762|529119388|FG002|Period II|Lack of Efficacy|0|||
146712836|NCT00359762|529119389|FG003|Period II|Lack of Efficacy|0|||
146712837|NCT00359762|529119390|FG004|Period II|Lack of Efficacy|8|||
146712838|NCT00359762|529119386|FG000|Period II|Lost to follow up|5|||
146712839|NCT00359762|529119387|FG001|Period II|Lost to follow up|0|||
146712840|NCT00359762|529119388|FG002|Period II|Lost to follow up|0|||
146712841|NCT00359762|529119389|FG003|Period II|Lost to follow up|0|||
146712842|NCT00359762|529119390|FG004|Period II|Lost to follow up|5|||
146712843|NCT00359762|529119386|FG000|Period II|Entry Criteria Not Met|8|||
146712844|NCT00359762|529119387|FG001|Period II|Entry Criteria Not Met|0|||
146712845|NCT00359762|529119388|FG002|Period II|Entry Criteria Not Met|0|||
146712846|NCT00359762|529119389|FG003|Period II|Entry Criteria Not Met|0|||
146712847|NCT00359762|529119390|FG004|Period II|Entry Criteria Not Met|4|||
146712848|NCT00359762|529119386|FG000|Period II|Subject Decision|50|||
146712849|NCT00359762|529119387|FG001|Period II|Subject Decision|0|||
146712850|NCT00359762|529119388|FG002|Period II|Subject Decision|0|||
146712851|NCT00359762|529119389|FG003|Period II|Subject Decision|0|||
146712852|NCT00359762|529119390|FG004|Period II|Subject Decision|70|||
146712853|NCT00359762|529119386|FG000|Period III|Protocol Violation|0|||
146712854|NCT00359762|529119387|FG001|Period III|Protocol Violation|5|||
146712855|NCT00359762|529119388|FG002|Period III|Protocol Violation|3|||
146712856|NCT00359762|529119389|FG003|Period III|Protocol Violation|8|||
146712857|NCT00359762|529119390|FG004|Period III|Protocol Violation|0|||
146712858|NCT00359762|529119386|FG000|Period III|Adverse Event|0|||
146780092|NCT00709098|529364109|FG000|Double-blind Period|Withdrawal of consent|3|||
146780093|NCT00709098|529364110|FG001|Double-blind Period|Withdrawal of consent|3|||
146780094|NCT00709098|529364111|FG002|Double-blind Period|Withdrawal of consent|0|||
146780095|NCT00709098|529364109|FG000|Double-blind Period|Administrative reason|1|||
146780096|NCT00709098|529364110|FG001|Double-blind Period|Administrative reason|3|||
146780097|NCT00709098|529364111|FG002|Double-blind Period|Administrative reason|0|||
146780098|NCT00709098|529364109|FG000|Double-blind Period|Death|1|||
146780099|NCT00709098|529364110|FG001|Double-blind Period|Death|1|||
146780100|NCT00709098|529364111|FG002|Double-blind Period|Death|0|||
146780101|NCT00709098|529364109|FG000|Double-blind Period|Lost to Follow-up|1|||
146712859|NCT00359762|529119387|FG001|Period III|Adverse Event|3|||
146712860|NCT00359762|529119388|FG002|Period III|Adverse Event|4|||
146712861|NCT00359762|529119389|FG003|Period III|Adverse Event|10|||
146712862|NCT00359762|529119390|FG004|Period III|Adverse Event|0|||
146712863|NCT00359762|529119386|FG000|Period III|Physician Decision|0|||
146712864|NCT00359762|529119387|FG001|Period III|Physician Decision|5|||
146712865|NCT00359762|529119388|FG002|Period III|Physician Decision|9|||
146712866|NCT00359762|529119389|FG003|Period III|Physician Decision|15|||
146712867|NCT00359762|529119390|FG004|Period III|Physician Decision|0|||
146712868|NCT00359762|529119386|FG000|Period III|Lack of Efficacy|0|||
146712869|NCT00359762|529119387|FG001|Period III|Lack of Efficacy|7|||
146712870|NCT00359762|529119388|FG002|Period III|Lack of Efficacy|5|||
146712871|NCT00359762|529119389|FG003|Period III|Lack of Efficacy|9|||
146712872|NCT00359762|529119390|FG004|Period III|Lack of Efficacy|0|||
146712873|NCT00359762|529119386|FG000|Period III|Lost to follow up|0|||
146712874|NCT00359762|529119387|FG001|Period III|Lost to follow up|1|||
146712875|NCT00359762|529119388|FG002|Period III|Lost to follow up|1|||
146712876|NCT00359762|529119389|FG003|Period III|Lost to follow up|2|||
146712877|NCT00359762|529119390|FG004|Period III|Lost to follow up|0|||
146712878|NCT00359762|529119386|FG000|Period III|Entry Criteria Not Met|0|||
146712879|NCT00359762|529119387|FG001|Period III|Entry Criteria Not Met|1|||
146712880|NCT00359762|529119388|FG002|Period III|Entry Criteria Not Met|0|||
146712881|NCT00359762|529119389|FG003|Period III|Entry Criteria Not Met|1|||
146712882|NCT00359762|529119390|FG004|Period III|Entry Criteria Not Met|0|||
146712883|NCT00359762|529119386|FG000|Period III|Subject Decision|0|||
146712884|NCT00359762|529119387|FG001|Period III|Subject Decision|7|||
146712885|NCT00359762|529119388|FG002|Period III|Subject Decision|8|||
146712886|NCT00359762|529119389|FG003|Period III|Subject Decision|20|||
146712887|NCT00359762|529119390|FG004|Period III|Subject Decision|0|||
146712888|NCT02819726|529119391|FG000|Part A (All Participants)|Lost to Follow-up|0|||
146712889|NCT02819726|529119392|FG001|Part A (All Participants)|Lost to Follow-up|1|||
146712890|NCT02819726|529119393|FG002|Part A (All Participants)|Lost to Follow-up|0|||
146712891|NCT02819726|529119394|FG003|Part A (All Participants)|Lost to Follow-up|0|||
146712892|NCT02819726|529119391|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
146712893|NCT02819726|529119392|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
146712894|NCT02819726|529119393|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
146712895|NCT02819726|529119394|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
146712896|NCT02819726|529119391|FG000|Part A (All Participants)|Protocol non-compliance|3|||
146712897|NCT02819726|529119392|FG001|Part A (All Participants)|Protocol non-compliance|4|||
146712898|NCT02819726|529119393|FG002|Part A (All Participants)|Protocol non-compliance|5|||
146712899|NCT02819726|529119394|FG003|Part A (All Participants)|Protocol non-compliance|0|||
146712900|NCT02819726|529119391|FG000|Part B (All Participants)|Lost to Follow-up|1|||
146712901|NCT02819726|529119392|FG001|Part B (All Participants)|Lost to Follow-up|1|||
146712902|NCT02819726|529119393|FG002|Part B (All Participants)|Lost to Follow-up|2|||
146712903|NCT02819726|529119394|FG003|Part B (All Participants)|Lost to Follow-up|2|||
146712904|NCT02819726|529119391|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
146712905|NCT02819726|529119392|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
146712906|NCT02819726|529119393|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
146712907|NCT02819726|529119394|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
146712908|NCT02819726|529119391|FG000|Part B (All Participants)|Protocol non-compliance|0|||
146712909|NCT02819726|529119392|FG001|Part B (All Participants)|Protocol non-compliance|0|||
146712910|NCT02819726|529119393|FG002|Part B (All Participants)|Protocol non-compliance|1|||
146712911|NCT02819726|529119394|FG003|Part B (All Participants)|Protocol non-compliance|0|||
146712912|NCT01033747|529119398|FG000|Overall Study|Adverse Event|9|||
146712913|NCT01033747|529119399|FG001|Overall Study|Adverse Event|4|||
146712914|NCT01033747|529119398|FG000|Overall Study|Abnormal Laboratory Value|1|||
146712915|NCT01033747|529119399|FG001|Overall Study|Abnormal Laboratory Value|0|||
146712916|NCT01033747|529119398|FG000|Overall Study|Abnormal test procedure|0|||
146712917|NCT01033747|529119399|FG001|Overall Study|Abnormal test procedure|1|||
146712918|NCT01033747|529119398|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
146712919|NCT01033747|529119399|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
146712920|NCT01033747|529119398|FG000|Overall Study|Protocol Violation|1|||
146712921|NCT01033747|529119399|FG001|Overall Study|Protocol Violation|0|||
146712922|NCT01033747|529119398|FG000|Overall Study|Withdrawal by Subject|9|||
146712923|NCT01033747|529119399|FG001|Overall Study|Withdrawal by Subject|6|||
146712924|NCT01033747|529119398|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
146712925|NCT01033747|529119399|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
146712926|NCT01033747|529119398|FG000|Overall Study|Stopped at end of Extension 1|2|||
146712927|NCT01033747|529119399|FG001|Overall Study|Stopped at end of Extension 1|0|||
146712928|NCT02613481|529119400|FG000|Overall Study|Lost to Follow-up|7|||
146712929|NCT02613481|529119400|FG000|Overall Study|Withdrawal by Subject|2|||
146712930|NCT00803023|529119401|FG000|Overall Study|Adverse Event|5|||
146712931|NCT00803023|529119402|FG001|Overall Study|Adverse Event|4|||
146712932|NCT00803023|529119403|FG002|Overall Study|Adverse Event|8|||
146712933|NCT00803023|529119404|FG003|Overall Study|Adverse Event|6|||
146712934|NCT00803023|529119401|FG000|Overall Study|Withdrawal by Subject|0|||
146712935|NCT00803023|529119402|FG001|Overall Study|Withdrawal by Subject|2|||
146712936|NCT00803023|529119403|FG002|Overall Study|Withdrawal by Subject|0|||
146712937|NCT00803023|529119404|FG003|Overall Study|Withdrawal by Subject|0|||
146981143|NCT00447603|530093753|FG000|Screening|Withdrawal by Subject|1|||
146712938|NCT00803023|529119401|FG000|Overall Study|Lost to Follow-up|0|||
146712939|NCT00803023|529119402|FG001|Overall Study|Lost to Follow-up|1|||
146712940|NCT00803023|529119403|FG002|Overall Study|Lost to Follow-up|2|||
146712941|NCT00803023|529119404|FG003|Overall Study|Lost to Follow-up|1|||
146712942|NCT00803023|529119401|FG000|Overall Study|Lack of Efficacy|0|||
146712943|NCT00803023|529119402|FG001|Overall Study|Lack of Efficacy|1|||
146712944|NCT00803023|529119403|FG002|Overall Study|Lack of Efficacy|1|||
146712945|NCT00803023|529119404|FG003|Overall Study|Lack of Efficacy|1|||
146712946|NCT02647658|529119405|FG000|Overall Study|Consent refusal|15|||
146712947|NCT02647658|529119406|FG001|Overall Study|Consent refusal|24|||
146780102|NCT00709098|529364110|FG001|Double-blind Period|Lost to Follow-up|1|||
146780103|NCT00709098|529364111|FG002|Double-blind Period|Lost to Follow-up|0|||
146780104|NCT00709098|529364109|FG000|Open-label Period|Withdrawal of consent|0|||
146780105|NCT00709098|529364110|FG001|Open-label Period|Withdrawal of consent|0|||
146780106|NCT00709098|529364111|FG002|Open-label Period|Withdrawal of consent|7|||
146780107|NCT00709098|529364109|FG000|Open-label Period|Administrative reason|0|||
146780108|NCT00709098|529364110|FG001|Open-label Period|Administrative reason|0|||
146780109|NCT00709098|529364111|FG002|Open-label Period|Administrative reason|5|||
146780110|NCT00709098|529364109|FG000|Open-label Period|Death|0|||
146780111|NCT00709098|529364110|FG001|Open-label Period|Death|0|||
146780112|NCT00709098|529364111|FG002|Open-label Period|Death|1|||
146780113|NCT00709098|529364109|FG000|Open-label Period|Lost to Follow-up|0|||
146780114|NCT00709098|529364110|FG001|Open-label Period|Lost to Follow-up|0|||
146780115|NCT00709098|529364111|FG002|Open-label Period|Lost to Follow-up|1|||
146780116|NCT03939312|529364112|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
146780117|NCT03939312|529364112|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
146780118|NCT03939312|529364112|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
146780119|NCT03939312|529364112|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
146780120|NCT03939312|529364112|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
146780121|NCT03939312|529364112|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
146780122|NCT03939312|529364112|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
146780123|NCT03939312|529364112|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
146780124|NCT03939312|529364112|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
146780125|NCT03939312|529364112|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
146780126|NCT03939312|529364112|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
146780127|NCT03939312|529364112|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
146780128|NCT02119650|529364113|FG000|Overall Study|Adverse Event|3|||
146780129|NCT02119650|529364114|FG001|Overall Study|Adverse Event|4|||
146933966|NCT00050960|529916021|FG001|Overall Study|Lost to Follow-up|1|||
146933967|NCT00050960|529916020|FG000|Overall Study|Withdrawal by Subject|23|||
146933968|NCT00050960|529916021|FG001|Overall Study|Withdrawal by Subject|18|||
146933969|NCT00050960|529916020|FG000|Overall Study|Administrative|31|||
146933970|NCT00050960|529916021|FG001|Overall Study|Administrative|46|||
146933971|NCT00050960|529916020|FG000|Overall Study|Non-compliance|3|||
146933972|NCT00050960|529916021|FG001|Overall Study|Non-compliance|1|||
146933973|NCT00050960|529916020|FG000|Overall Study|Death|13|||
146933974|NCT00050960|529916021|FG001|Overall Study|Death|15|||
146933975|NCT01996904|529916025|FG000|Overall Study|Lost to Follow-up|38|||
146712948|NCT01542528|529119407|FG000|Overall Study|Lost to Follow-up|2|||
146712949|NCT01542528|529119408|FG001|Overall Study|Lost to Follow-up|1|||
146712950|NCT01542528|529119407|FG000|Overall Study|Physician Decision|1|||
146712951|NCT01542528|529119408|FG001|Overall Study|Physician Decision|0|||
146712952|NCT01542528|529119407|FG000|Overall Study|Withdrawal by Subject|9|||
146712953|NCT01542528|529119408|FG001|Overall Study|Withdrawal by Subject|6|||
146712954|NCT04382326|529119415|FG000|Overall Study|Adverse Event, not serious|1|||
146712955|NCT04382326|529119416|FG001|Overall Study|Adverse Event, not serious|2|||
146712956|NCT04382326|529119415|FG000|Overall Study|Other|1|||
146712957|NCT04382326|529119416|FG001|Overall Study|Other|0|||
146712958|NCT04382326|529119415|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
146712959|NCT04382326|529119416|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
146712960|NCT04382326|529119415|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
146712961|NCT04382326|529119416|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
146712962|NCT04382326|529119415|FG000|Overall Study|Protocol Violation|29|||
146712963|NCT04382326|529119416|FG001|Overall Study|Protocol Violation|23|||
146712964|NCT04382326|529119415|FG000|Overall Study|Physician Decision|0|||
146712965|NCT04382326|529119416|FG001|Overall Study|Physician Decision|1|||
146712966|NCT04382326|529119415|FG000|Overall Study|Lost to Follow-up|48|||
146712967|NCT04382326|529119416|FG001|Overall Study|Lost to Follow-up|63|||
146712968|NCT04382326|529119415|FG000|Overall Study|Adverse Event, non-fatal|1|||
146712969|NCT04382326|529119416|FG001|Overall Study|Adverse Event, non-fatal|1|||
146712970|NCT01762761|529119417|FG000|Overall Study|Adverse Event|15|||
146712971|NCT01762761|529119418|FG001|Overall Study|Adverse Event|17|||
146780130|NCT02119650|529364113|FG000|Overall Study|Subject decision|2|||
146780131|NCT02119650|529364114|FG001|Overall Study|Subject decision|3|||
146780132|NCT02119650|529364113|FG000|Overall Study|Disease progression|11|||
146780133|NCT02119650|529364114|FG001|Overall Study|Disease progression|14|||
146712972|NCT01762761|529119417|FG000|Overall Study|Lack of Efficacy|9|||
146712973|NCT01762761|529119418|FG001|Overall Study|Lack of Efficacy|25|||
146780134|NCT02119650|529364113|FG000|Overall Study|Death|5|||
146780135|NCT02119650|529364114|FG001|Overall Study|Death|1|||
146780136|NCT02119650|529364113|FG000|Overall Study|Noncompliance with study treatment|1|||
146780137|NCT02119650|529364114|FG001|Overall Study|Noncompliance with study treatment|1|||
146780138|NCT02119650|529364113|FG000|Overall Study|Study terminated by the sponsor|1|||
146780139|NCT02119650|529364114|FG001|Overall Study|Study terminated by the sponsor|0|||
146933976|NCT01996904|529916026|FG001|Overall Study|Lost to Follow-up|27|||
146933977|NCT00585923|529916027|FG000|Overall Study|Physician decided not to continue|31|||
146712974|NCT01762761|529119417|FG000|Overall Study|Protocol Violation|1|||
146712975|NCT01762761|529119418|FG001|Overall Study|Protocol Violation|1|||
146712976|NCT01762761|529119417|FG000|Overall Study|Study closed/terminated|0|||
146712977|NCT01762761|529119418|FG001|Overall Study|Study closed/terminated|2|||
146712978|NCT01762761|529119417|FG000|Overall Study|Lost to Follow-up|3|||
146712979|NCT01762761|529119418|FG001|Overall Study|Lost to Follow-up|6|||
146712980|NCT01762761|529119417|FG000|Overall Study|Physician Decision|4|||
146712981|NCT01762761|529119418|FG001|Overall Study|Physician Decision|6|||
146712982|NCT01762761|529119417|FG000|Overall Study|Withdrawal by Subject|7|||
146712983|NCT01762761|529119418|FG001|Overall Study|Withdrawal by Subject|8|||
146712984|NCT00534352|529119423|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
146712985|NCT00534352|529119423|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
146712986|NCT00534352|529119423|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
146712987|NCT00534352|529119423|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
146712988|NCT00534352|529119423|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
146712989|NCT00534352|529119423|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
146712990|NCT04788147|529119424|FG000|Overall Study|Screen Failure|3|||
146712991|NCT04788147|529119425|FG001|Overall Study|Screen Failure|10|||
146712992|NCT04788147|529119424|FG000|Overall Study|Incomplete RMRS image session|2|||
146712993|NCT04788147|529119425|FG001|Overall Study|Incomplete RMRS image session|0|||
146712994|NCT00781326|529119428|FG000|Phase I|Adverse Event|1|||
146712995|NCT00781326|529119428|FG000|Phase I|Withdrawal by Subject|1|||
146712996|NCT00781326|529119428|FG000|Phase I|Physician Decision|2|||
146712997|NCT02401672|529119431|FG000|Overall Study|Withdrawal by Subject|1|||
146712998|NCT02401672|529119432|FG001|Overall Study|Withdrawal by Subject|3|||
146712999|NCT04796610|529119433|FG000|Overall Study|Withdrawal by Subject|1|||
146713000|NCT04796610|529119434|FG001|Overall Study|Withdrawal by Subject|0|||
146713001|NCT04796610|529119435|FG002|Overall Study|Withdrawal by Subject|0|||
146713002|NCT04796610|529119436|FG003|Overall Study|Withdrawal by Subject|0|||
146713003|NCT04796610|529119433|FG000|Overall Study|Lost to Follow-up|2|||
146713004|NCT04796610|529119434|FG001|Overall Study|Lost to Follow-up|0|||
146713005|NCT04796610|529119435|FG002|Overall Study|Lost to Follow-up|1|||
146713006|NCT04796610|529119436|FG003|Overall Study|Lost to Follow-up|1|||
146713007|NCT01459796|529119437|FG000|Overall Study|Non compliance with protocol|2|||
146713008|NCT01459796|529119438|FG001|Overall Study|Non compliance with protocol|4|||
146713009|NCT01459796|529119437|FG000|Overall Study|Adverse Event|5|||
146713010|NCT01459796|529119438|FG001|Overall Study|Adverse Event|5|||
146713011|NCT01459796|529119437|FG000|Overall Study|Withdrawal by Subject|6|||
146713012|NCT01459796|529119438|FG001|Overall Study|Withdrawal by Subject|3|||
146713013|NCT01459796|529119437|FG000|Overall Study|Lost to Follow-up|5|||
146713014|NCT01459796|529119438|FG001|Overall Study|Lost to Follow-up|4|||
146713015|NCT01459796|529119437|FG000|Overall Study|Reason unspecified|1|||
146713016|NCT01459796|529119438|FG001|Overall Study|Reason unspecified|2|||
146713017|NCT01459796|529119437|FG000|Overall Study|Decision by the sponsor|75|||
146713018|NCT01459796|529119438|FG001|Overall Study|Decision by the sponsor|108|||
146713019|NCT00701051|529119439|FG000|Screening|Failed Screening|40|||
146713020|NCT00701051|529119440|FG001|Screening|Failed Screening|0|||
146713021|NCT00701051|529119441|FG002|Screening|Failed Screening|0|||
146713022|NCT00701051|529119439|FG000|Screening|Time conflicts|19|||
146713023|NCT00701051|529119440|FG001|Screening|Time conflicts|0|||
146713024|NCT00701051|529119441|FG002|Screening|Time conflicts|0|||
146713025|NCT00701051|529119439|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
146713026|NCT00701051|529119440|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
146713027|NCT00701051|529119441|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
146713028|NCT05857527|529119442|FG000|Overall Study|Withdrawal by Subject|0|||
146713029|NCT05857527|529119443|FG001|Overall Study|Withdrawal by Subject|1|||
146713030|NCT02543346|529119444|FG000|Second Priming Visit|Withdrawal by Subject|0|||
146713031|NCT02543346|529119445|FG001|Second Priming Visit|Withdrawal by Subject|2|||
146713032|NCT02543346|529119446|FG002|Second Priming Visit|Withdrawal by Subject|2|||
146713033|NCT02543346|529119447|FG003|Second Priming Visit|Withdrawal by Subject|2|||
146713034|NCT02543346|529119444|FG000|Second Priming Visit|Adverse Event|1|||
146713035|NCT02543346|529119445|FG001|Second Priming Visit|Adverse Event|0|||
146713036|NCT02543346|529119446|FG002|Second Priming Visit|Adverse Event|0|||
146713037|NCT02543346|529119447|FG003|Second Priming Visit|Adverse Event|0|||
146713038|NCT01748994|529119448|FG000|Overall Study|Lost to Follow-up|8|||
146713039|NCT01748994|529119449|FG001|Overall Study|Lost to Follow-up|6|||
146713040|NCT02141516|529119450|FG000|Overall Study|Adverse Event|0|||
146713041|NCT02141516|529119451|FG001|Overall Study|Adverse Event|1|||
146713042|NCT02141516|529119452|FG002|Overall Study|Adverse Event|0|||
146713043|NCT02141516|529119450|FG000|Overall Study|Lost to Follow-up|0|||
146713044|NCT02141516|529119451|FG001|Overall Study|Lost to Follow-up|1|||
146713045|NCT02141516|529119452|FG002|Overall Study|Lost to Follow-up|0|||
146713046|NCT02141516|529119450|FG000|Overall Study|Other|0|||
146713047|NCT02141516|529119451|FG001|Overall Study|Other|3|||
146713048|NCT02141516|529119452|FG002|Overall Study|Other|0|||
146713049|NCT03251924|529119453|FG000|Overall Study|Disease Progression|6|||
146713050|NCT03251924|529119454|FG001|Overall Study|Disease Progression|6|||
146713051|NCT03251924|529119455|FG002|Overall Study|Disease Progression|7|||
146713052|NCT03251924|529119456|FG003|Overall Study|Disease Progression|8|||
146713053|NCT03251924|529119457|FG004|Overall Study|Disease Progression|8|||
146713054|NCT03251924|529119458|FG005|Overall Study|Disease Progression|7|||
146713055|NCT03251924|529119459|FG006|Overall Study|Disease Progression|6|||
146713056|NCT03251924|529119460|FG007|Overall Study|Disease Progression|10|||
146713057|NCT03251924|529119461|FG008|Overall Study|Disease Progression|6|||
146713058|NCT03251924|529119453|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
146713059|NCT03251924|529119454|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
146713060|NCT03251924|529119455|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
146713061|NCT03251924|529119456|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
146713062|NCT03251924|529119457|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
146713063|NCT03251924|529119458|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
146713064|NCT03251924|529119459|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
146713065|NCT03251924|529119460|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
146713066|NCT03251924|529119461|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
146713067|NCT03251924|529119453|FG000|Overall Study|Death|0|||
146713068|NCT03251924|529119454|FG001|Overall Study|Death|1|||
146713069|NCT03251924|529119455|FG002|Overall Study|Death|0|||
146713070|NCT03251924|529119456|FG003|Overall Study|Death|1|||
146713071|NCT03251924|529119457|FG004|Overall Study|Death|1|||
146713072|NCT03251924|529119458|FG005|Overall Study|Death|1|||
146713073|NCT03251924|529119459|FG006|Overall Study|Death|0|||
146713074|NCT03251924|529119460|FG007|Overall Study|Death|0|||
146713075|NCT03251924|529119461|FG008|Overall Study|Death|0|||
146713076|NCT03251924|529119453|FG000|Overall Study|Study Drug Toxicity|0|||
146713077|NCT03251924|529119454|FG001|Overall Study|Study Drug Toxicity|0|||
146713078|NCT03251924|529119455|FG002|Overall Study|Study Drug Toxicity|0|||
146713079|NCT03251924|529119456|FG003|Overall Study|Study Drug Toxicity|1|||
146713080|NCT03251924|529119457|FG004|Overall Study|Study Drug Toxicity|0|||
146713081|NCT03251924|529119458|FG005|Overall Study|Study Drug Toxicity|0|||
146713082|NCT03251924|529119459|FG006|Overall Study|Study Drug Toxicity|0|||
146713083|NCT03251924|529119460|FG007|Overall Study|Study Drug Toxicity|0|||
146713084|NCT03251924|529119461|FG008|Overall Study|Study Drug Toxicity|1|||
146713085|NCT03251924|529119453|FG000|Overall Study|Other Reasons|0|||
146713086|NCT03251924|529119454|FG001|Overall Study|Other Reasons|0|||
146713087|NCT03251924|529119455|FG002|Overall Study|Other Reasons|0|||
146713088|NCT03251924|529119456|FG003|Overall Study|Other Reasons|0|||
146713089|NCT03251924|529119457|FG004|Overall Study|Other Reasons|0|||
146713090|NCT03251924|529119458|FG005|Overall Study|Other Reasons|0|||
146713091|NCT03251924|529119459|FG006|Overall Study|Other Reasons|0|||
146713092|NCT03251924|529119460|FG007|Overall Study|Other Reasons|0|||
146713093|NCT03251924|529119461|FG008|Overall Study|Other Reasons|1|||
146713094|NCT03251924|529119453|FG000|Overall Study|Participant request to discontinue study treatment|0|||
146713095|NCT03251924|529119454|FG001|Overall Study|Participant request to discontinue study treatment|0|||
146713096|NCT03251924|529119455|FG002|Overall Study|Participant request to discontinue study treatment|0|||
146713097|NCT03251924|529119456|FG003|Overall Study|Participant request to discontinue study treatment|0|||
146713098|NCT03251924|529119457|FG004|Overall Study|Participant request to discontinue study treatment|0|||
146713099|NCT03251924|529119458|FG005|Overall Study|Participant request to discontinue study treatment|0|||
146713100|NCT03251924|529119459|FG006|Overall Study|Participant request to discontinue study treatment|0|||
146713101|NCT03251924|529119460|FG007|Overall Study|Participant request to discontinue study treatment|1|||
146713102|NCT03251924|529119461|FG008|Overall Study|Participant request to discontinue study treatment|0|||
146713103|NCT00153101|529119462|FG000|Overall Study|Lost to Follow-up|14|||
146713104|NCT00153101|529119463|FG001|Overall Study|Lost to Follow-up|14|||
146713105|NCT00153101|529119464|FG002|Overall Study|Lost to Follow-up|12|||
146713106|NCT00153101|529119465|FG003|Overall Study|Lost to Follow-up|5|||
146713107|NCT00153101|529119466|FG004|Overall Study|Lost to Follow-up|5|||
146713108|NCT00153101|529119462|FG000|Overall Study|Withdrawal by Subject|3|||
146713109|NCT00153101|529119463|FG001|Overall Study|Withdrawal by Subject|4|||
146713110|NCT00153101|529119464|FG002|Overall Study|Withdrawal by Subject|3|||
146713111|NCT00153101|529119465|FG003|Overall Study|Withdrawal by Subject|3|||
146713112|NCT00153101|529119466|FG004|Overall Study|Withdrawal by Subject|5|||
146713113|NCT03169153|529119467|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
146981144|NCT00447603|530093754|FG001|Screening|Withdrawal by Subject|0|||
146713114|NCT03169153|529119468|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
146713115|NCT03169153|529119467|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
146713116|NCT03169153|529119468|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
146713117|NCT03169153|529119467|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
146713118|NCT03169153|529119468|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
146713119|NCT03169153|529119467|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
146713120|NCT03169153|529119468|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
146713121|NCT01440946|529119469|FG000|Overall Study|Lost to Follow-up|1|||
146713122|NCT01440946|529119470|FG001|Overall Study|Lost to Follow-up|1|||
146713123|NCT01440946|529119469|FG000|Overall Study|Physician Decision|1|||
146713124|NCT01440946|529119470|FG001|Overall Study|Physician Decision|0|||
146713125|NCT03299192|529119471|FG000|Overall Study|Fell before classes started|1|||
146713126|NCT03299192|529119472|FG001|Overall Study|Fell before classes started|0|||
146713127|NCT03299192|529119473|FG002|Overall Study|Fell before classes started|0|||
146713128|NCT03299192|529119471|FG000|Overall Study|Other|0|||
146713129|NCT03299192|529119472|FG001|Overall Study|Other|2|||
146713130|NCT03299192|529119473|FG002|Overall Study|Other|1|||
146713131|NCT00983580|529119476|FG000|Overall Study|Cancel Prior to treatment|1|||
146713132|NCT00983580|529119477|FG001|Overall Study|Cancel Prior to treatment|3|||
146713133|NCT00983580|529119476|FG000|Overall Study|Protocol Violation|1|||
146713134|NCT00983580|529119477|FG001|Overall Study|Protocol Violation|1|||
146713135|NCT00983580|529119476|FG000|Overall Study|Ineligible|3|||
146713136|NCT00983580|529119477|FG001|Overall Study|Ineligible|0|||
146713137|NCT01603875|529119480|FG000|Overall Study|Preexisting rabies antibody|3|||
146713138|NCT01603875|529119481|FG001|Overall Study|Preexisting rabies antibody|4|||
146713139|NCT01603875|529119482|FG002|Overall Study|Preexisting rabies antibody|3|||
146713140|NCT01603875|529119480|FG000|Overall Study|Lost to Follow-up|4|||
146713141|NCT01603875|529119481|FG001|Overall Study|Lost to Follow-up|3|||
146713142|NCT01603875|529119482|FG002|Overall Study|Lost to Follow-up|6|||
146713143|NCT01603875|529119480|FG000|Overall Study|Protocol Violation|0|||
146713144|NCT01603875|529119481|FG001|Overall Study|Protocol Violation|1|||
146713145|NCT01603875|529119482|FG002|Overall Study|Protocol Violation|0|||
146713146|NCT01652716|529119486|FG000|Overall Study|Loss of glucose control|1|||
146713147|NCT01652716|529119487|FG001|Overall Study|Loss of glucose control|0|||
146713148|NCT01652716|529119486|FG000|Overall Study|Administrative|0|||
146713149|NCT01652716|529119487|FG001|Overall Study|Administrative|2|||
146713150|NCT01652716|529119486|FG000|Overall Study|Investigator decision|1|||
146713151|NCT01652716|529119487|FG001|Overall Study|Investigator decision|4|||
146713152|NCT01652716|529119486|FG000|Overall Study|Lost to Follow-up|12|||
146713153|NCT01652716|529119487|FG001|Overall Study|Lost to Follow-up|11|||
146713154|NCT01652716|529119486|FG000|Overall Study|Protocol Violation|2|||
146713155|NCT01652716|529119487|FG001|Overall Study|Protocol Violation|1|||
146713156|NCT01652716|529119486|FG000|Overall Study|Adverse Event|7|||
146713157|NCT01652716|529119487|FG001|Overall Study|Adverse Event|10|||
146713158|NCT01652716|529119486|FG000|Overall Study|Withdrawal by Subject|33|||
146713159|NCT01652716|529119487|FG001|Overall Study|Withdrawal by Subject|18|||
146713160|NCT01337297|529119490|FG000|Overall Study|They entered to single anodal tDCS|4|||
146713161|NCT01337297|529119491|FG001|Overall Study|They entered to single anodal tDCS|3|||
146713162|NCT01337297|529119490|FG000|Overall Study|Lost to Follow-up|1|||
146713163|NCT01337297|529119491|FG001|Overall Study|Lost to Follow-up|3|||
146713164|NCT02778204|529119492|FG000|Overall Study|Adverse Event|1|||
146713165|NCT02778204|529119493|FG001|Overall Study|Adverse Event|0|||
146713166|NCT02778204|529119494|FG002|Overall Study|Adverse Event|0|||
146713167|NCT02778204|529119495|FG003|Overall Study|Adverse Event|0|||
146713168|NCT02778204|529119492|FG000|Overall Study|Withdrawal by Subject|0|||
146713169|NCT02778204|529119493|FG001|Overall Study|Withdrawal by Subject|0|||
146713170|NCT02778204|529119494|FG002|Overall Study|Withdrawal by Subject|1|||
146713171|NCT02778204|529119495|FG003|Overall Study|Withdrawal by Subject|2|||
146713172|NCT02778204|529119492|FG000|Overall Study|Lost to Follow-up|1|||
146713173|NCT02778204|529119493|FG001|Overall Study|Lost to Follow-up|0|||
146713174|NCT02778204|529119494|FG002|Overall Study|Lost to Follow-up|2|||
146713175|NCT02778204|529119495|FG003|Overall Study|Lost to Follow-up|1|||
146713176|NCT02778204|529119492|FG000|Overall Study|Protocol Violation|0|||
146713177|NCT02778204|529119493|FG001|Overall Study|Protocol Violation|0|||
146713178|NCT02778204|529119494|FG002|Overall Study|Protocol Violation|1|||
146713179|NCT02778204|529119495|FG003|Overall Study|Protocol Violation|0|||
146713180|NCT02778204|529119492|FG000|Overall Study|Eligibility Violation|0|||
146713181|NCT02778204|529119493|FG001|Overall Study|Eligibility Violation|0|||
146713182|NCT02778204|529119494|FG002|Overall Study|Eligibility Violation|0|||
146713183|NCT02778204|529119495|FG003|Overall Study|Eligibility Violation|1|||
146713184|NCT00360334|529119496|FG000|Overall Study|Adverse Event|7|||
146713185|NCT00360334|529119497|FG001|Overall Study|Adverse Event|4|||
146713186|NCT00360334|529119496|FG000|Overall Study|Protocol Violation|1|||
146713187|NCT00360334|529119497|FG001|Overall Study|Protocol Violation|1|||
146713188|NCT00360334|529119496|FG000|Overall Study|Physician Decision|2|||
146713189|NCT00360334|529119497|FG001|Overall Study|Physician Decision|3|||
146933978|NCT00585923|529916028|FG001|Overall Study|Physician decided not to continue|33|||
146933979|NCT00138424|529916029|FG000|Overall Study|Physician Decision|0|||
146713190|NCT00360334|529119496|FG000|Overall Study|Lack of Efficacy|0|||
146713191|NCT00360334|529119497|FG001|Overall Study|Lack of Efficacy|1|||
146713192|NCT00360334|529119496|FG000|Overall Study|Entry criterion not met|1|||
146713193|NCT00360334|529119497|FG001|Overall Study|Entry criterion not met|2|||
146713194|NCT00360334|529119496|FG000|Overall Study|Subject decision|8|||
146713195|NCT00360334|529119497|FG001|Overall Study|Subject decision|2|||
146713196|NCT01916304|529119498|FG000|Overall Study|Screening failure|17|||
146713197|NCT01898793|529119499|FG000|Overall Study|Death|2|||
146713198|NCT01898793|529119500|FG001|Overall Study|Death|1|||
146713199|NCT01898793|529119501|FG002|Overall Study|Death|4|||
146713200|NCT01898793|529119502|FG003|Overall Study|Death|0|||
146713201|NCT01898793|529119503|FG004|Overall Study|Death|0|||
146933980|NCT00138424|529916030|FG001|Overall Study|Physician Decision|1|||
146780140|NCT02119650|529364113|FG000|Overall Study|Physician Decision|0|||
146780141|NCT02119650|529364114|FG001|Overall Study|Physician Decision|2|||
146780142|NCT02119650|529364113|FG000|Overall Study|Multiple reasons for termination|2|||
146780143|NCT02119650|529364114|FG001|Overall Study|Multiple reasons for termination|1|||
146780144|NCT02730871|529364116|FG000|Overall Study|Adverse Event|6|||
146713202|NCT01898793|529119504|FG005|Overall Study|Death|0|||
146713203|NCT01898793|529119505|FG006|Overall Study|Death|0|||
146713204|NCT04666441|529119506|FG000|Overall Study|Lost to Follow-up|1|||
146780145|NCT02730871|529364117|FG001|Overall Study|Adverse Event|0|||
146780146|NCT04623775|529364118|FG000|Randomization|No Longer Meets Study Criteria|2|||
146780147|NCT04623775|529364119|FG001|Randomization|No Longer Meets Study Criteria|1|||
146780148|NCT04623775|529364120|FG002|Randomization|No Longer Meets Study Criteria|0|||
146780149|NCT04623775|529364121|FG003|Randomization|No Longer Meets Study Criteria|0|||
146780150|NCT04623775|529364118|FG000|Randomization|Withdrew Consent|0|||
146780151|NCT04623775|529364119|FG001|Randomization|Withdrew Consent|0|||
146780152|NCT04623775|529364120|FG002|Randomization|Withdrew Consent|0|||
146780153|NCT04623775|529364121|FG003|Randomization|Withdrew Consent|1|||
146780154|NCT04623775|529364118|FG000|Randomization|Other Reasons|0|||
146780155|NCT04623775|529364119|FG001|Randomization|Other Reasons|0|||
146780156|NCT04623775|529364120|FG002|Randomization|Other Reasons|0|||
146780157|NCT04623775|529364121|FG003|Randomization|Other Reasons|1|||
146780158|NCT04623775|529364118|FG000|Treatment Period|participant withdrew consent|4|||
146780159|NCT04623775|529364119|FG001|Treatment Period|participant withdrew consent|0|||
146780160|NCT04623775|529364120|FG002|Treatment Period|participant withdrew consent|1|||
146780161|NCT04623775|529364121|FG003|Treatment Period|participant withdrew consent|2|||
146780162|NCT04623775|529364118|FG000|Treatment Period|Death|3|||
146780163|NCT04623775|529364119|FG001|Treatment Period|Death|1|||
146780164|NCT04623775|529364120|FG002|Treatment Period|Death|4|||
146780165|NCT04623775|529364121|FG003|Treatment Period|Death|2|||
146780166|NCT04623775|529364118|FG000|Treatment Period|Lost to Follow-up|0|||
146780167|NCT04623775|529364119|FG001|Treatment Period|Lost to Follow-up|2|||
146780168|NCT04623775|529364120|FG002|Treatment Period|Lost to Follow-up|0|||
146780169|NCT04623775|529364121|FG003|Treatment Period|Lost to Follow-up|0|||
146780170|NCT04623775|529364118|FG000|Treatment Period|poor/non compliance|0|||
146780171|NCT04623775|529364119|FG001|Treatment Period|poor/non compliance|0|||
146780172|NCT04623775|529364120|FG002|Treatment Period|poor/non compliance|1|||
146780173|NCT04623775|529364121|FG003|Treatment Period|poor/non compliance|0|||
146780174|NCT04623775|529364118|FG000|Treatment Period|participant no longer meets study criteria|0|||
146780175|NCT04623775|529364119|FG001|Treatment Period|participant no longer meets study criteria|1|||
146780176|NCT04623775|529364120|FG002|Treatment Period|participant no longer meets study criteria|0|||
146780177|NCT04623775|529364121|FG003|Treatment Period|participant no longer meets study criteria|0|||
146713205|NCT04666441|529119507|FG001|Overall Study|Lost to Follow-up|4|||
146713206|NCT04666441|529119508|FG002|Overall Study|Lost to Follow-up|1|||
146713207|NCT04666441|529119509|FG003|Overall Study|Lost to Follow-up|3|||
146713208|NCT04666441|529119510|FG004|Overall Study|Lost to Follow-up|0|||
146713209|NCT04666441|529119511|FG005|Overall Study|Lost to Follow-up|2|||
146713210|NCT04666441|529119512|FG006|Overall Study|Lost to Follow-up|2|||
146713211|NCT04666441|529119513|FG007|Overall Study|Lost to Follow-up|2|||
146713212|NCT04666441|529119506|FG000|Overall Study|Subject Decision|1|||
146713213|NCT04666441|529119507|FG001|Overall Study|Subject Decision|1|||
146713214|NCT04666441|529119508|FG002|Overall Study|Subject Decision|3|||
146713215|NCT04666441|529119509|FG003|Overall Study|Subject Decision|1|||
146713216|NCT04666441|529119510|FG004|Overall Study|Subject Decision|0|||
146780178|NCT04623775|529364118|FG000|Treatment Period|administrative reasons by sponsor|3|||
146780179|NCT04623775|529364119|FG001|Treatment Period|administrative reasons by sponsor|2|||
146780180|NCT04623775|529364120|FG002|Treatment Period|administrative reasons by sponsor|0|||
146780181|NCT04623775|529364121|FG003|Treatment Period|administrative reasons by sponsor|0|||
146780182|NCT04623775|529364118|FG000|Treatment Period|other reasons|2|||
146780183|NCT04623775|529364119|FG001|Treatment Period|other reasons|0|||
146780184|NCT04623775|529364120|FG002|Treatment Period|other reasons|1|||
146780185|NCT04623775|529364121|FG003|Treatment Period|other reasons|1|||
146780186|NCT04623775|529364118|FG000|Treatment Period|disease progression|40|||
146780187|NCT04623775|529364119|FG001|Treatment Period|disease progression|35|||
146780188|NCT04623775|529364120|FG002|Treatment Period|disease progression|63|||
146780189|NCT04623775|529364121|FG003|Treatment Period|disease progression|63|||
146780190|NCT04623775|529364118|FG000|Treatment Period|study drug toxicity|12|||
146780191|NCT04623775|529364119|FG001|Treatment Period|study drug toxicity|15|||
146780192|NCT04623775|529364120|FG002|Treatment Period|study drug toxicity|13|||
146780193|NCT04623775|529364121|FG003|Treatment Period|study drug toxicity|12|||
146780194|NCT04623775|529364118|FG000|Treatment Period|AE unrelated to study drug|4|||
146780195|NCT04623775|529364119|FG001|Treatment Period|AE unrelated to study drug|9|||
146780196|NCT04623775|529364120|FG002|Treatment Period|AE unrelated to study drug|12|||
146780197|NCT04623775|529364121|FG003|Treatment Period|AE unrelated to study drug|9|||
146780198|NCT04623775|529364118|FG000|Treatment Period|participant request to discontinue treatment|0|||
146780199|NCT04623775|529364119|FG001|Treatment Period|participant request to discontinue treatment|2|||
146713217|NCT04666441|529119511|FG005|Overall Study|Subject Decision|1|||
146713218|NCT04666441|529119512|FG006|Overall Study|Subject Decision|3|||
146713219|NCT04666441|529119513|FG007|Overall Study|Subject Decision|2|||
146713220|NCT01578551|529119515|FG000|Overall Study|Adverse Event|1|||
146713221|NCT01578551|529119516|FG001|Overall Study|Adverse Event|0|||
146713222|NCT04028388|529119518|FG000|Overall Study|Evaluations missing|3|||
146713223|NCT04028388|529119519|FG001|Overall Study|Evaluations missing|6|||
146713224|NCT04028388|529119518|FG000|Overall Study|Not started|2|||
146713225|NCT04028388|529119519|FG001|Overall Study|Not started|0|||
146713226|NCT00818441|529119520|FG000|Overall Study|Death|69|||
146713227|NCT00818441|529119521|FG001|Overall Study|Death|26|||
146713228|NCT00818441|529119520|FG000|Overall Study|Other|5|||
146713229|NCT00818441|529119521|FG001|Overall Study|Other|0|||
146713230|NCT00818441|529119520|FG000|Overall Study|Lost to Follow-up|2|||
146713231|NCT00818441|529119521|FG001|Overall Study|Lost to Follow-up|1|||
146713232|NCT00818441|529119520|FG000|Overall Study|Withdrawal by Subject|2|||
146713233|NCT00818441|529119521|FG001|Overall Study|Withdrawal by Subject|0|||
146713234|NCT00818441|529119520|FG000|Overall Study|Adverse Event|0|||
146713235|NCT00818441|529119521|FG001|Overall Study|Adverse Event|1|||
146713236|NCT00818441|529119520|FG000|Overall Study|Study terminated by sponsor|11|||
146713237|NCT00818441|529119521|FG001|Overall Study|Study terminated by sponsor|2|||
146713238|NCT03964454|529119525|FG000|Overall Study|Lost to Follow-up|13|||
146713239|NCT03964454|529119526|FG001|Overall Study|Lost to Follow-up|7|||
146713240|NCT03964454|529119525|FG000|Overall Study|Withdrawal by Subject|4|||
146713241|NCT03964454|529119526|FG001|Overall Study|Withdrawal by Subject|11|||
146713242|NCT01539291|529121128|FG000|Study GS-US-312-0116|Adverse Event|9|||
146713243|NCT01539291|529121129|FG001|Study GS-US-312-0116|Adverse Event|0|||
146713244|NCT01539291|529121130|FG002|Study GS-US-312-0116|Adverse Event|0|||
146713245|NCT01539291|529121131|FG003|Study GS-US-312-0116|Adverse Event|0|||
146713246|NCT01539291|529121128|FG000|Study GS-US-312-0116|Physician Decision|1|||
146713247|NCT01539291|529121129|FG001|Study GS-US-312-0116|Physician Decision|0|||
146713248|NCT01539291|529121130|FG002|Study GS-US-312-0116|Physician Decision|0|||
146713249|NCT01539291|529121131|FG003|Study GS-US-312-0116|Physician Decision|0|||
146713250|NCT01539291|529121128|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
146713251|NCT01539291|529121129|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
146713252|NCT01539291|529121130|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
146713253|NCT01539291|529121131|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
146713254|NCT01539291|529121128|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
146713255|NCT01539291|529121129|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
146713256|NCT01539291|529121130|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
146713257|NCT01539291|529121131|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
146713258|NCT01539291|529121128|FG000|Study GS-US-312-0116|Other|1|||
146713259|NCT01539291|529121129|FG001|Study GS-US-312-0116|Other|0|||
146713260|NCT01539291|529121130|FG002|Study GS-US-312-0116|Other|0|||
146713261|NCT01539291|529121131|FG003|Study GS-US-312-0116|Other|0|||
146713262|NCT01539291|529121128|FG000|Study GS-US-312-0117|Adverse Event|22|||
146713263|NCT01539291|529121129|FG001|Study GS-US-312-0117|Adverse Event|1|||
146713264|NCT01539291|529121130|FG002|Study GS-US-312-0117|Adverse Event|9|||
146713265|NCT01539291|529121131|FG003|Study GS-US-312-0117|Adverse Event|12|||
146713266|NCT01539291|529121128|FG000|Study GS-US-312-0117|Physician Decision|9|||
146713267|NCT01539291|529121129|FG001|Study GS-US-312-0117|Physician Decision|0|||
146713268|NCT01539291|529121130|FG002|Study GS-US-312-0117|Physician Decision|6|||
146713269|NCT01539291|529121131|FG003|Study GS-US-312-0117|Physician Decision|4|||
146713270|NCT01539291|529121128|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
146713271|NCT01539291|529121129|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
146713272|NCT01539291|529121130|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
146713273|NCT01539291|529121131|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
146981145|NCT00447603|530093755|FG002|Screening|Withdrawal by Subject|0|||
146713274|NCT01539291|529121128|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
146713275|NCT01539291|529121129|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
146713276|NCT01539291|529121130|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
146713277|NCT01539291|529121131|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
146713278|NCT01539291|529121128|FG000|Study GS-US-312-0117|Other|2|||
146713279|NCT01539291|529121129|FG001|Study GS-US-312-0117|Other|1|||
146713280|NCT01539291|529121130|FG002|Study GS-US-312-0117|Other|1|||
146713281|NCT01539291|529121131|FG003|Study GS-US-312-0117|Other|1|||
146713282|NCT03985423|529121132|FG000|Overall Study|Adverse Event|1|||
146713283|NCT03985423|529121132|FG000|Overall Study|Death|2|||
146713284|NCT03985423|529121132|FG000|Overall Study|Physician Decision|1|||
146713285|NCT03985423|529121132|FG000|Overall Study|Withdrawal by Subject|2|||
146713286|NCT03985423|529121132|FG000|Overall Study|Lack of insurance and citizenship|1|||
146713287|NCT01045447|529121143|FG000|Overall Study|Adverse Event|0|||
146713288|NCT01045447|529121144|FG001|Overall Study|Adverse Event|1|||
146713289|NCT01045447|529121143|FG000|Overall Study|Lack of Efficacy|3|||
146713290|NCT01045447|529121144|FG001|Overall Study|Lack of Efficacy|1|||
146713291|NCT01045447|529121143|FG000|Overall Study|Protocol Violation|6|||
146713292|NCT01045447|529121144|FG001|Overall Study|Protocol Violation|3|||
146713293|NCT01045447|529121143|FG000|Overall Study|Withdrawal Criteria|10|||
146713294|NCT01045447|529121144|FG001|Overall Study|Withdrawal Criteria|10|||
146713295|NCT01045447|529121143|FG000|Overall Study|Unclassified|17|||
146713296|NCT01045447|529121144|FG001|Overall Study|Unclassified|13|||
146713297|NCT00129987|529121145|FG000|1st Educational Session|Withdrawal by Subject|141|||
146713298|NCT00129987|529121146|FG001|1st Educational Session|Withdrawal by Subject|109|||
146713299|NCT00129987|529121145|FG000|1 Year|Withdrawal by Subject|32|||
146713300|NCT00129987|529121146|FG001|1 Year|Withdrawal by Subject|21|||
146713301|NCT01159938|529121147|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
146713302|NCT01159938|529121148|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
146713303|NCT01159938|529121149|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
146713304|NCT01159938|529121150|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
146713305|NCT01159938|529121151|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
146713306|NCT00581945|529121152|FG000|Overall Study|Adverse Event|4|||
146713307|NCT00581945|529121153|FG001|Overall Study|Adverse Event|4|||
146713308|NCT00581945|529121152|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146713309|NCT00581945|529121153|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146713310|NCT00581945|529121152|FG000|Overall Study|Withdrawal by Subject|2|||
146713311|NCT00581945|529121153|FG001|Overall Study|Withdrawal by Subject|6|||
146713312|NCT00581945|529121152|FG000|Overall Study|Death|1|||
146713313|NCT00581945|529121153|FG001|Overall Study|Death|0|||
146713314|NCT01075321|529121160|FG000|Overall Study|Withdrawal by Subject|0|||
146713315|NCT01075321|529121161|FG001|Overall Study|Withdrawal by Subject|0|||
146713316|NCT01075321|529121162|FG002|Overall Study|Withdrawal by Subject|1|||
146713317|NCT01075321|529121163|FG003|Overall Study|Withdrawal by Subject|1|||
146713318|NCT01075321|529121160|FG000|Overall Study|Protocol Violation|0|||
146713319|NCT01075321|529121161|FG001|Overall Study|Protocol Violation|0|||
146713320|NCT01075321|529121162|FG002|Overall Study|Protocol Violation|1|||
146713321|NCT01075321|529121163|FG003|Overall Study|Protocol Violation|0|||
146713322|NCT01075321|529121160|FG000|Overall Study|Treatment Incomplete due to progression|1|||
146713323|NCT01075321|529121161|FG001|Overall Study|Treatment Incomplete due to progression|0|||
146713324|NCT01075321|529121162|FG002|Overall Study|Treatment Incomplete due to progression|0|||
146713325|NCT01075321|529121163|FG003|Overall Study|Treatment Incomplete due to progression|0|||
146713326|NCT01075321|529121160|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
146713327|NCT01075321|529121161|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
146713328|NCT01075321|529121162|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
146713329|NCT01075321|529121163|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
146713330|NCT00982020|529121164|FG000|Overall Study|Adverse Event|19|||
146713331|NCT00982020|529121165|FG001|Overall Study|Adverse Event|15|||
146713332|NCT00982020|529121164|FG000|Overall Study|Withdrawal by Subject|11|||
146713333|NCT00982020|529121165|FG001|Overall Study|Withdrawal by Subject|14|||
146713334|NCT00982020|529121164|FG000|Overall Study|Lost to Follow-up|5|||
146713335|NCT00982020|529121165|FG001|Overall Study|Lost to Follow-up|11|||
146713336|NCT00982020|529121164|FG000|Overall Study|Lack of Efficacy|10|||
146713337|NCT00982020|529121165|FG001|Overall Study|Lack of Efficacy|4|||
146713338|NCT00982020|529121164|FG000|Overall Study|Parent/Caregiver Decision|5|||
146713339|NCT00982020|529121165|FG001|Overall Study|Parent/Caregiver Decision|5|||
146713340|NCT00982020|529121164|FG000|Overall Study|Treatment Non-compliance|3|||
146713341|NCT00982020|529121165|FG001|Overall Study|Treatment Non-compliance|6|||
146713342|NCT00982020|529121164|FG000|Overall Study|Physician Decision|2|||
146713343|NCT00982020|529121165|FG001|Overall Study|Physician Decision|5|||
146713344|NCT00982020|529121164|FG000|Overall Study|Entry Criteria Not Met|2|||
146713345|NCT00982020|529121165|FG001|Overall Study|Entry Criteria Not Met|1|||
146713346|NCT00982020|529121164|FG000|Overall Study|Protocol Violation|0|||
146713347|NCT00982020|529121165|FG001|Overall Study|Protocol Violation|2|||
146713348|NCT00982020|529121164|FG000|Overall Study|Clinical Relapse|0|||
146713349|NCT00982020|529121165|FG001|Overall Study|Clinical Relapse|1|||
146713350|NCT00003457|529121168|FG000|Overall Study|Not evaluable|9|||
146713351|NCT00466193|529121169|FG000|Overall Study|Adverse Event|0|||
146713352|NCT00466193|529121170|FG001|Overall Study|Adverse Event|1|||
146713353|NCT00466193|529121169|FG000|Overall Study|Lost to Follow-up|2|||
146713354|NCT00466193|529121170|FG001|Overall Study|Lost to Follow-up|4|||
146981146|NCT00447603|530093753|FG000|Screening|Protocol Violation|1|||
146981147|NCT00447603|530093754|FG001|Screening|Protocol Violation|0|||
146713355|NCT00466193|529121169|FG000|Overall Study|Physician Decision|1|||
146713356|NCT00466193|529121170|FG001|Overall Study|Physician Decision|0|||
146713357|NCT00466193|529121169|FG000|Overall Study|Protocol Violation|1|||
146713358|NCT00466193|529121170|FG001|Overall Study|Protocol Violation|1|||
146713359|NCT00466193|529121169|FG000|Overall Study|Withdrawal by Subject|7|||
146713360|NCT00466193|529121170|FG001|Overall Study|Withdrawal by Subject|2|||
146713361|NCT00466193|529121169|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
146713362|NCT00466193|529121170|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
146713363|NCT02246998|529121171|FG000|Overall Study|Adverse Event|0|||
146713364|NCT02246998|529121172|FG001|Overall Study|Adverse Event|1|||
146713365|NCT02246998|529121173|FG002|Overall Study|Adverse Event|1|||
146713366|NCT02246998|529121174|FG003|Overall Study|Adverse Event|0|||
146713367|NCT02246998|529121171|FG000|Overall Study|Lost to Follow-up|1|||
146713368|NCT02246998|529121172|FG001|Overall Study|Lost to Follow-up|0|||
146713369|NCT02246998|529121173|FG002|Overall Study|Lost to Follow-up|0|||
146713370|NCT02246998|529121174|FG003|Overall Study|Lost to Follow-up|1|||
146713371|NCT02246998|529121171|FG000|Overall Study|Randomized but Never Dosed|1|||
146713372|NCT02246998|529121172|FG001|Overall Study|Randomized but Never Dosed|2|||
146713373|NCT02246998|529121173|FG002|Overall Study|Randomized but Never Dosed|2|||
146713374|NCT02246998|529121174|FG003|Overall Study|Randomized but Never Dosed|1|||
146713375|NCT02473614|529121175|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
146713376|NCT02473614|529121176|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
146713377|NCT02525133|529121177|FG000|Overall Study|Adverse Event|0|||
146713378|NCT02525133|529121178|FG001|Overall Study|Adverse Event|1|||
146713379|NCT02525133|529121177|FG000|Overall Study|Death|0|||
146713380|NCT02525133|529121178|FG001|Overall Study|Death|1|||
146713381|NCT02525133|529121177|FG000|Overall Study|did not meet randomization criteria|1|||
146713382|NCT02525133|529121178|FG001|Overall Study|did not meet randomization criteria|0|||
146713383|NCT02525133|529121177|FG000|Overall Study|Lost to Follow-up|5|||
146713384|NCT02525133|529121178|FG001|Overall Study|Lost to Follow-up|1|||
146713385|NCT02525133|529121177|FG000|Overall Study|randomized not enrolled|3|||
146713386|NCT02525133|529121178|FG001|Overall Study|randomized not enrolled|0|||
146713387|NCT02525133|529121177|FG000|Overall Study|Withdrawal by Subject|1|||
146713388|NCT02525133|529121178|FG001|Overall Study|Withdrawal by Subject|0|||
146713389|NCT01075074|529121179|FG000|Overall Study|Surgeon changed to open incisional case|1|||
146713390|NCT01075074|529121180|FG001|Overall Study|Surgeon changed to open incisional case|2|||
146713391|NCT01075074|529121181|FG002|Overall Study|Surgeon changed to open incisional case|2|||
146713392|NCT01181921|529121183|FG000|Overall Study|Lost to Follow-up|1|||
146713393|NCT03669081|529121184|FG000|Overall Study|Data could not be validated|1|||
146713394|NCT03669081|529121185|FG001|Overall Study|Data could not be validated|1|||
146713395|NCT00389324|529121186|FG000|Run-In Phase|Adverse Event|1|||
146713396|NCT00389324|529121186|FG000|Run-In Phase|Lost to Follow-up|1|||
146713397|NCT00389324|529121186|FG000|Run-In Phase|Withdrawal by Subject|1|||
146713398|NCT00389324|529121186|FG000|Subcutaneous Phase|Adverse Event|2|||
146713399|NCT00389324|529121186|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
146713400|NCT00389324|529121186|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
146713401|NCT00389324|529121186|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
146713402|NCT02519504|529121187|FG000|Overall Study|Protocol Violation|6|||
146713403|NCT02519504|529121188|FG001|Overall Study|Protocol Violation|5|||
146713404|NCT02519504|529121187|FG000|Overall Study|Ineligible for direct testing|12|||
146713405|NCT02519504|529121188|FG001|Overall Study|Ineligible for direct testing|12|||
146713406|NCT02519504|529121187|FG000|Overall Study|Did not participate in direct testing|95|||
146713407|NCT02519504|529121188|FG001|Overall Study|Did not participate in direct testing|86|||
146713408|NCT02317575|529121189|FG000|Period 1|Difficulty with venous cannulation|0|||
146713409|NCT02317575|529121190|FG001|Period 1|Difficulty with venous cannulation|1|||
146713410|NCT02317575|529121191|FG002|Period 1|Difficulty with venous cannulation|0|||
146713411|NCT02317575|529121192|FG003|Period 1|Difficulty with venous cannulation|0|||
146713412|NCT02317575|529121193|FG004|Period 1|Difficulty with venous cannulation|0|||
146713413|NCT02317575|529121189|FG000|Period 1|Withdrawal by Subject|1|||
146713414|NCT02317575|529121190|FG001|Period 1|Withdrawal by Subject|0|||
146713415|NCT02317575|529121191|FG002|Period 1|Withdrawal by Subject|0|||
146713416|NCT02317575|529121192|FG003|Period 1|Withdrawal by Subject|0|||
146713417|NCT02317575|529121193|FG004|Period 1|Withdrawal by Subject|0|||
146713418|NCT02548962|529121196|FG000|Overall Study|Withdrawal by Subject|1|||
146713419|NCT02548962|529121197|FG001|Overall Study|Withdrawal by Subject|0|||
146713420|NCT04831736|529121198|FG000|Overall Study|Withdrawal by Subject|0|||
146713421|NCT04831736|529121199|FG001|Overall Study|Withdrawal by Subject|1|||
146713422|NCT01925183|529121202|FG000|Overall Study|Adverse Event|1|||
146713423|NCT01925183|529121203|FG001|Overall Study|Adverse Event|0|||
146713424|NCT01114646|529121204|FG000|Overall Study|Withdrawal by Subject|3|||
146713425|NCT01114646|529121205|FG001|Overall Study|Withdrawal by Subject|2|||
146713426|NCT02159482|529121206|FG000|Overall Study|Withdrawal by Subject|2|||
146713427|NCT02159482|529121206|FG000|Overall Study|Physician Decision|3|||
146713428|NCT03525834|529121211|FG000|Overall Study|Progressive disease|1|||
146713429|NCT02828111|529121213|FG000|Overall Study|Withdrawal by Subject|0|||
146713430|NCT02828111|529121214|FG001|Overall Study|Withdrawal by Subject|0|||
146713431|NCT02828111|529121215|FG002|Overall Study|Withdrawal by Subject|2|||
146713432|NCT02828111|529121216|FG003|Overall Study|Withdrawal by Subject|0|||
146713433|NCT02828111|529121217|FG004|Overall Study|Withdrawal by Subject|0|||
146713434|NCT02828111|529121213|FG000|Overall Study|Lost to Follow-up|0|||
146713435|NCT02828111|529121214|FG001|Overall Study|Lost to Follow-up|0|||
146713436|NCT02828111|529121215|FG002|Overall Study|Lost to Follow-up|0|||
146713437|NCT02828111|529121216|FG003|Overall Study|Lost to Follow-up|1|||
146713438|NCT02828111|529121217|FG004|Overall Study|Lost to Follow-up|1|||
146713439|NCT00614939|529121218|FG000|Overall Study|Withdrawal by Subject|10|||
146713440|NCT00614939|529121219|FG001|Overall Study|Withdrawal by Subject|17|||
146713441|NCT00614939|529121218|FG000|Overall Study|Study specific discontinuation criteris|13|||
146713442|NCT00614939|529121219|FG001|Overall Study|Study specific discontinuation criteris|16|||
146713443|NCT00614939|529121218|FG000|Overall Study|Adverse Event|2|||
146713444|NCT00614939|529121219|FG001|Overall Study|Adverse Event|5|||
146713445|NCT00614939|529121218|FG000|Overall Study|Incorrect enrollment|1|||
146713446|NCT00614939|529121219|FG001|Overall Study|Incorrect enrollment|2|||
146713447|NCT00614939|529121218|FG000|Overall Study|Death|4|||
146713448|NCT00614939|529121219|FG001|Overall Study|Death|3|||
146713449|NCT00614939|529121218|FG000|Overall Study|Poor/non-compliance|4|||
146713450|NCT00614939|529121219|FG001|Overall Study|Poor/non-compliance|0|||
146713451|NCT00614939|529121218|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
146713452|NCT00614939|529121219|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
146713453|NCT00840970|529121220|FG000|Overall Study|Adverse Event|0|||
146713454|NCT00840970|529121221|FG001|Overall Study|Adverse Event|0|||
146713455|NCT00840970|529121222|FG002|Overall Study|Adverse Event|1|||
146713456|NCT03465540|529121223|FG000|Overall Study|Withdrawal by Subject|0|||
146713457|NCT03465540|529121224|FG001|Overall Study|Withdrawal by Subject|0|||
146713458|NCT03465540|529121225|FG002|Overall Study|Withdrawal by Subject|1|||
146713459|NCT03465540|529121226|FG003|Overall Study|Withdrawal by Subject|1|||
146713460|NCT03465540|529121227|FG004|Overall Study|Withdrawal by Subject|1|||
146713461|NCT03465540|529121228|FG005|Overall Study|Withdrawal by Subject|0|||
146981148|NCT00447603|530093755|FG002|Screening|Protocol Violation|0|||
146981149|NCT00447603|530093753|FG000|Screening|Screen Failure|4|||
146981150|NCT00447603|530093754|FG001|Screening|Screen Failure|0|||
146981151|NCT00447603|530093755|FG002|Screening|Screen Failure|0|||
146981152|NCT00447603|530093753|FG000|Screening|Study Terminated by Sponsor|15|||
146981153|NCT00447603|530093754|FG001|Screening|Study Terminated by Sponsor|0|||
146981154|NCT00447603|530093755|FG002|Screening|Study Terminated by Sponsor|0|||
146981155|NCT00447603|530093753|FG000|Filter Period|Adverse Event|0|||
146981156|NCT00447603|530093754|FG001|Filter Period|Adverse Event|0|||
146981157|NCT00447603|530093755|FG002|Filter Period|Adverse Event|1|||
146981158|NCT00447603|530093753|FG000|Filter Period|Screen Failure|0|||
146981159|NCT00447603|530093754|FG001|Filter Period|Screen Failure|3|||
146981160|NCT00447603|530093755|FG002|Filter Period|Screen Failure|4|||
146713462|NCT03465540|529121223|FG000|Overall Study|Lost to Follow-up|0|||
146713463|NCT03465540|529121224|FG001|Overall Study|Lost to Follow-up|1|||
146713464|NCT03465540|529121225|FG002|Overall Study|Lost to Follow-up|0|||
146713465|NCT03465540|529121226|FG003|Overall Study|Lost to Follow-up|0|||
146713466|NCT03465540|529121227|FG004|Overall Study|Lost to Follow-up|1|||
146713467|NCT03465540|529121228|FG005|Overall Study|Lost to Follow-up|0|||
146713468|NCT03465540|529121223|FG000|Overall Study|Death|1|||
146713469|NCT03465540|529121224|FG001|Overall Study|Death|1|||
146713470|NCT03465540|529121225|FG002|Overall Study|Death|0|||
146713471|NCT03465540|529121226|FG003|Overall Study|Death|2|||
146713472|NCT03465540|529121227|FG004|Overall Study|Death|0|||
146713473|NCT03465540|529121228|FG005|Overall Study|Death|2|||
146713474|NCT03465540|529121223|FG000|Overall Study|Protocol specified criteria|0|||
146713475|NCT03465540|529121224|FG001|Overall Study|Protocol specified criteria|2|||
146713476|NCT03465540|529121225|FG002|Overall Study|Protocol specified criteria|2|||
146713477|NCT03465540|529121226|FG003|Overall Study|Protocol specified criteria|0|||
146713478|NCT03465540|529121227|FG004|Overall Study|Protocol specified criteria|2|||
146713479|NCT03465540|529121228|FG005|Overall Study|Protocol specified criteria|0|||
146713480|NCT04443218|529121229|FG000|Overall Study|Exited study for other reasons|9|||
146713481|NCT04443218|529121229|FG000|Overall Study|Withdrawal by Subject|1|||
146713482|NCT04443218|529121229|FG000|Overall Study|Lost to Follow-up|4|||
146981161|NCT00447603|530093753|FG000|Filter Period|Study terminated by Sponsor|0|||
146981162|NCT00447603|530093754|FG001|Filter Period|Study terminated by Sponsor|1|||
146981163|NCT00447603|530093755|FG002|Filter Period|Study terminated by Sponsor|10|||
146981164|NCT01165684|530093762|FG000|Overall Study|Adverse Event|1|||
146981165|NCT01165684|530093763|FG001|Overall Study|Adverse Event|1|||
146981166|NCT01165684|530093762|FG000|Overall Study|Lack of Efficacy|2|||
146981167|NCT01165684|530093763|FG001|Overall Study|Lack of Efficacy|1|||
146713483|NCT04443218|529121229|FG000|Overall Study|Death|19|||
146713484|NCT02660944|529121230|FG000|Overall Study|Adverse Event|3|||
146713485|NCT02660944|529121231|FG001|Overall Study|Adverse Event|4|||
146713486|NCT02660944|529121230|FG000|Overall Study|Physician Decision|3|||
146713487|NCT02660944|529121231|FG001|Overall Study|Physician Decision|1|||
146713488|NCT02660944|529121230|FG000|Overall Study|Withdrawal by Subject|5|||
146713489|NCT02660944|529121231|FG001|Overall Study|Withdrawal by Subject|3|||
146713490|NCT02660944|529121230|FG000|Overall Study|Lost to Follow-up|4|||
146713491|NCT02660944|529121231|FG001|Overall Study|Lost to Follow-up|1|||
146713492|NCT02660944|529121230|FG000|Overall Study|Subject schedule|0|||
146713493|NCT02660944|529121231|FG001|Overall Study|Subject schedule|1|||
146713494|NCT02660944|529121230|FG000|Overall Study|Exclusion criteria met|2|||
146713495|NCT02660944|529121231|FG001|Overall Study|Exclusion criteria met|0|||
146713496|NCT03586999|529121232|FG000|Overall Study|Lack of Efficacy|2|||
146713497|NCT04096560|529121233|FG000|Overall Study|Reason not Specified|1|||
146713498|NCT04096560|529121234|FG001|Overall Study|Reason not Specified|0|||
146713499|NCT04096560|529121235|FG002|Overall Study|Reason not Specified|0|||
146981168|NCT01165684|530093762|FG000|Overall Study|Protocol Violation|7|||
146713500|NCT04096560|529121236|FG003|Overall Study|Reason not Specified|0|||
146713501|NCT04096560|529121237|FG004|Overall Study|Reason not Specified|1|||
146713502|NCT04096560|529121238|FG005|Overall Study|Reason not Specified|1|||
146713503|NCT04096560|529121239|FG006|Overall Study|Reason not Specified|1|||
146713504|NCT04096560|529121240|FG007|Overall Study|Reason not Specified|0|||
146713505|NCT04096560|529121233|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
146713506|NCT04096560|529121234|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
146713507|NCT04096560|529121235|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
146713508|NCT04096560|529121236|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
146713509|NCT04096560|529121237|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
146713510|NCT04096560|529121238|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
146713511|NCT04096560|529121239|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
146713512|NCT04096560|529121240|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
146713513|NCT04096560|529121233|FG000|Overall Study|Study Terminated by Sponsor|0|||
146713514|NCT04096560|529121234|FG001|Overall Study|Study Terminated by Sponsor|0|||
146713515|NCT04096560|529121235|FG002|Overall Study|Study Terminated by Sponsor|0|||
146713516|NCT04096560|529121236|FG003|Overall Study|Study Terminated by Sponsor|5|||
146713517|NCT04096560|529121237|FG004|Overall Study|Study Terminated by Sponsor|6|||
146713518|NCT04096560|529121238|FG005|Overall Study|Study Terminated by Sponsor|4|||
146713519|NCT04096560|529121239|FG006|Overall Study|Study Terminated by Sponsor|6|||
146713520|NCT04096560|529121240|FG007|Overall Study|Study Terminated by Sponsor|1|||
146713521|NCT04096560|529121233|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
146713522|NCT04096560|529121234|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
146713523|NCT04096560|529121235|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
146713524|NCT04096560|529121236|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
146713525|NCT04096560|529121237|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
146713526|NCT04096560|529121238|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
146713527|NCT04096560|529121239|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
146713528|NCT04096560|529121240|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
146713529|NCT03634579|529121246|FG000|Overall Study|study termination|9|||
146713530|NCT04122443|529121247|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
146713531|NCT04122443|529121248|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
146713532|NCT04122443|529121249|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
146713533|NCT04122443|529121247|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
146713534|NCT04122443|529121248|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
146713535|NCT04122443|529121249|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
146713536|NCT01072201|529121250|FG000|Overall Study|Lost to Follow-up|0|||
146713537|NCT01072201|529121251|FG001|Overall Study|Lost to Follow-up|1|||
146713538|NCT02752048|529121259|FG000|Overall Study|Withdrawal by Subject|0|||
146713539|NCT02752048|529121260|FG001|Overall Study|Withdrawal by Subject|0|||
146713540|NCT02752048|529121261|FG002|Overall Study|Withdrawal by Subject|3|||
146713541|NCT02199691|529121262|FG000|Overall Study|Protocol Violation|3|||
146713542|NCT02199691|529121263|FG001|Overall Study|Protocol Violation|3|||
146713543|NCT02199691|529121264|FG002|Overall Study|Protocol Violation|6|||
146713544|NCT02199691|529121265|FG003|Overall Study|Protocol Violation|7|||
146713545|NCT02199691|529121262|FG000|Overall Study|Withdrawal by Subject|5|||
146713546|NCT02199691|529121263|FG001|Overall Study|Withdrawal by Subject|3|||
146713547|NCT02199691|529121264|FG002|Overall Study|Withdrawal by Subject|12|||
146713548|NCT02199691|529121265|FG003|Overall Study|Withdrawal by Subject|13|||
146713549|NCT02199691|529121262|FG000|Overall Study|Lost to Follow-up|2|||
146713550|NCT02199691|529121263|FG001|Overall Study|Lost to Follow-up|1|||
146713551|NCT02199691|529121264|FG002|Overall Study|Lost to Follow-up|9|||
146713552|NCT02199691|529121265|FG003|Overall Study|Lost to Follow-up|10|||
146713553|NCT00774995|529121266|FG000|Overall Study|Protocol Violation|0|||
146780200|NCT04623775|529364120|FG002|Treatment Period|participant request to discontinue treatment|2|||
146780201|NCT04623775|529364121|FG003|Treatment Period|participant request to discontinue treatment|0|||
146780202|NCT01303445|529364123|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
146713554|NCT00774995|529121267|FG001|Overall Study|Protocol Violation|0|||
146713555|NCT00774995|529121268|FG002|Overall Study|Protocol Violation|1|||
146713556|NCT00774995|529121269|FG003|Overall Study|Protocol Violation|0|||
146713557|NCT01209624|529121275|FG000|Overall Study|Death|2|||
146713558|NCT01209624|529121275|FG000|Overall Study|Adverse Event|13|||
146713559|NCT01209624|529121275|FG000|Overall Study|Lack of Efficacy|17|||
146713560|NCT01209624|529121275|FG000|Overall Study|Lost to Follow-up|290|||
146713561|NCT01209624|529121275|FG000|Overall Study|Other|4|||
146713562|NCT03403634|529121280|FG000|Overall Study|Disease progression|3|||
146780203|NCT01303445|529364124|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
146933981|NCT00138424|529916031|FG002|Overall Study|Physician Decision|0|||
146933982|NCT00138424|529916032|FG003|Overall Study|Physician Decision|0|||
146933983|NCT04311177|529916033|FG000|Overall Study|Adverse Event|3|||
146933984|NCT04311177|529916034|FG001|Overall Study|Adverse Event|1|||
146713563|NCT03403634|529121280|FG000|Overall Study|Did not meet eligibility criteria|4|||
146713564|NCT00428610|529121281|FG000|Overall Study|Death Due to Adverse Event|3|||
146713565|NCT00428610|529121282|FG001|Overall Study|Death Due to Adverse Event|0|||
146713566|NCT00428610|529121283|FG002|Overall Study|Death Due to Adverse Event|5|||
146713567|NCT00428610|529121281|FG000|Overall Study|Death Due to Progressive Disease|0|||
146713568|NCT00428610|529121282|FG001|Overall Study|Death Due to Progressive Disease|0|||
146713569|NCT00428610|529121283|FG002|Overall Study|Death Due to Progressive Disease|2|||
146713570|NCT00428610|529121281|FG000|Overall Study|Adverse Event|2|||
146713571|NCT00428610|529121282|FG001|Overall Study|Adverse Event|3|||
146713572|NCT00428610|529121283|FG002|Overall Study|Adverse Event|2|||
146713573|NCT00428610|529121281|FG000|Overall Study|Investigator Decision|2|||
146713574|NCT00428610|529121282|FG001|Overall Study|Investigator Decision|1|||
146713575|NCT00428610|529121283|FG002|Overall Study|Investigator Decision|1|||
146713576|NCT00428610|529121281|FG000|Overall Study|Progressive Disease|42|||
146713577|NCT00428610|529121282|FG001|Overall Study|Progressive Disease|14|||
146713578|NCT00428610|529121283|FG002|Overall Study|Progressive Disease|22|||
146713579|NCT00428610|529121281|FG000|Overall Study|Withdrawal by Subject|4|||
146713580|NCT00428610|529121282|FG001|Overall Study|Withdrawal by Subject|0|||
146713581|NCT00428610|529121283|FG002|Overall Study|Withdrawal by Subject|0|||
146713582|NCT04450264|529123879|FG000|Overall Study|Incomplete survey|13|||
146713583|NCT04450264|529123880|FG001|Overall Study|Incomplete survey|19|||
146713584|NCT03320070|529123883|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
146713585|NCT03320070|529123884|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
146713586|NCT03320070|529123883|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
146713587|NCT03320070|529123884|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
146713588|NCT03320070|529123883|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
146713589|NCT03320070|529123884|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
146713590|NCT03320070|529123883|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
146713591|NCT03320070|529123884|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
146713592|NCT03320070|529123883|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
146713593|NCT03320070|529123884|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
146713594|NCT03320070|529123883|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
146713595|NCT03320070|529123884|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
146713596|NCT02416791|529123887|FG000|6 Months|Lost to Follow-up|0|||
146713597|NCT02416791|529123888|FG001|6 Months|Lost to Follow-up|0|||
146713598|NCT02416791|529123889|FG002|6 Months|Lost to Follow-up|1|||
146713599|NCT01054729|529123890|FG000|Overall Study|Randomized but Not Treated|0|||
146713600|NCT01054729|529123891|FG001|Overall Study|Randomized but Not Treated|1|||
146713601|NCT01054729|529123892|FG002|Overall Study|Randomized but Not Treated|0|||
146713602|NCT01054729|529123893|FG003|Overall Study|Randomized but Not Treated|0|||
146713603|NCT01054729|529123890|FG000|Overall Study|Adverse Event|1|||
146713604|NCT01054729|529123891|FG001|Overall Study|Adverse Event|1|||
146713605|NCT01054729|529123892|FG002|Overall Study|Adverse Event|2|||
146713606|NCT01054729|529123893|FG003|Overall Study|Adverse Event|1|||
146713607|NCT01054729|529123890|FG000|Overall Study|Withdrawal by Subject|1|||
146713608|NCT01054729|529123891|FG001|Overall Study|Withdrawal by Subject|0|||
146713609|NCT01054729|529123892|FG002|Overall Study|Withdrawal by Subject|1|||
146713610|NCT01054729|529123893|FG003|Overall Study|Withdrawal by Subject|0|||
146713611|NCT01054729|529123890|FG000|Overall Study|Lost to Follow-up|0|||
146713612|NCT01054729|529123891|FG001|Overall Study|Lost to Follow-up|1|||
146713613|NCT01054729|529123892|FG002|Overall Study|Lost to Follow-up|0|||
146713614|NCT01054729|529123893|FG003|Overall Study|Lost to Follow-up|0|||
146713615|NCT01054729|529123890|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
146713616|NCT01054729|529123891|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
146713617|NCT01054729|529123892|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
146713618|NCT01054729|529123893|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
146713619|NCT01054729|529123890|FG000|Overall Study|Non-responder|1|||
146713620|NCT01054729|529123891|FG001|Overall Study|Non-responder|0|||
146713621|NCT01054729|529123892|FG002|Overall Study|Non-responder|1|||
146713622|NCT01054729|529123893|FG003|Overall Study|Non-responder|1|||
146713623|NCT01054729|529123890|FG000|Overall Study|PEG/RBV Non-responder|1|||
146713624|NCT01054729|529123891|FG001|Overall Study|PEG/RBV Non-responder|0|||
146713625|NCT01054729|529123892|FG002|Overall Study|PEG/RBV Non-responder|1|||
146713626|NCT01054729|529123893|FG003|Overall Study|PEG/RBV Non-responder|0|||
146713627|NCT01054729|529123890|FG000|Overall Study|Personal/Obligations|0|||
146713628|NCT01054729|529123891|FG001|Overall Study|Personal/Obligations|1|||
146713629|NCT01054729|529123892|FG002|Overall Study|Personal/Obligations|0|||
146713630|NCT01054729|529123893|FG003|Overall Study|Personal/Obligations|0|||
146713631|NCT01054729|529123890|FG000|Overall Study|Subject moved|0|||
146713632|NCT01054729|529123891|FG001|Overall Study|Subject moved|0|||
146713633|NCT01054729|529123892|FG002|Overall Study|Subject moved|1|||
146713634|NCT01054729|529123893|FG003|Overall Study|Subject moved|0|||
146713635|NCT01054729|529123890|FG000|Overall Study|Lack of Efficacy|0|||
146713636|NCT01054729|529123891|FG001|Overall Study|Lack of Efficacy|0|||
146713637|NCT01054729|529123892|FG002|Overall Study|Lack of Efficacy|0|||
146713638|NCT01054729|529123893|FG003|Overall Study|Lack of Efficacy|1|||
146713639|NCT00562159|529123894|FG000|Overall Study|Adverse Event|11|||
146713640|NCT00562159|529123895|FG001|Overall Study|Adverse Event|8|||
146713641|NCT00562159|529123894|FG000|Overall Study|Lost to Follow-up|5|||
146713642|NCT00562159|529123895|FG001|Overall Study|Lost to Follow-up|4|||
146713643|NCT00562159|529123894|FG000|Overall Study|Withdrawal by Subject|9|||
146713644|NCT00562159|529123895|FG001|Overall Study|Withdrawal by Subject|8|||
146713645|NCT00562159|529123894|FG000|Overall Study|Protocol Violation|12|||
146713646|NCT00562159|529123895|FG001|Overall Study|Protocol Violation|12|||
146713647|NCT00562159|529123894|FG000|Overall Study|Did not meet protocol eligibility|1|||
146713648|NCT00562159|529123895|FG001|Overall Study|Did not meet protocol eligibility|1|||
146713649|NCT01992536|529123899|FG000|Overall Study|Administrative Reason|0|||
146713650|NCT01992536|529123900|FG001|Overall Study|Administrative Reason|0|||
146713651|NCT01992536|529123901|FG002|Overall Study|Administrative Reason|0|||
146713652|NCT01992536|529123902|FG003|Overall Study|Administrative Reason|0|||
146713653|NCT01992536|529123903|FG004|Overall Study|Administrative Reason|0|||
146713654|NCT01992536|529123904|FG005|Overall Study|Administrative Reason|0|||
146713655|NCT01992536|529123905|FG006|Overall Study|Administrative Reason|7|||
146713656|NCT01992536|529123906|FG007|Overall Study|Administrative Reason|0|||
146713657|NCT01992536|529123907|FG008|Overall Study|Administrative Reason|0|||
146713658|NCT01992536|529123908|FG009|Overall Study|Administrative Reason|0|||
146713659|NCT01992536|529123899|FG000|Overall Study|Lost to Follow-up|4|||
146713660|NCT01992536|529123900|FG001|Overall Study|Lost to Follow-up|2|||
146713661|NCT01992536|529123901|FG002|Overall Study|Lost to Follow-up|1|||
146713662|NCT01992536|529123902|FG003|Overall Study|Lost to Follow-up|0|||
146713663|NCT01992536|529123903|FG004|Overall Study|Lost to Follow-up|0|||
146713664|NCT01992536|529123904|FG005|Overall Study|Lost to Follow-up|1|||
146713665|NCT01992536|529123905|FG006|Overall Study|Lost to Follow-up|0|||
146713666|NCT01992536|529123906|FG007|Overall Study|Lost to Follow-up|0|||
146713667|NCT01992536|529123907|FG008|Overall Study|Lost to Follow-up|1|||
146713668|NCT01992536|529123908|FG009|Overall Study|Lost to Follow-up|1|||
146713669|NCT01992536|529123899|FG000|Overall Study|Withdrawal by Subject|0|||
146713670|NCT01992536|529123900|FG001|Overall Study|Withdrawal by Subject|1|||
146713671|NCT01992536|529123901|FG002|Overall Study|Withdrawal by Subject|0|||
146713672|NCT01992536|529123902|FG003|Overall Study|Withdrawal by Subject|2|||
146713673|NCT01992536|529123903|FG004|Overall Study|Withdrawal by Subject|0|||
146713674|NCT01992536|529123904|FG005|Overall Study|Withdrawal by Subject|0|||
146713675|NCT01992536|529123905|FG006|Overall Study|Withdrawal by Subject|0|||
146713676|NCT01992536|529123906|FG007|Overall Study|Withdrawal by Subject|0|||
146713677|NCT01992536|529123907|FG008|Overall Study|Withdrawal by Subject|0|||
146713678|NCT01992536|529123908|FG009|Overall Study|Withdrawal by Subject|0|||
146713679|NCT02352493|529123909|FG000|Overall Study|Pregnancy|0|||
146713680|NCT02352493|529123910|FG001|Overall Study|Pregnancy|0|||
146713681|NCT02352493|529123911|FG002|Overall Study|Pregnancy|0|||
146713682|NCT02352493|529123912|FG003|Overall Study|Pregnancy|0|||
146713683|NCT02352493|529123913|FG004|Overall Study|Pregnancy|0|||
146713684|NCT02352493|529123914|FG005|Overall Study|Pregnancy|0|||
146713685|NCT02352493|529123915|FG006|Overall Study|Pregnancy|1|||
146713686|NCT02352493|529123916|FG007|Overall Study|Pregnancy|0|||
146713687|NCT02352493|529123917|FG008|Overall Study|Pregnancy|1|||
146713688|NCT02352493|529123918|FG009|Overall Study|Pregnancy|0|||
146713689|NCT02352493|529123919|FG010|Overall Study|Pregnancy|0|||
146713690|NCT02352493|529123920|FG011|Overall Study|Pregnancy|0|||
146713691|NCT02352493|529123921|FG012|Overall Study|Pregnancy|0|||
146713692|NCT02352493|529123922|FG013|Overall Study|Pregnancy|0|||
146713693|NCT02352493|529123923|FG014|Overall Study|Pregnancy|0|||
146713694|NCT02352493|529123924|FG015|Overall Study|Pregnancy|0|||
146713695|NCT02352493|529123925|FG016|Overall Study|Pregnancy|0|||
146713696|NCT02352493|529123926|FG017|Overall Study|Pregnancy|0|||
146713697|NCT02352493|529123909|FG000|Overall Study|Withdrawal by Subject|0|||
146713698|NCT02352493|529123910|FG001|Overall Study|Withdrawal by Subject|0|||
146713699|NCT02352493|529123911|FG002|Overall Study|Withdrawal by Subject|0|||
146780204|NCT01303445|529364123|FG000|Second Intervention (7 Days)|Adverse Event|0|||
146713700|NCT02352493|529123912|FG003|Overall Study|Withdrawal by Subject|0|||
146713701|NCT02352493|529123913|FG004|Overall Study|Withdrawal by Subject|0|||
146713702|NCT02352493|529123914|FG005|Overall Study|Withdrawal by Subject|0|||
146713703|NCT02352493|529123915|FG006|Overall Study|Withdrawal by Subject|0|||
146713704|NCT02352493|529123916|FG007|Overall Study|Withdrawal by Subject|0|||
146713705|NCT02352493|529123917|FG008|Overall Study|Withdrawal by Subject|1|||
146713706|NCT02352493|529123918|FG009|Overall Study|Withdrawal by Subject|0|||
146713707|NCT02352493|529123919|FG010|Overall Study|Withdrawal by Subject|0|||
146713708|NCT02352493|529123920|FG011|Overall Study|Withdrawal by Subject|0|||
146713709|NCT02352493|529123921|FG012|Overall Study|Withdrawal by Subject|0|||
146713710|NCT02352493|529123922|FG013|Overall Study|Withdrawal by Subject|0|||
146713711|NCT02352493|529123923|FG014|Overall Study|Withdrawal by Subject|1|||
146713712|NCT02352493|529123924|FG015|Overall Study|Withdrawal by Subject|0|||
146713713|NCT02352493|529123925|FG016|Overall Study|Withdrawal by Subject|0|||
146713714|NCT02352493|529123926|FG017|Overall Study|Withdrawal by Subject|0|||
146713715|NCT02352493|529123909|FG000|Overall Study|Lost to Follow-up|0|||
146713716|NCT02352493|529123910|FG001|Overall Study|Lost to Follow-up|0|||
146713717|NCT02352493|529123911|FG002|Overall Study|Lost to Follow-up|0|||
146713718|NCT02352493|529123912|FG003|Overall Study|Lost to Follow-up|0|||
146713719|NCT02352493|529123913|FG004|Overall Study|Lost to Follow-up|0|||
146713720|NCT02352493|529123914|FG005|Overall Study|Lost to Follow-up|0|||
146713721|NCT02352493|529123915|FG006|Overall Study|Lost to Follow-up|0|||
146713722|NCT02352493|529123916|FG007|Overall Study|Lost to Follow-up|0|||
146713723|NCT02352493|529123917|FG008|Overall Study|Lost to Follow-up|0|||
146713724|NCT02352493|529123918|FG009|Overall Study|Lost to Follow-up|1|||
146933985|NCT04311177|529916033|FG000|Overall Study|Physician Decision|4|||
146933986|NCT04311177|529916034|FG001|Overall Study|Physician Decision|3|||
146713725|NCT02352493|529123919|FG010|Overall Study|Lost to Follow-up|0|||
146713726|NCT02352493|529123920|FG011|Overall Study|Lost to Follow-up|0|||
146713727|NCT02352493|529123921|FG012|Overall Study|Lost to Follow-up|1|||
146713728|NCT02352493|529123922|FG013|Overall Study|Lost to Follow-up|2|||
146713729|NCT02352493|529123923|FG014|Overall Study|Lost to Follow-up|0|||
146713730|NCT02352493|529123924|FG015|Overall Study|Lost to Follow-up|0|||
146713731|NCT02352493|529123925|FG016|Overall Study|Lost to Follow-up|0|||
146713732|NCT02352493|529123926|FG017|Overall Study|Lost to Follow-up|0|||
146713733|NCT02162810|529123927|FG000|Overall Study|Protocol Violation|1|||
146713734|NCT02162810|529123928|FG001|Overall Study|Protocol Violation|0|||
146713735|NCT02162810|529123927|FG000|Overall Study|patients did not report compliance|4|||
146713736|NCT02162810|529123928|FG001|Overall Study|patients did not report compliance|1|||
146713737|NCT02546544|529123933|FG000|Overall Study|Disease Progression|14|||
146713738|NCT02546544|529123933|FG000|Overall Study|Adverse Event|1|||
146713739|NCT02546544|529123933|FG000|Overall Study|Withdrawal by Subject|1|||
146713740|NCT01921348|529123934|FG000|Overall Study|Withdrawal by Subject|1|||
146713741|NCT01921348|529123935|FG001|Overall Study|Withdrawal by Subject|0|||
146713742|NCT01921348|529123934|FG000|Overall Study|Lost to Follow-up|0|||
146713743|NCT01921348|529123935|FG001|Overall Study|Lost to Follow-up|2|||
146713744|NCT02223390|529123936|FG000|Overall Study|Lost to Follow-up|9|||
146713745|NCT02223390|529123937|FG001|Overall Study|Lost to Follow-up|4|||
146713746|NCT01465334|529123938|FG000|Overall Study|Disease Progression|1|||
146713747|NCT01465334|529123939|FG001|Overall Study|Disease Progression|0|||
146713748|NCT01465334|529123938|FG000|Overall Study|Adverse Event|1|||
146713749|NCT01465334|529123939|FG001|Overall Study|Adverse Event|0|||
146713750|NCT01465334|529123938|FG000|Overall Study|Richter's transformation|0|||
146713751|NCT01465334|529123939|FG001|Overall Study|Richter's transformation|3|||
146713752|NCT01465334|529123938|FG000|Overall Study|Refractory Disease|0|||
146713753|NCT01465334|529123939|FG001|Overall Study|Refractory Disease|3|||
146713754|NCT00795600|529123944|FG000|Overall Study|Adverse Event|1|||
146713755|NCT00795600|529123945|FG001|Overall Study|Adverse Event|1|||
146713756|NCT00795600|529123944|FG000|Overall Study|Protocol Violation|1|||
146713757|NCT00795600|529123945|FG001|Overall Study|Protocol Violation|2|||
146713758|NCT00795600|529123944|FG000|Overall Study|Withdrawal by Subject|1|||
146713759|NCT00795600|529123945|FG001|Overall Study|Withdrawal by Subject|0|||
146713760|NCT00795600|529123944|FG000|Overall Study|Unclassified|1|||
146713761|NCT00795600|529123945|FG001|Overall Study|Unclassified|1|||
146713762|NCT03936244|529123949|FG000|Overall Study|Lost to Follow-up|5|||
146713763|NCT03936244|529123950|FG001|Overall Study|Lost to Follow-up|1|||
146713764|NCT03936244|529123949|FG000|Overall Study|Physician Decision|7|||
146713765|NCT03936244|529123950|FG001|Overall Study|Physician Decision|3|||
146713766|NCT03551938|529123951|FG000|3-Month Follow Up|Lost to Follow-up|39|||
146933987|NCT04311177|529916033|FG000|Overall Study|Withdrawal by Subject|1|||
146933988|NCT04311177|529916034|FG001|Overall Study|Withdrawal by Subject|0|||
146933989|NCT03448224|529916039|FG000|Overall Study|Provided same answer to every question|1|||
146933990|NCT03448224|529916040|FG001|Overall Study|Provided same answer to every question|0|||
146713767|NCT03551938|529123952|FG001|3-Month Follow Up|Lost to Follow-up|38|||
146713768|NCT03551938|529123951|FG000|6-Month Follow Up|Lost to Follow-up|46|||
146713769|NCT03551938|529123952|FG001|6-Month Follow Up|Lost to Follow-up|42|||
146713770|NCT03551938|529123951|FG000|9-Month Follow Up|Lost to Follow-up|44|||
146713771|NCT03551938|529123952|FG001|9-Month Follow Up|Lost to Follow-up|43|||
146933991|NCT00764478|529916041|FG000|Overall Study|Adverse Event|1|||
146713772|NCT01046110|529123953|FG000|Overall Study|Adverse Event|9|||
146713773|NCT01046110|529123954|FG001|Overall Study|Adverse Event|2|||
146713774|NCT01046110|529123953|FG000|Overall Study|Lack of Efficacy|0|||
146713775|NCT01046110|529123954|FG001|Overall Study|Lack of Efficacy|1|||
146713776|NCT01046110|529123953|FG000|Overall Study|Protocol Violation|7|||
146713777|NCT01046110|529123954|FG001|Overall Study|Protocol Violation|12|||
146713778|NCT01046110|529123953|FG000|Overall Study|Withdrawal Criteria|3|||
146713779|NCT01046110|529123954|FG001|Overall Study|Withdrawal Criteria|5|||
146713780|NCT01046110|529123953|FG000|Overall Study|Unclassified|36|||
146713781|NCT01046110|529123954|FG001|Overall Study|Unclassified|35|||
146713782|NCT01233817|529123957|FG000|Overall Study|Lost to Follow-up|1|||
146713783|NCT01233817|529123957|FG000|Overall Study|Withdrawal by Subject|2|||
146713784|NCT01248884|529123958|FG000|Overall Study|Withdrawal by Subject|1|||
146713785|NCT01248884|529123959|FG001|Overall Study|Withdrawal by Subject|3|||
146933992|NCT00764478|529916042|FG001|Overall Study|Adverse Event|1|||
146933993|NCT00764478|529916043|FG002|Overall Study|Adverse Event|1|||
146780205|NCT01303445|529364124|FG001|Second Intervention (7 Days)|Adverse Event|2|||
146780206|NCT01303445|529364123|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
146780207|NCT01303445|529364124|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
146780208|NCT01303445|529364123|FG000|Washout (14 Days)|Protocol Violation|1|||
146780209|NCT01303445|529364124|FG001|Washout (14 Days)|Protocol Violation|0|||
146780210|NCT01303445|529364123|FG000|Washout (14 Days)|Lost to Follow-up|0|||
146933994|NCT00764478|529916041|FG000|Overall Study|Withdrawal by Subject|7|||
146713786|NCT01248884|529123960|FG002|Overall Study|Withdrawal by Subject|1|||
146713787|NCT01248884|529123958|FG000|Overall Study|Adverse Event|1|||
146713788|NCT01248884|529123959|FG001|Overall Study|Adverse Event|0|||
146713789|NCT01248884|529123960|FG002|Overall Study|Adverse Event|0|||
146713790|NCT01202773|529123961|FG000|Overall Study|Adverse Event|4|||
146713791|NCT01202773|529123962|FG001|Overall Study|Adverse Event|5|||
146713792|NCT01202773|529123963|FG002|Overall Study|Adverse Event|5|||
146713793|NCT01202773|529123961|FG000|Overall Study|Lack of Efficacy|5|||
146713794|NCT01202773|529123962|FG001|Overall Study|Lack of Efficacy|4|||
146713795|NCT01202773|529123963|FG002|Overall Study|Lack of Efficacy|9|||
146713796|NCT01202773|529123961|FG000|Overall Study|Entry Criteria Not Met|2|||
146713797|NCT01202773|529123962|FG001|Overall Study|Entry Criteria Not Met|0|||
146713798|NCT01202773|529123963|FG002|Overall Study|Entry Criteria Not Met|1|||
146713799|NCT01202773|529123961|FG000|Overall Study|Lost to Follow-up|1|||
146713800|NCT01202773|529123962|FG001|Overall Study|Lost to Follow-up|2|||
146713801|NCT01202773|529123963|FG002|Overall Study|Lost to Follow-up|2|||
146713802|NCT01202773|529123961|FG000|Overall Study|Withdrawal by Subject|13|||
146713803|NCT01202773|529123962|FG001|Overall Study|Withdrawal by Subject|6|||
146713804|NCT01202773|529123963|FG002|Overall Study|Withdrawal by Subject|5|||
146713805|NCT01202773|529123961|FG000|Overall Study|Physician Decision|2|||
146713806|NCT01202773|529123962|FG001|Overall Study|Physician Decision|0|||
146713807|NCT01202773|529123963|FG002|Overall Study|Physician Decision|0|||
146713808|NCT01202773|529123961|FG000|Overall Study|Protocol Violation|11|||
146713809|NCT01202773|529123962|FG001|Overall Study|Protocol Violation|6|||
146713810|NCT01202773|529123963|FG002|Overall Study|Protocol Violation|10|||
146713811|NCT01202773|529123961|FG000|Overall Study|Sponsor Decision|19|||
146713812|NCT01202773|529123962|FG001|Overall Study|Sponsor Decision|20|||
146713813|NCT01202773|529123963|FG002|Overall Study|Sponsor Decision|23|||
146713814|NCT00575588|529123968|FG000|Overall Study|Adverse Event|11|||
146713815|NCT00575588|529123969|FG001|Overall Study|Adverse Event|13|||
146713816|NCT00575588|529123968|FG000|Overall Study|Withdrawal by Subject|27|||
146713817|NCT00575588|529123969|FG001|Overall Study|Withdrawal by Subject|31|||
146713818|NCT00575588|529123968|FG000|Overall Study|Lost to Follow-up|1|||
146713819|NCT00575588|529123969|FG001|Overall Study|Lost to Follow-up|3|||
146713820|NCT00575588|529123968|FG000|Overall Study|Death|4|||
146713821|NCT00575588|529123969|FG001|Overall Study|Death|2|||
146713822|NCT00575588|529123968|FG000|Overall Study|Incorrect enrollment|8|||
146713823|NCT00575588|529123969|FG001|Overall Study|Incorrect enrollment|4|||
146713824|NCT00575588|529123968|FG000|Overall Study|Study specific discontinuation criteria|203|||
146713825|NCT00575588|529123969|FG001|Overall Study|Study specific discontinuation criteria|218|||
146713826|NCT00575588|529123968|FG000|Overall Study|Severe non-compliance to protocol|5|||
146713827|NCT00575588|529123969|FG001|Overall Study|Severe non-compliance to protocol|7|||
146713828|NCT00575588|529123968|FG000|Overall Study|Safety reasons|2|||
146713829|NCT00575588|529123969|FG001|Overall Study|Safety reasons|1|||
146713830|NCT00575588|529123968|FG000|Overall Study|Elevated triglyceride|1|||
146713831|NCT00575588|529123969|FG001|Overall Study|Elevated triglyceride|0|||
146713832|NCT00575588|529123968|FG000|Overall Study|Patient moved|1|||
146713833|NCT00575588|529123969|FG001|Overall Study|Patient moved|3|||
146713834|NCT00575588|529123968|FG000|Overall Study|Impossible to determine HbA1c|0|||
146713835|NCT00575588|529123969|FG001|Overall Study|Impossible to determine HbA1c|1|||
146713836|NCT01430130|529123970|FG000|Overall Study|Lost to Follow-up|1|||
146713837|NCT01430130|529123970|FG000|Overall Study|Infection on Control Side of Incision|1|||
146713838|NCT00504829|529123975|FG000|Overall Study|Protocol Violation|6|||
146713839|NCT00504829|529123976|FG001|Overall Study|Protocol Violation|4|||
146713840|NCT00504829|529123977|FG002|Overall Study|Protocol Violation|10|||
146713841|NCT01854827|529123978|FG000|Overall Study|Death|1|||
146713842|NCT02843568|529123987|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
146713843|NCT02843568|529123988|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
146713844|NCT02843568|529123987|FG000|Overall Study|Death|3|||
146713845|NCT02843568|529123988|FG001|Overall Study|Death|3|||
146713846|NCT02843568|529123987|FG000|Overall Study|Withdrawal by Subject|1|||
146713847|NCT02843568|529123988|FG001|Overall Study|Withdrawal by Subject|1|||
146713848|NCT02843568|529123987|FG000|Overall Study|Lost to Follow-up|2|||
146713849|NCT02843568|529123988|FG001|Overall Study|Lost to Follow-up|0|||
146713850|NCT01343407|529123991|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
146780211|NCT01303445|529364124|FG001|Washout (14 Days)|Lost to Follow-up|2|||
146780212|NCT01303445|529364123|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
146780213|NCT01303445|529364124|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
146780214|NCT01303445|529364123|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
146780215|NCT01303445|529364124|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
146780216|NCT03978637|529364125|FG000|Overall Study|Death|0|||
146780217|NCT03978637|529364126|FG001|Overall Study|Death|2|||
146780218|NCT03978637|529364127|FG002|Overall Study|Death|2|||
146780219|NCT03978637|529364128|FG003|Overall Study|Death|0|||
146780220|NCT03978637|529364125|FG000|Overall Study|Withdrawal by Subject|0|||
146780221|NCT03978637|529364126|FG001|Overall Study|Withdrawal by Subject|0|||
146780222|NCT03978637|529364127|FG002|Overall Study|Withdrawal by Subject|1|||
146780223|NCT03978637|529364128|FG003|Overall Study|Withdrawal by Subject|0|||
146780224|NCT03978637|529364125|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
146780225|NCT03978637|529364126|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
146780226|NCT03978637|529364127|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
146780227|NCT03978637|529364128|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
146780228|NCT04924062|529366096|FG000|Overall Study|Death|49|||
146780229|NCT04924062|529366097|FG001|Overall Study|Death|63|||
146780230|NCT04924062|529366096|FG000|Overall Study|Participant On-going|26|||
146780231|NCT04924062|529366097|FG001|Overall Study|Participant On-going|20|||
146780232|NCT03899961|529366098|FG000|Overall Study|-delivery prior to|2|||
146780233|NCT03899961|529366099|FG001|Overall Study|-delivery prior to|7|||
146780234|NCT03899961|529366098|FG000|Overall Study|req general anesth|1|||
146780235|NCT03899961|529366099|FG001|Overall Study|req general anesth|2|||
146780236|NCT03899961|529366098|FG000|Overall Study|capacity|5|||
146780237|NCT03899961|529366099|FG001|Overall Study|capacity|6|||
146780238|NCT03899961|529366098|FG000|Overall Study|Withdrawal by Subject|1|||
146780239|NCT03899961|529366099|FG001|Overall Study|Withdrawal by Subject|1|||
146780240|NCT04112316|529366104|FG000|First Period (8 Weeks)|Protocol Violation|1|||
146780241|NCT04112316|529366105|FG001|First Period (8 Weeks)|Protocol Violation|0|||
146780242|NCT04112316|529366104|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
146780243|NCT04112316|529366105|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
146780244|NCT04093362|529366106|FG000|Overall Study|Study Termination|1|||
146780245|NCT04093362|529366107|FG001|Overall Study|Study Termination|1|||
146780246|NCT04093362|529366106|FG000|Overall Study|Withdrawal of Consent|1|||
146780247|NCT04093362|529366107|FG001|Overall Study|Withdrawal of Consent|0|||
146780248|NCT04093362|529366106|FG000|Overall Study|Death|1|||
146780249|NCT04093362|529366107|FG001|Overall Study|Death|3|||
146780250|NCT04093362|529366106|FG000|Overall Study|Reason not Specified|1|||
146780251|NCT04093362|529366107|FG001|Overall Study|Reason not Specified|2|||
146780252|NCT03055377|529366117|FG000|Treatment Phase|Lost to Follow-up|28|||
146780253|NCT03055377|529366118|FG001|Treatment Phase|Lost to Follow-up|24|||
146780254|NCT03055377|529366117|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
146780255|NCT03055377|529366118|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
146780256|NCT01938547|529366127|FG000|Overall Study|Physician Decision|1|||
146780257|NCT04823611|529366130|FG000|Overall Study|Adverse Event|2|||
146780258|NCT04823611|529366131|FG001|Overall Study|Adverse Event|0|||
146780259|NCT04823611|529366132|FG002|Overall Study|Adverse Event|1|||
146780260|NCT04823611|529366133|FG003|Overall Study|Adverse Event|0|||
146780261|NCT04823611|529366134|FG004|Overall Study|Adverse Event|0|||
146780262|NCT04823611|529366135|FG005|Overall Study|Adverse Event|0|||
146780263|NCT04823611|529366136|FG006|Overall Study|Adverse Event|0|||
146780264|NCT04716634|529366139|FG000|Overall Study|Death|24|||
146780265|NCT04716634|529366140|FG001|Overall Study|Death|24|||
146780266|NCT04716634|529366141|FG002|Overall Study|Death|8|||
146780267|NCT04716634|529366139|FG000|Overall Study|Closed by Sponsor|4|||
146780268|NCT04716634|529366140|FG001|Overall Study|Closed by Sponsor|4|||
146780269|NCT04716634|529366141|FG002|Overall Study|Closed by Sponsor|5|||
146780270|NCT04716634|529366139|FG000|Overall Study|Lost to Follow-up|1|||
146780271|NCT04716634|529366140|FG001|Overall Study|Lost to Follow-up|0|||
146780272|NCT04716634|529366141|FG002|Overall Study|Lost to Follow-up|1|||
146780273|NCT04716634|529366139|FG000|Overall Study|Withdrawal by Subject|0|||
146780274|NCT04716634|529366140|FG001|Overall Study|Withdrawal by Subject|0|||
146780275|NCT04716634|529366141|FG002|Overall Study|Withdrawal by Subject|1|||
146780276|NCT01673984|529366145|FG000|Overall Study|Adverse Event|1|||
146780277|NCT01673984|529366146|FG001|Overall Study|Adverse Event|0|||
146780278|NCT01673984|529366145|FG000|Overall Study|Study termination|9|||
146780279|NCT01673984|529366146|FG001|Overall Study|Study termination|6|||
146780280|NCT00150813|529366149|FG000|Overall Study|Adverse Event|1|||
146780281|NCT00150813|529366149|FG000|Overall Study|Lack of Efficacy|1|||
146780282|NCT00150813|529366149|FG000|Overall Study|Lost to Follow-up|5|||
146780283|NCT00150813|529366149|FG000|Overall Study|Withdrawal by Subject|5|||
146780284|NCT00150813|529366149|FG000|Overall Study|Remission|3|||
146780285|NCT00150813|529366149|FG000|Overall Study|Planned pregancy|1|||
146780286|NCT00150813|529366149|FG000|Overall Study|Switch to commercially available LEV|2|||
146780287|NCT01820260|529366151|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146780288|NCT01820260|529366152|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146780289|NCT01820260|529366153|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146780290|NCT01820260|529366154|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146780291|NCT01820260|529366155|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146780292|NCT01820260|529366156|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146780293|NCT01820260|529366157|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
146780294|NCT01820260|529366158|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146780295|NCT01820260|529366159|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146780296|NCT01820260|529366160|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146780297|NCT01820260|529366161|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146780298|NCT01820260|529366162|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146780299|NCT01820260|529366163|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146780300|NCT01820260|529366164|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146780301|NCT01820260|529366151|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146780302|NCT01820260|529366152|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146780303|NCT01820260|529366153|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146780304|NCT01820260|529366154|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146780305|NCT01820260|529366155|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146780306|NCT01820260|529366156|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146780307|NCT01820260|529366157|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146780308|NCT01820260|529366158|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146780309|NCT01820260|529366159|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146780310|NCT01820260|529366160|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
146780311|NCT01820260|529366161|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146780312|NCT01820260|529366162|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146780313|NCT01820260|529366163|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146780314|NCT01820260|529366164|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146780315|NCT05415410|529366165|FG000|Overall Study|Death|3|||
146780316|NCT05415410|529366166|FG001|Overall Study|Death|6|||
146780317|NCT05415410|529366167|FG002|Overall Study|Death|1|||
146780318|NCT05415410|529366165|FG000|Overall Study|Trial Terminated by Sponsor|1|||
146780319|NCT05415410|529366166|FG001|Overall Study|Trial Terminated by Sponsor|5|||
146780320|NCT05415410|529366167|FG002|Overall Study|Trial Terminated by Sponsor|0|||
146780321|NCT05415410|529366165|FG000|Overall Study|Adverse Event|2|||
146780322|NCT05415410|529366166|FG001|Overall Study|Adverse Event|1|||
146780323|NCT05415410|529366167|FG002|Overall Study|Adverse Event|0|||
146780324|NCT05415410|529366165|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
146780325|NCT05415410|529366166|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
146780326|NCT05415410|529366167|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
146780327|NCT05415410|529366165|FG000|Overall Study|Withdrawal by Subject|1|||
146780328|NCT05415410|529366166|FG001|Overall Study|Withdrawal by Subject|0|||
146780329|NCT05415410|529366167|FG002|Overall Study|Withdrawal by Subject|0|||
146780330|NCT05415410|529366165|FG000|Overall Study|Pregnancy|5|||
146780331|NCT05415410|529366166|FG001|Overall Study|Pregnancy|2|||
146780332|NCT05415410|529366167|FG002|Overall Study|Pregnancy|0|||
146780333|NCT02365766|529366171|FG000|Overall Study|Withdrawal by Subject|0|||
146780334|NCT02365766|529366172|FG001|Overall Study|Withdrawal by Subject|0|||
146780335|NCT02365766|529366173|FG002|Overall Study|Withdrawal by Subject|1|||
146780336|NCT02365766|529366171|FG000|Overall Study|Eligibility Criteria Not Met|0|||
146780337|NCT02365766|529366172|FG001|Overall Study|Eligibility Criteria Not Met|0|||
146780338|NCT02365766|529366173|FG002|Overall Study|Eligibility Criteria Not Met|1|||
146780339|NCT00650104|529366180|FG000|Overall Study|Adverse Event|17|||
146780340|NCT00650104|529366180|FG000|Overall Study|Death|2|||
146780341|NCT00650104|529366180|FG000|Overall Study|Withdrawal by Subject|11|||
146780342|NCT00650104|529366180|FG000|Overall Study|Physician Decision|7|||
146780343|NCT00650104|529366180|FG000|Overall Study|Lost to Follow-up|1|||
146780344|NCT00650104|529366180|FG000|Overall Study|Non-compliance|2|||
146780345|NCT00650104|529366180|FG000|Overall Study|Sponsor Terminated Dosing|1|||
146780346|NCT00894543|529366181|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
146780347|NCT00894543|529366182|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
146780348|NCT00894543|529366181|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
146780349|NCT00894543|529366182|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
146780350|NCT04048681|529366183|FG000|Overall Study|family emergency|0|||
146780351|NCT04048681|529366184|FG001|Overall Study|family emergency|0|||
146780352|NCT04048681|529366185|FG002|Overall Study|family emergency|0|||
146780353|NCT04048681|529366186|FG003|Overall Study|family emergency|1|||
146780354|NCT04048681|529366187|FG004|Overall Study|family emergency|0|||
146780355|NCT03385629|529366193|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
146780356|NCT03385629|529366194|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
146780357|NCT03385629|529366193|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
146780358|NCT03385629|529366194|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
146933995|NCT00764478|529916042|FG001|Overall Study|Withdrawal by Subject|12|||
146933996|NCT00764478|529916043|FG002|Overall Study|Withdrawal by Subject|1|||
146933997|NCT00764478|529916041|FG000|Overall Study|Lost to Follow-up|7|||
146780359|NCT03385629|529366193|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
146780360|NCT03385629|529366194|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
146713851|NCT01343407|529123992|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
146713852|NCT01343407|529123993|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
146713853|NCT01343407|529123994|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
146713854|NCT01343407|529123995|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
146713855|NCT01343407|529123996|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
146713856|NCT01343407|529123991|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
146713857|NCT01343407|529123992|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
146713858|NCT01343407|529123993|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
146713859|NCT01343407|529123994|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
146713860|NCT01343407|529123995|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
146713861|NCT01343407|529123996|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
146713862|NCT04079933|529124002|FG000|Overall Study|Withdrawal by Subject|3|||
146713863|NCT04079933|529124003|FG001|Overall Study|Withdrawal by Subject|4|||
146713864|NCT04079933|529124002|FG000|Overall Study|Lost to Follow-up|0|||
146713865|NCT04079933|529124003|FG001|Overall Study|Lost to Follow-up|1|||
146713866|NCT01986829|529124008|FG000|Overall Study|Death|1|||
146713867|NCT02504866|529124009|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
146713868|NCT02504866|529124010|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
146713869|NCT02504866|529124011|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
146713870|NCT01229436|529124012|FG000|Overall Study|Withdrawal by Subject|2|||
146713871|NCT01229436|529124012|FG000|Overall Study|Lost to Follow-up|3|||
146713872|NCT00096941|529124013|FG000|Overall Study|disease progression|3|||
146713873|NCT01775137|529124014|FG000|Overall Study|Death|1|||
146713874|NCT01775137|529124014|FG000|Overall Study|Protocol deviation|2|||
146713875|NCT01775137|529124014|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146713876|NCT01775137|529124014|FG000|Overall Study|Adverse Event|1|||
146713877|NCT01775137|529124014|FG000|Overall Study|Withdrawal by participants|5|||
146713878|NCT02059148|529124015|FG000|Treatment 1|Protocol Violation|0|||
146713879|NCT02059148|529124016|FG001|Treatment 1|Protocol Violation|0|||
146713880|NCT02059148|529124017|FG002|Treatment 1|Protocol Violation|0|||
146713881|NCT02059148|529124018|FG003|Treatment 1|Protocol Violation|0|||
146713882|NCT02059148|529124019|FG004|Treatment 1|Protocol Violation|0|||
146713883|NCT02059148|529124020|FG005|Treatment 1|Protocol Violation|1|||
146713884|NCT03231371|529124021|FG000|Overall Study|Withdrawal by Subject|1|||
146713885|NCT03231371|529124021|FG000|Overall Study|chose or were ineligible to have MRI|12|||
146713886|NCT01525082|529124023|FG000|Overall Study|Death|1|||
146713887|NCT03321981|529124024|FG000|Overall Study|Progressive Disease (PD)|15|||
146713888|NCT03321981|529124025|FG001|Overall Study|Progressive Disease (PD)|30|||
146713889|NCT03321981|529124026|FG002|Overall Study|Progressive Disease (PD)|47|||
146713890|NCT03321981|529124024|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
146713891|NCT03321981|529124025|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
146713892|NCT03321981|529124026|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
146713893|NCT03321981|529124024|FG000|Overall Study|Adverse Event|0|||
146713894|NCT03321981|529124025|FG001|Overall Study|Adverse Event|0|||
146713895|NCT03321981|529124026|FG002|Overall Study|Adverse Event|2|||
146713896|NCT03321981|529124024|FG000|Overall Study|symptomatic deterioration|0|||
146713897|NCT03321981|529124025|FG001|Overall Study|symptomatic deterioration|1|||
146713898|NCT03321981|529124026|FG002|Overall Study|symptomatic deterioration|1|||
146713899|NCT03321981|529124024|FG000|Overall Study|Lack of compliance|0|||
146713900|NCT03321981|529124025|FG001|Overall Study|Lack of compliance|1|||
146713901|NCT03321981|529124026|FG002|Overall Study|Lack of compliance|0|||
146713902|NCT03321981|529124024|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
146713903|NCT03321981|529124025|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
146713904|NCT03321981|529124026|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
146713905|NCT03321981|529124024|FG000|Overall Study|Death|0|||
146713906|NCT03321981|529124025|FG001|Overall Study|Death|1|||
146713907|NCT03321981|529124026|FG002|Overall Study|Death|0|||
146713908|NCT03321981|529124024|FG000|Overall Study|Subject withdrawal of investigational product|0|||
146713909|NCT03321981|529124025|FG001|Overall Study|Subject withdrawal of investigational product|1|||
146713910|NCT03321981|529124026|FG002|Overall Study|Subject withdrawal of investigational product|0|||
146713911|NCT03321981|529124024|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
146713912|NCT03321981|529124025|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
146713913|NCT03321981|529124026|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
146713914|NCT03321981|529124024|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
146713915|NCT03321981|529124025|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
146713916|NCT03321981|529124026|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
146780361|NCT02919449|529366195|FG000|Overall Study|Withdrawal by Subject|1|||
146780362|NCT02919449|529366195|FG000|Overall Study|Investigator decision|1|||
146780363|NCT04838613|529366196|FG000|Overall Study|Withdrawal by Subject|3|||
146713917|NCT04111497|529124029|FG000|Overall Study|relapse of primary disease|1|||
146713918|NCT04111497|529124029|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
146713919|NCT03880578|529124030|FG000|Overall Study|Withdrawal by Subject|0|||
146713920|NCT03880578|529124031|FG001|Overall Study|Withdrawal by Subject|3|||
146713921|NCT03880578|529124032|FG002|Overall Study|Withdrawal by Subject|1|||
146713922|NCT03880578|529124030|FG000|Overall Study|Death|0|||
146713923|NCT03880578|529124031|FG001|Overall Study|Death|1|||
146713924|NCT03880578|529124032|FG002|Overall Study|Death|0|||
146713925|NCT02328326|529124036|FG000|Overall Study|Withdrawal by Subject|10|||
146713926|NCT02328326|529124037|FG001|Overall Study|Withdrawal by Subject|3|||
146713927|NCT02328326|529124036|FG000|Overall Study|Death|2|||
146713928|NCT02328326|529124037|FG001|Overall Study|Death|1|||
146713929|NCT02328326|529124036|FG000|Overall Study|Lost to Follow-up|10|||
146713930|NCT02328326|529124037|FG001|Overall Study|Lost to Follow-up|4|||
146713931|NCT02056301|529124038|FG000|Overall Study|Protocol Violation|1|||
146713932|NCT02056301|529124039|FG001|Overall Study|Protocol Violation|2|||
146713933|NCT02056301|529124038|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
146713934|NCT02056301|529124039|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
146713935|NCT02056301|529124038|FG000|Overall Study|Withdrawal by Subject|0|||
146713936|NCT02056301|529124039|FG001|Overall Study|Withdrawal by Subject|1|||
146713937|NCT02056301|529124038|FG000|Overall Study|Issues with epidural|0|||
146713938|NCT02056301|529124039|FG001|Overall Study|Issues with epidural|3|||
146713939|NCT02209324|529124043|FG000|Overall Study|Adverse Event|2|||
146713940|NCT02209324|529124043|FG000|Overall Study|Lack of Efficacy|1|||
146713941|NCT02209324|529124043|FG000|Overall Study|Lost to Follow-up|1|||
146713942|NCT02209324|529124043|FG000|Overall Study|Physician Decision|3|||
146713943|NCT02209324|529124043|FG000|Overall Study|Protocol Violation|14|||
146713944|NCT02209324|529124043|FG000|Overall Study|Withdrawal by Subject|8|||
146713945|NCT02209324|529124043|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
146713946|NCT02209324|529124043|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
146713947|NCT02209324|529124043|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
146713948|NCT03105362|529124044|FG000|Overall Study|Withdrawal by Subject|1|||
146713949|NCT03105362|529124044|FG000|Overall Study|Lost to Follow-up|1|||
146713950|NCT01785602|529124048|FG000|Overall Study|Withdrawal by Subject|2|||
146713951|NCT01785602|529124049|FG001|Overall Study|Withdrawal by Subject|0|||
146713952|NCT01785602|529124048|FG000|Overall Study|Lost to Follow-up|1|||
146713953|NCT01785602|529124049|FG001|Overall Study|Lost to Follow-up|1|||
146713954|NCT01785602|529124048|FG000|Overall Study|Adverse Event|3|||
146713955|NCT01785602|529124049|FG001|Overall Study|Adverse Event|5|||
146713956|NCT01785602|529124048|FG000|Overall Study|Administrative problems|7|||
146713957|NCT01785602|529124049|FG001|Overall Study|Administrative problems|3|||
146713958|NCT02041429|529124053|FG000|Overall Study|Progressive Disease|2|||
146713959|NCT02041429|529124054|FG001|Overall Study|Progressive Disease|2|||
146713960|NCT02041429|529124055|FG002|Overall Study|Progressive Disease|3|||
146713961|NCT02041429|529124056|FG003|Overall Study|Progressive Disease|2|||
146713962|NCT02041429|529124053|FG000|Overall Study|Toxicity|0|||
146713963|NCT02041429|529124054|FG001|Overall Study|Toxicity|1|||
146713964|NCT02041429|529124055|FG002|Overall Study|Toxicity|4|||
146713965|NCT02041429|529124056|FG003|Overall Study|Toxicity|2|||
146713966|NCT02041429|529124053|FG000|Overall Study|Withdrawal by Subject|0|||
146713967|NCT02041429|529124054|FG001|Overall Study|Withdrawal by Subject|1|||
146780364|NCT04838613|529366197|FG001|Overall Study|Withdrawal by Subject|6|||
146780365|NCT04838613|529366196|FG000|Overall Study|Protocol Deviation|3|||
146713968|NCT02041429|529124055|FG002|Overall Study|Withdrawal by Subject|0|||
146713969|NCT02041429|529124056|FG003|Overall Study|Withdrawal by Subject|0|||
146713970|NCT02041429|529124053|FG000|Overall Study|On Maintenance Therapy|1|||
146713971|NCT02041429|529124054|FG001|Overall Study|On Maintenance Therapy|0|||
146713972|NCT02041429|529124055|FG002|Overall Study|On Maintenance Therapy|0|||
146713973|NCT02041429|529124056|FG003|Overall Study|On Maintenance Therapy|2|||
146713974|NCT05204134|529124061|FG000|Overall Study|Withdrawal by Subject|3|||
146713975|NCT05204134|529124061|FG000|Overall Study|Physician Decision|1|||
146713976|NCT01312467|529124063|FG000|Overall Study|Adverse Event|4|||
146713977|NCT01312467|529124063|FG000|Overall Study|Lost to Follow-up|1|||
146713978|NCT01312467|529124063|FG000|Overall Study|Withdrawal by Subject|2|||
146713979|NCT01312467|529124063|FG000|Overall Study|Deported to country of origin|1|||
146713980|NCT01312467|529124063|FG000|Overall Study|Another medical condition|1|||
146713981|NCT01312467|529124063|FG000|Overall Study|Ineligible|4|||
146713982|NCT00132769|529124064|FG000|Overall Study|Withdrawal by Subject|1|||
146713983|NCT00132769|529124065|FG001|Overall Study|Withdrawal by Subject|3|||
146713984|NCT00132769|529124064|FG000|Overall Study|Lack of Efficacy|7|||
146713985|NCT00132769|529124065|FG001|Overall Study|Lack of Efficacy|6|||
146713986|NCT00132769|529124064|FG000|Overall Study|Adverse Event|2|||
146713987|NCT00132769|529124065|FG001|Overall Study|Adverse Event|1|||
146713988|NCT00132769|529124064|FG000|Overall Study|Protocol Violation|1|||
146713989|NCT00132769|529124065|FG001|Overall Study|Protocol Violation|1|||
146713990|NCT01431508|529124066|FG000|Overall Study|Lack of Efficacy|1|||
146713991|NCT01431508|529124066|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
146780366|NCT04838613|529366197|FG001|Overall Study|Protocol Deviation|2|||
146981169|NCT01165684|530093763|FG001|Overall Study|Protocol Violation|15|||
146981170|NCT01165684|530093762|FG000|Overall Study|Withdrawal Criteria|2|||
146981171|NCT01165684|530093763|FG001|Overall Study|Withdrawal Criteria|13|||
146981172|NCT01165684|530093762|FG000|Overall Study|Unclassified|16|||
146981173|NCT01165684|530093763|FG001|Overall Study|Unclassified|22|||
146713992|NCT00129259|529124067|FG000|Overall Study|Lost to Follow-up|1|||
146713993|NCT00129259|529124068|FG001|Overall Study|Lost to Follow-up|1|||
146713994|NCT00129259|529124067|FG000|Overall Study|Withdrawal by Subject|2|||
146713995|NCT00129259|529124068|FG001|Overall Study|Withdrawal by Subject|1|||
146713996|NCT00129259|529124067|FG000|Overall Study|Only available minimal phone assessments|0|||
146713997|NCT00129259|529124068|FG001|Overall Study|Only available minimal phone assessments|1|||
146713998|NCT01609556|529124072|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146713999|NCT01609556|529124073|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146714000|NCT01609556|529124074|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146714001|NCT01609556|529124075|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146714002|NCT01609556|529124076|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
146714003|NCT01609556|529124077|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146714004|NCT01609556|529124078|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146714005|NCT01609556|529124079|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
146714006|NCT01609556|529124080|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
146714007|NCT01609556|529124081|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146714008|NCT01609556|529124082|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
146714009|NCT01609556|529124083|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
146714010|NCT01609556|529124084|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146714011|NCT01609556|529124085|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146714012|NCT01609556|529124086|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146714013|NCT01609556|529124087|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146714014|NCT01609556|529124072|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
146714015|NCT01609556|529124073|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
146714016|NCT01609556|529124074|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
146714017|NCT01609556|529124075|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
146714018|NCT01609556|529124076|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
146714019|NCT01609556|529124077|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
146714020|NCT01609556|529124078|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
146714021|NCT01609556|529124079|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
146714022|NCT01609556|529124080|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
146714023|NCT01609556|529124081|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
146714024|NCT01609556|529124082|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
146714025|NCT01609556|529124083|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
146714026|NCT01609556|529124084|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
146714027|NCT01609556|529124085|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
146714028|NCT01609556|529124086|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
146714029|NCT01609556|529124087|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
146714030|NCT01609556|529124072|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146714031|NCT01609556|529124073|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146714032|NCT01609556|529124074|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146714033|NCT01609556|529124075|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146714034|NCT01609556|529124076|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146714035|NCT01609556|529124077|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
146714036|NCT01609556|529124078|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
146714037|NCT01609556|529124079|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146714038|NCT01609556|529124080|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146714039|NCT01609556|529124081|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
146714040|NCT01609556|529124082|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
146714041|NCT01609556|529124083|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
146714042|NCT01609556|529124084|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146714043|NCT01609556|529124085|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146714044|NCT01609556|529124086|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146714045|NCT01609556|529124087|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146714046|NCT01609556|529124072|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146714047|NCT01609556|529124073|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146714048|NCT01609556|529124074|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146714049|NCT01609556|529124075|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146714050|NCT01609556|529124076|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146714051|NCT01609556|529124077|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
146714052|NCT01609556|529124078|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146780367|NCT04838613|529366196|FG000|Overall Study|Technical Problems|0|||
146714053|NCT01609556|529124079|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146714054|NCT01609556|529124080|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146714055|NCT01609556|529124081|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146714056|NCT01609556|529124082|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146714057|NCT01609556|529124083|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
146714058|NCT01609556|529124084|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146714059|NCT01609556|529124085|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146714060|NCT01609556|529124086|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146714061|NCT01609556|529124087|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146714062|NCT01609556|529124072|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146714063|NCT01609556|529124073|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146714064|NCT01609556|529124074|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146714065|NCT01609556|529124075|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146714066|NCT01609556|529124076|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146714067|NCT01609556|529124077|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
146714068|NCT01609556|529124078|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146714069|NCT01609556|529124079|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146714070|NCT01609556|529124080|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146714071|NCT01609556|529124081|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146714072|NCT01609556|529124082|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146714073|NCT01609556|529124083|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146714074|NCT01609556|529124084|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146714075|NCT01609556|529124085|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146714076|NCT01609556|529124086|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146714077|NCT01609556|529124087|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146714078|NCT01609556|529124072|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146714079|NCT01609556|529124073|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146714080|NCT01609556|529124074|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146714081|NCT01609556|529124075|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146714082|NCT01609556|529124076|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146714083|NCT01609556|529124077|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146714084|NCT01609556|529124078|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146714085|NCT01609556|529124079|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146714086|NCT01609556|529124080|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
146714087|NCT01609556|529124081|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146714088|NCT01609556|529124082|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146714089|NCT01609556|529124083|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146714090|NCT01609556|529124084|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146714091|NCT01609556|529124085|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146714092|NCT01609556|529124086|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146714093|NCT01609556|529124087|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146714094|NCT01609556|529124072|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
146714095|NCT01609556|529124073|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146714096|NCT01609556|529124074|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146714097|NCT01609556|529124075|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146714098|NCT01609556|529124076|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146714099|NCT01609556|529124077|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
146714100|NCT01609556|529124078|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146714101|NCT01609556|529124079|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146714102|NCT01609556|529124080|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146714103|NCT01609556|529124081|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146714104|NCT01609556|529124082|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
146714105|NCT01609556|529124083|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146714106|NCT01609556|529124084|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146714107|NCT01609556|529124085|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146714108|NCT01609556|529124086|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146714109|NCT01609556|529124087|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146714110|NCT01609556|529124072|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146780368|NCT04838613|529366197|FG001|Overall Study|Technical Problems|5|||
146780369|NCT04838613|529366196|FG000|Overall Study|Physician Decision|2|||
146780370|NCT04838613|529366197|FG001|Overall Study|Physician Decision|0|||
146780371|NCT04970654|529366198|FG000|Overall Study|Withdrawal by parents/guardian|1|||
146780372|NCT04970654|529366199|FG001|Overall Study|Withdrawal by parents/guardian|2|||
146780373|NCT04970654|529366198|FG000|Overall Study|Unclassified|2|||
146780374|NCT04970654|529366199|FG001|Overall Study|Unclassified|1|||
146780375|NCT04970654|529366198|FG000|Overall Study|Lost to Follow-up|1|||
146780376|NCT04970654|529366199|FG001|Overall Study|Lost to Follow-up|0|||
146780377|NCT02137850|529366200|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
146780378|NCT02137850|529366201|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
146780379|NCT02137850|529366202|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
146780380|NCT02137850|529366200|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
146780381|NCT02137850|529366201|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
146780382|NCT02137850|529366202|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
146780383|NCT02137850|529366200|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
146780384|NCT02137850|529366201|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
146780385|NCT02137850|529366202|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
146780386|NCT02137850|529366200|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
146780387|NCT02137850|529366201|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
146780388|NCT02137850|529366202|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
146780389|NCT02137850|529366200|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
146780390|NCT02137850|529366201|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
146780391|NCT02137850|529366202|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
146780392|NCT02137850|529366200|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
146780393|NCT02137850|529366201|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
146780394|NCT02137850|529366202|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
146780395|NCT02137850|529366200|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
146780396|NCT02137850|529366201|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
146780397|NCT02137850|529366202|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
146780398|NCT02137850|529366200|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
146780399|NCT02137850|529366201|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
146780400|NCT02137850|529366202|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
146780401|NCT02137850|529366200|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
146780402|NCT02137850|529366201|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
146780403|NCT02137850|529366202|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
146780404|NCT02137850|529366200|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
146780405|NCT02137850|529366201|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
146780406|NCT02137850|529366202|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
146780407|NCT02137850|529366200|FG000|Main Phase: Prophylaxis|Other|0|||
146780408|NCT02137850|529366201|FG001|Main Phase: Prophylaxis|Other|1|||
146780409|NCT02137850|529366202|FG002|Main Phase: Prophylaxis|Other|0|||
146780410|NCT02137850|529366200|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
146780411|NCT02137850|529366201|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
146780412|NCT02137850|529366202|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
146780413|NCT02137850|529366200|FG000|Main Phase: Prophylaxis|Early site closure|0|||
146780414|NCT02137850|529366201|FG001|Main Phase: Prophylaxis|Early site closure|2|||
146780415|NCT02137850|529366202|FG002|Main Phase: Prophylaxis|Early site closure|0|||
146780416|NCT02137850|529366200|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
146714111|NCT01609556|529124073|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146714112|NCT01609556|529124074|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146714113|NCT01609556|529124075|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146714114|NCT01609556|529124076|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146714115|NCT01609556|529124077|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146714116|NCT01609556|529124078|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146714117|NCT01609556|529124079|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146714118|NCT01609556|529124080|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146714119|NCT01609556|529124081|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146714120|NCT01609556|529124082|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146714121|NCT01609556|529124083|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146714122|NCT01609556|529124084|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
146714123|NCT01609556|529124085|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
146714124|NCT01609556|529124086|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
146714125|NCT01609556|529124087|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
146714126|NCT01609556|529124072|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146714127|NCT01609556|529124073|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146714128|NCT01609556|529124074|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146714129|NCT01609556|529124075|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146714130|NCT01609556|529124076|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146714131|NCT01609556|529124077|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146780417|NCT02137850|529366201|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
146780418|NCT02137850|529366202|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
146780419|NCT02137850|529366200|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
146780420|NCT02137850|529366201|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
146933998|NCT00764478|529916042|FG001|Overall Study|Lost to Follow-up|8|||
146714132|NCT01609556|529124078|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146714133|NCT01609556|529124079|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146714134|NCT01609556|529124080|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146714135|NCT01609556|529124081|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146714136|NCT01609556|529124082|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146714137|NCT01609556|529124083|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146714138|NCT01609556|529124084|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
146714139|NCT01609556|529124085|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
146714140|NCT01609556|529124086|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
146714141|NCT01609556|529124087|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
146714142|NCT01609556|529124072|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146714143|NCT01609556|529124073|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146714144|NCT01609556|529124074|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146714145|NCT01609556|529124075|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146714146|NCT01609556|529124076|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146714147|NCT01609556|529124077|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146714148|NCT01609556|529124078|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146714149|NCT01609556|529124079|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146714150|NCT01609556|529124080|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146714151|NCT01609556|529124081|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146714152|NCT01609556|529124082|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146714153|NCT01609556|529124083|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146714154|NCT01609556|529124084|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
146714155|NCT01609556|529124085|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
146714156|NCT01609556|529124086|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
146714157|NCT01609556|529124087|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
146714158|NCT01609556|529124072|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146714159|NCT01609556|529124073|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146714160|NCT01609556|529124074|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146714161|NCT01609556|529124075|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146714162|NCT01609556|529124076|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146714163|NCT01609556|529124077|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146714164|NCT01609556|529124078|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146714165|NCT01609556|529124079|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146714166|NCT01609556|529124080|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146714167|NCT01609556|529124081|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146714168|NCT01609556|529124082|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146714169|NCT01609556|529124083|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146714170|NCT01609556|529124084|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
146714171|NCT01609556|529124085|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146714172|NCT01609556|529124086|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146714173|NCT01609556|529124087|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146714174|NCT01609556|529124072|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146714175|NCT01609556|529124073|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146714176|NCT01609556|529124074|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146714177|NCT01609556|529124075|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146714178|NCT01609556|529124076|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146714179|NCT01609556|529124077|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146714180|NCT01609556|529124078|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146714181|NCT01609556|529124079|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146714182|NCT01609556|529124080|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146714183|NCT01609556|529124081|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146714184|NCT01609556|529124082|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146714185|NCT01609556|529124083|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146714186|NCT01609556|529124084|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
146714187|NCT01609556|529124085|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
146714188|NCT01609556|529124086|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
146714189|NCT01609556|529124087|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
146714190|NCT01609556|529124072|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146714191|NCT01609556|529124073|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146714192|NCT01609556|529124074|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146714193|NCT01609556|529124075|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146714194|NCT01609556|529124076|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146714195|NCT01609556|529124077|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146714196|NCT01609556|529124078|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146714197|NCT01609556|529124079|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146933999|NCT00764478|529916043|FG002|Overall Study|Lost to Follow-up|5|||
146714198|NCT01609556|529124080|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146714199|NCT01609556|529124081|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146714200|NCT01609556|529124082|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146714201|NCT01609556|529124083|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146714202|NCT01609556|529124084|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146714203|NCT01609556|529124085|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146714204|NCT01609556|529124086|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146714205|NCT01609556|529124087|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
146714206|NCT01609556|529124072|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
146714207|NCT01609556|529124073|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
146714208|NCT01609556|529124074|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
146714209|NCT01609556|529124075|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
146714210|NCT01609556|529124076|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
146714211|NCT01609556|529124077|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
146714212|NCT01609556|529124078|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
146714213|NCT01609556|529124079|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
146714214|NCT01609556|529124080|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
146714215|NCT01609556|529124081|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
146714216|NCT01609556|529124082|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
146714217|NCT01609556|529124083|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
146714218|NCT01609556|529124084|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
146714219|NCT01609556|529124085|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
146714220|NCT01609556|529124086|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
146714221|NCT01609556|529124087|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
146714222|NCT01609556|529124072|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146714223|NCT01609556|529124073|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146714224|NCT01609556|529124074|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146714225|NCT01609556|529124075|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146714226|NCT01609556|529124076|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146714227|NCT01609556|529124077|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146714228|NCT01609556|529124078|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146714229|NCT01609556|529124079|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146714230|NCT01609556|529124080|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146714231|NCT01609556|529124081|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146714232|NCT01609556|529124082|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146714233|NCT01609556|529124083|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146714234|NCT01609556|529124084|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
146714235|NCT01609556|529124085|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146714236|NCT01609556|529124086|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146714237|NCT01609556|529124087|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146714238|NCT04452344|529124088|FG000|Overall Study|Withdrawal by Subject|3|||
146714239|NCT04452344|529124089|FG001|Overall Study|Withdrawal by Subject|6|||
146714240|NCT04452344|529124088|FG000|Overall Study|Adverse Event|1|||
146714241|NCT04452344|529124089|FG001|Overall Study|Adverse Event|2|||
146714242|NCT04452344|529124088|FG000|Overall Study|Lost to Follow-up|2|||
146714243|NCT04452344|529124089|FG001|Overall Study|Lost to Follow-up|2|||
146714244|NCT04452344|529124088|FG000|Overall Study|No Post-Op Visit|6|||
146714245|NCT04452344|529124089|FG001|Overall Study|No Post-Op Visit|7|||
146714246|NCT02788175|529124093|FG000|Overall Study|Protocol Violation|3|||
146714247|NCT02788175|529124093|FG000|Overall Study|Withdrawal by Subject|4|||
146714248|NCT02788175|529124093|FG000|Overall Study|Ineligible prior to study agent|6|||
146714249|NCT00162136|529124094|FG000|Overall Study|Adverse Event|1|||
146714250|NCT00162136|529124094|FG000|Overall Study|Death|1|||
146714251|NCT00162136|529124094|FG000|Overall Study|Disease Progression/Relapse|23|||
146714252|NCT00162136|529124094|FG000|Overall Study|Investigator Request|5|||
146714253|NCT00162136|529124094|FG000|Overall Study|Study Drug Toxicity|4|||
146714254|NCT00162136|529124094|FG000|Overall Study|Withdrawal by Subject|1|||
146714255|NCT01968434|529124099|FG000|Overall Study|Lost to Follow-up|3|||
146714256|NCT01968434|529124100|FG001|Overall Study|Lost to Follow-up|6|||
146714257|NCT00262834|529125884|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
146714258|NCT00262834|529125885|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
146714259|NCT00844194|529125886|FG000|Overall Study|Adverse Event|17|||
146714260|NCT00844194|529125887|FG001|Overall Study|Adverse Event|5|||
146714261|NCT00844194|529125886|FG000|Overall Study|Protocol Violation|1|||
146714262|NCT00844194|529125887|FG001|Overall Study|Protocol Violation|1|||
146714263|NCT00844194|529125886|FG000|Overall Study|Lost to Follow-up|1|||
146714264|NCT00844194|529125887|FG001|Overall Study|Lost to Follow-up|1|||
146714265|NCT00844194|529125886|FG000|Overall Study|Withdrawal by Subject|2|||
146714266|NCT00844194|529125887|FG001|Overall Study|Withdrawal by Subject|1|||
146714267|NCT00844194|529125886|FG000|Overall Study|Lack of Efficacy|3|||
146714268|NCT00844194|529125887|FG001|Overall Study|Lack of Efficacy|0|||
146714269|NCT00844194|529125886|FG000|Overall Study|Other reason (not specified)|1|||
146714270|NCT00844194|529125887|FG001|Overall Study|Other reason (not specified)|0|||
146714271|NCT00736996|529125896|FG000|Overall Study|Lost to Follow-up|1|||
146714272|NCT00736996|529125897|FG001|Overall Study|Lost to Follow-up|9|||
146714273|NCT00736996|529125898|FG002|Overall Study|Lost to Follow-up|2|||
146714274|NCT02667912|529125899|FG000|Overall Study|Death|3|||
146714275|NCT02667912|529125900|FG001|Overall Study|Death|1|||
146714276|NCT02667912|529125899|FG000|Overall Study|Withdrawal by Subject|1|||
146714277|NCT02667912|529125900|FG001|Overall Study|Withdrawal by Subject|2|||
146714278|NCT02667912|529125899|FG000|Overall Study|Withdrawal by Subject|1|||
146714279|NCT02667912|529125900|FG001|Overall Study|Withdrawal by Subject|0|||
146714280|NCT01751568|529125905|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
146714281|NCT01751568|529125906|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
146714282|NCT01751568|529125907|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
146714283|NCT00797667|529125908|FG000|Overall Study|Lack of Efficacy|0|||
146714284|NCT00797667|529125909|FG001|Overall Study|Lack of Efficacy|1|||
146714285|NCT00797667|529125910|FG002|Overall Study|Lack of Efficacy|0|||
146714286|NCT00797667|529125908|FG000|Overall Study|Lost to Follow-up|8|||
146714287|NCT00797667|529125909|FG001|Overall Study|Lost to Follow-up|12|||
146714288|NCT00797667|529125910|FG002|Overall Study|Lost to Follow-up|2|||
146714289|NCT00797667|529125908|FG000|Overall Study|Physician Decision|3|||
146714290|NCT00797667|529125909|FG001|Overall Study|Physician Decision|1|||
146714291|NCT00797667|529125910|FG002|Overall Study|Physician Decision|0|||
146714292|NCT00797667|529125908|FG000|Overall Study|Pregnancy|2|||
146714293|NCT00797667|529125909|FG001|Overall Study|Pregnancy|0|||
146714294|NCT00797667|529125910|FG002|Overall Study|Pregnancy|0|||
146714295|NCT00797667|529125908|FG000|Overall Study|Protocol Violation|2|||
146714296|NCT00797667|529125909|FG001|Overall Study|Protocol Violation|7|||
146714297|NCT00797667|529125910|FG002|Overall Study|Protocol Violation|0|||
146714298|NCT00797667|529125908|FG000|Overall Study|Study Terminated by Sponsor|217|||
146714299|NCT00797667|529125909|FG001|Overall Study|Study Terminated by Sponsor|216|||
146714300|NCT00797667|529125910|FG002|Overall Study|Study Terminated by Sponsor|115|||
146714301|NCT00797667|529125908|FG000|Overall Study|Withdrawal by Subject|9|||
146714302|NCT00797667|529125909|FG001|Overall Study|Withdrawal by Subject|14|||
146714303|NCT00797667|529125910|FG002|Overall Study|Withdrawal by Subject|2|||
146714304|NCT00797667|529125908|FG000|Overall Study|Adverse Event|19|||
146714305|NCT00797667|529125909|FG001|Overall Study|Adverse Event|8|||
146714306|NCT00797667|529125910|FG002|Overall Study|Adverse Event|8|||
146714307|NCT02673697|529125913|FG000|Overall Study|Adverse Event|2|||
146714308|NCT02673697|529125914|FG001|Overall Study|Adverse Event|0|||
146714309|NCT02673697|529125913|FG000|Overall Study|Death|32|||
146714310|NCT02673697|529125914|FG001|Overall Study|Death|24|||
146714311|NCT02673697|529125913|FG000|Overall Study|Lost to Follow-up|5|||
146714312|NCT02673697|529125914|FG001|Overall Study|Lost to Follow-up|2|||
146714313|NCT02673697|529125913|FG000|Overall Study|Physician Decision|2|||
146714314|NCT02673697|529125914|FG001|Overall Study|Physician Decision|1|||
146714315|NCT02673697|529125913|FG000|Overall Study|Withdrawal by Subject|10|||
146714316|NCT02673697|529125914|FG001|Overall Study|Withdrawal by Subject|7|||
146714317|NCT02673697|529125913|FG000|Overall Study|Change subj medical status|1|||
146714318|NCT02673697|529125914|FG001|Overall Study|Change subj medical status|2|||
146714319|NCT02673697|529125913|FG000|Overall Study|Explant|10|||
146714320|NCT02673697|529125914|FG001|Overall Study|Explant|5|||
146714321|NCT02673697|529125913|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
146714322|NCT02673697|529125914|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
146714323|NCT00437489|529125915|FG000|Overall Study|Study terminated by sponsor|23|||
146714324|NCT00437489|529125916|FG001|Overall Study|Study terminated by sponsor|21|||
146714325|NCT00437489|529125915|FG000|Overall Study|Lost to Follow-up|0|||
146714326|NCT00437489|529125916|FG001|Overall Study|Lost to Follow-up|1|||
146714327|NCT00022516|529125925|FG000|Overall Study|Adverse Event|0|||
146714328|NCT00022516|529125926|FG001|Overall Study|Adverse Event|59|||
146714329|NCT00022516|529125925|FG000|Overall Study|Lack of Efficacy|0|||
146714330|NCT00022516|529125926|FG001|Overall Study|Lack of Efficacy|27|||
146714331|NCT00022516|529125925|FG000|Overall Study|Physician Decision|0|||
146714332|NCT00022516|529125926|FG001|Overall Study|Physician Decision|1|||
146714333|NCT00022516|529125925|FG000|Overall Study|Protocol Violation|1|||
146934000|NCT00764478|529916041|FG000|Overall Study|Protocol Violation|0|||
146714334|NCT00022516|529125926|FG001|Overall Study|Protocol Violation|3|||
146714335|NCT00022516|529125925|FG000|Overall Study|Withdrawal by Subject|2|||
146714336|NCT00022516|529125926|FG001|Overall Study|Withdrawal by Subject|113|||
146934001|NCT00764478|529916042|FG001|Overall Study|Protocol Violation|1|||
146934002|NCT00764478|529916043|FG002|Overall Study|Protocol Violation|1|||
146934003|NCT03498287|529916046|FG000|Overall Study|Withdrawal by Subject|3|||
146714337|NCT00022516|529125925|FG000|Overall Study|Incomplete documentation|0|||
146714338|NCT00022516|529125926|FG001|Overall Study|Incomplete documentation|27|||
146714339|NCT03321019|529125928|FG000|Overall Study|Withdrawal by Subject|0|||
146714340|NCT03321019|529125929|FG001|Overall Study|Withdrawal by Subject|6|||
146714341|NCT03321019|529125928|FG000|Overall Study|Lost to Follow-up|0|||
146714342|NCT03321019|529125929|FG001|Overall Study|Lost to Follow-up|22|||
146934004|NCT03498287|529916047|FG001|Overall Study|Withdrawal by Subject|0|||
146780421|NCT02137850|529366202|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
146780422|NCT02137850|529366200|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
146780423|NCT02137850|529366201|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
146780424|NCT02137850|529366202|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
146780425|NCT02137850|529366200|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
146780426|NCT02137850|529366201|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
146780427|NCT02137850|529366202|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
146780428|NCT02137850|529366200|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
146780429|NCT02137850|529366201|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
146780430|NCT02137850|529366202|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
146780431|NCT02137850|529366200|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
146780432|NCT02137850|529366201|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
146780433|NCT02137850|529366202|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
146780434|NCT02137850|529366200|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
146780435|NCT02137850|529366201|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
146780436|NCT02137850|529366202|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
146780437|NCT02137850|529366200|FG000|Extension Phase: Prophylaxis|Other|0|||
146780438|NCT02137850|529366201|FG001|Extension Phase: Prophylaxis|Other|1|||
146780439|NCT02137850|529366202|FG002|Extension Phase: Prophylaxis|Other|0|||
146780440|NCT02137850|529366200|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
146780441|NCT02137850|529366201|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
146780442|NCT02137850|529366202|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
146780443|NCT00136435|529366203|FG000|Overall Study|Ineligible|8|||
146780444|NCT00136435|529366203|FG000|Overall Study|Induction Death|1|||
146780445|NCT00136435|529366203|FG000|Overall Study|Induction Failure|10|||
146780446|NCT00136435|529366203|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
146780447|NCT00136435|529366203|FG000|Overall Study|Withdrawal by Subject|3|||
146780448|NCT00136435|529366203|FG000|Overall Study|Adverse Event|19|||
146780449|NCT00136435|529366203|FG000|Overall Study|Relapse|4|||
146780450|NCT00136435|529366203|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
146780451|NCT02794480|529366204|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
146780452|NCT02794480|529366205|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
146780453|NCT02794480|529366206|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
146780454|NCT02794480|529366207|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
146780455|NCT02794480|529366204|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
146780456|NCT02794480|529366205|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
146780457|NCT02794480|529366206|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
146780458|NCT02794480|529366207|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
146780459|NCT02794480|529366204|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146780460|NCT02794480|529366205|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146780461|NCT02794480|529366206|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146780462|NCT02794480|529366207|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
146780463|NCT02794480|529366204|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146780464|NCT02794480|529366205|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
146780465|NCT02794480|529366206|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146780466|NCT02794480|529366207|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
146780467|NCT02794480|529366204|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
146780468|NCT02794480|529366205|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146780469|NCT02794480|529366206|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146780470|NCT02794480|529366207|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
146780471|NCT00901901|529366208|FG000|Treatment Period|Adverse Event|120|||
146780472|NCT00901901|529366209|FG001|Treatment Period|Adverse Event|128|||
146780473|NCT00901901|529366208|FG000|Treatment Period|Withdrawal by Subject|26|||
146934005|NCT03498287|529916046|FG000|Overall Study|Protocol Violation|0|||
146934006|NCT03498287|529916047|FG001|Overall Study|Protocol Violation|4|||
146714343|NCT04934670|529125930|FG000|Overall Study|Death|4|||
146714344|NCT04934670|529125931|FG001|Overall Study|Death|0|||
146714345|NCT04934670|529125930|FG000|Overall Study|Lost to Follow-up|1|||
146714346|NCT04934670|529125931|FG001|Overall Study|Lost to Follow-up|4|||
146714347|NCT03067441|529125934|FG000|Overall Study|Withdrawal by Subject|16|||
146714348|NCT03067441|529125935|FG001|Overall Study|Withdrawal by Subject|34|||
146714349|NCT03067441|529125934|FG000|Overall Study|Lost to Follow-up|7|||
146714350|NCT03067441|529125935|FG001|Overall Study|Lost to Follow-up|5|||
146714351|NCT03067441|529125934|FG000|Overall Study|Adverse Event|7|||
146780474|NCT00901901|529366209|FG001|Treatment Period|Withdrawal by Subject|24|||
146780475|NCT00901901|529366208|FG000|Treatment Period|Physician Decision|2|||
146780476|NCT00901901|529366209|FG001|Treatment Period|Physician Decision|2|||
146780477|NCT00901901|529366208|FG000|Treatment Period|Lost to Follow-up|3|||
146934007|NCT03498287|529916046|FG000|Overall Study|Adverse Event|0|||
146934008|NCT03498287|529916047|FG001|Overall Study|Adverse Event|1|||
146714352|NCT03067441|529125935|FG001|Overall Study|Adverse Event|14|||
146780478|NCT00901901|529366209|FG001|Treatment Period|Lost to Follow-up|5|||
146780479|NCT00901901|529366208|FG000|Treatment Period|Noncompliance with study medication|4|||
146780480|NCT00901901|529366209|FG001|Treatment Period|Noncompliance with study medication|1|||
146780481|NCT00901901|529366208|FG000|Treatment Period|Missing|1|||
146780482|NCT00901901|529366209|FG001|Treatment Period|Missing|0|||
146780483|NCT00901901|529366208|FG000|Treatment Period|Never treated|0|||
146780484|NCT00901901|529366209|FG001|Treatment Period|Never treated|3|||
146780485|NCT00901901|529366208|FG000|Treatment Period|Protocol driven decision point|0|||
146780486|NCT00901901|529366209|FG001|Treatment Period|Protocol driven decision point|2|||
146780487|NCT00901901|529366208|FG000|Treatment Period|Study terminated by sponsor|2|||
146780488|NCT00901901|529366209|FG001|Treatment Period|Study terminated by sponsor|0|||
146780489|NCT00901901|529366208|FG000|Treatment Period|Protocol Violation|5|||
146780490|NCT00901901|529366209|FG001|Treatment Period|Protocol Violation|9|||
146780491|NCT00901901|529366208|FG000|Treatment Period|Switch to commercial drug|1|||
146780492|NCT00901901|529366209|FG001|Treatment Period|Switch to commercial drug|1|||
146780493|NCT00901901|529366208|FG000|Treatment Period|Transfer to treatment continuation study|5|||
146780494|NCT00901901|529366209|FG001|Treatment Period|Transfer to treatment continuation study|2|||
146780495|NCT00901901|529366208|FG000|Follow-up Period|Death|181|||
146780496|NCT00901901|529366209|FG001|Follow-up Period|Death|208|||
146780497|NCT00901901|529366208|FG000|Follow-up Period|Protocol driven decision point|47|||
146780498|NCT00901901|529366209|FG001|Follow-up Period|Protocol driven decision point|36|||
146780499|NCT00901901|529366208|FG000|Follow-up Period|Withdrawal by Subject|6|||
146780500|NCT00901901|529366209|FG001|Follow-up Period|Withdrawal by Subject|9|||
146780501|NCT00901901|529366208|FG000|Follow-up Period|Lost to Follow-up|12|||
146780502|NCT00901901|529366209|FG001|Follow-up Period|Lost to Follow-up|8|||
146780503|NCT00901901|529366208|FG000|Follow-up Period|Missing|94|||
146780504|NCT00901901|529366209|FG001|Follow-up Period|Missing|80|||
146780505|NCT00632749|529366212|FG000|Overall Study|Progressive disease|3|||
146780506|NCT00632749|529366213|FG001|Overall Study|Progressive disease|2|||
146780507|NCT00632749|529366214|FG002|Overall Study|Progressive disease|2|||
146780508|NCT00632749|529366215|FG003|Overall Study|Progressive disease|2|||
146780509|NCT00632749|529366216|FG004|Overall Study|Progressive disease|4|||
146780510|NCT00632749|529366217|FG005|Overall Study|Progressive disease|4|||
146780511|NCT00632749|529366218|FG006|Overall Study|Progressive disease|3|||
146780512|NCT00632749|529366219|FG007|Overall Study|Progressive disease|2|||
146780513|NCT00632749|529366220|FG008|Overall Study|Progressive disease|3|||
146780514|NCT00632749|529366221|FG009|Overall Study|Progressive disease|2|||
146780515|NCT00632749|529366222|FG010|Overall Study|Progressive disease|4|||
146780516|NCT00632749|529366223|FG011|Overall Study|Progressive disease|3|||
146780517|NCT00632749|529366224|FG012|Overall Study|Progressive disease|2|||
146780518|NCT00632749|529366225|FG013|Overall Study|Progressive disease|4|||
146780519|NCT00632749|529366212|FG000|Overall Study|Other Adverse event|1|||
146780520|NCT00632749|529366213|FG001|Overall Study|Other Adverse event|1|||
146780521|NCT00632749|529366214|FG002|Overall Study|Other Adverse event|1|||
146780522|NCT00632749|529366215|FG003|Overall Study|Other Adverse event|1|||
146780523|NCT00632749|529366216|FG004|Overall Study|Other Adverse event|2|||
146780524|NCT00632749|529366217|FG005|Overall Study|Other Adverse event|4|||
146780525|NCT00632749|529366218|FG006|Overall Study|Other Adverse event|1|||
146780526|NCT00632749|529366219|FG007|Overall Study|Other Adverse event|2|||
146780527|NCT00632749|529366220|FG008|Overall Study|Other Adverse event|2|||
146780528|NCT00632749|529366221|FG009|Overall Study|Other Adverse event|0|||
146780529|NCT00632749|529366222|FG010|Overall Study|Other Adverse event|1|||
146780530|NCT00632749|529366223|FG011|Overall Study|Other Adverse event|0|||
146780531|NCT00632749|529366224|FG012|Overall Study|Other Adverse event|1|||
146780532|NCT00632749|529366225|FG013|Overall Study|Other Adverse event|0|||
146780533|NCT00632749|529366212|FG000|Overall Study|Refuse to continue medication|0|||
146780534|NCT00632749|529366213|FG001|Overall Study|Refuse to continue medication|0|||
146780535|NCT00632749|529366214|FG002|Overall Study|Refuse to continue medication|0|||
146780536|NCT00632749|529366215|FG003|Overall Study|Refuse to continue medication|1|||
146780537|NCT00632749|529366216|FG004|Overall Study|Refuse to continue medication|0|||
146780538|NCT00632749|529366217|FG005|Overall Study|Refuse to continue medication|0|||
146780539|NCT00632749|529366218|FG006|Overall Study|Refuse to continue medication|0|||
146780540|NCT00632749|529366219|FG007|Overall Study|Refuse to continue medication|0|||
146780541|NCT00632749|529366220|FG008|Overall Study|Refuse to continue medication|0|||
146780542|NCT00632749|529366221|FG009|Overall Study|Refuse to continue medication|1|||
146780543|NCT00632749|529366222|FG010|Overall Study|Refuse to continue medication|0|||
146780544|NCT00632749|529366223|FG011|Overall Study|Refuse to continue medication|0|||
146780545|NCT00632749|529366224|FG012|Overall Study|Refuse to continue medication|0|||
146780546|NCT00632749|529366225|FG013|Overall Study|Refuse to continue medication|0|||
146780547|NCT00632749|529366212|FG000|Overall Study|Reason other than those specified above|0|||
146780548|NCT00632749|529366213|FG001|Overall Study|Reason other than those specified above|2|||
146780549|NCT00632749|529366214|FG002|Overall Study|Reason other than those specified above|0|||
146780550|NCT00632749|529366215|FG003|Overall Study|Reason other than those specified above|0|||
146780551|NCT00632749|529366216|FG004|Overall Study|Reason other than those specified above|1|||
146981174|NCT00901628|530093780|FG000|Overall Study|disconnection of catheter|4|||
146714353|NCT03067441|529125934|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
146714354|NCT03067441|529125935|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
146714355|NCT03067441|529125934|FG000|Overall Study|Physician Decision|1|||
146714356|NCT03067441|529125935|FG001|Overall Study|Physician Decision|3|||
146714357|NCT03067441|529125934|FG000|Overall Study|Other|1|||
146714358|NCT03067441|529125935|FG001|Overall Study|Other|1|||
146714359|NCT01592708|529125936|FG000|Overall Study|Protocol Violation|3|||
146714360|NCT01592708|529125937|FG001|Overall Study|Protocol Violation|0|||
146714361|NCT03433456|529125940|FG000|Overall Study|Death|1|||
146714362|NCT03433456|529125941|FG001|Overall Study|Death|1|||
146714363|NCT03433456|529125940|FG000|Overall Study|Lost to Follow-up|14|||
146714364|NCT03433456|529125941|FG001|Overall Study|Lost to Follow-up|11|||
146714365|NCT03433456|529125940|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
146714366|NCT03433456|529125941|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
146714367|NCT01198600|529125946|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
146714368|NCT01198600|529125947|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
146714369|NCT01198600|529125948|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
146714370|NCT01198600|529125949|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
146714371|NCT01198600|529125946|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
146714372|NCT01198600|529125947|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
146714373|NCT01198600|529125948|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
146714374|NCT01198600|529125949|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
146714375|NCT01198600|529125946|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
146714376|NCT01198600|529125947|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
146714377|NCT01198600|529125948|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
146714378|NCT01198600|529125949|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
146714379|NCT01198600|529125946|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
146714380|NCT01198600|529125947|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
146714381|NCT01198600|529125948|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
146714382|NCT01198600|529125949|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
146714383|NCT01198600|529125946|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
146714384|NCT01198600|529125947|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
146714385|NCT01198600|529125948|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
146714386|NCT01198600|529125949|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
146714387|NCT01198600|529125946|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
146714388|NCT01198600|529125947|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
146714389|NCT01198600|529125948|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
146714390|NCT01198600|529125949|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
146714391|NCT01198600|529125946|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
146714392|NCT01198600|529125947|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
146714393|NCT01198600|529125948|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
146714394|NCT01198600|529125949|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
146714395|NCT04177108|529125950|FG000|Overall Study|Withdrawal by Subject|4|||
146714396|NCT04177108|529125951|FG001|Overall Study|Withdrawal by Subject|8|||
146714397|NCT04177108|529125952|FG002|Overall Study|Withdrawal by Subject|9|||
146714398|NCT04177108|529125953|FG003|Overall Study|Withdrawal by Subject|11|||
146714399|NCT04177108|529125954|FG004|Overall Study|Withdrawal by Subject|13|||
146714400|NCT04177108|529125950|FG000|Overall Study|Physician Decision|23|||
146714401|NCT04177108|529125951|FG001|Overall Study|Physician Decision|15|||
146714402|NCT04177108|529125952|FG002|Overall Study|Physician Decision|18|||
146714403|NCT04177108|529125953|FG003|Overall Study|Physician Decision|29|||
146714404|NCT04177108|529125954|FG004|Overall Study|Physician Decision|23|||
146714405|NCT04177108|529125950|FG000|Overall Study|Reason Not Specified|0|||
146714406|NCT04177108|529125951|FG001|Overall Study|Reason Not Specified|1|||
146714407|NCT04177108|529125952|FG002|Overall Study|Reason Not Specified|0|||
146714408|NCT04177108|529125953|FG003|Overall Study|Reason Not Specified|0|||
146714409|NCT04177108|529125954|FG004|Overall Study|Reason Not Specified|2|||
146714410|NCT04177108|529125950|FG000|Overall Study|Lost to Follow-up|0|||
146714411|NCT04177108|529125951|FG001|Overall Study|Lost to Follow-up|0|||
146714412|NCT04177108|529125952|FG002|Overall Study|Lost to Follow-up|1|||
146714413|NCT04177108|529125953|FG003|Overall Study|Lost to Follow-up|1|||
146714414|NCT04177108|529125954|FG004|Overall Study|Lost to Follow-up|1|||
146714415|NCT04177108|529125950|FG000|Overall Study|Death|16|||
146714416|NCT04177108|529125951|FG001|Overall Study|Death|19|||
146714417|NCT04177108|529125952|FG002|Overall Study|Death|13|||
146714418|NCT04177108|529125953|FG003|Overall Study|Death|17|||
146714419|NCT04177108|529125954|FG004|Overall Study|Death|18|||
146714420|NCT01427712|529125955|FG000|Overall Study|Transfer to a different hospital|2|||
146714421|NCT01427712|529125955|FG000|Overall Study|Lost to Follow-up|1|||
146714422|NCT01427712|529125955|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
146714423|NCT01427712|529125955|FG000|Overall Study|Failure to visit|1|||
146714424|NCT00784043|529125956|FG000|Overall Study|Withdrawal by Subject|8|||
146714425|NCT00784043|529125957|FG001|Overall Study|Withdrawal by Subject|5|||
146934009|NCT01740388|529916048|FG000|Overall Study|Withdrawal by Subject|1|||
146934010|NCT01740388|529916049|FG001|Overall Study|Withdrawal by Subject|2|||
146934011|NCT01740388|529916048|FG000|Overall Study|Lost to Follow-up|2|||
146934012|NCT01740388|529916049|FG001|Overall Study|Lost to Follow-up|0|||
146934013|NCT01740388|529916048|FG000|Overall Study|Physician Decision|2|||
146934014|NCT01740388|529916049|FG001|Overall Study|Physician Decision|6|||
146934015|NCT01740388|529916048|FG000|Overall Study|Subjects missing data, completed|41|||
146934016|NCT01740388|529916049|FG001|Overall Study|Subjects missing data, completed|36|||
146934017|NCT04142216|529916050|FG000|Overall Study|Hospitalization|0|||
146981175|NCT00901628|530093781|FG001|Overall Study|disconnection of catheter|8|||
146714426|NCT00784043|529125956|FG000|Overall Study|Protocol Terminated|23|||
146714427|NCT00784043|529125957|FG001|Overall Study|Protocol Terminated|1|||
146714428|NCT01143259|529125958|FG000|Overall Study|Withdrawal by Subject|3|||
146714429|NCT01143259|529125959|FG001|Overall Study|Withdrawal by Subject|2|||
146714430|NCT01143259|529125958|FG000|Overall Study|Protocol Violation|13|||
146714431|NCT01143259|529125959|FG001|Overall Study|Protocol Violation|9|||
146714432|NCT01143259|529125958|FG000|Overall Study|Screen Failure|7|||
146714433|NCT01143259|529125959|FG001|Overall Study|Screen Failure|9|||
146714434|NCT00099983|529125960|FG000|Overall Study|Lost to Follow-up|2|||
146714435|NCT00099983|529125961|FG001|Overall Study|Lost to Follow-up|3|||
146714436|NCT00099983|529125960|FG000|Overall Study|Missing Source Documents|14|||
146714437|NCT00099983|529125961|FG001|Overall Study|Missing Source Documents|15|||
146714438|NCT00099983|529125960|FG000|Overall Study|Withdrawal by Subject|3|||
146714439|NCT00099983|529125961|FG001|Overall Study|Withdrawal by Subject|2|||
146714440|NCT00099983|529125960|FG000|Overall Study|Adverse Event|1|||
146714441|NCT00099983|529125961|FG001|Overall Study|Adverse Event|1|||
146714442|NCT00099983|529125960|FG000|Overall Study|Lack of Efficacy|0|||
146714443|NCT00099983|529125961|FG001|Overall Study|Lack of Efficacy|1|||
146714444|NCT00099983|529125960|FG000|Overall Study|Unable to return for appointments|1|||
146714445|NCT00099983|529125961|FG001|Overall Study|Unable to return for appointments|1|||
146714446|NCT00099983|529125960|FG000|Overall Study|Moved|1|||
146714447|NCT00099983|529125961|FG001|Overall Study|Moved|0|||
146714448|NCT00099983|529125960|FG000|Overall Study|Other psychiatric problem|1|||
146714449|NCT00099983|529125961|FG001|Overall Study|Other psychiatric problem|0|||
146714450|NCT00099983|529125960|FG000|Overall Study|Incarcerated|0|||
146714451|NCT00099983|529125961|FG001|Overall Study|Incarcerated|1|||
146714452|NCT00099983|529125960|FG000|Overall Study|Intolerant of burden of visits|0|||
146714453|NCT00099983|529125961|FG001|Overall Study|Intolerant of burden of visits|1|||
146714454|NCT00099983|529125960|FG000|Overall Study|Other issue|1|||
146714455|NCT00099983|529125961|FG001|Overall Study|Other issue|0|||
146714456|NCT02641080|529125962|FG000|Overall Study|Physician Decision|2|||
146714457|NCT02641080|529125963|FG001|Overall Study|Physician Decision|0|||
146714458|NCT02641080|529125962|FG000|Overall Study|Withdrawal by Subject|0|||
146714459|NCT02641080|529125963|FG001|Overall Study|Withdrawal by Subject|1|||
146714460|NCT02641080|529125962|FG000|Overall Study|Rehab Center denied use of pumps|0|||
146714461|NCT02641080|529125963|FG001|Overall Study|Rehab Center denied use of pumps|3|||
146714462|NCT02641080|529125962|FG000|Overall Study|Lost to Follow-up|0|||
146714463|NCT02641080|529125963|FG001|Overall Study|Lost to Follow-up|3|||
146714464|NCT00803634|529125964|FG000|Overall Study|Withdrew Consent|1|||
146714465|NCT00803634|529125965|FG001|Overall Study|Withdrew Consent|0|||
146714466|NCT00803634|529125964|FG000|Overall Study|Lost to Follow-up|2|||
146714467|NCT00803634|529125965|FG001|Overall Study|Lost to Follow-up|3|||
146714468|NCT00803634|529125964|FG000|Overall Study|Death|3|||
146714469|NCT00803634|529125965|FG001|Overall Study|Death|2|||
146714470|NCT04307186|529125966|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
146714471|NCT04307186|529125966|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
146714472|NCT04307186|529125966|FG000|Washout 3-14 Days|Progressive disease|1|||
146714473|NCT04307186|529125966|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
146714474|NCT04307186|529125966|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
146714475|NCT03835533|529125968|FG000|Overall Study|Death|5|||
146714476|NCT03835533|529125969|FG001|Overall Study|Death|10|||
146714477|NCT03835533|529125970|FG002|Overall Study|Death|9|||
146714478|NCT03835533|529125968|FG000|Overall Study|Withdrawal by Subject|2|||
146714479|NCT03835533|529125969|FG001|Overall Study|Withdrawal by Subject|2|||
146714480|NCT03835533|529125970|FG002|Overall Study|Withdrawal by Subject|2|||
146714481|NCT03835533|529125968|FG000|Overall Study|Lost to Follow-up|1|||
146714482|NCT03835533|529125969|FG001|Overall Study|Lost to Follow-up|0|||
146714483|NCT03835533|529125970|FG002|Overall Study|Lost to Follow-up|0|||
146714484|NCT03238001|529125971|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
146714485|NCT03238001|529125971|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
146714486|NCT03238001|529125971|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
146714487|NCT03238001|529125971|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
146714488|NCT03238001|529125971|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
146714489|NCT03238001|529125971|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
146934018|NCT04142216|529916051|FG001|Overall Study|Hospitalization|2|||
146934019|NCT04142216|529916050|FG000|Overall Study|Death|3|||
146934020|NCT04142216|529916051|FG001|Overall Study|Death|1|||
146981176|NCT00901628|530093780|FG000|Overall Study|disconnection of drain|0|||
146981177|NCT00901628|530093781|FG001|Overall Study|disconnection of drain|1|||
146981178|NCT00901628|530093780|FG000|Overall Study|peroneal nerve palsy|0|||
146981179|NCT00901628|530093781|FG001|Overall Study|peroneal nerve palsy|1|||
146981180|NCT00608205|530093784|FG000|Overall Study|Adverse Event|3|||
146981181|NCT00608205|530093785|FG001|Overall Study|Adverse Event|2|||
146714490|NCT03238001|529125971|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
146714491|NCT03238001|529125971|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
146714492|NCT03791398|529125975|FG000|Overall Study|Progression of Disease Under Study|2|||
146714493|NCT03791398|529125976|FG001|Overall Study|Progression of Disease Under Study|0|||
146714494|NCT03791398|529125977|FG002|Overall Study|Progression of Disease Under Study|0|||
146714495|NCT02207829|529125980|FG000|Overall Study|Adverse Event|10|||
146714496|NCT02207829|529125981|FG001|Overall Study|Adverse Event|9|||
146714497|NCT02207829|529125980|FG000|Overall Study|Lack of Efficacy|7|||
146714498|NCT02207829|529125981|FG001|Overall Study|Lack of Efficacy|5|||
146714499|NCT02207829|529125980|FG000|Overall Study|Lost to Follow-up|2|||
146714500|NCT02207829|529125981|FG001|Overall Study|Lost to Follow-up|2|||
146714501|NCT02207829|529125980|FG000|Overall Study|Protocol deviation|5|||
146714502|NCT02207829|529125981|FG001|Overall Study|Protocol deviation|4|||
146714503|NCT02207829|529125980|FG000|Overall Study|Withdrew consent|18|||
146714504|NCT02207829|529125981|FG001|Overall Study|Withdrew consent|14|||
146714505|NCT00766376|529125982|FG000|Overall Study|Withdrawal by Subject|27|||
146714506|NCT01418209|529125983|FG000|Overall Study|Withdrawal by Subject|1|||
146714507|NCT01418209|529125984|FG001|Overall Study|Withdrawal by Subject|0|||
146714508|NCT01418209|529125985|FG002|Overall Study|Withdrawal by Subject|1|||
146714509|NCT01418209|529125983|FG000|Overall Study|Did not provide hot flash diary data|1|||
146714510|NCT01418209|529125984|FG001|Overall Study|Did not provide hot flash diary data|3|||
146714511|NCT01418209|529125985|FG002|Overall Study|Did not provide hot flash diary data|3|||
146714512|NCT00101101|529125986|FG000|Overall Study|never received vaccine|20|||
146714513|NCT01800903|529125987|FG000|Second Test Period|unable to catheterise|1|||
146714514|NCT01800903|529125988|FG001|Second Test Period|unable to catheterise|0|||
146714515|NCT01800903|529125989|FG002|Second Test Period|unable to catheterise|0|||
146714516|NCT01800903|529125990|FG003|Second Test Period|unable to catheterise|0|||
146714517|NCT01800903|529125991|FG004|Second Test Period|unable to catheterise|0|||
146714518|NCT01800903|529125992|FG005|Second Test Period|unable to catheterise|0|||
146714519|NCT01110239|529125995|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
146714520|NCT01110239|529125996|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
146714521|NCT01110239|529125997|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
146714522|NCT01110239|529125998|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
146714523|NCT01110239|529125995|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
146714524|NCT01110239|529125996|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
146714525|NCT01110239|529125997|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
146714526|NCT01110239|529125998|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
146714527|NCT00080223|529125999|FG000|Overall Study|Adverse Event|23|||
146714528|NCT00080223|529125999|FG000|Overall Study|Death|21|||
146714529|NCT00080223|529125999|FG000|Overall Study|Withdrawal by Subject|13|||
146714530|NCT00080223|529125999|FG000|Overall Study|Lung Transplantation|9|||
146714531|NCT00080223|529125999|FG000|Overall Study|Non-compliance With Study Treatment|7|||
146714532|NCT00080223|529125999|FG000|Overall Study|Participant unwilling to continue|2|||
146714533|NCT00080223|529125999|FG000|Overall Study|Physician Decision|1|||
146714534|NCT03099382|529126006|FG000|Overall Study|Protocol Violation|2|||
146714535|NCT03099382|529126007|FG001|Overall Study|Protocol Violation|3|||
146714536|NCT01802411|529126008|FG000|Overall Study|Death|2|||
146714537|NCT01802411|529126009|FG001|Overall Study|Death|1|||
146714538|NCT01802411|529126008|FG000|Overall Study|Adverse Event|2|||
146714539|NCT01802411|529126009|FG001|Overall Study|Adverse Event|7|||
146714540|NCT01802411|529126008|FG000|Overall Study|Lack of Efficacy|8|||
146714541|NCT01802411|529126009|FG001|Overall Study|Lack of Efficacy|10|||
146714542|NCT01802411|529126008|FG000|Overall Study|Withdrawal by Subject|0|||
146714543|NCT01802411|529126009|FG001|Overall Study|Withdrawal by Subject|2|||
146714544|NCT01802411|529126008|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
146714545|NCT01802411|529126009|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
146714546|NCT01802411|529126008|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
146714547|NCT01802411|529126009|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
146714548|NCT01802411|529126008|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
146714549|NCT01802411|529126009|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
146714550|NCT03930745|529126010|FG000|Overall Study|Lost to Follow-up|10|||
146714551|NCT03930745|529126011|FG001|Overall Study|Lost to Follow-up|5|||
146714552|NCT03930745|529126010|FG000|Overall Study|Withdrawal by Subject|1|||
146714553|NCT03930745|529126011|FG001|Overall Study|Withdrawal by Subject|2|||
146714554|NCT03930745|529126010|FG000|Overall Study|Protocol Violation|2|||
146714555|NCT03930745|529126011|FG001|Overall Study|Protocol Violation|2|||
146714556|NCT03930745|529126010|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
146780552|NCT00632749|529366217|FG005|Overall Study|Reason other than those specified above|0|||
146981182|NCT00608205|530093784|FG000|Overall Study|Patient non-compliant|0|||
146780553|NCT00632749|529366218|FG006|Overall Study|Reason other than those specified above|1|||
146780554|NCT00632749|529366219|FG007|Overall Study|Reason other than those specified above|0|||
146981183|NCT00608205|530093785|FG001|Overall Study|Patient non-compliant|1|||
146981184|NCT01003886|530093786|FG000|Overall Study|Lack of Efficacy|5|||
146981185|NCT01003886|530093786|FG000|Overall Study|Lost to Follow-up|169|||
146981186|NCT01003886|530093786|FG000|Overall Study|Withdrawal by Subject|39|||
146981187|NCT01003886|530093786|FG000|Overall Study|Other|14|||
146981188|NCT01003886|530093786|FG000|Overall Study|Adverse Event|3|||
146981189|NCT01339910|530093808|FG000|Overall Study|Withdrawal by Subject|1|||
146981190|NCT01339910|530093809|FG001|Overall Study|Withdrawal by Subject|0|||
146981191|NCT01339910|530093808|FG000|Overall Study|Physician Decision|1|||
146981192|NCT01339910|530093809|FG001|Overall Study|Physician Decision|0|||
146981193|NCT01339910|530093808|FG000|Overall Study|Disease relapse|1|||
146981194|NCT01339910|530093809|FG001|Overall Study|Disease relapse|4|||
146981195|NCT02965820|530093811|FG000|Period 2, Second 30 Days|Adverse Event|1|||
146981196|NCT02965820|530093812|FG001|Period 2, Second 30 Days|Adverse Event|1|||
146981197|NCT01567306|530093813|FG000|Overall Study|Protocol Violation|2|||
146981198|NCT01567306|530093814|FG001|Overall Study|Protocol Violation|2|||
146981199|NCT01567306|530093815|FG002|Overall Study|Protocol Violation|0|||
146981200|NCT01567306|530093816|FG003|Overall Study|Protocol Violation|3|||
146714557|NCT03930745|529126011|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
146981201|NCT01567306|530093817|FG004|Overall Study|Protocol Violation|1|||
146981202|NCT01567306|530093818|FG005|Overall Study|Protocol Violation|1|||
146981203|NCT01567306|530093813|FG000|Overall Study|Change site living|1|||
146981204|NCT01567306|530093814|FG001|Overall Study|Change site living|0|||
146981205|NCT01567306|530093815|FG002|Overall Study|Change site living|0|||
146981206|NCT01567306|530093816|FG003|Overall Study|Change site living|0|||
146981207|NCT01567306|530093817|FG004|Overall Study|Change site living|0|||
146981208|NCT01567306|530093818|FG005|Overall Study|Change site living|0|||
146981209|NCT01567306|530093813|FG000|Overall Study|Adverse Event|0|||
146981210|NCT01567306|530093814|FG001|Overall Study|Adverse Event|0|||
146981211|NCT01567306|530093815|FG002|Overall Study|Adverse Event|0|||
146714558|NCT03930745|529126010|FG000|Overall Study|Adverse Event|0|||
146714559|NCT03930745|529126011|FG001|Overall Study|Adverse Event|1|||
146714560|NCT03930745|529126010|FG000|Overall Study|Pregnancy|0|||
146714561|NCT03930745|529126011|FG001|Overall Study|Pregnancy|1|||
146714562|NCT01337245|529126012|FG000|Overall Study|Lost to Follow-up|1|||
146714563|NCT04095858|529126015|FG000|Overall Study|Death|1|||
146714564|NCT04095858|529126016|FG001|Overall Study|Death|0|||
146714565|NCT04095858|529126015|FG000|Overall Study|Study terminated by Sponsor|2|||
146714566|NCT04095858|529126016|FG001|Overall Study|Study terminated by Sponsor|4|||
146714567|NCT01344460|529126017|FG000|Overall Study|Withdrawal by Subject|1|||
146714568|NCT01344460|529126017|FG000|Overall Study|Lost to Follow-up|2|||
146714569|NCT03285477|529126030|FG000|Treatment and Response Assessment Period|Death|1|||
146714570|NCT03285477|529126031|FG001|Treatment and Response Assessment Period|Death|0|||
146714571|NCT03285477|529126030|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
146714572|NCT03285477|529126031|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
146714573|NCT03285477|529126030|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
146714574|NCT03285477|529126031|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
146714575|NCT03285477|529126030|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
146714576|NCT03285477|529126031|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
146714577|NCT03285477|529126030|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
146714578|NCT03285477|529126031|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
146714579|NCT03483623|529126032|FG000|Overall Study|43 complete sets achieved|1|||
146714580|NCT00560833|529126033|FG000|Overall Study|Adverse Event|16|||
146714581|NCT00560833|529126034|FG001|Overall Study|Adverse Event|10|||
146714582|NCT00560833|529126035|FG002|Overall Study|Adverse Event|25|||
146714583|NCT00560833|529126036|FG003|Overall Study|Adverse Event|23|||
146714584|NCT00560833|529126037|FG004|Overall Study|Adverse Event|35|||
146714585|NCT00560833|529126033|FG000|Overall Study|Lost to Follow-up|0|||
146714586|NCT00560833|529126034|FG001|Overall Study|Lost to Follow-up|0|||
146714587|NCT00560833|529126035|FG002|Overall Study|Lost to Follow-up|1|||
146714588|NCT00560833|529126036|FG003|Overall Study|Lost to Follow-up|0|||
146714589|NCT00560833|529126037|FG004|Overall Study|Lost to Follow-up|0|||
146714590|NCT00560833|529126033|FG000|Overall Study|Lack of Efficacy|22|||
146714591|NCT00560833|529126034|FG001|Overall Study|Lack of Efficacy|9|||
146714592|NCT00560833|529126035|FG002|Overall Study|Lack of Efficacy|6|||
146714593|NCT00560833|529126036|FG003|Overall Study|Lack of Efficacy|4|||
146780555|NCT00632749|529366220|FG008|Overall Study|Reason other than those specified above|0|||
146981212|NCT01567306|530093816|FG003|Overall Study|Adverse Event|2|||
146981213|NCT01567306|530093817|FG004|Overall Study|Adverse Event|4|||
146981214|NCT01567306|530093818|FG005|Overall Study|Adverse Event|1|||
146981215|NCT01567306|530093813|FG000|Overall Study|Lost to Follow-up|0|||
146981216|NCT01567306|530093814|FG001|Overall Study|Lost to Follow-up|0|||
146981217|NCT01567306|530093815|FG002|Overall Study|Lost to Follow-up|0|||
146981218|NCT01567306|530093816|FG003|Overall Study|Lost to Follow-up|0|||
146981219|NCT01567306|530093817|FG004|Overall Study|Lost to Follow-up|2|||
146714594|NCT00560833|529126037|FG004|Overall Study|Lack of Efficacy|4|||
146714595|NCT00560833|529126033|FG000|Overall Study|Participant uncooperative|5|||
146714596|NCT00560833|529126034|FG001|Overall Study|Participant uncooperative|5|||
146714597|NCT00560833|529126035|FG002|Overall Study|Participant uncooperative|4|||
146714598|NCT00560833|529126036|FG003|Overall Study|Participant uncooperative|4|||
146714599|NCT00560833|529126037|FG004|Overall Study|Participant uncooperative|2|||
146714600|NCT00560833|529126033|FG000|Overall Study|Other|1|||
146714601|NCT00560833|529126034|FG001|Overall Study|Other|1|||
146714602|NCT00560833|529126035|FG002|Overall Study|Other|3|||
146714603|NCT00560833|529126036|FG003|Overall Study|Other|0|||
146714604|NCT00560833|529126037|FG004|Overall Study|Other|0|||
146714605|NCT00560833|529126033|FG000|Overall Study|Never received drug|0|||
146714606|NCT00560833|529126034|FG001|Overall Study|Never received drug|1|||
146714607|NCT00560833|529126035|FG002|Overall Study|Never received drug|0|||
146714608|NCT00560833|529126036|FG003|Overall Study|Never received drug|0|||
146714609|NCT00560833|529126037|FG004|Overall Study|Never received drug|1|||
146714610|NCT01059617|529126040|FG000|Overall Study|Other|7|||
146714611|NCT01059617|529126041|FG001|Overall Study|Other|1|||
146714612|NCT01059617|529126042|FG002|Overall Study|Other|8|||
146714613|NCT01059617|529126043|FG003|Overall Study|Other|6|||
146714614|NCT00852397|529126045|FG000|Overall Study|Adverse Event|4|||
146714615|NCT00852397|529126046|FG001|Overall Study|Adverse Event|6|||
146714616|NCT00852397|529126047|FG002|Overall Study|Adverse Event|4|||
146714617|NCT00852397|529126045|FG000|Overall Study|Death|0|||
146714618|NCT00852397|529126046|FG001|Overall Study|Death|0|||
146714619|NCT00852397|529126047|FG002|Overall Study|Death|1|||
146714620|NCT00852397|529126045|FG000|Overall Study|Withdrawal by Subject|4|||
146714621|NCT00852397|529126046|FG001|Overall Study|Withdrawal by Subject|1|||
146714622|NCT00852397|529126047|FG002|Overall Study|Withdrawal by Subject|2|||
146714623|NCT00852397|529126045|FG000|Overall Study|Study terminated by sponsor|2|||
146714624|NCT00852397|529126046|FG001|Overall Study|Study terminated by sponsor|1|||
146714625|NCT00852397|529126047|FG002|Overall Study|Study terminated by sponsor|6|||
146714626|NCT00852397|529126045|FG000|Overall Study|Difficulty in study site visit|1|||
146714627|NCT00852397|529126046|FG001|Overall Study|Difficulty in study site visit|0|||
146714628|NCT00852397|529126047|FG002|Overall Study|Difficulty in study site visit|0|||
146714629|NCT00852397|529126045|FG000|Overall Study|Protocol Violation|0|||
146714630|NCT00852397|529126046|FG001|Overall Study|Protocol Violation|0|||
146714631|NCT00852397|529126047|FG002|Overall Study|Protocol Violation|1|||
146714632|NCT03864614|529126053|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
146714633|NCT03864614|529126054|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
146714634|NCT03864614|529126055|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
146714635|NCT03864614|529126056|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
146714636|NCT03864614|529126053|FG000|Overall Study|Withdrawal by Subject|72|||
146714637|NCT03864614|529126054|FG001|Overall Study|Withdrawal by Subject|100|||
146714638|NCT03864614|529126055|FG002|Overall Study|Withdrawal by Subject|1|||
146714639|NCT03864614|529126056|FG003|Overall Study|Withdrawal by Subject|21|||
146714640|NCT03864614|529126053|FG000|Overall Study|Lost to Follow-up|45|||
146714641|NCT03864614|529126054|FG001|Overall Study|Lost to Follow-up|54|||
146714642|NCT03864614|529126055|FG002|Overall Study|Lost to Follow-up|0|||
146714643|NCT03864614|529126056|FG003|Overall Study|Lost to Follow-up|9|||
146714644|NCT03864614|529126053|FG000|Overall Study|Adverse Event|42|||
146714645|NCT03864614|529126054|FG001|Overall Study|Adverse Event|30|||
146714646|NCT03864614|529126055|FG002|Overall Study|Adverse Event|1|||
146714647|NCT03864614|529126056|FG003|Overall Study|Adverse Event|9|||
146714648|NCT03864614|529126053|FG000|Overall Study|Protocol Deviation|6|||
146714649|NCT03864614|529126054|FG001|Overall Study|Protocol Deviation|26|||
146714650|NCT03864614|529126055|FG002|Overall Study|Protocol Deviation|0|||
146714651|NCT03864614|529126056|FG003|Overall Study|Protocol Deviation|1|||
146714652|NCT03864614|529126053|FG000|Overall Study|Physician Decision|7|||
146714653|NCT03864614|529126054|FG001|Overall Study|Physician Decision|10|||
146714654|NCT03864614|529126055|FG002|Overall Study|Physician Decision|1|||
146714655|NCT03864614|529126056|FG003|Overall Study|Physician Decision|5|||
146714656|NCT03864614|529126053|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
146714657|NCT03864614|529126054|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
146714658|NCT03864614|529126055|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
146714659|NCT03864614|529126056|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
146714660|NCT03864614|529126053|FG000|Overall Study|Sponsor Decision|1|||
146714661|NCT03864614|529126054|FG001|Overall Study|Sponsor Decision|2|||
146714662|NCT03864614|529126055|FG002|Overall Study|Sponsor Decision|0|||
146714663|NCT03864614|529126056|FG003|Overall Study|Sponsor Decision|0|||
146714664|NCT03864614|529126053|FG000|Overall Study|Pregnancy|0|||
146714665|NCT03864614|529126054|FG001|Overall Study|Pregnancy|1|||
146714666|NCT03864614|529126055|FG002|Overall Study|Pregnancy|0|||
146714667|NCT03864614|529126056|FG003|Overall Study|Pregnancy|0|||
146714668|NCT03864614|529126053|FG000|Overall Study|Other|7|||
146714669|NCT03864614|529126054|FG001|Overall Study|Other|9|||
146714670|NCT03864614|529126055|FG002|Overall Study|Other|1|||
146714671|NCT03864614|529126056|FG003|Overall Study|Other|4|||
146714672|NCT03864614|529126053|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
146714673|NCT03864614|529126054|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
146714674|NCT03864614|529126055|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
146714675|NCT03864614|529126056|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
146714676|NCT00136955|529127720|FG000|Overall Study|Adverse Event|8|||
146714677|NCT00136955|529127720|FG000|Overall Study|Lost to Follow-up|1|||
146714678|NCT00136955|529127720|FG000|Overall Study|Withdrawal by Subject|2|||
146714679|NCT00136955|529127720|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
146714680|NCT02239510|529127721|FG000|Overall Study|Lost to Follow-up|2|||
146714681|NCT02239510|529127722|FG001|Overall Study|Lost to Follow-up|1|||
146714682|NCT00074282|529127725|FG000|Step 1|Adverse Event|32|||
146714683|NCT00074282|529127726|FG001|Step 1|Adverse Event|0|||
146714684|NCT00074282|529127727|FG002|Step 1|Adverse Event|0|||
146714685|NCT00074282|529127725|FG000|Step 1|Death|6|||
146714686|NCT00074282|529127726|FG001|Step 1|Death|0|||
146714687|NCT00074282|529127727|FG002|Step 1|Death|0|||
146714688|NCT00074282|529127725|FG000|Step 1|Withdrawal by Subject|7|||
146714689|NCT00074282|529127726|FG001|Step 1|Withdrawal by Subject|0|||
146714690|NCT00074282|529127727|FG002|Step 1|Withdrawal by Subject|0|||
146714691|NCT00074282|529127725|FG000|Step 1|Disease progression|2|||
146714692|NCT00074282|529127726|FG001|Step 1|Disease progression|0|||
146714693|NCT00074282|529127727|FG002|Step 1|Disease progression|0|||
146714694|NCT00074282|529127725|FG000|Step 1|Alternative therapy|2|||
146714695|NCT00074282|529127726|FG001|Step 1|Alternative therapy|0|||
146714696|NCT00074282|529127727|FG002|Step 1|Alternative therapy|0|||
146714697|NCT00074282|529127725|FG000|Step 1|Other complicating disease|2|||
146714698|NCT00074282|529127726|FG001|Step 1|Other complicating disease|0|||
146714699|NCT00074282|529127727|FG002|Step 1|Other complicating disease|0|||
146714700|NCT00074282|529127725|FG000|Step 1|Physician Decision|1|||
146714701|NCT00074282|529127726|FG001|Step 1|Physician Decision|0|||
146714702|NCT00074282|529127727|FG002|Step 1|Physician Decision|0|||
146714703|NCT00074282|529127725|FG000|Step 1|Ineligible|4|||
146714704|NCT00074282|529127726|FG001|Step 1|Ineligible|0|||
146714705|NCT00074282|529127727|FG002|Step 1|Ineligible|0|||
146714706|NCT00074282|529127725|FG000|Step 1|Never started treatment|2|||
146714707|NCT00074282|529127726|FG001|Step 1|Never started treatment|0|||
146714708|NCT00074282|529127727|FG002|Step 1|Never started treatment|0|||
146714709|NCT00074282|529127725|FG000|Step 2|Adverse Event|0|||
146714710|NCT00074282|529127726|FG001|Step 2|Adverse Event|2|||
146714711|NCT00074282|529127727|FG002|Step 2|Adverse Event|12|||
146714712|NCT00074282|529127725|FG000|Step 2|Disease progression|0|||
146714713|NCT00074282|529127726|FG001|Step 2|Disease progression|0|||
146714714|NCT00074282|529127727|FG002|Step 2|Disease progression|5|||
146714715|NCT00074282|529127725|FG000|Step 2|Death|0|||
146714716|NCT00074282|529127726|FG001|Step 2|Death|0|||
146714717|NCT00074282|529127727|FG002|Step 2|Death|3|||
146714718|NCT00074282|529127725|FG000|Step 2|Withdrawal by Subject|0|||
146714719|NCT00074282|529127726|FG001|Step 2|Withdrawal by Subject|0|||
146714720|NCT00074282|529127727|FG002|Step 2|Withdrawal by Subject|2|||
146714721|NCT00074282|529127725|FG000|Step 2|Physician Decision|0|||
146714722|NCT00074282|529127726|FG001|Step 2|Physician Decision|0|||
146714723|NCT00074282|529127727|FG002|Step 2|Physician Decision|1|||
146714724|NCT00074282|529127725|FG000|Step 2|Ineligible|0|||
146714725|NCT00074282|529127726|FG001|Step 2|Ineligible|0|||
146714726|NCT00074282|529127727|FG002|Step 2|Ineligible|1|||
146714727|NCT00464542|529127728|FG000|Pre-treatment|Withdrawal by Subject|2|||
146714728|NCT03859323|529127730|FG000|Overall Study|Lost to Follow-up|0|||
146714729|NCT03859323|529127731|FG001|Overall Study|Lost to Follow-up|0|||
146714730|NCT03859323|529127732|FG002|Overall Study|Lost to Follow-up|0|||
146714731|NCT03859323|529127733|FG003|Overall Study|Lost to Follow-up|0|||
146714732|NCT03859323|529127734|FG004|Overall Study|Lost to Follow-up|0|||
146714733|NCT03859323|529127735|FG005|Overall Study|Lost to Follow-up|0|||
146714734|NCT03859323|529127736|FG006|Overall Study|Lost to Follow-up|1|||
146714735|NCT03859323|529127737|FG007|Overall Study|Lost to Follow-up|0|||
146714736|NCT03859323|529127738|FG008|Overall Study|Lost to Follow-up|0|||
146714737|NCT03859323|529127739|FG009|Overall Study|Lost to Follow-up|0|||
146714738|NCT03859323|529127740|FG010|Overall Study|Lost to Follow-up|0|||
146714739|NCT03859323|529127741|FG011|Overall Study|Lost to Follow-up|0|||
146714740|NCT03859323|529127742|FG012|Overall Study|Lost to Follow-up|0|||
146714741|NCT03859323|529127730|FG000|Overall Study|Withdrawal by Subject|0|||
146714742|NCT03859323|529127731|FG001|Overall Study|Withdrawal by Subject|0|||
146714743|NCT03859323|529127732|FG002|Overall Study|Withdrawal by Subject|1|||
146714744|NCT03859323|529127733|FG003|Overall Study|Withdrawal by Subject|0|||
146714745|NCT03859323|529127734|FG004|Overall Study|Withdrawal by Subject|0|||
146714746|NCT03859323|529127735|FG005|Overall Study|Withdrawal by Subject|1|||
146714747|NCT03859323|529127736|FG006|Overall Study|Withdrawal by Subject|0|||
146714748|NCT03859323|529127737|FG007|Overall Study|Withdrawal by Subject|0|||
146714749|NCT03859323|529127738|FG008|Overall Study|Withdrawal by Subject|0|||
146714750|NCT03859323|529127739|FG009|Overall Study|Withdrawal by Subject|1|||
146714751|NCT03859323|529127740|FG010|Overall Study|Withdrawal by Subject|1|||
146714752|NCT03859323|529127741|FG011|Overall Study|Withdrawal by Subject|2|||
146714753|NCT03859323|529127742|FG012|Overall Study|Withdrawal by Subject|1|||
146714754|NCT03859323|529127730|FG000|Overall Study|Pregnancy|0|||
146981220|NCT01567306|530093818|FG005|Overall Study|Lost to Follow-up|0|||
146981221|NCT01567306|530093813|FG000|Overall Study|Withdrawal by Subject|0|||
146981222|NCT01567306|530093814|FG001|Overall Study|Withdrawal by Subject|0|||
146981223|NCT01567306|530093815|FG002|Overall Study|Withdrawal by Subject|0|||
146981224|NCT01567306|530093816|FG003|Overall Study|Withdrawal by Subject|0|||
146981225|NCT01567306|530093817|FG004|Overall Study|Withdrawal by Subject|0|||
146981226|NCT01567306|530093818|FG005|Overall Study|Withdrawal by Subject|1|||
146981227|NCT00738673|530093819|FG000|Overall Study|Adverse Event|1|||
146981228|NCT00738673|530093820|FG001|Overall Study|Adverse Event|0|||
146981229|NCT00738673|530093819|FG000|Overall Study|Lack of Efficacy|19|||
146981230|NCT00738673|530093820|FG001|Overall Study|Lack of Efficacy|8|||
146981231|NCT00738673|530093819|FG000|Overall Study|Protocol Violation|1|||
146981232|NCT00738673|530093820|FG001|Overall Study|Protocol Violation|2|||
146981233|NCT00738673|530093819|FG000|Overall Study|Withdrawal by Subject|3|||
146981234|NCT00738673|530093820|FG001|Overall Study|Withdrawal by Subject|1|||
146981235|NCT03882047|530093821|FG000|Overall Study|Adverse Event|0|||
146981236|NCT03882047|530093822|FG001|Overall Study|Adverse Event|2|||
146981237|NCT03882047|530093823|FG002|Overall Study|Adverse Event|2|||
146981238|NCT03882047|530093821|FG000|Overall Study|Treatment Failure|3|||
146981239|NCT03882047|530093822|FG001|Overall Study|Treatment Failure|3|||
146981240|NCT03882047|530093823|FG002|Overall Study|Treatment Failure|12|||
146981241|NCT03882047|530093821|FG000|Overall Study|Lost to Follow-up|0|||
146981242|NCT03882047|530093822|FG001|Overall Study|Lost to Follow-up|1|||
146981243|NCT03882047|530093823|FG002|Overall Study|Lost to Follow-up|0|||
146981244|NCT03882047|530093821|FG000|Overall Study|Did Not Wish to Continue|1|||
146981245|NCT03882047|530093822|FG001|Overall Study|Did Not Wish to Continue|4|||
146714755|NCT03859323|529127731|FG001|Overall Study|Pregnancy|0|||
146714756|NCT03859323|529127732|FG002|Overall Study|Pregnancy|0|||
146714757|NCT03859323|529127733|FG003|Overall Study|Pregnancy|0|||
146714758|NCT03859323|529127734|FG004|Overall Study|Pregnancy|0|||
146714759|NCT03859323|529127735|FG005|Overall Study|Pregnancy|0|||
146714760|NCT03859323|529127736|FG006|Overall Study|Pregnancy|0|||
146714761|NCT03859323|529127737|FG007|Overall Study|Pregnancy|0|||
146714762|NCT03859323|529127738|FG008|Overall Study|Pregnancy|0|||
146714763|NCT03859323|529127739|FG009|Overall Study|Pregnancy|1|||
146714764|NCT03859323|529127740|FG010|Overall Study|Pregnancy|0|||
146714765|NCT03859323|529127741|FG011|Overall Study|Pregnancy|0|||
146714766|NCT03859323|529127742|FG012|Overall Study|Pregnancy|0|||
146714767|NCT01682460|529127743|FG000|Overall Study|Withdrawal by Subject|2|||
146714768|NCT01682460|529127743|FG000|Overall Study|Did not meet inclusion criteria|2|||
146714769|NCT02055352|529127747|FG000|Overall Study|Adverse Event|0|||
146714770|NCT02055352|529127748|FG001|Overall Study|Adverse Event|1|||
146714771|NCT02055352|529127747|FG000|Overall Study|Non-eligible|0|||
146714772|NCT02055352|529127748|FG001|Overall Study|Non-eligible|1|||
146714773|NCT02055352|529127747|FG000|Overall Study|Poor compliance|1|||
146714774|NCT02055352|529127748|FG001|Overall Study|Poor compliance|1|||
146714775|NCT02055352|529127747|FG000|Overall Study|Death|1|||
146714776|NCT02055352|529127748|FG001|Overall Study|Death|2|||
146714777|NCT02055352|529127747|FG000|Overall Study|Patient decision|1|||
146714778|NCT02055352|529127748|FG001|Overall Study|Patient decision|1|||
146714779|NCT02055352|529127747|FG000|Overall Study|Use of prohibited treatment|0|||
146714780|NCT02055352|529127748|FG001|Overall Study|Use of prohibited treatment|3|||
146714781|NCT02055352|529127747|FG000|Overall Study|AE, study drug would be detrimental|1|||
146714782|NCT02055352|529127748|FG001|Overall Study|AE, study drug would be detrimental|3|||
146981246|NCT03882047|530093823|FG002|Overall Study|Did Not Wish to Continue|1|||
146981247|NCT03882047|530093821|FG000|Overall Study|Noncompliance With Protocol|2|||
146981248|NCT03882047|530093822|FG001|Overall Study|Noncompliance With Protocol|0|||
146981249|NCT03882047|530093823|FG002|Overall Study|Noncompliance With Protocol|0|||
146981250|NCT03882047|530093821|FG000|Overall Study|Did Not Meet Eligibility|0|||
146981251|NCT03882047|530093822|FG001|Overall Study|Did Not Meet Eligibility|0|||
146981252|NCT03882047|530093823|FG002|Overall Study|Did Not Meet Eligibility|1|||
146981253|NCT00723554|530093824|FG000|Overall Study|Adverse Event|12|||
146981254|NCT00723554|530093824|FG000|Overall Study|Investigator's judgement|5|||
146981255|NCT00723554|530093824|FG000|Overall Study|Inhaled medication other than iloprost|4|||
146981256|NCT00723554|530093824|FG000|Overall Study|Withdrawal of consent|3|||
146981257|NCT00723554|530093824|FG000|Overall Study|Other|3|||
146981258|NCT00723554|530093824|FG000|Overall Study|Lost to Follow-up|1|||
146981259|NCT00723554|530093824|FG000|Overall Study|Non-compliance|1|||
146714783|NCT02055352|529127747|FG000|Overall Study|Withdrawal of informed consent|1|||
146714784|NCT02055352|529127748|FG001|Overall Study|Withdrawal of informed consent|0|||
146714785|NCT02055352|529127747|FG000|Overall Study|Reason unknown|1|||
146714786|NCT02055352|529127748|FG001|Overall Study|Reason unknown|5|||
146714787|NCT05349617|529127751|FG000|Overall Study|Death|1|||
146981260|NCT02436135|530093826|FG000|Overall Study|Progressive Disease|3|||
146981261|NCT02436135|530093827|FG001|Overall Study|Progressive Disease|1|||
146981262|NCT02436135|530093826|FG000|Overall Study|Investigator Discretion|1|||
146981263|NCT02436135|530093827|FG001|Overall Study|Investigator Discretion|2|||
146714788|NCT05349617|529127752|FG001|Overall Study|Death|1|||
146714789|NCT05349617|529127751|FG000|Overall Study|Lost to Follow-up|3|||
146714790|NCT05349617|529127752|FG001|Overall Study|Lost to Follow-up|8|||
146714791|NCT05349617|529127751|FG000|Overall Study|Withdrawal by Subject|2|||
146714792|NCT05349617|529127752|FG001|Overall Study|Withdrawal by Subject|10|||
146714793|NCT03811912|529127755|FG000|Overall Study|Withdrew Consent|4|||
146714794|NCT03811912|529127756|FG001|Overall Study|Withdrew Consent|2|||
146714795|NCT04401579|529127757|FG000|Overall Study|Death|23|||
146714796|NCT04401579|529127758|FG001|Overall Study|Death|36|||
146714797|NCT04401579|529127757|FG000|Overall Study|Lost to Follow-up|40|||
146714798|NCT04401579|529127758|FG001|Overall Study|Lost to Follow-up|41|||
146714799|NCT04401579|529127757|FG000|Overall Study|Withdrawal by Subject|8|||
146714800|NCT04401579|529127758|FG001|Overall Study|Withdrawal by Subject|16|||
146714801|NCT04401579|529127757|FG000|Overall Study|Physician Decision|1|||
146714802|NCT04401579|529127758|FG001|Overall Study|Physician Decision|2|||
146714803|NCT04401579|529127757|FG000|Overall Study|Became ineligible after enrollment|1|||
146714804|NCT04401579|529127758|FG001|Overall Study|Became ineligible after enrollment|1|||
146714805|NCT04401579|529127757|FG000|Overall Study|Enrolled but treatment not administered|7|||
146714806|NCT04401579|529127758|FG001|Overall Study|Enrolled but treatment not administered|9|||
146714807|NCT04401579|529127757|FG000|Overall Study|Adverse Event|2|||
146714808|NCT04401579|529127758|FG001|Overall Study|Adverse Event|1|||
146714809|NCT04401579|529127757|FG000|Overall Study|Scheduling error|1|||
146714810|NCT04401579|529127758|FG001|Overall Study|Scheduling error|2|||
146714811|NCT04401579|529127757|FG000|Overall Study|Transferred to another hospital|1|||
146714812|NCT04401579|529127758|FG001|Overall Study|Transferred to another hospital|2|||
146714813|NCT00489970|529127759|FG000|Persistence Year 9|Lost to Follow-up|2|||
146714814|NCT00489970|529127760|FG001|Persistence Year 9|Lost to Follow-up|2|||
146714815|NCT00489970|529127761|FG002|Persistence Year 9|Lost to Follow-up|3|||
146714816|NCT00489970|529127759|FG000|Persistence Year 9|Other|1|||
146714817|NCT00489970|529127760|FG001|Persistence Year 9|Other|0|||
146714818|NCT00489970|529127761|FG002|Persistence Year 9|Other|2|||
146714819|NCT01438411|529127762|FG000|Overall Study|Adverse Event|8|||
146714820|NCT01438411|529127762|FG000|Overall Study|Lost to Follow-up|1|||
146714821|NCT01438411|529127762|FG000|Overall Study|Lack of Efficacy|1|||
146714822|NCT01438411|529127762|FG000|Overall Study|Withdrawal by Subject|3|||
146714823|NCT01863680|529127763|FG000|Overall Study|Adverse Event|17|||
146714824|NCT01863680|529127763|FG000|Overall Study|Risk of OHSS|17|||
146714825|NCT01863680|529127763|FG000|Overall Study|Spontaneous pregnancy|2|||
146714826|NCT01863680|529127763|FG000|Overall Study|Withdrawal by Subject|1|||
146714827|NCT01863680|529127763|FG000|Overall Study|Did not undergo IVF/ET|14|||
146714828|NCT01863680|529127763|FG000|Overall Study|Other|6|||
146714829|NCT00618514|529127764|FG000|Overall Study|Lost to Follow-up|11|||
146714830|NCT00618514|529127765|FG001|Overall Study|Lost to Follow-up|12|||
146714831|NCT00618514|529127766|FG002|Overall Study|Lost to Follow-up|4|||
146714832|NCT00566228|529127771|FG000|Overall Study|Withdrawal by Subject|1|||
146714833|NCT00566228|529127772|FG001|Overall Study|Withdrawal by Subject|0|||
146714834|NCT00566228|529127771|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
146714835|NCT00566228|529127772|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
146714836|NCT00566228|529127771|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
146714837|NCT00566228|529127772|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
146714838|NCT00566228|529127771|FG000|Overall Study|progressed before infusion could occur|0|||
146714839|NCT00566228|529127772|FG001|Overall Study|progressed before infusion could occur|1|||
146714840|NCT02707055|529127775|FG000|Phase 1|Withdrawal by Subject|1|||
146714841|NCT02707055|529127776|FG001|Phase 1|Withdrawal by Subject|2|||
146714842|NCT02707055|529127775|FG000|Phase 1|Physician Decision|0|||
146714843|NCT02707055|529127776|FG001|Phase 1|Physician Decision|1|||
146714844|NCT02707055|529127775|FG000|Phase 2|Adverse Event|1|||
146714845|NCT02707055|529127776|FG001|Phase 2|Adverse Event|2|||
146714846|NCT02280044|529127779|FG000|Overall Study|Planned alternate|0|||
146714847|NCT02280044|529127780|FG001|Overall Study|Planned alternate|2|||
146714848|NCT02105116|529127783|FG000|Overall Study|not eligible for step 2 of trial|5|||
146714849|NCT02105116|529127783|FG000|Overall Study|Death|1|||
146714850|NCT00902304|529127784|FG000|Overall Study|Adverse Event|4|||
146714851|NCT00902304|529127785|FG001|Overall Study|Adverse Event|10|||
146714852|NCT00902304|529127786|FG002|Overall Study|Adverse Event|25|||
146780556|NCT00632749|529366221|FG009|Overall Study|Reason other than those specified above|0|||
146934021|NCT04142216|529916050|FG000|Overall Study|Referral to another hemodialysis unit|3|||
146934022|NCT04142216|529916051|FG001|Overall Study|Referral to another hemodialysis unit|2|||
146714853|NCT00902304|529127784|FG000|Overall Study|Investigator discretion|3|||
146714854|NCT00902304|529127785|FG001|Overall Study|Investigator discretion|5|||
146714855|NCT00902304|529127786|FG002|Overall Study|Investigator discretion|13|||
146714856|NCT00902304|529127784|FG000|Overall Study|Lost to Follow-up|7|||
146714857|NCT00902304|529127785|FG001|Overall Study|Lost to Follow-up|7|||
146714858|NCT00902304|529127786|FG002|Overall Study|Lost to Follow-up|7|||
146714859|NCT00902304|529127784|FG000|Overall Study|Protocol Violation|9|||
146714860|NCT00902304|529127785|FG001|Overall Study|Protocol Violation|18|||
146714861|NCT00902304|529127786|FG002|Overall Study|Protocol Violation|20|||
146714862|NCT00902304|529127784|FG000|Overall Study|Withdrawal by Subject|32|||
146714863|NCT00902304|529127785|FG001|Overall Study|Withdrawal by Subject|22|||
146714864|NCT00902304|529127786|FG002|Overall Study|Withdrawal by Subject|43|||
146714865|NCT00902304|529127784|FG000|Overall Study|includes pregnancy|3|||
146714866|NCT00902304|529127785|FG001|Overall Study|includes pregnancy|9|||
146714867|NCT00902304|529127786|FG002|Overall Study|includes pregnancy|2|||
146714868|NCT02492100|529127787|FG000|Overall Study|Death|1|||
146714869|NCT05706506|529127788|FG000|Overall Study|Adverse Event|1|||
146714870|NCT05706506|529127788|FG000|Overall Study|Withdrawal by Subject|4|||
146714871|NCT05706506|529127788|FG000|Overall Study|Lost to Follow-up|2|||
146714872|NCT05706506|529127788|FG000|Overall Study|Inadvertent Enrolment|12|||
146714873|NCT05706506|529127788|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
146714874|NCT05706506|529127788|FG000|Overall Study|Participant Moved Out of State|1|||
146714875|NCT03832010|529127789|FG000|Overall Study|Withdrawal by Subject|2|||
146714876|NCT03832010|529127790|FG001|Overall Study|Withdrawal by Subject|1|||
146714877|NCT03832010|529127791|FG002|Overall Study|Withdrawal by Subject|0|||
146714878|NCT03832010|529127789|FG000|Overall Study|Lost to Follow-up|2|||
146714879|NCT03832010|529127790|FG001|Overall Study|Lost to Follow-up|1|||
146714880|NCT03832010|529127791|FG002|Overall Study|Lost to Follow-up|1|||
146714881|NCT04837482|529127792|FG000|Period 2|Withdrawal by Subject|0|||
146714882|NCT04837482|529127793|FG001|Period 2|Withdrawal by Subject|1|||
146714883|NCT02646423|529127794|FG000|Overall Study|Adverse Event|5|||
146714884|NCT02646423|529127795|FG001|Overall Study|Adverse Event|7|||
146714885|NCT02646423|529127794|FG000|Overall Study|Ineligible|2|||
146714886|NCT02646423|529127795|FG001|Overall Study|Ineligible|1|||
146714887|NCT02807948|529127799|FG000|Overall Study|Physician Decision|1|||
146714888|NCT02807948|529127800|FG001|Overall Study|Physician Decision|0|||
146714889|NCT01175382|529127802|FG000|Overall Study|Lost to Follow-up|4|||
146714890|NCT01175382|529127803|FG001|Overall Study|Lost to Follow-up|3|||
146714891|NCT01175382|529127804|FG002|Overall Study|Lost to Follow-up|1|||
146714892|NCT01175382|529127802|FG000|Overall Study|Physician Decision|0|||
146714893|NCT01175382|529127803|FG001|Overall Study|Physician Decision|1|||
146714894|NCT01175382|529127804|FG002|Overall Study|Physician Decision|0|||
146714895|NCT01175382|529127802|FG000|Overall Study|Withdrawal by Subject|0|||
146714896|NCT01175382|529127803|FG001|Overall Study|Withdrawal by Subject|0|||
146714897|NCT01175382|529127804|FG002|Overall Study|Withdrawal by Subject|1|||
146714898|NCT01175382|529127802|FG000|Overall Study|No longer having problem|1|||
146714899|NCT01175382|529127803|FG001|Overall Study|No longer having problem|0|||
146714900|NCT01175382|529127804|FG002|Overall Study|No longer having problem|1|||
146714901|NCT01175382|529127802|FG000|Overall Study|Unable/unwilling to attend visits|3|||
146714902|NCT01175382|529127803|FG001|Overall Study|Unable/unwilling to attend visits|1|||
146714903|NCT01175382|529127804|FG002|Overall Study|Unable/unwilling to attend visits|2|||
146714904|NCT01175382|529127802|FG000|Overall Study|Unwilling to follow protocol|0|||
146714905|NCT01175382|529127803|FG001|Overall Study|Unwilling to follow protocol|1|||
146714906|NCT01175382|529127804|FG002|Overall Study|Unwilling to follow protocol|0|||
146714907|NCT01175382|529127802|FG000|Overall Study|Unable to tolerate study meds|0|||
146714908|NCT01175382|529127803|FG001|Overall Study|Unable to tolerate study meds|1|||
146714909|NCT01175382|529127804|FG002|Overall Study|Unable to tolerate study meds|1|||
146714910|NCT01659021|529127810|FG000|Main Study|Adverse Event|2|||
146714911|NCT01659021|529127811|FG001|Main Study|Adverse Event|3|||
146714912|NCT01659021|529127810|FG000|Main Study|Lost to Follow-up|1|||
146714913|NCT01659021|529127811|FG001|Main Study|Lost to Follow-up|0|||
146714914|NCT01659021|529127810|FG000|Main Study|Unknown Reasons|2|||
146714915|NCT01659021|529127811|FG001|Main Study|Unknown Reasons|1|||
146714916|NCT01659021|529127810|FG000|Main Study|Physician Decision|34|||
146714917|NCT01659021|529127811|FG001|Main Study|Physician Decision|16|||
146714918|NCT01659021|529127810|FG000|Main Study|Withdrawal by Subject|19|||
146714919|NCT01659021|529127811|FG001|Main Study|Withdrawal by Subject|16|||
146714920|NCT01659021|529127810|FG000|Main Study|Study Terminated by Sponsor|16|||
146714921|NCT01659021|529127811|FG001|Main Study|Study Terminated by Sponsor|1|||
146714922|NCT01659021|529127810|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
146714923|NCT01659021|529127811|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
146714924|NCT01659021|529127810|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
146714925|NCT01659021|529127811|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
146714926|NCT02511431|529127812|FG000|Treatment|Lost to Follow-up|0|||
146714927|NCT02511431|529127813|FG001|Treatment|Lost to Follow-up|0|||
146714928|NCT02511431|529127814|FG002|Treatment|Lost to Follow-up|1|||
146714929|NCT02511431|529127815|FG003|Treatment|Lost to Follow-up|0|||
146714930|NCT02511431|529127816|FG004|Treatment|Lost to Follow-up|0|||
146714931|NCT02511431|529127817|FG005|Treatment|Lost to Follow-up|1|||
146714932|NCT00462384|529127818|FG000|Overall Study|Adverse Event|2|||
146714933|NCT00462384|529127818|FG000|Overall Study|Death|2|||
146714934|NCT00462384|529127818|FG000|Overall Study|Withdrawal by Subject|1|||
146714935|NCT00462384|529127818|FG000|Overall Study|Other|4|||
146714936|NCT03447769|529127819|FG000|Overall Study|Progressive disease|138|||
146714937|NCT03447769|529127820|FG001|Overall Study|Progressive disease|148|||
146714938|NCT03447769|529127819|FG000|Overall Study|Study terminated by Sponsor|60|||
146714939|NCT03447769|529127820|FG001|Overall Study|Study terminated by Sponsor|44|||
146714940|NCT03447769|529127819|FG000|Overall Study|Adverse Event|34|||
146714941|NCT03447769|529127820|FG001|Overall Study|Adverse Event|31|||
146714942|NCT03447769|529127819|FG000|Overall Study|Patient decision|27|||
146714943|NCT03447769|529127820|FG001|Overall Study|Patient decision|27|||
146714944|NCT03447769|529127819|FG000|Overall Study|Protocol deviation|4|||
146714945|NCT03447769|529127820|FG001|Overall Study|Protocol deviation|6|||
146714946|NCT03447769|529127819|FG000|Overall Study|Death|2|||
146714947|NCT03447769|529127820|FG001|Overall Study|Death|7|||
146714948|NCT03447769|529127819|FG000|Overall Study|Technical problems|1|||
146714949|NCT03447769|529127820|FG001|Overall Study|Technical problems|0|||
146714950|NCT03447769|529127819|FG000|Overall Study|Lost to Follow-up|0|||
146714951|NCT03447769|529127820|FG001|Overall Study|Lost to Follow-up|1|||
146714952|NCT03447769|529127819|FG000|Overall Study|Physician Decision|13|||
146714953|NCT03447769|529127820|FG001|Overall Study|Physician Decision|5|||
146714954|NCT03879798|529127822|FG000|Overall Study|Adverse Event|0|||
146714955|NCT03879798|529127823|FG001|Overall Study|Adverse Event|0|||
146714956|NCT03879798|529127824|FG002|Overall Study|Adverse Event|0|||
146714957|NCT03879798|529127825|FG003|Overall Study|Adverse Event|0|||
146714958|NCT03879798|529127826|FG004|Overall Study|Adverse Event|0|||
146714959|NCT03879798|529127827|FG005|Overall Study|Adverse Event|1|||
146714960|NCT03879798|529127822|FG000|Overall Study|Lack of Efficacy|0|||
146714961|NCT03879798|529127823|FG001|Overall Study|Lack of Efficacy|0|||
146714962|NCT03879798|529127824|FG002|Overall Study|Lack of Efficacy|0|||
146714963|NCT03879798|529127825|FG003|Overall Study|Lack of Efficacy|0|||
146714964|NCT03879798|529127826|FG004|Overall Study|Lack of Efficacy|0|||
146714965|NCT03879798|529127827|FG005|Overall Study|Lack of Efficacy|1|||
146714966|NCT03879798|529127822|FG000|Overall Study|Withdrawal by Subject|0|||
146714967|NCT03879798|529127823|FG001|Overall Study|Withdrawal by Subject|0|||
146714968|NCT03879798|529127824|FG002|Overall Study|Withdrawal by Subject|0|||
146714969|NCT03879798|529127825|FG003|Overall Study|Withdrawal by Subject|0|||
146714970|NCT03879798|529127826|FG004|Overall Study|Withdrawal by Subject|0|||
146714971|NCT03879798|529127827|FG005|Overall Study|Withdrawal by Subject|1|||
146714972|NCT00817089|529127834|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
146714973|NCT00817089|529127835|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
146714974|NCT00817089|529127836|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
146714975|NCT00817089|529127837|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
146714976|NCT00817089|529127834|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
146714977|NCT00817089|529127835|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
146714978|NCT00817089|529127836|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
146714979|NCT00817089|529127837|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
146714980|NCT03783923|529127838|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
146714981|NCT03783923|529127839|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
146714982|NCT03783923|529127838|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
146714983|NCT03783923|529127839|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
146714984|NCT03783923|529127838|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
146714985|NCT03783923|529127839|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
146714986|NCT03783923|529127838|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
146714987|NCT03783923|529127839|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
146714988|NCT03783923|529127838|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
146714989|NCT03783923|529127839|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
146714990|NCT01767116|529127848|FG000|Overall Study|Lost to Follow-up|2|||
146714991|NCT01767116|529127849|FG001|Overall Study|Lost to Follow-up|2|||
146714992|NCT05799495|529127854|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
146714993|NCT05799495|529127855|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
146714994|NCT05799495|529127856|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
146714995|NCT05799495|529127857|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
146714996|NCT05799495|529127854|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
146714997|NCT05799495|529127855|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
146714998|NCT05799495|529127856|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
146714999|NCT05799495|529127857|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
146715000|NCT05799495|529127854|FG000|Treatment (Up to 5 Days)|Other|0|||
146715001|NCT05799495|529127855|FG001|Treatment (Up to 5 Days)|Other|1|||
146715002|NCT05799495|529127856|FG002|Treatment (Up to 5 Days)|Other|0|||
146715003|NCT05799495|529127857|FG003|Treatment (Up to 5 Days)|Other|0|||
146715004|NCT05799495|529127854|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
146715005|NCT05799495|529127855|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
146715006|NCT05799495|529127856|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
146715007|NCT05799495|529127857|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
146715008|NCT05799495|529127854|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
146715009|NCT05799495|529127855|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
146715010|NCT05799495|529127856|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
146715011|NCT05799495|529127857|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
146715012|NCT05799495|529127854|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
146715013|NCT05799495|529127855|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
146715014|NCT05799495|529127856|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
146715015|NCT05799495|529127857|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
146715016|NCT03694548|529127858|FG000|Part A Survey|Protocol Violation|3|||
146715017|NCT03694548|529127859|FG001|Part A Survey|Protocol Violation|3|||
146715018|NCT03694548|529127860|FG002|Part A Survey|Protocol Violation|0|||
146715019|NCT03694548|529127858|FG000|Part B Yoga Program|Protocol Violation|0|||
146715020|NCT03694548|529127859|FG001|Part B Yoga Program|Protocol Violation|0|||
146715021|NCT03694548|529127860|FG002|Part B Yoga Program|Protocol Violation|3|||
146715022|NCT03694548|529127858|FG000|Part B Yoga Program|Did not attend intervention|0|||
146715023|NCT03694548|529127859|FG001|Part B Yoga Program|Did not attend intervention|0|||
146715024|NCT03694548|529127860|FG002|Part B Yoga Program|Did not attend intervention|8|||
146715025|NCT00305058|529127861|FG000|Overall Study|Participant too young|1|||
146715026|NCT00305058|529127862|FG001|Overall Study|Participant too young|0|||
146715027|NCT00305058|529127861|FG000|Overall Study|Missing data collection instrument|3|||
146715028|NCT00305058|529127862|FG001|Overall Study|Missing data collection instrument|2|||
146715029|NCT00305058|529127861|FG000|Overall Study|Missing outcome data|3|||
146715030|NCT00305058|529127862|FG001|Overall Study|Missing outcome data|2|||
146715031|NCT04102501|529127863|FG000|Overall Study|Withdrawal by Subject|7|||
146715032|NCT04102501|529127864|FG001|Overall Study|Withdrawal by Subject|9|||
146715033|NCT04102501|529127863|FG000|Overall Study|Adverse Event|1|||
146715034|NCT04102501|529127864|FG001|Overall Study|Adverse Event|3|||
146715035|NCT02338362|529127865|FG000|Overall Study|Withdrawal by Subject|1|||
146715036|NCT02338362|529127866|FG001|Overall Study|Withdrawal by Subject|1|||
146715037|NCT01669343|529127867|FG000|Part A: All Patients|Withdrawal by Subject|7|||
146715038|NCT01669343|529127867|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
146715039|NCT01669343|529127867|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
146715040|NCT01669343|529127867|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
146715041|NCT01669343|529127867|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
146715042|NCT00439777|529127868|FG000|Treatment Period|Death|29|||
146715043|NCT00439777|529127869|FG001|Treatment Period|Death|21|||
146715044|NCT00439777|529127868|FG000|Treatment Period|Study terminated by sponsor|125|||
146715045|NCT00439777|529127869|FG001|Treatment Period|Study terminated by sponsor|132|||
146715046|NCT00439777|529127868|FG000|Treatment Period|Site closed by investigator|0|||
146715047|NCT00439777|529127869|FG001|Treatment Period|Site closed by investigator|1|||
146715048|NCT00439777|529127868|FG000|Treatment Period|Did not take study treatment|7|||
146715049|NCT00439777|529127869|FG001|Treatment Period|Did not take study treatment|8|||
146715050|NCT00439777|529127868|FG000|Treatment Period|Adverse Event|111|||
146715051|NCT00439777|529127869|FG001|Treatment Period|Adverse Event|92|||
146715052|NCT00439777|529127868|FG000|Treatment Period|Protocol Violation|23|||
146715053|NCT00439777|529127869|FG001|Treatment Period|Protocol Violation|30|||
146715054|NCT00439777|529127868|FG000|Treatment Period|Withdrawal by Subject|66|||
146715055|NCT00439777|529127869|FG001|Treatment Period|Withdrawal by Subject|118|||
146715056|NCT00439777|529127868|FG000|Treatment Period|Lack of Efficacy|1|||
146715057|NCT00439777|529127869|FG001|Treatment Period|Lack of Efficacy|4|||
146715058|NCT00439777|529127868|FG000|Treatment Period|Lost to Follow-up|8|||
146715059|NCT00439777|529127869|FG001|Treatment Period|Lost to Follow-up|10|||
146715060|NCT00439777|529127868|FG000|Treatment Period|Protocol driven decision point|1|||
146715061|NCT00439777|529127869|FG001|Treatment Period|Protocol driven decision point|3|||
146715062|NCT00439777|529127868|FG000|Treatment Period|Physician Decision|7|||
146715063|NCT00439777|529127869|FG001|Treatment Period|Physician Decision|18|||
146715064|NCT00439777|529127868|FG000|Treatment Period|Clinical endpoint reached|26|||
146715065|NCT00439777|529127869|FG001|Treatment Period|Clinical endpoint reached|13|||
146715066|NCT00439777|529127868|FG000|Treatment Period|Technical problems|3|||
146715067|NCT00439777|529127869|FG001|Treatment Period|Technical problems|1|||
146715068|NCT00439777|529127868|FG000|Treatment Period|Participant convenience|12|||
146715069|NCT00439777|529127869|FG001|Treatment Period|Participant convenience|8|||
146715070|NCT00439777|529127868|FG000|Observational Period|Protocol Violation|0|||
146715071|NCT00439777|529127869|FG001|Observational Period|Protocol Violation|2|||
146715072|NCT00439777|529127868|FG000|Observational Period|Withdrawal by Subject|9|||
146715073|NCT00439777|529127869|FG001|Observational Period|Withdrawal by Subject|5|||
146715074|NCT00439777|529127868|FG000|Observational Period|Lost to Follow-up|1|||
146715075|NCT00439777|529127869|FG001|Observational Period|Lost to Follow-up|11|||
146715076|NCT00439777|529127868|FG000|Observational Period|Death|27|||
146715077|NCT00439777|529127869|FG001|Observational Period|Death|20|||
146715078|NCT00439777|529127868|FG000|Observational Period|Study terminated by sponsor|3|||
146715079|NCT00439777|529127869|FG001|Observational Period|Study terminated by sponsor|1|||
146715080|NCT00439777|529127868|FG000|Observational Period|Protocol driven decision point|0|||
146715081|NCT00439777|529127869|FG001|Observational Period|Protocol driven decision point|1|||
146715082|NCT00439777|529127868|FG000|Observational Period|Lack of Efficacy|1|||
146981264|NCT02436135|530093826|FG000|Overall Study|Adverse Event|1|||
146715083|NCT00439777|529127869|FG001|Observational Period|Lack of Efficacy|0|||
146981265|NCT02436135|530093827|FG001|Overall Study|Adverse Event|0|||
146715084|NCT00439777|529127868|FG000|Observational Period|Technical problems|0|||
146715085|NCT00439777|529127869|FG001|Observational Period|Technical problems|1|||
146715086|NCT00661492|529127870|FG000|Overall Study|Adverse Event|16|||
146715087|NCT00661492|529127871|FG001|Overall Study|Adverse Event|13|||
146715088|NCT00661492|529127870|FG000|Overall Study|Disease Progression|44|||
146715089|NCT00661492|529127871|FG001|Overall Study|Disease Progression|14|||
146715090|NCT00661492|529127870|FG000|Overall Study|Patient Request|6|||
146715091|NCT00661492|529127871|FG001|Overall Study|Patient Request|1|||
146715092|NCT00661492|529127870|FG000|Overall Study|Investigator Request|1|||
146715093|NCT00661492|529127871|FG001|Overall Study|Investigator Request|0|||
146715094|NCT00661492|529127870|FG000|Overall Study|Lost to Follow-up|0|||
146715095|NCT00661492|529127871|FG001|Overall Study|Lost to Follow-up|1|||
146715096|NCT00661492|529127870|FG000|Overall Study|Other|1|||
146715097|NCT00661492|529127871|FG001|Overall Study|Other|0|||
146715098|NCT01024387|529127872|FG000|Overall Study|Radiographic Progression|29|||
146715099|NCT01024387|529127872|FG000|Overall Study|Symptomatic Progression|10|||
146715100|NCT01024387|529127872|FG000|Overall Study|Physician Decision|5|||
146715101|NCT01024387|529127872|FG000|Overall Study|Withdrawal by Subject|5|||
146715102|NCT01024387|529127872|FG000|Overall Study|Death|2|||
146715103|NCT01024387|529127872|FG000|Overall Study|Prolonged Treatment Delay|1|||
146715104|NCT01024387|529127872|FG000|Overall Study|Adverse Event|3|||
146715105|NCT01024387|529127872|FG000|Overall Study|Other|5|||
146715106|NCT03855189|529127873|FG000|Overall Study|Adverse Event|5|||
146715107|NCT03855189|529127874|FG001|Overall Study|Adverse Event|2|||
146715108|NCT03855189|529127875|FG002|Overall Study|Adverse Event|4|||
146715109|NCT03855189|529127873|FG000|Overall Study|Treatment Failure|1|||
146715110|NCT03855189|529127874|FG001|Overall Study|Treatment Failure|1|||
146715111|NCT03855189|529127875|FG002|Overall Study|Treatment Failure|2|||
146715112|NCT03855189|529127873|FG000|Overall Study|Noncompliance with Protocol|0|||
146715113|NCT03855189|529127874|FG001|Overall Study|Noncompliance with Protocol|1|||
146715114|NCT03855189|529127875|FG002|Overall Study|Noncompliance with Protocol|0|||
146715115|NCT03855189|529127873|FG000|Overall Study|Did Not Return|4|||
146715116|NCT03855189|529127874|FG001|Overall Study|Did Not Return|3|||
146715117|NCT03855189|529127875|FG002|Overall Study|Did Not Return|0|||
146715118|NCT06281548|529127876|FG000|Overall Study|Lost to Follow-up|3|||
146715119|NCT00586105|529127877|FG000|Overall Study|Adverse Event|4|||
146715120|NCT00586105|529127877|FG000|Overall Study|Death|2|||
146715121|NCT00586105|529127877|FG000|Overall Study|Protocol Violation|1|||
146715122|NCT00586105|529127877|FG000|Overall Study|Withdrawal by Subject|3|||
146715123|NCT00586105|529127877|FG000|Overall Study|Disease progression|19|||
146715124|NCT00586105|529127877|FG000|Overall Study|Switched to commercial drug|9|||
146715125|NCT00586105|529127877|FG000|Overall Study|Reason not reported|1|||
146715126|NCT00503685|529127880|FG000|Overall Study|Adverse Event|0|||
146715127|NCT00503685|529127881|FG001|Overall Study|Adverse Event|0|||
146934023|NCT04142216|529916050|FG000|Overall Study|Use of clove|0|||
146934024|NCT04142216|529916051|FG001|Overall Study|Use of clove|1|||
146934025|NCT01641991|529916052|FG000|Overall Study|Physician Decision|0|||
146934026|NCT01641991|529916053|FG001|Overall Study|Physician Decision|1|||
146934027|NCT01641991|529916054|FG002|Overall Study|Physician Decision|7|||
146934028|NCT01641991|529916055|FG003|Overall Study|Physician Decision|5|||
146934029|NCT01641991|529916052|FG000|Overall Study|Withdrawal by Subject|4|||
146934030|NCT01641991|529916053|FG001|Overall Study|Withdrawal by Subject|2|||
146934031|NCT01641991|529916054|FG002|Overall Study|Withdrawal by Subject|1|||
146934032|NCT01641991|529916055|FG003|Overall Study|Withdrawal by Subject|5|||
146934033|NCT01641991|529916052|FG000|Overall Study|Adverse Event|2|||
146934034|NCT01641991|529916053|FG001|Overall Study|Adverse Event|1|||
146934035|NCT01641991|529916054|FG002|Overall Study|Adverse Event|2|||
146934036|NCT01641991|529916055|FG003|Overall Study|Adverse Event|1|||
146934037|NCT01641991|529916052|FG000|Overall Study|Lost to Follow-up|0|||
146934038|NCT01641991|529916053|FG001|Overall Study|Lost to Follow-up|2|||
146934039|NCT01641991|529916054|FG002|Overall Study|Lost to Follow-up|3|||
146934040|NCT01641991|529916055|FG003|Overall Study|Lost to Follow-up|1|||
146934041|NCT01641991|529916052|FG000|Overall Study|Protocol Violation|1|||
146934042|NCT01641991|529916053|FG001|Overall Study|Protocol Violation|1|||
146934043|NCT01641991|529916054|FG002|Overall Study|Protocol Violation|3|||
146934044|NCT01641991|529916055|FG003|Overall Study|Protocol Violation|0|||
146934045|NCT01641991|529916052|FG000|Overall Study|Pregnancy|0|||
146934046|NCT01641991|529916053|FG001|Overall Study|Pregnancy|0|||
146934047|NCT01641991|529916054|FG002|Overall Study|Pregnancy|1|||
146934048|NCT01641991|529916055|FG003|Overall Study|Pregnancy|0|||
146934049|NCT01641991|529916052|FG000|Overall Study|no longer eligible|2|||
146934050|NCT01641991|529916053|FG001|Overall Study|no longer eligible|1|||
146934051|NCT01641991|529916054|FG002|Overall Study|no longer eligible|0|||
146934052|NCT01641991|529916055|FG003|Overall Study|no longer eligible|4|||
146934053|NCT02555657|529916056|FG000|Overall Study|Death|274|||
146934054|NCT02555657|529916057|FG001|Overall Study|Death|262|||
146934055|NCT02555657|529916056|FG000|Overall Study|Physician Decision|0|||
146934056|NCT02555657|529916057|FG001|Overall Study|Physician Decision|1|||
146934057|NCT02555657|529916056|FG000|Overall Study|Sponsor Decision|27|||
146934058|NCT02555657|529916057|FG001|Overall Study|Sponsor Decision|15|||
146934059|NCT02555657|529916056|FG000|Overall Study|Withdrawal by Subject|11|||
146715128|NCT00503685|529127882|FG002|Overall Study|Adverse Event|2|||
146934060|NCT02555657|529916057|FG001|Overall Study|Withdrawal by Subject|32|||
146715129|NCT00503685|529127880|FG000|Overall Study|Withdrawal by Subject|0|||
146715130|NCT00503685|529127881|FG001|Overall Study|Withdrawal by Subject|1|||
146934061|NCT00599027|529916063|FG000|Overall Study|Withdrawal by Subject|1|||
146715131|NCT00503685|529127882|FG002|Overall Study|Withdrawal by Subject|0|||
146715132|NCT00503685|529127880|FG000|Overall Study|Protocol Violation|0|||
146715133|NCT00503685|529127881|FG001|Overall Study|Protocol Violation|1|||
146715134|NCT00503685|529127882|FG002|Overall Study|Protocol Violation|0|||
146715135|NCT00503685|529127880|FG000|Overall Study|Eligibility Criteria Not Met|0|||
146715136|NCT00503685|529127881|FG001|Overall Study|Eligibility Criteria Not Met|1|||
146715137|NCT00503685|529127882|FG002|Overall Study|Eligibility Criteria Not Met|0|||
146715138|NCT00987467|529129448|FG000|Overall Study|Lost to Follow-up|2|||
146715139|NCT00086346|529129449|FG000|Randomization|Did not receive test article|4|||
146715140|NCT00086346|529129450|FG001|Randomization|Did not receive test article|4|||
146715141|NCT00086346|529129449|FG000|Patients Dosed With Test Article|Adverse Event|94|||
146715142|NCT00086346|529129450|FG001|Patients Dosed With Test Article|Adverse Event|11|||
146715143|NCT00086346|529129449|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
146715144|NCT00086346|529129450|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
146715145|NCT00086346|529129449|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
146715146|NCT00086346|529129450|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
146715147|NCT00086346|529129449|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
146715148|NCT00086346|529129450|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
146715149|NCT00086346|529129449|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
146715150|NCT00086346|529129450|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
146715151|NCT00086346|529129449|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
146715152|NCT00086346|529129450|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
146715153|NCT03727750|529129451|FG000|Overall Study|Death|45|||
146715154|NCT03727750|529129451|FG000|Overall Study|Withdrawal by Subject|2|||
146715155|NCT03727750|529129451|FG000|Overall Study|Lost to Follow-up|1|||
146715156|NCT03727750|529129451|FG000|Overall Study|Other|1|||
146715157|NCT01303627|529129453|FG000|Overall Study|the failure while performing URS|0|||
146715158|NCT01303627|529129454|FG001|Overall Study|the failure while performing URS|1|||
146715159|NCT01054820|529129458|FG000|Overall Study|Withdrawal by Subject|2|||
146715160|NCT00321919|529129459|FG000|Overall Study|Adverse Event|17|||
146715161|NCT00321919|529129460|FG001|Overall Study|Adverse Event|10|||
146715162|NCT00321919|529129459|FG000|Overall Study|Death|21|||
146715163|NCT00321919|529129460|FG001|Overall Study|Death|17|||
146715164|NCT00321919|529129459|FG000|Overall Study|Insufficient Therapeutic Response|1|||
146715165|NCT00321919|529129460|FG001|Overall Study|Insufficient Therapeutic Response|0|||
146715166|NCT00321919|529129459|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
146715167|NCT00321919|529129460|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
146715168|NCT00321919|529129459|FG000|Overall Study|Refused Treatment|23|||
146715169|NCT00321919|529129460|FG001|Overall Study|Refused Treatment|14|||
146715170|NCT00321919|529129459|FG000|Overall Study|Other Protocol Violation|2|||
146715171|NCT00321919|529129460|FG001|Overall Study|Other Protocol Violation|3|||
146715172|NCT00321919|529129459|FG000|Overall Study|Failure to Return|3|||
146715173|NCT00321919|529129460|FG001|Overall Study|Failure to Return|1|||
146715174|NCT00321919|529129459|FG000|Overall Study|Other withdrawal reason|7|||
146715175|NCT00321919|529129460|FG001|Overall Study|Other withdrawal reason|6|||
146715176|NCT02624804|529129461|FG000|Overall Study|Screen Failure|5|||
146715177|NCT01227889|529129462|FG000|Randomized Phase (RP)|Adverse Event|13|||
146715178|NCT01227889|529129463|FG001|Randomized Phase (RP)|Adverse Event|0|||
146715179|NCT01227889|529129462|FG000|Randomized Phase (RP)|Physician Decision|13|||
146715180|NCT01227889|529129463|FG001|Randomized Phase (RP)|Physician Decision|5|||
146715181|NCT01227889|529129462|FG000|Randomized Phase (RP)|Progressive Disease|135|||
146715182|NCT01227889|529129463|FG001|Randomized Phase (RP)|Progressive Disease|52|||
146715183|NCT01227889|529129462|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
146715184|NCT01227889|529129463|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
146715185|NCT01227889|529129462|FG000|Randomized Phase (RP)|Missing|1|||
146715186|NCT01227889|529129463|FG001|Randomized Phase (RP)|Missing|3|||
146715187|NCT01227889|529129462|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
146715188|NCT01227889|529129463|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
146715189|NCT01227889|529129462|FG000|Crossover Phase|Adverse Event|0|||
146715190|NCT01227889|529129463|FG001|Crossover Phase|Adverse Event|1|||
146715191|NCT01227889|529129462|FG000|Crossover Phase|Physician Decision|0|||
146715192|NCT01227889|529129463|FG001|Crossover Phase|Physician Decision|3|||
146715193|NCT01227889|529129462|FG000|Crossover Phase|Progressive Disease|0|||
146715194|NCT01227889|529129463|FG001|Crossover Phase|Progressive Disease|31|||
146715195|NCT01227889|529129462|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
146715196|NCT01227889|529129463|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
146934062|NCT00599027|529916064|FG001|Overall Study|Withdrawal by Subject|1|||
146715197|NCT01227889|529129462|FG000|Crossover Phase|Withdrawal by Subject|0|||
146715198|NCT01227889|529129463|FG001|Crossover Phase|Withdrawal by Subject|1|||
146715199|NCT04121962|529129466|FG000|Overall Study|Lost to Follow-up|42|||
146715200|NCT04121962|529129467|FG001|Overall Study|Lost to Follow-up|39|||
146715201|NCT00774787|529129468|FG000|Overall Study|Lost to Follow-up|1|||
146715202|NCT02019719|529129469|FG000|Overall Study|Adverse Event|1|||
146715203|NCT02019719|529129470|FG001|Overall Study|Adverse Event|0|||
146981266|NCT02436135|530093826|FG000|Overall Study|Withdrawal by Participant|1|||
146981267|NCT02436135|530093827|FG001|Overall Study|Withdrawal by Participant|0|||
146981268|NCT02436135|530093826|FG000|Overall Study|Study Terminated By Sponsor|0|||
146981269|NCT02436135|530093827|FG001|Overall Study|Study Terminated By Sponsor|1|||
146981270|NCT00475852|530093828|FG000|Overall Study|Death|444|||
146981271|NCT00475852|530093829|FG001|Overall Study|Death|456|||
146981272|NCT00475852|530093828|FG000|Overall Study|Withdrawal by Subject|19|||
146981273|NCT00475852|530093829|FG001|Overall Study|Withdrawal by Subject|24|||
146981274|NCT00475852|530093828|FG000|Overall Study|Lost to Follow-up|54|||
146981275|NCT00475852|530093829|FG001|Overall Study|Lost to Follow-up|68|||
146981276|NCT02063698|530093830|FG000|Overall Study|did not complete booklet for days 2-8|1|||
146981277|NCT02063698|530093831|FG001|Overall Study|did not complete booklet for days 2-8|2|||
146715204|NCT02019719|529129471|FG002|Overall Study|Adverse Event|0|||
146715205|NCT02019719|529129472|FG003|Overall Study|Adverse Event|1|||
146715206|NCT02019719|529129473|FG004|Overall Study|Adverse Event|1|||
146715207|NCT02019719|529129469|FG000|Overall Study|Protocol Violation|1|||
146715208|NCT02019719|529129470|FG001|Overall Study|Protocol Violation|1|||
146715209|NCT02019719|529129471|FG002|Overall Study|Protocol Violation|0|||
146715210|NCT02019719|529129472|FG003|Overall Study|Protocol Violation|0|||
146715211|NCT02019719|529129473|FG004|Overall Study|Protocol Violation|0|||
146715212|NCT02019719|529129469|FG000|Overall Study|Protocol defined stopping criteria|2|||
146715213|NCT02019719|529129470|FG001|Overall Study|Protocol defined stopping criteria|0|||
146715214|NCT02019719|529129471|FG002|Overall Study|Protocol defined stopping criteria|0|||
146715215|NCT02019719|529129472|FG003|Overall Study|Protocol defined stopping criteria|1|||
146715216|NCT02019719|529129473|FG004|Overall Study|Protocol defined stopping criteria|1|||
146715217|NCT02019719|529129469|FG000|Overall Study|Physician Decision|2|||
146715218|NCT02019719|529129470|FG001|Overall Study|Physician Decision|0|||
146715219|NCT02019719|529129471|FG002|Overall Study|Physician Decision|0|||
146715220|NCT02019719|529129472|FG003|Overall Study|Physician Decision|0|||
146715221|NCT02019719|529129473|FG004|Overall Study|Physician Decision|0|||
146715222|NCT01055639|529129475|FG000|Overall Study|Adverse Event|0|||
146715223|NCT01055639|529129476|FG001|Overall Study|Adverse Event|1|||
146715224|NCT01055639|529129475|FG000|Overall Study|Lack of Efficacy|0|||
146715225|NCT01055639|529129476|FG001|Overall Study|Lack of Efficacy|1|||
146715226|NCT01055639|529129475|FG000|Overall Study|Lost to Follow-up|8|||
146715227|NCT01055639|529129476|FG001|Overall Study|Lost to Follow-up|11|||
146715228|NCT01055639|529129475|FG000|Overall Study|Protocol Violation|5|||
146715229|NCT01055639|529129476|FG001|Overall Study|Protocol Violation|5|||
146715230|NCT01055639|529129475|FG000|Overall Study|Withdrawal by Subject|8|||
146715231|NCT01055639|529129476|FG001|Overall Study|Withdrawal by Subject|11|||
146715232|NCT00765245|529129477|FG000|Overall Study|disease progression|3|||
146715233|NCT00765245|529129478|FG001|Overall Study|disease progression|2|||
146715234|NCT00765245|529129477|FG000|Overall Study|Withdrawal by Subject|3|||
146715235|NCT00765245|529129478|FG001|Overall Study|Withdrawal by Subject|0|||
146715236|NCT00765245|529129477|FG000|Overall Study|Adverse Event|5|||
146715237|NCT00765245|529129478|FG001|Overall Study|Adverse Event|0|||
146715238|NCT00765245|529129477|FG000|Overall Study|Physician Decision|1|||
146715239|NCT00765245|529129478|FG001|Overall Study|Physician Decision|0|||
146715240|NCT00765245|529129477|FG000|Overall Study|Death|1|||
146715241|NCT00765245|529129478|FG001|Overall Study|Death|0|||
146715242|NCT01197950|529129479|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
146715243|NCT01197950|529129480|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
146715244|NCT01197950|529129481|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
146715245|NCT04000165|529129488|FG000|Overall Study|Physician Decision|1|||
146715246|NCT04000165|529129488|FG000|Overall Study|Withdrawal by Subject|1|||
146715247|NCT00941603|529129489|FG000|Overall Study|Adverse Event|10|||
146715248|NCT00941603|529129490|FG001|Overall Study|Adverse Event|15|||
146981278|NCT00297479|530093832|FG000|Overall Study|Lost to Follow-up|37|||
146981279|NCT00297479|530093833|FG001|Overall Study|Lost to Follow-up|54|||
146981280|NCT00297479|530093834|FG002|Overall Study|Lost to Follow-up|51|||
146981281|NCT01664494|530093835|FG000|Overall Study|Withdrawal by Subject|27|||
146981282|NCT01664494|530093835|FG000|Overall Study|Death|18|||
146715249|NCT00941603|529129491|FG002|Overall Study|Adverse Event|5|||
146715250|NCT00941603|529129492|FG003|Overall Study|Adverse Event|1|||
146715251|NCT00941603|529129493|FG004|Overall Study|Adverse Event|4|||
146715252|NCT00941603|529129494|FG005|Overall Study|Adverse Event|0|||
146715253|NCT00941603|529129489|FG000|Overall Study|Lost to Follow-up|0|||
146715254|NCT00941603|529129490|FG001|Overall Study|Lost to Follow-up|0|||
146715255|NCT00941603|529129491|FG002|Overall Study|Lost to Follow-up|0|||
146715256|NCT00941603|529129492|FG003|Overall Study|Lost to Follow-up|1|||
146715257|NCT00941603|529129493|FG004|Overall Study|Lost to Follow-up|0|||
146715258|NCT00941603|529129494|FG005|Overall Study|Lost to Follow-up|2|||
146715259|NCT00941603|529129489|FG000|Overall Study|Withdrawal by Subject|0|||
146715260|NCT00941603|529129490|FG001|Overall Study|Withdrawal by Subject|0|||
146715261|NCT00941603|529129491|FG002|Overall Study|Withdrawal by Subject|0|||
146715262|NCT00941603|529129492|FG003|Overall Study|Withdrawal by Subject|2|||
146981283|NCT01664494|530093835|FG000|Overall Study|Other|49|||
146780557|NCT00632749|529366222|FG010|Overall Study|Reason other than those specified above|2|||
146780558|NCT00632749|529366223|FG011|Overall Study|Reason other than those specified above|1|||
146780559|NCT00632749|529366224|FG012|Overall Study|Reason other than those specified above|0|||
146780560|NCT00632749|529366225|FG013|Overall Study|Reason other than those specified above|2|||
146780561|NCT04999592|529366226|FG000|Overall Study|Withdrawal by Subject|1|||
146780562|NCT04999592|529366227|FG001|Overall Study|Withdrawal by Subject|0|||
146780563|NCT00879333|529366228|FG000|Overall Study|Adverse Event|94|||
146780564|NCT00879333|529366229|FG001|Overall Study|Adverse Event|34|||
146780565|NCT00879333|529366228|FG000|Overall Study|Abnormal Laboratory Value|1|||
146780566|NCT00879333|529366229|FG001|Overall Study|Abnormal Laboratory Value|0|||
146780567|NCT00879333|529366228|FG000|Overall Study|Withdrawal by Subject|20|||
146780568|NCT00879333|529366229|FG001|Overall Study|Withdrawal by Subject|7|||
146780569|NCT00879333|529366228|FG000|Overall Study|Lost to Follow-up|2|||
146780570|NCT00879333|529366229|FG001|Overall Study|Lost to Follow-up|1|||
146780571|NCT00879333|529366228|FG000|Overall Study|Administrative Problems|2|||
146780572|NCT00879333|529366229|FG001|Overall Study|Administrative Problems|0|||
146780573|NCT00879333|529366228|FG000|Overall Study|Death|16|||
146780574|NCT00879333|529366229|FG001|Overall Study|Death|5|||
146780575|NCT00879333|529366228|FG000|Overall Study|Disease Progression|292|||
146780576|NCT00879333|529366229|FG001|Overall Study|Disease Progression|169|||
146780577|NCT00879333|529366228|FG000|Overall Study|Protocol Violation|1|||
146780578|NCT00879333|529366229|FG001|Overall Study|Protocol Violation|1|||
146780579|NCT02671435|529366236|FG000|Overall Study|Death|1|||
146780580|NCT02671435|529366237|FG001|Overall Study|Death|3|||
146780581|NCT02671435|529366238|FG002|Overall Study|Death|0|||
146780582|NCT02671435|529366239|FG003|Overall Study|Death|16|||
146780583|NCT02671435|529366240|FG004|Overall Study|Death|14|||
146780584|NCT02671435|529366241|FG005|Overall Study|Death|29|||
146780585|NCT02671435|529366242|FG006|Overall Study|Death|34|||
146780586|NCT02671435|529366243|FG007|Overall Study|Death|28|||
146780587|NCT02671435|529366244|FG008|Overall Study|Death|19|||
146780588|NCT02671435|529366245|FG009|Overall Study|Death|10|||
146780589|NCT02671435|529366246|FG010|Overall Study|Death|8|||
146780590|NCT02671435|529366247|FG011|Overall Study|Death|29|||
146780591|NCT02671435|529366248|FG012|Overall Study|Death|29|||
146780592|NCT02671435|529366249|FG013|Overall Study|Death|29|||
146780593|NCT02671435|529366250|FG014|Overall Study|Death|27|||
146780594|NCT02671435|529366236|FG000|Overall Study|Lost to Follow-up|0|||
146780595|NCT02671435|529366237|FG001|Overall Study|Lost to Follow-up|0|||
146780596|NCT02671435|529366238|FG002|Overall Study|Lost to Follow-up|1|||
146780597|NCT02671435|529366239|FG003|Overall Study|Lost to Follow-up|0|||
146780598|NCT02671435|529366240|FG004|Overall Study|Lost to Follow-up|1|||
146780599|NCT02671435|529366241|FG005|Overall Study|Lost to Follow-up|1|||
146780600|NCT02671435|529366242|FG006|Overall Study|Lost to Follow-up|2|||
146780601|NCT02671435|529366243|FG007|Overall Study|Lost to Follow-up|2|||
146934063|NCT00599027|529916063|FG000|Overall Study|Adverse Event|0|||
146934064|NCT00599027|529916064|FG001|Overall Study|Adverse Event|1|||
146934065|NCT00599027|529916063|FG000|Overall Study|Treatment Failure|0|||
146934066|NCT00599027|529916064|FG001|Overall Study|Treatment Failure|1|||
146934067|NCT00475540|529916065|FG000|36 Months|Lost to Follow-up|4|||
146934068|NCT00475540|529916066|FG001|36 Months|Lost to Follow-up|4|||
146934069|NCT00475540|529916065|FG000|36 Months|Death|1|||
146934070|NCT00475540|529916066|FG001|36 Months|Death|2|||
146934071|NCT00475540|529916065|FG000|36 Months|Censored due to reoperation|3|||
146934072|NCT00475540|529916066|FG001|36 Months|Censored due to reoperation|0|||
146934073|NCT02133742|529916085|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
146934074|NCT02133742|529916085|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
146934075|NCT02133742|529916085|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
146934076|NCT02133742|529916085|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
146934077|NCT02133742|529916085|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
146934078|NCT03479216|529916086|FG000|Overall Study|Withdrawal by Subject|3|||
146780602|NCT02671435|529366244|FG008|Overall Study|Lost to Follow-up|0|||
146780603|NCT02671435|529366245|FG009|Overall Study|Lost to Follow-up|2|||
146780604|NCT02671435|529366246|FG010|Overall Study|Lost to Follow-up|0|||
146780605|NCT02671435|529366247|FG011|Overall Study|Lost to Follow-up|3|||
146780606|NCT02671435|529366248|FG012|Overall Study|Lost to Follow-up|3|||
146981284|NCT01664494|530093835|FG000|Overall Study|Lost to Follow-up|99|||
146780607|NCT02671435|529366249|FG013|Overall Study|Lost to Follow-up|2|||
146780608|NCT02671435|529366250|FG014|Overall Study|Lost to Follow-up|0|||
146780609|NCT02671435|529366236|FG000|Overall Study|Withdrawal by Subject|2|||
146780610|NCT02671435|529366237|FG001|Overall Study|Withdrawal by Subject|0|||
146780611|NCT02671435|529366238|FG002|Overall Study|Withdrawal by Subject|2|||
146780612|NCT02671435|529366239|FG003|Overall Study|Withdrawal by Subject|2|||
146780613|NCT02671435|529366240|FG004|Overall Study|Withdrawal by Subject|2|||
146780614|NCT02671435|529366241|FG005|Overall Study|Withdrawal by Subject|7|||
146780615|NCT02671435|529366242|FG006|Overall Study|Withdrawal by Subject|2|||
146780616|NCT02671435|529366243|FG007|Overall Study|Withdrawal by Subject|7|||
146780617|NCT02671435|529366244|FG008|Overall Study|Withdrawal by Subject|1|||
146780618|NCT02671435|529366245|FG009|Overall Study|Withdrawal by Subject|1|||
146780619|NCT02671435|529366246|FG010|Overall Study|Withdrawal by Subject|2|||
146780620|NCT02671435|529366247|FG011|Overall Study|Withdrawal by Subject|4|||
146780621|NCT02671435|529366248|FG012|Overall Study|Withdrawal by Subject|4|||
146780622|NCT02671435|529366249|FG013|Overall Study|Withdrawal by Subject|4|||
146780623|NCT02671435|529366250|FG014|Overall Study|Withdrawal by Subject|2|||
146780624|NCT02671435|529366236|FG000|Overall Study|Un-specified|0|||
146780625|NCT02671435|529366237|FG001|Overall Study|Un-specified|0|||
146780626|NCT02671435|529366238|FG002|Overall Study|Un-specified|0|||
146780627|NCT02671435|529366239|FG003|Overall Study|Un-specified|0|||
146780628|NCT02671435|529366240|FG004|Overall Study|Un-specified|1|||
146780629|NCT02671435|529366241|FG005|Overall Study|Un-specified|3|||
146780630|NCT02671435|529366242|FG006|Overall Study|Un-specified|2|||
146780631|NCT02671435|529366243|FG007|Overall Study|Un-specified|3|||
146780632|NCT02671435|529366244|FG008|Overall Study|Un-specified|0|||
146780633|NCT02671435|529366245|FG009|Overall Study|Un-specified|5|||
146780634|NCT02671435|529366246|FG010|Overall Study|Un-specified|8|||
146780635|NCT02671435|529366247|FG011|Overall Study|Un-specified|4|||
146780636|NCT02671435|529366248|FG012|Overall Study|Un-specified|5|||
146780637|NCT02671435|529366249|FG013|Overall Study|Un-specified|9|||
146780638|NCT02671435|529366250|FG014|Overall Study|Un-specified|8|||
146780639|NCT04095104|529366251|FG000|Overall Study|Withdrawal by Subject|0|||
146780640|NCT04095104|529366252|FG001|Overall Study|Withdrawal by Subject|1|||
146780641|NCT01721291|529366255|FG000|Overall Study|Withdrawal by Subject|1|||
146780642|NCT01721291|529366256|FG001|Overall Study|Withdrawal by Subject|0|||
146780643|NCT01721291|529366255|FG000|Overall Study|did not like the treatment|1|||
146780644|NCT01721291|529366256|FG001|Overall Study|did not like the treatment|0|||
146780645|NCT01091168|529366257|FG000|Overall Study|Progressive disease|250|||
146715263|NCT00941603|529129493|FG004|Overall Study|Withdrawal by Subject|0|||
146715264|NCT00941603|529129494|FG005|Overall Study|Withdrawal by Subject|1|||
146715265|NCT00941603|529129489|FG000|Overall Study|Protocol Violation|0|||
146715266|NCT00941603|529129490|FG001|Overall Study|Protocol Violation|1|||
146715267|NCT00941603|529129491|FG002|Overall Study|Protocol Violation|0|||
146715268|NCT00941603|529129492|FG003|Overall Study|Protocol Violation|0|||
146715269|NCT00941603|529129493|FG004|Overall Study|Protocol Violation|0|||
146715270|NCT00941603|529129494|FG005|Overall Study|Protocol Violation|0|||
146715271|NCT00941603|529129489|FG000|Overall Study|Did not meet protocol eligibility|1|||
146715272|NCT00941603|529129490|FG001|Overall Study|Did not meet protocol eligibility|0|||
146715273|NCT00941603|529129491|FG002|Overall Study|Did not meet protocol eligibility|0|||
146715274|NCT00941603|529129492|FG003|Overall Study|Did not meet protocol eligibility|0|||
146715275|NCT00941603|529129493|FG004|Overall Study|Did not meet protocol eligibility|0|||
146715276|NCT00941603|529129494|FG005|Overall Study|Did not meet protocol eligibility|0|||
146715277|NCT02079805|529129495|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
146715278|NCT02079805|529129496|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
146715279|NCT02079805|529129495|FG000|Overall Study|Voluntary Withdrawal|0|||
146715280|NCT02079805|529129496|FG001|Overall Study|Voluntary Withdrawal|1|||
146715281|NCT00383435|529129497|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
146715282|NCT00383435|529129498|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
146715283|NCT00383435|529129499|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
146715284|NCT00383435|529129500|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
146715285|NCT00383435|529129501|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
146715286|NCT00383435|529129497|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
146715287|NCT00383435|529129498|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
146715288|NCT00383435|529129499|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
146715289|NCT00383435|529129500|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
146715290|NCT00383435|529129501|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
146715291|NCT00383435|529129497|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
146715292|NCT00383435|529129498|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
146715293|NCT00383435|529129499|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
146715294|NCT00383435|529129500|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
146715295|NCT00383435|529129501|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
146715296|NCT00383435|529129497|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
146780646|NCT01091168|529366258|FG001|Overall Study|Progressive disease|234|||
146780647|NCT01091168|529366257|FG000|Overall Study|Adverse Event|21|||
146780648|NCT01091168|529366258|FG001|Overall Study|Adverse Event|24|||
146780649|NCT01091168|529366257|FG000|Overall Study|Lost to Follow-up|0|||
146780650|NCT01091168|529366258|FG001|Overall Study|Lost to Follow-up|1|||
146780651|NCT01091168|529366257|FG000|Overall Study|Physician, patient's decision, other|27|||
146780652|NCT01091168|529366258|FG001|Overall Study|Physician, patient's decision, other|37|||
146780653|NCT03767517|529366259|FG000|Overall Study|Lost to Follow-up|16|||
146780654|NCT03767517|529366260|FG001|Overall Study|Lost to Follow-up|10|||
146715297|NCT00383435|529129498|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
146715298|NCT00383435|529129499|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
146715299|NCT00383435|529129500|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
146715300|NCT00383435|529129501|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
146715301|NCT00383435|529129497|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
146715302|NCT00383435|529129498|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
146715303|NCT00383435|529129499|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
146715304|NCT00383435|529129500|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
146715305|NCT00383435|529129501|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
146715306|NCT00383435|529129497|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
146715307|NCT00383435|529129498|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
146715308|NCT00383435|529129499|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
146715309|NCT00383435|529129500|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
146715310|NCT00383435|529129501|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
146715311|NCT00383435|529129497|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
146715312|NCT00383435|529129498|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
146715313|NCT00383435|529129499|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
146715314|NCT00383435|529129500|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
146715315|NCT00383435|529129501|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
146715316|NCT00383435|529129497|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
146715317|NCT00383435|529129498|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
146715318|NCT00383435|529129499|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
146715319|NCT00383435|529129500|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
146715320|NCT00383435|529129501|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
146715321|NCT00383435|529129497|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
146715322|NCT00383435|529129498|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
146715323|NCT00383435|529129499|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
146715324|NCT00383435|529129500|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
146715325|NCT00383435|529129501|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
146715326|NCT00383435|529129497|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
146715327|NCT00383435|529129498|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
146715328|NCT00383435|529129499|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
146715329|NCT00383435|529129500|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
146715330|NCT00383435|529129501|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
146715331|NCT00383435|529129497|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
146715332|NCT00383435|529129498|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
146715333|NCT00383435|529129499|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
146715334|NCT00383435|529129500|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
146715335|NCT00383435|529129501|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
146715336|NCT00383435|529129497|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
146715337|NCT00383435|529129498|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
146715338|NCT00383435|529129499|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
146715339|NCT00383435|529129500|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
146715340|NCT00383435|529129501|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
146715341|NCT00383435|529129497|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
146715342|NCT00383435|529129498|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
146715343|NCT00383435|529129499|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
146715344|NCT00383435|529129500|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
146715345|NCT00383435|529129501|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
146715346|NCT00383435|529129497|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
146715347|NCT00383435|529129498|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
146715348|NCT00383435|529129499|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
146715349|NCT00383435|529129500|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
146715350|NCT00383435|529129501|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
146715351|NCT00383435|529129497|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
146715352|NCT00383435|529129498|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
146715353|NCT00383435|529129499|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
146715354|NCT00383435|529129500|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
146715355|NCT00383435|529129501|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
146715356|NCT00383435|529129497|FG000|26-Week Treatment Safety Extension|Administrative|1|||
146715357|NCT00383435|529129498|FG001|26-Week Treatment Safety Extension|Administrative|1|||
146715358|NCT00383435|529129499|FG002|26-Week Treatment Safety Extension|Administrative|0|||
146715359|NCT00383435|529129500|FG003|26-Week Treatment Safety Extension|Administrative|1|||
146715360|NCT00383435|529129501|FG004|26-Week Treatment Safety Extension|Administrative|0|||
146934079|NCT03479216|529916087|FG001|Overall Study|Withdrawal by Subject|2|||
146780655|NCT03767517|529366259|FG000|Overall Study|Death|2|||
146780656|NCT03767517|529366260|FG001|Overall Study|Death|3|||
146780657|NCT03690206|529366262|FG000|Overall Study|Withdrawal by Subject|2|||
146780658|NCT03690206|529366263|FG001|Overall Study|Withdrawal by Subject|0|||
146780659|NCT03690206|529366264|FG002|Overall Study|Withdrawal by Subject|0|||
146780660|NCT03690206|529366262|FG000|Overall Study|ICF withdrawal|2|||
146780661|NCT03690206|529366263|FG001|Overall Study|ICF withdrawal|0|||
146780662|NCT03690206|529366264|FG002|Overall Study|ICF withdrawal|0|||
146780663|NCT04059354|529367498|FG000|Overall Study|COVID-19 pandemic|3|||
146780664|NCT02396199|529367500|FG000|Overall Study|Lost to Follow-up|1|||
146780665|NCT02396199|529367500|FG000|Overall Study|Death|4|||
146780666|NCT04868110|529367505|FG000|Overall Study|Withdrawal by Subject|3|||
146780667|NCT04868110|529367506|FG001|Overall Study|Withdrawal by Subject|4|||
146780668|NCT03263026|529367507|FG000|Overall Study|Withdrawal by Subject|1|||
146780669|NCT03263026|529367508|FG001|Overall Study|Withdrawal by Subject|0|||
146780670|NCT03263026|529367507|FG000|Overall Study|Death|1|||
146780671|NCT03263026|529367508|FG001|Overall Study|Death|0|||
146780672|NCT03263026|529367507|FG000|Overall Study|Other/ Various|41|||
146780673|NCT03263026|529367508|FG001|Overall Study|Other/ Various|29|||
146780674|NCT05320432|529367512|FG000|Overall Study|Withdrawal by Subject|0|||
146780675|NCT05320432|529367513|FG001|Overall Study|Withdrawal by Subject|2|||
146780676|NCT03739996|529367517|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
146780677|NCT03739996|529367517|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
146780678|NCT03739996|529367517|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
146780679|NCT03739996|529367517|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
146780680|NCT03739996|529367517|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
146780681|NCT03739996|529367517|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
146780682|NCT03739996|529367517|FG000|Step 3 (SOC ART)|Death|1|||
146780683|NCT03739996|529367517|FG000|Step 3 (SOC ART)|Participant moved|1|||
146780684|NCT04711135|529367521|FG000|Overall Study|Physician Decision|0|||
146780685|NCT04711135|529367522|FG001|Overall Study|Physician Decision|1|||
146780686|NCT04711135|529367521|FG000|Overall Study|Ongoing treatment|0|||
146780687|NCT04711135|529367522|FG001|Overall Study|Ongoing treatment|1|||
146780688|NCT03578536|529367526|FG000|Overall Study|Lost to Follow-up|1|||
146780689|NCT02538900|529367528|FG000|Overall Study|Death|2|||
146780690|NCT02538900|529367529|FG001|Overall Study|Death|2|||
146780691|NCT02538900|529367530|FG002|Overall Study|Death|2|||
146780692|NCT02538900|529367528|FG000|Overall Study|Withdrawal by Subject|18|||
146780693|NCT02538900|529367529|FG001|Overall Study|Withdrawal by Subject|16|||
146780694|NCT02538900|529367530|FG002|Overall Study|Withdrawal by Subject|15|||
146780695|NCT02874534|529367531|FG000|Overall Study|Withdrawal by Subject|5|||
146780696|NCT02874534|529367532|FG001|Overall Study|Withdrawal by Subject|8|||
146780697|NCT02874534|529367531|FG000|Overall Study|Lost to Follow-up|2|||
146780698|NCT02874534|529367532|FG001|Overall Study|Lost to Follow-up|2|||
146780699|NCT02874534|529367531|FG000|Overall Study|Ongoing in study|1|||
146780700|NCT02874534|529367532|FG001|Overall Study|Ongoing in study|1|||
146780701|NCT04431726|529367533|FG000|Overall Study|Ongoing in the Study|55|||
146780702|NCT05198310|529367534|FG000|Overall Study|Lost to Follow-up|0|||
146780703|NCT05198310|529367535|FG001|Overall Study|Lost to Follow-up|1|||
146780704|NCT05198310|529367536|FG002|Overall Study|Lost to Follow-up|0|||
146780705|NCT05198310|529367537|FG003|Overall Study|Lost to Follow-up|0|||
146780706|NCT05198310|529367538|FG004|Overall Study|Lost to Follow-up|0|||
146780707|NCT05198310|529367539|FG005|Overall Study|Lost to Follow-up|0|||
146780708|NCT05198310|529367540|FG006|Overall Study|Lost to Follow-up|0|||
146780709|NCT05198310|529367541|FG007|Overall Study|Lost to Follow-up|0|||
146780710|NCT05198310|529367534|FG000|Overall Study|Withdrawal by Subject|0|||
146780711|NCT05198310|529367535|FG001|Overall Study|Withdrawal by Subject|0|||
146780712|NCT05198310|529367536|FG002|Overall Study|Withdrawal by Subject|0|||
146780713|NCT05198310|529367537|FG003|Overall Study|Withdrawal by Subject|2|||
146780714|NCT05198310|529367538|FG004|Overall Study|Withdrawal by Subject|0|||
146780715|NCT05198310|529367539|FG005|Overall Study|Withdrawal by Subject|2|||
146934080|NCT03479216|529916086|FG000|Overall Study|Physician Decision|2|||
146934081|NCT03479216|529916087|FG001|Overall Study|Physician Decision|3|||
146780716|NCT05198310|529367540|FG006|Overall Study|Withdrawal by Subject|1|||
146934082|NCT02031432|529916088|FG000|Overall Study|Protocol Violation|1|||
146934083|NCT02031432|529916088|FG000|Overall Study|Lack of Efficacy|5|||
146780717|NCT05198310|529367541|FG007|Overall Study|Withdrawal by Subject|3|||
146780718|NCT04281485|529367542|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
146780719|NCT04281485|529367543|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
146780720|NCT04281485|529367542|FG000|Overall Study|Ongoing (Safety data collection)|10|||
146780721|NCT04281485|529367543|FG001|Overall Study|Ongoing (Safety data collection)|5|||
146780722|NCT04436107|529367544|FG000|Overall Study|Sponsor Ended Study|2|||
146780723|NCT04436107|529367545|FG001|Overall Study|Sponsor Ended Study|4|||
146780724|NCT04436107|529367546|FG002|Overall Study|Sponsor Ended Study|8|||
146780725|NCT04436107|529367547|FG003|Overall Study|Sponsor Ended Study|20|||
146780726|NCT04436107|529367544|FG000|Overall Study|Death|3|||
146934084|NCT02031432|529916088|FG000|Overall Study|Cancer Progression|2|||
146715361|NCT02347761|529129502|FG000|All Collected|Death|1|||
146715362|NCT02347761|529129503|FG001|All Collected|Death|0|||
146715363|NCT02347761|529129504|FG002|All Collected|Death|0|||
146715364|NCT02347761|529129502|FG000|All Collected|Lost to Follow-up|3|||
146715365|NCT02347761|529129503|FG001|All Collected|Lost to Follow-up|2|||
146715366|NCT02347761|529129504|FG002|All Collected|Lost to Follow-up|3|||
146715367|NCT02347761|529129502|FG000|All Collected|Withdrawal by Subject|11|||
146715368|NCT02347761|529129503|FG001|All Collected|Withdrawal by Subject|11|||
146715369|NCT02347761|529129504|FG002|All Collected|Withdrawal by Subject|22|||
146715370|NCT02347761|529129502|FG000|All Collected|invetigator disretion|2|||
146715371|NCT02347761|529129503|FG001|All Collected|invetigator disretion|0|||
146715372|NCT02347761|529129504|FG002|All Collected|invetigator disretion|0|||
146715373|NCT02347761|529129502|FG000|All Collected|instillation site pain|0|||
146715374|NCT02347761|529129503|FG001|All Collected|instillation site pain|0|||
146715375|NCT02347761|529129504|FG002|All Collected|instillation site pain|1|||
146715376|NCT02347761|529129502|FG000|All Collected|exacerbation of COPD|0|||
146715377|NCT02347761|529129503|FG001|All Collected|exacerbation of COPD|0|||
146715378|NCT02347761|529129504|FG002|All Collected|exacerbation of COPD|1|||
146715379|NCT02347761|529129502|FG000|All Collected|moved/travel|0|||
146715380|NCT02347761|529129503|FG001|All Collected|moved/travel|1|||
146715381|NCT02347761|529129504|FG002|All Collected|moved/travel|0|||
146715382|NCT02347761|529129502|FG000|On Study Treatment|Lack of Efficacy|2|||
146715383|NCT02347761|529129503|FG001|On Study Treatment|Lack of Efficacy|3|||
146715384|NCT02347761|529129504|FG002|On Study Treatment|Lack of Efficacy|4|||
146715385|NCT02347761|529129502|FG000|On Study Treatment|non-compliance with study medication|0|||
146715386|NCT02347761|529129503|FG001|On Study Treatment|non-compliance with study medication|0|||
146715387|NCT02347761|529129504|FG002|On Study Treatment|non-compliance with study medication|2|||
146715388|NCT02347761|529129502|FG000|On Study Treatment|Withdrawal by Subject|7|||
146715389|NCT02347761|529129503|FG001|On Study Treatment|Withdrawal by Subject|3|||
146715390|NCT02347761|529129504|FG002|On Study Treatment|Withdrawal by Subject|5|||
146715391|NCT02347761|529129502|FG000|On Study Treatment|move/travel|2|||
146715392|NCT02347761|529129503|FG001|On Study Treatment|move/travel|6|||
146715393|NCT02347761|529129504|FG002|On Study Treatment|move/travel|5|||
146715394|NCT02347761|529129502|FG000|On Study Treatment|dissastisfaction with device|2|||
146715395|NCT02347761|529129503|FG001|On Study Treatment|dissastisfaction with device|1|||
146715396|NCT02347761|529129504|FG002|On Study Treatment|dissastisfaction with device|4|||
146715397|NCT02347761|529129502|FG000|On Study Treatment|Lost to Follow-up|2|||
146715398|NCT02347761|529129503|FG001|On Study Treatment|Lost to Follow-up|1|||
146715399|NCT02347761|529129504|FG002|On Study Treatment|Lost to Follow-up|1|||
146715400|NCT02347761|529129502|FG000|On Study Treatment|investigator discretion|2|||
146715401|NCT02347761|529129503|FG001|On Study Treatment|investigator discretion|0|||
146715402|NCT02347761|529129504|FG002|On Study Treatment|investigator discretion|0|||
146715403|NCT02347761|529129502|FG000|On Study Treatment|durg not working|0|||
146715404|NCT02347761|529129503|FG001|On Study Treatment|durg not working|1|||
146715405|NCT02347761|529129504|FG002|On Study Treatment|durg not working|1|||
146715406|NCT02347761|529129502|FG000|On Study Treatment|Adverse Event|10|||
146715407|NCT02347761|529129503|FG001|On Study Treatment|Adverse Event|8|||
146715408|NCT02347761|529129504|FG002|On Study Treatment|Adverse Event|20|||
146715409|NCT01131312|529129505|FG000|Overall Study|Lost to Follow-up|425|||
146715410|NCT01131312|529129506|FG001|Overall Study|Lost to Follow-up|229|||
146715411|NCT01131312|529129507|FG002|Overall Study|Lost to Follow-up|351|||
146715412|NCT02682264|529129508|FG000|Overall Study|Withdrawal by Subject|56|||
146715413|NCT02682264|529129509|FG001|Overall Study|Withdrawal by Subject|45|||
146715414|NCT02682264|529129508|FG000|Overall Study|Lost to Follow-up|49|||
146715415|NCT02682264|529129509|FG001|Overall Study|Lost to Follow-up|41|||
146715416|NCT02682264|529129508|FG000|Overall Study|Lack of Efficacy|14|||
146715417|NCT02682264|529129509|FG001|Overall Study|Lack of Efficacy|16|||
146715418|NCT02682264|529129508|FG000|Overall Study|Withdrawal by Parent|6|||
146715419|NCT02682264|529129509|FG001|Overall Study|Withdrawal by Parent|7|||
146780727|NCT04436107|529367545|FG001|Overall Study|Death|5|||
146780728|NCT04436107|529367546|FG002|Overall Study|Death|3|||
146780729|NCT04436107|529367547|FG003|Overall Study|Death|18|||
146715420|NCT02682264|529129508|FG000|Overall Study|Adverse Event|9|||
146715421|NCT02682264|529129509|FG001|Overall Study|Adverse Event|0|||
146715422|NCT02682264|529129508|FG000|Overall Study|Noncompliance with study drug|1|||
146715423|NCT02682264|529129509|FG001|Overall Study|Noncompliance with study drug|4|||
146715424|NCT02682264|529129508|FG000|Overall Study|Pregnancy|1|||
146715425|NCT02682264|529129509|FG001|Overall Study|Pregnancy|2|||
146715426|NCT02682264|529129508|FG000|Overall Study|Recovery|1|||
146715427|NCT02682264|529129509|FG001|Overall Study|Recovery|2|||
146715428|NCT02682264|529129508|FG000|Overall Study|Progressive Disease|1|||
146715429|NCT02682264|529129509|FG001|Overall Study|Progressive Disease|0|||
146715430|NCT02682264|529129508|FG000|Overall Study|Technical Problems|0|||
146715431|NCT02682264|529129509|FG001|Overall Study|Technical Problems|1|||
146715432|NCT02682264|529129508|FG000|Overall Study|Moved abroad and unable to continue|0|||
146715433|NCT02682264|529129509|FG001|Overall Study|Moved abroad and unable to continue|3|||
146780730|NCT04436107|529367544|FG000|Overall Study|Withdrawal by Subject|1|||
146715434|NCT02682264|529129508|FG000|Overall Study|Stopped test article application|0|||
146715435|NCT02682264|529129509|FG001|Overall Study|Stopped test article application|1|||
146715436|NCT01255358|529129511|FG000|Overall Study|Adverse Event|2|||
146715437|NCT01255358|529129511|FG000|Overall Study|Protocol Violation|2|||
146715438|NCT03950739|529129512|FG000|Treatment Phase|Adverse Event|2|||
146715439|NCT03950739|529129512|FG000|Optional Extension Phase|Death|1|||
146715440|NCT03950739|529129512|FG000|Optional Extension Phase|Progressive Disease|5|||
146715441|NCT03950739|529129512|FG000|Optional Extension Phase|Adverse Event|7|||
146715442|NCT03950739|529129512|FG000|Optional Extension Phase|Lost to Follow-up|2|||
146715443|NCT03950739|529129512|FG000|Optional Extension Phase|Site Closure|2|||
146715444|NCT03950739|529129512|FG000|Optional Extension Phase|Pregnancy|1|||
146715445|NCT03264989|529129514|FG000|Overall Study|Lost to Follow-up|1|||
146715446|NCT03264989|529129515|FG001|Overall Study|Lost to Follow-up|0|||
146715447|NCT03264989|529129514|FG000|Overall Study|New Therapy for study Indication|1|||
146715448|NCT03264989|529129515|FG001|Overall Study|New Therapy for study Indication|0|||
146715449|NCT03264989|529129514|FG000|Overall Study|Protocol Violation|0|||
146715450|NCT03264989|529129515|FG001|Overall Study|Protocol Violation|1|||
146715451|NCT03264989|529129514|FG000|Overall Study|Patient decision|13|||
146715452|NCT03264989|529129515|FG001|Overall Study|Patient decision|0|||
146715453|NCT03264989|529129514|FG000|Overall Study|Physician Decision|6|||
146715454|NCT03264989|529129515|FG001|Overall Study|Physician Decision|4|||
146715455|NCT03264989|529129514|FG000|Overall Study|Adverse Event|2|||
146715456|NCT03264989|529129515|FG001|Overall Study|Adverse Event|1|||
146715457|NCT03264989|529129514|FG000|Overall Study|Death|1|||
146715458|NCT03264989|529129515|FG001|Overall Study|Death|1|||
146715459|NCT03264989|529129514|FG000|Overall Study|Pregnancy|2|||
146715460|NCT03264989|529129515|FG001|Overall Study|Pregnancy|0|||
146715461|NCT03264989|529129514|FG000|Overall Study|End of Study|19|||
146715462|NCT03264989|529129515|FG001|Overall Study|End of Study|5|||
146715463|NCT01343056|529129518|FG000|Overall Study|Lost to Follow-up|7|||
146715464|NCT01343056|529129519|FG001|Overall Study|Lost to Follow-up|5|||
146715465|NCT01343056|529129520|FG002|Overall Study|Lost to Follow-up|3|||
146715466|NCT01343056|529129521|FG003|Overall Study|Lost to Follow-up|9|||
146715467|NCT00345579|529129522|FG000|Overall Study|Adverse Event|9|||
146715468|NCT00345579|529129523|FG001|Overall Study|Adverse Event|6|||
146715469|NCT00345579|529129522|FG000|Overall Study|Protocol Violation|14|||
146715470|NCT00345579|529129523|FG001|Overall Study|Protocol Violation|5|||
146715471|NCT00345579|529129522|FG000|Overall Study|Withdrawal by Subject|50|||
146715472|NCT00345579|529129523|FG001|Overall Study|Withdrawal by Subject|17|||
146715473|NCT00345579|529129522|FG000|Overall Study|Lost to Follow-up|82|||
146715474|NCT00345579|529129523|FG001|Overall Study|Lost to Follow-up|36|||
146715475|NCT00345579|529129522|FG000|Overall Study|Other|9|||
146715476|NCT00345579|529129523|FG001|Overall Study|Other|1|||
146715477|NCT01732835|529129524|FG000|6-month Primary Endpoint|Did not receive device|19|||
146715478|NCT01732835|529129524|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
146715479|NCT01732835|529129524|FG000|6-month Primary Endpoint|Adverse Event|3|||
146715480|NCT01732835|529129524|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
146715481|NCT01732835|529129524|FG000|2-year Extended Follow-up|Adverse Event|3|||
146715482|NCT01732835|529129524|FG000|2-year Extended Follow-up|Death|1|||
146715483|NCT02493361|529129525|FG000|Overall Study|Withdrawal by Subject|3|||
146715484|NCT03893448|529129530|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
146715485|NCT03893448|529129531|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
146715486|NCT03893448|529129530|FG000|Overall Study|Physician Decision|8|||
146715487|NCT03893448|529129531|FG001|Overall Study|Physician Decision|14|||
146715488|NCT03893448|529129530|FG000|Overall Study|Lost to Follow-up|34|||
146715489|NCT03893448|529129531|FG001|Overall Study|Lost to Follow-up|27|||
146715490|NCT03893448|529129530|FG000|Overall Study|Death|1|||
146715491|NCT03893448|529129531|FG001|Overall Study|Death|0|||
146715492|NCT00856583|529129536|FG000|Overall Study|Lack of Efficacy|389|||
146715493|NCT00856583|529129537|FG001|Overall Study|Lack of Efficacy|377|||
146715494|NCT00856583|529129536|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
146715495|NCT00856583|529129537|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
146715496|NCT00856583|529129536|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
146715497|NCT00856583|529129537|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
146715498|NCT00856583|529129536|FG000|Overall Study|Non-compliance|305|||
146715499|NCT00856583|529129537|FG001|Overall Study|Non-compliance|262|||
146715500|NCT00856583|529129536|FG000|Overall Study|Withdrawal by Subject|1092|||
146715501|NCT00856583|529129537|FG001|Overall Study|Withdrawal by Subject|919|||
146715502|NCT00856583|529129536|FG000|Overall Study|Physician Decision|59|||
146715503|NCT00856583|529129537|FG001|Overall Study|Physician Decision|82|||
146715504|NCT00856583|529129536|FG000|Overall Study|Pregnancy|14|||
146715505|NCT00856583|529129537|FG001|Overall Study|Pregnancy|5|||
146715506|NCT00856583|529129536|FG000|Overall Study|Other|92|||
146715507|NCT00856583|529129537|FG001|Overall Study|Other|104|||
146715508|NCT00856583|529129536|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
146715509|NCT00856583|529129537|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
146715510|NCT01944046|529129538|FG000|Randomized to DB|Adverse Event|5|||
146715511|NCT01944046|529129539|FG001|Randomized to DB|Adverse Event|2|||
146715512|NCT01944046|529129538|FG000|Randomized to DB|Clinical Worsening|3|||
146934085|NCT02031432|529916088|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
146715513|NCT01944046|529129539|FG001|Randomized to DB|Clinical Worsening|2|||
146715514|NCT01944046|529129538|FG000|Randomized to DB|Lost to Follow-up|3|||
146715515|NCT01944046|529129539|FG001|Randomized to DB|Lost to Follow-up|3|||
146715516|NCT01944046|529129538|FG000|Randomized to DB|Withdrawal by Subject|2|||
146715517|NCT01944046|529129539|FG001|Randomized to DB|Withdrawal by Subject|4|||
146715518|NCT01944046|529129538|FG000|Randomized to DB|Physician Decision|1|||
146715519|NCT01944046|529129539|FG001|Randomized to DB|Physician Decision|2|||
146715520|NCT01944046|529129538|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
146715521|NCT01944046|529129539|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
146715522|NCT01944046|529129538|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
146715523|NCT01944046|529129539|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
146715524|NCT01944046|529129538|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
146715525|NCT01944046|529129539|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
146715526|NCT01944046|529129538|FG000|Open Label Eligible and Consented|Adverse Event|6|||
146715527|NCT01944046|529129539|FG001|Open Label Eligible and Consented|Adverse Event|1|||
146715528|NCT01944046|529129538|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
146715529|NCT01944046|529129539|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
146715530|NCT01944046|529129538|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
146715531|NCT01944046|529129539|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
146715532|NCT01985126|529129543|FG000|Overall Study|Death|15|||
146715533|NCT01985126|529129544|FG001|Overall Study|Death|69|||
146715534|NCT01985126|529129543|FG000|Overall Study|Lost to Follow-up|0|||
146715535|NCT01985126|529129544|FG001|Overall Study|Lost to Follow-up|8|||
146715536|NCT01985126|529129543|FG000|Overall Study|Study Terminated By Sponsor|1|||
146715537|NCT01985126|529129544|FG001|Overall Study|Study Terminated By Sponsor|22|||
146715538|NCT01985126|529129543|FG000|Overall Study|Withdrawal by Subject|2|||
146715539|NCT01985126|529129544|FG001|Overall Study|Withdrawal by Subject|7|||
146715540|NCT02371369|529129547|FG000|Part 1|Physician Decision|0|||
146715541|NCT02371369|529129548|FG001|Part 1|Physician Decision|3|||
146715542|NCT02371369|529129547|FG000|Part 1|Adverse Event|8|||
146715543|NCT02371369|529129548|FG001|Part 1|Adverse Event|0|||
146715544|NCT02371369|529129547|FG000|Part 1|Withdrawal by Subject|1|||
146715545|NCT02371369|529129548|FG001|Part 1|Withdrawal by Subject|6|||
146715546|NCT02371369|529129547|FG000|Part 1|Disease progression|0|||
146715547|NCT02371369|529129548|FG001|Part 1|Disease progression|1|||
146715548|NCT02371369|529129547|FG000|Part 1|Protocol Violation|0|||
146715549|NCT02371369|529129548|FG001|Part 1|Protocol Violation|1|||
146715550|NCT02371369|529129547|FG000|Part 2|Adverse Event|6|||
146715551|NCT02371369|529129548|FG001|Part 2|Adverse Event|5|||
146715552|NCT02371369|529129547|FG000|Part 2|Withdrawal by Subject|16|||
146715553|NCT02371369|529129548|FG001|Part 2|Withdrawal by Subject|6|||
146715554|NCT02371369|529129547|FG000|Part 2|Investigator decision|1|||
146715555|NCT02371369|529129548|FG001|Part 2|Investigator decision|2|||
146715556|NCT02371369|529129547|FG000|Part 2|Death|0|||
146715557|NCT02371369|529129548|FG001|Part 2|Death|1|||
146715558|NCT02371369|529129547|FG000|Part 2|Disease progression|1|||
146715559|NCT02371369|529129548|FG001|Part 2|Disease progression|0|||
146715560|NCT02371369|529129547|FG000|Part 2|Subject Noncompliance|1|||
146715561|NCT02371369|529129548|FG001|Part 2|Subject Noncompliance|0|||
146715562|NCT02371369|529129547|FG000|Part 2|Lost to Follow-up|1|||
146715563|NCT02371369|529129548|FG001|Part 2|Lost to Follow-up|1|||
146715564|NCT02371369|529129547|FG000|Part 2|Subject transitioned to commercial supply|6|||
146715565|NCT02371369|529129548|FG001|Part 2|Subject transitioned to commercial supply|4|||
146715566|NCT02371369|529129547|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
146715567|NCT02371369|529129548|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
146715568|NCT02371369|529129547|FG000|Part 2|Surgical resection of tumor|1|||
146715569|NCT02371369|529129548|FG001|Part 2|Surgical resection of tumor|1|||
146715570|NCT02371369|529129547|FG000|Part 2|Other|0|||
146715571|NCT02371369|529129548|FG001|Part 2|Other|1|||
146715572|NCT01587651|529129551|FG000|Overall Study|Adverse Event|0|||
146715573|NCT01587651|529129552|FG001|Overall Study|Adverse Event|1|||
146715574|NCT01587651|529129553|FG002|Overall Study|Adverse Event|0|||
146715575|NCT01587651|529129551|FG000|Overall Study|Protocol Violation|0|||
146715576|NCT01587651|529129552|FG001|Overall Study|Protocol Violation|1|||
146715577|NCT01587651|529129553|FG002|Overall Study|Protocol Violation|1|||
146715578|NCT01587651|529129551|FG000|Overall Study|Withdrawal by Subject|0|||
146715579|NCT01587651|529129552|FG001|Overall Study|Withdrawal by Subject|1|||
146715580|NCT01587651|529129553|FG002|Overall Study|Withdrawal by Subject|0|||
146715581|NCT03864900|529129558|FG000|Overall Study|Withdrawal by Subject|1|||
146715582|NCT03864900|529129559|FG001|Overall Study|Withdrawal by Subject|1|||
146715583|NCT03864900|529129558|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
146715584|NCT03864900|529129559|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
146715585|NCT01866709|529129562|FG000|Overall Study|Adverse Event|1|||
146715586|NCT01866709|529129563|FG001|Overall Study|Adverse Event|0|||
146934086|NCT02031432|529916088|FG000|Overall Study|Adverse Event|8|||
146934087|NCT02031432|529916088|FG000|Overall Study|Withdrawal by Subject|5|||
146715587|NCT03191903|529129567|FG000|Overall Study|Withdrawal by Subject|6|||
146715588|NCT03191903|529129568|FG001|Overall Study|Withdrawal by Subject|5|||
146715589|NCT03191903|529129569|FG002|Overall Study|Withdrawal by Subject|4|||
146715590|NCT03191903|529129567|FG000|Overall Study|Adverse Event|1|||
146715591|NCT03191903|529129568|FG001|Overall Study|Adverse Event|0|||
146715592|NCT03191903|529129569|FG002|Overall Study|Adverse Event|0|||
146715593|NCT00927927|529129575|FG000|Overall Study|Withdrawal by Subject|0|||
146715594|NCT00927927|529129576|FG001|Overall Study|Withdrawal by Subject|0|||
146715595|NCT00927927|529129577|FG002|Overall Study|Withdrawal by Subject|0|||
146715596|NCT00927927|529129578|FG003|Overall Study|Withdrawal by Subject|0|||
146715597|NCT00927927|529129579|FG004|Overall Study|Withdrawal by Subject|0|||
146715598|NCT00927927|529129580|FG005|Overall Study|Withdrawal by Subject|0|||
146715599|NCT00927927|529129581|FG006|Overall Study|Withdrawal by Subject|0|||
146715600|NCT00927927|529129582|FG007|Overall Study|Withdrawal by Subject|2|||
146715601|NCT00927927|529129583|FG008|Overall Study|Withdrawal by Subject|0|||
146715602|NCT00927927|529129584|FG009|Overall Study|Withdrawal by Subject|0|||
146715603|NCT00927927|529129585|FG010|Overall Study|Withdrawal by Subject|0|||
146715604|NCT00927927|529129586|FG011|Overall Study|Withdrawal by Subject|2|||
146715605|NCT00927927|529129587|FG012|Overall Study|Withdrawal by Subject|0|||
146715606|NCT00927927|529129588|FG013|Overall Study|Withdrawal by Subject|0|||
146715607|NCT00927927|529129589|FG014|Overall Study|Withdrawal by Subject|0|||
146715608|NCT03135522|529129596|FG000|Overall Study|Adverse Event|1|||
146715609|NCT03135522|529129597|FG001|Overall Study|Adverse Event|0|||
146715610|NCT00499369|529129598|FG000|Overall Study|Adverse Event|2|||
146715611|NCT00499369|529129599|FG001|Overall Study|Adverse Event|2|||
146715612|NCT00499369|529129600|FG002|Overall Study|Adverse Event|3|||
146715613|NCT00499369|529129601|FG003|Overall Study|Adverse Event|1|||
146715614|NCT00499369|529129602|FG004|Overall Study|Adverse Event|2|||
146715615|NCT00499369|529129598|FG000|Overall Study|Withdrawal by Subject|0|||
146715616|NCT00499369|529129599|FG001|Overall Study|Withdrawal by Subject|1|||
146715617|NCT00499369|529129600|FG002|Overall Study|Withdrawal by Subject|1|||
146715618|NCT00499369|529129601|FG003|Overall Study|Withdrawal by Subject|0|||
146715619|NCT00499369|529129602|FG004|Overall Study|Withdrawal by Subject|0|||
146715620|NCT00499369|529129598|FG000|Overall Study|Progression|10|||
146715621|NCT00499369|529129599|FG001|Overall Study|Progression|12|||
146715622|NCT00499369|529129600|FG002|Overall Study|Progression|9|||
146715623|NCT00499369|529129601|FG003|Overall Study|Progression|6|||
146715624|NCT00499369|529129602|FG004|Overall Study|Progression|10|||
146715625|NCT00499369|529129598|FG000|Overall Study|Death|0|||
146715626|NCT00499369|529129599|FG001|Overall Study|Death|1|||
146715627|NCT00499369|529129600|FG002|Overall Study|Death|0|||
146715628|NCT00499369|529129601|FG003|Overall Study|Death|0|||
146715629|NCT00499369|529129602|FG004|Overall Study|Death|0|||
146715630|NCT00499369|529129598|FG000|Overall Study|Not protocol specified|2|||
146715631|NCT00499369|529129599|FG001|Overall Study|Not protocol specified|0|||
146715632|NCT00499369|529129600|FG002|Overall Study|Not protocol specified|3|||
146715633|NCT00499369|529129601|FG003|Overall Study|Not protocol specified|1|||
146715634|NCT00499369|529129602|FG004|Overall Study|Not protocol specified|0|||
146715635|NCT00499369|529129598|FG000|Overall Study|Ineligible|2|||
146715636|NCT00499369|529129599|FG001|Overall Study|Ineligible|2|||
146715637|NCT00499369|529129600|FG002|Overall Study|Ineligible|1|||
146715638|NCT00499369|529129601|FG003|Overall Study|Ineligible|1|||
146715639|NCT00499369|529129602|FG004|Overall Study|Ineligible|0|||
146715640|NCT01898195|529129603|FG000|Smoking Abstinence|Did not have good measurements|35|||
146715641|NCT01898195|529129604|FG001|Smoking Abstinence|Did not have good measurements|38|||
146715642|NCT01898195|529129605|FG002|Smoking Abstinence|Did not have good measurements|36|||
146715643|NCT03283670|529129606|FG000|Placebo Gas|Withdrawal by Subject|2|||
146715644|NCT03283670|529129606|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
146715645|NCT03283670|529129606|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
146780731|NCT04436107|529367545|FG001|Overall Study|Withdrawal by Subject|1|||
146780732|NCT04436107|529367546|FG002|Overall Study|Withdrawal by Subject|0|||
146715646|NCT00612313|529129610|FG000|Overall Study|Withdrawal by Subject|6|||
146715647|NCT00612313|529129611|FG001|Overall Study|Withdrawal by Subject|9|||
146715648|NCT00612313|529129610|FG000|Overall Study|Lost to Follow-up|11|||
146715649|NCT00612313|529129611|FG001|Overall Study|Lost to Follow-up|4|||
146715650|NCT03823651|529129612|FG000|Overall Study|Death|5|||
146715651|NCT03823651|529129613|FG001|Overall Study|Death|0|||
146715652|NCT03823651|529129612|FG000|Overall Study|Physician Decision|1|||
146715653|NCT03823651|529129613|FG001|Overall Study|Physician Decision|0|||
146715654|NCT03823651|529129612|FG000|Overall Study|Caregiver to patient who died|0|||
146715655|NCT03823651|529129613|FG001|Overall Study|Caregiver to patient who died|5|||
146715656|NCT03823651|529129612|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
146715657|NCT03823651|529129613|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
146715658|NCT01850004|529129614|FG000|Overall Study|Poor/Non-compliance|1|||
146715659|NCT01850004|529129614|FG000|Overall Study|Participant Withdrew Consent|9|||
146715660|NCT01850004|529129614|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
146715661|NCT01850004|529129614|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
146715662|NCT01850004|529129614|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
146715663|NCT01850004|529129614|FG000|Overall Study|Other Reasons|2|||
146715664|NCT01850004|529129614|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
146715665|NCT01850004|529129614|FG000|Overall Study|Maximum Clinical Benefit|4|||
146715666|NCT05350449|529129615|FG000|Overall Study|Withdrawal by Subject|4|||
146715667|NCT05350449|529129616|FG001|Overall Study|Withdrawal by Subject|8|||
146715668|NCT01773226|529131688|FG000|Overall Study|Withdrawal by Subject|1|||
146715669|NCT00993447|529131693|FG000|Overall Study|Withdrawal by Subject|23|||
146715670|NCT00993447|529131694|FG001|Overall Study|Withdrawal by Subject|8|||
146715671|NCT00993447|529131693|FG000|Overall Study|Protocol Violation|12|||
146715672|NCT00993447|529131694|FG001|Overall Study|Protocol Violation|8|||
146715673|NCT00993447|529131693|FG000|Overall Study|Lost to Follow-up|1|||
146715674|NCT00993447|529131694|FG001|Overall Study|Lost to Follow-up|3|||
146715675|NCT00993447|529131693|FG000|Overall Study|Adverse Event|1|||
146715676|NCT00993447|529131694|FG001|Overall Study|Adverse Event|0|||
146715677|NCT00970502|529131695|FG000|Overall Study|Withdrawal by Subject|1|||
146715678|NCT02041195|529131696|FG000|Overall Study|Adverse Event|1|||
146715679|NCT02041195|529131697|FG001|Overall Study|Adverse Event|2|||
146715680|NCT02041195|529131698|FG002|Overall Study|Adverse Event|0|||
146715681|NCT02041195|529131699|FG003|Overall Study|Adverse Event|0|||
146715682|NCT02041195|529131700|FG004|Overall Study|Adverse Event|0|||
146715683|NCT02041195|529131701|FG005|Overall Study|Adverse Event|0|||
146715684|NCT02041195|529131702|FG006|Overall Study|Adverse Event|3|||
146715685|NCT02041195|529131703|FG007|Overall Study|Adverse Event|0|||
146715686|NCT02041195|529131696|FG000|Overall Study|Withdrawal by Subject|1|||
146715687|NCT02041195|529131697|FG001|Overall Study|Withdrawal by Subject|0|||
146715688|NCT02041195|529131698|FG002|Overall Study|Withdrawal by Subject|0|||
146715689|NCT02041195|529131699|FG003|Overall Study|Withdrawal by Subject|0|||
146715690|NCT02041195|529131700|FG004|Overall Study|Withdrawal by Subject|0|||
146715691|NCT02041195|529131701|FG005|Overall Study|Withdrawal by Subject|0|||
146715692|NCT02041195|529131702|FG006|Overall Study|Withdrawal by Subject|4|||
146715693|NCT02041195|529131703|FG007|Overall Study|Withdrawal by Subject|3|||
146715694|NCT02041195|529131696|FG000|Overall Study|Unable to comply with study visits|0|||
146715695|NCT02041195|529131697|FG001|Overall Study|Unable to comply with study visits|1|||
146715696|NCT02041195|529131698|FG002|Overall Study|Unable to comply with study visits|0|||
146715697|NCT02041195|529131699|FG003|Overall Study|Unable to comply with study visits|0|||
146715698|NCT02041195|529131700|FG004|Overall Study|Unable to comply with study visits|1|||
146715699|NCT02041195|529131701|FG005|Overall Study|Unable to comply with study visits|0|||
146715700|NCT02041195|529131702|FG006|Overall Study|Unable to comply with study visits|0|||
146715701|NCT02041195|529131703|FG007|Overall Study|Unable to comply with study visits|0|||
146715702|NCT03564496|529131704|FG000|Overall Study|Withdrawal by Subject|1|||
146715703|NCT03564496|529131705|FG001|Overall Study|Withdrawal by Subject|1|||
146715704|NCT03564496|529131706|FG002|Overall Study|Withdrawal by Subject|0|||
146715705|NCT03564496|529131704|FG000|Overall Study|Screen failure|0|||
146715706|NCT03564496|529131705|FG001|Overall Study|Screen failure|3|||
146715707|NCT03564496|529131706|FG002|Overall Study|Screen failure|0|||
146715708|NCT00674986|529131707|FG000|Overall Study|Adverse Event|2|||
146715709|NCT00674986|529131708|FG001|Overall Study|Adverse Event|1|||
146715710|NCT00674986|529131707|FG000|Overall Study|Subject withdrew consent|12|||
146715711|NCT00674986|529131708|FG001|Overall Study|Subject withdrew consent|19|||
146715712|NCT00674986|529131707|FG000|Overall Study|Lost to Follow-up|25|||
146715713|NCT00674986|529131708|FG001|Overall Study|Lost to Follow-up|53|||
146715714|NCT00674986|529131707|FG000|Overall Study|Other reasons|4|||
146715715|NCT00674986|529131708|FG001|Overall Study|Other reasons|8|||
146715716|NCT01880424|529131709|FG000|Overall Study|Adverse Event|7|||
146715717|NCT01880424|529131710|FG001|Overall Study|Adverse Event|6|||
146715718|NCT01880424|529131709|FG000|Overall Study|Lack of Efficacy|1|||
146715719|NCT01880424|529131710|FG001|Overall Study|Lack of Efficacy|4|||
146715720|NCT01880424|529131709|FG000|Overall Study|Lost to Follow-up|3|||
146715721|NCT01880424|529131710|FG001|Overall Study|Lost to Follow-up|2|||
146715722|NCT01880424|529131709|FG000|Overall Study|Protocol Violation|11|||
146715723|NCT01880424|529131710|FG001|Overall Study|Protocol Violation|13|||
146715724|NCT01880424|529131709|FG000|Overall Study|Withdrawal by Subject|10|||
146715725|NCT01880424|529131710|FG001|Overall Study|Withdrawal by Subject|30|||
146715726|NCT01880424|529131709|FG000|Overall Study|Other|1|||
146715727|NCT01880424|529131710|FG001|Overall Study|Other|0|||
146715728|NCT03521635|529131713|FG000|Overall Study|Adverse Event|1|||
146715729|NCT03521635|529131714|FG001|Overall Study|Adverse Event|1|||
146715730|NCT03521635|529131713|FG000|Overall Study|Refused to complete study visit|1|||
146715731|NCT03521635|529131714|FG001|Overall Study|Refused to complete study visit|0|||
146715732|NCT03521635|529131713|FG000|Overall Study|Refused to continue trial medication|2|||
146715733|NCT03521635|529131714|FG001|Overall Study|Refused to continue trial medication|2|||
146715734|NCT03521635|529131713|FG000|Overall Study|Lost to Follow-up|0|||
146715735|NCT03521635|529131714|FG001|Overall Study|Lost to Follow-up|1|||
146715736|NCT03521635|529131713|FG000|Overall Study|Meet exclusion criteria|0|||
146715737|NCT03521635|529131714|FG001|Overall Study|Meet exclusion criteria|1|||
146715738|NCT03521635|529131713|FG000|Overall Study|Patient not taken study medicine|0|||
146780733|NCT04436107|529367547|FG003|Overall Study|Withdrawal by Subject|1|||
146780734|NCT01095796|529367548|FG000|Overall Study|Randomized but Not Treated|5|||
146780735|NCT01095796|529367549|FG001|Overall Study|Randomized but Not Treated|2|||
146780736|NCT01095796|529367548|FG000|Overall Study|Adverse Event|9|||
146780737|NCT01095796|529367549|FG001|Overall Study|Adverse Event|19|||
146780738|NCT01095796|529367548|FG000|Overall Study|Death|3|||
146780739|NCT01095796|529367549|FG001|Overall Study|Death|2|||
146780740|NCT01095796|529367548|FG000|Overall Study|Pregnancy|2|||
146780741|NCT01095796|529367549|FG001|Overall Study|Pregnancy|0|||
146780742|NCT01095796|529367548|FG000|Overall Study|Lack of Efficacy|5|||
146780743|NCT01095796|529367549|FG001|Overall Study|Lack of Efficacy|3|||
146780744|NCT01095796|529367548|FG000|Overall Study|Investigator's Discretion|7|||
146780745|NCT01095796|529367549|FG001|Overall Study|Investigator's Discretion|2|||
146780746|NCT01095796|529367548|FG000|Overall Study|Withdrew Consent|16|||
146780747|NCT01095796|529367549|FG001|Overall Study|Withdrew Consent|22|||
146780748|NCT01095796|529367548|FG000|Overall Study|Lost to Follow-up|27|||
146780749|NCT01095796|529367549|FG001|Overall Study|Lost to Follow-up|29|||
146780750|NCT01095796|529367548|FG000|Overall Study|Participant Noncompliance|5|||
146780751|NCT01095796|529367549|FG001|Overall Study|Participant Noncompliance|10|||
146780752|NCT01095796|529367548|FG000|Overall Study|Protocol Violation|1|||
146780753|NCT01095796|529367549|FG001|Overall Study|Protocol Violation|0|||
146780754|NCT01095796|529367548|FG000|Overall Study|Participant Transferred to Another Study|215|||
146780755|NCT01095796|529367549|FG001|Overall Study|Participant Transferred to Another Study|200|||
146780756|NCT04116736|529367554|FG000|Overall Study|Withdrew consent during study|3|||
146780757|NCT04116736|529367555|FG001|Overall Study|Withdrew consent during study|1|||
146780758|NCT04116736|529367554|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
146780759|NCT04116736|529367555|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
146780760|NCT04116736|529367554|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
146780761|NCT04116736|529367555|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
146780762|NCT04116736|529367554|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
146780763|NCT04116736|529367555|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
146780764|NCT04116736|529367554|FG000|Overall Study|Subject was enrolled in error|2|||
146780765|NCT04116736|529367555|FG001|Overall Study|Subject was enrolled in error|0|||
146780766|NCT04116736|529367554|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
146780767|NCT04116736|529367555|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
146780768|NCT04116736|529367554|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
146780769|NCT04116736|529367555|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
146780770|NCT04116736|529367554|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
146780771|NCT04116736|529367555|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
146780772|NCT03517969|529367557|FG000|Overall Study|Never started protocol treatment|3|||
146780773|NCT03517969|529367558|FG001|Overall Study|Never started protocol treatment|5|||
146780774|NCT03517969|529367557|FG000|Overall Study|Disease progression|11|||
146780775|NCT03517969|529367558|FG001|Overall Study|Disease progression|16|||
146780776|NCT03517969|529367557|FG000|Overall Study|PSA progression|8|||
146780777|NCT03517969|529367558|FG001|Overall Study|PSA progression|1|||
146780778|NCT03517969|529367557|FG000|Overall Study|Clinical progression|4|||
146780779|NCT03517969|529367558|FG001|Overall Study|Clinical progression|2|||
146780780|NCT03517969|529367557|FG000|Overall Study|Adverse Event|5|||
146934088|NCT02031432|529916088|FG000|Overall Study|Lost to Follow-up|1|||
146934089|NCT02031432|529916088|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
146934090|NCT02031432|529916088|FG000|Overall Study|Death|10|||
146934091|NCT02148211|529916089|FG000|Overall Study|Lost to Follow-up|352|||
146934092|NCT02726113|529916090|FG000|Total Enrollment|Physician Decision|0|||
146934093|NCT02726113|529916091|FG001|Total Enrollment|Physician Decision|1|||
146934094|NCT02726113|529916090|FG000|Total Enrollment|Protocol Violation|1|||
146934095|NCT02726113|529916091|FG001|Total Enrollment|Protocol Violation|0|||
146934096|NCT02726113|529916090|FG000|Total Enrollment|Withdrawal by Subject|2|||
146934097|NCT02726113|529916091|FG001|Total Enrollment|Withdrawal by Subject|1|||
146934098|NCT02726113|529916090|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
146780781|NCT03517969|529367558|FG001|Overall Study|Adverse Event|4|||
146780782|NCT03517969|529367557|FG000|Overall Study|Intercurrent illness|1|||
146780783|NCT03517969|529367558|FG001|Overall Study|Intercurrent illness|2|||
146780784|NCT03517969|529367557|FG000|Overall Study|Death|1|||
146780785|NCT03517969|529367558|FG001|Overall Study|Death|1|||
146780786|NCT03517969|529367557|FG000|Overall Study|Withdrawal by Subject|1|||
146780787|NCT03517969|529367558|FG001|Overall Study|Withdrawal by Subject|2|||
146780788|NCT03517969|529367557|FG000|Overall Study|Physician Decision|1|||
146780789|NCT03517969|529367558|FG001|Overall Study|Physician Decision|1|||
146780790|NCT03517969|529367557|FG000|Overall Study|No clinical benefit|1|||
146780791|NCT03517969|529367558|FG001|Overall Study|No clinical benefit|0|||
146780792|NCT03517969|529367557|FG000|Overall Study|Delayed treatment for dental treatment|1|||
146780793|NCT03517969|529367558|FG001|Overall Study|Delayed treatment for dental treatment|0|||
146715739|NCT03521635|529131714|FG001|Overall Study|Patient not taken study medicine|1|||
146715740|NCT04495374|529131715|FG000|Overall Study|Protocol Violation|2|||
146715741|NCT04495374|529131716|FG001|Overall Study|Protocol Violation|1|||
146715742|NCT02590354|529131717|FG000|Phase 1|Active hepatitis B or C infection|1|||
146715743|NCT02590354|529131717|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
146715744|NCT02590354|529131717|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
146715745|NCT02590354|529131717|FG000|Phase 1|Subject does not want to participate|20|||
146715746|NCT02590354|529131717|FG000|Phase 1|Lost to Follow-up|1|||
146715747|NCT02590354|529131717|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
146715748|NCT00996996|529131718|FG000|Overall Study|Progressive Disease|10|||
146715749|NCT00996996|529131718|FG000|Overall Study|Non-compliance|8|||
146715750|NCT00996996|529131718|FG000|Overall Study|Lost to Follow-up|9|||
146715751|NCT00996996|529131718|FG000|Overall Study|Death|5|||
146715752|NCT00996996|529131718|FG000|Overall Study|Did Not Receive Study Medications|1|||
146715753|NCT00760929|529131719|FG000|Overall Study|Adverse Event|2|||
146715754|NCT00760929|529131720|FG001|Overall Study|Adverse Event|0|||
146715755|NCT00760929|529131721|FG002|Overall Study|Adverse Event|6|||
146715756|NCT00760929|529131722|FG003|Overall Study|Adverse Event|10|||
146715757|NCT00760929|529131719|FG000|Overall Study|Lack of Efficacy|0|||
146715758|NCT00760929|529131720|FG001|Overall Study|Lack of Efficacy|2|||
146715759|NCT00760929|529131721|FG002|Overall Study|Lack of Efficacy|1|||
146715760|NCT00760929|529131722|FG003|Overall Study|Lack of Efficacy|0|||
146715761|NCT00760929|529131719|FG000|Overall Study|Withdrawal by Subject|1|||
146715762|NCT00760929|529131720|FG001|Overall Study|Withdrawal by Subject|0|||
146715763|NCT00760929|529131721|FG002|Overall Study|Withdrawal by Subject|9|||
146715764|NCT00760929|529131722|FG003|Overall Study|Withdrawal by Subject|1|||
146715765|NCT00760929|529131719|FG000|Overall Study|Lost to Follow-up|0|||
146715766|NCT00760929|529131720|FG001|Overall Study|Lost to Follow-up|0|||
146715767|NCT00760929|529131721|FG002|Overall Study|Lost to Follow-up|1|||
146715768|NCT00760929|529131722|FG003|Overall Study|Lost to Follow-up|0|||
146715769|NCT00760929|529131719|FG000|Overall Study|Progression of Disease|21|||
146715770|NCT00760929|529131720|FG001|Overall Study|Progression of Disease|26|||
146715771|NCT00760929|529131721|FG002|Overall Study|Progression of Disease|38|||
146715772|NCT00760929|529131722|FG003|Overall Study|Progression of Disease|42|||
146715773|NCT00760929|529131719|FG000|Overall Study|Other|2|||
146715774|NCT00760929|529131720|FG001|Overall Study|Other|0|||
146715775|NCT00760929|529131721|FG002|Overall Study|Other|2|||
146715776|NCT00760929|529131722|FG003|Overall Study|Other|1|||
146715777|NCT00760929|529131719|FG000|Overall Study|Death|0|||
146715778|NCT00760929|529131720|FG001|Overall Study|Death|0|||
146715779|NCT00760929|529131721|FG002|Overall Study|Death|1|||
146715780|NCT00760929|529131722|FG003|Overall Study|Death|0|||
146715781|NCT00760929|529131719|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
146715782|NCT00760929|529131720|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
146715783|NCT00760929|529131721|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
146715784|NCT00760929|529131722|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
146715785|NCT02099838|529131723|FG000|Overall Study|Death|1|||
146715786|NCT02099838|529131724|FG001|Overall Study|Death|0|||
146715787|NCT02099838|529131723|FG000|Overall Study|Lost to Follow-up|3|||
146715788|NCT02099838|529131724|FG001|Overall Study|Lost to Follow-up|1|||
146715789|NCT02099838|529131723|FG000|Overall Study|Withdrawal by Subject|0|||
146715790|NCT02099838|529131724|FG001|Overall Study|Withdrawal by Subject|1|||
146715791|NCT04535037|529131725|FG000|Overall Study|Protocol Violation|1|||
146715792|NCT04535037|529131726|FG001|Overall Study|Protocol Violation|0|||
146715793|NCT04535037|529131725|FG000|Overall Study|Withdrawal by Subject|8|||
146715794|NCT04535037|529131726|FG001|Overall Study|Withdrawal by Subject|9|||
146715795|NCT04535037|529131725|FG000|Overall Study|Migrated / moved from the study area|1|||
146715796|NCT04535037|529131726|FG001|Overall Study|Migrated / moved from the study area|4|||
146715797|NCT04535037|529131725|FG000|Overall Study|Other|2|||
146715798|NCT04535037|529131726|FG001|Overall Study|Other|5|||
146715799|NCT02731131|529131727|FG000|Overall Study|Psychiatric Disorder|0|||
146715800|NCT02731131|529131728|FG001|Overall Study|Psychiatric Disorder|1|||
146715801|NCT02731131|529131727|FG000|Overall Study|Refused Therapy|0|||
146715802|NCT02731131|529131728|FG001|Overall Study|Refused Therapy|1|||
146715803|NCT02348216|529131733|FG000|Overall Study|Death|5|||
146715804|NCT02348216|529131734|FG001|Overall Study|Death|53|||
146715805|NCT02348216|529131735|FG002|Overall Study|Death|11|||
146715806|NCT02348216|529131736|FG003|Overall Study|Death|20|||
146715807|NCT02348216|529131737|FG004|Overall Study|Death|16|||
146715808|NCT02348216|529131738|FG005|Overall Study|Death|32|||
146715809|NCT02348216|529131739|FG006|Overall Study|Death|17|||
146715810|NCT02348216|529131733|FG000|Overall Study|Full consent withdrawal|0|||
146715811|NCT02348216|529131734|FG001|Overall Study|Full consent withdrawal|0|||
146715812|NCT02348216|529131735|FG002|Overall Study|Full consent withdrawal|0|||
146715813|NCT02348216|529131736|FG003|Overall Study|Full consent withdrawal|1|||
146715814|NCT02348216|529131737|FG004|Overall Study|Full consent withdrawal|3|||
146715815|NCT02348216|529131738|FG005|Overall Study|Full consent withdrawal|0|||
146715816|NCT02348216|529131739|FG006|Overall Study|Full consent withdrawal|3|||
146715817|NCT02348216|529131733|FG000|Overall Study|Lost to Follow-up|0|||
146780794|NCT03517969|529367557|FG000|Overall Study|Difficult to maintain appointment|0|||
146780795|NCT03517969|529367558|FG001|Overall Study|Difficult to maintain appointment|1|||
146780796|NCT03517969|529367557|FG000|Overall Study|Protocol Violation|0|||
146780797|NCT03517969|529367558|FG001|Overall Study|Protocol Violation|1|||
146780798|NCT02140645|529367559|FG000|Overall Study|Not linked|5489|||
146780799|NCT02140645|529367560|FG001|Overall Study|Not linked|61654|||
146780800|NCT02140645|529367561|FG002|Overall Study|Not linked|4236|||
146780801|NCT02140645|529367562|FG003|Overall Study|Not linked|13833|||
146780802|NCT02140645|529367563|FG004|Overall Study|Not linked|3286|||
146780803|NCT02140645|529367564|FG005|Overall Study|Not linked|70896|||
146780804|NCT04854096|529367565|FG000|Overall Study|Adverse Event|1|||
146780805|NCT04854096|529367566|FG001|Overall Study|Adverse Event|0|||
146780806|NCT04854096|529367565|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
146780807|NCT04854096|529367566|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
146780808|NCT04854096|529367565|FG000|Overall Study|Withdrawal by Subject|1|||
146780809|NCT04854096|529367566|FG001|Overall Study|Withdrawal by Subject|0|||
146780810|NCT04854096|529367565|FG000|Overall Study|Other reasons|1|||
146780811|NCT04854096|529367566|FG001|Overall Study|Other reasons|0|||
146780812|NCT02965846|529367569|FG000|Overall Study|Lost to Follow-up|1|||
146780813|NCT02965846|529367570|FG001|Overall Study|Lost to Follow-up|0|||
146780814|NCT02965846|529367571|FG002|Overall Study|Lost to Follow-up|0|||
146780815|NCT02965846|529367569|FG000|Overall Study|Withdrawal by Subject|0|||
146780816|NCT02965846|529367570|FG001|Overall Study|Withdrawal by Subject|1|||
146780817|NCT02965846|529367571|FG002|Overall Study|Withdrawal by Subject|0|||
146780818|NCT02965846|529367569|FG000|Overall Study|Study Terminated By Sponsor|4|||
146780819|NCT02965846|529367570|FG001|Overall Study|Study Terminated By Sponsor|4|||
146780820|NCT02965846|529367571|FG002|Overall Study|Study Terminated By Sponsor|0|||
146780821|NCT02965846|529367569|FG000|Overall Study|Participants not randomized|0|||
146780822|NCT02965846|529367570|FG001|Overall Study|Participants not randomized|0|||
146780823|NCT02965846|529367571|FG002|Overall Study|Participants not randomized|33|||
146780824|NCT02814838|529367572|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
146780825|NCT02814838|529367573|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
146780826|NCT02814838|529367572|FG000|Overall Study|Consent withdrawal|1|||
146780827|NCT02814838|529367573|FG001|Overall Study|Consent withdrawal|1|||
146780828|NCT00593489|529367574|FG000|Allocation|did not attend workshop; allocation not|2|||
146780829|NCT00593489|529367575|FG001|Allocation|did not attend workshop; allocation not|1|||
146780830|NCT00073749|529367576|FG000|Overall Study|Disease Progression|2|||
146780831|NCT00073749|529367577|FG001|Overall Study|Disease Progression|0|||
146780832|NCT00073749|529367578|FG002|Overall Study|Disease Progression|3|||
146780833|NCT00073749|529367579|FG003|Overall Study|Disease Progression|2|||
146780834|NCT00073749|529367580|FG004|Overall Study|Disease Progression|3|||
146780835|NCT00073749|529367581|FG005|Overall Study|Disease Progression|1|||
146780836|NCT00073749|529367582|FG006|Overall Study|Disease Progression|3|||
146780837|NCT00073749|529367576|FG000|Overall Study|Death|0|||
146780838|NCT00073749|529367577|FG001|Overall Study|Death|1|||
146780839|NCT00073749|529367578|FG002|Overall Study|Death|1|||
146780840|NCT00073749|529367579|FG003|Overall Study|Death|0|||
146780841|NCT00073749|529367580|FG004|Overall Study|Death|0|||
146780842|NCT00073749|529367581|FG005|Overall Study|Death|0|||
146780843|NCT00073749|529367582|FG006|Overall Study|Death|29|||
146780844|NCT00073749|529367576|FG000|Overall Study|Adverse Event|0|||
146780845|NCT00073749|529367577|FG001|Overall Study|Adverse Event|3|||
146715818|NCT02348216|529131734|FG001|Overall Study|Lost to Follow-up|5|||
146715819|NCT02348216|529131735|FG002|Overall Study|Lost to Follow-up|2|||
146715820|NCT02348216|529131736|FG003|Overall Study|Lost to Follow-up|0|||
146715821|NCT02348216|529131737|FG004|Overall Study|Lost to Follow-up|1|||
146715822|NCT02348216|529131738|FG005|Overall Study|Lost to Follow-up|1|||
146715823|NCT02348216|529131739|FG006|Overall Study|Lost to Follow-up|1|||
146715824|NCT02348216|529131733|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
146715825|NCT02348216|529131734|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
146715826|NCT02348216|529131735|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
146780846|NCT00073749|529367578|FG002|Overall Study|Adverse Event|6|||
146780847|NCT00073749|529367579|FG003|Overall Study|Adverse Event|4|||
146780848|NCT00073749|529367580|FG004|Overall Study|Adverse Event|2|||
146780849|NCT00073749|529367581|FG005|Overall Study|Adverse Event|1|||
146780850|NCT00073749|529367582|FG006|Overall Study|Adverse Event|0|||
146780851|NCT00073749|529367576|FG000|Overall Study|Physician Decision|0|||
146780852|NCT00073749|529367577|FG001|Overall Study|Physician Decision|0|||
146780853|NCT00073749|529367578|FG002|Overall Study|Physician Decision|1|||
146780854|NCT00073749|529367579|FG003|Overall Study|Physician Decision|0|||
146780855|NCT00073749|529367580|FG004|Overall Study|Physician Decision|0|||
146780856|NCT00073749|529367581|FG005|Overall Study|Physician Decision|2|||
146780857|NCT00073749|529367582|FG006|Overall Study|Physician Decision|0|||
146780858|NCT00073749|529367576|FG000|Overall Study|Withdrawal by Subject|0|||
146780859|NCT00073749|529367577|FG001|Overall Study|Withdrawal by Subject|1|||
146780860|NCT00073749|529367578|FG002|Overall Study|Withdrawal by Subject|0|||
146780861|NCT00073749|529367579|FG003|Overall Study|Withdrawal by Subject|0|||
146780862|NCT00073749|529367580|FG004|Overall Study|Withdrawal by Subject|1|||
146715827|NCT02348216|529131736|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
146715828|NCT02348216|529131737|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
146715829|NCT02348216|529131738|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
146715830|NCT02348216|529131739|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
146715831|NCT02348216|529131733|FG000|Overall Study|Reason not specified|2|||
146715832|NCT02348216|529131734|FG001|Overall Study|Reason not specified|19|||
146715833|NCT02348216|529131735|FG002|Overall Study|Reason not specified|11|||
146715834|NCT02348216|529131736|FG003|Overall Study|Reason not specified|17|||
146715835|NCT02348216|529131737|FG004|Overall Study|Reason not specified|21|||
146715836|NCT02348216|529131738|FG005|Overall Study|Reason not specified|17|||
146715837|NCT02348216|529131739|FG006|Overall Study|Reason not specified|19|||
146715838|NCT02553330|529131741|FG000|Overall Study|Study Terminated by Sponsor|2|||
146715839|NCT02553330|529131742|FG001|Overall Study|Study Terminated by Sponsor|13|||
146715840|NCT02553330|529131743|FG002|Overall Study|Study Terminated by Sponsor|12|||
146715841|NCT02553330|529131741|FG000|Overall Study|Withdrawal by Subject|3|||
146715842|NCT02553330|529131742|FG001|Overall Study|Withdrawal by Subject|19|||
146715843|NCT02553330|529131743|FG002|Overall Study|Withdrawal by Subject|21|||
146715844|NCT02553330|529131741|FG000|Overall Study|Other|0|||
146715845|NCT02553330|529131742|FG001|Overall Study|Other|1|||
146715846|NCT02553330|529131743|FG002|Overall Study|Other|0|||
146715847|NCT02553330|529131741|FG000|Overall Study|Non compliance to study treatment|0|||
146715848|NCT02553330|529131742|FG001|Overall Study|Non compliance to study treatment|1|||
146715849|NCT02553330|529131743|FG002|Overall Study|Non compliance to study treatment|0|||
146715850|NCT02553330|529131741|FG000|Overall Study|Adverse Event|0|||
146715851|NCT02553330|529131742|FG001|Overall Study|Adverse Event|1|||
146715852|NCT02553330|529131743|FG002|Overall Study|Adverse Event|0|||
146715853|NCT02553330|529131741|FG000|Overall Study|Lost to Follow-up|0|||
146715854|NCT02553330|529131742|FG001|Overall Study|Lost to Follow-up|4|||
146715855|NCT02553330|529131743|FG002|Overall Study|Lost to Follow-up|4|||
146715856|NCT02896855|529131744|FG000|Overall Study|Death|50|||
146715857|NCT02896855|529131745|FG001|Overall Study|Death|40|||
146715858|NCT02896855|529131744|FG000|Overall Study|Lost to Follow-up|15|||
146715859|NCT02896855|529131745|FG001|Overall Study|Lost to Follow-up|9|||
146715860|NCT02896855|529131744|FG000|Overall Study|Withdrawal by Subject|7|||
146715861|NCT02896855|529131745|FG001|Overall Study|Withdrawal by Subject|4|||
146715862|NCT01205685|529131746|FG000|Overall Study|Disease Progression|10|||
146715863|NCT01205685|529131746|FG000|Overall Study|Withdrawal by Subject|1|||
146715864|NCT02169674|529131747|FG000|Overall Study|Withdrawal by Subject|2|||
146715865|NCT02169674|529131748|FG001|Overall Study|Withdrawal by Subject|1|||
146715866|NCT02169674|529131747|FG000|Overall Study|Seroprotected|30|||
146715867|NCT02169674|529131748|FG001|Overall Study|Seroprotected|76|||
146715868|NCT02169674|529131747|FG000|Overall Study|Lost to Follow-up|0|||
146715869|NCT02169674|529131748|FG001|Overall Study|Lost to Follow-up|1|||
146715870|NCT01666002|529131749|FG000|Overall Study|Lost to Follow-up|5|||
146715871|NCT01666002|529131750|FG001|Overall Study|Lost to Follow-up|0|||
146715872|NCT02265705|529131767|FG000|Treatment Period Week 0-24|Adverse Event|3|||
146715873|NCT02265705|529131768|FG001|Treatment Period Week 0-24|Adverse Event|2|||
146715874|NCT02265705|529131769|FG002|Treatment Period Week 0-24|Adverse Event|0|||
146715875|NCT02265705|529131770|FG003|Treatment Period Week 0-24|Adverse Event|0|||
146715876|NCT02265705|529131771|FG004|Treatment Period Week 0-24|Adverse Event|0|||
146715877|NCT02265705|529131772|FG005|Treatment Period Week 0-24|Adverse Event|0|||
146715878|NCT02265705|529131773|FG006|Treatment Period Week 0-24|Adverse Event|0|||
146715879|NCT02265705|529131767|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
146715880|NCT02265705|529131768|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
146715881|NCT02265705|529131769|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
146715882|NCT02265705|529131770|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
146715883|NCT02265705|529131771|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
146715884|NCT02265705|529131772|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
146715885|NCT02265705|529131773|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
146715886|NCT02265705|529131767|FG000|Treatment Period Week 0-24|Physician Decision|1|||
146715887|NCT02265705|529131768|FG001|Treatment Period Week 0-24|Physician Decision|0|||
146715888|NCT02265705|529131769|FG002|Treatment Period Week 0-24|Physician Decision|0|||
146934099|NCT02726113|529916091|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
146934100|NCT02726113|529916090|FG000|Genomic Analysis|Protocol Violation|1|||
146934101|NCT02726113|529916091|FG001|Genomic Analysis|Protocol Violation|0|||
146934102|NCT02726113|529916090|FG000|Genomic Analysis|Withdrawal by Subject|2|||
146715889|NCT02265705|529131770|FG003|Treatment Period Week 0-24|Physician Decision|0|||
146715890|NCT02265705|529131771|FG004|Treatment Period Week 0-24|Physician Decision|0|||
146715891|NCT02265705|529131772|FG005|Treatment Period Week 0-24|Physician Decision|0|||
146715892|NCT02265705|529131773|FG006|Treatment Period Week 0-24|Physician Decision|0|||
146715893|NCT02265705|529131767|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
146715894|NCT02265705|529131768|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
146715895|NCT02265705|529131769|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
146715896|NCT02265705|529131770|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
146715897|NCT02265705|529131771|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
146715898|NCT02265705|529131772|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
146715899|NCT02265705|529131773|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
146715900|NCT02265705|529131767|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
146715901|NCT02265705|529131768|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
146715902|NCT02265705|529131769|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
146715903|NCT02265705|529131770|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
146715904|NCT02265705|529131771|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
146715905|NCT02265705|529131772|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
146715906|NCT02265705|529131773|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
146715907|NCT02265705|529131767|FG000|Rescue Period|Withdrawal by Subject|0|||
146715908|NCT02265705|529131768|FG001|Rescue Period|Withdrawal by Subject|0|||
146715909|NCT02265705|529131769|FG002|Rescue Period|Withdrawal by Subject|1|||
146715910|NCT02265705|529131770|FG003|Rescue Period|Withdrawal by Subject|0|||
146715911|NCT02265705|529131771|FG004|Rescue Period|Withdrawal by Subject|0|||
146715912|NCT02265705|529131772|FG005|Rescue Period|Withdrawal by Subject|0|||
146715913|NCT02265705|529131773|FG006|Rescue Period|Withdrawal by Subject|0|||
146715914|NCT02265705|529131767|FG000|Rescue Period|Death|0|||
146715915|NCT02265705|529131768|FG001|Rescue Period|Death|0|||
146715916|NCT02265705|529131769|FG002|Rescue Period|Death|1|||
146715917|NCT02265705|529131770|FG003|Rescue Period|Death|0|||
146715918|NCT02265705|529131771|FG004|Rescue Period|Death|0|||
146715919|NCT02265705|529131772|FG005|Rescue Period|Death|0|||
146715920|NCT02265705|529131773|FG006|Rescue Period|Death|0|||
146715921|NCT02265705|529131767|FG000|Rescue Period|Lack of Efficacy|0|||
146715922|NCT02265705|529131768|FG001|Rescue Period|Lack of Efficacy|0|||
146715923|NCT02265705|529131769|FG002|Rescue Period|Lack of Efficacy|1|||
146715924|NCT02265705|529131770|FG003|Rescue Period|Lack of Efficacy|0|||
146715925|NCT02265705|529131771|FG004|Rescue Period|Lack of Efficacy|0|||
146715926|NCT02265705|529131772|FG005|Rescue Period|Lack of Efficacy|0|||
146715927|NCT02265705|529131773|FG006|Rescue Period|Lack of Efficacy|0|||
146715928|NCT02265705|529131767|FG000|Open Label Period|Adverse Event|0|||
146715929|NCT02265705|529131768|FG001|Open Label Period|Adverse Event|0|||
146715930|NCT02265705|529131769|FG002|Open Label Period|Adverse Event|0|||
146715931|NCT02265705|529131770|FG003|Open Label Period|Adverse Event|2|||
146715932|NCT02265705|529131771|FG004|Open Label Period|Adverse Event|2|||
146715933|NCT02265705|529131772|FG005|Open Label Period|Adverse Event|0|||
146715934|NCT02265705|529131773|FG006|Open Label Period|Adverse Event|0|||
146715935|NCT02265705|529131767|FG000|Open Label Period|Physician Decision|0|||
146715936|NCT02265705|529131768|FG001|Open Label Period|Physician Decision|0|||
146715937|NCT02265705|529131769|FG002|Open Label Period|Physician Decision|0|||
146715938|NCT02265705|529131770|FG003|Open Label Period|Physician Decision|0|||
146715939|NCT02265705|529131771|FG004|Open Label Period|Physician Decision|1|||
146715940|NCT02265705|529131772|FG005|Open Label Period|Physician Decision|0|||
146715941|NCT02265705|529131773|FG006|Open Label Period|Physician Decision|0|||
146715942|NCT02265705|529131767|FG000|Open Label Period|Withdrawal by Subject|0|||
146715943|NCT02265705|529131768|FG001|Open Label Period|Withdrawal by Subject|0|||
146715944|NCT02265705|529131769|FG002|Open Label Period|Withdrawal by Subject|0|||
146715945|NCT02265705|529131770|FG003|Open Label Period|Withdrawal by Subject|0|||
146715946|NCT02265705|529131771|FG004|Open Label Period|Withdrawal by Subject|2|||
146715947|NCT02265705|529131772|FG005|Open Label Period|Withdrawal by Subject|0|||
146715948|NCT02265705|529131773|FG006|Open Label Period|Withdrawal by Subject|0|||
146715949|NCT02265705|529131767|FG000|Follow-up Period|Sponsor Decision|0|||
146715950|NCT02265705|529131768|FG001|Follow-up Period|Sponsor Decision|0|||
146715951|NCT02265705|529131769|FG002|Follow-up Period|Sponsor Decision|0|||
146715952|NCT02265705|529131770|FG003|Follow-up Period|Sponsor Decision|0|||
146715953|NCT02265705|529131771|FG004|Follow-up Period|Sponsor Decision|0|||
146715954|NCT02265705|529131772|FG005|Follow-up Period|Sponsor Decision|1|||
146715955|NCT02265705|529131773|FG006|Follow-up Period|Sponsor Decision|6|||
146715956|NCT02265705|529131767|FG000|Follow-up Period|Adverse Event|0|||
146715957|NCT02265705|529131768|FG001|Follow-up Period|Adverse Event|0|||
146715958|NCT02265705|529131769|FG002|Follow-up Period|Adverse Event|0|||
146715959|NCT02265705|529131770|FG003|Follow-up Period|Adverse Event|0|||
146715960|NCT02265705|529131771|FG004|Follow-up Period|Adverse Event|0|||
146715961|NCT02265705|529131772|FG005|Follow-up Period|Adverse Event|0|||
146715962|NCT02265705|529131773|FG006|Follow-up Period|Adverse Event|3|||
146715963|NCT02265705|529131767|FG000|Follow-up Period|Physician Decision|0|||
146715964|NCT02265705|529131768|FG001|Follow-up Period|Physician Decision|0|||
146715965|NCT02265705|529131769|FG002|Follow-up Period|Physician Decision|0|||
146715966|NCT02265705|529131770|FG003|Follow-up Period|Physician Decision|0|||
146715967|NCT02265705|529131771|FG004|Follow-up Period|Physician Decision|0|||
146715968|NCT02265705|529131772|FG005|Follow-up Period|Physician Decision|0|||
146715969|NCT02265705|529131773|FG006|Follow-up Period|Physician Decision|1|||
146715970|NCT02265705|529131767|FG000|Follow-up Period|Withdrawal by Subject|0|||
146715971|NCT02265705|529131768|FG001|Follow-up Period|Withdrawal by Subject|0|||
146715972|NCT02265705|529131769|FG002|Follow-up Period|Withdrawal by Subject|0|||
146715973|NCT02265705|529131770|FG003|Follow-up Period|Withdrawal by Subject|0|||
146715974|NCT02265705|529131771|FG004|Follow-up Period|Withdrawal by Subject|0|||
146934103|NCT02726113|529916091|FG001|Genomic Analysis|Withdrawal by Subject|1|||
146934104|NCT02726113|529916090|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
146715975|NCT02265705|529131772|FG005|Follow-up Period|Withdrawal by Subject|0|||
146715976|NCT02265705|529131773|FG006|Follow-up Period|Withdrawal by Subject|1|||
146715977|NCT00346034|529131774|FG000|Overall Study|Adverse Event|34|||
146715978|NCT00346034|529131774|FG000|Overall Study|Lack of Efficacy|8|||
146715979|NCT00346034|529131774|FG000|Overall Study|Withdrawal by Subject|13|||
146715980|NCT00346034|529131774|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
146715981|NCT00346034|529131774|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
146715982|NCT01753193|529131778|FG000|Overall Study|Withdrawal by Subject|23|||
146715983|NCT01753193|529131778|FG000|Overall Study|Lost to Follow-up|6|||
146715984|NCT01753193|529131778|FG000|Overall Study|Death|1|||
146715985|NCT01753193|529131778|FG000|Overall Study|Other|16|||
146715986|NCT00583557|529131779|FG000|Overall Study|Withdrawal by Subject|18|||
146715987|NCT00583557|529131779|FG000|Overall Study|Adverse Event|9|||
146715988|NCT00583557|529131779|FG000|Overall Study|Lack of Efficacy|31|||
146715989|NCT00583557|529131779|FG000|Overall Study|Lack of Compliance|5|||
146715990|NCT00583557|529131779|FG000|Overall Study|Other|5|||
146715991|NCT00583557|529131779|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
146715992|NCT03625570|529131780|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
146715993|NCT03625570|529131781|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
146715994|NCT03625570|529131780|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
146715995|NCT03625570|529131781|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
146715996|NCT03625570|529131780|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
146715997|NCT03625570|529131781|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
146715998|NCT03029208|529131782|FG000|Overall Study|Withdrawal by Subject|2|||
146715999|NCT03029208|529131783|FG001|Overall Study|Withdrawal by Subject|3|||
146716000|NCT03029208|529131782|FG000|Overall Study|Lost to Follow-up|0|||
146716001|NCT03029208|529131783|FG001|Overall Study|Lost to Follow-up|1|||
146716002|NCT03207750|529131786|FG000|Overall Study|Adverse Event|3|||
146716003|NCT03207750|529131787|FG001|Overall Study|Adverse Event|2|||
146716004|NCT03207750|529131786|FG000|Overall Study|Lost to Follow-up|21|||
146716005|NCT03207750|529131787|FG001|Overall Study|Lost to Follow-up|29|||
146716006|NCT03207750|529131786|FG000|Overall Study|Protocol Violation|0|||
146716007|NCT03207750|529131787|FG001|Overall Study|Protocol Violation|1|||
146716008|NCT03207750|529131786|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
146716009|NCT03207750|529131787|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
146716010|NCT03207750|529131786|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
146716011|NCT03207750|529131787|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
146716012|NCT03207750|529131786|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
146716013|NCT03207750|529131787|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
146716014|NCT03207750|529131786|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
146716015|NCT03207750|529131787|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
146716016|NCT03207750|529131786|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
146716017|NCT03207750|529131787|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
146716018|NCT02334748|529131788|FG000|Overall Study|Adverse Event|1|||
146716019|NCT02334748|529131788|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
146716020|NCT02334748|529131788|FG000|Overall Study|Patient no longer required study drug|2|||
146716021|NCT02334748|529131788|FG000|Overall Study|Lack of Efficacy|4|||
146716022|NCT01046643|529131789|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
146716023|NCT01046643|529131790|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
146716024|NCT01046643|529131791|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
146716025|NCT01046643|529131792|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
146716026|NCT01568047|529131795|FG000|Overall Study|Ineligibility|1|||
146716027|NCT01568047|529131796|FG001|Overall Study|Ineligibility|0|||
146716028|NCT01568047|529131797|FG002|Overall Study|Ineligibility|0|||
146716029|NCT01568047|529131798|FG003|Overall Study|Ineligibility|0|||
146716030|NCT01568047|529131795|FG000|Overall Study|Withdrawal by Subject|0|||
146716031|NCT01568047|529131796|FG001|Overall Study|Withdrawal by Subject|1|||
146716032|NCT01568047|529131797|FG002|Overall Study|Withdrawal by Subject|0|||
146716033|NCT01568047|529131798|FG003|Overall Study|Withdrawal by Subject|0|||
146934105|NCT02726113|529916091|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
146716034|NCT01568047|529131795|FG000|Overall Study|Adverse Event|0|||
146934106|NCT01617187|529916092|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
146934107|NCT01617187|529916093|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
146716035|NCT01568047|529131796|FG001|Overall Study|Adverse Event|0|||
146716036|NCT01568047|529131797|FG002|Overall Study|Adverse Event|1|||
146716037|NCT01568047|529131798|FG003|Overall Study|Adverse Event|1|||
146716038|NCT00874029|529131799|FG000|Overall Study|Withdrawal by Subject|10|||
146716039|NCT00874029|529131799|FG000|Overall Study|Pregnancy|4|||
146716040|NCT00874029|529131799|FG000|Overall Study|Physician Decision|1|||
146716041|NCT00874029|529131799|FG000|Overall Study|Adverse Event|1|||
146716042|NCT00874029|529131799|FG000|Overall Study|Lost to Follow-up|5|||
146716043|NCT02937545|529131805|FG000|Overall Study|Withdrawal by Subject|1|||
146716044|NCT02937545|529131806|FG001|Overall Study|Withdrawal by Subject|2|||
146716045|NCT02937545|529131807|FG002|Overall Study|Withdrawal by Subject|6|||
146716046|NCT02937545|529131808|FG003|Overall Study|Withdrawal by Subject|7|||
146716047|NCT02937545|529131805|FG000|Overall Study|Lost to Follow-up|1|||
146716048|NCT02937545|529131806|FG001|Overall Study|Lost to Follow-up|0|||
146716049|NCT02937545|529131807|FG002|Overall Study|Lost to Follow-up|0|||
146716050|NCT02937545|529131808|FG003|Overall Study|Lost to Follow-up|0|||
146716051|NCT00968669|529131809|FG000|Overall Study|Lost to Follow-up|5|||
146716052|NCT00968669|529131810|FG001|Overall Study|Lost to Follow-up|2|||
146716053|NCT00968669|529131811|FG002|Overall Study|Lost to Follow-up|1|||
146716054|NCT00968669|529131812|FG003|Overall Study|Lost to Follow-up|4|||
146716055|NCT00968669|529131809|FG000|Overall Study|Withdrawal by Subject|9|||
146716056|NCT00968669|529131810|FG001|Overall Study|Withdrawal by Subject|7|||
146716057|NCT00968669|529131811|FG002|Overall Study|Withdrawal by Subject|5|||
146716058|NCT00968669|529131812|FG003|Overall Study|Withdrawal by Subject|3|||
146716059|NCT00968669|529131809|FG000|Overall Study|Pregnancy|0|||
146716060|NCT00968669|529131810|FG001|Overall Study|Pregnancy|0|||
146716061|NCT00968669|529131811|FG002|Overall Study|Pregnancy|2|||
146716062|NCT00968669|529131812|FG003|Overall Study|Pregnancy|0|||
146716063|NCT00968669|529131809|FG000|Overall Study|AE|1|||
146716064|NCT00968669|529131810|FG001|Overall Study|AE|0|||
146716065|NCT00968669|529131811|FG002|Overall Study|AE|0|||
146716066|NCT00968669|529131812|FG003|Overall Study|AE|0|||
146716067|NCT00968669|529131809|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
146716068|NCT00968669|529131810|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
146716069|NCT00968669|529131811|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
146716070|NCT00968669|529131812|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
146716071|NCT00968669|529131809|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
146716072|NCT00968669|529131810|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
146716073|NCT00968669|529131811|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
146716074|NCT00968669|529131812|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
146716075|NCT00968669|529131809|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
146716076|NCT00968669|529131810|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
146716077|NCT00968669|529131811|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
146716078|NCT00968669|529131812|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
146716079|NCT00968669|529131809|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
146716080|NCT00968669|529131810|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
146716081|NCT00968669|529131811|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
146780863|NCT00073749|529367581|FG005|Overall Study|Withdrawal by Subject|0|||
146780864|NCT00073749|529367582|FG006|Overall Study|Withdrawal by Subject|2|||
146780865|NCT00073749|529367576|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
146780866|NCT00073749|529367577|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
146780867|NCT00073749|529367578|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
146780868|NCT00073749|529367579|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
146780869|NCT00073749|529367580|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
146780870|NCT00073749|529367581|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
146780871|NCT00073749|529367582|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
146780872|NCT00073749|529367576|FG000|Overall Study|Lost to Follow-up|0|||
146780873|NCT00073749|529367577|FG001|Overall Study|Lost to Follow-up|0|||
146780874|NCT00073749|529367578|FG002|Overall Study|Lost to Follow-up|0|||
146780875|NCT00073749|529367579|FG003|Overall Study|Lost to Follow-up|0|||
146780876|NCT00073749|529367580|FG004|Overall Study|Lost to Follow-up|0|||
146780877|NCT00073749|529367581|FG005|Overall Study|Lost to Follow-up|0|||
146780878|NCT00073749|529367582|FG006|Overall Study|Lost to Follow-up|2|||
146780879|NCT00073749|529367576|FG000|Overall Study|Other|0|||
146780880|NCT00073749|529367577|FG001|Overall Study|Other|0|||
146780881|NCT00073749|529367578|FG002|Overall Study|Other|0|||
146780882|NCT00073749|529367579|FG003|Overall Study|Other|0|||
146780883|NCT00073749|529367580|FG004|Overall Study|Other|0|||
146780884|NCT00073749|529367581|FG005|Overall Study|Other|2|||
146716082|NCT00968669|529131812|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
146716083|NCT00968669|529131809|FG000|Overall Study|EARLY WITHDRAWAL|0|||
146716084|NCT00968669|529131810|FG001|Overall Study|EARLY WITHDRAWAL|1|||
146716085|NCT00968669|529131811|FG002|Overall Study|EARLY WITHDRAWAL|0|||
146716086|NCT00968669|529131812|FG003|Overall Study|EARLY WITHDRAWAL|0|||
146716087|NCT00968669|529131809|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
146716088|NCT00968669|529131810|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
146716089|NCT00968669|529131811|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
146716090|NCT00968669|529131812|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
146780885|NCT00073749|529367582|FG006|Overall Study|Other|0|||
146780886|NCT00611559|529367583|FG000|Overall Study|Lost to Follow-up|0|||
146780887|NCT00611559|529367584|FG001|Overall Study|Lost to Follow-up|1|||
146780888|NCT00611559|529367585|FG002|Overall Study|Lost to Follow-up|0|||
146780889|NCT00611559|529367583|FG000|Overall Study|Protocol Violation|1|||
146780890|NCT00611559|529367584|FG001|Overall Study|Protocol Violation|0|||
146780891|NCT00611559|529367585|FG002|Overall Study|Protocol Violation|1|||
146716091|NCT00968669|529131809|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
146716092|NCT00968669|529131810|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
146716093|NCT00968669|529131811|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
146716094|NCT00968669|529131812|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
146716095|NCT00968669|529131809|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
146716096|NCT00968669|529131810|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
146716097|NCT00968669|529131811|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
146716098|NCT00968669|529131812|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
146716099|NCT00968669|529131809|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
146716100|NCT00968669|529131810|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
146716101|NCT00968669|529131811|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
146716102|NCT00968669|529131812|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
146716103|NCT00968669|529131809|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
146716104|NCT00968669|529131810|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
146716105|NCT00968669|529131811|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
146716106|NCT00968669|529131812|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
146716107|NCT00968669|529131809|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
146716108|NCT00968669|529131810|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
146716109|NCT00968669|529131811|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
146716110|NCT00968669|529131812|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
146716111|NCT00968669|529131809|FG000|Overall Study|SPONSOR DECISION|0|||
146716112|NCT00968669|529131810|FG001|Overall Study|SPONSOR DECISION|1|||
146716113|NCT00968669|529131811|FG002|Overall Study|SPONSOR DECISION|0|||
146716114|NCT00968669|529131812|FG003|Overall Study|SPONSOR DECISION|0|||
146716115|NCT00968669|529131809|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
146716116|NCT00968669|529131810|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
146716117|NCT00968669|529131811|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
146716118|NCT00968669|529131812|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
146716119|NCT00968669|529131809|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
146716120|NCT00968669|529131810|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
146716121|NCT00968669|529131811|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
146716122|NCT00968669|529131812|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
146716123|NCT00968669|529131809|FG000|Overall Study|SUBJECT INCARCERATED|0|||
146716124|NCT00968669|529131810|FG001|Overall Study|SUBJECT INCARCERATED|1|||
146716125|NCT00968669|529131811|FG002|Overall Study|SUBJECT INCARCERATED|0|||
146716126|NCT00968669|529131812|FG003|Overall Study|SUBJECT INCARCERATED|0|||
146716127|NCT00968669|529131809|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
146716128|NCT00968669|529131810|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
146716129|NCT00968669|529131811|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
146716130|NCT00968669|529131812|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
146716131|NCT00968669|529131809|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
146716132|NCT00968669|529131810|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
146716133|NCT00968669|529131811|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
146716134|NCT00968669|529131812|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
146716135|NCT04798586|529131819|FG000|Overall Study|Death|2|||
146716136|NCT00968617|529131820|FG000|Overall Study|Study terminated by sponsor|6|||
146716137|NCT04433767|529131821|FG000|Overall Study|Adverse Event|1|||
146716138|NCT01618838|529131829|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
146716139|NCT00288587|529131830|FG000|Overall Study|Death|4|||
146716140|NCT00288587|529131831|FG001|Overall Study|Death|4|||
146716141|NCT00288587|529131830|FG000|Overall Study|Transplant|0|||
146716142|NCT00288587|529131831|FG001|Overall Study|Transplant|3|||
146716143|NCT00288587|529131830|FG000|Overall Study|Adverse Event|0|||
146716144|NCT00288587|529131831|FG001|Overall Study|Adverse Event|1|||
146716145|NCT00288587|529131830|FG000|Overall Study|Physician Decision|0|||
146716146|NCT00288587|529131831|FG001|Overall Study|Physician Decision|2|||
146716147|NCT00288587|529131830|FG000|Overall Study|Severe Aortic Stenosis|1|||
146716148|NCT00288587|529131831|FG001|Overall Study|Severe Aortic Stenosis|0|||
146716149|NCT01434602|529131832|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
146716150|NCT01434602|529131833|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
146716151|NCT01434602|529131834|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
146716152|NCT01434602|529131835|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
146716153|NCT01434602|529131836|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
146716154|NCT01434602|529131832|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
146716155|NCT01434602|529131833|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
146716156|NCT01434602|529131834|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
146716157|NCT01434602|529131835|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
146780892|NCT05048186|529367589|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
146780893|NCT05048186|529367590|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
146780894|NCT05048186|529367589|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
146780895|NCT05048186|529367590|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
146780896|NCT00951379|529367591|FG000|Overall Study|Adverse Event|4|||
146780897|NCT00951379|529367592|FG001|Overall Study|Adverse Event|1|||
146780898|NCT00951379|529367591|FG000|Overall Study|Withdrawal by Subject|1|||
146780899|NCT00951379|529367592|FG001|Overall Study|Withdrawal by Subject|0|||
146780900|NCT00951379|529367591|FG000|Overall Study|Noncompliance|1|||
146780901|NCT00951379|529367592|FG001|Overall Study|Noncompliance|0|||
146780902|NCT00951379|529367591|FG000|Overall Study|Disease Progression|0|||
146780903|NCT00951379|529367592|FG001|Overall Study|Disease Progression|1|||
146780904|NCT02742519|529367596|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
146780905|NCT02742519|529367597|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
146780906|NCT02742519|529367598|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
146780907|NCT02742519|529367596|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
146780908|NCT02742519|529367597|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
146780909|NCT02742519|529367598|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
146780910|NCT02742519|529367596|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
146780911|NCT02742519|529367597|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
146780912|NCT02742519|529367598|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
146780913|NCT01872078|529367599|FG000|Overall Study|Adverse Event|0|||
146780914|NCT01872078|529367600|FG001|Overall Study|Adverse Event|0|||
146780915|NCT01872078|529367601|FG002|Overall Study|Adverse Event|1|||
146780916|NCT01872078|529367602|FG003|Overall Study|Adverse Event|0|||
146780917|NCT01872078|529367599|FG000|Overall Study|Dose administration non-compliance|0|||
146780918|NCT01872078|529367600|FG001|Overall Study|Dose administration non-compliance|0|||
146780919|NCT01872078|529367601|FG002|Overall Study|Dose administration non-compliance|0|||
146780920|NCT01872078|529367602|FG003|Overall Study|Dose administration non-compliance|1|||
146780921|NCT01872078|529367599|FG000|Overall Study|Protocol Violation|0|||
146780922|NCT01872078|529367600|FG001|Overall Study|Protocol Violation|0|||
146780923|NCT01872078|529367601|FG002|Overall Study|Protocol Violation|1|||
146780924|NCT01872078|529367602|FG003|Overall Study|Protocol Violation|0|||
146780925|NCT01872078|529367599|FG000|Overall Study|Withdrawal by Subject|0|||
146780926|NCT01872078|529367600|FG001|Overall Study|Withdrawal by Subject|0|||
146780927|NCT01872078|529367601|FG002|Overall Study|Withdrawal by Subject|1|||
146780928|NCT01872078|529367602|FG003|Overall Study|Withdrawal by Subject|0|||
146780929|NCT01872078|529367599|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
146780930|NCT01872078|529367600|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
146780931|NCT01872078|529367601|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
146780932|NCT01872078|529367602|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
146780933|NCT03912831|529367603|FG000|Overall Study|Death|1|||
146780934|NCT03912831|529367604|FG001|Overall Study|Death|1|||
146780935|NCT03912831|529367605|FG002|Overall Study|Death|1|||
146780936|NCT03912831|529367606|FG003|Overall Study|Death|1|||
146780937|NCT03912831|529367607|FG004|Overall Study|Death|1|||
146780938|NCT03912831|529367608|FG005|Overall Study|Death|1|||
146780939|NCT03912831|529367603|FG000|Overall Study|Reason not Specified|0|||
146780940|NCT03912831|529367604|FG001|Overall Study|Reason not Specified|0|||
146780941|NCT03912831|529367605|FG002|Overall Study|Reason not Specified|0|||
146780942|NCT03912831|529367606|FG003|Overall Study|Reason not Specified|0|||
146780943|NCT03912831|529367607|FG004|Overall Study|Reason not Specified|1|||
146780944|NCT03912831|529367608|FG005|Overall Study|Reason not Specified|0|||
146780945|NCT03912831|529367603|FG000|Overall Study|Withdrawal by Participant|0|||
146780946|NCT03912831|529367604|FG001|Overall Study|Withdrawal by Participant|0|||
146780947|NCT03912831|529367605|FG002|Overall Study|Withdrawal by Participant|0|||
146780948|NCT03912831|529367606|FG003|Overall Study|Withdrawal by Participant|0|||
146780949|NCT03912831|529367607|FG004|Overall Study|Withdrawal by Participant|1|||
146780950|NCT03912831|529367608|FG005|Overall Study|Withdrawal by Participant|0|||
146780951|NCT03580369|529367609|FG000|Overall Study|No treatment due to mis-randomization|1|||
146780952|NCT03580369|529367610|FG001|Overall Study|No treatment due to mis-randomization|0|||
146780953|NCT03580369|529367611|FG002|Overall Study|No treatment due to mis-randomization|0|||
146780954|NCT03580369|529367612|FG003|Overall Study|No treatment due to mis-randomization|0|||
146780955|NCT03580369|529367613|FG004|Overall Study|No treatment due to mis-randomization|3|||
146780956|NCT03580369|529367614|FG005|Overall Study|No treatment due to mis-randomization|0|||
146780957|NCT03580369|529367615|FG006|Overall Study|No treatment due to mis-randomization|0|||
146780958|NCT03580369|529367616|FG007|Overall Study|No treatment due to mis-randomization|0|||
146780959|NCT03580369|529367609|FG000|Overall Study|Reason unknown|0|||
146780960|NCT03580369|529367610|FG001|Overall Study|Reason unknown|0|||
146780961|NCT03580369|529367611|FG002|Overall Study|Reason unknown|1|||
146780962|NCT03580369|529367612|FG003|Overall Study|Reason unknown|0|||
146780963|NCT03580369|529367613|FG004|Overall Study|Reason unknown|0|||
146780964|NCT03580369|529367614|FG005|Overall Study|Reason unknown|0|||
146780965|NCT03580369|529367615|FG006|Overall Study|Reason unknown|0|||
146716158|NCT01434602|529131836|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
146716159|NCT01434602|529131832|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
146716160|NCT01434602|529131833|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
146716161|NCT01434602|529131834|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
146716162|NCT01434602|529131835|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
146716163|NCT01434602|529131836|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
146716164|NCT01434602|529131832|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
146716165|NCT01434602|529131833|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
146716166|NCT01434602|529131834|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
146716167|NCT01434602|529131835|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
146716168|NCT01434602|529131836|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
146716169|NCT01434602|529131832|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
146716170|NCT01434602|529131833|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
146716171|NCT01434602|529131834|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
146716172|NCT01434602|529131835|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
146716173|NCT01434602|529131836|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
146716174|NCT01434602|529131832|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
146716175|NCT01434602|529131833|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
146716176|NCT01434602|529131834|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
146716177|NCT01434602|529131835|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
146716178|NCT01434602|529131836|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
146716179|NCT01434602|529131832|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
146716180|NCT01434602|529131833|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
146716181|NCT01434602|529131834|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
146716182|NCT01434602|529131835|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
146716183|NCT01434602|529131836|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
146716184|NCT01434602|529131832|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
146716185|NCT01434602|529131833|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
146716186|NCT01434602|529131834|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
146716187|NCT01434602|529131835|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
146716188|NCT01434602|529131836|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
146716189|NCT01434602|529131832|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
146716190|NCT01434602|529131833|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
146716191|NCT01434602|529131834|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
146716192|NCT01434602|529131835|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
146716193|NCT01434602|529131836|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
146716194|NCT01434602|529131832|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
146716195|NCT01434602|529131833|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
146716196|NCT01434602|529131834|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
146716197|NCT01434602|529131835|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
146716198|NCT01434602|529131836|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
146716199|NCT01764945|529131841|FG000|Overall Study|Adverse Event|0|||
146716200|NCT01764945|529131842|FG001|Overall Study|Adverse Event|1|||
146716201|NCT01764945|529131843|FG002|Overall Study|Adverse Event|0|||
146716202|NCT01764945|529131844|FG003|Overall Study|Adverse Event|0|||
146716203|NCT01764945|529131845|FG004|Overall Study|Adverse Event|0|||
146716204|NCT01764945|529131846|FG005|Overall Study|Adverse Event|0|||
146716205|NCT01764945|529131847|FG006|Overall Study|Adverse Event|1|||
146716206|NCT01764945|529131848|FG007|Overall Study|Adverse Event|0|||
146716207|NCT05077267|529131850|FG000|Treatment Period|Lost to Follow-up|0|||
146716208|NCT05077267|529131851|FG001|Treatment Period|Lost to Follow-up|1|||
146716209|NCT05077267|529131852|FG002|Treatment Period|Lost to Follow-up|0|||
146716210|NCT05077267|529131850|FG000|Treatment Period|Withdrawal by Subject|0|||
146716211|NCT05077267|529131851|FG001|Treatment Period|Withdrawal by Subject|1|||
146716212|NCT05077267|529131852|FG002|Treatment Period|Withdrawal by Subject|0|||
146716213|NCT05077267|529131850|FG000|Follow-up Period|Lost to Follow-up|0|||
146716214|NCT05077267|529131851|FG001|Follow-up Period|Lost to Follow-up|5|||
146716215|NCT05077267|529131852|FG002|Follow-up Period|Lost to Follow-up|7|||
146716216|NCT05077267|529131850|FG000|Follow-up Period|Withdrawal by Subject|0|||
146716217|NCT05077267|529131851|FG001|Follow-up Period|Withdrawal by Subject|2|||
146716218|NCT05077267|529131852|FG002|Follow-up Period|Withdrawal by Subject|5|||
146716219|NCT05077267|529131850|FG000|Follow-up Period|Study terminated by sponsor|0|||
146934108|NCT01617187|529916094|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
146934109|NCT01617187|529916095|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
146716220|NCT05077267|529131851|FG001|Follow-up Period|Study terminated by sponsor|27|||
146716221|NCT05077267|529131852|FG002|Follow-up Period|Study terminated by sponsor|23|||
146716222|NCT05077267|529131850|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
146716223|NCT05077267|529131851|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
146716224|NCT05077267|529131852|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
146716225|NCT05077267|529131850|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
146716226|NCT05077267|529131851|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
146716227|NCT05077267|529131852|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
146716228|NCT01136291|529131856|FG000|Overall Study|Lost to Follow-up|1|||
146716229|NCT01136291|529131857|FG001|Overall Study|Lost to Follow-up|1|||
146716230|NCT02308033|529131863|FG000|Overall Study|Normal Gram stain at Baseline|13|||
146716231|NCT02308033|529131864|FG001|Overall Study|Normal Gram stain at Baseline|10|||
146716232|NCT02308033|529131863|FG000|Overall Study|Positive for STD at Baseline|7|||
146716233|NCT02308033|529131864|FG001|Overall Study|Positive for STD at Baseline|4|||
146716234|NCT02308033|529131863|FG000|Overall Study|Lost to Follow-up|6|||
146716235|NCT02308033|529131864|FG001|Overall Study|Lost to Follow-up|5|||
146716236|NCT03165045|529131865|FG000|Visit 1|No registration after visit 1|9|||
146716237|NCT03165045|529131865|FG000|Visit 1|No treatment documented|10|||
146716238|NCT03165045|529131865|FG000|Visit 1|No visit 1|10|||
146716239|NCT03165045|529131865|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
146716240|NCT03165045|529131865|FG000|Visit 2|No available total CCQ score at all|29|||
146716241|NCT03165045|529131865|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
146716242|NCT00499889|529131869|FG000|Overall Study|Infection prior to treatment|1|||
146716243|NCT00345397|529131873|FG000|Overall Study|Death|1|||
146716244|NCT01870843|529131874|FG000|Overall Study|Adverse Event|10|||
146716245|NCT01870843|529131874|FG000|Overall Study|Lost to Follow-up|24|||
146716246|NCT01870843|529131874|FG000|Overall Study|Death|1|||
146716247|NCT01870843|529131874|FG000|Overall Study|Withdrawal by Subject|18|||
146716248|NCT03325712|529131875|FG000|Overall Study|Protocol Violation|0|||
146716249|NCT03325712|529131876|FG001|Overall Study|Protocol Violation|0|||
146716250|NCT03325712|529131877|FG002|Overall Study|Protocol Violation|0|||
146716251|NCT03325712|529131878|FG003|Overall Study|Protocol Violation|0|||
146716252|NCT03325712|529131879|FG004|Overall Study|Protocol Violation|1|||
146716253|NCT03325712|529131880|FG005|Overall Study|Protocol Violation|0|||
146716254|NCT03325712|529131881|FG006|Overall Study|Protocol Violation|0|||
146716255|NCT03325712|529131882|FG007|Overall Study|Protocol Violation|0|||
146716256|NCT03325712|529131875|FG000|Overall Study|Adverse Event|0|||
146716257|NCT03325712|529131876|FG001|Overall Study|Adverse Event|0|||
146716258|NCT03325712|529131877|FG002|Overall Study|Adverse Event|0|||
146716259|NCT03325712|529131878|FG003|Overall Study|Adverse Event|0|||
146716260|NCT03325712|529131879|FG004|Overall Study|Adverse Event|1|||
146716261|NCT03325712|529131880|FG005|Overall Study|Adverse Event|0|||
146716262|NCT03325712|529131881|FG006|Overall Study|Adverse Event|0|||
146716263|NCT03325712|529131882|FG007|Overall Study|Adverse Event|0|||
146716264|NCT01297062|529131883|FG000|Overall Study|Adverse Event|2|||
146716265|NCT01297062|529131884|FG001|Overall Study|Adverse Event|0|||
146716266|NCT01297062|529131885|FG002|Overall Study|Adverse Event|1|||
146716267|NCT01297062|529131886|FG003|Overall Study|Adverse Event|0|||
146716268|NCT01297062|529131887|FG004|Overall Study|Adverse Event|0|||
146716269|NCT01297062|529131888|FG005|Overall Study|Adverse Event|0|||
146716270|NCT01297062|529131889|FG006|Overall Study|Adverse Event|0|||
146716271|NCT01297062|529131883|FG000|Overall Study|Physician Decision|1|||
146716272|NCT01297062|529131884|FG001|Overall Study|Physician Decision|0|||
146716273|NCT01297062|529131885|FG002|Overall Study|Physician Decision|1|||
146716274|NCT01297062|529131886|FG003|Overall Study|Physician Decision|0|||
146716275|NCT01297062|529131887|FG004|Overall Study|Physician Decision|0|||
146716276|NCT01297062|529131888|FG005|Overall Study|Physician Decision|0|||
146716277|NCT01297062|529131889|FG006|Overall Study|Physician Decision|6|||
146716278|NCT01297062|529131883|FG000|Overall Study|Protocol Violation|0|||
146716279|NCT01297062|529131884|FG001|Overall Study|Protocol Violation|0|||
146716280|NCT01297062|529131885|FG002|Overall Study|Protocol Violation|0|||
146716281|NCT01297062|529131886|FG003|Overall Study|Protocol Violation|0|||
146716282|NCT01297062|529131887|FG004|Overall Study|Protocol Violation|1|||
146716283|NCT01297062|529131888|FG005|Overall Study|Protocol Violation|0|||
146716284|NCT01297062|529131889|FG006|Overall Study|Protocol Violation|0|||
146780966|NCT03580369|529367616|FG007|Overall Study|Reason unknown|0|||
146780967|NCT03580369|529367609|FG000|Overall Study|Technical problems|0|||
146780968|NCT03580369|529367610|FG001|Overall Study|Technical problems|0|||
146716285|NCT01297062|529131883|FG000|Overall Study|Subject Decision|1|||
146716286|NCT01297062|529131884|FG001|Overall Study|Subject Decision|1|||
146716287|NCT01297062|529131885|FG002|Overall Study|Subject Decision|0|||
146716288|NCT01297062|529131886|FG003|Overall Study|Subject Decision|1|||
146716289|NCT01297062|529131887|FG004|Overall Study|Subject Decision|1|||
146716290|NCT01297062|529131888|FG005|Overall Study|Subject Decision|1|||
146716291|NCT01297062|529131889|FG006|Overall Study|Subject Decision|2|||
146716292|NCT04782323|529131890|FG000|Overall Study|Death|1|||
146716293|NCT04782323|529131891|FG001|Overall Study|Death|0|||
146780969|NCT03580369|529367611|FG002|Overall Study|Technical problems|0|||
146716294|NCT04782323|529131892|FG002|Overall Study|Death|0|||
146716295|NCT04782323|529131893|FG003|Overall Study|Death|0|||
146716296|NCT04782323|529131894|FG004|Overall Study|Death|1|||
146716297|NCT04782323|529131895|FG005|Overall Study|Death|1|||
146716298|NCT04782323|529131896|FG006|Overall Study|Death|1|||
146716299|NCT04782323|529131897|FG007|Overall Study|Death|0|||
146716300|NCT04782323|529131890|FG000|Overall Study|Withdrawal by Subject|0|||
146716301|NCT04782323|529131891|FG001|Overall Study|Withdrawal by Subject|0|||
146716302|NCT04782323|529131892|FG002|Overall Study|Withdrawal by Subject|1|||
146716303|NCT04782323|529131893|FG003|Overall Study|Withdrawal by Subject|0|||
146716304|NCT04782323|529131894|FG004|Overall Study|Withdrawal by Subject|0|||
146716305|NCT04782323|529131895|FG005|Overall Study|Withdrawal by Subject|1|||
146716306|NCT04782323|529131896|FG006|Overall Study|Withdrawal by Subject|0|||
146716307|NCT04782323|529131897|FG007|Overall Study|Withdrawal by Subject|1|||
146716308|NCT04782323|529131890|FG000|Overall Study|Lost to Follow-up|0|||
146716309|NCT04782323|529131891|FG001|Overall Study|Lost to Follow-up|1|||
146716310|NCT04782323|529131892|FG002|Overall Study|Lost to Follow-up|1|||
146716311|NCT04782323|529131893|FG003|Overall Study|Lost to Follow-up|0|||
146716312|NCT04782323|529131894|FG004|Overall Study|Lost to Follow-up|0|||
146716313|NCT04782323|529131895|FG005|Overall Study|Lost to Follow-up|1|||
146716314|NCT04782323|529131896|FG006|Overall Study|Lost to Follow-up|1|||
146716315|NCT04782323|529131897|FG007|Overall Study|Lost to Follow-up|2|||
146716316|NCT04782323|529131890|FG000|Overall Study|randomization in error|1|||
146716317|NCT04782323|529131891|FG001|Overall Study|randomization in error|0|||
146716318|NCT04782323|529131892|FG002|Overall Study|randomization in error|0|||
146716319|NCT04782323|529131893|FG003|Overall Study|randomization in error|0|||
146716320|NCT04782323|529131894|FG004|Overall Study|randomization in error|0|||
146716321|NCT04782323|529131895|FG005|Overall Study|randomization in error|0|||
146716322|NCT04782323|529131896|FG006|Overall Study|randomization in error|0|||
146716323|NCT04782323|529131897|FG007|Overall Study|randomization in error|0|||
146716324|NCT04369469|529131898|FG000|Overall Study|Lost to Follow-up|2|||
146716325|NCT04369469|529131899|FG001|Overall Study|Lost to Follow-up|4|||
146716326|NCT04369469|529131898|FG000|Overall Study|Physician Decision|2|||
146716327|NCT04369469|529131899|FG001|Overall Study|Physician Decision|1|||
146716328|NCT04369469|529131898|FG000|Overall Study|Withdrawal by Subject|2|||
146716329|NCT04369469|529131899|FG001|Overall Study|Withdrawal by Subject|3|||
146716330|NCT04369469|529131898|FG000|Overall Study|Adverse Event|1|||
146716331|NCT04369469|529131899|FG001|Overall Study|Adverse Event|0|||
146716332|NCT04369469|529131898|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
146716333|NCT04369469|529131899|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
146716334|NCT04369469|529131898|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
146716335|NCT04369469|529131899|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
146716336|NCT04369469|529131898|FG000|Overall Study|Unable to Provide Consent|0|||
146716337|NCT04369469|529131899|FG001|Overall Study|Unable to Provide Consent|1|||
146716338|NCT01660906|529131900|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
146716339|NCT04745169|529133840|FG000|Overall Study|Kidney transplantation|1|||
146716340|NCT04745169|529133840|FG000|Overall Study|Participant health problems|3|||
146716341|NCT04745169|529133840|FG000|Overall Study|Physician Decision|2|||
146716342|NCT02053350|529133843|FG000|Overall Study|Withdrawal by Subject|1|||
146716343|NCT02053350|529133843|FG000|Overall Study|Adverse Event|4|||
146716344|NCT01747772|529133844|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
146716345|NCT02367911|529133845|FG000|Overall Study|Withdrawal by Subject|3|||
146716346|NCT02367911|529133846|FG001|Overall Study|Withdrawal by Subject|2|||
146716347|NCT02367911|529133845|FG000|Overall Study|Lost to Follow-up|2|||
146716348|NCT02367911|529133846|FG001|Overall Study|Lost to Follow-up|2|||
146716349|NCT01153633|529133847|FG000|Overall Study|Protocol Violation|1|||
146716350|NCT01153633|529133848|FG001|Overall Study|Protocol Violation|1|||
146716351|NCT01153633|529133847|FG000|Overall Study|Therapeutic failure|3|||
146716352|NCT01153633|529133848|FG001|Overall Study|Therapeutic failure|3|||
146716353|NCT00512135|529133849|FG000|Overall Study|Not Treated|5|||
146716354|NCT00512135|529133849|FG000|Overall Study|Lack of Efficacy|2|||
146716355|NCT00512135|529133849|FG000|Overall Study|Adverse Event|6|||
146716356|NCT00512135|529133849|FG000|Overall Study|Withdrawal by Subject|22|||
146716357|NCT00512135|529133849|FG000|Overall Study|Lost to Follow-up|27|||
146716358|NCT00512135|529133849|FG000|Overall Study|Other|22|||
146716359|NCT01148810|529133853|FG000|Overall Study|Adverse Event|0|||
146716360|NCT01148810|529133854|FG001|Overall Study|Adverse Event|2|||
146716361|NCT01148810|529133853|FG000|Overall Study|Lack of Efficacy|0|||
146716362|NCT01148810|529133854|FG001|Overall Study|Lack of Efficacy|1|||
146716363|NCT01148810|529133853|FG000|Overall Study|Withdrawal by Subject|0|||
146716364|NCT01148810|529133854|FG001|Overall Study|Withdrawal by Subject|2|||
146716365|NCT01148810|529133853|FG000|Overall Study|Protocol Violation|1|||
146716366|NCT01148810|529133854|FG001|Overall Study|Protocol Violation|0|||
146716367|NCT02417246|529133860|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
146716368|NCT02417246|529133861|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
146716369|NCT02417246|529133860|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
146716370|NCT02417246|529133861|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
146780970|NCT03580369|529367612|FG003|Overall Study|Technical problems|0|||
146780971|NCT03580369|529367613|FG004|Overall Study|Technical problems|1|||
146780972|NCT03580369|529367614|FG005|Overall Study|Technical problems|0|||
146780973|NCT03580369|529367615|FG006|Overall Study|Technical problems|2|||
146780974|NCT03580369|529367616|FG007|Overall Study|Technical problems|0|||
146780975|NCT03580369|529367609|FG000|Overall Study|Pregnancy|2|||
146780976|NCT03580369|529367610|FG001|Overall Study|Pregnancy|0|||
146780977|NCT03580369|529367611|FG002|Overall Study|Pregnancy|3|||
146780978|NCT03580369|529367612|FG003|Overall Study|Pregnancy|0|||
146780979|NCT03580369|529367613|FG004|Overall Study|Pregnancy|2|||
146780980|NCT03580369|529367614|FG005|Overall Study|Pregnancy|0|||
146780981|NCT03580369|529367615|FG006|Overall Study|Pregnancy|0|||
146780982|NCT03580369|529367616|FG007|Overall Study|Pregnancy|0|||
146716371|NCT02417246|529133860|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
146716372|NCT02417246|529133861|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
146716373|NCT02417246|529133860|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
146716374|NCT02417246|529133861|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
146716375|NCT04408469|529133864|FG000|Overall Study|Lost to Follow-up|6|||
146716376|NCT04408469|529133865|FG001|Overall Study|Lost to Follow-up|9|||
146716377|NCT04408469|529133864|FG000|Overall Study|Withdrawal by Subject|6|||
146716378|NCT04408469|529133865|FG001|Overall Study|Withdrawal by Subject|1|||
146716379|NCT04408469|529133864|FG000|Overall Study|Dismissal due to ineligibility|0|||
146716380|NCT04408469|529133865|FG001|Overall Study|Dismissal due to ineligibility|1|||
146716381|NCT04321460|529133866|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
146716382|NCT04321460|529133867|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
146716383|NCT01308749|529133868|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
146716384|NCT01308749|529133869|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
146716385|NCT01308749|529133868|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
146716386|NCT01308749|529133869|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
146716387|NCT01308749|529133868|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
146716388|NCT01308749|529133869|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
146716389|NCT03058679|529133874|FG000|Baseline to Week 6|Lost to Follow-up|3|||
146716390|NCT03058679|529133875|FG001|Baseline to Week 6|Lost to Follow-up|2|||
146716391|NCT03058679|529133874|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
146716392|NCT03058679|529133875|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
146716393|NCT03058679|529133874|FG000|Baseline to Week 6|Adverse Event|6|||
146716394|NCT03058679|529133875|FG001|Baseline to Week 6|Adverse Event|6|||
146716395|NCT03058679|529133874|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
146716396|NCT03058679|529133875|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
146716397|NCT03058679|529133874|FG000|Baseline to Week 6|Difficulty following the diet|0|||
146716398|NCT03058679|529133875|FG001|Baseline to Week 6|Difficulty following the diet|2|||
146716399|NCT03058679|529133874|FG000|Baseline to Week 6|Physician Decision|1|||
146716400|NCT03058679|529133875|FG001|Baseline to Week 6|Physician Decision|0|||
146716401|NCT03058679|529133874|FG000|Week 6 to Week 12|Change in medication|5|||
146716402|NCT03058679|529133875|FG001|Week 6 to Week 12|Change in medication|7|||
146716403|NCT03058679|529133874|FG000|Week 6 to Week 12|Adverse Event|4|||
146716404|NCT03058679|529133875|FG001|Week 6 to Week 12|Adverse Event|3|||
146716405|NCT03058679|529133874|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
146716406|NCT03058679|529133875|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
146716407|NCT03058679|529133874|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
146716408|NCT03058679|529133875|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
146716409|NCT00599326|529133880|FG000|Overall Study|Lost to Follow-up|1|||
146716410|NCT00599326|529133880|FG000|Overall Study|Noncompliant|1|||
146716411|NCT00784810|529133881|FG000|Overall Study|Adverse Event|32|||
146716412|NCT00784810|529133882|FG001|Overall Study|Adverse Event|20|||
146780983|NCT03580369|529367609|FG000|Overall Study|Lost to Follow-up|2|||
146934110|NCT01617187|529916092|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
146716413|NCT00784810|529133881|FG000|Overall Study|Lack of Efficacy|14|||
146716414|NCT00784810|529133882|FG001|Overall Study|Lack of Efficacy|11|||
146716415|NCT00784810|529133881|FG000|Overall Study|Withdrawal by Subject|11|||
146780984|NCT03580369|529367610|FG001|Overall Study|Lost to Follow-up|0|||
146780985|NCT03580369|529367611|FG002|Overall Study|Lost to Follow-up|2|||
146780986|NCT03580369|529367612|FG003|Overall Study|Lost to Follow-up|0|||
146780987|NCT03580369|529367613|FG004|Overall Study|Lost to Follow-up|3|||
146934111|NCT01617187|529916093|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
146716416|NCT00784810|529133882|FG001|Overall Study|Withdrawal by Subject|9|||
146716417|NCT00784810|529133881|FG000|Overall Study|Administrative|5|||
146716418|NCT00784810|529133882|FG001|Overall Study|Administrative|8|||
146780988|NCT03580369|529367614|FG005|Overall Study|Lost to Follow-up|0|||
146780989|NCT03580369|529367615|FG006|Overall Study|Lost to Follow-up|1|||
146780990|NCT03580369|529367616|FG007|Overall Study|Lost to Follow-up|0|||
146716419|NCT00784810|529133881|FG000|Overall Study|Lost to Follow-up|1|||
146716420|NCT00784810|529133882|FG001|Overall Study|Lost to Follow-up|1|||
146780991|NCT03580369|529367609|FG000|Overall Study|Physician Decision|4|||
146780992|NCT03580369|529367610|FG001|Overall Study|Physician Decision|0|||
146780993|NCT03580369|529367611|FG002|Overall Study|Physician Decision|4|||
146780994|NCT03580369|529367612|FG003|Overall Study|Physician Decision|1|||
146780995|NCT03580369|529367613|FG004|Overall Study|Physician Decision|1|||
146780996|NCT03580369|529367614|FG005|Overall Study|Physician Decision|0|||
146780997|NCT03580369|529367615|FG006|Overall Study|Physician Decision|0|||
146780998|NCT03580369|529367616|FG007|Overall Study|Physician Decision|0|||
146780999|NCT03580369|529367609|FG000|Overall Study|Lack of Efficacy|3|||
146781000|NCT03580369|529367610|FG001|Overall Study|Lack of Efficacy|0|||
146781001|NCT03580369|529367611|FG002|Overall Study|Lack of Efficacy|7|||
146781002|NCT03580369|529367612|FG003|Overall Study|Lack of Efficacy|0|||
146781003|NCT03580369|529367613|FG004|Overall Study|Lack of Efficacy|2|||
146781004|NCT03580369|529367614|FG005|Overall Study|Lack of Efficacy|0|||
146781005|NCT03580369|529367615|FG006|Overall Study|Lack of Efficacy|3|||
146781006|NCT03580369|529367616|FG007|Overall Study|Lack of Efficacy|0|||
146781007|NCT03580369|529367609|FG000|Overall Study|Protocol Violation|6|||
146781008|NCT03580369|529367610|FG001|Overall Study|Protocol Violation|0|||
146781009|NCT03580369|529367611|FG002|Overall Study|Protocol Violation|6|||
146781010|NCT03580369|529367612|FG003|Overall Study|Protocol Violation|1|||
146781011|NCT03580369|529367613|FG004|Overall Study|Protocol Violation|8|||
146781012|NCT03580369|529367614|FG005|Overall Study|Protocol Violation|2|||
146781013|NCT03580369|529367615|FG006|Overall Study|Protocol Violation|1|||
146781014|NCT03580369|529367616|FG007|Overall Study|Protocol Violation|0|||
146781015|NCT03580369|529367609|FG000|Overall Study|Adverse Event|7|||
146781016|NCT03580369|529367610|FG001|Overall Study|Adverse Event|0|||
146781017|NCT03580369|529367611|FG002|Overall Study|Adverse Event|14|||
146781018|NCT03580369|529367612|FG003|Overall Study|Adverse Event|1|||
146781019|NCT03580369|529367613|FG004|Overall Study|Adverse Event|6|||
146781020|NCT03580369|529367614|FG005|Overall Study|Adverse Event|0|||
146781021|NCT03580369|529367615|FG006|Overall Study|Adverse Event|1|||
146781022|NCT03580369|529367616|FG007|Overall Study|Adverse Event|0|||
146781023|NCT03580369|529367609|FG000|Overall Study|Withdrawal by Subject|19|||
146781024|NCT03580369|529367610|FG001|Overall Study|Withdrawal by Subject|0|||
146781025|NCT03580369|529367611|FG002|Overall Study|Withdrawal by Subject|17|||
146781026|NCT03580369|529367612|FG003|Overall Study|Withdrawal by Subject|0|||
146781027|NCT03580369|529367613|FG004|Overall Study|Withdrawal by Subject|16|||
146781028|NCT03580369|529367614|FG005|Overall Study|Withdrawal by Subject|1|||
146781029|NCT03580369|529367615|FG006|Overall Study|Withdrawal by Subject|7|||
146781030|NCT03580369|529367616|FG007|Overall Study|Withdrawal by Subject|0|||
146781031|NCT05239039|529367622|FG000|Overall Study|Withdrawal by Subject|0|||
146781032|NCT05239039|529367623|FG001|Overall Study|Withdrawal by Subject|1|||
146781033|NCT03152786|529368550|FG000|Overall Study|Withdrawal by Subject|2|||
146781034|NCT03152786|529368551|FG001|Overall Study|Withdrawal by Subject|1|||
146781035|NCT02349412|529368556|FG000|Overall Study|Withdrawal by Subject|7|||
146781036|NCT02349412|529368557|FG001|Overall Study|Withdrawal by Subject|7|||
146716421|NCT04137380|529133883|FG000|Overall Study|Physician Decision|0|||
146716422|NCT04137380|529133884|FG001|Overall Study|Physician Decision|0|||
146716423|NCT04137380|529133885|FG002|Overall Study|Physician Decision|0|||
146716424|NCT04137380|529133886|FG003|Overall Study|Physician Decision|1|||
146716425|NCT04137380|529133887|FG004|Overall Study|Physician Decision|0|||
146716426|NCT04137380|529133888|FG005|Overall Study|Physician Decision|0|||
146716427|NCT04137380|529133889|FG006|Overall Study|Physician Decision|0|||
146716428|NCT00779246|529133890|FG000|Overall Study|Missing sufficient data for analysis|33|||
146716429|NCT00779246|529133891|FG001|Overall Study|Missing sufficient data for analysis|53|||
146716430|NCT03579459|529133892|FG000|Overall Study|Adverse Event|7|||
146716431|NCT03579459|529133893|FG001|Overall Study|Adverse Event|6|||
146716432|NCT03579459|529133894|FG002|Overall Study|Adverse Event|2|||
146716433|NCT03579459|529133895|FG003|Overall Study|Adverse Event|6|||
146781037|NCT06066541|529368558|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
146781038|NCT06066541|529368559|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
146781039|NCT06066541|529368560|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
146781040|NCT06066541|529368561|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
146716434|NCT03579459|529133892|FG000|Overall Study|Death|1|||
146716435|NCT03579459|529133893|FG001|Overall Study|Death|0|||
146781041|NCT06066541|529368562|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
146781042|NCT06066541|529368563|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
146781043|NCT06066541|529368564|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
146781044|NCT06066541|529368558|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
146781045|NCT06066541|529368559|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
146781046|NCT06066541|529368560|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
146781047|NCT06066541|529368561|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
146781048|NCT06066541|529368562|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
146781049|NCT06066541|529368563|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
146716436|NCT03579459|529133894|FG002|Overall Study|Death|1|||
146716437|NCT03579459|529133895|FG003|Overall Study|Death|2|||
146716438|NCT03579459|529133892|FG000|Overall Study|Lost to Follow-up|6|||
146716439|NCT03579459|529133893|FG001|Overall Study|Lost to Follow-up|2|||
146716440|NCT03579459|529133894|FG002|Overall Study|Lost to Follow-up|4|||
146716441|NCT03579459|529133895|FG003|Overall Study|Lost to Follow-up|1|||
146716442|NCT03579459|529133892|FG000|Overall Study|Physician Decision|0|||
146716443|NCT03579459|529133893|FG001|Overall Study|Physician Decision|1|||
146716444|NCT03579459|529133894|FG002|Overall Study|Physician Decision|0|||
146716445|NCT03579459|529133895|FG003|Overall Study|Physician Decision|1|||
146716446|NCT03579459|529133892|FG000|Overall Study|Protocol Violation|1|||
146716447|NCT03579459|529133893|FG001|Overall Study|Protocol Violation|2|||
146716448|NCT03579459|529133894|FG002|Overall Study|Protocol Violation|3|||
146716449|NCT03579459|529133895|FG003|Overall Study|Protocol Violation|5|||
146716450|NCT03579459|529133892|FG000|Overall Study|Withdrawal by Subject|12|||
146716451|NCT03579459|529133893|FG001|Overall Study|Withdrawal by Subject|8|||
146716452|NCT03579459|529133894|FG002|Overall Study|Withdrawal by Subject|11|||
146716453|NCT03579459|529133895|FG003|Overall Study|Withdrawal by Subject|8|||
146716454|NCT03579459|529133892|FG000|Overall Study|Medication error without associated adverse event|2|||
146716455|NCT03579459|529133893|FG001|Overall Study|Medication error without associated adverse event|1|||
146716456|NCT03579459|529133894|FG002|Overall Study|Medication error without associated adverse event|1|||
146716457|NCT03579459|529133895|FG003|Overall Study|Medication error without associated adverse event|0|||
146716458|NCT03579459|529133892|FG000|Overall Study|Other|0|||
146716459|NCT03579459|529133893|FG001|Overall Study|Other|1|||
146716460|NCT03579459|529133894|FG002|Overall Study|Other|1|||
146716461|NCT03579459|529133895|FG003|Overall Study|Other|0|||
146716462|NCT03579459|529133892|FG000|Overall Study|Randomized not vaccinated|0|||
146716463|NCT03579459|529133893|FG001|Overall Study|Randomized not vaccinated|2|||
146716464|NCT03579459|529133894|FG002|Overall Study|Randomized not vaccinated|0|||
146716465|NCT03579459|529133895|FG003|Overall Study|Randomized not vaccinated|1|||
146716466|NCT02844946|529133897|FG000|Overall Study|Lost to Follow-up|7|||
146716467|NCT02844946|529133898|FG001|Overall Study|Lost to Follow-up|0|||
146716468|NCT02806986|529133899|FG000|Treatment Stage 1|Adverse Event|1|||
146716469|NCT02806986|529133899|FG000|Treatment Stage 2|Adverse Event|3|||
146716470|NCT02806986|529133899|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
146716471|NCT00407537|529133900|FG000|Overall Study|Death|5|||
146716472|NCT00407537|529133901|FG001|Overall Study|Death|2|||
146716473|NCT00407537|529133900|FG000|Overall Study|Adverse Event|36|||
146716474|NCT00407537|529133901|FG001|Overall Study|Adverse Event|0|||
146716475|NCT00407537|529133900|FG000|Overall Study|Lost to Follow-up|12|||
146716476|NCT00407537|529133901|FG001|Overall Study|Lost to Follow-up|19|||
146716477|NCT00407537|529133900|FG000|Overall Study|Other|6|||
146716478|NCT00407537|529133901|FG001|Overall Study|Other|7|||
146716479|NCT00407537|529133900|FG000|Overall Study|Withdrawal by Subject|34|||
146716480|NCT00407537|529133901|FG001|Overall Study|Withdrawal by Subject|16|||
146716481|NCT06027216|529133902|FG000|Overall Study|Did not qualify|8|||
146716482|NCT00413413|529133906|FG000|Single-Blind|Adverse Event|0|||
146716483|NCT00413413|529133907|FG001|Single-Blind|Adverse Event|9|||
146716484|NCT00413413|529133908|FG002|Single-Blind|Adverse Event|0|||
146716485|NCT00413413|529133906|FG000|Single-Blind|Lack of Efficacy|0|||
146716486|NCT00413413|529133907|FG001|Single-Blind|Lack of Efficacy|5|||
146716487|NCT00413413|529133908|FG002|Single-Blind|Lack of Efficacy|0|||
146716488|NCT00413413|529133906|FG000|Single-Blind|Subject no longer requires study drug|0|||
146716489|NCT00413413|529133907|FG001|Single-Blind|Subject no longer requires study drug|151|||
146716490|NCT00413413|529133908|FG002|Single-Blind|Subject no longer requires study drug|0|||
146716491|NCT00413413|529133906|FG000|Single-Blind|Protocol Violation|0|||
146716492|NCT00413413|529133907|FG001|Single-Blind|Protocol Violation|16|||
146716493|NCT00413413|529133908|FG002|Single-Blind|Protocol Violation|0|||
146716494|NCT00413413|529133906|FG000|Single-Blind|Withdrawal by Subject|0|||
146716495|NCT00413413|529133907|FG001|Single-Blind|Withdrawal by Subject|27|||
146716496|NCT00413413|529133908|FG002|Single-Blind|Withdrawal by Subject|0|||
146716497|NCT00413413|529133906|FG000|Single-Blind|Lost to Follow-up|0|||
146716498|NCT00413413|529133907|FG001|Single-Blind|Lost to Follow-up|8|||
146716499|NCT00413413|529133908|FG002|Single-Blind|Lost to Follow-up|0|||
146716500|NCT00413413|529133906|FG000|Double-Blind|Adverse Event|6|||
146716501|NCT00413413|529133907|FG001|Double-Blind|Adverse Event|0|||
146716502|NCT00413413|529133908|FG002|Double-Blind|Adverse Event|5|||
146716503|NCT00413413|529133906|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
146716504|NCT00413413|529133907|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
146716505|NCT00413413|529133908|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
146716506|NCT00413413|529133906|FG000|Double-Blind|Protocol deviation|1|||
146716507|NCT00413413|529133907|FG001|Double-Blind|Protocol deviation|2|||
146716508|NCT00413413|529133908|FG002|Double-Blind|Protocol deviation|1|||
146716509|NCT00413413|529133906|FG000|Double-Blind|Subject withdrew consent|4|||
146716510|NCT00413413|529133907|FG001|Double-Blind|Subject withdrew consent|6|||
146716511|NCT00413413|529133908|FG002|Double-Blind|Subject withdrew consent|9|||
146716512|NCT00413413|529133906|FG000|Double-Blind|Lost to Follow-up|3|||
146716513|NCT00413413|529133907|FG001|Double-Blind|Lost to Follow-up|4|||
146716514|NCT00413413|529133908|FG002|Double-Blind|Lost to Follow-up|2|||
146716515|NCT01040130|529133909|FG000|Overall Study|Adverse Event|1|||
146716516|NCT01040130|529133910|FG001|Overall Study|Adverse Event|1|||
146716517|NCT01040130|529133911|FG002|Overall Study|Adverse Event|0|||
146716518|NCT01040130|529133912|FG003|Overall Study|Adverse Event|5|||
146716519|NCT01040130|529133913|FG004|Overall Study|Adverse Event|0|||
146716520|NCT01040130|529133914|FG005|Overall Study|Adverse Event|3|||
146716521|NCT01040130|529133909|FG000|Overall Study|Protocol Violation|0|||
146716522|NCT01040130|529133910|FG001|Overall Study|Protocol Violation|0|||
146716523|NCT01040130|529133911|FG002|Overall Study|Protocol Violation|2|||
146716524|NCT01040130|529133912|FG003|Overall Study|Protocol Violation|0|||
146716525|NCT01040130|529133913|FG004|Overall Study|Protocol Violation|0|||
146716526|NCT01040130|529133914|FG005|Overall Study|Protocol Violation|0|||
146716527|NCT01040130|529133909|FG000|Overall Study|Withdrawal by Subject|0|||
146716528|NCT01040130|529133910|FG001|Overall Study|Withdrawal by Subject|2|||
146716529|NCT01040130|529133911|FG002|Overall Study|Withdrawal by Subject|0|||
146716530|NCT01040130|529133912|FG003|Overall Study|Withdrawal by Subject|0|||
146716531|NCT01040130|529133913|FG004|Overall Study|Withdrawal by Subject|0|||
146716532|NCT01040130|529133914|FG005|Overall Study|Withdrawal by Subject|1|||
146716533|NCT01040130|529133909|FG000|Overall Study|Other reasons not listed above|2|||
146716534|NCT01040130|529133910|FG001|Overall Study|Other reasons not listed above|0|||
146716535|NCT01040130|529133911|FG002|Overall Study|Other reasons not listed above|0|||
146716536|NCT01040130|529133912|FG003|Overall Study|Other reasons not listed above|0|||
146716537|NCT01040130|529133913|FG004|Overall Study|Other reasons not listed above|0|||
146716538|NCT01040130|529133914|FG005|Overall Study|Other reasons not listed above|0|||
146716539|NCT01175668|529133915|FG000|Overall Study|Withdrawal by Subject|2|||
146716540|NCT01175668|529133916|FG001|Overall Study|Withdrawal by Subject|0|||
146716541|NCT00096135|529133917|FG000|Overall Study|Physician Decision|20|||
146716542|NCT00096135|529133918|FG001|Overall Study|Physician Decision|4|||
146716543|NCT00096135|529133917|FG000|Overall Study|Refusal of further protocol therapy|4|||
146716544|NCT00096135|529133918|FG001|Overall Study|Refusal of further protocol therapy|1|||
146716545|NCT00096135|529133917|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
146716546|NCT00096135|529133918|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
146716547|NCT00096135|529133917|FG000|Overall Study|Other, specify|15|||
146716548|NCT00096135|529133918|FG001|Overall Study|Other, specify|3|||
146716549|NCT00096135|529133917|FG000|Overall Study|Ineligible|2|||
146716550|NCT00096135|529133918|FG001|Overall Study|Ineligible|0|||
146716551|NCT02007577|529133920|FG000|Overall Study|Adverse Event|1|||
146716552|NCT02007577|529133921|FG001|Overall Study|Adverse Event|0|||
146716553|NCT02007577|529133920|FG000|Overall Study|Withdrawal by Subject|0|||
146716554|NCT02007577|529133921|FG001|Overall Study|Withdrawal by Subject|1|||
146781050|NCT06066541|529368564|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
146781051|NCT04533022|529368565|FG000|Overall Study|Withdrawal by Subject|15|||
146781052|NCT04533022|529368565|FG000|Overall Study|Adverse Event|6|||
146781053|NCT04533022|529368565|FG000|Overall Study|Death|1|||
146781054|NCT04533022|529368565|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
146781055|NCT04533022|529368565|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
146781056|NCT02163447|529368566|FG000|Overall Study|Withdrawal by Subject|2|||
146781057|NCT02163447|529368567|FG001|Overall Study|Withdrawal by Subject|0|||
146781058|NCT02163447|529368568|FG002|Overall Study|Withdrawal by Subject|1|||
146781059|NCT02163447|529368566|FG000|Overall Study|Lost to Follow-up|1|||
146781060|NCT02163447|529368567|FG001|Overall Study|Lost to Follow-up|3|||
146781061|NCT02163447|529368568|FG002|Overall Study|Lost to Follow-up|0|||
146781062|NCT02163447|529368566|FG000|Overall Study|Moved out of study area|2|||
146781063|NCT02163447|529368567|FG001|Overall Study|Moved out of study area|3|||
146781064|NCT02163447|529368568|FG002|Overall Study|Moved out of study area|2|||
146781065|NCT02163447|529368566|FG000|Overall Study|Became HIV infected at time of delivery|1|||
146781066|NCT02163447|529368567|FG001|Overall Study|Became HIV infected at time of delivery|0|||
146781067|NCT02163447|529368568|FG002|Overall Study|Became HIV infected at time of delivery|0|||
146781068|NCT03897686|529368570|FG000|Overall Study|Protocol Violation|1|||
146781069|NCT03897686|529368571|FG001|Overall Study|Protocol Violation|1|||
146781070|NCT03897686|529368570|FG000|Overall Study|Withdrawal by Subject|1|||
146781071|NCT03897686|529368571|FG001|Overall Study|Withdrawal by Subject|1|||
146781072|NCT05415436|529368572|FG000|Overall Study|Surgeon cancelled procedure|1|||
146716555|NCT02504294|529133924|FG000|Overall Study|Adverse Event|15|||
146716556|NCT02504294|529133925|FG001|Overall Study|Adverse Event|12|||
146716557|NCT02504294|529133924|FG000|Overall Study|Withdrawal by Subject|7|||
146716558|NCT02504294|529133925|FG001|Overall Study|Withdrawal by Subject|1|||
146716559|NCT02504294|529133924|FG000|Overall Study|Protocol Violation|27|||
146716560|NCT02504294|529133925|FG001|Overall Study|Protocol Violation|26|||
146781073|NCT05415436|529368573|FG001|Overall Study|Surgeon cancelled procedure|0|||
146716561|NCT02504294|529133924|FG000|Overall Study|Physician Decision|1|||
146716562|NCT02504294|529133925|FG001|Overall Study|Physician Decision|2|||
146716563|NCT02504294|529133924|FG000|Overall Study|Lost to Follow-up|6|||
146716564|NCT02504294|529133925|FG001|Overall Study|Lost to Follow-up|7|||
146716565|NCT02252211|529133931|FG000|Overall Study|Adverse Event|0|||
146716566|NCT02252211|529133932|FG001|Overall Study|Adverse Event|1|||
146716567|NCT02252211|529133933|FG002|Overall Study|Adverse Event|0|||
146716568|NCT02252211|529133931|FG000|Overall Study|Progressive disease|3|||
146781074|NCT05415436|529368572|FG000|Overall Study|Death|1|||
146781075|NCT05415436|529368573|FG001|Overall Study|Death|0|||
146781076|NCT03819686|529368575|FG000|Overall Study|Lost to Follow-up|2|||
146781077|NCT03819686|529368576|FG001|Overall Study|Lost to Follow-up|3|||
146781078|NCT03157167|529368579|FG000|Overall Study|Withdrawal by Subject|1|||
146781079|NCT03157167|529368580|FG001|Overall Study|Withdrawal by Subject|0|||
146781080|NCT03157167|529368581|FG002|Overall Study|Withdrawal by Subject|0|||
146781081|NCT02597946|529368582|FG000|Overall Study|Withdrawal by Subject|1|||
146781082|NCT02597946|529368582|FG000|Overall Study|Progressive disease|16|||
146781083|NCT02597946|529368582|FG000|Overall Study|Other than above|1|||
146781084|NCT05038566|529368594|FG000|Overall Study|Technical Difficulties with the Device|0|||
146781085|NCT05038566|529368595|FG001|Overall Study|Technical Difficulties with the Device|1|||
146781086|NCT04842643|529368596|FG000|Overall Study|Physician Decision|1|||
146781087|NCT04842643|529368596|FG000|Overall Study|Other|1|||
146781088|NCT00739648|529368604|FG000|Overall Study|Adverse Event|3|||
146781089|NCT00739648|529368605|FG001|Overall Study|Adverse Event|15|||
146781090|NCT00739648|529368604|FG000|Overall Study|Withdrawal by Subject|13|||
146781091|NCT00739648|529368605|FG001|Overall Study|Withdrawal by Subject|25|||
146781092|NCT00739648|529368604|FG000|Overall Study|Lost to Follow-up|4|||
146781093|NCT00739648|529368605|FG001|Overall Study|Lost to Follow-up|7|||
146781094|NCT00739648|529368604|FG000|Overall Study|Death|2|||
146781095|NCT00739648|529368605|FG001|Overall Study|Death|0|||
146781096|NCT00739648|529368604|FG000|Overall Study|Do not know|4|||
146781097|NCT00739648|529368605|FG001|Overall Study|Do not know|6|||
146781098|NCT02840474|529368608|FG000|Overall Study|Lost to Follow-up|1|||
146781099|NCT02840474|529368609|FG001|Overall Study|Lost to Follow-up|0|||
146781100|NCT03192891|529368610|FG000|Overall Study|Lost to Follow-up|55|||
146781101|NCT04850807|529368611|FG000|Overall Study|Death|50|||
146781102|NCT04850807|529368612|FG001|Overall Study|Death|55|||
146781103|NCT04850807|529368611|FG000|Overall Study|Discharged|17|||
146781104|NCT04850807|529368612|FG001|Overall Study|Discharged|13|||
146781105|NCT04850807|529368611|FG000|Overall Study|Incomplete baseline data|3|||
146781106|NCT04850807|529368612|FG001|Overall Study|Incomplete baseline data|2|||
146781107|NCT05387447|529368616|FG000|Overall Study|Participants changed their minds about study participation.|3|||
146781108|NCT05387447|529368617|FG001|Overall Study|Participants changed their minds about study participation.|5|||
146781109|NCT04178733|529368618|FG000|Overall Study|Investigator Decision|0|||
146781110|NCT04178733|529368619|FG001|Overall Study|Investigator Decision|0|||
146781111|NCT04178733|529368620|FG002|Overall Study|Investigator Decision|0|||
146781112|NCT04178733|529368621|FG003|Overall Study|Investigator Decision|1|||
146781113|NCT04178733|529368622|FG004|Overall Study|Investigator Decision|2|||
146781114|NCT03655132|529368625|FG000|Overall Study|Lost to Follow-up|2|||
146781115|NCT03655132|529368626|FG001|Overall Study|Lost to Follow-up|1|||
146781116|NCT03655132|529368625|FG000|Overall Study|Withdrawal by Subject|0|||
146781117|NCT03655132|529368626|FG001|Overall Study|Withdrawal by Subject|1|||
146781118|NCT03655132|529368625|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
146781119|NCT03655132|529368626|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
146781120|NCT02651324|529368628|FG000|Overall Study|drug not administered, due dispensing issue|1|||
146781121|NCT02651324|529368629|FG001|Overall Study|drug not administered, due dispensing issue|0|||
146781122|NCT05919082|529368632|FG000|Overall Study|Adverse Event|3|||
146781123|NCT05919082|529368633|FG001|Overall Study|Adverse Event|0|||
146781124|NCT05919082|529368632|FG000|Overall Study|Lost to Follow-up|0|||
146781125|NCT05919082|529368633|FG001|Overall Study|Lost to Follow-up|1|||
146781126|NCT05919082|529368632|FG000|Overall Study|Withdrawal by Subject|8|||
146781127|NCT05919082|529368633|FG001|Overall Study|Withdrawal by Subject|9|||
146781128|NCT05919082|529368632|FG000|Overall Study|Lack of Efficacy|0|||
146781129|NCT05919082|529368633|FG001|Overall Study|Lack of Efficacy|1|||
146781130|NCT05919082|529368632|FG000|Overall Study|Investigator Decision|1|||
146781131|NCT05919082|529368633|FG001|Overall Study|Investigator Decision|0|||
146781132|NCT02249949|529368635|FG000|Overall Study|Cancelled prior to treatment|2|||
146781133|NCT00601900|529368638|FG000|Overall Study|Withdrawal by Subject|0|||
146781134|NCT00601900|529368639|FG001|Overall Study|Withdrawal by Subject|3|||
146781135|NCT02697136|529368641|FG000|Overall Study|Adverse Event|3|||
146781136|NCT02697136|529368642|FG001|Overall Study|Adverse Event|0|||
146781137|NCT02500758|529368646|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
146781138|NCT02500758|529368647|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
146781139|NCT02500758|529368646|FG000|Washout (1 Week)|Lost to Follow-up|2|||
146781140|NCT02500758|529368647|FG001|Washout (1 Week)|Lost to Follow-up|2|||
146781141|NCT02500758|529368646|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
146781142|NCT02500758|529368647|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
146781143|NCT02500758|529368646|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
146781144|NCT02500758|529368647|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
146781145|NCT02500758|529368646|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
146781146|NCT02500758|529368647|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
146781147|NCT02923180|529368648|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
146781148|NCT02923180|529368648|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
146781149|NCT01101451|529368651|FG000|Overall Study|Eligible and never treated|0|||
146781150|NCT01101451|529368652|FG001|Overall Study|Eligible and never treated|5|||
146781151|NCT01101451|529368651|FG000|Overall Study|Ineligible and treated|12|||
146781152|NCT01101451|529368652|FG001|Overall Study|Ineligible and treated|8|||
146781153|NCT01101451|529368651|FG000|Overall Study|Ineligible and never treated|2|||
146781154|NCT01101451|529368652|FG001|Overall Study|Ineligible and never treated|2|||
146781155|NCT04923347|529370057|FG000|Overall Study|Withdrawal by Subject|14|||
146781156|NCT04052516|529370058|FG000|Overall Study|Withdrawal by Subject|4|||
146781157|NCT04052516|529370059|FG001|Overall Study|Withdrawal by Subject|5|||
146781158|NCT04052516|529370060|FG002|Overall Study|Withdrawal by Subject|6|||
146781159|NCT04052516|529370058|FG000|Overall Study|Adverse Event|3|||
146781160|NCT04052516|529370059|FG001|Overall Study|Adverse Event|2|||
146781161|NCT04052516|529370060|FG002|Overall Study|Adverse Event|8|||
146781162|NCT04052516|529370058|FG000|Overall Study|Lost to Follow-up|2|||
146781163|NCT04052516|529370059|FG001|Overall Study|Lost to Follow-up|5|||
146781164|NCT04052516|529370060|FG002|Overall Study|Lost to Follow-up|3|||
146781165|NCT04052516|529370058|FG000|Overall Study|Protocol Violation|1|||
146781166|NCT04052516|529370059|FG001|Overall Study|Protocol Violation|1|||
146781167|NCT04052516|529370060|FG002|Overall Study|Protocol Violation|0|||
146781168|NCT04052516|529370058|FG000|Overall Study|Death|1|||
146781169|NCT04052516|529370059|FG001|Overall Study|Death|0|||
146781170|NCT04052516|529370060|FG002|Overall Study|Death|0|||
146781171|NCT04052516|529370058|FG000|Overall Study|Physician Decision|0|||
146781172|NCT04052516|529370059|FG001|Overall Study|Physician Decision|1|||
146781173|NCT04052516|529370060|FG002|Overall Study|Physician Decision|0|||
146781174|NCT04052516|529370058|FG000|Overall Study|Pregnancy|1|||
146781175|NCT04052516|529370059|FG001|Overall Study|Pregnancy|0|||
146781176|NCT04052516|529370060|FG002|Overall Study|Pregnancy|0|||
146781177|NCT04052516|529370058|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
146716569|NCT02252211|529133932|FG001|Overall Study|Progressive disease|2|||
146716570|NCT02252211|529133933|FG002|Overall Study|Progressive disease|0|||
146716571|NCT02252211|529133931|FG000|Overall Study|Withdrawal by Subject|1|||
146716572|NCT02252211|529133932|FG001|Overall Study|Withdrawal by Subject|0|||
146716573|NCT02252211|529133933|FG002|Overall Study|Withdrawal by Subject|0|||
146716574|NCT02252211|529133931|FG000|Overall Study|Serious Adverse Event During Screening|1|||
146716575|NCT02252211|529133932|FG001|Overall Study|Serious Adverse Event During Screening|0|||
146716576|NCT02252211|529133933|FG002|Overall Study|Serious Adverse Event During Screening|1|||
146716577|NCT01953926|529133935|FG000|Overall Study|Withdrawal by Subject|23|||
146716578|NCT01953926|529133936|FG001|Overall Study|Withdrawal by Subject|3|||
146716579|NCT01953926|529133937|FG002|Overall Study|Withdrawal by Subject|3|||
146781178|NCT04052516|529370059|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
146781179|NCT04052516|529370060|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
146781180|NCT04052516|529370058|FG000|Overall Study|Reason not recorded|0|||
146781181|NCT04052516|529370059|FG001|Overall Study|Reason not recorded|1|||
146781182|NCT04052516|529370060|FG002|Overall Study|Reason not recorded|0|||
146781183|NCT03484702|529370063|FG000|Treatment Period|Death|3|||
146781184|NCT03484702|529370064|FG001|Treatment Period|Death|1|||
146781185|NCT03484702|529370065|FG002|Treatment Period|Death|0|||
146781186|NCT03484702|529370066|FG003|Treatment Period|Death|0|||
146781187|NCT03484702|529370067|FG004|Treatment Period|Death|0|||
146781188|NCT03484702|529370068|FG005|Treatment Period|Death|0|||
146781189|NCT03484702|529370063|FG000|Treatment Period|Adverse Event|1|||
146781190|NCT03484702|529370064|FG001|Treatment Period|Adverse Event|0|||
146781191|NCT03484702|529370065|FG002|Treatment Period|Adverse Event|0|||
146781192|NCT03484702|529370066|FG003|Treatment Period|Adverse Event|0|||
146781193|NCT03484702|529370067|FG004|Treatment Period|Adverse Event|0|||
146781194|NCT03484702|529370068|FG005|Treatment Period|Adverse Event|0|||
146781195|NCT03484702|529370063|FG000|Treatment Period|Participant Withdrew from Study|0|||
146781196|NCT03484702|529370064|FG001|Treatment Period|Participant Withdrew from Study|1|||
146716580|NCT01953926|529133938|FG003|Overall Study|Withdrawal by Subject|5|||
146716581|NCT01953926|529133939|FG004|Overall Study|Withdrawal by Subject|6|||
146716582|NCT01953926|529133940|FG005|Overall Study|Withdrawal by Subject|0|||
146716583|NCT01953926|529133941|FG006|Overall Study|Withdrawal by Subject|1|||
146781197|NCT03484702|529370065|FG002|Treatment Period|Participant Withdrew from Study|0|||
146781198|NCT03484702|529370066|FG003|Treatment Period|Participant Withdrew from Study|0|||
146781199|NCT03484702|529370067|FG004|Treatment Period|Participant Withdrew from Study|0|||
146781200|NCT03484702|529370068|FG005|Treatment Period|Participant Withdrew from Study|0|||
146781201|NCT03484702|529370063|FG000|Treatment Period|Physician Decision|0|||
146716584|NCT01953926|529133935|FG000|Overall Study|Physician Decision|1|||
146781202|NCT03484702|529370064|FG001|Treatment Period|Physician Decision|1|||
146716585|NCT01953926|529133936|FG001|Overall Study|Physician Decision|0|||
146716586|NCT01953926|529133937|FG002|Overall Study|Physician Decision|0|||
146716587|NCT01953926|529133938|FG003|Overall Study|Physician Decision|0|||
146716588|NCT01953926|529133939|FG004|Overall Study|Physician Decision|2|||
146781203|NCT03484702|529370065|FG002|Treatment Period|Physician Decision|0|||
146781204|NCT03484702|529370066|FG003|Treatment Period|Physician Decision|0|||
146716589|NCT01953926|529133940|FG005|Overall Study|Physician Decision|0|||
146781205|NCT03484702|529370067|FG004|Treatment Period|Physician Decision|0|||
146781206|NCT03484702|529370068|FG005|Treatment Period|Physician Decision|1|||
146781207|NCT01894061|529370071|FG000|Overall Study|Screen failure|1|||
146781208|NCT01894061|529370071|FG000|Overall Study|Withdrawal by Subject|1|||
146981285|NCT03263819|530093836|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
146981286|NCT03263819|530093837|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
146981287|NCT01427803|530093839|FG000|Overall Study|Lost to Follow-up|32|||
146981288|NCT01427803|530093840|FG001|Overall Study|Lost to Follow-up|26|||
146716590|NCT01953926|529133941|FG006|Overall Study|Physician Decision|0|||
146781209|NCT05110495|529370072|FG000|Overall Study|Lost to Follow-up|1|||
146781210|NCT05110495|529370072|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
146781211|NCT05141903|529370074|FG000|Overall Study|Withdrawal by Subject|0|||
146716591|NCT01953926|529133935|FG000|Overall Study|Lost to Follow-up|18|||
146716592|NCT01953926|529133936|FG001|Overall Study|Lost to Follow-up|3|||
146716593|NCT01953926|529133937|FG002|Overall Study|Lost to Follow-up|0|||
146716594|NCT01953926|529133938|FG003|Overall Study|Lost to Follow-up|5|||
146716595|NCT01953926|529133939|FG004|Overall Study|Lost to Follow-up|3|||
146716596|NCT01953926|529133940|FG005|Overall Study|Lost to Follow-up|0|||
146716597|NCT01953926|529133941|FG006|Overall Study|Lost to Follow-up|0|||
146716598|NCT01953926|529133935|FG000|Overall Study|Protocol Violation|1|||
146716599|NCT01953926|529133936|FG001|Overall Study|Protocol Violation|0|||
146716600|NCT01953926|529133937|FG002|Overall Study|Protocol Violation|0|||
146716601|NCT01953926|529133938|FG003|Overall Study|Protocol Violation|0|||
146716602|NCT01953926|529133939|FG004|Overall Study|Protocol Violation|0|||
146716603|NCT01953926|529133940|FG005|Overall Study|Protocol Violation|0|||
146716604|NCT01953926|529133941|FG006|Overall Study|Protocol Violation|0|||
146716605|NCT01953926|529133935|FG000|Overall Study|Other, Disease progression|2|||
146716606|NCT01953926|529133936|FG001|Overall Study|Other, Disease progression|1|||
146716607|NCT01953926|529133937|FG002|Overall Study|Other, Disease progression|0|||
146716608|NCT01953926|529133938|FG003|Overall Study|Other, Disease progression|0|||
146716609|NCT01953926|529133939|FG004|Overall Study|Other, Disease progression|1|||
146716610|NCT01953926|529133940|FG005|Overall Study|Other, Disease progression|0|||
146716611|NCT01953926|529133941|FG006|Overall Study|Other, Disease progression|0|||
146716612|NCT01953926|529133935|FG000|Overall Study|Discontinuation of study by sponsor|41|||
146716613|NCT01953926|529133936|FG001|Overall Study|Discontinuation of study by sponsor|7|||
146716614|NCT01953926|529133937|FG002|Overall Study|Discontinuation of study by sponsor|5|||
146716615|NCT01953926|529133938|FG003|Overall Study|Discontinuation of study by sponsor|12|||
146716616|NCT01953926|529133939|FG004|Overall Study|Discontinuation of study by sponsor|46|||
146716617|NCT01953926|529133940|FG005|Overall Study|Discontinuation of study by sponsor|5|||
146716618|NCT01953926|529133941|FG006|Overall Study|Discontinuation of study by sponsor|6|||
146716619|NCT01953926|529133935|FG000|Overall Study|Not Treated|1|||
146716620|NCT01953926|529133936|FG001|Overall Study|Not Treated|0|||
146716621|NCT01953926|529133937|FG002|Overall Study|Not Treated|1|||
146716622|NCT01953926|529133938|FG003|Overall Study|Not Treated|0|||
146716623|NCT01953926|529133939|FG004|Overall Study|Not Treated|0|||
146716624|NCT01953926|529133940|FG005|Overall Study|Not Treated|0|||
146716625|NCT01953926|529133941|FG006|Overall Study|Not Treated|0|||
146716626|NCT01949480|529133947|FG000|Overall Study|Physician Decision|5|||
146716627|NCT01949480|529133948|FG001|Overall Study|Physician Decision|8|||
146716628|NCT00144339|529133949|FG000|Overall Study|Adverse Event|746|||
146716629|NCT00144339|529133950|FG001|Overall Study|Adverse Event|627|||
146716630|NCT00144339|529133949|FG000|Overall Study|Protocol Violation|75|||
146716631|NCT00144339|529133950|FG001|Overall Study|Protocol Violation|48|||
146716632|NCT00144339|529133949|FG000|Overall Study|Withdrawal by Subject|403|||
146716633|NCT00144339|529133950|FG001|Overall Study|Withdrawal by Subject|300|||
146716634|NCT00144339|529133949|FG000|Overall Study|Lost to Follow-up|76|||
146716635|NCT00144339|529133950|FG001|Overall Study|Lost to Follow-up|64|||
146716636|NCT00144339|529133949|FG000|Overall Study|Other|58|||
146716637|NCT00144339|529133950|FG001|Overall Study|Other|60|||
146716638|NCT01827904|529133960|FG000|Main Study|Withdrawal by Subject|1|||
146781212|NCT05141903|529370075|FG001|Overall Study|Withdrawal by Subject|1|||
146781213|NCT05141903|529370076|FG002|Overall Study|Withdrawal by Subject|1|||
146781214|NCT05141903|529370077|FG003|Overall Study|Withdrawal by Subject|0|||
146716639|NCT01827904|529133961|FG001|Main Study|Withdrawal by Subject|0|||
146716640|NCT01827904|529133962|FG002|Main Study|Withdrawal by Subject|0|||
146716641|NCT01827904|529133960|FG000|Main Study|Adverse Event|1|||
146716642|NCT01827904|529133961|FG001|Main Study|Adverse Event|0|||
146716643|NCT01827904|529133962|FG002|Main Study|Adverse Event|0|||
146781215|NCT05141903|529370078|FG004|Overall Study|Withdrawal by Subject|0|||
146781216|NCT05141903|529370074|FG000|Overall Study|Other|1|||
146716644|NCT01827904|529133960|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
146716645|NCT01827904|529133961|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
146716646|NCT01827904|529133962|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
146716647|NCT01827904|529133960|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
146716648|NCT01827904|529133961|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
146781217|NCT05141903|529370075|FG001|Overall Study|Other|1|||
146781218|NCT05141903|529370076|FG002|Overall Study|Other|0|||
146781219|NCT05141903|529370077|FG003|Overall Study|Other|0|||
146781220|NCT05141903|529370078|FG004|Overall Study|Other|0|||
146781221|NCT02630823|529370079|FG000|Overall Study|Withdrawal by Subject|1|||
146781222|NCT02630823|529370079|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
146781223|NCT02287311|529370088|FG000|Cohort 1: Dose Level 1|Death|2|||
146781224|NCT02287311|529370089|FG001|Cohort 1: Dose Level 1|Death|0|||
146781225|NCT02287311|529370090|FG002|Cohort 1: Dose Level 1|Death|0|||
146781226|NCT02287311|529370091|FG003|Cohort 1: Dose Level 1|Death|3|||
146781227|NCT02287311|529370092|FG004|Cohort 1: Dose Level 1|Death|0|||
146781228|NCT02287311|529370093|FG005|Cohort 1: Dose Level 1|Death|0|||
146781229|NCT02287311|529370094|FG006|Cohort 1: Dose Level 1|Death|1|||
146781230|NCT02287311|529370095|FG007|Cohort 1: Dose Level 1|Death|0|||
146781231|NCT02287311|529370096|FG008|Cohort 1: Dose Level 1|Death|0|||
146781232|NCT02287311|529370088|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
146781233|NCT02287311|529370089|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
146781234|NCT02287311|529370090|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
146781235|NCT02287311|529370091|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
146781236|NCT02287311|529370092|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
146781237|NCT02287311|529370093|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
146781238|NCT02287311|529370094|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
146781239|NCT02287311|529370095|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
146781240|NCT02287311|529370096|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
146781241|NCT02287311|529370088|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
146781242|NCT02287311|529370089|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
146781243|NCT02287311|529370090|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
146781244|NCT02287311|529370091|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
146781245|NCT02287311|529370092|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
146781246|NCT02287311|529370093|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
146781247|NCT02287311|529370094|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
146781248|NCT02287311|529370095|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
146781249|NCT02287311|529370096|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
146781250|NCT02287311|529370088|FG000|Cohort 2: Dose Level 2|Death|0|||
146781251|NCT02287311|529370089|FG001|Cohort 2: Dose Level 2|Death|2|||
146781252|NCT02287311|529370090|FG002|Cohort 2: Dose Level 2|Death|0|||
146781253|NCT02287311|529370091|FG003|Cohort 2: Dose Level 2|Death|0|||
146781254|NCT02287311|529370092|FG004|Cohort 2: Dose Level 2|Death|2|||
146781255|NCT02287311|529370093|FG005|Cohort 2: Dose Level 2|Death|0|||
146781256|NCT02287311|529370094|FG006|Cohort 2: Dose Level 2|Death|0|||
146781257|NCT02287311|529370095|FG007|Cohort 2: Dose Level 2|Death|2|||
146781258|NCT02287311|529370096|FG008|Cohort 2: Dose Level 2|Death|0|||
146781259|NCT02287311|529370088|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
146781260|NCT02287311|529370089|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
146781261|NCT02287311|529370090|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
146781262|NCT02287311|529370091|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
146781263|NCT02287311|529370092|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
146781264|NCT02287311|529370093|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
146781265|NCT02287311|529370094|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
146781266|NCT02287311|529370095|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
146781267|NCT02287311|529370096|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
146781268|NCT02287311|529370088|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
146781269|NCT02287311|529370089|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
146781270|NCT02287311|529370090|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
146781271|NCT02287311|529370091|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
146781272|NCT02287311|529370092|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
146781273|NCT02287311|529370093|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
146781274|NCT02287311|529370094|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
146781275|NCT02287311|529370095|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
146781276|NCT02287311|529370096|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
146781277|NCT02287311|529370088|FG000|Cohort 3: Dose Level 3|Death|0|||
146781278|NCT02287311|529370089|FG001|Cohort 3: Dose Level 3|Death|0|||
146781279|NCT02287311|529370090|FG002|Cohort 3: Dose Level 3|Death|4|||
146781280|NCT02287311|529370091|FG003|Cohort 3: Dose Level 3|Death|0|||
146781281|NCT02287311|529370092|FG004|Cohort 3: Dose Level 3|Death|0|||
146781282|NCT02287311|529370093|FG005|Cohort 3: Dose Level 3|Death|4|||
146781283|NCT02287311|529370094|FG006|Cohort 3: Dose Level 3|Death|0|||
146781284|NCT02287311|529370095|FG007|Cohort 3: Dose Level 3|Death|0|||
146781285|NCT02287311|529370096|FG008|Cohort 3: Dose Level 3|Death|2|||
146781286|NCT02287311|529370088|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
146781287|NCT02287311|529370089|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
146781288|NCT02287311|529370090|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
146781289|NCT02287311|529370091|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
146781290|NCT02287311|529370092|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
146781291|NCT02287311|529370093|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
146781292|NCT02287311|529370094|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
146781293|NCT02287311|529370095|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
146781294|NCT02287311|529370096|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
146716649|NCT01827904|529133962|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
146716650|NCT01827904|529133960|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
146716651|NCT01827904|529133961|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
146716652|NCT01827904|529133962|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
146716653|NCT01827904|529133960|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
146716654|NCT01827904|529133961|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
146716655|NCT01827904|529133962|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
146716656|NCT01827904|529133960|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
146716657|NCT01827904|529133961|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
146716658|NCT01827904|529133962|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
146716659|NCT01827904|529133960|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
146716660|NCT01827904|529133961|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
146716661|NCT01827904|529133962|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
146716662|NCT01827904|529133960|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
146716663|NCT01827904|529133961|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
146716664|NCT01827904|529133962|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
146716665|NCT01827904|529133960|FG000|Long-term Annual Follow-up|Physician Decision|1|||
146716666|NCT01827904|529133961|FG001|Long-term Annual Follow-up|Physician Decision|0|||
146716667|NCT01827904|529133962|FG002|Long-term Annual Follow-up|Physician Decision|0|||
146716668|NCT01827904|529133960|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
146716669|NCT01827904|529133961|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
146716670|NCT01827904|529133962|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
146716671|NCT01827904|529133960|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
146716672|NCT01827904|529133961|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
146716673|NCT01827904|529133962|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
146716674|NCT00142909|529133968|FG000|Randomization|Various Reasons|7|||
146716675|NCT00142909|529133969|FG001|Randomization|Various Reasons|10|||
146716676|NCT00142909|529133968|FG000|Medications Begin|Protocol Violation|2|||
146716677|NCT00142909|529133969|FG001|Medications Begin|Protocol Violation|0|||
146716678|NCT00142909|529133968|FG000|Medications Begin|Withdrawal by Subject|5|||
146716679|NCT00142909|529133969|FG001|Medications Begin|Withdrawal by Subject|3|||
146716680|NCT00142909|529133968|FG000|Medications Begin|Withdrawal by Subject|2|||
146716681|NCT00142909|529133969|FG001|Medications Begin|Withdrawal by Subject|0|||
146716682|NCT02265237|529133970|FG000|As Treated (Overall Study)|Adverse Event|1|||
146716683|NCT02265237|529133971|FG001|As Treated (Overall Study)|Adverse Event|1|||
146716684|NCT02265237|529133972|FG002|As Treated (Overall Study)|Adverse Event|0|||
146716685|NCT02265237|529133973|FG003|As Treated (Overall Study)|Adverse Event|0|||
146716686|NCT02265237|529133970|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
146716687|NCT02265237|529133971|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
146716688|NCT02265237|529133972|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
146716689|NCT02265237|529133973|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
146716690|NCT02265237|529133970|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
146716691|NCT02265237|529133971|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
146716692|NCT02265237|529133972|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
146716693|NCT02265237|529133973|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
146716694|NCT02265237|529133970|FG000|As Treated (Overall Study)|Other|2|||
146716695|NCT02265237|529133971|FG001|As Treated (Overall Study)|Other|0|||
146716696|NCT02265237|529133972|FG002|As Treated (Overall Study)|Other|3|||
146716697|NCT02265237|529133973|FG003|As Treated (Overall Study)|Other|1|||
146716698|NCT01178853|529133975|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
146716699|NCT01178853|529133976|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
146716700|NCT01178853|529133975|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
146716701|NCT01178853|529133976|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
146716702|NCT01178853|529133975|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
146716703|NCT01178853|529133976|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
146716704|NCT01178853|529133975|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
146716705|NCT01178853|529133976|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
146716706|NCT01178853|529133975|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
146716707|NCT01178853|529133976|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
146716708|NCT03550313|529133977|FG000|Overall Study|Adverse Event|0|||
146716709|NCT03550313|529133978|FG001|Overall Study|Adverse Event|1|||
146716710|NCT03550313|529133979|FG002|Overall Study|Adverse Event|0|||
146716711|NCT03550313|529133977|FG000|Overall Study|Lost to Follow-up|5|||
146716712|NCT03550313|529133978|FG001|Overall Study|Lost to Follow-up|7|||
146716713|NCT03550313|529133979|FG002|Overall Study|Lost to Follow-up|12|||
146716714|NCT03550313|529133977|FG000|Overall Study|Study terminated by sponsor|44|||
146716715|NCT03550313|529133978|FG001|Overall Study|Study terminated by sponsor|37|||
146716716|NCT03550313|529133979|FG002|Overall Study|Study terminated by sponsor|48|||
146934112|NCT01617187|529916094|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
146934113|NCT01617187|529916095|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
146934114|NCT01617187|529916092|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
146716717|NCT03550313|529133977|FG000|Overall Study|No longer met eligibility criteria|3|||
146716718|NCT03550313|529133978|FG001|Overall Study|No longer met eligibility criteria|5|||
146716719|NCT03550313|529133979|FG002|Overall Study|No longer met eligibility criteria|6|||
146716720|NCT03550313|529133977|FG000|Overall Study|Withdrawal by parent/guardian|20|||
146716721|NCT03550313|529133978|FG001|Overall Study|Withdrawal by parent/guardian|18|||
146716722|NCT03550313|529133979|FG002|Overall Study|Withdrawal by parent/guardian|26|||
146716723|NCT03550313|529133977|FG000|Overall Study|Other|4|||
146716724|NCT03550313|529133978|FG001|Overall Study|Other|2|||
146716725|NCT03550313|529133979|FG002|Overall Study|Other|2|||
146716726|NCT03550313|529133977|FG000|Overall Study|Randomized but not vaccinated|3|||
146716727|NCT03550313|529133978|FG001|Overall Study|Randomized but not vaccinated|23|||
146716728|NCT03550313|529133979|FG002|Overall Study|Randomized but not vaccinated|2|||
146716729|NCT03550313|529133977|FG000|Overall Study|Sites terminated due to quality issues|18|||
146716730|NCT03550313|529133978|FG001|Overall Study|Sites terminated due to quality issues|17|||
146716731|NCT03550313|529133979|FG002|Overall Study|Sites terminated due to quality issues|18|||
146716732|NCT00839072|529133980|FG000|First Intervention Period|Withdrawal by Subject|1|||
146716733|NCT00839072|529133981|FG001|First Intervention Period|Withdrawal by Subject|0|||
146716734|NCT00839072|529133980|FG000|First Intervention Period|Adverse Event|1|||
146716735|NCT00839072|529133981|FG001|First Intervention Period|Adverse Event|1|||
146716736|NCT00839072|529133980|FG000|Second Intervention Period|Withdrawal by Subject|1|||
146716737|NCT00839072|529133981|FG001|Second Intervention Period|Withdrawal by Subject|0|||
146716738|NCT01682837|529133982|FG000|Baseline|Withdrawal by Subject|5|||
146716739|NCT01165281|529133983|FG000|Overall Study|Adverse Event|12|||
146716740|NCT01165281|529133984|FG001|Overall Study|Adverse Event|14|||
146716741|NCT01165281|529133983|FG000|Overall Study|Death|3|||
146716742|NCT01165281|529133984|FG001|Overall Study|Death|4|||
146716743|NCT01165281|529133983|FG000|Overall Study|Lack of Efficacy|4|||
146716744|NCT01165281|529133984|FG001|Overall Study|Lack of Efficacy|1|||
146716745|NCT01165281|529133983|FG000|Overall Study|Lost to Follow-up|0|||
146716746|NCT01165281|529133984|FG001|Overall Study|Lost to Follow-up|1|||
146716747|NCT01165281|529133983|FG000|Overall Study|Physician Decision|8|||
146716748|NCT01165281|529133984|FG001|Overall Study|Physician Decision|1|||
146716749|NCT01165281|529133983|FG000|Overall Study|Protocol Violation|6|||
146716750|NCT01165281|529133984|FG001|Overall Study|Protocol Violation|5|||
146716751|NCT01165281|529133983|FG000|Overall Study|Withdrawal by Subject|8|||
146716752|NCT01165281|529133984|FG001|Overall Study|Withdrawal by Subject|7|||
146716753|NCT01165281|529133983|FG000|Overall Study|Noncompliance with Study Drug|1|||
146716754|NCT01165281|529133984|FG001|Overall Study|Noncompliance with Study Drug|4|||
146716755|NCT01165281|529133983|FG000|Overall Study|Progressive Disease|10|||
146716756|NCT01165281|529133984|FG001|Overall Study|Progressive Disease|14|||
146716757|NCT01165281|529133983|FG000|Overall Study|Other|6|||
146716758|NCT01165281|529133984|FG001|Overall Study|Other|0|||
146716759|NCT02863991|529133985|FG000|Overall Study|Death|0|||
146716760|NCT02863991|529133986|FG001|Overall Study|Death|3|||
146716761|NCT02863991|529133985|FG000|Overall Study|Lack of Efficacy|0|||
146716762|NCT02863991|529133986|FG001|Overall Study|Lack of Efficacy|1|||
146716763|NCT02863991|529133985|FG000|Overall Study|Study Terminated|2|||
146716764|NCT02863991|529133986|FG001|Overall Study|Study Terminated|8|||
146716765|NCT00364858|529133991|FG000|Overall Study|Adverse Event|1|||
146716766|NCT00364858|529133992|FG001|Overall Study|Adverse Event|5|||
146716767|NCT00364858|529133991|FG000|Overall Study|Withdrawal by Subject|1|||
146716768|NCT00364858|529133992|FG001|Overall Study|Withdrawal by Subject|1|||
146716769|NCT00364858|529133991|FG000|Overall Study|Pregnancy|1|||
146716770|NCT00364858|529133992|FG001|Overall Study|Pregnancy|1|||
146716771|NCT00364858|529133991|FG000|Overall Study|Clinical failure|2|||
146716772|NCT00364858|529133992|FG001|Overall Study|Clinical failure|13|||
146716773|NCT00364858|529133991|FG000|Overall Study|Discontinuation at baseline|1|||
146716774|NCT00364858|529133992|FG001|Overall Study|Discontinuation at baseline|0|||
146716775|NCT00364858|529133991|FG000|Overall Study|Non-compliant|1|||
146716776|NCT00364858|529133992|FG001|Overall Study|Non-compliant|0|||
146716777|NCT00364858|529133991|FG000|Overall Study|Return to Q2 regimen|0|||
146716778|NCT00364858|529133992|FG001|Overall Study|Return to Q2 regimen|1|||
146716779|NCT00364858|529133991|FG000|Overall Study|Clinical baseline issue|0|||
146716780|NCT00364858|529133992|FG001|Overall Study|Clinical baseline issue|1|||
146716781|NCT01307501|529133993|FG000|Overall Study|Treatment Failure|1|||
146716782|NCT01307501|529133993|FG000|Overall Study|Death|20|||
146716783|NCT01307501|529133993|FG000|Overall Study|Lost to Follow-up|1|||
146716784|NCT01307501|529133993|FG000|Overall Study|Starting Hospice|1|||
146716785|NCT00363766|529133994|FG000|Overall Study|Progressive Disease|15|||
146716786|NCT00363766|529133995|FG001|Overall Study|Progressive Disease|9|||
146716787|NCT00363766|529133994|FG000|Overall Study|Adverse Event|10|||
146716788|NCT00363766|529133995|FG001|Overall Study|Adverse Event|2|||
146716789|NCT00363766|529133994|FG000|Overall Study|Disease Related Death|1|||
146716790|NCT00363766|529133995|FG001|Overall Study|Disease Related Death|3|||
146716791|NCT00363766|529133994|FG000|Overall Study|Not Disease Related Death|3|||
146716792|NCT00363766|529133995|FG001|Overall Study|Not Disease Related Death|4|||
146716793|NCT00363766|529133994|FG000|Overall Study|Withdrawal by Subject|2|||
146716794|NCT00363766|529133995|FG001|Overall Study|Withdrawal by Subject|0|||
146716795|NCT00363766|529133994|FG000|Overall Study|Physician Decision|1|||
146716796|NCT00363766|529133995|FG001|Overall Study|Physician Decision|2|||
146716797|NCT00558285|529133996|FG000|Overall Study|Adverse Event|1|||
146716798|NCT00558285|529133997|FG001|Overall Study|Adverse Event|1|||
146716799|NCT00558285|529133998|FG002|Overall Study|Adverse Event|4|||
146716800|NCT00558285|529133999|FG003|Overall Study|Adverse Event|1|||
146716801|NCT00558285|529134000|FG004|Overall Study|Adverse Event|2|||
146716802|NCT00558285|529133996|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146716803|NCT00558285|529133997|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146716804|NCT00558285|529133998|FG002|Overall Study|Abnormal test procedure result(s)|0|||
146716805|NCT00558285|529133999|FG003|Overall Study|Abnormal test procedure result(s)|0|||
146716806|NCT00558285|529134000|FG004|Overall Study|Abnormal test procedure result(s)|0|||
146716807|NCT00558285|529133996|FG000|Overall Study|Subject withdrew consent|2|||
146716808|NCT00558285|529133997|FG001|Overall Study|Subject withdrew consent|0|||
146716809|NCT00558285|529133998|FG002|Overall Study|Subject withdrew consent|1|||
146716810|NCT00558285|529133999|FG003|Overall Study|Subject withdrew consent|1|||
146716811|NCT00558285|529134000|FG004|Overall Study|Subject withdrew consent|1|||
146716812|NCT00558285|529133996|FG000|Overall Study|Lost to Follow-up|1|||
146716813|NCT00558285|529133997|FG001|Overall Study|Lost to Follow-up|1|||
146716814|NCT00558285|529133998|FG002|Overall Study|Lost to Follow-up|0|||
146716815|NCT00558285|529133999|FG003|Overall Study|Lost to Follow-up|0|||
146716816|NCT00558285|529134000|FG004|Overall Study|Lost to Follow-up|0|||
146716817|NCT00558285|529133996|FG000|Overall Study|Administrative problems|0|||
146716818|NCT00558285|529133997|FG001|Overall Study|Administrative problems|0|||
146716819|NCT00558285|529133998|FG002|Overall Study|Administrative problems|0|||
146716820|NCT00558285|529133999|FG003|Overall Study|Administrative problems|1|||
146716821|NCT00558285|529134000|FG004|Overall Study|Administrative problems|1|||
146716822|NCT00558285|529133996|FG000|Overall Study|Protocol deviation|1|||
146716823|NCT00558285|529133997|FG001|Overall Study|Protocol deviation|1|||
146716824|NCT00558285|529133998|FG002|Overall Study|Protocol deviation|0|||
146716825|NCT00558285|529133999|FG003|Overall Study|Protocol deviation|1|||
146716826|NCT00558285|529134000|FG004|Overall Study|Protocol deviation|0|||
146716827|NCT02345512|529134007|FG000|Overall Study|Adverse Event|1|||
146716828|NCT02345512|529134007|FG000|Overall Study|Withdrawal by Subject|1|||
146716829|NCT03478891|529134010|FG000|Overall Study|Enrolled, but product never administered|0|||
146716830|NCT03478891|529134011|FG001|Overall Study|Enrolled, but product never administered|0|||
146716831|NCT03478891|529134012|FG002|Overall Study|Enrolled, but product never administered|1|||
146716832|NCT03478891|529134010|FG000|Overall Study|Moved from area|0|||
146716833|NCT03478891|529134011|FG001|Overall Study|Moved from area|0|||
146716834|NCT03478891|529134012|FG002|Overall Study|Moved from area|1|||
146716835|NCT03478891|529134010|FG000|Overall Study|Lost to Follow-up|1|||
146716836|NCT03478891|529134011|FG001|Overall Study|Lost to Follow-up|0|||
146716837|NCT03478891|529134012|FG002|Overall Study|Lost to Follow-up|1|||
146716838|NCT04827576|529135795|FG000|Overall Study|Death|5|||
146716839|NCT04827576|529135796|FG001|Overall Study|Death|17|||
146716840|NCT04827576|529135797|FG002|Overall Study|Death|17|||
146716841|NCT04827576|529135798|FG003|Overall Study|Death|32|||
146716842|NCT04827576|529135795|FG000|Overall Study|Study Terminated by Sponsor|2|||
146716843|NCT04827576|529135796|FG001|Overall Study|Study Terminated by Sponsor|9|||
146716844|NCT04827576|529135797|FG002|Overall Study|Study Terminated by Sponsor|7|||
146716845|NCT04827576|529135798|FG003|Overall Study|Study Terminated by Sponsor|5|||
146716846|NCT04827576|529135795|FG000|Overall Study|Investigator's Discretion|1|||
146716847|NCT04827576|529135796|FG001|Overall Study|Investigator's Discretion|0|||
146716848|NCT04827576|529135797|FG002|Overall Study|Investigator's Discretion|2|||
146716849|NCT04827576|529135798|FG003|Overall Study|Investigator's Discretion|5|||
146716850|NCT04827576|529135795|FG000|Overall Study|Withdrew Consent|0|||
146716851|NCT04827576|529135796|FG001|Overall Study|Withdrew Consent|3|||
146716852|NCT04827576|529135797|FG002|Overall Study|Withdrew Consent|0|||
146716853|NCT04827576|529135798|FG003|Overall Study|Withdrew Consent|0|||
146716854|NCT04827576|529135795|FG000|Overall Study|Lost to Follow-up|1|||
146716855|NCT04827576|529135796|FG001|Overall Study|Lost to Follow-up|0|||
146716856|NCT04827576|529135797|FG002|Overall Study|Lost to Follow-up|0|||
146716857|NCT04827576|529135798|FG003|Overall Study|Lost to Follow-up|0|||
146716858|NCT04295564|529135799|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
146716859|NCT04295564|529135800|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
146716860|NCT02527798|529135801|FG000|Overall Study|Physician Decision|1|||
146716861|NCT02527798|529135802|FG001|Overall Study|Physician Decision|0|||
146716862|NCT02527798|529135803|FG002|Overall Study|Physician Decision|1|||
146716863|NCT02527798|529135804|FG003|Overall Study|Physician Decision|1|||
146716864|NCT02527798|529135805|FG004|Overall Study|Physician Decision|0|||
146716865|NCT02527798|529135806|FG005|Overall Study|Physician Decision|0|||
146716866|NCT02527798|529135801|FG000|Overall Study|Death|0|||
146716867|NCT02527798|529135802|FG001|Overall Study|Death|0|||
146716868|NCT02527798|529135803|FG002|Overall Study|Death|1|||
146716869|NCT02527798|529135804|FG003|Overall Study|Death|0|||
146716870|NCT02527798|529135805|FG004|Overall Study|Death|0|||
146716871|NCT02527798|529135806|FG005|Overall Study|Death|0|||
146716872|NCT02527798|529135801|FG000|Overall Study|Withdrawal by Subject|0|||
146716873|NCT02527798|529135802|FG001|Overall Study|Withdrawal by Subject|1|||
146716874|NCT02527798|529135803|FG002|Overall Study|Withdrawal by Subject|2|||
146716875|NCT02527798|529135804|FG003|Overall Study|Withdrawal by Subject|0|||
146716876|NCT02527798|529135805|FG004|Overall Study|Withdrawal by Subject|0|||
146716877|NCT02527798|529135806|FG005|Overall Study|Withdrawal by Subject|0|||
146716878|NCT02527798|529135801|FG000|Overall Study|Reason undisclosed|1|||
146716879|NCT02527798|529135802|FG001|Overall Study|Reason undisclosed|0|||
146716880|NCT02527798|529135803|FG002|Overall Study|Reason undisclosed|1|||
146716881|NCT02527798|529135804|FG003|Overall Study|Reason undisclosed|0|||
146716882|NCT02527798|529135805|FG004|Overall Study|Reason undisclosed|0|||
146716883|NCT02527798|529135806|FG005|Overall Study|Reason undisclosed|0|||
146716884|NCT02527798|529135801|FG000|Overall Study|Did not receive intervention|1|||
146716885|NCT02527798|529135802|FG001|Overall Study|Did not receive intervention|1|||
146716886|NCT02527798|529135803|FG002|Overall Study|Did not receive intervention|0|||
146716887|NCT02527798|529135804|FG003|Overall Study|Did not receive intervention|0|||
146716888|NCT02527798|529135805|FG004|Overall Study|Did not receive intervention|0|||
146716889|NCT02527798|529135806|FG005|Overall Study|Did not receive intervention|0|||
146716890|NCT00724282|529135808|FG000|Overall Study|Withdrawal by Subject|3|||
146716891|NCT00724282|529135808|FG000|Overall Study|Physician Decision|1|||
146716892|NCT01808690|529135809|FG000|Overall Study|Withdrawal by Subject|1|||
146716893|NCT01808690|529135810|FG001|Overall Study|Withdrawal by Subject|2|||
146716894|NCT02244944|529135815|FG000|Overall Study|Withdrawal by Subject|1|||
146716895|NCT02244944|529135815|FG000|Overall Study|Study Terminated|1|||
146716896|NCT01928719|529135818|FG000|Overall Study|Lost to Follow-up|26|||
146716897|NCT01928719|529135819|FG001|Overall Study|Lost to Follow-up|11|||
146716898|NCT01928719|529135818|FG000|Overall Study|Withdrawal by Subject|22|||
146716899|NCT01928719|529135819|FG001|Overall Study|Withdrawal by Subject|7|||
146716900|NCT01928719|529135818|FG000|Overall Study|Protocol Violation|3|||
146716901|NCT01928719|529135819|FG001|Overall Study|Protocol Violation|1|||
146716902|NCT01928719|529135818|FG000|Overall Study|Adverse Event|1|||
146716903|NCT01928719|529135819|FG001|Overall Study|Adverse Event|0|||
146716904|NCT00263666|529135820|FG000|Overall Study|Adverse Event|6|||
146716905|NCT00263666|529135821|FG001|Overall Study|Adverse Event|8|||
146716906|NCT00263666|529135820|FG000|Overall Study|Lost to Follow-up|1|||
146716907|NCT00263666|529135821|FG001|Overall Study|Lost to Follow-up|2|||
146716908|NCT00263666|529135820|FG000|Overall Study|Withdrawal by Subject|0|||
146716909|NCT00263666|529135821|FG001|Overall Study|Withdrawal by Subject|1|||
146716910|NCT00896168|529135822|FG000|Overall Study|Adverse Event|4|||
146716911|NCT00896168|529135823|FG001|Overall Study|Adverse Event|7|||
146716912|NCT00896168|529135822|FG000|Overall Study|Treatment failure|8|||
146716913|NCT00896168|529135823|FG001|Overall Study|Treatment failure|10|||
146716914|NCT00896168|529135822|FG000|Overall Study|Lost to Follow-up|1|||
146716915|NCT00896168|529135823|FG001|Overall Study|Lost to Follow-up|1|||
146716916|NCT00896168|529135822|FG000|Overall Study|Other|1|||
146716917|NCT00896168|529135823|FG001|Overall Study|Other|1|||
146716918|NCT01490632|529135824|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
146716919|NCT01490632|529135825|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
146716920|NCT01490632|529135826|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
146716921|NCT01490632|529135827|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
146716922|NCT01490632|529135828|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
146716923|NCT01490632|529135829|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
146716924|NCT01490632|529135830|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
146716925|NCT01490632|529135831|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
146716926|NCT01490632|529135832|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
146716927|NCT01490632|529135833|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
146716928|NCT01490632|529135834|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
146716929|NCT01490632|529135835|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
146716930|NCT01490632|529135836|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
146716931|NCT01490632|529135837|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
146781295|NCT02287311|529370088|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
146716932|NCT01490632|529135838|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
146781296|NCT02287311|529370089|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
146781297|NCT02287311|529370090|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
146716933|NCT01490632|529135839|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
146716934|NCT01490632|529135840|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
146716935|NCT01490632|529135841|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
146716936|NCT01490632|529135842|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
146716937|NCT01490632|529135843|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
146716938|NCT01490632|529135824|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
146716939|NCT01490632|529135825|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
146716940|NCT01490632|529135826|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
146716941|NCT01490632|529135827|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
146716942|NCT01490632|529135828|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146716943|NCT01490632|529135829|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146716944|NCT01490632|529135830|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146716945|NCT01490632|529135831|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146716946|NCT01490632|529135832|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146716947|NCT01490632|529135833|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146716948|NCT01490632|529135834|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146716949|NCT01490632|529135835|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146716950|NCT01490632|529135836|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146716951|NCT01490632|529135837|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146716952|NCT01490632|529135838|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146716953|NCT01490632|529135839|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146716954|NCT01490632|529135840|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146716955|NCT01490632|529135841|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146716956|NCT01490632|529135842|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146716957|NCT01490632|529135843|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146716958|NCT01490632|529135824|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716959|NCT01490632|529135825|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716960|NCT01490632|529135826|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
146716961|NCT01490632|529135827|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
146716962|NCT01490632|529135828|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
146716963|NCT01490632|529135829|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716964|NCT01490632|529135830|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716965|NCT01490632|529135831|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716966|NCT01490632|529135832|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716967|NCT01490632|529135833|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716968|NCT01490632|529135834|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716969|NCT01490632|529135835|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716970|NCT01490632|529135836|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716971|NCT01490632|529135837|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716972|NCT01490632|529135838|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716973|NCT01490632|529135839|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716974|NCT01490632|529135840|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716975|NCT01490632|529135841|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716976|NCT01490632|529135842|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716977|NCT01490632|529135843|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146716978|NCT01490632|529135824|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
146716979|NCT01490632|529135825|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
146716980|NCT01490632|529135826|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
146716981|NCT01490632|529135827|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
146716982|NCT01490632|529135828|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
146716983|NCT01490632|529135829|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
146716984|NCT01490632|529135830|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
146716985|NCT01490632|529135831|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
146716986|NCT01490632|529135832|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
146716987|NCT01490632|529135833|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
146716988|NCT01490632|529135834|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
146716989|NCT01490632|529135835|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
146716990|NCT01490632|529135836|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
146716991|NCT01490632|529135837|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
146716992|NCT01490632|529135838|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
146716993|NCT01490632|529135839|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
146716994|NCT01490632|529135840|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
146716995|NCT01490632|529135841|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
146716996|NCT01490632|529135842|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
146716997|NCT01490632|529135843|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
146716998|NCT01490632|529135824|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
146716999|NCT01490632|529135825|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717000|NCT01490632|529135826|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717001|NCT01490632|529135827|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717002|NCT01490632|529135828|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717003|NCT01490632|529135829|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717004|NCT01490632|529135830|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717005|NCT01490632|529135831|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717006|NCT01490632|529135832|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
146981289|NCT01427803|530093839|FG000|Overall Study|Withdrawal by Subject|20|||
146717007|NCT01490632|529135833|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717008|NCT01490632|529135834|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717009|NCT01490632|529135835|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717010|NCT01490632|529135836|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
146934115|NCT01617187|529916093|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
146934116|NCT01617187|529916094|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
146934117|NCT01617187|529916095|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
146934118|NCT01617187|529916092|FG000|Treatment Through Study Completion|Adverse Event|1|||
146717011|NCT01490632|529135837|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717012|NCT01490632|529135838|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717013|NCT01490632|529135839|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717014|NCT01490632|529135840|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717015|NCT01490632|529135841|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717016|NCT01490632|529135842|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717017|NCT01490632|529135843|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
146717018|NCT01490632|529135824|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
146717019|NCT01490632|529135825|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
146717020|NCT01490632|529135826|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146717021|NCT01490632|529135827|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
146717022|NCT01490632|529135828|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
146717023|NCT01490632|529135829|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146717024|NCT01490632|529135830|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146717025|NCT01490632|529135831|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146717026|NCT01490632|529135832|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146717027|NCT01490632|529135833|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146717028|NCT01490632|529135834|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146717029|NCT01490632|529135835|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146717030|NCT01490632|529135836|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146717031|NCT01490632|529135837|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146717032|NCT01490632|529135838|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146717033|NCT01490632|529135839|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146717034|NCT01490632|529135840|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146717035|NCT01490632|529135841|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146717036|NCT01490632|529135842|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146717037|NCT01490632|529135843|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146717038|NCT01490632|529135824|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717039|NCT01490632|529135825|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717040|NCT01490632|529135826|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717041|NCT01490632|529135827|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717042|NCT01490632|529135828|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
146717043|NCT01490632|529135829|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717044|NCT01490632|529135830|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717045|NCT01490632|529135831|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717046|NCT01490632|529135832|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717047|NCT01490632|529135833|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717048|NCT01490632|529135834|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717049|NCT01490632|529135835|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717050|NCT01490632|529135836|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717051|NCT01490632|529135837|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717052|NCT01490632|529135838|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717053|NCT01490632|529135839|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717054|NCT01490632|529135840|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717055|NCT01490632|529135841|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717056|NCT01490632|529135842|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717057|NCT01490632|529135843|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146717058|NCT01490632|529135824|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
146717059|NCT01490632|529135825|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
146717060|NCT01490632|529135826|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
146717061|NCT01490632|529135827|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
146717062|NCT01490632|529135828|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
146717063|NCT01490632|529135829|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
146781298|NCT02287311|529370091|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
146934119|NCT01617187|529916093|FG001|Treatment Through Study Completion|Adverse Event|1|||
146934120|NCT01617187|529916094|FG002|Treatment Through Study Completion|Adverse Event|0|||
146717064|NCT01490632|529135830|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
146934121|NCT01617187|529916095|FG003|Treatment Through Study Completion|Adverse Event|1|||
146717065|NCT01490632|529135831|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
146717066|NCT01490632|529135832|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
146717067|NCT01490632|529135833|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
146717068|NCT01490632|529135834|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
146717069|NCT01490632|529135835|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
146717070|NCT01490632|529135836|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
146717071|NCT01490632|529135837|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
146717072|NCT01490632|529135838|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
146717073|NCT01490632|529135839|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
146717074|NCT01490632|529135840|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
146717075|NCT01490632|529135841|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
146717076|NCT01490632|529135842|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
146717077|NCT01490632|529135843|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
146717078|NCT01490632|529135824|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146717079|NCT01490632|529135825|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146717080|NCT01490632|529135826|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146717081|NCT01490632|529135827|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146717082|NCT01490632|529135828|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146717083|NCT01490632|529135829|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146717084|NCT01490632|529135830|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
146717085|NCT01490632|529135831|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146717086|NCT01490632|529135832|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
146717087|NCT01490632|529135833|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
146717088|NCT01490632|529135834|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
146717089|NCT01490632|529135835|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146717090|NCT01490632|529135836|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146717091|NCT01490632|529135837|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146717092|NCT01490632|529135838|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146717093|NCT01490632|529135839|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146717094|NCT01490632|529135840|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146717095|NCT01490632|529135841|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146717096|NCT01490632|529135842|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146717097|NCT01490632|529135843|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146717098|NCT01490632|529135824|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717099|NCT01490632|529135825|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717100|NCT01490632|529135826|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717101|NCT01490632|529135827|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717102|NCT01490632|529135828|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717103|NCT01490632|529135829|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717104|NCT01490632|529135830|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
146717105|NCT01490632|529135831|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717106|NCT01490632|529135832|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717107|NCT01490632|529135833|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
146717108|NCT01490632|529135834|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717109|NCT01490632|529135835|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717110|NCT01490632|529135836|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717111|NCT01490632|529135837|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717112|NCT01490632|529135838|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717113|NCT01490632|529135839|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717114|NCT01490632|529135840|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717115|NCT01490632|529135841|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717116|NCT01490632|529135842|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717117|NCT01490632|529135843|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146717118|NCT01490632|529135824|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717119|NCT01490632|529135825|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717120|NCT01490632|529135826|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717121|NCT01490632|529135827|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717122|NCT01490632|529135828|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717123|NCT01490632|529135829|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717124|NCT01490632|529135830|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
146717125|NCT01490632|529135831|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717126|NCT01490632|529135832|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
146781299|NCT02287311|529370092|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
146781300|NCT02287311|529370093|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
146781301|NCT02287311|529370094|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
146781302|NCT02287311|529370095|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
146781303|NCT02287311|529370096|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
146717127|NCT01490632|529135833|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717128|NCT01490632|529135834|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717129|NCT01490632|529135835|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717130|NCT01490632|529135836|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717131|NCT01490632|529135837|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717132|NCT01490632|529135838|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717133|NCT01490632|529135839|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717134|NCT01490632|529135840|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717135|NCT01490632|529135841|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717136|NCT01490632|529135842|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717137|NCT01490632|529135843|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
146717138|NCT01490632|529135824|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717139|NCT01490632|529135825|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717140|NCT01490632|529135826|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717141|NCT01490632|529135827|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717142|NCT01490632|529135828|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717143|NCT01490632|529135829|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
146717144|NCT01490632|529135830|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717145|NCT01490632|529135831|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717146|NCT01490632|529135832|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717147|NCT01490632|529135833|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717148|NCT01490632|529135834|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717149|NCT01490632|529135835|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717150|NCT01490632|529135836|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717151|NCT01490632|529135837|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717152|NCT01490632|529135838|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717153|NCT01490632|529135839|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717154|NCT01490632|529135840|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717155|NCT01490632|529135841|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717156|NCT01490632|529135842|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717157|NCT01490632|529135843|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146717158|NCT01490632|529135824|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146717159|NCT01490632|529135825|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146717160|NCT01490632|529135826|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146717161|NCT01490632|529135827|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146717162|NCT01490632|529135828|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146717163|NCT01490632|529135829|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146717164|NCT01490632|529135830|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
146717165|NCT01490632|529135831|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146717166|NCT01490632|529135832|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
146717167|NCT01490632|529135833|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146717168|NCT01490632|529135834|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
146717169|NCT01490632|529135835|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
146717170|NCT01490632|529135836|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146717171|NCT01490632|529135837|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146717172|NCT01490632|529135838|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146717173|NCT01490632|529135839|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146717174|NCT01490632|529135840|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146717175|NCT01490632|529135841|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146717176|NCT01490632|529135842|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146717177|NCT01490632|529135843|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146717178|NCT01490632|529135824|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146717179|NCT01490632|529135825|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146717180|NCT01490632|529135826|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146717181|NCT01490632|529135827|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146717182|NCT01490632|529135828|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146717183|NCT01490632|529135829|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
146717184|NCT01490632|529135830|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
146717185|NCT01490632|529135831|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
146717186|NCT01490632|529135832|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
146717187|NCT01490632|529135833|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
146717188|NCT01490632|529135834|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
146717189|NCT01490632|529135835|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
146717190|NCT01490632|529135836|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146717191|NCT01490632|529135837|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146717192|NCT01490632|529135838|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146717193|NCT01490632|529135839|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146717194|NCT01490632|529135840|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146717195|NCT01490632|529135841|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146717196|NCT01490632|529135842|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146717197|NCT01490632|529135843|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146717198|NCT01490632|529135824|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717199|NCT01490632|529135825|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717200|NCT01490632|529135826|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717201|NCT01490632|529135827|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717202|NCT01490632|529135828|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717203|NCT01490632|529135829|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717204|NCT01490632|529135830|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717205|NCT01490632|529135831|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717206|NCT01490632|529135832|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717207|NCT01490632|529135833|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717208|NCT01490632|529135834|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717209|NCT01490632|529135835|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717210|NCT01490632|529135836|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717211|NCT01490632|529135837|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717212|NCT01490632|529135838|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
146717213|NCT01490632|529135839|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
146717214|NCT01490632|529135840|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717215|NCT01490632|529135841|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717216|NCT01490632|529135842|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717217|NCT01490632|529135843|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
146717218|NCT01490632|529135824|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717219|NCT01490632|529135825|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717220|NCT01490632|529135826|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717221|NCT01490632|529135827|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717222|NCT01490632|529135828|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717223|NCT01490632|529135829|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717224|NCT01490632|529135830|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717225|NCT01490632|529135831|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717226|NCT01490632|529135832|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717227|NCT01490632|529135833|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717228|NCT01490632|529135834|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717229|NCT01490632|529135835|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717230|NCT01490632|529135836|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717231|NCT01490632|529135837|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
146717232|NCT01490632|529135838|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717233|NCT01490632|529135839|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717234|NCT01490632|529135840|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717235|NCT01490632|529135841|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717236|NCT01490632|529135842|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717237|NCT01490632|529135843|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146717238|NCT01490632|529135824|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717239|NCT01490632|529135825|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717240|NCT01490632|529135826|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717241|NCT01490632|529135827|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717242|NCT01490632|529135828|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717243|NCT01490632|529135829|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717244|NCT01490632|529135830|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717245|NCT01490632|529135831|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717246|NCT01490632|529135832|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717247|NCT01490632|529135833|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717248|NCT01490632|529135834|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717249|NCT01490632|529135835|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717250|NCT01490632|529135836|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717251|NCT01490632|529135837|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717252|NCT01490632|529135838|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
146717253|NCT01490632|529135839|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
146781304|NCT05461131|529370097|FG000|Overall Study|Lost to Follow-up|0|||
146781305|NCT05461131|529370098|FG001|Overall Study|Lost to Follow-up|2|||
146717254|NCT01490632|529135840|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717255|NCT01490632|529135841|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717256|NCT01490632|529135842|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717257|NCT01490632|529135843|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146717258|NCT01490632|529135824|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146717259|NCT01490632|529135825|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146717260|NCT01490632|529135826|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146717261|NCT01490632|529135827|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146717262|NCT01490632|529135828|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146717263|NCT01490632|529135829|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146717264|NCT01490632|529135830|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146717265|NCT01490632|529135831|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146717266|NCT01490632|529135832|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146717267|NCT01490632|529135833|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146717268|NCT01490632|529135834|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146717269|NCT01490632|529135835|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146717270|NCT01490632|529135836|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
146717271|NCT01490632|529135837|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
146717272|NCT01490632|529135838|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
146717273|NCT01490632|529135839|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
146717274|NCT01490632|529135840|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146717275|NCT01490632|529135841|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146717276|NCT01490632|529135842|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146717277|NCT01490632|529135843|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146717278|NCT01490632|529135824|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
146717279|NCT01490632|529135825|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
146717280|NCT01490632|529135826|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
146717281|NCT01490632|529135827|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
146717282|NCT01490632|529135828|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
146717283|NCT01490632|529135829|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
146717284|NCT01490632|529135830|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
146717285|NCT01490632|529135831|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
146717286|NCT01490632|529135832|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
146717287|NCT01490632|529135833|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
146717288|NCT01490632|529135834|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
146717289|NCT01490632|529135835|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
146717290|NCT01490632|529135836|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
146717291|NCT01490632|529135837|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
146717292|NCT01490632|529135838|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
146717293|NCT01490632|529135839|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
146717294|NCT01490632|529135840|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
146717295|NCT01490632|529135841|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
146717296|NCT01490632|529135842|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
146717297|NCT01490632|529135843|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
146717298|NCT01490632|529135824|FG000|Part D: Re-Treatment Period|Death|0|||
146717299|NCT01490632|529135825|FG001|Part D: Re-Treatment Period|Death|0|||
146717300|NCT01490632|529135826|FG002|Part D: Re-Treatment Period|Death|0|||
146717301|NCT01490632|529135827|FG003|Part D: Re-Treatment Period|Death|0|||
146717302|NCT01490632|529135828|FG004|Part D: Re-Treatment Period|Death|0|||
146717303|NCT01490632|529135829|FG005|Part D: Re-Treatment Period|Death|0|||
146717304|NCT01490632|529135830|FG006|Part D: Re-Treatment Period|Death|0|||
146717305|NCT01490632|529135831|FG007|Part D: Re-Treatment Period|Death|0|||
146717306|NCT01490632|529135832|FG008|Part D: Re-Treatment Period|Death|0|||
146717307|NCT01490632|529135833|FG009|Part D: Re-Treatment Period|Death|0|||
146717308|NCT01490632|529135834|FG010|Part D: Re-Treatment Period|Death|0|||
146717309|NCT01490632|529135835|FG011|Part D: Re-Treatment Period|Death|0|||
146717310|NCT01490632|529135836|FG012|Part D: Re-Treatment Period|Death|0|||
146717311|NCT01490632|529135837|FG013|Part D: Re-Treatment Period|Death|0|||
146717312|NCT01490632|529135838|FG014|Part D: Re-Treatment Period|Death|0|||
146717313|NCT01490632|529135839|FG015|Part D: Re-Treatment Period|Death|0|||
146717314|NCT01490632|529135840|FG016|Part D: Re-Treatment Period|Death|0|||
146717315|NCT01490632|529135841|FG017|Part D: Re-Treatment Period|Death|0|||
146717316|NCT01490632|529135842|FG018|Part D: Re-Treatment Period|Death|1|||
146717317|NCT01490632|529135843|FG019|Part D: Re-Treatment Period|Death|0|||
146717318|NCT01490632|529135824|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717319|NCT01490632|529135825|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717320|NCT01490632|529135826|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717321|NCT01490632|529135827|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717322|NCT01490632|529135828|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717323|NCT01490632|529135829|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717324|NCT01490632|529135830|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717325|NCT01490632|529135831|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717326|NCT01490632|529135832|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717327|NCT01490632|529135833|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717328|NCT01490632|529135834|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717329|NCT01490632|529135835|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717330|NCT01490632|529135836|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717331|NCT01490632|529135837|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717332|NCT01490632|529135838|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717333|NCT01490632|529135839|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717334|NCT01490632|529135840|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146717335|NCT01490632|529135841|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
146717336|NCT01490632|529135842|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
146717337|NCT01490632|529135843|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
146717338|NCT01490632|529135824|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717339|NCT01490632|529135825|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717340|NCT01490632|529135826|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717341|NCT01490632|529135827|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717342|NCT01490632|529135828|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717343|NCT01490632|529135829|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717344|NCT01490632|529135830|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717345|NCT01490632|529135831|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717346|NCT01490632|529135832|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717347|NCT01490632|529135833|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717348|NCT01490632|529135834|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717349|NCT01490632|529135835|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717350|NCT01490632|529135836|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717351|NCT01490632|529135837|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717352|NCT01490632|529135838|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717353|NCT01490632|529135839|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717354|NCT01490632|529135840|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717355|NCT01490632|529135841|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717356|NCT01490632|529135842|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
146717357|NCT01490632|529135843|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146717358|NCT01490632|529135824|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
146717359|NCT01490632|529135825|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
146717360|NCT01490632|529135826|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
146717361|NCT01490632|529135827|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
146717362|NCT01490632|529135828|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
146717363|NCT01490632|529135829|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
146717364|NCT01490632|529135830|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
146717365|NCT01490632|529135831|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
146717366|NCT01490632|529135832|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
146717367|NCT01490632|529135833|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
146717368|NCT01490632|529135834|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
146717369|NCT01490632|529135835|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
146717370|NCT01490632|529135836|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
146717371|NCT01490632|529135837|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
146717372|NCT01490632|529135838|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
146717373|NCT01490632|529135839|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
146717374|NCT01490632|529135840|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
146717375|NCT01490632|529135841|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
146717376|NCT01490632|529135842|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
146717377|NCT01490632|529135843|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
146717378|NCT01490632|529135824|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
146717379|NCT01490632|529135825|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
146717380|NCT01490632|529135826|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
146781306|NCT04538417|529370099|FG000|Overall Study|Withdrawal by Subject|2|||
146781307|NCT04549168|529370101|FG000|Randomization Phase|Adverse Event|0|||
146717381|NCT01490632|529135827|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
146717382|NCT01490632|529135828|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
146717383|NCT01490632|529135829|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
146717384|NCT01490632|529135830|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
146717385|NCT01490632|529135831|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
146717386|NCT01490632|529135832|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
146781308|NCT04549168|529370102|FG001|Randomization Phase|Adverse Event|0|||
146781309|NCT04549168|529370103|FG002|Randomization Phase|Adverse Event|1|||
146781310|NCT04549168|529370101|FG000|Randomization Phase|Other|0|||
146781311|NCT04549168|529370102|FG001|Randomization Phase|Other|2|||
146717387|NCT01490632|529135833|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
146717388|NCT01490632|529135834|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
146717389|NCT01490632|529135835|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
146717390|NCT01490632|529135836|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
146717391|NCT01490632|529135837|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
146717392|NCT01490632|529135838|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
146717393|NCT01490632|529135839|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
146717394|NCT01490632|529135840|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
146717395|NCT01490632|529135841|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
146717396|NCT01490632|529135842|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
146717397|NCT01490632|529135843|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
146717398|NCT01490632|529135824|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717399|NCT01490632|529135825|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717400|NCT01490632|529135826|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717401|NCT01490632|529135827|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717402|NCT01490632|529135828|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717403|NCT01490632|529135829|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717404|NCT01490632|529135830|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717405|NCT01490632|529135831|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717406|NCT01490632|529135832|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717407|NCT01490632|529135833|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717408|NCT01490632|529135834|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717409|NCT01490632|529135835|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717410|NCT01490632|529135836|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717411|NCT01490632|529135837|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717412|NCT01490632|529135838|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717413|NCT01490632|529135839|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717414|NCT01490632|529135840|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146717415|NCT01490632|529135841|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
146717416|NCT01490632|529135842|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
146717417|NCT01490632|529135843|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
146717418|NCT05732454|529135845|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
146717419|NCT05732454|529135846|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
146717420|NCT05732454|529135845|FG000|Part 1: DB Period|Adverse Event|1|||
146717421|NCT05732454|529135846|FG001|Part 1: DB Period|Adverse Event|0|||
146717422|NCT05732454|529135845|FG000|Part 1: DB Period|Lost to Follow-up|1|||
146717423|NCT05732454|529135846|FG001|Part 1: DB Period|Lost to Follow-up|0|||
146717424|NCT05732454|529135845|FG000|Part 1: DB Period|Protocol Violation|0|||
146717425|NCT05732454|529135846|FG001|Part 1: DB Period|Protocol Violation|1|||
146717426|NCT05732454|529135845|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
146717427|NCT05732454|529135846|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
146717428|NCT05732454|529135845|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
146717429|NCT05732454|529135846|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
146717430|NCT05732454|529135845|FG000|Part 1: OLE Period|Adverse Event|0|||
146717431|NCT05732454|529135846|FG001|Part 1: OLE Period|Adverse Event|1|||
146717432|NCT05732454|529135845|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
146717433|NCT05732454|529135846|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
146717434|NCT00384085|529135847|FG000|Overall Study|Adverse Event|5|||
146717435|NCT00384085|529135848|FG001|Overall Study|Adverse Event|5|||
146717436|NCT00384085|529135849|FG002|Overall Study|Adverse Event|4|||
146717437|NCT00384085|529135847|FG000|Overall Study|Lack of Efficacy|0|||
146717438|NCT00384085|529135848|FG001|Overall Study|Lack of Efficacy|3|||
146717439|NCT00384085|529135849|FG002|Overall Study|Lack of Efficacy|2|||
146717440|NCT00384085|529135847|FG000|Overall Study|No longer Requires Study Treatment|1|||
146717441|NCT00384085|529135848|FG001|Overall Study|No longer Requires Study Treatment|0|||
146717442|NCT00384085|529135849|FG002|Overall Study|No longer Requires Study Treatment|1|||
146717443|NCT00384085|529135847|FG000|Overall Study|Protocol Violation|2|||
146717444|NCT00384085|529135848|FG001|Overall Study|Protocol Violation|2|||
146717445|NCT00384085|529135849|FG002|Overall Study|Protocol Violation|2|||
146717446|NCT00384085|529135847|FG000|Overall Study|Lost to Follow-up|9|||
146717447|NCT00384085|529135848|FG001|Overall Study|Lost to Follow-up|9|||
146717448|NCT00384085|529135849|FG002|Overall Study|Lost to Follow-up|10|||
146717449|NCT00384085|529135847|FG000|Overall Study|Progressive Disease|0|||
146717450|NCT00384085|529135848|FG001|Overall Study|Progressive Disease|1|||
146717451|NCT00384085|529135849|FG002|Overall Study|Progressive Disease|0|||
146781312|NCT04549168|529370103|FG002|Randomization Phase|Other|0|||
146781313|NCT04549168|529370101|FG000|Randomization Phase|Withdrawal by Subject|0|||
146981290|NCT01427803|530093840|FG001|Overall Study|Withdrawal by Subject|0|||
146717452|NCT00384085|529135847|FG000|Overall Study|Withdrawal by Subject|14|||
146717453|NCT00384085|529135848|FG001|Overall Study|Withdrawal by Subject|19|||
146717454|NCT00384085|529135849|FG002|Overall Study|Withdrawal by Subject|29|||
146717455|NCT00384085|529135847|FG000|Overall Study|Patient non-compliant|4|||
146981291|NCT01427803|530093839|FG000|Overall Study|Unable to complete full treatment period|6|||
146781314|NCT04549168|529370102|FG001|Randomization Phase|Withdrawal by Subject|2|||
146717456|NCT00384085|529135848|FG001|Overall Study|Patient non-compliant|4|||
146717457|NCT00384085|529135849|FG002|Overall Study|Patient non-compliant|5|||
146717458|NCT00384085|529135847|FG000|Overall Study|Physician Decision|1|||
146717459|NCT00384085|529135848|FG001|Overall Study|Physician Decision|0|||
146717460|NCT00384085|529135849|FG002|Overall Study|Physician Decision|0|||
146717461|NCT00384085|529135847|FG000|Overall Study|Loss of site personnel|1|||
146717462|NCT00384085|529135848|FG001|Overall Study|Loss of site personnel|0|||
146717463|NCT00384085|529135849|FG002|Overall Study|Loss of site personnel|1|||
146717464|NCT00384085|529135847|FG000|Overall Study|Sponsor decision|1|||
146717465|NCT00384085|529135848|FG001|Overall Study|Sponsor decision|2|||
146717466|NCT00384085|529135849|FG002|Overall Study|Sponsor decision|1|||
146717467|NCT00384085|529135847|FG000|Overall Study|Patient moved|1|||
146717468|NCT00384085|529135848|FG001|Overall Study|Patient moved|0|||
146717469|NCT00384085|529135849|FG002|Overall Study|Patient moved|1|||
146717470|NCT00384085|529135847|FG000|Overall Study|Patient required surgery|0|||
146717471|NCT00384085|529135848|FG001|Overall Study|Patient required surgery|1|||
146717472|NCT00384085|529135849|FG002|Overall Study|Patient required surgery|0|||
146717473|NCT03725982|529135852|FG000|First Intervention|Withdrawal by Subject|0|||
146717474|NCT03725982|529135853|FG001|First Intervention|Withdrawal by Subject|1|||
146717475|NCT03725982|529135852|FG000|First Intervention|Physician Decision|1|||
146717476|NCT03725982|529135853|FG001|First Intervention|Physician Decision|1|||
146717477|NCT01944631|529135857|FG000|Overall Study|Adverse Event|1|||
146717478|NCT01944631|529135858|FG001|Overall Study|Adverse Event|0|||
146717479|NCT01944631|529135857|FG000|Overall Study|Lost to Follow-up|3|||
146717480|NCT01944631|529135858|FG001|Overall Study|Lost to Follow-up|1|||
146717481|NCT01944631|529135857|FG000|Overall Study|Withdrawal by Subject|0|||
146717482|NCT01944631|529135858|FG001|Overall Study|Withdrawal by Subject|1|||
146717483|NCT00838110|529135859|FG000|Overall Study|Death|0|||
146717484|NCT00838110|529135860|FG001|Overall Study|Death|0|||
146717485|NCT00838110|529135861|FG002|Overall Study|Death|1|||
146717486|NCT00838110|529135862|FG003|Overall Study|Death|2|||
146717487|NCT00838110|529135859|FG000|Overall Study|Adverse Event|11|||
146717488|NCT00838110|529135860|FG001|Overall Study|Adverse Event|10|||
146717489|NCT00838110|529135861|FG002|Overall Study|Adverse Event|8|||
146717490|NCT00838110|529135862|FG003|Overall Study|Adverse Event|7|||
146717491|NCT00838110|529135859|FG000|Overall Study|Withdrawal by Subject|5|||
146717492|NCT00838110|529135860|FG001|Overall Study|Withdrawal by Subject|6|||
146717493|NCT00838110|529135861|FG002|Overall Study|Withdrawal by Subject|3|||
146717494|NCT00838110|529135862|FG003|Overall Study|Withdrawal by Subject|4|||
146717495|NCT00838110|529135859|FG000|Overall Study|Other|3|||
146717496|NCT00838110|529135860|FG001|Overall Study|Other|3|||
146717497|NCT00838110|529135861|FG002|Overall Study|Other|3|||
146717498|NCT00838110|529135862|FG003|Overall Study|Other|2|||
146717499|NCT00838110|529135859|FG000|Overall Study|Protocol Violation|0|||
146717500|NCT00838110|529135860|FG001|Overall Study|Protocol Violation|2|||
146717501|NCT00838110|529135861|FG002|Overall Study|Protocol Violation|1|||
146717502|NCT00838110|529135862|FG003|Overall Study|Protocol Violation|1|||
146717503|NCT00838110|529135859|FG000|Overall Study|Lost to Follow-up|3|||
146717504|NCT00838110|529135860|FG001|Overall Study|Lost to Follow-up|0|||
146717505|NCT00838110|529135861|FG002|Overall Study|Lost to Follow-up|0|||
146717506|NCT00838110|529135862|FG003|Overall Study|Lost to Follow-up|0|||
146717507|NCT00838110|529135859|FG000|Overall Study|Did not meet eligibility criteria|0|||
146717508|NCT00838110|529135860|FG001|Overall Study|Did not meet eligibility criteria|0|||
146717509|NCT00838110|529135861|FG002|Overall Study|Did not meet eligibility criteria|1|||
146717510|NCT00838110|529135862|FG003|Overall Study|Did not meet eligibility criteria|2|||
146717511|NCT00838110|529135859|FG000|Overall Study|Randomized but not treated|0|||
146717512|NCT00838110|529135860|FG001|Overall Study|Randomized but not treated|1|||
146717513|NCT00838110|529135861|FG002|Overall Study|Randomized but not treated|0|||
146717514|NCT00838110|529135862|FG003|Overall Study|Randomized but not treated|0|||
146717515|NCT01003899|529135863|FG000|Overall Study|Other Adverse Event|8|||
146717516|NCT01003899|529135863|FG000|Overall Study|Not entered|4|||
146717517|NCT01003899|529135863|FG000|Overall Study|Not treated|1|||
146717518|NCT01003899|529135863|FG000|Overall Study|Progressive disease|34|||
146781315|NCT04549168|529370103|FG002|Randomization Phase|Withdrawal by Subject|1|||
146717519|NCT00352365|529135864|FG000|Induction Therapy|Adverse Event|7|||
146717520|NCT00352365|529135864|FG000|Induction Therapy|Progression/Relapse|8|||
146717521|NCT00352365|529135864|FG000|Induction Therapy|Death|7|||
146717522|NCT00352365|529135864|FG000|Induction Therapy|Not protocol specified|1|||
146717523|NCT00352365|529135864|FG000|Induction Therapy|Not eligible|3|||
146781316|NCT00676715|529370106|FG000|Treatment Period (TP)|Adverse Event|0|||
146717524|NCT00352365|529135864|FG000|Induction Therapy|Death before starting protocol therapy|1|||
146717525|NCT00352365|529135864|FG000|Maintenance Therapy|Progression/Relapse|3|||
146717526|NCT00352365|529135864|FG000|Maintenance Therapy|Death|2|||
146717527|NCT00352365|529135864|FG000|Maintenance Therapy|Not protocol specified|3|||
146717528|NCT00352365|529135864|FG000|Maintenance Therapy|Not eligible|4|||
146717529|NCT01262651|529135865|FG000|Overall Study|Adverse Event|40|||
146717530|NCT01262651|529135866|FG001|Overall Study|Adverse Event|35|||
146781317|NCT00676715|529370107|FG001|Treatment Period (TP)|Adverse Event|3|||
146781318|NCT00676715|529370108|FG002|Treatment Period (TP)|Adverse Event|2|||
146717531|NCT01262651|529135865|FG000|Overall Study|Withdrawal by Subject|15|||
146717532|NCT01262651|529135866|FG001|Overall Study|Withdrawal by Subject|11|||
146717533|NCT01262651|529135865|FG000|Overall Study|Withdrawal by Investigator|2|||
146717534|NCT01262651|529135866|FG001|Overall Study|Withdrawal by Investigator|2|||
146717535|NCT01262651|529135865|FG000|Overall Study|Met Withdrawal Criteria|1|||
146717536|NCT01262651|529135866|FG001|Overall Study|Met Withdrawal Criteria|0|||
146717537|NCT02811861|529135867|FG000|Overall Study|Radiological Disease Progression|123|||
146717538|NCT02811861|529135868|FG001|Overall Study|Radiological Disease Progression|97|||
146717539|NCT02811861|529135869|FG002|Overall Study|Radiological Disease Progression|174|||
146717540|NCT02811861|529135867|FG000|Overall Study|Clinical Disease Progression|20|||
146717541|NCT02811861|529135868|FG001|Overall Study|Clinical Disease Progression|19|||
146717542|NCT02811861|529135869|FG002|Overall Study|Clinical Disease Progression|22|||
146717543|NCT02811861|529135867|FG000|Overall Study|Adverse Event|63|||
146717544|NCT02811861|529135868|FG001|Overall Study|Adverse Event|60|||
146717545|NCT02811861|529135869|FG002|Overall Study|Adverse Event|41|||
146717546|NCT02811861|529135867|FG000|Overall Study|Lost to Follow-up|0|||
146717547|NCT02811861|529135868|FG001|Overall Study|Lost to Follow-up|0|||
146717548|NCT02811861|529135869|FG002|Overall Study|Lost to Follow-up|1|||
146717549|NCT02811861|529135867|FG000|Overall Study|Subject Choice|29|||
146717550|NCT02811861|529135868|FG001|Overall Study|Subject Choice|17|||
146717551|NCT02811861|529135869|FG002|Overall Study|Subject Choice|23|||
146717552|NCT02811861|529135867|FG000|Overall Study|Withdrawal by Subject|4|||
146717553|NCT02811861|529135868|FG001|Overall Study|Withdrawal by Subject|4|||
146717554|NCT02811861|529135869|FG002|Overall Study|Withdrawal by Subject|9|||
146717555|NCT02811861|529135867|FG000|Overall Study|Other|4|||
146717556|NCT02811861|529135868|FG001|Overall Study|Other|13|||
146717557|NCT02811861|529135869|FG002|Overall Study|Other|3|||
146717558|NCT02811861|529135867|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
146717559|NCT02811861|529135868|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
146717560|NCT02811861|529135869|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
146717561|NCT02811861|529135867|FG000|Overall Study|Randomized but not treated|2|||
146717562|NCT02811861|529135868|FG001|Overall Study|Randomized but not treated|3|||
146717563|NCT02811861|529135869|FG002|Overall Study|Randomized but not treated|17|||
146717564|NCT04743908|529135870|FG000|Overall Study|Death|1|||
146717565|NCT04743908|529135871|FG001|Overall Study|Death|0|||
146717566|NCT04743908|529135870|FG000|Overall Study|Lost to Follow-up|181|||
146717567|NCT04743908|529135871|FG001|Overall Study|Lost to Follow-up|180|||
146717568|NCT04743908|529135870|FG000|Overall Study|Withdrawal by Subject|1|||
146717569|NCT04743908|529135871|FG001|Overall Study|Withdrawal by Subject|2|||
146717570|NCT04969783|529135875|FG000|Overall Study|Lost to Follow-up|2|||
146717571|NCT04969783|529135876|FG001|Overall Study|Lost to Follow-up|0|||
146717572|NCT04969783|529135875|FG000|Overall Study|Withdrawal by Subject|4|||
146717573|NCT04969783|529135876|FG001|Overall Study|Withdrawal by Subject|0|||
146717574|NCT04969783|529135875|FG000|Overall Study|Physician Decision|6|||
146717575|NCT04969783|529135876|FG001|Overall Study|Physician Decision|0|||
146717576|NCT03422250|529135877|FG000|Intervention|Adverse Event|0|||
146717577|NCT03422250|529135878|FG001|Intervention|Adverse Event|1|||
146717578|NCT03422250|529135879|FG002|Intervention|Adverse Event|0|||
146717579|NCT03422250|529135880|FG003|Intervention|Adverse Event|1|||
146717580|NCT03422250|529135877|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
146717581|NCT03422250|529135878|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
146717582|NCT03422250|529135879|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
146717583|NCT03422250|529135880|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
146717584|NCT03422250|529135877|FG000|Follow-up|Withdrawal by Subject|0|||
146717585|NCT03422250|529135878|FG001|Follow-up|Withdrawal by Subject|0|||
146717586|NCT03422250|529135879|FG002|Follow-up|Withdrawal by Subject|0|||
146717587|NCT03422250|529135880|FG003|Follow-up|Withdrawal by Subject|1|||
146717588|NCT03422250|529135877|FG000|Follow-up|Adverse Event|0|||
146717589|NCT03422250|529135878|FG001|Follow-up|Adverse Event|0|||
146717590|NCT03422250|529135879|FG002|Follow-up|Adverse Event|0|||
146717591|NCT03422250|529135880|FG003|Follow-up|Adverse Event|1|||
146717592|NCT00377819|529135883|FG000|Overall Study|Adverse Event|2|||
146717593|NCT00377819|529135884|FG001|Overall Study|Adverse Event|3|||
146717594|NCT00377819|529135883|FG000|Overall Study|Withdrawal by Subject|10|||
146717595|NCT00377819|529135884|FG001|Overall Study|Withdrawal by Subject|4|||
146717596|NCT00377819|529135883|FG000|Overall Study|Death|0|||
146717597|NCT00377819|529135884|FG001|Overall Study|Death|1|||
146717598|NCT00377819|529135883|FG000|Overall Study|Lost to Follow-up|0|||
146717599|NCT00377819|529135884|FG001|Overall Study|Lost to Follow-up|1|||
146717600|NCT00377819|529135883|FG000|Overall Study|Protocol Violation|1|||
146717601|NCT00377819|529135884|FG001|Overall Study|Protocol Violation|1|||
146717602|NCT00467870|529135891|FG000|Overall Study|Adverse Event|13|||
146717603|NCT00467870|529135892|FG001|Overall Study|Adverse Event|9|||
146717604|NCT00467870|529135893|FG002|Overall Study|Adverse Event|1|||
146717605|NCT00467870|529135894|FG003|Overall Study|Adverse Event|15|||
146717606|NCT00467870|529135895|FG004|Overall Study|Adverse Event|15|||
146717607|NCT00467870|529135896|FG005|Overall Study|Adverse Event|1|||
146717608|NCT00467870|529135891|FG000|Overall Study|Protocol Violation|2|||
146717609|NCT00467870|529135892|FG001|Overall Study|Protocol Violation|1|||
146717610|NCT00467870|529135893|FG002|Overall Study|Protocol Violation|1|||
146717611|NCT00467870|529135894|FG003|Overall Study|Protocol Violation|2|||
146717612|NCT00467870|529135895|FG004|Overall Study|Protocol Violation|0|||
146717613|NCT00467870|529135896|FG005|Overall Study|Protocol Violation|0|||
146717614|NCT00467870|529135891|FG000|Overall Study|Withdrawal by Subject|14|||
146717615|NCT00467870|529135892|FG001|Overall Study|Withdrawal by Subject|21|||
146717616|NCT00467870|529135893|FG002|Overall Study|Withdrawal by Subject|0|||
146717617|NCT00467870|529135894|FG003|Overall Study|Withdrawal by Subject|9|||
146717618|NCT00467870|529135895|FG004|Overall Study|Withdrawal by Subject|10|||
146717619|NCT00467870|529135896|FG005|Overall Study|Withdrawal by Subject|1|||
146717620|NCT00467870|529135891|FG000|Overall Study|Lost to Follow-up|5|||
146717621|NCT00467870|529135892|FG001|Overall Study|Lost to Follow-up|3|||
146717622|NCT00467870|529135893|FG002|Overall Study|Lost to Follow-up|1|||
146717623|NCT00467870|529135894|FG003|Overall Study|Lost to Follow-up|1|||
146717624|NCT00467870|529135895|FG004|Overall Study|Lost to Follow-up|3|||
146717625|NCT00467870|529135896|FG005|Overall Study|Lost to Follow-up|0|||
146717626|NCT00467870|529135891|FG000|Overall Study|Subject Non-compliance|3|||
146717627|NCT00467870|529135892|FG001|Overall Study|Subject Non-compliance|4|||
146717628|NCT00467870|529135893|FG002|Overall Study|Subject Non-compliance|0|||
146717629|NCT00467870|529135894|FG003|Overall Study|Subject Non-compliance|1|||
146717630|NCT00467870|529135895|FG004|Overall Study|Subject Non-compliance|5|||
146717631|NCT00467870|529135896|FG005|Overall Study|Subject Non-compliance|0|||
146717632|NCT00467870|529135891|FG000|Overall Study|Other/Unknown|8|||
146717633|NCT00467870|529135892|FG001|Overall Study|Other/Unknown|5|||
146717634|NCT00467870|529135893|FG002|Overall Study|Other/Unknown|1|||
146717635|NCT00467870|529135894|FG003|Overall Study|Other/Unknown|5|||
146717636|NCT00467870|529135895|FG004|Overall Study|Other/Unknown|4|||
146717637|NCT00467870|529135896|FG005|Overall Study|Other/Unknown|0|||
146717638|NCT01917526|529135897|FG000|Overall Study|Protocol Violation|1|||
146717639|NCT01917526|529135898|FG001|Overall Study|Protocol Violation|1|||
146717640|NCT02261363|529135899|FG000|Overall Study|Lost to Follow-up|21|||
146717641|NCT01517802|529135900|FG000|Overall Study|Death|1|||
146717642|NCT03268811|529135905|FG000|Overall Study|Adverse Event|0|||
146717643|NCT03268811|529135906|FG001|Overall Study|Adverse Event|1|||
146717644|NCT02031276|529135907|FG000|Period 1 Double-blind IV|Adverse Event|6|||
146717645|NCT02031276|529135908|FG001|Period 1 Double-blind IV|Adverse Event|5|||
146717646|NCT02031276|529135909|FG002|Period 1 Double-blind IV|Adverse Event|1|||
146717647|NCT02031276|529135907|FG000|Period 1 Double-blind IV|Other|0|||
146717648|NCT02031276|529135908|FG001|Period 1 Double-blind IV|Other|1|||
146717649|NCT02031276|529135909|FG002|Period 1 Double-blind IV|Other|0|||
146717650|NCT02031276|529135907|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
146717651|NCT02031276|529135908|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
146717652|NCT02031276|529135909|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
146717653|NCT02031276|529135907|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
146717654|NCT02031276|529135908|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
146717655|NCT02031276|529135909|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
146717656|NCT02031276|529135907|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
146717657|NCT02031276|529135908|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
146717658|NCT02031276|529135909|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
146717659|NCT02031276|529135907|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
146717660|NCT02031276|529135908|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
146717661|NCT02031276|529135909|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
146717662|NCT02031276|529135907|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
146717663|NCT02031276|529135908|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
146717664|NCT02031276|529135909|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
146717665|NCT02031276|529135907|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
146717666|NCT02031276|529135908|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
146717667|NCT02031276|529135909|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
146717668|NCT02031276|529135907|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
146717669|NCT02031276|529135908|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
146717670|NCT02031276|529135909|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
146717671|NCT04726709|529135916|FG000|Overall Study|Withdrawal by Subject|2|||
146717672|NCT04726709|529135917|FG001|Overall Study|Withdrawal by Subject|2|||
146717673|NCT03073603|529135919|FG000|Overall Study|Noncompliance|3|||
146717674|NCT03073603|529135920|FG001|Overall Study|Noncompliance|1|||
146717675|NCT03073603|529135919|FG000|Overall Study|Adverse Event|5|||
146717676|NCT03073603|529135920|FG001|Overall Study|Adverse Event|3|||
146717677|NCT03073603|529135919|FG000|Overall Study|Physician Decision|1|||
146717678|NCT03073603|529135920|FG001|Overall Study|Physician Decision|2|||
146717679|NCT03073603|529135919|FG000|Overall Study|Required treatment not allowed by protocol|1|||
146717680|NCT03073603|529135920|FG001|Overall Study|Required treatment not allowed by protocol|0|||
146717681|NCT03073603|529135919|FG000|Overall Study|Financial or insurance-related|8|||
146717682|NCT03073603|529135920|FG001|Overall Study|Financial or insurance-related|0|||
146717683|NCT03073603|529135919|FG000|Overall Study|Withdrawal by Subject|0|||
146934122|NCT01617187|529916092|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
146934123|NCT01617187|529916093|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
146934124|NCT01617187|529916094|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
146934125|NCT01617187|529916095|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
146934126|NCT01617187|529916092|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
146934127|NCT01617187|529916093|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
146981292|NCT01427803|530093840|FG001|Overall Study|Unable to complete full treatment period|0|||
146981293|NCT01427803|530093839|FG000|Overall Study|Protocol Violation|1|||
146717684|NCT03073603|529135920|FG001|Overall Study|Withdrawal by Subject|1|||
146717685|NCT03073603|529135919|FG000|Overall Study|Discontinued DMT|4|||
146717686|NCT03073603|529135920|FG001|Overall Study|Discontinued DMT|0|||
146717687|NCT03073603|529135919|FG000|Overall Study|Restarted DMT|0|||
146717688|NCT03073603|529135920|FG001|Overall Study|Restarted DMT|1|||
146717689|NCT04827212|529135924|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
146717690|NCT04827212|529135925|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
146717691|NCT04827212|529135924|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
146717692|NCT04827212|529135925|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
146717693|NCT00563784|529135928|FG000|Overall Study|Withdrawal by Subject|2|||
146717694|NCT00563784|529135928|FG000|Overall Study|Screen Failures|20|||
146717695|NCT00148343|529135929|FG000|Overall Study|Withdrawal by Subject|12|||
146717696|NCT00148343|529135930|FG001|Overall Study|Withdrawal by Subject|7|||
146717697|NCT00148343|529135929|FG000|Overall Study|Physician Decision|3|||
146717698|NCT00148343|529135930|FG001|Overall Study|Physician Decision|4|||
146717699|NCT02528214|529135933|FG000|Overall Study|Protocol Violation|0|||
146717700|NCT02528214|529135934|FG001|Overall Study|Protocol Violation|1|||
146717701|NCT02528214|529135933|FG000|Overall Study|Adverse Event|0|||
146717702|NCT02528214|529135934|FG001|Overall Study|Adverse Event|1|||
146717703|NCT02528214|529135933|FG000|Overall Study|Other than specified above|0|||
146717704|NCT02528214|529135934|FG001|Overall Study|Other than specified above|1|||
146717705|NCT01380327|529135935|FG000|Overall Study|Lost to Follow-up|0|||
146717706|NCT01380327|529135936|FG001|Overall Study|Lost to Follow-up|1|||
146717707|NCT01380327|529135937|FG002|Overall Study|Lost to Follow-up|1|||
146717708|NCT01380327|529135935|FG000|Overall Study|Protocol Violation|3|||
146717709|NCT01380327|529135936|FG001|Overall Study|Protocol Violation|2|||
146717710|NCT01380327|529135937|FG002|Overall Study|Protocol Violation|3|||
146717711|NCT01380327|529135935|FG000|Overall Study|Withdrawal by Subject|0|||
146717712|NCT01380327|529135936|FG001|Overall Study|Withdrawal by Subject|0|||
146717713|NCT01380327|529135937|FG002|Overall Study|Withdrawal by Subject|1|||
146717714|NCT01380327|529135935|FG000|Overall Study|Housing situation precluded ability to k|0|||
146717715|NCT01380327|529135936|FG001|Overall Study|Housing situation precluded ability to k|0|||
146717716|NCT01380327|529135937|FG002|Overall Study|Housing situation precluded ability to k|1|||
146717717|NCT01380327|529135935|FG000|Overall Study|Questionable onset of epilepsy|0|||
146717718|NCT01380327|529135936|FG001|Overall Study|Questionable onset of epilepsy|0|||
146717719|NCT01380327|529135937|FG002|Overall Study|Questionable onset of epilepsy|1|||
146717720|NCT00759109|529135938|FG000|Overall Study|Adverse Event|17|||
146717721|NCT00759109|529135939|FG001|Overall Study|Adverse Event|12|||
146717722|NCT00759109|529135938|FG000|Overall Study|Inability to comply|1|||
146717723|NCT00759109|529135939|FG001|Overall Study|Inability to comply|1|||
146717724|NCT00759109|529135938|FG000|Overall Study|Withdrawal by Subject|9|||
146717725|NCT00759109|529135939|FG001|Overall Study|Withdrawal by Subject|5|||
146717726|NCT00759109|529135938|FG000|Overall Study|Death|4|||
146717727|NCT00759109|529135939|FG001|Overall Study|Death|3|||
146717728|NCT00759109|529135938|FG000|Overall Study|Lost to Follow-up|4|||
146717729|NCT00759109|529135939|FG001|Overall Study|Lost to Follow-up|6|||
146717730|NCT00759109|529135938|FG000|Overall Study|Started new therapy|2|||
146717731|NCT00759109|529135939|FG001|Overall Study|Started new therapy|6|||
146717732|NCT00759109|529135938|FG000|Overall Study|HCV RNA negative|1|||
146717733|NCT00759109|529135939|FG001|Overall Study|HCV RNA negative|0|||
146717734|NCT00759109|529135938|FG000|Overall Study|Participant moved to a different city|0|||
146717735|NCT00759109|529135939|FG001|Overall Study|Participant moved to a different city|1|||
146717736|NCT00759109|529135938|FG000|Overall Study|Participant had a liver transplant|0|||
146717737|NCT00759109|529135939|FG001|Overall Study|Participant had a liver transplant|1|||
146717738|NCT00759109|529135938|FG000|Overall Study|Lost during study|1|||
146717739|NCT00759109|529135939|FG001|Overall Study|Lost during study|0|||
146981294|NCT01427803|530093840|FG001|Overall Study|Protocol Violation|0|||
146717740|NCT01664078|529135944|FG000|Overall Study|Death|9|||
146717741|NCT01664078|529135944|FG000|Overall Study|Withdrawal by Subject|4|||
146717742|NCT01664078|529135944|FG000|Overall Study|Lost to Follow-up|2|||
146717743|NCT01664078|529135944|FG000|Overall Study|missed 5 year visit|1|||
146717744|NCT01664078|529135944|FG000|Overall Study|Other|53|||
146717745|NCT02720484|529135953|FG000|Treatment on Study|Adverse Event|1|||
146717746|NCT02720484|529135953|FG000|Treatment on Study|Withdrawal by Subject|1|||
146717747|NCT02720484|529135953|FG000|Treatment on Study|Progressive Disease|4|||
146717748|NCT02720484|529135953|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
146717749|NCT02720484|529135953|FG000|Follow Up for 2 Years|Death|3|||
146717750|NCT02720484|529135953|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
146717751|NCT05070897|529135956|FG000|Overall Study|Protocol Violation|123|||
146717752|NCT05070897|529135957|FG001|Overall Study|Protocol Violation|68|||
146717753|NCT01617629|529135958|FG000|Overall Study|Death|2|||
146717754|NCT01617629|529135958|FG000|Overall Study|Investigator's Clinical Judgement|1|||
146717755|NCT01617629|529135958|FG000|Overall Study|Reason Not Specified|1|||
146717756|NCT01617629|529135958|FG000|Overall Study|Participant Withdrew Consent|2|||
146717757|NCT01663636|529135959|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
146717758|NCT01663636|529135960|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
146717759|NCT03832946|529135961|FG000|Overall Study|Adverse Event|3|||
146717760|NCT03832946|529135962|FG001|Overall Study|Adverse Event|1|||
146717761|NCT03832946|529135961|FG000|Overall Study|Lost to Follow-up|1|||
146717762|NCT03832946|529135962|FG001|Overall Study|Lost to Follow-up|0|||
146717763|NCT03832946|529135961|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
146717764|NCT03832946|529135962|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
146717765|NCT03832946|529135961|FG000|Overall Study|Lack of Efficacy|1|||
146717766|NCT03832946|529135962|FG001|Overall Study|Lack of Efficacy|0|||
146717767|NCT03832946|529135961|FG000|Overall Study|Withdrawal by Subject|12|||
146717768|NCT03832946|529135962|FG001|Overall Study|Withdrawal by Subject|9|||
146717769|NCT02715765|529135963|FG000|Overall Study|Study Termination|3|||
146717770|NCT02715765|529135964|FG001|Overall Study|Study Termination|0|||
146717771|NCT02715765|529135965|FG002|Overall Study|Study Termination|0|||
146717772|NCT02838017|529135967|FG000|Overall Study|Lost to Follow-up|14|||
146717773|NCT02838017|529135968|FG001|Overall Study|Lost to Follow-up|11|||
146717774|NCT01692197|529135969|FG000|Overall Study|Failed Screening|3|||
146717775|NCT02120924|529135970|FG000|Overall Study|Lack of Efficacy|1|||
146717776|NCT02120924|529135971|FG001|Overall Study|Lack of Efficacy|2|||
146717777|NCT02120924|529135972|FG002|Overall Study|Lack of Efficacy|3|||
146717778|NCT02120924|529135970|FG000|Overall Study|Adverse Event|0|||
146717779|NCT02120924|529135971|FG001|Overall Study|Adverse Event|1|||
146717780|NCT02120924|529135972|FG002|Overall Study|Adverse Event|3|||
146717781|NCT02120924|529135970|FG000|Overall Study|Withdrawal by Subject|16|||
146717782|NCT02120924|529135971|FG001|Overall Study|Withdrawal by Subject|20|||
146717783|NCT02120924|529135972|FG002|Overall Study|Withdrawal by Subject|8|||
146717784|NCT02120924|529135970|FG000|Overall Study|Lost to Follow-up|14|||
146717785|NCT02120924|529135971|FG001|Overall Study|Lost to Follow-up|14|||
146717786|NCT02120924|529135972|FG002|Overall Study|Lost to Follow-up|11|||
146717787|NCT02120924|529135970|FG000|Overall Study|Pregnancy|2|||
146717788|NCT02120924|529135971|FG001|Overall Study|Pregnancy|0|||
146717789|NCT02120924|529135972|FG002|Overall Study|Pregnancy|0|||
146717790|NCT02120924|529135970|FG000|Overall Study|Protocol Violation|3|||
146717791|NCT02120924|529135971|FG001|Overall Study|Protocol Violation|7|||
146717792|NCT02120924|529135972|FG002|Overall Study|Protocol Violation|2|||
146717793|NCT02120924|529135970|FG000|Overall Study|Physician Decision|0|||
146717794|NCT02120924|529135971|FG001|Overall Study|Physician Decision|1|||
146717795|NCT02120924|529135972|FG002|Overall Study|Physician Decision|1|||
146717796|NCT02120924|529135970|FG000|Overall Study|Death|1|||
146717797|NCT02120924|529135971|FG001|Overall Study|Death|0|||
146717798|NCT02120924|529135972|FG002|Overall Study|Death|0|||
146717799|NCT02120924|529135970|FG000|Overall Study|Compliance with IP|5|||
146717800|NCT02120924|529135971|FG001|Overall Study|Compliance with IP|1|||
146717801|NCT02120924|529135972|FG002|Overall Study|Compliance with IP|1|||
146717802|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
146717803|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
146717804|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
146717805|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
146717806|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
146717807|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
146717808|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
146717809|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
146717810|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
146717811|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
146717812|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
146717813|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
146981295|NCT01427803|530093839|FG000|Overall Study|Physician Decision|3|||
146717814|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
146717815|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
146717816|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
146717817|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
146717818|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
146717819|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
146717820|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
146717821|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
146717822|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
146717823|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
146717824|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
146717825|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
146717826|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
146717827|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
146717828|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
146717829|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
146717830|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
146717831|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
146717832|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
146717833|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
146717834|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
146717835|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
146717836|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
146717837|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
146717838|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
146717839|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
146717840|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
146717841|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
146717842|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
146717843|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
146717844|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
146717845|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
146717846|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
146717847|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
146717848|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
146717849|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
146717850|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
146717851|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
146717852|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
146717853|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
146717854|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
146717855|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
146717856|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
146717857|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
146717858|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
146717859|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
146717860|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
146717861|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
146717862|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
146717863|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
146717864|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
146717865|NCT01884350|529135973|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
146717866|NCT01884350|529135974|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
146717867|NCT01884350|529135975|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
146717868|NCT01308580|529135980|FG000|Overall Study|Lost to Follow-up|12|||
146717869|NCT01308580|529135981|FG001|Overall Study|Lost to Follow-up|7|||
146717870|NCT03712917|529135982|FG000|Overall Study|Pregnancy|0|||
146717871|NCT03712917|529135983|FG001|Overall Study|Pregnancy|0|||
146717872|NCT03712917|529135984|FG002|Overall Study|Pregnancy|1|||
146717873|NCT03712917|529135982|FG000|Overall Study|Adverse Event|0|||
146717874|NCT03712917|529135983|FG001|Overall Study|Adverse Event|4|||
146717875|NCT03712917|529135984|FG002|Overall Study|Adverse Event|3|||
146717876|NCT03712917|529135982|FG000|Overall Study|Lost to Follow-up|9|||
146717877|NCT03712917|529135983|FG001|Overall Study|Lost to Follow-up|4|||
146717878|NCT03712917|529135984|FG002|Overall Study|Lost to Follow-up|5|||
146717879|NCT01438541|529135985|FG000|Overall Study|Physician Decision|1|||
146717880|NCT01438541|529135985|FG000|Overall Study|Withdrawal by Subject|1|||
146717881|NCT01438541|529135985|FG000|Overall Study|discharge from the hospital|5|||
146717882|NCT02091167|529135986|FG000|Overall Study|Lost to Follow-up|0|||
146717883|NCT02091167|529135987|FG001|Overall Study|Lost to Follow-up|2|||
146717884|NCT03096782|529135988|FG000|Overall Study|Death|1|||
146717885|NCT03096782|529135988|FG000|Overall Study|Participant Relapsed|1|||
146717886|NCT04537923|529137822|FG000|Overall Study|Adverse Event|2|||
146717887|NCT04537923|529137823|FG001|Overall Study|Adverse Event|1|||
146981296|NCT01427803|530093840|FG001|Overall Study|Physician Decision|0|||
146981297|NCT01427803|530093839|FG000|Overall Study|did not take product|1|||
146717888|NCT04537923|529137824|FG002|Overall Study|Adverse Event|2|||
146717889|NCT04537923|529137825|FG003|Overall Study|Adverse Event|4|||
146717890|NCT04537923|529137822|FG000|Overall Study|Death|3|||
146717891|NCT04537923|529137823|FG001|Overall Study|Death|3|||
146717892|NCT04537923|529137824|FG002|Overall Study|Death|1|||
146717893|NCT04537923|529137825|FG003|Overall Study|Death|11|||
146717894|NCT04537923|529137822|FG000|Overall Study|Lost to Follow-up|1|||
146717895|NCT04537923|529137823|FG001|Overall Study|Lost to Follow-up|2|||
146717896|NCT04537923|529137824|FG002|Overall Study|Lost to Follow-up|1|||
146717897|NCT04537923|529137825|FG003|Overall Study|Lost to Follow-up|6|||
146717898|NCT04537923|529137822|FG000|Overall Study|Physician Decision|1|||
146717899|NCT04537923|529137823|FG001|Overall Study|Physician Decision|0|||
146717900|NCT04537923|529137824|FG002|Overall Study|Physician Decision|2|||
146717901|NCT04537923|529137825|FG003|Overall Study|Physician Decision|5|||
146717902|NCT04537923|529137822|FG000|Overall Study|Pregnancy|1|||
146717903|NCT04537923|529137823|FG001|Overall Study|Pregnancy|0|||
146717904|NCT04537923|529137824|FG002|Overall Study|Pregnancy|0|||
146717905|NCT04537923|529137825|FG003|Overall Study|Pregnancy|0|||
146717906|NCT04537923|529137822|FG000|Overall Study|Withdrawal by Subject|4|||
146717907|NCT04537923|529137823|FG001|Overall Study|Withdrawal by Subject|4|||
146717908|NCT04537923|529137824|FG002|Overall Study|Withdrawal by Subject|4|||
146717909|NCT04537923|529137825|FG003|Overall Study|Withdrawal by Subject|58|||
146717910|NCT04537923|529137822|FG000|Overall Study|Missed study visits|2|||
146717911|NCT04537923|529137823|FG001|Overall Study|Missed study visits|0|||
146717912|NCT04537923|529137824|FG002|Overall Study|Missed study visits|0|||
146717913|NCT04537923|529137825|FG003|Overall Study|Missed study visits|3|||
146717914|NCT04537923|529137822|FG000|Overall Study|Sponsor's decision|0|||
146717915|NCT04537923|529137823|FG001|Overall Study|Sponsor's decision|0|||
146717916|NCT04537923|529137824|FG002|Overall Study|Sponsor's decision|1|||
146717917|NCT04537923|529137825|FG003|Overall Study|Sponsor's decision|1|||
146717918|NCT04537923|529137822|FG000|Overall Study|Safety reasons|1|||
146717919|NCT04537923|529137823|FG001|Overall Study|Safety reasons|0|||
146717920|NCT04537923|529137824|FG002|Overall Study|Safety reasons|0|||
146717921|NCT04537923|529137825|FG003|Overall Study|Safety reasons|0|||
146717922|NCT01261611|529137826|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
146717923|NCT01261611|529137827|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
146717924|NCT01261611|529137828|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
146717925|NCT01261611|529137826|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
146717926|NCT01261611|529137827|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
146717927|NCT01261611|529137828|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
146717928|NCT01261611|529137826|FG000|Treatment Cycle 1|Adverse Event|0|||
146717929|NCT01261611|529137827|FG001|Treatment Cycle 1|Adverse Event|1|||
146717930|NCT01261611|529137828|FG002|Treatment Cycle 1|Adverse Event|0|||
146717931|NCT01261611|529137826|FG000|Treatment Cycle 1|Protocol Violation|0|||
146717932|NCT01261611|529137827|FG001|Treatment Cycle 1|Protocol Violation|0|||
146717933|NCT01261611|529137828|FG002|Treatment Cycle 1|Protocol Violation|2|||
146717934|NCT01261611|529137826|FG000|Treatment Cycle 2|Completed study|4|||
146717935|NCT01261611|529137827|FG001|Treatment Cycle 2|Completed study|0|||
146717936|NCT01261611|529137828|FG002|Treatment Cycle 2|Completed study|0|||
146717937|NCT01261611|529137826|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
146717938|NCT01261611|529137827|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
146717939|NCT01261611|529137828|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
146717940|NCT01261611|529137826|FG000|Treatment Cycle 2|Adverse Event|1|||
146717941|NCT01261611|529137827|FG001|Treatment Cycle 2|Adverse Event|0|||
146717942|NCT01261611|529137828|FG002|Treatment Cycle 2|Adverse Event|0|||
146717943|NCT01261611|529137826|FG000|Treatment Cycle 2|Protocol Violation|2|||
146717944|NCT01261611|529137827|FG001|Treatment Cycle 2|Protocol Violation|0|||
146717945|NCT01261611|529137828|FG002|Treatment Cycle 2|Protocol Violation|0|||
146717946|NCT01261611|529137826|FG000|Treatment Cycle 2|Not otherwise specified|2|||
146717947|NCT01261611|529137827|FG001|Treatment Cycle 2|Not otherwise specified|0|||
146717948|NCT01261611|529137828|FG002|Treatment Cycle 2|Not otherwise specified|0|||
146717949|NCT01261611|529137826|FG000|Treatment Cycle 3|Completed study|24|||
146717950|NCT01261611|529137827|FG001|Treatment Cycle 3|Completed study|0|||
146717951|NCT01261611|529137828|FG002|Treatment Cycle 3|Completed study|0|||
146717952|NCT01261611|529137826|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
146717953|NCT01261611|529137827|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
146717954|NCT01261611|529137828|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
146717955|NCT01261611|529137826|FG000|Treatment Cycle 3|Adverse Event|1|||
146717956|NCT01261611|529137827|FG001|Treatment Cycle 3|Adverse Event|0|||
146717957|NCT01261611|529137828|FG002|Treatment Cycle 3|Adverse Event|0|||
146717958|NCT01261611|529137826|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
146717959|NCT01261611|529137827|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
146717960|NCT01261611|529137828|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
146717961|NCT01261611|529137826|FG000|Treatment Cycle 4|Completed study|87|||
146717962|NCT01261611|529137827|FG001|Treatment Cycle 4|Completed study|0|||
146717963|NCT01261611|529137828|FG002|Treatment Cycle 4|Completed study|0|||
146717964|NCT01261611|529137826|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
146717965|NCT01261611|529137827|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
146717966|NCT01261611|529137828|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
146717967|NCT01261611|529137826|FG000|Treatment Cycle 4|Adverse Event|1|||
146717968|NCT01261611|529137827|FG001|Treatment Cycle 4|Adverse Event|0|||
146717969|NCT01261611|529137828|FG002|Treatment Cycle 4|Adverse Event|0|||
146717970|NCT01261611|529137826|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
146717971|NCT01261611|529137827|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
146717972|NCT01261611|529137828|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
146717973|NCT01261611|529137826|FG000|Treatment Cycle 4|Not otherwise specified|3|||
146717974|NCT01261611|529137827|FG001|Treatment Cycle 4|Not otherwise specified|0|||
146717975|NCT01261611|529137828|FG002|Treatment Cycle 4|Not otherwise specified|0|||
146717976|NCT01261611|529137826|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
146717977|NCT01261611|529137827|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
146717978|NCT01261611|529137828|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
146717979|NCT01261611|529137826|FG000|Treatment Cycle 5|Adverse Event|1|||
146717980|NCT01261611|529137827|FG001|Treatment Cycle 5|Adverse Event|0|||
146717981|NCT01261611|529137828|FG002|Treatment Cycle 5|Adverse Event|0|||
146717982|NCT01261611|529137826|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
146717983|NCT01261611|529137827|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
146717984|NCT01261611|529137828|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
146717985|NCT03586648|529137832|FG000|Period 1|Withdrawal by Subject|0|||
146717986|NCT03586648|529137833|FG001|Period 1|Withdrawal by Subject|1|||
146717987|NCT03586648|529137832|FG000|Period 1|Lost to Follow-up|1|||
146717988|NCT03586648|529137833|FG001|Period 1|Lost to Follow-up|1|||
146717989|NCT03586648|529137832|FG000|Period 1|Adverse Event|1|||
146717990|NCT03586648|529137833|FG001|Period 1|Adverse Event|0|||
146717991|NCT03586648|529137832|FG000|Period 1|Study related symptoms or complaints|2|||
146717992|NCT03586648|529137833|FG001|Period 1|Study related symptoms or complaints|1|||
146717993|NCT03586648|529137832|FG000|Period 1|Physician Decision|0|||
146717994|NCT03586648|529137833|FG001|Period 1|Physician Decision|1|||
146717995|NCT03586648|529137832|FG000|Period 2|Adverse Event|1|||
146717996|NCT03586648|529137833|FG001|Period 2|Adverse Event|0|||
146717997|NCT02395120|529137834|FG000|Overall Study|Missed follow-up dental exam|57|||
146717998|NCT02395120|529137835|FG001|Overall Study|Missed follow-up dental exam|62|||
146717999|NCT02395120|529137836|FG002|Overall Study|Missed follow-up dental exam|6|||
146718000|NCT02395120|529137837|FG003|Overall Study|Missed follow-up dental exam|6|||
146718001|NCT02395120|529137838|FG004|Overall Study|Missed follow-up dental exam|51|||
146718002|NCT00377234|529137839|FG000|Overall Study|Adverse Event|14|||
146718003|NCT00377234|529137840|FG001|Overall Study|Adverse Event|17|||
146718004|NCT00377234|529137839|FG000|Overall Study|Withdrawal by Subject|11|||
146718005|NCT00377234|529137840|FG001|Overall Study|Withdrawal by Subject|9|||
146718006|NCT00377234|529137839|FG000|Overall Study|Lost to Follow-up|4|||
146718007|NCT00377234|529137840|FG001|Overall Study|Lost to Follow-up|2|||
146718008|NCT00377234|529137839|FG000|Overall Study|Administrative|2|||
146718009|NCT00377234|529137840|FG001|Overall Study|Administrative|1|||
146718010|NCT00377234|529137839|FG000|Overall Study|Not assigned|3|||
146718011|NCT00377234|529137840|FG001|Overall Study|Not assigned|2|||
146718012|NCT01159691|529137842|FG000|Overall Study|Lost to Follow-up|2|||
146718013|NCT01159691|529137842|FG000|Overall Study|Unknown reasons|1|||
146718014|NCT01159691|529137842|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
146718015|NCT01159691|529137842|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
146718016|NCT01159691|529137842|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
146718017|NCT01159691|529137842|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
146718018|NCT01159691|529137842|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
146718019|NCT01159691|529137842|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
146718020|NCT03822533|529137843|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
146718021|NCT03822533|529137844|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
146718022|NCT03822533|529137843|FG000|3 Month Follow-up|Lost to Follow-up|2|||
146718023|NCT03822533|529137844|FG001|3 Month Follow-up|Lost to Follow-up|2|||
146718024|NCT03822533|529137843|FG000|6 Month Follow-up|Lost to Follow-up|3|||
146718025|NCT03822533|529137844|FG001|6 Month Follow-up|Lost to Follow-up|0|||
146718026|NCT03822533|529137843|FG000|12 Month Follow-up|Lost to Follow-up|2|||
146718027|NCT03822533|529137844|FG001|12 Month Follow-up|Lost to Follow-up|3|||
146718028|NCT03822533|529137843|FG000|12 Month Follow-up|Pregnancy|0|||
146718029|NCT03822533|529137844|FG001|12 Month Follow-up|Pregnancy|1|||
146718030|NCT03822533|529137843|FG000|12 Month Follow-up|Surgery|2|||
146718031|NCT03822533|529137844|FG001|12 Month Follow-up|Surgery|0|||
146718032|NCT03822533|529137843|FG000|12 Month Follow-up|Wrong address|1|||
146781319|NCT00676715|529370109|FG003|Treatment Period (TP)|Adverse Event|2|||
146718033|NCT03822533|529137844|FG001|12 Month Follow-up|Wrong address|0|||
146718034|NCT03822533|529137843|FG000|12 Month Follow-up|No symptoms|1|||
146718035|NCT03822533|529137844|FG001|12 Month Follow-up|No symptoms|0|||
146718036|NCT03822533|529137843|FG000|12 Month Follow-up|Changed primary care center|0|||
146718037|NCT03822533|529137844|FG001|12 Month Follow-up|Changed primary care center|1|||
146718038|NCT02489500|529137845|FG000|Overall Study|Death|1|||
146781320|NCT00676715|529370106|FG000|Treatment Period (TP)|Death|0|||
146718039|NCT02489500|529137846|FG001|Overall Study|Death|1|||
146718040|NCT02863926|529137847|FG000|Overall Study|Physician Decision|1|||
146718041|NCT02863926|529137848|FG001|Overall Study|Physician Decision|0|||
146718042|NCT02863926|529137847|FG000|Overall Study|Lost to Follow-up|1|||
146718043|NCT02863926|529137848|FG001|Overall Study|Lost to Follow-up|1|||
146718044|NCT00823719|529137850|FG000|Overall Study|Adverse Event|1|||
146718045|NCT00823719|529137851|FG001|Overall Study|Adverse Event|2|||
146718046|NCT00823719|529137850|FG000|Overall Study|Physician Decision|1|||
146718047|NCT00823719|529137851|FG001|Overall Study|Physician Decision|4|||
146718048|NCT00823719|529137850|FG000|Overall Study|Withdrawal by Subject|0|||
146718049|NCT00823719|529137851|FG001|Overall Study|Withdrawal by Subject|1|||
146718050|NCT00823719|529137850|FG000|Overall Study|Disease Progression|4|||
146718051|NCT00823719|529137851|FG001|Overall Study|Disease Progression|4|||
146718052|NCT04757649|529137852|FG000|Overall Study|Withdrawal by Subject|1|||
146718053|NCT04757649|529137852|FG000|Overall Study|Adverse Event|1|||
146718054|NCT01286779|529137853|FG000|Overall Study|Withdrawal by Subject|9|||
146718055|NCT01286779|529137853|FG000|Overall Study|Protocol Violation|5|||
146718056|NCT01286779|529137853|FG000|Overall Study|Physician Decision|2|||
146718057|NCT01286779|529137853|FG000|Overall Study|Participant had scheduled surgery|1|||
146718058|NCT01286779|529137853|FG000|Overall Study|Participant moved to another country|1|||
146718059|NCT01286779|529137853|FG000|Overall Study|Discontinued by sponsor|1|||
146718060|NCT00574080|529137858|FG000|Overall Study|Death|10|||
146718061|NCT00574080|529137859|FG001|Overall Study|Death|10|||
146718062|NCT02862106|529137860|FG000|Overall Study|Adverse Event|4|||
146718063|NCT02862106|529137861|FG001|Overall Study|Adverse Event|0|||
146718064|NCT02862106|529137860|FG000|Overall Study|Protocol Violation|16|||
146718065|NCT02862106|529137861|FG001|Overall Study|Protocol Violation|1|||
146718066|NCT02862106|529137860|FG000|Overall Study|Lost to Follow-up|15|||
146718067|NCT02862106|529137861|FG001|Overall Study|Lost to Follow-up|5|||
146718068|NCT02862106|529137860|FG000|Overall Study|Withdrawal by Subject|2|||
146718069|NCT02862106|529137861|FG001|Overall Study|Withdrawal by Subject|0|||
146718070|NCT02862106|529137860|FG000|Overall Study|Subjects moved to other city|1|||
146718071|NCT02862106|529137861|FG001|Overall Study|Subjects moved to other city|0|||
146718072|NCT03434119|529137862|FG000|Overall Study|Randomized but not treated|1|||
146718073|NCT03434119|529137863|FG001|Overall Study|Randomized but not treated|0|||
146718074|NCT03434119|529137862|FG000|Overall Study|Adverse Event|1|||
146718075|NCT03434119|529137863|FG001|Overall Study|Adverse Event|0|||
146718076|NCT03434119|529137862|FG000|Overall Study|Poor Compliance to Protocol|0|||
146718077|NCT03434119|529137863|FG001|Overall Study|Poor Compliance to Protocol|1|||
146718078|NCT03434119|529137862|FG000|Overall Study|Study Terminated by Sponsor|91|||
146718079|NCT03434119|529137863|FG001|Overall Study|Study Terminated by Sponsor|102|||
146718080|NCT03434119|529137862|FG000|Overall Study|Withdrawal by Subject|7|||
146718081|NCT03434119|529137863|FG001|Overall Study|Withdrawal by Subject|5|||
146718082|NCT03434119|529137862|FG000|Overall Study|Other than specified|7|||
146718083|NCT03434119|529137863|FG001|Overall Study|Other than specified|5|||
146718084|NCT04360824|529137864|FG000|Overall Study|Withdrawal by Subject|2|||
146718085|NCT04360824|529137865|FG001|Overall Study|Withdrawal by Subject|1|||
146718086|NCT04360824|529137864|FG000|Overall Study|Did not receive assigned treatment|1|||
146718087|NCT04360824|529137865|FG001|Overall Study|Did not receive assigned treatment|3|||
146718088|NCT00304070|529137866|FG000|Overall Study|Death|0|||
146718089|NCT00304070|529137867|FG001|Overall Study|Death|0|||
146718090|NCT00304070|529137868|FG002|Overall Study|Death|3|||
146718091|NCT00304070|529137866|FG000|Overall Study|Lost to Follow-up|0|||
146718092|NCT00304070|529137867|FG001|Overall Study|Lost to Follow-up|0|||
146718093|NCT00304070|529137868|FG002|Overall Study|Lost to Follow-up|1|||
146718094|NCT00304070|529137866|FG000|Overall Study|Physician Decision|0|||
146718095|NCT00304070|529137867|FG001|Overall Study|Physician Decision|0|||
146718096|NCT00304070|529137868|FG002|Overall Study|Physician Decision|3|||
146718097|NCT00304070|529137866|FG000|Overall Study|Withdrawal by Subject|0|||
146718098|NCT00304070|529137867|FG001|Overall Study|Withdrawal by Subject|0|||
146718099|NCT00304070|529137868|FG002|Overall Study|Withdrawal by Subject|1|||
146718100|NCT00304070|529137866|FG000|Overall Study|Progressive Disease|3|||
146934128|NCT01617187|529916094|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
146934129|NCT01617187|529916095|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
146934130|NCT01617187|529916092|FG000|Treatment Through Study Completion|Protocol Violation|1|||
146934131|NCT01617187|529916093|FG001|Treatment Through Study Completion|Protocol Violation|0|||
146718101|NCT00304070|529137867|FG001|Overall Study|Progressive Disease|7|||
146718102|NCT00304070|529137868|FG002|Overall Study|Progressive Disease|4|||
146718103|NCT00320216|529137869|FG000|Overall Study|Adverse Event|0|||
146718104|NCT00320216|529137870|FG001|Overall Study|Adverse Event|6|||
146718105|NCT00320216|529137871|FG002|Overall Study|Adverse Event|0|||
146718106|NCT00320216|529137872|FG003|Overall Study|Adverse Event|2|||
146718107|NCT00320216|529137873|FG004|Overall Study|Adverse Event|2|||
146718108|NCT00320216|529137869|FG000|Overall Study|Lack of Efficacy|6|||
146718109|NCT00320216|529137870|FG001|Overall Study|Lack of Efficacy|2|||
146718110|NCT00320216|529137871|FG002|Overall Study|Lack of Efficacy|1|||
146934132|NCT01617187|529916094|FG002|Treatment Through Study Completion|Protocol Violation|0|||
146718111|NCT00320216|529137872|FG003|Overall Study|Lack of Efficacy|0|||
146718112|NCT00320216|529137873|FG004|Overall Study|Lack of Efficacy|1|||
146718113|NCT00320216|529137869|FG000|Overall Study|Lost to Follow-up|3|||
146718114|NCT00320216|529137870|FG001|Overall Study|Lost to Follow-up|0|||
146718115|NCT00320216|529137871|FG002|Overall Study|Lost to Follow-up|0|||
146718116|NCT00320216|529137872|FG003|Overall Study|Lost to Follow-up|0|||
146718117|NCT00320216|529137873|FG004|Overall Study|Lost to Follow-up|0|||
146718118|NCT00320216|529137869|FG000|Overall Study|Other|7|||
146718119|NCT00320216|529137870|FG001|Overall Study|Other|2|||
146718120|NCT00320216|529137871|FG002|Overall Study|Other|5|||
146718121|NCT00320216|529137872|FG003|Overall Study|Other|1|||
146718122|NCT00320216|529137873|FG004|Overall Study|Other|3|||
146718123|NCT00377676|529137874|FG000|Overall Study|Adverse Event|498|||
146718124|NCT00377676|529137875|FG001|Overall Study|Adverse Event|107|||
146718125|NCT00377676|529137874|FG000|Overall Study|Protocol Violation|33|||
146718126|NCT00377676|529137875|FG001|Overall Study|Protocol Violation|27|||
146718127|NCT00377676|529137874|FG000|Overall Study|Death|5|||
146718128|NCT00377676|529137875|FG001|Overall Study|Death|2|||
146718129|NCT00377676|529137874|FG000|Overall Study|Withdrawal by Subject|187|||
146718130|NCT00377676|529137875|FG001|Overall Study|Withdrawal by Subject|72|||
146718131|NCT00377676|529137874|FG000|Overall Study|Lost to Follow-up|120|||
146718132|NCT00377676|529137875|FG001|Overall Study|Lost to Follow-up|56|||
146718133|NCT00377676|529137874|FG000|Overall Study|Other|118|||
146718134|NCT00377676|529137875|FG001|Overall Study|Other|58|||
146718135|NCT05046795|529137886|FG000|Overall Study|Adverse Event|13|||
146718136|NCT05046795|529137887|FG001|Overall Study|Adverse Event|15|||
146718137|NCT05046795|529137886|FG000|Overall Study|Withdrawal by Subject|4|||
146718138|NCT05046795|529137887|FG001|Overall Study|Withdrawal by Subject|7|||
146718139|NCT05046795|529137886|FG000|Overall Study|Physician Decision|1|||
146718140|NCT05046795|529137887|FG001|Overall Study|Physician Decision|2|||
146718141|NCT05046795|529137886|FG000|Overall Study|Protocol Violation|1|||
146718142|NCT05046795|529137887|FG001|Overall Study|Protocol Violation|2|||
146718143|NCT05046795|529137886|FG000|Overall Study|Death|1|||
146718144|NCT05046795|529137887|FG001|Overall Study|Death|0|||
146718145|NCT05046795|529137886|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
146718146|NCT05046795|529137887|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
146718147|NCT01127178|529137888|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
146718148|NCT01127178|529137889|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
146718149|NCT01127178|529137888|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
146718150|NCT01127178|529137889|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
146718151|NCT01127178|529137888|FG000|Dose Escalation: Treatment Phase|Other|2|||
146718152|NCT01127178|529137889|FG001|Dose Escalation: Treatment Phase|Other|0|||
146718153|NCT01127178|529137888|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
146718154|NCT01127178|529137889|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
146718155|NCT01127178|529137888|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
146718156|NCT01127178|529137889|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
146718157|NCT01127178|529137888|FG000|Dose Escalation: Extension Phase|Other|1|||
146718158|NCT01127178|529137889|FG001|Dose Escalation: Extension Phase|Other|0|||
146718159|NCT05348681|529137890|FG000|Overall Study|Study terminated by Sponsor|8|||
146718160|NCT05348681|529137891|FG001|Overall Study|Study terminated by Sponsor|3|||
146718161|NCT05348681|529137890|FG000|Overall Study|Withdrawal by Subject|1|||
146718162|NCT05348681|529137891|FG001|Overall Study|Withdrawal by Subject|1|||
146718163|NCT05348681|529137890|FG000|Overall Study|Lost to Follow-up|1|||
146718164|NCT05348681|529137891|FG001|Overall Study|Lost to Follow-up|1|||
146718165|NCT05348681|529137890|FG000|Overall Study|Adverse Event|1|||
146718166|NCT05348681|529137891|FG001|Overall Study|Adverse Event|0|||
146718167|NCT05348681|529137890|FG000|Overall Study|Other|2|||
146718168|NCT05348681|529137891|FG001|Overall Study|Other|1|||
146718169|NCT03646513|529137895|FG000|Overall Study|Premature study termination|4|||
146718170|NCT00782340|529137896|FG000|Open Label Titration|Adverse Event|12|||
146718171|NCT00782340|529137897|FG001|Open Label Titration|Adverse Event|0|||
146718172|NCT00782340|529137898|FG002|Open Label Titration|Adverse Event|0|||
146718173|NCT00782340|529137896|FG000|Open Label Titration|Treatment failure|50|||
146718174|NCT00782340|529137897|FG001|Open Label Titration|Treatment failure|0|||
146718175|NCT00782340|529137898|FG002|Open Label Titration|Treatment failure|0|||
146781321|NCT00676715|529370107|FG001|Treatment Period (TP)|Death|0|||
146981298|NCT01427803|530093840|FG001|Overall Study|did not take product|0|||
146718176|NCT00782340|529137896|FG000|Open Label Titration|Protocol Violation|5|||
146718177|NCT00782340|529137897|FG001|Open Label Titration|Protocol Violation|0|||
146718178|NCT00782340|529137898|FG002|Open Label Titration|Protocol Violation|0|||
146718179|NCT00782340|529137896|FG000|Open Label Titration|Withdrawal by Subject|5|||
146718180|NCT00782340|529137897|FG001|Open Label Titration|Withdrawal by Subject|0|||
146718181|NCT00782340|529137898|FG002|Open Label Titration|Withdrawal by Subject|0|||
146718182|NCT00782340|529137896|FG000|Open Label Titration|Enrollment capped|16|||
146718183|NCT00782340|529137897|FG001|Open Label Titration|Enrollment capped|0|||
146718184|NCT00782340|529137898|FG002|Open Label Titration|Enrollment capped|0|||
146718185|NCT00782340|529137896|FG000|Open Label Titration|Did not meet responder criteria|2|||
146718186|NCT00782340|529137897|FG001|Open Label Titration|Did not meet responder criteria|0|||
146718187|NCT00782340|529137898|FG002|Open Label Titration|Did not meet responder criteria|0|||
146718188|NCT00782340|529137896|FG000|Open Label Titration|Lost to Follow-up|5|||
146718189|NCT00782340|529137897|FG001|Open Label Titration|Lost to Follow-up|0|||
146718190|NCT00782340|529137898|FG002|Open Label Titration|Lost to Follow-up|0|||
146718191|NCT00782340|529137896|FG000|Open Label Titration|Randomized in error|6|||
146718192|NCT00782340|529137897|FG001|Open Label Titration|Randomized in error|0|||
146718193|NCT00782340|529137898|FG002|Open Label Titration|Randomized in error|0|||
146718194|NCT00093145|529137904|FG000|Overall Study|Unacceptable Toxicity Only|2|||
146718195|NCT00093145|529137904|FG000|Overall Study|Physician Decision|5|||
146718196|NCT00093145|529137904|FG000|Overall Study|Withdrawal by Subject|9|||
146718197|NCT00093145|529137904|FG000|Overall Study|Other|1|||
146718198|NCT00553267|529137905|FG000|Overall Study|Adverse Event|8|||
146718199|NCT00553267|529137906|FG001|Overall Study|Adverse Event|10|||
146718200|NCT00553267|529137907|FG002|Overall Study|Adverse Event|5|||
146718201|NCT00553267|529137905|FG000|Overall Study|Non compliant with protocol|3|||
146718202|NCT00553267|529137906|FG001|Overall Study|Non compliant with protocol|3|||
146718203|NCT00553267|529137907|FG002|Overall Study|Non compliant with protocol|2|||
146718204|NCT00553267|529137905|FG000|Overall Study|Lost to Follow-up|0|||
146718205|NCT00553267|529137906|FG001|Overall Study|Lost to Follow-up|0|||
146718206|NCT00553267|529137907|FG002|Overall Study|Lost to Follow-up|1|||
146718207|NCT00553267|529137905|FG000|Overall Study|Consent withdrawn|2|||
146718208|NCT00553267|529137906|FG001|Overall Study|Consent withdrawn|3|||
146718209|NCT00553267|529137907|FG002|Overall Study|Consent withdrawn|1|||
146718210|NCT00553267|529137905|FG000|Overall Study|Specified category|1|||
146718211|NCT00553267|529137906|FG001|Overall Study|Specified category|2|||
146718212|NCT00553267|529137907|FG002|Overall Study|Specified category|1|||
146718213|NCT01310036|529137908|FG000|Overall Study|Administrative/other|10|||
146718214|NCT01310036|529137908|FG000|Overall Study|Withdrew Consent|11|||
146718215|NCT01310036|529137908|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
146718216|NCT01310036|529137908|FG000|Overall Study|Progression of Disease|164|||
146718217|NCT01310036|529137908|FG000|Overall Study|Death|1|||
146718218|NCT01310036|529137908|FG000|Overall Study|Adverse event or intercurrent illness|12|||
146718219|NCT04389840|529137909|FG000|Overall Study|Adverse Event|0|||
146718220|NCT04389840|529137910|FG001|Overall Study|Adverse Event|0|||
146718221|NCT04389840|529137911|FG002|Overall Study|Adverse Event|0|||
146718222|NCT04389840|529137912|FG003|Overall Study|Adverse Event|1|||
146718223|NCT04389840|529137913|FG004|Overall Study|Adverse Event|0|||
146718224|NCT04389840|529137914|FG005|Overall Study|Adverse Event|0|||
146718225|NCT04389840|529137909|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
146718226|NCT04389840|529137910|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
146718227|NCT04389840|529137911|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
146718228|NCT04389840|529137912|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
146718229|NCT04389840|529137913|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
146718230|NCT04389840|529137914|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
146718231|NCT04389840|529137909|FG000|Overall Study|Death|0|||
146718232|NCT04389840|529137910|FG001|Overall Study|Death|1|||
146718233|NCT04389840|529137911|FG002|Overall Study|Death|0|||
146718234|NCT04389840|529137912|FG003|Overall Study|Death|0|||
146718235|NCT04389840|529137913|FG004|Overall Study|Death|0|||
146718236|NCT04389840|529137914|FG005|Overall Study|Death|0|||
146718237|NCT02365467|529137920|FG000|Overall Study|Death|3|||
146718238|NCT02043782|529137921|FG000|Period 1|Adverse Event|0|||
146718239|NCT02043782|529137922|FG001|Period 1|Adverse Event|0|||
146718240|NCT02043782|529137923|FG002|Period 1|Adverse Event|1|||
146718241|NCT02043782|529137924|FG003|Period 1|Adverse Event|0|||
146718242|NCT02043782|529137925|FG004|Period 1|Adverse Event|0|||
146718243|NCT02043782|529137926|FG005|Period 1|Adverse Event|0|||
146718244|NCT00709722|529137927|FG000|Overall Study|Adverse Event|1|||
146718245|NCT04667117|529137928|FG000|Investigational Period|Lost to Follow-up|0|||
146718246|NCT04667117|529137929|FG001|Investigational Period|Lost to Follow-up|0|||
146718247|NCT04667117|529137930|FG002|Investigational Period|Lost to Follow-up|1|||
146718248|NCT04667117|529137928|FG000|Investigational Period|Protocol Deviation|0|||
146718249|NCT04667117|529137929|FG001|Investigational Period|Protocol Deviation|1|||
146718250|NCT04667117|529137930|FG002|Investigational Period|Protocol Deviation|0|||
146718251|NCT04667117|529137928|FG000|Extension Period|Lost to Follow-up|1|||
146718252|NCT04667117|529137929|FG001|Extension Period|Lost to Follow-up|0|||
146718253|NCT04667117|529137930|FG002|Extension Period|Lost to Follow-up|0|||
146718254|NCT03359096|529137931|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
146718255|NCT03359096|529137932|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
146718256|NCT03359096|529137931|FG000|First Intervention (4 Weeks)|Death|1|||
146718257|NCT03359096|529137932|FG001|First Intervention (4 Weeks)|Death|0|||
146718258|NCT03359096|529137931|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
146718259|NCT03359096|529137932|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
146718260|NCT01306162|529137933|FG000|Period 1|Adverse Event|0|||
146718261|NCT01306162|529137934|FG001|Period 1|Adverse Event|0|||
146718262|NCT01306162|529137935|FG002|Period 1|Adverse Event|0|||
146781322|NCT00676715|529370108|FG002|Treatment Period (TP)|Death|1|||
146718263|NCT01306162|529137936|FG003|Period 1|Adverse Event|1|||
146718264|NCT01306162|529137933|FG000|Washout 1|Non-compliance to protocol|0|||
146718265|NCT01306162|529137934|FG001|Washout 1|Non-compliance to protocol|1|||
146718266|NCT01306162|529137935|FG002|Washout 1|Non-compliance to protocol|0|||
146718267|NCT01306162|529137936|FG003|Washout 1|Non-compliance to protocol|0|||
146718268|NCT00833989|529137940|FG000|Overall Study|Physician Decision|0|||
146718269|NCT00833989|529137941|FG001|Overall Study|Physician Decision|0|||
146718270|NCT00833989|529137942|FG002|Overall Study|Physician Decision|0|||
146718271|NCT00833989|529137943|FG003|Overall Study|Physician Decision|1|||
146718272|NCT00833989|529137940|FG000|Overall Study|Withdrawal by Subject|3|||
146718273|NCT00833989|529137941|FG001|Overall Study|Withdrawal by Subject|0|||
146718274|NCT00833989|529137942|FG002|Overall Study|Withdrawal by Subject|1|||
146718275|NCT00833989|529137943|FG003|Overall Study|Withdrawal by Subject|1|||
146718276|NCT02952924|529137944|FG000|Overall Study|Protocol Violation|0|||
146718277|NCT02952924|529137945|FG001|Overall Study|Protocol Violation|0|||
146718278|NCT02952924|529137946|FG002|Overall Study|Protocol Violation|0|||
146718279|NCT02952924|529137947|FG003|Overall Study|Protocol Violation|0|||
146718280|NCT02952924|529137948|FG004|Overall Study|Protocol Violation|0|||
146718281|NCT02952924|529137949|FG005|Overall Study|Protocol Violation|0|||
146718282|NCT02952924|529137950|FG006|Overall Study|Protocol Violation|0|||
146718283|NCT02952924|529137951|FG007|Overall Study|Protocol Violation|0|||
146718284|NCT02952924|529137952|FG008|Overall Study|Protocol Violation|0|||
146718285|NCT02952924|529137953|FG009|Overall Study|Protocol Violation|0|||
146718286|NCT02952924|529137954|FG010|Overall Study|Protocol Violation|0|||
146718287|NCT02952924|529137955|FG011|Overall Study|Protocol Violation|0|||
146718288|NCT02952924|529137956|FG012|Overall Study|Protocol Violation|0|||
146718289|NCT02952924|529137957|FG013|Overall Study|Protocol Violation|0|||
146718290|NCT02952924|529137958|FG014|Overall Study|Protocol Violation|0|||
146718291|NCT02952924|529137959|FG015|Overall Study|Protocol Violation|0|||
146718292|NCT02952924|529137960|FG016|Overall Study|Protocol Violation|0|||
146718293|NCT02952924|529137961|FG017|Overall Study|Protocol Violation|0|||
146718294|NCT02952924|529137962|FG018|Overall Study|Protocol Violation|0|||
146718295|NCT02952924|529137963|FG019|Overall Study|Protocol Violation|1|||
146718296|NCT02952924|529137964|FG020|Overall Study|Protocol Violation|0|||
146718297|NCT02952924|529137965|FG021|Overall Study|Protocol Violation|0|||
146718298|NCT02952924|529137944|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
146718299|NCT02952924|529137945|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
146718300|NCT02952924|529137946|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
146718301|NCT02952924|529137947|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
146718302|NCT02952924|529137948|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
146718303|NCT02952924|529137949|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
146718304|NCT02952924|529137950|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
146718305|NCT02952924|529137951|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
146718306|NCT02952924|529137952|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
146718307|NCT02952924|529137953|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
146718308|NCT02952924|529137954|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
146718309|NCT02952924|529137955|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
146718310|NCT02952924|529137956|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
146718311|NCT02952924|529137957|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
146718312|NCT02952924|529137958|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
146718313|NCT02952924|529137959|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
146718314|NCT02952924|529137960|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
146718315|NCT02952924|529137961|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
146718316|NCT02952924|529137962|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
146718317|NCT02952924|529137963|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
146718318|NCT02952924|529137964|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
146718319|NCT02952924|529137965|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
146718320|NCT02952924|529137944|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718321|NCT02952924|529137945|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718322|NCT02952924|529137946|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718323|NCT02952924|529137947|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718324|NCT02952924|529137948|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718325|NCT02952924|529137949|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718326|NCT02952924|529137950|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718327|NCT02952924|529137951|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718328|NCT02952924|529137952|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718329|NCT02952924|529137953|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
146981299|NCT00863057|530093843|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
146718330|NCT02952924|529137954|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
146736415|NCT02343003|529206836|FG000|Overall Study|terminated by sponsor|2|||
146736416|NCT02343003|529206837|FG001|Overall Study|terminated by sponsor|0|||
146718331|NCT02952924|529137955|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718332|NCT02952924|529137956|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718333|NCT02952924|529137957|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718334|NCT02952924|529137958|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718335|NCT02952924|529137959|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718336|NCT02952924|529137960|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718337|NCT02952924|529137961|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718338|NCT02952924|529137962|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718339|NCT02952924|529137963|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718340|NCT02952924|529137964|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
146718341|NCT02952924|529137965|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
146718342|NCT02952924|529137944|FG000|Overall Study|Noncompliance with study drug|0|||
146718343|NCT02952924|529137945|FG001|Overall Study|Noncompliance with study drug|0|||
146718344|NCT02952924|529137946|FG002|Overall Study|Noncompliance with study drug|0|||
146718345|NCT02952924|529137947|FG003|Overall Study|Noncompliance with study drug|0|||
146718346|NCT02952924|529137948|FG004|Overall Study|Noncompliance with study drug|0|||
146718347|NCT02952924|529137949|FG005|Overall Study|Noncompliance with study drug|0|||
146718348|NCT02952924|529137950|FG006|Overall Study|Noncompliance with study drug|0|||
146718349|NCT02952924|529137951|FG007|Overall Study|Noncompliance with study drug|0|||
146718350|NCT02952924|529137952|FG008|Overall Study|Noncompliance with study drug|0|||
146718351|NCT02952924|529137953|FG009|Overall Study|Noncompliance with study drug|0|||
146718352|NCT02952924|529137954|FG010|Overall Study|Noncompliance with study drug|0|||
146718353|NCT02952924|529137955|FG011|Overall Study|Noncompliance with study drug|0|||
146718354|NCT02952924|529137956|FG012|Overall Study|Noncompliance with study drug|0|||
146718355|NCT02952924|529137957|FG013|Overall Study|Noncompliance with study drug|0|||
146718356|NCT02952924|529137958|FG014|Overall Study|Noncompliance with study drug|0|||
146718357|NCT02952924|529137959|FG015|Overall Study|Noncompliance with study drug|0|||
146718358|NCT02952924|529137960|FG016|Overall Study|Noncompliance with study drug|0|||
146718359|NCT02952924|529137961|FG017|Overall Study|Noncompliance with study drug|0|||
146718360|NCT02952924|529137962|FG018|Overall Study|Noncompliance with study drug|0|||
146718361|NCT02952924|529137963|FG019|Overall Study|Noncompliance with study drug|0|||
146718362|NCT02952924|529137964|FG020|Overall Study|Noncompliance with study drug|0|||
146718363|NCT02952924|529137965|FG021|Overall Study|Noncompliance with study drug|1|||
146718364|NCT01660763|529137967|FG000|Overall Study|Lack of Efficacy|45|||
146718365|NCT01660763|529137968|FG001|Overall Study|Lack of Efficacy|50|||
146718366|NCT01660763|529137967|FG000|Overall Study|Adverse Event|22|||
146718367|NCT01660763|529137968|FG001|Overall Study|Adverse Event|7|||
146718368|NCT01660763|529137967|FG000|Overall Study|Protocol Violation|1|||
146718369|NCT01660763|529137968|FG001|Overall Study|Protocol Violation|0|||
146718370|NCT01660763|529137967|FG000|Overall Study|Withdrawal by Subject|4|||
146718371|NCT01660763|529137968|FG001|Overall Study|Withdrawal by Subject|0|||
146718372|NCT01660763|529137967|FG000|Overall Study|Patient ready for early discharge|28|||
146718373|NCT01660763|529137968|FG001|Overall Study|Patient ready for early discharge|4|||
146718374|NCT01910519|529137969|FG000|Overall Study|Withdrawal by Subject|2|||
146718375|NCT01910519|529137970|FG001|Overall Study|Withdrawal by Subject|0|||
146718376|NCT01910519|529137969|FG000|Overall Study|Adverse Event|2|||
146718377|NCT01910519|529137970|FG001|Overall Study|Adverse Event|0|||
146718378|NCT04266028|529137971|FG000|Overall Study|Adverse Event|0|||
146718379|NCT04266028|529137972|FG001|Overall Study|Adverse Event|0|||
146718380|NCT04266028|529137973|FG002|Overall Study|Adverse Event|1|||
146718381|NCT04266028|529137974|FG003|Overall Study|Adverse Event|0|||
146718382|NCT04266028|529137975|FG004|Overall Study|Adverse Event|1|||
146718383|NCT04266028|529137976|FG005|Overall Study|Adverse Event|0|||
146718384|NCT04266028|529137977|FG006|Overall Study|Adverse Event|2|||
146718385|NCT04266028|529137978|FG007|Overall Study|Adverse Event|0|||
146718386|NCT04266028|529137971|FG000|Overall Study|temporary halt of the study|0|||
146718387|NCT04266028|529137972|FG001|Overall Study|temporary halt of the study|0|||
146718388|NCT04266028|529137973|FG002|Overall Study|temporary halt of the study|0|||
146718389|NCT04266028|529137974|FG003|Overall Study|temporary halt of the study|0|||
146718390|NCT04266028|529137975|FG004|Overall Study|temporary halt of the study|0|||
146718391|NCT04266028|529137976|FG005|Overall Study|temporary halt of the study|0|||
146781323|NCT00676715|529370109|FG003|Treatment Period (TP)|Death|0|||
146781324|NCT00676715|529370106|FG000|Treatment Period (TP)|Failure to return|1|||
146781325|NCT00676715|529370107|FG001|Treatment Period (TP)|Failure to return|0|||
146718392|NCT04266028|529137977|FG006|Overall Study|temporary halt of the study|2|||
146718393|NCT04266028|529137978|FG007|Overall Study|temporary halt of the study|1|||
146781326|NCT00676715|529370108|FG002|Treatment Period (TP)|Failure to return|0|||
146781327|NCT00676715|529370109|FG003|Treatment Period (TP)|Failure to return|0|||
146718394|NCT04266028|529137971|FG000|Overall Study|Onset of birch pollen season|0|||
146781328|NCT00676715|529370106|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
146934133|NCT01617187|529916095|FG003|Treatment Through Study Completion|Protocol Violation|1|||
146718395|NCT04266028|529137972|FG001|Overall Study|Onset of birch pollen season|0|||
146718396|NCT04266028|529137973|FG002|Overall Study|Onset of birch pollen season|0|||
146718397|NCT04266028|529137974|FG003|Overall Study|Onset of birch pollen season|0|||
146718398|NCT04266028|529137975|FG004|Overall Study|Onset of birch pollen season|1|||
146718399|NCT04266028|529137976|FG005|Overall Study|Onset of birch pollen season|0|||
146718400|NCT04266028|529137977|FG006|Overall Study|Onset of birch pollen season|0|||
146718401|NCT04266028|529137978|FG007|Overall Study|Onset of birch pollen season|0|||
146718402|NCT00380068|529137980|FG000|Overall Study|Adverse Event|40|||
146718403|NCT00380068|529137980|FG000|Overall Study|Withdrawal by Subject|10|||
146718404|NCT00380068|529137980|FG000|Overall Study|Not compliant|6|||
146718405|NCT00380068|529137980|FG000|Overall Study|Lost to Follow-up|1|||
146718406|NCT00380068|529137980|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
146718407|NCT00380068|529137980|FG000|Overall Study|Lung transplant|3|||
146718408|NCT00380068|529137980|FG000|Overall Study|Physician Decision|2|||
146718409|NCT00380068|529137980|FG000|Overall Study|Partipant moved away|1|||
146718410|NCT00380068|529137980|FG000|Overall Study|Lack of Efficacy|5|||
146718411|NCT01458574|529137981|FG000|Overall Study|Adverse Event|5|||
146718412|NCT01458574|529137982|FG001|Overall Study|Adverse Event|9|||
146718413|NCT01458574|529137983|FG002|Overall Study|Adverse Event|7|||
146718414|NCT01458574|529137981|FG000|Overall Study|Lack of Efficacy|70|||
146718415|NCT01458574|529137982|FG001|Overall Study|Lack of Efficacy|53|||
146718416|NCT01458574|529137983|FG002|Overall Study|Lack of Efficacy|132|||
146718417|NCT01458574|529137981|FG000|Overall Study|Lost to Follow-up|3|||
146718418|NCT01458574|529137982|FG001|Overall Study|Lost to Follow-up|2|||
146718419|NCT01458574|529137983|FG002|Overall Study|Lost to Follow-up|1|||
146718420|NCT01458574|529137981|FG000|Overall Study|Pregnancy|1|||
146718421|NCT01458574|529137982|FG001|Overall Study|Pregnancy|1|||
146718422|NCT01458574|529137983|FG002|Overall Study|Pregnancy|0|||
146718423|NCT01458574|529137981|FG000|Overall Study|Protocol Violation|0|||
146718424|NCT01458574|529137982|FG001|Overall Study|Protocol Violation|1|||
146718425|NCT01458574|529137983|FG002|Overall Study|Protocol Violation|0|||
146718426|NCT01458574|529137981|FG000|Overall Study|Withdrawal by Subject|6|||
146718427|NCT01458574|529137982|FG001|Overall Study|Withdrawal by Subject|3|||
146718428|NCT01458574|529137983|FG002|Overall Study|Withdrawal by Subject|5|||
146718429|NCT01458574|529137981|FG000|Overall Study|Other|2|||
146718430|NCT01458574|529137982|FG001|Overall Study|Other|1|||
146718431|NCT01458574|529137983|FG002|Overall Study|Other|0|||
146718432|NCT01458574|529137981|FG000|Overall Study|Randomized but not treated|0|||
146718433|NCT01458574|529137982|FG001|Overall Study|Randomized but not treated|1|||
146718434|NCT01458574|529137983|FG002|Overall Study|Randomized but not treated|0|||
146718435|NCT02125786|529137984|FG000|Overall Study|Still in Follow-up|3|||
146718436|NCT02125786|529137984|FG000|Overall Study|Screen Failure|2|||
146718437|NCT02125786|529137984|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
146718438|NCT02125786|529137984|FG000|Overall Study|Progressive Disease|44|||
146718439|NCT02125786|529137984|FG000|Overall Study|Death|8|||
146718440|NCT04964089|529137987|FG000|Overall Study|Adverse Event|8|||
146718441|NCT04964089|529137988|FG001|Overall Study|Adverse Event|6|||
146718442|NCT04964089|529137987|FG000|Overall Study|Non-compliance with study schedule|1|||
146718443|NCT04964089|529137988|FG001|Overall Study|Non-compliance with study schedule|0|||
146718444|NCT04964089|529137987|FG000|Overall Study|Withdrawal by Subject|6|||
146718445|NCT04964089|529137988|FG001|Overall Study|Withdrawal by Subject|5|||
146718446|NCT04964089|529137987|FG000|Overall Study|Lost to Follow-up|1|||
146718447|NCT04964089|529137988|FG001|Overall Study|Lost to Follow-up|1|||
146718448|NCT04964089|529137987|FG000|Overall Study|Progressive disease|4|||
146718449|NCT04964089|529137988|FG001|Overall Study|Progressive disease|0|||
146718450|NCT04964089|529137987|FG000|Overall Study|Physician Decision|1|||
146718451|NCT04964089|529137988|FG001|Overall Study|Physician Decision|0|||
146718452|NCT04964089|529137987|FG000|Overall Study|Participant did not want to continue study treatment|1|||
146718453|NCT04964089|529137988|FG001|Overall Study|Participant did not want to continue study treatment|0|||
146718454|NCT04964089|529137987|FG000|Overall Study|Participant moved to different state|1|||
146718455|NCT04964089|529137988|FG001|Overall Study|Participant moved to different state|0|||
146718456|NCT04964089|529137987|FG000|Overall Study|Participant decided to discontinue|0|||
146718457|NCT04964089|529137988|FG001|Overall Study|Participant decided to discontinue|1|||
146718458|NCT03588572|529137991|FG000|Visitation 1|Lack of Efficacy|1|||
146718459|NCT03588572|529137992|FG001|Visitation 1|Lack of Efficacy|1|||
146718460|NCT03588572|529137991|FG000|Visitation 2|Lost to Follow-up|1|||
146718461|NCT03588572|529137992|FG001|Visitation 2|Lost to Follow-up|1|||
146718462|NCT03588572|529137991|FG000|Visitation 2|Lack of Efficacy|0|||
146718463|NCT03588572|529137992|FG001|Visitation 2|Lack of Efficacy|1|||
146718464|NCT03588572|529137991|FG000|Visitation 2|Withdrawal by Subject|1|||
146718465|NCT03588572|529137992|FG001|Visitation 2|Withdrawal by Subject|0|||
146718466|NCT03588572|529137991|FG000|Visitation 3|Lost to Follow-up|1|||
146718467|NCT03588572|529137992|FG001|Visitation 3|Lost to Follow-up|1|||
146718468|NCT03588572|529137991|FG000|Visitation 3|Physician Decision|1|||
146718469|NCT03588572|529137992|FG001|Visitation 3|Physician Decision|1|||
146718470|NCT03588572|529137991|FG000|Visitation 3|Withdrawal by Subject|1|||
146718471|NCT03588572|529137992|FG001|Visitation 3|Withdrawal by Subject|0|||
146718472|NCT02663817|529137993|FG000|Overall Study|Screen failure|2|||
146718473|NCT01585103|529140261|FG000|Overall Study|Unable to swallow Cytosponge|6|||
146718474|NCT01349569|529140262|FG000|Overall Study|Lack of Efficacy|4|||
146718475|NCT03581305|529140263|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
146718476|NCT03581305|529140264|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
146718477|NCT03581305|529140263|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
146718478|NCT03581305|529140264|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
146718479|NCT03581305|529140263|FG000|Serotonergic Study|Withdrawal by Subject|5|||
146718480|NCT03581305|529140264|FG001|Serotonergic Study|Withdrawal by Subject|1|||
146718481|NCT01798927|529140265|FG000|Overall Study|Withdrawal by Subject|1|||
146718482|NCT00626522|529140266|FG000|Overall Study|Protocol Violation|0|||
146718483|NCT00626522|529140267|FG001|Overall Study|Protocol Violation|0|||
146718484|NCT00626522|529140268|FG002|Overall Study|Protocol Violation|0|||
146718485|NCT00626522|529140269|FG003|Overall Study|Protocol Violation|0|||
146718486|NCT00626522|529140270|FG004|Overall Study|Protocol Violation|1|||
146718487|NCT00626522|529140271|FG005|Overall Study|Protocol Violation|0|||
146718488|NCT00626522|529140266|FG000|Overall Study|Adverse Event|2|||
146718489|NCT00626522|529140267|FG001|Overall Study|Adverse Event|1|||
146718490|NCT00626522|529140268|FG002|Overall Study|Adverse Event|2|||
146718491|NCT00626522|529140269|FG003|Overall Study|Adverse Event|0|||
146718492|NCT00626522|529140270|FG004|Overall Study|Adverse Event|1|||
146718493|NCT00626522|529140271|FG005|Overall Study|Adverse Event|1|||
146718494|NCT00626522|529140266|FG000|Overall Study|Withdrawal by Subject|2|||
146718495|NCT00626522|529140267|FG001|Overall Study|Withdrawal by Subject|5|||
146718496|NCT00626522|529140268|FG002|Overall Study|Withdrawal by Subject|5|||
146718497|NCT00626522|529140269|FG003|Overall Study|Withdrawal by Subject|0|||
146718498|NCT00626522|529140270|FG004|Overall Study|Withdrawal by Subject|4|||
146718499|NCT00626522|529140271|FG005|Overall Study|Withdrawal by Subject|1|||
146718500|NCT00626522|529140266|FG000|Overall Study|COPD exacerbation|0|||
146718501|NCT00626522|529140267|FG001|Overall Study|COPD exacerbation|0|||
146718502|NCT00626522|529140268|FG002|Overall Study|COPD exacerbation|0|||
146718503|NCT00626522|529140269|FG003|Overall Study|COPD exacerbation|1|||
146718504|NCT00626522|529140270|FG004|Overall Study|COPD exacerbation|1|||
146718505|NCT00626522|529140271|FG005|Overall Study|COPD exacerbation|0|||
146718506|NCT00626522|529140266|FG000|Overall Study|Lost to Follow-up|0|||
146718507|NCT00626522|529140267|FG001|Overall Study|Lost to Follow-up|1|||
146718508|NCT00626522|529140268|FG002|Overall Study|Lost to Follow-up|0|||
146718509|NCT00626522|529140269|FG003|Overall Study|Lost to Follow-up|0|||
146718510|NCT00626522|529140270|FG004|Overall Study|Lost to Follow-up|0|||
146718511|NCT00626522|529140271|FG005|Overall Study|Lost to Follow-up|0|||
146718512|NCT00626522|529140266|FG000|Overall Study|Inconsistent reason reported|1|||
146718513|NCT00626522|529140267|FG001|Overall Study|Inconsistent reason reported|0|||
146718514|NCT00626522|529140268|FG002|Overall Study|Inconsistent reason reported|0|||
146718515|NCT00626522|529140269|FG003|Overall Study|Inconsistent reason reported|0|||
146718516|NCT00626522|529140270|FG004|Overall Study|Inconsistent reason reported|0|||
146718517|NCT00626522|529140271|FG005|Overall Study|Inconsistent reason reported|0|||
146718518|NCT00626522|529140266|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
146718519|NCT00626522|529140267|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
146718520|NCT00626522|529140268|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
146718521|NCT00626522|529140269|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
146718522|NCT00626522|529140270|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
146718523|NCT00626522|529140271|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
146934134|NCT01265420|529916096|FG000|Overall Study|Lost to Follow-up|1|||
146934135|NCT02554253|529916103|FG000|Overall Study|ineligible after enrollment|1|||
146934136|NCT02554253|529916104|FG001|Overall Study|ineligible after enrollment|0|||
146934137|NCT02554253|529916103|FG000|Overall Study|converted to transcatheter procedure|0|||
146718524|NCT03489304|529140278|FG000|Overall Study|Lost to Follow-up|4|||
146718525|NCT02239679|529140279|FG000|Overall Study|Lost to Follow-up|1|||
146934138|NCT02554253|529916104|FG001|Overall Study|converted to transcatheter procedure|1|||
146718526|NCT02239679|529140280|FG001|Overall Study|Lost to Follow-up|0|||
146718527|NCT02239679|529140281|FG002|Overall Study|Lost to Follow-up|0|||
146718528|NCT02239679|529140279|FG000|Overall Study|Withdrawal by Subject|2|||
146934139|NCT02554253|529916103|FG000|Overall Study|received both drugs|0|||
146981300|NCT00863057|530093844|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
146718529|NCT02239679|529140280|FG001|Overall Study|Withdrawal by Subject|3|||
146718530|NCT02239679|529140281|FG002|Overall Study|Withdrawal by Subject|1|||
146718531|NCT02605954|529140283|FG000|Overall Study|Adverse Event|5|||
146718532|NCT02605954|529140284|FG001|Overall Study|Adverse Event|1|||
146718533|NCT02605954|529140283|FG000|Overall Study|Investigator's Discretion|1|||
146718534|NCT02605954|529140284|FG001|Overall Study|Investigator's Discretion|0|||
146718535|NCT02605954|529140283|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146718536|NCT02605954|529140284|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146934140|NCT02554253|529916104|FG001|Overall Study|received both drugs|1|||
146718537|NCT02605954|529140283|FG000|Overall Study|Withdrew Consent|2|||
146718538|NCT02605954|529140284|FG001|Overall Study|Withdrew Consent|2|||
146934141|NCT01736254|529916106|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
146718539|NCT02605954|529140283|FG000|Overall Study|Lost to Follow-up|3|||
146718540|NCT02605954|529140284|FG001|Overall Study|Lost to Follow-up|0|||
146718541|NCT02605954|529140283|FG000|Overall Study|Randomized but not treated|0|||
146718542|NCT02605954|529140284|FG001|Overall Study|Randomized but not treated|1|||
146718543|NCT02301143|529140285|FG000|Induction Period|Enrolled But Not Treated|1|||
146718544|NCT02301143|529140286|FG001|Induction Period|Enrolled But Not Treated|0|||
146718545|NCT02301143|529140285|FG000|Induction Period|Death|1|||
146718546|NCT02301143|529140286|FG001|Induction Period|Death|0|||
146718547|NCT02301143|529140285|FG000|Induction Period|Adverse Event|22|||
146718548|NCT02301143|529140286|FG001|Induction Period|Adverse Event|0|||
146718549|NCT02301143|529140285|FG000|Induction Period|Progressive Disease|8|||
146718550|NCT02301143|529140286|FG001|Induction Period|Progressive Disease|0|||
146718551|NCT02301143|529140285|FG000|Induction Period|Withdrawal by Subject|3|||
146718552|NCT02301143|529140286|FG001|Induction Period|Withdrawal by Subject|0|||
146718553|NCT02301143|529140285|FG000|Induction Period|Noncompliance with Study Drug|1|||
146718554|NCT02301143|529140286|FG001|Induction Period|Noncompliance with Study Drug|0|||
146718555|NCT02301143|529140285|FG000|Induction Period|Physician Decision|4|||
146718556|NCT02301143|529140286|FG001|Induction Period|Physician Decision|0|||
146718557|NCT02301143|529140285|FG000|Induction Period|Symptomatic Deterioration|2|||
146718558|NCT02301143|529140286|FG001|Induction Period|Symptomatic Deterioration|0|||
146718559|NCT02301143|529140285|FG000|Induction Period|Protocol Violation|2|||
146718560|NCT02301143|529140286|FG001|Induction Period|Protocol Violation|0|||
146718561|NCT02301143|529140285|FG000|Induction Period|Other|1|||
146718562|NCT02301143|529140286|FG001|Induction Period|Other|0|||
146718563|NCT02301143|529140285|FG000|Investigator's Choice|Adverse Event|0|||
146718564|NCT02301143|529140286|FG001|Investigator's Choice|Adverse Event|3|||
146718565|NCT02301143|529140285|FG000|Investigator's Choice|Progressive Disease|0|||
146718566|NCT02301143|529140286|FG001|Investigator's Choice|Progressive Disease|3|||
146718567|NCT02301143|529140285|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
146718568|NCT02301143|529140286|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
146718569|NCT02301143|529140285|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
146718570|NCT02301143|529140286|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
146718571|NCT02301143|529140285|FG000|Investigator's Choice|Other|0|||
146718572|NCT02301143|529140286|FG001|Investigator's Choice|Other|1|||
146718573|NCT02301143|529140285|FG000|Investigator's Choice|Unresectable Surgery|0|||
146718574|NCT02301143|529140286|FG001|Investigator's Choice|Unresectable Surgery|1|||
146718575|NCT03555396|529140287|FG000|Overall Study|Death|3|||
146718576|NCT03555396|529140288|FG001|Overall Study|Death|1|||
146718577|NCT03555396|529140287|FG000|Overall Study|Lost to Follow-up|0|||
146718578|NCT03555396|529140288|FG001|Overall Study|Lost to Follow-up|2|||
146718579|NCT02536508|529140289|FG000|Overall Study|Withdrawal by Subject|18|||
146718580|NCT02536508|529140290|FG001|Overall Study|Withdrawal by Subject|13|||
146718581|NCT02536508|529140291|FG002|Overall Study|Withdrawal by Subject|7|||
146718582|NCT02536508|529140289|FG000|Overall Study|Adverse Event|14|||
146718583|NCT02536508|529140290|FG001|Overall Study|Adverse Event|13|||
146718584|NCT02536508|529140291|FG002|Overall Study|Adverse Event|6|||
146718585|NCT02536508|529140289|FG000|Overall Study|Lost to Follow-up|12|||
146718586|NCT02536508|529140290|FG001|Overall Study|Lost to Follow-up|4|||
146718587|NCT02536508|529140291|FG002|Overall Study|Lost to Follow-up|0|||
146718588|NCT02536508|529140289|FG000|Overall Study|Lack of Efficacy|3|||
146718589|NCT02536508|529140290|FG001|Overall Study|Lack of Efficacy|5|||
146718590|NCT02536508|529140291|FG002|Overall Study|Lack of Efficacy|4|||
146718591|NCT02536508|529140289|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
146718592|NCT02536508|529140290|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
146718593|NCT02536508|529140291|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
146718594|NCT02536508|529140289|FG000|Overall Study|Physician Decision|0|||
146718595|NCT02536508|529140290|FG001|Overall Study|Physician Decision|4|||
146718596|NCT02536508|529140291|FG002|Overall Study|Physician Decision|2|||
146718597|NCT02536508|529140289|FG000|Overall Study|Major Protocol Deviation|2|||
146718598|NCT02536508|529140290|FG001|Overall Study|Major Protocol Deviation|2|||
146718599|NCT02536508|529140291|FG002|Overall Study|Major Protocol Deviation|2|||
146718600|NCT02536508|529140289|FG000|Overall Study|Administrative Reasons|0|||
146718601|NCT02536508|529140290|FG001|Overall Study|Administrative Reasons|1|||
146718602|NCT02536508|529140291|FG002|Overall Study|Administrative Reasons|0|||
146718603|NCT00130533|529140293|FG000|Overall Study|Withdrawal by Subject|33|||
146718604|NCT00130533|529140294|FG001|Overall Study|Withdrawal by Subject|6|||
146718605|NCT00130533|529140293|FG000|Overall Study|Adverse Event|34|||
146718606|NCT00130533|529140294|FG001|Overall Study|Adverse Event|1|||
146718607|NCT00130533|529140293|FG000|Overall Study|Disease relapse|9|||
146718608|NCT00130533|529140294|FG001|Overall Study|Disease relapse|13|||
146718609|NCT00130533|529140293|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
146718610|NCT00130533|529140294|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
146718611|NCT00130533|529140293|FG000|Overall Study|Death|4|||
146718612|NCT00130533|529140294|FG001|Overall Study|Death|2|||
146718613|NCT00130533|529140293|FG000|Overall Study|Protocol Violation|5|||
146718614|NCT00130533|529140294|FG001|Overall Study|Protocol Violation|1|||
146718615|NCT00130533|529140293|FG000|Overall Study|Lost to Follow-up|1|||
146718616|NCT00130533|529140294|FG001|Overall Study|Lost to Follow-up|1|||
146718617|NCT00130533|529140293|FG000|Overall Study|Sponsor´s decision|2|||
146718618|NCT00130533|529140294|FG001|Overall Study|Sponsor´s decision|0|||
146718619|NCT00130533|529140293|FG000|Overall Study|Second Primary Malignancy|0|||
146718620|NCT00130533|529140294|FG001|Overall Study|Second Primary Malignancy|1|||
146718621|NCT00130533|529140293|FG000|Overall Study|Other|12|||
146718622|NCT00130533|529140294|FG001|Overall Study|Other|5|||
146718623|NCT04139317|529140302|FG000|Overall Study|Adverse Event|10|||
146718624|NCT04139317|529140303|FG001|Overall Study|Adverse Event|2|||
146718625|NCT04139317|529140302|FG000|Overall Study|Death|6|||
146718626|NCT04139317|529140303|FG001|Overall Study|Death|4|||
146718627|NCT04139317|529140302|FG000|Overall Study|Lost to Follow-up|1|||
146718628|NCT04139317|529140303|FG001|Overall Study|Lost to Follow-up|0|||
146718629|NCT04139317|529140302|FG000|Overall Study|Physician Decision|3|||
146718630|NCT04139317|529140303|FG001|Overall Study|Physician Decision|1|||
146718631|NCT04139317|529140302|FG000|Overall Study|Progressive Disease|19|||
146718632|NCT04139317|529140303|FG001|Overall Study|Progressive Disease|9|||
146718633|NCT04139317|529140302|FG000|Overall Study|Subject Decision|2|||
146718634|NCT04139317|529140303|FG001|Overall Study|Subject Decision|2|||
146718635|NCT01109992|529140308|FG000|Overall Study|Withdrawal by Subject|0|||
146718636|NCT01109992|529140309|FG001|Overall Study|Withdrawal by Subject|1|||
146718637|NCT01109992|529140308|FG000|Overall Study|Movement during rest scan.|0|||
146718638|NCT01109992|529140309|FG001|Overall Study|Movement during rest scan.|1|||
146718639|NCT00690755|529140312|FG000|Overall Study|Physician Decision|2|||
146718640|NCT00690755|529140313|FG001|Overall Study|Physician Decision|0|||
146718641|NCT00690755|529140314|FG002|Overall Study|Physician Decision|46|||
146718642|NCT00690755|529140315|FG003|Overall Study|Physician Decision|5|||
146718643|NCT00690755|529140316|FG004|Overall Study|Physician Decision|0|||
146718644|NCT00690755|529140317|FG005|Overall Study|Physician Decision|4|||
146718645|NCT00690755|529140318|FG006|Overall Study|Physician Decision|0|||
146718646|NCT00214136|529140321|FG000|Overall Study|Death|5|||
146718647|NCT04287920|529140322|FG000|Overall Study|Lost to Follow-up|1|||
146718648|NCT04287920|529140323|FG001|Overall Study|Lost to Follow-up|1|||
146718649|NCT04287920|529140322|FG000|Overall Study|Withdrawal by Subject|0|||
146718650|NCT04287920|529140323|FG001|Overall Study|Withdrawal by Subject|3|||
146718651|NCT02310750|529140324|FG000|HP Period 1|Lost to Follow-up|0|||
146718652|NCT02310750|529140325|FG001|HP Period 1|Lost to Follow-up|0|||
146718653|NCT02310750|529140326|FG002|HP Period 1|Lost to Follow-up|0|||
146718654|NCT02310750|529140327|FG003|HP Period 1|Lost to Follow-up|0|||
146718655|NCT02310750|529140328|FG004|HP Period 1|Lost to Follow-up|0|||
146718656|NCT02310750|529140329|FG005|HP Period 1|Lost to Follow-up|0|||
146718657|NCT02310750|529140330|FG006|HP Period 1|Lost to Follow-up|1|||
146718658|NCT02310750|529140331|FG007|HP Period 1|Lost to Follow-up|0|||
146718659|NCT02310750|529140332|FG008|HP Period 1|Lost to Follow-up|0|||
146718660|NCT02310750|529140333|FG009|HP Period 1|Lost to Follow-up|0|||
146718661|NCT02310750|529140334|FG010|HP Period 1|Lost to Follow-up|0|||
146718662|NCT02310750|529140335|FG011|HP Period 1|Lost to Follow-up|0|||
146718663|NCT02310750|529140336|FG012|HP Period 1|Lost to Follow-up|0|||
146718664|NCT02310750|529140337|FG013|HP Period 1|Lost to Follow-up|0|||
146718665|NCT02310750|529140338|FG014|HP Period 1|Lost to Follow-up|0|||
146718666|NCT02310750|529140339|FG015|HP Period 1|Lost to Follow-up|0|||
146718667|NCT02310750|529140324|FG000|HP Period 1|Withdrawal by Subject|1|||
146718668|NCT02310750|529140325|FG001|HP Period 1|Withdrawal by Subject|0|||
146718669|NCT02310750|529140326|FG002|HP Period 1|Withdrawal by Subject|0|||
146718670|NCT02310750|529140327|FG003|HP Period 1|Withdrawal by Subject|1|||
146718671|NCT02310750|529140328|FG004|HP Period 1|Withdrawal by Subject|0|||
146718672|NCT02310750|529140329|FG005|HP Period 1|Withdrawal by Subject|0|||
146718673|NCT02310750|529140330|FG006|HP Period 1|Withdrawal by Subject|0|||
146718674|NCT02310750|529140331|FG007|HP Period 1|Withdrawal by Subject|0|||
146718675|NCT02310750|529140332|FG008|HP Period 1|Withdrawal by Subject|0|||
146718676|NCT02310750|529140333|FG009|HP Period 1|Withdrawal by Subject|0|||
146718677|NCT02310750|529140334|FG010|HP Period 1|Withdrawal by Subject|0|||
146718678|NCT02310750|529140335|FG011|HP Period 1|Withdrawal by Subject|0|||
146718679|NCT02310750|529140336|FG012|HP Period 1|Withdrawal by Subject|0|||
146718680|NCT02310750|529140337|FG013|HP Period 1|Withdrawal by Subject|0|||
146718681|NCT02310750|529140338|FG014|HP Period 1|Withdrawal by Subject|0|||
146718682|NCT02310750|529140339|FG015|HP Period 1|Withdrawal by Subject|0|||
146718683|NCT02310750|529140324|FG000|HP Washout 1|Lost to Follow-up|0|||
146718684|NCT02310750|529140325|FG001|HP Washout 1|Lost to Follow-up|0|||
146718685|NCT02310750|529140326|FG002|HP Washout 1|Lost to Follow-up|1|||
146718686|NCT02310750|529140327|FG003|HP Washout 1|Lost to Follow-up|1|||
146718687|NCT02310750|529140328|FG004|HP Washout 1|Lost to Follow-up|2|||
146718688|NCT02310750|529140329|FG005|HP Washout 1|Lost to Follow-up|2|||
146718689|NCT02310750|529140330|FG006|HP Washout 1|Lost to Follow-up|3|||
146718690|NCT02310750|529140331|FG007|HP Washout 1|Lost to Follow-up|0|||
146718691|NCT02310750|529140332|FG008|HP Washout 1|Lost to Follow-up|0|||
146718692|NCT02310750|529140333|FG009|HP Washout 1|Lost to Follow-up|0|||
146718693|NCT02310750|529140334|FG010|HP Washout 1|Lost to Follow-up|0|||
146718694|NCT02310750|529140335|FG011|HP Washout 1|Lost to Follow-up|0|||
146718695|NCT02310750|529140336|FG012|HP Washout 1|Lost to Follow-up|0|||
146718696|NCT02310750|529140337|FG013|HP Washout 1|Lost to Follow-up|0|||
146718697|NCT02310750|529140338|FG014|HP Washout 1|Lost to Follow-up|0|||
146718698|NCT02310750|529140339|FG015|HP Washout 1|Lost to Follow-up|0|||
146718699|NCT02310750|529140324|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146718700|NCT02310750|529140325|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146718701|NCT02310750|529140326|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146718702|NCT02310750|529140327|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
146718703|NCT02310750|529140328|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146718704|NCT02310750|529140329|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
146718705|NCT02310750|529140330|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146718706|NCT02310750|529140331|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146718707|NCT02310750|529140332|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
146718708|NCT02310750|529140333|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
146718709|NCT02310750|529140334|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146718710|NCT02310750|529140335|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146718711|NCT02310750|529140336|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146718712|NCT02310750|529140337|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146718713|NCT02310750|529140338|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146718714|NCT02310750|529140339|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146718715|NCT02310750|529140324|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146718716|NCT02310750|529140325|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146718717|NCT02310750|529140326|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146718718|NCT02310750|529140327|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146718719|NCT02310750|529140328|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146718720|NCT02310750|529140329|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146718721|NCT02310750|529140330|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146718722|NCT02310750|529140331|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146718723|NCT02310750|529140332|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146718724|NCT02310750|529140333|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
146718725|NCT02310750|529140334|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146718726|NCT02310750|529140335|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146718727|NCT02310750|529140336|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146718728|NCT02310750|529140337|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146718729|NCT02310750|529140338|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146718730|NCT02310750|529140339|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146718731|NCT02310750|529140324|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146718732|NCT02310750|529140325|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146718733|NCT02310750|529140326|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146718734|NCT02310750|529140327|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146718735|NCT02310750|529140328|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146718736|NCT02310750|529140329|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146718737|NCT02310750|529140330|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146718738|NCT02310750|529140331|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
146718739|NCT02310750|529140332|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
146718740|NCT02310750|529140333|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
146718741|NCT02310750|529140334|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146718742|NCT02310750|529140335|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146718743|NCT02310750|529140336|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146718744|NCT02310750|529140337|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146718745|NCT02310750|529140338|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146718746|NCT02310750|529140339|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146718747|NCT02310750|529140324|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146718748|NCT02310750|529140325|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146718749|NCT02310750|529140326|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146781329|NCT00676715|529370107|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
146781330|NCT00676715|529370108|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
146781331|NCT00676715|529370109|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
146781332|NCT00676715|529370106|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
146781333|NCT00676715|529370107|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
146781334|NCT00676715|529370108|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
146781335|NCT00676715|529370109|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
146781336|NCT00676715|529370106|FG000|Treatment Period (TP)|Withdrew consent|3|||
146781337|NCT00676715|529370107|FG001|Treatment Period (TP)|Withdrew consent|3|||
146781338|NCT00676715|529370108|FG002|Treatment Period (TP)|Withdrew consent|3|||
146981301|NCT00863057|530093845|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
146718750|NCT02310750|529140327|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146718751|NCT02310750|529140328|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146718752|NCT02310750|529140329|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146718753|NCT02310750|529140330|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146718754|NCT02310750|529140331|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
146718755|NCT02310750|529140332|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
146718756|NCT02310750|529140333|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146718757|NCT02310750|529140334|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146718758|NCT02310750|529140335|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146718759|NCT02310750|529140336|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146718760|NCT02310750|529140337|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146718761|NCT02310750|529140338|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146718762|NCT02310750|529140339|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146718763|NCT02310750|529140324|FG000|HP Washout 2|Lost to Follow-up|0|||
146718764|NCT02310750|529140325|FG001|HP Washout 2|Lost to Follow-up|0|||
146718765|NCT02310750|529140326|FG002|HP Washout 2|Lost to Follow-up|0|||
146718766|NCT02310750|529140327|FG003|HP Washout 2|Lost to Follow-up|0|||
146718767|NCT02310750|529140328|FG004|HP Washout 2|Lost to Follow-up|1|||
146718768|NCT02310750|529140329|FG005|HP Washout 2|Lost to Follow-up|0|||
146718769|NCT02310750|529140330|FG006|HP Washout 2|Lost to Follow-up|7|||
146718770|NCT02310750|529140331|FG007|HP Washout 2|Lost to Follow-up|0|||
146718771|NCT02310750|529140332|FG008|HP Washout 2|Lost to Follow-up|0|||
146718772|NCT02310750|529140333|FG009|HP Washout 2|Lost to Follow-up|0|||
146718773|NCT02310750|529140334|FG010|HP Washout 2|Lost to Follow-up|0|||
146718774|NCT02310750|529140335|FG011|HP Washout 2|Lost to Follow-up|0|||
146718775|NCT02310750|529140336|FG012|HP Washout 2|Lost to Follow-up|0|||
146718776|NCT02310750|529140337|FG013|HP Washout 2|Lost to Follow-up|0|||
146718777|NCT02310750|529140338|FG014|HP Washout 2|Lost to Follow-up|0|||
146718778|NCT02310750|529140339|FG015|HP Washout 2|Lost to Follow-up|0|||
146718779|NCT01226745|529140342|FG000|Overall Study|Did not complete schedule of assessments|8|||
146718780|NCT01226745|529140343|FG001|Overall Study|Did not complete schedule of assessments|3|||
146718781|NCT01226745|529140344|FG002|Overall Study|Did not complete schedule of assessments|6|||
146718782|NCT01226745|529140345|FG003|Overall Study|Did not complete schedule of assessments|0|||
146718783|NCT01226745|529140346|FG004|Overall Study|Did not complete schedule of assessments|0|||
146718784|NCT01226745|529140347|FG005|Overall Study|Did not complete schedule of assessments|1|||
146718785|NCT01226745|529140342|FG000|Overall Study|Lost to Follow-up|2|||
146718786|NCT01226745|529140343|FG001|Overall Study|Lost to Follow-up|6|||
146718787|NCT01226745|529140344|FG002|Overall Study|Lost to Follow-up|6|||
146718788|NCT01226745|529140345|FG003|Overall Study|Lost to Follow-up|1|||
146718789|NCT01226745|529140346|FG004|Overall Study|Lost to Follow-up|1|||
146718790|NCT01226745|529140347|FG005|Overall Study|Lost to Follow-up|2|||
146718791|NCT01226745|529140342|FG000|Overall Study|Death|1|||
146718792|NCT01226745|529140343|FG001|Overall Study|Death|0|||
146718793|NCT01226745|529140344|FG002|Overall Study|Death|0|||
146718794|NCT01226745|529140345|FG003|Overall Study|Death|0|||
146718795|NCT01226745|529140346|FG004|Overall Study|Death|0|||
146718796|NCT01226745|529140347|FG005|Overall Study|Death|1|||
146718797|NCT01226745|529140342|FG000|Overall Study|Other|6|||
146718798|NCT01226745|529140343|FG001|Overall Study|Other|7|||
146718799|NCT01226745|529140344|FG002|Overall Study|Other|8|||
146718800|NCT01226745|529140345|FG003|Overall Study|Other|4|||
146718801|NCT01226745|529140346|FG004|Overall Study|Other|3|||
146718802|NCT01226745|529140347|FG005|Overall Study|Other|1|||
146718803|NCT01435577|529140348|FG000|Overall Study|Adverse Event|10|||
146718804|NCT01435577|529140349|FG001|Overall Study|Adverse Event|0|||
146718805|NCT01435577|529140348|FG000|Overall Study|Lack of Efficacy|7|||
146934142|NCT01736254|529916106|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
146934143|NCT01561560|529916107|FG000|First Two Weeks of Wear|Time/job conflict|0|||
146718806|NCT01435577|529140349|FG001|Overall Study|Lack of Efficacy|51|||
146718807|NCT01435577|529140348|FG000|Overall Study|Alternative treatment started|0|||
146718808|NCT01435577|529140349|FG001|Overall Study|Alternative treatment started|1|||
146718809|NCT03538626|529140352|FG000|Overall Study|Withdrawal by Subject|0|||
146718810|NCT03538626|529140353|FG001|Overall Study|Withdrawal by Subject|1|||
146718811|NCT03538626|529140354|FG002|Overall Study|Withdrawal by Subject|0|||
146718812|NCT03538626|529140355|FG003|Overall Study|Withdrawal by Subject|0|||
146934144|NCT01561560|529916108|FG001|First Two Weeks of Wear|Time/job conflict|1|||
146781339|NCT00676715|529370109|FG003|Treatment Period (TP)|Withdrew consent|3|||
146718813|NCT03538626|529140356|FG004|Overall Study|Withdrawal by Subject|0|||
146718814|NCT03538626|529140357|FG005|Overall Study|Withdrawal by Subject|0|||
146781340|NCT00676715|529370106|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
146934145|NCT01561560|529916107|FG000|First Two Weeks of Wear|Adverse Event|0|||
146934146|NCT01561560|529916108|FG001|First Two Weeks of Wear|Adverse Event|1|||
146934147|NCT01561560|529916107|FG000|Second Two Weeks of Wear|Adverse Event|0|||
146718815|NCT03538626|529140358|FG006|Overall Study|Withdrawal by Subject|0|||
146718816|NCT03538626|529140359|FG007|Overall Study|Withdrawal by Subject|0|||
146718817|NCT03538626|529140352|FG000|Overall Study|Lost to Follow-up|0|||
146718818|NCT03538626|529140353|FG001|Overall Study|Lost to Follow-up|0|||
146718819|NCT03538626|529140354|FG002|Overall Study|Lost to Follow-up|0|||
146718820|NCT03538626|529140355|FG003|Overall Study|Lost to Follow-up|0|||
146718821|NCT03538626|529140356|FG004|Overall Study|Lost to Follow-up|0|||
146718822|NCT03538626|529140357|FG005|Overall Study|Lost to Follow-up|0|||
146718823|NCT03538626|529140358|FG006|Overall Study|Lost to Follow-up|1|||
146718824|NCT03538626|529140359|FG007|Overall Study|Lost to Follow-up|0|||
146718825|NCT01934218|529140360|FG000|Double-blind Phase|Adverse Event|8|||
146718826|NCT01934218|529140361|FG001|Double-blind Phase|Adverse Event|8|||
146718827|NCT01934218|529140360|FG000|Double-blind Phase|Lack of Efficacy|6|||
146718828|NCT01934218|529140361|FG001|Double-blind Phase|Lack of Efficacy|7|||
146718829|NCT01934218|529140360|FG000|Double-blind Phase|Lost to Follow-up|7|||
146718830|NCT01934218|529140361|FG001|Double-blind Phase|Lost to Follow-up|14|||
146718831|NCT01934218|529140360|FG000|Double-blind Phase|Physician Decision|1|||
146718832|NCT01934218|529140361|FG001|Double-blind Phase|Physician Decision|2|||
146718833|NCT01934218|529140360|FG000|Double-blind Phase|Protocol Violation|4|||
146718834|NCT01934218|529140361|FG001|Double-blind Phase|Protocol Violation|0|||
146718835|NCT01934218|529140360|FG000|Double-blind Phase|Withdrawal by Subject|16|||
146718836|NCT01934218|529140361|FG001|Double-blind Phase|Withdrawal by Subject|13|||
146718837|NCT01934218|529140360|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
146718838|NCT01934218|529140361|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
146718839|NCT01934218|529140360|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
146718840|NCT01934218|529140361|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
146718841|NCT01934218|529140360|FG000|Open-Label Phase|Adverse Event|2|||
146718842|NCT01934218|529140361|FG001|Open-Label Phase|Adverse Event|4|||
146718843|NCT01934218|529140360|FG000|Open-Label Phase|Lack of Efficacy|1|||
146718844|NCT01934218|529140361|FG001|Open-Label Phase|Lack of Efficacy|4|||
146718845|NCT01934218|529140360|FG000|Open-Label Phase|Lost to Follow-up|4|||
146718846|NCT01934218|529140361|FG001|Open-Label Phase|Lost to Follow-up|2|||
146718847|NCT01934218|529140360|FG000|Open-Label Phase|Physician Decision|1|||
146718848|NCT01934218|529140361|FG001|Open-Label Phase|Physician Decision|0|||
146718849|NCT01934218|529140360|FG000|Open-Label Phase|Protocol Violation|1|||
146718850|NCT01934218|529140361|FG001|Open-Label Phase|Protocol Violation|0|||
146718851|NCT01934218|529140360|FG000|Open-Label Phase|Withdrawal by Subject|13|||
146718852|NCT01934218|529140361|FG001|Open-Label Phase|Withdrawal by Subject|11|||
146718853|NCT01934218|529140360|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
146718854|NCT01934218|529140361|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
146718855|NCT01934218|529140360|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
146718856|NCT01934218|529140361|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
146718857|NCT02232893|529140367|FG000|Overall Study|Withdrawal by Subject|4|||
146718858|NCT02232893|529140368|FG001|Overall Study|Withdrawal by Subject|1|||
146718859|NCT02232893|529140367|FG000|Overall Study|Adverse Event|0|||
146718860|NCT02232893|529140368|FG001|Overall Study|Adverse Event|1|||
146718861|NCT02232893|529140367|FG000|Overall Study|Sponsor request early termination|0|||
146718862|NCT02232893|529140368|FG001|Overall Study|Sponsor request early termination|1|||
146718863|NCT02232893|529140367|FG000|Overall Study|Developed exclusion criteria|0|||
146718864|NCT02232893|529140368|FG001|Overall Study|Developed exclusion criteria|1|||
146718865|NCT02232893|529140367|FG000|Overall Study|Other|0|||
146718866|NCT02232893|529140368|FG001|Overall Study|Other|3|||
146718867|NCT02911948|529140369|FG000|Overall Study|Protocol Violation|0|||
146718868|NCT02911948|529140370|FG001|Overall Study|Protocol Violation|1|||
146718869|NCT02911948|529140369|FG000|Overall Study|Withdrawal by Subject|0|||
146718870|NCT02911948|529140370|FG001|Overall Study|Withdrawal by Subject|2|||
146718871|NCT02911948|529140369|FG000|Overall Study|Lack of Efficacy|0|||
146718872|NCT02911948|529140370|FG001|Overall Study|Lack of Efficacy|1|||
146718873|NCT02911948|529140369|FG000|Overall Study|Unclassified|0|||
146718874|NCT02911948|529140370|FG001|Overall Study|Unclassified|3|||
146718875|NCT01090453|529140373|FG000|Overall Study|Withdrawal by Subject|1|||
146718876|NCT01090453|529140374|FG001|Overall Study|Withdrawal by Subject|2|||
146718877|NCT01090453|529140373|FG000|Overall Study|Lost to Follow-up|7|||
146718878|NCT01090453|529140374|FG001|Overall Study|Lost to Follow-up|7|||
146718879|NCT01090453|529140373|FG000|Overall Study|Non serious AEs|1|||
146934148|NCT01561560|529916108|FG001|Second Two Weeks of Wear|Adverse Event|1|||
146934149|NCT03862131|529916109|FG000|Overall Study|Lost to Follow-up|1|||
146934150|NCT03862131|529916110|FG001|Overall Study|Lost to Follow-up|0|||
146934151|NCT03862131|529916111|FG002|Overall Study|Lost to Follow-up|1|||
146781341|NCT00676715|529370107|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
146718880|NCT01090453|529140374|FG001|Overall Study|Non serious AEs|0|||
146718881|NCT01090453|529140373|FG000|Overall Study|Protocol Violation|2|||
146934152|NCT03862131|529916109|FG000|Overall Study|Determined to be ineligible|0|||
146934153|NCT03862131|529916110|FG001|Overall Study|Determined to be ineligible|0|||
146934154|NCT03862131|529916111|FG002|Overall Study|Determined to be ineligible|5|||
146718882|NCT01090453|529140374|FG001|Overall Study|Protocol Violation|0|||
146718883|NCT01090453|529140373|FG000|Overall Study|Other|2|||
146718884|NCT01090453|529140374|FG001|Overall Study|Other|4|||
146718885|NCT01090453|529140373|FG000|Overall Study|Eligibility Criteria|0|||
146718886|NCT01090453|529140374|FG001|Overall Study|Eligibility Criteria|1|||
146718887|NCT00522275|529140375|FG000|Overall Study|Adverse Event|35|||
146718888|NCT00522275|529140375|FG000|Overall Study|Lack of Efficacy|80|||
146718889|NCT00522275|529140375|FG000|Overall Study|Subject withdrew consent|16|||
146718890|NCT00522275|529140375|FG000|Overall Study|Protocol deviation|1|||
146718891|NCT00522275|529140375|FG000|Overall Study|Unsatisfactory compliance|11|||
146718892|NCT00522275|529140375|FG000|Overall Study|Lost to Follow-up|8|||
146718893|NCT00522275|529140375|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
146718894|NCT00522275|529140375|FG000|Overall Study|Other: Subject is pregnant|2|||
146718895|NCT00522275|529140375|FG000|Overall Study|Other: Subject relocated|2|||
146718896|NCT00522275|529140375|FG000|Overall Study|Other: Subject arrested|1|||
146718897|NCT00522275|529140375|FG000|Overall Study|Other: Site / clinic closed|4|||
146718898|NCT00522275|529140375|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
146718899|NCT00522275|529140375|FG000|Overall Study|Other: Sponsor request|2|||
146718900|NCT00522275|529140375|FG000|Overall Study|Other: Subject ran out of medication|1|||
146718901|NCT00522275|529140375|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
146718902|NCT03867734|529140377|FG000|Overall Study|Lost to Follow-up|2|||
146718903|NCT03965052|529140378|FG000|Overall Study|Protocol Violation|1|||
146718904|NCT03965052|529140379|FG001|Overall Study|Protocol Violation|0|||
146718905|NCT04323436|529140385|FG000|Overall Study|Adverse Event|7|||
146718906|NCT04323436|529140386|FG001|Overall Study|Adverse Event|0|||
146718907|NCT04323436|529140387|FG002|Overall Study|Adverse Event|0|||
146718908|NCT04323436|529140385|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
146718909|NCT04323436|529140386|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
146718910|NCT04323436|529140387|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
146718911|NCT04323436|529140385|FG000|Overall Study|Death|1|||
146718912|NCT04323436|529140386|FG001|Overall Study|Death|0|||
146718913|NCT04323436|529140387|FG002|Overall Study|Death|0|||
146718914|NCT04323436|529140385|FG000|Overall Study|Physician Decision|2|||
146718915|NCT04323436|529140386|FG001|Overall Study|Physician Decision|0|||
146718916|NCT04323436|529140387|FG002|Overall Study|Physician Decision|0|||
146718917|NCT04323436|529140385|FG000|Overall Study|Progressive disease|10|||
146718918|NCT04323436|529140386|FG001|Overall Study|Progressive disease|0|||
146718919|NCT04323436|529140387|FG002|Overall Study|Progressive disease|0|||
146718920|NCT04323436|529140385|FG000|Overall Study|Subject decision|3|||
146718921|NCT04323436|529140386|FG001|Overall Study|Subject decision|0|||
146718922|NCT04323436|529140387|FG002|Overall Study|Subject decision|0|||
146718923|NCT01365494|529140388|FG000|Overall Study|Adverse Event|1|||
146718924|NCT01365494|529140389|FG001|Overall Study|Adverse Event|0|||
146718925|NCT01365494|529140388|FG000|Overall Study|Withdrawal by Subject|0|||
146718926|NCT01365494|529140389|FG001|Overall Study|Withdrawal by Subject|1|||
146718927|NCT01365494|529140388|FG000|Overall Study|Lost to Follow-up|1|||
146718928|NCT01365494|529140389|FG001|Overall Study|Lost to Follow-up|2|||
146718929|NCT03351049|529140390|FG000|Overall Study|Withdrawal|26|||
146718930|NCT03351049|529140391|FG001|Overall Study|Withdrawal|22|||
146718931|NCT03832192|529140394|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
146718932|NCT03832192|529140395|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
146718933|NCT02663128|529140396|FG000|Period 2|Physician Decision|0|||
146718934|NCT02663128|529140397|FG001|Period 2|Physician Decision|0|||
146718935|NCT02663128|529140398|FG002|Period 2|Physician Decision|0|||
146718936|NCT02663128|529140399|FG003|Period 2|Physician Decision|0|||
146718937|NCT02663128|529140400|FG004|Period 2|Physician Decision|1|||
146718938|NCT02663128|529140401|FG005|Period 2|Physician Decision|0|||
146718939|NCT02730819|529140413|FG000|Overall Study|Lost to Follow-up|9|||
146718940|NCT02121847|529140414|FG000|Overall Study|Administrative Reasons|1|||
146718941|NCT02121847|529140414|FG000|Overall Study|Adverse Event|2|||
146718942|NCT01410448|529140420|FG000|Overall Study|No conversion to everolimus|0|||
146718943|NCT01410448|529140421|FG001|Overall Study|No conversion to everolimus|24|||
146718944|NCT01410448|529140420|FG000|Overall Study|Graft loss|4|||
146718945|NCT01410448|529140421|FG001|Overall Study|Graft loss|1|||
146718946|NCT01410448|529140420|FG000|Overall Study|Administrative issues|2|||
146718947|NCT01410448|529140421|FG001|Overall Study|Administrative issues|1|||
146718948|NCT01410448|529140420|FG000|Overall Study|Lost to Follow-up|1|||
146718949|NCT01410448|529140421|FG001|Overall Study|Lost to Follow-up|0|||
146718950|NCT01410448|529140420|FG000|Overall Study|Withdrawal by Subject|3|||
146718951|NCT01410448|529140421|FG001|Overall Study|Withdrawal by Subject|2|||
146718952|NCT01410448|529140420|FG000|Overall Study|Protocol Violation|0|||
146718953|NCT01410448|529140421|FG001|Overall Study|Protocol Violation|4|||
146981302|NCT00863057|530093846|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
146981303|NCT00863057|530093843|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
146718954|NCT01410448|529140420|FG000|Overall Study|Death|2|||
146718955|NCT01410448|529140421|FG001|Overall Study|Death|3|||
146718956|NCT02535065|529140422|FG000|Overall Study|Death|13|||
146718957|NCT02535065|529140422|FG000|Overall Study|Lost to Follow-up|1|||
146718958|NCT02535065|529140422|FG000|Overall Study|Withdrawal by Subject|6|||
146718959|NCT00360529|529140423|FG000|Overall Study|Adverse Event|10|||
146718960|NCT00360529|529140424|FG001|Overall Study|Adverse Event|23|||
146718961|NCT00360529|529140425|FG002|Overall Study|Adverse Event|33|||
146718962|NCT00360529|529140423|FG000|Overall Study|Protocol Violation|3|||
146718963|NCT00360529|529140424|FG001|Overall Study|Protocol Violation|3|||
146981304|NCT00863057|530093844|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
146718964|NCT00360529|529140425|FG002|Overall Study|Protocol Violation|11|||
146718965|NCT00360529|529140423|FG000|Overall Study|Lost to Follow-up|14|||
146718966|NCT00360529|529140424|FG001|Overall Study|Lost to Follow-up|10|||
146718967|NCT00360529|529140425|FG002|Overall Study|Lost to Follow-up|13|||
146718968|NCT00360529|529140423|FG000|Overall Study|Withdrawal by Subject|22|||
146718969|NCT00360529|529140424|FG001|Overall Study|Withdrawal by Subject|14|||
146718970|NCT00360529|529140425|FG002|Overall Study|Withdrawal by Subject|18|||
146718971|NCT00360529|529140423|FG000|Overall Study|Lack of Efficacy|8|||
146718972|NCT00360529|529140424|FG001|Overall Study|Lack of Efficacy|6|||
146718973|NCT00360529|529140425|FG002|Overall Study|Lack of Efficacy|5|||
146718974|NCT00360529|529140423|FG000|Overall Study|Reason discontinued not explained above|4|||
146718975|NCT00360529|529140424|FG001|Overall Study|Reason discontinued not explained above|9|||
146718976|NCT00360529|529140425|FG002|Overall Study|Reason discontinued not explained above|11|||
146718977|NCT01781572|529140426|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
146718978|NCT01781572|529140427|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
146718979|NCT01781572|529140428|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
146718980|NCT01781572|529140426|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
146718981|NCT01781572|529140427|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
146718982|NCT01781572|529140428|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
146718983|NCT01781572|529140426|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
146718984|NCT01781572|529140427|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
146718985|NCT01781572|529140428|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
146718986|NCT01781572|529140426|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
146718987|NCT01781572|529140427|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
146718988|NCT01781572|529140428|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
146718989|NCT01781572|529140426|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
146718990|NCT01781572|529140427|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
146718991|NCT01781572|529140428|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
146718992|NCT01781572|529140426|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
146718993|NCT01781572|529140427|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
146718994|NCT01781572|529140428|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
146718995|NCT01781572|529140426|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
146718996|NCT01781572|529140427|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
146718997|NCT01781572|529140428|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
146718998|NCT01781572|529140426|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
146718999|NCT01781572|529140427|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
146719000|NCT01781572|529140428|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
146719001|NCT01781572|529140426|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
146719002|NCT01781572|529140427|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
146719003|NCT01781572|529140428|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
146719004|NCT01781572|529140426|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
146719005|NCT01781572|529140427|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
146719006|NCT01781572|529140428|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
146719007|NCT01781572|529140426|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
146719008|NCT01781572|529140427|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
146719009|NCT01781572|529140428|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
146719010|NCT01781572|529140426|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
146719011|NCT01781572|529140427|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
146781342|NCT00676715|529370108|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
146719012|NCT01781572|529140428|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
146719013|NCT01781572|529140426|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
146719014|NCT01781572|529140427|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
146719015|NCT01781572|529140428|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
146719016|NCT01781572|529140426|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
146719017|NCT01781572|529140427|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
146781343|NCT00676715|529370109|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
146781344|NCT00676715|529370106|FG000|Treatment Period (TP)|Administrative|0|||
146781345|NCT00676715|529370107|FG001|Treatment Period (TP)|Administrative|0|||
146781346|NCT00676715|529370108|FG002|Treatment Period (TP)|Administrative|0|||
146781347|NCT00676715|529370109|FG003|Treatment Period (TP)|Administrative|1|||
146719018|NCT01781572|529140428|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
146719019|NCT01781572|529140426|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
146719020|NCT01781572|529140427|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
146719021|NCT01781572|529140428|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
146781348|NCT00676715|529370106|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
146934155|NCT03862131|529916109|FG000|Overall Study|Death|4|||
146934156|NCT03862131|529916110|FG001|Overall Study|Death|4|||
146719022|NCT01781572|529140426|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
146934157|NCT03862131|529916111|FG002|Overall Study|Death|0|||
146934158|NCT03862131|529916109|FG000|Overall Study|Withdrawal by Subject|5|||
146934159|NCT03862131|529916110|FG001|Overall Study|Withdrawal by Subject|3|||
146934160|NCT03862131|529916111|FG002|Overall Study|Withdrawal by Subject|0|||
146781349|NCT00676715|529370107|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
146781350|NCT00676715|529370108|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
146781351|NCT00676715|529370109|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
146781352|NCT00676715|529370106|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
146781353|NCT00676715|529370107|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
146781354|NCT00676715|529370108|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
146781355|NCT00676715|529370109|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
146781356|NCT00676715|529370106|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
146781357|NCT00676715|529370107|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
146781358|NCT00676715|529370108|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
146781359|NCT00676715|529370109|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
146781360|NCT00676715|529370106|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
146781361|NCT00676715|529370107|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
146781362|NCT00676715|529370108|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
146781363|NCT00676715|529370109|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
146781364|NCT00676715|529370106|FG000|Treatment-free Period (TFP)|Death|1|||
146781365|NCT00676715|529370107|FG001|Treatment-free Period (TFP)|Death|1|||
146781366|NCT00676715|529370108|FG002|Treatment-free Period (TFP)|Death|1|||
146781367|NCT00676715|529370109|FG003|Treatment-free Period (TFP)|Death|0|||
146781368|NCT00676715|529370106|FG000|Open Label Extension (OLE)|Reason not provided|3|||
146781369|NCT00676715|529370107|FG001|Open Label Extension (OLE)|Reason not provided|4|||
146719023|NCT01781572|529140427|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
146719024|NCT01781572|529140428|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
146719025|NCT01781572|529140426|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
146719026|NCT01781572|529140427|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
146719027|NCT01781572|529140428|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
146719028|NCT01781572|529140426|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
146719029|NCT01781572|529140427|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
146719030|NCT01781572|529140428|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
146719031|NCT03156023|529140431|FG000|Overall Study|Withdrawal by Subject|1|||
146719032|NCT03156023|529140432|FG001|Overall Study|Withdrawal by Subject|0|||
146719033|NCT03156023|529140433|FG002|Overall Study|Withdrawal by Subject|2|||
146719034|NCT03156023|529140434|FG003|Overall Study|Withdrawal by Subject|1|||
146719035|NCT03156023|529140435|FG004|Overall Study|Withdrawal by Subject|1|||
146719036|NCT03156023|529140431|FG000|Overall Study|Lost to Follow-up|0|||
146719037|NCT03156023|529140432|FG001|Overall Study|Lost to Follow-up|0|||
146719038|NCT03156023|529140433|FG002|Overall Study|Lost to Follow-up|0|||
146719039|NCT03156023|529140434|FG003|Overall Study|Lost to Follow-up|0|||
146719040|NCT03156023|529140435|FG004|Overall Study|Lost to Follow-up|1|||
146719041|NCT00932893|529140436|FG000|Overall Study|Death|115|||
146719042|NCT00932893|529140437|FG001|Overall Study|Death|24|||
146719043|NCT00932893|529140436|FG000|Overall Study|Lost to Follow-up|8|||
146719044|NCT00932893|529140437|FG001|Overall Study|Lost to Follow-up|0|||
146719045|NCT00932893|529140436|FG000|Overall Study|Withdrawal by Subject|5|||
146719046|NCT00932893|529140437|FG001|Overall Study|Withdrawal by Subject|2|||
146719047|NCT00932893|529140436|FG000|Overall Study|Other|5|||
146719048|NCT00932893|529140437|FG001|Overall Study|Other|144|||
146719049|NCT02526693|529142039|FG000|Overall Study|Physician Decision|3|||
146719050|NCT02526693|529142040|FG001|Overall Study|Physician Decision|1|||
146719051|NCT00328510|529142043|FG000|Overall Study|Gag disorder, could not use frame|4|||
146719052|NCT00328510|529142044|FG001|Overall Study|Gag disorder, could not use frame|0|||
146719053|NCT00328510|529142043|FG000|Overall Study|Dentition problems, could not use frame|1|||
146719054|NCT00328510|529142044|FG001|Overall Study|Dentition problems, could not use frame|0|||
146719055|NCT00328510|529142043|FG000|Overall Study|Withdrawal by Subject|4|||
146719056|NCT00328510|529142044|FG001|Overall Study|Withdrawal by Subject|2|||
146719057|NCT00328510|529142043|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
146719058|NCT00328510|529142044|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
146719059|NCT00328510|529142043|FG000|Overall Study|Treatment changed to a single fraction|1|||
146719060|NCT00328510|529142044|FG001|Overall Study|Treatment changed to a single fraction|1|||
146719061|NCT01412944|529142046|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
146719062|NCT01412944|529142047|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
146719063|NCT01412944|529142048|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
146719064|NCT01412944|529142049|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
146719065|NCT01412944|529142050|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
146719066|NCT01412944|529142051|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
146719067|NCT01412944|529142046|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
146719068|NCT01412944|529142047|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
146781370|NCT00676715|529370108|FG002|Open Label Extension (OLE)|Reason not provided|1|||
146781371|NCT00676715|529370109|FG003|Open Label Extension (OLE)|Reason not provided|4|||
146781372|NCT00676715|529370106|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
146934161|NCT03862131|529916109|FG000|Overall Study|Physician Decision|0|||
146934162|NCT03862131|529916110|FG001|Overall Study|Physician Decision|1|||
146934163|NCT03862131|529916111|FG002|Overall Study|Physician Decision|0|||
146719069|NCT01412944|529142048|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
146719070|NCT01412944|529142049|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
146719071|NCT01412944|529142050|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
146719072|NCT01412944|529142051|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
146719073|NCT01412944|529142046|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
146719074|NCT01412944|529142047|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
146719075|NCT01412944|529142048|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
146719076|NCT01412944|529142049|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
146719077|NCT01412944|529142050|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
146719078|NCT01412944|529142051|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
146719079|NCT01412944|529142046|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
146719080|NCT01412944|529142047|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
146719081|NCT01412944|529142048|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
146719082|NCT01412944|529142049|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
146719083|NCT01412944|529142050|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
146719084|NCT01412944|529142051|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
146719085|NCT01412944|529142046|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
146719086|NCT01412944|529142047|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
146719087|NCT01412944|529142048|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
146719088|NCT01412944|529142049|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
146719089|NCT01412944|529142050|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
146719090|NCT01412944|529142051|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
146719091|NCT01412944|529142046|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
146719092|NCT01412944|529142047|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
146719093|NCT01412944|529142048|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
146719094|NCT01412944|529142049|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
146719095|NCT01412944|529142050|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
146719096|NCT01412944|529142051|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
146719097|NCT01412944|529142046|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
146719098|NCT01412944|529142047|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
146719099|NCT01412944|529142048|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
146719100|NCT01412944|529142049|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
146719101|NCT01412944|529142050|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
146719102|NCT01412944|529142051|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
146719103|NCT01412944|529142046|FG000|Entire: IV + Maintenance|Adverse Event|0|||
146719104|NCT01412944|529142047|FG001|Entire: IV + Maintenance|Adverse Event|0|||
146719105|NCT01412944|529142048|FG002|Entire: IV + Maintenance|Adverse Event|0|||
146719106|NCT01412944|529142049|FG003|Entire: IV + Maintenance|Adverse Event|0|||
146719107|NCT01412944|529142050|FG004|Entire: IV + Maintenance|Adverse Event|1|||
146719108|NCT01412944|529142051|FG005|Entire: IV + Maintenance|Adverse Event|0|||
146719109|NCT01412944|529142046|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
146719110|NCT01412944|529142047|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
146719111|NCT01412944|529142048|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
146719112|NCT01412944|529142049|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
146719113|NCT01412944|529142050|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
146719114|NCT01412944|529142051|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
146719115|NCT01412944|529142046|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
146719116|NCT01412944|529142047|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
146719117|NCT01412944|529142048|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
146719118|NCT01412944|529142049|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
146719119|NCT01412944|529142050|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
146719120|NCT01412944|529142051|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
146719121|NCT01412944|529142046|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
146719122|NCT01412944|529142047|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
146719123|NCT01412944|529142048|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
146719124|NCT01412944|529142049|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
146719125|NCT01412944|529142050|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
146719126|NCT01412944|529142051|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
146719127|NCT01412944|529142046|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
146719128|NCT01412944|529142047|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
146719129|NCT01412944|529142048|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
146719130|NCT01412944|529142049|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
146719131|NCT01412944|529142050|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
146719132|NCT01412944|529142051|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
146719133|NCT01412944|529142046|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
146719134|NCT01412944|529142047|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
146719135|NCT01412944|529142048|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
146719136|NCT01412944|529142049|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
146719137|NCT01412944|529142050|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
146719138|NCT01412944|529142051|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
146781373|NCT00676715|529370107|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
146781374|NCT00676715|529370108|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
146781375|NCT00676715|529370109|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
146781376|NCT00676715|529370106|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
146781377|NCT00676715|529370107|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
146781378|NCT00676715|529370108|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
146781379|NCT00676715|529370109|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
146781380|NCT00676715|529370106|FG000|Open Label Extension (OLE)|Adverse Event|0|||
146781381|NCT00676715|529370107|FG001|Open Label Extension (OLE)|Adverse Event|3|||
146781382|NCT00676715|529370108|FG002|Open Label Extension (OLE)|Adverse Event|1|||
146781383|NCT00676715|529370109|FG003|Open Label Extension (OLE)|Adverse Event|0|||
146781384|NCT00676715|529370106|FG000|Open Label Extension (OLE)|Death|2|||
146781385|NCT00676715|529370107|FG001|Open Label Extension (OLE)|Death|0|||
146781386|NCT00676715|529370108|FG002|Open Label Extension (OLE)|Death|2|||
146781387|NCT00676715|529370109|FG003|Open Label Extension (OLE)|Death|2|||
146781388|NCT05249439|529370110|FG000|Overall Study|Withdrawal by Subject|2|||
146781389|NCT05249439|529370111|FG001|Overall Study|Withdrawal by Subject|5|||
146781390|NCT05249439|529370110|FG000|Overall Study|Physician Decision|3|||
146781391|NCT05249439|529370111|FG001|Overall Study|Physician Decision|1|||
146781392|NCT02097420|529370112|FG000|Overall Study|Death|6|||
146781393|NCT02097420|529370112|FG000|Overall Study|Valve explanted|13|||
146781394|NCT02097420|529370112|FG000|Overall Study|Other Reason|1|||
146781395|NCT02728076|529370115|FG000|Overall Study|Physician Decision|4|||
146781396|NCT05054374|529370132|FG000|Overall Study|Withdrawal by Subject|1|||
146781397|NCT05054374|529370133|FG001|Overall Study|Withdrawal by Subject|0|||
146781398|NCT05054374|529370134|FG002|Overall Study|Withdrawal by Subject|0|||
146781399|NCT05054374|529370135|FG003|Overall Study|Withdrawal by Subject|0|||
146781400|NCT05054374|529370132|FG000|Overall Study|Progressive Disease|5|||
146781401|NCT05054374|529370133|FG001|Overall Study|Progressive Disease|0|||
146781402|NCT05054374|529370134|FG002|Overall Study|Progressive Disease|0|||
146781403|NCT05054374|529370135|FG003|Overall Study|Progressive Disease|0|||
146781404|NCT01707030|529370136|FG000|Overall Study|Death|1|||
146781405|NCT01707030|529370137|FG001|Overall Study|Death|1|||
146781406|NCT01707030|529370136|FG000|Overall Study|Withdrawal by Subject|2|||
146781407|NCT01707030|529370137|FG001|Overall Study|Withdrawal by Subject|3|||
146781408|NCT01707030|529370136|FG000|Overall Study|Lost to Follow-up|8|||
146781409|NCT01707030|529370137|FG001|Overall Study|Lost to Follow-up|13|||
146781410|NCT04820855|529370139|FG000|Overall Study|Lost to Follow-up|6|||
146781411|NCT04820855|529370140|FG001|Overall Study|Lost to Follow-up|9|||
146781412|NCT04838262|529370141|FG000|Overall Study|Withdrawal by Subject|9|||
146781413|NCT04838262|529370142|FG001|Overall Study|Withdrawal by Subject|4|||
146781414|NCT04437433|529370143|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
146781415|NCT04437433|529370144|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
146781416|NCT04437433|529370143|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
146781417|NCT04437433|529370144|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
146781418|NCT04437433|529370143|FG000|Overall Study|Adverse Event|9|||
146781419|NCT04437433|529370144|FG001|Overall Study|Adverse Event|0|||
146781420|NCT04437433|529370143|FG000|Overall Study|Lack of Efficacy|4|||
146781421|NCT04437433|529370144|FG001|Overall Study|Lack of Efficacy|0|||
146781422|NCT04437433|529370143|FG000|Overall Study|Withdrawal by Subject|4|||
146781423|NCT04437433|529370144|FG001|Overall Study|Withdrawal by Subject|1|||
146781424|NCT04437433|529370143|FG000|Overall Study|Protocol Deviation|0|||
146781425|NCT04437433|529370144|FG001|Overall Study|Protocol Deviation|1|||
146781426|NCT04437433|529370143|FG000|Overall Study|Other, not specified|0|||
146781427|NCT04437433|529370144|FG001|Overall Study|Other, not specified|1|||
146781428|NCT04245501|529370145|FG000|Overall Study|Adverse Event|2|||
146934164|NCT00859573|529917793|FG000|Overall Study|Withdrawal by Subject|4|||
146934165|NCT00859573|529917794|FG001|Overall Study|Withdrawal by Subject|1|||
146934166|NCT00859573|529917793|FG000|Overall Study|Physician Decision|1|||
146934167|NCT00859573|529917794|FG001|Overall Study|Physician Decision|1|||
146934168|NCT03488238|529917795|FG000|Overall Study|Equipment malfunction|1|||
146934169|NCT03488238|529917795|FG000|Overall Study|Adverse Event|1|||
146934170|NCT01316939|529917796|FG000|Overall Study|Study closed/terminated|26|||
146934171|NCT01316939|529917797|FG001|Overall Study|Study closed/terminated|25|||
146981305|NCT00863057|530093845|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
146981306|NCT00863057|530093846|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
146781429|NCT04245501|529370146|FG001|Overall Study|Adverse Event|0|||
146934172|NCT01316939|529917798|FG002|Overall Study|Study closed/terminated|23|||
146934173|NCT01316939|529917796|FG000|Overall Study|Lack of Efficacy|24|||
146934174|NCT01316939|529917797|FG001|Overall Study|Lack of Efficacy|25|||
146934175|NCT01316939|529917798|FG002|Overall Study|Lack of Efficacy|25|||
146781430|NCT04245501|529370145|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
146781431|NCT04245501|529370146|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
146781432|NCT03526861|529370147|FG000|Initial Treatment Period|Not dosed|1|||
146781433|NCT03526861|529370148|FG001|Initial Treatment Period|Not dosed|1|||
146781434|NCT03526861|529370149|FG002|Initial Treatment Period|Not dosed|1|||
146719139|NCT01412944|529142046|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
146719140|NCT01412944|529142047|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
146719141|NCT01412944|529142048|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
146719142|NCT01412944|529142049|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
146719143|NCT01412944|529142050|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
146719144|NCT01412944|529142051|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
146719145|NCT01412944|529142046|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
146719146|NCT01412944|529142047|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
146719147|NCT01412944|529142048|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
146719148|NCT01412944|529142049|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
146719149|NCT01412944|529142050|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
146719150|NCT01412944|529142051|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
146719151|NCT01412944|529142046|FG000|Entire: IV + Maintenance|Adverse Event|0|||
146719152|NCT01412944|529142047|FG001|Entire: IV + Maintenance|Adverse Event|1|||
146719153|NCT01412944|529142048|FG002|Entire: IV + Maintenance|Adverse Event|0|||
146719154|NCT01412944|529142049|FG003|Entire: IV + Maintenance|Adverse Event|0|||
146719155|NCT01412944|529142050|FG004|Entire: IV + Maintenance|Adverse Event|0|||
146719156|NCT01412944|529142051|FG005|Entire: IV + Maintenance|Adverse Event|0|||
146719157|NCT01990950|529142052|FG000|Overall Study|Death|3|||
146719158|NCT01990950|529142052|FG000|Overall Study|Lost to Follow-up|2|||
146719159|NCT01990950|529142052|FG000|Overall Study|Withdrawal by Subject|6|||
146719160|NCT02349295|529142053|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
146719161|NCT02349295|529142054|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
146719162|NCT02349295|529142055|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
146719163|NCT02349295|529142056|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146719164|NCT02349295|529142057|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146719165|NCT02349295|529142058|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146719166|NCT02349295|529142059|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146719167|NCT02349295|529142060|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146719168|NCT02349295|529142061|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146719169|NCT02349295|529142062|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146719170|NCT02349295|529142063|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146719171|NCT02349295|529142064|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146719172|NCT02349295|529142065|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146719173|NCT02349295|529142066|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146719174|NCT02349295|529142053|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
146719175|NCT02349295|529142054|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
146719176|NCT02349295|529142055|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
146719177|NCT02349295|529142056|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146719178|NCT02349295|529142057|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146719179|NCT02349295|529142058|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146719180|NCT02349295|529142059|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146719181|NCT02349295|529142060|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146719182|NCT02349295|529142061|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146719183|NCT02349295|529142062|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146719184|NCT02349295|529142063|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146719185|NCT02349295|529142064|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146719186|NCT02349295|529142065|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146719187|NCT02349295|529142066|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146719188|NCT02349295|529142053|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
146719189|NCT02349295|529142054|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
146719190|NCT02349295|529142055|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
146719191|NCT02349295|529142056|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146719192|NCT02349295|529142057|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146719193|NCT02349295|529142058|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146719194|NCT02349295|529142059|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146719195|NCT02349295|529142060|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146719196|NCT02349295|529142061|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146719197|NCT02349295|529142062|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146719198|NCT02349295|529142063|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146719199|NCT02349295|529142064|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146719200|NCT02349295|529142065|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146719201|NCT02349295|529142066|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146719202|NCT02349295|529142053|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
146719203|NCT02349295|529142054|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
146719204|NCT02349295|529142055|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
146719205|NCT02349295|529142056|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146719206|NCT02349295|529142057|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146719207|NCT02349295|529142058|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146719208|NCT02349295|529142059|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146719209|NCT02349295|529142060|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146719210|NCT02349295|529142061|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146719211|NCT02349295|529142062|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146719212|NCT02349295|529142063|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146719213|NCT02349295|529142064|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146719214|NCT02349295|529142065|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146719215|NCT02349295|529142066|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146719216|NCT02349295|529142053|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146719217|NCT02349295|529142054|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
146719218|NCT02349295|529142055|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
146719219|NCT02349295|529142056|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146719220|NCT02349295|529142057|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146719221|NCT02349295|529142058|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146719222|NCT02349295|529142059|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146719223|NCT02349295|529142060|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146719224|NCT02349295|529142061|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146719225|NCT02349295|529142062|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146719226|NCT02349295|529142063|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146719227|NCT02349295|529142064|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146719228|NCT02349295|529142065|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146719229|NCT02349295|529142066|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146719230|NCT02349295|529142053|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
146719231|NCT02349295|529142054|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
146719232|NCT02349295|529142055|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
146719233|NCT02349295|529142056|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
146719234|NCT02349295|529142057|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
146719235|NCT02349295|529142058|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
146719236|NCT02349295|529142059|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
146719237|NCT02349295|529142060|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
146719238|NCT02349295|529142061|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
146719239|NCT02349295|529142062|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
146719240|NCT02349295|529142063|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
146719241|NCT02349295|529142064|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
146719242|NCT02349295|529142065|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
146719243|NCT02349295|529142066|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
146719244|NCT02349295|529142053|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146719245|NCT02349295|529142054|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146719246|NCT02349295|529142055|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146719247|NCT02349295|529142056|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146719248|NCT02349295|529142057|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146719249|NCT02349295|529142058|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146719250|NCT02349295|529142059|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146719251|NCT02349295|529142060|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
146719252|NCT02349295|529142061|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
146719253|NCT02349295|529142062|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
146719254|NCT02349295|529142063|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
146719255|NCT02349295|529142064|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146719256|NCT02349295|529142065|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146719257|NCT02349295|529142066|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146719258|NCT02349295|529142053|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146719259|NCT02349295|529142054|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146719260|NCT02349295|529142055|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146719261|NCT02349295|529142056|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146719262|NCT02349295|529142057|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146719263|NCT02349295|529142058|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146719264|NCT02349295|529142059|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146719265|NCT02349295|529142060|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
146719266|NCT02349295|529142061|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
146719267|NCT02349295|529142062|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
146719268|NCT02349295|529142063|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
146719269|NCT02349295|529142064|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146719270|NCT02349295|529142065|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146719271|NCT02349295|529142066|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146934176|NCT01316939|529917796|FG000|Overall Study|Adverse Event|9|||
146934177|NCT01316939|529917797|FG001|Overall Study|Adverse Event|12|||
146934178|NCT01316939|529917798|FG002|Overall Study|Adverse Event|11|||
146934179|NCT01316939|529917796|FG000|Overall Study|Withdrawal by Subject|1|||
146781435|NCT03526861|529370150|FG003|Initial Treatment Period|Not dosed|0|||
146781436|NCT03526861|529370151|FG004|Initial Treatment Period|Not dosed|0|||
146781437|NCT03526861|529370152|FG005|Initial Treatment Period|Not dosed|0|||
146781438|NCT03526861|529370153|FG006|Initial Treatment Period|Not dosed|0|||
146781439|NCT03526861|529370154|FG007|Initial Treatment Period|Not dosed|0|||
146781440|NCT03526861|529370155|FG008|Initial Treatment Period|Not dosed|0|||
146719272|NCT02349295|529142053|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146719273|NCT02349295|529142054|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146719274|NCT02349295|529142055|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146719275|NCT02349295|529142056|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146719276|NCT02349295|529142057|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146719277|NCT02349295|529142058|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146719278|NCT02349295|529142059|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146719279|NCT02349295|529142060|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
146719280|NCT02349295|529142061|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146719281|NCT02349295|529142062|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
146719282|NCT02349295|529142063|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146719283|NCT02349295|529142064|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146719284|NCT02349295|529142065|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146719285|NCT02349295|529142066|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146719286|NCT02349295|529142053|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
146719287|NCT02349295|529142054|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
146719288|NCT02349295|529142055|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
146719289|NCT02349295|529142056|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
146719290|NCT02349295|529142057|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
146719291|NCT02349295|529142058|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
146719292|NCT02349295|529142059|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
146719293|NCT02349295|529142060|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
146719294|NCT02349295|529142061|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
146719295|NCT02349295|529142062|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
146719296|NCT02349295|529142063|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
146719297|NCT02349295|529142064|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
146719298|NCT02349295|529142065|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
146719299|NCT02349295|529142066|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
146719300|NCT02349295|529142053|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146719301|NCT02349295|529142054|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146719302|NCT02349295|529142055|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146719303|NCT02349295|529142056|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146719304|NCT02349295|529142057|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146719305|NCT02349295|529142058|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146719306|NCT02349295|529142059|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146719307|NCT02349295|529142060|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
146719308|NCT02349295|529142061|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
146719309|NCT02349295|529142062|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
146719310|NCT02349295|529142063|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
146719311|NCT02349295|529142064|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146719312|NCT02349295|529142065|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146719313|NCT02349295|529142066|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146719314|NCT02349295|529142053|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146719315|NCT02349295|529142054|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146719316|NCT02349295|529142055|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146719317|NCT02349295|529142056|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146719318|NCT02349295|529142057|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146719319|NCT02349295|529142058|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146719320|NCT02349295|529142059|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146719321|NCT02349295|529142060|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
146719322|NCT02349295|529142061|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
146719323|NCT02349295|529142062|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146719324|NCT02349295|529142063|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146781441|NCT03526861|529370147|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
146781442|NCT03526861|529370148|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
146781443|NCT03526861|529370149|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
146781444|NCT03526861|529370150|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146848432|NCT03122223|529615679|FG000|Overall Study|Participant unable to adhere|1|||
146719325|NCT02349295|529142064|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146719326|NCT02349295|529142065|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146719327|NCT02349295|529142066|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146719328|NCT02349295|529142053|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146934180|NCT01316939|529917797|FG001|Overall Study|Withdrawal by Subject|3|||
146934181|NCT01316939|529917798|FG002|Overall Study|Withdrawal by Subject|6|||
146934182|NCT01316939|529917796|FG000|Overall Study|Physician Decision|2|||
146934183|NCT01316939|529917797|FG001|Overall Study|Physician Decision|2|||
146719329|NCT02349295|529142054|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146719330|NCT02349295|529142055|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146719331|NCT02349295|529142056|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146719332|NCT02349295|529142057|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146719333|NCT02349295|529142058|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146719334|NCT02349295|529142059|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146719335|NCT02349295|529142060|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
146719336|NCT02349295|529142061|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
146719337|NCT02349295|529142062|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146719338|NCT02349295|529142063|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146719339|NCT02349295|529142064|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146719340|NCT02349295|529142065|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146719341|NCT02349295|529142066|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146719342|NCT02349295|529142053|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146719343|NCT02349295|529142054|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146719344|NCT02349295|529142055|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146719345|NCT02349295|529142056|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146719346|NCT02349295|529142057|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146719347|NCT02349295|529142058|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146719348|NCT02349295|529142059|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146719349|NCT02349295|529142060|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146719350|NCT02349295|529142061|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146719351|NCT02349295|529142062|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146719352|NCT02349295|529142063|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146719353|NCT02349295|529142064|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
146719354|NCT02349295|529142065|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
146719355|NCT02349295|529142066|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
146719356|NCT02349295|529142053|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146781445|NCT03526861|529370151|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781446|NCT03526861|529370152|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781447|NCT03526861|529370153|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781448|NCT03526861|529370154|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781449|NCT03526861|529370155|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781450|NCT03526861|529370147|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
146781451|NCT03526861|529370148|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
146781452|NCT03526861|529370149|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
146781453|NCT03526861|529370150|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
146781454|NCT03526861|529370151|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
146781455|NCT03526861|529370152|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
146781456|NCT03526861|529370153|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
146781457|NCT03526861|529370154|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
146781458|NCT03526861|529370155|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
146781459|NCT03526861|529370147|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146781460|NCT03526861|529370148|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146781461|NCT03526861|529370149|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146781462|NCT03526861|529370150|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
146781463|NCT03526861|529370151|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
146934184|NCT01316939|529917798|FG002|Overall Study|Physician Decision|1|||
146934185|NCT01316939|529917796|FG000|Overall Study|Lost to Follow-up|0|||
146934186|NCT01316939|529917797|FG001|Overall Study|Lost to Follow-up|0|||
146934187|NCT01316939|529917798|FG002|Overall Study|Lost to Follow-up|2|||
146934188|NCT01316939|529917796|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
146934189|NCT01316939|529917797|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
146934190|NCT01316939|529917798|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
146934191|NCT01316939|529917796|FG000|Overall Study|Protocol Violation|0|||
146934192|NCT01316939|529917797|FG001|Overall Study|Protocol Violation|1|||
146934193|NCT01316939|529917798|FG002|Overall Study|Protocol Violation|0|||
146719357|NCT02349295|529142054|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146719358|NCT02349295|529142055|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146719359|NCT02349295|529142056|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146719360|NCT02349295|529142057|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146719361|NCT02349295|529142058|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146719362|NCT02349295|529142059|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146719363|NCT02349295|529142060|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146719364|NCT02349295|529142061|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146719365|NCT02349295|529142062|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146719366|NCT02349295|529142063|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146719367|NCT02349295|529142064|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
146719368|NCT02349295|529142065|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
146719369|NCT02349295|529142066|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146719370|NCT02349295|529142053|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146719371|NCT02349295|529142054|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146719372|NCT02349295|529142055|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146719373|NCT02349295|529142056|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146719374|NCT02349295|529142057|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146719375|NCT02349295|529142058|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146719376|NCT02349295|529142059|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146719377|NCT02349295|529142060|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146719378|NCT02349295|529142061|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146719379|NCT02349295|529142062|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146719380|NCT02349295|529142063|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146719381|NCT02349295|529142064|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
146719382|NCT02349295|529142065|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
146719383|NCT02349295|529142066|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146719384|NCT02349295|529142053|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146719385|NCT02349295|529142054|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146719386|NCT02349295|529142055|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146719387|NCT02349295|529142056|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146719388|NCT02349295|529142057|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146719389|NCT02349295|529142058|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146719390|NCT02349295|529142059|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146719391|NCT02349295|529142060|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146719392|NCT02349295|529142061|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146719393|NCT02349295|529142062|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146719394|NCT02349295|529142063|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146719395|NCT02349295|529142064|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
146719396|NCT02349295|529142065|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146719397|NCT02349295|529142066|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146719398|NCT02349295|529142053|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146719399|NCT02349295|529142054|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146719400|NCT02349295|529142055|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146719401|NCT02349295|529142056|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146719402|NCT02349295|529142057|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146719403|NCT02349295|529142058|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146719404|NCT02349295|529142059|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146719405|NCT02349295|529142060|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146719406|NCT02349295|529142061|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146719407|NCT02349295|529142062|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146719408|NCT02349295|529142063|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146719409|NCT02349295|529142064|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
146719410|NCT02349295|529142065|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146719411|NCT02349295|529142066|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146719412|NCT06111742|529142075|FG000|Overall Study|Did not receive intervention|1|||
146719413|NCT06111742|529142076|FG001|Overall Study|Did not receive intervention|0|||
146719414|NCT06111742|529142077|FG002|Overall Study|Did not receive intervention|0|||
146934194|NCT01432457|529917799|FG000|Overall Study|Adverse Event|7|||
146934195|NCT01432457|529917800|FG001|Overall Study|Adverse Event|10|||
146934196|NCT01432457|529917801|FG002|Overall Study|Adverse Event|16|||
146934197|NCT01432457|529917799|FG000|Overall Study|Lack of Efficacy|2|||
146934198|NCT01432457|529917800|FG001|Overall Study|Lack of Efficacy|1|||
146781464|NCT03526861|529370152|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146781465|NCT03526861|529370153|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
146781466|NCT03526861|529370154|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146719415|NCT06111742|529142075|FG000|Overall Study|Withdrawal by Subject|2|||
146719416|NCT06111742|529142076|FG001|Overall Study|Withdrawal by Subject|0|||
146719417|NCT06111742|529142077|FG002|Overall Study|Withdrawal by Subject|0|||
146719418|NCT01914926|529142078|FG000|Overall Study|Adverse Event|1|||
146719419|NCT01914926|529142079|FG001|Overall Study|Adverse Event|0|||
146719420|NCT01914926|529142078|FG000|Overall Study|uncooperative, agitated and removed|0|||
146719421|NCT01914926|529142079|FG001|Overall Study|uncooperative, agitated and removed|1|||
146719422|NCT03214367|529142080|FG000|Lead-in Period|Withdrawal by Subject|50|||
146719423|NCT03214367|529142081|FG001|Lead-in Period|Withdrawal by Subject|0|||
146719424|NCT03214367|529142082|FG002|Lead-in Period|Withdrawal by Subject|0|||
146719425|NCT03214367|529142083|FG003|Lead-in Period|Withdrawal by Subject|0|||
146719426|NCT03214367|529142084|FG004|Lead-in Period|Withdrawal by Subject|2|||
146719427|NCT03214367|529142085|FG005|Lead-in Period|Withdrawal by Subject|0|||
146719428|NCT03214367|529142086|FG006|Lead-in Period|Withdrawal by Subject|0|||
146719429|NCT03214367|529142087|FG007|Lead-in Period|Withdrawal by Subject|0|||
146719430|NCT03214367|529142080|FG000|Lead-in Period|Adverse Event|3|||
146719431|NCT03214367|529142081|FG001|Lead-in Period|Adverse Event|0|||
146719432|NCT03214367|529142082|FG002|Lead-in Period|Adverse Event|0|||
146719433|NCT03214367|529142083|FG003|Lead-in Period|Adverse Event|0|||
146719434|NCT03214367|529142084|FG004|Lead-in Period|Adverse Event|0|||
146719435|NCT03214367|529142085|FG005|Lead-in Period|Adverse Event|0|||
146719436|NCT03214367|529142086|FG006|Lead-in Period|Adverse Event|0|||
146719437|NCT03214367|529142087|FG007|Lead-in Period|Adverse Event|0|||
146719438|NCT03214367|529142080|FG000|Lead-in Period|Lost to Follow-up|12|||
146719439|NCT03214367|529142081|FG001|Lead-in Period|Lost to Follow-up|0|||
146719440|NCT03214367|529142082|FG002|Lead-in Period|Lost to Follow-up|0|||
146719441|NCT03214367|529142083|FG003|Lead-in Period|Lost to Follow-up|0|||
146719442|NCT03214367|529142084|FG004|Lead-in Period|Lost to Follow-up|0|||
146719443|NCT03214367|529142085|FG005|Lead-in Period|Lost to Follow-up|0|||
146719444|NCT03214367|529142086|FG006|Lead-in Period|Lost to Follow-up|0|||
146719445|NCT03214367|529142087|FG007|Lead-in Period|Lost to Follow-up|0|||
146719446|NCT03214367|529142080|FG000|Lead-in Period|Sponsor Decision|11|||
146719447|NCT03214367|529142081|FG001|Lead-in Period|Sponsor Decision|0|||
146719448|NCT03214367|529142082|FG002|Lead-in Period|Sponsor Decision|0|||
146719449|NCT03214367|529142083|FG003|Lead-in Period|Sponsor Decision|0|||
146719450|NCT03214367|529142084|FG004|Lead-in Period|Sponsor Decision|0|||
146719451|NCT03214367|529142085|FG005|Lead-in Period|Sponsor Decision|0|||
146719452|NCT03214367|529142086|FG006|Lead-in Period|Sponsor Decision|0|||
146719453|NCT03214367|529142087|FG007|Lead-in Period|Sponsor Decision|0|||
146719454|NCT03214367|529142080|FG000|Lead-in Period|Physician Decision|12|||
146719455|NCT03214367|529142081|FG001|Lead-in Period|Physician Decision|0|||
146719456|NCT03214367|529142082|FG002|Lead-in Period|Physician Decision|0|||
146719457|NCT03214367|529142083|FG003|Lead-in Period|Physician Decision|0|||
146719458|NCT03214367|529142084|FG004|Lead-in Period|Physician Decision|0|||
146719459|NCT03214367|529142085|FG005|Lead-in Period|Physician Decision|0|||
146719460|NCT03214367|529142086|FG006|Lead-in Period|Physician Decision|0|||
146719461|NCT03214367|529142087|FG007|Lead-in Period|Physician Decision|0|||
146719462|NCT03214367|529142080|FG000|Lead-in Period|Protocol Violation|5|||
146719463|NCT03214367|529142081|FG001|Lead-in Period|Protocol Violation|0|||
146719464|NCT03214367|529142082|FG002|Lead-in Period|Protocol Violation|0|||
146719465|NCT03214367|529142083|FG003|Lead-in Period|Protocol Violation|0|||
146719466|NCT03214367|529142084|FG004|Lead-in Period|Protocol Violation|0|||
146719467|NCT03214367|529142085|FG005|Lead-in Period|Protocol Violation|0|||
146719468|NCT03214367|529142086|FG006|Lead-in Period|Protocol Violation|0|||
146719469|NCT03214367|529142087|FG007|Lead-in Period|Protocol Violation|0|||
146719470|NCT03214367|529142080|FG000|Lead-in Period|Treatment Interruption|1|||
146719471|NCT03214367|529142081|FG001|Lead-in Period|Treatment Interruption|0|||
146719472|NCT03214367|529142082|FG002|Lead-in Period|Treatment Interruption|0|||
146719473|NCT03214367|529142083|FG003|Lead-in Period|Treatment Interruption|0|||
146781467|NCT03526861|529370155|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146781468|NCT03526861|529370147|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
146719474|NCT03214367|529142084|FG004|Lead-in Period|Treatment Interruption|0|||
146719475|NCT03214367|529142085|FG005|Lead-in Period|Treatment Interruption|0|||
146719476|NCT03214367|529142086|FG006|Lead-in Period|Treatment Interruption|0|||
146719477|NCT03214367|529142087|FG007|Lead-in Period|Treatment Interruption|0|||
146781469|NCT03526861|529370148|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
146719478|NCT03214367|529142080|FG000|Treatment Period|Adverse Event|0|||
146719479|NCT03214367|529142081|FG001|Treatment Period|Adverse Event|1|||
146719480|NCT03214367|529142082|FG002|Treatment Period|Adverse Event|4|||
146719481|NCT03214367|529142083|FG003|Treatment Period|Adverse Event|2|||
146719482|NCT03214367|529142084|FG004|Treatment Period|Adverse Event|0|||
146719483|NCT03214367|529142085|FG005|Treatment Period|Adverse Event|0|||
146719484|NCT03214367|529142086|FG006|Treatment Period|Adverse Event|0|||
146719485|NCT03214367|529142087|FG007|Treatment Period|Adverse Event|0|||
146781470|NCT03526861|529370149|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
146781471|NCT03526861|529370150|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
146781472|NCT03526861|529370151|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
146781473|NCT03526861|529370152|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
146781474|NCT03526861|529370153|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
146781475|NCT03526861|529370154|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
146781476|NCT03526861|529370155|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
146781477|NCT03526861|529370147|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781478|NCT03526861|529370148|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781479|NCT03526861|529370149|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781480|NCT03526861|529370150|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
146781481|NCT03526861|529370151|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781482|NCT03526861|529370152|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781483|NCT03526861|529370153|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781484|NCT03526861|529370154|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781485|NCT03526861|529370155|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781486|NCT03526861|529370147|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146781487|NCT03526861|529370148|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146781488|NCT03526861|529370149|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146781489|NCT03526861|529370150|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146781490|NCT03526861|529370151|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146781491|NCT03526861|529370152|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146781492|NCT03526861|529370153|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146781493|NCT03526861|529370154|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146781494|NCT03526861|529370155|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
146781495|NCT03526861|529370147|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
146781496|NCT03526861|529370148|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
146781497|NCT03526861|529370149|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
146781498|NCT03526861|529370150|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
146781499|NCT03526861|529370151|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
146781500|NCT03526861|529370152|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
146781501|NCT03526861|529370153|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
146781502|NCT03526861|529370154|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
146781503|NCT03526861|529370155|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
146848433|NCT03122223|529615680|FG001|Overall Study|Participant unable to adhere|1|||
146719486|NCT03214367|529142080|FG000|Treatment Period|Death|0|||
146719487|NCT03214367|529142081|FG001|Treatment Period|Death|1|||
146719488|NCT03214367|529142082|FG002|Treatment Period|Death|1|||
146719489|NCT03214367|529142083|FG003|Treatment Period|Death|1|||
146719490|NCT03214367|529142084|FG004|Treatment Period|Death|0|||
146719491|NCT03214367|529142085|FG005|Treatment Period|Death|0|||
146719492|NCT03214367|529142086|FG006|Treatment Period|Death|0|||
146719493|NCT03214367|529142087|FG007|Treatment Period|Death|0|||
146719494|NCT03214367|529142080|FG000|Treatment Period|Lost to Follow-up|0|||
146719495|NCT03214367|529142081|FG001|Treatment Period|Lost to Follow-up|5|||
146719496|NCT03214367|529142082|FG002|Treatment Period|Lost to Follow-up|3|||
146719497|NCT03214367|529142083|FG003|Treatment Period|Lost to Follow-up|2|||
146719498|NCT03214367|529142084|FG004|Treatment Period|Lost to Follow-up|0|||
146719499|NCT03214367|529142085|FG005|Treatment Period|Lost to Follow-up|2|||
146719500|NCT03214367|529142086|FG006|Treatment Period|Lost to Follow-up|1|||
146719501|NCT03214367|529142087|FG007|Treatment Period|Lost to Follow-up|0|||
146719502|NCT03214367|529142080|FG000|Treatment Period|Sponsor Decision|0|||
146719503|NCT03214367|529142081|FG001|Treatment Period|Sponsor Decision|3|||
146719504|NCT03214367|529142082|FG002|Treatment Period|Sponsor Decision|0|||
146719505|NCT03214367|529142083|FG003|Treatment Period|Sponsor Decision|0|||
146719506|NCT03214367|529142084|FG004|Treatment Period|Sponsor Decision|0|||
146719507|NCT03214367|529142085|FG005|Treatment Period|Sponsor Decision|0|||
146719508|NCT03214367|529142086|FG006|Treatment Period|Sponsor Decision|0|||
146719509|NCT03214367|529142087|FG007|Treatment Period|Sponsor Decision|0|||
146719510|NCT03214367|529142080|FG000|Treatment Period|Physician Decision|0|||
146719511|NCT03214367|529142081|FG001|Treatment Period|Physician Decision|1|||
146719512|NCT03214367|529142082|FG002|Treatment Period|Physician Decision|2|||
146719513|NCT03214367|529142083|FG003|Treatment Period|Physician Decision|0|||
146719514|NCT03214367|529142084|FG004|Treatment Period|Physician Decision|0|||
146719515|NCT03214367|529142085|FG005|Treatment Period|Physician Decision|0|||
146719516|NCT03214367|529142086|FG006|Treatment Period|Physician Decision|0|||
146719517|NCT03214367|529142087|FG007|Treatment Period|Physician Decision|0|||
146719518|NCT03214367|529142080|FG000|Treatment Period|Protocol Violation|0|||
146719519|NCT03214367|529142081|FG001|Treatment Period|Protocol Violation|3|||
146719520|NCT03214367|529142082|FG002|Treatment Period|Protocol Violation|0|||
146719521|NCT03214367|529142083|FG003|Treatment Period|Protocol Violation|0|||
146719522|NCT03214367|529142084|FG004|Treatment Period|Protocol Violation|0|||
146719523|NCT03214367|529142085|FG005|Treatment Period|Protocol Violation|0|||
146719524|NCT03214367|529142086|FG006|Treatment Period|Protocol Violation|0|||
146719525|NCT03214367|529142087|FG007|Treatment Period|Protocol Violation|0|||
146719526|NCT03214367|529142080|FG000|Treatment Period|Withdrawal by Subject|0|||
146719527|NCT03214367|529142081|FG001|Treatment Period|Withdrawal by Subject|20|||
146719528|NCT03214367|529142082|FG002|Treatment Period|Withdrawal by Subject|23|||
146719529|NCT03214367|529142083|FG003|Treatment Period|Withdrawal by Subject|14|||
146719530|NCT03214367|529142084|FG004|Treatment Period|Withdrawal by Subject|0|||
146719531|NCT03214367|529142085|FG005|Treatment Period|Withdrawal by Subject|1|||
146719532|NCT03214367|529142086|FG006|Treatment Period|Withdrawal by Subject|1|||
146719533|NCT03214367|529142087|FG007|Treatment Period|Withdrawal by Subject|1|||
146719534|NCT03508843|529142088|FG000|Overall Study|Withdrawal by Subject|1|||
146719535|NCT03508843|529142088|FG000|Overall Study|technical difficulties|2|||
146719536|NCT04717596|529142089|FG000|Overall Study|Withdrawal by Subject|4|||
146719537|NCT02473952|529142090|FG000|Overall Study|Adverse Event|2|||
146719538|NCT02473952|529142091|FG001|Overall Study|Adverse Event|2|||
146719539|NCT02473952|529142090|FG000|Overall Study|Withdrawal by Subject|0|||
146719540|NCT02473952|529142091|FG001|Overall Study|Withdrawal by Subject|6|||
146719541|NCT00237744|529142095|FG000|Overall Study|Withdrawal by Subject|3|||
146719542|NCT00237744|529142096|FG001|Overall Study|Withdrawal by Subject|1|||
146719543|NCT00237744|529142097|FG002|Overall Study|Withdrawal by Subject|0|||
146719544|NCT04955639|529142098|FG000|Overall Study|Withdrawal by Subject|2|||
146719545|NCT04955639|529142099|FG001|Overall Study|Withdrawal by Subject|2|||
146719546|NCT04955639|529142098|FG000|Overall Study|Week 26 survey not completed|2|||
146719547|NCT04955639|529142099|FG001|Overall Study|Week 26 survey not completed|2|||
146719548|NCT01369342|529142100|FG000|Overall Study|Withdrawal by Subject|7|||
146719549|NCT01369342|529142101|FG001|Overall Study|Withdrawal by Subject|7|||
146719550|NCT01369342|529142102|FG002|Overall Study|Withdrawal by Subject|2|||
146719551|NCT01369342|529142100|FG000|Overall Study|Lost to Follow-up|5|||
146719552|NCT01369342|529142101|FG001|Overall Study|Lost to Follow-up|2|||
146719553|NCT01369342|529142102|FG002|Overall Study|Lost to Follow-up|1|||
146719554|NCT01369342|529142100|FG000|Overall Study|Not Treated|1|||
146719555|NCT01369342|529142101|FG001|Overall Study|Not Treated|0|||
146719556|NCT01369342|529142102|FG002|Overall Study|Not Treated|0|||
146719557|NCT03204279|529142106|FG000|Overall Study|Withdrawal by Subject|0|||
146719558|NCT03204279|529142107|FG001|Overall Study|Withdrawal by Subject|1|||
146719559|NCT03305016|529142112|FG000|Overall Study|Withdrawal by Subject|2|||
146719560|NCT04969250|529142113|FG000|Overall Study|Protocol Violation|0|||
146719561|NCT04969250|529142114|FG001|Overall Study|Protocol Violation|2|||
146719562|NCT04969250|529142115|FG002|Overall Study|Protocol Violation|3|||
146719563|NCT04969250|529142116|FG003|Overall Study|Protocol Violation|8|||
146719564|NCT04969250|529142113|FG000|Overall Study|Withdrawal by Subject|0|||
146719565|NCT04969250|529142114|FG001|Overall Study|Withdrawal by Subject|1|||
146719566|NCT04969250|529142115|FG002|Overall Study|Withdrawal by Subject|0|||
146719567|NCT04969250|529142116|FG003|Overall Study|Withdrawal by Subject|0|||
146719568|NCT02119416|529142117|FG000|Overall Study|Protocol Violation|1|||
146719569|NCT02119416|529142118|FG001|Overall Study|Protocol Violation|1|||
146719570|NCT02119416|529142119|FG002|Overall Study|Protocol Violation|1|||
146719571|NCT02119416|529142117|FG000|Overall Study|wrong pubertal stage|1|||
146719572|NCT02119416|529142118|FG001|Overall Study|wrong pubertal stage|0|||
146719573|NCT02119416|529142119|FG002|Overall Study|wrong pubertal stage|1|||
146719574|NCT02278328|529142120|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
146719575|NCT02278328|529142121|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
146719576|NCT02278328|529142122|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
146719577|NCT02278328|529142120|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
146719578|NCT02278328|529142121|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
146719579|NCT02278328|529142122|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
146719580|NCT02278328|529142120|FG000|Neuropsych Screening|incomplete consent|0|||
146719581|NCT02278328|529142121|FG001|Neuropsych Screening|incomplete consent|0|||
146719582|NCT02278328|529142122|FG002|Neuropsych Screening|incomplete consent|2|||
146719583|NCT01059565|529142123|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
146719584|NCT01059565|529142124|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
146719585|NCT01059565|529142123|FG000|24-Week Randomized Phase|Adverse Event|5|||
146719586|NCT01059565|529142124|FG001|24-Week Randomized Phase|Adverse Event|0|||
146719587|NCT01059565|529142123|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
146719588|NCT01059565|529142124|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
146719589|NCT01059565|529142123|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
146719590|NCT01059565|529142124|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
146719591|NCT01059565|529142123|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
146719592|NCT01059565|529142124|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
146719593|NCT01059565|529142123|FG000|24-Week Open-Label Phase|Adverse Event|2|||
146719594|NCT01059565|529142124|FG001|24-Week Open-Label Phase|Adverse Event|0|||
146719595|NCT01059565|529142123|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
146719596|NCT01059565|529142124|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
146719597|NCT01059565|529142123|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
146719598|NCT01059565|529142124|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
146719599|NCT01059565|529142123|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
146719600|NCT01059565|529142124|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
146719601|NCT01059565|529142123|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
146719602|NCT01059565|529142124|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
146719603|NCT01059565|529142123|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
146719604|NCT01059565|529142124|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
146719605|NCT03927950|529142125|FG000|Overall Study|Adverse Event|9|||
146719606|NCT03263429|529142126|FG000|Overall Study|Withdrawal by Subject|0|||
146719607|NCT03263429|529142127|FG001|Overall Study|Withdrawal by Subject|1|||
146719608|NCT03263429|529142128|FG002|Overall Study|Withdrawal by Subject|0|||
146719609|NCT03263429|529142126|FG000|Overall Study|Follow-Up Period Completed|0|||
146719610|NCT03263429|529142127|FG001|Overall Study|Follow-Up Period Completed|2|||
146719611|NCT03263429|529142128|FG002|Overall Study|Follow-Up Period Completed|0|||
146719612|NCT03263429|529142126|FG000|Overall Study|Death|3|||
146719613|NCT03263429|529142127|FG001|Overall Study|Death|5|||
146719614|NCT03263429|529142128|FG002|Overall Study|Death|16|||
146719615|NCT03263429|529142126|FG000|Overall Study|Participant unable to return|0|||
146719616|NCT03263429|529142127|FG001|Overall Study|Participant unable to return|0|||
146719617|NCT03263429|529142128|FG002|Overall Study|Participant unable to return|1|||
146719618|NCT03263429|529142126|FG000|Overall Study|Study Closed|0|||
146719619|NCT03263429|529142127|FG001|Overall Study|Study Closed|0|||
146719620|NCT03263429|529142128|FG002|Overall Study|Study Closed|1|||
146719621|NCT02384759|529142129|FG000|Overall Study|Patients not treated|3|||
146719622|NCT02384759|529142130|FG001|Overall Study|Patients not treated|2|||
146719623|NCT01605617|529142131|FG000|First Intervention|Adverse Event|0|||
146719624|NCT01605617|529142132|FG001|First Intervention|Adverse Event|1|||
146719625|NCT01605617|529142131|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
146719626|NCT01605617|529142132|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
146719627|NCT02014116|529142134|FG000|Overall Study|Progressive Disease|3|||
146719628|NCT02014116|529142135|FG001|Overall Study|Progressive Disease|4|||
146719629|NCT02014116|529142136|FG002|Overall Study|Progressive Disease|2|||
146719630|NCT02014116|529142137|FG003|Overall Study|Progressive Disease|6|||
146719631|NCT02014116|529142138|FG004|Overall Study|Progressive Disease|1|||
146719632|NCT02014116|529142139|FG005|Overall Study|Progressive Disease|13|||
146719633|NCT02014116|529142140|FG006|Overall Study|Progressive Disease|1|||
146719634|NCT02014116|529142141|FG007|Overall Study|Progressive Disease|3|||
146719635|NCT02014116|529142142|FG008|Overall Study|Progressive Disease|7|||
146719636|NCT02014116|529142134|FG000|Overall Study|Adverse Event|0|||
146719637|NCT02014116|529142135|FG001|Overall Study|Adverse Event|0|||
146719638|NCT02014116|529142136|FG002|Overall Study|Adverse Event|0|||
146719639|NCT02014116|529142137|FG003|Overall Study|Adverse Event|0|||
146719640|NCT02014116|529142138|FG004|Overall Study|Adverse Event|1|||
146719641|NCT02014116|529142139|FG005|Overall Study|Adverse Event|0|||
146719642|NCT02014116|529142140|FG006|Overall Study|Adverse Event|0|||
146719643|NCT02014116|529142141|FG007|Overall Study|Adverse Event|1|||
146719644|NCT02014116|529142142|FG008|Overall Study|Adverse Event|0|||
146719645|NCT02014116|529142134|FG000|Overall Study|Lost to Follow-up|0|||
146719646|NCT02014116|529142135|FG001|Overall Study|Lost to Follow-up|0|||
146719647|NCT02014116|529142136|FG002|Overall Study|Lost to Follow-up|0|||
146719648|NCT02014116|529142137|FG003|Overall Study|Lost to Follow-up|0|||
146719649|NCT02014116|529142138|FG004|Overall Study|Lost to Follow-up|0|||
146719650|NCT02014116|529142139|FG005|Overall Study|Lost to Follow-up|1|||
146719651|NCT02014116|529142140|FG006|Overall Study|Lost to Follow-up|0|||
146719652|NCT02014116|529142141|FG007|Overall Study|Lost to Follow-up|0|||
146719653|NCT02014116|529142142|FG008|Overall Study|Lost to Follow-up|1|||
146719654|NCT02014116|529142134|FG000|Overall Study|Death|0|||
146719655|NCT02014116|529142135|FG001|Overall Study|Death|0|||
146719656|NCT02014116|529142136|FG002|Overall Study|Death|0|||
146719657|NCT02014116|529142137|FG003|Overall Study|Death|0|||
146719658|NCT02014116|529142138|FG004|Overall Study|Death|0|||
146934199|NCT01432457|529917801|FG002|Overall Study|Lack of Efficacy|1|||
146781504|NCT03526861|529370147|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781505|NCT03526861|529370148|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781506|NCT03526861|529370149|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781507|NCT03526861|529370150|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781508|NCT03526861|529370151|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781509|NCT03526861|529370152|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781510|NCT03526861|529370153|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781511|NCT03526861|529370154|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146781512|NCT03526861|529370155|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
146781513|NCT02323321|529370167|FG000|Overall Study|Re-Transplant|1|||
146781514|NCT02323321|529370167|FG000|Overall Study|Death|12|||
146781515|NCT00446225|529370168|FG000|Overall Study|Protocol Violation|1|||
146781516|NCT00446225|529370169|FG001|Overall Study|Protocol Violation|0|||
146781517|NCT04450342|529370170|FG000|Overall Study|Adverse Event|1|||
146781518|NCT04450342|529370171|FG001|Overall Study|Adverse Event|1|||
146781519|NCT04450342|529370172|FG002|Overall Study|Adverse Event|0|||
146781520|NCT04450342|529370170|FG000|Overall Study|Device not used|1|||
146781521|NCT04450342|529370171|FG001|Overall Study|Device not used|0|||
146781522|NCT04450342|529370172|FG002|Overall Study|Device not used|0|||
146781523|NCT04450342|529370170|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
146934200|NCT01432457|529917799|FG000|Overall Study|Lost to Follow-up|11|||
146934201|NCT01432457|529917800|FG001|Overall Study|Lost to Follow-up|15|||
146934202|NCT01432457|529917801|FG002|Overall Study|Lost to Follow-up|20|||
146934203|NCT01432457|529917799|FG000|Overall Study|Protocol Violation|3|||
146934204|NCT01432457|529917800|FG001|Overall Study|Protocol Violation|2|||
146934205|NCT01432457|529917801|FG002|Overall Study|Protocol Violation|6|||
146934206|NCT01432457|529917799|FG000|Overall Study|Withdrawal by Subject|6|||
146934207|NCT01432457|529917800|FG001|Overall Study|Withdrawal by Subject|11|||
146934208|NCT01432457|529917801|FG002|Overall Study|Withdrawal by Subject|9|||
146719659|NCT02014116|529142139|FG005|Overall Study|Death|0|||
146719660|NCT02014116|529142140|FG006|Overall Study|Death|0|||
146719661|NCT02014116|529142141|FG007|Overall Study|Death|1|||
146719662|NCT02014116|529142142|FG008|Overall Study|Death|1|||
146719663|NCT02014116|529142134|FG000|Overall Study|Withdrawal by Subject|0|||
146719664|NCT02014116|529142135|FG001|Overall Study|Withdrawal by Subject|0|||
146719665|NCT02014116|529142136|FG002|Overall Study|Withdrawal by Subject|1|||
146719666|NCT02014116|529142137|FG003|Overall Study|Withdrawal by Subject|1|||
146719667|NCT02014116|529142138|FG004|Overall Study|Withdrawal by Subject|0|||
146719668|NCT02014116|529142139|FG005|Overall Study|Withdrawal by Subject|1|||
146719669|NCT02014116|529142140|FG006|Overall Study|Withdrawal by Subject|0|||
146719670|NCT02014116|529142141|FG007|Overall Study|Withdrawal by Subject|0|||
146719671|NCT02014116|529142142|FG008|Overall Study|Withdrawal by Subject|0|||
146719672|NCT02014116|529142134|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
146719673|NCT02014116|529142135|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
146719674|NCT02014116|529142136|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
146719675|NCT02014116|529142137|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
146719676|NCT02014116|529142138|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
146719677|NCT02014116|529142139|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
146719678|NCT02014116|529142140|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
146719679|NCT02014116|529142141|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
146719680|NCT02014116|529142142|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
146719681|NCT02014116|529142134|FG000|Overall Study|Physician Decision|0|||
146719682|NCT02014116|529142135|FG001|Overall Study|Physician Decision|0|||
146719683|NCT02014116|529142136|FG002|Overall Study|Physician Decision|0|||
146719684|NCT02014116|529142137|FG003|Overall Study|Physician Decision|0|||
146719685|NCT02014116|529142138|FG004|Overall Study|Physician Decision|0|||
146719686|NCT02014116|529142139|FG005|Overall Study|Physician Decision|0|||
146719687|NCT02014116|529142140|FG006|Overall Study|Physician Decision|0|||
146719688|NCT02014116|529142141|FG007|Overall Study|Physician Decision|0|||
146719689|NCT02014116|529142142|FG008|Overall Study|Physician Decision|1|||
146719690|NCT00121238|529142143|FG000|Overall Study|disease progression before intervention|1|||
146719691|NCT00121238|529142143|FG000|Overall Study|Protocol Violation|2|||
146719692|NCT03043664|529142144|FG000|Overall Study|Lost to Follow-up|1|||
146719693|NCT01540851|529142145|FG000|Overall Study|Lost to Follow-up|14|||
146719694|NCT01540851|529142146|FG001|Overall Study|Lost to Follow-up|15|||
146719695|NCT01540851|529142145|FG000|Overall Study|Withdrawal by Subject|7|||
146719696|NCT01540851|529142146|FG001|Overall Study|Withdrawal by Subject|3|||
146719697|NCT00325468|529142147|FG000|Overall Study|Adverse Event|1|||
146719698|NCT00325468|529142148|FG001|Overall Study|Adverse Event|1|||
146719699|NCT00325468|529142149|FG002|Overall Study|Adverse Event|0|||
146781524|NCT04450342|529370171|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
146781525|NCT04450342|529370172|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
146781526|NCT04450342|529370170|FG000|Overall Study|Physician Decision|1|||
146781527|NCT04450342|529370171|FG001|Overall Study|Physician Decision|0|||
146781528|NCT04450342|529370172|FG002|Overall Study|Physician Decision|1|||
146781529|NCT04450342|529370170|FG000|Overall Study|Protocol Deviation|0|||
146781530|NCT04450342|529370171|FG001|Overall Study|Protocol Deviation|1|||
146781531|NCT04450342|529370172|FG002|Overall Study|Protocol Deviation|0|||
146781532|NCT04450342|529370170|FG000|Overall Study|Reoperation|1|||
146781533|NCT04450342|529370171|FG001|Overall Study|Reoperation|1|||
146781534|NCT04450342|529370172|FG002|Overall Study|Reoperation|0|||
146781535|NCT04450342|529370170|FG000|Overall Study|Screen Failures|0|||
146781536|NCT04450342|529370171|FG001|Overall Study|Screen Failures|0|||
146781537|NCT04450342|529370172|FG002|Overall Study|Screen Failures|2|||
146781538|NCT04450342|529370170|FG000|Overall Study|Site Terminated by Sponsor|1|||
146781539|NCT04450342|529370171|FG001|Overall Study|Site Terminated by Sponsor|1|||
146781540|NCT04450342|529370172|FG002|Overall Study|Site Terminated by Sponsor|1|||
146781541|NCT04450342|529370170|FG000|Overall Study|Study Terminated by Sponsor|31|||
146781542|NCT04450342|529370171|FG001|Overall Study|Study Terminated by Sponsor|29|||
146781543|NCT04450342|529370172|FG002|Overall Study|Study Terminated by Sponsor|6|||
146781544|NCT04450342|529370170|FG000|Overall Study|Withdrawal by Subject|0|||
146781545|NCT04450342|529370171|FG001|Overall Study|Withdrawal by Subject|1|||
146781546|NCT04450342|529370172|FG002|Overall Study|Withdrawal by Subject|2|||
146781547|NCT05633407|529370173|FG000|Overall Study|Physician Decision|2|||
146781548|NCT05633407|529370174|FG001|Overall Study|Physician Decision|0|||
146781549|NCT05633407|529370173|FG000|Overall Study|Adverse Event|1|||
146781550|NCT05633407|529370174|FG001|Overall Study|Adverse Event|0|||
146781551|NCT05633407|529370173|FG000|Overall Study|Withdrawal by Subject|1|||
146781552|NCT05633407|529370174|FG001|Overall Study|Withdrawal by Subject|0|||
146781553|NCT05633407|529370173|FG000|Overall Study|Other|1|||
146781554|NCT05633407|529370174|FG001|Overall Study|Other|1|||
146781555|NCT00220740|529370179|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
146781556|NCT00220740|529370180|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
146781557|NCT00220740|529370179|FG000|Efficacy Period|Adverse Event|1|||
146781558|NCT00220740|529370180|FG001|Efficacy Period|Adverse Event|1|||
146781559|NCT00220740|529370179|FG000|Efficacy Period|Withdrawal by Subject|1|||
146781560|NCT00220740|529370180|FG001|Efficacy Period|Withdrawal by Subject|0|||
146781561|NCT00220740|529370179|FG000|Efficacy Period|Protocol Violation|1|||
146781562|NCT00220740|529370180|FG001|Efficacy Period|Protocol Violation|0|||
146781563|NCT00220740|529370179|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
146781564|NCT00220740|529370180|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
146781565|NCT01057433|529370181|FG000|Overall Study|Adverse Event|1|||
146781566|NCT05268302|529370182|FG000|Overall Study|Death|0|||
146781567|NCT05268302|529370183|FG001|Overall Study|Death|1|||
146781568|NCT04093752|529370187|FG000|Overall Study|Adverse Event|7|||
146781569|NCT04093752|529370188|FG001|Overall Study|Adverse Event|19|||
146781570|NCT04093752|529370189|FG002|Overall Study|Adverse Event|18|||
146781571|NCT04093752|529370190|FG003|Overall Study|Adverse Event|4|||
146781572|NCT04093752|529370187|FG000|Overall Study|Withdrawal by Subject|6|||
146781573|NCT04093752|529370188|FG001|Overall Study|Withdrawal by Subject|6|||
146781574|NCT04093752|529370189|FG002|Overall Study|Withdrawal by Subject|8|||
146781575|NCT04093752|529370190|FG003|Overall Study|Withdrawal by Subject|20|||
146781576|NCT04093752|529370187|FG000|Overall Study|Lost to Follow-up|2|||
146781577|NCT04093752|529370188|FG001|Overall Study|Lost to Follow-up|1|||
146781578|NCT04093752|529370189|FG002|Overall Study|Lost to Follow-up|1|||
146781579|NCT04093752|529370190|FG003|Overall Study|Lost to Follow-up|1|||
146781580|NCT04093752|529370187|FG000|Overall Study|Death|0|||
146781581|NCT04093752|529370188|FG001|Overall Study|Death|0|||
146781582|NCT04093752|529370189|FG002|Overall Study|Death|1|||
146781583|NCT04093752|529370190|FG003|Overall Study|Death|2|||
146781584|NCT04093752|529370187|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
146781585|NCT04093752|529370188|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
146781586|NCT04093752|529370189|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
146781587|NCT04093752|529370190|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
146781588|NCT04093752|529370187|FG000|Overall Study|Covid 19|0|||
146781589|NCT04093752|529370188|FG001|Overall Study|Covid 19|0|||
146781590|NCT04093752|529370189|FG002|Overall Study|Covid 19|0|||
146781591|NCT04093752|529370190|FG003|Overall Study|Covid 19|1|||
146781592|NCT04093752|529370187|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
146781593|NCT04093752|529370188|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
146781594|NCT04093752|529370189|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
146781595|NCT04093752|529370190|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
146781596|NCT04093752|529370187|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
146781597|NCT04093752|529370188|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
146934209|NCT01432457|529917799|FG000|Overall Study|Reasons not defined|2|||
146934210|NCT01432457|529917800|FG001|Overall Study|Reasons not defined|3|||
146781598|NCT04093752|529370189|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
146781599|NCT04093752|529370190|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
146719700|NCT00325468|529142150|FG003|Overall Study|Adverse Event|5|||
146719701|NCT00325468|529142151|FG004|Overall Study|Adverse Event|1|||
146719702|NCT00325468|529142147|FG000|Overall Study|Death|2|||
146719703|NCT00325468|529142148|FG001|Overall Study|Death|0|||
146719704|NCT00325468|529142149|FG002|Overall Study|Death|2|||
146781600|NCT04093752|529370187|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
146781601|NCT04093752|529370188|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
146719705|NCT00325468|529142150|FG003|Overall Study|Death|4|||
146719706|NCT00325468|529142151|FG004|Overall Study|Death|0|||
146719707|NCT00325468|529142147|FG000|Overall Study|Lost to Follow-up|0|||
146719708|NCT00325468|529142148|FG001|Overall Study|Lost to Follow-up|0|||
146719709|NCT00325468|529142149|FG002|Overall Study|Lost to Follow-up|1|||
146719710|NCT00325468|529142150|FG003|Overall Study|Lost to Follow-up|2|||
146719711|NCT00325468|529142151|FG004|Overall Study|Lost to Follow-up|2|||
146719712|NCT00325468|529142147|FG000|Overall Study|Physician Decision|1|||
146719713|NCT00325468|529142148|FG001|Overall Study|Physician Decision|1|||
146719714|NCT00325468|529142149|FG002|Overall Study|Physician Decision|0|||
146719715|NCT00325468|529142150|FG003|Overall Study|Physician Decision|1|||
146719716|NCT00325468|529142151|FG004|Overall Study|Physician Decision|0|||
146719717|NCT00325468|529142147|FG000|Overall Study|Withdrawal by Subject|3|||
146781602|NCT04093752|529370189|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
146781603|NCT04093752|529370190|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
146781604|NCT03527160|529370196|FG000|Overall Study|No urine collected|13|||
146781605|NCT03527160|529370196|FG000|Overall Study|No clinical serum creatinine collected|6|||
146781606|NCT03527160|529370196|FG000|Overall Study|Did not meet inclusion|2|||
146781607|NCT02910713|529370197|FG000|Overall Study|Protocol Violation|2|||
146781608|NCT02910713|529370197|FG000|Overall Study|Subject Choice|4|||
146781609|NCT02910713|529370197|FG000|Overall Study|Received One Application|10|||
146781610|NCT02910713|529370197|FG000|Overall Study|Received Neither Application|18|||
146781611|NCT02910713|529370197|FG000|Overall Study|Enrollment cap|7|||
146781612|NCT02910713|529370197|FG000|Overall Study|Investigator Discretion|1|||
146781613|NCT04442126|529370206|FG000|Overall Study|Withdrawal by Subject|0|||
146781614|NCT04442126|529370207|FG001|Overall Study|Withdrawal by Subject|0|||
146781615|NCT04442126|529370208|FG002|Overall Study|Withdrawal by Subject|0|||
146781616|NCT04442126|529370209|FG003|Overall Study|Withdrawal by Subject|2|||
146781617|NCT04442126|529370210|FG004|Overall Study|Withdrawal by Subject|1|||
146781618|NCT04442126|529370211|FG005|Overall Study|Withdrawal by Subject|0|||
146719718|NCT00325468|529142148|FG001|Overall Study|Withdrawal by Subject|1|||
146719719|NCT00325468|529142149|FG002|Overall Study|Withdrawal by Subject|0|||
146719720|NCT00325468|529142150|FG003|Overall Study|Withdrawal by Subject|14|||
146719721|NCT00325468|529142151|FG004|Overall Study|Withdrawal by Subject|4|||
146719722|NCT00325468|529142147|FG000|Overall Study|site closure etc|4|||
146719723|NCT00325468|529142148|FG001|Overall Study|site closure etc|2|||
146719724|NCT00325468|529142149|FG002|Overall Study|site closure etc|1|||
146719725|NCT00325468|529142150|FG003|Overall Study|site closure etc|8|||
146719726|NCT00325468|529142151|FG004|Overall Study|site closure etc|1|||
146719727|NCT03593655|529142152|FG000|First Product Use Period|Withdrawal by Subject|1|||
146719728|NCT03593655|529142153|FG001|First Product Use Period|Withdrawal by Subject|1|||
146719729|NCT03593655|529142152|FG000|First Product Use Period|Lost to Follow-up|1|||
146719730|NCT03593655|529142153|FG001|First Product Use Period|Lost to Follow-up|3|||
146719731|NCT03593655|529142152|FG000|Second Product Use Period|Withdrawal by Subject|1|||
146719732|NCT03593655|529142153|FG001|Second Product Use Period|Withdrawal by Subject|1|||
146719733|NCT03593655|529142152|FG000|Second Product Use Period|Lost to Follow-up|1|||
146719734|NCT03593655|529142153|FG001|Second Product Use Period|Lost to Follow-up|0|||
146719735|NCT03593655|529142152|FG000|Third Product Use Period|Lost to Follow-up|1|||
146719736|NCT03593655|529142153|FG001|Third Product Use Period|Lost to Follow-up|2|||
146719737|NCT03593655|529142152|FG000|Third Product Use Period|Physician Decision|0|||
146719738|NCT03593655|529142153|FG001|Third Product Use Period|Physician Decision|1|||
146719739|NCT03593655|529142152|FG000|Third Product Use Period|Withdrawal by Subject|0|||
146781619|NCT04442126|529370212|FG006|Overall Study|Withdrawal by Subject|1|||
146781620|NCT04442126|529370213|FG007|Overall Study|Withdrawal by Subject|1|||
146781621|NCT04442126|529370214|FG008|Overall Study|Withdrawal by Subject|3|||
146781622|NCT04442126|529370206|FG000|Overall Study|Death|1|||
146781623|NCT04442126|529370207|FG001|Overall Study|Death|0|||
146781624|NCT04442126|529370208|FG002|Overall Study|Death|0|||
146781625|NCT04442126|529370209|FG003|Overall Study|Death|1|||
146781626|NCT04442126|529370210|FG004|Overall Study|Death|2|||
146781627|NCT04442126|529370211|FG005|Overall Study|Death|2|||
146781628|NCT04442126|529370212|FG006|Overall Study|Death|4|||
146781629|NCT04442126|529370213|FG007|Overall Study|Death|1|||
146781630|NCT04442126|529370214|FG008|Overall Study|Death|5|||
146719740|NCT03593655|529142153|FG001|Third Product Use Period|Withdrawal by Subject|1|||
146781631|NCT04442126|529370206|FG000|Overall Study|Study Terminated by Sponsor|0|||
146781632|NCT04442126|529370207|FG001|Overall Study|Study Terminated by Sponsor|0|||
146781633|NCT04442126|529370208|FG002|Overall Study|Study Terminated by Sponsor|0|||
146719741|NCT03732209|529142154|FG000|Overall Study|Lost to Follow-up|4|||
146719742|NCT03732209|529142155|FG001|Overall Study|Lost to Follow-up|4|||
146719743|NCT03732209|529142154|FG000|Overall Study|Withdrawal by Subject|8|||
146719744|NCT03732209|529142155|FG001|Overall Study|Withdrawal by Subject|9|||
146719745|NCT02864082|529142156|FG000|Overall Study|Adverse Event|1|||
146719746|NCT02864082|529142157|FG001|Overall Study|Adverse Event|1|||
146719747|NCT02864082|529142156|FG000|Overall Study|Lost to Follow-up|0|||
146719748|NCT02864082|529142157|FG001|Overall Study|Lost to Follow-up|1|||
146719749|NCT02864082|529142156|FG000|Overall Study|Withdrawal by Subject|2|||
146719750|NCT02864082|529142157|FG001|Overall Study|Withdrawal by Subject|2|||
146719751|NCT03621696|529142158|FG000|Overall Study|Not eligible|0|||
146719752|NCT03621696|529142159|FG001|Overall Study|Not eligible|0|||
146719753|NCT03621696|529142160|FG002|Overall Study|Not eligible|0|||
146719754|NCT03621696|529142161|FG003|Overall Study|Not eligible|5|||
146719755|NCT03621696|529142158|FG000|Overall Study|Withdrawal by Subject|1|||
146719756|NCT03621696|529142159|FG001|Overall Study|Withdrawal by Subject|1|||
146719757|NCT03621696|529142160|FG002|Overall Study|Withdrawal by Subject|1|||
146719758|NCT03621696|529142161|FG003|Overall Study|Withdrawal by Subject|0|||
146719759|NCT03621696|529142158|FG000|Overall Study|Physician Decision|0|||
146719760|NCT03621696|529142159|FG001|Overall Study|Physician Decision|0|||
146719761|NCT03621696|529142160|FG002|Overall Study|Physician Decision|1|||
146719762|NCT03621696|529142161|FG003|Overall Study|Physician Decision|0|||
146719763|NCT03021187|529142162|FG000|Overall Study|Death|0|||
146719764|NCT03021187|529142163|FG001|Overall Study|Death|0|||
146719765|NCT03021187|529142164|FG002|Overall Study|Death|3|||
146719766|NCT03021187|529142165|FG003|Overall Study|Death|0|||
146719767|NCT03021187|529142162|FG000|Overall Study|Withdrawal by Subject|0|||
146719768|NCT03021187|529142163|FG001|Overall Study|Withdrawal by Subject|6|||
146719769|NCT03021187|529142164|FG002|Overall Study|Withdrawal by Subject|2|||
146719770|NCT03021187|529142165|FG003|Overall Study|Withdrawal by Subject|5|||
146719771|NCT03021187|529142162|FG000|Overall Study|Lost to Follow-up|10|||
146719772|NCT03021187|529142163|FG001|Overall Study|Lost to Follow-up|3|||
146719773|NCT03021187|529142164|FG002|Overall Study|Lost to Follow-up|1|||
146719774|NCT03021187|529142165|FG003|Overall Study|Lost to Follow-up|4|||
146719775|NCT00718718|529142166|FG000|Prior to Week 12|Adverse Event|0|||
146719776|NCT00718718|529142167|FG001|Prior to Week 12|Adverse Event|0|||
146719777|NCT00718718|529142168|FG002|Prior to Week 12|Adverse Event|0|||
146719778|NCT00718718|529142169|FG003|Prior to Week 12|Adverse Event|0|||
146719779|NCT00718718|529142170|FG004|Prior to Week 12|Adverse Event|0|||
146719780|NCT00718718|529142171|FG005|Prior to Week 12|Adverse Event|0|||
146719781|NCT00718718|529142172|FG006|Prior to Week 12|Adverse Event|0|||
146719782|NCT00718718|529142173|FG007|Prior to Week 12|Adverse Event|1|||
146719783|NCT00718718|529142174|FG008|Prior to Week 12|Adverse Event|1|||
146719784|NCT00718718|529142175|FG009|Prior to Week 12|Adverse Event|0|||
146719785|NCT00718718|529142166|FG000|Prior to Week 12|Withdrawal by Subject|0|||
146719786|NCT00718718|529142167|FG001|Prior to Week 12|Withdrawal by Subject|0|||
146719787|NCT00718718|529142168|FG002|Prior to Week 12|Withdrawal by Subject|0|||
146719788|NCT00718718|529142169|FG003|Prior to Week 12|Withdrawal by Subject|0|||
146719789|NCT00718718|529142170|FG004|Prior to Week 12|Withdrawal by Subject|3|||
146719790|NCT00718718|529142171|FG005|Prior to Week 12|Withdrawal by Subject|0|||
146719791|NCT00718718|529142172|FG006|Prior to Week 12|Withdrawal by Subject|1|||
146719792|NCT00718718|529142173|FG007|Prior to Week 12|Withdrawal by Subject|1|||
146719793|NCT00718718|529142174|FG008|Prior to Week 12|Withdrawal by Subject|1|||
146719794|NCT00718718|529142175|FG009|Prior to Week 12|Withdrawal by Subject|0|||
146719795|NCT00718718|529142166|FG000|Prior to Week 12|Other|1|||
146719796|NCT00718718|529142167|FG001|Prior to Week 12|Other|0|||
146719797|NCT00718718|529142168|FG002|Prior to Week 12|Other|1|||
146719798|NCT00718718|529142169|FG003|Prior to Week 12|Other|0|||
146781634|NCT04442126|529370209|FG003|Overall Study|Study Terminated by Sponsor|0|||
146781635|NCT04442126|529370210|FG004|Overall Study|Study Terminated by Sponsor|0|||
146781636|NCT04442126|529370211|FG005|Overall Study|Study Terminated by Sponsor|1|||
146719799|NCT00718718|529142170|FG004|Prior to Week 12|Other|0|||
146719800|NCT00718718|529142171|FG005|Prior to Week 12|Other|0|||
146781637|NCT04442126|529370212|FG006|Overall Study|Study Terminated by Sponsor|4|||
146781638|NCT04442126|529370213|FG007|Overall Study|Study Terminated by Sponsor|2|||
146934211|NCT01432457|529917801|FG002|Overall Study|Reasons not defined|4|||
146934212|NCT01432457|529917799|FG000|Overall Study|Did not take study drug|6|||
146719801|NCT00718718|529142172|FG006|Prior to Week 12|Other|0|||
146719802|NCT00718718|529142173|FG007|Prior to Week 12|Other|0|||
146719803|NCT00718718|529142174|FG008|Prior to Week 12|Other|0|||
146719804|NCT00718718|529142175|FG009|Prior to Week 12|Other|0|||
146719805|NCT00718718|529142166|FG000|Week 12 to End of Study|Adverse Event|0|||
146719806|NCT00718718|529142167|FG001|Week 12 to End of Study|Adverse Event|0|||
146781639|NCT04442126|529370214|FG008|Overall Study|Study Terminated by Sponsor|10|||
146719807|NCT00718718|529142168|FG002|Week 12 to End of Study|Adverse Event|0|||
146719808|NCT00718718|529142169|FG003|Week 12 to End of Study|Adverse Event|0|||
146719809|NCT00718718|529142170|FG004|Week 12 to End of Study|Adverse Event|0|||
146719810|NCT00718718|529142171|FG005|Week 12 to End of Study|Adverse Event|0|||
146719811|NCT00718718|529142172|FG006|Week 12 to End of Study|Adverse Event|0|||
146781640|NCT04442126|529370206|FG000|Overall Study|Lost to Follow-up|0|||
146781641|NCT04442126|529370207|FG001|Overall Study|Lost to Follow-up|0|||
146781642|NCT04442126|529370208|FG002|Overall Study|Lost to Follow-up|0|||
146781643|NCT04442126|529370209|FG003|Overall Study|Lost to Follow-up|0|||
146781644|NCT04442126|529370210|FG004|Overall Study|Lost to Follow-up|0|||
146781645|NCT04442126|529370211|FG005|Overall Study|Lost to Follow-up|0|||
146781646|NCT04442126|529370212|FG006|Overall Study|Lost to Follow-up|0|||
146781647|NCT04442126|529370213|FG007|Overall Study|Lost to Follow-up|1|||
146781648|NCT04442126|529370214|FG008|Overall Study|Lost to Follow-up|2|||
146781649|NCT04442126|529370206|FG000|Overall Study|Progressive Disease|0|||
146781650|NCT04442126|529370207|FG001|Overall Study|Progressive Disease|1|||
146781651|NCT04442126|529370208|FG002|Overall Study|Progressive Disease|3|||
146781652|NCT04442126|529370209|FG003|Overall Study|Progressive Disease|0|||
146781653|NCT04442126|529370210|FG004|Overall Study|Progressive Disease|3|||
146781654|NCT04442126|529370211|FG005|Overall Study|Progressive Disease|0|||
146781655|NCT04442126|529370212|FG006|Overall Study|Progressive Disease|0|||
146781656|NCT04442126|529370213|FG007|Overall Study|Progressive Disease|0|||
146781657|NCT04442126|529370214|FG008|Overall Study|Progressive Disease|0|||
146781658|NCT04442126|529370206|FG000|Overall Study|Other|0|||
146781659|NCT04442126|529370207|FG001|Overall Study|Other|0|||
146781660|NCT04442126|529370208|FG002|Overall Study|Other|0|||
146781661|NCT04442126|529370209|FG003|Overall Study|Other|0|||
146781662|NCT04442126|529370210|FG004|Overall Study|Other|0|||
146781663|NCT04442126|529370211|FG005|Overall Study|Other|0|||
146781664|NCT04442126|529370212|FG006|Overall Study|Other|0|||
146781665|NCT04442126|529370213|FG007|Overall Study|Other|0|||
146781666|NCT04442126|529370214|FG008|Overall Study|Other|1|||
146781667|NCT06450405|529370215|FG000|Overall Study|Study funding terminated.|0|||
146781668|NCT06450405|529370216|FG001|Overall Study|Study funding terminated.|2|||
146781669|NCT05338086|529371850|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
146781670|NCT05338086|529371851|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
146781671|NCT05338086|529371852|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
146781672|NCT05338086|529371853|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
146781673|NCT05338086|529371854|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
146781674|NCT05338086|529371850|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
146781675|NCT05338086|529371851|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
146781676|NCT05338086|529371852|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
146781677|NCT05338086|529371853|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
146781678|NCT05338086|529371854|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
146781679|NCT05338086|529371850|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
146781680|NCT05338086|529371851|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
146781681|NCT05338086|529371852|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
146781682|NCT05338086|529371853|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
146781683|NCT05338086|529371854|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
146781684|NCT05338086|529371850|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
146781685|NCT05338086|529371851|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
146781686|NCT05338086|529371852|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
146781687|NCT05338086|529371853|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
146781688|NCT05338086|529371854|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
146781689|NCT05338086|529371850|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
146781690|NCT05338086|529371851|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
146781691|NCT05338086|529371852|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
146781692|NCT05338086|529371853|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
146781693|NCT05338086|529371854|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
146781694|NCT05338086|529371850|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
146781695|NCT05338086|529371851|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
146781696|NCT05338086|529371852|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
146781697|NCT05338086|529371853|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
146781698|NCT05338086|529371854|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
146781699|NCT05338086|529371850|FG000|Transition Period (M12 to M18)|Death|0|||
146781700|NCT05338086|529371851|FG001|Transition Period (M12 to M18)|Death|0|||
146781701|NCT05338086|529371852|FG002|Transition Period (M12 to M18)|Death|1|||
146781702|NCT05338086|529371853|FG003|Transition Period (M12 to M18)|Death|0|||
146781703|NCT05338086|529371854|FG004|Transition Period (M12 to M18)|Death|0|||
146781704|NCT05338086|529371850|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
146781705|NCT05338086|529371851|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
146781706|NCT05338086|529371852|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
146781707|NCT05338086|529371853|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
146781708|NCT05338086|529371854|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
146719812|NCT00718718|529142173|FG007|Week 12 to End of Study|Adverse Event|1|||
146719813|NCT00718718|529142174|FG008|Week 12 to End of Study|Adverse Event|0|||
146719814|NCT00718718|529142175|FG009|Week 12 to End of Study|Adverse Event|0|||
146719815|NCT00718718|529142166|FG000|Week 12 to End of Study|Death|0|||
146719816|NCT00718718|529142167|FG001|Week 12 to End of Study|Death|0|||
146719817|NCT00718718|529142168|FG002|Week 12 to End of Study|Death|0|||
146719818|NCT00718718|529142169|FG003|Week 12 to End of Study|Death|0|||
146719819|NCT00718718|529142170|FG004|Week 12 to End of Study|Death|0|||
146719820|NCT00718718|529142171|FG005|Week 12 to End of Study|Death|1|||
146719821|NCT00718718|529142172|FG006|Week 12 to End of Study|Death|0|||
146719822|NCT00718718|529142173|FG007|Week 12 to End of Study|Death|0|||
146719823|NCT00718718|529142174|FG008|Week 12 to End of Study|Death|0|||
146719824|NCT00718718|529142175|FG009|Week 12 to End of Study|Death|0|||
146719825|NCT00718718|529142166|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
146719826|NCT00718718|529142167|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
146719827|NCT00718718|529142168|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
146719828|NCT00718718|529142169|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
146719829|NCT00718718|529142170|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
146719830|NCT00718718|529142171|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
146719831|NCT00718718|529142172|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
146719832|NCT00718718|529142173|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
146719833|NCT00718718|529142174|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
146719834|NCT00718718|529142175|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
146719835|NCT00718718|529142166|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
146719836|NCT00718718|529142167|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
146719837|NCT00718718|529142168|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
146719838|NCT00718718|529142169|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
146719839|NCT00718718|529142170|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
146719840|NCT00718718|529142171|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
146719841|NCT00718718|529142172|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
146719842|NCT00718718|529142173|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
146719843|NCT00718718|529142174|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
146719844|NCT00718718|529142175|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
146719845|NCT00718718|529142166|FG000|Week 12 to End of Study|Other|0|||
146719846|NCT00718718|529142167|FG001|Week 12 to End of Study|Other|1|||
146719847|NCT00718718|529142168|FG002|Week 12 to End of Study|Other|0|||
146719848|NCT00718718|529142169|FG003|Week 12 to End of Study|Other|1|||
146719849|NCT00718718|529142170|FG004|Week 12 to End of Study|Other|0|||
146719850|NCT00718718|529142171|FG005|Week 12 to End of Study|Other|0|||
146719851|NCT00718718|529142172|FG006|Week 12 to End of Study|Other|1|||
146719852|NCT00718718|529142173|FG007|Week 12 to End of Study|Other|0|||
146719853|NCT00718718|529142174|FG008|Week 12 to End of Study|Other|0|||
146719854|NCT00718718|529142175|FG009|Week 12 to End of Study|Other|0|||
146719855|NCT03394924|529142178|FG000|Overall Study|Adverse Event|0|||
146719856|NCT03394924|529142179|FG001|Overall Study|Adverse Event|5|||
146719857|NCT03394924|529142180|FG002|Overall Study|Adverse Event|0|||
146719858|NCT03394924|529142178|FG000|Overall Study|Withdrawal by Subject|2|||
146719859|NCT03394924|529142179|FG001|Overall Study|Withdrawal by Subject|0|||
146719860|NCT03394924|529142180|FG002|Overall Study|Withdrawal by Subject|0|||
146719861|NCT03394924|529142178|FG000|Overall Study|Lost to Follow-up|0|||
146719862|NCT03394924|529142179|FG001|Overall Study|Lost to Follow-up|1|||
146719863|NCT03394924|529142180|FG002|Overall Study|Lost to Follow-up|0|||
146719864|NCT03394924|529142178|FG000|Overall Study|Did not meet all inclusion criteria|1|||
146719865|NCT03394924|529142179|FG001|Overall Study|Did not meet all inclusion criteria|0|||
146719866|NCT03394924|529142180|FG002|Overall Study|Did not meet all inclusion criteria|0|||
146719867|NCT02276482|529142181|FG000|Overall Study|Adverse Event|1|||
146719868|NCT02276482|529142182|FG001|Overall Study|Adverse Event|0|||
146719869|NCT02276482|529142181|FG000|Overall Study|Withdrawal by Subject|1|||
146719870|NCT02276482|529142182|FG001|Overall Study|Withdrawal by Subject|0|||
146719871|NCT02276482|529142181|FG000|Overall Study|Gram-negative infection|1|||
146719872|NCT02276482|529142182|FG001|Overall Study|Gram-negative infection|0|||
146719873|NCT02276482|529142181|FG000|Overall Study|Reason not specified|0|||
146719874|NCT02276482|529142182|FG001|Overall Study|Reason not specified|1|||
146719875|NCT03277313|529142183|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
146719876|NCT03277313|529142184|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
146719877|NCT03277313|529142183|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
146719878|NCT03277313|529142184|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
146719879|NCT03277313|529142183|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
146719880|NCT03277313|529142184|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
146719881|NCT03277313|529142183|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
146719882|NCT03277313|529142184|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
146719883|NCT03277313|529142183|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
146719884|NCT03277313|529142184|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
146719885|NCT02005471|529142187|FG000|Main Study|Adverse Event|0|||
146719886|NCT02005471|529142188|FG001|Main Study|Adverse Event|1|||
146719887|NCT02005471|529142189|FG002|Main Study|Adverse Event|0|||
146719888|NCT02005471|529142190|FG003|Main Study|Adverse Event|0|||
146719889|NCT02005471|529142187|FG000|Main Study|Death|83|||
146719890|NCT02005471|529142188|FG001|Main Study|Death|52|||
146719891|NCT02005471|529142189|FG002|Main Study|Death|0|||
146719892|NCT02005471|529142190|FG003|Main Study|Death|0|||
146719893|NCT02005471|529142187|FG000|Main Study|Lost to Follow-up|4|||
146719894|NCT02005471|529142188|FG001|Main Study|Lost to Follow-up|5|||
146719895|NCT02005471|529142189|FG002|Main Study|Lost to Follow-up|0|||
146719896|NCT02005471|529142190|FG003|Main Study|Lost to Follow-up|0|||
146719897|NCT02005471|529142187|FG000|Main Study|Physician Decision|3|||
146719898|NCT02005471|529142188|FG001|Main Study|Physician Decision|1|||
146719899|NCT02005471|529142189|FG002|Main Study|Physician Decision|0|||
146719900|NCT02005471|529142190|FG003|Main Study|Physician Decision|0|||
146719901|NCT02005471|529142187|FG000|Main Study|Withdrawal by Subject|26|||
146719902|NCT02005471|529142188|FG001|Main Study|Withdrawal by Subject|11|||
146719903|NCT02005471|529142189|FG002|Main Study|Withdrawal by Subject|0|||
146719904|NCT02005471|529142190|FG003|Main Study|Withdrawal by Subject|0|||
146719905|NCT02005471|529142187|FG000|Main Study|Reason not Specified|0|||
146719906|NCT02005471|529142188|FG001|Main Study|Reason not Specified|6|||
146719907|NCT02005471|529142189|FG002|Main Study|Reason not Specified|0|||
146719908|NCT02005471|529142190|FG003|Main Study|Reason not Specified|0|||
146719909|NCT02005471|529142187|FG000|Main Study|Randomized but not Dosed|8|||
146719910|NCT02005471|529142188|FG001|Main Study|Randomized but not Dosed|0|||
146719911|NCT02005471|529142189|FG002|Main Study|Randomized but not Dosed|0|||
146719912|NCT02005471|529142190|FG003|Main Study|Randomized but not Dosed|0|||
146719913|NCT02005471|529142187|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
146719914|NCT02005471|529142188|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
146719915|NCT02005471|529142189|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
146719916|NCT02005471|529142190|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
146719917|NCT02005471|529142187|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
146719918|NCT02005471|529142188|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
146719919|NCT02005471|529142189|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
146719920|NCT02005471|529142190|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
146719921|NCT02005471|529142187|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
146719922|NCT02005471|529142188|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
146719923|NCT02005471|529142189|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
146719924|NCT02005471|529142190|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
146719925|NCT00627705|529142192|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
146719926|NCT00627705|529142193|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
146719927|NCT00627705|529142192|FG000|Overall Study|Adverse Event|1|||
146719928|NCT00627705|529142193|FG001|Overall Study|Adverse Event|0|||
146719929|NCT00627705|529142192|FG000|Overall Study|Withdrawal by Subject|0|||
146719930|NCT00627705|529142193|FG001|Overall Study|Withdrawal by Subject|2|||
146719931|NCT00627705|529142192|FG000|Overall Study|Lost to Follow-up|0|||
146719932|NCT00627705|529142193|FG001|Overall Study|Lost to Follow-up|1|||
146719933|NCT00253864|529142196|FG000|Overall Study|Lost to Follow-up|5|||
146719934|NCT00253864|529142197|FG001|Overall Study|Lost to Follow-up|8|||
146719935|NCT00110617|529142201|FG000|Overall Study|Adverse Event|2|||
146719936|NCT00110617|529142202|FG001|Overall Study|Adverse Event|4|||
146719937|NCT00110617|529142201|FG000|Overall Study|Abnormal Laboratory Value|4|||
146719938|NCT00110617|529142202|FG001|Overall Study|Abnormal Laboratory Value|2|||
146719939|NCT00110617|529142201|FG000|Overall Study|Lack of Efficacy|1|||
146719940|NCT00110617|529142202|FG001|Overall Study|Lack of Efficacy|0|||
146719941|NCT00110617|529142201|FG000|Overall Study|Patient no longer requires study drug|1|||
146719942|NCT00110617|529142202|FG001|Overall Study|Patient no longer requires study drug|0|||
146719943|NCT00110617|529142201|FG000|Overall Study|Protocol Violation|5|||
146719944|NCT00110617|529142202|FG001|Overall Study|Protocol Violation|0|||
146719945|NCT00110617|529142201|FG000|Overall Study|Withdrawal by Subject|10|||
146719946|NCT00110617|529142202|FG001|Overall Study|Withdrawal by Subject|4|||
146719947|NCT00110617|529142201|FG000|Overall Study|Lost to Follow-up|9|||
146719948|NCT00110617|529142202|FG001|Overall Study|Lost to Follow-up|1|||
146719949|NCT00110617|529142201|FG000|Overall Study|Administrative problems|6|||
146719950|NCT00110617|529142202|FG001|Overall Study|Administrative problems|5|||
146719951|NCT00110617|529142201|FG000|Overall Study|Death|1|||
146719952|NCT00110617|529142202|FG001|Overall Study|Death|1|||
146719953|NCT00110617|529142201|FG000|Overall Study|Did not receive study drug|0|||
146719954|NCT00110617|529142202|FG001|Overall Study|Did not receive study drug|12|||
146719955|NCT00045110|529142205|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
146719956|NCT00045110|529142206|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
146719957|NCT00045110|529142207|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
146781709|NCT05338086|529371850|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
146719958|NCT00045110|529142205|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
146781710|NCT05338086|529371851|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
146719959|NCT00045110|529142206|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
146719960|NCT00045110|529142207|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
146719961|NCT00045110|529142205|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
146719962|NCT00045110|529142206|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
146719963|NCT00045110|529142207|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
146719964|NCT03662750|529142212|FG000|Overall Study|Withdrawal by Subject|1|||
146719965|NCT00791765|529144271|FG000|Weeks 1 to 12|Adverse Event|0|||
146719966|NCT00791765|529144272|FG001|Weeks 1 to 12|Adverse Event|1|||
146719967|NCT00791765|529144271|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
146719968|NCT00791765|529144272|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
146719969|NCT00791765|529144271|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
146719970|NCT00791765|529144272|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
146719971|NCT00791765|529144271|FG000|Weeks 1 to 12|Physician Decision|1|||
146719972|NCT00791765|529144272|FG001|Weeks 1 to 12|Physician Decision|0|||
146719973|NCT00791765|529144271|FG000|Weeks 1 to 12|Disease progression|3|||
146719974|NCT00791765|529144272|FG001|Weeks 1 to 12|Disease progression|0|||
146719975|NCT00791765|529144271|FG000|Weeks 1 to 12|Ineligibility determined|0|||
146719976|NCT00791765|529144272|FG001|Weeks 1 to 12|Ineligibility determined|3|||
146719977|NCT00791765|529144271|FG000|Weeks 13 to 24|Protocol deviation|2|||
146719978|NCT00791765|529144272|FG001|Weeks 13 to 24|Protocol deviation|0|||
146719979|NCT00791765|529144271|FG000|Weeks 13 to 24|Adverse Event|0|||
146719980|NCT00791765|529144272|FG001|Weeks 13 to 24|Adverse Event|3|||
146719981|NCT00791765|529144271|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
146719982|NCT00791765|529144272|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
146719983|NCT00791765|529144271|FG000|Weeks 13 to 24|Disease progression|0|||
146719984|NCT00791765|529144272|FG001|Weeks 13 to 24|Disease progression|1|||
146719985|NCT00791765|529144271|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
146719986|NCT00791765|529144272|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
146719987|NCT00791765|529144271|FG000|Weeks 13 to 24|Other|0|||
146719988|NCT00791765|529144272|FG001|Weeks 13 to 24|Other|1|||
146719989|NCT00924287|529144274|FG000|Overall Study|Death|1|||
146719990|NCT01625897|529144281|FG000|Overall Study|Adverse Event|27|||
146719991|NCT01625897|529144282|FG001|Overall Study|Adverse Event|10|||
146719992|NCT01625897|529144281|FG000|Overall Study|Physician Decision|0|||
146719993|NCT01625897|529144282|FG001|Overall Study|Physician Decision|1|||
146719994|NCT01625897|529144281|FG000|Overall Study|Withdrawal by Subject|25|||
146719995|NCT01625897|529144282|FG001|Overall Study|Withdrawal by Subject|3|||
146719996|NCT00156065|529144283|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
146719997|NCT00156065|529144284|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
146719998|NCT00156065|529144285|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
146719999|NCT00156065|529144283|FG000|Overall Study|Adverse Event|8|||
146720000|NCT00156065|529144284|FG001|Overall Study|Adverse Event|11|||
146720001|NCT00156065|529144285|FG002|Overall Study|Adverse Event|4|||
146720002|NCT00156065|529144283|FG000|Overall Study|Lack of Efficacy|2|||
146720003|NCT00156065|529144284|FG001|Overall Study|Lack of Efficacy|9|||
146720004|NCT00156065|529144285|FG002|Overall Study|Lack of Efficacy|3|||
146720005|NCT00156065|529144283|FG000|Overall Study|Withdrawal by Subject|13|||
146720006|NCT00156065|529144284|FG001|Overall Study|Withdrawal by Subject|26|||
146720007|NCT00156065|529144285|FG002|Overall Study|Withdrawal by Subject|16|||
146720008|NCT00156065|529144283|FG000|Overall Study|Lost to Follow-up|5|||
146720009|NCT00156065|529144284|FG001|Overall Study|Lost to Follow-up|7|||
146720010|NCT00156065|529144285|FG002|Overall Study|Lost to Follow-up|1|||
146720011|NCT00156065|529144283|FG000|Overall Study|Other|2|||
146720012|NCT00156065|529144284|FG001|Overall Study|Other|9|||
146720013|NCT00156065|529144285|FG002|Overall Study|Other|3|||
146720014|NCT01432366|529144286|FG000|Overall Study|Non-Responder|7|||
146720015|NCT01432366|529144286|FG000|Overall Study|Adverse Event|8|||
146720016|NCT01432366|529144286|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
146720017|NCT01432366|529144286|FG000|Overall Study|Pregnancy|1|||
146720018|NCT01432366|529144286|FG000|Overall Study|Lost to Follow-up|13|||
146720019|NCT01432366|529144286|FG000|Overall Study|Lack of Efficacy|1|||
146720020|NCT01432366|529144286|FG000|Overall Study|Site Closed|20|||
146781711|NCT05338086|529371852|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
146981307|NCT00863057|530093843|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
146720021|NCT01432366|529144286|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
146720022|NCT01432366|529144286|FG000|Overall Study|Other|14|||
146720023|NCT02891187|529144287|FG000|Overall Study|Lost to Follow-up|1|||
146720024|NCT02891187|529144288|FG001|Overall Study|Lost to Follow-up|2|||
146720025|NCT04546581|529144289|FG000|Overall Study|Adverse Event|9|||
146981308|NCT00863057|530093844|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
146981309|NCT00863057|530093845|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
146981310|NCT00863057|530093846|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
146981311|NCT00863057|530093843|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
146981312|NCT00863057|530093844|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
146981313|NCT00863057|530093845|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
146720026|NCT04546581|529144290|FG001|Overall Study|Adverse Event|3|||
146720027|NCT04546581|529144289|FG000|Overall Study|Physician Decision|0|||
146720028|NCT04546581|529144290|FG001|Overall Study|Physician Decision|1|||
146720029|NCT04546581|529144289|FG000|Overall Study|Protocol Violation|1|||
146981314|NCT00863057|530093846|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
146981315|NCT03412019|530093847|FG000|Overall Study|Withdrawal by Subject|1|||
146981316|NCT03412019|530093848|FG001|Overall Study|Withdrawal by Subject|1|||
146981317|NCT02974114|530093859|FG000|Overall Study|Other (Not specified)|0|||
146981318|NCT02974114|530093860|FG001|Overall Study|Other (Not specified)|1|||
146981319|NCT02974114|530093861|FG002|Overall Study|Other (Not specified)|2|||
146981320|NCT01138150|530093864|FG000|Overall Study|blood unable to be processed|0|||
146981321|NCT01138150|530093865|FG001|Overall Study|blood unable to be processed|1|||
146981322|NCT01138150|530093864|FG000|Overall Study|Physician Decision|1|||
146981323|NCT01138150|530093865|FG001|Overall Study|Physician Decision|0|||
146981324|NCT00545233|530093866|FG000|Overall Study|Adverse Event|10|||
146981325|NCT00545233|530093867|FG001|Overall Study|Adverse Event|5|||
146981326|NCT00545233|530093866|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
146981327|NCT00545233|530093867|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
146981328|NCT00545233|530093866|FG000|Overall Study|Protocol Violation|2|||
146981329|NCT00545233|530093867|FG001|Overall Study|Protocol Violation|0|||
146981330|NCT00545233|530093866|FG000|Overall Study|Refused Treatment|9|||
146981331|NCT00545233|530093867|FG001|Overall Study|Refused Treatment|7|||
146981332|NCT00545233|530093866|FG000|Overall Study|Failure to Return|4|||
146720030|NCT04546581|529144290|FG001|Overall Study|Protocol Violation|2|||
146720031|NCT04546581|529144289|FG000|Overall Study|Withdrawal by Subject|3|||
146720032|NCT04546581|529144290|FG001|Overall Study|Withdrawal by Subject|7|||
146720033|NCT01275625|529144291|FG000|Overall Study|Death|1|||
146720034|NCT01275625|529144291|FG000|Overall Study|Lack of Efficacy|2|||
146720035|NCT01275625|529144291|FG000|Overall Study|Lost to Follow-up|1|||
146720036|NCT01275625|529144291|FG000|Overall Study|Withdrawal by Subject|3|||
146720037|NCT01275625|529144291|FG000|Overall Study|Protocol Violation|1|||
146720038|NCT01275625|529144291|FG000|Overall Study|Adverse Event|4|||
146720039|NCT01275625|529144291|FG000|Overall Study|Other|1|||
146720040|NCT04579757|529144294|FG000|Overall Study|Adverse Event|0|||
146720041|NCT04579757|529144295|FG001|Overall Study|Adverse Event|0|||
146720042|NCT04579757|529144296|FG002|Overall Study|Adverse Event|0|||
146720043|NCT04579757|529144297|FG003|Overall Study|Adverse Event|2|||
146720044|NCT04579757|529144298|FG004|Overall Study|Adverse Event|1|||
146720045|NCT04579757|529144299|FG005|Overall Study|Adverse Event|1|||
146720046|NCT04579757|529144300|FG006|Overall Study|Adverse Event|0|||
146720047|NCT04579757|529144301|FG007|Overall Study|Adverse Event|0|||
146720048|NCT04579757|529144302|FG008|Overall Study|Adverse Event|0|||
146720049|NCT04579757|529144294|FG000|Overall Study|Death|4|||
146720050|NCT04579757|529144295|FG001|Overall Study|Death|1|||
146720051|NCT04579757|529144296|FG002|Overall Study|Death|14|||
146720052|NCT04579757|529144297|FG003|Overall Study|Death|3|||
146720053|NCT04579757|529144298|FG004|Overall Study|Death|2|||
146720054|NCT04579757|529144299|FG005|Overall Study|Death|7|||
146720055|NCT04579757|529144300|FG006|Overall Study|Death|0|||
146720056|NCT04579757|529144301|FG007|Overall Study|Death|1|||
146720057|NCT04579757|529144302|FG008|Overall Study|Death|3|||
146720058|NCT04579757|529144294|FG000|Overall Study|Physician Decision|0|||
146720059|NCT04579757|529144295|FG001|Overall Study|Physician Decision|0|||
146720060|NCT04579757|529144296|FG002|Overall Study|Physician Decision|0|||
146720061|NCT04579757|529144297|FG003|Overall Study|Physician Decision|2|||
146720062|NCT04579757|529144298|FG004|Overall Study|Physician Decision|1|||
146720063|NCT04579757|529144299|FG005|Overall Study|Physician Decision|1|||
146720064|NCT04579757|529144300|FG006|Overall Study|Physician Decision|1|||
146720065|NCT04579757|529144301|FG007|Overall Study|Physician Decision|0|||
146720066|NCT04579757|529144302|FG008|Overall Study|Physician Decision|0|||
146720067|NCT04579757|529144294|FG000|Overall Study|Study Terminated By Sponsor|0|||
146720068|NCT04579757|529144295|FG001|Overall Study|Study Terminated By Sponsor|0|||
146720069|NCT04579757|529144296|FG002|Overall Study|Study Terminated By Sponsor|0|||
146720070|NCT04579757|529144297|FG003|Overall Study|Study Terminated By Sponsor|0|||
146720071|NCT04579757|529144298|FG004|Overall Study|Study Terminated By Sponsor|2|||
146720072|NCT04579757|529144299|FG005|Overall Study|Study Terminated By Sponsor|0|||
146720073|NCT04579757|529144300|FG006|Overall Study|Study Terminated By Sponsor|0|||
146720074|NCT04579757|529144301|FG007|Overall Study|Study Terminated By Sponsor|2|||
146720075|NCT04579757|529144302|FG008|Overall Study|Study Terminated By Sponsor|0|||
146720076|NCT04579757|529144294|FG000|Overall Study|Withdrawal by Subject|1|||
146720077|NCT04579757|529144295|FG001|Overall Study|Withdrawal by Subject|1|||
146720078|NCT04579757|529144296|FG002|Overall Study|Withdrawal by Subject|0|||
146720079|NCT04579757|529144297|FG003|Overall Study|Withdrawal by Subject|0|||
146720080|NCT04579757|529144298|FG004|Overall Study|Withdrawal by Subject|2|||
146720081|NCT04579757|529144299|FG005|Overall Study|Withdrawal by Subject|1|||
146720082|NCT04579757|529144300|FG006|Overall Study|Withdrawal by Subject|0|||
146720083|NCT04579757|529144301|FG007|Overall Study|Withdrawal by Subject|3|||
146781712|NCT05338086|529371853|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
146781713|NCT05338086|529371854|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
146981333|NCT00545233|530093867|FG001|Overall Study|Failure to Return|6|||
146720084|NCT04579757|529144302|FG008|Overall Study|Withdrawal by Subject|0|||
146720085|NCT04579757|529144294|FG000|Overall Study|Radiological or Clinical PD|1|||
146720086|NCT04579757|529144295|FG001|Overall Study|Radiological or Clinical PD|4|||
146720087|NCT04579757|529144296|FG002|Overall Study|Radiological or Clinical PD|1|||
146720088|NCT04579757|529144297|FG003|Overall Study|Radiological or Clinical PD|3|||
146720089|NCT04579757|529144298|FG004|Overall Study|Radiological or Clinical PD|9|||
146720090|NCT04579757|529144299|FG005|Overall Study|Radiological or Clinical PD|4|||
146720091|NCT04579757|529144300|FG006|Overall Study|Radiological or Clinical PD|2|||
146720092|NCT04579757|529144301|FG007|Overall Study|Radiological or Clinical PD|2|||
146720093|NCT04579757|529144302|FG008|Overall Study|Radiological or Clinical PD|0|||
146720094|NCT04579757|529144294|FG000|Overall Study|Start of New Therapy|0|||
146720095|NCT04579757|529144295|FG001|Overall Study|Start of New Therapy|0|||
146720096|NCT04579757|529144296|FG002|Overall Study|Start of New Therapy|0|||
146720097|NCT04579757|529144297|FG003|Overall Study|Start of New Therapy|0|||
146720098|NCT04579757|529144298|FG004|Overall Study|Start of New Therapy|2|||
146720099|NCT04579757|529144299|FG005|Overall Study|Start of New Therapy|1|||
146720100|NCT04579757|529144300|FG006|Overall Study|Start of New Therapy|0|||
146720101|NCT04579757|529144301|FG007|Overall Study|Start of New Therapy|0|||
146720102|NCT04579757|529144302|FG008|Overall Study|Start of New Therapy|0|||
146720103|NCT02207816|529144303|FG000|Overall Study|Serious Adverse Event|0|||
146720104|NCT02207816|529144304|FG001|Overall Study|Serious Adverse Event|5|||
146720105|NCT02207816|529144305|FG002|Overall Study|Serious Adverse Event|2|||
146720106|NCT02207816|529144303|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
146720107|NCT02207816|529144304|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
146720108|NCT02207816|529144305|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
146720109|NCT02207816|529144303|FG000|Overall Study|Withdrawal by Subject|4|||
146720110|NCT02207816|529144304|FG001|Overall Study|Withdrawal by Subject|9|||
146720111|NCT02207816|529144305|FG002|Overall Study|Withdrawal by Subject|7|||
146720112|NCT02207816|529144303|FG000|Overall Study|Migrated/Moved From Study Area|41|||
146720113|NCT02207816|529144304|FG001|Overall Study|Migrated/Moved From Study Area|60|||
146720114|NCT02207816|529144305|FG002|Overall Study|Migrated/Moved From Study Area|51|||
146720115|NCT02207816|529144303|FG000|Overall Study|Lost to Follow-up|3|||
146720116|NCT02207816|529144304|FG001|Overall Study|Lost to Follow-up|9|||
146720117|NCT02207816|529144305|FG002|Overall Study|Lost to Follow-up|1|||
146720118|NCT02207816|529144303|FG000|Overall Study|Other|1|||
146720119|NCT02207816|529144304|FG001|Overall Study|Other|2|||
146720120|NCT02207816|529144305|FG002|Overall Study|Other|4|||
146720121|NCT03240588|529144306|FG000|Overall Study|Death|3|||
146720122|NCT03240588|529144307|FG001|Overall Study|Death|0|||
146720123|NCT03240588|529144308|FG002|Overall Study|Death|0|||
146720124|NCT03240588|529144306|FG000|Overall Study|Adverse Event|5|||
146720125|NCT03240588|529144307|FG001|Overall Study|Adverse Event|4|||
146720126|NCT03240588|529144308|FG002|Overall Study|Adverse Event|0|||
146720127|NCT03240588|529144306|FG000|Overall Study|Lost to Follow-up|9|||
146720128|NCT03240588|529144307|FG001|Overall Study|Lost to Follow-up|4|||
146720129|NCT03240588|529144308|FG002|Overall Study|Lost to Follow-up|0|||
146720130|NCT03240588|529144306|FG000|Overall Study|Physician Decision|3|||
146720131|NCT03240588|529144307|FG001|Overall Study|Physician Decision|2|||
146720132|NCT03240588|529144308|FG002|Overall Study|Physician Decision|0|||
146720133|NCT03240588|529144306|FG000|Overall Study|Did not meet eligibility criteria|0|||
146720134|NCT03240588|529144307|FG001|Overall Study|Did not meet eligibility criteria|6|||
146720135|NCT03240588|529144308|FG002|Overall Study|Did not meet eligibility criteria|0|||
146720136|NCT03240588|529144306|FG000|Overall Study|No longer meets protocol criteria|12|||
146720137|NCT03240588|529144307|FG001|Overall Study|No longer meets protocol criteria|7|||
146720138|NCT03240588|529144308|FG002|Overall Study|No longer meets protocol criteria|0|||
146720139|NCT03240588|529144306|FG000|Overall Study|Withdrawal by Subject|60|||
146720140|NCT03240588|529144307|FG001|Overall Study|Withdrawal by Subject|52|||
146720141|NCT03240588|529144308|FG002|Overall Study|Withdrawal by Subject|7|||
146720142|NCT03240588|529144306|FG000|Overall Study|Other, additional details not available.|0|||
146720143|NCT03240588|529144307|FG001|Overall Study|Other, additional details not available.|12|||
146720144|NCT03240588|529144308|FG002|Overall Study|Other, additional details not available.|1|||
146720145|NCT03240588|529144306|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
146720146|NCT03240588|529144307|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
146720147|NCT03240588|529144308|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
146720148|NCT03240588|529144306|FG000|Overall Study|Closure of study|55|||
146720149|NCT03240588|529144307|FG001|Overall Study|Closure of study|3|||
146720150|NCT03240588|529144308|FG002|Overall Study|Closure of study|0|||
146720151|NCT03240588|529144306|FG000|Overall Study|Subject non-compliance|23|||
146720152|NCT03240588|529144307|FG001|Overall Study|Subject non-compliance|2|||
146720153|NCT03240588|529144308|FG002|Overall Study|Subject non-compliance|1|||
146720154|NCT03240588|529144306|FG000|Overall Study|Device Deficiency|1|||
146720155|NCT03240588|529144307|FG001|Overall Study|Device Deficiency|0|||
146720156|NCT03240588|529144308|FG002|Overall Study|Device Deficiency|0|||
146720157|NCT03240588|529144306|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
146781714|NCT05338086|529371850|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
146720158|NCT03240588|529144307|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
146781715|NCT05338086|529371851|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
146781716|NCT05338086|529371852|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
146781717|NCT05338086|529371853|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
146781718|NCT05338086|529371854|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
146781719|NCT03940703|529371855|FG000|Overall Study|Still under treatment|31|||
146781720|NCT03940703|529371856|FG001|Overall Study|Still under treatment|0|||
146781721|NCT00753090|529371868|FG000|Overall Study|Withdrawal by Subject|10|||
146781722|NCT00753090|529371869|FG001|Overall Study|Withdrawal by Subject|10|||
146781723|NCT00753090|529371868|FG000|Overall Study|Death|17|||
146781724|NCT00753090|529371869|FG001|Overall Study|Death|6|||
146781725|NCT00753090|529371868|FG000|Overall Study|Study Prosthesis Removed|12|||
146781726|NCT00753090|529371869|FG001|Overall Study|Study Prosthesis Removed|3|||
146781727|NCT00753090|529371868|FG000|Overall Study|Lost to Follow-up|2|||
146781728|NCT00753090|529371869|FG001|Overall Study|Lost to Follow-up|2|||
146781729|NCT00753090|529371868|FG000|Overall Study|Other|127|||
146781730|NCT00753090|529371869|FG001|Overall Study|Other|75|||
146781731|NCT05113966|529371872|FG000|Overall Study|Death|21|||
146781732|NCT05113966|529371872|FG000|Overall Study|Study Terminated by Sponsor|9|||
146781733|NCT05386355|529371873|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
146781734|NCT05386355|529371874|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
146781735|NCT05386355|529371875|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
146781736|NCT05386355|529371876|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
146781737|NCT04521478|529371879|FG000|Overall Study|Protocol Violation|2|||
146781738|NCT04521478|529371880|FG001|Overall Study|Protocol Violation|0|||
146781739|NCT04521478|529371881|FG002|Overall Study|Protocol Violation|1|||
146781740|NCT04521478|529371882|FG003|Overall Study|Protocol Violation|0|||
146781741|NCT04521478|529371883|FG004|Overall Study|Protocol Violation|0|||
146781742|NCT04521478|529371884|FG005|Overall Study|Protocol Violation|0|||
146781743|NCT04521478|529371879|FG000|Overall Study|Technical Problems|0|||
146781744|NCT04521478|529371880|FG001|Overall Study|Technical Problems|0|||
146781745|NCT04521478|529371881|FG002|Overall Study|Technical Problems|0|||
146781746|NCT04521478|529371882|FG003|Overall Study|Technical Problems|1|||
146781747|NCT04521478|529371883|FG004|Overall Study|Technical Problems|0|||
146781748|NCT04521478|529371884|FG005|Overall Study|Technical Problems|0|||
146781749|NCT04521478|529371879|FG000|Overall Study|Burden of Study Procedures|1|||
146781750|NCT04521478|529371880|FG001|Overall Study|Burden of Study Procedures|0|||
146781751|NCT04521478|529371881|FG002|Overall Study|Burden of Study Procedures|0|||
146781752|NCT04521478|529371882|FG003|Overall Study|Burden of Study Procedures|1|||
146781753|NCT04521478|529371883|FG004|Overall Study|Burden of Study Procedures|0|||
146781754|NCT04521478|529371884|FG005|Overall Study|Burden of Study Procedures|1|||
146781755|NCT04521478|529371879|FG000|Overall Study|Lack of Efficacy|0|||
146781756|NCT04521478|529371880|FG001|Overall Study|Lack of Efficacy|0|||
146781757|NCT04521478|529371881|FG002|Overall Study|Lack of Efficacy|0|||
146781758|NCT04521478|529371882|FG003|Overall Study|Lack of Efficacy|0|||
146781759|NCT04521478|529371883|FG004|Overall Study|Lack of Efficacy|1|||
146781760|NCT04521478|529371884|FG005|Overall Study|Lack of Efficacy|1|||
146781761|NCT04521478|529371879|FG000|Overall Study|Adverse Event|7|||
146781762|NCT04521478|529371880|FG001|Overall Study|Adverse Event|0|||
146781763|NCT04521478|529371881|FG002|Overall Study|Adverse Event|2|||
146781764|NCT04521478|529371882|FG003|Overall Study|Adverse Event|1|||
146781765|NCT04521478|529371883|FG004|Overall Study|Adverse Event|2|||
146781766|NCT04521478|529371884|FG005|Overall Study|Adverse Event|7|||
146781767|NCT04521478|529371879|FG000|Overall Study|No Reason Available|0|||
146781768|NCT04521478|529371880|FG001|Overall Study|No Reason Available|2|||
146781769|NCT04521478|529371881|FG002|Overall Study|No Reason Available|0|||
146781770|NCT04521478|529371882|FG003|Overall Study|No Reason Available|0|||
146781771|NCT04521478|529371883|FG004|Overall Study|No Reason Available|1|||
146781772|NCT04521478|529371884|FG005|Overall Study|No Reason Available|0|||
146781773|NCT04521478|529371879|FG000|Overall Study|Other than listed|3|||
146781774|NCT04521478|529371880|FG001|Overall Study|Other than listed|3|||
146781775|NCT04521478|529371881|FG002|Overall Study|Other than listed|3|||
146781776|NCT04521478|529371882|FG003|Overall Study|Other than listed|2|||
146781777|NCT04521478|529371883|FG004|Overall Study|Other than listed|3|||
146781778|NCT04521478|529371884|FG005|Overall Study|Other than listed|3|||
146781779|NCT04521478|529371879|FG000|Overall Study|Not treated|0|||
146781780|NCT04521478|529371880|FG001|Overall Study|Not treated|0|||
146781781|NCT04521478|529371881|FG002|Overall Study|Not treated|0|||
146781782|NCT04521478|529371882|FG003|Overall Study|Not treated|0|||
146781783|NCT04521478|529371883|FG004|Overall Study|Not treated|0|||
146781784|NCT04521478|529371884|FG005|Overall Study|Not treated|1|||
146781785|NCT03625882|529371885|FG000|Overall Study|Protocol Violation|3|||
146781786|NCT05058391|529371888|FG000|Overall Study|Adverse Event|1|||
146781787|NCT03833245|529371890|FG000|Overall Study|Death|0|||
146781788|NCT03833245|529371891|FG001|Overall Study|Death|1|||
146781789|NCT03775109|529371892|FG000|Overall Study|Adverse Event|1|||
146781790|NCT03775109|529371893|FG001|Overall Study|Adverse Event|0|||
146781791|NCT03775109|529371892|FG000|Overall Study|COVID-19 outbreak|2|||
146781792|NCT03775109|529371893|FG001|Overall Study|COVID-19 outbreak|0|||
146781793|NCT03775109|529371892|FG000|Overall Study|Lost to Follow-up|0|||
146781794|NCT03775109|529371893|FG001|Overall Study|Lost to Follow-up|2|||
146781795|NCT03775109|529371892|FG000|Overall Study|Withdrawal by Subject|1|||
146781796|NCT03775109|529371893|FG001|Overall Study|Withdrawal by Subject|1|||
146781797|NCT03775109|529371892|FG000|Overall Study|Death|0|||
146781798|NCT03775109|529371893|FG001|Overall Study|Death|1|||
146781799|NCT03775109|529371892|FG000|Overall Study|Lack of Efficacy|1|||
146781800|NCT03775109|529371893|FG001|Overall Study|Lack of Efficacy|0|||
146781801|NCT03347383|529371894|FG000|Overall Study|Death|39|||
146781802|NCT03347383|529371894|FG000|Overall Study|Withdrawal by Subject|3|||
146781803|NCT03347383|529371894|FG000|Overall Study|Lost to Follow-up|9|||
146781804|NCT03896516|529371899|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
146781805|NCT03896516|529371900|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
146781806|NCT03896516|529371899|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
146781807|NCT03896516|529371900|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
146781808|NCT03896516|529371899|FG000|Washout Period|Physician Decision|3|||
146781809|NCT03896516|529371900|FG001|Washout Period|Physician Decision|1|||
146781810|NCT03896516|529371899|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
146781811|NCT03896516|529371900|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
146781812|NCT02682316|529371905|FG000|Overall Study|Benign Final Pathology|27|||
146781813|NCT02682316|529371906|FG001|Overall Study|Benign Final Pathology|26|||
146781814|NCT02682316|529371905|FG000|Overall Study|Reoperation before 30 days|7|||
146781815|NCT02682316|529371906|FG001|Overall Study|Reoperation before 30 days|6|||
146781816|NCT02682316|529371905|FG000|Overall Study|Ineligible|1|||
146781817|NCT02682316|529371906|FG001|Overall Study|Ineligible|0|||
146781818|NCT02682316|529371905|FG000|Overall Study|Death|1|||
146781819|NCT02682316|529371906|FG001|Overall Study|Death|0|||
146781820|NCT02682316|529371905|FG000|Overall Study|Lost to Follow-up|7|||
146781821|NCT02682316|529371906|FG001|Overall Study|Lost to Follow-up|3|||
146781822|NCT02662062|529371912|FG000|Overall Study|Withdrawal by Subject|1|||
146781823|NCT05374837|529371913|FG000|Overall Study|Lost to Follow-up|17|||
146781824|NCT05374837|529371914|FG001|Overall Study|Lost to Follow-up|18|||
146781825|NCT05406921|529371915|FG000|Overall Study|Withdrawal by Subject|25|||
146781826|NCT05406921|529371916|FG001|Overall Study|Withdrawal by Subject|0|||
146781827|NCT05406921|529371917|FG002|Overall Study|Withdrawal by Subject|25|||
146781828|NCT05406921|529371915|FG000|Overall Study|Protocol Violation|0|||
146781829|NCT05406921|529371916|FG001|Overall Study|Protocol Violation|12|||
146781830|NCT05406921|529371917|FG002|Overall Study|Protocol Violation|0|||
146781831|NCT04831281|529371920|FG000|Overall Study|Adverse Event|1|||
146781832|NCT04831281|529371921|FG001|Overall Study|Adverse Event|0|||
146781833|NCT04831281|529371922|FG002|Overall Study|Adverse Event|3|||
146781834|NCT04831281|529371920|FG000|Overall Study|Withdrawal by Subject|0|||
146781835|NCT04831281|529371921|FG001|Overall Study|Withdrawal by Subject|1|||
146781836|NCT04831281|529371922|FG002|Overall Study|Withdrawal by Subject|2|||
146781837|NCT04831281|529371920|FG000|Overall Study|Undetermined|1|||
146781838|NCT04831281|529371921|FG001|Overall Study|Undetermined|1|||
146781839|NCT04831281|529371922|FG002|Overall Study|Undetermined|0|||
146781840|NCT05059262|529371923|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
146781841|NCT05059262|529371924|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
146781842|NCT05059262|529371923|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
146781843|NCT05059262|529371924|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
146781844|NCT05059262|529371923|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
146781845|NCT05059262|529371924|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
146781846|NCT05059262|529371923|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
146781847|NCT05059262|529371924|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
146781848|NCT05059262|529371923|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
146781849|NCT05059262|529371924|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
146781850|NCT05059262|529371923|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
146781851|NCT05059262|529371924|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
146781852|NCT05059262|529371923|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
146781853|NCT05059262|529371924|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
146781854|NCT05059262|529371923|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
146781855|NCT05059262|529371924|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
146781856|NCT05059262|529371923|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
146781857|NCT05059262|529371924|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
146781858|NCT05021640|529371928|FG000|Overall Study|Lost to Follow-up|0|||
146781859|NCT05021640|529371929|FG001|Overall Study|Lost to Follow-up|0|||
146781860|NCT05021640|529371930|FG002|Overall Study|Lost to Follow-up|0|||
146781861|NCT05021640|529371931|FG003|Overall Study|Lost to Follow-up|0|||
146781862|NCT05021640|529371932|FG004|Overall Study|Lost to Follow-up|1|||
146781863|NCT04737772|529371933|FG000|Phase 2 Study|Lost to Follow-up|15|||
146781864|NCT04737772|529371934|FG001|Phase 2 Study|Lost to Follow-up|15|||
146781865|NCT04737772|529371933|FG000|Phase 2 Study|Withdrawal by Subject|0|||
146781866|NCT04737772|529371934|FG001|Phase 2 Study|Withdrawal by Subject|1|||
146720159|NCT03240588|529144308|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
146720160|NCT02091726|529144310|FG000|Overall Study|Lost to Follow-up|6|||
146720161|NCT04066114|529144314|FG000|Overall Study|Adverse Event|1|||
146720162|NCT04066114|529144315|FG001|Overall Study|Adverse Event|0|||
146720163|NCT04066114|529144316|FG002|Overall Study|Adverse Event|0|||
146720164|NCT04066114|529144314|FG000|Overall Study|Withdrawal by Subject|1|||
146720165|NCT04066114|529144315|FG001|Overall Study|Withdrawal by Subject|0|||
146720166|NCT04066114|529144316|FG002|Overall Study|Withdrawal by Subject|0|||
146720167|NCT04066114|529144314|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
146720168|NCT04066114|529144315|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
146720169|NCT04066114|529144316|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
146720170|NCT00434057|529144318|FG000|Overall Study|Withdrawal by Subject|1|||
146720171|NCT00455195|529144321|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
146720172|NCT00455195|529144322|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
146720173|NCT00455195|529144321|FG000|Double-blind Study AGLU02704|Death|1|||
146720174|NCT00455195|529144322|FG001|Double-blind Study AGLU02704|Death|0|||
146720175|NCT00455195|529144321|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
146720176|NCT00455195|529144322|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
146720177|NCT00455195|529144321|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
146720178|NCT00455195|529144322|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
146720179|NCT02148250|529144325|FG000|Screening|Withdrawal by Subject|5|||
146720180|NCT02148250|529144326|FG001|Screening|Withdrawal by Subject|0|||
146720181|NCT00922428|529144327|FG000|Overall Study|retrospective/extremely implausible data|2|||
146720182|NCT00922428|529144327|FG000|Overall Study|no medication use or questionable use|13|||
146720183|NCT04447404|529144331|FG000|Overall Study|Death|2|||
146720184|NCT04447404|529144332|FG001|Overall Study|Death|0|||
146720185|NCT04258020|529144335|FG000|Overall Study|Withdrawal by Subject|1|||
146720186|NCT04258020|529144336|FG001|Overall Study|Withdrawal by Subject|0|||
146720187|NCT02097472|529144337|FG000|Received Vaccination 2|Adverse Event|0|||
146720188|NCT02097472|529144338|FG001|Received Vaccination 2|Adverse Event|0|||
146720189|NCT02097472|529144339|FG002|Received Vaccination 2|Adverse Event|0|||
146720190|NCT02097472|529144340|FG003|Received Vaccination 2|Adverse Event|0|||
146720191|NCT02097472|529144341|FG004|Received Vaccination 2|Adverse Event|0|||
146720192|NCT02097472|529144342|FG005|Received Vaccination 2|Adverse Event|0|||
146720193|NCT02097472|529144343|FG006|Received Vaccination 2|Adverse Event|1|||
146720194|NCT02097472|529144344|FG007|Received Vaccination 2|Adverse Event|0|||
146720195|NCT01519206|529144345|FG000|Overall Study|Lost to Follow-up|3|||
146720196|NCT01519206|529144345|FG000|Overall Study|Missed Visit|2|||
146720197|NCT03579563|529144349|FG000|Overall Study|Lost to Follow-up|0|||
146720198|NCT03579563|529144350|FG001|Overall Study|Lost to Follow-up|0|||
146720199|NCT03579563|529144351|FG002|Overall Study|Lost to Follow-up|0|||
146720200|NCT03579563|529144352|FG003|Overall Study|Lost to Follow-up|0|||
146720201|NCT03579563|529144353|FG004|Overall Study|Lost to Follow-up|1|||
146720202|NCT03579563|529144354|FG005|Overall Study|Lost to Follow-up|0|||
146720203|NCT03579563|529144349|FG000|Overall Study|Lack of Efficacy|1|||
146720204|NCT03579563|529144350|FG001|Overall Study|Lack of Efficacy|1|||
146720205|NCT03579563|529144351|FG002|Overall Study|Lack of Efficacy|4|||
146720206|NCT03579563|529144352|FG003|Overall Study|Lack of Efficacy|1|||
146720207|NCT03579563|529144353|FG004|Overall Study|Lack of Efficacy|2|||
146720208|NCT03579563|529144354|FG005|Overall Study|Lack of Efficacy|3|||
146720209|NCT03579563|529144349|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
146720210|NCT03579563|529144350|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
146720211|NCT03579563|529144351|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
146720212|NCT03579563|529144352|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
146720213|NCT03579563|529144353|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
146720214|NCT03579563|529144354|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
146720215|NCT03579563|529144349|FG000|Overall Study|Time/distance concern|0|||
146720216|NCT03579563|529144350|FG001|Overall Study|Time/distance concern|0|||
146720217|NCT03579563|529144351|FG002|Overall Study|Time/distance concern|1|||
146720218|NCT03579563|529144352|FG003|Overall Study|Time/distance concern|0|||
146720219|NCT03579563|529144353|FG004|Overall Study|Time/distance concern|0|||
146720220|NCT03579563|529144354|FG005|Overall Study|Time/distance concern|1|||
146720221|NCT03579563|529144349|FG000|Overall Study|COVID shutdown|2|||
146720222|NCT03579563|529144350|FG001|Overall Study|COVID shutdown|3|||
146720223|NCT03579563|529144351|FG002|Overall Study|COVID shutdown|4|||
146720224|NCT03579563|529144352|FG003|Overall Study|COVID shutdown|3|||
146720225|NCT03579563|529144353|FG004|Overall Study|COVID shutdown|1|||
146720226|NCT03579563|529144354|FG005|Overall Study|COVID shutdown|2|||
146720227|NCT03579563|529144349|FG000|Overall Study|Protocol administration error|1|||
146720228|NCT03579563|529144350|FG001|Overall Study|Protocol administration error|0|||
146720229|NCT03579563|529144351|FG002|Overall Study|Protocol administration error|1|||
146781867|NCT04737772|529371933|FG000|Phase 2 Study|Did not take any coaching calls|4|||
146781868|NCT04737772|529371934|FG001|Phase 2 Study|Did not take any coaching calls|0|||
146720230|NCT03579563|529144352|FG003|Overall Study|Protocol administration error|0|||
146720231|NCT03579563|529144353|FG004|Overall Study|Protocol administration error|1|||
146720232|NCT03579563|529144354|FG005|Overall Study|Protocol administration error|5|||
146720233|NCT04349553|529144358|FG000|Overall Study|Withdrawal by Subject|1|||
146720234|NCT04349553|529144359|FG001|Overall Study|Withdrawal by Subject|0|||
146720235|NCT04349553|529144360|FG002|Overall Study|Withdrawal by Subject|1|||
146720236|NCT04349553|529144361|FG003|Overall Study|Withdrawal by Subject|0|||
146720237|NCT03526250|529144362|FG000|Overall Study|Adverse Event|4|||
146720238|NCT03526250|529144362|FG000|Overall Study|Progressive Disease|16|||
146720239|NCT03526250|529144362|FG000|Overall Study|No Treatment|3|||
146720240|NCT04420221|529144363|FG000|Overall Study|Withdrawal by Subject|0|||
146720241|NCT04420221|529144364|FG001|Overall Study|Withdrawal by Subject|0|||
146720242|NCT04420221|529144365|FG002|Overall Study|Withdrawal by Subject|0|||
146720243|NCT04420221|529144366|FG003|Overall Study|Withdrawal by Subject|0|||
146720244|NCT04420221|529144367|FG004|Overall Study|Withdrawal by Subject|0|||
146720245|NCT04420221|529144368|FG005|Overall Study|Withdrawal by Subject|20|||
146720246|NCT04420221|529144369|FG006|Overall Study|Withdrawal by Subject|5|||
146720247|NCT04420221|529144363|FG000|Overall Study|Other|0|||
146720248|NCT04420221|529144364|FG001|Overall Study|Other|0|||
146720249|NCT04420221|529144365|FG002|Overall Study|Other|0|||
146720250|NCT04420221|529144366|FG003|Overall Study|Other|0|||
146720251|NCT04420221|529144367|FG004|Overall Study|Other|0|||
146720252|NCT04420221|529144368|FG005|Overall Study|Other|1|||
146720253|NCT04420221|529144369|FG006|Overall Study|Other|1|||
146720254|NCT04420221|529144363|FG000|Overall Study|Lost to Follow-up|0|||
146720255|NCT04420221|529144364|FG001|Overall Study|Lost to Follow-up|0|||
146720256|NCT04420221|529144365|FG002|Overall Study|Lost to Follow-up|0|||
146720257|NCT04420221|529144366|FG003|Overall Study|Lost to Follow-up|0|||
146720258|NCT04420221|529144367|FG004|Overall Study|Lost to Follow-up|0|||
146720259|NCT04420221|529144368|FG005|Overall Study|Lost to Follow-up|3|||
146720260|NCT04420221|529144369|FG006|Overall Study|Lost to Follow-up|2|||
146720261|NCT04420221|529144363|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
146720262|NCT04420221|529144364|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
146720263|NCT04420221|529144365|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
146720264|NCT04420221|529144366|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
146720265|NCT04420221|529144367|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
146720266|NCT04420221|529144368|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
146720267|NCT04420221|529144369|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
146720268|NCT02219932|529144370|FG000|Overall Study|Other|5|||
146720269|NCT02219932|529144371|FG001|Overall Study|Other|11|||
146720270|NCT02219932|529144370|FG000|Overall Study|Death|1|||
146720271|NCT02219932|529144371|FG001|Overall Study|Death|1|||
146720272|NCT02219932|529144370|FG000|Overall Study|Investigator Decision|0|||
146720273|NCT02219932|529144371|FG001|Overall Study|Investigator Decision|1|||
146720274|NCT02219932|529144370|FG000|Overall Study|Consent Withdrawn|11|||
146720275|NCT02219932|529144371|FG001|Overall Study|Consent Withdrawn|7|||
146720276|NCT02219932|529144370|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
146720277|NCT02219932|529144371|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
146720278|NCT02219932|529144370|FG000|Overall Study|Protocol Violation|10|||
146720279|NCT02219932|529144371|FG001|Overall Study|Protocol Violation|6|||
146720280|NCT02219932|529144370|FG000|Overall Study|Pregnancy|1|||
146720281|NCT02219932|529144371|FG001|Overall Study|Pregnancy|0|||
146720282|NCT02219932|529144370|FG000|Overall Study|Lost to Follow-up|4|||
146720283|NCT02219932|529144371|FG001|Overall Study|Lost to Follow-up|2|||
146720284|NCT02219932|529144370|FG000|Overall Study|Adverse Event|23|||
146720285|NCT02219932|529144371|FG001|Overall Study|Adverse Event|21|||
146720286|NCT01618864|529144372|FG000|Overall Study|Withdrawal by Subject|2|||
146720287|NCT01618864|529144372|FG000|Overall Study|Lost to Follow-up|2|||
146720288|NCT05177770|529144373|FG000|Overall Study|Death|4|||
146720289|NCT05177770|529144373|FG000|Overall Study|Withdrawal by Subject|1|||
146720290|NCT05177770|529144373|FG000|Overall Study|Adverse Event prior to dosing|1|||
146720291|NCT03585244|529144376|FG000|Overall Study|Withdrawal by Subject|15|||
146720292|NCT02105948|529144377|FG000|Overall Study|Adverse Event|10|||
146720293|NCT02105948|529144378|FG001|Overall Study|Adverse Event|7|||
146720294|NCT02105948|529144379|FG002|Overall Study|Adverse Event|11|||
146720295|NCT02105948|529144380|FG003|Overall Study|Adverse Event|11|||
146720296|NCT02105948|529144377|FG000|Overall Study|Lack of Efficacy|0|||
146720297|NCT02105948|529144378|FG001|Overall Study|Lack of Efficacy|1|||
146720298|NCT02105948|529144379|FG002|Overall Study|Lack of Efficacy|3|||
146720299|NCT02105948|529144380|FG003|Overall Study|Lack of Efficacy|2|||
146720300|NCT02105948|529144377|FG000|Overall Study|Lost to Follow-up|0|||
146720301|NCT02105948|529144378|FG001|Overall Study|Lost to Follow-up|0|||
146720302|NCT02105948|529144379|FG002|Overall Study|Lost to Follow-up|2|||
146720303|NCT02105948|529144380|FG003|Overall Study|Lost to Follow-up|1|||
146720304|NCT02105948|529144377|FG000|Overall Study|Physician Decision|2|||
146720305|NCT02105948|529144378|FG001|Overall Study|Physician Decision|2|||
146720306|NCT02105948|529144379|FG002|Overall Study|Physician Decision|2|||
146720307|NCT02105948|529144380|FG003|Overall Study|Physician Decision|2|||
146720308|NCT02105948|529144377|FG000|Overall Study|Withdrawal by Subject|15|||
146720309|NCT02105948|529144378|FG001|Overall Study|Withdrawal by Subject|10|||
146720310|NCT02105948|529144379|FG002|Overall Study|Withdrawal by Subject|10|||
146720311|NCT02105948|529144380|FG003|Overall Study|Withdrawal by Subject|11|||
146720312|NCT03273946|529144385|FG000|Overall Study|Withdrawal by Subject|5|||
146720313|NCT03273946|529144385|FG000|Overall Study|Unwillingness of the guardian|1|||
146720314|NCT03273946|529144385|FG000|Overall Study|Participant refused to use the drug|2|||
146720315|NCT03273946|529144385|FG000|Overall Study|Participant relative refused to use drug|1|||
146720316|NCT01220557|529144387|FG000|Overall Study|Lost to Follow-up|5|||
146720317|NCT01220557|529144388|FG001|Overall Study|Lost to Follow-up|3|||
146720318|NCT01220557|529144387|FG000|Overall Study|attended less than 6 lessons|1|||
146720319|NCT01220557|529144388|FG001|Overall Study|attended less than 6 lessons|2|||
146720320|NCT02199028|529144395|FG000|Week 1|Adverse Event|1|||
146720321|NCT02199028|529144396|FG001|Week 1|Adverse Event|0|||
146720322|NCT02199028|529144395|FG000|Week 3|Adverse Event|1|||
146720323|NCT02199028|529144396|FG001|Week 3|Adverse Event|0|||
146720324|NCT01881126|529144397|FG000|Overall Study|Non-compliance|1|||
146720325|NCT01881126|529144398|FG001|Overall Study|Non-compliance|1|||
146720326|NCT01881126|529144397|FG000|Overall Study|Adverse Event|0|||
146720327|NCT01881126|529144398|FG001|Overall Study|Adverse Event|1|||
146720328|NCT04072159|529144401|FG000|Overall Study|Lost to Follow-up|6|||
146720329|NCT04072159|529144402|FG001|Overall Study|Lost to Follow-up|6|||
146720330|NCT04072159|529144401|FG000|Overall Study|Withdrawal by Subject|2|||
146720331|NCT04072159|529144402|FG001|Overall Study|Withdrawal by Subject|0|||
146720332|NCT00695669|529144405|FG000|Overall Study|Adverse Event|0|||
146720333|NCT00695669|529144406|FG001|Overall Study|Adverse Event|0|||
146720334|NCT00695669|529144407|FG002|Overall Study|Adverse Event|2|||
146720335|NCT00695669|529144408|FG003|Overall Study|Adverse Event|0|||
146720336|NCT00695669|529144405|FG000|Overall Study|Lost to Follow-up|4|||
146720337|NCT00695669|529144406|FG001|Overall Study|Lost to Follow-up|4|||
146720338|NCT00695669|529144407|FG002|Overall Study|Lost to Follow-up|1|||
146720339|NCT00695669|529144408|FG003|Overall Study|Lost to Follow-up|4|||
146720340|NCT05045625|529144409|FG000|Overall Study|Lost to Follow-up|3|||
146720341|NCT00047879|529144411|FG000|Overall Study|Progressive disease|4|||
146720342|NCT00047879|529144412|FG001|Overall Study|Progressive disease|3|||
146720343|NCT01196975|529144414|FG000|Overall Study|Adverse Event|2|||
146720344|NCT01196975|529144415|FG001|Overall Study|Adverse Event|2|||
146720345|NCT01196975|529144416|FG002|Overall Study|Adverse Event|0|||
146720346|NCT01196975|529144417|FG003|Overall Study|Adverse Event|0|||
146720347|NCT01196975|529144418|FG004|Overall Study|Adverse Event|2|||
146720348|NCT01196975|529144414|FG000|Overall Study|Withdrawal by Subject|2|||
146720349|NCT01196975|529144415|FG001|Overall Study|Withdrawal by Subject|1|||
146720350|NCT01196975|529144416|FG002|Overall Study|Withdrawal by Subject|0|||
146720351|NCT01196975|529144417|FG003|Overall Study|Withdrawal by Subject|1|||
146720352|NCT01196975|529144418|FG004|Overall Study|Withdrawal by Subject|0|||
146720353|NCT01196975|529144414|FG000|Overall Study|Lost to Follow-up|11|||
146720354|NCT01196975|529144415|FG001|Overall Study|Lost to Follow-up|6|||
146720355|NCT01196975|529144416|FG002|Overall Study|Lost to Follow-up|5|||
146720356|NCT01196975|529144417|FG003|Overall Study|Lost to Follow-up|5|||
146720357|NCT01196975|529144418|FG004|Overall Study|Lost to Follow-up|11|||
146720358|NCT03738150|529144419|FG000|Base Study|Withdrawal by Subject|1|||
146720359|NCT03738150|529144419|FG000|Extension Study|Withdrawal by Subject|1|||
146720360|NCT01358526|529144434|FG000|Open-label Titration Period|Adverse Event|95|||
146720361|NCT01358526|529144435|FG001|Open-label Titration Period|Adverse Event|0|||
146720362|NCT01358526|529144436|FG002|Open-label Titration Period|Adverse Event|0|||
146720363|NCT01358526|529144434|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
146720364|NCT01358526|529144435|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
146720365|NCT01358526|529144436|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
146720366|NCT01358526|529144434|FG000|Open-label Titration Period|Lost to Follow-up|25|||
146720367|NCT01358526|529144435|FG001|Open-label Titration Period|Lost to Follow-up|0|||
146720368|NCT01358526|529144436|FG002|Open-label Titration Period|Lost to Follow-up|0|||
146720369|NCT01358526|529144434|FG000|Open-label Titration Period|Lack of Efficacy|107|||
146720370|NCT01358526|529144435|FG001|Open-label Titration Period|Lack of Efficacy|0|||
146720371|NCT01358526|529144436|FG002|Open-label Titration Period|Lack of Efficacy|0|||
146720372|NCT01358526|529144434|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
146720373|NCT01358526|529144435|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
146720374|NCT01358526|529144436|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
146720375|NCT01358526|529144434|FG000|Open-label Titration Period|Administrative|8|||
146934213|NCT01432457|529917800|FG001|Overall Study|Did not take study drug|6|||
146720376|NCT01358526|529144435|FG001|Open-label Titration Period|Administrative|0|||
146720377|NCT01358526|529144436|FG002|Open-label Titration Period|Administrative|0|||
146720378|NCT01358526|529144434|FG000|Open-label Titration Period|Did not qualify|178|||
146720379|NCT01358526|529144435|FG001|Open-label Titration Period|Did not qualify|0|||
146720380|NCT01358526|529144436|FG002|Open-label Titration Period|Did not qualify|0|||
146720381|NCT01358526|529144434|FG000|Double-blind Phase|Adverse Event|0|||
146720382|NCT01358526|529144435|FG001|Double-blind Phase|Adverse Event|24|||
146720383|NCT01358526|529144436|FG002|Double-blind Phase|Adverse Event|23|||
146720384|NCT01358526|529144434|FG000|Double-blind Phase|Withdrawal by Subject|0|||
146720385|NCT01358526|529144435|FG001|Double-blind Phase|Withdrawal by Subject|10|||
146720386|NCT01358526|529144436|FG002|Double-blind Phase|Withdrawal by Subject|8|||
146720387|NCT01358526|529144434|FG000|Double-blind Phase|Lost to Follow-up|0|||
146720388|NCT01358526|529144435|FG001|Double-blind Phase|Lost to Follow-up|4|||
146720389|NCT01358526|529144436|FG002|Double-blind Phase|Lost to Follow-up|1|||
146720390|NCT01358526|529144434|FG000|Double-blind Phase|Lack of Efficacy|0|||
146720391|NCT01358526|529144435|FG001|Double-blind Phase|Lack of Efficacy|31|||
146720392|NCT01358526|529144436|FG002|Double-blind Phase|Lack of Efficacy|73|||
146720393|NCT01358526|529144434|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
146720394|NCT01358526|529144435|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
146720395|NCT01358526|529144436|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
146720396|NCT01358526|529144434|FG000|Double-blind Phase|Administrative|0|||
146720397|NCT01358526|529144435|FG001|Double-blind Phase|Administrative|6|||
146720398|NCT01358526|529144436|FG002|Double-blind Phase|Administrative|10|||
146720399|NCT04558346|529144437|FG000|Overall Study|Withdrawal by Subject|2|||
146720400|NCT04558346|529144438|FG001|Overall Study|Withdrawal by Subject|0|||
146720401|NCT04558346|529144437|FG000|Overall Study|Lost to Follow-up|0|||
146720402|NCT04558346|529144438|FG001|Overall Study|Lost to Follow-up|1|||
146720403|NCT04558346|529144437|FG000|Overall Study|Adverse Event|0|||
146720404|NCT04558346|529144438|FG001|Overall Study|Adverse Event|1|||
146720405|NCT01462344|529144439|FG000|Overall Study|Withdrawal by Subject|245|||
146720406|NCT01462344|529144440|FG001|Overall Study|Withdrawal by Subject|226|||
146720407|NCT01462344|529144439|FG000|Overall Study|Adverse Event|24|||
146720408|NCT01462344|529144440|FG001|Overall Study|Adverse Event|23|||
146720409|NCT01462344|529144439|FG000|Overall Study|Asthma Exacerbation|34|||
146720410|NCT01462344|529144440|FG001|Overall Study|Asthma Exacerbation|35|||
146720411|NCT01462344|529144439|FG000|Overall Study|Lack of Efficacy|5|||
146720412|NCT01462344|529144440|FG001|Overall Study|Lack of Efficacy|6|||
146720413|NCT01462344|529144439|FG000|Overall Study|Protocol Violation|68|||
146720414|NCT01462344|529144440|FG001|Overall Study|Protocol Violation|53|||
146720415|NCT01462344|529144439|FG000|Overall Study|Lost to Follow-up|7|||
146720416|NCT01462344|529144440|FG001|Overall Study|Lost to Follow-up|7|||
146720417|NCT01962974|529144443|FG000|Overall Study|Study termination|7|||
146720418|NCT03086447|529144444|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
146720419|NCT03086447|529144445|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
146720420|NCT03086447|529144444|FG000|Overall Study|Lost Lens|2|||
146720421|NCT03086447|529144445|FG001|Overall Study|Lost Lens|5|||
146720422|NCT03086447|529144444|FG000|Overall Study|Product quality complaint|0|||
146720423|NCT03086447|529144445|FG001|Overall Study|Product quality complaint|1|||
146720424|NCT03086447|529144444|FG000|Overall Study|Lens Damage|1|||
146720425|NCT03086447|529144445|FG001|Overall Study|Lens Damage|6|||
146720426|NCT03086447|529144444|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
146720427|NCT03086447|529144445|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
146720428|NCT03086447|529144444|FG000|Overall Study|Test Article No Longer Available|1|||
146720429|NCT03086447|529144445|FG001|Overall Study|Test Article No Longer Available|0|||
146720430|NCT03086447|529144444|FG000|Overall Study|Protocol Violation|2|||
146720431|NCT03086447|529144445|FG001|Overall Study|Protocol Violation|4|||
146720432|NCT03086447|529144444|FG000|Overall Study|Lost to Follow-up|0|||
146720433|NCT03086447|529144445|FG001|Overall Study|Lost to Follow-up|1|||
146720434|NCT03086447|529144444|FG000|Overall Study|Adverse Event|3|||
146720435|NCT03086447|529144445|FG001|Overall Study|Adverse Event|0|||
146720436|NCT03086447|529144444|FG000|Overall Study|Lens Discomfort|2|||
146720437|NCT03086447|529144445|FG001|Overall Study|Lens Discomfort|1|||
146720438|NCT00809757|529144447|FG000|Overall Study|Adverse Event|2|||
146720439|NCT00809757|529144448|FG001|Overall Study|Adverse Event|3|||
146720440|NCT00809757|529144449|FG002|Overall Study|Adverse Event|3|||
146720441|NCT00809757|529144447|FG000|Overall Study|Lost to Follow-up|0|||
146720442|NCT00809757|529144448|FG001|Overall Study|Lost to Follow-up|0|||
146720443|NCT00809757|529144449|FG002|Overall Study|Lost to Follow-up|1|||
146720444|NCT00809757|529144447|FG000|Overall Study|Protocol Violation|1|||
146720445|NCT00809757|529144448|FG001|Overall Study|Protocol Violation|1|||
146720446|NCT00809757|529144449|FG002|Overall Study|Protocol Violation|1|||
146720447|NCT00809757|529144447|FG000|Overall Study|Withdrawal by Subject|2|||
146720448|NCT00809757|529144448|FG001|Overall Study|Withdrawal by Subject|1|||
146720449|NCT00809757|529144449|FG002|Overall Study|Withdrawal by Subject|3|||
146720450|NCT00809757|529144447|FG000|Overall Study|Subject Uncooperative|1|||
146720451|NCT00809757|529144448|FG001|Overall Study|Subject Uncooperative|0|||
146720452|NCT00809757|529144449|FG002|Overall Study|Subject Uncooperative|2|||
146720453|NCT00809757|529144447|FG000|Overall Study|Noncompliance with Medication|0|||
146720454|NCT00809757|529144448|FG001|Overall Study|Noncompliance with Medication|0|||
146720455|NCT00809757|529144449|FG002|Overall Study|Noncompliance with Medication|1|||
146720456|NCT00659334|529144450|FG000|Overall Study|Screen Failure|8|||
146720457|NCT00659334|529144451|FG001|Overall Study|Screen Failure|5|||
146720458|NCT00659334|529144452|FG002|Overall Study|Screen Failure|0|||
146720459|NCT00659334|529144453|FG003|Overall Study|Screen Failure|0|||
146720460|NCT00659334|529144454|FG004|Overall Study|Screen Failure|0|||
146781869|NCT04737772|529371933|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
146781870|NCT04737772|529371934|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
146781871|NCT04737772|529371933|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
146781872|NCT04737772|529371934|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
146781873|NCT02549339|529371935|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
146781874|NCT02549339|529371936|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
146781875|NCT02549339|529371935|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
146781876|NCT02549339|529371936|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
146781877|NCT02549339|529371935|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
146781878|NCT02549339|529371936|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
146781879|NCT02549339|529371935|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
146781880|NCT02549339|529371936|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
146781881|NCT02549339|529371935|FG000|12-month Follow-up|Lack of Efficacy|0|||
146781882|NCT02549339|529371936|FG001|12-month Follow-up|Lack of Efficacy|2|||
146781883|NCT02549339|529371935|FG000|12-month Follow-up|Withdrawal by Subject|8|||
146781884|NCT02549339|529371936|FG001|12-month Follow-up|Withdrawal by Subject|3|||
146781885|NCT02549339|529371935|FG000|12-month Follow-up|Lost to Follow-up|1|||
146781886|NCT02549339|529371936|FG001|12-month Follow-up|Lost to Follow-up|3|||
146781887|NCT02549339|529371935|FG000|12-month Follow-up|Other|0|||
146781888|NCT02549339|529371936|FG001|12-month Follow-up|Other|3|||
146781889|NCT05691309|529371937|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
146781890|NCT05691309|529371937|FG000|Overall Study|vancomycin levels not evaluable|2|||
146781891|NCT04382898|529371944|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
146781892|NCT04382898|529371945|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
146781893|NCT04382898|529371946|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
146781894|NCT04382898|529371947|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
146781895|NCT04382898|529371948|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
146781896|NCT04382898|529371944|FG000|Part 1: Dose Titration|Death|6|||
146781897|NCT04382898|529371945|FG001|Part 1: Dose Titration|Death|0|||
146781898|NCT04382898|529371946|FG002|Part 1: Dose Titration|Death|0|||
146781899|NCT04382898|529371947|FG003|Part 1: Dose Titration|Death|0|||
146781900|NCT04382898|529371948|FG004|Part 1: Dose Titration|Death|0|||
146781901|NCT04382898|529371944|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146720461|NCT00659334|529144455|FG005|Overall Study|Screen Failure|0|||
146720462|NCT00659334|529144456|FG006|Overall Study|Screen Failure|1|||
146720463|NCT01174342|529144457|FG000|Overall Study|Conversion to cesarean section|4|||
146720464|NCT03069482|529147075|FG000|Overall Study|Lost to Follow-up|0|||
146720465|NCT03069482|529147076|FG001|Overall Study|Lost to Follow-up|1|||
146720466|NCT03069482|529147075|FG000|Overall Study|Physician Decision|1|||
146720467|NCT03069482|529147076|FG001|Overall Study|Physician Decision|0|||
146720468|NCT01983293|529147082|FG000|Overall Study|Withdrawal by Subject|29|||
146720469|NCT01983293|529147083|FG001|Overall Study|Withdrawal by Subject|15|||
146720470|NCT01983293|529147082|FG000|Overall Study|Missing 12-month visit|3|||
146720471|NCT01983293|529147083|FG001|Overall Study|Missing 12-month visit|3|||
146720472|NCT01983293|529147082|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
146720473|NCT01983293|529147083|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
146720474|NCT03147248|529147085|FG000|Overall Study|Adverse Event|0|||
146720475|NCT03147248|529147086|FG001|Overall Study|Adverse Event|2|||
146720476|NCT03147248|529147087|FG002|Overall Study|Adverse Event|2|||
146720477|NCT03147248|529147088|FG003|Overall Study|Adverse Event|2|||
146720478|NCT03147248|529147089|FG004|Overall Study|Adverse Event|6|||
146720479|NCT03147248|529147090|FG005|Overall Study|Adverse Event|11|||
146720480|NCT03147248|529147085|FG000|Overall Study|Disease progression|1|||
146720481|NCT03147248|529147086|FG001|Overall Study|Disease progression|0|||
146720482|NCT03147248|529147087|FG002|Overall Study|Disease progression|0|||
146720483|NCT03147248|529147088|FG003|Overall Study|Disease progression|0|||
146720484|NCT03147248|529147089|FG004|Overall Study|Disease progression|0|||
146720485|NCT03147248|529147090|FG005|Overall Study|Disease progression|2|||
146720486|NCT03147248|529147085|FG000|Overall Study|Withdrawal by Subject|0|||
146720487|NCT03147248|529147086|FG001|Overall Study|Withdrawal by Subject|0|||
146781902|NCT04382898|529371945|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146781903|NCT04382898|529371946|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
146781904|NCT04382898|529371947|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146720488|NCT03147248|529147087|FG002|Overall Study|Withdrawal by Subject|0|||
146720489|NCT03147248|529147088|FG003|Overall Study|Withdrawal by Subject|0|||
146720490|NCT03147248|529147089|FG004|Overall Study|Withdrawal by Subject|12|||
146720491|NCT03147248|529147090|FG005|Overall Study|Withdrawal by Subject|9|||
146720492|NCT03147248|529147085|FG000|Overall Study|Protocol Violation|0|||
146720493|NCT03147248|529147086|FG001|Overall Study|Protocol Violation|0|||
146781905|NCT04382898|529371948|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146781906|NCT04382898|529371944|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
146781907|NCT04382898|529371945|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
146781908|NCT04382898|529371946|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
146781909|NCT04382898|529371947|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
146781910|NCT04382898|529371948|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
146781911|NCT04382898|529371944|FG000|Part 2: Dose Expansion|Death|0|||
146720494|NCT03147248|529147087|FG002|Overall Study|Protocol Violation|0|||
146720495|NCT03147248|529147088|FG003|Overall Study|Protocol Violation|0|||
146720496|NCT03147248|529147089|FG004|Overall Study|Protocol Violation|2|||
146720497|NCT03147248|529147090|FG005|Overall Study|Protocol Violation|0|||
146720498|NCT03147248|529147085|FG000|Overall Study|Lost to Follow-up|0|||
146720499|NCT03147248|529147086|FG001|Overall Study|Lost to Follow-up|0|||
146720500|NCT03147248|529147087|FG002|Overall Study|Lost to Follow-up|0|||
146720501|NCT03147248|529147088|FG003|Overall Study|Lost to Follow-up|0|||
146720502|NCT03147248|529147089|FG004|Overall Study|Lost to Follow-up|2|||
146720503|NCT03147248|529147090|FG005|Overall Study|Lost to Follow-up|0|||
146720504|NCT03147248|529147085|FG000|Overall Study|Pregnancy|0|||
146720505|NCT03147248|529147086|FG001|Overall Study|Pregnancy|0|||
146720506|NCT03147248|529147087|FG002|Overall Study|Pregnancy|0|||
146720507|NCT03147248|529147088|FG003|Overall Study|Pregnancy|0|||
146720508|NCT03147248|529147089|FG004|Overall Study|Pregnancy|1|||
146720509|NCT03147248|529147090|FG005|Overall Study|Pregnancy|0|||
146720510|NCT03147248|529147085|FG000|Overall Study|Death|0|||
146720511|NCT03147248|529147086|FG001|Overall Study|Death|0|||
146720512|NCT03147248|529147087|FG002|Overall Study|Death|0|||
146720513|NCT03147248|529147088|FG003|Overall Study|Death|0|||
146720514|NCT03147248|529147089|FG004|Overall Study|Death|0|||
146720515|NCT03147248|529147090|FG005|Overall Study|Death|4|||
146720516|NCT03147248|529147085|FG000|Overall Study|Physician Decision|0|||
146720517|NCT03147248|529147086|FG001|Overall Study|Physician Decision|0|||
146720518|NCT03147248|529147087|FG002|Overall Study|Physician Decision|0|||
146720519|NCT03147248|529147088|FG003|Overall Study|Physician Decision|0|||
146720520|NCT03147248|529147089|FG004|Overall Study|Physician Decision|2|||
146720521|NCT03147248|529147090|FG005|Overall Study|Physician Decision|4|||
146720522|NCT03147248|529147085|FG000|Overall Study|Prolonged Dosing Interval|0|||
146720523|NCT03147248|529147086|FG001|Overall Study|Prolonged Dosing Interval|0|||
146720524|NCT03147248|529147087|FG002|Overall Study|Prolonged Dosing Interval|0|||
146720525|NCT03147248|529147088|FG003|Overall Study|Prolonged Dosing Interval|0|||
146720526|NCT03147248|529147089|FG004|Overall Study|Prolonged Dosing Interval|1|||
146720527|NCT03147248|529147090|FG005|Overall Study|Prolonged Dosing Interval|1|||
146720528|NCT03750552|529147091|FG000|Overall Study|Adverse Event|5|||
146720529|NCT03750552|529147092|FG001|Overall Study|Adverse Event|1|||
146720530|NCT03750552|529147091|FG000|Overall Study|Withdrawal by Subject|1|||
146720531|NCT03750552|529147092|FG001|Overall Study|Withdrawal by Subject|1|||
146720532|NCT03750552|529147091|FG000|Overall Study|Other|2|||
146720533|NCT03750552|529147092|FG001|Overall Study|Other|0|||
146720534|NCT02062632|529147093|FG000|Overall Study|No treatment data|1|||
146720535|NCT00773968|529147096|FG000|Overall Study|Adverse Event|2|||
146720536|NCT00773968|529147096|FG000|Overall Study|Death|1|||
146720537|NCT00773968|529147096|FG000|Overall Study|Failure to Return|2|||
146720538|NCT00773968|529147096|FG000|Overall Study|Lack of Efficacy|3|||
146720539|NCT00773968|529147096|FG000|Overall Study|Protocol Violation|1|||
146720540|NCT00773968|529147096|FG000|Overall Study|Withdrawal by Subject|11|||
146720541|NCT00773968|529147096|FG000|Overall Study|Screen Failure|17|||
146720542|NCT00773968|529147096|FG000|Overall Study|Other|8|||
146720543|NCT02008890|529147104|FG000|Period 1|Withdrawal by Subject|7|||
146720544|NCT02008890|529147105|FG001|Period 1|Withdrawal by Subject|7|||
146720545|NCT02008890|529147106|FG002|Period 1|Withdrawal by Subject|5|||
146720546|NCT02008890|529147107|FG003|Period 1|Withdrawal by Subject|0|||
146720547|NCT02008890|529147108|FG004|Period 1|Withdrawal by Subject|0|||
146720548|NCT02008890|529147104|FG000|Period 1|Pregnancy|1|||
146720549|NCT02008890|529147105|FG001|Period 1|Pregnancy|0|||
146720550|NCT02008890|529147106|FG002|Period 1|Pregnancy|0|||
146720551|NCT02008890|529147107|FG003|Period 1|Pregnancy|0|||
146720552|NCT02008890|529147108|FG004|Period 1|Pregnancy|0|||
146720553|NCT02008890|529147104|FG000|Period 1|Physician Decision|1|||
146720554|NCT02008890|529147105|FG001|Period 1|Physician Decision|0|||
146720555|NCT02008890|529147106|FG002|Period 1|Physician Decision|1|||
146720556|NCT02008890|529147107|FG003|Period 1|Physician Decision|0|||
146720557|NCT02008890|529147108|FG004|Period 1|Physician Decision|0|||
146720558|NCT02008890|529147104|FG000|Period 1|Adverse Event|6|||
146720559|NCT02008890|529147105|FG001|Period 1|Adverse Event|8|||
146781912|NCT04382898|529371945|FG001|Part 2: Dose Expansion|Death|17|||
146981334|NCT00545233|530093866|FG000|Overall Study|Insufficient response|14|||
146720560|NCT02008890|529147106|FG002|Period 1|Adverse Event|6|||
146720561|NCT02008890|529147107|FG003|Period 1|Adverse Event|0|||
146720562|NCT02008890|529147108|FG004|Period 1|Adverse Event|0|||
146720563|NCT02008890|529147104|FG000|Period 2|Adverse Event|12|||
146720564|NCT02008890|529147105|FG001|Period 2|Adverse Event|7|||
146720565|NCT02008890|529147106|FG002|Period 2|Adverse Event|0|||
146720566|NCT02008890|529147107|FG003|Period 2|Adverse Event|5|||
146781913|NCT04382898|529371946|FG002|Part 2: Dose Expansion|Death|13|||
146720567|NCT02008890|529147108|FG004|Period 2|Adverse Event|5|||
146720568|NCT02008890|529147104|FG000|Period 2|Withdrawal by Subject|11|||
146720569|NCT02008890|529147105|FG001|Period 2|Withdrawal by Subject|8|||
146720570|NCT02008890|529147106|FG002|Period 2|Withdrawal by Subject|0|||
146720571|NCT02008890|529147107|FG003|Period 2|Withdrawal by Subject|7|||
146720572|NCT02008890|529147108|FG004|Period 2|Withdrawal by Subject|2|||
146720573|NCT02008890|529147104|FG000|Period 2|Physician Decision|4|||
146720574|NCT02008890|529147105|FG001|Period 2|Physician Decision|0|||
146720575|NCT02008890|529147106|FG002|Period 2|Physician Decision|0|||
146720576|NCT02008890|529147107|FG003|Period 2|Physician Decision|2|||
146720577|NCT02008890|529147108|FG004|Period 2|Physician Decision|1|||
146720578|NCT02008890|529147104|FG000|Period 2|Lost to Follow-up|0|||
146720579|NCT02008890|529147105|FG001|Period 2|Lost to Follow-up|0|||
146720580|NCT02008890|529147106|FG002|Period 2|Lost to Follow-up|1|||
146720581|NCT02008890|529147107|FG003|Period 2|Lost to Follow-up|0|||
146720582|NCT02008890|529147108|FG004|Period 2|Lost to Follow-up|0|||
146720583|NCT02008890|529147104|FG000|Extension Period|Withdrawal by Subject|3|||
146720584|NCT02008890|529147105|FG001|Extension Period|Withdrawal by Subject|2|||
146720585|NCT02008890|529147106|FG002|Extension Period|Withdrawal by Subject|0|||
146720586|NCT02008890|529147107|FG003|Extension Period|Withdrawal by Subject|4|||
146720587|NCT02008890|529147108|FG004|Extension Period|Withdrawal by Subject|2|||
146720588|NCT02008890|529147104|FG000|Extension Period|Lost to Follow-up|1|||
146720589|NCT02008890|529147105|FG001|Extension Period|Lost to Follow-up|0|||
146720590|NCT02008890|529147106|FG002|Extension Period|Lost to Follow-up|0|||
146720591|NCT02008890|529147107|FG003|Extension Period|Lost to Follow-up|0|||
146720592|NCT02008890|529147108|FG004|Extension Period|Lost to Follow-up|0|||
146720593|NCT02008890|529147104|FG000|Extension Period|Adverse Event|1|||
146720594|NCT02008890|529147105|FG001|Extension Period|Adverse Event|3|||
146720595|NCT02008890|529147106|FG002|Extension Period|Adverse Event|0|||
146720596|NCT02008890|529147107|FG003|Extension Period|Adverse Event|0|||
146720597|NCT02008890|529147108|FG004|Extension Period|Adverse Event|2|||
146720598|NCT02332720|529147109|FG000|Part A and Part B|Lost to Follow-up|1|||
146720599|NCT02332720|529147110|FG001|Part A and Part B|Lost to Follow-up|0|||
146720600|NCT02332720|529147111|FG002|Part A and Part B|Lost to Follow-up|0|||
146720601|NCT02332720|529147112|FG003|Part A and Part B|Lost to Follow-up|0|||
146720602|NCT02332720|529147113|FG004|Part A and Part B|Lost to Follow-up|0|||
146720603|NCT02332720|529147114|FG005|Part A and Part B|Lost to Follow-up|2|||
146720604|NCT02332720|529147115|FG006|Part A and Part B|Lost to Follow-up|1|||
146720605|NCT02332720|529147116|FG007|Part A and Part B|Lost to Follow-up|1|||
146720606|NCT02332720|529147117|FG008|Part A and Part B|Lost to Follow-up|0|||
146720607|NCT02332720|529147118|FG009|Part A and Part B|Lost to Follow-up|0|||
146720608|NCT02332720|529147119|FG010|Part A and Part B|Lost to Follow-up|0|||
146720609|NCT02332720|529147120|FG011|Part A and Part B|Lost to Follow-up|0|||
146720610|NCT02332720|529147121|FG012|Part A and Part B|Lost to Follow-up|0|||
146720611|NCT02332720|529147122|FG013|Part A and Part B|Lost to Follow-up|0|||
146720612|NCT02332720|529147123|FG014|Part A and Part B|Lost to Follow-up|0|||
146720613|NCT02332720|529147124|FG015|Part A and Part B|Lost to Follow-up|1|||
146720614|NCT02332720|529147125|FG016|Part A and Part B|Lost to Follow-up|0|||
146720615|NCT02332720|529147126|FG017|Part A and Part B|Lost to Follow-up|0|||
146720616|NCT02332720|529147127|FG018|Part A and Part B|Lost to Follow-up|0|||
146720617|NCT02332720|529147128|FG019|Part A and Part B|Lost to Follow-up|0|||
146720618|NCT02332720|529147129|FG020|Part A and Part B|Lost to Follow-up|0|||
146720619|NCT02332720|529147130|FG021|Part A and Part B|Lost to Follow-up|0|||
146720620|NCT02332720|529147131|FG022|Part A and Part B|Lost to Follow-up|0|||
146720621|NCT02332720|529147109|FG000|Part A and Part B|Adverse Event|0|||
146720622|NCT02332720|529147110|FG001|Part A and Part B|Adverse Event|0|||
146720623|NCT02332720|529147111|FG002|Part A and Part B|Adverse Event|0|||
146720624|NCT02332720|529147112|FG003|Part A and Part B|Adverse Event|0|||
146720625|NCT02332720|529147113|FG004|Part A and Part B|Adverse Event|0|||
146720626|NCT02332720|529147114|FG005|Part A and Part B|Adverse Event|0|||
146720627|NCT02332720|529147115|FG006|Part A and Part B|Adverse Event|0|||
146720628|NCT02332720|529147116|FG007|Part A and Part B|Adverse Event|0|||
146720629|NCT02332720|529147117|FG008|Part A and Part B|Adverse Event|0|||
146720630|NCT02332720|529147118|FG009|Part A and Part B|Adverse Event|0|||
146720631|NCT02332720|529147119|FG010|Part A and Part B|Adverse Event|0|||
146720632|NCT02332720|529147120|FG011|Part A and Part B|Adverse Event|0|||
146720633|NCT02332720|529147121|FG012|Part A and Part B|Adverse Event|0|||
146720634|NCT02332720|529147122|FG013|Part A and Part B|Adverse Event|0|||
146720635|NCT02332720|529147123|FG014|Part A and Part B|Adverse Event|0|||
146720636|NCT02332720|529147124|FG015|Part A and Part B|Adverse Event|0|||
146981335|NCT00545233|530093867|FG001|Overall Study|Insufficient response|15|||
146981336|NCT00545233|530093866|FG000|Overall Study|Physician Decision|2|||
146720637|NCT02332720|529147125|FG016|Part A and Part B|Adverse Event|0|||
146720638|NCT02332720|529147126|FG017|Part A and Part B|Adverse Event|1|||
146720639|NCT02332720|529147127|FG018|Part A and Part B|Adverse Event|0|||
146720640|NCT02332720|529147128|FG019|Part A and Part B|Adverse Event|0|||
146720641|NCT02332720|529147129|FG020|Part A and Part B|Adverse Event|0|||
146720642|NCT02332720|529147130|FG021|Part A and Part B|Adverse Event|0|||
146720643|NCT02332720|529147131|FG022|Part A and Part B|Adverse Event|0|||
146720644|NCT02332720|529147109|FG000|Part A and Part B|Physician Decision|0|||
146981337|NCT00545233|530093867|FG001|Overall Study|Physician Decision|1|||
146720645|NCT02332720|529147110|FG001|Part A and Part B|Physician Decision|0|||
146720646|NCT02332720|529147111|FG002|Part A and Part B|Physician Decision|0|||
146781914|NCT04382898|529371947|FG003|Part 2: Dose Expansion|Death|1|||
146781915|NCT04382898|529371948|FG004|Part 2: Dose Expansion|Death|0|||
146781916|NCT04382898|529371944|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
146781917|NCT04382898|529371945|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
146781918|NCT04382898|529371946|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
146781919|NCT04382898|529371947|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
146781920|NCT04382898|529371948|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
146781921|NCT04382898|529371944|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
146781922|NCT04382898|529371945|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
146781923|NCT04382898|529371946|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
146781924|NCT04382898|529371947|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
146781925|NCT04382898|529371948|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
146781926|NCT04382898|529371944|FG000|Part 2: Dose Expansion|Other|0|||
146781927|NCT04382898|529371945|FG001|Part 2: Dose Expansion|Other|0|||
146781928|NCT04382898|529371946|FG002|Part 2: Dose Expansion|Other|1|||
146781929|NCT04382898|529371947|FG003|Part 2: Dose Expansion|Other|0|||
146781930|NCT04382898|529371948|FG004|Part 2: Dose Expansion|Other|0|||
146781931|NCT05229120|529371949|FG000|Overall Study|Withdrawal by Subject|8|||
146781932|NCT05956002|529371950|FG000|Treatment Period 3|Adverse Event|0|||
146781933|NCT05956002|529371951|FG001|Treatment Period 3|Adverse Event|0|||
146781934|NCT05956002|529371952|FG002|Treatment Period 3|Adverse Event|1|||
146781935|NCT05956002|529371953|FG003|Treatment Period 3|Adverse Event|0|||
146781936|NCT02307565|529371954|FG000|Overall Study|Adverse Event|3|||
146781937|NCT02307565|529371955|FG001|Overall Study|Adverse Event|2|||
146781938|NCT02307565|529371954|FG000|Overall Study|Withdrawal by Subject|2|||
146781939|NCT02307565|529371955|FG001|Overall Study|Withdrawal by Subject|2|||
146781940|NCT04936035|529371956|FG000|Overall Study|Adverse Event|0|||
146781941|NCT04936035|529371957|FG001|Overall Study|Adverse Event|1|||
146781942|NCT04936035|529371958|FG002|Overall Study|Adverse Event|0|||
146781943|NCT04936035|529371959|FG003|Overall Study|Adverse Event|0|||
146781944|NCT04936035|529371960|FG004|Overall Study|Adverse Event|0|||
146781945|NCT04936035|529371956|FG000|Overall Study|Death|0|||
146781946|NCT04936035|529371957|FG001|Overall Study|Death|0|||
146781947|NCT04936035|529371958|FG002|Overall Study|Death|0|||
146781948|NCT04936035|529371959|FG003|Overall Study|Death|1|||
146781949|NCT04936035|529371960|FG004|Overall Study|Death|0|||
146781950|NCT04936035|529371956|FG000|Overall Study|Lost to Follow-up|0|||
146781951|NCT04936035|529371957|FG001|Overall Study|Lost to Follow-up|1|||
146781952|NCT04936035|529371958|FG002|Overall Study|Lost to Follow-up|1|||
146781953|NCT04936035|529371959|FG003|Overall Study|Lost to Follow-up|2|||
146781954|NCT04936035|529371960|FG004|Overall Study|Lost to Follow-up|1|||
146781955|NCT04936035|529371956|FG000|Overall Study|Physician Decision|0|||
146781956|NCT04936035|529371957|FG001|Overall Study|Physician Decision|1|||
146781957|NCT04936035|529371958|FG002|Overall Study|Physician Decision|0|||
146781958|NCT04936035|529371959|FG003|Overall Study|Physician Decision|0|||
146781959|NCT04936035|529371960|FG004|Overall Study|Physician Decision|0|||
146781960|NCT04936035|529371956|FG000|Overall Study|Protocol Deviation|0|||
146720647|NCT02332720|529147112|FG003|Part A and Part B|Physician Decision|0|||
146720648|NCT02332720|529147113|FG004|Part A and Part B|Physician Decision|0|||
146720649|NCT02332720|529147114|FG005|Part A and Part B|Physician Decision|0|||
146720650|NCT02332720|529147115|FG006|Part A and Part B|Physician Decision|0|||
146720651|NCT02332720|529147116|FG007|Part A and Part B|Physician Decision|0|||
146720652|NCT02332720|529147117|FG008|Part A and Part B|Physician Decision|0|||
146720653|NCT02332720|529147118|FG009|Part A and Part B|Physician Decision|0|||
146720654|NCT02332720|529147119|FG010|Part A and Part B|Physician Decision|0|||
146720655|NCT02332720|529147120|FG011|Part A and Part B|Physician Decision|0|||
146720656|NCT02332720|529147121|FG012|Part A and Part B|Physician Decision|0|||
146720657|NCT02332720|529147122|FG013|Part A and Part B|Physician Decision|0|||
146720658|NCT02332720|529147123|FG014|Part A and Part B|Physician Decision|0|||
146720659|NCT02332720|529147124|FG015|Part A and Part B|Physician Decision|0|||
146720660|NCT02332720|529147125|FG016|Part A and Part B|Physician Decision|0|||
146720661|NCT02332720|529147126|FG017|Part A and Part B|Physician Decision|0|||
146720662|NCT02332720|529147127|FG018|Part A and Part B|Physician Decision|1|||
146781961|NCT04936035|529371957|FG001|Overall Study|Protocol Deviation|0|||
146781962|NCT04936035|529371958|FG002|Overall Study|Protocol Deviation|1|||
146781963|NCT04936035|529371959|FG003|Overall Study|Protocol Deviation|0|||
146781964|NCT04936035|529371960|FG004|Overall Study|Protocol Deviation|0|||
146781965|NCT04936035|529371956|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
146781966|NCT04936035|529371957|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
146781967|NCT04936035|529371958|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
146781968|NCT04936035|529371959|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
146781969|NCT04936035|529371960|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
146781970|NCT04936035|529371956|FG000|Overall Study|Reason Unknown|0|||
146781971|NCT04936035|529371957|FG001|Overall Study|Reason Unknown|0|||
146781972|NCT04936035|529371958|FG002|Overall Study|Reason Unknown|0|||
146781973|NCT04936035|529371959|FG003|Overall Study|Reason Unknown|0|||
146781974|NCT04936035|529371960|FG004|Overall Study|Reason Unknown|1|||
146781975|NCT04936035|529371956|FG000|Overall Study|Withdrawal by Subject|1|||
146781976|NCT04936035|529371957|FG001|Overall Study|Withdrawal by Subject|0|||
146781977|NCT04936035|529371958|FG002|Overall Study|Withdrawal by Subject|0|||
146781978|NCT04936035|529371959|FG003|Overall Study|Withdrawal by Subject|0|||
146781979|NCT04936035|529371960|FG004|Overall Study|Withdrawal by Subject|0|||
146781980|NCT04936035|529371956|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
146781981|NCT04936035|529371957|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
146781982|NCT04936035|529371958|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
146781983|NCT04936035|529371959|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
146781984|NCT04936035|529371960|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
146781985|NCT04936035|529371956|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
146781986|NCT04936035|529371957|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
146781987|NCT04936035|529371958|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
146781988|NCT04936035|529371959|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
146781989|NCT04936035|529371960|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
146781990|NCT04936035|529371956|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
146781991|NCT04936035|529371957|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
146781992|NCT04936035|529371958|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
146781993|NCT04936035|529371959|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
146781994|NCT04936035|529371960|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
146781995|NCT04401800|529371961|FG000|Overall Study|Death|17|||
146781996|NCT04401800|529371961|FG000|Overall Study|Lost to Follow-up|5|||
146781997|NCT04401800|529371961|FG000|Overall Study|Withdrawal by Subject|4|||
146781998|NCT04391894|529371969|FG000|Overall Study|Adverse Event|1|||
146781999|NCT04391894|529371970|FG001|Overall Study|Adverse Event|1|||
146782000|NCT04391894|529371971|FG002|Overall Study|Adverse Event|1|||
146782001|NCT04391894|529371972|FG003|Overall Study|Adverse Event|1|||
146782002|NCT04391894|529371973|FG004|Overall Study|Adverse Event|1|||
146782003|NCT04391894|529371969|FG000|Overall Study|Lost to Follow-up|1|||
146782004|NCT04391894|529371970|FG001|Overall Study|Lost to Follow-up|0|||
146782005|NCT04391894|529371971|FG002|Overall Study|Lost to Follow-up|0|||
146720663|NCT02332720|529147128|FG019|Part A and Part B|Physician Decision|0|||
146720664|NCT02332720|529147129|FG020|Part A and Part B|Physician Decision|0|||
146720665|NCT02332720|529147130|FG021|Part A and Part B|Physician Decision|0|||
146720666|NCT02332720|529147131|FG022|Part A and Part B|Physician Decision|0|||
146720667|NCT02332720|529147109|FG000|Part A and Part B|Withdrawal by Subject|0|||
146720668|NCT02332720|529147110|FG001|Part A and Part B|Withdrawal by Subject|0|||
146720669|NCT02332720|529147111|FG002|Part A and Part B|Withdrawal by Subject|0|||
146720670|NCT02332720|529147112|FG003|Part A and Part B|Withdrawal by Subject|0|||
146720671|NCT02332720|529147113|FG004|Part A and Part B|Withdrawal by Subject|0|||
146720672|NCT02332720|529147114|FG005|Part A and Part B|Withdrawal by Subject|1|||
146720673|NCT02332720|529147115|FG006|Part A and Part B|Withdrawal by Subject|0|||
146720674|NCT02332720|529147116|FG007|Part A and Part B|Withdrawal by Subject|0|||
146720675|NCT02332720|529147117|FG008|Part A and Part B|Withdrawal by Subject|0|||
146720676|NCT02332720|529147118|FG009|Part A and Part B|Withdrawal by Subject|0|||
146720677|NCT02332720|529147119|FG010|Part A and Part B|Withdrawal by Subject|0|||
146720678|NCT02332720|529147120|FG011|Part A and Part B|Withdrawal by Subject|0|||
146720679|NCT02332720|529147121|FG012|Part A and Part B|Withdrawal by Subject|0|||
146720680|NCT02332720|529147122|FG013|Part A and Part B|Withdrawal by Subject|0|||
146720681|NCT02332720|529147123|FG014|Part A and Part B|Withdrawal by Subject|0|||
146720682|NCT02332720|529147124|FG015|Part A and Part B|Withdrawal by Subject|0|||
146720683|NCT02332720|529147125|FG016|Part A and Part B|Withdrawal by Subject|0|||
146720684|NCT02332720|529147126|FG017|Part A and Part B|Withdrawal by Subject|0|||
146720685|NCT02332720|529147127|FG018|Part A and Part B|Withdrawal by Subject|0|||
146720686|NCT02332720|529147128|FG019|Part A and Part B|Withdrawal by Subject|1|||
146782006|NCT04391894|529371972|FG003|Overall Study|Lost to Follow-up|0|||
146782007|NCT04391894|529371973|FG004|Overall Study|Lost to Follow-up|0|||
146782008|NCT04391894|529371969|FG000|Overall Study|Protocol Violation|0|||
146782009|NCT04391894|529371970|FG001|Overall Study|Protocol Violation|0|||
146782010|NCT04391894|529371971|FG002|Overall Study|Protocol Violation|0|||
146782011|NCT04391894|529371972|FG003|Overall Study|Protocol Violation|1|||
146782012|NCT04391894|529371973|FG004|Overall Study|Protocol Violation|0|||
146782013|NCT04391894|529371969|FG000|Overall Study|Withdrawal by Subject|2|||
146981338|NCT00479401|530093871|FG000|Overall Study|Adverse Event|24|||
146720687|NCT02332720|529147129|FG020|Part A and Part B|Withdrawal by Subject|0|||
146720688|NCT02332720|529147130|FG021|Part A and Part B|Withdrawal by Subject|0|||
146720689|NCT02332720|529147131|FG022|Part A and Part B|Withdrawal by Subject|0|||
146720690|NCT05912400|529147132|FG000|Overall Study|Lost to Follow-up|1|||
146720691|NCT05912400|529147133|FG001|Overall Study|Lost to Follow-up|0|||
146720692|NCT05912400|529147132|FG000|Overall Study|Physician Decision|6|||
146720693|NCT05912400|529147133|FG001|Overall Study|Physician Decision|0|||
146720694|NCT05912400|529147132|FG000|Overall Study|Withdrawal by Subject|1|||
146720695|NCT05912400|529147133|FG001|Overall Study|Withdrawal by Subject|0|||
146720696|NCT02522494|529147136|FG000|Overall Study|Lost to Follow-up|6|||
146720697|NCT02522494|529147137|FG001|Overall Study|Lost to Follow-up|2|||
146720698|NCT02522494|529147136|FG000|Overall Study|Withdrawal by Subject|1|||
146720699|NCT02522494|529147137|FG001|Overall Study|Withdrawal by Subject|0|||
146720700|NCT02522494|529147136|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
146720701|NCT02522494|529147137|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
146720702|NCT02522494|529147136|FG000|Overall Study|Participant did not watch the video|1|||
146720703|NCT02522494|529147137|FG001|Overall Study|Participant did not watch the video|0|||
146720704|NCT02522494|529147136|FG000|Overall Study|Death|0|||
146720705|NCT02522494|529147137|FG001|Overall Study|Death|1|||
146720706|NCT03461003|529147142|FG000|Overall Study|Lost to Follow-up|2|||
146720707|NCT03461003|529147143|FG001|Overall Study|Lost to Follow-up|2|||
146720708|NCT03461003|529147142|FG000|Overall Study|Withdrawal by Subject|3|||
146720709|NCT03461003|529147143|FG001|Overall Study|Withdrawal by Subject|1|||
146720710|NCT02047045|529147146|FG000|Baseline|Withdrawal by Subject|3|||
146720711|NCT02047045|529147147|FG001|Baseline|Withdrawal by Subject|2|||
146720712|NCT02047045|529147146|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
146720713|NCT02047045|529147147|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
146720714|NCT02047045|529147146|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
146720715|NCT02047045|529147147|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
146720716|NCT02047045|529147146|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
146720717|NCT02047045|529147147|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
146720718|NCT02047045|529147146|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
146720719|NCT02047045|529147147|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
146720720|NCT02047045|529147146|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
146720721|NCT02047045|529147147|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
146720722|NCT02047045|529147146|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
146720723|NCT02047045|529147147|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
146720724|NCT02047045|529147146|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
146720725|NCT02047045|529147147|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
146720726|NCT02047045|529147146|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
146720727|NCT02047045|529147147|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
146720728|NCT00856856|529147148|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
146720729|NCT00856856|529147148|FG000|4-year Clinical Follow-up|Missed visit|1|||
146720730|NCT02117570|529147151|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
146720731|NCT02117570|529147152|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
146720732|NCT02117570|529147153|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
146720733|NCT02117570|529147151|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
146720734|NCT02117570|529147152|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
146720735|NCT02117570|529147153|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
146720736|NCT02117570|529147151|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
146720737|NCT02117570|529147152|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
146720738|NCT02117570|529147153|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
146720739|NCT02117570|529147151|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
146720740|NCT02117570|529147152|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
146720741|NCT02117570|529147153|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
146720742|NCT02117570|529147151|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
146720743|NCT02117570|529147152|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
146720744|NCT02117570|529147153|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
146720745|NCT02117570|529147151|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
146720746|NCT02117570|529147152|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
146720747|NCT02117570|529147153|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
146720748|NCT02117570|529147151|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
146720749|NCT02117570|529147152|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
146720750|NCT02117570|529147153|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
146720751|NCT03701555|529147165|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
146720752|NCT03701555|529147166|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
146720753|NCT03701555|529147167|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
146720754|NCT03701555|529147168|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
146720755|NCT03701555|529147169|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
146720756|NCT03701555|529147170|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
146720757|NCT03701555|529147171|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
146720758|NCT03701555|529147172|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
146720759|NCT03701555|529147173|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
146720760|NCT03701555|529147174|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
146720761|NCT03701555|529147175|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
146720762|NCT03701555|529147176|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
146782014|NCT04391894|529371970|FG001|Overall Study|Withdrawal by Subject|0|||
146782015|NCT04391894|529371971|FG002|Overall Study|Withdrawal by Subject|3|||
146782016|NCT04391894|529371972|FG003|Overall Study|Withdrawal by Subject|0|||
146782017|NCT04391894|529371973|FG004|Overall Study|Withdrawal by Subject|1|||
146782018|NCT04391894|529371969|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
146782019|NCT04391894|529371970|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
146782020|NCT04391894|529371971|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
146782021|NCT04391894|529371972|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
146782022|NCT04391894|529371973|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
146782023|NCT04757610|529371978|FG000|Overall Study|Adverse Event|13|||
146782024|NCT04757610|529371979|FG001|Overall Study|Adverse Event|10|||
146782025|NCT04757610|529371980|FG002|Overall Study|Adverse Event|5|||
146782026|NCT04757610|529371978|FG000|Overall Study|Death|5|||
146782027|NCT04757610|529371979|FG001|Overall Study|Death|13|||
146782028|NCT04757610|529371980|FG002|Overall Study|Death|8|||
146782029|NCT04757610|529371978|FG000|Overall Study|Lack of Efficacy|1|||
146782030|NCT04757610|529371979|FG001|Overall Study|Lack of Efficacy|2|||
146782031|NCT04757610|529371980|FG002|Overall Study|Lack of Efficacy|3|||
146782032|NCT04757610|529371978|FG000|Overall Study|Lost to Follow-up|7|||
146782033|NCT04757610|529371979|FG001|Overall Study|Lost to Follow-up|2|||
146782034|NCT04757610|529371980|FG002|Overall Study|Lost to Follow-up|7|||
146782035|NCT04757610|529371978|FG000|Overall Study|Physician Decision|4|||
146782036|NCT04757610|529371979|FG001|Overall Study|Physician Decision|1|||
146782037|NCT04757610|529371980|FG002|Overall Study|Physician Decision|2|||
146782038|NCT04757610|529371978|FG000|Overall Study|Withdrawal by Subject|26|||
146782039|NCT04757610|529371979|FG001|Overall Study|Withdrawal by Subject|25|||
146782040|NCT04757610|529371980|FG002|Overall Study|Withdrawal by Subject|25|||
146782041|NCT04757610|529371978|FG000|Overall Study|Study Terminated by Sponsor|105|||
146782042|NCT04757610|529371979|FG001|Overall Study|Study Terminated by Sponsor|105|||
146782043|NCT04757610|529371980|FG002|Overall Study|Study Terminated by Sponsor|110|||
146782044|NCT04757610|529371978|FG000|Overall Study|Randomized in Error|1|||
146782045|NCT04757610|529371979|FG001|Overall Study|Randomized in Error|0|||
146782046|NCT04757610|529371980|FG002|Overall Study|Randomized in Error|0|||
146782047|NCT04774237|529371985|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
146782048|NCT04774237|529371986|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
146782049|NCT04774237|529371987|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
146782050|NCT04774237|529371988|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
146782051|NCT04774237|529371989|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
146782052|NCT04774237|529371990|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
146782053|NCT06143670|529373481|FG000|Overall Study|Lost to Follow-up|0|||
146782054|NCT06143670|529373482|FG001|Overall Study|Lost to Follow-up|1|||
146782055|NCT06143670|529373481|FG000|Overall Study|Withdrawal by Subject|3|||
146782056|NCT06143670|529373482|FG001|Overall Study|Withdrawal by Subject|0|||
146782057|NCT03747484|529373483|FG000|Overall Study|Lack of Efficacy|0|||
146782058|NCT03747484|529373484|FG001|Overall Study|Lack of Efficacy|1|||
146782059|NCT03747484|529373485|FG002|Overall Study|Lack of Efficacy|1|||
146782060|NCT03747484|529373486|FG003|Overall Study|Lack of Efficacy|2|||
146782061|NCT03747484|529373487|FG004|Overall Study|Lack of Efficacy|2|||
146782062|NCT04173663|529373497|FG000|Overall Study|Withdrawal by Subject|1|||
146782063|NCT04173663|529373498|FG001|Overall Study|Withdrawal by Subject|6|||
146782064|NCT04173663|529373497|FG000|Overall Study|Lost to Follow-up|17|||
146782065|NCT04173663|529373498|FG001|Overall Study|Lost to Follow-up|24|||
146782066|NCT04402489|529373500|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
146934214|NCT01432457|529917801|FG002|Overall Study|Did not take study drug|3|||
146934215|NCT05905601|529917803|FG000|Overall Study|Lost to Follow-up|1|||
146934216|NCT05905601|529917804|FG001|Overall Study|Lost to Follow-up|3|||
146934217|NCT03583606|529917805|FG000|Overall Study|Lost to Follow-up|0|||
146934218|NCT03583606|529917806|FG001|Overall Study|Lost to Follow-up|1|||
146720763|NCT03701555|529147177|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
146720764|NCT03701555|529147178|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
146720765|NCT03701555|529147179|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
146720766|NCT03701555|529147180|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
146720767|NCT03701555|529147181|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
146720768|NCT03701555|529147182|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
146720769|NCT03701555|529147183|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
146720770|NCT03701555|529147184|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
146720771|NCT03701555|529147185|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
146720772|NCT03701555|529147186|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
146720773|NCT03701555|529147187|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
146720774|NCT03701555|529147188|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
146720775|NCT03701555|529147189|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
146720776|NCT03701555|529147190|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
146720777|NCT03701555|529147191|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
146720778|NCT03701555|529147192|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
146720779|NCT03701555|529147193|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
146720780|NCT03701555|529147194|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
146720781|NCT03701555|529147195|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
146720782|NCT03701555|529147196|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
146782067|NCT04402489|529373501|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
146782068|NCT04402489|529373502|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
146782069|NCT04402489|529373503|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
146782070|NCT04402489|529373504|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
146782071|NCT04402489|529373500|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
146782072|NCT04402489|529373501|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
146782073|NCT04402489|529373502|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
146782074|NCT04402489|529373503|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
146782075|NCT04402489|529373504|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
146782076|NCT04402489|529373500|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
146782077|NCT04402489|529373501|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
146782078|NCT04402489|529373502|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
146782079|NCT04402489|529373503|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
146782080|NCT04402489|529373504|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
146782081|NCT04402489|529373500|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
146782082|NCT04402489|529373501|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
146782083|NCT04402489|529373502|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
146782084|NCT04402489|529373503|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
146782085|NCT04402489|529373504|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
146782086|NCT04402489|529373500|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
146782087|NCT04402489|529373501|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
146782088|NCT04402489|529373502|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
146782089|NCT04402489|529373503|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
146782090|NCT04402489|529373504|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
146782091|NCT04402489|529373500|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
146782092|NCT04402489|529373501|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
146782093|NCT04402489|529373502|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
146782094|NCT04402489|529373503|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
146782095|NCT04402489|529373504|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
146782096|NCT03089398|529373513|FG000|Overall Study|Death|4|||
146782097|NCT03089398|529373514|FG001|Overall Study|Death|9|||
146782098|NCT03089398|529373513|FG000|Overall Study|Lost to Follow-up|21|||
146782099|NCT03089398|529373514|FG001|Overall Study|Lost to Follow-up|30|||
146782100|NCT03089398|529373513|FG000|Overall Study|Withdrawal by Subject|2|||
146782101|NCT03089398|529373514|FG001|Overall Study|Withdrawal by Subject|2|||
146782102|NCT05439603|529373515|FG000|Overall Study|met withdrawal criteria|2|||
146782103|NCT04630262|529373518|FG000|Overall Study|Intraoperative Screen Failure|5|||
146782104|NCT04630262|529373518|FG000|Overall Study|Study terminated prematurely|71|||
146782105|NCT04630262|529373518|FG000|Overall Study|Withdrawal by Subject|2|||
146782106|NCT04630262|529373518|FG000|Overall Study|Physician Decision|2|||
146782107|NCT01195831|529373519|FG000|Overall Study|Lost to Follow-up|2|||
146782108|NCT01195831|529373520|FG001|Overall Study|Lost to Follow-up|4|||
146782109|NCT01195831|529373519|FG000|Overall Study|Withdrawal by Subject|2|||
146782110|NCT01195831|529373520|FG001|Overall Study|Withdrawal by Subject|2|||
146782111|NCT01195831|529373519|FG000|Overall Study|Adverse Event|4|||
146720783|NCT03701555|529147197|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
146720784|NCT03701555|529147198|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
146720785|NCT03701555|529147199|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
146720786|NCT03701555|529147200|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
146720787|NCT03701555|529147165|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
146720788|NCT03701555|529147166|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
146720789|NCT03701555|529147167|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
146720790|NCT03701555|529147168|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
146720791|NCT03701555|529147169|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
146720792|NCT03701555|529147170|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
146720793|NCT03701555|529147171|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
146720794|NCT03701555|529147172|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
146720795|NCT03701555|529147173|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
146720796|NCT03701555|529147174|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
146720797|NCT03701555|529147175|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
146720798|NCT03701555|529147176|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
146720799|NCT03701555|529147177|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
146720800|NCT03701555|529147178|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
146720801|NCT03701555|529147179|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
146720802|NCT03701555|529147180|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
146720803|NCT03701555|529147181|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
146720804|NCT03701555|529147182|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
146720805|NCT03701555|529147183|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
146720806|NCT03701555|529147184|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
146782112|NCT01195831|529373520|FG001|Overall Study|Adverse Event|2|||
146720807|NCT03701555|529147185|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
146720808|NCT03701555|529147186|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
146720809|NCT03701555|529147187|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
146720810|NCT03701555|529147188|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
146720811|NCT03701555|529147189|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
146720812|NCT03701555|529147190|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
146720813|NCT03701555|529147191|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
146720814|NCT03701555|529147192|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
146720815|NCT03701555|529147193|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
146720816|NCT03701555|529147194|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
146720817|NCT03701555|529147195|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
146720818|NCT03701555|529147196|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
146720819|NCT03701555|529147197|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
146720820|NCT03701555|529147198|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
146720821|NCT03701555|529147199|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
146720822|NCT03701555|529147200|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
146720823|NCT03701555|529147165|FG000|Part 2 (Day 1)|Other|0|||
146720824|NCT03701555|529147166|FG001|Part 2 (Day 1)|Other|0|||
146720825|NCT03701555|529147167|FG002|Part 2 (Day 1)|Other|0|||
146720826|NCT03701555|529147168|FG003|Part 2 (Day 1)|Other|0|||
146720827|NCT03701555|529147169|FG004|Part 2 (Day 1)|Other|0|||
146720828|NCT03701555|529147170|FG005|Part 2 (Day 1)|Other|0|||
146720829|NCT03701555|529147171|FG006|Part 2 (Day 1)|Other|0|||
146720830|NCT03701555|529147172|FG007|Part 2 (Day 1)|Other|0|||
146720831|NCT03701555|529147173|FG008|Part 2 (Day 1)|Other|0|||
146720832|NCT03701555|529147174|FG009|Part 2 (Day 1)|Other|0|||
146720833|NCT03701555|529147175|FG010|Part 2 (Day 1)|Other|3|||
146720834|NCT03701555|529147176|FG011|Part 2 (Day 1)|Other|1|||
146720835|NCT03701555|529147177|FG012|Part 2 (Day 1)|Other|0|||
146720836|NCT03701555|529147178|FG013|Part 2 (Day 1)|Other|1|||
146720837|NCT03701555|529147179|FG014|Part 2 (Day 1)|Other|0|||
146720838|NCT03701555|529147180|FG015|Part 2 (Day 1)|Other|2|||
146720839|NCT03701555|529147181|FG016|Part 2 (Day 1)|Other|2|||
146720840|NCT03701555|529147182|FG017|Part 2 (Day 1)|Other|0|||
146720841|NCT03701555|529147183|FG018|Part 2 (Day 1)|Other|0|||
146720842|NCT03701555|529147184|FG019|Part 2 (Day 1)|Other|0|||
146720843|NCT03701555|529147185|FG020|Part 2 (Day 1)|Other|0|||
146720844|NCT03701555|529147186|FG021|Part 2 (Day 1)|Other|0|||
146720845|NCT03701555|529147187|FG022|Part 2 (Day 1)|Other|0|||
146720846|NCT03701555|529147188|FG023|Part 2 (Day 1)|Other|0|||
146720847|NCT03701555|529147189|FG024|Part 2 (Day 1)|Other|0|||
146720848|NCT03701555|529147190|FG025|Part 2 (Day 1)|Other|0|||
146720849|NCT03701555|529147191|FG026|Part 2 (Day 1)|Other|0|||
146720850|NCT03701555|529147192|FG027|Part 2 (Day 1)|Other|0|||
146720851|NCT03701555|529147193|FG028|Part 2 (Day 1)|Other|0|||
146720852|NCT03701555|529147194|FG029|Part 2 (Day 1)|Other|0|||
146720853|NCT03701555|529147195|FG030|Part 2 (Day 1)|Other|0|||
146720854|NCT03701555|529147196|FG031|Part 2 (Day 1)|Other|0|||
146720855|NCT03701555|529147197|FG032|Part 2 (Day 1)|Other|0|||
146720856|NCT03701555|529147198|FG033|Part 2 (Day 1)|Other|0|||
146720857|NCT03701555|529147199|FG034|Part 2 (Day 1)|Other|0|||
146720858|NCT03701555|529147200|FG035|Part 2 (Day 1)|Other|0|||
146720859|NCT03701555|529147165|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
146720860|NCT03701555|529147166|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
146720861|NCT03701555|529147167|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
146720862|NCT03701555|529147168|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
146720863|NCT03701555|529147169|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
146720864|NCT03701555|529147170|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
146720865|NCT03701555|529147171|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
146720866|NCT03701555|529147172|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
146720867|NCT03701555|529147173|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
146720868|NCT03701555|529147174|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
146720869|NCT03701555|529147175|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
146720870|NCT03701555|529147176|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
146720871|NCT03701555|529147177|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
146720872|NCT03701555|529147178|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
146720873|NCT03701555|529147179|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
146720874|NCT03701555|529147180|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
146720875|NCT03701555|529147181|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
146720876|NCT03701555|529147182|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
146720877|NCT03701555|529147183|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
146720878|NCT03701555|529147184|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
146720879|NCT03701555|529147185|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
146720880|NCT03701555|529147186|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
146720881|NCT03701555|529147187|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
146720882|NCT03701555|529147188|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
146720883|NCT03701555|529147189|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
146720884|NCT03701555|529147190|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
146720885|NCT03701555|529147191|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
146720886|NCT03701555|529147192|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
146720887|NCT03701555|529147193|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
146782113|NCT01195831|529373519|FG000|Overall Study|Protocol Violation|0|||
146720888|NCT03701555|529147194|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
146720889|NCT03701555|529147195|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
146720890|NCT03701555|529147196|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
146720891|NCT03701555|529147197|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
146720892|NCT03701555|529147198|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
146720893|NCT03701555|529147199|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
146720894|NCT03701555|529147200|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
146720895|NCT03701555|529147165|FG000|Part 3 (Day 1)|Subject Decision|0|||
146720896|NCT03701555|529147166|FG001|Part 3 (Day 1)|Subject Decision|0|||
146720897|NCT03701555|529147167|FG002|Part 3 (Day 1)|Subject Decision|0|||
146720898|NCT03701555|529147168|FG003|Part 3 (Day 1)|Subject Decision|0|||
146720899|NCT03701555|529147169|FG004|Part 3 (Day 1)|Subject Decision|0|||
146720900|NCT03701555|529147170|FG005|Part 3 (Day 1)|Subject Decision|0|||
146720901|NCT03701555|529147171|FG006|Part 3 (Day 1)|Subject Decision|0|||
146720902|NCT03701555|529147172|FG007|Part 3 (Day 1)|Subject Decision|0|||
146720903|NCT03701555|529147173|FG008|Part 3 (Day 1)|Subject Decision|0|||
146720904|NCT03701555|529147174|FG009|Part 3 (Day 1)|Subject Decision|0|||
146720905|NCT03701555|529147175|FG010|Part 3 (Day 1)|Subject Decision|0|||
146720906|NCT03701555|529147176|FG011|Part 3 (Day 1)|Subject Decision|0|||
146720907|NCT03701555|529147177|FG012|Part 3 (Day 1)|Subject Decision|0|||
146720908|NCT03701555|529147178|FG013|Part 3 (Day 1)|Subject Decision|0|||
146720909|NCT03701555|529147179|FG014|Part 3 (Day 1)|Subject Decision|0|||
146720910|NCT03701555|529147180|FG015|Part 3 (Day 1)|Subject Decision|0|||
146720911|NCT03701555|529147181|FG016|Part 3 (Day 1)|Subject Decision|0|||
146720912|NCT03701555|529147182|FG017|Part 3 (Day 1)|Subject Decision|0|||
146720913|NCT03701555|529147183|FG018|Part 3 (Day 1)|Subject Decision|0|||
146720914|NCT03701555|529147184|FG019|Part 3 (Day 1)|Subject Decision|0|||
146720915|NCT03701555|529147185|FG020|Part 3 (Day 1)|Subject Decision|0|||
146720916|NCT03701555|529147186|FG021|Part 3 (Day 1)|Subject Decision|0|||
146720917|NCT03701555|529147187|FG022|Part 3 (Day 1)|Subject Decision|0|||
146720918|NCT03701555|529147188|FG023|Part 3 (Day 1)|Subject Decision|0|||
146720919|NCT03701555|529147189|FG024|Part 3 (Day 1)|Subject Decision|0|||
146720920|NCT03701555|529147190|FG025|Part 3 (Day 1)|Subject Decision|0|||
146720921|NCT03701555|529147191|FG026|Part 3 (Day 1)|Subject Decision|1|||
146720922|NCT03701555|529147192|FG027|Part 3 (Day 1)|Subject Decision|0|||
146720923|NCT03701555|529147193|FG028|Part 3 (Day 1)|Subject Decision|0|||
146720924|NCT03701555|529147194|FG029|Part 3 (Day 1)|Subject Decision|0|||
146720925|NCT03701555|529147195|FG030|Part 3 (Day 1)|Subject Decision|0|||
146720926|NCT03701555|529147196|FG031|Part 3 (Day 1)|Subject Decision|2|||
146720927|NCT03701555|529147197|FG032|Part 3 (Day 1)|Subject Decision|1|||
146720928|NCT03701555|529147198|FG033|Part 3 (Day 1)|Subject Decision|1|||
146720929|NCT03701555|529147199|FG034|Part 3 (Day 1)|Subject Decision|0|||
146720930|NCT03701555|529147200|FG035|Part 3 (Day 1)|Subject Decision|0|||
146720931|NCT03701555|529147165|FG000|Part 3 (Day 1)|Other|0|||
146720932|NCT03701555|529147166|FG001|Part 3 (Day 1)|Other|0|||
146720933|NCT03701555|529147167|FG002|Part 3 (Day 1)|Other|0|||
146720934|NCT03701555|529147168|FG003|Part 3 (Day 1)|Other|0|||
146720935|NCT03701555|529147169|FG004|Part 3 (Day 1)|Other|0|||
146720936|NCT03701555|529147170|FG005|Part 3 (Day 1)|Other|0|||
146720937|NCT03701555|529147171|FG006|Part 3 (Day 1)|Other|0|||
146720938|NCT03701555|529147172|FG007|Part 3 (Day 1)|Other|0|||
146720939|NCT03701555|529147173|FG008|Part 3 (Day 1)|Other|0|||
146720940|NCT03701555|529147174|FG009|Part 3 (Day 1)|Other|0|||
146720941|NCT03701555|529147175|FG010|Part 3 (Day 1)|Other|0|||
146720942|NCT03701555|529147176|FG011|Part 3 (Day 1)|Other|0|||
146720943|NCT03701555|529147177|FG012|Part 3 (Day 1)|Other|0|||
146720944|NCT03701555|529147178|FG013|Part 3 (Day 1)|Other|0|||
146720945|NCT03701555|529147179|FG014|Part 3 (Day 1)|Other|0|||
146782114|NCT01195831|529373520|FG001|Overall Study|Protocol Violation|2|||
146782115|NCT04703322|529373521|FG000|Overall Study|Ongoing|8|||
146782116|NCT04703322|529373521|FG000|Overall Study|Withdrawal by Subject|1|||
146782117|NCT01180634|529373524|FG000|Overall Study|Adverse Event|4|||
146782118|NCT01180634|529373525|FG001|Overall Study|Adverse Event|1|||
146782119|NCT01180634|529373524|FG000|Overall Study|Miscellaneous|2|||
146782120|NCT01180634|529373525|FG001|Overall Study|Miscellaneous|0|||
146782121|NCT01180634|529373524|FG000|Overall Study|Withdrawal by Subject|4|||
146782122|NCT01180634|529373525|FG001|Overall Study|Withdrawal by Subject|0|||
146782123|NCT04419168|529373526|FG000|Overall Study|Protocol Violation|1|||
146782124|NCT04419168|529373527|FG001|Overall Study|Protocol Violation|1|||
146782125|NCT04419168|529373526|FG000|Overall Study|Lost to Follow-up|7|||
146782126|NCT04419168|529373527|FG001|Overall Study|Lost to Follow-up|7|||
146720946|NCT03701555|529147180|FG015|Part 3 (Day 1)|Other|0|||
146720947|NCT03701555|529147181|FG016|Part 3 (Day 1)|Other|0|||
146720948|NCT03701555|529147182|FG017|Part 3 (Day 1)|Other|0|||
146720949|NCT03701555|529147183|FG018|Part 3 (Day 1)|Other|0|||
146720950|NCT03701555|529147184|FG019|Part 3 (Day 1)|Other|0|||
146720951|NCT03701555|529147185|FG020|Part 3 (Day 1)|Other|0|||
146720952|NCT03701555|529147186|FG021|Part 3 (Day 1)|Other|0|||
146720953|NCT03701555|529147187|FG022|Part 3 (Day 1)|Other|0|||
146720954|NCT03701555|529147188|FG023|Part 3 (Day 1)|Other|0|||
146720955|NCT03701555|529147189|FG024|Part 3 (Day 1)|Other|1|||
146720956|NCT03701555|529147190|FG025|Part 3 (Day 1)|Other|1|||
146934219|NCT03583606|529917807|FG002|Overall Study|Lost to Follow-up|0|||
146720957|NCT03701555|529147191|FG026|Part 3 (Day 1)|Other|0|||
146720958|NCT03701555|529147192|FG027|Part 3 (Day 1)|Other|0|||
146720959|NCT03701555|529147193|FG028|Part 3 (Day 1)|Other|0|||
146720960|NCT03701555|529147194|FG029|Part 3 (Day 1)|Other|1|||
146720961|NCT03701555|529147195|FG030|Part 3 (Day 1)|Other|1|||
146720962|NCT03701555|529147196|FG031|Part 3 (Day 1)|Other|0|||
146720963|NCT03701555|529147197|FG032|Part 3 (Day 1)|Other|1|||
146720964|NCT03701555|529147198|FG033|Part 3 (Day 1)|Other|1|||
146720965|NCT03701555|529147199|FG034|Part 3 (Day 1)|Other|0|||
146720966|NCT03701555|529147200|FG035|Part 3 (Day 1)|Other|0|||
146720967|NCT02508311|529147203|FG000|Overall Study|Withdrawal by Subject|1|||
146720968|NCT02508311|529147204|FG001|Overall Study|Withdrawal by Subject|0|||
146720969|NCT00448539|529147205|FG000|Overall Study|Medication non-compliance|4|||
146720970|NCT00448539|529147206|FG001|Overall Study|Medication non-compliance|1|||
146720971|NCT00448539|529147205|FG000|Overall Study|Protocol Violation|1|||
146720972|NCT00448539|529147206|FG001|Overall Study|Protocol Violation|0|||
146720973|NCT00448539|529147205|FG000|Overall Study|Request of the investigator or sponsor|67|||
146720974|NCT00448539|529147206|FG001|Overall Study|Request of the investigator or sponsor|54|||
146720975|NCT00448539|529147205|FG000|Overall Study|Withdrawal by Subject|20|||
146720976|NCT00448539|529147206|FG001|Overall Study|Withdrawal by Subject|24|||
146720977|NCT00448539|529147205|FG000|Overall Study|Diary non-compliance|1|||
146720978|NCT00448539|529147206|FG001|Overall Study|Diary non-compliance|0|||
146720979|NCT00448539|529147205|FG000|Overall Study|Adverse Event|9|||
146720980|NCT00448539|529147206|FG001|Overall Study|Adverse Event|26|||
146720981|NCT00448539|529147205|FG000|Overall Study|Lack of Efficacy|27|||
146720982|NCT00448539|529147206|FG001|Overall Study|Lack of Efficacy|40|||
146720983|NCT00448539|529147205|FG000|Overall Study|Miscellaneous|2|||
146720984|NCT00448539|529147206|FG001|Overall Study|Miscellaneous|1|||
146720985|NCT00448539|529147205|FG000|Overall Study|Change of meds|2|||
146720986|NCT00448539|529147206|FG001|Overall Study|Change of meds|3|||
146720987|NCT00448539|529147205|FG000|Overall Study|Lost to Follow-up|1|||
146720988|NCT00448539|529147206|FG001|Overall Study|Lost to Follow-up|3|||
146720989|NCT04862143|529147207|FG000|Overall Study|Adverse Event|1|||
146720990|NCT04862143|529147207|FG000|Overall Study|Study terminated by sponsor|1|||
146720991|NCT02370602|529147208|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
146720992|NCT02370602|529147209|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
146720993|NCT02370602|529147210|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
146720994|NCT02370602|529147211|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
146720995|NCT02370602|529147212|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
146720996|NCT02370602|529147213|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
146720997|NCT02103439|529147214|FG000|Overall Study|Adverse Event|0|||
146720998|NCT02103439|529147215|FG001|Overall Study|Adverse Event|2|||
146720999|NCT02103439|529147214|FG000|Overall Study|Withdrawal by Subject|3|||
146721000|NCT02103439|529147215|FG001|Overall Study|Withdrawal by Subject|1|||
146721001|NCT03349710|529147216|FG000|Treatment Period|Death|0|||
146721002|NCT03349710|529147217|FG001|Treatment Period|Death|0|||
146721003|NCT03349710|529147218|FG002|Treatment Period|Death|1|||
146721004|NCT03349710|529147219|FG003|Treatment Period|Death|0|||
146721005|NCT03349710|529147216|FG000|Treatment Period|Disease Progression|0|||
146721006|NCT03349710|529147217|FG001|Treatment Period|Disease Progression|2|||
146721007|NCT03349710|529147218|FG002|Treatment Period|Disease Progression|0|||
146721008|NCT03349710|529147219|FG003|Treatment Period|Disease Progression|1|||
146721009|NCT03349710|529147216|FG000|Treatment Period|Study Drug Toxicity|1|||
146721010|NCT03349710|529147217|FG001|Treatment Period|Study Drug Toxicity|0|||
146721011|NCT03349710|529147218|FG002|Treatment Period|Study Drug Toxicity|1|||
146721012|NCT03349710|529147219|FG003|Treatment Period|Study Drug Toxicity|1|||
146721013|NCT03349710|529147216|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
146721014|NCT03349710|529147217|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
146721015|NCT03349710|529147218|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
146721016|NCT03349710|529147219|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
146721017|NCT03349710|529147216|FG000|Treatment Period|admin reason by sponsor|0|||
146721018|NCT03349710|529147217|FG001|Treatment Period|admin reason by sponsor|7|||
146721019|NCT03349710|529147218|FG002|Treatment Period|admin reason by sponsor|0|||
146721020|NCT03349710|529147219|FG003|Treatment Period|admin reason by sponsor|19|||
146721021|NCT03349710|529147216|FG000|Treatment Period|Other Reason|2|||
146721022|NCT03349710|529147217|FG001|Treatment Period|Other Reason|0|||
146721023|NCT03349710|529147218|FG002|Treatment Period|Other Reason|2|||
146721024|NCT03349710|529147219|FG003|Treatment Period|Other Reason|1|||
146721025|NCT03349710|529147216|FG000|Treatment Period|completed|6|||
146721026|NCT03349710|529147217|FG001|Treatment Period|completed|0|||
146721027|NCT03349710|529147218|FG002|Treatment Period|completed|18|||
146721028|NCT03349710|529147219|FG003|Treatment Period|completed|1|||
146721029|NCT03349710|529147216|FG000|Treatment Period|participant request to discontinue|0|||
146721030|NCT03349710|529147217|FG001|Treatment Period|participant request to discontinue|0|||
146721031|NCT03349710|529147218|FG002|Treatment Period|participant request to discontinue|4|||
146721032|NCT03349710|529147219|FG003|Treatment Period|participant request to discontinue|0|||
146721033|NCT03349710|529147216|FG000|Treatment Period|participant withdrew consent|1|||
146782127|NCT04419168|529373526|FG000|Overall Study|Missed 6-month Visit|48|||
146782128|NCT04419168|529373527|FG001|Overall Study|Missed 6-month Visit|45|||
146782129|NCT03713086|529373529|FG000|Overall Study|Withdrawal by Subject|0|||
146782130|NCT03713086|529373530|FG001|Overall Study|Withdrawal by Subject|2|||
146782131|NCT03713086|529373531|FG002|Overall Study|Withdrawal by Subject|1|||
146782132|NCT03713086|529373532|FG003|Overall Study|Withdrawal by Subject|0|||
146782133|NCT03713086|529373529|FG000|Overall Study|Lost to Follow-up|0|||
146782134|NCT03713086|529373530|FG001|Overall Study|Lost to Follow-up|1|||
146782135|NCT03713086|529373531|FG002|Overall Study|Lost to Follow-up|0|||
146782136|NCT03713086|529373532|FG003|Overall Study|Lost to Follow-up|1|||
146782137|NCT05009251|529373533|FG000|Overall Study|Protocol Violation|100|||
146782138|NCT05009251|529373534|FG001|Overall Study|Protocol Violation|105|||
146782139|NCT05009251|529373535|FG002|Overall Study|Protocol Violation|119|||
146782140|NCT05009251|529373536|FG003|Overall Study|Protocol Violation|120|||
146782141|NCT05009251|529373537|FG004|Overall Study|Protocol Violation|119|||
146782142|NCT05009251|529373533|FG000|Overall Study|Death|25|||
146782143|NCT05009251|529373534|FG001|Overall Study|Death|22|||
146782144|NCT05009251|529373535|FG002|Overall Study|Death|24|||
146782145|NCT05009251|529373536|FG003|Overall Study|Death|19|||
146782146|NCT05009251|529373537|FG004|Overall Study|Death|15|||
146782147|NCT06311084|529373542|FG000|Overall Study|Lost to Follow-up|14|||
146782148|NCT03988634|529373543|FG000|Double-Blind|Adverse Event|4|||
146721034|NCT03349710|529147217|FG001|Treatment Period|participant withdrew consent|0|||
146782149|NCT03988634|529373544|FG001|Double-Blind|Adverse Event|0|||
146782150|NCT03988634|529373545|FG002|Double-Blind|Adverse Event|0|||
146721035|NCT03349710|529147218|FG002|Treatment Period|participant withdrew consent|0|||
146721036|NCT03349710|529147219|FG003|Treatment Period|participant withdrew consent|0|||
146721037|NCT00695903|529147220|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
146721038|NCT00695903|529147221|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
146721039|NCT00695903|529147220|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
146721040|NCT00695903|529147221|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
146721041|NCT00695903|529147220|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
146721042|NCT00695903|529147221|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
146721043|NCT00695903|529147220|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
146721044|NCT00695903|529147221|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
146721045|NCT00695903|529147220|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
146721046|NCT00695903|529147221|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
146721047|NCT00695903|529147220|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
146721048|NCT00695903|529147221|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
146721049|NCT00695903|529147220|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
146721050|NCT00695903|529147221|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
146721051|NCT00695903|529147220|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
146721052|NCT00695903|529147221|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
146721053|NCT00695903|529147220|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
146721054|NCT00695903|529147221|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
146721055|NCT00321854|529147224|FG000|Overall Study|Adverse Event|41|||
146721056|NCT00321854|529147225|FG001|Overall Study|Adverse Event|43|||
146721057|NCT00321854|529147224|FG000|Overall Study|Lack of Efficacy|9|||
146721058|NCT00321854|529147225|FG001|Overall Study|Lack of Efficacy|14|||
146721059|NCT00321854|529147224|FG000|Overall Study|Protocol Violation|6|||
146721060|NCT00321854|529147225|FG001|Overall Study|Protocol Violation|5|||
146721061|NCT00321854|529147224|FG000|Overall Study|Lost to Follow-up|0|||
146721062|NCT00321854|529147225|FG001|Overall Study|Lost to Follow-up|2|||
146721063|NCT00321854|529147224|FG000|Overall Study|Withdrawal by Subject|6|||
146721064|NCT00321854|529147225|FG001|Overall Study|Withdrawal by Subject|17|||
146721065|NCT00321854|529147224|FG000|Overall Study|Other|1|||
146721066|NCT00321854|529147225|FG001|Overall Study|Other|1|||
146721067|NCT04723576|529147226|FG000|Overall Study|Withdrawal by Subject|2133|||
146721068|NCT04723576|529147227|FG001|Overall Study|Withdrawal by Subject|3234|||
146721069|NCT00413153|529147228|FG000|Overall Study|Withdrawal by Subject|1|||
146721070|NCT00413153|529147229|FG001|Overall Study|Withdrawal by Subject|1|||
146721071|NCT00413153|529147228|FG000|Overall Study|Adverse Event|1|||
146721072|NCT00413153|529147229|FG001|Overall Study|Adverse Event|0|||
146721073|NCT01064739|529147230|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
146721074|NCT00454051|529147231|FG000|Overall Study|Adverse Event|1|||
146721075|NCT00454051|529147232|FG001|Overall Study|Adverse Event|2|||
146721076|NCT00454051|529147231|FG000|Overall Study|Withdrawal by Subject|1|||
146782151|NCT03988634|529373543|FG000|Double-Blind|Death|18|||
146782152|NCT03988634|529373544|FG001|Double-Blind|Death|26|||
146782153|NCT03988634|529373545|FG002|Double-Blind|Death|0|||
146782154|NCT03988634|529373543|FG000|Double-Blind|Lost to Follow-up|6|||
146782155|NCT03988634|529373544|FG001|Double-Blind|Lost to Follow-up|7|||
146782156|NCT03988634|529373545|FG002|Double-Blind|Lost to Follow-up|0|||
146782157|NCT03988634|529373543|FG000|Double-Blind|Physician Decision|9|||
146782158|NCT03988634|529373544|FG001|Double-Blind|Physician Decision|5|||
146782159|NCT03988634|529373545|FG002|Double-Blind|Physician Decision|0|||
146721077|NCT00454051|529147232|FG001|Overall Study|Withdrawal by Subject|0|||
146721078|NCT00454051|529147231|FG000|Overall Study|Protocol Violation|1|||
146721079|NCT00454051|529147232|FG001|Overall Study|Protocol Violation|1|||
146721080|NCT03966157|529147233|FG000|Overall Study|Physician Decision|1|||
146721081|NCT03966157|529147234|FG001|Overall Study|Physician Decision|0|||
146721082|NCT04004611|529147235|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
146721083|NCT04004611|529147236|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
146721084|NCT04004611|529147237|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
146721085|NCT04004611|529147238|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
146721086|NCT04004611|529147239|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
146721087|NCT04004611|529147240|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
146721088|NCT04004611|529147241|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
146721089|NCT04004611|529147242|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
146721090|NCT04004611|529147243|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
146721091|NCT04004611|529147235|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
146721092|NCT04004611|529147236|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
146721093|NCT04004611|529147237|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
146721094|NCT04004611|529147238|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
146721095|NCT04004611|529147239|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
146721096|NCT04004611|529147240|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
146721097|NCT04004611|529147241|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
146721098|NCT04004611|529147242|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
146721099|NCT04004611|529147243|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
146721100|NCT04004611|529147235|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
146721101|NCT04004611|529147236|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
146721102|NCT04004611|529147237|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
146721103|NCT04004611|529147238|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
146721104|NCT04004611|529147239|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
146721105|NCT04004611|529147240|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
146721106|NCT04004611|529147241|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
146721107|NCT04004611|529147242|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
146721108|NCT04004611|529147243|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
146721109|NCT04004611|529147235|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
146721110|NCT04004611|529147236|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
146721111|NCT04004611|529147237|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
146721112|NCT04004611|529147238|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
146721113|NCT04004611|529147239|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
146721114|NCT04004611|529147240|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
146721115|NCT04004611|529147241|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
146721116|NCT04004611|529147242|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
146721117|NCT04004611|529147243|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
146721118|NCT04004611|529147235|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
146721119|NCT04004611|529147236|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
146721120|NCT04004611|529147237|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
146721121|NCT04004611|529147238|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
146721122|NCT04004611|529147239|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
146721123|NCT04004611|529147240|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
146721124|NCT04004611|529147241|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
146721125|NCT04004611|529147242|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
146721126|NCT04004611|529147243|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
146721127|NCT04004611|529147235|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
146721128|NCT04004611|529147236|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
146721129|NCT04004611|529147237|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
146721130|NCT04004611|529147238|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
146721131|NCT04004611|529147239|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
146721132|NCT04004611|529147240|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
146721133|NCT04004611|529147241|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
146721134|NCT04004611|529147242|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
146721135|NCT04004611|529147243|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
146721136|NCT04420689|529147244|FG000|Overall Study|COVID-19 related hospitalization|0|||
146782160|NCT03988634|529373543|FG000|Double-Blind|Subject decision|24|||
146721137|NCT04420689|529147245|FG001|Overall Study|COVID-19 related hospitalization|0|||
146721138|NCT04420689|529147246|FG002|Overall Study|COVID-19 related hospitalization|0|||
146721139|NCT04420689|529147247|FG003|Overall Study|COVID-19 related hospitalization|0|||
146721140|NCT04420689|529147248|FG004|Overall Study|COVID-19 related hospitalization|1|||
146782161|NCT03988634|529373544|FG001|Double-Blind|Subject decision|13|||
146934220|NCT03583606|529917805|FG000|Overall Study|Ineligible at baseline|1|||
146721141|NCT04420689|529147249|FG005|Overall Study|COVID-19 related hospitalization|0|||
146721142|NCT04420689|529147250|FG006|Overall Study|COVID-19 related hospitalization|0|||
146721143|NCT04420689|529147244|FG000|Overall Study|Physician Decision|0|||
146721144|NCT04420689|529147245|FG001|Overall Study|Physician Decision|0|||
146721145|NCT04420689|529147246|FG002|Overall Study|Physician Decision|0|||
146721146|NCT04420689|529147247|FG003|Overall Study|Physician Decision|0|||
146721147|NCT04420689|529147248|FG004|Overall Study|Physician Decision|0|||
146721148|NCT04420689|529147249|FG005|Overall Study|Physician Decision|1|||
146721149|NCT04420689|529147250|FG006|Overall Study|Physician Decision|0|||
146721150|NCT03834779|529147262|FG000|Overall Study|Death|1|||
146721151|NCT03834779|529147263|FG001|Overall Study|Death|2|||
146721152|NCT03834779|529147262|FG000|Overall Study|Lost to Follow-up|6|||
146721153|NCT03834779|529147263|FG001|Overall Study|Lost to Follow-up|4|||
146721154|NCT00511004|529147268|FG000|Overall Study|Lost to Follow-up|0|||
146721155|NCT00511004|529147269|FG001|Overall Study|Lost to Follow-up|0|||
146721156|NCT00511004|529147270|FG002|Overall Study|Lost to Follow-up|4|||
146721157|NCT04642638|529147271|FG000|Overall Study|Withdrawal by Subject|23|||
146721158|NCT04642638|529147272|FG001|Overall Study|Withdrawal by Subject|29|||
146721159|NCT04642638|529147273|FG002|Overall Study|Withdrawal by Subject|9|||
146721160|NCT04642638|529147274|FG003|Overall Study|Withdrawal by Subject|7|||
146721161|NCT04642638|529147275|FG004|Overall Study|Withdrawal by Subject|61|||
146721162|NCT04642638|529147276|FG005|Overall Study|Withdrawal by Subject|27|||
146721163|NCT04642638|529147271|FG000|Overall Study|Lost to Follow-up|17|||
146721164|NCT04642638|529147272|FG001|Overall Study|Lost to Follow-up|18|||
146721165|NCT04642638|529147273|FG002|Overall Study|Lost to Follow-up|5|||
146721166|NCT04642638|529147274|FG003|Overall Study|Lost to Follow-up|5|||
146721167|NCT04642638|529147275|FG004|Overall Study|Lost to Follow-up|6|||
146721168|NCT04642638|529147276|FG005|Overall Study|Lost to Follow-up|3|||
146721169|NCT04642638|529147271|FG000|Overall Study|Adverse Event|0|||
146721170|NCT04642638|529147272|FG001|Overall Study|Adverse Event|0|||
146721171|NCT04642638|529147273|FG002|Overall Study|Adverse Event|1|||
146721172|NCT04642638|529147274|FG003|Overall Study|Adverse Event|0|||
146721173|NCT04642638|529147275|FG004|Overall Study|Adverse Event|10|||
146721174|NCT04642638|529147276|FG005|Overall Study|Adverse Event|3|||
146721175|NCT04642638|529147271|FG000|Overall Study|Reason Not Specified|1|||
146721176|NCT04642638|529147272|FG001|Overall Study|Reason Not Specified|4|||
146721177|NCT04642638|529147273|FG002|Overall Study|Reason Not Specified|0|||
146721178|NCT04642638|529147274|FG003|Overall Study|Reason Not Specified|0|||
146721179|NCT04642638|529147275|FG004|Overall Study|Reason Not Specified|38|||
146721180|NCT04642638|529147276|FG005|Overall Study|Reason Not Specified|16|||
146721181|NCT04642638|529147271|FG000|Overall Study|Physician Decision|0|||
146721182|NCT04642638|529147272|FG001|Overall Study|Physician Decision|0|||
146721183|NCT04642638|529147273|FG002|Overall Study|Physician Decision|0|||
146721184|NCT04642638|529147274|FG003|Overall Study|Physician Decision|0|||
146721185|NCT04642638|529147275|FG004|Overall Study|Physician Decision|2|||
146721186|NCT04642638|529147276|FG005|Overall Study|Physician Decision|1|||
146721187|NCT04642638|529147271|FG000|Overall Study|Protocol Deviation|0|||
146721188|NCT04642638|529147272|FG001|Overall Study|Protocol Deviation|0|||
146721189|NCT04642638|529147273|FG002|Overall Study|Protocol Deviation|0|||
146721190|NCT04642638|529147274|FG003|Overall Study|Protocol Deviation|0|||
146721191|NCT04642638|529147275|FG004|Overall Study|Protocol Deviation|1|||
146721192|NCT04642638|529147276|FG005|Overall Study|Protocol Deviation|3|||
146721193|NCT04642638|529147271|FG000|Overall Study|Study Terminated|0|||
146721194|NCT04642638|529147272|FG001|Overall Study|Study Terminated|0|||
146721195|NCT04642638|529147273|FG002|Overall Study|Study Terminated|0|||
146721196|NCT04642638|529147274|FG003|Overall Study|Study Terminated|0|||
146721197|NCT04642638|529147275|FG004|Overall Study|Study Terminated|484|||
146721198|NCT04642638|529147276|FG005|Overall Study|Study Terminated|250|||
146721199|NCT04642638|529147271|FG000|Overall Study|Pregnancy|0|||
146721200|NCT04642638|529147272|FG001|Overall Study|Pregnancy|0|||
146721201|NCT04642638|529147273|FG002|Overall Study|Pregnancy|0|||
146721202|NCT04642638|529147274|FG003|Overall Study|Pregnancy|0|||
146721203|NCT04642638|529147275|FG004|Overall Study|Pregnancy|1|||
146721204|NCT04642638|529147276|FG005|Overall Study|Pregnancy|0|||
146721205|NCT00990652|529147277|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
146721206|NCT00990652|529147277|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
146721207|NCT01672801|529147280|FG000|Overall Study|Screen Failure|0|||
146721208|NCT01672801|529147281|FG001|Overall Study|Screen Failure|1|||
146721209|NCT02384954|529147289|FG000|Phase 1|Progressive Disease|2|||
146721210|NCT02384954|529147290|FG001|Phase 1|Progressive Disease|0|||
146721211|NCT02384954|529147291|FG002|Phase 1|Progressive Disease|1|||
146721212|NCT02384954|529147292|FG003|Phase 1|Progressive Disease|1|||
146721213|NCT02384954|529147293|FG004|Phase 1|Progressive Disease|0|||
146721214|NCT02384954|529147294|FG005|Phase 1|Progressive Disease|0|||
146721215|NCT02384954|529147295|FG006|Phase 1|Progressive Disease|0|||
146721216|NCT02384954|529147296|FG007|Phase 1|Progressive Disease|0|||
146721217|NCT02384954|529147297|FG008|Phase 1|Progressive Disease|0|||
146721218|NCT02384954|529147289|FG000|Phase 1|Adverse Event|0|||
146721219|NCT02384954|529147290|FG001|Phase 1|Adverse Event|0|||
146721220|NCT02384954|529147291|FG002|Phase 1|Adverse Event|1|||
146782162|NCT03988634|529373545|FG002|Double-Blind|Subject decision|0|||
146782163|NCT03988634|529373543|FG000|Open-Label|Adverse Event|0|||
146782164|NCT03988634|529373544|FG001|Open-Label|Adverse Event|0|||
146782165|NCT03988634|529373545|FG002|Open-Label|Adverse Event|7|||
146782166|NCT03988634|529373543|FG000|Open-Label|Physician Decision|0|||
146782167|NCT03988634|529373544|FG001|Open-Label|Physician Decision|0|||
146782168|NCT03988634|529373545|FG002|Open-Label|Physician Decision|1|||
146782169|NCT03988634|529373543|FG000|Open-Label|Technical problems|0|||
146782170|NCT03988634|529373544|FG001|Open-Label|Technical problems|0|||
146782171|NCT03988634|529373545|FG002|Open-Label|Technical problems|1|||
146782172|NCT03161379|529373560|FG000|Overall Study|Withdrawal by Subject|4|||
146782173|NCT03161379|529373560|FG000|Overall Study|disease progression during chemotherapy|5|||
146782174|NCT03161379|529373560|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
146782175|NCT03161379|529373560|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
146782176|NCT03393975|529373562|FG000|Urgent Treatment Period|Physician Decision|0|||
146782177|NCT03393975|529373563|FG001|Urgent Treatment Period|Physician Decision|0|||
146782178|NCT03393975|529373564|FG002|Urgent Treatment Period|Physician Decision|0|||
146782179|NCT03393975|529373565|FG003|Urgent Treatment Period|Physician Decision|1|||
146782180|NCT03393975|529373562|FG000|Prophylaxis Period 1|Reason not Specified|0|||
146782181|NCT03393975|529373563|FG001|Prophylaxis Period 1|Reason not Specified|1|||
146782182|NCT03393975|529373564|FG002|Prophylaxis Period 1|Reason not Specified|0|||
146782183|NCT03393975|529373565|FG003|Prophylaxis Period 1|Reason not Specified|0|||
146782184|NCT03393975|529373562|FG000|Prophylaxis Period 2|Reason not Specified|0|||
146782185|NCT03393975|529373563|FG001|Prophylaxis Period 2|Reason not Specified|1|||
146782186|NCT03393975|529373564|FG002|Prophylaxis Period 2|Reason not Specified|0|||
146782187|NCT03393975|529373565|FG003|Prophylaxis Period 2|Reason not Specified|0|||
146782188|NCT03315754|529373566|FG000|Overall Study|COVID-19 complications leading to death|1|||
146782189|NCT03315754|529373566|FG000|Overall Study|insurance coverage issue|1|||
146782190|NCT04024813|529373567|FG000|Overall Study|Study terminated by Sponsor|1|||
146782191|NCT04089371|529373569|FG000|Overall Study|Withdrawal by Subject|0|||
146782192|NCT04089371|529373570|FG001|Overall Study|Withdrawal by Subject|1|||
146782193|NCT04089371|529373569|FG000|Overall Study|Study terminated early|0|||
146782194|NCT04089371|529373570|FG001|Overall Study|Study terminated early|9|||
146782195|NCT03932682|529373571|FG000|Overall Study|Death|1|||
146782196|NCT03932682|529373572|FG001|Overall Study|Death|2|||
146782197|NCT03932682|529373571|FG000|Overall Study|Withdrawal by Subject|37|||
146782198|NCT03932682|529373572|FG001|Overall Study|Withdrawal by Subject|45|||
146782199|NCT03932682|529373571|FG000|Overall Study|Lost to Follow-up|19|||
146782200|NCT03932682|529373572|FG001|Overall Study|Lost to Follow-up|25|||
146782201|NCT03932682|529373571|FG000|Overall Study|Protocol Violation|0|||
146782202|NCT03932682|529373572|FG001|Overall Study|Protocol Violation|2|||
146782203|NCT03932682|529373571|FG000|Overall Study|Other|9|||
146782204|NCT03932682|529373572|FG001|Overall Study|Other|23|||
146782205|NCT02900924|529373573|FG000|Overall Study|Death|52|||
146782206|NCT02900924|529373573|FG000|Overall Study|Lost to Follow-up|4|||
146782207|NCT02900924|529373573|FG000|Overall Study|Withdrawal by Subject|20|||
146782208|NCT02900924|529373573|FG000|Overall Study|Missed Visit|33|||
146782209|NCT05536440|529373574|FG000|Overall Study|Adverse Event|0|||
146782210|NCT05536440|529373575|FG001|Overall Study|Adverse Event|0|||
146782211|NCT05536440|529373576|FG002|Overall Study|Adverse Event|0|||
146782212|NCT05536440|529373577|FG003|Overall Study|Adverse Event|0|||
146782213|NCT05536440|529373578|FG004|Overall Study|Adverse Event|0|||
146934221|NCT03583606|529917806|FG001|Overall Study|Ineligible at baseline|0|||
146934222|NCT03583606|529917807|FG002|Overall Study|Ineligible at baseline|0|||
146934223|NCT00793182|529917812|FG000|Overall Study|Adverse Event|0|||
146934224|NCT00793182|529917813|FG001|Overall Study|Adverse Event|1|||
146934225|NCT00851253|529917814|FG000|Overall Study|Disease Progression|1|||
146934226|NCT00851253|529917815|FG001|Overall Study|Disease Progression|0|||
146721221|NCT02384954|529147292|FG003|Phase 1|Adverse Event|0|||
146721222|NCT02384954|529147293|FG004|Phase 1|Adverse Event|0|||
146721223|NCT02384954|529147294|FG005|Phase 1|Adverse Event|0|||
146721224|NCT02384954|529147295|FG006|Phase 1|Adverse Event|0|||
146721225|NCT02384954|529147296|FG007|Phase 1|Adverse Event|0|||
146721226|NCT02384954|529147297|FG008|Phase 1|Adverse Event|0|||
146721227|NCT02384954|529147289|FG000|Phase 2|Progressive Disease|0|||
146721228|NCT02384954|529147290|FG001|Phase 2|Progressive Disease|0|||
146721229|NCT02384954|529147291|FG002|Phase 2|Progressive Disease|0|||
146721230|NCT02384954|529147292|FG003|Phase 2|Progressive Disease|0|||
146721231|NCT02384954|529147293|FG004|Phase 2|Progressive Disease|0|||
146721232|NCT02384954|529147294|FG005|Phase 2|Progressive Disease|0|||
146782214|NCT05536440|529373579|FG005|Overall Study|Adverse Event|0|||
146782215|NCT05536440|529373580|FG006|Overall Study|Adverse Event|0|||
146782216|NCT05536440|529373581|FG007|Overall Study|Adverse Event|0|||
146782217|NCT05536440|529373582|FG008|Overall Study|Adverse Event|1|||
146782218|NCT00931710|529373585|FG000|Overall Study|Adverse Event|16|||
146782219|NCT00931710|529373586|FG001|Overall Study|Adverse Event|10|||
146782220|NCT00931710|529373585|FG000|Overall Study|Abnormal test procedure results|2|||
146782221|NCT00931710|529373586|FG001|Overall Study|Abnormal test procedure results|0|||
146721233|NCT02384954|529147295|FG006|Phase 2|Progressive Disease|0|||
146782222|NCT00931710|529373585|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
146782223|NCT00931710|529373586|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
146782224|NCT00931710|529373585|FG000|Overall Study|Patient withdrew consent|4|||
146782225|NCT00931710|529373586|FG001|Overall Study|Patient withdrew consent|9|||
146782226|NCT00931710|529373585|FG000|Overall Study|Lost to Follow-up|6|||
146782227|NCT00931710|529373586|FG001|Overall Study|Lost to Follow-up|5|||
146782228|NCT00931710|529373585|FG000|Overall Study|Protocol deviation|1|||
146782229|NCT00931710|529373586|FG001|Overall Study|Protocol deviation|2|||
146782230|NCT03338790|529373590|FG000|Overall Study|Disease Progression|65|||
146782231|NCT03338790|529373591|FG001|Overall Study|Disease Progression|43|||
146782232|NCT03338790|529373592|FG002|Overall Study|Disease Progression|50|||
146782233|NCT03338790|529373593|FG003|Overall Study|Disease Progression|37|||
146782234|NCT03338790|529373590|FG000|Overall Study|Study Drug Toxicity|9|||
146782235|NCT03338790|529373591|FG001|Overall Study|Study Drug Toxicity|8|||
146782236|NCT03338790|529373592|FG002|Overall Study|Study Drug Toxicity|15|||
146934227|NCT01779648|529917816|FG000|Overall Study|Protocol Violation|1|||
146934228|NCT01779648|529917817|FG001|Overall Study|Protocol Violation|0|||
146934229|NCT00367341|529917820|FG000|Overall Study|Physician Decision|1|||
146934230|NCT00367341|529917821|FG001|Overall Study|Physician Decision|0|||
146934231|NCT00367341|529917820|FG000|Overall Study|Protocol Violation|1|||
146721234|NCT02384954|529147296|FG007|Phase 2|Progressive Disease|1|||
146721235|NCT02384954|529147297|FG008|Phase 2|Progressive Disease|2|||
146721236|NCT02384954|529147289|FG000|Phase 2|Adverse Event|0|||
146721237|NCT02384954|529147290|FG001|Phase 2|Adverse Event|0|||
146721238|NCT02384954|529147291|FG002|Phase 2|Adverse Event|0|||
146721239|NCT02384954|529147292|FG003|Phase 2|Adverse Event|0|||
146721240|NCT02384954|529147293|FG004|Phase 2|Adverse Event|0|||
146721241|NCT02384954|529147294|FG005|Phase 2|Adverse Event|0|||
146721242|NCT02384954|529147295|FG006|Phase 2|Adverse Event|0|||
146721243|NCT02384954|529147296|FG007|Phase 2|Adverse Event|1|||
146721244|NCT02384954|529147297|FG008|Phase 2|Adverse Event|1|||
146721245|NCT02384954|529147289|FG000|Phase 2|Failure to meet continuation criteria|0|||
146721246|NCT02384954|529147290|FG001|Phase 2|Failure to meet continuation criteria|0|||
146721247|NCT02384954|529147291|FG002|Phase 2|Failure to meet continuation criteria|0|||
146721248|NCT02384954|529147292|FG003|Phase 2|Failure to meet continuation criteria|0|||
146721249|NCT02384954|529147293|FG004|Phase 2|Failure to meet continuation criteria|0|||
146721250|NCT02384954|529147294|FG005|Phase 2|Failure to meet continuation criteria|0|||
146721251|NCT02384954|529147295|FG006|Phase 2|Failure to meet continuation criteria|0|||
146721252|NCT02384954|529147296|FG007|Phase 2|Failure to meet continuation criteria|1|||
146721253|NCT02384954|529147297|FG008|Phase 2|Failure to meet continuation criteria|0|||
146721254|NCT02372396|529147303|FG000|Overall Study|Lost to Follow-up|7|||
146721255|NCT02372396|529147304|FG001|Overall Study|Lost to Follow-up|9|||
146721256|NCT01272934|529147306|FG000|Overall Study|Adverse Event|0|||
146721257|NCT01272934|529147307|FG001|Overall Study|Adverse Event|1|||
146721258|NCT01272934|529147306|FG000|Overall Study|Abnormal Laboratory Value|0|||
146721259|NCT01272934|529147307|FG001|Overall Study|Abnormal Laboratory Value|1|||
146721260|NCT04313634|529147308|FG000|Overall Study|Adverse Event|2|||
146721261|NCT04313634|529147309|FG001|Overall Study|Adverse Event|2|||
146721262|NCT04313634|529147310|FG002|Overall Study|Adverse Event|0|||
146721263|NCT04313634|529147308|FG000|Overall Study|Withdrawal by Subject|1|||
146721264|NCT04313634|529147309|FG001|Overall Study|Withdrawal by Subject|0|||
146721265|NCT04313634|529147310|FG002|Overall Study|Withdrawal by Subject|1|||
146721266|NCT04313634|529147308|FG000|Overall Study|Protocol Violation|0|||
146721267|NCT04313634|529147309|FG001|Overall Study|Protocol Violation|0|||
146721268|NCT04313634|529147310|FG002|Overall Study|Protocol Violation|1|||
146721269|NCT03595904|529147320|FG000|Overall Study|Protocol Violation|3|||
146721270|NCT03595904|529147321|FG001|Overall Study|Protocol Violation|1|||
146721271|NCT03595904|529147320|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
146721272|NCT03595904|529147321|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
146721273|NCT03595904|529147320|FG000|Overall Study|Insurance complications|1|||
146721274|NCT03595904|529147321|FG001|Overall Study|Insurance complications|0|||
146721275|NCT03595904|529147320|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
146782237|NCT03338790|529373593|FG003|Overall Study|Study Drug Toxicity|0|||
146782238|NCT03338790|529373590|FG000|Overall Study|Death|1|||
146782239|NCT03338790|529373591|FG001|Overall Study|Death|1|||
146782240|NCT03338790|529373592|FG002|Overall Study|Death|1|||
146782241|NCT03338790|529373593|FG003|Overall Study|Death|0|||
146782242|NCT03338790|529373590|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
146782243|NCT03338790|529373591|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
146934232|NCT00367341|529917821|FG001|Overall Study|Protocol Violation|0|||
146721276|NCT03595904|529147321|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
146721277|NCT01218438|529147323|FG000|Epoch 1|Physician Decision|2|||
146721278|NCT01218438|529147323|FG000|Epoch 1|Adverse Event|1|||
146721279|NCT01218438|529147323|FG000|Epoch 3|Withdrawal by Subject|3|||
146721280|NCT01218438|529147323|FG000|Epoch 3|Adverse Event|1|||
146721281|NCT01218438|529147323|FG000|Epoch 4|Physician Decision|1|||
146721282|NCT01218438|529147323|FG000|Epoch 4|Withdrawal by Subject|2|||
146934233|NCT02119026|529917824|FG000|1st-line Treatment|Adverse Event|9|||
146934234|NCT02119026|529917825|FG001|1st-line Treatment|Adverse Event|14|||
146934235|NCT02119026|529917824|FG000|1st-line Treatment|Physician Decision|3|||
146934236|NCT02119026|529917825|FG001|1st-line Treatment|Physician Decision|8|||
146934237|NCT02119026|529917824|FG000|1st-line Treatment|Withdrawal by Subject|4|||
146934238|NCT02119026|529917825|FG001|1st-line Treatment|Withdrawal by Subject|10|||
146934239|NCT02119026|529917824|FG000|1st-line Treatment|Patient condition or compliance|6|||
146721283|NCT02075593|529147324|FG000|Overall Study|Withdrawal by Subject|1|||
146721284|NCT05819749|529147325|FG000|Overall Study|Lost to Follow-up|1|||
146721285|NCT00726752|529147326|FG000|Overall Study|Lack of Efficacy|6|||
146721286|NCT02120027|529149399|FG000|Overall Study|Adverse Event|4|||
146721287|NCT02120027|529149400|FG001|Overall Study|Adverse Event|5|||
146721288|NCT02120027|529149399|FG000|Overall Study|Lack of Efficacy|3|||
146721289|NCT02120027|529149400|FG001|Overall Study|Lack of Efficacy|5|||
146721290|NCT02120027|529149399|FG000|Overall Study|Lost to Follow-up|5|||
146721291|NCT02120027|529149400|FG001|Overall Study|Lost to Follow-up|13|||
146721292|NCT02120027|529149399|FG000|Overall Study|Other|4|||
146721293|NCT02120027|529149400|FG001|Overall Study|Other|0|||
146721294|NCT02120027|529149399|FG000|Overall Study|Physician Decision|4|||
146721295|NCT02120027|529149400|FG001|Overall Study|Physician Decision|3|||
146721296|NCT02120027|529149399|FG000|Overall Study|Protocol Violation|18|||
146721297|NCT02120027|529149400|FG001|Overall Study|Protocol Violation|21|||
146721298|NCT02120027|529149399|FG000|Overall Study|Study terminated by Sponsor|45|||
146721299|NCT02120027|529149400|FG001|Overall Study|Study terminated by Sponsor|47|||
146721300|NCT02120027|529149399|FG000|Overall Study|Withdrawal by Subject|33|||
146721301|NCT02120027|529149400|FG001|Overall Study|Withdrawal by Subject|25|||
146721302|NCT03393000|529149403|FG000|Overall Study|Death|11|||
146721303|NCT03393000|529149403|FG000|Overall Study|Withdrawal by Subject|2|||
146721304|NCT03393000|529149403|FG000|Overall Study|Physician Decision|1|||
146721305|NCT01773070|529149404|FG000|Overall Study|Withdrawal by Subject|24|||
146721306|NCT01773070|529149404|FG000|Overall Study|Lost to Follow-up|39|||
146721307|NCT01773070|529149404|FG000|Overall Study|Other|15|||
146721308|NCT01773070|529149404|FG000|Overall Study|Death (unrelated to study procedures)|3|||
146721309|NCT01843192|529149405|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
146721310|NCT01843192|529149406|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
146721311|NCT01843192|529149407|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
146721312|NCT01471054|529149408|FG000|Overall Study|Study terminated prematurely|4|||
146721313|NCT01471054|529149409|FG001|Overall Study|Study terminated prematurely|0|||
146721314|NCT02181803|529149410|FG000|Overall Study|Withdrawal by Subject|0|||
146721315|NCT02181803|529149411|FG001|Overall Study|Withdrawal by Subject|2|||
146721316|NCT02181803|529149412|FG002|Overall Study|Withdrawal by Subject|0|||
146721317|NCT02181803|529149413|FG003|Overall Study|Withdrawal by Subject|0|||
146721318|NCT02181803|529149414|FG004|Overall Study|Withdrawal by Subject|0|||
146721319|NCT02181803|529149415|FG005|Overall Study|Withdrawal by Subject|0|||
146721320|NCT02181803|529149416|FG006|Overall Study|Withdrawal by Subject|0|||
146721321|NCT02181803|529149417|FG007|Overall Study|Withdrawal by Subject|0|||
146721322|NCT02181803|529149418|FG008|Overall Study|Withdrawal by Subject|0|||
146721323|NCT02181803|529149410|FG000|Overall Study|Physician Decision|0|||
146721324|NCT02181803|529149411|FG001|Overall Study|Physician Decision|0|||
146721325|NCT02181803|529149412|FG002|Overall Study|Physician Decision|0|||
146721326|NCT02181803|529149413|FG003|Overall Study|Physician Decision|1|||
146721327|NCT02181803|529149414|FG004|Overall Study|Physician Decision|0|||
146721328|NCT02181803|529149415|FG005|Overall Study|Physician Decision|0|||
146721329|NCT02181803|529149416|FG006|Overall Study|Physician Decision|0|||
146721330|NCT02181803|529149417|FG007|Overall Study|Physician Decision|1|||
146721331|NCT02181803|529149418|FG008|Overall Study|Physician Decision|0|||
146721332|NCT02181803|529149410|FG000|Overall Study|Adverse Event|0|||
146721333|NCT02181803|529149411|FG001|Overall Study|Adverse Event|2|||
146721334|NCT02181803|529149412|FG002|Overall Study|Adverse Event|0|||
146721335|NCT02181803|529149413|FG003|Overall Study|Adverse Event|1|||
146721336|NCT02181803|529149414|FG004|Overall Study|Adverse Event|0|||
146721337|NCT02181803|529149415|FG005|Overall Study|Adverse Event|0|||
146721338|NCT02181803|529149416|FG006|Overall Study|Adverse Event|1|||
146721339|NCT02181803|529149417|FG007|Overall Study|Adverse Event|0|||
146721340|NCT02181803|529149418|FG008|Overall Study|Adverse Event|0|||
146721341|NCT00951041|529149419|FG000|Overall Study|Withdrawal by Subject|1|||
146721342|NCT00951041|529149420|FG001|Overall Study|Withdrawal by Subject|1|||
146721343|NCT00951041|529149419|FG000|Overall Study|Lost to Follow-up|1|||
146721344|NCT00951041|529149420|FG001|Overall Study|Lost to Follow-up|0|||
146721345|NCT00951041|529149419|FG000|Overall Study|Other|3|||
146721346|NCT00951041|529149420|FG001|Overall Study|Other|0|||
146721347|NCT01259713|529149421|FG000|Overall Study|Adverse Event|54|||
146934240|NCT02119026|529917825|FG001|1st-line Treatment|Patient condition or compliance|4|||
146934241|NCT02119026|529917824|FG000|1st-line Treatment|Surgery of metastases|2|||
146934242|NCT02119026|529917825|FG001|1st-line Treatment|Surgery of metastases|1|||
146721348|NCT01259713|529149422|FG001|Overall Study|Adverse Event|23|||
146721349|NCT01259713|529149421|FG000|Overall Study|Death Not Related to IFI|8|||
146721350|NCT01259713|529149422|FG001|Overall Study|Death Not Related to IFI|1|||
146934243|NCT02119026|529917824|FG000|1st-line Treatment|Death|2|||
146782244|NCT03338790|529373592|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
146782245|NCT03338790|529373593|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
146782246|NCT03338790|529373590|FG000|Overall Study|Participant request to discontinue study treatment|3|||
146782247|NCT03338790|529373591|FG001|Overall Study|Participant request to discontinue study treatment|3|||
146782248|NCT03338790|529373592|FG002|Overall Study|Participant request to discontinue study treatment|2|||
146782249|NCT03338790|529373593|FG003|Overall Study|Participant request to discontinue study treatment|1|||
146782250|NCT03338790|529373590|FG000|Overall Study|Poor/non-compliance|0|||
146782251|NCT03338790|529373591|FG001|Overall Study|Poor/non-compliance|1|||
146782252|NCT03338790|529373592|FG002|Overall Study|Poor/non-compliance|0|||
146782253|NCT03338790|529373593|FG003|Overall Study|Poor/non-compliance|0|||
146782254|NCT03338790|529373590|FG000|Overall Study|Participant withdrew consent|1|||
146782255|NCT03338790|529373591|FG001|Overall Study|Participant withdrew consent|0|||
146782256|NCT03338790|529373592|FG002|Overall Study|Participant withdrew consent|1|||
146782257|NCT03338790|529373593|FG003|Overall Study|Participant withdrew consent|1|||
146782258|NCT03338790|529373590|FG000|Overall Study|Other reasons|0|||
146782259|NCT03338790|529373591|FG001|Overall Study|Other reasons|5|||
146782260|NCT03338790|529373592|FG002|Overall Study|Other reasons|0|||
146782261|NCT03338790|529373593|FG003|Overall Study|Other reasons|2|||
146782262|NCT03338790|529373590|FG000|Overall Study|Not reported|0|||
146782263|NCT03338790|529373591|FG001|Overall Study|Not reported|0|||
146782264|NCT03338790|529373592|FG002|Overall Study|Not reported|1|||
146782265|NCT03338790|529373593|FG003|Overall Study|Not reported|0|||
146782266|NCT03338790|529373590|FG000|Overall Study|Completed treatment period|1|||
146782267|NCT03338790|529373591|FG001|Overall Study|Completed treatment period|2|||
146782268|NCT03338790|529373592|FG002|Overall Study|Completed treatment period|0|||
146782269|NCT03338790|529373593|FG003|Overall Study|Completed treatment period|0|||
146782270|NCT01772472|529373594|FG000|Overall Study|Death|126|||
146782271|NCT01772472|529373595|FG001|Overall Study|Death|94|||
146782272|NCT01772472|529373594|FG000|Overall Study|Lost to Follow-up|51|||
146782273|NCT01772472|529373595|FG001|Overall Study|Lost to Follow-up|50|||
146782274|NCT01772472|529373594|FG000|Overall Study|Other|9|||
146782275|NCT01772472|529373595|FG001|Overall Study|Other|7|||
146782276|NCT01772472|529373594|FG000|Overall Study|Physician Decision|1|||
146782277|NCT01772472|529373595|FG001|Overall Study|Physician Decision|7|||
146782278|NCT01772472|529373594|FG000|Overall Study|Withdrawal by Subject|115|||
146782279|NCT01772472|529373595|FG001|Overall Study|Withdrawal by Subject|90|||
146782280|NCT01772472|529373594|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
146782281|NCT01772472|529373595|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
146782282|NCT05319860|529373597|FG000|Overall Study|Death|1|||
146782283|NCT05319860|529373598|FG001|Overall Study|Death|1|||
146782284|NCT05319860|529373597|FG000|Overall Study|Lost to Follow-up|3|||
146782285|NCT05319860|529373598|FG001|Overall Study|Lost to Follow-up|1|||
146782286|NCT05319860|529373597|FG000|Overall Study|Withdrawal by Subject|1|||
146782287|NCT05319860|529373598|FG001|Overall Study|Withdrawal by Subject|7|||
146782288|NCT04314895|529373599|FG000|Overall Study|Lost to Follow-up|1|||
146782289|NCT04314895|529373599|FG000|Overall Study|Death|10|||
146934244|NCT02119026|529917825|FG001|1st-line Treatment|Death|1|||
146934245|NCT02119026|529917824|FG000|2nd-line Treatment|Lost to Follow-up|2|||
146934246|NCT02119026|529917825|FG001|2nd-line Treatment|Lost to Follow-up|0|||
146934247|NCT02119026|529917824|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
146782290|NCT04314895|529373599|FG000|Overall Study|Physician Decision|2|||
146782291|NCT03941860|529373600|FG000|Overall Study|Withdrawal by Subject|0|||
146782292|NCT03941860|529373601|FG001|Overall Study|Withdrawal by Subject|1|||
146782293|NCT03361748|529373605|FG000|Overall Study|Death|77|||
146782294|NCT03361748|529373605|FG000|Overall Study|Lost to Follow-up|4|||
146782295|NCT03361748|529373605|FG000|Overall Study|Withdrawal by Subject|20|||
146782296|NCT02596126|529373606|FG000|Overall Study|Lost to Follow-up|12|||
146782297|NCT02596126|529373607|FG001|Overall Study|Lost to Follow-up|21|||
146782298|NCT02596126|529373606|FG000|Overall Study|Protocol Violation|7|||
146782299|NCT02596126|529373607|FG001|Overall Study|Protocol Violation|9|||
146934248|NCT02119026|529917825|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
146934249|NCT02119026|529917824|FG000|2nd-line Treatment|Adverse Event|4|||
146934250|NCT02119026|529917825|FG001|2nd-line Treatment|Adverse Event|1|||
146934251|NCT01373918|529917826|FG000|Overall Study|Physician Decision|0|||
146782300|NCT05691452|529374644|FG000|Overall Study|Withdrawal by Subject|1|||
146782301|NCT05691452|529374645|FG001|Overall Study|Withdrawal by Subject|1|||
146782302|NCT05691452|529374646|FG002|Overall Study|Withdrawal by Subject|0|||
146782303|NCT05691452|529374644|FG000|Overall Study|Physician Decision|1|||
146782304|NCT05691452|529374645|FG001|Overall Study|Physician Decision|0|||
146782305|NCT05691452|529374646|FG002|Overall Study|Physician Decision|0|||
146782306|NCT05691452|529374644|FG000|Overall Study|Lost to Follow-up|0|||
146782307|NCT05691452|529374645|FG001|Overall Study|Lost to Follow-up|0|||
146782308|NCT05691452|529374646|FG002|Overall Study|Lost to Follow-up|1|||
146782309|NCT05691452|529374644|FG000|Overall Study|Adverse Event|0|||
146782310|NCT05691452|529374645|FG001|Overall Study|Adverse Event|0|||
146782311|NCT05691452|529374646|FG002|Overall Study|Adverse Event|1|||
146782312|NCT05816551|529374655|FG000|Overall Study|Withdrawal by Subject|0|||
146934252|NCT01373918|529917827|FG001|Overall Study|Physician Decision|1|||
146782313|NCT05816551|529374656|FG001|Overall Study|Withdrawal by Subject|1|||
146782314|NCT05816551|529374655|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
146782315|NCT05816551|529374656|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
146782316|NCT05062265|529374667|FG000|Overall Study|Withdrawal by Subject|1|||
146782317|NCT05062265|529374668|FG001|Overall Study|Withdrawal by Subject|0|||
146782318|NCT05418296|529374673|FG000|Overall Study|Withdrawal by Subject|4|||
146782319|NCT05418296|529374674|FG001|Overall Study|Withdrawal by Subject|1|||
146782320|NCT05382936|529374675|FG000|Overall Study|Progressive Disease|3|||
146782321|NCT05382936|529374676|FG001|Overall Study|Progressive Disease|5|||
146782322|NCT05382936|529374677|FG002|Overall Study|Progressive Disease|2|||
146782323|NCT05382936|529374678|FG003|Overall Study|Progressive Disease|5|||
146782324|NCT05382936|529374675|FG000|Overall Study|Adverse Event|0|||
146782325|NCT05382936|529374676|FG001|Overall Study|Adverse Event|1|||
146782326|NCT05382936|529374677|FG002|Overall Study|Adverse Event|1|||
146782327|NCT05382936|529374678|FG003|Overall Study|Adverse Event|0|||
146782328|NCT05382936|529374675|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
146782329|NCT05382936|529374676|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
146782330|NCT05382936|529374677|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
146782331|NCT05382936|529374678|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
146782332|NCT05382936|529374675|FG000|Overall Study|Withdrawal by Subject|0|||
146782333|NCT05382936|529374676|FG001|Overall Study|Withdrawal by Subject|0|||
146782334|NCT05382936|529374677|FG002|Overall Study|Withdrawal by Subject|1|||
146782335|NCT05382936|529374678|FG003|Overall Study|Withdrawal by Subject|1|||
146782336|NCT03101904|529374679|FG000|Wash Out (10 Days)|Adverse Event|1|||
146782337|NCT03101904|529374680|FG001|Wash Out (10 Days)|Adverse Event|0|||
146782338|NCT03101904|529374679|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
146782339|NCT03101904|529374680|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
146782340|NCT04638998|529374682|FG000|Overall Study|Withdrawal by Subject|1|||
146782341|NCT04638998|529374683|FG001|Overall Study|Withdrawal by Subject|3|||
146782342|NCT03692611|529374684|FG000|Overall Study|Found to be ineligible postrandomization|3|||
146782343|NCT03692611|529374685|FG001|Overall Study|Found to be ineligible postrandomization|0|||
146782344|NCT00616967|529374686|FG000|Overall Study|Withdrawal by Subject|0|||
146782345|NCT00616967|529374687|FG001|Overall Study|Withdrawal by Subject|0|||
146782346|NCT00616967|529374688|FG002|Overall Study|Withdrawal by Subject|1|||
146782347|NCT02910583|529374689|FG000|Overall Study|Death|7|||
146782348|NCT02910583|529374690|FG001|Overall Study|Death|3|||
146782349|NCT02910583|529374689|FG000|Overall Study|Lost to Follow-up|1|||
146782350|NCT02910583|529374690|FG001|Overall Study|Lost to Follow-up|0|||
146782351|NCT02910583|529374689|FG000|Overall Study|Withdrawal by Subject|12|||
146782352|NCT02910583|529374690|FG001|Overall Study|Withdrawal by Subject|8|||
146782353|NCT02910583|529374689|FG000|Overall Study|Other, Not Specified|6|||
146782354|NCT02910583|529374690|FG001|Overall Study|Other, Not Specified|3|||
146782355|NCT04263311|529374691|FG000|Overall Study|Lost to Follow-up|1|||
146782356|NCT04263311|529374692|FG001|Overall Study|Lost to Follow-up|2|||
146782357|NCT04263311|529374693|FG002|Overall Study|Lost to Follow-up|0|||
146782358|NCT04263311|529374691|FG000|Overall Study|Health Issues|1|||
146782359|NCT04263311|529374692|FG001|Overall Study|Health Issues|0|||
146782360|NCT04263311|529374693|FG002|Overall Study|Health Issues|0|||
146782361|NCT04263311|529374691|FG000|Overall Study|Left the country|1|||
146782362|NCT04263311|529374692|FG001|Overall Study|Left the country|0|||
146782363|NCT04263311|529374693|FG002|Overall Study|Left the country|0|||
146782364|NCT04263311|529374691|FG000|Overall Study|Unable to maintain time commitment|1|||
146934253|NCT00340834|529917828|FG000|Core Phase of Study|Adverse Event|26|||
146782365|NCT04263311|529374692|FG001|Overall Study|Unable to maintain time commitment|0|||
146782366|NCT04263311|529374693|FG002|Overall Study|Unable to maintain time commitment|0|||
146782367|NCT04263311|529374691|FG000|Overall Study|No longer interested|1|||
146782368|NCT04263311|529374692|FG001|Overall Study|No longer interested|0|||
146782369|NCT04263311|529374693|FG002|Overall Study|No longer interested|0|||
146782370|NCT04263311|529374691|FG000|Overall Study|Ineligible post consent|0|||
146782371|NCT04263311|529374692|FG001|Overall Study|Ineligible post consent|0|||
146782372|NCT04263311|529374693|FG002|Overall Study|Ineligible post consent|5|||
146782373|NCT03958955|529374694|FG000|Overall Study|Adverse Event|1|||
146934254|NCT00340834|529917829|FG001|Core Phase of Study|Adverse Event|9|||
146782374|NCT04673929|529374695|FG000|Overall Study|Death|73|||
146782375|NCT04673929|529374695|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
146934255|NCT00340834|529917830|FG002|Core Phase of Study|Adverse Event|9|||
146782376|NCT05082909|529374697|FG000|Overall Study|Protocol Violation|0|||
146782377|NCT05082909|529374698|FG001|Overall Study|Protocol Violation|0|||
146782378|NCT05082909|529374699|FG002|Overall Study|Protocol Violation|1|||
146782379|NCT05082909|529374700|FG003|Overall Study|Protocol Violation|0|||
146782380|NCT05082909|529374701|FG004|Overall Study|Protocol Violation|0|||
146782381|NCT05082909|529374702|FG005|Overall Study|Protocol Violation|0|||
146782382|NCT04088630|529374703|FG000|Overall Study|Lost to Follow-up|3|||
146782383|NCT04088630|529374704|FG001|Overall Study|Lost to Follow-up|2|||
146782384|NCT04088630|529374705|FG002|Overall Study|Lost to Follow-up|6|||
146782385|NCT04088630|529374703|FG000|Overall Study|Death|3|||
146721351|NCT01259713|529149421|FG000|Overall Study|Investigators Discretion|14|||
146721352|NCT01259713|529149422|FG001|Overall Study|Investigators Discretion|6|||
146721353|NCT01259713|529149421|FG000|Overall Study|Lack of Efficacy|2|||
146721354|NCT01259713|529149422|FG001|Overall Study|Lack of Efficacy|0|||
146721355|NCT01259713|529149421|FG000|Overall Study|Protocol Violation|5|||
146721356|NCT01259713|529149422|FG001|Overall Study|Protocol Violation|4|||
146721357|NCT01259713|529149421|FG000|Overall Study|Subject Withdrew Consent|12|||
146721358|NCT01259713|529149422|FG001|Overall Study|Subject Withdrew Consent|7|||
146721359|NCT02388724|529149424|FG000|Overall Study|Reason not Specified|0|||
146721360|NCT02388724|529149425|FG001|Overall Study|Reason not Specified|1|||
146721361|NCT02388724|529149424|FG000|Overall Study|Major Protocol Deviation|3|||
146721362|NCT02388724|529149425|FG001|Overall Study|Major Protocol Deviation|3|||
146721363|NCT02388724|529149424|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
146721364|NCT02388724|529149425|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
146721365|NCT02388724|529149424|FG000|Overall Study|Voluntary Withdrawal|6|||
146721366|NCT02388724|529149425|FG001|Overall Study|Voluntary Withdrawal|5|||
146721367|NCT02388724|529149424|FG000|Overall Study|Randomized but not Treated|0|||
146721368|NCT02388724|529149425|FG001|Overall Study|Randomized but not Treated|2|||
146721369|NCT00765843|529149427|FG000|Overall Study|Lost to Follow-up|1|||
146721370|NCT00765843|529149428|FG001|Overall Study|Lost to Follow-up|3|||
146721371|NCT00765843|529149429|FG002|Overall Study|Lost to Follow-up|2|||
146721372|NCT00765843|529149427|FG000|Overall Study|did not return to receive intervention|0|||
146721373|NCT00765843|529149428|FG001|Overall Study|did not return to receive intervention|1|||
146721374|NCT00765843|529149429|FG002|Overall Study|did not return to receive intervention|0|||
146721375|NCT00765843|529149427|FG000|Overall Study|Adverse Event|0|||
146721376|NCT00765843|529149428|FG001|Overall Study|Adverse Event|0|||
146721377|NCT00765843|529149429|FG002|Overall Study|Adverse Event|1|||
146721378|NCT02696317|529149430|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
146721379|NCT02696317|529149431|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
146721380|NCT02696317|529149430|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
146721381|NCT02696317|529149431|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
146721382|NCT01343368|529149432|FG000|Overall Study|Death|1|||
146721383|NCT01343368|529149433|FG001|Overall Study|Death|0|||
146721384|NCT01343368|529149432|FG000|Overall Study|Lost to Follow-up|1|||
146721385|NCT01343368|529149433|FG001|Overall Study|Lost to Follow-up|0|||
146721386|NCT01296568|529149436|FG000|Continued Access Phase|Lost to Follow-up|1|||
146721387|NCT01296568|529149436|FG000|Continued Access Phase|Withdrawal by Subject|1|||
146721388|NCT01296568|529149436|FG000|Continued Access Phase|Disease Progression|1|||
146721389|NCT01816594|529149440|FG000|Overall Study|Local Progress|0|||
146721390|NCT01816594|529149441|FG001|Overall Study|Local Progress|2|||
146721391|NCT01816594|529149440|FG000|Overall Study|Adverse Event|9|||
146721392|NCT01816594|529149441|FG001|Overall Study|Adverse Event|0|||
146721393|NCT01816594|529149440|FG000|Overall Study|Withdrawal by Subject|1|||
146721394|NCT01816594|529149441|FG001|Overall Study|Withdrawal by Subject|0|||
146721395|NCT01816594|529149440|FG000|Overall Study|Physician Decision|1|||
146721396|NCT01816594|529149441|FG001|Overall Study|Physician Decision|0|||
146721397|NCT01571362|529149442|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
146721398|NCT01571362|529149443|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
146721399|NCT01571362|529149444|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
146721400|NCT01571362|529149442|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
146721401|NCT01571362|529149443|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
146721402|NCT01571362|529149444|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
146721403|NCT01571362|529149442|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
146721404|NCT01571362|529149443|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
146721405|NCT01571362|529149444|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
146721406|NCT01571362|529149442|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
146721407|NCT01571362|529149443|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
146721408|NCT01571362|529149444|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
146721409|NCT01571362|529149442|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
146721410|NCT01571362|529149443|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
146721411|NCT01571362|529149444|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
146721412|NCT01571362|529149442|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
146721413|NCT01571362|529149443|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
146721414|NCT01571362|529149444|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
146721415|NCT01571362|529149442|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146721416|NCT01571362|529149443|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
146721417|NCT01571362|529149444|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
146721418|NCT01571362|529149442|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
146721419|NCT01571362|529149443|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
146721420|NCT01571362|529149444|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
146782386|NCT04088630|529374704|FG001|Overall Study|Death|1|||
146934256|NCT00340834|529917831|FG003|Core Phase of Study|Adverse Event|0|||
146934257|NCT00340834|529917832|FG004|Core Phase of Study|Adverse Event|0|||
146934258|NCT00340834|529917828|FG000|Core Phase of Study|Withdrawal by Subject|11|||
146934259|NCT00340834|529917829|FG001|Core Phase of Study|Withdrawal by Subject|9|||
146934260|NCT00340834|529917830|FG002|Core Phase of Study|Withdrawal by Subject|16|||
146934261|NCT00340834|529917831|FG003|Core Phase of Study|Withdrawal by Subject|0|||
146721421|NCT01571362|529149442|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146721422|NCT01571362|529149443|FG001|Double-Blind Treatment Period|Adverse Event|9|||
146721423|NCT01571362|529149444|FG002|Double-Blind Treatment Period|Adverse Event|14|||
146721424|NCT01571362|529149442|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146721425|NCT01571362|529149443|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
146721426|NCT01571362|529149444|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
146721427|NCT01571362|529149442|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
146721428|NCT01571362|529149443|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
146721429|NCT01571362|529149444|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
146721430|NCT01571362|529149442|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
146721431|NCT01571362|529149443|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
146721432|NCT01571362|529149444|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
146721433|NCT03117738|529149445|FG000|Overall Study|Withdrawal by Subject|3|||
146721434|NCT03117738|529149446|FG001|Overall Study|Withdrawal by Subject|1|||
146721435|NCT03117738|529149445|FG000|Overall Study|Lost to Follow-up|1|||
146721436|NCT03117738|529149446|FG001|Overall Study|Lost to Follow-up|4|||
146721437|NCT01669629|529149447|FG000|Period 1|protocol deviation|1|||
146721438|NCT01669629|529149448|FG001|Period 1|protocol deviation|2|||
146721439|NCT01221597|529149449|FG000|Overall Study|Adverse Event|4|||
146721440|NCT01221597|529149450|FG001|Overall Study|Adverse Event|1|||
146721441|NCT01221597|529149449|FG000|Overall Study|Withdrawal by Subject|20|||
146721442|NCT01221597|529149450|FG001|Overall Study|Withdrawal by Subject|6|||
146721443|NCT01221597|529149449|FG000|Overall Study|Lost to Follow-up|6|||
146721444|NCT01221597|529149450|FG001|Overall Study|Lost to Follow-up|5|||
146721445|NCT01221597|529149449|FG000|Overall Study|Protocol Violation|1|||
146721446|NCT01221597|529149450|FG001|Overall Study|Protocol Violation|0|||
146721447|NCT01221597|529149449|FG000|Overall Study|Other|3|||
146721448|NCT01221597|529149450|FG001|Overall Study|Other|4|||
146721449|NCT01221597|529149449|FG000|Overall Study|Death|2|||
146721450|NCT01221597|529149450|FG001|Overall Study|Death|0|||
146721451|NCT01292928|529149452|FG000|Overall Study|Death|8|||
146721452|NCT01292928|529149452|FG000|Overall Study|Withdrawal by Subject|8|||
146721453|NCT01292928|529149452|FG000|Overall Study|Lost to Follow-up|6|||
146721454|NCT01292928|529149452|FG000|Overall Study|Physician Decision|2|||
146721455|NCT04530448|529149453|FG000|Overall Study|Physician Decision|3|||
146721456|NCT04530448|529149454|FG001|Overall Study|Physician Decision|0|||
146721457|NCT01491854|529149455|FG000|Overall Study|mainly due to premature termination|93|||
146721458|NCT01491854|529149455|FG000|Overall Study|Death|1|||
146721459|NCT01491854|529149455|FG000|Overall Study|Withdrawal by Subject|3|||
146721460|NCT01491854|529149455|FG000|Overall Study|Lost to Follow-up|33|||
146721461|NCT01026974|529149467|FG000|Overall Study|Withdrawal by Subject|0|||
146721462|NCT01026974|529149468|FG001|Overall Study|Withdrawal by Subject|1|||
146721463|NCT01026974|529149469|FG002|Overall Study|Withdrawal by Subject|7|||
146721464|NCT01026974|529149470|FG003|Overall Study|Withdrawal by Subject|2|||
146721465|NCT01026974|529149467|FG000|Overall Study|Lost to Follow-up|1|||
146721466|NCT01026974|529149468|FG001|Overall Study|Lost to Follow-up|1|||
146721467|NCT01026974|529149469|FG002|Overall Study|Lost to Follow-up|4|||
146721468|NCT01026974|529149470|FG003|Overall Study|Lost to Follow-up|0|||
146721469|NCT01026974|529149467|FG000|Overall Study|Adverse Event|0|||
146721470|NCT01026974|529149468|FG001|Overall Study|Adverse Event|0|||
146721471|NCT01026974|529149469|FG002|Overall Study|Adverse Event|0|||
146721472|NCT01026974|529149470|FG003|Overall Study|Adverse Event|1|||
146721473|NCT01026974|529149467|FG000|Overall Study|Inappropriate enrollment|0|||
146721474|NCT01026974|529149468|FG001|Overall Study|Inappropriate enrollment|0|||
146721475|NCT01026974|529149469|FG002|Overall Study|Inappropriate enrollment|1|||
146721476|NCT01026974|529149470|FG003|Overall Study|Inappropriate enrollment|0|||
146721477|NCT01715805|529149472|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
146721478|NCT01715805|529149473|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
146721479|NCT01715805|529149474|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
146721480|NCT01715805|529149475|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
146721481|NCT01715805|529149472|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
146721482|NCT01715805|529149473|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
146934262|NCT00340834|529917832|FG004|Core Phase of Study|Withdrawal by Subject|0|||
146721483|NCT01715805|529149474|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
146721484|NCT01715805|529149475|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
146721485|NCT01715805|529149472|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
146721486|NCT01715805|529149473|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
146782387|NCT04088630|529374705|FG002|Overall Study|Death|1|||
146934263|NCT00340834|529917828|FG000|Core Phase of Study|Administrative Problems|6|||
146721487|NCT01715805|529149474|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
146721488|NCT01715805|529149475|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
146721489|NCT01715805|529149472|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
146721490|NCT01715805|529149473|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
146721491|NCT01715805|529149474|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
146721492|NCT01715805|529149475|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
146721493|NCT01715805|529149472|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
146721494|NCT01715805|529149473|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
146721495|NCT01715805|529149474|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
146721496|NCT01715805|529149475|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
146721497|NCT01715805|529149472|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
146721498|NCT01715805|529149473|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
146721499|NCT01715805|529149474|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
146721500|NCT01715805|529149475|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
146721501|NCT01715805|529149472|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
146721502|NCT01715805|529149473|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
146721503|NCT01715805|529149474|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
146721504|NCT01715805|529149475|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
146721505|NCT01715805|529149472|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
146721506|NCT01715805|529149473|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
146721507|NCT01715805|529149474|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
146721508|NCT01715805|529149475|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
146721509|NCT01715805|529149472|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
146721510|NCT01715805|529149473|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
146721511|NCT01715805|529149474|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
146721512|NCT01715805|529149475|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
146721513|NCT01715805|529149472|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
146721514|NCT01715805|529149473|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
146721515|NCT01715805|529149474|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
146721516|NCT01715805|529149475|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
146721517|NCT01715805|529149472|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
146721518|NCT01715805|529149473|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
146721519|NCT01715805|529149474|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
146721520|NCT01715805|529149475|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
146721521|NCT01715805|529149472|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
146721522|NCT01715805|529149473|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
146721523|NCT01715805|529149474|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
146721524|NCT01715805|529149475|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
146721525|NCT01715805|529149472|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
146721526|NCT01715805|529149473|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
146721527|NCT01715805|529149474|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
146721528|NCT01715805|529149475|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
146721529|NCT01715805|529149472|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
146721530|NCT01715805|529149473|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
146721531|NCT01715805|529149474|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
146721532|NCT01715805|529149475|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
146721533|NCT02647359|529149478|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
146721534|NCT02647359|529149479|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
146721535|NCT02647359|529149478|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
146721536|NCT02647359|529149479|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
146721537|NCT02647359|529149478|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
146721538|NCT02647359|529149479|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
146721539|NCT02647359|529149478|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
146721540|NCT02647359|529149479|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
146721541|NCT02647359|529149478|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
146721542|NCT02647359|529149479|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
146721543|NCT02647359|529149478|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
146721544|NCT02647359|529149479|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
146721545|NCT01581281|529149487|FG000|Overall Study|Early Study Closure|15|||
146721546|NCT01581281|529149488|FG001|Overall Study|Early Study Closure|6|||
146721547|NCT01581281|529149489|FG002|Overall Study|Early Study Closure|12|||
146721548|NCT00700401|529149498|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
146721549|NCT00700401|529149498|FG000|Overall Study|Adverse Event|5|||
146721550|NCT00700401|529149498|FG000|Overall Study|Refused Treatment|2|||
146721551|NCT00700401|529149498|FG000|Overall Study|Lost to Follow-up|1|||
146721552|NCT00700401|529149498|FG000|Overall Study|Treatment never started|1|||
146934264|NCT00340834|529917829|FG001|Core Phase of Study|Administrative Problems|2|||
146934265|NCT00340834|529917830|FG002|Core Phase of Study|Administrative Problems|7|||
146934266|NCT00340834|529917831|FG003|Core Phase of Study|Administrative Problems|0|||
146934267|NCT00340834|529917832|FG004|Core Phase of Study|Administrative Problems|0|||
146934268|NCT00340834|529917828|FG000|Core Phase of Study|Lack of Efficacy|3|||
146934269|NCT00340834|529917829|FG001|Core Phase of Study|Lack of Efficacy|3|||
146934270|NCT00340834|529917830|FG002|Core Phase of Study|Lack of Efficacy|7|||
146721553|NCT00700401|529149498|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
146721554|NCT00700401|529149498|FG000|Overall Study|Withdrawal by Subject|2|||
146782388|NCT04088630|529374703|FG000|Overall Study|Physician Decision|0|||
146782389|NCT04088630|529374704|FG001|Overall Study|Physician Decision|1|||
146782390|NCT04088630|529374705|FG002|Overall Study|Physician Decision|1|||
146782391|NCT02954341|529374706|FG000|Overall Study|Attempted Implant unsuccessful|5|||
146782392|NCT02954341|529374706|FG000|Overall Study|Death|90|||
146782393|NCT02954341|529374706|FG000|Overall Study|Withdrawal by Subject|4|||
146782394|NCT02954341|529374706|FG000|Overall Study|Physician Decision|13|||
146782395|NCT02954341|529374706|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
146782396|NCT02954341|529374706|FG000|Overall Study|Not implanted due to physician's decision|1|||
146782397|NCT02954341|529374706|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
146782398|NCT04410042|529374710|FG000|Overall Study|Not Eligible|1|||
146782399|NCT04410042|529374711|FG001|Overall Study|Not Eligible|1|||
146782400|NCT01494662|529374712|FG000|Overall Study|Withdrawal by Subject|0|||
146782401|NCT01494662|529374713|FG001|Overall Study|Withdrawal by Subject|0|||
146782402|NCT01494662|529374714|FG002|Overall Study|Withdrawal by Subject|1|||
146782403|NCT01494662|529374715|FG003|Overall Study|Withdrawal by Subject|0|||
146721555|NCT00295750|529149502|FG000|Overall Study|Adverse Event|19|||
146721556|NCT00295750|529149503|FG001|Overall Study|Adverse Event|15|||
146721557|NCT00295750|529149504|FG002|Overall Study|Adverse Event|12|||
146721558|NCT00295750|529149502|FG000|Overall Study|Lack of Efficacy|1|||
146721559|NCT00295750|529149503|FG001|Overall Study|Lack of Efficacy|1|||
146721560|NCT00295750|529149504|FG002|Overall Study|Lack of Efficacy|0|||
146721561|NCT00295750|529149502|FG000|Overall Study|Lost to Follow-up|1|||
146721562|NCT00295750|529149503|FG001|Overall Study|Lost to Follow-up|4|||
146721563|NCT00295750|529149504|FG002|Overall Study|Lost to Follow-up|1|||
146721564|NCT00295750|529149502|FG000|Overall Study|Taking prohibited therapy|2|||
146721565|NCT00295750|529149503|FG001|Overall Study|Taking prohibited therapy|3|||
146721566|NCT00295750|529149504|FG002|Overall Study|Taking prohibited therapy|2|||
146721567|NCT00295750|529149502|FG000|Overall Study|Administrative errors|2|||
146721568|NCT00295750|529149503|FG001|Overall Study|Administrative errors|4|||
146721569|NCT00295750|529149504|FG002|Overall Study|Administrative errors|5|||
146721570|NCT00295750|529149502|FG000|Overall Study|Trial drug errors|1|||
146721571|NCT00295750|529149503|FG001|Overall Study|Trial drug errors|1|||
146721572|NCT00295750|529149504|FG002|Overall Study|Trial drug errors|0|||
146721573|NCT00295750|529149502|FG000|Overall Study|Disease progression|2|||
146721574|NCT00295750|529149503|FG001|Overall Study|Disease progression|1|||
146721575|NCT00295750|529149504|FG002|Overall Study|Disease progression|0|||
146721576|NCT00295750|529149502|FG000|Overall Study|Personal reasons|0|||
146721577|NCT00295750|529149503|FG001|Overall Study|Personal reasons|1|||
146721578|NCT00295750|529149504|FG002|Overall Study|Personal reasons|0|||
146721579|NCT00295750|529149502|FG000|Overall Study|Randomized but never received trial drug|4|||
146721580|NCT00295750|529149503|FG001|Overall Study|Randomized but never received trial drug|3|||
146721581|NCT00295750|529149504|FG002|Overall Study|Randomized but never received trial drug|3|||
146721582|NCT00295750|529149502|FG000|Overall Study|Withdrawal by Subject|9|||
146721583|NCT00295750|529149503|FG001|Overall Study|Withdrawal by Subject|4|||
146721584|NCT00295750|529149504|FG002|Overall Study|Withdrawal by Subject|7|||
146721585|NCT00295750|529149502|FG000|Overall Study|Protocol Violation|2|||
146721586|NCT00295750|529149503|FG001|Overall Study|Protocol Violation|4|||
146721587|NCT00295750|529149504|FG002|Overall Study|Protocol Violation|2|||
146721588|NCT01650259|529149505|FG000|Overall Study|Improvement|105|||
146721589|NCT01650259|529149506|FG001|Overall Study|Improvement|0|||
146721590|NCT01650259|529149505|FG000|Overall Study|Adverse Event|127|||
146721591|NCT01650259|529149506|FG001|Overall Study|Adverse Event|0|||
146782404|NCT01494662|529374716|FG004|Overall Study|Withdrawal by Subject|0|||
146782405|NCT01494662|529374717|FG005|Overall Study|Withdrawal by Subject|0|||
146782406|NCT01494662|529374718|FG006|Overall Study|Withdrawal by Subject|0|||
146782407|NCT01494662|529374712|FG000|Overall Study|Physician Decision|0|||
146782408|NCT01494662|529374713|FG001|Overall Study|Physician Decision|0|||
146934271|NCT00340834|529917831|FG003|Core Phase of Study|Lack of Efficacy|0|||
146934272|NCT00340834|529917832|FG004|Core Phase of Study|Lack of Efficacy|0|||
146721592|NCT01650259|529149505|FG000|Overall Study|Lack of Efficacy|143|||
146721593|NCT01650259|529149506|FG001|Overall Study|Lack of Efficacy|0|||
146721594|NCT01650259|529149505|FG000|Overall Study|Lost to Follow-up|435|||
146721595|NCT01650259|529149506|FG001|Overall Study|Lost to Follow-up|0|||
146721596|NCT01650259|529149505|FG000|Overall Study|Patients had no visit after entry|70|||
146721597|NCT01650259|529149506|FG001|Overall Study|Patients had no visit after entry|0|||
146721598|NCT01650259|529149505|FG000|Overall Study|CRF not collected|98|||
146721599|NCT01650259|529149506|FG001|Overall Study|CRF not collected|82|||
146782409|NCT01494662|529374714|FG002|Overall Study|Physician Decision|1|||
146782410|NCT01494662|529374715|FG003|Overall Study|Physician Decision|0|||
146782411|NCT01494662|529374716|FG004|Overall Study|Physician Decision|0|||
146782412|NCT01494662|529374717|FG005|Overall Study|Physician Decision|0|||
146782413|NCT01494662|529374718|FG006|Overall Study|Physician Decision|0|||
146782414|NCT04072822|529374719|FG000|Treatment|Adverse Event|9|||
146782415|NCT04072822|529374720|FG001|Treatment|Adverse Event|5|||
146782416|NCT04072822|529374719|FG000|Treatment|Met Stopping Criteria|13|||
146782417|NCT04072822|529374720|FG001|Treatment|Met Stopping Criteria|24|||
146782418|NCT04072822|529374719|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
146782419|NCT04072822|529374720|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
146782420|NCT04072822|529374719|FG000|Treatment|Withdrawal by Subject|0|||
146782421|NCT04072822|529374720|FG001|Treatment|Withdrawal by Subject|2|||
146782422|NCT04072822|529374719|FG000|Treatment|Death|0|||
146782423|NCT04072822|529374720|FG001|Treatment|Death|2|||
146782424|NCT04072822|529374719|FG000|Treatment|Lost to Follow-up|11|||
146782425|NCT04072822|529374720|FG001|Treatment|Lost to Follow-up|3|||
146782426|NCT04072822|529374719|FG000|Treatment|Physician Decision|1|||
146782427|NCT04072822|529374720|FG001|Treatment|Physician Decision|0|||
146782428|NCT04072822|529374719|FG000|Treatment|Other|7|||
146782429|NCT04072822|529374720|FG001|Treatment|Other|9|||
146782430|NCT04072822|529374719|FG000|Follow-up|Withdrawal by Subject|1|||
146782431|NCT04072822|529374720|FG001|Follow-up|Withdrawal by Subject|0|||
146782432|NCT04072822|529374719|FG000|Follow-up|Lost to Follow-up|5|||
146782433|NCT04072822|529374720|FG001|Follow-up|Lost to Follow-up|4|||
146782434|NCT05481320|529374721|FG000|Overall Study|Withdrawal by Subject|1|||
146782435|NCT05481320|529374722|FG001|Overall Study|Withdrawal by Subject|1|||
146782436|NCT05481320|529374721|FG000|Overall Study|Care recipent passed away|0|||
146782437|NCT05481320|529374722|FG001|Overall Study|Care recipent passed away|1|||
146782438|NCT05481320|529374721|FG000|Overall Study|Out-of-window assessment|0|||
146782439|NCT05481320|529374722|FG001|Overall Study|Out-of-window assessment|1|||
146782440|NCT05481320|529374721|FG000|Overall Study|No longer a primary caregiver|3|||
146782441|NCT05481320|529374722|FG001|Overall Study|No longer a primary caregiver|0|||
146782442|NCT05481320|529374721|FG000|Overall Study|Unable to contact|1|||
146782443|NCT05481320|529374722|FG001|Overall Study|Unable to contact|0|||
146782444|NCT02811679|529374723|FG000|Overall Study|Adverse Event|1|||
146782445|NCT02811679|529374723|FG000|Overall Study|Lack of Efficacy|6|||
146782446|NCT02811679|529374723|FG000|Overall Study|Early study closure due to slow accrual|3|||
146782447|NCT01361711|529374728|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
146782448|NCT01361711|529374728|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
146782449|NCT01361711|529374728|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
146782450|NCT01361711|529374728|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
146782451|NCT01361711|529374728|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
146782452|NCT01361711|529374728|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
146782453|NCT01361711|529374728|FG000|Completed Week 18 of Treatment|Other|9|||
146782454|NCT01361711|529374728|FG000|10 Year Follow-up|Still in follow-up|22|||
146782455|NCT01361711|529374728|FG000|10 Year Follow-up|Death|7|||
146782456|NCT01361711|529374728|FG000|10 Year Follow-up|Developed new cancer|1|||
146721600|NCT01650259|529149505|FG000|Overall Study|Not treated|1|||
146721601|NCT01650259|529149506|FG001|Overall Study|Not treated|7|||
146721602|NCT01650259|529149505|FG000|Overall Study|Other than listed|64|||
146721603|NCT01650259|529149506|FG001|Overall Study|Other than listed|146|||
146721604|NCT00355082|529149512|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
146721605|NCT00355082|529149513|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
146721606|NCT00355082|529149514|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
146721607|NCT00355082|529149512|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
146721608|NCT00355082|529149513|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
146721609|NCT00355082|529149514|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
146721610|NCT00355082|529149512|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
146782457|NCT01361711|529374728|FG000|10 Year Follow-up|Lost to Follow-up|2|||
146721611|NCT00355082|529149513|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
146721612|NCT00355082|529149514|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
146721613|NCT00355082|529149512|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
146782458|NCT01361711|529374728|FG000|10 Year Follow-up|New treatment started|6|||
146782459|NCT01361711|529374728|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
146782460|NCT01361711|529374728|FG000|10 Year Follow-up|Progressive Disease|1|||
146782461|NCT03930342|529374729|FG000|Overall Study|Lost to Follow-up|70|||
146782462|NCT03930342|529374730|FG001|Overall Study|Lost to Follow-up|77|||
146721614|NCT00355082|529149513|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
146721615|NCT00355082|529149514|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
146782463|NCT05792423|529374739|FG000|Overall Study|Withdrawal by Subject|2|||
146782464|NCT02471638|529374740|FG000|Overall Study|Early Term Withdrawal|10|||
146934273|NCT00340834|529917828|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
146782465|NCT04593472|529376639|FG000|Overall Study|Death|31|||
146782466|NCT04593472|529376640|FG001|Overall Study|Death|27|||
146782467|NCT04593472|529376639|FG000|Overall Study|Withdrawal by Subject|12|||
146782468|NCT04593472|529376640|FG001|Overall Study|Withdrawal by Subject|12|||
146782469|NCT04593472|529376639|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
146782470|NCT04593472|529376640|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
146782471|NCT04593472|529376639|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
146782472|NCT04593472|529376640|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
146782473|NCT04593472|529376639|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
146782474|NCT04593472|529376640|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
146782475|NCT04593472|529376639|FG000|Overall Study|Lost to Follow-up|0|||
146782476|NCT04593472|529376640|FG001|Overall Study|Lost to Follow-up|2|||
146782477|NCT04593472|529376639|FG000|Overall Study|Still collecting 24-month assessment|17|||
146934274|NCT00340834|529917829|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
146934275|NCT00340834|529917830|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
146934276|NCT00340834|529917831|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
146934277|NCT00340834|529917832|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
146934278|NCT00340834|529917828|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
146934279|NCT00340834|529917829|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
146934280|NCT00340834|529917830|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
146934281|NCT00340834|529917831|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
146934282|NCT00340834|529917832|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
146934283|NCT00340834|529917828|FG000|Core Phase of Study|Lost to Follow-up|1|||
146934284|NCT00340834|529917829|FG001|Core Phase of Study|Lost to Follow-up|1|||
146934285|NCT00340834|529917830|FG002|Core Phase of Study|Lost to Follow-up|4|||
146934286|NCT00340834|529917831|FG003|Core Phase of Study|Lost to Follow-up|0|||
146782478|NCT04593472|529376640|FG001|Overall Study|Still collecting 24-month assessment|10|||
146782479|NCT03648840|529376641|FG000|First IV Infusion Session|Adverse Event|0|||
146782480|NCT03648840|529376642|FG001|First IV Infusion Session|Adverse Event|2|||
146782481|NCT03648840|529376641|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
146782482|NCT03648840|529376642|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
146782483|NCT03648840|529376641|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
146782484|NCT03648840|529376642|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
146782485|NCT03648840|529376641|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
146782486|NCT03648840|529376642|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
146782487|NCT05063994|529376647|FG000|Cortef Run-In|Withdrawal of Consent|1|||
146782488|NCT05063994|529376648|FG001|Cortef Run-In|Withdrawal of Consent|0|||
146782489|NCT05063994|529376649|FG002|Cortef Run-In|Withdrawal of Consent|0|||
146782490|NCT05063994|529376647|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
146782491|NCT05063994|529376648|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
146782492|NCT05063994|529376649|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
146782493|NCT05063994|529376647|FG000|Treatment|Physician Decision|0|||
146782494|NCT05063994|529376648|FG001|Treatment|Physician Decision|0|||
146782495|NCT05063994|529376649|FG002|Treatment|Physician Decision|1|||
146782496|NCT05063994|529376647|FG000|Treatment|Withdrawal by Subject|0|||
146782497|NCT05063994|529376648|FG001|Treatment|Withdrawal by Subject|0|||
146782498|NCT05063994|529376649|FG002|Treatment|Withdrawal by Subject|1|||
146782499|NCT05063994|529376647|FG000|Treatment|Withdrawal of Consent|0|||
146782500|NCT05063994|529376648|FG001|Treatment|Withdrawal of Consent|0|||
146782501|NCT05063994|529376649|FG002|Treatment|Withdrawal of Consent|1|||
146782502|NCT03692676|529376652|FG000|Overall Study|exclude patients with prior use|4424|||
146782503|NCT03692676|529376653|FG001|Overall Study|exclude patients with prior use|24726|||
146782504|NCT03692676|529376654|FG002|Overall Study|exclude patients with prior use|0|||
146782505|NCT03692676|529376655|FG003|Overall Study|exclude patients with prior use|0|||
146782506|NCT03692676|529376652|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
146782507|NCT03692676|529376653|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
146782508|NCT03692676|529376654|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
146782509|NCT03692676|529376655|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
146782510|NCT03692676|529376652|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
146782511|NCT03692676|529376653|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
146934287|NCT00340834|529917832|FG004|Core Phase of Study|Lost to Follow-up|0|||
146934288|NCT00340834|529917828|FG000|Core Phase of Study|Death|2|||
146934289|NCT00340834|529917829|FG001|Core Phase of Study|Death|0|||
146934290|NCT00340834|529917830|FG002|Core Phase of Study|Death|0|||
146934291|NCT00340834|529917831|FG003|Core Phase of Study|Death|0|||
146934292|NCT00340834|529917832|FG004|Core Phase of Study|Death|0|||
146934293|NCT00340834|529917828|FG000|Core Phase of Study|Protocol Violation|0|||
146782512|NCT03692676|529376654|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
146934294|NCT00340834|529917829|FG001|Core Phase of Study|Protocol Violation|0|||
146934295|NCT00340834|529917830|FG002|Core Phase of Study|Protocol Violation|2|||
146934296|NCT00340834|529917831|FG003|Core Phase of Study|Protocol Violation|0|||
146782513|NCT03692676|529376655|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
146782514|NCT03692676|529376652|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
146782515|NCT03692676|529376653|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
146782516|NCT03692676|529376654|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
146782517|NCT03692676|529376655|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
146782518|NCT03692676|529376652|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
146782519|NCT03692676|529376653|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
146782520|NCT03692676|529376654|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
146782521|NCT03692676|529376655|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
146782522|NCT03692676|529376652|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
146782523|NCT03692676|529376653|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
146782524|NCT03692676|529376654|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
146782525|NCT03692676|529376655|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
146782526|NCT03692676|529376652|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
146782527|NCT03692676|529376653|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
146782528|NCT03692676|529376654|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
146782529|NCT03692676|529376655|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
146782530|NCT03692676|529376652|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
146782531|NCT03692676|529376653|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
146782532|NCT03692676|529376654|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
146782533|NCT03692676|529376655|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
146782534|NCT03692676|529376652|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
146782535|NCT03692676|529376653|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
146782536|NCT03692676|529376654|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
146782537|NCT03692676|529376655|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
146782538|NCT03692676|529376652|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
146782539|NCT03692676|529376653|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
146782540|NCT03692676|529376654|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
146782541|NCT03692676|529376655|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
146782542|NCT03692676|529376652|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
146782543|NCT03692676|529376653|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
146782544|NCT03692676|529376654|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
146782545|NCT03692676|529376655|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
146782546|NCT03692676|529376652|FG000|Overall Study|Other|0|||
146782547|NCT03692676|529376653|FG001|Overall Study|Other|805|||
146782548|NCT03692676|529376654|FG002|Overall Study|Other|758|||
146782549|NCT03692676|529376655|FG003|Overall Study|Other|277|||
146782550|NCT03692676|529376652|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
146782551|NCT03692676|529376653|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
146782552|NCT03692676|529376654|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
146782553|NCT03692676|529376655|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
146782554|NCT04490915|529376657|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
146782555|NCT04490915|529376658|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
146782556|NCT04490915|529376657|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146782557|NCT04490915|529376658|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146782558|NCT04490915|529376657|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
146782559|NCT04490915|529376658|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
146721616|NCT00355082|529149512|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
146721617|NCT00355082|529149513|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
146721618|NCT00355082|529149514|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
146721619|NCT00355082|529149512|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
146721620|NCT00355082|529149513|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
146721621|NCT00355082|529149514|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
146721622|NCT00355082|529149512|FG000|Continuation Phase|Adverse Event|2|||
146721623|NCT00355082|529149513|FG001|Continuation Phase|Adverse Event|0|||
146721624|NCT00355082|529149514|FG002|Continuation Phase|Adverse Event|1|||
146721625|NCT00355082|529149512|FG000|Continuation Phase|Lost to Follow-up|2|||
146721626|NCT00355082|529149513|FG001|Continuation Phase|Lost to Follow-up|0|||
146721627|NCT00355082|529149514|FG002|Continuation Phase|Lost to Follow-up|1|||
146721628|NCT00355082|529149512|FG000|Continuation Phase|Protocol Violation|1|||
146721629|NCT00355082|529149513|FG001|Continuation Phase|Protocol Violation|0|||
146721630|NCT00355082|529149514|FG002|Continuation Phase|Protocol Violation|1|||
146721631|NCT00355082|529149512|FG000|Continuation Phase|Withdrawal by Subject|4|||
146721632|NCT00355082|529149513|FG001|Continuation Phase|Withdrawal by Subject|0|||
146721633|NCT00355082|529149514|FG002|Continuation Phase|Withdrawal by Subject|0|||
146721634|NCT00355082|529149512|FG000|Continuation Phase|Lack of Efficacy|5|||
146721635|NCT00355082|529149513|FG001|Continuation Phase|Lack of Efficacy|0|||
146721636|NCT00355082|529149514|FG002|Continuation Phase|Lack of Efficacy|0|||
146721637|NCT00355082|529149512|FG000|Continuation Phase|Site Closed by Sponsor|8|||
146721638|NCT00355082|529149513|FG001|Continuation Phase|Site Closed by Sponsor|0|||
146721639|NCT00355082|529149514|FG002|Continuation Phase|Site Closed by Sponsor|0|||
146721640|NCT00355082|529149512|FG000|Continuation Phase|Scheduling Error|1|||
146721641|NCT00355082|529149513|FG001|Continuation Phase|Scheduling Error|0|||
146721642|NCT00355082|529149514|FG002|Continuation Phase|Scheduling Error|0|||
146721643|NCT00355082|529149512|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
146721644|NCT00355082|529149513|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
146721645|NCT00355082|529149514|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
146721646|NCT00724971|529149524|FG000|Overall Study|Adverse Event|5|||
146721647|NCT00724971|529149524|FG000|Overall Study|Withdrawal by Subject|1|||
146721648|NCT01003249|529149525|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
146721649|NCT01003249|529149526|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
146721650|NCT01003249|529149525|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
146721651|NCT01003249|529149526|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
146721652|NCT01003249|529149525|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
146721653|NCT01003249|529149526|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
146721654|NCT01003249|529149525|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
146721655|NCT01003249|529149526|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
146721656|NCT02132611|529149531|FG000|Overall Study|Death|2|||
146721657|NCT03387852|529149532|FG000|Overall Study|Adverse event (AE)|3|||
146721658|NCT03387852|529149533|FG001|Overall Study|Adverse event (AE)|0|||
146721659|NCT03387852|529149534|FG002|Overall Study|Adverse event (AE)|2|||
146721660|NCT03387852|529149535|FG003|Overall Study|Adverse event (AE)|0|||
146721661|NCT03387852|529149532|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
146721662|NCT03387852|529149533|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
146721663|NCT03387852|529149534|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
146721664|NCT03387852|529149535|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
146721665|NCT03387852|529149532|FG000|Overall Study|Withdrawal by participant|1|||
146721666|NCT03387852|529149533|FG001|Overall Study|Withdrawal by participant|1|||
146721667|NCT03387852|529149534|FG002|Overall Study|Withdrawal by participant|3|||
146721668|NCT03387852|529149535|FG003|Overall Study|Withdrawal by participant|2|||
146721669|NCT03387852|529149532|FG000|Overall Study|Other- Unspecified|1|||
146721670|NCT03387852|529149533|FG001|Overall Study|Other- Unspecified|1|||
146721671|NCT03387852|529149534|FG002|Overall Study|Other- Unspecified|2|||
146721672|NCT03387852|529149535|FG003|Overall Study|Other- Unspecified|1|||
146721673|NCT03387852|529149532|FG000|Overall Study|Poor compliance to protocol|0|||
146721674|NCT03387852|529149533|FG001|Overall Study|Poor compliance to protocol|0|||
146721675|NCT03387852|529149534|FG002|Overall Study|Poor compliance to protocol|0|||
146721676|NCT03387852|529149535|FG003|Overall Study|Poor compliance to protocol|1|||
146721677|NCT03387852|529149532|FG000|Overall Study|Randomized and not treated|0|||
146721678|NCT03387852|529149533|FG001|Overall Study|Randomized and not treated|0|||
146721679|NCT03387852|529149534|FG002|Overall Study|Randomized and not treated|0|||
146721680|NCT03387852|529149535|FG003|Overall Study|Randomized and not treated|1|||
146721681|NCT02194621|529149536|FG000|Overall Study|6 withdrew prior to randomization|2|||
146721682|NCT02194621|529149537|FG001|Overall Study|6 withdrew prior to randomization|2|||
146721683|NCT02194621|529149538|FG002|Overall Study|6 withdrew prior to randomization|2|||
146721684|NCT02194621|529149536|FG000|Overall Study|Withdrawal by Subject|4|||
146721685|NCT02194621|529149537|FG001|Overall Study|Withdrawal by Subject|4|||
146721686|NCT02194621|529149538|FG002|Overall Study|Withdrawal by Subject|7|||
146721687|NCT02493127|529149546|FG000|Overall Study|Lost to Follow-up|1|||
146721688|NCT02493127|529149547|FG001|Overall Study|Lost to Follow-up|1|||
146721689|NCT02763384|529149548|FG000|Overall Study|Physician Decision|1|||
146721690|NCT02763384|529149548|FG000|Overall Study|Rapid decline - went on hospice|1|||
146721691|NCT02096900|529149549|FG000|Overall Study|Did not receive medication|3|||
146721692|NCT02096900|529149550|FG001|Overall Study|Did not receive medication|1|||
146721693|NCT02096900|529149549|FG000|Overall Study|Surgery cancelled- medication received|1|||
146721694|NCT02096900|529149550|FG001|Overall Study|Surgery cancelled- medication received|1|||
146981339|NCT00479401|530093872|FG001|Overall Study|Adverse Event|20|||
146721695|NCT00808808|529149554|FG000|Overall Study|Vaccinated; survey not completed|131|||
146721696|NCT00808808|529149555|FG001|Overall Study|Vaccinated; survey not completed|169|||
146721697|NCT00808808|529149556|FG002|Overall Study|Vaccinated; survey not completed|302|||
146721698|NCT00808808|529149554|FG000|Overall Study|Employee was not vaccinated.|2686|||
146721699|NCT00808808|529149555|FG001|Overall Study|Employee was not vaccinated.|2268|||
146721700|NCT00808808|529149556|FG002|Overall Study|Employee was not vaccinated.|2255|||
146782560|NCT04490915|529376657|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
146782561|NCT04490915|529376658|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
146782562|NCT04490915|529376657|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
146782563|NCT04490915|529376658|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
146782564|NCT04490915|529376657|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
146782565|NCT04490915|529376658|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
146782566|NCT04490915|529376657|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
146782567|NCT04490915|529376658|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
146782568|NCT04725240|529376659|FG000|Overall Study|Adverse Event|2|||
146782569|NCT04083235|529376683|FG000|Overall Study|Death|252|||
146782570|NCT04083235|529376684|FG001|Overall Study|Death|277|||
146782571|NCT04083235|529376683|FG000|Overall Study|Withdrawal by Subject|13|||
146782572|NCT04083235|529376684|FG001|Overall Study|Withdrawal by Subject|17|||
146782573|NCT04083235|529376683|FG000|Overall Study|Lost to Follow-up|1|||
146782574|NCT04083235|529376684|FG001|Overall Study|Lost to Follow-up|1|||
146782575|NCT04083235|529376683|FG000|Overall Study|Does not meet entry criteria|1|||
146782576|NCT04083235|529376684|FG001|Overall Study|Does not meet entry criteria|0|||
146782577|NCT04083235|529376683|FG000|Overall Study|Did not receive treatment|13|||
146782578|NCT04083235|529376684|FG001|Overall Study|Did not receive treatment|8|||
146782579|NCT04083235|529376683|FG000|Overall Study|Ongoing at the time of DCO|44|||
146782580|NCT04083235|529376684|FG001|Overall Study|Ongoing at the time of DCO|7|||
146782581|NCT02312960|529376687|FG000|Overall Study|Death|24|||
146782582|NCT02312960|529376688|FG001|Overall Study|Death|32|||
146782583|NCT02312960|529376689|FG002|Overall Study|Death|25|||
146782584|NCT02312960|529376690|FG003|Overall Study|Death|11|||
146782585|NCT02312960|529376691|FG004|Overall Study|Death|5|||
146782586|NCT02312960|529376692|FG005|Overall Study|Death|5|||
146782587|NCT02312960|529376693|FG006|Overall Study|Death|8|||
146782588|NCT02312960|529376694|FG007|Overall Study|Death|5|||
146782589|NCT02312960|529376695|FG008|Overall Study|Death|7|||
146782590|NCT02312960|529376696|FG009|Overall Study|Death|3|||
146782591|NCT02312960|529376697|FG010|Overall Study|Death|3|||
146782592|NCT02312960|529376698|FG011|Overall Study|Death|1|||
146782593|NCT02312960|529376699|FG012|Overall Study|Death|25|||
146782594|NCT02312960|529376700|FG013|Overall Study|Death|19|||
146782595|NCT02312960|529376687|FG000|Overall Study|Missing|0|||
146782596|NCT02312960|529376688|FG001|Overall Study|Missing|0|||
146782597|NCT02312960|529376689|FG002|Overall Study|Missing|2|||
146782598|NCT02312960|529376690|FG003|Overall Study|Missing|0|||
146782599|NCT02312960|529376691|FG004|Overall Study|Missing|0|||
146782600|NCT02312960|529376692|FG005|Overall Study|Missing|0|||
146782601|NCT02312960|529376693|FG006|Overall Study|Missing|0|||
146782602|NCT02312960|529376694|FG007|Overall Study|Missing|0|||
146782603|NCT02312960|529376695|FG008|Overall Study|Missing|0|||
146782604|NCT02312960|529376696|FG009|Overall Study|Missing|0|||
146782605|NCT02312960|529376697|FG010|Overall Study|Missing|0|||
146782606|NCT02312960|529376698|FG011|Overall Study|Missing|0|||
146782607|NCT02312960|529376699|FG012|Overall Study|Missing|0|||
146782608|NCT02312960|529376700|FG013|Overall Study|Missing|0|||
146782609|NCT02312960|529376687|FG000|Overall Study|Lost to Follow-up|0|||
146782610|NCT02312960|529376688|FG001|Overall Study|Lost to Follow-up|0|||
146782611|NCT02312960|529376689|FG002|Overall Study|Lost to Follow-up|1|||
146782612|NCT02312960|529376690|FG003|Overall Study|Lost to Follow-up|0|||
146782613|NCT02312960|529376691|FG004|Overall Study|Lost to Follow-up|0|||
146934297|NCT00340834|529917832|FG004|Core Phase of Study|Protocol Violation|0|||
146934298|NCT00340834|529917828|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
146934299|NCT00340834|529917829|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
146934300|NCT00340834|529917830|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
146934301|NCT00340834|529917831|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
146934302|NCT00340834|529917832|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
146934303|NCT00340834|529917828|FG000|Extension Phase of Study|Subject withdrew consent|26|||
146934304|NCT00340834|529917829|FG001|Extension Phase of Study|Subject withdrew consent|31|||
146782614|NCT02312960|529376692|FG005|Overall Study|Lost to Follow-up|0|||
146934305|NCT00340834|529917830|FG002|Extension Phase of Study|Subject withdrew consent|0|||
146934306|NCT00340834|529917831|FG003|Extension Phase of Study|Subject withdrew consent|12|||
146782615|NCT02312960|529376693|FG006|Overall Study|Lost to Follow-up|1|||
146782616|NCT02312960|529376694|FG007|Overall Study|Lost to Follow-up|1|||
146782617|NCT02312960|529376695|FG008|Overall Study|Lost to Follow-up|0|||
146782618|NCT02312960|529376696|FG009|Overall Study|Lost to Follow-up|1|||
146782619|NCT02312960|529376697|FG010|Overall Study|Lost to Follow-up|0|||
146782620|NCT02312960|529376698|FG011|Overall Study|Lost to Follow-up|0|||
146782621|NCT02312960|529376699|FG012|Overall Study|Lost to Follow-up|1|||
146782622|NCT02312960|529376700|FG013|Overall Study|Lost to Follow-up|0|||
146782623|NCT02312960|529376687|FG000|Overall Study|Withdrawal by Subject|1|||
146782624|NCT02312960|529376688|FG001|Overall Study|Withdrawal by Subject|2|||
146782625|NCT02312960|529376689|FG002|Overall Study|Withdrawal by Subject|0|||
146782626|NCT02312960|529376690|FG003|Overall Study|Withdrawal by Subject|0|||
146782627|NCT02312960|529376691|FG004|Overall Study|Withdrawal by Subject|1|||
146782628|NCT02312960|529376692|FG005|Overall Study|Withdrawal by Subject|0|||
146782629|NCT02312960|529376693|FG006|Overall Study|Withdrawal by Subject|1|||
146782630|NCT02312960|529376694|FG007|Overall Study|Withdrawal by Subject|2|||
146782631|NCT02312960|529376695|FG008|Overall Study|Withdrawal by Subject|2|||
146782632|NCT02312960|529376696|FG009|Overall Study|Withdrawal by Subject|3|||
146782633|NCT02312960|529376697|FG010|Overall Study|Withdrawal by Subject|0|||
146782634|NCT02312960|529376698|FG011|Overall Study|Withdrawal by Subject|0|||
146782635|NCT02312960|529376699|FG012|Overall Study|Withdrawal by Subject|2|||
146782636|NCT02312960|529376700|FG013|Overall Study|Withdrawal by Subject|0|||
146782637|NCT04060355|529376702|FG000|Overall Study|Lost to Follow-up|41|||
146782638|NCT01140880|529376703|FG000|Overall Study|Death|0|||
146782639|NCT01140880|529376704|FG001|Overall Study|Death|1|||
146782640|NCT01140880|529376703|FG000|Overall Study|Withdrawal by Subject|6|||
146782641|NCT01140880|529376704|FG001|Overall Study|Withdrawal by Subject|3|||
146782642|NCT01140880|529376703|FG000|Overall Study|Lost to Follow-up|8|||
146782643|NCT01140880|529376704|FG001|Overall Study|Lost to Follow-up|10|||
146782644|NCT01140880|529376703|FG000|Overall Study|Protocol Violation|0|||
146782645|NCT01140880|529376704|FG001|Overall Study|Protocol Violation|30|||
146782646|NCT04421378|529376708|FG000|Overall Study|Adverse Event|2|||
146782647|NCT04421378|529376709|FG001|Overall Study|Adverse Event|7|||
146782648|NCT04421378|529376710|FG002|Overall Study|Adverse Event|0|||
146782649|NCT04421378|529376711|FG003|Overall Study|Adverse Event|1|||
146782650|NCT04421378|529376712|FG004|Overall Study|Adverse Event|0|||
146782651|NCT04421378|529376708|FG000|Overall Study|Physician Decision|1|||
146782652|NCT04421378|529376709|FG001|Overall Study|Physician Decision|2|||
146782653|NCT04421378|529376710|FG002|Overall Study|Physician Decision|0|||
146782654|NCT04421378|529376711|FG003|Overall Study|Physician Decision|0|||
146782655|NCT04421378|529376712|FG004|Overall Study|Physician Decision|0|||
146782656|NCT04421378|529376708|FG000|Overall Study|Progressive Disease|16|||
146782657|NCT04421378|529376709|FG001|Overall Study|Progressive Disease|4|||
146782658|NCT04421378|529376710|FG002|Overall Study|Progressive Disease|18|||
146782659|NCT04421378|529376711|FG003|Overall Study|Progressive Disease|11|||
146782660|NCT04421378|529376712|FG004|Overall Study|Progressive Disease|3|||
146782661|NCT04421378|529376708|FG000|Overall Study|Study Terminated by Sponsor|0|||
146782662|NCT04421378|529376709|FG001|Overall Study|Study Terminated by Sponsor|1|||
146782663|NCT04421378|529376710|FG002|Overall Study|Study Terminated by Sponsor|1|||
146782664|NCT04421378|529376711|FG003|Overall Study|Study Terminated by Sponsor|0|||
146782665|NCT04421378|529376712|FG004|Overall Study|Study Terminated by Sponsor|0|||
146782666|NCT04421378|529376708|FG000|Overall Study|Withdrawal by Subject|3|||
146782667|NCT04421378|529376709|FG001|Overall Study|Withdrawal by Subject|1|||
146782668|NCT04421378|529376710|FG002|Overall Study|Withdrawal by Subject|0|||
146782669|NCT04421378|529376711|FG003|Overall Study|Withdrawal by Subject|2|||
146782670|NCT04421378|529376712|FG004|Overall Study|Withdrawal by Subject|0|||
146782671|NCT04421378|529376708|FG000|Overall Study|Other|1|||
146782672|NCT04421378|529376709|FG001|Overall Study|Other|0|||
146782673|NCT04421378|529376710|FG002|Overall Study|Other|0|||
146782674|NCT04421378|529376711|FG003|Overall Study|Other|0|||
146782675|NCT04421378|529376712|FG004|Overall Study|Other|0|||
146782676|NCT02927769|529376713|FG000|Induction Phase|Study drug toxicity|1|||
146782677|NCT02927769|529376714|FG001|Induction Phase|Study drug toxicity|1|||
146782678|NCT02927769|529376713|FG000|Induction Phase|Disease progression|0|||
146981340|NCT00479401|530093873|FG002|Overall Study|Adverse Event|4|||
146981341|NCT00479401|530093871|FG000|Overall Study|Lack of Efficacy|2|||
146782679|NCT02927769|529376714|FG001|Induction Phase|Disease progression|1|||
146782680|NCT02927769|529376713|FG000|Intensification Phase|Study drug toxicity|1|||
146782681|NCT02927769|529376714|FG001|Intensification Phase|Study drug toxicity|0|||
146782682|NCT02807636|529376715|FG000|Overall Study|Lost to Follow-up|10|||
146782683|NCT02807636|529376716|FG001|Overall Study|Lost to Follow-up|13|||
146782684|NCT02807636|529376717|FG002|Overall Study|Lost to Follow-up|6|||
146782685|NCT02807636|529376715|FG000|Overall Study|Protocol Deviation|1|||
146782686|NCT02807636|529376716|FG001|Overall Study|Protocol Deviation|0|||
146782687|NCT02807636|529376717|FG002|Overall Study|Protocol Deviation|0|||
146782688|NCT02807636|529376715|FG000|Overall Study|Symptomatic Deterioration|0|||
146981342|NCT00479401|530093872|FG001|Overall Study|Lack of Efficacy|2|||
146782689|NCT02807636|529376716|FG001|Overall Study|Symptomatic Deterioration|1|||
146782690|NCT02807636|529376717|FG002|Overall Study|Symptomatic Deterioration|0|||
146782691|NCT02807636|529376715|FG000|Overall Study|Withdrawal by Subject|39|||
146782692|NCT02807636|529376716|FG001|Overall Study|Withdrawal by Subject|28|||
146782693|NCT02807636|529376717|FG002|Overall Study|Withdrawal by Subject|24|||
146782694|NCT02807636|529376715|FG000|Overall Study|Death|303|||
146782695|NCT02807636|529376716|FG001|Overall Study|Death|332|||
146782696|NCT02807636|529376717|FG002|Overall Study|Death|272|||
146782697|NCT02807636|529376715|FG000|Overall Study|Study Terminated By Sponsor|47|||
146782698|NCT02807636|529376716|FG001|Overall Study|Study Terminated By Sponsor|76|||
146782699|NCT02807636|529376717|FG002|Overall Study|Study Terminated By Sponsor|60|||
146782700|NCT02807636|529376715|FG000|Overall Study|Physician Decision|0|||
146782701|NCT02807636|529376716|FG001|Overall Study|Physician Decision|1|||
146782702|NCT02807636|529376717|FG002|Overall Study|Physician Decision|0|||
146782703|NCT03175029|529376720|FG000|Overall Study|Withdrawal by Subject|2|||
146782704|NCT03175029|529376721|FG001|Overall Study|Withdrawal by Subject|1|||
146782705|NCT03175029|529376720|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
146782706|NCT03175029|529376721|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
146782707|NCT05227209|529376722|FG000|Overall Study|Adverse Event|11|||
146782708|NCT05227209|529376722|FG000|Overall Study|Lost to Follow-up|1|||
146782709|NCT05227209|529376722|FG000|Overall Study|Withdrawal by Subject|7|||
146782710|NCT05227209|529376722|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
146782711|NCT05633953|529376723|FG000|Overall Study|Adverse Event|7|||
146782712|NCT05633953|529376723|FG000|Overall Study|Death|30|||
146782713|NCT05633953|529376723|FG000|Overall Study|Lost to Follow-up|1|||
146782714|NCT05633953|529376723|FG000|Overall Study|Osilodrostat discontinued|4|||
146782715|NCT05633953|529376723|FG000|Overall Study|Physician Decision|1|||
146782716|NCT05633953|529376723|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
146782717|NCT05633953|529376723|FG000|Overall Study|Progressive disease|2|||
146782718|NCT00512070|529376731|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
146782719|NCT00512070|529376732|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
146782720|NCT00512070|529376733|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
146782721|NCT00512070|529376731|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
146782722|NCT00512070|529376732|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
146782723|NCT00512070|529376733|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
146782724|NCT00961571|529376734|FG000|Overall Study|Physician Decision|39|||
146782725|NCT05524233|529376735|FG000|Overall Study|Lost to Follow-up|2|||
146782726|NCT05524233|529376735|FG000|Overall Study|Adverse Event|2|||
146782727|NCT05524233|529376735|FG000|Overall Study|Withdrawal by Subject|1|||
146782728|NCT05337748|529376739|FG000|Overall Study|Withdrawal by Subject|1|||
146782729|NCT05337748|529376740|FG001|Overall Study|Withdrawal by Subject|0|||
146782730|NCT05337748|529376739|FG000|Overall Study|Death|1|||
146782731|NCT05337748|529376740|FG001|Overall Study|Death|0|||
146782732|NCT02506959|529376741|FG000|Overall Study|Physician Decision|2|||
146782733|NCT02506959|529376742|FG001|Overall Study|Physician Decision|1|||
146782734|NCT03453619|529376748|FG000|Core Study (Part A)|Physician Decision|0|||
146782735|NCT03453619|529376749|FG001|Core Study (Part A)|Physician Decision|0|||
146782736|NCT03453619|529376750|FG002|Core Study (Part A)|Physician Decision|2|||
146782737|NCT03453619|529376751|FG003|Core Study (Part A)|Physician Decision|0|||
146782738|NCT03453619|529376748|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
146782739|NCT03453619|529376749|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
146782740|NCT03453619|529376750|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
146782741|NCT03453619|529376751|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
146782742|NCT03453619|529376748|FG000|Core Study (Part A)|Other|0|||
146782743|NCT03453619|529376749|FG001|Core Study (Part A)|Other|1|||
146782744|NCT03453619|529376750|FG002|Core Study (Part A)|Other|0|||
146782745|NCT03453619|529376751|FG003|Core Study (Part A)|Other|0|||
146782746|NCT03453619|529376748|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
146782747|NCT03453619|529376749|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
146782748|NCT03453619|529376750|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
146782749|NCT03453619|529376751|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
146782750|NCT03453619|529376748|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
146782751|NCT03453619|529376749|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
146782752|NCT03453619|529376750|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
146782753|NCT03453619|529376751|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
146782754|NCT03453619|529376748|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
146782755|NCT03453619|529376749|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
146782756|NCT03453619|529376750|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
146782757|NCT03453619|529376751|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
146782758|NCT03453619|529376748|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
146782759|NCT03453619|529376749|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
146782760|NCT03453619|529376750|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
146782761|NCT03453619|529376751|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
146782762|NCT05862870|529376752|FG000|Overall Study|Lost to Follow-up|3|||
146782763|NCT04321031|529376753|FG000|Overall Study|Adverse Event|0|||
146782764|NCT04321031|529376754|FG001|Overall Study|Adverse Event|2|||
146782765|NCT04321031|529376755|FG002|Overall Study|Adverse Event|2|||
146782766|NCT04321031|529376756|FG003|Overall Study|Adverse Event|2|||
146782767|NCT04321031|529376757|FG004|Overall Study|Adverse Event|2|||
146782768|NCT04321031|529376758|FG005|Overall Study|Adverse Event|2|||
146934307|NCT00340834|529917832|FG004|Extension Phase of Study|Subject withdrew consent|15|||
146782769|NCT04321031|529376759|FG006|Overall Study|Adverse Event|0|||
146782770|NCT04321031|529376753|FG000|Overall Study|Lost to Follow-up|0|||
146782771|NCT04321031|529376754|FG001|Overall Study|Lost to Follow-up|0|||
146782772|NCT04321031|529376755|FG002|Overall Study|Lost to Follow-up|0|||
146782773|NCT04321031|529376756|FG003|Overall Study|Lost to Follow-up|1|||
146782774|NCT04321031|529376757|FG004|Overall Study|Lost to Follow-up|0|||
146782775|NCT04321031|529376758|FG005|Overall Study|Lost to Follow-up|2|||
146934308|NCT00340834|529917828|FG000|Extension Phase of Study|Adverse Event|21|||
146721701|NCT02298192|529149557|FG000|Overall Study|Unclassified|3|||
146721702|NCT02298192|529149558|FG001|Overall Study|Unclassified|2|||
146721703|NCT02298192|529149557|FG000|Overall Study|Withdrawal criteria|2|||
146721704|NCT02298192|529149558|FG001|Overall Study|Withdrawal criteria|0|||
146721705|NCT02298192|529149557|FG000|Overall Study|Withdrawal by Subject|6|||
146721706|NCT02298192|529149558|FG001|Overall Study|Withdrawal by Subject|1|||
146721707|NCT02298192|529149557|FG000|Overall Study|Lost to Follow-up|2|||
146721708|NCT02298192|529149558|FG001|Overall Study|Lost to Follow-up|1|||
146721709|NCT02298192|529149557|FG000|Overall Study|Adverse Event|6|||
146721710|NCT02298192|529149558|FG001|Overall Study|Adverse Event|2|||
146721711|NCT04764396|529149561|FG000|Overall Study|Physician Decision|1|||
146721712|NCT04764396|529149562|FG001|Overall Study|Physician Decision|0|||
146721713|NCT03230916|529149563|FG000|Overall Study|Withdrawal by Subject|0|||
146721714|NCT03230916|529149564|FG001|Overall Study|Withdrawal by Subject|0|||
146721715|NCT03230916|529149565|FG002|Overall Study|Withdrawal by Subject|0|||
146721716|NCT03230916|529149566|FG003|Overall Study|Withdrawal by Subject|0|||
146721717|NCT03230916|529149567|FG004|Overall Study|Withdrawal by Subject|0|||
146721718|NCT03230916|529149568|FG005|Overall Study|Withdrawal by Subject|1|||
146721719|NCT03230916|529149569|FG006|Overall Study|Withdrawal by Subject|0|||
146721720|NCT03230916|529149570|FG007|Overall Study|Withdrawal by Subject|0|||
146721721|NCT03230916|529149571|FG008|Overall Study|Withdrawal by Subject|0|||
146721722|NCT03230916|529149572|FG009|Overall Study|Withdrawal by Subject|0|||
146721723|NCT03230916|529149573|FG010|Overall Study|Withdrawal by Subject|0|||
146721724|NCT01128413|529149575|FG000|Overall Study|Withdrawal by Subject|1|||
146721725|NCT01128413|529149576|FG001|Overall Study|Withdrawal by Subject|0|||
146721726|NCT01128413|529149575|FG000|Overall Study|NICOM Monitor Problems|2|||
146721727|NCT01128413|529149576|FG001|Overall Study|NICOM Monitor Problems|1|||
146721728|NCT01128413|529149575|FG000|Overall Study|Pt made DNR|1|||
146721729|NCT01128413|529149576|FG001|Overall Study|Pt made DNR|0|||
146721730|NCT01218646|529149579|FG000|Overall Study|Adverse Event|0|||
146721731|NCT01218646|529149580|FG001|Overall Study|Adverse Event|0|||
146721732|NCT01218646|529149581|FG002|Overall Study|Adverse Event|1|||
146721733|NCT01218646|529149582|FG003|Overall Study|Adverse Event|0|||
146721734|NCT01218646|529149579|FG000|Overall Study|Lost to Follow-up|1|||
146721735|NCT01218646|529149580|FG001|Overall Study|Lost to Follow-up|0|||
146721736|NCT01218646|529149581|FG002|Overall Study|Lost to Follow-up|0|||
146721737|NCT01218646|529149582|FG003|Overall Study|Lost to Follow-up|0|||
146721738|NCT01218646|529149579|FG000|Overall Study|Protocol Violation|0|||
146721739|NCT01218646|529149580|FG001|Overall Study|Protocol Violation|0|||
146721740|NCT01218646|529149581|FG002|Overall Study|Protocol Violation|1|||
146721741|NCT01218646|529149582|FG003|Overall Study|Protocol Violation|1|||
146721742|NCT00722761|529149583|FG000|Overall Study|Lost to Follow-up|1|||
146721743|NCT00722761|529149584|FG001|Overall Study|Lost to Follow-up|4|||
146721744|NCT00722761|529149583|FG000|Overall Study|Withdrawal by Subject|5|||
146721745|NCT00722761|529149584|FG001|Overall Study|Withdrawal by Subject|2|||
146721746|NCT02693665|529149585|FG000|Overall Study|Death|3|||
146721747|NCT02693665|529149586|FG001|Overall Study|Death|2|||
146721748|NCT02693665|529149585|FG000|Overall Study|Lost to Follow-up|7|||
146721749|NCT02693665|529149586|FG001|Overall Study|Lost to Follow-up|3|||
146721750|NCT02693665|529149585|FG000|Overall Study|Protocol Violation|1|||
146721751|NCT02693665|529149586|FG001|Overall Study|Protocol Violation|0|||
146721752|NCT02693665|529149585|FG000|Overall Study|Withdrawal by Subject|2|||
146721753|NCT02693665|529149586|FG001|Overall Study|Withdrawal by Subject|0|||
146721754|NCT02693665|529149585|FG000|Overall Study|patient wanted to leave it behind|1|||
146721755|NCT02693665|529149586|FG001|Overall Study|patient wanted to leave it behind|0|||
146721756|NCT02693665|529149585|FG000|Overall Study|anxiety|1|||
146721757|NCT02693665|529149586|FG001|Overall Study|anxiety|0|||
146721758|NCT02693665|529149585|FG000|Overall Study|family issues|1|||
146721759|NCT02693665|529149586|FG001|Overall Study|family issues|0|||
146721760|NCT02693665|529149585|FG000|Overall Study|no reason given|1|||
146721761|NCT02693665|529149586|FG001|Overall Study|no reason given|0|||
146721762|NCT02010060|529149589|FG000|Overall Study|Lost to Follow-up|1|||
146721763|NCT02010060|529149590|FG001|Overall Study|Lost to Follow-up|2|||
146721764|NCT02010060|529149591|FG002|Overall Study|Lost to Follow-up|2|||
146721765|NCT02010060|529149589|FG000|Overall Study|Injury|0|||
146721766|NCT02010060|529149590|FG001|Overall Study|Injury|1|||
146721767|NCT02010060|529149591|FG002|Overall Study|Injury|0|||
146721768|NCT04414696|529149592|FG000|3-month Follow up|Withdrawal by Subject|1|||
146721769|NCT04414696|529149593|FG001|3-month Follow up|Withdrawal by Subject|0|||
146721770|NCT04414696|529149592|FG000|3-month Follow up|Lost to Follow-up|22|||
146721771|NCT04414696|529149593|FG001|3-month Follow up|Lost to Follow-up|23|||
146721772|NCT04414696|529149592|FG000|6-month Follow up|Withdrawal by Subject|1|||
146721773|NCT04414696|529149593|FG001|6-month Follow up|Withdrawal by Subject|2|||
146721774|NCT04414696|529149592|FG000|6-month Follow up|Lost to Follow-up|5|||
146721775|NCT04414696|529149593|FG001|6-month Follow up|Lost to Follow-up|2|||
146721776|NCT00660010|529149594|FG000|Overall Study|Withdrawal by Subject|2|||
146721777|NCT00660010|529149594|FG000|Overall Study|Lost to Follow-up|3|||
146934309|NCT00340834|529917829|FG001|Extension Phase of Study|Adverse Event|22|||
146934310|NCT00340834|529917830|FG002|Extension Phase of Study|Adverse Event|0|||
146782776|NCT04321031|529376759|FG006|Overall Study|Lost to Follow-up|1|||
146782777|NCT04321031|529376753|FG000|Overall Study|Withdrawal by Subject|2|||
146782778|NCT04321031|529376754|FG001|Overall Study|Withdrawal by Subject|2|||
146721778|NCT00660010|529149594|FG000|Overall Study|Adverse Event|1|||
146721779|NCT00660010|529149594|FG000|Overall Study|Noncompliance with visit schedule|3|||
146721780|NCT06167031|529149595|FG000|Overall Study|Lost to Follow-up|5|||
146721781|NCT06167031|529149596|FG001|Overall Study|Lost to Follow-up|1|||
146721782|NCT01877408|529152663|FG000|Overall Study|Lost to Follow-up|0|||
146721783|NCT01877408|529152664|FG001|Overall Study|Lost to Follow-up|2|||
146721784|NCT02621931|529152665|FG000|Overall Study|Death|0|||
146721785|NCT02621931|529152666|FG001|Overall Study|Death|1|||
146721786|NCT02621931|529152667|FG002|Overall Study|Death|0|||
146721787|NCT02621931|529152665|FG000|Overall Study|Adverse Event|8|||
146721788|NCT02621931|529152666|FG001|Overall Study|Adverse Event|5|||
146721789|NCT02621931|529152667|FG002|Overall Study|Adverse Event|7|||
146721790|NCT02621931|529152665|FG000|Overall Study|Withdrawal by Subject|12|||
146721791|NCT02621931|529152666|FG001|Overall Study|Withdrawal by Subject|10|||
146721792|NCT02621931|529152667|FG002|Overall Study|Withdrawal by Subject|11|||
146721793|NCT02621931|529152665|FG000|Overall Study|Protocol Violation|2|||
146721794|NCT02621931|529152666|FG001|Overall Study|Protocol Violation|2|||
146721795|NCT02621931|529152667|FG002|Overall Study|Protocol Violation|2|||
146721796|NCT02621931|529152665|FG000|Overall Study|Pregnancy|2|||
146721797|NCT02621931|529152666|FG001|Overall Study|Pregnancy|0|||
146721798|NCT02621931|529152667|FG002|Overall Study|Pregnancy|0|||
146721799|NCT02621931|529152665|FG000|Overall Study|Noncompliance to study procedures|0|||
146721800|NCT02621931|529152666|FG001|Overall Study|Noncompliance to study procedures|1|||
146721801|NCT02621931|529152667|FG002|Overall Study|Noncompliance to study procedures|2|||
146721802|NCT02621931|529152665|FG000|Overall Study|Lost to Follow-up|8|||
146721803|NCT02621931|529152666|FG001|Overall Study|Lost to Follow-up|7|||
146721804|NCT02621931|529152667|FG002|Overall Study|Lost to Follow-up|10|||
146721805|NCT02621931|529152665|FG000|Overall Study|Lack of Efficacy|0|||
146721806|NCT02621931|529152666|FG001|Overall Study|Lack of Efficacy|0|||
146721807|NCT02621931|529152667|FG002|Overall Study|Lack of Efficacy|1|||
146721808|NCT02621931|529152665|FG000|Overall Study|Other|1|||
146721809|NCT02621931|529152666|FG001|Overall Study|Other|1|||
146721810|NCT02621931|529152667|FG002|Overall Study|Other|3|||
146721811|NCT00920426|529152668|FG000|ITZ111451|Adverse Event|1|||
146721812|NCT00920426|529152669|FG001|ITZ111451|Adverse Event|0|||
146721813|NCT00920426|529152670|FG002|ITZ111451|Adverse Event|0|||
146721814|NCT00920426|529152671|FG003|ITZ111451|Adverse Event|0|||
146721815|NCT01292603|529152672|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
146721816|NCT01292603|529152673|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
146721817|NCT01292603|529152674|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
146721818|NCT01292603|529152675|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
146721819|NCT01292603|529152676|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
146721820|NCT01292603|529152677|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
146721821|NCT01292603|529152672|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
146721822|NCT01292603|529152673|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
146721823|NCT01292603|529152674|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
146721824|NCT01292603|529152675|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
146721825|NCT01292603|529152676|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
146721826|NCT01292603|529152677|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
146721827|NCT01292603|529152672|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
146721828|NCT01292603|529152673|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
146721829|NCT01292603|529152674|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
146721830|NCT01292603|529152675|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
146721831|NCT01292603|529152676|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
146721832|NCT01292603|529152677|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
146721833|NCT01292603|529152672|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
146721834|NCT01292603|529152673|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
146721835|NCT01292603|529152674|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
146721836|NCT01292603|529152675|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
146721837|NCT01292603|529152676|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
146721838|NCT01292603|529152677|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
146721839|NCT01292603|529152672|FG000|Part 1: Regular Follow-Up Period|Death|3|||
146721840|NCT01292603|529152673|FG001|Part 1: Regular Follow-Up Period|Death|1|||
146721841|NCT01292603|529152674|FG002|Part 1: Regular Follow-Up Period|Death|3|||
146721842|NCT01292603|529152675|FG003|Part 1: Regular Follow-Up Period|Death|1|||
146721843|NCT01292603|529152676|FG004|Part 1: Regular Follow-Up Period|Death|0|||
146721844|NCT01292603|529152677|FG005|Part 1: Regular Follow-Up Period|Death|0|||
146782779|NCT04321031|529376755|FG002|Overall Study|Withdrawal by Subject|1|||
146981343|NCT00479401|530093873|FG002|Overall Study|Lack of Efficacy|4|||
146721845|NCT01292603|529152672|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
146721846|NCT01292603|529152673|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
146721847|NCT01292603|529152674|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
146981344|NCT00479401|530093871|FG000|Overall Study|Protocol Violation|2|||
146782780|NCT04321031|529376756|FG003|Overall Study|Withdrawal by Subject|3|||
146782781|NCT04321031|529376757|FG004|Overall Study|Withdrawal by Subject|1|||
146782782|NCT04321031|529376758|FG005|Overall Study|Withdrawal by Subject|0|||
146782783|NCT04321031|529376759|FG006|Overall Study|Withdrawal by Subject|1|||
146934311|NCT00340834|529917831|FG003|Extension Phase of Study|Adverse Event|19|||
146934312|NCT00340834|529917832|FG004|Extension Phase of Study|Adverse Event|7|||
146721848|NCT01292603|529152675|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
146721849|NCT01292603|529152676|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
146721850|NCT01292603|529152677|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
146721851|NCT01292603|529152672|FG000|Part 2: Dose Confirmation Period|Death|0|||
146721852|NCT01292603|529152673|FG001|Part 2: Dose Confirmation Period|Death|0|||
146721853|NCT01292603|529152674|FG002|Part 2: Dose Confirmation Period|Death|0|||
146721854|NCT01292603|529152675|FG003|Part 2: Dose Confirmation Period|Death|0|||
146721855|NCT01292603|529152676|FG004|Part 2: Dose Confirmation Period|Death|1|||
146721856|NCT01292603|529152677|FG005|Part 2: Dose Confirmation Period|Death|0|||
146721857|NCT01292603|529152672|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
146721858|NCT01292603|529152673|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
146721859|NCT01292603|529152674|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
146721860|NCT01292603|529152675|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
146721861|NCT01292603|529152676|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
146721862|NCT01292603|529152677|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
146721863|NCT01292603|529152672|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
146721864|NCT01292603|529152673|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
146721865|NCT01292603|529152674|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
146721866|NCT01292603|529152675|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
146721867|NCT01292603|529152676|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
146721868|NCT01292603|529152677|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
146721869|NCT01292603|529152672|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
146721870|NCT01292603|529152673|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
146721871|NCT01292603|529152674|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
146721872|NCT01292603|529152675|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
146721873|NCT01292603|529152676|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
146721874|NCT01292603|529152677|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
146721875|NCT01292603|529152672|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
146721876|NCT01292603|529152673|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
146721877|NCT01292603|529152674|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
146721878|NCT01292603|529152675|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
146721879|NCT01292603|529152676|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
146721880|NCT01292603|529152677|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
146721881|NCT01292603|529152672|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
146721882|NCT01292603|529152673|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
146721883|NCT01292603|529152674|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
146721884|NCT01292603|529152675|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
146721885|NCT01292603|529152676|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
146721886|NCT01292603|529152677|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
146721887|NCT01292603|529152672|FG000|Part 2: Regular Follow-Up|Death|0|||
146721888|NCT01292603|529152673|FG001|Part 2: Regular Follow-Up|Death|0|||
146721889|NCT01292603|529152674|FG002|Part 2: Regular Follow-Up|Death|0|||
146721890|NCT01292603|529152675|FG003|Part 2: Regular Follow-Up|Death|0|||
146721891|NCT01292603|529152676|FG004|Part 2: Regular Follow-Up|Death|6|||
146721892|NCT01292603|529152677|FG005|Part 2: Regular Follow-Up|Death|3|||
146721893|NCT01292603|529152672|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
146721894|NCT01292603|529152673|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
146721895|NCT01292603|529152674|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
146721896|NCT01292603|529152675|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
146721897|NCT01292603|529152676|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
146721898|NCT01292603|529152677|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
146721899|NCT01292603|529152672|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
146721900|NCT01292603|529152673|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
146721901|NCT01292603|529152674|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
146934313|NCT00340834|529917828|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
146721902|NCT01292603|529152675|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
146721903|NCT01292603|529152676|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
146782784|NCT04321031|529376753|FG000|Overall Study|Non-compliance with study drug|0|||
146721904|NCT01292603|529152677|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
146721905|NCT01292603|529152672|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
146721906|NCT01292603|529152673|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
146721907|NCT01292603|529152674|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
146934314|NCT00340834|529917829|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
146934315|NCT00340834|529917830|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
146934316|NCT00340834|529917831|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
146934317|NCT00340834|529917832|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
146934318|NCT00340834|529917828|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
146934319|NCT00340834|529917829|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
146934320|NCT00340834|529917830|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
146934321|NCT00340834|529917831|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
146934322|NCT00340834|529917832|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
146934323|NCT00340834|529917828|FG000|Extension Phase of Study|Lost to Follow-up|1|||
146934324|NCT00340834|529917829|FG001|Extension Phase of Study|Lost to Follow-up|1|||
146934325|NCT00340834|529917830|FG002|Extension Phase of Study|Lost to Follow-up|0|||
146934326|NCT00340834|529917831|FG003|Extension Phase of Study|Lost to Follow-up|2|||
146934327|NCT00340834|529917832|FG004|Extension Phase of Study|Lost to Follow-up|3|||
146721908|NCT01292603|529152675|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
146721909|NCT01292603|529152676|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
146721910|NCT01292603|529152677|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
146721911|NCT01292603|529152672|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
146721912|NCT01292603|529152673|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
146721913|NCT01292603|529152674|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
146721914|NCT01292603|529152675|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
146721915|NCT01292603|529152676|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
146721916|NCT01292603|529152677|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
146721917|NCT01292603|529152672|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
146721918|NCT01292603|529152673|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
146721919|NCT01292603|529152674|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
146721920|NCT01292603|529152675|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
146721921|NCT01292603|529152676|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
146721922|NCT01292603|529152677|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
146721923|NCT01292603|529152672|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
146721924|NCT01292603|529152673|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
146721925|NCT01292603|529152674|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
146721926|NCT01292603|529152675|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
146721927|NCT01292603|529152676|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
146721928|NCT01292603|529152677|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
146721929|NCT01292603|529152672|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
146721930|NCT01292603|529152673|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
146721931|NCT01292603|529152674|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
146721932|NCT01292603|529152675|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
146721933|NCT01292603|529152676|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
146721934|NCT01292603|529152677|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
146721935|NCT01292603|529152672|FG000|Overall Survival Status|Death|3|||
146721936|NCT01292603|529152673|FG001|Overall Survival Status|Death|1|||
146721937|NCT01292603|529152674|FG002|Overall Survival Status|Death|3|||
146721938|NCT01292603|529152675|FG003|Overall Survival Status|Death|1|||
146721939|NCT01292603|529152676|FG004|Overall Survival Status|Death|16|||
146721940|NCT01292603|529152677|FG005|Overall Survival Status|Death|10|||
146721941|NCT03870763|529152680|FG000|Overall Study|Study terminated by sponsor|0|||
146721942|NCT03870763|529152681|FG001|Overall Study|Study terminated by sponsor|2|||
146721943|NCT03870763|529152682|FG002|Overall Study|Study terminated by sponsor|0|||
146721944|NCT03870763|529152680|FG000|Overall Study|Withdrawal by Subject|0|||
146721945|NCT03870763|529152681|FG001|Overall Study|Withdrawal by Subject|1|||
146721946|NCT03870763|529152682|FG002|Overall Study|Withdrawal by Subject|0|||
146721947|NCT03870763|529152680|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
146721948|NCT03870763|529152681|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
146721949|NCT03870763|529152682|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
146721950|NCT01912612|529152691|FG000|Overall Study|Adverse Event|4|||
146721951|NCT01912612|529152692|FG001|Overall Study|Adverse Event|0|||
146721952|NCT01912612|529152693|FG002|Overall Study|Adverse Event|0|||
146721953|NCT01912612|529152691|FG000|Overall Study|Withdrew consent|1|||
146782785|NCT04321031|529376754|FG001|Overall Study|Non-compliance with study drug|0|||
146934328|NCT00340834|529917828|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
146934329|NCT00340834|529917829|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
146721954|NCT01912612|529152692|FG001|Overall Study|Withdrew consent|0|||
146721955|NCT01912612|529152693|FG002|Overall Study|Withdrew consent|0|||
146782786|NCT04321031|529376755|FG002|Overall Study|Non-compliance with study drug|0|||
146934330|NCT00340834|529917830|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
146934331|NCT00340834|529917831|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
146934332|NCT00340834|529917832|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
146721956|NCT01912612|529152691|FG000|Overall Study|Study design change|0|||
146721957|NCT01912612|529152692|FG001|Overall Study|Study design change|0|||
146721958|NCT01912612|529152693|FG002|Overall Study|Study design change|3|||
146721959|NCT01588184|529152694|FG000|Overall Study|Death|1|||
146782787|NCT04321031|529376756|FG003|Overall Study|Non-compliance with study drug|0|||
146782788|NCT04321031|529376757|FG004|Overall Study|Non-compliance with study drug|0|||
146782789|NCT04321031|529376758|FG005|Overall Study|Non-compliance with study drug|1|||
146782790|NCT04321031|529376759|FG006|Overall Study|Non-compliance with study drug|0|||
146782791|NCT04321031|529376753|FG000|Overall Study|Other|0|||
146782792|NCT04321031|529376754|FG001|Overall Study|Other|0|||
146782793|NCT04321031|529376755|FG002|Overall Study|Other|0|||
146782794|NCT04321031|529376756|FG003|Overall Study|Other|1|||
146782795|NCT04321031|529376757|FG004|Overall Study|Other|0|||
146782796|NCT04321031|529376758|FG005|Overall Study|Other|0|||
146782797|NCT04321031|529376759|FG006|Overall Study|Other|0|||
146782798|NCT03143153|529376762|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
146782799|NCT03143153|529376763|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
146782800|NCT03143153|529376764|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
146782801|NCT03143153|529376762|FG000|Pre-Treatment|Participant withdrew consent|0|||
146782802|NCT03143153|529376763|FG001|Pre-Treatment|Participant withdrew consent|1|||
146782803|NCT03143153|529376764|FG002|Pre-Treatment|Participant withdrew consent|12|||
146782804|NCT03143153|529376762|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
146782805|NCT03143153|529376763|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
146782806|NCT03143153|529376764|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
146782807|NCT03143153|529376762|FG000|Pre-Treatment|Other Reasons|1|||
146782808|NCT03143153|529376763|FG001|Pre-Treatment|Other Reasons|2|||
146782809|NCT03143153|529376764|FG002|Pre-Treatment|Other Reasons|1|||
146782810|NCT03143153|529376762|FG000|Pre-Treatment|Disease Progression|1|||
146782811|NCT03143153|529376763|FG001|Pre-Treatment|Disease Progression|1|||
146782812|NCT03143153|529376764|FG002|Pre-Treatment|Disease Progression|2|||
146782813|NCT03143153|529376762|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
146782814|NCT03143153|529376763|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
146782815|NCT03143153|529376764|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
146782816|NCT03143153|529376762|FG000|Treatment|Disease progression|174|||
146782817|NCT03143153|529376763|FG001|Treatment|Disease progression|184|||
146934333|NCT00340834|529917828|FG000|Extension Phase of Study|Administrative problems|3|||
146934334|NCT00340834|529917829|FG001|Extension Phase of Study|Administrative problems|0|||
146782818|NCT03143153|529376764|FG002|Treatment|Disease progression|193|||
146782819|NCT03143153|529376762|FG000|Treatment|Study drug toxicity|59|||
146782820|NCT03143153|529376763|FG001|Treatment|Study drug toxicity|33|||
146782821|NCT03143153|529376764|FG002|Treatment|Study drug toxicity|40|||
146782822|NCT03143153|529376762|FG000|Treatment|Death|5|||
146782823|NCT03143153|529376763|FG001|Treatment|Death|3|||
146782824|NCT03143153|529376764|FG002|Treatment|Death|4|||
146782825|NCT03143153|529376762|FG000|Treatment|Adverse event unrelated to study drug|19|||
146782826|NCT03143153|529376763|FG001|Treatment|Adverse event unrelated to study drug|28|||
146782827|NCT03143153|529376764|FG002|Treatment|Adverse event unrelated to study drug|12|||
146782828|NCT03143153|529376762|FG000|Treatment|Participant request to discontinue study treatment|13|||
146782829|NCT03143153|529376763|FG001|Treatment|Participant request to discontinue study treatment|15|||
146782830|NCT03143153|529376764|FG002|Treatment|Participant request to discontinue study treatment|20|||
146782831|NCT03143153|529376762|FG000|Treatment|Participant withdrew consent|3|||
146782832|NCT03143153|529376763|FG001|Treatment|Participant withdrew consent|4|||
146782833|NCT03143153|529376764|FG002|Treatment|Participant withdrew consent|12|||
146782834|NCT03143153|529376762|FG000|Treatment|Pregnancy|1|||
146782835|NCT03143153|529376763|FG001|Treatment|Pregnancy|0|||
146782836|NCT03143153|529376764|FG002|Treatment|Pregnancy|0|||
146782837|NCT03143153|529376762|FG000|Treatment|Maximum clinical benefit|1|||
146782838|NCT03143153|529376763|FG001|Treatment|Maximum clinical benefit|3|||
146782839|NCT03143153|529376764|FG002|Treatment|Maximum clinical benefit|4|||
146782840|NCT03143153|529376762|FG000|Treatment|Completed treatment as per Protocol|13|||
146782841|NCT03143153|529376763|FG001|Treatment|Completed treatment as per Protocol|8|||
146782842|NCT03143153|529376764|FG002|Treatment|Completed treatment as per Protocol|0|||
146782843|NCT03143153|529376762|FG000|Treatment|Other reasons|12|||
146782844|NCT03143153|529376763|FG001|Treatment|Other reasons|7|||
146934335|NCT00340834|529917830|FG002|Extension Phase of Study|Administrative problems|0|||
146934336|NCT00340834|529917831|FG003|Extension Phase of Study|Administrative problems|1|||
146934337|NCT00340834|529917832|FG004|Extension Phase of Study|Administrative problems|1|||
146934338|NCT00340834|529917828|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
146782845|NCT03143153|529376764|FG002|Treatment|Other reasons|15|||
146782846|NCT03143153|529376762|FG000|Treatment|Not reported|1|||
146782847|NCT03143153|529376763|FG001|Treatment|Not reported|0|||
146782848|NCT03143153|529376764|FG002|Treatment|Not reported|0|||
146782849|NCT04237298|529376765|FG000|Overall Study|Lost to Follow-up|4|||
146782850|NCT04237298|529376766|FG001|Overall Study|Lost to Follow-up|5|||
146782851|NCT02530671|529376767|FG000|Overall Study|Lost to Follow-up|2|||
146782852|NCT02530671|529376768|FG001|Overall Study|Lost to Follow-up|0|||
146782853|NCT02530671|529376767|FG000|Overall Study|Withdrawal by Subject|1|||
146782854|NCT02530671|529376768|FG001|Overall Study|Withdrawal by Subject|0|||
146782855|NCT05470400|529376777|FG000|Overall Study|Lost to Follow-up|0|||
146782856|NCT05470400|529376778|FG001|Overall Study|Lost to Follow-up|0|||
146782857|NCT05470400|529376779|FG002|Overall Study|Lost to Follow-up|0|||
146782858|NCT05470400|529376780|FG003|Overall Study|Lost to Follow-up|0|||
146782859|NCT05470400|529376781|FG004|Overall Study|Lost to Follow-up|0|||
146782860|NCT05470400|529376782|FG005|Overall Study|Lost to Follow-up|0|||
146782861|NCT05470400|529376783|FG006|Overall Study|Lost to Follow-up|0|||
146782862|NCT05470400|529376784|FG007|Overall Study|Lost to Follow-up|1|||
146782863|NCT05470400|529376777|FG000|Overall Study|Withdrawal by Subject|1|||
146782864|NCT05470400|529376778|FG001|Overall Study|Withdrawal by Subject|0|||
146782865|NCT05470400|529376779|FG002|Overall Study|Withdrawal by Subject|0|||
146782866|NCT05470400|529376780|FG003|Overall Study|Withdrawal by Subject|0|||
146782867|NCT05470400|529376781|FG004|Overall Study|Withdrawal by Subject|0|||
146782868|NCT05470400|529376782|FG005|Overall Study|Withdrawal by Subject|1|||
146782869|NCT05470400|529376783|FG006|Overall Study|Withdrawal by Subject|0|||
146782870|NCT05470400|529376784|FG007|Overall Study|Withdrawal by Subject|2|||
146782871|NCT04812535|529376793|FG000|Overall Study|Withdrawal by Subject|0|||
146782872|NCT04812535|529376794|FG001|Overall Study|Withdrawal by Subject|0|||
146782873|NCT04812535|529376795|FG002|Overall Study|Withdrawal by Subject|0|||
146782874|NCT04812535|529376796|FG003|Overall Study|Withdrawal by Subject|1|||
146782875|NCT04812535|529376793|FG000|Overall Study|Death|7|||
146782876|NCT04812535|529376794|FG001|Overall Study|Death|2|||
146782877|NCT04812535|529376795|FG002|Overall Study|Death|4|||
146782878|NCT04812535|529376796|FG003|Overall Study|Death|1|||
146782879|NCT04812535|529376793|FG000|Overall Study|Due to premature study termination by sponsor|2|||
146782880|NCT04812535|529376794|FG001|Overall Study|Due to premature study termination by sponsor|0|||
146782881|NCT04812535|529376795|FG002|Overall Study|Due to premature study termination by sponsor|1|||
146782882|NCT04812535|529376796|FG003|Overall Study|Due to premature study termination by sponsor|3|||
146782883|NCT03436745|529376797|FG000|Overall Study|Ineligible|0|||
146782884|NCT03436745|529376798|FG001|Overall Study|Ineligible|0|||
146782885|NCT03436745|529376799|FG002|Overall Study|Ineligible|1|||
146782886|NCT03846505|529376802|FG000|Treatment Phase|Withdrawal by Subject|9|||
146782887|NCT03846505|529376803|FG001|Treatment Phase|Withdrawal by Subject|11|||
146782888|NCT03846505|529376802|FG000|Treatment Phase|Lost to Follow-up|6|||
146782889|NCT03846505|529376803|FG001|Treatment Phase|Lost to Follow-up|2|||
146782890|NCT03846505|529376802|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
146782891|NCT03846505|529376803|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
146782892|NCT03846505|529376802|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
146782893|NCT03846505|529376803|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
146782894|NCT05592418|529376804|FG000|Overall Study|Adverse Event|1|||
146782895|NCT05592418|529376805|FG001|Overall Study|Adverse Event|0|||
146782896|NCT05592418|529376804|FG000|Overall Study|Lost to Follow-up|1|||
146782897|NCT05592418|529376805|FG001|Overall Study|Lost to Follow-up|3|||
146782898|NCT05592418|529376804|FG000|Overall Study|Withdrawal by Subject|2|||
146782899|NCT05592418|529376805|FG001|Overall Study|Withdrawal by Subject|7|||
146782900|NCT05569252|529376806|FG000|Overall Study|Adverse event (central vision loss)|1|||
146782901|NCT05569252|529376807|FG001|Overall Study|Adverse event (central vision loss)|0|||
146782902|NCT05569252|529376808|FG002|Overall Study|Adverse event (central vision loss)|0|||
146782903|NCT05569252|529376809|FG003|Overall Study|Adverse event (central vision loss)|0|||
146782904|NCT03665597|529376810|FG000|Period 1|Adverse Event|1|||
146782905|NCT03665597|529376811|FG001|Period 1|Adverse Event|0|||
146782906|NCT03665597|529376812|FG002|Period 1|Adverse Event|0|||
146782907|NCT03665597|529376813|FG003|Period 1|Adverse Event|1|||
146782908|NCT03665597|529376814|FG004|Period 1|Adverse Event|0|||
146782909|NCT03665597|529376815|FG005|Period 1|Adverse Event|0|||
146782910|NCT03665597|529376816|FG006|Period 1|Adverse Event|0|||
146782911|NCT03665597|529376810|FG000|Period 1|Screen Failure|0|||
146782912|NCT03665597|529376811|FG001|Period 1|Screen Failure|0|||
146782913|NCT03665597|529376812|FG002|Period 1|Screen Failure|0|||
146782914|NCT03665597|529376813|FG003|Period 1|Screen Failure|1|||
146782915|NCT03665597|529376814|FG004|Period 1|Screen Failure|0|||
146782916|NCT03665597|529376815|FG005|Period 1|Screen Failure|0|||
146981345|NCT00479401|530093872|FG001|Overall Study|Protocol Violation|1|||
146981346|NCT00479401|530093873|FG002|Overall Study|Protocol Violation|1|||
146981347|NCT00479401|530093871|FG000|Overall Study|Lost to Follow-up|1|||
146782917|NCT03665597|529376816|FG006|Period 1|Screen Failure|0|||
146782918|NCT03665597|529376810|FG000|Period 1|Death|0|||
146782919|NCT03665597|529376811|FG001|Period 1|Death|0|||
146782920|NCT03665597|529376812|FG002|Period 1|Death|0|||
146981348|NCT00479401|530093872|FG001|Overall Study|Lost to Follow-up|1|||
146782921|NCT03665597|529376813|FG003|Period 1|Death|0|||
146782922|NCT03665597|529376814|FG004|Period 1|Death|0|||
146782923|NCT03665597|529376815|FG005|Period 1|Death|0|||
146782924|NCT03665597|529376816|FG006|Period 1|Death|45|||
146782925|NCT03665597|529376810|FG000|Period 1|Withdrawal by Subject|0|||
146782926|NCT03665597|529376811|FG001|Period 1|Withdrawal by Subject|0|||
146782927|NCT03665597|529376812|FG002|Period 1|Withdrawal by Subject|0|||
146782928|NCT03665597|529376813|FG003|Period 1|Withdrawal by Subject|0|||
146782929|NCT03665597|529376814|FG004|Period 1|Withdrawal by Subject|0|||
146782930|NCT03665597|529376815|FG005|Period 1|Withdrawal by Subject|0|||
146782931|NCT03665597|529376816|FG006|Period 1|Withdrawal by Subject|5|||
146782932|NCT03665597|529376810|FG000|Period 2|Adverse Event|0|||
146782933|NCT03665597|529376811|FG001|Period 2|Adverse Event|0|||
146782934|NCT03665597|529376812|FG002|Period 2|Adverse Event|0|||
146782935|NCT03665597|529376813|FG003|Period 2|Adverse Event|0|||
146782936|NCT03665597|529376814|FG004|Period 2|Adverse Event|0|||
146782937|NCT03665597|529376815|FG005|Period 2|Adverse Event|1|||
146782938|NCT03665597|529376816|FG006|Period 2|Adverse Event|0|||
146782939|NCT03665597|529376810|FG000|Period 3|Adverse Event|0|||
146782940|NCT03665597|529376811|FG001|Period 3|Adverse Event|1|||
146782941|NCT03665597|529376812|FG002|Period 3|Adverse Event|0|||
146782942|NCT03665597|529376813|FG003|Period 3|Adverse Event|0|||
146782943|NCT03665597|529376814|FG004|Period 3|Adverse Event|0|||
146782944|NCT03665597|529376815|FG005|Period 3|Adverse Event|0|||
146782945|NCT03665597|529376816|FG006|Period 3|Adverse Event|0|||
146782946|NCT03665597|529376810|FG000|Period 3|Death|0|||
146782947|NCT03665597|529376811|FG001|Period 3|Death|0|||
146782948|NCT03665597|529376812|FG002|Period 3|Death|0|||
146782949|NCT03665597|529376813|FG003|Period 3|Death|0|||
146782950|NCT03665597|529376814|FG004|Period 3|Death|1|||
146782951|NCT03665597|529376815|FG005|Period 3|Death|0|||
146782952|NCT03665597|529376816|FG006|Period 3|Death|0|||
146782953|NCT03665597|529376810|FG000|Period 4|Adverse Event|2|||
146782954|NCT03665597|529376811|FG001|Period 4|Adverse Event|2|||
146782955|NCT03665597|529376812|FG002|Period 4|Adverse Event|2|||
146782956|NCT03665597|529376813|FG003|Period 4|Adverse Event|2|||
146782957|NCT03665597|529376814|FG004|Period 4|Adverse Event|1|||
146782958|NCT03665597|529376815|FG005|Period 4|Adverse Event|0|||
146782959|NCT03665597|529376816|FG006|Period 4|Adverse Event|0|||
146782960|NCT03665597|529376810|FG000|Period 4|Death|0|||
146782961|NCT03665597|529376811|FG001|Period 4|Death|0|||
146782962|NCT03665597|529376812|FG002|Period 4|Death|2|||
146782963|NCT03665597|529376813|FG003|Period 4|Death|0|||
146782964|NCT03665597|529376814|FG004|Period 4|Death|0|||
146782965|NCT03665597|529376815|FG005|Period 4|Death|0|||
146782966|NCT03665597|529376816|FG006|Period 4|Death|0|||
146782967|NCT03665597|529376810|FG000|Period 4|Physician Decision|1|||
146782968|NCT03665597|529376811|FG001|Period 4|Physician Decision|2|||
146782969|NCT03665597|529376812|FG002|Period 4|Physician Decision|0|||
146782970|NCT03665597|529376813|FG003|Period 4|Physician Decision|0|||
146782971|NCT03665597|529376814|FG004|Period 4|Physician Decision|0|||
146782972|NCT03665597|529376815|FG005|Period 4|Physician Decision|0|||
146782973|NCT03665597|529376816|FG006|Period 4|Physician Decision|0|||
146782974|NCT04831216|529376817|FG000|Overall Study|Lost to Follow-up|32|||
146782975|NCT05371652|529376820|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
146782976|NCT05371652|529376820|FG000|Overall Study|Withdrawal by Subject|12|||
146782977|NCT05371652|529376820|FG000|Overall Study|Adverse Event|1|||
146782978|NCT05371652|529376820|FG000|Overall Study|Other|11|||
146782979|NCT03978871|529376821|FG000|Overall Study|Lost to Follow-up|11|||
146782980|NCT03978871|529376822|FG001|Overall Study|Lost to Follow-up|12|||
146782981|NCT02187003|529379023|FG000|Overall Study|Adverse Event|2|||
146782982|NCT02187003|529379024|FG001|Overall Study|Adverse Event|0|||
146782983|NCT02187003|529379023|FG000|Overall Study|Lost to Follow-up|14|||
146782984|NCT02187003|529379024|FG001|Overall Study|Lost to Follow-up|10|||
146782985|NCT02187003|529379023|FG000|Overall Study|Withdrawal by Subject|3|||
146782986|NCT02187003|529379024|FG001|Overall Study|Withdrawal by Subject|7|||
146782987|NCT02187003|529379023|FG000|Overall Study|Protocol Violation|2|||
146782988|NCT02187003|529379024|FG001|Overall Study|Protocol Violation|4|||
146782989|NCT02187003|529379023|FG000|Overall Study|Other|5|||
146782990|NCT02187003|529379024|FG001|Overall Study|Other|5|||
146782991|NCT02187003|529379023|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146782992|NCT02187003|529379024|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
146782993|NCT04833777|529379028|FG000|Overall Study|Lost to Follow-up|1|||
146782994|NCT04833777|529379029|FG001|Overall Study|Lost to Follow-up|0|||
146782995|NCT02724878|529379035|FG000|Overall Study|Still on Active Therapy|15|||
146782996|NCT02724878|529379035|FG000|Overall Study|Disease Progression|31|||
146782997|NCT02724878|529379035|FG000|Overall Study|Toxicity|5|||
146782998|NCT02724878|529379035|FG000|Overall Study|Death|1|||
146782999|NCT02724878|529379035|FG000|Overall Study|Withdrawal by Subject|4|||
146934339|NCT00340834|529917829|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
146934340|NCT00340834|529917830|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
146783000|NCT02724878|529379035|FG000|Overall Study|Lost to Follow-up|2|||
146783001|NCT02724878|529379035|FG000|Overall Study|Protocol Violation|1|||
146783002|NCT02724878|529379035|FG000|Overall Study|Ineligible for Study Drug|5|||
146783003|NCT02724878|529379035|FG000|Overall Study|not started|1|||
146783004|NCT03779204|529379036|FG000|Overall Study|Lost to Follow-up|2|||
146783005|NCT03779204|529379037|FG001|Overall Study|Lost to Follow-up|0|||
146783006|NCT04258709|529379038|FG000|Overall Study|Lost to Follow-up|10|||
146783007|NCT04258709|529379039|FG001|Overall Study|Lost to Follow-up|4|||
146783008|NCT04258709|529379038|FG000|Overall Study|Withdrawal by Subject|1|||
146783009|NCT04258709|529379039|FG001|Overall Study|Withdrawal by Subject|0|||
146783010|NCT04258709|529379038|FG000|Overall Study|Fetal demise|0|||
146783011|NCT04258709|529379039|FG001|Overall Study|Fetal demise|1|||
146783012|NCT04258709|529379038|FG000|Overall Study|Protocol Violation|1|||
146783013|NCT04258709|529379039|FG001|Overall Study|Protocol Violation|1|||
146783014|NCT02592330|529379040|FG000|Overall Study|Withdrawal by Subject|1|||
146783015|NCT02592330|529379041|FG001|Overall Study|Withdrawal by Subject|0|||
146783016|NCT02592330|529379040|FG000|Overall Study|Failed Biopsy|1|||
146783017|NCT02592330|529379041|FG001|Overall Study|Failed Biopsy|0|||
146783018|NCT03090152|529379042|FG000|Overall Study|Withdrawal by Subject|0|||
146783019|NCT03090152|529379043|FG001|Overall Study|Withdrawal by Subject|2|||
146783020|NCT03090152|529379044|FG002|Overall Study|Withdrawal by Subject|1|||
146783021|NCT03090152|529379042|FG000|Overall Study|Surgery Canceled|1|||
146783022|NCT03090152|529379043|FG001|Overall Study|Surgery Canceled|0|||
146783023|NCT03090152|529379044|FG002|Overall Study|Surgery Canceled|0|||
146783024|NCT03090152|529379042|FG000|Overall Study|Epidural catheter could not be placed|0|||
146783025|NCT03090152|529379043|FG001|Overall Study|Epidural catheter could not be placed|2|||
146783026|NCT03090152|529379044|FG002|Overall Study|Epidural catheter could not be placed|0|||
146783027|NCT02729311|529379048|FG000|Overall Study|Withdrawal by Subject|8|||
146783028|NCT02729311|529379049|FG001|Overall Study|Withdrawal by Subject|2|||
146783029|NCT05324124|529379050|FG000|Period 1|Withdrawal by Subject|1|||
146783030|NCT05324124|529379051|FG001|Period 1|Withdrawal by Subject|0|||
146783031|NCT05324124|529379050|FG000|Period 1|Physician Decision|0|||
146783032|NCT05324124|529379051|FG001|Period 1|Physician Decision|1|||
146783033|NCT04034251|529379052|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
146783034|NCT04034251|529379053|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
146783035|NCT04034251|529379054|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
146783036|NCT05034952|529379055|FG000|Overall Study|Adverse Event|1|||
146783037|NCT05034952|529379056|FG001|Overall Study|Adverse Event|0|||
146783038|NCT05034952|529379057|FG002|Overall Study|Adverse Event|0|||
146783039|NCT05034952|529379058|FG003|Overall Study|Adverse Event|0|||
146783040|NCT05034952|529379055|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
146783041|NCT05034952|529379056|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
146783042|NCT05034952|529379057|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
146783043|NCT05034952|529379058|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
146783044|NCT05034952|529379055|FG000|Overall Study|Lost to Follow-up|1|||
146783045|NCT05034952|529379056|FG001|Overall Study|Lost to Follow-up|4|||
146783046|NCT05034952|529379057|FG002|Overall Study|Lost to Follow-up|3|||
146783047|NCT05034952|529379058|FG003|Overall Study|Lost to Follow-up|3|||
146783048|NCT05034952|529379055|FG000|Overall Study|Other|0|||
146783049|NCT05034952|529379056|FG001|Overall Study|Other|0|||
146783050|NCT05034952|529379057|FG002|Overall Study|Other|0|||
146783051|NCT05034952|529379058|FG003|Overall Study|Other|1|||
146783052|NCT02287610|529379059|FG000|Overall Study|Lost to Follow-up|3|||
146783053|NCT02287610|529379059|FG000|Overall Study|Withdrawal by Subject|8|||
146783054|NCT02287610|529379059|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
146783055|NCT04950660|529379064|FG000|Overall Study|Protocol Violation|4|||
146783056|NCT04950660|529379065|FG001|Overall Study|Protocol Violation|2|||
146783057|NCT04950660|529379064|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
146783058|NCT04950660|529379065|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
146783059|NCT04950660|529379064|FG000|Overall Study|Withdrawal by Subject|0|||
146783060|NCT04950660|529379065|FG001|Overall Study|Withdrawal by Subject|1|||
146783061|NCT04950660|529379064|FG000|Overall Study|Hypotension|1|||
146783062|NCT04950660|529379065|FG001|Overall Study|Hypotension|0|||
146783063|NCT04783935|529379080|FG000|Overall Study|Withdrawal by Subject|6|||
146783064|NCT04783935|529379080|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
146783065|NCT04783935|529379080|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
146783066|NCT04783935|529379080|FG000|Overall Study|Lost to Follow-up|3|||
146783067|NCT04783935|529379080|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
146783068|NCT02437318|529379082|FG000|Overall Study|Progressive disease|207|||
146783069|NCT02437318|529379083|FG001|Overall Study|Progressive disease|240|||
146783070|NCT02437318|529379082|FG000|Overall Study|Subject/guardian decision|24|||
146783071|NCT02437318|529379083|FG001|Overall Study|Subject/guardian decision|11|||
146783072|NCT02437318|529379082|FG000|Overall Study|Physician Decision|29|||
146783073|NCT02437318|529379083|FG001|Overall Study|Physician Decision|22|||
146783074|NCT02437318|529379082|FG000|Overall Study|Adverse Event|14|||
146783075|NCT02437318|529379083|FG001|Overall Study|Adverse Event|4|||
146783076|NCT02437318|529379082|FG000|Overall Study|Death|4|||
146783077|NCT02437318|529379083|FG001|Overall Study|Death|4|||
146934341|NCT00340834|529917831|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
146783078|NCT02437318|529379082|FG000|Overall Study|Protocol deviation|5|||
146783079|NCT02437318|529379083|FG001|Overall Study|Protocol deviation|7|||
146783080|NCT02437318|529379082|FG000|Overall Study|Sponsor decision|1|||
146934342|NCT00340834|529917832|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
146783081|NCT02437318|529379083|FG001|Overall Study|Sponsor decision|0|||
146783082|NCT00920621|529379089|FG000|Overall Study|Lost to Follow-up|16|||
146783083|NCT00920621|529379090|FG001|Overall Study|Lost to Follow-up|17|||
146783084|NCT00920621|529379091|FG002|Overall Study|Lost to Follow-up|19|||
146783085|NCT00920621|529379092|FG003|Overall Study|Lost to Follow-up|21|||
146783086|NCT00920621|529379089|FG000|Overall Study|Fetal/neonatal deaths|16|||
146934343|NCT00340834|529917828|FG000|Extension Phase of Study|Protocol Violation|3|||
146934344|NCT00340834|529917829|FG001|Extension Phase of Study|Protocol Violation|0|||
146934345|NCT00340834|529917830|FG002|Extension Phase of Study|Protocol Violation|0|||
146934346|NCT00340834|529917831|FG003|Extension Phase of Study|Protocol Violation|0|||
146934347|NCT00340834|529917832|FG004|Extension Phase of Study|Protocol Violation|0|||
146934348|NCT00340834|529917828|FG000|Extension Phase of Study|Death|0|||
146934349|NCT00340834|529917829|FG001|Extension Phase of Study|Death|0|||
146934350|NCT00340834|529917830|FG002|Extension Phase of Study|Death|0|||
146934351|NCT00340834|529917831|FG003|Extension Phase of Study|Death|0|||
146981349|NCT00479401|530093873|FG002|Overall Study|Lost to Follow-up|1|||
146981350|NCT00479401|530093871|FG000|Overall Study|Withdrawal by Subject|16|||
146721960|NCT01588184|529152695|FG001|Overall Study|Death|0|||
146721961|NCT01588184|529152696|FG002|Overall Study|Death|0|||
146721962|NCT01588184|529152697|FG003|Overall Study|Death|1|||
146721963|NCT01588184|529152698|FG004|Overall Study|Death|1|||
146721964|NCT01588184|529152699|FG005|Overall Study|Death|1|||
146721965|NCT01588184|529152694|FG000|Overall Study|Withdrawal by Subject|2|||
146721966|NCT01588184|529152695|FG001|Overall Study|Withdrawal by Subject|4|||
146721967|NCT01588184|529152696|FG002|Overall Study|Withdrawal by Subject|0|||
146721968|NCT01588184|529152697|FG003|Overall Study|Withdrawal by Subject|1|||
146721969|NCT01588184|529152698|FG004|Overall Study|Withdrawal by Subject|0|||
146721970|NCT01588184|529152699|FG005|Overall Study|Withdrawal by Subject|0|||
146721971|NCT01588184|529152694|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
146721972|NCT01588184|529152695|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
146721973|NCT01588184|529152696|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
146721974|NCT01588184|529152697|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
146721975|NCT01588184|529152698|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
146721976|NCT01588184|529152699|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
146721977|NCT01588184|529152694|FG000|Overall Study|multiple reasons|0|||
146721978|NCT01588184|529152695|FG001|Overall Study|multiple reasons|3|||
146721979|NCT01588184|529152696|FG002|Overall Study|multiple reasons|0|||
146721980|NCT01588184|529152697|FG003|Overall Study|multiple reasons|1|||
146721981|NCT01588184|529152698|FG004|Overall Study|multiple reasons|0|||
146721982|NCT01588184|529152699|FG005|Overall Study|multiple reasons|0|||
146721983|NCT00907153|529152700|FG000|Overall Study|Lost to Follow-up|1|||
146721984|NCT00907153|529152701|FG001|Overall Study|Lost to Follow-up|1|||
146721985|NCT00907153|529152700|FG000|Overall Study|Withdrawal by Subject|1|||
146721986|NCT00907153|529152701|FG001|Overall Study|Withdrawal by Subject|3|||
146721987|NCT01559844|529152704|FG000|Overall Study|Consent Withdrawn|7|||
146721988|NCT01559844|529152704|FG000|Overall Study|Death|5|||
146721989|NCT01559844|529152704|FG000|Overall Study|Efficacy Failure|10|||
146721990|NCT01559844|529152704|FG000|Overall Study|No Longer A Transplant Candidate|3|||
146721991|NCT01217073|529152705|FG000|Base Period|Adverse Event|1|||
146721992|NCT01217073|529152706|FG001|Base Period|Adverse Event|0|||
146721993|NCT01217073|529152707|FG002|Base Period|Adverse Event|1|||
146721994|NCT01217073|529152708|FG003|Base Period|Adverse Event|0|||
146721995|NCT01217073|529152709|FG004|Base Period|Adverse Event|4|||
146721996|NCT01217073|529152710|FG005|Base Period|Adverse Event|1|||
146721997|NCT01217073|529152711|FG006|Base Period|Adverse Event|0|||
146721998|NCT01217073|529152712|FG007|Base Period|Adverse Event|0|||
146721999|NCT01217073|529152705|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
146722000|NCT01217073|529152706|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
146722001|NCT01217073|529152707|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
146722002|NCT01217073|529152708|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
146722003|NCT01217073|529152709|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
146722004|NCT01217073|529152710|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
146722005|NCT01217073|529152711|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
146722006|NCT01217073|529152712|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
146722007|NCT01217073|529152705|FG000|Base Period|Excluded medication|0|||
146722008|NCT01217073|529152706|FG001|Base Period|Excluded medication|0|||
146722009|NCT01217073|529152707|FG002|Base Period|Excluded medication|0|||
146722010|NCT01217073|529152708|FG003|Base Period|Excluded medication|0|||
146722011|NCT01217073|529152709|FG004|Base Period|Excluded medication|1|||
146722012|NCT01217073|529152710|FG005|Base Period|Excluded medication|0|||
146722013|NCT01217073|529152711|FG006|Base Period|Excluded medication|0|||
146722014|NCT01217073|529152712|FG007|Base Period|Excluded medication|0|||
146722015|NCT01217073|529152705|FG000|Base Period|Lack of Efficacy|0|||
146722016|NCT01217073|529152706|FG001|Base Period|Lack of Efficacy|0|||
146722017|NCT01217073|529152707|FG002|Base Period|Lack of Efficacy|0|||
146722018|NCT01217073|529152708|FG003|Base Period|Lack of Efficacy|0|||
146722019|NCT01217073|529152709|FG004|Base Period|Lack of Efficacy|0|||
146722020|NCT01217073|529152710|FG005|Base Period|Lack of Efficacy|1|||
146934352|NCT00340834|529917832|FG004|Extension Phase of Study|Death|1|||
146934353|NCT00291499|529917833|FG000|Overall Study|Adverse Event|3|||
146722021|NCT01217073|529152711|FG006|Base Period|Lack of Efficacy|0|||
146722022|NCT01217073|529152712|FG007|Base Period|Lack of Efficacy|0|||
146722023|NCT01217073|529152705|FG000|Base Period|Lost to Follow-up|0|||
146722024|NCT01217073|529152706|FG001|Base Period|Lost to Follow-up|0|||
146934354|NCT00291499|529917834|FG001|Overall Study|Adverse Event|8|||
146934355|NCT00291499|529917833|FG000|Overall Study|Change to other therapy|2|||
146934356|NCT00291499|529917834|FG001|Overall Study|Change to other therapy|1|||
146934357|NCT00291499|529917833|FG000|Overall Study|Intercurrent illness|1|||
146934358|NCT00291499|529917834|FG001|Overall Study|Intercurrent illness|0|||
146934359|NCT00291499|529917833|FG000|Overall Study|Protocol Violation|2|||
146783087|NCT00920621|529379090|FG001|Overall Study|Fetal/neonatal deaths|14|||
146783088|NCT00920621|529379091|FG002|Overall Study|Fetal/neonatal deaths|16|||
146783089|NCT00920621|529379092|FG003|Overall Study|Fetal/neonatal deaths|14|||
146783090|NCT00920621|529379089|FG000|Overall Study|Blood sample not collected|22|||
146783091|NCT00920621|529379090|FG001|Overall Study|Blood sample not collected|14|||
146783092|NCT00920621|529379091|FG002|Overall Study|Blood sample not collected|0|||
146783093|NCT00920621|529379092|FG003|Overall Study|Blood sample not collected|0|||
146783094|NCT06074523|529379093|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
146783095|NCT06074523|529379093|FG000|Overall Study|Withdrawal by Subject|1|||
146783096|NCT01426425|529379094|FG000|Overall Study|Exited prior to EP study|22|||
146783097|NCT01426425|529379094|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
146783098|NCT01426425|529379094|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
146783099|NCT03281291|529379095|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
146783100|NCT03281291|529379096|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
146783101|NCT03281291|529379097|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
146783102|NCT03281291|529379098|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
146783103|NCT03281291|529379099|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
146783104|NCT03281291|529379095|FG000|Overall Study|Protocol Deviation|2|||
146783105|NCT03281291|529379096|FG001|Overall Study|Protocol Deviation|0|||
146934360|NCT00291499|529917834|FG001|Overall Study|Protocol Violation|2|||
146934361|NCT00291499|529917833|FG000|Overall Study|Other reasons|1|||
146934362|NCT00291499|529917834|FG001|Overall Study|Other reasons|4|||
146934363|NCT02786836|529917837|FG000|Overall Study|Death|1|||
146934364|NCT02786836|529917837|FG000|Overall Study|Lack of Efficacy|2|||
146722025|NCT01217073|529152707|FG002|Base Period|Lost to Follow-up|1|||
146722026|NCT01217073|529152708|FG003|Base Period|Lost to Follow-up|1|||
146722027|NCT01217073|529152709|FG004|Base Period|Lost to Follow-up|3|||
146722028|NCT01217073|529152710|FG005|Base Period|Lost to Follow-up|0|||
146722029|NCT01217073|529152711|FG006|Base Period|Lost to Follow-up|0|||
146722030|NCT01217073|529152712|FG007|Base Period|Lost to Follow-up|0|||
146722031|NCT01217073|529152705|FG000|Base Period|Physician Decision|0|||
146722032|NCT01217073|529152706|FG001|Base Period|Physician Decision|0|||
146722033|NCT01217073|529152707|FG002|Base Period|Physician Decision|0|||
146722034|NCT01217073|529152708|FG003|Base Period|Physician Decision|0|||
146722035|NCT01217073|529152709|FG004|Base Period|Physician Decision|1|||
146722036|NCT01217073|529152710|FG005|Base Period|Physician Decision|0|||
146722037|NCT01217073|529152711|FG006|Base Period|Physician Decision|0|||
146722038|NCT01217073|529152712|FG007|Base Period|Physician Decision|0|||
146722039|NCT01217073|529152705|FG000|Base Period|Protocol Violation|1|||
146722040|NCT01217073|529152706|FG001|Base Period|Protocol Violation|0|||
146722041|NCT01217073|529152707|FG002|Base Period|Protocol Violation|0|||
146722042|NCT01217073|529152708|FG003|Base Period|Protocol Violation|0|||
146722043|NCT01217073|529152709|FG004|Base Period|Protocol Violation|1|||
146722044|NCT01217073|529152710|FG005|Base Period|Protocol Violation|2|||
146722045|NCT01217073|529152711|FG006|Base Period|Protocol Violation|0|||
146722046|NCT01217073|529152712|FG007|Base Period|Protocol Violation|0|||
146722047|NCT01217073|529152705|FG000|Base Period|Withdrawal by Subject|4|||
146722048|NCT01217073|529152706|FG001|Base Period|Withdrawal by Subject|5|||
146722049|NCT01217073|529152707|FG002|Base Period|Withdrawal by Subject|5|||
146722050|NCT01217073|529152708|FG003|Base Period|Withdrawal by Subject|1|||
146722051|NCT01217073|529152709|FG004|Base Period|Withdrawal by Subject|5|||
146722052|NCT01217073|529152710|FG005|Base Period|Withdrawal by Subject|5|||
146722053|NCT01217073|529152711|FG006|Base Period|Withdrawal by Subject|0|||
146722054|NCT01217073|529152712|FG007|Base Period|Withdrawal by Subject|0|||
146722055|NCT01217073|529152705|FG000|Extension Period|Adverse Event|0|||
146722056|NCT01217073|529152706|FG001|Extension Period|Adverse Event|0|||
146783106|NCT03281291|529379097|FG002|Overall Study|Protocol Deviation|1|||
146783107|NCT03281291|529379098|FG003|Overall Study|Protocol Deviation|2|||
146783108|NCT03281291|529379099|FG004|Overall Study|Protocol Deviation|1|||
146934365|NCT02786836|529917837|FG000|Overall Study|Protocol Violation|3|||
146934366|NCT02786836|529917837|FG000|Overall Study|Withdrawal by Subject|3|||
146934367|NCT02786836|529917837|FG000|Overall Study|Liver Transplantation|2|||
146722057|NCT01217073|529152707|FG002|Extension Period|Adverse Event|0|||
146722058|NCT01217073|529152708|FG003|Extension Period|Adverse Event|0|||
146722059|NCT01217073|529152709|FG004|Extension Period|Adverse Event|0|||
146722060|NCT01217073|529152710|FG005|Extension Period|Adverse Event|0|||
146722061|NCT01217073|529152711|FG006|Extension Period|Adverse Event|19|||
146722062|NCT01217073|529152712|FG007|Extension Period|Adverse Event|5|||
146722063|NCT01217073|529152705|FG000|Extension Period|ALT/AST|0|||
146722064|NCT01217073|529152706|FG001|Extension Period|ALT/AST|0|||
146722065|NCT01217073|529152707|FG002|Extension Period|ALT/AST|0|||
146722066|NCT01217073|529152708|FG003|Extension Period|ALT/AST|0|||
146934368|NCT02786836|529917837|FG000|Overall Study|Device or Pharmacy Issues|3|||
146934369|NCT01532570|529917847|FG000|Overall Study|Lack of Efficacy|1|||
146934370|NCT01532570|529917848|FG001|Overall Study|Lack of Efficacy|0|||
146934371|NCT01532570|529917849|FG002|Overall Study|Lack of Efficacy|0|||
146934372|NCT01532570|529917850|FG003|Overall Study|Lack of Efficacy|0|||
146934373|NCT01532570|529917847|FG000|Overall Study|Withdrawal by Subject|0|||
146934374|NCT01532570|529917848|FG001|Overall Study|Withdrawal by Subject|1|||
146934375|NCT01532570|529917849|FG002|Overall Study|Withdrawal by Subject|0|||
146934376|NCT01532570|529917850|FG003|Overall Study|Withdrawal by Subject|0|||
146934377|NCT03892707|529917853|FG000|Overall Study|Screen failure|6|||
146934378|NCT03892707|529917854|FG001|Overall Study|Screen failure|0|||
146934379|NCT03892707|529917853|FG000|Overall Study|Pain resolution|0|||
146934380|NCT03892707|529917854|FG001|Overall Study|Pain resolution|4|||
146934381|NCT03892707|529917853|FG000|Overall Study|Withdrawal by Subject|0|||
146934382|NCT03892707|529917854|FG001|Overall Study|Withdrawal by Subject|1|||
146934383|NCT03892707|529917853|FG000|Overall Study|Other (long business trip)|0|||
146934384|NCT03892707|529917854|FG001|Overall Study|Other (long business trip)|1|||
146934385|NCT04190186|529917858|FG000|Overall Study|ILR is no longer functioning|0|||
146934386|NCT04190186|529917859|FG001|Overall Study|ILR is no longer functioning|1|||
146934387|NCT04190186|529917858|FG000|Overall Study|Lost to Follow-up|0|||
146934388|NCT04190186|529917859|FG001|Overall Study|Lost to Follow-up|1|||
146934389|NCT04190186|529917858|FG000|Overall Study|Withdrawal by Subject|2|||
146934390|NCT04190186|529917859|FG001|Overall Study|Withdrawal by Subject|0|||
146934391|NCT04190186|529917858|FG000|Overall Study|Subject choice to explant|1|||
146934392|NCT04190186|529917859|FG001|Overall Study|Subject choice to explant|0|||
146934393|NCT04190186|529917858|FG000|Overall Study|Physician Decision|0|||
146934394|NCT04190186|529917859|FG001|Overall Study|Physician Decision|1|||
146934395|NCT04190186|529917858|FG000|Overall Study|Study was stopped|4|||
146934396|NCT04190186|529917859|FG001|Overall Study|Study was stopped|5|||
146934397|NCT01665768|529917860|FG000|Overall Study|Adverse Event|3|||
146934398|NCT01665768|529917860|FG000|Overall Study|Lack of Efficacy|19|||
146934399|NCT01665768|529917860|FG000|Overall Study|Withdrawal by Subject|1|||
146934400|NCT02151682|529917861|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
146934401|NCT02151682|529917862|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
146934402|NCT02151682|529917863|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
146934403|NCT02151682|529917864|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
146934404|NCT02151682|529917865|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
146934405|NCT02151682|529917866|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
146934406|NCT02151682|529917861|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
146934407|NCT02151682|529917862|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
146934408|NCT02151682|529917863|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
146934409|NCT02151682|529917864|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
146934410|NCT02151682|529917865|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
146934411|NCT02151682|529917866|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
146934412|NCT02151682|529917861|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
146934413|NCT02151682|529917862|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
146934414|NCT02151682|529917863|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
146934415|NCT02151682|529917864|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
146934416|NCT02151682|529917865|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
146934417|NCT02151682|529917866|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
146934418|NCT02151682|529917861|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
146934419|NCT02151682|529917862|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
146934420|NCT02151682|529917863|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
146934421|NCT02151682|529917864|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
146934422|NCT02151682|529917865|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
146934423|NCT02151682|529917866|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
146722067|NCT01217073|529152709|FG004|Extension Period|ALT/AST|0|||
146722068|NCT01217073|529152710|FG005|Extension Period|ALT/AST|0|||
146722069|NCT01217073|529152711|FG006|Extension Period|ALT/AST|2|||
146722070|NCT01217073|529152712|FG007|Extension Period|ALT/AST|0|||
146722071|NCT01217073|529152705|FG000|Extension Period|Contraindication to study medication|0|||
146722072|NCT01217073|529152706|FG001|Extension Period|Contraindication to study medication|0|||
146722073|NCT01217073|529152707|FG002|Extension Period|Contraindication to study medication|0|||
146722074|NCT01217073|529152708|FG003|Extension Period|Contraindication to study medication|0|||
146722075|NCT01217073|529152709|FG004|Extension Period|Contraindication to study medication|0|||
146722076|NCT01217073|529152710|FG005|Extension Period|Contraindication to study medication|0|||
146722077|NCT01217073|529152711|FG006|Extension Period|Contraindication to study medication|1|||
146934424|NCT02151682|529917861|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
146981351|NCT00479401|530093872|FG001|Overall Study|Withdrawal by Subject|10|||
146722078|NCT01217073|529152712|FG007|Extension Period|Contraindication to study medication|0|||
146722079|NCT01217073|529152705|FG000|Extension Period|Creatinine/eGFR|0|||
146783109|NCT03281291|529379095|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
146783110|NCT03281291|529379096|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
146783111|NCT03281291|529379097|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
146783112|NCT03281291|529379098|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
146783113|NCT03281291|529379099|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
146783114|NCT03281291|529379095|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
146783115|NCT03281291|529379096|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
146783116|NCT03281291|529379097|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
146783117|NCT03281291|529379098|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
146783118|NCT03281291|529379099|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
146783119|NCT03281291|529379095|FG000|Overall Study|Lost to Follow-up|10|||
146783120|NCT03281291|529379096|FG001|Overall Study|Lost to Follow-up|10|||
146783121|NCT03281291|529379097|FG002|Overall Study|Lost to Follow-up|4|||
146783122|NCT03281291|529379098|FG003|Overall Study|Lost to Follow-up|6|||
146783123|NCT03281291|529379099|FG004|Overall Study|Lost to Follow-up|10|||
146783124|NCT03281291|529379095|FG000|Overall Study|Other|0|||
146783125|NCT03281291|529379096|FG001|Overall Study|Other|2|||
146783126|NCT03281291|529379097|FG002|Overall Study|Other|0|||
146783127|NCT03281291|529379098|FG003|Overall Study|Other|2|||
146783128|NCT03281291|529379099|FG004|Overall Study|Other|1|||
146783129|NCT04956861|529379100|FG000|Overall Study|Withdrawal by Subject|4|||
146783130|NCT04956861|529379101|FG001|Overall Study|Withdrawal by Subject|4|||
146783131|NCT04956861|529379102|FG002|Overall Study|Withdrawal by Subject|2|||
146783132|NCT04956861|529379100|FG000|Overall Study|Physician Decision|4|||
146783133|NCT04956861|529379101|FG001|Overall Study|Physician Decision|5|||
146783134|NCT04956861|529379102|FG002|Overall Study|Physician Decision|1|||
146783135|NCT03126019|529379107|FG000|Overall Study|Death|5|||
146783136|NCT03126019|529379108|FG001|Overall Study|Death|27|||
146783137|NCT03126019|529379107|FG000|Overall Study|Lost to Follow-up|2|||
146783138|NCT03126019|529379108|FG001|Overall Study|Lost to Follow-up|4|||
146783139|NCT03126019|529379107|FG000|Overall Study|Withdrawal by Subject|1|||
146783140|NCT03126019|529379108|FG001|Overall Study|Withdrawal by Subject|9|||
146783141|NCT03126019|529379107|FG000|Overall Study|Physician Decision|1|||
146783142|NCT03126019|529379108|FG001|Overall Study|Physician Decision|0|||
146783143|NCT03126019|529379107|FG000|Overall Study|Transitioned to Rollover Study|0|||
146783144|NCT03126019|529379108|FG001|Overall Study|Transitioned to Rollover Study|11|||
146783145|NCT03126019|529379107|FG000|Overall Study|Did Not Return to Site for Care|0|||
146783146|NCT03126019|529379108|FG001|Overall Study|Did Not Return to Site for Care|1|||
146783147|NCT03126019|529379107|FG000|Overall Study|Site Closed|0|||
146783148|NCT03126019|529379108|FG001|Overall Study|Site Closed|1|||
146783149|NCT00170573|529379110|FG000|Overall Study|Violation of inclusion criteria|13|||
146783150|NCT04556656|529379111|FG000|Overall Study|Withdrawal by Subject|14|||
146783151|NCT04556656|529379112|FG001|Overall Study|Withdrawal by Subject|12|||
146783152|NCT04556656|529379111|FG000|Overall Study|Physician Decision|1|||
146783153|NCT04556656|529379112|FG001|Overall Study|Physician Decision|0|||
146783154|NCT04556656|529379111|FG000|Overall Study|Adverse Event|4|||
146783155|NCT04556656|529379112|FG001|Overall Study|Adverse Event|7|||
146783156|NCT04556656|529379111|FG000|Overall Study|Death|4|||
146783157|NCT04556656|529379112|FG001|Overall Study|Death|0|||
146783158|NCT04556656|529379111|FG000|Overall Study|Lost to Follow-up|3|||
146783159|NCT04556656|529379112|FG001|Overall Study|Lost to Follow-up|2|||
146783160|NCT04556656|529379111|FG000|Overall Study|Not further specified|2|||
146783161|NCT04556656|529379112|FG001|Overall Study|Not further specified|1|||
146783162|NCT04541706|529379116|FG000|Overall Study|Withdrawal by Subject|3|||
146934425|NCT02151682|529917862|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
146934426|NCT02151682|529917863|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
146934427|NCT02151682|529917864|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
146934428|NCT02151682|529917865|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
146934429|NCT02151682|529917866|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
146783163|NCT04541706|529379116|FG000|Overall Study|Progressive disease|33|||
146783164|NCT04541706|529379116|FG000|Overall Study|Physician Decision|1|||
146783165|NCT04541706|529379116|FG000|Overall Study|Lost to Follow-up|2|||
146783166|NCT04541706|529379116|FG000|Overall Study|Death|5|||
146783167|NCT04541706|529379116|FG000|Overall Study|Adverse Event|1|||
146783168|NCT05563246|529379124|FG000|Overall Study|Withdrawal by Subject|1|||
146783169|NCT05563246|529379125|FG001|Overall Study|Withdrawal by Subject|2|||
146783170|NCT05563246|529379126|FG002|Overall Study|Withdrawal by Subject|0|||
146934430|NCT02151682|529917861|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
146934431|NCT02151682|529917862|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
146934432|NCT02151682|529917863|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
146783171|NCT05563246|529379127|FG003|Overall Study|Withdrawal by Subject|0|||
146783172|NCT05563246|529379124|FG000|Overall Study|Protocol Deviation|0|||
146783173|NCT05563246|529379125|FG001|Overall Study|Protocol Deviation|1|||
146783174|NCT05563246|529379126|FG002|Overall Study|Protocol Deviation|0|||
146783175|NCT05563246|529379127|FG003|Overall Study|Protocol Deviation|0|||
146722080|NCT01217073|529152706|FG001|Extension Period|Creatinine/eGFR|0|||
146722081|NCT01217073|529152707|FG002|Extension Period|Creatinine/eGFR|0|||
146722082|NCT01217073|529152708|FG003|Extension Period|Creatinine/eGFR|0|||
146722083|NCT01217073|529152709|FG004|Extension Period|Creatinine/eGFR|0|||
146722084|NCT01217073|529152710|FG005|Extension Period|Creatinine/eGFR|0|||
146722085|NCT01217073|529152711|FG006|Extension Period|Creatinine/eGFR|11|||
146722086|NCT01217073|529152712|FG007|Extension Period|Creatinine/eGFR|1|||
146722087|NCT01217073|529152705|FG000|Extension Period|Death|0|||
146722088|NCT01217073|529152706|FG001|Extension Period|Death|0|||
146722089|NCT01217073|529152707|FG002|Extension Period|Death|0|||
146722090|NCT01217073|529152708|FG003|Extension Period|Death|0|||
146722091|NCT01217073|529152709|FG004|Extension Period|Death|0|||
146722092|NCT01217073|529152710|FG005|Extension Period|Death|0|||
146722093|NCT01217073|529152711|FG006|Extension Period|Death|1|||
146722094|NCT01217073|529152712|FG007|Extension Period|Death|0|||
146722095|NCT01217073|529152705|FG000|Extension Period|Excluded medication|0|||
146722096|NCT01217073|529152706|FG001|Extension Period|Excluded medication|0|||
146722097|NCT01217073|529152707|FG002|Extension Period|Excluded medication|0|||
146722098|NCT01217073|529152708|FG003|Extension Period|Excluded medication|0|||
146722099|NCT01217073|529152709|FG004|Extension Period|Excluded medication|0|||
146722100|NCT01217073|529152710|FG005|Extension Period|Excluded medication|0|||
146722101|NCT01217073|529152711|FG006|Extension Period|Excluded medication|2|||
146722102|NCT01217073|529152712|FG007|Extension Period|Excluded medication|0|||
146722103|NCT01217073|529152705|FG000|Extension Period|Lack of Efficacy|0|||
146722104|NCT01217073|529152706|FG001|Extension Period|Lack of Efficacy|0|||
146722105|NCT01217073|529152707|FG002|Extension Period|Lack of Efficacy|0|||
146722106|NCT01217073|529152708|FG003|Extension Period|Lack of Efficacy|0|||
146722107|NCT01217073|529152709|FG004|Extension Period|Lack of Efficacy|0|||
146722108|NCT01217073|529152710|FG005|Extension Period|Lack of Efficacy|0|||
146722109|NCT01217073|529152711|FG006|Extension Period|Lack of Efficacy|3|||
146722110|NCT01217073|529152712|FG007|Extension Period|Lack of Efficacy|0|||
146722111|NCT01217073|529152705|FG000|Extension Period|Lost to Follow-up|0|||
146722112|NCT01217073|529152706|FG001|Extension Period|Lost to Follow-up|0|||
146722113|NCT01217073|529152707|FG002|Extension Period|Lost to Follow-up|0|||
146722114|NCT01217073|529152708|FG003|Extension Period|Lost to Follow-up|0|||
146722115|NCT01217073|529152709|FG004|Extension Period|Lost to Follow-up|0|||
146722116|NCT01217073|529152710|FG005|Extension Period|Lost to Follow-up|0|||
146722117|NCT01217073|529152711|FG006|Extension Period|Lost to Follow-up|9|||
146722118|NCT01217073|529152712|FG007|Extension Period|Lost to Follow-up|1|||
146722119|NCT01217073|529152705|FG000|Extension Period|Non-compliance with study drug|0|||
146722120|NCT01217073|529152706|FG001|Extension Period|Non-compliance with study drug|0|||
146722121|NCT01217073|529152707|FG002|Extension Period|Non-compliance with study drug|0|||
146722122|NCT01217073|529152708|FG003|Extension Period|Non-compliance with study drug|0|||
146722123|NCT01217073|529152709|FG004|Extension Period|Non-compliance with study drug|0|||
146722124|NCT01217073|529152710|FG005|Extension Period|Non-compliance with study drug|0|||
146722125|NCT01217073|529152711|FG006|Extension Period|Non-compliance with study drug|0|||
146722126|NCT01217073|529152712|FG007|Extension Period|Non-compliance with study drug|1|||
146722127|NCT01217073|529152705|FG000|Extension Period|Physician Decision|0|||
146722128|NCT01217073|529152706|FG001|Extension Period|Physician Decision|0|||
146722129|NCT01217073|529152707|FG002|Extension Period|Physician Decision|0|||
146722130|NCT01217073|529152708|FG003|Extension Period|Physician Decision|0|||
146722131|NCT01217073|529152709|FG004|Extension Period|Physician Decision|0|||
146722132|NCT01217073|529152710|FG005|Extension Period|Physician Decision|0|||
146722133|NCT01217073|529152711|FG006|Extension Period|Physician Decision|4|||
146722134|NCT01217073|529152712|FG007|Extension Period|Physician Decision|1|||
146722135|NCT01217073|529152705|FG000|Extension Period|Protocol Violation|0|||
146722136|NCT01217073|529152706|FG001|Extension Period|Protocol Violation|0|||
146722137|NCT01217073|529152707|FG002|Extension Period|Protocol Violation|0|||
146722138|NCT01217073|529152708|FG003|Extension Period|Protocol Violation|0|||
146722139|NCT01217073|529152709|FG004|Extension Period|Protocol Violation|0|||
146722140|NCT01217073|529152710|FG005|Extension Period|Protocol Violation|0|||
146722141|NCT01217073|529152711|FG006|Extension Period|Protocol Violation|2|||
146722142|NCT01217073|529152712|FG007|Extension Period|Protocol Violation|1|||
146722143|NCT01217073|529152705|FG000|Extension Period|Site discontinued study participation|0|||
146722144|NCT01217073|529152706|FG001|Extension Period|Site discontinued study participation|0|||
146722145|NCT01217073|529152707|FG002|Extension Period|Site discontinued study participation|0|||
146722146|NCT01217073|529152708|FG003|Extension Period|Site discontinued study participation|0|||
146722147|NCT01217073|529152709|FG004|Extension Period|Site discontinued study participation|0|||
146722148|NCT01217073|529152710|FG005|Extension Period|Site discontinued study participation|0|||
146722149|NCT01217073|529152711|FG006|Extension Period|Site discontinued study participation|7|||
146722150|NCT01217073|529152712|FG007|Extension Period|Site discontinued study participation|2|||
146783176|NCT05563246|529379124|FG000|Overall Study|Physician Decision|0|||
146722151|NCT01217073|529152705|FG000|Extension Period|Withdrawal by Subject|0|||
146722152|NCT01217073|529152706|FG001|Extension Period|Withdrawal by Subject|0|||
146722153|NCT01217073|529152707|FG002|Extension Period|Withdrawal by Subject|0|||
146722154|NCT01217073|529152708|FG003|Extension Period|Withdrawal by Subject|0|||
146783177|NCT05563246|529379125|FG001|Overall Study|Physician Decision|1|||
146783178|NCT05563246|529379126|FG002|Overall Study|Physician Decision|0|||
146783179|NCT05563246|529379127|FG003|Overall Study|Physician Decision|0|||
146783180|NCT05563246|529379124|FG000|Overall Study|Adverse Event|0|||
146783181|NCT05563246|529379125|FG001|Overall Study|Adverse Event|0|||
146783182|NCT05563246|529379126|FG002|Overall Study|Adverse Event|2|||
146783183|NCT05563246|529379127|FG003|Overall Study|Adverse Event|0|||
146783184|NCT05563246|529379124|FG000|Overall Study|Lost to Follow-up|0|||
146783185|NCT05563246|529379125|FG001|Overall Study|Lost to Follow-up|0|||
146783186|NCT05563246|529379126|FG002|Overall Study|Lost to Follow-up|1|||
146783187|NCT05563246|529379127|FG003|Overall Study|Lost to Follow-up|0|||
146783188|NCT01566695|529379128|FG000|Overall Study|Lack of Efficacy|1|||
146783189|NCT01566695|529379129|FG001|Overall Study|Lack of Efficacy|0|||
146783190|NCT01566695|529379128|FG000|Overall Study|Adverse Event|3|||
146783191|NCT01566695|529379129|FG001|Overall Study|Adverse Event|0|||
146783192|NCT01566695|529379128|FG000|Overall Study|Death|79|||
146783193|NCT01566695|529379129|FG001|Overall Study|Death|86|||
146783194|NCT01566695|529379128|FG000|Overall Study|Withdrawal by Subject|13|||
146783195|NCT01566695|529379129|FG001|Overall Study|Withdrawal by Subject|12|||
146783196|NCT01566695|529379128|FG000|Overall Study|Lost to Follow-up|0|||
146783197|NCT01566695|529379129|FG001|Overall Study|Lost to Follow-up|3|||
146783198|NCT01566695|529379128|FG000|Overall Study|Other reasons|11|||
146783199|NCT01566695|529379129|FG001|Overall Study|Other reasons|8|||
146783200|NCT03763708|529379130|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
146783201|NCT03763708|529379131|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
146722155|NCT01217073|529152709|FG004|Extension Period|Withdrawal by Subject|0|||
146722156|NCT01217073|529152710|FG005|Extension Period|Withdrawal by Subject|0|||
146722157|NCT01217073|529152711|FG006|Extension Period|Withdrawal by Subject|30|||
146722158|NCT01217073|529152712|FG007|Extension Period|Withdrawal by Subject|8|||
146722159|NCT00620750|529152713|FG000|Overall Study|Lost to Follow-up|25|||
146722160|NCT04477187|529152714|FG000|Overall Study|Lost to Follow-up|2|||
146722161|NCT02460991|529152715|FG000|Overall Study|Withdrawal by Subject|0|||
146722162|NCT02460991|529152716|FG001|Overall Study|Withdrawal by Subject|2|||
146722163|NCT02564523|529152717|FG000|Overall Study|Withdrawal by Subject|3|||
146722164|NCT02564523|529152718|FG001|Overall Study|Withdrawal by Subject|0|||
146722165|NCT02564523|529152719|FG002|Overall Study|Withdrawal by Subject|1|||
146722166|NCT02564523|529152720|FG003|Overall Study|Withdrawal by Subject|0|||
146722167|NCT02564523|529152721|FG004|Overall Study|Withdrawal by Subject|1|||
146722168|NCT02564523|529152722|FG005|Overall Study|Withdrawal by Subject|0|||
146722169|NCT02564523|529152723|FG006|Overall Study|Withdrawal by Subject|1|||
146722170|NCT02564523|529152724|FG007|Overall Study|Withdrawal by Subject|0|||
146722171|NCT02564523|529152725|FG008|Overall Study|Withdrawal by Subject|0|||
146722172|NCT02564523|529152726|FG009|Overall Study|Withdrawal by Subject|0|||
146722173|NCT02564523|529152727|FG010|Overall Study|Withdrawal by Subject|1|||
146722174|NCT02564523|529152728|FG011|Overall Study|Withdrawal by Subject|0|||
146722175|NCT02564523|529152729|FG012|Overall Study|Withdrawal by Subject|1|||
146722176|NCT02564523|529152730|FG013|Overall Study|Withdrawal by Subject|0|||
146722177|NCT02564523|529152731|FG014|Overall Study|Withdrawal by Subject|0|||
146722178|NCT02564523|529152732|FG015|Overall Study|Withdrawal by Subject|0|||
146722179|NCT02564523|529152733|FG016|Overall Study|Withdrawal by Subject|0|||
146722180|NCT02564523|529152734|FG017|Overall Study|Withdrawal by Subject|0|||
146722181|NCT02564523|529152717|FG000|Overall Study|Adverse Event|0|||
146722182|NCT02564523|529152718|FG001|Overall Study|Adverse Event|0|||
146722183|NCT02564523|529152719|FG002|Overall Study|Adverse Event|0|||
146722184|NCT02564523|529152720|FG003|Overall Study|Adverse Event|0|||
146722185|NCT02564523|529152721|FG004|Overall Study|Adverse Event|0|||
146722186|NCT02564523|529152722|FG005|Overall Study|Adverse Event|0|||
146722187|NCT02564523|529152723|FG006|Overall Study|Adverse Event|0|||
146722188|NCT02564523|529152724|FG007|Overall Study|Adverse Event|0|||
146783202|NCT03763708|529379132|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
146783203|NCT03763708|529379133|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
146783204|NCT03763708|529379134|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
146783205|NCT03763708|529379135|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
146783206|NCT03763708|529379136|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
146783207|NCT03763708|529379137|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
146783208|NCT03763708|529379138|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
146783209|NCT03763708|529379130|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
146783210|NCT03763708|529379131|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
146783211|NCT03763708|529379132|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
146783212|NCT03763708|529379133|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
146783213|NCT03763708|529379134|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
146783214|NCT03763708|529379135|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
146783215|NCT03763708|529379136|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
146783216|NCT03763708|529379137|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
146783217|NCT03763708|529379138|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
146783218|NCT03763708|529379130|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
146783219|NCT03763708|529379131|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
146783220|NCT03763708|529379132|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
146783221|NCT03763708|529379133|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
146783222|NCT03763708|529379134|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
146783223|NCT03763708|529379135|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
146783224|NCT03763708|529379136|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
146783225|NCT03763708|529379137|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
146783226|NCT03763708|529379138|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
146783227|NCT03763708|529379130|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
146783228|NCT03763708|529379131|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
146783229|NCT03763708|529379132|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
146783230|NCT03763708|529379133|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
146783231|NCT03763708|529379134|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
146783232|NCT03763708|529379135|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
146783233|NCT03763708|529379136|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
146783234|NCT03763708|529379137|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
146783235|NCT03763708|529379138|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
146783236|NCT03763708|529379130|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
146783237|NCT03763708|529379131|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
146783238|NCT03763708|529379132|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
146783239|NCT03763708|529379133|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
146783240|NCT03763708|529379134|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
146783241|NCT03763708|529379135|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
146783242|NCT03763708|529379136|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
146783243|NCT03763708|529379137|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
146783244|NCT03763708|529379138|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
146783245|NCT03763708|529379130|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
146783246|NCT03763708|529379131|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
146783247|NCT03763708|529379132|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
146783248|NCT03763708|529379133|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
146722189|NCT02564523|529152725|FG008|Overall Study|Adverse Event|0|||
146722190|NCT02564523|529152726|FG009|Overall Study|Adverse Event|0|||
146722191|NCT02564523|529152727|FG010|Overall Study|Adverse Event|0|||
146722192|NCT02564523|529152728|FG011|Overall Study|Adverse Event|0|||
146722193|NCT02564523|529152729|FG012|Overall Study|Adverse Event|0|||
146722194|NCT02564523|529152730|FG013|Overall Study|Adverse Event|0|||
146722195|NCT02564523|529152731|FG014|Overall Study|Adverse Event|0|||
146722196|NCT02564523|529152732|FG015|Overall Study|Adverse Event|0|||
146722197|NCT02564523|529152733|FG016|Overall Study|Adverse Event|0|||
146722198|NCT02564523|529152734|FG017|Overall Study|Adverse Event|1|||
146722199|NCT02564523|529152717|FG000|Overall Study|Death|0|||
146722200|NCT02564523|529152718|FG001|Overall Study|Death|0|||
146722201|NCT02564523|529152719|FG002|Overall Study|Death|0|||
146722202|NCT02564523|529152720|FG003|Overall Study|Death|0|||
146722203|NCT02564523|529152721|FG004|Overall Study|Death|0|||
146722204|NCT02564523|529152722|FG005|Overall Study|Death|0|||
146722205|NCT02564523|529152723|FG006|Overall Study|Death|1|||
146722206|NCT02564523|529152724|FG007|Overall Study|Death|0|||
146722207|NCT02564523|529152725|FG008|Overall Study|Death|0|||
146722208|NCT02564523|529152726|FG009|Overall Study|Death|0|||
146722209|NCT02564523|529152727|FG010|Overall Study|Death|1|||
146722210|NCT02564523|529152728|FG011|Overall Study|Death|0|||
146722211|NCT02564523|529152729|FG012|Overall Study|Death|0|||
146783249|NCT03763708|529379134|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
146783250|NCT03763708|529379135|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
146783251|NCT03763708|529379136|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
146783252|NCT03763708|529379137|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
146783253|NCT03763708|529379138|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
146783254|NCT03763708|529379130|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
146783255|NCT03763708|529379131|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
146783256|NCT03763708|529379132|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
146783257|NCT03763708|529379133|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
146783258|NCT03763708|529379134|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
146783259|NCT03763708|529379135|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
146722212|NCT02564523|529152730|FG013|Overall Study|Death|0|||
146783260|NCT03763708|529379136|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
146783261|NCT03763708|529379137|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
146722213|NCT02564523|529152731|FG014|Overall Study|Death|0|||
146722214|NCT02564523|529152732|FG015|Overall Study|Death|0|||
146722215|NCT02564523|529152733|FG016|Overall Study|Death|0|||
146722216|NCT02564523|529152734|FG017|Overall Study|Death|0|||
146722217|NCT02564523|529152717|FG000|Overall Study|Lost to Follow-up|2|||
146722218|NCT02564523|529152718|FG001|Overall Study|Lost to Follow-up|1|||
146722219|NCT02564523|529152719|FG002|Overall Study|Lost to Follow-up|4|||
146783262|NCT03763708|529379138|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
146783263|NCT03763708|529379130|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
146783264|NCT03763708|529379131|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
146783265|NCT03763708|529379132|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
146783266|NCT03763708|529379133|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
146783267|NCT03763708|529379134|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
146783268|NCT03763708|529379135|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
146783269|NCT03763708|529379136|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
146783270|NCT03763708|529379137|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
146783271|NCT03763708|529379138|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
146783272|NCT03763708|529379130|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
146783273|NCT03763708|529379131|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
146783274|NCT03763708|529379132|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
146783275|NCT03763708|529379133|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
146783276|NCT03763708|529379134|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
146783277|NCT03763708|529379135|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
146783278|NCT03763708|529379136|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
146783279|NCT03763708|529379137|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
146783280|NCT03763708|529379138|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
146783281|NCT04294225|529379143|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
146783282|NCT04294225|529379143|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
146783283|NCT04294225|529379143|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
146783284|NCT04294225|529379143|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
146783285|NCT04294225|529379143|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
146783286|NCT01809691|529379144|FG000|Overall Study|Currently on Treatment|192|||
146783287|NCT01809691|529379145|FG001|Overall Study|Currently on Treatment|100|||
146783288|NCT01809691|529379144|FG000|Overall Study|No Protocol Treatment|10|||
146783289|NCT01809691|529379145|FG001|Overall Study|No Protocol Treatment|11|||
146783290|NCT01809691|529379144|FG000|Overall Study|Adverse Event|80|||
146783291|NCT01809691|529379145|FG001|Overall Study|Adverse Event|21|||
146783292|NCT01809691|529379144|FG000|Overall Study|Disease Progression|226|||
146783293|NCT01809691|529379145|FG001|Overall Study|Disease Progression|372|||
146783294|NCT01809691|529379144|FG000|Overall Study|Death|26|||
146783295|NCT01809691|529379145|FG001|Overall Study|Death|13|||
146783296|NCT01809691|529379144|FG000|Overall Study|Participant Refusal|70|||
146783297|NCT01809691|529379145|FG001|Overall Study|Participant Refusal|72|||
146783298|NCT01809691|529379144|FG000|Overall Study|Other, Not Specified|34|||
146783299|NCT01809691|529379145|FG001|Overall Study|Other, Not Specified|52|||
146783300|NCT04588298|529379155|FG000|Overall Study|Adverse Event|0|||
146783301|NCT04588298|529379156|FG001|Overall Study|Adverse Event|0|||
146783302|NCT04588298|529379157|FG002|Overall Study|Adverse Event|1|||
146783303|NCT04588298|529379158|FG003|Overall Study|Adverse Event|0|||
146783304|NCT04588298|529379159|FG004|Overall Study|Adverse Event|2|||
146783305|NCT04588298|529379155|FG000|Overall Study|Withdrawal by Subject|1|||
146783306|NCT04588298|529379156|FG001|Overall Study|Withdrawal by Subject|0|||
146722220|NCT02564523|529152720|FG003|Overall Study|Lost to Follow-up|0|||
146722221|NCT02564523|529152721|FG004|Overall Study|Lost to Follow-up|1|||
146722222|NCT02564523|529152722|FG005|Overall Study|Lost to Follow-up|0|||
146722223|NCT02564523|529152723|FG006|Overall Study|Lost to Follow-up|1|||
146722224|NCT02564523|529152724|FG007|Overall Study|Lost to Follow-up|0|||
146722225|NCT02564523|529152725|FG008|Overall Study|Lost to Follow-up|0|||
146722226|NCT02564523|529152726|FG009|Overall Study|Lost to Follow-up|0|||
146722227|NCT02564523|529152727|FG010|Overall Study|Lost to Follow-up|0|||
146722228|NCT02564523|529152728|FG011|Overall Study|Lost to Follow-up|1|||
146722229|NCT02564523|529152729|FG012|Overall Study|Lost to Follow-up|1|||
146722230|NCT02564523|529152730|FG013|Overall Study|Lost to Follow-up|0|||
146722231|NCT02564523|529152731|FG014|Overall Study|Lost to Follow-up|0|||
146722232|NCT02564523|529152732|FG015|Overall Study|Lost to Follow-up|0|||
146722233|NCT02564523|529152733|FG016|Overall Study|Lost to Follow-up|0|||
146722234|NCT02564523|529152734|FG017|Overall Study|Lost to Follow-up|0|||
146722235|NCT02564523|529152717|FG000|Overall Study|Physician Decision|0|||
146722236|NCT02564523|529152718|FG001|Overall Study|Physician Decision|0|||
146722237|NCT02564523|529152719|FG002|Overall Study|Physician Decision|0|||
146722238|NCT02564523|529152720|FG003|Overall Study|Physician Decision|0|||
146722239|NCT02564523|529152721|FG004|Overall Study|Physician Decision|1|||
146722240|NCT02564523|529152722|FG005|Overall Study|Physician Decision|0|||
146722241|NCT02564523|529152723|FG006|Overall Study|Physician Decision|0|||
146783307|NCT04588298|529379157|FG002|Overall Study|Withdrawal by Subject|0|||
146783308|NCT04588298|529379158|FG003|Overall Study|Withdrawal by Subject|1|||
146722242|NCT02564523|529152724|FG007|Overall Study|Physician Decision|0|||
146783309|NCT04588298|529379159|FG004|Overall Study|Withdrawal by Subject|0|||
146783310|NCT02281955|529379161|FG000|Overall Study|Death|1|||
146783311|NCT02783300|529379170|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783312|NCT02783300|529379171|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783313|NCT02783300|529379172|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146722243|NCT02564523|529152725|FG008|Overall Study|Physician Decision|0|||
146783314|NCT02783300|529379173|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146722244|NCT02564523|529152726|FG009|Overall Study|Physician Decision|0|||
146981352|NCT00479401|530093873|FG002|Overall Study|Withdrawal by Subject|2|||
146981353|NCT00479401|530093871|FG000|Overall Study|Exclusion criteria, relocation|4|||
146981354|NCT00479401|530093872|FG001|Overall Study|Exclusion criteria, relocation|3|||
146981355|NCT00479401|530093873|FG002|Overall Study|Exclusion criteria, relocation|0|||
146722245|NCT02564523|529152727|FG010|Overall Study|Physician Decision|1|||
146722246|NCT02564523|529152728|FG011|Overall Study|Physician Decision|0|||
146722247|NCT02564523|529152729|FG012|Overall Study|Physician Decision|0|||
146722248|NCT02564523|529152730|FG013|Overall Study|Physician Decision|0|||
146722249|NCT02564523|529152731|FG014|Overall Study|Physician Decision|0|||
146722250|NCT02564523|529152732|FG015|Overall Study|Physician Decision|0|||
146722251|NCT02564523|529152733|FG016|Overall Study|Physician Decision|0|||
146722252|NCT02564523|529152734|FG017|Overall Study|Physician Decision|0|||
146722253|NCT02564523|529152717|FG000|Overall Study|Protocol Violation|2|||
146722254|NCT02564523|529152718|FG001|Overall Study|Protocol Violation|2|||
146722255|NCT02564523|529152719|FG002|Overall Study|Protocol Violation|5|||
146722256|NCT02564523|529152720|FG003|Overall Study|Protocol Violation|0|||
146722257|NCT02564523|529152721|FG004|Overall Study|Protocol Violation|1|||
146722258|NCT02564523|529152722|FG005|Overall Study|Protocol Violation|0|||
146722259|NCT02564523|529152723|FG006|Overall Study|Protocol Violation|0|||
146722260|NCT02564523|529152724|FG007|Overall Study|Protocol Violation|0|||
146722261|NCT02564523|529152725|FG008|Overall Study|Protocol Violation|0|||
146722262|NCT02564523|529152726|FG009|Overall Study|Protocol Violation|0|||
146722263|NCT02564523|529152727|FG010|Overall Study|Protocol Violation|0|||
146722264|NCT02564523|529152728|FG011|Overall Study|Protocol Violation|0|||
146722265|NCT02564523|529152729|FG012|Overall Study|Protocol Violation|0|||
146722266|NCT02564523|529152730|FG013|Overall Study|Protocol Violation|0|||
146722267|NCT02564523|529152731|FG014|Overall Study|Protocol Violation|0|||
146722268|NCT02564523|529152732|FG015|Overall Study|Protocol Violation|0|||
146722269|NCT02564523|529152733|FG016|Overall Study|Protocol Violation|0|||
146722270|NCT02564523|529152734|FG017|Overall Study|Protocol Violation|0|||
146722271|NCT02564523|529152717|FG000|Overall Study|Other|3|||
146722272|NCT02564523|529152718|FG001|Overall Study|Other|0|||
146722273|NCT02564523|529152719|FG002|Overall Study|Other|0|||
146722274|NCT02564523|529152720|FG003|Overall Study|Other|1|||
146722275|NCT02564523|529152721|FG004|Overall Study|Other|0|||
146722276|NCT02564523|529152722|FG005|Overall Study|Other|0|||
146722277|NCT02564523|529152723|FG006|Overall Study|Other|0|||
146722278|NCT02564523|529152724|FG007|Overall Study|Other|0|||
146722279|NCT02564523|529152725|FG008|Overall Study|Other|0|||
146722280|NCT02564523|529152726|FG009|Overall Study|Other|0|||
146722281|NCT02564523|529152727|FG010|Overall Study|Other|0|||
146722282|NCT02564523|529152728|FG011|Overall Study|Other|0|||
146722283|NCT02564523|529152729|FG012|Overall Study|Other|0|||
146722284|NCT02564523|529152730|FG013|Overall Study|Other|0|||
146722285|NCT02564523|529152731|FG014|Overall Study|Other|0|||
146722286|NCT02564523|529152732|FG015|Overall Study|Other|0|||
146722287|NCT02564523|529152733|FG016|Overall Study|Other|0|||
146722288|NCT02564523|529152734|FG017|Overall Study|Other|0|||
146722289|NCT03905655|529152737|FG000|Overall Study|Adverse Event|1|||
146722290|NCT03905655|529152738|FG001|Overall Study|Adverse Event|0|||
146722291|NCT03905655|529152739|FG002|Overall Study|Adverse Event|1|||
146722292|NCT03905655|529152740|FG003|Overall Study|Adverse Event|1|||
146722293|NCT02566031|529152741|FG000|Overall Study|Patient/guardian decision|14|||
146722294|NCT02566031|529152742|FG001|Overall Study|Patient/guardian decision|7|||
146722295|NCT02566031|529152741|FG000|Overall Study|Protocol deviation|2|||
146722296|NCT02566031|529152742|FG001|Overall Study|Protocol deviation|3|||
146722297|NCT02566031|529152741|FG000|Overall Study|Adverse Event|3|||
146722298|NCT02566031|529152742|FG001|Overall Study|Adverse Event|1|||
146722299|NCT02566031|529152741|FG000|Overall Study|Lost to Follow-up|1|||
146722300|NCT02566031|529152742|FG001|Overall Study|Lost to Follow-up|1|||
146722301|NCT02277106|529152743|FG000|Stage 2|Adverse Event|0|||
146722302|NCT02277106|529152744|FG001|Stage 2|Adverse Event|0|||
146722303|NCT02277106|529152745|FG002|Stage 2|Adverse Event|1|||
146722304|NCT03031938|529152746|FG000|Overall Study|Death|1|||
146722305|NCT03031938|529152747|FG001|Overall Study|Death|0|||
146722306|NCT02479412|529152750|FG000|Overall Study|Adverse Event|0|||
146722307|NCT02479412|529152751|FG001|Overall Study|Adverse Event|0|||
146722308|NCT02479412|529152752|FG002|Overall Study|Adverse Event|1|||
146722309|NCT02479412|529152753|FG003|Overall Study|Adverse Event|0|||
146722310|NCT02479412|529152754|FG004|Overall Study|Adverse Event|0|||
146722311|NCT02479412|529152755|FG005|Overall Study|Adverse Event|0|||
146722312|NCT02479412|529152756|FG006|Overall Study|Adverse Event|0|||
146722313|NCT02479412|529152757|FG007|Overall Study|Adverse Event|0|||
146722314|NCT02479412|529152758|FG008|Overall Study|Adverse Event|0|||
146722315|NCT02479412|529152750|FG000|Overall Study|Study-specific withdrawal criteria|0|||
146722316|NCT02479412|529152751|FG001|Overall Study|Study-specific withdrawal criteria|0|||
146722317|NCT02479412|529152752|FG002|Overall Study|Study-specific withdrawal criteria|1|||
146722318|NCT02479412|529152753|FG003|Overall Study|Study-specific withdrawal criteria|1|||
146722319|NCT02479412|529152754|FG004|Overall Study|Study-specific withdrawal criteria|0|||
146722320|NCT02479412|529152755|FG005|Overall Study|Study-specific withdrawal criteria|0|||
146722321|NCT02479412|529152756|FG006|Overall Study|Study-specific withdrawal criteria|0|||
146722322|NCT02479412|529152757|FG007|Overall Study|Study-specific withdrawal criteria|1|||
146722323|NCT02479412|529152758|FG008|Overall Study|Study-specific withdrawal criteria|1|||
146722324|NCT02479412|529152750|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
146722325|NCT02479412|529152751|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
146722326|NCT02479412|529152752|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
146722327|NCT02479412|529152753|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
146722328|NCT02479412|529152754|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
146722329|NCT02479412|529152755|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
146722330|NCT02479412|529152756|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
146722331|NCT02479412|529152757|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
146722332|NCT02479412|529152758|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
146722333|NCT03667053|529152759|FG000|Overall Study|Withdrawal by Subject|1|||
146722334|NCT03667053|529152760|FG001|Overall Study|Withdrawal by Subject|0|||
146722335|NCT03667053|529152761|FG002|Overall Study|Withdrawal by Subject|0|||
146722336|NCT00515502|529152762|FG000|Treatment Period 1|Adverse Event|0|||
146722337|NCT00515502|529152763|FG001|Treatment Period 1|Adverse Event|0|||
146722338|NCT00515502|529152764|FG002|Treatment Period 1|Adverse Event|0|||
146722339|NCT00515502|529152765|FG003|Treatment Period 1|Adverse Event|0|||
146722340|NCT00515502|529152766|FG004|Treatment Period 1|Adverse Event|0|||
146722341|NCT00515502|529152767|FG005|Treatment Period 1|Adverse Event|0|||
146722342|NCT00515502|529152768|FG006|Treatment Period 1|Adverse Event|1|||
146722343|NCT00515502|529152769|FG007|Treatment Period 1|Adverse Event|0|||
146722344|NCT00515502|529152770|FG008|Treatment Period 1|Adverse Event|1|||
146722345|NCT00515502|529152771|FG009|Treatment Period 1|Adverse Event|0|||
146783315|NCT02783300|529379174|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783316|NCT02783300|529379175|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783317|NCT02783300|529379176|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
146783318|NCT02783300|529379177|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783319|NCT02783300|529379178|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783320|NCT02783300|529379179|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783321|NCT02783300|529379180|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783322|NCT02783300|529379181|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783323|NCT02783300|529379182|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783324|NCT02783300|529379183|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783325|NCT02783300|529379184|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783326|NCT02783300|529379185|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783327|NCT02783300|529379186|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783328|NCT02783300|529379187|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783329|NCT02783300|529379188|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783330|NCT02783300|529379189|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783331|NCT02783300|529379190|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783332|NCT02783300|529379191|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783333|NCT02783300|529379192|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783334|NCT02783300|529379193|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783335|NCT02783300|529379194|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783336|NCT02783300|529379195|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783337|NCT02783300|529379196|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146783338|NCT02783300|529379170|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783339|NCT02783300|529379171|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783340|NCT02783300|529379172|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783341|NCT02783300|529379173|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
146783342|NCT02783300|529379174|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783343|NCT02783300|529379175|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783344|NCT02783300|529379176|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783345|NCT02783300|529379177|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783346|NCT02783300|529379178|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783347|NCT02783300|529379179|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783348|NCT02783300|529379180|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783349|NCT02783300|529379181|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783350|NCT02783300|529379182|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783351|NCT02783300|529379183|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783352|NCT02783300|529379184|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783353|NCT02783300|529379185|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783354|NCT02783300|529379186|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146722346|NCT00515502|529152772|FG010|Treatment Period 1|Adverse Event|0|||
146722347|NCT00515502|529152773|FG011|Treatment Period 1|Adverse Event|1|||
146783355|NCT02783300|529379187|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783356|NCT02783300|529379188|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783357|NCT02783300|529379189|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146934433|NCT02151682|529917864|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
146934434|NCT02151682|529917865|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
146934435|NCT02151682|529917866|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
146934436|NCT02151682|529917861|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
146934437|NCT02151682|529917862|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
146934438|NCT02151682|529917863|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
146934439|NCT02151682|529917864|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
146934440|NCT02151682|529917865|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
146934441|NCT02151682|529917866|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
146934442|NCT02151682|529917861|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
146934443|NCT02151682|529917862|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
146934444|NCT02151682|529917863|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
146934445|NCT02151682|529917864|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
146934446|NCT02151682|529917865|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
146934447|NCT02151682|529917866|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
146934448|NCT02151682|529917861|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
146934449|NCT02151682|529917862|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
146934450|NCT02151682|529917863|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
146934451|NCT02151682|529917864|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
146934452|NCT02151682|529917865|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
146934453|NCT02151682|529917866|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
146934454|NCT02151682|529917861|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
146934455|NCT02151682|529917862|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
146934456|NCT02151682|529917863|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
146934457|NCT02151682|529917864|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
146934458|NCT02151682|529917865|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
146934459|NCT02151682|529917866|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
146934460|NCT02151682|529917861|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
146934461|NCT02151682|529917862|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
146934462|NCT02151682|529917863|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
146934463|NCT02151682|529917864|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
146934464|NCT02151682|529917865|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
146934465|NCT02151682|529917866|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
146934466|NCT02151682|529917861|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
146934467|NCT02151682|529917862|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
146934468|NCT02151682|529917863|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
146934469|NCT02151682|529917864|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
146934470|NCT02151682|529917865|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
146934471|NCT02151682|529917866|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
146934472|NCT02151682|529917861|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
146934473|NCT02151682|529917862|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
146934474|NCT02151682|529917863|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
146934475|NCT02151682|529917864|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
146722348|NCT00515502|529152762|FG000|Treatment Period 2|Adverse Event|0|||
146722349|NCT00515502|529152763|FG001|Treatment Period 2|Adverse Event|1|||
146722350|NCT00515502|529152764|FG002|Treatment Period 2|Adverse Event|0|||
146722351|NCT00515502|529152765|FG003|Treatment Period 2|Adverse Event|0|||
146722352|NCT00515502|529152766|FG004|Treatment Period 2|Adverse Event|0|||
146722353|NCT00515502|529152767|FG005|Treatment Period 2|Adverse Event|0|||
146722354|NCT00515502|529152768|FG006|Treatment Period 2|Adverse Event|0|||
146722355|NCT00515502|529152769|FG007|Treatment Period 2|Adverse Event|0|||
146934476|NCT02151682|529917865|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
146934477|NCT02151682|529917866|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
146934478|NCT02151682|529917861|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
146934479|NCT02151682|529917862|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
146934480|NCT02151682|529917863|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
146934481|NCT02151682|529917864|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
146722356|NCT00515502|529152770|FG008|Treatment Period 2|Adverse Event|0|||
146934482|NCT02151682|529917865|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
146934483|NCT02151682|529917866|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
146934484|NCT02151682|529917861|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
146934485|NCT02151682|529917862|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
146934486|NCT02151682|529917863|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
146934487|NCT02151682|529917864|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
146722357|NCT00515502|529152771|FG009|Treatment Period 2|Adverse Event|0|||
146722358|NCT00515502|529152772|FG010|Treatment Period 2|Adverse Event|0|||
146722359|NCT00515502|529152773|FG011|Treatment Period 2|Adverse Event|0|||
146722360|NCT02732938|529152777|FG000|Overall Study|Death|0|||
146722361|NCT02732938|529152778|FG001|Overall Study|Death|11|||
146722362|NCT02732938|529152779|FG002|Overall Study|Death|0|||
146722363|NCT02732938|529152777|FG000|Overall Study|Randomized but did not receive treatment|0|||
146722364|NCT02732938|529152778|FG001|Overall Study|Randomized but did not receive treatment|1|||
146722365|NCT02732938|529152779|FG002|Overall Study|Randomized but did not receive treatment|0|||
146722366|NCT02732938|529152777|FG000|Overall Study|Refused further follow-up|1|||
146722367|NCT02732938|529152778|FG001|Overall Study|Refused further follow-up|0|||
146722368|NCT02732938|529152779|FG002|Overall Study|Refused further follow-up|0|||
146722369|NCT02732938|529152777|FG000|Overall Study|Study terminated by sponsor|3|||
146722370|NCT02732938|529152778|FG001|Overall Study|Study terminated by sponsor|6|||
146722371|NCT02732938|529152779|FG002|Overall Study|Study terminated by sponsor|0|||
146722372|NCT01613248|529152780|FG000|Overall Study|Adverse Event|0|||
146722373|NCT01613248|529152781|FG001|Overall Study|Adverse Event|0|||
146722374|NCT01613248|529152782|FG002|Overall Study|Adverse Event|0|||
146722375|NCT01613248|529152783|FG003|Overall Study|Adverse Event|1|||
146722376|NCT01613248|529152784|FG004|Overall Study|Adverse Event|0|||
146722377|NCT01613248|529152785|FG005|Overall Study|Adverse Event|0|||
146722378|NCT01613248|529152780|FG000|Overall Study|Withdrawal by Subject|3|||
146722379|NCT01613248|529152781|FG001|Overall Study|Withdrawal by Subject|2|||
146722380|NCT01613248|529152782|FG002|Overall Study|Withdrawal by Subject|2|||
146722381|NCT01613248|529152783|FG003|Overall Study|Withdrawal by Subject|5|||
146722382|NCT01613248|529152784|FG004|Overall Study|Withdrawal by Subject|0|||
146722383|NCT01613248|529152785|FG005|Overall Study|Withdrawal by Subject|1|||
146722384|NCT01613248|529152780|FG000|Overall Study|Lost to Follow-up|5|||
146722385|NCT01613248|529152781|FG001|Overall Study|Lost to Follow-up|7|||
146722386|NCT01613248|529152782|FG002|Overall Study|Lost to Follow-up|4|||
146722387|NCT01613248|529152783|FG003|Overall Study|Lost to Follow-up|8|||
146722388|NCT01613248|529152784|FG004|Overall Study|Lost to Follow-up|4|||
146722389|NCT01613248|529152785|FG005|Overall Study|Lost to Follow-up|2|||
146722390|NCT01613248|529152780|FG000|Overall Study|Study Terminated by Sponsor|4|||
146722391|NCT01613248|529152781|FG001|Overall Study|Study Terminated by Sponsor|6|||
146722392|NCT01613248|529152782|FG002|Overall Study|Study Terminated by Sponsor|8|||
146722393|NCT01613248|529152783|FG003|Overall Study|Study Terminated by Sponsor|8|||
146722394|NCT01613248|529152784|FG004|Overall Study|Study Terminated by Sponsor|9|||
146722395|NCT01613248|529152785|FG005|Overall Study|Study Terminated by Sponsor|11|||
146722396|NCT01613248|529152780|FG000|Overall Study|Physician Decision|8|||
146722397|NCT01613248|529152781|FG001|Overall Study|Physician Decision|8|||
146722398|NCT01613248|529152782|FG002|Overall Study|Physician Decision|9|||
146722399|NCT01613248|529152783|FG003|Overall Study|Physician Decision|4|||
146722400|NCT01613248|529152784|FG004|Overall Study|Physician Decision|7|||
146722401|NCT01613248|529152785|FG005|Overall Study|Physician Decision|6|||
146722402|NCT01613248|529152780|FG000|Overall Study|Lack of Qualifying Event|9|||
146722403|NCT01613248|529152781|FG001|Overall Study|Lack of Qualifying Event|11|||
146722404|NCT01613248|529152782|FG002|Overall Study|Lack of Qualifying Event|10|||
146722405|NCT01613248|529152783|FG003|Overall Study|Lack of Qualifying Event|11|||
146722406|NCT01613248|529152784|FG004|Overall Study|Lack of Qualifying Event|15|||
146722407|NCT01613248|529152785|FG005|Overall Study|Lack of Qualifying Event|18|||
146722408|NCT01613248|529152780|FG000|Overall Study|Pregnancy|0|||
146722409|NCT01613248|529152781|FG001|Overall Study|Pregnancy|0|||
146722410|NCT01613248|529152782|FG002|Overall Study|Pregnancy|0|||
146722411|NCT01613248|529152783|FG003|Overall Study|Pregnancy|1|||
146722412|NCT01613248|529152784|FG004|Overall Study|Pregnancy|0|||
146722413|NCT01613248|529152785|FG005|Overall Study|Pregnancy|0|||
146722414|NCT03280121|529152787|FG000|Overall Study|Physician Decision|1|||
146722415|NCT03280121|529152787|FG000|Overall Study|Lost to Follow-up|1|||
146722416|NCT03280121|529152787|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
146722417|NCT03638141|529152797|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
146722418|NCT03996473|529152798|FG000|Treatment Assignment|Withdrawal by Subject|1|||
146722419|NCT03996473|529152798|FG000|Treatment Assignment|Progressive disease|6|||
146722420|NCT03996473|529152798|FG000|Treatment Assignment|Study drug never administered|1|||
146722421|NCT03996473|529152798|FG000|Active Follow-up|Death|1|||
146722422|NCT03996473|529152798|FG000|Long-term Follow-up|Death|5|||
146722423|NCT03759873|529152799|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
146722424|NCT03759873|529152800|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
146722425|NCT03759873|529152801|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
146722426|NCT03759873|529152802|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
146722427|NCT03759873|529152799|FG000|Overall Study|Moved outside eligible area|0|||
146722428|NCT03759873|529152800|FG001|Overall Study|Moved outside eligible area|2|||
146722429|NCT03759873|529152801|FG002|Overall Study|Moved outside eligible area|0|||
146722430|NCT03759873|529152802|FG003|Overall Study|Moved outside eligible area|0|||
146722431|NCT03759873|529152799|FG000|Overall Study|Withdrawal by Subject|0|||
146722432|NCT03759873|529152800|FG001|Overall Study|Withdrawal by Subject|0|||
146722433|NCT03759873|529152801|FG002|Overall Study|Withdrawal by Subject|1|||
146722434|NCT03759873|529152802|FG003|Overall Study|Withdrawal by Subject|0|||
146722435|NCT06116591|529152805|FG000|Overall Study|No longer met eligibility criteria|0|||
146722436|NCT06116591|529152806|FG001|Overall Study|No longer met eligibility criteria|1|||
146722437|NCT06116591|529152805|FG000|Overall Study|Other: Change in life situation|0|||
146722438|NCT06116591|529152806|FG001|Overall Study|Other: Change in life situation|1|||
146722439|NCT05585307|529152807|FG000|Overall Study|Lost to Follow-up|0|||
146722440|NCT05585307|529152808|FG001|Overall Study|Lost to Follow-up|0|||
146722441|NCT05585307|529152809|FG002|Overall Study|Lost to Follow-up|0|||
146722442|NCT05585307|529152810|FG003|Overall Study|Lost to Follow-up|0|||
146722443|NCT05585307|529152811|FG004|Overall Study|Lost to Follow-up|0|||
146722444|NCT05585307|529152812|FG005|Overall Study|Lost to Follow-up|0|||
146722445|NCT05585307|529152813|FG006|Overall Study|Lost to Follow-up|1|||
146722446|NCT05585307|529152814|FG007|Overall Study|Lost to Follow-up|0|||
146722447|NCT06476366|529152821|FG000|Overall Study|Lost to Follow-up|1|||
146722448|NCT06476366|529152822|FG001|Overall Study|Lost to Follow-up|3|||
146722449|NCT06476366|529152821|FG000|Overall Study|Adverse Event|1|||
146722450|NCT06476366|529152822|FG001|Overall Study|Adverse Event|0|||
146722451|NCT03449030|529152826|FG000|Overall Study|Withdrawal by Subject|0|||
146722452|NCT03449030|529152827|FG001|Overall Study|Withdrawal by Subject|0|||
146722453|NCT03449030|529152828|FG002|Overall Study|Withdrawal by Subject|0|||
146722454|NCT03449030|529152829|FG003|Overall Study|Withdrawal by Subject|1|||
146722455|NCT03449030|529152830|FG004|Overall Study|Withdrawal by Subject|1|||
146722456|NCT03449030|529152831|FG005|Overall Study|Withdrawal by Subject|1|||
146722457|NCT03449030|529152832|FG006|Overall Study|Withdrawal by Subject|1|||
146722458|NCT03449030|529152833|FG007|Overall Study|Withdrawal by Subject|2|||
146722459|NCT03449030|529152834|FG008|Overall Study|Withdrawal by Subject|0|||
146722460|NCT03449030|529152835|FG009|Overall Study|Withdrawal by Subject|0|||
146722461|NCT03449030|529152826|FG000|Overall Study|Symptomatic Deterioration|0|||
146722462|NCT03449030|529152827|FG001|Overall Study|Symptomatic Deterioration|1|||
146722463|NCT03449030|529152828|FG002|Overall Study|Symptomatic Deterioration|0|||
146722464|NCT03449030|529152829|FG003|Overall Study|Symptomatic Deterioration|0|||
146722465|NCT03449030|529152830|FG004|Overall Study|Symptomatic Deterioration|0|||
146722466|NCT03449030|529152831|FG005|Overall Study|Symptomatic Deterioration|1|||
146722467|NCT03449030|529152832|FG006|Overall Study|Symptomatic Deterioration|1|||
146722468|NCT03449030|529152833|FG007|Overall Study|Symptomatic Deterioration|0|||
146722469|NCT03449030|529152834|FG008|Overall Study|Symptomatic Deterioration|2|||
146722470|NCT03449030|529152835|FG009|Overall Study|Symptomatic Deterioration|0|||
146722471|NCT03449030|529152826|FG000|Overall Study|Progressive Disease|1|||
146722472|NCT03449030|529152827|FG001|Overall Study|Progressive Disease|0|||
146722473|NCT03449030|529152828|FG002|Overall Study|Progressive Disease|1|||
146722474|NCT03449030|529152829|FG003|Overall Study|Progressive Disease|4|||
146722475|NCT03449030|529152830|FG004|Overall Study|Progressive Disease|5|||
146722476|NCT03449030|529152831|FG005|Overall Study|Progressive Disease|3|||
146722477|NCT03449030|529152832|FG006|Overall Study|Progressive Disease|0|||
146722478|NCT03449030|529152833|FG007|Overall Study|Progressive Disease|1|||
146722479|NCT03449030|529152834|FG008|Overall Study|Progressive Disease|1|||
146722480|NCT03449030|529152835|FG009|Overall Study|Progressive Disease|1|||
146722481|NCT03449030|529152826|FG000|Overall Study|Adverse Event|0|||
146722482|NCT03449030|529152827|FG001|Overall Study|Adverse Event|0|||
146722483|NCT03449030|529152828|FG002|Overall Study|Adverse Event|0|||
146722484|NCT03449030|529152829|FG003|Overall Study|Adverse Event|0|||
146722485|NCT03449030|529152830|FG004|Overall Study|Adverse Event|0|||
146722486|NCT03449030|529152831|FG005|Overall Study|Adverse Event|2|||
146722487|NCT03449030|529152832|FG006|Overall Study|Adverse Event|0|||
146722488|NCT03449030|529152833|FG007|Overall Study|Adverse Event|0|||
146722489|NCT03449030|529152834|FG008|Overall Study|Adverse Event|0|||
146722490|NCT03449030|529152835|FG009|Overall Study|Adverse Event|0|||
146722491|NCT03449030|529152826|FG000|Overall Study|Death|0|||
146722492|NCT03449030|529152827|FG001|Overall Study|Death|0|||
146722493|NCT03449030|529152828|FG002|Overall Study|Death|0|||
146722494|NCT03449030|529152829|FG003|Overall Study|Death|0|||
146722495|NCT03449030|529152830|FG004|Overall Study|Death|1|||
146722496|NCT03449030|529152831|FG005|Overall Study|Death|0|||
146934488|NCT02151682|529917865|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
146934489|NCT02151682|529917866|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
146722497|NCT03449030|529152832|FG006|Overall Study|Death|0|||
146722498|NCT03449030|529152833|FG007|Overall Study|Death|0|||
146722499|NCT03449030|529152834|FG008|Overall Study|Death|0|||
146722500|NCT03449030|529152835|FG009|Overall Study|Death|0|||
146722501|NCT03943095|529152836|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
146722502|NCT03943095|529152837|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
146722503|NCT03943095|529152836|FG000|Overall Study|Withdrawal by Subject|1|||
146722504|NCT03943095|529152837|FG001|Overall Study|Withdrawal by Subject|0|||
146722505|NCT03034577|529152846|FG000|Overall Study|Withdrawal by Subject|6|||
146722506|NCT03034577|529152847|FG001|Overall Study|Withdrawal by Subject|9|||
146722507|NCT03034577|529152846|FG000|Overall Study|Lost to Follow-up|25|||
146722508|NCT03034577|529152847|FG001|Overall Study|Lost to Follow-up|26|||
146722509|NCT04177758|529152850|FG000|Overall Study|Lost to Follow-up|19|||
146722510|NCT04177758|529152851|FG001|Overall Study|Lost to Follow-up|11|||
146722511|NCT02653482|529152854|FG000|Overall Study|Death|1|||
146722512|NCT02653482|529152855|FG001|Overall Study|Death|1|||
146722513|NCT05374421|529152856|FG000|Overall Study|Withdrawal by Subject|3|||
146722514|NCT05374421|529152857|FG001|Overall Study|Withdrawal by Subject|4|||
146722515|NCT04370054|529152860|FG000|Treatment Phase|Lost to Follow-up|1|||
146722516|NCT04370054|529152860|FG000|Treatment Phase|Withdrawal by Subject|1|||
146722517|NCT04370054|529152860|FG000|Follow-Up Phase|Ongoing|75|||
146722518|NCT04657211|529152861|FG000|Overall Study|Withdrawal by Subject|21|||
146722519|NCT04657211|529152861|FG000|Overall Study|Lost to Follow-up|113|||
146722520|NCT04657211|529152861|FG000|Overall Study|Death|47|||
146722521|NCT04657211|529152861|FG000|Overall Study|Transfer to another institution|21|||
146722522|NCT04657211|529152861|FG000|Overall Study|Other|29|||
146722523|NCT01962493|529152864|FG000|Overall Study|Adverse Event|1|||
146722524|NCT01962493|529152865|FG001|Overall Study|Adverse Event|2|||
146722525|NCT01962493|529152864|FG000|Overall Study|Protocol Violation|0|||
146722526|NCT01962493|529152865|FG001|Overall Study|Protocol Violation|1|||
146722527|NCT01962493|529152864|FG000|Overall Study|Withdrawal by Subject|4|||
146722528|NCT01962493|529152865|FG001|Overall Study|Withdrawal by Subject|2|||
146722529|NCT06273774|529152866|FG000|Overall Study|Participant was out of state.|0|||
146722530|NCT06273774|529152867|FG001|Overall Study|Participant was out of state.|0|||
146722531|NCT06273774|529152868|FG002|Overall Study|Participant was out of state.|0|||
146722532|NCT06273774|529152869|FG003|Overall Study|Participant was out of state.|0|||
146722533|NCT06273774|529152870|FG004|Overall Study|Participant was out of state.|0|||
146722534|NCT06273774|529152871|FG005|Overall Study|Participant was out of state.|1|||
146722535|NCT06273774|529152866|FG000|Overall Study|Lost to Follow-up|0|||
146722536|NCT06273774|529152867|FG001|Overall Study|Lost to Follow-up|0|||
146722537|NCT06273774|529152868|FG002|Overall Study|Lost to Follow-up|0|||
146722538|NCT06273774|529152869|FG003|Overall Study|Lost to Follow-up|0|||
146722539|NCT06273774|529152870|FG004|Overall Study|Lost to Follow-up|1|||
146722540|NCT06273774|529152871|FG005|Overall Study|Lost to Follow-up|0|||
146722541|NCT00844857|529154773|FG000|Overall Study|Adverse Event|24|||
146722542|NCT00844857|529154774|FG001|Overall Study|Adverse Event|5|||
146722543|NCT00844857|529154773|FG000|Overall Study|Sponsor Decision|1|||
146722544|NCT00844857|529154774|FG001|Overall Study|Sponsor Decision|1|||
146722545|NCT00844857|529154773|FG000|Overall Study|Physician Decision|2|||
146722546|NCT00844857|529154774|FG001|Overall Study|Physician Decision|0|||
146722547|NCT00844857|529154773|FG000|Overall Study|Parent/Caregiver Decision|6|||
146722548|NCT00844857|529154774|FG001|Overall Study|Parent/Caregiver Decision|2|||
146722549|NCT00844857|529154773|FG000|Overall Study|Withdrawal by Subject|8|||
146722550|NCT00844857|529154774|FG001|Overall Study|Withdrawal by Subject|7|||
146722551|NCT00844857|529154773|FG000|Overall Study|Protocol Violation|6|||
146722552|NCT00844857|529154774|FG001|Overall Study|Protocol Violation|0|||
146722553|NCT00844857|529154773|FG000|Overall Study|Lack of Efficacy|5|||
146722554|NCT00844857|529154774|FG001|Overall Study|Lack of Efficacy|5|||
146722555|NCT00844857|529154773|FG000|Overall Study|Clinical Relapse|0|||
146722556|NCT00844857|529154774|FG001|Overall Study|Clinical Relapse|1|||
146722557|NCT00844857|529154773|FG000|Overall Study|Entry Criteria Not Met|0|||
146722558|NCT00844857|529154774|FG001|Overall Study|Entry Criteria Not Met|1|||
146722559|NCT00844857|529154773|FG000|Overall Study|Lost to Follow-up|2|||
146722560|NCT00844857|529154774|FG001|Overall Study|Lost to Follow-up|3|||
146722561|NCT00844857|529154773|FG000|Overall Study|Did Not Take Study Drug|3|||
146722562|NCT00844857|529154774|FG001|Overall Study|Did Not Take Study Drug|1|||
146722563|NCT00844857|529154773|FG000|Overall Study|Good Clinical Practice Violations|21|||
146722564|NCT00844857|529154774|FG001|Overall Study|Good Clinical Practice Violations|11|||
146722565|NCT00570674|529154775|FG000|Overall Study|Withdrawal by Subject|0|||
146722566|NCT00570674|529154776|FG001|Overall Study|Withdrawal by Subject|0|||
146722567|NCT00570674|529154777|FG002|Overall Study|Withdrawal by Subject|1|||
146722568|NCT00570674|529154778|FG003|Overall Study|Withdrawal by Subject|0|||
146722569|NCT00570674|529154779|FG004|Overall Study|Withdrawal by Subject|0|||
146722570|NCT00570674|529154780|FG005|Overall Study|Withdrawal by Subject|0|||
146722571|NCT00570674|529154781|FG006|Overall Study|Withdrawal by Subject|0|||
146722572|NCT01869491|529154783|FG000|Overall Study|Adverse Event|3|||
146722573|NCT01869491|529154784|FG001|Overall Study|Adverse Event|5|||
146722574|NCT01869491|529154783|FG000|Overall Study|Lack of Efficacy|0|||
146722575|NCT01869491|529154784|FG001|Overall Study|Lack of Efficacy|3|||
146722576|NCT01869491|529154783|FG000|Overall Study|Withdrawal by Subject|6|||
146722577|NCT01869491|529154784|FG001|Overall Study|Withdrawal by Subject|7|||
146722578|NCT01869491|529154783|FG000|Overall Study|Lost to Follow-up|11|||
146722579|NCT01869491|529154784|FG001|Overall Study|Lost to Follow-up|9|||
146722580|NCT01869491|529154783|FG000|Overall Study|No further need of investigational product|1|||
146722581|NCT01869491|529154784|FG001|Overall Study|No further need of investigational product|0|||
146722582|NCT01362140|529154785|FG000|Overall Study|Noncompliance|1|||
146722583|NCT01362140|529154786|FG001|Overall Study|Noncompliance|0|||
146722584|NCT01362140|529154785|FG000|Overall Study|Adverse Event|2|||
146722585|NCT01362140|529154786|FG001|Overall Study|Adverse Event|2|||
146722586|NCT01362140|529154785|FG000|Overall Study|Withdrawal by Subject|3|||
146722587|NCT01362140|529154786|FG001|Overall Study|Withdrawal by Subject|3|||
146722588|NCT01362140|529154785|FG000|Overall Study|Administrative Decision|0|||
146722589|NCT01362140|529154786|FG001|Overall Study|Administrative Decision|1|||
146722590|NCT01362140|529154785|FG000|Overall Study|Death|2|||
146722591|NCT01362140|529154786|FG001|Overall Study|Death|1|||
146722592|NCT01362140|529154785|FG000|Overall Study|Other|1|||
146722593|NCT01362140|529154786|FG001|Overall Study|Other|1|||
146722594|NCT01362140|529154785|FG000|Overall Study|Protocol-specified Criteria|1|||
146722595|NCT01362140|529154786|FG001|Overall Study|Protocol-specified Criteria|2|||
146722596|NCT01362140|529154785|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
146722597|NCT01362140|529154786|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
146722598|NCT01910129|529154789|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
146722599|NCT01910129|529154790|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
146722600|NCT01910129|529154791|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
146722601|NCT01910129|529154789|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
146722602|NCT01910129|529154790|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
146722603|NCT01910129|529154791|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
146722604|NCT02195986|529154792|FG000|Overall Study|Adverse Event|3|||
146722605|NCT02195986|529154793|FG001|Overall Study|Adverse Event|0|||
146722606|NCT02195986|529154794|FG002|Overall Study|Adverse Event|0|||
146722607|NCT02195986|529154792|FG000|Overall Study|Withdrawal by Subject|0|||
146722608|NCT02195986|529154793|FG001|Overall Study|Withdrawal by Subject|3|||
146722609|NCT02195986|529154794|FG002|Overall Study|Withdrawal by Subject|0|||
146722610|NCT02195986|529154792|FG000|Overall Study|Family Emergency|0|||
146722611|NCT02195986|529154793|FG001|Overall Study|Family Emergency|0|||
146722612|NCT02195986|529154794|FG002|Overall Study|Family Emergency|1|||
146722613|NCT02195986|529154792|FG000|Overall Study|Protocol Violation|0|||
146722614|NCT02195986|529154793|FG001|Overall Study|Protocol Violation|1|||
146722615|NCT02195986|529154794|FG002|Overall Study|Protocol Violation|1|||
146722616|NCT02195986|529154792|FG000|Overall Study|Non-compliance|0|||
146722617|NCT02195986|529154793|FG001|Overall Study|Non-compliance|1|||
146722618|NCT02195986|529154794|FG002|Overall Study|Non-compliance|0|||
146722619|NCT00319098|529154795|FG000|Overall Study|Serious adverse event|3|||
146722620|NCT00319098|529154796|FG001|Overall Study|Serious adverse event|0|||
146722621|NCT00319098|529154795|FG000|Overall Study|Adverse Event|20|||
146722622|NCT00319098|529154796|FG001|Overall Study|Adverse Event|1|||
146722623|NCT00319098|529154795|FG000|Overall Study|Withdrawal by Subject|37|||
146722624|NCT00319098|529154796|FG001|Overall Study|Withdrawal by Subject|8|||
146722625|NCT00319098|529154795|FG000|Overall Study|Migrated/moved from study area|2|||
146722626|NCT00319098|529154796|FG001|Overall Study|Migrated/moved from study area|1|||
146722627|NCT00319098|529154795|FG000|Overall Study|Lost to Follow-up|37|||
146722628|NCT00319098|529154796|FG001|Overall Study|Lost to Follow-up|13|||
146722629|NCT00319098|529154795|FG000|Overall Study|Others|33|||
146722630|NCT00319098|529154796|FG001|Overall Study|Others|8|||
146722631|NCT00319098|529154795|FG000|Overall Study|Protocol Violation|3|||
146722632|NCT00319098|529154796|FG001|Overall Study|Protocol Violation|1|||
146722633|NCT02834780|529154797|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
146722634|NCT02834780|529154798|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
146722635|NCT02834780|529154799|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
146722636|NCT02834780|529154800|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
146722637|NCT02834780|529154801|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
146722638|NCT02834780|529154802|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
146722639|NCT02834780|529154803|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
146722640|NCT02834780|529154804|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
146722641|NCT02834780|529154805|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
146722642|NCT02834780|529154806|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
146722643|NCT02834780|529154807|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
146722644|NCT02834780|529154808|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
146722645|NCT02834780|529154809|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
146722646|NCT02834780|529154797|FG000|Overall Study|Withdrawal by Subject|0|||
146722647|NCT02834780|529154798|FG001|Overall Study|Withdrawal by Subject|0|||
146722648|NCT02834780|529154799|FG002|Overall Study|Withdrawal by Subject|1|||
146722649|NCT02834780|529154800|FG003|Overall Study|Withdrawal by Subject|0|||
146722650|NCT02834780|529154801|FG004|Overall Study|Withdrawal by Subject|0|||
146722651|NCT02834780|529154802|FG005|Overall Study|Withdrawal by Subject|0|||
146722652|NCT02834780|529154803|FG006|Overall Study|Withdrawal by Subject|0|||
146722653|NCT02834780|529154804|FG007|Overall Study|Withdrawal by Subject|0|||
146722654|NCT02834780|529154805|FG008|Overall Study|Withdrawal by Subject|0|||
146722655|NCT02834780|529154806|FG009|Overall Study|Withdrawal by Subject|0|||
146722656|NCT02834780|529154807|FG010|Overall Study|Withdrawal by Subject|1|||
146722657|NCT02834780|529154808|FG011|Overall Study|Withdrawal by Subject|0|||
146722658|NCT02834780|529154809|FG012|Overall Study|Withdrawal by Subject|0|||
146783358|NCT02783300|529379190|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783359|NCT02783300|529379191|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783360|NCT02783300|529379192|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146722659|NCT02834780|529154797|FG000|Overall Study|Adverse Event|0|||
146783361|NCT02783300|529379193|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783362|NCT02783300|529379194|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146981356|NCT01208402|530093876|FG000|Overall Study|Withdrawal by Subject|1|||
146981357|NCT01208402|530093877|FG001|Overall Study|Withdrawal by Subject|0|||
146981358|NCT01571635|530093878|FG000|Overall Study|Adverse Event|3|||
146722660|NCT02834780|529154798|FG001|Overall Study|Adverse Event|0|||
146722661|NCT02834780|529154799|FG002|Overall Study|Adverse Event|0|||
146722662|NCT02834780|529154800|FG003|Overall Study|Adverse Event|0|||
146722663|NCT02834780|529154801|FG004|Overall Study|Adverse Event|1|||
146722664|NCT02834780|529154802|FG005|Overall Study|Adverse Event|0|||
146722665|NCT02834780|529154803|FG006|Overall Study|Adverse Event|1|||
146722666|NCT02834780|529154804|FG007|Overall Study|Adverse Event|1|||
146722667|NCT02834780|529154805|FG008|Overall Study|Adverse Event|0|||
146722668|NCT02834780|529154806|FG009|Overall Study|Adverse Event|2|||
146722669|NCT02834780|529154807|FG010|Overall Study|Adverse Event|0|||
146722670|NCT02834780|529154808|FG011|Overall Study|Adverse Event|3|||
146722671|NCT02834780|529154809|FG012|Overall Study|Adverse Event|2|||
146722672|NCT02834780|529154797|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
146722673|NCT02834780|529154798|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
146722674|NCT02834780|529154799|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
146722675|NCT02834780|529154800|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
146722676|NCT02834780|529154801|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
146722677|NCT02834780|529154802|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
146722678|NCT02834780|529154803|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
146722679|NCT02834780|529154804|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
146722680|NCT02834780|529154805|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
146722681|NCT02834780|529154806|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
146722682|NCT02834780|529154807|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
146722683|NCT02834780|529154808|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
146722684|NCT02834780|529154809|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
146722685|NCT02834780|529154797|FG000|Overall Study|Other|1|||
146722686|NCT02834780|529154798|FG001|Overall Study|Other|0|||
146722687|NCT02834780|529154799|FG002|Overall Study|Other|1|||
146722688|NCT02834780|529154800|FG003|Overall Study|Other|2|||
146722689|NCT02834780|529154801|FG004|Overall Study|Other|0|||
146722690|NCT02834780|529154802|FG005|Overall Study|Other|0|||
146722691|NCT02834780|529154803|FG006|Overall Study|Other|0|||
146722692|NCT02834780|529154804|FG007|Overall Study|Other|0|||
146722693|NCT02834780|529154805|FG008|Overall Study|Other|0|||
146722694|NCT02834780|529154806|FG009|Overall Study|Other|0|||
146722695|NCT02834780|529154807|FG010|Overall Study|Other|0|||
146722696|NCT02834780|529154808|FG011|Overall Study|Other|0|||
146722697|NCT02834780|529154809|FG012|Overall Study|Other|1|||
146722698|NCT03150056|529154810|FG000|Overall Study|Withdrawal by Subject|0|||
146722699|NCT03150056|529154811|FG001|Overall Study|Withdrawal by Subject|0|||
146722700|NCT03150056|529154812|FG002|Overall Study|Withdrawal by Subject|0|||
146722701|NCT03150056|529154813|FG003|Overall Study|Withdrawal by Subject|0|||
146722702|NCT03150056|529154814|FG004|Overall Study|Withdrawal by Subject|0|||
146722703|NCT03150056|529154815|FG005|Overall Study|Withdrawal by Subject|2|||
146722704|NCT03150056|529154810|FG000|Overall Study|Study terminated by Sponsor|1|||
146722705|NCT03150056|529154811|FG001|Overall Study|Study terminated by Sponsor|3|||
146722706|NCT03150056|529154812|FG002|Overall Study|Study terminated by Sponsor|1|||
146722707|NCT03150056|529154813|FG003|Overall Study|Study terminated by Sponsor|1|||
146722708|NCT03150056|529154814|FG004|Overall Study|Study terminated by Sponsor|5|||
146722709|NCT03150056|529154815|FG005|Overall Study|Study terminated by Sponsor|6|||
146722710|NCT03150056|529154810|FG000|Overall Study|Death|9|||
146722711|NCT03150056|529154811|FG001|Overall Study|Death|2|||
146722712|NCT03150056|529154812|FG002|Overall Study|Death|2|||
146722713|NCT03150056|529154813|FG003|Overall Study|Death|7|||
146783363|NCT02783300|529379195|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783364|NCT02783300|529379196|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146783365|NCT02783300|529379170|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
146783366|NCT02783300|529379171|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
146783367|NCT02783300|529379172|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
146783368|NCT02783300|529379173|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
146783369|NCT02783300|529379174|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
146783370|NCT02783300|529379175|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
146722714|NCT03150056|529154814|FG004|Overall Study|Death|8|||
146722715|NCT03150056|529154815|FG005|Overall Study|Death|10|||
146722716|NCT00965523|529154816|FG000|Study 221|Progressive Disease|4|||
146722717|NCT00965523|529154816|FG000|Study 221|Physician Decision|3|||
146722718|NCT00965523|529154816|FG000|Study 224|Progressive Disease|5|||
146722719|NCT00965523|529154816|FG000|Study 224|Physician Decision|1|||
146783371|NCT02783300|529379176|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
146722720|NCT02415400|529154817|FG000|Overall Study|Adverse Event|0|||
146722721|NCT02415400|529154818|FG001|Overall Study|Adverse Event|1|||
146722722|NCT02415400|529154819|FG002|Overall Study|Adverse Event|1|||
146722723|NCT02415400|529154820|FG003|Overall Study|Adverse Event|2|||
146722724|NCT02415400|529154817|FG000|Overall Study|Participant request to stop therapy|4|||
146722725|NCT02415400|529154818|FG001|Overall Study|Participant request to stop therapy|3|||
146722726|NCT02415400|529154819|FG002|Overall Study|Participant request to stop therapy|8|||
146722727|NCT02415400|529154820|FG003|Overall Study|Participant request to stop therapy|6|||
146722728|NCT02415400|529154817|FG000|Overall Study|Participant withdrew consent|14|||
146722729|NCT02415400|529154818|FG001|Overall Study|Participant withdrew consent|12|||
146722730|NCT02415400|529154819|FG002|Overall Study|Participant withdrew consent|30|||
146722731|NCT02415400|529154820|FG003|Overall Study|Participant withdrew consent|21|||
146722732|NCT02415400|529154817|FG000|Overall Study|Death|39|||
146722733|NCT02415400|529154818|FG001|Overall Study|Death|41|||
146722734|NCT02415400|529154819|FG002|Overall Study|Death|35|||
146722735|NCT02415400|529154820|FG003|Overall Study|Death|42|||
146722736|NCT02415400|529154817|FG000|Overall Study|Lost to Follow-up|3|||
146722737|NCT02415400|529154818|FG001|Overall Study|Lost to Follow-up|3|||
146722738|NCT02415400|529154819|FG002|Overall Study|Lost to Follow-up|2|||
146722739|NCT02415400|529154820|FG003|Overall Study|Lost to Follow-up|5|||
146722740|NCT02415400|529154817|FG000|Overall Study|Poor/Non-Compliance|0|||
146722741|NCT02415400|529154818|FG001|Overall Study|Poor/Non-Compliance|1|||
146722742|NCT02415400|529154819|FG002|Overall Study|Poor/Non-Compliance|3|||
146722743|NCT02415400|529154820|FG003|Overall Study|Poor/Non-Compliance|4|||
146722744|NCT02415400|529154817|FG000|Overall Study|Participant no longer meets criteria|2|||
146722745|NCT02415400|529154818|FG001|Overall Study|Participant no longer meets criteria|0|||
146722746|NCT02415400|529154819|FG002|Overall Study|Participant no longer meets criteria|0|||
146722747|NCT02415400|529154820|FG003|Overall Study|Participant no longer meets criteria|1|||
146722748|NCT02415400|529154817|FG000|Overall Study|Participant doesn't answer phone|1|||
146722749|NCT02415400|529154818|FG001|Overall Study|Participant doesn't answer phone|0|||
146722750|NCT02415400|529154819|FG002|Overall Study|Participant doesn't answer phone|0|||
146722751|NCT02415400|529154820|FG003|Overall Study|Participant doesn't answer phone|0|||
146722752|NCT02415400|529154817|FG000|Overall Study|Participant wanted home visits|1|||
146722753|NCT02415400|529154818|FG001|Overall Study|Participant wanted home visits|0|||
146722754|NCT02415400|529154819|FG002|Overall Study|Participant wanted home visits|0|||
146722755|NCT02415400|529154820|FG003|Overall Study|Participant wanted home visits|0|||
146722756|NCT02415400|529154817|FG000|Overall Study|Randomized in error|2|||
146722757|NCT02415400|529154818|FG001|Overall Study|Randomized in error|0|||
146722758|NCT02415400|529154819|FG002|Overall Study|Randomized in error|0|||
146722759|NCT02415400|529154820|FG003|Overall Study|Randomized in error|0|||
146722760|NCT02415400|529154817|FG000|Overall Study|No study drug on site|0|||
146722761|NCT02415400|529154818|FG001|Overall Study|No study drug on site|1|||
146722762|NCT02415400|529154819|FG002|Overall Study|No study drug on site|0|||
146722763|NCT02415400|529154820|FG003|Overall Study|No study drug on site|0|||
146722764|NCT02415400|529154817|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
146722765|NCT02415400|529154818|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
146722766|NCT02415400|529154819|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
146722767|NCT02415400|529154820|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
146722768|NCT02415400|529154817|FG000|Overall Study|Coagulation values cannot be set|0|||
146722769|NCT02415400|529154818|FG001|Overall Study|Coagulation values cannot be set|0|||
146722770|NCT02415400|529154819|FG002|Overall Study|Coagulation values cannot be set|1|||
146722771|NCT02415400|529154820|FG003|Overall Study|Coagulation values cannot be set|0|||
146722772|NCT02415400|529154817|FG000|Overall Study|State regulations prevent participation|0|||
146722773|NCT02415400|529154818|FG001|Overall Study|State regulations prevent participation|0|||
146722774|NCT02415400|529154819|FG002|Overall Study|State regulations prevent participation|1|||
146722775|NCT02415400|529154820|FG003|Overall Study|State regulations prevent participation|0|||
146722776|NCT02415400|529154817|FG000|Overall Study|Poor treatment monitoring|0|||
146722777|NCT02415400|529154818|FG001|Overall Study|Poor treatment monitoring|0|||
146722778|NCT02415400|529154819|FG002|Overall Study|Poor treatment monitoring|1|||
146722779|NCT02415400|529154820|FG003|Overall Study|Poor treatment monitoring|0|||
146722780|NCT02415400|529154817|FG000|Overall Study|Participant in jail|0|||
146722781|NCT02415400|529154818|FG001|Overall Study|Participant in jail|0|||
146722782|NCT02415400|529154819|FG002|Overall Study|Participant in jail|1|||
146934490|NCT02151682|529917861|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
146934491|NCT02151682|529917862|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
146934492|NCT02151682|529917863|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
146722783|NCT02415400|529154820|FG003|Overall Study|Participant in jail|0|||
146722784|NCT02415400|529154817|FG000|Overall Study|Investigator decision|0|||
146722785|NCT02415400|529154818|FG001|Overall Study|Investigator decision|0|||
146722786|NCT02415400|529154819|FG002|Overall Study|Investigator decision|1|||
146722787|NCT02415400|529154820|FG003|Overall Study|Investigator decision|1|||
146722788|NCT02415400|529154817|FG000|Overall Study|Site closure; participant won't transfer|0|||
146722789|NCT02415400|529154818|FG001|Overall Study|Site closure; participant won't transfer|0|||
146722790|NCT02415400|529154819|FG002|Overall Study|Site closure; participant won't transfer|0|||
146722791|NCT02415400|529154820|FG003|Overall Study|Site closure; participant won't transfer|1|||
146722792|NCT02270450|529154825|FG000|Overall Study|Refusal unrelated to adverse event|3|||
146722793|NCT02270450|529154826|FG001|Overall Study|Refusal unrelated to adverse event|1|||
146722794|NCT02270450|529154827|FG002|Overall Study|Refusal unrelated to adverse event|5|||
146722795|NCT02270450|529154828|FG003|Overall Study|Refusal unrelated to adverse event|14|||
146722796|NCT02270450|529154825|FG000|Overall Study|Progression/relapse|1|||
146722797|NCT02270450|529154826|FG001|Overall Study|Progression/relapse|2|||
146722798|NCT02270450|529154827|FG002|Overall Study|Progression/relapse|4|||
146722799|NCT02270450|529154828|FG003|Overall Study|Progression/relapse|9|||
146722800|NCT02270450|529154825|FG000|Overall Study|Death|19|||
146722801|NCT02270450|529154826|FG001|Overall Study|Death|19|||
146722802|NCT02270450|529154827|FG002|Overall Study|Death|31|||
146722803|NCT02270450|529154828|FG003|Overall Study|Death|59|||
146722804|NCT02363738|529154829|FG000|Overall Study|Adverse Event|5|||
146722805|NCT02363738|529154830|FG001|Overall Study|Adverse Event|2|||
146722806|NCT02363738|529154829|FG000|Overall Study|Lack of Efficacy|1|||
146722807|NCT02363738|529154830|FG001|Overall Study|Lack of Efficacy|2|||
146722808|NCT02363738|529154829|FG000|Overall Study|Lost to Follow-up|2|||
146722809|NCT02363738|529154830|FG001|Overall Study|Lost to Follow-up|1|||
146722810|NCT02187991|529154832|FG000|Overall Study|Adverse Event|13|||
146722811|NCT02187991|529154833|FG001|Overall Study|Adverse Event|14|||
146722812|NCT02187991|529154834|FG002|Overall Study|Adverse Event|3|||
146722813|NCT02187991|529154835|FG003|Overall Study|Adverse Event|2|||
146722814|NCT02187991|529154832|FG000|Overall Study|Withdrawal by Subject|9|||
146722815|NCT02187991|529154833|FG001|Overall Study|Withdrawal by Subject|6|||
146722816|NCT02187991|529154834|FG002|Overall Study|Withdrawal by Subject|3|||
146722817|NCT02187991|529154835|FG003|Overall Study|Withdrawal by Subject|2|||
146722818|NCT02187991|529154832|FG000|Overall Study|Physician Decision|4|||
146722819|NCT02187991|529154833|FG001|Overall Study|Physician Decision|4|||
146722820|NCT02187991|529154834|FG002|Overall Study|Physician Decision|0|||
146722821|NCT02187991|529154835|FG003|Overall Study|Physician Decision|2|||
146722822|NCT02187991|529154832|FG000|Overall Study|Other, unrelated complication|7|||
146722823|NCT02187991|529154833|FG001|Overall Study|Other, unrelated complication|1|||
146722824|NCT02187991|529154834|FG002|Overall Study|Other, unrelated complication|1|||
146722825|NCT02187991|529154835|FG003|Overall Study|Other, unrelated complication|2|||
146722826|NCT02187991|529154832|FG000|Overall Study|Death|1|||
146722827|NCT02187991|529154833|FG001|Overall Study|Death|3|||
146722828|NCT02187991|529154834|FG002|Overall Study|Death|0|||
146722829|NCT02187991|529154835|FG003|Overall Study|Death|0|||
146722830|NCT01392560|529154836|FG000|Overall Study|Adverse Event|2|||
146722831|NCT01392560|529154836|FG000|Overall Study|not entered|8|||
146722832|NCT01392560|529154836|FG000|Overall Study|discontinued during placebo run-in|2|||
146722833|NCT01939028|529154839|FG000|Overall Study|Withdrawal by Subject|5|||
146722834|NCT01939028|529154839|FG000|Overall Study|Physician Decision|7|||
146722835|NCT02081846|529154840|FG000|Overall Study|Withdrawal by Subject|1|||
146722836|NCT02081846|529154841|FG001|Overall Study|Withdrawal by Subject|0|||
146722837|NCT02081846|529154840|FG000|Overall Study|invalid consent|1|||
146722838|NCT02081846|529154841|FG001|Overall Study|invalid consent|0|||
146722839|NCT00322348|529154845|FG000|Overall Study|Adverse Event|0|||
146722840|NCT00322348|529154846|FG001|Overall Study|Adverse Event|1|||
146722841|NCT00322348|529154845|FG000|Overall Study|Withdrawal by Subject|1|||
146722842|NCT00322348|529154846|FG001|Overall Study|Withdrawal by Subject|4|||
146722843|NCT00322348|529154845|FG000|Overall Study|Lost to Follow-up|1|||
146722844|NCT00322348|529154846|FG001|Overall Study|Lost to Follow-up|0|||
146722845|NCT00322348|529154845|FG000|Overall Study|Death|0|||
146722846|NCT00322348|529154846|FG001|Overall Study|Death|2|||
146722847|NCT00322348|529154845|FG000|Overall Study|Disease Progression|30|||
146722848|NCT00322348|529154846|FG001|Overall Study|Disease Progression|25|||
146722849|NCT00322348|529154845|FG000|Overall Study|Reasons not specified|5|||
146722850|NCT00322348|529154846|FG001|Overall Study|Reasons not specified|1|||
146722851|NCT00936858|529154848|FG000|Overall Study|Death|3|||
146722852|NCT00936858|529154848|FG000|Overall Study|Progression|29|||
146722853|NCT00936858|529154848|FG000|Overall Study|Withdrawal by Subject|5|||
146722854|NCT00936858|529154848|FG000|Overall Study|Adverse Event|1|||
146722855|NCT00936858|529154848|FG000|Overall Study|Physician Decision|7|||
146722856|NCT00936858|529154848|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
146722857|NCT00936858|529154848|FG000|Overall Study|Lost to Follow-up|1|||
146722858|NCT00989287|529154860|FG000|Overall Study|Adverse Event|1|||
146722859|NCT00989287|529154861|FG001|Overall Study|Adverse Event|0|||
146722860|NCT00989287|529154860|FG000|Overall Study|Lost to Follow-up|0|||
146722861|NCT00989287|529154861|FG001|Overall Study|Lost to Follow-up|1|||
146722862|NCT00092131|529154862|FG000|Treatment Period I|Adverse Event|1|||
146722863|NCT00092131|529154863|FG001|Treatment Period I|Adverse Event|0|||
146722864|NCT00092131|529154862|FG000|Treatment Period II|Adverse Event|0|||
146722865|NCT00092131|529154863|FG001|Treatment Period II|Adverse Event|1|||
146722866|NCT02341417|529154864|FG000|Overall Study|Withdrawal by Subject|0|||
146722867|NCT02341417|529154865|FG001|Overall Study|Withdrawal by Subject|2|||
146722868|NCT02341417|529154866|FG002|Overall Study|Withdrawal by Subject|0|||
146722869|NCT02341417|529154864|FG000|Overall Study|Decision by sponsor|2|||
146722870|NCT02341417|529154865|FG001|Overall Study|Decision by sponsor|0|||
146722871|NCT02341417|529154866|FG002|Overall Study|Decision by sponsor|0|||
146783372|NCT02783300|529379177|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
146783373|NCT02783300|529379178|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
146783374|NCT02783300|529379179|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
146783375|NCT02783300|529379180|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
146783376|NCT02783300|529379181|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
146783377|NCT02783300|529379182|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
146783378|NCT02783300|529379183|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
146783379|NCT02783300|529379184|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
146783380|NCT02783300|529379185|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
146783381|NCT02783300|529379186|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
146783382|NCT02783300|529379187|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
146783383|NCT02783300|529379188|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
146783384|NCT02783300|529379189|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
146783385|NCT02783300|529379190|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
146783386|NCT02783300|529379191|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
146783387|NCT02783300|529379192|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
146783388|NCT02783300|529379193|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
146783389|NCT02783300|529379194|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
146783390|NCT02783300|529379195|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
146783391|NCT02783300|529379196|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
146783392|NCT02783300|529379170|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783393|NCT02783300|529379171|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783394|NCT02783300|529379172|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783395|NCT02783300|529379173|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783396|NCT02783300|529379174|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783397|NCT02783300|529379175|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783398|NCT02783300|529379176|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
146783399|NCT02783300|529379177|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783400|NCT02783300|529379178|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783401|NCT02783300|529379179|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783402|NCT02783300|529379180|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783403|NCT02783300|529379181|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783404|NCT02783300|529379182|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
146783405|NCT02783300|529379183|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783406|NCT02783300|529379184|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783407|NCT02783300|529379185|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783408|NCT02783300|529379186|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783409|NCT02783300|529379187|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783410|NCT02783300|529379188|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783411|NCT02783300|529379189|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783412|NCT02783300|529379190|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783413|NCT02783300|529379191|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783414|NCT02783300|529379192|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783415|NCT02783300|529379193|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783416|NCT02783300|529379194|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783417|NCT02783300|529379195|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783418|NCT02783300|529379196|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146783419|NCT02783300|529379170|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783420|NCT02783300|529379171|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783421|NCT02783300|529379172|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783422|NCT02783300|529379173|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783423|NCT02783300|529379174|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
146783424|NCT02783300|529379175|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783425|NCT02783300|529379176|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
146783426|NCT02783300|529379177|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783427|NCT02783300|529379178|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783428|NCT02783300|529379179|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
146783429|NCT02783300|529379180|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783430|NCT02783300|529379181|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783431|NCT02783300|529379182|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
146783432|NCT02783300|529379183|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783433|NCT02783300|529379184|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783434|NCT02783300|529379185|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783435|NCT02783300|529379186|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783436|NCT02783300|529379187|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783437|NCT02783300|529379188|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783438|NCT02783300|529379189|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146722872|NCT02341417|529154864|FG000|Overall Study|Death|0|||
146722873|NCT02341417|529154865|FG001|Overall Study|Death|0|||
146722874|NCT02341417|529154866|FG002|Overall Study|Death|1|||
146934493|NCT02151682|529917864|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
146934494|NCT02151682|529917865|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
146934495|NCT02151682|529917866|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
146934496|NCT02151682|529917861|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
146934497|NCT02151682|529917862|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
146934498|NCT02151682|529917863|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
146934499|NCT02151682|529917864|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
146934500|NCT02151682|529917865|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
146934501|NCT02151682|529917866|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
146934502|NCT02151682|529917861|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
146934503|NCT02151682|529917862|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
146934504|NCT02151682|529917863|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
146934505|NCT02151682|529917864|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
146934506|NCT02151682|529917865|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
146934507|NCT02151682|529917866|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
146934508|NCT01522443|529917867|FG000|Overall Study|No longer receiving clinical benefit|36|||
146934509|NCT01522443|529917868|FG001|Overall Study|No longer receiving clinical benefit|28|||
146934510|NCT01522443|529917867|FG000|Overall Study|Adverse Event|10|||
146934511|NCT01522443|529917868|FG001|Overall Study|Adverse Event|15|||
146934512|NCT01522443|529917867|FG000|Overall Study|Withdrawal by Subject|5|||
146934513|NCT01522443|529917868|FG001|Overall Study|Withdrawal by Subject|8|||
146934514|NCT01522443|529917867|FG000|Overall Study|No study treatment given|1|||
146934515|NCT01522443|529917868|FG001|Overall Study|No study treatment given|1|||
146934516|NCT01522443|529917867|FG000|Overall Study|Other|1|||
146934517|NCT01522443|529917868|FG001|Overall Study|Other|3|||
146934518|NCT00290589|529917869|FG000|Overall Study|Lost to Follow-up|2|||
146934519|NCT00290589|529917870|FG001|Overall Study|Lost to Follow-up|2|||
146934520|NCT00555568|529917871|FG000|Overall Study|Lost to Follow-up|26|||
146934521|NCT00555568|529917872|FG001|Overall Study|Lost to Follow-up|16|||
146934522|NCT00555568|529917873|FG002|Overall Study|Lost to Follow-up|16|||
146934523|NCT01588353|529917874|FG000|Step2|Withdrawal by Subject|0|||
146934524|NCT01588353|529917875|FG001|Step2|Withdrawal by Subject|1|||
146934525|NCT01588353|529917876|FG002|Step2|Withdrawal by Subject|0|||
146934526|NCT01588353|529917874|FG000|Step3|Adverse Event|0|||
146934527|NCT01588353|529917875|FG001|Step3|Adverse Event|0|||
146934528|NCT01588353|529917876|FG002|Step3|Adverse Event|2|||
146934529|NCT01409993|529917877|FG000|Overall Study|Adverse Event|4|||
146934530|NCT01409993|529917878|FG001|Overall Study|Adverse Event|4|||
146934531|NCT01409993|529917879|FG002|Overall Study|Adverse Event|3|||
146934532|NCT01409993|529917880|FG003|Overall Study|Adverse Event|1|||
146934533|NCT01409993|529917877|FG000|Overall Study|Withdrawal by Subject|0|||
146934534|NCT01409993|529917878|FG001|Overall Study|Withdrawal by Subject|0|||
146934535|NCT01409993|529917879|FG002|Overall Study|Withdrawal by Subject|0|||
146934536|NCT01409993|529917880|FG003|Overall Study|Withdrawal by Subject|4|||
146934537|NCT01409993|529917877|FG000|Overall Study|Lost to Follow-up|0|||
146934538|NCT01409993|529917878|FG001|Overall Study|Lost to Follow-up|1|||
146934539|NCT01409993|529917879|FG002|Overall Study|Lost to Follow-up|0|||
146934540|NCT01409993|529917880|FG003|Overall Study|Lost to Follow-up|0|||
146934541|NCT02677220|529917881|FG000|Overall Study|Adverse Event|1|||
146934542|NCT00965146|529917882|FG000|Overall Study|Death|7|||
146934543|NCT00965146|529917882|FG000|Overall Study|Lost to Follow-up|22|||
146934544|NCT00965146|529917882|FG000|Overall Study|Withdrawal by Subject|17|||
146934545|NCT00965146|529917882|FG000|Overall Study|Unable to return|1|||
146934546|NCT00965146|529917882|FG000|Overall Study|Unwilling to return|11|||
146934547|NCT00965146|529917882|FG000|Overall Study|Intercurrent illness|1|||
146934548|NCT00965146|529917882|FG000|Overall Study|Revision / Removal of Study Implant|6|||
146722875|NCT01857531|529154880|FG000|Overall Study|Withdrawal by Subject|4|||
146934549|NCT00965146|529917882|FG000|Overall Study|Overall Study Termination|145|||
146934550|NCT05067452|529917883|FG000|Overall Study|Lost to Follow-up|0|||
146934551|NCT05067452|529917884|FG001|Overall Study|Lost to Follow-up|4|||
146934552|NCT00067470|529917885|FG000|Overall Study|Withdrawal by Subject|0|||
146934553|NCT00067470|529917886|FG001|Overall Study|Withdrawal by Subject|1|||
146934554|NCT01135017|529917887|FG000|Overall Study|Adverse Event|3|||
146934555|NCT01135017|529917888|FG001|Overall Study|Adverse Event|8|||
146934556|NCT01135017|529917887|FG000|Overall Study|Other than above|3|||
146934557|NCT01135017|529917888|FG001|Overall Study|Other than above|4|||
146934558|NCT01148693|529917889|FG000|Overall Study|Attempts for cannulation were failed|13|||
146934559|NCT01148693|529917890|FG001|Overall Study|Attempts for cannulation were failed|10|||
146934560|NCT01504971|529917892|FG000|Overall Study|Physician Decision|13|||
146934561|NCT00050622|529917893|FG000|Overall Study|Adverse Event|1|||
146934562|NCT00936117|529917896|FG000|Overall Study|Adverse Event|7|||
146934563|NCT00936117|529917896|FG000|Overall Study|Unable to continue oral medication|3|||
146722876|NCT02576067|529154881|FG000|Overall Study|Death|0|||
146981359|NCT01571635|530093879|FG001|Overall Study|Adverse Event|0|||
146783439|NCT02783300|529379190|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783440|NCT02783300|529379191|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783441|NCT02783300|529379192|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783442|NCT02783300|529379193|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783443|NCT02783300|529379194|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783444|NCT02783300|529379195|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783445|NCT02783300|529379196|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146783446|NCT02783300|529379170|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783447|NCT02783300|529379171|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783448|NCT02783300|529379172|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783449|NCT02783300|529379173|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783450|NCT02783300|529379174|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783451|NCT02783300|529379175|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783452|NCT02783300|529379176|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783453|NCT02783300|529379177|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783454|NCT02783300|529379178|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783455|NCT02783300|529379179|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783456|NCT02783300|529379180|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783457|NCT02783300|529379181|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783458|NCT02783300|529379182|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783459|NCT02783300|529379183|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783460|NCT02783300|529379184|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783461|NCT02783300|529379185|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
146783462|NCT02783300|529379186|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783463|NCT02783300|529379187|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
146783464|NCT02783300|529379188|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
146783465|NCT02783300|529379189|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
146783466|NCT02783300|529379190|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783467|NCT02783300|529379191|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783468|NCT02783300|529379192|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783469|NCT02783300|529379193|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783470|NCT02783300|529379194|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
146783471|NCT02783300|529379195|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783472|NCT02783300|529379196|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146783473|NCT02783300|529379170|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783474|NCT02783300|529379171|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783475|NCT02783300|529379172|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783476|NCT02783300|529379173|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783477|NCT02783300|529379174|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783478|NCT02783300|529379175|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783479|NCT02783300|529379176|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783480|NCT02783300|529379177|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783481|NCT02783300|529379178|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783482|NCT02783300|529379179|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783483|NCT02783300|529379180|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783484|NCT02783300|529379181|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783485|NCT02783300|529379182|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783486|NCT02783300|529379183|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783487|NCT02783300|529379184|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783488|NCT02783300|529379185|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783489|NCT02783300|529379186|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
146783490|NCT02783300|529379187|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783491|NCT02783300|529379188|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
146783492|NCT02783300|529379189|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
146783493|NCT02783300|529379190|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783494|NCT02783300|529379191|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783495|NCT02783300|529379192|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783496|NCT02783300|529379193|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783497|NCT02783300|529379194|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783498|NCT02783300|529379195|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146934564|NCT04581863|529917897|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
146934565|NCT04581863|529917898|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
146934566|NCT01803711|529917899|FG000|Overall Study|Adverse Event|1|||
146934567|NCT01803711|529917900|FG001|Overall Study|Adverse Event|1|||
146934568|NCT00225212|529917901|FG000|Overall Study|Disease progression|2|||
146934569|NCT00225212|529917901|FG000|Overall Study|Death|1|||
146934570|NCT00225212|529917901|FG000|Overall Study|Adverse Event|2|||
146934571|NCT00225212|529917901|FG000|Overall Study|Intercurrent illness|1|||
146934572|NCT01357889|529917904|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
146934573|NCT01357889|529917905|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
146934574|NCT01357889|529917904|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
146722877|NCT02576067|529154882|FG001|Overall Study|Death|1|||
146722878|NCT02576067|529154881|FG000|Overall Study|Lack of Efficacy|1|||
146722879|NCT02576067|529154882|FG001|Overall Study|Lack of Efficacy|0|||
146722880|NCT02576067|529154881|FG000|Overall Study|Lost to Follow-up|11|||
146722881|NCT02576067|529154882|FG001|Overall Study|Lost to Follow-up|0|||
146722882|NCT02576067|529154881|FG000|Overall Study|Withdrawal by Subject|11|||
146722883|NCT02576067|529154882|FG001|Overall Study|Withdrawal by Subject|2|||
146722884|NCT02576067|529154881|FG000|Overall Study|study closure of main CIRT trial)|0|||
146722885|NCT02576067|529154882|FG001|Overall Study|study closure of main CIRT trial)|8|||
146722886|NCT02576067|529154881|FG000|Overall Study|not randomized, failed run-in|7|||
146722887|NCT02576067|529154882|FG001|Overall Study|not randomized, failed run-in|0|||
146722888|NCT02576067|529154881|FG000|Overall Study|screen failure/ re-enrolled|0|||
146722889|NCT02576067|529154882|FG001|Overall Study|screen failure/ re-enrolled|25|||
146722890|NCT02576067|529154881|FG000|Overall Study|Physician Decision|4|||
146722891|NCT02576067|529154882|FG001|Overall Study|Physician Decision|0|||
146722892|NCT03570619|529154885|FG000|Overall Study|Adverse Event|2|||
146722893|NCT03570619|529154886|FG001|Overall Study|Adverse Event|0|||
146722894|NCT03570619|529154887|FG002|Overall Study|Adverse Event|1|||
146722895|NCT03570619|529154885|FG000|Overall Study|new diagnosis of new malignancy|1|||
146722896|NCT03570619|529154886|FG001|Overall Study|new diagnosis of new malignancy|0|||
146722897|NCT03570619|529154887|FG002|Overall Study|new diagnosis of new malignancy|0|||
146722898|NCT03570619|529154885|FG000|Overall Study|Physician Decision|1|||
146722899|NCT03570619|529154886|FG001|Overall Study|Physician Decision|1|||
146722900|NCT03570619|529154887|FG002|Overall Study|Physician Decision|0|||
146722901|NCT03570619|529154885|FG000|Overall Study|Withdrawal by Subject|0|||
146722902|NCT03570619|529154886|FG001|Overall Study|Withdrawal by Subject|2|||
146722903|NCT03570619|529154887|FG002|Overall Study|Withdrawal by Subject|0|||
146722904|NCT04773587|529154888|FG000|Overall Study|Lost to Follow-up|11|||
146722905|NCT04773587|529154889|FG001|Overall Study|Lost to Follow-up|3|||
146722906|NCT04773587|529154888|FG000|Overall Study|Adverse Event|6|||
146722907|NCT04773587|529154889|FG001|Overall Study|Adverse Event|3|||
146722908|NCT04773587|529154888|FG000|Overall Study|Lack of Efficacy|5|||
146722909|NCT04773587|529154889|FG001|Overall Study|Lack of Efficacy|2|||
146722910|NCT04773587|529154888|FG000|Overall Study|Withdrawal by Subject|4|||
146722911|NCT04773587|529154889|FG001|Overall Study|Withdrawal by Subject|5|||
146722912|NCT04773587|529154888|FG000|Overall Study|Noncompliance|1|||
146722913|NCT04773587|529154889|FG001|Overall Study|Noncompliance|0|||
146722914|NCT04773587|529154888|FG000|Overall Study|Protocol Violation|1|||
146722915|NCT04773587|529154889|FG001|Overall Study|Protocol Violation|0|||
146722916|NCT04773587|529154888|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
146722917|NCT04773587|529154889|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
146722918|NCT02372409|529154890|FG000|Overall Study|Lost to Follow-up|1|||
146722919|NCT02372409|529154891|FG001|Overall Study|Lost to Follow-up|0|||
146722920|NCT02372409|529154890|FG000|Overall Study|Disease progression|1|||
146722921|NCT02372409|529154891|FG001|Overall Study|Disease progression|1|||
146722922|NCT01808313|529154892|FG000|Overall Study|Adverse Event|5|||
146722923|NCT01808313|529154892|FG000|Overall Study|Protocol Violation|2|||
146722924|NCT01808313|529154892|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
146934575|NCT01357889|529917905|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
146934576|NCT01357889|529917904|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
146934577|NCT01357889|529917905|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
146981360|NCT01571635|530093880|FG002|Overall Study|Adverse Event|2|||
146722925|NCT01808313|529154892|FG000|Overall Study|Lost to Follow-up|1|||
146722926|NCT01808313|529154892|FG000|Overall Study|Physician Decision|1|||
146722927|NCT04656847|529154895|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
146722928|NCT03301051|529154896|FG000|Overall Study|Adverse Event|0|||
146722929|NCT03301051|529154897|FG001|Overall Study|Adverse Event|4|||
146722930|NCT03301051|529154896|FG000|Overall Study|Withdrawal by Subject|59|||
146722931|NCT03301051|529154897|FG001|Overall Study|Withdrawal by Subject|65|||
146722932|NCT03301051|529154896|FG000|Overall Study|Lost to Follow-up|263|||
146722933|NCT03301051|529154897|FG001|Overall Study|Lost to Follow-up|282|||
146722934|NCT03301051|529154896|FG000|Overall Study|Protocol Violation|1|||
146722935|NCT03301051|529154897|FG001|Overall Study|Protocol Violation|3|||
146783499|NCT02783300|529379196|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146783500|NCT02783300|529379170|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783501|NCT02783300|529379171|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783502|NCT02783300|529379172|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783503|NCT02783300|529379173|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783504|NCT02783300|529379174|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783505|NCT02783300|529379175|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783506|NCT02783300|529379176|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783507|NCT02783300|529379177|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783508|NCT02783300|529379178|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783509|NCT02783300|529379179|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783510|NCT02783300|529379180|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783511|NCT02783300|529379181|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783512|NCT02783300|529379182|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783513|NCT02783300|529379183|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783514|NCT02783300|529379184|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783515|NCT02783300|529379185|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783516|NCT02783300|529379186|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
146783517|NCT02783300|529379187|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783518|NCT02783300|529379188|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
146783519|NCT02783300|529379189|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
146783520|NCT02783300|529379190|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
146783521|NCT02783300|529379191|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783522|NCT02783300|529379192|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783523|NCT02783300|529379193|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783524|NCT02783300|529379194|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783525|NCT02783300|529379195|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783526|NCT02783300|529379196|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146783527|NCT02783300|529379170|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783528|NCT02783300|529379171|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783529|NCT02783300|529379172|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783530|NCT02783300|529379173|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783531|NCT02783300|529379174|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783532|NCT02783300|529379175|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783533|NCT02783300|529379176|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783534|NCT02783300|529379177|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783535|NCT02783300|529379178|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783536|NCT02783300|529379179|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783537|NCT02783300|529379180|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783538|NCT02783300|529379181|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783539|NCT02783300|529379182|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783540|NCT02783300|529379183|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783541|NCT02783300|529379184|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783542|NCT02783300|529379185|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
146783543|NCT02783300|529379186|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783544|NCT02783300|529379187|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783545|NCT02783300|529379188|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783546|NCT02783300|529379189|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783547|NCT02783300|529379190|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783548|NCT02783300|529379191|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783549|NCT02783300|529379192|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
146783550|NCT02783300|529379193|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783551|NCT02783300|529379194|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783552|NCT02783300|529379195|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783553|NCT02783300|529379196|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146783554|NCT02783300|529379170|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783555|NCT02783300|529379171|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783556|NCT02783300|529379172|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146934578|NCT01357889|529917904|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
146934579|NCT01357889|529917905|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
146934580|NCT01357889|529917904|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
146934581|NCT01357889|529917905|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
146934582|NCT01357889|529917904|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
146934583|NCT01357889|529917905|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
146934584|NCT01357889|529917904|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
146934585|NCT01357889|529917905|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
146934586|NCT01357889|529917904|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
146934587|NCT01357889|529917905|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
146934588|NCT01357889|529917904|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
146934589|NCT01357889|529917905|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
146934590|NCT01357889|529917904|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
146934591|NCT01357889|529917905|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
146934592|NCT01357889|529917904|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
146934593|NCT01357889|529917905|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
146934594|NCT01357889|529917904|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
146934595|NCT01357889|529917905|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
146934596|NCT01357889|529917904|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
146934597|NCT01357889|529917905|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
146934598|NCT02693691|529917906|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
146934599|NCT02693691|529917906|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
146934600|NCT02693691|529917906|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
146934601|NCT02693691|529917906|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
146934602|NCT02693691|529917906|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
146934603|NCT02693691|529917906|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
146934604|NCT02693691|529917906|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
146934605|NCT02727660|529917907|FG000|Overall Study|Lack of Efficacy|40|||
146934606|NCT02727660|529917908|FG001|Overall Study|Lack of Efficacy|40|||
146934607|NCT02727660|529917909|FG002|Overall Study|Lack of Efficacy|70|||
146934608|NCT02727660|529917907|FG000|Overall Study|Adverse Event|28|||
146934609|NCT02727660|529917908|FG001|Overall Study|Adverse Event|21|||
146934610|NCT02727660|529917909|FG002|Overall Study|Adverse Event|32|||
146934611|NCT02727660|529917907|FG000|Overall Study|Withdrawal by Subject|26|||
146934612|NCT02727660|529917908|FG001|Overall Study|Withdrawal by Subject|25|||
146934613|NCT02727660|529917909|FG002|Overall Study|Withdrawal by Subject|30|||
146934614|NCT02727660|529917907|FG000|Overall Study|Physician Decision|3|||
146934615|NCT02727660|529917908|FG001|Overall Study|Physician Decision|8|||
146934616|NCT02727660|529917909|FG002|Overall Study|Physician Decision|14|||
146934617|NCT02727660|529917907|FG000|Overall Study|Lost to Follow-up|5|||
146934618|NCT02727660|529917908|FG001|Overall Study|Lost to Follow-up|9|||
146934619|NCT02727660|529917909|FG002|Overall Study|Lost to Follow-up|8|||
146934620|NCT02727660|529917907|FG000|Overall Study|Protocol Violation|7|||
146934621|NCT02727660|529917908|FG001|Overall Study|Protocol Violation|5|||
146934622|NCT02727660|529917909|FG002|Overall Study|Protocol Violation|5|||
146934623|NCT02727660|529917907|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
146934624|NCT02727660|529917908|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
146934625|NCT02727660|529917909|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
146934626|NCT02727660|529917907|FG000|Overall Study|Administrative Reasons|2|||
146934627|NCT02727660|529917908|FG001|Overall Study|Administrative Reasons|3|||
146934628|NCT02727660|529917909|FG002|Overall Study|Administrative Reasons|4|||
146934629|NCT00764946|529917912|FG000|Overall Study|Lack of Efficacy|1|||
146934630|NCT00764946|529917913|FG001|Overall Study|Lack of Efficacy|0|||
146934631|NCT00764946|529917914|FG002|Overall Study|Lack of Efficacy|0|||
146934632|NCT00764946|529917912|FG000|Overall Study|Lost to Follow-up|3|||
146934633|NCT00764946|529917913|FG001|Overall Study|Lost to Follow-up|4|||
146934634|NCT00764946|529917914|FG002|Overall Study|Lost to Follow-up|0|||
146934635|NCT00764946|529917912|FG000|Overall Study|Physician Decision|2|||
146722936|NCT03301051|529154896|FG000|Overall Study|Physician Decision|1|||
146722937|NCT03301051|529154897|FG001|Overall Study|Physician Decision|3|||
146934636|NCT00764946|529917913|FG001|Overall Study|Physician Decision|4|||
146934637|NCT00764946|529917914|FG002|Overall Study|Physician Decision|0|||
146934638|NCT00764946|529917912|FG000|Overall Study|Adverse Event|3|||
146934639|NCT00764946|529917913|FG001|Overall Study|Adverse Event|2|||
146934640|NCT00764946|529917914|FG002|Overall Study|Adverse Event|1|||
146934641|NCT00764946|529917912|FG000|Overall Study|Withdrawal by Subject|3|||
146934642|NCT00764946|529917913|FG001|Overall Study|Withdrawal by Subject|6|||
146934643|NCT00764946|529917914|FG002|Overall Study|Withdrawal by Subject|2|||
146934644|NCT00764946|529917912|FG000|Overall Study|Never Treated|1|||
146934645|NCT00764946|529917913|FG001|Overall Study|Never Treated|1|||
146934646|NCT00764946|529917914|FG002|Overall Study|Never Treated|1|||
146934647|NCT01162304|529917915|FG000|Overall Study|Beck scale to high|11|||
146934648|NCT02940626|529917916|FG000|Overall Study|Death|40|||
146934649|NCT02940626|529917917|FG001|Overall Study|Death|32|||
146934650|NCT02940626|529917916|FG000|Overall Study|Lost to Follow-up|5|||
146934651|NCT02940626|529917917|FG001|Overall Study|Lost to Follow-up|2|||
146934652|NCT02940626|529917916|FG000|Overall Study|Withdrawal by Subject|1|||
146934653|NCT02940626|529917917|FG001|Overall Study|Withdrawal by Subject|0|||
146934654|NCT02940626|529917916|FG000|Overall Study|Transfer to Hospice Care|1|||
146934655|NCT02940626|529917917|FG001|Overall Study|Transfer to Hospice Care|0|||
146722938|NCT03301051|529154896|FG000|Overall Study|Death|1|||
146783557|NCT02783300|529379173|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783558|NCT02783300|529379174|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783559|NCT02783300|529379175|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783560|NCT02783300|529379176|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783561|NCT02783300|529379177|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783562|NCT02783300|529379178|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783563|NCT02783300|529379179|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783564|NCT02783300|529379180|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783565|NCT02783300|529379181|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783566|NCT02783300|529379182|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783567|NCT02783300|529379183|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
146783568|NCT02783300|529379184|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
146783569|NCT02783300|529379185|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
146783570|NCT02783300|529379186|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
146783571|NCT02783300|529379187|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783572|NCT02783300|529379188|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
146783573|NCT02783300|529379189|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
146783574|NCT02783300|529379190|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783575|NCT02783300|529379191|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783576|NCT02783300|529379192|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783577|NCT02783300|529379193|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783578|NCT02783300|529379194|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783579|NCT02783300|529379195|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783580|NCT02783300|529379196|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146783581|NCT02783300|529379170|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146783582|NCT02783300|529379171|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146783583|NCT02783300|529379172|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146783584|NCT02783300|529379173|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146783585|NCT02783300|529379174|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146783586|NCT02783300|529379175|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146783587|NCT02783300|529379176|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146783588|NCT02783300|529379177|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146783589|NCT02783300|529379178|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146783590|NCT02783300|529379179|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146783591|NCT02783300|529379180|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146783592|NCT02783300|529379181|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146783593|NCT02783300|529379182|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146783594|NCT02783300|529379183|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
146783595|NCT02783300|529379184|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
146783596|NCT02783300|529379185|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
146783597|NCT02783300|529379186|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
146783598|NCT02783300|529379187|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
146783599|NCT02783300|529379188|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
146783600|NCT02783300|529379189|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
146783601|NCT02783300|529379190|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
146783602|NCT02783300|529379191|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
146783603|NCT02783300|529379192|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
146783604|NCT02783300|529379193|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
146783605|NCT02783300|529379194|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
146783606|NCT02783300|529379195|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
146783607|NCT02783300|529379196|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146783608|NCT02783300|529379170|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783609|NCT02783300|529379171|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783610|NCT02783300|529379172|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783611|NCT02783300|529379173|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783612|NCT02783300|529379174|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783613|NCT02783300|529379175|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783614|NCT02783300|529379176|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783615|NCT02783300|529379177|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783616|NCT02783300|529379178|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783617|NCT02783300|529379179|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783618|NCT02783300|529379180|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783619|NCT02783300|529379181|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783620|NCT02783300|529379182|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783621|NCT02783300|529379183|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783622|NCT02783300|529379184|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783623|NCT02783300|529379185|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783624|NCT02783300|529379186|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783625|NCT02783300|529379187|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783626|NCT02783300|529379188|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783627|NCT02783300|529379189|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783628|NCT02783300|529379190|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783629|NCT02783300|529379191|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783630|NCT02783300|529379192|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783631|NCT02783300|529379193|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783632|NCT02783300|529379194|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783633|NCT02783300|529379195|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146783634|NCT02783300|529379196|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
146783635|NCT02783300|529379170|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783636|NCT02783300|529379171|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783637|NCT02783300|529379172|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783638|NCT02783300|529379173|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783639|NCT02783300|529379174|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783640|NCT02783300|529379175|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783641|NCT02783300|529379176|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783642|NCT02783300|529379177|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783643|NCT02783300|529379178|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783644|NCT02783300|529379179|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783645|NCT02783300|529379180|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783646|NCT02783300|529379181|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783647|NCT02783300|529379182|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783648|NCT02783300|529379183|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783649|NCT02783300|529379184|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783650|NCT02783300|529379185|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783651|NCT02783300|529379186|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783652|NCT02783300|529379187|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783653|NCT02783300|529379188|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783654|NCT02783300|529379189|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783655|NCT02783300|529379190|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783656|NCT02783300|529379191|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783657|NCT02783300|529379192|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783658|NCT02783300|529379193|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783659|NCT02783300|529379194|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783660|NCT02783300|529379195|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
146783661|NCT02783300|529379196|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
146783662|NCT03535272|529379197|FG000|Overall Study|Lost to Follow-up|71|||
146783663|NCT03535272|529379198|FG001|Overall Study|Lost to Follow-up|73|||
146783664|NCT01331005|529380228|FG000|Overall Study|Lost to Follow-up|2|||
146783665|NCT01331005|529380229|FG001|Overall Study|Lost to Follow-up|1|||
146783666|NCT01331005|529380228|FG000|Overall Study|Withdrawal by Subject|2|||
146783667|NCT01331005|529380229|FG001|Overall Study|Withdrawal by Subject|3|||
146783668|NCT03016169|529380230|FG000|Overall Study|Lost to Follow-up|4|||
146783669|NCT03016169|529380230|FG000|Overall Study|Death|54|||
146783670|NCT03016169|529380230|FG000|Overall Study|Device Explant|11|||
146783671|NCT03016169|529380230|FG000|Overall Study|Withdrawal by Subject|19|||
146783672|NCT03016169|529380230|FG000|Overall Study|Other Reasons|1|||
146783673|NCT03131648|529380232|FG000|Initial Treatment Period|Not dosed|2|||
146783674|NCT03131648|529380233|FG001|Initial Treatment Period|Not dosed|2|||
146783675|NCT03131648|529380234|FG002|Initial Treatment Period|Not dosed|0|||
146783676|NCT03131648|529380235|FG003|Initial Treatment Period|Not dosed|0|||
146783677|NCT03131648|529380236|FG004|Initial Treatment Period|Not dosed|0|||
146783678|NCT03131648|529380237|FG005|Initial Treatment Period|Not dosed|0|||
146783679|NCT03131648|529380238|FG006|Initial Treatment Period|Not dosed|0|||
146783680|NCT03131648|529380239|FG007|Initial Treatment Period|Not dosed|0|||
146783681|NCT03131648|529380232|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
146783682|NCT03131648|529380233|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
146783683|NCT03131648|529380234|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146783684|NCT03131648|529380235|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146783685|NCT03131648|529380236|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146783686|NCT03131648|529380237|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146981361|NCT01571635|530093881|FG003|Overall Study|Adverse Event|3|||
146783687|NCT03131648|529380238|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146783688|NCT03131648|529380239|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146783689|NCT03131648|529380232|FG000|Open-label Treatment|Discontinued IMP|0|||
146783690|NCT03131648|529380233|FG001|Open-label Treatment|Discontinued IMP|0|||
146783691|NCT03131648|529380234|FG002|Open-label Treatment|Discontinued IMP|0|||
146783692|NCT03131648|529380235|FG003|Open-label Treatment|Discontinued IMP|0|||
146783693|NCT03131648|529380236|FG004|Open-label Treatment|Discontinued IMP|0|||
146783694|NCT03131648|529380237|FG005|Open-label Treatment|Discontinued IMP|0|||
146783695|NCT03131648|529380238|FG006|Open-label Treatment|Discontinued IMP|112|||
146783696|NCT03131648|529380239|FG007|Open-label Treatment|Discontinued IMP|0|||
146783697|NCT03131648|529380232|FG000|Open-label Treatment|Completed Week 50|0|||
146783698|NCT03131648|529380233|FG001|Open-label Treatment|Completed Week 50|0|||
146783699|NCT03131648|529380234|FG002|Open-label Treatment|Completed Week 50|0|||
146783700|NCT03131648|529380235|FG003|Open-label Treatment|Completed Week 50|0|||
146783701|NCT03131648|529380236|FG004|Open-label Treatment|Completed Week 50|0|||
146783702|NCT03131648|529380237|FG005|Open-label Treatment|Completed Week 50|0|||
146783703|NCT03131648|529380238|FG006|Open-label Treatment|Completed Week 50|6|||
146783704|NCT03131648|529380239|FG007|Open-label Treatment|Completed Week 50|0|||
146783705|NCT03131648|529380232|FG000|Maintenance Treatment Period|Not dosed|0|||
146783706|NCT03131648|529380233|FG001|Maintenance Treatment Period|Not dosed|0|||
146783707|NCT03131648|529380234|FG002|Maintenance Treatment Period|Not dosed|3|||
146783708|NCT03131648|529380235|FG003|Maintenance Treatment Period|Not dosed|2|||
146783709|NCT03131648|529380236|FG004|Maintenance Treatment Period|Not dosed|1|||
146783710|NCT03131648|529380237|FG005|Maintenance Treatment Period|Not dosed|0|||
146783711|NCT03131648|529380238|FG006|Maintenance Treatment Period|Not dosed|0|||
146783712|NCT03131648|529380239|FG007|Maintenance Treatment Period|Not dosed|0|||
146783713|NCT03131648|529380232|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
146783714|NCT03131648|529380233|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
146783715|NCT03131648|529380234|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
146783716|NCT03131648|529380235|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
146783717|NCT03131648|529380236|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
146783718|NCT03131648|529380237|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
146783719|NCT03131648|529380238|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
146783720|NCT03131648|529380239|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
146783721|NCT03131648|529380232|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
146783722|NCT03131648|529380233|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
146783723|NCT03131648|529380234|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
146783724|NCT03131648|529380235|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
146783725|NCT03131648|529380236|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
146783726|NCT03131648|529380237|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
146783727|NCT03131648|529380238|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
146722939|NCT03301051|529154897|FG001|Overall Study|Death|1|||
146722940|NCT03301051|529154896|FG000|Overall Study|Miscellaneous|8|||
146722941|NCT03301051|529154897|FG001|Overall Study|Miscellaneous|4|||
146722942|NCT03301051|529154896|FG000|Overall Study|Randomized, not vaccinated|13|||
146722943|NCT03301051|529154897|FG001|Overall Study|Randomized, not vaccinated|10|||
146722944|NCT00622167|529154898|FG000|Overall Study|Did not meet angiographic criteria|20|||
146722945|NCT00435370|529154903|FG000|Overall Study|Adverse Event|8|||
146722946|NCT00435370|529154904|FG001|Overall Study|Adverse Event|8|||
146722947|NCT00435370|529154903|FG000|Overall Study|Withdrawal by Subject|10|||
146722948|NCT00435370|529154904|FG001|Overall Study|Withdrawal by Subject|10|||
146722949|NCT00435370|529154903|FG000|Overall Study|Antipsychotic medication changed|4|||
146722950|NCT00435370|529154904|FG001|Overall Study|Antipsychotic medication changed|2|||
146722951|NCT01965834|529154906|FG000|Overall Study|Lack of Efficacy|4|||
146722952|NCT03674177|529154909|FG000|Overall Study|Lost to Follow-up|2|||
146722953|NCT03674177|529154910|FG001|Overall Study|Lost to Follow-up|1|||
146722954|NCT03674177|529154911|FG002|Overall Study|Lost to Follow-up|0|||
146722955|NCT03674177|529154912|FG003|Overall Study|Lost to Follow-up|2|||
146722956|NCT00714168|529154913|FG000|Overall Study|Pregnancy|5|||
146722957|NCT00714168|529154914|FG001|Overall Study|Pregnancy|4|||
146722958|NCT00714168|529154913|FG000|Overall Study|Lost to Follow-up|32|||
146722959|NCT00714168|529154914|FG001|Overall Study|Lost to Follow-up|50|||
146783728|NCT03131648|529380239|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
146783729|NCT03131648|529380232|FG000|Maintenance Treatment Period|Completed Week 50|0|||
146783730|NCT03131648|529380233|FG001|Maintenance Treatment Period|Completed Week 50|0|||
146783731|NCT03131648|529380234|FG002|Maintenance Treatment Period|Completed Week 50|0|||
146783732|NCT03131648|529380235|FG003|Maintenance Treatment Period|Completed Week 50|0|||
146783733|NCT03131648|529380236|FG004|Maintenance Treatment Period|Completed Week 50|1|||
146722960|NCT00714168|529154913|FG000|Overall Study|Relocation|4|||
146722961|NCT00714168|529154914|FG001|Overall Study|Relocation|3|||
146722962|NCT00714168|529154913|FG000|Overall Study|Non-study medical condition|3|||
146722963|NCT00714168|529154914|FG001|Overall Study|Non-study medical condition|2|||
146722964|NCT04988308|529154915|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
146722965|NCT04988308|529154916|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
146722966|NCT04988308|529154917|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
146722967|NCT04988308|529154918|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
146722968|NCT04988308|529154919|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
146722969|NCT04988308|529154920|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
146722970|NCT04988308|529154915|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
146722971|NCT04988308|529154916|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
146722972|NCT04988308|529154917|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
146722973|NCT04988308|529154918|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
146722974|NCT04988308|529154919|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
146722975|NCT04988308|529154920|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
146722976|NCT04988308|529154915|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
146722977|NCT04988308|529154916|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
146722978|NCT04988308|529154917|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
146722979|NCT04988308|529154918|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
146722980|NCT04988308|529154919|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
146722981|NCT04988308|529154920|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
146722982|NCT04988308|529154915|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
146722983|NCT04988308|529154916|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
146722984|NCT04988308|529154917|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
146722985|NCT04988308|529154918|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
146722986|NCT04988308|529154919|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
146722987|NCT04988308|529154920|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
146722988|NCT04988308|529154915|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
146722989|NCT04988308|529154916|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
146722990|NCT04988308|529154917|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
146722991|NCT04988308|529154918|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
146722992|NCT04988308|529154919|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
146722993|NCT04988308|529154920|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
146722994|NCT04988308|529154915|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
146722995|NCT04988308|529154916|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
146722996|NCT04988308|529154917|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
146722997|NCT04988308|529154918|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
146722998|NCT04988308|529154919|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
146722999|NCT04988308|529154920|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
146723000|NCT04988308|529154915|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
146723001|NCT04988308|529154916|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
146723002|NCT04988308|529154917|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
146723003|NCT04988308|529154918|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
146723004|NCT04988308|529154919|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
146723005|NCT04988308|529154920|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
146723006|NCT04988308|529154915|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
146723007|NCT04988308|529154916|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
146723008|NCT04988308|529154917|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
146723009|NCT04988308|529154918|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
146723010|NCT04988308|529154919|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
146723011|NCT04988308|529154920|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
146723012|NCT04988308|529154915|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
146723013|NCT04988308|529154916|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
146723014|NCT04988308|529154917|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
146723015|NCT04988308|529154918|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
146723016|NCT04988308|529154919|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
146723017|NCT04988308|529154920|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
146723018|NCT02625623|529154925|FG000|Overall Study|Participants randomized but not treated|9|||
146723019|NCT02625623|529154926|FG001|Overall Study|Participants randomized but not treated|1|||
146723020|NCT00744653|529154927|FG000|Overall Study|antineoplastic treatment|11|||
146723021|NCT00744653|529154927|FG000|Overall Study|Death|1|||
146723022|NCT00744653|529154927|FG000|Overall Study|Lost to Follow-up|1|||
146723023|NCT00744653|529154927|FG000|Overall Study|Physician Decision|3|||
146723024|NCT03826667|529154928|FG000|Overall Study|Protocol deviation|21|||
146723025|NCT02352948|529154932|FG000|Overall Study|Death|47|||
146723026|NCT02352948|529154933|FG001|Overall Study|Death|48|||
146723027|NCT02352948|529154934|FG002|Overall Study|Death|114|||
146723028|NCT02352948|529154935|FG003|Overall Study|Death|74|||
146723029|NCT02352948|529154936|FG004|Overall Study|Death|77|||
146783734|NCT03131648|529380237|FG005|Maintenance Treatment Period|Completed Week 50|0|||
146783735|NCT03131648|529380238|FG006|Maintenance Treatment Period|Completed Week 50|0|||
146783736|NCT03131648|529380239|FG007|Maintenance Treatment Period|Completed Week 50|0|||
146783737|NCT03131648|529380232|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
146783738|NCT03131648|529380233|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
146783739|NCT03131648|529380234|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
146783740|NCT03131648|529380235|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
146783741|NCT03131648|529380236|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
146783742|NCT03131648|529380237|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
146783743|NCT03131648|529380238|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
146783744|NCT03131648|529380239|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
146783745|NCT04150718|529380247|FG000|Overall Study|Withdrawal by Subject|2|||
146783746|NCT04150718|529380248|FG001|Overall Study|Withdrawal by Subject|7|||
146783747|NCT04150718|529380249|FG002|Overall Study|Withdrawal by Subject|1|||
146783748|NCT04150718|529380247|FG000|Overall Study|Lost to Follow-up|1|||
146783749|NCT04150718|529380248|FG001|Overall Study|Lost to Follow-up|2|||
146783750|NCT04150718|529380249|FG002|Overall Study|Lost to Follow-up|0|||
146783751|NCT04150718|529380247|FG000|Overall Study|Ineligible|1|||
146783752|NCT04150718|529380248|FG001|Overall Study|Ineligible|0|||
146783753|NCT04150718|529380249|FG002|Overall Study|Ineligible|10|||
146783754|NCT01416831|529380267|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
146783755|NCT01416831|529380268|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
146783756|NCT04784559|529380271|FG000|Overall Study|Withdrawal by Subject|3|||
146783757|NCT04784559|529380272|FG001|Overall Study|Withdrawal by Subject|2|||
146783758|NCT04784559|529380273|FG002|Overall Study|Withdrawal by Subject|1|||
146783759|NCT04784559|529380271|FG000|Overall Study|Death|2|||
146783760|NCT04784559|529380272|FG001|Overall Study|Death|1|||
146783761|NCT04784559|529380273|FG002|Overall Study|Death|2|||
146783762|NCT04784559|529380271|FG000|Overall Study|Lost to Follow-up|0|||
146783763|NCT04784559|529380272|FG001|Overall Study|Lost to Follow-up|0|||
146783764|NCT04784559|529380273|FG002|Overall Study|Lost to Follow-up|2|||
146783765|NCT04784559|529380271|FG000|Overall Study|Participant worsened, PI decision|1|||
146783766|NCT04784559|529380272|FG001|Overall Study|Participant worsened, PI decision|0|||
146783767|NCT04784559|529380273|FG002|Overall Study|Participant worsened, PI decision|0|||
146783768|NCT04784559|529380271|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
146783769|NCT04784559|529380272|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
146783770|NCT04784559|529380273|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
146783771|NCT04784559|529380271|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
146783772|NCT04784559|529380272|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
146783773|NCT04784559|529380273|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
146783774|NCT04784559|529380271|FG000|Overall Study|Did not meet all inclusion criteria|0|||
146783775|NCT04784559|529380272|FG001|Overall Study|Did not meet all inclusion criteria|1|||
146783776|NCT04784559|529380273|FG002|Overall Study|Did not meet all inclusion criteria|0|||
146783777|NCT04784559|529380271|FG000|Overall Study|The participant was transferred to IRCU|0|||
146783778|NCT04784559|529380272|FG001|Overall Study|The participant was transferred to IRCU|1|||
146783779|NCT04784559|529380273|FG002|Overall Study|The participant was transferred to IRCU|0|||
146783780|NCT04784559|529380271|FG000|Overall Study|SAE|0|||
146783781|NCT04784559|529380272|FG001|Overall Study|SAE|1|||
146783782|NCT04784559|529380273|FG002|Overall Study|SAE|0|||
146934656|NCT02940626|529917916|FG000|Overall Study|Prohibited Concomitant Medication|0|||
146934657|NCT02940626|529917917|FG001|Overall Study|Prohibited Concomitant Medication|1|||
146934658|NCT00413062|529917920|FG000|Overall Study|Adverse event/serious adverse event|289|||
146934659|NCT00413062|529917921|FG001|Overall Study|Adverse event/serious adverse event|56|||
146934660|NCT00413062|529917920|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
146934661|NCT00413062|529917921|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
146934662|NCT00413062|529917920|FG000|Overall Study|Withdrawal of informed consent|111|||
146934663|NCT00413062|529917921|FG001|Overall Study|Withdrawal of informed consent|36|||
146934664|NCT00413062|529917920|FG000|Overall Study|Pregnancy|15|||
146934665|NCT00413062|529917921|FG001|Overall Study|Pregnancy|5|||
146934666|NCT00413062|529917920|FG000|Overall Study|Pregnancy wish|17|||
146934667|NCT00413062|529917921|FG001|Overall Study|Pregnancy wish|6|||
146934668|NCT00413062|529917920|FG000|Overall Study|Lost to Follow-up|175|||
146934669|NCT00413062|529917921|FG001|Overall Study|Lost to Follow-up|73|||
146934670|NCT00413062|529917920|FG000|Overall Study|Other reason|70|||
146934671|NCT00413062|529917921|FG001|Overall Study|Other reason|34|||
146934672|NCT02176291|529917922|FG000|Overall Study|Death|1|||
146934673|NCT02176291|529917923|FG001|Overall Study|Death|0|||
146934674|NCT02176291|529917922|FG000|Overall Study|non compliance with protocol|2|||
146934675|NCT02176291|529917923|FG001|Overall Study|non compliance with protocol|0|||
146783783|NCT04784559|529380271|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
146783784|NCT04784559|529380272|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
146934676|NCT02176291|529917922|FG000|Overall Study|Withdrawal by Subject|2|||
146934677|NCT02176291|529917923|FG001|Overall Study|Withdrawal by Subject|0|||
146723030|NCT02352948|529154937|FG005|Overall Study|Death|44|||
146723031|NCT02352948|529154932|FG000|Overall Study|Lost to Follow-up|1|||
146723032|NCT02352948|529154933|FG001|Overall Study|Lost to Follow-up|0|||
146723033|NCT02352948|529154934|FG002|Overall Study|Lost to Follow-up|2|||
146723034|NCT02352948|529154935|FG003|Overall Study|Lost to Follow-up|1|||
146723035|NCT02352948|529154936|FG004|Overall Study|Lost to Follow-up|2|||
146723036|NCT02352948|529154937|FG005|Overall Study|Lost to Follow-up|1|||
146723037|NCT02352948|529154932|FG000|Overall Study|Withdrawal by Subject|1|||
146723038|NCT02352948|529154933|FG001|Overall Study|Withdrawal by Subject|10|||
146723039|NCT02352948|529154934|FG002|Overall Study|Withdrawal by Subject|11|||
146723040|NCT02352948|529154935|FG003|Overall Study|Withdrawal by Subject|23|||
146723041|NCT02352948|529154936|FG004|Overall Study|Withdrawal by Subject|9|||
146723042|NCT02352948|529154937|FG005|Overall Study|Withdrawal by Subject|4|||
146723043|NCT02352948|529154932|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146723044|NCT02352948|529154933|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146723045|NCT02352948|529154934|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
146723046|NCT02352948|529154935|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
146723047|NCT02352948|529154936|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
146723048|NCT02352948|529154937|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
146723049|NCT02352948|529154932|FG000|Overall Study|Other|0|||
146723050|NCT02352948|529154933|FG001|Overall Study|Other|0|||
146723051|NCT02352948|529154934|FG002|Overall Study|Other|2|||
146723052|NCT02352948|529154935|FG003|Overall Study|Other|0|||
146723053|NCT02352948|529154936|FG004|Overall Study|Other|0|||
146723054|NCT02352948|529154937|FG005|Overall Study|Other|0|||
146723055|NCT00679939|529154938|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
146723056|NCT00679939|529154939|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
146723057|NCT00679939|529154938|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
146723058|NCT00679939|529154939|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
146723059|NCT00679939|529154938|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
146723060|NCT00679939|529154939|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
146723061|NCT00679939|529154938|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
146723062|NCT00679939|529154939|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
146723063|NCT00679939|529154938|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
146723064|NCT00679939|529154939|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
146723065|NCT00679939|529154938|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
146723066|NCT00679939|529154939|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
146723067|NCT00679939|529154938|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
146723068|NCT00679939|529154939|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
146723069|NCT00679939|529154938|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
146723070|NCT00679939|529154939|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
146723071|NCT00679939|529154938|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
146723072|NCT00679939|529154939|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
146723073|NCT00679939|529154938|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
146723074|NCT00679939|529154939|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
146723075|NCT03077724|529154943|FG000|Overall Study|Lost to Follow-up|5|||
146723076|NCT03077724|529154944|FG001|Overall Study|Lost to Follow-up|1|||
146723077|NCT03077724|529154943|FG000|Overall Study|Withdrawal by Subject|3|||
146723078|NCT03077724|529154944|FG001|Overall Study|Withdrawal by Subject|1|||
146723079|NCT02269670|529154945|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
146723080|NCT02313428|529154946|FG000|Overall Study|Lost to Follow-up|1|||
146723081|NCT02313428|529154947|FG001|Overall Study|Lost to Follow-up|1|||
146723082|NCT02979639|529156926|FG000|Overall Study|Withdrawal based on medical judgement|1|||
146723083|NCT02979639|529156926|FG000|Overall Study|Lost to Follow-up|8|||
146723084|NCT02979639|529156926|FG000|Overall Study|Withdrawal by Subject|3|||
146723085|NCT02979639|529156926|FG000|Overall Study|Adverse Event|2|||
146723086|NCT02985866|529156939|FG000|Overall Study|Poor CGM data|1|||
146723087|NCT02985866|529156940|FG001|Overall Study|Poor CGM data|1|||
146723088|NCT04402866|529156947|FG000|Overall Study|Discontinued Prior to Treatment|0|||
146723089|NCT04402866|529156948|FG001|Overall Study|Discontinued Prior to Treatment|0|||
146723090|NCT04402866|529156949|FG002|Overall Study|Discontinued Prior to Treatment|0|||
146723091|NCT04402866|529156950|FG003|Overall Study|Discontinued Prior to Treatment|0|||
146723092|NCT04402866|529156951|FG004|Overall Study|Discontinued Prior to Treatment|2|||
146723093|NCT04402866|529156952|FG005|Overall Study|Discontinued Prior to Treatment|3|||
146783785|NCT04784559|529380273|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
146783786|NCT03138512|529380275|FG000|Randomization|Participants withdrew consent|0|||
146723094|NCT04402866|529156947|FG000|Overall Study|Adverse Event|2|||
146723095|NCT04402866|529156948|FG001|Overall Study|Adverse Event|1|||
146783787|NCT03138512|529380276|FG001|Randomization|Participants withdrew consent|1|||
146783788|NCT03138512|529380277|FG002|Randomization|Participants withdrew consent|1|||
146723096|NCT04402866|529156949|FG002|Overall Study|Adverse Event|0|||
146723097|NCT04402866|529156950|FG003|Overall Study|Adverse Event|0|||
146723098|NCT04402866|529156951|FG004|Overall Study|Adverse Event|13|||
146723099|NCT04402866|529156952|FG005|Overall Study|Adverse Event|8|||
146934678|NCT03454412|529917924|FG000|Baseline Assesment|Physician Decision|12|||
146934679|NCT01167582|529917925|FG000|Overall Study|Lost to Follow-up|0|||
146934680|NCT01167582|529917926|FG001|Overall Study|Lost to Follow-up|1|||
146934681|NCT01928485|529917927|FG000|Overall Study|Physician Decision|0|||
146934682|NCT01928485|529917928|FG001|Overall Study|Physician Decision|1|||
146934683|NCT03589885|529917929|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
146934684|NCT03589885|529917930|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
146934685|NCT03589885|529917931|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
146934686|NCT03589885|529917932|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
146934687|NCT03589885|529917933|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
146934688|NCT03589885|529917929|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
146934689|NCT03589885|529917930|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
146934690|NCT03589885|529917931|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
146934691|NCT03589885|529917932|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
146934692|NCT03589885|529917933|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
146934693|NCT03589885|529917929|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
146934694|NCT03589885|529917930|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
146934695|NCT03589885|529917931|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
146934696|NCT03589885|529917932|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
146934697|NCT03589885|529917933|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
146934698|NCT03589885|529917929|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
146723100|NCT04402866|529156947|FG000|Overall Study|Miscellaneous|0|||
146723101|NCT04402866|529156948|FG001|Overall Study|Miscellaneous|0|||
146723102|NCT04402866|529156949|FG002|Overall Study|Miscellaneous|1|||
146723103|NCT04402866|529156950|FG003|Overall Study|Miscellaneous|0|||
146723104|NCT04402866|529156951|FG004|Overall Study|Miscellaneous|0|||
146723105|NCT04402866|529156952|FG005|Overall Study|Miscellaneous|0|||
146723106|NCT04402866|529156947|FG000|Overall Study|Lost to Follow-up|0|||
146723107|NCT04402866|529156948|FG001|Overall Study|Lost to Follow-up|0|||
146723108|NCT04402866|529156949|FG002|Overall Study|Lost to Follow-up|0|||
146723109|NCT04402866|529156950|FG003|Overall Study|Lost to Follow-up|0|||
146723110|NCT04402866|529156951|FG004|Overall Study|Lost to Follow-up|0|||
146723111|NCT04402866|529156952|FG005|Overall Study|Lost to Follow-up|1|||
146723112|NCT04402866|529156947|FG000|Overall Study|Withdrawal by Subject|0|||
146723113|NCT04402866|529156948|FG001|Overall Study|Withdrawal by Subject|0|||
146723114|NCT04402866|529156949|FG002|Overall Study|Withdrawal by Subject|0|||
146723115|NCT04402866|529156950|FG003|Overall Study|Withdrawal by Subject|0|||
146723116|NCT04402866|529156951|FG004|Overall Study|Withdrawal by Subject|0|||
146723117|NCT04402866|529156952|FG005|Overall Study|Withdrawal by Subject|2|||
146723118|NCT03647501|529156953|FG000|Overall Study|Lost to Follow-up|1|||
146723119|NCT03647501|529156954|FG001|Overall Study|Lost to Follow-up|1|||
146723120|NCT03647501|529156953|FG000|Overall Study|Withdrawal by Subject|0|||
146723121|NCT03647501|529156954|FG001|Overall Study|Withdrawal by Subject|1|||
146723122|NCT05545072|529156963|FG000|Overall Study|Lost to Follow-up|1|||
146723123|NCT05545072|529156964|FG001|Overall Study|Lost to Follow-up|0|||
146723124|NCT05545072|529156963|FG000|Overall Study|Study ended prematurely due to funding|2|||
146723125|NCT05545072|529156964|FG001|Overall Study|Study ended prematurely due to funding|2|||
146723126|NCT01324271|529156965|FG000|Overall Study|Lost to Follow-up|3|||
146723127|NCT01324271|529156966|FG001|Overall Study|Lost to Follow-up|0|||
146723128|NCT01324271|529156965|FG000|Overall Study|Physician Decision|1|||
146723129|NCT01324271|529156966|FG001|Overall Study|Physician Decision|0|||
146723130|NCT02807558|529156967|FG000|Overall Study|Consent withdrawn by participant|4|||
146723131|NCT02807558|529156968|FG001|Overall Study|Consent withdrawn by participant|0|||
146723132|NCT02807558|529156969|FG002|Overall Study|Consent withdrawn by participant|4|||
146723133|NCT02807558|529156970|FG003|Overall Study|Consent withdrawn by participant|2|||
146723134|NCT02807558|529156971|FG004|Overall Study|Consent withdrawn by participant|1|||
146723135|NCT02807558|529156972|FG005|Overall Study|Consent withdrawn by participant|0|||
146723136|NCT02807558|529156967|FG000|Overall Study|Non-compliance with Study Drug|0|||
146723137|NCT02807558|529156968|FG001|Overall Study|Non-compliance with Study Drug|0|||
146723138|NCT02807558|529156969|FG002|Overall Study|Non-compliance with Study Drug|1|||
146723139|NCT02807558|529156970|FG003|Overall Study|Non-compliance with Study Drug|0|||
146723140|NCT02807558|529156971|FG004|Overall Study|Non-compliance with Study Drug|0|||
146723141|NCT02807558|529156972|FG005|Overall Study|Non-compliance with Study Drug|0|||
146723142|NCT02807558|529156967|FG000|Overall Study|Adverse Event|0|||
146723143|NCT02807558|529156968|FG001|Overall Study|Adverse Event|0|||
146723144|NCT02807558|529156969|FG002|Overall Study|Adverse Event|9|||
146723145|NCT02807558|529156970|FG003|Overall Study|Adverse Event|0|||
146723146|NCT02807558|529156971|FG004|Overall Study|Adverse Event|0|||
146723147|NCT02807558|529156972|FG005|Overall Study|Adverse Event|0|||
146723148|NCT02807558|529156967|FG000|Overall Study|Death|23|||
146723149|NCT02807558|529156968|FG001|Overall Study|Death|2|||
146723150|NCT02807558|529156969|FG002|Overall Study|Death|3|||
146934699|NCT03589885|529917930|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
146934700|NCT03589885|529917931|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
146934701|NCT03589885|529917932|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
146934702|NCT03589885|529917933|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
146934703|NCT03589885|529917929|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
146934704|NCT03589885|529917930|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
146934705|NCT03589885|529917931|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
146934706|NCT03589885|529917932|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
146934707|NCT03589885|529917933|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
146934708|NCT03589885|529917929|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
146934709|NCT03589885|529917930|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
146934710|NCT03589885|529917931|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
146934711|NCT03589885|529917932|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
146934712|NCT03589885|529917933|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
146934713|NCT03589885|529917929|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
146934714|NCT03589885|529917930|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
146934715|NCT03589885|529917931|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
146934716|NCT03589885|529917932|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
146934717|NCT03589885|529917933|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
146934718|NCT03589885|529917929|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
146934719|NCT03589885|529917930|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
146934720|NCT03589885|529917931|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
146934721|NCT03589885|529917932|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
146934722|NCT03589885|529917933|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
146934723|NCT00039741|529917934|FG000|Overall Study|Death|0|||
146934724|NCT00039741|529917935|FG001|Overall Study|Death|1|||
146934725|NCT00039741|529917936|FG002|Overall Study|Death|0|||
146934726|NCT00039741|529917937|FG003|Overall Study|Death|0|||
146934727|NCT00039741|529917934|FG000|Overall Study|Lost to Follow-up|3|||
146934728|NCT00039741|529917935|FG001|Overall Study|Lost to Follow-up|1|||
146934729|NCT00039741|529917936|FG002|Overall Study|Lost to Follow-up|5|||
146934730|NCT00039741|529917937|FG003|Overall Study|Lost to Follow-up|2|||
146934731|NCT00039741|529917934|FG000|Overall Study|Confounding medical condition|1|||
146934732|NCT00039741|529917935|FG001|Overall Study|Confounding medical condition|0|||
146934733|NCT00039741|529917936|FG002|Overall Study|Confounding medical condition|0|||
146934734|NCT00039741|529917937|FG003|Overall Study|Confounding medical condition|0|||
146934735|NCT00039741|529917934|FG000|Overall Study|Not able to get to clinic|5|||
146934736|NCT00039741|529917935|FG001|Overall Study|Not able to get to clinic|2|||
146934737|NCT00039741|529917936|FG002|Overall Study|Not able to get to clinic|0|||
146934738|NCT00039741|529917937|FG003|Overall Study|Not able to get to clinic|3|||
146934739|NCT00039741|529917934|FG000|Overall Study|Moved|3|||
146934740|NCT00039741|529917935|FG001|Overall Study|Moved|2|||
146934741|NCT00039741|529917936|FG002|Overall Study|Moved|3|||
146934742|NCT00039741|529917937|FG003|Overall Study|Moved|6|||
146934743|NCT00039741|529917934|FG000|Overall Study|Non-compliance with protocol|1|||
146934744|NCT00039741|529917935|FG001|Overall Study|Non-compliance with protocol|0|||
146934745|NCT00039741|529917936|FG002|Overall Study|Non-compliance with protocol|1|||
146934746|NCT00039741|529917937|FG003|Overall Study|Non-compliance with protocol|0|||
146934747|NCT00039741|529917934|FG000|Overall Study|Withdrew consent|0|||
146934748|NCT00039741|529917935|FG001|Overall Study|Withdrew consent|5|||
146723151|NCT02807558|529156970|FG003|Overall Study|Death|43|||
146723152|NCT02807558|529156971|FG004|Overall Study|Death|24|||
146723153|NCT02807558|529156972|FG005|Overall Study|Death|15|||
146723154|NCT02807558|529156967|FG000|Overall Study|Progressive Disease|0|||
146723155|NCT02807558|529156968|FG001|Overall Study|Progressive Disease|0|||
146723156|NCT02807558|529156969|FG002|Overall Study|Progressive Disease|1|||
146723157|NCT02807558|529156970|FG003|Overall Study|Progressive Disease|0|||
146723158|NCT02807558|529156971|FG004|Overall Study|Progressive Disease|0|||
146723159|NCT02807558|529156972|FG005|Overall Study|Progressive Disease|0|||
146723160|NCT02807558|529156967|FG000|Overall Study|Other than specified|1|||
146723161|NCT02807558|529156968|FG001|Overall Study|Other than specified|0|||
146723162|NCT02807558|529156969|FG002|Overall Study|Other than specified|2|||
146934749|NCT00039741|529917936|FG002|Overall Study|Withdrew consent|0|||
146934750|NCT00039741|529917937|FG003|Overall Study|Withdrew consent|1|||
146934751|NCT00039741|529917934|FG000|Overall Study|Missed final visit|2|||
146934752|NCT00039741|529917935|FG001|Overall Study|Missed final visit|1|||
146934753|NCT00039741|529917936|FG002|Overall Study|Missed final visit|2|||
146723163|NCT02807558|529156970|FG003|Overall Study|Other than specified|0|||
146934754|NCT00039741|529917937|FG003|Overall Study|Missed final visit|2|||
146934755|NCT00946881|529917938|FG000|First Treatment|Withdrawal by Subject|1|||
146934756|NCT00946881|529917938|FG000|First Treatment|Patient relocated to another state|1|||
146934757|NCT00946881|529917938|FG000|Retreatment|Withdrawal by Subject|1|||
146723164|NCT02807558|529156971|FG004|Overall Study|Other than specified|1|||
146723165|NCT02807558|529156972|FG005|Overall Study|Other than specified|1|||
146723166|NCT02807558|529156967|FG000|Overall Study|Lack of Efficacy|0|||
146934758|NCT03103906|529917939|FG000|Overall Study|Adverse Event|2|||
146981362|NCT01571635|530093882|FG004|Overall Study|Adverse Event|5|||
146934759|NCT03103906|529917940|FG001|Overall Study|Adverse Event|3|||
146934760|NCT03103906|529917939|FG000|Overall Study|Other|2|||
146934761|NCT03103906|529917940|FG001|Overall Study|Other|0|||
146934762|NCT03571256|529917941|FG000|Overall Study|Adverse Event|3|||
146934763|NCT03571256|529917942|FG001|Overall Study|Adverse Event|0|||
146934764|NCT03571256|529917943|FG002|Overall Study|Adverse Event|1|||
146934765|NCT03571256|529917941|FG000|Overall Study|Withdrawal by Subject|3|||
146723167|NCT02807558|529156968|FG001|Overall Study|Lack of Efficacy|0|||
146723168|NCT02807558|529156969|FG002|Overall Study|Lack of Efficacy|9|||
146723169|NCT02807558|529156970|FG003|Overall Study|Lack of Efficacy|0|||
146723170|NCT02807558|529156971|FG004|Overall Study|Lack of Efficacy|0|||
146723171|NCT02807558|529156972|FG005|Overall Study|Lack of Efficacy|0|||
146723172|NCT01972841|529156973|FG000|Overall Study|Randomized but Never Received Treatment|2|||
146723173|NCT01972841|529156974|FG001|Overall Study|Randomized but Never Received Treatment|5|||
146723174|NCT01972841|529156975|FG002|Overall Study|Randomized but Never Received Treatment|4|||
146723175|NCT01972841|529156976|FG003|Overall Study|Randomized but Never Received Treatment|2|||
146723176|NCT01972841|529156977|FG004|Overall Study|Randomized but Never Received Treatment|6|||
146723177|NCT01972841|529156978|FG005|Overall Study|Randomized but Never Received Treatment|13|||
146723178|NCT01972841|529156973|FG000|Overall Study|Adverse Event|13|||
146723179|NCT01972841|529156974|FG001|Overall Study|Adverse Event|8|||
146723180|NCT01972841|529156975|FG002|Overall Study|Adverse Event|12|||
146723181|NCT01972841|529156976|FG003|Overall Study|Adverse Event|9|||
146723182|NCT01972841|529156977|FG004|Overall Study|Adverse Event|21|||
146723183|NCT01972841|529156978|FG005|Overall Study|Adverse Event|26|||
146723184|NCT01972841|529156973|FG000|Overall Study|Lack of Efficacy|1|||
146723185|NCT01972841|529156974|FG001|Overall Study|Lack of Efficacy|0|||
146723186|NCT01972841|529156975|FG002|Overall Study|Lack of Efficacy|0|||
146723187|NCT01972841|529156976|FG003|Overall Study|Lack of Efficacy|2|||
146723188|NCT01972841|529156977|FG004|Overall Study|Lack of Efficacy|4|||
146723189|NCT01972841|529156978|FG005|Overall Study|Lack of Efficacy|1|||
146723190|NCT01972841|529156973|FG000|Overall Study|Lost to Follow-up|4|||
146723191|NCT01972841|529156974|FG001|Overall Study|Lost to Follow-up|2|||
146723192|NCT01972841|529156975|FG002|Overall Study|Lost to Follow-up|4|||
146723193|NCT01972841|529156976|FG003|Overall Study|Lost to Follow-up|2|||
146723194|NCT01972841|529156977|FG004|Overall Study|Lost to Follow-up|9|||
146723195|NCT01972841|529156978|FG005|Overall Study|Lost to Follow-up|3|||
146723196|NCT01972841|529156973|FG000|Overall Study|Protocol Violation|2|||
146723197|NCT01972841|529156974|FG001|Overall Study|Protocol Violation|2|||
146723198|NCT01972841|529156975|FG002|Overall Study|Protocol Violation|3|||
146723199|NCT01972841|529156976|FG003|Overall Study|Protocol Violation|5|||
146723200|NCT01972841|529156977|FG004|Overall Study|Protocol Violation|9|||
146723201|NCT01972841|529156978|FG005|Overall Study|Protocol Violation|4|||
146723202|NCT01972841|529156973|FG000|Overall Study|Withdrawal by participants|21|||
146723203|NCT01972841|529156974|FG001|Overall Study|Withdrawal by participants|27|||
146723204|NCT01972841|529156975|FG002|Overall Study|Withdrawal by participants|23|||
146723205|NCT01972841|529156976|FG003|Overall Study|Withdrawal by participants|16|||
146723206|NCT01972841|529156977|FG004|Overall Study|Withdrawal by participants|33|||
146723207|NCT01972841|529156978|FG005|Overall Study|Withdrawal by participants|34|||
146723208|NCT01972841|529156973|FG000|Overall Study|Miscellaneous|0|||
146723209|NCT01972841|529156974|FG001|Overall Study|Miscellaneous|0|||
146723210|NCT01972841|529156975|FG002|Overall Study|Miscellaneous|4|||
146723211|NCT01972841|529156976|FG003|Overall Study|Miscellaneous|1|||
146723212|NCT01972841|529156977|FG004|Overall Study|Miscellaneous|0|||
146723213|NCT01972841|529156978|FG005|Overall Study|Miscellaneous|4|||
146723214|NCT01972841|529156973|FG000|Overall Study|Did not have end of treatment page|0|||
146723215|NCT01972841|529156974|FG001|Overall Study|Did not have end of treatment page|0|||
146723216|NCT01972841|529156975|FG002|Overall Study|Did not have end of treatment page|0|||
146723217|NCT01972841|529156976|FG003|Overall Study|Did not have end of treatment page|0|||
146723218|NCT01972841|529156977|FG004|Overall Study|Did not have end of treatment page|1|||
146723219|NCT01972841|529156978|FG005|Overall Study|Did not have end of treatment page|0|||
146723220|NCT04818346|529156981|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
146723221|NCT04818346|529156982|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
146723222|NCT04818346|529156983|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
146723223|NCT04818346|529156984|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
146723224|NCT04818346|529156981|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
146723225|NCT04818346|529156982|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
146723226|NCT04818346|529156983|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
146723227|NCT04818346|529156984|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
146723228|NCT04818346|529156981|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
146934766|NCT03571256|529917942|FG001|Overall Study|Withdrawal by Subject|1|||
146934767|NCT03571256|529917943|FG002|Overall Study|Withdrawal by Subject|1|||
146934768|NCT03571256|529917941|FG000|Overall Study|Other than specified|0|||
146723229|NCT04818346|529156982|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
146723230|NCT04818346|529156983|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
146723231|NCT04818346|529156984|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
146934769|NCT03571256|529917942|FG001|Overall Study|Other than specified|1|||
146723232|NCT04818346|529156981|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
146783789|NCT03138512|529380278|FG003|Randomization|Participants withdrew consent|0|||
146783790|NCT03138512|529380279|FG004|Randomization|Participants withdrew consent|0|||
146783791|NCT03138512|529380275|FG000|Randomization|Participant no longer meets study criteria|0|||
146783792|NCT03138512|529380276|FG001|Randomization|Participant no longer meets study criteria|3|||
146783793|NCT03138512|529380277|FG002|Randomization|Participant no longer meets study criteria|1|||
146783794|NCT03138512|529380278|FG003|Randomization|Participant no longer meets study criteria|1|||
146783795|NCT03138512|529380279|FG004|Randomization|Participant no longer meets study criteria|3|||
146783796|NCT03138512|529380275|FG000|Randomization|Other reasons|1|||
146783797|NCT03138512|529380276|FG001|Randomization|Other reasons|0|||
146783798|NCT03138512|529380277|FG002|Randomization|Other reasons|0|||
146783799|NCT03138512|529380278|FG003|Randomization|Other reasons|0|||
146783800|NCT03138512|529380279|FG004|Randomization|Other reasons|0|||
146723233|NCT04818346|529156982|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
146723234|NCT04818346|529156983|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
146723235|NCT04818346|529156984|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
146723236|NCT04818346|529156981|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
146723237|NCT04818346|529156982|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
146723238|NCT04818346|529156983|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
146723239|NCT04818346|529156984|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
146723240|NCT04818346|529156981|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
146723241|NCT04818346|529156982|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
146723242|NCT04818346|529156983|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
146723243|NCT04818346|529156984|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
146723244|NCT04818346|529156981|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
146723245|NCT04818346|529156982|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
146723246|NCT04818346|529156983|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
146723247|NCT04818346|529156984|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
146723248|NCT04818346|529156981|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
146723249|NCT04818346|529156982|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
146723250|NCT04818346|529156983|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
146723251|NCT04818346|529156984|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
146723252|NCT04818346|529156981|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
146723253|NCT04818346|529156982|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
146723254|NCT04818346|529156983|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
146723255|NCT04818346|529156984|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
146723256|NCT04818346|529156981|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
146723257|NCT04818346|529156982|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
146723258|NCT04818346|529156983|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
146723259|NCT04818346|529156984|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
146723260|NCT04818346|529156981|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
146723261|NCT04818346|529156982|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
146723262|NCT04818346|529156983|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
146723263|NCT04818346|529156984|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
146723264|NCT04818346|529156981|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
146723265|NCT04818346|529156982|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
146723266|NCT04818346|529156983|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
146723267|NCT04818346|529156984|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
146723268|NCT04818346|529156981|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
146723269|NCT04818346|529156982|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
146723270|NCT04818346|529156983|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
146723271|NCT04818346|529156984|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
146723272|NCT04818346|529156981|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
146723273|NCT04818346|529156982|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
146723274|NCT04818346|529156983|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
146723275|NCT04818346|529156984|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
146723276|NCT04818346|529156981|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
146723277|NCT04818346|529156982|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
146723278|NCT04818346|529156983|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
146723279|NCT04818346|529156984|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
146783801|NCT03138512|529380275|FG000|Treatment Part A|Disease recurrence|10|||
146783802|NCT03138512|529380276|FG001|Treatment Part A|Disease recurrence|20|||
146783803|NCT03138512|529380277|FG002|Treatment Part A|Disease recurrence|0|||
146783804|NCT03138512|529380278|FG003|Treatment Part A|Disease recurrence|0|||
146783805|NCT03138512|529380279|FG004|Treatment Part A|Disease recurrence|0|||
146783806|NCT03138512|529380275|FG000|Treatment Part A|Study Drug Toxicity|132|||
146783807|NCT03138512|529380276|FG001|Treatment Part A|Study Drug Toxicity|5|||
146783808|NCT03138512|529380277|FG002|Treatment Part A|Study Drug Toxicity|0|||
146783809|NCT03138512|529380278|FG003|Treatment Part A|Study Drug Toxicity|0|||
146783810|NCT03138512|529380279|FG004|Treatment Part A|Study Drug Toxicity|0|||
146783811|NCT03138512|529380275|FG000|Treatment Part A|Death|1|||
146783812|NCT03138512|529380276|FG001|Treatment Part A|Death|0|||
146783813|NCT03138512|529380277|FG002|Treatment Part A|Death|0|||
146783814|NCT03138512|529380278|FG003|Treatment Part A|Death|0|||
146783815|NCT03138512|529380279|FG004|Treatment Part A|Death|0|||
146783816|NCT03138512|529380275|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
146783817|NCT03138512|529380276|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
146783818|NCT03138512|529380277|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
146783819|NCT03138512|529380278|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
146783820|NCT03138512|529380279|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
146783821|NCT03138512|529380275|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
146783822|NCT03138512|529380276|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
146783823|NCT03138512|529380277|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
146783824|NCT03138512|529380278|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
146783825|NCT03138512|529380279|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
146783826|NCT03138512|529380275|FG000|Treatment Part A|Participant withdrew consent|2|||
146783827|NCT03138512|529380276|FG001|Treatment Part A|Participant withdrew consent|4|||
146783828|NCT03138512|529380277|FG002|Treatment Part A|Participant withdrew consent|0|||
146783829|NCT03138512|529380278|FG003|Treatment Part A|Participant withdrew consent|0|||
146783830|NCT03138512|529380279|FG004|Treatment Part A|Participant withdrew consent|0|||
146783831|NCT03138512|529380275|FG000|Treatment Part A|Lost to Follow-up|0|||
146783832|NCT03138512|529380276|FG001|Treatment Part A|Lost to Follow-up|1|||
146783833|NCT03138512|529380277|FG002|Treatment Part A|Lost to Follow-up|0|||
146783834|NCT03138512|529380278|FG003|Treatment Part A|Lost to Follow-up|0|||
146783835|NCT03138512|529380279|FG004|Treatment Part A|Lost to Follow-up|0|||
146783836|NCT03138512|529380275|FG000|Treatment Part A|Poor/non-compliance|1|||
146783837|NCT03138512|529380276|FG001|Treatment Part A|Poor/non-compliance|0|||
146783838|NCT03138512|529380277|FG002|Treatment Part A|Poor/non-compliance|0|||
146783839|NCT03138512|529380278|FG003|Treatment Part A|Poor/non-compliance|0|||
146783840|NCT03138512|529380279|FG004|Treatment Part A|Poor/non-compliance|0|||
146783841|NCT03138512|529380275|FG000|Treatment Part A|Pregnancy|0|||
146783842|NCT03138512|529380276|FG001|Treatment Part A|Pregnancy|1|||
146783843|NCT03138512|529380277|FG002|Treatment Part A|Pregnancy|0|||
146783844|NCT03138512|529380278|FG003|Treatment Part A|Pregnancy|0|||
146783845|NCT03138512|529380279|FG004|Treatment Part A|Pregnancy|0|||
146783846|NCT03138512|529380275|FG000|Treatment Part A|Other reasons|11|||
146783847|NCT03138512|529380276|FG001|Treatment Part A|Other reasons|8|||
146783848|NCT03138512|529380277|FG002|Treatment Part A|Other reasons|0|||
146783849|NCT03138512|529380278|FG003|Treatment Part A|Other reasons|0|||
146783850|NCT03138512|529380279|FG004|Treatment Part A|Other reasons|0|||
146783851|NCT03138512|529380275|FG000|Treatment Part B|Disease recurrence|0|||
146783852|NCT03138512|529380276|FG001|Treatment Part B|Disease recurrence|0|||
146783853|NCT03138512|529380277|FG002|Treatment Part B|Disease recurrence|6|||
146783854|NCT03138512|529380278|FG003|Treatment Part B|Disease recurrence|12|||
146783855|NCT03138512|529380279|FG004|Treatment Part B|Disease recurrence|10|||
146783856|NCT03138512|529380275|FG000|Treatment Part B|Study drug toxicity|0|||
146783857|NCT03138512|529380276|FG001|Treatment Part B|Study drug toxicity|0|||
146783858|NCT03138512|529380277|FG002|Treatment Part B|Study drug toxicity|63|||
146783859|NCT03138512|529380278|FG003|Treatment Part B|Study drug toxicity|3|||
146783860|NCT03138512|529380279|FG004|Treatment Part B|Study drug toxicity|45|||
146783861|NCT03138512|529380275|FG000|Treatment Part B|Death|0|||
146783862|NCT03138512|529380276|FG001|Treatment Part B|Death|0|||
146783863|NCT03138512|529380277|FG002|Treatment Part B|Death|1|||
146783864|NCT03138512|529380278|FG003|Treatment Part B|Death|0|||
146783865|NCT03138512|529380279|FG004|Treatment Part B|Death|0|||
146783866|NCT03138512|529380275|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
146783867|NCT03138512|529380276|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
146783868|NCT03138512|529380277|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
146783869|NCT03138512|529380278|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
146783870|NCT03138512|529380279|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
146783871|NCT03138512|529380275|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
146783872|NCT03138512|529380276|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
146783873|NCT03138512|529380277|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
146783874|NCT03138512|529380278|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
146783875|NCT03138512|529380279|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
146783876|NCT03138512|529380275|FG000|Treatment Part B|Participant withdrew consent|0|||
146783877|NCT03138512|529380276|FG001|Treatment Part B|Participant withdrew consent|0|||
146783878|NCT03138512|529380277|FG002|Treatment Part B|Participant withdrew consent|1|||
146783879|NCT03138512|529380278|FG003|Treatment Part B|Participant withdrew consent|1|||
146783880|NCT03138512|529380279|FG004|Treatment Part B|Participant withdrew consent|2|||
146783881|NCT03138512|529380275|FG000|Treatment Part B|Lost to Follow-up|0|||
146783882|NCT03138512|529380276|FG001|Treatment Part B|Lost to Follow-up|0|||
146783883|NCT03138512|529380277|FG002|Treatment Part B|Lost to Follow-up|0|||
146783884|NCT03138512|529380278|FG003|Treatment Part B|Lost to Follow-up|1|||
146783885|NCT03138512|529380279|FG004|Treatment Part B|Lost to Follow-up|0|||
146783886|NCT03138512|529380275|FG000|Treatment Part B|Poor/non-compliance|0|||
146783887|NCT03138512|529380276|FG001|Treatment Part B|Poor/non-compliance|0|||
146783888|NCT03138512|529380277|FG002|Treatment Part B|Poor/non-compliance|1|||
146783889|NCT03138512|529380278|FG003|Treatment Part B|Poor/non-compliance|1|||
146783890|NCT03138512|529380279|FG004|Treatment Part B|Poor/non-compliance|1|||
146783891|NCT03138512|529380275|FG000|Treatment Part B|Other reasons|0|||
146783892|NCT03138512|529380276|FG001|Treatment Part B|Other reasons|0|||
146783893|NCT03138512|529380277|FG002|Treatment Part B|Other reasons|3|||
146783894|NCT03138512|529380278|FG003|Treatment Part B|Other reasons|1|||
146783895|NCT03138512|529380279|FG004|Treatment Part B|Other reasons|5|||
146783896|NCT05323084|529380281|FG000|Period 2 - Washout|Lost to Follow-up|0|||
146783897|NCT05323084|529380282|FG001|Period 2 - Washout|Lost to Follow-up|1|||
146783898|NCT04382404|529380283|FG000|Overall Study|Adverse Event|1|||
146783899|NCT04382404|529380283|FG000|Overall Study|Lost to Follow-up|2|||
146783900|NCT01580488|529380288|FG000|Overall Study|Withdrawal by Subject|1|||
146783901|NCT03892616|529380295|FG000|Washout Period 2|Met discontinuation criterion|0|||
146783902|NCT03892616|529380296|FG001|Washout Period 2|Met discontinuation criterion|0|||
146783903|NCT03892616|529380297|FG002|Washout Period 2|Met discontinuation criterion|0|||
146783904|NCT03892616|529380298|FG003|Washout Period 2|Met discontinuation criterion|0|||
146783905|NCT03892616|529380299|FG004|Washout Period 2|Met discontinuation criterion|0|||
146783906|NCT03892616|529380300|FG005|Washout Period 2|Met discontinuation criterion|0|||
146783907|NCT03892616|529380301|FG006|Washout Period 2|Met discontinuation criterion|0|||
146783908|NCT03892616|529380302|FG007|Washout Period 2|Met discontinuation criterion|0|||
146783909|NCT03892616|529380303|FG008|Washout Period 2|Met discontinuation criterion|1|||
146783910|NCT03892616|529380304|FG009|Washout Period 2|Met discontinuation criterion|0|||
146783911|NCT03892616|529380305|FG010|Washout Period 2|Met discontinuation criterion|0|||
146783912|NCT03892616|529380306|FG011|Washout Period 2|Met discontinuation criterion|0|||
146783913|NCT02243709|529380307|FG000|Phase 1|Lost to Follow-up|0|||
146783914|NCT02243709|529380308|FG001|Phase 1|Lost to Follow-up|1|||
146783915|NCT02243709|529380307|FG000|Phase 1|Withdrawal by Subject|1|||
146783916|NCT02243709|529380308|FG001|Phase 1|Withdrawal by Subject|0|||
146783917|NCT02243709|529380307|FG000|Phase 1|Protocol Violation|0|||
146783918|NCT02243709|529380308|FG001|Phase 1|Protocol Violation|1|||
146783919|NCT02243709|529380307|FG000|Phase 1|Adverse Event|0|||
146783920|NCT02243709|529380308|FG001|Phase 1|Adverse Event|1|||
146783921|NCT04347161|529380311|FG000|Overall Study|Death|0|||
146783922|NCT04347161|529380312|FG001|Overall Study|Death|2|||
146783923|NCT04347161|529380311|FG000|Overall Study|Withdrawal by Subject|1|||
146723280|NCT00492284|529156985|FG000|Overall Study|Adverse Event|0|||
146723281|NCT00492284|529156986|FG001|Overall Study|Adverse Event|1|||
146723282|NCT00492284|529156987|FG002|Overall Study|Adverse Event|1|||
146723283|NCT00492284|529156988|FG003|Overall Study|Adverse Event|2|||
146723284|NCT00492284|529156985|FG000|Overall Study|Lost to Follow-up|0|||
146723285|NCT00492284|529156986|FG001|Overall Study|Lost to Follow-up|0|||
146723286|NCT00492284|529156987|FG002|Overall Study|Lost to Follow-up|3|||
146723287|NCT00492284|529156988|FG003|Overall Study|Lost to Follow-up|1|||
146723288|NCT00492284|529156985|FG000|Overall Study|Death|0|||
146723289|NCT00492284|529156986|FG001|Overall Study|Death|3|||
146723290|NCT00492284|529156987|FG002|Overall Study|Death|2|||
146723291|NCT00492284|529156988|FG003|Overall Study|Death|5|||
146723292|NCT00492284|529156985|FG000|Overall Study|Withdrawal by Subject|1|||
146723293|NCT00492284|529156986|FG001|Overall Study|Withdrawal by Subject|0|||
146723294|NCT00492284|529156987|FG002|Overall Study|Withdrawal by Subject|0|||
146723295|NCT00492284|529156988|FG003|Overall Study|Withdrawal by Subject|2|||
146723296|NCT03695172|529156989|FG000|Overall Study|Withdrawal by Subject|1|||
146723297|NCT03695172|529156990|FG001|Overall Study|Withdrawal by Subject|1|||
146783924|NCT04347161|529380312|FG001|Overall Study|Withdrawal by Subject|0|||
146783925|NCT04347161|529380311|FG000|Overall Study|Lost to Follow-up|0|||
146783926|NCT04347161|529380312|FG001|Overall Study|Lost to Follow-up|1|||
146783927|NCT04347161|529380311|FG000|Overall Study|No longer on study medication|1|||
146783928|NCT04347161|529380312|FG001|Overall Study|No longer on study medication|1|||
146783929|NCT04533347|529380313|FG000|Overall Study|Adverse Event|1|||
146783930|NCT04533347|529380314|FG001|Overall Study|Adverse Event|2|||
146783931|NCT04533347|529380313|FG000|Overall Study|Lost to Follow-up|2|||
146783932|NCT04533347|529380314|FG001|Overall Study|Lost to Follow-up|0|||
146783933|NCT04533347|529380313|FG000|Overall Study|Withdrawal by Subject|1|||
146723298|NCT03695172|529156991|FG002|Overall Study|Withdrawal by Subject|0|||
146783934|NCT04533347|529380314|FG001|Overall Study|Withdrawal by Subject|0|||
146783935|NCT05520190|529380315|FG000|Overall Study|Lost to Follow-up|7|||
146783936|NCT05520190|529380315|FG000|Overall Study|Withdrawal by Subject|2|||
146783937|NCT01748448|529380316|FG000|Treatment Period|Consent withdrawn by subject|1|||
146783938|NCT01748448|529380317|FG001|Treatment Period|Consent withdrawn by subject|0|||
146783939|NCT01748448|529380316|FG000|Treatment Period|Adverse Event|1|||
146783940|NCT01748448|529380317|FG001|Treatment Period|Adverse Event|0|||
146783941|NCT01748448|529380316|FG000|Treatment Period|Personal|0|||
146783942|NCT01748448|529380317|FG001|Treatment Period|Personal|1|||
146783943|NCT03699709|529380323|FG000|Overall Study|Death|1|||
146783944|NCT03699709|529380324|FG001|Overall Study|Death|2|||
146783945|NCT03699709|529380323|FG000|Overall Study|Lost to Follow-up|10|||
146783946|NCT03699709|529380324|FG001|Overall Study|Lost to Follow-up|3|||
146934770|NCT03571256|529917943|FG002|Overall Study|Other than specified|1|||
146934771|NCT03571256|529917941|FG000|Overall Study|Protocol Violation|0|||
146934772|NCT03571256|529917942|FG001|Overall Study|Protocol Violation|1|||
146723299|NCT02734212|529156992|FG000|Overall Study|Lost to Follow-up|5|||
146723300|NCT02734212|529156993|FG001|Overall Study|Lost to Follow-up|10|||
146723301|NCT04313881|529156996|FG000|Overall Study|Death|138|||
146723302|NCT04313881|529156997|FG001|Overall Study|Death|126|||
146723303|NCT04313881|529156996|FG000|Overall Study|Study terminated by sponsor|108|||
146723304|NCT04313881|529156997|FG001|Overall Study|Study terminated by sponsor|129|||
146723305|NCT04313881|529156996|FG000|Overall Study|Consent withdrawn|19|||
146723306|NCT04313881|529156997|FG001|Overall Study|Consent withdrawn|15|||
146723307|NCT04313881|529156996|FG000|Overall Study|Reason not Specified|3|||
146723308|NCT04313881|529156997|FG001|Overall Study|Reason not Specified|1|||
146723309|NCT00727272|529156998|FG000|Washout Period A|Adverse Event|0|||
146723310|NCT00727272|529156999|FG001|Washout Period A|Adverse Event|0|||
146723311|NCT00727272|529157000|FG002|Washout Period A|Adverse Event|1|||
146723312|NCT00727272|529156998|FG000|Washout Period B|Withdrawal by Subject|0|||
146723313|NCT00727272|529156999|FG001|Washout Period B|Withdrawal by Subject|0|||
146723314|NCT00727272|529157000|FG002|Washout Period B|Withdrawal by Subject|1|||
146723315|NCT00651664|529157001|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
146723316|NCT00651664|529157002|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
146723317|NCT00651664|529157003|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
146723318|NCT00651664|529157004|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
146723319|NCT00651664|529157005|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
146723320|NCT00651664|529157006|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
146723321|NCT00651664|529157007|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
146723322|NCT00651664|529157008|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
146723323|NCT00651664|529157009|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
146723324|NCT00651664|529157010|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
146723325|NCT00651664|529157001|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
146723326|NCT00651664|529157002|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
146723327|NCT00651664|529157003|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
146723328|NCT00651664|529157004|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
146723329|NCT00651664|529157005|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
146723330|NCT00651664|529157006|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
146723331|NCT00651664|529157007|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
146723332|NCT00651664|529157008|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
146723333|NCT00651664|529157009|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
146723334|NCT00651664|529157010|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
146723335|NCT00651664|529157001|FG000|Overall Study|Progressive Disease|3|||
146723336|NCT00651664|529157002|FG001|Overall Study|Progressive Disease|3|||
146723337|NCT00651664|529157003|FG002|Overall Study|Progressive Disease|3|||
146723338|NCT00651664|529157004|FG003|Overall Study|Progressive Disease|12|||
146723339|NCT00651664|529157005|FG004|Overall Study|Progressive Disease|4|||
146723340|NCT00651664|529157006|FG005|Overall Study|Progressive Disease|1|||
146723341|NCT00651664|529157007|FG006|Overall Study|Progressive Disease|3|||
146723342|NCT00651664|529157008|FG007|Overall Study|Progressive Disease|6|||
146723343|NCT00651664|529157009|FG008|Overall Study|Progressive Disease|5|||
146723344|NCT00651664|529157010|FG009|Overall Study|Progressive Disease|5|||
146783947|NCT03699709|529380323|FG000|Overall Study|Withdrawal by Subject|5|||
146783948|NCT03699709|529380324|FG001|Overall Study|Withdrawal by Subject|0|||
146723345|NCT00651664|529157001|FG000|Overall Study|Patient Declined Further Treatment|0|||
146723346|NCT00651664|529157002|FG001|Overall Study|Patient Declined Further Treatment|0|||
146723347|NCT00651664|529157003|FG002|Overall Study|Patient Declined Further Treatment|0|||
146723348|NCT00651664|529157004|FG003|Overall Study|Patient Declined Further Treatment|1|||
146723349|NCT00651664|529157005|FG004|Overall Study|Patient Declined Further Treatment|1|||
146723350|NCT00651664|529157006|FG005|Overall Study|Patient Declined Further Treatment|1|||
146723351|NCT00651664|529157007|FG006|Overall Study|Patient Declined Further Treatment|0|||
146783949|NCT03699709|529380323|FG000|Overall Study|incarcerated|1|||
146783950|NCT03699709|529380324|FG001|Overall Study|incarcerated|0|||
146783951|NCT03699709|529380323|FG000|Overall Study|scheduled, but no show|0|||
146934773|NCT03571256|529917943|FG002|Overall Study|Protocol Violation|1|||
146783952|NCT03699709|529380324|FG001|Overall Study|scheduled, but no show|1|||
146723352|NCT00651664|529157008|FG007|Overall Study|Patient Declined Further Treatment|0|||
146723353|NCT00651664|529157009|FG008|Overall Study|Patient Declined Further Treatment|0|||
146723354|NCT00651664|529157010|FG009|Overall Study|Patient Declined Further Treatment|1|||
146723355|NCT00651664|529157001|FG000|Overall Study|Symptomatic Deterioration|0|||
146723356|NCT00651664|529157002|FG001|Overall Study|Symptomatic Deterioration|0|||
146723357|NCT00651664|529157003|FG002|Overall Study|Symptomatic Deterioration|0|||
146723358|NCT00651664|529157004|FG003|Overall Study|Symptomatic Deterioration|1|||
146723359|NCT00651664|529157005|FG004|Overall Study|Symptomatic Deterioration|0|||
146723360|NCT00651664|529157006|FG005|Overall Study|Symptomatic Deterioration|0|||
146723361|NCT00651664|529157007|FG006|Overall Study|Symptomatic Deterioration|1|||
146723362|NCT00651664|529157008|FG007|Overall Study|Symptomatic Deterioration|0|||
146723363|NCT00651664|529157009|FG008|Overall Study|Symptomatic Deterioration|1|||
146723364|NCT00651664|529157010|FG009|Overall Study|Symptomatic Deterioration|0|||
146723365|NCT00651664|529157001|FG000|Overall Study|Reason not Specified|0|||
146723366|NCT00651664|529157002|FG001|Overall Study|Reason not Specified|0|||
146723367|NCT00651664|529157003|FG002|Overall Study|Reason not Specified|0|||
146723368|NCT00651664|529157004|FG003|Overall Study|Reason not Specified|0|||
146723369|NCT00651664|529157005|FG004|Overall Study|Reason not Specified|0|||
146723370|NCT00651664|529157006|FG005|Overall Study|Reason not Specified|0|||
146723371|NCT00651664|529157007|FG006|Overall Study|Reason not Specified|1|||
146723372|NCT00651664|529157008|FG007|Overall Study|Reason not Specified|0|||
146723373|NCT00651664|529157009|FG008|Overall Study|Reason not Specified|0|||
146723374|NCT00651664|529157010|FG009|Overall Study|Reason not Specified|0|||
146723375|NCT00688636|529157011|FG000|Overall Study|Adverse Event|2|||
146723376|NCT00688636|529157012|FG001|Overall Study|Adverse Event|1|||
146723377|NCT01572727|529157013|FG000|Overall Study|Adverse Event|43|||
146723378|NCT01572727|529157014|FG001|Overall Study|Adverse Event|15|||
146723379|NCT01572727|529157013|FG000|Overall Study|Lost to Follow-up|1|||
146723380|NCT01572727|529157014|FG001|Overall Study|Lost to Follow-up|1|||
146723381|NCT01572727|529157013|FG000|Overall Study|Physician Decision|23|||
146723382|NCT01572727|529157014|FG001|Overall Study|Physician Decision|9|||
146723383|NCT01572727|529157013|FG000|Overall Study|Progressive disease|59|||
146723384|NCT01572727|529157014|FG001|Overall Study|Progressive disease|82|||
146723385|NCT01572727|529157013|FG000|Overall Study|Protocol Violation|0|||
146723386|NCT01572727|529157014|FG001|Overall Study|Protocol Violation|1|||
146723387|NCT01572727|529157013|FG000|Overall Study|Study terminated by sponsor|61|||
146723388|NCT01572727|529157014|FG001|Overall Study|Study terminated by sponsor|83|||
146723389|NCT01572727|529157013|FG000|Overall Study|Parent/guardian decision|14|||
146723390|NCT01572727|529157014|FG001|Overall Study|Parent/guardian decision|9|||
146723391|NCT01572727|529157013|FG000|Overall Study|Death|2|||
146723392|NCT01572727|529157014|FG001|Overall Study|Death|2|||
146723393|NCT01572727|529157013|FG000|Overall Study|Untreated|4|||
146723394|NCT01572727|529157014|FG001|Overall Study|Untreated|7|||
146723395|NCT04053764|529157015|FG000|Overall Study|Withdrawal by Subject|6|||
146723396|NCT04053764|529157016|FG001|Overall Study|Withdrawal by Subject|2|||
146723397|NCT04053764|529157015|FG000|Overall Study|Physician Decision|2|||
146723398|NCT04053764|529157016|FG001|Overall Study|Physician Decision|1|||
146723399|NCT04053764|529157015|FG000|Overall Study|Adverse Event|1|||
146723400|NCT04053764|529157016|FG001|Overall Study|Adverse Event|0|||
146723401|NCT04053764|529157015|FG000|Overall Study|Pregnancy|1|||
146723402|NCT04053764|529157016|FG001|Overall Study|Pregnancy|0|||
146723403|NCT04732286|529157017|FG000|Overall Study|Progressive Disease|2|||
146723404|NCT04732286|529157017|FG000|Overall Study|Physician Decision|1|||
146723405|NCT04732286|529157017|FG000|Overall Study|Study Terminated by Sponsor|31|||
146723406|NCT04732286|529157017|FG000|Overall Study|Withdrawal by Subject|10|||
146723407|NCT04732286|529157017|FG000|Overall Study|Non-compliance With Study Drug|1|||
146723408|NCT04732286|529157017|FG000|Overall Study|Lost to Follow-up|4|||
146934774|NCT01714817|529917950|FG000|Year 1 Period|Lack of Efficacy|11|||
146934775|NCT01714817|529917951|FG001|Year 1 Period|Lack of Efficacy|9|||
146723409|NCT04732286|529157017|FG000|Overall Study|Death|51|||
146723410|NCT01474681|529157018|FG000|Overall Study|Death|0|||
146723411|NCT01474681|529157019|FG001|Overall Study|Death|3|||
146723412|NCT01474681|529157020|FG002|Overall Study|Death|2|||
146723413|NCT01474681|529157021|FG003|Overall Study|Death|6|||
146723414|NCT03282227|529157027|FG000|Overall Study|Exposure Goals Achieved|60|||
146723415|NCT03282227|529157027|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
146723416|NCT03282227|529157027|FG000|Overall Study|Adverse Event|15|||
146723417|NCT03282227|529157027|FG000|Overall Study|Lost to Follow-up|21|||
146723418|NCT03282227|529157027|FG000|Overall Study|Withdrawal by Subject|20|||
146723419|NCT03282227|529157027|FG000|Overall Study|Lack of Efficacy|12|||
146723420|NCT03282227|529157027|FG000|Overall Study|Sponsor decision|3|||
146723421|NCT03282227|529157027|FG000|Overall Study|Physician Decision|2|||
146723422|NCT03282227|529157027|FG000|Overall Study|Pregnancy|2|||
146723423|NCT03282227|529157027|FG000|Overall Study|Other|1|||
146723424|NCT02491671|529157030|FG000|Overall Study|Adverse Event|6|||
146934776|NCT01714817|529917950|FG000|Year 1 Period|Adverse Event|20|||
146723425|NCT02491671|529157031|FG001|Overall Study|Adverse Event|8|||
146723426|NCT02491671|529157030|FG000|Overall Study|Death|0|||
146723427|NCT02491671|529157031|FG001|Overall Study|Death|2|||
146723428|NCT02491671|529157030|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
146723429|NCT02491671|529157031|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
146723430|NCT02251990|529157032|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
146723431|NCT02251990|529157033|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
146723432|NCT02251990|529157032|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
146723433|NCT02251990|529157033|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
146723434|NCT02251990|529157032|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
146723435|NCT02251990|529157033|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
146723436|NCT02251990|529157032|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
146723437|NCT02251990|529157033|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
146723438|NCT02251990|529157032|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
146723439|NCT02251990|529157033|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
146723440|NCT02251990|529157032|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
146723441|NCT02251990|529157033|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
146723442|NCT03265600|529157034|FG000|Overall Study|Lost to Follow-up|17|||
146723443|NCT03265600|529157035|FG001|Overall Study|Lost to Follow-up|5|||
146723444|NCT03265600|529157034|FG000|Overall Study|Withdrawal by Subject|4|||
146723445|NCT03265600|529157035|FG001|Overall Study|Withdrawal by Subject|2|||
146723446|NCT03265600|529157034|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
146723447|NCT03265600|529157035|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
146723448|NCT00535730|529157036|FG000|Overall Study|Adverse Event|1|||
146723449|NCT00535730|529157037|FG001|Overall Study|Adverse Event|1|||
146723450|NCT00535730|529157036|FG000|Overall Study|Lost to Follow-up|0|||
146723451|NCT00535730|529157037|FG001|Overall Study|Lost to Follow-up|1|||
146723452|NCT00535730|529157036|FG000|Overall Study|Physician Decision|0|||
146723453|NCT00535730|529157037|FG001|Overall Study|Physician Decision|1|||
146723454|NCT00535730|529157036|FG000|Overall Study|Protocol Violation|1|||
146723455|NCT00535730|529157037|FG001|Overall Study|Protocol Violation|0|||
146723456|NCT00535730|529157036|FG000|Overall Study|Withdrawal by Subject|0|||
146723457|NCT00535730|529157037|FG001|Overall Study|Withdrawal by Subject|4|||
146723458|NCT02293538|529157038|FG000|Overall Study|Adverse Event|0|||
146723459|NCT02293538|529157039|FG001|Overall Study|Adverse Event|1|||
146723460|NCT02293538|529157038|FG000|Overall Study|Lost to Follow-up|1|||
146723461|NCT02293538|529157039|FG001|Overall Study|Lost to Follow-up|0|||
146723462|NCT02293538|529157038|FG000|Overall Study|Withdrawal by Subject|0|||
146723463|NCT02293538|529157039|FG001|Overall Study|Withdrawal by Subject|1|||
146723464|NCT00584727|529157041|FG000|First Intervention|Discontinuation|0|||
146723465|NCT00584727|529157042|FG001|First Intervention|Discontinuation|0|||
146723466|NCT00584727|529157043|FG002|First Intervention|Discontinuation|1|||
146723467|NCT00584727|529157044|FG003|First Intervention|Discontinuation|0|||
146723468|NCT00584727|529157045|FG004|First Intervention|Discontinuation|0|||
146723469|NCT00584727|529157046|FG005|First Intervention|Discontinuation|0|||
146723470|NCT00584727|529157041|FG000|Third Intervention|Protocol Violation|0|||
146723471|NCT00584727|529157042|FG001|Third Intervention|Protocol Violation|0|||
146723472|NCT00584727|529157043|FG002|Third Intervention|Protocol Violation|1|||
146723473|NCT00584727|529157044|FG003|Third Intervention|Protocol Violation|0|||
146723474|NCT00584727|529157045|FG004|Third Intervention|Protocol Violation|4|||
146723475|NCT00584727|529157046|FG005|Third Intervention|Protocol Violation|2|||
146723476|NCT00729833|529157049|FG000|Overall Study|Death|5|||
146723477|NCT00729833|529157050|FG001|Overall Study|Death|1|||
146723478|NCT00729833|529157051|FG002|Overall Study|Death|3|||
146723479|NCT00729833|529157052|FG003|Overall Study|Death|5|||
146723480|NCT00729833|529157049|FG000|Overall Study|Study Terminated by Sponsor|0|||
146723481|NCT00729833|529157050|FG001|Overall Study|Study Terminated by Sponsor|0|||
146723482|NCT00729833|529157051|FG002|Overall Study|Study Terminated by Sponsor|1|||
146723483|NCT00729833|529157052|FG003|Overall Study|Study Terminated by Sponsor|0|||
146723484|NCT00729833|529157049|FG000|Overall Study|Lost to Follow-up|1|||
146723485|NCT00729833|529157050|FG001|Overall Study|Lost to Follow-up|0|||
146723486|NCT00729833|529157051|FG002|Overall Study|Lost to Follow-up|0|||
146723487|NCT00729833|529157052|FG003|Overall Study|Lost to Follow-up|0|||
146723488|NCT00729833|529157049|FG000|Overall Study|Withdrawal by Subject|3|||
146723489|NCT00729833|529157050|FG001|Overall Study|Withdrawal by Subject|1|||
146723490|NCT00729833|529157051|FG002|Overall Study|Withdrawal by Subject|3|||
146723491|NCT00729833|529157052|FG003|Overall Study|Withdrawal by Subject|0|||
146723492|NCT00729833|529157049|FG000|Overall Study|Unspecified Reasons|11|||
146723493|NCT00729833|529157050|FG001|Overall Study|Unspecified Reasons|5|||
146723494|NCT00729833|529157051|FG002|Overall Study|Unspecified Reasons|5|||
146723495|NCT00729833|529157052|FG003|Overall Study|Unspecified Reasons|1|||
146783953|NCT02907099|529380325|FG000|Overall Study|Adverse Event|1|||
146981363|NCT01571635|530093878|FG000|Overall Study|Other reasons|2|||
146723496|NCT02820623|529157053|FG000|Overall Study|Withdrawal by Subject|1|||
146723497|NCT02820623|529157054|FG001|Overall Study|Withdrawal by Subject|3|||
146723498|NCT02820623|529157055|FG002|Overall Study|Withdrawal by Subject|3|||
146723499|NCT02820623|529157053|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
146723500|NCT02820623|529157054|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
146934777|NCT01714817|529917951|FG001|Year 1 Period|Adverse Event|17|||
146934778|NCT01714817|529917950|FG000|Year 1 Period|Withdrawal by Subject|6|||
146934779|NCT01714817|529917951|FG001|Year 1 Period|Withdrawal by Subject|7|||
146934780|NCT01714817|529917950|FG000|Year 1 Period|Death|1|||
146934781|NCT01714817|529917951|FG001|Year 1 Period|Death|1|||
146934782|NCT01714817|529917950|FG000|Year 1 Period|Lost to Follow-up|0|||
146934783|NCT01714817|529917951|FG001|Year 1 Period|Lost to Follow-up|2|||
146934784|NCT01714817|529917950|FG000|Year 1 Period|Poor / non-compliance|0|||
146723501|NCT02820623|529157055|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
146723502|NCT02820623|529157053|FG000|Overall Study|Therapist unable to enroll clients|1|||
146723503|NCT02820623|529157054|FG001|Overall Study|Therapist unable to enroll clients|1|||
146723504|NCT02820623|529157055|FG002|Overall Study|Therapist unable to enroll clients|3|||
146723505|NCT02820623|529157053|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
146723506|NCT02820623|529157054|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
146723507|NCT02820623|529157055|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
146723508|NCT04598152|529157065|FG000|Overall Study|Lost to Follow-up|0|||
146723509|NCT04598152|529157066|FG001|Overall Study|Lost to Follow-up|1|||
146723510|NCT01954017|529157067|FG000|Overall Study|Adverse Event|0|||
146723511|NCT01954017|529157068|FG001|Overall Study|Adverse Event|0|||
146723512|NCT01954017|529157069|FG002|Overall Study|Adverse Event|1|||
146723513|NCT01954017|529157067|FG000|Overall Study|Death|2|||
146723514|NCT01954017|529157068|FG001|Overall Study|Death|1|||
146723515|NCT01954017|529157069|FG002|Overall Study|Death|1|||
146723516|NCT01954017|529157067|FG000|Overall Study|Withdrawal by Subject|0|||
146723517|NCT01954017|529157068|FG001|Overall Study|Withdrawal by Subject|1|||
146723518|NCT01954017|529157069|FG002|Overall Study|Withdrawal by Subject|0|||
146723519|NCT01954017|529157067|FG000|Overall Study|Protocol Violation|0|||
146723520|NCT01954017|529157068|FG001|Overall Study|Protocol Violation|3|||
146723521|NCT01954017|529157069|FG002|Overall Study|Protocol Violation|2|||
146723522|NCT01954017|529157067|FG000|Overall Study|Necrotizing enterocolitis|1|||
146723523|NCT01954017|529157068|FG001|Overall Study|Necrotizing enterocolitis|0|||
146723524|NCT01954017|529157069|FG002|Overall Study|Necrotizing enterocolitis|1|||
146723525|NCT01954017|529157067|FG000|Overall Study|Enteral intake stopped >7 days|0|||
146723526|NCT01954017|529157068|FG001|Overall Study|Enteral intake stopped >7 days|1|||
146723527|NCT01954017|529157069|FG002|Overall Study|Enteral intake stopped >7 days|1|||
146723528|NCT01954017|529157067|FG000|Overall Study|All other reasons|2|||
146723529|NCT01954017|529157068|FG001|Overall Study|All other reasons|2|||
146723530|NCT01954017|529157069|FG002|Overall Study|All other reasons|7|||
146723531|NCT03346759|529157070|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
146723532|NCT03346759|529157071|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
146723533|NCT03346759|529157070|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
146723534|NCT03346759|529157071|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
146723535|NCT03346759|529157070|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
146723536|NCT03346759|529157071|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
146723537|NCT01453595|529157073|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
146723538|NCT01453595|529157074|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
146723539|NCT01453595|529157075|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
146723540|NCT01864564|529157081|FG000|Overall Study|Lost to Follow-up|17|||
146723541|NCT01864564|529157082|FG001|Overall Study|Lost to Follow-up|23|||
146723542|NCT01864564|529157081|FG000|Overall Study|Withdrawal by Subject|20|||
146723543|NCT01864564|529157082|FG001|Overall Study|Withdrawal by Subject|11|||
146723544|NCT01864564|529157081|FG000|Overall Study|Protocol Violation|0|||
146723545|NCT01864564|529157082|FG001|Overall Study|Protocol Violation|27|||
146723546|NCT01864564|529157081|FG000|Overall Study|not reported|0|||
146723547|NCT01864564|529157082|FG001|Overall Study|not reported|34|||
146723548|NCT00710424|529157085|FG000|Overall Study|Adverse Event|30|||
146723549|NCT00710424|529157086|FG001|Overall Study|Adverse Event|12|||
146723550|NCT00710424|529157085|FG000|Overall Study|Lack of Efficacy|4|||
146723551|NCT00710424|529157086|FG001|Overall Study|Lack of Efficacy|5|||
146723552|NCT00710424|529157085|FG000|Overall Study|Withdrawal by Subject|5|||
146723553|NCT00710424|529157086|FG001|Overall Study|Withdrawal by Subject|3|||
146723554|NCT00710424|529157085|FG000|Overall Study|Lost to Follow-up|0|||
146723555|NCT00710424|529157086|FG001|Overall Study|Lost to Follow-up|1|||
146723556|NCT00710424|529157085|FG000|Overall Study|Refused medication, no side effects|1|||
146723557|NCT00710424|529157086|FG001|Overall Study|Refused medication, no side effects|0|||
146723558|NCT00710424|529157085|FG000|Overall Study|Non-compliance with stable analgesia|1|||
146723559|NCT00710424|529157086|FG001|Overall Study|Non-compliance with stable analgesia|0|||
146723560|NCT00710424|529157085|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
146723561|NCT00710424|529157086|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
146723562|NCT00710424|529157085|FG000|Overall Study|Subject thought medication changed|1|||
146723563|NCT00710424|529157086|FG001|Overall Study|Subject thought medication changed|0|||
146723564|NCT00710424|529157085|FG000|Overall Study|Ceased treatment due to travel|1|||
146934785|NCT01714817|529917951|FG001|Year 1 Period|Poor / non-compliance|1|||
146934786|NCT01714817|529917950|FG000|Year 1 Period|Pregnancy|2|||
146934787|NCT01714817|529917951|FG001|Year 1 Period|Pregnancy|0|||
146934788|NCT01714817|529917950|FG000|Year 1 Period|Participant no longer meets criteria|6|||
146723565|NCT00710424|529157086|FG001|Overall Study|Ceased treatment due to travel|0|||
146723566|NCT00710424|529157085|FG000|Overall Study|Subject preferred paracetamol|0|||
146723567|NCT00710424|529157086|FG001|Overall Study|Subject preferred paracetamol|1|||
146723568|NCT00710424|529157085|FG000|Overall Study|Felt good so stopped treatment|0|||
146723569|NCT00710424|529157086|FG001|Overall Study|Felt good so stopped treatment|1|||
146723570|NCT01738984|529158645|FG000|Overall Study|Pregnancy|4|||
146723571|NCT01738984|529158646|FG001|Overall Study|Pregnancy|0|||
146723572|NCT01738984|529158645|FG000|Overall Study|Withdrawal by Subject|1|||
146723573|NCT01738984|529158646|FG001|Overall Study|Withdrawal by Subject|0|||
146723574|NCT01738984|529158645|FG000|Overall Study|Lost to Follow-up|59|||
146723575|NCT01738984|529158646|FG001|Overall Study|Lost to Follow-up|39|||
146723576|NCT00955357|529158650|FG000|Titration Phase|Adverse Event|9|||
146723577|NCT00955357|529158651|FG001|Titration Phase|Adverse Event|46|||
146723578|NCT00955357|529158650|FG000|Titration Phase|Lack of Efficacy|0|||
146723579|NCT00955357|529158651|FG001|Titration Phase|Lack of Efficacy|2|||
146723580|NCT00955357|529158650|FG000|Titration Phase|Protocol Violation|3|||
146723581|NCT00955357|529158651|FG001|Titration Phase|Protocol Violation|7|||
146723582|NCT00955357|529158650|FG000|Titration Phase|Lost to Follow-up|1|||
146723583|NCT00955357|529158651|FG001|Titration Phase|Lost to Follow-up|3|||
146723584|NCT00955357|529158650|FG000|Titration Phase|Withdrawal by Subject|3|||
146723585|NCT00955357|529158651|FG001|Titration Phase|Withdrawal by Subject|5|||
146723586|NCT00955357|529158650|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
146723587|NCT00955357|529158651|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
146723588|NCT00955357|529158650|FG000|Titration Phase|Study medication not tolerated|0|||
146723589|NCT00955357|529158651|FG001|Titration Phase|Study medication not tolerated|1|||
146723590|NCT00955357|529158650|FG000|Titration Phase|Non compliance to study procedures|0|||
146723591|NCT00955357|529158651|FG001|Titration Phase|Non compliance to study procedures|1|||
146723592|NCT00955357|529158650|FG000|Maintenance Phase|Adverse Event|3|||
146723593|NCT00955357|529158651|FG001|Maintenance Phase|Adverse Event|23|||
146723594|NCT00955357|529158650|FG000|Maintenance Phase|Lack of Efficacy|0|||
146723595|NCT00955357|529158651|FG001|Maintenance Phase|Lack of Efficacy|4|||
146723596|NCT00955357|529158650|FG000|Maintenance Phase|Protocol Violation|2|||
146723597|NCT00955357|529158651|FG001|Maintenance Phase|Protocol Violation|6|||
146723598|NCT00955357|529158650|FG000|Maintenance Phase|Lost to Follow-up|2|||
146723599|NCT00955357|529158651|FG001|Maintenance Phase|Lost to Follow-up|7|||
146723600|NCT00955357|529158650|FG000|Maintenance Phase|Withdrawal by Subject|4|||
146723601|NCT00955357|529158651|FG001|Maintenance Phase|Withdrawal by Subject|4|||
146723602|NCT00955357|529158650|FG000|Maintenance Phase|Patient moving out of area|0|||
146723603|NCT00955357|529158651|FG001|Maintenance Phase|Patient moving out of area|1|||
146723604|NCT00955357|529158650|FG000|Maintenance Phase|Non compliance to study procedures|1|||
146723605|NCT00955357|529158651|FG001|Maintenance Phase|Non compliance to study procedures|0|||
146723606|NCT01258608|529158652|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
146723607|NCT01258608|529158653|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
146723608|NCT01258608|529158652|FG000|Overall Study|Clinical progression|1|||
146723609|NCT01258608|529158653|FG001|Overall Study|Clinical progression|0|||
146723610|NCT01258608|529158652|FG000|Overall Study|Sponsor decision|0|||
146723611|NCT01258608|529158653|FG001|Overall Study|Sponsor decision|1|||
146723612|NCT01258608|529158652|FG000|Overall Study|Physician Decision|6|||
146723613|NCT01258608|529158653|FG001|Overall Study|Physician Decision|1|||
146723614|NCT01258608|529158652|FG000|Overall Study|Lost to Follow-up|0|||
146723615|NCT01258608|529158653|FG001|Overall Study|Lost to Follow-up|1|||
146723616|NCT01258608|529158652|FG000|Overall Study|Lack of compliance|1|||
146723617|NCT01258608|529158653|FG001|Overall Study|Lack of compliance|0|||
146723618|NCT01258608|529158652|FG000|Overall Study|Lack of Efficacy|0|||
146723619|NCT01258608|529158653|FG001|Overall Study|Lack of Efficacy|1|||
146723620|NCT01258608|529158652|FG000|Overall Study|Adverse Event|6|||
146723621|NCT01258608|529158653|FG001|Overall Study|Adverse Event|10|||
146723622|NCT01258608|529158652|FG000|Overall Study|Withdrawal by Subject|6|||
146723623|NCT01258608|529158653|FG001|Overall Study|Withdrawal by Subject|5|||
146723624|NCT02943408|529158659|FG000|Overall Study|Lost to Follow-up|7|||
146723625|NCT02943408|529158660|FG001|Overall Study|Lost to Follow-up|1|||
146723626|NCT02943408|529158659|FG000|Overall Study|Withdrawal by Subject|0|||
146723627|NCT02943408|529158660|FG001|Overall Study|Withdrawal by Subject|1|||
146723628|NCT01621126|529158665|FG000|Overall Study|Physician Decision|6|||
146723629|NCT01949311|529158666|FG000|Overall Study|Lost to Follow-up|73|||
146723630|NCT01949311|529158666|FG000|Overall Study|Terminated by Sponsor|708|||
146723631|NCT01949311|529158666|FG000|Overall Study|Withdrawal by Subject|375|||
146723632|NCT01949311|529158666|FG000|Overall Study|Lack of Efficacy|50|||
146723633|NCT01949311|529158666|FG000|Overall Study|Protocol Deviation|34|||
146723634|NCT01949311|529158666|FG000|Overall Study|Pregnancy|20|||
146723635|NCT01949311|529158666|FG000|Overall Study|Physician Decision|9|||
146723636|NCT01949311|529158666|FG000|Overall Study|Other|4|||
146723637|NCT01949311|529158666|FG000|Overall Study|Adverse Event|107|||
146723638|NCT02338154|529158667|FG000|Overall Study|Death|46|||
146723639|NCT02338154|529158667|FG000|Overall Study|Valve Implant Failure|17|||
146723640|NCT02338154|529158667|FG000|Overall Study|Valve Explant|11|||
146723641|NCT02338154|529158667|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
146723642|NCT02338154|529158667|FG000|Overall Study|Lost to Follow-up|8|||
146723643|NCT02338154|529158667|FG000|Overall Study|Other Reason|3|||
146723644|NCT02338154|529158667|FG000|Overall Study|Patients Without Exit Form|47|||
146723645|NCT02338154|529158667|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
146723646|NCT04279314|529158668|FG000|Overall Study|Adverse Event|55|||
146723647|NCT04279314|529158668|FG000|Overall Study|Withdrawal by Subject|5|||
146723648|NCT04279314|529158668|FG000|Overall Study|Lack of Efficacy|5|||
146723649|NCT04279314|529158668|FG000|Overall Study|Protocol Violation|3|||
146723650|NCT04279314|529158668|FG000|Overall Study|Other (not COVID-19 related)|2|||
146723651|NCT03166618|529158673|FG000|Overall Study|Study was Terminated|0|||
146723652|NCT03166618|529158674|FG001|Overall Study|Study was Terminated|1|||
146723653|NCT01925950|529158675|FG000|Part 2|Withdrawal by Subject|1|||
146723654|NCT01925950|529158676|FG001|Part 2|Withdrawal by Subject|0|||
146723655|NCT03137303|529158678|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
146723656|NCT03137303|529158679|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
146723657|NCT03137303|529158678|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
146723658|NCT03137303|529158679|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
146723659|NCT03137303|529158678|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
146723660|NCT03137303|529158679|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
146723661|NCT03137303|529158678|FG000|T3: 9-month Follow-up|Death|1|||
146723662|NCT03137303|529158679|FG001|T3: 9-month Follow-up|Death|0|||
146723663|NCT03137303|529158678|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
146723664|NCT03137303|529158679|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
146723665|NCT03137303|529158678|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
146723666|NCT03137303|529158679|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
146723667|NCT03137303|529158678|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
146723668|NCT03137303|529158679|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
146723669|NCT03561090|529158680|FG000|Overall Study|Adverse Event|11|||
146723670|NCT03561090|529158681|FG001|Overall Study|Adverse Event|7|||
146723671|NCT03561090|529158680|FG000|Overall Study|Non-Compliance With Study Drug|2|||
146723672|NCT03561090|529158681|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146723673|NCT03561090|529158680|FG000|Overall Study|Protocol Violation|2|||
146723674|NCT03561090|529158681|FG001|Overall Study|Protocol Violation|2|||
146723675|NCT03561090|529158680|FG000|Overall Study|Withdrawal by Subject|7|||
146723676|NCT03561090|529158681|FG001|Overall Study|Withdrawal by Subject|7|||
146723677|NCT03561090|529158680|FG000|Overall Study|Lost to Follow-up|7|||
146723678|NCT03561090|529158681|FG001|Overall Study|Lost to Follow-up|2|||
146723679|NCT03561090|529158680|FG000|Overall Study|Study Terminated by Sponsor|10|||
146723680|NCT03561090|529158681|FG001|Overall Study|Study Terminated by Sponsor|15|||
146723681|NCT03561090|529158680|FG000|Overall Study|Randomized by Mistake|1|||
146723682|NCT03561090|529158681|FG001|Overall Study|Randomized by Mistake|1|||
146723683|NCT03561090|529158680|FG000|Overall Study|Other Not Specified|0|||
146723684|NCT03561090|529158681|FG001|Overall Study|Other Not Specified|2|||
146723685|NCT01433354|529158692|FG000|Overall Study|Adverse Event|6|||
146723686|NCT01433354|529158692|FG000|Overall Study|Lost to Follow-up|1|||
146723687|NCT01433354|529158692|FG000|Overall Study|Administrative problems|90|||
146723688|NCT01433354|529158692|FG000|Overall Study|Protocol Violation|2|||
146723689|NCT01433354|529158692|FG000|Overall Study|Lack of Efficacy|17|||
146723690|NCT01433354|529158692|FG000|Overall Study|Subject Withdrew Consent|3|||
146723691|NCT02015676|529158697|FG000|Overall Study|Adverse Event|2|||
146723692|NCT02015676|529158698|FG001|Overall Study|Adverse Event|18|||
146723693|NCT02015676|529158699|FG002|Overall Study|Adverse Event|0|||
146723694|NCT02015676|529158697|FG000|Overall Study|Lack of Efficacy|2|||
146723695|NCT02015676|529158698|FG001|Overall Study|Lack of Efficacy|4|||
146723696|NCT02015676|529158699|FG002|Overall Study|Lack of Efficacy|0|||
146723697|NCT02015676|529158697|FG000|Overall Study|Protocol Violation|1|||
146723698|NCT02015676|529158698|FG001|Overall Study|Protocol Violation|0|||
146723699|NCT02015676|529158699|FG002|Overall Study|Protocol Violation|0|||
146723700|NCT02015676|529158697|FG000|Overall Study|Withdrawal by Subject|1|||
146723701|NCT02015676|529158698|FG001|Overall Study|Withdrawal by Subject|7|||
146723702|NCT02015676|529158699|FG002|Overall Study|Withdrawal by Subject|1|||
146723703|NCT02015676|529158697|FG000|Overall Study|Administrative reasons|0|||
146723704|NCT02015676|529158698|FG001|Overall Study|Administrative reasons|3|||
146723705|NCT02015676|529158699|FG002|Overall Study|Administrative reasons|1|||
146723706|NCT02015676|529158697|FG000|Overall Study|Death|0|||
146723707|NCT02015676|529158698|FG001|Overall Study|Death|1|||
146723708|NCT02015676|529158699|FG002|Overall Study|Death|0|||
146723709|NCT02015676|529158697|FG000|Overall Study|Disease progression|3|||
146723710|NCT02015676|529158698|FG001|Overall Study|Disease progression|1|||
146723711|NCT02015676|529158699|FG002|Overall Study|Disease progression|1|||
146723712|NCT01618162|529158700|FG000|Overall Study|Protocol Violation|13|||
146723713|NCT01618162|529158701|FG001|Overall Study|Protocol Violation|10|||
146783954|NCT02907099|529380325|FG000|Overall Study|Withdrawal by Subject|2|||
146783955|NCT02907099|529380325|FG000|Overall Study|Screen Fail|2|||
146723714|NCT01618162|529158700|FG000|Overall Study|Adverse Event|9|||
146723715|NCT01618162|529158701|FG001|Overall Study|Adverse Event|2|||
146723716|NCT01618162|529158700|FG000|Overall Study|Withdrawal Criteria|2|||
146723717|NCT01618162|529158701|FG001|Overall Study|Withdrawal Criteria|10|||
146723718|NCT01618162|529158700|FG000|Overall Study|Unclassified|14|||
146723719|NCT01618162|529158701|FG001|Overall Study|Unclassified|13|||
146723720|NCT04794803|529158702|FG000|Overall Study|Death|1|||
146723721|NCT04794803|529158703|FG001|Overall Study|Death|3|||
146723722|NCT04794803|529158702|FG000|Overall Study|Lost to Follow-up|2|||
146723723|NCT04794803|529158703|FG001|Overall Study|Lost to Follow-up|2|||
146723724|NCT04794803|529158702|FG000|Overall Study|Withdrawal by Subject|1|||
146723725|NCT04794803|529158703|FG001|Overall Study|Withdrawal by Subject|0|||
146723726|NCT04794803|529158702|FG000|Overall Study|Physician Decision|1|||
146723727|NCT04794803|529158703|FG001|Overall Study|Physician Decision|1|||
146723728|NCT04794803|529158702|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
146723729|NCT04794803|529158703|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
146723730|NCT04794803|529158702|FG000|Overall Study|Refused to continue the treatment|1|||
146723731|NCT04794803|529158703|FG001|Overall Study|Refused to continue the treatment|0|||
146723732|NCT04794803|529158702|FG000|Overall Study|Patient admitted to ICU|0|||
146723733|NCT04794803|529158703|FG001|Overall Study|Patient admitted to ICU|1|||
146723734|NCT00476476|529158705|FG000|Overall Study|Adverse Event|2|||
146723735|NCT00476476|529158706|FG001|Overall Study|Adverse Event|7|||
146723736|NCT00476476|529158705|FG000|Overall Study|Progressive Disease|0|||
146723737|NCT00476476|529158706|FG001|Overall Study|Progressive Disease|17|||
146723738|NCT00971048|529158710|FG000|Overall Study|Protocol Violation|1|||
146723739|NCT00971048|529158711|FG001|Overall Study|Protocol Violation|2|||
146723740|NCT00971048|529158712|FG002|Overall Study|Protocol Violation|0|||
146723741|NCT00971048|529158713|FG003|Overall Study|Protocol Violation|1|||
146723742|NCT00971048|529158710|FG000|Overall Study|Adverse Event|0|||
146723743|NCT00971048|529158711|FG001|Overall Study|Adverse Event|0|||
146723744|NCT00971048|529158712|FG002|Overall Study|Adverse Event|1|||
146723745|NCT00971048|529158713|FG003|Overall Study|Adverse Event|0|||
146723746|NCT00971048|529158710|FG000|Overall Study|Physician Decision|0|||
146723747|NCT00971048|529158711|FG001|Overall Study|Physician Decision|0|||
146723748|NCT00971048|529158712|FG002|Overall Study|Physician Decision|0|||
146723749|NCT00971048|529158713|FG003|Overall Study|Physician Decision|1|||
146723750|NCT03321396|529158714|FG000|Overall Study|Physician Decision|1|||
146723751|NCT01654549|529158717|FG000|Overall Study|H.pylori eradication not successful|0|||
146723752|NCT01654549|529158718|FG001|Overall Study|H.pylori eradication not successful|1|||
146723753|NCT00937924|529158721|FG000|Overall Study|Lost to Follow-up|44|||
146723754|NCT00937924|529158722|FG001|Overall Study|Lost to Follow-up|44|||
146723755|NCT00937924|529158723|FG002|Overall Study|Lost to Follow-up|41|||
146723756|NCT02633137|529158742|FG000|Overall Study|Adverse Event|1|||
146723757|NCT02633137|529158742|FG000|Overall Study|Lack of Efficacy|2|||
146723758|NCT02633137|529158742|FG000|Overall Study|Withdrawal by Subject|1|||
146723759|NCT03152526|529158743|FG000|Overall Study|Withdrawal by Subject|0|||
146723760|NCT03152526|529158744|FG001|Overall Study|Withdrawal by Subject|1|||
146723761|NCT04307004|529158745|FG000|Randomization 1|Withdrawal by Subject|25|||
146723762|NCT04307004|529158746|FG001|Randomization 1|Withdrawal by Subject|26|||
146723763|NCT04307004|529158747|FG002|Randomization 1|Withdrawal by Subject|0|||
146723764|NCT04307004|529158748|FG003|Randomization 1|Withdrawal by Subject|0|||
146723765|NCT04307004|529158745|FG000|Randomization 2|Withdrawal by Subject|0|||
146723766|NCT04307004|529158746|FG001|Randomization 2|Withdrawal by Subject|0|||
146723767|NCT04307004|529158747|FG002|Randomization 2|Withdrawal by Subject|28|||
146723768|NCT04307004|529158748|FG003|Randomization 2|Withdrawal by Subject|23|||
146723769|NCT02395042|529158749|FG000|Treatment 1 Period|Adverse Event|1|||
146723770|NCT02395042|529158750|FG001|Treatment 1 Period|Adverse Event|3|||
146723771|NCT02395042|529158751|FG002|Treatment 1 Period|Adverse Event|1|||
146723772|NCT02395042|529158749|FG000|Treatment 1 Period|Lack of Efficacy|1|||
146723773|NCT02395042|529158750|FG001|Treatment 1 Period|Lack of Efficacy|1|||
146723774|NCT02395042|529158751|FG002|Treatment 1 Period|Lack of Efficacy|0|||
146723775|NCT02395042|529158749|FG000|Treatment 1 Period|Lost to Follow-up|1|||
146723776|NCT02395042|529158750|FG001|Treatment 1 Period|Lost to Follow-up|0|||
146723777|NCT02395042|529158751|FG002|Treatment 1 Period|Lost to Follow-up|0|||
146723778|NCT02395042|529158749|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
146723779|NCT02395042|529158750|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
146723780|NCT02395042|529158751|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
146723781|NCT02395042|529158749|FG000|Treatment 2 Period|Lack of Efficacy|1|||
146723782|NCT02395042|529158750|FG001|Treatment 2 Period|Lack of Efficacy|1|||
146723783|NCT02395042|529158751|FG002|Treatment 2 Period|Lack of Efficacy|0|||
146723784|NCT04969198|529158752|FG000|Overall Study|Withdrawal by Subject|20|||
146723785|NCT04969198|529158752|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
146723786|NCT04969198|529158752|FG000|Overall Study|Lost to Follow-up|20|||
146723787|NCT04009291|529158753|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
146723788|NCT04009291|529158754|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
146723789|NCT04009291|529158755|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
146723790|NCT04009291|529158756|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
146723791|NCT04009291|529158757|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
146783956|NCT02913872|529380328|FG000|Overall Study|Withdrawal by Subject|1|||
146783957|NCT04739956|529380331|FG000|Overall Study|Withdrawal by Subject|1|||
146783958|NCT04739956|529380332|FG001|Overall Study|Withdrawal by Subject|1|||
146783959|NCT03519581|529380333|FG000|Overall Study|Lost to Follow-up|3|||
146783960|NCT03519581|529380334|FG001|Overall Study|Lost to Follow-up|2|||
146783961|NCT03519581|529380333|FG000|Overall Study|Adverse Event|5|||
146783962|NCT03519581|529380334|FG001|Overall Study|Adverse Event|2|||
146783963|NCT03519581|529380333|FG000|Overall Study|Withdrawal by Subject|2|||
146783964|NCT03519581|529380334|FG001|Overall Study|Withdrawal by Subject|0|||
146783965|NCT03519581|529380333|FG000|Overall Study|Change to insurance|2|||
146783966|NCT03519581|529380334|FG001|Overall Study|Change to insurance|1|||
146783967|NCT03519581|529380333|FG000|Overall Study|Other|2|||
146783968|NCT03519581|529380334|FG001|Overall Study|Other|4|||
146783969|NCT03110315|529380335|FG000|Overall Study|Withdrawal by Subject|1|||
146783970|NCT03110315|529380336|FG001|Overall Study|Withdrawal by Subject|0|||
146783971|NCT05134233|529380343|FG000|Overall Study|Pregnancy|1|||
146783972|NCT05134233|529380343|FG000|Overall Study|MEP value too low|2|||
146783973|NCT05134233|529380343|FG000|Overall Study|Lost to Follow-up|1|||
146783974|NCT03468218|529380344|FG000|Overall Study|Adverse Event|5|||
146783975|NCT03468218|529380344|FG000|Overall Study|Progressive Disease|16|||
146783976|NCT03468218|529380344|FG000|Overall Study|Death|1|||
146783977|NCT03468218|529380344|FG000|Overall Study|Alternate therapy|1|||
146783978|NCT03468218|529380344|FG000|Overall Study|Withdrawal by Subject|2|||
146783979|NCT02736409|529382224|FG000|Overall Study|Withdrawal by Subject|4|||
146783980|NCT02736409|529382225|FG001|Overall Study|Withdrawal by Subject|2|||
146783981|NCT02736409|529382226|FG002|Overall Study|Withdrawal by Subject|17|||
146783982|NCT02736409|529382227|FG003|Overall Study|Withdrawal by Subject|3|||
146783983|NCT02736409|529382224|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146783984|NCT02736409|529382225|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146783985|NCT02736409|529382226|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146783986|NCT02736409|529382227|FG003|Overall Study|Non-Compliance with Study Drug|1|||
146783987|NCT02736409|529382224|FG000|Overall Study|Adverse Event|0|||
146783988|NCT02736409|529382225|FG001|Overall Study|Adverse Event|1|||
146783989|NCT02736409|529382226|FG002|Overall Study|Adverse Event|5|||
146783990|NCT02736409|529382227|FG003|Overall Study|Adverse Event|4|||
146783991|NCT02736409|529382224|FG000|Overall Study|Other|0|||
146783992|NCT02736409|529382225|FG001|Overall Study|Other|0|||
146783993|NCT02736409|529382226|FG002|Overall Study|Other|1|||
146783994|NCT02736409|529382227|FG003|Overall Study|Other|1|||
146783995|NCT02736409|529382224|FG000|Overall Study|Pregnancy|0|||
146783996|NCT02736409|529382225|FG001|Overall Study|Pregnancy|0|||
146783997|NCT02736409|529382226|FG002|Overall Study|Pregnancy|1|||
146783998|NCT02736409|529382227|FG003|Overall Study|Pregnancy|0|||
146783999|NCT02736409|529382224|FG000|Overall Study|Lost to Follow-up|0|||
146784000|NCT02736409|529382225|FG001|Overall Study|Lost to Follow-up|0|||
146784001|NCT02736409|529382226|FG002|Overall Study|Lost to Follow-up|2|||
146784002|NCT02736409|529382227|FG003|Overall Study|Lost to Follow-up|1|||
146784003|NCT02736409|529382224|FG000|Overall Study|Physician Decision|0|||
146784004|NCT02736409|529382225|FG001|Overall Study|Physician Decision|0|||
146784005|NCT02736409|529382226|FG002|Overall Study|Physician Decision|0|||
146784006|NCT02736409|529382227|FG003|Overall Study|Physician Decision|2|||
146784007|NCT04390048|529382228|FG000|Overall Study|Withdrawal by Subject|1|||
146784008|NCT04390048|529382229|FG001|Overall Study|Withdrawal by Subject|3|||
146784009|NCT01415154|529382230|FG000|Overall Study|Lack of Efficacy|4|||
146784010|NCT01415154|529382231|FG001|Overall Study|Lack of Efficacy|5|||
146784011|NCT01415154|529382230|FG000|Overall Study|Withdrawal by Subject|7|||
146784012|NCT01415154|529382231|FG001|Overall Study|Withdrawal by Subject|8|||
146784013|NCT01415154|529382230|FG000|Overall Study|Lost to Follow-up|1|||
146784014|NCT01415154|529382231|FG001|Overall Study|Lost to Follow-up|4|||
146784015|NCT01415154|529382230|FG000|Overall Study|Protocol Violation|0|||
146784016|NCT01415154|529382231|FG001|Overall Study|Protocol Violation|1|||
146784017|NCT01415154|529382230|FG000|Overall Study|Satisfactory Response|0|||
146784018|NCT01415154|529382231|FG001|Overall Study|Satisfactory Response|1|||
146784019|NCT01415154|529382230|FG000|Overall Study|Adverse Event|1|||
146784020|NCT01415154|529382231|FG001|Overall Study|Adverse Event|1|||
146784021|NCT06283173|529382250|FG000|Overall Study|Did not show for first visit|10|||
146784022|NCT06283173|529382250|FG000|Overall Study|Lost to Follow-up|12|||
146784023|NCT06283173|529382250|FG000|Overall Study|Physician Decision|7|||
146784024|NCT05687916|529382251|FG000|Overall Study|Adverse Event|1|||
146784025|NCT05687916|529382252|FG001|Overall Study|Adverse Event|2|||
146784026|NCT05687916|529382253|FG002|Overall Study|Adverse Event|0|||
146784027|NCT05687916|529382251|FG000|Overall Study|Withdrawal by Subject|1|||
146784028|NCT05687916|529382252|FG001|Overall Study|Withdrawal by Subject|0|||
146784029|NCT05687916|529382253|FG002|Overall Study|Withdrawal by Subject|1|||
146784030|NCT05687916|529382251|FG000|Overall Study|Protocol Violation|0|||
146784031|NCT05687916|529382252|FG001|Overall Study|Protocol Violation|2|||
146784032|NCT05687916|529382253|FG002|Overall Study|Protocol Violation|1|||
146784033|NCT05687916|529382251|FG000|Overall Study|Reason not Specified|1|||
146784034|NCT05687916|529382252|FG001|Overall Study|Reason not Specified|0|||
146981364|NCT01571635|530093879|FG001|Overall Study|Other reasons|1|||
146784035|NCT05687916|529382253|FG002|Overall Study|Reason not Specified|0|||
146784036|NCT03332017|529382254|FG000|Overall Study|Lost to Follow-up|1|||
146784037|NCT03332017|529382255|FG001|Overall Study|Lost to Follow-up|2|||
146784038|NCT03332017|529382254|FG000|Overall Study|Death|17|||
146784039|NCT03332017|529382255|FG001|Overall Study|Death|16|||
146784040|NCT03332017|529382254|FG000|Overall Study|Withdrawal by Subject|6|||
146784041|NCT03332017|529382255|FG001|Overall Study|Withdrawal by Subject|14|||
146784042|NCT03332017|529382254|FG000|Overall Study|Other|1|||
146784043|NCT03332017|529382255|FG001|Overall Study|Other|3|||
146784044|NCT03332017|529382254|FG000|Overall Study|Remained in Study (Ongoing)|47|||
146981365|NCT01571635|530093880|FG002|Overall Study|Other reasons|2|||
146981366|NCT01571635|530093881|FG003|Overall Study|Other reasons|2|||
146981367|NCT01571635|530093882|FG004|Overall Study|Other reasons|1|||
146981368|NCT01571635|530093878|FG000|Overall Study|Study terminated by sponsor|0|||
146981369|NCT01571635|530093879|FG001|Overall Study|Study terminated by sponsor|4|||
146723792|NCT04009291|529158753|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
146723793|NCT04009291|529158754|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
146784045|NCT03332017|529382255|FG001|Overall Study|Remained in Study (Ongoing)|110|||
146784046|NCT01261312|529382256|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
146784047|NCT01261312|529382257|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
146784048|NCT01261312|529382258|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
146784049|NCT01261312|529382259|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146784050|NCT01261312|529382260|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146784051|NCT01261312|529382261|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146784052|NCT01261312|529382262|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146784053|NCT01261312|529382263|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146723794|NCT04009291|529158755|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
146723795|NCT04009291|529158756|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
146723796|NCT04009291|529158757|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
146723797|NCT01270347|529158758|FG000|Core Phase|Adverse Event|1|||
146723798|NCT01270347|529158759|FG001|Core Phase|Adverse Event|6|||
146723799|NCT01270347|529158758|FG000|Core Phase|Withdrawal by Subject|1|||
146723800|NCT01270347|529158759|FG001|Core Phase|Withdrawal by Subject|2|||
146723801|NCT01270347|529158758|FG000|Core Phase|Lost to Follow-up|0|||
146723802|NCT01270347|529158759|FG001|Core Phase|Lost to Follow-up|1|||
146723803|NCT01270347|529158758|FG000|Core Phase|Miscellaneous|8|||
146723804|NCT01270347|529158759|FG001|Core Phase|Miscellaneous|14|||
146723805|NCT01270347|529158758|FG000|Extension Phase|Adverse Event|1|||
146723806|NCT01270347|529158759|FG001|Extension Phase|Adverse Event|3|||
146723807|NCT01270347|529158758|FG000|Extension Phase|Withdrawal by Subject|3|||
146723808|NCT01270347|529158759|FG001|Extension Phase|Withdrawal by Subject|4|||
146723809|NCT01270347|529158758|FG000|Extension Phase|Miscellaneous|2|||
146723810|NCT01270347|529158759|FG001|Extension Phase|Miscellaneous|2|||
146723811|NCT01556438|529158762|FG000|Overall Study|Adverse Event|4|||
146723812|NCT01556438|529158763|FG001|Overall Study|Adverse Event|2|||
146723813|NCT01556438|529158762|FG000|Overall Study|Sponsor Decision|0|||
146723814|NCT01556438|529158763|FG001|Overall Study|Sponsor Decision|2|||
146723815|NCT01556438|529158762|FG000|Overall Study|Progressive Disease|0|||
146723816|NCT01556438|529158763|FG001|Overall Study|Progressive Disease|6|||
146723817|NCT01556438|529158762|FG000|Overall Study|Death|0|||
146723818|NCT01556438|529158763|FG001|Overall Study|Death|1|||
146723819|NCT03206203|529158766|FG000|Treatment|Death|38|||
146723820|NCT03206203|529158767|FG001|Treatment|Death|26|||
146723821|NCT03206203|529158768|FG002|Treatment|Death|0|||
146723822|NCT03206203|529158766|FG000|Treatment|Withdrawal by Subject|1|||
146723823|NCT03206203|529158767|FG001|Treatment|Withdrawal by Subject|0|||
146723824|NCT03206203|529158768|FG002|Treatment|Withdrawal by Subject|0|||
146723825|NCT03206203|529158766|FG000|Treatment|Lost to Follow-up|4|||
146723826|NCT03206203|529158767|FG001|Treatment|Lost to Follow-up|0|||
146723827|NCT03206203|529158768|FG002|Treatment|Lost to Follow-up|0|||
146723828|NCT03206203|529158766|FG000|Treatment|N/A in Follow-Up|8|||
146723829|NCT03206203|529158767|FG001|Treatment|N/A in Follow-Up|1|||
146723830|NCT03206203|529158768|FG002|Treatment|N/A in Follow-Up|0|||
146723831|NCT03206203|529158766|FG000|Treatment|Disease progression|0|||
146784054|NCT01261312|529382264|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146784055|NCT01261312|529382265|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146784056|NCT01261312|529382266|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146784057|NCT01261312|529382267|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146784058|NCT01261312|529382268|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146784059|NCT01261312|529382256|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
146784060|NCT01261312|529382257|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
146784061|NCT01261312|529382258|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146981370|NCT01571635|530093880|FG002|Overall Study|Study terminated by sponsor|1|||
146723832|NCT03206203|529158767|FG001|Treatment|Disease progression|1|||
146723833|NCT03206203|529158768|FG002|Treatment|Disease progression|0|||
146723834|NCT03206203|529158766|FG000|Treatment|Refused follow-up|0|||
146784062|NCT01261312|529382259|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146784063|NCT01261312|529382260|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146784064|NCT01261312|529382261|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146723835|NCT03206203|529158767|FG001|Treatment|Refused follow-up|1|||
146784065|NCT01261312|529382262|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146784066|NCT01261312|529382263|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146784067|NCT01261312|529382264|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146784068|NCT01261312|529382265|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146784069|NCT01261312|529382266|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146784070|NCT01261312|529382267|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146784071|NCT01261312|529382268|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146784072|NCT01261312|529382256|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
146784073|NCT01261312|529382257|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
146784074|NCT01261312|529382258|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146784075|NCT01261312|529382259|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146784076|NCT01261312|529382260|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146784077|NCT01261312|529382261|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146784078|NCT01261312|529382262|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146784079|NCT01261312|529382263|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146784080|NCT01261312|529382264|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146723836|NCT03206203|529158768|FG002|Treatment|Refused follow-up|0|||
146723837|NCT03206203|529158766|FG000|Treatment|Cross over to Arm 1|0|||
146723838|NCT03206203|529158767|FG001|Treatment|Cross over to Arm 1|19|||
146723839|NCT03206203|529158768|FG002|Treatment|Cross over to Arm 1|0|||
146723840|NCT03206203|529158766|FG000|Optional Cross-Over|Death|0|||
146723841|NCT03206203|529158767|FG001|Optional Cross-Over|Death|0|||
146723842|NCT03206203|529158768|FG002|Optional Cross-Over|Death|14|||
146723843|NCT03206203|529158766|FG000|Optional Cross-Over|Refused follow-up|0|||
146723844|NCT03206203|529158767|FG001|Optional Cross-Over|Refused follow-up|0|||
146723845|NCT03206203|529158768|FG002|Optional Cross-Over|Refused follow-up|2|||
146723846|NCT03998618|529158769|FG000|Overall Study|Death|7|||
146723847|NCT03998618|529158770|FG001|Overall Study|Death|11|||
146723848|NCT03998618|529158769|FG000|Overall Study|hospice enrollment|3|||
146723849|NCT03998618|529158770|FG001|Overall Study|hospice enrollment|3|||
146723850|NCT03998618|529158769|FG000|Overall Study|Not feeling well/health problems|3|||
146723851|NCT03998618|529158770|FG001|Overall Study|Not feeling well/health problems|5|||
146723852|NCT03998618|529158769|FG000|Overall Study|Lost to Follow-up|6|||
146723853|NCT03998618|529158770|FG001|Overall Study|Lost to Follow-up|6|||
146723854|NCT03998618|529158769|FG000|Overall Study|Withdrawal by Subject|0|||
146723855|NCT03998618|529158770|FG001|Overall Study|Withdrawal by Subject|4|||
146723856|NCT01483924|529158771|FG000|Overall Study|Withdrawal by Subject|2|||
146723857|NCT01483924|529158772|FG001|Overall Study|Withdrawal by Subject|0|||
146723858|NCT01483924|529158773|FG002|Overall Study|Withdrawal by Subject|0|||
146723859|NCT01483924|529158774|FG003|Overall Study|Withdrawal by Subject|1|||
146723860|NCT01483924|529158775|FG004|Overall Study|Withdrawal by Subject|1|||
146723861|NCT01483924|529158771|FG000|Overall Study|Adverse Event|0|||
146723862|NCT01483924|529158772|FG001|Overall Study|Adverse Event|0|||
146723863|NCT01483924|529158773|FG002|Overall Study|Adverse Event|1|||
146723864|NCT01483924|529158774|FG003|Overall Study|Adverse Event|1|||
146723865|NCT01483924|529158775|FG004|Overall Study|Adverse Event|0|||
146723866|NCT01483924|529158771|FG000|Overall Study|Non-compliance|0|||
146723867|NCT01483924|529158772|FG001|Overall Study|Non-compliance|0|||
146723868|NCT01483924|529158773|FG002|Overall Study|Non-compliance|0|||
146723869|NCT01483924|529158774|FG003|Overall Study|Non-compliance|1|||
146723870|NCT01483924|529158775|FG004|Overall Study|Non-compliance|1|||
146723871|NCT01483924|529158771|FG000|Overall Study|Sponsor concern over ECG result|0|||
146723872|NCT01483924|529158772|FG001|Overall Study|Sponsor concern over ECG result|0|||
146723873|NCT01483924|529158773|FG002|Overall Study|Sponsor concern over ECG result|0|||
146723874|NCT01483924|529158774|FG003|Overall Study|Sponsor concern over ECG result|1|||
146723875|NCT01483924|529158775|FG004|Overall Study|Sponsor concern over ECG result|0|||
146723876|NCT00003298|529158776|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
146723877|NCT00003298|529158776|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
146723878|NCT00003298|529158776|FG000|Surgery|Unresectable at surgery|3|||
146784081|NCT01261312|529382265|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146784082|NCT01261312|529382266|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146784083|NCT01261312|529382267|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146784084|NCT01261312|529382268|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146784085|NCT01261312|529382256|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
146784086|NCT01261312|529382257|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
146784087|NCT01261312|529382258|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146784088|NCT01261312|529382259|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146723879|NCT00003298|529158776|FG000|Surgery|Progression before surgery|2|||
146723880|NCT00003298|529158776|FG000|Surgery|Unevaluable and off study|2|||
146723881|NCT00003298|529158776|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
146723882|NCT00003298|529158776|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
146723883|NCT00003298|529158776|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
146723884|NCT00003298|529158776|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
146723885|NCT00003298|529158776|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
146723886|NCT00003298|529158776|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
146723887|NCT00003298|529158776|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
146723888|NCT00003298|529158776|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
146934789|NCT01714817|529917951|FG001|Year 1 Period|Participant no longer meets criteria|2|||
146934790|NCT01714817|529917950|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
146934791|NCT01714817|529917951|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
146723889|NCT00003298|529158776|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
146723890|NCT00003298|529158776|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
146723891|NCT00335322|529158778|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
146723892|NCT00335322|529158779|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
146723893|NCT00335322|529158780|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
146723894|NCT04330638|529158781|FG000|Overall Study|Adverse Event|9|||
146723895|NCT04330638|529158782|FG001|Overall Study|Adverse Event|10|||
146723896|NCT04330638|529158783|FG002|Overall Study|Adverse Event|15|||
146723897|NCT04330638|529158784|FG003|Overall Study|Adverse Event|6|||
146723898|NCT04330638|529158785|FG004|Overall Study|Adverse Event|10|||
146723899|NCT04330638|529158786|FG005|Overall Study|Adverse Event|5|||
146723900|NCT04330638|529158781|FG000|Overall Study|Other|2|||
146723901|NCT04330638|529158782|FG001|Overall Study|Other|2|||
146723902|NCT04330638|529158783|FG002|Overall Study|Other|5|||
146723903|NCT04330638|529158784|FG003|Overall Study|Other|1|||
146723904|NCT04330638|529158785|FG004|Overall Study|Other|3|||
146723905|NCT04330638|529158786|FG005|Overall Study|Other|2|||
146723906|NCT04330638|529158781|FG000|Overall Study|Withdrawal by Subject|4|||
146723907|NCT04330638|529158782|FG001|Overall Study|Withdrawal by Subject|0|||
146723908|NCT04330638|529158783|FG002|Overall Study|Withdrawal by Subject|0|||
146723909|NCT04330638|529158784|FG003|Overall Study|Withdrawal by Subject|0|||
146723910|NCT04330638|529158785|FG004|Overall Study|Withdrawal by Subject|0|||
146723911|NCT04330638|529158786|FG005|Overall Study|Withdrawal by Subject|0|||
146723912|NCT04330638|529158781|FG000|Overall Study|Lost to Follow-up|3|||
146723913|NCT04330638|529158782|FG001|Overall Study|Lost to Follow-up|2|||
146723914|NCT04330638|529158783|FG002|Overall Study|Lost to Follow-up|3|||
146723915|NCT04330638|529158784|FG003|Overall Study|Lost to Follow-up|2|||
146723916|NCT04330638|529158785|FG004|Overall Study|Lost to Follow-up|3|||
146723917|NCT04330638|529158786|FG005|Overall Study|Lost to Follow-up|0|||
146723918|NCT01041638|529158788|FG000|Overall Study|Adverse Event|4|||
146723919|NCT01041638|529158788|FG000|Overall Study|Death|1|||
146723920|NCT01041638|529158788|FG000|Overall Study|Lack of Efficacy|7|||
146723921|NCT01041638|529158788|FG000|Overall Study|Physician Decision|4|||
146723922|NCT01041638|529158788|FG000|Overall Study|Withdrawal by Subject|11|||
146723923|NCT03152552|529158789|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
146723924|NCT03152552|529158790|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
146723925|NCT03152552|529158791|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
146723926|NCT03152552|529158792|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
146723927|NCT03152552|529158793|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
146723928|NCT03152552|529158789|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
146723929|NCT03152552|529158790|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
146723930|NCT03152552|529158791|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
146723931|NCT03152552|529158792|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
146723932|NCT03152552|529158793|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
146723933|NCT03152552|529158789|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
146723934|NCT03152552|529158790|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
146723935|NCT03152552|529158791|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
146723936|NCT03152552|529158792|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
146723937|NCT03152552|529158793|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
146723938|NCT03152552|529158789|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146723939|NCT03152552|529158790|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146723940|NCT03152552|529158791|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
146723941|NCT03152552|529158792|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146723942|NCT03152552|529158793|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146723943|NCT03152552|529158789|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
146723944|NCT03152552|529158790|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
146723945|NCT03152552|529158791|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
146723946|NCT03152552|529158792|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
146723947|NCT03152552|529158793|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
146723948|NCT03152552|529158789|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
146723949|NCT03152552|529158790|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
146934792|NCT01714817|529917950|FG000|Year 1 Period|Change in Concomitant Medication|0|||
146934793|NCT01714817|529917951|FG001|Year 1 Period|Change in Concomitant Medication|1|||
146934794|NCT01714817|529917950|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
146934795|NCT01714817|529917951|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
146934796|NCT01714817|529917950|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
146723950|NCT03152552|529158791|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
146723951|NCT03152552|529158792|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
146934797|NCT01714817|529917951|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
146934798|NCT01714817|529917950|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
146723952|NCT03152552|529158793|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
146723953|NCT03152552|529158789|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
146723954|NCT03152552|529158790|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
146723955|NCT03152552|529158791|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
146723956|NCT03152552|529158792|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
146723957|NCT03152552|529158793|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
146723958|NCT04084314|529158796|FG000|Overall Study|Subject/guardian decision|91|||
146723959|NCT04084314|529158796|FG000|Overall Study|Adverse Event|24|||
146723960|NCT04084314|529158796|FG000|Overall Study|Lost to Follow-up|19|||
146723961|NCT04084314|529158796|FG000|Overall Study|New therapy for study indication|9|||
146723962|NCT04084314|529158796|FG000|Overall Study|Pregnancy|9|||
146723963|NCT04084314|529158796|FG000|Overall Study|Withdrawal of informed consent|8|||
146723964|NCT04084314|529158796|FG000|Overall Study|Physician Decision|4|||
146723965|NCT04084314|529158796|FG000|Overall Study|Protocol Deviation|3|||
146723966|NCT03336619|529158797|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
146723967|NCT03336619|529158798|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
146723968|NCT03336619|529158797|FG000|Overall Study|Withdrawal by Subject|17|||
146723969|NCT03336619|529158798|FG001|Overall Study|Withdrawal by Subject|16|||
146723970|NCT03336619|529158797|FG000|Overall Study|Adverse Event|2|||
146723971|NCT03336619|529158798|FG001|Overall Study|Adverse Event|5|||
146723972|NCT03336619|529158797|FG000|Overall Study|Physician Decision|3|||
146723973|NCT03336619|529158798|FG001|Overall Study|Physician Decision|0|||
146723974|NCT01300546|529158799|FG000|Overall Study|Withdrawal by Subject|1|||
146723975|NCT01300546|529158800|FG001|Overall Study|Withdrawal by Subject|0|||
146723976|NCT01300546|529158799|FG000|Overall Study|Lost to Follow-up|0|||
146723977|NCT01300546|529158800|FG001|Overall Study|Lost to Follow-up|2|||
146723978|NCT01300546|529158799|FG000|Overall Study|Lack of Efficacy|0|||
146723979|NCT01300546|529158800|FG001|Overall Study|Lack of Efficacy|3|||
146723980|NCT01300546|529158799|FG000|Overall Study|Adverse Event|0|||
146723981|NCT01300546|529158800|FG001|Overall Study|Adverse Event|1|||
146723982|NCT00983073|529158808|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
146723983|NCT00983073|529158808|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
146723984|NCT00983073|529158808|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
146723985|NCT00983073|529158808|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
146723986|NCT00983073|529158808|FG000|Titration and Optimal Dose Period|Other reason|4|||
146723987|NCT00983073|529158808|FG000|Maintenance Period|Adverse Event|5|||
146723988|NCT00983073|529158808|FG000|Maintenance Period|Withdrawal by Subject|2|||
146723989|NCT00983073|529158808|FG000|Maintenance Period|Lack of Efficacy|2|||
146723990|NCT00983073|529158808|FG000|Maintenance Period|Other Reason|7|||
146723991|NCT00234065|529158809|FG000|Overall Study|Adverse Event|268|||
146723992|NCT00234065|529158810|FG001|Overall Study|Adverse Event|166|||
146723993|NCT00234065|529158809|FG000|Overall Study|Withdrawal by Subject|73|||
146723994|NCT00234065|529158810|FG001|Overall Study|Withdrawal by Subject|56|||
146723995|NCT00234065|529158809|FG000|Overall Study|Physician Decision|23|||
146723996|NCT00234065|529158810|FG001|Overall Study|Physician Decision|22|||
146723997|NCT00234065|529158809|FG000|Overall Study|Not Classified|111|||
146723998|NCT00234065|529158810|FG001|Overall Study|Not Classified|112|||
146723999|NCT05557942|529158811|FG000|Overall Study|Death|0|||
146724000|NCT05557942|529158812|FG001|Overall Study|Death|0|||
146724001|NCT05557942|529158813|FG002|Overall Study|Death|0|||
146724002|NCT05557942|529158814|FG003|Overall Study|Death|2|||
146724003|NCT05557942|529158815|FG004|Overall Study|Death|1|||
146724004|NCT05557942|529158816|FG005|Overall Study|Death|1|||
146934799|NCT01714817|529917951|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
146934800|NCT01714817|529917950|FG000|Year 2 Period|Lack of Efficacy|4|||
146724005|NCT05557942|529158811|FG000|Overall Study|Physician Decision|1|||
146724006|NCT05557942|529158812|FG001|Overall Study|Physician Decision|1|||
146724007|NCT05557942|529158813|FG002|Overall Study|Physician Decision|2|||
146934801|NCT01714817|529917951|FG001|Year 2 Period|Lack of Efficacy|12|||
146934802|NCT01714817|529917950|FG000|Year 2 Period|Adverse Event|7|||
146934803|NCT01714817|529917951|FG001|Year 2 Period|Adverse Event|6|||
146724008|NCT05557942|529158814|FG003|Overall Study|Physician Decision|3|||
146724009|NCT05557942|529158815|FG004|Overall Study|Physician Decision|0|||
146724010|NCT05557942|529158816|FG005|Overall Study|Physician Decision|2|||
146724011|NCT05557942|529158811|FG000|Overall Study|Study terminated by sponsor|17|||
146784089|NCT01261312|529382260|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146784090|NCT01261312|529382261|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146784091|NCT01261312|529382262|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146784092|NCT01261312|529382263|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146784093|NCT01261312|529382264|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146784094|NCT01261312|529382265|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146784095|NCT01261312|529382266|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146784096|NCT01261312|529382267|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146784097|NCT01261312|529382268|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146784098|NCT01261312|529382256|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
146784099|NCT01261312|529382257|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
146784100|NCT01261312|529382258|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
146784101|NCT01261312|529382259|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146784102|NCT01261312|529382260|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146784103|NCT01261312|529382261|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146784104|NCT01261312|529382262|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146784105|NCT01261312|529382263|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146784106|NCT01261312|529382264|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146784107|NCT01261312|529382265|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146784108|NCT01261312|529382266|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146784109|NCT01261312|529382267|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146784110|NCT01261312|529382268|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146784111|NCT01261312|529382256|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
146784112|NCT01261312|529382257|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
146784113|NCT01261312|529382258|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
146784114|NCT01261312|529382259|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146784115|NCT01261312|529382260|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146784116|NCT01261312|529382261|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146784117|NCT01261312|529382262|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146784118|NCT01261312|529382263|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146784119|NCT01261312|529382264|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146784120|NCT01261312|529382265|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146784121|NCT01261312|529382266|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146784122|NCT01261312|529382267|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146784123|NCT01261312|529382268|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146784124|NCT01261312|529382256|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
146784125|NCT01261312|529382257|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146784126|NCT01261312|529382258|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
146784127|NCT01261312|529382259|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146784128|NCT01261312|529382260|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146784129|NCT01261312|529382261|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146784130|NCT01261312|529382262|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146784131|NCT01261312|529382263|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146784132|NCT01261312|529382264|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146784133|NCT01261312|529382265|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146784134|NCT01261312|529382266|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146784135|NCT01261312|529382267|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146784136|NCT01261312|529382268|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146784137|NCT01261312|529382256|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146784138|NCT01261312|529382257|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146784139|NCT01261312|529382258|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146784140|NCT01261312|529382259|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
146784141|NCT01261312|529382260|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
146784142|NCT01261312|529382261|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
146784143|NCT01261312|529382262|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146784144|NCT01261312|529382263|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146784145|NCT01261312|529382264|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146784146|NCT01261312|529382265|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146784147|NCT01261312|529382266|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146981371|NCT01571635|530093881|FG003|Overall Study|Study terminated by sponsor|3|||
146981372|NCT01571635|530093882|FG004|Overall Study|Study terminated by sponsor|1|||
146784148|NCT01261312|529382267|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146934804|NCT01714817|529917950|FG000|Year 2 Period|Participant request to stop treatment|4|||
146934805|NCT01714817|529917951|FG001|Year 2 Period|Participant request to stop treatment|4|||
146934806|NCT01714817|529917950|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
146934807|NCT01714817|529917951|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
146934808|NCT01714817|529917950|FG000|Year 2 Period|Participant withdrew consent|1|||
146934809|NCT01714817|529917951|FG001|Year 2 Period|Participant withdrew consent|5|||
146934810|NCT01714817|529917950|FG000|Year 2 Period|Participant no longer meets criteria|1|||
146934811|NCT01714817|529917951|FG001|Year 2 Period|Participant no longer meets criteria|4|||
146934812|NCT01714817|529917950|FG000|Year 2 Period|Lost to Follow-up|2|||
146934813|NCT01714817|529917951|FG001|Year 2 Period|Lost to Follow-up|0|||
146934814|NCT01714817|529917950|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
146934815|NCT01714817|529917951|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
146934816|NCT01714817|529917950|FG000|Year 2 Period|Pregnancy|1|||
146934817|NCT01714817|529917951|FG001|Year 2 Period|Pregnancy|1|||
146934818|NCT01714817|529917950|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
146934819|NCT01714817|529917951|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
146934820|NCT01714817|529917950|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
146934821|NCT01714817|529917951|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
146934822|NCT01714817|529917950|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
146934823|NCT01714817|529917951|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
146934824|NCT01714817|529917950|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
146934825|NCT01714817|529917951|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
146934826|NCT01714817|529917950|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
146934827|NCT01714817|529917951|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
146934828|NCT01714817|529917950|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
146934829|NCT01714817|529917951|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
146934830|NCT01714817|529917950|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
146934831|NCT01714817|529917951|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
146934832|NCT01714817|529917950|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
146934833|NCT01714817|529917951|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
146934834|NCT01714817|529917950|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
146934835|NCT01714817|529917951|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
146934836|NCT01714817|529917950|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
146934837|NCT01714817|529917951|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
146934838|NCT01714817|529917950|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
146934839|NCT01714817|529917951|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
146934840|NCT01714817|529917950|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
146934841|NCT01714817|529917951|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
146934842|NCT01714817|529917950|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
146934843|NCT01714817|529917951|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
146934844|NCT01714817|529917950|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
146934845|NCT01714817|529917951|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
146724012|NCT05557942|529158812|FG001|Overall Study|Study terminated by sponsor|17|||
146724013|NCT05557942|529158813|FG002|Overall Study|Study terminated by sponsor|14|||
146724014|NCT05557942|529158814|FG003|Overall Study|Study terminated by sponsor|40|||
146724015|NCT05557942|529158815|FG004|Overall Study|Study terminated by sponsor|45|||
146724016|NCT05557942|529158816|FG005|Overall Study|Study terminated by sponsor|37|||
146724017|NCT05557942|529158811|FG000|Overall Study|Protocol Violation|0|||
146724018|NCT05557942|529158812|FG001|Overall Study|Protocol Violation|0|||
146724019|NCT05557942|529158813|FG002|Overall Study|Protocol Violation|0|||
146724020|NCT05557942|529158814|FG003|Overall Study|Protocol Violation|0|||
146724021|NCT05557942|529158815|FG004|Overall Study|Protocol Violation|0|||
146724022|NCT05557942|529158816|FG005|Overall Study|Protocol Violation|1|||
146724023|NCT05557942|529158811|FG000|Overall Study|Withdrawal by Subject|0|||
146784149|NCT01261312|529382268|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146934846|NCT01714817|529917950|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
146934847|NCT01714817|529917951|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
146934848|NCT01714817|529917950|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
146934849|NCT01714817|529917951|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
146934850|NCT05406440|529920090|FG000|Overall Study|Lost to Follow-up|0|||
146934851|NCT05406440|529920091|FG001|Overall Study|Lost to Follow-up|0|||
146934852|NCT05406440|529920092|FG002|Overall Study|Lost to Follow-up|0|||
146934853|NCT05406440|529920093|FG003|Overall Study|Lost to Follow-up|0|||
146934854|NCT05406440|529920094|FG004|Overall Study|Lost to Follow-up|2|||
146724024|NCT05557942|529158812|FG001|Overall Study|Withdrawal by Subject|0|||
146784150|NCT01261312|529382256|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146724025|NCT05557942|529158813|FG002|Overall Study|Withdrawal by Subject|0|||
146724026|NCT05557942|529158814|FG003|Overall Study|Withdrawal by Subject|0|||
146784151|NCT01261312|529382257|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146784152|NCT01261312|529382258|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146784153|NCT01261312|529382259|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146784154|NCT01261312|529382260|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
146784155|NCT01261312|529382261|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
146784156|NCT01261312|529382262|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146784157|NCT01261312|529382263|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146784158|NCT01261312|529382264|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146784159|NCT01261312|529382265|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146784160|NCT01261312|529382266|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146784161|NCT01261312|529382267|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146784162|NCT01261312|529382268|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146784163|NCT01261312|529382256|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146784164|NCT01261312|529382257|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146784165|NCT01261312|529382258|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146784166|NCT01261312|529382259|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146784167|NCT01261312|529382260|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
146784168|NCT01261312|529382261|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
146784169|NCT01261312|529382262|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146784170|NCT01261312|529382263|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146784171|NCT01261312|529382264|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146784172|NCT01261312|529382265|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146784173|NCT01261312|529382266|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146784174|NCT01261312|529382267|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146784175|NCT01261312|529382268|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146784176|NCT01261312|529382256|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
146784177|NCT01261312|529382257|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
146784178|NCT01261312|529382258|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
146784179|NCT01261312|529382259|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
146784180|NCT01261312|529382260|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
146784181|NCT01261312|529382261|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
146784182|NCT01261312|529382262|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
146784183|NCT01261312|529382263|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
146784184|NCT01261312|529382264|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
146784185|NCT01261312|529382265|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
146784186|NCT01261312|529382266|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
146784187|NCT01261312|529382267|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
146934855|NCT05406440|529920095|FG005|Overall Study|Lost to Follow-up|0|||
146934856|NCT05406440|529920096|FG006|Overall Study|Lost to Follow-up|0|||
146934857|NCT05406440|529920090|FG000|Overall Study|Physician Decision|0|||
146934858|NCT05406440|529920091|FG001|Overall Study|Physician Decision|0|||
146934859|NCT05406440|529920092|FG002|Overall Study|Physician Decision|0|||
146934860|NCT05406440|529920093|FG003|Overall Study|Physician Decision|0|||
146934861|NCT05406440|529920094|FG004|Overall Study|Physician Decision|1|||
146934862|NCT05406440|529920095|FG005|Overall Study|Physician Decision|0|||
146934863|NCT05406440|529920096|FG006|Overall Study|Physician Decision|0|||
146934864|NCT05406440|529920090|FG000|Overall Study|Withdrawal by Subject|0|||
146934865|NCT05406440|529920091|FG001|Overall Study|Withdrawal by Subject|0|||
146934866|NCT05406440|529920092|FG002|Overall Study|Withdrawal by Subject|0|||
146934867|NCT05406440|529920093|FG003|Overall Study|Withdrawal by Subject|0|||
146934868|NCT05406440|529920094|FG004|Overall Study|Withdrawal by Subject|0|||
146934869|NCT05406440|529920095|FG005|Overall Study|Withdrawal by Subject|2|||
146981373|NCT01571635|530093878|FG000|Overall Study|Withdrew consent|1|||
146981374|NCT01571635|530093879|FG001|Overall Study|Withdrew consent|1|||
146784188|NCT01261312|529382268|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
146784189|NCT01261312|529382256|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146784190|NCT01261312|529382257|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146981375|NCT01571635|530093880|FG002|Overall Study|Withdrew consent|2|||
146784191|NCT01261312|529382258|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146784192|NCT01261312|529382259|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146784193|NCT01261312|529382260|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146981376|NCT01571635|530093881|FG003|Overall Study|Withdrew consent|3|||
146784194|NCT01261312|529382261|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
146784195|NCT01261312|529382262|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146981377|NCT01571635|530093882|FG004|Overall Study|Withdrew consent|0|||
146784196|NCT01261312|529382263|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146784197|NCT01261312|529382264|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146784198|NCT01261312|529382265|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146981378|NCT01571635|530093878|FG000|Overall Study|Lack of Efficacy|0|||
146981379|NCT01571635|530093879|FG001|Overall Study|Lack of Efficacy|2|||
146981380|NCT01571635|530093880|FG002|Overall Study|Lack of Efficacy|0|||
146981381|NCT01571635|530093881|FG003|Overall Study|Lack of Efficacy|1|||
146784199|NCT01261312|529382266|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146784200|NCT01261312|529382267|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146784201|NCT01261312|529382268|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146784202|NCT01261312|529382256|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146784203|NCT01261312|529382257|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146784204|NCT01261312|529382258|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146784205|NCT01261312|529382259|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
146784206|NCT01261312|529382260|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
146784207|NCT01261312|529382261|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
146784208|NCT01261312|529382262|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146784209|NCT01261312|529382263|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146784210|NCT01261312|529382264|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146784211|NCT01261312|529382265|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146784212|NCT01261312|529382266|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146784213|NCT01261312|529382267|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146784214|NCT01261312|529382268|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146784215|NCT01261312|529382256|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146784216|NCT01261312|529382257|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146784217|NCT01261312|529382258|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146784218|NCT01261312|529382259|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
146784219|NCT01261312|529382260|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
146784220|NCT01261312|529382261|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
146784221|NCT01261312|529382262|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146784222|NCT01261312|529382263|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146784223|NCT01261312|529382264|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146784224|NCT01261312|529382265|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146784225|NCT01261312|529382266|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146784226|NCT01261312|529382267|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146784227|NCT01261312|529382268|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146784228|NCT01261312|529382256|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146784229|NCT01261312|529382257|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146784230|NCT01261312|529382258|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146784231|NCT01261312|529382259|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146784232|NCT01261312|529382260|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146784233|NCT01261312|529382261|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146784234|NCT01261312|529382262|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
146784235|NCT01261312|529382263|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
146784236|NCT01261312|529382264|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
146784237|NCT01261312|529382265|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146784238|NCT01261312|529382266|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146934870|NCT05406440|529920096|FG006|Overall Study|Withdrawal by Subject|0|||
146934871|NCT04507776|529920098|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
146934872|NCT01711541|529920101|FG000|Overall Study|Cancel prior to treatment|0|||
146934873|NCT01711541|529920102|FG001|Overall Study|Cancel prior to treatment|0|||
146934874|NCT01711541|529920103|FG002|Overall Study|Cancel prior to treatment|0|||
146934875|NCT01711541|529920104|FG003|Overall Study|Cancel prior to treatment|1|||
146934876|NCT01711541|529920105|FG004|Overall Study|Cancel prior to treatment|0|||
146934877|NCT01711541|529920101|FG000|Overall Study|Ineligible|0|||
146934878|NCT01711541|529920102|FG001|Overall Study|Ineligible|1|||
146934879|NCT01711541|529920103|FG002|Overall Study|Ineligible|0|||
146934880|NCT01711541|529920104|FG003|Overall Study|Ineligible|0|||
146934881|NCT01711541|529920105|FG004|Overall Study|Ineligible|0|||
146934882|NCT03943446|529920106|FG000|Overall Study|Lost to Follow-up|0|||
146934883|NCT03943446|529920107|FG001|Overall Study|Lost to Follow-up|0|||
146934884|NCT03943446|529920108|FG002|Overall Study|Lost to Follow-up|1|||
146934885|NCT03943446|529920106|FG000|Overall Study|Withdrawal by Subject|1|||
146934886|NCT03943446|529920107|FG001|Overall Study|Withdrawal by Subject|1|||
146934887|NCT03943446|529920108|FG002|Overall Study|Withdrawal by Subject|2|||
146934888|NCT03943446|529920106|FG000|Overall Study|Study Terminated by Sponsor|1|||
146934889|NCT03943446|529920107|FG001|Overall Study|Study Terminated by Sponsor|2|||
146934890|NCT03943446|529920108|FG002|Overall Study|Study Terminated by Sponsor|1|||
146934891|NCT03943446|529920106|FG000|Overall Study|Reason not Specified|5|||
146934892|NCT03943446|529920107|FG001|Overall Study|Reason not Specified|1|||
146934893|NCT03943446|529920108|FG002|Overall Study|Reason not Specified|3|||
146934894|NCT01281189|529920118|FG000|Overall Study|Adverse Event|7|||
146934895|NCT01281189|529920119|FG001|Overall Study|Adverse Event|9|||
146934896|NCT01281189|529920118|FG000|Overall Study|Lost to Follow-up|6|||
146934897|NCT01281189|529920119|FG001|Overall Study|Lost to Follow-up|4|||
146934898|NCT01281189|529920118|FG000|Overall Study|Withdrawal by Subject|21|||
146934899|NCT01281189|529920119|FG001|Overall Study|Withdrawal by Subject|24|||
146934900|NCT01281189|529920118|FG000|Overall Study|Physician Decision|2|||
146934901|NCT01281189|529920119|FG001|Overall Study|Physician Decision|3|||
146934902|NCT01281189|529920118|FG000|Overall Study|Death|103|||
146934903|NCT01281189|529920119|FG001|Overall Study|Death|91|||
146784239|NCT01261312|529382267|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146784240|NCT01261312|529382268|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146784241|NCT01261312|529382256|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146784242|NCT01261312|529382257|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146784243|NCT01261312|529382258|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146784244|NCT01261312|529382259|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146784245|NCT01261312|529382260|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146784246|NCT01261312|529382261|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146784247|NCT01261312|529382262|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146784248|NCT01261312|529382263|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
146784249|NCT01261312|529382264|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
146784250|NCT01261312|529382265|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146784251|NCT01261312|529382266|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146784252|NCT01261312|529382267|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146784253|NCT01261312|529382268|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146784254|NCT01261312|529382256|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146784255|NCT01261312|529382257|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146784256|NCT01261312|529382258|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146784257|NCT01261312|529382259|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146784258|NCT01261312|529382260|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146784259|NCT01261312|529382261|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146784260|NCT01261312|529382262|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
146784261|NCT01261312|529382263|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
146784262|NCT01261312|529382264|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
146784263|NCT01261312|529382265|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146784264|NCT01261312|529382266|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146784265|NCT01261312|529382267|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146784266|NCT01261312|529382268|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146784267|NCT01261312|529382256|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
146784268|NCT01261312|529382257|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
146784269|NCT01261312|529382258|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
146784270|NCT01261312|529382259|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
146784271|NCT01261312|529382260|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
146784272|NCT01261312|529382261|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
146784273|NCT01261312|529382262|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
146784274|NCT01261312|529382263|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
146784275|NCT01261312|529382264|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
146784276|NCT01261312|529382265|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
146784277|NCT01261312|529382266|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
146784278|NCT01261312|529382267|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
146784279|NCT01261312|529382268|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
146784280|NCT01261312|529382256|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146784281|NCT01261312|529382257|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146784282|NCT01261312|529382258|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146784283|NCT01261312|529382259|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146784284|NCT01261312|529382260|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146784285|NCT01261312|529382261|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146784286|NCT01261312|529382262|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
146784287|NCT01261312|529382263|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
146784288|NCT01261312|529382264|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
146784289|NCT01261312|529382265|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146784290|NCT01261312|529382266|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146784291|NCT01261312|529382267|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146784292|NCT01261312|529382268|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146784293|NCT01261312|529382256|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146784294|NCT01261312|529382257|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146784295|NCT01261312|529382258|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146784296|NCT01261312|529382259|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146784297|NCT01261312|529382260|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146784298|NCT01261312|529382261|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146784299|NCT01261312|529382262|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
146784300|NCT01261312|529382263|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
146784301|NCT01261312|529382264|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
146784302|NCT01261312|529382265|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146784303|NCT01261312|529382266|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146784304|NCT01261312|529382267|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146784305|NCT01261312|529382268|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146724027|NCT05557942|529158815|FG004|Overall Study|Withdrawal by Subject|2|||
146724028|NCT05557942|529158816|FG005|Overall Study|Withdrawal by Subject|0|||
146724029|NCT03776136|529158817|FG000|Overall Study|Death|85|||
146724030|NCT03776136|529158817|FG000|Overall Study|Withdrawal by Subject|3|||
146724031|NCT03776136|529158817|FG000|Overall Study|Sponsor Decision|15|||
146724032|NCT00003508|529160610|FG000|Overall Study|Not evaluable|5|||
146724033|NCT02160314|529160611|FG000|Overall Study|Adverse Event|0|||
146724034|NCT02160314|529160612|FG001|Overall Study|Adverse Event|6|||
146724035|NCT02160314|529160611|FG000|Overall Study|Protocol Violation|0|||
146724036|NCT02160314|529160612|FG001|Overall Study|Protocol Violation|4|||
146724037|NCT02160314|529160611|FG000|Overall Study|Withdrawal by Subject|1|||
146724038|NCT02160314|529160612|FG001|Overall Study|Withdrawal by Subject|2|||
146724039|NCT02160314|529160611|FG000|Overall Study|Lost to Follow-up|0|||
146724040|NCT02160314|529160612|FG001|Overall Study|Lost to Follow-up|1|||
146724041|NCT00593567|529160613|FG000|Overall Study|Adverse Event|2|||
146724042|NCT00593567|529160614|FG001|Overall Study|Adverse Event|0|||
146724043|NCT00593567|529160613|FG000|Overall Study|Physician Decision|2|||
146724044|NCT00593567|529160614|FG001|Overall Study|Physician Decision|0|||
146724045|NCT00593567|529160613|FG000|Overall Study|Protocol Violation|13|||
146724046|NCT00593567|529160614|FG001|Overall Study|Protocol Violation|7|||
146724047|NCT00593567|529160613|FG000|Overall Study|Lack of Efficacy|2|||
146724048|NCT00593567|529160614|FG001|Overall Study|Lack of Efficacy|1|||
146724049|NCT00593567|529160613|FG000|Overall Study|Withdrawal by Subject|1|||
146724050|NCT00593567|529160614|FG001|Overall Study|Withdrawal by Subject|2|||
146724051|NCT03576768|529160620|FG000|Overall Study|Lost to Follow-up|3|||
146724052|NCT03576768|529160621|FG001|Overall Study|Lost to Follow-up|3|||
146724053|NCT03576768|529160622|FG002|Overall Study|Lost to Follow-up|0|||
146724054|NCT03576768|529160623|FG003|Overall Study|Lost to Follow-up|0|||
146724055|NCT00590902|529160624|FG000|Overall Study|Death|1|||
146724056|NCT00785291|529160625|FG000|Overall Study|Never began treatment|8|||
146724057|NCT00785291|529160626|FG001|Overall Study|Never began treatment|4|||
146724058|NCT00785291|529160627|FG002|Overall Study|Never began treatment|4|||
146724059|NCT00785291|529160625|FG000|Overall Study|Adverse Event|39|||
146724060|NCT00785291|529160626|FG001|Overall Study|Adverse Event|70|||
146724061|NCT00785291|529160627|FG002|Overall Study|Adverse Event|56|||
146724062|NCT00785291|529160625|FG000|Overall Study|Death|7|||
146724063|NCT00785291|529160626|FG001|Overall Study|Death|4|||
146724064|NCT00785291|529160627|FG002|Overall Study|Death|3|||
146724065|NCT00785291|529160625|FG000|Overall Study|Withdrawal by Subject|35|||
146724066|NCT00785291|529160626|FG001|Overall Study|Withdrawal by Subject|36|||
146724067|NCT00785291|529160627|FG002|Overall Study|Withdrawal by Subject|17|||
146724068|NCT00785291|529160625|FG000|Overall Study|Alternative Therapy|12|||
146724069|NCT00785291|529160626|FG001|Overall Study|Alternative Therapy|6|||
146724070|NCT00785291|529160627|FG002|Overall Study|Alternative Therapy|7|||
146724071|NCT00785291|529160625|FG000|Overall Study|Complicating illness|6|||
146724072|NCT00785291|529160626|FG001|Overall Study|Complicating illness|4|||
146724073|NCT00785291|529160627|FG002|Overall Study|Complicating illness|4|||
146724074|NCT00785291|529160625|FG000|Overall Study|Other Medical Reasons|29|||
146724075|NCT00785291|529160626|FG001|Overall Study|Other Medical Reasons|25|||
146724076|NCT00785291|529160627|FG002|Overall Study|Other Medical Reasons|15|||
146724077|NCT02119260|529160628|FG000|Overall Study|Adverse Event|1|||
146724078|NCT02119260|529160629|FG001|Overall Study|Adverse Event|0|||
146724079|NCT02119260|529160630|FG002|Overall Study|Adverse Event|0|||
146724080|NCT02119260|529160631|FG003|Overall Study|Adverse Event|0|||
146724081|NCT02119260|529160632|FG004|Overall Study|Adverse Event|0|||
146724082|NCT02119260|529160633|FG005|Overall Study|Adverse Event|0|||
146724083|NCT02119260|529160634|FG006|Overall Study|Adverse Event|0|||
146724084|NCT02119260|529160628|FG000|Overall Study|Withdrew consent|0|||
146724085|NCT02119260|529160629|FG001|Overall Study|Withdrew consent|1|||
146724086|NCT02119260|529160630|FG002|Overall Study|Withdrew consent|1|||
146724087|NCT02119260|529160631|FG003|Overall Study|Withdrew consent|0|||
146724088|NCT02119260|529160632|FG004|Overall Study|Withdrew consent|0|||
146724089|NCT02119260|529160633|FG005|Overall Study|Withdrew consent|0|||
146724090|NCT02119260|529160634|FG006|Overall Study|Withdrew consent|0|||
146724091|NCT01986881|529160635|FG000|Overall Study|Death|228|||
146724092|NCT01986881|529160636|FG001|Overall Study|Death|233|||
146724093|NCT01986881|529160637|FG002|Overall Study|Death|247|||
146724094|NCT01986881|529160635|FG000|Overall Study|Lost to Follow-up|51|||
146724095|NCT01986881|529160636|FG001|Overall Study|Lost to Follow-up|44|||
146724096|NCT01986881|529160637|FG002|Overall Study|Lost to Follow-up|55|||
146724097|NCT01986881|529160635|FG000|Overall Study|Physician Decision|7|||
146724098|NCT01986881|529160636|FG001|Overall Study|Physician Decision|4|||
146724099|NCT01986881|529160637|FG002|Overall Study|Physician Decision|6|||
146724100|NCT01986881|529160635|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
146724101|NCT01986881|529160636|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
146724102|NCT01986881|529160637|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
146724103|NCT01986881|529160635|FG000|Overall Study|Withdrawal by Subject|41|||
146724104|NCT01986881|529160636|FG001|Overall Study|Withdrawal by Subject|60|||
146724105|NCT01986881|529160637|FG002|Overall Study|Withdrawal by Subject|45|||
146724106|NCT01986881|529160635|FG000|Overall Study|Subject Moved|0|||
146934904|NCT01281189|529920118|FG000|Overall Study|Other|8|||
146934905|NCT01281189|529920119|FG001|Overall Study|Other|12|||
146934906|NCT05355818|529920120|FG000|Overall Study|Adverse Event|1|||
146934907|NCT05355818|529920121|FG001|Overall Study|Adverse Event|1|||
146934908|NCT05355818|529920120|FG000|Overall Study|Lack of Efficacy|2|||
146934909|NCT05355818|529920121|FG001|Overall Study|Lack of Efficacy|1|||
146934910|NCT05355818|529920120|FG000|Overall Study|Lost to Follow-up|0|||
146934911|NCT05355818|529920121|FG001|Overall Study|Lost to Follow-up|1|||
146934912|NCT01136746|529920122|FG000|Overall Study|Lost to Follow-up|0|||
146934913|NCT01136746|529920123|FG001|Overall Study|Lost to Follow-up|2|||
146934914|NCT01136746|529920122|FG000|Overall Study|Protocol Violation|2|||
146724107|NCT01986881|529160636|FG001|Overall Study|Subject Moved|1|||
146724108|NCT01986881|529160637|FG002|Overall Study|Subject Moved|0|||
146724109|NCT01986881|529160635|FG000|Overall Study|Other|1|||
146724110|NCT01986881|529160636|FG001|Overall Study|Other|2|||
146724111|NCT01986881|529160637|FG002|Overall Study|Other|2|||
146724112|NCT02057874|529160638|FG000|Overall Study|participant did not return for scan|1|||
146724113|NCT04205630|529160639|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
146724114|NCT04205630|529160639|FG000|Overall Study|Disease clinical progression|7|||
146724115|NCT04205630|529160639|FG000|Overall Study|Withdrawal by Subject|2|||
146934915|NCT01136746|529920123|FG001|Overall Study|Protocol Violation|1|||
146934916|NCT01136746|529920122|FG000|Overall Study|Death|1|||
146981382|NCT01571635|530093882|FG004|Overall Study|Lack of Efficacy|2|||
146724116|NCT04205630|529160639|FG000|Overall Study|Adverse Event|17|||
146724117|NCT04205630|529160639|FG000|Overall Study|Other|1|||
146724118|NCT00886340|529160640|FG000|Overall Study|Withdrawal by Subject|0|||
146724119|NCT00886340|529160641|FG001|Overall Study|Withdrawal by Subject|7|||
146724120|NCT03224182|529160642|FG000|Overall Study|Study Drug Not Instilled|6|||
146724121|NCT03224182|529160643|FG001|Overall Study|Study Drug Not Instilled|1|||
146724122|NCT03224182|529160642|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
146724123|NCT03224182|529160643|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
146724124|NCT03224182|529160642|FG000|Overall Study|Withdrew of Consent|4|||
146724125|NCT03224182|529160643|FG001|Overall Study|Withdrew of Consent|2|||
146724126|NCT03224182|529160642|FG000|Overall Study|Investigator Decision|3|||
146724127|NCT03224182|529160643|FG001|Overall Study|Investigator Decision|1|||
146724128|NCT03224182|529160642|FG000|Overall Study|Sponsor Decision|26|||
146724129|NCT03224182|529160643|FG001|Overall Study|Sponsor Decision|12|||
146724130|NCT03224182|529160642|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
146724131|NCT03224182|529160643|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
146724132|NCT03224182|529160642|FG000|Overall Study|Lost to Follow-up|1|||
146724133|NCT03224182|529160643|FG001|Overall Study|Lost to Follow-up|0|||
146724134|NCT03224182|529160642|FG000|Overall Study|Participant Had Recurrence|11|||
146724135|NCT03224182|529160643|FG001|Overall Study|Participant Had Recurrence|5|||
146724136|NCT03224182|529160642|FG000|Overall Study|Death|0|||
146724137|NCT03224182|529160643|FG001|Overall Study|Death|1|||
146724138|NCT03224182|529160642|FG000|Overall Study|Reason not Specified|3|||
146724139|NCT03224182|529160643|FG001|Overall Study|Reason not Specified|3|||
146724140|NCT03224182|529160642|FG000|Overall Study|Other|1|||
146724141|NCT03224182|529160643|FG001|Overall Study|Other|0|||
146724142|NCT02481310|529160644|FG000|Follow up|Still in follow up|0|||
146724143|NCT02481310|529160645|FG001|Follow up|Still in follow up|3|||
146724144|NCT02481310|529160646|FG002|Follow up|Still in follow up|0|||
146724145|NCT02925455|529160651|FG000|Overall Study|Withdrawal by Subject|2|||
146724146|NCT02925455|529160652|FG001|Overall Study|Withdrawal by Subject|0|||
146724147|NCT00686166|529160653|FG000|Overall Study|Adverse Event|7|||
146724148|NCT00686166|529160653|FG000|Overall Study|Withdrawal by Subject|1|||
146724149|NCT00686166|529160653|FG000|Overall Study|Progression/Relapse|1|||
146724150|NCT00686166|529160653|FG000|Overall Study|Death|1|||
146724151|NCT00686166|529160653|FG000|Overall Study|Not Protocol Specified|1|||
146724152|NCT00686166|529160653|FG000|Overall Study|Ineligible|5|||
146724153|NCT00686166|529160653|FG000|Overall Study|Did not begin protocol therapy|4|||
146724154|NCT01514448|529160654|FG000|Overall Study|Death|7|||
146934917|NCT01136746|529920123|FG001|Overall Study|Death|0|||
146934918|NCT01175590|529920124|FG000|Overall Study|Lost to Follow-up|1|||
146724155|NCT01514448|529160655|FG001|Overall Study|Death|8|||
146724156|NCT01514448|529160654|FG000|Overall Study|Withdrawal by Subject|2|||
146724157|NCT01514448|529160655|FG001|Overall Study|Withdrawal by Subject|0|||
146724158|NCT01514448|529160654|FG000|Overall Study|Lost to Follow-up|2|||
146724159|NCT01514448|529160655|FG001|Overall Study|Lost to Follow-up|0|||
146724160|NCT01514448|529160654|FG000|Overall Study|New Cancer Therapy|1|||
146724161|NCT01514448|529160655|FG001|Overall Study|New Cancer Therapy|0|||
146724162|NCT02314624|529160656|FG000|Overall Study|No participating patient|16|||
146724163|NCT02314624|529160657|FG001|Overall Study|No participating patient|13|||
146724164|NCT02314624|529160656|FG000|Overall Study|Participant withdrew|7|||
146724165|NCT02314624|529160657|FG001|Overall Study|Participant withdrew|2|||
146934919|NCT01175590|529920125|FG001|Overall Study|Lost to Follow-up|0|||
146934920|NCT01175590|529920124|FG000|Overall Study|Withdrawal by Subject|0|||
146724166|NCT02314624|529160656|FG000|Overall Study|Lost to Follow-up|2|||
146934921|NCT01175590|529920125|FG001|Overall Study|Withdrawal by Subject|2|||
146784306|NCT01261312|529382256|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146784307|NCT01261312|529382257|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146784308|NCT01261312|529382258|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146784309|NCT01261312|529382259|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146784310|NCT01261312|529382260|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146784311|NCT01261312|529382261|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146784312|NCT01261312|529382262|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
146784313|NCT01261312|529382263|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
146784314|NCT01261312|529382264|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
146981383|NCT02151461|530093885|FG000|Overall Study|Adverse Event|5|||
146981384|NCT02151461|530093886|FG001|Overall Study|Adverse Event|1|||
146981385|NCT02151461|530093887|FG002|Overall Study|Adverse Event|0|||
146981386|NCT02151461|530093888|FG003|Overall Study|Adverse Event|2|||
146981387|NCT02151461|530093885|FG000|Overall Study|Lost to Follow-up|0|||
146981388|NCT02151461|530093886|FG001|Overall Study|Lost to Follow-up|0|||
146981389|NCT02151461|530093887|FG002|Overall Study|Lost to Follow-up|1|||
146981390|NCT02151461|530093888|FG003|Overall Study|Lost to Follow-up|1|||
146981391|NCT02151461|530093885|FG000|Overall Study|Withdrawal by Subject|1|||
146981392|NCT02151461|530093886|FG001|Overall Study|Withdrawal by Subject|0|||
146981393|NCT02151461|530093887|FG002|Overall Study|Withdrawal by Subject|1|||
146981394|NCT02151461|530093888|FG003|Overall Study|Withdrawal by Subject|1|||
146981395|NCT02151461|530093885|FG000|Overall Study|Treatment discontinuation|0|||
146981396|NCT02151461|530093886|FG001|Overall Study|Treatment discontinuation|0|||
146981397|NCT02151461|530093887|FG002|Overall Study|Treatment discontinuation|1|||
146981398|NCT02151461|530093888|FG003|Overall Study|Treatment discontinuation|0|||
146981399|NCT00706706|530093889|FG000|Overall Study|Death|53|||
146981400|NCT00706706|530093889|FG000|Overall Study|Lost to Follow-up|7|||
146981401|NCT00706706|530093889|FG000|Overall Study|Study endpoint had reached|45|||
146981402|NCT02191579|530093890|FG000|Treatment 1|Multiple Reasons Specified|27|||
146981403|NCT02191579|530093891|FG001|Treatment 1|Multiple Reasons Specified|58|||
146981404|NCT02191579|530093890|FG000|Treatment 2|Multiple Reasons Specified|0|||
146981405|NCT02191579|530093891|FG001|Treatment 2|Multiple Reasons Specified|25|||
146981406|NCT01606137|530093896|FG000|Overall Study|Adverse Event|85|||
146981407|NCT01606137|530093896|FG000|Overall Study|Withdrawal by Subject|74|||
146981408|NCT01606137|530093896|FG000|Overall Study|Lack of Efficacy|56|||
146981409|NCT01606137|530093896|FG000|Overall Study|Lost to Follow-up|15|||
146981410|NCT01606137|530093896|FG000|Overall Study|Protocol Violation|1|||
146981411|NCT01606137|530093896|FG000|Overall Study|Patient non-compliance|9|||
146981412|NCT01606137|530093896|FG000|Overall Study|Death|1|||
146724167|NCT02314624|529160657|FG001|Overall Study|Lost to Follow-up|5|||
146724168|NCT02314624|529160656|FG000|Overall Study|Dropped/Excluded by PI|6|||
146724169|NCT02314624|529160657|FG001|Overall Study|Dropped/Excluded by PI|6|||
146724170|NCT03912259|529160660|FG000|Overall Study|Adverse Event (AE)|2|||
146724171|NCT03912259|529160661|FG001|Overall Study|Adverse Event (AE)|4|||
146724172|NCT03912259|529160660|FG000|Overall Study|Lack of Efficacy|4|||
146724173|NCT03912259|529160661|FG001|Overall Study|Lack of Efficacy|1|||
146724174|NCT03912259|529160660|FG000|Overall Study|Withdrawal by Subject|11|||
146724175|NCT03912259|529160661|FG001|Overall Study|Withdrawal by Subject|1|||
146724176|NCT00360308|529160662|FG000|Overall Study|Adverse Event|15|||
146724177|NCT00360308|529160663|FG001|Overall Study|Adverse Event|14|||
146724178|NCT00360308|529160664|FG002|Overall Study|Adverse Event|25|||
146724179|NCT00360308|529160662|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
146724180|NCT00360308|529160663|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
146724181|NCT00360308|529160664|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
146724182|NCT00360308|529160662|FG000|Overall Study|Protocol Violation|2|||
146724183|NCT00360308|529160663|FG001|Overall Study|Protocol Violation|1|||
146724184|NCT00360308|529160664|FG002|Overall Study|Protocol Violation|2|||
146724185|NCT00360308|529160662|FG000|Overall Study|Withdrawal by Subject|11|||
146724186|NCT00360308|529160663|FG001|Overall Study|Withdrawal by Subject|7|||
146724187|NCT00360308|529160664|FG002|Overall Study|Withdrawal by Subject|14|||
146724188|NCT00360308|529160662|FG000|Overall Study|Lack of Efficacy|3|||
146724189|NCT00360308|529160663|FG001|Overall Study|Lack of Efficacy|0|||
146784315|NCT01261312|529382265|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146981413|NCT01606137|530093896|FG000|Overall Study|Decreased/no pain|4|||
146784316|NCT01261312|529382266|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146981414|NCT01606137|530093896|FG000|Overall Study|Issues with driving|4|||
146981415|NCT01606137|530093896|FG000|Overall Study|multiple sclerosis less stable|1|||
146981416|NCT01606137|530093896|FG000|Overall Study|Increased bilirubin|1|||
146981417|NCT01606137|530093896|FG000|Overall Study|Spray causes nausea|1|||
146724190|NCT00360308|529160664|FG002|Overall Study|Lack of Efficacy|2|||
146724191|NCT00360308|529160662|FG000|Overall Study|Other|2|||
146724192|NCT00360308|529160663|FG001|Overall Study|Other|1|||
146724193|NCT00360308|529160664|FG002|Overall Study|Other|1|||
146724194|NCT00360308|529160662|FG000|Overall Study|Study termination by sponsor|43|||
146724195|NCT00360308|529160663|FG001|Overall Study|Study termination by sponsor|55|||
146724196|NCT00360308|529160664|FG002|Overall Study|Study termination by sponsor|44|||
146934922|NCT01175590|529920124|FG000|Overall Study|Adverse Event|4|||
146934923|NCT01175590|529920125|FG001|Overall Study|Adverse Event|0|||
146934924|NCT01175590|529920124|FG000|Overall Study|Physician Decision|1|||
146934925|NCT01175590|529920125|FG001|Overall Study|Physician Decision|4|||
146934926|NCT01175590|529920124|FG000|Overall Study|Lack of Efficacy|1|||
146934927|NCT01175590|529920125|FG001|Overall Study|Lack of Efficacy|1|||
146934928|NCT01175590|529920124|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
146934929|NCT01175590|529920125|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
146934930|NCT01175590|529920124|FG000|Overall Study|Treated not as randomized|3|||
146934931|NCT01175590|529920125|FG001|Overall Study|Treated not as randomized|2|||
146934932|NCT01175590|529920124|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
146934933|NCT01175590|529920125|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
146934934|NCT01175590|529920124|FG000|Overall Study|Protocol Violation|0|||
146934935|NCT01175590|529920125|FG001|Overall Study|Protocol Violation|1|||
146934936|NCT00092677|529920131|FG000|Overall Study|Lost to Follow-up|0|||
146934937|NCT00092677|529920132|FG001|Overall Study|Lost to Follow-up|2|||
146934938|NCT00092677|529920131|FG000|Overall Study|Adminstrative|5|||
146934939|NCT00092677|529920132|FG001|Overall Study|Adminstrative|9|||
146981418|NCT01606137|530093896|FG000|Overall Study|Not enough improvement|4|||
146724197|NCT04786444|529160665|FG000|Overall Study|Withdrawal by Subject|4|||
146724198|NCT04786444|529160666|FG001|Overall Study|Withdrawal by Subject|7|||
146724199|NCT04786444|529160667|FG002|Overall Study|Withdrawal by Subject|2|||
146724200|NCT04786444|529160665|FG000|Overall Study|Lost to Follow-up|11|||
146724201|NCT04786444|529160666|FG001|Overall Study|Lost to Follow-up|9|||
146724202|NCT04786444|529160667|FG002|Overall Study|Lost to Follow-up|10|||
146724203|NCT04786444|529160665|FG000|Overall Study|Subject would like to become pregnant|0|||
146724204|NCT04786444|529160666|FG001|Overall Study|Subject would like to become pregnant|1|||
146724205|NCT04786444|529160667|FG002|Overall Study|Subject would like to become pregnant|0|||
146724206|NCT04162769|529160668|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
146724207|NCT04162769|529160669|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
146724208|NCT04162769|529160670|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
146724209|NCT04162769|529160671|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
146724210|NCT04162769|529160668|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
146724211|NCT04162769|529160669|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
146724212|NCT04162769|529160670|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
146724213|NCT04162769|529160671|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
146724214|NCT04162769|529160668|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
146724215|NCT04162769|529160669|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
146724216|NCT04162769|529160670|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
146724217|NCT04162769|529160671|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
146724218|NCT04162769|529160668|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
146724219|NCT04162769|529160669|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
146724220|NCT04162769|529160670|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
146724221|NCT04162769|529160671|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
146724222|NCT04162769|529160668|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
146724223|NCT04162769|529160669|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
146724224|NCT04162769|529160670|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
146724225|NCT04162769|529160671|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
146724226|NCT04162769|529160668|FG000|Double-blind Treatment (12-Week)|Other|0|||
146724227|NCT04162769|529160669|FG001|Double-blind Treatment (12-Week)|Other|1|||
146724228|NCT04162769|529160670|FG002|Double-blind Treatment (12-Week)|Other|1|||
146724229|NCT04162769|529160671|FG003|Double-blind Treatment (12-Week)|Other|0|||
146724230|NCT04162769|529160668|FG000|OLE Period (52-Week)|Adverse Event|0|||
146724231|NCT04162769|529160669|FG001|OLE Period (52-Week)|Adverse Event|0|||
146724232|NCT04162769|529160670|FG002|OLE Period (52-Week)|Adverse Event|0|||
146724233|NCT04162769|529160671|FG003|OLE Period (52-Week)|Adverse Event|5|||
146724234|NCT04162769|529160668|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
146724235|NCT04162769|529160669|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
146724236|NCT04162769|529160670|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
146724237|NCT04162769|529160671|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
146724238|NCT04162769|529160668|FG000|OLE Period (52-Week)|Physician Decision|0|||
146724239|NCT04162769|529160669|FG001|OLE Period (52-Week)|Physician Decision|0|||
146724240|NCT04162769|529160670|FG002|OLE Period (52-Week)|Physician Decision|0|||
146724241|NCT04162769|529160671|FG003|OLE Period (52-Week)|Physician Decision|1|||
146724242|NCT04162769|529160668|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
146724243|NCT04162769|529160669|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
146724244|NCT04162769|529160670|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
146724245|NCT04162769|529160671|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
146934940|NCT00010803|529920140|FG000|Overall Study|Withdrawal by Subject|97|||
146934941|NCT00010803|529920141|FG001|Overall Study|Withdrawal by Subject|98|||
146934942|NCT04671342|529920142|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
146934943|NCT04671342|529920142|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
146724246|NCT04162769|529160668|FG000|OLE Period (52-Week)|Protocol deviation|0|||
146724247|NCT04162769|529160669|FG001|OLE Period (52-Week)|Protocol deviation|0|||
146724248|NCT04162769|529160670|FG002|OLE Period (52-Week)|Protocol deviation|0|||
146724249|NCT04162769|529160671|FG003|OLE Period (52-Week)|Protocol deviation|2|||
146724250|NCT00725452|529160673|FG000|Overall Study|Adverse Event|3|||
146724251|NCT00725452|529160673|FG000|Overall Study|Lack of Efficacy|2|||
146724252|NCT00725452|529160673|FG000|Overall Study|Reason not specified|1|||
146724253|NCT00725452|529160673|FG000|Overall Study|Physician Decision|1|||
146724254|NCT00725452|529160673|FG000|Overall Study|Withdrawal by Subject|3|||
146724255|NCT00725452|529160673|FG000|Overall Study|Lost to Follow-up|1|||
146724256|NCT02163733|529160674|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
146724257|NCT02163733|529160675|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
146724258|NCT02163733|529160676|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
146724259|NCT02163733|529160674|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
146724260|NCT02163733|529160675|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
146724261|NCT02163733|529160676|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
146724262|NCT02723864|529160677|FG000|Overall Study|Refused further treatment|1|||
146724263|NCT02723864|529160678|FG001|Overall Study|Refused further treatment|0|||
146724264|NCT02723864|529160679|FG002|Overall Study|Refused further treatment|0|||
146724265|NCT02723864|529160680|FG003|Overall Study|Refused further treatment|0|||
146724266|NCT02723864|529160681|FG004|Overall Study|Refused further treatment|1|||
146724267|NCT02723864|529160682|FG005|Overall Study|Refused further treatment|2|||
146724268|NCT02723864|529160683|FG006|Overall Study|Refused further treatment|0|||
146724269|NCT02723864|529160677|FG000|Overall Study|Exceed treatment hold time|0|||
146724270|NCT02723864|529160678|FG001|Overall Study|Exceed treatment hold time|1|||
146724271|NCT02723864|529160679|FG002|Overall Study|Exceed treatment hold time|0|||
146724272|NCT02723864|529160680|FG003|Overall Study|Exceed treatment hold time|0|||
146724273|NCT02723864|529160681|FG004|Overall Study|Exceed treatment hold time|0|||
146724274|NCT02723864|529160682|FG005|Overall Study|Exceed treatment hold time|0|||
146724275|NCT02723864|529160683|FG006|Overall Study|Exceed treatment hold time|0|||
146724276|NCT02723864|529160677|FG000|Overall Study|Clinical progression|0|||
146724277|NCT02723864|529160678|FG001|Overall Study|Clinical progression|0|||
146724278|NCT02723864|529160679|FG002|Overall Study|Clinical progression|1|||
146724279|NCT02723864|529160680|FG003|Overall Study|Clinical progression|0|||
146724280|NCT02723864|529160681|FG004|Overall Study|Clinical progression|0|||
146724281|NCT02723864|529160682|FG005|Overall Study|Clinical progression|3|||
146724282|NCT02723864|529160683|FG006|Overall Study|Clinical progression|1|||
146724283|NCT02723864|529160677|FG000|Overall Study|Physician Decision|0|||
146724284|NCT02723864|529160678|FG001|Overall Study|Physician Decision|0|||
146724285|NCT02723864|529160679|FG002|Overall Study|Physician Decision|0|||
146724286|NCT02723864|529160680|FG003|Overall Study|Physician Decision|0|||
146724287|NCT02723864|529160681|FG004|Overall Study|Physician Decision|0|||
146724288|NCT02723864|529160682|FG005|Overall Study|Physician Decision|0|||
146724289|NCT02723864|529160683|FG006|Overall Study|Physician Decision|1|||
146724290|NCT02723864|529160677|FG000|Overall Study|Changes in patient condition|0|||
146724291|NCT02723864|529160678|FG001|Overall Study|Changes in patient condition|0|||
146724292|NCT02723864|529160679|FG002|Overall Study|Changes in patient condition|0|||
146724293|NCT02723864|529160680|FG003|Overall Study|Changes in patient condition|0|||
146724294|NCT02723864|529160681|FG004|Overall Study|Changes in patient condition|0|||
146724295|NCT02723864|529160682|FG005|Overall Study|Changes in patient condition|1|||
146724296|NCT02723864|529160683|FG006|Overall Study|Changes in patient condition|0|||
146724297|NCT02723864|529160677|FG000|Overall Study|Patient choice|0|||
146724298|NCT02723864|529160678|FG001|Overall Study|Patient choice|0|||
146724299|NCT02723864|529160679|FG002|Overall Study|Patient choice|0|||
146724300|NCT02723864|529160680|FG003|Overall Study|Patient choice|0|||
146724301|NCT02723864|529160681|FG004|Overall Study|Patient choice|0|||
146724302|NCT02723864|529160682|FG005|Overall Study|Patient choice|1|||
146724303|NCT02723864|529160683|FG006|Overall Study|Patient choice|0|||
146724304|NCT02723864|529160677|FG000|Overall Study|Adverse Event|0|||
146724305|NCT02723864|529160678|FG001|Overall Study|Adverse Event|0|||
146724306|NCT02723864|529160679|FG002|Overall Study|Adverse Event|0|||
146724307|NCT02723864|529160680|FG003|Overall Study|Adverse Event|0|||
146784317|NCT01261312|529382267|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146784318|NCT01261312|529382268|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146784319|NCT01261312|529382256|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146784320|NCT01261312|529382257|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146784321|NCT01261312|529382258|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146934944|NCT04671342|529920142|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
146724308|NCT02723864|529160681|FG004|Overall Study|Adverse Event|0|||
146724309|NCT02723864|529160682|FG005|Overall Study|Adverse Event|1|||
146724310|NCT02723864|529160683|FG006|Overall Study|Adverse Event|0|||
146724311|NCT02723864|529160677|FG000|Overall Study|Started new treatment|0|||
146724312|NCT02723864|529160678|FG001|Overall Study|Started new treatment|0|||
146724313|NCT02723864|529160679|FG002|Overall Study|Started new treatment|0|||
146724314|NCT02723864|529160680|FG003|Overall Study|Started new treatment|0|||
146724315|NCT02723864|529160681|FG004|Overall Study|Started new treatment|0|||
146724316|NCT02723864|529160682|FG005|Overall Study|Started new treatment|1|||
146724317|NCT02723864|529160683|FG006|Overall Study|Started new treatment|0|||
146724318|NCT02723864|529160677|FG000|Overall Study|Switched to alternative treatment|0|||
146724319|NCT02723864|529160678|FG001|Overall Study|Switched to alternative treatment|0|||
146724320|NCT02723864|529160679|FG002|Overall Study|Switched to alternative treatment|0|||
146724321|NCT02723864|529160680|FG003|Overall Study|Switched to alternative treatment|0|||
146724322|NCT02723864|529160681|FG004|Overall Study|Switched to alternative treatment|0|||
146724323|NCT02723864|529160682|FG005|Overall Study|Switched to alternative treatment|1|||
146724324|NCT02723864|529160683|FG006|Overall Study|Switched to alternative treatment|0|||
146724325|NCT02723864|529160677|FG000|Overall Study|Late determination of ineligibility|0|||
146724326|NCT02723864|529160678|FG001|Overall Study|Late determination of ineligibility|0|||
146724327|NCT02723864|529160679|FG002|Overall Study|Late determination of ineligibility|0|||
146724328|NCT02723864|529160680|FG003|Overall Study|Late determination of ineligibility|0|||
146724329|NCT02723864|529160681|FG004|Overall Study|Late determination of ineligibility|0|||
146724330|NCT02723864|529160682|FG005|Overall Study|Late determination of ineligibility|1|||
146724331|NCT02723864|529160683|FG006|Overall Study|Late determination of ineligibility|0|||
146724332|NCT00713648|529160686|FG000|Overall Study|Adverse Event|1|||
146724333|NCT00713648|529160686|FG000|Overall Study|Unclassified|2|||
146724334|NCT00713648|529160686|FG000|Overall Study|According to Protocol|2|||
146724335|NCT00713648|529160686|FG000|Overall Study|Development of antibodies|3|||
146724336|NCT00082173|529160687|FG000|Overall Study|Withdrawal by Subject|3|||
146724337|NCT00082173|529160688|FG001|Overall Study|Withdrawal by Subject|5|||
146724338|NCT00082173|529160687|FG000|Overall Study|Lost to Follow-up|1|||
146724339|NCT00082173|529160688|FG001|Overall Study|Lost to Follow-up|0|||
146724340|NCT00082173|529160687|FG000|Overall Study|Adverse Event|1|||
146724341|NCT00082173|529160688|FG001|Overall Study|Adverse Event|0|||
146724342|NCT00082173|529160687|FG000|Overall Study|Culture negative or resistant at baselin|5|||
146724343|NCT00082173|529160688|FG001|Overall Study|Culture negative or resistant at baselin|6|||
146724344|NCT01733732|529160689|FG000|Overall Study|Adverse Event|1|||
146724345|NCT01733732|529160690|FG001|Overall Study|Adverse Event|0|||
146724346|NCT01733732|529160689|FG000|Overall Study|Did not attend all study visits|1|||
146724347|NCT01733732|529160690|FG001|Overall Study|Did not attend all study visits|0|||
146724348|NCT00746590|529160691|FG000|Overall Study|Death|1|||
146724349|NCT00464815|529160694|FG000|Overall Study|Withdrawal by Subject|6|||
146724350|NCT00464815|529160695|FG001|Overall Study|Withdrawal by Subject|3|||
146724351|NCT02633800|529160698|FG000|Overall Study|Death|3|||
146724352|NCT02633800|529160699|FG001|Overall Study|Death|3|||
146724353|NCT02633800|529160698|FG000|Overall Study|Reason not provided|1|||
146724354|NCT02633800|529160699|FG001|Overall Study|Reason not provided|0|||
146724355|NCT02633800|529160698|FG000|Overall Study|Radiologic(al) progression|23|||
146724356|NCT02633800|529160699|FG001|Overall Study|Radiologic(al) progression|23|||
146724357|NCT02633800|529160698|FG000|Overall Study|Clinical progression|3|||
146724358|NCT02633800|529160699|FG001|Overall Study|Clinical progression|6|||
146724359|NCT02633800|529160698|FG000|Overall Study|Study terminated by sponsor|6|||
146724360|NCT02633800|529160699|FG001|Overall Study|Study terminated by sponsor|5|||
146724361|NCT02633800|529160698|FG000|Overall Study|Adverse event, non-fatal|7|||
146724362|NCT02633800|529160699|FG001|Overall Study|Adverse event, non-fatal|2|||
146724363|NCT02633800|529160698|FG000|Overall Study|Withdrawal by Subject|0|||
146724364|NCT02633800|529160699|FG001|Overall Study|Withdrawal by Subject|3|||
146724365|NCT02633800|529160698|FG000|Overall Study|Patient Request|1|||
146724366|NCT02633800|529160699|FG001|Overall Study|Patient Request|1|||
146724367|NCT00254982|529160704|FG000|Overall Study|Other|2|||
146724368|NCT00254982|529160705|FG001|Overall Study|Other|1|||
146724369|NCT00254982|529160704|FG000|Overall Study|Lack of Efficacy|5|||
146724370|NCT00254982|529160705|FG001|Overall Study|Lack of Efficacy|3|||
146724371|NCT00254982|529160704|FG000|Overall Study|Lost to Follow-up|5|||
146724372|NCT00254982|529160705|FG001|Overall Study|Lost to Follow-up|3|||
146724373|NCT00254982|529160704|FG000|Overall Study|Adverse Event|18|||
146724374|NCT00254982|529160705|FG001|Overall Study|Adverse Event|16|||
146724375|NCT00254982|529160704|FG000|Overall Study|Withdrawal by Subject|1|||
146724376|NCT00254982|529160705|FG001|Overall Study|Withdrawal by Subject|1|||
146724377|NCT00254982|529160704|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
146724378|NCT00254982|529160705|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
146724379|NCT00254982|529160704|FG000|Overall Study|Protocol deviation|1|||
146724380|NCT00254982|529160705|FG001|Overall Study|Protocol deviation|1|||
146784322|NCT01261312|529382259|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146724381|NCT00254982|529160704|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
146724382|NCT00254982|529160705|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
146724383|NCT00254982|529160704|FG000|Overall Study|Malignancy|0|||
146724384|NCT00254982|529160705|FG001|Overall Study|Malignancy|2|||
146724385|NCT00254982|529160704|FG000|Overall Study|Opportunistic infection|1|||
146724386|NCT00254982|529160705|FG001|Overall Study|Opportunistic infection|0|||
146724387|NCT00254982|529160704|FG000|Overall Study|Abnormal liver function tests|2|||
146724388|NCT00254982|529160705|FG001|Overall Study|Abnormal liver function tests|1|||
146724389|NCT03643952|529160709|FG000|Overall Study|Lack of Efficacy|1|||
146724390|NCT01358968|529160710|FG000|Period 2|Adverse Event|0|||
146724391|NCT01358968|529160711|FG001|Period 2|Adverse Event|1|||
146724392|NCT01358968|529160712|FG002|Period 2|Adverse Event|0|||
146724393|NCT01358968|529160713|FG003|Period 2|Adverse Event|0|||
146724394|NCT01358968|529160710|FG000|Continued Access Phase|Progression of Disease|0|||
146724395|NCT01358968|529160711|FG001|Continued Access Phase|Progression of Disease|0|||
146724396|NCT01358968|529160712|FG002|Continued Access Phase|Progression of Disease|8|||
146724397|NCT01358968|529160713|FG003|Continued Access Phase|Progression of Disease|4|||
146724398|NCT01358968|529160710|FG000|Continued Access Phase|Protocol Violation|0|||
146724399|NCT01358968|529160711|FG001|Continued Access Phase|Protocol Violation|0|||
146724400|NCT01358968|529160712|FG002|Continued Access Phase|Protocol Violation|0|||
146724401|NCT01358968|529160713|FG003|Continued Access Phase|Protocol Violation|2|||
146724402|NCT01358968|529160710|FG000|Continued Access Phase|Withdrawal by Subject|0|||
146724403|NCT01358968|529160711|FG001|Continued Access Phase|Withdrawal by Subject|0|||
146724404|NCT01358968|529160712|FG002|Continued Access Phase|Withdrawal by Subject|3|||
146724405|NCT01358968|529160713|FG003|Continued Access Phase|Withdrawal by Subject|0|||
146724406|NCT01358968|529160710|FG000|Continued Access Phase|Death|0|||
146724407|NCT01358968|529160711|FG001|Continued Access Phase|Death|0|||
146724408|NCT01358968|529160712|FG002|Continued Access Phase|Death|1|||
146724409|NCT01358968|529160713|FG003|Continued Access Phase|Death|1|||
146724410|NCT00487162|529160714|FG000|Overall Study|Adverse Event|0|||
146724411|NCT00487162|529160715|FG001|Overall Study|Adverse Event|1|||
146724412|NCT00487162|529160714|FG000|Overall Study|Physician Decision|0|||
146724413|NCT00487162|529160715|FG001|Overall Study|Physician Decision|1|||
146784323|NCT01261312|529382260|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146784324|NCT01261312|529382261|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146784325|NCT01261312|529382262|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146934945|NCT04671342|529920142|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
146934946|NCT04671342|529920142|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
146934947|NCT04671342|529920142|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
146934948|NCT03351478|529920145|FG000|Overall Study|At the subject's own request|11|||
146934949|NCT03351478|529920146|FG001|Overall Study|At the subject's own request|12|||
146934950|NCT03351478|529920147|FG002|Overall Study|At the subject's own request|5|||
146934951|NCT03351478|529920145|FG000|Overall Study|Adverse Event|1|||
146934952|NCT03351478|529920146|FG001|Overall Study|Adverse Event|2|||
146934953|NCT03351478|529920147|FG002|Overall Study|Adverse Event|1|||
146934954|NCT03351478|529920145|FG000|Overall Study|Poor compliance to protocol|1|||
146934955|NCT03351478|529920146|FG001|Overall Study|Poor compliance to protocol|0|||
146934956|NCT03351478|529920147|FG002|Overall Study|Poor compliance to protocol|0|||
146934957|NCT03351478|529920145|FG000|Overall Study|Reason not Specified|1|||
146934958|NCT03351478|529920146|FG001|Overall Study|Reason not Specified|3|||
146934959|NCT03351478|529920147|FG002|Overall Study|Reason not Specified|0|||
146934960|NCT03351478|529920145|FG000|Overall Study|Lost to Follow-up|0|||
146934961|NCT03351478|529920146|FG001|Overall Study|Lost to Follow-up|0|||
146934962|NCT03351478|529920147|FG002|Overall Study|Lost to Follow-up|1|||
146934963|NCT03911869|529920148|FG000|Safety Lead-in Phase|Death|7|||
146934964|NCT03911869|529920149|FG001|Safety Lead-in Phase|Death|0|||
146934965|NCT03911869|529920150|FG002|Safety Lead-in Phase|Death|0|||
146934966|NCT03911869|529920148|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
146934967|NCT03911869|529920149|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
146934968|NCT03911869|529920150|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
146934969|NCT03911869|529920148|FG000|Safety Lead-in Phase|Other|1|||
146934970|NCT03911869|529920149|FG001|Safety Lead-in Phase|Other|0|||
146934971|NCT03911869|529920150|FG002|Safety Lead-in Phase|Other|0|||
146934972|NCT03911869|529920148|FG000|Phase 2|Death|0|||
146934973|NCT03911869|529920149|FG001|Phase 2|Death|3|||
146724414|NCT00487162|529160714|FG000|Overall Study|Withdrawal by Subject|2|||
146784326|NCT01261312|529382263|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146934974|NCT03911869|529920150|FG002|Phase 2|Death|0|||
146934975|NCT00985738|529920154|FG000|Overall Study|Study closed prematurely|8|||
146934976|NCT00985738|529920155|FG001|Overall Study|Study closed prematurely|8|||
146934977|NCT01387074|529920159|FG000|Overall Study|Lost to Follow-up|7|||
146934978|NCT01387074|529920159|FG000|Overall Study|Lack of Efficacy|1|||
146981419|NCT01606137|530093896|FG000|Overall Study|Wanted to try another treatment|1|||
146724415|NCT00487162|529160715|FG001|Overall Study|Withdrawal by Subject|3|||
146724416|NCT00815295|529160718|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
146724417|NCT00815295|529160719|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
146934979|NCT02141217|529920162|FG000|Overall Study|Adverse Event|1|||
146934980|NCT02141217|529920163|FG001|Overall Study|Adverse Event|2|||
146934981|NCT02141217|529920162|FG000|Overall Study|Protocol Violation|1|||
146934982|NCT02141217|529920163|FG001|Overall Study|Protocol Violation|4|||
146934983|NCT02141217|529920162|FG000|Overall Study|Withdrawal by Subject|6|||
146981420|NCT01606137|530093896|FG000|Overall Study|Patient leaving country|1|||
146934984|NCT02141217|529920163|FG001|Overall Study|Withdrawal by Subject|0|||
146934985|NCT02141217|529920162|FG000|Overall Study|Lost to Follow-up|1|||
146934986|NCT02141217|529920163|FG001|Overall Study|Lost to Follow-up|1|||
146934987|NCT02141217|529920162|FG000|Overall Study|Physician Decision|1|||
146934988|NCT02141217|529920163|FG001|Overall Study|Physician Decision|0|||
146934989|NCT02141217|529920162|FG000|Overall Study|Surgical Intervention|1|||
146934990|NCT02141217|529920163|FG001|Overall Study|Surgical Intervention|1|||
146981421|NCT01606137|530093896|FG000|Overall Study|Personal reasons|1|||
146981422|NCT01606137|530093896|FG000|Overall Study|Unable to tolerate study med. taste|1|||
146724418|NCT00815295|529160720|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
146724419|NCT03644186|529160727|FG000|Overall Study|Withdrawal by Subject|1|||
146724420|NCT03644186|529160728|FG001|Overall Study|Withdrawal by Subject|1|||
146724421|NCT02701985|529160731|FG000|Overall Study|Withdrawal by Subject|1|||
146724422|NCT02701985|529160732|FG001|Overall Study|Withdrawal by Subject|1|||
146724423|NCT02701985|529160731|FG000|Overall Study|Lost to Follow-up|1|||
146724424|NCT02701985|529160732|FG001|Overall Study|Lost to Follow-up|0|||
146724425|NCT02701985|529160731|FG000|Overall Study|Death|1|||
146724426|NCT02701985|529160732|FG001|Overall Study|Death|0|||
146724427|NCT02701985|529160731|FG000|Overall Study|Adverse Event|0|||
146724428|NCT02701985|529160732|FG001|Overall Study|Adverse Event|5|||
146724429|NCT04391023|529160733|FG000|Overall Study|Withdrawal by Subject|2|||
146724430|NCT04391023|529160734|FG001|Overall Study|Withdrawal by Subject|2|||
146724431|NCT02085408|529160738|FG000|Step 1: Induction|Disease Progression|19|||
146724432|NCT02085408|529160739|FG001|Step 1: Induction|Disease Progression|19|||
146724433|NCT02085408|529160738|FG000|Step 1: Induction|Adverse Event|18|||
146724434|NCT02085408|529160739|FG001|Step 1: Induction|Adverse Event|17|||
146724435|NCT02085408|529160738|FG000|Step 1: Induction|Death|33|||
146724436|NCT02085408|529160739|FG001|Step 1: Induction|Death|30|||
146724437|NCT02085408|529160738|FG000|Step 1: Induction|Withdrawal by Subject|16|||
146724438|NCT02085408|529160739|FG001|Step 1: Induction|Withdrawal by Subject|8|||
146724439|NCT02085408|529160738|FG000|Step 1: Induction|Alternative Therapy|15|||
146724440|NCT02085408|529160739|FG001|Step 1: Induction|Alternative Therapy|19|||
146724441|NCT02085408|529160738|FG000|Step 1: Induction|Complicating Disease|2|||
146724442|NCT02085408|529160739|FG001|Step 1: Induction|Complicating Disease|3|||
146724443|NCT02085408|529160738|FG000|Step 1: Induction|Other|27|||
146724444|NCT02085408|529160739|FG001|Step 1: Induction|Other|39|||
146724445|NCT02085408|529160738|FG000|Step 1: Induction|Never started treatment|6|||
146724446|NCT02085408|529160739|FG001|Step 1: Induction|Never started treatment|4|||
146724447|NCT02085408|529160738|FG000|Step 2: Consolidation|Disease Progression|5|||
146724448|NCT02085408|529160739|FG001|Step 2: Consolidation|Disease Progression|20|||
146724449|NCT02085408|529160738|FG000|Step 2: Consolidation|Adverse Event|9|||
146724450|NCT02085408|529160739|FG001|Step 2: Consolidation|Adverse Event|8|||
146724451|NCT02085408|529160738|FG000|Step 2: Consolidation|Death|4|||
146724452|NCT02085408|529160739|FG001|Step 2: Consolidation|Death|3|||
146724453|NCT02085408|529160738|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
146724454|NCT02085408|529160739|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
146724455|NCT02085408|529160738|FG000|Step 2: Consolidation|Alternative Therapy|9|||
146724456|NCT02085408|529160739|FG001|Step 2: Consolidation|Alternative Therapy|3|||
146724457|NCT02085408|529160738|FG000|Step 2: Consolidation|Complicating Disease|0|||
146724458|NCT02085408|529160739|FG001|Step 2: Consolidation|Complicating Disease|2|||
146724459|NCT02085408|529160738|FG000|Step 2: Consolidation|Other|6|||
146724460|NCT02085408|529160739|FG001|Step 2: Consolidation|Other|6|||
146724461|NCT02085408|529160738|FG000|Step 2: Consolidation|Never started treatment|4|||
146724462|NCT02085408|529160739|FG001|Step 2: Consolidation|Never started treatment|3|||
146724463|NCT02085408|529160738|FG000|Step 3: Maintenance|Disease Progression|13|||
146724464|NCT02085408|529160739|FG001|Step 3: Maintenance|Disease Progression|11|||
146724465|NCT02085408|529160738|FG000|Step 3: Maintenance|Adverse Event|2|||
146724466|NCT02085408|529160739|FG001|Step 3: Maintenance|Adverse Event|4|||
146724467|NCT02085408|529160738|FG000|Step 3: Maintenance|Death|1|||
146724468|NCT02085408|529160739|FG001|Step 3: Maintenance|Death|2|||
146724469|NCT02085408|529160738|FG000|Step 3: Maintenance|Alternative Therapy|1|||
146724470|NCT02085408|529160739|FG001|Step 3: Maintenance|Alternative Therapy|1|||
146724471|NCT02085408|529160738|FG000|Step 3: Maintenance|Complicating Disease|0|||
146724472|NCT02085408|529160739|FG001|Step 3: Maintenance|Complicating Disease|1|||
146724473|NCT02085408|529160738|FG000|Step 3: Maintenance|Other|3|||
146934991|NCT04603391|529920164|FG000|First Intervention (4 Days)|Adverse Event|1|||
146981423|NCT01606137|530093896|FG000|Overall Study|Patient moving|1|||
146981424|NCT01606137|530093896|FG000|Overall Study|Unable to collect consistent data|1|||
146981425|NCT00066807|530093897|FG000|Overall Study|Study was terminated early|14|||
146981426|NCT00066807|530093898|FG001|Overall Study|Study was terminated early|15|||
146724474|NCT02085408|529160739|FG001|Step 3: Maintenance|Other|2|||
146724475|NCT02085408|529160738|FG000|Step 3: Maintenance|Never started treatment|5|||
146724476|NCT02085408|529160739|FG001|Step 3: Maintenance|Never started treatment|1|||
146724477|NCT02189798|529160740|FG000|Extended Use Phase|Withdrawal by Subject|0|||
146934992|NCT04603391|529920165|FG001|First Intervention (4 Days)|Adverse Event|0|||
146934993|NCT04603391|529920164|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
146981427|NCT05028751|530093899|FG000|Overall Study|Study Terminated by Sponsor|3|||
146784327|NCT01261312|529382264|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146784328|NCT01261312|529382265|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
146784329|NCT01261312|529382266|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
146784330|NCT01261312|529382267|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
146784331|NCT01261312|529382268|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
146784332|NCT01261312|529382256|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146784333|NCT01261312|529382257|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146784334|NCT01261312|529382258|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146784335|NCT01261312|529382259|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146784336|NCT01261312|529382260|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146784337|NCT01261312|529382261|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146784338|NCT01261312|529382262|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146784339|NCT01261312|529382263|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146784340|NCT01261312|529382264|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146784341|NCT01261312|529382265|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
146784342|NCT01261312|529382266|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146784343|NCT01261312|529382267|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
146784344|NCT01261312|529382268|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
146784345|NCT01261312|529382256|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146784346|NCT01261312|529382257|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146784347|NCT01261312|529382258|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146784348|NCT01261312|529382259|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146784349|NCT01261312|529382260|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146784350|NCT01261312|529382261|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146784351|NCT01261312|529382262|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146784352|NCT01261312|529382263|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146784353|NCT01261312|529382264|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146784354|NCT01261312|529382265|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
146784355|NCT01261312|529382266|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
146784356|NCT01261312|529382267|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
146784357|NCT01261312|529382268|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
146784358|NCT01261312|529382256|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146784359|NCT01261312|529382257|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146784360|NCT01261312|529382258|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146784361|NCT01261312|529382259|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146784362|NCT01261312|529382260|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146784363|NCT01261312|529382261|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146784364|NCT01261312|529382262|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146784365|NCT01261312|529382263|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146784366|NCT01261312|529382264|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146784367|NCT01261312|529382265|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
146784368|NCT01261312|529382266|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
146784369|NCT01261312|529382267|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
146784370|NCT01261312|529382268|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
146784371|NCT01261312|529382256|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146784372|NCT01261312|529382257|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146784373|NCT01261312|529382258|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146784374|NCT01261312|529382259|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146784375|NCT01261312|529382260|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146784376|NCT01261312|529382261|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146784377|NCT01261312|529382262|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146784378|NCT01261312|529382263|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146784379|NCT01261312|529382264|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146784380|NCT01261312|529382265|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
146784381|NCT01261312|529382266|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
146784382|NCT01261312|529382267|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
146784383|NCT01261312|529382268|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
146784384|NCT01261312|529382256|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146784385|NCT01261312|529382257|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146784386|NCT01261312|529382258|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146784387|NCT01261312|529382259|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146784388|NCT01261312|529382260|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146784389|NCT01261312|529382261|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146784390|NCT01261312|529382262|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146934994|NCT04603391|529920165|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
146724478|NCT02189798|529160741|FG001|Extended Use Phase|Withdrawal by Subject|4|||
146724479|NCT02189798|529160740|FG000|Extended Use Phase|Physician Decision|1|||
146724480|NCT02189798|529160741|FG001|Extended Use Phase|Physician Decision|0|||
146724481|NCT02189798|529160740|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
146724482|NCT02189798|529160741|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
146724483|NCT02189798|529160740|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
146724484|NCT02189798|529160741|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
146724485|NCT02189798|529160740|FG000|Extended Use Phase|Travel Issues|2|||
146724486|NCT02189798|529160741|FG001|Extended Use Phase|Travel Issues|1|||
146724487|NCT02189798|529160740|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
146724488|NCT02189798|529160741|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
146724489|NCT05553808|529160744|FG000|Overall Study|Death|25|||
146724490|NCT05553808|529160745|FG001|Overall Study|Death|62|||
146724491|NCT05553808|529160744|FG000|Overall Study|Site Closed|6|||
146724492|NCT05553808|529160745|FG001|Overall Study|Site Closed|6|||
146724493|NCT05553808|529160744|FG000|Overall Study|Lost to Follow-up|1|||
146724494|NCT05553808|529160745|FG001|Overall Study|Lost to Follow-up|0|||
146724495|NCT05553808|529160744|FG000|Overall Study|Withdrawal by Subject|3|||
146724496|NCT05553808|529160745|FG001|Overall Study|Withdrawal by Subject|2|||
146724497|NCT02273141|529160746|FG000|Overall Study|Adverse Event|0|||
146724498|NCT02273141|529160747|FG001|Overall Study|Adverse Event|1|||
146724499|NCT02273141|529160746|FG000|Overall Study|Lost to Follow-up|1|||
146724500|NCT02273141|529160747|FG001|Overall Study|Lost to Follow-up|3|||
146724501|NCT02273141|529160746|FG000|Overall Study|Withdrawal by Subject|10|||
146724502|NCT02273141|529160747|FG001|Overall Study|Withdrawal by Subject|15|||
146724503|NCT02273141|529160746|FG000|Overall Study|Various|6|||
146724504|NCT02273141|529160747|FG001|Overall Study|Various|6|||
146724505|NCT00529399|529160748|FG000|Overall Study|Lost to Follow-up|1|||
146724506|NCT00529399|529160749|FG001|Overall Study|Lost to Follow-up|0|||
146724507|NCT00529399|529160750|FG002|Overall Study|Lost to Follow-up|1|||
146724508|NCT00529399|529160748|FG000|Overall Study|Withdrawal by Subject|1|||
146724509|NCT00529399|529160749|FG001|Overall Study|Withdrawal by Subject|0|||
146724510|NCT00529399|529160750|FG002|Overall Study|Withdrawal by Subject|1|||
146724511|NCT00529399|529160748|FG000|Overall Study|Non-compliant|0|||
146724512|NCT00529399|529160749|FG001|Overall Study|Non-compliant|1|||
146724513|NCT00529399|529160750|FG002|Overall Study|Non-compliant|0|||
146724514|NCT05245864|529160771|FG000|Overall Study|Withdrawal by Subject|1|||
146724515|NCT05245864|529160772|FG001|Overall Study|Withdrawal by Subject|1|||
146724516|NCT01329029|529160773|FG000|Overall Study|Withdrawal by Subject|117|||
146724517|NCT01329029|529160774|FG001|Overall Study|Withdrawal by Subject|87|||
146724518|NCT01329029|529160773|FG000|Overall Study|Adverse Event|82|||
146724519|NCT01329029|529160774|FG001|Overall Study|Adverse Event|29|||
146724520|NCT01329029|529160773|FG000|Overall Study|Death|16|||
146724521|NCT01329029|529160774|FG001|Overall Study|Death|19|||
146724522|NCT01329029|529160773|FG000|Overall Study|Other|14|||
146724523|NCT01329029|529160774|FG001|Overall Study|Other|20|||
146724524|NCT01329029|529160773|FG000|Overall Study|COPD Exacerbation|11|||
146724525|NCT01329029|529160774|FG001|Overall Study|COPD Exacerbation|18|||
146724526|NCT01329029|529160773|FG000|Overall Study|Physician Decision|16|||
146724527|NCT01329029|529160774|FG001|Overall Study|Physician Decision|13|||
146724528|NCT01329029|529160773|FG000|Overall Study|Lost to Follow-up|8|||
146724529|NCT01329029|529160774|FG001|Overall Study|Lost to Follow-up|5|||
146724530|NCT01329029|529160773|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
146724531|NCT01329029|529160774|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
146724532|NCT01549613|529162389|FG000|Overall Study|Lost to Follow-up|11|||
146724533|NCT01549613|529162390|FG001|Overall Study|Lost to Follow-up|11|||
146724534|NCT02216123|529162391|FG000|Overall Study|Lost to Follow-up|4|||
146724535|NCT02216123|529162392|FG001|Overall Study|Lost to Follow-up|2|||
146724536|NCT02216123|529162391|FG000|Overall Study|Withdrawal by Subject|2|||
146724537|NCT02216123|529162392|FG001|Overall Study|Withdrawal by Subject|0|||
146724538|NCT02131272|529162393|FG000|Overall Study|Withdrawal by parent|0|||
146724539|NCT02131272|529162394|FG001|Overall Study|Withdrawal by parent|1|||
146724540|NCT02131272|529162393|FG000|Overall Study|Withdrawal by Subject|0|||
146724541|NCT02131272|529162394|FG001|Overall Study|Withdrawal by Subject|1|||
146724542|NCT02131272|529162393|FG000|Overall Study|Withdrawal Criteria|1|||
146724543|NCT02131272|529162394|FG001|Overall Study|Withdrawal Criteria|0|||
146724544|NCT00381940|529162395|FG000|Overall Study|Lack of Efficacy|3|||
146724545|NCT00381940|529162395|FG000|Overall Study|Protocol Violation|1|||
146724546|NCT00381940|529162395|FG000|Overall Study|Ineligible|1|||
146724547|NCT03162224|529162396|FG000|Overall Study|Death|4|||
146724548|NCT03162224|529162397|FG001|Overall Study|Death|5|||
146724549|NCT03162224|529162398|FG002|Overall Study|Death|8|||
146724550|NCT03162224|529162396|FG000|Overall Study|Withdrawal by Subject|1|||
146724551|NCT03162224|529162397|FG001|Overall Study|Withdrawal by Subject|0|||
146724552|NCT03162224|529162398|FG002|Overall Study|Withdrawal by Subject|1|||
146724553|NCT03162224|529162396|FG000|Overall Study|Lost to Follow-up|0|||
146724554|NCT03162224|529162397|FG001|Overall Study|Lost to Follow-up|1|||
146724555|NCT03162224|529162398|FG002|Overall Study|Lost to Follow-up|0|||
146724556|NCT03162224|529162396|FG000|Overall Study|Other|6|||
146724557|NCT03162224|529162397|FG001|Overall Study|Other|2|||
146724558|NCT03162224|529162398|FG002|Overall Study|Other|1|||
146724559|NCT05159622|529162399|FG000|Overall Study|Lost to Follow-up|4|||
146724560|NCT05159622|529162400|FG001|Overall Study|Lost to Follow-up|5|||
146724561|NCT04052204|529162401|FG000|Overall Study|Death|1|||
146724562|NCT04052204|529162402|FG001|Overall Study|Death|0|||
146724563|NCT04052204|529162403|FG002|Overall Study|Death|0|||
146724564|NCT04052204|529162401|FG000|Overall Study|Progressive disease|1|||
146724565|NCT04052204|529162402|FG001|Overall Study|Progressive disease|0|||
146724566|NCT04052204|529162403|FG002|Overall Study|Progressive disease|0|||
146724567|NCT04052204|529162401|FG000|Overall Study|Other|1|||
146724568|NCT04052204|529162402|FG001|Overall Study|Other|0|||
146724569|NCT04052204|529162403|FG002|Overall Study|Other|0|||
146724570|NCT04124926|529162422|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
146724571|NCT04124926|529162423|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
146724572|NCT04124926|529162424|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
146724573|NCT04124926|529162425|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
146724574|NCT04124926|529162426|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
146724575|NCT04124926|529162422|FG000|Healing Phase|Protocol Violation|0|||
146724576|NCT04124926|529162423|FG001|Healing Phase|Protocol Violation|1|||
146724577|NCT04124926|529162424|FG002|Healing Phase|Protocol Violation|0|||
146724578|NCT04124926|529162425|FG003|Healing Phase|Protocol Violation|0|||
146724579|NCT04124926|529162426|FG004|Healing Phase|Protocol Violation|0|||
146724580|NCT04124926|529162422|FG000|Healing Phase|Lost to Follow-up|5|||
146724581|NCT04124926|529162423|FG001|Healing Phase|Lost to Follow-up|4|||
146724582|NCT04124926|529162424|FG002|Healing Phase|Lost to Follow-up|0|||
146724583|NCT04124926|529162425|FG003|Healing Phase|Lost to Follow-up|0|||
146724584|NCT04124926|529162426|FG004|Healing Phase|Lost to Follow-up|0|||
146724585|NCT04124926|529162422|FG000|Healing Phase|Voluntary Withdrawal|10|||
146724586|NCT04124926|529162423|FG001|Healing Phase|Voluntary Withdrawal|7|||
146724587|NCT04124926|529162424|FG002|Healing Phase|Voluntary Withdrawal|0|||
146724588|NCT04124926|529162425|FG003|Healing Phase|Voluntary Withdrawal|0|||
146724589|NCT04124926|529162426|FG004|Healing Phase|Voluntary Withdrawal|0|||
146724590|NCT04124926|529162422|FG000|Healing Phase|Withdrawal of Consent|5|||
146724591|NCT04124926|529162423|FG001|Healing Phase|Withdrawal of Consent|3|||
146724592|NCT04124926|529162424|FG002|Healing Phase|Withdrawal of Consent|0|||
146724593|NCT04124926|529162425|FG003|Healing Phase|Withdrawal of Consent|0|||
146724594|NCT04124926|529162426|FG004|Healing Phase|Withdrawal of Consent|0|||
146724595|NCT04124926|529162422|FG000|Healing Phase|Miscellaneous|8|||
146724596|NCT04124926|529162423|FG001|Healing Phase|Miscellaneous|7|||
146724597|NCT04124926|529162424|FG002|Healing Phase|Miscellaneous|0|||
146724598|NCT04124926|529162425|FG003|Healing Phase|Miscellaneous|0|||
146724599|NCT04124926|529162426|FG004|Healing Phase|Miscellaneous|0|||
146724600|NCT04124926|529162422|FG000|Healing Phase|Randomized but not Treated|0|||
146724601|NCT04124926|529162423|FG001|Healing Phase|Randomized but not Treated|3|||
146724602|NCT04124926|529162424|FG002|Healing Phase|Randomized but not Treated|0|||
146724603|NCT04124926|529162425|FG003|Healing Phase|Randomized but not Treated|0|||
146724604|NCT04124926|529162426|FG004|Healing Phase|Randomized but not Treated|0|||
146724605|NCT04124926|529162422|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
146724606|NCT04124926|529162423|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
146724607|NCT04124926|529162424|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
146724608|NCT04124926|529162425|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
146724609|NCT04124926|529162426|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
146724610|NCT04124926|529162422|FG000|Maintenance Phase|Protocol Violation|0|||
146724611|NCT04124926|529162423|FG001|Maintenance Phase|Protocol Violation|0|||
146724612|NCT04124926|529162424|FG002|Maintenance Phase|Protocol Violation|3|||
146724613|NCT04124926|529162425|FG003|Maintenance Phase|Protocol Violation|0|||
146724614|NCT04124926|529162426|FG004|Maintenance Phase|Protocol Violation|0|||
146724615|NCT04124926|529162422|FG000|Maintenance Phase|Lost to Follow-up|0|||
146724616|NCT04124926|529162423|FG001|Maintenance Phase|Lost to Follow-up|0|||
146724617|NCT04124926|529162424|FG002|Maintenance Phase|Lost to Follow-up|7|||
146724618|NCT04124926|529162425|FG003|Maintenance Phase|Lost to Follow-up|8|||
146724619|NCT04124926|529162426|FG004|Maintenance Phase|Lost to Follow-up|9|||
146934995|NCT02759861|529920168|FG000|Overall Study|Death|1|||
146724620|NCT04124926|529162422|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
146724621|NCT04124926|529162423|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
146724622|NCT04124926|529162424|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
146724623|NCT04124926|529162425|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
146724624|NCT04124926|529162426|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
146724625|NCT04124926|529162422|FG000|Maintenance Phase|Pregnancy|0|||
146724626|NCT04124926|529162423|FG001|Maintenance Phase|Pregnancy|0|||
146724627|NCT04124926|529162424|FG002|Maintenance Phase|Pregnancy|0|||
146724628|NCT04124926|529162425|FG003|Maintenance Phase|Pregnancy|1|||
146724629|NCT04124926|529162426|FG004|Maintenance Phase|Pregnancy|0|||
146724630|NCT04124926|529162422|FG000|Maintenance Phase|Lack of Efficacy|0|||
146724631|NCT04124926|529162423|FG001|Maintenance Phase|Lack of Efficacy|0|||
146724632|NCT04124926|529162424|FG002|Maintenance Phase|Lack of Efficacy|0|||
146724633|NCT04124926|529162425|FG003|Maintenance Phase|Lack of Efficacy|0|||
146724634|NCT04124926|529162426|FG004|Maintenance Phase|Lack of Efficacy|1|||
146724635|NCT04124926|529162422|FG000|Maintenance Phase|Withdrawal of Consent|0|||
146724636|NCT04124926|529162423|FG001|Maintenance Phase|Withdrawal of Consent|0|||
146724637|NCT04124926|529162424|FG002|Maintenance Phase|Withdrawal of Consent|5|||
146724638|NCT04124926|529162425|FG003|Maintenance Phase|Withdrawal of Consent|5|||
146724639|NCT04124926|529162426|FG004|Maintenance Phase|Withdrawal of Consent|5|||
146724640|NCT04124926|529162422|FG000|Maintenance Phase|Miscellaneous|0|||
146724641|NCT04124926|529162423|FG001|Maintenance Phase|Miscellaneous|0|||
146724642|NCT04124926|529162424|FG002|Maintenance Phase|Miscellaneous|1|||
146724643|NCT04124926|529162425|FG003|Maintenance Phase|Miscellaneous|2|||
146724644|NCT04124926|529162426|FG004|Maintenance Phase|Miscellaneous|4|||
146724645|NCT04124926|529162422|FG000|Maintenance Phase|Randomized but not Treated|0|||
146724646|NCT04124926|529162423|FG001|Maintenance Phase|Randomized but not Treated|0|||
146724647|NCT04124926|529162424|FG002|Maintenance Phase|Randomized but not Treated|2|||
146724648|NCT04124926|529162425|FG003|Maintenance Phase|Randomized but not Treated|2|||
146724649|NCT04124926|529162426|FG004|Maintenance Phase|Randomized but not Treated|0|||
146724650|NCT02013622|529162432|FG000|Overall Study|Lost to Follow-up|10|||
146724651|NCT02013622|529162432|FG000|Overall Study|Adverse Event|3|||
146724652|NCT02013622|529162432|FG000|Overall Study|Met Withdrawal Criteria|3|||
146724653|NCT02013622|529162432|FG000|Overall Study|Withdrawal by Subject|6|||
146724654|NCT02013622|529162432|FG000|Overall Study|Protocol Deviation|1|||
146724655|NCT02013622|529162432|FG000|Overall Study|Lack of Efficacy|1|||
146724656|NCT05130970|529162435|FG000|Overall Study|Adverse Event|1|||
146724657|NCT05130970|529162436|FG001|Overall Study|Adverse Event|1|||
146724658|NCT05130970|529162435|FG000|Overall Study|Death|0|||
146724659|NCT05130970|529162436|FG001|Overall Study|Death|1|||
146724660|NCT05130970|529162435|FG000|Overall Study|Lost to Follow-up|0|||
146724661|NCT05130970|529162436|FG001|Overall Study|Lost to Follow-up|1|||
146724662|NCT05130970|529162435|FG000|Overall Study|Physician Decision|0|||
146724663|NCT05130970|529162436|FG001|Overall Study|Physician Decision|1|||
146724664|NCT05130970|529162435|FG000|Overall Study|Withdrawal by Subject|1|||
146724665|NCT05130970|529162436|FG001|Overall Study|Withdrawal by Subject|1|||
146724666|NCT01388816|529162439|FG000|Overall Study|Adverse Event|0|||
146724667|NCT01388816|529162440|FG001|Overall Study|Adverse Event|2|||
146724668|NCT01388816|529162441|FG002|Overall Study|Adverse Event|0|||
146724669|NCT01388816|529162442|FG003|Overall Study|Adverse Event|0|||
146724670|NCT01388816|529162439|FG000|Overall Study|Lost to Follow-up|0|||
146724671|NCT01388816|529162440|FG001|Overall Study|Lost to Follow-up|1|||
146724672|NCT01388816|529162441|FG002|Overall Study|Lost to Follow-up|0|||
146724673|NCT01388816|529162442|FG003|Overall Study|Lost to Follow-up|0|||
146724674|NCT01388816|529162439|FG000|Overall Study|Withdrawal by Subject|2|||
146724675|NCT01388816|529162440|FG001|Overall Study|Withdrawal by Subject|1|||
146724676|NCT01388816|529162441|FG002|Overall Study|Withdrawal by Subject|1|||
146724677|NCT01388816|529162442|FG003|Overall Study|Withdrawal by Subject|0|||
146724678|NCT01388816|529162439|FG000|Overall Study|Protocol Violation|0|||
146724679|NCT01388816|529162440|FG001|Overall Study|Protocol Violation|0|||
146724680|NCT01388816|529162441|FG002|Overall Study|Protocol Violation|2|||
146724681|NCT01388816|529162442|FG003|Overall Study|Protocol Violation|0|||
146724682|NCT00743366|529162443|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
146724683|NCT00743366|529162444|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
146724684|NCT02308748|529162451|FG000|Period 1|Withdrawal by Subject|0|||
146724685|NCT02308748|529162452|FG001|Period 1|Withdrawal by Subject|0|||
146724686|NCT02308748|529162453|FG002|Period 1|Withdrawal by Subject|1|||
146724687|NCT02308748|529162454|FG003|Period 1|Withdrawal by Subject|0|||
146724688|NCT02308748|529162455|FG004|Period 1|Withdrawal by Subject|0|||
146724689|NCT02308748|529162456|FG005|Period 1|Withdrawal by Subject|0|||
146724690|NCT02308748|529162457|FG006|Period 1|Withdrawal by Subject|0|||
146724691|NCT02308748|529162458|FG007|Period 1|Withdrawal by Subject|0|||
146724692|NCT02308748|529162459|FG008|Period 1|Withdrawal by Subject|0|||
146724693|NCT02308748|529162460|FG009|Period 1|Withdrawal by Subject|0|||
146724694|NCT02308748|529162451|FG000|Period 2|Adverse Event|0|||
146724695|NCT02308748|529162452|FG001|Period 2|Adverse Event|0|||
146724696|NCT02308748|529162453|FG002|Period 2|Adverse Event|0|||
146724697|NCT02308748|529162454|FG003|Period 2|Adverse Event|0|||
146724698|NCT02308748|529162455|FG004|Period 2|Adverse Event|0|||
146724699|NCT02308748|529162456|FG005|Period 2|Adverse Event|0|||
146724700|NCT02308748|529162457|FG006|Period 2|Adverse Event|0|||
146934996|NCT02988219|529920171|FG000|Overall Study|Lack of Efficacy|1|||
146724701|NCT02308748|529162458|FG007|Period 2|Adverse Event|1|||
146724702|NCT02308748|529162459|FG008|Period 2|Adverse Event|0|||
146724703|NCT02308748|529162460|FG009|Period 2|Adverse Event|0|||
146724704|NCT02308748|529162451|FG000|Period 3|Protocol Violation|0|||
146724705|NCT02308748|529162452|FG001|Period 3|Protocol Violation|0|||
146724706|NCT02308748|529162453|FG002|Period 3|Protocol Violation|0|||
146724707|NCT02308748|529162454|FG003|Period 3|Protocol Violation|0|||
146724708|NCT02308748|529162455|FG004|Period 3|Protocol Violation|0|||
146724709|NCT02308748|529162456|FG005|Period 3|Protocol Violation|0|||
146724710|NCT02308748|529162457|FG006|Period 3|Protocol Violation|0|||
146784391|NCT01261312|529382263|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146784392|NCT01261312|529382264|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146784393|NCT01261312|529382265|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
146784394|NCT01261312|529382266|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
146784395|NCT01261312|529382267|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
146784396|NCT01261312|529382268|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
146784397|NCT01261312|529382256|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146784398|NCT01261312|529382257|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146784399|NCT01261312|529382258|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146784400|NCT01261312|529382259|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146784401|NCT01261312|529382260|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146784402|NCT01261312|529382261|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146784403|NCT01261312|529382262|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146784404|NCT01261312|529382263|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146784405|NCT01261312|529382264|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146784406|NCT01261312|529382265|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
146784407|NCT01261312|529382266|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
146784408|NCT01261312|529382267|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
146784409|NCT01261312|529382268|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
146784410|NCT03336333|529382276|FG000|Overall Study|Remained on study at time of data cut-off|202|||
146784411|NCT03336333|529382277|FG001|Overall Study|Remained on study at time of data cut-off|219|||
146784412|NCT03336333|529382278|FG002|Overall Study|Remained on study at time of data cut-off|102|||
146784413|NCT03336333|529382276|FG000|Overall Study|Death|14|||
146784414|NCT03336333|529382277|FG001|Overall Study|Death|16|||
146784415|NCT03336333|529382278|FG002|Overall Study|Death|8|||
146784416|NCT03336333|529382276|FG000|Overall Study|Withdrawal by Subject|16|||
146784417|NCT03336333|529382277|FG001|Overall Study|Withdrawal by Subject|5|||
146784418|NCT03336333|529382278|FG002|Overall Study|Withdrawal by Subject|1|||
146981428|NCT05028751|530093900|FG001|Overall Study|Study Terminated by Sponsor|0|||
146981429|NCT05028751|530093901|FG002|Overall Study|Study Terminated by Sponsor|0|||
146981430|NCT05028751|530093902|FG003|Overall Study|Study Terminated by Sponsor|0|||
146981431|NCT05028751|530093899|FG000|Overall Study|Death|9|||
146724711|NCT02308748|529162458|FG007|Period 3|Protocol Violation|0|||
146724712|NCT02308748|529162459|FG008|Period 3|Protocol Violation|0|||
146724713|NCT02308748|529162460|FG009|Period 3|Protocol Violation|1|||
146724714|NCT02308748|529162451|FG000|Period 5|Adverse Event|1|||
146724715|NCT02308748|529162452|FG001|Period 5|Adverse Event|0|||
146724716|NCT02308748|529162453|FG002|Period 5|Adverse Event|0|||
146724717|NCT02308748|529162454|FG003|Period 5|Adverse Event|0|||
146724718|NCT02308748|529162455|FG004|Period 5|Adverse Event|0|||
146724719|NCT02308748|529162456|FG005|Period 5|Adverse Event|0|||
146724720|NCT02308748|529162457|FG006|Period 5|Adverse Event|0|||
146724721|NCT02308748|529162458|FG007|Period 5|Adverse Event|0|||
146724722|NCT02308748|529162459|FG008|Period 5|Adverse Event|1|||
146724723|NCT02308748|529162460|FG009|Period 5|Adverse Event|0|||
146724724|NCT01994954|529162461|FG000|Overall Study|Death|1|||
146724725|NCT01994954|529162462|FG001|Overall Study|Death|0|||
146724726|NCT01994954|529162461|FG000|Overall Study|Withdrawal by Subject|9|||
146724727|NCT01994954|529162462|FG001|Overall Study|Withdrawal by Subject|14|||
146724728|NCT01994954|529162461|FG000|Overall Study|Physician Decision|2|||
146724729|NCT01994954|529162462|FG001|Overall Study|Physician Decision|2|||
146724730|NCT01994954|529162461|FG000|Overall Study|Lost to Follow-up|8|||
146724731|NCT01994954|529162462|FG001|Overall Study|Lost to Follow-up|10|||
146724732|NCT01994954|529162461|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
146724733|NCT01994954|529162462|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
146724734|NCT00449176|529162463|FG000|Overall Study|Withdrawal by Subject|39|||
146724735|NCT00449176|529162464|FG001|Overall Study|Withdrawal by Subject|43|||
146724736|NCT00449176|529162465|FG002|Overall Study|Withdrawal by Subject|59|||
146724737|NCT00449176|529162463|FG000|Overall Study|Lost to Follow-up|13|||
146724738|NCT00449176|529162464|FG001|Overall Study|Lost to Follow-up|8|||
146724739|NCT00449176|529162465|FG002|Overall Study|Lost to Follow-up|12|||
146724740|NCT00449176|529162463|FG000|Overall Study|Adverse Event|51|||
146724741|NCT00449176|529162464|FG001|Overall Study|Adverse Event|107|||
146724742|NCT00449176|529162465|FG002|Overall Study|Adverse Event|15|||
146724743|NCT00449176|529162463|FG000|Overall Study|Lack of Efficacy|13|||
146724744|NCT00449176|529162464|FG001|Overall Study|Lack of Efficacy|7|||
146724745|NCT00449176|529162465|FG002|Overall Study|Lack of Efficacy|50|||
146724746|NCT00449176|529162463|FG000|Overall Study|Study drug non-compliant|14|||
146724747|NCT00449176|529162464|FG001|Overall Study|Study drug non-compliant|11|||
146724748|NCT00449176|529162465|FG002|Overall Study|Study drug non-compliant|11|||
146724749|NCT00449176|529162463|FG000|Overall Study|all other|22|||
146724750|NCT00449176|529162464|FG001|Overall Study|all other|19|||
146724751|NCT00449176|529162465|FG002|Overall Study|all other|20|||
146724752|NCT00675766|529162466|FG000|Overall Study|Lost to Follow-up|6|||
146724753|NCT00675766|529162467|FG001|Overall Study|Lost to Follow-up|5|||
146724754|NCT00675766|529162468|FG002|Overall Study|Lost to Follow-up|21|||
146724755|NCT00675766|529162469|FG003|Overall Study|Lost to Follow-up|26|||
146724756|NCT02576678|529162470|FG000|Overall Study|Adverse Event|0|||
146724757|NCT02576678|529162471|FG001|Overall Study|Adverse Event|0|||
146724758|NCT02576678|529162472|FG002|Overall Study|Adverse Event|2|||
146724759|NCT02576678|529162470|FG000|Overall Study|Withdrawal by Subject|3|||
146724760|NCT02576678|529162471|FG001|Overall Study|Withdrawal by Subject|1|||
146724761|NCT02576678|529162472|FG002|Overall Study|Withdrawal by Subject|2|||
146724762|NCT02576678|529162470|FG000|Overall Study|Lost to Follow-up|0|||
146724763|NCT02576678|529162471|FG001|Overall Study|Lost to Follow-up|0|||
146724764|NCT02576678|529162472|FG002|Overall Study|Lost to Follow-up|1|||
146724765|NCT02576678|529162470|FG000|Overall Study|Miscellaneous|2|||
146724766|NCT02576678|529162471|FG001|Overall Study|Miscellaneous|0|||
146724767|NCT02576678|529162472|FG002|Overall Study|Miscellaneous|0|||
146724768|NCT02472964|529162473|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
146724769|NCT02472964|529162474|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
146724770|NCT02472964|529162473|FG000|Part 1 (up to Week 24)|disease progression|58|||
146724771|NCT02472964|529162474|FG001|Part 1 (up to Week 24)|disease progression|47|||
146724772|NCT02472964|529162473|FG000|Part 1 (up to Week 24)|Death|3|||
146724773|NCT02472964|529162474|FG001|Part 1 (up to Week 24)|Death|6|||
146724774|NCT02472964|529162473|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
146724775|NCT02472964|529162474|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
146724776|NCT02472964|529162473|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
146724777|NCT02472964|529162474|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
146724778|NCT02472964|529162473|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
146724779|NCT02472964|529162474|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
146724780|NCT02472964|529162473|FG000|Part 1 (up to Week 24)|Other|2|||
146724781|NCT02472964|529162474|FG001|Part 1 (up to Week 24)|Other|1|||
146724782|NCT02472964|529162473|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
146724783|NCT02472964|529162474|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
146724784|NCT02472964|529162473|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
146724785|NCT02472964|529162474|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
146724786|NCT02472964|529162473|FG000|Part 2 (Week 24-week 48)|Death|0|||
146724787|NCT02472964|529162474|FG001|Part 2 (Week 24-week 48)|Death|1|||
146724788|NCT02472964|529162473|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
146724789|NCT02472964|529162474|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
146724790|NCT02472964|529162473|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
146724791|NCT02472964|529162474|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
146724792|NCT02472964|529162473|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
146724793|NCT02472964|529162474|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
146724794|NCT02472964|529162473|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
146724795|NCT02472964|529162474|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
146724796|NCT01454583|529162477|FG000|1st Year|Lost to Follow-up|1057|||
146724797|NCT01454583|529162478|FG001|1st Year|Lost to Follow-up|318|||
146724798|NCT01454583|529162479|FG002|1st Year|Lost to Follow-up|180|||
146724799|NCT01454583|529162477|FG000|2nd Year|Lost to Follow-up|3965|||
146724800|NCT01454583|529162478|FG001|2nd Year|Lost to Follow-up|1049|||
146724801|NCT01454583|529162479|FG002|2nd Year|Lost to Follow-up|737|||
146724802|NCT01454583|529162477|FG000|3rd Year|Lost to Follow-up|1959|||
146724803|NCT01454583|529162478|FG001|3rd Year|Lost to Follow-up|512|||
146724804|NCT01454583|529162479|FG002|3rd Year|Lost to Follow-up|297|||
146724805|NCT01749982|529162482|FG000|Overall Study|Physician Decision|0|||
146724806|NCT01749982|529162483|FG001|Overall Study|Physician Decision|0|||
146724807|NCT01749982|529162484|FG002|Overall Study|Physician Decision|0|||
146724808|NCT01749982|529162485|FG003|Overall Study|Physician Decision|1|||
146724809|NCT01749982|529162482|FG000|Overall Study|Lost to Follow-up|0|||
146724810|NCT01749982|529162483|FG001|Overall Study|Lost to Follow-up|0|||
146724811|NCT01749982|529162484|FG002|Overall Study|Lost to Follow-up|0|||
146724812|NCT01749982|529162485|FG003|Overall Study|Lost to Follow-up|1|||
146724813|NCT01749982|529162482|FG000|Overall Study|Withdrawal by Subject|0|||
146724814|NCT01749982|529162483|FG001|Overall Study|Withdrawal by Subject|0|||
146724815|NCT01749982|529162484|FG002|Overall Study|Withdrawal by Subject|0|||
146724816|NCT01749982|529162485|FG003|Overall Study|Withdrawal by Subject|1|||
146724817|NCT01967732|529162486|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
146724818|NCT01967732|529162487|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
146724819|NCT01967732|529162488|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
146724820|NCT01967732|529162489|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
146724821|NCT01967732|529162486|FG000|First Intervention (Day 1)|Poor venous access|0|||
146724822|NCT01967732|529162487|FG001|First Intervention (Day 1)|Poor venous access|1|||
146724823|NCT01967732|529162488|FG002|First Intervention (Day 1)|Poor venous access|0|||
146724824|NCT01967732|529162489|FG003|First Intervention (Day 1)|Poor venous access|0|||
146724825|NCT01988779|529162500|FG000|Overall Study|Withdrawal by Subject|2|||
146724826|NCT01988779|529162501|FG001|Overall Study|Withdrawal by Subject|2|||
146724827|NCT01988779|529162500|FG000|Overall Study|Protocol Violation|1|||
146724828|NCT01988779|529162501|FG001|Overall Study|Protocol Violation|0|||
146724829|NCT00377403|529162502|FG000|Overall Study|Unable to contact for telephone intervie|4|||
146724830|NCT00377403|529162503|FG001|Overall Study|Unable to contact for telephone intervie|7|||
146724831|NCT00417079|529162505|FG000|Overall Study|Disease progression|267|||
146724832|NCT00417079|529162506|FG001|Overall Study|Disease progression|180|||
146724833|NCT00417079|529162505|FG000|Overall Study|Adverse Event|32|||
146724834|NCT00417079|529162506|FG001|Overall Study|Adverse Event|67|||
146724835|NCT00417079|529162505|FG000|Overall Study|Non-compliance to protocol|0|||
146724836|NCT00417079|529162506|FG001|Overall Study|Non-compliance to protocol|1|||
146724837|NCT00417079|529162505|FG000|Overall Study|Lost to Follow-up|2|||
146724838|NCT00417079|529162506|FG001|Overall Study|Lost to Follow-up|0|||
146724839|NCT00417079|529162505|FG000|Overall Study|Withdrawal by Subject|17|||
146724840|NCT00417079|529162506|FG001|Overall Study|Withdrawal by Subject|8|||
146784419|NCT03336333|529382276|FG000|Overall Study|Physician Decision|5|||
146784420|NCT03336333|529382277|FG001|Overall Study|Physician Decision|1|||
146784421|NCT03336333|529382278|FG002|Overall Study|Physician Decision|0|||
146784422|NCT03336333|529382276|FG000|Overall Study|Lost to Follow-up|1|||
146784423|NCT03336333|529382277|FG001|Overall Study|Lost to Follow-up|0|||
146784424|NCT03336333|529382278|FG002|Overall Study|Lost to Follow-up|0|||
146784425|NCT04927065|529382279|FG000|First Booster|Adverse Event|1|||
146784426|NCT04927065|529382280|FG001|First Booster|Adverse Event|0|||
146784427|NCT04927065|529382281|FG002|First Booster|Adverse Event|0|||
146784428|NCT04927065|529382282|FG003|First Booster|Adverse Event|0|||
146784429|NCT04927065|529382283|FG004|First Booster|Adverse Event|0|||
146784430|NCT04927065|529382284|FG005|First Booster|Adverse Event|0|||
146784431|NCT04927065|529382285|FG006|First Booster|Adverse Event|0|||
146784432|NCT04927065|529382286|FG007|First Booster|Adverse Event|1|||
146784433|NCT04927065|529382287|FG008|First Booster|Adverse Event|0|||
146784434|NCT04927065|529382288|FG009|First Booster|Adverse Event|0|||
146784435|NCT04927065|529382289|FG010|First Booster|Adverse Event|0|||
146784436|NCT04927065|529382290|FG011|First Booster|Adverse Event|0|||
146784437|NCT04927065|529382291|FG012|First Booster|Adverse Event|0|||
146784438|NCT04927065|529382292|FG013|First Booster|Adverse Event|0|||
146784439|NCT04927065|529382293|FG014|First Booster|Adverse Event|0|||
146784440|NCT04927065|529382294|FG015|First Booster|Adverse Event|0|||
146784441|NCT04927065|529382279|FG000|First Booster|Death|1|||
146784442|NCT04927065|529382280|FG001|First Booster|Death|0|||
146784443|NCT04927065|529382281|FG002|First Booster|Death|0|||
146784444|NCT04927065|529382282|FG003|First Booster|Death|1|||
146784445|NCT04927065|529382283|FG004|First Booster|Death|0|||
146784446|NCT04927065|529382284|FG005|First Booster|Death|1|||
146784447|NCT04927065|529382285|FG006|First Booster|Death|0|||
146784448|NCT04927065|529382286|FG007|First Booster|Death|0|||
146784449|NCT04927065|529382287|FG008|First Booster|Death|0|||
146784450|NCT04927065|529382288|FG009|First Booster|Death|0|||
146784451|NCT04927065|529382289|FG010|First Booster|Death|0|||
146784452|NCT04927065|529382290|FG011|First Booster|Death|0|||
146784453|NCT04927065|529382291|FG012|First Booster|Death|0|||
146784454|NCT04927065|529382292|FG013|First Booster|Death|0|||
146784455|NCT04927065|529382293|FG014|First Booster|Death|0|||
146784456|NCT04927065|529382294|FG015|First Booster|Death|0|||
146784457|NCT04927065|529382279|FG000|First Booster|Lost to Follow-up|8|||
146784458|NCT04927065|529382280|FG001|First Booster|Lost to Follow-up|20|||
146784459|NCT04927065|529382281|FG002|First Booster|Lost to Follow-up|0|||
146784460|NCT04927065|529382282|FG003|First Booster|Lost to Follow-up|11|||
146784461|NCT04927065|529382283|FG004|First Booster|Lost to Follow-up|43|||
146784462|NCT04927065|529382284|FG005|First Booster|Lost to Follow-up|30|||
146784463|NCT04927065|529382285|FG006|First Booster|Lost to Follow-up|28|||
146784464|NCT04927065|529382286|FG007|First Booster|Lost to Follow-up|23|||
146784465|NCT04927065|529382287|FG008|First Booster|Lost to Follow-up|4|||
146784466|NCT04927065|529382288|FG009|First Booster|Lost to Follow-up|15|||
146784467|NCT04927065|529382289|FG010|First Booster|Lost to Follow-up|0|||
146784468|NCT04927065|529382290|FG011|First Booster|Lost to Follow-up|0|||
146784469|NCT04927065|529382291|FG012|First Booster|Lost to Follow-up|0|||
146784470|NCT04927065|529382292|FG013|First Booster|Lost to Follow-up|0|||
146784471|NCT04927065|529382293|FG014|First Booster|Lost to Follow-up|0|||
146784472|NCT04927065|529382294|FG015|First Booster|Lost to Follow-up|0|||
146784473|NCT04927065|529382279|FG000|First Booster|Physician Decision|1|||
146784474|NCT04927065|529382280|FG001|First Booster|Physician Decision|0|||
146784475|NCT04927065|529382281|FG002|First Booster|Physician Decision|0|||
146724841|NCT00417079|529162505|FG000|Overall Study|Not treated|6|||
146724842|NCT00417079|529162506|FG001|Overall Study|Not treated|7|||
146784476|NCT04927065|529382282|FG003|First Booster|Physician Decision|3|||
146784477|NCT04927065|529382283|FG004|First Booster|Physician Decision|1|||
146934997|NCT02988219|529920172|FG001|Overall Study|Lack of Efficacy|1|||
146784478|NCT04927065|529382284|FG005|First Booster|Physician Decision|1|||
146784479|NCT04927065|529382285|FG006|First Booster|Physician Decision|0|||
146784480|NCT04927065|529382286|FG007|First Booster|Physician Decision|3|||
146784481|NCT04927065|529382287|FG008|First Booster|Physician Decision|0|||
146784482|NCT04927065|529382288|FG009|First Booster|Physician Decision|0|||
146784483|NCT04927065|529382289|FG010|First Booster|Physician Decision|0|||
146784484|NCT04927065|529382290|FG011|First Booster|Physician Decision|0|||
146784485|NCT04927065|529382291|FG012|First Booster|Physician Decision|0|||
146724843|NCT00417079|529162505|FG000|Overall Study|Screened failure|2|||
146724844|NCT00417079|529162506|FG001|Overall Study|Screened failure|1|||
146724845|NCT00417079|529162505|FG000|Overall Study|Investigator's decision|1|||
146724846|NCT00417079|529162506|FG001|Overall Study|Investigator's decision|4|||
146724847|NCT00417079|529162505|FG000|Overall Study|Non-confirmed Disease progression|1|||
146724848|NCT00417079|529162506|FG001|Overall Study|Non-confirmed Disease progression|1|||
146724849|NCT00417079|529162505|FG000|Overall Study|Clinical deterioration|1|||
146724850|NCT00417079|529162506|FG001|Overall Study|Clinical deterioration|0|||
146724851|NCT00417079|529162505|FG000|Overall Study|Screening error|2|||
146724852|NCT00417079|529162506|FG001|Overall Study|Screening error|1|||
146724853|NCT00417079|529162505|FG000|Overall Study|Withdrawal by subject's family|0|||
146724854|NCT00417079|529162506|FG001|Overall Study|Withdrawal by subject's family|1|||
146724855|NCT00417079|529162505|FG000|Overall Study|Patient unable to come to the clinic|0|||
146724856|NCT00417079|529162506|FG001|Overall Study|Patient unable to come to the clinic|1|||
146724857|NCT00417079|529162505|FG000|Overall Study|abnormal liver function tests|0|||
146724858|NCT00417079|529162506|FG001|Overall Study|abnormal liver function tests|1|||
146724859|NCT01922076|529162509|FG000|Overall Study|Adverse Event|0|||
146724860|NCT01922076|529162510|FG001|Overall Study|Adverse Event|0|||
146724861|NCT01922076|529162511|FG002|Overall Study|Adverse Event|0|||
146724862|NCT01922076|529162512|FG003|Overall Study|Adverse Event|0|||
146724863|NCT01922076|529162513|FG004|Overall Study|Adverse Event|1|||
146724864|NCT01922076|529162514|FG005|Overall Study|Adverse Event|0|||
146724865|NCT01922076|529162515|FG006|Overall Study|Adverse Event|0|||
146724866|NCT01922076|529162509|FG000|Overall Study|Physician Decision|0|||
146724867|NCT01922076|529162510|FG001|Overall Study|Physician Decision|0|||
146724868|NCT01922076|529162511|FG002|Overall Study|Physician Decision|1|||
146724869|NCT01922076|529162512|FG003|Overall Study|Physician Decision|0|||
146724870|NCT01922076|529162513|FG004|Overall Study|Physician Decision|0|||
146724871|NCT01922076|529162514|FG005|Overall Study|Physician Decision|0|||
146724872|NCT01922076|529162515|FG006|Overall Study|Physician Decision|0|||
146724873|NCT01922076|529162509|FG000|Overall Study|Withdrawal by Subject|0|||
146724874|NCT01922076|529162510|FG001|Overall Study|Withdrawal by Subject|0|||
146724875|NCT01922076|529162511|FG002|Overall Study|Withdrawal by Subject|0|||
146724876|NCT01922076|529162512|FG003|Overall Study|Withdrawal by Subject|1|||
146724877|NCT01922076|529162513|FG004|Overall Study|Withdrawal by Subject|0|||
146724878|NCT01922076|529162514|FG005|Overall Study|Withdrawal by Subject|1|||
146724879|NCT01922076|529162515|FG006|Overall Study|Withdrawal by Subject|1|||
146724880|NCT01022762|529162516|FG000|Overall Study|Adverse Event|3|||
146724881|NCT01022762|529162517|FG001|Overall Study|Adverse Event|1|||
146724882|NCT01022762|529162516|FG000|Overall Study|Lack of Efficacy|0|||
146724883|NCT01022762|529162517|FG001|Overall Study|Lack of Efficacy|1|||
146724884|NCT01022762|529162516|FG000|Overall Study|Protocol Violation|7|||
146724885|NCT01022762|529162517|FG001|Overall Study|Protocol Violation|6|||
146724886|NCT01022762|529162516|FG000|Overall Study|Unclassified|12|||
146724887|NCT01022762|529162517|FG001|Overall Study|Unclassified|20|||
146724888|NCT00802074|529162518|FG000|Overall Study|Adverse Event|1|||
146724889|NCT00802074|529162519|FG001|Overall Study|Adverse Event|1|||
146724890|NCT00802074|529162520|FG002|Overall Study|Adverse Event|1|||
146724891|NCT00802074|529162521|FG003|Overall Study|Adverse Event|0|||
146724892|NCT00802074|529162522|FG004|Overall Study|Adverse Event|0|||
146724893|NCT00802074|529162523|FG005|Overall Study|Adverse Event|0|||
146724894|NCT00802074|529162518|FG000|Overall Study|Withdrawal by Subject|1|||
146724895|NCT00802074|529162519|FG001|Overall Study|Withdrawal by Subject|0|||
146724896|NCT00802074|529162520|FG002|Overall Study|Withdrawal by Subject|0|||
146724897|NCT00802074|529162521|FG003|Overall Study|Withdrawal by Subject|0|||
146724898|NCT00802074|529162522|FG004|Overall Study|Withdrawal by Subject|0|||
146724899|NCT00802074|529162523|FG005|Overall Study|Withdrawal by Subject|0|||
146724900|NCT00827918|529162524|FG000|Overall Study|Adverse Event|4|||
146724901|NCT00827918|529162525|FG001|Overall Study|Adverse Event|0|||
146724902|NCT00827918|529162526|FG002|Overall Study|Adverse Event|0|||
146724903|NCT00827918|529162524|FG000|Overall Study|Lack of Efficacy|16|||
146724904|NCT00827918|529162525|FG001|Overall Study|Lack of Efficacy|4|||
146724905|NCT00827918|529162526|FG002|Overall Study|Lack of Efficacy|15|||
146981432|NCT05028751|530093900|FG001|Overall Study|Death|3|||
146981433|NCT05028751|530093901|FG002|Overall Study|Death|2|||
146724906|NCT00827918|529162524|FG000|Overall Study|Physician Decision|1|||
146724907|NCT00827918|529162525|FG001|Overall Study|Physician Decision|0|||
146724908|NCT00827918|529162526|FG002|Overall Study|Physician Decision|0|||
146724909|NCT00827918|529162524|FG000|Overall Study|Pregnancy|0|||
146724910|NCT00827918|529162525|FG001|Overall Study|Pregnancy|1|||
146724911|NCT00827918|529162526|FG002|Overall Study|Pregnancy|0|||
146724912|NCT00827918|529162524|FG000|Overall Study|Progressive Disease|1|||
146724913|NCT00827918|529162525|FG001|Overall Study|Progressive Disease|1|||
146724914|NCT00827918|529162526|FG002|Overall Study|Progressive Disease|0|||
146724915|NCT00827918|529162524|FG000|Overall Study|Protocol Violation|0|||
146724916|NCT00827918|529162525|FG001|Overall Study|Protocol Violation|1|||
146724917|NCT00827918|529162526|FG002|Overall Study|Protocol Violation|0|||
146724918|NCT00827918|529162524|FG000|Overall Study|Withdrawal by Subject|6|||
146724919|NCT00827918|529162525|FG001|Overall Study|Withdrawal by Subject|2|||
146724920|NCT00827918|529162526|FG002|Overall Study|Withdrawal by Subject|6|||
146724921|NCT03743038|529162529|FG000|Overall Study|Physician Decision|1|||
146724922|NCT01565707|529162530|FG000|Overall Study|Adverse Event|1|||
146724923|NCT01565707|529162531|FG001|Overall Study|Adverse Event|6|||
146724924|NCT01565707|529162532|FG002|Overall Study|Adverse Event|2|||
146724925|NCT01565707|529162533|FG003|Overall Study|Adverse Event|1|||
146724926|NCT01565707|529162530|FG000|Overall Study|Lost to Follow-up|1|||
146724927|NCT01565707|529162531|FG001|Overall Study|Lost to Follow-up|0|||
146724928|NCT01565707|529162532|FG002|Overall Study|Lost to Follow-up|0|||
146724929|NCT01565707|529162533|FG003|Overall Study|Lost to Follow-up|0|||
146724930|NCT01565707|529162530|FG000|Overall Study|Protocol Violation|1|||
146724931|NCT01565707|529162531|FG001|Overall Study|Protocol Violation|0|||
146724932|NCT01565707|529162532|FG002|Overall Study|Protocol Violation|0|||
146724933|NCT01565707|529162533|FG003|Overall Study|Protocol Violation|1|||
146724934|NCT01565707|529162530|FG000|Overall Study|Withdrawal by Subject|3|||
146724935|NCT01565707|529162531|FG001|Overall Study|Withdrawal by Subject|1|||
146724936|NCT01565707|529162532|FG002|Overall Study|Withdrawal by Subject|1|||
146724937|NCT01565707|529162533|FG003|Overall Study|Withdrawal by Subject|1|||
146724938|NCT01565707|529162530|FG000|Overall Study|Randomized but not evaluable|2|||
146724939|NCT01565707|529162531|FG001|Overall Study|Randomized but not evaluable|0|||
146724940|NCT01565707|529162532|FG002|Overall Study|Randomized but not evaluable|0|||
146724941|NCT01565707|529162533|FG003|Overall Study|Randomized but not evaluable|0|||
146724942|NCT01565707|529162530|FG000|Overall Study|Miscellaneous|1|||
146724943|NCT01565707|529162531|FG001|Overall Study|Miscellaneous|1|||
146724944|NCT01565707|529162532|FG002|Overall Study|Miscellaneous|0|||
146724945|NCT01565707|529162533|FG003|Overall Study|Miscellaneous|2|||
146724946|NCT05207813|529162534|FG000|Overall Study|Lost to Follow-up|2|||
146724947|NCT00617344|529162536|FG000|Overall Study|Serious adverse event|1|||
146724948|NCT00617344|529162537|FG001|Overall Study|Serious adverse event|0|||
146724949|NCT00617344|529162538|FG002|Overall Study|Serious adverse event|0|||
146724950|NCT00617344|529162536|FG000|Overall Study|Other Adverse Event|1|||
146724951|NCT00617344|529162537|FG001|Overall Study|Other Adverse Event|1|||
146724952|NCT00617344|529162538|FG002|Overall Study|Other Adverse Event|0|||
146724953|NCT00617344|529162536|FG000|Overall Study|Protocol Violation|10|||
146724954|NCT00617344|529162537|FG001|Overall Study|Protocol Violation|8|||
146724955|NCT00617344|529162538|FG002|Overall Study|Protocol Violation|5|||
146724956|NCT00617344|529162536|FG000|Overall Study|Lost to Follow-up|5|||
146724957|NCT00617344|529162537|FG001|Overall Study|Lost to Follow-up|4|||
146724958|NCT00617344|529162538|FG002|Overall Study|Lost to Follow-up|1|||
146724959|NCT00617344|529162536|FG000|Overall Study|Withdrawal by Subject|8|||
146724960|NCT00617344|529162537|FG001|Overall Study|Withdrawal by Subject|9|||
146724961|NCT00617344|529162538|FG002|Overall Study|Withdrawal by Subject|2|||
146724962|NCT01261338|529162543|FG000|Overall Study|Withdrawal by Subject|3|||
146724963|NCT01261338|529162544|FG001|Overall Study|Withdrawal by Subject|2|||
146724964|NCT03754803|529162545|FG000|Overall Study|Withdrawal by Subject|2|||
146724965|NCT04050865|529164198|FG000|Overall Study|Adverse Event|1|||
146724966|NCT04050865|529164199|FG001|Overall Study|Adverse Event|0|||
146724967|NCT04050865|529164198|FG000|Overall Study|no insert|1|||
146724968|NCT04050865|529164199|FG001|Overall Study|no insert|0|||
146724969|NCT04050865|529164198|FG000|Overall Study|Only 1 insert|2|||
146724970|NCT04050865|529164199|FG001|Overall Study|Only 1 insert|3|||
146724971|NCT04050865|529164198|FG000|Overall Study|Physician Decision|0|||
146724972|NCT04050865|529164199|FG001|Overall Study|Physician Decision|1|||
146724973|NCT04050865|529164198|FG000|Overall Study|Withdrawal by Subject|0|||
146724974|NCT04050865|529164199|FG001|Overall Study|Withdrawal by Subject|1|||
146724975|NCT00857207|529164204|FG000|Overall Study|Withdrawal by Subject|13|||
146724976|NCT00857207|529164205|FG001|Overall Study|Withdrawal by Subject|0|||
146724977|NCT00857207|529164204|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
146724978|NCT00857207|529164205|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
146724979|NCT00857207|529164204|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
146981434|NCT05028751|530093902|FG003|Overall Study|Death|4|||
146724980|NCT00857207|529164205|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
146724981|NCT00643916|529164209|FG000|Overall Study|Protocol Violation|0|||
146724982|NCT00643916|529164210|FG001|Overall Study|Protocol Violation|1|||
146724983|NCT00643916|529164211|FG002|Overall Study|Protocol Violation|1|||
146724984|NCT00643916|529164212|FG003|Overall Study|Protocol Violation|1|||
146724985|NCT00643916|529164213|FG004|Overall Study|Protocol Violation|0|||
146724986|NCT00643916|529164214|FG005|Overall Study|Protocol Violation|0|||
146724987|NCT00643916|529164209|FG000|Overall Study|Lost to Follow-up|0|||
146724988|NCT00643916|529164210|FG001|Overall Study|Lost to Follow-up|1|||
146724989|NCT00643916|529164211|FG002|Overall Study|Lost to Follow-up|0|||
146724990|NCT00643916|529164212|FG003|Overall Study|Lost to Follow-up|0|||
146724991|NCT00643916|529164213|FG004|Overall Study|Lost to Follow-up|0|||
146724992|NCT00643916|529164214|FG005|Overall Study|Lost to Follow-up|0|||
146724993|NCT00643916|529164209|FG000|Overall Study|Withdrawal by Subject|2|||
146724994|NCT00643916|529164210|FG001|Overall Study|Withdrawal by Subject|2|||
146724995|NCT00643916|529164211|FG002|Overall Study|Withdrawal by Subject|2|||
146724996|NCT00643916|529164212|FG003|Overall Study|Withdrawal by Subject|1|||
146724997|NCT00643916|529164213|FG004|Overall Study|Withdrawal by Subject|0|||
146724998|NCT00643916|529164214|FG005|Overall Study|Withdrawal by Subject|1|||
146724999|NCT00643916|529164209|FG000|Overall Study|Not Vaccinated|2|||
146725000|NCT00643916|529164210|FG001|Overall Study|Not Vaccinated|2|||
146725001|NCT00643916|529164211|FG002|Overall Study|Not Vaccinated|3|||
146725002|NCT00643916|529164212|FG003|Overall Study|Not Vaccinated|0|||
146725003|NCT00643916|529164213|FG004|Overall Study|Not Vaccinated|2|||
146725004|NCT00643916|529164214|FG005|Overall Study|Not Vaccinated|0|||
146725005|NCT00447057|529164216|FG000|Overall Study|Adverse Event|4|||
146725006|NCT00447057|529164217|FG001|Overall Study|Adverse Event|10|||
146725007|NCT00447057|529164218|FG002|Overall Study|Adverse Event|0|||
146725008|NCT00447057|529164219|FG003|Overall Study|Adverse Event|3|||
146725009|NCT00447057|529164216|FG000|Overall Study|Death due to study disease|6|||
146725010|NCT00447057|529164217|FG001|Overall Study|Death due to study disease|4|||
146784486|NCT04927065|529382292|FG013|First Booster|Physician Decision|0|||
146784487|NCT04927065|529382293|FG014|First Booster|Physician Decision|0|||
146784488|NCT04927065|529382294|FG015|First Booster|Physician Decision|0|||
146784489|NCT04927065|529382279|FG000|First Booster|Protocol Violation|4|||
146784490|NCT04927065|529382280|FG001|First Booster|Protocol Violation|4|||
146784491|NCT04927065|529382281|FG002|First Booster|Protocol Violation|0|||
146784492|NCT04927065|529382282|FG003|First Booster|Protocol Violation|3|||
146784493|NCT04927065|529382283|FG004|First Booster|Protocol Violation|0|||
146784494|NCT04927065|529382284|FG005|First Booster|Protocol Violation|0|||
146784495|NCT04927065|529382285|FG006|First Booster|Protocol Violation|0|||
146725011|NCT00447057|529164218|FG002|Overall Study|Death due to study disease|1|||
146725012|NCT00447057|529164219|FG003|Overall Study|Death due to study disease|1|||
146725013|NCT00447057|529164216|FG000|Overall Study|Lost to Follow-up|0|||
146725014|NCT00447057|529164217|FG001|Overall Study|Lost to Follow-up|1|||
146725015|NCT00447057|529164218|FG002|Overall Study|Lost to Follow-up|0|||
146725016|NCT00447057|529164219|FG003|Overall Study|Lost to Follow-up|0|||
146725017|NCT00447057|529164216|FG000|Overall Study|Entry criteria not met|1|||
146725018|NCT00447057|529164217|FG001|Overall Study|Entry criteria not met|1|||
146725019|NCT00447057|529164218|FG002|Overall Study|Entry criteria not met|0|||
146725020|NCT00447057|529164219|FG003|Overall Study|Entry criteria not met|0|||
146725021|NCT00447057|529164216|FG000|Overall Study|Protocol Violation|0|||
146725022|NCT00447057|529164217|FG001|Overall Study|Protocol Violation|1|||
146725023|NCT00447057|529164218|FG002|Overall Study|Protocol Violation|0|||
146725024|NCT00447057|529164219|FG003|Overall Study|Protocol Violation|0|||
146725025|NCT00447057|529164216|FG000|Overall Study|Withdrawal by Subject|4|||
146725026|NCT00447057|529164217|FG001|Overall Study|Withdrawal by Subject|5|||
146725027|NCT00447057|529164218|FG002|Overall Study|Withdrawal by Subject|1|||
146725028|NCT00447057|529164219|FG003|Overall Study|Withdrawal by Subject|1|||
146725029|NCT00447057|529164216|FG000|Overall Study|Physician Decision|9|||
146725030|NCT00447057|529164217|FG001|Overall Study|Physician Decision|6|||
146725031|NCT00447057|529164218|FG002|Overall Study|Physician Decision|3|||
146725032|NCT00447057|529164219|FG003|Overall Study|Physician Decision|1|||
146725033|NCT00447057|529164216|FG000|Overall Study|Sponsor decision|1|||
146725034|NCT00447057|529164217|FG001|Overall Study|Sponsor decision|1|||
146725035|NCT00447057|529164218|FG002|Overall Study|Sponsor decision|0|||
146725036|NCT00447057|529164219|FG003|Overall Study|Sponsor decision|0|||
146725037|NCT00447057|529164216|FG000|Overall Study|Progressive disease|58|||
146725038|NCT00447057|529164217|FG001|Overall Study|Progressive disease|43|||
146725039|NCT00447057|529164218|FG002|Overall Study|Progressive disease|13|||
146725040|NCT00447057|529164219|FG003|Overall Study|Progressive disease|18|||
146725041|NCT00447057|529164216|FG000|Overall Study|Death due to adverse event|0|||
146725042|NCT00447057|529164217|FG001|Overall Study|Death due to adverse event|0|||
146725043|NCT00447057|529164218|FG002|Overall Study|Death due to adverse event|1|||
146784496|NCT04927065|529382286|FG007|First Booster|Protocol Violation|2|||
146784497|NCT04927065|529382287|FG008|First Booster|Protocol Violation|0|||
146784498|NCT04927065|529382288|FG009|First Booster|Protocol Violation|0|||
146784499|NCT04927065|529382289|FG010|First Booster|Protocol Violation|0|||
146784500|NCT04927065|529382290|FG011|First Booster|Protocol Violation|0|||
146784501|NCT04927065|529382291|FG012|First Booster|Protocol Violation|0|||
146725044|NCT00447057|529164219|FG003|Overall Study|Death due to adverse event|2|||
146725045|NCT00447057|529164216|FG000|Overall Study|Death, study drug related|0|||
146725046|NCT00447057|529164217|FG001|Overall Study|Death, study drug related|1|||
146725047|NCT00447057|529164218|FG002|Overall Study|Death, study drug related|0|||
146725048|NCT00447057|529164219|FG003|Overall Study|Death, study drug related|0|||
146784502|NCT04927065|529382292|FG013|First Booster|Protocol Violation|0|||
146784503|NCT04927065|529382293|FG014|First Booster|Protocol Violation|0|||
146784504|NCT04927065|529382294|FG015|First Booster|Protocol Violation|0|||
146725049|NCT00985725|529164222|FG000|Overall Study|Adverse Event|4|||
146725050|NCT00985725|529164223|FG001|Overall Study|Adverse Event|1|||
146725051|NCT00985725|529164222|FG000|Overall Study|Protocol Violation|1|||
146725052|NCT00985725|529164223|FG001|Overall Study|Protocol Violation|3|||
146725053|NCT00985725|529164222|FG000|Overall Study|Withdrawal by Subject|4|||
146784505|NCT04927065|529382279|FG000|First Booster|Withdrawal by Subject|8|||
146784506|NCT04927065|529382280|FG001|First Booster|Withdrawal by Subject|23|||
146725054|NCT00985725|529164223|FG001|Overall Study|Withdrawal by Subject|4|||
146725055|NCT00985725|529164222|FG000|Overall Study|Lost to Follow-up|1|||
146725056|NCT00985725|529164223|FG001|Overall Study|Lost to Follow-up|1|||
146725057|NCT00985725|529164222|FG000|Overall Study|Lack of Efficacy|0|||
146725058|NCT00985725|529164223|FG001|Overall Study|Lack of Efficacy|1|||
146725059|NCT00985725|529164222|FG000|Overall Study|Non-compliance|1|||
146725060|NCT00985725|529164223|FG001|Overall Study|Non-compliance|2|||
146725061|NCT00985725|529164222|FG000|Overall Study|Out-of-window visits|0|||
146725062|NCT00985725|529164223|FG001|Overall Study|Out-of-window visits|1|||
146725063|NCT03151005|529164227|FG000|Overall Study|Lost to Follow-up|5|||
146725064|NCT03151005|529164228|FG001|Overall Study|Lost to Follow-up|5|||
146725065|NCT03318523|529164233|FG000|PC Period: Up to Year 1|Adverse Event|1|||
146725066|NCT03318523|529164234|FG001|PC Period: Up to Year 1|Adverse Event|0|||
146725067|NCT03318523|529164235|FG002|PC Period: Up to Year 1|Adverse Event|2|||
146725068|NCT03318523|529164236|FG003|PC Period: Up to Year 1|Adverse Event|0|||
146725069|NCT03318523|529164237|FG004|PC Period: Up to Year 1|Adverse Event|0|||
146725070|NCT03318523|529164238|FG005|PC Period: Up to Year 1|Adverse Event|0|||
146725071|NCT03318523|529164239|FG006|PC Period: Up to Year 1|Adverse Event|0|||
146725072|NCT03318523|529164240|FG007|PC Period: Up to Year 1|Adverse Event|0|||
146725073|NCT03318523|529164241|FG008|PC Period: Up to Year 1|Adverse Event|0|||
146725074|NCT03318523|529164242|FG009|PC Period: Up to Year 1|Adverse Event|0|||
146725075|NCT03318523|529164233|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
146725076|NCT03318523|529164234|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
146725077|NCT03318523|529164235|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
146725078|NCT03318523|529164236|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
146725079|NCT03318523|529164237|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
146725080|NCT03318523|529164238|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
146725081|NCT03318523|529164239|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
146725082|NCT03318523|529164240|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
146725083|NCT03318523|529164241|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
146725084|NCT03318523|529164242|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
146725085|NCT03318523|529164233|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
146725086|NCT03318523|529164234|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
146725087|NCT03318523|529164235|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
146725088|NCT03318523|529164236|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
146725089|NCT03318523|529164237|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
146725090|NCT03318523|529164238|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
146725091|NCT03318523|529164239|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
146725092|NCT03318523|529164240|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
146725093|NCT03318523|529164241|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
146725094|NCT03318523|529164242|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
146725095|NCT03318523|529164233|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
146725096|NCT03318523|529164234|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
146725097|NCT03318523|529164235|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
146725098|NCT03318523|529164236|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
146725099|NCT03318523|529164237|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
146725100|NCT03318523|529164238|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
146725101|NCT03318523|529164239|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
146725102|NCT03318523|529164240|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
146725103|NCT03318523|529164241|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
146725104|NCT03318523|529164242|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
146725105|NCT03318523|529164233|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146725106|NCT03318523|529164234|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146725107|NCT03318523|529164235|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146725108|NCT03318523|529164236|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146725109|NCT03318523|529164237|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146725110|NCT03318523|529164238|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
146725111|NCT03318523|529164239|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146725112|NCT03318523|529164240|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146725113|NCT03318523|529164241|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146725114|NCT03318523|529164242|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146725115|NCT03318523|529164233|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146725116|NCT03318523|529164234|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146725117|NCT03318523|529164235|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146725118|NCT03318523|529164236|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146725119|NCT03318523|529164237|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146725120|NCT03318523|529164238|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146981435|NCT05028751|530093899|FG000|Overall Study|Withdrawal by Subject|0|||
146981436|NCT05028751|530093900|FG001|Overall Study|Withdrawal by Subject|0|||
146725121|NCT03318523|529164239|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146725122|NCT03318523|529164240|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146725123|NCT03318523|529164241|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146725124|NCT03318523|529164242|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
146725125|NCT03318523|529164233|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
146725126|NCT03318523|529164234|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
146725127|NCT03318523|529164235|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
146725128|NCT03318523|529164236|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
146725129|NCT03318523|529164237|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
146725130|NCT03318523|529164238|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
146725131|NCT03318523|529164239|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
146725132|NCT03318523|529164240|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
146725133|NCT03318523|529164241|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
146725134|NCT03318523|529164242|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
146725135|NCT03318523|529164233|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
146725136|NCT03318523|529164234|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
146725137|NCT03318523|529164235|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
146725138|NCT03318523|529164236|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
146725139|NCT03318523|529164237|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
146725140|NCT03318523|529164238|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
146725141|NCT03318523|529164239|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
146725142|NCT03318523|529164240|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
146725143|NCT03318523|529164241|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
146725144|NCT03318523|529164242|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
146725145|NCT02794285|529164245|FG000|Overall Study|Adverse Event|11|||
146725146|NCT02794285|529164246|FG001|Overall Study|Adverse Event|4|||
146725147|NCT02794285|529164247|FG002|Overall Study|Adverse Event|5|||
146725148|NCT02794285|529164248|FG003|Overall Study|Adverse Event|8|||
146725149|NCT02794285|529164245|FG000|Overall Study|Condition Under Investigation Improved|1|||
146725150|NCT02794285|529164246|FG001|Overall Study|Condition Under Investigation Improved|0|||
146725151|NCT02794285|529164247|FG002|Overall Study|Condition Under Investigation Improved|0|||
146725152|NCT02794285|529164248|FG003|Overall Study|Condition Under Investigation Improved|0|||
146725153|NCT02794285|529164245|FG000|Overall Study|Condition Under Investigation Worsened|0|||
146725154|NCT02794285|529164246|FG001|Overall Study|Condition Under Investigation Worsened|2|||
146725155|NCT02794285|529164247|FG002|Overall Study|Condition Under Investigation Worsened|1|||
146725156|NCT02794285|529164248|FG003|Overall Study|Condition Under Investigation Worsened|0|||
146725157|NCT02794285|529164245|FG000|Overall Study|Death|2|||
146725158|NCT02794285|529164246|FG001|Overall Study|Death|1|||
146725159|NCT02794285|529164247|FG002|Overall Study|Death|2|||
146725160|NCT02794285|529164248|FG003|Overall Study|Death|0|||
146725161|NCT02794285|529164245|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
146725162|NCT02794285|529164246|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
146725163|NCT02794285|529164247|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
146725164|NCT02794285|529164248|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
146725165|NCT02794285|529164245|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
146725166|NCT02794285|529164246|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
146725167|NCT02794285|529164247|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
146725168|NCT02794285|529164248|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
146725169|NCT02794285|529164245|FG000|Overall Study|Lack of Efficacy|10|||
146725170|NCT02794285|529164246|FG001|Overall Study|Lack of Efficacy|6|||
146725171|NCT02794285|529164247|FG002|Overall Study|Lack of Efficacy|3|||
146725172|NCT02794285|529164248|FG003|Overall Study|Lack of Efficacy|3|||
146725173|NCT02794285|529164245|FG000|Overall Study|Lost to Follow-up|5|||
146725174|NCT02794285|529164246|FG001|Overall Study|Lost to Follow-up|6|||
146725175|NCT02794285|529164247|FG002|Overall Study|Lost to Follow-up|3|||
146725176|NCT02794285|529164248|FG003|Overall Study|Lost to Follow-up|1|||
146725177|NCT02794285|529164245|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
146725178|NCT02794285|529164246|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
146725179|NCT02794285|529164247|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
146725180|NCT02794285|529164248|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
146725181|NCT02794285|529164245|FG000|Overall Study|Withdrawal by Subject|38|||
146725182|NCT02794285|529164246|FG001|Overall Study|Withdrawal by Subject|29|||
146725183|NCT02794285|529164247|FG002|Overall Study|Withdrawal by Subject|20|||
146725184|NCT02794285|529164248|FG003|Overall Study|Withdrawal by Subject|12|||
146725185|NCT02794285|529164245|FG000|Overall Study|Missing|1|||
146725186|NCT02794285|529164246|FG001|Overall Study|Missing|0|||
146725187|NCT02794285|529164247|FG002|Overall Study|Missing|0|||
146725188|NCT02794285|529164248|FG003|Overall Study|Missing|0|||
146725189|NCT02794285|529164245|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
146725190|NCT02794285|529164246|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
146934998|NCT02988219|529920171|FG000|Overall Study|Withdrawal by Subject|0|||
146934999|NCT02988219|529920172|FG001|Overall Study|Withdrawal by Subject|2|||
146935000|NCT01306032|529920173|FG000|First Intervention|Adverse Event|1|||
146935001|NCT01306032|529920174|FG001|First Intervention|Adverse Event|0|||
146935002|NCT01306032|529920175|FG002|First Intervention|Adverse Event|1|||
146725191|NCT02794285|529164247|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
146725192|NCT02794285|529164248|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
146725193|NCT02794285|529164245|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
146725194|NCT02794285|529164246|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
146725195|NCT02794285|529164247|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
146725196|NCT02794285|529164248|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
146725197|NCT03252587|529164249|FG000|Overall Study|Adverse Event|3|||
146725198|NCT03252587|529164250|FG001|Overall Study|Adverse Event|8|||
146725199|NCT03252587|529164251|FG002|Overall Study|Adverse Event|6|||
146725200|NCT03252587|529164252|FG003|Overall Study|Adverse Event|12|||
146725201|NCT03252587|529164249|FG000|Overall Study|Lack of Efficacy|7|||
146725202|NCT03252587|529164250|FG001|Overall Study|Lack of Efficacy|2|||
146725203|NCT03252587|529164251|FG002|Overall Study|Lack of Efficacy|2|||
146725204|NCT03252587|529164252|FG003|Overall Study|Lack of Efficacy|4|||
146725205|NCT03252587|529164249|FG000|Overall Study|Lost to Follow-up|2|||
146725206|NCT03252587|529164250|FG001|Overall Study|Lost to Follow-up|0|||
146725207|NCT03252587|529164251|FG002|Overall Study|Lost to Follow-up|0|||
146725208|NCT03252587|529164252|FG003|Overall Study|Lost to Follow-up|2|||
146725209|NCT03252587|529164249|FG000|Overall Study|Pregnancy|2|||
146725210|NCT03252587|529164250|FG001|Overall Study|Pregnancy|1|||
146725211|NCT03252587|529164251|FG002|Overall Study|Pregnancy|0|||
146725212|NCT03252587|529164252|FG003|Overall Study|Pregnancy|1|||
146725213|NCT03252587|529164249|FG000|Overall Study|Withdrawal by Subject|8|||
146725214|NCT03252587|529164250|FG001|Overall Study|Withdrawal by Subject|4|||
146725215|NCT03252587|529164251|FG002|Overall Study|Withdrawal by Subject|4|||
146725216|NCT03252587|529164252|FG003|Overall Study|Withdrawal by Subject|4|||
146725217|NCT03252587|529164249|FG000|Overall Study|Other Reasons|2|||
146725218|NCT03252587|529164250|FG001|Overall Study|Other Reasons|5|||
146725219|NCT03252587|529164251|FG002|Overall Study|Other Reasons|5|||
146725220|NCT03252587|529164252|FG003|Overall Study|Other Reasons|4|||
146725221|NCT01640808|529164254|FG000|Overall Study|Unable to continue dynamic CT|14|||
146725222|NCT01640808|529164255|FG001|Overall Study|Unable to continue dynamic CT|4|||
146725223|NCT01640808|529164254|FG000|Overall Study|Withdrawal by Subject|12|||
146725224|NCT01640808|529164255|FG001|Overall Study|Withdrawal by Subject|4|||
146725225|NCT01640808|529164254|FG000|Overall Study|Lost to Follow-up|4|||
146725226|NCT01640808|529164255|FG001|Overall Study|Lost to Follow-up|0|||
146725227|NCT01640808|529164254|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
146725228|NCT01640808|529164255|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
146725229|NCT01640808|529164254|FG000|Overall Study|Administration of anticancer drugs|2|||
146725230|NCT01640808|529164255|FG001|Overall Study|Administration of anticancer drugs|1|||
146725231|NCT01640808|529164254|FG000|Overall Study|Physician Decision|19|||
146725232|NCT01640808|529164255|FG001|Overall Study|Physician Decision|5|||
146725233|NCT01640808|529164254|FG000|Overall Study|Randomized but not treated|4|||
146725234|NCT01640808|529164255|FG001|Overall Study|Randomized but not treated|2|||
146725235|NCT02477111|529164256|FG000|Overall Study|Death|28|||
146725236|NCT02477111|529164256|FG000|Overall Study|Withdrawal by Subject|19|||
146725237|NCT02477111|529164256|FG000|Overall Study|Lost to Follow-up|4|||
146725238|NCT02192502|529164258|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
146725239|NCT02192502|529164259|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
146725240|NCT02192502|529164258|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
146725241|NCT02192502|529164259|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
146725242|NCT02192502|529164258|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
146736417|NCT01153269|529206838|FG000|Overall Study|Withdrawal by Subject|1|||
146736418|NCT01153269|529206838|FG000|Overall Study|Antiretroviral therapy break|1|||
146736419|NCT02635724|529206839|FG000|Overall Study|Withdrawal by Subject|0|||
146736420|NCT02635724|529206840|FG001|Overall Study|Withdrawal by Subject|1|||
146736421|NCT02635724|529206841|FG002|Overall Study|Withdrawal by Subject|0|||
146736422|NCT02281760|529206842|FG000|Overall Study|Withdrawal by Subject|1|||
146736423|NCT00100932|529206849|FG000|Overall Study|Adverse Event|11|||
146736424|NCT00100932|529206850|FG001|Overall Study|Adverse Event|2|||
146736425|NCT00100932|529206849|FG000|Overall Study|Withdrawal by Subject|6|||
146736426|NCT00100932|529206850|FG001|Overall Study|Withdrawal by Subject|0|||
146736427|NCT00100932|529206849|FG000|Overall Study|Progressive Disease|44|||
146736428|NCT00100932|529206850|FG001|Overall Study|Progressive Disease|18|||
146736429|NCT00100932|529206849|FG000|Overall Study|Physician Decision|7|||
146736430|NCT00100932|529206850|FG001|Overall Study|Physician Decision|5|||
146736431|NCT00100932|529206849|FG000|Overall Study|Other|5|||
146736432|NCT00100932|529206850|FG001|Overall Study|Other|2|||
146736433|NCT02387996|529206853|FG000|Overall Study|Disease Progression|167|||
146736434|NCT02387996|529206853|FG000|Overall Study|Study Drug Toxicity|31|||
146935003|NCT01306032|529920176|FG003|First Intervention|Adverse Event|0|||
146725243|NCT02192502|529164259|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
146725244|NCT01381692|529164260|FG000|Overall Study|Adverse Event|1|||
146725245|NCT01381692|529164261|FG001|Overall Study|Adverse Event|0|||
146725246|NCT01381692|529164262|FG002|Overall Study|Adverse Event|0|||
146725247|NCT01381692|529164263|FG003|Overall Study|Adverse Event|0|||
146725248|NCT01381692|529164264|FG004|Overall Study|Adverse Event|0|||
146725249|NCT01381692|529164265|FG005|Overall Study|Adverse Event|0|||
146725250|NCT03896035|529164267|FG000|Overall Study|Lost to Follow-up|2|||
146725251|NCT03896035|529164268|FG001|Overall Study|Lost to Follow-up|6|||
146725252|NCT03896035|529164267|FG000|Overall Study|Withdrawal by Subject|0|||
146725253|NCT03896035|529164268|FG001|Overall Study|Withdrawal by Subject|1|||
146725254|NCT03896035|529164267|FG000|Overall Study|Health/family health issues during COVID|0|||
146725255|NCT03896035|529164268|FG001|Overall Study|Health/family health issues during COVID|4|||
146725256|NCT01506193|529164271|FG000|Overall Study|Protocol Violation|1|||
146725257|NCT01506193|529164272|FG001|Overall Study|Protocol Violation|0|||
146725258|NCT01506193|529164273|FG002|Overall Study|Protocol Violation|1|||
146725259|NCT01506193|529164271|FG000|Overall Study|Migrated/moved from study area|0|||
146725260|NCT01506193|529164272|FG001|Overall Study|Migrated/moved from study area|0|||
146725261|NCT01506193|529164273|FG002|Overall Study|Migrated/moved from study area|1|||
146725262|NCT01506193|529164271|FG000|Overall Study|Adverse event, non-fatal|0|||
146725263|NCT01506193|529164272|FG001|Overall Study|Adverse event, non-fatal|0|||
146725264|NCT01506193|529164273|FG002|Overall Study|Adverse event, non-fatal|1|||
146725265|NCT01506193|529164271|FG000|Overall Study|Withdrawal by Subject|5|||
146725266|NCT01506193|529164272|FG001|Overall Study|Withdrawal by Subject|1|||
146725267|NCT01506193|529164273|FG002|Overall Study|Withdrawal by Subject|8|||
146725268|NCT01506193|529164271|FG000|Overall Study|Lost to Follow-up|8|||
146725269|NCT01506193|529164272|FG001|Overall Study|Lost to Follow-up|3|||
146725270|NCT01506193|529164273|FG002|Overall Study|Lost to Follow-up|3|||
146725271|NCT01687257|529164274|FG000|Overall Study|Efficacy Failure|6|||
146725272|NCT01687257|529164275|FG001|Overall Study|Efficacy Failure|0|||
146725273|NCT01687257|529164276|FG002|Overall Study|Efficacy Failure|5|||
146725274|NCT01687257|529164274|FG000|Overall Study|Subject Withdrew Consent|1|||
146725275|NCT01687257|529164275|FG001|Overall Study|Subject Withdrew Consent|1|||
146725276|NCT01687257|529164276|FG002|Overall Study|Subject Withdrew Consent|1|||
146725277|NCT01687257|529164274|FG000|Overall Study|Adverse Event|1|||
146725278|NCT01687257|529164275|FG001|Overall Study|Adverse Event|0|||
146725279|NCT01687257|529164276|FG002|Overall Study|Adverse Event|0|||
146725280|NCT01687257|529164274|FG000|Overall Study|Investigator's Discretion|0|||
146725281|NCT01687257|529164275|FG001|Overall Study|Investigator's Discretion|3|||
146725282|NCT01687257|529164276|FG002|Overall Study|Investigator's Discretion|0|||
146725283|NCT04403698|529164277|FG000|Overall Study|Adverse Event|1|||
146725284|NCT04403698|529164278|FG001|Overall Study|Adverse Event|1|||
146725285|NCT04403698|529164277|FG000|Overall Study|Lost to Follow-up|1|||
146725286|NCT04403698|529164278|FG001|Overall Study|Lost to Follow-up|0|||
146725287|NCT04403698|529164277|FG000|Overall Study|Protocol Violation|0|||
146725288|NCT04403698|529164278|FG001|Overall Study|Protocol Violation|1|||
146725289|NCT04899349|529164281|FG000|Overall Study|Study terminated by Sponsor|2|||
146725290|NCT04899349|529164282|FG001|Overall Study|Study terminated by Sponsor|0|||
146725291|NCT01018394|529164283|FG000|Overall Study|Withdrawal by Subject|5|||
146725292|NCT01018394|529164284|FG001|Overall Study|Withdrawal by Subject|5|||
146725293|NCT01018394|529164283|FG000|Overall Study|Lost to Follow-up|4|||
146725294|NCT01018394|529164284|FG001|Overall Study|Lost to Follow-up|3|||
146725295|NCT03792126|529164285|FG000|Overall Study|Adverse Event|1|||
146725296|NCT03792126|529164286|FG001|Overall Study|Adverse Event|2|||
146725297|NCT03792126|529164285|FG000|Overall Study|Death|0|||
146725298|NCT03792126|529164286|FG001|Overall Study|Death|1|||
146725299|NCT03792126|529164285|FG000|Overall Study|Lost to Follow-up|1|||
146725300|NCT03792126|529164286|FG001|Overall Study|Lost to Follow-up|0|||
146725301|NCT03792126|529164285|FG000|Overall Study|Withdrawal by Subject|0|||
146725302|NCT03792126|529164286|FG001|Overall Study|Withdrawal by Subject|1|||
146725303|NCT03792126|529164285|FG000|Overall Study|COVID-19 Restrictions|1|||
146725304|NCT03792126|529164286|FG001|Overall Study|COVID-19 Restrictions|3|||
146725305|NCT03792126|529164285|FG000|Overall Study|Symptoms resolved|0|||
146725306|NCT03792126|529164286|FG001|Overall Study|Symptoms resolved|3|||
146935004|NCT01306032|529920177|FG004|First Intervention|Adverse Event|0|||
146935005|NCT01306032|529920178|FG005|First Intervention|Adverse Event|1|||
146935006|NCT01306032|529920173|FG000|First Intervention|Withdrawal by Subject|0|||
146935007|NCT01306032|529920174|FG001|First Intervention|Withdrawal by Subject|2|||
146725307|NCT00683644|529164287|FG000|Overall Study|Withdrawal by Subject|4|||
146725308|NCT00683644|529164288|FG001|Overall Study|Withdrawal by Subject|2|||
146725309|NCT00683644|529164287|FG000|Overall Study|Lost to Follow-up|1|||
146725310|NCT00683644|529164288|FG001|Overall Study|Lost to Follow-up|4|||
146725311|NCT00683644|529164287|FG000|Overall Study|Adverse Event|1|||
146725312|NCT00683644|529164288|FG001|Overall Study|Adverse Event|2|||
146784507|NCT04927065|529382281|FG002|First Booster|Withdrawal by Subject|0|||
146935008|NCT01306032|529920175|FG002|First Intervention|Withdrawal by Subject|0|||
146935009|NCT01306032|529920176|FG003|First Intervention|Withdrawal by Subject|1|||
146935010|NCT01306032|529920177|FG004|First Intervention|Withdrawal by Subject|0|||
146935011|NCT01306032|529920178|FG005|First Intervention|Withdrawal by Subject|0|||
146725313|NCT00683644|529164287|FG000|Overall Study|Low copper, other health problems,|7|||
146725314|NCT00683644|529164288|FG001|Overall Study|Low copper, other health problems,|6|||
146725315|NCT00441090|529164290|FG000|Overall Study|Adverse Event|0|||
146725316|NCT00441090|529164291|FG001|Overall Study|Adverse Event|1|||
146725317|NCT00441090|529164292|FG002|Overall Study|Adverse Event|1|||
146725318|NCT00441090|529164293|FG003|Overall Study|Adverse Event|0|||
146725319|NCT00441090|529164294|FG004|Overall Study|Adverse Event|0|||
146725320|NCT00441090|529164290|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
146725321|NCT00441090|529164291|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
146725322|NCT00441090|529164292|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
146725323|NCT00441090|529164293|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
146725324|NCT00441090|529164294|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
146725325|NCT00441090|529164290|FG000|Overall Study|Withdrawal by Subject|1|||
146725326|NCT00441090|529164291|FG001|Overall Study|Withdrawal by Subject|0|||
146725327|NCT00441090|529164292|FG002|Overall Study|Withdrawal by Subject|1|||
146725328|NCT00441090|529164293|FG003|Overall Study|Withdrawal by Subject|0|||
146725329|NCT00441090|529164294|FG004|Overall Study|Withdrawal by Subject|0|||
146725330|NCT00441090|529164290|FG000|Overall Study|Lack of Efficacy|1|||
146725331|NCT00441090|529164291|FG001|Overall Study|Lack of Efficacy|0|||
146725332|NCT00441090|529164292|FG002|Overall Study|Lack of Efficacy|0|||
146725333|NCT00441090|529164293|FG003|Overall Study|Lack of Efficacy|0|||
146725334|NCT00441090|529164294|FG004|Overall Study|Lack of Efficacy|0|||
146725335|NCT03085485|529164295|FG000|Overall Study|Death|1|||
146725336|NCT03085485|529164296|FG001|Overall Study|Death|0|||
146725337|NCT03085485|529164295|FG000|Overall Study|Lost to Follow-up|1|||
146725338|NCT03085485|529164296|FG001|Overall Study|Lost to Follow-up|0|||
146725339|NCT01302119|529164297|FG000|Overall Study|Withdrawal by Subject|30|||
146725340|NCT01302119|529164298|FG001|Overall Study|Withdrawal by Subject|20|||
146725341|NCT01302119|529164297|FG000|Overall Study|Lost to Follow-up|10|||
146725342|NCT01302119|529164298|FG001|Overall Study|Lost to Follow-up|4|||
146725343|NCT01302119|529164297|FG000|Overall Study|Adverse Event|2|||
146725344|NCT01302119|529164298|FG001|Overall Study|Adverse Event|1|||
146725345|NCT01302119|529164297|FG000|Overall Study|Non-compliance|4|||
146725346|NCT01302119|529164298|FG001|Overall Study|Non-compliance|2|||
146725347|NCT01302119|529164297|FG000|Overall Study|Non-specific|4|||
146725348|NCT01302119|529164298|FG001|Overall Study|Non-specific|1|||
146725349|NCT01775904|529164302|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
146725350|NCT01775904|529164302|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
146725351|NCT04891419|529164303|FG000|Overall Study|Withdrawal by Subject|4|||
146725352|NCT04891419|529164304|FG001|Overall Study|Withdrawal by Subject|0|||
146725353|NCT04891419|529164303|FG000|Overall Study|Lost to Follow-up|1|||
146725354|NCT04891419|529164304|FG001|Overall Study|Lost to Follow-up|3|||
146725355|NCT00833638|529164308|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
146725356|NCT00833638|529164309|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
146725357|NCT00833638|529164310|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
146725358|NCT00833638|529164308|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
146725359|NCT00833638|529164309|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
146725360|NCT00833638|529164310|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
146725361|NCT00833638|529164308|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
146725362|NCT00833638|529164309|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
146725363|NCT00833638|529164310|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
146725364|NCT00833638|529164308|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
146725365|NCT00833638|529164309|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
146725366|NCT00833638|529164310|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
146725367|NCT00833638|529164308|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
146725368|NCT00833638|529164309|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
146725369|NCT00833638|529164310|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
146784508|NCT04927065|529382282|FG003|First Booster|Withdrawal by Subject|19|||
146784509|NCT04927065|529382283|FG004|First Booster|Withdrawal by Subject|20|||
146784510|NCT04927065|529382284|FG005|First Booster|Withdrawal by Subject|15|||
146935012|NCT01306032|529920173|FG000|First Intervention|Death|0|||
146935013|NCT01306032|529920174|FG001|First Intervention|Death|0|||
146725370|NCT00833638|529164308|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
146725371|NCT00833638|529164309|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
146725372|NCT00833638|529164310|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
146725373|NCT00833638|529164308|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
146784511|NCT04927065|529382285|FG006|First Booster|Withdrawal by Subject|6|||
146725374|NCT00833638|529164309|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
146725375|NCT00833638|529164310|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
146725376|NCT00833638|529164308|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
146935014|NCT01306032|529920175|FG002|First Intervention|Death|1|||
146725377|NCT00833638|529164309|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
146725378|NCT00833638|529164310|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
146725379|NCT00833638|529164308|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
146725380|NCT00833638|529164309|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
146725381|NCT00833638|529164310|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
146935015|NCT01306032|529920176|FG003|First Intervention|Death|0|||
146935016|NCT01306032|529920177|FG004|First Intervention|Death|0|||
146935017|NCT01306032|529920178|FG005|First Intervention|Death|0|||
146935018|NCT01306032|529920173|FG000|First Intervention|Ineligible|0|||
146935019|NCT01306032|529920174|FG001|First Intervention|Ineligible|0|||
146935020|NCT01306032|529920175|FG002|First Intervention|Ineligible|0|||
146935021|NCT01306032|529920176|FG003|First Intervention|Ineligible|0|||
146935022|NCT01306032|529920177|FG004|First Intervention|Ineligible|0|||
146935023|NCT01306032|529920178|FG005|First Intervention|Ineligible|1|||
146935024|NCT01306032|529920173|FG000|First Intervention|Progressive disease|0|||
146935025|NCT01306032|529920174|FG001|First Intervention|Progressive disease|0|||
146935026|NCT01306032|529920175|FG002|First Intervention|Progressive disease|0|||
146935027|NCT01306032|529920176|FG003|First Intervention|Progressive disease|0|||
146935028|NCT01306032|529920177|FG004|First Intervention|Progressive disease|2|||
146935029|NCT01306032|529920178|FG005|First Intervention|Progressive disease|0|||
146935030|NCT01306032|529920173|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
146935031|NCT01306032|529920174|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
146935032|NCT01306032|529920175|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
146935033|NCT01306032|529920176|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
146935034|NCT01306032|529920177|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
146935035|NCT01306032|529920178|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
146935036|NCT01306032|529920173|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
146935037|NCT01306032|529920174|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
146935038|NCT01306032|529920175|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
146935039|NCT01306032|529920176|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
146935040|NCT01306032|529920177|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
146935041|NCT01306032|529920178|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
146935042|NCT03260894|529920180|FG000|Overall Study|Death|6|||
146935043|NCT03260894|529920181|FG001|Overall Study|Death|8|||
146935044|NCT03260894|529920180|FG000|Overall Study|Withdrawal by Subject|4|||
146935045|NCT03260894|529920181|FG001|Overall Study|Withdrawal by Subject|11|||
146935046|NCT03260894|529920180|FG000|Overall Study|On-going at clinical cut off date|36|||
146935047|NCT03260894|529920181|FG001|Overall Study|On-going at clinical cut off date|31|||
146935048|NCT02378883|529920183|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
146935049|NCT02378883|529920183|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
146935050|NCT02378883|529920183|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
146935051|NCT02378883|529920183|FG000|30 Day Follow-Up|Physician Decision|2|||
146935052|NCT02378883|529920183|FG000|30 Day Follow-Up|Missed Visit|2|||
146935053|NCT02378883|529920183|FG000|30 Day Follow-Up|Death|1|||
146935054|NCT02378883|529920183|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
146935055|NCT02378883|529920183|FG000|12 Months Follow-Up|Death|2|||
146935056|NCT00318565|529920184|FG000|Overall Study|Excluded per protocol|24|||
146935057|NCT00691093|529920185|FG000|Overall Study|Adverse Event|1|||
146935058|NCT00691093|529920185|FG000|Overall Study|Lost to Follow-up|1|||
146935059|NCT00691093|529920185|FG000|Overall Study|Lack of Efficacy|1|||
146935060|NCT00691093|529920185|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
146935061|NCT03814005|529920188|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
146935062|NCT03814005|529920189|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
146935063|NCT03814005|529920190|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
146935064|NCT03814005|529920188|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
146935065|NCT03814005|529920189|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
146935066|NCT03814005|529920190|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
146935067|NCT03814005|529920188|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
146935068|NCT03814005|529920189|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
146935069|NCT03814005|529920190|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
146935070|NCT03814005|529920188|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
146935071|NCT03814005|529920189|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
146935072|NCT03814005|529920190|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
146935073|NCT03814005|529920188|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
146935074|NCT03814005|529920189|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
146935075|NCT03814005|529920190|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
146935076|NCT03814005|529920188|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
146935077|NCT03814005|529920189|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
146935078|NCT03814005|529920190|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
146935079|NCT01896856|529920191|FG000|Overall Study|Transportation issues / Non-compliance|0|||
146935080|NCT01896856|529920192|FG001|Overall Study|Transportation issues / Non-compliance|0|||
146935081|NCT01896856|529920193|FG002|Overall Study|Transportation issues / Non-compliance|1|||
146981437|NCT05028751|530093901|FG002|Overall Study|Withdrawal by Subject|1|||
146981438|NCT05028751|530093902|FG003|Overall Study|Withdrawal by Subject|0|||
146981439|NCT05028751|530093899|FG000|Overall Study|Miscellaneous|2|||
146981440|NCT05028751|530093900|FG001|Overall Study|Miscellaneous|0|||
146981441|NCT05028751|530093901|FG002|Overall Study|Miscellaneous|0|||
146981442|NCT05028751|530093902|FG003|Overall Study|Miscellaneous|0|||
146981443|NCT04578548|530093903|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
146981444|NCT04578548|530093904|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
146981445|NCT04578548|530093903|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
146981446|NCT04578548|530093904|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
146981447|NCT04578548|530093903|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
146981448|NCT04578548|530093904|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
146981449|NCT04578548|530093903|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
146981450|NCT04578548|530093904|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
146981451|NCT04578548|530093903|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
146981452|NCT04578548|530093904|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
146981453|NCT04578548|530093903|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
146981454|NCT04578548|530093904|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
146981455|NCT00395083|530093907|FG000|Overall Study|Withdrawal by Subject|6|||
146981456|NCT00395083|530093908|FG001|Overall Study|Withdrawal by Subject|5|||
146981457|NCT00395083|530093907|FG000|Overall Study|Developed another disease|4|||
146981458|NCT00395083|530093908|FG001|Overall Study|Developed another disease|3|||
146981459|NCT00972153|530093909|FG000|Overall Study|Equipment malfunction during case|0|||
146981460|NCT00972153|530093910|FG001|Overall Study|Equipment malfunction during case|1|||
146981461|NCT00972153|530093911|FG002|Overall Study|Equipment malfunction during case|0|||
146981462|NCT01077713|530093912|FG000|Overall Study|Withdrawal by Subject|1|||
146981463|NCT01077713|530093913|FG001|Overall Study|Withdrawal by Subject|2|||
146981464|NCT01077713|530093912|FG000|Overall Study|Progressive Disease (PD)|0|||
146981465|NCT01077713|530093913|FG001|Overall Study|Progressive Disease (PD)|1|||
146981466|NCT01077713|530093912|FG000|Overall Study|Death|28|||
146981467|NCT01077713|530093913|FG001|Overall Study|Death|29|||
146981468|NCT01077713|530093912|FG000|Overall Study|Lost to Follow-up|1|||
146981469|NCT01077713|530093913|FG001|Overall Study|Lost to Follow-up|1|||
146981470|NCT01077713|530093912|FG000|Overall Study|Adverse Event|2|||
146981471|NCT01077713|530093913|FG001|Overall Study|Adverse Event|1|||
146981472|NCT01077713|530093912|FG000|Overall Study|Other|4|||
146981473|NCT01077713|530093913|FG001|Overall Study|Other|2|||
146981474|NCT04136626|530093914|FG000|Treatment Phase|Withdrawal by Subject|1|||
146981475|NCT04136626|530093915|FG001|Treatment Phase|Withdrawal by Subject|9|||
146981476|NCT04136626|530093914|FG000|Treatment Phase|Adverse Event|1|||
146981477|NCT04136626|530093915|FG001|Treatment Phase|Adverse Event|0|||
146981478|NCT04136626|530093914|FG000|Treatment Phase|Lost to Follow-up|1|||
146981479|NCT04136626|530093915|FG001|Treatment Phase|Lost to Follow-up|5|||
146981480|NCT04136626|530093914|FG000|12-month Follow-up|Lost to Follow-up|8|||
146981481|NCT04136626|530093915|FG001|12-month Follow-up|Lost to Follow-up|7|||
146981482|NCT00628745|530093916|FG000|Overall Study|Withdrawal by Subject|63|||
146981483|NCT00628745|530093917|FG001|Overall Study|Withdrawal by Subject|3|||
146981484|NCT00628745|530093918|FG002|Overall Study|Withdrawal by Subject|9|||
146981485|NCT00628745|530093919|FG003|Overall Study|Withdrawal by Subject|2|||
146981486|NCT00628745|530093920|FG004|Overall Study|Withdrawal by Subject|69|||
146981487|NCT00628745|530093916|FG000|Overall Study|Does not meet inclusion criteria|0|||
146981488|NCT00628745|530093917|FG001|Overall Study|Does not meet inclusion criteria|12|||
146981489|NCT00628745|530093918|FG002|Overall Study|Does not meet inclusion criteria|0|||
146981490|NCT00628745|530093919|FG003|Overall Study|Does not meet inclusion criteria|0|||
146935082|NCT01896856|529920194|FG003|Overall Study|Transportation issues / Non-compliance|0|||
146935083|NCT01896856|529920195|FG004|Overall Study|Transportation issues / Non-compliance|0|||
146935084|NCT01896856|529920196|FG005|Overall Study|Transportation issues / Non-compliance|0|||
146935085|NCT01700985|529920199|FG000|Overall Study|Incarcerated|0|||
146935086|NCT01700985|529920200|FG001|Overall Study|Incarcerated|1|||
146935087|NCT01192204|529920204|FG000|Overall Study|could not keep recall appointments|1|||
146935088|NCT01192204|529920205|FG001|Overall Study|could not keep recall appointments|0|||
146981491|NCT00628745|530093920|FG004|Overall Study|Does not meet inclusion criteria|18|||
146981492|NCT00628745|530093916|FG000|Overall Study|Participation in an interventional clinical trial|81|||
146981493|NCT00628745|530093917|FG001|Overall Study|Participation in an interventional clinical trial|4|||
146981494|NCT00628745|530093918|FG002|Overall Study|Participation in an interventional clinical trial|7|||
146981495|NCT00628745|530093919|FG003|Overall Study|Participation in an interventional clinical trial|0|||
146981496|NCT00628745|530093920|FG004|Overall Study|Participation in an interventional clinical trial|63|||
146935089|NCT01767519|529920206|FG000|Overall Study|Other Reasons|4|||
146981497|NCT00628745|530093916|FG000|Overall Study|Physician Decision|8|||
146981498|NCT00628745|530093917|FG001|Overall Study|Physician Decision|4|||
146981499|NCT00628745|530093918|FG002|Overall Study|Physician Decision|3|||
146935090|NCT01767519|529920207|FG001|Overall Study|Other Reasons|4|||
146935091|NCT01767519|529920208|FG002|Overall Study|Other Reasons|2|||
146935092|NCT01767519|529920206|FG000|Overall Study|Protocol Violation|0|||
146935093|NCT01767519|529920207|FG001|Overall Study|Protocol Violation|3|||
146784512|NCT04927065|529382286|FG007|First Booster|Withdrawal by Subject|24|||
146935094|NCT01767519|529920208|FG002|Overall Study|Protocol Violation|0|||
146935095|NCT01767519|529920206|FG000|Overall Study|Personal Reasons|1|||
146935096|NCT01767519|529920207|FG001|Overall Study|Personal Reasons|0|||
146935097|NCT01767519|529920208|FG002|Overall Study|Personal Reasons|0|||
146935098|NCT01767519|529920206|FG000|Overall Study|Lost to Follow-up|3|||
146935099|NCT01767519|529920207|FG001|Overall Study|Lost to Follow-up|1|||
146935100|NCT01767519|529920208|FG002|Overall Study|Lost to Follow-up|2|||
146935101|NCT01767519|529920206|FG000|Overall Study|Lack of Efficacy|1|||
146935102|NCT01767519|529920207|FG001|Overall Study|Lack of Efficacy|0|||
146935103|NCT01767519|529920208|FG002|Overall Study|Lack of Efficacy|0|||
146935104|NCT01767519|529920206|FG000|Overall Study|Adverse Event|5|||
146935105|NCT01767519|529920207|FG001|Overall Study|Adverse Event|5|||
146935106|NCT01767519|529920208|FG002|Overall Study|Adverse Event|1|||
146935107|NCT00293423|529920209|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
146935108|NCT00293423|529920210|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
146935109|NCT00293423|529920209|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
146935110|NCT00293423|529920210|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
146935111|NCT00293423|529920209|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
146935112|NCT00293423|529920210|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
146935113|NCT00293423|529920209|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
146935114|NCT00293423|529920210|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
146935115|NCT00293423|529920209|FG000|Surgical Resection|processing error during surgical resection|1|||
146935116|NCT00293423|529920210|FG001|Surgical Resection|processing error during surgical resection|0|||
146935117|NCT00293423|529920209|FG000|Surgical Resection|Withdrawal by Subject|4|||
146935118|NCT00293423|529920210|FG001|Surgical Resection|Withdrawal by Subject|0|||
146935119|NCT00293423|529920209|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
146935120|NCT00293423|529920210|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
146935121|NCT00964158|529920211|FG000|Overall Study|Lost to Follow-up|0|||
146935122|NCT00964158|529920212|FG001|Overall Study|Lost to Follow-up|1|||
146935123|NCT00964158|529920213|FG002|Overall Study|Lost to Follow-up|2|||
146935124|NCT00964158|529920211|FG000|Overall Study|Withdrawal by Subject|0|||
146935125|NCT00964158|529920212|FG001|Overall Study|Withdrawal by Subject|0|||
146935126|NCT00964158|529920213|FG002|Overall Study|Withdrawal by Subject|6|||
146935127|NCT00507416|529920214|FG000|Overall Study|Adverse Event|58|||
146935128|NCT00507416|529920215|FG001|Overall Study|Adverse Event|67|||
146935129|NCT00507416|529920216|FG002|Overall Study|Adverse Event|65|||
146935130|NCT00507416|529920214|FG000|Overall Study|Protocol Violation|1|||
146935131|NCT00507416|529920215|FG001|Overall Study|Protocol Violation|2|||
146935132|NCT00507416|529920216|FG002|Overall Study|Protocol Violation|0|||
146935133|NCT00507416|529920214|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
146935134|NCT00507416|529920215|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
146935135|NCT00507416|529920216|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
146935136|NCT00507416|529920214|FG000|Overall Study|Progressive Disease|20|||
146935137|NCT00507416|529920215|FG001|Overall Study|Progressive Disease|10|||
146935138|NCT00507416|529920216|FG002|Overall Study|Progressive Disease|13|||
146935139|NCT00507416|529920214|FG000|Overall Study|Patient declined further treatment|18|||
146935140|NCT00507416|529920215|FG001|Overall Study|Patient declined further treatment|14|||
146935141|NCT00507416|529920216|FG002|Overall Study|Patient declined further treatment|11|||
146935142|NCT00507416|529920214|FG000|Overall Study|Other|11|||
146935143|NCT00507416|529920215|FG001|Overall Study|Other|16|||
146935144|NCT00507416|529920216|FG002|Overall Study|Other|13|||
146935145|NCT00507416|529920214|FG000|Overall Study|Did not Receive Study Treatment|3|||
146935146|NCT00507416|529920215|FG001|Overall Study|Did not Receive Study Treatment|9|||
146935147|NCT00507416|529920216|FG002|Overall Study|Did not Receive Study Treatment|4|||
146935148|NCT01182337|529920217|FG000|Overall Study|Withdrawal by Subject|3|||
146935149|NCT01182337|529920218|FG001|Overall Study|Withdrawal by Subject|1|||
146935150|NCT01182337|529920217|FG000|Overall Study|Lost to Follow-up|0|||
146935151|NCT01182337|529920218|FG001|Overall Study|Lost to Follow-up|1|||
146935152|NCT03101514|529920219|FG000|Overall Study|Withdrawal by Subject|4|||
146935153|NCT03101514|529920219|FG000|Overall Study|Protocol Violation|2|||
146935154|NCT03101514|529920219|FG000|Overall Study|patient's information was incomplete|1|||
146935155|NCT01021813|529920220|FG000|DB Treatment Phase|Adverse Event|60|||
146935156|NCT01021813|529920221|FG001|DB Treatment Phase|Adverse Event|22|||
146935157|NCT01021813|529920222|FG002|DB Treatment Phase|Adverse Event|0|||
146935158|NCT01021813|529920223|FG003|DB Treatment Phase|Adverse Event|0|||
146935159|NCT01021813|529920224|FG004|DB Treatment Phase|Adverse Event|0|||
146935160|NCT01021813|529920220|FG000|DB Treatment Phase|Lack of Efficacy|44|||
146935161|NCT01021813|529920221|FG001|DB Treatment Phase|Lack of Efficacy|28|||
146784513|NCT04927065|529382287|FG008|First Booster|Withdrawal by Subject|0|||
146935162|NCT01021813|529920222|FG002|DB Treatment Phase|Lack of Efficacy|0|||
146935163|NCT01021813|529920223|FG003|DB Treatment Phase|Lack of Efficacy|0|||
146935164|NCT01021813|529920224|FG004|DB Treatment Phase|Lack of Efficacy|0|||
146935165|NCT01021813|529920220|FG000|DB Treatment Phase|Lost to Follow-up|14|||
146935166|NCT01021813|529920221|FG001|DB Treatment Phase|Lost to Follow-up|12|||
146935167|NCT01021813|529920222|FG002|DB Treatment Phase|Lost to Follow-up|0|||
146935168|NCT01021813|529920223|FG003|DB Treatment Phase|Lost to Follow-up|0|||
146935169|NCT01021813|529920224|FG004|DB Treatment Phase|Lost to Follow-up|0|||
146935170|NCT01021813|529920220|FG000|DB Treatment Phase|Physician Decision|17|||
146935171|NCT01021813|529920221|FG001|DB Treatment Phase|Physician Decision|8|||
146935172|NCT01021813|529920222|FG002|DB Treatment Phase|Physician Decision|0|||
146935173|NCT01021813|529920223|FG003|DB Treatment Phase|Physician Decision|0|||
146935174|NCT01021813|529920224|FG004|DB Treatment Phase|Physician Decision|0|||
146935175|NCT01021813|529920220|FG000|DB Treatment Phase|Pregnancy|1|||
146935176|NCT01021813|529920221|FG001|DB Treatment Phase|Pregnancy|0|||
146935177|NCT01021813|529920222|FG002|DB Treatment Phase|Pregnancy|0|||
146935178|NCT01021813|529920223|FG003|DB Treatment Phase|Pregnancy|0|||
146935179|NCT01021813|529920224|FG004|DB Treatment Phase|Pregnancy|0|||
146935180|NCT01021813|529920220|FG000|DB Treatment Phase|Protocol Violation|4|||
146935181|NCT01021813|529920221|FG001|DB Treatment Phase|Protocol Violation|3|||
146935182|NCT01021813|529920222|FG002|DB Treatment Phase|Protocol Violation|0|||
146935183|NCT01021813|529920223|FG003|DB Treatment Phase|Protocol Violation|0|||
146935184|NCT01021813|529920224|FG004|DB Treatment Phase|Protocol Violation|0|||
146935185|NCT01021813|529920220|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
146981500|NCT00628745|530093919|FG003|Overall Study|Physician Decision|0|||
146981501|NCT00628745|530093920|FG004|Overall Study|Physician Decision|30|||
146981502|NCT00628745|530093916|FG000|Overall Study|Lost to Follow-up|109|||
146981503|NCT00628745|530093917|FG001|Overall Study|Lost to Follow-up|7|||
146981504|NCT00628745|530093918|FG002|Overall Study|Lost to Follow-up|7|||
146981505|NCT00628745|530093919|FG003|Overall Study|Lost to Follow-up|0|||
146981506|NCT00628745|530093920|FG004|Overall Study|Lost to Follow-up|498|||
146981507|NCT00628745|530093916|FG000|Overall Study|Death|197|||
146981508|NCT00628745|530093917|FG001|Overall Study|Death|81|||
146981509|NCT00628745|530093918|FG002|Overall Study|Death|12|||
146981510|NCT00628745|530093919|FG003|Overall Study|Death|4|||
146981511|NCT00628745|530093920|FG004|Overall Study|Death|939|||
146981512|NCT00628745|530093916|FG000|Overall Study|Participant transferred to another THAOS site|6|||
146981513|NCT00628745|530093917|FG001|Overall Study|Participant transferred to another THAOS site|0|||
146981514|NCT00628745|530093918|FG002|Overall Study|Participant transferred to another THAOS site|0|||
146981515|NCT00628745|530093919|FG003|Overall Study|Participant transferred to another THAOS site|0|||
146981516|NCT00628745|530093920|FG004|Overall Study|Participant transferred to another THAOS site|7|||
146981517|NCT00628745|530093916|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
146981518|NCT00628745|530093917|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
146981519|NCT00628745|530093918|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
146981520|NCT00628745|530093919|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
146981521|NCT00628745|530093920|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
146981522|NCT00628745|530093916|FG000|Overall Study|Site closure|152|||
146981523|NCT00628745|530093917|FG001|Overall Study|Site closure|146|||
146981524|NCT00628745|530093918|FG002|Overall Study|Site closure|6|||
146981525|NCT00628745|530093919|FG003|Overall Study|Site closure|8|||
146981526|NCT00628745|530093920|FG004|Overall Study|Site closure|691|||
146981527|NCT00628745|530093916|FG000|Overall Study|Duplicate participant|0|||
146981528|NCT00628745|530093917|FG001|Overall Study|Duplicate participant|0|||
146981529|NCT00628745|530093918|FG002|Overall Study|Duplicate participant|0|||
146981530|NCT00628745|530093919|FG003|Overall Study|Duplicate participant|0|||
146981531|NCT00628745|530093920|FG004|Overall Study|Duplicate participant|1|||
146981532|NCT00628745|530093916|FG000|Overall Study|Missing|4|||
146981533|NCT00628745|530093917|FG001|Overall Study|Missing|3|||
146981534|NCT00628745|530093918|FG002|Overall Study|Missing|0|||
146981535|NCT00628745|530093919|FG003|Overall Study|Missing|0|||
146981536|NCT00628745|530093920|FG004|Overall Study|Missing|10|||
146935186|NCT01021813|529920221|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
146935187|NCT01021813|529920222|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
146981537|NCT00628745|530093916|FG000|Overall Study|Othe reasons|987|||
146981538|NCT00628745|530093917|FG001|Overall Study|Othe reasons|373|||
146981539|NCT00628745|530093918|FG002|Overall Study|Othe reasons|105|||
146981540|NCT00628745|530093919|FG003|Overall Study|Othe reasons|1|||
146981541|NCT00628745|530093920|FG004|Overall Study|Othe reasons|1772|||
146981542|NCT00331630|530096075|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
146981543|NCT00331630|530096075|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
146981544|NCT00331630|530096075|FG000|Follow up for 5 Years|Death|5|||
146981545|NCT00331630|530096075|FG000|Follow up for 5 Years|Data collection was stopped|24|||
146935188|NCT01021813|529920223|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
146981546|NCT03342898|530096078|FG000|Overall Study|Adverse Event|3|||
146784514|NCT04927065|529382288|FG009|First Booster|Withdrawal by Subject|4|||
146784515|NCT04927065|529382289|FG010|First Booster|Withdrawal by Subject|0|||
146784516|NCT04927065|529382290|FG011|First Booster|Withdrawal by Subject|0|||
146784517|NCT04927065|529382291|FG012|First Booster|Withdrawal by Subject|0|||
146784518|NCT04927065|529382292|FG013|First Booster|Withdrawal by Subject|0|||
146784519|NCT04927065|529382293|FG014|First Booster|Withdrawal by Subject|0|||
146784520|NCT04927065|529382294|FG015|First Booster|Withdrawal by Subject|0|||
146784521|NCT04927065|529382279|FG000|First Booster|Other Than Specified|1|||
146935189|NCT01021813|529920224|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
146935190|NCT01021813|529920220|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
146935191|NCT01021813|529920221|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
146784522|NCT04927065|529382280|FG001|First Booster|Other Than Specified|1|||
146784523|NCT04927065|529382281|FG002|First Booster|Other Than Specified|0|||
146935192|NCT01021813|529920222|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
146935193|NCT01021813|529920223|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
146935194|NCT01021813|529920224|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
146935195|NCT01021813|529920220|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
146935196|NCT01021813|529920221|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
146935197|NCT01021813|529920222|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
146935198|NCT01021813|529920223|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
146935199|NCT01021813|529920224|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
146935200|NCT01021813|529920220|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
146935201|NCT01021813|529920221|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
146935202|NCT01021813|529920222|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
146935203|NCT01021813|529920223|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
146935204|NCT01021813|529920224|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
146935205|NCT01021813|529920220|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
146935206|NCT01021813|529920221|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
146935207|NCT01021813|529920222|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
146935208|NCT01021813|529920223|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
146935209|NCT01021813|529920224|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
146935210|NCT01021813|529920220|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
146935211|NCT01021813|529920221|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
146935212|NCT01021813|529920222|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
146935213|NCT01021813|529920223|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
146935214|NCT01021813|529920224|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
146935215|NCT02270684|529920225|FG000|Overall Study|Lost to Follow-up|0|||
146935216|NCT02270684|529920226|FG001|Overall Study|Lost to Follow-up|3|||
146935217|NCT02270684|529920225|FG000|Overall Study|Study terminated|1|||
146935218|NCT02270684|529920226|FG001|Overall Study|Study terminated|0|||
146935219|NCT02247401|529920227|FG000|Overall Study|Adverse Event|1|||
146935220|NCT02247401|529920228|FG001|Overall Study|Adverse Event|0|||
146935221|NCT02247401|529920229|FG002|Overall Study|Adverse Event|0|||
146935222|NCT02247401|529920227|FG000|Overall Study|Withdrawal by Subject|4|||
146935223|NCT02247401|529920228|FG001|Overall Study|Withdrawal by Subject|1|||
146935224|NCT02247401|529920229|FG002|Overall Study|Withdrawal by Subject|1|||
146935225|NCT02247401|529920227|FG000|Overall Study|Lost to Follow-up|1|||
146935226|NCT02247401|529920228|FG001|Overall Study|Lost to Follow-up|1|||
146935227|NCT02247401|529920229|FG002|Overall Study|Lost to Follow-up|1|||
146935228|NCT00476996|529920232|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
146935229|NCT00476996|529920233|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
146935230|NCT00476996|529920234|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
146935231|NCT00476996|529920235|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
146935232|NCT00476996|529920232|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
146935233|NCT00476996|529920233|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
146935234|NCT00476996|529920234|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
146935235|NCT00476996|529920235|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
146935236|NCT00476996|529920232|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
146935237|NCT00476996|529920233|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
146935238|NCT00476996|529920234|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
146935239|NCT00476996|529920235|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
146935240|NCT00476996|529920232|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
146935241|NCT00476996|529920233|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
146935242|NCT00476996|529920234|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
146935243|NCT00476996|529920235|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
146935244|NCT00476996|529920232|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
146784524|NCT04927065|529382282|FG003|First Booster|Other Than Specified|1|||
146784525|NCT04927065|529382283|FG004|First Booster|Other Than Specified|2|||
146784526|NCT04927065|529382284|FG005|First Booster|Other Than Specified|3|||
146784527|NCT04927065|529382285|FG006|First Booster|Other Than Specified|2|||
146784528|NCT04927065|529382286|FG007|First Booster|Other Than Specified|6|||
146784529|NCT04927065|529382287|FG008|First Booster|Other Than Specified|0|||
146784530|NCT04927065|529382288|FG009|First Booster|Other Than Specified|4|||
146784531|NCT04927065|529382289|FG010|First Booster|Other Than Specified|0|||
146784532|NCT04927065|529382290|FG011|First Booster|Other Than Specified|0|||
146784533|NCT04927065|529382291|FG012|First Booster|Other Than Specified|0|||
146784534|NCT04927065|529382292|FG013|First Booster|Other Than Specified|0|||
146784535|NCT04927065|529382293|FG014|First Booster|Other Than Specified|0|||
146784536|NCT04927065|529382294|FG015|First Booster|Other Than Specified|0|||
146784537|NCT04927065|529382279|FG000|Second Booster|Death|0|||
146784538|NCT04927065|529382280|FG001|Second Booster|Death|0|||
146784539|NCT04927065|529382281|FG002|Second Booster|Death|0|||
146784540|NCT04927065|529382282|FG003|Second Booster|Death|0|||
146784541|NCT04927065|529382283|FG004|Second Booster|Death|0|||
146784542|NCT04927065|529382284|FG005|Second Booster|Death|0|||
146784543|NCT04927065|529382285|FG006|Second Booster|Death|0|||
146784544|NCT04927065|529382286|FG007|Second Booster|Death|0|||
146784545|NCT04927065|529382287|FG008|Second Booster|Death|0|||
146784546|NCT04927065|529382288|FG009|Second Booster|Death|0|||
146784547|NCT04927065|529382289|FG010|Second Booster|Death|2|||
146784548|NCT04927065|529382290|FG011|Second Booster|Death|0|||
146784549|NCT04927065|529382291|FG012|Second Booster|Death|2|||
146784550|NCT04927065|529382292|FG013|Second Booster|Death|2|||
146784551|NCT04927065|529382293|FG014|Second Booster|Death|0|||
146784552|NCT04927065|529382294|FG015|Second Booster|Death|0|||
146784553|NCT04927065|529382279|FG000|Second Booster|Lost to Follow-up|0|||
146784554|NCT04927065|529382280|FG001|Second Booster|Lost to Follow-up|0|||
146784555|NCT04927065|529382281|FG002|Second Booster|Lost to Follow-up|3|||
146784556|NCT04927065|529382282|FG003|Second Booster|Lost to Follow-up|0|||
146784557|NCT04927065|529382283|FG004|Second Booster|Lost to Follow-up|0|||
146784558|NCT04927065|529382284|FG005|Second Booster|Lost to Follow-up|0|||
146784559|NCT04927065|529382285|FG006|Second Booster|Lost to Follow-up|0|||
146784560|NCT04927065|529382286|FG007|Second Booster|Lost to Follow-up|0|||
146784561|NCT04927065|529382287|FG008|Second Booster|Lost to Follow-up|0|||
146784562|NCT04927065|529382288|FG009|Second Booster|Lost to Follow-up|0|||
146784563|NCT04927065|529382289|FG010|Second Booster|Lost to Follow-up|14|||
146784564|NCT04927065|529382290|FG011|Second Booster|Lost to Follow-up|10|||
146784565|NCT04927065|529382291|FG012|Second Booster|Lost to Follow-up|13|||
146784566|NCT04927065|529382292|FG013|Second Booster|Lost to Follow-up|16|||
146784567|NCT04927065|529382293|FG014|Second Booster|Lost to Follow-up|0|||
146784568|NCT04927065|529382294|FG015|Second Booster|Lost to Follow-up|0|||
146784569|NCT04927065|529382279|FG000|Second Booster|Physician Decision|0|||
146935245|NCT00476996|529920233|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
146935246|NCT00476996|529920234|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
146935247|NCT00476996|529920235|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
146935248|NCT00476996|529920232|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
146935249|NCT00476996|529920233|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
146935250|NCT00476996|529920234|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
146935251|NCT00476996|529920235|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
146935252|NCT00476996|529920232|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
146935253|NCT00476996|529920233|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
146935254|NCT00476996|529920234|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
146935255|NCT00476996|529920235|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
146935256|NCT00476996|529920232|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
146935257|NCT00476996|529920233|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
146935258|NCT00476996|529920234|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
146935259|NCT00476996|529920235|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
146935260|NCT00476996|529920232|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
146935261|NCT00476996|529920233|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
146935262|NCT00476996|529920234|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
146935263|NCT00476996|529920235|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
146935264|NCT00476996|529920232|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
146981547|NCT03342898|530096079|FG001|Overall Study|Adverse Event|1|||
146784570|NCT04927065|529382280|FG001|Second Booster|Physician Decision|0|||
146784571|NCT04927065|529382281|FG002|Second Booster|Physician Decision|0|||
146784572|NCT04927065|529382282|FG003|Second Booster|Physician Decision|0|||
146784573|NCT04927065|529382283|FG004|Second Booster|Physician Decision|0|||
146784574|NCT04927065|529382284|FG005|Second Booster|Physician Decision|0|||
146784575|NCT04927065|529382285|FG006|Second Booster|Physician Decision|0|||
146784576|NCT04927065|529382286|FG007|Second Booster|Physician Decision|0|||
146784577|NCT04927065|529382287|FG008|Second Booster|Physician Decision|0|||
146784578|NCT04927065|529382288|FG009|Second Booster|Physician Decision|0|||
146784579|NCT04927065|529382289|FG010|Second Booster|Physician Decision|0|||
146784580|NCT04927065|529382290|FG011|Second Booster|Physician Decision|3|||
146784581|NCT04927065|529382291|FG012|Second Booster|Physician Decision|0|||
146981548|NCT03342898|530096080|FG002|Overall Study|Adverse Event|0|||
146981549|NCT03342898|530096078|FG000|Overall Study|Lost to Follow-up|44|||
146981550|NCT03342898|530096079|FG001|Overall Study|Lost to Follow-up|40|||
146981551|NCT03342898|530096080|FG002|Overall Study|Lost to Follow-up|42|||
146981552|NCT03342898|530096078|FG000|Overall Study|Withdrawal of Consent|5|||
146981553|NCT03342898|530096079|FG001|Overall Study|Withdrawal of Consent|9|||
146981554|NCT03342898|530096080|FG002|Overall Study|Withdrawal of Consent|11|||
146981555|NCT03342898|530096078|FG000|Overall Study|Death|0|||
146981556|NCT03342898|530096079|FG001|Overall Study|Death|1|||
146981557|NCT03342898|530096080|FG002|Overall Study|Death|1|||
146981558|NCT03342898|530096078|FG000|Overall Study|Reason not Specified|2|||
146981559|NCT03342898|530096079|FG001|Overall Study|Reason not Specified|2|||
146981560|NCT03342898|530096080|FG002|Overall Study|Reason not Specified|0|||
146981561|NCT01387282|530096081|FG000|Overall Study|Death|47|||
146981562|NCT01387282|530096082|FG001|Overall Study|Death|16|||
146981563|NCT01387282|530096081|FG000|Overall Study|Other|5|||
146981564|NCT01387282|530096082|FG001|Overall Study|Other|1|||
146981565|NCT01387282|530096081|FG000|Overall Study|Unrelated AE|6|||
146981566|NCT01387282|530096082|FG001|Overall Study|Unrelated AE|4|||
146981567|NCT01387282|530096081|FG000|Overall Study|Withdrawal by patient|33|||
146981568|NCT01387282|530096082|FG001|Overall Study|Withdrawal by patient|23|||
146981569|NCT01387282|530096081|FG000|Overall Study|Study drug-related AE|2|||
146981570|NCT01387282|530096082|FG001|Overall Study|Study drug-related AE|2|||
146981571|NCT01387282|530096081|FG000|Overall Study|Lost to Follow-up|4|||
146981572|NCT01387282|530096082|FG001|Overall Study|Lost to Follow-up|1|||
146725382|NCT00490646|529164311|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
146725383|NCT00490646|529164312|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
146725384|NCT00490646|529164311|FG000|Overall Study|Never Treated (had an adverse event)|1|||
146725385|NCT00490646|529164312|FG001|Overall Study|Never Treated (had an adverse event)|0|||
146725386|NCT00490646|529164311|FG000|Overall Study|Never Treated (withdrew consent)|0|||
146725387|NCT00490646|529164312|FG001|Overall Study|Never Treated (withdrew consent)|1|||
146725388|NCT01178086|529164313|FG000|Overall Study|Participant refusal|7|||
146725389|NCT01178086|529164313|FG000|Overall Study|Physician Decision|44|||
146725390|NCT01178086|529164313|FG000|Overall Study|Switch to other CLL therapy|113|||
146725391|NCT01178086|529164313|FG000|Overall Study|Death|59|||
146725392|NCT01178086|529164313|FG000|Overall Study|Other unspecified|89|||
146725393|NCT01178086|529164313|FG000|Overall Study|Excluded from EAS|20|||
146725394|NCT02137369|529164314|FG000|Overall Study|Withdrawal by Subject|3|||
146725395|NCT02137369|529164315|FG001|Overall Study|Withdrawal by Subject|2|||
146725396|NCT02137369|529164314|FG000|Overall Study|Adverse Event|2|||
146725397|NCT02137369|529164315|FG001|Overall Study|Adverse Event|0|||
146725398|NCT02137369|529164314|FG000|Overall Study|Lost to Follow-up|1|||
146725399|NCT02137369|529164315|FG001|Overall Study|Lost to Follow-up|0|||
146725400|NCT02137369|529164314|FG000|Overall Study|Moved away|2|||
146725401|NCT02137369|529164315|FG001|Overall Study|Moved away|0|||
146725402|NCT03762473|529164317|FG000|Overall Study|Death|1|||
146725403|NCT03762473|529164318|FG001|Overall Study|Death|0|||
146725404|NCT02962908|529164319|FG000|Overall Study|Lost to Follow-up|0|||
146725405|NCT02962908|529164320|FG001|Overall Study|Lost to Follow-up|3|||
146725406|NCT02962908|529164321|FG002|Overall Study|Lost to Follow-up|0|||
146725407|NCT02962908|529164322|FG003|Overall Study|Lost to Follow-up|1|||
146725408|NCT02962908|529164319|FG000|Overall Study|Withdrawal by Subject|0|||
146725409|NCT02962908|529164320|FG001|Overall Study|Withdrawal by Subject|3|||
146725410|NCT02962908|529164321|FG002|Overall Study|Withdrawal by Subject|0|||
146725411|NCT02962908|529164322|FG003|Overall Study|Withdrawal by Subject|2|||
146725412|NCT02962908|529164319|FG000|Overall Study|Protocol Violation|0|||
146725413|NCT02962908|529164320|FG001|Overall Study|Protocol Violation|1|||
146725414|NCT02962908|529164321|FG002|Overall Study|Protocol Violation|0|||
146725415|NCT02962908|529164322|FG003|Overall Study|Protocol Violation|0|||
146725416|NCT02962908|529164319|FG000|Overall Study|Physician Decision|0|||
146725417|NCT02962908|529164320|FG001|Overall Study|Physician Decision|1|||
146725418|NCT02962908|529164321|FG002|Overall Study|Physician Decision|0|||
146725419|NCT02962908|529164322|FG003|Overall Study|Physician Decision|0|||
146725420|NCT00126438|529164323|FG000|Overall Study|Withdrawal due to adverse event|1|||
146725421|NCT00126438|529164324|FG001|Overall Study|Withdrawal due to adverse event|0|||
146725422|NCT00126438|529164323|FG000|Overall Study|Lost to Follow-up|22|||
146981573|NCT03997448|530096085|FG000|Study Treatment|Disease Progression|1|||
146981574|NCT03997448|530096085|FG000|Study Treatment|Symptomatic Deterioration|1|||
146981575|NCT03997448|530096085|FG000|Follow up|Death|2|||
146981576|NCT03997448|530096085|FG000|Follow up|study terminated|1|||
146725423|NCT00126438|529164324|FG001|Overall Study|Lost to Follow-up|0|||
146725424|NCT00126438|529164323|FG000|Overall Study|Protocol Violation|8|||
146725425|NCT00126438|529164324|FG001|Overall Study|Protocol Violation|8|||
146725426|NCT00126438|529164323|FG000|Overall Study|Withdrawal by Subject|3|||
146725427|NCT00126438|529164324|FG001|Overall Study|Withdrawal by Subject|2|||
146725428|NCT02899728|529164328|FG000|Overall Study|Withdrawal by Subject|1|||
146725429|NCT02899728|529164329|FG001|Overall Study|Withdrawal by Subject|1|||
146725430|NCT02626780|529164331|FG000|Overall Study|Withdrawal by Subject|3|||
146784582|NCT04927065|529382292|FG013|Second Booster|Physician Decision|1|||
146784583|NCT04927065|529382293|FG014|Second Booster|Physician Decision|0|||
146784584|NCT04927065|529382294|FG015|Second Booster|Physician Decision|0|||
146784585|NCT04927065|529382279|FG000|Second Booster|Withdrawal by Subject|0|||
146784586|NCT04927065|529382280|FG001|Second Booster|Withdrawal by Subject|0|||
146784587|NCT04927065|529382281|FG002|Second Booster|Withdrawal by Subject|4|||
146784588|NCT04927065|529382282|FG003|Second Booster|Withdrawal by Subject|0|||
146784589|NCT04927065|529382283|FG004|Second Booster|Withdrawal by Subject|0|||
146784590|NCT04927065|529382284|FG005|Second Booster|Withdrawal by Subject|0|||
146784591|NCT04927065|529382285|FG006|Second Booster|Withdrawal by Subject|0|||
146784592|NCT04927065|529382286|FG007|Second Booster|Withdrawal by Subject|0|||
146784593|NCT04927065|529382287|FG008|Second Booster|Withdrawal by Subject|0|||
146784594|NCT04927065|529382288|FG009|Second Booster|Withdrawal by Subject|0|||
146784595|NCT04927065|529382289|FG010|Second Booster|Withdrawal by Subject|3|||
146784596|NCT04927065|529382290|FG011|Second Booster|Withdrawal by Subject|16|||
146784597|NCT04927065|529382291|FG012|Second Booster|Withdrawal by Subject|13|||
146784598|NCT04927065|529382292|FG013|Second Booster|Withdrawal by Subject|9|||
146935265|NCT00476996|529920233|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
146935266|NCT00476996|529920234|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
146725431|NCT04304833|529164332|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
146725432|NCT04304833|529164333|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
146725433|NCT01951625|529164334|FG000|Treatment Period|Protocol Violation|2|||
146725434|NCT01951625|529164335|FG001|Treatment Period|Protocol Violation|0|||
146725435|NCT01951625|529164336|FG002|Treatment Period|Protocol Violation|1|||
146725436|NCT01951625|529164337|FG003|Treatment Period|Protocol Violation|3|||
146725437|NCT01951625|529164338|FG004|Treatment Period|Protocol Violation|2|||
146725438|NCT01951625|529164334|FG000|Treatment Period|Physician Decision|0|||
146725439|NCT01951625|529164335|FG001|Treatment Period|Physician Decision|0|||
146725440|NCT01951625|529164336|FG002|Treatment Period|Physician Decision|0|||
146725441|NCT01951625|529164337|FG003|Treatment Period|Physician Decision|0|||
146725442|NCT01951625|529164338|FG004|Treatment Period|Physician Decision|1|||
146725443|NCT01951625|529164334|FG000|Treatment Period|Protocol driven decision point|0|||
146725444|NCT01951625|529164335|FG001|Treatment Period|Protocol driven decision point|5|||
146725445|NCT01951625|529164336|FG002|Treatment Period|Protocol driven decision point|0|||
146725446|NCT01951625|529164337|FG003|Treatment Period|Protocol driven decision point|2|||
146725447|NCT01951625|529164338|FG004|Treatment Period|Protocol driven decision point|1|||
146725448|NCT01951625|529164334|FG000|Treatment Period|Non compliance with study drug|1|||
146725449|NCT01951625|529164335|FG001|Treatment Period|Non compliance with study drug|2|||
146725450|NCT01951625|529164336|FG002|Treatment Period|Non compliance with study drug|2|||
146725451|NCT01951625|529164337|FG003|Treatment Period|Non compliance with study drug|0|||
146725452|NCT01951625|529164338|FG004|Treatment Period|Non compliance with study drug|0|||
146725453|NCT01951625|529164334|FG000|Treatment Period|Death|3|||
146725454|NCT01951625|529164335|FG001|Treatment Period|Death|2|||
146725455|NCT01951625|529164336|FG002|Treatment Period|Death|2|||
146725456|NCT01951625|529164337|FG003|Treatment Period|Death|1|||
146725457|NCT01951625|529164338|FG004|Treatment Period|Death|2|||
146725458|NCT01951625|529164334|FG000|Treatment Period|Adverse Event|7|||
146725459|NCT01951625|529164335|FG001|Treatment Period|Adverse Event|10|||
146725460|NCT01951625|529164336|FG002|Treatment Period|Adverse Event|9|||
146725461|NCT01951625|529164337|FG003|Treatment Period|Adverse Event|8|||
146725462|NCT01951625|529164338|FG004|Treatment Period|Adverse Event|8|||
146725463|NCT01951625|529164334|FG000|Treatment Period|Withdrawal by Subject|5|||
146725464|NCT01951625|529164335|FG001|Treatment Period|Withdrawal by Subject|2|||
146725465|NCT01951625|529164336|FG002|Treatment Period|Withdrawal by Subject|1|||
146725466|NCT01951625|529164337|FG003|Treatment Period|Withdrawal by Subject|7|||
146725467|NCT01951625|529164338|FG004|Treatment Period|Withdrawal by Subject|3|||
146725468|NCT01951625|529164334|FG000|Treatment Period|Lost to Follow-up|1|||
146725469|NCT01951625|529164335|FG001|Treatment Period|Lost to Follow-up|0|||
146725470|NCT01951625|529164336|FG002|Treatment Period|Lost to Follow-up|0|||
146725471|NCT01951625|529164337|FG003|Treatment Period|Lost to Follow-up|1|||
146784599|NCT04927065|529382293|FG014|Second Booster|Withdrawal by Subject|0|||
146784600|NCT04927065|529382294|FG015|Second Booster|Withdrawal by Subject|0|||
146784601|NCT04927065|529382279|FG000|Second Booster|Other Than Specified|0|||
146784602|NCT04927065|529382280|FG001|Second Booster|Other Than Specified|0|||
146784603|NCT04927065|529382281|FG002|Second Booster|Other Than Specified|0|||
146784604|NCT04927065|529382282|FG003|Second Booster|Other Than Specified|0|||
146725472|NCT01951625|529164338|FG004|Treatment Period|Lost to Follow-up|0|||
146725473|NCT01951625|529164334|FG000|Follow Up Period|Non-compliance with study drug|1|||
146725474|NCT01951625|529164335|FG001|Follow Up Period|Non-compliance with study drug|0|||
146784605|NCT04927065|529382283|FG004|Second Booster|Other Than Specified|0|||
146784606|NCT04927065|529382284|FG005|Second Booster|Other Than Specified|0|||
146784607|NCT04927065|529382285|FG006|Second Booster|Other Than Specified|0|||
146784608|NCT04927065|529382286|FG007|Second Booster|Other Than Specified|0|||
146784609|NCT04927065|529382287|FG008|Second Booster|Other Than Specified|0|||
146935267|NCT00476996|529920235|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
146935268|NCT00476996|529920232|FG000|OLE Phase (From Week 48)|Death|0|||
146725475|NCT01951625|529164336|FG002|Follow Up Period|Non-compliance with study drug|0|||
146725476|NCT01951625|529164337|FG003|Follow Up Period|Non-compliance with study drug|0|||
146725477|NCT01951625|529164338|FG004|Follow Up Period|Non-compliance with study drug|0|||
146725478|NCT01951625|529164334|FG000|Follow Up Period|Death|1|||
146725479|NCT01951625|529164335|FG001|Follow Up Period|Death|3|||
146725480|NCT01951625|529164336|FG002|Follow Up Period|Death|2|||
146725481|NCT01951625|529164337|FG003|Follow Up Period|Death|2|||
146725482|NCT01951625|529164338|FG004|Follow Up Period|Death|1|||
146725483|NCT01951625|529164334|FG000|Follow Up Period|Logistical difficulties|1|||
146725484|NCT01951625|529164335|FG001|Follow Up Period|Logistical difficulties|2|||
146725485|NCT01951625|529164336|FG002|Follow Up Period|Logistical difficulties|0|||
146725486|NCT01951625|529164337|FG003|Follow Up Period|Logistical difficulties|0|||
146725487|NCT01951625|529164338|FG004|Follow Up Period|Logistical difficulties|0|||
146725488|NCT01951625|529164334|FG000|Follow Up Period|Adverse Event|0|||
146725489|NCT01951625|529164335|FG001|Follow Up Period|Adverse Event|3|||
146725490|NCT01951625|529164336|FG002|Follow Up Period|Adverse Event|2|||
146725491|NCT01951625|529164337|FG003|Follow Up Period|Adverse Event|3|||
146725492|NCT01951625|529164338|FG004|Follow Up Period|Adverse Event|5|||
146725493|NCT01951625|529164334|FG000|Follow Up Period|Withdrawal by Subject|4|||
146725494|NCT01951625|529164335|FG001|Follow Up Period|Withdrawal by Subject|1|||
146725495|NCT01951625|529164336|FG002|Follow Up Period|Withdrawal by Subject|0|||
146725496|NCT01951625|529164337|FG003|Follow Up Period|Withdrawal by Subject|5|||
146725497|NCT01951625|529164338|FG004|Follow Up Period|Withdrawal by Subject|3|||
146725498|NCT01951625|529164334|FG000|Follow Up Period|Lost to Follow-up|1|||
146725499|NCT01951625|529164335|FG001|Follow Up Period|Lost to Follow-up|0|||
146725500|NCT01951625|529164336|FG002|Follow Up Period|Lost to Follow-up|0|||
146725501|NCT01951625|529164337|FG003|Follow Up Period|Lost to Follow-up|1|||
146725502|NCT01951625|529164338|FG004|Follow Up Period|Lost to Follow-up|1|||
146725503|NCT00613951|529164341|FG000|Overall Study|Adverse Event|1|||
146725504|NCT00613951|529164342|FG001|Overall Study|Adverse Event|0|||
146725505|NCT00613951|529164343|FG002|Overall Study|Adverse Event|1|||
146725506|NCT00613951|529164341|FG000|Overall Study|Lack of Efficacy|0|||
146725507|NCT00613951|529164342|FG001|Overall Study|Lack of Efficacy|1|||
146725508|NCT00613951|529164343|FG002|Overall Study|Lack of Efficacy|1|||
146725509|NCT00613951|529164341|FG000|Overall Study|Protocol Violation|1|||
146725510|NCT00613951|529164342|FG001|Overall Study|Protocol Violation|1|||
146725511|NCT00613951|529164343|FG002|Overall Study|Protocol Violation|1|||
146725512|NCT00613951|529164341|FG000|Overall Study|Unclassified|5|||
146725513|NCT00613951|529164342|FG001|Overall Study|Unclassified|3|||
146725514|NCT00613951|529164343|FG002|Overall Study|Unclassified|2|||
146725515|NCT05540522|529164345|FG000|Overall Study|Adverse Event|1|||
146725516|NCT05540522|529164346|FG001|Overall Study|Adverse Event|0|||
146725517|NCT05540522|529164347|FG002|Overall Study|Adverse Event|2|||
146725518|NCT05540522|529164348|FG003|Overall Study|Adverse Event|5|||
146725519|NCT05540522|529164345|FG000|Overall Study|Lost to Follow-up|487|||
146725520|NCT05540522|529164346|FG001|Overall Study|Lost to Follow-up|427|||
146725521|NCT05540522|529164347|FG002|Overall Study|Lost to Follow-up|146|||
146725522|NCT05540522|529164348|FG003|Overall Study|Lost to Follow-up|166|||
146725523|NCT05540522|529164345|FG000|Overall Study|Physician Decision|11|||
146725524|NCT05540522|529164346|FG001|Overall Study|Physician Decision|19|||
146725525|NCT05540522|529164347|FG002|Overall Study|Physician Decision|8|||
146725526|NCT05540522|529164348|FG003|Overall Study|Physician Decision|13|||
146725527|NCT05540522|529164345|FG000|Overall Study|Pregnancy|1|||
146725528|NCT05540522|529164346|FG001|Overall Study|Pregnancy|0|||
146725529|NCT05540522|529164347|FG002|Overall Study|Pregnancy|0|||
146725530|NCT05540522|529164348|FG003|Overall Study|Pregnancy|0|||
146725531|NCT05540522|529164345|FG000|Overall Study|Protocol Violation|3|||
146725532|NCT05540522|529164346|FG001|Overall Study|Protocol Violation|1|||
146725533|NCT05540522|529164347|FG002|Overall Study|Protocol Violation|9|||
146725534|NCT05540522|529164348|FG003|Overall Study|Protocol Violation|7|||
146725535|NCT05540522|529164345|FG000|Overall Study|Withdrawal by Subject|168|||
146725536|NCT05540522|529164346|FG001|Overall Study|Withdrawal by Subject|134|||
146725537|NCT05540522|529164347|FG002|Overall Study|Withdrawal by Subject|331|||
146725538|NCT05540522|529164348|FG003|Overall Study|Withdrawal by Subject|322|||
146725539|NCT05540522|529164345|FG000|Overall Study|Death|7|||
146725540|NCT05540522|529164346|FG001|Overall Study|Death|9|||
146725541|NCT05540522|529164347|FG002|Overall Study|Death|49|||
146725542|NCT05540522|529164348|FG003|Overall Study|Death|46|||
146725543|NCT05540522|529164345|FG000|Overall Study|Not vaccinated|34|||
146725544|NCT05540522|529164346|FG001|Overall Study|Not vaccinated|53|||
146725545|NCT05540522|529164347|FG002|Overall Study|Not vaccinated|57|||
146725546|NCT05540522|529164348|FG003|Overall Study|Not vaccinated|50|||
146725547|NCT05540522|529164345|FG000|Overall Study|No longer meets eligibility criteria|0|||
146725548|NCT05540522|529164346|FG001|Overall Study|No longer meets eligibility criteria|0|||
146725549|NCT05540522|529164347|FG002|Overall Study|No longer meets eligibility criteria|3|||
146725550|NCT05540522|529164348|FG003|Overall Study|No longer meets eligibility criteria|2|||
146725551|NCT05540522|529164345|FG000|Overall Study|Other (Unspecified)|8|||
146725552|NCT05540522|529164346|FG001|Overall Study|Other (Unspecified)|10|||
146725553|NCT05540522|529164347|FG002|Overall Study|Other (Unspecified)|4|||
146784610|NCT04927065|529382288|FG009|Second Booster|Other Than Specified|0|||
146784611|NCT04927065|529382289|FG010|Second Booster|Other Than Specified|1|||
146784612|NCT04927065|529382290|FG011|Second Booster|Other Than Specified|1|||
146784613|NCT04927065|529382291|FG012|Second Booster|Other Than Specified|4|||
146784614|NCT04927065|529382292|FG013|Second Booster|Other Than Specified|0|||
146784615|NCT04927065|529382293|FG014|Second Booster|Other Than Specified|0|||
146725554|NCT05540522|529164348|FG003|Overall Study|Other (Unspecified)|2|||
146725555|NCT04348604|529164349|FG000|Week 8|Withdrawal by Subject|1|||
146725556|NCT04348604|529164350|FG001|Week 8|Withdrawal by Subject|1|||
146725557|NCT04348604|529164349|FG000|Week 8|Lost to Follow-up|1|||
146725558|NCT04348604|529164350|FG001|Week 8|Lost to Follow-up|2|||
146725559|NCT04348604|529164349|FG000|Week 8|Suspended|0|||
146725560|NCT04348604|529164350|FG001|Week 8|Suspended|1|||
146725561|NCT04348604|529164349|FG000|Week 12|Lost to Follow-up|1|||
146725562|NCT04348604|529164350|FG001|Week 12|Lost to Follow-up|2|||
146725563|NCT04348604|529164349|FG000|Week 12|Withdrawal by Subject|1|||
146725564|NCT04348604|529164350|FG001|Week 12|Withdrawal by Subject|0|||
146725565|NCT04348604|529164349|FG000|Week 24|Lost to Follow-up|2|||
146725566|NCT04348604|529164350|FG001|Week 24|Lost to Follow-up|1|||
146725567|NCT02097108|529164351|FG000|Overall Study|Adverse Event|1|||
146725568|NCT02097108|529164351|FG000|Overall Study|patient was abroad for 6 months|1|||
146725569|NCT00127608|529164354|FG000|Overall Study|VZV DNA negative|1|||
146725570|NCT00680407|529164362|FG000|Overall Study|Lost to Follow-up|3|||
146725571|NCT00680407|529164363|FG001|Overall Study|Lost to Follow-up|3|||
146725572|NCT00680407|529164364|FG002|Overall Study|Lost to Follow-up|1|||
146725573|NCT00680407|529164362|FG000|Overall Study|Withdrawal by Subject|5|||
146725574|NCT00680407|529164363|FG001|Overall Study|Withdrawal by Subject|2|||
146725575|NCT00680407|529164364|FG002|Overall Study|Withdrawal by Subject|2|||
146725576|NCT00506493|529164365|FG000|Overall Study|Death|6|||
146725577|NCT00506493|529164365|FG000|Overall Study|Withdrawal by Subject|5|||
146725578|NCT04918784|529166813|FG000|Overall Study|Amputation - no longer eligible|1|||
146725579|NCT04918784|529166814|FG001|Overall Study|Amputation - no longer eligible|2|||
146725580|NCT04918784|529166813|FG000|Overall Study|Death|1|||
146725581|NCT04918784|529166814|FG001|Overall Study|Death|0|||
146725582|NCT04918784|529166813|FG000|Overall Study|patient non-compliance|3|||
146725583|NCT04918784|529166814|FG001|Overall Study|patient non-compliance|1|||
146725584|NCT04918784|529166813|FG000|Overall Study|Adverse Event|1|||
146725585|NCT04918784|529166814|FG001|Overall Study|Adverse Event|0|||
146725586|NCT01712009|529166815|FG000|Overall Study|Withdrawal by Subject|24|||
146725587|NCT01712009|529166816|FG001|Overall Study|Withdrawal by Subject|15|||
146725588|NCT01712009|529166817|FG002|Overall Study|Withdrawal by Subject|8|||
146725589|NCT01712009|529166815|FG000|Overall Study|Lost to Follow-up|2|||
146725590|NCT01712009|529166816|FG001|Overall Study|Lost to Follow-up|0|||
146725591|NCT01712009|529166817|FG002|Overall Study|Lost to Follow-up|1|||
146725592|NCT01712009|529166815|FG000|Overall Study|Decision by Sponsor|12|||
146725593|NCT01712009|529166816|FG001|Overall Study|Decision by Sponsor|14|||
146725594|NCT01712009|529166817|FG002|Overall Study|Decision by Sponsor|12|||
146725595|NCT02822222|529166818|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
146725596|NCT02822222|529166819|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
146725597|NCT00428090|529166820|FG000|Overall Study|Adverse Event|10|||
146725598|NCT00428090|529166821|FG001|Overall Study|Adverse Event|8|||
146725599|NCT00428090|529166822|FG002|Overall Study|Adverse Event|10|||
146725600|NCT00428090|529166823|FG003|Overall Study|Adverse Event|11|||
146725601|NCT00428090|529166820|FG000|Overall Study|Lost to Follow-up|3|||
146725602|NCT00428090|529166821|FG001|Overall Study|Lost to Follow-up|6|||
146725603|NCT00428090|529166822|FG002|Overall Study|Lost to Follow-up|1|||
146725604|NCT00428090|529166823|FG003|Overall Study|Lost to Follow-up|4|||
146725605|NCT00428090|529166820|FG000|Overall Study|Protocol Violation|3|||
146725606|NCT00428090|529166821|FG001|Overall Study|Protocol Violation|1|||
146725607|NCT00428090|529166822|FG002|Overall Study|Protocol Violation|3|||
146725608|NCT00428090|529166823|FG003|Overall Study|Protocol Violation|3|||
146725609|NCT00428090|529166820|FG000|Overall Study|Withdrawal by Subject|10|||
146725610|NCT00428090|529166821|FG001|Overall Study|Withdrawal by Subject|12|||
146725611|NCT00428090|529166822|FG002|Overall Study|Withdrawal by Subject|15|||
146725612|NCT00428090|529166823|FG003|Overall Study|Withdrawal by Subject|5|||
146784616|NCT04927065|529382294|FG015|Second Booster|Other Than Specified|0|||
146725613|NCT00428090|529166820|FG000|Overall Study|Sponsor terminated study|0|||
146725614|NCT00428090|529166821|FG001|Overall Study|Sponsor terminated study|1|||
146725615|NCT00428090|529166822|FG002|Overall Study|Sponsor terminated study|0|||
146725616|NCT00428090|529166823|FG003|Overall Study|Sponsor terminated study|0|||
146725617|NCT00428090|529166820|FG000|Overall Study|Non-compliance|4|||
146725618|NCT00428090|529166821|FG001|Overall Study|Non-compliance|0|||
146725619|NCT00428090|529166822|FG002|Overall Study|Non-compliance|1|||
146725620|NCT00428090|529166823|FG003|Overall Study|Non-compliance|3|||
146725621|NCT00428090|529166820|FG000|Overall Study|Par. did not returned to visit|1|||
146784617|NCT04927065|529382279|FG000|Third Booster|Lost to Follow-up|0|||
146725622|NCT00428090|529166821|FG001|Overall Study|Par. did not returned to visit|0|||
146725623|NCT00428090|529166822|FG002|Overall Study|Par. did not returned to visit|0|||
146725624|NCT00428090|529166823|FG003|Overall Study|Par. did not returned to visit|1|||
146725625|NCT00428090|529166820|FG000|Overall Study|Follow-Up visit not possible|1|||
146725626|NCT00428090|529166821|FG001|Overall Study|Follow-Up visit not possible|0|||
146725627|NCT00428090|529166822|FG002|Overall Study|Follow-Up visit not possible|0|||
146725628|NCT00428090|529166823|FG003|Overall Study|Follow-Up visit not possible|0|||
146725629|NCT00428090|529166820|FG000|Overall Study|Prohibited medication used for SAE|1|||
146725630|NCT00428090|529166821|FG001|Overall Study|Prohibited medication used for SAE|0|||
146725631|NCT00428090|529166822|FG002|Overall Study|Prohibited medication used for SAE|0|||
146725632|NCT00428090|529166823|FG003|Overall Study|Prohibited medication used for SAE|0|||
146725633|NCT00428090|529166820|FG000|Overall Study|Death of par.|1|||
146725634|NCT00428090|529166821|FG001|Overall Study|Death of par.|0|||
146725635|NCT00428090|529166822|FG002|Overall Study|Death of par.|1|||
146725636|NCT00428090|529166823|FG003|Overall Study|Death of par.|0|||
146725637|NCT00428090|529166820|FG000|Overall Study|Visit 7 exceed the visit window|0|||
146725638|NCT00428090|529166821|FG001|Overall Study|Visit 7 exceed the visit window|1|||
146725639|NCT00428090|529166822|FG002|Overall Study|Visit 7 exceed the visit window|0|||
146725640|NCT00428090|529166823|FG003|Overall Study|Visit 7 exceed the visit window|0|||
146725641|NCT00428090|529166820|FG000|Overall Study|Medical monitor terminated par.|0|||
146725642|NCT00428090|529166821|FG001|Overall Study|Medical monitor terminated par.|1|||
146725643|NCT00428090|529166822|FG002|Overall Study|Medical monitor terminated par.|0|||
146725644|NCT00428090|529166823|FG003|Overall Study|Medical monitor terminated par.|0|||
146725645|NCT00428090|529166820|FG000|Overall Study|Mental status of par. was|0|||
146725646|NCT00428090|529166821|FG001|Overall Study|Mental status of par. was|1|||
146725647|NCT00428090|529166822|FG002|Overall Study|Mental status of par. was|0|||
146725648|NCT00428090|529166823|FG003|Overall Study|Mental status of par. was|0|||
146725649|NCT00428090|529166820|FG000|Overall Study|Worsening of AD|0|||
146725650|NCT00428090|529166821|FG001|Overall Study|Worsening of AD|0|||
146725651|NCT00428090|529166822|FG002|Overall Study|Worsening of AD|1|||
146725652|NCT00428090|529166823|FG003|Overall Study|Worsening of AD|0|||
146725653|NCT00428090|529166820|FG000|Overall Study|Excluded for concerning QTc value|0|||
146725654|NCT00428090|529166821|FG001|Overall Study|Excluded for concerning QTc value|0|||
146725655|NCT00428090|529166822|FG002|Overall Study|Excluded for concerning QTc value|1|||
146725656|NCT00428090|529166823|FG003|Overall Study|Excluded for concerning QTc value|0|||
146725657|NCT00428090|529166820|FG000|Overall Study|Insufficient AD documentation|0|||
146725658|NCT00428090|529166821|FG001|Overall Study|Insufficient AD documentation|0|||
146725659|NCT00428090|529166822|FG002|Overall Study|Insufficient AD documentation|1|||
146725660|NCT00428090|529166823|FG003|Overall Study|Insufficient AD documentation|0|||
146725661|NCT00428090|529166820|FG000|Overall Study|High MMSE scores|0|||
146725662|NCT00428090|529166821|FG001|Overall Study|High MMSE scores|0|||
146725663|NCT00428090|529166822|FG002|Overall Study|High MMSE scores|1|||
146725664|NCT00428090|529166823|FG003|Overall Study|High MMSE scores|0|||
146725665|NCT00428090|529166820|FG000|Overall Study|Deterioration of cognitive status|0|||
146725666|NCT00428090|529166821|FG001|Overall Study|Deterioration of cognitive status|0|||
146725667|NCT00428090|529166822|FG002|Overall Study|Deterioration of cognitive status|1|||
146725668|NCT00428090|529166823|FG003|Overall Study|Deterioration of cognitive status|0|||
146725669|NCT00428090|529166820|FG000|Overall Study|Serious adverse event|0|||
146725670|NCT00428090|529166821|FG001|Overall Study|Serious adverse event|0|||
146725671|NCT00428090|529166822|FG002|Overall Study|Serious adverse event|1|||
146725672|NCT00428090|529166823|FG003|Overall Study|Serious adverse event|0|||
146725673|NCT00428090|529166820|FG000|Overall Study|Excluded for heart insufficiency|0|||
146725674|NCT00428090|529166821|FG001|Overall Study|Excluded for heart insufficiency|0|||
146725675|NCT00428090|529166822|FG002|Overall Study|Excluded for heart insufficiency|1|||
146725676|NCT00428090|529166823|FG003|Overall Study|Excluded for heart insufficiency|0|||
146725677|NCT00428090|529166820|FG000|Overall Study|Raised Creatinine Value|0|||
146725678|NCT00428090|529166821|FG001|Overall Study|Raised Creatinine Value|0|||
146725679|NCT00428090|529166822|FG002|Overall Study|Raised Creatinine Value|0|||
146725680|NCT00428090|529166823|FG003|Overall Study|Raised Creatinine Value|1|||
146725681|NCT00440531|529166826|FG000|Overall Study|Adverse Event|1|||
146725682|NCT00440531|529166827|FG001|Overall Study|Adverse Event|0|||
146725683|NCT00440531|529166828|FG002|Overall Study|Adverse Event|2|||
146725684|NCT00440531|529166826|FG000|Overall Study|Withdrawal by Subject|2|||
146725685|NCT00440531|529166827|FG001|Overall Study|Withdrawal by Subject|0|||
146725686|NCT00440531|529166828|FG002|Overall Study|Withdrawal by Subject|0|||
146725687|NCT00440531|529166826|FG000|Overall Study|Protocol Violation|1|||
146725688|NCT00440531|529166827|FG001|Overall Study|Protocol Violation|2|||
146725689|NCT00440531|529166828|FG002|Overall Study|Protocol Violation|0|||
146725690|NCT00440531|529166826|FG000|Overall Study|Lost to Follow-up|4|||
146725691|NCT00440531|529166827|FG001|Overall Study|Lost to Follow-up|3|||
146784618|NCT04927065|529382280|FG001|Third Booster|Lost to Follow-up|0|||
146725692|NCT00440531|529166828|FG002|Overall Study|Lost to Follow-up|5|||
146725693|NCT00440531|529166826|FG000|Overall Study|see pre-assignment details|2|||
146725694|NCT00440531|529166827|FG001|Overall Study|see pre-assignment details|0|||
146725695|NCT00440531|529166828|FG002|Overall Study|see pre-assignment details|0|||
146725696|NCT00677833|529166831|FG000|Overall Study|Withdrawal by Subject|4|||
146725697|NCT00677833|529166832|FG001|Overall Study|Withdrawal by Subject|0|||
146784619|NCT04927065|529382281|FG002|Third Booster|Lost to Follow-up|0|||
146725698|NCT00677833|529166833|FG002|Overall Study|Withdrawal by Subject|1|||
146725699|NCT00677833|529166834|FG003|Overall Study|Withdrawal by Subject|3|||
146725700|NCT00677833|529166831|FG000|Overall Study|Lost to Follow-up|0|||
146725701|NCT00677833|529166832|FG001|Overall Study|Lost to Follow-up|0|||
146725702|NCT00677833|529166833|FG002|Overall Study|Lost to Follow-up|1|||
146725703|NCT00677833|529166834|FG003|Overall Study|Lost to Follow-up|0|||
146725704|NCT02606279|529166835|FG000|Overall Study|Lost to Follow-up|0|||
146784620|NCT04927065|529382282|FG003|Third Booster|Lost to Follow-up|0|||
146784621|NCT04927065|529382283|FG004|Third Booster|Lost to Follow-up|0|||
146784622|NCT04927065|529382284|FG005|Third Booster|Lost to Follow-up|0|||
146784623|NCT04927065|529382285|FG006|Third Booster|Lost to Follow-up|0|||
146725705|NCT02606279|529166836|FG001|Overall Study|Lost to Follow-up|1|||
146725706|NCT02184611|529166837|FG000|Overall Study|Lack of Efficacy|11|||
146725707|NCT02184611|529166838|FG001|Overall Study|Lack of Efficacy|15|||
146725708|NCT02184611|529166837|FG000|Overall Study|Withdrawal by Subject|5|||
146725709|NCT02184611|529166838|FG001|Overall Study|Withdrawal by Subject|6|||
146725710|NCT02184611|529166837|FG000|Overall Study|Adverse Event|4|||
146725711|NCT02184611|529166838|FG001|Overall Study|Adverse Event|5|||
146725712|NCT02184611|529166837|FG000|Overall Study|Protocol Violation|1|||
146725713|NCT02184611|529166838|FG001|Overall Study|Protocol Violation|1|||
146725714|NCT02184611|529166837|FG000|Overall Study|Protocol defined stopping criteria|0|||
146725715|NCT02184611|529166838|FG001|Overall Study|Protocol defined stopping criteria|1|||
146725716|NCT00160680|529166839|FG000|Overall Study|Adverse Event|0|||
146725717|NCT00160680|529166840|FG001|Overall Study|Adverse Event|1|||
146725718|NCT00160680|529166839|FG000|Overall Study|Lack of Efficacy|2|||
146725719|NCT00160680|529166840|FG001|Overall Study|Lack of Efficacy|1|||
146725720|NCT00160680|529166839|FG000|Overall Study|Lost to Follow-up|3|||
146725721|NCT00160680|529166840|FG001|Overall Study|Lost to Follow-up|2|||
146725722|NCT00160680|529166839|FG000|Overall Study|Withdrawal by Subject|4|||
146725723|NCT00160680|529166840|FG001|Overall Study|Withdrawal by Subject|9|||
146725724|NCT04493216|529166841|FG000|Overall Study|Study terminated by sponsor|30|||
146725725|NCT04493216|529166842|FG001|Overall Study|Study terminated by sponsor|33|||
146725726|NCT04493216|529166843|FG002|Overall Study|Study terminated by sponsor|28|||
146725727|NCT04493216|529166844|FG003|Overall Study|Study terminated by sponsor|27|||
146725728|NCT04493216|529166841|FG000|Overall Study|Withdrawal by Subject|2|||
146725729|NCT04493216|529166842|FG001|Overall Study|Withdrawal by Subject|1|||
146725730|NCT04493216|529166843|FG002|Overall Study|Withdrawal by Subject|1|||
146725731|NCT04493216|529166844|FG003|Overall Study|Withdrawal by Subject|2|||
146725732|NCT04493216|529166841|FG000|Overall Study|Protocol Violation|1|||
146725733|NCT04493216|529166842|FG001|Overall Study|Protocol Violation|2|||
146725734|NCT04493216|529166843|FG002|Overall Study|Protocol Violation|0|||
146725735|NCT04493216|529166844|FG003|Overall Study|Protocol Violation|2|||
146725736|NCT04493216|529166841|FG000|Overall Study|Physician Decision|0|||
146725737|NCT04493216|529166842|FG001|Overall Study|Physician Decision|0|||
146725738|NCT04493216|529166843|FG002|Overall Study|Physician Decision|1|||
146725739|NCT04493216|529166844|FG003|Overall Study|Physician Decision|0|||
146725740|NCT04493216|529166841|FG000|Overall Study|Lost to Follow-up|2|||
146725741|NCT04493216|529166842|FG001|Overall Study|Lost to Follow-up|1|||
146725742|NCT04493216|529166843|FG002|Overall Study|Lost to Follow-up|0|||
146725743|NCT04493216|529166844|FG003|Overall Study|Lost to Follow-up|1|||
146725744|NCT04493216|529166841|FG000|Overall Study|Adverse Event|1|||
146725745|NCT04493216|529166842|FG001|Overall Study|Adverse Event|4|||
146725746|NCT04493216|529166843|FG002|Overall Study|Adverse Event|5|||
146784624|NCT04927065|529382286|FG007|Third Booster|Lost to Follow-up|0|||
146784625|NCT04927065|529382287|FG008|Third Booster|Lost to Follow-up|0|||
146784626|NCT04927065|529382288|FG009|Third Booster|Lost to Follow-up|0|||
146784627|NCT04927065|529382289|FG010|Third Booster|Lost to Follow-up|0|||
146784628|NCT04927065|529382290|FG011|Third Booster|Lost to Follow-up|0|||
146784629|NCT04927065|529382291|FG012|Third Booster|Lost to Follow-up|0|||
146725747|NCT04493216|529166844|FG003|Overall Study|Adverse Event|2|||
146725748|NCT04493216|529166841|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
146725749|NCT04493216|529166842|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
146725750|NCT04493216|529166843|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
146725751|NCT04493216|529166844|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
146784630|NCT04927065|529382292|FG013|Third Booster|Lost to Follow-up|0|||
146784631|NCT04927065|529382293|FG014|Third Booster|Lost to Follow-up|0|||
146725752|NCT03232983|529166845|FG000|Period 1|Physician Decision|0|||
146784632|NCT04927065|529382294|FG015|Third Booster|Lost to Follow-up|1|||
146725753|NCT03232983|529166846|FG001|Period 1|Physician Decision|0|||
146725754|NCT03232983|529166847|FG002|Period 1|Physician Decision|1|||
146725755|NCT03232983|529166848|FG003|Period 1|Physician Decision|0|||
146725756|NCT03232983|529166845|FG000|Washout Period 2|Physician Decision|0|||
146725757|NCT03232983|529166846|FG001|Washout Period 2|Physician Decision|0|||
146725758|NCT03232983|529166847|FG002|Washout Period 2|Physician Decision|1|||
146784633|NCT04927065|529382279|FG000|Third Booster|Withdrawal by Subject|0|||
146784634|NCT04927065|529382280|FG001|Third Booster|Withdrawal by Subject|0|||
146784635|NCT04927065|529382281|FG002|Third Booster|Withdrawal by Subject|0|||
146935269|NCT00476996|529920233|FG001|OLE Phase (From Week 48)|Death|0|||
146935270|NCT00476996|529920234|FG002|OLE Phase (From Week 48)|Death|0|||
146935271|NCT00476996|529920235|FG003|OLE Phase (From Week 48)|Death|7|||
146725759|NCT03232983|529166848|FG003|Washout Period 2|Physician Decision|0|||
146935272|NCT00476996|529920232|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
146935273|NCT00476996|529920233|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
146935274|NCT00476996|529920234|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
146935275|NCT00476996|529920235|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
146935276|NCT00476996|529920232|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
146935277|NCT00476996|529920233|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
146935278|NCT00476996|529920234|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
146935279|NCT00476996|529920235|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
146935280|NCT00476996|529920232|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
146935281|NCT00476996|529920233|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
146935282|NCT00476996|529920234|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
146935283|NCT00476996|529920235|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
146935284|NCT00476996|529920232|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
146935285|NCT00476996|529920233|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
146935286|NCT00476996|529920234|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
146935287|NCT00476996|529920235|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
146935288|NCT01769469|529920240|FG000|Overall Study|Consent Withdrawn|5|||
146935289|NCT01769469|529920240|FG000|Overall Study|Moved Out Of Area|3|||
146935290|NCT01769469|529920240|FG000|Overall Study|Lost to Follow-up|17|||
146935291|NCT01769469|529920240|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
146935292|NCT01769469|529920240|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
146935293|NCT02447458|529920243|FG000|Overall Study|Other|0|||
146935294|NCT02447458|529920244|FG001|Overall Study|Other|0|||
146935295|NCT02447458|529920245|FG002|Overall Study|Other|1|||
146935296|NCT02447458|529920246|FG003|Overall Study|Other|0|||
146935297|NCT02447458|529920247|FG004|Overall Study|Other|0|||
146935298|NCT02447458|529920248|FG005|Overall Study|Other|0|||
146935299|NCT01181778|529920253|FG000|Overall Study|Physician Decision|48|||
146935300|NCT02674685|529920254|FG000|Overall Study|Withdrawal by Subject|4|||
146935301|NCT03148756|529920256|FG000|Overall Study|Study Terminated|0|||
146935302|NCT03148756|529920257|FG001|Overall Study|Study Terminated|1|||
146935303|NCT00719862|529920264|FG000|Overall Study|Adverse Event|1|||
146935304|NCT00719862|529920265|FG001|Overall Study|Adverse Event|2|||
146935305|NCT00719862|529920264|FG000|Overall Study|Lack of Efficacy|3|||
146935306|NCT00719862|529920265|FG001|Overall Study|Lack of Efficacy|0|||
146725760|NCT03232983|529166845|FG000|Washout Period 2|Withdrawal by Subject|0|||
146725761|NCT03232983|529166846|FG001|Washout Period 2|Withdrawal by Subject|0|||
146725762|NCT03232983|529166847|FG002|Washout Period 2|Withdrawal by Subject|0|||
146725763|NCT03232983|529166848|FG003|Washout Period 2|Withdrawal by Subject|1|||
146725764|NCT03232983|529166845|FG000|Period 4|Withdrawal by Subject|1|||
146725765|NCT03232983|529166846|FG001|Period 4|Withdrawal by Subject|0|||
146725766|NCT03232983|529166847|FG002|Period 4|Withdrawal by Subject|0|||
146725767|NCT03232983|529166848|FG003|Period 4|Withdrawal by Subject|0|||
146725768|NCT01615328|529166849|FG000|Overall Study|Lost to Follow-up|3|||
146725769|NCT01615328|529166850|FG001|Overall Study|Lost to Follow-up|5|||
146725770|NCT00863655|529166851|FG000|Overall Study|Protocol Violation|4|||
146725771|NCT00863655|529166852|FG001|Overall Study|Protocol Violation|0|||
146725772|NCT00863655|529166851|FG000|Overall Study|Adverse Event|52|||
146725773|NCT00863655|529166852|FG001|Overall Study|Adverse Event|8|||
146725774|NCT00863655|529166851|FG000|Overall Study|Withdrawal by Subject|47|||
146725775|NCT00863655|529166852|FG001|Overall Study|Withdrawal by Subject|7|||
146725776|NCT00863655|529166851|FG000|Overall Study|Administrative problems|1|||
146725777|NCT00863655|529166852|FG001|Overall Study|Administrative problems|0|||
146725778|NCT00863655|529166851|FG000|Overall Study|Death|7|||
146935307|NCT00719862|529920264|FG000|Overall Study|Non-Compliance|1|||
146935308|NCT00719862|529920265|FG001|Overall Study|Non-Compliance|0|||
146935309|NCT00719862|529920264|FG000|Overall Study|Withdrawal by Subject|1|||
146935310|NCT00719862|529920265|FG001|Overall Study|Withdrawal by Subject|0|||
146935311|NCT00719862|529920264|FG000|Overall Study|Lost to Follow-up|0|||
146935312|NCT00719862|529920265|FG001|Overall Study|Lost to Follow-up|1|||
146935313|NCT00719862|529920264|FG000|Overall Study|Other|2|||
146935314|NCT00719862|529920265|FG001|Overall Study|Other|3|||
146935315|NCT01184846|529920266|FG000|Overall Study|Adverse Event|2|||
146935316|NCT01184846|529920266|FG000|Overall Study|Insufficient response|1|||
146935317|NCT01999946|529920267|FG000|Overall Study|Participant not released from jail|2|||
146935318|NCT01999946|529920268|FG001|Overall Study|Participant not released from jail|2|||
146935319|NCT01999946|529920269|FG002|Overall Study|Participant not released from jail|0|||
146935320|NCT01999946|529920267|FG000|Overall Study|Not included in primary outcome analysis|0|||
146935321|NCT01999946|529920268|FG001|Overall Study|Not included in primary outcome analysis|0|||
146725779|NCT00863655|529166852|FG001|Overall Study|Death|1|||
146725780|NCT00863655|529166851|FG000|Overall Study|New cancer therapy|5|||
146725781|NCT00863655|529166852|FG001|Overall Study|New cancer therapy|1|||
146725782|NCT00863655|529166851|FG000|Overall Study|Disease progression|364|||
146784636|NCT04927065|529382282|FG003|Third Booster|Withdrawal by Subject|0|||
146784637|NCT04927065|529382283|FG004|Third Booster|Withdrawal by Subject|0|||
146784638|NCT04927065|529382284|FG005|Third Booster|Withdrawal by Subject|0|||
146784639|NCT04927065|529382285|FG006|Third Booster|Withdrawal by Subject|0|||
146725783|NCT00863655|529166852|FG001|Overall Study|Disease progression|221|||
146725784|NCT00863655|529166851|FG000|Overall Study|Treatment completed as per protocol|5|||
146784640|NCT04927065|529382286|FG007|Third Booster|Withdrawal by Subject|0|||
146784641|NCT04927065|529382287|FG008|Third Booster|Withdrawal by Subject|0|||
146784642|NCT04927065|529382288|FG009|Third Booster|Withdrawal by Subject|0|||
146784643|NCT04927065|529382289|FG010|Third Booster|Withdrawal by Subject|0|||
146784644|NCT04927065|529382290|FG011|Third Booster|Withdrawal by Subject|0|||
146784645|NCT04927065|529382291|FG012|Third Booster|Withdrawal by Subject|0|||
146784646|NCT04927065|529382292|FG013|Third Booster|Withdrawal by Subject|0|||
146784647|NCT04927065|529382293|FG014|Third Booster|Withdrawal by Subject|0|||
146784648|NCT04927065|529382294|FG015|Third Booster|Withdrawal by Subject|1|||
146784649|NCT03406871|529382295|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
146784650|NCT03406871|529382296|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
146784651|NCT03406871|529382297|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
146784652|NCT03406871|529382295|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
146784653|NCT03406871|529382296|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
146784654|NCT03406871|529382297|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
146784655|NCT03406871|529382295|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
146784656|NCT03406871|529382296|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
146784657|NCT03406871|529382297|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
146784658|NCT03406871|529382295|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
146784659|NCT03406871|529382296|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
146784660|NCT03406871|529382297|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
146725785|NCT00863655|529166852|FG001|Overall Study|Treatment completed as per protocol|1|||
146725786|NCT02261493|529166853|FG000|Overall Study|Noncompliance|0|||
146725787|NCT02261493|529166854|FG001|Overall Study|Noncompliance|0|||
146725788|NCT02261493|529166855|FG002|Overall Study|Noncompliance|2|||
146725789|NCT02261493|529166853|FG000|Overall Study|Physician Decision|0|||
146725790|NCT02261493|529166854|FG001|Overall Study|Physician Decision|1|||
146725791|NCT02261493|529166855|FG002|Overall Study|Physician Decision|0|||
146725792|NCT02261493|529166853|FG000|Overall Study|Undisclosed alcohol abuse|0|||
146725793|NCT02261493|529166854|FG001|Overall Study|Undisclosed alcohol abuse|1|||
146725794|NCT02261493|529166855|FG002|Overall Study|Undisclosed alcohol abuse|0|||
146725795|NCT02261493|529166853|FG000|Overall Study|Protocol Violation|1|||
146725796|NCT02261493|529166854|FG001|Overall Study|Protocol Violation|0|||
146725797|NCT02261493|529166855|FG002|Overall Study|Protocol Violation|0|||
146725798|NCT02261493|529166853|FG000|Overall Study|Personal Reasons|14|||
146725799|NCT02261493|529166854|FG001|Overall Study|Personal Reasons|14|||
146725800|NCT02261493|529166855|FG002|Overall Study|Personal Reasons|16|||
146725801|NCT02261493|529166853|FG000|Overall Study|Lost to Follow-up|14|||
146725802|NCT02261493|529166854|FG001|Overall Study|Lost to Follow-up|27|||
146725803|NCT02261493|529166855|FG002|Overall Study|Lost to Follow-up|8|||
146725804|NCT02261493|529166853|FG000|Overall Study|Pregnancy|1|||
146725805|NCT02261493|529166854|FG001|Overall Study|Pregnancy|2|||
146725806|NCT02261493|529166855|FG002|Overall Study|Pregnancy|0|||
146725807|NCT02261493|529166853|FG000|Overall Study|Lack of Efficacy|0|||
146725808|NCT02261493|529166854|FG001|Overall Study|Lack of Efficacy|1|||
146725809|NCT02261493|529166855|FG002|Overall Study|Lack of Efficacy|0|||
146725810|NCT02261493|529166853|FG000|Overall Study|Adverse Event|0|||
146725811|NCT02261493|529166854|FG001|Overall Study|Adverse Event|1|||
146725812|NCT02261493|529166855|FG002|Overall Study|Adverse Event|0|||
146725813|NCT01597050|529166856|FG000|Overall Study|Withdrawal by Subject|1|||
146725814|NCT01597050|529166857|FG001|Overall Study|Withdrawal by Subject|0|||
146725815|NCT00483184|529166858|FG000|Overall Study|Withdrawal by Subject|2|||
146725816|NCT00483184|529166859|FG001|Overall Study|Withdrawal by Subject|2|||
146725817|NCT00483184|529166860|FG002|Overall Study|Withdrawal by Subject|0|||
146725818|NCT00483184|529166858|FG000|Overall Study|Lost to Follow-up|1|||
146725819|NCT00483184|529166859|FG001|Overall Study|Lost to Follow-up|0|||
146725820|NCT00483184|529166860|FG002|Overall Study|Lost to Follow-up|0|||
146725821|NCT00483184|529166858|FG000|Overall Study|Adverse Event|1|||
146725822|NCT00483184|529166859|FG001|Overall Study|Adverse Event|2|||
146784661|NCT03406871|529382295|FG000|Expansion Cohort(Final Analysis)|Death|0|||
146784662|NCT03406871|529382296|FG001|Expansion Cohort(Final Analysis)|Death|1|||
146784663|NCT03406871|529382297|FG002|Expansion Cohort(Final Analysis)|Death|0|||
146784664|NCT03406871|529382295|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
146725823|NCT00483184|529166860|FG002|Overall Study|Adverse Event|2|||
146725824|NCT00483184|529166858|FG000|Overall Study|Protocol Violation|1|||
146725825|NCT00483184|529166859|FG001|Overall Study|Protocol Violation|0|||
146725826|NCT00483184|529166860|FG002|Overall Study|Protocol Violation|1|||
146725827|NCT02065336|529166861|FG000|Extension Phase|Study Terminated by Sponsor|0|||
146725828|NCT02065336|529166862|FG001|Extension Phase|Study Terminated by Sponsor|0|||
146725829|NCT02065336|529166863|FG002|Extension Phase|Study Terminated by Sponsor|0|||
146725830|NCT02065336|529166864|FG003|Extension Phase|Study Terminated by Sponsor|0|||
146725831|NCT02065336|529166865|FG004|Extension Phase|Study Terminated by Sponsor|0|||
146725832|NCT02065336|529166866|FG005|Extension Phase|Study Terminated by Sponsor|0|||
146725833|NCT02065336|529166867|FG006|Extension Phase|Study Terminated by Sponsor|0|||
146725834|NCT02065336|529166868|FG007|Extension Phase|Study Terminated by Sponsor|0|||
146725835|NCT02065336|529166869|FG008|Extension Phase|Study Terminated by Sponsor|2|||
146725836|NCT02065336|529166870|FG009|Extension Phase|Study Terminated by Sponsor|8|||
146725837|NCT00530855|529166871|FG000|Overall Study|Lack of Efficacy|20|||
146725838|NCT00530855|529166871|FG000|Overall Study|Withdrawal by Subject|30|||
146725839|NCT00530855|529166871|FG000|Overall Study|Fatal Serious AE|3|||
146725840|NCT00530855|529166871|FG000|Overall Study|Non Fatal Serious AE|7|||
146725841|NCT00530855|529166871|FG000|Overall Study|Non Fatal Non Serious AE|12|||
146725842|NCT00530855|529166871|FG000|Overall Study|Protocol Violation|3|||
146725843|NCT00530855|529166871|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
146725844|NCT00530855|529166871|FG000|Overall Study|Lost to Follow-up|9|||
146725845|NCT00530855|529166871|FG000|Overall Study|Other reason for premature termination|17|||
146725846|NCT01627327|529166872|FG000|Overall Study|Adverse Event|6|||
146725847|NCT01627327|529166873|FG001|Overall Study|Adverse Event|12|||
146725848|NCT01627327|529166872|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
146725849|NCT01627327|529166873|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
146725850|NCT01627327|529166872|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
146725851|NCT01627327|529166873|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
146725852|NCT01627327|529166872|FG000|Overall Study|Protocol Violation|4|||
146725853|NCT01627327|529166873|FG001|Overall Study|Protocol Violation|10|||
146725854|NCT01627327|529166872|FG000|Overall Study|Lost to Follow-up|1|||
146725855|NCT01627327|529166873|FG001|Overall Study|Lost to Follow-up|3|||
146725856|NCT01627327|529166872|FG000|Overall Study|Physician Decision|1|||
146725857|NCT01627327|529166873|FG001|Overall Study|Physician Decision|0|||
146725858|NCT01627327|529166872|FG000|Overall Study|Withdrawal by Subject|3|||
146725859|NCT01627327|529166873|FG001|Overall Study|Withdrawal by Subject|3|||
146725860|NCT00868439|529166881|FG000|Overall Study|Adverse Event|4|||
146725861|NCT00868439|529166882|FG001|Overall Study|Adverse Event|3|||
146725862|NCT00868439|529166881|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
146725863|NCT00868439|529166882|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
146725864|NCT00868439|529166881|FG000|Overall Study|Death|0|||
146725865|NCT00868439|529166882|FG001|Overall Study|Death|1|||
146725866|NCT00868439|529166881|FG000|Overall Study|Protocol Violation|1|||
146725867|NCT00868439|529166882|FG001|Overall Study|Protocol Violation|1|||
146725868|NCT00868439|529166881|FG000|Overall Study|Physician Decision|1|||
146725869|NCT00868439|529166882|FG001|Overall Study|Physician Decision|0|||
146725870|NCT00868439|529166881|FG000|Overall Study|Withdrawal by Subject|0|||
146725871|NCT00868439|529166882|FG001|Overall Study|Withdrawal by Subject|1|||
146725872|NCT00423176|529166883|FG000|Overall Study|Adverse Event|4|||
146725873|NCT00423176|529166884|FG001|Overall Study|Adverse Event|6|||
146725874|NCT00423176|529166883|FG000|Overall Study|Treatment Failure|1|||
146725875|NCT00423176|529166884|FG001|Overall Study|Treatment Failure|6|||
146725876|NCT00423176|529166883|FG000|Overall Study|Lost to Follow-up|4|||
146725877|NCT00423176|529166884|FG001|Overall Study|Lost to Follow-up|7|||
146725878|NCT00423176|529166883|FG000|Overall Study|Withdrawal by Subject|4|||
146725879|NCT00423176|529166884|FG001|Overall Study|Withdrawal by Subject|3|||
146725880|NCT00423176|529166883|FG000|Overall Study|Protocol Violation|1|||
146725881|NCT00423176|529166884|FG001|Overall Study|Protocol Violation|3|||
146725882|NCT00423176|529166883|FG000|Overall Study|Did not meet protocol eligibility|2|||
146725883|NCT00423176|529166884|FG001|Overall Study|Did not meet protocol eligibility|4|||
146725884|NCT00224874|529166887|FG000|Overall Study|Withdrawal by Subject|0|||
146725885|NCT00224874|529166888|FG001|Overall Study|Withdrawal by Subject|0|||
146725886|NCT00224874|529166889|FG002|Overall Study|Withdrawal by Subject|1|||
146725887|NCT00224874|529166890|FG003|Overall Study|Withdrawal by Subject|0|||
146725888|NCT00911534|529166891|FG000|Overall Study|Adverse Event|4|||
146725889|NCT00911534|529166892|FG001|Overall Study|Adverse Event|4|||
146725890|NCT00911534|529166891|FG000|Overall Study|Lost to Follow-up|2|||
146725891|NCT00911534|529166892|FG001|Overall Study|Lost to Follow-up|4|||
146725892|NCT00911534|529166891|FG000|Overall Study|Withdrawal by Subject|2|||
146725893|NCT00911534|529166892|FG001|Overall Study|Withdrawal by Subject|1|||
146935322|NCT01999946|529920269|FG002|Overall Study|Not included in primary outcome analysis|79|||
146725894|NCT00911534|529166891|FG000|Overall Study|Lack of Efficacy|4|||
146725895|NCT00911534|529166892|FG001|Overall Study|Lack of Efficacy|1|||
146725896|NCT00911534|529166891|FG000|Overall Study|Withdrawal of consent|1|||
146725897|NCT00911534|529166892|FG001|Overall Study|Withdrawal of consent|4|||
146725898|NCT00911534|529166891|FG000|Overall Study|Other|2|||
146725899|NCT00911534|529166892|FG001|Overall Study|Other|2|||
146725900|NCT05072080|529166893|FG000|Overall Study|Death|0|||
146725901|NCT05072080|529166894|FG001|Overall Study|Death|0|||
146725902|NCT05072080|529166895|FG002|Overall Study|Death|1|||
146935323|NCT01770145|529922430|FG000|Baseline|Adverse Event|20|||
146725903|NCT05072080|529166896|FG003|Overall Study|Death|0|||
146725904|NCT05072080|529166893|FG000|Overall Study|Lost to Follow-up|65|||
146725905|NCT05072080|529166894|FG001|Overall Study|Lost to Follow-up|70|||
146725906|NCT05072080|529166895|FG002|Overall Study|Lost to Follow-up|58|||
146725907|NCT05072080|529166896|FG003|Overall Study|Lost to Follow-up|23|||
146725908|NCT05072080|529166893|FG000|Overall Study|Physician Decision|2|||
146725909|NCT05072080|529166894|FG001|Overall Study|Physician Decision|1|||
146725910|NCT05072080|529166895|FG002|Overall Study|Physician Decision|1|||
146725911|NCT05072080|529166896|FG003|Overall Study|Physician Decision|0|||
146725912|NCT05072080|529166893|FG000|Overall Study|Withdrawal by Subject|45|||
146725913|NCT05072080|529166894|FG001|Overall Study|Withdrawal by Subject|30|||
146725914|NCT05072080|529166895|FG002|Overall Study|Withdrawal by Subject|27|||
146725915|NCT05072080|529166896|FG003|Overall Study|Withdrawal by Subject|7|||
146725916|NCT05072080|529166893|FG000|Overall Study|Sponsor Decision|0|||
146725917|NCT05072080|529166894|FG001|Overall Study|Sponsor Decision|1|||
146725918|NCT05072080|529166895|FG002|Overall Study|Sponsor Decision|0|||
146725919|NCT05072080|529166896|FG003|Overall Study|Sponsor Decision|0|||
146725920|NCT05072080|529166893|FG000|Overall Study|Subject moved|1|||
146725921|NCT05072080|529166894|FG001|Overall Study|Subject moved|3|||
146725922|NCT05072080|529166895|FG002|Overall Study|Subject moved|5|||
146725923|NCT05072080|529166896|FG003|Overall Study|Subject moved|2|||
146725924|NCT05072080|529166893|FG000|Overall Study|Withdrawal by parent|0|||
146725925|NCT05072080|529166894|FG001|Overall Study|Withdrawal by parent|0|||
146725926|NCT05072080|529166895|FG002|Overall Study|Withdrawal by parent|1|||
146725927|NCT05072080|529166896|FG003|Overall Study|Withdrawal by parent|0|||
146725928|NCT05072080|529166893|FG000|Overall Study|Subject was deployed|0|||
146725929|NCT05072080|529166894|FG001|Overall Study|Subject was deployed|1|||
146725930|NCT05072080|529166895|FG002|Overall Study|Subject was deployed|0|||
146725931|NCT05072080|529166896|FG003|Overall Study|Subject was deployed|0|||
146725932|NCT05072080|529166893|FG000|Overall Study|Subject left site without receiving dose|0|||
146725933|NCT05072080|529166894|FG001|Overall Study|Subject left site without receiving dose|1|||
146725934|NCT05072080|529166895|FG002|Overall Study|Subject left site without receiving dose|0|||
146725935|NCT05072080|529166896|FG003|Overall Study|Subject left site without receiving dose|0|||
146725936|NCT05072080|529166893|FG000|Overall Study|Subject incarcerated|0|||
146725937|NCT05072080|529166894|FG001|Overall Study|Subject incarcerated|1|||
146725938|NCT05072080|529166895|FG002|Overall Study|Subject incarcerated|0|||
146725939|NCT05072080|529166896|FG003|Overall Study|Subject incarcerated|1|||
146725940|NCT05072080|529166893|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
146725941|NCT05072080|529166894|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
146725942|NCT05072080|529166895|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
146725943|NCT05072080|529166896|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
146725944|NCT05072080|529166893|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
146725945|NCT05072080|529166894|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
146725946|NCT05072080|529166895|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
146725947|NCT05072080|529166896|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
146725948|NCT04867369|529166897|FG000|Overall Study|Withdrawal by Subject|1|||
146725949|NCT04867369|529166898|FG001|Overall Study|Withdrawal by Subject|0|||
146725950|NCT05554237|529166899|FG000|Part 2 (7 Days)|Adverse Event|0|||
146725951|NCT05554237|529166900|FG001|Part 2 (7 Days)|Adverse Event|0|||
146725952|NCT05554237|529166901|FG002|Part 2 (7 Days)|Adverse Event|0|||
146725953|NCT05554237|529166902|FG003|Part 2 (7 Days)|Adverse Event|0|||
146725954|NCT05554237|529166903|FG004|Part 2 (7 Days)|Adverse Event|2|||
146725955|NCT05554237|529166904|FG005|Part 2 (7 Days)|Adverse Event|0|||
146725956|NCT05554237|529166905|FG006|Part 2 (7 Days)|Adverse Event|0|||
146725957|NCT05554237|529166906|FG007|Part 2 (7 Days)|Adverse Event|0|||
146725958|NCT05554237|529166907|FG008|Part 2 (7 Days)|Adverse Event|0|||
146725959|NCT05554237|529166908|FG009|Part 2 (7 Days)|Adverse Event|1|||
146725960|NCT05554237|529166909|FG010|Part 2 (7 Days)|Adverse Event|0|||
146725961|NCT05554237|529166910|FG011|Part 2 (7 Days)|Adverse Event|0|||
146725962|NCT05554237|529166911|FG012|Part 2 (7 Days)|Adverse Event|1|||
146725963|NCT05554237|529166912|FG013|Part 2 (7 Days)|Adverse Event|0|||
146725964|NCT04575467|529166916|FG000|Overall Study|Adverse Event|0|||
146725965|NCT04575467|529166917|FG001|Overall Study|Adverse Event|1|||
146725966|NCT04575467|529166918|FG002|Overall Study|Adverse Event|0|||
146725967|NCT04575467|529166919|FG003|Overall Study|Adverse Event|0|||
146784665|NCT03406871|529382296|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
146725968|NCT01328574|529166920|FG000|Overall Study|Refused further treatment|1|||
146725969|NCT01152580|529166923|FG000|Overall Study|Withdrawal by Subject|0|||
146725970|NCT01152580|529166924|FG001|Overall Study|Withdrawal by Subject|1|||
146725971|NCT00113568|529166932|FG000|Overall Study|Adverse Event|97|||
146725972|NCT00113568|529166932|FG000|Overall Study|Death|1|||
146725973|NCT00113568|529166932|FG000|Overall Study|Lack of Efficacy|30|||
146725974|NCT00113568|529166932|FG000|Overall Study|Lost to Follow-up|156|||
146725975|NCT00113568|529166932|FG000|Overall Study|Protocol Violation|32|||
146725976|NCT00113568|529166932|FG000|Overall Study|Withdrawal by Subject|117|||
146725977|NCT00113568|529166932|FG000|Overall Study|Other|112|||
146725978|NCT00736645|529166934|FG000|Overall Study|Adverse Event|0|||
146935324|NCT01770145|529922430|FG000|Baseline|Withdrawal by Subject|1|||
146935325|NCT01770145|529922430|FG000|Baseline|Lost to Follow-up|1|||
146935326|NCT01770145|529922430|FG000|Baseline|Unable to define optimal dose|4|||
146935327|NCT01770145|529922430|FG000|Treatment|Adverse Event|3|||
146725979|NCT00736645|529166935|FG001|Overall Study|Adverse Event|2|||
146725980|NCT00736645|529166936|FG002|Overall Study|Adverse Event|0|||
146725981|NCT00736645|529166937|FG003|Overall Study|Adverse Event|0|||
146725982|NCT00734630|529166938|FG000|Overall Study|Lack of Efficacy|4|||
146725983|NCT00734630|529166939|FG001|Overall Study|Lack of Efficacy|4|||
146725984|NCT00734630|529166938|FG000|Overall Study|Withdrawal by Subject|7|||
146725985|NCT00734630|529166939|FG001|Overall Study|Withdrawal by Subject|9|||
146725986|NCT00734630|529166938|FG000|Overall Study|Lost to Follow-up|13|||
146725987|NCT00734630|529166939|FG001|Overall Study|Lost to Follow-up|7|||
146725988|NCT00734630|529166938|FG000|Overall Study|Protocol Violation|0|||
146725989|NCT00734630|529166939|FG001|Overall Study|Protocol Violation|3|||
146725990|NCT00734630|529166938|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
146725991|NCT00734630|529166939|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
146725992|NCT00734630|529166938|FG000|Overall Study|Adverse Event|3|||
146725993|NCT00734630|529166939|FG001|Overall Study|Adverse Event|6|||
146725994|NCT00734630|529166938|FG000|Overall Study|Randomized in Error|0|||
146725995|NCT00734630|529166939|FG001|Overall Study|Randomized in Error|1|||
146725996|NCT00734630|529166938|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
146725997|NCT00734630|529166939|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
146725998|NCT00734630|529166938|FG000|Overall Study|Poor Compliance|1|||
146725999|NCT00734630|529166939|FG001|Overall Study|Poor Compliance|1|||
146726000|NCT00977665|529166940|FG000|Overall Study|Withdrawal by Subject|1|||
146726001|NCT00977665|529166941|FG001|Overall Study|Withdrawal by Subject|3|||
146726002|NCT00977665|529166940|FG000|Overall Study|Physician Decision|2|||
146726003|NCT00977665|529166941|FG001|Overall Study|Physician Decision|1|||
146726004|NCT00977665|529166940|FG000|Overall Study|Sponsor requested withdrawal|0|||
146726005|NCT00977665|529166941|FG001|Overall Study|Sponsor requested withdrawal|1|||
146726006|NCT00977665|529166940|FG000|Overall Study|Lost to Follow-up|1|||
146726007|NCT00977665|529166941|FG001|Overall Study|Lost to Follow-up|0|||
146726008|NCT00977665|529166940|FG000|Overall Study|Death|3|||
146726009|NCT00977665|529166941|FG001|Overall Study|Death|2|||
146726010|NCT00977665|529166940|FG000|Overall Study|Adverse Event|14|||
146726011|NCT00977665|529166941|FG001|Overall Study|Adverse Event|7|||
146726012|NCT00977665|529166940|FG000|Overall Study|Treatment failure|0|||
146726013|NCT00977665|529166941|FG001|Overall Study|Treatment failure|1|||
146726014|NCT01330433|529166942|FG000|Overall Study|Death|1|||
146726015|NCT01330433|529166943|FG001|Overall Study|Death|3|||
146726016|NCT01330433|529166942|FG000|Overall Study|Lost to Follow-up|1|||
146726017|NCT01330433|529166943|FG001|Overall Study|Lost to Follow-up|0|||
146726018|NCT04322682|529166950|FG000|Overall Study|Withdrawal by Subject|33|||
146726019|NCT04322682|529166951|FG001|Overall Study|Withdrawal by Subject|47|||
146726020|NCT04322682|529166950|FG000|Overall Study|Death|5|||
146726021|NCT04322682|529166951|FG001|Overall Study|Death|9|||
146726022|NCT04322682|529166950|FG000|Overall Study|Lost to Follow-up|4|||
146726023|NCT04322682|529166951|FG001|Overall Study|Lost to Follow-up|8|||
146726024|NCT04322682|529166950|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
146726025|NCT04322682|529166951|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
146935328|NCT01770145|529922430|FG000|Treatment|Withdrawal by Subject|1|||
146935329|NCT04268303|529922431|FG000|Overall Study|Lost to Follow-up|1|||
146935330|NCT04268303|529922432|FG001|Overall Study|Lost to Follow-up|1|||
146935331|NCT04268303|529922433|FG002|Overall Study|Lost to Follow-up|2|||
146935332|NCT04268303|529922431|FG000|Overall Study|Withdrawal by Subject|0|||
146935333|NCT04268303|529922432|FG001|Overall Study|Withdrawal by Subject|1|||
146935334|NCT04268303|529922433|FG002|Overall Study|Withdrawal by Subject|1|||
146935335|NCT04268303|529922431|FG000|Overall Study|Adverse Event|2|||
146935336|NCT04268303|529922432|FG001|Overall Study|Adverse Event|0|||
146935337|NCT04268303|529922433|FG002|Overall Study|Adverse Event|0|||
146935338|NCT00355134|529922434|FG000|Core Phase|Withdrawal by Subject|35|||
146935339|NCT00355134|529922435|FG001|Core Phase|Withdrawal by Subject|24|||
146935340|NCT00355134|529922436|FG002|Core Phase|Withdrawal by Subject|35|||
146935341|NCT00355134|529922437|FG003|Core Phase|Withdrawal by Subject|0|||
146935342|NCT00355134|529922438|FG004|Core Phase|Withdrawal by Subject|0|||
146935343|NCT00355134|529922434|FG000|Core Phase|Adverse Event|28|||
146726026|NCT04123067|529166952|FG000|Overall Study|Lost to Follow-up|0|||
146726027|NCT04123067|529166953|FG001|Overall Study|Lost to Follow-up|1|||
146726028|NCT02238379|529166954|FG000|Overall Study|Lost to Follow-up|1|||
146726029|NCT02238379|529166955|FG001|Overall Study|Lost to Follow-up|0|||
146726030|NCT01441102|529166956|FG000|Overall Study|Adverse Event|1|||
146726031|NCT01441102|529166956|FG000|Overall Study|Withdrawal by Subject|2|||
146726032|NCT00605280|529166957|FG000|Year 1|Protocol Violation|0|||
146726033|NCT00605280|529166958|FG001|Year 1|Protocol Violation|0|||
146726034|NCT00605280|529166959|FG002|Year 1|Protocol Violation|0|||
146726035|NCT00605280|529166960|FG003|Year 1|Protocol Violation|1|||
146935344|NCT00355134|529922435|FG001|Core Phase|Adverse Event|22|||
146935345|NCT00355134|529922436|FG002|Core Phase|Adverse Event|16|||
146935346|NCT00355134|529922437|FG003|Core Phase|Adverse Event|0|||
146935347|NCT00355134|529922438|FG004|Core Phase|Adverse Event|0|||
146935348|NCT00355134|529922434|FG000|Core Phase|Lost to Follow-up|17|||
146935349|NCT00355134|529922435|FG001|Core Phase|Lost to Follow-up|13|||
146935350|NCT00355134|529922436|FG002|Core Phase|Lost to Follow-up|21|||
146935351|NCT00355134|529922437|FG003|Core Phase|Lost to Follow-up|0|||
146935352|NCT00355134|529922438|FG004|Core Phase|Lost to Follow-up|0|||
146935353|NCT00355134|529922434|FG000|Core Phase|Abnormal laboratory value(s)|19|||
146935354|NCT00355134|529922435|FG001|Core Phase|Abnormal laboratory value(s)|14|||
146981577|NCT01312779|530096086|FG000|Overall Study|Withdrawal by Subject|2|||
146726036|NCT00605280|529166957|FG000|Year 1|Adverse Event|3|||
146726037|NCT00605280|529166958|FG001|Year 1|Adverse Event|1|||
146726038|NCT00605280|529166959|FG002|Year 1|Adverse Event|1|||
146726039|NCT00605280|529166960|FG003|Year 1|Adverse Event|5|||
146726040|NCT00605280|529166957|FG000|Year 1|Physician Decision|7|||
146726041|NCT00605280|529166958|FG001|Year 1|Physician Decision|4|||
146726042|NCT00605280|529166959|FG002|Year 1|Physician Decision|0|||
146726043|NCT00605280|529166960|FG003|Year 1|Physician Decision|6|||
146726044|NCT00605280|529166957|FG000|Year 1|Withdrawal by Subject|2|||
146726045|NCT00605280|529166958|FG001|Year 1|Withdrawal by Subject|4|||
146726046|NCT00605280|529166959|FG002|Year 1|Withdrawal by Subject|0|||
146726047|NCT00605280|529166960|FG003|Year 1|Withdrawal by Subject|4|||
146726048|NCT00605280|529166957|FG000|Year 1|Other|2|||
146726049|NCT00605280|529166958|FG001|Year 1|Other|1|||
146726050|NCT00605280|529166959|FG002|Year 1|Other|0|||
146726051|NCT00605280|529166960|FG003|Year 1|Other|1|||
146726052|NCT00605280|529166957|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
146726053|NCT00605280|529166958|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
146726054|NCT00605280|529166959|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
146726055|NCT00605280|529166960|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
146726056|NCT00605280|529166957|FG000|Year 2|Adverse Event|4|||
146726057|NCT00605280|529166958|FG001|Year 2|Adverse Event|0|||
146726058|NCT00605280|529166959|FG002|Year 2|Adverse Event|2|||
146726059|NCT00605280|529166960|FG003|Year 2|Adverse Event|4|||
146726060|NCT00605280|529166957|FG000|Year 2|Physician Decision|11|||
146726061|NCT00605280|529166958|FG001|Year 2|Physician Decision|6|||
146726062|NCT00605280|529166959|FG002|Year 2|Physician Decision|4|||
146726063|NCT00605280|529166960|FG003|Year 2|Physician Decision|11|||
146726064|NCT00605280|529166957|FG000|Year 2|Withdrawal by Subject|4|||
146726065|NCT00605280|529166958|FG001|Year 2|Withdrawal by Subject|0|||
146726066|NCT00605280|529166959|FG002|Year 2|Withdrawal by Subject|0|||
146726067|NCT00605280|529166960|FG003|Year 2|Withdrawal by Subject|4|||
146726068|NCT00605280|529166957|FG000|Year 2|Other|1|||
146726069|NCT00605280|529166958|FG001|Year 2|Other|0|||
146726070|NCT00605280|529166959|FG002|Year 2|Other|0|||
146726071|NCT00605280|529166960|FG003|Year 2|Other|1|||
146726072|NCT00605280|529166957|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
146726073|NCT00605280|529166958|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
146726074|NCT00605280|529166959|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
146726075|NCT00605280|529166960|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
146726076|NCT00605280|529166957|FG000|Year 3 Extension|Adverse Event|2|||
146726077|NCT00605280|529166958|FG001|Year 3 Extension|Adverse Event|0|||
146726078|NCT00605280|529166959|FG002|Year 3 Extension|Adverse Event|0|||
146726079|NCT00605280|529166960|FG003|Year 3 Extension|Adverse Event|2|||
146726080|NCT00605280|529166957|FG000|Year 3 Extension|Physician Decision|0|||
146726081|NCT00605280|529166958|FG001|Year 3 Extension|Physician Decision|0|||
146726082|NCT00605280|529166959|FG002|Year 3 Extension|Physician Decision|0|||
146726083|NCT00605280|529166960|FG003|Year 3 Extension|Physician Decision|2|||
146726084|NCT00605280|529166957|FG000|Year 3 Extension|Withdrawal by Subject|2|||
146726085|NCT00605280|529166958|FG001|Year 3 Extension|Withdrawal by Subject|0|||
146726086|NCT00605280|529166959|FG002|Year 3 Extension|Withdrawal by Subject|0|||
146726087|NCT00605280|529166960|FG003|Year 3 Extension|Withdrawal by Subject|5|||
146726088|NCT00605280|529166957|FG000|Year 3 Extension|Other|2|||
146726089|NCT00605280|529166958|FG001|Year 3 Extension|Other|0|||
146726090|NCT00605280|529166959|FG002|Year 3 Extension|Other|0|||
146726091|NCT00605280|529166960|FG003|Year 3 Extension|Other|0|||
146981578|NCT01312779|530096086|FG000|Overall Study|Death|3|||
146981579|NCT01312779|530096086|FG000|Overall Study|Not Implanted with Device|27|||
146726092|NCT00605280|529166957|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
146726093|NCT00605280|529166958|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
146726094|NCT00605280|529166959|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
146726095|NCT00605280|529166960|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
146726096|NCT00518115|529166961|FG000|Overall Study|Adverse Event|6|||
146726097|NCT00518115|529166962|FG001|Overall Study|Adverse Event|1|||
146726098|NCT00518115|529166963|FG002|Overall Study|Adverse Event|5|||
146726099|NCT00518115|529166964|FG003|Overall Study|Adverse Event|6|||
146726100|NCT00518115|529166965|FG004|Overall Study|Adverse Event|5|||
146726101|NCT00518115|529166966|FG005|Overall Study|Adverse Event|5|||
146726102|NCT00518115|529166967|FG006|Overall Study|Adverse Event|5|||
146726103|NCT00518115|529166968|FG007|Overall Study|Adverse Event|10|||
146935355|NCT00355134|529922436|FG002|Core Phase|Abnormal laboratory value(s)|2|||
146935356|NCT00355134|529922437|FG003|Core Phase|Abnormal laboratory value(s)|0|||
146784666|NCT03406871|529382297|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
146726104|NCT00518115|529166969|FG008|Overall Study|Adverse Event|2|||
146726105|NCT00518115|529166970|FG009|Overall Study|Adverse Event|9|||
146726106|NCT00518115|529166961|FG000|Overall Study|Lost to Follow-up|0|||
146726107|NCT00518115|529166962|FG001|Overall Study|Lost to Follow-up|0|||
146726108|NCT00518115|529166963|FG002|Overall Study|Lost to Follow-up|2|||
146726109|NCT00518115|529166964|FG003|Overall Study|Lost to Follow-up|3|||
146726110|NCT00518115|529166965|FG004|Overall Study|Lost to Follow-up|1|||
146726111|NCT00518115|529166966|FG005|Overall Study|Lost to Follow-up|3|||
146726112|NCT00518115|529166967|FG006|Overall Study|Lost to Follow-up|0|||
146726113|NCT00518115|529166968|FG007|Overall Study|Lost to Follow-up|1|||
146726114|NCT00518115|529166969|FG008|Overall Study|Lost to Follow-up|1|||
146726115|NCT00518115|529166970|FG009|Overall Study|Lost to Follow-up|1|||
146726116|NCT00518115|529166961|FG000|Overall Study|Protocol Violation|1|||
146726117|NCT00518115|529166962|FG001|Overall Study|Protocol Violation|3|||
146726118|NCT00518115|529166963|FG002|Overall Study|Protocol Violation|1|||
146726119|NCT00518115|529166964|FG003|Overall Study|Protocol Violation|0|||
146726120|NCT00518115|529166965|FG004|Overall Study|Protocol Violation|0|||
146726121|NCT00518115|529166966|FG005|Overall Study|Protocol Violation|0|||
146726122|NCT00518115|529166967|FG006|Overall Study|Protocol Violation|0|||
146726123|NCT00518115|529166968|FG007|Overall Study|Protocol Violation|0|||
146726124|NCT00518115|529166969|FG008|Overall Study|Protocol Violation|0|||
146726125|NCT00518115|529166970|FG009|Overall Study|Protocol Violation|0|||
146726126|NCT00518115|529166961|FG000|Overall Study|Withdrawal by Subject|1|||
146726127|NCT00518115|529166962|FG001|Overall Study|Withdrawal by Subject|1|||
146726128|NCT00518115|529166963|FG002|Overall Study|Withdrawal by Subject|5|||
146726129|NCT00518115|529166964|FG003|Overall Study|Withdrawal by Subject|0|||
146726130|NCT00518115|529166965|FG004|Overall Study|Withdrawal by Subject|2|||
146726131|NCT00518115|529166966|FG005|Overall Study|Withdrawal by Subject|1|||
146726132|NCT00518115|529166967|FG006|Overall Study|Withdrawal by Subject|0|||
146726133|NCT00518115|529166968|FG007|Overall Study|Withdrawal by Subject|2|||
146726134|NCT00518115|529166969|FG008|Overall Study|Withdrawal by Subject|1|||
146726135|NCT00518115|529166970|FG009|Overall Study|Withdrawal by Subject|3|||
146726136|NCT00518115|529166961|FG000|Overall Study|Lack of Efficacy|1|||
146726137|NCT00518115|529166962|FG001|Overall Study|Lack of Efficacy|0|||
146726138|NCT00518115|529166963|FG002|Overall Study|Lack of Efficacy|1|||
146726139|NCT00518115|529166964|FG003|Overall Study|Lack of Efficacy|1|||
146726140|NCT00518115|529166965|FG004|Overall Study|Lack of Efficacy|0|||
146726141|NCT00518115|529166966|FG005|Overall Study|Lack of Efficacy|0|||
146726142|NCT00518115|529166967|FG006|Overall Study|Lack of Efficacy|0|||
146726143|NCT00518115|529166968|FG007|Overall Study|Lack of Efficacy|1|||
146726144|NCT00518115|529166969|FG008|Overall Study|Lack of Efficacy|0|||
146726145|NCT00518115|529166970|FG009|Overall Study|Lack of Efficacy|0|||
146726146|NCT00518115|529166961|FG000|Overall Study|Non-Compliance|1|||
146726147|NCT00518115|529166962|FG001|Overall Study|Non-Compliance|0|||
146726148|NCT00518115|529166963|FG002|Overall Study|Non-Compliance|1|||
146726149|NCT00518115|529166964|FG003|Overall Study|Non-Compliance|0|||
146726150|NCT00518115|529166965|FG004|Overall Study|Non-Compliance|1|||
146726151|NCT00518115|529166966|FG005|Overall Study|Non-Compliance|1|||
146726152|NCT00518115|529166967|FG006|Overall Study|Non-Compliance|1|||
146726153|NCT00518115|529166968|FG007|Overall Study|Non-Compliance|1|||
146726154|NCT00518115|529166969|FG008|Overall Study|Non-Compliance|0|||
146726155|NCT00518115|529166970|FG009|Overall Study|Non-Compliance|1|||
146726156|NCT00518115|529166961|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
146726157|NCT00518115|529166962|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
146726158|NCT00518115|529166963|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
146726159|NCT00518115|529166964|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
146726160|NCT00518115|529166965|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
146726161|NCT00518115|529166966|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
146726162|NCT00518115|529166967|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
146935357|NCT00355134|529922438|FG004|Core Phase|Abnormal laboratory value(s)|0|||
146935358|NCT00355134|529922434|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
146935359|NCT00355134|529922435|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
146726163|NCT00518115|529166968|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
146726164|NCT00518115|529166969|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
146726165|NCT00518115|529166970|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
146726166|NCT00518115|529166961|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
146726167|NCT00518115|529166962|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146726168|NCT00518115|529166963|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146726169|NCT00518115|529166964|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146726170|NCT00518115|529166965|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146726171|NCT00518115|529166966|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146935360|NCT00355134|529922436|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
146935361|NCT00355134|529922437|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
146935362|NCT00355134|529922438|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
146726172|NCT00518115|529166967|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146726173|NCT00518115|529166968|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146726174|NCT00518115|529166969|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146726175|NCT00518115|529166970|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146726176|NCT00518115|529166961|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
146726177|NCT00518115|529166962|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
146726178|NCT00518115|529166963|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
146726179|NCT00518115|529166964|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
146726180|NCT00518115|529166965|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
146726181|NCT00518115|529166966|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
146726182|NCT00518115|529166967|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
146726183|NCT00518115|529166968|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
146726184|NCT00518115|529166969|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
146726185|NCT00518115|529166970|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
146726186|NCT00518115|529166961|FG000|Overall Study|Wrong Monotherapy Administered|0|||
146726187|NCT00518115|529166962|FG001|Overall Study|Wrong Monotherapy Administered|0|||
146726188|NCT00518115|529166963|FG002|Overall Study|Wrong Monotherapy Administered|1|||
146726189|NCT00518115|529166964|FG003|Overall Study|Wrong Monotherapy Administered|0|||
146726190|NCT00518115|529166965|FG004|Overall Study|Wrong Monotherapy Administered|0|||
146726191|NCT00518115|529166966|FG005|Overall Study|Wrong Monotherapy Administered|0|||
146726192|NCT00518115|529166967|FG006|Overall Study|Wrong Monotherapy Administered|1|||
146726193|NCT00518115|529166968|FG007|Overall Study|Wrong Monotherapy Administered|0|||
146726194|NCT00518115|529166969|FG008|Overall Study|Wrong Monotherapy Administered|0|||
146726195|NCT00518115|529166970|FG009|Overall Study|Wrong Monotherapy Administered|0|||
146726196|NCT00518115|529166961|FG000|Overall Study|Violation of Exclusion Criteria|0|||
146726197|NCT00518115|529166962|FG001|Overall Study|Violation of Exclusion Criteria|0|||
146726198|NCT00518115|529166963|FG002|Overall Study|Violation of Exclusion Criteria|0|||
146726199|NCT00518115|529166964|FG003|Overall Study|Violation of Exclusion Criteria|1|||
146726200|NCT00518115|529166965|FG004|Overall Study|Violation of Exclusion Criteria|0|||
146726201|NCT00518115|529166966|FG005|Overall Study|Violation of Exclusion Criteria|0|||
146726202|NCT00518115|529166967|FG006|Overall Study|Violation of Exclusion Criteria|1|||
146726203|NCT00518115|529166968|FG007|Overall Study|Violation of Exclusion Criteria|0|||
146726204|NCT00518115|529166969|FG008|Overall Study|Violation of Exclusion Criteria|0|||
146726205|NCT00518115|529166970|FG009|Overall Study|Violation of Exclusion Criteria|0|||
146726206|NCT00518115|529166961|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
146726207|NCT00518115|529166962|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
146726208|NCT00518115|529166963|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
146726209|NCT00518115|529166964|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
146726210|NCT00518115|529166965|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
146726211|NCT00518115|529166966|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
146726212|NCT00518115|529166967|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
146726213|NCT00518115|529166968|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
146784667|NCT04021602|529382300|FG000|Overall Study|Lost to Follow-up|3|||
146784668|NCT04021602|529382301|FG001|Overall Study|Lost to Follow-up|3|||
146784669|NCT04021602|529382302|FG002|Overall Study|Lost to Follow-up|1|||
146784670|NCT04021602|529382300|FG000|Overall Study|Adverse Event|1|||
146784671|NCT04021602|529382301|FG001|Overall Study|Adverse Event|0|||
146784672|NCT04021602|529382302|FG002|Overall Study|Adverse Event|1|||
146784673|NCT04169373|529382309|FG000|Week 1 to Week 14|Adverse Event|1|||
146784674|NCT04169373|529382310|FG001|Week 1 to Week 14|Adverse Event|0|||
146784675|NCT04169373|529382311|FG002|Week 1 to Week 14|Adverse Event|1|||
146784676|NCT04169373|529382312|FG003|Week 1 to Week 14|Adverse Event|2|||
146784677|NCT04169373|529382309|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
146784678|NCT04169373|529382310|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
146784679|NCT04169373|529382311|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
146784680|NCT04169373|529382312|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
146784681|NCT04169373|529382309|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
146726214|NCT00518115|529166969|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
146784682|NCT04169373|529382310|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
146784683|NCT04169373|529382311|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
146784684|NCT04169373|529382312|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
146784685|NCT04169373|529382309|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
146784686|NCT04169373|529382310|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
146784687|NCT04169373|529382311|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
146848434|NCT03122223|529615681|FG002|Overall Study|Participant unable to adhere|1|||
146726215|NCT00518115|529166970|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
146726216|NCT00518115|529166961|FG000|Overall Study|Withdrew Consent|0|||
146726217|NCT00518115|529166962|FG001|Overall Study|Withdrew Consent|0|||
146726218|NCT00518115|529166963|FG002|Overall Study|Withdrew Consent|0|||
146726219|NCT00518115|529166964|FG003|Overall Study|Withdrew Consent|0|||
146726220|NCT00518115|529166965|FG004|Overall Study|Withdrew Consent|0|||
146784688|NCT04169373|529382312|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
146784689|NCT04169373|529382309|FG000|Week 1 to Week 14|Other|1|||
146784690|NCT04169373|529382310|FG001|Week 1 to Week 14|Other|3|||
146784691|NCT04169373|529382311|FG002|Week 1 to Week 14|Other|3|||
146784692|NCT04169373|529382312|FG003|Week 1 to Week 14|Other|5|||
146784693|NCT04169373|529382309|FG000|Week 14 to Week 52|Adverse Event|1|||
146784694|NCT04169373|529382310|FG001|Week 14 to Week 52|Adverse Event|0|||
146784695|NCT04169373|529382311|FG002|Week 14 to Week 52|Adverse Event|0|||
146784696|NCT04169373|529382312|FG003|Week 14 to Week 52|Adverse Event|1|||
146784697|NCT04169373|529382309|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
146784698|NCT04169373|529382310|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
146784699|NCT04169373|529382311|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
146784700|NCT04169373|529382312|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
146784701|NCT04169373|529382309|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
146784702|NCT04169373|529382310|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
146784703|NCT04169373|529382311|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
146784704|NCT04169373|529382312|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
146784705|NCT04169373|529382309|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
146784706|NCT04169373|529382310|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
146784707|NCT04169373|529382311|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
146784708|NCT04169373|529382312|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
146784709|NCT04169373|529382309|FG000|Week 14 to Week 52|Other|4|||
146784710|NCT04169373|529382310|FG001|Week 14 to Week 52|Other|5|||
146784711|NCT04169373|529382311|FG002|Week 14 to Week 52|Other|4|||
146784712|NCT04169373|529382312|FG003|Week 14 to Week 52|Other|5|||
146784713|NCT04169373|529382309|FG000|Week 14 to Week 52|Ongoing|0|||
146784714|NCT04169373|529382310|FG001|Week 14 to Week 52|Ongoing|1|||
146784715|NCT04169373|529382311|FG002|Week 14 to Week 52|Ongoing|0|||
146784716|NCT04169373|529382312|FG003|Week 14 to Week 52|Ongoing|0|||
146784717|NCT04610892|529382313|FG000|Overall Study|Adverse Event|1|||
146784718|NCT04610892|529382314|FG001|Overall Study|Adverse Event|0|||
146784719|NCT04610892|529382315|FG002|Overall Study|Adverse Event|0|||
146784720|NCT04610892|529382316|FG003|Overall Study|Adverse Event|1|||
146784721|NCT04610892|529382317|FG004|Overall Study|Adverse Event|3|||
146784722|NCT04610892|529382313|FG000|Overall Study|Death|0|||
146784723|NCT04610892|529382314|FG001|Overall Study|Death|1|||
146784724|NCT04610892|529382315|FG002|Overall Study|Death|0|||
146784725|NCT04610892|529382316|FG003|Overall Study|Death|1|||
146784726|NCT04610892|529382317|FG004|Overall Study|Death|0|||
146784727|NCT04610892|529382313|FG000|Overall Study|Withdrawal by Subject|3|||
146784728|NCT04610892|529382314|FG001|Overall Study|Withdrawal by Subject|2|||
146784729|NCT04610892|529382315|FG002|Overall Study|Withdrawal by Subject|0|||
146784730|NCT04610892|529382316|FG003|Overall Study|Withdrawal by Subject|6|||
146784731|NCT04610892|529382317|FG004|Overall Study|Withdrawal by Subject|6|||
146784732|NCT04610892|529382313|FG000|Overall Study|Subjects who did not receive treatment|1|||
146784733|NCT04610892|529382314|FG001|Overall Study|Subjects who did not receive treatment|0|||
146784734|NCT04610892|529382315|FG002|Overall Study|Subjects who did not receive treatment|0|||
146784735|NCT04610892|529382316|FG003|Overall Study|Subjects who did not receive treatment|0|||
146784736|NCT04610892|529382317|FG004|Overall Study|Subjects who did not receive treatment|2|||
146784737|NCT03924986|529382324|FG000|Overall Study|Death|57|||
146784738|NCT03924986|529382325|FG001|Overall Study|Death|66|||
146784739|NCT03924986|529382324|FG000|Overall Study|Study Concluded by Sponsor|51|||
146784740|NCT03924986|529382325|FG001|Overall Study|Study Concluded by Sponsor|41|||
146726221|NCT00518115|529166966|FG005|Overall Study|Withdrew Consent|1|||
146726222|NCT00518115|529166967|FG006|Overall Study|Withdrew Consent|0|||
146726223|NCT00518115|529166968|FG007|Overall Study|Withdrew Consent|0|||
146726224|NCT00518115|529166969|FG008|Overall Study|Withdrew Consent|0|||
146726225|NCT00518115|529166970|FG009|Overall Study|Withdrew Consent|0|||
146726226|NCT00518115|529166961|FG000|Overall Study|Moved Out of State|0|||
146726227|NCT00518115|529166962|FG001|Overall Study|Moved Out of State|0|||
146726228|NCT00518115|529166963|FG002|Overall Study|Moved Out of State|0|||
146726229|NCT00518115|529166964|FG003|Overall Study|Moved Out of State|0|||
146726230|NCT00518115|529166965|FG004|Overall Study|Moved Out of State|0|||
146726231|NCT00518115|529166966|FG005|Overall Study|Moved Out of State|0|||
146726232|NCT00518115|529166967|FG006|Overall Study|Moved Out of State|0|||
146726233|NCT00518115|529166968|FG007|Overall Study|Moved Out of State|0|||
146726234|NCT00518115|529166969|FG008|Overall Study|Moved Out of State|0|||
146726235|NCT00518115|529166970|FG009|Overall Study|Moved Out of State|1|||
146784741|NCT03924986|529382324|FG000|Overall Study|Withdrawal by Subject|15|||
146784742|NCT03924986|529382325|FG001|Overall Study|Withdrawal by Subject|20|||
146784743|NCT03924986|529382324|FG000|Overall Study|Lost to Follow-up|7|||
146784744|NCT03924986|529382325|FG001|Overall Study|Lost to Follow-up|5|||
146784745|NCT03924986|529382324|FG000|Overall Study|Miscellaneous|1|||
146784746|NCT03924986|529382325|FG001|Overall Study|Miscellaneous|0|||
146784747|NCT02689284|529382326|FG000|Overall Study|Adverse Event|1|||
146784748|NCT02689284|529382327|FG001|Overall Study|Adverse Event|8|||
146726236|NCT00127101|529166971|FG000|Base Protocol|Adverse Event|0|||
146726237|NCT00127101|529166972|FG001|Base Protocol|Adverse Event|2|||
146784749|NCT02689284|529382326|FG000|Overall Study|Death|0|||
146784750|NCT02689284|529382327|FG001|Overall Study|Death|1|||
146784751|NCT02689284|529382326|FG000|Overall Study|Physician Decision|1|||
146784752|NCT02689284|529382327|FG001|Overall Study|Physician Decision|2|||
146935363|NCT00355134|529922434|FG000|Core Phase|Administrative problems|5|||
146935364|NCT00355134|529922435|FG001|Core Phase|Administrative problems|3|||
146726238|NCT00127101|529166973|FG002|Base Protocol|Adverse Event|1|||
146726239|NCT00127101|529166974|FG003|Base Protocol|Adverse Event|0|||
146726240|NCT00127101|529166975|FG004|Base Protocol|Adverse Event|0|||
146726241|NCT00127101|529166976|FG005|Base Protocol|Adverse Event|0|||
146726242|NCT00127101|529166971|FG000|Base Protocol|Lack of Efficacy|1|||
146726243|NCT00127101|529166972|FG001|Base Protocol|Lack of Efficacy|0|||
146726244|NCT00127101|529166973|FG002|Base Protocol|Lack of Efficacy|0|||
146726245|NCT00127101|529166974|FG003|Base Protocol|Lack of Efficacy|0|||
146726246|NCT00127101|529166975|FG004|Base Protocol|Lack of Efficacy|2|||
146726247|NCT00127101|529166976|FG005|Base Protocol|Lack of Efficacy|0|||
146726248|NCT00127101|529166971|FG000|Base Protocol|Withdrawal by Subject|1|||
146726249|NCT00127101|529166972|FG001|Base Protocol|Withdrawal by Subject|2|||
146726250|NCT00127101|529166973|FG002|Base Protocol|Withdrawal by Subject|1|||
146726251|NCT00127101|529166974|FG003|Base Protocol|Withdrawal by Subject|0|||
146726252|NCT00127101|529166975|FG004|Base Protocol|Withdrawal by Subject|0|||
146726253|NCT00127101|529166976|FG005|Base Protocol|Withdrawal by Subject|1|||
146726254|NCT00127101|529166971|FG000|Continuation Phase|Adverse Event|0|||
146726255|NCT00127101|529166972|FG001|Continuation Phase|Adverse Event|0|||
146726256|NCT00127101|529166973|FG002|Continuation Phase|Adverse Event|0|||
146726257|NCT00127101|529166974|FG003|Continuation Phase|Adverse Event|0|||
146726258|NCT00127101|529166975|FG004|Continuation Phase|Adverse Event|1|||
146726259|NCT00127101|529166976|FG005|Continuation Phase|Adverse Event|1|||
146726260|NCT00127101|529166971|FG000|Continuation Phase|Lack of Efficacy|0|||
146726261|NCT00127101|529166972|FG001|Continuation Phase|Lack of Efficacy|0|||
146726262|NCT00127101|529166973|FG002|Continuation Phase|Lack of Efficacy|0|||
146726263|NCT00127101|529166974|FG003|Continuation Phase|Lack of Efficacy|0|||
146726264|NCT00127101|529166975|FG004|Continuation Phase|Lack of Efficacy|0|||
146726265|NCT00127101|529166976|FG005|Continuation Phase|Lack of Efficacy|1|||
146726266|NCT00127101|529166971|FG000|Continuation Phase|Withdrawal by Subject|0|||
146726267|NCT00127101|529166972|FG001|Continuation Phase|Withdrawal by Subject|0|||
146726268|NCT00127101|529166973|FG002|Continuation Phase|Withdrawal by Subject|1|||
146726269|NCT00127101|529166974|FG003|Continuation Phase|Withdrawal by Subject|0|||
146726270|NCT00127101|529166975|FG004|Continuation Phase|Withdrawal by Subject|2|||
146726271|NCT00127101|529166976|FG005|Continuation Phase|Withdrawal by Subject|1|||
146726272|NCT00843167|529166977|FG000|Treatment Period|Adverse Event|1|||
146726273|NCT00843167|529166978|FG001|Treatment Period|Adverse Event|5|||
146726274|NCT00843167|529166977|FG000|Treatment Period|Withdrawal by Subject|2|||
146726275|NCT00843167|529166978|FG001|Treatment Period|Withdrawal by Subject|3|||
146726276|NCT02291614|529166979|FG000|Overall Study|Lost to Follow-up|0|||
146726277|NCT02291614|529166980|FG001|Overall Study|Lost to Follow-up|0|||
146726278|NCT02291614|529166981|FG002|Overall Study|Lost to Follow-up|0|||
146726279|NCT02291614|529166982|FG003|Overall Study|Lost to Follow-up|0|||
146726280|NCT02291614|529166983|FG004|Overall Study|Lost to Follow-up|0|||
146726281|NCT02291614|529166984|FG005|Overall Study|Lost to Follow-up|0|||
146726282|NCT02291614|529166985|FG006|Overall Study|Lost to Follow-up|0|||
146726283|NCT02291614|529166986|FG007|Overall Study|Lost to Follow-up|1|||
146726284|NCT02291614|529166987|FG008|Overall Study|Lost to Follow-up|0|||
146726285|NCT02291614|529166988|FG009|Overall Study|Lost to Follow-up|0|||
146726286|NCT02291614|529166989|FG010|Overall Study|Lost to Follow-up|0|||
146726287|NCT02291614|529166979|FG000|Overall Study|Withdrawal by Subject|0|||
146726288|NCT02291614|529166980|FG001|Overall Study|Withdrawal by Subject|1|||
146726289|NCT02291614|529166981|FG002|Overall Study|Withdrawal by Subject|0|||
146726290|NCT02291614|529166982|FG003|Overall Study|Withdrawal by Subject|0|||
146726291|NCT02291614|529166983|FG004|Overall Study|Withdrawal by Subject|0|||
146726292|NCT02291614|529166984|FG005|Overall Study|Withdrawal by Subject|0|||
146726293|NCT02291614|529166985|FG006|Overall Study|Withdrawal by Subject|0|||
146726294|NCT02291614|529166986|FG007|Overall Study|Withdrawal by Subject|0|||
146726295|NCT02291614|529166987|FG008|Overall Study|Withdrawal by Subject|0|||
146726296|NCT02291614|529166988|FG009|Overall Study|Withdrawal by Subject|2|||
146726297|NCT02291614|529166989|FG010|Overall Study|Withdrawal by Subject|2|||
146784753|NCT02689284|529382326|FG000|Overall Study|Withdrawal by Subject|0|||
146935365|NCT00355134|529922436|FG002|Core Phase|Administrative problems|5|||
146935366|NCT00355134|529922437|FG003|Core Phase|Administrative problems|0|||
146726298|NCT02291614|529166979|FG000|Overall Study|Decision by sponsor|0|||
146726299|NCT02291614|529166980|FG001|Overall Study|Decision by sponsor|0|||
146726300|NCT02291614|529166981|FG002|Overall Study|Decision by sponsor|0|||
146726301|NCT02291614|529166982|FG003|Overall Study|Decision by sponsor|1|||
146726302|NCT02291614|529166983|FG004|Overall Study|Decision by sponsor|0|||
146726303|NCT02291614|529166984|FG005|Overall Study|Decision by sponsor|0|||
146784754|NCT02689284|529382327|FG001|Overall Study|Withdrawal by Subject|1|||
146726304|NCT02291614|529166985|FG006|Overall Study|Decision by sponsor|0|||
146726305|NCT02291614|529166986|FG007|Overall Study|Decision by sponsor|0|||
146726306|NCT02291614|529166987|FG008|Overall Study|Decision by sponsor|0|||
146726307|NCT02291614|529166988|FG009|Overall Study|Decision by sponsor|0|||
146726308|NCT02291614|529166989|FG010|Overall Study|Decision by sponsor|0|||
146726309|NCT02291614|529166979|FG000|Overall Study|Death|0|||
146726310|NCT02291614|529166980|FG001|Overall Study|Death|0|||
146726311|NCT02291614|529166981|FG002|Overall Study|Death|1|||
146726312|NCT02291614|529166982|FG003|Overall Study|Death|0|||
146726313|NCT02291614|529166983|FG004|Overall Study|Death|1|||
146726314|NCT02291614|529166984|FG005|Overall Study|Death|1|||
146726315|NCT02291614|529166985|FG006|Overall Study|Death|1|||
146726316|NCT02291614|529166986|FG007|Overall Study|Death|0|||
146726317|NCT02291614|529166987|FG008|Overall Study|Death|0|||
146726318|NCT02291614|529166988|FG009|Overall Study|Death|0|||
146726319|NCT02291614|529166989|FG010|Overall Study|Death|0|||
146726320|NCT01662310|529166991|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
146726321|NCT01662310|529166992|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
146726322|NCT01662310|529166993|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
146726323|NCT01662310|529166994|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
146726324|NCT01662310|529166995|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
146726325|NCT01662310|529166991|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
146726326|NCT01662310|529166992|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
146726327|NCT01662310|529166993|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
146726328|NCT01662310|529166994|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
146726329|NCT01662310|529166995|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
146726330|NCT01662310|529166991|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
146726331|NCT01662310|529166992|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
146726332|NCT01662310|529166993|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
146726333|NCT01662310|529166994|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
146726334|NCT01662310|529166995|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
146726335|NCT01662310|529166991|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
146726336|NCT01662310|529166992|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
146726337|NCT01662310|529166993|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
146726338|NCT01662310|529166994|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
146726339|NCT01662310|529166995|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
146726340|NCT01662310|529166991|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
146726341|NCT01662310|529166992|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
146726342|NCT01662310|529166993|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
146726343|NCT01662310|529166994|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
146726344|NCT01662310|529166995|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
146726345|NCT01662310|529166991|FG000|Run-In or Stabilization Phase|Other|1|||
146726346|NCT01662310|529166992|FG001|Run-In or Stabilization Phase|Other|0|||
146726347|NCT01662310|529166993|FG002|Run-In or Stabilization Phase|Other|0|||
146726348|NCT01662310|529166994|FG003|Run-In or Stabilization Phase|Other|0|||
146726349|NCT01662310|529166995|FG004|Run-In or Stabilization Phase|Other|0|||
146726350|NCT01662310|529166991|FG000|Double-Blind Phase|Adverse Event|0|||
146726351|NCT01662310|529166992|FG001|Double-Blind Phase|Adverse Event|0|||
146726352|NCT01662310|529166993|FG002|Double-Blind Phase|Adverse Event|1|||
146726353|NCT01662310|529166994|FG003|Double-Blind Phase|Adverse Event|0|||
146726354|NCT01662310|529166995|FG004|Double-Blind Phase|Adverse Event|0|||
146726355|NCT01662310|529166991|FG000|Double-Blind Phase|Lost to Follow-up|0|||
146726356|NCT01662310|529166992|FG001|Double-Blind Phase|Lost to Follow-up|3|||
146726357|NCT01662310|529166993|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146726358|NCT01662310|529166994|FG003|Double-Blind Phase|Lost to Follow-up|0|||
146726359|NCT01662310|529166995|FG004|Double-Blind Phase|Lost to Follow-up|0|||
146726360|NCT01662310|529166991|FG000|Double-Blind Phase|Pregnancy|0|||
146726361|NCT01662310|529166992|FG001|Double-Blind Phase|Pregnancy|2|||
146726362|NCT01662310|529166993|FG002|Double-Blind Phase|Pregnancy|0|||
146726363|NCT01662310|529166994|FG003|Double-Blind Phase|Pregnancy|0|||
146726364|NCT01662310|529166995|FG004|Double-Blind Phase|Pregnancy|0|||
146726365|NCT01662310|529166991|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
146726366|NCT01662310|529166992|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
146726367|NCT01662310|529166993|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
146726368|NCT01662310|529166994|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
146726369|NCT01662310|529166995|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
146726370|NCT01662310|529166991|FG000|Double-Blind Phase|Other|0|||
146726371|NCT01662310|529166992|FG001|Double-Blind Phase|Other|0|||
146726372|NCT01662310|529166993|FG002|Double-Blind Phase|Other|1|||
146726373|NCT01662310|529166994|FG003|Double-Blind Phase|Other|0|||
146726374|NCT01662310|529166995|FG004|Double-Blind Phase|Other|0|||
146726375|NCT01662310|529166991|FG000|Double-Blind Phase|Randomized but not treated|0|||
146726376|NCT01662310|529166992|FG001|Double-Blind Phase|Randomized but not treated|1|||
146726377|NCT01662310|529166993|FG002|Double-Blind Phase|Randomized but not treated|0|||
146726378|NCT01662310|529166994|FG003|Double-Blind Phase|Randomized but not treated|0|||
146726379|NCT01662310|529166995|FG004|Double-Blind Phase|Randomized but not treated|0|||
146726380|NCT01662310|529166991|FG000|Open-Label Extension Phase|Adverse Event|0|||
146726381|NCT01662310|529166992|FG001|Open-Label Extension Phase|Adverse Event|0|||
146726382|NCT01662310|529166993|FG002|Open-Label Extension Phase|Adverse Event|0|||
146726383|NCT01662310|529166994|FG003|Open-Label Extension Phase|Adverse Event|3|||
146726384|NCT01662310|529166995|FG004|Open-Label Extension Phase|Adverse Event|0|||
146726385|NCT01662310|529166991|FG000|Open-Label Extension Phase|Death|0|||
146726386|NCT01662310|529166992|FG001|Open-Label Extension Phase|Death|0|||
146726387|NCT01662310|529166993|FG002|Open-Label Extension Phase|Death|0|||
146726388|NCT01662310|529166994|FG003|Open-Label Extension Phase|Death|1|||
146726389|NCT01662310|529166995|FG004|Open-Label Extension Phase|Death|0|||
146726390|NCT01662310|529166991|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
146726391|NCT01662310|529166992|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
146726392|NCT01662310|529166993|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
146726393|NCT01662310|529166994|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
146726394|NCT01662310|529166995|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
146726395|NCT01662310|529166991|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
146726396|NCT01662310|529166992|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
146726397|NCT01662310|529166993|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
146726398|NCT01662310|529166994|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
146726399|NCT01662310|529166995|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
146726400|NCT01662310|529166991|FG000|Open-Label Extension Phase|Pregnancy|0|||
146726401|NCT01662310|529166992|FG001|Open-Label Extension Phase|Pregnancy|0|||
146726402|NCT01662310|529166993|FG002|Open-Label Extension Phase|Pregnancy|0|||
146726403|NCT01662310|529166994|FG003|Open-Label Extension Phase|Pregnancy|1|||
146726404|NCT01662310|529166995|FG004|Open-Label Extension Phase|Pregnancy|0|||
146726405|NCT01662310|529166991|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
146726406|NCT01662310|529166992|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
146726407|NCT01662310|529166993|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
146726408|NCT01662310|529166994|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
146726409|NCT01662310|529166995|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
146726410|NCT02432105|529166998|FG000|Overall Study|Lost to Follow-up|1|||
146726411|NCT02432105|529166999|FG001|Overall Study|Lost to Follow-up|1|||
146726412|NCT02432105|529167000|FG002|Overall Study|Lost to Follow-up|0|||
146726413|NCT02432105|529166998|FG000|Overall Study|Withdrawal by Subject|1|||
146726414|NCT02432105|529166999|FG001|Overall Study|Withdrawal by Subject|0|||
146726415|NCT02432105|529167000|FG002|Overall Study|Withdrawal by Subject|1|||
146726416|NCT02432105|529166998|FG000|Overall Study|Culture positive for yeast|0|||
146726417|NCT02432105|529166999|FG001|Overall Study|Culture positive for yeast|1|||
146726418|NCT02432105|529167000|FG002|Overall Study|Culture positive for yeast|0|||
146726419|NCT02432105|529166998|FG000|Overall Study|Randomized in error|0|||
146726420|NCT02432105|529166999|FG001|Overall Study|Randomized in error|0|||
146726421|NCT02432105|529167000|FG002|Overall Study|Randomized in error|2|||
146726422|NCT04302350|529167002|FG000|Overall Study|Physician Decision|1|||
146726423|NCT04302350|529167003|FG001|Overall Study|Physician Decision|1|||
146726424|NCT04302350|529167004|FG002|Overall Study|Physician Decision|2|||
146726425|NCT04302350|529167002|FG000|Overall Study|Lack of Efficacy|1|||
146726426|NCT04302350|529167003|FG001|Overall Study|Lack of Efficacy|1|||
146726427|NCT04302350|529167004|FG002|Overall Study|Lack of Efficacy|4|||
146726428|NCT04302350|529167002|FG000|Overall Study|Adverse Event|0|||
146726429|NCT04302350|529167003|FG001|Overall Study|Adverse Event|1|||
146726430|NCT04302350|529167004|FG002|Overall Study|Adverse Event|2|||
146726431|NCT01400503|529167005|FG000|Overall Study|Withdrawal by Subject|1|||
146726432|NCT01400503|529167005|FG000|Overall Study|Study Terminated by Sponsor|58|||
146726433|NCT01400503|529167005|FG000|Overall Study|Other|1|||
146726434|NCT01669122|529167006|FG000|Period I|Lost to Follow-up|1|||
146726435|NCT01669122|529167006|FG000|Washout Period II|Protocol Violation|2|||
146726436|NCT03543254|529167007|FG000|Overall Study|Lost to Follow-up|1|||
146726437|NCT02077166|529167008|FG000|Overall Study|Death|6|||
146726438|NCT02077166|529167009|FG001|Overall Study|Death|7|||
146726439|NCT02077166|529167010|FG002|Overall Study|Death|5|||
146726440|NCT02077166|529167011|FG003|Overall Study|Death|6|||
146726441|NCT02077166|529167012|FG004|Overall Study|Death|4|||
146726442|NCT02077166|529167013|FG005|Overall Study|Death|32|||
146726443|NCT02077166|529167014|FG006|Overall Study|Death|22|||
146726444|NCT02077166|529167008|FG000|Overall Study|Study Closure by Sponsor|3|||
146726445|NCT02077166|529167009|FG001|Overall Study|Study Closure by Sponsor|0|||
146726446|NCT02077166|529167010|FG002|Overall Study|Study Closure by Sponsor|2|||
146726447|NCT02077166|529167011|FG003|Overall Study|Study Closure by Sponsor|2|||
146726448|NCT02077166|529167012|FG004|Overall Study|Study Closure by Sponsor|2|||
146726449|NCT02077166|529167013|FG005|Overall Study|Study Closure by Sponsor|12|||
146726450|NCT02077166|529167014|FG006|Overall Study|Study Closure by Sponsor|4|||
146726451|NCT02077166|529167008|FG000|Overall Study|Lost to Follow-up|0|||
146726452|NCT02077166|529167009|FG001|Overall Study|Lost to Follow-up|0|||
146726453|NCT02077166|529167010|FG002|Overall Study|Lost to Follow-up|0|||
146726454|NCT02077166|529167011|FG003|Overall Study|Lost to Follow-up|0|||
146726455|NCT02077166|529167012|FG004|Overall Study|Lost to Follow-up|0|||
146726456|NCT02077166|529167013|FG005|Overall Study|Lost to Follow-up|1|||
146726457|NCT02077166|529167014|FG006|Overall Study|Lost to Follow-up|0|||
146726458|NCT02077166|529167008|FG000|Overall Study|Withdrawal by Subject|3|||
146726459|NCT02077166|529167009|FG001|Overall Study|Withdrawal by Subject|0|||
146726460|NCT02077166|529167010|FG002|Overall Study|Withdrawal by Subject|1|||
146726461|NCT02077166|529167011|FG003|Overall Study|Withdrawal by Subject|1|||
146726462|NCT02077166|529167012|FG004|Overall Study|Withdrawal by Subject|1|||
146726463|NCT02077166|529167013|FG005|Overall Study|Withdrawal by Subject|3|||
146726464|NCT02077166|529167014|FG006|Overall Study|Withdrawal by Subject|0|||
146726465|NCT02077166|529167008|FG000|Overall Study|Other, Not Specified|0|||
146726466|NCT02077166|529167009|FG001|Overall Study|Other, Not Specified|0|||
146726467|NCT02077166|529167010|FG002|Overall Study|Other, Not Specified|1|||
146726468|NCT02077166|529167011|FG003|Overall Study|Other, Not Specified|0|||
146726469|NCT02077166|529167012|FG004|Overall Study|Other, Not Specified|1|||
146726470|NCT02077166|529167013|FG005|Overall Study|Other, Not Specified|7|||
146726471|NCT02077166|529167014|FG006|Overall Study|Other, Not Specified|8|||
146726472|NCT03519854|529167015|FG000|Overall Study|Technical Error|0|||
146726473|NCT03519854|529167016|FG001|Overall Study|Technical Error|0|||
146726474|NCT03519854|529167017|FG002|Overall Study|Technical Error|1|||
146726475|NCT03519854|529167018|FG003|Overall Study|Technical Error|0|||
146726476|NCT03519854|529167019|FG004|Overall Study|Technical Error|0|||
146726477|NCT03519854|529167020|FG005|Overall Study|Technical Error|0|||
146726478|NCT03519854|529167021|FG006|Overall Study|Technical Error|0|||
146726479|NCT03519854|529167022|FG007|Overall Study|Technical Error|0|||
146726480|NCT03519854|529167023|FG008|Overall Study|Technical Error|0|||
146726481|NCT03519854|529167024|FG009|Overall Study|Technical Error|0|||
146726482|NCT03519854|529167025|FG010|Overall Study|Technical Error|0|||
146726483|NCT03519854|529167026|FG011|Overall Study|Technical Error|0|||
146726484|NCT03519854|529167027|FG012|Overall Study|Technical Error|0|||
146726485|NCT03519854|529167028|FG013|Overall Study|Technical Error|0|||
146726486|NCT03519854|529167029|FG014|Overall Study|Technical Error|0|||
146726487|NCT03519854|529167030|FG015|Overall Study|Technical Error|0|||
146726488|NCT03519854|529167031|FG016|Overall Study|Technical Error|0|||
146726489|NCT03519854|529167032|FG017|Overall Study|Technical Error|0|||
146726490|NCT05132699|529167033|FG000|Overall Study|Withdrawal by Subject|3|||
146726491|NCT05132699|529167034|FG001|Overall Study|Withdrawal by Subject|0|||
146726492|NCT00655980|529167037|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
146726493|NCT00655980|529167038|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
146726494|NCT00655980|529167039|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
146726495|NCT01266642|529167050|FG000|Overall Study|Protocol Violation|0|||
146726496|NCT01266642|529167051|FG001|Overall Study|Protocol Violation|1|||
146726497|NCT01194570|529169060|FG000|Overall Study|Adverse Event|22|||
146726498|NCT01194570|529169061|FG001|Overall Study|Adverse Event|40|||
146726499|NCT01194570|529169060|FG000|Overall Study|Death|6|||
146726500|NCT01194570|529169061|FG001|Overall Study|Death|20|||
146726501|NCT01194570|529169060|FG000|Overall Study|Lack of Efficacy|32|||
146726502|NCT01194570|529169061|FG001|Overall Study|Lack of Efficacy|33|||
146726503|NCT01194570|529169060|FG000|Overall Study|Lost to Follow-up|4|||
146726504|NCT01194570|529169061|FG001|Overall Study|Lost to Follow-up|15|||
146726505|NCT01194570|529169060|FG000|Overall Study|Non-Compliance|2|||
146726506|NCT01194570|529169061|FG001|Overall Study|Non-Compliance|2|||
146726507|NCT01194570|529169060|FG000|Overall Study|Non-Compliance With Study Drug|2|||
146726508|NCT01194570|529169061|FG001|Overall Study|Non-Compliance With Study Drug|2|||
146726509|NCT01194570|529169060|FG000|Overall Study|Other|18|||
146726510|NCT01194570|529169061|FG001|Overall Study|Other|47|||
146726511|NCT01194570|529169060|FG000|Overall Study|Physician Decision|10|||
146726512|NCT01194570|529169061|FG001|Overall Study|Physician Decision|25|||
146726513|NCT01194570|529169060|FG000|Overall Study|Protocol Violation|1|||
146726514|NCT01194570|529169061|FG001|Overall Study|Protocol Violation|2|||
146726515|NCT01194570|529169060|FG000|Overall Study|Study Terminated By Sponsor|0|||
146726516|NCT01194570|529169061|FG001|Overall Study|Study Terminated By Sponsor|1|||
146726517|NCT01194570|529169060|FG000|Overall Study|Withdrawal by Subject|57|||
146726518|NCT01194570|529169061|FG001|Overall Study|Withdrawal by Subject|82|||
146726519|NCT01194570|529169060|FG000|Overall Study|Pregnancy|1|||
146726520|NCT01194570|529169061|FG001|Overall Study|Pregnancy|1|||
146726521|NCT01266850|529169066|FG000|Overall Study|Lost to Follow-up|19|||
146726522|NCT01266850|529169067|FG001|Overall Study|Lost to Follow-up|19|||
146726523|NCT01266850|529169068|FG002|Overall Study|Lost to Follow-up|13|||
146726524|NCT01266850|529169069|FG003|Overall Study|Lost to Follow-up|13|||
146726525|NCT01266850|529169070|FG004|Overall Study|Lost to Follow-up|12|||
146726526|NCT01266850|529169066|FG000|Overall Study|Withdrawal by Subject|8|||
146726527|NCT01266850|529169067|FG001|Overall Study|Withdrawal by Subject|9|||
146726528|NCT01266850|529169068|FG002|Overall Study|Withdrawal by Subject|6|||
146726529|NCT01266850|529169069|FG003|Overall Study|Withdrawal by Subject|9|||
146726530|NCT01266850|529169070|FG004|Overall Study|Withdrawal by Subject|12|||
146726531|NCT01266850|529169066|FG000|Overall Study|Physician Decision|3|||
146726532|NCT01266850|529169067|FG001|Overall Study|Physician Decision|6|||
146726533|NCT01266850|529169068|FG002|Overall Study|Physician Decision|4|||
146726534|NCT01266850|529169069|FG003|Overall Study|Physician Decision|4|||
146726535|NCT01266850|529169070|FG004|Overall Study|Physician Decision|3|||
146726536|NCT01266850|529169066|FG000|Overall Study|Protocol Violation|0|||
146726537|NCT01266850|529169067|FG001|Overall Study|Protocol Violation|1|||
146726538|NCT01266850|529169068|FG002|Overall Study|Protocol Violation|0|||
146726539|NCT01266850|529169069|FG003|Overall Study|Protocol Violation|1|||
146726540|NCT01266850|529169070|FG004|Overall Study|Protocol Violation|2|||
146726541|NCT01266850|529169066|FG000|Overall Study|Adverse Event|0|||
146726542|NCT01266850|529169067|FG001|Overall Study|Adverse Event|0|||
146726543|NCT01266850|529169068|FG002|Overall Study|Adverse Event|0|||
146726544|NCT01266850|529169069|FG003|Overall Study|Adverse Event|0|||
146726545|NCT01266850|529169070|FG004|Overall Study|Adverse Event|1|||
146726546|NCT01266850|529169066|FG000|Overall Study|Site Closure|0|||
146726547|NCT01266850|529169067|FG001|Overall Study|Site Closure|1|||
146726548|NCT01266850|529169068|FG002|Overall Study|Site Closure|1|||
146726549|NCT01266850|529169069|FG003|Overall Study|Site Closure|1|||
146726550|NCT01266850|529169070|FG004|Overall Study|Site Closure|0|||
146726551|NCT03409666|529169071|FG000|Overall Study|Physician Decision|0|||
146726552|NCT03409666|529169072|FG001|Overall Study|Physician Decision|1|||
146726553|NCT03409666|529169071|FG000|Overall Study|Protocol Violation|0|||
146726554|NCT03409666|529169072|FG001|Overall Study|Protocol Violation|3|||
146726555|NCT02690974|529169082|FG000|Overall Study|Adverse Event|16|||
146726556|NCT02690974|529169082|FG000|Overall Study|Death|9|||
146726557|NCT02690974|529169082|FG000|Overall Study|Subject/guardian decision|4|||
146726558|NCT02690974|529169082|FG000|Overall Study|Lost to Follow-up|3|||
146726559|NCT02690974|529169082|FG000|Overall Study|Withdrawal of Informed Consent|3|||
146726560|NCT02690974|529169082|FG000|Overall Study|Physician Decision|2|||
146726561|NCT02690974|529169082|FG000|Overall Study|Non-compliance with study treatment|1|||
146726562|NCT02690974|529169082|FG000|Overall Study|Protocol-defined stopping criteria|1|||
146726563|NCT02690974|529169082|FG000|Overall Study|Protocol Deviation|1|||
146726564|NCT03563716|529169089|FG000|Overall Study|Death|20|||
146726565|NCT03563716|529169090|FG001|Overall Study|Death|14|||
146726566|NCT03563716|529169089|FG000|Overall Study|Withdrawal by Subject|3|||
146726567|NCT03563716|529169090|FG001|Overall Study|Withdrawal by Subject|3|||
146726568|NCT03563716|529169089|FG000|Overall Study|Still on Study|45|||
146726569|NCT03563716|529169090|FG001|Overall Study|Still on Study|50|||
146726570|NCT04605978|529169091|FG000|Overall Study|Adverse Event|2|||
146726571|NCT04605978|529169092|FG001|Overall Study|Adverse Event|1|||
146726572|NCT04605978|529169091|FG000|Overall Study|Withdrawal nonmedical reason|1|||
146726573|NCT04605978|529169092|FG001|Overall Study|Withdrawal nonmedical reason|1|||
146726574|NCT02583425|529169093|FG000|Screening|Did not meet entry criteria|12|||
146726575|NCT02583425|529169093|FG000|Baseline|Did not meet continued criteria|5|||
146726576|NCT02583425|529169093|FG000|Treatment Period|Adverse Event|1|||
146726577|NCT03104699|529169094|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
146726578|NCT03104699|529169095|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
146726579|NCT03104699|529169096|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
146726580|NCT03104699|529169097|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
146726581|NCT03104699|529169098|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
146726582|NCT03104699|529169099|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146726583|NCT03104699|529169094|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
146726584|NCT03104699|529169095|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
146726585|NCT03104699|529169096|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
146726586|NCT03104699|529169097|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
146726587|NCT03104699|529169098|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
146726588|NCT03104699|529169099|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
146726589|NCT03104699|529169094|FG000|Phase 1: Dose Escalation|Death|6|||
146726590|NCT03104699|529169095|FG001|Phase 1: Dose Escalation|Death|3|||
146726591|NCT03104699|529169096|FG002|Phase 1: Dose Escalation|Death|0|||
146726592|NCT03104699|529169097|FG003|Phase 1: Dose Escalation|Death|1|||
146726593|NCT03104699|529169098|FG004|Phase 1: Dose Escalation|Death|1|||
146726594|NCT03104699|529169099|FG005|Phase 1: Dose Escalation|Death|0|||
146726595|NCT03104699|529169094|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
146726596|NCT03104699|529169095|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
146726597|NCT03104699|529169096|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
146726598|NCT03104699|529169097|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
146726599|NCT03104699|529169098|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
146726600|NCT03104699|529169099|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
146726601|NCT03104699|529169094|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
146726602|NCT03104699|529169095|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
146726603|NCT03104699|529169096|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
146726604|NCT03104699|529169097|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
146726605|NCT03104699|529169098|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
146935367|NCT00355134|529922438|FG004|Core Phase|Administrative problems|0|||
146726606|NCT03104699|529169099|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
146935368|NCT00355134|529922434|FG000|Core Phase|Protocol Violation|3|||
146935369|NCT00355134|529922435|FG001|Core Phase|Protocol Violation|2|||
146726607|NCT03104699|529169094|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
146726608|NCT03104699|529169095|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
146726609|NCT03104699|529169096|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
146726610|NCT03104699|529169097|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
146726611|NCT03104699|529169098|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
146726612|NCT03104699|529169099|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
146726613|NCT03104699|529169094|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
146726614|NCT03104699|529169095|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
146726615|NCT03104699|529169096|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
146726616|NCT03104699|529169097|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
146726617|NCT03104699|529169098|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
146726618|NCT03104699|529169099|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
146726619|NCT03104699|529169094|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
146726620|NCT03104699|529169095|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
146726621|NCT03104699|529169096|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
146726622|NCT03104699|529169097|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
146726623|NCT03104699|529169098|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
146726624|NCT03104699|529169099|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
146726625|NCT03104699|529169094|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146726626|NCT03104699|529169095|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146726627|NCT03104699|529169096|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146726628|NCT03104699|529169097|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146726629|NCT03104699|529169098|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146726630|NCT03104699|529169099|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
146726631|NCT03104699|529169094|FG000|Phase 2: Dose Expansion|Death|0|||
146726632|NCT03104699|529169095|FG001|Phase 2: Dose Expansion|Death|0|||
146726633|NCT03104699|529169096|FG002|Phase 2: Dose Expansion|Death|0|||
146726634|NCT03104699|529169097|FG003|Phase 2: Dose Expansion|Death|0|||
146726635|NCT03104699|529169098|FG004|Phase 2: Dose Expansion|Death|0|||
146726636|NCT03104699|529169099|FG005|Phase 2: Dose Expansion|Death|107|||
146726637|NCT03104699|529169094|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
146726638|NCT03104699|529169095|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
146726639|NCT03104699|529169096|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
146726640|NCT03104699|529169097|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
146726641|NCT03104699|529169098|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
146726642|NCT03104699|529169099|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
146726643|NCT03104699|529169094|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
146726644|NCT03104699|529169095|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
146726645|NCT03104699|529169096|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
146726646|NCT03104699|529169097|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
146726647|NCT03104699|529169098|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
146726648|NCT03104699|529169099|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
146726649|NCT03104699|529169094|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146726650|NCT03104699|529169095|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146726651|NCT03104699|529169096|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146726652|NCT03104699|529169097|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146726653|NCT03104699|529169098|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146726654|NCT03104699|529169099|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
146726655|NCT03104699|529169094|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
146726656|NCT03104699|529169095|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
146726657|NCT03104699|529169096|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
146726658|NCT03104699|529169097|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
146726659|NCT03104699|529169098|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
146726660|NCT03104699|529169099|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
146726661|NCT01644734|529169100|FG000|Overall Study|Adverse Event|4|||
146726662|NCT01644734|529169100|FG000|Overall Study|Lost to Follow-up|17|||
146726663|NCT01644734|529169100|FG000|Overall Study|Reasons other than stated above|7|||
146726664|NCT01644734|529169100|FG000|Overall Study|Missing documentation|238|||
146726665|NCT02157779|529169105|FG000|Overall Study|Logistical|9|||
146726666|NCT02157779|529169106|FG001|Overall Study|Logistical|3|||
146726667|NCT02157779|529169105|FG000|Overall Study|Stopped attending, reason unknown|11|||
146726668|NCT02157779|529169106|FG001|Overall Study|Stopped attending, reason unknown|7|||
146726669|NCT02157779|529169105|FG000|Overall Study|No response to outreach after Baseline|1|||
146726670|NCT02157779|529169106|FG001|Overall Study|No response to outreach after Baseline|1|||
146726671|NCT02157779|529169105|FG000|Overall Study|Moved|1|||
146726672|NCT02157779|529169106|FG001|Overall Study|Moved|0|||
146726673|NCT02157779|529169105|FG000|Overall Study|Medical|1|||
146726674|NCT02157779|529169106|FG001|Overall Study|Medical|0|||
146726675|NCT02157779|529169105|FG000|Overall Study|Legal issue|1|||
146726676|NCT02157779|529169106|FG001|Overall Study|Legal issue|0|||
146726677|NCT02548455|529169108|FG000|Overall Study|Withdrawal by Subject|27|||
146726678|NCT02548455|529169108|FG000|Overall Study|Death|26|||
146726679|NCT02548455|529169108|FG000|Overall Study|Lost to Follow-up|14|||
146726680|NCT02548455|529169108|FG000|Overall Study|Visit not completed|173|||
146726681|NCT01292876|529169112|FG000|Overall Study|Physician Decision|4|||
146726682|NCT04528069|529169118|FG000|Overall Study|Adverse Event|1|||
146726683|NCT04528069|529169118|FG000|Overall Study|Lost to Follow-up|1|||
146726684|NCT04528069|529169118|FG000|Overall Study|Patient Unable to Come|1|||
146726685|NCT04528069|529169118|FG000|Overall Study|Patient Unable to Attend|1|||
146726686|NCT01137474|529169119|FG000|Overall Study|Adverse Event|3|||
146726687|NCT01137474|529169120|FG001|Overall Study|Adverse Event|5|||
146726688|NCT01137474|529169121|FG002|Overall Study|Adverse Event|1|||
146726689|NCT01137474|529169122|FG003|Overall Study|Adverse Event|3|||
146726690|NCT01137474|529169119|FG000|Overall Study|Withdrawal by Subject|7|||
146726691|NCT01137474|529169120|FG001|Overall Study|Withdrawal by Subject|2|||
146726692|NCT01137474|529169121|FG002|Overall Study|Withdrawal by Subject|6|||
146726693|NCT01137474|529169122|FG003|Overall Study|Withdrawal by Subject|9|||
146726694|NCT01137474|529169119|FG000|Overall Study|No longer met study criteria|6|||
146726695|NCT01137474|529169120|FG001|Overall Study|No longer met study criteria|1|||
146726696|NCT01137474|529169121|FG002|Overall Study|No longer met study criteria|0|||
146726697|NCT01137474|529169122|FG003|Overall Study|No longer met study criteria|5|||
146726698|NCT01137474|529169119|FG000|Overall Study|Lost to Follow-up|5|||
146726699|NCT01137474|529169120|FG001|Overall Study|Lost to Follow-up|1|||
146726700|NCT01137474|529169121|FG002|Overall Study|Lost to Follow-up|0|||
146726701|NCT01137474|529169122|FG003|Overall Study|Lost to Follow-up|2|||
146726702|NCT01137474|529169119|FG000|Overall Study|Lack of Efficacy|0|||
146726703|NCT01137474|529169120|FG001|Overall Study|Lack of Efficacy|0|||
146726704|NCT01137474|529169121|FG002|Overall Study|Lack of Efficacy|0|||
146726705|NCT01137474|529169122|FG003|Overall Study|Lack of Efficacy|2|||
146726706|NCT01137474|529169119|FG000|Overall Study|Other|3|||
146726707|NCT01137474|529169120|FG001|Overall Study|Other|1|||
146726708|NCT01137474|529169121|FG002|Overall Study|Other|0|||
146726709|NCT01137474|529169122|FG003|Overall Study|Other|0|||
146726710|NCT01137474|529169119|FG000|Overall Study|Pregnancy|0|||
146726711|NCT01137474|529169120|FG001|Overall Study|Pregnancy|1|||
146726712|NCT01137474|529169121|FG002|Overall Study|Pregnancy|0|||
146726713|NCT01137474|529169122|FG003|Overall Study|Pregnancy|0|||
146726714|NCT01137474|529169119|FG000|Overall Study|Administrative reason by sponsor|0|||
146726715|NCT01137474|529169120|FG001|Overall Study|Administrative reason by sponsor|1|||
146726716|NCT01137474|529169121|FG002|Overall Study|Administrative reason by sponsor|0|||
146726717|NCT01137474|529169122|FG003|Overall Study|Administrative reason by sponsor|0|||
146726718|NCT02525874|529169123|FG000|Overall Study|Other|1|||
146726719|NCT02525874|529169123|FG000|Overall Study|Investigator Decision|1|||
146726720|NCT02525874|529169123|FG000|Overall Study|Consent withdrawn|22|||
146726721|NCT02525874|529169123|FG000|Overall Study|Non-compliance with study drug|3|||
146726722|NCT02525874|529169123|FG000|Overall Study|Adverse Event|17|||
146726723|NCT02525874|529169123|FG000|Overall Study|Lost to Follow-up|7|||
146726724|NCT02525874|529169123|FG000|Overall Study|Disease progression, defined by protocol|2|||
146726725|NCT02525874|529169123|FG000|Overall Study|Disease relapse|4|||
146726726|NCT02525874|529169123|FG000|Overall Study|Alternative Treatment for MS|2|||
146726727|NCT02525874|529169123|FG000|Overall Study|New lesions in Brain|1|||
146726728|NCT01814371|529169124|FG000|Overall Study|Lost to Follow-up|30|||
146726729|NCT01814371|529169125|FG001|Overall Study|Lost to Follow-up|27|||
146726730|NCT01692782|529169126|FG000|Overall Study|Adverse Event|12|||
146726731|NCT01692782|529169127|FG001|Overall Study|Adverse Event|32|||
146726732|NCT01692782|529169128|FG002|Overall Study|Adverse Event|2|||
146726733|NCT01692782|529169126|FG000|Overall Study|Lack of Efficacy|1|||
146726734|NCT01692782|529169127|FG001|Overall Study|Lack of Efficacy|2|||
146726735|NCT01692782|529169128|FG002|Overall Study|Lack of Efficacy|0|||
146726736|NCT01692782|529169126|FG000|Overall Study|Lost to Follow-up|2|||
146726737|NCT01692782|529169127|FG001|Overall Study|Lost to Follow-up|7|||
146726738|NCT01692782|529169128|FG002|Overall Study|Lost to Follow-up|1|||
146726739|NCT01692782|529169126|FG000|Overall Study|Pregnancy|1|||
146726740|NCT01692782|529169127|FG001|Overall Study|Pregnancy|0|||
146726741|NCT01692782|529169128|FG002|Overall Study|Pregnancy|0|||
146726742|NCT01692782|529169126|FG000|Overall Study|Protocol Violation|1|||
146726743|NCT01692782|529169127|FG001|Overall Study|Protocol Violation|0|||
146726744|NCT01692782|529169128|FG002|Overall Study|Protocol Violation|2|||
146726745|NCT01692782|529169126|FG000|Overall Study|Non-complance with study drug|0|||
146784755|NCT02689284|529382326|FG000|Overall Study|progression of cancer|1|||
146784756|NCT02689284|529382327|FG001|Overall Study|progression of cancer|72|||
146784757|NCT02689284|529382326|FG000|Overall Study|decreased heart function|0|||
146726746|NCT01692782|529169127|FG001|Overall Study|Non-complance with study drug|4|||
146726747|NCT01692782|529169128|FG002|Overall Study|Non-complance with study drug|1|||
146726748|NCT01692782|529169126|FG000|Overall Study|Non-compliant with study visits|0|||
146726749|NCT01692782|529169127|FG001|Overall Study|Non-compliant with study visits|0|||
146726750|NCT01692782|529169128|FG002|Overall Study|Non-compliant with study visits|1|||
146726751|NCT01692782|529169126|FG000|Overall Study|SAE not related to study drug|0|||
146726752|NCT01692782|529169127|FG001|Overall Study|SAE not related to study drug|1|||
146726753|NCT01692782|529169128|FG002|Overall Study|SAE not related to study drug|0|||
146726754|NCT01692782|529169126|FG000|Overall Study|Withdrawal by Subject|3|||
146726755|NCT01692782|529169127|FG001|Overall Study|Withdrawal by Subject|10|||
146726756|NCT01692782|529169128|FG002|Overall Study|Withdrawal by Subject|3|||
146784758|NCT02689284|529382327|FG001|Overall Study|decreased heart function|1|||
146726757|NCT03945188|529169132|FG000|Overall Study|Protocol Violation|1|||
146726758|NCT03945188|529169133|FG001|Overall Study|Protocol Violation|0|||
146726759|NCT03945188|529169132|FG000|Overall Study|Disease worsening|79|||
146726760|NCT03945188|529169133|FG001|Overall Study|Disease worsening|73|||
146726761|NCT03945188|529169132|FG000|Overall Study|Physician Decision|2|||
146726762|NCT03945188|529169133|FG001|Overall Study|Physician Decision|2|||
146726763|NCT03945188|529169132|FG000|Overall Study|Lack of Efficacy|7|||
146726764|NCT03945188|529169133|FG001|Overall Study|Lack of Efficacy|4|||
146726765|NCT03945188|529169132|FG000|Overall Study|Pregnancy|2|||
146726766|NCT03945188|529169133|FG001|Overall Study|Pregnancy|0|||
146726767|NCT03945188|529169132|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
146726768|NCT03945188|529169133|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
146726769|NCT03945188|529169132|FG000|Overall Study|Adverse Event|10|||
146726770|NCT03945188|529169133|FG001|Overall Study|Adverse Event|5|||
146726771|NCT03945188|529169132|FG000|Overall Study|Other|2|||
146726772|NCT03945188|529169133|FG001|Overall Study|Other|2|||
146726773|NCT03945188|529169132|FG000|Overall Study|Lost to Follow-up|1|||
146726774|NCT03945188|529169133|FG001|Overall Study|Lost to Follow-up|2|||
146726775|NCT02677116|529169147|FG000|Overall Study|Adverse Event|0|||
146726776|NCT02677116|529169148|FG001|Overall Study|Adverse Event|1|||
146726777|NCT02677116|529169149|FG002|Overall Study|Adverse Event|0|||
146726778|NCT02677116|529169150|FG003|Overall Study|Adverse Event|0|||
146726779|NCT02677116|529169151|FG004|Overall Study|Adverse Event|0|||
146726780|NCT02677116|529169152|FG005|Overall Study|Adverse Event|1|||
146726781|NCT02677116|529169153|FG006|Overall Study|Adverse Event|1|||
146726782|NCT02677116|529169154|FG007|Overall Study|Adverse Event|0|||
146726783|NCT02677116|529169155|FG008|Overall Study|Adverse Event|0|||
146726784|NCT02677116|529169147|FG000|Overall Study|Physician Decision|0|||
146726785|NCT02677116|529169148|FG001|Overall Study|Physician Decision|2|||
146726786|NCT02677116|529169149|FG002|Overall Study|Physician Decision|3|||
146726787|NCT02677116|529169150|FG003|Overall Study|Physician Decision|2|||
146726788|NCT02677116|529169151|FG004|Overall Study|Physician Decision|1|||
146726789|NCT02677116|529169152|FG005|Overall Study|Physician Decision|3|||
146726790|NCT02677116|529169153|FG006|Overall Study|Physician Decision|1|||
146726791|NCT02677116|529169154|FG007|Overall Study|Physician Decision|1|||
146726792|NCT02677116|529169155|FG008|Overall Study|Physician Decision|2|||
146726793|NCT02677116|529169147|FG000|Overall Study|Withdrawal by parent or guardian|2|||
146726794|NCT02677116|529169148|FG001|Overall Study|Withdrawal by parent or guardian|1|||
146726795|NCT02677116|529169149|FG002|Overall Study|Withdrawal by parent or guardian|0|||
146726796|NCT02677116|529169150|FG003|Overall Study|Withdrawal by parent or guardian|1|||
146726797|NCT02677116|529169151|FG004|Overall Study|Withdrawal by parent or guardian|0|||
146726798|NCT02677116|529169152|FG005|Overall Study|Withdrawal by parent or guardian|0|||
146726799|NCT02677116|529169153|FG006|Overall Study|Withdrawal by parent or guardian|2|||
146726800|NCT02677116|529169154|FG007|Overall Study|Withdrawal by parent or guardian|1|||
146726801|NCT02677116|529169155|FG008|Overall Study|Withdrawal by parent or guardian|0|||
146726802|NCT02677116|529169147|FG000|Overall Study|Withdrawal by Subject|1|||
146726803|NCT02677116|529169148|FG001|Overall Study|Withdrawal by Subject|0|||
146726804|NCT02677116|529169149|FG002|Overall Study|Withdrawal by Subject|0|||
146726805|NCT02677116|529169150|FG003|Overall Study|Withdrawal by Subject|0|||
146726806|NCT02677116|529169151|FG004|Overall Study|Withdrawal by Subject|0|||
146726807|NCT02677116|529169152|FG005|Overall Study|Withdrawal by Subject|0|||
146726808|NCT02677116|529169153|FG006|Overall Study|Withdrawal by Subject|0|||
146726809|NCT02677116|529169154|FG007|Overall Study|Withdrawal by Subject|0|||
146726810|NCT02677116|529169155|FG008|Overall Study|Withdrawal by Subject|0|||
146726811|NCT03182868|529169156|FG000|Overall Study|Protocol Violation|3|||
146726812|NCT03182868|529169157|FG001|Overall Study|Protocol Violation|0|||
146726813|NCT03182868|529169158|FG002|Overall Study|Protocol Violation|4|||
146726814|NCT03182868|529169159|FG003|Overall Study|Protocol Violation|1|||
146726815|NCT03182868|529169160|FG004|Overall Study|Protocol Violation|8|||
146726816|NCT03342638|529169161|FG000|Overall Study|Withdrawal by Subject|1|||
146726817|NCT03342638|529169162|FG001|Overall Study|Withdrawal by Subject|0|||
146726818|NCT03342638|529169161|FG000|Overall Study|Physician Decision|0|||
146726819|NCT03342638|529169162|FG001|Overall Study|Physician Decision|1|||
146726820|NCT02275065|529169168|FG000|Overall Study|Randomized but not treated|1|||
146726821|NCT02275065|529169169|FG001|Overall Study|Randomized but not treated|0|||
146726822|NCT02275065|529169170|FG002|Overall Study|Randomized but not treated|1|||
146726823|NCT02275065|529169171|FG003|Overall Study|Randomized but not treated|1|||
146726824|NCT02275065|529169172|FG004|Overall Study|Randomized but not treated|0|||
146726825|NCT03213158|529169175|FG000|Overall Study|Withdrawal by Subject|1|||
146726826|NCT03213158|529169175|FG000|Overall Study|Physician Decision|2|||
146784759|NCT02689284|529382326|FG000|Overall Study|concern for anemia|0|||
146726827|NCT01569438|529169182|FG000|Overall Study|Lack of Efficacy|1|||
146726828|NCT01569438|529169183|FG001|Overall Study|Lack of Efficacy|2|||
146726829|NCT01569438|529169182|FG000|Overall Study|Withdrawal by Subject|0|||
146726830|NCT01569438|529169183|FG001|Overall Study|Withdrawal by Subject|3|||
146726831|NCT01569438|529169182|FG000|Overall Study|Adverse Event|2|||
146726832|NCT01569438|529169183|FG001|Overall Study|Adverse Event|15|||
146726833|NCT01569438|529169182|FG000|Overall Study|Protocol Violation|2|||
146726834|NCT01569438|529169183|FG001|Overall Study|Protocol Violation|0|||
146726835|NCT01569438|529169182|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
146726836|NCT01569438|529169183|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
146726837|NCT01569438|529169182|FG000|Overall Study|Sponsor/Physician decision|1|||
146726838|NCT01569438|529169183|FG001|Overall Study|Sponsor/Physician decision|1|||
146726839|NCT01569438|529169182|FG000|Overall Study|Unable to adhere to study schedule|0|||
146726840|NCT01569438|529169183|FG001|Overall Study|Unable to adhere to study schedule|1|||
146726841|NCT01207102|529169184|FG000|Overall Study|Withdrawal by Subject|5|||
146726842|NCT01207102|529169184|FG000|Overall Study|Adverse Event|2|||
146726843|NCT01207102|529169184|FG000|Overall Study|progression|2|||
146726844|NCT01207102|529169184|FG000|Overall Study|Withdrawal by Treating Physician|1|||
146726845|NCT03649230|529169185|FG000|Overall Study|Adverse Event|12|||
146726846|NCT03649230|529169185|FG000|Overall Study|Death|8|||
146726847|NCT03649230|529169185|FG000|Overall Study|Withdrawal by Subject|6|||
146726848|NCT03649230|529169185|FG000|Overall Study|Physician Decision|5|||
146726849|NCT03649230|529169185|FG000|Overall Study|Disease progression|5|||
146726850|NCT03649230|529169185|FG000|Overall Study|Switched to non-HEC|5|||
146726851|NCT03649230|529169185|FG000|Overall Study|Chemotherapy discontinued|4|||
146726852|NCT03649230|529169185|FG000|Overall Study|Received only 3 HEC cycles|4|||
146726853|NCT03649230|529169185|FG000|Overall Study|Screen Failure|3|||
146726854|NCT03649230|529169185|FG000|Overall Study|Patient stopped treatment|2|||
146726855|NCT03649230|529169185|FG000|Overall Study|Protocol Violation|1|||
146726856|NCT03649230|529169185|FG000|Overall Study|Non-compliance|1|||
146726857|NCT03649230|529169185|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
146726858|NCT01693068|529169189|FG000|Randomization Period|On-study|2|||
146726859|NCT01693068|529169190|FG001|Randomization Period|On-study|5|||
146726860|NCT01693068|529169191|FG002|Randomization Period|On-study|0|||
146726861|NCT01693068|529169189|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
146726862|NCT01693068|529169190|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
146726863|NCT01693068|529169191|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
146726864|NCT00295022|529169194|FG000|Overall Study|Adverse Event|1|||
146726865|NCT00295022|529169195|FG001|Overall Study|Adverse Event|1|||
146726866|NCT00295022|529169196|FG002|Overall Study|Adverse Event|2|||
146726867|NCT00295022|529169194|FG000|Overall Study|Lost to Follow-up|0|||
146726868|NCT00295022|529169195|FG001|Overall Study|Lost to Follow-up|0|||
146726869|NCT00295022|529169196|FG002|Overall Study|Lost to Follow-up|1|||
146726870|NCT00295022|529169194|FG000|Overall Study|Withdrawal by Subject|0|||
146726871|NCT00295022|529169195|FG001|Overall Study|Withdrawal by Subject|0|||
146726872|NCT00295022|529169196|FG002|Overall Study|Withdrawal by Subject|2|||
146726873|NCT01239030|529169198|FG000|Double Blind|Adverse Event|0|||
146726874|NCT01239030|529169199|FG001|Double Blind|Adverse Event|1|||
146726875|NCT01239030|529169200|FG002|Double Blind|Adverse Event|0|||
146726876|NCT01239030|529169201|FG003|Double Blind|Adverse Event|2|||
146726877|NCT01239030|529169202|FG004|Double Blind|Adverse Event|0|||
146726878|NCT01239030|529169198|FG000|Double Blind|Withdrawal by Subject|0|||
146726879|NCT01239030|529169199|FG001|Double Blind|Withdrawal by Subject|1|||
146726880|NCT01239030|529169200|FG002|Double Blind|Withdrawal by Subject|1|||
146726881|NCT01239030|529169201|FG003|Double Blind|Withdrawal by Subject|0|||
146726882|NCT01239030|529169202|FG004|Double Blind|Withdrawal by Subject|1|||
146726883|NCT01239030|529169198|FG000|Double Blind|Lost to Follow-up|1|||
146726884|NCT01239030|529169199|FG001|Double Blind|Lost to Follow-up|1|||
146726885|NCT01239030|529169200|FG002|Double Blind|Lost to Follow-up|0|||
146726886|NCT01239030|529169201|FG003|Double Blind|Lost to Follow-up|0|||
146726887|NCT01239030|529169202|FG004|Double Blind|Lost to Follow-up|0|||
146726888|NCT01239030|529169198|FG000|Double Blind|Physician Decision|0|||
146726889|NCT01239030|529169199|FG001|Double Blind|Physician Decision|1|||
146726890|NCT01239030|529169200|FG002|Double Blind|Physician Decision|0|||
146726891|NCT01239030|529169201|FG003|Double Blind|Physician Decision|0|||
146726892|NCT01239030|529169202|FG004|Double Blind|Physician Decision|0|||
146726893|NCT01239030|529169198|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
146726894|NCT01239030|529169199|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
146726895|NCT01239030|529169200|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
146726896|NCT01239030|529169201|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
146726897|NCT01239030|529169202|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
146726898|NCT01239030|529169198|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
146726899|NCT01239030|529169199|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
146726900|NCT01239030|529169200|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
146726901|NCT01239030|529169201|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
146726902|NCT01239030|529169202|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
146726903|NCT01239030|529169198|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
146726904|NCT01239030|529169199|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
146726905|NCT01239030|529169200|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
146726906|NCT01239030|529169201|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
146726907|NCT01239030|529169202|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
146726908|NCT01239030|529169198|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
146726909|NCT01239030|529169199|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
146726910|NCT01239030|529169200|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
146726911|NCT01239030|529169201|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
146726912|NCT01239030|529169202|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
146726913|NCT03240692|529169207|FG000|Overall Study|Physician Decision|1|||
146726914|NCT03240692|529169207|FG000|Overall Study|Withdrawal by Subject|1|||
146726915|NCT02300220|529169208|FG000|Overall Study|Lost to Follow-up|1|||
146726916|NCT02300220|529169209|FG001|Overall Study|Lost to Follow-up|2|||
146726917|NCT02300220|529169208|FG000|Overall Study|Death|1|||
146726918|NCT02300220|529169209|FG001|Overall Study|Death|1|||
146726919|NCT02300220|529169208|FG000|Overall Study|Adverse Event|1|||
146726920|NCT02300220|529169209|FG001|Overall Study|Adverse Event|1|||
146726921|NCT02300220|529169208|FG000|Overall Study|Protocol Violation|1|||
146726922|NCT02300220|529169209|FG001|Overall Study|Protocol Violation|0|||
146726923|NCT02300220|529169208|FG000|Overall Study|Withdrawal by Subject|0|||
146726924|NCT02300220|529169209|FG001|Overall Study|Withdrawal by Subject|2|||
146726925|NCT02300220|529169208|FG000|Overall Study|Did not tolerate IMP|0|||
146726926|NCT02300220|529169209|FG001|Overall Study|Did not tolerate IMP|1|||
146726927|NCT02012491|529169213|FG000|Overall Study|Lost to Follow-up|1|||
146726928|NCT02012491|529169214|FG001|Overall Study|Lost to Follow-up|0|||
146726929|NCT02012491|529169213|FG000|Overall Study|Protocol Violation|0|||
146726930|NCT02012491|529169214|FG001|Overall Study|Protocol Violation|1|||
146726931|NCT02012491|529169213|FG000|Overall Study|Withdrawal by Subject|1|||
146726932|NCT02012491|529169214|FG001|Overall Study|Withdrawal by Subject|0|||
146726933|NCT03969719|529169225|FG000|Overall Study|Other reasons not specified|1|||
146726934|NCT03969719|529169226|FG001|Overall Study|Other reasons not specified|1|||
146726935|NCT03969719|529169227|FG002|Overall Study|Other reasons not specified|3|||
146726936|NCT03969719|529169225|FG000|Overall Study|Withdrawal by Subject|2|||
146726937|NCT03969719|529169226|FG001|Overall Study|Withdrawal by Subject|3|||
146726938|NCT03969719|529169227|FG002|Overall Study|Withdrawal by Subject|2|||
146726939|NCT03969719|529169225|FG000|Overall Study|Protocol Violation|1|||
146726940|NCT03969719|529169226|FG001|Overall Study|Protocol Violation|2|||
146726941|NCT03969719|529169227|FG002|Overall Study|Protocol Violation|0|||
146726942|NCT03969719|529169225|FG000|Overall Study|Adverse Event|0|||
146726943|NCT03969719|529169226|FG001|Overall Study|Adverse Event|2|||
146726944|NCT03969719|529169227|FG002|Overall Study|Adverse Event|0|||
146726945|NCT03969719|529169225|FG000|Overall Study|Lost to Follow-up|0|||
146726946|NCT03969719|529169226|FG001|Overall Study|Lost to Follow-up|1|||
146726947|NCT03969719|529169227|FG002|Overall Study|Lost to Follow-up|0|||
146726948|NCT05608629|529169228|FG000|Overall Study|Lost to Follow-up|2|||
146726949|NCT02130193|529169229|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
146726950|NCT02130193|529169230|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
146726951|NCT02130193|529169231|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
146726952|NCT02130193|529169229|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
146726953|NCT02130193|529169230|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
146726954|NCT02130193|529169231|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
146726955|NCT02130193|529169229|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
146726956|NCT02130193|529169230|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
146726957|NCT02130193|529169231|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
146726958|NCT02130193|529169229|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
146726959|NCT02130193|529169230|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
146726960|NCT02130193|529169231|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
146726961|NCT01212770|529169232|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
146726962|NCT01212770|529169233|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
146726963|NCT01212770|529169234|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
146726964|NCT01212770|529169235|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146726965|NCT01212770|529169236|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146726966|NCT01212770|529169237|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146726967|NCT01212770|529169238|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146726968|NCT01212770|529169239|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146726969|NCT01212770|529169240|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146726970|NCT01212770|529169232|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
146726971|NCT01212770|529169233|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
146726972|NCT01212770|529169234|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
146726973|NCT01212770|529169235|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146726974|NCT01212770|529169236|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146726975|NCT01212770|529169237|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146726976|NCT01212770|529169238|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146726977|NCT01212770|529169239|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146726978|NCT01212770|529169240|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146726979|NCT01212770|529169232|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
146726980|NCT01212770|529169233|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
146726981|NCT01212770|529169234|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
146726982|NCT01212770|529169235|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146726983|NCT01212770|529169236|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146726984|NCT01212770|529169237|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146726985|NCT01212770|529169238|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146726986|NCT01212770|529169239|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146726987|NCT01212770|529169240|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146726988|NCT01212770|529169232|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
146726989|NCT01212770|529169233|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146726990|NCT01212770|529169234|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
146726991|NCT01212770|529169235|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146726992|NCT01212770|529169236|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146726993|NCT01212770|529169237|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146726994|NCT01212770|529169238|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146726995|NCT01212770|529169239|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146726996|NCT01212770|529169240|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146726997|NCT01212770|529169232|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146726998|NCT01212770|529169233|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146726999|NCT01212770|529169234|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
146727000|NCT01212770|529169235|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146727001|NCT01212770|529169236|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146727002|NCT01212770|529169237|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146727003|NCT01212770|529169238|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146727004|NCT01212770|529169239|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146727005|NCT01212770|529169240|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146727006|NCT01212770|529169232|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
146727007|NCT01212770|529169233|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
146727008|NCT01212770|529169234|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
146727009|NCT01212770|529169235|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
146727010|NCT01212770|529169236|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
146727011|NCT01212770|529169237|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
146727012|NCT01212770|529169238|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
146727013|NCT01212770|529169239|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
146727014|NCT01212770|529169240|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
146727015|NCT01212770|529169232|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
146727016|NCT01212770|529169233|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
146727017|NCT01212770|529169234|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
146727018|NCT01212770|529169235|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
146727019|NCT01212770|529169236|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
146727020|NCT01212770|529169237|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
146727021|NCT01212770|529169238|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
146727022|NCT01212770|529169239|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
146727023|NCT01212770|529169240|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
146727024|NCT01212770|529169232|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
146727025|NCT01212770|529169233|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
146727026|NCT01212770|529169234|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
146727027|NCT01212770|529169235|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
146727028|NCT01212770|529169236|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
146727029|NCT01212770|529169237|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
146727030|NCT01212770|529169238|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
146727031|NCT01212770|529169239|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
146727032|NCT01212770|529169240|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
146727033|NCT01212770|529169232|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
146727034|NCT01212770|529169233|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
146727035|NCT01212770|529169234|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
146727036|NCT01212770|529169235|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
146727037|NCT01212770|529169236|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
146727038|NCT01212770|529169237|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
146727039|NCT01212770|529169238|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
146727040|NCT01212770|529169239|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
146727041|NCT01212770|529169240|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
146727042|NCT01212770|529169232|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
146727043|NCT01212770|529169233|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
146727044|NCT01212770|529169234|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
146784760|NCT02689284|529382327|FG001|Overall Study|concern for anemia|1|||
146784761|NCT02689284|529382326|FG000|Overall Study|no measurable cancer for evaluation|0|||
146784762|NCT02689284|529382327|FG001|Overall Study|no measurable cancer for evaluation|1|||
146784763|NCT05516147|529382330|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
146784764|NCT03396926|529382332|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
146784765|NCT03396926|529382333|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
146784766|NCT02035787|529382334|FG000|Overall Study- 12 Months|Adverse Event|3|||
146784767|NCT02035787|529382335|FG001|Overall Study- 12 Months|Adverse Event|0|||
146784768|NCT02035787|529382334|FG000|Overall Study- 12 Months|Complete response|4|||
146784769|NCT02035787|529382335|FG001|Overall Study- 12 Months|Complete response|1|||
146784770|NCT02035787|529382334|FG000|Overall Study- 12 Months|Protocol Violation|1|||
146784771|NCT02035787|529382335|FG001|Overall Study- 12 Months|Protocol Violation|1|||
146784772|NCT06414213|529382336|FG000|Overall Study|Lost to Follow-up|1|||
146784773|NCT06414213|529382337|FG001|Overall Study|Lost to Follow-up|1|||
146784774|NCT06414213|529382338|FG002|Overall Study|Lost to Follow-up|3|||
146784775|NCT00450658|529382341|FG000|Overall Study|Adverse Event|24|||
146784776|NCT00450658|529382342|FG001|Overall Study|Adverse Event|15|||
146784777|NCT00450658|529382341|FG000|Overall Study|Withdrawal by Subject|43|||
146784778|NCT00450658|529382342|FG001|Overall Study|Withdrawal by Subject|26|||
146784779|NCT00450658|529382341|FG000|Overall Study|Lost to Follow-up|22|||
146935370|NCT00355134|529922436|FG002|Core Phase|Protocol Violation|2|||
146935371|NCT00355134|529922437|FG003|Core Phase|Protocol Violation|0|||
146935372|NCT00355134|529922438|FG004|Core Phase|Protocol Violation|0|||
146935373|NCT00355134|529922434|FG000|Core Phase|Abnormal test procedure result(s)|1|||
146935374|NCT00355134|529922435|FG001|Core Phase|Abnormal test procedure result(s)|2|||
146935375|NCT00355134|529922436|FG002|Core Phase|Abnormal test procedure result(s)|1|||
146935376|NCT00355134|529922437|FG003|Core Phase|Abnormal test procedure result(s)|0|||
146935377|NCT00355134|529922438|FG004|Core Phase|Abnormal test procedure result(s)|0|||
146935378|NCT00355134|529922434|FG000|Core Phase|Condition no longer requires study drug|1|||
146935379|NCT00355134|529922435|FG001|Core Phase|Condition no longer requires study drug|0|||
146935380|NCT00355134|529922436|FG002|Core Phase|Condition no longer requires study drug|1|||
146935381|NCT00355134|529922437|FG003|Core Phase|Condition no longer requires study drug|0|||
146935382|NCT00355134|529922438|FG004|Core Phase|Condition no longer requires study drug|0|||
146935383|NCT00355134|529922434|FG000|Extension Phase|Withdrawal by Subject|7|||
146935384|NCT00355134|529922435|FG001|Extension Phase|Withdrawal by Subject|11|||
146935385|NCT00355134|529922436|FG002|Extension Phase|Withdrawal by Subject|0|||
146935386|NCT00355134|529922437|FG003|Extension Phase|Withdrawal by Subject|7|||
146935387|NCT00355134|529922438|FG004|Extension Phase|Withdrawal by Subject|5|||
146935388|NCT00355134|529922434|FG000|Extension Phase|Adverse Event|13|||
146935389|NCT00355134|529922435|FG001|Extension Phase|Adverse Event|9|||
146935390|NCT00355134|529922436|FG002|Extension Phase|Adverse Event|0|||
146935391|NCT00355134|529922437|FG003|Extension Phase|Adverse Event|3|||
146935392|NCT00355134|529922438|FG004|Extension Phase|Adverse Event|5|||
146935393|NCT00355134|529922434|FG000|Extension Phase|Lost to Follow-up|2|||
146935394|NCT00355134|529922435|FG001|Extension Phase|Lost to Follow-up|6|||
146935395|NCT00355134|529922436|FG002|Extension Phase|Lost to Follow-up|0|||
146935396|NCT00355134|529922437|FG003|Extension Phase|Lost to Follow-up|2|||
146935397|NCT00355134|529922438|FG004|Extension Phase|Lost to Follow-up|4|||
146935398|NCT00355134|529922434|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
146935399|NCT00355134|529922435|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
146935400|NCT00355134|529922436|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
146935401|NCT00355134|529922437|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
146935402|NCT00355134|529922438|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
146935403|NCT00355134|529922434|FG000|Extension Phase|Administrative problems|2|||
146935404|NCT00355134|529922435|FG001|Extension Phase|Administrative problems|4|||
146935405|NCT00355134|529922436|FG002|Extension Phase|Administrative problems|0|||
146935406|NCT00355134|529922437|FG003|Extension Phase|Administrative problems|1|||
146935407|NCT00355134|529922438|FG004|Extension Phase|Administrative problems|1|||
146935408|NCT00355134|529922434|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
146935409|NCT00355134|529922435|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
146935410|NCT00355134|529922436|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
146935411|NCT00355134|529922437|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
146935412|NCT00355134|529922438|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
146935413|NCT00355134|529922434|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
146784780|NCT00450658|529382342|FG001|Overall Study|Lost to Follow-up|5|||
146784781|NCT00450658|529382341|FG000|Overall Study|UGI ulcer|33|||
146935414|NCT00355134|529922435|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
146935415|NCT00355134|529922436|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
146935416|NCT00355134|529922437|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
146935417|NCT00355134|529922438|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
146935418|NCT00355134|529922434|FG000|Extension Phase|Protocol Violation|0|||
146784782|NCT00450658|529382342|FG001|Overall Study|UGI ulcer|34|||
146784783|NCT00450658|529382341|FG000|Overall Study|misc|21|||
146784784|NCT00450658|529382342|FG001|Overall Study|misc|10|||
146727045|NCT01212770|529169235|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
146727046|NCT01212770|529169236|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
146727047|NCT01212770|529169237|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
146727048|NCT01212770|529169238|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
146727049|NCT01212770|529169239|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
146727050|NCT01212770|529169240|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
146727051|NCT01212770|529169232|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
146727052|NCT01212770|529169233|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
146727053|NCT01212770|529169234|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
146727054|NCT01212770|529169235|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
146727055|NCT01212770|529169236|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
146727056|NCT01212770|529169237|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
146727057|NCT01212770|529169238|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
146727058|NCT01212770|529169239|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
146727059|NCT01212770|529169240|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
146727060|NCT01212770|529169232|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
146727061|NCT01212770|529169233|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
146727062|NCT01212770|529169234|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
146727063|NCT01212770|529169235|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
146727064|NCT01212770|529169236|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
146727065|NCT01212770|529169237|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
146727066|NCT01212770|529169238|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
146727067|NCT01212770|529169239|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
146727068|NCT01212770|529169240|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
146727069|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146727070|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
146727071|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
146727072|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146727073|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146727074|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146727075|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146727076|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146727077|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
146727078|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146727079|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
146727080|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
146727081|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146727082|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146727083|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146727084|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146727085|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
146727086|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
146727087|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
146727088|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
146727089|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
146727090|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
146727091|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
146727092|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
146727093|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
146727094|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
146727095|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
146727096|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146727097|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
146727098|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
146935419|NCT00355134|529922435|FG001|Extension Phase|Protocol Violation|0|||
146727099|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146727100|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146727101|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146727102|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146727103|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
146727104|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
146727105|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
146727106|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
146727107|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
146727108|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
146935420|NCT00355134|529922436|FG002|Extension Phase|Protocol Violation|0|||
146935421|NCT00355134|529922437|FG003|Extension Phase|Protocol Violation|1|||
146784785|NCT05311384|529382346|FG000|Overall Study|Uncontrolled health conditions|2|||
146784786|NCT05311384|529382346|FG000|Overall Study|Withdrawal by Subject|1|||
146784787|NCT04322643|529382347|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
146784788|NCT03302494|529382348|FG000|Overall Study|Other|7|||
146784789|NCT03302494|529382349|FG001|Overall Study|Other|4|||
146784790|NCT03302494|529382350|FG002|Overall Study|Other|6|||
146784791|NCT03302494|529382348|FG000|Overall Study|Withdrawal by Subject|10|||
146784792|NCT03302494|529382349|FG001|Overall Study|Withdrawal by Subject|2|||
146784793|NCT03302494|529382350|FG002|Overall Study|Withdrawal by Subject|9|||
146784794|NCT03302494|529382348|FG000|Overall Study|Study Terminated by Sponsor|32|||
146784795|NCT03302494|529382349|FG001|Overall Study|Study Terminated by Sponsor|29|||
146784796|NCT03302494|529382350|FG002|Overall Study|Study Terminated by Sponsor|30|||
146784797|NCT03302494|529382348|FG000|Overall Study|Physician Decision|1|||
146784798|NCT03302494|529382349|FG001|Overall Study|Physician Decision|0|||
146784799|NCT03302494|529382350|FG002|Overall Study|Physician Decision|1|||
146784800|NCT03302494|529382348|FG000|Overall Study|Lost to Follow-up|1|||
146784801|NCT03302494|529382349|FG001|Overall Study|Lost to Follow-up|3|||
146784802|NCT03302494|529382350|FG002|Overall Study|Lost to Follow-up|3|||
146784803|NCT03302494|529382348|FG000|Overall Study|Death|13|||
146784804|NCT03302494|529382349|FG001|Overall Study|Death|11|||
146784805|NCT03302494|529382350|FG002|Overall Study|Death|4|||
146784806|NCT03302494|529382348|FG000|Overall Study|Adverse Event|1|||
146784807|NCT03302494|529382349|FG001|Overall Study|Adverse Event|2|||
146784808|NCT03302494|529382350|FG002|Overall Study|Adverse Event|0|||
146784809|NCT03302494|529382348|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
146784810|NCT03302494|529382349|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
146784811|NCT03302494|529382350|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
146784812|NCT01573442|529382351|FG000|Overall Study|Cancels|9|||
146784813|NCT01573442|529382352|FG001|Overall Study|Cancels|10|||
146784814|NCT05710107|529382355|FG000|Overall Study|Withdrawal by Subject|1|||
146784815|NCT05710107|529382356|FG001|Overall Study|Withdrawal by Subject|1|||
146784816|NCT05710107|529382355|FG000|Overall Study|Lost to Follow-up|8|||
146784817|NCT05710107|529382356|FG001|Overall Study|Lost to Follow-up|9|||
146784818|NCT05710107|529382355|FG000|Overall Study|Unable to place assigned block|2|||
146784819|NCT05710107|529382356|FG001|Overall Study|Unable to place assigned block|0|||
146784820|NCT05710107|529382355|FG000|Overall Study|Withdrawn by study team|0|||
146784821|NCT05710107|529382356|FG001|Overall Study|Withdrawn by study team|1|||
146784822|NCT04952909|529382361|FG000|Overall Study|Death|3|||
146784823|NCT02515773|529382365|FG000|Overall Study|Withdrawal by Subject|12|||
146784824|NCT02515773|529382366|FG001|Overall Study|Withdrawal by Subject|2|||
146784825|NCT02515773|529382365|FG000|Overall Study|Lost to Follow-up|119|||
146784826|NCT02515773|529382366|FG001|Overall Study|Lost to Follow-up|126|||
146784827|NCT02515773|529382365|FG000|Overall Study|Discharged from Clinic Services|53|||
146784828|NCT02515773|529382366|FG001|Overall Study|Discharged from Clinic Services|84|||
146784829|NCT02515773|529382365|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
146784830|NCT02515773|529382366|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
146784831|NCT02515773|529382365|FG000|Overall Study|Follow-up at non-study site|8|||
146784832|NCT02515773|529382366|FG001|Overall Study|Follow-up at non-study site|16|||
146784833|NCT02515773|529382365|FG000|Overall Study|Moved from area|9|||
146784834|NCT02515773|529382366|FG001|Overall Study|Moved from area|14|||
146784835|NCT05434078|529382367|FG000|Overall Study|Lost to Follow-up|2|||
146784836|NCT05434078|529382368|FG001|Overall Study|Lost to Follow-up|1|||
146784837|NCT05434078|529382367|FG000|Overall Study|Withdrawal by Subject|1|||
146784838|NCT05434078|529382368|FG001|Overall Study|Withdrawal by Subject|0|||
146784839|NCT04072380|529382370|FG000|Overall Study|Adverse Event|4|||
146784840|NCT04072380|529382371|FG001|Overall Study|Adverse Event|6|||
146784841|NCT04072380|529382372|FG002|Overall Study|Adverse Event|0|||
146784842|NCT04072380|529382370|FG000|Overall Study|Withdrawal by Subject|3|||
146784843|NCT04072380|529382371|FG001|Overall Study|Withdrawal by Subject|1|||
146784844|NCT04072380|529382372|FG002|Overall Study|Withdrawal by Subject|1|||
146784845|NCT04072380|529382370|FG000|Overall Study|Physician Decision|2|||
146784846|NCT04072380|529382371|FG001|Overall Study|Physician Decision|0|||
146784847|NCT04072380|529382372|FG002|Overall Study|Physician Decision|0|||
146784848|NCT04072380|529382370|FG000|Overall Study|Protocol Violation|0|||
146784849|NCT04072380|529382371|FG001|Overall Study|Protocol Violation|2|||
146784850|NCT04072380|529382372|FG002|Overall Study|Protocol Violation|3|||
146784851|NCT04072380|529382370|FG000|Overall Study|Intercurrent Illness and Others|3|||
146784852|NCT04072380|529382371|FG001|Overall Study|Intercurrent Illness and Others|5|||
146784853|NCT04072380|529382372|FG002|Overall Study|Intercurrent Illness and Others|6|||
146784854|NCT03652688|529382373|FG000|Baseline|Withdrawal by Subject|0|||
146784855|NCT03652688|529382374|FG001|Baseline|Withdrawal by Subject|3|||
146784856|NCT03652688|529382373|FG000|Follow-up|Lost to Follow-up|56|||
146784857|NCT03652688|529382374|FG001|Follow-up|Lost to Follow-up|54|||
146784858|NCT03033576|529382378|FG000|Overall Study|Ineligible|1|||
146784859|NCT03033576|529382379|FG001|Overall Study|Ineligible|1|||
146784860|NCT03033576|529382378|FG000|Overall Study|Adverse Event|4|||
146727109|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
146727110|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
146727111|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
146727112|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
146727113|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
146727114|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146727115|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
146727116|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
146727117|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146727118|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146727119|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146727120|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146727121|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146727122|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
146727123|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146727124|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
146727125|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
146727126|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146727127|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146727128|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146727129|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146727130|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
146727131|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
146727132|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146727133|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
146727134|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
146727135|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146727136|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146727137|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146727138|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146727139|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
146727140|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
146727141|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146727142|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
146727143|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
146727144|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146727145|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146727146|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146727147|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146727148|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
146727149|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
146727150|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146727151|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
146727152|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146727153|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146727154|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146727155|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146727156|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146727157|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146727158|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146727159|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
146727160|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
146727161|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
146727162|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
146727163|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
146727164|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
146727165|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
146727166|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
146727167|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
146727168|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146727169|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
146727170|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
146784861|NCT03033576|529382379|FG001|Overall Study|Adverse Event|20|||
146935422|NCT00355134|529922438|FG004|Extension Phase|Protocol Violation|0|||
146935423|NCT03621189|529922454|FG000|Overall Study|Withdrawal by Subject|0|||
146727171|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146727172|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146727173|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146784862|NCT03033576|529382378|FG000|Overall Study|Progression/relapse|9|||
146727174|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146727175|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
146727176|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
146727177|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146727178|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
146727179|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
146727180|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146727181|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146727182|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146727183|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146727184|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146727185|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
146727186|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146727187|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
146727188|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
146727189|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146727190|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146727191|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146727192|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146727193|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
146727194|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146727195|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
146727196|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
146727197|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
146727198|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
146727199|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
146727200|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
146727201|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
146727202|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
146727203|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
146727204|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146727205|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
146727206|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
146727207|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146727208|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146727209|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146727210|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146727211|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146727212|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146727213|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146727214|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146727215|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
146727216|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146727217|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146727218|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146727219|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146727220|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146727221|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146727222|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146727223|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
146727224|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146727225|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146727226|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146727227|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146727228|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146727229|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146727230|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
146727231|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
146727232|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
146727233|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
146727234|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
146727235|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
146727236|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
146727237|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
146727238|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
146727239|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
146727240|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146727241|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146727242|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
146727243|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146727244|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146727245|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146727246|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146727247|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146727248|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146727249|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146727250|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146727251|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
146727252|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146727253|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146727254|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146727255|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146727256|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146727257|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
146727258|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146727259|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146727260|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
146727261|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146727262|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146727263|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146727264|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146727265|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146727266|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146727267|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146727268|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
146727269|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
146727270|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146727271|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146727272|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146727273|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146727274|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
146727275|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146727276|NCT01212770|529169232|FG000|Long-term Safety Phase (Year 5)|Death|0|||
146727277|NCT01212770|529169233|FG001|Long-term Safety Phase (Year 5)|Death|0|||
146727278|NCT01212770|529169234|FG002|Long-term Safety Phase (Year 5)|Death|0|||
146727279|NCT01212770|529169235|FG003|Long-term Safety Phase (Year 5)|Death|0|||
146727280|NCT01212770|529169236|FG004|Long-term Safety Phase (Year 5)|Death|0|||
146727281|NCT01212770|529169237|FG005|Long-term Safety Phase (Year 5)|Death|0|||
146727282|NCT01212770|529169238|FG006|Long-term Safety Phase (Year 5)|Death|0|||
146727283|NCT01212770|529169239|FG007|Long-term Safety Phase (Year 5)|Death|1|||
146727284|NCT01212770|529169240|FG008|Long-term Safety Phase (Year 5)|Death|0|||
146727285|NCT00829387|529169243|FG000|Overall Study|Withdrawal by Subject|2|||
146727286|NCT00829387|529169244|FG001|Overall Study|Withdrawal by Subject|3|||
146727287|NCT00829387|529169243|FG000|Overall Study|Disqualified by PI|1|||
146727288|NCT00829387|529169244|FG001|Overall Study|Disqualified by PI|0|||
146727289|NCT00707031|529169252|FG000|Overall Study|Adverse Event|45|||
146727290|NCT00707031|529169253|FG001|Overall Study|Adverse Event|45|||
146727291|NCT00707031|529169252|FG000|Overall Study|Lack of Efficacy|19|||
146727292|NCT00707031|529169253|FG001|Overall Study|Lack of Efficacy|6|||
146727293|NCT00707031|529169252|FG000|Overall Study|Lost to Follow-up|2|||
146727294|NCT00707031|529169253|FG001|Overall Study|Lost to Follow-up|1|||
146727295|NCT00707031|529169252|FG000|Overall Study|Protocol Violation|1|||
146727296|NCT00707031|529169253|FG001|Overall Study|Protocol Violation|0|||
146727297|NCT00707031|529169252|FG000|Overall Study|Withdrawal by Subject|7|||
146727298|NCT00707031|529169253|FG001|Overall Study|Withdrawal by Subject|8|||
146727299|NCT00707031|529169252|FG000|Overall Study|Poor Compliance to Protocol|7|||
146727300|NCT00707031|529169253|FG001|Overall Study|Poor Compliance to Protocol|13|||
146727301|NCT00707031|529169252|FG000|Overall Study|Familial or Personal Reasons|12|||
146727302|NCT00707031|529169253|FG001|Overall Study|Familial or Personal Reasons|15|||
146727303|NCT00707031|529169252|FG000|Overall Study|Serious Noncompliance|2|||
146727304|NCT00707031|529169253|FG001|Overall Study|Serious Noncompliance|3|||
146727305|NCT00707031|529169252|FG000|Overall Study|Sponsor Decision|9|||
146727306|NCT00707031|529169253|FG001|Overall Study|Sponsor Decision|8|||
146727307|NCT00941330|529169254|FG000|Overall Study|Other|1|||
146727308|NCT00941330|529169255|FG001|Overall Study|Other|0|||
146727309|NCT00941330|529169254|FG000|Overall Study|Physician Decision|0|||
146727310|NCT00941330|529169255|FG001|Overall Study|Physician Decision|2|||
146727311|NCT02747238|529169256|FG000|Overall Study|Lack of Efficacy|0|||
146727312|NCT02747238|529169257|FG001|Overall Study|Lack of Efficacy|1|||
146727313|NCT02747238|529169256|FG000|Overall Study|Data lost|3|||
146727314|NCT02747238|529169257|FG001|Overall Study|Data lost|5|||
146727315|NCT00541450|529169258|FG000|Phase A|Adverse Event|3|||
146727316|NCT00541450|529169259|FG001|Phase A|Adverse Event|0|||
146727317|NCT00541450|529169258|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
146727318|NCT00541450|529169259|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
146727319|NCT00541450|529169258|FG000|Phase A|Hyperglycemia|0|||
146727320|NCT00541450|529169259|FG001|Phase A|Hyperglycemia|1|||
146727321|NCT00541450|529169258|FG000|Phase A|Lost to Follow-up|6|||
146727322|NCT00541450|529169259|FG001|Phase A|Lost to Follow-up|4|||
146727323|NCT00541450|529169258|FG000|Phase A|Physician Decision|2|||
146727324|NCT00541450|529169259|FG001|Phase A|Physician Decision|0|||
146727325|NCT00541450|529169258|FG000|Phase A|Protocol Violation|2|||
146727326|NCT00541450|529169259|FG001|Phase A|Protocol Violation|3|||
146727327|NCT00541450|529169258|FG000|Phase A|Withdrawal by Subject|7|||
146727328|NCT00541450|529169259|FG001|Phase A|Withdrawal by Subject|7|||
146727329|NCT00541450|529169258|FG000|Phase B|Adverse Event|6|||
146727330|NCT00541450|529169259|FG001|Phase B|Adverse Event|6|||
146727331|NCT00541450|529169258|FG000|Phase B|Hyperglycemia|10|||
146727332|NCT00541450|529169259|FG001|Phase B|Hyperglycemia|9|||
146727333|NCT00541450|529169258|FG000|Phase B|Lost to Follow-up|6|||
146727334|NCT00541450|529169259|FG001|Phase B|Lost to Follow-up|4|||
146727335|NCT00541450|529169258|FG000|Phase B|Physician Decision|4|||
146727336|NCT00541450|529169259|FG001|Phase B|Physician Decision|2|||
146727337|NCT00541450|529169258|FG000|Phase B|Pregnancy|0|||
146727338|NCT00541450|529169259|FG001|Phase B|Pregnancy|1|||
146727339|NCT00541450|529169258|FG000|Phase B|Protocol Violation|3|||
146727340|NCT00541450|529169259|FG001|Phase B|Protocol Violation|3|||
146727341|NCT00541450|529169258|FG000|Phase B|Withdrawal by Subject|8|||
146727342|NCT00541450|529169259|FG001|Phase B|Withdrawal by Subject|6|||
146727343|NCT02858895|529169260|FG000|Overall Study|Disease progression|31|||
146727344|NCT02858895|529169260|FG000|Overall Study|Death|2|||
146727345|NCT02858895|529169260|FG000|Overall Study|Adverse Event|1|||
146727346|NCT02858895|529169260|FG000|Overall Study|Withdrawal by Subject|3|||
146727347|NCT02858895|529169260|FG000|Overall Study|hospice,|1|||
146727348|NCT02858895|529169260|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
146727349|NCT05338333|529169261|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
146727350|NCT05338333|529169262|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
146727351|NCT01475136|529169263|FG000|Overall Study|Sponsor Decision|0|||
146727352|NCT01475136|529169264|FG001|Overall Study|Sponsor Decision|1|||
146727353|NCT01475136|529169265|FG002|Overall Study|Sponsor Decision|0|||
146727354|NCT01475136|529169266|FG003|Overall Study|Sponsor Decision|0|||
146727355|NCT01475136|529169263|FG000|Overall Study|Entry Criteria Not Met|0|||
146727356|NCT01475136|529169264|FG001|Overall Study|Entry Criteria Not Met|2|||
146727357|NCT01475136|529169265|FG002|Overall Study|Entry Criteria Not Met|3|||
146727358|NCT01475136|529169266|FG003|Overall Study|Entry Criteria Not Met|1|||
146727359|NCT01475136|529169263|FG000|Overall Study|Withdrawal by Subject|0|||
146727360|NCT01475136|529169264|FG001|Overall Study|Withdrawal by Subject|0|||
146727361|NCT01475136|529169265|FG002|Overall Study|Withdrawal by Subject|0|||
146727362|NCT01475136|529169266|FG003|Overall Study|Withdrawal by Subject|2|||
146727363|NCT01475136|529169263|FG000|Overall Study|Adverse Event|1|||
146727364|NCT01475136|529169264|FG001|Overall Study|Adverse Event|0|||
146727365|NCT01475136|529169265|FG002|Overall Study|Adverse Event|0|||
146727366|NCT01475136|529169266|FG003|Overall Study|Adverse Event|1|||
146727367|NCT01475136|529169263|FG000|Overall Study|Death|0|||
146727368|NCT01475136|529169264|FG001|Overall Study|Death|0|||
146727369|NCT01475136|529169265|FG002|Overall Study|Death|0|||
146727370|NCT01475136|529169266|FG003|Overall Study|Death|1|||
146727371|NCT01323530|529171032|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
146727372|NCT01323530|529171033|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146727373|NCT01323530|529171034|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146727374|NCT01323530|529171035|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146727375|NCT01323530|529171036|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146727376|NCT01323530|529171037|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
146727377|NCT01323530|529171038|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146727378|NCT01323530|529171032|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
146727379|NCT01323530|529171033|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
146727380|NCT01323530|529171034|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
146727381|NCT01323530|529171035|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
146727382|NCT01323530|529171036|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
146727383|NCT01323530|529171037|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
146727384|NCT01323530|529171038|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
146727385|NCT01323530|529171032|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
146727386|NCT01323530|529171033|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
146727387|NCT01323530|529171034|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
146727388|NCT01323530|529171035|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
146727389|NCT01323530|529171036|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
146727390|NCT01323530|529171037|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
146727391|NCT01323530|529171038|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
146727392|NCT01323530|529171032|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
146935424|NCT03621189|529922455|FG001|Overall Study|Withdrawal by Subject|3|||
146935425|NCT03621189|529922454|FG000|Overall Study|Physician Decision|0|||
146935426|NCT03621189|529922455|FG001|Overall Study|Physician Decision|2|||
146935427|NCT01135394|529922456|FG000|Screening|Lost to Follow-up|2|||
146935428|NCT01135394|529922456|FG000|Screening|Withdrawal by Subject|10|||
146935429|NCT01135394|529922456|FG000|Screening|Screening failure|16|||
146935430|NCT01135394|529922456|FG000|Screening|Physician Decision|5|||
146935431|NCT01135394|529922456|FG000|Baseline Assessment|Withdrawal by Subject|9|||
146935432|NCT01135394|529922456|FG000|Baseline Assessment|Physician Decision|3|||
146935433|NCT01135394|529922456|FG000|Baseline Assessment|Lost to Follow-up|2|||
146935434|NCT01135394|529922456|FG000|Baseline Assessment|Adverse Event|1|||
146935435|NCT01135394|529922456|FG000|Study Treatment|Withdrawal by Subject|1|||
146935436|NCT01135394|529922456|FG000|Study Treatment|Physician Decision|1|||
146935437|NCT01135394|529922456|FG000|Study Treatment|Adverse Event|2|||
146935438|NCT04432376|529922457|FG000|Double-blind Treatment Period|Adverse Event|2|||
146935439|NCT04432376|529922458|FG001|Double-blind Treatment Period|Adverse Event|6|||
146935440|NCT04432376|529922459|FG002|Double-blind Treatment Period|Adverse Event|0|||
146935441|NCT04432376|529922457|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
146935442|NCT04432376|529922458|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
146727393|NCT01323530|529171033|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
146727394|NCT01323530|529171034|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
146727395|NCT01323530|529171035|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
146727396|NCT01323530|529171036|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
146727397|NCT01323530|529171037|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
146727398|NCT01323530|529171038|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
146727399|NCT01323530|529171032|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
146727400|NCT01323530|529171033|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
146727401|NCT01323530|529171034|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
146727402|NCT01323530|529171035|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
146727403|NCT01323530|529171036|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
146727404|NCT01323530|529171037|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
146727405|NCT01323530|529171038|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
146727406|NCT01323530|529171032|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
146727407|NCT01323530|529171033|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
146727408|NCT01323530|529171034|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
146727409|NCT01323530|529171035|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
146727410|NCT01323530|529171036|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
146727411|NCT01323530|529171037|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
146727412|NCT01323530|529171038|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
146727413|NCT01323530|529171032|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
146727414|NCT01323530|529171033|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
146727415|NCT01323530|529171034|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
146727416|NCT01323530|529171035|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
146727417|NCT01323530|529171036|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
146727418|NCT01323530|529171037|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
146727419|NCT01323530|529171038|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
146727420|NCT01323530|529171032|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
146727421|NCT01323530|529171033|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
146727422|NCT01323530|529171034|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
146727423|NCT01323530|529171035|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
146727424|NCT01323530|529171036|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
146727425|NCT01323530|529171037|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
146727426|NCT01323530|529171038|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
146727427|NCT00289887|529171040|FG000|Overall Study|Adverse Event|3|||
146727428|NCT00289887|529171041|FG001|Overall Study|Adverse Event|3|||
146727429|NCT00289887|529171040|FG000|Overall Study|Lack of Efficacy|3|||
146727430|NCT00289887|529171041|FG001|Overall Study|Lack of Efficacy|11|||
146727431|NCT00289887|529171040|FG000|Overall Study|Lost to Follow-up|3|||
146727432|NCT00289887|529171041|FG001|Overall Study|Lost to Follow-up|3|||
146727433|NCT00289887|529171040|FG000|Overall Study|Protocol Violation|3|||
146727434|NCT00289887|529171041|FG001|Overall Study|Protocol Violation|1|||
146727435|NCT00289887|529171040|FG000|Overall Study|Withdrawal by Subject|3|||
146727436|NCT00289887|529171041|FG001|Overall Study|Withdrawal by Subject|8|||
146727437|NCT00289887|529171040|FG000|Overall Study|Other|7|||
146727438|NCT00289887|529171041|FG001|Overall Study|Other|3|||
146727439|NCT04128293|529171043|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
146727440|NCT04128293|529171044|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
146727441|NCT04128293|529171045|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
146727442|NCT04128293|529171046|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
146784863|NCT03033576|529382379|FG001|Overall Study|Progression/relapse|36|||
146935443|NCT04432376|529922459|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
146727443|NCT02035332|529171047|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
146727444|NCT02030015|529171052|FG000|Overall Study|Withdrawal by Subject|3|||
146727445|NCT02030015|529171052|FG000|Overall Study|Death|13|||
146727446|NCT01332227|529171054|FG000|Overall Study|Adverse Event|4|||
146727447|NCT01332227|529171055|FG001|Overall Study|Adverse Event|1|||
146727448|NCT01332227|529171054|FG000|Overall Study|Withdrawal by Subject|5|||
146727449|NCT01332227|529171055|FG001|Overall Study|Withdrawal by Subject|1|||
146727450|NCT01332227|529171054|FG000|Overall Study|Lost to Follow-up|2|||
146727451|NCT01332227|529171055|FG001|Overall Study|Lost to Follow-up|0|||
146727452|NCT01332227|529171054|FG000|Overall Study|Lack of Efficacy|3|||
146727453|NCT01332227|529171055|FG001|Overall Study|Lack of Efficacy|1|||
146727454|NCT01332227|529171054|FG000|Overall Study|Poor compliance/noncompliance|1|||
146727455|NCT01332227|529171055|FG001|Overall Study|Poor compliance/noncompliance|1|||
146727456|NCT01332227|529171054|FG000|Overall Study|Patient moved from area|1|||
146727457|NCT01332227|529171055|FG001|Overall Study|Patient moved from area|0|||
146727458|NCT01332227|529171054|FG000|Overall Study|Patient began prohibited medication|0|||
146727459|NCT01332227|529171055|FG001|Overall Study|Patient began prohibited medication|1|||
146727460|NCT00514943|529171056|FG000|Stage 1|Progressive disease|4|||
146727461|NCT00514943|529171057|FG001|Stage 1|Progressive disease|8|||
146727462|NCT00514943|529171056|FG000|Stage 1|Other Adverse Event|16|||
146727463|NCT00514943|529171057|FG001|Stage 1|Other Adverse Event|6|||
146727464|NCT00514943|529171056|FG000|Stage 1|Not treated|1|||
146727465|NCT00514943|529171057|FG001|Stage 1|Not treated|2|||
146935444|NCT04432376|529922457|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
146935445|NCT04432376|529922458|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
146935446|NCT04432376|529922459|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146935447|NCT04432376|529922457|FG000|Double-blind Treatment Period|Protocol Violation|0|||
146935448|NCT04432376|529922458|FG001|Double-blind Treatment Period|Protocol Violation|1|||
146935449|NCT04432376|529922459|FG002|Double-blind Treatment Period|Protocol Violation|0|||
146935450|NCT04432376|529922457|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
146935451|NCT04432376|529922458|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
146935452|NCT04432376|529922459|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
146935453|NCT02088541|529922460|FG000|Overall Study|Adverse Event|3|||
146935454|NCT02088541|529922461|FG001|Overall Study|Adverse Event|0|||
146935455|NCT02088541|529922462|FG002|Overall Study|Adverse Event|3|||
146935456|NCT02088541|529922463|FG003|Overall Study|Adverse Event|3|||
146935457|NCT02088541|529922464|FG004|Overall Study|Adverse Event|0|||
146935458|NCT02088541|529922460|FG000|Overall Study|Death|51|||
146935459|NCT02088541|529922461|FG001|Overall Study|Death|21|||
146935460|NCT02088541|529922462|FG002|Overall Study|Death|85|||
146935461|NCT02088541|529922463|FG003|Overall Study|Death|28|||
146935462|NCT02088541|529922464|FG004|Overall Study|Death|38|||
146935463|NCT02088541|529922460|FG000|Overall Study|Lost to Follow-up|2|||
146935464|NCT02088541|529922461|FG001|Overall Study|Lost to Follow-up|0|||
146727466|NCT00514943|529171056|FG000|Stage 1|Patient refused to continue study meds|8|||
146727467|NCT00514943|529171057|FG001|Stage 1|Patient refused to continue study meds|3|||
146727468|NCT00514943|529171056|FG000|Stage 1|Other than stated above|1|||
146727469|NCT00514943|529171057|FG001|Stage 1|Other than stated above|7|||
146727470|NCT00514943|529171056|FG000|Stage 2|Progressive disease|27|||
146727471|NCT00514943|529171057|FG001|Stage 2|Progressive disease|24|||
146727472|NCT00514943|529171056|FG000|Stage 2|Other Adverse Event|3|||
146727473|NCT00514943|529171057|FG001|Stage 2|Other Adverse Event|10|||
146727474|NCT00514943|529171056|FG000|Stage 2|Patient refused to continue study meds|2|||
146727475|NCT00514943|529171057|FG001|Stage 2|Patient refused to continue study meds|0|||
146727476|NCT00514943|529171056|FG000|Stage 2|Other than stated above|0|||
146727477|NCT00514943|529171057|FG001|Stage 2|Other than stated above|2|||
146935465|NCT02088541|529922462|FG002|Overall Study|Lost to Follow-up|1|||
146935466|NCT02088541|529922463|FG003|Overall Study|Lost to Follow-up|0|||
146935467|NCT02088541|529922464|FG004|Overall Study|Lost to Follow-up|0|||
146935468|NCT02088541|529922460|FG000|Overall Study|Physician Decision|2|||
146981580|NCT01621490|530096087|FG000|Overall Study|Subject no longer meets study criteria|0|||
146981581|NCT01621490|530096088|FG001|Overall Study|Subject no longer meets study criteria|0|||
146981582|NCT01621490|530096089|FG002|Overall Study|Subject no longer meets study criteria|0|||
146981583|NCT01621490|530096090|FG003|Overall Study|Subject no longer meets study criteria|0|||
146981584|NCT01621490|530096091|FG004|Overall Study|Subject no longer meets study criteria|1|||
146981585|NCT01621490|530096092|FG005|Overall Study|Subject no longer meets study criteria|0|||
146727478|NCT03751631|529171063|FG000|Overall Study|Withdrawal by Subject|0|||
146727479|NCT03751631|529171064|FG001|Overall Study|Withdrawal by Subject|0|||
146727480|NCT03751631|529171065|FG002|Overall Study|Withdrawal by Subject|1|||
146727481|NCT03751631|529171066|FG003|Overall Study|Withdrawal by Subject|1|||
146727482|NCT03751631|529171067|FG004|Overall Study|Withdrawal by Subject|0|||
146784864|NCT03033576|529382378|FG000|Overall Study|Death|1|||
146935469|NCT02088541|529922461|FG001|Overall Study|Physician Decision|1|||
146935470|NCT02088541|529922462|FG002|Overall Study|Physician Decision|2|||
146935471|NCT02088541|529922463|FG003|Overall Study|Physician Decision|0|||
146935472|NCT02088541|529922464|FG004|Overall Study|Physician Decision|2|||
146935473|NCT02088541|529922460|FG000|Overall Study|Disease progression|7|||
146981586|NCT01621490|530096093|FG006|Overall Study|Subject no longer meets study criteria|0|||
146981587|NCT01621490|530096094|FG007|Overall Study|Subject no longer meets study criteria|0|||
146981588|NCT01621490|530096095|FG008|Overall Study|Subject no longer meets study criteria|0|||
146981589|NCT01621490|530096096|FG009|Overall Study|Subject no longer meets study criteria|0|||
146981590|NCT01621490|530096097|FG010|Overall Study|Subject no longer meets study criteria|0|||
146981591|NCT01621490|530096087|FG000|Overall Study|Maximum clinical benefit|3|||
146981592|NCT01621490|530096088|FG001|Overall Study|Maximum clinical benefit|2|||
146981593|NCT01621490|530096089|FG002|Overall Study|Maximum clinical benefit|0|||
146981594|NCT01621490|530096090|FG003|Overall Study|Maximum clinical benefit|0|||
146981595|NCT01621490|530096091|FG004|Overall Study|Maximum clinical benefit|0|||
146981596|NCT01621490|530096092|FG005|Overall Study|Maximum clinical benefit|0|||
146981597|NCT01621490|530096093|FG006|Overall Study|Maximum clinical benefit|1|||
146981598|NCT01621490|530096094|FG007|Overall Study|Maximum clinical benefit|2|||
146981599|NCT01621490|530096095|FG008|Overall Study|Maximum clinical benefit|2|||
146981600|NCT01621490|530096096|FG009|Overall Study|Maximum clinical benefit|0|||
146981601|NCT01621490|530096097|FG010|Overall Study|Maximum clinical benefit|0|||
146981602|NCT01621490|530096087|FG000|Overall Study|Withdrawal by Subject|1|||
146981603|NCT01621490|530096088|FG001|Overall Study|Withdrawal by Subject|0|||
146981604|NCT01621490|530096089|FG002|Overall Study|Withdrawal by Subject|0|||
146981605|NCT01621490|530096090|FG003|Overall Study|Withdrawal by Subject|0|||
146981606|NCT01621490|530096091|FG004|Overall Study|Withdrawal by Subject|0|||
146981607|NCT01621490|530096092|FG005|Overall Study|Withdrawal by Subject|1|||
146981608|NCT01621490|530096093|FG006|Overall Study|Withdrawal by Subject|0|||
146981609|NCT01621490|530096094|FG007|Overall Study|Withdrawal by Subject|0|||
146981610|NCT01621490|530096095|FG008|Overall Study|Withdrawal by Subject|0|||
146981611|NCT01621490|530096096|FG009|Overall Study|Withdrawal by Subject|0|||
146981612|NCT01621490|530096097|FG010|Overall Study|Withdrawal by Subject|0|||
146981613|NCT01621490|530096087|FG000|Overall Study|Subject request to discontinue study|1|||
146981614|NCT01621490|530096088|FG001|Overall Study|Subject request to discontinue study|3|||
146981615|NCT01621490|530096089|FG002|Overall Study|Subject request to discontinue study|1|||
146981616|NCT01621490|530096090|FG003|Overall Study|Subject request to discontinue study|1|||
146981617|NCT01621490|530096091|FG004|Overall Study|Subject request to discontinue study|0|||
146981618|NCT01621490|530096092|FG005|Overall Study|Subject request to discontinue study|2|||
146981619|NCT01621490|530096093|FG006|Overall Study|Subject request to discontinue study|1|||
146981620|NCT01621490|530096094|FG007|Overall Study|Subject request to discontinue study|0|||
146727483|NCT03751631|529171068|FG005|Overall Study|Withdrawal by Subject|0|||
146727484|NCT00833560|529171069|FG000|Overall Study|Toxicity|13|||
146727485|NCT00833560|529171069|FG000|Overall Study|Adverse Event|11|||
146727486|NCT00833560|529171069|FG000|Overall Study|Protocol Violation|6|||
146727487|NCT00833560|529171069|FG000|Overall Study|Lack of Efficacy|4|||
146727488|NCT00833560|529171069|FG000|Overall Study|Death|2|||
146727489|NCT00833560|529171069|FG000|Overall Study|Pregression of other disease|1|||
146727490|NCT00833560|529171069|FG000|Overall Study|Other|5|||
146727491|NCT00499031|529171070|FG000|Overall Study|Improper pre-protocol treatment|1|||
146727492|NCT00499031|529171070|FG000|Overall Study|Required test not done|1|||
146727493|NCT00499031|529171070|FG000|Overall Study|Never treated|1|||
146727494|NCT03382782|529171075|FG000|Cohort 1|Withdrawal by Subject|11|||
146727495|NCT03382782|529171076|FG001|Cohort 1|Withdrawal by Subject|5|||
146727496|NCT03382782|529171077|FG002|Cohort 1|Withdrawal by Subject|0|||
146727497|NCT03382782|529171075|FG000|Cohort 2|Withdrawal by Subject|1|||
146727498|NCT03382782|529171076|FG001|Cohort 2|Withdrawal by Subject|1|||
146727499|NCT03382782|529171077|FG002|Cohort 2|Withdrawal by Subject|0|||
146727500|NCT03382782|529171075|FG000|Cohort 3|Withdrawal by Subject|1|||
146727501|NCT03382782|529171076|FG001|Cohort 3|Withdrawal by Subject|2|||
146727502|NCT03382782|529171077|FG002|Cohort 3|Withdrawal by Subject|0|||
146727503|NCT01791725|529171082|FG000|Overall Study|Withdrawal by Subject|0|||
146727504|NCT01791725|529171083|FG001|Overall Study|Withdrawal by Subject|1|||
146727505|NCT01791725|529171084|FG002|Overall Study|Withdrawal by Subject|0|||
146727506|NCT00512148|529171085|FG000|Primay Study Period|Withdrawal by Subject|1|||
146727507|NCT01666951|529171086|FG000|Overall Study|Not dosed|1|||
146727508|NCT01666951|529171087|FG001|Overall Study|Not dosed|1|||
146727509|NCT02366910|529171088|FG000|Overall Study|Withdrawal by Subject|2|||
146935474|NCT02088541|529922461|FG001|Overall Study|Disease progression|1|||
146727510|NCT02366910|529171088|FG000|Overall Study|Screen Failure|3|||
146935475|NCT02088541|529922462|FG002|Overall Study|Disease progression|2|||
146935476|NCT02088541|529922463|FG003|Overall Study|Disease progression|3|||
146935477|NCT02088541|529922464|FG004|Overall Study|Disease progression|1|||
146981621|NCT01621490|530096095|FG008|Overall Study|Subject request to discontinue study|1|||
146981622|NCT01621490|530096096|FG009|Overall Study|Subject request to discontinue study|0|||
146981623|NCT01621490|530096097|FG010|Overall Study|Subject request to discontinue study|0|||
146935478|NCT02088541|529922460|FG000|Overall Study|Study terminated by sponsor|1|||
146935479|NCT02088541|529922461|FG001|Overall Study|Study terminated by sponsor|1|||
146727511|NCT02623322|529171092|FG000|Overall Study|Lost to Follow-up|2|||
146727512|NCT02623322|529171093|FG001|Overall Study|Lost to Follow-up|1|||
146727513|NCT02623322|529171094|FG002|Overall Study|Lost to Follow-up|0|||
146727514|NCT03284788|529171095|FG000|Overall Study|Withdrawal by Subject|2|||
146727515|NCT03813238|529171099|FG000|Overall Study|Adverse Event|0|||
146727516|NCT03813238|529171100|FG001|Overall Study|Adverse Event|6|||
146727517|NCT03813238|529171099|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146727518|NCT03813238|529171100|FG001|Overall Study|Withdrawal by parent/guardian|2|||
146727519|NCT03813238|529171099|FG000|Overall Study|Lost to Follow-up|0|||
146727520|NCT03813238|529171100|FG001|Overall Study|Lost to Follow-up|1|||
146727521|NCT03813238|529171099|FG000|Overall Study|Other than specified|1|||
146727522|NCT03813238|529171100|FG001|Overall Study|Other than specified|2|||
146727523|NCT01690130|529171101|FG000|Overall Study|Subject have cancelled visit.|1|||
146727524|NCT01690130|529171102|FG001|Overall Study|Subject have cancelled visit.|0|||
146727525|NCT02462876|529171103|FG000|Overall Study|Death|3|||
146727526|NCT02462876|529171103|FG000|Overall Study|Lost to Follow-up|7|||
146727527|NCT02462876|529171103|FG000|Overall Study|Surgical Bypass|9|||
146727528|NCT02462876|529171103|FG000|Overall Study|Amputation Above the Metatarsals|1|||
146727529|NCT02462876|529171103|FG000|Overall Study|36 months follow-up visit missed|1|||
146727530|NCT02462876|529171103|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
146727531|NCT02462876|529171103|FG000|Overall Study|Patient did not come back to the vascular department|1|||
146727532|NCT02462876|529171103|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
146727533|NCT02462876|529171103|FG000|Overall Study|Patient refused to come back|1|||
146727534|NCT02462876|529171103|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
146727535|NCT02462876|529171103|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
146727536|NCT01786512|529171104|FG000|Overall Study|Lost to Follow-up|0|||
146727537|NCT01786512|529171105|FG001|Overall Study|Lost to Follow-up|0|||
146727538|NCT01786512|529171106|FG002|Overall Study|Lost to Follow-up|0|||
146727539|NCT01786512|529171107|FG003|Overall Study|Lost to Follow-up|0|||
146727540|NCT01786512|529171108|FG004|Overall Study|Lost to Follow-up|0|||
146727541|NCT01786512|529171109|FG005|Overall Study|Lost to Follow-up|0|||
146727542|NCT01786512|529171110|FG006|Overall Study|Lost to Follow-up|0|||
146727543|NCT01786512|529171111|FG007|Overall Study|Lost to Follow-up|0|||
146727544|NCT01786512|529171112|FG008|Overall Study|Lost to Follow-up|0|||
146727545|NCT01786512|529171113|FG009|Overall Study|Lost to Follow-up|1|||
146727546|NCT01786512|529171114|FG010|Overall Study|Lost to Follow-up|0|||
146727547|NCT01786512|529171104|FG000|Overall Study|Decision by sponsor|0|||
146727548|NCT01786512|529171105|FG001|Overall Study|Decision by sponsor|0|||
146727549|NCT01786512|529171106|FG002|Overall Study|Decision by sponsor|0|||
146727550|NCT01786512|529171107|FG003|Overall Study|Decision by sponsor|0|||
146727551|NCT01786512|529171108|FG004|Overall Study|Decision by sponsor|0|||
146727552|NCT01786512|529171109|FG005|Overall Study|Decision by sponsor|0|||
146727553|NCT01786512|529171110|FG006|Overall Study|Decision by sponsor|0|||
146727554|NCT01786512|529171111|FG007|Overall Study|Decision by sponsor|0|||
146727555|NCT01786512|529171112|FG008|Overall Study|Decision by sponsor|0|||
146727556|NCT01786512|529171113|FG009|Overall Study|Decision by sponsor|0|||
146727557|NCT01786512|529171114|FG010|Overall Study|Decision by sponsor|2|||
146727558|NCT01786512|529171104|FG000|Overall Study|Withdrawal by Subject|0|||
146727559|NCT01786512|529171105|FG001|Overall Study|Withdrawal by Subject|1|||
146727560|NCT01786512|529171106|FG002|Overall Study|Withdrawal by Subject|0|||
146727561|NCT01786512|529171107|FG003|Overall Study|Withdrawal by Subject|0|||
146727562|NCT01786512|529171108|FG004|Overall Study|Withdrawal by Subject|0|||
146727563|NCT01786512|529171109|FG005|Overall Study|Withdrawal by Subject|0|||
146727564|NCT01786512|529171110|FG006|Overall Study|Withdrawal by Subject|1|||
146727565|NCT01786512|529171111|FG007|Overall Study|Withdrawal by Subject|0|||
146727566|NCT01786512|529171112|FG008|Overall Study|Withdrawal by Subject|0|||
146727567|NCT01786512|529171113|FG009|Overall Study|Withdrawal by Subject|3|||
146727568|NCT01786512|529171114|FG010|Overall Study|Withdrawal by Subject|7|||
146727569|NCT01786512|529171104|FG000|Overall Study|Death|0|||
146727570|NCT01786512|529171105|FG001|Overall Study|Death|0|||
146727571|NCT01786512|529171106|FG002|Overall Study|Death|0|||
146727572|NCT01786512|529171107|FG003|Overall Study|Death|0|||
146727573|NCT01786512|529171108|FG004|Overall Study|Death|0|||
146727574|NCT01786512|529171109|FG005|Overall Study|Death|0|||
146727575|NCT01786512|529171110|FG006|Overall Study|Death|0|||
146727576|NCT01786512|529171111|FG007|Overall Study|Death|0|||
146727577|NCT01786512|529171112|FG008|Overall Study|Death|4|||
146727578|NCT01786512|529171113|FG009|Overall Study|Death|1|||
146727579|NCT01786512|529171114|FG010|Overall Study|Death|3|||
146727580|NCT02450331|529171115|FG000|Overall Study|Death|162|||
146727581|NCT02450331|529171116|FG001|Overall Study|Death|171|||
146727582|NCT02450331|529171115|FG000|Overall Study|Lost to Follow-up|14|||
146727583|NCT02450331|529171116|FG001|Overall Study|Lost to Follow-up|12|||
146727584|NCT02450331|529171115|FG000|Overall Study|Withdrawal by Subject|55|||
146727585|NCT02450331|529171116|FG001|Overall Study|Withdrawal by Subject|44|||
146727586|NCT02450331|529171115|FG000|Overall Study|Non-specified other|1|||
146727587|NCT02450331|529171116|FG001|Overall Study|Non-specified other|1|||
146727588|NCT03581981|529171117|FG000|Overall Study|Withdrawal by Subject|12|||
146784865|NCT03033576|529382379|FG001|Overall Study|Death|1|||
146935480|NCT02088541|529922462|FG002|Overall Study|Study terminated by sponsor|12|||
146935481|NCT02088541|529922463|FG003|Overall Study|Study terminated by sponsor|2|||
146935482|NCT02088541|529922464|FG004|Overall Study|Study terminated by sponsor|6|||
146935483|NCT02088541|529922460|FG000|Overall Study|Withdrawal by Subject|3|||
146935484|NCT02088541|529922461|FG001|Overall Study|Withdrawal by Subject|2|||
146727589|NCT03581981|529171118|FG001|Overall Study|Withdrawal by Subject|13|||
146727590|NCT03581981|529171117|FG000|Overall Study|Physician Decision|1|||
146727591|NCT03581981|529171118|FG001|Overall Study|Physician Decision|2|||
146727592|NCT03581981|529171117|FG000|Overall Study|Lost to Follow-up|0|||
146727593|NCT03581981|529171118|FG001|Overall Study|Lost to Follow-up|4|||
146727594|NCT02080871|529171119|FG000|Overall Study|Death|1|||
146727595|NCT02080871|529171119|FG000|Overall Study|Lost to Follow-up|1|||
146727596|NCT00338884|529171126|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
146727597|NCT00338884|529171126|FG000|Overall Study|Adverse Event|14|||
146727598|NCT00338884|529171126|FG000|Overall Study|Death|8|||
146727599|NCT00338884|529171126|FG000|Overall Study|Other|4|||
146727600|NCT00338884|529171126|FG000|Overall Study|Global Deterioration of Health Status|3|||
146727601|NCT00338884|529171126|FG000|Overall Study|Withdrawal by Subject|3|||
146727602|NCT00338884|529171126|FG000|Overall Study|Lost to Follow-up|1|||
146727603|NCT00338884|529171126|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
146727604|NCT02355002|529171128|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
146727605|NCT02355002|529171129|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
146727606|NCT02355002|529171128|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
146727607|NCT02355002|529171129|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
146727608|NCT02355002|529171128|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
146727609|NCT02355002|529171129|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
146727610|NCT02355002|529171128|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
146727611|NCT02355002|529171129|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
146727612|NCT02355002|529171128|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
146727613|NCT02355002|529171129|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
146727614|NCT02355002|529171128|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
146727615|NCT02355002|529171129|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
146727616|NCT02355002|529171128|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
146727617|NCT02355002|529171129|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
146727618|NCT00587964|529171132|FG000|Overall Study|Withdrawal by Subject|1|||
146727619|NCT00587964|529171132|FG000|Overall Study|Lost to Follow-up|1|||
146727620|NCT00587964|529171132|FG000|Overall Study|Patient found to be ineligible|1|||
146727621|NCT00587964|529171132|FG000|Overall Study|Patient did not receive intervention|5|||
146727622|NCT00587964|529171132|FG000|Overall Study|Progression of Disease|4|||
146727623|NCT01302847|529171138|FG000|Overall Study|Death|0|||
146727624|NCT01302847|529171139|FG001|Overall Study|Death|1|||
146727625|NCT01302847|529171140|FG002|Overall Study|Death|0|||
146727626|NCT01302847|529171141|FG003|Overall Study|Death|0|||
146727627|NCT01302847|529171142|FG004|Overall Study|Death|0|||
146727628|NCT01302847|529171143|FG005|Overall Study|Death|1|||
146727629|NCT01302847|529171144|FG006|Overall Study|Death|1|||
146727630|NCT01302847|529171145|FG007|Overall Study|Death|0|||
146727631|NCT01302847|529171138|FG000|Overall Study|Pregnancy|2|||
146727632|NCT01302847|529171139|FG001|Overall Study|Pregnancy|0|||
146727633|NCT01302847|529171140|FG002|Overall Study|Pregnancy|0|||
146727634|NCT01302847|529171141|FG003|Overall Study|Pregnancy|0|||
146727635|NCT01302847|529171142|FG004|Overall Study|Pregnancy|0|||
146727636|NCT01302847|529171143|FG005|Overall Study|Pregnancy|0|||
146727637|NCT01302847|529171144|FG006|Overall Study|Pregnancy|0|||
146727638|NCT01302847|529171145|FG007|Overall Study|Pregnancy|0|||
146727639|NCT01302847|529171138|FG000|Overall Study|Virologic failure|0|||
146727640|NCT01302847|529171139|FG001|Overall Study|Virologic failure|2|||
146727641|NCT01302847|529171140|FG002|Overall Study|Virologic failure|0|||
146727642|NCT01302847|529171141|FG003|Overall Study|Virologic failure|2|||
146727643|NCT01302847|529171142|FG004|Overall Study|Virologic failure|1|||
146727644|NCT01302847|529171143|FG005|Overall Study|Virologic failure|3|||
146727645|NCT01302847|529171144|FG006|Overall Study|Virologic failure|1|||
146727646|NCT01302847|529171145|FG007|Overall Study|Virologic failure|2|||
146727647|NCT01302847|529171138|FG000|Overall Study|Severe debilitation, unable to continue|0|||
146935485|NCT02088541|529922462|FG002|Overall Study|Withdrawal by Subject|9|||
146935486|NCT02088541|529922463|FG003|Overall Study|Withdrawal by Subject|7|||
146935487|NCT02088541|529922464|FG004|Overall Study|Withdrawal by Subject|10|||
146727648|NCT01302847|529171139|FG001|Overall Study|Severe debilitation, unable to continue|0|||
146727649|NCT01302847|529171140|FG002|Overall Study|Severe debilitation, unable to continue|0|||
146727650|NCT01302847|529171141|FG003|Overall Study|Severe debilitation, unable to continue|0|||
146727651|NCT01302847|529171142|FG004|Overall Study|Severe debilitation, unable to continue|0|||
146727652|NCT01302847|529171143|FG005|Overall Study|Severe debilitation, unable to continue|1|||
146727653|NCT01302847|529171144|FG006|Overall Study|Severe debilitation, unable to continue|1|||
146727654|NCT01302847|529171145|FG007|Overall Study|Severe debilitation, unable to continue|0|||
146727655|NCT01302847|529171138|FG000|Overall Study|Not able to get to clinic|1|||
146727656|NCT01302847|529171139|FG001|Overall Study|Not able to get to clinic|1|||
146727657|NCT01302847|529171140|FG002|Overall Study|Not able to get to clinic|0|||
146727658|NCT01302847|529171141|FG003|Overall Study|Not able to get to clinic|0|||
146727659|NCT01302847|529171142|FG004|Overall Study|Not able to get to clinic|0|||
146727660|NCT01302847|529171143|FG005|Overall Study|Not able to get to clinic|0|||
146727661|NCT01302847|529171144|FG006|Overall Study|Not able to get to clinic|0|||
146727662|NCT01302847|529171145|FG007|Overall Study|Not able to get to clinic|0|||
146727663|NCT01302847|529171138|FG000|Overall Study|Site closing|2|||
146727664|NCT01302847|529171139|FG001|Overall Study|Site closing|2|||
146727665|NCT01302847|529171140|FG002|Overall Study|Site closing|0|||
146727666|NCT01302847|529171141|FG003|Overall Study|Site closing|0|||
146727667|NCT01302847|529171142|FG004|Overall Study|Site closing|0|||
146727668|NCT01302847|529171143|FG005|Overall Study|Site closing|0|||
146727669|NCT01302847|529171144|FG006|Overall Study|Site closing|0|||
146727670|NCT01302847|529171145|FG007|Overall Study|Site closing|0|||
146727671|NCT01302847|529171138|FG000|Overall Study|Withdrawal by Subject|1|||
146727672|NCT01302847|529171139|FG001|Overall Study|Withdrawal by Subject|0|||
146727673|NCT01302847|529171140|FG002|Overall Study|Withdrawal by Subject|0|||
146727674|NCT01302847|529171141|FG003|Overall Study|Withdrawal by Subject|0|||
146727675|NCT01302847|529171142|FG004|Overall Study|Withdrawal by Subject|1|||
146727676|NCT01302847|529171143|FG005|Overall Study|Withdrawal by Subject|0|||
146727677|NCT01302847|529171144|FG006|Overall Study|Withdrawal by Subject|0|||
146727678|NCT01302847|529171145|FG007|Overall Study|Withdrawal by Subject|1|||
146727679|NCT01302847|529171138|FG000|Overall Study|Not willing to adhere to requirements|5|||
146727680|NCT01302847|529171139|FG001|Overall Study|Not willing to adhere to requirements|0|||
146727681|NCT01302847|529171140|FG002|Overall Study|Not willing to adhere to requirements|1|||
146727682|NCT01302847|529171141|FG003|Overall Study|Not willing to adhere to requirements|0|||
146727683|NCT01302847|529171142|FG004|Overall Study|Not willing to adhere to requirements|0|||
146727684|NCT01302847|529171143|FG005|Overall Study|Not willing to adhere to requirements|0|||
146727685|NCT01302847|529171144|FG006|Overall Study|Not willing to adhere to requirements|0|||
146727686|NCT01302847|529171145|FG007|Overall Study|Not willing to adhere to requirements|2|||
146727687|NCT01302847|529171138|FG000|Overall Study|Site unable to contact participant|2|||
146727688|NCT01302847|529171139|FG001|Overall Study|Site unable to contact participant|1|||
146727689|NCT01302847|529171140|FG002|Overall Study|Site unable to contact participant|0|||
146727690|NCT01302847|529171141|FG003|Overall Study|Site unable to contact participant|0|||
146727691|NCT01302847|529171142|FG004|Overall Study|Site unable to contact participant|0|||
146727692|NCT01302847|529171143|FG005|Overall Study|Site unable to contact participant|0|||
146727693|NCT01302847|529171144|FG006|Overall Study|Site unable to contact participant|2|||
146727694|NCT01302847|529171145|FG007|Overall Study|Site unable to contact participant|0|||
146727695|NCT01371851|529171146|FG000|Overall Study|Lost to Follow-up|5|||
146727696|NCT01371851|529171147|FG001|Overall Study|Lost to Follow-up|8|||
146727697|NCT01371851|529171146|FG000|Overall Study|was arrested and put in jail|0|||
146727698|NCT01371851|529171147|FG001|Overall Study|was arrested and put in jail|1|||
146727699|NCT01371851|529171146|FG000|Overall Study|non study related adverse event|1|||
146727700|NCT01371851|529171147|FG001|Overall Study|non study related adverse event|0|||
146727701|NCT01371851|529171146|FG000|Overall Study|Blood Pressure outside study parameters|2|||
146727702|NCT01371851|529171147|FG001|Overall Study|Blood Pressure outside study parameters|0|||
146727703|NCT00450411|529171148|FG000|Overall Study|Protocol Violation|6|||
146727704|NCT00450411|529171148|FG000|Overall Study|No protocol treatment|2|||
146727705|NCT00344461|529171151|FG000|Overall Study|Adverse Event|6|||
146727706|NCT00344461|529171151|FG000|Overall Study|Death|1|||
146727707|NCT00344461|529171151|FG000|Overall Study|Lack of Efficacy|2|||
146727708|NCT00344461|529171151|FG000|Overall Study|Lost to Follow-up|2|||
146727709|NCT00344461|529171151|FG000|Overall Study|Physician Decision|2|||
146727710|NCT00344461|529171151|FG000|Overall Study|Protocol Violation|6|||
146727711|NCT00344461|529171151|FG000|Overall Study|Withdrawal by Subject|2|||
146727712|NCT00951275|529171154|FG000|Overall Study|Administrative Reason|1|||
146727713|NCT00951275|529171154|FG000|Overall Study|Adverse Event|7|||
146727714|NCT00951275|529171154|FG000|Overall Study|Withdrawal by Subject|4|||
146727715|NCT00951275|529171154|FG000|Overall Study|Protocol Violation|1|||
146727716|NCT03645759|529171158|FG000|Overall Study|Lost to Follow-up|3|||
146727717|NCT03645759|529171159|FG001|Overall Study|Lost to Follow-up|2|||
146935488|NCT02088541|529922460|FG000|Overall Study|Other|2|||
146935489|NCT02088541|529922461|FG001|Overall Study|Other|1|||
146935490|NCT02088541|529922462|FG002|Overall Study|Other|3|||
146727718|NCT01389973|529171160|FG000|Overall Study|Lost to Follow-up|1|||
146727719|NCT01389973|529171160|FG000|Overall Study|Trial Stopped by Sponsor|9|||
146727720|NCT01389973|529171160|FG000|Overall Study|Other|10|||
146727721|NCT02693743|529171161|FG000|Overall Study|Physician Decision|1|||
146727722|NCT02693743|529171162|FG001|Overall Study|Physician Decision|0|||
146727723|NCT02459574|529171168|FG000|Overall Study|Withdrawal by Subject|6|||
146727724|NCT02459574|529171169|FG001|Overall Study|Withdrawal by Subject|6|||
146935491|NCT02088541|529922463|FG003|Overall Study|Other|1|||
146727725|NCT02459574|529171170|FG002|Overall Study|Withdrawal by Subject|2|||
146727726|NCT02459574|529171168|FG000|Overall Study|Lost to Follow-up|1|||
146727727|NCT02459574|529171169|FG001|Overall Study|Lost to Follow-up|1|||
146727728|NCT02459574|529171170|FG002|Overall Study|Lost to Follow-up|0|||
146727729|NCT02459574|529171168|FG000|Overall Study|Death|0|||
146727730|NCT02459574|529171169|FG001|Overall Study|Death|1|||
146727731|NCT02459574|529171170|FG002|Overall Study|Death|0|||
146727732|NCT00251745|529171171|FG000|Overall Study|Adverse Event|7|||
146727733|NCT00251745|529171172|FG001|Overall Study|Adverse Event|9|||
146727734|NCT00251745|529171173|FG002|Overall Study|Adverse Event|11|||
146727735|NCT00251745|529171171|FG000|Overall Study|Lost to Follow-up|4|||
146727736|NCT00251745|529171172|FG001|Overall Study|Lost to Follow-up|2|||
146727737|NCT00251745|529171173|FG002|Overall Study|Lost to Follow-up|5|||
146727738|NCT00251745|529171171|FG000|Overall Study|Withdrawal by Subject|13|||
146727739|NCT00251745|529171172|FG001|Overall Study|Withdrawal by Subject|7|||
146727740|NCT00251745|529171173|FG002|Overall Study|Withdrawal by Subject|3|||
146727741|NCT00251745|529171171|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
146727742|NCT00251745|529171172|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
146727743|NCT00251745|529171173|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
146727744|NCT00251745|529171171|FG000|Overall Study|Lack of Efficacy|3|||
146727745|NCT00251745|529171172|FG001|Overall Study|Lack of Efficacy|0|||
146727746|NCT00251745|529171173|FG002|Overall Study|Lack of Efficacy|0|||
146727747|NCT00251745|529171171|FG000|Overall Study|Noncompliant|0|||
146727748|NCT00251745|529171172|FG001|Overall Study|Noncompliant|2|||
146727749|NCT00251745|529171173|FG002|Overall Study|Noncompliant|2|||
146727750|NCT00251745|529171171|FG000|Overall Study|Pregnancy|0|||
146727751|NCT00251745|529171172|FG001|Overall Study|Pregnancy|1|||
146727752|NCT00251745|529171173|FG002|Overall Study|Pregnancy|0|||
146727753|NCT00251745|529171171|FG000|Overall Study|Per Subject Request|0|||
146727754|NCT00251745|529171172|FG001|Overall Study|Per Subject Request|0|||
146727755|NCT00251745|529171173|FG002|Overall Study|Per Subject Request|1|||
146727756|NCT00251745|529171171|FG000|Overall Study|Per Investigator Request|1|||
146727757|NCT00251745|529171172|FG001|Overall Study|Per Investigator Request|0|||
146727758|NCT00251745|529171173|FG002|Overall Study|Per Investigator Request|0|||
146727759|NCT04508699|529171176|FG000|Overall Study|Lack of Efficacy|2|||
146727760|NCT04508699|529171177|FG001|Overall Study|Lack of Efficacy|15|||
146727761|NCT04508699|529171176|FG000|Overall Study|Withdrawal by Subject|0|||
146727762|NCT04508699|529171177|FG001|Overall Study|Withdrawal by Subject|2|||
146727763|NCT03355326|529171178|FG000|Overall Study|Protocol Violation|3|||
146727764|NCT03355326|529171179|FG001|Overall Study|Protocol Violation|3|||
146727765|NCT01377480|529172770|FG000|Overall Study|Protocol Violation|0|||
146727766|NCT01377480|529172771|FG001|Overall Study|Protocol Violation|0|||
146727767|NCT01377480|529172772|FG002|Overall Study|Protocol Violation|0|||
146727768|NCT01377480|529172773|FG003|Overall Study|Protocol Violation|4|||
146727769|NCT01377480|529172770|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
146727770|NCT01377480|529172771|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
146727771|NCT01377480|529172772|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
146727772|NCT01377480|529172773|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
146727773|NCT01377480|529172770|FG000|Overall Study|Withdrawal by Subject|0|||
146727774|NCT01377480|529172771|FG001|Overall Study|Withdrawal by Subject|0|||
146727775|NCT01377480|529172772|FG002|Overall Study|Withdrawal by Subject|1|||
146727776|NCT01377480|529172773|FG003|Overall Study|Withdrawal by Subject|0|||
146727777|NCT01377480|529172770|FG000|Overall Study|Serious adverse event|0|||
146727778|NCT01377480|529172771|FG001|Overall Study|Serious adverse event|0|||
146727779|NCT01377480|529172772|FG002|Overall Study|Serious adverse event|1|||
146727780|NCT01377480|529172773|FG003|Overall Study|Serious adverse event|1|||
146727781|NCT01377480|529172770|FG000|Overall Study|Other|0|||
146727782|NCT01377480|529172771|FG001|Overall Study|Other|0|||
146727783|NCT01377480|529172772|FG002|Overall Study|Other|7|||
146727784|NCT01377480|529172773|FG003|Overall Study|Other|6|||
146727785|NCT01111123|529172777|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
146727786|NCT01111123|529172778|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
146727787|NCT01111123|529172777|FG000|Maintenance Phase|Lost to Follow-up|0|||
146727788|NCT01111123|529172778|FG001|Maintenance Phase|Lost to Follow-up|2|||
146727789|NCT01735201|529172779|FG000|Overall Study|Adverse Event|1|||
146727790|NCT01735201|529172780|FG001|Overall Study|Adverse Event|1|||
146727791|NCT01735201|529172781|FG002|Overall Study|Adverse Event|0|||
146727792|NCT01735201|529172782|FG003|Overall Study|Adverse Event|1|||
146727793|NCT01735201|529172783|FG004|Overall Study|Adverse Event|1|||
146727794|NCT01735201|529172784|FG005|Overall Study|Adverse Event|3|||
146727795|NCT01735201|529172785|FG006|Overall Study|Adverse Event|2|||
146727796|NCT01735201|529172786|FG007|Overall Study|Adverse Event|1|||
146727797|NCT01735201|529172779|FG000|Overall Study|Personal Reasons|1|||
146727798|NCT01735201|529172780|FG001|Overall Study|Personal Reasons|0|||
146727799|NCT01735201|529172781|FG002|Overall Study|Personal Reasons|0|||
146727800|NCT01735201|529172782|FG003|Overall Study|Personal Reasons|0|||
146727801|NCT01735201|529172783|FG004|Overall Study|Personal Reasons|0|||
146727802|NCT01735201|529172784|FG005|Overall Study|Personal Reasons|0|||
146727803|NCT01735201|529172785|FG006|Overall Study|Personal Reasons|0|||
146935492|NCT02088541|529922464|FG004|Overall Study|Other|1|||
146935493|NCT05742841|529922465|FG000|Overall Study|Withdrawal by Subject|1|||
146935494|NCT05742841|529922465|FG000|Overall Study|Lost to Follow-up|1|||
146935495|NCT04134728|529922466|FG000|Overall Study|Adverse Event|3|||
146935496|NCT04134728|529922467|FG001|Overall Study|Adverse Event|2|||
146935497|NCT04134728|529922468|FG002|Overall Study|Adverse Event|9|||
146935498|NCT04134728|529922469|FG003|Overall Study|Adverse Event|0|||
146935499|NCT04134728|529922470|FG004|Overall Study|Adverse Event|0|||
146935500|NCT04134728|529922471|FG005|Overall Study|Adverse Event|0|||
146935501|NCT04134728|529922466|FG000|Overall Study|Lack of Efficacy|3|||
146935502|NCT04134728|529922467|FG001|Overall Study|Lack of Efficacy|3|||
146935503|NCT04134728|529922468|FG002|Overall Study|Lack of Efficacy|1|||
146935504|NCT04134728|529922469|FG003|Overall Study|Lack of Efficacy|2|||
146935505|NCT04134728|529922470|FG004|Overall Study|Lack of Efficacy|0|||
146935506|NCT04134728|529922471|FG005|Overall Study|Lack of Efficacy|0|||
146935507|NCT04134728|529922466|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
146935508|NCT04134728|529922467|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146935509|NCT04134728|529922468|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
146935510|NCT04134728|529922469|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146935511|NCT04134728|529922470|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146935512|NCT04134728|529922471|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146935513|NCT04134728|529922466|FG000|Overall Study|Protocol Deviation|0|||
146935514|NCT04134728|529922467|FG001|Overall Study|Protocol Deviation|0|||
146935515|NCT04134728|529922468|FG002|Overall Study|Protocol Deviation|1|||
146935516|NCT04134728|529922469|FG003|Overall Study|Protocol Deviation|0|||
146935517|NCT04134728|529922470|FG004|Overall Study|Protocol Deviation|0|||
146727804|NCT01735201|529172786|FG007|Overall Study|Personal Reasons|0|||
146727805|NCT01735201|529172779|FG000|Overall Study|Protocol Violation|1|||
146727806|NCT01735201|529172780|FG001|Overall Study|Protocol Violation|0|||
146727807|NCT01735201|529172781|FG002|Overall Study|Protocol Violation|0|||
146727808|NCT01735201|529172782|FG003|Overall Study|Protocol Violation|0|||
146727809|NCT01735201|529172783|FG004|Overall Study|Protocol Violation|0|||
146727810|NCT01735201|529172784|FG005|Overall Study|Protocol Violation|0|||
146727811|NCT01735201|529172785|FG006|Overall Study|Protocol Violation|0|||
146727812|NCT01735201|529172786|FG007|Overall Study|Protocol Violation|0|||
146727813|NCT01735201|529172779|FG000|Overall Study|Other Miscellaneous Reasons|0|||
146727814|NCT01735201|529172780|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146727815|NCT01735201|529172781|FG002|Overall Study|Other Miscellaneous Reasons|0|||
146727816|NCT01735201|529172782|FG003|Overall Study|Other Miscellaneous Reasons|1|||
146727817|NCT01735201|529172783|FG004|Overall Study|Other Miscellaneous Reasons|0|||
146727818|NCT01735201|529172784|FG005|Overall Study|Other Miscellaneous Reasons|2|||
146727819|NCT01735201|529172785|FG006|Overall Study|Other Miscellaneous Reasons|1|||
146727820|NCT01735201|529172786|FG007|Overall Study|Other Miscellaneous Reasons|1|||
146727821|NCT01203930|529172791|FG000|Overall Study|Disease Progression|0|||
146727822|NCT01203930|529172792|FG001|Overall Study|Disease Progression|4|||
146727823|NCT01203930|529172791|FG000|Overall Study|Death|3|||
146727824|NCT01203930|529172792|FG001|Overall Study|Death|1|||
146727825|NCT01203930|529172791|FG000|Overall Study|Withdrew Consent|1|||
146727826|NCT01203930|529172792|FG001|Overall Study|Withdrew Consent|10|||
146727827|NCT01203930|529172791|FG000|Overall Study|Investigator Request|0|||
146727828|NCT01203930|529172792|FG001|Overall Study|Investigator Request|8|||
146727829|NCT01203930|529172791|FG000|Overall Study|Study Terminated by Sponsor|0|||
146727830|NCT01203930|529172792|FG001|Overall Study|Study Terminated by Sponsor|12|||
146727831|NCT01203930|529172791|FG000|Overall Study|Poor tolerance of study drug|0|||
146935518|NCT04134728|529922471|FG005|Overall Study|Protocol Deviation|0|||
146935519|NCT04134728|529922466|FG000|Overall Study|Informed Consent Withdrawn|3|||
146935520|NCT04134728|529922467|FG001|Overall Study|Informed Consent Withdrawn|6|||
146935521|NCT04134728|529922468|FG002|Overall Study|Informed Consent Withdrawn|8|||
146727832|NCT01203930|529172792|FG001|Overall Study|Poor tolerance of study drug|1|||
146727833|NCT01203930|529172791|FG000|Overall Study|Adverse Event|17|||
146727834|NCT01203930|529172792|FG001|Overall Study|Adverse Event|5|||
146727835|NCT03014674|529172795|FG000|Overall Study|Withdrawal by Subject|1|||
146727836|NCT03014674|529172796|FG001|Overall Study|Withdrawal by Subject|0|||
146727837|NCT03014674|529172797|FG002|Overall Study|Withdrawal by Subject|0|||
146727838|NCT00234052|529172798|FG000|Treatment|Withdrawal by Subject|3|||
146727839|NCT00234052|529172798|FG000|Treatment|Adverse Event|5|||
146727840|NCT00234052|529172798|FG000|Treatment|Death|2|||
146727841|NCT00234052|529172798|FG000|Treatment|Progressive Disease|11|||
146935522|NCT04134728|529922469|FG003|Overall Study|Informed Consent Withdrawn|1|||
146935523|NCT04134728|529922470|FG004|Overall Study|Informed Consent Withdrawn|1|||
146935524|NCT04134728|529922471|FG005|Overall Study|Informed Consent Withdrawn|0|||
146727842|NCT00234052|529172798|FG000|Follow-up for 5 Years|Death|41|||
146727843|NCT00234052|529172798|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
146727844|NCT00234052|529172798|FG000|Follow-up for 5 Years|Other|7|||
146727845|NCT01410474|529172799|FG000|Overall Study|Withdrawal by Subject|0|||
146935525|NCT04134728|529922466|FG000|Overall Study|Physician Decision|2|||
146935526|NCT04134728|529922467|FG001|Overall Study|Physician Decision|0|||
146935527|NCT04134728|529922468|FG002|Overall Study|Physician Decision|0|||
146784866|NCT03033576|529382378|FG000|Overall Study|Patient refusal|1|||
146784867|NCT03033576|529382379|FG001|Overall Study|Patient refusal|6|||
146784868|NCT03033576|529382378|FG000|Overall Study|Other, unspecified reasons|0|||
146784869|NCT03033576|529382379|FG001|Overall Study|Other, unspecified reasons|4|||
146784870|NCT03033576|529382378|FG000|Overall Study|Currently on protocol therapy|0|||
146784871|NCT03033576|529382379|FG001|Overall Study|Currently on protocol therapy|2|||
146784872|NCT03557697|529382380|FG000|Overall Study|Withdrawal by Subject|2|||
146784873|NCT03557697|529382381|FG001|Overall Study|Withdrawal by Subject|4|||
146784874|NCT01214616|529382385|FG000|Overall Study|Progressive disease|2|||
146784875|NCT01214616|529382386|FG001|Overall Study|Progressive disease|2|||
146784876|NCT01214616|529382387|FG002|Overall Study|Progressive disease|2|||
146784877|NCT01214616|529382388|FG003|Overall Study|Progressive disease|4|||
146784878|NCT01214616|529382385|FG000|Overall Study|Dose limiting toxicity|0|||
146784879|NCT01214616|529382386|FG001|Overall Study|Dose limiting toxicity|2|||
146784880|NCT01214616|529382387|FG002|Overall Study|Dose limiting toxicity|0|||
146784881|NCT01214616|529382388|FG003|Overall Study|Dose limiting toxicity|0|||
146784882|NCT01214616|529382385|FG000|Overall Study|Other adverse events|0|||
146784883|NCT01214616|529382386|FG001|Overall Study|Other adverse events|1|||
146784884|NCT01214616|529382387|FG002|Overall Study|Other adverse events|1|||
146784885|NCT01214616|529382388|FG003|Overall Study|Other adverse events|1|||
146784886|NCT01214616|529382385|FG000|Overall Study|Withdrawal by Subject|1|||
146784887|NCT01214616|529382386|FG001|Overall Study|Withdrawal by Subject|0|||
146784888|NCT01214616|529382387|FG002|Overall Study|Withdrawal by Subject|0|||
146784889|NCT01214616|529382388|FG003|Overall Study|Withdrawal by Subject|1|||
146784890|NCT04015167|529382394|FG000|Overall Study|Lost to Follow-up|40|||
146784891|NCT04015167|529382394|FG000|Overall Study|Adverse Event|5|||
146784892|NCT04015167|529382394|FG000|Overall Study|Withdrawal by Subject|2|||
146784893|NCT04015167|529382394|FG000|Overall Study|Subject went to jail|1|||
146784894|NCT03640312|529382395|FG000|Overall Study|Lost to Follow-up|3|||
146784895|NCT03640312|529382396|FG001|Overall Study|Lost to Follow-up|6|||
146784896|NCT02761057|529382402|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
146784897|NCT02761057|529382403|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
146784898|NCT02761057|529382404|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
146784899|NCT02761057|529382405|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
146784900|NCT02761057|529382402|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
146784901|NCT02761057|529382403|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
146784902|NCT02761057|529382404|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
146784903|NCT02761057|529382405|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
146784904|NCT02761057|529382402|FG000|Overall Study|Currently On Study Treatment|0|||
146784905|NCT02761057|529382403|FG001|Overall Study|Currently On Study Treatment|3|||
146784906|NCT02761057|529382404|FG002|Overall Study|Currently On Study Treatment|0|||
146784907|NCT02761057|529382405|FG003|Overall Study|Currently On Study Treatment|0|||
146784908|NCT02761057|529382402|FG000|Overall Study|Adverse Event|11|||
146784909|NCT02761057|529382403|FG001|Overall Study|Adverse Event|9|||
146784910|NCT02761057|529382404|FG002|Overall Study|Adverse Event|5|||
146784911|NCT02761057|529382405|FG003|Overall Study|Adverse Event|3|||
146784912|NCT02761057|529382402|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
146784913|NCT02761057|529382403|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
146784914|NCT02761057|529382404|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
146784915|NCT02761057|529382405|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
146784916|NCT02761057|529382402|FG000|Overall Study|Progression/Relapse|29|||
146784917|NCT02761057|529382403|FG001|Overall Study|Progression/Relapse|27|||
146784918|NCT02761057|529382404|FG002|Overall Study|Progression/Relapse|20|||
146784919|NCT02761057|529382405|FG003|Overall Study|Progression/Relapse|23|||
146784920|NCT02761057|529382402|FG000|Overall Study|Death|2|||
146784921|NCT02761057|529382403|FG001|Overall Study|Death|2|||
146784922|NCT02761057|529382404|FG002|Overall Study|Death|1|||
146784923|NCT02761057|529382405|FG003|Overall Study|Death|1|||
146784924|NCT02761057|529382402|FG000|Overall Study|Other - Not Protocol Specified|2|||
146784925|NCT02761057|529382403|FG001|Overall Study|Other - Not Protocol Specified|1|||
146784926|NCT02761057|529382404|FG002|Overall Study|Other - Not Protocol Specified|2|||
146784927|NCT02761057|529382405|FG003|Overall Study|Other - Not Protocol Specified|0|||
146784928|NCT06037369|529382406|FG000|Overall Study|Lost to Follow-up|0|||
146784929|NCT06037369|529382407|FG001|Overall Study|Lost to Follow-up|1|||
146784930|NCT05008835|529382409|FG000|Overall Study|Adverse Event|5|||
146784931|NCT05008835|529382410|FG001|Overall Study|Adverse Event|2|||
146784932|NCT05008835|529382411|FG002|Overall Study|Adverse Event|1|||
146784933|NCT05008835|529382409|FG000|Overall Study|Lack of Efficacy|0|||
146784934|NCT05008835|529382410|FG001|Overall Study|Lack of Efficacy|0|||
146784935|NCT05008835|529382411|FG002|Overall Study|Lack of Efficacy|1|||
146784936|NCT05008835|529382409|FG000|Overall Study|Study terminated by sponsor|0|||
146784937|NCT05008835|529382410|FG001|Overall Study|Study terminated by sponsor|0|||
146784938|NCT05008835|529382411|FG002|Overall Study|Study terminated by sponsor|1|||
146935528|NCT04134728|529922469|FG003|Overall Study|Physician Decision|0|||
146935529|NCT04134728|529922470|FG004|Overall Study|Physician Decision|0|||
146935530|NCT04134728|529922471|FG005|Overall Study|Physician Decision|0|||
146935531|NCT04134728|529922466|FG000|Overall Study|Lost to Follow-up|1|||
146727846|NCT01410474|529172800|FG001|Overall Study|Withdrawal by Subject|1|||
146727847|NCT00828984|529172801|FG000|Overall Study|Adverse Event|2|||
146727848|NCT00828984|529172802|FG001|Overall Study|Adverse Event|3|||
146727849|NCT00828984|529172803|FG002|Overall Study|Adverse Event|0|||
146727850|NCT00828984|529172801|FG000|Overall Study|Lost to Follow-up|5|||
146727851|NCT00828984|529172802|FG001|Overall Study|Lost to Follow-up|3|||
146727852|NCT00828984|529172803|FG002|Overall Study|Lost to Follow-up|1|||
146727853|NCT00828984|529172801|FG000|Overall Study|Withdrawal by Subject|4|||
146727854|NCT00828984|529172802|FG001|Overall Study|Withdrawal by Subject|4|||
146727855|NCT00828984|529172803|FG002|Overall Study|Withdrawal by Subject|4|||
146727856|NCT00828984|529172801|FG000|Overall Study|Ineligable|1|||
146727857|NCT00828984|529172802|FG001|Overall Study|Ineligable|2|||
146727858|NCT00828984|529172803|FG002|Overall Study|Ineligable|0|||
146727859|NCT00828984|529172801|FG000|Overall Study|Medical Contraindication|0|||
146727860|NCT00828984|529172802|FG001|Overall Study|Medical Contraindication|1|||
146727861|NCT00828984|529172803|FG002|Overall Study|Medical Contraindication|0|||
146727862|NCT00828984|529172801|FG000|Overall Study|Noncompliant|1|||
146727863|NCT00828984|529172802|FG001|Overall Study|Noncompliant|2|||
146727864|NCT00828984|529172803|FG002|Overall Study|Noncompliant|3|||
146727865|NCT00828984|529172801|FG000|Overall Study|ConMed|1|||
146727866|NCT00828984|529172802|FG001|Overall Study|ConMed|1|||
146727867|NCT00828984|529172803|FG002|Overall Study|ConMed|1|||
146727868|NCT00420199|529172804|FG000|Overall Study|Participant no longer met study criteria|1|||
146727869|NCT00420199|529172805|FG001|Overall Study|Participant no longer met study criteria|0|||
146727870|NCT00002558|529172814|FG000|Overall Study|Withdrawal by Subject|0|||
146727871|NCT00002558|529172815|FG001|Overall Study|Withdrawal by Subject|1|||
146727872|NCT01260350|529172816|FG000|Overall Study|Lack of Efficacy|0|||
146727873|NCT01260350|529172817|FG001|Overall Study|Lack of Efficacy|0|||
146727874|NCT01260350|529172818|FG002|Overall Study|Lack of Efficacy|0|||
146727875|NCT01260350|529172819|FG003|Overall Study|Lack of Efficacy|0|||
146727876|NCT01260350|529172820|FG004|Overall Study|Lack of Efficacy|0|||
146727877|NCT01260350|529172821|FG005|Overall Study|Lack of Efficacy|0|||
146727878|NCT01260350|529172822|FG006|Overall Study|Lack of Efficacy|0|||
146727879|NCT01260350|529172823|FG007|Overall Study|Lack of Efficacy|0|||
146727880|NCT01260350|529172824|FG008|Overall Study|Lack of Efficacy|0|||
146727881|NCT01260350|529172825|FG009|Overall Study|Lack of Efficacy|0|||
146727882|NCT01260350|529172826|FG010|Overall Study|Lack of Efficacy|0|||
146727883|NCT01260350|529172827|FG011|Overall Study|Lack of Efficacy|0|||
146727884|NCT01260350|529172828|FG012|Overall Study|Lack of Efficacy|0|||
146727885|NCT01260350|529172829|FG013|Overall Study|Lack of Efficacy|0|||
146727886|NCT01260350|529172830|FG014|Overall Study|Lack of Efficacy|0|||
146727887|NCT01260350|529172831|FG015|Overall Study|Lack of Efficacy|0|||
146727888|NCT01260350|529172832|FG016|Overall Study|Lack of Efficacy|0|||
146727889|NCT01260350|529172833|FG017|Overall Study|Lack of Efficacy|1|||
146727890|NCT01260350|529172834|FG018|Overall Study|Lack of Efficacy|0|||
146727891|NCT01260350|529172835|FG019|Overall Study|Lack of Efficacy|0|||
146727892|NCT01260350|529172836|FG020|Overall Study|Lack of Efficacy|3|||
146727893|NCT01260350|529172837|FG021|Overall Study|Lack of Efficacy|0|||
146727894|NCT01260350|529172816|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727895|NCT01260350|529172817|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727896|NCT01260350|529172818|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727897|NCT01260350|529172819|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727898|NCT01260350|529172820|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727899|NCT01260350|529172821|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727900|NCT01260350|529172822|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727901|NCT01260350|529172823|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727902|NCT01260350|529172824|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
146727903|NCT01260350|529172825|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727904|NCT01260350|529172826|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727905|NCT01260350|529172827|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727906|NCT01260350|529172828|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146935532|NCT04134728|529922467|FG001|Overall Study|Lost to Follow-up|2|||
146727907|NCT01260350|529172829|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727908|NCT01260350|529172830|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727909|NCT01260350|529172831|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727910|NCT01260350|529172832|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727911|NCT01260350|529172833|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727912|NCT01260350|529172834|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727913|NCT01260350|529172835|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727914|NCT01260350|529172836|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727915|NCT01260350|529172837|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146727916|NCT00558428|529172840|FG000|Overall Study|Adverse Event|6|||
146935533|NCT04134728|529922468|FG002|Overall Study|Lost to Follow-up|1|||
146727917|NCT00558428|529172841|FG001|Overall Study|Adverse Event|22|||
146727918|NCT00558428|529172842|FG002|Overall Study|Adverse Event|3|||
146935534|NCT04134728|529922469|FG003|Overall Study|Lost to Follow-up|0|||
146727919|NCT00558428|529172843|FG003|Overall Study|Adverse Event|4|||
146727920|NCT00558428|529172840|FG000|Overall Study|Lost to Follow-up|0|||
146727921|NCT00558428|529172841|FG001|Overall Study|Lost to Follow-up|1|||
146727922|NCT00558428|529172842|FG002|Overall Study|Lost to Follow-up|0|||
146727923|NCT00558428|529172843|FG003|Overall Study|Lost to Follow-up|0|||
146727924|NCT00558428|529172840|FG000|Overall Study|Lack of Efficacy|0|||
146727925|NCT00558428|529172841|FG001|Overall Study|Lack of Efficacy|0|||
146727926|NCT00558428|529172842|FG002|Overall Study|Lack of Efficacy|1|||
146727927|NCT00558428|529172843|FG003|Overall Study|Lack of Efficacy|2|||
146727928|NCT00558428|529172840|FG000|Overall Study|Non compliant with protocol|1|||
146727929|NCT00558428|529172841|FG001|Overall Study|Non compliant with protocol|0|||
146727930|NCT00558428|529172842|FG002|Overall Study|Non compliant with protocol|0|||
146727931|NCT00558428|529172843|FG003|Overall Study|Non compliant with protocol|3|||
146727932|NCT00558428|529172840|FG000|Overall Study|Consent withdrawn|2|||
146727933|NCT00558428|529172841|FG001|Overall Study|Consent withdrawn|1|||
146727934|NCT00558428|529172842|FG002|Overall Study|Consent withdrawn|0|||
146727935|NCT00558428|529172843|FG003|Overall Study|Consent withdrawn|1|||
146727936|NCT00558428|529172840|FG000|Overall Study|Other|3|||
146727937|NCT00558428|529172841|FG001|Overall Study|Other|0|||
146727938|NCT00558428|529172842|FG002|Overall Study|Other|0|||
146727939|NCT00558428|529172843|FG003|Overall Study|Other|1|||
146727940|NCT00626028|529172844|FG000|Overall Study|Adverse Event|1|||
146727941|NCT00626028|529172845|FG001|Overall Study|Adverse Event|1|||
146727942|NCT00626028|529172844|FG000|Overall Study|Device Failure|0|||
146727943|NCT00626028|529172845|FG001|Overall Study|Device Failure|1|||
146727944|NCT00626028|529172844|FG000|Overall Study|Physician Decision|2|||
146727945|NCT00626028|529172845|FG001|Overall Study|Physician Decision|1|||
146727946|NCT00626028|529172844|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
146727947|NCT00626028|529172845|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
146727948|NCT05224050|529172846|FG000|Overall Study|Withdrawal by Subject|9|||
146727949|NCT05224050|529172846|FG000|Overall Study|Lost to Follow-up|3|||
146727950|NCT02436330|529172847|FG000|Cohort 1|Lost to Follow-up|5|||
146727951|NCT02436330|529172848|FG001|Cohort 1|Lost to Follow-up|2|||
146727952|NCT02436330|529172847|FG000|Cohort 1|Withdrawal by Subject|0|||
146727953|NCT02436330|529172848|FG001|Cohort 1|Withdrawal by Subject|1|||
146727954|NCT02436330|529172847|FG000|Cohort 2|Lost to Follow-up|2|||
146727955|NCT02436330|529172848|FG001|Cohort 2|Lost to Follow-up|0|||
146727956|NCT02436330|529172847|FG000|Cohort 2|Withdrawal by Subject|2|||
146727957|NCT02436330|529172848|FG001|Cohort 2|Withdrawal by Subject|3|||
146727958|NCT02436330|529172847|FG000|Cohort 3|Lost to Follow-up|1|||
146727959|NCT02436330|529172848|FG001|Cohort 3|Lost to Follow-up|0|||
146727960|NCT02436330|529172847|FG000|Cohort 3|Withdrawal by Subject|4|||
146727961|NCT02436330|529172848|FG001|Cohort 3|Withdrawal by Subject|0|||
146727962|NCT02436330|529172847|FG000|Cohort 4|Lost to Follow-up|1|||
146727963|NCT02436330|529172848|FG001|Cohort 4|Lost to Follow-up|0|||
146727964|NCT02436330|529172847|FG000|Cohort 4|Withdrawal by Subject|1|||
146727965|NCT02436330|529172848|FG001|Cohort 4|Withdrawal by Subject|0|||
146727966|NCT02436330|529172847|FG000|Cohort 5|Lost to Follow-up|3|||
146727967|NCT02436330|529172848|FG001|Cohort 5|Lost to Follow-up|2|||
146935535|NCT04134728|529922470|FG004|Overall Study|Lost to Follow-up|0|||
146727968|NCT02436330|529172847|FG000|Cohort 5|Withdrawal by Subject|3|||
146727969|NCT02436330|529172848|FG001|Cohort 5|Withdrawal by Subject|2|||
146727970|NCT02436330|529172847|FG000|Cohort 6|Lost to Follow-up|2|||
146727971|NCT02436330|529172848|FG001|Cohort 6|Lost to Follow-up|0|||
146727972|NCT02436330|529172847|FG000|Cohort 6|Withdrawal by Subject|1|||
146727973|NCT02436330|529172848|FG001|Cohort 6|Withdrawal by Subject|1|||
146727974|NCT00781391|529172849|FG000|Overall Study|never received study drug|24|||
146727975|NCT00781391|529172850|FG001|Overall Study|never received study drug|23|||
146784939|NCT05008835|529382409|FG000|Overall Study|Not further specified|3|||
146784940|NCT05008835|529382410|FG001|Overall Study|Not further specified|2|||
146784941|NCT05008835|529382411|FG002|Overall Study|Not further specified|1|||
146784942|NCT04876118|529382416|FG000|Overall Study|Pregnancy|1|||
146784943|NCT04876118|529382416|FG000|Overall Study|Withdrawal by Subject|14|||
146784944|NCT05089734|529382417|FG000|Overall Study|Still on study|122|||
146784945|NCT05089734|529382418|FG001|Overall Study|Still on study|101|||
146784946|NCT05089734|529382417|FG000|Overall Study|Death|161|||
146784947|NCT05089734|529382418|FG001|Overall Study|Death|179|||
146784948|NCT05089734|529382417|FG000|Overall Study|Withdrew consent|11|||
146784949|NCT05089734|529382418|FG001|Overall Study|Withdrew consent|24|||
146784950|NCT05089734|529382417|FG000|Overall Study|Lost to Follow-up|5|||
146784951|NCT05089734|529382418|FG001|Overall Study|Lost to Follow-up|0|||
146784952|NCT03047928|529384384|FG000|Overall Study|Adverse Event|0|||
146784953|NCT03047928|529384385|FG001|Overall Study|Adverse Event|2|||
146784954|NCT03047928|529384386|FG002|Overall Study|Adverse Event|0|||
146784955|NCT03047928|529384384|FG000|Overall Study|Protocol Violation|0|||
146727976|NCT00781391|529172851|FG002|Overall Study|never received study drug|32|||
146784956|NCT03047928|529384385|FG001|Overall Study|Protocol Violation|1|||
146727977|NCT00781391|529172849|FG000|Overall Study|Protocol Violation|19|||
146727978|NCT00781391|529172850|FG001|Overall Study|Protocol Violation|17|||
146727979|NCT00781391|529172851|FG002|Overall Study|Protocol Violation|20|||
146935536|NCT04134728|529922471|FG005|Overall Study|Lost to Follow-up|1|||
146935537|NCT04134728|529922466|FG000|Overall Study|Investigator Site Closed|0|||
146935538|NCT04134728|529922467|FG001|Overall Study|Investigator Site Closed|1|||
146935539|NCT04134728|529922468|FG002|Overall Study|Investigator Site Closed|1|||
146935540|NCT04134728|529922469|FG003|Overall Study|Investigator Site Closed|0|||
146935541|NCT04134728|529922470|FG004|Overall Study|Investigator Site Closed|0|||
146935542|NCT04134728|529922471|FG005|Overall Study|Investigator Site Closed|0|||
146935543|NCT03518034|529922477|FG000|Overall Study|Not Treated|5|||
146935544|NCT03518034|529922478|FG001|Overall Study|Not Treated|1|||
146935545|NCT03518034|529922477|FG000|Overall Study|Withdrawal by Subject|309|||
146935546|NCT03518034|529922478|FG001|Overall Study|Withdrawal by Subject|351|||
146935547|NCT03518034|529922477|FG000|Overall Study|Lost to Follow-up|446|||
146935548|NCT03518034|529922478|FG001|Overall Study|Lost to Follow-up|458|||
146935549|NCT03518034|529922477|FG000|Overall Study|Adverse Event|138|||
146935550|NCT03518034|529922478|FG001|Overall Study|Adverse Event|130|||
146935551|NCT03518034|529922477|FG000|Overall Study|Lack of Efficacy|11|||
146935552|NCT03518034|529922478|FG001|Overall Study|Lack of Efficacy|23|||
146935553|NCT03518034|529922477|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
146935554|NCT03518034|529922478|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
146935555|NCT03518034|529922477|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
146935556|NCT03518034|529922478|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
146935557|NCT03518034|529922477|FG000|Overall Study|Other, Not Specified|84|||
146935558|NCT03518034|529922478|FG001|Overall Study|Other, Not Specified|53|||
146935559|NCT03518034|529922477|FG000|Overall Study|Reason Missing|2|||
146935560|NCT03518034|529922478|FG001|Overall Study|Reason Missing|3|||
146935561|NCT01019252|529922479|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
146935562|NCT01019252|529922480|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
146935563|NCT01019252|529922479|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
146935564|NCT01019252|529922480|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
146935565|NCT01019252|529922479|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
146935566|NCT01019252|529922480|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
146935567|NCT01019252|529922479|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
146935568|NCT01019252|529922480|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
146935569|NCT02062398|529922481|FG000|Overall Study|Implant removal|1|||
146935570|NCT00415519|529922482|FG000|Overall Study|Adverse Event|1|||
146935571|NCT00415519|529922483|FG001|Overall Study|Adverse Event|0|||
146935572|NCT00415519|529922482|FG000|Overall Study|Withdrawal by Subject|2|||
146935573|NCT00415519|529922483|FG001|Overall Study|Withdrawal by Subject|0|||
146935574|NCT00415519|529922482|FG000|Overall Study|Patient's convenience|1|||
146935575|NCT00415519|529922483|FG001|Overall Study|Patient's convenience|0|||
146935576|NCT03657810|529922488|FG000|Overall Study|Adverse Event|0|||
146935577|NCT03657810|529922489|FG001|Overall Study|Adverse Event|1|||
146935578|NCT03657810|529922490|FG002|Overall Study|Adverse Event|0|||
146935579|NCT03657810|529922488|FG000|Overall Study|Lack of Efficacy|4|||
146935580|NCT03657810|529922489|FG001|Overall Study|Lack of Efficacy|1|||
146727980|NCT00781391|529172849|FG000|Overall Study|Death|789|||
146727981|NCT00781391|529172850|FG001|Overall Study|Death|730|||
146727982|NCT00781391|529172851|FG002|Overall Study|Death|706|||
146727983|NCT00781391|529172849|FG000|Overall Study|Withdrawal by Subject|47|||
146727984|NCT00781391|529172850|FG001|Overall Study|Withdrawal by Subject|37|||
146727985|NCT00781391|529172851|FG002|Overall Study|Withdrawal by Subject|25|||
146727986|NCT00781391|529172849|FG000|Overall Study|Lost to Follow-up|0|||
146727987|NCT00781391|529172850|FG001|Overall Study|Lost to Follow-up|0|||
146727988|NCT00781391|529172851|FG002|Overall Study|Lost to Follow-up|1|||
146727989|NCT04535947|529172852|FG000|Overall Study|Adverse Event|1|||
146727990|NCT04535947|529172853|FG001|Overall Study|Adverse Event|4|||
146727991|NCT04535947|529172852|FG000|Overall Study|Other reasons not specified|2|||
146727992|NCT04535947|529172853|FG001|Overall Study|Other reasons not specified|0|||
146727993|NCT04535947|529172852|FG000|Overall Study|Withdrawal by Subject|1|||
146727994|NCT04535947|529172853|FG001|Overall Study|Withdrawal by Subject|1|||
146727995|NCT03205371|529172870|FG000|Overall Study|Withdrawal by Subject|4|||
146935581|NCT03657810|529922490|FG002|Overall Study|Lack of Efficacy|3|||
146935582|NCT03657810|529922488|FG000|Overall Study|Protocol Violation|1|||
146935583|NCT03657810|529922489|FG001|Overall Study|Protocol Violation|0|||
146935584|NCT03657810|529922490|FG002|Overall Study|Protocol Violation|0|||
146727996|NCT03205371|529172871|FG001|Overall Study|Withdrawal by Subject|1|||
146935585|NCT03657810|529922488|FG000|Overall Study|Lost to Follow-up|0|||
146935586|NCT03657810|529922489|FG001|Overall Study|Lost to Follow-up|1|||
146935587|NCT03657810|529922490|FG002|Overall Study|Lost to Follow-up|0|||
146935588|NCT03657810|529922488|FG000|Overall Study|Not provided|0|||
146935589|NCT03657810|529922489|FG001|Overall Study|Not provided|1|||
146935590|NCT03657810|529922490|FG002|Overall Study|Not provided|0|||
146727997|NCT03205371|529172872|FG002|Overall Study|Withdrawal by Subject|0|||
146727998|NCT03205371|529172873|FG003|Overall Study|Withdrawal by Subject|0|||
146727999|NCT03205371|529172874|FG004|Overall Study|Withdrawal by Subject|0|||
146784957|NCT03047928|529384386|FG002|Overall Study|Protocol Violation|0|||
146728000|NCT03205371|529172875|FG005|Overall Study|Withdrawal by Subject|0|||
146935591|NCT03325556|529922491|FG000|Open-label Period|Lack of Response in OL period|70|||
146935592|NCT03325556|529922492|FG001|Open-label Period|Lack of Response in OL period|0|||
146935593|NCT03325556|529922493|FG002|Open-label Period|Lack of Response in OL period|0|||
146935594|NCT03325556|529922491|FG000|Open-label Period|Adverse Event|27|||
146728001|NCT03205371|529172876|FG006|Overall Study|Withdrawal by Subject|4|||
146728002|NCT03205371|529172877|FG007|Overall Study|Withdrawal by Subject|0|||
146728003|NCT03205371|529172878|FG008|Overall Study|Withdrawal by Subject|2|||
146728004|NCT03205371|529172879|FG009|Overall Study|Withdrawal by Subject|0|||
146728005|NCT03205371|529172880|FG010|Overall Study|Withdrawal by Subject|0|||
146728006|NCT03205371|529172881|FG011|Overall Study|Withdrawal by Subject|1|||
146728007|NCT03205371|529172870|FG000|Overall Study|Lost to Follow-up|0|||
146728008|NCT03205371|529172871|FG001|Overall Study|Lost to Follow-up|0|||
146728009|NCT03205371|529172872|FG002|Overall Study|Lost to Follow-up|0|||
146728010|NCT03205371|529172873|FG003|Overall Study|Lost to Follow-up|0|||
146728011|NCT03205371|529172874|FG004|Overall Study|Lost to Follow-up|0|||
146728012|NCT03205371|529172875|FG005|Overall Study|Lost to Follow-up|0|||
146728013|NCT03205371|529172876|FG006|Overall Study|Lost to Follow-up|5|||
146728014|NCT03205371|529172877|FG007|Overall Study|Lost to Follow-up|2|||
146728015|NCT03205371|529172878|FG008|Overall Study|Lost to Follow-up|3|||
146728016|NCT03205371|529172879|FG009|Overall Study|Lost to Follow-up|0|||
146728017|NCT03205371|529172880|FG010|Overall Study|Lost to Follow-up|0|||
146728018|NCT03205371|529172881|FG011|Overall Study|Lost to Follow-up|0|||
146728019|NCT03205371|529172870|FG000|Overall Study|Protocol Violation|0|||
146728020|NCT03205371|529172871|FG001|Overall Study|Protocol Violation|0|||
146728021|NCT03205371|529172872|FG002|Overall Study|Protocol Violation|0|||
146728022|NCT03205371|529172873|FG003|Overall Study|Protocol Violation|0|||
146728023|NCT03205371|529172874|FG004|Overall Study|Protocol Violation|0|||
146728024|NCT03205371|529172875|FG005|Overall Study|Protocol Violation|0|||
146728025|NCT03205371|529172876|FG006|Overall Study|Protocol Violation|1|||
146728026|NCT03205371|529172877|FG007|Overall Study|Protocol Violation|0|||
146728027|NCT03205371|529172878|FG008|Overall Study|Protocol Violation|0|||
146728028|NCT03205371|529172879|FG009|Overall Study|Protocol Violation|0|||
146728029|NCT03205371|529172880|FG010|Overall Study|Protocol Violation|0|||
146728030|NCT03205371|529172881|FG011|Overall Study|Protocol Violation|0|||
146728031|NCT03205371|529172870|FG000|Overall Study|Adverse Event|0|||
146728032|NCT03205371|529172871|FG001|Overall Study|Adverse Event|0|||
146728033|NCT03205371|529172872|FG002|Overall Study|Adverse Event|0|||
146728034|NCT03205371|529172873|FG003|Overall Study|Adverse Event|0|||
146728035|NCT03205371|529172874|FG004|Overall Study|Adverse Event|0|||
146728036|NCT03205371|529172875|FG005|Overall Study|Adverse Event|0|||
146728037|NCT03205371|529172876|FG006|Overall Study|Adverse Event|0|||
146728038|NCT03205371|529172877|FG007|Overall Study|Adverse Event|1|||
146728039|NCT03205371|529172878|FG008|Overall Study|Adverse Event|0|||
146728040|NCT03205371|529172879|FG009|Overall Study|Adverse Event|0|||
146728041|NCT03205371|529172880|FG010|Overall Study|Adverse Event|0|||
146728042|NCT03205371|529172881|FG011|Overall Study|Adverse Event|0|||
146728043|NCT03575325|529172883|FG000|Overall Study|Death|1|||
146728044|NCT05711641|529172884|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
146728045|NCT05711641|529172885|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
146728046|NCT05711641|529172884|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
146728047|NCT05711641|529172885|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
146728048|NCT04575051|529172889|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
146728049|NCT04575051|529172890|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
146728050|NCT04575051|529172891|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
146728051|NCT04575051|529172892|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
146728052|NCT04575051|529172893|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
146728053|NCT04575051|529172889|FG000|Time Period 1|Missing follow up|1|||
146728054|NCT04575051|529172890|FG001|Time Period 1|Missing follow up|3|||
146728055|NCT04575051|529172891|FG002|Time Period 1|Missing follow up|1|||
146728056|NCT04575051|529172892|FG003|Time Period 1|Missing follow up|3|||
146728057|NCT04575051|529172893|FG004|Time Period 1|Missing follow up|2|||
146728058|NCT04575051|529172889|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
146728059|NCT04575051|529172890|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
146728060|NCT04575051|529172891|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
146728061|NCT04575051|529172892|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
146728062|NCT04575051|529172893|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
146728063|NCT04575051|529172889|FG000|Time Period 2|Missing follow up|1|||
146728064|NCT04575051|529172890|FG001|Time Period 2|Missing follow up|8|||
146728065|NCT04575051|529172891|FG002|Time Period 2|Missing follow up|7|||
146935595|NCT03325556|529922492|FG001|Open-label Period|Adverse Event|0|||
146728066|NCT04575051|529172892|FG003|Time Period 2|Missing follow up|0|||
146728067|NCT04575051|529172893|FG004|Time Period 2|Missing follow up|1|||
146728068|NCT04575051|529172889|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
146935596|NCT03325556|529922493|FG002|Open-label Period|Adverse Event|0|||
146728069|NCT04575051|529172890|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
146728070|NCT04575051|529172891|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
146728071|NCT04575051|529172892|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
146728072|NCT04575051|529172893|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
146728073|NCT04575051|529172889|FG000|Time Period 3|Missing follow up|8|||
146728074|NCT04575051|529172890|FG001|Time Period 3|Missing follow up|6|||
146728075|NCT04575051|529172891|FG002|Time Period 3|Missing follow up|4|||
146728076|NCT04575051|529172892|FG003|Time Period 3|Missing follow up|3|||
146728077|NCT04575051|529172893|FG004|Time Period 3|Missing follow up|0|||
146728078|NCT04575051|529172889|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
146728079|NCT04575051|529172890|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
146728080|NCT04575051|529172891|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
146728081|NCT04575051|529172892|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
146728082|NCT04575051|529172893|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
146728083|NCT04575051|529172889|FG000|Time Period 4|Missing follow up|17|||
146728084|NCT04575051|529172890|FG001|Time Period 4|Missing follow up|3|||
146728085|NCT04575051|529172891|FG002|Time Period 4|Missing follow up|4|||
146728086|NCT04575051|529172892|FG003|Time Period 4|Missing follow up|2|||
146728087|NCT04575051|529172893|FG004|Time Period 4|Missing follow up|1|||
146728088|NCT04575051|529172889|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
146728089|NCT04575051|529172890|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
146728090|NCT04575051|529172891|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
146728091|NCT04575051|529172892|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
146728092|NCT04575051|529172893|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
146728093|NCT04575051|529172889|FG000|Time Period 5|Missing follow up|11|||
146728094|NCT04575051|529172890|FG001|Time Period 5|Missing follow up|8|||
146728095|NCT04575051|529172891|FG002|Time Period 5|Missing follow up|12|||
146728096|NCT04575051|529172892|FG003|Time Period 5|Missing follow up|3|||
146728097|NCT04575051|529172893|FG004|Time Period 5|Missing follow up|11|||
146728098|NCT03492281|529172894|FG000|Overall Study|Withdrawal by Subject|21|||
146728099|NCT03492281|529172895|FG001|Overall Study|Withdrawal by Subject|14|||
146728100|NCT03492281|529172896|FG002|Overall Study|Withdrawal by Subject|13|||
146728101|NCT03492281|529172894|FG000|Overall Study|Lost to Follow-up|14|||
146728102|NCT03492281|529172895|FG001|Overall Study|Lost to Follow-up|15|||
146728103|NCT03492281|529172896|FG002|Overall Study|Lost to Follow-up|10|||
146728104|NCT03492281|529172894|FG000|Overall Study|Adverse Event|6|||
146728105|NCT03492281|529172895|FG001|Overall Study|Adverse Event|8|||
146728106|NCT03492281|529172896|FG002|Overall Study|Adverse Event|13|||
146728107|NCT03492281|529172894|FG000|Overall Study|Lack of Efficacy|3|||
146728108|NCT03492281|529172895|FG001|Overall Study|Lack of Efficacy|0|||
146728109|NCT03492281|529172896|FG002|Overall Study|Lack of Efficacy|1|||
146728110|NCT03492281|529172894|FG000|Overall Study|Physician Decision|1|||
146728111|NCT03492281|529172895|FG001|Overall Study|Physician Decision|0|||
146728112|NCT03492281|529172896|FG002|Overall Study|Physician Decision|3|||
146728113|NCT03492281|529172894|FG000|Overall Study|Protocol Violation|0|||
146728114|NCT03492281|529172895|FG001|Overall Study|Protocol Violation|2|||
146728115|NCT03492281|529172896|FG002|Overall Study|Protocol Violation|1|||
146728116|NCT03492281|529172894|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
146728117|NCT03492281|529172895|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
146728118|NCT03492281|529172896|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
146728119|NCT03492281|529172894|FG000|Overall Study|Death|0|||
146728120|NCT03492281|529172895|FG001|Overall Study|Death|0|||
146728121|NCT03492281|529172896|FG002|Overall Study|Death|1|||
146728122|NCT03492281|529172894|FG000|Overall Study|Captured as Other in Database|8|||
146728123|NCT03492281|529172895|FG001|Overall Study|Captured as Other in Database|6|||
146728124|NCT03492281|529172896|FG002|Overall Study|Captured as Other in Database|3|||
146728125|NCT03624504|529172897|FG000|Overall Study|Unsuccessful Implant|1|||
146728126|NCT02363946|529172899|FG000|Overall Study|Lost to Follow-up|0|||
146728127|NCT02363946|529172900|FG001|Overall Study|Lost to Follow-up|0|||
146728128|NCT02363946|529172901|FG002|Overall Study|Lost to Follow-up|0|||
146728129|NCT02363946|529172902|FG003|Overall Study|Lost to Follow-up|0|||
146728130|NCT02363946|529172903|FG004|Overall Study|Lost to Follow-up|0|||
146728131|NCT02363946|529172904|FG005|Overall Study|Lost to Follow-up|0|||
146728132|NCT02363946|529172905|FG006|Overall Study|Lost to Follow-up|0|||
146728133|NCT02363946|529172906|FG007|Overall Study|Lost to Follow-up|1|||
146728134|NCT02363946|529172907|FG008|Overall Study|Lost to Follow-up|0|||
146728135|NCT02363946|529172908|FG009|Overall Study|Lost to Follow-up|0|||
146728136|NCT02363946|529172909|FG010|Overall Study|Lost to Follow-up|0|||
146728137|NCT02363946|529172910|FG011|Overall Study|Lost to Follow-up|0|||
146728138|NCT02363946|529172911|FG012|Overall Study|Lost to Follow-up|0|||
146728139|NCT01292239|529172912|FG000|Overall Study|Other|1|||
146728140|NCT01292239|529172913|FG001|Overall Study|Other|1|||
146728141|NCT01292239|529172912|FG000|Overall Study|Withdrawal by Subject|3|||
146728142|NCT01292239|529172913|FG001|Overall Study|Withdrawal by Subject|6|||
146728143|NCT00262821|529172914|FG000|Overall Study|Ineligible - wrong stage|0|||
146935597|NCT03325556|529922491|FG000|Open-label Period|Death|1|||
146728144|NCT00262821|529172915|FG001|Overall Study|Ineligible - wrong stage|3|||
146728145|NCT00262821|529172914|FG000|Overall Study|Ineligible - wrong cell type|2|||
146728146|NCT00262821|529172915|FG001|Overall Study|Ineligible - wrong cell type|2|||
146728147|NCT00262821|529172914|FG000|Overall Study|Ineligible - wrong primary|0|||
146728148|NCT00262821|529172915|FG001|Overall Study|Ineligible - wrong primary|1|||
146728149|NCT00262821|529172914|FG000|Overall Study|Ineligible - inadequate pathology|1|||
146728150|NCT00262821|529172915|FG001|Overall Study|Ineligible - inadequate pathology|3|||
146728151|NCT00262821|529172914|FG000|Overall Study|Ineligible - elevated creatinine|0|||
146728152|NCT00262821|529172915|FG001|Overall Study|Ineligible - elevated creatinine|2|||
146728153|NCT00262821|529172914|FG000|Overall Study|Ineligible - required test not done|1|||
146728154|NCT00262821|529172915|FG001|Overall Study|Ineligible - required test not done|4|||
146728155|NCT00262821|529172914|FG000|Overall Study|Inevaluable - inadequate data|0|||
146728156|NCT00262821|529172915|FG001|Overall Study|Inevaluable - inadequate data|4|||
146728157|NCT00765388|529172916|FG000|Period 1|Lack of Efficacy|1|||
146728158|NCT00765388|529172917|FG001|Period 1|Lack of Efficacy|2|||
146728159|NCT00765388|529172916|FG000|Period 1|Lost to Follow-up|0|||
146728160|NCT00765388|529172917|FG001|Period 1|Lost to Follow-up|1|||
146728161|NCT00765388|529172916|FG000|Period 1|Herpes Zoster|0|||
146728162|NCT00765388|529172917|FG001|Period 1|Herpes Zoster|1|||
146728163|NCT00765388|529172916|FG000|Period 1|Hip operation|0|||
146728164|NCT00765388|529172917|FG001|Period 1|Hip operation|1|||
146728165|NCT03923933|529172921|FG000|Overall Study|Lost to Follow-up|1|||
146728166|NCT03923933|529172922|FG001|Overall Study|Lost to Follow-up|0|||
146728167|NCT03923933|529172921|FG000|Overall Study|Withdrawal by Subject|0|||
146728168|NCT03923933|529172922|FG001|Overall Study|Withdrawal by Subject|1|||
146728169|NCT01830127|529172925|FG000|Overall Study|Adverse Event|1|||
146728170|NCT01830127|529172926|FG001|Overall Study|Adverse Event|6|||
146728171|NCT01830127|529172925|FG000|Overall Study|Lack of Efficacy|3|||
146728172|NCT01830127|529172926|FG001|Overall Study|Lack of Efficacy|0|||
146728173|NCT01830127|529172925|FG000|Overall Study|Withdrawal by Subject|1|||
146728174|NCT01830127|529172926|FG001|Overall Study|Withdrawal by Subject|1|||
146728175|NCT01830127|529172925|FG000|Overall Study|Other reason not defined above|0|||
146728176|NCT01830127|529172926|FG001|Overall Study|Other reason not defined above|2|||
146728177|NCT00671931|529172927|FG000|Overall Study|Physician Decision|1|||
146728178|NCT00671931|529172928|FG001|Overall Study|Physician Decision|0|||
146728179|NCT00671931|529172929|FG002|Overall Study|Physician Decision|0|||
146728180|NCT00671931|529172930|FG003|Overall Study|Physician Decision|2|||
146728181|NCT00671931|529172931|FG004|Overall Study|Physician Decision|1|||
146728182|NCT00818753|529172932|FG000|Overall Study|Protocol Violation|1|||
146728183|NCT00818753|529172933|FG001|Overall Study|Protocol Violation|0|||
146728184|NCT00818753|529172934|FG002|Overall Study|Protocol Violation|0|||
146728185|NCT00818753|529172932|FG000|Overall Study|Other reason (not specified)|0|||
146728186|NCT00818753|529172933|FG001|Overall Study|Other reason (not specified)|0|||
146728187|NCT00818753|529172934|FG002|Overall Study|Other reason (not specified)|1|||
146728188|NCT00818753|529172932|FG000|Overall Study|Randomised and not treated|2|||
146728189|NCT00818753|529172933|FG001|Overall Study|Randomised and not treated|0|||
146728190|NCT00818753|529172934|FG002|Overall Study|Randomised and not treated|0|||
146728191|NCT00725296|529172935|FG000|Overall Study|Adverse Event|11|||
146728192|NCT00725296|529172935|FG000|Overall Study|Lack of Efficacy|7|||
146728193|NCT00725296|529172935|FG000|Overall Study|Withdrawal by Subject|3|||
146728194|NCT00725296|529172935|FG000|Overall Study|Non-Compliance|2|||
146728195|NCT00725296|529172935|FG000|Overall Study|Lost to Follow-up|1|||
146728196|NCT00725296|529172935|FG000|Overall Study|Other|38|||
146728197|NCT03360942|529172936|FG000|Overall Study|Device explanted|2|||
146728198|NCT03360942|529172936|FG000|Overall Study|Study closure|1|||
146728199|NCT03360942|529172936|FG000|Overall Study|Withdrawal by Subject|2|||
146728200|NCT04866017|529172940|FG000|Overall Study|Study Terminated by Sponsor|13|||
146728201|NCT04866017|529172941|FG001|Overall Study|Study Terminated by Sponsor|14|||
146728202|NCT04866017|529172942|FG002|Overall Study|Study Terminated by Sponsor|13|||
146728203|NCT04866017|529172940|FG000|Overall Study|Death|8|||
146935598|NCT03325556|529922492|FG001|Open-label Period|Death|0|||
146935599|NCT03325556|529922493|FG002|Open-label Period|Death|0|||
146935600|NCT03325556|529922491|FG000|Open-label Period|Lost to Follow-up|1|||
146728204|NCT04866017|529172941|FG001|Overall Study|Death|4|||
146728205|NCT04866017|529172942|FG002|Overall Study|Death|8|||
146728206|NCT04866017|529172940|FG000|Overall Study|Withdrawal by Subject|1|||
146728207|NCT04866017|529172941|FG001|Overall Study|Withdrawal by Subject|0|||
146728208|NCT04866017|529172942|FG002|Overall Study|Withdrawal by Subject|1|||
146728209|NCT04866017|529172940|FG000|Overall Study|Physician Decision|0|||
146728210|NCT04866017|529172941|FG001|Overall Study|Physician Decision|1|||
146728211|NCT04866017|529172942|FG002|Overall Study|Physician Decision|0|||
146728212|NCT00605293|529174511|FG000|Overall Study|Death|2|||
146728213|NCT00605293|529174512|FG001|Overall Study|Death|1|||
146728214|NCT00605293|529174511|FG000|Overall Study|Insufficient Therapeutic Response|2|||
146728215|NCT00605293|529174512|FG001|Overall Study|Insufficient Therapeutic Response|0|||
146728216|NCT00605293|529174511|FG000|Overall Study|Adverse Event|1|||
146728217|NCT00605293|529174512|FG001|Overall Study|Adverse Event|0|||
146784958|NCT03047928|529384384|FG000|Overall Study|included in another protocol|0|||
146784959|NCT03047928|529384385|FG001|Overall Study|included in another protocol|1|||
146784960|NCT03047928|529384386|FG002|Overall Study|included in another protocol|0|||
146784961|NCT04005716|529384390|FG000|Overall Study|Death|175|||
146784962|NCT04005716|529384391|FG001|Overall Study|Death|196|||
146784963|NCT04005716|529384390|FG000|Overall Study|Withdrawal by Subject|1|||
146784964|NCT04005716|529384391|FG001|Overall Study|Withdrawal by Subject|6|||
146784965|NCT04005716|529384390|FG000|Overall Study|Lost to Follow-up|2|||
146784966|NCT04005716|529384391|FG001|Overall Study|Lost to Follow-up|2|||
146784967|NCT05178316|529384393|FG000|Overall Study|Adverse Event|5|||
146784968|NCT05178316|529384394|FG001|Overall Study|Adverse Event|4|||
146784969|NCT05178316|529384395|FG002|Overall Study|Adverse Event|9|||
146784970|NCT05178316|529384393|FG000|Overall Study|Enrolled in Error|1|||
146784971|NCT05178316|529384394|FG001|Overall Study|Enrolled in Error|2|||
146784972|NCT05178316|529384395|FG002|Overall Study|Enrolled in Error|1|||
146784973|NCT05178316|529384393|FG000|Overall Study|Lost to Follow-up|3|||
146784974|NCT05178316|529384394|FG001|Overall Study|Lost to Follow-up|15|||
146784975|NCT05178316|529384395|FG002|Overall Study|Lost to Follow-up|11|||
146784976|NCT05178316|529384393|FG000|Overall Study|Noncompliance|1|||
146784977|NCT05178316|529384394|FG001|Overall Study|Noncompliance|3|||
146784978|NCT05178316|529384395|FG002|Overall Study|Noncompliance|1|||
146784979|NCT05178316|529384393|FG000|Overall Study|Other|0|||
146784980|NCT05178316|529384394|FG001|Overall Study|Other|1|||
146784981|NCT05178316|529384395|FG002|Overall Study|Other|0|||
146784982|NCT05178316|529384393|FG000|Overall Study|Physician Decision|0|||
146784983|NCT05178316|529384394|FG001|Overall Study|Physician Decision|3|||
146784984|NCT05178316|529384395|FG002|Overall Study|Physician Decision|2|||
146784985|NCT05178316|529384393|FG000|Overall Study|Protocol deviation|1|||
146784986|NCT05178316|529384394|FG001|Overall Study|Protocol deviation|0|||
146784987|NCT05178316|529384395|FG002|Overall Study|Protocol deviation|1|||
146784988|NCT05178316|529384393|FG000|Overall Study|Sponsor decision|1|||
146784989|NCT05178316|529384394|FG001|Overall Study|Sponsor decision|0|||
146784990|NCT05178316|529384395|FG002|Overall Study|Sponsor decision|1|||
146784991|NCT05178316|529384393|FG000|Overall Study|Withdrawal by Subject|5|||
146728218|NCT00605293|529174511|FG000|Overall Study|Holidays Dialysis Out|1|||
146728219|NCT00605293|529174512|FG001|Overall Study|Holidays Dialysis Out|0|||
146728220|NCT00605293|529174511|FG000|Overall Study|Blood Transfusion|7|||
146728221|NCT00605293|529174512|FG001|Overall Study|Blood Transfusion|1|||
146728222|NCT00605293|529174511|FG000|Overall Study|Renal Transplantation|3|||
146728223|NCT00605293|529174512|FG001|Overall Study|Renal Transplantation|1|||
146728224|NCT00605293|529174511|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
146728225|NCT00605293|529174512|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
146728226|NCT00605293|529174511|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
146935601|NCT03325556|529922492|FG001|Open-label Period|Lost to Follow-up|0|||
146935602|NCT03325556|529922493|FG002|Open-label Period|Lost to Follow-up|0|||
146728227|NCT00605293|529174512|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
146728228|NCT00605293|529174511|FG000|Overall Study|Principal Investigator Decision|0|||
146728229|NCT00605293|529174512|FG001|Overall Study|Principal Investigator Decision|1|||
146728230|NCT02565914|529174513|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
146728231|NCT02565914|529174513|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
146728232|NCT02565914|529174513|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
146728233|NCT02565914|529174513|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
146728234|NCT02565914|529174513|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
146728235|NCT02565914|529174513|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
146728236|NCT02565914|529174513|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
146784992|NCT05178316|529384394|FG001|Overall Study|Withdrawal by Subject|11|||
146784993|NCT05178316|529384395|FG002|Overall Study|Withdrawal by Subject|5|||
146784994|NCT03683719|529384396|FG000|Overall Study|Lack of Efficacy|1|||
146784995|NCT03683719|529384397|FG001|Overall Study|Lack of Efficacy|3|||
146784996|NCT03683719|529384398|FG002|Overall Study|Lack of Efficacy|4|||
146935603|NCT03325556|529922491|FG000|Open-label Period|Non-compliance with study drug|5|||
146935604|NCT03325556|529922492|FG001|Open-label Period|Non-compliance with study drug|0|||
146728237|NCT02565914|529174513|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
146728238|NCT02565914|529174513|FG000|Part A (Up to 96 Weeks)|Other|18|||
146728239|NCT02565914|529174513|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
146728240|NCT02565914|529174513|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
146784997|NCT03683719|529384399|FG003|Overall Study|Lack of Efficacy|0|||
146784998|NCT03683719|529384400|FG004|Overall Study|Lack of Efficacy|4|||
146784999|NCT03683719|529384396|FG000|Overall Study|Adverse Event|6|||
146785000|NCT03683719|529384397|FG001|Overall Study|Adverse Event|6|||
146785001|NCT03683719|529384398|FG002|Overall Study|Adverse Event|0|||
146785002|NCT03683719|529384399|FG003|Overall Study|Adverse Event|1|||
146785003|NCT03683719|529384400|FG004|Overall Study|Adverse Event|3|||
146728241|NCT02565914|529174513|FG000|Part B (Up to 96 Weeks)|Other|1|||
146728242|NCT02565914|529174513|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
146785004|NCT03683719|529384396|FG000|Overall Study|Withdrawal by Subject|4|||
146728243|NCT02565914|529174513|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
146728244|NCT02565914|529174513|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
146728245|NCT02565914|529174513|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
146728246|NCT02565914|529174513|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
146728247|NCT02565914|529174513|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
146728248|NCT02565914|529174513|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
146728249|NCT02565914|529174513|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
146728250|NCT02565914|529174513|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
146728251|NCT02565914|529174513|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
146728252|NCT02565914|529174513|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
146728253|NCT02565914|529174513|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
146728254|NCT02428296|529174517|FG000|Overall Study|Adverse Event|7|||
146728255|NCT02428296|529174517|FG000|Overall Study|Withdrawal by Subject|2|||
146728256|NCT00831779|529174522|FG000|Overall Study|Lost to Follow-up|1|||
146728257|NCT00831779|529174523|FG001|Overall Study|Lost to Follow-up|0|||
146728258|NCT00831779|529174522|FG000|Overall Study|No longer met criteria|0|||
146728259|NCT00831779|529174523|FG001|Overall Study|No longer met criteria|1|||
146728260|NCT04683926|529174525|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
146728261|NCT04683926|529174526|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
146728262|NCT04683926|529174527|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
146728263|NCT04683926|529174528|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
146728264|NCT04385368|529174530|FG000|Overall Study|Death|5|||
146728265|NCT04385368|529174531|FG001|Overall Study|Death|5|||
146728266|NCT04385368|529174530|FG000|Overall Study|Physician Decision|3|||
146728267|NCT04385368|529174531|FG001|Overall Study|Physician Decision|0|||
146728268|NCT04385368|529174530|FG000|Overall Study|Withdrawal by Subject|4|||
146728269|NCT04385368|529174531|FG001|Overall Study|Withdrawal by Subject|3|||
146728270|NCT02123108|529174534|FG000|Overall Study|Death|2|||
146728271|NCT02123108|529174535|FG001|Overall Study|Death|3|||
146728272|NCT00716092|529174536|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
146728273|NCT00716092|529174537|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
146728274|NCT00716092|529174538|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
146728275|NCT02219048|529174539|FG000|Overall Study|Adverse Event|2|||
146728276|NCT02219048|529174540|FG001|Overall Study|Adverse Event|5|||
146728277|NCT02219048|529174539|FG000|Overall Study|No longer meets eligibility criteria|1|||
146728278|NCT02219048|529174540|FG001|Overall Study|No longer meets eligibility criteria|0|||
146728279|NCT02219048|529174539|FG000|Overall Study|Study terminated by sponsor|16|||
146728280|NCT02219048|529174540|FG001|Overall Study|Study terminated by sponsor|15|||
146728281|NCT02219048|529174539|FG000|Overall Study|Withdrawal by Subject|2|||
146728282|NCT02219048|529174540|FG001|Overall Study|Withdrawal by Subject|0|||
146728283|NCT02219048|529174539|FG000|Overall Study|Other|0|||
146728284|NCT02219048|529174540|FG001|Overall Study|Other|1|||
146728285|NCT02054806|529174541|FG000|Overall Study|Sponsor Decision|31|||
146728286|NCT02054806|529174541|FG000|Overall Study|Withdrawal by Subject|43|||
146728287|NCT02054806|529174541|FG000|Overall Study|Protocol Violation|2|||
146728288|NCT02054806|529174541|FG000|Overall Study|Lost to Follow-up|10|||
146728289|NCT02054806|529174541|FG000|Overall Study|Death|391|||
146728290|NCT01132326|529174542|FG000|Overall Study|Lack of Efficacy|25|||
146728291|NCT01132326|529174542|FG000|Overall Study|Adverse Event|37|||
146728292|NCT01132326|529174542|FG000|Overall Study|Protocol Violation|1|||
146728293|NCT01132326|529174542|FG000|Overall Study|Lost to Follow-up|16|||
146728294|NCT01132326|529174542|FG000|Overall Study|Withdrawal by Subject|40|||
146728295|NCT01132326|529174542|FG000|Overall Study|Physician Decision|10|||
146728296|NCT01132326|529174542|FG000|Overall Study|Study Termination|80|||
146728297|NCT01132326|529174542|FG000|Overall Study|Declining Health|1|||
146728298|NCT01132326|529174542|FG000|Overall Study|Pregnancy|1|||
146728299|NCT01132326|529174542|FG000|Overall Study|Caregiver Withdrew Consent|1|||
146728300|NCT01132326|529174542|FG000|Overall Study|Death|5|||
146728301|NCT01132326|529174542|FG000|Overall Study|Subject Unable to Come To Visits|1|||
146728302|NCT00677235|529174543|FG000|Overall Study|Withdrawal by Subject|1|||
146728303|NCT00677235|529174544|FG001|Overall Study|Withdrawal by Subject|1|||
146728304|NCT00677235|529174543|FG000|Overall Study|Lost to Follow-up|2|||
146728305|NCT00677235|529174544|FG001|Overall Study|Lost to Follow-up|1|||
146728306|NCT00677235|529174543|FG000|Overall Study|Death|37|||
146728307|NCT00677235|529174544|FG001|Overall Study|Death|36|||
146728308|NCT00677235|529174543|FG000|Overall Study|Adverse Experience|1|||
146728309|NCT00677235|529174544|FG001|Overall Study|Adverse Experience|0|||
146728310|NCT00952367|529174545|FG000|Overall Study|Withdrawal by Subject|2|||
146728311|NCT00952367|529174545|FG000|Overall Study|Noncoordination|1|||
146728312|NCT00952367|529174545|FG000|Overall Study|Protocol Violation|3|||
146728313|NCT02230956|529174546|FG000|Overall Study|Adverse Event|1|||
146728314|NCT02230956|529174547|FG001|Overall Study|Adverse Event|1|||
146728315|NCT02230956|529174548|FG002|Overall Study|Adverse Event|0|||
146785005|NCT03683719|529384397|FG001|Overall Study|Withdrawal by Subject|4|||
146728316|NCT02230956|529174546|FG000|Overall Study|Lack of Efficacy|1|||
146728317|NCT02230956|529174547|FG001|Overall Study|Lack of Efficacy|1|||
146728318|NCT02230956|529174548|FG002|Overall Study|Lack of Efficacy|1|||
146935605|NCT03325556|529922493|FG002|Open-label Period|Non-compliance with study drug|0|||
146935606|NCT03325556|529922491|FG000|Open-label Period|Use of prohibited medication|1|||
146935607|NCT03325556|529922492|FG001|Open-label Period|Use of prohibited medication|0|||
146935608|NCT03325556|529922493|FG002|Open-label Period|Use of prohibited medication|0|||
146935609|NCT03325556|529922491|FG000|Open-label Period|Protocol Violation|4|||
146935610|NCT03325556|529922492|FG001|Open-label Period|Protocol Violation|0|||
146935611|NCT03325556|529922493|FG002|Open-label Period|Protocol Violation|0|||
146935612|NCT03325556|529922491|FG000|Open-label Period|Withdrawal by Subject|17|||
146935613|NCT03325556|529922492|FG001|Open-label Period|Withdrawal by Subject|0|||
146728319|NCT02230956|529174546|FG000|Overall Study|Lost to Follow-up|1|||
146728320|NCT02230956|529174547|FG001|Overall Study|Lost to Follow-up|1|||
146728321|NCT02230956|529174548|FG002|Overall Study|Lost to Follow-up|2|||
146728322|NCT02230956|529174546|FG000|Overall Study|Personal Reasons|2|||
146728323|NCT02230956|529174547|FG001|Overall Study|Personal Reasons|1|||
146728324|NCT02230956|529174548|FG002|Overall Study|Personal Reasons|1|||
146728325|NCT02230956|529174546|FG000|Overall Study|Protocol Violation|0|||
146728326|NCT02230956|529174547|FG001|Overall Study|Protocol Violation|1|||
146728327|NCT02230956|529174548|FG002|Overall Study|Protocol Violation|1|||
146728328|NCT02230956|529174546|FG000|Overall Study|Other Miscellaneous Reason|0|||
146728329|NCT02230956|529174547|FG001|Overall Study|Other Miscellaneous Reason|1|||
146728330|NCT02230956|529174548|FG002|Overall Study|Other Miscellaneous Reason|2|||
146728331|NCT03574597|529174550|FG000|Overall Study|Withdrawal by Subject|67|||
146728332|NCT03574597|529174551|FG001|Overall Study|Withdrawal by Subject|96|||
146728333|NCT03574597|529174550|FG000|Overall Study|Lost to Follow-up|192|||
146728334|NCT03574597|529174551|FG001|Overall Study|Lost to Follow-up|188|||
146728335|NCT02355743|529174552|FG000|Overall Study|Withdrawal by Subject|1|||
146728336|NCT02355743|529174552|FG000|Overall Study|Lost to Follow-up|1|||
146728337|NCT02862457|529174556|FG000|Overall Study|Death|1|||
146728338|NCT02862457|529174557|FG001|Overall Study|Death|3|||
146728339|NCT02862457|529174558|FG002|Overall Study|Death|2|||
146728340|NCT02862457|529174559|FG003|Overall Study|Death|3|||
146728341|NCT02862457|529174560|FG004|Overall Study|Death|0|||
146728342|NCT02862457|529174561|FG005|Overall Study|Death|2|||
146728343|NCT02862457|529174562|FG006|Overall Study|Death|1|||
146728344|NCT02862457|529174556|FG000|Overall Study|Lost to Follow-up|1|||
146728345|NCT02862457|529174557|FG001|Overall Study|Lost to Follow-up|0|||
146728346|NCT02862457|529174558|FG002|Overall Study|Lost to Follow-up|0|||
146728347|NCT02862457|529174559|FG003|Overall Study|Lost to Follow-up|1|||
146728348|NCT02862457|529174560|FG004|Overall Study|Lost to Follow-up|0|||
146728349|NCT02862457|529174561|FG005|Overall Study|Lost to Follow-up|0|||
146728350|NCT02862457|529174562|FG006|Overall Study|Lost to Follow-up|0|||
146728351|NCT02862457|529174556|FG000|Overall Study|Withdrawal by Subject|0|||
146728352|NCT02862457|529174557|FG001|Overall Study|Withdrawal by Subject|0|||
146728353|NCT02862457|529174558|FG002|Overall Study|Withdrawal by Subject|1|||
146728354|NCT02862457|529174559|FG003|Overall Study|Withdrawal by Subject|0|||
146728355|NCT02862457|529174560|FG004|Overall Study|Withdrawal by Subject|0|||
146728356|NCT02862457|529174561|FG005|Overall Study|Withdrawal by Subject|1|||
146728357|NCT02862457|529174562|FG006|Overall Study|Withdrawal by Subject|0|||
146728358|NCT00951483|529174565|FG000|Overall Study|Physician Decision|4|||
146728359|NCT00951483|529174566|FG001|Overall Study|Physician Decision|0|||
146728360|NCT00951483|529174565|FG000|Overall Study|Withdrawal by Subject|15|||
146728361|NCT00951483|529174566|FG001|Overall Study|Withdrawal by Subject|0|||
146728362|NCT03565887|529174567|FG000|Overall Study|Adverse Event|1|||
146728363|NCT03565887|529174568|FG001|Overall Study|Adverse Event|0|||
146728364|NCT03565887|529174567|FG000|Overall Study|Withdrawal by Subject|0|||
146728365|NCT03565887|529174568|FG001|Overall Study|Withdrawal by Subject|2|||
146728366|NCT03364751|529174569|FG000|Overall Study|Withdrawal by Subject|1|||
146728367|NCT03364751|529174570|FG001|Overall Study|Withdrawal by Subject|0|||
146728368|NCT03364751|529174571|FG002|Overall Study|Withdrawal by Subject|0|||
146728369|NCT03364751|529174572|FG003|Overall Study|Withdrawal by Subject|0|||
146728370|NCT03364751|529174569|FG000|Overall Study|Lost to Follow-up|0|||
146728371|NCT03364751|529174570|FG001|Overall Study|Lost to Follow-up|1|||
146728372|NCT03364751|529174571|FG002|Overall Study|Lost to Follow-up|0|||
146728373|NCT03364751|529174572|FG003|Overall Study|Lost to Follow-up|0|||
146728374|NCT02975973|529174573|FG000|Overall Study|Adverse Event|1|||
146728375|NCT02975973|529174574|FG001|Overall Study|Adverse Event|1|||
146728376|NCT02975973|529174575|FG002|Overall Study|Adverse Event|1|||
146728377|NCT02975973|529174576|FG003|Overall Study|Adverse Event|0|||
146728378|NCT03804710|529174578|FG000|Overall Study|Adverse Event|0|||
146728379|NCT03804710|529174579|FG001|Overall Study|Adverse Event|3|||
146728380|NCT03804710|529174578|FG000|Overall Study|Withdrawal by Subject|2|||
146728381|NCT03804710|529174579|FG001|Overall Study|Withdrawal by Subject|1|||
146728382|NCT03804710|529174578|FG000|Overall Study|Other|0|||
146935614|NCT03325556|529922493|FG002|Open-label Period|Withdrawal by Subject|0|||
146728383|NCT03804710|529174579|FG001|Overall Study|Other|1|||
146728384|NCT04542018|529174580|FG000|Overall Study|Withdrawal by Subject|0|||
146728385|NCT04542018|529174581|FG001|Overall Study|Withdrawal by Subject|0|||
146728386|NCT04542018|529174582|FG002|Overall Study|Withdrawal by Subject|4|||
146728387|NCT04542018|529174580|FG000|Overall Study|Protocol Violation|0|||
146728388|NCT04542018|529174581|FG001|Overall Study|Protocol Violation|0|||
146728389|NCT04542018|529174582|FG002|Overall Study|Protocol Violation|2|||
146728390|NCT03583554|529174583|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
146728391|NCT03583554|529174584|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
146728392|NCT03583554|529174585|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
146728393|NCT03178266|529174586|FG000|Overall Study|Death|0|||
146728394|NCT03178266|529174587|FG001|Overall Study|Death|1|||
146728395|NCT03178266|529174586|FG000|Overall Study|Disont. Early|0|||
146728396|NCT03178266|529174587|FG001|Overall Study|Disont. Early|1|||
146728397|NCT03178266|529174586|FG000|Overall Study|Withdrawal by Subject|0|||
146728398|NCT03178266|529174587|FG001|Overall Study|Withdrawal by Subject|2|||
146728399|NCT00765674|529174593|FG000|Overall Study|Adverse Event|7|||
146728400|NCT00765674|529174594|FG001|Overall Study|Adverse Event|2|||
146728401|NCT00765674|529174595|FG002|Overall Study|Adverse Event|8|||
146728402|NCT00765674|529174596|FG003|Overall Study|Adverse Event|11|||
146728403|NCT00765674|529174593|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
146728404|NCT00765674|529174594|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
146728405|NCT00765674|529174595|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
146728406|NCT00765674|529174596|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
146728407|NCT00765674|529174593|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
146728408|NCT00765674|529174594|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
146728409|NCT00765674|529174595|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
146728410|NCT00765674|529174596|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
146728411|NCT00765674|529174593|FG000|Overall Study|Lack of Efficacy|2|||
146728412|NCT00765674|529174594|FG001|Overall Study|Lack of Efficacy|3|||
146728413|NCT00765674|529174595|FG002|Overall Study|Lack of Efficacy|1|||
146728414|NCT00765674|529174596|FG003|Overall Study|Lack of Efficacy|2|||
146728415|NCT00765674|529174593|FG000|Overall Study|Protocol Violation|2|||
146728416|NCT00765674|529174594|FG001|Overall Study|Protocol Violation|0|||
146728417|NCT00765674|529174595|FG002|Overall Study|Protocol Violation|1|||
146728418|NCT00765674|529174596|FG003|Overall Study|Protocol Violation|0|||
146728419|NCT00765674|529174593|FG000|Overall Study|Withdrawal by Subject|5|||
146728420|NCT00765674|529174594|FG001|Overall Study|Withdrawal by Subject|7|||
146728421|NCT00765674|529174595|FG002|Overall Study|Withdrawal by Subject|3|||
146728422|NCT00765674|529174596|FG003|Overall Study|Withdrawal by Subject|8|||
146728423|NCT00765674|529174593|FG000|Overall Study|Lost to Follow-up|4|||
146728424|NCT00765674|529174594|FG001|Overall Study|Lost to Follow-up|6|||
146728425|NCT00765674|529174595|FG002|Overall Study|Lost to Follow-up|2|||
146728426|NCT00765674|529174596|FG003|Overall Study|Lost to Follow-up|1|||
146728427|NCT00765674|529174593|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
146728428|NCT00765674|529174594|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
146728429|NCT00765674|529174595|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
146728430|NCT00765674|529174596|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
146728431|NCT01813474|529174597|FG000|Overall Study|Withdrawal by Subject|0|||
146728432|NCT01813474|529174598|FG001|Overall Study|Withdrawal by Subject|0|||
146728433|NCT01813474|529174599|FG002|Overall Study|Withdrawal by Subject|1|||
146728434|NCT01813474|529174597|FG000|Overall Study|Adverse Event|1|||
146728435|NCT01813474|529174598|FG001|Overall Study|Adverse Event|1|||
146728436|NCT01813474|529174599|FG002|Overall Study|Adverse Event|0|||
146728437|NCT01813474|529174597|FG000|Overall Study|Lack of Efficacy|2|||
146728438|NCT01813474|529174598|FG001|Overall Study|Lack of Efficacy|6|||
146728439|NCT01813474|529174599|FG002|Overall Study|Lack of Efficacy|9|||
146728440|NCT01813474|529174597|FG000|Overall Study|Death|0|||
146728441|NCT01813474|529174598|FG001|Overall Study|Death|0|||
146728442|NCT01813474|529174599|FG002|Overall Study|Death|1|||
146728443|NCT03015402|529174605|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
146728444|NCT03015402|529174606|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
146728445|NCT03015402|529174605|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
146728446|NCT03015402|529174606|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
146728447|NCT00316082|529174607|FG000|Overall Study|Lack of Efficacy|2|||
146728448|NCT00316082|529174608|FG001|Overall Study|Lack of Efficacy|3|||
146728449|NCT00316082|529174609|FG002|Overall Study|Lack of Efficacy|3|||
146728450|NCT00316082|529174610|FG003|Overall Study|Lack of Efficacy|4|||
146728451|NCT00316082|529174611|FG004|Overall Study|Lack of Efficacy|6|||
146728452|NCT00316082|529174607|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
146728453|NCT00316082|529174608|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
146728454|NCT00316082|529174609|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
146728455|NCT00316082|529174610|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
146785006|NCT03683719|529384398|FG002|Overall Study|Withdrawal by Subject|3|||
146728456|NCT00316082|529174611|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
146728457|NCT00316082|529174607|FG000|Overall Study|Lost to Follow-up|7|||
146728458|NCT00316082|529174608|FG001|Overall Study|Lost to Follow-up|6|||
146728459|NCT00316082|529174609|FG002|Overall Study|Lost to Follow-up|7|||
146785007|NCT03683719|529384399|FG003|Overall Study|Withdrawal by Subject|5|||
146728460|NCT00316082|529174610|FG003|Overall Study|Lost to Follow-up|8|||
146728461|NCT00316082|529174611|FG004|Overall Study|Lost to Follow-up|6|||
146728462|NCT00316082|529174607|FG000|Overall Study|Poor/noncompliance|6|||
146785008|NCT03683719|529384400|FG004|Overall Study|Withdrawal by Subject|5|||
146785009|NCT03683719|529384396|FG000|Overall Study|Lost to Follow-up|1|||
146785010|NCT03683719|529384397|FG001|Overall Study|Lost to Follow-up|0|||
146785011|NCT03683719|529384398|FG002|Overall Study|Lost to Follow-up|0|||
146785012|NCT03683719|529384399|FG003|Overall Study|Lost to Follow-up|1|||
146785013|NCT03683719|529384400|FG004|Overall Study|Lost to Follow-up|1|||
146785014|NCT03683719|529384396|FG000|Overall Study|Other personal reasons|0|||
146785015|NCT03683719|529384397|FG001|Overall Study|Other personal reasons|0|||
146785016|NCT03683719|529384398|FG002|Overall Study|Other personal reasons|1|||
146785017|NCT03683719|529384399|FG003|Overall Study|Other personal reasons|0|||
146785018|NCT03683719|529384400|FG004|Overall Study|Other personal reasons|1|||
146785019|NCT03907397|529384401|FG000|Overall Study|Lost to Follow-up|0|||
146785020|NCT03907397|529384402|FG001|Overall Study|Lost to Follow-up|1|||
146785021|NCT03907397|529384401|FG000|Overall Study|Physician Decision|2|||
146785022|NCT03907397|529384402|FG001|Overall Study|Physician Decision|1|||
146785023|NCT03907397|529384401|FG000|Overall Study|Withdrawal by Subject|5|||
146785024|NCT03907397|529384402|FG001|Overall Study|Withdrawal by Subject|4|||
146785025|NCT03907397|529384401|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
146785026|NCT03907397|529384402|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
146785027|NCT05369403|529384403|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
146935615|NCT03325556|529922491|FG000|Open-label Period|Not otherwise specified|8|||
146935616|NCT03325556|529922492|FG001|Open-label Period|Not otherwise specified|0|||
146935617|NCT03325556|529922493|FG002|Open-label Period|Not otherwise specified|0|||
146935618|NCT03325556|529922491|FG000|Open-label Period|Administrative discont. at study termination|41|||
146935619|NCT03325556|529922492|FG001|Open-label Period|Administrative discont. at study termination|0|||
146935620|NCT03325556|529922493|FG002|Open-label Period|Administrative discont. at study termination|0|||
146935621|NCT03325556|529922491|FG000|Double-blind Period|Relapse|0|||
146785028|NCT05369403|529384404|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
146785029|NCT05369403|529384405|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
146785030|NCT05369403|529384403|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
146785031|NCT05369403|529384404|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
146785032|NCT05369403|529384405|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
146785033|NCT05369403|529384403|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
146785034|NCT05369403|529384404|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
146935622|NCT03325556|529922492|FG001|Double-blind Period|Relapse|15|||
146935623|NCT03325556|529922493|FG002|Double-blind Period|Relapse|34|||
146935624|NCT03325556|529922491|FG000|Double-blind Period|Adverse Event|0|||
146935625|NCT03325556|529922492|FG001|Double-blind Period|Adverse Event|3|||
146935626|NCT03325556|529922493|FG002|Double-blind Period|Adverse Event|1|||
146935627|NCT03325556|529922491|FG000|Double-blind Period|Noncompliance with study drug|0|||
146935628|NCT03325556|529922492|FG001|Double-blind Period|Noncompliance with study drug|0|||
146935629|NCT03325556|529922493|FG002|Double-blind Period|Noncompliance with study drug|1|||
146935630|NCT03325556|529922491|FG000|Double-blind Period|Use of prohibited medication|0|||
146935631|NCT03325556|529922492|FG001|Double-blind Period|Use of prohibited medication|1|||
146935632|NCT03325556|529922493|FG002|Double-blind Period|Use of prohibited medication|0|||
146935633|NCT03325556|529922491|FG000|Double-blind Period|Physician Decision|0|||
146935634|NCT03325556|529922492|FG001|Double-blind Period|Physician Decision|0|||
146935635|NCT03325556|529922493|FG002|Double-blind Period|Physician Decision|1|||
146935636|NCT03325556|529922491|FG000|Double-blind Period|Withdrawal by Subject|0|||
146935637|NCT03325556|529922492|FG001|Double-blind Period|Withdrawal by Subject|6|||
146935638|NCT03325556|529922493|FG002|Double-blind Period|Withdrawal by Subject|4|||
146935639|NCT03325556|529922491|FG000|Double-blind Period|Not otherwise specified|0|||
146935640|NCT03325556|529922492|FG001|Double-blind Period|Not otherwise specified|1|||
146935641|NCT03325556|529922493|FG002|Double-blind Period|Not otherwise specified|5|||
146935642|NCT03325556|529922491|FG000|Double-blind Period|Administrative discont. at study termination|0|||
146935643|NCT03325556|529922492|FG001|Double-blind Period|Administrative discont. at study termination|35|||
146935644|NCT03325556|529922493|FG002|Double-blind Period|Administrative discont. at study termination|31|||
146785035|NCT05369403|529384405|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
146785036|NCT05369403|529384403|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
146785037|NCT05369403|529384404|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
146785038|NCT05369403|529384405|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
146785039|NCT05369403|529384403|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
146785040|NCT05369403|529384404|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
146785041|NCT05369403|529384405|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
146785042|NCT05369403|529384403|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
146785043|NCT05369403|529384404|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
146785044|NCT05369403|529384405|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
146935645|NCT01705587|529922494|FG000|Overall Study|Withdrawal by Subject|0|||
146935646|NCT01705587|529922495|FG001|Overall Study|Withdrawal by Subject|1|||
146935647|NCT02227849|529922496|FG000|Overall Study|Adverse Event|4|||
146935648|NCT02227849|529922496|FG000|Overall Study|Physician Decision|1|||
146728463|NCT00316082|529174608|FG001|Overall Study|Poor/noncompliance|1|||
146728464|NCT00316082|529174609|FG002|Overall Study|Poor/noncompliance|4|||
146728465|NCT00316082|529174610|FG003|Overall Study|Poor/noncompliance|1|||
146728466|NCT00316082|529174611|FG004|Overall Study|Poor/noncompliance|4|||
146728467|NCT00316082|529174607|FG000|Overall Study|Adverse Event|4|||
146728468|NCT00316082|529174608|FG001|Overall Study|Adverse Event|2|||
146728469|NCT00316082|529174609|FG002|Overall Study|Adverse Event|5|||
146728470|NCT00316082|529174610|FG003|Overall Study|Adverse Event|1|||
146728471|NCT00316082|529174611|FG004|Overall Study|Adverse Event|3|||
146728472|NCT00316082|529174607|FG000|Overall Study|Subject no longer meets study criteria|3|||
146728473|NCT00316082|529174608|FG001|Overall Study|Subject no longer meets study criteria|1|||
146728474|NCT00316082|529174609|FG002|Overall Study|Subject no longer meets study criteria|2|||
146728475|NCT00316082|529174610|FG003|Overall Study|Subject no longer meets study criteria|2|||
146728476|NCT00316082|529174611|FG004|Overall Study|Subject no longer meets study criteria|1|||
146728477|NCT00316082|529174607|FG000|Overall Study|Physician Decision|1|||
146728478|NCT00316082|529174608|FG001|Overall Study|Physician Decision|1|||
146728479|NCT00316082|529174609|FG002|Overall Study|Physician Decision|2|||
146728480|NCT00316082|529174610|FG003|Overall Study|Physician Decision|1|||
146728481|NCT00316082|529174611|FG004|Overall Study|Physician Decision|1|||
146728482|NCT00316082|529174607|FG000|Overall Study|Death|0|||
146728483|NCT00316082|529174608|FG001|Overall Study|Death|0|||
146728484|NCT00316082|529174609|FG002|Overall Study|Death|1|||
146728485|NCT00316082|529174610|FG003|Overall Study|Death|0|||
146728486|NCT00316082|529174611|FG004|Overall Study|Death|0|||
146728487|NCT00316082|529174607|FG000|Overall Study|Administrative reason by sponsor|0|||
146728488|NCT00316082|529174608|FG001|Overall Study|Administrative reason by sponsor|0|||
146728489|NCT00316082|529174609|FG002|Overall Study|Administrative reason by sponsor|1|||
146728490|NCT00316082|529174610|FG003|Overall Study|Administrative reason by sponsor|0|||
146728491|NCT00316082|529174611|FG004|Overall Study|Administrative reason by sponsor|0|||
146728492|NCT00528775|529174614|FG000|Overall Study|Other not specified|1|||
146728493|NCT01995461|529174615|FG000|Overall Study|Death|1|||
146728494|NCT01995461|529174615|FG000|Overall Study|Lost to Follow-up|2|||
146728495|NCT01995461|529174615|FG000|Overall Study|Withdrawal by Subject|2|||
146728496|NCT00540124|529174616|FG000|Overall Study|Adverse Event|0|||
146728497|NCT00540124|529174617|FG001|Overall Study|Adverse Event|2|||
146728498|NCT00540124|529174618|FG002|Overall Study|Adverse Event|1|||
146728499|NCT00540124|529174616|FG000|Overall Study|Entry Criteria Not Met|2|||
146728500|NCT00540124|529174617|FG001|Overall Study|Entry Criteria Not Met|0|||
146728501|NCT00540124|529174618|FG002|Overall Study|Entry Criteria Not Met|0|||
146728502|NCT00540124|529174616|FG000|Overall Study|Lack of Efficacy|1|||
146728503|NCT00540124|529174617|FG001|Overall Study|Lack of Efficacy|0|||
146785045|NCT05369403|529384403|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
146785046|NCT05369403|529384404|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
146785047|NCT05369403|529384405|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
146785048|NCT05369403|529384403|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
146785049|NCT05369403|529384404|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
146785050|NCT05369403|529384405|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
146785051|NCT05369403|529384403|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
146785052|NCT05369403|529384404|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
146785053|NCT05369403|529384405|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
146785054|NCT05369403|529384403|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
146785055|NCT05369403|529384404|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
146785056|NCT05369403|529384405|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
146785057|NCT05369403|529384403|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
146785058|NCT05369403|529384404|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
146785059|NCT05369403|529384405|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
146785060|NCT03056040|529384409|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
146785061|NCT03056040|529384410|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
146785062|NCT03056040|529384409|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
146785063|NCT03056040|529384410|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
146785064|NCT03056040|529384409|FG000|Primary Evaluation Period|Pregnancy|0|||
146785065|NCT03056040|529384410|FG001|Primary Evaluation Period|Pregnancy|1|||
146785066|NCT03056040|529384409|FG000|Primary Evaluation Period|Randomized, not treated|1|||
146785067|NCT03056040|529384410|FG001|Primary Evaluation Period|Randomized, not treated|1|||
146785068|NCT03056040|529384409|FG000|Extension Period|Physician Decision|3|||
146785069|NCT03056040|529384410|FG001|Extension Period|Physician Decision|3|||
146785070|NCT03056040|529384409|FG000|Extension Period|Lost to Follow-up|0|||
146728504|NCT00540124|529174618|FG002|Overall Study|Lack of Efficacy|0|||
146728505|NCT00540124|529174616|FG000|Overall Study|Withdrawal by Subject|1|||
146728506|NCT00540124|529174617|FG001|Overall Study|Withdrawal by Subject|1|||
146728507|NCT00540124|529174618|FG002|Overall Study|Withdrawal by Subject|0|||
146728508|NCT01777854|529174625|FG000|Overall Study|Physician Decision|3|||
146935649|NCT02227849|529922496|FG000|Overall Study|Withdrawal by Subject|3|||
146935650|NCT00510484|529922497|FG000|Wash-out Period|Adverse Event|0|||
146935651|NCT00510484|529922498|FG001|Wash-out Period|Adverse Event|1|||
146935652|NCT01590212|529922499|FG000|Overall Study|Withdrawal by Subject|2|||
146935653|NCT01590212|529922500|FG001|Overall Study|Withdrawal by Subject|2|||
146935654|NCT01590212|529922501|FG002|Overall Study|Withdrawal by Subject|2|||
146935655|NCT01590212|529922499|FG000|Overall Study|Lost to Follow-up|1|||
146935656|NCT01590212|529922500|FG001|Overall Study|Lost to Follow-up|2|||
146935657|NCT01590212|529922501|FG002|Overall Study|Lost to Follow-up|3|||
146935658|NCT00762268|529922502|FG000|Overall Study|Withdrawal by Subject|3|||
146935659|NCT00762268|529922503|FG001|Overall Study|Withdrawal by Subject|3|||
146935660|NCT02533401|529922504|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
146935661|NCT02533401|529922504|FG000|Overall Study|Death|5|||
146935662|NCT02533401|529922504|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
146728509|NCT01777854|529174626|FG001|Overall Study|Physician Decision|3|||
146728510|NCT03311373|529174629|FG000|Overall Study|Adverse Event|1|||
146728511|NCT03311373|529174629|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
146728512|NCT03311373|529174629|FG000|Overall Study|Lost to Follow-up|1|||
146728513|NCT03311373|529174629|FG000|Overall Study|Physician Decision|1|||
146728514|NCT03311373|529174629|FG000|Overall Study|Withdrawal by Subject|3|||
146728515|NCT00374322|529174638|FG000|Overall Study|Lost to Follow-up|92|||
146728516|NCT00374322|529174639|FG001|Overall Study|Lost to Follow-up|90|||
146728517|NCT00374322|529174638|FG000|Overall Study|Protocol Violation|8|||
146728518|NCT00374322|529174639|FG001|Overall Study|Protocol Violation|3|||
146728519|NCT00374322|529174638|FG000|Overall Study|Withdrawal by Subject|235|||
146728520|NCT00374322|529174639|FG001|Overall Study|Withdrawal by Subject|167|||
146728521|NCT00374322|529174638|FG000|Overall Study|Sponsor Terminated Study|866|||
146728522|NCT00374322|529174639|FG001|Overall Study|Sponsor Terminated Study|990|||
146728523|NCT00374322|529174638|FG000|Overall Study|Physician Decision|36|||
146728524|NCT00374322|529174639|FG001|Overall Study|Physician Decision|32|||
146728525|NCT00374322|529174638|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
146728526|NCT00374322|529174639|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
146728527|NCT00374322|529174638|FG000|Overall Study|Sponsor Decision|2|||
146728528|NCT00374322|529174639|FG001|Overall Study|Sponsor Decision|3|||
146728529|NCT00374322|529174638|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
146728530|NCT00374322|529174639|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
146728531|NCT00374322|529174638|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
146728532|NCT00374322|529174639|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
146728533|NCT00374322|529174638|FG000|Overall Study|Severe Toxicity|1|||
146728534|NCT00374322|529174639|FG001|Overall Study|Severe Toxicity|0|||
146728535|NCT00374322|529174638|FG000|Overall Study|Site Closed|2|||
146728536|NCT00374322|529174639|FG001|Overall Study|Site Closed|2|||
146728537|NCT00374322|529174638|FG000|Overall Study|Participant Changed Physician|1|||
146728538|NCT00374322|529174639|FG001|Overall Study|Participant Changed Physician|0|||
146728539|NCT00374322|529174638|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
146728540|NCT00374322|529174639|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
146728541|NCT00374322|529174638|FG000|Overall Study|Noncompliance with Study Requirements|0|||
146728542|NCT00374322|529174639|FG001|Overall Study|Noncompliance with Study Requirements|1|||
146728543|NCT00374322|529174638|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
146728544|NCT00374322|529174639|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
146728545|NCT00374322|529174638|FG000|Overall Study|Did Not Receive Study Medication|8|||
146728546|NCT00374322|529174639|FG001|Overall Study|Did Not Receive Study Medication|6|||
146728547|NCT01297959|529174642|FG000|Overall Study|Adverse Event|0|||
146728548|NCT01297959|529174643|FG001|Overall Study|Adverse Event|1|||
146728549|NCT01297959|529174642|FG000|Overall Study|Protocol Violation|2|||
146728550|NCT01297959|529174643|FG001|Overall Study|Protocol Violation|1|||
146728551|NCT01297959|529174642|FG000|Overall Study|Withdrawal by Subject|5|||
146728552|NCT01297959|529174643|FG001|Overall Study|Withdrawal by Subject|4|||
146728553|NCT01297959|529174642|FG000|Overall Study|Physician Decision|0|||
146728554|NCT01297959|529174643|FG001|Overall Study|Physician Decision|1|||
146728555|NCT01297959|529174642|FG000|Overall Study|Unrelated medical illness / complication|0|||
146728556|NCT01297959|529174643|FG001|Overall Study|Unrelated medical illness / complication|2|||
146728557|NCT01297959|529174642|FG000|Overall Study|Other|13|||
146728558|NCT01297959|529174643|FG001|Overall Study|Other|7|||
146728559|NCT01667432|529174644|FG000|Overall Study|Premature Study Termination|26|||
146728560|NCT01667432|529174644|FG000|Overall Study|Failure to Return|10|||
146728561|NCT01667432|529174644|FG000|Overall Study|Moved to Another Center|3|||
146728562|NCT01667432|529174644|FG000|Overall Study|Lost to Follow-up|3|||
146728563|NCT01667432|529174644|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
146728564|NCT01667432|529174644|FG000|Overall Study|Insufficient Therapeutic Response|4|||
146728565|NCT01667432|529174644|FG000|Overall Study|Adverse Event|1|||
146935663|NCT02533401|529922504|FG000|Overall Study|Lost to Follow-up|1|||
146935664|NCT02533401|529922504|FG000|Overall Study|Violation of Selection Criteria|1|||
146935665|NCT04897594|529922506|FG000|Overall Study|Lost to Follow-up|0|||
146935666|NCT04897594|529922507|FG001|Overall Study|Lost to Follow-up|1|||
146785071|NCT03056040|529384410|FG001|Extension Period|Lost to Follow-up|1|||
146785072|NCT03056040|529384409|FG000|Extension Period|Death|0|||
146785073|NCT03056040|529384410|FG001|Extension Period|Death|3|||
146785074|NCT03056040|529384409|FG000|Extension Period|Withdrawal by Subject|1|||
146785075|NCT03056040|529384410|FG001|Extension Period|Withdrawal by Subject|0|||
146785076|NCT03445988|529384413|FG000|Overall Study|Lost to Follow-up|14|||
146785077|NCT03445988|529384414|FG001|Overall Study|Lost to Follow-up|26|||
146785078|NCT03445988|529384415|FG002|Overall Study|Lost to Follow-up|27|||
146785079|NCT03445988|529384416|FG003|Overall Study|Lost to Follow-up|66|||
146785080|NCT03445988|529384413|FG000|Overall Study|Withdrawal by Subject|7|||
146785081|NCT03445988|529384414|FG001|Overall Study|Withdrawal by Subject|4|||
146785082|NCT03445988|529384415|FG002|Overall Study|Withdrawal by Subject|3|||
146785083|NCT03445988|529384416|FG003|Overall Study|Withdrawal by Subject|5|||
146785084|NCT03445988|529384413|FG000|Overall Study|Death (unrelated to study)|5|||
146785085|NCT03445988|529384414|FG001|Overall Study|Death (unrelated to study)|1|||
146785086|NCT03445988|529384415|FG002|Overall Study|Death (unrelated to study)|2|||
146785087|NCT03445988|529384416|FG003|Overall Study|Death (unrelated to study)|4|||
146785088|NCT03232138|529384417|FG000|Overall Study|Physician Decision|1|||
146785089|NCT03232138|529384418|FG001|Overall Study|Physician Decision|0|||
146785090|NCT03232138|529384417|FG000|Overall Study|Adverse Event|2|||
146785091|NCT03232138|529384418|FG001|Overall Study|Adverse Event|0|||
146785092|NCT03232138|529384417|FG000|Overall Study|Withdrawal by Subject|1|||
146785093|NCT03232138|529384418|FG001|Overall Study|Withdrawal by Subject|2|||
146785094|NCT03920111|529384422|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
146785095|NCT03920111|529384423|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
146785096|NCT03920111|529384424|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
146785097|NCT05268393|529384425|FG000|Overall Study|Withdrawal by Subject|2|||
146785098|NCT05268393|529384426|FG001|Overall Study|Withdrawal by Subject|1|||
146785099|NCT04727554|529384427|FG000|Overall Study|Lost to Follow-up|0|||
146785100|NCT04727554|529384428|FG001|Overall Study|Lost to Follow-up|1|||
146785101|NCT04727554|529384427|FG000|Overall Study|Death|2|||
146785102|NCT04727554|529384428|FG001|Overall Study|Death|6|||
146785103|NCT04727554|529384427|FG000|Overall Study|Withdrawal by Subject|1|||
146785104|NCT04727554|529384428|FG001|Overall Study|Withdrawal by Subject|0|||
146785105|NCT05763823|529384429|FG000|Overall Study|Death|6|||
146785106|NCT05763823|529384429|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146785107|NCT05763823|529384429|FG000|Overall Study|Withdrawal by Subject|6|||
146785108|NCT01997840|529384432|FG000|Overall Study|Lost to Follow-up|0|||
146785109|NCT01997840|529384433|FG001|Overall Study|Lost to Follow-up|0|||
146785110|NCT01997840|529384434|FG002|Overall Study|Lost to Follow-up|1|||
146785111|NCT01997840|529384435|FG003|Overall Study|Lost to Follow-up|0|||
146785112|NCT01997840|529384432|FG000|Overall Study|Withdrawal by participant|0|||
146785113|NCT01997840|529384433|FG001|Overall Study|Withdrawal by participant|0|||
146785114|NCT01997840|529384434|FG002|Overall Study|Withdrawal by participant|8|||
146785115|NCT01997840|529384435|FG003|Overall Study|Withdrawal by participant|1|||
146785116|NCT01997840|529384432|FG000|Overall Study|Physician Decision|0|||
146785117|NCT01997840|529384433|FG001|Overall Study|Physician Decision|0|||
146935667|NCT04897594|529922508|FG002|Overall Study|Lost to Follow-up|1|||
146935668|NCT04897594|529922506|FG000|Overall Study|Sponsor Decision|0|||
146935669|NCT04897594|529922507|FG001|Overall Study|Sponsor Decision|0|||
146785118|NCT01997840|529384434|FG002|Overall Study|Physician Decision|3|||
146785119|NCT01997840|529384435|FG003|Overall Study|Physician Decision|0|||
146785120|NCT01997840|529384432|FG000|Overall Study|Progressive disease|3|||
146785121|NCT01997840|529384433|FG001|Overall Study|Progressive disease|4|||
146785122|NCT01997840|529384434|FG002|Overall Study|Progressive disease|57|||
146785123|NCT01997840|529384435|FG003|Overall Study|Progressive disease|8|||
146785124|NCT01997840|529384432|FG000|Overall Study|Other reasons|0|||
146785125|NCT01997840|529384433|FG001|Overall Study|Other reasons|0|||
146785126|NCT01997840|529384434|FG002|Overall Study|Other reasons|1|||
146785127|NCT01997840|529384435|FG003|Overall Study|Other reasons|0|||
146785128|NCT01997840|529384432|FG000|Overall Study|Adverse Event|0|||
146785129|NCT01997840|529384433|FG001|Overall Study|Adverse Event|0|||
146935670|NCT04897594|529922508|FG002|Overall Study|Sponsor Decision|1|||
146935671|NCT04897594|529922506|FG000|Overall Study|Withdrawal by Subject|1|||
146935672|NCT04897594|529922507|FG001|Overall Study|Withdrawal by Subject|0|||
146935673|NCT04897594|529922508|FG002|Overall Study|Withdrawal by Subject|1|||
146935674|NCT01457924|529922513|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
146935675|NCT01457924|529922514|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
146935676|NCT01457924|529922515|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
146935677|NCT01457924|529922516|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
146935678|NCT01457924|529922517|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
146935679|NCT01457924|529922513|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
146935680|NCT01457924|529922514|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
146935681|NCT01457924|529922515|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
146935682|NCT01457924|529922516|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
146935683|NCT01457924|529922517|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
146935684|NCT01457924|529922513|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
146728566|NCT01667432|529174644|FG000|Overall Study|Protocol Deviation|2|||
146728567|NCT01667432|529174644|FG000|Overall Study|Principal Investigator Decision|1|||
146728568|NCT01667432|529174644|FG000|Overall Study|Reason Not Specified|2|||
146728569|NCT01667432|529174644|FG000|Overall Study|Missing Information|4|||
146728570|NCT02048072|529174649|FG000|Overall Study|Adverse Event|3|||
146728571|NCT02048072|529174649|FG000|Overall Study|Lost to Follow-up|1|||
146728572|NCT01112579|529174650|FG000|Overall Study|Missed Visit|1|||
146728573|NCT01112579|529174651|FG001|Overall Study|Missed Visit|1|||
146728574|NCT01112579|529174650|FG000|Overall Study|Death|0|||
146728575|NCT01112579|529174651|FG001|Overall Study|Death|2|||
146728576|NCT01648270|529174652|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
146728577|NCT00902694|529174653|FG000|Overall Study|Death|1|||
146728578|NCT00902694|529174654|FG001|Overall Study|Death|3|||
146728579|NCT00902694|529174653|FG000|Overall Study|Lost to Follow-up|1|||
146935685|NCT01457924|529922514|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
146935686|NCT01457924|529922515|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
146935687|NCT01457924|529922516|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
146935688|NCT01457924|529922517|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
146935689|NCT01457924|529922513|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
146935690|NCT01457924|529922514|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
146935691|NCT01457924|529922515|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
146935692|NCT01457924|529922516|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
146935693|NCT01457924|529922517|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
146935694|NCT01457924|529922513|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
146935695|NCT01457924|529922514|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
146935696|NCT01457924|529922515|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
146935697|NCT01457924|529922516|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
146935698|NCT01457924|529922517|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
146935699|NCT01457924|529922513|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
146935700|NCT01457924|529922514|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
146935701|NCT01457924|529922515|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
146935702|NCT01457924|529922516|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
146935703|NCT01457924|529922517|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
146935704|NCT01457924|529922513|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
146935705|NCT01457924|529922514|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
146935706|NCT01457924|529922515|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
146935707|NCT01457924|529922516|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
146935708|NCT01457924|529922517|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
146935709|NCT01457924|529922513|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
146935710|NCT01457924|529922514|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
146935711|NCT01457924|529922515|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
146935712|NCT01457924|529922516|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
146935713|NCT01457924|529922517|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
146935714|NCT01457924|529922513|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
146935715|NCT01457924|529922514|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
146935716|NCT01457924|529922515|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
146935717|NCT01457924|529922516|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
146935718|NCT01457924|529922517|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
146935719|NCT01457924|529922513|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
146728580|NCT00902694|529174654|FG001|Overall Study|Lost to Follow-up|0|||
146728581|NCT00902694|529174653|FG000|Overall Study|Censored per protocol|3|||
146728582|NCT00902694|529174654|FG001|Overall Study|Censored per protocol|1|||
146728583|NCT00902694|529174653|FG000|Overall Study|Pregnancy|1|||
146728584|NCT00902694|529174654|FG001|Overall Study|Pregnancy|1|||
146728585|NCT00902694|529174653|FG000|Overall Study|Incarceration|1|||
146728586|NCT00902694|529174654|FG001|Overall Study|Incarceration|0|||
146728587|NCT04969263|529174655|FG000|Overall Study|Death|1|||
146728588|NCT04969263|529174655|FG000|Overall Study|Lost to Follow-up|2|||
146728589|NCT04969263|529174655|FG000|Overall Study|Withdrawal by Subject|5|||
146728590|NCT04969263|529174655|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
146728591|NCT03456700|529174656|FG000|Overall Study|Withdrawal by Subject|1|||
146728592|NCT04154787|529174657|FG000|Overall Study|Adverse Event|0|||
146935720|NCT01457924|529922514|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
146935721|NCT01457924|529922515|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
146935722|NCT01457924|529922516|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
146935723|NCT01457924|529922517|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
146935724|NCT01457924|529922513|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
146935725|NCT01457924|529922514|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
146728593|NCT04154787|529174658|FG001|Overall Study|Adverse Event|1|||
146728594|NCT04154787|529174659|FG002|Overall Study|Adverse Event|0|||
146728595|NCT04154787|529174657|FG000|Overall Study|Patient Requires Other Treatment|0|||
146728596|NCT04154787|529174658|FG001|Overall Study|Patient Requires Other Treatment|1|||
146728597|NCT04154787|529174659|FG002|Overall Study|Patient Requires Other Treatment|0|||
146728598|NCT04154787|529174657|FG000|Overall Study|Study Terminated By Sponsor|0|||
146935726|NCT01457924|529922515|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
146935727|NCT01457924|529922516|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
146728599|NCT04154787|529174658|FG001|Overall Study|Study Terminated By Sponsor|6|||
146728600|NCT04154787|529174659|FG002|Overall Study|Study Terminated By Sponsor|1|||
146728601|NCT04154787|529174657|FG000|Overall Study|Subject Decision|0|||
146728602|NCT04154787|529174658|FG001|Overall Study|Subject Decision|1|||
146728603|NCT04154787|529174659|FG002|Overall Study|Subject Decision|0|||
146728604|NCT04154787|529174657|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
146728605|NCT04154787|529174658|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
146728606|NCT04154787|529174659|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
146728607|NCT03053050|529174660|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
146728608|NCT03053050|529174661|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
146728609|NCT03053050|529174662|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
146728610|NCT03053050|529174663|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
146728611|NCT03053050|529174660|FG000|Randomized Phase|Withdrew Consent|16|||
146728612|NCT03053050|529174661|FG001|Randomized Phase|Withdrew Consent|8|||
146728613|NCT03053050|529174662|FG002|Randomized Phase|Withdrew Consent|9|||
146728614|NCT03053050|529174663|FG003|Randomized Phase|Withdrew Consent|0|||
146728615|NCT03053050|529174660|FG000|Randomized Phase|Investigator's Discretion|6|||
146728616|NCT03053050|529174661|FG001|Randomized Phase|Investigator's Discretion|6|||
146728617|NCT03053050|529174662|FG002|Randomized Phase|Investigator's Discretion|3|||
146728618|NCT03053050|529174663|FG003|Randomized Phase|Investigator's Discretion|0|||
146728619|NCT03053050|529174660|FG000|Randomized Phase|Lost to Follow-up|5|||
146728620|NCT03053050|529174661|FG001|Randomized Phase|Lost to Follow-up|1|||
146728621|NCT03053050|529174662|FG002|Randomized Phase|Lost to Follow-up|1|||
146728622|NCT03053050|529174663|FG003|Randomized Phase|Lost to Follow-up|0|||
146728623|NCT03053050|529174660|FG000|Randomized Phase|Adverse Event|0|||
146935728|NCT01457924|529922517|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
146935729|NCT01457924|529922513|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
146728624|NCT03053050|529174661|FG001|Randomized Phase|Adverse Event|1|||
146728625|NCT03053050|529174662|FG002|Randomized Phase|Adverse Event|0|||
146728626|NCT03053050|529174663|FG003|Randomized Phase|Adverse Event|0|||
146728627|NCT03053050|529174660|FG000|Randomized Phase|Randomized but Never Treated|2|||
146728628|NCT03053050|529174661|FG001|Randomized Phase|Randomized but Never Treated|2|||
146728629|NCT03053050|529174662|FG002|Randomized Phase|Randomized but Never Treated|2|||
146728630|NCT03053050|529174663|FG003|Randomized Phase|Randomized but Never Treated|0|||
146728631|NCT03053050|529174660|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
146728632|NCT03053050|529174661|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
146728633|NCT03053050|529174662|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
146728634|NCT03053050|529174663|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
146728635|NCT03053050|529174660|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
146728636|NCT03053050|529174661|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
146728637|NCT03053050|529174662|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
146728638|NCT03053050|529174663|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
146728639|NCT03053050|529174660|FG000|Open-label Phase|Withdrew Consent|0|||
146728640|NCT03053050|529174661|FG001|Open-label Phase|Withdrew Consent|0|||
146728641|NCT03053050|529174662|FG002|Open-label Phase|Withdrew Consent|0|||
146728642|NCT03053050|529174663|FG003|Open-label Phase|Withdrew Consent|6|||
146728643|NCT03053050|529174660|FG000|Open-label Phase|Investigator's Discretion|0|||
146728644|NCT03053050|529174661|FG001|Open-label Phase|Investigator's Discretion|0|||
146728645|NCT03053050|529174662|FG002|Open-label Phase|Investigator's Discretion|0|||
146728646|NCT03053050|529174663|FG003|Open-label Phase|Investigator's Discretion|4|||
146728647|NCT03703466|529174664|FG000|Overall Study|Death|2|||
146728648|NCT03703466|529174665|FG001|Overall Study|Death|1|||
146728649|NCT03703466|529174666|FG002|Overall Study|Death|0|||
146728650|NCT03703466|529174664|FG000|Overall Study|Withdrawal by Subject|0|||
146728651|NCT03703466|529174665|FG001|Overall Study|Withdrawal by Subject|3|||
146728652|NCT03703466|529174666|FG002|Overall Study|Withdrawal by Subject|0|||
146728653|NCT03703466|529174664|FG000|Overall Study|Completed < 3 Cycles|2|||
146728654|NCT03703466|529174665|FG001|Overall Study|Completed < 3 Cycles|2|||
146728655|NCT03703466|529174666|FG002|Overall Study|Completed < 3 Cycles|2|||
146728656|NCT01553318|529177010|FG000|Overall Study|Protocol Violation|3|||
146935730|NCT01457924|529922514|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
146728657|NCT01553318|529177011|FG001|Overall Study|Protocol Violation|2|||
146728658|NCT02178059|529177013|FG000|Washout|Physician Decision|1|||
146728659|NCT02178059|529177014|FG001|Washout|Physician Decision|0|||
146728660|NCT02586025|529177017|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
146728661|NCT02586025|529177018|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
146728662|NCT02586025|529177017|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
146728663|NCT02586025|529177018|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
146728664|NCT02586025|529177017|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
146728665|NCT02586025|529177018|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
146728666|NCT02586025|529177017|FG000|Neoadjuvant Treatment|Death|1|||
146728667|NCT02586025|529177018|FG001|Neoadjuvant Treatment|Death|0|||
146785130|NCT01997840|529384434|FG002|Overall Study|Adverse Event|15|||
146935731|NCT01457924|529922515|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
146935732|NCT01457924|529922516|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
146728668|NCT02586025|529177017|FG000|Neoadjuvant Treatment|Adverse Event|1|||
146728669|NCT02586025|529177018|FG001|Neoadjuvant Treatment|Adverse Event|0|||
146728670|NCT02586025|529177017|FG000|Neoadjuvant Treatment|Physician Decision|2|||
146728671|NCT02586025|529177018|FG001|Neoadjuvant Treatment|Physician Decision|1|||
146728672|NCT02586025|529177017|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
146728673|NCT02586025|529177018|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
146728674|NCT02586025|529177017|FG000|Adjuvant Treatment|Recurrent Disease|4|||
146728675|NCT02586025|529177018|FG001|Adjuvant Treatment|Recurrent Disease|5|||
146728676|NCT02586025|529177017|FG000|Adjuvant Treatment|Physician Decision|0|||
146728677|NCT02586025|529177018|FG001|Adjuvant Treatment|Physician Decision|1|||
146728678|NCT02586025|529177017|FG000|Adjuvant Treatment|Pregnancy|1|||
146728679|NCT02586025|529177018|FG001|Adjuvant Treatment|Pregnancy|0|||
146728680|NCT02586025|529177017|FG000|Treatment-Free Follow-Up|Death|11|||
146728681|NCT02586025|529177018|FG001|Treatment-Free Follow-Up|Death|11|||
146728682|NCT02586025|529177017|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
146728683|NCT02586025|529177018|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
146728684|NCT02586025|529177017|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
146728685|NCT02586025|529177018|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
146728686|NCT02586025|529177017|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
146728687|NCT02586025|529177018|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
146728688|NCT02586025|529177017|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
146728689|NCT02586025|529177018|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
146728690|NCT03597568|529177019|FG000|Overall Study|Withdrawal by Subject|1|||
146728691|NCT03597568|529177020|FG001|Overall Study|Withdrawal by Subject|1|||
146728692|NCT03597568|529177019|FG000|Overall Study|Unable to analyze vascular data|1|||
146728693|NCT03597568|529177020|FG001|Overall Study|Unable to analyze vascular data|1|||
146728694|NCT00999466|529177023|FG000|Main Part|Withdrawal by Subject|0|||
146728695|NCT00999466|529177024|FG001|Main Part|Withdrawal by Subject|0|||
146728696|NCT00999466|529177025|FG002|Main Part|Withdrawal by Subject|2|||
146728697|NCT00999466|529177023|FG000|Main Part|Adverse Event|0|||
146728698|NCT00999466|529177024|FG001|Main Part|Adverse Event|4|||
146728699|NCT00999466|529177025|FG002|Main Part|Adverse Event|2|||
146728700|NCT03255824|529177027|FG000|Overall Study|Under-sedation|2|||
146728701|NCT03255824|529177028|FG001|Overall Study|Under-sedation|1|||
146728702|NCT02001194|529177030|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
146728703|NCT02001194|529177031|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
146728704|NCT02001194|529177032|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
146728705|NCT02001194|529177033|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
146728706|NCT02001194|529177030|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
146728707|NCT02001194|529177031|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
146728708|NCT02001194|529177032|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
146728709|NCT02001194|529177033|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
146728710|NCT03040713|529177035|FG000|Overall Study|Positive amyloid scan|3|||
146728711|NCT02570126|529177042|FG000|Overall Study|Lost to Follow-up|2|||
146728712|NCT02570126|529177043|FG001|Overall Study|Lost to Follow-up|0|||
146728713|NCT02570126|529177042|FG000|Overall Study|Unable To Arrange Visit 3|1|||
146728714|NCT02570126|529177043|FG001|Overall Study|Unable To Arrange Visit 3|0|||
146728715|NCT02570126|529177042|FG000|Overall Study|Violation Of Procedures GSK|0|||
146728716|NCT02570126|529177043|FG001|Overall Study|Violation Of Procedures GSK|1|||
146728717|NCT02570126|529177042|FG000|Overall Study|Protocol Violation|0|||
146728718|NCT02570126|529177043|FG001|Overall Study|Protocol Violation|1|||
146728719|NCT02570126|529177042|FG000|Overall Study|Withdrawal by Subject|3|||
146728720|NCT02570126|529177043|FG001|Overall Study|Withdrawal by Subject|7|||
146728721|NCT01040260|529177050|FG000|Overall Study|Withdrawal by Subject|12|||
146728722|NCT01040260|529177051|FG001|Overall Study|Withdrawal by Subject|6|||
146728723|NCT01040260|529177050|FG000|Overall Study|Lost to Follow-up|3|||
146728724|NCT01040260|529177051|FG001|Overall Study|Lost to Follow-up|5|||
146728725|NCT01113502|529177055|FG000|Overall Study|Withdrawal by Subject|1|||
146728726|NCT01113502|529177056|FG001|Overall Study|Withdrawal by Subject|0|||
146728727|NCT01113502|529177057|FG002|Overall Study|Withdrawal by Subject|1|||
146728728|NCT01113502|529177058|FG003|Overall Study|Withdrawal by Subject|1|||
146728729|NCT01113502|529177059|FG004|Overall Study|Withdrawal by Subject|0|||
146728730|NCT01113502|529177055|FG000|Overall Study|Adverse Event|0|||
146728731|NCT01113502|529177056|FG001|Overall Study|Adverse Event|0|||
146728732|NCT01113502|529177057|FG002|Overall Study|Adverse Event|3|||
146728733|NCT01113502|529177058|FG003|Overall Study|Adverse Event|2|||
146728734|NCT01113502|529177059|FG004|Overall Study|Adverse Event|0|||
146935733|NCT01457924|529922517|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
146728735|NCT01970982|529177062|FG000|Overall Study|Withdrawal by Subject|0|||
146785131|NCT01997840|529384435|FG003|Overall Study|Adverse Event|2|||
146728736|NCT01970982|529177063|FG001|Overall Study|Withdrawal by Subject|0|||
146728737|NCT01970982|529177064|FG002|Overall Study|Withdrawal by Subject|2|||
146728738|NCT00708916|529177067|FG000|Overall Study|Subject Noncompliance|2|||
146728739|NCT00708916|529177067|FG000|Overall Study|Adverse Event|2|||
146728740|NCT01984684|529177070|FG000|Overall Study|Lost to Follow-up|25|||
146935734|NCT01457924|529922513|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
146935735|NCT01457924|529922514|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
146935736|NCT01457924|529922515|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
146935737|NCT01457924|529922516|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
146935738|NCT01457924|529922517|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
146728741|NCT01984684|529177071|FG001|Overall Study|Lost to Follow-up|24|||
146728742|NCT01984684|529177070|FG000|Overall Study|Adverse Event|8|||
146728743|NCT01984684|529177071|FG001|Overall Study|Adverse Event|12|||
146728744|NCT01984684|529177070|FG000|Overall Study|Withdrawal by Subject|9|||
146728745|NCT01984684|529177071|FG001|Overall Study|Withdrawal by Subject|9|||
146728746|NCT01984684|529177070|FG000|Overall Study|Lack of Efficacy|3|||
146728747|NCT01984684|529177071|FG001|Overall Study|Lack of Efficacy|6|||
146728748|NCT01984684|529177070|FG000|Overall Study|Physician Decision|4|||
146728749|NCT01984684|529177071|FG001|Overall Study|Physician Decision|2|||
146728750|NCT01984684|529177070|FG000|Overall Study|Protocol Violation|4|||
146728751|NCT01984684|529177071|FG001|Overall Study|Protocol Violation|2|||
146728752|NCT01984684|529177070|FG000|Overall Study|Death|0|||
146728753|NCT01984684|529177071|FG001|Overall Study|Death|1|||
146728754|NCT01984684|529177070|FG000|Overall Study|Noncompliance with study drug|2|||
146728755|NCT01984684|529177071|FG001|Overall Study|Noncompliance with study drug|1|||
146728756|NCT01984684|529177070|FG000|Overall Study|Subject incarcerated|1|||
146728757|NCT01984684|529177071|FG001|Overall Study|Subject incarcerated|0|||
146728758|NCT01984684|529177070|FG000|Overall Study|Study drug not available at site|1|||
146728759|NCT01984684|529177071|FG001|Overall Study|Study drug not available at site|1|||
146728760|NCT01984684|529177070|FG000|Overall Study|Subject had inadequate IV access|0|||
146728761|NCT01984684|529177071|FG001|Overall Study|Subject had inadequate IV access|1|||
146728762|NCT02835339|529177075|FG000|Overall Study|Did not receive allocated intervention|13|||
146728763|NCT02835339|529177076|FG001|Overall Study|Did not receive allocated intervention|16|||
146728764|NCT01077544|529177077|FG000|Overall Study|New Cancer Therapy|3|||
146728765|NCT01077544|529177078|FG001|Overall Study|New Cancer Therapy|3|||
146728766|NCT01077544|529177077|FG000|Overall Study|Adverse Event|0|||
146728767|NCT01077544|529177078|FG001|Overall Study|Adverse Event|1|||
146728768|NCT01077544|529177077|FG000|Overall Study|Disease Progression|0|||
146728769|NCT01077544|529177078|FG001|Overall Study|Disease Progression|1|||
146728770|NCT03923959|529177087|FG000|Overall Study|Death|16|||
146728771|NCT03923959|529177088|FG001|Overall Study|Death|12|||
146728772|NCT03923959|529177087|FG000|Overall Study|Lost to Follow-up|56|||
146728773|NCT03923959|529177088|FG001|Overall Study|Lost to Follow-up|56|||
146728774|NCT03923959|529177087|FG000|Overall Study|Withdrawal by Subject|1|||
146728775|NCT03923959|529177088|FG001|Overall Study|Withdrawal by Subject|1|||
146728776|NCT03923959|529177087|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
146728777|NCT03923959|529177088|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
146728778|NCT04918147|529177089|FG000|Overall Study|Disease flare as defined in protocol|0|||
146728779|NCT04918147|529177090|FG001|Overall Study|Disease flare as defined in protocol|2|||
146728780|NCT01362439|529177091|FG000|Overall Study|Adverse Event|1|||
146728781|NCT01362439|529177091|FG000|Overall Study|Lack of Efficacy|3|||
146728782|NCT01362439|529177091|FG000|Overall Study|Lost to Follow-up|2|||
146728783|NCT01362439|529177091|FG000|Overall Study|Study medication non-compliant|1|||
146728784|NCT01362439|529177091|FG000|Overall Study|Participant who withdrew consent|8|||
146728785|NCT04040751|529177102|FG000|Overall Study|Withdrawal by Subject|2|||
146728786|NCT04040751|529177103|FG001|Overall Study|Withdrawal by Subject|0|||
146728787|NCT04040751|529177104|FG002|Overall Study|Withdrawal by Subject|2|||
146728788|NCT04040751|529177105|FG003|Overall Study|Withdrawal by Subject|0|||
146728789|NCT04212091|529177106|FG000|Overall Study|Lost to Follow-up|0|||
146728790|NCT04212091|529177107|FG001|Overall Study|Lost to Follow-up|0|||
146728791|NCT04212091|529177108|FG002|Overall Study|Lost to Follow-up|0|||
146728792|NCT04212091|529177109|FG003|Overall Study|Lost to Follow-up|0|||
146728793|NCT04212091|529177110|FG004|Overall Study|Lost to Follow-up|1|||
146728794|NCT04212091|529177111|FG005|Overall Study|Lost to Follow-up|1|||
146728795|NCT04212091|529177106|FG000|Overall Study|Participant unable to adhere to visit|0|||
146728796|NCT04212091|529177107|FG001|Overall Study|Participant unable to adhere to visit|0|||
146728797|NCT04212091|529177108|FG002|Overall Study|Participant unable to adhere to visit|0|||
146728798|NCT04212091|529177109|FG003|Overall Study|Participant unable to adhere to visit|0|||
146728799|NCT04212091|529177110|FG004|Overall Study|Participant unable to adhere to visit|1|||
146935739|NCT01329341|529922518|FG000|Overall Study|Withdrawal by Subject|44|||
146728800|NCT04212091|529177111|FG005|Overall Study|Participant unable to adhere to visit|0|||
146728801|NCT02712905|529177112|FG000|Monotherapy|Death|2|||
146728802|NCT02712905|529177113|FG001|Monotherapy|Death|5|||
146728803|NCT02712905|529177114|FG002|Monotherapy|Death|0|||
146728804|NCT02712905|529177115|FG003|Monotherapy|Death|3|||
146728805|NCT02712905|529177116|FG004|Monotherapy|Death|15|||
146935740|NCT00448760|529922519|FG000|Overall Study|Death|3|||
146785132|NCT05256706|529384437|FG000|Overall Study|Lost to Follow-up|9|||
146785133|NCT05256706|529384438|FG001|Overall Study|Lost to Follow-up|3|||
146785134|NCT05256706|529384437|FG000|Overall Study|Withdrawal by Subject|7|||
146785135|NCT05256706|529384438|FG001|Overall Study|Withdrawal by Subject|11|||
146785136|NCT05256706|529384437|FG000|Overall Study|Screen Failures|3|||
146785137|NCT05256706|529384438|FG001|Overall Study|Screen Failures|0|||
146785138|NCT03850678|529384441|FG000|Overall Study|Withdrawal by Subject|3|||
146785139|NCT03850678|529384442|FG001|Overall Study|Withdrawal by Subject|0|||
146785140|NCT03850678|529384441|FG000|Overall Study|Experimenter Error|1|||
146785141|NCT03850678|529384442|FG001|Overall Study|Experimenter Error|1|||
146785142|NCT03850678|529384441|FG000|Overall Study|Did Not Condition To Experiment|7|||
146785143|NCT03850678|529384442|FG001|Overall Study|Did Not Condition To Experiment|2|||
146785144|NCT03720795|529384443|FG000|Phase 1|Lost to Follow-up|4|||
146785145|NCT03720795|529384443|FG000|Phase 1|Withdrawal by Subject|6|||
146785146|NCT03720795|529384443|FG000|Phase 1|Protocol Violation|1|||
146785147|NCT03720795|529384443|FG000|Phase 1|Other|1|||
146785148|NCT03720795|529384443|FG000|Phase 2|Lost to Follow-up|5|||
146785149|NCT03720795|529384443|FG000|Phase 2|Withdrawal by Subject|10|||
146785150|NCT03720795|529384443|FG000|Phase 2|Protocol Violation|2|||
146785151|NCT03720795|529384443|FG000|3 Month Follow Up|Lost to Follow-up|2|||
146785152|NCT04166773|529384446|FG000|Overall Study|Adverse Event|2|||
146785153|NCT04166773|529384447|FG001|Overall Study|Adverse Event|0|||
146785154|NCT04166773|529384448|FG002|Overall Study|Adverse Event|2|||
146785155|NCT04166773|529384449|FG003|Overall Study|Adverse Event|1|||
146785156|NCT04166773|529384446|FG000|Overall Study|Lost to Follow-up|4|||
146785157|NCT04166773|529384447|FG001|Overall Study|Lost to Follow-up|2|||
146785158|NCT04166773|529384448|FG002|Overall Study|Lost to Follow-up|1|||
146785159|NCT04166773|529384449|FG003|Overall Study|Lost to Follow-up|3|||
146785160|NCT04166773|529384446|FG000|Overall Study|Physician Decision|0|||
146785161|NCT04166773|529384447|FG001|Overall Study|Physician Decision|0|||
146785162|NCT04166773|529384448|FG002|Overall Study|Physician Decision|0|||
146785163|NCT04166773|529384449|FG003|Overall Study|Physician Decision|1|||
146785164|NCT04166773|529384446|FG000|Overall Study|Withdrawal by Subject|1|||
146785165|NCT04166773|529384447|FG001|Overall Study|Withdrawal by Subject|1|||
146785166|NCT04166773|529384448|FG002|Overall Study|Withdrawal by Subject|2|||
146785167|NCT04166773|529384449|FG003|Overall Study|Withdrawal by Subject|5|||
146785168|NCT04763265|529384453|FG000|Overall Study|Adverse Event|1|||
146785169|NCT04763265|529384454|FG001|Overall Study|Adverse Event|0|||
146785170|NCT04763265|529384453|FG000|Overall Study|Lost to Follow-up|2|||
146785171|NCT04763265|529384454|FG001|Overall Study|Lost to Follow-up|4|||
146785172|NCT04763265|529384453|FG000|Overall Study|Withdrawal by Subject|0|||
146785173|NCT04763265|529384454|FG001|Overall Study|Withdrawal by Subject|1|||
146785174|NCT03269136|529384456|FG000|Part 1: Dose Escalation|Other|0|||
146785175|NCT03269136|529384457|FG001|Part 1: Dose Escalation|Other|0|||
146785176|NCT03269136|529384458|FG002|Part 1: Dose Escalation|Other|0|||
146785177|NCT03269136|529384459|FG003|Part 1: Dose Escalation|Other|0|||
146785178|NCT03269136|529384460|FG004|Part 1: Dose Escalation|Other|0|||
146785179|NCT03269136|529384461|FG005|Part 1: Dose Escalation|Other|0|||
146785180|NCT03269136|529384462|FG006|Part 1: Dose Escalation|Other|0|||
146785181|NCT03269136|529384463|FG007|Part 1: Dose Escalation|Other|0|||
146785182|NCT03269136|529384464|FG008|Part 1: Dose Escalation|Other|0|||
146785183|NCT03269136|529384465|FG009|Part 1: Dose Escalation|Other|0|||
146785184|NCT03269136|529384466|FG010|Part 1: Dose Escalation|Other|1|||
146728806|NCT02712905|529177117|FG005|Monotherapy|Death|1|||
146728807|NCT02712905|529177118|FG006|Monotherapy|Death|3|||
146728808|NCT02712905|529177119|FG007|Monotherapy|Death|3|||
146728809|NCT02712905|529177120|FG008|Monotherapy|Death|0|||
146728810|NCT02712905|529177121|FG009|Monotherapy|Death|27|||
146728811|NCT02712905|529177122|FG010|Monotherapy|Death|2|||
146728812|NCT02712905|529177123|FG011|Monotherapy|Death|5|||
146728813|NCT02712905|529177124|FG012|Monotherapy|Death|0|||
146728814|NCT02712905|529177125|FG013|Monotherapy|Death|0|||
146728815|NCT02712905|529177126|FG014|Monotherapy|Death|0|||
146728816|NCT02712905|529177127|FG015|Monotherapy|Death|0|||
146728817|NCT02712905|529177128|FG016|Monotherapy|Death|0|||
146728818|NCT02712905|529177129|FG017|Monotherapy|Death|0|||
146728819|NCT02712905|529177112|FG000|Monotherapy|Lost to Follow-up|0|||
146728820|NCT02712905|529177113|FG001|Monotherapy|Lost to Follow-up|1|||
146728821|NCT02712905|529177114|FG002|Monotherapy|Lost to Follow-up|0|||
146728822|NCT02712905|529177115|FG003|Monotherapy|Lost to Follow-up|1|||
146785185|NCT03269136|529384467|FG011|Part 1: Dose Escalation|Other|1|||
146785186|NCT03269136|529384468|FG012|Part 1: Dose Escalation|Other|1|||
146728823|NCT02712905|529177116|FG004|Monotherapy|Lost to Follow-up|0|||
146785187|NCT03269136|529384469|FG013|Part 1: Dose Escalation|Other|0|||
146785188|NCT03269136|529384470|FG014|Part 1: Dose Escalation|Other|3|||
146785189|NCT03269136|529384471|FG015|Part 1: Dose Escalation|Other|1|||
146935741|NCT03017846|529922522|FG000|Overall Study|Lost to Follow-up|3|||
146728824|NCT02712905|529177117|FG005|Monotherapy|Lost to Follow-up|0|||
146728825|NCT02712905|529177118|FG006|Monotherapy|Lost to Follow-up|0|||
146785190|NCT03269136|529384472|FG016|Part 1: Dose Escalation|Other|1|||
146785191|NCT03269136|529384473|FG017|Part 1: Dose Escalation|Other|0|||
146785192|NCT03269136|529384456|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
146785193|NCT03269136|529384457|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
146785194|NCT03269136|529384458|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
146785195|NCT03269136|529384459|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
146785196|NCT03269136|529384460|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
146785197|NCT03269136|529384461|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
146785198|NCT03269136|529384462|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
146785199|NCT03269136|529384463|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
146785200|NCT03269136|529384464|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
146785201|NCT03269136|529384465|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
146785202|NCT03269136|529384466|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
146785203|NCT03269136|529384467|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
146785204|NCT03269136|529384468|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
146785205|NCT03269136|529384469|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
146785206|NCT03269136|529384470|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
146785207|NCT03269136|529384471|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
146785208|NCT03269136|529384472|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
146785209|NCT03269136|529384473|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
146785210|NCT03269136|529384456|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785211|NCT03269136|529384457|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785212|NCT03269136|529384458|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785213|NCT03269136|529384459|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785214|NCT03269136|529384460|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785215|NCT03269136|529384461|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785216|NCT03269136|529384462|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785217|NCT03269136|529384463|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
146785218|NCT03269136|529384464|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785219|NCT03269136|529384465|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785220|NCT03269136|529384466|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785221|NCT03269136|529384467|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785222|NCT03269136|529384468|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785223|NCT03269136|529384469|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785224|NCT03269136|529384470|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785225|NCT03269136|529384471|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785226|NCT03269136|529384472|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785227|NCT03269136|529384473|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146785228|NCT03269136|529384456|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
146785229|NCT03269136|529384457|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
146785230|NCT03269136|529384458|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
146785231|NCT03269136|529384459|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
146785232|NCT03269136|529384460|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
146785233|NCT03269136|529384461|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
146785234|NCT03269136|529384462|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
146785235|NCT03269136|529384463|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
146785236|NCT03269136|529384464|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
146785237|NCT03269136|529384465|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
146785238|NCT03269136|529384466|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
146785239|NCT03269136|529384467|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
146785240|NCT03269136|529384468|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
146785241|NCT03269136|529384469|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
146785242|NCT03269136|529384470|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
146785243|NCT03269136|529384471|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
146785244|NCT03269136|529384472|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
146785245|NCT03269136|529384473|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
146935742|NCT03017846|529922522|FG000|Overall Study|Adverse Event|2|||
146935743|NCT00618995|529922524|FG000|Period 1|Adverse Event|0|||
146935744|NCT00618995|529922525|FG001|Period 1|Adverse Event|0|||
146935745|NCT00618995|529922526|FG002|Period 1|Adverse Event|1|||
146935746|NCT00618995|529922527|FG003|Period 1|Adverse Event|0|||
146935747|NCT00618995|529922524|FG000|Period 1|Protocol Violation|0|||
146935748|NCT00618995|529922525|FG001|Period 1|Protocol Violation|1|||
146935749|NCT00618995|529922526|FG002|Period 1|Protocol Violation|1|||
146935750|NCT00618995|529922527|FG003|Period 1|Protocol Violation|0|||
146785246|NCT03269136|529384456|FG000|Part 1: Dose Escalation|Death|0|||
146785247|NCT03269136|529384457|FG001|Part 1: Dose Escalation|Death|0|||
146785248|NCT03269136|529384458|FG002|Part 1: Dose Escalation|Death|0|||
146785249|NCT03269136|529384459|FG003|Part 1: Dose Escalation|Death|0|||
146785250|NCT03269136|529384460|FG004|Part 1: Dose Escalation|Death|0|||
146935751|NCT00618995|529922524|FG000|Period 2|Protocol Violation|0|||
146935752|NCT00618995|529922525|FG001|Period 2|Protocol Violation|0|||
146935753|NCT00618995|529922526|FG002|Period 2|Protocol Violation|1|||
146935754|NCT00618995|529922527|FG003|Period 2|Protocol Violation|0|||
146935755|NCT00618995|529922524|FG000|Period 4|Adverse Event|1|||
146935756|NCT00618995|529922525|FG001|Period 4|Adverse Event|0|||
146935757|NCT00618995|529922526|FG002|Period 4|Adverse Event|0|||
146935758|NCT00618995|529922527|FG003|Period 4|Adverse Event|0|||
146935759|NCT01213264|529922528|FG000|Overall Study|Adverse Event|1|||
146935760|NCT01213264|529922529|FG001|Overall Study|Adverse Event|0|||
146935761|NCT01213264|529922530|FG002|Overall Study|Adverse Event|0|||
146935762|NCT01213264|529922528|FG000|Overall Study|Lost to Follow-up|1|||
146935763|NCT01213264|529922529|FG001|Overall Study|Lost to Follow-up|2|||
146935764|NCT01213264|529922530|FG002|Overall Study|Lost to Follow-up|6|||
146935765|NCT05014542|529922531|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
146935766|NCT05014542|529922532|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
146728826|NCT02712905|529177119|FG007|Monotherapy|Lost to Follow-up|0|||
146728827|NCT02712905|529177120|FG008|Monotherapy|Lost to Follow-up|0|||
146728828|NCT02712905|529177121|FG009|Monotherapy|Lost to Follow-up|2|||
146728829|NCT02712905|529177122|FG010|Monotherapy|Lost to Follow-up|0|||
146728830|NCT02712905|529177123|FG011|Monotherapy|Lost to Follow-up|0|||
146728831|NCT02712905|529177124|FG012|Monotherapy|Lost to Follow-up|0|||
146728832|NCT02712905|529177125|FG013|Monotherapy|Lost to Follow-up|0|||
146728833|NCT02712905|529177126|FG014|Monotherapy|Lost to Follow-up|0|||
146728834|NCT02712905|529177127|FG015|Monotherapy|Lost to Follow-up|0|||
146728835|NCT02712905|529177128|FG016|Monotherapy|Lost to Follow-up|0|||
146728836|NCT02712905|529177129|FG017|Monotherapy|Lost to Follow-up|0|||
146728837|NCT02712905|529177112|FG000|Monotherapy|Physician Decision|1|||
146728838|NCT02712905|529177113|FG001|Monotherapy|Physician Decision|0|||
146728839|NCT02712905|529177114|FG002|Monotherapy|Physician Decision|0|||
146728840|NCT02712905|529177115|FG003|Monotherapy|Physician Decision|1|||
146728841|NCT02712905|529177116|FG004|Monotherapy|Physician Decision|0|||
146728842|NCT02712905|529177117|FG005|Monotherapy|Physician Decision|0|||
146728843|NCT02712905|529177118|FG006|Monotherapy|Physician Decision|0|||
146728844|NCT02712905|529177119|FG007|Monotherapy|Physician Decision|0|||
146728845|NCT02712905|529177120|FG008|Monotherapy|Physician Decision|0|||
146728846|NCT02712905|529177121|FG009|Monotherapy|Physician Decision|1|||
146728847|NCT02712905|529177122|FG010|Monotherapy|Physician Decision|0|||
146728848|NCT02712905|529177123|FG011|Monotherapy|Physician Decision|0|||
146728849|NCT02712905|529177124|FG012|Monotherapy|Physician Decision|0|||
146728850|NCT02712905|529177125|FG013|Monotherapy|Physician Decision|0|||
146728851|NCT02712905|529177126|FG014|Monotherapy|Physician Decision|0|||
146728852|NCT02712905|529177127|FG015|Monotherapy|Physician Decision|0|||
146728853|NCT02712905|529177128|FG016|Monotherapy|Physician Decision|0|||
146728854|NCT02712905|529177129|FG017|Monotherapy|Physician Decision|0|||
146728855|NCT02712905|529177112|FG000|Monotherapy|Study Terminated by Sponsor|0|||
146728856|NCT02712905|529177113|FG001|Monotherapy|Study Terminated by Sponsor|0|||
146728857|NCT02712905|529177114|FG002|Monotherapy|Study Terminated by Sponsor|0|||
146728858|NCT02712905|529177115|FG003|Monotherapy|Study Terminated by Sponsor|0|||
146728859|NCT02712905|529177116|FG004|Monotherapy|Study Terminated by Sponsor|1|||
146728860|NCT02712905|529177117|FG005|Monotherapy|Study Terminated by Sponsor|0|||
146728861|NCT02712905|529177118|FG006|Monotherapy|Study Terminated by Sponsor|0|||
146728862|NCT02712905|529177119|FG007|Monotherapy|Study Terminated by Sponsor|0|||
146728863|NCT02712905|529177120|FG008|Monotherapy|Study Terminated by Sponsor|0|||
146728864|NCT02712905|529177121|FG009|Monotherapy|Study Terminated by Sponsor|2|||
146728865|NCT02712905|529177122|FG010|Monotherapy|Study Terminated by Sponsor|0|||
146728866|NCT02712905|529177123|FG011|Monotherapy|Study Terminated by Sponsor|0|||
146728867|NCT02712905|529177124|FG012|Monotherapy|Study Terminated by Sponsor|0|||
146728868|NCT02712905|529177125|FG013|Monotherapy|Study Terminated by Sponsor|0|||
146728869|NCT02712905|529177126|FG014|Monotherapy|Study Terminated by Sponsor|0|||
146728870|NCT02712905|529177127|FG015|Monotherapy|Study Terminated by Sponsor|0|||
146728871|NCT02712905|529177128|FG016|Monotherapy|Study Terminated by Sponsor|0|||
146728872|NCT02712905|529177129|FG017|Monotherapy|Study Terminated by Sponsor|0|||
146728873|NCT02712905|529177112|FG000|Monotherapy|Withdrawal by Subject|0|||
146728874|NCT02712905|529177113|FG001|Monotherapy|Withdrawal by Subject|0|||
146728875|NCT02712905|529177114|FG002|Monotherapy|Withdrawal by Subject|1|||
146728876|NCT02712905|529177115|FG003|Monotherapy|Withdrawal by Subject|0|||
146728877|NCT02712905|529177116|FG004|Monotherapy|Withdrawal by Subject|2|||
146728878|NCT02712905|529177117|FG005|Monotherapy|Withdrawal by Subject|0|||
146728879|NCT02712905|529177118|FG006|Monotherapy|Withdrawal by Subject|0|||
146728880|NCT02712905|529177119|FG007|Monotherapy|Withdrawal by Subject|0|||
146728881|NCT02712905|529177120|FG008|Monotherapy|Withdrawal by Subject|0|||
146728882|NCT02712905|529177121|FG009|Monotherapy|Withdrawal by Subject|4|||
146728883|NCT02712905|529177122|FG010|Monotherapy|Withdrawal by Subject|1|||
146728884|NCT02712905|529177123|FG011|Monotherapy|Withdrawal by Subject|2|||
146728885|NCT02712905|529177124|FG012|Monotherapy|Withdrawal by Subject|0|||
146728886|NCT02712905|529177125|FG013|Monotherapy|Withdrawal by Subject|0|||
146728887|NCT02712905|529177126|FG014|Monotherapy|Withdrawal by Subject|0|||
146728888|NCT02712905|529177127|FG015|Monotherapy|Withdrawal by Subject|0|||
146728889|NCT02712905|529177128|FG016|Monotherapy|Withdrawal by Subject|0|||
146935767|NCT05014542|529922531|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
146981624|NCT01621490|530096087|FG000|Overall Study|Adverse event unrelated to study drug|1|||
146728890|NCT02712905|529177129|FG017|Monotherapy|Withdrawal by Subject|0|||
146728891|NCT02712905|529177112|FG000|Monotherapy|Started New Cancer Drug|0|||
146728892|NCT02712905|529177113|FG001|Monotherapy|Started New Cancer Drug|0|||
146728893|NCT02712905|529177114|FG002|Monotherapy|Started New Cancer Drug|0|||
146728894|NCT02712905|529177115|FG003|Monotherapy|Started New Cancer Drug|0|||
146728895|NCT02712905|529177116|FG004|Monotherapy|Started New Cancer Drug|0|||
146728896|NCT02712905|529177117|FG005|Monotherapy|Started New Cancer Drug|1|||
146728897|NCT02712905|529177118|FG006|Monotherapy|Started New Cancer Drug|0|||
146728898|NCT02712905|529177119|FG007|Monotherapy|Started New Cancer Drug|0|||
146728899|NCT02712905|529177120|FG008|Monotherapy|Started New Cancer Drug|0|||
146728900|NCT02712905|529177121|FG009|Monotherapy|Started New Cancer Drug|0|||
146728901|NCT02712905|529177122|FG010|Monotherapy|Started New Cancer Drug|0|||
146728902|NCT02712905|529177123|FG011|Monotherapy|Started New Cancer Drug|0|||
146728903|NCT02712905|529177124|FG012|Monotherapy|Started New Cancer Drug|0|||
146728904|NCT02712905|529177125|FG013|Monotherapy|Started New Cancer Drug|0|||
146728905|NCT02712905|529177126|FG014|Monotherapy|Started New Cancer Drug|0|||
146728906|NCT02712905|529177127|FG015|Monotherapy|Started New Cancer Drug|0|||
146728907|NCT02712905|529177128|FG016|Monotherapy|Started New Cancer Drug|0|||
146728908|NCT02712905|529177129|FG017|Monotherapy|Started New Cancer Drug|0|||
146728909|NCT02712905|529177112|FG000|Monotherapy|Adverse Event|0|||
146728910|NCT02712905|529177113|FG001|Monotherapy|Adverse Event|0|||
146728911|NCT02712905|529177114|FG002|Monotherapy|Adverse Event|0|||
146728912|NCT02712905|529177115|FG003|Monotherapy|Adverse Event|0|||
146728913|NCT02712905|529177116|FG004|Monotherapy|Adverse Event|0|||
146728914|NCT02712905|529177117|FG005|Monotherapy|Adverse Event|0|||
146728915|NCT02712905|529177118|FG006|Monotherapy|Adverse Event|0|||
146728916|NCT02712905|529177119|FG007|Monotherapy|Adverse Event|0|||
146728917|NCT02712905|529177120|FG008|Monotherapy|Adverse Event|1|||
146728918|NCT02712905|529177121|FG009|Monotherapy|Adverse Event|0|||
146728919|NCT02712905|529177122|FG010|Monotherapy|Adverse Event|0|||
146728920|NCT02712905|529177123|FG011|Monotherapy|Adverse Event|0|||
146728921|NCT02712905|529177124|FG012|Monotherapy|Adverse Event|0|||
146728922|NCT02712905|529177125|FG013|Monotherapy|Adverse Event|0|||
146728923|NCT02712905|529177126|FG014|Monotherapy|Adverse Event|0|||
146728924|NCT02712905|529177127|FG015|Monotherapy|Adverse Event|0|||
146728925|NCT02712905|529177128|FG016|Monotherapy|Adverse Event|0|||
146728926|NCT02712905|529177129|FG017|Monotherapy|Adverse Event|0|||
146728927|NCT02712905|529177112|FG000|Combination Therapy|Death|0|||
146728928|NCT02712905|529177113|FG001|Combination Therapy|Death|0|||
146728929|NCT02712905|529177114|FG002|Combination Therapy|Death|0|||
146728930|NCT02712905|529177115|FG003|Combination Therapy|Death|0|||
146728931|NCT02712905|529177116|FG004|Combination Therapy|Death|0|||
146728932|NCT02712905|529177117|FG005|Combination Therapy|Death|0|||
146728933|NCT02712905|529177118|FG006|Combination Therapy|Death|0|||
146728934|NCT02712905|529177119|FG007|Combination Therapy|Death|0|||
146728935|NCT02712905|529177120|FG008|Combination Therapy|Death|0|||
146728936|NCT02712905|529177121|FG009|Combination Therapy|Death|0|||
146728937|NCT02712905|529177122|FG010|Combination Therapy|Death|0|||
146728938|NCT02712905|529177123|FG011|Combination Therapy|Death|0|||
146728939|NCT02712905|529177124|FG012|Combination Therapy|Death|5|||
146728940|NCT02712905|529177125|FG013|Combination Therapy|Death|6|||
146728941|NCT02712905|529177126|FG014|Combination Therapy|Death|1|||
146728942|NCT02712905|529177127|FG015|Combination Therapy|Death|3|||
146728943|NCT02712905|529177128|FG016|Combination Therapy|Death|1|||
146728944|NCT02712905|529177129|FG017|Combination Therapy|Death|3|||
146728945|NCT02712905|529177112|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
146728946|NCT02712905|529177113|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
146728947|NCT02712905|529177114|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
146728948|NCT02712905|529177115|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
146728949|NCT02712905|529177116|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
146728950|NCT02712905|529177117|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
146728951|NCT02712905|529177118|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
146728952|NCT02712905|529177119|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
146728953|NCT02712905|529177120|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
146728954|NCT02712905|529177121|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
146728955|NCT02712905|529177122|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
146728956|NCT02712905|529177123|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
146728957|NCT02712905|529177124|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
146728958|NCT02712905|529177125|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
146728959|NCT02712905|529177126|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
146728960|NCT02712905|529177127|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
146728961|NCT02712905|529177128|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
146728962|NCT02712905|529177129|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
146728963|NCT02712905|529177112|FG000|Combination Therapy|Withdrawal by Subject|0|||
146728964|NCT02712905|529177113|FG001|Combination Therapy|Withdrawal by Subject|0|||
146728965|NCT02712905|529177114|FG002|Combination Therapy|Withdrawal by Subject|0|||
146728966|NCT02712905|529177115|FG003|Combination Therapy|Withdrawal by Subject|0|||
146728967|NCT02712905|529177116|FG004|Combination Therapy|Withdrawal by Subject|0|||
146728968|NCT02712905|529177117|FG005|Combination Therapy|Withdrawal by Subject|0|||
146728969|NCT02712905|529177118|FG006|Combination Therapy|Withdrawal by Subject|0|||
146728970|NCT02712905|529177119|FG007|Combination Therapy|Withdrawal by Subject|0|||
146785251|NCT03269136|529384461|FG005|Part 1: Dose Escalation|Death|0|||
146785252|NCT03269136|529384462|FG006|Part 1: Dose Escalation|Death|0|||
146785253|NCT03269136|529384463|FG007|Part 1: Dose Escalation|Death|0|||
146785254|NCT03269136|529384464|FG008|Part 1: Dose Escalation|Death|0|||
146785255|NCT03269136|529384465|FG009|Part 1: Dose Escalation|Death|1|||
146785256|NCT03269136|529384466|FG010|Part 1: Dose Escalation|Death|0|||
146785257|NCT03269136|529384467|FG011|Part 1: Dose Escalation|Death|1|||
146785258|NCT03269136|529384468|FG012|Part 1: Dose Escalation|Death|0|||
146785259|NCT03269136|529384469|FG013|Part 1: Dose Escalation|Death|1|||
146785260|NCT03269136|529384470|FG014|Part 1: Dose Escalation|Death|0|||
146785261|NCT03269136|529384471|FG015|Part 1: Dose Escalation|Death|0|||
146785262|NCT03269136|529384472|FG016|Part 1: Dose Escalation|Death|2|||
146785263|NCT03269136|529384473|FG017|Part 1: Dose Escalation|Death|0|||
146785264|NCT03269136|529384456|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
146785265|NCT03269136|529384457|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
146785266|NCT03269136|529384458|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
146785267|NCT03269136|529384459|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
146785268|NCT03269136|529384460|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
146785269|NCT03269136|529384461|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
146785270|NCT03269136|529384462|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
146785271|NCT03269136|529384463|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
146785272|NCT03269136|529384464|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
146785273|NCT03269136|529384465|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
146785274|NCT03269136|529384466|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
146785275|NCT03269136|529384467|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
146785276|NCT03269136|529384468|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
146785277|NCT03269136|529384469|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
146785278|NCT03269136|529384470|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
146785279|NCT03269136|529384471|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
146785280|NCT03269136|529384472|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
146785281|NCT03269136|529384473|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
146785282|NCT03269136|529384456|FG000|Part 1: Dose Escalation|Adverse Event|0|||
146785283|NCT03269136|529384457|FG001|Part 1: Dose Escalation|Adverse Event|0|||
146785284|NCT03269136|529384458|FG002|Part 1: Dose Escalation|Adverse Event|0|||
146785285|NCT03269136|529384459|FG003|Part 1: Dose Escalation|Adverse Event|0|||
146785286|NCT03269136|529384460|FG004|Part 1: Dose Escalation|Adverse Event|0|||
146785287|NCT03269136|529384461|FG005|Part 1: Dose Escalation|Adverse Event|0|||
146785288|NCT03269136|529384462|FG006|Part 1: Dose Escalation|Adverse Event|2|||
146785289|NCT03269136|529384463|FG007|Part 1: Dose Escalation|Adverse Event|0|||
146785290|NCT03269136|529384464|FG008|Part 1: Dose Escalation|Adverse Event|0|||
146785291|NCT03269136|529384465|FG009|Part 1: Dose Escalation|Adverse Event|0|||
146785292|NCT03269136|529384466|FG010|Part 1: Dose Escalation|Adverse Event|1|||
146785293|NCT03269136|529384467|FG011|Part 1: Dose Escalation|Adverse Event|2|||
146785294|NCT03269136|529384468|FG012|Part 1: Dose Escalation|Adverse Event|0|||
146785295|NCT03269136|529384469|FG013|Part 1: Dose Escalation|Adverse Event|1|||
146785296|NCT03269136|529384470|FG014|Part 1: Dose Escalation|Adverse Event|0|||
146785297|NCT03269136|529384471|FG015|Part 1: Dose Escalation|Adverse Event|0|||
146785298|NCT03269136|529384472|FG016|Part 1: Dose Escalation|Adverse Event|1|||
146785299|NCT03269136|529384473|FG017|Part 1: Dose Escalation|Adverse Event|0|||
146785300|NCT03269136|529384456|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
146785301|NCT03269136|529384457|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
146785302|NCT03269136|529384458|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
146785303|NCT03269136|529384459|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
146785304|NCT03269136|529384460|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
146785305|NCT03269136|529384461|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
146785306|NCT03269136|529384462|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
146785307|NCT03269136|529384463|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
146785308|NCT03269136|529384464|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
146785309|NCT03269136|529384465|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
146785310|NCT03269136|529384466|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
146935768|NCT05014542|529922532|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
146785311|NCT03269136|529384467|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
146785312|NCT03269136|529384468|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
146785313|NCT03269136|529384469|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
146785314|NCT03269136|529384470|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
146785315|NCT03269136|529384471|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
146785316|NCT03269136|529384472|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
146785317|NCT03269136|529384473|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
146785318|NCT03269136|529384456|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146785319|NCT03269136|529384457|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146785320|NCT03269136|529384458|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146785321|NCT03269136|529384459|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146785322|NCT03269136|529384460|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146935769|NCT05014542|529922531|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
146785323|NCT03269136|529384461|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146785324|NCT03269136|529384462|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146785325|NCT03269136|529384463|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146785326|NCT03269136|529384464|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146785327|NCT03269136|529384465|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146785328|NCT03269136|529384466|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146785329|NCT03269136|529384467|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146785330|NCT03269136|529384468|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
146785331|NCT03269136|529384469|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
146785332|NCT03269136|529384470|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
146785333|NCT03269136|529384471|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146785334|NCT03269136|529384472|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
146785335|NCT03269136|529384473|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146785336|NCT03269136|529384456|FG000|Part 2A: Dose Expansion|Other|0|||
146785337|NCT03269136|529384457|FG001|Part 2A: Dose Expansion|Other|0|||
146785338|NCT03269136|529384458|FG002|Part 2A: Dose Expansion|Other|0|||
146785339|NCT03269136|529384459|FG003|Part 2A: Dose Expansion|Other|0|||
146785340|NCT03269136|529384460|FG004|Part 2A: Dose Expansion|Other|0|||
146785341|NCT03269136|529384461|FG005|Part 2A: Dose Expansion|Other|0|||
146785342|NCT03269136|529384462|FG006|Part 2A: Dose Expansion|Other|0|||
146785343|NCT03269136|529384463|FG007|Part 2A: Dose Expansion|Other|0|||
146785344|NCT03269136|529384464|FG008|Part 2A: Dose Expansion|Other|0|||
146785345|NCT03269136|529384465|FG009|Part 2A: Dose Expansion|Other|0|||
146785346|NCT03269136|529384466|FG010|Part 2A: Dose Expansion|Other|0|||
146785347|NCT03269136|529384467|FG011|Part 2A: Dose Expansion|Other|0|||
146785348|NCT03269136|529384468|FG012|Part 2A: Dose Expansion|Other|0|||
146785349|NCT03269136|529384469|FG013|Part 2A: Dose Expansion|Other|0|||
146785350|NCT03269136|529384470|FG014|Part 2A: Dose Expansion|Other|0|||
146785351|NCT03269136|529384471|FG015|Part 2A: Dose Expansion|Other|0|||
146785352|NCT03269136|529384472|FG016|Part 2A: Dose Expansion|Other|0|||
146785353|NCT03269136|529384473|FG017|Part 2A: Dose Expansion|Other|1|||
146785354|NCT03269136|529384456|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785355|NCT03269136|529384457|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785356|NCT03269136|529384458|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785357|NCT03269136|529384459|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785358|NCT03269136|529384460|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785359|NCT03269136|529384461|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785360|NCT03269136|529384462|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785361|NCT03269136|529384463|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785362|NCT03269136|529384464|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785363|NCT03269136|529384465|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785364|NCT03269136|529384466|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785365|NCT03269136|529384467|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785366|NCT03269136|529384468|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785367|NCT03269136|529384469|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785368|NCT03269136|529384470|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785369|NCT03269136|529384471|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785370|NCT03269136|529384472|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146785371|NCT03269136|529384473|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
146785372|NCT03269136|529384456|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
146785373|NCT03269136|529384457|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
146785374|NCT03269136|529384458|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
146785375|NCT03269136|529384459|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
146785376|NCT03269136|529384460|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
146785377|NCT03269136|529384461|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
146785378|NCT03269136|529384462|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
146785379|NCT03269136|529384463|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
146785380|NCT03269136|529384464|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
146785381|NCT03269136|529384465|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
146785382|NCT03269136|529384466|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
146785383|NCT03269136|529384467|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
146785384|NCT03269136|529384468|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
146785385|NCT03269136|529384469|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
146785386|NCT03269136|529384470|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
146785387|NCT03269136|529384471|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
146785388|NCT03269136|529384472|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
146785389|NCT03269136|529384473|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
146785390|NCT03269136|529384456|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
146785391|NCT03269136|529384457|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
146785392|NCT03269136|529384458|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
146785393|NCT03269136|529384459|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
146785394|NCT03269136|529384460|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
146785395|NCT03269136|529384461|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
146785396|NCT03269136|529384462|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
146935770|NCT05014542|529922532|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
146935771|NCT05014542|529922531|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
146728971|NCT02712905|529177120|FG008|Combination Therapy|Withdrawal by Subject|0|||
146728972|NCT02712905|529177121|FG009|Combination Therapy|Withdrawal by Subject|0|||
146728973|NCT02712905|529177122|FG010|Combination Therapy|Withdrawal by Subject|0|||
146728974|NCT02712905|529177123|FG011|Combination Therapy|Withdrawal by Subject|0|||
146728975|NCT02712905|529177124|FG012|Combination Therapy|Withdrawal by Subject|0|||
146728976|NCT02712905|529177125|FG013|Combination Therapy|Withdrawal by Subject|0|||
146728977|NCT02712905|529177126|FG014|Combination Therapy|Withdrawal by Subject|0|||
146728978|NCT02712905|529177127|FG015|Combination Therapy|Withdrawal by Subject|1|||
146728979|NCT02712905|529177128|FG016|Combination Therapy|Withdrawal by Subject|0|||
146728980|NCT02712905|529177129|FG017|Combination Therapy|Withdrawal by Subject|2|||
146728981|NCT02712905|529177112|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728982|NCT02712905|529177113|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728983|NCT02712905|529177114|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728984|NCT02712905|529177115|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728985|NCT02712905|529177116|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728986|NCT02712905|529177117|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728987|NCT02712905|529177118|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728988|NCT02712905|529177119|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728989|NCT02712905|529177120|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728990|NCT02712905|529177121|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728991|NCT02712905|529177122|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728992|NCT02712905|529177123|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728993|NCT02712905|529177124|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728994|NCT02712905|529177125|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728995|NCT02712905|529177126|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728996|NCT02712905|529177127|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
146736435|NCT02387996|529206853|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
146736436|NCT02387996|529206853|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
146736437|NCT02387996|529206853|FG000|Overall Study|Subject Withdrew Consent|5|||
146736438|NCT02387996|529206853|FG000|Overall Study|Lost to Follow-up|1|||
146736439|NCT02387996|529206853|FG000|Overall Study|Poor/Non-Compliance|1|||
146736440|NCT02387996|529206853|FG000|Overall Study|Other Reasons|5|||
146736441|NCT02387996|529206853|FG000|Overall Study|Death|1|||
146736442|NCT01446796|529206854|FG000|Overall Study|Withdrawal by Subject|1|||
146736443|NCT01446796|529206855|FG001|Overall Study|Withdrawal by Subject|0|||
146736444|NCT02424591|529206856|FG000|Overall Study|Protocol Violation|2|||
146736445|NCT02424591|529206857|FG001|Overall Study|Protocol Violation|3|||
146736446|NCT00312702|529206858|FG000|Immunization Phase|Lost to Follow-up|0|||
146736447|NCT00312702|529206859|FG001|Immunization Phase|Lost to Follow-up|1|||
146736448|NCT00312702|529206860|FG002|Immunization Phase|Lost to Follow-up|0|||
146736449|NCT00770432|529206863|FG000|Overall Study|Other|4|||
146736450|NCT00770432|529206864|FG001|Overall Study|Other|6|||
146736451|NCT00770432|529206863|FG000|Overall Study|Non-compliance|0|||
146736452|NCT00770432|529206864|FG001|Overall Study|Non-compliance|1|||
146736453|NCT01453348|529206865|FG000|Overall Study|Death|0|||
146736454|NCT01453348|529206866|FG001|Overall Study|Death|0|||
146736455|NCT01453348|529206867|FG002|Overall Study|Death|1|||
146736456|NCT01453348|529206865|FG000|Overall Study|Withdrawal by Subject|0|||
146736457|NCT01453348|529206866|FG001|Overall Study|Withdrawal by Subject|1|||
146736458|NCT01453348|529206867|FG002|Overall Study|Withdrawal by Subject|0|||
146736459|NCT01453348|529206865|FG000|Overall Study|Protocol Violation|1|||
146736460|NCT01453348|529206866|FG001|Overall Study|Protocol Violation|0|||
146736461|NCT01453348|529206867|FG002|Overall Study|Protocol Violation|0|||
146736462|NCT02756832|529206871|FG000|Overall Study|Lost for Observation after Baseline|6|||
146736463|NCT02756832|529206871|FG000|Overall Study|Lost for Observation|13|||
146736464|NCT02756832|529206871|FG000|Overall Study|Patient's Unwillingness|12|||
146736465|NCT02756832|529206871|FG000|Overall Study|Insufficient Efficacy|2|||
146736466|NCT02756832|529206871|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
146736467|NCT02756832|529206871|FG000|Overall Study|Reason not Specified|9|||
146736468|NCT02756832|529206871|FG000|Overall Study|Protocol Deviation|10|||
146736469|NCT03579290|529206874|FG000|Overall Study|Lost to Follow-up|9|||
146736470|NCT05375955|529206888|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
146736471|NCT05375955|529206889|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
146736472|NCT05375955|529206890|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
146785397|NCT03269136|529384463|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
146785398|NCT03269136|529384464|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
146785399|NCT03269136|529384465|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
146785400|NCT03269136|529384466|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
146785401|NCT03269136|529384467|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
146785402|NCT03269136|529384468|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
146785403|NCT03269136|529384469|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
146785404|NCT03269136|529384470|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
146785405|NCT03269136|529384471|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
146785406|NCT03269136|529384472|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
146785407|NCT03269136|529384473|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
146785408|NCT03269136|529384456|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
146785409|NCT03269136|529384457|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
146785410|NCT03269136|529384458|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
146785411|NCT03269136|529384459|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
146785412|NCT03269136|529384460|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
146785413|NCT03269136|529384461|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
146785414|NCT03269136|529384462|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
146785415|NCT03269136|529384463|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
146785416|NCT03269136|529384464|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
146785417|NCT03269136|529384465|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
146785418|NCT03269136|529384466|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
146785419|NCT03269136|529384467|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
146785420|NCT03269136|529384468|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
146785421|NCT03269136|529384469|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
146785422|NCT03269136|529384470|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
146785423|NCT03269136|529384471|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
146785424|NCT03269136|529384472|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
146785425|NCT03269136|529384473|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
146785426|NCT05071807|529384474|FG000|Overall Study|Withdrawal by Subject|4|||
146785427|NCT05071807|529384475|FG001|Overall Study|Withdrawal by Subject|0|||
146785428|NCT05071807|529384474|FG000|Overall Study|Unrelated medical issues|3|||
146785429|NCT05071807|529384475|FG001|Overall Study|Unrelated medical issues|0|||
146785430|NCT05071807|529384474|FG000|Overall Study|Relocated|0|||
146785431|NCT05071807|529384475|FG001|Overall Study|Relocated|1|||
146785432|NCT05308004|529384477|FG000|Overall Study|Not seen by Palliative Care NP|0|||
146785433|NCT05308004|529384478|FG001|Overall Study|Not seen by Palliative Care NP|1|||
146785434|NCT04552223|529384485|FG000|Overall Study|Withdrawal by Subject|1|||
146785435|NCT04856163|529384486|FG000|Overall Study|Lost to Follow-up|97|||
146785436|NCT04856163|529384487|FG001|Overall Study|Lost to Follow-up|100|||
146785437|NCT04359108|529384494|FG000|Overall Study|Withdrawal by Subject|1|||
146785438|NCT04359108|529384495|FG001|Overall Study|Withdrawal by Subject|0|||
146785439|NCT04359108|529384494|FG000|Overall Study|Unable or too feeble to walk independently|0|||
146785440|NCT04359108|529384495|FG001|Overall Study|Unable or too feeble to walk independently|2|||
146785441|NCT04359108|529384494|FG000|Overall Study|Argus II system stopped functioning|0|||
146785442|NCT04359108|529384495|FG001|Overall Study|Argus II system stopped functioning|1|||
146785443|NCT04359108|529384494|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
146785444|NCT04359108|529384495|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
146785445|NCT06393088|529384496|FG000|Overall Study|Withdrawal by Subject|0|||
146785446|NCT06393088|529384497|FG001|Overall Study|Withdrawal by Subject|2|||
146785447|NCT03903146|529384498|FG000|Overall Study|Lost to Follow-up|6|||
146785448|NCT03903146|529384499|FG001|Overall Study|Lost to Follow-up|4|||
146785449|NCT03903146|529384498|FG000|Overall Study|Withdrawal by Subject|0|||
146785450|NCT03903146|529384499|FG001|Overall Study|Withdrawal by Subject|1|||
146785451|NCT04176965|529384500|FG000|Overall Study|Death|1|||
146785452|NCT04176965|529384501|FG001|Overall Study|Death|2|||
146785453|NCT04176965|529384500|FG000|Overall Study|Lost to Follow-up|10|||
146785454|NCT04176965|529384501|FG001|Overall Study|Lost to Follow-up|2|||
146785455|NCT04176965|529384500|FG000|Overall Study|Withdrawal by Subject|6|||
146785456|NCT04176965|529384501|FG001|Overall Study|Withdrawal by Subject|1|||
146785457|NCT05551637|529384504|FG000|Overall Study|Lack of Efficacy|0|||
146785458|NCT05551637|529384505|FG001|Overall Study|Lack of Efficacy|6|||
146785459|NCT05551637|529384504|FG000|Overall Study|Lost to Follow-up|1|||
146785460|NCT05551637|529384505|FG001|Overall Study|Lost to Follow-up|1|||
146785461|NCT04924660|529384508|FG000|United States|Death|29|||
146785462|NCT04924660|529384509|FG001|United States|Death|32|||
146785463|NCT04924660|529384510|FG002|United States|Death|34|||
146785464|NCT04924660|529384511|FG003|United States|Death|25|||
146785465|NCT04924660|529384512|FG004|United States|Death|26|||
146785466|NCT04924660|529384513|FG005|United States|Death|23|||
146785467|NCT04924660|529384508|FG000|United States|Lost to Follow-up|15|||
146785468|NCT04924660|529384509|FG001|United States|Lost to Follow-up|10|||
146785469|NCT04924660|529384510|FG002|United States|Lost to Follow-up|13|||
146785470|NCT04924660|529384511|FG003|United States|Lost to Follow-up|5|||
146785471|NCT04924660|529384512|FG004|United States|Lost to Follow-up|19|||
146785472|NCT04924660|529384513|FG005|United States|Lost to Follow-up|20|||
146935772|NCT05014542|529922532|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
146935773|NCT01438307|529922534|FG000|Overall Study|Death|1|||
146935774|NCT01438307|529922535|FG001|Overall Study|Death|1|||
146935775|NCT00810810|529922537|FG000|Overall Study|Withdrawal by Subject|0|||
146935776|NCT00810810|529922538|FG001|Overall Study|Withdrawal by Subject|8|||
146728997|NCT02712905|529177128|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728998|NCT02712905|529177129|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146728999|NCT03721965|529177130|FG000|Overall Study|Death|1|||
146729000|NCT03721965|529177130|FG000|Overall Study|Study Terminated by Sponsor|1|||
146729001|NCT04085328|529177131|FG000|Overall Study|Witihdrew Consent|16|||
146729002|NCT04085328|529177132|FG001|Overall Study|Witihdrew Consent|16|||
146729003|NCT04085328|529177131|FG000|Overall Study|Adverse Event|8|||
146729004|NCT04085328|529177132|FG001|Overall Study|Adverse Event|7|||
146729005|NCT04085328|529177131|FG000|Overall Study|Lost to Follow-up|7|||
146729006|NCT04085328|529177132|FG001|Overall Study|Lost to Follow-up|2|||
146729007|NCT04085328|529177131|FG000|Overall Study|Physician Decision|0|||
146729008|NCT04085328|529177132|FG001|Overall Study|Physician Decision|1|||
146729009|NCT04085328|529177131|FG000|Overall Study|Pregnancy|0|||
146729010|NCT04085328|529177132|FG001|Overall Study|Pregnancy|1|||
146729011|NCT04085328|529177131|FG000|Overall Study|Reasons Related to COVID-19|5|||
146729012|NCT04085328|529177132|FG001|Overall Study|Reasons Related to COVID-19|8|||
146729013|NCT04085328|529177131|FG000|Overall Study|Did not meet inclusion criteria|1|||
146729014|NCT04085328|529177132|FG001|Overall Study|Did not meet inclusion criteria|1|||
146729015|NCT04085328|529177131|FG000|Overall Study|Early termination|1|||
146729016|NCT04085328|529177132|FG001|Overall Study|Early termination|0|||
146729017|NCT00689221|529177136|FG000|Overall Study|Ongoing at cut-off date|39|||
146729018|NCT00689221|529177137|FG001|Overall Study|Ongoing at cut-off date|36|||
146729019|NCT01812655|529177138|FG000|Overall Study|Protocol Violation|1|||
146729020|NCT01812655|529177139|FG001|Overall Study|Protocol Violation|1|||
146729021|NCT01812655|529177140|FG002|Overall Study|Protocol Violation|0|||
146729022|NCT04435665|529177142|FG000|Overall Study|Lost to Follow-up|0|||
146729023|NCT04435665|529177143|FG001|Overall Study|Lost to Follow-up|0|||
146729024|NCT04435665|529177144|FG002|Overall Study|Lost to Follow-up|0|||
146729025|NCT04435665|529177145|FG003|Overall Study|Lost to Follow-up|1|||
146729026|NCT02454101|529177146|FG000|Overall Study|Adverse Event|2|||
146729027|NCT02454101|529177147|FG001|Overall Study|Adverse Event|3|||
146729028|NCT02454101|529177146|FG000|Overall Study|Lost to Follow-up|3|||
146729029|NCT02454101|529177147|FG001|Overall Study|Lost to Follow-up|4|||
146729030|NCT00419263|529177148|FG000|Overall Study|Lost to Follow-up|2|||
146729031|NCT00419263|529177149|FG001|Overall Study|Lost to Follow-up|1|||
146729032|NCT00419263|529177150|FG002|Overall Study|Lost to Follow-up|1|||
146729033|NCT00419263|529177148|FG000|Overall Study|Randomized in Error, Not Treated|1|||
146729034|NCT00419263|529177149|FG001|Overall Study|Randomized in Error, Not Treated|1|||
146729035|NCT00419263|529177150|FG002|Overall Study|Randomized in Error, Not Treated|0|||
146729036|NCT00419263|529177148|FG000|Overall Study|Adverse Event|0|||
146729037|NCT00419263|529177149|FG001|Overall Study|Adverse Event|0|||
146729038|NCT00419263|529177150|FG002|Overall Study|Adverse Event|1|||
146729039|NCT00419263|529177148|FG000|Overall Study|Withdrawal by Subject|0|||
146729040|NCT00419263|529177149|FG001|Overall Study|Withdrawal by Subject|0|||
146729041|NCT00419263|529177150|FG002|Overall Study|Withdrawal by Subject|1|||
146729042|NCT02342886|529177151|FG000|Overall Study|Treatment non-compliance|1|||
146729043|NCT02342886|529177152|FG001|Overall Study|Treatment non-compliance|0|||
146729044|NCT02342886|529177153|FG002|Overall Study|Treatment non-compliance|0|||
146729045|NCT02342886|529177154|FG003|Overall Study|Treatment non-compliance|1|||
146729046|NCT02342886|529177155|FG004|Overall Study|Treatment non-compliance|0|||
146729047|NCT02342886|529177151|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
146729048|NCT02342886|529177152|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
146729049|NCT02342886|529177153|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
146729050|NCT02342886|529177154|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
146729051|NCT02342886|529177155|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
146729052|NCT02342886|529177151|FG000|Overall Study|Adverse event/specific toxicity|4|||
146729053|NCT02342886|529177152|FG001|Overall Study|Adverse event/specific toxicity|3|||
146729054|NCT02342886|529177153|FG002|Overall Study|Adverse event/specific toxicity|11|||
146729055|NCT02342886|529177154|FG003|Overall Study|Adverse event/specific toxicity|2|||
146729056|NCT02342886|529177155|FG004|Overall Study|Adverse event/specific toxicity|1|||
146729057|NCT02342886|529177151|FG000|Overall Study|Lost to Follow-up|1|||
146729058|NCT02342886|529177152|FG001|Overall Study|Lost to Follow-up|0|||
146729059|NCT02342886|529177153|FG002|Overall Study|Lost to Follow-up|0|||
146729060|NCT02342886|529177154|FG003|Overall Study|Lost to Follow-up|0|||
146729061|NCT02342886|529177155|FG004|Overall Study|Lost to Follow-up|0|||
146729062|NCT02342886|529177151|FG000|Overall Study|Death|1|||
146729063|NCT02342886|529177152|FG001|Overall Study|Death|2|||
146729064|NCT02342886|529177153|FG002|Overall Study|Death|1|||
146729065|NCT02342886|529177154|FG003|Overall Study|Death|0|||
146935777|NCT00810810|529922539|FG002|Overall Study|Withdrawal by Subject|10|||
146729066|NCT02342886|529177155|FG004|Overall Study|Death|1|||
146935778|NCT00810810|529922540|FG003|Overall Study|Withdrawal by Subject|8|||
146935779|NCT00810810|529922537|FG000|Overall Study|Physician Decision|0|||
146935780|NCT00810810|529922538|FG001|Overall Study|Physician Decision|3|||
146935781|NCT00810810|529922539|FG002|Overall Study|Physician Decision|1|||
146935782|NCT00810810|529922540|FG003|Overall Study|Physician Decision|5|||
146935783|NCT02563925|529922541|FG000|Overall Study|Withdrawal by Subject|2|||
146935784|NCT00282867|529922542|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
146935785|NCT00282867|529922543|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
146935786|NCT00282867|529922544|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
146935787|NCT01342952|529922545|FG000|Overall Study|Adverse Event|0|||
146981625|NCT01621490|530096088|FG001|Overall Study|Adverse event unrelated to study drug|1|||
146729067|NCT02342886|529177151|FG000|Overall Study|Withdrawal by Subject|0|||
146729068|NCT02342886|529177152|FG001|Overall Study|Withdrawal by Subject|1|||
146729069|NCT02342886|529177153|FG002|Overall Study|Withdrawal by Subject|0|||
146729070|NCT02342886|529177154|FG003|Overall Study|Withdrawal by Subject|1|||
146729071|NCT02342886|529177155|FG004|Overall Study|Withdrawal by Subject|0|||
146729072|NCT02342886|529177151|FG000|Overall Study|Investigator/sponsor decision|0|||
146729073|NCT02342886|529177152|FG001|Overall Study|Investigator/sponsor decision|2|||
146729074|NCT02342886|529177153|FG002|Overall Study|Investigator/sponsor decision|0|||
146729075|NCT02342886|529177154|FG003|Overall Study|Investigator/sponsor decision|3|||
146729076|NCT02342886|529177155|FG004|Overall Study|Investigator/sponsor decision|1|||
146729077|NCT02342886|529177151|FG000|Overall Study|Pregnancy|0|||
146729078|NCT02342886|529177152|FG001|Overall Study|Pregnancy|0|||
146729079|NCT02342886|529177153|FG002|Overall Study|Pregnancy|2|||
146729080|NCT02342886|529177154|FG003|Overall Study|Pregnancy|0|||
146729081|NCT02342886|529177155|FG004|Overall Study|Pregnancy|0|||
146729082|NCT02342886|529177151|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
146729083|NCT02342886|529177152|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
146729084|NCT02342886|529177153|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
146729085|NCT02342886|529177154|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
146729086|NCT02342886|529177155|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
146729087|NCT02342886|529177151|FG000|Overall Study|Protocol Violation|0|||
146729088|NCT02342886|529177152|FG001|Overall Study|Protocol Violation|0|||
146729089|NCT02342886|529177153|FG002|Overall Study|Protocol Violation|0|||
146729090|NCT02342886|529177154|FG003|Overall Study|Protocol Violation|2|||
146729091|NCT02342886|529177155|FG004|Overall Study|Protocol Violation|0|||
146729092|NCT01328080|529177156|FG000|Overall Study|Lost to Follow-up|5|||
146729093|NCT00862134|529177157|FG000|Overall Study|Death|1|||
146729094|NCT00862134|529177158|FG001|Overall Study|Death|0|||
146729095|NCT00862134|529177157|FG000|Overall Study|Physician Decision|0|||
146729096|NCT00862134|529177158|FG001|Overall Study|Physician Decision|1|||
146729097|NCT00862134|529177157|FG000|Overall Study|Withdrawal by Subject|1|||
146729098|NCT00862134|529177158|FG001|Overall Study|Withdrawal by Subject|2|||
146729099|NCT00862134|529177157|FG000|Overall Study|Sponsor terminated study|5|||
146729100|NCT00862134|529177158|FG001|Overall Study|Sponsor terminated study|7|||
146729101|NCT00862134|529177157|FG000|Overall Study|Adverse Event|2|||
146729102|NCT00862134|529177158|FG001|Overall Study|Adverse Event|2|||
146729103|NCT00862134|529177157|FG000|Overall Study|Withdrew prior to dosing|2|||
146729104|NCT00862134|529177158|FG001|Overall Study|Withdrew prior to dosing|0|||
146729105|NCT02191267|529177159|FG000|Overall Study|Withdrawal by Subject|1|||
146729106|NCT02191267|529177160|FG001|Overall Study|Withdrawal by Subject|0|||
146729107|NCT02191267|529177161|FG002|Overall Study|Withdrawal by Subject|0|||
146729108|NCT02124265|529177162|FG000|Overall Study|Adverse Event|1|||
146729109|NCT00810264|529177165|FG000|Overall Study|Lost to Follow-up|191|||
146729110|NCT00810264|529177165|FG000|Overall Study|Withdrawal by subject or physician|721|||
146729111|NCT00810264|529177165|FG000|Overall Study|Death|641|||
146729112|NCT01563536|529177166|FG000|Overall Study|Withdrawal by Subject|0|||
146729113|NCT01563536|529177167|FG001|Overall Study|Withdrawal by Subject|2|||
146729114|NCT01563536|529177166|FG000|Overall Study|Lost to Follow-up|1|||
146729115|NCT01563536|529177167|FG001|Overall Study|Lost to Follow-up|0|||
146729116|NCT00538590|529177175|FG000|Overall Study|Death|1|||
146729117|NCT00538590|529177176|FG001|Overall Study|Death|0|||
146729118|NCT00567190|529177177|FG000|Overall Study|Death|235|||
146729119|NCT00567190|529177178|FG001|Overall Study|Death|280|||
146729120|NCT00567190|529177177|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
146729121|NCT00567190|529177178|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
146729122|NCT00636610|529177187|FG000|Overall Study|Adverse Event|4|||
146729123|NCT00636610|529177188|FG001|Overall Study|Adverse Event|4|||
146729124|NCT00636610|529177187|FG000|Overall Study|Death|6|||
146729125|NCT00636610|529177188|FG001|Overall Study|Death|3|||
146729126|NCT00636610|529177187|FG000|Overall Study|Physician decision to withdraw patient|15|||
146729127|NCT00636610|529177188|FG001|Overall Study|Physician decision to withdraw patient|9|||
146729128|NCT00636610|529177187|FG000|Overall Study|Subject decision to withdraw|15|||
146729129|NCT00636610|529177188|FG001|Overall Study|Subject decision to withdraw|11|||
146729130|NCT00636610|529177187|FG000|Overall Study|Disease progression - radiographic|41|||
146935788|NCT01342952|529922546|FG001|Overall Study|Adverse Event|5|||
146785473|NCT04924660|529384508|FG000|United States|Withdrawal by Subject|8|||
146785474|NCT04924660|529384509|FG001|United States|Withdrawal by Subject|3|||
146785475|NCT04924660|529384510|FG002|United States|Withdrawal by Subject|3|||
146785476|NCT04924660|529384511|FG003|United States|Withdrawal by Subject|3|||
146785477|NCT04924660|529384512|FG004|United States|Withdrawal by Subject|8|||
146785478|NCT04924660|529384513|FG005|United States|Withdrawal by Subject|4|||
146785479|NCT04924660|529384508|FG000|Spain|Death|0|||
146785480|NCT04924660|529384509|FG001|Spain|Death|0|||
146785481|NCT04924660|529384510|FG002|Spain|Death|0|||
146785482|NCT04924660|529384511|FG003|Spain|Death|0|||
146785483|NCT04924660|529384512|FG004|Spain|Death|0|||
146785484|NCT04924660|529384513|FG005|Spain|Death|2|||
146785485|NCT04924660|529384508|FG000|Spain|Lost to Follow-up|0|||
146935789|NCT01342952|529922547|FG002|Overall Study|Adverse Event|1|||
146935790|NCT01342952|529922548|FG003|Overall Study|Adverse Event|0|||
146935791|NCT01342952|529922545|FG000|Overall Study|Lost to Follow-up|0|||
146935792|NCT01342952|529922546|FG001|Overall Study|Lost to Follow-up|2|||
146935793|NCT01342952|529922547|FG002|Overall Study|Lost to Follow-up|0|||
146935794|NCT01342952|529922548|FG003|Overall Study|Lost to Follow-up|0|||
146785486|NCT04924660|529384509|FG001|Spain|Lost to Follow-up|0|||
146785487|NCT04924660|529384510|FG002|Spain|Lost to Follow-up|0|||
146785488|NCT04924660|529384511|FG003|Spain|Lost to Follow-up|0|||
146785489|NCT04924660|529384512|FG004|Spain|Lost to Follow-up|1|||
146785490|NCT04924660|529384513|FG005|Spain|Lost to Follow-up|0|||
146785491|NCT04924660|529384508|FG000|Brazil|Death|0|||
146785492|NCT04924660|529384509|FG001|Brazil|Death|0|||
146785493|NCT04924660|529384510|FG002|Brazil|Death|0|||
146785494|NCT04924660|529384511|FG003|Brazil|Death|0|||
146785495|NCT04924660|529384512|FG004|Brazil|Death|1|||
146785496|NCT04924660|529384513|FG005|Brazil|Death|0|||
146785497|NCT04924660|529384508|FG000|Italy|Lost to Follow-up|0|||
146785498|NCT04924660|529384509|FG001|Italy|Lost to Follow-up|0|||
146785499|NCT04924660|529384510|FG002|Italy|Lost to Follow-up|0|||
146785500|NCT04924660|529384511|FG003|Italy|Lost to Follow-up|0|||
146785501|NCT04924660|529384512|FG004|Italy|Lost to Follow-up|0|||
146785502|NCT04924660|529384513|FG005|Italy|Lost to Follow-up|1|||
146785503|NCT04924660|529384508|FG000|South Africa|Death|0|||
146785504|NCT04924660|529384509|FG001|South Africa|Death|0|||
146785505|NCT04924660|529384510|FG002|South Africa|Death|0|||
146785506|NCT04924660|529384511|FG003|South Africa|Death|0|||
146785507|NCT04924660|529384512|FG004|South Africa|Death|0|||
146785508|NCT04924660|529384513|FG005|South Africa|Death|1|||
146785509|NCT04924660|529384508|FG000|South Africa|Lost to Follow-up|0|||
146785510|NCT04924660|529384509|FG001|South Africa|Lost to Follow-up|0|||
146785511|NCT04924660|529384510|FG002|South Africa|Lost to Follow-up|0|||
146785512|NCT04924660|529384511|FG003|South Africa|Lost to Follow-up|0|||
146785513|NCT04924660|529384512|FG004|South Africa|Lost to Follow-up|0|||
146785514|NCT04924660|529384513|FG005|South Africa|Lost to Follow-up|1|||
146785515|NCT06491433|529384514|FG000|Overall Study|Protocol Violation|51|||
146785516|NCT06491433|529384514|FG000|Overall Study|consent withdrawal|2|||
146785517|NCT06491433|529384514|FG000|Overall Study|screen failure|1|||
146785518|NCT05894577|529384517|FG000|Overall Study|No receipt of study drug|14|||
146785519|NCT05894577|529384518|FG001|Overall Study|No receipt of study drug|13|||
146785520|NCT05894577|529384517|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
146785521|NCT05894577|529384518|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
146785522|NCT05894577|529384517|FG000|Overall Study|Screen Fail|2|||
146785523|NCT05894577|529384518|FG001|Overall Study|Screen Fail|0|||
146785524|NCT05894577|529384517|FG000|Overall Study|Study drug recall|86|||
146785525|NCT05894577|529384518|FG001|Overall Study|Study drug recall|63|||
146981626|NCT01621490|530096089|FG002|Overall Study|Adverse event unrelated to study drug|0|||
146785526|NCT03197662|529384521|FG000|Overall Study|Withdrawn by family|0|||
146785527|NCT03197662|529384522|FG001|Overall Study|Withdrawn by family|2|||
146785528|NCT02949362|529384526|FG000|Retrospective Period|Inform consent not signed by participant|4|||
146785529|NCT02949362|529384527|FG001|Retrospective Period|Inform consent not signed by participant|1|||
146785530|NCT02949362|529384528|FG002|Retrospective Period|Inform consent not signed by participant|0|||
146785531|NCT02949362|529384529|FG003|Retrospective Period|Inform consent not signed by participant|0|||
146785532|NCT02949362|529384526|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
146785533|NCT02949362|529384527|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
146785534|NCT02949362|529384528|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
146935795|NCT01342952|529922545|FG000|Overall Study|Withdrawal by Subject|1|||
146935796|NCT01342952|529922546|FG001|Overall Study|Withdrawal by Subject|1|||
146981627|NCT01621490|530096090|FG003|Overall Study|Adverse event unrelated to study drug|0|||
146785535|NCT02949362|529384529|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
146785536|NCT02949362|529384526|FG000|Prospective Period|Other|0|||
146785537|NCT02949362|529384527|FG001|Prospective Period|Other|0|||
146785538|NCT02949362|529384528|FG002|Prospective Period|Other|0|||
146785539|NCT02949362|529384529|FG003|Prospective Period|Other|4|||
146785540|NCT03476460|529384530|FG000|Overall Study|Withdrawal by Subject|3|||
146785541|NCT03476460|529384531|FG001|Overall Study|Withdrawal by Subject|2|||
146935797|NCT01342952|529922547|FG002|Overall Study|Withdrawal by Subject|0|||
146785542|NCT03476460|529384530|FG000|Overall Study|Non-compliance with treatment|3|||
146785543|NCT03476460|529384531|FG001|Overall Study|Non-compliance with treatment|0|||
146785544|NCT03476460|529384530|FG000|Overall Study|Missing laboratory tests|5|||
146785545|NCT03476460|529384531|FG001|Overall Study|Missing laboratory tests|5|||
146785546|NCT03476460|529384530|FG000|Overall Study|Adverse Event|0|||
146785547|NCT03476460|529384531|FG001|Overall Study|Adverse Event|1|||
146785548|NCT05609760|529384545|FG000|Overall Study|Lost to Follow-up|0|||
146785549|NCT05609760|529384546|FG001|Overall Study|Lost to Follow-up|1|||
146785550|NCT05609760|529384545|FG000|Overall Study|Withdrawal by Subject|1|||
146785551|NCT05609760|529384546|FG001|Overall Study|Withdrawal by Subject|0|||
146785552|NCT03396588|529384547|FG000|Overall Study|Physician Decision|2|||
146785553|NCT03396588|529384548|FG001|Overall Study|Physician Decision|3|||
146785554|NCT05179395|529384549|FG000|Overall Study|Lack of Efficacy|1|||
146785555|NCT00812461|529384550|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
146935798|NCT01342952|529922548|FG003|Overall Study|Withdrawal by Subject|0|||
146935799|NCT01342952|529922545|FG000|Overall Study|Physician Decision|3|||
146935800|NCT01342952|529922546|FG001|Overall Study|Physician Decision|3|||
146935801|NCT01342952|529922547|FG002|Overall Study|Physician Decision|1|||
146935802|NCT01342952|529922548|FG003|Overall Study|Physician Decision|0|||
146935803|NCT00426556|529922551|FG000|Phase I - Core Phase|Disease Progression|0|||
146935804|NCT00426556|529922552|FG001|Phase I - Core Phase|Disease Progression|6|||
146785556|NCT00812461|529384551|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
146785557|NCT00812461|529384550|FG000|All Treated Patients|Adverse Event|8|||
146785558|NCT00812461|529384551|FG001|All Treated Patients|Adverse Event|15|||
146785559|NCT00812461|529384550|FG000|All Treated Patients|Lack of Efficacy|13|||
146785560|NCT00812461|529384551|FG001|All Treated Patients|Lack of Efficacy|7|||
146785561|NCT00812461|529384550|FG000|All Treated Patients|Non-compliance|6|||
146785562|NCT00812461|529384551|FG001|All Treated Patients|Non-compliance|9|||
146785563|NCT00812461|529384550|FG000|All Treated Patients|Protocol Violation|36|||
146785564|NCT00812461|529384551|FG001|All Treated Patients|Protocol Violation|27|||
146785565|NCT00812461|529384550|FG000|All Treated Patients|Withdrawal by Subject|45|||
146785566|NCT00812461|529384551|FG001|All Treated Patients|Withdrawal by Subject|54|||
146785567|NCT00812461|529384550|FG000|All Treated Patients|Lost to Follow-up|11|||
146785568|NCT00812461|529384551|FG001|All Treated Patients|Lost to Follow-up|14|||
146785569|NCT00812461|529384550|FG000|All Treated Patients|Other Reason|13|||
146785570|NCT00812461|529384551|FG001|All Treated Patients|Other Reason|21|||
146785571|NCT05351554|529384553|FG000|Overall Study|Study terminated by sponsor|1|||
146785572|NCT03366649|529386271|FG000|Overall Study|Failed preoperative screening|4|||
146785573|NCT03366649|529386272|FG001|Overall Study|Failed preoperative screening|0|||
146785574|NCT03366649|529386273|FG002|Overall Study|Failed preoperative screening|0|||
146785575|NCT03366649|529386271|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
146785576|NCT03366649|529386272|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
146785577|NCT03366649|529386273|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
146785578|NCT03673111|529386274|FG000|Overall Study|Protocol Violation|0|||
146785579|NCT03673111|529386275|FG001|Overall Study|Protocol Violation|0|||
146785580|NCT03673111|529386276|FG002|Overall Study|Protocol Violation|0|||
146785581|NCT03673111|529386277|FG003|Overall Study|Protocol Violation|0|||
146785582|NCT03673111|529386278|FG004|Overall Study|Protocol Violation|0|||
146785583|NCT03673111|529386279|FG005|Overall Study|Protocol Violation|0|||
146785584|NCT03673111|529386280|FG006|Overall Study|Protocol Violation|0|||
146785585|NCT03673111|529386281|FG007|Overall Study|Protocol Violation|0|||
146785586|NCT03673111|529386282|FG008|Overall Study|Protocol Violation|0|||
146785587|NCT03673111|529386283|FG009|Overall Study|Protocol Violation|0|||
146785588|NCT03673111|529386284|FG010|Overall Study|Protocol Violation|1|||
146785589|NCT03673111|529386285|FG011|Overall Study|Protocol Violation|0|||
146785590|NCT03673111|529386286|FG012|Overall Study|Protocol Violation|0|||
146785591|NCT03673111|529386287|FG013|Overall Study|Protocol Violation|0|||
146785592|NCT03673111|529386274|FG000|Overall Study|Adverse Event|1|||
146785593|NCT03673111|529386275|FG001|Overall Study|Adverse Event|0|||
146785594|NCT03673111|529386276|FG002|Overall Study|Adverse Event|0|||
146785595|NCT03673111|529386277|FG003|Overall Study|Adverse Event|0|||
146785596|NCT03673111|529386278|FG004|Overall Study|Adverse Event|0|||
146785597|NCT03673111|529386279|FG005|Overall Study|Adverse Event|0|||
146935805|NCT00426556|529922553|FG002|Phase I - Core Phase|Disease Progression|2|||
146935806|NCT00426556|529922554|FG003|Phase I - Core Phase|Disease Progression|0|||
146935807|NCT00426556|529922551|FG000|Phase I - Core Phase|Adverse Event|1|||
146935808|NCT00426556|529922552|FG001|Phase I - Core Phase|Adverse Event|3|||
146935809|NCT00426556|529922553|FG002|Phase I - Core Phase|Adverse Event|1|||
146935810|NCT00426556|529922554|FG003|Phase I - Core Phase|Adverse Event|0|||
146785598|NCT03673111|529386280|FG006|Overall Study|Adverse Event|0|||
146785599|NCT03673111|529386281|FG007|Overall Study|Adverse Event|0|||
146785600|NCT03673111|529386282|FG008|Overall Study|Adverse Event|0|||
146785601|NCT03673111|529386283|FG009|Overall Study|Adverse Event|0|||
146785602|NCT03673111|529386284|FG010|Overall Study|Adverse Event|0|||
146785603|NCT03673111|529386285|FG011|Overall Study|Adverse Event|0|||
146785604|NCT03673111|529386286|FG012|Overall Study|Adverse Event|0|||
146785605|NCT03673111|529386287|FG013|Overall Study|Adverse Event|0|||
146785606|NCT03792555|529386288|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
146785607|NCT03792555|529386289|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
146785608|NCT03792555|529386290|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
146785609|NCT03792555|529386288|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
146785610|NCT03792555|529386289|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
146785611|NCT03792555|529386290|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
146785612|NCT03792555|529386288|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
146785613|NCT03792555|529386289|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
146785614|NCT03792555|529386290|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
146785615|NCT04485039|529386294|FG000|TPOXX Only|Adverse Event|2|||
146785616|NCT04485039|529386294|FG000|TPOXX Only|Physician Decision|1|||
146785617|NCT04485039|529386294|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
146785618|NCT04485039|529386294|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
146785619|NCT00378105|529386296|FG000|Overall Study|Adverse Event|3|||
146785620|NCT00378105|529386297|FG001|Overall Study|Adverse Event|1|||
146785621|NCT00378105|529386296|FG000|Overall Study|Withdrawal by Subject|3|||
146785622|NCT00378105|529386297|FG001|Overall Study|Withdrawal by Subject|3|||
146785623|NCT00378105|529386296|FG000|Overall Study|Death|1|||
146785624|NCT00378105|529386297|FG001|Overall Study|Death|0|||
146785625|NCT00378105|529386296|FG000|Overall Study|Going to transplant|7|||
146785626|NCT00378105|529386297|FG001|Overall Study|Going to transplant|8|||
146785627|NCT00378105|529386296|FG000|Overall Study|Progressive disease|3|||
146785628|NCT00378105|529386297|FG001|Overall Study|Progressive disease|3|||
146785629|NCT00378105|529386296|FG000|Overall Study|remain on study|3|||
146785630|NCT00378105|529386297|FG001|Overall Study|remain on study|11|||
146785631|NCT00378105|529386296|FG000|Overall Study|Physician Decision|0|||
146785632|NCT00378105|529386297|FG001|Overall Study|Physician Decision|2|||
146785633|NCT00378105|529386296|FG000|Overall Study|Going non-protocol therapy|0|||
146785634|NCT00378105|529386297|FG001|Overall Study|Going non-protocol therapy|1|||
146785635|NCT00378105|529386296|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
146785636|NCT00378105|529386297|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
146785637|NCT02120456|529386298|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
146785638|NCT02120456|529386299|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
146785639|NCT02120456|529386300|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
146785640|NCT02120456|529386301|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
146785641|NCT02120456|529386302|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
146785642|NCT02120456|529386303|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
146785643|NCT02120456|529386304|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
146785644|NCT02120456|529386305|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
146785645|NCT02120456|529386306|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
146785646|NCT02120456|529386298|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
146785647|NCT02120456|529386299|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
146785648|NCT02120456|529386300|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
146785649|NCT02120456|529386301|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
146785650|NCT02120456|529386302|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
146785651|NCT02120456|529386303|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
146785652|NCT02120456|529386304|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
146785653|NCT02120456|529386305|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
146785654|NCT02120456|529386306|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
146785655|NCT02120456|529386298|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
146785656|NCT02120456|529386299|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
146785657|NCT02120456|529386300|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
146785658|NCT02120456|529386301|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
146785659|NCT02120456|529386302|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
146785660|NCT02120456|529386303|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
146785661|NCT02120456|529386304|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
146785662|NCT02120456|529386305|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
146785663|NCT02120456|529386306|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
146785664|NCT05192200|529386307|FG000|Treatment Period|Other|1|||
146785665|NCT05192200|529386307|FG000|Treatment Period|Lack of Efficacy|1|||
146785666|NCT05192200|529386307|FG000|Treatment Period|Withdrawal by Subject|1|||
146785667|NCT05192200|529386307|FG000|Follow-up|Withdrawal by Subject|1|||
146785668|NCT03623321|529386308|FG000|Overall Study|Adverse Event|32|||
146785669|NCT03623321|529386308|FG000|Overall Study|Death|9|||
146785670|NCT03623321|529386308|FG000|Overall Study|Lack of Efficacy|9|||
146785671|NCT03623321|529386308|FG000|Overall Study|Lost to Follow-up|6|||
146785672|NCT03623321|529386308|FG000|Overall Study|Noncompliance with study drug|6|||
146785673|NCT03623321|529386308|FG000|Overall Study|Use of prohibited medication|3|||
146785674|NCT03623321|529386308|FG000|Overall Study|Physician Decision|5|||
146785675|NCT03623321|529386308|FG000|Overall Study|Protocol Violation|1|||
146785676|NCT03623321|529386308|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
146785677|NCT03623321|529386308|FG000|Overall Study|Not further specified|43|||
146785678|NCT04241068|529386311|FG000|Core Treatment Period|Adverse Event|91|||
146785679|NCT04241068|529386311|FG000|Core Treatment Period|Change of Treatment|4|||
146785680|NCT04241068|529386311|FG000|Core Treatment Period|Consent Withdrawn|143|||
146785681|NCT04241068|529386311|FG000|Core Treatment Period|Death|26|||
146785682|NCT04241068|529386311|FG000|Core Treatment Period|Disease Progression|67|||
146785683|NCT04241068|529386311|FG000|Core Treatment Period|Investigator Decision|40|||
146785684|NCT04241068|529386311|FG000|Core Treatment Period|Loss of Capacity|9|||
146785685|NCT04241068|529386311|FG000|Core Treatment Period|Lost to Follow-up|11|||
146785686|NCT04241068|529386311|FG000|Core Treatment Period|Relocation|4|||
146785687|NCT04241068|529386311|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
146785688|NCT04241068|529386311|FG000|Core Treatment Period|Study Visit Burden|40|||
146785689|NCT04241068|529386311|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
146785690|NCT04241068|529386311|FG000|Core Treatment Period|Missing|2|||
146785691|NCT04241068|529386311|FG000|Core Treatment Period|Reason Not Specified|41|||
146785692|NCT04241068|529386311|FG000|LTE Period|Adverse Event|19|||
146785693|NCT04241068|529386311|FG000|LTE Period|Change of Treatment|1|||
146785694|NCT04241068|529386311|FG000|LTE Period|Consent Withdrawn|71|||
146785695|NCT04241068|529386311|FG000|LTE Period|Death|8|||
146785696|NCT04241068|529386311|FG000|LTE Period|Disease Progression|11|||
146785697|NCT04241068|529386311|FG000|LTE Period|Investigator Decision|12|||
146785698|NCT04241068|529386311|FG000|LTE Period|Loss of Capacity|2|||
146785699|NCT04241068|529386311|FG000|LTE Period|Lost to Follow-up|7|||
146785700|NCT04241068|529386311|FG000|LTE Period|Relocation|6|||
146785701|NCT04241068|529386311|FG000|LTE Period|Site Terminated by Sponsor|26|||
146785702|NCT04241068|529386311|FG000|LTE Period|Study Terminated by Sponsor|276|||
146785703|NCT04241068|529386311|FG000|LTE Period|Study Visit Burden|10|||
146785704|NCT04241068|529386311|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
146785705|NCT04241068|529386311|FG000|LTE Period|Reason Not Specified|65|||
146785706|NCT03443323|529386313|FG000|Overall Study|Lost to Follow-up|2|||
146785707|NCT03443323|529386314|FG001|Overall Study|Lost to Follow-up|2|||
146785708|NCT03443323|529386313|FG000|Overall Study|PI withdrawal|1|||
146785709|NCT03443323|529386314|FG001|Overall Study|PI withdrawal|0|||
146785710|NCT04492007|529386315|FG000|Overall Study|Lost to Follow-up|1|||
146785711|NCT04492007|529386316|FG001|Overall Study|Lost to Follow-up|1|||
146785712|NCT04492007|529386317|FG002|Overall Study|Lost to Follow-up|2|||
146785713|NCT04492007|529386318|FG003|Overall Study|Lost to Follow-up|2|||
146785714|NCT04492007|529386315|FG000|Overall Study|Protocol Violation|1|||
146785715|NCT04492007|529386316|FG001|Overall Study|Protocol Violation|1|||
146785716|NCT04492007|529386317|FG002|Overall Study|Protocol Violation|1|||
146785717|NCT04492007|529386318|FG003|Overall Study|Protocol Violation|1|||
146785718|NCT04492007|529386315|FG000|Overall Study|Withdrawal by Subject|0|||
146785719|NCT04492007|529386316|FG001|Overall Study|Withdrawal by Subject|0|||
146785720|NCT04492007|529386317|FG002|Overall Study|Withdrawal by Subject|1|||
146785721|NCT04492007|529386318|FG003|Overall Study|Withdrawal by Subject|1|||
146785722|NCT04177823|529386321|FG000|Overall Study|Physician Decision|1|||
146785723|NCT04177823|529386321|FG000|Overall Study|Withdrawal by Subject|1|||
146785724|NCT04229992|529386322|FG000|Overall Study|Withdrawal by Subject|0|||
146785725|NCT04229992|529386323|FG001|Overall Study|Withdrawal by Subject|2|||
146785726|NCT04229992|529386324|FG002|Overall Study|Withdrawal by Subject|1|||
146785727|NCT04229992|529386325|FG003|Overall Study|Withdrawal by Subject|1|||
146785728|NCT04229992|529386322|FG000|Overall Study|Adverse Event|1|||
146785729|NCT04229992|529386323|FG001|Overall Study|Adverse Event|1|||
146785730|NCT04229992|529386324|FG002|Overall Study|Adverse Event|3|||
146785731|NCT04229992|529386325|FG003|Overall Study|Adverse Event|1|||
146785732|NCT04229992|529386322|FG000|Overall Study|Lost to Follow-up|0|||
146785733|NCT04229992|529386323|FG001|Overall Study|Lost to Follow-up|0|||
146785734|NCT04229992|529386324|FG002|Overall Study|Lost to Follow-up|0|||
146785735|NCT04229992|529386325|FG003|Overall Study|Lost to Follow-up|1|||
146785736|NCT03770273|529386326|FG000|Overall Study|Adverse Event|2|||
146981628|NCT01621490|530096091|FG004|Overall Study|Adverse event unrelated to study drug|0|||
146785737|NCT03770273|529386327|FG001|Overall Study|Adverse Event|0|||
146785738|NCT03770273|529386326|FG000|Overall Study|Lost to Follow-up|1|||
146785739|NCT03770273|529386327|FG001|Overall Study|Lost to Follow-up|1|||
146785740|NCT00418886|529386328|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
146785741|NCT00418886|529386329|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
146785742|NCT00418886|529386328|FG000|Randomized Period|Death|122|||
146785743|NCT00418886|529386329|FG001|Randomized Period|Death|147|||
146785744|NCT00418886|529386328|FG000|Randomized Period|Withdrawal by Subject|9|||
146785745|NCT00418886|529386329|FG001|Randomized Period|Withdrawal by Subject|10|||
146785746|NCT00418886|529386328|FG000|Randomized Period|Lost to Follow-up|4|||
146785747|NCT00418886|529386329|FG001|Randomized Period|Lost to Follow-up|6|||
146785748|NCT00418886|529386328|FG000|Randomized Period|withdrawn due to other reason|1|||
146785749|NCT00418886|529386329|FG001|Randomized Period|withdrawn due to other reason|0|||
146785750|NCT00418886|529386328|FG000|Randomized Period|randomised but no treatment received|0|||
146785751|NCT00418886|529386329|FG001|Randomized Period|randomised but no treatment received|1|||
146785752|NCT04060654|529386330|FG000|Overall Study|Withdrawal by Subject|1|||
146785753|NCT04060654|529386330|FG000|Overall Study|Lost to Follow-up|5|||
146785754|NCT03707951|529386331|FG000|Overall Study|Lost to Follow-up|8|||
146785755|NCT03707951|529386332|FG001|Overall Study|Lost to Follow-up|17|||
146785756|NCT03707951|529386331|FG000|Overall Study|Withdrawal by Subject|6|||
146785757|NCT03707951|529386332|FG001|Overall Study|Withdrawal by Subject|6|||
146785758|NCT04887129|529386333|FG000|Overall Study|Lost to Follow-up|0|||
146785759|NCT04887129|529386334|FG001|Overall Study|Lost to Follow-up|24|||
146785760|NCT04887129|529386333|FG000|Overall Study|Withdrawal by Subject|9|||
146785761|NCT04887129|529386334|FG001|Overall Study|Withdrawal by Subject|57|||
146785762|NCT04887129|529386333|FG000|Overall Study|Other|2|||
146785763|NCT04887129|529386334|FG001|Overall Study|Other|9|||
146785764|NCT01999075|529386336|FG000|Overall Study|Lost to Follow-up|0|||
146785765|NCT01999075|529386337|FG001|Overall Study|Lost to Follow-up|2|||
146785766|NCT01999075|529386336|FG000|Overall Study|Withdrawal by Subject|2|||
146785767|NCT01999075|529386337|FG001|Overall Study|Withdrawal by Subject|7|||
146785768|NCT01999075|529386336|FG000|Overall Study|Enrolled in drug trial|3|||
146785769|NCT01999075|529386337|FG001|Overall Study|Enrolled in drug trial|1|||
146785770|NCT01999075|529386336|FG000|Overall Study|Became ineligible|0|||
146785771|NCT01999075|529386337|FG001|Overall Study|Became ineligible|2|||
146785772|NCT03792256|529386339|FG000|Overall Study|Death|0|||
146785773|NCT03792256|529386340|FG001|Overall Study|Death|1|||
146785774|NCT03792256|529386339|FG000|Overall Study|Lack of Efficacy|0|||
146785775|NCT03792256|529386340|FG001|Overall Study|Lack of Efficacy|1|||
146785776|NCT03792256|529386339|FG000|Overall Study|Withdrawal by Subject|0|||
146785777|NCT03792256|529386340|FG001|Overall Study|Withdrawal by Subject|1|||
146785778|NCT04760678|529386341|FG000|Overall Study|Death|13|||
146785779|NCT04760678|529386341|FG000|Overall Study|Lost to Follow-up|48|||
146785780|NCT04760678|529386341|FG000|Overall Study|Withdrawal by Subject|1|||
146785781|NCT04562649|529386342|FG000|Overall Study|Withdrawal by Subject|11|||
146785782|NCT04562649|529386343|FG001|Overall Study|Withdrawal by Subject|8|||
146785783|NCT04562649|529386342|FG000|Overall Study|Lost to Follow-up|26|||
146785784|NCT04562649|529386343|FG001|Overall Study|Lost to Follow-up|20|||
146785785|NCT05368103|529386344|FG000|Overall Study|Withdrawal by Subject|4|||
146785786|NCT05368103|529386344|FG000|Overall Study|Lost to Follow-up|1|||
146785787|NCT05368103|529386344|FG000|Overall Study|Lack of Efficacy|3|||
146785788|NCT03675282|529386347|FG000|Overall Study|Lost to Follow-up|4|||
146785789|NCT03675282|529386348|FG001|Overall Study|Lost to Follow-up|8|||
146785790|NCT03675282|529386349|FG002|Overall Study|Lost to Follow-up|1|||
146785791|NCT03675282|529386350|FG003|Overall Study|Lost to Follow-up|0|||
146785792|NCT03675282|529386351|FG004|Overall Study|Lost to Follow-up|2|||
146785793|NCT03675282|529386352|FG005|Overall Study|Lost to Follow-up|7|||
146785794|NCT03675282|529386347|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
146785795|NCT03675282|529386348|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
146785796|NCT03675282|529386349|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
146785797|NCT03675282|529386350|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
146785798|NCT03675282|529386351|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
146785799|NCT03675282|529386352|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
146785800|NCT03675282|529386347|FG000|Overall Study|Physician Decision|1|||
146785801|NCT03675282|529386348|FG001|Overall Study|Physician Decision|0|||
146785802|NCT03675282|529386349|FG002|Overall Study|Physician Decision|0|||
146785803|NCT03675282|529386350|FG003|Overall Study|Physician Decision|0|||
146785804|NCT03675282|529386351|FG004|Overall Study|Physician Decision|0|||
146785805|NCT03675282|529386352|FG005|Overall Study|Physician Decision|0|||
146785806|NCT05784662|529386356|FG000|Overall Study|Lost to Follow-up|21|||
146785807|NCT05784662|529386357|FG001|Overall Study|Lost to Follow-up|17|||
146785808|NCT04274764|529386358|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
146785809|NCT04274764|529386359|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
146785810|NCT03611621|529386362|FG000|Overall Study|Graft loss|3|||
146785811|NCT03611621|529386362|FG000|Overall Study|Death|3|||
146785812|NCT03611621|529386362|FG000|Overall Study|Lost to Follow-up|1|||
146785813|NCT05177848|529386380|FG000|Overall Study|Lost to Follow-up|1|||
146785814|NCT05177848|529386381|FG001|Overall Study|Lost to Follow-up|4|||
146785815|NCT05177848|529386380|FG000|Overall Study|Discontinued|2|||
146785816|NCT05177848|529386381|FG001|Overall Study|Discontinued|1|||
146785817|NCT03853746|529386382|FG000|Overall Study|Withdrawal by Subject|1|||
146785818|NCT01084876|529386383|FG000|Main Study Treatment Period|Adverse Event|12|||
146785819|NCT01084876|529386384|FG001|Main Study Treatment Period|Adverse Event|7|||
146785820|NCT01084876|529386383|FG000|Main Study Treatment Period|Disease Progression|41|||
146785821|NCT01084876|529386384|FG001|Main Study Treatment Period|Disease Progression|24|||
146785822|NCT01084876|529386383|FG000|Main Study Treatment Period|Physician Decision|2|||
146785823|NCT01084876|529386384|FG001|Main Study Treatment Period|Physician Decision|0|||
146785824|NCT01084876|529386383|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
146785825|NCT01084876|529386384|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
146785826|NCT01084876|529386383|FG000|Main Study Treatment Period|Other Reason|0|||
146785827|NCT01084876|529386384|FG001|Main Study Treatment Period|Other Reason|1|||
146785828|NCT01084876|529386383|FG000|Main Study Treatment Period|Other|0|||
146785829|NCT01084876|529386384|FG001|Main Study Treatment Period|Other|1|||
146785830|NCT01084876|529386383|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
146785831|NCT01084876|529386384|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
146785832|NCT01084876|529386383|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
146785833|NCT01084876|529386384|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
146785834|NCT01084876|529386383|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
146785835|NCT01084876|529386384|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
146785836|NCT01084876|529386383|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
146785837|NCT01084876|529386384|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
146785838|NCT01084876|529386383|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
146785839|NCT01084876|529386384|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
146785840|NCT01084876|529386383|FG000|Treatment Period Beyond Cycle 8|Other|6|||
146785841|NCT01084876|529386384|FG001|Treatment Period Beyond Cycle 8|Other|9|||
146785842|NCT05486078|529386396|FG000|Overall Study|4 drop out and one withdrawn|5|||
146785843|NCT02724631|529386397|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
146785844|NCT05076708|529386398|FG000|Overall Study|Withdrawal by Subject|4|||
146785845|NCT05076708|529386398|FG000|Overall Study|Lost to study during switch phase|8|||
146785846|NCT02908477|529386399|FG000|Overall Study|Withdrawal by Subject|8|||
146785847|NCT02908477|529386400|FG001|Overall Study|Withdrawal by Subject|28|||
146785848|NCT04971395|529386403|FG000|Overall Study|Withdrawal by Subject|0|||
146785849|NCT04971395|529386404|FG001|Overall Study|Withdrawal by Subject|1|||
146785850|NCT04971395|529386405|FG002|Overall Study|Withdrawal by Subject|0|||
146785851|NCT02924272|529386407|FG000|Overall Study|Site Terminated by Sponsor|4|||
146785852|NCT02924272|529386408|FG001|Overall Study|Site Terminated by Sponsor|1|||
146785853|NCT02924272|529386407|FG000|Overall Study|Withdrawal by Subject|2|||
146785854|NCT02924272|529386408|FG001|Overall Study|Withdrawal by Subject|0|||
146785855|NCT02924272|529386407|FG000|Overall Study|Adverse Event|3|||
146785856|NCT02924272|529386408|FG001|Overall Study|Adverse Event|0|||
146785857|NCT02924272|529386407|FG000|Overall Study|Progressive Disease|11|||
146785858|NCT02924272|529386408|FG001|Overall Study|Progressive Disease|8|||
146785859|NCT02924272|529386407|FG000|Overall Study|Clinical Deterioration|1|||
146785860|NCT02924272|529386408|FG001|Overall Study|Clinical Deterioration|0|||
146785861|NCT02924272|529386407|FG000|Overall Study|Death|1|||
146785862|NCT02924272|529386408|FG001|Overall Study|Death|0|||
146785863|NCT02924272|529386407|FG000|Overall Study|Reason Not Specified|1|||
146785864|NCT02924272|529386408|FG001|Overall Study|Reason Not Specified|0|||
146785865|NCT03150810|529386413|FG000|Overall Study|Death|4|||
146785866|NCT03150810|529386414|FG001|Overall Study|Death|8|||
146785867|NCT03150810|529386415|FG002|Overall Study|Death|7|||
146785868|NCT03150810|529386416|FG003|Overall Study|Death|2|||
146785869|NCT03150810|529386417|FG004|Overall Study|Death|2|||
146785870|NCT03150810|529386418|FG005|Overall Study|Death|10|||
146785871|NCT03150810|529386419|FG006|Overall Study|Death|8|||
146785872|NCT03150810|529386420|FG007|Overall Study|Death|6|||
146785873|NCT03150810|529386421|FG008|Overall Study|Death|18|||
146785874|NCT03150810|529386422|FG009|Overall Study|Death|3|||
146785875|NCT03150810|529386423|FG010|Overall Study|Death|19|||
146785876|NCT03150810|529386424|FG011|Overall Study|Death|1|||
146785877|NCT03150810|529386425|FG012|Overall Study|Death|19|||
146785878|NCT03150810|529386413|FG000|Overall Study|Withdrawal by Subject|0|||
146785879|NCT03150810|529386414|FG001|Overall Study|Withdrawal by Subject|1|||
146785880|NCT03150810|529386415|FG002|Overall Study|Withdrawal by Subject|1|||
146785881|NCT03150810|529386416|FG003|Overall Study|Withdrawal by Subject|1|||
146785882|NCT03150810|529386417|FG004|Overall Study|Withdrawal by Subject|0|||
146785883|NCT03150810|529386418|FG005|Overall Study|Withdrawal by Subject|0|||
146785884|NCT03150810|529386419|FG006|Overall Study|Withdrawal by Subject|2|||
146785885|NCT03150810|529386420|FG007|Overall Study|Withdrawal by Subject|0|||
146785886|NCT03150810|529386421|FG008|Overall Study|Withdrawal by Subject|2|||
146785887|NCT03150810|529386422|FG009|Overall Study|Withdrawal by Subject|0|||
146785888|NCT03150810|529386423|FG010|Overall Study|Withdrawal by Subject|1|||
146785889|NCT03150810|529386424|FG011|Overall Study|Withdrawal by Subject|0|||
146785890|NCT03150810|529386425|FG012|Overall Study|Withdrawal by Subject|1|||
146785891|NCT03150810|529386413|FG000|Overall Study|Sponsor Decision|0|||
146785892|NCT03150810|529386414|FG001|Overall Study|Sponsor Decision|2|||
146785893|NCT03150810|529386415|FG002|Overall Study|Sponsor Decision|0|||
146785894|NCT03150810|529386416|FG003|Overall Study|Sponsor Decision|0|||
146785895|NCT03150810|529386417|FG004|Overall Study|Sponsor Decision|1|||
146785896|NCT03150810|529386418|FG005|Overall Study|Sponsor Decision|1|||
146935811|NCT00426556|529922551|FG000|Phase I - Core Phase|Death|0|||
146785897|NCT03150810|529386419|FG006|Overall Study|Sponsor Decision|0|||
146785898|NCT03150810|529386420|FG007|Overall Study|Sponsor Decision|0|||
146785899|NCT03150810|529386421|FG008|Overall Study|Sponsor Decision|1|||
146785900|NCT03150810|529386422|FG009|Overall Study|Sponsor Decision|0|||
146935812|NCT00426556|529922552|FG001|Phase I - Core Phase|Death|1|||
146935813|NCT00426556|529922553|FG002|Phase I - Core Phase|Death|0|||
146785901|NCT03150810|529386423|FG010|Overall Study|Sponsor Decision|0|||
146785902|NCT03150810|529386424|FG011|Overall Study|Sponsor Decision|0|||
146785903|NCT03150810|529386425|FG012|Overall Study|Sponsor Decision|5|||
146785904|NCT03150810|529386413|FG000|Overall Study|Lost to Follow-up|0|||
146785905|NCT03150810|529386414|FG001|Overall Study|Lost to Follow-up|1|||
146785906|NCT03150810|529386415|FG002|Overall Study|Lost to Follow-up|1|||
146785907|NCT03150810|529386416|FG003|Overall Study|Lost to Follow-up|0|||
146785908|NCT03150810|529386417|FG004|Overall Study|Lost to Follow-up|0|||
146785909|NCT03150810|529386418|FG005|Overall Study|Lost to Follow-up|0|||
146785910|NCT03150810|529386419|FG006|Overall Study|Lost to Follow-up|1|||
146785911|NCT03150810|529386420|FG007|Overall Study|Lost to Follow-up|0|||
146785912|NCT03150810|529386421|FG008|Overall Study|Lost to Follow-up|0|||
146785913|NCT03150810|529386422|FG009|Overall Study|Lost to Follow-up|0|||
146785914|NCT03150810|529386423|FG010|Overall Study|Lost to Follow-up|1|||
146785915|NCT03150810|529386424|FG011|Overall Study|Lost to Follow-up|0|||
146785916|NCT03150810|529386425|FG012|Overall Study|Lost to Follow-up|0|||
146785917|NCT03150810|529386413|FG000|Overall Study|Physician Decision|0|||
146785918|NCT03150810|529386414|FG001|Overall Study|Physician Decision|0|||
146785919|NCT03150810|529386415|FG002|Overall Study|Physician Decision|0|||
146785920|NCT03150810|529386416|FG003|Overall Study|Physician Decision|0|||
146785921|NCT03150810|529386417|FG004|Overall Study|Physician Decision|0|||
146785922|NCT03150810|529386418|FG005|Overall Study|Physician Decision|1|||
146785923|NCT03150810|529386419|FG006|Overall Study|Physician Decision|1|||
146785924|NCT03150810|529386420|FG007|Overall Study|Physician Decision|0|||
146785925|NCT03150810|529386421|FG008|Overall Study|Physician Decision|0|||
146785926|NCT03150810|529386422|FG009|Overall Study|Physician Decision|0|||
146785927|NCT03150810|529386423|FG010|Overall Study|Physician Decision|0|||
146785928|NCT03150810|529386424|FG011|Overall Study|Physician Decision|0|||
146785929|NCT03150810|529386425|FG012|Overall Study|Physician Decision|0|||
146785930|NCT03150810|529386413|FG000|Overall Study|Site withdrawal from study|0|||
146785931|NCT03150810|529386414|FG001|Overall Study|Site withdrawal from study|1|||
146785932|NCT03150810|529386415|FG002|Overall Study|Site withdrawal from study|0|||
146785933|NCT03150810|529386416|FG003|Overall Study|Site withdrawal from study|0|||
146785934|NCT03150810|529386417|FG004|Overall Study|Site withdrawal from study|0|||
146785935|NCT03150810|529386418|FG005|Overall Study|Site withdrawal from study|0|||
146785936|NCT03150810|529386419|FG006|Overall Study|Site withdrawal from study|0|||
146785937|NCT03150810|529386420|FG007|Overall Study|Site withdrawal from study|0|||
146785938|NCT03150810|529386421|FG008|Overall Study|Site withdrawal from study|0|||
146785939|NCT03150810|529386422|FG009|Overall Study|Site withdrawal from study|1|||
146785940|NCT03150810|529386423|FG010|Overall Study|Site withdrawal from study|1|||
146785941|NCT03150810|529386424|FG011|Overall Study|Site withdrawal from study|0|||
146785942|NCT03150810|529386425|FG012|Overall Study|Site withdrawal from study|0|||
146785943|NCT03150810|529386413|FG000|Overall Study|Hospice|0|||
146785944|NCT03150810|529386414|FG001|Overall Study|Hospice|0|||
146785945|NCT03150810|529386415|FG002|Overall Study|Hospice|0|||
146785946|NCT03150810|529386416|FG003|Overall Study|Hospice|0|||
146785947|NCT03150810|529386417|FG004|Overall Study|Hospice|0|||
146785948|NCT03150810|529386418|FG005|Overall Study|Hospice|1|||
146785949|NCT03150810|529386419|FG006|Overall Study|Hospice|0|||
146785950|NCT03150810|529386420|FG007|Overall Study|Hospice|0|||
146785951|NCT03150810|529386421|FG008|Overall Study|Hospice|0|||
146785952|NCT03150810|529386422|FG009|Overall Study|Hospice|0|||
146785953|NCT03150810|529386423|FG010|Overall Study|Hospice|0|||
146785954|NCT03150810|529386424|FG011|Overall Study|Hospice|0|||
146785955|NCT03150810|529386425|FG012|Overall Study|Hospice|0|||
146785956|NCT03150810|529386413|FG000|Overall Study|Participant relocated abroad.|0|||
146785957|NCT03150810|529386414|FG001|Overall Study|Participant relocated abroad.|0|||
146785958|NCT03150810|529386415|FG002|Overall Study|Participant relocated abroad.|0|||
146785959|NCT03150810|529386416|FG003|Overall Study|Participant relocated abroad.|0|||
146785960|NCT03150810|529386417|FG004|Overall Study|Participant relocated abroad.|0|||
146785961|NCT03150810|529386418|FG005|Overall Study|Participant relocated abroad.|1|||
146785962|NCT03150810|529386419|FG006|Overall Study|Participant relocated abroad.|0|||
146785963|NCT03150810|529386420|FG007|Overall Study|Participant relocated abroad.|0|||
146785964|NCT03150810|529386421|FG008|Overall Study|Participant relocated abroad.|0|||
146785965|NCT03150810|529386422|FG009|Overall Study|Participant relocated abroad.|0|||
146785966|NCT03150810|529386423|FG010|Overall Study|Participant relocated abroad.|0|||
146785967|NCT03150810|529386424|FG011|Overall Study|Participant relocated abroad.|0|||
146785968|NCT03150810|529386425|FG012|Overall Study|Participant relocated abroad.|0|||
146785969|NCT03150810|529386413|FG000|Overall Study|Transferred care to oncologist|0|||
146785970|NCT03150810|529386414|FG001|Overall Study|Transferred care to oncologist|0|||
146785971|NCT03150810|529386415|FG002|Overall Study|Transferred care to oncologist|0|||
146785972|NCT03150810|529386416|FG003|Overall Study|Transferred care to oncologist|0|||
146785973|NCT03150810|529386417|FG004|Overall Study|Transferred care to oncologist|0|||
146785974|NCT03150810|529386418|FG005|Overall Study|Transferred care to oncologist|0|||
146785975|NCT03150810|529386419|FG006|Overall Study|Transferred care to oncologist|2|||
146785976|NCT03150810|529386420|FG007|Overall Study|Transferred care to oncologist|0|||
146785977|NCT03150810|529386421|FG008|Overall Study|Transferred care to oncologist|0|||
146785978|NCT03150810|529386422|FG009|Overall Study|Transferred care to oncologist|0|||
146785979|NCT03150810|529386423|FG010|Overall Study|Transferred care to oncologist|0|||
146785980|NCT03150810|529386424|FG011|Overall Study|Transferred care to oncologist|0|||
146785981|NCT03150810|529386425|FG012|Overall Study|Transferred care to oncologist|0|||
146785982|NCT02919683|529386426|FG000|Post-Surgery Follow-Up|Death|2|||
146785983|NCT02919683|529386427|FG001|Post-Surgery Follow-Up|Death|2|||
146785984|NCT02919683|529386426|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
146785985|NCT02919683|529386427|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
146785986|NCT03721952|529386428|FG000|Overall Study|Lost to Follow-up|0|||
146785987|NCT03721952|529386429|FG001|Overall Study|Lost to Follow-up|0|||
146785988|NCT03721952|529386430|FG002|Overall Study|Lost to Follow-up|2|||
146785989|NCT03721952|529386431|FG003|Overall Study|Lost to Follow-up|0|||
146785990|NCT03721952|529386432|FG004|Overall Study|Lost to Follow-up|0|||
146785991|NCT03721952|529386428|FG000|Overall Study|Protocol Violation|0|||
146785992|NCT03721952|529386429|FG001|Overall Study|Protocol Violation|1|||
146785993|NCT03721952|529386430|FG002|Overall Study|Protocol Violation|0|||
146785994|NCT03721952|529386431|FG003|Overall Study|Protocol Violation|0|||
146785995|NCT03721952|529386432|FG004|Overall Study|Protocol Violation|0|||
146785996|NCT03721952|529386428|FG000|Overall Study|Withdrawal by Subject|1|||
146785997|NCT03721952|529386429|FG001|Overall Study|Withdrawal by Subject|0|||
146785998|NCT03721952|529386430|FG002|Overall Study|Withdrawal by Subject|40|||
146785999|NCT03721952|529386431|FG003|Overall Study|Withdrawal by Subject|28|||
146786000|NCT03721952|529386432|FG004|Overall Study|Withdrawal by Subject|0|||
146786001|NCT04495894|529386436|FG000|Overall Study|Withdrawal by Subject|2|||
146786002|NCT04495894|529386437|FG001|Overall Study|Withdrawal by Subject|0|||
146786003|NCT04495894|529386438|FG002|Overall Study|Withdrawal by Subject|2|||
146786004|NCT04495894|529386439|FG003|Overall Study|Withdrawal by Subject|3|||
146786005|NCT04495894|529386436|FG000|Overall Study|Early termination|0|||
146786006|NCT04495894|529386437|FG001|Overall Study|Early termination|0|||
146786007|NCT04495894|529386438|FG002|Overall Study|Early termination|3|||
146786008|NCT04495894|529386439|FG003|Overall Study|Early termination|0|||
146786009|NCT01000961|529386440|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
146786010|NCT01000961|529386441|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
146786011|NCT01000961|529386440|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
146786012|NCT01000961|529386441|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
146786013|NCT05184192|529386453|FG000|Overall Study|Lost to Follow-up|4|||
146935814|NCT00426556|529922554|FG003|Phase I - Core Phase|Death|0|||
146786014|NCT05184192|529386454|FG001|Overall Study|Lost to Follow-up|7|||
146786015|NCT05184192|529386453|FG000|Overall Study|Adverse Event|1|||
146786016|NCT05184192|529386454|FG001|Overall Study|Adverse Event|4|||
146786017|NCT05184192|529386453|FG000|Overall Study|PI withdrawal|1|||
146786018|NCT05184192|529386454|FG001|Overall Study|PI withdrawal|2|||
146786019|NCT05184192|529386453|FG000|Overall Study|Withdrew due to adverse effect|1|||
146786020|NCT05184192|529386454|FG001|Overall Study|Withdrew due to adverse effect|0|||
146786021|NCT05184192|529386453|FG000|Overall Study|Medication schedule|1|||
146786022|NCT05184192|529386454|FG001|Overall Study|Medication schedule|0|||
146786023|NCT05184192|529386453|FG000|Overall Study|Concern for adverse effects|0|||
146786024|NCT05184192|529386454|FG001|Overall Study|Concern for adverse effects|4|||
146786025|NCT05603143|529386455|FG000|Overall Study|Withdrew consent|6|||
146786026|NCT05603143|529386456|FG001|Overall Study|Withdrew consent|2|||
146786027|NCT05603143|529386455|FG000|Overall Study|Randomized but never treated|0|||
146786028|NCT05603143|529386456|FG001|Overall Study|Randomized but never treated|3|||
146786029|NCT05603143|529386455|FG000|Overall Study|Adverse Event|2|||
146786030|NCT05603143|529386456|FG001|Overall Study|Adverse Event|0|||
146786031|NCT05603143|529386455|FG000|Overall Study|Death|0|||
146786032|NCT05603143|529386456|FG001|Overall Study|Death|1|||
146786033|NCT05603143|529386455|FG000|Overall Study|Investigator's discretion|1|||
146786034|NCT05603143|529386456|FG001|Overall Study|Investigator's discretion|0|||
146786035|NCT05603143|529386455|FG000|Overall Study|Lost to Follow-up|0|||
146786036|NCT05603143|529386456|FG001|Overall Study|Lost to Follow-up|1|||
146786037|NCT05603143|529386455|FG000|Overall Study|Protocol Violation|0|||
146786038|NCT05603143|529386456|FG001|Overall Study|Protocol Violation|1|||
146786039|NCT04277442|529386457|FG000|Overall Study|Death|1|||
146786040|NCT05084508|529386458|FG000|Overall Study|Lost to Follow-up|6|||
146935815|NCT00426556|529922551|FG000|Phase I - Extension Phase|Adverse Event|0|||
146786041|NCT05084508|529386459|FG001|Overall Study|Lost to Follow-up|3|||
146786042|NCT05084508|529386460|FG002|Overall Study|Lost to Follow-up|7|||
146786043|NCT05084508|529386461|FG003|Overall Study|Lost to Follow-up|3|||
146786044|NCT05084508|529386458|FG000|Overall Study|Withdrawal by Subject|0|||
146935816|NCT00426556|529922552|FG001|Phase I - Extension Phase|Adverse Event|1|||
146786045|NCT05084508|529386459|FG001|Overall Study|Withdrawal by Subject|2|||
146786046|NCT05084508|529386460|FG002|Overall Study|Withdrawal by Subject|3|||
146786047|NCT05084508|529386461|FG003|Overall Study|Withdrawal by Subject|1|||
146786048|NCT05084508|529386458|FG000|Overall Study|Other|0|||
146786049|NCT05084508|529386459|FG001|Overall Study|Other|0|||
146786050|NCT05084508|529386460|FG002|Overall Study|Other|0|||
146786051|NCT05084508|529386461|FG003|Overall Study|Other|1|||
146786052|NCT05093829|529386463|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
146786053|NCT05093829|529386464|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
146786054|NCT05093829|529386465|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
146786055|NCT05093829|529386466|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
146786056|NCT05093829|529386467|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
146786057|NCT04353661|529388377|FG000|Overall Study|Protocol Violation|0|||
146786058|NCT04353661|529388378|FG001|Overall Study|Protocol Violation|0|||
146786059|NCT04353661|529388379|FG002|Overall Study|Protocol Violation|1|||
146786060|NCT04353661|529388377|FG000|Overall Study|Study termination by the Sponsor|1|||
146786061|NCT04353661|529388378|FG001|Overall Study|Study termination by the Sponsor|1|||
146786062|NCT04353661|529388379|FG002|Overall Study|Study termination by the Sponsor|1|||
146786063|NCT00667251|529388380|FG000|Overall Study|Disease progression|232|||
146786064|NCT00667251|529388381|FG001|Overall Study|Disease progression|203|||
146786065|NCT00667251|529388380|FG000|Overall Study|Toxicity|44|||
146786066|NCT00667251|529388381|FG001|Overall Study|Toxicity|23|||
146786067|NCT00667251|529388380|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
146786068|NCT00667251|529388381|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
146786069|NCT00667251|529388380|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
146786070|NCT00667251|529388381|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
146786071|NCT00667251|529388380|FG000|Overall Study|Symptomatic progression|8|||
146786072|NCT00667251|529388381|FG001|Overall Study|Symptomatic progression|4|||
146786073|NCT00667251|529388380|FG000|Overall Study|Death|6|||
146786074|NCT00667251|529388381|FG001|Overall Study|Death|11|||
146786075|NCT00667251|529388380|FG000|Overall Study|Intercurrent illness|5|||
146786076|NCT00667251|529388381|FG001|Overall Study|Intercurrent illness|6|||
146786077|NCT00667251|529388380|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
146786078|NCT00667251|529388381|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
146786079|NCT00667251|529388380|FG000|Overall Study|Randomized not Treated|4|||
146786080|NCT00667251|529388381|FG001|Overall Study|Randomized not Treated|1|||
146786081|NCT02727699|529388383|FG000|Overall Study|Adverse Event|2|||
146786082|NCT02727699|529388384|FG001|Overall Study|Adverse Event|0|||
146786083|NCT02727699|529388383|FG000|Overall Study|Withdrawal by Subject|5|||
146786084|NCT02727699|529388384|FG001|Overall Study|Withdrawal by Subject|3|||
146786085|NCT02727699|529388383|FG000|Overall Study|Protocol Violation|0|||
146786086|NCT02727699|529388384|FG001|Overall Study|Protocol Violation|1|||
146786087|NCT02727699|529388383|FG000|Overall Study|Physician Decision|0|||
146786088|NCT02727699|529388384|FG001|Overall Study|Physician Decision|1|||
146786089|NCT02727699|529388383|FG000|Overall Study|Lost to Follow-up|1|||
146786090|NCT02727699|529388384|FG001|Overall Study|Lost to Follow-up|0|||
146786091|NCT02727699|529388383|FG000|Overall Study|Sponsor Decision|1|||
146786092|NCT02727699|529388384|FG001|Overall Study|Sponsor Decision|0|||
146786093|NCT02671903|529388396|FG000|Period 0 (Run-In)|Death|0|||
146786094|NCT02671903|529388397|FG001|Period 0 (Run-In)|Death|0|||
146786095|NCT02671903|529388398|FG002|Period 0 (Run-In)|Death|3|||
146786096|NCT02671903|529388396|FG000|Period 0 (Run-In)|Physician Decision|0|||
146786097|NCT02671903|529388397|FG001|Period 0 (Run-In)|Physician Decision|0|||
146786098|NCT02671903|529388398|FG002|Period 0 (Run-In)|Physician Decision|4|||
146786099|NCT02671903|529388396|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
146786100|NCT02671903|529388397|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
146786101|NCT02671903|529388398|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
146786102|NCT02671903|529388396|FG000|Period 0 (Run-In)|Protocol Violation|0|||
146786103|NCT02671903|529388397|FG001|Period 0 (Run-In)|Protocol Violation|0|||
146786104|NCT02671903|529388398|FG002|Period 0 (Run-In)|Protocol Violation|1|||
146786105|NCT02671903|529388396|FG000|Period 0 (Run-In)|Adverse Event|0|||
146786106|NCT02671903|529388397|FG001|Period 0 (Run-In)|Adverse Event|0|||
146786107|NCT02671903|529388398|FG002|Period 0 (Run-In)|Adverse Event|1|||
146786108|NCT02671903|529388396|FG000|Period 0 (Run-In)|Implantation Failure|0|||
146786109|NCT02671903|529388397|FG001|Period 0 (Run-In)|Implantation Failure|0|||
146786110|NCT02671903|529388398|FG002|Period 0 (Run-In)|Implantation Failure|2|||
146786111|NCT02671903|529388396|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
146786112|NCT02671903|529388397|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
146786113|NCT02671903|529388398|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
146786114|NCT03376321|529388399|FG000|Overall Study|Other|5|||
146786115|NCT03376321|529388400|FG001|Overall Study|Other|1|||
146786116|NCT03376321|529388399|FG000|Overall Study|Withdrawal by Subject|8|||
146786117|NCT03376321|529388400|FG001|Overall Study|Withdrawal by Subject|14|||
146786118|NCT03376321|529388399|FG000|Overall Study|Lost to Follow-up|1|||
146786119|NCT03376321|529388400|FG001|Overall Study|Lost to Follow-up|7|||
146786120|NCT03376321|529388399|FG000|Overall Study|Death|4|||
146786121|NCT03376321|529388400|FG001|Overall Study|Death|0|||
146786122|NCT03376321|529388399|FG000|Overall Study|Randomized, not treated|5|||
146786123|NCT03376321|529388400|FG001|Overall Study|Randomized, not treated|3|||
146786124|NCT02992925|529388401|FG000|Cohort 2|Physician Decision|0|||
146786125|NCT02992925|529388402|FG001|Cohort 2|Physician Decision|0|||
146786126|NCT02992925|529388403|FG002|Cohort 2|Physician Decision|1|||
146786127|NCT02992925|529388404|FG003|Cohort 2|Physician Decision|0|||
146786128|NCT02992925|529388401|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
146786129|NCT02992925|529388402|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
146786130|NCT02992925|529388403|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
146786131|NCT02992925|529388404|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
146786132|NCT02995434|529388405|FG000|Overall Study|Adverse Event|1|||
146786133|NCT02995434|529388406|FG001|Overall Study|Adverse Event|0|||
146786134|NCT02995434|529388405|FG000|Overall Study|Withdrawal by Subject|6|||
146786135|NCT02995434|529388406|FG001|Overall Study|Withdrawal by Subject|3|||
146786136|NCT05273749|529388407|FG000|Overall Study|Adverse Event|14|||
146786137|NCT05273749|529388408|FG001|Overall Study|Adverse Event|8|||
146786138|NCT05273749|529388407|FG000|Overall Study|Lack of Efficacy|2|||
146786139|NCT05273749|529388408|FG001|Overall Study|Lack of Efficacy|8|||
146786140|NCT05273749|529388407|FG000|Overall Study|Physician Decision|0|||
146786141|NCT05273749|529388408|FG001|Overall Study|Physician Decision|2|||
146786142|NCT05273749|529388407|FG000|Overall Study|Withdrawal by Subject|14|||
146786143|NCT05273749|529388408|FG001|Overall Study|Withdrawal by Subject|16|||
146786144|NCT05273749|529388407|FG000|Overall Study|Lost to Follow-up|10|||
146786145|NCT05273749|529388408|FG001|Overall Study|Lost to Follow-up|10|||
146786146|NCT05273749|529388407|FG000|Overall Study|Pregnancy|1|||
146786147|NCT05273749|529388408|FG001|Overall Study|Pregnancy|0|||
146786148|NCT05273749|529388407|FG000|Overall Study|Non-Compliance|3|||
146786149|NCT05273749|529388408|FG001|Overall Study|Non-Compliance|2|||
146786150|NCT05273749|529388407|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
146786151|NCT05273749|529388408|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
146786152|NCT04806594|529388415|FG000|Overall Study|Withdrawal by Subject|2|||
146786153|NCT04806594|529388415|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
146786154|NCT02543281|529388418|FG000|Overall Study|Lost to Follow-up|0|||
146786155|NCT02543281|529388419|FG001|Overall Study|Lost to Follow-up|0|||
146786156|NCT02543281|529388420|FG002|Overall Study|Lost to Follow-up|1|||
146786157|NCT04318548|529388421|FG000|Overall Study|Adverse Event|0|||
146786158|NCT04318548|529388422|FG001|Overall Study|Adverse Event|0|||
146786159|NCT04318548|529388423|FG002|Overall Study|Adverse Event|1|||
146786160|NCT04318548|529388421|FG000|Overall Study|Lost to Follow-up|6|||
146786161|NCT04318548|529388422|FG001|Overall Study|Lost to Follow-up|13|||
146786162|NCT04318548|529388423|FG002|Overall Study|Lost to Follow-up|9|||
146786163|NCT04318548|529388421|FG000|Overall Study|Protocol Violation|1|||
146786164|NCT04318548|529388422|FG001|Overall Study|Protocol Violation|0|||
146786165|NCT04318548|529388423|FG002|Overall Study|Protocol Violation|2|||
146786166|NCT04318548|529388421|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
146786167|NCT04318548|529388422|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
146786168|NCT04318548|529388423|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
146786169|NCT04318548|529388421|FG000|Overall Study|Migrated / moved from the study area|0|||
146786170|NCT04318548|529388422|FG001|Overall Study|Migrated / moved from the study area|0|||
146786171|NCT04318548|529388423|FG002|Overall Study|Migrated / moved from the study area|1|||
146786172|NCT04318548|529388421|FG000|Overall Study|Other|1|||
146786173|NCT04318548|529388422|FG001|Overall Study|Other|2|||
146786174|NCT04318548|529388423|FG002|Overall Study|Other|3|||
146786175|NCT05247489|529388424|FG000|Overall Study|Lost to Follow-up|5|||
146786176|NCT05247489|529388425|FG001|Overall Study|Lost to Follow-up|1|||
146786177|NCT05247489|529388424|FG000|Overall Study|Withdrawal by Subject|6|||
146786178|NCT05247489|529388425|FG001|Overall Study|Withdrawal by Subject|7|||
146786179|NCT05247489|529388424|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
146786180|NCT05247489|529388425|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
146786181|NCT05247489|529388424|FG000|Overall Study|Left Country|1|||
146786182|NCT05247489|529388425|FG001|Overall Study|Left Country|0|||
146786183|NCT05247489|529388424|FG000|Overall Study|Noncompliance with Investigational Product|1|||
146786184|NCT05247489|529388425|FG001|Overall Study|Noncompliance with Investigational Product|0|||
146786185|NCT05247489|529388424|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
146786186|NCT05247489|529388425|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
146786187|NCT05215314|529388432|FG000|Overall Study|Lost to Follow-up|2|||
146786188|NCT05215314|529388433|FG001|Overall Study|Lost to Follow-up|2|||
146786189|NCT05215314|529388432|FG000|Overall Study|Withdrawal by Subject|2|||
146786190|NCT05215314|529388433|FG001|Overall Study|Withdrawal by Subject|0|||
146786191|NCT05215314|529388432|FG000|Overall Study|Physician Decision|1|||
146786192|NCT05215314|529388433|FG001|Overall Study|Physician Decision|0|||
146786193|NCT04179500|529388434|FG000|Treatment|Withdrawal by Subject|1|||
146786194|NCT04179500|529388434|FG000|Treatment|Adverse Event|2|||
146786195|NCT04179500|529388434|FG000|Treatment|pyrazinamide resistance|1|||
146786196|NCT03457142|529388435|FG000|Overall Study|Death|1|||
146786197|NCT01413100|529388436|FG000|Overall Study|Withdrawal by Subject|1|||
146786198|NCT04896476|529388446|FG000|Overall Study|Withdrawal by Subject|1|||
146786199|NCT04896476|529388446|FG000|Overall Study|Lost to Follow-up|2|||
146786200|NCT03476187|529388447|FG000|Overall Study|Protocol Violation|7|||
146786201|NCT03476187|529388447|FG000|Overall Study|Physician Decision|5|||
146786202|NCT05948670|529388449|FG000|Overall Study|Protocol Violation|6|||
146786203|NCT05948670|529388450|FG001|Overall Study|Protocol Violation|8|||
146786204|NCT05948670|529388449|FG000|Overall Study|Withdrawal by Subject|0|||
146786205|NCT05948670|529388450|FG001|Overall Study|Withdrawal by Subject|1|||
146786206|NCT02677298|529388464|FG000|Double Blind Phase|Adverse Event|2|||
146786207|NCT02677298|529388465|FG001|Double Blind Phase|Adverse Event|1|||
146786208|NCT02677298|529388466|FG002|Double Blind Phase|Adverse Event|0|||
146786209|NCT02677298|529388464|FG000|Double Blind Phase|Physician Decision|5|||
146786210|NCT02677298|529388465|FG001|Double Blind Phase|Physician Decision|0|||
146786211|NCT02677298|529388466|FG002|Double Blind Phase|Physician Decision|0|||
146786212|NCT02677298|529388464|FG000|Double Blind Phase|Lost to Follow-up|11|||
146786213|NCT02677298|529388465|FG001|Double Blind Phase|Lost to Follow-up|7|||
146786214|NCT02677298|529388466|FG002|Double Blind Phase|Lost to Follow-up|0|||
146786215|NCT02677298|529388464|FG000|Double Blind Phase|Withdrawal by Subject|11|||
146786216|NCT02677298|529388465|FG001|Double Blind Phase|Withdrawal by Subject|8|||
146786217|NCT02677298|529388466|FG002|Double Blind Phase|Withdrawal by Subject|0|||
146786218|NCT02677298|529388464|FG000|Double Blind Phase|No study drug available at site|0|||
146786219|NCT02677298|529388465|FG001|Double Blind Phase|No study drug available at site|1|||
146786220|NCT02677298|529388466|FG002|Double Blind Phase|No study drug available at site|0|||
146786221|NCT02677298|529388464|FG000|Open Label Phase|Adverse Event|0|||
146786222|NCT02677298|529388465|FG001|Open Label Phase|Adverse Event|0|||
146786223|NCT02677298|529388466|FG002|Open Label Phase|Adverse Event|4|||
146786224|NCT02677298|529388464|FG000|Open Label Phase|Physician Decision|0|||
146786225|NCT02677298|529388465|FG001|Open Label Phase|Physician Decision|0|||
146786226|NCT02677298|529388466|FG002|Open Label Phase|Physician Decision|1|||
146786227|NCT02677298|529388464|FG000|Open Label Phase|Lost to Follow-up|0|||
146786228|NCT02677298|529388465|FG001|Open Label Phase|Lost to Follow-up|0|||
146786229|NCT02677298|529388466|FG002|Open Label Phase|Lost to Follow-up|17|||
146786230|NCT02677298|529388464|FG000|Open Label Phase|Withdrawal by Subject|0|||
146786231|NCT02677298|529388465|FG001|Open Label Phase|Withdrawal by Subject|0|||
146786232|NCT02677298|529388466|FG002|Open Label Phase|Withdrawal by Subject|38|||
146786233|NCT04526704|529388474|FG000|Overall Study|Adverse Event|1|||
146786234|NCT04526704|529388475|FG001|Overall Study|Adverse Event|0|||
146786235|NCT04526704|529388474|FG000|Overall Study|Physician Decision|1|||
146786236|NCT04526704|529388475|FG001|Overall Study|Physician Decision|0|||
146786237|NCT04526704|529388474|FG000|Overall Study|Withdrawal by Subject|2|||
146786238|NCT04526704|529388475|FG001|Overall Study|Withdrawal by Subject|0|||
146786239|NCT00881621|529388476|FG000|Overall Study|Physician Decision|34|||
146786240|NCT05116787|529388477|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
146786241|NCT05116787|529388478|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
146786242|NCT05116787|529388477|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
146786243|NCT05116787|529388478|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
146786244|NCT05116787|529388477|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
146786245|NCT05116787|529388478|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
146786246|NCT05116787|529388477|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
146786247|NCT05116787|529388478|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
146786248|NCT02737436|529388479|FG000|Washout Period|Lost to Follow-up|5|||
146786249|NCT02737436|529388480|FG001|Washout Period|Lost to Follow-up|11|||
146786250|NCT02737436|529388479|FG000|Data Analysis|Scanning data problems|5|||
146786251|NCT02737436|529388480|FG001|Data Analysis|Scanning data problems|8|||
146786252|NCT05179837|529388482|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
146786253|NCT05179837|529388482|FG000|Overall Study|Device malfunctioned|1|||
146786254|NCT05179837|529388482|FG000|Overall Study|Image quality too low|2|||
146786255|NCT03158129|529388483|FG000|Overall Study|Adverse Event|0|||
146786256|NCT03158129|529388484|FG001|Overall Study|Adverse Event|1|||
146786257|NCT03158129|529388485|FG002|Overall Study|Adverse Event|0|||
146786258|NCT03158129|529388486|FG003|Overall Study|Adverse Event|0|||
146786259|NCT03158129|529388483|FG000|Overall Study|Death|0|||
146786260|NCT03158129|529388484|FG001|Overall Study|Death|0|||
146786261|NCT03158129|529388485|FG002|Overall Study|Death|0|||
146935817|NCT00426556|529922553|FG002|Phase I - Extension Phase|Adverse Event|1|||
146935818|NCT00426556|529922554|FG003|Phase I - Extension Phase|Adverse Event|0|||
146786262|NCT03158129|529388486|FG003|Overall Study|Death|1|||
146786263|NCT03158129|529388483|FG000|Overall Study|High surgical risk|1|||
146786264|NCT03158129|529388484|FG001|Overall Study|High surgical risk|1|||
146786265|NCT03158129|529388485|FG002|Overall Study|High surgical risk|0|||
146786266|NCT03158129|529388486|FG003|Overall Study|High surgical risk|0|||
146786267|NCT03158129|529388483|FG000|Overall Study|Progression|1|||
146935819|NCT00426556|529922551|FG000|Phase I - Extension Phase|Disease Progression|5|||
146786268|NCT03158129|529388484|FG001|Overall Study|Progression|1|||
146786269|NCT03158129|529388485|FG002|Overall Study|Progression|0|||
146786270|NCT03158129|529388486|FG003|Overall Study|Progression|0|||
146786271|NCT03158129|529388483|FG000|Overall Study|Lack of resectability|0|||
146786272|NCT03158129|529388484|FG001|Overall Study|Lack of resectability|1|||
146786273|NCT03158129|529388485|FG002|Overall Study|Lack of resectability|0|||
146786274|NCT03158129|529388486|FG003|Overall Study|Lack of resectability|0|||
146786275|NCT03158129|529388483|FG000|Overall Study|Declined surgery|0|||
146786276|NCT03158129|529388484|FG001|Overall Study|Declined surgery|1|||
146935820|NCT00426556|529922552|FG001|Phase I - Extension Phase|Disease Progression|5|||
146786277|NCT03158129|529388485|FG002|Overall Study|Declined surgery|0|||
146786278|NCT03158129|529388486|FG003|Overall Study|Declined surgery|0|||
146786279|NCT03158129|529388483|FG000|Overall Study|No longer surgical candidate|0|||
146786280|NCT03158129|529388484|FG001|Overall Study|No longer surgical candidate|0|||
146786281|NCT03158129|529388485|FG002|Overall Study|No longer surgical candidate|0|||
146786282|NCT03158129|529388486|FG003|Overall Study|No longer surgical candidate|1|||
146786283|NCT03719443|529388487|FG000|Overall Study|Lost to Follow-up|0|||
146786284|NCT03719443|529388488|FG001|Overall Study|Lost to Follow-up|0|||
146786285|NCT03719443|529388489|FG002|Overall Study|Lost to Follow-up|1|||
146786286|NCT03719443|529388490|FG003|Overall Study|Lost to Follow-up|0|||
146786287|NCT03719443|529388491|FG004|Overall Study|Lost to Follow-up|1|||
146786288|NCT03719443|529388492|FG005|Overall Study|Lost to Follow-up|0|||
146786289|NCT03719443|529388493|FG006|Overall Study|Lost to Follow-up|1|||
146786290|NCT03719443|529388487|FG000|Overall Study|Withdrawal by Subject|0|||
146786291|NCT03719443|529388488|FG001|Overall Study|Withdrawal by Subject|0|||
146786292|NCT03719443|529388489|FG002|Overall Study|Withdrawal by Subject|1|||
146786293|NCT03719443|529388490|FG003|Overall Study|Withdrawal by Subject|0|||
146786294|NCT03719443|529388491|FG004|Overall Study|Withdrawal by Subject|0|||
146786295|NCT03719443|529388492|FG005|Overall Study|Withdrawal by Subject|0|||
146786296|NCT03719443|529388493|FG006|Overall Study|Withdrawal by Subject|0|||
146786297|NCT05051124|529388494|FG000|Overall Study|Lost to Follow-up|2|||
146786298|NCT05051124|529388494|FG000|Overall Study|Withdrawal by Subject|1|||
146786299|NCT05051124|529388494|FG000|Overall Study|Residential relocation|2|||
146786300|NCT05051124|529388494|FG000|Overall Study|Death|1|||
146786301|NCT04782973|529388495|FG000|Overall Study|Withdrawal by Subject|5|||
146786302|NCT04782973|529388495|FG000|Overall Study|Protocol Violation|6|||
146786303|NCT04782973|529388495|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
146786304|NCT00554788|529388496|FG000|Overall Study|Adverse Event|0|||
146786305|NCT00554788|529388497|FG001|Overall Study|Adverse Event|1|||
146786306|NCT00554788|529388498|FG002|Overall Study|Adverse Event|2|||
146786307|NCT00554788|529388496|FG000|Overall Study|Lost to Follow-up|4|||
146786308|NCT00554788|529388497|FG001|Overall Study|Lost to Follow-up|3|||
146786309|NCT00554788|529388498|FG002|Overall Study|Lost to Follow-up|3|||
146786310|NCT00554788|529388496|FG000|Overall Study|Physician Decision|1|||
146786311|NCT00554788|529388497|FG001|Overall Study|Physician Decision|1|||
146786312|NCT00554788|529388498|FG002|Overall Study|Physician Decision|3|||
146786313|NCT00554788|529388496|FG000|Overall Study|Withdrawal by Subject|0|||
146786314|NCT00554788|529388497|FG001|Overall Study|Withdrawal by Subject|0|||
146786315|NCT00554788|529388498|FG002|Overall Study|Withdrawal by Subject|1|||
146786316|NCT00554788|529388496|FG000|Overall Study|Refusal of further protocol therapy|0|||
146786317|NCT00554788|529388497|FG001|Overall Study|Refusal of further protocol therapy|1|||
146786318|NCT00554788|529388498|FG002|Overall Study|Refusal of further protocol therapy|1|||
146786319|NCT00554788|529388496|FG000|Overall Study|Progressive disease|0|||
146786320|NCT00554788|529388497|FG001|Overall Study|Progressive disease|0|||
146786321|NCT00554788|529388498|FG002|Overall Study|Progressive disease|3|||
146786322|NCT00554788|529388496|FG000|Overall Study|Ineligible|2|||
146786323|NCT00554788|529388497|FG001|Overall Study|Ineligible|0|||
146786324|NCT00554788|529388498|FG002|Overall Study|Ineligible|1|||
146786325|NCT02577835|529388500|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
146786326|NCT04749615|529388501|FG000|Overall Study|Lost to Follow-up|6|||
146786327|NCT04749615|529388502|FG001|Overall Study|Lost to Follow-up|10|||
146786328|NCT05292365|529388516|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
146786329|NCT05292365|529388517|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
146786330|NCT05292365|529388518|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
146786331|NCT05292365|529388519|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
146786332|NCT03364647|529388520|FG000|Overall Study|Withdrawal by Subject|3|||
146786333|NCT03364647|529388521|FG001|Overall Study|Withdrawal by Subject|1|||
146786334|NCT05746455|529388524|FG000|Overall Study|Discharged from Clinical Service|1|||
146786335|NCT05746455|529388524|FG000|Overall Study|Lost to Follow-up|1|||
146786336|NCT03896789|529388525|FG000|Baseline|Lost to Follow-up|1|||
146786337|NCT03896789|529388526|FG001|Baseline|Lost to Follow-up|2|||
146786338|NCT03896789|529388525|FG000|Baseline|Death|3|||
146786339|NCT03896789|529388526|FG001|Baseline|Death|6|||
146786340|NCT03896789|529388525|FG000|Post-Randomization|Lost to Follow-up|12|||
146786341|NCT03896789|529388526|FG001|Post-Randomization|Lost to Follow-up|11|||
146786342|NCT03896789|529388525|FG000|Post-Randomization|Death|12|||
146786343|NCT03896789|529388526|FG001|Post-Randomization|Death|13|||
146786344|NCT03447470|529388530|FG000|Overall Study|Death|0|||
146786345|NCT03447470|529388531|FG001|Overall Study|Death|1|||
146786346|NCT03447470|529388532|FG002|Overall Study|Death|3|||
146786347|NCT03447470|529388533|FG003|Overall Study|Death|0|||
146786348|NCT03447470|529388534|FG004|Overall Study|Death|1|||
146786349|NCT03447470|529388535|FG005|Overall Study|Death|0|||
146786350|NCT03447470|529388536|FG006|Overall Study|Death|3|||
146786351|NCT03447470|529388537|FG007|Overall Study|Death|3|||
146786352|NCT03447470|529388538|FG008|Overall Study|Death|1|||
146786353|NCT03447470|529388530|FG000|Overall Study|Withdrawal by Subject|1|||
146786354|NCT03447470|529388531|FG001|Overall Study|Withdrawal by Subject|0|||
146786355|NCT03447470|529388532|FG002|Overall Study|Withdrawal by Subject|0|||
146786356|NCT03447470|529388533|FG003|Overall Study|Withdrawal by Subject|0|||
146786357|NCT03447470|529388534|FG004|Overall Study|Withdrawal by Subject|1|||
146786358|NCT03447470|529388535|FG005|Overall Study|Withdrawal by Subject|0|||
146786359|NCT03447470|529388536|FG006|Overall Study|Withdrawal by Subject|1|||
146786360|NCT03447470|529388537|FG007|Overall Study|Withdrawal by Subject|1|||
146786361|NCT03447470|529388538|FG008|Overall Study|Withdrawal by Subject|3|||
146786362|NCT03447470|529388530|FG000|Overall Study|Treatment discontinued|3|||
146786363|NCT03447470|529388531|FG001|Overall Study|Treatment discontinued|2|||
146786364|NCT03447470|529388532|FG002|Overall Study|Treatment discontinued|4|||
146786365|NCT03447470|529388533|FG003|Overall Study|Treatment discontinued|6|||
146786366|NCT03447470|529388534|FG004|Overall Study|Treatment discontinued|2|||
146786367|NCT03447470|529388535|FG005|Overall Study|Treatment discontinued|1|||
146786368|NCT03447470|529388536|FG006|Overall Study|Treatment discontinued|2|||
146786369|NCT03447470|529388537|FG007|Overall Study|Treatment discontinued|4|||
146786370|NCT03447470|529388538|FG008|Overall Study|Treatment discontinued|3|||
146786371|NCT04295798|529388540|FG000|Overall Study|Lost to Follow-up|1|||
146786372|NCT04624633|529388546|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
146786373|NCT04624633|529388547|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
146786374|NCT04624633|529388546|FG000|Overall Study|Death|1|||
146786375|NCT04624633|529388547|FG001|Overall Study|Death|0|||
146786376|NCT01902173|529388548|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
146786377|NCT01902173|529388549|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
146786378|NCT01902173|529388550|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
146786379|NCT01902173|529388551|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
146786380|NCT01902173|529388552|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
146786381|NCT01902173|529388553|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
146786382|NCT01902173|529388548|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
146786383|NCT01902173|529388549|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
146786384|NCT01902173|529388550|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
146786385|NCT01902173|529388551|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
146786386|NCT01902173|529388552|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
146786387|NCT01902173|529388553|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
146786388|NCT01902173|529388548|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
146786389|NCT01902173|529388549|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
146786390|NCT01902173|529388550|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
146786391|NCT01902173|529388551|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
146786392|NCT01902173|529388552|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
146786393|NCT01902173|529388553|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
146786394|NCT01902173|529388548|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
146786395|NCT01902173|529388549|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
146786396|NCT01902173|529388550|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
146786397|NCT01902173|529388551|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
146786398|NCT01902173|529388552|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
146786399|NCT01902173|529388553|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
146786400|NCT01902173|529388548|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
146786401|NCT01902173|529388549|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
146786402|NCT01902173|529388550|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
146786403|NCT01902173|529388551|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
146786404|NCT01902173|529388552|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
146786405|NCT01902173|529388553|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
146786406|NCT01902173|529388548|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
146786407|NCT01902173|529388549|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
146786408|NCT01902173|529388550|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
146786409|NCT01902173|529388551|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
146786410|NCT01902173|529388552|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
146786411|NCT01902173|529388553|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
146786412|NCT01902173|529388548|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
146786413|NCT01902173|529388549|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
146786414|NCT01902173|529388550|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
146935821|NCT00426556|529922553|FG002|Phase I - Extension Phase|Disease Progression|6|||
146786415|NCT01902173|529388551|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
146786416|NCT01902173|529388552|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
146786417|NCT01902173|529388553|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
146935822|NCT00426556|529922554|FG003|Phase I - Extension Phase|Disease Progression|0|||
146786418|NCT01902173|529388548|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
146786419|NCT01902173|529388549|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
146786420|NCT01902173|529388550|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
146935823|NCT00426556|529922551|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
146935824|NCT00426556|529922552|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
146935825|NCT00426556|529922553|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
146935826|NCT00426556|529922554|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
146935827|NCT00426556|529922551|FG000|Phase II - Core Phase|Disease Progression|0|||
146935828|NCT00426556|529922552|FG001|Phase II - Core Phase|Disease Progression|0|||
146935829|NCT00426556|529922553|FG002|Phase II - Core Phase|Disease Progression|0|||
146935830|NCT00426556|529922554|FG003|Phase II - Core Phase|Disease Progression|16|||
146935831|NCT00426556|529922551|FG000|Phase II - Core Phase|Adverse Event|0|||
146935832|NCT00426556|529922552|FG001|Phase II - Core Phase|Adverse Event|0|||
146935833|NCT00426556|529922553|FG002|Phase II - Core Phase|Adverse Event|0|||
146935834|NCT00426556|529922554|FG003|Phase II - Core Phase|Adverse Event|8|||
146729131|NCT00636610|529177188|FG001|Overall Study|Disease progression - radiographic|51|||
146729132|NCT00636610|529177187|FG000|Overall Study|Disease progression - clinical|8|||
146786421|NCT01902173|529388551|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
146786422|NCT01902173|529388552|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
146786423|NCT01902173|529388553|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
146786424|NCT01902173|529388548|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
146786425|NCT01902173|529388549|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
146786426|NCT01902173|529388550|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
146786427|NCT01902173|529388551|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
146786428|NCT01902173|529388552|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
146786429|NCT01902173|529388553|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
146786430|NCT01902173|529388548|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
146786431|NCT01902173|529388549|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
146786432|NCT01902173|529388550|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
146786433|NCT01902173|529388551|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
146786434|NCT01902173|529388552|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
146786435|NCT01902173|529388553|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
146935835|NCT00426556|529922551|FG000|Phase II - Extension Phase|Disease Progression|0|||
146935836|NCT00426556|529922552|FG001|Phase II - Extension Phase|Disease Progression|0|||
146935837|NCT00426556|529922553|FG002|Phase II - Extension Phase|Disease Progression|0|||
146729133|NCT00636610|529177188|FG001|Overall Study|Disease progression - clinical|3|||
146729134|NCT00636610|529177187|FG000|Overall Study|Reason for discontinuation not available|3|||
146729135|NCT00636610|529177188|FG001|Overall Study|Reason for discontinuation not available|2|||
146729136|NCT00313820|529177189|FG000|Assigned to Treatment|Other|1|||
146729137|NCT00313820|529177190|FG001|Assigned to Treatment|Other|0|||
146729138|NCT00313820|529177189|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
146729139|NCT00313820|529177190|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
146729140|NCT00313820|529177189|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
146729141|NCT00313820|529177190|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
146729142|NCT00313820|529177189|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
146729143|NCT00313820|529177190|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
146729144|NCT00313820|529177189|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
146729145|NCT00313820|529177190|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
146729146|NCT00313820|529177189|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
146729147|NCT00313820|529177190|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
146729148|NCT00553696|529177195|FG000|Overall Study|Adverse Event|2|||
146729149|NCT00553696|529177196|FG001|Overall Study|Adverse Event|4|||
146729150|NCT00553696|529177197|FG002|Overall Study|Adverse Event|0|||
146729151|NCT00553696|529177198|FG003|Overall Study|Adverse Event|1|||
146729152|NCT00553696|529177195|FG000|Overall Study|Global deterioration of health status|0|||
146729153|NCT00553696|529177196|FG001|Overall Study|Global deterioration of health status|2|||
146729154|NCT00553696|529177197|FG002|Overall Study|Global deterioration of health status|0|||
146729155|NCT00553696|529177198|FG003|Overall Study|Global deterioration of health status|0|||
146729156|NCT00553696|529177195|FG000|Overall Study|Objective progression or relapse|2|||
146729157|NCT00553696|529177196|FG001|Overall Study|Objective progression or relapse|9|||
146729158|NCT00553696|529177197|FG002|Overall Study|Objective progression or relapse|6|||
146729159|NCT00553696|529177198|FG003|Overall Study|Objective progression or relapse|0|||
146729160|NCT00553696|529177195|FG000|Overall Study|Withdrawal by Subject|0|||
146729161|NCT00553696|529177196|FG001|Overall Study|Withdrawal by Subject|1|||
146729162|NCT00553696|529177197|FG002|Overall Study|Withdrawal by Subject|0|||
146729163|NCT00553696|529177198|FG003|Overall Study|Withdrawal by Subject|0|||
146729164|NCT00686881|529177199|FG000|Overall Study|Withdrawal by Subject|11|||
146729165|NCT00686881|529177200|FG001|Overall Study|Withdrawal by Subject|18|||
146729166|NCT00686881|529177199|FG000|Overall Study|Lost to Follow-up|0|||
146729167|NCT00686881|529177200|FG001|Overall Study|Lost to Follow-up|1|||
146786436|NCT01902173|529388548|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
146729168|NCT00686881|529177199|FG000|Overall Study|Treatment-related adverse event|10|||
146729169|NCT00686881|529177200|FG001|Overall Study|Treatment-related adverse event|9|||
146729170|NCT00686881|529177199|FG000|Overall Study|Met discontinuation criteria|5|||
146786437|NCT01902173|529388549|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
146786438|NCT01902173|529388550|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
146786439|NCT01902173|529388551|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
146786440|NCT01902173|529388552|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
146786441|NCT01902173|529388553|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
146786442|NCT01902173|529388548|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
146786443|NCT01902173|529388549|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
146786444|NCT01902173|529388550|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
146786445|NCT01902173|529388551|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
146786446|NCT01902173|529388552|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
146786447|NCT01902173|529388553|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
146786448|NCT01902173|529388548|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
146786449|NCT01902173|529388549|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
146786450|NCT01902173|529388550|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
146935838|NCT00426556|529922554|FG003|Phase II - Extension Phase|Disease Progression|21|||
146935839|NCT00426556|529922551|FG000|Phase II - Extension Phase|Adverse Event|0|||
146935840|NCT00426556|529922552|FG001|Phase II - Extension Phase|Adverse Event|0|||
146935841|NCT00426556|529922553|FG002|Phase II - Extension Phase|Adverse Event|0|||
146935842|NCT00426556|529922554|FG003|Phase II - Extension Phase|Adverse Event|2|||
146935843|NCT03970824|529922556|FG000|Overall Study|Withdrawal by Subject|1|||
146935844|NCT03970824|529922557|FG001|Overall Study|Withdrawal by Subject|1|||
146935845|NCT03970824|529922558|FG002|Overall Study|Withdrawal by Subject|3|||
146935846|NCT03970824|529922556|FG000|Overall Study|Lost to Follow-up|0|||
146935847|NCT03970824|529922557|FG001|Overall Study|Lost to Follow-up|2|||
146935848|NCT03970824|529922558|FG002|Overall Study|Lost to Follow-up|1|||
146935849|NCT03970824|529922556|FG000|Overall Study|Adverse Event|1|||
146935850|NCT03970824|529922557|FG001|Overall Study|Adverse Event|0|||
146935851|NCT03970824|529922558|FG002|Overall Study|Adverse Event|0|||
146935852|NCT00105560|529922561|FG000|Overall Study|Lost to Follow-up|1|||
146935853|NCT01315847|529922564|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
146935854|NCT01315847|529922565|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
146935855|NCT01315847|529922564|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
146935856|NCT01315847|529922565|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
146935857|NCT03699631|529922568|FG000|Overall Study|Adverse Event|3|||
146935858|NCT03695393|529922575|FG000|Overall Study|Death|3|||
146935859|NCT03695393|529922576|FG001|Overall Study|Death|1|||
146935860|NCT03695393|529922575|FG000|Overall Study|Lost to Follow-up|0|||
146935861|NCT03695393|529922576|FG001|Overall Study|Lost to Follow-up|1|||
146935862|NCT04169061|529922577|FG000|Overall Study|Adverse Event|2|||
146935863|NCT04169061|529922577|FG000|Overall Study|Death|1|||
146935864|NCT04169061|529922577|FG000|Overall Study|Withdrawal by Subject|1|||
146935865|NCT04169061|529922577|FG000|Overall Study|Protocol Violation|1|||
146786451|NCT01902173|529388551|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
146786452|NCT01902173|529388552|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
146786453|NCT01902173|529388553|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
146786454|NCT01902173|529388548|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
146786455|NCT01902173|529388549|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
146786456|NCT01902173|529388550|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
146786457|NCT01902173|529388551|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
146786458|NCT01902173|529388552|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
146786459|NCT01902173|529388553|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
146786460|NCT04625283|529388555|FG000|Overall Study|post randomization exclusion|28|||
146786461|NCT04625283|529388556|FG001|Overall Study|post randomization exclusion|20|||
146786462|NCT03382652|529388557|FG000|Overall Study|Lost to Follow-up|6|||
146786463|NCT03382652|529388557|FG000|Overall Study|Death|4|||
146786464|NCT03382652|529388557|FG000|Overall Study|Revision|5|||
146786465|NCT03382652|529388557|FG000|Overall Study|Patient withdrew|3|||
146786466|NCT03382652|529388557|FG000|Overall Study|Other reasons|21|||
146786467|NCT05783102|529388558|FG000|Overall Study|Lost to Follow-up|1|||
146786468|NCT05783102|529388558|FG000|Overall Study|Withdrawal by Subject|2|||
146786469|NCT04505904|529388559|FG000|Overall Study|Withdrawal by Subject|1|||
146935866|NCT04585451|529922578|FG000|Overall Study|Withdrawal by Subject|26|||
146935867|NCT04585451|529922579|FG001|Overall Study|Withdrawal by Subject|0|||
146935868|NCT00673894|529922580|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
146786470|NCT04505904|529388560|FG001|Overall Study|Withdrawal by Subject|2|||
146786471|NCT04505904|529388561|FG002|Overall Study|Withdrawal by Subject|0|||
146786472|NCT04505904|529388562|FG003|Overall Study|Withdrawal by Subject|0|||
146786473|NCT04505904|529388559|FG000|Overall Study|Physician Decision|1|||
146786474|NCT04505904|529388560|FG001|Overall Study|Physician Decision|0|||
146786475|NCT04505904|529388561|FG002|Overall Study|Physician Decision|0|||
146935869|NCT00673894|529922581|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
146935870|NCT00673894|529922580|FG000|First Intervention 4 Weeks|Adverse Event|1|||
146935871|NCT00673894|529922581|FG001|First Intervention 4 Weeks|Adverse Event|0|||
146935872|NCT00493974|529922582|FG000|Overall Study|Death|1|||
146935873|NCT00493974|529922583|FG001|Overall Study|Death|2|||
146935874|NCT00493974|529922582|FG000|Overall Study|Withdrawal by Subject|8|||
146935875|NCT00493974|529922583|FG001|Overall Study|Withdrawal by Subject|6|||
146935876|NCT00493974|529922582|FG000|Overall Study|Lost to Follow-up|4|||
146935877|NCT00493974|529922583|FG001|Overall Study|Lost to Follow-up|6|||
146935878|NCT02807363|529922584|FG000|Dosing Period|Adverse Event|0|||
146935879|NCT02807363|529922585|FG001|Dosing Period|Adverse Event|1|||
146935880|NCT02807363|529922586|FG002|Dosing Period|Adverse Event|0|||
146935881|NCT02807363|529922587|FG003|Dosing Period|Adverse Event|0|||
146935882|NCT02188719|529922588|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
146935883|NCT02188719|529922589|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
146935884|NCT02188719|529922590|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
146935885|NCT02188719|529922591|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
146935886|NCT00966693|529922592|FG000|Overall Study|Adverse Event|0|||
146935887|NCT00966693|529922593|FG001|Overall Study|Adverse Event|0|||
146935888|NCT00966693|529922594|FG002|Overall Study|Adverse Event|1|||
146729171|NCT00686881|529177200|FG001|Overall Study|Met discontinuation criteria|0|||
146729172|NCT00686881|529177199|FG000|Overall Study|Onset of malignant tumor|11|||
146729173|NCT00686881|529177200|FG001|Overall Study|Onset of malignant tumor|11|||
146729174|NCT00686881|529177199|FG000|Overall Study|Lack of Efficacy|4|||
146729175|NCT00686881|529177200|FG001|Overall Study|Lack of Efficacy|3|||
146729176|NCT00686881|529177199|FG000|Overall Study|Physician Decision|1|||
146935889|NCT00966693|529922595|FG003|Overall Study|Adverse Event|2|||
146935890|NCT00966693|529922592|FG000|Overall Study|Death|0|||
146935891|NCT00966693|529922593|FG001|Overall Study|Death|0|||
146935892|NCT00966693|529922594|FG002|Overall Study|Death|1|||
146981629|NCT01621490|530096092|FG005|Overall Study|Adverse event unrelated to study drug|0|||
146981630|NCT01621490|530096093|FG006|Overall Study|Adverse event unrelated to study drug|0|||
146729177|NCT00686881|529177200|FG001|Overall Study|Physician Decision|0|||
146935893|NCT00966693|529922595|FG003|Overall Study|Death|0|||
146935894|NCT00966693|529922592|FG000|Overall Study|Withdrawal by Subject|1|||
146729178|NCT00686881|529177199|FG000|Overall Study|Circumstances of site|1|||
146729179|NCT00686881|529177200|FG001|Overall Study|Circumstances of site|1|||
146729180|NCT00686881|529177199|FG000|Overall Study|Did not meet protocol eligibility|1|||
146729181|NCT00686881|529177200|FG001|Overall Study|Did not meet protocol eligibility|0|||
146729182|NCT00686881|529177199|FG000|Overall Study|Irregular visits|1|||
146729183|NCT00686881|529177200|FG001|Overall Study|Irregular visits|0|||
146729184|NCT00686881|529177199|FG000|Overall Study|Study discontinuation|35|||
146729185|NCT00686881|529177200|FG001|Overall Study|Study discontinuation|32|||
146729186|NCT00686881|529177199|FG000|Overall Study|Never received study drug|2|||
146729187|NCT00686881|529177200|FG001|Overall Study|Never received study drug|6|||
146729188|NCT02085252|529177201|FG000|Overall Study|Withdrawal of Consent|1|||
146729189|NCT02085252|529177202|FG001|Overall Study|Withdrawal of Consent|0|||
146729190|NCT02085252|529177201|FG000|Overall Study|Adverse Event|0|||
146729191|NCT02085252|529177202|FG001|Overall Study|Adverse Event|1|||
146729192|NCT02085252|529177201|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
146729193|NCT02085252|529177202|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
146729194|NCT02085252|529177201|FG000|Overall Study|Reason Not Specified|0|||
146729195|NCT02085252|529177202|FG001|Overall Study|Reason Not Specified|1|||
146729196|NCT02085252|529177201|FG000|Overall Study|Reason Unknown|0|||
146729197|NCT02085252|529177202|FG001|Overall Study|Reason Unknown|1|||
146729198|NCT01298999|529177204|FG000|Overall Study|Physician Decision|0|||
146729199|NCT01298999|529177205|FG001|Overall Study|Physician Decision|1|||
146729200|NCT01298999|529177204|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
146729201|NCT01298999|529177205|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
146729202|NCT02151266|529177206|FG000|Overall Study|Lost to Follow-up|1|||
146729203|NCT02151266|529177207|FG001|Overall Study|Lost to Follow-up|4|||
146729204|NCT02151266|529177208|FG002|Overall Study|Lost to Follow-up|1|||
146729205|NCT02151266|529177206|FG000|Overall Study|Did NOT receive intervention|3|||
146729206|NCT02151266|529177207|FG001|Overall Study|Did NOT receive intervention|6|||
146729207|NCT02151266|529177208|FG002|Overall Study|Did NOT receive intervention|2|||
146729208|NCT02151266|529177206|FG000|Overall Study|Not able to exercise|4|||
146729209|NCT02151266|529177207|FG001|Overall Study|Not able to exercise|5|||
146729210|NCT02151266|529177208|FG002|Overall Study|Not able to exercise|4|||
146729211|NCT04839965|529177210|FG000|Overall Study|Death|6|||
146729212|NCT04839965|529177211|FG001|Overall Study|Death|6|||
146729213|NCT04839965|529177210|FG000|Overall Study|Lost to Follow-up|1|||
146729214|NCT04839965|529177211|FG001|Overall Study|Lost to Follow-up|0|||
146786476|NCT04505904|529388562|FG003|Overall Study|Physician Decision|0|||
146935895|NCT00966693|529922593|FG001|Overall Study|Withdrawal by Subject|0|||
146729215|NCT00981084|529177212|FG000|Post Intervention (Data Analysis)|poor effort|1|||
146729216|NCT00981084|529177213|FG001|Post Intervention (Data Analysis)|poor effort|1|||
146729217|NCT00981084|529177212|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
146729218|NCT00981084|529177213|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
146729219|NCT02291679|529177214|FG000|Overall Study|Adverse Event|2|||
146935896|NCT00966693|529922594|FG002|Overall Study|Withdrawal by Subject|0|||
146935897|NCT00966693|529922595|FG003|Overall Study|Withdrawal by Subject|5|||
146935898|NCT00966693|529922592|FG000|Overall Study|Disease Progression|0|||
146935899|NCT00966693|529922593|FG001|Overall Study|Disease Progression|0|||
146935900|NCT00966693|529922594|FG002|Overall Study|Disease Progression|1|||
146935901|NCT00966693|529922595|FG003|Overall Study|Disease Progression|16|||
146935902|NCT00192036|529922596|FG000|Overall Study|Protocol Violation|3|||
146935903|NCT00192036|529922596|FG000|Overall Study|Adverse Event|6|||
146935904|NCT00192036|529922596|FG000|Overall Study|Patient/Physician Perception|1|||
146935905|NCT00192036|529922596|FG000|Overall Study|Objective Tumor Progression|4|||
146935906|NCT00192036|529922596|FG000|Overall Study|Clinical Disease Progression|1|||
146935907|NCT00192036|529922596|FG000|Overall Study|Death|1|||
146935908|NCT00192036|529922596|FG000|Overall Study|Unknown or Not Specified|5|||
146935909|NCT03371732|529922597|FG000|Overall Study|Withdrawal by Subject|9|||
146935910|NCT03371732|529922598|FG001|Overall Study|Withdrawal by Subject|3|||
146935911|NCT03371732|529922597|FG000|Overall Study|Refusal to continue|3|||
146935912|NCT03371732|529922598|FG001|Overall Study|Refusal to continue|4|||
146935913|NCT02581982|529922601|FG000|Overall Study|Lack of Efficacy|12|||
146935914|NCT02581982|529922601|FG000|Overall Study|Adverse Event|3|||
146935915|NCT02581982|529922601|FG000|Overall Study|Physician Decision|1|||
146935916|NCT00405821|529922602|FG000|Overall Study|Death|5|||
146935917|NCT00405821|529922603|FG001|Overall Study|Death|7|||
146935918|NCT00405821|529922602|FG000|Overall Study|Lost to Follow-up|7|||
146935919|NCT00405821|529922603|FG001|Overall Study|Lost to Follow-up|7|||
146935920|NCT00405821|529922602|FG000|Overall Study|Protocol Violation|1|||
146935921|NCT00405821|529922603|FG001|Overall Study|Protocol Violation|0|||
146935922|NCT00405821|529922602|FG000|Overall Study|initiated ART|9|||
146935923|NCT00405821|529922603|FG001|Overall Study|initiated ART|8|||
146935924|NCT01033487|529922609|FG000|Fourth Intervention Period|Adverse Event|0|||
146935925|NCT01033487|529922610|FG001|Fourth Intervention Period|Adverse Event|0|||
146935926|NCT01033487|529922611|FG002|Fourth Intervention Period|Adverse Event|0|||
146935927|NCT01033487|529922612|FG003|Fourth Intervention Period|Adverse Event|0|||
146935928|NCT01033487|529922613|FG004|Fourth Intervention Period|Adverse Event|0|||
146935929|NCT01033487|529922614|FG005|Fourth Intervention Period|Adverse Event|0|||
146935930|NCT01033487|529922615|FG006|Fourth Intervention Period|Adverse Event|0|||
146935931|NCT01033487|529922616|FG007|Fourth Intervention Period|Adverse Event|0|||
146935932|NCT01033487|529922617|FG008|Fourth Intervention Period|Adverse Event|1|||
146935933|NCT01033487|529922618|FG009|Fourth Intervention Period|Adverse Event|0|||
146935934|NCT00862654|529922619|FG000|Overall Study|Lack of Efficacy|1|||
146935935|NCT00862654|529922620|FG001|Overall Study|Lack of Efficacy|0|||
146935936|NCT00862654|529922621|FG002|Overall Study|Lack of Efficacy|1|||
146935937|NCT00862654|529922622|FG003|Overall Study|Lack of Efficacy|0|||
146935938|NCT00862654|529922619|FG000|Overall Study|Lost to Follow-up|1|||
146935939|NCT00862654|529922620|FG001|Overall Study|Lost to Follow-up|2|||
146935940|NCT00862654|529922621|FG002|Overall Study|Lost to Follow-up|1|||
146935941|NCT00862654|529922622|FG003|Overall Study|Lost to Follow-up|3|||
146935942|NCT00862654|529922619|FG000|Overall Study|Adverse Event|0|||
146935943|NCT00862654|529922620|FG001|Overall Study|Adverse Event|1|||
146935944|NCT00862654|529922621|FG002|Overall Study|Adverse Event|1|||
146786477|NCT04505904|529388559|FG000|Overall Study|Adverse Event|0|||
146786478|NCT04505904|529388560|FG001|Overall Study|Adverse Event|1|||
146786479|NCT04505904|529388561|FG002|Overall Study|Adverse Event|0|||
146786480|NCT04505904|529388562|FG003|Overall Study|Adverse Event|0|||
146786481|NCT05302596|529388567|FG000|Overall Study|Withdrawal by Subject|1|||
146786482|NCT05302596|529388568|FG001|Overall Study|Withdrawal by Subject|1|||
146786483|NCT01744782|529390567|FG000|Overall Study|Death|1|||
146786484|NCT01785719|529390568|FG000|4-week Baseline Evaluation|Physician Decision|1|||
146786485|NCT01785719|529390569|FG001|4-week Baseline Evaluation|Physician Decision|0|||
146786486|NCT01785719|529390568|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
146786487|NCT01785719|529390569|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
146935945|NCT00862654|529922622|FG003|Overall Study|Adverse Event|0|||
146935946|NCT00862654|529922619|FG000|Overall Study|Pregnancy|1|||
146935947|NCT00862654|529922620|FG001|Overall Study|Pregnancy|1|||
146935948|NCT00862654|529922621|FG002|Overall Study|Pregnancy|0|||
146935949|NCT00862654|529922622|FG003|Overall Study|Pregnancy|0|||
146935950|NCT00862654|529922619|FG000|Overall Study|Withdrawal by Subject|2|||
146786488|NCT01785719|529390568|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
146935951|NCT00862654|529922620|FG001|Overall Study|Withdrawal by Subject|2|||
146935952|NCT00862654|529922621|FG002|Overall Study|Withdrawal by Subject|2|||
146935953|NCT00862654|529922622|FG003|Overall Study|Withdrawal by Subject|3|||
146786489|NCT01785719|529390569|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
146935954|NCT00862654|529922619|FG000|Overall Study|Subject mistake|0|||
146935955|NCT00862654|529922620|FG001|Overall Study|Subject mistake|1|||
146935956|NCT00862654|529922621|FG002|Overall Study|Subject mistake|0|||
146935957|NCT00862654|529922622|FG003|Overall Study|Subject mistake|0|||
146935958|NCT00862654|529922619|FG000|Overall Study|Familly constraint|0|||
146935959|NCT00862654|529922620|FG001|Overall Study|Familly constraint|1|||
146935960|NCT00862654|529922621|FG002|Overall Study|Familly constraint|0|||
146935961|NCT00862654|529922622|FG003|Overall Study|Familly constraint|0|||
146935962|NCT00862654|529922619|FG000|Overall Study|Never used study drugs|1|||
146786490|NCT01785719|529390568|FG000|4-week Baseline Evaluation|Pregnancy|0|||
146786491|NCT01785719|529390569|FG001|4-week Baseline Evaluation|Pregnancy|2|||
146786492|NCT01785719|529390568|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
146786493|NCT01785719|529390569|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
146786494|NCT01785719|529390568|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
146786495|NCT01785719|529390569|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
146786496|NCT01785719|529390568|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
146786497|NCT01785719|529390569|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
146786498|NCT01785719|529390568|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
146786499|NCT01785719|529390569|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
146786500|NCT01785719|529390568|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
146786501|NCT01785719|529390569|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
146786502|NCT01785719|529390568|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
146786503|NCT01785719|529390569|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
146786504|NCT01785719|529390568|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
146786505|NCT01785719|529390569|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
146786506|NCT01785719|529390568|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
146786507|NCT01785719|529390569|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
146786508|NCT01785719|529390568|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
146786509|NCT01785719|529390569|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
146786510|NCT01785719|529390568|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
146786511|NCT01785719|529390569|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
146786512|NCT01785719|529390568|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
146786513|NCT01785719|529390569|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
146786514|NCT02921230|529390575|FG000|Overall Study|Withdrawal by Subject|20|||
146786515|NCT02921230|529390576|FG001|Overall Study|Withdrawal by Subject|8|||
146786516|NCT02921230|529390575|FG000|Overall Study|Death|12|||
146786517|NCT02921230|529390576|FG001|Overall Study|Death|3|||
146786518|NCT02921230|529390575|FG000|Overall Study|Protocol Violation|17|||
146786519|NCT02921230|529390576|FG001|Overall Study|Protocol Violation|6|||
146786520|NCT02921230|529390575|FG000|Overall Study|Early completion|5|||
146786521|NCT02921230|529390576|FG001|Overall Study|Early completion|1|||
146786522|NCT02921230|529390575|FG000|Overall Study|Pending data entry|1|||
146786523|NCT02921230|529390576|FG001|Overall Study|Pending data entry|0|||
146786524|NCT04977947|529390577|FG000|Overall Study|Lost to Follow-up|1|||
146786525|NCT04977947|529390578|FG001|Overall Study|Lost to Follow-up|1|||
146786526|NCT05875142|529390579|FG000|Overall Study|Lost to Follow-up|0|||
146786527|NCT05875142|529390580|FG001|Overall Study|Lost to Follow-up|1|||
146786528|NCT05875142|529390581|FG002|Overall Study|Lost to Follow-up|1|||
146786529|NCT03436290|529390582|FG000|Overall Study|Post-randomization Exclusion|1|||
146786530|NCT03436290|529390583|FG001|Overall Study|Post-randomization Exclusion|0|||
146786531|NCT03436290|529390582|FG000|Overall Study|Death|6|||
146786532|NCT03436290|529390583|FG001|Overall Study|Death|0|||
146786533|NCT03436290|529390582|FG000|Overall Study|Withdrawal by Subject|4|||
146786534|NCT03436290|529390583|FG001|Overall Study|Withdrawal by Subject|0|||
146786535|NCT03436290|529390582|FG000|Overall Study|Protocol Violation|30|||
146786536|NCT03436290|529390583|FG001|Overall Study|Protocol Violation|0|||
146786537|NCT03988608|529390584|FG000|Overall Study|Adverse Event|1|||
146786538|NCT03988608|529390584|FG000|Overall Study|Lost to Follow-up|1|||
146786539|NCT03988608|529390584|FG000|Overall Study|Withdrawal by Subject|3|||
146786540|NCT03988608|529390584|FG000|Overall Study|Death|1|||
146786541|NCT04142788|529390585|FG000|Overall Study|Trial terminated prematurely|2|||
146786542|NCT04142788|529390586|FG001|Overall Study|Trial terminated prematurely|2|||
146786543|NCT03338933|529390590|FG000|Screening Visit|Lost to Follow-up|1|||
146786544|NCT03338933|529390591|FG001|Screening Visit|Lost to Follow-up|3|||
146786545|NCT03338933|529390592|FG002|Screening Visit|Lost to Follow-up|1|||
146786546|NCT03338933|529390593|FG003|Screening Visit|Lost to Follow-up|4|||
146786547|NCT03338933|529390590|FG000|Screening Visit|Screen fail after consent|2|||
146935963|NCT00862654|529922620|FG001|Overall Study|Never used study drugs|0|||
146935964|NCT00862654|529922621|FG002|Overall Study|Never used study drugs|0|||
146786548|NCT03338933|529390591|FG001|Screening Visit|Screen fail after consent|7|||
146935965|NCT00862654|529922622|FG003|Overall Study|Never used study drugs|0|||
146786549|NCT03338933|529390592|FG002|Screening Visit|Screen fail after consent|1|||
146935966|NCT00862654|529922619|FG000|Overall Study|Included after end of inclusions|0|||
146786550|NCT03338933|529390593|FG003|Screening Visit|Screen fail after consent|4|||
146786551|NCT03338933|529390590|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
146786552|NCT03338933|529390591|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
146786553|NCT03338933|529390592|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
146786554|NCT03338933|529390593|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
146786555|NCT03338933|529390590|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
146935967|NCT00862654|529922620|FG001|Overall Study|Included after end of inclusions|0|||
146935968|NCT00862654|529922621|FG002|Overall Study|Included after end of inclusions|1|||
146935969|NCT00862654|529922622|FG003|Overall Study|Included after end of inclusions|0|||
146935970|NCT03954444|529922623|FG000|Overall Study|Withdrawal by Subject|5|||
146935971|NCT03954444|529922624|FG001|Overall Study|Withdrawal by Subject|5|||
146935972|NCT03954444|529922625|FG002|Overall Study|Withdrawal by Subject|5|||
146935973|NCT03954444|529922623|FG000|Overall Study|Adverse Event|1|||
146935974|NCT03954444|529922624|FG001|Overall Study|Adverse Event|3|||
146935975|NCT03954444|529922625|FG002|Overall Study|Adverse Event|2|||
146935976|NCT03954444|529922623|FG000|Overall Study|Protocol Violation|0|||
146981631|NCT01621490|530096094|FG007|Overall Study|Adverse event unrelated to study drug|2|||
146729220|NCT02291679|529177215|FG001|Overall Study|Adverse Event|12|||
146729221|NCT02291679|529177216|FG002|Overall Study|Adverse Event|19|||
146729222|NCT02291679|529177214|FG000|Overall Study|Protocol Violation|5|||
146729223|NCT02291679|529177215|FG001|Overall Study|Protocol Violation|1|||
146729224|NCT02291679|529177216|FG002|Overall Study|Protocol Violation|7|||
146729225|NCT02291679|529177214|FG000|Overall Study|Withdrew Consent|18|||
146729226|NCT02291679|529177215|FG001|Overall Study|Withdrew Consent|10|||
146729227|NCT02291679|529177216|FG002|Overall Study|Withdrew Consent|15|||
146729228|NCT02291679|529177214|FG000|Overall Study|Lost to Follow-up|12|||
146729229|NCT02291679|529177215|FG001|Overall Study|Lost to Follow-up|10|||
146729230|NCT02291679|529177216|FG002|Overall Study|Lost to Follow-up|9|||
146729231|NCT02291679|529177214|FG000|Overall Study|Insufficient Therapeutic Response|5|||
146729232|NCT02291679|529177215|FG001|Overall Study|Insufficient Therapeutic Response|5|||
146729233|NCT02291679|529177216|FG002|Overall Study|Insufficient Therapeutic Response|7|||
146729234|NCT02291679|529177214|FG000|Overall Study|Other|2|||
146729235|NCT02291679|529177215|FG001|Overall Study|Other|4|||
146729236|NCT02291679|529177216|FG002|Overall Study|Other|2|||
146729237|NCT02276222|529177217|FG000|Overall Study|Adverse Event|62|||
146729238|NCT02276222|529177218|FG001|Overall Study|Adverse Event|11|||
146729239|NCT02276222|529177217|FG000|Overall Study|Death|3|||
146729240|NCT02276222|529177218|FG001|Overall Study|Death|4|||
146729241|NCT02276222|529177217|FG000|Overall Study|Lack of Efficacy|13|||
146729242|NCT02276222|529177218|FG001|Overall Study|Lack of Efficacy|3|||
146729243|NCT02276222|529177217|FG000|Overall Study|Protocol Violation|3|||
146729244|NCT02276222|529177218|FG001|Overall Study|Protocol Violation|2|||
146729245|NCT02276222|529177217|FG000|Overall Study|Withdrawal by Subject|79|||
146729246|NCT02276222|529177218|FG001|Overall Study|Withdrawal by Subject|33|||
146729247|NCT02276222|529177217|FG000|Overall Study|non compliance with study medication|6|||
146729248|NCT02276222|529177218|FG001|Overall Study|non compliance with study medication|2|||
146729249|NCT02276222|529177217|FG000|Overall Study|sponsor decision|0|||
146729250|NCT02276222|529177218|FG001|Overall Study|sponsor decision|3|||
146729251|NCT02276222|529177217|FG000|Overall Study|Lost to Follow-up|15|||
146729252|NCT02276222|529177218|FG001|Overall Study|Lost to Follow-up|5|||
146729253|NCT02276222|529177217|FG000|Overall Study|Physician Decision|2|||
146729254|NCT02276222|529177218|FG001|Overall Study|Physician Decision|1|||
146729255|NCT02276222|529177217|FG000|Overall Study|sheduling conflict|1|||
146729256|NCT02276222|529177218|FG001|Overall Study|sheduling conflict|0|||
146729257|NCT02276222|529177217|FG000|Overall Study|subject withdrew after randomization|1|||
146729258|NCT02276222|529177218|FG001|Overall Study|subject withdrew after randomization|0|||
146729259|NCT02543658|529178786|FG000|Overall Study|Lack of Efficacy|0|||
146729260|NCT02543658|529178787|FG001|Overall Study|Lack of Efficacy|4|||
146729261|NCT00437645|529178794|FG000|Overall Study|Adverse Event|15|||
146729262|NCT00437645|529178795|FG001|Overall Study|Adverse Event|84|||
146729263|NCT00437645|529178794|FG000|Overall Study|Withdrawal by Subject|10|||
146729264|NCT00437645|529178795|FG001|Overall Study|Withdrawal by Subject|22|||
146729265|NCT00437645|529178794|FG000|Overall Study|Protocol Violation|3|||
146729266|NCT00437645|529178795|FG001|Overall Study|Protocol Violation|3|||
146729267|NCT00437645|529178794|FG000|Overall Study|Lost to Follow-up|2|||
146729268|NCT00437645|529178795|FG001|Overall Study|Lost to Follow-up|3|||
146729269|NCT00437645|529178794|FG000|Overall Study|Administrative problems|2|||
146729270|NCT00437645|529178795|FG001|Overall Study|Administrative problems|1|||
146729271|NCT00437645|529178794|FG000|Overall Study|Lack of Efficacy|2|||
146729272|NCT00437645|529178795|FG001|Overall Study|Lack of Efficacy|1|||
146729273|NCT00437645|529178794|FG000|Overall Study|Condition no longer requires study drug|1|||
146729274|NCT00437645|529178795|FG001|Overall Study|Condition no longer requires study drug|1|||
146729275|NCT03966053|529178796|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
146729276|NCT00175825|529178797|FG000|Overall Study|Adverse Event|3|||
146729277|NCT00175825|529178798|FG001|Overall Study|Adverse Event|2|||
146729278|NCT00175825|529178799|FG002|Overall Study|Adverse Event|1|||
146729279|NCT00175825|529178800|FG003|Overall Study|Adverse Event|1|||
146729280|NCT00175825|529178797|FG000|Overall Study|Lost to Follow-up|1|||
146729281|NCT00175825|529178798|FG001|Overall Study|Lost to Follow-up|2|||
146729282|NCT00175825|529178799|FG002|Overall Study|Lost to Follow-up|0|||
146729283|NCT00175825|529178800|FG003|Overall Study|Lost to Follow-up|0|||
146729284|NCT00175825|529178797|FG000|Overall Study|Withdrawal by Subject|1|||
146729285|NCT00175825|529178798|FG001|Overall Study|Withdrawal by Subject|0|||
146729286|NCT00175825|529178799|FG002|Overall Study|Withdrawal by Subject|0|||
146729287|NCT00175825|529178800|FG003|Overall Study|Withdrawal by Subject|0|||
146935977|NCT03954444|529922624|FG001|Overall Study|Protocol Violation|3|||
146935978|NCT03954444|529922625|FG002|Overall Study|Protocol Violation|5|||
146935979|NCT03954444|529922623|FG000|Overall Study|Use of prohibited therapy|1|||
146935980|NCT03954444|529922624|FG001|Overall Study|Use of prohibited therapy|1|||
146935981|NCT03954444|529922625|FG002|Overall Study|Use of prohibited therapy|2|||
146935982|NCT03954444|529922623|FG000|Overall Study|Lost to Follow-up|1|||
146935983|NCT03954444|529922624|FG001|Overall Study|Lost to Follow-up|0|||
146935984|NCT03954444|529922625|FG002|Overall Study|Lost to Follow-up|1|||
146935985|NCT03954444|529922623|FG000|Overall Study|Non-compliant with study drug application|2|||
146935986|NCT03954444|529922624|FG001|Overall Study|Non-compliant with study drug application|2|||
146935987|NCT03954444|529922625|FG002|Overall Study|Non-compliant with study drug application|0|||
146935988|NCT03954444|529922623|FG000|Overall Study|Administrative reasons|0|||
146981632|NCT01621490|530096095|FG008|Overall Study|Adverse event unrelated to study drug|0|||
146786556|NCT03338933|529390591|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
146786557|NCT03338933|529390592|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
146786558|NCT03338933|529390593|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
146786559|NCT03338933|529390590|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
146786560|NCT03338933|529390591|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
146786561|NCT03338933|529390592|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
146786562|NCT03338933|529390593|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
146786563|NCT00999804|529390596|FG000|Overall Study|Lack of Efficacy|9|||
146935989|NCT03954444|529922624|FG001|Overall Study|Administrative reasons|0|||
146981633|NCT01621490|530096096|FG009|Overall Study|Adverse event unrelated to study drug|0|||
146729288|NCT04586569|529178801|FG000|Overall Study|Withdrawal by Subject|0|||
146729289|NCT04586569|529178802|FG001|Overall Study|Withdrawal by Subject|2|||
146729290|NCT04586569|529178801|FG000|Overall Study|No longer eligible|2|||
146729291|NCT04586569|529178802|FG001|Overall Study|No longer eligible|3|||
146729292|NCT04586569|529178801|FG000|Overall Study|Physician Decision|1|||
146729293|NCT04586569|529178802|FG001|Overall Study|Physician Decision|0|||
146729294|NCT04098406|529178804|FG000|Overall Study|Adverse Event|2|||
146729295|NCT04098406|529178805|FG001|Overall Study|Adverse Event|1|||
146729296|NCT04098406|529178804|FG000|Overall Study|Withdrawal by Subject|1|||
146729297|NCT04098406|529178805|FG001|Overall Study|Withdrawal by Subject|0|||
146729298|NCT03548207|529178806|FG000|Overall Study|Death|10|||
146729299|NCT03548207|529178807|FG001|Overall Study|Death|23|||
146729300|NCT03548207|529178808|FG002|Overall Study|Death|3|||
146729301|NCT03548207|529178806|FG000|Overall Study|Lost to Follow-up|0|||
146729302|NCT03548207|529178807|FG001|Overall Study|Lost to Follow-up|2|||
146729303|NCT03548207|529178808|FG002|Overall Study|Lost to Follow-up|0|||
146729304|NCT03548207|529178806|FG000|Overall Study|Withdrawal by Subject|0|||
146729305|NCT03548207|529178807|FG001|Overall Study|Withdrawal by Subject|3|||
146729306|NCT03548207|529178808|FG002|Overall Study|Withdrawal by Subject|0|||
146729307|NCT03548207|529178806|FG000|Overall Study|Sponsor decision|19|||
146729308|NCT03548207|529178807|FG001|Overall Study|Sponsor decision|40|||
146729309|NCT03548207|529178808|FG002|Overall Study|Sponsor decision|6|||
146729310|NCT03548207|529178806|FG000|Overall Study|Randomized but not treated|6|||
146729311|NCT03548207|529178807|FG001|Overall Study|Randomized but not treated|10|||
146729312|NCT03548207|529178808|FG002|Overall Study|Randomized but not treated|4|||
146729313|NCT01357616|529178809|FG000|Overall Study|Adverse Event|1|||
146729314|NCT01357616|529178810|FG001|Overall Study|Adverse Event|1|||
146729315|NCT01357616|529178809|FG000|Overall Study|Lost to Follow-up|4|||
146729316|NCT01357616|529178810|FG001|Overall Study|Lost to Follow-up|3|||
146729317|NCT01357616|529178809|FG000|Overall Study|Protocol Violation|0|||
146729318|NCT01357616|529178810|FG001|Overall Study|Protocol Violation|2|||
146729319|NCT01357616|529178809|FG000|Overall Study|Inadequate Control of IOP|1|||
146729320|NCT01357616|529178810|FG001|Overall Study|Inadequate Control of IOP|2|||
146729321|NCT01357616|529178809|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
146729322|NCT01357616|529178810|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
146729323|NCT01357616|529178809|FG000|Overall Study|Withdrawal by Subject|1|||
146729324|NCT01357616|529178810|FG001|Overall Study|Withdrawal by Subject|0|||
146729325|NCT03432364|529178811|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
146729326|NCT00522301|529178812|FG000|Overall Study|Withdrawal by Subject|1|||
146729327|NCT00522301|529178812|FG000|Overall Study|Adverse Event|5|||
146729328|NCT00337272|529178815|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
146729329|NCT00337272|529178816|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
146729330|NCT00337272|529178815|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
146729331|NCT00337272|529178816|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
146729332|NCT00337272|529178815|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
146729333|NCT00337272|529178816|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
146729334|NCT00337272|529178815|FG000|Treatment Period|Non-compliance|1|||
146729335|NCT00337272|529178816|FG001|Treatment Period|Non-compliance|1|||
146729336|NCT00337272|529178815|FG000|Treatment Period|Withdrawal by Subject|0|||
146935990|NCT03954444|529922625|FG002|Overall Study|Administrative reasons|1|||
146935991|NCT03954444|529922623|FG000|Overall Study|Miscellaneous|3|||
146935992|NCT03954444|529922624|FG001|Overall Study|Miscellaneous|2|||
146935993|NCT03954444|529922625|FG002|Overall Study|Miscellaneous|1|||
146786564|NCT00999804|529390597|FG001|Overall Study|Lack of Efficacy|2|||
146786565|NCT00999804|529390596|FG000|Overall Study|Adverse Event|4|||
146786566|NCT00999804|529390597|FG001|Overall Study|Adverse Event|3|||
146786567|NCT00999804|529390596|FG000|Overall Study|Withdrawal by Subject|4|||
146786568|NCT00999804|529390597|FG001|Overall Study|Withdrawal by Subject|0|||
146786569|NCT00999804|529390596|FG000|Overall Study|Death|1|||
146786570|NCT00999804|529390597|FG001|Overall Study|Death|0|||
146786571|NCT00999804|529390596|FG000|Overall Study|Ineligible|3|||
146786572|NCT00999804|529390597|FG001|Overall Study|Ineligible|0|||
146786573|NCT03891667|529390603|FG000|Overall Study|Physician Decision|1|||
146786574|NCT03891667|529390604|FG001|Overall Study|Physician Decision|1|||
146786575|NCT03891667|529390603|FG000|Overall Study|COVID related pause|1|||
146786576|NCT03891667|529390604|FG001|Overall Study|COVID related pause|0|||
146786577|NCT03891667|529390603|FG000|Overall Study|Withdrawal by Subject|0|||
146786578|NCT03891667|529390604|FG001|Overall Study|Withdrawal by Subject|1|||
146786579|NCT03891667|529390603|FG000|Overall Study|Adverse Event|0|||
146786580|NCT03891667|529390604|FG001|Overall Study|Adverse Event|1|||
146786581|NCT04256941|529390605|FG000|Overall Study|Withdrawal by Subject|0|||
146786582|NCT04256941|529390606|FG001|Overall Study|Withdrawal by Subject|1|||
146786583|NCT04256941|529390605|FG000|Overall Study|Death|1|||
146786584|NCT04256941|529390606|FG001|Overall Study|Death|0|||
146786585|NCT04256941|529390605|FG000|Overall Study|Disease Progession|0|||
146786586|NCT04256941|529390606|FG001|Overall Study|Disease Progession|2|||
146786587|NCT04717492|529390623|FG000|Overall Study|Withdrawal by Subject|2|||
146786588|NCT04717492|529390624|FG001|Overall Study|Withdrawal by Subject|13|||
146786589|NCT04717492|529390623|FG000|Overall Study|Lost to Follow-up|2|||
146786590|NCT04717492|529390624|FG001|Overall Study|Lost to Follow-up|9|||
146786591|NCT04456517|529390625|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
146786592|NCT04456517|529390626|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
146786593|NCT03766009|529390627|FG000|Usual Care|Death|0|||
146786594|NCT03766009|529390628|FG001|Usual Care|Death|0|||
146786595|NCT03766009|529390629|FG002|Usual Care|Death|0|||
146786596|NCT03766009|529390630|FG003|Usual Care|Death|1|||
146786597|NCT03766009|529390631|FG004|Usual Care|Death|0|||
146786598|NCT03766009|529390632|FG005|Usual Care|Death|0|||
146786599|NCT03766009|529390627|FG000|Usual Care|Lost to Follow-up|0|||
146786600|NCT03766009|529390628|FG001|Usual Care|Lost to Follow-up|0|||
146786601|NCT03766009|529390629|FG002|Usual Care|Lost to Follow-up|0|||
146786602|NCT03766009|529390630|FG003|Usual Care|Lost to Follow-up|1|||
146786603|NCT03766009|529390631|FG004|Usual Care|Lost to Follow-up|0|||
146786604|NCT03766009|529390632|FG005|Usual Care|Lost to Follow-up|0|||
146786605|NCT03766009|529390627|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
146786606|NCT03766009|529390628|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
146786607|NCT03766009|529390629|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
146786608|NCT03766009|529390630|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
146786609|NCT03766009|529390631|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
146786610|NCT03766009|529390632|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
146786611|NCT03766009|529390627|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
146786612|NCT03766009|529390628|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
146786613|NCT03766009|529390629|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
146786614|NCT03766009|529390630|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
146786615|NCT03766009|529390631|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
146786616|NCT03766009|529390632|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
146786617|NCT03766009|529390627|FG000|Usual Care|No treatment or declined surgery|0|||
146786618|NCT03766009|529390628|FG001|Usual Care|No treatment or declined surgery|0|||
146935994|NCT03094832|529922630|FG000|Overall Study|Lost to Follow-up|0|||
146935995|NCT03094832|529922631|FG001|Overall Study|Lost to Follow-up|0|||
146935996|NCT03094832|529922632|FG002|Overall Study|Lost to Follow-up|0|||
146786619|NCT03766009|529390629|FG002|Usual Care|No treatment or declined surgery|0|||
146935997|NCT03094832|529922633|FG003|Overall Study|Lost to Follow-up|1|||
146786620|NCT03766009|529390630|FG003|Usual Care|No treatment or declined surgery|2|||
146786621|NCT03766009|529390631|FG004|Usual Care|No treatment or declined surgery|0|||
146786622|NCT03766009|529390632|FG005|Usual Care|No treatment or declined surgery|0|||
146786623|NCT03766009|529390627|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
146786624|NCT03766009|529390628|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
146786625|NCT03766009|529390629|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
146786626|NCT03766009|529390630|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
146786627|NCT03766009|529390631|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
146935998|NCT03094832|529922634|FG004|Overall Study|Lost to Follow-up|1|||
146935999|NCT03094832|529922630|FG000|Overall Study|Death|1|||
146936000|NCT03094832|529922631|FG001|Overall Study|Death|0|||
146936001|NCT03094832|529922632|FG002|Overall Study|Death|0|||
146936002|NCT03094832|529922633|FG003|Overall Study|Death|0|||
146936003|NCT03094832|529922634|FG004|Overall Study|Death|0|||
146936004|NCT03094832|529922630|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146936005|NCT03094832|529922631|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146936006|NCT03094832|529922632|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146936007|NCT03094832|529922633|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146936008|NCT03094832|529922634|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
146936009|NCT03094832|529922630|FG000|Overall Study|Other|13|||
146936010|NCT03094832|529922631|FG001|Overall Study|Other|20|||
146936011|NCT03094832|529922632|FG002|Overall Study|Other|1|||
146936012|NCT03094832|529922633|FG003|Overall Study|Other|7|||
146936013|NCT03094832|529922634|FG004|Overall Study|Other|1|||
146936014|NCT02661464|529922638|FG000|Overall Study|Lost to Follow-up|28|||
146936015|NCT02661464|529922639|FG001|Overall Study|Lost to Follow-up|0|||
146936016|NCT02661464|529922640|FG002|Overall Study|Lost to Follow-up|0|||
146936017|NCT02661464|529922641|FG003|Overall Study|Lost to Follow-up|0|||
146936018|NCT02661464|529922638|FG000|Overall Study|Withdrawal by Subject|3|||
146936019|NCT02661464|529922639|FG001|Overall Study|Withdrawal by Subject|1|||
146936020|NCT02661464|529922640|FG002|Overall Study|Withdrawal by Subject|0|||
146936021|NCT02661464|529922641|FG003|Overall Study|Withdrawal by Subject|0|||
146936022|NCT02661464|529922638|FG000|Overall Study|Participants terminated prematurely|288|||
146936023|NCT02661464|529922639|FG001|Overall Study|Participants terminated prematurely|52|||
146936024|NCT02661464|529922640|FG002|Overall Study|Participants terminated prematurely|1|||
146936025|NCT02661464|529922641|FG003|Overall Study|Participants terminated prematurely|1|||
146936026|NCT02661464|529922638|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
146936027|NCT02661464|529922639|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
146936028|NCT02661464|529922640|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
146936029|NCT02661464|529922641|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
146936030|NCT00903370|529922642|FG000|Overall Study|Death|13|||
146936031|NCT00903370|529922643|FG001|Overall Study|Death|10|||
146936032|NCT00903370|529922642|FG000|Overall Study|Withdrawal by Subject|9|||
146936033|NCT00903370|529922643|FG001|Overall Study|Withdrawal by Subject|6|||
146786628|NCT03766009|529390632|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
146786629|NCT03766009|529390627|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
146786630|NCT03766009|529390628|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
146786631|NCT03766009|529390629|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
146786632|NCT03766009|529390630|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
146786633|NCT03766009|529390631|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
146786634|NCT03766009|529390632|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
146786635|NCT03766009|529390627|FG000|Usual Care|Ineligible|0|||
146786636|NCT03766009|529390628|FG001|Usual Care|Ineligible|1|||
146786637|NCT03766009|529390629|FG002|Usual Care|Ineligible|0|||
146786638|NCT03766009|529390630|FG003|Usual Care|Ineligible|0|||
146786639|NCT03766009|529390631|FG004|Usual Care|Ineligible|0|||
146786640|NCT03766009|529390632|FG005|Usual Care|Ineligible|0|||
146786641|NCT03766009|529390627|FG000|Usual Care|Other: Staff turnover|0|||
146786642|NCT03766009|529390628|FG001|Usual Care|Other: Staff turnover|0|||
146786643|NCT03766009|529390629|FG002|Usual Care|Other: Staff turnover|0|||
146786644|NCT03766009|529390630|FG003|Usual Care|Other: Staff turnover|0|||
146786645|NCT03766009|529390631|FG004|Usual Care|Other: Staff turnover|0|||
146786646|NCT03766009|529390632|FG005|Usual Care|Other: Staff turnover|2|||
146786647|NCT03936322|529390637|FG000|Overall Study|Lost to Follow-up|1|||
146786648|NCT03936322|529390637|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
146786649|NCT02734290|529390638|FG000|Overall Study|Adverse Event|1|||
146786650|NCT02734290|529390639|FG001|Overall Study|Adverse Event|0|||
146786651|NCT02734290|529390638|FG000|Overall Study|Death|1|||
146786652|NCT02734290|529390639|FG001|Overall Study|Death|0|||
146786653|NCT03829410|529390641|FG000|Overall Study|Adverse Event|1|||
146786654|NCT03829410|529390642|FG001|Overall Study|Adverse Event|0|||
146786655|NCT03829410|529390643|FG002|Overall Study|Adverse Event|1|||
146786656|NCT03829410|529390644|FG003|Overall Study|Adverse Event|4|||
146936034|NCT00903370|529922642|FG000|Overall Study|Lost to Follow-up|6|||
146936035|NCT00903370|529922643|FG001|Overall Study|Lost to Follow-up|8|||
146962305|NCT01049360|530021577|FG003|Period 1|Did not meet inc/exc criteria|0|||
146962306|NCT01049360|530021578|FG004|Period 1|Did not meet inc/exc criteria|0|||
146962307|NCT01049360|530021579|FG005|Period 1|Did not meet inc/exc criteria|0|||
146786657|NCT03829410|529390641|FG000|Overall Study|Physician Decision|0|||
146786658|NCT03829410|529390642|FG001|Overall Study|Physician Decision|0|||
146786659|NCT03829410|529390643|FG002|Overall Study|Physician Decision|0|||
146786660|NCT03829410|529390644|FG003|Overall Study|Physician Decision|2|||
146786661|NCT03829410|529390641|FG000|Overall Study|Disease Progressing|3|||
146786662|NCT03829410|529390642|FG001|Overall Study|Disease Progressing|4|||
146786663|NCT03829410|529390643|FG002|Overall Study|Disease Progressing|2|||
146786664|NCT03829410|529390644|FG003|Overall Study|Disease Progressing|31|||
146786665|NCT03829410|529390641|FG000|Overall Study|Miscellaneous|2|||
146786666|NCT03829410|529390642|FG001|Overall Study|Miscellaneous|4|||
146786667|NCT03829410|529390643|FG002|Overall Study|Miscellaneous|3|||
146786668|NCT03829410|529390644|FG003|Overall Study|Miscellaneous|10|||
146786669|NCT06205407|529390645|FG000|Period 2|Withdrawal by Subject|0|||
146786670|NCT06205407|529390646|FG001|Period 2|Withdrawal by Subject|1|||
146786671|NCT06205407|529390645|FG000|Period 2|Adverse Event|2|||
146786672|NCT06205407|529390646|FG001|Period 2|Adverse Event|1|||
146786673|NCT04676022|529390647|FG000|Overall Study|Screen Failure/|1|||
146786674|NCT04676022|529390648|FG001|Overall Study|Screen Failure/|1|||
146786675|NCT04676022|529390649|FG002|Overall Study|Screen Failure/|85|||
146786676|NCT04676022|529390647|FG000|Overall Study|Lost to Follow-up|1|||
146786677|NCT04676022|529390648|FG001|Overall Study|Lost to Follow-up|1|||
146786678|NCT04676022|529390649|FG002|Overall Study|Lost to Follow-up|0|||
146786679|NCT04676022|529390647|FG000|Overall Study|Adverse Event|2|||
146786680|NCT04676022|529390648|FG001|Overall Study|Adverse Event|0|||
146786681|NCT04676022|529390649|FG002|Overall Study|Adverse Event|1|||
146786682|NCT04676022|529390647|FG000|Overall Study|Physician Decision|2|||
146786683|NCT04676022|529390648|FG001|Overall Study|Physician Decision|0|||
146786684|NCT04676022|529390649|FG002|Overall Study|Physician Decision|1|||
146786685|NCT04676022|529390647|FG000|Overall Study|Withdrawal by Subject|3|||
146786686|NCT04676022|529390648|FG001|Overall Study|Withdrawal by Subject|1|||
146786687|NCT04676022|529390649|FG002|Overall Study|Withdrawal by Subject|6|||
146786688|NCT04676022|529390647|FG000|Overall Study|Will not move forward with permanent implant|6|||
146786689|NCT04676022|529390648|FG001|Overall Study|Will not move forward with permanent implant|0|||
146786690|NCT04676022|529390649|FG002|Overall Study|Will not move forward with permanent implant|0|||
146786691|NCT04676022|529390647|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
146786692|NCT04676022|529390648|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
146786693|NCT04676022|529390649|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
146786694|NCT05409183|529390653|FG000|Complete Study|Adverse Event|1|||
146786695|NCT05409183|529390654|FG001|Complete Study|Adverse Event|2|||
146786696|NCT05409183|529390653|FG000|Complete Study|Withdrawal by Subject|3|||
146786697|NCT05409183|529390654|FG001|Complete Study|Withdrawal by Subject|0|||
146786698|NCT02274662|529390655|FG000|Overall Study|Death|1|||
146786699|NCT02274662|529390655|FG000|Overall Study|Lost to Follow-up|3|||
146786700|NCT02962895|529390656|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
146786701|NCT02962895|529390657|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
146786702|NCT02962895|529390658|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
146786703|NCT02962895|529390659|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
146786704|NCT02962895|529390660|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
146786705|NCT02962895|529390661|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
146786706|NCT02962895|529390662|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
146786707|NCT02962895|529390656|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
146786708|NCT02962895|529390657|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
146786709|NCT02962895|529390658|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
146786710|NCT02962895|529390659|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
146786711|NCT02962895|529390660|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
146786712|NCT02962895|529390661|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
146786713|NCT02962895|529390662|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
146786714|NCT02962895|529390656|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
146786715|NCT02962895|529390657|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
146786716|NCT02962895|529390658|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
146786717|NCT02962895|529390659|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
146786718|NCT02962895|529390660|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
146786719|NCT02962895|529390661|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
146786720|NCT02962895|529390662|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
146786721|NCT02962895|529390656|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
146786722|NCT02962895|529390657|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
146786723|NCT02962895|529390658|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
146786724|NCT02962895|529390659|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
146786725|NCT02962895|529390660|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
146786726|NCT02962895|529390661|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
146786727|NCT02962895|529390662|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
146786728|NCT02962895|529390656|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
146786729|NCT02962895|529390657|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
146786730|NCT02962895|529390658|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
146936036|NCT00379236|529924142|FG000|Double-blind|Adverse Event|11|||
146786731|NCT02962895|529390659|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
146786732|NCT02962895|529390660|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
146786733|NCT02962895|529390661|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
146786734|NCT02962895|529390662|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
146786735|NCT02962895|529390656|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
146786736|NCT02962895|529390657|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
146786737|NCT02962895|529390658|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
146786738|NCT02962895|529390659|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
146786739|NCT02962895|529390660|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
146786740|NCT02962895|529390661|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
146786741|NCT02962895|529390662|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
146786742|NCT02962895|529390656|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
146786743|NCT02962895|529390657|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
146786744|NCT02962895|529390658|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
146786745|NCT02962895|529390659|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
146786746|NCT02962895|529390660|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
146786747|NCT02962895|529390661|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
146786748|NCT02962895|529390662|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
146786749|NCT02962895|529390656|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
146786750|NCT02962895|529390657|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
146786751|NCT02962895|529390658|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
146786752|NCT02962895|529390659|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
146786753|NCT02962895|529390660|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
146786754|NCT02962895|529390661|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
146786755|NCT02962895|529390662|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
146786756|NCT02962895|529390656|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
146786757|NCT02962895|529390657|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
146786758|NCT02962895|529390658|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
146786759|NCT02962895|529390659|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
146786760|NCT02962895|529390660|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
146786761|NCT02962895|529390661|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
146786762|NCT02962895|529390662|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
146786763|NCT02962895|529390656|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
146786764|NCT02962895|529390657|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
146786765|NCT02962895|529390658|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
146786766|NCT02962895|529390659|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
146786767|NCT02962895|529390660|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
146786768|NCT02962895|529390661|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
146786769|NCT02962895|529390662|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
146786770|NCT02962895|529390656|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
146786771|NCT02962895|529390657|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
146786772|NCT02962895|529390658|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
146786773|NCT02962895|529390659|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
146786774|NCT02962895|529390660|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
146786775|NCT02962895|529390661|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
146786776|NCT02962895|529390662|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
146786777|NCT02962895|529390656|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
146786778|NCT02962895|529390657|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
146786779|NCT02962895|529390658|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
146786780|NCT02962895|529390659|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
146786781|NCT02962895|529390660|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
146786782|NCT02962895|529390661|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
146786783|NCT02962895|529390662|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
146786784|NCT02962895|529390656|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
146786785|NCT02962895|529390657|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
146786786|NCT02962895|529390658|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
146786787|NCT02962895|529390659|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
146786788|NCT02962895|529390660|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
146786789|NCT02962895|529390661|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
146786790|NCT02962895|529390662|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
146786791|NCT02962895|529390656|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
146786792|NCT02962895|529390657|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
146786793|NCT02962895|529390658|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
146936037|NCT00379236|529924143|FG001|Double-blind|Adverse Event|6|||
146936038|NCT00379236|529924144|FG002|Double-blind|Adverse Event|0|||
146786794|NCT02962895|529390659|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
146786795|NCT02962895|529390660|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
146786796|NCT02962895|529390661|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
146786797|NCT02962895|529390662|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
146786798|NCT02936752|529390663|FG000|Overall Study|Death|2|||
146786799|NCT02936752|529390664|FG001|Overall Study|Death|1|||
146786800|NCT02936752|529390663|FG000|Overall Study|Physician Decision|4|||
146786801|NCT02936752|529390664|FG001|Overall Study|Physician Decision|0|||
146786802|NCT02936752|529390663|FG000|Overall Study|Withdrawal by Subject|0|||
146786803|NCT02936752|529390664|FG001|Overall Study|Withdrawal by Subject|2|||
146786804|NCT05282173|529390677|FG000|Overall Study|Missed|3|||
146786805|NCT05282173|529390678|FG001|Overall Study|Missed|2|||
146786806|NCT05282173|529390679|FG002|Overall Study|Missed|4|||
146786807|NCT04719390|529390688|FG000|Overall Study|Withdrawal by Subject|1|||
146786808|NCT03307343|529390689|FG000|Overall Study|Withdrawal by Subject|1|||
146786809|NCT03307343|529390690|FG001|Overall Study|Withdrawal by Subject|2|||
146786810|NCT03307343|529390689|FG000|Overall Study|Pregnancy|0|||
146786811|NCT03307343|529390690|FG001|Overall Study|Pregnancy|2|||
146786812|NCT03307343|529390689|FG000|Overall Study|Physician Decision|1|||
146786813|NCT03307343|529390690|FG001|Overall Study|Physician Decision|0|||
146786814|NCT03307343|529390689|FG000|Overall Study|Lost to Follow-up|0|||
146786815|NCT03307343|529390690|FG001|Overall Study|Lost to Follow-up|2|||
146786816|NCT01798498|529390699|FG000|Overall Study|Lost to Follow-up|1|||
146786817|NCT01606215|529390701|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
146786818|NCT01606215|529390702|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
146786819|NCT04592549|529390703|FG000|Overall Study|Withdrawal by Subject|0|||
146786820|NCT04592549|529390704|FG001|Overall Study|Withdrawal by Subject|1|||
146786821|NCT04592549|529390705|FG002|Overall Study|Withdrawal by Subject|0|||
146786822|NCT04592549|529390706|FG003|Overall Study|Withdrawal by Subject|1|||
146786823|NCT04592549|529390707|FG004|Overall Study|Withdrawal by Subject|1|||
146786824|NCT04592549|529390708|FG005|Overall Study|Withdrawal by Subject|0|||
146786825|NCT04592549|529390703|FG000|Overall Study|Lost to Follow-up|2|||
146786826|NCT04592549|529390704|FG001|Overall Study|Lost to Follow-up|0|||
146786827|NCT04592549|529390705|FG002|Overall Study|Lost to Follow-up|0|||
146786828|NCT04592549|529390706|FG003|Overall Study|Lost to Follow-up|1|||
146786829|NCT04592549|529390707|FG004|Overall Study|Lost to Follow-up|1|||
146786830|NCT04592549|529390708|FG005|Overall Study|Lost to Follow-up|1|||
146786831|NCT01959425|529390709|FG000|Overall Study|Withdrawal by Subject|5|||
146786832|NCT01959425|529390710|FG001|Overall Study|Withdrawal by Subject|4|||
146786833|NCT01959425|529390709|FG000|Overall Study|Lost to Follow-up|1|||
146786834|NCT01959425|529390710|FG001|Overall Study|Lost to Follow-up|0|||
146786835|NCT01959425|529390709|FG000|Overall Study|Discontinued Subjects|6|||
146786836|NCT01959425|529390710|FG001|Overall Study|Discontinued Subjects|4|||
146786837|NCT01824394|529390713|FG000|Overall Study|Early Termination|1|||
146786838|NCT01824394|529390714|FG001|Overall Study|Early Termination|1|||
146786839|NCT01824394|529390715|FG002|Overall Study|Early Termination|3|||
146786840|NCT01824394|529390713|FG000|Overall Study|Withdrawn due to Study Termination|91|||
146786841|NCT01824394|529390714|FG001|Overall Study|Withdrawn due to Study Termination|83|||
146786842|NCT01824394|529390715|FG002|Overall Study|Withdrawn due to Study Termination|41|||
146786843|NCT01824394|529390713|FG000|Overall Study|Lost to Follow-up|0|||
146786844|NCT01824394|529390714|FG001|Overall Study|Lost to Follow-up|9|||
146786845|NCT01824394|529390715|FG002|Overall Study|Lost to Follow-up|3|||
146786846|NCT01824394|529390713|FG000|Overall Study|Death|3|||
146786847|NCT01824394|529390714|FG001|Overall Study|Death|2|||
146786848|NCT01824394|529390715|FG002|Overall Study|Death|4|||
146786849|NCT01824394|529390713|FG000|Overall Study|Discontinued Subjects|1|||
146786850|NCT01824394|529390714|FG001|Overall Study|Discontinued Subjects|1|||
146786851|NCT01824394|529390715|FG002|Overall Study|Discontinued Subjects|2|||
146786852|NCT01824394|529390713|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
146786853|NCT01824394|529390714|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
146786854|NCT01824394|529390715|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
146786855|NCT02619838|529390716|FG000|Overall Study|Lost to Follow-up|9|||
146786856|NCT02619838|529390716|FG000|Overall Study|Withdrawal by Subject|15|||
146786857|NCT05020249|529390717|FG000|Overall Study|Protocol Violation|1|||
146786858|NCT05020249|529390718|FG001|Overall Study|Protocol Violation|0|||
146786859|NCT05364671|529390719|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
146786860|NCT05364671|529390720|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
146786861|NCT05364671|529390719|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
146936039|NCT00379236|529924142|FG000|Double-blind|Protocol Violation|3|||
146786862|NCT05364671|529390720|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
146786863|NCT05364671|529390719|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
146786864|NCT05364671|529390720|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
146786865|NCT05364671|529390719|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
146936040|NCT00379236|529924143|FG001|Double-blind|Protocol Violation|3|||
146786866|NCT05364671|529390720|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
146786867|NCT05364671|529390719|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
146786868|NCT05364671|529390720|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
146786869|NCT03536754|529390723|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
146786870|NCT03536754|529390724|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
146786871|NCT03536754|529390725|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
146786872|NCT03536754|529390726|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
146786873|NCT03536754|529390727|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
146786874|NCT03536754|529390723|FG000|Open Label Extension|Other|0|||
146786875|NCT03536754|529390724|FG001|Open Label Extension|Other|0|||
146786876|NCT03536754|529390725|FG002|Open Label Extension|Other|0|||
146786877|NCT03536754|529390726|FG003|Open Label Extension|Other|0|||
146786878|NCT03536754|529390727|FG004|Open Label Extension|Other|1|||
146786879|NCT04810650|529390731|FG000|Overall Study|Disenrolled in error|0|||
146786880|NCT04810650|529390732|FG001|Overall Study|Disenrolled in error|0|||
146786881|NCT04810650|529390733|FG002|Overall Study|Disenrolled in error|0|||
146786882|NCT04810650|529390734|FG003|Overall Study|Disenrolled in error|0|||
146786883|NCT04810650|529390735|FG004|Overall Study|Disenrolled in error|0|||
146786884|NCT04810650|529390736|FG005|Overall Study|Disenrolled in error|0|||
146786885|NCT04810650|529390737|FG006|Overall Study|Disenrolled in error|0|||
146786886|NCT04810650|529390738|FG007|Overall Study|Disenrolled in error|0|||
146786887|NCT04810650|529390739|FG008|Overall Study|Disenrolled in error|1|||
146786888|NCT04810650|529390740|FG009|Overall Study|Disenrolled in error|0|||
146786889|NCT04810650|529390741|FG010|Overall Study|Disenrolled in error|0|||
146786890|NCT04810650|529390742|FG011|Overall Study|Disenrolled in error|0|||
146786891|NCT04810650|529390743|FG012|Overall Study|Disenrolled in error|0|||
146786892|NCT04810650|529390744|FG013|Overall Study|Disenrolled in error|0|||
146786893|NCT04810650|529390731|FG000|Overall Study|Death|0|||
146786894|NCT04810650|529390732|FG001|Overall Study|Death|0|||
146786895|NCT04810650|529390733|FG002|Overall Study|Death|0|||
146786896|NCT04810650|529390734|FG003|Overall Study|Death|0|||
146786897|NCT04810650|529390735|FG004|Overall Study|Death|0|||
146786898|NCT04810650|529390736|FG005|Overall Study|Death|0|||
146786899|NCT04810650|529390737|FG006|Overall Study|Death|2|||
146786900|NCT04810650|529390738|FG007|Overall Study|Death|2|||
146786901|NCT04810650|529390739|FG008|Overall Study|Death|0|||
146786902|NCT04810650|529390740|FG009|Overall Study|Death|1|||
146786903|NCT04810650|529390741|FG010|Overall Study|Death|0|||
146786904|NCT04810650|529390742|FG011|Overall Study|Death|0|||
146786905|NCT04810650|529390743|FG012|Overall Study|Death|2|||
146786906|NCT04810650|529390744|FG013|Overall Study|Death|1|||
146786907|NCT04810650|529390731|FG000|Overall Study|Moved/transferred care|0|||
146786908|NCT04810650|529390732|FG001|Overall Study|Moved/transferred care|0|||
146786909|NCT04810650|529390733|FG002|Overall Study|Moved/transferred care|0|||
146786910|NCT04810650|529390734|FG003|Overall Study|Moved/transferred care|0|||
146786911|NCT04810650|529390735|FG004|Overall Study|Moved/transferred care|0|||
146786912|NCT04810650|529390736|FG005|Overall Study|Moved/transferred care|0|||
146786913|NCT04810650|529390737|FG006|Overall Study|Moved/transferred care|0|||
146786914|NCT04810650|529390738|FG007|Overall Study|Moved/transferred care|1|||
146786915|NCT04810650|529390739|FG008|Overall Study|Moved/transferred care|12|||
146786916|NCT04810650|529390740|FG009|Overall Study|Moved/transferred care|10|||
146786917|NCT04810650|529390741|FG010|Overall Study|Moved/transferred care|0|||
146786918|NCT04810650|529390742|FG011|Overall Study|Moved/transferred care|0|||
146786919|NCT04810650|529390743|FG012|Overall Study|Moved/transferred care|0|||
146786920|NCT04810650|529390744|FG013|Overall Study|Moved/transferred care|0|||
146786921|NCT04810650|529390731|FG000|Overall Study|Lost to Follow-up|15|||
146786922|NCT04810650|529390732|FG001|Overall Study|Lost to Follow-up|12|||
146786923|NCT04810650|529390733|FG002|Overall Study|Lost to Follow-up|7|||
146786924|NCT04810650|529390734|FG003|Overall Study|Lost to Follow-up|9|||
146786925|NCT04810650|529390735|FG004|Overall Study|Lost to Follow-up|10|||
146786926|NCT04810650|529390736|FG005|Overall Study|Lost to Follow-up|6|||
146786927|NCT04810650|529390737|FG006|Overall Study|Lost to Follow-up|0|||
146786928|NCT04810650|529390738|FG007|Overall Study|Lost to Follow-up|0|||
146786929|NCT04810650|529390739|FG008|Overall Study|Lost to Follow-up|0|||
146786930|NCT04810650|529390740|FG009|Overall Study|Lost to Follow-up|0|||
146786931|NCT04810650|529390741|FG010|Overall Study|Lost to Follow-up|1|||
146786932|NCT04810650|529390742|FG011|Overall Study|Lost to Follow-up|0|||
146786933|NCT04810650|529390743|FG012|Overall Study|Lost to Follow-up|3|||
146786934|NCT04810650|529390744|FG013|Overall Study|Lost to Follow-up|9|||
146786935|NCT04810650|529390731|FG000|Overall Study|Participant declined|0|||
146786936|NCT04810650|529390732|FG001|Overall Study|Participant declined|0|||
146786937|NCT04810650|529390733|FG002|Overall Study|Participant declined|0|||
146786938|NCT04810650|529390734|FG003|Overall Study|Participant declined|0|||
146786939|NCT04810650|529390735|FG004|Overall Study|Participant declined|0|||
146786940|NCT04810650|529390736|FG005|Overall Study|Participant declined|0|||
146786941|NCT04810650|529390737|FG006|Overall Study|Participant declined|0|||
146786942|NCT04810650|529390738|FG007|Overall Study|Participant declined|0|||
146786943|NCT04810650|529390739|FG008|Overall Study|Participant declined|0|||
146786944|NCT04810650|529390740|FG009|Overall Study|Participant declined|0|||
146786945|NCT04810650|529390741|FG010|Overall Study|Participant declined|2|||
146786946|NCT04810650|529390742|FG011|Overall Study|Participant declined|0|||
146786947|NCT04810650|529390743|FG012|Overall Study|Participant declined|0|||
146786948|NCT04810650|529390744|FG013|Overall Study|Participant declined|0|||
146786949|NCT05794243|529390745|FG000|Overall Study|Withdrawal by Subject|1|||
146786950|NCT05794243|529390746|FG001|Overall Study|Withdrawal by Subject|0|||
146786951|NCT05794243|529390747|FG002|Overall Study|Withdrawal by Subject|1|||
146786952|NCT05794243|529390745|FG000|Overall Study|Physician Decision|0|||
146786953|NCT05794243|529390746|FG001|Overall Study|Physician Decision|3|||
146786954|NCT05794243|529390747|FG002|Overall Study|Physician Decision|1|||
146786955|NCT00686335|529390748|FG000|Run-in Period|Adverse Event|1|||
146786956|NCT00686335|529390748|FG000|Run-in Period|asthma exacerbation|1|||
146786957|NCT00686335|529390748|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
146786958|NCT04652700|529390751|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
146786959|NCT04652700|529390752|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
146786960|NCT04652700|529390751|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
146786961|NCT04652700|529390752|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
146786962|NCT04652700|529390751|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
146786963|NCT04652700|529390752|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
146786964|NCT04652700|529390751|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
146786965|NCT04652700|529390752|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
146786966|NCT04652700|529390751|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
146786967|NCT04652700|529390752|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
146786968|NCT04652700|529390751|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
146786969|NCT04652700|529390752|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
146786970|NCT04652700|529390751|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
146786971|NCT04652700|529390752|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
146786972|NCT04652700|529390751|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
146786973|NCT04652700|529390752|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
146786974|NCT04652700|529390751|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
146786975|NCT04652700|529390752|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
146786976|NCT04187833|529390753|FG000|Overall Study|Withdrawal by Subject|1|||
146786977|NCT04209465|529390756|FG000|Overall Study|Adverse Event|0|||
146786978|NCT04209465|529390757|FG001|Overall Study|Adverse Event|0|||
146786979|NCT04209465|529390758|FG002|Overall Study|Adverse Event|0|||
146786980|NCT04209465|529390759|FG003|Overall Study|Adverse Event|0|||
146786981|NCT04209465|529390760|FG004|Overall Study|Adverse Event|0|||
146786982|NCT04209465|529390761|FG005|Overall Study|Adverse Event|1|||
146786983|NCT04209465|529390762|FG006|Overall Study|Adverse Event|0|||
146786984|NCT04209465|529390763|FG007|Overall Study|Adverse Event|0|||
146786985|NCT04209465|529390764|FG008|Overall Study|Adverse Event|1|||
146786986|NCT04209465|529390765|FG009|Overall Study|Adverse Event|0|||
146786987|NCT04209465|529390766|FG010|Overall Study|Adverse Event|2|||
146786988|NCT04209465|529390767|FG011|Overall Study|Adverse Event|1|||
146786989|NCT04209465|529390768|FG012|Overall Study|Adverse Event|1|||
146786990|NCT04209465|529390756|FG000|Overall Study|Death|1|||
146786991|NCT04209465|529390757|FG001|Overall Study|Death|0|||
146786992|NCT04209465|529390758|FG002|Overall Study|Death|0|||
146786993|NCT04209465|529390759|FG003|Overall Study|Death|0|||
146786994|NCT04209465|529390760|FG004|Overall Study|Death|2|||
146786995|NCT04209465|529390761|FG005|Overall Study|Death|7|||
146786996|NCT04209465|529390762|FG006|Overall Study|Death|2|||
146786997|NCT04209465|529390763|FG007|Overall Study|Death|2|||
146786998|NCT04209465|529390764|FG008|Overall Study|Death|1|||
146786999|NCT04209465|529390765|FG009|Overall Study|Death|1|||
146787000|NCT04209465|529390766|FG010|Overall Study|Death|1|||
146787001|NCT04209465|529390767|FG011|Overall Study|Death|0|||
146936041|NCT00379236|529924144|FG002|Double-blind|Protocol Violation|0|||
146936042|NCT00379236|529924142|FG000|Double-blind|Withdrawal by Subject|12|||
146787002|NCT04209465|529390768|FG012|Overall Study|Death|10|||
146787003|NCT04209465|529390756|FG000|Overall Study|Physician Decision|0|||
146787004|NCT04209465|529390757|FG001|Overall Study|Physician Decision|1|||
146787005|NCT04209465|529390758|FG002|Overall Study|Physician Decision|0|||
146787006|NCT04209465|529390759|FG003|Overall Study|Physician Decision|0|||
146787007|NCT04209465|529390760|FG004|Overall Study|Physician Decision|0|||
146787008|NCT04209465|529390761|FG005|Overall Study|Physician Decision|0|||
146787009|NCT04209465|529390762|FG006|Overall Study|Physician Decision|0|||
146787010|NCT04209465|529390763|FG007|Overall Study|Physician Decision|0|||
146787011|NCT04209465|529390764|FG008|Overall Study|Physician Decision|0|||
146787012|NCT04209465|529390765|FG009|Overall Study|Physician Decision|0|||
146787013|NCT04209465|529390766|FG010|Overall Study|Physician Decision|0|||
146936043|NCT00379236|529924143|FG001|Double-blind|Withdrawal by Subject|13|||
146936044|NCT00379236|529924144|FG002|Double-blind|Withdrawal by Subject|0|||
146936045|NCT00379236|529924142|FG000|Double-blind|Lost to Follow-up|4|||
146729337|NCT00337272|529178816|FG001|Treatment Period|Withdrawal by Subject|1|||
146729338|NCT00337272|529178815|FG000|Withdrawal Period|Non-compliance|0|||
146729339|NCT00337272|529178816|FG001|Withdrawal Period|Non-compliance|1|||
146729340|NCT01699022|529178822|FG000|Overall Study|Early discontinuation from the study|3|||
146729341|NCT04539821|529178823|FG000|Overall Study|Withdrawal by Subject|2|||
146729342|NCT04539821|529178823|FG000|Overall Study|continued care with their physician|20|||
146729343|NCT04539821|529178823|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
146729344|NCT02066402|529178826|FG000|Overall Study|Adverse Event|1|||
146729345|NCT02066402|529178827|FG001|Overall Study|Adverse Event|2|||
146729346|NCT02066402|529178826|FG000|Overall Study|Lost to Follow-up|11|||
146729347|NCT02066402|529178827|FG001|Overall Study|Lost to Follow-up|8|||
146729348|NCT02066402|529178826|FG000|Overall Study|Withdrawal by Subject|14|||
146729349|NCT02066402|529178827|FG001|Overall Study|Withdrawal by Subject|11|||
146729350|NCT02066402|529178826|FG000|Overall Study|Progressive disease-clinical progression|0|||
146729351|NCT02066402|529178827|FG001|Overall Study|Progressive disease-clinical progression|1|||
146729352|NCT02066402|529178826|FG000|Overall Study|Protocol driven decision point|0|||
146729353|NCT02066402|529178827|FG001|Overall Study|Protocol driven decision point|1|||
146729354|NCT00152464|529178828|FG000|Overall Study|Adverse Event|3|||
146729355|NCT00152464|529178829|FG001|Overall Study|Adverse Event|6|||
146729356|NCT00152464|529178828|FG000|Overall Study|Lost to Follow-up|8|||
146729357|NCT00152464|529178829|FG001|Overall Study|Lost to Follow-up|4|||
146729358|NCT00152464|529178828|FG000|Overall Study|Protocol Violation|3|||
146729359|NCT00152464|529178829|FG001|Overall Study|Protocol Violation|1|||
146729360|NCT00152464|529178828|FG000|Overall Study|Withdrawal by Subject|21|||
146729361|NCT00152464|529178829|FG001|Overall Study|Withdrawal by Subject|22|||
146729362|NCT00152464|529178828|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
146729363|NCT00152464|529178829|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
146729364|NCT00152464|529178828|FG000|Overall Study|Eczema deterioration|0|||
146729365|NCT00152464|529178829|FG001|Overall Study|Eczema deterioration|1|||
146729366|NCT00152464|529178828|FG000|Overall Study|Parent decision|1|||
146729367|NCT00152464|529178829|FG001|Overall Study|Parent decision|1|||
146729368|NCT00152464|529178828|FG000|Overall Study|Investigator decision|1|||
146729369|NCT00152464|529178829|FG001|Overall Study|Investigator decision|0|||
146729370|NCT00152464|529178828|FG000|Overall Study|Lack of Efficacy|1|||
146729371|NCT00152464|529178829|FG001|Overall Study|Lack of Efficacy|0|||
146729372|NCT00152464|529178828|FG000|Overall Study|Eczema poorly controlled|1|||
146729373|NCT00152464|529178829|FG001|Overall Study|Eczema poorly controlled|0|||
146729374|NCT00152464|529178828|FG000|Overall Study|Patient relocated|1|||
146729375|NCT00152464|529178829|FG001|Overall Study|Patient relocated|0|||
146729376|NCT04493931|529178831|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
146729377|NCT04493931|529178832|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
146729378|NCT04493931|529178833|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
146729379|NCT04493931|529178834|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
146729380|NCT04493931|529178835|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
146729381|NCT04493931|529178836|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
146729382|NCT04493931|529178837|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
146729383|NCT04493931|529178831|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
146729384|NCT04493931|529178832|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
146729385|NCT04493931|529178833|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
146729386|NCT04493931|529178834|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
146729387|NCT04493931|529178835|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
146729388|NCT04493931|529178836|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
146729389|NCT04493931|529178837|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
146729390|NCT04493931|529178831|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
146729391|NCT04493931|529178832|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
146729392|NCT04493931|529178833|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
146729393|NCT04493931|529178834|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
146729394|NCT04493931|529178835|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
146729395|NCT04493931|529178836|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
146729396|NCT04493931|529178837|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
146729397|NCT04493931|529178831|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
146729398|NCT04493931|529178832|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
146729399|NCT04493931|529178833|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
146729400|NCT04493931|529178834|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
146729401|NCT04493931|529178835|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
146729402|NCT04493931|529178836|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
146729403|NCT04493931|529178837|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
146787014|NCT04209465|529390767|FG011|Overall Study|Physician Decision|0|||
146936046|NCT00379236|529924143|FG001|Double-blind|Lost to Follow-up|3|||
146787015|NCT04209465|529390768|FG012|Overall Study|Physician Decision|0|||
146787016|NCT04209465|529390756|FG000|Overall Study|Progressive Disease|0|||
146787017|NCT04209465|529390757|FG001|Overall Study|Progressive Disease|0|||
146787018|NCT04209465|529390758|FG002|Overall Study|Progressive Disease|1|||
146787019|NCT04209465|529390759|FG003|Overall Study|Progressive Disease|2|||
146787020|NCT04209465|529390760|FG004|Overall Study|Progressive Disease|8|||
146787021|NCT04209465|529390761|FG005|Overall Study|Progressive Disease|5|||
146787022|NCT04209465|529390762|FG006|Overall Study|Progressive Disease|3|||
146787023|NCT04209465|529390763|FG007|Overall Study|Progressive Disease|4|||
146787024|NCT04209465|529390764|FG008|Overall Study|Progressive Disease|1|||
146787025|NCT04209465|529390765|FG009|Overall Study|Progressive Disease|3|||
146787026|NCT04209465|529390766|FG010|Overall Study|Progressive Disease|2|||
146787027|NCT04209465|529390767|FG011|Overall Study|Progressive Disease|1|||
146787028|NCT04209465|529390768|FG012|Overall Study|Progressive Disease|0|||
146787029|NCT04209465|529390756|FG000|Overall Study|Withdrawal by Subject|0|||
146787030|NCT04209465|529390757|FG001|Overall Study|Withdrawal by Subject|0|||
146787031|NCT04209465|529390758|FG002|Overall Study|Withdrawal by Subject|0|||
146787032|NCT04209465|529390759|FG003|Overall Study|Withdrawal by Subject|0|||
146787033|NCT04209465|529390760|FG004|Overall Study|Withdrawal by Subject|0|||
146787034|NCT04209465|529390761|FG005|Overall Study|Withdrawal by Subject|1|||
146787035|NCT04209465|529390762|FG006|Overall Study|Withdrawal by Subject|2|||
146787036|NCT04209465|529390763|FG007|Overall Study|Withdrawal by Subject|0|||
146729404|NCT03338894|529178838|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
146729405|NCT04465357|529178839|FG000|Overall Study|Adverse Event|2|||
146729406|NCT04465357|529178839|FG000|Overall Study|Lack of Efficacy|1|||
146729407|NCT04465357|529178839|FG000|Overall Study|Lost to Follow-up|2|||
146729408|NCT04465357|529178839|FG000|Overall Study|Withdrawal by Subject|6|||
146729409|NCT04465357|529178839|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
146729410|NCT00266825|529178846|FG000|Completed Follow-Up|Lost to Follow-up|14|||
146729411|NCT00266825|529178847|FG001|Completed Follow-Up|Lost to Follow-up|19|||
146787037|NCT04209465|529390764|FG008|Overall Study|Withdrawal by Subject|1|||
146787038|NCT04209465|529390765|FG009|Overall Study|Withdrawal by Subject|0|||
146787039|NCT04209465|529390766|FG010|Overall Study|Withdrawal by Subject|0|||
146787040|NCT04209465|529390767|FG011|Overall Study|Withdrawal by Subject|2|||
146787041|NCT04209465|529390768|FG012|Overall Study|Withdrawal by Subject|2|||
146787042|NCT04209465|529390756|FG000|Overall Study|Lost to Follow-up|0|||
146787043|NCT04209465|529390757|FG001|Overall Study|Lost to Follow-up|0|||
146787044|NCT04209465|529390758|FG002|Overall Study|Lost to Follow-up|0|||
146787045|NCT04209465|529390759|FG003|Overall Study|Lost to Follow-up|0|||
146787046|NCT04209465|529390760|FG004|Overall Study|Lost to Follow-up|0|||
146787047|NCT04209465|529390761|FG005|Overall Study|Lost to Follow-up|1|||
146787048|NCT04209465|529390762|FG006|Overall Study|Lost to Follow-up|0|||
146787049|NCT04209465|529390763|FG007|Overall Study|Lost to Follow-up|0|||
146787050|NCT04209465|529390764|FG008|Overall Study|Lost to Follow-up|1|||
146787051|NCT04209465|529390765|FG009|Overall Study|Lost to Follow-up|0|||
146787052|NCT04209465|529390766|FG010|Overall Study|Lost to Follow-up|0|||
146787053|NCT04209465|529390767|FG011|Overall Study|Lost to Follow-up|1|||
146787054|NCT04209465|529390768|FG012|Overall Study|Lost to Follow-up|0|||
146787055|NCT04209465|529390756|FG000|Overall Study|Started new therapy|0|||
146787056|NCT04209465|529390757|FG001|Overall Study|Started new therapy|0|||
146787057|NCT04209465|529390758|FG002|Overall Study|Started new therapy|0|||
146787058|NCT04209465|529390759|FG003|Overall Study|Started new therapy|0|||
146787059|NCT04209465|529390760|FG004|Overall Study|Started new therapy|0|||
146787060|NCT04209465|529390761|FG005|Overall Study|Started new therapy|1|||
146787061|NCT04209465|529390762|FG006|Overall Study|Started new therapy|0|||
146787062|NCT04209465|529390763|FG007|Overall Study|Started new therapy|0|||
146787063|NCT04209465|529390764|FG008|Overall Study|Started new therapy|0|||
146787064|NCT04209465|529390765|FG009|Overall Study|Started new therapy|0|||
146787065|NCT04209465|529390766|FG010|Overall Study|Started new therapy|0|||
146787066|NCT04209465|529390767|FG011|Overall Study|Started new therapy|0|||
146729412|NCT00266825|529178846|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
146729413|NCT00266825|529178847|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
146729414|NCT00430248|529178848|FG000|Overall Study|Adverse Event|49|||
146787067|NCT04209465|529390768|FG012|Overall Study|Started new therapy|0|||
146787068|NCT04209465|529390756|FG000|Overall Study|Study terminated early by sponsor|0|||
146787069|NCT04209465|529390757|FG001|Overall Study|Study terminated early by sponsor|0|||
146787070|NCT04209465|529390758|FG002|Overall Study|Study terminated early by sponsor|0|||
146787071|NCT04209465|529390759|FG003|Overall Study|Study terminated early by sponsor|0|||
146787072|NCT04209465|529390760|FG004|Overall Study|Study terminated early by sponsor|0|||
146787073|NCT04209465|529390761|FG005|Overall Study|Study terminated early by sponsor|0|||
146787074|NCT04209465|529390762|FG006|Overall Study|Study terminated early by sponsor|3|||
146787075|NCT04209465|529390763|FG007|Overall Study|Study terminated early by sponsor|0|||
146787076|NCT04209465|529390764|FG008|Overall Study|Study terminated early by sponsor|0|||
146787077|NCT04209465|529390765|FG009|Overall Study|Study terminated early by sponsor|0|||
146787078|NCT04209465|529390766|FG010|Overall Study|Study terminated early by sponsor|0|||
146729415|NCT00430248|529178849|FG001|Overall Study|Adverse Event|61|||
146787079|NCT04209465|529390767|FG011|Overall Study|Study terminated early by sponsor|0|||
146787080|NCT04209465|529390768|FG012|Overall Study|Study terminated early by sponsor|3|||
146787081|NCT04209465|529390756|FG000|Overall Study|Other|0|||
146787082|NCT04209465|529390757|FG001|Overall Study|Other|0|||
146787083|NCT04209465|529390758|FG002|Overall Study|Other|0|||
146787084|NCT04209465|529390759|FG003|Overall Study|Other|0|||
146787085|NCT04209465|529390760|FG004|Overall Study|Other|0|||
146787086|NCT04209465|529390761|FG005|Overall Study|Other|0|||
146787087|NCT04209465|529390762|FG006|Overall Study|Other|0|||
146787088|NCT04209465|529390763|FG007|Overall Study|Other|0|||
146787089|NCT04209465|529390764|FG008|Overall Study|Other|1|||
146787090|NCT04209465|529390765|FG009|Overall Study|Other|0|||
146787091|NCT04209465|529390766|FG010|Overall Study|Other|0|||
146787092|NCT04209465|529390767|FG011|Overall Study|Other|0|||
146787093|NCT04209465|529390768|FG012|Overall Study|Other|0|||
146787094|NCT03097549|529390769|FG000|Overall Study|Withdrawal by Subject|1|||
146787095|NCT03097549|529390770|FG001|Overall Study|Withdrawal by Subject|0|||
146787096|NCT03097549|529390769|FG000|Overall Study|Lost to Follow-up|1|||
146787097|NCT03097549|529390770|FG001|Overall Study|Lost to Follow-up|0|||
146787098|NCT04029688|529392826|FG000|Overall Study|Death|8|||
146787099|NCT04029688|529392827|FG001|Overall Study|Death|3|||
146787100|NCT04029688|529392828|FG002|Overall Study|Death|6|||
146787101|NCT04029688|529392829|FG003|Overall Study|Death|2|||
146787102|NCT04029688|529392830|FG004|Overall Study|Death|5|||
146787103|NCT04029688|529392831|FG005|Overall Study|Death|0|||
146787104|NCT04029688|529392832|FG006|Overall Study|Death|2|||
146787105|NCT04029688|529392833|FG007|Overall Study|Death|3|||
146787106|NCT04029688|529392826|FG000|Overall Study|Study Terminated by Sponsor|0|||
146787107|NCT04029688|529392827|FG001|Overall Study|Study Terminated by Sponsor|0|||
146787108|NCT04029688|529392828|FG002|Overall Study|Study Terminated by Sponsor|0|||
146787109|NCT04029688|529392829|FG003|Overall Study|Study Terminated by Sponsor|0|||
146787110|NCT04029688|529392830|FG004|Overall Study|Study Terminated by Sponsor|1|||
146787111|NCT04029688|529392831|FG005|Overall Study|Study Terminated by Sponsor|3|||
146787112|NCT04029688|529392832|FG006|Overall Study|Study Terminated by Sponsor|1|||
146787113|NCT04029688|529392833|FG007|Overall Study|Study Terminated by Sponsor|3|||
146787114|NCT04029688|529392826|FG000|Overall Study|Withdrawal by Subject|0|||
146787115|NCT04029688|529392827|FG001|Overall Study|Withdrawal by Subject|0|||
146787116|NCT04029688|529392828|FG002|Overall Study|Withdrawal by Subject|0|||
146787117|NCT04029688|529392829|FG003|Overall Study|Withdrawal by Subject|1|||
146787118|NCT04029688|529392830|FG004|Overall Study|Withdrawal by Subject|0|||
146787119|NCT04029688|529392831|FG005|Overall Study|Withdrawal by Subject|0|||
146787120|NCT04029688|529392832|FG006|Overall Study|Withdrawal by Subject|0|||
146787121|NCT04029688|529392833|FG007|Overall Study|Withdrawal by Subject|0|||
146787122|NCT01396278|529392835|FG000|Overall Study|Adverse Event|0|||
146787123|NCT01396278|529392836|FG001|Overall Study|Adverse Event|0|||
146787124|NCT01396278|529392837|FG002|Overall Study|Adverse Event|0|||
146787125|NCT01396278|529392838|FG003|Overall Study|Adverse Event|2|||
146787126|NCT01396278|529392839|FG004|Overall Study|Adverse Event|0|||
146981634|NCT01621490|530096097|FG010|Overall Study|Adverse event unrelated to study drug|0|||
146981635|NCT01621490|530096087|FG000|Overall Study|Disease progression|27|||
146981636|NCT01621490|530096088|FG001|Overall Study|Disease progression|28|||
146981637|NCT01621490|530096089|FG002|Overall Study|Disease progression|1|||
146981638|NCT01621490|530096090|FG003|Overall Study|Disease progression|5|||
146981639|NCT01621490|530096091|FG004|Overall Study|Disease progression|3|||
146981640|NCT01621490|530096092|FG005|Overall Study|Disease progression|8|||
146981641|NCT01621490|530096093|FG006|Overall Study|Disease progression|7|||
146981642|NCT01621490|530096094|FG007|Overall Study|Disease progression|1|||
146981643|NCT01621490|530096095|FG008|Overall Study|Disease progression|4|||
146981644|NCT01621490|530096096|FG009|Overall Study|Disease progression|1|||
146981645|NCT01621490|530096097|FG010|Overall Study|Disease progression|1|||
146981646|NCT01621490|530096087|FG000|Overall Study|Study drug toxicity|1|||
146981647|NCT01621490|530096088|FG001|Overall Study|Study drug toxicity|4|||
146981648|NCT01621490|530096089|FG002|Overall Study|Study drug toxicity|5|||
146981649|NCT01621490|530096090|FG003|Overall Study|Study drug toxicity|3|||
146981650|NCT01621490|530096091|FG004|Overall Study|Study drug toxicity|1|||
146981651|NCT01621490|530096092|FG005|Overall Study|Study drug toxicity|10|||
146981652|NCT01621490|530096093|FG006|Overall Study|Study drug toxicity|1|||
146981653|NCT01621490|530096094|FG007|Overall Study|Study drug toxicity|4|||
146981654|NCT01621490|530096095|FG008|Overall Study|Study drug toxicity|1|||
146981655|NCT01621490|530096096|FG009|Overall Study|Study drug toxicity|0|||
146981656|NCT01621490|530096097|FG010|Overall Study|Study drug toxicity|0|||
146981657|NCT01621490|530096087|FG000|Overall Study|Death|0|||
146981658|NCT01621490|530096088|FG001|Overall Study|Death|0|||
146787127|NCT01396278|529392835|FG000|Overall Study|Withdraw due to trial termination|2|||
146981659|NCT01621490|530096089|FG002|Overall Study|Death|0|||
146981660|NCT01621490|530096090|FG003|Overall Study|Death|0|||
146981661|NCT01621490|530096091|FG004|Overall Study|Death|0|||
146787128|NCT01396278|529392836|FG001|Overall Study|Withdraw due to trial termination|1|||
146787129|NCT01396278|529392837|FG002|Overall Study|Withdraw due to trial termination|1|||
146787130|NCT01396278|529392838|FG003|Overall Study|Withdraw due to trial termination|0|||
146787131|NCT01396278|529392839|FG004|Overall Study|Withdraw due to trial termination|2|||
146981662|NCT01621490|530096092|FG005|Overall Study|Death|0|||
146787132|NCT04764448|529392842|FG000|Overall Study|Study terminated by sponsor|2|||
146787133|NCT04764448|529392843|FG001|Overall Study|Study terminated by sponsor|2|||
146787134|NCT04764448|529392844|FG002|Overall Study|Study terminated by sponsor|5|||
146787135|NCT04764448|529392842|FG000|Overall Study|Withdrawal by Subject|3|||
146787136|NCT04764448|529392843|FG001|Overall Study|Withdrawal by Subject|3|||
146787137|NCT04764448|529392844|FG002|Overall Study|Withdrawal by Subject|1|||
146787138|NCT04515576|529392845|FG000|Overall Study|Withdrawal by Subject|0|||
146787139|NCT04515576|529392846|FG001|Overall Study|Withdrawal by Subject|0|||
146787140|NCT04515576|529392847|FG002|Overall Study|Withdrawal by Subject|0|||
146787141|NCT04515576|529392848|FG003|Overall Study|Withdrawal by Subject|0|||
146787142|NCT04515576|529392849|FG004|Overall Study|Withdrawal by Subject|0|||
146787143|NCT04515576|529392850|FG005|Overall Study|Withdrawal by Subject|1|||
146787144|NCT03812679|529392851|FG000|Overall Study|Adverse Event|2|||
146787145|NCT03812679|529392851|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
146787146|NCT03812679|529392851|FG000|Overall Study|Renal transplant|1|||
146787147|NCT03812679|529392851|FG000|Overall Study|Withdrawal by Subject|1|||
146787148|NCT03812679|529392851|FG000|Overall Study|Termination of study|2|||
146787149|NCT03812679|529392851|FG000|Overall Study|Water device replacement|1|||
146787150|NCT05653427|529392852|FG000|Overall Study|Study Terminated by Sponsor|13|||
146787151|NCT05590403|529392856|FG000|Overall Study|Lost to Follow-up|13|||
146787152|NCT05590403|529392857|FG001|Overall Study|Lost to Follow-up|1|||
146787153|NCT05590403|529392858|FG002|Overall Study|Lost to Follow-up|7|||
146787154|NCT05590403|529392859|FG003|Overall Study|Lost to Follow-up|3|||
146787155|NCT05590403|529392860|FG004|Overall Study|Lost to Follow-up|4|||
146787156|NCT05590403|529392856|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
146787157|NCT05590403|529392857|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
146787158|NCT05590403|529392858|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
146787159|NCT05590403|529392859|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
146787160|NCT05590403|529392860|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
146787161|NCT05590403|529392856|FG000|Overall Study|Other|2|||
146787162|NCT05590403|529392857|FG001|Overall Study|Other|0|||
146787163|NCT05590403|529392858|FG002|Overall Study|Other|2|||
146787164|NCT05590403|529392859|FG003|Overall Study|Other|2|||
146787165|NCT05590403|529392860|FG004|Overall Study|Other|0|||
146787166|NCT05590403|529392856|FG000|Overall Study|Migrated / moved from the study area|1|||
146787167|NCT05590403|529392857|FG001|Overall Study|Migrated / moved from the study area|1|||
146787168|NCT05590403|529392858|FG002|Overall Study|Migrated / moved from the study area|0|||
146787169|NCT05590403|529392859|FG003|Overall Study|Migrated / moved from the study area|3|||
146787170|NCT05590403|529392860|FG004|Overall Study|Migrated / moved from the study area|1|||
146787171|NCT05590403|529392856|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
146787172|NCT05590403|529392857|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
146787173|NCT05590403|529392858|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
146787174|NCT05590403|529392859|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
146787175|NCT05590403|529392860|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
146787176|NCT05659537|529392861|FG000|Overall Study|Adverse Event|5|||
146787177|NCT05659537|529392861|FG000|Overall Study|Lost to Follow-up|4|||
146787178|NCT05659537|529392861|FG000|Overall Study|Withdrawal by Subject|13|||
146787179|NCT05659537|529392861|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
146787180|NCT05659537|529392861|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
146787181|NCT05659537|529392861|FG000|Overall Study|Participant was suffering from anaemia|1|||
146787182|NCT03575897|529392865|FG000|Overall Study|Lost to Follow-up|12|||
146787183|NCT03575897|529392866|FG001|Overall Study|Lost to Follow-up|13|||
146787184|NCT01160211|529392868|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
146787185|NCT01160211|529392869|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
146787186|NCT01160211|529392870|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
146787187|NCT01160211|529392868|FG000|Overall Study|Lost to Follow-up|4|||
146787188|NCT01160211|529392869|FG001|Overall Study|Lost to Follow-up|8|||
146787189|NCT01160211|529392870|FG002|Overall Study|Lost to Follow-up|4|||
146787190|NCT01160211|529392868|FG000|Overall Study|Physician Decision|1|||
146787191|NCT01160211|529392869|FG001|Overall Study|Physician Decision|0|||
146787192|NCT01160211|529392870|FG002|Overall Study|Physician Decision|0|||
146787193|NCT01160211|529392868|FG000|Overall Study|Withdrawal by Subject|4|||
146787194|NCT01160211|529392869|FG001|Overall Study|Withdrawal by Subject|2|||
146787195|NCT01160211|529392870|FG002|Overall Study|Withdrawal by Subject|2|||
146787196|NCT01160211|529392868|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
146787197|NCT01160211|529392869|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
146787198|NCT01160211|529392870|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
146787199|NCT03611491|529392875|FG000|Overall Study|Lost to Follow-up|1|||
146787200|NCT03194217|529392876|FG000|Overall Study|Adverse Event|0|||
146787201|NCT03194217|529392877|FG001|Overall Study|Adverse Event|2|||
146787202|NCT03194217|529392878|FG002|Overall Study|Adverse Event|3|||
146787203|NCT03194217|529392879|FG003|Overall Study|Adverse Event|3|||
146787204|NCT03194217|529392876|FG000|Overall Study|Failure to meet randomisation criteria|0|||
146787205|NCT03194217|529392877|FG001|Overall Study|Failure to meet randomisation criteria|0|||
146787206|NCT03194217|529392878|FG002|Overall Study|Failure to meet randomisation criteria|0|||
146787207|NCT03194217|529392879|FG003|Overall Study|Failure to meet randomisation criteria|1|||
146787208|NCT03194217|529392876|FG000|Overall Study|Other|0|||
146787209|NCT03194217|529392877|FG001|Overall Study|Other|1|||
146787210|NCT03194217|529392878|FG002|Overall Study|Other|1|||
146787211|NCT03194217|529392879|FG003|Overall Study|Other|0|||
146787212|NCT04806451|529392880|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
146787213|NCT04806451|529392881|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
146787214|NCT04806451|529392880|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
146787215|NCT04806451|529392881|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
146787216|NCT04806451|529392880|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
146787217|NCT04806451|529392881|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
146787218|NCT05835336|529392882|FG000|Overall Study|Withdrawal by Subject|5|||
146787219|NCT05835336|529392882|FG000|Overall Study|Did not complete the personalization process|3|||
146787220|NCT03134196|529392894|FG000|Overall Study|Death|2|||
146787221|NCT03134196|529392895|FG001|Overall Study|Death|1|||
146787222|NCT03134196|529392894|FG000|Overall Study|Lost to Follow-up|13|||
146787223|NCT03134196|529392895|FG001|Overall Study|Lost to Follow-up|15|||
146787224|NCT03134196|529392894|FG000|Overall Study|Physician Decision|0|||
146787225|NCT03134196|529392895|FG001|Overall Study|Physician Decision|1|||
146787226|NCT03134196|529392894|FG000|Overall Study|Withdrawal by Subject|19|||
146787227|NCT03134196|529392895|FG001|Overall Study|Withdrawal by Subject|12|||
146936047|NCT00379236|529924144|FG002|Double-blind|Lost to Follow-up|0|||
146936048|NCT00379236|529924142|FG000|Double-blind|Use of exclusionary medication|1|||
146936049|NCT00379236|529924143|FG001|Double-blind|Use of exclusionary medication|2|||
146617985|NCT02222558|528773156|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
146617986|NCT02222558|528773157|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
146617987|NCT02222558|528773158|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
146617988|NCT02222558|528773159|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
146617989|NCT02222558|528773160|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
146617990|NCT02222558|528773161|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
146617991|NCT02222558|528773156|FG000|Period 3|Withdrawal by Subject|0|||
146617992|NCT02222558|528773157|FG001|Period 3|Withdrawal by Subject|0|||
146617993|NCT02222558|528773158|FG002|Period 3|Withdrawal by Subject|0|||
146617994|NCT02222558|528773159|FG003|Period 3|Withdrawal by Subject|0|||
146617995|NCT02222558|528773160|FG004|Period 3|Withdrawal by Subject|0|||
146617996|NCT02222558|528773161|FG005|Period 3|Withdrawal by Subject|1|||
146617997|NCT02322281|528773164|FG000|Overall Study|Progressive Disease|42|||
146617998|NCT02322281|528773165|FG001|Overall Study|Progressive Disease|14|||
146617999|NCT02322281|528773166|FG002|Overall Study|Progressive Disease|49|||
146618000|NCT02322281|528773164|FG000|Overall Study|Adverse Event|3|||
146618001|NCT02322281|528773165|FG001|Overall Study|Adverse Event|4|||
146618002|NCT02322281|528773166|FG002|Overall Study|Adverse Event|6|||
146618003|NCT02322281|528773164|FG000|Overall Study|Death|3|||
146618004|NCT02322281|528773165|FG001|Overall Study|Death|3|||
146618005|NCT02322281|528773166|FG002|Overall Study|Death|3|||
146618006|NCT02322281|528773164|FG000|Overall Study|Withdrawal by Subject|1|||
146618007|NCT02322281|528773165|FG001|Overall Study|Withdrawal by Subject|1|||
146618008|NCT02322281|528773166|FG002|Overall Study|Withdrawal by Subject|6|||
146618009|NCT02322281|528773164|FG000|Overall Study|Physician Decision|2|||
146618010|NCT02322281|528773165|FG001|Overall Study|Physician Decision|0|||
146618011|NCT02322281|528773166|FG002|Overall Study|Physician Decision|5|||
146936050|NCT00379236|529924144|FG002|Double-blind|Use of exclusionary medication|0|||
146936051|NCT00379236|529924142|FG000|Double-blind|Other|3|||
146618012|NCT02322281|528773164|FG000|Overall Study|Study Terminated by Sponsor|2|||
146618013|NCT02322281|528773165|FG001|Overall Study|Study Terminated by Sponsor|0|||
146618014|NCT02322281|528773166|FG002|Overall Study|Study Terminated by Sponsor|0|||
146618015|NCT02322281|528773164|FG000|Overall Study|Missing|0|||
146618016|NCT02322281|528773165|FG001|Overall Study|Missing|0|||
146618017|NCT02322281|528773166|FG002|Overall Study|Missing|1|||
146618018|NCT02322281|528773164|FG000|Overall Study|Miscellaneous|0|||
146618019|NCT02322281|528773165|FG001|Overall Study|Miscellaneous|0|||
146618020|NCT02322281|528773166|FG002|Overall Study|Miscellaneous|4|||
146618021|NCT00936702|528773170|FG000|Overall Study|Disease progression|34|||
146618022|NCT00936702|528773170|FG000|Overall Study|Adverse Event|8|||
146618023|NCT00936702|528773170|FG000|Overall Study|Withdrawal by Subject|2|||
146618024|NCT00936702|528773170|FG000|Overall Study|Alternative Treatment|1|||
146618025|NCT00936702|528773170|FG000|Overall Study|Other|1|||
146618026|NCT02420093|528773173|FG000|Overall Study|Withdrawal by Subject|1|||
146618027|NCT02420093|528773174|FG001|Overall Study|Withdrawal by Subject|1|||
146618028|NCT03001557|528773176|FG000|Core Phase|Randomized but not treated|0|||
146618029|NCT03001557|528773177|FG001|Core Phase|Randomized but not treated|0|||
146618030|NCT03001557|528773178|FG002|Core Phase|Randomized but not treated|1|||
146618031|NCT03001557|528773179|FG003|Core Phase|Randomized but not treated|0|||
146618032|NCT03001557|528773180|FG004|Core Phase|Randomized but not treated|0|||
146618033|NCT03001557|528773181|FG005|Core Phase|Randomized but not treated|0|||
146936052|NCT00379236|529924143|FG001|Double-blind|Other|7|||
146936053|NCT00379236|529924144|FG002|Double-blind|Other|0|||
146936054|NCT00379236|529924142|FG000|Double-blind|Data could not be retrieved|2|||
146936055|NCT00379236|529924143|FG001|Double-blind|Data could not be retrieved|2|||
146936056|NCT00379236|529924144|FG002|Double-blind|Data could not be retrieved|0|||
146936057|NCT00379236|529924142|FG000|Open-label Extension|Adverse Event|0|||
146936058|NCT00379236|529924143|FG001|Open-label Extension|Adverse Event|0|||
146936059|NCT00379236|529924144|FG002|Open-label Extension|Adverse Event|13|||
146936060|NCT00379236|529924142|FG000|Open-label Extension|Protocol Violation|0|||
146936061|NCT00379236|529924143|FG001|Open-label Extension|Protocol Violation|0|||
146936062|NCT00379236|529924144|FG002|Open-label Extension|Protocol Violation|7|||
146936063|NCT00379236|529924142|FG000|Open-label Extension|Withdrawal by Subject|0|||
146936064|NCT00379236|529924143|FG001|Open-label Extension|Withdrawal by Subject|0|||
146936065|NCT00379236|529924144|FG002|Open-label Extension|Withdrawal by Subject|13|||
146936066|NCT00379236|529924142|FG000|Open-label Extension|Lost to Follow-up|0|||
146936067|NCT00379236|529924143|FG001|Open-label Extension|Lost to Follow-up|0|||
146936068|NCT00379236|529924144|FG002|Open-label Extension|Lost to Follow-up|12|||
146936069|NCT00379236|529924142|FG000|Open-label Extension|Use of exclusionary medication|0|||
146936070|NCT00379236|529924143|FG001|Open-label Extension|Use of exclusionary medication|0|||
146936071|NCT00379236|529924144|FG002|Open-label Extension|Use of exclusionary medication|3|||
146936072|NCT00379236|529924142|FG000|Open-label Extension|Other|0|||
146936073|NCT00379236|529924143|FG001|Open-label Extension|Other|0|||
146936074|NCT00379236|529924144|FG002|Open-label Extension|Other|7|||
146936075|NCT00801892|529924145|FG000|Main Study Period|Withdrawal by Subject|0|||
146936076|NCT00801892|529924146|FG001|Main Study Period|Withdrawal by Subject|1|||
146936077|NCT00801892|529924145|FG000|Sham Crossover Period|Lost to Follow-up|0|||
146936078|NCT00801892|529924146|FG001|Sham Crossover Period|Lost to Follow-up|2|||
146936079|NCT00728936|529924147|FG000|Overall Study|Withdrawal by Subject|0|||
146936080|NCT00728936|529924148|FG001|Overall Study|Withdrawal by Subject|0|||
146936081|NCT00728936|529924149|FG002|Overall Study|Withdrawal by Subject|0|||
146936082|NCT00728936|529924150|FG003|Overall Study|Withdrawal by Subject|0|||
146936083|NCT00728936|529924151|FG004|Overall Study|Withdrawal by Subject|0|||
146936084|NCT00728936|529924152|FG005|Overall Study|Withdrawal by Subject|1|||
146936085|NCT00728936|529924153|FG006|Overall Study|Withdrawal by Subject|0|||
146936086|NCT00438464|529924154|FG000|Overall Study|Terminated Early|14|||
146936087|NCT00438464|529924155|FG001|Overall Study|Terminated Early|5|||
146936088|NCT00438464|529924154|FG000|Overall Study|Incomplete data submission|0|||
146936089|NCT00438464|529924155|FG001|Overall Study|Incomplete data submission|2|||
146936090|NCT01601704|529924156|FG000|Overall Study|Randomized but not dispensed study med|1|||
146936091|NCT01601704|529924157|FG001|Overall Study|Randomized but not dispensed study med|4|||
146936092|NCT01090102|529924158|FG000|First 12 Weeks|Withdrawal by Subject|1|||
146936093|NCT01090102|529924159|FG001|First 12 Weeks|Withdrawal by Subject|1|||
146936094|NCT01090102|529924158|FG000|First 12 Weeks|Adverse Event|2|||
146936095|NCT01090102|529924159|FG001|First 12 Weeks|Adverse Event|0|||
146936096|NCT01090102|529924158|FG000|First 12 Weeks|Death|1|||
146936097|NCT01090102|529924159|FG001|First 12 Weeks|Death|1|||
146936098|NCT01090102|529924158|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
146936099|NCT01090102|529924159|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
146936100|NCT02273037|529924161|FG000|Overall Study|Lost to Follow-up|1|||
146936101|NCT02273037|529924162|FG001|Overall Study|Lost to Follow-up|0|||
146936102|NCT02273037|529924161|FG000|Overall Study|Delivered before monitoring initiated|1|||
146936103|NCT02273037|529924162|FG001|Overall Study|Delivered before monitoring initiated|3|||
146936104|NCT02273037|529924161|FG000|Overall Study|Breech delivery|2|||
146936105|NCT02273037|529924162|FG001|Overall Study|Breech delivery|3|||
146936106|NCT02273037|529924161|FG000|Overall Study|Multiple delivery|2|||
146936107|NCT02273037|529924162|FG001|Overall Study|Multiple delivery|2|||
146936108|NCT02273037|529924161|FG000|Overall Study|Other complication|2|||
146936109|NCT02273037|529924162|FG001|Overall Study|Other complication|0|||
146936110|NCT00881361|529924171|FG000|Overall Study|Terminated prior to surgery|27|||
146936111|NCT00881361|529924172|FG001|Overall Study|Terminated prior to surgery|7|||
146936112|NCT00881361|529924173|FG002|Overall Study|Terminated prior to surgery|0|||
146936113|NCT00881361|529924171|FG000|Overall Study|Ineligible|17|||
146936114|NCT00881361|529924172|FG001|Overall Study|Ineligible|2|||
146936115|NCT00881361|529924173|FG002|Overall Study|Ineligible|2|||
146618034|NCT03001557|528773182|FG006|Core Phase|Randomized but not treated|0|||
146936116|NCT02137837|529924174|FG000|Overall Study|Adverse Event|0|||
146936117|NCT02137837|529924175|FG001|Overall Study|Adverse Event|2|||
146936118|NCT02137837|529924176|FG002|Overall Study|Adverse Event|1|||
146618035|NCT03001557|528773183|FG007|Core Phase|Randomized but not treated|0|||
146618036|NCT03001557|528773176|FG000|Extension Phase|Adverse Event|0|||
146936119|NCT02137837|529924174|FG000|Overall Study|Refusal unrelated to adverse event|2|||
146936120|NCT02137837|529924175|FG001|Overall Study|Refusal unrelated to adverse event|2|||
146936121|NCT02137837|529924176|FG002|Overall Study|Refusal unrelated to adverse event|1|||
146936122|NCT02137837|529924174|FG000|Overall Study|Progression/relapse|9|||
146936123|NCT02137837|529924175|FG001|Overall Study|Progression/relapse|7|||
146936124|NCT02137837|529924176|FG002|Overall Study|Progression/relapse|7|||
146936125|NCT02137837|529924174|FG000|Overall Study|Not protocol specified|2|||
146936126|NCT02137837|529924175|FG001|Overall Study|Not protocol specified|1|||
146936127|NCT02137837|529924176|FG002|Overall Study|Not protocol specified|3|||
146936128|NCT01181141|529924179|FG000|Overall Study|Adverse Event|2|||
146936129|NCT01181141|529924180|FG001|Overall Study|Adverse Event|1|||
146936130|NCT01181141|529924179|FG000|Overall Study|Lack of Efficacy|1|||
146936131|NCT01181141|529924180|FG001|Overall Study|Lack of Efficacy|0|||
146936132|NCT01181141|529924179|FG000|Overall Study|Lost to Follow-up|1|||
146936133|NCT01181141|529924180|FG001|Overall Study|Lost to Follow-up|1|||
146936134|NCT01181141|529924179|FG000|Overall Study|Physician Decision|2|||
146936135|NCT01181141|529924180|FG001|Overall Study|Physician Decision|0|||
146936136|NCT01181141|529924179|FG000|Overall Study|Protocol Violation|3|||
146936137|NCT01181141|529924180|FG001|Overall Study|Protocol Violation|1|||
146936138|NCT01181141|529924179|FG000|Overall Study|Withdrawal by Subject|3|||
146936139|NCT01181141|529924180|FG001|Overall Study|Withdrawal by Subject|1|||
146936140|NCT00118911|529924181|FG000|Overall Study|Withdrawal by Subject|2|||
146936141|NCT00118911|529924182|FG001|Overall Study|Withdrawal by Subject|5|||
146618037|NCT03001557|528773177|FG001|Extension Phase|Adverse Event|0|||
146618038|NCT03001557|528773178|FG002|Extension Phase|Adverse Event|0|||
146618039|NCT03001557|528773179|FG003|Extension Phase|Adverse Event|0|||
146618040|NCT03001557|528773180|FG004|Extension Phase|Adverse Event|0|||
146618041|NCT03001557|528773181|FG005|Extension Phase|Adverse Event|2|||
146618042|NCT03001557|528773182|FG006|Extension Phase|Adverse Event|0|||
146618043|NCT03001557|528773183|FG007|Extension Phase|Adverse Event|0|||
146618044|NCT03001557|528773176|FG000|Extension Phase|Withdrawal by Subject|0|||
146618045|NCT03001557|528773177|FG001|Extension Phase|Withdrawal by Subject|0|||
146936142|NCT05507580|529924183|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146936143|NCT05507580|529924184|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
146936144|NCT05507580|529924185|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
146936145|NCT05507580|529924186|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
146936146|NCT05507580|529924187|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
146618046|NCT03001557|528773178|FG002|Extension Phase|Withdrawal by Subject|0|||
146618047|NCT03001557|528773179|FG003|Extension Phase|Withdrawal by Subject|0|||
146618048|NCT03001557|528773180|FG004|Extension Phase|Withdrawal by Subject|0|||
146618049|NCT03001557|528773181|FG005|Extension Phase|Withdrawal by Subject|1|||
146618050|NCT03001557|528773182|FG006|Extension Phase|Withdrawal by Subject|5|||
146618051|NCT03001557|528773183|FG007|Extension Phase|Withdrawal by Subject|2|||
146618052|NCT03001557|528773176|FG000|Extension Phase|Lost to Follow-up|0|||
146618053|NCT03001557|528773177|FG001|Extension Phase|Lost to Follow-up|0|||
146618054|NCT03001557|528773178|FG002|Extension Phase|Lost to Follow-up|0|||
146618055|NCT03001557|528773179|FG003|Extension Phase|Lost to Follow-up|0|||
146618056|NCT03001557|528773180|FG004|Extension Phase|Lost to Follow-up|0|||
146618057|NCT03001557|528773181|FG005|Extension Phase|Lost to Follow-up|0|||
146618058|NCT03001557|528773182|FG006|Extension Phase|Lost to Follow-up|2|||
146618059|NCT03001557|528773183|FG007|Extension Phase|Lost to Follow-up|1|||
146729416|NCT00430248|529178850|FG002|Overall Study|Adverse Event|64|||
146936147|NCT05507580|529924188|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
146936148|NCT05507580|529924183|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
146936149|NCT05507580|529924184|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146936150|NCT05507580|529924185|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146729417|NCT00430248|529178848|FG000|Overall Study|Protocol Violation|10|||
146729418|NCT00430248|529178849|FG001|Overall Study|Protocol Violation|2|||
146729419|NCT00430248|529178850|FG002|Overall Study|Protocol Violation|4|||
146729420|NCT00430248|529178848|FG000|Overall Study|Personal Reasons|12|||
146729421|NCT00430248|529178849|FG001|Overall Study|Personal Reasons|24|||
146729422|NCT00430248|529178850|FG002|Overall Study|Personal Reasons|9|||
146729423|NCT00430248|529178848|FG000|Overall Study|Lost to Follow-up|28|||
146729424|NCT00430248|529178849|FG001|Overall Study|Lost to Follow-up|33|||
146729425|NCT00430248|529178850|FG002|Overall Study|Lost to Follow-up|28|||
146729426|NCT00430248|529178848|FG000|Overall Study|Therapeutic Failure|1|||
146729427|NCT00430248|529178849|FG001|Overall Study|Therapeutic Failure|1|||
146729428|NCT00430248|529178850|FG002|Overall Study|Therapeutic Failure|1|||
146729429|NCT00430248|529178848|FG000|Overall Study|Withdrawal by Subject|14|||
146729430|NCT00430248|529178849|FG001|Overall Study|Withdrawal by Subject|20|||
146729431|NCT00430248|529178850|FG002|Overall Study|Withdrawal by Subject|16|||
146729432|NCT00430248|529178848|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146729433|NCT00430248|529178849|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
146729434|NCT00430248|529178850|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146729435|NCT00430248|529178848|FG000|Overall Study|Gout Flare|3|||
146729436|NCT00430248|529178849|FG001|Overall Study|Gout Flare|7|||
146936151|NCT05507580|529924186|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146936152|NCT05507580|529924187|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146618060|NCT03001557|528773176|FG000|Extension Phase|Administrative Reason|0|||
146618061|NCT03001557|528773177|FG001|Extension Phase|Administrative Reason|0|||
146618062|NCT03001557|528773178|FG002|Extension Phase|Administrative Reason|0|||
146729437|NCT00430248|529178850|FG002|Overall Study|Gout Flare|2|||
146729438|NCT00430248|529178848|FG000|Overall Study|Reason Not Specified|8|||
146618063|NCT03001557|528773179|FG003|Extension Phase|Administrative Reason|0|||
146618064|NCT03001557|528773180|FG004|Extension Phase|Administrative Reason|0|||
146618065|NCT03001557|528773181|FG005|Extension Phase|Administrative Reason|1|||
146618066|NCT03001557|528773182|FG006|Extension Phase|Administrative Reason|3|||
146618067|NCT03001557|528773183|FG007|Extension Phase|Administrative Reason|3|||
146618068|NCT03001557|528773176|FG000|Extension Phase|Loss of caregiver|0|||
146618069|NCT03001557|528773177|FG001|Extension Phase|Loss of caregiver|0|||
146618070|NCT03001557|528773178|FG002|Extension Phase|Loss of caregiver|0|||
146618071|NCT03001557|528773179|FG003|Extension Phase|Loss of caregiver|0|||
146618072|NCT03001557|528773180|FG004|Extension Phase|Loss of caregiver|0|||
146618073|NCT03001557|528773181|FG005|Extension Phase|Loss of caregiver|0|||
146618074|NCT03001557|528773182|FG006|Extension Phase|Loss of caregiver|1|||
146618075|NCT03001557|528773183|FG007|Extension Phase|Loss of caregiver|0|||
146618076|NCT03001557|528773176|FG000|Extension Phase|Others|0|||
146618077|NCT03001557|528773177|FG001|Extension Phase|Others|0|||
146618078|NCT03001557|528773178|FG002|Extension Phase|Others|0|||
146618079|NCT03001557|528773179|FG003|Extension Phase|Others|0|||
146618080|NCT03001557|528773180|FG004|Extension Phase|Others|0|||
146618081|NCT03001557|528773181|FG005|Extension Phase|Others|1|||
146618082|NCT03001557|528773182|FG006|Extension Phase|Others|3|||
146618083|NCT03001557|528773183|FG007|Extension Phase|Others|0|||
146618084|NCT01794000|528773184|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
146618085|NCT01794000|528773185|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
146618086|NCT01794000|528773184|FG000|Double-Blind Phase (DBP)|Death|1|||
146618087|NCT01794000|528773185|FG001|Double-Blind Phase (DBP)|Death|2|||
146618088|NCT01794000|528773184|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
146618089|NCT01794000|528773185|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
146618090|NCT01794000|528773184|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
146618091|NCT01794000|528773185|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
146618092|NCT01794000|528773184|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
146618093|NCT01794000|528773185|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
146618094|NCT01794000|528773184|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
146618095|NCT01794000|528773185|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
146618096|NCT01794000|528773184|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
146618097|NCT01794000|528773185|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
146618098|NCT01794000|528773184|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
146618099|NCT01794000|528773185|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
146618100|NCT01308736|528773191|FG000|Overall Study|Did not attend a single session|6|||
146618101|NCT01308736|528773192|FG001|Overall Study|Did not attend a single session|5|||
146618102|NCT01946139|528773193|FG000|Overall Study|Withdrawal by Subject|8|||
146618103|NCT01946139|528773193|FG000|Overall Study|ineligible|8|||
146618104|NCT01946139|528773193|FG000|Overall Study|Specimens not available|4|||
146618105|NCT01363700|528773202|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
146618106|NCT01363700|528773203|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
146618107|NCT01363700|528773204|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
146618108|NCT01363700|528773205|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
146618109|NCT01363700|528773206|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
146618110|NCT02721875|528773207|FG000|Overall Study|Progressive disease/relapse|1|||
146618111|NCT02721875|528773208|FG001|Overall Study|Progressive disease/relapse|0|||
146618112|NCT00857285|528773211|FG000|Overall Study|Adverse Event|4|||
146618113|NCT00857285|528773212|FG001|Overall Study|Adverse Event|2|||
146618114|NCT00857285|528773211|FG000|Overall Study|Lack of Efficacy|0|||
146618115|NCT00857285|528773212|FG001|Overall Study|Lack of Efficacy|2|||
146618116|NCT00857285|528773211|FG000|Overall Study|Protocol Violation|3|||
146618117|NCT00857285|528773212|FG001|Overall Study|Protocol Violation|1|||
146618118|NCT00857285|528773211|FG000|Overall Study|Withdrawal by Subject|4|||
146618119|NCT00857285|528773212|FG001|Overall Study|Withdrawal by Subject|0|||
146618120|NCT00857285|528773211|FG000|Overall Study|Randomization criteria not met|1|||
146618121|NCT00857285|528773212|FG001|Overall Study|Randomization criteria not met|1|||
146618122|NCT01329978|528773219|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
146618123|NCT01329978|528773220|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
146618124|NCT01329978|528773221|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
146618125|NCT01329978|528773222|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
146618126|NCT01329978|528773223|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
146618127|NCT01329978|528773219|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
146618128|NCT01329978|528773220|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
146618129|NCT01329978|528773221|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
146618130|NCT01329978|528773222|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
146618131|NCT01329978|528773223|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
146618132|NCT01329978|528773219|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
146618133|NCT01329978|528773220|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
146618134|NCT01329978|528773221|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
146618135|NCT01329978|528773222|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
146618136|NCT01329978|528773223|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
146981663|NCT01621490|530096093|FG006|Overall Study|Death|0|||
146729439|NCT00430248|529178849|FG001|Overall Study|Reason Not Specified|8|||
146729440|NCT00430248|529178850|FG002|Overall Study|Reason Not Specified|11|||
146729441|NCT01754467|529178854|FG000|Overall Study|Lost to Follow-up|1|||
146729442|NCT01970462|529178855|FG000|Overall Study|Lost to Follow-up|0|||
146729443|NCT01970462|529178856|FG001|Overall Study|Lost to Follow-up|2|||
146729444|NCT00917579|529178857|FG000|Washout >= 2 Weeks|Adverse Event|1|||
146729445|NCT00917579|529178858|FG001|Washout >= 2 Weeks|Adverse Event|0|||
146729446|NCT00917579|529178857|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
146729447|NCT00917579|529178858|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
146729448|NCT00754338|529178859|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
146729449|NCT00754338|529178860|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
146729450|NCT00754338|529178861|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
146729451|NCT00754338|529178862|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
146729452|NCT00754338|529178859|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
146729453|NCT00754338|529178860|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
146729454|NCT00754338|529178861|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
146729455|NCT00754338|529178862|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
146729456|NCT04020341|529178865|FG000|Overall Study|Adverse Event|8|||
146729457|NCT04020341|529178866|FG001|Overall Study|Adverse Event|6|||
146729458|NCT04020341|529178865|FG000|Overall Study|Lost to Follow-up|8|||
146729459|NCT04020341|529178866|FG001|Overall Study|Lost to Follow-up|2|||
146729460|NCT04020341|529178865|FG000|Overall Study|Withdrawal by Subject|16|||
146729461|NCT04020341|529178866|FG001|Overall Study|Withdrawal by Subject|16|||
146729462|NCT04020341|529178865|FG000|Overall Study|Participant not able to swallow the tablet|1|||
146729463|NCT04020341|529178866|FG001|Overall Study|Participant not able to swallow the tablet|0|||
146729464|NCT04020341|529178865|FG000|Overall Study|Physician Decision|0|||
146729465|NCT04020341|529178866|FG001|Overall Study|Physician Decision|2|||
146729466|NCT04020341|529178865|FG000|Overall Study|Protocol Deviation|0|||
146729467|NCT04020341|529178866|FG001|Overall Study|Protocol Deviation|2|||
146729468|NCT05763628|529178867|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
146729469|NCT05763628|529178868|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
146729470|NCT05763628|529178867|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
146729471|NCT05763628|529178868|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
146729472|NCT05763628|529178867|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
146729473|NCT05763628|529178868|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
146729474|NCT04860518|529178869|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
146729475|NCT04860518|529178870|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
146729476|NCT04555096|529178874|FG000|Overall Study|Death|4|||
146729477|NCT04555096|529178875|FG001|Overall Study|Death|4|||
146729478|NCT04555096|529178874|FG000|Overall Study|Withdrawal by Subject|1|||
146729479|NCT04555096|529178875|FG001|Overall Study|Withdrawal by Subject|0|||
146729480|NCT04555096|529178874|FG000|Overall Study|Other|0|||
146729481|NCT04555096|529178875|FG001|Overall Study|Other|1|||
146729482|NCT04495179|529178882|FG000|Overall Study|Lost to Follow-up|0|||
146729483|NCT04495179|529178883|FG001|Overall Study|Lost to Follow-up|1|||
146729484|NCT04495179|529178882|FG000|Overall Study|Withdrawal by Subject|2|||
146729485|NCT04495179|529178883|FG001|Overall Study|Withdrawal by Subject|4|||
146729486|NCT04495179|529178882|FG000|Overall Study|Study terminated by sponsor|0|||
146729487|NCT04495179|529178883|FG001|Overall Study|Study terminated by sponsor|18|||
146729488|NCT04495179|529178882|FG000|Overall Study|Death|0|||
146729489|NCT04495179|529178883|FG001|Overall Study|Death|4|||
146729490|NCT04495179|529178882|FG000|Overall Study|Adverse Event|0|||
146729491|NCT04495179|529178883|FG001|Overall Study|Adverse Event|1|||
146729492|NCT00162370|529178884|FG000|Efficacy Population|Lost to Follow-up|51|||
146729493|NCT00569582|529178885|FG000|Overall Study|Withdrawal by Subject|5|||
146729494|NCT00569582|529178885|FG000|Overall Study|Death|2|||
146729495|NCT00569582|529178885|FG000|Overall Study|Adverse Event|7|||
146729496|NCT00569582|529178885|FG000|Overall Study|Subject was too ill to travel.|1|||
146729497|NCT00569582|529178885|FG000|Overall Study|Subject was non-compliant.|1|||
146729498|NCT02612311|529178888|FG000|Overall Study|Adverse Event|16|||
146729499|NCT02612311|529178889|FG001|Overall Study|Adverse Event|12|||
146729500|NCT02612311|529178890|FG002|Overall Study|Adverse Event|7|||
146729501|NCT02612311|529178891|FG003|Overall Study|Adverse Event|13|||
146729502|NCT02612311|529178888|FG000|Overall Study|Death|29|||
146729503|NCT02612311|529178889|FG001|Overall Study|Death|10|||
146729504|NCT02612311|529178890|FG002|Overall Study|Death|11|||
146729505|NCT02612311|529178891|FG003|Overall Study|Death|11|||
146729506|NCT02612311|529178888|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
146729507|NCT02612311|529178889|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
146729508|NCT02612311|529178890|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
146729509|NCT02612311|529178891|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
146729510|NCT02612311|529178888|FG000|Overall Study|Investigator's Decision|11|||
146729511|NCT02612311|529178889|FG001|Overall Study|Investigator's Decision|15|||
146981664|NCT01621490|530096094|FG007|Overall Study|Death|0|||
146618137|NCT01329978|528773219|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
146618138|NCT01329978|528773220|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
146618139|NCT01329978|528773221|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
146618140|NCT01329978|528773222|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
146618141|NCT01329978|528773223|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
146618142|NCT01329978|528773219|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
146618143|NCT01329978|528773220|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
146618144|NCT01329978|528773221|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
146618145|NCT01329978|528773222|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
146618146|NCT01329978|528773223|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
146618147|NCT01329978|528773219|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
146618148|NCT01329978|528773220|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
146618149|NCT01329978|528773221|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
146618150|NCT01329978|528773222|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
146618151|NCT01329978|528773223|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
146618152|NCT01329978|528773219|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
146618153|NCT01329978|528773220|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
146618154|NCT01329978|528773221|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
146618155|NCT01329978|528773222|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
146618156|NCT01329978|528773223|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
146618157|NCT03901144|528773224|FG000|Overall Study|Lost to Follow-up|1|||
146618158|NCT03901144|528773225|FG001|Overall Study|Lost to Follow-up|1|||
146618159|NCT03901144|528773226|FG002|Overall Study|Lost to Follow-up|1|||
146618160|NCT03901144|528773227|FG003|Overall Study|Lost to Follow-up|1|||
146618161|NCT01807598|528773228|FG000|Overall Study|Withdrawal by Subject|4|||
146618162|NCT01807598|528773228|FG000|Overall Study|Adverse Event|1|||
146618163|NCT01807598|528773228|FG000|Overall Study|Other Physician Decision|1|||
146618164|NCT04896593|528773232|FG000|Overall Study|Withdrawal by Subject|2|||
146618165|NCT04896593|528773232|FG000|Overall Study|Lost to Follow-up|1|||
146618166|NCT04896593|528773232|FG000|Overall Study|Did not complete onboarding|2|||
146618167|NCT00452790|528773233|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
146618168|NCT00452790|528773234|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
146618169|NCT00452790|528773233|FG000|Infant Series|Parent/legal guardian request|8|||
146618170|NCT00452790|528773234|FG001|Infant Series|Parent/legal guardian request|6|||
146618171|NCT00452790|528773233|FG000|Infant Series|Failed to return|4|||
146618172|NCT00452790|528773234|FG001|Infant Series|Failed to return|1|||
146618173|NCT00452790|528773233|FG000|Infant Series|Protocol Violation|1|||
146618174|NCT00452790|528773234|FG001|Infant Series|Protocol Violation|3|||
146618175|NCT00452790|528773233|FG000|Infant Series|Lost to Follow-up|2|||
146618176|NCT00452790|528773234|FG001|Infant Series|Lost to Follow-up|2|||
146618177|NCT00452790|528773233|FG000|Infant Series|Adverse Event|1|||
146618178|NCT00452790|528773234|FG001|Infant Series|Adverse Event|2|||
146618179|NCT00452790|528773233|FG000|Infant Series|Other reasons|1|||
146618180|NCT00452790|528773234|FG001|Infant Series|Other reasons|2|||
146618181|NCT00452790|528773233|FG000|Infant Series|Investigator request|0|||
146618182|NCT00452790|528773234|FG001|Infant Series|Investigator request|1|||
146618183|NCT00452790|528773233|FG000|Infant Series|Death|0|||
146618184|NCT00452790|528773234|FG001|Infant Series|Death|1|||
146618185|NCT00452790|528773233|FG000|After Infant Series|Investigator request|10|||
146618186|NCT00452790|528773234|FG001|After Infant Series|Investigator request|10|||
146618187|NCT00452790|528773233|FG000|After Infant Series|Adverse Event|4|||
146618188|NCT00452790|528773234|FG001|After Infant Series|Adverse Event|1|||
146618189|NCT00452790|528773233|FG000|After Infant Series|Parent/legal guardian request|1|||
146618190|NCT00452790|528773234|FG001|After Infant Series|Parent/legal guardian request|3|||
146618191|NCT00452790|528773233|FG000|After Infant Series|Lost to Follow-up|4|||
146936153|NCT05507580|529924188|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146936154|NCT05507580|529924183|FG000|Double-Blind Treatment Period|Other, not specified|5|||
146618192|NCT00452790|528773234|FG001|After Infant Series|Lost to Follow-up|0|||
146618193|NCT00452790|528773233|FG000|After Infant Series|Failed to return|1|||
146618194|NCT00452790|528773234|FG001|After Infant Series|Failed to return|0|||
146618195|NCT00452790|528773233|FG000|After Infant Series|Other reasons|1|||
146936155|NCT05507580|529924184|FG001|Double-Blind Treatment Period|Other, not specified|4|||
146936156|NCT05507580|529924185|FG002|Double-Blind Treatment Period|Other, not specified|0|||
146936157|NCT05507580|529924186|FG003|Double-Blind Treatment Period|Other, not specified|0|||
146936158|NCT05507580|529924187|FG004|Double-Blind Treatment Period|Other, not specified|0|||
146936159|NCT05507580|529924188|FG005|Double-Blind Treatment Period|Other, not specified|0|||
146936160|NCT05507580|529924183|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
146618196|NCT00452790|528773234|FG001|After Infant Series|Other reasons|0|||
146618197|NCT00452790|528773233|FG000|Toddler Dose|Failed to return|0|||
146618198|NCT00452790|528773234|FG001|Toddler Dose|Failed to return|1|||
146618199|NCT00452790|528773233|FG000|Toddler Dose|Parent/legal guardian request|0|||
146729512|NCT02612311|529178890|FG002|Overall Study|Investigator's Decision|6|||
146618200|NCT00452790|528773234|FG001|Toddler Dose|Parent/legal guardian request|1|||
146618201|NCT00176462|528773245|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
146618202|NCT00176462|528773246|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
146618203|NCT00176462|528773245|FG000|Induction (4 Weeks)|Death|1|||
146618204|NCT00176462|528773246|FG001|Induction (4 Weeks)|Death|2|||
146618205|NCT00176462|528773245|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
146618206|NCT00176462|528773246|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
146618207|NCT00176462|528773245|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
146618208|NCT00176462|528773246|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
146618209|NCT00176462|528773245|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
146618210|NCT00176462|528773246|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
146618211|NCT00176462|528773245|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
146618212|NCT00176462|528773246|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
146618213|NCT00176462|528773245|FG000|Consolidation (12 Weeks)|Not documented|0|||
146618214|NCT00176462|528773246|FG001|Consolidation (12 Weeks)|Not documented|1|||
146618215|NCT00176462|528773245|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
146618216|NCT00176462|528773246|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
146618217|NCT00176462|528773245|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
146618218|NCT00176462|528773246|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
146618219|NCT01150097|528773248|FG000|Months 24 to 36 Post-transplantation|Death|2|||
146618220|NCT01150097|528773249|FG001|Months 24 to 36 Post-transplantation|Death|0|||
146618221|NCT01150097|528773250|FG002|Months 24 to 36 Post-transplantation|Death|0|||
146618222|NCT01150097|528773248|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
146618223|NCT01150097|528773249|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
146618224|NCT01150097|528773250|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
146618225|NCT01150097|528773248|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
146618226|NCT01150097|528773249|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
146618227|NCT01150097|528773250|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
146618228|NCT01150097|528773248|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
146618229|NCT01150097|528773249|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
146618230|NCT01150097|528773250|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
146618231|NCT01150097|528773248|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
146618232|NCT01150097|528773249|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
146618233|NCT01150097|528773250|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
146618234|NCT01150097|528773248|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
146618235|NCT01150097|528773249|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
146618236|NCT01150097|528773250|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
146618237|NCT01150097|528773248|FG000|Months 24 to 48 Post-transplantation|Death|2|||
146618238|NCT01150097|528773249|FG001|Months 24 to 48 Post-transplantation|Death|0|||
146618239|NCT01150097|528773250|FG002|Months 24 to 48 Post-transplantation|Death|0|||
146618240|NCT01301833|528773255|FG000|Overall Study|Adverse Event|7|||
146618241|NCT01301833|528773256|FG001|Overall Study|Adverse Event|5|||
146618242|NCT01301833|528773257|FG002|Overall Study|Adverse Event|5|||
146618243|NCT01301833|528773258|FG003|Overall Study|Adverse Event|5|||
146618244|NCT01301833|528773255|FG000|Overall Study|Lack of Efficacy|1|||
146618245|NCT01301833|528773256|FG001|Overall Study|Lack of Efficacy|1|||
146618246|NCT01301833|528773257|FG002|Overall Study|Lack of Efficacy|0|||
146618247|NCT01301833|528773258|FG003|Overall Study|Lack of Efficacy|0|||
146618248|NCT01301833|528773255|FG000|Overall Study|Physician Decision|3|||
146618249|NCT01301833|528773256|FG001|Overall Study|Physician Decision|1|||
146618250|NCT01301833|528773257|FG002|Overall Study|Physician Decision|1|||
146618251|NCT01301833|528773258|FG003|Overall Study|Physician Decision|0|||
146618252|NCT01301833|528773255|FG000|Overall Study|Withdrawal by Subject|3|||
146618253|NCT01301833|528773256|FG001|Overall Study|Withdrawal by Subject|1|||
146618254|NCT01301833|528773257|FG002|Overall Study|Withdrawal by Subject|1|||
146618255|NCT01301833|528773258|FG003|Overall Study|Withdrawal by Subject|2|||
146618256|NCT01301833|528773255|FG000|Overall Study|Personal matter|1|||
146618257|NCT01301833|528773256|FG001|Overall Study|Personal matter|0|||
146618258|NCT01301833|528773257|FG002|Overall Study|Personal matter|0|||
146618259|NCT01301833|528773258|FG003|Overall Study|Personal matter|0|||
146618260|NCT01279681|528773259|FG000|Overall Study|Disease Progression|9|||
146618261|NCT01279681|528773260|FG001|Overall Study|Disease Progression|6|||
146618262|NCT01279681|528773259|FG000|Overall Study|Withdrawal by Subject|3|||
146618263|NCT01279681|528773260|FG001|Overall Study|Withdrawal by Subject|4|||
146618264|NCT01279681|528773259|FG000|Overall Study|Adverse Event|2|||
146618265|NCT01279681|528773260|FG001|Overall Study|Adverse Event|3|||
146618266|NCT01279681|528773259|FG000|Overall Study|Death|0|||
146618267|NCT01279681|528773260|FG001|Overall Study|Death|1|||
146618268|NCT01279681|528773259|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
146618269|NCT01279681|528773260|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
146618270|NCT01279681|528773259|FG000|Overall Study|Physician Decision|1|||
146618271|NCT01279681|528773260|FG001|Overall Study|Physician Decision|0|||
146618272|NCT01279681|528773259|FG000|Overall Study|Other Reason|0|||
146936161|NCT05507580|529924184|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
146936162|NCT05507580|529924185|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
146936163|NCT05507580|529924186|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
146936164|NCT05507580|529924187|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
146936165|NCT05507580|529924188|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
146936166|NCT05507580|529924183|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
146936167|NCT05507580|529924184|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
146936168|NCT05507580|529924185|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
146936169|NCT05507580|529924186|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
146936170|NCT05507580|529924187|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
146936171|NCT05507580|529924188|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
146936172|NCT05507580|529924183|FG000|Single-Blind Treatment Period|Other, not specified|0|||
146936173|NCT05507580|529924184|FG001|Single-Blind Treatment Period|Other, not specified|0|||
146936174|NCT05507580|529924185|FG002|Single-Blind Treatment Period|Other, not specified|2|||
146936175|NCT05507580|529924186|FG003|Single-Blind Treatment Period|Other, not specified|7|||
146936176|NCT05507580|529924187|FG004|Single-Blind Treatment Period|Other, not specified|3|||
146936177|NCT05507580|529924188|FG005|Single-Blind Treatment Period|Other, not specified|5|||
146936178|NCT06000501|529924189|FG000|Overall Study|Screen failure|3|||
146936179|NCT06000501|529924189|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
146936180|NCT06000501|529924189|FG000|Overall Study|Physician Decision|4|||
146936181|NCT06000501|529924189|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
146618273|NCT01279681|528773260|FG001|Overall Study|Other Reason|2|||
146618274|NCT02252146|528775158|FG000|Overall Study|Lack of Efficacy|4|||
146618275|NCT02252146|528775158|FG000|Overall Study|Entered hospice care|1|||
146618276|NCT02252146|528775158|FG000|Overall Study|Inability to travel to study site|1|||
146618277|NCT02544321|528775163|FG000|Overall Study|Withdrawal by Subject|1|||
146618278|NCT02544321|528775164|FG001|Overall Study|Withdrawal by Subject|2|||
146618279|NCT02544321|528775163|FG000|Overall Study|Adverse Event|1|||
146618280|NCT02544321|528775164|FG001|Overall Study|Adverse Event|1|||
146618281|NCT02544321|528775163|FG000|Overall Study|Protocol Violation|0|||
146618282|NCT02544321|528775164|FG001|Overall Study|Protocol Violation|1|||
146618283|NCT04388111|528775165|FG000|Overall Study|Lost to Follow-up|5|||
146618284|NCT04388111|528775166|FG001|Overall Study|Lost to Follow-up|3|||
146618285|NCT04388111|528775165|FG000|Overall Study|Adverse Event|1|||
146618286|NCT04388111|528775166|FG001|Overall Study|Adverse Event|1|||
146618287|NCT04388111|528775165|FG000|Overall Study|Protocol Violation|2|||
146618288|NCT04388111|528775166|FG001|Overall Study|Protocol Violation|4|||
146618289|NCT04388111|528775165|FG000|Overall Study|Withdrawal by Subject|1|||
146618290|NCT04388111|528775166|FG001|Overall Study|Withdrawal by Subject|0|||
146618291|NCT02038153|528775169|FG000|Overall Study|Withdrawal by Subject|1|||
146618292|NCT02647281|528775170|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
146618293|NCT02647281|528775171|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
146618294|NCT02647281|528775172|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
146618295|NCT02647281|528775173|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
146618296|NCT02647281|528775174|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
146618297|NCT02647281|528775175|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
146618298|NCT02647281|528775176|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
146618299|NCT02647281|528775177|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
146618300|NCT02647281|528775178|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
146618301|NCT01050634|528775179|FG000|Overall Study|Enrolled, but Not Treated|56|||
146618302|NCT01050634|528775179|FG000|Overall Study|Death|2|||
146618303|NCT01050634|528775179|FG000|Overall Study|Adverse Event|42|||
146618304|NCT01050634|528775179|FG000|Overall Study|Lost to Follow-up|2|||
146618305|NCT01050634|528775179|FG000|Overall Study|Other|21|||
146618306|NCT01050634|528775179|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
146618307|NCT03347123|528775182|FG000|Overall Study|Death|1|||
146618308|NCT03347123|528775183|FG001|Overall Study|Death|2|||
146618309|NCT03347123|528775184|FG002|Overall Study|Death|0|||
146936182|NCT06000501|529924189|FG000|Overall Study|Scheduling issues|2|||
146936183|NCT03496662|529924190|FG000|Overall Study|Adverse Event|0|||
146936184|NCT03496662|529924191|FG001|Overall Study|Adverse Event|0|||
146936185|NCT03496662|529924192|FG002|Overall Study|Adverse Event|4|||
146936186|NCT03496662|529924190|FG000|Overall Study|Withdrawal by Subject|1|||
146936187|NCT03496662|529924191|FG001|Overall Study|Withdrawal by Subject|0|||
146618310|NCT03347123|528775185|FG003|Overall Study|Death|0|||
146618311|NCT03347123|528775186|FG004|Overall Study|Death|0|||
146618312|NCT03347123|528775187|FG005|Overall Study|Death|0|||
146618313|NCT03347123|528775188|FG006|Overall Study|Death|0|||
146618314|NCT03347123|528775182|FG000|Overall Study|Withdrawal by Subject|1|||
146618315|NCT03347123|528775183|FG001|Overall Study|Withdrawal by Subject|0|||
146618316|NCT03347123|528775184|FG002|Overall Study|Withdrawal by Subject|0|||
146618317|NCT03347123|528775185|FG003|Overall Study|Withdrawal by Subject|0|||
146618318|NCT03347123|528775186|FG004|Overall Study|Withdrawal by Subject|0|||
146981665|NCT01621490|530096095|FG008|Overall Study|Death|1|||
146618319|NCT03347123|528775187|FG005|Overall Study|Withdrawal by Subject|0|||
146618320|NCT03347123|528775188|FG006|Overall Study|Withdrawal by Subject|0|||
146618321|NCT03347123|528775182|FG000|Overall Study|Reason not Specified|3|||
146618322|NCT03347123|528775183|FG001|Overall Study|Reason not Specified|4|||
146618323|NCT03347123|528775184|FG002|Overall Study|Reason not Specified|0|||
146618324|NCT03347123|528775185|FG003|Overall Study|Reason not Specified|0|||
146618325|NCT03347123|528775186|FG004|Overall Study|Reason not Specified|0|||
146618326|NCT03347123|528775187|FG005|Overall Study|Reason not Specified|0|||
146618327|NCT03347123|528775188|FG006|Overall Study|Reason not Specified|0|||
146618328|NCT03431441|528775196|FG000|Overall Study|Withdrawal by Subject|2|||
146618329|NCT03431441|528775196|FG000|Overall Study|Adverse Event|2|||
146618330|NCT03431441|528775196|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
146618331|NCT01276639|528775197|FG000|Week 0 to 16|Death|1|||
146618332|NCT01276639|528775198|FG001|Week 0 to 16|Death|0|||
146618333|NCT01276639|528775199|FG002|Week 0 to 16|Death|0|||
146618334|NCT01276639|528775200|FG003|Week 0 to 16|Death|0|||
146618335|NCT01276639|528775201|FG004|Week 0 to 16|Death|0|||
146618336|NCT01276639|528775197|FG000|Week 0 to 16|Adverse Event|11|||
146618337|NCT01276639|528775198|FG001|Week 0 to 16|Adverse Event|8|||
146618338|NCT01276639|528775199|FG002|Week 0 to 16|Adverse Event|11|||
146618339|NCT01276639|528775200|FG003|Week 0 to 16|Adverse Event|0|||
146618340|NCT01276639|528775201|FG004|Week 0 to 16|Adverse Event|0|||
146618341|NCT01276639|528775197|FG000|Week 0 to 16|Lack of Efficacy|20|||
146618342|NCT01276639|528775198|FG001|Week 0 to 16|Lack of Efficacy|15|||
146618343|NCT01276639|528775199|FG002|Week 0 to 16|Lack of Efficacy|25|||
146618344|NCT01276639|528775200|FG003|Week 0 to 16|Lack of Efficacy|0|||
146618345|NCT01276639|528775201|FG004|Week 0 to 16|Lack of Efficacy|0|||
146618346|NCT01276639|528775197|FG000|Week 0 to 16|Lost to Follow-up|3|||
146618347|NCT01276639|528775198|FG001|Week 0 to 16|Lost to Follow-up|5|||
146618348|NCT01276639|528775199|FG002|Week 0 to 16|Lost to Follow-up|3|||
146618349|NCT01276639|528775200|FG003|Week 0 to 16|Lost to Follow-up|0|||
146618350|NCT01276639|528775201|FG004|Week 0 to 16|Lost to Follow-up|0|||
146618351|NCT01276639|528775197|FG000|Week 0 to 16|Withdrawal by Subject|8|||
146618352|NCT01276639|528775198|FG001|Week 0 to 16|Withdrawal by Subject|5|||
146618353|NCT01276639|528775199|FG002|Week 0 to 16|Withdrawal by Subject|4|||
146618354|NCT01276639|528775200|FG003|Week 0 to 16|Withdrawal by Subject|0|||
146618355|NCT01276639|528775201|FG004|Week 0 to 16|Withdrawal by Subject|0|||
146618356|NCT01276639|528775197|FG000|Week 0 to 16|Other|7|||
146618357|NCT01276639|528775198|FG001|Week 0 to 16|Other|7|||
146618358|NCT01276639|528775199|FG002|Week 0 to 16|Other|2|||
146618359|NCT01276639|528775200|FG003|Week 0 to 16|Other|0|||
146618360|NCT01276639|528775201|FG004|Week 0 to 16|Other|0|||
146618361|NCT01276639|528775197|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
146618362|NCT01276639|528775198|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
146618363|NCT01276639|528775199|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
146618364|NCT01276639|528775200|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
146618365|NCT01276639|528775201|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
146618366|NCT01276639|528775197|FG000|Week 16 to 52|Death|1|||
146618367|NCT01276639|528775198|FG001|Week 16 to 52|Death|0|||
146618368|NCT01276639|528775199|FG002|Week 16 to 52|Death|0|||
146618369|NCT01276639|528775200|FG003|Week 16 to 52|Death|0|||
146618370|NCT01276639|528775201|FG004|Week 16 to 52|Death|0|||
146618371|NCT01276639|528775197|FG000|Week 16 to 52|Adverse Event|10|||
146618372|NCT01276639|528775198|FG001|Week 16 to 52|Adverse Event|13|||
146618373|NCT01276639|528775199|FG002|Week 16 to 52|Adverse Event|0|||
146618374|NCT01276639|528775200|FG003|Week 16 to 52|Adverse Event|1|||
146618375|NCT01276639|528775201|FG004|Week 16 to 52|Adverse Event|3|||
146618376|NCT01276639|528775197|FG000|Week 16 to 52|Lack of Efficacy|99|||
146618377|NCT01276639|528775198|FG001|Week 16 to 52|Lack of Efficacy|71|||
146618378|NCT01276639|528775199|FG002|Week 16 to 52|Lack of Efficacy|0|||
146618379|NCT01276639|528775200|FG003|Week 16 to 52|Lack of Efficacy|14|||
146618380|NCT01276639|528775201|FG004|Week 16 to 52|Lack of Efficacy|13|||
146618381|NCT01276639|528775197|FG000|Week 16 to 52|Lost to Follow-up|3|||
146618382|NCT01276639|528775198|FG001|Week 16 to 52|Lost to Follow-up|1|||
146618383|NCT01276639|528775199|FG002|Week 16 to 52|Lost to Follow-up|0|||
146618384|NCT01276639|528775200|FG003|Week 16 to 52|Lost to Follow-up|0|||
146618385|NCT01276639|528775201|FG004|Week 16 to 52|Lost to Follow-up|1|||
146618386|NCT01276639|528775197|FG000|Week 16 to 52|Withdrawal by Subject|4|||
146618387|NCT01276639|528775198|FG001|Week 16 to 52|Withdrawal by Subject|4|||
146618388|NCT01276639|528775199|FG002|Week 16 to 52|Withdrawal by Subject|0|||
146618389|NCT01276639|528775200|FG003|Week 16 to 52|Withdrawal by Subject|0|||
146618390|NCT01276639|528775201|FG004|Week 16 to 52|Withdrawal by Subject|1|||
146618391|NCT01276639|528775197|FG000|Week 16 to 52|Other|10|||
146618392|NCT01276639|528775198|FG001|Week 16 to 52|Other|12|||
146618393|NCT01276639|528775199|FG002|Week 16 to 52|Other|0|||
146618394|NCT01276639|528775200|FG003|Week 16 to 52|Other|1|||
146618395|NCT01276639|528775201|FG004|Week 16 to 52|Other|3|||
146618396|NCT03985761|528775204|FG000|Overall Study|Withdrawal by Subject|2|||
146618397|NCT03985761|528775205|FG001|Overall Study|Withdrawal by Subject|3|||
146618398|NCT03956550|528775206|FG000|Overall Study|Sponsor decision|65|||
146618399|NCT03956550|528775207|FG001|Overall Study|Sponsor decision|66|||
146618400|NCT03956550|528775208|FG002|Overall Study|Sponsor decision|64|||
146618401|NCT03956550|528775206|FG000|Overall Study|Adverse Event|0|||
146618402|NCT03956550|528775207|FG001|Overall Study|Adverse Event|1|||
146618403|NCT03956550|528775208|FG002|Overall Study|Adverse Event|0|||
146618404|NCT03956550|528775206|FG000|Overall Study|Withdrawal by Subject|5|||
146618405|NCT03956550|528775207|FG001|Overall Study|Withdrawal by Subject|5|||
146618406|NCT03956550|528775208|FG002|Overall Study|Withdrawal by Subject|6|||
146618407|NCT03400852|528775209|FG000|Blinded Treatment Period|Physician Decision|0|||
146618408|NCT03400852|528775210|FG001|Blinded Treatment Period|Physician Decision|1|||
146618409|NCT03400852|528775211|FG002|Blinded Treatment Period|Physician Decision|0|||
146618410|NCT03400852|528775209|FG000|Blinded Treatment Period|Adverse Event|1|||
146618411|NCT03400852|528775210|FG001|Blinded Treatment Period|Adverse Event|1|||
146618412|NCT03400852|528775211|FG002|Blinded Treatment Period|Adverse Event|0|||
146618413|NCT03400852|528775209|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
146618414|NCT03400852|528775210|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
146618415|NCT03400852|528775211|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
146618416|NCT03400852|528775209|FG000|Open Label Period|Physician Decision|0|||
146618417|NCT03400852|528775210|FG001|Open Label Period|Physician Decision|0|||
146618418|NCT03400852|528775211|FG002|Open Label Period|Physician Decision|1|||
146618419|NCT03400852|528775209|FG000|Open Label Period|Study terminated by sponsor|0|||
146618420|NCT03400852|528775210|FG001|Open Label Period|Study terminated by sponsor|0|||
146618421|NCT03400852|528775211|FG002|Open Label Period|Study terminated by sponsor|21|||
146618422|NCT01285401|528775212|FG000|Overall Study|Prematurely withdrawn from the study|17|||
146618423|NCT01285401|528775213|FG001|Overall Study|Prematurely withdrawn from the study|29|||
146618424|NCT02366312|528775214|FG000|Overall Study|Lost to Follow-up|0|||
146618425|NCT02366312|528775215|FG001|Overall Study|Lost to Follow-up|1|||
146618426|NCT02532465|528775216|FG000|Overall Study|Protocol Violation|1|||
146618427|NCT02532465|528775217|FG001|Overall Study|Protocol Violation|0|||
146618428|NCT02532465|528775216|FG000|Overall Study|Lack of Efficacy|0|||
146618429|NCT02532465|528775217|FG001|Overall Study|Lack of Efficacy|1|||
146618430|NCT03719131|528775219|FG000|Overall Study|Death|1|||
146618431|NCT03719131|528775220|FG001|Overall Study|Death|2|||
146618432|NCT01544920|528775221|FG000|Overall Study|Adverse Event|0|||
146618433|NCT01544920|528775222|FG001|Overall Study|Adverse Event|3|||
146618434|NCT01544920|528775221|FG000|Overall Study|Death|0|||
146618435|NCT01544920|528775222|FG001|Overall Study|Death|1|||
146618436|NCT01544920|528775221|FG000|Overall Study|Lost to Follow-up|11|||
146618437|NCT01544920|528775222|FG001|Overall Study|Lost to Follow-up|12|||
146618438|NCT01544920|528775221|FG000|Overall Study|Protocol Violation|0|||
146618439|NCT01544920|528775222|FG001|Overall Study|Protocol Violation|2|||
146618440|NCT01544920|528775221|FG000|Overall Study|Physician Decision|4|||
146618441|NCT01544920|528775222|FG001|Overall Study|Physician Decision|1|||
146618442|NCT01544920|528775221|FG000|Overall Study|Withdrawal by Subject|4|||
146618443|NCT01544920|528775222|FG001|Overall Study|Withdrawal by Subject|4|||
146618444|NCT03244917|528775228|FG000|Overall Study|Lost to Follow-up|2|||
146618445|NCT03244917|528775229|FG001|Overall Study|Lost to Follow-up|2|||
146618446|NCT01272232|528775230|FG000|Weeks 0-56|Adverse Event|39|||
146618447|NCT01272232|528775231|FG001|Weeks 0-56|Adverse Event|18|||
146618448|NCT01272232|528775232|FG002|Weeks 0-56|Adverse Event|7|||
146618449|NCT01272232|528775230|FG000|Weeks 0-56|Lack of Efficacy|0|||
146618450|NCT01272232|528775231|FG001|Weeks 0-56|Lack of Efficacy|0|||
146618451|NCT01272232|528775232|FG002|Weeks 0-56|Lack of Efficacy|3|||
146618452|NCT01272232|528775230|FG000|Weeks 0-56|Protocol Violation|12|||
146618453|NCT01272232|528775231|FG001|Weeks 0-56|Protocol Violation|8|||
146618454|NCT01272232|528775232|FG002|Weeks 0-56|Protocol Violation|13|||
146618455|NCT01272232|528775230|FG000|Weeks 0-56|Withdrawal criteria|32|||
146618456|NCT01272232|528775231|FG001|Weeks 0-56|Withdrawal criteria|14|||
146618457|NCT01272232|528775232|FG002|Weeks 0-56|Withdrawal criteria|37|||
146936188|NCT03496662|529924192|FG002|Overall Study|Withdrawal by Subject|2|||
146936189|NCT03496662|529924190|FG000|Overall Study|Death|0|||
146936190|NCT03496662|529924191|FG001|Overall Study|Death|0|||
146936191|NCT03496662|529924192|FG002|Overall Study|Death|2|||
146936192|NCT03496662|529924190|FG000|Overall Study|Noncompliance|0|||
146936193|NCT03496662|529924191|FG001|Overall Study|Noncompliance|0|||
146936194|NCT03496662|529924192|FG002|Overall Study|Noncompliance|1|||
146936195|NCT00493467|529924193|FG000|Overall Study|Death|1|||
146618458|NCT01272232|528775230|FG000|Weeks 0-56|Unclassified|16|||
146618459|NCT01272232|528775231|FG001|Weeks 0-56|Unclassified|7|||
146618460|NCT01272232|528775232|FG002|Weeks 0-56|Unclassified|12|||
146618461|NCT01272232|528775230|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
146618462|NCT01272232|528775231|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
146618463|NCT01272232|528775232|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
146618464|NCT01272232|528775230|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
146618465|NCT01272232|528775231|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
146618466|NCT01272232|528775232|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
146618467|NCT01272232|528775230|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
146936196|NCT01074658|529924197|FG000|Overall Study|No implant attempted|19|||
146936197|NCT00432562|529924201|FG000|Overall Study|Death|3|||
146936198|NCT00432562|529924202|FG001|Overall Study|Death|0|||
146936199|NCT00416312|529924203|FG000|Overall Study|tumors not visible on imaging|2|||
146936200|NCT02146248|529924204|FG000|Overall Study|Withdrawal by Subject|2|||
146936201|NCT00425100|529924205|FG000|Overall Study|Adverse Event|36|||
146936202|NCT00425100|529924205|FG000|Overall Study|Lack of Efficacy|4|||
146936203|NCT00425100|529924205|FG000|Overall Study|Lost to Follow-up|2|||
146936204|NCT00425100|529924205|FG000|Overall Study|Protocol Violation|4|||
146936205|NCT00425100|529924205|FG000|Overall Study|Withdrawal by Subject|7|||
146936206|NCT02559713|529924208|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
146936207|NCT01374217|529924210|FG000|Overall Study|Lack of Efficacy|13|||
146936208|NCT00555906|529924214|FG000|Phase 1|Objective Progression or Relapse|3|||
146936209|NCT00555906|529924215|FG001|Phase 1|Objective Progression or Relapse|5|||
146936210|NCT00555906|529924216|FG002|Phase 1|Objective Progression or Relapse|3|||
146936211|NCT00555906|529924217|FG003|Phase 1|Objective Progression or Relapse|1|||
146936212|NCT00555906|529924218|FG004|Phase 1|Objective Progression or Relapse|0|||
146936213|NCT00555906|529924214|FG000|Phase 1|Global Deterioration of Health Status|0|||
146936214|NCT00555906|529924215|FG001|Phase 1|Global Deterioration of Health Status|1|||
146936215|NCT00555906|529924216|FG002|Phase 1|Global Deterioration of Health Status|1|||
146936216|NCT00555906|529924217|FG003|Phase 1|Global Deterioration of Health Status|1|||
146936217|NCT00555906|529924218|FG004|Phase 1|Global Deterioration of Health Status|0|||
146936218|NCT00555906|529924214|FG000|Phase 1|Adverse Event|0|||
146936219|NCT00555906|529924215|FG001|Phase 1|Adverse Event|0|||
146936220|NCT00555906|529924216|FG002|Phase 1|Adverse Event|3|||
146936221|NCT00555906|529924217|FG003|Phase 1|Adverse Event|2|||
146936222|NCT00555906|529924218|FG004|Phase 1|Adverse Event|0|||
146936223|NCT00555906|529924214|FG000|Phase 1|Withdrawal by Subject|0|||
146936224|NCT00555906|529924215|FG001|Phase 1|Withdrawal by Subject|0|||
146936225|NCT00555906|529924216|FG002|Phase 1|Withdrawal by Subject|0|||
146936226|NCT00555906|529924217|FG003|Phase 1|Withdrawal by Subject|1|||
146936227|NCT00555906|529924218|FG004|Phase 1|Withdrawal by Subject|0|||
146936228|NCT00555906|529924214|FG000|Phase 2|Adverse Event|0|||
146936229|NCT00555906|529924215|FG001|Phase 2|Adverse Event|0|||
146936230|NCT00555906|529924216|FG002|Phase 2|Adverse Event|0|||
146936231|NCT00555906|529924217|FG003|Phase 2|Adverse Event|0|||
146936232|NCT00555906|529924218|FG004|Phase 2|Adverse Event|4|||
146936233|NCT00555906|529924214|FG000|Phase 2|Global Deterioration of Health Status|0|||
146936234|NCT00555906|529924215|FG001|Phase 2|Global Deterioration of Health Status|0|||
146936235|NCT00555906|529924216|FG002|Phase 2|Global Deterioration of Health Status|0|||
146936236|NCT00555906|529924217|FG003|Phase 2|Global Deterioration of Health Status|0|||
146936237|NCT00555906|529924218|FG004|Phase 2|Global Deterioration of Health Status|2|||
146936238|NCT00555906|529924214|FG000|Phase 2|Objective Progression or Relapse|0|||
146936239|NCT00555906|529924215|FG001|Phase 2|Objective Progression or Relapse|0|||
146936240|NCT00555906|529924216|FG002|Phase 2|Objective Progression or Relapse|0|||
146936241|NCT00555906|529924217|FG003|Phase 2|Objective Progression or Relapse|0|||
146936242|NCT00555906|529924218|FG004|Phase 2|Objective Progression or Relapse|16|||
146936243|NCT00555906|529924214|FG000|Phase 2|Withdrawal by Subject|0|||
146936244|NCT00555906|529924215|FG001|Phase 2|Withdrawal by Subject|0|||
146936245|NCT00555906|529924216|FG002|Phase 2|Withdrawal by Subject|0|||
146936246|NCT00555906|529924217|FG003|Phase 2|Withdrawal by Subject|0|||
146936247|NCT00555906|529924218|FG004|Phase 2|Withdrawal by Subject|2|||
146936248|NCT00555906|529924214|FG000|Phase 2|Other|0|||
146936249|NCT00555906|529924215|FG001|Phase 2|Other|0|||
146936250|NCT00555906|529924216|FG002|Phase 2|Other|0|||
146618468|NCT01272232|528775231|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
146618469|NCT01272232|528775232|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
146618470|NCT01272232|528775230|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
146618471|NCT01272232|528775231|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
146936251|NCT00555906|529924217|FG003|Phase 2|Other|0|||
146936252|NCT00555906|529924218|FG004|Phase 2|Other|6|||
146936253|NCT00555906|529924214|FG000|Phase 2|Randomized but not Treated|0|||
146936254|NCT00555906|529924215|FG001|Phase 2|Randomized but not Treated|0|||
146936255|NCT00555906|529924216|FG002|Phase 2|Randomized but not Treated|0|||
146936256|NCT00555906|529924217|FG003|Phase 2|Randomized but not Treated|0|||
146936257|NCT00555906|529924218|FG004|Phase 2|Randomized but not Treated|2|||
146936258|NCT02193828|529924219|FG000|Overall Study|Withdrawal by Subject|0|||
146936259|NCT02193828|529924220|FG001|Overall Study|Withdrawal by Subject|0|||
146936260|NCT02193828|529924221|FG002|Overall Study|Withdrawal by Subject|1|||
146936261|NCT02193828|529924222|FG003|Overall Study|Withdrawal by Subject|1|||
146936262|NCT03219567|529924223|FG000|Overall Study|Withdrawal by Subject|0|||
146936263|NCT03219567|529924224|FG001|Overall Study|Withdrawal by Subject|1|||
146936264|NCT02849626|529924225|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
146936265|NCT02849626|529924226|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
146936266|NCT02849626|529924227|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
146936267|NCT02849626|529924228|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
146936268|NCT02849626|529924225|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
146981666|NCT01621490|530096096|FG009|Overall Study|Death|0|||
146981667|NCT01621490|530096097|FG010|Overall Study|Death|0|||
146729513|NCT02612311|529178891|FG003|Overall Study|Investigator's Decision|6|||
146729514|NCT02612311|529178888|FG000|Overall Study|Lack of Efficacy|0|||
146729515|NCT02612311|529178889|FG001|Overall Study|Lack of Efficacy|0|||
146729516|NCT02612311|529178890|FG002|Overall Study|Lack of Efficacy|1|||
146729517|NCT02612311|529178891|FG003|Overall Study|Lack of Efficacy|1|||
146729518|NCT02612311|529178888|FG000|Overall Study|Lost to Follow-up|2|||
146729519|NCT02612311|529178889|FG001|Overall Study|Lost to Follow-up|2|||
146729520|NCT02612311|529178890|FG002|Overall Study|Lost to Follow-up|1|||
146729521|NCT02612311|529178891|FG003|Overall Study|Lost to Follow-up|2|||
146729522|NCT02612311|529178888|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
146729523|NCT02612311|529178889|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
146729524|NCT02612311|529178890|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
146729525|NCT02612311|529178891|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
146729526|NCT02612311|529178888|FG000|Overall Study|Site Terminated by Sponsor|29|||
146729527|NCT02612311|529178889|FG001|Overall Study|Site Terminated by Sponsor|12|||
146729528|NCT02612311|529178890|FG002|Overall Study|Site Terminated by Sponsor|13|||
146729529|NCT02612311|529178891|FG003|Overall Study|Site Terminated by Sponsor|5|||
146729530|NCT02612311|529178888|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
146729531|NCT02612311|529178889|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
146729532|NCT02612311|529178890|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
146729533|NCT02612311|529178891|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
146729534|NCT02612311|529178888|FG000|Overall Study|Reason Not Specified|3|||
146729535|NCT02612311|529178889|FG001|Overall Study|Reason Not Specified|7|||
146729536|NCT02612311|529178890|FG002|Overall Study|Reason Not Specified|4|||
146729537|NCT02612311|529178891|FG003|Overall Study|Reason Not Specified|5|||
146729538|NCT02612311|529178888|FG000|Overall Study|Unknown/Missing|10|||
146729539|NCT02612311|529178889|FG001|Overall Study|Unknown/Missing|13|||
146729540|NCT02612311|529178890|FG002|Overall Study|Unknown/Missing|4|||
146729541|NCT02612311|529178891|FG003|Overall Study|Unknown/Missing|0|||
146729542|NCT02612311|529178888|FG000|Overall Study|Non-Compliance with Study|1|||
146729543|NCT02612311|529178889|FG001|Overall Study|Non-Compliance with Study|0|||
146729544|NCT02612311|529178890|FG002|Overall Study|Non-Compliance with Study|0|||
146729545|NCT02612311|529178891|FG003|Overall Study|Non-Compliance with Study|0|||
146729546|NCT01596582|529178892|FG000|Overall Study|Deemed ineligible after study visit|3|||
146729547|NCT01596582|529178893|FG001|Overall Study|Deemed ineligible after study visit|6|||
146729548|NCT01596582|529178892|FG000|Overall Study|Missing all outcome data|1|||
146729549|NCT01596582|529178893|FG001|Overall Study|Missing all outcome data|1|||
146729550|NCT01428076|529178894|FG000|Overall Study|Adverse Event|0|||
146729551|NCT01428076|529178895|FG001|Overall Study|Adverse Event|1|||
146729552|NCT02216773|529178899|FG000|Overall Study|Disease progression|4|||
146729553|NCT02216773|529178900|FG001|Overall Study|Disease progression|2|||
146729554|NCT02216773|529178899|FG000|Overall Study|Insufficient FLRV|4|||
146729555|NCT02216773|529178900|FG001|Overall Study|Insufficient FLRV|0|||
146729556|NCT02216773|529178899|FG000|Overall Study|Abandoned|4|||
146729557|NCT02216773|529178900|FG001|Overall Study|Abandoned|3|||
146729558|NCT04510675|529178904|FG000|Overall Study|Withdrawal by Subject|5|||
146729559|NCT00058123|529178905|FG000|Overall Study|Wrong histology|9|||
146729560|NCT00058123|529178905|FG000|Overall Study|Received >3 prior treatments|1|||
146729561|NCT02925676|529178909|FG000|Overall Study|Withdrawal by Subject|1|||
146729562|NCT03260868|529178910|FG000|Overall Study|Poor Compliance to Protocol|0|||
146729563|NCT03260868|529178911|FG001|Overall Study|Poor Compliance to Protocol|2|||
146729564|NCT03260868|529178910|FG000|Overall Study|Study Terminated By Sponsor|2|||
146729565|NCT03260868|529178911|FG001|Overall Study|Study Terminated By Sponsor|1|||
146729566|NCT03260868|529178910|FG000|Overall Study|Other than specified above|1|||
146729567|NCT03260868|529178911|FG001|Overall Study|Other than specified above|0|||
146729568|NCT02170025|529178912|FG000|Overall Study|Adverse Event|2|||
146729569|NCT02170025|529178913|FG001|Overall Study|Adverse Event|0|||
146729570|NCT02127372|529180487|FG000|Overall Study|Withdrawal by Subject|1|||
146729571|NCT02127372|529180488|FG001|Overall Study|Withdrawal by Subject|0|||
146729572|NCT01756352|529180489|FG000|Overall Study|moved away and lost to followup|1|||
146729573|NCT00415610|529180490|FG000|Overall Study|Death|3|||
146729574|NCT00415610|529180491|FG001|Overall Study|Death|2|||
146729575|NCT00415610|529180492|FG002|Overall Study|Death|5|||
146729576|NCT05131165|529180494|FG000|Overall Study|Death|1|||
146729577|NCT05131165|529180495|FG001|Overall Study|Death|1|||
146981668|NCT01621490|530096087|FG000|Overall Study|Other reasons|7|||
146729578|NCT05131165|529180496|FG002|Overall Study|Death|0|||
146729579|NCT05131165|529180494|FG000|Overall Study|Lost to Follow-up|2|||
146729580|NCT05131165|529180495|FG001|Overall Study|Lost to Follow-up|2|||
146729581|NCT05131165|529180496|FG002|Overall Study|Lost to Follow-up|5|||
146729582|NCT05131165|529180494|FG000|Overall Study|Transferred out of clinic|1|||
146729583|NCT05131165|529180495|FG001|Overall Study|Transferred out of clinic|0|||
146729584|NCT05131165|529180496|FG002|Overall Study|Transferred out of clinic|3|||
146729585|NCT05131165|529180494|FG000|Overall Study|Dropped out|1|||
146936269|NCT02849626|529924226|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
146936270|NCT02849626|529924227|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
146936271|NCT02849626|529924228|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
146936272|NCT02849626|529924225|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
146936273|NCT02849626|529924226|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
146936274|NCT02849626|529924227|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
146936275|NCT02849626|529924228|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
146618472|NCT01272232|528775232|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
146618473|NCT01272232|528775230|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
146618474|NCT01272232|528775231|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
146618475|NCT01272232|528775232|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
146618476|NCT02159066|528775233|FG000|Part I|Adverse Event|7|||
146618477|NCT02159066|528775234|FG001|Part I|Adverse Event|5|||
146618478|NCT02159066|528775235|FG002|Part I|Adverse Event|0|||
146618479|NCT02159066|528775236|FG003|Part I|Adverse Event|0|||
146618480|NCT02159066|528775237|FG004|Part I|Adverse Event|0|||
146618481|NCT02159066|528775238|FG005|Part I|Adverse Event|0|||
146618482|NCT02159066|528775233|FG000|Part I|Death|11|||
146936276|NCT02849626|529924225|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
146936277|NCT02849626|529924226|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
146618483|NCT02159066|528775234|FG001|Part I|Death|9|||
146618484|NCT02159066|528775235|FG002|Part I|Death|0|||
146618485|NCT02159066|528775236|FG003|Part I|Death|0|||
146618486|NCT02159066|528775237|FG004|Part I|Death|0|||
146618487|NCT02159066|528775238|FG005|Part I|Death|0|||
146618488|NCT02159066|528775233|FG000|Part I|Progressive Disease|37|||
146618489|NCT02159066|528775234|FG001|Part I|Progressive Disease|46|||
146618490|NCT02159066|528775235|FG002|Part I|Progressive Disease|0|||
146618491|NCT02159066|528775236|FG003|Part I|Progressive Disease|0|||
146618492|NCT02159066|528775237|FG004|Part I|Progressive Disease|0|||
146618493|NCT02159066|528775238|FG005|Part I|Progressive Disease|0|||
146618494|NCT02159066|528775233|FG000|Part I|New Therapy for Study Indication|5|||
146618495|NCT02159066|528775234|FG001|Part I|New Therapy for Study Indication|4|||
146618496|NCT02159066|528775235|FG002|Part I|New Therapy for Study Indication|0|||
146618497|NCT02159066|528775236|FG003|Part I|New Therapy for Study Indication|0|||
146618498|NCT02159066|528775237|FG004|Part I|New Therapy for Study Indication|0|||
146618499|NCT02159066|528775238|FG005|Part I|New Therapy for Study Indication|0|||
146618500|NCT02159066|528775233|FG000|Part I|Termination of participants from the study|3|||
146618501|NCT02159066|528775234|FG001|Part I|Termination of participants from the study|3|||
146618502|NCT02159066|528775235|FG002|Part I|Termination of participants from the study|0|||
146618503|NCT02159066|528775236|FG003|Part I|Termination of participants from the study|0|||
146618504|NCT02159066|528775237|FG004|Part I|Termination of participants from the study|0|||
146618505|NCT02159066|528775238|FG005|Part I|Termination of participants from the study|0|||
146618506|NCT02159066|528775233|FG000|Part I|Physician Decision|2|||
146618507|NCT02159066|528775234|FG001|Part I|Physician Decision|9|||
146618508|NCT02159066|528775235|FG002|Part I|Physician Decision|0|||
146618509|NCT02159066|528775236|FG003|Part I|Physician Decision|0|||
146618510|NCT02159066|528775237|FG004|Part I|Physician Decision|0|||
146618511|NCT02159066|528775238|FG005|Part I|Physician Decision|0|||
146618512|NCT02159066|528775233|FG000|Part I|Participant/Guardian Decision|9|||
146618513|NCT02159066|528775234|FG001|Part I|Participant/Guardian Decision|3|||
146618514|NCT02159066|528775235|FG002|Part I|Participant/Guardian Decision|0|||
146618515|NCT02159066|528775236|FG003|Part I|Participant/Guardian Decision|0|||
146618516|NCT02159066|528775237|FG004|Part I|Participant/Guardian Decision|0|||
146618517|NCT02159066|528775238|FG005|Part I|Participant/Guardian Decision|0|||
146618518|NCT02159066|528775233|FG000|Part I|Missing Data|1|||
146618519|NCT02159066|528775234|FG001|Part I|Missing Data|0|||
146618520|NCT02159066|528775235|FG002|Part I|Missing Data|0|||
146618521|NCT02159066|528775236|FG003|Part I|Missing Data|0|||
146618522|NCT02159066|528775237|FG004|Part I|Missing Data|0|||
146618523|NCT02159066|528775238|FG005|Part I|Missing Data|0|||
146618524|NCT02159066|528775233|FG000|Part II|Adverse Event|0|||
146936278|NCT02849626|529924227|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
146936279|NCT02849626|529924228|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
146618525|NCT02159066|528775234|FG001|Part II|Adverse Event|0|||
146618526|NCT02159066|528775235|FG002|Part II|Adverse Event|1|||
146618527|NCT02159066|528775236|FG003|Part II|Adverse Event|0|||
146618528|NCT02159066|528775237|FG004|Part II|Adverse Event|1|||
146618529|NCT02159066|528775238|FG005|Part II|Adverse Event|1|||
146618530|NCT02159066|528775233|FG000|Part II|Death|0|||
146618531|NCT02159066|528775234|FG001|Part II|Death|0|||
146618532|NCT02159066|528775235|FG002|Part II|Death|1|||
146936280|NCT02849626|529924225|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
146618533|NCT02159066|528775236|FG003|Part II|Death|0|||
146618534|NCT02159066|528775237|FG004|Part II|Death|2|||
146618535|NCT02159066|528775238|FG005|Part II|Death|1|||
146618536|NCT02159066|528775233|FG000|Part II|Progressive Disease|0|||
146618537|NCT02159066|528775234|FG001|Part II|Progressive Disease|0|||
146618538|NCT02159066|528775235|FG002|Part II|Progressive Disease|35|||
146618539|NCT02159066|528775236|FG003|Part II|Progressive Disease|1|||
146618540|NCT02159066|528775237|FG004|Part II|Progressive Disease|7|||
146618541|NCT02159066|528775238|FG005|Part II|Progressive Disease|4|||
146618542|NCT02159066|528775233|FG000|Part II|New Therapy for Study Indication|0|||
146618543|NCT02159066|528775234|FG001|Part II|New Therapy for Study Indication|0|||
146618544|NCT02159066|528775235|FG002|Part II|New Therapy for Study Indication|0|||
146618545|NCT02159066|528775236|FG003|Part II|New Therapy for Study Indication|0|||
146618546|NCT02159066|528775237|FG004|Part II|New Therapy for Study Indication|1|||
146618547|NCT02159066|528775238|FG005|Part II|New Therapy for Study Indication|0|||
146618548|NCT02159066|528775233|FG000|Part II|Physician Decision|0|||
146618549|NCT02159066|528775234|FG001|Part II|Physician Decision|0|||
146618550|NCT02159066|528775235|FG002|Part II|Physician Decision|1|||
146618551|NCT02159066|528775236|FG003|Part II|Physician Decision|0|||
146618552|NCT02159066|528775237|FG004|Part II|Physician Decision|0|||
146618553|NCT02159066|528775238|FG005|Part II|Physician Decision|0|||
146618554|NCT02159066|528775233|FG000|Part II|Participant/Guardian Decision|0|||
146618555|NCT02159066|528775234|FG001|Part II|Participant/Guardian Decision|0|||
146618556|NCT02159066|528775235|FG002|Part II|Participant/Guardian Decision|0|||
146618557|NCT02159066|528775236|FG003|Part II|Participant/Guardian Decision|0|||
146618558|NCT02159066|528775237|FG004|Part II|Participant/Guardian Decision|2|||
146618559|NCT02159066|528775238|FG005|Part II|Participant/Guardian Decision|0|||
146618560|NCT01135134|528775239|FG000|Overall Study|Adverse Event|1|||
146618561|NCT01135134|528775240|FG001|Overall Study|Adverse Event|1|||
146618562|NCT01135134|528775239|FG000|Overall Study|Did not meet protocol eligibility|1|||
146618563|NCT01135134|528775240|FG001|Overall Study|Did not meet protocol eligibility|0|||
146618564|NCT00255190|528775241|FG000|Overall Study|Adverse Event|17|||
146618565|NCT00255190|528775242|FG001|Overall Study|Adverse Event|36|||
146618566|NCT00255190|528775241|FG000|Overall Study|Protocol Violation|2|||
146618567|NCT00255190|528775242|FG001|Overall Study|Protocol Violation|2|||
146618568|NCT00255190|528775241|FG000|Overall Study|Lost to Follow-up|10|||
146618569|NCT00255190|528775242|FG001|Overall Study|Lost to Follow-up|27|||
146618570|NCT00255190|528775241|FG000|Overall Study|Withdrew Consent|17|||
146618571|NCT00255190|528775242|FG001|Overall Study|Withdrew Consent|48|||
146618572|NCT00255190|528775241|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
146618573|NCT00255190|528775242|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
146618574|NCT00255190|528775241|FG000|Overall Study|Erosive esophagitis not healed|0|||
146618575|NCT00255190|528775242|FG001|Overall Study|Erosive esophagitis not healed|20|||
146618576|NCT00255190|528775241|FG000|Overall Study|Various|4|||
146618577|NCT00255190|528775242|FG001|Overall Study|Various|23|||
146618578|NCT01156480|528775248|FG000|Overall Study|change in diagnosis|0|||
146618579|NCT01156480|528775249|FG001|Overall Study|change in diagnosis|1|||
146618580|NCT04537793|528775250|FG000|Part B (24 Weeks)|Adverse Event|0|||
146618581|NCT04537793|528775251|FG001|Part B (24 Weeks)|Adverse Event|1|||
146618582|NCT05470387|528775252|FG000|Overall Study|Protocol Violation|0|||
146618583|NCT05470387|528775253|FG001|Overall Study|Protocol Violation|3|||
146618584|NCT01176058|528775255|FG000|Overall Study|Adverse Event|1|||
146618585|NCT01176058|528775256|FG001|Overall Study|Adverse Event|0|||
146618586|NCT01176058|528775255|FG000|Overall Study|Insufficient clinical response|2|||
146618587|NCT01176058|528775256|FG001|Overall Study|Insufficient clinical response|2|||
146618588|NCT01176058|528775255|FG000|Overall Study|Insufficient mycological response|0|||
146618589|NCT01176058|528775256|FG001|Overall Study|Insufficient mycological response|1|||
146618590|NCT01176058|528775255|FG000|Overall Study|Withdrawal by Subject|1|||
146618591|NCT01176058|528775256|FG001|Overall Study|Withdrawal by Subject|0|||
146618592|NCT00256724|528775259|FG000|Overall Study|Physician Decision|2|||
146618593|NCT00256724|528775260|FG001|Overall Study|Physician Decision|5|||
146618594|NCT00256724|528775259|FG000|Overall Study|Protocol Violation|3|||
146618595|NCT00256724|528775260|FG001|Overall Study|Protocol Violation|3|||
146618596|NCT01217463|528775261|FG000|Overall Study|Adverse Event|8|||
146618597|NCT01217463|528775262|FG001|Overall Study|Adverse Event|5|||
146618598|NCT01217463|528775261|FG000|Overall Study|Physician Decision|0|||
146618599|NCT01217463|528775262|FG001|Overall Study|Physician Decision|1|||
146618600|NCT01217463|528775261|FG000|Overall Study|Withdrawal by Subject|3|||
146618601|NCT01217463|528775262|FG001|Overall Study|Withdrawal by Subject|0|||
146936281|NCT02849626|529924226|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
146618602|NCT01217463|528775261|FG000|Overall Study|Surgery on the Target Limb|0|||
146618603|NCT01217463|528775262|FG001|Overall Study|Surgery on the Target Limb|1|||
146618604|NCT01217463|528775261|FG000|Overall Study|Patient Non-compliant|1|||
146618605|NCT01217463|528775262|FG001|Overall Study|Patient Non-compliant|0|||
146618606|NCT01217463|528775261|FG000|Overall Study|Other|1|||
146618607|NCT01217463|528775262|FG001|Overall Study|Other|1|||
146618608|NCT01569841|528775265|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
146618609|NCT01569841|528775266|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
146618610|NCT01858363|528775267|FG000|Overall Study|Death|35|||
146618611|NCT01858363|528775268|FG001|Overall Study|Death|9|||
146618612|NCT01858363|528775267|FG000|Overall Study|Withdrawal by Subject|28|||
146618613|NCT01858363|528775268|FG001|Overall Study|Withdrawal by Subject|14|||
146618614|NCT01858363|528775267|FG000|Overall Study|Lost to Follow-up|13|||
146618615|NCT01858363|528775268|FG001|Overall Study|Lost to Follow-up|3|||
146618616|NCT00057863|528775278|FG000|Overall Study|Death|1|||
146618617|NCT00057863|528775278|FG000|Overall Study|Withdrawal by Subject|2|||
146618618|NCT00764361|528775279|FG000|Overall Study|Withdrawal by Subject|2|||
146618619|NCT00764361|528775280|FG001|Overall Study|Withdrawal by Subject|3|||
146618620|NCT00764361|528775279|FG000|Overall Study|Adverse Event|0|||
146618621|NCT00764361|528775280|FG001|Overall Study|Adverse Event|1|||
146618622|NCT02090426|528775281|FG000|Overall Study|Lost to Follow-up|12|||
146618623|NCT02090426|528775282|FG001|Overall Study|Lost to Follow-up|6|||
146618624|NCT02079038|528775283|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
146618625|NCT02079038|528775284|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
146618626|NCT02079038|528775283|FG000|Modified Intent to Treat Population|Death|1|||
146618627|NCT02079038|528775284|FG001|Modified Intent to Treat Population|Death|0|||
146618628|NCT02079038|528775283|FG000|Completed 6 Months|Lost to Follow-up|2|||
146618629|NCT02079038|528775284|FG001|Completed 6 Months|Lost to Follow-up|1|||
146618630|NCT03480152|528775285|FG000|Phase I|Signed consent. Died before treatment.|1|||
146618631|NCT03480152|528775286|FG001|Phase I|Signed consent. Died before treatment.|0|||
146618632|NCT03480152|528775287|FG002|Phase I|Signed consent. Died before treatment.|0|||
146618633|NCT03634085|528775288|FG000|Overall Study|Adverse Event|1|||
146618634|NCT03634085|528775289|FG001|Overall Study|Adverse Event|0|||
146618635|NCT03634085|528775288|FG000|Overall Study|Withdrawal by Subject|0|||
146618636|NCT03634085|528775289|FG001|Overall Study|Withdrawal by Subject|2|||
146618637|NCT04276233|528775290|FG000|Overall Study|Adverse Event|1|||
146618638|NCT04276233|528775290|FG000|Overall Study|Lost to Follow-up|3|||
146618639|NCT04276233|528775290|FG000|Overall Study|Physician Decision|4|||
146618640|NCT04276233|528775290|FG000|Overall Study|Withdrawal by Subject|2|||
146618641|NCT00148759|528775293|FG000|Overall Study|Withdrawal by Subject|1|||
146618642|NCT00148759|528775294|FG001|Overall Study|Withdrawal by Subject|1|||
146618643|NCT00148759|528775293|FG000|Overall Study|Lost to Follow-up|1|||
146618644|NCT00148759|528775294|FG001|Overall Study|Lost to Follow-up|0|||
146618645|NCT01454596|528775295|FG000|Overall Study|Death|0|||
146618646|NCT01454596|528775296|FG001|Overall Study|Death|0|||
146618647|NCT01454596|528775297|FG002|Overall Study|Death|0|||
146618648|NCT01454596|528775298|FG003|Overall Study|Death|0|||
146618649|NCT01454596|528775299|FG004|Overall Study|Death|0|||
146618650|NCT01454596|528775300|FG005|Overall Study|Death|0|||
146618651|NCT01454596|528775301|FG006|Overall Study|Death|0|||
146618652|NCT01454596|528775302|FG007|Overall Study|Death|0|||
146618653|NCT01454596|528775303|FG008|Overall Study|Death|0|||
146618654|NCT01454596|528775304|FG009|Overall Study|Death|1|||
146618655|NCT01454596|528775305|FG010|Overall Study|Death|1|||
146618656|NCT01454596|528775306|FG011|Overall Study|Death|0|||
146618657|NCT02800863|528775315|FG000|Overall Study|Adverse Event|14|||
146618658|NCT02800863|528775315|FG000|Overall Study|Another Device Implanted|1|||
146618659|NCT02800863|528775315|FG000|Overall Study|Device Explanted|1|||
146618660|NCT02800863|528775315|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
146618661|NCT02800863|528775315|FG000|Overall Study|Health Issues|1|||
146618662|NCT02800863|528775315|FG000|Overall Study|Insurance Denial|8|||
146618663|NCT02800863|528775315|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
146618664|NCT02800863|528775315|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
146618665|NCT02800863|528775315|FG000|Overall Study|Screen Failure|1|||
146618666|NCT02800863|528775315|FG000|Overall Study|Sponsor Request|6|||
146618667|NCT02800863|528775315|FG000|Overall Study|Death|3|||
146618668|NCT02800863|528775315|FG000|Overall Study|Subject Implant at Another Facility|1|||
146618669|NCT02800863|528775315|FG000|Overall Study|Lost to Follow-up|26|||
146618670|NCT02800863|528775315|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
146618671|NCT02800863|528775315|FG000|Overall Study|Subject and/or Family Request|64|||
146618672|NCT02800863|528775315|FG000|Overall Study|Trial Failure|81|||
146618673|NCT02800863|528775315|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
146618674|NCT03957551|528775316|FG000|Overall Study|Adverse Event|2|||
146618675|NCT03957551|528775317|FG001|Overall Study|Adverse Event|2|||
146618676|NCT03957551|528775318|FG002|Overall Study|Adverse Event|6|||
146618677|NCT03957551|528775316|FG000|Overall Study|Physician Decision|1|||
146618678|NCT03957551|528775317|FG001|Overall Study|Physician Decision|0|||
146618679|NCT03957551|528775318|FG002|Overall Study|Physician Decision|2|||
146936282|NCT02849626|529924227|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
146618680|NCT03957551|528775316|FG000|Overall Study|Withdrawal by Subject|1|||
146618681|NCT03957551|528775317|FG001|Overall Study|Withdrawal by Subject|0|||
146729586|NCT05131165|529180495|FG001|Overall Study|Dropped out|2|||
146618682|NCT03957551|528775318|FG002|Overall Study|Withdrawal by Subject|2|||
146618683|NCT03957551|528775316|FG000|Overall Study|Disease progression|1|||
146618684|NCT03957551|528775317|FG001|Overall Study|Disease progression|0|||
146618685|NCT03957551|528775318|FG002|Overall Study|Disease progression|8|||
146618686|NCT03775486|528775319|FG000|Initial Therapy Phase|Other reason provided|0|||
146618687|NCT03775486|528775320|FG001|Initial Therapy Phase|Other reason provided|15|||
146618688|NCT03775486|528775319|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
146618689|NCT03775486|528775320|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
146618690|NCT03775486|528775319|FG000|Initial Therapy Phase|Protocol Violation|0|||
146618691|NCT03775486|528775320|FG001|Initial Therapy Phase|Protocol Violation|2|||
146936283|NCT02849626|529924228|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
146936284|NCT02849626|529924225|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
146936285|NCT02849626|529924226|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
146936286|NCT02849626|529924227|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
146936287|NCT02849626|529924228|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
146936288|NCT02849626|529924225|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
146936289|NCT02849626|529924226|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
146936290|NCT02849626|529924227|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
146936291|NCT02849626|529924228|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
146729587|NCT05131165|529180496|FG002|Overall Study|Dropped out|0|||
146729588|NCT03320018|529180500|FG000|Treatment Period|Withdrawal by Subject|1|||
146729589|NCT03320018|529180501|FG001|Treatment Period|Withdrawal by Subject|0|||
146729590|NCT03320018|529180500|FG000|Day 90 Follow up|Death|0|||
146729591|NCT03320018|529180501|FG001|Day 90 Follow up|Death|1|||
146729592|NCT02691182|529180502|FG000|Overall Study|Withdrawal by Subject|4|||
146729593|NCT02691182|529180503|FG001|Overall Study|Withdrawal by Subject|7|||
146729594|NCT02691182|529180504|FG002|Overall Study|Withdrawal by Subject|6|||
146729595|NCT02691182|529180505|FG003|Overall Study|Withdrawal by Subject|8|||
146729596|NCT02691182|529180502|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
146729597|NCT02691182|529180503|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
146729598|NCT02691182|529180504|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
146729599|NCT02691182|529180505|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
146729600|NCT02691182|529180502|FG000|Overall Study|Lost to Follow-up|8|||
146729601|NCT02691182|529180503|FG001|Overall Study|Lost to Follow-up|33|||
146729602|NCT02691182|529180504|FG002|Overall Study|Lost to Follow-up|19|||
146729603|NCT02691182|529180505|FG003|Overall Study|Lost to Follow-up|22|||
146729604|NCT02691182|529180502|FG000|Overall Study|Adverse Event|3|||
146729605|NCT02691182|529180503|FG001|Overall Study|Adverse Event|10|||
146729606|NCT02691182|529180504|FG002|Overall Study|Adverse Event|10|||
146729607|NCT02691182|529180505|FG003|Overall Study|Adverse Event|11|||
146729608|NCT02691182|529180502|FG000|Overall Study|Physician Decision|3|||
146729609|NCT02691182|529180503|FG001|Overall Study|Physician Decision|7|||
146729610|NCT02691182|529180504|FG002|Overall Study|Physician Decision|14|||
146729611|NCT02691182|529180505|FG003|Overall Study|Physician Decision|8|||
146729612|NCT02691182|529180502|FG000|Overall Study|Lack of Efficacy|0|||
146729613|NCT02691182|529180503|FG001|Overall Study|Lack of Efficacy|0|||
146729614|NCT02691182|529180504|FG002|Overall Study|Lack of Efficacy|0|||
146729615|NCT02691182|529180505|FG003|Overall Study|Lack of Efficacy|4|||
146729616|NCT02691182|529180502|FG000|Overall Study|Protocol Violation|2|||
146729617|NCT02691182|529180503|FG001|Overall Study|Protocol Violation|6|||
146729618|NCT02691182|529180504|FG002|Overall Study|Protocol Violation|6|||
146729619|NCT02691182|529180505|FG003|Overall Study|Protocol Violation|8|||
146729620|NCT02691182|529180502|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
146729621|NCT02691182|529180503|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
146729622|NCT02691182|529180504|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
146729623|NCT02691182|529180505|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
146729624|NCT02691182|529180502|FG000|Overall Study|Missing|0|||
146729625|NCT02691182|529180503|FG001|Overall Study|Missing|5|||
146729626|NCT02691182|529180504|FG002|Overall Study|Missing|1|||
146729627|NCT02691182|529180505|FG003|Overall Study|Missing|5|||
146729628|NCT02563002|529180508|FG000|Overall Study|Death|72|||
146729629|NCT02563002|529180509|FG001|Overall Study|Death|87|||
146729630|NCT02563002|529180508|FG000|Overall Study|Lost to Follow-up|5|||
146729631|NCT02563002|529180509|FG001|Overall Study|Lost to Follow-up|0|||
146729632|NCT02563002|529180508|FG000|Overall Study|Physician Decision|0|||
146729633|NCT02563002|529180509|FG001|Overall Study|Physician Decision|2|||
146729634|NCT02563002|529180508|FG000|Overall Study|Withdrawal by Subject|2|||
146729635|NCT02563002|529180509|FG001|Overall Study|Withdrawal by Subject|10|||
146729636|NCT02563002|529180508|FG000|Overall Study|Sponsor decision|74|||
146729637|NCT02563002|529180509|FG001|Overall Study|Sponsor decision|55|||
146729638|NCT05453110|529180518|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
146729639|NCT05453110|529180519|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
146729640|NCT05453110|529180520|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
146936292|NCT02849626|529924225|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
146729641|NCT05906368|529180521|FG000|Overall Study|Withdrawal by Subject|1|||
146729642|NCT05906368|529180522|FG001|Overall Study|Withdrawal by Subject|1|||
146729643|NCT05906368|529180521|FG000|Overall Study|Ineligibility criteria identified|2|||
146729644|NCT05906368|529180522|FG001|Overall Study|Ineligibility criteria identified|0|||
146729645|NCT01127646|529180523|FG000|Overall Study|Entry Criteria Not Met|1|||
146729646|NCT01127646|529180524|FG001|Overall Study|Entry Criteria Not Met|0|||
146729647|NCT01127646|529180523|FG000|Overall Study|Protocol Violation|0|||
146729648|NCT01127646|529180524|FG001|Overall Study|Protocol Violation|1|||
146729649|NCT03466086|529180525|FG000|Period 1|Sponsor decision due to study timeline|1|||
146936293|NCT02849626|529924226|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
146618692|NCT03775486|528775319|FG000|Initial Therapy Phase|Adverse Event|0|||
146618693|NCT03775486|528775320|FG001|Initial Therapy Phase|Adverse Event|34|||
146618694|NCT03775486|528775319|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
146618695|NCT03775486|528775320|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
146618696|NCT03775486|528775319|FG000|Maintenance Phase|Withdrawal by Subject|13|||
146618697|NCT03775486|528775320|FG001|Maintenance Phase|Withdrawal by Subject|12|||
146618698|NCT03775486|528775319|FG000|Maintenance Phase|Death|44|||
146618699|NCT03775486|528775320|FG001|Maintenance Phase|Death|45|||
146618700|NCT01572480|528775321|FG000|Participants Enrolled|Withdrawal by Subject|1|||
146618701|NCT01572480|528775321|FG000|Drug Administration|Discontinued drug/Off Study|1|||
146618702|NCT01572480|528775321|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
146618703|NCT01572480|528775321|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
146618704|NCT04194944|528775322|FG000|Overall Study|Lost to Follow-up|3|||
146618705|NCT04194944|528775323|FG001|Overall Study|Lost to Follow-up|0|||
146618706|NCT04194944|528775322|FG000|Overall Study|Withdrawal by Subject|2|||
146618707|NCT04194944|528775323|FG001|Overall Study|Withdrawal by Subject|2|||
146618708|NCT04194944|528775322|FG000|Overall Study|On Treatment|93|||
146618709|NCT04194944|528775323|FG001|Overall Study|On Treatment|30|||
146618710|NCT06235905|528775324|FG000|Overall Study|Adverse Event|1|||
146618711|NCT06235905|528775324|FG000|Overall Study|Non-compliant with protocol procedures|1|||
146618712|NCT00319254|528775325|FG000|Overall Study|Withdrawal by Subject|4|||
146618713|NCT00319254|528775325|FG000|Overall Study|Death|46|||
146618714|NCT00319254|528775325|FG000|Overall Study|Lost to Follow-up|2|||
146618715|NCT00319254|528775325|FG000|Overall Study|Enrolled, Not Treated|2|||
146618716|NCT04177212|528775327|FG000|Overall Study|Withdrawal by Subject|9|||
146618717|NCT04177212|528775328|FG001|Overall Study|Withdrawal by Subject|7|||
146618718|NCT04177212|528775327|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
146618719|NCT04177212|528775328|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
146618720|NCT04177212|528775327|FG000|Overall Study|Physician Decision|1|||
146618721|NCT04177212|528775328|FG001|Overall Study|Physician Decision|0|||
146618722|NCT04177212|528775327|FG000|Overall Study|Lost to Follow-up|0|||
146618723|NCT04177212|528775328|FG001|Overall Study|Lost to Follow-up|3|||
146618724|NCT04177212|528775327|FG000|Overall Study|Adverse Event|0|||
146618725|NCT04177212|528775328|FG001|Overall Study|Adverse Event|1|||
146618726|NCT04177212|528775327|FG000|Overall Study|Other|1|||
146618727|NCT04177212|528775328|FG001|Overall Study|Other|2|||
146618728|NCT01147666|528777458|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
146618729|NCT01147666|528777459|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
146618730|NCT01147666|528777460|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
146618731|NCT01147666|528777461|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146618732|NCT01147666|528777462|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146618733|NCT01147666|528777463|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146618734|NCT01147666|528777464|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146618735|NCT01147666|528777465|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146618736|NCT01147666|528777466|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146618737|NCT01147666|528777467|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146618738|NCT01147666|528777468|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146618739|NCT01147666|528777469|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146618740|NCT01147666|528777470|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
146618741|NCT01147666|528777471|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146618742|NCT01147666|528777472|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146618743|NCT01147666|528777458|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
146618744|NCT01147666|528777459|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
146618745|NCT01147666|528777460|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
146936294|NCT02849626|529924227|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
146936295|NCT02849626|529924228|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
146618746|NCT01147666|528777461|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
146618747|NCT01147666|528777462|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
146618748|NCT01147666|528777463|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
146618749|NCT01147666|528777464|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
146618750|NCT01147666|528777465|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
146936296|NCT02849626|529924225|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
146618751|NCT01147666|528777466|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
146618752|NCT01147666|528777467|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
146618753|NCT01147666|528777468|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
146618754|NCT01147666|528777469|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
146618755|NCT01147666|528777470|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
146618756|NCT01147666|528777471|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
146618757|NCT01147666|528777472|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
146618758|NCT01147666|528777458|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
146936297|NCT02849626|529924226|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
146936298|NCT02849626|529924227|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
146936299|NCT02849626|529924228|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
146936300|NCT02849626|529924225|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
146936301|NCT02849626|529924226|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
146936302|NCT02849626|529924227|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
146936303|NCT02849626|529924228|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
146936304|NCT02849626|529924225|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
146981669|NCT01621490|530096088|FG001|Overall Study|Other reasons|6|||
146981670|NCT01621490|530096089|FG002|Overall Study|Other reasons|4|||
146981671|NCT01621490|530096090|FG003|Overall Study|Other reasons|1|||
146981672|NCT01621490|530096091|FG004|Overall Study|Other reasons|1|||
146981673|NCT01621490|530096092|FG005|Overall Study|Other reasons|3|||
146981674|NCT01621490|530096093|FG006|Overall Study|Other reasons|1|||
146981675|NCT01621490|530096094|FG007|Overall Study|Other reasons|1|||
146981676|NCT01621490|530096095|FG008|Overall Study|Other reasons|1|||
146981677|NCT01621490|530096096|FG009|Overall Study|Other reasons|0|||
146981678|NCT01621490|530096097|FG010|Overall Study|Other reasons|0|||
146981679|NCT00506753|530096098|FG000|Overall Study|Lost to Follow-up|21|||
146981680|NCT00506753|530096099|FG001|Overall Study|Lost to Follow-up|15|||
146981681|NCT00125359|530096100|FG000|Overall Study|Death|4|||
146981682|NCT00125359|530096100|FG000|Overall Study|Adverse Event|5|||
146981683|NCT00125359|530096100|FG000|Overall Study|Physician Decision|14|||
146981684|NCT02451670|530096101|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
146981685|NCT02451670|530096102|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
146981686|NCT00461500|530096103|FG000|Overall Study|Adverse Event|1|||
146981687|NCT00461500|530096104|FG001|Overall Study|Adverse Event|0|||
146981688|NCT00461500|530096103|FG000|Overall Study|Lack of Efficacy|0|||
146981689|NCT00461500|530096104|FG001|Overall Study|Lack of Efficacy|1|||
146981690|NCT00461500|530096103|FG000|Overall Study|Expired Drug Treatment|1|||
146981691|NCT00461500|530096104|FG001|Overall Study|Expired Drug Treatment|1|||
146981692|NCT00461500|530096103|FG000|Overall Study|Study Stopped|1|||
146981693|NCT00461500|530096104|FG001|Overall Study|Study Stopped|2|||
146981694|NCT00461500|530096103|FG000|Overall Study|Drug Treatment Misuse|1|||
146981695|NCT00461500|530096104|FG001|Overall Study|Drug Treatment Misuse|0|||
146981696|NCT00461500|530096103|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
146981697|NCT00461500|530096104|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
146981698|NCT00461500|530096103|FG000|Overall Study|Lost to Follow-up|2|||
146981699|NCT00461500|530096104|FG001|Overall Study|Lost to Follow-up|2|||
146981700|NCT01513551|530096109|FG000|Overall Study|Death|0|||
146981701|NCT01513551|530096110|FG001|Overall Study|Death|1|||
146981702|NCT01513551|530096111|FG002|Overall Study|Death|0|||
146981703|NCT01513551|530096109|FG000|Overall Study|Lost to Follow-up|3|||
146981704|NCT01513551|530096110|FG001|Overall Study|Lost to Follow-up|5|||
146981705|NCT01513551|530096111|FG002|Overall Study|Lost to Follow-up|2|||
146981706|NCT01513551|530096109|FG000|Overall Study|Withdrawal by Subject|1|||
146981707|NCT01513551|530096110|FG001|Overall Study|Withdrawal by Subject|0|||
146981708|NCT01513551|530096111|FG002|Overall Study|Withdrawal by Subject|2|||
146981709|NCT01513551|530096109|FG000|Overall Study|Randomized but not vaccinated|0|||
146981710|NCT01513551|530096110|FG001|Overall Study|Randomized but not vaccinated|0|||
146981711|NCT01513551|530096111|FG002|Overall Study|Randomized but not vaccinated|1|||
146981712|NCT02763579|530096112|FG000|Global Period|Death|167|||
146981713|NCT02763579|530096113|FG001|Global Period|Death|151|||
146981714|NCT02763579|530096114|FG002|Global Period|Death|0|||
146981715|NCT02763579|530096115|FG003|Global Period|Death|0|||
146981716|NCT02763579|530096112|FG000|Global Period|Lost to Follow-up|2|||
146981717|NCT02763579|530096113|FG001|Global Period|Lost to Follow-up|4|||
146981718|NCT02763579|530096114|FG002|Global Period|Lost to Follow-up|0|||
146981719|NCT02763579|530096115|FG003|Global Period|Lost to Follow-up|0|||
146981720|NCT02763579|530096112|FG000|Global Period|Physician Decision|0|||
146981721|NCT02763579|530096113|FG001|Global Period|Physician Decision|2|||
146981722|NCT02763579|530096114|FG002|Global Period|Physician Decision|0|||
146981723|NCT02763579|530096115|FG003|Global Period|Physician Decision|0|||
146981724|NCT02763579|530096112|FG000|Global Period|Study Terminated By Sponsor|21|||
146981725|NCT02763579|530096113|FG001|Global Period|Study Terminated By Sponsor|26|||
146981726|NCT02763579|530096114|FG002|Global Period|Study Terminated By Sponsor|0|||
146981727|NCT02763579|530096115|FG003|Global Period|Study Terminated By Sponsor|0|||
146618759|NCT01147666|528777459|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
146981728|NCT02763579|530096112|FG000|Global Period|Withdrawal by Subject|12|||
146981729|NCT02763579|530096113|FG001|Global Period|Withdrawal by Subject|18|||
146981730|NCT02763579|530096114|FG002|Global Period|Withdrawal by Subject|0|||
146981731|NCT02763579|530096115|FG003|Global Period|Withdrawal by Subject|0|||
146618760|NCT01147666|528777460|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
146618761|NCT01147666|528777461|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
146981732|NCT02763579|530096112|FG000|China Period|Death|0|||
146981733|NCT02763579|530096113|FG001|China Period|Death|0|||
146981734|NCT02763579|530096114|FG002|China Period|Death|46|||
146618762|NCT01147666|528777462|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
146618763|NCT01147666|528777463|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
146618764|NCT01147666|528777464|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
146618765|NCT01147666|528777465|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
146618766|NCT01147666|528777466|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
146618767|NCT01147666|528777467|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
146618768|NCT01147666|528777468|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
146618769|NCT01147666|528777469|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
146618770|NCT01147666|528777470|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
146618771|NCT01147666|528777471|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
146618772|NCT01147666|528777472|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
146618773|NCT01147666|528777458|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
146618774|NCT01147666|528777459|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146618775|NCT01147666|528777460|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146618776|NCT01147666|528777461|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
146618777|NCT01147666|528777462|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146618778|NCT01147666|528777463|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146618779|NCT01147666|528777464|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146618780|NCT01147666|528777465|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146618781|NCT01147666|528777466|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146618782|NCT01147666|528777467|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146618783|NCT01147666|528777468|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
146618784|NCT01147666|528777469|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146618785|NCT01147666|528777470|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146618786|NCT01147666|528777471|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146618787|NCT01147666|528777472|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146618788|NCT01147666|528777458|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146618789|NCT01147666|528777459|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146618790|NCT01147666|528777460|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146618791|NCT01147666|528777461|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146618792|NCT01147666|528777462|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
146618793|NCT01147666|528777463|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
146618794|NCT01147666|528777464|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146618795|NCT01147666|528777465|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
146618796|NCT01147666|528777466|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146618797|NCT01147666|528777467|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
146618798|NCT01147666|528777468|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146618799|NCT01147666|528777469|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
146618800|NCT01147666|528777470|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146618801|NCT01147666|528777471|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
146618802|NCT01147666|528777472|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146618803|NCT01147666|528777458|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146618804|NCT01147666|528777459|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146618805|NCT01147666|528777460|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146618806|NCT01147666|528777461|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
146618807|NCT01147666|528777462|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146618808|NCT01147666|528777463|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146618809|NCT01147666|528777464|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146618810|NCT01147666|528777465|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146618811|NCT01147666|528777466|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146618812|NCT01147666|528777467|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146618813|NCT01147666|528777468|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
146618814|NCT01147666|528777469|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146618815|NCT01147666|528777470|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146618816|NCT01147666|528777471|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146618817|NCT01147666|528777472|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146618818|NCT01147666|528777458|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146618819|NCT01147666|528777459|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146618820|NCT01147666|528777460|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146618821|NCT01147666|528777461|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146618822|NCT01147666|528777462|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146618823|NCT01147666|528777463|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146618824|NCT01147666|528777464|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146618825|NCT01147666|528777465|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146618826|NCT01147666|528777466|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146618827|NCT01147666|528777467|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146936305|NCT02849626|529924226|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
146936306|NCT02849626|529924227|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
146936307|NCT02849626|529924228|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
146936308|NCT00889681|529924229|FG000|Overall Study|Not meeting qualification Criteria|2|||
146936309|NCT00889681|529924229|FG000|Overall Study|Insurance disapproval|1|||
146936310|NCT01185704|529924230|FG000|Overall Study|Randomized but not treated|3|||
146936311|NCT01185704|529924231|FG001|Overall Study|Randomized but not treated|3|||
146936312|NCT01185704|529924230|FG000|Overall Study|Lack of ovarian response|5|||
146936313|NCT01185704|529924231|FG001|Overall Study|Lack of ovarian response|1|||
146936314|NCT01185704|529924230|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
146936315|NCT01185704|529924231|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
146936316|NCT01185704|529924230|FG000|Overall Study|Ectopic pregnancy|0|||
146936317|NCT01185704|529924231|FG001|Overall Study|Ectopic pregnancy|1|||
146936318|NCT01313208|529924232|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
146936319|NCT01313208|529924233|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
146936320|NCT01313208|529924232|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
146936321|NCT01313208|529924233|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
146936322|NCT01313208|529924232|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
146936323|NCT01313208|529924233|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
146936324|NCT01313208|529924232|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
146936325|NCT01313208|529924233|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
146936326|NCT01313208|529924232|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
146936327|NCT01313208|529924233|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
146936328|NCT01313208|529924232|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
146936329|NCT01313208|529924233|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
146936330|NCT01313208|529924232|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
146936331|NCT01313208|529924233|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
146936332|NCT01313208|529924232|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
146936333|NCT01313208|529924233|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
146936334|NCT01313208|529924232|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
146936335|NCT01313208|529924233|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
146936336|NCT01957787|529924234|FG000|Overall Study|Death|18|||
146936337|NCT01957787|529924234|FG000|Overall Study|Lost to Follow-up|3|||
146936338|NCT01957787|529924234|FG000|Overall Study|Withdrawal by Subject|3|||
146936339|NCT01957787|529924234|FG000|Overall Study|Entered Hospice or Similar Program|2|||
146936340|NCT01957787|529924234|FG000|Overall Study|Index Tumor(s) Resected|2|||
146936341|NCT01957787|529924234|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
146936342|NCT01957787|529924234|FG000|Overall Study|Local therapy, not cryoablation|6|||
146936343|NCT04176445|529924237|FG000|Overall Study|Adverse Event|0|||
146936344|NCT04176445|529924238|FG001|Overall Study|Adverse Event|1|||
146936345|NCT04176445|529924237|FG000|Overall Study|change plans weaning after first intervention|0|||
146936346|NCT04176445|529924238|FG001|Overall Study|change plans weaning after first intervention|1|||
146936347|NCT00187889|529924239|FG000|Overall Study|Withdrawal by Subject|6|||
146936348|NCT00187889|529924240|FG001|Overall Study|Withdrawal by Subject|4|||
146936349|NCT04046341|529924241|FG000|Overall Study|Lost to Follow-up|2|||
146936350|NCT04046341|529924241|FG000|Overall Study|Withdrawal by Subject|1|||
146936351|NCT04377672|529924243|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
146936352|NCT00405652|529924247|FG000|Overall Study|Adverse Event|4|||
146936353|NCT05109702|529924248|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
146936354|NCT05109702|529924249|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
146936355|NCT05109702|529924250|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
146936356|NCT05109702|529924248|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
146936357|NCT05109702|529924249|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
146936358|NCT05109702|529924250|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
146936359|NCT05109702|529924248|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
146936360|NCT05109702|529924249|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
146936361|NCT05109702|529924250|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
146936362|NCT05109702|529924248|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
146936363|NCT05109702|529924249|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
146936364|NCT05109702|529924250|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
146936365|NCT05109702|529924248|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
146936366|NCT05109702|529924249|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
146936367|NCT05109702|529924250|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
146936368|NCT02713789|529924251|FG000|Overall Study|Lost to Follow-up|0|||
146729650|NCT03466086|529180526|FG001|Period 1|Sponsor decision due to study timeline|0|||
146729651|NCT03466086|529180525|FG000|Period 1|Withdrawal by Subject|1|||
146729652|NCT03466086|529180526|FG001|Period 1|Withdrawal by Subject|0|||
146936369|NCT02713789|529924252|FG001|Overall Study|Lost to Follow-up|1|||
146936370|NCT02713789|529924253|FG002|Overall Study|Lost to Follow-up|1|||
146936371|NCT01293084|529924257|FG000|Overall Study|Physician Decision|3|||
146936372|NCT01293084|529924257|FG000|Overall Study|Withdrawal by Subject|2|||
146936373|NCT00719953|529924260|FG000|Overall Study|Adverse Event|4|||
146936374|NCT01626989|529924261|FG000|Screening Period|Screen Failure|15|||
146936375|NCT01626989|529924262|FG001|Screening Period|Screen Failure|0|||
146936376|NCT01626989|529924263|FG002|Screening Period|Screen Failure|0|||
146936377|NCT01626989|529924261|FG000|Screening Period|Withdrawal by Subject|2|||
146936378|NCT01626989|529924262|FG001|Screening Period|Withdrawal by Subject|0|||
146936379|NCT01626989|529924263|FG002|Screening Period|Withdrawal by Subject|0|||
146936380|NCT02947022|529924266|FG000|Overall Study|Study Stopped|1|||
146936381|NCT04021706|529926142|FG000|Overall Study|Adverse Event|2|||
146936382|NCT04021706|529926143|FG001|Overall Study|Adverse Event|0|||
146936383|NCT04021706|529926142|FG000|Overall Study|Withdrawal by Subject|1|||
146936384|NCT04021706|529926143|FG001|Overall Study|Withdrawal by Subject|2|||
146936385|NCT04021706|529926142|FG000|Overall Study|Physician Decision|1|||
146936386|NCT04021706|529926143|FG001|Overall Study|Physician Decision|0|||
146936387|NCT01375647|529926144|FG000|Overall Study|Lost to Follow-up|3|||
146936388|NCT01375647|529926145|FG001|Overall Study|Lost to Follow-up|3|||
146936389|NCT01375647|529926146|FG002|Overall Study|Lost to Follow-up|7|||
146936390|NCT01375647|529926147|FG003|Overall Study|Lost to Follow-up|10|||
146618828|NCT01147666|528777468|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146618829|NCT01147666|528777469|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
146618830|NCT01147666|528777470|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
146618831|NCT01147666|528777471|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146618832|NCT01147666|528777472|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
146618833|NCT01147666|528777458|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
146618834|NCT01147666|528777459|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
146618835|NCT01147666|528777460|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
146618836|NCT01147666|528777461|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
146618837|NCT01147666|528777462|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
146618838|NCT01147666|528777463|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
146618839|NCT01147666|528777464|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
146618840|NCT01147666|528777465|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
146618841|NCT01147666|528777466|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
146618842|NCT01147666|528777467|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
146618843|NCT01147666|528777468|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
146618844|NCT01147666|528777469|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
146618845|NCT01147666|528777470|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
146618846|NCT01147666|528777471|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
146618847|NCT01147666|528777472|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
146618848|NCT01147666|528777458|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
146618849|NCT01147666|528777459|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
146618850|NCT01147666|528777460|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
146618851|NCT01147666|528777461|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
146618852|NCT01147666|528777462|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
146618853|NCT01147666|528777463|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
146618854|NCT01147666|528777464|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
146618855|NCT01147666|528777465|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
146618856|NCT01147666|528777466|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
146618857|NCT01147666|528777467|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
146618858|NCT01147666|528777468|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
146618859|NCT01147666|528777469|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
146618860|NCT01147666|528777470|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
146618861|NCT01147666|528777471|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
146618862|NCT01147666|528777472|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
146618863|NCT01147666|528777458|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146618864|NCT01147666|528777459|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146618865|NCT01147666|528777460|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146618866|NCT01147666|528777461|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
146618867|NCT01147666|528777462|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146618868|NCT01147666|528777463|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146618869|NCT01147666|528777464|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146618870|NCT01147666|528777465|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146936391|NCT01375647|529926144|FG000|Overall Study|Death|1|||
146936392|NCT01375647|529926145|FG001|Overall Study|Death|2|||
146936393|NCT01375647|529926146|FG002|Overall Study|Death|1|||
146936394|NCT01375647|529926147|FG003|Overall Study|Death|0|||
146936395|NCT01375647|529926144|FG000|Overall Study|Withdrawal by Subject|17|||
146618871|NCT01147666|528777466|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146618872|NCT01147666|528777467|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146618873|NCT01147666|528777468|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146618874|NCT01147666|528777469|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146618875|NCT01147666|528777470|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146936396|NCT01375647|529926145|FG001|Overall Study|Withdrawal by Subject|20|||
146936397|NCT01375647|529926146|FG002|Overall Study|Withdrawal by Subject|26|||
146936398|NCT01375647|529926147|FG003|Overall Study|Withdrawal by Subject|14|||
146936399|NCT01375647|529926144|FG000|Overall Study|Physician Decision|1|||
146936400|NCT01375647|529926145|FG001|Overall Study|Physician Decision|0|||
146936401|NCT01375647|529926146|FG002|Overall Study|Physician Decision|0|||
146936402|NCT01375647|529926147|FG003|Overall Study|Physician Decision|0|||
146936403|NCT02332798|529926150|FG000|Overall Study|Unwilling to Participate in Study|0|||
146936404|NCT02332798|529926151|FG001|Overall Study|Unwilling to Participate in Study|1|||
146936405|NCT02332798|529926152|FG002|Overall Study|Unwilling to Participate in Study|1|||
146936406|NCT02332798|529926150|FG000|Overall Study|Positive Urine Drug Test|0|||
146936407|NCT02332798|529926151|FG001|Overall Study|Positive Urine Drug Test|1|||
146936408|NCT02332798|529926152|FG002|Overall Study|Positive Urine Drug Test|0|||
146936409|NCT02332798|529926150|FG000|Overall Study|Abnormal Laboratory Findings|1|||
146936410|NCT02332798|529926151|FG001|Overall Study|Abnormal Laboratory Findings|0|||
146936411|NCT02332798|529926152|FG002|Overall Study|Abnormal Laboratory Findings|0|||
146936412|NCT00595868|529926153|FG000|Overall Study|Lost to Follow-up|45|||
146936413|NCT00595868|529926154|FG001|Overall Study|Lost to Follow-up|50|||
146936414|NCT01102140|529926155|FG000|Overall Study|Lost to Follow-up|1|||
146729653|NCT04721925|529180531|FG000|2-Month Assessment|Lost to Follow-up|5|||
146729654|NCT04721925|529180532|FG001|2-Month Assessment|Lost to Follow-up|3|||
146729655|NCT04721925|529180531|FG000|4-Month Assessment|Lost to Follow-up|3|||
146729656|NCT04721925|529180532|FG001|4-Month Assessment|Lost to Follow-up|6|||
146729657|NCT04570436|529180536|FG000|Overall Study|Adverse Event|0|||
146729658|NCT04570436|529180537|FG001|Overall Study|Adverse Event|0|||
146729659|NCT04570436|529180538|FG002|Overall Study|Adverse Event|1|||
146729660|NCT04570436|529180539|FG003|Overall Study|Adverse Event|0|||
146729661|NCT04570436|529180540|FG004|Overall Study|Adverse Event|0|||
146729662|NCT04570436|529180541|FG005|Overall Study|Adverse Event|0|||
146729663|NCT04570436|529180542|FG006|Overall Study|Adverse Event|0|||
146729664|NCT04570436|529180543|FG007|Overall Study|Adverse Event|0|||
146729665|NCT04570436|529180544|FG008|Overall Study|Adverse Event|0|||
146729666|NCT04570436|529180545|FG009|Overall Study|Adverse Event|0|||
146729667|NCT04570436|529180536|FG000|Overall Study|Physician Decision|1|||
146729668|NCT04570436|529180537|FG001|Overall Study|Physician Decision|0|||
146729669|NCT04570436|529180538|FG002|Overall Study|Physician Decision|0|||
146729670|NCT04570436|529180539|FG003|Overall Study|Physician Decision|0|||
146729671|NCT04570436|529180540|FG004|Overall Study|Physician Decision|0|||
146729672|NCT04570436|529180541|FG005|Overall Study|Physician Decision|0|||
146729673|NCT04570436|529180542|FG006|Overall Study|Physician Decision|0|||
146729674|NCT04570436|529180543|FG007|Overall Study|Physician Decision|0|||
146729675|NCT04570436|529180544|FG008|Overall Study|Physician Decision|0|||
146729676|NCT04570436|529180545|FG009|Overall Study|Physician Decision|0|||
146729677|NCT03002610|529180546|FG000|Overall Study|Withdrawal by Subject|6|||
146729678|NCT03002610|529180547|FG001|Overall Study|Withdrawal by Subject|25|||
146729679|NCT03002610|529180548|FG002|Overall Study|Withdrawal by Subject|13|||
146729680|NCT03802123|529180549|FG000|Overall Study|Withdrawal by Subject|3|||
146729681|NCT03802123|529180549|FG000|Overall Study|Physician Decision|1|||
146729682|NCT03802123|529180549|FG000|Overall Study|Subject moved to hospice care|1|||
146729683|NCT03802123|529180549|FG000|Overall Study|technician error|1|||
146729684|NCT03802123|529180549|FG000|Overall Study|Death|3|||
146729685|NCT01822587|529180550|FG000|Overall Study|Lost to Follow-up|7|||
146729686|NCT01822587|529180551|FG001|Overall Study|Lost to Follow-up|9|||
146729687|NCT01822587|529180552|FG002|Overall Study|Lost to Follow-up|12|||
146729688|NCT01822587|529180550|FG000|Overall Study|Physician Decision|9|||
146729689|NCT01822587|529180551|FG001|Overall Study|Physician Decision|6|||
146729690|NCT01822587|529180552|FG002|Overall Study|Physician Decision|6|||
146729691|NCT01274182|529180553|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
146729692|NCT01274182|529180554|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
146729693|NCT01274182|529180555|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
146729694|NCT01274182|529180553|FG000|Overall Study|Adverse Event|4|||
146729695|NCT01274182|529180554|FG001|Overall Study|Adverse Event|5|||
146729696|NCT01274182|529180555|FG002|Overall Study|Adverse Event|3|||
146729697|NCT01274182|529180553|FG000|Overall Study|Withdrawal by Subject|5|||
146729698|NCT01274182|529180554|FG001|Overall Study|Withdrawal by Subject|5|||
146729699|NCT01274182|529180555|FG002|Overall Study|Withdrawal by Subject|3|||
146729700|NCT01274182|529180553|FG000|Overall Study|Lost to Follow-up|2|||
146729701|NCT01274182|529180554|FG001|Overall Study|Lost to Follow-up|3|||
146729702|NCT01274182|529180555|FG002|Overall Study|Lost to Follow-up|1|||
146729703|NCT01274182|529180553|FG000|Overall Study|Protocol Violation|3|||
146729704|NCT01274182|529180554|FG001|Overall Study|Protocol Violation|2|||
146729705|NCT01274182|529180555|FG002|Overall Study|Protocol Violation|0|||
146729706|NCT01274182|529180553|FG000|Overall Study|Death|1|||
146936415|NCT01102140|529926156|FG001|Overall Study|Lost to Follow-up|0|||
146981735|NCT02763579|530096115|FG003|China Period|Death|48|||
146729707|NCT01274182|529180554|FG001|Overall Study|Death|0|||
146729708|NCT01274182|529180555|FG002|Overall Study|Death|1|||
146729709|NCT00658567|529180556|FG000|Overall Study|Adverse Event|5|||
146729710|NCT00658567|529180557|FG001|Overall Study|Adverse Event|2|||
146729711|NCT00658567|529180558|FG002|Overall Study|Adverse Event|3|||
146936416|NCT01102140|529926155|FG000|Overall Study|Investigator terminated study|2|||
146936417|NCT01102140|529926156|FG001|Overall Study|Investigator terminated study|2|||
146936418|NCT03788967|529926159|FG000|Overall Study|Lost to Follow-up|14|||
146936419|NCT03788967|529926160|FG001|Overall Study|Lost to Follow-up|10|||
146936420|NCT03788967|529926159|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
146936421|NCT03788967|529926160|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
146936422|NCT03788967|529926159|FG000|Overall Study|Participant Withdrawal of Consent|13|||
146936423|NCT03788967|529926160|FG001|Overall Study|Participant Withdrawal of Consent|5|||
146936424|NCT03788967|529926159|FG000|Overall Study|Adverse Event|1|||
146936425|NCT03788967|529926160|FG001|Overall Study|Adverse Event|1|||
146936426|NCT03788967|529926159|FG000|Overall Study|COVID-19|1|||
146936427|NCT03788967|529926160|FG001|Overall Study|COVID-19|2|||
146936428|NCT01625611|529926168|FG000|Overall Study|No adlib drinks Lab 1|3|||
146936429|NCT01625611|529926169|FG001|Overall Study|No adlib drinks Lab 1|0|||
146936430|NCT01625611|529926168|FG000|Overall Study|Technical issues with PET|1|||
146936431|NCT01625611|529926169|FG001|Overall Study|Technical issues with PET|0|||
146936432|NCT01625611|529926168|FG000|Overall Study|Unable to complete study procedures|1|||
146936433|NCT01625611|529926169|FG001|Overall Study|Unable to complete study procedures|0|||
146936434|NCT01625611|529926168|FG000|Overall Study|Withdrawal by Subject|3|||
146936435|NCT01625611|529926169|FG001|Overall Study|Withdrawal by Subject|0|||
146936436|NCT00948194|529926170|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
146936437|NCT00948194|529926171|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
146936438|NCT00233324|529926172|FG000|Main Study|Death|68|||
146936439|NCT00233324|529926173|FG001|Main Study|Death|60|||
146936440|NCT00233324|529926174|FG002|Main Study|Death|62|||
146936441|NCT00233324|529926175|FG003|Main Study|Death|47|||
146936442|NCT00233324|529926172|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
146936443|NCT00233324|529926173|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
146936444|NCT00233324|529926174|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
146936445|NCT00233324|529926175|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
146936446|NCT00233324|529926172|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
146936447|NCT00233324|529926173|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
146936448|NCT00233324|529926174|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
146936449|NCT00233324|529926175|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
146936450|NCT02905825|529926176|FG000|Overall Study|Protocol Violation|11|||
146936451|NCT02905825|529926176|FG000|Overall Study|Device Malfunction|1|||
146936452|NCT04702984|529926178|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
146936453|NCT00270998|529926181|FG000|3 Month Follow-up|Adverse Event|1|||
146936454|NCT00270998|529926182|FG001|3 Month Follow-up|Adverse Event|0|||
146936455|NCT00270998|529926183|FG002|3 Month Follow-up|Adverse Event|0|||
146936456|NCT00270998|529926181|FG000|3 Month Follow-up|Lack of Efficacy|1|||
146936457|NCT00270998|529926182|FG001|3 Month Follow-up|Lack of Efficacy|2|||
146936458|NCT00270998|529926183|FG002|3 Month Follow-up|Lack of Efficacy|1|||
146936459|NCT00270998|529926181|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
146936460|NCT00270998|529926182|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
146936461|NCT00270998|529926183|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
146936462|NCT00270998|529926181|FG000|3 Month Follow-up|Pessary did not fit|12|||
146936463|NCT00270998|529926182|FG001|3 Month Follow-up|Pessary did not fit|0|||
146618876|NCT01147666|528777471|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146618877|NCT01147666|528777472|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146618878|NCT01147666|528777458|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146618879|NCT01147666|528777459|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146618880|NCT01147666|528777460|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146618881|NCT01147666|528777461|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146618882|NCT01147666|528777462|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
146618883|NCT01147666|528777463|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
146618884|NCT01147666|528777464|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146936464|NCT00270998|529926183|FG002|3 Month Follow-up|Pessary did not fit|0|||
146936465|NCT00270998|529926181|FG000|3 Month Follow-up|Personal/family health|1|||
146936466|NCT00270998|529926182|FG001|3 Month Follow-up|Personal/family health|1|||
146936467|NCT00270998|529926183|FG002|3 Month Follow-up|Personal/family health|0|||
146936468|NCT00270998|529926181|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
146936469|NCT00270998|529926182|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
146936470|NCT00270998|529926183|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
146936471|NCT00270998|529926181|FG000|12 Month Follow-up|Lack of Efficacy|5|||
146936472|NCT00270998|529926182|FG001|12 Month Follow-up|Lack of Efficacy|4|||
146618885|NCT01147666|528777465|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
146936473|NCT00270998|529926183|FG002|12 Month Follow-up|Lack of Efficacy|3|||
146936474|NCT00270998|529926181|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
146936475|NCT00270998|529926182|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
146936476|NCT00270998|529926183|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
146936477|NCT00270998|529926181|FG000|12 Month Follow-up|Pessary did not fit|1|||
146936478|NCT00270998|529926182|FG001|12 Month Follow-up|Pessary did not fit|0|||
146936479|NCT00270998|529926183|FG002|12 Month Follow-up|Pessary did not fit|0|||
146936480|NCT00270998|529926181|FG000|12 Month Follow-up|Personal/family health|0|||
146936481|NCT00270998|529926182|FG001|12 Month Follow-up|Personal/family health|5|||
146936482|NCT00270998|529926183|FG002|12 Month Follow-up|Personal/family health|1|||
146936483|NCT00270998|529926181|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
146936484|NCT00270998|529926182|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
146936485|NCT00270998|529926183|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
146936486|NCT03395223|529926184|FG000|Overall Study|Lost to Follow-up|3|||
146936487|NCT03395223|529926184|FG000|Overall Study|Other|1|||
146936488|NCT01248364|529926188|FG000|Overall Study|Adverse Event|0|||
146729712|NCT00658567|529180556|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
146729713|NCT00658567|529180557|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
146729714|NCT00658567|529180558|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
146729715|NCT00658567|529180556|FG000|Overall Study|Physician Decision|0|||
146729716|NCT00658567|529180557|FG001|Overall Study|Physician Decision|1|||
146729717|NCT00658567|529180558|FG002|Overall Study|Physician Decision|0|||
146729718|NCT00658567|529180556|FG000|Overall Study|At Discretion of Sponsor|1|||
146729719|NCT00658567|529180557|FG001|Overall Study|At Discretion of Sponsor|1|||
146729720|NCT00658567|529180558|FG002|Overall Study|At Discretion of Sponsor|1|||
146729721|NCT00691938|529180559|FG000|Overall Study|QTc prolongation|1|||
146729722|NCT00691938|529180560|FG001|Overall Study|QTc prolongation|0|||
146729723|NCT00691938|529180561|FG002|Overall Study|QTc prolongation|0|||
146729724|NCT00691938|529180562|FG003|Overall Study|QTc prolongation|0|||
146729725|NCT00691938|529180563|FG004|Overall Study|QTc prolongation|0|||
146729726|NCT00691938|529180564|FG005|Overall Study|QTc prolongation|0|||
146729727|NCT00691938|529180565|FG006|Overall Study|QTc prolongation|0|||
146729728|NCT03172702|529180570|FG000|Overall Study|Adverse Event|9|||
146729729|NCT03172702|529180570|FG000|Overall Study|Death|2|||
146729730|NCT03172702|529180570|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
146729731|NCT03172702|529180570|FG000|Overall Study|Withdrawal by Subject|5|||
146729732|NCT03172702|529180570|FG000|Overall Study|Other|2|||
146729733|NCT02954354|529180571|FG000|Overall Study|Adverse Event|2|||
146729734|NCT02954354|529180572|FG001|Overall Study|Adverse Event|2|||
146729735|NCT02954354|529180573|FG002|Overall Study|Adverse Event|4|||
146729736|NCT02954354|529180571|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
146729737|NCT02954354|529180572|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
146729738|NCT02954354|529180573|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
146729739|NCT02954354|529180571|FG000|Overall Study|Lack of Efficacy|0|||
146729740|NCT02954354|529180572|FG001|Overall Study|Lack of Efficacy|2|||
146729741|NCT02954354|529180573|FG002|Overall Study|Lack of Efficacy|0|||
146729742|NCT02954354|529180571|FG000|Overall Study|Withdrawal by Subject|17|||
146729743|NCT02954354|529180572|FG001|Overall Study|Withdrawal by Subject|9|||
146729744|NCT02954354|529180573|FG002|Overall Study|Withdrawal by Subject|11|||
146729745|NCT02954354|529180571|FG000|Overall Study|Lost to Follow-up|12|||
146729746|NCT02954354|529180572|FG001|Overall Study|Lost to Follow-up|5|||
146729747|NCT02954354|529180573|FG002|Overall Study|Lost to Follow-up|0|||
146729748|NCT02954354|529180571|FG000|Overall Study|Miscellaneous|2|||
146729749|NCT02954354|529180572|FG001|Overall Study|Miscellaneous|2|||
146729750|NCT02954354|529180573|FG002|Overall Study|Miscellaneous|1|||
146729751|NCT06134180|529180576|FG000|Overall Study|Lost to Follow-up|4|||
146729752|NCT01936857|529180577|FG000|Overall Study|Sent to prison or 06 center|11|||
146729753|NCT01936857|529180578|FG001|Overall Study|Sent to prison or 06 center|12|||
146729754|NCT01936857|529180577|FG000|Overall Study|Lost to Follow-up|10|||
146729755|NCT01936857|529180578|FG001|Overall Study|Lost to Follow-up|7|||
146729756|NCT01936857|529180577|FG000|Overall Study|Death|7|||
146729757|NCT01936857|529180578|FG001|Overall Study|Death|3|||
146729758|NCT01936857|529180577|FG000|Overall Study|Moved|2|||
146729759|NCT01936857|529180578|FG001|Overall Study|Moved|1|||
146729760|NCT01936857|529180577|FG000|Overall Study|Withdrawal by Subject|1|||
146729761|NCT01936857|529180578|FG001|Overall Study|Withdrawal by Subject|0|||
146729762|NCT01936857|529180577|FG000|Overall Study|Side effect of medication|1|||
146729763|NCT01936857|529180578|FG001|Overall Study|Side effect of medication|0|||
146729764|NCT01936857|529180577|FG000|Overall Study|Other|2|||
146729765|NCT01936857|529180578|FG001|Overall Study|Other|2|||
146729766|NCT02279043|529180579|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
146729767|NCT02279043|529180580|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
146729768|NCT02279043|529180581|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
146729769|NCT02279043|529180579|FG000|Overall Study|Lost to Follow-up|46|||
146729770|NCT02279043|529180580|FG001|Overall Study|Lost to Follow-up|88|||
146729771|NCT02279043|529180581|FG002|Overall Study|Lost to Follow-up|0|||
146729772|NCT01939548|529180582|FG000|Overall Study|Non compliance|0|||
146729773|NCT01939548|529180583|FG001|Overall Study|Non compliance|2|||
146729774|NCT01939548|529180584|FG002|Overall Study|Non compliance|0|||
146729775|NCT01939548|529180582|FG000|Overall Study|Study Terminated by Sponsor|17|||
146729776|NCT01939548|529180583|FG001|Overall Study|Study Terminated by Sponsor|19|||
146936489|NCT01248364|529926189|FG001|Overall Study|Adverse Event|1|||
146936490|NCT01248364|529926190|FG002|Overall Study|Adverse Event|0|||
146936491|NCT01248364|529926191|FG003|Overall Study|Adverse Event|0|||
146936492|NCT01117012|529926194|FG000|Overall Study|Adverse Event|0|||
146936493|NCT01117012|529926195|FG001|Overall Study|Adverse Event|1|||
146936494|NCT01117012|529926194|FG000|Overall Study|Death|1|||
146936495|NCT01117012|529926195|FG001|Overall Study|Death|1|||
146936496|NCT01117012|529926194|FG000|Overall Study|Withdrawal by Subject|3|||
146936497|NCT01117012|529926195|FG001|Overall Study|Withdrawal by Subject|0|||
146936498|NCT01117012|529926194|FG000|Overall Study|Undefined|4|||
146936499|NCT01117012|529926195|FG001|Overall Study|Undefined|3|||
146936500|NCT05425719|529926203|FG000|Overall Study|Lost to Follow-up|4|||
146936501|NCT05425719|529926204|FG001|Overall Study|Lost to Follow-up|0|||
146936502|NCT05425719|529926203|FG000|Overall Study|Withdrew consent|1|||
146936503|NCT05425719|529926204|FG001|Overall Study|Withdrew consent|1|||
146936504|NCT04682353|529926205|FG000|Overall Study|Lost to Follow-up|0|||
146936505|NCT04682353|529926206|FG001|Overall Study|Lost to Follow-up|1|||
146936506|NCT04682353|529926207|FG002|Overall Study|Lost to Follow-up|0|||
146936507|NCT04682353|529926208|FG003|Overall Study|Lost to Follow-up|1|||
146729777|NCT01939548|529180584|FG002|Overall Study|Study Terminated by Sponsor|12|||
146729778|NCT01939548|529180582|FG000|Overall Study|Insufficient Clinical Response|1|||
146729779|NCT01939548|529180583|FG001|Overall Study|Insufficient Clinical Response|0|||
146729780|NCT01939548|529180584|FG002|Overall Study|Insufficient Clinical Response|0|||
146729781|NCT01939548|529180582|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
146729782|NCT01939548|529180583|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
146729783|NCT01939548|529180584|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
146729784|NCT01939548|529180582|FG000|Overall Study|Withdrawal by Subject|4|||
146729785|NCT01939548|529180583|FG001|Overall Study|Withdrawal by Subject|4|||
146729786|NCT01939548|529180584|FG002|Overall Study|Withdrawal by Subject|1|||
146729787|NCT01939548|529180582|FG000|Overall Study|Protocol Violation|7|||
146729788|NCT01939548|529180583|FG001|Overall Study|Protocol Violation|6|||
146729789|NCT01939548|529180584|FG002|Overall Study|Protocol Violation|5|||
146729790|NCT01939548|529180582|FG000|Overall Study|Lost to Follow-up|5|||
146729791|NCT01939548|529180583|FG001|Overall Study|Lost to Follow-up|5|||
146729792|NCT01939548|529180584|FG002|Overall Study|Lost to Follow-up|3|||
146729793|NCT01939548|529180582|FG000|Overall Study|Adverse Event|2|||
146729794|NCT01939548|529180583|FG001|Overall Study|Adverse Event|9|||
146729795|NCT01939548|529180584|FG002|Overall Study|Adverse Event|7|||
146729796|NCT01939548|529180582|FG000|Overall Study|Death|0|||
146729797|NCT01939548|529180583|FG001|Overall Study|Death|0|||
146729798|NCT01939548|529180584|FG002|Overall Study|Death|1|||
146729799|NCT01939548|529180582|FG000|Overall Study|Participant dropped|0|||
146729800|NCT01939548|529180583|FG001|Overall Study|Participant dropped|0|||
146729801|NCT01939548|529180584|FG002|Overall Study|Participant dropped|1|||
146729802|NCT01939548|529180582|FG000|Overall Study|Participant unwilling to continue|0|||
146729803|NCT01939548|529180583|FG001|Overall Study|Participant unwilling to continue|1|||
146729804|NCT01939548|529180584|FG002|Overall Study|Participant unwilling to continue|0|||
146729805|NCT01939548|529180582|FG000|Overall Study|Participant withdrew consent|0|||
146729806|NCT01939548|529180583|FG001|Overall Study|Participant withdrew consent|2|||
146729807|NCT01939548|529180584|FG002|Overall Study|Participant withdrew consent|0|||
146729808|NCT01939548|529180582|FG000|Overall Study|Did not complete follow-up|0|||
146729809|NCT01939548|529180583|FG001|Overall Study|Did not complete follow-up|1|||
146729810|NCT01939548|529180584|FG002|Overall Study|Did not complete follow-up|0|||
146729811|NCT00490282|529180585|FG000|Overall Study|Withdrawal by Subject|3|||
146729812|NCT01494584|529180590|FG000|Overall Study|Study Closed/Terminated|1|||
146729813|NCT01499082|529180591|FG000|Overall Study|Randomized but not Treated|0|||
146729814|NCT01499082|529180592|FG001|Overall Study|Randomized but not Treated|1|||
146729815|NCT01499082|529180591|FG000|Overall Study|Adverse Event|12|||
146729816|NCT01499082|529180592|FG001|Overall Study|Adverse Event|16|||
146729817|NCT01499082|529180591|FG000|Overall Study|Lack of Efficacy|1|||
146729818|NCT01499082|529180592|FG001|Overall Study|Lack of Efficacy|1|||
146729819|NCT01499082|529180591|FG000|Overall Study|Protocol Violation|6|||
146729820|NCT01499082|529180592|FG001|Overall Study|Protocol Violation|8|||
146729821|NCT01499082|529180591|FG000|Overall Study|Diverse Reasons|18|||
146729822|NCT01499082|529180592|FG001|Overall Study|Diverse Reasons|14|||
146729823|NCT01499082|529180591|FG000|Overall Study|Site Closure for Noncompliance|5|||
146729824|NCT01499082|529180592|FG001|Overall Study|Site Closure for Noncompliance|2|||
146729825|NCT01499082|529180591|FG000|Overall Study|Hypoglycemia|2|||
146729826|NCT01499082|529180592|FG001|Overall Study|Hypoglycemia|3|||
146936508|NCT04682353|529926205|FG000|Overall Study|Personal reasons|0|||
146729827|NCT01499082|529180591|FG000|Overall Study|Lost to Follow-up|1|||
146729828|NCT01499082|529180592|FG001|Overall Study|Lost to Follow-up|3|||
146729829|NCT05380947|529180598|FG000|Washout Period 1|Not attend visit|1|||
146936509|NCT04682353|529926206|FG001|Overall Study|Personal reasons|1|||
146936510|NCT04682353|529926207|FG002|Overall Study|Personal reasons|0|||
146936511|NCT04682353|529926208|FG003|Overall Study|Personal reasons|0|||
146729830|NCT05380947|529180599|FG001|Washout Period 1|Not attend visit|0|||
146729831|NCT05380947|529180600|FG002|Washout Period 1|Not attend visit|0|||
146936512|NCT03505749|529926209|FG000|Overall Study|Lost to Follow-up|7|||
146936513|NCT03505749|529926210|FG001|Overall Study|Lost to Follow-up|11|||
146729832|NCT05380947|529180601|FG003|Washout Period 1|Not attend visit|0|||
146729833|NCT05380947|529180598|FG000|Washout Period 2|Adverse Event|1|||
146729834|NCT05380947|529180599|FG001|Washout Period 2|Adverse Event|0|||
146729835|NCT05380947|529180600|FG002|Washout Period 2|Adverse Event|0|||
146729836|NCT05380947|529180601|FG003|Washout Period 2|Adverse Event|0|||
146729837|NCT05380947|529180598|FG000|Washout Period 3|Adverse Event|0|||
146729838|NCT05380947|529180599|FG001|Washout Period 3|Adverse Event|1|||
146729839|NCT05380947|529180600|FG002|Washout Period 3|Adverse Event|0|||
146729840|NCT05380947|529180601|FG003|Washout Period 3|Adverse Event|0|||
146729841|NCT05380947|529180598|FG000|Washout Period 3|Not attend visit|0|||
146729842|NCT05380947|529180599|FG001|Washout Period 3|Not attend visit|1|||
146729843|NCT05380947|529180600|FG002|Washout Period 3|Not attend visit|0|||
146729844|NCT05380947|529180601|FG003|Washout Period 3|Not attend visit|1|||
146729845|NCT01256567|529180603|FG000|Overall Study|Withdrawal by Subject|1|||
146729846|NCT02453685|529180616|FG000|Overall Study|Adverse Event|0|||
146729847|NCT02453685|529180617|FG001|Overall Study|Adverse Event|1|||
146729848|NCT02453685|529180616|FG000|Overall Study|Protocol Violation|7|||
146729849|NCT02453685|529180617|FG001|Overall Study|Protocol Violation|4|||
146729850|NCT02453685|529180616|FG000|Overall Study|Lost to Follow-up|0|||
146729851|NCT02453685|529180617|FG001|Overall Study|Lost to Follow-up|1|||
146729852|NCT02453685|529180616|FG000|Overall Study|Withdrawal by Subject|8|||
146729853|NCT02453685|529180617|FG001|Overall Study|Withdrawal by Subject|4|||
146729854|NCT02453685|529180616|FG000|Overall Study|Unclassified|4|||
146729855|NCT02453685|529180617|FG001|Overall Study|Unclassified|2|||
146729856|NCT00522626|529180622|FG000|Overall Study|Lost to Follow-up|7|||
146729857|NCT01169675|529180625|FG000|Overall Study|Progressive disease|13|||
146729858|NCT01169675|529180626|FG001|Overall Study|Progressive disease|2|||
146729859|NCT01169675|529180627|FG002|Overall Study|Progressive disease|5|||
146618886|NCT01147666|528777466|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146618887|NCT01147666|528777467|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
146618888|NCT01147666|528777468|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146618889|NCT01147666|528777469|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146618890|NCT01147666|528777470|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146618891|NCT01147666|528777471|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
146618892|NCT01147666|528777472|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146618893|NCT01147666|528777458|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146618894|NCT01147666|528777459|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146618895|NCT01147666|528777460|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146618896|NCT01147666|528777461|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
146618897|NCT01147666|528777462|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146618898|NCT01147666|528777463|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146618899|NCT01147666|528777464|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146618900|NCT01147666|528777465|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146618901|NCT01147666|528777466|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146618902|NCT01147666|528777467|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146618903|NCT01147666|528777468|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
146618904|NCT01147666|528777469|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146618905|NCT01147666|528777470|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146618906|NCT01147666|528777471|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146618907|NCT01147666|528777472|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146618908|NCT01147666|528777458|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146618909|NCT01147666|528777459|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146618910|NCT01147666|528777460|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146618911|NCT01147666|528777461|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146618912|NCT01147666|528777462|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146618913|NCT01147666|528777463|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146618914|NCT01147666|528777464|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146618915|NCT01147666|528777465|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146618916|NCT01147666|528777466|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146618917|NCT01147666|528777467|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146618918|NCT01147666|528777468|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146618919|NCT01147666|528777469|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146618920|NCT01147666|528777470|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
146618921|NCT01147666|528777471|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146618922|NCT01147666|528777472|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146729860|NCT01169675|529180628|FG003|Overall Study|Progressive disease|15|||
146729861|NCT01169675|529180629|FG004|Overall Study|Progressive disease|1|||
146618923|NCT01147666|528777458|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146618924|NCT01147666|528777459|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146618925|NCT01147666|528777460|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146618926|NCT01147666|528777461|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146729862|NCT01169675|529180625|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
146936514|NCT03505749|529926209|FG000|Overall Study|Withdrawal by Subject|6|||
146936515|NCT03505749|529926210|FG001|Overall Study|Withdrawal by Subject|0|||
146936516|NCT03505749|529926209|FG000|Overall Study|Discharged from treatment|3|||
146936517|NCT03505749|529926210|FG001|Overall Study|Discharged from treatment|6|||
146936518|NCT01151540|529926211|FG000|Overall Study|Other|2|||
146936519|NCT01151540|529926211|FG000|Overall Study|Adverse event, non-fatal|4|||
146618927|NCT01147666|528777462|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146618928|NCT01147666|528777463|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146618929|NCT01147666|528777464|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146618930|NCT01147666|528777465|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146618931|NCT01147666|528777466|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146618932|NCT01147666|528777467|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146618933|NCT01147666|528777468|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146936520|NCT01151540|529926211|FG000|Overall Study|Withdrawal by Subject|7|||
146936521|NCT03846219|529926213|FG000|Overall Study|Withdrawal by Subject|3|||
146936522|NCT03846219|529926214|FG001|Overall Study|Withdrawal by Subject|2|||
146936523|NCT03846219|529926215|FG002|Overall Study|Withdrawal by Subject|2|||
146936524|NCT03846219|529926213|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
146936525|NCT03846219|529926214|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
146936526|NCT03846219|529926215|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
146936527|NCT03846219|529926213|FG000|Overall Study|Physician Decision|0|||
146936528|NCT03846219|529926214|FG001|Overall Study|Physician Decision|0|||
146936529|NCT03846219|529926215|FG002|Overall Study|Physician Decision|2|||
146936530|NCT01392378|529926218|FG000|Infant Series|Adverse Event|0|||
146936531|NCT01392378|529926219|FG001|Infant Series|Adverse Event|0|||
146729863|NCT01169675|529180626|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146729864|NCT01169675|529180627|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146729865|NCT01169675|529180628|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146729866|NCT01169675|529180629|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
146729867|NCT01169675|529180625|FG000|Overall Study|Adverse Event|5|||
146729868|NCT01169675|529180626|FG001|Overall Study|Adverse Event|1|||
146729869|NCT01169675|529180627|FG002|Overall Study|Adverse Event|2|||
146729870|NCT01169675|529180628|FG003|Overall Study|Adverse Event|0|||
146729871|NCT01169675|529180629|FG004|Overall Study|Adverse Event|0|||
146729872|NCT01169675|529180625|FG000|Overall Study|Withdrawal by Subject|1|||
146729873|NCT01169675|529180626|FG001|Overall Study|Withdrawal by Subject|0|||
146729874|NCT01169675|529180627|FG002|Overall Study|Withdrawal by Subject|0|||
146729875|NCT01169675|529180628|FG003|Overall Study|Withdrawal by Subject|1|||
146729876|NCT01169675|529180629|FG004|Overall Study|Withdrawal by Subject|2|||
146729877|NCT01169675|529180625|FG000|Overall Study|Other Reason Not Defined Above|0|||
146729878|NCT01169675|529180626|FG001|Overall Study|Other Reason Not Defined Above|0|||
146729879|NCT01169675|529180627|FG002|Overall Study|Other Reason Not Defined Above|0|||
146729880|NCT01169675|529180628|FG003|Overall Study|Other Reason Not Defined Above|1|||
146729881|NCT01169675|529180629|FG004|Overall Study|Other Reason Not Defined Above|1|||
146729882|NCT02816138|529180632|FG000|Overall Study|Adverse Event|1|||
146729883|NCT02355028|529180633|FG000|Overall Study|Adverse Event|2|||
146729884|NCT02355028|529180634|FG001|Overall Study|Adverse Event|0|||
146729885|NCT02355028|529180633|FG000|Overall Study|Withdrawal by Subject|1|||
146729886|NCT02355028|529180634|FG001|Overall Study|Withdrawal by Subject|1|||
146729887|NCT02355028|529180633|FG000|Overall Study|Deemed ineligible after randomization|8|||
146729888|NCT02355028|529180634|FG001|Overall Study|Deemed ineligible after randomization|4|||
146729889|NCT04102579|529180635|FG000|Overall Study|Withdrawal by Subject|3|||
146729890|NCT04102579|529180636|FG001|Overall Study|Withdrawal by Subject|4|||
146729891|NCT04102579|529180635|FG000|Overall Study|Lost to Follow-up|0|||
146729892|NCT04102579|529180636|FG001|Overall Study|Lost to Follow-up|1|||
146729893|NCT04102579|529180635|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
146729894|NCT04102579|529180636|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
146729895|NCT04102579|529180635|FG000|Overall Study|Other than Specified|1|||
146729896|NCT04102579|529180636|FG001|Overall Study|Other than Specified|0|||
146729897|NCT04102579|529180635|FG000|Overall Study|Not Dosed with Study Drug|0|||
146729898|NCT04102579|529180636|FG001|Overall Study|Not Dosed with Study Drug|1|||
146729899|NCT05899686|529180637|FG000|Overall Study|Protocol Violation|1|||
146729900|NCT00572195|529180638|FG000|Overall Study|Withdrawal by Subject|50|||
146729901|NCT00572195|529180638|FG000|Overall Study|Death|9|||
146729902|NCT00572195|529180638|FG000|Overall Study|Adverse Event|4|||
146729903|NCT00572195|529180638|FG000|Overall Study|Lost to Follow-up|5|||
146729904|NCT01525602|529180639|FG000|Overall Study|Adverse Event|1|||
146729905|NCT01525602|529180640|FG001|Overall Study|Adverse Event|0|||
146936532|NCT01392378|529926220|FG002|Infant Series|Adverse Event|0|||
146936533|NCT01392378|529926221|FG003|Infant Series|Adverse Event|1|||
146729906|NCT01525602|529180641|FG002|Overall Study|Adverse Event|1|||
146729907|NCT01525602|529180642|FG003|Overall Study|Adverse Event|1|||
146729908|NCT01525602|529180643|FG004|Overall Study|Adverse Event|3|||
146936534|NCT01392378|529926222|FG004|Infant Series|Adverse Event|0|||
146936535|NCT01392378|529926218|FG000|Infant Series|Lost to Follow-up|0|||
146618934|NCT01147666|528777469|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146618935|NCT01147666|528777470|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
146618936|NCT01147666|528777471|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146618937|NCT01147666|528777472|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
146618938|NCT00796666|528777473|FG000|Overall Study|Death|2|||
146618939|NCT00796666|528777474|FG001|Overall Study|Death|4|||
146618940|NCT00796666|528777473|FG000|Overall Study|Withdrawal by Subject|2|||
146618941|NCT00796666|528777474|FG001|Overall Study|Withdrawal by Subject|0|||
146618942|NCT00796666|528777473|FG000|Overall Study|Adverse Event|7|||
146618943|NCT00796666|528777474|FG001|Overall Study|Adverse Event|5|||
146618944|NCT00796666|528777473|FG000|Overall Study|Protocol Violation|1|||
146618945|NCT00796666|528777474|FG001|Overall Study|Protocol Violation|0|||
146618946|NCT00796666|528777473|FG000|Overall Study|Other|1|||
146618947|NCT00796666|528777474|FG001|Overall Study|Other|0|||
146618948|NCT00796666|528777473|FG000|Overall Study|Terminated by sponsor|53|||
146618949|NCT00796666|528777474|FG001|Overall Study|Terminated by sponsor|55|||
146618950|NCT00796666|528777473|FG000|Overall Study|Randomized and not treated|1|||
146618951|NCT00796666|528777474|FG001|Overall Study|Randomized and not treated|0|||
146618952|NCT00474955|528777476|FG000|Overall Study|Adverse Event|2|||
146618953|NCT00474955|528777476|FG000|Overall Study|Drug unavailability|1|||
146618954|NCT00474955|528777476|FG000|Overall Study|Personal reasons|5|||
146618955|NCT02576639|528777477|FG000|Overall Study|Withdrawal by Subject|1|||
146618956|NCT02576639|528777478|FG001|Overall Study|Withdrawal by Subject|2|||
146618957|NCT02576639|528777479|FG002|Overall Study|Withdrawal by Subject|1|||
146618958|NCT02576639|528777480|FG003|Overall Study|Withdrawal by Subject|0|||
146618959|NCT02576639|528777481|FG004|Overall Study|Withdrawal by Subject|1|||
146618960|NCT02576639|528777477|FG000|Overall Study|Adverse Event|1|||
146618961|NCT02576639|528777478|FG001|Overall Study|Adverse Event|0|||
146618962|NCT02576639|528777479|FG002|Overall Study|Adverse Event|1|||
146618963|NCT02576639|528777480|FG003|Overall Study|Adverse Event|1|||
146618964|NCT02576639|528777481|FG004|Overall Study|Adverse Event|2|||
146618965|NCT02576639|528777477|FG000|Overall Study|Physician Decision|0|||
146618966|NCT02576639|528777478|FG001|Overall Study|Physician Decision|0|||
146618967|NCT02576639|528777479|FG002|Overall Study|Physician Decision|0|||
146618968|NCT02576639|528777480|FG003|Overall Study|Physician Decision|0|||
146618969|NCT02576639|528777481|FG004|Overall Study|Physician Decision|1|||
146618970|NCT01859923|528777486|FG000|Overall Study|Adverse Event|0|||
146618971|NCT01859923|528777487|FG001|Overall Study|Adverse Event|0|||
146618972|NCT01859923|528777488|FG002|Overall Study|Adverse Event|1|||
146618973|NCT01859923|528777489|FG003|Overall Study|Adverse Event|1|||
146618974|NCT00296816|528777495|FG000|Overall Study|Disease Progression|37|||
146618975|NCT00296816|528777495|FG000|Overall Study|Adverse Event|18|||
146618976|NCT00296816|528777495|FG000|Overall Study|Investigator/Participant request|5|||
146618977|NCT00296816|528777495|FG000|Overall Study|Non-compliance|1|||
146618978|NCT00296816|528777495|FG000|Overall Study|Missing for end of treatment|4|||
146618979|NCT00296816|528777495|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
146618980|NCT00296816|528777495|FG000|Overall Study|Poor performance status|1|||
146618981|NCT00296816|528777495|FG000|Overall Study|Relocation to Florida|1|||
146618982|NCT00296816|528777495|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
146618983|NCT00296816|528777495|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
146618984|NCT00296816|528777495|FG000|Overall Study|Neuropathy/patient preference|1|||
146618985|NCT00296816|528777495|FG000|Overall Study|Proteinuria|1|||
146618986|NCT00296816|528777495|FG000|Overall Study|ineligibility due to radiation treatment|1|||
146618987|NCT00985465|528777496|FG000|Overall Study|Withdrawal by Subject|1|||
146618988|NCT00985465|528777497|FG001|Overall Study|Withdrawal by Subject|2|||
146618989|NCT00985465|528777496|FG000|Overall Study|Considered to be part of the other group|0|||
146618990|NCT00985465|528777497|FG001|Overall Study|Considered to be part of the other group|1|||
146618991|NCT01054456|528777498|FG000|Overall Study|Other|1|||
146618992|NCT00687401|528777499|FG000|Overall Study|Protocol Violation|7|||
146618993|NCT00687401|528777499|FG000|Overall Study|Adverse Event|6|||
146936536|NCT01392378|529926219|FG001|Infant Series|Lost to Follow-up|0|||
146618994|NCT00687401|528777499|FG000|Overall Study|Lack of Efficacy|6|||
146618995|NCT00687401|528777499|FG000|Overall Study|Withdrawal by Subject|4|||
146936537|NCT01392378|529926220|FG002|Infant Series|Lost to Follow-up|0|||
146936538|NCT01392378|529926221|FG003|Infant Series|Lost to Follow-up|1|||
146618996|NCT00687401|528777499|FG000|Overall Study|Did not return for visit|3|||
146618997|NCT00687401|528777499|FG000|Overall Study|For reasons different from those above|4|||
146618998|NCT01721161|528777502|FG000|Overall Study|Adverse Event|2|||
146618999|NCT01721161|528777503|FG001|Overall Study|Adverse Event|3|||
146619000|NCT01721161|528777502|FG000|Overall Study|Lost to Follow-up|1|||
146619001|NCT01721161|528777503|FG001|Overall Study|Lost to Follow-up|2|||
146619002|NCT01721161|528777502|FG000|Overall Study|Withdrawal by Subject|1|||
146619003|NCT01721161|528777503|FG001|Overall Study|Withdrawal by Subject|1|||
146619004|NCT01721161|528777502|FG000|Overall Study|Other|0|||
146619005|NCT01721161|528777503|FG001|Overall Study|Other|1|||
146936539|NCT01392378|529926222|FG004|Infant Series|Lost to Follow-up|0|||
146619006|NCT02888106|528777511|FG000|Overall Study|Withdrawal by Subject|1|||
146619007|NCT02888106|528777512|FG001|Overall Study|Withdrawal by Subject|2|||
146936540|NCT01392378|529926218|FG000|Infant Series|Protocol Violation|0|||
146936541|NCT01392378|529926219|FG001|Infant Series|Protocol Violation|1|||
146936542|NCT01392378|529926220|FG002|Infant Series|Protocol Violation|0|||
146936543|NCT01392378|529926221|FG003|Infant Series|Protocol Violation|0|||
146936544|NCT01392378|529926222|FG004|Infant Series|Protocol Violation|0|||
146936545|NCT01392378|529926218|FG000|Infant Series|Withdrawal by Parent|4|||
146936546|NCT01392378|529926219|FG001|Infant Series|Withdrawal by Parent|1|||
146936547|NCT01392378|529926220|FG002|Infant Series|Withdrawal by Parent|0|||
146936548|NCT01392378|529926221|FG003|Infant Series|Withdrawal by Parent|0|||
146936549|NCT01392378|529926222|FG004|Infant Series|Withdrawal by Parent|0|||
146936550|NCT01392378|529926218|FG000|After Infant Series|Lost to Follow-up|0|||
146936551|NCT01392378|529926219|FG001|After Infant Series|Lost to Follow-up|0|||
146936552|NCT01392378|529926220|FG002|After Infant Series|Lost to Follow-up|1|||
146981736|NCT02763579|530096112|FG000|China Period|Lost to Follow-up|0|||
146981737|NCT02763579|530096113|FG001|China Period|Lost to Follow-up|0|||
146981738|NCT02763579|530096114|FG002|China Period|Lost to Follow-up|1|||
146981739|NCT02763579|530096115|FG003|China Period|Lost to Follow-up|1|||
146981740|NCT02763579|530096112|FG000|China Period|Physician Decision|0|||
146981741|NCT02763579|530096113|FG001|China Period|Physician Decision|0|||
146981742|NCT02763579|530096114|FG002|China Period|Physician Decision|0|||
146981743|NCT02763579|530096115|FG003|China Period|Physician Decision|1|||
146981744|NCT02763579|530096112|FG000|China Period|Study Terminated By Sponsor|0|||
146981745|NCT02763579|530096113|FG001|China Period|Study Terminated By Sponsor|0|||
146981746|NCT02763579|530096114|FG002|China Period|Study Terminated By Sponsor|3|||
146981747|NCT02763579|530096115|FG003|China Period|Study Terminated By Sponsor|4|||
146981748|NCT02763579|530096112|FG000|China Period|Withdrawal by Subject|0|||
146981749|NCT02763579|530096113|FG001|China Period|Withdrawal by Subject|0|||
146981750|NCT02763579|530096114|FG002|China Period|Withdrawal by Subject|3|||
146981751|NCT02763579|530096115|FG003|China Period|Withdrawal by Subject|3|||
146981752|NCT04467697|530096119|FG000|Overall Study|Adverse Event|2|||
146981753|NCT04467697|530096119|FG000|Overall Study|Lost to Follow-up|6|||
146981754|NCT04467697|530096119|FG000|Overall Study|Withdrawal by Subject|9|||
146981755|NCT04467697|530096119|FG000|Overall Study|Protocol Violation|3|||
146619008|NCT02888106|528777513|FG002|Overall Study|Withdrawal by Subject|0|||
146619009|NCT02888106|528777514|FG003|Overall Study|Withdrawal by Subject|1|||
146619010|NCT02888106|528777515|FG004|Overall Study|Withdrawal by Subject|0|||
146619011|NCT02888106|528777516|FG005|Overall Study|Withdrawal by Subject|0|||
146619012|NCT02888106|528777511|FG000|Overall Study|Lost to Follow-up|1|||
146619013|NCT02888106|528777512|FG001|Overall Study|Lost to Follow-up|0|||
146619014|NCT02888106|528777513|FG002|Overall Study|Lost to Follow-up|0|||
146619015|NCT02888106|528777514|FG003|Overall Study|Lost to Follow-up|1|||
146619016|NCT02888106|528777515|FG004|Overall Study|Lost to Follow-up|0|||
146619017|NCT02888106|528777516|FG005|Overall Study|Lost to Follow-up|1|||
146619018|NCT02888106|528777511|FG000|Overall Study|Adverse Event|2|||
146619019|NCT02888106|528777512|FG001|Overall Study|Adverse Event|0|||
146619020|NCT02888106|528777513|FG002|Overall Study|Adverse Event|0|||
146619021|NCT02888106|528777514|FG003|Overall Study|Adverse Event|0|||
146619022|NCT02888106|528777515|FG004|Overall Study|Adverse Event|0|||
146619023|NCT02888106|528777516|FG005|Overall Study|Adverse Event|0|||
146619024|NCT02888106|528777511|FG000|Overall Study|Withdrawal of consent|0|||
146619025|NCT02888106|528777512|FG001|Overall Study|Withdrawal of consent|0|||
146619026|NCT02888106|528777513|FG002|Overall Study|Withdrawal of consent|0|||
146619027|NCT02888106|528777514|FG003|Overall Study|Withdrawal of consent|0|||
146619028|NCT02888106|528777515|FG004|Overall Study|Withdrawal of consent|1|||
146619029|NCT02888106|528777516|FG005|Overall Study|Withdrawal of consent|0|||
146619030|NCT02888106|528777511|FG000|Overall Study|Pregnancy|1|||
146619031|NCT02888106|528777512|FG001|Overall Study|Pregnancy|0|||
146619032|NCT02888106|528777513|FG002|Overall Study|Pregnancy|0|||
146619033|NCT02888106|528777514|FG003|Overall Study|Pregnancy|0|||
146936553|NCT01392378|529926221|FG003|After Infant Series|Lost to Follow-up|0|||
146936554|NCT01392378|529926222|FG004|After Infant Series|Lost to Follow-up|0|||
146936555|NCT01392378|529926218|FG000|After Infant Series|Withdrawal by Parent|0|||
146936556|NCT01392378|529926219|FG001|After Infant Series|Withdrawal by Parent|1|||
146936557|NCT01392378|529926220|FG002|After Infant Series|Withdrawal by Parent|1|||
146936558|NCT01392378|529926221|FG003|After Infant Series|Withdrawal by Parent|0|||
146936559|NCT01392378|529926222|FG004|After Infant Series|Withdrawal by Parent|1|||
146981756|NCT05751629|530096120|FG000|Overall Study|Withdrawal by Subject|6|||
146981757|NCT05751629|530096120|FG000|Overall Study|Death|25|||
146619034|NCT02888106|528777515|FG004|Overall Study|Pregnancy|0|||
146981758|NCT05751629|530096120|FG000|Overall Study|Study Site Closed|9|||
146619035|NCT02888106|528777516|FG005|Overall Study|Pregnancy|0|||
146619036|NCT00430716|528777521|FG000|Double Blind Phase|Death|1|||
146981759|NCT05751629|530096120|FG000|Overall Study|Physician Decision|1|||
146936560|NCT01392378|529926218|FG000|Toddler Dose|Lost to Follow-up|0|||
146936561|NCT01392378|529926219|FG001|Toddler Dose|Lost to Follow-up|0|||
146619037|NCT00430716|528777522|FG001|Double Blind Phase|Death|0|||
146619038|NCT00430716|528777523|FG002|Double Blind Phase|Death|0|||
146619039|NCT00430716|528777521|FG000|Double Blind Phase|No longer willing to participate|2|||
146619040|NCT00430716|528777522|FG001|Double Blind Phase|No longer willing to participate|1|||
146619041|NCT00430716|528777523|FG002|Double Blind Phase|No longer willing to participate|1|||
146619042|NCT00430716|528777521|FG000|Double Blind Phase|Other|0|||
146619043|NCT00430716|528777522|FG001|Double Blind Phase|Other|2|||
146619044|NCT00430716|528777523|FG002|Double Blind Phase|Other|0|||
146619045|NCT00430716|528777521|FG000|Double Blind Phase|Study terminated by sponsor|1|||
146619046|NCT00430716|528777522|FG001|Double Blind Phase|Study terminated by sponsor|1|||
146619047|NCT00430716|528777523|FG002|Double Blind Phase|Study terminated by sponsor|2|||
146619048|NCT00430716|528777521|FG000|Double Blind Phase|Adverse Event|1|||
146619049|NCT00430716|528777522|FG001|Double Blind Phase|Adverse Event|1|||
146619050|NCT00430716|528777523|FG002|Double Blind Phase|Adverse Event|3|||
146619051|NCT00430716|528777521|FG000|Double Blind Phase|Not treated|1|||
146619052|NCT00430716|528777522|FG001|Double Blind Phase|Not treated|0|||
146619053|NCT00430716|528777523|FG002|Double Blind Phase|Not treated|0|||
146619054|NCT00430716|528777521|FG000|Open Label Phase|Lost to Follow-up|1|||
146619055|NCT00430716|528777522|FG001|Open Label Phase|Lost to Follow-up|0|||
146619056|NCT00430716|528777523|FG002|Open Label Phase|Lost to Follow-up|1|||
146619057|NCT00430716|528777521|FG000|Open Label Phase|No longer willing to participate|0|||
146619058|NCT00430716|528777522|FG001|Open Label Phase|No longer willing to participate|1|||
146619059|NCT00430716|528777523|FG002|Open Label Phase|No longer willing to participate|1|||
146619060|NCT00430716|528777521|FG000|Open Label Phase|Other|3|||
146619061|NCT00430716|528777522|FG001|Open Label Phase|Other|1|||
146619062|NCT00430716|528777523|FG002|Open Label Phase|Other|1|||
146619063|NCT00430716|528777521|FG000|Open Label Phase|Protocol Violation|1|||
146619064|NCT00430716|528777522|FG001|Open Label Phase|Protocol Violation|0|||
146619065|NCT00430716|528777523|FG002|Open Label Phase|Protocol Violation|0|||
146619066|NCT00430716|528777521|FG000|Open Label Phase|Study terminated by sponsor|4|||
146619067|NCT00430716|528777522|FG001|Open Label Phase|Study terminated by sponsor|5|||
146619068|NCT00430716|528777523|FG002|Open Label Phase|Study terminated by sponsor|4|||
146619069|NCT01433172|528777529|FG000|Overall Study|Withdrawal by Subject|0|||
146619070|NCT01433172|528777530|FG001|Overall Study|Withdrawal by Subject|1|||
146619071|NCT01433172|528777531|FG002|Overall Study|Withdrawal by Subject|0|||
146619072|NCT01433172|528777529|FG000|Overall Study|Disease Progression|0|||
146619073|NCT01433172|528777530|FG001|Overall Study|Disease Progression|0|||
146619074|NCT01433172|528777531|FG002|Overall Study|Disease Progression|1|||
146619075|NCT01433172|528777529|FG000|Overall Study|Death|0|||
146619076|NCT01433172|528777530|FG001|Overall Study|Death|2|||
146619077|NCT01433172|528777531|FG002|Overall Study|Death|0|||
146619078|NCT00104650|528777532|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
146619079|NCT00104650|528777533|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
146619080|NCT00104650|528777534|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
146619081|NCT00104650|528777532|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
146619082|NCT00104650|528777533|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
146619083|NCT00104650|528777534|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
146619084|NCT00104650|528777532|FG000|Treatment Period (25 Weeks)|Death|7|||
146619085|NCT00104650|528777533|FG001|Treatment Period (25 Weeks)|Death|5|||
146619086|NCT00104650|528777534|FG002|Treatment Period (25 Weeks)|Death|6|||
146619087|NCT00104650|528777532|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
146619088|NCT00104650|528777533|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
146619089|NCT00104650|528777534|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
146619090|NCT00104650|528777532|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
146619091|NCT00104650|528777533|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
146619092|NCT00104650|528777534|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
146619093|NCT00104650|528777532|FG000|Treatment Period (25 Weeks)|Other|1|||
146619094|NCT00104650|528777533|FG001|Treatment Period (25 Weeks)|Other|0|||
146619095|NCT00104650|528777534|FG002|Treatment Period (25 Weeks)|Other|0|||
146619096|NCT00104650|528777532|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
146619097|NCT00104650|528777533|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
146619098|NCT00104650|528777534|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
146619099|NCT00104650|528777532|FG000|Follow-up Period|Physician Decision|1|||
146619100|NCT00104650|528777533|FG001|Follow-up Period|Physician Decision|1|||
146619101|NCT00104650|528777534|FG002|Follow-up Period|Physician Decision|0|||
146619102|NCT00104650|528777532|FG000|Follow-up Period|Adverse Event|1|||
146619103|NCT00104650|528777533|FG001|Follow-up Period|Adverse Event|0|||
146619104|NCT00104650|528777534|FG002|Follow-up Period|Adverse Event|1|||
146619105|NCT00104650|528777532|FG000|Follow-up Period|Withdrawal by Subject|0|||
146619106|NCT00104650|528777533|FG001|Follow-up Period|Withdrawal by Subject|3|||
146619107|NCT00104650|528777534|FG002|Follow-up Period|Withdrawal by Subject|3|||
146619108|NCT00104650|528777532|FG000|Follow-up Period|Death|6|||
146619109|NCT00104650|528777533|FG001|Follow-up Period|Death|6|||
146619110|NCT00104650|528777534|FG002|Follow-up Period|Death|4|||
146619111|NCT00104650|528777532|FG000|Follow-up Period|Disease progression|3|||
146619112|NCT00104650|528777533|FG001|Follow-up Period|Disease progression|1|||
146619113|NCT00104650|528777534|FG002|Follow-up Period|Disease progression|0|||
146619114|NCT00104650|528777532|FG000|Follow-up Period|Lost to Follow-up|0|||
146936562|NCT01392378|529926220|FG002|Toddler Dose|Lost to Follow-up|0|||
146936563|NCT01392378|529926221|FG003|Toddler Dose|Lost to Follow-up|1|||
146936564|NCT01392378|529926222|FG004|Toddler Dose|Lost to Follow-up|0|||
146936565|NCT01392378|529926218|FG000|Toddler Dose|Withdrawal by Parent|0|||
146936566|NCT01392378|529926219|FG001|Toddler Dose|Withdrawal by Parent|1|||
146936567|NCT01392378|529926220|FG002|Toddler Dose|Withdrawal by Parent|0|||
146936568|NCT01392378|529926221|FG003|Toddler Dose|Withdrawal by Parent|1|||
146936569|NCT01392378|529926222|FG004|Toddler Dose|Withdrawal by Parent|1|||
146936570|NCT02322411|529926223|FG000|Overall Study|Lost to Follow-up|4|||
146936571|NCT02322411|529926224|FG001|Overall Study|Lost to Follow-up|7|||
146936572|NCT02322411|529926223|FG000|Overall Study|Withdrawal by Subject|1|||
146936573|NCT02322411|529926224|FG001|Overall Study|Withdrawal by Subject|0|||
146936574|NCT00788697|529926230|FG000|Overall Study|No study drug administered|12|||
146936575|NCT00788697|529926230|FG000|Overall Study|Training Patients|74|||
146936576|NCT00788697|529926230|FG000|Overall Study|no truth standard procedure available|5|||
146936577|NCT00788697|529926230|FG000|Overall Study|Technically inadequate truth standard|1|||
146936578|NCT00788697|529926230|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
146936579|NCT01998880|529926232|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
146936580|NCT01998880|529926233|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
146729909|NCT01525602|529180644|FG005|Overall Study|Adverse Event|3|||
146729910|NCT01525602|529180645|FG006|Overall Study|Adverse Event|0|||
146729911|NCT01525602|529180646|FG007|Overall Study|Adverse Event|1|||
146729912|NCT01525602|529180639|FG000|Overall Study|Disease progression|6|||
146619115|NCT00104650|528777533|FG001|Follow-up Period|Lost to Follow-up|1|||
146619116|NCT00104650|528777534|FG002|Follow-up Period|Lost to Follow-up|2|||
146619117|NCT00104650|528777532|FG000|Follow-up Period|Other|0|||
146619118|NCT00104650|528777533|FG001|Follow-up Period|Other|1|||
146619119|NCT00104650|528777534|FG002|Follow-up Period|Other|0|||
146619120|NCT02294058|528777535|FG000|Overall Study|Adverse Event|16|||
146619121|NCT02294058|528777536|FG001|Overall Study|Adverse Event|7|||
146619122|NCT02294058|528777537|FG002|Overall Study|Adverse Event|13|||
146619123|NCT02294058|528777535|FG000|Overall Study|Lack of Efficacy|3|||
146619124|NCT02294058|528777536|FG001|Overall Study|Lack of Efficacy|3|||
146619125|NCT02294058|528777537|FG002|Overall Study|Lack of Efficacy|0|||
146619126|NCT02294058|528777535|FG000|Overall Study|Lost to Follow-up|1|||
146619127|NCT02294058|528777536|FG001|Overall Study|Lost to Follow-up|0|||
146619128|NCT02294058|528777537|FG002|Overall Study|Lost to Follow-up|2|||
146619129|NCT02294058|528777535|FG000|Overall Study|Withdrawal by Subject|10|||
146619130|NCT02294058|528777536|FG001|Overall Study|Withdrawal by Subject|14|||
146619131|NCT02294058|528777537|FG002|Overall Study|Withdrawal by Subject|13|||
146619132|NCT02294058|528777535|FG000|Overall Study|Physician Decision|2|||
146619133|NCT02294058|528777536|FG001|Overall Study|Physician Decision|1|||
146619134|NCT02294058|528777537|FG002|Overall Study|Physician Decision|0|||
146619135|NCT02294058|528777535|FG000|Overall Study|Miscellaneous|4|||
146619136|NCT02294058|528777536|FG001|Overall Study|Miscellaneous|1|||
146619137|NCT02294058|528777537|FG002|Overall Study|Miscellaneous|1|||
146619138|NCT01894607|528777538|FG000|Overall Study|Ineligible|1|||
146619139|NCT03084796|528777541|FG000|Overall Study|Adverse Event|4|||
146619140|NCT03084796|528777542|FG001|Overall Study|Adverse Event|5|||
146619141|NCT03084796|528777543|FG002|Overall Study|Adverse Event|6|||
146729913|NCT01525602|529180640|FG001|Overall Study|Disease progression|3|||
146729914|NCT01525602|529180641|FG002|Overall Study|Disease progression|2|||
146729915|NCT01525602|529180642|FG003|Overall Study|Disease progression|5|||
146729916|NCT01525602|529180643|FG004|Overall Study|Disease progression|22|||
146729917|NCT01525602|529180644|FG005|Overall Study|Disease progression|2|||
146729918|NCT01525602|529180645|FG006|Overall Study|Disease progression|3|||
146729919|NCT01525602|529180646|FG007|Overall Study|Disease progression|3|||
146729920|NCT01525602|529180639|FG000|Overall Study|Clinical progression|2|||
146729921|NCT01525602|529180640|FG001|Overall Study|Clinical progression|0|||
146729922|NCT01525602|529180641|FG002|Overall Study|Clinical progression|0|||
146729923|NCT01525602|529180642|FG003|Overall Study|Clinical progression|0|||
146729924|NCT01525602|529180643|FG004|Overall Study|Clinical progression|0|||
146729925|NCT01525602|529180644|FG005|Overall Study|Clinical progression|0|||
146729926|NCT01525602|529180645|FG006|Overall Study|Clinical progression|1|||
146619142|NCT03084796|528777544|FG003|Overall Study|Adverse Event|2|||
146619143|NCT03084796|528777545|FG004|Overall Study|Adverse Event|3|||
146619144|NCT03084796|528777546|FG005|Overall Study|Adverse Event|5|||
146619145|NCT03084796|528777541|FG000|Overall Study|Withdrawal by Subject|3|||
146936581|NCT01998880|529926232|FG000|Overall Study|Disease Progression|1|||
146936582|NCT01998880|529926233|FG001|Overall Study|Disease Progression|8|||
146936583|NCT01998880|529926232|FG000|Overall Study|Withdrew Consent|2|||
146936584|NCT01998880|529926233|FG001|Overall Study|Withdrew Consent|1|||
146936585|NCT01998880|529926232|FG000|Overall Study|Death|3|||
146729927|NCT01525602|529180646|FG007|Overall Study|Clinical progression|1|||
146729928|NCT01525602|529180639|FG000|Overall Study|Non-compliance|0|||
146619146|NCT03084796|528777542|FG001|Overall Study|Withdrawal by Subject|5|||
146936586|NCT01998880|529926233|FG001|Overall Study|Death|6|||
146619147|NCT03084796|528777543|FG002|Overall Study|Withdrawal by Subject|2|||
146619148|NCT03084796|528777544|FG003|Overall Study|Withdrawal by Subject|1|||
146729929|NCT01525602|529180640|FG001|Overall Study|Non-compliance|0|||
146729930|NCT01525602|529180641|FG002|Overall Study|Non-compliance|0|||
146729931|NCT01525602|529180642|FG003|Overall Study|Non-compliance|0|||
146729932|NCT01525602|529180643|FG004|Overall Study|Non-compliance|1|||
146729933|NCT01525602|529180644|FG005|Overall Study|Non-compliance|0|||
146729934|NCT01525602|529180645|FG006|Overall Study|Non-compliance|0|||
146729935|NCT01525602|529180646|FG007|Overall Study|Non-compliance|0|||
146729936|NCT01525602|529180639|FG000|Overall Study|Withdrawal by Subject|0|||
146729937|NCT01525602|529180640|FG001|Overall Study|Withdrawal by Subject|0|||
146729938|NCT01525602|529180641|FG002|Overall Study|Withdrawal by Subject|0|||
146729939|NCT01525602|529180642|FG003|Overall Study|Withdrawal by Subject|0|||
146729940|NCT01525602|529180643|FG004|Overall Study|Withdrawal by Subject|3|||
146729941|NCT01525602|529180644|FG005|Overall Study|Withdrawal by Subject|1|||
146729942|NCT01525602|529180645|FG006|Overall Study|Withdrawal by Subject|0|||
146729943|NCT01525602|529180646|FG007|Overall Study|Withdrawal by Subject|1|||
146729944|NCT01525602|529180639|FG000|Overall Study|Physician Decision|0|||
146729945|NCT01525602|529180640|FG001|Overall Study|Physician Decision|0|||
146729946|NCT01525602|529180641|FG002|Overall Study|Physician Decision|0|||
146729947|NCT01525602|529180642|FG003|Overall Study|Physician Decision|0|||
146729948|NCT01525602|529180643|FG004|Overall Study|Physician Decision|3|||
146729949|NCT01525602|529180644|FG005|Overall Study|Physician Decision|0|||
146729950|NCT01525602|529180645|FG006|Overall Study|Physician Decision|1|||
146729951|NCT01525602|529180646|FG007|Overall Study|Physician Decision|0|||
146729952|NCT01525602|529180639|FG000|Overall Study|Death|0|||
146729953|NCT01525602|529180640|FG001|Overall Study|Death|0|||
146729954|NCT01525602|529180641|FG002|Overall Study|Death|0|||
146729955|NCT01525602|529180642|FG003|Overall Study|Death|0|||
146729956|NCT01525602|529180643|FG004|Overall Study|Death|1|||
146729957|NCT01525602|529180644|FG005|Overall Study|Death|1|||
146729958|NCT01525602|529180645|FG006|Overall Study|Death|0|||
146729959|NCT01525602|529180646|FG007|Overall Study|Death|0|||
146729960|NCT01525602|529180639|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
146729961|NCT01525602|529180640|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
146729962|NCT01525602|529180641|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
146729963|NCT01525602|529180642|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
146729964|NCT01525602|529180643|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
146729965|NCT01525602|529180644|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
146729966|NCT01525602|529180645|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
146729967|NCT01525602|529180646|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
146729968|NCT01024608|529180649|FG000|Overall Study|Adverse Event|1|||
146729969|NCT01024608|529180650|FG001|Overall Study|Adverse Event|0|||
146729970|NCT01024608|529180649|FG000|Overall Study|Withdrawal by Subject|1|||
146729971|NCT01024608|529180650|FG001|Overall Study|Withdrawal by Subject|0|||
146729972|NCT01024608|529180649|FG000|Overall Study|Lost to Follow-up|0|||
146729973|NCT01024608|529180650|FG001|Overall Study|Lost to Follow-up|1|||
146729974|NCT01024608|529180649|FG000|Overall Study|Protocol Violation|0|||
146729975|NCT01024608|529180650|FG001|Overall Study|Protocol Violation|3|||
146729976|NCT01024608|529180649|FG000|Overall Study|Never received study treatment|2|||
146729977|NCT01024608|529180650|FG001|Overall Study|Never received study treatment|0|||
146729978|NCT02532179|529182410|FG000|Overall Study|Lost to Follow-up|1|||
146729979|NCT02532179|529182410|FG000|Overall Study|Pregnancy|1|||
146729980|NCT02532179|529182410|FG000|Overall Study|Subject received depot steroid injection|1|||
146729981|NCT01337674|529182416|FG000|Treatment Period 1|Adverse Event|0|||
146729982|NCT01337674|529182417|FG001|Treatment Period 1|Adverse Event|1|||
146729983|NCT01337674|529182418|FG002|Treatment Period 1|Adverse Event|0|||
146729984|NCT01337674|529182419|FG003|Treatment Period 1|Adverse Event|0|||
146729985|NCT01337674|529182416|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
146729986|NCT01337674|529182417|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
146729987|NCT01337674|529182418|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
146729988|NCT01337674|529182419|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
146729989|NCT01337674|529182416|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146729990|NCT01337674|529182417|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146936587|NCT01998880|529926232|FG000|Overall Study|Insufficient Therapeutic Response|1|||
146936588|NCT01998880|529926233|FG001|Overall Study|Insufficient Therapeutic Response|5|||
146936589|NCT01998880|529926232|FG000|Overall Study|Administrative/Other|1|||
146936590|NCT01998880|529926233|FG001|Overall Study|Administrative/Other|1|||
146729991|NCT01337674|529182418|FG002|Treatment Period 2|Withdrawal by Subject|1|||
146729992|NCT01337674|529182419|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146729993|NCT03076970|529182420|FG000|Washout Period 2|Adverse Event|0|||
146729994|NCT03076970|529182421|FG001|Washout Period 2|Adverse Event|0|||
146729995|NCT03076970|529182422|FG002|Washout Period 2|Adverse Event|0|||
146729996|NCT03076970|529182423|FG003|Washout Period 2|Adverse Event|0|||
146936591|NCT01998880|529926232|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
146936592|NCT01998880|529926233|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
146729997|NCT03076970|529182424|FG004|Washout Period 2|Adverse Event|1|||
146729998|NCT03076970|529182425|FG005|Washout Period 2|Adverse Event|0|||
146981760|NCT01909466|530096121|FG000|Overall Study|Lost to Follow-up|5|||
146936593|NCT01998880|529926232|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
146936594|NCT01998880|529926233|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
146936595|NCT01998880|529926232|FG000|Overall Study|Did Not Receive Treatment|3|||
146936596|NCT01998880|529926233|FG001|Overall Study|Did Not Receive Treatment|2|||
146936597|NCT02248857|529926234|FG000|3 Month|Withdrawal by Subject|9|||
146936598|NCT02248857|529926235|FG001|3 Month|Withdrawal by Subject|3|||
146729999|NCT03076970|529182420|FG000|Period 3|Withdrawal by Subject|0|||
146730000|NCT03076970|529182421|FG001|Period 3|Withdrawal by Subject|0|||
146730001|NCT03076970|529182422|FG002|Period 3|Withdrawal by Subject|0|||
146730002|NCT03076970|529182423|FG003|Period 3|Withdrawal by Subject|0|||
146730003|NCT03076970|529182424|FG004|Period 3|Withdrawal by Subject|0|||
146730004|NCT03076970|529182425|FG005|Period 3|Withdrawal by Subject|1|||
146730005|NCT03076970|529182420|FG000|Period 3|Failure to meet I/E criteria|0|||
146730006|NCT03076970|529182421|FG001|Period 3|Failure to meet I/E criteria|0|||
146730007|NCT03076970|529182422|FG002|Period 3|Failure to meet I/E criteria|0|||
146730008|NCT03076970|529182423|FG003|Period 3|Failure to meet I/E criteria|0|||
146730009|NCT03076970|529182424|FG004|Period 3|Failure to meet I/E criteria|1|||
146730010|NCT03076970|529182425|FG005|Period 3|Failure to meet I/E criteria|0|||
146730011|NCT00789815|529182426|FG000|Overall Study|Protocol Violation|6|||
146730012|NCT00789815|529182427|FG001|Overall Study|Protocol Violation|1|||
146730013|NCT00789815|529182426|FG000|Overall Study|Intubation due to massive bleeding|1|||
146730014|NCT00789815|529182427|FG001|Overall Study|Intubation due to massive bleeding|0|||
146730015|NCT00119405|529182428|FG000|Overall Study|Withdrawal by Subject|1|||
146730016|NCT04958785|529182432|FG000|Overall Study|Study Terminated by Sponsor|4|||
146730017|NCT04958785|529182433|FG001|Overall Study|Study Terminated by Sponsor|10|||
146730018|NCT04958785|529182434|FG002|Overall Study|Study Terminated by Sponsor|7|||
146730019|NCT04958785|529182435|FG003|Overall Study|Study Terminated by Sponsor|6|||
146730020|NCT04958785|529182436|FG004|Overall Study|Study Terminated by Sponsor|34|||
146730021|NCT04958785|529182432|FG000|Overall Study|Death|2|||
146730022|NCT04958785|529182433|FG001|Overall Study|Death|3|||
146730023|NCT04958785|529182434|FG002|Overall Study|Death|4|||
146730024|NCT04958785|529182435|FG003|Overall Study|Death|5|||
146730025|NCT04958785|529182436|FG004|Overall Study|Death|5|||
146730026|NCT04958785|529182432|FG000|Overall Study|Withdrew consent|2|||
146730027|NCT04958785|529182433|FG001|Overall Study|Withdrew consent|0|||
146730028|NCT04958785|529182434|FG002|Overall Study|Withdrew consent|3|||
146730029|NCT04958785|529182435|FG003|Overall Study|Withdrew consent|1|||
146730030|NCT04958785|529182436|FG004|Overall Study|Withdrew consent|0|||
146730031|NCT04958785|529182432|FG000|Overall Study|Investigator's discretion|0|||
146730032|NCT04958785|529182433|FG001|Overall Study|Investigator's discretion|1|||
146730033|NCT04958785|529182434|FG002|Overall Study|Investigator's discretion|0|||
146730034|NCT04958785|529182435|FG003|Overall Study|Investigator's discretion|1|||
146730035|NCT04958785|529182436|FG004|Overall Study|Investigator's discretion|2|||
146730036|NCT04958785|529182432|FG000|Overall Study|Adverse Event|0|||
146730037|NCT04958785|529182433|FG001|Overall Study|Adverse Event|0|||
146730038|NCT04958785|529182434|FG002|Overall Study|Adverse Event|0|||
146730039|NCT04958785|529182435|FG003|Overall Study|Adverse Event|0|||
146730040|NCT04958785|529182436|FG004|Overall Study|Adverse Event|1|||
146730041|NCT04958785|529182432|FG000|Overall Study|Lost to Follow-up|0|||
146730042|NCT04958785|529182433|FG001|Overall Study|Lost to Follow-up|0|||
146730043|NCT04958785|529182434|FG002|Overall Study|Lost to Follow-up|0|||
146730044|NCT04958785|529182435|FG003|Overall Study|Lost to Follow-up|0|||
146730045|NCT04958785|529182436|FG004|Overall Study|Lost to Follow-up|1|||
146730046|NCT01224925|529182437|FG000|Overall Study|Lost to Follow-up|3|||
146730047|NCT01224925|529182438|FG001|Overall Study|Lost to Follow-up|2|||
146730048|NCT00949884|529182441|FG000|Overall Study|Adverse Event|14|||
146730049|NCT00949884|529182442|FG001|Overall Study|Adverse Event|3|||
146730050|NCT00949884|529182443|FG002|Overall Study|Adverse Event|12|||
146730051|NCT00949884|529182441|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
146730052|NCT00949884|529182442|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
146730053|NCT00949884|529182443|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
146730054|NCT00949884|529182441|FG000|Overall Study|Lost to Follow-up|7|||
146730055|NCT00949884|529182442|FG001|Overall Study|Lost to Follow-up|5|||
146730056|NCT00949884|529182443|FG002|Overall Study|Lost to Follow-up|5|||
146730057|NCT00949884|529182441|FG000|Overall Study|Physician Decision|5|||
146730058|NCT00949884|529182442|FG001|Overall Study|Physician Decision|0|||
146730059|NCT00949884|529182443|FG002|Overall Study|Physician Decision|6|||
146936599|NCT02248857|529926236|FG002|3 Month|Withdrawal by Subject|4|||
146730060|NCT00949884|529182441|FG000|Overall Study|Treatment non-compliance|5|||
146730061|NCT00949884|529182442|FG001|Overall Study|Treatment non-compliance|0|||
146730062|NCT00949884|529182443|FG002|Overall Study|Treatment non-compliance|8|||
146936600|NCT02248857|529926234|FG000|3 Month|Unable to reach for 3 month|35|||
146730063|NCT00949884|529182441|FG000|Overall Study|Withdrawal by Subject|13|||
146730064|NCT00949884|529182442|FG001|Overall Study|Withdrawal by Subject|4|||
146730065|NCT00949884|529182443|FG002|Overall Study|Withdrawal by Subject|16|||
146730066|NCT00949884|529182441|FG000|Overall Study|Lack of Efficacy|4|||
146730067|NCT00949884|529182442|FG001|Overall Study|Lack of Efficacy|2|||
146730068|NCT00949884|529182443|FG002|Overall Study|Lack of Efficacy|7|||
146619149|NCT03084796|528777545|FG004|Overall Study|Withdrawal by Subject|3|||
146619150|NCT03084796|528777546|FG005|Overall Study|Withdrawal by Subject|0|||
146619151|NCT03084796|528777541|FG000|Overall Study|Protocol Violation|0|||
146619152|NCT03084796|528777542|FG001|Overall Study|Protocol Violation|0|||
146619153|NCT03084796|528777543|FG002|Overall Study|Protocol Violation|1|||
146619154|NCT03084796|528777544|FG003|Overall Study|Protocol Violation|0|||
146619155|NCT03084796|528777545|FG004|Overall Study|Protocol Violation|1|||
146619156|NCT03084796|528777546|FG005|Overall Study|Protocol Violation|1|||
146619157|NCT03084796|528777541|FG000|Overall Study|Lack of Efficacy|0|||
146619158|NCT03084796|528777542|FG001|Overall Study|Lack of Efficacy|0|||
146619159|NCT03084796|528777543|FG002|Overall Study|Lack of Efficacy|1|||
146619160|NCT03084796|528777544|FG003|Overall Study|Lack of Efficacy|0|||
146619161|NCT03084796|528777545|FG004|Overall Study|Lack of Efficacy|1|||
146619162|NCT03084796|528777546|FG005|Overall Study|Lack of Efficacy|0|||
146936601|NCT02248857|529926235|FG001|3 Month|Unable to reach for 3 month|29|||
146619163|NCT03084796|528777541|FG000|Overall Study|Lost to Follow-up|0|||
146619164|NCT03084796|528777542|FG001|Overall Study|Lost to Follow-up|0|||
146619165|NCT03084796|528777543|FG002|Overall Study|Lost to Follow-up|1|||
146619166|NCT03084796|528777544|FG003|Overall Study|Lost to Follow-up|1|||
146619167|NCT03084796|528777545|FG004|Overall Study|Lost to Follow-up|3|||
146619168|NCT03084796|528777546|FG005|Overall Study|Lost to Follow-up|1|||
146619169|NCT03084796|528777541|FG000|Overall Study|Randomization error|0|||
146619170|NCT03084796|528777542|FG001|Overall Study|Randomization error|0|||
146619171|NCT03084796|528777543|FG002|Overall Study|Randomization error|1|||
146619172|NCT03084796|528777544|FG003|Overall Study|Randomization error|0|||
146619173|NCT03084796|528777545|FG004|Overall Study|Randomization error|0|||
146619174|NCT03084796|528777546|FG005|Overall Study|Randomization error|0|||
146619175|NCT00607087|528777551|FG000|Overall Study|Withdrawal by Subject|9|||
146619176|NCT00607087|528777552|FG001|Overall Study|Withdrawal by Subject|4|||
146936602|NCT02248857|529926236|FG002|3 Month|Unable to reach for 3 month|26|||
146936603|NCT02248857|529926234|FG000|3 Month|Partially completed, unable to finish|2|||
146936604|NCT02248857|529926235|FG001|3 Month|Partially completed, unable to finish|2|||
146936605|NCT02248857|529926236|FG002|3 Month|Partially completed, unable to finish|1|||
146936606|NCT02248857|529926234|FG000|6 Month|Lost to Follow-up|27|||
146936607|NCT02248857|529926235|FG001|6 Month|Lost to Follow-up|26|||
146936608|NCT02248857|529926236|FG002|6 Month|Lost to Follow-up|15|||
146936609|NCT02248857|529926234|FG000|6 Month|Partially completed, unable to finish|0|||
146936610|NCT02248857|529926235|FG001|6 Month|Partially completed, unable to finish|1|||
146936611|NCT02248857|529926236|FG002|6 Month|Partially completed, unable to finish|0|||
146936612|NCT02248857|529926234|FG000|6 Month|Withdrawal by Subject|0|||
146936613|NCT02248857|529926235|FG001|6 Month|Withdrawal by Subject|2|||
146936614|NCT02248857|529926236|FG002|6 Month|Withdrawal by Subject|2|||
146936615|NCT02248857|529926234|FG000|6 Month|Death|1|||
146936616|NCT02248857|529926235|FG001|6 Month|Death|0|||
146936617|NCT02248857|529926236|FG002|6 Month|Death|0|||
146936618|NCT02671461|529926237|FG000|Treatment|Adverse Event|0|||
146936619|NCT02671461|529926238|FG001|Treatment|Adverse Event|0|||
146936620|NCT02671461|529926239|FG002|Treatment|Adverse Event|1|||
146936621|NCT02671461|529926237|FG000|Treatment|Administrative Reason by Sponsor|1|||
146936622|NCT02671461|529926238|FG001|Treatment|Administrative Reason by Sponsor|3|||
146936623|NCT02671461|529926239|FG002|Treatment|Administrative Reason by Sponsor|4|||
146936624|NCT02671461|529926237|FG000|Treatment|Randomized, not treated|1|||
146936625|NCT02671461|529926238|FG001|Treatment|Randomized, not treated|0|||
146936626|NCT02671461|529926239|FG002|Treatment|Randomized, not treated|0|||
146936627|NCT02671461|529926237|FG000|Follow-up|Withdrawal by Subject|1|||
146936628|NCT02671461|529926238|FG001|Follow-up|Withdrawal by Subject|0|||
146619177|NCT00607087|528777553|FG002|Overall Study|Withdrawal by Subject|4|||
146619178|NCT00607087|528777551|FG000|Overall Study|Adverse Event|3|||
146619179|NCT00607087|528777552|FG001|Overall Study|Adverse Event|2|||
146619180|NCT00607087|528777553|FG002|Overall Study|Adverse Event|3|||
146936629|NCT02671461|529926239|FG002|Follow-up|Withdrawal by Subject|0|||
146981761|NCT01909466|530096122|FG001|Overall Study|Lost to Follow-up|7|||
146981762|NCT01909466|530096121|FG000|Overall Study|Adverse Event|3|||
146981763|NCT01909466|530096122|FG001|Overall Study|Adverse Event|4|||
146981764|NCT01909466|530096121|FG000|Overall Study|Met Withdrawal Criteria|0|||
146619181|NCT00607087|528777551|FG000|Overall Study|Other reason|1|||
146619182|NCT00607087|528777552|FG001|Overall Study|Other reason|5|||
146619183|NCT00607087|528777553|FG002|Overall Study|Other reason|2|||
146619184|NCT00607087|528777551|FG000|Overall Study|Poor compliance to protocol|1|||
146619185|NCT00607087|528777552|FG001|Overall Study|Poor compliance to protocol|0|||
146936630|NCT02671461|529926237|FG000|Follow-up|Lost to Follow-up|0|||
146936631|NCT02671461|529926238|FG001|Follow-up|Lost to Follow-up|0|||
146936632|NCT02671461|529926239|FG002|Follow-up|Lost to Follow-up|1|||
146619186|NCT00607087|528777553|FG002|Overall Study|Poor compliance to protocol|1|||
146619187|NCT00607087|528777551|FG000|Overall Study|Lost to Follow-up|1|||
146619188|NCT00607087|528777552|FG001|Overall Study|Lost to Follow-up|0|||
146619189|NCT00607087|528777553|FG002|Overall Study|Lost to Follow-up|0|||
146936633|NCT02671461|529926237|FG000|Follow-up|Administrative Reason by Sponsor|0|||
146936634|NCT02671461|529926238|FG001|Follow-up|Administrative Reason by Sponsor|1|||
146619190|NCT00607087|528777551|FG000|Period 1|Withdrawal by Subject|7|||
146619191|NCT00607087|528777552|FG001|Period 1|Withdrawal by Subject|2|||
146619192|NCT00607087|528777553|FG002|Period 1|Withdrawal by Subject|3|||
146619193|NCT00607087|528777551|FG000|Period 1|Adverse Event|3|||
146619194|NCT00607087|528777552|FG001|Period 1|Adverse Event|0|||
146619195|NCT00607087|528777553|FG002|Period 1|Adverse Event|0|||
146619196|NCT00607087|528777551|FG000|Period 1|Poor compliance to protocol|1|||
146619197|NCT00607087|528777552|FG001|Period 1|Poor compliance to protocol|0|||
146619198|NCT00607087|528777553|FG002|Period 1|Poor compliance to protocol|0|||
146619199|NCT00607087|528777551|FG000|Period 1|Lost to Follow-up|1|||
146619200|NCT00607087|528777552|FG001|Period 1|Lost to Follow-up|0|||
146619201|NCT00607087|528777553|FG002|Period 1|Lost to Follow-up|0|||
146619202|NCT00607087|528777551|FG000|Period 1|Other reason|0|||
146619203|NCT00607087|528777552|FG001|Period 1|Other reason|4|||
146619204|NCT00607087|528777553|FG002|Period 1|Other reason|2|||
146619205|NCT00607087|528777551|FG000|Period 2|Withdrawal by Subject|0|||
146619206|NCT00607087|528777552|FG001|Period 2|Withdrawal by Subject|1|||
146619207|NCT00607087|528777553|FG002|Period 2|Withdrawal by Subject|1|||
146619208|NCT00607087|528777551|FG000|Period 2|Other reason|1|||
146619209|NCT00607087|528777552|FG001|Period 2|Other reason|1|||
146619210|NCT00607087|528777553|FG002|Period 2|Other reason|0|||
146619211|NCT00607087|528777551|FG000|Period 2|Adverse Event|0|||
146619212|NCT00607087|528777552|FG001|Period 2|Adverse Event|1|||
146619213|NCT00607087|528777553|FG002|Period 2|Adverse Event|3|||
146619214|NCT00607087|528777551|FG000|Period 2|Poor compliance to protocol|0|||
146619215|NCT00607087|528777552|FG001|Period 2|Poor compliance to protocol|0|||
146619216|NCT00607087|528777553|FG002|Period 2|Poor compliance to protocol|1|||
146619217|NCT00607087|528777551|FG000|Period 3|Withdrawal by Subject|2|||
146619218|NCT00607087|528777552|FG001|Period 3|Withdrawal by Subject|1|||
146619219|NCT00607087|528777553|FG002|Period 3|Withdrawal by Subject|0|||
146619220|NCT00607087|528777551|FG000|Period 3|Adverse Event|0|||
146619221|NCT00607087|528777552|FG001|Period 3|Adverse Event|1|||
146619222|NCT00607087|528777553|FG002|Period 3|Adverse Event|0|||
146619223|NCT02717494|528777555|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
146619224|NCT02717494|528777556|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
146619225|NCT02717494|528777557|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
146619226|NCT02717494|528777555|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
146619227|NCT02717494|528777556|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
146619228|NCT02717494|528777557|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
146619229|NCT02717494|528777555|FG000|First Intervention (Step 1)|Death|0|||
146619230|NCT02717494|528777556|FG001|First Intervention (Step 1)|Death|0|||
146619231|NCT02717494|528777557|FG002|First Intervention (Step 1)|Death|1|||
146619232|NCT02717494|528777555|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
146619233|NCT02717494|528777556|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
146619234|NCT02717494|528777557|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
146619235|NCT03370718|528777565|FG000|Overall Study|Withdrawal by Subject|1|||
146619236|NCT05477485|528777572|FG000|Overall Study|Lost to Follow-up|0|||
146619237|NCT05477485|528777573|FG001|Overall Study|Lost to Follow-up|4|||
146619238|NCT06172348|528777574|FG000|Treatment Period 2|Adverse Event|0|||
146619239|NCT06172348|528777575|FG001|Treatment Period 2|Adverse Event|0|||
146619240|NCT06172348|528777576|FG002|Treatment Period 2|Adverse Event|1|||
146619241|NCT06172348|528777577|FG003|Treatment Period 2|Adverse Event|0|||
146619242|NCT06172348|528777578|FG004|Treatment Period 2|Adverse Event|0|||
146619243|NCT06172348|528777579|FG005|Treatment Period 2|Adverse Event|0|||
146619244|NCT03116685|528777580|FG000|Overall Study|Physician Decision|0|||
146619245|NCT03116685|528777581|FG001|Overall Study|Physician Decision|1|||
146619246|NCT00801216|528777582|FG000|Overall Study|Screening Failure|2|||
146619247|NCT05274958|528777583|FG000|Overall Study|Only completed 1 set of PROMs|22|||
146619248|NCT05274958|528777584|FG001|Overall Study|Only completed 1 set of PROMs|35|||
146619249|NCT05214768|528777585|FG000|Induction Period|Withdrawal by Subject|1|||
146619250|NCT05214768|528777586|FG001|Induction Period|Withdrawal by Subject|0|||
146619251|NCT05214768|528777587|FG002|Induction Period|Withdrawal by Subject|0|||
146619252|NCT05214768|528777588|FG003|Induction Period|Withdrawal by Subject|0|||
146619253|NCT05214768|528777589|FG004|Induction Period|Withdrawal by Subject|0|||
146619254|NCT05214768|528777590|FG005|Induction Period|Withdrawal by Subject|0|||
146619255|NCT05214768|528777585|FG000|Induction Period|Physician Decision|1|||
146619256|NCT05214768|528777586|FG001|Induction Period|Physician Decision|0|||
146619257|NCT05214768|528777587|FG002|Induction Period|Physician Decision|0|||
146619258|NCT05214768|528777588|FG003|Induction Period|Physician Decision|0|||
146619259|NCT05214768|528777589|FG004|Induction Period|Physician Decision|0|||
146619260|NCT05214768|528777590|FG005|Induction Period|Physician Decision|0|||
146619261|NCT05214768|528777585|FG000|Maintenance Period|Other Reasons|0|||
146619262|NCT05214768|528777586|FG001|Maintenance Period|Other Reasons|0|||
146619263|NCT05214768|528777587|FG002|Maintenance Period|Other Reasons|1|||
146619264|NCT05214768|528777588|FG003|Maintenance Period|Other Reasons|1|||
146619265|NCT05214768|528777589|FG004|Maintenance Period|Other Reasons|0|||
146619266|NCT05214768|528777590|FG005|Maintenance Period|Other Reasons|0|||
146619267|NCT05214768|528777585|FG000|Maintenance Period|Withdrawal by Subject|0|||
146936635|NCT02671461|529926239|FG002|Follow-up|Administrative Reason by Sponsor|0|||
146936636|NCT02261883|529926240|FG000|Overall Study|Death|3|||
146936637|NCT02261883|529926241|FG001|Overall Study|Death|2|||
146936638|NCT02261883|529926240|FG000|Overall Study|Physician Decision|1|||
146936639|NCT02261883|529926241|FG001|Overall Study|Physician Decision|0|||
146936640|NCT02261883|529926240|FG000|Overall Study|Protocol Violation|1|||
146936641|NCT02261883|529926241|FG001|Overall Study|Protocol Violation|0|||
146936642|NCT02261883|529926240|FG000|Overall Study|Withdrawal by Subject|0|||
146936643|NCT02261883|529926241|FG001|Overall Study|Withdrawal by Subject|1|||
146936644|NCT02261883|529926240|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
146936645|NCT02261883|529926241|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
146936646|NCT01412060|529926242|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
146936647|NCT01412060|529926243|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
146936648|NCT01412060|529926244|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
146936649|NCT01412060|529926242|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
146936650|NCT01412060|529926243|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
146936651|NCT01412060|529926244|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
146936652|NCT01412060|529926242|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
146936653|NCT01412060|529926243|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
146936654|NCT01412060|529926244|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
146936655|NCT01412060|529926242|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
146936656|NCT01412060|529926243|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
146936657|NCT01412060|529926244|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
146936658|NCT01412060|529926242|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
146936659|NCT01412060|529926243|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
146936660|NCT01412060|529926244|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
146936661|NCT01412060|529926242|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
146936662|NCT01412060|529926243|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
146936663|NCT01412060|529926244|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
146936664|NCT01412060|529926242|FG000|Period Between RIP and SP|Adverse Event|4|||
146619268|NCT05214768|528777586|FG001|Maintenance Period|Withdrawal by Subject|0|||
146619269|NCT05214768|528777587|FG002|Maintenance Period|Withdrawal by Subject|0|||
146936665|NCT01412060|529926243|FG001|Period Between RIP and SP|Adverse Event|0|||
146936666|NCT01412060|529926244|FG002|Period Between RIP and SP|Adverse Event|0|||
146936667|NCT01412060|529926242|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
146936668|NCT01412060|529926243|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
146936669|NCT01412060|529926244|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
146936670|NCT01412060|529926242|FG000|Period Between RIP and SP|Protocol Violation|2|||
146936671|NCT01412060|529926243|FG001|Period Between RIP and SP|Protocol Violation|0|||
146936672|NCT01412060|529926244|FG002|Period Between RIP and SP|Protocol Violation|0|||
146936673|NCT01412060|529926242|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
146936674|NCT01412060|529926243|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
146936675|NCT01412060|529926244|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
146936676|NCT01412060|529926242|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
146936677|NCT01412060|529926243|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
146936678|NCT01412060|529926244|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
146936679|NCT01412060|529926242|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
146936680|NCT01412060|529926243|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
146936681|NCT01412060|529926244|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
146936682|NCT01412060|529926242|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
146936683|NCT01412060|529926243|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
146936684|NCT01412060|529926244|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
146936685|NCT01412060|529926242|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
146936686|NCT01412060|529926243|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
146936687|NCT01412060|529926244|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
146619270|NCT05214768|528777588|FG003|Maintenance Period|Withdrawal by Subject|1|||
146619271|NCT05214768|528777589|FG004|Maintenance Period|Withdrawal by Subject|0|||
146619272|NCT05214768|528777590|FG005|Maintenance Period|Withdrawal by Subject|0|||
146619273|NCT05214768|528777585|FG000|Maintenance Period|Lack of Efficacy|0|||
146619274|NCT05214768|528777586|FG001|Maintenance Period|Lack of Efficacy|0|||
146619275|NCT05214768|528777587|FG002|Maintenance Period|Lack of Efficacy|1|||
146619276|NCT05214768|528777588|FG003|Maintenance Period|Lack of Efficacy|0|||
146619277|NCT05214768|528777589|FG004|Maintenance Period|Lack of Efficacy|1|||
146936688|NCT01412060|529926242|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
146619278|NCT05214768|528777590|FG005|Maintenance Period|Lack of Efficacy|0|||
146619279|NCT05214768|528777585|FG000|Open Label Extension Period|Physician Decision|0|||
146936689|NCT01412060|529926243|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
146619280|NCT05214768|528777586|FG001|Open Label Extension Period|Physician Decision|0|||
146619281|NCT05214768|528777587|FG002|Open Label Extension Period|Physician Decision|0|||
146936690|NCT01412060|529926244|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
146936691|NCT01412060|529926242|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
146936692|NCT01412060|529926243|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
146936693|NCT01412060|529926244|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
146936694|NCT01412060|529926242|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
146936695|NCT01412060|529926243|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
146936696|NCT01412060|529926244|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
146936697|NCT01412060|529926242|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
146936698|NCT01412060|529926243|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
146936699|NCT01412060|529926244|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
146936700|NCT01412060|529926242|FG000|Period Between SP and DBP|Protocol Violation|2|||
146936701|NCT01412060|529926243|FG001|Period Between SP and DBP|Protocol Violation|0|||
146936702|NCT01412060|529926244|FG002|Period Between SP and DBP|Protocol Violation|0|||
146936703|NCT01412060|529926242|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
146936704|NCT01412060|529926243|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
146936705|NCT01412060|529926244|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
146936706|NCT01412060|529926242|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
146936707|NCT01412060|529926243|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
146936708|NCT01412060|529926244|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
146936709|NCT01412060|529926242|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
146936710|NCT01412060|529926243|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
146936711|NCT01412060|529926244|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
146936712|NCT01412060|529926242|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
146936713|NCT01412060|529926243|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
146936714|NCT01412060|529926244|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
146936715|NCT01412060|529926242|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
146936716|NCT01412060|529926243|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
146936717|NCT01412060|529926244|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
146936718|NCT01412060|529926242|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
146936719|NCT01412060|529926243|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
146936720|NCT01412060|529926244|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
146936721|NCT01412060|529926242|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
146936722|NCT01412060|529926243|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
146936723|NCT01412060|529926244|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
146936724|NCT01412060|529926242|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
146936725|NCT01412060|529926243|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
146936726|NCT01412060|529926244|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
146936727|NCT01412060|529926242|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
146936728|NCT01412060|529926243|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
146936729|NCT01412060|529926244|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
146936730|NCT01412060|529926242|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
146936731|NCT01412060|529926243|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
146936732|NCT01412060|529926244|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
146936733|NCT00004732|529926246|FG000|Overall Study|Withdrawal by Subject|36|||
146936734|NCT00004732|529926247|FG001|Overall Study|Withdrawal by Subject|64|||
146936735|NCT00004732|529926246|FG000|Overall Study|Lost to Follow-up|33|||
146936736|NCT00004732|529926247|FG001|Overall Study|Lost to Follow-up|47|||
146619282|NCT05214768|528777588|FG003|Open Label Extension Period|Physician Decision|0|||
146619283|NCT05214768|528777589|FG004|Open Label Extension Period|Physician Decision|0|||
146619284|NCT05214768|528777590|FG005|Open Label Extension Period|Physician Decision|1|||
146619285|NCT05214768|528777585|FG000|Open Label Extension Period|Lack of Efficacy|0|||
146619286|NCT05214768|528777586|FG001|Open Label Extension Period|Lack of Efficacy|0|||
146619287|NCT05214768|528777587|FG002|Open Label Extension Period|Lack of Efficacy|0|||
146619288|NCT05214768|528777588|FG003|Open Label Extension Period|Lack of Efficacy|0|||
146619289|NCT05214768|528777589|FG004|Open Label Extension Period|Lack of Efficacy|0|||
146619290|NCT05214768|528777590|FG005|Open Label Extension Period|Lack of Efficacy|1|||
146619291|NCT05214768|528777585|FG000|Open Label Extension Period|Ongoing Study|0|||
146936737|NCT01688635|529926250|FG000|Washout 1|Withdrawal by Subject|1|||
146936738|NCT01688635|529926251|FG001|Washout 1|Withdrawal by Subject|0|||
146619292|NCT05214768|528777586|FG001|Open Label Extension Period|Ongoing Study|0|||
146619293|NCT05214768|528777587|FG002|Open Label Extension Period|Ongoing Study|0|||
146619294|NCT05214768|528777588|FG003|Open Label Extension Period|Ongoing Study|0|||
146619295|NCT05214768|528777589|FG004|Open Label Extension Period|Ongoing Study|0|||
146936739|NCT01688635|529926250|FG000|Washout 1|Adverse Event|0|||
146936740|NCT01688635|529926251|FG001|Washout 1|Adverse Event|1|||
146936741|NCT01688635|529926250|FG000|Washout 1|Physician Decision|0|||
146619296|NCT05214768|528777590|FG005|Open Label Extension Period|Ongoing Study|42|||
146619297|NCT05481359|528777591|FG000|Overall Study|Lost to Follow-up|3|||
146619298|NCT05481359|528777591|FG000|Overall Study|Withdrawal by Subject|1|||
146619299|NCT05579977|528777596|FG000|Treatment Phase|Other|0|||
146619300|NCT05579977|528777597|FG001|Treatment Phase|Other|0|||
146619301|NCT05579977|528777598|FG002|Treatment Phase|Other|0|||
146619302|NCT05579977|528777599|FG003|Treatment Phase|Other|2|||
146619303|NCT05579977|528777600|FG004|Treatment Phase|Other|1|||
146619304|NCT05579977|528777601|FG005|Treatment Phase|Other|2|||
146619305|NCT05579977|528777602|FG006|Treatment Phase|Other|1|||
146619306|NCT05579977|528777603|FG007|Treatment Phase|Other|2|||
146619307|NCT05579977|528777604|FG008|Treatment Phase|Other|2|||
146619308|NCT05579977|528777605|FG009|Treatment Phase|Other|1|||
146619309|NCT05579977|528777606|FG010|Treatment Phase|Other|0|||
146619310|NCT05579977|528777607|FG011|Treatment Phase|Other|0|||
146619311|NCT05579977|528777608|FG012|Treatment Phase|Other|3|||
146619312|NCT05579977|528777596|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
146619313|NCT05579977|528777597|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
146619314|NCT05579977|528777598|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
146619315|NCT05579977|528777599|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
146619316|NCT05579977|528777600|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
146619317|NCT05579977|528777601|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
146619318|NCT05579977|528777602|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
146619319|NCT05579977|528777603|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
146619320|NCT05579977|528777604|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
146619321|NCT05579977|528777605|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
146619322|NCT05579977|528777606|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
146619323|NCT05579977|528777607|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
146619324|NCT05579977|528777608|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
146619325|NCT05579977|528777596|FG000|Treatment Phase|Withdrawal by Subject|2|||
146619326|NCT05579977|528777597|FG001|Treatment Phase|Withdrawal by Subject|0|||
146619327|NCT05579977|528777598|FG002|Treatment Phase|Withdrawal by Subject|0|||
146619328|NCT05579977|528777599|FG003|Treatment Phase|Withdrawal by Subject|1|||
146619329|NCT05579977|528777600|FG004|Treatment Phase|Withdrawal by Subject|2|||
146619330|NCT05579977|528777601|FG005|Treatment Phase|Withdrawal by Subject|0|||
146619331|NCT05579977|528777602|FG006|Treatment Phase|Withdrawal by Subject|1|||
146619332|NCT05579977|528777603|FG007|Treatment Phase|Withdrawal by Subject|8|||
146619333|NCT05579977|528777604|FG008|Treatment Phase|Withdrawal by Subject|3|||
146619334|NCT05579977|528777605|FG009|Treatment Phase|Withdrawal by Subject|3|||
146619335|NCT05579977|528777606|FG010|Treatment Phase|Withdrawal by Subject|5|||
146619336|NCT05579977|528777607|FG011|Treatment Phase|Withdrawal by Subject|1|||
146619337|NCT05579977|528777608|FG012|Treatment Phase|Withdrawal by Subject|3|||
146619338|NCT05579977|528777596|FG000|Treatment Phase|Study terminated by sponsor|70|||
146619339|NCT05579977|528777597|FG001|Treatment Phase|Study terminated by sponsor|70|||
146619340|NCT05579977|528777598|FG002|Treatment Phase|Study terminated by sponsor|61|||
146619341|NCT05579977|528777599|FG003|Treatment Phase|Study terminated by sponsor|59|||
146619342|NCT05579977|528777600|FG004|Treatment Phase|Study terminated by sponsor|63|||
146619343|NCT05579977|528777601|FG005|Treatment Phase|Study terminated by sponsor|53|||
146619344|NCT05579977|528777602|FG006|Treatment Phase|Study terminated by sponsor|66|||
146619345|NCT05579977|528777603|FG007|Treatment Phase|Study terminated by sponsor|48|||
146619346|NCT05579977|528777604|FG008|Treatment Phase|Study terminated by sponsor|47|||
146619347|NCT05579977|528777605|FG009|Treatment Phase|Study terminated by sponsor|37|||
146619348|NCT05579977|528777606|FG010|Treatment Phase|Study terminated by sponsor|44|||
146619349|NCT05579977|528777607|FG011|Treatment Phase|Study terminated by sponsor|36|||
146619350|NCT05579977|528777608|FG012|Treatment Phase|Study terminated by sponsor|32|||
146619351|NCT05579977|528777596|FG000|Treatment Phase|Pregnancy|0|||
146619352|NCT05579977|528777597|FG001|Treatment Phase|Pregnancy|0|||
146619353|NCT05579977|528777598|FG002|Treatment Phase|Pregnancy|0|||
146619354|NCT05579977|528777599|FG003|Treatment Phase|Pregnancy|0|||
146619355|NCT05579977|528777600|FG004|Treatment Phase|Pregnancy|0|||
146619356|NCT05579977|528777601|FG005|Treatment Phase|Pregnancy|0|||
146619357|NCT05579977|528777602|FG006|Treatment Phase|Pregnancy|0|||
146619358|NCT05579977|528777603|FG007|Treatment Phase|Pregnancy|0|||
146936742|NCT01688635|529926251|FG001|Washout 1|Physician Decision|1|||
146936743|NCT01688635|529926250|FG000|Washout 2|Physician Decision|1|||
146619359|NCT05579977|528777604|FG008|Treatment Phase|Pregnancy|0|||
146619360|NCT05579977|528777605|FG009|Treatment Phase|Pregnancy|1|||
146619361|NCT05579977|528777606|FG010|Treatment Phase|Pregnancy|0|||
146619362|NCT05579977|528777607|FG011|Treatment Phase|Pregnancy|0|||
146619363|NCT05579977|528777608|FG012|Treatment Phase|Pregnancy|0|||
146619364|NCT05579977|528777596|FG000|Treatment Phase|Physician Decision|0|||
146619365|NCT05579977|528777597|FG001|Treatment Phase|Physician Decision|0|||
146619366|NCT05579977|528777598|FG002|Treatment Phase|Physician Decision|0|||
146619367|NCT05579977|528777599|FG003|Treatment Phase|Physician Decision|0|||
146619368|NCT05579977|528777600|FG004|Treatment Phase|Physician Decision|0|||
146619369|NCT05579977|528777601|FG005|Treatment Phase|Physician Decision|0|||
146619370|NCT05579977|528777602|FG006|Treatment Phase|Physician Decision|0|||
146936744|NCT01688635|529926251|FG001|Washout 2|Physician Decision|0|||
146936745|NCT01688635|529926250|FG000|Washout 2|Withdrawal by Subject|1|||
146936746|NCT01688635|529926251|FG001|Washout 2|Withdrawal by Subject|0|||
146936747|NCT01688635|529926250|FG000|Washout 2|Sponsor Decision|1|||
146936748|NCT01688635|529926251|FG001|Washout 2|Sponsor Decision|2|||
146936749|NCT01688635|529926250|FG000|Washout 3|Withdrawal by Subject|1|||
146936750|NCT01688635|529926251|FG001|Washout 3|Withdrawal by Subject|0|||
146936751|NCT03549117|529926255|FG000|Overall Study|Withdrawal by Subject|1|||
146936752|NCT03549117|529926256|FG001|Overall Study|Withdrawal by Subject|0|||
146936753|NCT00367432|529926260|FG000|First Period (16 Weeks)|Adverse Event|6|||
146936754|NCT00367432|529926261|FG001|First Period (16 Weeks)|Adverse Event|0|||
146936755|NCT00367432|529926260|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
146936756|NCT00367432|529926261|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
146936757|NCT00367432|529926260|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
146936758|NCT00367432|529926261|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
146936759|NCT00367432|529926260|FG000|First Period (16 Weeks)|Other Reason|2|||
146936760|NCT00367432|529926261|FG001|First Period (16 Weeks)|Other Reason|0|||
146936761|NCT00367432|529926260|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
146936762|NCT00367432|529926261|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
146936763|NCT00367432|529926260|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
146936764|NCT00367432|529926261|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
146936765|NCT00367432|529926260|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
146936766|NCT00367432|529926261|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
146936767|NCT00367432|529926260|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
146936768|NCT00367432|529926261|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
146936769|NCT00367432|529926260|FG000|Second Period (up to 54 Months)|Other Reason|6|||
146936770|NCT00367432|529926261|FG001|Second Period (up to 54 Months)|Other Reason|2|||
146936771|NCT00014911|529926262|FG000|Overall Study|Adverse Event|1|||
146936772|NCT00014911|529926262|FG000|Overall Study|Lost to Follow-up|1|||
146936773|NCT00014911|529926262|FG000|Overall Study|Withdrawal by Subject|6|||
146936774|NCT00014911|529926262|FG000|Overall Study|Unknown Reasons|2|||
146936775|NCT00014911|529926262|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
146936776|NCT05567393|529926263|FG000|Overall Study|Voluntary Withdrawal|0|||
146936777|NCT05567393|529926264|FG001|Overall Study|Voluntary Withdrawal|0|||
146936778|NCT05567393|529926265|FG002|Overall Study|Voluntary Withdrawal|0|||
146936779|NCT05567393|529926266|FG003|Overall Study|Voluntary Withdrawal|0|||
146936780|NCT05567393|529926267|FG004|Overall Study|Voluntary Withdrawal|0|||
146936781|NCT05567393|529926268|FG005|Overall Study|Voluntary Withdrawal|0|||
146936782|NCT05567393|529926269|FG006|Overall Study|Voluntary Withdrawal|0|||
146936783|NCT05567393|529926270|FG007|Overall Study|Voluntary Withdrawal|0|||
146936784|NCT05567393|529926271|FG008|Overall Study|Voluntary Withdrawal|0|||
146936785|NCT05567393|529926272|FG009|Overall Study|Voluntary Withdrawal|0|||
146936786|NCT05567393|529926273|FG010|Overall Study|Voluntary Withdrawal|0|||
146936787|NCT05567393|529926274|FG011|Overall Study|Voluntary Withdrawal|0|||
146936788|NCT05567393|529926275|FG012|Overall Study|Voluntary Withdrawal|0|||
146936789|NCT05567393|529926276|FG013|Overall Study|Voluntary Withdrawal|1|||
146936790|NCT05567393|529926277|FG014|Overall Study|Voluntary Withdrawal|0|||
146936791|NCT05567393|529926278|FG015|Overall Study|Voluntary Withdrawal|0|||
146936792|NCT05567393|529926279|FG016|Overall Study|Voluntary Withdrawal|0|||
146936793|NCT05567393|529926280|FG017|Overall Study|Voluntary Withdrawal|0|||
146936794|NCT02177175|529926285|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
146936795|NCT02177175|529926286|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
146936796|NCT01924299|529926287|FG000|Period 2|Withdrawal by Subject|1|||
146936797|NCT01924299|529926288|FG001|Period 2|Withdrawal by Subject|0|||
146936798|NCT01924299|529926287|FG000|Period 2|Adverse Event|0|||
146936799|NCT01924299|529926288|FG001|Period 2|Adverse Event|1|||
146936800|NCT00888615|529926293|FG000|Overall Study|No treatment|2|||
146936801|NCT00141037|529926294|FG000|Overall Study|Physician Decision|1|||
146936802|NCT00141037|529926295|FG001|Overall Study|Physician Decision|2|||
146936803|NCT00141037|529926294|FG000|Overall Study|Lost to Follow-up|3|||
146936804|NCT00141037|529926295|FG001|Overall Study|Lost to Follow-up|1|||
146936805|NCT00141037|529926294|FG000|Overall Study|Protocol Violation|0|||
146936806|NCT00141037|529926295|FG001|Overall Study|Protocol Violation|2|||
146936807|NCT00141037|529926294|FG000|Overall Study|Withdrawal by Subject|2|||
146936808|NCT00141037|529926295|FG001|Overall Study|Withdrawal by Subject|1|||
146936809|NCT00141037|529926294|FG000|Overall Study|Other|0|||
146936810|NCT00141037|529926295|FG001|Overall Study|Other|1|||
146936811|NCT00141037|529926294|FG000|Overall Study|Moved from area|1|||
146936812|NCT00141037|529926295|FG001|Overall Study|Moved from area|7|||
146936813|NCT00141037|529926294|FG000|Overall Study|Graft Failure|3|||
146936814|NCT00141037|529926295|FG001|Overall Study|Graft Failure|4|||
146936815|NCT00637377|529926296|FG000|Overall Study|Adverse Event|2|||
146936816|NCT00637377|529926297|FG001|Overall Study|Adverse Event|6|||
146936817|NCT00637377|529926298|FG002|Overall Study|Adverse Event|8|||
146936818|NCT00637377|529926299|FG003|Overall Study|Adverse Event|9|||
146936819|NCT00637377|529926296|FG000|Overall Study|Death|1|||
146936820|NCT00637377|529926297|FG001|Overall Study|Death|3|||
146936821|NCT00637377|529926298|FG002|Overall Study|Death|2|||
146936822|NCT00637377|529926299|FG003|Overall Study|Death|1|||
146730069|NCT00949884|529182441|FG000|Overall Study|Study terminated by sponsor|0|||
146730070|NCT00949884|529182442|FG001|Overall Study|Study terminated by sponsor|0|||
146730071|NCT00949884|529182443|FG002|Overall Study|Study terminated by sponsor|1|||
146730072|NCT00245102|529182444|FG000|Overall Study|Not Treated|1|||
146730073|NCT00245102|529182445|FG001|Overall Study|Not Treated|0|||
146730074|NCT00245102|529182446|FG002|Overall Study|Not Treated|1|||
146730075|NCT00245102|529182447|FG003|Overall Study|Not Treated|0|||
146936823|NCT00637377|529926296|FG000|Overall Study|Lack of Efficacy|0|||
146936824|NCT00637377|529926297|FG001|Overall Study|Lack of Efficacy|0|||
146936825|NCT00637377|529926298|FG002|Overall Study|Lack of Efficacy|1|||
146936826|NCT00637377|529926299|FG003|Overall Study|Lack of Efficacy|1|||
146936827|NCT00637377|529926296|FG000|Overall Study|Lost to Follow-up|4|||
146936828|NCT00637377|529926297|FG001|Overall Study|Lost to Follow-up|1|||
146936829|NCT00637377|529926298|FG002|Overall Study|Lost to Follow-up|2|||
146936830|NCT00637377|529926299|FG003|Overall Study|Lost to Follow-up|2|||
146936831|NCT00637377|529926296|FG000|Overall Study|Protocol Violation|2|||
146936832|NCT00637377|529926297|FG001|Overall Study|Protocol Violation|1|||
146936833|NCT00637377|529926298|FG002|Overall Study|Protocol Violation|1|||
146936834|NCT00637377|529926299|FG003|Overall Study|Protocol Violation|0|||
146936835|NCT00637377|529926296|FG000|Overall Study|Withdrawal by Subject|11|||
146936836|NCT00637377|529926297|FG001|Overall Study|Withdrawal by Subject|15|||
146936837|NCT00637377|529926298|FG002|Overall Study|Withdrawal by Subject|13|||
146936838|NCT00637377|529926299|FG003|Overall Study|Withdrawal by Subject|11|||
146936839|NCT00637377|529926296|FG000|Overall Study|Other (no further information available)|7|||
146936840|NCT00637377|529926297|FG001|Overall Study|Other (no further information available)|6|||
146936841|NCT00637377|529926298|FG002|Overall Study|Other (no further information available)|10|||
146936842|NCT00637377|529926299|FG003|Overall Study|Other (no further information available)|5|||
146936843|NCT04186663|529926302|FG000|Overall Study|Lost to Follow-up|1|||
146936844|NCT04186663|529926302|FG000|Overall Study|Unable to complete blood draw|3|||
146936845|NCT02293902|529926303|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
146936846|NCT02293902|529926304|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
146936847|NCT02293902|529926305|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
146936848|NCT02293902|529926306|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
146936849|NCT02293902|529926307|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
146936850|NCT02293902|529926303|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
146936851|NCT02293902|529926304|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
146936852|NCT02293902|529926305|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
146936853|NCT02293902|529926306|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
146936854|NCT02293902|529926307|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
146936855|NCT02293902|529926303|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
146936856|NCT02293902|529926304|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
146936857|NCT02293902|529926305|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
146936858|NCT02293902|529926306|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
146936859|NCT02293902|529926307|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
146936860|NCT02293902|529926303|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
146936861|NCT02293902|529926304|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
146936862|NCT02293902|529926305|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
146936863|NCT02293902|529926306|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
146936864|NCT02293902|529926307|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
146936865|NCT02293902|529926303|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
146936866|NCT02293902|529926304|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
146936867|NCT02293902|529926305|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
146936868|NCT02293902|529926306|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
146936869|NCT02293902|529926307|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
146936870|NCT00462488|529928209|FG000|Overall Study|Protocol Violation|1|||
146936871|NCT00462488|529928210|FG001|Overall Study|Protocol Violation|0|||
146936872|NCT00462488|529928209|FG000|Overall Study|Lack of Efficacy|19|||
146936873|NCT00462488|529928210|FG001|Overall Study|Lack of Efficacy|17|||
146936874|NCT01742091|529928215|FG000|Overall Study|Adverse Event|0|||
146936875|NCT01742091|529928216|FG001|Overall Study|Adverse Event|0|||
146936876|NCT01742091|529928217|FG002|Overall Study|Adverse Event|0|||
146936877|NCT01742091|529928218|FG003|Overall Study|Adverse Event|0|||
146936878|NCT01742091|529928219|FG004|Overall Study|Adverse Event|1|||
146936879|NCT01742091|529928220|FG005|Overall Study|Adverse Event|0|||
146936880|NCT01742091|529928215|FG000|Overall Study|Physician Decision|0|||
146936881|NCT01742091|529928216|FG001|Overall Study|Physician Decision|0|||
146936882|NCT01742091|529928217|FG002|Overall Study|Physician Decision|0|||
146936883|NCT01742091|529928218|FG003|Overall Study|Physician Decision|0|||
146936884|NCT01742091|529928219|FG004|Overall Study|Physician Decision|0|||
146936885|NCT01742091|529928220|FG005|Overall Study|Physician Decision|1|||
146936886|NCT01742091|529928215|FG000|Overall Study|Withdrawal by Subject|0|||
146936887|NCT01742091|529928216|FG001|Overall Study|Withdrawal by Subject|0|||
146936888|NCT01742091|529928217|FG002|Overall Study|Withdrawal by Subject|0|||
146936889|NCT01742091|529928218|FG003|Overall Study|Withdrawal by Subject|1|||
146936890|NCT01742091|529928219|FG004|Overall Study|Withdrawal by Subject|0|||
146936891|NCT01742091|529928220|FG005|Overall Study|Withdrawal by Subject|0|||
146936892|NCT01742091|529928215|FG000|Overall Study|Lost to Follow-up|0|||
146936893|NCT01742091|529928216|FG001|Overall Study|Lost to Follow-up|0|||
146936894|NCT01742091|529928217|FG002|Overall Study|Lost to Follow-up|0|||
146936895|NCT01742091|529928218|FG003|Overall Study|Lost to Follow-up|0|||
146936896|NCT01742091|529928219|FG004|Overall Study|Lost to Follow-up|0|||
146936897|NCT01742091|529928220|FG005|Overall Study|Lost to Follow-up|1|||
146936898|NCT02848313|529928221|FG000|Overall Study|Adverse Event|1|||
146936899|NCT02848313|529928222|FG001|Overall Study|Adverse Event|2|||
146936900|NCT02848313|529928221|FG000|Overall Study|Lack of Efficacy|0|||
146936901|NCT02848313|529928222|FG001|Overall Study|Lack of Efficacy|1|||
146936902|NCT02848313|529928221|FG000|Overall Study|Withdrawal by Subject|1|||
146936903|NCT02848313|529928222|FG001|Overall Study|Withdrawal by Subject|1|||
146936904|NCT02848313|529928221|FG000|Overall Study|Lost to follow up|1|||
146936905|NCT02848313|529928222|FG001|Overall Study|Lost to follow up|0|||
146936906|NCT00212758|529928223|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
146936907|NCT00212758|529928224|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
146619371|NCT05579977|528777603|FG007|Treatment Phase|Physician Decision|0|||
146619372|NCT05579977|528777604|FG008|Treatment Phase|Physician Decision|0|||
146619373|NCT05579977|528777605|FG009|Treatment Phase|Physician Decision|0|||
146936908|NCT00212758|529928223|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
146936909|NCT00212758|529928224|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
146936910|NCT03510910|529928225|FG000|Overall Study|Incomplete Survey|2|||
146936911|NCT03510910|529928226|FG001|Overall Study|Incomplete Survey|3|||
146730076|NCT00245102|529182448|FG004|Overall Study|Not Treated|0|||
146619374|NCT05579977|528777606|FG010|Treatment Phase|Physician Decision|0|||
146619375|NCT05579977|528777607|FG011|Treatment Phase|Physician Decision|1|||
146619376|NCT05579977|528777608|FG012|Treatment Phase|Physician Decision|0|||
146619377|NCT05579977|528777596|FG000|Treatment Phase|Lost to Follow-up|0|||
146619378|NCT05579977|528777597|FG001|Treatment Phase|Lost to Follow-up|0|||
146619379|NCT05579977|528777598|FG002|Treatment Phase|Lost to Follow-up|0|||
146619380|NCT05579977|528777599|FG003|Treatment Phase|Lost to Follow-up|1|||
146619381|NCT05579977|528777600|FG004|Treatment Phase|Lost to Follow-up|1|||
146619382|NCT05579977|528777601|FG005|Treatment Phase|Lost to Follow-up|1|||
146619383|NCT05579977|528777602|FG006|Treatment Phase|Lost to Follow-up|0|||
146619384|NCT05579977|528777603|FG007|Treatment Phase|Lost to Follow-up|1|||
146619385|NCT05579977|528777604|FG008|Treatment Phase|Lost to Follow-up|2|||
146619386|NCT05579977|528777605|FG009|Treatment Phase|Lost to Follow-up|2|||
146619387|NCT05579977|528777606|FG010|Treatment Phase|Lost to Follow-up|1|||
146619388|NCT05579977|528777607|FG011|Treatment Phase|Lost to Follow-up|4|||
146619389|NCT05579977|528777608|FG012|Treatment Phase|Lost to Follow-up|3|||
146619390|NCT05579977|528777596|FG000|Treatment Phase|Death|1|||
146619391|NCT05579977|528777597|FG001|Treatment Phase|Death|0|||
146619392|NCT05579977|528777598|FG002|Treatment Phase|Death|0|||
146619393|NCT05579977|528777599|FG003|Treatment Phase|Death|0|||
146619394|NCT05579977|528777600|FG004|Treatment Phase|Death|0|||
146619395|NCT05579977|528777601|FG005|Treatment Phase|Death|0|||
146619396|NCT05579977|528777602|FG006|Treatment Phase|Death|0|||
146619397|NCT05579977|528777603|FG007|Treatment Phase|Death|0|||
146619398|NCT05579977|528777604|FG008|Treatment Phase|Death|0|||
146619399|NCT05579977|528777605|FG009|Treatment Phase|Death|0|||
146619400|NCT05579977|528777606|FG010|Treatment Phase|Death|0|||
146619401|NCT05579977|528777607|FG011|Treatment Phase|Death|0|||
146619402|NCT05579977|528777608|FG012|Treatment Phase|Death|0|||
146619403|NCT05579977|528777596|FG000|Treatment Phase|Adverse Event|0|||
146619404|NCT05579977|528777597|FG001|Treatment Phase|Adverse Event|3|||
146619405|NCT05579977|528777598|FG002|Treatment Phase|Adverse Event|11|||
146619406|NCT05579977|528777599|FG003|Treatment Phase|Adverse Event|10|||
146619407|NCT05579977|528777600|FG004|Treatment Phase|Adverse Event|5|||
146619408|NCT05579977|528777601|FG005|Treatment Phase|Adverse Event|17|||
146619409|NCT05579977|528777602|FG006|Treatment Phase|Adverse Event|5|||
146619410|NCT05579977|528777603|FG007|Treatment Phase|Adverse Event|5|||
146619411|NCT05579977|528777604|FG008|Treatment Phase|Adverse Event|12|||
146619412|NCT05579977|528777605|FG009|Treatment Phase|Adverse Event|20|||
146619413|NCT05579977|528777606|FG010|Treatment Phase|Adverse Event|15|||
146619414|NCT05579977|528777607|FG011|Treatment Phase|Adverse Event|24|||
146619415|NCT05579977|528777608|FG012|Treatment Phase|Adverse Event|23|||
146619416|NCT05579977|528777596|FG000|Treatment Phase|Randomized not treated|0|||
146619417|NCT05579977|528777597|FG001|Treatment Phase|Randomized not treated|0|||
146619418|NCT05579977|528777598|FG002|Treatment Phase|Randomized not treated|0|||
146936912|NCT02574481|529928227|FG000|Overall Study|Withdrawal by Subject|29|||
146936913|NCT02574481|529928228|FG001|Overall Study|Withdrawal by Subject|15|||
146936914|NCT02574481|529928229|FG002|Overall Study|Withdrawal by Subject|4|||
146619419|NCT05579977|528777599|FG003|Treatment Phase|Randomized not treated|0|||
146619420|NCT05579977|528777600|FG004|Treatment Phase|Randomized not treated|1|||
146619421|NCT05579977|528777601|FG005|Treatment Phase|Randomized not treated|0|||
146619422|NCT05579977|528777602|FG006|Treatment Phase|Randomized not treated|0|||
146936915|NCT02574481|529928230|FG003|Overall Study|Withdrawal by Subject|1|||
146619423|NCT05579977|528777603|FG007|Treatment Phase|Randomized not treated|0|||
146619424|NCT05579977|528777604|FG008|Treatment Phase|Randomized not treated|0|||
146619425|NCT05579977|528777605|FG009|Treatment Phase|Randomized not treated|0|||
146619426|NCT05579977|528777606|FG010|Treatment Phase|Randomized not treated|0|||
146619427|NCT05579977|528777607|FG011|Treatment Phase|Randomized not treated|0|||
146619428|NCT05579977|528777608|FG012|Treatment Phase|Randomized not treated|0|||
146619429|NCT05579977|528777596|FG000|Follow up|Death|1|||
146619430|NCT05579977|528777597|FG001|Follow up|Death|0|||
146619431|NCT05579977|528777598|FG002|Follow up|Death|0|||
146619432|NCT05579977|528777599|FG003|Follow up|Death|0|||
146619433|NCT05579977|528777600|FG004|Follow up|Death|0|||
146619434|NCT05579977|528777601|FG005|Follow up|Death|0|||
146619435|NCT05579977|528777602|FG006|Follow up|Death|0|||
146619436|NCT05579977|528777603|FG007|Follow up|Death|0|||
146619437|NCT05579977|528777604|FG008|Follow up|Death|0|||
146619438|NCT05579977|528777605|FG009|Follow up|Death|0|||
146619439|NCT05579977|528777606|FG010|Follow up|Death|0|||
146619440|NCT05579977|528777607|FG011|Follow up|Death|0|||
146619441|NCT05579977|528777608|FG012|Follow up|Death|0|||
146619442|NCT05579977|528777596|FG000|Follow up|Lost to Follow-up|0|||
146619443|NCT05579977|528777597|FG001|Follow up|Lost to Follow-up|0|||
146619444|NCT05579977|528777598|FG002|Follow up|Lost to Follow-up|0|||
146619445|NCT05579977|528777599|FG003|Follow up|Lost to Follow-up|1|||
146619446|NCT05579977|528777600|FG004|Follow up|Lost to Follow-up|1|||
146619447|NCT05579977|528777601|FG005|Follow up|Lost to Follow-up|2|||
146619448|NCT05579977|528777602|FG006|Follow up|Lost to Follow-up|1|||
146619449|NCT05579977|528777603|FG007|Follow up|Lost to Follow-up|1|||
146619450|NCT05579977|528777604|FG008|Follow up|Lost to Follow-up|3|||
146619451|NCT05579977|528777605|FG009|Follow up|Lost to Follow-up|2|||
146619452|NCT05579977|528777606|FG010|Follow up|Lost to Follow-up|2|||
146619453|NCT05579977|528777607|FG011|Follow up|Lost to Follow-up|4|||
146619454|NCT05579977|528777608|FG012|Follow up|Lost to Follow-up|4|||
146619455|NCT05579977|528777596|FG000|Follow up|Withdrawal by Subject|2|||
146619456|NCT05579977|528777597|FG001|Follow up|Withdrawal by Subject|0|||
146619457|NCT05579977|528777598|FG002|Follow up|Withdrawal by Subject|0|||
146619458|NCT05579977|528777599|FG003|Follow up|Withdrawal by Subject|0|||
146619459|NCT05579977|528777600|FG004|Follow up|Withdrawal by Subject|1|||
146619460|NCT05579977|528777601|FG005|Follow up|Withdrawal by Subject|0|||
146619461|NCT05579977|528777602|FG006|Follow up|Withdrawal by Subject|1|||
146619462|NCT05579977|528777603|FG007|Follow up|Withdrawal by Subject|4|||
146619463|NCT05579977|528777604|FG008|Follow up|Withdrawal by Subject|2|||
146619464|NCT05579977|528777605|FG009|Follow up|Withdrawal by Subject|3|||
146619465|NCT05579977|528777606|FG010|Follow up|Withdrawal by Subject|3|||
146619466|NCT05579977|528777607|FG011|Follow up|Withdrawal by Subject|1|||
146619467|NCT05579977|528777608|FG012|Follow up|Withdrawal by Subject|3|||
146619468|NCT01611194|528777610|FG000|Overall Study|Lost to Follow-up|0|||
146619469|NCT01611194|528777611|FG001|Overall Study|Lost to Follow-up|1|||
146619470|NCT01611194|528777610|FG000|Overall Study|Withdrawal by Subject|0|||
146619471|NCT01611194|528777611|FG001|Overall Study|Withdrawal by Subject|1|||
146619472|NCT01611194|528777610|FG000|Overall Study|drug use|0|||
146619473|NCT01611194|528777611|FG001|Overall Study|drug use|1|||
146619474|NCT00348673|528777612|FG000|Stage 1|Randomized but not Treated|0|||
146619475|NCT00348673|528777613|FG001|Stage 1|Randomized but not Treated|0|||
146619476|NCT00348673|528777614|FG002|Stage 1|Randomized but not Treated|1|||
146619477|NCT00348673|528777615|FG003|Stage 1|Randomized but not Treated|0|||
146619478|NCT00348673|528777616|FG004|Stage 1|Randomized but not Treated|0|||
146619479|NCT00348673|528777617|FG005|Stage 1|Randomized but not Treated|0|||
146619480|NCT00348673|528777618|FG006|Stage 1|Randomized but not Treated|0|||
146619481|NCT00348673|528777619|FG007|Stage 1|Randomized but not Treated|0|||
146619482|NCT00348673|528777620|FG008|Stage 1|Randomized but not Treated|0|||
146619483|NCT01712204|528777622|FG000|Overall Study|Adverse Event|3|||
146619484|NCT01712204|528777623|FG001|Overall Study|Adverse Event|1|||
146619485|NCT01712204|528777622|FG000|Overall Study|Withdrawal by Subject|3|||
146619486|NCT01712204|528777623|FG001|Overall Study|Withdrawal by Subject|3|||
146619487|NCT01712204|528777622|FG000|Overall Study|Lost to Follow-up|1|||
146619488|NCT01712204|528777623|FG001|Overall Study|Lost to Follow-up|0|||
146619489|NCT01712204|528777622|FG000|Overall Study|Protocol Violation|1|||
146619490|NCT01712204|528777623|FG001|Overall Study|Protocol Violation|1|||
146619491|NCT02679287|528777624|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
146619492|NCT02679287|528777625|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
146619493|NCT02679287|528777624|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
146619494|NCT02679287|528777625|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
146619495|NCT02679287|528777624|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
146619496|NCT02679287|528777625|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
146619497|NCT02679287|528777624|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
146619498|NCT02679287|528777625|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
146619499|NCT02679287|528777624|FG000|Period 2|Work/Scheduling Conflict|1|||
146619500|NCT02679287|528777625|FG001|Period 2|Work/Scheduling Conflict|0|||
146619501|NCT02679287|528777624|FG000|Period 2|Disliked Mobile System|2|||
146619502|NCT02679287|528777625|FG001|Period 2|Disliked Mobile System|0|||
146619503|NCT02679287|528777624|FG000|Period 3|Work/Scheduling Conflict|0|||
146619504|NCT02679287|528777625|FG001|Period 3|Work/Scheduling Conflict|1|||
146619505|NCT01114828|528777626|FG000|Overall Study|Adverse Event|1|||
146619506|NCT01114828|528777627|FG001|Overall Study|Adverse Event|1|||
146619507|NCT01114828|528777626|FG000|Overall Study|Lack of Efficacy|0|||
146619508|NCT01114828|528777627|FG001|Overall Study|Lack of Efficacy|2|||
146619509|NCT01114828|528777626|FG000|Overall Study|Protocol Violation|2|||
146619510|NCT01114828|528777627|FG001|Overall Study|Protocol Violation|0|||
146619511|NCT01114828|528777626|FG000|Overall Study|Withdrawal by Subject|0|||
146619512|NCT01114828|528777627|FG001|Overall Study|Withdrawal by Subject|1|||
146619513|NCT00794950|528777628|FG000|BCG Induction|Withdrawal by Subject|2|||
146619514|NCT00794950|528777628|FG000|BCG Induction|ineligible|3|||
146619515|NCT00794950|528777628|FG000|BCG Induction|noncompliant w. BCG|1|||
146619516|NCT00794950|528777628|FG000|BCG Induction|Adverse Event|1|||
146619517|NCT00794950|528777628|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
146619518|NCT00794950|528777628|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
146619519|NCT00794950|528777628|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
146619520|NCT00794950|528777628|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
146619521|NCT02485704|528777629|FG000|Overall Study|Lost to Follow-up|4|||
146619522|NCT02485704|528777630|FG001|Overall Study|Lost to Follow-up|5|||
146619523|NCT02485704|528777629|FG000|Overall Study|Withdrawal by Subject|0|||
146619524|NCT02485704|528777630|FG001|Overall Study|Withdrawal by Subject|3|||
146619525|NCT02485704|528777629|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
146619526|NCT02485704|528777630|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
146619527|NCT01777776|528777631|FG000|Overall Study|Adverse Event|2|||
146619528|NCT01777776|528777632|FG001|Overall Study|Adverse Event|4|||
146619529|NCT01777776|528777633|FG002|Overall Study|Adverse Event|0|||
146619530|NCT01777776|528777634|FG003|Overall Study|Adverse Event|0|||
146619531|NCT01777776|528777631|FG000|Overall Study|Disease Progression|4|||
146619532|NCT01777776|528777632|FG001|Overall Study|Disease Progression|8|||
146619533|NCT01777776|528777633|FG002|Overall Study|Disease Progression|6|||
146619534|NCT01777776|528777634|FG003|Overall Study|Disease Progression|3|||
146619535|NCT01777776|528777631|FG000|Overall Study|Withdrawal by Subject|0|||
146936916|NCT02574481|529928227|FG000|Overall Study|Adverse Event|5|||
146936917|NCT02574481|529928228|FG001|Overall Study|Adverse Event|1|||
146936918|NCT02574481|529928229|FG002|Overall Study|Adverse Event|1|||
146936919|NCT02574481|529928230|FG003|Overall Study|Adverse Event|0|||
146936920|NCT02574481|529928227|FG000|Overall Study|Visit Missed|15|||
146936921|NCT02574481|529928228|FG001|Overall Study|Visit Missed|7|||
146936922|NCT02574481|529928229|FG002|Overall Study|Visit Missed|5|||
146936923|NCT02574481|529928230|FG003|Overall Study|Visit Missed|0|||
146936924|NCT02574481|529928227|FG000|Overall Study|Other|7|||
146936925|NCT02574481|529928228|FG001|Overall Study|Other|2|||
146936926|NCT02574481|529928229|FG002|Overall Study|Other|0|||
146936927|NCT02574481|529928230|FG003|Overall Study|Other|0|||
146619536|NCT01777776|528777632|FG001|Overall Study|Withdrawal by Subject|0|||
146619537|NCT01777776|528777633|FG002|Overall Study|Withdrawal by Subject|0|||
146619538|NCT01777776|528777634|FG003|Overall Study|Withdrawal by Subject|1|||
146619539|NCT01943591|528777637|FG000|Overall Study|Lost to Follow-up|3|||
146619540|NCT01943591|528777638|FG001|Overall Study|Lost to Follow-up|4|||
146619541|NCT01943591|528777637|FG000|Overall Study|Death|2|||
146619542|NCT01943591|528777638|FG001|Overall Study|Death|7|||
146619543|NCT05473026|528780075|FG000|Overall Study|Lost to Follow-up|5|||
146619544|NCT05473026|528780076|FG001|Overall Study|Lost to Follow-up|2|||
146619545|NCT00248495|528780082|FG000|Overall Study|Withdrawal by Subject|1|||
146619546|NCT03812380|528780083|FG000|Overall Study|Protocol Violation|3|||
146619547|NCT03812380|528780084|FG001|Overall Study|Protocol Violation|3|||
146619548|NCT03812380|528780083|FG000|Overall Study|Withdrawal by Subject|5|||
146619549|NCT03812380|528780084|FG001|Overall Study|Withdrawal by Subject|4|||
146619550|NCT03812380|528780083|FG000|Overall Study|Early termination of study|14|||
146619551|NCT03812380|528780084|FG001|Overall Study|Early termination of study|14|||
146619552|NCT00981149|528780085|FG000|Overall Study|Lost to Follow-up|1|||
146619553|NCT00981149|528780086|FG001|Overall Study|Lost to Follow-up|2|||
146619554|NCT00981149|528780085|FG000|Overall Study|Withdrawal by Subject|1|||
146619555|NCT00981149|528780086|FG001|Overall Study|Withdrawal by Subject|1|||
146619556|NCT04244253|528780092|FG000|Overall Study|Adverse Event|2|||
146619557|NCT04244253|528780093|FG001|Overall Study|Adverse Event|2|||
146619558|NCT04244253|528780094|FG002|Overall Study|Adverse Event|4|||
146619559|NCT04244253|528780092|FG000|Overall Study|Protocol Violation|1|||
146619560|NCT04244253|528780093|FG001|Overall Study|Protocol Violation|2|||
146619561|NCT04244253|528780094|FG002|Overall Study|Protocol Violation|1|||
146619562|NCT04244253|528780092|FG000|Overall Study|Withdrawal by Subject|0|||
146619563|NCT04244253|528780093|FG001|Overall Study|Withdrawal by Subject|1|||
146619564|NCT04244253|528780094|FG002|Overall Study|Withdrawal by Subject|6|||
146619565|NCT04244253|528780092|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146619566|NCT04244253|528780093|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146619567|NCT04244253|528780094|FG002|Overall Study|Non-Compliance With Study Drug|1|||
146619568|NCT00619515|528780095|FG000|Overall Study|Study Termination by IRB|73|||
146619569|NCT03294590|528780098|FG000|Overall Study|Lost to Follow-up|105|||
146619570|NCT03294590|528780099|FG001|Overall Study|Lost to Follow-up|107|||
146619571|NCT00628030|528780104|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
146619572|NCT00628030|528780105|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
146619573|NCT00628030|528780104|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
146619574|NCT00628030|528780105|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
146619575|NCT00628030|528780104|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
146619576|NCT00628030|528780105|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
146619577|NCT01255423|528780106|FG000|Overall Study|Abnormal Laboratory value|3|||
146619578|NCT01255423|528780107|FG001|Overall Study|Abnormal Laboratory value|2|||
146619579|NCT01255423|528780106|FG000|Overall Study|Use of prohibited medications|0|||
146619580|NCT01255423|528780107|FG001|Overall Study|Use of prohibited medications|1|||
146619581|NCT03367858|528780108|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
146619582|NCT03367858|528780109|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
146619583|NCT03367858|528780108|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
146619584|NCT03367858|528780109|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
146619585|NCT03367858|528780108|FG000|3 Month Follow Up|Lost to Follow-up|8|||
146619586|NCT03367858|528780109|FG001|3 Month Follow Up|Lost to Follow-up|3|||
146619587|NCT03367858|528780108|FG000|3 Month Follow Up|Moved out of study area|2|||
146619588|NCT03367858|528780109|FG001|3 Month Follow Up|Moved out of study area|6|||
146619589|NCT03367858|528780108|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
146619590|NCT03367858|528780109|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
146619591|NCT03367858|528780108|FG000|3 Month Follow Up|MRI contraindication|2|||
146619592|NCT03367858|528780109|FG001|3 Month Follow Up|MRI contraindication|1|||
146619593|NCT03367858|528780108|FG000|3 Month Follow Up|Incarcerated|0|||
146619594|NCT03367858|528780109|FG001|3 Month Follow Up|Incarcerated|1|||
146619595|NCT03367858|528780108|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
146619596|NCT03367858|528780109|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
146619597|NCT03367858|528780108|FG000|6 Month Follow Up|Lost to Follow-up|5|||
146619598|NCT03367858|528780109|FG001|6 Month Follow Up|Lost to Follow-up|2|||
146619599|NCT03367858|528780108|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
146619600|NCT03367858|528780109|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
146619601|NCT03367858|528780108|FG000|12 Month Follow Up|Lost to Follow-up|3|||
146936928|NCT02574481|529928227|FG000|Overall Study|Death|48|||
146936929|NCT02574481|529928228|FG001|Overall Study|Death|26|||
146936930|NCT02574481|529928229|FG002|Overall Study|Death|12|||
146936931|NCT02574481|529928230|FG003|Overall Study|Death|4|||
146936932|NCT02574481|529928227|FG000|Overall Study|Physician Decision|5|||
146936933|NCT02574481|529928228|FG001|Overall Study|Physician Decision|2|||
146936934|NCT02574481|529928229|FG002|Overall Study|Physician Decision|0|||
146936935|NCT02574481|529928230|FG003|Overall Study|Physician Decision|0|||
146936936|NCT02574481|529928227|FG000|Overall Study|Lost to Follow-up|5|||
146936937|NCT02574481|529928228|FG001|Overall Study|Lost to Follow-up|1|||
146936938|NCT02574481|529928229|FG002|Overall Study|Lost to Follow-up|3|||
146936939|NCT02574481|529928230|FG003|Overall Study|Lost to Follow-up|0|||
146936940|NCT01105936|529928234|FG000|Period 1|Adverse Event|0|||
146936941|NCT01105936|529928235|FG001|Period 1|Adverse Event|0|||
146936942|NCT01105936|529928236|FG002|Period 1|Adverse Event|0|||
146936943|NCT01105936|529928237|FG003|Period 1|Adverse Event|1|||
146936944|NCT01105936|529928234|FG000|Period 2|Adverse Event|1|||
146936945|NCT01105936|529928235|FG001|Period 2|Adverse Event|0|||
146936946|NCT01105936|529928236|FG002|Period 2|Adverse Event|0|||
146619602|NCT03367858|528780109|FG001|12 Month Follow Up|Lost to Follow-up|3|||
146619603|NCT03367858|528780108|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
146619604|NCT03367858|528780109|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
146619605|NCT04154943|528780112|FG000|Overall Study|Study Ongoing|68|||
146619606|NCT04154943|528780112|FG000|Overall Study|Lost to Follow-up|1|||
146619607|NCT04154943|528780112|FG000|Overall Study|Decision by the Investigator|1|||
146619608|NCT04154943|528780112|FG000|Overall Study|Death|5|||
146936947|NCT01105936|529928237|FG003|Period 2|Adverse Event|0|||
146936948|NCT01105936|529928234|FG000|Period 3|Protocol Violation|0|||
146936949|NCT01105936|529928235|FG001|Period 3|Protocol Violation|2|||
146619609|NCT04154943|528780112|FG000|Overall Study|Withdrawal by Subject|4|||
146619610|NCT00101686|528780113|FG000|Overall Study|Progressive Disease|37|||
146619611|NCT00101686|528780114|FG001|Overall Study|Progressive Disease|28|||
146619612|NCT00101686|528780115|FG002|Overall Study|Progressive Disease|37|||
146619613|NCT00101686|528780116|FG003|Overall Study|Progressive Disease|38|||
146619614|NCT00101686|528780117|FG004|Overall Study|Progressive Disease|28|||
146619615|NCT00101686|528780118|FG005|Overall Study|Progressive Disease|25|||
146936950|NCT01105936|529928236|FG002|Period 3|Protocol Violation|0|||
146936951|NCT01105936|529928237|FG003|Period 3|Protocol Violation|0|||
146936952|NCT01673490|529928238|FG000|Overall Study|Lost to Follow-up|1|||
146936953|NCT01673490|529928238|FG000|Overall Study|Adverse Event|3|||
146936954|NCT01673490|529928238|FG000|Overall Study|Withdrawal by Subject|3|||
146936955|NCT03382262|529928241|FG000|Overall Study|Physician Decision|0|||
146936956|NCT03382262|529928242|FG001|Overall Study|Physician Decision|0|||
146936957|NCT03382262|529928243|FG002|Overall Study|Physician Decision|1|||
146619616|NCT00101686|528780119|FG006|Overall Study|Progressive Disease|5|||
146619617|NCT00101686|528780120|FG007|Overall Study|Progressive Disease|7|||
146619618|NCT00101686|528780121|FG008|Overall Study|Progressive Disease|10|||
146619619|NCT00101686|528780122|FG009|Overall Study|Progressive Disease|8|||
146619620|NCT00101686|528780113|FG000|Overall Study|initiation other anti-cancer treatment|4|||
146619621|NCT00101686|528780114|FG001|Overall Study|initiation other anti-cancer treatment|3|||
146619622|NCT00101686|528780115|FG002|Overall Study|initiation other anti-cancer treatment|4|||
146619623|NCT00101686|528780116|FG003|Overall Study|initiation other anti-cancer treatment|3|||
146619624|NCT00101686|528780117|FG004|Overall Study|initiation other anti-cancer treatment|1|||
146619625|NCT00101686|528780118|FG005|Overall Study|initiation other anti-cancer treatment|1|||
146619626|NCT00101686|528780119|FG006|Overall Study|initiation other anti-cancer treatment|2|||
146619627|NCT00101686|528780120|FG007|Overall Study|initiation other anti-cancer treatment|2|||
146619628|NCT00101686|528780121|FG008|Overall Study|initiation other anti-cancer treatment|3|||
146619629|NCT00101686|528780122|FG009|Overall Study|initiation other anti-cancer treatment|3|||
146619630|NCT00101686|528780113|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
146619631|NCT00101686|528780114|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
146619632|NCT00101686|528780115|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
146619633|NCT00101686|528780116|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
146619634|NCT00101686|528780117|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
146619635|NCT00101686|528780118|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
146619636|NCT00101686|528780119|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
146619637|NCT00101686|528780120|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
146619638|NCT00101686|528780121|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
146619639|NCT00101686|528780122|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
146619640|NCT00101686|528780113|FG000|Overall Study|unacceptable toxicity|3|||
146619641|NCT00101686|528780114|FG001|Overall Study|unacceptable toxicity|9|||
146619642|NCT00101686|528780115|FG002|Overall Study|unacceptable toxicity|10|||
146619643|NCT00101686|528780116|FG003|Overall Study|unacceptable toxicity|6|||
146619644|NCT00101686|528780117|FG004|Overall Study|unacceptable toxicity|16|||
146619645|NCT00101686|528780118|FG005|Overall Study|unacceptable toxicity|10|||
146619646|NCT00101686|528780119|FG006|Overall Study|unacceptable toxicity|4|||
146619647|NCT00101686|528780120|FG007|Overall Study|unacceptable toxicity|2|||
146619648|NCT00101686|528780121|FG008|Overall Study|unacceptable toxicity|1|||
146619649|NCT00101686|528780122|FG009|Overall Study|unacceptable toxicity|4|||
146619650|NCT00101686|528780113|FG000|Overall Study|Randomized but did not receive treament|1|||
146619651|NCT00101686|528780114|FG001|Overall Study|Randomized but did not receive treament|6|||
146619652|NCT00101686|528780115|FG002|Overall Study|Randomized but did not receive treament|2|||
146619653|NCT00101686|528780116|FG003|Overall Study|Randomized but did not receive treament|2|||
146619654|NCT00101686|528780117|FG004|Overall Study|Randomized but did not receive treament|2|||
146619655|NCT00101686|528780118|FG005|Overall Study|Randomized but did not receive treament|2|||
146619656|NCT00101686|528780119|FG006|Overall Study|Randomized but did not receive treament|0|||
146619657|NCT00101686|528780120|FG007|Overall Study|Randomized but did not receive treament|1|||
146619658|NCT00101686|528780121|FG008|Overall Study|Randomized but did not receive treament|0|||
146619659|NCT00101686|528780122|FG009|Overall Study|Randomized but did not receive treament|1|||
146619660|NCT00101686|528780113|FG000|Overall Study|intercurrent non-cancer related illness|0|||
146619661|NCT00101686|528780114|FG001|Overall Study|intercurrent non-cancer related illness|0|||
146619662|NCT00101686|528780115|FG002|Overall Study|intercurrent non-cancer related illness|2|||
146619663|NCT00101686|528780116|FG003|Overall Study|intercurrent non-cancer related illness|0|||
146619664|NCT00101686|528780117|FG004|Overall Study|intercurrent non-cancer related illness|1|||
146619665|NCT00101686|528780118|FG005|Overall Study|intercurrent non-cancer related illness|3|||
146619666|NCT00101686|528780119|FG006|Overall Study|intercurrent non-cancer related illness|1|||
146619667|NCT00101686|528780120|FG007|Overall Study|intercurrent non-cancer related illness|0|||
146619668|NCT00101686|528780121|FG008|Overall Study|intercurrent non-cancer related illness|1|||
146619669|NCT00101686|528780122|FG009|Overall Study|intercurrent non-cancer related illness|1|||
146619670|NCT00101686|528780113|FG000|Overall Study|Physician Decision|10|||
146619671|NCT00101686|528780114|FG001|Overall Study|Physician Decision|13|||
146619672|NCT00101686|528780115|FG002|Overall Study|Physician Decision|6|||
146619673|NCT00101686|528780116|FG003|Overall Study|Physician Decision|7|||
146619674|NCT00101686|528780117|FG004|Overall Study|Physician Decision|8|||
146619675|NCT00101686|528780118|FG005|Overall Study|Physician Decision|9|||
146619676|NCT00101686|528780119|FG006|Overall Study|Physician Decision|5|||
146619677|NCT00101686|528780120|FG007|Overall Study|Physician Decision|5|||
146936958|NCT03382262|529928244|FG003|Overall Study|Physician Decision|0|||
146936959|NCT03382262|529928241|FG000|Overall Study|Withdrawal by Subject|0|||
146619678|NCT00101686|528780121|FG008|Overall Study|Physician Decision|1|||
146619679|NCT00101686|528780122|FG009|Overall Study|Physician Decision|1|||
146619680|NCT00101686|528780113|FG000|Overall Study|Other|1|||
146619681|NCT00101686|528780114|FG001|Overall Study|Other|4|||
146619682|NCT00101686|528780115|FG002|Overall Study|Other|1|||
146619683|NCT00101686|528780116|FG003|Overall Study|Other|6|||
146936960|NCT03382262|529928242|FG001|Overall Study|Withdrawal by Subject|0|||
146619684|NCT00101686|528780117|FG004|Overall Study|Other|2|||
146619685|NCT00101686|528780118|FG005|Overall Study|Other|12|||
146619686|NCT00101686|528780119|FG006|Overall Study|Other|1|||
146619687|NCT00101686|528780120|FG007|Overall Study|Other|5|||
146619688|NCT00101686|528780121|FG008|Overall Study|Other|3|||
146619689|NCT00101686|528780122|FG009|Overall Study|Other|3|||
146619690|NCT00101686|528780113|FG000|Overall Study|Withdrawal by Subject|9|||
146619691|NCT00101686|528780114|FG001|Overall Study|Withdrawal by Subject|8|||
146619692|NCT00101686|528780115|FG002|Overall Study|Withdrawal by Subject|6|||
146619693|NCT00101686|528780116|FG003|Overall Study|Withdrawal by Subject|8|||
146619694|NCT00101686|528780117|FG004|Overall Study|Withdrawal by Subject|8|||
146619695|NCT00101686|528780118|FG005|Overall Study|Withdrawal by Subject|7|||
146936961|NCT03382262|529928243|FG002|Overall Study|Withdrawal by Subject|0|||
146730077|NCT00245102|529182449|FG005|Overall Study|Not Treated|0|||
146730078|NCT00245102|529182444|FG000|Overall Study|Protocol Violation|1|||
146730079|NCT00245102|529182445|FG001|Overall Study|Protocol Violation|0|||
146730080|NCT00245102|529182446|FG002|Overall Study|Protocol Violation|0|||
146730081|NCT00245102|529182447|FG003|Overall Study|Protocol Violation|0|||
146730082|NCT00245102|529182448|FG004|Overall Study|Protocol Violation|0|||
146730083|NCT00245102|529182449|FG005|Overall Study|Protocol Violation|0|||
146730084|NCT00245102|529182444|FG000|Overall Study|Death|0|||
146730085|NCT00245102|529182445|FG001|Overall Study|Death|0|||
146730086|NCT00245102|529182446|FG002|Overall Study|Death|0|||
146730087|NCT00245102|529182447|FG003|Overall Study|Death|1|||
146730088|NCT00245102|529182448|FG004|Overall Study|Death|0|||
146730089|NCT00245102|529182449|FG005|Overall Study|Death|0|||
146730090|NCT00245102|529182444|FG000|Overall Study|Adverse Event|4|||
146730091|NCT00245102|529182445|FG001|Overall Study|Adverse Event|2|||
146730092|NCT00245102|529182446|FG002|Overall Study|Adverse Event|5|||
146730093|NCT00245102|529182447|FG003|Overall Study|Adverse Event|1|||
146730094|NCT00245102|529182448|FG004|Overall Study|Adverse Event|0|||
146730095|NCT00245102|529182449|FG005|Overall Study|Adverse Event|2|||
146730096|NCT00245102|529182444|FG000|Overall Study|Decline in performance|0|||
146730097|NCT00245102|529182445|FG001|Overall Study|Decline in performance|2|||
146730098|NCT00245102|529182446|FG002|Overall Study|Decline in performance|0|||
146730099|NCT00245102|529182447|FG003|Overall Study|Decline in performance|1|||
146730100|NCT00245102|529182448|FG004|Overall Study|Decline in performance|0|||
146730101|NCT00245102|529182449|FG005|Overall Study|Decline in performance|2|||
146730102|NCT00245102|529182444|FG000|Overall Study|Participant needed surgery|0|||
146730103|NCT00245102|529182445|FG001|Overall Study|Participant needed surgery|0|||
146730104|NCT00245102|529182446|FG002|Overall Study|Participant needed surgery|1|||
146730105|NCT00245102|529182447|FG003|Overall Study|Participant needed surgery|0|||
146730106|NCT00245102|529182448|FG004|Overall Study|Participant needed surgery|0|||
146730107|NCT00245102|529182449|FG005|Overall Study|Participant needed surgery|0|||
146730108|NCT00245102|529182444|FG000|Overall Study|Clinical progression|1|||
146730109|NCT00245102|529182445|FG001|Overall Study|Clinical progression|0|||
146730110|NCT00245102|529182446|FG002|Overall Study|Clinical progression|0|||
146730111|NCT00245102|529182447|FG003|Overall Study|Clinical progression|0|||
146730112|NCT00245102|529182448|FG004|Overall Study|Clinical progression|0|||
146730113|NCT00245102|529182449|FG005|Overall Study|Clinical progression|0|||
146730114|NCT02293395|529182456|FG000|Overall Study|Lost to Follow-up|1|||
146730115|NCT02293395|529182457|FG001|Overall Study|Lost to Follow-up|0|||
146730116|NCT02293395|529182456|FG000|Overall Study|Withdrawal by Subject|8|||
146730117|NCT02293395|529182457|FG001|Overall Study|Withdrawal by Subject|7|||
146730118|NCT00224770|529182463|FG000|Overall Study|Lost to Follow-up|4|||
146730119|NCT00224770|529182464|FG001|Overall Study|Lost to Follow-up|2|||
146730120|NCT00224770|529182465|FG002|Overall Study|Lost to Follow-up|0|||
146730121|NCT01106430|529182466|FG000|Overall Study|Adverse Event|8|||
146730122|NCT01106430|529182467|FG001|Overall Study|Adverse Event|10|||
146730123|NCT01106430|529182466|FG000|Overall Study|Lack of Efficacy|2|||
146730124|NCT01106430|529182467|FG001|Overall Study|Lack of Efficacy|13|||
146730125|NCT01106430|529182466|FG000|Overall Study|Lost to Follow-up|5|||
146730126|NCT01106430|529182467|FG001|Overall Study|Lost to Follow-up|1|||
146730127|NCT01106430|529182466|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
146730128|NCT01106430|529182467|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
146730129|NCT01106430|529182466|FG000|Overall Study|Moved Out Of State|0|||
146730130|NCT01106430|529182467|FG001|Overall Study|Moved Out Of State|1|||
146730131|NCT01106430|529182466|FG000|Overall Study|Refused To Take Medication|0|||
146730132|NCT01106430|529182467|FG001|Overall Study|Refused To Take Medication|1|||
146730133|NCT01106430|529182466|FG000|Overall Study|Noncompliance|0|||
146936962|NCT03382262|529928244|FG003|Overall Study|Withdrawal by Subject|1|||
146619696|NCT00101686|528780119|FG006|Overall Study|Withdrawal by Subject|7|||
146619697|NCT00101686|528780120|FG007|Overall Study|Withdrawal by Subject|7|||
146619698|NCT00101686|528780121|FG008|Overall Study|Withdrawal by Subject|8|||
146730134|NCT01106430|529182467|FG001|Overall Study|Noncompliance|1|||
146730135|NCT01106430|529182466|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
146730136|NCT01106430|529182467|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
146730137|NCT01106430|529182466|FG000|Overall Study|Previous Use Of Marijuana|1|||
146619699|NCT00101686|528780122|FG009|Overall Study|Withdrawal by Subject|9|||
146619700|NCT01292187|528780123|FG000|Overall Study|Adverse Event|10|||
146619701|NCT01292187|528780124|FG001|Overall Study|Adverse Event|5|||
146619702|NCT01292187|528780123|FG000|Overall Study|Withdrawal by Subject|6|||
146619703|NCT01292187|528780124|FG001|Overall Study|Withdrawal by Subject|5|||
146619704|NCT01292187|528780123|FG000|Overall Study|All other reasons|1|||
146619705|NCT01292187|528780124|FG001|Overall Study|All other reasons|3|||
146619706|NCT03827655|528780126|FG000|Overall Study|Death|0|||
146619707|NCT03827655|528780127|FG001|Overall Study|Death|0|||
146619708|NCT03827655|528780128|FG002|Overall Study|Death|0|||
146619709|NCT03827655|528780129|FG003|Overall Study|Death|0|||
146619710|NCT03827655|528780130|FG004|Overall Study|Death|1|||
146619711|NCT03827655|528780126|FG000|Overall Study|Protocol Deviation|1|||
146619712|NCT03827655|528780127|FG001|Overall Study|Protocol Deviation|0|||
146619713|NCT03827655|528780128|FG002|Overall Study|Protocol Deviation|1|||
146619714|NCT03827655|528780129|FG003|Overall Study|Protocol Deviation|1|||
146619715|NCT03827655|528780130|FG004|Overall Study|Protocol Deviation|0|||
146619716|NCT03827655|528780126|FG000|Overall Study|Withdrawal by Subject|3|||
146619717|NCT03827655|528780127|FG001|Overall Study|Withdrawal by Subject|2|||
146619718|NCT03827655|528780128|FG002|Overall Study|Withdrawal by Subject|2|||
146619719|NCT03827655|528780129|FG003|Overall Study|Withdrawal by Subject|0|||
146619720|NCT03827655|528780130|FG004|Overall Study|Withdrawal by Subject|1|||
146619721|NCT03827655|528780126|FG000|Overall Study|Reason not Specified|3|||
146619722|NCT03827655|528780127|FG001|Overall Study|Reason not Specified|1|||
146619723|NCT03827655|528780128|FG002|Overall Study|Reason not Specified|1|||
146619724|NCT03827655|528780129|FG003|Overall Study|Reason not Specified|1|||
146619725|NCT03827655|528780130|FG004|Overall Study|Reason not Specified|1|||
146619726|NCT03649217|528780131|FG000|Overall Study|subject had severe ataxia not initially found|1|||
146619727|NCT03649217|528780131|FG000|Overall Study|subject had cognitive issues not initially found|1|||
146619728|NCT02520726|528780132|FG000|Overall Study|Lost to Follow-up|3|||
146619729|NCT02520726|528780133|FG001|Overall Study|Lost to Follow-up|2|||
146619730|NCT01092728|528780134|FG000|Overall Study|Withdrawal by Subject|2|||
146619731|NCT01092728|528780135|FG001|Overall Study|Withdrawal by Subject|0|||
146619732|NCT01092728|528780134|FG000|Overall Study|Adverse Event|0|||
146619733|NCT01092728|528780135|FG001|Overall Study|Adverse Event|1|||
146619734|NCT01092728|528780134|FG000|Overall Study|Disease Progression|1|||
146619735|NCT01092728|528780135|FG001|Overall Study|Disease Progression|13|||
146619736|NCT01092728|528780134|FG000|Overall Study|Prohibited Concomitant Medications|1|||
146619737|NCT01092728|528780135|FG001|Overall Study|Prohibited Concomitant Medications|0|||
146619738|NCT02336607|528780136|FG000|Overall Study|Physician Decision|1|||
146619739|NCT02336607|528780137|FG001|Overall Study|Physician Decision|4|||
146619740|NCT02336607|528780138|FG002|Overall Study|Physician Decision|3|||
146619741|NCT02336607|528780139|FG003|Overall Study|Physician Decision|15|||
146619742|NCT02336607|528780136|FG000|Overall Study|Lack of Efficacy|1|||
146619743|NCT02336607|528780137|FG001|Overall Study|Lack of Efficacy|0|||
146619744|NCT02336607|528780138|FG002|Overall Study|Lack of Efficacy|0|||
146619745|NCT02336607|528780139|FG003|Overall Study|Lack of Efficacy|2|||
146619746|NCT02336607|528780136|FG000|Overall Study|Lost to Follow-up|2|||
146619747|NCT02336607|528780137|FG001|Overall Study|Lost to Follow-up|1|||
146619748|NCT02336607|528780138|FG002|Overall Study|Lost to Follow-up|0|||
146619749|NCT02336607|528780139|FG003|Overall Study|Lost to Follow-up|21|||
146619750|NCT02336607|528780136|FG000|Overall Study|Protocol Violation|0|||
146619751|NCT02336607|528780137|FG001|Overall Study|Protocol Violation|1|||
146619752|NCT02336607|528780138|FG002|Overall Study|Protocol Violation|1|||
146619753|NCT02336607|528780139|FG003|Overall Study|Protocol Violation|3|||
146619754|NCT02336607|528780136|FG000|Overall Study|Adverse Event|0|||
146619755|NCT02336607|528780137|FG001|Overall Study|Adverse Event|2|||
146619756|NCT02336607|528780138|FG002|Overall Study|Adverse Event|2|||
146619757|NCT02336607|528780139|FG003|Overall Study|Adverse Event|26|||
146936963|NCT02940860|529928245|FG000|Overall Study|Non-serious AE|1|||
146936964|NCT02940860|529928246|FG001|Overall Study|Non-serious AE|2|||
146936965|NCT02940860|529928245|FG000|Overall Study|Serious AE|7|||
146936966|NCT02940860|529928246|FG001|Overall Study|Serious AE|3|||
146619758|NCT02336607|528780136|FG000|Overall Study|Withdrawal by Subject|0|||
146619759|NCT02336607|528780137|FG001|Overall Study|Withdrawal by Subject|2|||
146619760|NCT02336607|528780138|FG002|Overall Study|Withdrawal by Subject|0|||
146619761|NCT02336607|528780139|FG003|Overall Study|Withdrawal by Subject|20|||
146619762|NCT02552966|528780142|FG000|Overall Study|Lost to Follow-up|2|||
146619763|NCT02552966|528780142|FG000|Overall Study|Withdrawal by Subject|3|||
146619764|NCT00721396|528780144|FG000|Overall Study|Adverse Event|4|||
146619765|NCT00721396|528780145|FG001|Overall Study|Adverse Event|7|||
146619766|NCT00721396|528780146|FG002|Overall Study|Adverse Event|2|||
146619767|NCT00721396|528780147|FG003|Overall Study|Adverse Event|0|||
146619768|NCT00721396|528780144|FG000|Overall Study|Withdrawal by Subject|12|||
146619769|NCT00721396|528780145|FG001|Overall Study|Withdrawal by Subject|15|||
146619770|NCT00721396|528780146|FG002|Overall Study|Withdrawal by Subject|3|||
146619771|NCT00721396|528780147|FG003|Overall Study|Withdrawal by Subject|7|||
146619772|NCT00721396|528780144|FG000|Overall Study|Lost to Follow-up|7|||
146619773|NCT00721396|528780145|FG001|Overall Study|Lost to Follow-up|9|||
146936967|NCT02940860|529928245|FG000|Overall Study|Withdrawal by Subject|19|||
146619774|NCT00721396|528780146|FG002|Overall Study|Lost to Follow-up|3|||
146619775|NCT00721396|528780147|FG003|Overall Study|Lost to Follow-up|3|||
146619776|NCT00721396|528780144|FG000|Overall Study|Protocol Violation|4|||
146936968|NCT02940860|529928246|FG001|Overall Study|Withdrawal by Subject|9|||
146936969|NCT02940860|529928245|FG000|Overall Study|Lost to Follow-up|13|||
146936970|NCT02940860|529928246|FG001|Overall Study|Lost to Follow-up|7|||
146936971|NCT02940860|529928245|FG000|Overall Study|Physician Decision|5|||
146936972|NCT02940860|529928246|FG001|Overall Study|Physician Decision|3|||
146936973|NCT02940860|529928245|FG000|Overall Study|Sponsor Decision|0|||
146936974|NCT02940860|529928246|FG001|Overall Study|Sponsor Decision|1|||
146936975|NCT02940860|529928245|FG000|Overall Study|Protocol Violation|0|||
146936976|NCT02940860|529928246|FG001|Overall Study|Protocol Violation|2|||
146936977|NCT02940860|529928245|FG000|Overall Study|Death|3|||
146936978|NCT02940860|529928246|FG001|Overall Study|Death|2|||
146936979|NCT02940860|529928245|FG000|Overall Study|Moved, poor venous access, transport|6|||
146936980|NCT02940860|529928246|FG001|Overall Study|Moved, poor venous access, transport|4|||
146936981|NCT02940860|529928245|FG000|Overall Study|Not treated|2|||
146936982|NCT02940860|529928246|FG001|Overall Study|Not treated|2|||
146936983|NCT04914819|529928248|FG000|Overall Study|Pregnancy|3|||
146981765|NCT01909466|530096122|FG001|Overall Study|Met Withdrawal Criteria|3|||
146981766|NCT01909466|530096121|FG000|Overall Study|Physician Decision|2|||
146619777|NCT00721396|528780145|FG001|Overall Study|Protocol Violation|3|||
146619778|NCT00721396|528780146|FG002|Overall Study|Protocol Violation|1|||
146619779|NCT00721396|528780147|FG003|Overall Study|Protocol Violation|0|||
146619780|NCT00721396|528780144|FG000|Overall Study|Inappropriate enrollment|0|||
146619781|NCT00721396|528780145|FG001|Overall Study|Inappropriate enrollment|2|||
146619782|NCT00721396|528780146|FG002|Overall Study|Inappropriate enrollment|0|||
146619783|NCT00721396|528780147|FG003|Overall Study|Inappropriate enrollment|0|||
146619784|NCT00721396|528780144|FG000|Overall Study|Administrative reason|3|||
146619785|NCT00721396|528780145|FG001|Overall Study|Administrative reason|0|||
146619786|NCT00721396|528780146|FG002|Overall Study|Administrative reason|1|||
146619787|NCT00721396|528780147|FG003|Overall Study|Administrative reason|0|||
146619788|NCT02365649|528780151|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146619789|NCT02365649|528780152|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146619790|NCT02365649|528780153|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146619791|NCT02365649|528780154|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
146619792|NCT02365649|528780155|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146619793|NCT02365649|528780156|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146619794|NCT02365649|528780157|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146619795|NCT02365649|528780158|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146619796|NCT02365649|528780159|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146619797|NCT02365649|528780160|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146619798|NCT02365649|528780151|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
146619799|NCT02365649|528780152|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
146619800|NCT02365649|528780153|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
146619801|NCT02365649|528780154|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
146619802|NCT02365649|528780155|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
146619803|NCT02365649|528780156|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
146619804|NCT02365649|528780157|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
146619805|NCT02365649|528780158|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
146619806|NCT02365649|528780159|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
146619807|NCT02365649|528780160|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
146619808|NCT02365649|528780151|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
146619809|NCT02365649|528780152|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
146619810|NCT02365649|528780153|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
146619811|NCT02365649|528780154|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
146619812|NCT02365649|528780155|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
146619813|NCT02365649|528780156|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
146619814|NCT02365649|528780157|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
146619815|NCT02365649|528780158|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
146619816|NCT02365649|528780159|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
146619817|NCT02365649|528780160|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
146619818|NCT02365649|528780151|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
146619819|NCT02365649|528780152|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
146619820|NCT02365649|528780153|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
146619821|NCT02365649|528780154|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
146619822|NCT02365649|528780155|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
146619823|NCT02365649|528780156|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
146619824|NCT02365649|528780157|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
146936984|NCT04914819|529928249|FG001|Overall Study|Pregnancy|1|||
146936985|NCT04914819|529928248|FG000|Overall Study|Discontinued study|4|||
146936986|NCT04914819|529928249|FG001|Overall Study|Discontinued study|1|||
146936987|NCT04914819|529928248|FG000|Overall Study|Lost to Follow-up|7|||
146619825|NCT02365649|528780158|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
146619826|NCT02365649|528780159|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
146619827|NCT02365649|528780160|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
146619828|NCT02365649|528780151|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
146619829|NCT02365649|528780152|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
146619830|NCT02365649|528780153|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
146619831|NCT02365649|528780154|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
146619832|NCT02365649|528780155|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
146619833|NCT02365649|528780156|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
146619834|NCT02365649|528780157|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
146619835|NCT02365649|528780158|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
146619836|NCT02365649|528780159|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
146619837|NCT02365649|528780160|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
146619838|NCT02365649|528780151|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
146619839|NCT02365649|528780152|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
146619840|NCT02365649|528780153|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
146619841|NCT02365649|528780154|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
146619842|NCT02365649|528780155|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
146619843|NCT02365649|528780156|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
146619844|NCT02365649|528780157|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
146619845|NCT02365649|528780158|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
146619846|NCT02365649|528780159|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
146619847|NCT02365649|528780160|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
146619848|NCT02365649|528780151|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146619849|NCT02365649|528780152|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146619850|NCT02365649|528780153|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
146619851|NCT02365649|528780154|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146619852|NCT02365649|528780155|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146619853|NCT02365649|528780156|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146619854|NCT02365649|528780157|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146619855|NCT02365649|528780158|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146619856|NCT02365649|528780159|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146619857|NCT02365649|528780160|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146619858|NCT02365649|528780151|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146619859|NCT02365649|528780152|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146619860|NCT02365649|528780153|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146619861|NCT02365649|528780154|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146619862|NCT02365649|528780155|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146619863|NCT02365649|528780156|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146619864|NCT02365649|528780157|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
146619865|NCT02365649|528780158|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146619866|NCT02365649|528780159|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146619867|NCT02365649|528780160|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146619868|NCT02365649|528780151|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
146619869|NCT02365649|528780152|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
146619870|NCT02365649|528780153|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
146619871|NCT02365649|528780154|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
146619872|NCT02365649|528780155|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
146619873|NCT02365649|528780156|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
146619874|NCT02365649|528780157|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
146619875|NCT02365649|528780158|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
146619876|NCT02365649|528780159|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
146619877|NCT02365649|528780160|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
146619878|NCT02365649|528780151|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
146619879|NCT02365649|528780152|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
146619880|NCT02365649|528780153|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
146619881|NCT02365649|528780154|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
146619882|NCT02365649|528780155|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
146619883|NCT02365649|528780156|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
146936988|NCT04914819|529928249|FG001|Overall Study|Lost to Follow-up|0|||
146619884|NCT02365649|528780157|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
146619885|NCT02365649|528780158|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
146936989|NCT02715804|529928250|FG000|Overall Study|Death|222|||
146936990|NCT02715804|529928251|FG001|Overall Study|Death|106|||
146936991|NCT02715804|529928250|FG000|Overall Study|Withdrawal by Subject|5|||
146981767|NCT01909466|530096122|FG001|Overall Study|Physician Decision|0|||
146619886|NCT02365649|528780159|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
146619887|NCT02365649|528780160|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
146619888|NCT02365649|528780151|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
146619889|NCT02365649|528780152|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
146619890|NCT02365649|528780153|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
146619891|NCT02365649|528780154|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
146619892|NCT02365649|528780155|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
146619893|NCT02365649|528780156|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
146619894|NCT02365649|528780157|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
146619895|NCT02365649|528780158|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
146619896|NCT02365649|528780159|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
146619897|NCT02365649|528780160|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
146619898|NCT02365649|528780151|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
146619899|NCT02365649|528780152|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
146619900|NCT02365649|528780153|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
146619901|NCT02365649|528780154|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
146619902|NCT02365649|528780155|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
146619903|NCT02365649|528780156|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
146619904|NCT02365649|528780157|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
146619905|NCT02365649|528780158|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
146619906|NCT02365649|528780159|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
146619907|NCT02365649|528780160|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
146619908|NCT02021565|528780172|FG000|Baseline Through Intervention|Death|0|||
146619909|NCT02021565|528780173|FG001|Baseline Through Intervention|Death|1|||
146619910|NCT02021565|528780172|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
146619911|NCT02021565|528780173|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
146619912|NCT02021565|528780172|FG000|Baseline Through Intervention|Protocol Violation|0|||
146619913|NCT02021565|528780173|FG001|Baseline Through Intervention|Protocol Violation|7|||
146619914|NCT02021565|528780172|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
146619915|NCT02021565|528780173|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
146619916|NCT02021565|528780172|FG000|3-month Follow-up|Death|3|||
146619917|NCT02021565|528780173|FG001|3-month Follow-up|Death|0|||
146619918|NCT02021565|528780172|FG000|3-month Follow-up|Withdrawal by Subject|4|||
146619919|NCT02021565|528780173|FG001|3-month Follow-up|Withdrawal by Subject|0|||
146619920|NCT02021565|528780172|FG000|3-month Follow-up|Protocol Violation|3|||
146619921|NCT02021565|528780173|FG001|3-month Follow-up|Protocol Violation|2|||
146619922|NCT01188772|528780174|FG000|Overall Study|Randomized but Not Treated|0|||
146619923|NCT01188772|528780175|FG001|Overall Study|Randomized but Not Treated|1|||
146619924|NCT01188772|528780176|FG002|Overall Study|Randomized but Not Treated|0|||
146619925|NCT01188772|528780177|FG003|Overall Study|Randomized but Not Treated|0|||
146619926|NCT01188772|528780174|FG000|Overall Study|Adverse Event|0|||
146619927|NCT01188772|528780175|FG001|Overall Study|Adverse Event|1|||
146619928|NCT01188772|528780176|FG002|Overall Study|Adverse Event|2|||
146619929|NCT01188772|528780177|FG003|Overall Study|Adverse Event|0|||
146619930|NCT01188772|528780174|FG000|Overall Study|Lost to Follow-up|4|||
146619931|NCT01188772|528780175|FG001|Overall Study|Lost to Follow-up|1|||
146619932|NCT01188772|528780176|FG002|Overall Study|Lost to Follow-up|1|||
146619933|NCT01188772|528780177|FG003|Overall Study|Lost to Follow-up|1|||
146619934|NCT01188772|528780174|FG000|Overall Study|Non-responder|0|||
146619935|NCT01188772|528780175|FG001|Overall Study|Non-responder|0|||
146619936|NCT01188772|528780176|FG002|Overall Study|Non-responder|3|||
146619937|NCT01188772|528780177|FG003|Overall Study|Non-responder|0|||
146619938|NCT01188772|528780174|FG000|Overall Study|Physician Decision|0|||
146619939|NCT01188772|528780175|FG001|Overall Study|Physician Decision|0|||
146619940|NCT01188772|528780176|FG002|Overall Study|Physician Decision|1|||
146619941|NCT01188772|528780177|FG003|Overall Study|Physician Decision|0|||
146619942|NCT01188772|528780174|FG000|Overall Study|Terminated by Sponsor|0|||
146619943|NCT01188772|528780175|FG001|Overall Study|Terminated by Sponsor|0|||
146619944|NCT01188772|528780176|FG002|Overall Study|Terminated by Sponsor|1|||
146619945|NCT01188772|528780177|FG003|Overall Study|Terminated by Sponsor|0|||
146619946|NCT01188772|528780174|FG000|Overall Study|Treatment Failure|0|||
146619947|NCT01188772|528780175|FG001|Overall Study|Treatment Failure|0|||
146619948|NCT01188772|528780176|FG002|Overall Study|Treatment Failure|1|||
146619949|NCT01188772|528780177|FG003|Overall Study|Treatment Failure|0|||
146619950|NCT01188772|528780174|FG000|Overall Study|Virologic Failure|1|||
146619951|NCT01188772|528780175|FG001|Overall Study|Virologic Failure|0|||
146619952|NCT01188772|528780176|FG002|Overall Study|Virologic Failure|0|||
146619953|NCT01188772|528780177|FG003|Overall Study|Virologic Failure|0|||
146619954|NCT01188772|528780174|FG000|Overall Study|Withdrawal by Subject|0|||
146619955|NCT01188772|528780175|FG001|Overall Study|Withdrawal by Subject|0|||
146619956|NCT01188772|528780176|FG002|Overall Study|Withdrawal by Subject|2|||
146981768|NCT01909466|530096121|FG000|Overall Study|Withdrawal by Subject|11|||
146730138|NCT01106430|529182467|FG001|Overall Study|Previous Use Of Marijuana|0|||
146730139|NCT01106430|529182466|FG000|Overall Study|Protocol Violation|7|||
146730140|NCT01106430|529182467|FG001|Overall Study|Protocol Violation|2|||
146730141|NCT01106430|529182466|FG000|Overall Study|Withdrawal by Subject|8|||
146730142|NCT01106430|529182467|FG001|Overall Study|Withdrawal by Subject|4|||
146730143|NCT00662857|529182470|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
146730144|NCT00662857|529182471|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
146730145|NCT00662857|529182470|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
146730146|NCT00662857|529182471|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
146730147|NCT00662857|529182470|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
146730148|NCT00662857|529182471|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
146730149|NCT00989092|529182472|FG000|Overall Study|Physician Decision|9|||
146730150|NCT00989092|529182473|FG001|Overall Study|Physician Decision|6|||
146730151|NCT00989092|529182472|FG000|Overall Study|Adverse Event|20|||
146730152|NCT00989092|529182473|FG001|Overall Study|Adverse Event|1|||
146730153|NCT00989092|529182472|FG000|Overall Study|Chemotherapy initiated|12|||
146730154|NCT00989092|529182473|FG001|Overall Study|Chemotherapy initiated|4|||
146730155|NCT00989092|529182472|FG000|Overall Study|Withdrawal by Subject|17|||
146730156|NCT00989092|529182473|FG001|Overall Study|Withdrawal by Subject|9|||
146730157|NCT00989092|529182472|FG000|Overall Study|Death|14|||
146730158|NCT00989092|529182473|FG001|Overall Study|Death|2|||
146730159|NCT00989092|529182472|FG000|Overall Study|Ineligibility determined|3|||
146730160|NCT00989092|529182473|FG001|Overall Study|Ineligibility determined|3|||
146730161|NCT00989092|529182472|FG000|Overall Study|Lost to Follow-up|6|||
146730162|NCT00989092|529182473|FG001|Overall Study|Lost to Follow-up|2|||
146730163|NCT00989092|529182472|FG000|Overall Study|Other|3|||
146730164|NCT00989092|529182473|FG001|Overall Study|Other|1|||
146730165|NCT00989092|529182472|FG000|Overall Study|Protocol deviation|2|||
146730166|NCT00989092|529182473|FG001|Overall Study|Protocol deviation|0|||
146730167|NCT00989092|529182472|FG000|Overall Study|Erythropoietin therapy initiated|2|||
146730168|NCT00989092|529182473|FG001|Overall Study|Erythropoietin therapy initiated|0|||
146730169|NCT00989092|529182472|FG000|Overall Study|Did not receive study drug|2|||
146730170|NCT00989092|529182473|FG001|Overall Study|Did not receive study drug|0|||
146730171|NCT02832622|529182475|FG000|Overall Study|MPP not programmed|1259|||
146730172|NCT02832622|529182475|FG000|Overall Study|Withdrawal by Subject|123|||
146730173|NCT02832622|529182475|FG000|Overall Study|Death|119|||
146730174|NCT02832622|529182475|FG000|Overall Study|Unsuccessful CRT implant|93|||
146730175|NCT02832622|529182475|FG000|Overall Study|Lost to Follow-up|45|||
146730176|NCT02832622|529182475|FG000|Overall Study|Patient non-compliance|42|||
146730177|NCT02832622|529182475|FG000|Overall Study|Withdrawal by other reasons|25|||
146730178|NCT02832622|529182475|FG000|Overall Study|System explant|24|||
146730179|NCT02832622|529182475|FG000|Overall Study|Physician Decision|6|||
146730180|NCT02173548|529182476|FG000|Overall Study|Lost to Follow-up|0|||
146730181|NCT02173548|529182477|FG001|Overall Study|Lost to Follow-up|2|||
146730182|NCT02173548|529182476|FG000|Overall Study|Withdrawal by Subject|1|||
146730183|NCT02173548|529182477|FG001|Overall Study|Withdrawal by Subject|0|||
146730184|NCT03822117|529182480|FG000|Overall Study|Death|18|||
146730185|NCT03822117|529182481|FG001|Overall Study|Death|17|||
146730186|NCT03822117|529182482|FG002|Overall Study|Death|12|||
146730187|NCT03822117|529182483|FG003|Overall Study|Death|4|||
146730188|NCT03822117|529182480|FG000|Overall Study|Lost to Follow-up|1|||
146730189|NCT03822117|529182481|FG001|Overall Study|Lost to Follow-up|2|||
146730190|NCT03822117|529182482|FG002|Overall Study|Lost to Follow-up|3|||
146730191|NCT03822117|529182483|FG003|Overall Study|Lost to Follow-up|0|||
146730192|NCT03822117|529182480|FG000|Overall Study|Study Terminated by Sponsor|25|||
146730193|NCT03822117|529182481|FG001|Overall Study|Study Terminated by Sponsor|11|||
146730194|NCT03822117|529182482|FG002|Overall Study|Study Terminated by Sponsor|6|||
146730195|NCT03822117|529182483|FG003|Overall Study|Study Terminated by Sponsor|0|||
146730196|NCT03822117|529182480|FG000|Overall Study|Withdrawal by Subject|4|||
146730197|NCT03822117|529182481|FG001|Overall Study|Withdrawal by Subject|0|||
146730198|NCT03822117|529182482|FG002|Overall Study|Withdrawal by Subject|3|||
146730199|NCT03822117|529182483|FG003|Overall Study|Withdrawal by Subject|0|||
146730200|NCT03822117|529182480|FG000|Overall Study|Disease Progression|1|||
146730201|NCT03822117|529182481|FG001|Overall Study|Disease Progression|2|||
146730202|NCT03822117|529182482|FG002|Overall Study|Disease Progression|1|||
146730203|NCT03822117|529182483|FG003|Overall Study|Disease Progression|0|||
146730204|NCT03822117|529182480|FG000|Overall Study|Never Returned to Hospital|0|||
146730205|NCT03822117|529182481|FG001|Overall Study|Never Returned to Hospital|0|||
146730206|NCT03822117|529182482|FG002|Overall Study|Never Returned to Hospital|1|||
146730207|NCT03822117|529182483|FG003|Overall Study|Never Returned to Hospital|0|||
146730208|NCT00594854|529182494|FG000|Overall Study|Study terminated|7|||
146730209|NCT00594854|529182495|FG001|Overall Study|Study terminated|10|||
146730210|NCT03292146|529182496|FG000|Baseline to 12 months|Relocation|1|||
146730211|NCT03292146|529182497|FG001|Baseline to 12 months|Relocation|0|||
146730212|NCT03292146|529182496|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
146730213|NCT03292146|529182497|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
146730214|NCT03292146|529182496|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
146619957|NCT01188772|528780177|FG003|Overall Study|Withdrawal by Subject|0|||
146619958|NCT03259555|528780188|FG000|Overall Study|Adverse Event|6|||
146619959|NCT03259555|528780189|FG001|Overall Study|Adverse Event|4|||
146619960|NCT03259555|528780188|FG000|Overall Study|Lack of Efficacy|6|||
146619961|NCT03259555|528780189|FG001|Overall Study|Lack of Efficacy|4|||
146619962|NCT03259555|528780188|FG000|Overall Study|Lost to Follow-up|0|||
146619963|NCT03259555|528780189|FG001|Overall Study|Lost to Follow-up|2|||
146619964|NCT03259555|528780188|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146619965|NCT03259555|528780189|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146619966|NCT03259555|528780188|FG000|Overall Study|Progressive Disease|0|||
146619967|NCT03259555|528780189|FG001|Overall Study|Progressive Disease|2|||
146619968|NCT03259555|528780188|FG000|Overall Study|Withdrawal by Subject|19|||
146619969|NCT03259555|528780189|FG001|Overall Study|Withdrawal by Subject|16|||
146619970|NCT03259555|528780188|FG000|Overall Study|Physician Decision|1|||
146619971|NCT03259555|528780189|FG001|Overall Study|Physician Decision|2|||
146619972|NCT03259555|528780188|FG000|Overall Study|Other|1|||
146619973|NCT03259555|528780189|FG001|Overall Study|Other|0|||
146619974|NCT00154297|528780191|FG000|Overall Study|Death|5|||
146619975|NCT00154297|528780192|FG001|Overall Study|Death|2|||
146619976|NCT00154297|528780191|FG000|Overall Study|Withdrawal by Subject|0|||
146619977|NCT00154297|528780192|FG001|Overall Study|Withdrawal by Subject|5|||
146619978|NCT00154297|528780191|FG000|Overall Study|Lost to Follow-up|3|||
146619979|NCT00154297|528780192|FG001|Overall Study|Lost to Follow-up|0|||
146619980|NCT00650767|528780193|FG000|Overall Study|Adverse Event|0|||
146619981|NCT00650767|528780194|FG001|Overall Study|Adverse Event|3|||
146619982|NCT00650767|528780195|FG002|Overall Study|Adverse Event|10|||
146619983|NCT00650767|528780196|FG003|Overall Study|Adverse Event|8|||
146619984|NCT00650767|528780193|FG000|Overall Study|Death|1|||
146619985|NCT00650767|528780194|FG001|Overall Study|Death|0|||
146619986|NCT00650767|528780195|FG002|Overall Study|Death|0|||
146619987|NCT00650767|528780196|FG003|Overall Study|Death|0|||
146619988|NCT00650767|528780193|FG000|Overall Study|Withdrawal by Subject|2|||
146619989|NCT00650767|528780194|FG001|Overall Study|Withdrawal by Subject|4|||
146619990|NCT00650767|528780195|FG002|Overall Study|Withdrawal by Subject|3|||
146619991|NCT00650767|528780196|FG003|Overall Study|Withdrawal by Subject|3|||
146619992|NCT00650767|528780193|FG000|Overall Study|Lost to Follow-up|1|||
146619993|NCT00650767|528780194|FG001|Overall Study|Lost to Follow-up|1|||
146619994|NCT00650767|528780195|FG002|Overall Study|Lost to Follow-up|1|||
146619995|NCT00650767|528780196|FG003|Overall Study|Lost to Follow-up|0|||
146619996|NCT00650767|528780193|FG000|Overall Study|Other|1|||
146619997|NCT00650767|528780194|FG001|Overall Study|Other|1|||
146619998|NCT00650767|528780195|FG002|Overall Study|Other|0|||
146619999|NCT00650767|528780196|FG003|Overall Study|Other|0|||
146936992|NCT02715804|529928251|FG001|Overall Study|Withdrawal by Subject|4|||
146936993|NCT02715804|529928250|FG000|Overall Study|Other than specified|2|||
146936994|NCT02715804|529928251|FG001|Overall Study|Other than specified|3|||
146620000|NCT01774799|528780197|FG000|Overall Study|Lost to Follow-up|1|||
146620001|NCT01774799|528780198|FG001|Overall Study|Lost to Follow-up|1|||
146620002|NCT01774799|528780199|FG002|Overall Study|Lost to Follow-up|0|||
146620003|NCT01774799|528780200|FG003|Overall Study|Lost to Follow-up|0|||
146620004|NCT02910466|528780201|FG000|Overall Study|Adverse Event|1|||
146620005|NCT02910466|528780201|FG000|Overall Study|Withdrawal by Subject|3|||
146620006|NCT02910466|528780201|FG000|Overall Study|Lost to Follow-up|5|||
146620007|NCT02910466|528780201|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
146620008|NCT02910466|528780201|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
146620009|NCT01125800|528780202|FG000|Phase I|Protocol Violation|0|||
146620010|NCT01125800|528780203|FG001|Phase I|Protocol Violation|3|||
146620011|NCT01125800|528780204|FG002|Phase I|Protocol Violation|1|||
146620012|NCT01125800|528780205|FG003|Phase I|Protocol Violation|1|||
146620013|NCT01125800|528780206|FG004|Phase I|Protocol Violation|0|||
146620014|NCT01125800|528780202|FG000|Phase I|Adverse Event|2|||
146936995|NCT04209530|529928254|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
146936996|NCT04209530|529928255|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
146936997|NCT04209530|529928254|FG000|Overall Study|Withdrawal by Subject|0|||
146620015|NCT01125800|528780203|FG001|Phase I|Adverse Event|2|||
146620016|NCT01125800|528780204|FG002|Phase I|Adverse Event|1|||
146620017|NCT01125800|528780205|FG003|Phase I|Adverse Event|7|||
146620018|NCT01125800|528780206|FG004|Phase I|Adverse Event|0|||
146620019|NCT01125800|528780202|FG000|Phase I|Administrative problems|1|||
146620020|NCT01125800|528780203|FG001|Phase I|Administrative problems|0|||
146620021|NCT01125800|528780204|FG002|Phase I|Administrative problems|0|||
146620022|NCT01125800|528780205|FG003|Phase I|Administrative problems|0|||
146620023|NCT01125800|528780206|FG004|Phase I|Administrative problems|0|||
146620024|NCT01125800|528780202|FG000|Phase I|Withdrawal by Subject|0|||
146620025|NCT01125800|528780203|FG001|Phase I|Withdrawal by Subject|0|||
146620026|NCT01125800|528780204|FG002|Phase I|Withdrawal by Subject|1|||
146620027|NCT01125800|528780205|FG003|Phase I|Withdrawal by Subject|0|||
146620028|NCT01125800|528780206|FG004|Phase I|Withdrawal by Subject|0|||
146620029|NCT01125800|528780202|FG000|Phase I|Disease progression|5|||
146981769|NCT01909466|530096122|FG001|Overall Study|Withdrawal by Subject|9|||
146981770|NCT01909466|530096121|FG000|Overall Study|Lack of Efficacy|1|||
146981771|NCT01909466|530096122|FG001|Overall Study|Lack of Efficacy|0|||
146981772|NCT00673361|530096126|FG000|Overall Study|Screen Failure|2|||
146981773|NCT03038113|530096131|FG000|Overall Study|Withdrawal by Subject|0|||
146981774|NCT03038113|530096132|FG001|Overall Study|Withdrawal by Subject|0|||
146981775|NCT03038113|530096133|FG002|Overall Study|Withdrawal by Subject|1|||
146981776|NCT03038113|530096134|FG003|Overall Study|Withdrawal by Subject|0|||
146981777|NCT03038113|530096135|FG004|Overall Study|Withdrawal by Subject|0|||
146981778|NCT03038113|530096136|FG005|Overall Study|Withdrawal by Subject|0|||
146981779|NCT03038113|530096137|FG006|Overall Study|Withdrawal by Subject|0|||
146981780|NCT03038113|530096138|FG007|Overall Study|Withdrawal by Subject|0|||
146981781|NCT03038113|530096139|FG008|Overall Study|Withdrawal by Subject|0|||
146981782|NCT03038113|530096140|FG009|Overall Study|Withdrawal by Subject|0|||
146981783|NCT03038113|530096141|FG010|Overall Study|Withdrawal by Subject|0|||
146981784|NCT03038113|530096142|FG011|Overall Study|Withdrawal by Subject|0|||
146981785|NCT03038113|530096143|FG012|Overall Study|Withdrawal by Subject|0|||
146936998|NCT04209530|529928255|FG001|Overall Study|Withdrawal by Subject|1|||
146936999|NCT03276572|529928256|FG000|Overall Study|In follow-up|0|||
146937000|NCT03276572|529928257|FG001|Overall Study|In follow-up|0|||
146937001|NCT03276572|529928258|FG002|Overall Study|In follow-up|0|||
146937002|NCT03276572|529928259|FG003|Overall Study|In follow-up|0|||
146937003|NCT03276572|529928260|FG004|Overall Study|In follow-up|0|||
146937004|NCT03276572|529928261|FG005|Overall Study|In follow-up|1|||
146937005|NCT03276572|529928262|FG006|Overall Study|In follow-up|1|||
146937006|NCT03276572|529928256|FG000|Overall Study|Lost to Follow-up|0|||
146937007|NCT03276572|529928257|FG001|Overall Study|Lost to Follow-up|0|||
146937008|NCT03276572|529928258|FG002|Overall Study|Lost to Follow-up|0|||
146937009|NCT03276572|529928259|FG003|Overall Study|Lost to Follow-up|0|||
146937010|NCT03276572|529928260|FG004|Overall Study|Lost to Follow-up|0|||
146937011|NCT03276572|529928261|FG005|Overall Study|Lost to Follow-up|0|||
146937012|NCT03276572|529928262|FG006|Overall Study|Lost to Follow-up|1|||
146937013|NCT00607919|529928275|FG000|Acute Phase|Adverse Event|9|||
146937014|NCT00607919|529928276|FG001|Acute Phase|Adverse Event|2|||
146937015|NCT00607919|529928275|FG000|Acute Phase|Entry Criteria Not Met|1|||
146937016|NCT00607919|529928276|FG001|Acute Phase|Entry Criteria Not Met|1|||
146937017|NCT00607919|529928275|FG000|Acute Phase|Lack of Efficacy|1|||
146620030|NCT01125800|528780203|FG001|Phase I|Disease progression|4|||
146620031|NCT01125800|528780204|FG002|Phase I|Disease progression|1|||
146620032|NCT01125800|528780205|FG003|Phase I|Disease progression|3|||
146620033|NCT01125800|528780206|FG004|Phase I|Disease progression|0|||
146620034|NCT01125800|528780202|FG000|Phase II|Protocol Violation|0|||
146620035|NCT01125800|528780203|FG001|Phase II|Protocol Violation|0|||
146620036|NCT01125800|528780204|FG002|Phase II|Protocol Violation|0|||
146620037|NCT01125800|528780205|FG003|Phase II|Protocol Violation|0|||
146620038|NCT01125800|528780206|FG004|Phase II|Protocol Violation|1|||
146620039|NCT01125800|528780202|FG000|Phase II|Adverse Event|0|||
146620040|NCT01125800|528780203|FG001|Phase II|Adverse Event|0|||
146620041|NCT01125800|528780204|FG002|Phase II|Adverse Event|0|||
146620042|NCT01125800|528780205|FG003|Phase II|Adverse Event|0|||
146937018|NCT00607919|529928276|FG001|Acute Phase|Lack of Efficacy|2|||
146937019|NCT00607919|529928275|FG000|Acute Phase|Lost to Follow-up|9|||
146937020|NCT00607919|529928276|FG001|Acute Phase|Lost to Follow-up|3|||
146937021|NCT00607919|529928275|FG000|Acute Phase|Parent/Caregiver Decision|6|||
146937022|NCT00607919|529928276|FG001|Acute Phase|Parent/Caregiver Decision|4|||
146937023|NCT00607919|529928275|FG000|Acute Phase|Protocol Violation|5|||
146937024|NCT00607919|529928276|FG001|Acute Phase|Protocol Violation|1|||
146937025|NCT00607919|529928275|FG000|Acute Phase|Withdrawal by Subject|3|||
146937026|NCT00607919|529928276|FG001|Acute Phase|Withdrawal by Subject|3|||
146981786|NCT03038113|530096144|FG013|Overall Study|Withdrawal by Subject|1|||
146981787|NCT03038113|530096131|FG000|Overall Study|Lost to Follow-up|0|||
146981788|NCT03038113|530096132|FG001|Overall Study|Lost to Follow-up|0|||
146937027|NCT00607919|529928275|FG000|Open-Label Phase|Adverse Event|1|||
146620043|NCT01125800|528780206|FG004|Phase II|Adverse Event|2|||
146620044|NCT01125800|528780202|FG000|Phase II|Disease progression|0|||
146620045|NCT01125800|528780203|FG001|Phase II|Disease progression|0|||
146620046|NCT01125800|528780204|FG002|Phase II|Disease progression|0|||
146620047|NCT01125800|528780205|FG003|Phase II|Disease progression|1|||
146620048|NCT01125800|528780206|FG004|Phase II|Disease progression|8|||
146937028|NCT00607919|529928276|FG001|Open-Label Phase|Adverse Event|5|||
146937029|NCT00607919|529928275|FG000|Open-Label Phase|Lost to Follow-up|4|||
146937030|NCT00607919|529928276|FG001|Open-Label Phase|Lost to Follow-up|1|||
146937031|NCT00607919|529928275|FG000|Open-Label Phase|Protocol Violation|2|||
146937032|NCT00607919|529928276|FG001|Open-Label Phase|Protocol Violation|2|||
146937033|NCT00607919|529928275|FG000|Open-Label Phase|Withdrawal by Subject|2|||
146937034|NCT00607919|529928276|FG001|Open-Label Phase|Withdrawal by Subject|2|||
146981789|NCT03038113|530096133|FG002|Overall Study|Lost to Follow-up|0|||
146981790|NCT03038113|530096134|FG003|Overall Study|Lost to Follow-up|0|||
146981791|NCT03038113|530096135|FG004|Overall Study|Lost to Follow-up|0|||
146981792|NCT03038113|530096136|FG005|Overall Study|Lost to Follow-up|0|||
146937035|NCT00607919|529928275|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
146937036|NCT00607919|529928276|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
146937037|NCT01527110|529928277|FG000|Overall Study|Adverse Event|1|||
146937038|NCT01709708|529928278|FG000|Overall Study|Protocol Violation|1|||
146937039|NCT01709708|529928279|FG001|Overall Study|Protocol Violation|2|||
146937040|NCT00527072|529928282|FG000|Overall Study|Adverse Event|13|||
146620049|NCT03061201|528780207|FG000|Overall Study|Participants Terminated at Month 36|0|||
146620050|NCT03061201|528780208|FG001|Overall Study|Participants Terminated at Month 36|1|||
146620051|NCT03061201|528780209|FG002|Overall Study|Participants Terminated at Month 36|0|||
146620052|NCT03061201|528780210|FG003|Overall Study|Participants Terminated at Month 36|1|||
146620053|NCT03061201|528780207|FG000|Overall Study|Lost to Follow-up|1|||
146620054|NCT03061201|528780208|FG001|Overall Study|Lost to Follow-up|0|||
146620055|NCT03061201|528780209|FG002|Overall Study|Lost to Follow-up|0|||
146620056|NCT03061201|528780210|FG003|Overall Study|Lost to Follow-up|0|||
146620057|NCT04037891|528780211|FG000|Open-label Period|Withdrawal by Subject|1|||
146620058|NCT04037891|528780212|FG001|Open-label Period|Withdrawal by Subject|0|||
146620059|NCT04037891|528780213|FG002|Open-label Period|Withdrawal by Subject|0|||
146620060|NCT04037891|528780211|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
146620061|NCT04037891|528780212|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
146620062|NCT04037891|528780213|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
146620063|NCT03446313|528780215|FG000|Overall Study|Lost to Follow-up|1|||
146620064|NCT03446313|528780216|FG001|Overall Study|Lost to Follow-up|2|||
146620065|NCT03446313|528780215|FG000|Overall Study|Failed primary screening|3|||
146620066|NCT03446313|528780216|FG001|Overall Study|Failed primary screening|0|||
146620067|NCT03446313|528780215|FG000|Overall Study|Diagnosed with terminal cancer|1|||
146620068|NCT03446313|528780216|FG001|Overall Study|Diagnosed with terminal cancer|0|||
146620069|NCT03446313|528780215|FG000|Overall Study|Excluded from analysis|1|||
146620070|NCT03446313|528780216|FG001|Overall Study|Excluded from analysis|1|||
146620071|NCT04491136|528780222|FG000|Overall Study|Patient withdraw informed consent|9|||
146620072|NCT04491136|528780222|FG000|Overall Study|Adverse Event|2|||
146620073|NCT04491136|528780222|FG000|Overall Study|Death|3|||
146620074|NCT04491136|528780222|FG000|Overall Study|Lost to Follow-up|3|||
146620075|NCT04491136|528780222|FG000|Overall Study|Physician Decision|45|||
146620076|NCT04491136|528780222|FG000|Overall Study|sponsor terminated the study early|16|||
146620077|NCT04491136|528780222|FG000|Overall Study|Patient/guardian's decision|1|||
146620078|NCT01505374|528780224|FG000|Overall Study|Lost to Follow-up|1|||
146620079|NCT01505374|528780225|FG001|Overall Study|Lost to Follow-up|0|||
146620080|NCT02360228|528780226|FG000|Overall Study|Withdrawal by Subject|1|||
146620081|NCT02360228|528780227|FG001|Overall Study|Withdrawal by Subject|0|||
146620082|NCT02360228|528780228|FG002|Overall Study|Withdrawal by Subject|0|||
146620083|NCT02360228|528780226|FG000|Overall Study|Self-discontinued medication|0|||
146620084|NCT02360228|528780227|FG001|Overall Study|Self-discontinued medication|1|||
146620085|NCT02360228|528780228|FG002|Overall Study|Self-discontinued medication|0|||
146620086|NCT02360228|528780226|FG000|Overall Study|Unstable symptoms during screening|0|||
146620087|NCT02360228|528780227|FG001|Overall Study|Unstable symptoms during screening|0|||
146620088|NCT02360228|528780228|FG002|Overall Study|Unstable symptoms during screening|1|||
146620089|NCT02464410|528780231|FG000|Overall Study|Death|3|||
146620090|NCT02464410|528780232|FG001|Overall Study|Death|4|||
146620091|NCT02464410|528780231|FG000|Overall Study|Lost to Follow-up|7|||
146620092|NCT02464410|528780232|FG001|Overall Study|Lost to Follow-up|9|||
146620093|NCT02464410|528780231|FG000|Overall Study|Withdrawal by Subject|12|||
146620094|NCT02464410|528780232|FG001|Overall Study|Withdrawal by Subject|3|||
146620095|NCT00851786|528780233|FG000|Overall Study|Withdrawal by Subject|0|||
146620096|NCT00851786|528780234|FG001|Overall Study|Withdrawal by Subject|1|||
146620097|NCT00851786|528780233|FG000|Overall Study|Protocol Violation|0|||
146620098|NCT00851786|528780234|FG001|Overall Study|Protocol Violation|1|||
146620099|NCT00851786|528780233|FG000|Overall Study|Lost to Follow-up|1|||
146620100|NCT00851786|528780234|FG001|Overall Study|Lost to Follow-up|0|||
146937041|NCT00527072|529928282|FG000|Overall Study|Lack of Efficacy|11|||
146937042|NCT00527072|529928282|FG000|Overall Study|Lost to Follow-up|3|||
146620101|NCT00851786|528780233|FG000|Overall Study|Incarceration|1|||
146620102|NCT00851786|528780234|FG001|Overall Study|Incarceration|0|||
146620103|NCT00851786|528780233|FG000|Overall Study|Site Closure|1|||
146620104|NCT00851786|528780234|FG001|Overall Study|Site Closure|0|||
146620105|NCT00851786|528780233|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
146620106|NCT00851786|528780234|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
146620107|NCT02831764|528781649|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
146620108|NCT02831764|528781650|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
146620109|NCT02831764|528781651|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
146620110|NCT02831764|528781652|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
146620111|NCT02831764|528781653|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
146620112|NCT02831764|528781649|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
146937043|NCT00527072|529928282|FG000|Overall Study|Protocol Violation|2|||
146937044|NCT00527072|529928282|FG000|Overall Study|Withdrawal by Subject|7|||
146937045|NCT02007252|529928283|FG000|Overall Study|Administrative problems|3|||
146937046|NCT02007252|529928284|FG001|Overall Study|Administrative problems|7|||
146937047|NCT02007252|529928283|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146937048|NCT02007252|529928284|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146937049|NCT02007252|529928283|FG000|Overall Study|Adverse Event|7|||
146937050|NCT02007252|529928284|FG001|Overall Study|Adverse Event|4|||
146937051|NCT02657434|529928285|FG000|Overall Study|Study Terminated By Sponsor|64|||
146937052|NCT02657434|529928286|FG001|Overall Study|Study Terminated By Sponsor|82|||
146937053|NCT02657434|529928285|FG000|Overall Study|Death|189|||
146937054|NCT02657434|529928286|FG001|Overall Study|Death|190|||
146937055|NCT02657434|529928285|FG000|Overall Study|Lost to Follow-up|2|||
146937056|NCT02657434|529928286|FG001|Overall Study|Lost to Follow-up|2|||
146937057|NCT02657434|529928285|FG000|Overall Study|Randomization by Error|2|||
146937058|NCT02657434|529928286|FG001|Overall Study|Randomization by Error|0|||
146937059|NCT02657434|529928285|FG000|Overall Study|Withdrawal by Subject|28|||
146937060|NCT02657434|529928286|FG001|Overall Study|Withdrawal by Subject|17|||
146937061|NCT02657434|529928285|FG000|Overall Study|Protocol Violation|1|||
146937062|NCT02657434|529928286|FG001|Overall Study|Protocol Violation|0|||
146937063|NCT02657434|529928285|FG000|Overall Study|Physician Decision|0|||
146937064|NCT02657434|529928286|FG001|Overall Study|Physician Decision|1|||
146937065|NCT00608881|529928287|FG000|Overall Study|Death|22|||
146620113|NCT02831764|528781650|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
146730215|NCT03292146|529182497|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
146730216|NCT03292146|529182496|FG000|12 months to 24 months|Planning pregnancy|2|||
146937066|NCT00608881|529928288|FG001|Overall Study|Death|13|||
146620114|NCT02831764|528781651|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
146620115|NCT02831764|528781652|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
146620116|NCT02831764|528781653|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
146620117|NCT02831764|528781649|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
146620118|NCT02831764|528781650|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
146620119|NCT02831764|528781651|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
146620120|NCT02831764|528781652|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
146620121|NCT02831764|528781653|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
146620122|NCT02831764|528781649|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
146620123|NCT02831764|528781650|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
146620124|NCT02831764|528781651|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
146620125|NCT02831764|528781652|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
146620126|NCT02831764|528781653|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
146620127|NCT02831764|528781649|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
146620128|NCT02831764|528781650|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
146620129|NCT02831764|528781651|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
146620130|NCT02831764|528781652|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
146620131|NCT02831764|528781653|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
146620132|NCT02831764|528781649|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
146620133|NCT02831764|528781650|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
146620134|NCT02831764|528781651|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
146620135|NCT02831764|528781652|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
146620136|NCT02831764|528781653|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
146620137|NCT02831764|528781649|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
146620138|NCT02831764|528781650|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
146620139|NCT02831764|528781651|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
146620140|NCT02831764|528781652|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
146620141|NCT02831764|528781653|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
146620142|NCT02831764|528781649|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
146620143|NCT02831764|528781650|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
146620144|NCT02831764|528781651|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
146620145|NCT02831764|528781652|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
146620146|NCT02831764|528781653|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
146620147|NCT02831764|528781649|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
146620148|NCT02831764|528781650|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
146620149|NCT02831764|528781651|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
146620150|NCT02831764|528781652|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
146620151|NCT02831764|528781653|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
146620152|NCT02831764|528781649|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
146620153|NCT02831764|528781650|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
146620154|NCT02831764|528781651|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
146937067|NCT00608881|529928287|FG000|Overall Study|Adverse Event|5|||
146937068|NCT00608881|529928288|FG001|Overall Study|Adverse Event|3|||
146620155|NCT02831764|528781652|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
146620156|NCT02831764|528781653|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
146620157|NCT02831764|528781649|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
146620158|NCT02831764|528781650|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
146620159|NCT02831764|528781651|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
146620160|NCT02831764|528781652|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
146620161|NCT02831764|528781653|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
146620162|NCT02831764|528781649|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
146620163|NCT02831764|528781650|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
146620164|NCT02831764|528781651|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
146620165|NCT02831764|528781652|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
146620166|NCT02831764|528781653|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
146620167|NCT02831764|528781649|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
146620168|NCT02831764|528781650|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
146620169|NCT02831764|528781651|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
146620170|NCT02831764|528781652|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
146620171|NCT02831764|528781653|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
146620172|NCT02831764|528781649|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
146620173|NCT02831764|528781650|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
146620174|NCT02831764|528781651|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
146620175|NCT02831764|528781652|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
146620176|NCT02831764|528781653|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
146620177|NCT02831764|528781649|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
146620178|NCT02831764|528781650|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
146620179|NCT02831764|528781651|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
146620180|NCT02831764|528781652|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
146620181|NCT02831764|528781653|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
146620182|NCT02831764|528781649|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
146620183|NCT02831764|528781650|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
146620184|NCT02831764|528781651|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
146620185|NCT02831764|528781652|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
146620186|NCT02831764|528781653|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
146620187|NCT02831764|528781649|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
146620188|NCT02831764|528781650|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
146620189|NCT02831764|528781651|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
146620190|NCT02831764|528781652|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
146620191|NCT02831764|528781653|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
146620192|NCT02831764|528781649|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
146620193|NCT02831764|528781650|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
146620194|NCT02831764|528781651|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
146620195|NCT02831764|528781652|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
146620196|NCT02831764|528781653|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
146620197|NCT02831764|528781649|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
146620198|NCT02831764|528781650|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
146620199|NCT02831764|528781651|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
146620200|NCT02831764|528781652|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
146620201|NCT02831764|528781653|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
146620202|NCT00865345|528781654|FG000|Overall Study|Withdrawal by Subject|2|||
146620203|NCT03737123|528781655|FG000|Study Treatment|Adverse Event|2|||
146620204|NCT03737123|528781656|FG001|Study Treatment|Adverse Event|0|||
146620205|NCT03737123|528781655|FG000|Study Treatment|Disease Progression|2|||
146620206|NCT03737123|528781656|FG001|Study Treatment|Disease Progression|0|||
146620207|NCT03737123|528781655|FG000|Study Treatment|Withdrawal by Subject|2|||
146620208|NCT03737123|528781656|FG001|Study Treatment|Withdrawal by Subject|0|||
146620209|NCT03737123|528781655|FG000|Follow up|Death|1|||
146620210|NCT03737123|528781656|FG001|Follow up|Death|0|||
146620211|NCT03737123|528781655|FG000|Follow up|Withdrawal by Subject|1|||
146620212|NCT03737123|528781656|FG001|Follow up|Withdrawal by Subject|0|||
146620213|NCT03737123|528781655|FG000|Follow up|Termination of study|4|||
146620214|NCT03737123|528781656|FG001|Follow up|Termination of study|0|||
146620215|NCT01519323|528781657|FG000|Overall Study|Death|3|||
146620216|NCT01519323|528781658|FG001|Overall Study|Death|2|||
146937069|NCT00608881|529928287|FG000|Overall Study|Lost to Follow-up|28|||
146937070|NCT00608881|529928288|FG001|Overall Study|Lost to Follow-up|14|||
146937071|NCT00608881|529928287|FG000|Overall Study|Withdrawal by Subject|18|||
146937072|NCT00608881|529928288|FG001|Overall Study|Withdrawal by Subject|29|||
146937073|NCT00608881|529928287|FG000|Overall Study|Physician Decision|5|||
146937074|NCT00608881|529928288|FG001|Overall Study|Physician Decision|5|||
146937075|NCT00608881|529928287|FG000|Overall Study|Institutionalized|1|||
146937076|NCT00608881|529928288|FG001|Overall Study|Institutionalized|2|||
146730217|NCT03292146|529182497|FG001|12 months to 24 months|Planning pregnancy|2|||
146730218|NCT03292146|529182496|FG000|12 months to 24 months|Personal reasons|1|||
146730219|NCT03292146|529182497|FG001|12 months to 24 months|Personal reasons|0|||
146730220|NCT03292146|529182496|FG000|12 months to 24 months|Lost to Follow-up|0|||
146730221|NCT03292146|529182497|FG001|12 months to 24 months|Lost to Follow-up|1|||
146730222|NCT03039023|529182498|FG000|Overall Study|Withdrawal by Subject|1|||
146730223|NCT03039023|529182499|FG001|Overall Study|Withdrawal by Subject|0|||
146730224|NCT03039023|529182500|FG002|Overall Study|Withdrawal by Subject|1|||
146730225|NCT03039023|529182501|FG003|Overall Study|Withdrawal by Subject|1|||
146730226|NCT03039023|529182502|FG004|Overall Study|Withdrawal by Subject|0|||
146730227|NCT03039023|529182498|FG000|Overall Study|Physician Decision|0|||
146730228|NCT03039023|529182499|FG001|Overall Study|Physician Decision|0|||
146730229|NCT03039023|529182500|FG002|Overall Study|Physician Decision|0|||
146730230|NCT03039023|529182501|FG003|Overall Study|Physician Decision|1|||
146730231|NCT03039023|529182502|FG004|Overall Study|Physician Decision|0|||
146730232|NCT03701399|529182505|FG000|Overall Study|Adverse Event|3|||
146730233|NCT03701399|529182506|FG001|Overall Study|Adverse Event|5|||
146730234|NCT03701399|529182505|FG000|Overall Study|Withdrawal by Subject|6|||
146730235|NCT03701399|529182506|FG001|Overall Study|Withdrawal by Subject|3|||
146730236|NCT03701399|529182505|FG000|Overall Study|Investigators decision|1|||
146730237|NCT03701399|529182506|FG001|Overall Study|Investigators decision|2|||
146730238|NCT03701399|529182505|FG000|Overall Study|Lost to Follow-up|1|||
146730239|NCT03701399|529182506|FG001|Overall Study|Lost to Follow-up|2|||
146730240|NCT03701399|529182505|FG000|Overall Study|Death|1|||
146730241|NCT03701399|529182506|FG001|Overall Study|Death|1|||
146730242|NCT03701399|529182505|FG000|Overall Study|Randomized but not treated|1|||
146730243|NCT03701399|529182506|FG001|Overall Study|Randomized but not treated|0|||
146730244|NCT00448448|529182507|FG000|Overall Study|Withdrawal by Subject|13|||
146730245|NCT00448448|529182508|FG001|Overall Study|Withdrawal by Subject|2|||
146730246|NCT00448448|529182507|FG000|Overall Study|On protocol when study ended|83|||
146730247|NCT00448448|529182508|FG001|Overall Study|On protocol when study ended|36|||
146730248|NCT00448448|529182507|FG000|Overall Study|Lost to Follow-up|2|||
146730249|NCT00448448|529182508|FG001|Overall Study|Lost to Follow-up|1|||
146730250|NCT00448448|529182507|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
146730251|NCT00448448|529182508|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
146730252|NCT00448448|529182507|FG000|Overall Study|Signed consent lost|0|||
146730253|NCT00448448|529182508|FG001|Overall Study|Signed consent lost|1|||
146730254|NCT04642898|529182509|FG000|Overall Study|Withdrawal by Subject|2|||
146730255|NCT04642898|529182510|FG001|Overall Study|Withdrawal by Subject|4|||
146730256|NCT04642898|529182511|FG002|Overall Study|Withdrawal by Subject|4|||
146730257|NCT04642898|529182512|FG003|Overall Study|Withdrawal by Subject|6|||
146730258|NCT04642898|529182513|FG004|Overall Study|Withdrawal by Subject|2|||
146730259|NCT04642898|529182514|FG005|Overall Study|Withdrawal by Subject|6|||
146730260|NCT04642898|529182509|FG000|Overall Study|Lost to Follow-up|0|||
146730261|NCT04642898|529182510|FG001|Overall Study|Lost to Follow-up|0|||
146730262|NCT04642898|529182511|FG002|Overall Study|Lost to Follow-up|0|||
146730263|NCT04642898|529182512|FG003|Overall Study|Lost to Follow-up|2|||
146730264|NCT04642898|529182513|FG004|Overall Study|Lost to Follow-up|0|||
146730265|NCT04642898|529182514|FG005|Overall Study|Lost to Follow-up|1|||
146730266|NCT04642898|529182509|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
146730267|NCT04642898|529182510|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
146730268|NCT04642898|529182511|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
146730269|NCT04642898|529182512|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
146730270|NCT04642898|529182513|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
146730271|NCT04642898|529182514|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
146730272|NCT04642898|529182509|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
146730273|NCT04642898|529182510|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
146730274|NCT04642898|529182511|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
146730275|NCT04642898|529182512|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
146730276|NCT04642898|529182513|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
146730277|NCT04642898|529182514|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
146730278|NCT04280562|529182515|FG000|Study|Adverse Event|2|||
146730279|NCT04280562|529182516|FG001|Study|Adverse Event|0|||
146730280|NCT04280562|529182515|FG000|Study|Lost to Follow-up|3|||
146730281|NCT04280562|529182516|FG001|Study|Lost to Follow-up|3|||
146730282|NCT02618967|529182520|FG000|Overall Study|Lost to Follow-up|0|||
146730283|NCT02618967|529182521|FG001|Overall Study|Lost to Follow-up|0|||
146730284|NCT02618967|529182522|FG002|Overall Study|Lost to Follow-up|1|||
146730285|NCT02618967|529182523|FG003|Overall Study|Lost to Follow-up|0|||
146730286|NCT02618967|529182524|FG004|Overall Study|Lost to Follow-up|2|||
146937077|NCT00511108|529928291|FG000|Overall Study|Adverse Event|2|||
146730287|NCT02618967|529182525|FG005|Overall Study|Lost to Follow-up|0|||
146730288|NCT02618967|529182526|FG006|Overall Study|Lost to Follow-up|0|||
146730289|NCT02618967|529182527|FG007|Overall Study|Lost to Follow-up|0|||
146730290|NCT02618967|529182520|FG000|Overall Study|Withdrawal by Subject|1|||
146730291|NCT02618967|529182521|FG001|Overall Study|Withdrawal by Subject|0|||
146730292|NCT02618967|529182522|FG002|Overall Study|Withdrawal by Subject|0|||
146730293|NCT02618967|529182523|FG003|Overall Study|Withdrawal by Subject|0|||
146730294|NCT02618967|529182524|FG004|Overall Study|Withdrawal by Subject|0|||
146730295|NCT02618967|529182525|FG005|Overall Study|Withdrawal by Subject|0|||
146730296|NCT02618967|529182526|FG006|Overall Study|Withdrawal by Subject|0|||
146730297|NCT02618967|529182527|FG007|Overall Study|Withdrawal by Subject|0|||
146730298|NCT01368965|529182528|FG000|Overall Study|Lost to Follow-up|12|||
146730299|NCT04559568|529182532|FG000|Overall Study|Physician Decision|0|||
146730300|NCT04559568|529182533|FG001|Overall Study|Physician Decision|0|||
146730301|NCT04559568|529182534|FG002|Overall Study|Physician Decision|0|||
146730302|NCT04559568|529182535|FG003|Overall Study|Physician Decision|0|||
146730303|NCT04559568|529182536|FG004|Overall Study|Physician Decision|0|||
146730304|NCT04559568|529182537|FG005|Overall Study|Physician Decision|0|||
146730305|NCT04559568|529182538|FG006|Overall Study|Physician Decision|0|||
146730306|NCT04559568|529182539|FG007|Overall Study|Physician Decision|0|||
146730307|NCT04559568|529182540|FG008|Overall Study|Physician Decision|0|||
146730308|NCT04559568|529182541|FG009|Overall Study|Physician Decision|1|||
146730309|NCT04559568|529182542|FG010|Overall Study|Physician Decision|0|||
146730310|NCT04559568|529182532|FG000|Overall Study|Withdrawal by Subject|0|||
146730311|NCT04559568|529182533|FG001|Overall Study|Withdrawal by Subject|0|||
146730312|NCT04559568|529182534|FG002|Overall Study|Withdrawal by Subject|0|||
146730313|NCT04559568|529182535|FG003|Overall Study|Withdrawal by Subject|0|||
146730314|NCT04559568|529182536|FG004|Overall Study|Withdrawal by Subject|0|||
146730315|NCT04559568|529182537|FG005|Overall Study|Withdrawal by Subject|0|||
146730316|NCT04559568|529182538|FG006|Overall Study|Withdrawal by Subject|0|||
146730317|NCT04559568|529182539|FG007|Overall Study|Withdrawal by Subject|0|||
146730318|NCT04559568|529182540|FG008|Overall Study|Withdrawal by Subject|0|||
146730319|NCT04559568|529182541|FG009|Overall Study|Withdrawal by Subject|0|||
146730320|NCT04559568|529182542|FG010|Overall Study|Withdrawal by Subject|1|||
146730321|NCT05608499|529182545|FG000|Overall Study|Lack of Efficacy|1|||
146730322|NCT05608499|529182546|FG001|Overall Study|Lack of Efficacy|0|||
146730323|NCT05608499|529182545|FG000|Overall Study|Lost to Follow-up|0|||
146730324|NCT05608499|529182546|FG001|Overall Study|Lost to Follow-up|1|||
146730325|NCT00514735|529182547|FG000|Overall Study|Withdrawal by Subject|13|||
146730326|NCT00514735|529182548|FG001|Overall Study|Withdrawal by Subject|5|||
146730327|NCT00514735|529182547|FG000|Overall Study|Death|1|||
146730328|NCT00514735|529182548|FG001|Overall Study|Death|0|||
146730329|NCT00514735|529182547|FG000|Overall Study|Lost to Follow-up|0|||
146730330|NCT00514735|529182548|FG001|Overall Study|Lost to Follow-up|1|||
146730331|NCT02660827|529182551|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
146730332|NCT02660827|529182551|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
146730333|NCT02660827|529182551|FG000|From Study to End of Continued Access|Adverse Event|3|||
146730334|NCT02660827|529182551|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
146730335|NCT02660827|529182551|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
146730336|NCT02660827|529182551|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
146730337|NCT02660827|529182551|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
146730338|NCT02660827|529182551|FG000|Period 2: Continued Access Period|Adverse Event|3|||
146730339|NCT01422408|529182552|FG000|Overall Study|Adverse Event|1|||
146730340|NCT01422408|529182552|FG000|Overall Study|Withdrawal by Subject|3|||
146730341|NCT04672941|529182553|FG000|Overall Study|Investigator decision|1|||
146730342|NCT04672941|529182553|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
146730343|NCT04672941|529182553|FG000|Overall Study|COVID-19 related but no adverse event|1|||
146730344|NCT04672941|529182553|FG000|Overall Study|Adverse Event|2|||
146730345|NCT04672941|529182553|FG000|Overall Study|Lost to Follow-up|2|||
146730346|NCT02953938|529182554|FG000|Overall Study|Adverse Event|0|||
146730347|NCT02953938|529182555|FG001|Overall Study|Adverse Event|1|||
146730348|NCT02953938|529182554|FG000|Overall Study|Withdrawal by Subject|1|||
146730349|NCT02953938|529182555|FG001|Overall Study|Withdrawal by Subject|1|||
146730350|NCT00045305|529182560|FG000|Overall Study|Lack of Efficacy|6|||
146730351|NCT00045305|529182560|FG000|Overall Study|Adverse Event|3|||
146730352|NCT00045305|529182560|FG000|Overall Study|Death|3|||
146730353|NCT00045305|529182560|FG000|Overall Study|site error|2|||
146730354|NCT04274894|529182561|FG000|Overall Study|Adverse Event|7|||
146730355|NCT04274894|529182561|FG000|Overall Study|Withdrew consent|5|||
146730356|NCT04274894|529182561|FG000|Overall Study|Lost to Follow-up|9|||
146730357|NCT04274894|529182561|FG000|Overall Study|COVID-19 infection|1|||
146730358|NCT04274894|529182561|FG000|Overall Study|Other, not specified|20|||
146730359|NCT03848403|529182562|FG000|Period 2 (Day 8)|Adverse Event|1|||
146730360|NCT03848403|529182563|FG001|Period 2 (Day 8)|Adverse Event|2|||
146730361|NCT03848403|529182564|FG002|Period 2 (Day 8)|Adverse Event|2|||
146730362|NCT03848403|529182562|FG000|Period 2 (Day 8)|Physician Decision|0|||
146730363|NCT03848403|529182563|FG001|Period 2 (Day 8)|Physician Decision|1|||
146620217|NCT01519323|528781657|FG000|Overall Study|Study terminated by sponsor|0|||
146620218|NCT01519323|528781658|FG001|Overall Study|Study terminated by sponsor|1|||
146620219|NCT03858049|528781673|FG000|Overall Study|Adverse Event|16|||
146620220|NCT03858049|528781674|FG001|Overall Study|Adverse Event|9|||
146620221|NCT03858049|528781673|FG000|Overall Study|Other|1|||
146937078|NCT00511108|529928292|FG001|Overall Study|Adverse Event|0|||
146937079|NCT00511108|529928293|FG002|Overall Study|Adverse Event|1|||
146937080|NCT00511108|529928294|FG003|Overall Study|Adverse Event|2|||
146937081|NCT00511108|529928291|FG000|Overall Study|Lost to Follow-up|0|||
146937082|NCT00511108|529928292|FG001|Overall Study|Lost to Follow-up|2|||
146937083|NCT00511108|529928293|FG002|Overall Study|Lost to Follow-up|1|||
146937084|NCT00511108|529928294|FG003|Overall Study|Lost to Follow-up|0|||
146937085|NCT00511108|529928291|FG000|Overall Study|Physician Decision|0|||
146937086|NCT00511108|529928292|FG001|Overall Study|Physician Decision|0|||
146937087|NCT00511108|529928293|FG002|Overall Study|Physician Decision|0|||
146937088|NCT00511108|529928294|FG003|Overall Study|Physician Decision|1|||
146937089|NCT00511108|529928291|FG000|Overall Study|Withdrawal by Subject|4|||
146937090|NCT00511108|529928292|FG001|Overall Study|Withdrawal by Subject|0|||
146937091|NCT00511108|529928293|FG002|Overall Study|Withdrawal by Subject|3|||
146937092|NCT00511108|529928294|FG003|Overall Study|Withdrawal by Subject|2|||
146937093|NCT02147691|529928297|FG000|Overall Study|Withdrawal by Subject|2|||
146937094|NCT02147691|529928298|FG001|Overall Study|Withdrawal by Subject|0|||
146937095|NCT02147691|529928297|FG000|Overall Study|Adverse Event|2|||
146937096|NCT02147691|529928298|FG001|Overall Study|Adverse Event|0|||
146937097|NCT02147691|529928297|FG000|Overall Study|Lost to Follow-up|0|||
146937098|NCT02147691|529928298|FG001|Overall Study|Lost to Follow-up|1|||
146937099|NCT01392742|529928301|FG000|Overall Study|Premature study termination|42|||
146937100|NCT01392742|529928301|FG000|Overall Study|Failure to return|35|||
146937101|NCT01392742|529928301|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
146937102|NCT01392742|529928301|FG000|Overall Study|Lost to Follow-up|34|||
146937103|NCT01392742|529928301|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
146620222|NCT03858049|528781674|FG001|Overall Study|Other|1|||
146620223|NCT02079740|528781675|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
146620224|NCT02079740|528781676|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
146620225|NCT02079740|528781677|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
146620226|NCT02079740|528781678|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
146620227|NCT02079740|528781679|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
146620228|NCT02079740|528781680|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
146620229|NCT02079740|528781681|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
146620230|NCT02079740|528781682|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
146620231|NCT02079740|528781683|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
146620232|NCT02079740|528781684|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
146620233|NCT02079740|528781685|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
146620234|NCT02079740|528781686|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
146620235|NCT02079740|528781687|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
146620236|NCT02079740|528781675|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
146620237|NCT02079740|528781676|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
146620238|NCT02079740|528781677|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
146620239|NCT02079740|528781678|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
146620240|NCT02079740|528781679|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
146620241|NCT02079740|528781680|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
146620242|NCT02079740|528781681|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
146620243|NCT02079740|528781682|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
146620244|NCT02079740|528781683|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
146620245|NCT02079740|528781684|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
146620246|NCT02079740|528781685|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
146620247|NCT02079740|528781686|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
146620248|NCT02079740|528781687|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
146620249|NCT02079740|528781675|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
146620250|NCT02079740|528781676|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
146620251|NCT02079740|528781677|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
146620252|NCT02079740|528781678|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
146620253|NCT02079740|528781679|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
146937104|NCT01392742|529928301|FG000|Overall Study|ITR and Protocol deviation|1|||
146937105|NCT01392742|529928301|FG000|Overall Study|Adverse event/intercurrent illness|17|||
146937106|NCT01392742|529928301|FG000|Overall Study|Protocol Violation|14|||
146937107|NCT01392742|529928301|FG000|Overall Study|Other|3|||
146620254|NCT02079740|528781680|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
146620255|NCT02079740|528781681|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
146937108|NCT01392742|529928301|FG000|Overall Study|Missing information|13|||
146937109|NCT01998958|529928302|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937110|NCT01998958|529928303|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
146937111|NCT01998958|529928304|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937112|NCT01998958|529928305|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937113|NCT01998958|529928306|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937114|NCT01998958|529928307|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937115|NCT01998958|529928308|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937116|NCT01998958|529928309|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937117|NCT01998958|529928310|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937118|NCT01998958|529928311|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937119|NCT01998958|529928312|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937120|NCT01998958|529928313|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937121|NCT01998958|529928314|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937122|NCT01998958|529928315|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937123|NCT01998958|529928316|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937124|NCT01998958|529928317|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937125|NCT01998958|529928318|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937126|NCT01998958|529928319|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937127|NCT01998958|529928320|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937128|NCT01998958|529928321|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937129|NCT01998958|529928322|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937130|NCT01998958|529928323|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937131|NCT01998958|529928324|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937132|NCT01998958|529928325|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937133|NCT01998958|529928326|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937134|NCT01998958|529928327|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937135|NCT01998958|529928328|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937136|NCT01998958|529928329|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937137|NCT01998958|529928330|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937138|NCT01998958|529928331|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937139|NCT01998958|529928332|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937140|NCT01998958|529928333|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146937141|NCT01998958|529928302|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937142|NCT01998958|529928303|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
146937143|NCT01998958|529928304|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937144|NCT01998958|529928305|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937145|NCT01998958|529928306|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937146|NCT01998958|529928307|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937147|NCT01998958|529928308|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937148|NCT01998958|529928309|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937149|NCT01998958|529928310|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937150|NCT01998958|529928311|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937151|NCT01998958|529928312|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937152|NCT01998958|529928313|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937153|NCT01998958|529928314|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937154|NCT01998958|529928315|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937155|NCT01998958|529928316|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937156|NCT01998958|529928317|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937157|NCT01998958|529928318|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937158|NCT01998958|529928319|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937159|NCT01998958|529928320|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937160|NCT01998958|529928321|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937161|NCT01998958|529928322|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937162|NCT01998958|529928323|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937163|NCT01998958|529928324|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146981793|NCT03038113|530096137|FG006|Overall Study|Lost to Follow-up|1|||
146981794|NCT03038113|530096138|FG007|Overall Study|Lost to Follow-up|0|||
146620256|NCT02079740|528781682|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
146620257|NCT02079740|528781683|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
146620258|NCT02079740|528781684|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
146620259|NCT02079740|528781685|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
146620260|NCT02079740|528781686|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
146620261|NCT02079740|528781687|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
146620262|NCT02079740|528781675|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146620263|NCT02079740|528781676|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146620264|NCT02079740|528781677|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146620265|NCT02079740|528781678|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146620266|NCT02079740|528781679|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146937164|NCT01998958|529928325|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937165|NCT01998958|529928326|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146981795|NCT03038113|530096139|FG008|Overall Study|Lost to Follow-up|0|||
146981796|NCT03038113|530096140|FG009|Overall Study|Lost to Follow-up|0|||
146937166|NCT01998958|529928327|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937167|NCT01998958|529928328|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937168|NCT01998958|529928329|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937169|NCT01998958|529928330|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146981797|NCT03038113|530096141|FG010|Overall Study|Lost to Follow-up|0|||
146620267|NCT02079740|528781680|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146620268|NCT02079740|528781681|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146620269|NCT02079740|528781682|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
146620270|NCT02079740|528781683|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146620271|NCT02079740|528781684|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146620272|NCT02079740|528781685|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146620273|NCT02079740|528781686|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146620274|NCT02079740|528781687|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146620275|NCT02079740|528781675|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146620276|NCT02079740|528781676|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146620277|NCT02079740|528781677|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146620278|NCT02079740|528781678|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146620279|NCT02079740|528781679|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146620280|NCT02079740|528781680|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146620281|NCT02079740|528781681|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146620282|NCT02079740|528781682|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146620283|NCT02079740|528781683|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146620284|NCT02079740|528781684|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
146620285|NCT02079740|528781685|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146620286|NCT02079740|528781686|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
146620287|NCT02079740|528781687|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
146620288|NCT04617782|528781688|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
146620289|NCT04617782|528781688|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
146620290|NCT04617782|528781688|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
146620291|NCT04617782|528781688|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
146620292|NCT04617782|528781688|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
146620293|NCT04617782|528781688|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
146620294|NCT01131507|528781689|FG000|Overall Study|Adverse Event|1|||
146620295|NCT01131507|528781689|FG000|Overall Study|Lost to Follow-up|1|||
146620296|NCT01131507|528781689|FG000|Overall Study|Withdrawal by Subject|1|||
146620297|NCT01474317|528781693|FG000|Overall Study|Adverse Event|1|||
146620298|NCT01474317|528781693|FG000|Overall Study|Subject ineligible for study|1|||
146620299|NCT00387881|528781696|FG000|Overall Study|Lost to Follow-up|23|||
146620300|NCT00387881|528781697|FG001|Overall Study|Lost to Follow-up|23|||
146620301|NCT00387881|528781696|FG000|Overall Study|Protocol Violation|2|||
146620302|NCT00387881|528781697|FG001|Overall Study|Protocol Violation|12|||
146620303|NCT00387881|528781696|FG000|Overall Study|Withdrawal by Subject|15|||
146620304|NCT00387881|528781697|FG001|Overall Study|Withdrawal by Subject|18|||
146620305|NCT00387881|528781696|FG000|Overall Study|Sponsor terminated Study|0|||
146620306|NCT00387881|528781697|FG001|Overall Study|Sponsor terminated Study|1|||
146620307|NCT00387881|528781696|FG000|Overall Study|Not eligible|6|||
146620308|NCT00387881|528781697|FG001|Overall Study|Not eligible|7|||
146620309|NCT00387881|528781696|FG000|Overall Study|No opportunity to treat headache|32|||
146620310|NCT00387881|528781697|FG001|Overall Study|No opportunity to treat headache|34|||
146620311|NCT00387881|528781696|FG000|Overall Study|Not otherwise specified|11|||
146620312|NCT00387881|528781697|FG001|Overall Study|Not otherwise specified|7|||
146620313|NCT00453154|528781698|FG000|Double BIind Maintenance|Adverse Event|0|||
146620314|NCT00453154|528781699|FG001|Double BIind Maintenance|Adverse Event|0|||
146620315|NCT00453154|528781700|FG002|Double BIind Maintenance|Adverse Event|3|||
146620316|NCT00453154|528781701|FG003|Double BIind Maintenance|Adverse Event|12|||
146620317|NCT00453154|528781698|FG000|Double BIind Maintenance|Death|0|||
146620318|NCT00453154|528781699|FG001|Double BIind Maintenance|Death|0|||
146620319|NCT00453154|528781700|FG002|Double BIind Maintenance|Death|2|||
146620320|NCT00453154|528781701|FG003|Double BIind Maintenance|Death|1|||
146620321|NCT00453154|528781698|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
146620322|NCT00453154|528781699|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
146620323|NCT00453154|528781700|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
146620324|NCT00453154|528781701|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
146620325|NCT00453154|528781698|FG000|Double BIind Maintenance|Progression|0|||
146620326|NCT00453154|528781699|FG001|Double BIind Maintenance|Progression|0|||
146937170|NCT01998958|529928331|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937171|NCT01998958|529928332|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146937172|NCT01998958|529928333|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146620327|NCT00453154|528781700|FG002|Double BIind Maintenance|Progression|29|||
146620328|NCT00453154|528781701|FG003|Double BIind Maintenance|Progression|26|||
146620329|NCT00453154|528781698|FG000|Double BIind Maintenance|Medical Issues|0|||
146620330|NCT00453154|528781699|FG001|Double BIind Maintenance|Medical Issues|0|||
146620331|NCT00453154|528781700|FG002|Double BIind Maintenance|Medical Issues|3|||
146620332|NCT00453154|528781701|FG003|Double BIind Maintenance|Medical Issues|1|||
146620333|NCT00453154|528781698|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
146620334|NCT00453154|528781699|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
146620335|NCT00453154|528781700|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
146620336|NCT00453154|528781701|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
146620337|NCT03629886|528781702|FG000|Overall Study|Migrated / moved from the study area|0|||
146620338|NCT03629886|528781703|FG001|Overall Study|Migrated / moved from the study area|55|||
146620339|NCT03629886|528781702|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
146620340|NCT03629886|528781703|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
146620341|NCT03629886|528781702|FG000|Overall Study|Study vaccine not administrated|0|||
146620342|NCT03629886|528781703|FG001|Overall Study|Study vaccine not administrated|3|||
146620343|NCT03629886|528781702|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
146620344|NCT03629886|528781703|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
146620345|NCT03629886|528781702|FG000|Overall Study|Refused vaccination step of the study|0|||
146620346|NCT03629886|528781703|FG001|Overall Study|Refused vaccination step of the study|44|||
146620347|NCT03291067|528781704|FG000|Overall Study|Adverse Event|0|||
146620348|NCT03291067|528781705|FG001|Overall Study|Adverse Event|2|||
146620349|NCT03291067|528781706|FG002|Overall Study|Adverse Event|17|||
146620350|NCT03291067|528781707|FG003|Overall Study|Adverse Event|3|||
146620351|NCT03291067|528781704|FG000|Overall Study|Lost to Follow-up|2|||
146620352|NCT03291067|528781705|FG001|Overall Study|Lost to Follow-up|1|||
146620353|NCT03291067|528781706|FG002|Overall Study|Lost to Follow-up|0|||
146620354|NCT03291067|528781707|FG003|Overall Study|Lost to Follow-up|1|||
146620355|NCT03291067|528781704|FG000|Overall Study|Physician Decision|0|||
146620356|NCT03291067|528781705|FG001|Overall Study|Physician Decision|0|||
146620357|NCT03291067|528781706|FG002|Overall Study|Physician Decision|1|||
146620358|NCT03291067|528781707|FG003|Overall Study|Physician Decision|0|||
146620359|NCT03291067|528781704|FG000|Overall Study|Protocol Violation|5|||
146787228|NCT03134196|529392894|FG000|Overall Study|Site Unable to Contact Participant|2|||
146787229|NCT03134196|529392895|FG001|Overall Study|Site Unable to Contact Participant|0|||
146787230|NCT03134196|529392894|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
146787231|NCT03134196|529392895|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
146787232|NCT03134196|529392894|FG000|Overall Study|Scheduling Conflict|1|||
146787233|NCT03134196|529392895|FG001|Overall Study|Scheduling Conflict|0|||
146787234|NCT03016754|529392897|FG000|Overall Study|Death|5|||
146787235|NCT03016754|529392898|FG001|Overall Study|Death|4|||
146787236|NCT03016754|529392899|FG002|Overall Study|Death|5|||
146787237|NCT03016754|529392900|FG003|Overall Study|Death|1|||
146787238|NCT03016754|529392897|FG000|Overall Study|Lost to Follow-up|23|||
146787239|NCT03016754|529392898|FG001|Overall Study|Lost to Follow-up|17|||
146787240|NCT03016754|529392899|FG002|Overall Study|Lost to Follow-up|4|||
146787241|NCT03016754|529392900|FG003|Overall Study|Lost to Follow-up|2|||
146787242|NCT03016754|529392897|FG000|Overall Study|Withdrawal by Subject|6|||
146787243|NCT03016754|529392898|FG001|Overall Study|Withdrawal by Subject|6|||
146787244|NCT03016754|529392899|FG002|Overall Study|Withdrawal by Subject|2|||
146787245|NCT03016754|529392900|FG003|Overall Study|Withdrawal by Subject|2|||
146787246|NCT03016754|529392897|FG000|Overall Study|Other/Unknown|2|||
146787247|NCT03016754|529392898|FG001|Overall Study|Other/Unknown|4|||
146787248|NCT03016754|529392899|FG002|Overall Study|Other/Unknown|2|||
146787249|NCT03016754|529392900|FG003|Overall Study|Other/Unknown|1|||
146787250|NCT03016754|529392897|FG000|Overall Study|Protocol Violation|0|||
146787251|NCT03016754|529392898|FG001|Overall Study|Protocol Violation|0|||
146787252|NCT03016754|529392899|FG002|Overall Study|Protocol Violation|0|||
146787253|NCT03016754|529392900|FG003|Overall Study|Protocol Violation|4|||
146787254|NCT04683744|529392902|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
146787255|NCT04683744|529392903|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
146787256|NCT04683744|529392904|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
146787257|NCT04185298|529392906|FG000|Overall Study|Lost to Follow-up|1|||
146787258|NCT04185298|529392907|FG001|Overall Study|Lost to Follow-up|3|||
146787259|NCT04185298|529392906|FG000|Overall Study|Withdrawal by Subject|0|||
146787260|NCT04185298|529392907|FG001|Overall Study|Withdrawal by Subject|3|||
146787261|NCT04927364|529392910|FG000|Overall Study|Withdrawal by Subject|3|||
146787262|NCT04927364|529392910|FG000|Overall Study|Unable to complete preassessment MRI|1|||
146787263|NCT04316871|529392917|FG000|Overall Study|Protocol Violation|2|||
146937173|NCT01998958|529928302|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
146937174|NCT01998958|529928303|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
146937175|NCT01998958|529928304|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
146787264|NCT04316871|529392918|FG001|Overall Study|Protocol Violation|2|||
146787265|NCT04316871|529392919|FG002|Overall Study|Protocol Violation|2|||
146787266|NCT04316871|529392920|FG003|Overall Study|Protocol Violation|2|||
146787267|NCT04650269|529392921|FG000|Overall Study|Death|3|||
146787268|NCT04650269|529392921|FG000|Overall Study|Lost to Follow-up|6|||
146787269|NCT05087992|529392922|FG000|Overall Study|Adverse Event|0|||
146787270|NCT05087992|529392923|FG001|Overall Study|Adverse Event|1|||
146787271|NCT05087992|529392924|FG002|Overall Study|Adverse Event|0|||
146787272|NCT05087992|529392922|FG000|Overall Study|Withdrawal by Subject|2|||
146787273|NCT05087992|529392923|FG001|Overall Study|Withdrawal by Subject|0|||
146787274|NCT05087992|529392924|FG002|Overall Study|Withdrawal by Subject|0|||
146981798|NCT03038113|530096142|FG011|Overall Study|Lost to Follow-up|0|||
146937176|NCT01998958|529928305|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
146937177|NCT01998958|529928306|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
146937178|NCT01998958|529928307|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
146937179|NCT01998958|529928308|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
146937180|NCT01998958|529928309|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
146937181|NCT01998958|529928310|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
146937182|NCT01998958|529928311|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
146937183|NCT01998958|529928312|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
146937184|NCT01998958|529928313|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
146937185|NCT01998958|529928314|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
146937186|NCT01998958|529928315|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
146937187|NCT01998958|529928316|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
146937188|NCT01998958|529928317|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
146937189|NCT01998958|529928318|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
146937190|NCT01998958|529928319|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
146937191|NCT01998958|529928320|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
146937192|NCT01998958|529928321|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
146981799|NCT03038113|530096143|FG012|Overall Study|Lost to Follow-up|0|||
146787275|NCT05087992|529392922|FG000|Overall Study|clinical disease progression|3|||
146787276|NCT05087992|529392923|FG001|Overall Study|clinical disease progression|1|||
146787277|NCT05087992|529392924|FG002|Overall Study|clinical disease progression|0|||
146787278|NCT05087992|529392922|FG000|Overall Study|objective disease progression|4|||
146787279|NCT05087992|529392923|FG001|Overall Study|objective disease progression|1|||
146787280|NCT05087992|529392924|FG002|Overall Study|objective disease progression|0|||
146787281|NCT04091750|529392925|FG000|Overall Study|Adverse Event|4|||
146787282|NCT04091750|529392925|FG000|Overall Study|Withdrawal by Subject|1|||
146787283|NCT02919306|529392926|FG000|Overall Study|Withdrawal by Subject|1|||
146787284|NCT02919306|529392927|FG001|Overall Study|Withdrawal by Subject|0|||
146787285|NCT02919306|529392926|FG000|Overall Study|Protocol Violation|1|||
146787286|NCT02919306|529392927|FG001|Overall Study|Protocol Violation|0|||
146787287|NCT04473222|529392928|FG000|Overall Study|Lost to Follow-up|13|||
146787288|NCT04473222|529392929|FG001|Overall Study|Lost to Follow-up|13|||
146787289|NCT04473222|529392928|FG000|Overall Study|Withdrawal by Subject|0|||
146787290|NCT04473222|529392929|FG001|Overall Study|Withdrawal by Subject|1|||
146787291|NCT04473222|529392928|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
146787292|NCT04473222|529392929|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
146787293|NCT03560609|529392930|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
146787294|NCT03560609|529392931|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
146787295|NCT04293055|529392932|FG000|Overall Study|Lost to Follow-up|1|||
146787296|NCT04293055|529392933|FG001|Overall Study|Lost to Follow-up|1|||
146787297|NCT04293055|529392932|FG000|Overall Study|Did not trigger randomization|6|||
146787298|NCT04293055|529392933|FG001|Overall Study|Did not trigger randomization|5|||
146787299|NCT01369355|529392946|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
146787300|NCT01369355|529392947|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
146787301|NCT01369355|529392948|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
146787302|NCT01369355|529392949|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
146787303|NCT01369355|529392950|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
146787304|NCT01369355|529392951|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
146787305|NCT01369355|529392952|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
146787306|NCT01369355|529392953|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
146787307|NCT01369355|529392954|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
146787308|NCT01369355|529392946|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
146787309|NCT01369355|529392947|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
146787310|NCT01369355|529392948|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
146787311|NCT01369355|529392949|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
146787312|NCT01369355|529392950|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
146787313|NCT01369355|529392951|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
146787314|NCT01369355|529392952|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
146787315|NCT01369355|529392953|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
146787316|NCT01369355|529392954|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
146787317|NCT01369355|529392946|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
146787318|NCT01369355|529392947|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
146787319|NCT01369355|529392948|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
146787320|NCT01369355|529392949|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
146787321|NCT01369355|529392950|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
146787322|NCT01369355|529392951|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
146787323|NCT01369355|529392952|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
146937193|NCT01998958|529928322|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
146937194|NCT01998958|529928323|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
146937195|NCT01998958|529928324|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
146981800|NCT03038113|530096144|FG013|Overall Study|Lost to Follow-up|0|||
146787324|NCT01369355|529392953|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
146787325|NCT01369355|529392954|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
146787326|NCT01369355|529392946|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
146787327|NCT01369355|529392947|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
146787328|NCT01369355|529392948|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
146787329|NCT01369355|529392949|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
146787330|NCT01369355|529392950|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
146787331|NCT01369355|529392951|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
146787332|NCT01369355|529392952|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
146787333|NCT01369355|529392953|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
146787334|NCT01369355|529392954|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
146787335|NCT01369355|529392946|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
146981801|NCT01698320|530096153|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
146787336|NCT01369355|529392947|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
146787337|NCT01369355|529392948|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
146787338|NCT01369355|529392949|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
146787339|NCT01369355|529392950|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
146787340|NCT01369355|529392951|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
146787341|NCT01369355|529392952|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
146787342|NCT01369355|529392953|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
146787343|NCT01369355|529392954|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
146787344|NCT01369355|529392946|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
146787345|NCT01369355|529392947|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
146787346|NCT01369355|529392948|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
146787347|NCT01369355|529392949|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
146787348|NCT01369355|529392950|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
146787349|NCT01369355|529392951|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
146787350|NCT01369355|529392952|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
146787351|NCT01369355|529392953|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
146787352|NCT01369355|529392954|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
146787353|NCT01369355|529392946|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
146787354|NCT01369355|529392947|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
146787355|NCT01369355|529392948|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
146787356|NCT01369355|529392949|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
146787357|NCT01369355|529392950|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
146787358|NCT01369355|529392951|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
146787359|NCT01369355|529392952|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
146787360|NCT01369355|529392953|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
146787361|NCT01369355|529392954|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
146787362|NCT01369355|529392946|FG000|Long-term Extension (Week 44-272)|Death|0|||
146787363|NCT01369355|529392947|FG001|Long-term Extension (Week 44-272)|Death|0|||
146787364|NCT01369355|529392948|FG002|Long-term Extension (Week 44-272)|Death|0|||
146787365|NCT01369355|529392949|FG003|Long-term Extension (Week 44-272)|Death|0|||
146787366|NCT01369355|529392950|FG004|Long-term Extension (Week 44-272)|Death|0|||
146787367|NCT01369355|529392951|FG005|Long-term Extension (Week 44-272)|Death|0|||
146787368|NCT01369355|529392952|FG006|Long-term Extension (Week 44-272)|Death|0|||
146787369|NCT01369355|529392953|FG007|Long-term Extension (Week 44-272)|Death|1|||
146787370|NCT01369355|529392954|FG008|Long-term Extension (Week 44-272)|Death|3|||
146787371|NCT01369355|529392946|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
146787372|NCT01369355|529392947|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
146787373|NCT01369355|529392948|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
146787374|NCT01369355|529392949|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
146787375|NCT01369355|529392950|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
146787376|NCT01369355|529392951|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
146787377|NCT01369355|529392952|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
146787378|NCT01369355|529392953|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
146787379|NCT01369355|529392954|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
146787380|NCT01369355|529392946|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
146787381|NCT01369355|529392947|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
146787382|NCT01369355|529392948|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
146787383|NCT01369355|529392949|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
146787384|NCT01369355|529392950|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
146787385|NCT01369355|529392951|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
146787386|NCT01369355|529392952|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
146787387|NCT01369355|529392953|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
146787388|NCT01369355|529392954|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
146787389|NCT01369355|529392946|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
146787390|NCT01369355|529392947|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
146787391|NCT01369355|529392948|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
146937196|NCT01998958|529928325|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
146937197|NCT01998958|529928326|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
146937198|NCT01998958|529928327|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
146937199|NCT01998958|529928328|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
146937200|NCT01998958|529928329|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
146937201|NCT01998958|529928330|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
146937202|NCT01998958|529928331|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
146937203|NCT01998958|529928332|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
146937204|NCT01998958|529928333|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
146981802|NCT01698320|530096154|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
146981803|NCT01698320|530096155|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
146981804|NCT01698320|530096153|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
146981805|NCT01698320|530096154|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
146981806|NCT01698320|530096155|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
146981807|NCT01698320|530096153|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
146981808|NCT01698320|530096154|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
146981809|NCT01698320|530096155|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
146981810|NCT01698320|530096153|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
146981811|NCT01698320|530096154|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
146981812|NCT01698320|530096155|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
146981813|NCT01698320|530096153|FG000|12-Week Double-Blind Period|Adverse Event|0|||
146981814|NCT01698320|530096154|FG001|12-Week Double-Blind Period|Adverse Event|1|||
146981815|NCT01698320|530096155|FG002|12-Week Double-Blind Period|Adverse Event|1|||
146981816|NCT01698320|530096153|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
146981817|NCT01698320|530096154|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
146981818|NCT01698320|530096155|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
146981819|NCT01698320|530096153|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
146981820|NCT01698320|530096154|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
146981821|NCT01698320|530096155|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
146981822|NCT01698320|530096153|FG000|12-Week Double-Blind Period|Pregnancy|0|||
146981823|NCT01698320|530096154|FG001|12-Week Double-Blind Period|Pregnancy|1|||
146981824|NCT01698320|530096155|FG002|12-Week Double-Blind Period|Pregnancy|1|||
146981825|NCT01698320|530096153|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
146981826|NCT01698320|530096154|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
146981827|NCT01698320|530096155|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
146981828|NCT01698320|530096153|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
146981829|NCT01698320|530096154|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
146981830|NCT01698320|530096155|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
146981831|NCT01698320|530096153|FG000|40-Week Open-Label Period|Adverse Event|0|||
146981832|NCT01698320|530096154|FG001|40-Week Open-Label Period|Adverse Event|3|||
146981833|NCT01698320|530096155|FG002|40-Week Open-Label Period|Adverse Event|2|||
146981834|NCT01698320|530096153|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
146981835|NCT01698320|530096154|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
146981836|NCT01698320|530096155|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
146981837|NCT01698320|530096153|FG000|40-Week Open-Label Period|Pregnancy|0|||
146981838|NCT01698320|530096154|FG001|40-Week Open-Label Period|Pregnancy|2|||
146981839|NCT01698320|530096155|FG002|40-Week Open-Label Period|Pregnancy|1|||
146981840|NCT01698320|530096153|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
146981841|NCT01698320|530096154|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
146981842|NCT01698320|530096155|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
146981843|NCT01698320|530096153|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
146981844|NCT01698320|530096154|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
146981845|NCT01698320|530096155|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
146981846|NCT02040766|530096159|FG000|Overall Study|Adverse Event|1|||
146981847|NCT02040766|530096160|FG001|Overall Study|Adverse Event|1|||
146981848|NCT02040766|530096161|FG002|Overall Study|Adverse Event|1|||
146981849|NCT02040766|530096162|FG003|Overall Study|Adverse Event|0|||
146981850|NCT02040766|530096163|FG004|Overall Study|Adverse Event|2|||
146981851|NCT02040766|530096159|FG000|Overall Study|Withdrawal by Subject|4|||
146730364|NCT03848403|529182564|FG002|Period 2 (Day 8)|Physician Decision|0|||
146981852|NCT02040766|530096160|FG001|Overall Study|Withdrawal by Subject|3|||
146981853|NCT02040766|530096161|FG002|Overall Study|Withdrawal by Subject|2|||
146981854|NCT02040766|530096162|FG003|Overall Study|Withdrawal by Subject|3|||
146981855|NCT02040766|530096163|FG004|Overall Study|Withdrawal by Subject|2|||
146981856|NCT02040766|530096159|FG000|Overall Study|Non-compliance|0|||
146981857|NCT02040766|530096160|FG001|Overall Study|Non-compliance|1|||
146981858|NCT02040766|530096161|FG002|Overall Study|Non-compliance|0|||
146730365|NCT03848403|529182562|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
146730366|NCT03848403|529182563|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
146937205|NCT01998958|529928302|FG000|Period 1 (Panel A and B)|Other|1|||
146937206|NCT01998958|529928303|FG001|Period 1 (Panel A and B)|Other|0|||
146730367|NCT03848403|529182564|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
146937207|NCT01998958|529928304|FG002|Period 1 (Panel A and B)|Other|0|||
146937208|NCT01998958|529928305|FG003|Period 1 (Panel A and B)|Other|0|||
146937209|NCT01998958|529928306|FG004|Period 1 (Panel A and B)|Other|0|||
146937210|NCT01998958|529928307|FG005|Period 1 (Panel A and B)|Other|0|||
146937211|NCT01998958|529928308|FG006|Period 1 (Panel A and B)|Other|0|||
146937212|NCT01998958|529928309|FG007|Period 1 (Panel A and B)|Other|0|||
146937213|NCT01998958|529928310|FG008|Period 1 (Panel A and B)|Other|0|||
146937214|NCT01998958|529928311|FG009|Period 1 (Panel A and B)|Other|0|||
146937215|NCT01998958|529928312|FG010|Period 1 (Panel A and B)|Other|0|||
146937216|NCT01998958|529928313|FG011|Period 1 (Panel A and B)|Other|0|||
146937217|NCT01998958|529928314|FG012|Period 1 (Panel A and B)|Other|0|||
146937218|NCT01998958|529928315|FG013|Period 1 (Panel A and B)|Other|0|||
146787392|NCT01369355|529392949|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
146787393|NCT01369355|529392950|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
146787394|NCT01369355|529392951|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
146787395|NCT01369355|529392952|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
146787396|NCT01369355|529392953|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
146787397|NCT01369355|529392954|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
146787398|NCT01369355|529392946|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
146787399|NCT01369355|529392947|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
146787400|NCT01369355|529392948|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
146787401|NCT01369355|529392949|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
146787402|NCT01369355|529392950|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
146787403|NCT01369355|529392951|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
146787404|NCT01369355|529392952|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
146787405|NCT01369355|529392953|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
146787406|NCT01369355|529392954|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
146787407|NCT01369355|529392946|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
146787408|NCT01369355|529392947|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
146787409|NCT01369355|529392948|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
146787410|NCT01369355|529392949|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
146787411|NCT01369355|529392950|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
146787412|NCT01369355|529392951|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
146787413|NCT01369355|529392952|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
146787414|NCT01369355|529392953|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
146787415|NCT01369355|529392954|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
146787416|NCT01369355|529392946|FG000|Long-term Extension (Week 44-272)|Other|0|||
146787417|NCT01369355|529392947|FG001|Long-term Extension (Week 44-272)|Other|0|||
146787418|NCT01369355|529392948|FG002|Long-term Extension (Week 44-272)|Other|0|||
146787419|NCT01369355|529392949|FG003|Long-term Extension (Week 44-272)|Other|0|||
146787420|NCT01369355|529392950|FG004|Long-term Extension (Week 44-272)|Other|0|||
146787421|NCT01369355|529392951|FG005|Long-term Extension (Week 44-272)|Other|0|||
146787422|NCT01369355|529392952|FG006|Long-term Extension (Week 44-272)|Other|110|||
146787423|NCT01369355|529392953|FG007|Long-term Extension (Week 44-272)|Other|9|||
146787424|NCT01369355|529392954|FG008|Long-term Extension (Week 44-272)|Other|17|||
146787425|NCT02319759|529392957|FG000|Week 0 - 16|Lack of Efficacy|1|||
146787426|NCT02319759|529392958|FG001|Week 0 - 16|Lack of Efficacy|0|||
146787427|NCT02319759|529392959|FG002|Week 0 - 16|Lack of Efficacy|0|||
146787428|NCT02319759|529392960|FG003|Week 0 - 16|Lack of Efficacy|0|||
146787429|NCT02319759|529392961|FG004|Week 0 - 16|Lack of Efficacy|0|||
146787430|NCT02319759|529392957|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
146787431|NCT02319759|529392958|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
146787432|NCT02319759|529392959|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
146787433|NCT02319759|529392960|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
146787434|NCT02319759|529392961|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
146787435|NCT02319759|529392957|FG000|Week 16 - 24|Lack of Efficacy|1|||
146787436|NCT02319759|529392958|FG001|Week 16 - 24|Lack of Efficacy|0|||
146787437|NCT02319759|529392959|FG002|Week 16 - 24|Lack of Efficacy|1|||
146787438|NCT02319759|529392960|FG003|Week 16 - 24|Lack of Efficacy|0|||
146787439|NCT02319759|529392961|FG004|Week 16 - 24|Lack of Efficacy|0|||
146787440|NCT02319759|529392957|FG000|Week 16 - 24|Lost to Follow-up|1|||
146787441|NCT02319759|529392958|FG001|Week 16 - 24|Lost to Follow-up|0|||
146787442|NCT02319759|529392959|FG002|Week 16 - 24|Lost to Follow-up|0|||
146787443|NCT02319759|529392960|FG003|Week 16 - 24|Lost to Follow-up|0|||
146787444|NCT02319759|529392961|FG004|Week 16 - 24|Lost to Follow-up|0|||
146787445|NCT02319759|529392957|FG000|Week 16 - 24|Withdrawal by Subject|0|||
146787446|NCT02319759|529392958|FG001|Week 16 - 24|Withdrawal by Subject|0|||
146787447|NCT02319759|529392959|FG002|Week 16 - 24|Withdrawal by Subject|2|||
146787448|NCT02319759|529392960|FG003|Week 16 - 24|Withdrawal by Subject|0|||
146787449|NCT02319759|529392961|FG004|Week 16 - 24|Withdrawal by Subject|0|||
146787450|NCT02319759|529392957|FG000|Week 24 - 56|Adverse Event|0|||
146937219|NCT01998958|529928316|FG014|Period 1 (Panel A and B)|Other|0|||
146937220|NCT01998958|529928317|FG015|Period 1 (Panel A and B)|Other|0|||
146937221|NCT01998958|529928318|FG016|Period 1 (Panel A and B)|Other|0|||
146787451|NCT02319759|529392958|FG001|Week 24 - 56|Adverse Event|0|||
146787452|NCT02319759|529392959|FG002|Week 24 - 56|Adverse Event|2|||
146787453|NCT02319759|529392960|FG003|Week 24 - 56|Adverse Event|0|||
146787454|NCT02319759|529392961|FG004|Week 24 - 56|Adverse Event|0|||
146787455|NCT02319759|529392957|FG000|Week 24 - 56|Lack of Efficacy|0|||
146787456|NCT02319759|529392958|FG001|Week 24 - 56|Lack of Efficacy|0|||
146787457|NCT02319759|529392959|FG002|Week 24 - 56|Lack of Efficacy|0|||
146787458|NCT02319759|529392960|FG003|Week 24 - 56|Lack of Efficacy|2|||
146787459|NCT02319759|529392961|FG004|Week 24 - 56|Lack of Efficacy|1|||
146787460|NCT02319759|529392957|FG000|Week 24 - 56|Withdrawal by Subject|0|||
146787461|NCT02319759|529392958|FG001|Week 24 - 56|Withdrawal by Subject|1|||
146787462|NCT02319759|529392959|FG002|Week 24 - 56|Withdrawal by Subject|0|||
146787463|NCT02319759|529392960|FG003|Week 24 - 56|Withdrawal by Subject|0|||
146787464|NCT02319759|529392961|FG004|Week 24 - 56|Withdrawal by Subject|0|||
146787465|NCT02319759|529392957|FG000|Week 24 - 56|Lost to Follow-up|0|||
146787466|NCT02319759|529392958|FG001|Week 24 - 56|Lost to Follow-up|0|||
146787467|NCT02319759|529392959|FG002|Week 24 - 56|Lost to Follow-up|0|||
146787468|NCT02319759|529392960|FG003|Week 24 - 56|Lost to Follow-up|0|||
146787469|NCT02319759|529392961|FG004|Week 24 - 56|Lost to Follow-up|1|||
146787470|NCT06424236|529392962|FG000|Overall Study|Adverse Event|0|||
146787471|NCT06424236|529392963|FG001|Overall Study|Adverse Event|1|||
146787472|NCT06424236|529392964|FG002|Overall Study|Adverse Event|0|||
146787473|NCT06424236|529392962|FG000|Overall Study|Withdrawal by Subject|3|||
146787474|NCT06424236|529392963|FG001|Overall Study|Withdrawal by Subject|1|||
146787475|NCT06424236|529392964|FG002|Overall Study|Withdrawal by Subject|2|||
146787476|NCT06424236|529392962|FG000|Overall Study|Physician Decision|0|||
146787477|NCT06424236|529392963|FG001|Overall Study|Physician Decision|1|||
146787478|NCT06424236|529392964|FG002|Overall Study|Physician Decision|0|||
146787479|NCT06424236|529392962|FG000|Overall Study|Study Terminated by Sponsor|11|||
146787480|NCT06424236|529392963|FG001|Overall Study|Study Terminated by Sponsor|20|||
146787481|NCT06424236|529392964|FG002|Overall Study|Study Terminated by Sponsor|16|||
146787482|NCT06424236|529392962|FG000|Overall Study|Lost to Follow-up|0|||
146787483|NCT06424236|529392963|FG001|Overall Study|Lost to Follow-up|1|||
146787484|NCT06424236|529392964|FG002|Overall Study|Lost to Follow-up|0|||
146787485|NCT06424236|529392962|FG000|Overall Study|Disease Progression|0|||
146787486|NCT06424236|529392963|FG001|Overall Study|Disease Progression|1|||
146787487|NCT06424236|529392964|FG002|Overall Study|Disease Progression|2|||
146787488|NCT06424236|529392962|FG000|Overall Study|Other|0|||
146787489|NCT06424236|529392963|FG001|Overall Study|Other|0|||
146787490|NCT06424236|529392964|FG002|Overall Study|Other|1|||
146787491|NCT02262728|529392966|FG000|Follow-up Phase (3 Years)|Death|0|||
146787492|NCT02262728|529392967|FG001|Follow-up Phase (3 Years)|Death|1|||
146787493|NCT02262728|529392966|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
146787494|NCT02262728|529392967|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
146787495|NCT02262728|529392966|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
146787496|NCT02262728|529392967|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
146787497|NCT00227344|529392968|FG000|Overall Study|study terminated early|12|||
146787498|NCT00227344|529392969|FG001|Overall Study|study terminated early|5|||
146787499|NCT01987895|529392970|FG000|Overall Study|Withdrawal by Subject|12|||
146787500|NCT01987895|529392971|FG001|Overall Study|Withdrawal by Subject|7|||
146787501|NCT01987895|529392970|FG000|Overall Study|Physician Decision|8|||
146787502|NCT01987895|529392971|FG001|Overall Study|Physician Decision|10|||
146787503|NCT01987895|529392970|FG000|Overall Study|Death|7|||
146787504|NCT01987895|529392971|FG001|Overall Study|Death|7|||
146787505|NCT01987895|529392970|FG000|Overall Study|Lost to Follow-up|3|||
146787506|NCT01987895|529392971|FG001|Overall Study|Lost to Follow-up|5|||
146787507|NCT01987895|529392970|FG000|Overall Study|randomized before giving IC|0|||
146787508|NCT01987895|529392971|FG001|Overall Study|randomized before giving IC|1|||
146787509|NCT05006872|529392975|FG000|Overall Study|Lost to Follow-up|37|||
146787510|NCT05006872|529392976|FG001|Overall Study|Lost to Follow-up|31|||
146787511|NCT04971681|529392979|FG000|Followup|Lost to Follow-up|1|||
146787512|NCT04971681|529392980|FG001|Followup|Lost to Follow-up|0|||
146937222|NCT01998958|529928319|FG017|Period 1 (Panel A and B)|Other|0|||
146937223|NCT01998958|529928320|FG018|Period 1 (Panel A and B)|Other|0|||
146937224|NCT01998958|529928321|FG019|Period 1 (Panel A and B)|Other|0|||
146787513|NCT04788511|529392981|FG000|Overall Study|Withdrawal by Subject|2|||
146787514|NCT04788511|529392982|FG001|Overall Study|Withdrawal by Subject|1|||
146787515|NCT04788511|529392981|FG000|Overall Study|Lost to Follow-up|2|||
146787516|NCT04788511|529392982|FG001|Overall Study|Lost to Follow-up|7|||
146787517|NCT04788511|529392981|FG000|Overall Study|Death|3|||
146787518|NCT04788511|529392982|FG001|Overall Study|Death|4|||
146787519|NCT05647304|529392983|FG000|Overall Study|Withdrawal by Subject|1|||
146787520|NCT05647304|529392984|FG001|Overall Study|Withdrawal by Subject|0|||
146787521|NCT04171999|529392985|FG000|Overall Study|deemed ineligible after randomization|2|||
146787522|NCT04171999|529392986|FG001|Overall Study|deemed ineligible after randomization|1|||
146787523|NCT06181760|529392989|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
146787524|NCT06181760|529392990|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
146787525|NCT06181760|529392991|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
146730368|NCT00168038|529182565|FG000|Overall Study|Adverse Event|1|||
146730369|NCT00168038|529182565|FG000|Overall Study|Therapy failure|1|||
146730370|NCT04198805|529182569|FG000|Overall Study|Death|0|||
146730371|NCT04198805|529182570|FG001|Overall Study|Death|0|||
146730372|NCT04198805|529182571|FG002|Overall Study|Death|0|||
146730373|NCT04198805|529182572|FG003|Overall Study|Death|1|||
146730374|NCT04198805|529182569|FG000|Overall Study|Early Termination|8|||
146730375|NCT04198805|529182570|FG001|Overall Study|Early Termination|4|||
146730376|NCT04198805|529182571|FG002|Overall Study|Early Termination|6|||
146730377|NCT04198805|529182572|FG003|Overall Study|Early Termination|9|||
146730378|NCT03599349|529182575|FG000|Overall Study|Lost to Follow-up|1|||
146730379|NCT06213701|529182576|FG000|Overall Study|Withdrawal by Subject|2|||
146730380|NCT06213701|529182577|FG001|Overall Study|Withdrawal by Subject|1|||
146730381|NCT06213701|529182578|FG002|Overall Study|Withdrawal by Subject|0|||
146730382|NCT00453986|529182579|FG000|Overall Study|Lost to Follow-up|6|||
146730383|NCT00453986|529182580|FG001|Overall Study|Lost to Follow-up|5|||
146730384|NCT00453986|529182581|FG002|Overall Study|Lost to Follow-up|6|||
146730385|NCT00453986|529182582|FG003|Overall Study|Lost to Follow-up|2|||
146730386|NCT00453986|529182583|FG004|Overall Study|Lost to Follow-up|0|||
146730387|NCT00803452|529182584|FG000|Overall Study|Adverse Event|0|||
146730388|NCT00803452|529182585|FG001|Overall Study|Adverse Event|2|||
146730389|NCT00803452|529182584|FG000|Overall Study|Lost to Follow-up|0|||
146730390|NCT00803452|529182585|FG001|Overall Study|Lost to Follow-up|3|||
146730391|NCT02412137|529182595|FG000|Overall Study|Withdrawal by Subject|2|||
146730392|NCT02412137|529182596|FG001|Overall Study|Withdrawal by Subject|0|||
146730393|NCT02412137|529182595|FG000|Overall Study|Lost to Follow-up|21|||
146730394|NCT02412137|529182596|FG001|Overall Study|Lost to Follow-up|14|||
146730395|NCT02412137|529182595|FG000|Overall Study|Physician Decision|28|||
146730396|NCT02412137|529182596|FG001|Overall Study|Physician Decision|9|||
146730397|NCT00608582|529182608|FG000|Overall Study|Lost to Follow-up|2|||
146730398|NCT00608582|529182609|FG001|Overall Study|Lost to Follow-up|0|||
146730399|NCT00608582|529182608|FG000|Overall Study|No Best Response in Phase 1 located|1|||
146730400|NCT00608582|529182609|FG001|Overall Study|No Best Response in Phase 1 located|1|||
146730401|NCT00608582|529182608|FG000|Overall Study|Illicit Drug Use|1|||
146730402|NCT00608582|529182609|FG001|Overall Study|Illicit Drug Use|0|||
146730403|NCT00608582|529182608|FG000|Overall Study|Early stage Design Change|0|||
146730404|NCT00608582|529182609|FG001|Overall Study|Early stage Design Change|3|||
146730405|NCT02240108|529184328|FG000|Overall Study|Other than specified|8|||
146730406|NCT02240108|529184329|FG001|Overall Study|Other than specified|6|||
146730407|NCT02240108|529184328|FG000|Overall Study|Adverse Event|1|||
146730408|NCT02240108|529184329|FG001|Overall Study|Adverse Event|9|||
146730409|NCT02240108|529184328|FG000|Overall Study|Pregnancy|1|||
146730410|NCT02240108|529184329|FG001|Overall Study|Pregnancy|0|||
146730411|NCT02240108|529184328|FG000|Overall Study|Withdrawal by Subject|4|||
146730412|NCT02240108|529184329|FG001|Overall Study|Withdrawal by Subject|9|||
146730413|NCT02240108|529184328|FG000|Overall Study|StudyTerminated by Sponsor|0|||
146730414|NCT02240108|529184329|FG001|Overall Study|StudyTerminated by Sponsor|1|||
146730415|NCT04233372|529184330|FG000|Overall Study|Lost to Follow-up|104|||
146730416|NCT04233372|529184330|FG000|Overall Study|Adverse Event|8|||
146730417|NCT04233372|529184330|FG000|Overall Study|Withdrawal by Subject|2|||
146730418|NCT01090310|529184331|FG000|Core Study|Adverse Event|2|||
146730419|NCT01090310|529184332|FG001|Core Study|Adverse Event|2|||
146730420|NCT01090310|529184333|FG002|Core Study|Adverse Event|1|||
146730421|NCT01090310|529184334|FG003|Core Study|Adverse Event|1|||
146730422|NCT01090310|529184331|FG000|Core Study|Subject withdrew consent|0|||
146730423|NCT01090310|529184332|FG001|Core Study|Subject withdrew consent|3|||
146730424|NCT01090310|529184333|FG002|Core Study|Subject withdrew consent|1|||
146730425|NCT01090310|529184334|FG003|Core Study|Subject withdrew consent|1|||
146730426|NCT01090310|529184331|FG000|Core Study|Abnormal test procedure result|0|||
146730427|NCT01090310|529184332|FG001|Core Study|Abnormal test procedure result|0|||
146730428|NCT01090310|529184333|FG002|Core Study|Abnormal test procedure result|1|||
146730429|NCT01090310|529184334|FG003|Core Study|Abnormal test procedure result|0|||
146730430|NCT01090310|529184331|FG000|Core Study|Administrative reasons|5|||
146730431|NCT01090310|529184332|FG001|Core Study|Administrative reasons|6|||
146730432|NCT01090310|529184333|FG002|Core Study|Administrative reasons|4|||
146730433|NCT01090310|529184334|FG003|Core Study|Administrative reasons|4|||
146730434|NCT01090310|529184331|FG000|Core Study|Protocol deviation|1|||
146730435|NCT01090310|529184332|FG001|Core Study|Protocol deviation|0|||
146730436|NCT01090310|529184333|FG002|Core Study|Protocol deviation|0|||
146730437|NCT01090310|529184334|FG003|Core Study|Protocol deviation|1|||
146730438|NCT01090310|529184331|FG000|Extension Study|Aministrative problems|13|||
146730439|NCT01090310|529184332|FG001|Extension Study|Aministrative problems|15|||
146730440|NCT01090310|529184333|FG002|Extension Study|Aministrative problems|14|||
146730441|NCT01090310|529184334|FG003|Extension Study|Aministrative problems|18|||
146730442|NCT01090310|529184331|FG000|Extension Study|Adverse Event|0|||
146730443|NCT01090310|529184332|FG001|Extension Study|Adverse Event|0|||
146730444|NCT01090310|529184333|FG002|Extension Study|Adverse Event|0|||
146730445|NCT01090310|529184334|FG003|Extension Study|Adverse Event|1|||
146730446|NCT01090310|529184331|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
146787526|NCT06181760|529392992|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
146787527|NCT03524612|529392993|FG000|Overall Study|Lack of Efficacy|10|||
146787528|NCT03524612|529392993|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
146787529|NCT03524612|529392993|FG000|Overall Study|Adverse Event|10|||
146787530|NCT03524612|529392993|FG000|Overall Study|Withdrawal by Subject|7|||
146787531|NCT03524612|529392993|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
146787532|NCT03524612|529392993|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
146787533|NCT03524612|529392993|FG000|Overall Study|New therapy for study indication|6|||
146787534|NCT03524612|529392993|FG000|Overall Study|Death|3|||
146787535|NCT03524612|529392993|FG000|Overall Study|Lost to Follow-up|2|||
146787536|NCT03524612|529392993|FG000|Overall Study|Protocol Violation|1|||
146787537|NCT04623671|529392994|FG000|Overall Study|Adverse Event|0|||
146787538|NCT04623671|529392995|FG001|Overall Study|Adverse Event|1|||
146787539|NCT04623671|529392994|FG000|Overall Study|Lost to Follow-up|2|||
146787540|NCT04623671|529392995|FG001|Overall Study|Lost to Follow-up|1|||
146787541|NCT04623671|529392994|FG000|Overall Study|Death|5|||
146787542|NCT04623671|529392995|FG001|Overall Study|Death|5|||
146787543|NCT00613106|529392996|FG000|Overall Study|Adverse Event|3|||
146787544|NCT00613106|529392997|FG001|Overall Study|Adverse Event|1|||
146787545|NCT00613106|529392996|FG000|Overall Study|Withdrawal by Subject|6|||
146787546|NCT00613106|529392997|FG001|Overall Study|Withdrawal by Subject|3|||
146787547|NCT00613106|529392996|FG000|Overall Study|Lost to Follow-up|7|||
146787548|NCT00613106|529392997|FG001|Overall Study|Lost to Follow-up|2|||
146787549|NCT00613106|529392996|FG000|Overall Study|misc|4|||
146787550|NCT00613106|529392997|FG001|Overall Study|misc|3|||
146787551|NCT05296525|529393004|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
146787552|NCT05296525|529393005|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
146787553|NCT05296525|529393006|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
146787554|NCT05296525|529393007|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
146787555|NCT01420237|529393008|FG000|Overall Study|Death|13|||
146787556|NCT01420237|529393008|FG000|Overall Study|Withdrawal by Subject|41|||
146787557|NCT01420237|529393008|FG000|Overall Study|Lost to Follow-up|32|||
146787558|NCT01420237|529393008|FG000|Overall Study|Adverse Event|10|||
146787559|NCT01420237|529393008|FG000|Overall Study|Investigative Site Termination|43|||
146787560|NCT01420237|529393008|FG000|Overall Study|Censored because study device not implanted|21|||
146787561|NCT01420237|529393008|FG000|Overall Study|Censored because surgery not performed|2|||
146787562|NCT01420237|529393008|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
146787563|NCT01420237|529393008|FG000|Overall Study|Sponsor terminated study early|127|||
146787564|NCT04492722|529393010|FG000|Overall Study|Adverse Event|7|||
146787565|NCT04492722|529393011|FG001|Overall Study|Adverse Event|2|||
146787566|NCT04492722|529393012|FG002|Overall Study|Adverse Event|3|||
146787567|NCT04492722|529393013|FG003|Overall Study|Adverse Event|0|||
146787568|NCT04492722|529393010|FG000|Overall Study|Death|0|||
146787569|NCT04492722|529393011|FG001|Overall Study|Death|0|||
146787570|NCT04492722|529393012|FG002|Overall Study|Death|0|||
146787571|NCT04492722|529393013|FG003|Overall Study|Death|1|||
146787572|NCT04492722|529393010|FG000|Overall Study|Lost to Follow-up|0|||
146787573|NCT04492722|529393011|FG001|Overall Study|Lost to Follow-up|1|||
146787574|NCT04492722|529393012|FG002|Overall Study|Lost to Follow-up|0|||
146787575|NCT04492722|529393013|FG003|Overall Study|Lost to Follow-up|1|||
146787576|NCT04492722|529393010|FG000|Overall Study|Physician Decision|0|||
146787577|NCT04492722|529393011|FG001|Overall Study|Physician Decision|3|||
146787578|NCT04492722|529393012|FG002|Overall Study|Physician Decision|1|||
146787579|NCT04492722|529393013|FG003|Overall Study|Physician Decision|1|||
146787580|NCT04492722|529393010|FG000|Overall Study|Withdrawal by Subject|6|||
146787581|NCT04492722|529393011|FG001|Overall Study|Withdrawal by Subject|6|||
146787582|NCT04492722|529393012|FG002|Overall Study|Withdrawal by Subject|0|||
146787583|NCT04492722|529393013|FG003|Overall Study|Withdrawal by Subject|3|||
146787584|NCT04492722|529393010|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
146787585|NCT04492722|529393011|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
146787586|NCT04492722|529393012|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
146787587|NCT04492722|529393013|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
146787588|NCT04492722|529393010|FG000|Overall Study|Due to Covid-19 pandemic|7|||
146787589|NCT04492722|529393011|FG001|Overall Study|Due to Covid-19 pandemic|3|||
146620360|NCT03291067|528781705|FG001|Overall Study|Protocol Violation|3|||
146787590|NCT04492722|529393012|FG002|Overall Study|Due to Covid-19 pandemic|7|||
146787591|NCT04492722|529393013|FG003|Overall Study|Due to Covid-19 pandemic|6|||
146787592|NCT04492722|529393010|FG000|Overall Study|Failure to meet randomisation criteria|2|||
146787593|NCT04492722|529393011|FG001|Overall Study|Failure to meet randomisation criteria|3|||
146787594|NCT04492722|529393012|FG002|Overall Study|Failure to meet randomisation criteria|4|||
146787595|NCT04492722|529393013|FG003|Overall Study|Failure to meet randomisation criteria|2|||
146787596|NCT04492722|529393010|FG000|Overall Study|Early termination from the study|54|||
146787597|NCT04492722|529393011|FG001|Overall Study|Early termination from the study|51|||
146787598|NCT04492722|529393012|FG002|Overall Study|Early termination from the study|50|||
146787599|NCT04492722|529393013|FG003|Overall Study|Early termination from the study|50|||
146787600|NCT04492722|529393010|FG000|Overall Study|Missing|3|||
146787601|NCT04492722|529393011|FG001|Overall Study|Missing|0|||
146787602|NCT04492722|529393012|FG002|Overall Study|Missing|0|||
146787603|NCT04492722|529393013|FG003|Overall Study|Missing|5|||
146787604|NCT04492722|529393010|FG000|Overall Study|Participants who did not receive treatment|0|||
146787605|NCT04492722|529393011|FG001|Overall Study|Participants who did not receive treatment|1|||
146787606|NCT04492722|529393012|FG002|Overall Study|Participants who did not receive treatment|4|||
146787607|NCT04492722|529393013|FG003|Overall Study|Participants who did not receive treatment|0|||
146787608|NCT02547363|529393017|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
146787609|NCT02547363|529393018|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
146787610|NCT02547363|529393017|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
146787611|NCT02547363|529393018|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
146787612|NCT02547363|529393017|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
146787613|NCT02547363|529393018|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
146787614|NCT02547363|529393017|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
146787615|NCT02547363|529393018|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
146787616|NCT02547363|529393017|FG000|12-month Follow-up|Withdrawal by Subject|4|||
146787617|NCT02547363|529393018|FG001|12-month Follow-up|Withdrawal by Subject|3|||
146787618|NCT02547363|529393017|FG000|12-month Follow-up|Lost to Follow-up|4|||
146787619|NCT02547363|529393018|FG001|12-month Follow-up|Lost to Follow-up|1|||
146787620|NCT02547363|529393017|FG000|12-month Follow-up|Lack of Efficacy|1|||
146787621|NCT02547363|529393018|FG001|12-month Follow-up|Lack of Efficacy|1|||
146787622|NCT02547363|529393017|FG000|12-month Follow-up|Other|1|||
146787623|NCT02547363|529393018|FG001|12-month Follow-up|Other|0|||
146787624|NCT04130438|529395448|FG000|Overall Study|Lost to Follow-up|0|||
146787625|NCT04130438|529395449|FG001|Overall Study|Lost to Follow-up|0|||
146787626|NCT04130438|529395450|FG002|Overall Study|Lost to Follow-up|1|||
146787627|NCT03953508|529395451|FG000|Baseline|Lost to Follow-up|3|||
146787628|NCT03953508|529395452|FG001|Baseline|Lost to Follow-up|2|||
146787629|NCT03953508|529395451|FG000|6-month Follow-up|Lost to Follow-up|62|||
146787630|NCT03953508|529395452|FG001|6-month Follow-up|Lost to Follow-up|70|||
146787631|NCT05119023|529395455|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
146787632|NCT05119023|529395455|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
146787633|NCT05119023|529395455|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
146787634|NCT04489771|529395459|FG000|Overall Study|Death|27|||
146787635|NCT04489771|529395460|FG001|Overall Study|Death|25|||
146787636|NCT04489771|529395459|FG000|Overall Study|Withdrawal by Subject|1|||
146787637|NCT04489771|529395460|FG001|Overall Study|Withdrawal by Subject|0|||
146787638|NCT04489771|529395459|FG000|Overall Study|Participants Ongoing in Study|50|||
146787639|NCT04489771|529395460|FG001|Overall Study|Participants Ongoing in Study|51|||
146787640|NCT04509674|529395463|FG000|Overall Study|Not treated|33|||
146787641|NCT04509674|529395464|FG001|Overall Study|Not treated|26|||
146787642|NCT04509674|529395463|FG000|Overall Study|Protocol Violation|9|||
146787643|NCT04509674|529395464|FG001|Overall Study|Protocol Violation|10|||
146787644|NCT04509674|529395463|FG000|Overall Study|Lost to Follow-up|31|||
146787645|NCT04509674|529395464|FG001|Overall Study|Lost to Follow-up|39|||
146787646|NCT04509674|529395463|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
146787647|NCT04509674|529395464|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
146787648|NCT04509674|529395463|FG000|Overall Study|Adverse event, serious fatal event|11|||
146787649|NCT04509674|529395464|FG001|Overall Study|Adverse event, serious fatal event|4|||
146787650|NCT04509674|529395463|FG000|Overall Study|Adverse event, non-fatal event|107|||
146787651|NCT04509674|529395464|FG001|Overall Study|Adverse event, non-fatal event|118|||
146787652|NCT04509674|529395463|FG000|Overall Study|Other reason than listed|106|||
146787653|NCT04509674|529395464|FG001|Overall Study|Other reason than listed|95|||
146787654|NCT04064164|529395473|FG000|Overall Study|Withdrawal by Subject|8|||
146787655|NCT04064164|529395474|FG001|Overall Study|Withdrawal by Subject|8|||
146787656|NCT04059484|529395476|FG000|Overall Study|Adverse Event|2|||
146787657|NCT04059484|529395477|FG001|Overall Study|Adverse Event|5|||
146787658|NCT04059484|529395476|FG000|Overall Study|Withdrawal by Subject|5|||
146787659|NCT04059484|529395477|FG001|Overall Study|Withdrawal by Subject|3|||
146787660|NCT04059484|529395476|FG000|Overall Study|Progressive disease|112|||
146787661|NCT04059484|529395477|FG001|Overall Study|Progressive disease|112|||
146787662|NCT04059484|529395476|FG000|Overall Study|Other|8|||
146787663|NCT04059484|529395477|FG001|Overall Study|Other|3|||
146787664|NCT04059484|529395476|FG000|Overall Study|Ongoing|20|||
146787665|NCT04059484|529395477|FG001|Overall Study|Ongoing|20|||
146787666|NCT04292223|529395478|FG000|Overall Study|Adverse Event|1|||
146787667|NCT04292223|529395478|FG000|Overall Study|Lost to Follow-up|1|||
146787668|NCT04292223|529395478|FG000|Overall Study|Noncompliance with study drug|2|||
146787669|NCT04292223|529395478|FG000|Overall Study|Patient moved out of the state|1|||
146787670|NCT06190691|529395479|FG000|Overall Study|Adverse Event|2|||
146787671|NCT06190691|529395480|FG001|Overall Study|Adverse Event|0|||
146787672|NCT06190691|529395481|FG002|Overall Study|Adverse Event|0|||
146787673|NCT06190691|529395482|FG003|Overall Study|Adverse Event|0|||
146787674|NCT02023866|529395484|FG000|Overall Study|Non-compliance|2|||
146787675|NCT02023866|529395484|FG000|Overall Study|Adverse Event|3|||
146787676|NCT02023866|529395484|FG000|Overall Study|Withdrawal by Subject|1|||
146787677|NCT03839940|529395485|FG000|Overall Study|Withdrawal by Subject|3|||
146787678|NCT03839940|529395486|FG001|Overall Study|Withdrawal by Subject|0|||
146787679|NCT03839940|529395485|FG000|Overall Study|Protocol Violation|0|||
146787680|NCT03839940|529395486|FG001|Overall Study|Protocol Violation|1|||
146787681|NCT03839940|529395485|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
146787682|NCT03839940|529395486|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
146787683|NCT03524118|529395488|FG000|Overall Study|Lost to Follow-up|0|||
146787684|NCT03524118|529395489|FG001|Overall Study|Lost to Follow-up|0|||
146787685|NCT03524118|529395490|FG002|Overall Study|Lost to Follow-up|0|||
146787686|NCT03524118|529395491|FG003|Overall Study|Lost to Follow-up|0|||
146787687|NCT03524118|529395492|FG004|Overall Study|Lost to Follow-up|1|||
146787688|NCT03524118|529395493|FG005|Overall Study|Lost to Follow-up|0|||
146787689|NCT03524118|529395488|FG000|Overall Study|Other|0|||
146787690|NCT03524118|529395489|FG001|Overall Study|Other|1|||
146787691|NCT03524118|529395490|FG002|Overall Study|Other|0|||
146787692|NCT03524118|529395491|FG003|Overall Study|Other|0|||
146787693|NCT03524118|529395492|FG004|Overall Study|Other|1|||
146787694|NCT03524118|529395493|FG005|Overall Study|Other|1|||
146787695|NCT03524118|529395488|FG000|Overall Study|Physician Decision|0|||
146787696|NCT03524118|529395489|FG001|Overall Study|Physician Decision|0|||
146787697|NCT03524118|529395490|FG002|Overall Study|Physician Decision|0|||
146787698|NCT03524118|529395491|FG003|Overall Study|Physician Decision|0|||
146787699|NCT03524118|529395492|FG004|Overall Study|Physician Decision|1|||
146787700|NCT03524118|529395493|FG005|Overall Study|Physician Decision|0|||
146787701|NCT03524118|529395488|FG000|Overall Study|Protocol Violation|0|||
146787702|NCT03524118|529395489|FG001|Overall Study|Protocol Violation|0|||
146787703|NCT03524118|529395490|FG002|Overall Study|Protocol Violation|1|||
146787704|NCT03524118|529395491|FG003|Overall Study|Protocol Violation|0|||
146787705|NCT03524118|529395492|FG004|Overall Study|Protocol Violation|1|||
146787706|NCT03524118|529395493|FG005|Overall Study|Protocol Violation|0|||
146787707|NCT03524118|529395488|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146787708|NCT03524118|529395489|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146787709|NCT03524118|529395490|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146787710|NCT03524118|529395491|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
146787711|NCT03524118|529395492|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
146787712|NCT03524118|529395493|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
146787713|NCT01437709|529395494|FG000|Overall Study|Adverse Event|0|||
146787714|NCT01437709|529395495|FG001|Overall Study|Adverse Event|1|||
146787715|NCT01437709|529395496|FG002|Overall Study|Adverse Event|0|||
146787716|NCT01437709|529395494|FG000|Overall Study|Pt trasnferred care|0|||
146787717|NCT01437709|529395495|FG001|Overall Study|Pt trasnferred care|1|||
146787718|NCT01437709|529395496|FG002|Overall Study|Pt trasnferred care|0|||
146787719|NCT01842542|529395497|FG000|Overall Study|Withdrawal by Subject|2|||
146787720|NCT01842542|529395497|FG000|Overall Study|Lack of Efficacy|1|||
146787721|NCT01842542|529395497|FG000|Overall Study|Protocol Non-compliance|2|||
146787722|NCT01842542|529395497|FG000|Overall Study|Lost to Follow-up|1|||
146787723|NCT01715285|529395498|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
146787724|NCT01715285|529395499|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
146787725|NCT01715285|529395500|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
146787726|NCT01715285|529395498|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
146787727|NCT01715285|529395499|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
146787728|NCT01715285|529395500|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
146787729|NCT01715285|529395498|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
146787730|NCT01715285|529395499|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
146787731|NCT01715285|529395500|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
146787732|NCT01715285|529395498|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
146787733|NCT01715285|529395499|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
146787734|NCT01715285|529395500|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
146787735|NCT01715285|529395498|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
146787736|NCT01715285|529395499|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
146787737|NCT01715285|529395500|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
146787738|NCT01715285|529395498|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
146787739|NCT01715285|529395499|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
146787740|NCT01715285|529395500|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
146787741|NCT01715285|529395498|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
146787742|NCT01715285|529395499|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
146787743|NCT01715285|529395500|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
146787744|NCT01715285|529395498|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
146787745|NCT01715285|529395499|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
146787746|NCT01715285|529395500|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
146787747|NCT01715285|529395498|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
146937225|NCT01998958|529928322|FG020|Period 1 (Panel A and B)|Other|0|||
146787748|NCT01715285|529395499|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
146787749|NCT01715285|529395500|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
146787750|NCT01715285|529395498|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
146787751|NCT01715285|529395499|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
146787752|NCT01715285|529395500|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
146787753|NCT01715285|529395498|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
146787754|NCT01715285|529395499|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
146787755|NCT01715285|529395500|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
146787756|NCT01715285|529395498|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
146787757|NCT01715285|529395499|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
146787758|NCT01715285|529395500|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
146787759|NCT01715285|529395498|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
146787760|NCT01715285|529395499|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
146787761|NCT01715285|529395500|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
146787762|NCT01715285|529395498|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
146787763|NCT01715285|529395499|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
146787764|NCT01715285|529395500|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
146787765|NCT05780437|529395501|FG000|Overall Study|Withdrawal by Subject|22|||
146787766|NCT05780437|529395502|FG001|Overall Study|Withdrawal by Subject|16|||
146787767|NCT03452579|529395509|FG000|Overall Study|Death|0|||
146787768|NCT03452579|529395510|FG001|Overall Study|Death|1|||
146787769|NCT03452579|529395509|FG000|Overall Study|Withdrawal by Subject|2|||
146787770|NCT03452579|529395510|FG001|Overall Study|Withdrawal by Subject|0|||
146787771|NCT03452579|529395509|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
146787772|NCT03452579|529395510|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
146787773|NCT03452579|529395509|FG000|Overall Study|Physician Decision|1|||
146787774|NCT03452579|529395510|FG001|Overall Study|Physician Decision|1|||
146787775|NCT03452579|529395509|FG000|Overall Study|Adverse Event|1|||
146787776|NCT03452579|529395510|FG001|Overall Study|Adverse Event|4|||
146787777|NCT02573493|529395516|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
146787778|NCT02573493|529395517|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
146787779|NCT02573493|529395518|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
146787780|NCT02573493|529395519|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
146787781|NCT02677805|529395523|FG000|Double Blind Phase|Lost to Follow-up|8|||
146787782|NCT02677805|529395524|FG001|Double Blind Phase|Lost to Follow-up|3|||
146787783|NCT02677805|529395525|FG002|Double Blind Phase|Lost to Follow-up|0|||
146787784|NCT02677805|529395523|FG000|Double Blind Phase|Withdrawal by Subject|5|||
146787785|NCT02677805|529395524|FG001|Double Blind Phase|Withdrawal by Subject|2|||
146787786|NCT02677805|529395525|FG002|Double Blind Phase|Withdrawal by Subject|0|||
146787787|NCT02677805|529395523|FG000|Open Label Phase|Lost to Follow-up|0|||
146787788|NCT02677805|529395524|FG001|Open Label Phase|Lost to Follow-up|0|||
146787789|NCT02677805|529395525|FG002|Open Label Phase|Lost to Follow-up|10|||
146787790|NCT02677805|529395523|FG000|Open Label Phase|Withdrawal by Subject|0|||
146787791|NCT02677805|529395524|FG001|Open Label Phase|Withdrawal by Subject|0|||
146787792|NCT02677805|529395525|FG002|Open Label Phase|Withdrawal by Subject|6|||
146787793|NCT04111536|529395530|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
146787794|NCT04111536|529395531|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
146787795|NCT04111536|529395530|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
146787796|NCT04111536|529395531|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
146787797|NCT04111536|529395530|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
146787798|NCT04111536|529395531|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
146787799|NCT04111536|529395530|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
146787800|NCT04111536|529395531|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
146787801|NCT04350463|529395532|FG000|Overall Study|Other reason|0|||
146787802|NCT04350463|529395533|FG001|Overall Study|Other reason|0|||
146787803|NCT04350463|529395534|FG002|Overall Study|Other reason|0|||
146620361|NCT03291067|528781706|FG002|Overall Study|Protocol Violation|4|||
146787804|NCT04350463|529395535|FG003|Overall Study|Other reason|1|||
146787805|NCT04350463|529395532|FG000|Overall Study|Lost to Follow-up|0|||
146787806|NCT04350463|529395533|FG001|Overall Study|Lost to Follow-up|0|||
146787807|NCT04350463|529395534|FG002|Overall Study|Lost to Follow-up|0|||
146787808|NCT04350463|529395535|FG003|Overall Study|Lost to Follow-up|2|||
146787809|NCT04350463|529395532|FG000|Overall Study|Withdrawal by Subject|4|||
146787810|NCT04350463|529395533|FG001|Overall Study|Withdrawal by Subject|0|||
146787811|NCT04350463|529395534|FG002|Overall Study|Withdrawal by Subject|1|||
146787812|NCT04350463|529395535|FG003|Overall Study|Withdrawal by Subject|4|||
146787813|NCT04350463|529395532|FG000|Overall Study|Adverse Event|0|||
146787814|NCT04350463|529395533|FG001|Overall Study|Adverse Event|0|||
146787815|NCT04350463|529395534|FG002|Overall Study|Adverse Event|0|||
146787816|NCT04350463|529395535|FG003|Overall Study|Adverse Event|2|||
146787817|NCT04350463|529395532|FG000|Overall Study|Death|27|||
146787818|NCT04350463|529395533|FG001|Overall Study|Death|2|||
146787819|NCT04350463|529395534|FG002|Overall Study|Death|13|||
146787820|NCT04350463|529395535|FG003|Overall Study|Death|26|||
146787821|NCT03544281|529395536|FG000|Main Study Phase|Death|3|||
146787822|NCT03544281|529395537|FG001|Main Study Phase|Death|2|||
146787823|NCT03544281|529395538|FG002|Main Study Phase|Death|6|||
146787824|NCT03544281|529395539|FG003|Main Study Phase|Death|8|||
146787825|NCT03544281|529395540|FG004|Main Study Phase|Death|4|||
146787826|NCT03544281|529395541|FG005|Main Study Phase|Death|2|||
146787827|NCT03544281|529395542|FG006|Main Study Phase|Death|4|||
146787828|NCT03544281|529395543|FG007|Main Study Phase|Death|5|||
146787829|NCT03544281|529395544|FG008|Main Study Phase|Death|5|||
146787830|NCT03544281|529395545|FG009|Main Study Phase|Death|8|||
146787831|NCT03544281|529395546|FG010|Main Study Phase|Death|6|||
146787832|NCT03544281|529395547|FG011|Main Study Phase|Death|4|||
146787833|NCT03544281|529395548|FG012|Main Study Phase|Death|0|||
146787834|NCT03544281|529395549|FG013|Main Study Phase|Death|0|||
146787835|NCT03544281|529395550|FG014|Main Study Phase|Death|0|||
146787836|NCT03544281|529395551|FG015|Main Study Phase|Death|0|||
146787837|NCT03544281|529395552|FG016|Main Study Phase|Death|0|||
146787838|NCT03544281|529395553|FG017|Main Study Phase|Death|0|||
146787839|NCT03544281|529395554|FG018|Main Study Phase|Death|0|||
146787840|NCT03544281|529395555|FG019|Main Study Phase|Death|0|||
146787841|NCT03544281|529395556|FG020|Main Study Phase|Death|0|||
146787842|NCT03544281|529395557|FG021|Main Study Phase|Death|0|||
146787843|NCT03544281|529395536|FG000|Main Study Phase|Lost to Follow-up|0|||
146787844|NCT03544281|529395537|FG001|Main Study Phase|Lost to Follow-up|0|||
146787845|NCT03544281|529395538|FG002|Main Study Phase|Lost to Follow-up|0|||
146787846|NCT03544281|529395539|FG003|Main Study Phase|Lost to Follow-up|0|||
146787847|NCT03544281|529395540|FG004|Main Study Phase|Lost to Follow-up|0|||
146787848|NCT03544281|529395541|FG005|Main Study Phase|Lost to Follow-up|0|||
146787849|NCT03544281|529395542|FG006|Main Study Phase|Lost to Follow-up|0|||
146787850|NCT03544281|529395543|FG007|Main Study Phase|Lost to Follow-up|0|||
146787851|NCT03544281|529395544|FG008|Main Study Phase|Lost to Follow-up|0|||
146787852|NCT03544281|529395545|FG009|Main Study Phase|Lost to Follow-up|0|||
146787853|NCT03544281|529395546|FG010|Main Study Phase|Lost to Follow-up|1|||
146787854|NCT03544281|529395547|FG011|Main Study Phase|Lost to Follow-up|0|||
146787855|NCT03544281|529395548|FG012|Main Study Phase|Lost to Follow-up|0|||
146787856|NCT03544281|529395549|FG013|Main Study Phase|Lost to Follow-up|0|||
146787857|NCT03544281|529395550|FG014|Main Study Phase|Lost to Follow-up|0|||
146787858|NCT03544281|529395551|FG015|Main Study Phase|Lost to Follow-up|0|||
146787859|NCT03544281|529395552|FG016|Main Study Phase|Lost to Follow-up|0|||
146787860|NCT03544281|529395553|FG017|Main Study Phase|Lost to Follow-up|0|||
146787861|NCT03544281|529395554|FG018|Main Study Phase|Lost to Follow-up|0|||
146787862|NCT03544281|529395555|FG019|Main Study Phase|Lost to Follow-up|0|||
146787863|NCT03544281|529395556|FG020|Main Study Phase|Lost to Follow-up|0|||
146787864|NCT03544281|529395557|FG021|Main Study Phase|Lost to Follow-up|0|||
146787865|NCT03544281|529395536|FG000|Main Study Phase|Physician Decision|0|||
146787866|NCT03544281|529395537|FG001|Main Study Phase|Physician Decision|0|||
146787867|NCT03544281|529395538|FG002|Main Study Phase|Physician Decision|0|||
146787868|NCT03544281|529395539|FG003|Main Study Phase|Physician Decision|0|||
146787869|NCT03544281|529395540|FG004|Main Study Phase|Physician Decision|0|||
146787870|NCT03544281|529395541|FG005|Main Study Phase|Physician Decision|0|||
146787871|NCT03544281|529395542|FG006|Main Study Phase|Physician Decision|0|||
146787872|NCT03544281|529395543|FG007|Main Study Phase|Physician Decision|1|||
146787873|NCT03544281|529395544|FG008|Main Study Phase|Physician Decision|0|||
146787874|NCT03544281|529395545|FG009|Main Study Phase|Physician Decision|0|||
146787875|NCT03544281|529395546|FG010|Main Study Phase|Physician Decision|0|||
146787876|NCT03544281|529395547|FG011|Main Study Phase|Physician Decision|0|||
146787877|NCT03544281|529395548|FG012|Main Study Phase|Physician Decision|0|||
146787878|NCT03544281|529395549|FG013|Main Study Phase|Physician Decision|0|||
146787879|NCT03544281|529395550|FG014|Main Study Phase|Physician Decision|0|||
146787880|NCT03544281|529395551|FG015|Main Study Phase|Physician Decision|0|||
146787881|NCT03544281|529395552|FG016|Main Study Phase|Physician Decision|0|||
146620362|NCT03291067|528781707|FG003|Overall Study|Protocol Violation|2|||
146787882|NCT03544281|529395553|FG017|Main Study Phase|Physician Decision|0|||
146787883|NCT03544281|529395554|FG018|Main Study Phase|Physician Decision|0|||
146787884|NCT03544281|529395555|FG019|Main Study Phase|Physician Decision|0|||
146787885|NCT03544281|529395556|FG020|Main Study Phase|Physician Decision|0|||
146787886|NCT03544281|529395557|FG021|Main Study Phase|Physician Decision|0|||
146787887|NCT03544281|529395536|FG000|Main Study Phase|Withdrawal by Subject|2|||
146787888|NCT03544281|529395537|FG001|Main Study Phase|Withdrawal by Subject|0|||
146787889|NCT03544281|529395538|FG002|Main Study Phase|Withdrawal by Subject|1|||
146787890|NCT03544281|529395539|FG003|Main Study Phase|Withdrawal by Subject|2|||
146787891|NCT03544281|529395540|FG004|Main Study Phase|Withdrawal by Subject|0|||
146787892|NCT03544281|529395541|FG005|Main Study Phase|Withdrawal by Subject|0|||
146787893|NCT03544281|529395542|FG006|Main Study Phase|Withdrawal by Subject|0|||
146787894|NCT03544281|529395543|FG007|Main Study Phase|Withdrawal by Subject|0|||
146787895|NCT03544281|529395544|FG008|Main Study Phase|Withdrawal by Subject|2|||
146787896|NCT03544281|529395545|FG009|Main Study Phase|Withdrawal by Subject|3|||
146787897|NCT03544281|529395546|FG010|Main Study Phase|Withdrawal by Subject|0|||
146937226|NCT01998958|529928323|FG021|Period 1 (Panel A and B)|Other|0|||
146787898|NCT03544281|529395547|FG011|Main Study Phase|Withdrawal by Subject|4|||
146787899|NCT03544281|529395548|FG012|Main Study Phase|Withdrawal by Subject|0|||
146787900|NCT03544281|529395549|FG013|Main Study Phase|Withdrawal by Subject|0|||
146787901|NCT03544281|529395550|FG014|Main Study Phase|Withdrawal by Subject|0|||
146787902|NCT03544281|529395551|FG015|Main Study Phase|Withdrawal by Subject|0|||
146787903|NCT03544281|529395552|FG016|Main Study Phase|Withdrawal by Subject|0|||
146787904|NCT03544281|529395553|FG017|Main Study Phase|Withdrawal by Subject|0|||
146787905|NCT03544281|529395554|FG018|Main Study Phase|Withdrawal by Subject|0|||
146787906|NCT03544281|529395555|FG019|Main Study Phase|Withdrawal by Subject|0|||
146787907|NCT03544281|529395556|FG020|Main Study Phase|Withdrawal by Subject|0|||
146787908|NCT03544281|529395557|FG021|Main Study Phase|Withdrawal by Subject|0|||
146787909|NCT03544281|529395536|FG000|Main Study Phase|Ongoing|3|||
146787910|NCT03544281|529395537|FG001|Main Study Phase|Ongoing|1|||
146787911|NCT03544281|529395538|FG002|Main Study Phase|Ongoing|2|||
146787912|NCT03544281|529395539|FG003|Main Study Phase|Ongoing|4|||
146787913|NCT03544281|529395540|FG004|Main Study Phase|Ongoing|2|||
146787914|NCT03544281|529395541|FG005|Main Study Phase|Ongoing|4|||
146787915|NCT03544281|529395542|FG006|Main Study Phase|Ongoing|4|||
146787916|NCT03544281|529395543|FG007|Main Study Phase|Ongoing|0|||
146787917|NCT03544281|529395544|FG008|Main Study Phase|Ongoing|2|||
146787918|NCT03544281|529395545|FG009|Main Study Phase|Ongoing|2|||
146787919|NCT03544281|529395546|FG010|Main Study Phase|Ongoing|1|||
146787920|NCT03544281|529395547|FG011|Main Study Phase|Ongoing|0|||
146787921|NCT03544281|529395548|FG012|Main Study Phase|Ongoing|0|||
146787922|NCT03544281|529395549|FG013|Main Study Phase|Ongoing|0|||
146787923|NCT03544281|529395550|FG014|Main Study Phase|Ongoing|0|||
146787924|NCT03544281|529395551|FG015|Main Study Phase|Ongoing|0|||
146787925|NCT03544281|529395552|FG016|Main Study Phase|Ongoing|0|||
146787926|NCT03544281|529395553|FG017|Main Study Phase|Ongoing|0|||
146787927|NCT03544281|529395554|FG018|Main Study Phase|Ongoing|0|||
146787928|NCT03544281|529395555|FG019|Main Study Phase|Ongoing|0|||
146787929|NCT03544281|529395556|FG020|Main Study Phase|Ongoing|0|||
146787930|NCT03544281|529395557|FG021|Main Study Phase|Ongoing|0|||
146787931|NCT03544281|529395536|FG000|Main Study Phase|Investigator Site Closed|0|||
146787932|NCT03544281|529395537|FG001|Main Study Phase|Investigator Site Closed|0|||
146787933|NCT03544281|529395538|FG002|Main Study Phase|Investigator Site Closed|0|||
146787934|NCT03544281|529395539|FG003|Main Study Phase|Investigator Site Closed|0|||
146937227|NCT01998958|529928324|FG022|Period 1 (Panel A and B)|Other|0|||
146937228|NCT01998958|529928325|FG023|Period 1 (Panel A and B)|Other|0|||
146937229|NCT01998958|529928326|FG024|Period 1 (Panel A and B)|Other|0|||
146937230|NCT01998958|529928327|FG025|Period 1 (Panel A and B)|Other|0|||
146787935|NCT03544281|529395540|FG004|Main Study Phase|Investigator Site Closed|0|||
146787936|NCT03544281|529395541|FG005|Main Study Phase|Investigator Site Closed|0|||
146787937|NCT03544281|529395542|FG006|Main Study Phase|Investigator Site Closed|0|||
146787938|NCT03544281|529395543|FG007|Main Study Phase|Investigator Site Closed|0|||
146787939|NCT03544281|529395544|FG008|Main Study Phase|Investigator Site Closed|0|||
146787940|NCT03544281|529395545|FG009|Main Study Phase|Investigator Site Closed|1|||
146787941|NCT03544281|529395546|FG010|Main Study Phase|Investigator Site Closed|0|||
146787942|NCT03544281|529395547|FG011|Main Study Phase|Investigator Site Closed|0|||
146787943|NCT03544281|529395548|FG012|Main Study Phase|Investigator Site Closed|0|||
146787944|NCT03544281|529395549|FG013|Main Study Phase|Investigator Site Closed|0|||
146937231|NCT01998958|529928328|FG026|Period 1 (Panel A and B)|Other|0|||
146937232|NCT01998958|529928329|FG027|Period 1 (Panel A and B)|Other|0|||
146937233|NCT01998958|529928330|FG028|Period 1 (Panel A and B)|Other|0|||
146937234|NCT01998958|529928331|FG029|Period 1 (Panel A and B)|Other|0|||
146937235|NCT01998958|529928332|FG030|Period 1 (Panel A and B)|Other|0|||
146937236|NCT01998958|529928333|FG031|Period 1 (Panel A and B)|Other|0|||
146937237|NCT01998958|529928302|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
146937238|NCT01998958|529928303|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
146937239|NCT01998958|529928304|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
146937240|NCT01998958|529928305|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
146937241|NCT01998958|529928306|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
146937242|NCT01998958|529928307|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
146937243|NCT01998958|529928308|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
146937244|NCT01998958|529928309|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
146937245|NCT01998958|529928310|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
146937246|NCT01998958|529928311|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
146937247|NCT01998958|529928312|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
146937248|NCT01998958|529928313|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
146787945|NCT03544281|529395550|FG014|Main Study Phase|Investigator Site Closed|0|||
146787946|NCT03544281|529395551|FG015|Main Study Phase|Investigator Site Closed|0|||
146787947|NCT03544281|529395552|FG016|Main Study Phase|Investigator Site Closed|0|||
146787948|NCT03544281|529395553|FG017|Main Study Phase|Investigator Site Closed|0|||
146787949|NCT03544281|529395554|FG018|Main Study Phase|Investigator Site Closed|0|||
146937249|NCT01998958|529928314|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
146787950|NCT03544281|529395555|FG019|Main Study Phase|Investigator Site Closed|0|||
146787951|NCT03544281|529395556|FG020|Main Study Phase|Investigator Site Closed|0|||
146937250|NCT01998958|529928315|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
146937251|NCT01998958|529928316|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
146787952|NCT03544281|529395557|FG021|Main Study Phase|Investigator Site Closed|0|||
146787953|NCT03544281|529395536|FG000|Main Study Phase|Did not receive study treatment|0|||
146787954|NCT03544281|529395537|FG001|Main Study Phase|Did not receive study treatment|0|||
146787955|NCT03544281|529395538|FG002|Main Study Phase|Did not receive study treatment|0|||
146787956|NCT03544281|529395539|FG003|Main Study Phase|Did not receive study treatment|0|||
146787957|NCT03544281|529395540|FG004|Main Study Phase|Did not receive study treatment|0|||
146787958|NCT03544281|529395541|FG005|Main Study Phase|Did not receive study treatment|0|||
146787959|NCT03544281|529395542|FG006|Main Study Phase|Did not receive study treatment|1|||
146787960|NCT03544281|529395543|FG007|Main Study Phase|Did not receive study treatment|0|||
146787961|NCT03544281|529395544|FG008|Main Study Phase|Did not receive study treatment|0|||
146787962|NCT03544281|529395545|FG009|Main Study Phase|Did not receive study treatment|0|||
146787963|NCT03544281|529395546|FG010|Main Study Phase|Did not receive study treatment|0|||
146787964|NCT03544281|529395547|FG011|Main Study Phase|Did not receive study treatment|0|||
146787965|NCT03544281|529395548|FG012|Main Study Phase|Did not receive study treatment|0|||
146787966|NCT03544281|529395549|FG013|Main Study Phase|Did not receive study treatment|0|||
146787967|NCT03544281|529395550|FG014|Main Study Phase|Did not receive study treatment|0|||
146787968|NCT03544281|529395551|FG015|Main Study Phase|Did not receive study treatment|0|||
146787969|NCT03544281|529395552|FG016|Main Study Phase|Did not receive study treatment|0|||
146787970|NCT03544281|529395553|FG017|Main Study Phase|Did not receive study treatment|0|||
146787971|NCT03544281|529395554|FG018|Main Study Phase|Did not receive study treatment|0|||
146787972|NCT03544281|529395555|FG019|Main Study Phase|Did not receive study treatment|0|||
146787973|NCT03544281|529395556|FG020|Main Study Phase|Did not receive study treatment|0|||
146787974|NCT03544281|529395557|FG021|Main Study Phase|Did not receive study treatment|0|||
146787975|NCT03544281|529395536|FG000|PACT Phase|Adverse Event|0|||
146787976|NCT03544281|529395537|FG001|PACT Phase|Adverse Event|0|||
146787977|NCT03544281|529395538|FG002|PACT Phase|Adverse Event|0|||
146787978|NCT03544281|529395539|FG003|PACT Phase|Adverse Event|0|||
146787979|NCT03544281|529395540|FG004|PACT Phase|Adverse Event|0|||
146787980|NCT03544281|529395541|FG005|PACT Phase|Adverse Event|0|||
146787981|NCT03544281|529395542|FG006|PACT Phase|Adverse Event|0|||
146787982|NCT03544281|529395543|FG007|PACT Phase|Adverse Event|0|||
146787983|NCT03544281|529395544|FG008|PACT Phase|Adverse Event|0|||
146787984|NCT03544281|529395545|FG009|PACT Phase|Adverse Event|0|||
146787985|NCT03544281|529395546|FG010|PACT Phase|Adverse Event|0|||
146787986|NCT03544281|529395547|FG011|PACT Phase|Adverse Event|0|||
146787987|NCT03544281|529395548|FG012|PACT Phase|Adverse Event|1|||
146787988|NCT03544281|529395549|FG013|PACT Phase|Adverse Event|0|||
146787989|NCT03544281|529395550|FG014|PACT Phase|Adverse Event|0|||
146787990|NCT03544281|529395551|FG015|PACT Phase|Adverse Event|0|||
146787991|NCT03544281|529395552|FG016|PACT Phase|Adverse Event|0|||
146787992|NCT03544281|529395553|FG017|PACT Phase|Adverse Event|1|||
146787993|NCT03544281|529395554|FG018|PACT Phase|Adverse Event|1|||
146787994|NCT03544281|529395555|FG019|PACT Phase|Adverse Event|0|||
146787995|NCT03544281|529395556|FG020|PACT Phase|Adverse Event|0|||
146787996|NCT03544281|529395557|FG021|PACT Phase|Adverse Event|0|||
146787997|NCT02547987|529395558|FG000|Overall Study|Withdrawal by Subject|1|||
146787998|NCT02547987|529395558|FG000|Overall Study|Adverse Event|2|||
146787999|NCT04282148|529395559|FG000|Overall Study|Death|7|||
146788000|NCT04282148|529395559|FG000|Overall Study|Withdrawal by Subject|1|||
146788001|NCT04282148|529395559|FG000|Overall Study|Physician Decision|1|||
146788002|NCT04938492|529395561|FG000|Overall Study|Lost to Follow-up|17|||
146788003|NCT04938492|529395562|FG001|Overall Study|Lost to Follow-up|18|||
146788004|NCT01648023|529395563|FG000|Overall Study|Screen Fail Post Randomization|1|||
146788005|NCT01648023|529395564|FG001|Overall Study|Screen Fail Post Randomization|2|||
146788006|NCT04137289|529395567|FG000|Overall Study|Death|0|||
146788007|NCT04137289|529395568|FG001|Overall Study|Death|0|||
146788008|NCT04137289|529395569|FG002|Overall Study|Death|0|||
146788009|NCT04137289|529395570|FG003|Overall Study|Death|0|||
146788010|NCT04137289|529395571|FG004|Overall Study|Death|0|||
146788011|NCT04137289|529395572|FG005|Overall Study|Death|0|||
146788012|NCT04137289|529395573|FG006|Overall Study|Death|1|||
146788013|NCT04137289|529395574|FG007|Overall Study|Death|0|||
146788014|NCT04137289|529395575|FG008|Overall Study|Death|0|||
146937252|NCT01998958|529928317|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
146937253|NCT01998958|529928318|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
146788015|NCT04137289|529395567|FG000|Overall Study|Clinical disease progression|0|||
146788016|NCT04137289|529395568|FG001|Overall Study|Clinical disease progression|0|||
146788017|NCT04137289|529395569|FG002|Overall Study|Clinical disease progression|0|||
146788018|NCT04137289|529395570|FG003|Overall Study|Clinical disease progression|4|||
146788019|NCT04137289|529395571|FG004|Overall Study|Clinical disease progression|4|||
146788020|NCT04137289|529395572|FG005|Overall Study|Clinical disease progression|2|||
146788021|NCT04137289|529395573|FG006|Overall Study|Clinical disease progression|5|||
146788022|NCT04137289|529395574|FG007|Overall Study|Clinical disease progression|1|||
146788023|NCT04137289|529395575|FG008|Overall Study|Clinical disease progression|0|||
146788024|NCT04137289|529395567|FG000|Overall Study|Lost to Follow-up|0|||
146788025|NCT04137289|529395568|FG001|Overall Study|Lost to Follow-up|0|||
146788026|NCT04137289|529395569|FG002|Overall Study|Lost to Follow-up|0|||
146788027|NCT04137289|529395570|FG003|Overall Study|Lost to Follow-up|1|||
146788028|NCT04137289|529395571|FG004|Overall Study|Lost to Follow-up|0|||
146788029|NCT04137289|529395572|FG005|Overall Study|Lost to Follow-up|0|||
146788030|NCT04137289|529395573|FG006|Overall Study|Lost to Follow-up|0|||
146788031|NCT04137289|529395574|FG007|Overall Study|Lost to Follow-up|0|||
146788032|NCT04137289|529395575|FG008|Overall Study|Lost to Follow-up|0|||
146788033|NCT04137289|529395567|FG000|Overall Study|Adverse Event|0|||
146788034|NCT04137289|529395568|FG001|Overall Study|Adverse Event|0|||
146788035|NCT04137289|529395569|FG002|Overall Study|Adverse Event|1|||
146788036|NCT04137289|529395570|FG003|Overall Study|Adverse Event|0|||
146788037|NCT04137289|529395571|FG004|Overall Study|Adverse Event|0|||
146788038|NCT04137289|529395572|FG005|Overall Study|Adverse Event|1|||
146788039|NCT04137289|529395573|FG006|Overall Study|Adverse Event|0|||
146788040|NCT04137289|529395574|FG007|Overall Study|Adverse Event|0|||
146788041|NCT04137289|529395575|FG008|Overall Study|Adverse Event|0|||
146788042|NCT04137289|529395567|FG000|Overall Study|Lack of clinical benefit|0|||
146788043|NCT04137289|529395568|FG001|Overall Study|Lack of clinical benefit|0|||
146788044|NCT04137289|529395569|FG002|Overall Study|Lack of clinical benefit|0|||
146788045|NCT04137289|529395570|FG003|Overall Study|Lack of clinical benefit|0|||
146788046|NCT04137289|529395571|FG004|Overall Study|Lack of clinical benefit|0|||
146788047|NCT04137289|529395572|FG005|Overall Study|Lack of clinical benefit|0|||
146788048|NCT04137289|529395573|FG006|Overall Study|Lack of clinical benefit|0|||
146788049|NCT04137289|529395574|FG007|Overall Study|Lack of clinical benefit|0|||
146788050|NCT04137289|529395575|FG008|Overall Study|Lack of clinical benefit|1|||
146788051|NCT04137289|529395567|FG000|Overall Study|Objective disease progression|1|||
146788052|NCT04137289|529395568|FG001|Overall Study|Objective disease progression|1|||
146788053|NCT04137289|529395569|FG002|Overall Study|Objective disease progression|6|||
146788054|NCT04137289|529395570|FG003|Overall Study|Objective disease progression|18|||
146788055|NCT04137289|529395571|FG004|Overall Study|Objective disease progression|12|||
146788056|NCT04137289|529395572|FG005|Overall Study|Objective disease progression|20|||
146788057|NCT04137289|529395573|FG006|Overall Study|Objective disease progression|18|||
146788058|NCT04137289|529395574|FG007|Overall Study|Objective disease progression|7|||
146788059|NCT04137289|529395575|FG008|Overall Study|Objective disease progression|6|||
146788060|NCT04307355|529395576|FG000|Overall Study|Non-Compliance|3|||
146788061|NCT04307355|529395577|FG001|Overall Study|Non-Compliance|3|||
146788062|NCT04307355|529395578|FG002|Overall Study|Non-Compliance|0|||
146788063|NCT04338061|529395581|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
146788064|NCT04338061|529395582|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
146788065|NCT04338061|529395581|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
146788066|NCT04338061|529395582|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
146788067|NCT04338061|529395581|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
146788068|NCT04338061|529395582|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
146788069|NCT04338061|529395581|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
146788070|NCT04338061|529395582|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
146788071|NCT04338061|529395581|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
146788072|NCT04338061|529395582|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
146788073|NCT04338061|529395581|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
146788074|NCT04338061|529395582|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
146788075|NCT04338061|529395581|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
146788076|NCT04338061|529395582|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
146788077|NCT04338061|529395581|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
146788078|NCT04338061|529395582|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
146788079|NCT04338061|529395581|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
146788080|NCT04338061|529395582|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
146788081|NCT04338061|529395581|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
146788082|NCT04338061|529395582|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
146788083|NCT04338061|529395581|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
146788084|NCT04338061|529395582|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
146788085|NCT04338061|529395581|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
146788086|NCT04338061|529395582|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
146788087|NCT04074759|529395583|FG000|Overall Study|Withdrawal by Subject|0|||
146788088|NCT04074759|529395584|FG001|Overall Study|Withdrawal by Subject|0|||
146788089|NCT04074759|529395585|FG002|Overall Study|Withdrawal by Subject|0|||
146788090|NCT04074759|529395586|FG003|Overall Study|Withdrawal by Subject|0|||
146788091|NCT04074759|529395587|FG004|Overall Study|Withdrawal by Subject|0|||
146788092|NCT04074759|529395588|FG005|Overall Study|Withdrawal by Subject|2|||
146788093|NCT04074759|529395589|FG006|Overall Study|Withdrawal by Subject|0|||
146788094|NCT04074759|529395590|FG007|Overall Study|Withdrawal by Subject|2|||
146788095|NCT04074759|529395591|FG008|Overall Study|Withdrawal by Subject|1|||
146788096|NCT04074759|529395592|FG009|Overall Study|Withdrawal by Subject|2|||
146788097|NCT04074759|529395593|FG010|Overall Study|Withdrawal by Subject|9|||
146788098|NCT04074759|529395594|FG011|Overall Study|Withdrawal by Subject|2|||
146788099|NCT04074759|529395595|FG012|Overall Study|Withdrawal by Subject|1|||
146788100|NCT04074759|529395596|FG013|Overall Study|Withdrawal by Subject|3|||
146788101|NCT04074759|529395597|FG014|Overall Study|Withdrawal by Subject|2|||
146981859|NCT02040766|530096162|FG003|Overall Study|Non-compliance|0|||
146981860|NCT02040766|530096163|FG004|Overall Study|Non-compliance|0|||
146981861|NCT02040766|530096159|FG000|Overall Study|Protocol Violation|2|||
146788102|NCT04074759|529395598|FG015|Overall Study|Withdrawal by Subject|0|||
146788103|NCT04074759|529395599|FG016|Overall Study|Withdrawal by Subject|0|||
146788104|NCT04074759|529395600|FG017|Overall Study|Withdrawal by Subject|3|||
146788105|NCT04074759|529395601|FG018|Overall Study|Withdrawal by Subject|1|||
146788106|NCT04074759|529395583|FG000|Overall Study|Death|1|||
146788107|NCT04074759|529395584|FG001|Overall Study|Death|0|||
146788108|NCT04074759|529395585|FG002|Overall Study|Death|1|||
146788109|NCT04074759|529395586|FG003|Overall Study|Death|1|||
146788110|NCT04074759|529395587|FG004|Overall Study|Death|2|||
146788111|NCT04074759|529395588|FG005|Overall Study|Death|0|||
146788112|NCT04074759|529395589|FG006|Overall Study|Death|1|||
146788113|NCT04074759|529395590|FG007|Overall Study|Death|0|||
146788114|NCT04074759|529395591|FG008|Overall Study|Death|3|||
146788115|NCT04074759|529395592|FG009|Overall Study|Death|2|||
146788116|NCT04074759|529395593|FG010|Overall Study|Death|4|||
146788117|NCT04074759|529395594|FG011|Overall Study|Death|1|||
146788118|NCT04074759|529395595|FG012|Overall Study|Death|0|||
146788119|NCT04074759|529395596|FG013|Overall Study|Death|2|||
146788120|NCT04074759|529395597|FG014|Overall Study|Death|1|||
146788121|NCT04074759|529395598|FG015|Overall Study|Death|0|||
146788122|NCT04074759|529395599|FG016|Overall Study|Death|1|||
146788123|NCT04074759|529395600|FG017|Overall Study|Death|0|||
146788124|NCT04074759|529395601|FG018|Overall Study|Death|1|||
146788125|NCT04074759|529395583|FG000|Overall Study|Lost to Follow-up|0|||
146788126|NCT04074759|529395584|FG001|Overall Study|Lost to Follow-up|0|||
146788127|NCT04074759|529395585|FG002|Overall Study|Lost to Follow-up|0|||
146788128|NCT04074759|529395586|FG003|Overall Study|Lost to Follow-up|0|||
146788129|NCT04074759|529395587|FG004|Overall Study|Lost to Follow-up|0|||
146788130|NCT04074759|529395588|FG005|Overall Study|Lost to Follow-up|0|||
146788131|NCT04074759|529395589|FG006|Overall Study|Lost to Follow-up|0|||
146788132|NCT04074759|529395590|FG007|Overall Study|Lost to Follow-up|0|||
146788133|NCT04074759|529395591|FG008|Overall Study|Lost to Follow-up|0|||
146788134|NCT04074759|529395592|FG009|Overall Study|Lost to Follow-up|0|||
146788135|NCT04074759|529395593|FG010|Overall Study|Lost to Follow-up|1|||
146788136|NCT04074759|529395594|FG011|Overall Study|Lost to Follow-up|0|||
146788137|NCT04074759|529395595|FG012|Overall Study|Lost to Follow-up|0|||
146788138|NCT04074759|529395596|FG013|Overall Study|Lost to Follow-up|0|||
146788139|NCT04074759|529395597|FG014|Overall Study|Lost to Follow-up|0|||
146788140|NCT04074759|529395598|FG015|Overall Study|Lost to Follow-up|0|||
146788141|NCT04074759|529395599|FG016|Overall Study|Lost to Follow-up|1|||
146788142|NCT04074759|529395600|FG017|Overall Study|Lost to Follow-up|0|||
146788143|NCT04074759|529395601|FG018|Overall Study|Lost to Follow-up|1|||
146788144|NCT04074759|529395583|FG000|Overall Study|Other|0|||
146788145|NCT04074759|529395584|FG001|Overall Study|Other|1|||
146788146|NCT04074759|529395585|FG002|Overall Study|Other|1|||
146788147|NCT04074759|529395586|FG003|Overall Study|Other|0|||
146788148|NCT04074759|529395587|FG004|Overall Study|Other|2|||
146788149|NCT04074759|529395588|FG005|Overall Study|Other|1|||
146788150|NCT04074759|529395589|FG006|Overall Study|Other|2|||
146788151|NCT04074759|529395590|FG007|Overall Study|Other|1|||
146788152|NCT04074759|529395591|FG008|Overall Study|Other|1|||
146788153|NCT04074759|529395592|FG009|Overall Study|Other|4|||
146788154|NCT04074759|529395593|FG010|Overall Study|Other|4|||
146788155|NCT04074759|529395594|FG011|Overall Study|Other|2|||
146788156|NCT04074759|529395595|FG012|Overall Study|Other|0|||
146788157|NCT04074759|529395596|FG013|Overall Study|Other|0|||
146788158|NCT04074759|529395597|FG014|Overall Study|Other|0|||
146788159|NCT04074759|529395598|FG015|Overall Study|Other|1|||
146788160|NCT04074759|529395599|FG016|Overall Study|Other|0|||
146788161|NCT04074759|529395600|FG017|Overall Study|Other|0|||
146788162|NCT04074759|529395601|FG018|Overall Study|Other|0|||
146788163|NCT04074759|529395583|FG000|Overall Study|Missing end of study status|0|||
146788164|NCT04074759|529395584|FG001|Overall Study|Missing end of study status|0|||
146788165|NCT04074759|529395585|FG002|Overall Study|Missing end of study status|0|||
146788166|NCT04074759|529395586|FG003|Overall Study|Missing end of study status|0|||
146788167|NCT04074759|529395587|FG004|Overall Study|Missing end of study status|0|||
146981862|NCT02040766|530096160|FG001|Overall Study|Protocol Violation|1|||
146788168|NCT04074759|529395588|FG005|Overall Study|Missing end of study status|0|||
146788169|NCT04074759|529395589|FG006|Overall Study|Missing end of study status|0|||
146788170|NCT04074759|529395590|FG007|Overall Study|Missing end of study status|0|||
146788171|NCT04074759|529395591|FG008|Overall Study|Missing end of study status|0|||
146788172|NCT04074759|529395592|FG009|Overall Study|Missing end of study status|0|||
146788173|NCT04074759|529395593|FG010|Overall Study|Missing end of study status|2|||
146788174|NCT04074759|529395594|FG011|Overall Study|Missing end of study status|0|||
146788175|NCT04074759|529395595|FG012|Overall Study|Missing end of study status|0|||
146788176|NCT04074759|529395596|FG013|Overall Study|Missing end of study status|0|||
146981863|NCT02040766|530096161|FG002|Overall Study|Protocol Violation|2|||
146788177|NCT04074759|529395597|FG014|Overall Study|Missing end of study status|0|||
146788178|NCT04074759|529395598|FG015|Overall Study|Missing end of study status|0|||
146788179|NCT04074759|529395599|FG016|Overall Study|Missing end of study status|1|||
146788180|NCT04074759|529395600|FG017|Overall Study|Missing end of study status|0|||
146788181|NCT04074759|529395601|FG018|Overall Study|Missing end of study status|0|||
146788182|NCT03631784|529395602|FG000|Overall Study|Participants Ongoing|1|||
146788183|NCT03631784|529395603|FG001|Overall Study|Participants Ongoing|0|||
146788184|NCT03631784|529395602|FG000|Overall Study|Withdrawal by Subject|3|||
146788185|NCT03631784|529395603|FG001|Overall Study|Withdrawal by Subject|3|||
146788186|NCT03631784|529395602|FG000|Overall Study|Sponsor's Decision|36|||
146788187|NCT03631784|529395603|FG001|Overall Study|Sponsor's Decision|52|||
146788188|NCT03631784|529395602|FG000|Overall Study|Lost to Follow-up|1|||
146788189|NCT03631784|529395603|FG001|Overall Study|Lost to Follow-up|0|||
146788190|NCT03631784|529395602|FG000|Overall Study|Death|71|||
146788191|NCT03631784|529395603|FG001|Overall Study|Death|49|||
146788192|NCT05329220|529395604|FG000|Active Trial Period|Adverse Event|0|||
146788193|NCT05329220|529395605|FG001|Active Trial Period|Adverse Event|0|||
146788194|NCT05329220|529395606|FG002|Active Trial Period|Adverse Event|0|||
146788195|NCT05329220|529395607|FG003|Active Trial Period|Adverse Event|0|||
146788196|NCT05329220|529395608|FG004|Active Trial Period|Adverse Event|1|||
146788197|NCT05329220|529395609|FG005|Active Trial Period|Adverse Event|0|||
146788198|NCT05329220|529395604|FG000|Active Trial Period|Lost to Follow-up|0|||
146788199|NCT05329220|529395605|FG001|Active Trial Period|Lost to Follow-up|0|||
146788200|NCT05329220|529395606|FG002|Active Trial Period|Lost to Follow-up|0|||
146788201|NCT05329220|529395607|FG003|Active Trial Period|Lost to Follow-up|0|||
146788202|NCT05329220|529395608|FG004|Active Trial Period|Lost to Follow-up|32|||
146788203|NCT05329220|529395609|FG005|Active Trial Period|Lost to Follow-up|28|||
146788204|NCT05329220|529395604|FG000|Active Trial Period|Physician Decision|0|||
146788205|NCT05329220|529395605|FG001|Active Trial Period|Physician Decision|0|||
146788206|NCT05329220|529395606|FG002|Active Trial Period|Physician Decision|0|||
146788207|NCT05329220|529395607|FG003|Active Trial Period|Physician Decision|0|||
146788208|NCT05329220|529395608|FG004|Active Trial Period|Physician Decision|2|||
146788209|NCT05329220|529395609|FG005|Active Trial Period|Physician Decision|0|||
146788210|NCT05329220|529395604|FG000|Active Trial Period|Protocol Violation|0|||
146788211|NCT05329220|529395605|FG001|Active Trial Period|Protocol Violation|0|||
146788212|NCT05329220|529395606|FG002|Active Trial Period|Protocol Violation|0|||
146788213|NCT05329220|529395607|FG003|Active Trial Period|Protocol Violation|0|||
146788214|NCT05329220|529395608|FG004|Active Trial Period|Protocol Violation|1|||
146788215|NCT05329220|529395609|FG005|Active Trial Period|Protocol Violation|3|||
146788216|NCT05329220|529395604|FG000|Active Trial Period|Withdrawal by Subject|0|||
146788217|NCT05329220|529395605|FG001|Active Trial Period|Withdrawal by Subject|0|||
146788218|NCT05329220|529395606|FG002|Active Trial Period|Withdrawal by Subject|0|||
146788219|NCT05329220|529395607|FG003|Active Trial Period|Withdrawal by Subject|1|||
146788220|NCT05329220|529395608|FG004|Active Trial Period|Withdrawal by Subject|12|||
146788221|NCT05329220|529395609|FG005|Active Trial Period|Withdrawal by Subject|13|||
146788222|NCT05329220|529395604|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
146788223|NCT05329220|529395605|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
146788224|NCT05329220|529395606|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
146788225|NCT05329220|529395607|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
146788226|NCT05329220|529395608|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
146788227|NCT05329220|529395609|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
146788228|NCT05329220|529395604|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
146788229|NCT05329220|529395605|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
146788230|NCT05329220|529395606|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
146788231|NCT05329220|529395607|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
146788232|NCT05329220|529395608|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
146788233|NCT05329220|529395609|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
146788234|NCT05329220|529395604|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
146788235|NCT05329220|529395605|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
146788236|NCT05329220|529395606|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
146788237|NCT05329220|529395607|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
146788238|NCT05329220|529395608|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
146788239|NCT05329220|529395609|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
146788240|NCT05329220|529395604|FG000|Follow-up Period|Adverse Event|0|||
146788241|NCT05329220|529395605|FG001|Follow-up Period|Adverse Event|0|||
146937254|NCT01998958|529928319|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
146788242|NCT05329220|529395606|FG002|Follow-up Period|Adverse Event|0|||
146788243|NCT05329220|529395607|FG003|Follow-up Period|Adverse Event|0|||
146788244|NCT05329220|529395608|FG004|Follow-up Period|Adverse Event|2|||
146788245|NCT05329220|529395609|FG005|Follow-up Period|Adverse Event|1|||
146788246|NCT05329220|529395604|FG000|Follow-up Period|Death|0|||
146788247|NCT05329220|529395605|FG001|Follow-up Period|Death|0|||
146788248|NCT05329220|529395606|FG002|Follow-up Period|Death|1|||
146788249|NCT05329220|529395607|FG003|Follow-up Period|Death|1|||
146788250|NCT05329220|529395608|FG004|Follow-up Period|Death|0|||
146788251|NCT05329220|529395609|FG005|Follow-up Period|Death|1|||
146788252|NCT05329220|529395604|FG000|Follow-up Period|Lost to Follow-up|0|||
146788253|NCT05329220|529395605|FG001|Follow-up Period|Lost to Follow-up|1|||
146788254|NCT05329220|529395606|FG002|Follow-up Period|Lost to Follow-up|2|||
146788255|NCT05329220|529395607|FG003|Follow-up Period|Lost to Follow-up|2|||
146788256|NCT05329220|529395608|FG004|Follow-up Period|Lost to Follow-up|113|||
146788257|NCT05329220|529395609|FG005|Follow-up Period|Lost to Follow-up|89|||
146788258|NCT05329220|529395604|FG000|Follow-up Period|Physician Decision|0|||
146788259|NCT05329220|529395605|FG001|Follow-up Period|Physician Decision|0|||
146788260|NCT05329220|529395606|FG002|Follow-up Period|Physician Decision|0|||
146788261|NCT05329220|529395607|FG003|Follow-up Period|Physician Decision|0|||
146788262|NCT05329220|529395608|FG004|Follow-up Period|Physician Decision|2|||
146788263|NCT05329220|529395609|FG005|Follow-up Period|Physician Decision|2|||
146788264|NCT05329220|529395604|FG000|Follow-up Period|Protocol Violation|0|||
146788265|NCT05329220|529395605|FG001|Follow-up Period|Protocol Violation|0|||
146788266|NCT05329220|529395606|FG002|Follow-up Period|Protocol Violation|0|||
146788267|NCT05329220|529395607|FG003|Follow-up Period|Protocol Violation|0|||
146788268|NCT05329220|529395608|FG004|Follow-up Period|Protocol Violation|0|||
146788269|NCT05329220|529395609|FG005|Follow-up Period|Protocol Violation|1|||
146788270|NCT05329220|529395604|FG000|Follow-up Period|Withdrawal by Subject|0|||
146788271|NCT05329220|529395605|FG001|Follow-up Period|Withdrawal by Subject|0|||
146788272|NCT05329220|529395606|FG002|Follow-up Period|Withdrawal by Subject|1|||
146788273|NCT05329220|529395607|FG003|Follow-up Period|Withdrawal by Subject|1|||
146788274|NCT05329220|529395608|FG004|Follow-up Period|Withdrawal by Subject|34|||
146788275|NCT05329220|529395609|FG005|Follow-up Period|Withdrawal by Subject|35|||
146788276|NCT05329220|529395604|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
146788277|NCT05329220|529395605|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
146788278|NCT05329220|529395606|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
146788279|NCT05329220|529395607|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
146788280|NCT05329220|529395608|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
146788281|NCT05329220|529395609|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
146788282|NCT05329220|529395604|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
146788283|NCT05329220|529395605|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
146788284|NCT05329220|529395606|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
146788285|NCT05329220|529395607|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
146788286|NCT05329220|529395608|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
146788287|NCT05329220|529395609|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
146788288|NCT05329220|529395604|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
146788289|NCT05329220|529395605|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
146788290|NCT05329220|529395606|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
146788291|NCT05329220|529395607|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
146788292|NCT05329220|529395608|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
146788293|NCT05329220|529395609|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
146788294|NCT05329220|529395604|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
146788295|NCT05329220|529395605|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
146788296|NCT05329220|529395606|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
146788297|NCT05329220|529395607|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
146788298|NCT05329220|529395608|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
146788299|NCT05329220|529395609|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
146788300|NCT05329220|529395604|FG000|Follow-up Period|EARLY TERMINATION|0|||
146788301|NCT05329220|529395605|FG001|Follow-up Period|EARLY TERMINATION|0|||
146788302|NCT05329220|529395606|FG002|Follow-up Period|EARLY TERMINATION|0|||
146788303|NCT05329220|529395607|FG003|Follow-up Period|EARLY TERMINATION|0|||
146788304|NCT05329220|529395608|FG004|Follow-up Period|EARLY TERMINATION|0|||
146788305|NCT05329220|529395609|FG005|Follow-up Period|EARLY TERMINATION|1|||
146788306|NCT05329220|529395604|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
146848435|NCT03122223|529615682|FG003|Overall Study|Participant unable to adhere|0|||
146848436|NCT00291642|529615683|FG000|Overall Study|Adverse Event|1|||
146848437|NCT00291642|529615684|FG001|Overall Study|Adverse Event|0|||
146848438|NCT00291642|529615685|FG002|Overall Study|Adverse Event|1|||
146848439|NCT00291642|529615686|FG003|Overall Study|Adverse Event|0|||
146848440|NCT00291642|529615687|FG004|Overall Study|Adverse Event|1|||
146848441|NCT00291642|529615683|FG000|Overall Study|Patient missed visit|0|||
146848442|NCT00291642|529615684|FG001|Overall Study|Patient missed visit|0|||
146848443|NCT00291642|529615685|FG002|Overall Study|Patient missed visit|1|||
146937255|NCT01998958|529928320|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
146937256|NCT01998958|529928321|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
146937257|NCT01998958|529928322|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
146937258|NCT01998958|529928323|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
146937259|NCT01998958|529928324|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
146937260|NCT01998958|529928325|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
146788307|NCT05329220|529395605|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
146788308|NCT05329220|529395606|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
146788309|NCT05329220|529395607|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
146788310|NCT05329220|529395608|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
146788311|NCT05329220|529395609|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
146788312|NCT05329220|529395604|FG000|Follow-up Period|DROPPED|0|||
146788313|NCT05329220|529395605|FG001|Follow-up Period|DROPPED|0|||
146788314|NCT05329220|529395606|FG002|Follow-up Period|DROPPED|0|||
146788315|NCT05329220|529395607|FG003|Follow-up Period|DROPPED|0|||
146788316|NCT05329220|529395608|FG004|Follow-up Period|DROPPED|0|||
146788317|NCT05329220|529395609|FG005|Follow-up Period|DROPPED|1|||
146788318|NCT05329220|529395604|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
146788319|NCT05329220|529395605|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
146788320|NCT05329220|529395606|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
146788321|NCT05329220|529395607|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
146788322|NCT05329220|529395608|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
146788323|NCT05329220|529395609|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
146788324|NCT02465268|529395611|FG000|Overall Study|Withdrawal by Subject|4|||
146788325|NCT02465268|529395612|FG001|Overall Study|Withdrawal by Subject|3|||
146788326|NCT02465268|529395613|FG002|Overall Study|Withdrawal by Subject|1|||
146788327|NCT02465268|529395611|FG000|Overall Study|Not evaluable per protocol criteria|3|||
146788328|NCT02465268|529395612|FG001|Overall Study|Not evaluable per protocol criteria|2|||
146788329|NCT02465268|529395613|FG002|Overall Study|Not evaluable per protocol criteria|1|||
146788330|NCT02465268|529395611|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
146788331|NCT02465268|529395612|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
146788332|NCT02465268|529395613|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
146788333|NCT02465268|529395611|FG000|Overall Study|Study drug did not pass QA/QC|1|||
146788334|NCT02465268|529395612|FG001|Overall Study|Study drug did not pass QA/QC|0|||
146788335|NCT02465268|529395613|FG002|Overall Study|Study drug did not pass QA/QC|0|||
146788336|NCT02465268|529395611|FG000|Overall Study|Adverse Event|0|||
146788337|NCT02465268|529395612|FG001|Overall Study|Adverse Event|1|||
146788338|NCT02465268|529395613|FG002|Overall Study|Adverse Event|0|||
146788339|NCT02465268|529395611|FG000|Overall Study|Physician Decision|0|||
146788340|NCT02465268|529395612|FG001|Overall Study|Physician Decision|1|||
146788341|NCT02465268|529395613|FG002|Overall Study|Physician Decision|0|||
146788342|NCT05386030|529395614|FG000|Overall Study|Death|1|||
146788343|NCT05386030|529395615|FG001|Overall Study|Death|0|||
146788344|NCT05386030|529395614|FG000|Overall Study|Physician Decision|2|||
146788345|NCT05386030|529395615|FG001|Overall Study|Physician Decision|1|||
146788346|NCT05386030|529395614|FG000|Overall Study|Lost to Follow-up|19|||
146788347|NCT05386030|529395615|FG001|Overall Study|Lost to Follow-up|7|||
146788348|NCT05386030|529395614|FG000|Overall Study|Withdrawal by Subject|20|||
146788349|NCT05386030|529395615|FG001|Overall Study|Withdrawal by Subject|10|||
146788350|NCT05386030|529395614|FG000|Overall Study|Eligibility criteria violation|1|||
146788351|NCT05386030|529395615|FG001|Overall Study|Eligibility criteria violation|1|||
146788352|NCT05386030|529395614|FG000|Overall Study|Personal Reasons|1|||
146788353|NCT05386030|529395615|FG001|Overall Study|Personal Reasons|0|||
146788354|NCT00736723|529395616|FG000|Overall Study|Withdrawal by Subject|4|||
146788355|NCT00736723|529395617|FG001|Overall Study|Withdrawal by Subject|3|||
146788356|NCT04049643|529395618|FG000|Overall Study|Lack of Efficacy|1|||
146788357|NCT04049643|529395619|FG001|Overall Study|Lack of Efficacy|1|||
146937261|NCT01998958|529928326|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
146937262|NCT01998958|529928327|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
146937263|NCT01998958|529928328|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
146937264|NCT01998958|529928329|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
146937265|NCT01998958|529928330|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
146937266|NCT01998958|529928331|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
146937267|NCT01998958|529928332|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
146937268|NCT01998958|529928333|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
146937269|NCT01998958|529928302|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937270|NCT01998958|529928303|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937271|NCT01998958|529928304|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937272|NCT01998958|529928305|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937273|NCT01998958|529928306|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146788358|NCT04049643|529395620|FG002|Overall Study|Lack of Efficacy|0|||
146730447|NCT01090310|529184332|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
146730448|NCT01090310|529184333|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
146730449|NCT01090310|529184334|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
146730450|NCT01090310|529184331|FG000|Extension Study|Subject withdrew consent|0|||
146730451|NCT01090310|529184332|FG001|Extension Study|Subject withdrew consent|1|||
146730452|NCT01090310|529184333|FG002|Extension Study|Subject withdrew consent|0|||
146730453|NCT01090310|529184334|FG003|Extension Study|Subject withdrew consent|0|||
146730454|NCT00695786|529184335|FG000|Overall Study|Adverse Event|0|||
146730455|NCT00695786|529184336|FG001|Overall Study|Adverse Event|3|||
146730456|NCT00695786|529184337|FG002|Overall Study|Adverse Event|4|||
146730457|NCT00695786|529184338|FG003|Overall Study|Adverse Event|2|||
146730458|NCT00695786|529184335|FG000|Overall Study|Lost to Follow-up|0|||
146730459|NCT00695786|529184336|FG001|Overall Study|Lost to Follow-up|5|||
146730460|NCT00695786|529184337|FG002|Overall Study|Lost to Follow-up|1|||
146730461|NCT00695786|529184338|FG003|Overall Study|Lost to Follow-up|1|||
146730462|NCT00695786|529184335|FG000|Overall Study|Withdrawal by Subject|0|||
146730463|NCT00695786|529184336|FG001|Overall Study|Withdrawal by Subject|4|||
146730464|NCT00695786|529184337|FG002|Overall Study|Withdrawal by Subject|3|||
146730465|NCT00695786|529184338|FG003|Overall Study|Withdrawal by Subject|1|||
146730466|NCT00695786|529184335|FG000|Overall Study|Deemed Ineligible|1|||
146730467|NCT00695786|529184336|FG001|Overall Study|Deemed Ineligible|0|||
146730468|NCT00695786|529184337|FG002|Overall Study|Deemed Ineligible|0|||
146730469|NCT00695786|529184338|FG003|Overall Study|Deemed Ineligible|0|||
146730470|NCT00695786|529184335|FG000|Overall Study|Lack of Efficacy|0|||
146730471|NCT00695786|529184336|FG001|Overall Study|Lack of Efficacy|0|||
146730472|NCT00695786|529184337|FG002|Overall Study|Lack of Efficacy|0|||
146730473|NCT00695786|529184338|FG003|Overall Study|Lack of Efficacy|4|||
146730474|NCT01364922|529184344|FG000|Open-label (OL) Period|Adverse Event|7|||
146730475|NCT01364922|529184345|FG001|Open-label (OL) Period|Adverse Event|0|||
146730476|NCT01364922|529184346|FG002|Open-label (OL) Period|Adverse Event|0|||
146730477|NCT01364922|529184344|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
146730478|NCT01364922|529184345|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
146730479|NCT01364922|529184346|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
146730480|NCT01364922|529184344|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
146730481|NCT01364922|529184345|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
146730482|NCT01364922|529184346|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
146730483|NCT01364922|529184344|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
146730484|NCT01364922|529184345|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
146730485|NCT01364922|529184346|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
146730486|NCT01364922|529184344|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
146730487|NCT01364922|529184345|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
146730488|NCT01364922|529184346|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
146730489|NCT01364922|529184344|FG000|Open-label (OL) Period|Other, Unspecified|1|||
146730490|NCT01364922|529184345|FG001|Open-label (OL) Period|Other, Unspecified|0|||
146730491|NCT01364922|529184346|FG002|Open-label (OL) Period|Other, Unspecified|0|||
146730492|NCT01364922|529184344|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
146730493|NCT01364922|529184345|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
146730494|NCT01364922|529184346|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
146730495|NCT01364922|529184344|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
146730496|NCT01364922|529184345|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
146730497|NCT01364922|529184346|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
146730498|NCT01364922|529184344|FG000|Double-Blind (DB) Period|Adverse Event|0|||
146730499|NCT01364922|529184345|FG001|Double-Blind (DB) Period|Adverse Event|0|||
146730500|NCT01364922|529184346|FG002|Double-Blind (DB) Period|Adverse Event|1|||
146730501|NCT01364922|529184344|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
146730502|NCT01364922|529184345|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
146730503|NCT01364922|529184346|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
146730504|NCT04244396|529184349|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
146730505|NCT04244396|529184349|FG000|Overall Study|Withdrawal by Subject|2|||
146730506|NCT04244396|529184349|FG000|Overall Study|Study termination|37|||
146730507|NCT01787097|529184350|FG000|Overall Study|Withdrawal by Subject|1|||
146730508|NCT01787097|529184351|FG001|Overall Study|Withdrawal by Subject|0|||
146730509|NCT01787097|529184352|FG002|Overall Study|Withdrawal by Subject|0|||
146730510|NCT01787097|529184353|FG003|Overall Study|Withdrawal by Subject|0|||
146730511|NCT05178121|529184354|FG000|Overall Study|Other|4|||
146730512|NCT05178121|529184354|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
146730513|NCT01953003|529184355|FG000|Overall Study|Not treated|0|||
146730514|NCT01953003|529184356|FG001|Overall Study|Not treated|1|||
146730515|NCT01953003|529184355|FG000|Overall Study|Progressive disease|35|||
146730516|NCT01953003|529184356|FG001|Overall Study|Progressive disease|45|||
146730517|NCT01953003|529184355|FG000|Overall Study|Related Adverse events|7|||
146730518|NCT01953003|529184356|FG001|Overall Study|Related Adverse events|2|||
146730519|NCT01953003|529184355|FG000|Overall Study|Non-related adverse events|0|||
146730520|NCT01953003|529184356|FG001|Overall Study|Non-related adverse events|2|||
146730521|NCT01953003|529184355|FG000|Overall Study|Protocol Violation|0|||
146937274|NCT01998958|529928307|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937275|NCT01998958|529928308|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937276|NCT01998958|529928309|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937277|NCT01998958|529928310|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937278|NCT01998958|529928311|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937279|NCT01998958|529928312|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937280|NCT01998958|529928313|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937281|NCT01998958|529928314|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937282|NCT01998958|529928315|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937283|NCT01998958|529928316|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
146937284|NCT01998958|529928317|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937285|NCT01998958|529928318|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937286|NCT01998958|529928319|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937287|NCT01998958|529928320|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
146937288|NCT01998958|529928321|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937289|NCT01998958|529928322|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937290|NCT01998958|529928323|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937291|NCT01998958|529928324|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937292|NCT01998958|529928325|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937293|NCT01998958|529928326|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937294|NCT01998958|529928327|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937295|NCT01998958|529928328|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937296|NCT01998958|529928329|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937297|NCT01998958|529928330|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937298|NCT01998958|529928331|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937299|NCT01998958|529928332|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937300|NCT01998958|529928333|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146937301|NCT01998958|529928302|FG000|Open Label Phase (Optional)|Adverse Event|0|||
146937302|NCT01998958|529928303|FG001|Open Label Phase (Optional)|Adverse Event|0|||
146937303|NCT01998958|529928304|FG002|Open Label Phase (Optional)|Adverse Event|0|||
146937304|NCT01998958|529928305|FG003|Open Label Phase (Optional)|Adverse Event|0|||
146937305|NCT01998958|529928306|FG004|Open Label Phase (Optional)|Adverse Event|0|||
146937306|NCT01998958|529928307|FG005|Open Label Phase (Optional)|Adverse Event|0|||
146937307|NCT01998958|529928308|FG006|Open Label Phase (Optional)|Adverse Event|0|||
146937308|NCT01998958|529928309|FG007|Open Label Phase (Optional)|Adverse Event|0|||
146937309|NCT01998958|529928310|FG008|Open Label Phase (Optional)|Adverse Event|0|||
146937310|NCT01998958|529928311|FG009|Open Label Phase (Optional)|Adverse Event|0|||
146937311|NCT01998958|529928312|FG010|Open Label Phase (Optional)|Adverse Event|0|||
146937312|NCT01998958|529928313|FG011|Open Label Phase (Optional)|Adverse Event|0|||
146937313|NCT01998958|529928314|FG012|Open Label Phase (Optional)|Adverse Event|0|||
146937314|NCT01998958|529928315|FG013|Open Label Phase (Optional)|Adverse Event|0|||
146937315|NCT01998958|529928316|FG014|Open Label Phase (Optional)|Adverse Event|0|||
146937316|NCT01998958|529928317|FG015|Open Label Phase (Optional)|Adverse Event|0|||
146937317|NCT01998958|529928318|FG016|Open Label Phase (Optional)|Adverse Event|0|||
146937318|NCT01998958|529928319|FG017|Open Label Phase (Optional)|Adverse Event|0|||
146937319|NCT01998958|529928320|FG018|Open Label Phase (Optional)|Adverse Event|0|||
146937320|NCT01998958|529928321|FG019|Open Label Phase (Optional)|Adverse Event|0|||
146937321|NCT01998958|529928322|FG020|Open Label Phase (Optional)|Adverse Event|0|||
146937322|NCT01998958|529928323|FG021|Open Label Phase (Optional)|Adverse Event|0|||
146937323|NCT01998958|529928324|FG022|Open Label Phase (Optional)|Adverse Event|0|||
146937324|NCT01998958|529928325|FG023|Open Label Phase (Optional)|Adverse Event|1|||
146937325|NCT01998958|529928326|FG024|Open Label Phase (Optional)|Adverse Event|0|||
146937326|NCT01998958|529928327|FG025|Open Label Phase (Optional)|Adverse Event|0|||
146937327|NCT01998958|529928328|FG026|Open Label Phase (Optional)|Adverse Event|0|||
146937328|NCT01998958|529928329|FG027|Open Label Phase (Optional)|Adverse Event|0|||
146937329|NCT01998958|529928330|FG028|Open Label Phase (Optional)|Adverse Event|0|||
146937330|NCT01998958|529928331|FG029|Open Label Phase (Optional)|Adverse Event|0|||
146937331|NCT01998958|529928332|FG030|Open Label Phase (Optional)|Adverse Event|0|||
146937332|NCT01998958|529928333|FG031|Open Label Phase (Optional)|Adverse Event|0|||
146937333|NCT01998958|529928302|FG000|Open Label Phase (Optional)|Other|0|||
146937334|NCT01998958|529928303|FG001|Open Label Phase (Optional)|Other|0|||
146937335|NCT01998958|529928304|FG002|Open Label Phase (Optional)|Other|0|||
146937336|NCT01998958|529928305|FG003|Open Label Phase (Optional)|Other|0|||
146937337|NCT01998958|529928306|FG004|Open Label Phase (Optional)|Other|0|||
146981864|NCT02040766|530096162|FG003|Overall Study|Protocol Violation|3|||
146730522|NCT01953003|529184356|FG001|Overall Study|Protocol Violation|1|||
146730523|NCT01953003|529184355|FG000|Overall Study|Withdrawal by Subject|14|||
146730524|NCT01953003|529184356|FG001|Overall Study|Withdrawal by Subject|4|||
146730525|NCT03391765|529184362|FG000|Overall Study|Adverse Event|2|||
146937338|NCT01998958|529928307|FG005|Open Label Phase (Optional)|Other|0|||
146937339|NCT01998958|529928308|FG006|Open Label Phase (Optional)|Other|0|||
146937340|NCT01998958|529928309|FG007|Open Label Phase (Optional)|Other|0|||
146730526|NCT03391765|529184363|FG001|Overall Study|Adverse Event|0|||
146937341|NCT01998958|529928310|FG008|Open Label Phase (Optional)|Other|0|||
146788359|NCT04049643|529395618|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
146788360|NCT04049643|529395619|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
146788361|NCT04049643|529395620|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
146788362|NCT05028634|529397905|FG000|Overall Study|Withdrawal by Subject|0|||
146788363|NCT05028634|529397906|FG001|Overall Study|Withdrawal by Subject|1|||
146788364|NCT02140554|529397907|FG000|Overall Study|Withdrawal of consent|1|||
146788365|NCT02140554|529397908|FG001|Overall Study|Withdrawal of consent|0|||
146788366|NCT02140554|529397909|FG002|Overall Study|Withdrawal of consent|4|||
146788367|NCT02140554|529397907|FG000|Overall Study|Physician Decision|1|||
146788368|NCT02140554|529397908|FG001|Overall Study|Physician Decision|0|||
146788369|NCT02140554|529397909|FG002|Overall Study|Physician Decision|2|||
146788370|NCT02140554|529397907|FG000|Overall Study|Death|0|||
146788371|NCT02140554|529397908|FG001|Overall Study|Death|0|||
146788372|NCT02140554|529397909|FG002|Overall Study|Death|1|||
146788373|NCT02140554|529397907|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
146788374|NCT02140554|529397908|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
146937342|NCT01998958|529928311|FG009|Open Label Phase (Optional)|Other|0|||
146937343|NCT01998958|529928312|FG010|Open Label Phase (Optional)|Other|0|||
146937344|NCT01998958|529928313|FG011|Open Label Phase (Optional)|Other|0|||
146788375|NCT02140554|529397909|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
146788376|NCT03771417|529397910|FG000|Overall Study|Withdrawal by Subject|1|||
146788377|NCT03771417|529397911|FG001|Overall Study|Withdrawal by Subject|0|||
146788378|NCT03771417|529397912|FG002|Overall Study|Withdrawal by Subject|0|||
146788379|NCT03771417|529397910|FG000|Overall Study|Covid-19 Shutdown|0|||
146788380|NCT03771417|529397911|FG001|Overall Study|Covid-19 Shutdown|1|||
146788381|NCT03771417|529397912|FG002|Overall Study|Covid-19 Shutdown|0|||
146788382|NCT02100813|529397913|FG000|Overall Study|Adverse Event|0|||
146788383|NCT02100813|529397914|FG001|Overall Study|Adverse Event|0|||
146788384|NCT02100813|529397915|FG002|Overall Study|Adverse Event|0|||
146788385|NCT02100813|529397916|FG003|Overall Study|Adverse Event|0|||
146788386|NCT02100813|529397917|FG004|Overall Study|Adverse Event|0|||
146788387|NCT02100813|529397918|FG005|Overall Study|Adverse Event|0|||
146788388|NCT02100813|529397919|FG006|Overall Study|Adverse Event|0|||
146788389|NCT02100813|529397920|FG007|Overall Study|Adverse Event|1|||
146788390|NCT00506519|529397927|FG000|Overall Study|Death|4|||
146788391|NCT00506519|529397928|FG001|Overall Study|Death|6|||
146788392|NCT00506519|529397929|FG002|Overall Study|Death|0|||
146788393|NCT00506519|529397927|FG000|Overall Study|Adverse Event|1|||
146788394|NCT00506519|529397928|FG001|Overall Study|Adverse Event|0|||
146788395|NCT00506519|529397929|FG002|Overall Study|Adverse Event|0|||
146788396|NCT02975882|529397930|FG000|Overall Study|Adverse Event|1|||
146788397|NCT02975882|529397931|FG001|Overall Study|Adverse Event|2|||
146788398|NCT02975882|529397932|FG002|Overall Study|Adverse Event|1|||
146788399|NCT02975882|529397933|FG003|Overall Study|Adverse Event|1|||
146788400|NCT02975882|529397930|FG000|Overall Study|Death|0|||
146788401|NCT02975882|529397931|FG001|Overall Study|Death|1|||
146788402|NCT02975882|529397932|FG002|Overall Study|Death|0|||
146788403|NCT02975882|529397933|FG003|Overall Study|Death|0|||
146788404|NCT02975882|529397930|FG000|Overall Study|Lack of Efficacy|3|||
146788405|NCT02975882|529397931|FG001|Overall Study|Lack of Efficacy|7|||
146788406|NCT02975882|529397932|FG002|Overall Study|Lack of Efficacy|4|||
146788407|NCT02975882|529397933|FG003|Overall Study|Lack of Efficacy|3|||
146788408|NCT02975882|529397930|FG000|Overall Study|Physician Decision|0|||
146788409|NCT02975882|529397931|FG001|Overall Study|Physician Decision|2|||
146788410|NCT02975882|529397932|FG002|Overall Study|Physician Decision|4|||
146788411|NCT02975882|529397933|FG003|Overall Study|Physician Decision|2|||
146788412|NCT02975882|529397930|FG000|Overall Study|Ineligible|0|||
146788413|NCT02975882|529397931|FG001|Overall Study|Ineligible|1|||
146788414|NCT02975882|529397932|FG002|Overall Study|Ineligible|0|||
146937345|NCT01998958|529928314|FG012|Open Label Phase (Optional)|Other|0|||
146937346|NCT01998958|529928315|FG013|Open Label Phase (Optional)|Other|0|||
146937347|NCT01998958|529928316|FG014|Open Label Phase (Optional)|Other|0|||
146788415|NCT02975882|529397933|FG003|Overall Study|Ineligible|0|||
146788416|NCT02105766|529397934|FG000|Overall Study|Physician Decision|1|||
146788417|NCT02105766|529397935|FG001|Overall Study|Physician Decision|1|||
146788418|NCT02105766|529397936|FG002|Overall Study|Physician Decision|0|||
146937348|NCT01998958|529928317|FG015|Open Label Phase (Optional)|Other|0|||
146937349|NCT01998958|529928318|FG016|Open Label Phase (Optional)|Other|0|||
146788419|NCT02105766|529397934|FG000|Overall Study|Lost to Follow-up|2|||
146788420|NCT02105766|529397935|FG001|Overall Study|Lost to Follow-up|0|||
146788421|NCT02105766|529397936|FG002|Overall Study|Lost to Follow-up|0|||
146788422|NCT02105766|529397934|FG000|Overall Study|Death|1|||
146788423|NCT02105766|529397935|FG001|Overall Study|Death|1|||
146788424|NCT02105766|529397936|FG002|Overall Study|Death|0|||
146788425|NCT02985957|529397937|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146937350|NCT01998958|529928319|FG017|Open Label Phase (Optional)|Other|0|||
146937351|NCT01998958|529928320|FG018|Open Label Phase (Optional)|Other|0|||
146788426|NCT02985957|529397938|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146788427|NCT02985957|529397939|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146788428|NCT02985957|529397940|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146788429|NCT02985957|529397941|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
146788430|NCT02985957|529397942|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146788431|NCT02985957|529397943|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146788432|NCT02985957|529397937|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
146788433|NCT02985957|529397938|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
146788434|NCT02985957|529397939|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
146788435|NCT02985957|529397940|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
146788436|NCT02985957|529397941|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
146788437|NCT02985957|529397942|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
146788438|NCT02985957|529397943|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
146788439|NCT02985957|529397937|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
146788440|NCT02985957|529397938|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
146788441|NCT02985957|529397939|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
146788442|NCT02985957|529397940|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
146788443|NCT02985957|529397941|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
146788444|NCT02985957|529397942|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
146788445|NCT02985957|529397943|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
146788446|NCT02985957|529397937|FG000|Treatment Period|Death|0|||
146788447|NCT02985957|529397938|FG001|Treatment Period|Death|0|||
146788448|NCT02985957|529397939|FG002|Treatment Period|Death|0|||
146788449|NCT02985957|529397940|FG003|Treatment Period|Death|0|||
146788450|NCT02985957|529397941|FG004|Treatment Period|Death|1|||
146788451|NCT02985957|529397942|FG005|Treatment Period|Death|0|||
146788452|NCT02985957|529397943|FG006|Treatment Period|Death|0|||
146788453|NCT02985957|529397937|FG000|Treatment Period|Participant withdrew consent|0|||
146937352|NCT01998958|529928321|FG019|Open Label Phase (Optional)|Other|0|||
146937353|NCT01998958|529928322|FG020|Open Label Phase (Optional)|Other|0|||
146937354|NCT01998958|529928323|FG021|Open Label Phase (Optional)|Other|0|||
146937355|NCT01998958|529928324|FG022|Open Label Phase (Optional)|Other|5|||
146937356|NCT01998958|529928325|FG023|Open Label Phase (Optional)|Other|1|||
146937357|NCT01998958|529928326|FG024|Open Label Phase (Optional)|Other|0|||
146937358|NCT01998958|529928327|FG025|Open Label Phase (Optional)|Other|0|||
146937359|NCT01998958|529928328|FG026|Open Label Phase (Optional)|Other|0|||
146937360|NCT01998958|529928329|FG027|Open Label Phase (Optional)|Other|0|||
146937361|NCT01998958|529928330|FG028|Open Label Phase (Optional)|Other|0|||
146937362|NCT01998958|529928331|FG029|Open Label Phase (Optional)|Other|0|||
146937363|NCT01998958|529928332|FG030|Open Label Phase (Optional)|Other|0|||
146937364|NCT01998958|529928333|FG031|Open Label Phase (Optional)|Other|0|||
146937365|NCT01998958|529928302|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937366|NCT01998958|529928303|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937367|NCT01998958|529928304|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937368|NCT01998958|529928305|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937369|NCT01998958|529928306|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937370|NCT01998958|529928307|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937371|NCT01998958|529928308|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937372|NCT01998958|529928309|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937373|NCT01998958|529928310|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937374|NCT01998958|529928311|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937375|NCT01998958|529928312|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937376|NCT01998958|529928313|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937377|NCT01998958|529928314|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937378|NCT01998958|529928315|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937379|NCT01998958|529928316|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937380|NCT01998958|529928317|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937381|NCT01998958|529928318|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937382|NCT01998958|529928319|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937383|NCT01998958|529928320|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937384|NCT01998958|529928321|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937385|NCT01998958|529928322|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937386|NCT01998958|529928323|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937387|NCT01998958|529928324|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
146937388|NCT01998958|529928325|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937389|NCT01998958|529928326|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937390|NCT01998958|529928327|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937391|NCT01998958|529928328|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937392|NCT01998958|529928329|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937393|NCT01998958|529928330|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937394|NCT01998958|529928331|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
146788454|NCT02985957|529397938|FG001|Treatment Period|Participant withdrew consent|0|||
146788455|NCT02985957|529397939|FG002|Treatment Period|Participant withdrew consent|0|||
146788456|NCT02985957|529397940|FG003|Treatment Period|Participant withdrew consent|1|||
146937395|NCT01998958|529928332|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937396|NCT01998958|529928333|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
146937397|NCT01998958|529928302|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937398|NCT01998958|529928303|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937399|NCT01998958|529928304|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937400|NCT01998958|529928305|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
146730527|NCT03391765|529184364|FG002|Overall Study|Adverse Event|0|||
146730528|NCT03391765|529184365|FG003|Overall Study|Adverse Event|2|||
146730529|NCT03391765|529184362|FG000|Overall Study|Withdrew consent|5|||
146730530|NCT03391765|529184363|FG001|Overall Study|Withdrew consent|7|||
146730531|NCT03391765|529184364|FG002|Overall Study|Withdrew consent|2|||
146730532|NCT03391765|529184365|FG003|Overall Study|Withdrew consent|5|||
146730533|NCT03391765|529184362|FG000|Overall Study|Other, not specified|44|||
146730534|NCT03391765|529184363|FG001|Overall Study|Other, not specified|38|||
146730535|NCT03391765|529184364|FG002|Overall Study|Other, not specified|21|||
146730536|NCT03391765|529184365|FG003|Overall Study|Other, not specified|16|||
146730537|NCT00944658|529184366|FG000|Treatment 12 Weeks|Adverse Event|0|||
146730538|NCT00944658|529184367|FG001|Treatment 12 Weeks|Adverse Event|2|||
146730539|NCT00838682|529184373|FG000|Overall Study|Lost to Follow-up|21|||
146730540|NCT00838682|529184374|FG001|Overall Study|Lost to Follow-up|14|||
146730541|NCT00838682|529184373|FG000|Overall Study|detection of exclusion criteria|4|||
146730542|NCT00838682|529184374|FG001|Overall Study|detection of exclusion criteria|3|||
146730543|NCT00838682|529184373|FG000|Overall Study|Protocol Violation|0|||
146730544|NCT00838682|529184374|FG001|Overall Study|Protocol Violation|1|||
146730545|NCT00838682|529184373|FG000|Overall Study|Withdrawal by Subject|0|||
146730546|NCT00838682|529184374|FG001|Overall Study|Withdrawal by Subject|1|||
146730547|NCT02472652|529184379|FG000|Overall Study|Lost to Follow-up|1|||
146730548|NCT00998400|529184384|FG000|Overall Study|Lack of interest/motivation|1|||
146730549|NCT00998400|529184385|FG001|Overall Study|Lack of interest/motivation|2|||
146730550|NCT00998400|529184384|FG000|Overall Study|Logistical problems|1|||
146730551|NCT00998400|529184385|FG001|Overall Study|Logistical problems|0|||
146730552|NCT03704584|529184386|FG000|Overall Study|Withdrawal by Subject|1|||
146730553|NCT03704584|529184387|FG001|Overall Study|Withdrawal by Subject|0|||
146730554|NCT03185832|529184388|FG000|Overall Study|Death|9|||
146730555|NCT03185832|529184389|FG001|Overall Study|Death|14|||
146730556|NCT03185832|529184390|FG002|Overall Study|Death|9|||
146730557|NCT03185832|529184391|FG003|Overall Study|Death|7|||
146730558|NCT03185832|529184388|FG000|Overall Study|Withdrawn - vital status available|0|||
146730559|NCT03185832|529184389|FG001|Overall Study|Withdrawn - vital status available|1|||
146730560|NCT03185832|529184390|FG002|Overall Study|Withdrawn - vital status available|1|||
146730561|NCT03185832|529184391|FG003|Overall Study|Withdrawn - vital status available|4|||
146730562|NCT01083641|529184392|FG000|Overall Study|Withdrawal by Subject|2|||
146730563|NCT03439189|529184393|FG000|Overall Study|Protocol Violation|19|||
146730564|NCT03439189|529184393|FG000|Overall Study|Lack of Efficacy|63|||
146730565|NCT03412812|529184394|FG000|Level 1|Death|3|||
146730566|NCT03412812|529184395|FG001|Level 1|Death|0|||
146730567|NCT03412812|529184394|FG000|Level 1|Adverse Event|0|||
146730568|NCT03412812|529184395|FG001|Level 1|Adverse Event|1|||
146730569|NCT01777321|529184396|FG000|Overall Study|Withdrawal by Subject|0|||
146730570|NCT01777321|529184397|FG001|Overall Study|Withdrawal by Subject|1|||
146730571|NCT03837509|529184398|FG000|Phase 1|Death|5|||
146730572|NCT03837509|529184399|FG001|Phase 1|Death|2|||
146730573|NCT03837509|529184400|FG002|Phase 1|Death|0|||
146730574|NCT03837509|529184401|FG003|Phase 1|Death|0|||
146730575|NCT03837509|529184402|FG004|Phase 1|Death|0|||
146730576|NCT03837509|529184398|FG000|Phase 2|Death|0|||
146730577|NCT03837509|529184399|FG001|Phase 2|Death|0|||
146730578|NCT03837509|529184400|FG002|Phase 2|Death|0|||
146730579|NCT03837509|529184401|FG003|Phase 2|Death|1|||
146730580|NCT03837509|529184402|FG004|Phase 2|Death|1|||
146730581|NCT03315143|529184408|FG000|Overall Study|Death|240|||
146730582|NCT03315143|529184409|FG001|Overall Study|Death|246|||
146730583|NCT03315143|529184408|FG000|Overall Study|Withdrawal by Subject|57|||
146730584|NCT03315143|529184409|FG001|Overall Study|Withdrawal by Subject|68|||
146730585|NCT03315143|529184408|FG000|Overall Study|Site Terminated by Sponsor|256|||
146730586|NCT03315143|529184409|FG001|Overall Study|Site Terminated by Sponsor|282|||
146730587|NCT03315143|529184408|FG000|Overall Study|Study Terminated by Sponsor|4723|||
146730588|NCT03315143|529184409|FG001|Overall Study|Study Terminated by Sponsor|4664|||
146730589|NCT03315143|529184408|FG000|Overall Study|Reason not Specified|16|||
146730590|NCT03315143|529184409|FG001|Overall Study|Reason not Specified|32|||
146730591|NCT02799784|529184410|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
146730592|NCT02799784|529184411|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
146937401|NCT01998958|529928306|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
146730593|NCT02799784|529184410|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
146730594|NCT02799784|529184411|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
146730595|NCT02799784|529184410|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
146730596|NCT02799784|529184411|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
146730597|NCT02799784|529184410|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
146937402|NCT01998958|529928307|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937403|NCT01998958|529928308|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937404|NCT01998958|529928309|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937405|NCT01998958|529928310|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937406|NCT01998958|529928311|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937407|NCT01998958|529928312|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937408|NCT01998958|529928313|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937409|NCT01998958|529928314|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937410|NCT01998958|529928315|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937411|NCT01998958|529928316|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937412|NCT01998958|529928317|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937413|NCT01998958|529928318|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937414|NCT01998958|529928319|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937415|NCT01998958|529928320|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937416|NCT01998958|529928321|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937417|NCT01998958|529928322|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937418|NCT01998958|529928323|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
146937419|NCT01998958|529928324|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
146937420|NCT01998958|529928325|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937421|NCT01998958|529928326|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937422|NCT01998958|529928327|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937423|NCT01998958|529928328|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937424|NCT01998958|529928329|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937425|NCT01998958|529928330|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937426|NCT01998958|529928331|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937427|NCT01998958|529928332|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937428|NCT01998958|529928333|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
146937429|NCT01998958|529928302|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937430|NCT01998958|529928303|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937431|NCT01998958|529928304|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937432|NCT01998958|529928305|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937433|NCT01998958|529928306|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937434|NCT01998958|529928307|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937435|NCT01998958|529928308|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937436|NCT01998958|529928309|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937437|NCT01998958|529928310|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937438|NCT01998958|529928311|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937439|NCT01998958|529928312|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937440|NCT01998958|529928313|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937441|NCT01998958|529928314|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937442|NCT01998958|529928315|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937443|NCT01998958|529928316|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937444|NCT01998958|529928317|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937445|NCT01998958|529928318|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937446|NCT01998958|529928319|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937447|NCT01998958|529928320|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937448|NCT01998958|529928321|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937449|NCT01998958|529928322|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937450|NCT01998958|529928323|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
146937451|NCT01998958|529928324|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
146937452|NCT01998958|529928325|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
146937453|NCT01998958|529928326|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937454|NCT01998958|529928327|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937455|NCT01998958|529928328|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937456|NCT01998958|529928329|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937457|NCT01998958|529928330|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937458|NCT01998958|529928331|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937459|NCT01998958|529928332|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937460|NCT01998958|529928333|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146937461|NCT02432703|529928334|FG000|Overall Study|Adverse Event|1|||
146981865|NCT02040766|530096163|FG004|Overall Study|Protocol Violation|0|||
146730598|NCT02799784|529184411|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
146730599|NCT02799784|529184410|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
146937462|NCT02432703|529928335|FG001|Overall Study|Adverse Event|4|||
146937463|NCT02432703|529928334|FG000|Overall Study|Lack of Efficacy|1|||
146937464|NCT02432703|529928335|FG001|Overall Study|Lack of Efficacy|0|||
146937465|NCT02432703|529928334|FG000|Overall Study|Lost to Follow-up|5|||
146937466|NCT02432703|529928335|FG001|Overall Study|Lost to Follow-up|3|||
146937467|NCT02432703|529928334|FG000|Overall Study|Withdrawal by Subject|9|||
146937468|NCT02432703|529928335|FG001|Overall Study|Withdrawal by Subject|6|||
146937469|NCT02432703|529928334|FG000|Overall Study|Other|6|||
146730600|NCT02799784|529184411|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
146730601|NCT02799784|529184410|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
146730602|NCT02799784|529184411|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
146730603|NCT01804816|529184412|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
146730604|NCT01804816|529184412|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
146730605|NCT01050816|529184413|FG000|Overall Study|Lost to Follow-up|2|||
146730606|NCT01050816|529184413|FG000|Overall Study|patient's refusal|2|||
146730607|NCT03086330|529184414|FG000|Overall Study|Withdrawal by Subject|3|||
146730608|NCT03086330|529184415|FG001|Overall Study|Withdrawal by Subject|2|||
146730609|NCT03086330|529184414|FG000|Overall Study|Lost to Follow-up|1|||
146730610|NCT03086330|529184415|FG001|Overall Study|Lost to Follow-up|2|||
146788457|NCT02985957|529397941|FG004|Treatment Period|Participant withdrew consent|3|||
146788458|NCT02985957|529397942|FG005|Treatment Period|Participant withdrew consent|0|||
146788459|NCT02985957|529397943|FG006|Treatment Period|Participant withdrew consent|1|||
146788460|NCT02985957|529397937|FG000|Treatment Period|Lost to Follow-up|0|||
146788461|NCT02985957|529397938|FG001|Treatment Period|Lost to Follow-up|0|||
146788462|NCT02985957|529397939|FG002|Treatment Period|Lost to Follow-up|0|||
146788463|NCT02985957|529397940|FG003|Treatment Period|Lost to Follow-up|0|||
146788464|NCT02985957|529397941|FG004|Treatment Period|Lost to Follow-up|1|||
146788465|NCT02985957|529397942|FG005|Treatment Period|Lost to Follow-up|0|||
146788466|NCT02985957|529397943|FG006|Treatment Period|Lost to Follow-up|0|||
146788467|NCT02985957|529397937|FG000|Treatment Period|Other reasons|0|||
146788468|NCT02985957|529397938|FG001|Treatment Period|Other reasons|0|||
146788469|NCT02985957|529397939|FG002|Treatment Period|Other reasons|1|||
146788470|NCT02985957|529397940|FG003|Treatment Period|Other reasons|3|||
146788471|NCT02985957|529397941|FG004|Treatment Period|Other reasons|6|||
146788472|NCT02985957|529397942|FG005|Treatment Period|Other reasons|0|||
146788473|NCT02985957|529397943|FG006|Treatment Period|Other reasons|1|||
146788474|NCT02985957|529397937|FG000|Treatment Period|Not reported|0|||
146788475|NCT02985957|529397938|FG001|Treatment Period|Not reported|1|||
146788476|NCT02985957|529397939|FG002|Treatment Period|Not reported|2|||
146788477|NCT02985957|529397940|FG003|Treatment Period|Not reported|5|||
146788478|NCT02985957|529397941|FG004|Treatment Period|Not reported|0|||
146788479|NCT02985957|529397942|FG005|Treatment Period|Not reported|0|||
146788480|NCT02985957|529397943|FG006|Treatment Period|Not reported|0|||
146788481|NCT02985957|529397937|FG000|Treatment Period|Maximum clinical benefit|0|||
146788482|NCT02985957|529397938|FG001|Treatment Period|Maximum clinical benefit|0|||
146788483|NCT02985957|529397939|FG002|Treatment Period|Maximum clinical benefit|1|||
146788484|NCT02985957|529397940|FG003|Treatment Period|Maximum clinical benefit|1|||
146788485|NCT02985957|529397941|FG004|Treatment Period|Maximum clinical benefit|0|||
146788486|NCT02985957|529397942|FG005|Treatment Period|Maximum clinical benefit|0|||
146788487|NCT02985957|529397943|FG006|Treatment Period|Maximum clinical benefit|2|||
146788488|NCT02985957|529397937|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
146788489|NCT02985957|529397938|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
146788490|NCT02985957|529397939|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
146788491|NCT02985957|529397940|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
146788492|NCT02985957|529397941|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
146788493|NCT02985957|529397942|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
146937470|NCT02432703|529928335|FG001|Overall Study|Other|5|||
146937471|NCT00724815|529928338|FG000|Overall Study|Randomized, not treated|31|||
146937472|NCT00724815|529928339|FG001|Overall Study|Randomized, not treated|30|||
146937473|NCT00724815|529928338|FG000|Overall Study|Adverse Event|5|||
146937474|NCT00724815|529928339|FG001|Overall Study|Adverse Event|3|||
146937475|NCT00724815|529928338|FG000|Overall Study|Lost to Follow-up|4|||
146937476|NCT00724815|529928339|FG001|Overall Study|Lost to Follow-up|1|||
146937477|NCT00724815|529928338|FG000|Overall Study|Other Various|3|||
146937478|NCT00724815|529928339|FG001|Overall Study|Other Various|5|||
146937479|NCT01628393|529928340|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
146937480|NCT01628393|529928341|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
146937481|NCT01628393|529928342|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
146937482|NCT01628393|529928343|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
146937483|NCT01628393|529928344|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
146937484|NCT01628393|529928340|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
146981866|NCT02040766|530096159|FG000|Overall Study|Lost to Follow-up|4|||
146730611|NCT01256411|529184418|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
146730612|NCT01256411|529184419|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
146788494|NCT02985957|529397943|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
146788495|NCT02985957|529397937|FG000|Treatment Period|Study drug toxicity|1|||
146788496|NCT02985957|529397938|FG001|Treatment Period|Study drug toxicity|23|||
146788497|NCT02985957|529397939|FG002|Treatment Period|Study drug toxicity|20|||
146788498|NCT02985957|529397940|FG003|Treatment Period|Study drug toxicity|11|||
146788499|NCT02985957|529397941|FG004|Treatment Period|Study drug toxicity|19|||
146937485|NCT01628393|529928341|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
146937486|NCT01628393|529928342|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
146788500|NCT02985957|529397942|FG005|Treatment Period|Study drug toxicity|3|||
146788501|NCT02985957|529397943|FG006|Treatment Period|Study drug toxicity|5|||
146788502|NCT02985957|529397937|FG000|Treatment Period|Disease progression|0|||
146788503|NCT02985957|529397938|FG001|Treatment Period|Disease progression|16|||
146788504|NCT02985957|529397939|FG002|Treatment Period|Disease progression|20|||
146788505|NCT02985957|529397940|FG003|Treatment Period|Disease progression|39|||
146788506|NCT02985957|529397941|FG004|Treatment Period|Disease progression|29|||
146788507|NCT02985957|529397942|FG005|Treatment Period|Disease progression|11|||
146788508|NCT02985957|529397943|FG006|Treatment Period|Disease progression|28|||
146788509|NCT02985957|529397937|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
146788510|NCT02985957|529397938|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
146788511|NCT02985957|529397939|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
146788512|NCT02985957|529397940|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
146788513|NCT02985957|529397941|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
146788514|NCT02985957|529397942|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
146788515|NCT02985957|529397943|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
146788516|NCT02985957|529397937|FG000|Treatment Period|Poor/Non-Compliance|0|||
146788517|NCT02985957|529397938|FG001|Treatment Period|Poor/Non-Compliance|0|||
146788518|NCT02985957|529397939|FG002|Treatment Period|Poor/Non-Compliance|0|||
146788519|NCT02985957|529397940|FG003|Treatment Period|Poor/Non-Compliance|0|||
146788520|NCT02985957|529397941|FG004|Treatment Period|Poor/Non-Compliance|1|||
146788521|NCT02985957|529397942|FG005|Treatment Period|Poor/Non-Compliance|1|||
146788522|NCT02985957|529397943|FG006|Treatment Period|Poor/Non-Compliance|0|||
146788523|NCT02985957|529397937|FG000|Treatment Period|Continuing in Treatment Period|0|||
146788524|NCT02985957|529397938|FG001|Treatment Period|Continuing in Treatment Period|1|||
146788525|NCT02985957|529397939|FG002|Treatment Period|Continuing in Treatment Period|0|||
146788526|NCT02985957|529397940|FG003|Treatment Period|Continuing in Treatment Period|4|||
146788527|NCT02985957|529397941|FG004|Treatment Period|Continuing in Treatment Period|4|||
146788528|NCT02985957|529397942|FG005|Treatment Period|Continuing in Treatment Period|0|||
146788529|NCT02985957|529397943|FG006|Treatment Period|Continuing in Treatment Period|0|||
146788530|NCT04342494|529397944|FG000|Overall Study|Questionnaire partially completed|1|||
146788531|NCT04342494|529397945|FG001|Overall Study|Questionnaire partially completed|0|||
146788532|NCT04342494|529397946|FG002|Overall Study|Questionnaire partially completed|2|||
146788533|NCT04342494|529397947|FG003|Overall Study|Questionnaire partially completed|0|||
146788534|NCT04342494|529397948|FG004|Overall Study|Questionnaire partially completed|1|||
146788535|NCT04342494|529397944|FG000|Overall Study|Lost to Follow-up|49|||
146788536|NCT04342494|529397945|FG001|Overall Study|Lost to Follow-up|38|||
146788537|NCT04342494|529397946|FG002|Overall Study|Lost to Follow-up|34|||
146788538|NCT04342494|529397947|FG003|Overall Study|Lost to Follow-up|34|||
146788539|NCT04342494|529397948|FG004|Overall Study|Lost to Follow-up|35|||
146788540|NCT00753545|529397952|FG000|Overall Study|Death|98|||
146788541|NCT00753545|529397953|FG001|Overall Study|Death|112|||
146788542|NCT00753545|529397952|FG000|Overall Study|Lost to Follow-up|2|||
146788543|NCT00753545|529397953|FG001|Overall Study|Lost to Follow-up|3|||
146788544|NCT00753545|529397952|FG000|Overall Study|Protocol Violation|1|||
146788545|NCT00753545|529397953|FG001|Overall Study|Protocol Violation|0|||
146788546|NCT00753545|529397952|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
146788547|NCT00753545|529397953|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
146788548|NCT02485938|529397954|FG000|Overall Study|Withdrawal of consent|2|||
146788549|NCT02485938|529397955|FG001|Overall Study|Withdrawal of consent|0|||
146788550|NCT04633122|529397956|FG000|Overall Study|Remained on treatment|19|||
146788551|NCT04633122|529397957|FG001|Overall Study|Remained on treatment|14|||
146788552|NCT04633122|529397956|FG000|Overall Study|Survival follow-up stopped|22|||
146788553|NCT04633122|529397957|FG001|Overall Study|Survival follow-up stopped|25|||
146788554|NCT03241745|529397958|FG000|Overall Study|Adverse Event|7|||
146788555|NCT03241745|529397958|FG000|Overall Study|Death|1|||
146788556|NCT03241745|529397958|FG000|Overall Study|Withdrawal by Subject|5|||
146788557|NCT03241745|529397958|FG000|Overall Study|Treatment delay >28 days|2|||
146788558|NCT03241745|529397958|FG000|Overall Study|Lack of Efficacy|14|||
146788559|NCT04799899|529397959|FG000|Overall Study|Lost to Follow-up|2|||
146788560|NCT04799899|529397960|FG001|Overall Study|Lost to Follow-up|4|||
146788561|NCT04019873|529397961|FG000|Overall Study|Discontinued from the treatment|1|||
146788562|NCT04019873|529397962|FG001|Overall Study|Discontinued from the treatment|39|||
146788563|NCT04019873|529397963|FG002|Overall Study|Discontinued from the treatment|2|||
146788564|NCT04908722|529397966|FG000|Overall Study|Protocol deviation|1|||
146788565|NCT04908722|529397967|FG001|Overall Study|Protocol deviation|0|||
146788566|NCT04908722|529397968|FG002|Overall Study|Protocol deviation|0|||
146788567|NCT04908722|529397969|FG003|Overall Study|Protocol deviation|0|||
146788568|NCT04908722|529397970|FG004|Overall Study|Protocol deviation|0|||
146788569|NCT04908722|529397971|FG005|Overall Study|Protocol deviation|1|||
146788570|NCT04908722|529397966|FG000|Overall Study|Lost to Follow-up|33|||
146788571|NCT04908722|529397967|FG001|Overall Study|Lost to Follow-up|33|||
146788572|NCT04908722|529397968|FG002|Overall Study|Lost to Follow-up|36|||
146788573|NCT04908722|529397969|FG003|Overall Study|Lost to Follow-up|30|||
146730613|NCT01256411|529184420|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
146730614|NCT01256411|529184421|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
146730615|NCT01256411|529184422|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
146730616|NCT01256411|529184423|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
146730617|NCT01256411|529184418|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
146730618|NCT01256411|529184419|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
146730619|NCT01256411|529184420|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
146730620|NCT01256411|529184421|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
146730621|NCT01256411|529184422|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
146730622|NCT01256411|529184423|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
146730623|NCT01256411|529184418|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
146730624|NCT01256411|529184419|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
146730625|NCT01256411|529184420|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
146730626|NCT01256411|529184421|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
146730627|NCT01256411|529184422|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
146730628|NCT01256411|529184423|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
146730629|NCT01256411|529184418|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
146730630|NCT01256411|529184419|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
146730631|NCT01256411|529184420|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
146730632|NCT01256411|529184421|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
146730633|NCT01256411|529184422|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
146730634|NCT01256411|529184423|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
146730635|NCT01256411|529184418|FG000|Extension by Maximum Treatment|Adverse Event|4|||
146730636|NCT01256411|529184419|FG001|Extension by Maximum Treatment|Adverse Event|2|||
146730637|NCT01256411|529184420|FG002|Extension by Maximum Treatment|Adverse Event|1|||
146730638|NCT01256411|529184421|FG003|Extension by Maximum Treatment|Adverse Event|0|||
146730639|NCT01256411|529184422|FG004|Extension by Maximum Treatment|Adverse Event|0|||
146730640|NCT01256411|529184423|FG005|Extension by Maximum Treatment|Adverse Event|0|||
146730641|NCT01256411|529184418|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
146730642|NCT01256411|529184419|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
146730643|NCT01256411|529184420|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
146730644|NCT01256411|529184421|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
146730645|NCT01256411|529184422|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
146730646|NCT01256411|529184423|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
146730647|NCT01256411|529184418|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
146730648|NCT01256411|529184419|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
146730649|NCT01256411|529184420|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
146730650|NCT01256411|529184421|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
146730651|NCT01256411|529184422|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
146730652|NCT01256411|529184423|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
146730653|NCT01256411|529184418|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
146730654|NCT01256411|529184419|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
146730655|NCT01256411|529184420|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
146730656|NCT01256411|529184421|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
146730657|NCT01256411|529184422|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
146730658|NCT01256411|529184423|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
146730659|NCT01256411|529184418|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
146730660|NCT01256411|529184419|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
146730661|NCT01256411|529184420|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
146730662|NCT01256411|529184421|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
146730663|NCT01256411|529184422|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
146730664|NCT01256411|529184423|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
146730665|NCT01256411|529184418|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
146730666|NCT01256411|529184419|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
146730667|NCT01256411|529184420|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
146730668|NCT01256411|529184421|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
146730669|NCT01256411|529184422|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
146730670|NCT01256411|529184423|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
146730671|NCT01445652|529184424|FG000|Overall Study|Not comfortable in lenses|5|||
146730672|NCT01445652|529184425|FG001|Overall Study|Not comfortable in lenses|0|||
146730673|NCT01445652|529184424|FG000|Overall Study|Failed to attend scheduled visit|2|||
146730674|NCT01445652|529184425|FG001|Overall Study|Failed to attend scheduled visit|3|||
146730675|NCT01445652|529184424|FG000|Overall Study|Failed teach session|2|||
146730676|NCT01445652|529184425|FG001|Overall Study|Failed teach session|0|||
146730677|NCT01445652|529184424|FG000|Overall Study|Adverse Event|1|||
146730678|NCT01445652|529184425|FG001|Overall Study|Adverse Event|0|||
146730679|NCT00929162|529184426|FG000|Overall Study|Adverse Event|8|||
146730680|NCT00929162|529184427|FG001|Overall Study|Adverse Event|5|||
146730681|NCT00929162|529184426|FG000|Overall Study|Withdrawal by Subject|3|||
146730682|NCT00929162|529184427|FG001|Overall Study|Withdrawal by Subject|1|||
146730683|NCT00929162|529184426|FG000|Overall Study|Protocol Violation|32|||
146730684|NCT00929162|529184427|FG001|Overall Study|Protocol Violation|30|||
146730685|NCT00929162|529184426|FG000|Overall Study|Other termination reason|5|||
146730686|NCT00929162|529184427|FG001|Overall Study|Other termination reason|6|||
146730687|NCT00117676|529184430|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
146730688|NCT00117676|529184431|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
146730689|NCT00117676|529184430|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
146730690|NCT00117676|529184431|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
146730691|NCT00117676|529184430|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
146730692|NCT00117676|529184431|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
146730693|NCT00117676|529184430|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
146730694|NCT00117676|529184431|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
146730695|NCT00117676|529184430|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
146730696|NCT00117676|529184431|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
146730697|NCT00117676|529184430|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
146730698|NCT00117676|529184431|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
146730699|NCT00117676|529184430|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
146730700|NCT00117676|529184431|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
146730701|NCT00117676|529184430|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
146730702|NCT00117676|529184431|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
146730703|NCT00117676|529184430|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
146730704|NCT00117676|529184431|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
146730705|NCT00117676|529184430|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
146730706|NCT00117676|529184431|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
146730707|NCT00117676|529184430|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
146730708|NCT00117676|529184431|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
146730709|NCT00117676|529184430|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
146730710|NCT00117676|529184431|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
146730711|NCT00117676|529184430|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
146730712|NCT00117676|529184431|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
146730713|NCT00117676|529184430|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
146730714|NCT00117676|529184431|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
146730715|NCT00117676|529184430|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
146730716|NCT00117676|529184431|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
146730717|NCT00117676|529184430|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
146730718|NCT00117676|529184431|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
146730719|NCT00117676|529184430|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
146730720|NCT00117676|529184431|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
146730721|NCT00117676|529184430|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
146730722|NCT00117676|529184431|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
146730723|NCT00117676|529184430|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
146730724|NCT00117676|529184431|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
146730725|NCT00117676|529184430|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
146730726|NCT00117676|529184431|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
146730727|NCT00117676|529184430|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
146730728|NCT00117676|529184431|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
146730729|NCT00117676|529184430|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
146730730|NCT00117676|529184431|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
146730731|NCT00117676|529184430|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
146730732|NCT00117676|529184431|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
146730733|NCT00117676|529184430|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
146730734|NCT00117676|529184431|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
146730735|NCT00117676|529184430|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
146730736|NCT00117676|529184431|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
146730737|NCT00117676|529184430|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
146730738|NCT00117676|529184431|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
146730739|NCT00117676|529184430|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
146730740|NCT00117676|529184431|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
146730741|NCT00117676|529184430|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
146730742|NCT00117676|529184431|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
146788574|NCT04908722|529397970|FG004|Overall Study|Lost to Follow-up|32|||
146788575|NCT04908722|529397971|FG005|Overall Study|Lost to Follow-up|34|||
146788576|NCT04908722|529397966|FG000|Overall Study|Physician Decision|1|||
146788577|NCT04908722|529397967|FG001|Overall Study|Physician Decision|1|||
146788578|NCT04908722|529397968|FG002|Overall Study|Physician Decision|1|||
146788579|NCT04908722|529397969|FG003|Overall Study|Physician Decision|2|||
146788580|NCT04908722|529397970|FG004|Overall Study|Physician Decision|0|||
146788581|NCT04908722|529397971|FG005|Overall Study|Physician Decision|0|||
146788582|NCT04908722|529397966|FG000|Overall Study|Death|1|||
146788583|NCT04908722|529397967|FG001|Overall Study|Death|0|||
146788584|NCT04908722|529397968|FG002|Overall Study|Death|0|||
146788585|NCT04908722|529397969|FG003|Overall Study|Death|0|||
146788586|NCT04908722|529397970|FG004|Overall Study|Death|0|||
146788587|NCT04908722|529397971|FG005|Overall Study|Death|1|||
146788588|NCT04908722|529397966|FG000|Overall Study|Withdrawal by Subject|12|||
146788589|NCT04908722|529397967|FG001|Overall Study|Withdrawal by Subject|8|||
146788590|NCT04908722|529397968|FG002|Overall Study|Withdrawal by Subject|7|||
146788591|NCT04908722|529397969|FG003|Overall Study|Withdrawal by Subject|6|||
146788592|NCT04908722|529397970|FG004|Overall Study|Withdrawal by Subject|12|||
146788593|NCT04908722|529397971|FG005|Overall Study|Withdrawal by Subject|14|||
146788594|NCT04908722|529397966|FG000|Overall Study|Other|3|||
146788595|NCT04908722|529397967|FG001|Overall Study|Other|1|||
146788596|NCT04908722|529397968|FG002|Overall Study|Other|3|||
146788597|NCT04908722|529397969|FG003|Overall Study|Other|2|||
146788598|NCT04908722|529397970|FG004|Overall Study|Other|4|||
146788599|NCT04908722|529397971|FG005|Overall Study|Other|1|||
146788600|NCT04908722|529397966|FG000|Overall Study|Initiated prohibited medication|0|||
146788601|NCT04908722|529397967|FG001|Overall Study|Initiated prohibited medication|0|||
146788602|NCT04908722|529397968|FG002|Overall Study|Initiated prohibited medication|0|||
146788603|NCT04908722|529397969|FG003|Overall Study|Initiated prohibited medication|1|||
146788604|NCT04908722|529397970|FG004|Overall Study|Initiated prohibited medication|0|||
146788605|NCT04908722|529397971|FG005|Overall Study|Initiated prohibited medication|1|||
146788606|NCT04908722|529397966|FG000|Overall Study|Randomized but not vaccinated|3|||
146788607|NCT04908722|529397967|FG001|Overall Study|Randomized but not vaccinated|1|||
146788608|NCT04908722|529397968|FG002|Overall Study|Randomized but not vaccinated|2|||
146788609|NCT04908722|529397969|FG003|Overall Study|Randomized but not vaccinated|2|||
146788610|NCT04908722|529397970|FG004|Overall Study|Randomized but not vaccinated|3|||
146788611|NCT04908722|529397971|FG005|Overall Study|Randomized but not vaccinated|4|||
146788612|NCT03339713|529397972|FG000|Overall Study|Lost to Follow-up|2|||
146788613|NCT03339713|529397973|FG001|Overall Study|Lost to Follow-up|1|||
146788614|NCT03339713|529397972|FG000|Overall Study|Protocol Violation|1|||
146788615|NCT03339713|529397973|FG001|Overall Study|Protocol Violation|0|||
146788616|NCT03339713|529397972|FG000|Overall Study|Withdrawal by Subject|1|||
146788617|NCT03339713|529397973|FG001|Overall Study|Withdrawal by Subject|1|||
146788618|NCT03474679|529397974|FG000|Overall Study|Death|7|||
146788619|NCT03474679|529397974|FG000|Overall Study|Withdrawal by Subject|1|||
146788620|NCT04858321|529397979|FG000|Overall Study|Withdrawal by Subject|3|||
146788621|NCT03092518|529397981|FG000|Overall Study|Ineligible|2|||
146788622|NCT05170009|529397985|FG000|Overall Study|Physician Decision|0|||
146788623|NCT05170009|529397986|FG001|Overall Study|Physician Decision|1|||
146788624|NCT04925986|529397987|FG000|Overall Study|Death|0|||
146788625|NCT04925986|529397988|FG001|Overall Study|Death|0|||
146788626|NCT04925986|529397989|FG002|Overall Study|Death|2|||
146788627|NCT04925986|529397990|FG003|Overall Study|Death|0|||
146788628|NCT04925986|529397987|FG000|Overall Study|Lack of Efficacy|1|||
146788629|NCT04925986|529397988|FG001|Overall Study|Lack of Efficacy|2|||
146788630|NCT04925986|529397989|FG002|Overall Study|Lack of Efficacy|0|||
146788631|NCT04925986|529397990|FG003|Overall Study|Lack of Efficacy|1|||
146788632|NCT04925986|529397987|FG000|Overall Study|Withdrawal by Subject|0|||
146937487|NCT01628393|529928343|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
146937488|NCT01628393|529928344|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
146937489|NCT01628393|529928340|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
146937490|NCT01628393|529928341|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
146937491|NCT01628393|529928342|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
146937492|NCT01628393|529928343|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
146937493|NCT01628393|529928344|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
146937494|NCT01628393|529928340|FG000|Blinded Active Extension Period|Adverse Event|0|||
146788633|NCT04925986|529397988|FG001|Overall Study|Withdrawal by Subject|0|||
146937495|NCT01628393|529928341|FG001|Blinded Active Extension Period|Adverse Event|1|||
146788634|NCT04925986|529397989|FG002|Overall Study|Withdrawal by Subject|1|||
146788635|NCT04925986|529397990|FG003|Overall Study|Withdrawal by Subject|2|||
146788636|NCT04629716|529397992|FG000|Overall Study|Lost to Follow-up|7|||
146788637|NCT04629716|529397993|FG001|Overall Study|Lost to Follow-up|3|||
146788638|NCT04770532|529397994|FG000|Overall Study|Withdrawal by Subject|0|||
146788639|NCT04770532|529397995|FG001|Overall Study|Withdrawal by Subject|3|||
146788640|NCT04770532|529397994|FG000|Overall Study|Physician Decision|1|||
146788641|NCT04770532|529397995|FG001|Overall Study|Physician Decision|0|||
146788642|NCT04770532|529397994|FG000|Overall Study|Death|2|||
146788643|NCT04770532|529397995|FG001|Overall Study|Death|2|||
146788644|NCT05457647|529397996|FG000|Overall Study|Lost to Follow-up|3|||
146788645|NCT02683447|529397998|FG000|Overall Study|Lost to Follow-up|2|||
146788646|NCT03448107|529397999|FG000|Overall Study|Lost to Follow-up|229|||
146788647|NCT03448107|529398000|FG001|Overall Study|Lost to Follow-up|258|||
146788648|NCT04025554|529398001|FG000|Overall Study|Adverse Event|3|||
146788649|NCT03115476|529398002|FG000|LP0084-1369|Death|1|||
146788650|NCT03115476|529398003|FG001|LP0084-1369|Death|0|||
146788651|NCT03115476|529398004|FG002|LP0084-1369|Death|2|||
146788652|NCT03115476|529398002|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
146788653|NCT03115476|529398003|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
146788654|NCT03115476|529398004|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
146788655|NCT05257486|529398008|FG000|Overall Study|Protocol Violation|3|||
146788656|NCT02310646|529398009|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
146788657|NCT02310646|529398010|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
146788658|NCT02310646|529398009|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
146788659|NCT02310646|529398010|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
146788660|NCT03021096|529398011|FG000|Overall Study|Lost to Follow-up|4|||
146788661|NCT03021096|529398011|FG000|Overall Study|Protocol Violation|2|||
146788662|NCT04700163|529398012|FG000|Overall Study|Lost to Follow-up|0|||
146788663|NCT04700163|529398013|FG001|Overall Study|Lost to Follow-up|0|||
146788664|NCT04700163|529398014|FG002|Overall Study|Lost to Follow-up|0|||
146788665|NCT04700163|529398015|FG003|Overall Study|Lost to Follow-up|0|||
146788666|NCT04700163|529398016|FG004|Overall Study|Lost to Follow-up|0|||
146788667|NCT04700163|529398017|FG005|Overall Study|Lost to Follow-up|1|||
146788668|NCT03865498|529398024|FG000|Overall Study|Lack of Efficacy|12|||
146788669|NCT03865498|529398025|FG001|Overall Study|Lack of Efficacy|11|||
146788670|NCT03865498|529398024|FG000|Overall Study|Lost to Follow-up|125|||
146788671|NCT03865498|529398025|FG001|Overall Study|Lost to Follow-up|133|||
146788672|NCT03865498|529398024|FG000|Overall Study|Withdrawal by Subject|2|||
146788673|NCT03865498|529398025|FG001|Overall Study|Withdrawal by Subject|4|||
146788674|NCT04137367|529398032|FG000|Overall Study|Lost to Follow-up|8|||
146937496|NCT01628393|529928342|FG002|Blinded Active Extension Period|Adverse Event|0|||
146937497|NCT01628393|529928343|FG003|Blinded Active Extension Period|Adverse Event|2|||
146788675|NCT04137367|529398033|FG001|Overall Study|Lost to Follow-up|6|||
146788676|NCT04137367|529398034|FG002|Overall Study|Lost to Follow-up|4|||
146788677|NCT03270501|529398035|FG000|Overall Study|Screen failure|6|||
146788678|NCT03270501|529398035|FG000|Overall Study|Lost to Follow-up|2|||
146788679|NCT03270501|529398035|FG000|Overall Study|Adverse Event|1|||
146788680|NCT04065841|529398044|FG000|Overall Study|Adverse Event|4|||
146788681|NCT04065841|529398045|FG001|Overall Study|Adverse Event|2|||
146788682|NCT04065841|529398046|FG002|Overall Study|Adverse Event|10|||
146788683|NCT04065841|529398047|FG003|Overall Study|Adverse Event|1|||
146620363|NCT03291067|528781704|FG000|Overall Study|Withdrawal by Subject|3|||
146620364|NCT03291067|528781705|FG001|Overall Study|Withdrawal by Subject|4|||
146620365|NCT03291067|528781706|FG002|Overall Study|Withdrawal by Subject|7|||
146620366|NCT03291067|528781707|FG003|Overall Study|Withdrawal by Subject|5|||
146620367|NCT03291067|528781704|FG000|Overall Study|Other|0|||
146620368|NCT03291067|528781705|FG001|Overall Study|Other|4|||
146620369|NCT03291067|528781706|FG002|Overall Study|Other|4|||
146620370|NCT03291067|528781707|FG003|Overall Study|Other|6|||
146620371|NCT03683173|528781708|FG000|Completed Follow-up|Unavailable|235|||
146620372|NCT03683173|528781709|FG001|Completed Follow-up|Unavailable|217|||
146620373|NCT03683173|528781708|FG000|Completed Follow-up|Refused|69|||
146620374|NCT03683173|528781709|FG001|Completed Follow-up|Refused|59|||
146620375|NCT03683173|528781708|FG000|Completed Follow-up|Disconnected phone|65|||
146620376|NCT03683173|528781709|FG001|Completed Follow-up|Disconnected phone|95|||
146620377|NCT03683173|528781708|FG000|Completed Follow-up|Health issue/deceased|10|||
146620378|NCT03683173|528781709|FG001|Completed Follow-up|Health issue/deceased|4|||
146620379|NCT03683173|528781708|FG000|Completed Follow-up|Moved away|8|||
146620380|NCT03683173|528781709|FG001|Completed Follow-up|Moved away|1|||
146620381|NCT03016312|528781710|FG000|Overall Study|discontinued before the treatment started|0|||
146620382|NCT03016312|528781711|FG001|Overall Study|discontinued before the treatment started|1|||
146620383|NCT03016312|528781710|FG000|Overall Study|Withdrawal by Subject|37|||
146620384|NCT03016312|528781711|FG001|Overall Study|Withdrawal by Subject|44|||
146620385|NCT03016312|528781710|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
146620386|NCT03016312|528781711|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
146620387|NCT03016312|528781710|FG000|Overall Study|Physician Decision|1|||
146620388|NCT03016312|528781711|FG001|Overall Study|Physician Decision|3|||
146620389|NCT03016312|528781710|FG000|Overall Study|Lost to Follow-up|12|||
146620390|NCT03016312|528781711|FG001|Overall Study|Lost to Follow-up|12|||
146788684|NCT04065841|529398044|FG000|Overall Study|Lost to Follow-up|1|||
146788685|NCT04065841|529398045|FG001|Overall Study|Lost to Follow-up|2|||
146788686|NCT04065841|529398046|FG002|Overall Study|Lost to Follow-up|2|||
146788687|NCT04065841|529398047|FG003|Overall Study|Lost to Follow-up|2|||
146788688|NCT04065841|529398044|FG000|Overall Study|Physician Decision|1|||
146788689|NCT04065841|529398045|FG001|Overall Study|Physician Decision|0|||
146788690|NCT04065841|529398046|FG002|Overall Study|Physician Decision|0|||
146788691|NCT04065841|529398047|FG003|Overall Study|Physician Decision|0|||
146981867|NCT02040766|530096160|FG001|Overall Study|Lost to Follow-up|1|||
146730743|NCT00117676|529184430|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
146730744|NCT00117676|529184431|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
146730745|NCT00117676|529184430|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
146788692|NCT04065841|529398044|FG000|Overall Study|Protocol Violation|0|||
146620391|NCT03016312|528781710|FG000|Overall Study|Death|210|||
146620392|NCT03016312|528781711|FG001|Overall Study|Death|184|||
146620393|NCT03016312|528781710|FG000|Overall Study|loss to contact|1|||
146620394|NCT03016312|528781711|FG001|Overall Study|loss to contact|0|||
146620395|NCT03016312|528781710|FG000|Overall Study|started a new cancer therapy|1|||
146620396|NCT03016312|528781711|FG001|Overall Study|started a new cancer therapy|0|||
146620397|NCT00496015|528781712|FG000|Overall Study|Other|1|||
146620398|NCT00496015|528781713|FG001|Overall Study|Other|0|||
146620399|NCT00496015|528781714|FG002|Overall Study|Other|0|||
146620400|NCT00496015|528781715|FG003|Overall Study|Other|1|||
146620401|NCT00496015|528781716|FG004|Overall Study|Other|0|||
146620402|NCT01535807|528781718|FG000|Overall Study|Withdrawal by Subject|1|||
146620403|NCT01535807|528781719|FG001|Overall Study|Withdrawal by Subject|1|||
146620404|NCT01535807|528781718|FG000|Overall Study|Data collection error|1|||
146620405|NCT01535807|528781719|FG001|Overall Study|Data collection error|1|||
146620406|NCT02730728|528781722|FG000|Overall Study|Withdrawal by Subject|0|||
146620407|NCT02730728|528781723|FG001|Overall Study|Withdrawal by Subject|1|||
146620408|NCT02730728|528781724|FG002|Overall Study|Withdrawal by Subject|0|||
146620409|NCT02730728|528781722|FG000|Overall Study|Lack of Efficacy|0|||
146620410|NCT02730728|528781723|FG001|Overall Study|Lack of Efficacy|1|||
146620411|NCT02730728|528781724|FG002|Overall Study|Lack of Efficacy|1|||
146620412|NCT02193776|528781736|FG000|Overall Study|Consent withdrawn|1|||
146620413|NCT02193776|528781737|FG001|Overall Study|Consent withdrawn|0|||
146620414|NCT02193776|528781738|FG002|Overall Study|Consent withdrawn|0|||
146620415|NCT02193776|528781739|FG003|Overall Study|Consent withdrawn|0|||
146620416|NCT02193776|528781736|FG000|Overall Study|Failure to comply with protocol|0|||
146620417|NCT02193776|528781737|FG001|Overall Study|Failure to comply with protocol|1|||
146620418|NCT02193776|528781738|FG002|Overall Study|Failure to comply with protocol|0|||
146620419|NCT02193776|528781739|FG003|Overall Study|Failure to comply with protocol|0|||
146620420|NCT02193776|528781736|FG000|Overall Study|Investigator/Sponsor decision|1|||
146620421|NCT02193776|528781737|FG001|Overall Study|Investigator/Sponsor decision|1|||
146620422|NCT02193776|528781738|FG002|Overall Study|Investigator/Sponsor decision|0|||
146620423|NCT02193776|528781739|FG003|Overall Study|Investigator/Sponsor decision|0|||
146620424|NCT02193776|528781736|FG000|Overall Study|Death|1|||
146620425|NCT02193776|528781737|FG001|Overall Study|Death|0|||
146620426|NCT02193776|528781738|FG002|Overall Study|Death|0|||
146620427|NCT02193776|528781739|FG003|Overall Study|Death|0|||
146620428|NCT02193776|528781736|FG000|Overall Study|Adverse event/Specific toxicity|5|||
146620429|NCT02193776|528781737|FG001|Overall Study|Adverse event/Specific toxicity|5|||
146620430|NCT02193776|528781738|FG002|Overall Study|Adverse event/Specific toxicity|2|||
146620431|NCT02193776|528781739|FG003|Overall Study|Adverse event/Specific toxicity|2|||
146620432|NCT01702844|528781740|FG000|Overall Study|Adverse Event|9|||
146620433|NCT01702844|528781740|FG000|Overall Study|Death|1|||
146620434|NCT01702844|528781740|FG000|Overall Study|Withdrawal by Subject|3|||
146620435|NCT01702844|528781740|FG000|Overall Study|Physician Decision|6|||
146620436|NCT02123134|528781741|FG000|Overall Study|Withdrawal of consent|3|||
146620437|NCT02123134|528781742|FG001|Overall Study|Withdrawal of consent|2|||
146620438|NCT02123134|528781741|FG000|Overall Study|Administrative decision|0|||
146620439|NCT02123134|528781742|FG001|Overall Study|Administrative decision|1|||
146620440|NCT01731912|528781748|FG000|Overall Study|noncompliance|2|||
146620441|NCT02043938|528781749|FG000|Overall Study|Withdrawal by Subject|7|||
146620442|NCT02043938|528781749|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
146620443|NCT02043938|528781749|FG000|Overall Study|No show by subject|1|||
146620444|NCT02043938|528781749|FG000|Overall Study|Investigator decision|1|||
146620445|NCT03010527|528781750|FG000|Overall Study|Death|0|||
146620446|NCT03010527|528781751|FG001|Overall Study|Death|0|||
146620447|NCT03010527|528781752|FG002|Overall Study|Death|1|||
146620448|NCT03010527|528781750|FG000|Overall Study|Adverse Event|0|||
146620449|NCT03010527|528781751|FG001|Overall Study|Adverse Event|4|||
146620450|NCT03010527|528781752|FG002|Overall Study|Adverse Event|2|||
146620451|NCT03010527|528781750|FG000|Overall Study|Protocol Violation|0|||
146620452|NCT03010527|528781751|FG001|Overall Study|Protocol Violation|1|||
146620453|NCT03010527|528781752|FG002|Overall Study|Protocol Violation|0|||
146620454|NCT03010527|528781750|FG000|Overall Study|Lost to Follow-up|0|||
146620455|NCT03010527|528781751|FG001|Overall Study|Lost to Follow-up|2|||
146620456|NCT03010527|528781752|FG002|Overall Study|Lost to Follow-up|1|||
146620457|NCT03010527|528781750|FG000|Overall Study|Withdrawal by Subject|0|||
146620458|NCT03010527|528781751|FG001|Overall Study|Withdrawal by Subject|3|||
146620459|NCT03010527|528781752|FG002|Overall Study|Withdrawal by Subject|4|||
146620460|NCT03010527|528781750|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
146620461|NCT03010527|528781751|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
146620462|NCT03010527|528781752|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
146620463|NCT03010527|528781750|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
146620464|NCT03010527|528781751|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
146620465|NCT03010527|528781752|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
146620466|NCT03010527|528781750|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
146620467|NCT03010527|528781751|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
146620468|NCT03010527|528781752|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
146620469|NCT01458639|528781753|FG000|Overall Study|Physician Decision|4|||
146620470|NCT01458639|528781753|FG000|Overall Study|Equipment issue|1|||
146620471|NCT01458639|528781753|FG000|Overall Study|Inability to obtain subject blood sample|1|||
146620472|NCT02656017|528781754|FG000|Overall Study|Study burden|3|||
146620473|NCT02656017|528781755|FG001|Overall Study|Study burden|3|||
146620474|NCT02656017|528781754|FG000|Overall Study|Adverse Event|2|||
146620475|NCT02656017|528781755|FG001|Overall Study|Adverse Event|1|||
146620476|NCT02656017|528781754|FG000|Overall Study|Unable/unwilling to take study medication|2|||
146620477|NCT02656017|528781755|FG001|Overall Study|Unable/unwilling to take study medication|1|||
146620478|NCT02656017|528781754|FG000|Overall Study|Began Tolvaptan|1|||
146620479|NCT02656017|528781755|FG001|Overall Study|Began Tolvaptan|1|||
146620480|NCT02656017|528781754|FG000|Overall Study|Withdrawal by Subject|1|||
146620481|NCT02656017|528781755|FG001|Overall Study|Withdrawal by Subject|0|||
146620482|NCT01755234|528781756|FG000|Overall Study|Lost to Follow-up|11|||
146620483|NCT01755234|528781757|FG001|Overall Study|Lost to Follow-up|6|||
146620484|NCT01755234|528781756|FG000|Overall Study|Change in surgical case|2|||
146620485|NCT01755234|528781757|FG001|Overall Study|Change in surgical case|1|||
146620486|NCT01755234|528781756|FG000|Overall Study|case cancelled|1|||
146620487|NCT01755234|528781757|FG001|Overall Study|case cancelled|0|||
146620488|NCT01755234|528781756|FG000|Overall Study|Withdrawal by Subject|0|||
146620489|NCT01755234|528781757|FG001|Overall Study|Withdrawal by Subject|1|||
146620490|NCT01755234|528781756|FG000|Overall Study|unblinded|1|||
146620491|NCT01755234|528781757|FG001|Overall Study|unblinded|0|||
146620492|NCT00622505|528781758|FG000|Overall Study|Adverse Event|9|||
146620493|NCT00622505|528781759|FG001|Overall Study|Adverse Event|7|||
146620494|NCT00622505|528781758|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
146620495|NCT00622505|528781759|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
146620496|NCT00622505|528781758|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
146620497|NCT00622505|528781759|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
146620498|NCT00622505|528781758|FG000|Overall Study|Withdrawal by Subject|12|||
146620499|NCT00622505|528781759|FG001|Overall Study|Withdrawal by Subject|5|||
146620500|NCT00622505|528781758|FG000|Overall Study|Administrative Problems|2|||
146620501|NCT00622505|528781759|FG001|Overall Study|Administrative Problems|4|||
146620502|NCT00622505|528781758|FG000|Overall Study|Death|2|||
146620503|NCT00622505|528781759|FG001|Overall Study|Death|2|||
146620504|NCT01216202|528781770|FG000|Overall Study|Withdrawal by Subject|8|||
146620505|NCT01216202|528781771|FG001|Overall Study|Withdrawal by Subject|0|||
146620506|NCT01216202|528781770|FG000|Overall Study|Death|0|||
146620507|NCT01216202|528781771|FG001|Overall Study|Death|2|||
146620508|NCT01216202|528781770|FG000|Overall Study|Lost to Follow-up|14|||
146620509|NCT01216202|528781771|FG001|Overall Study|Lost to Follow-up|0|||
146620510|NCT00614380|528781775|FG000|Overall Study|Adverse Event|14|||
146620511|NCT00614380|528781776|FG001|Overall Study|Adverse Event|4|||
146620512|NCT00614380|528781777|FG002|Overall Study|Adverse Event|0|||
146620513|NCT00614380|528781778|FG003|Overall Study|Adverse Event|0|||
146620514|NCT00614380|528781775|FG000|Overall Study|Lost to Follow-up|6|||
146620515|NCT00614380|528781776|FG001|Overall Study|Lost to Follow-up|1|||
146620516|NCT00614380|528781777|FG002|Overall Study|Lost to Follow-up|0|||
146620517|NCT00614380|528781778|FG003|Overall Study|Lost to Follow-up|0|||
146620518|NCT00614380|528781775|FG000|Overall Study|Non compliant with the protocol|12|||
146620519|NCT00614380|528781776|FG001|Overall Study|Non compliant with the protocol|2|||
146620520|NCT00614380|528781777|FG002|Overall Study|Non compliant with the protocol|1|||
146620521|NCT00614380|528781778|FG003|Overall Study|Non compliant with the protocol|2|||
146620522|NCT00614380|528781775|FG000|Overall Study|Consent withdrawn|3|||
146620523|NCT00614380|528781776|FG001|Overall Study|Consent withdrawn|1|||
146620524|NCT00614380|528781777|FG002|Overall Study|Consent withdrawn|0|||
146620525|NCT00614380|528781778|FG003|Overall Study|Consent withdrawn|0|||
146620526|NCT01506271|528781779|FG000|Overall Study|Progressive disease|0|||
146620527|NCT01506271|528781780|FG001|Overall Study|Progressive disease|1|||
146620528|NCT01506271|528781781|FG002|Overall Study|Progressive disease|0|||
146620529|NCT01506271|528781779|FG000|Overall Study|Protocol Violation|3|||
146620530|NCT01506271|528781780|FG001|Overall Study|Protocol Violation|1|||
146620531|NCT01506271|528781781|FG002|Overall Study|Protocol Violation|0|||
146620532|NCT01506271|528781779|FG000|Overall Study|Death|0|||
146620533|NCT01506271|528781780|FG001|Overall Study|Death|1|||
146620534|NCT01506271|528781781|FG002|Overall Study|Death|0|||
146620535|NCT01506271|528781779|FG000|Overall Study|Adverse Event|0|||
146620536|NCT01506271|528781780|FG001|Overall Study|Adverse Event|2|||
146620537|NCT01506271|528781781|FG002|Overall Study|Adverse Event|0|||
146620538|NCT01506271|528781779|FG000|Overall Study|Insufficient supply of study drug|1|||
146620539|NCT01506271|528781780|FG001|Overall Study|Insufficient supply of study drug|0|||
146730746|NCT00117676|529184431|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
146730747|NCT00117676|529184430|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
146730748|NCT00117676|529184431|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
146730749|NCT00117676|529184430|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
146730750|NCT00117676|529184431|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
146730751|NCT00117676|529184430|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
146730752|NCT00117676|529184431|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
146730753|NCT00117676|529184430|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
146730754|NCT00117676|529184431|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
146730755|NCT00117676|529184430|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
146730756|NCT00117676|529184431|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
146730757|NCT00952822|529184432|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
146730758|NCT00952822|529184433|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
146730759|NCT00952822|529184434|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
146730760|NCT00952822|529184435|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
146730761|NCT00952822|529184432|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
146730762|NCT00952822|529184433|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
146730763|NCT00952822|529184434|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
146730764|NCT00952822|529184435|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
146730765|NCT01281644|529184438|FG000|Overall Study|Lost to Follow-up|3|||
146730766|NCT01281644|529184438|FG000|Overall Study|Withdrawal by Subject|2|||
146730767|NCT01755702|529184439|FG000|Wash Out Period I|Other Reason|3|||
146730768|NCT01755702|529184439|FG000|Washout Period II|Other Reason|5|||
146730769|NCT03440372|529184444|FG000|Treatment|Adverse Event|16|||
146730770|NCT03440372|529184445|FG001|Treatment|Adverse Event|8|||
146730771|NCT03440372|529184444|FG000|Treatment|Lack of Efficacy|4|||
146730772|NCT03440372|529184445|FG001|Treatment|Lack of Efficacy|2|||
146730773|NCT03440372|529184444|FG000|Treatment|Withdrawal by Subject|12|||
146730774|NCT03440372|529184445|FG001|Treatment|Withdrawal by Subject|8|||
146730775|NCT03440372|529184444|FG000|Treatment|Lost to Follow-up|1|||
146730776|NCT03440372|529184445|FG001|Treatment|Lost to Follow-up|0|||
146730777|NCT03440372|529184444|FG000|Treatment|Pregnancy|1|||
146730778|NCT03440372|529184445|FG001|Treatment|Pregnancy|0|||
146730779|NCT03440372|529184444|FG000|Treatment|Study Terminated by Sponsor|2|||
146730780|NCT03440372|529184445|FG001|Treatment|Study Terminated by Sponsor|1|||
146730781|NCT03440372|529184444|FG000|Treatment|Other Reason|2|||
146730782|NCT03440372|529184445|FG001|Treatment|Other Reason|3|||
146730783|NCT03945292|529184446|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
146730784|NCT03945292|529184447|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
146730785|NCT03945292|529184448|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
146730786|NCT03945292|529184449|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
146730787|NCT03945292|529184450|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
146730788|NCT03945292|529184451|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
146730789|NCT03945292|529184452|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
146730790|NCT03945292|529184453|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
146730791|NCT03945292|529184446|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
146730792|NCT03945292|529184447|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
146730793|NCT03945292|529184448|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
146730794|NCT03945292|529184449|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
146730795|NCT03945292|529184450|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
146730796|NCT03945292|529184451|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
146730797|NCT03945292|529184452|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
146730798|NCT03945292|529184453|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
146730799|NCT03945292|529184446|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
146730800|NCT03945292|529184447|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
146730801|NCT03945292|529184448|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
146730802|NCT03945292|529184449|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
146730803|NCT03945292|529184450|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
146730804|NCT03945292|529184451|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
146730805|NCT03945292|529184452|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
146730806|NCT03945292|529184453|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
146730807|NCT02684006|529184454|FG000|Overall Study|Other|18|||
146730808|NCT02684006|529184455|FG001|Overall Study|Other|6|||
146730809|NCT02684006|529184454|FG000|Overall Study|Protocol Violation|2|||
146730810|NCT02684006|529184455|FG001|Overall Study|Protocol Violation|1|||
146730811|NCT02684006|529184454|FG000|Overall Study|Non-compliance with study drug|1|||
146730812|NCT02684006|529184455|FG001|Overall Study|Non-compliance with study drug|1|||
146730813|NCT02684006|529184454|FG000|Overall Study|No longer met eligibility criteria|6|||
146730814|NCT02684006|529184455|FG001|Overall Study|No longer met eligibility criteria|2|||
146937498|NCT01628393|529928344|FG004|Blinded Active Extension Period|Adverse Event|2|||
146937499|NCT01628393|529928340|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
146937500|NCT01628393|529928341|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
146937501|NCT01628393|529928342|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
146937502|NCT01628393|529928343|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
146937503|NCT01628393|529928344|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
146937504|NCT01628393|529928340|FG000|Blinded Active Extension Period|Physician Decision|0|||
146937505|NCT01628393|529928341|FG001|Blinded Active Extension Period|Physician Decision|3|||
146730815|NCT02684006|529184454|FG000|Overall Study|Lost to Follow-up|0|||
146730816|NCT02684006|529184455|FG001|Overall Study|Lost to Follow-up|1|||
146730817|NCT02684006|529184454|FG000|Overall Study|Death|25|||
146730818|NCT02684006|529184455|FG001|Overall Study|Death|22|||
146730819|NCT02684006|529184454|FG000|Overall Study|Global deterioration of health status|18|||
146730820|NCT02684006|529184455|FG001|Overall Study|Global deterioration of health status|20|||
146730821|NCT02684006|529184454|FG000|Overall Study|Physician Decision|15|||
146730822|NCT02684006|529184455|FG001|Overall Study|Physician Decision|8|||
146730823|NCT02684006|529184454|FG000|Overall Study|Adverse Event|86|||
146730824|NCT02684006|529184455|FG001|Overall Study|Adverse Event|65|||
146730825|NCT02684006|529184454|FG000|Overall Study|Withdrawal by Subject|29|||
146730826|NCT02684006|529184455|FG001|Overall Study|Withdrawal by Subject|43|||
146730827|NCT02684006|529184454|FG000|Overall Study|Progressive disease|236|||
146730828|NCT02684006|529184455|FG001|Overall Study|Progressive disease|266|||
146730829|NCT02684006|529184454|FG000|Overall Study|Participation terminated by sponsor|6|||
146730830|NCT02684006|529184455|FG001|Overall Study|Participation terminated by sponsor|9|||
146730831|NCT05103384|529184456|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
146730832|NCT05007392|529184457|FG000|Overall Study|Randomized but not treated|1|||
146730833|NCT05007392|529184458|FG001|Overall Study|Randomized but not treated|2|||
146730834|NCT05007392|529184457|FG000|Overall Study|Other|5|||
146730835|NCT05007392|529184458|FG001|Overall Study|Other|4|||
146730836|NCT05007392|529184457|FG000|Overall Study|Lost to Follow-up|1|||
146730837|NCT05007392|529184458|FG001|Overall Study|Lost to Follow-up|2|||
146730838|NCT05007392|529184457|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
146730839|NCT05007392|529184458|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
146730840|NCT05007392|529184457|FG000|Overall Study|Use of prohibited concomitant drug|1|||
146730841|NCT05007392|529184458|FG001|Overall Study|Use of prohibited concomitant drug|1|||
146730842|NCT05007392|529184457|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
146730843|NCT05007392|529184458|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
146730844|NCT05007392|529184457|FG000|Overall Study|Adverse Event|10|||
146730845|NCT05007392|529184458|FG001|Overall Study|Adverse Event|6|||
146730846|NCT05007392|529184457|FG000|Overall Study|Participant choice|5|||
146730847|NCT05007392|529184458|FG001|Overall Study|Participant choice|10|||
146730848|NCT05007392|529184457|FG000|Overall Study|Withdrawal of consent|5|||
146730849|NCT05007392|529184458|FG001|Overall Study|Withdrawal of consent|4|||
146730850|NCT01659151|529184459|FG000|Overall Study|Inadequate TIL growth|1|||
146730851|NCT06223373|529184463|FG000|Overall Study|Lost to Follow-up|1|||
146730852|NCT06223373|529184464|FG001|Overall Study|Lost to Follow-up|2|||
146730853|NCT03421808|529184466|FG000|Overall Study|COVID related problems|2|||
146730854|NCT03421808|529184467|FG001|Overall Study|COVID related problems|0|||
146730855|NCT03421808|529184466|FG000|Overall Study|Withdrawal by Subject|1|||
146730856|NCT03421808|529184467|FG001|Overall Study|Withdrawal by Subject|0|||
146730857|NCT03421808|529184466|FG000|Overall Study|Protocol Violation|0|||
146730858|NCT03421808|529184467|FG001|Overall Study|Protocol Violation|1|||
146730859|NCT03764774|529184468|FG000|Overall Study|Withdrawal by Subject|0|||
146730860|NCT03764774|529184469|FG001|Overall Study|Withdrawal by Subject|0|||
146730861|NCT03764774|529184470|FG002|Overall Study|Withdrawal by Subject|0|||
146730862|NCT03764774|529184471|FG003|Overall Study|Withdrawal by Subject|0|||
146730863|NCT03764774|529184472|FG004|Overall Study|Withdrawal by Subject|0|||
146730864|NCT03764774|529184473|FG005|Overall Study|Withdrawal by Subject|0|||
146730865|NCT03764774|529184474|FG006|Overall Study|Withdrawal by Subject|0|||
146730866|NCT03764774|529184475|FG007|Overall Study|Withdrawal by Subject|0|||
146730867|NCT03764774|529184476|FG008|Overall Study|Withdrawal by Subject|0|||
146730868|NCT03764774|529184477|FG009|Overall Study|Withdrawal by Subject|0|||
146730869|NCT03764774|529184478|FG010|Overall Study|Withdrawal by Subject|1|||
146730870|NCT03764774|529184479|FG011|Overall Study|Withdrawal by Subject|0|||
146937506|NCT01628393|529928342|FG002|Blinded Active Extension Period|Physician Decision|0|||
146981868|NCT02040766|530096161|FG002|Overall Study|Lost to Follow-up|3|||
146730871|NCT03764774|529184480|FG012|Overall Study|Withdrawal by Subject|0|||
146730872|NCT03764774|529184481|FG013|Overall Study|Withdrawal by Subject|0|||
146730873|NCT03764774|529184468|FG000|Overall Study|Adverse Event|0|||
146730874|NCT03764774|529184469|FG001|Overall Study|Adverse Event|0|||
146730875|NCT03764774|529184470|FG002|Overall Study|Adverse Event|0|||
146730876|NCT03764774|529184471|FG003|Overall Study|Adverse Event|0|||
146730877|NCT03764774|529184472|FG004|Overall Study|Adverse Event|0|||
146730878|NCT03764774|529184473|FG005|Overall Study|Adverse Event|0|||
146937507|NCT01628393|529928343|FG003|Blinded Active Extension Period|Physician Decision|1|||
146937508|NCT01628393|529928344|FG004|Blinded Active Extension Period|Physician Decision|0|||
146937509|NCT01628393|529928340|FG000|Blinded Active Extension Period|Protocol Violation|0|||
146937510|NCT01628393|529928341|FG001|Blinded Active Extension Period|Protocol Violation|0|||
146937511|NCT01628393|529928342|FG002|Blinded Active Extension Period|Protocol Violation|2|||
146937512|NCT01628393|529928343|FG003|Blinded Active Extension Period|Protocol Violation|1|||
146937513|NCT01628393|529928344|FG004|Blinded Active Extension Period|Protocol Violation|0|||
146937514|NCT01628393|529928340|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
146937515|NCT01628393|529928341|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
146937516|NCT01628393|529928342|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
146937517|NCT01628393|529928343|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
146937518|NCT01628393|529928344|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
146937519|NCT00561340|529928345|FG000|Overall Study|refused to drink pediasure|6|||
146937520|NCT00561340|529928346|FG001|Overall Study|refused to drink pediasure|0|||
146937521|NCT01989754|529928347|FG000|Overall Study|Withdrawal by Subject|10|||
146937522|NCT01989754|529928348|FG001|Overall Study|Withdrawal by Subject|14|||
146937523|NCT01989754|529928347|FG000|Overall Study|Lost to Follow-up|28|||
146937524|NCT01989754|529928348|FG001|Overall Study|Lost to Follow-up|20|||
146937525|NCT01989754|529928347|FG000|Overall Study|Closed Site|1|||
146937526|NCT01989754|529928348|FG001|Overall Study|Closed Site|1|||
146937527|NCT01369225|529928351|FG000|Overall Study|Withdrawal by Subject|1|||
146937528|NCT01369225|529928352|FG001|Overall Study|Withdrawal by Subject|0|||
146937529|NCT01369225|529928353|FG002|Overall Study|Withdrawal by Subject|2|||
146937530|NCT01369225|529928354|FG003|Overall Study|Withdrawal by Subject|1|||
146937531|NCT01369225|529928355|FG004|Overall Study|Withdrawal by Subject|0|||
146937532|NCT01369225|529928356|FG005|Overall Study|Withdrawal by Subject|0|||
146937533|NCT01369225|529928351|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
146937534|NCT01369225|529928352|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
146937535|NCT01369225|529928353|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
146937536|NCT01369225|529928354|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
146937537|NCT01369225|529928355|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
146937538|NCT01369225|529928356|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
146937539|NCT01369225|529928351|FG000|Overall Study|Other|1|||
146937540|NCT01369225|529928352|FG001|Overall Study|Other|0|||
146937541|NCT01369225|529928353|FG002|Overall Study|Other|0|||
146937542|NCT01369225|529928354|FG003|Overall Study|Other|0|||
146937543|NCT01369225|529928355|FG004|Overall Study|Other|1|||
146937544|NCT01369225|529928356|FG005|Overall Study|Other|0|||
146937545|NCT01369225|529928351|FG000|Overall Study|Adverse Event|0|||
146937546|NCT01369225|529928352|FG001|Overall Study|Adverse Event|0|||
146937547|NCT01369225|529928353|FG002|Overall Study|Adverse Event|0|||
146937548|NCT01369225|529928354|FG003|Overall Study|Adverse Event|1|||
146937549|NCT01369225|529928355|FG004|Overall Study|Adverse Event|1|||
146937550|NCT01369225|529928356|FG005|Overall Study|Adverse Event|0|||
146937551|NCT00105183|529928360|FG000|Overall Study|Death|19|||
146937552|NCT00105183|529928361|FG001|Overall Study|Death|13|||
146937553|NCT00105183|529928362|FG002|Overall Study|Death|15|||
146937554|NCT00105183|529928360|FG000|Overall Study|Withdrawal by Subject|1|||
146937555|NCT00105183|529928361|FG001|Overall Study|Withdrawal by Subject|1|||
146937556|NCT00105183|529928362|FG002|Overall Study|Withdrawal by Subject|4|||
146937557|NCT00105183|529928360|FG000|Overall Study|Physician Decision|1|||
146937558|NCT00105183|529928361|FG001|Overall Study|Physician Decision|2|||
146937559|NCT00105183|529928362|FG002|Overall Study|Physician Decision|3|||
146937560|NCT00105183|529928360|FG000|Overall Study|Lost to Follow-up|0|||
146937561|NCT00105183|529928361|FG001|Overall Study|Lost to Follow-up|1|||
146937562|NCT00105183|529928362|FG002|Overall Study|Lost to Follow-up|1|||
146937563|NCT00105183|529928360|FG000|Overall Study|Other reason|1|||
146937564|NCT00105183|529928361|FG001|Overall Study|Other reason|2|||
146937565|NCT00105183|529928362|FG002|Overall Study|Other reason|0|||
146937566|NCT01467661|529928364|FG000|Overall Study|Adverse Event|16|||
146937567|NCT01467661|529928364|FG000|Overall Study|Withdrawal by Subject|1|||
146937568|NCT01467661|529928364|FG000|Overall Study|Lack of Efficacy|3|||
146937569|NCT01467661|529928364|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
146937570|NCT03037307|529928365|FG000|Period 1|Did Not Meet Study Criteria|0|||
146937571|NCT03037307|529928366|FG001|Period 1|Did Not Meet Study Criteria|0|||
146730879|NCT03764774|529184474|FG006|Overall Study|Adverse Event|0|||
146937572|NCT03037307|529928367|FG002|Period 1|Did Not Meet Study Criteria|0|||
146937573|NCT03037307|529928368|FG003|Period 1|Did Not Meet Study Criteria|1|||
146937574|NCT03037307|529928369|FG004|Period 1|Did Not Meet Study Criteria|0|||
146937575|NCT03037307|529928370|FG005|Period 1|Did Not Meet Study Criteria|0|||
146937576|NCT01855945|529928373|FG000|Overall Study|Adverse Event|0|||
146937577|NCT01855945|529928374|FG001|Overall Study|Adverse Event|0|||
146937578|NCT01855945|529928375|FG002|Overall Study|Adverse Event|0|||
146937579|NCT01855945|529928376|FG003|Overall Study|Adverse Event|0|||
146937580|NCT01855945|529928377|FG004|Overall Study|Adverse Event|0|||
146937581|NCT01855945|529928378|FG005|Overall Study|Adverse Event|0|||
146620540|NCT01506271|528781781|FG002|Overall Study|Insufficient supply of study drug|0|||
146620541|NCT01506271|528781779|FG000|Overall Study|Withdrawal by Subject|0|||
146620542|NCT01506271|528781780|FG001|Overall Study|Withdrawal by Subject|1|||
146620543|NCT01506271|528781781|FG002|Overall Study|Withdrawal by Subject|1|||
146620544|NCT01506271|528781779|FG000|Overall Study|Lost to Follow-up|0|||
146620545|NCT01506271|528781780|FG001|Overall Study|Lost to Follow-up|1|||
146620546|NCT01506271|528781781|FG002|Overall Study|Lost to Follow-up|2|||
146620547|NCT04393493|528781782|FG000|First 4 Days of Intervention|Early improvement|5|||
146620548|NCT04393493|528781783|FG001|First 4 Days of Intervention|Early improvement|7|||
146620549|NCT01808196|528781790|FG000|Overall Study|Lost to Follow-up|1|||
146620550|NCT01670721|528781791|FG000|Overall Study|Participant's decision|15|||
146620551|NCT01670721|528781791|FG000|Overall Study|Other than specified above|38|||
146620552|NCT00479713|528781792|FG000|Overall Study|Adverse Event|8|||
146620553|NCT00479713|528781793|FG001|Overall Study|Adverse Event|6|||
146620554|NCT00479713|528781792|FG000|Overall Study|Death|1|||
146620555|NCT00479713|528781793|FG001|Overall Study|Death|0|||
146620556|NCT00479713|528781792|FG000|Overall Study|Lost to Follow-up|0|||
146620557|NCT00479713|528781793|FG001|Overall Study|Lost to Follow-up|1|||
146620558|NCT00479713|528781792|FG000|Overall Study|Protocol Violation|0|||
146620559|NCT00479713|528781793|FG001|Overall Study|Protocol Violation|1|||
146620560|NCT00479713|528781792|FG000|Overall Study|Withdrawal by Subject|4|||
146620561|NCT00479713|528781793|FG001|Overall Study|Withdrawal by Subject|1|||
146620562|NCT00141102|528781796|FG000|Overall Study|Adverse Event|233|||
146620563|NCT00141102|528781797|FG001|Overall Study|Adverse Event|305|||
146620564|NCT00141102|528781796|FG000|Overall Study|Laboratory Abnormality|9|||
146620565|NCT00141102|528781797|FG001|Overall Study|Laboratory Abnormality|33|||
146620566|NCT00141102|528781796|FG000|Overall Study|Lack of Efficacy|21|||
146620567|NCT00141102|528781797|FG001|Overall Study|Lack of Efficacy|26|||
146620568|NCT00141102|528781796|FG000|Overall Study|Lost to Follow-up|29|||
146620569|NCT00141102|528781797|FG001|Overall Study|Lost to Follow-up|32|||
146620570|NCT00141102|528781796|FG000|Overall Study|Other|87|||
146620571|NCT00141102|528781797|FG001|Overall Study|Other|76|||
146620572|NCT00141102|528781796|FG000|Overall Study|Withdrawal by Subject|112|||
146620573|NCT00141102|528781797|FG001|Overall Study|Withdrawal by Subject|142|||
146620574|NCT00141102|528781796|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
146620575|NCT00141102|528781797|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
146620576|NCT00141102|528781796|FG000|Overall Study|Death|2|||
146620577|NCT00141102|528781797|FG001|Overall Study|Death|2|||
146620578|NCT00866814|528781801|FG000|Overall Study|Lost to Follow-up|12|||
146620579|NCT00866814|528781801|FG000|Overall Study|Adverse Event|2|||
146620580|NCT00866814|528781801|FG000|Overall Study|Physician Decision|1|||
146620581|NCT00866814|528781801|FG000|Overall Study|Death|1|||
146620582|NCT00866814|528781801|FG000|Overall Study|No longer wished to participate|1|||
146620583|NCT00866814|528781801|FG000|Overall Study|Unable to meet follow-up requirements|2|||
146620584|NCT00866814|528781801|FG000|Overall Study|Moved to area without study site|1|||
146620585|NCT01232868|528783345|FG000|Overall Study|Lost to Follow-up|2|||
146620586|NCT01232868|528783346|FG001|Overall Study|Lost to Follow-up|4|||
146620587|NCT04481243|528783347|FG000|Overall Study|Withdrawal by Subject|4|||
146620588|NCT04564846|528783348|FG000|Overall Study|Withdrawal by Subject|2|||
146620589|NCT04564846|528783349|FG001|Overall Study|Withdrawal by Subject|1|||
146620590|NCT04564846|528783348|FG000|Overall Study|Physician Decision|0|||
146620591|NCT04564846|528783349|FG001|Overall Study|Physician Decision|1|||
146620592|NCT04564846|528783348|FG000|Overall Study|Lost to Follow-up|0|||
146620593|NCT04564846|528783349|FG001|Overall Study|Lost to Follow-up|1|||
146620594|NCT04564846|528783348|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
146620595|NCT04564846|528783349|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
146620596|NCT04564846|528783348|FG000|Overall Study|Subject non-compliance|1|||
146620597|NCT04564846|528783349|FG001|Overall Study|Subject non-compliance|0|||
146620598|NCT01342913|528783350|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
146620599|NCT01342913|528783351|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
146620600|NCT01342913|528783352|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
146620601|NCT01342913|528783350|FG000|2-week Run-in Period|Physician Decision|6|||
146620602|NCT01342913|528783351|FG001|2-week Run-in Period|Physician Decision|0|||
146620603|NCT01342913|528783352|FG002|2-week Run-in Period|Physician Decision|0|||
146620604|NCT01342913|528783350|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
146620605|NCT01342913|528783351|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
146937582|NCT01855945|529928379|FG006|Overall Study|Adverse Event|1|||
146937583|NCT01855945|529928380|FG007|Overall Study|Adverse Event|0|||
146937584|NCT01855945|529928381|FG008|Overall Study|Adverse Event|0|||
146937585|NCT01855945|529928382|FG009|Overall Study|Adverse Event|0|||
146937586|NCT01855945|529928383|FG010|Overall Study|Adverse Event|0|||
146620606|NCT01342913|528783352|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
146620607|NCT01342913|528783350|FG000|2-week Run-in Period|Adverse Event|2|||
146620608|NCT01342913|528783351|FG001|2-week Run-in Period|Adverse Event|0|||
146620609|NCT01342913|528783352|FG002|2-week Run-in Period|Adverse Event|0|||
146620610|NCT01342913|528783350|FG000|2-week Run-in Period|Protocol Violation|5|||
146620611|NCT01342913|528783351|FG001|2-week Run-in Period|Protocol Violation|0|||
146620612|NCT01342913|528783352|FG002|2-week Run-in Period|Protocol Violation|0|||
146620613|NCT01342913|528783350|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
146620614|NCT01342913|528783351|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
146620615|NCT01342913|528783352|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
146620616|NCT01342913|528783350|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146620617|NCT01342913|528783351|FG001|Double-Blind Treatment Period|Adverse Event|3|||
146620618|NCT01342913|528783352|FG002|Double-Blind Treatment Period|Adverse Event|6|||
146620619|NCT01342913|528783350|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
146620620|NCT01342913|528783351|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
146620621|NCT01342913|528783352|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
146620622|NCT01342913|528783350|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
146620623|NCT01342913|528783351|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
146620624|NCT01342913|528783352|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
146620625|NCT01342913|528783350|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146620626|NCT01342913|528783351|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
146620627|NCT01342913|528783352|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
146620628|NCT01342913|528783350|FG000|Double-Blind Treatment Period|Physician Decision|0|||
146620629|NCT01342913|528783351|FG001|Double-Blind Treatment Period|Physician Decision|2|||
146620630|NCT01342913|528783352|FG002|Double-Blind Treatment Period|Physician Decision|0|||
146620631|NCT01342913|528783350|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146620632|NCT01342913|528783351|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
146620633|NCT01342913|528783352|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
146620634|NCT05482308|528783355|FG000|Overall Study|Withdrawal by Subject|1|||
146620635|NCT05482308|528783356|FG001|Overall Study|Withdrawal by Subject|0|||
146620636|NCT05482308|528783355|FG000|Overall Study|No longer meets eligibility criteria|0|||
146620637|NCT05482308|528783356|FG001|Overall Study|No longer meets eligibility criteria|1|||
146620638|NCT04319198|528783357|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
146620639|NCT04319198|528783358|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
146620640|NCT04319198|528783359|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
146620641|NCT04319198|528783357|FG000|Overall Study|Death|0|||
146620642|NCT04319198|528783358|FG001|Overall Study|Death|3|||
146620643|NCT04319198|528783359|FG002|Overall Study|Death|3|||
146620644|NCT04319198|528783357|FG000|Overall Study|Reason Not Specified|0|||
146620645|NCT04319198|528783358|FG001|Overall Study|Reason Not Specified|2|||
146620646|NCT04319198|528783359|FG002|Overall Study|Reason Not Specified|4|||
146620647|NCT04319198|528783357|FG000|Overall Study|Withdrawal of Consent|0|||
146620648|NCT04319198|528783358|FG001|Overall Study|Withdrawal of Consent|0|||
146620649|NCT04319198|528783359|FG002|Overall Study|Withdrawal of Consent|5|||
146620650|NCT04319198|528783357|FG000|Overall Study|Site Terminated by Sponsor|0|||
146620651|NCT04319198|528783358|FG001|Overall Study|Site Terminated by Sponsor|1|||
146620652|NCT04319198|528783359|FG002|Overall Study|Site Terminated by Sponsor|0|||
146620653|NCT05801991|528783360|FG000|Overall Study|Lost to Follow-up|1|||
146620654|NCT05801991|528783361|FG001|Overall Study|Lost to Follow-up|0|||
146620655|NCT03489863|528783365|FG000|Overall Study|Withdrawal by Subject|0|||
146620656|NCT03489863|528783366|FG001|Overall Study|Withdrawal by Subject|1|||
146620657|NCT02995980|528783367|FG000|Overall Study|Lost to Follow-up|14|||
146620658|NCT01169103|528783369|FG000|Overall Study|Lost to Follow-up|3|||
146620659|NCT01169103|528783370|FG001|Overall Study|Lost to Follow-up|3|||
146620660|NCT01169103|528783369|FG000|Overall Study|Withdrawal by Subject|3|||
146620661|NCT01169103|528783370|FG001|Overall Study|Withdrawal by Subject|1|||
146620662|NCT02634333|528783371|FG000|Overall Study|Completed out of Window|3|||
146620663|NCT02634333|528783372|FG001|Overall Study|Completed out of Window|2|||
146620664|NCT02634333|528783371|FG000|Overall Study|Missed Visit|5|||
146620665|NCT02634333|528783372|FG001|Overall Study|Missed Visit|2|||
146620666|NCT02634333|528783371|FG000|Overall Study|Lost to Follow-up|12|||
146620667|NCT02634333|528783372|FG001|Overall Study|Lost to Follow-up|7|||
146620668|NCT02634333|528783371|FG000|Overall Study|Withdrawal by Subject|9|||
146620669|NCT02634333|528783372|FG001|Overall Study|Withdrawal by Subject|13|||
146620670|NCT02634333|528783371|FG000|Overall Study|Death|11|||
146981869|NCT02040766|530096162|FG003|Overall Study|Lost to Follow-up|1|||
146981870|NCT02040766|530096163|FG004|Overall Study|Lost to Follow-up|4|||
146981871|NCT02040766|530096159|FG000|Overall Study|Not reported|1|||
146981872|NCT02040766|530096160|FG001|Overall Study|Not reported|0|||
146981873|NCT02040766|530096161|FG002|Overall Study|Not reported|0|||
146981874|NCT02040766|530096162|FG003|Overall Study|Not reported|0|||
146620671|NCT02634333|528783372|FG001|Overall Study|Death|8|||
146620672|NCT02611479|528783373|FG000|Baseline Enrollment|Exited study|13|||
146620673|NCT02611479|528783373|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
146620674|NCT02611479|528783373|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
146620675|NCT02611479|528783373|FG000|Data Cleaning|No baseline function or pain metrics|2|||
146620676|NCT03275740|528783377|FG000|Overall Study|Adverse Event|0|||
146620677|NCT03275740|528783378|FG001|Overall Study|Adverse Event|0|||
146620678|NCT03275740|528783379|FG002|Overall Study|Adverse Event|0|||
146937587|NCT01855945|529928384|FG011|Overall Study|Adverse Event|0|||
146937588|NCT01855945|529928373|FG000|Overall Study|Death|0|||
146937589|NCT01855945|529928374|FG001|Overall Study|Death|0|||
146937590|NCT01855945|529928375|FG002|Overall Study|Death|0|||
146937591|NCT01855945|529928376|FG003|Overall Study|Death|0|||
146937592|NCT01855945|529928377|FG004|Overall Study|Death|0|||
146937593|NCT01855945|529928378|FG005|Overall Study|Death|0|||
146937594|NCT01855945|529928379|FG006|Overall Study|Death|2|||
146937595|NCT01855945|529928380|FG007|Overall Study|Death|0|||
146937596|NCT01855945|529928381|FG008|Overall Study|Death|0|||
146937597|NCT01855945|529928382|FG009|Overall Study|Death|0|||
146937598|NCT01855945|529928383|FG010|Overall Study|Death|0|||
146937599|NCT01855945|529928384|FG011|Overall Study|Death|0|||
146937600|NCT01855945|529928373|FG000|Overall Study|Lost to Follow-up|11|||
146937601|NCT01855945|529928374|FG001|Overall Study|Lost to Follow-up|10|||
146937602|NCT01855945|529928375|FG002|Overall Study|Lost to Follow-up|7|||
146937603|NCT01855945|529928376|FG003|Overall Study|Lost to Follow-up|3|||
146937604|NCT01855945|529928377|FG004|Overall Study|Lost to Follow-up|0|||
146937605|NCT01855945|529928378|FG005|Overall Study|Lost to Follow-up|3|||
146937606|NCT01855945|529928379|FG006|Overall Study|Lost to Follow-up|4|||
146937607|NCT01855945|529928380|FG007|Overall Study|Lost to Follow-up|7|||
146937608|NCT01855945|529928381|FG008|Overall Study|Lost to Follow-up|2|||
146937609|NCT01855945|529928382|FG009|Overall Study|Lost to Follow-up|0|||
146937610|NCT01855945|529928383|FG010|Overall Study|Lost to Follow-up|0|||
146937611|NCT01855945|529928384|FG011|Overall Study|Lost to Follow-up|2|||
146937612|NCT01855945|529928373|FG000|Overall Study|Other - Unclassified|1|||
146937613|NCT01855945|529928374|FG001|Overall Study|Other - Unclassified|1|||
146981875|NCT02040766|530096163|FG004|Overall Study|Not reported|0|||
146981876|NCT02040766|530096159|FG000|Overall Study|Lack of Efficacy|6|||
146937614|NCT01855945|529928375|FG002|Overall Study|Other - Unclassified|1|||
146937615|NCT01855945|529928376|FG003|Overall Study|Other - Unclassified|0|||
146937616|NCT01855945|529928377|FG004|Overall Study|Other - Unclassified|0|||
146937617|NCT01855945|529928378|FG005|Overall Study|Other - Unclassified|0|||
146937618|NCT01855945|529928379|FG006|Overall Study|Other - Unclassified|2|||
146937619|NCT01855945|529928380|FG007|Overall Study|Other - Unclassified|1|||
146937620|NCT01855945|529928381|FG008|Overall Study|Other - Unclassified|0|||
146937621|NCT01855945|529928382|FG009|Overall Study|Other - Unclassified|0|||
146937622|NCT01855945|529928383|FG010|Overall Study|Other - Unclassified|1|||
146937623|NCT01855945|529928384|FG011|Overall Study|Other - Unclassified|0|||
146937624|NCT01855945|529928373|FG000|Overall Study|Withdrawal by Subject|4|||
146937625|NCT01855945|529928374|FG001|Overall Study|Withdrawal by Subject|0|||
146937626|NCT01855945|529928375|FG002|Overall Study|Withdrawal by Subject|4|||
146937627|NCT01855945|529928376|FG003|Overall Study|Withdrawal by Subject|1|||
146937628|NCT01855945|529928377|FG004|Overall Study|Withdrawal by Subject|1|||
146937629|NCT01855945|529928378|FG005|Overall Study|Withdrawal by Subject|0|||
146937630|NCT01855945|529928379|FG006|Overall Study|Withdrawal by Subject|1|||
146937631|NCT01855945|529928380|FG007|Overall Study|Withdrawal by Subject|0|||
146937632|NCT01855945|529928381|FG008|Overall Study|Withdrawal by Subject|0|||
146937633|NCT01855945|529928382|FG009|Overall Study|Withdrawal by Subject|2|||
146937634|NCT01855945|529928383|FG010|Overall Study|Withdrawal by Subject|4|||
146937635|NCT01855945|529928384|FG011|Overall Study|Withdrawal by Subject|1|||
146937636|NCT02156804|529928385|FG000|Overall Study|Withdrawal by Subject|1|||
146937637|NCT00389441|529928388|FG000|Overall Study|Adverse Event|7|||
146937638|NCT00389441|529928388|FG000|Overall Study|Death|4|||
146937639|NCT00389441|529928388|FG000|Overall Study|Lost to Follow-up|2|||
146937640|NCT00389441|529928388|FG000|Overall Study|Withdrawal by Subject|4|||
146937641|NCT00389441|529928388|FG000|Overall Study|Physician Decision|1|||
146937642|NCT00389441|529928388|FG000|Overall Study|Protocol Violation|1|||
146937643|NCT00389441|529928388|FG000|Overall Study|Global deterioration of health status|4|||
146937644|NCT00389441|529928388|FG000|Overall Study|Objective progression or relapse|26|||
146981877|NCT02040766|530096160|FG001|Overall Study|Lack of Efficacy|3|||
146730880|NCT03764774|529184475|FG007|Overall Study|Adverse Event|0|||
146730881|NCT03764774|529184476|FG008|Overall Study|Adverse Event|0|||
146730882|NCT03764774|529184477|FG009|Overall Study|Adverse Event|0|||
146937645|NCT00389441|529928388|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
146937646|NCT00389441|529928388|FG000|Overall Study|Clinical progression|1|||
146937647|NCT02260388|529928389|FG000|Overall Study|Lost to Follow-up|2|||
146937648|NCT02260388|529928390|FG001|Overall Study|Lost to Follow-up|8|||
146937649|NCT02260388|529928391|FG002|Overall Study|Lost to Follow-up|3|||
146937650|NCT02260388|529928392|FG003|Overall Study|Lost to Follow-up|4|||
146937651|NCT00636441|529928394|FG000|Overall Study|Adverse Event|0|||
146937652|NCT00636441|529928395|FG001|Overall Study|Adverse Event|1|||
146937653|NCT00636441|529928396|FG002|Overall Study|Adverse Event|1|||
146937654|NCT00636441|529928397|FG003|Overall Study|Adverse Event|0|||
146937655|NCT00636441|529928398|FG004|Overall Study|Adverse Event|0|||
146937656|NCT00636441|529928399|FG005|Overall Study|Adverse Event|1|||
146937657|NCT00636441|529928400|FG006|Overall Study|Adverse Event|0|||
146937658|NCT00636441|529928394|FG000|Overall Study|Late, ineligible|0|||
146937659|NCT00636441|529928395|FG001|Overall Study|Late, ineligible|0|||
146620679|NCT03275740|528783380|FG003|Overall Study|Adverse Event|0|||
146620680|NCT03275740|528783381|FG004|Overall Study|Adverse Event|1|||
146620681|NCT03275740|528783382|FG005|Overall Study|Adverse Event|0|||
146620682|NCT03275740|528783383|FG006|Overall Study|Adverse Event|0|||
146620683|NCT03275740|528783384|FG007|Overall Study|Adverse Event|0|||
146620684|NCT03275740|528783385|FG008|Overall Study|Adverse Event|0|||
146620685|NCT03275740|528783386|FG009|Overall Study|Adverse Event|0|||
146620686|NCT03275740|528783387|FG010|Overall Study|Adverse Event|0|||
146620687|NCT03275740|528783388|FG011|Overall Study|Adverse Event|0|||
146620688|NCT03275740|528783377|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146620689|NCT03275740|528783378|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146620690|NCT03275740|528783379|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146620691|NCT03275740|528783380|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146620692|NCT03275740|528783381|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146620693|NCT03275740|528783382|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
146620694|NCT03275740|528783383|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146620695|NCT03275740|528783384|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146620696|NCT03275740|528783385|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146620697|NCT03275740|528783386|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146620698|NCT03275740|528783387|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146620699|NCT03275740|528783388|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146620700|NCT03275740|528783377|FG000|Overall Study|Withdrawal by Subject|0|||
146620701|NCT03275740|528783378|FG001|Overall Study|Withdrawal by Subject|0|||
146620702|NCT03275740|528783379|FG002|Overall Study|Withdrawal by Subject|0|||
146620703|NCT03275740|528783380|FG003|Overall Study|Withdrawal by Subject|0|||
146620704|NCT03275740|528783381|FG004|Overall Study|Withdrawal by Subject|0|||
146620705|NCT03275740|528783382|FG005|Overall Study|Withdrawal by Subject|0|||
146620706|NCT03275740|528783383|FG006|Overall Study|Withdrawal by Subject|0|||
146937660|NCT00636441|529928396|FG002|Overall Study|Late, ineligible|0|||
146937661|NCT00636441|529928397|FG003|Overall Study|Late, ineligible|0|||
146937662|NCT00636441|529928398|FG004|Overall Study|Late, ineligible|0|||
146937663|NCT00636441|529928399|FG005|Overall Study|Late, ineligible|0|||
146937664|NCT00636441|529928400|FG006|Overall Study|Late, ineligible|1|||
146937665|NCT00636441|529928394|FG000|Overall Study|Screen Failure|0|||
146937666|NCT00636441|529928395|FG001|Overall Study|Screen Failure|0|||
146937667|NCT00636441|529928396|FG002|Overall Study|Screen Failure|0|||
146937668|NCT00636441|529928397|FG003|Overall Study|Screen Failure|0|||
146937669|NCT00636441|529928398|FG004|Overall Study|Screen Failure|0|||
146937670|NCT00636441|529928399|FG005|Overall Study|Screen Failure|0|||
146937671|NCT00636441|529928400|FG006|Overall Study|Screen Failure|17|||
146937672|NCT00305604|529928401|FG000|Overall Study|Adverse Event|6|||
146937673|NCT00305604|529928402|FG001|Overall Study|Adverse Event|3|||
146937674|NCT00305604|529928401|FG000|Overall Study|Lack of Efficacy|11|||
146937675|NCT00305604|529928402|FG001|Overall Study|Lack of Efficacy|18|||
146620707|NCT03275740|528783384|FG007|Overall Study|Withdrawal by Subject|0|||
146620708|NCT03275740|528783385|FG008|Overall Study|Withdrawal by Subject|1|||
146620709|NCT03275740|528783386|FG009|Overall Study|Withdrawal by Subject|1|||
146620710|NCT03275740|528783387|FG010|Overall Study|Withdrawal by Subject|0|||
146620711|NCT03275740|528783388|FG011|Overall Study|Withdrawal by Subject|0|||
146620712|NCT00890825|528783389|FG000|Overall Study|Withdrawal by Subject|1|||
146620713|NCT00890825|528783390|FG001|Overall Study|Withdrawal by Subject|0|||
146620714|NCT00890825|528783389|FG000|Overall Study|Alive at data cut off (DCO)|13|||
146620715|NCT00890825|528783390|FG001|Overall Study|Alive at data cut off (DCO)|14|||
146620716|NCT04701333|528783391|FG000|Overall Study|Lost to Follow-up|3|||
146620717|NCT04701333|528783392|FG001|Overall Study|Lost to Follow-up|7|||
146620718|NCT04701333|528783391|FG000|Overall Study|Withdrawal by Subject|0|||
146620719|NCT04701333|528783392|FG001|Overall Study|Withdrawal by Subject|1|||
146620720|NCT02920892|528783393|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
146620721|NCT02920892|528783394|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
146620722|NCT02920892|528783395|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
146620723|NCT02920892|528783393|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
146620724|NCT02920892|528783394|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
146620725|NCT02920892|528783395|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
146620726|NCT02920892|528783393|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
146620727|NCT02920892|528783394|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
146620728|NCT02920892|528783395|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
146937676|NCT00305604|529928401|FG000|Overall Study|Lost to Follow-up|0|||
146937677|NCT00305604|529928402|FG001|Overall Study|Lost to Follow-up|4|||
146937678|NCT00305604|529928401|FG000|Overall Study|Protocol Violation|2|||
146937679|NCT00305604|529928402|FG001|Overall Study|Protocol Violation|1|||
146620729|NCT02920892|528783393|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
146620730|NCT02920892|528783394|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
146937680|NCT00305604|529928401|FG000|Overall Study|Withdrawal by Subject|12|||
146937681|NCT00305604|529928402|FG001|Overall Study|Withdrawal by Subject|21|||
146620731|NCT02920892|528783395|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
146620732|NCT02920892|528783393|FG000|Placebo-Controlled Period|Physician Decision|0|||
146620733|NCT02920892|528783394|FG001|Placebo-Controlled Period|Physician Decision|0|||
146620734|NCT02920892|528783395|FG002|Placebo-Controlled Period|Physician Decision|1|||
146620735|NCT02920892|528783393|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
146620736|NCT02920892|528783394|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
146620737|NCT02920892|528783395|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
146620738|NCT02920892|528783393|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
146620739|NCT02920892|528783394|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
146620740|NCT02920892|528783395|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
146620741|NCT02920892|528783393|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
146620742|NCT02920892|528783394|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
146620743|NCT02920892|528783395|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
146620744|NCT00377520|528783404|FG000|Overall Study|Ineligible (Prior radiation)|1|||
146620745|NCT00660192|528783405|FG000|Overall Study|Lost to Follow-up|2|||
146620746|NCT00660192|528783406|FG001|Overall Study|Lost to Follow-up|3|||
146620747|NCT04908397|528783407|FG000|Overall Study|Withdrawal by Subject|2|||
146620748|NCT01391663|528783408|FG000|Overall Study|Withdrawal by Subject|0|||
146620749|NCT01391663|528783409|FG001|Overall Study|Withdrawal by Subject|0|||
146620750|NCT01391663|528783410|FG002|Overall Study|Withdrawal by Subject|1|||
146620751|NCT01391663|528783411|FG003|Overall Study|Withdrawal by Subject|0|||
146620752|NCT00462306|528783412|FG000|Overall Study|insufficient data|0|||
146620753|NCT00462306|528783413|FG001|Overall Study|insufficient data|13|||
146620754|NCT03515824|528783414|FG000|Overall Study|Death|3|||
146620755|NCT03515824|528783415|FG001|Overall Study|Death|2|||
146620756|NCT03515824|528783416|FG002|Overall Study|Death|6|||
146620757|NCT03515824|528783417|FG003|Overall Study|Death|0|||
146620758|NCT03515824|528783414|FG000|Overall Study|Lost to Follow-up|0|||
146620759|NCT03515824|528783415|FG001|Overall Study|Lost to Follow-up|1|||
146620760|NCT03515824|528783416|FG002|Overall Study|Lost to Follow-up|1|||
146620761|NCT03515824|528783417|FG003|Overall Study|Lost to Follow-up|0|||
146620762|NCT03515824|528783414|FG000|Overall Study|Study terminated by sponsor|0|||
146620763|NCT03515824|528783415|FG001|Overall Study|Study terminated by sponsor|1|||
146788693|NCT04065841|529398045|FG001|Overall Study|Protocol Violation|1|||
146788694|NCT04065841|529398046|FG002|Overall Study|Protocol Violation|0|||
146788695|NCT04065841|529398047|FG003|Overall Study|Protocol Violation|0|||
146788696|NCT04065841|529398044|FG000|Overall Study|Study terminated by Sponsor|22|||
146788697|NCT04065841|529398045|FG001|Overall Study|Study terminated by Sponsor|16|||
146788698|NCT04065841|529398046|FG002|Overall Study|Study terminated by Sponsor|28|||
146788699|NCT04065841|529398047|FG003|Overall Study|Study terminated by Sponsor|17|||
146788700|NCT04065841|529398044|FG000|Overall Study|Withdrawal by Subject|1|||
146788701|NCT04065841|529398045|FG001|Overall Study|Withdrawal by Subject|1|||
146788702|NCT04065841|529398046|FG002|Overall Study|Withdrawal by Subject|2|||
146788703|NCT04065841|529398047|FG003|Overall Study|Withdrawal by Subject|0|||
146788704|NCT04436276|529398049|FG000|Overall Study|Adverse Event|0|||
146788705|NCT04436276|529398050|FG001|Overall Study|Adverse Event|0|||
146788706|NCT04436276|529398051|FG002|Overall Study|Adverse Event|0|||
146788707|NCT04436276|529398052|FG003|Overall Study|Adverse Event|0|||
146788708|NCT04436276|529398053|FG004|Overall Study|Adverse Event|0|||
146788709|NCT04436276|529398054|FG005|Overall Study|Adverse Event|0|||
146788710|NCT04436276|529398055|FG006|Overall Study|Adverse Event|0|||
146788711|NCT04436276|529398056|FG007|Overall Study|Adverse Event|0|||
146788712|NCT04436276|529398057|FG008|Overall Study|Adverse Event|0|||
146788713|NCT04436276|529398058|FG009|Overall Study|Adverse Event|0|||
146788714|NCT04436276|529398059|FG010|Overall Study|Adverse Event|0|||
146788715|NCT04436276|529398060|FG011|Overall Study|Adverse Event|0|||
146788716|NCT04436276|529398061|FG012|Overall Study|Adverse Event|0|||
146788717|NCT04436276|529398062|FG013|Overall Study|Adverse Event|0|||
146788718|NCT04436276|529398063|FG014|Overall Study|Adverse Event|0|||
146788719|NCT04436276|529398064|FG015|Overall Study|Adverse Event|0|||
146788720|NCT04436276|529398065|FG016|Overall Study|Adverse Event|1|||
146788721|NCT04436276|529398066|FG017|Overall Study|Adverse Event|0|||
146937682|NCT00305604|529928401|FG000|Overall Study|Patient moved|1|||
146937683|NCT00305604|529928402|FG001|Overall Study|Patient moved|0|||
146788722|NCT04436276|529398067|FG018|Overall Study|Adverse Event|0|||
146788723|NCT04436276|529398068|FG019|Overall Study|Adverse Event|0|||
146788724|NCT04436276|529398069|FG020|Overall Study|Adverse Event|0|||
146788725|NCT04436276|529398070|FG021|Overall Study|Adverse Event|0|||
146788726|NCT04436276|529398071|FG022|Overall Study|Adverse Event|0|||
146788727|NCT04436276|529398049|FG000|Overall Study|Death|0|||
146788728|NCT04436276|529398050|FG001|Overall Study|Death|0|||
146788729|NCT04436276|529398051|FG002|Overall Study|Death|0|||
146937684|NCT00753623|529928404|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
146788730|NCT04436276|529398052|FG003|Overall Study|Death|0|||
146788731|NCT04436276|529398053|FG004|Overall Study|Death|0|||
146788732|NCT04436276|529398054|FG005|Overall Study|Death|0|||
146788733|NCT04436276|529398055|FG006|Overall Study|Death|0|||
146788734|NCT04436276|529398056|FG007|Overall Study|Death|0|||
146937685|NCT00753623|529928405|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
146937686|NCT00753623|529928404|FG000|Phase I (14 Days)|Physician Decision|1|||
146937687|NCT00753623|529928405|FG001|Phase I (14 Days)|Physician Decision|2|||
146937688|NCT00753623|529928404|FG000|Phase I (14 Days)|Adverse Event|0|||
146937689|NCT00753623|529928405|FG001|Phase I (14 Days)|Adverse Event|1|||
146937690|NCT00753623|529928404|FG000|Washout (7 Days)|Physician Decision|1|||
146937691|NCT00753623|529928405|FG001|Washout (7 Days)|Physician Decision|0|||
146937692|NCT00753623|529928404|FG000|Phase II (14 Days)|Physician Decision|0|||
146937693|NCT00753623|529928405|FG001|Phase II (14 Days)|Physician Decision|1|||
146937694|NCT03332303|529928406|FG000|Overall Study|Participant did not dose|1|||
146937695|NCT03332303|529928407|FG001|Overall Study|Participant did not dose|2|||
146937696|NCT03332303|529928408|FG002|Overall Study|Participant did not dose|0|||
146937697|NCT03332303|529928406|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
146937698|NCT03332303|529928407|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
146937699|NCT03332303|529928408|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
146937700|NCT03332303|529928406|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
146937701|NCT03332303|529928407|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
146937702|NCT03332303|529928408|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
146937703|NCT03332303|529928406|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
146937704|NCT03332303|529928407|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
146937705|NCT03332303|529928408|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
146937706|NCT03332303|529928406|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
146937707|NCT03332303|529928407|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
146937708|NCT03332303|529928408|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
146937709|NCT03332303|529928406|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
146937710|NCT03332303|529928407|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
146937711|NCT03332303|529928408|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
146937712|NCT03332303|529928406|FG000|Overall Study|Participant had a significant protocol deviation|0|||
146937713|NCT03332303|529928407|FG001|Overall Study|Participant had a significant protocol deviation|1|||
146937714|NCT03332303|529928408|FG002|Overall Study|Participant had a significant protocol deviation|0|||
146937715|NCT03495817|529928410|FG000|26 Week Open Label|Adverse Event|3|||
146937716|NCT03495817|529928410|FG000|26 Week Open Label|Withdrawal by Subject|4|||
146937717|NCT03495817|529928410|FG000|26 Week Open Label|Lost to Follow-up|1|||
146937718|NCT03495817|529928410|FG000|26 Week Extension|Lost to Follow-up|2|||
146937719|NCT00326417|529928411|FG000|Overall Study|Withdrawal by Subject|0|||
146937720|NCT00326417|529928412|FG001|Overall Study|Withdrawal by Subject|0|||
146937721|NCT00326417|529928413|FG002|Overall Study|Withdrawal by Subject|1|||
146937722|NCT00326417|529928414|FG003|Overall Study|Withdrawal by Subject|0|||
146937723|NCT00326417|529928411|FG000|Overall Study|Arm Closed|7|||
146937724|NCT00326417|529928412|FG001|Overall Study|Arm Closed|0|||
146937725|NCT00326417|529928413|FG002|Overall Study|Arm Closed|0|||
146937726|NCT00326417|529928414|FG003|Overall Study|Arm Closed|3|||
146937727|NCT00326417|529928411|FG000|Overall Study|Death|7|||
146937728|NCT00326417|529928412|FG001|Overall Study|Death|0|||
146937729|NCT00326417|529928413|FG002|Overall Study|Death|0|||
146937730|NCT00326417|529928414|FG003|Overall Study|Death|0|||
146937731|NCT00844285|529928415|FG000|Overall Study|Other|0|||
146937732|NCT00844285|529928416|FG001|Overall Study|Other|1|||
146937733|NCT00844285|529928417|FG002|Overall Study|Other|0|||
146937734|NCT00844285|529928415|FG000|Overall Study|Other than specified|95|||
146937735|NCT00844285|529928416|FG001|Overall Study|Other than specified|129|||
146937736|NCT00844285|529928417|FG002|Overall Study|Other than specified|12|||
146937737|NCT00844285|529928415|FG000|Overall Study|Site closure|256|||
146937738|NCT00844285|529928416|FG001|Overall Study|Site closure|450|||
146937739|NCT00844285|529928417|FG002|Overall Study|Site closure|50|||
146937740|NCT00844285|529928415|FG000|Overall Study|Follow-up < 8 years|16|||
146937741|NCT00844285|529928416|FG001|Overall Study|Follow-up < 8 years|23|||
146937742|NCT00844285|529928417|FG002|Overall Study|Follow-up < 8 years|4|||
146937743|NCT00844285|529928415|FG000|Overall Study|Protocol Violation|26|||
146937744|NCT00844285|529928416|FG001|Overall Study|Protocol Violation|28|||
146937745|NCT00844285|529928417|FG002|Overall Study|Protocol Violation|54|||
146937746|NCT00844285|529928415|FG000|Overall Study|Death|22|||
146937747|NCT00844285|529928416|FG001|Overall Study|Death|21|||
146937748|NCT00844285|529928417|FG002|Overall Study|Death|8|||
146937749|NCT00844285|529928415|FG000|Overall Study|Withdrew Consent|344|||
146937750|NCT00844285|529928416|FG001|Overall Study|Withdrew Consent|466|||
146937751|NCT00844285|529928417|FG002|Overall Study|Withdrew Consent|70|||
146937752|NCT00844285|529928415|FG000|Overall Study|Lost to Follow-up|330|||
146937753|NCT00844285|529928416|FG001|Overall Study|Lost to Follow-up|486|||
146937754|NCT00844285|529928417|FG002|Overall Study|Lost to Follow-up|74|||
146937755|NCT01586806|529928418|FG000|Overall Study|Protocol Violation|0|||
146937756|NCT01586806|529928419|FG001|Overall Study|Protocol Violation|1|||
146730883|NCT03764774|529184478|FG010|Overall Study|Adverse Event|0|||
146937757|NCT01586806|529928420|FG002|Overall Study|Protocol Violation|0|||
146937758|NCT01586806|529928418|FG000|Overall Study|Withdrawal by Subject|1|||
146937759|NCT01586806|529928419|FG001|Overall Study|Withdrawal by Subject|0|||
146937760|NCT01586806|529928420|FG002|Overall Study|Withdrawal by Subject|0|||
146937761|NCT01586806|529928418|FG000|Overall Study|Lost to Follow-up|2|||
146937762|NCT01586806|529928419|FG001|Overall Study|Lost to Follow-up|3|||
146937763|NCT01586806|529928420|FG002|Overall Study|Lost to Follow-up|2|||
146937764|NCT04199793|529928421|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
146937765|NCT04199793|529928422|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
146937766|NCT04199793|529928421|FG000|Overall Study|Withdrawal by Subject|1|||
146937767|NCT04199793|529928422|FG001|Overall Study|Withdrawal by Subject|1|||
146937768|NCT03820726|529928423|FG000|Overall Study|Other than listed|23|||
146937769|NCT03820726|529928423|FG000|Overall Study|Withdrawal by Subject|37|||
146937770|NCT03820726|529928423|FG000|Overall Study|Lost to Follow-up|3|||
146937771|NCT03820726|529928423|FG000|Overall Study|Protocol deviation|1|||
146937772|NCT03820726|529928423|FG000|Overall Study|Adverse Event|146|||
146937773|NCT03820726|529928423|FG000|Overall Study|Not treated|1|||
146937774|NCT00345540|529928428|FG000|Overall Study|Withdrawal by Subject|1|||
146981878|NCT02040766|530096161|FG002|Overall Study|Lack of Efficacy|4|||
146730884|NCT03764774|529184479|FG011|Overall Study|Adverse Event|0|||
146730885|NCT03764774|529184480|FG012|Overall Study|Adverse Event|2|||
146730886|NCT03764774|529184481|FG013|Overall Study|Adverse Event|0|||
146730887|NCT03764774|529184468|FG000|Overall Study|Lost to Follow-up|0|||
146730888|NCT03764774|529184469|FG001|Overall Study|Lost to Follow-up|0|||
146730889|NCT03764774|529184470|FG002|Overall Study|Lost to Follow-up|0|||
146730890|NCT03764774|529184471|FG003|Overall Study|Lost to Follow-up|0|||
146730891|NCT03764774|529184472|FG004|Overall Study|Lost to Follow-up|0|||
146730892|NCT03764774|529184473|FG005|Overall Study|Lost to Follow-up|0|||
146730893|NCT03764774|529184474|FG006|Overall Study|Lost to Follow-up|0|||
146730894|NCT03764774|529184475|FG007|Overall Study|Lost to Follow-up|0|||
146730895|NCT03764774|529184476|FG008|Overall Study|Lost to Follow-up|0|||
146730896|NCT03764774|529184477|FG009|Overall Study|Lost to Follow-up|0|||
146730897|NCT03764774|529184478|FG010|Overall Study|Lost to Follow-up|0|||
146730898|NCT03764774|529184479|FG011|Overall Study|Lost to Follow-up|0|||
146730899|NCT03764774|529184480|FG012|Overall Study|Lost to Follow-up|0|||
146730900|NCT03764774|529184481|FG013|Overall Study|Lost to Follow-up|1|||
146730901|NCT03764774|529184468|FG000|Overall Study|Physician Decision|0|||
146730902|NCT03764774|529184469|FG001|Overall Study|Physician Decision|0|||
146730903|NCT03764774|529184470|FG002|Overall Study|Physician Decision|0|||
146730904|NCT03764774|529184471|FG003|Overall Study|Physician Decision|0|||
146730905|NCT03764774|529184472|FG004|Overall Study|Physician Decision|0|||
146730906|NCT03764774|529184473|FG005|Overall Study|Physician Decision|0|||
146730907|NCT03764774|529184474|FG006|Overall Study|Physician Decision|0|||
146730908|NCT03764774|529184475|FG007|Overall Study|Physician Decision|0|||
146730909|NCT03764774|529184476|FG008|Overall Study|Physician Decision|0|||
146730910|NCT03764774|529184477|FG009|Overall Study|Physician Decision|4|||
146730911|NCT03764774|529184478|FG010|Overall Study|Physician Decision|1|||
146730912|NCT03764774|529184479|FG011|Overall Study|Physician Decision|4|||
146730913|NCT03764774|529184480|FG012|Overall Study|Physician Decision|9|||
146730914|NCT03764774|529184481|FG013|Overall Study|Physician Decision|0|||
146730915|NCT03764774|529184468|FG000|Overall Study|Study Termination|0|||
146730916|NCT03764774|529184469|FG001|Overall Study|Study Termination|0|||
146730917|NCT03764774|529184470|FG002|Overall Study|Study Termination|0|||
146730918|NCT03764774|529184471|FG003|Overall Study|Study Termination|0|||
146730919|NCT03764774|529184472|FG004|Overall Study|Study Termination|0|||
146730920|NCT03764774|529184473|FG005|Overall Study|Study Termination|0|||
146730921|NCT03764774|529184474|FG006|Overall Study|Study Termination|0|||
146730922|NCT03764774|529184475|FG007|Overall Study|Study Termination|0|||
146730923|NCT03764774|529184476|FG008|Overall Study|Study Termination|0|||
146730924|NCT03764774|529184477|FG009|Overall Study|Study Termination|1|||
146730925|NCT03764774|529184478|FG010|Overall Study|Study Termination|0|||
146730926|NCT03764774|529184479|FG011|Overall Study|Study Termination|0|||
146730927|NCT03764774|529184480|FG012|Overall Study|Study Termination|0|||
146730928|NCT03764774|529184481|FG013|Overall Study|Study Termination|2|||
146730929|NCT05809596|529184484|FG000|Overall Study|Death|16|||
146730930|NCT05809596|529184484|FG000|Overall Study|Withdrawal by Subject|4|||
146730931|NCT05809596|529184484|FG000|Overall Study|Physician Decision|1|||
146730932|NCT05809596|529184484|FG000|Overall Study|Missed Visit|2|||
146730933|NCT05809596|529184484|FG000|Overall Study|Other|3|||
146730934|NCT03770494|529184486|FG000|Overall Study|Lost to Follow-up|0|||
146730935|NCT03770494|529184487|FG001|Overall Study|Lost to Follow-up|0|||
146730936|NCT03770494|529184488|FG002|Overall Study|Lost to Follow-up|1|||
146730937|NCT03770494|529184489|FG003|Overall Study|Lost to Follow-up|1|||
146730938|NCT03770494|529184490|FG004|Overall Study|Lost to Follow-up|1|||
146730939|NCT03770494|529184491|FG005|Overall Study|Lost to Follow-up|0|||
146730940|NCT03770494|529184492|FG006|Overall Study|Lost to Follow-up|0|||
146730941|NCT03770494|529184493|FG007|Overall Study|Lost to Follow-up|0|||
146730942|NCT03770494|529184494|FG008|Overall Study|Lost to Follow-up|0|||
146788735|NCT04436276|529398057|FG008|Overall Study|Death|0|||
146788736|NCT04436276|529398058|FG009|Overall Study|Death|0|||
146788737|NCT04436276|529398059|FG010|Overall Study|Death|0|||
146788738|NCT04436276|529398060|FG011|Overall Study|Death|0|||
146788739|NCT04436276|529398061|FG012|Overall Study|Death|1|||
146788740|NCT04436276|529398062|FG013|Overall Study|Death|0|||
146788741|NCT04436276|529398063|FG014|Overall Study|Death|1|||
146788742|NCT04436276|529398064|FG015|Overall Study|Death|0|||
146788743|NCT04436276|529398065|FG016|Overall Study|Death|0|||
146788744|NCT04436276|529398066|FG017|Overall Study|Death|0|||
146788745|NCT04436276|529398067|FG018|Overall Study|Death|0|||
146788746|NCT04436276|529398068|FG019|Overall Study|Death|2|||
146788747|NCT04436276|529398069|FG020|Overall Study|Death|0|||
146788748|NCT04436276|529398070|FG021|Overall Study|Death|1|||
146788749|NCT04436276|529398071|FG022|Overall Study|Death|0|||
146788750|NCT04436276|529398049|FG000|Overall Study|Lost to Follow-up|0|||
146788751|NCT04436276|529398050|FG001|Overall Study|Lost to Follow-up|2|||
146788752|NCT04436276|529398051|FG002|Overall Study|Lost to Follow-up|2|||
146788753|NCT04436276|529398052|FG003|Overall Study|Lost to Follow-up|1|||
146788754|NCT04436276|529398053|FG004|Overall Study|Lost to Follow-up|4|||
146788755|NCT04436276|529398054|FG005|Overall Study|Lost to Follow-up|1|||
146788756|NCT04436276|529398055|FG006|Overall Study|Lost to Follow-up|0|||
146788757|NCT04436276|529398056|FG007|Overall Study|Lost to Follow-up|0|||
146788758|NCT04436276|529398057|FG008|Overall Study|Lost to Follow-up|1|||
146788759|NCT04436276|529398058|FG009|Overall Study|Lost to Follow-up|0|||
146788760|NCT04436276|529398059|FG010|Overall Study|Lost to Follow-up|5|||
146788761|NCT04436276|529398060|FG011|Overall Study|Lost to Follow-up|5|||
146788762|NCT04436276|529398061|FG012|Overall Study|Lost to Follow-up|4|||
146788763|NCT04436276|529398062|FG013|Overall Study|Lost to Follow-up|1|||
146788764|NCT04436276|529398063|FG014|Overall Study|Lost to Follow-up|7|||
146788765|NCT04436276|529398064|FG015|Overall Study|Lost to Follow-up|7|||
146788766|NCT04436276|529398065|FG016|Overall Study|Lost to Follow-up|1|||
146788767|NCT04436276|529398066|FG017|Overall Study|Lost to Follow-up|0|||
146788768|NCT04436276|529398067|FG018|Overall Study|Lost to Follow-up|1|||
146788769|NCT04436276|529398068|FG019|Overall Study|Lost to Follow-up|1|||
146788770|NCT04436276|529398069|FG020|Overall Study|Lost to Follow-up|2|||
146788771|NCT04436276|529398070|FG021|Overall Study|Lost to Follow-up|1|||
146788772|NCT04436276|529398071|FG022|Overall Study|Lost to Follow-up|1|||
146788773|NCT04436276|529398049|FG000|Overall Study|Physician Decision|1|||
146788774|NCT04436276|529398050|FG001|Overall Study|Physician Decision|0|||
146788775|NCT04436276|529398051|FG002|Overall Study|Physician Decision|2|||
146788776|NCT04436276|529398052|FG003|Overall Study|Physician Decision|1|||
146788777|NCT04436276|529398053|FG004|Overall Study|Physician Decision|0|||
146788778|NCT04436276|529398054|FG005|Overall Study|Physician Decision|0|||
146788779|NCT04436276|529398055|FG006|Overall Study|Physician Decision|0|||
146788780|NCT04436276|529398056|FG007|Overall Study|Physician Decision|0|||
146788781|NCT04436276|529398057|FG008|Overall Study|Physician Decision|0|||
146788782|NCT04436276|529398058|FG009|Overall Study|Physician Decision|0|||
146788783|NCT04436276|529398059|FG010|Overall Study|Physician Decision|0|||
146788784|NCT04436276|529398060|FG011|Overall Study|Physician Decision|1|||
146788785|NCT04436276|529398061|FG012|Overall Study|Physician Decision|2|||
146788786|NCT04436276|529398062|FG013|Overall Study|Physician Decision|0|||
146788787|NCT04436276|529398063|FG014|Overall Study|Physician Decision|0|||
146788788|NCT04436276|529398064|FG015|Overall Study|Physician Decision|0|||
146788789|NCT04436276|529398065|FG016|Overall Study|Physician Decision|0|||
146788790|NCT04436276|529398066|FG017|Overall Study|Physician Decision|0|||
146788791|NCT04436276|529398067|FG018|Overall Study|Physician Decision|0|||
146788792|NCT04436276|529398068|FG019|Overall Study|Physician Decision|0|||
146788793|NCT04436276|529398069|FG020|Overall Study|Physician Decision|1|||
146937775|NCT01938001|529928429|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
146937776|NCT01938001|529928430|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
146937777|NCT01938001|529928429|FG000|Pre-Treatment|Death|1|||
146788794|NCT04436276|529398070|FG021|Overall Study|Physician Decision|2|||
146788795|NCT04436276|529398071|FG022|Overall Study|Physician Decision|0|||
146788796|NCT04436276|529398049|FG000|Overall Study|Protocol Violation|0|||
146788797|NCT04436276|529398050|FG001|Overall Study|Protocol Violation|0|||
146788798|NCT04436276|529398051|FG002|Overall Study|Protocol Violation|0|||
146788799|NCT04436276|529398052|FG003|Overall Study|Protocol Violation|0|||
146788800|NCT04436276|529398053|FG004|Overall Study|Protocol Violation|0|||
146788801|NCT04436276|529398054|FG005|Overall Study|Protocol Violation|0|||
146788802|NCT04436276|529398055|FG006|Overall Study|Protocol Violation|0|||
146788803|NCT04436276|529398056|FG007|Overall Study|Protocol Violation|0|||
146788804|NCT04436276|529398057|FG008|Overall Study|Protocol Violation|0|||
146788805|NCT04436276|529398058|FG009|Overall Study|Protocol Violation|0|||
146788806|NCT04436276|529398059|FG010|Overall Study|Protocol Violation|0|||
146788807|NCT04436276|529398060|FG011|Overall Study|Protocol Violation|0|||
146788808|NCT04436276|529398061|FG012|Overall Study|Protocol Violation|0|||
146788809|NCT04436276|529398062|FG013|Overall Study|Protocol Violation|1|||
146788810|NCT04436276|529398063|FG014|Overall Study|Protocol Violation|0|||
146788811|NCT04436276|529398064|FG015|Overall Study|Protocol Violation|1|||
146788812|NCT04436276|529398065|FG016|Overall Study|Protocol Violation|0|||
146788813|NCT04436276|529398066|FG017|Overall Study|Protocol Violation|0|||
146730943|NCT03770494|529184495|FG009|Overall Study|Lost to Follow-up|0|||
146730944|NCT03770494|529184496|FG010|Overall Study|Lost to Follow-up|0|||
146730945|NCT03770494|529184497|FG011|Overall Study|Lost to Follow-up|0|||
146730946|NCT03770494|529184498|FG012|Overall Study|Lost to Follow-up|0|||
146730947|NCT03770494|529184499|FG013|Overall Study|Lost to Follow-up|0|||
146730948|NCT03770494|529184486|FG000|Overall Study|Study terminated by sponsor|1|||
146730949|NCT03770494|529184487|FG001|Overall Study|Study terminated by sponsor|2|||
146730950|NCT03770494|529184488|FG002|Overall Study|Study terminated by sponsor|1|||
146730951|NCT03770494|529184489|FG003|Overall Study|Study terminated by sponsor|1|||
146730952|NCT03770494|529184490|FG004|Overall Study|Study terminated by sponsor|1|||
146730953|NCT03770494|529184491|FG005|Overall Study|Study terminated by sponsor|2|||
146730954|NCT03770494|529184492|FG006|Overall Study|Study terminated by sponsor|1|||
146730955|NCT03770494|529184493|FG007|Overall Study|Study terminated by sponsor|2|||
146730956|NCT03770494|529184494|FG008|Overall Study|Study terminated by sponsor|1|||
146730957|NCT03770494|529184495|FG009|Overall Study|Study terminated by sponsor|2|||
146730958|NCT03770494|529184496|FG010|Overall Study|Study terminated by sponsor|1|||
146730959|NCT03770494|529184497|FG011|Overall Study|Study terminated by sponsor|2|||
146730960|NCT03770494|529184498|FG012|Overall Study|Study terminated by sponsor|0|||
146730961|NCT03770494|529184499|FG013|Overall Study|Study terminated by sponsor|0|||
146730962|NCT03770494|529184486|FG000|Overall Study|Withdrawal by Subject|1|||
146730963|NCT03770494|529184487|FG001|Overall Study|Withdrawal by Subject|1|||
146730964|NCT03770494|529184488|FG002|Overall Study|Withdrawal by Subject|0|||
146730965|NCT03770494|529184489|FG003|Overall Study|Withdrawal by Subject|0|||
146730966|NCT03770494|529184490|FG004|Overall Study|Withdrawal by Subject|2|||
146730967|NCT03770494|529184491|FG005|Overall Study|Withdrawal by Subject|2|||
146730968|NCT03770494|529184492|FG006|Overall Study|Withdrawal by Subject|2|||
146730969|NCT03770494|529184493|FG007|Overall Study|Withdrawal by Subject|0|||
146730970|NCT03770494|529184494|FG008|Overall Study|Withdrawal by Subject|2|||
146730971|NCT03770494|529184495|FG009|Overall Study|Withdrawal by Subject|3|||
146730972|NCT03770494|529184496|FG010|Overall Study|Withdrawal by Subject|1|||
146730973|NCT03770494|529184497|FG011|Overall Study|Withdrawal by Subject|0|||
146730974|NCT03770494|529184498|FG012|Overall Study|Withdrawal by Subject|0|||
146730975|NCT03770494|529184499|FG013|Overall Study|Withdrawal by Subject|0|||
146730976|NCT04922554|529184500|FG000|Overall Study|Adverse Event|4|||
146730977|NCT04922554|529184501|FG001|Overall Study|Adverse Event|0|||
146730978|NCT04922554|529184500|FG000|Overall Study|Withdrawal by Subject|1|||
146730979|NCT04922554|529184501|FG001|Overall Study|Withdrawal by Subject|0|||
146730980|NCT00939484|529185894|FG000|Overall Study|Progression/Relapse|8|||
146730981|NCT00939484|529185895|FG001|Overall Study|Progression/Relapse|20|||
146730982|NCT00939484|529185896|FG002|Overall Study|Progression/Relapse|3|||
146730983|NCT03938454|529185897|FG000|Overall Study|Protocol Violation|1|||
146730984|NCT03938454|529185897|FG000|Overall Study|Withdrawal by Subject|2|||
146730985|NCT03938454|529185897|FG000|Overall Study|Lost to Follow-up|3|||
146730986|NCT00553501|529185898|FG000|Overall Study|Adverse Event|2|||
146730987|NCT00553501|529185898|FG000|Overall Study|Death|1|||
146730988|NCT00553501|529185898|FG000|Overall Study|Progression|1|||
146730989|NCT01464021|529185899|FG000|Overall Study|Withdrawal by Subject|13|||
146730990|NCT01464021|529185899|FG000|Overall Study|Lost to Follow-up|1|||
146730991|NCT01464021|529185899|FG000|Overall Study|Lack of Efficacy|1|||
146730992|NCT01464021|529185899|FG000|Overall Study|various|11|||
146730993|NCT01255592|529185901|FG000|Overall Study|Adverse Event|5|||
146730994|NCT01255592|529185902|FG001|Overall Study|Adverse Event|0|||
146730995|NCT01255592|529185901|FG000|Overall Study|Withdrawal by Subject|1|||
146730996|NCT01255592|529185902|FG001|Overall Study|Withdrawal by Subject|0|||
146730997|NCT01255592|529185901|FG000|Overall Study|Other|0|||
146730998|NCT01255592|529185902|FG001|Overall Study|Other|1|||
146730999|NCT03928028|529185905|FG000|Overall Study|Physician Decision|9|||
146731000|NCT03928028|529185906|FG001|Overall Study|Physician Decision|6|||
146731001|NCT03928028|529185907|FG002|Overall Study|Physician Decision|3|||
146731002|NCT03928028|529185905|FG000|Overall Study|Withdrawal by Subject|12|||
146731003|NCT03928028|529185906|FG001|Overall Study|Withdrawal by Subject|3|||
146731004|NCT03928028|529185907|FG002|Overall Study|Withdrawal by Subject|3|||
146731005|NCT04525547|529185913|FG000|Overall Study|Not treated with Ofev|2|||
146731006|NCT04525547|529185913|FG000|Overall Study|Off-label use|2|||
146731007|NCT04525547|529185913|FG000|Overall Study|Lost to Follow-up|1|||
146731008|NCT00800202|529185914|FG000|Overall Study|Adverse Event|7|||
146731009|NCT00800202|529185915|FG001|Overall Study|Adverse Event|6|||
146731010|NCT00800202|529185914|FG000|Overall Study|Death|1|||
146731011|NCT00800202|529185915|FG001|Overall Study|Death|0|||
146731012|NCT00800202|529185914|FG000|Overall Study|Other|5|||
146731013|NCT00800202|529185915|FG001|Overall Study|Other|0|||
146731014|NCT00800202|529185914|FG000|Overall Study|Disease Progression|54|||
146731015|NCT00800202|529185915|FG001|Overall Study|Disease Progression|18|||
146731016|NCT02641392|529185921|FG000|Overall Study|Lost to Follow-up|0|||
146731017|NCT02641392|529185922|FG001|Overall Study|Lost to Follow-up|0|||
146731018|NCT02641392|529185923|FG002|Overall Study|Lost to Follow-up|2|||
146937778|NCT01938001|529928430|FG001|Pre-Treatment|Death|0|||
146937779|NCT01938001|529928429|FG000|Treatment|Death|2|||
146937780|NCT01938001|529928430|FG001|Treatment|Death|0|||
146937781|NCT01938001|529928429|FG000|Treatment|Adverse Event|14|||
146937782|NCT01938001|529928430|FG001|Treatment|Adverse Event|8|||
146937783|NCT01938001|529928429|FG000|Treatment|Progressive Disease|21|||
146937784|NCT01938001|529928430|FG001|Treatment|Progressive Disease|54|||
146731019|NCT02641392|529185921|FG000|Overall Study|Withdrawal by Subject|0|||
146731020|NCT02641392|529185922|FG001|Overall Study|Withdrawal by Subject|0|||
146731021|NCT02641392|529185923|FG002|Overall Study|Withdrawal by Subject|17|||
146731022|NCT02641392|529185921|FG000|Overall Study|Adverse Event|0|||
146731023|NCT02641392|529185922|FG001|Overall Study|Adverse Event|1|||
146731024|NCT02641392|529185923|FG002|Overall Study|Adverse Event|25|||
146731025|NCT02641392|529185921|FG000|Overall Study|Study Terminated by Sponsor|4|||
146731026|NCT02641392|529185922|FG001|Overall Study|Study Terminated by Sponsor|12|||
146731027|NCT02641392|529185923|FG002|Overall Study|Study Terminated by Sponsor|144|||
146731028|NCT02641392|529185921|FG000|Overall Study|Lack of Efficacy|0|||
146731029|NCT02641392|529185922|FG001|Overall Study|Lack of Efficacy|0|||
146731030|NCT02641392|529185923|FG002|Overall Study|Lack of Efficacy|101|||
146731031|NCT02641392|529185921|FG000|Overall Study|Miscellaneous|0|||
146731032|NCT02641392|529185922|FG001|Overall Study|Miscellaneous|0|||
146731033|NCT02641392|529185923|FG002|Overall Study|Miscellaneous|3|||
146731034|NCT02641392|529185921|FG000|Overall Study|Death|0|||
146731035|NCT02641392|529185922|FG001|Overall Study|Death|0|||
146731036|NCT02641392|529185923|FG002|Overall Study|Death|1|||
146731037|NCT02052310|529185924|FG000|Overall Study|Death|64|||
146731038|NCT02052310|529185925|FG001|Overall Study|Death|54|||
146731039|NCT02052310|529185924|FG000|Overall Study|Withdrawal by Subject|37|||
146731040|NCT02052310|529185925|FG001|Overall Study|Withdrawal by Subject|49|||
146731041|NCT02052310|529185924|FG000|Overall Study|Other than specified|32|||
146731042|NCT02052310|529185925|FG001|Overall Study|Other than specified|29|||
146731043|NCT02052310|529185924|FG000|Overall Study|Adverse Event|29|||
146731044|NCT02052310|529185925|FG001|Overall Study|Adverse Event|22|||
146731045|NCT02052310|529185924|FG000|Overall Study|Kidney Transplant|23|||
146731046|NCT02052310|529185925|FG001|Overall Study|Kidney Transplant|29|||
146731047|NCT02052310|529185924|FG000|Overall Study|Physician Decision|14|||
146731048|NCT02052310|529185925|FG001|Overall Study|Physician Decision|7|||
146731049|NCT02052310|529185924|FG000|Overall Study|Lack of Efficacy|6|||
146731050|NCT02052310|529185925|FG001|Overall Study|Lack of Efficacy|1|||
146731051|NCT02052310|529185924|FG000|Overall Study|Site Terminated by Sponsor|5|||
146731052|NCT02052310|529185925|FG001|Overall Study|Site Terminated by Sponsor|13|||
146731053|NCT02052310|529185924|FG000|Overall Study|Lost to Follow-up|4|||
146731054|NCT02052310|529185925|FG001|Overall Study|Lost to Follow-up|2|||
146731055|NCT02052310|529185924|FG000|Overall Study|Protocol Violation|1|||
146731056|NCT02052310|529185925|FG001|Overall Study|Protocol Violation|6|||
146731057|NCT03518125|529185926|FG000|Overall Study|Lost to Follow-up|0|||
146731058|NCT03518125|529185927|FG001|Overall Study|Lost to Follow-up|2|||
146731059|NCT03518125|529185928|FG002|Overall Study|Lost to Follow-up|0|||
146731060|NCT03518125|529185929|FG003|Overall Study|Lost to Follow-up|0|||
146731061|NCT03518125|529185930|FG004|Overall Study|Lost to Follow-up|3|||
146731062|NCT03518125|529185931|FG005|Overall Study|Lost to Follow-up|5|||
146731063|NCT03518125|529185926|FG000|Overall Study|Physician Decision|0|||
146731064|NCT03518125|529185927|FG001|Overall Study|Physician Decision|1|||
146731065|NCT03518125|529185928|FG002|Overall Study|Physician Decision|0|||
146731066|NCT03518125|529185929|FG003|Overall Study|Physician Decision|0|||
146731067|NCT03518125|529185930|FG004|Overall Study|Physician Decision|0|||
146731068|NCT03518125|529185931|FG005|Overall Study|Physician Decision|0|||
146731069|NCT03518125|529185926|FG000|Overall Study|Withdrawal by Subject|1|||
146731070|NCT03518125|529185927|FG001|Overall Study|Withdrawal by Subject|1|||
146731071|NCT03518125|529185928|FG002|Overall Study|Withdrawal by Subject|0|||
146731072|NCT03518125|529185929|FG003|Overall Study|Withdrawal by Subject|1|||
146731073|NCT03518125|529185930|FG004|Overall Study|Withdrawal by Subject|1|||
146731074|NCT03518125|529185931|FG005|Overall Study|Withdrawal by Subject|3|||
146731075|NCT03518125|529185926|FG000|Overall Study|Missed Day 394 Visit|1|||
146731076|NCT03518125|529185927|FG001|Overall Study|Missed Day 394 Visit|0|||
146937785|NCT01938001|529928429|FG000|Treatment|Withdrawal by Subject|13|||
146731077|NCT03518125|529185928|FG002|Overall Study|Missed Day 394 Visit|0|||
146731078|NCT03518125|529185929|FG003|Overall Study|Missed Day 394 Visit|0|||
146731079|NCT03518125|529185930|FG004|Overall Study|Missed Day 394 Visit|0|||
146731080|NCT03518125|529185931|FG005|Overall Study|Missed Day 394 Visit|0|||
146937786|NCT01938001|529928430|FG001|Treatment|Withdrawal by Subject|7|||
146731081|NCT04452877|529185932|FG000|Overall Study|Adverse Event|5|||
146731082|NCT04452877|529185932|FG000|Overall Study|Lost to Follow-up|1|||
146731083|NCT04452877|529185932|FG000|Overall Study|Physician Decision|4|||
146731084|NCT04452877|529185932|FG000|Overall Study|Progressive Disease|18|||
146731085|NCT04452877|529185932|FG000|Overall Study|Withdrawal by Subject|3|||
146731086|NCT01505387|529185933|FG000|Overall Study|Protocol Violation|1|||
146731087|NCT01505387|529185934|FG001|Overall Study|Protocol Violation|0|||
146937787|NCT01938001|529928429|FG000|Treatment|Other reasons|2|||
146937788|NCT01938001|529928430|FG001|Treatment|Other reasons|1|||
146731088|NCT01505387|529185933|FG000|Overall Study|Withdrawal by Subject|1|||
146731089|NCT01505387|529185934|FG001|Overall Study|Withdrawal by Subject|1|||
146731090|NCT01301391|529185935|FG000|Overall Study|Death|13|||
146731091|NCT01301391|529185935|FG000|Overall Study|Lost to Follow-up|3|||
146731092|NCT01301391|529185935|FG000|Overall Study|Physician Decision|2|||
146731093|NCT01301391|529185935|FG000|Overall Study|Sponsor's decision|8|||
146731094|NCT00595504|529185936|FG000|Overall Study|Withdrawal by Subject|1|||
146731095|NCT00595504|529185937|FG001|Overall Study|Withdrawal by Subject|3|||
146731096|NCT00595504|529185936|FG000|Overall Study|Physician Decision|1|||
146731097|NCT00595504|529185937|FG001|Overall Study|Physician Decision|0|||
146731098|NCT01949870|529185938|FG000|Overall Study|Lack of Efficacy|2|||
146731099|NCT01949870|529185938|FG000|Overall Study|Adverse Event|1|||
146731100|NCT01949870|529185938|FG000|Overall Study|Study termination|1|||
146731101|NCT01949870|529185938|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
146731102|NCT00293267|529185939|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
146731103|NCT00293267|529185940|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
146731104|NCT00293267|529185939|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
146731105|NCT00293267|529185940|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
146731106|NCT00293267|529185939|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
146731107|NCT00293267|529185940|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
146731108|NCT00293267|529185939|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
146731109|NCT00293267|529185940|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
146731110|NCT00293267|529185939|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
146731111|NCT00293267|529185940|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
146731112|NCT00293267|529185939|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
146731113|NCT00293267|529185940|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
146731114|NCT00293267|529185939|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
146731115|NCT00293267|529185940|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
146731116|NCT00293267|529185939|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
146731117|NCT00293267|529185940|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
146731118|NCT00293267|529185939|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
146731119|NCT00293267|529185940|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
146731120|NCT00293267|529185939|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
146731121|NCT00293267|529185940|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
146731122|NCT00293267|529185939|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
146731123|NCT00293267|529185940|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
146731124|NCT00293267|529185939|FG000|Extension - Double-Blind Week 49-156|Death|3|||
146731125|NCT00293267|529185940|FG001|Extension - Double-Blind Week 49-156|Death|0|||
146731126|NCT00293267|529185939|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
146731127|NCT00293267|529185940|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
146731128|NCT00293267|529185939|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
146731129|NCT00293267|529185940|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
146731130|NCT00293267|529185939|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
146731131|NCT00293267|529185940|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
146731132|NCT00293267|529185939|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
146731133|NCT00293267|529185940|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
146731134|NCT00293267|529185939|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
146731135|NCT00293267|529185940|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
146731136|NCT00293267|529185939|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
146731137|NCT00293267|529185940|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
146731138|NCT00293267|529185939|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
146731139|NCT00293267|529185940|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
146731140|NCT00293267|529185939|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
146731141|NCT00293267|529185940|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
146731142|NCT00293267|529185939|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
146731143|NCT00293267|529185940|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
146731144|NCT00293267|529185939|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
146731145|NCT00293267|529185940|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
146731146|NCT00293267|529185939|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
146731147|NCT00293267|529185940|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
146731148|NCT00293267|529185939|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
146731149|NCT00293267|529185940|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
146731150|NCT00293267|529185939|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
146731151|NCT00293267|529185940|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
146731152|NCT00293267|529185939|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
146731153|NCT00293267|529185940|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
146731154|NCT00293267|529185939|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
146981879|NCT02040766|530096162|FG003|Overall Study|Lack of Efficacy|6|||
146981880|NCT02040766|530096163|FG004|Overall Study|Lack of Efficacy|5|||
146981881|NCT01271933|530096164|FG000|Single-Blind Phase|Lack of Efficacy|37|||
146981882|NCT01271933|530096165|FG001|Single-Blind Phase|Lack of Efficacy|0|||
146981883|NCT01271933|530096166|FG002|Single-Blind Phase|Lack of Efficacy|0|||
146981884|NCT01271933|530096164|FG000|Single-Blind Phase|Lost to Follow-up|10|||
146981885|NCT01271933|530096165|FG001|Single-Blind Phase|Lost to Follow-up|0|||
146981886|NCT01271933|530096166|FG002|Single-Blind Phase|Lost to Follow-up|0|||
146981887|NCT01271933|530096164|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
146981888|NCT01271933|530096165|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
146981889|NCT01271933|530096166|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
146981890|NCT01271933|530096164|FG000|Single-Blind Phase|Protocol Violation|3|||
146981891|NCT01271933|530096165|FG001|Single-Blind Phase|Protocol Violation|0|||
146981892|NCT01271933|530096166|FG002|Single-Blind Phase|Protocol Violation|0|||
146981893|NCT01271933|530096164|FG000|Single-Blind Phase|Adverse Event|52|||
146981894|NCT01271933|530096165|FG001|Single-Blind Phase|Adverse Event|0|||
146981895|NCT01271933|530096166|FG002|Single-Blind Phase|Adverse Event|0|||
146981896|NCT01271933|530096164|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
146981897|NCT01271933|530096165|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
146981898|NCT01271933|530096166|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
146981899|NCT01271933|530096164|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
146981900|NCT01271933|530096165|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
146981901|NCT01271933|530096166|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
146981902|NCT01271933|530096164|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
146981903|NCT01271933|530096165|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
146981904|NCT01271933|530096166|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
146981905|NCT01271933|530096164|FG000|Double-Blind Phase|Randomized but not treated|0|||
146981906|NCT01271933|530096165|FG001|Double-Blind Phase|Randomized but not treated|0|||
146981907|NCT01271933|530096166|FG002|Double-Blind Phase|Randomized but not treated|1|||
146981908|NCT01271933|530096164|FG000|Double-Blind Phase|Lack of Efficacy|0|||
146981909|NCT01271933|530096165|FG001|Double-Blind Phase|Lack of Efficacy|6|||
146981910|NCT01271933|530096166|FG002|Double-Blind Phase|Lack of Efficacy|9|||
146981911|NCT01271933|530096164|FG000|Double-Blind Phase|Lost to Follow-up|0|||
146981912|NCT01271933|530096165|FG001|Double-Blind Phase|Lost to Follow-up|1|||
146981913|NCT01271933|530096166|FG002|Double-Blind Phase|Lost to Follow-up|1|||
146981914|NCT01271933|530096164|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
146981915|NCT01271933|530096165|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
146981916|NCT01271933|530096166|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
146788814|NCT04436276|529398067|FG018|Overall Study|Protocol Violation|0|||
146788815|NCT04436276|529398068|FG019|Overall Study|Protocol Violation|0|||
146620764|NCT03515824|528783416|FG002|Overall Study|Study terminated by sponsor|6|||
146620765|NCT03515824|528783417|FG003|Overall Study|Study terminated by sponsor|0|||
146620766|NCT03515824|528783414|FG000|Overall Study|Status not recorded|0|||
146620767|NCT03515824|528783415|FG001|Overall Study|Status not recorded|0|||
146620768|NCT03515824|528783416|FG002|Overall Study|Status not recorded|2|||
146620769|NCT03515824|528783417|FG003|Overall Study|Status not recorded|0|||
146788816|NCT04436276|529398069|FG020|Overall Study|Protocol Violation|0|||
146620770|NCT00920855|528783418|FG000|Overall Study|Adverse Event|1|||
146620771|NCT00920855|528783419|FG001|Overall Study|Adverse Event|1|||
146620772|NCT00920855|528783420|FG002|Overall Study|Adverse Event|4|||
146620773|NCT00920855|528783418|FG000|Overall Study|Withdrawal by Subject|2|||
146620774|NCT00920855|528783419|FG001|Overall Study|Withdrawal by Subject|1|||
146620775|NCT00920855|528783420|FG002|Overall Study|Withdrawal by Subject|6|||
146620776|NCT00920855|528783418|FG000|Overall Study|Disease progression|2|||
146620777|NCT00920855|528783419|FG001|Overall Study|Disease progression|1|||
146620778|NCT00920855|528783420|FG002|Overall Study|Disease progression|10|||
146620779|NCT00920855|528783418|FG000|Overall Study|Noncompliance to study medication|0|||
146620780|NCT00920855|528783419|FG001|Overall Study|Noncompliance to study medication|0|||
146620781|NCT00920855|528783420|FG002|Overall Study|Noncompliance to study medication|1|||
146620782|NCT00920855|528783418|FG000|Overall Study|Response plateau; started maintenance|0|||
146620783|NCT00920855|528783419|FG001|Overall Study|Response plateau; started maintenance|0|||
146620784|NCT00920855|528783420|FG002|Overall Study|Response plateau; started maintenance|1|||
146620785|NCT00510835|528783424|FG000|Overall Study|Withdrawal by Subject|6|||
146620786|NCT00510835|528783425|FG001|Overall Study|Withdrawal by Subject|2|||
146620787|NCT00510835|528783426|FG002|Overall Study|Withdrawal by Subject|2|||
146620788|NCT05470985|528783427|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
146788817|NCT04436276|529398070|FG021|Overall Study|Protocol Violation|0|||
146981917|NCT01271933|530096164|FG000|Double-Blind Phase|Adverse Event|0|||
146981918|NCT01271933|530096165|FG001|Double-Blind Phase|Adverse Event|3|||
146981919|NCT01271933|530096166|FG002|Double-Blind Phase|Adverse Event|0|||
146981920|NCT01271933|530096164|FG000|Double-Blind Phase|Participant request-personal reason|0|||
146981921|NCT01271933|530096165|FG001|Double-Blind Phase|Participant request-personal reason|1|||
146981922|NCT01271933|530096166|FG002|Double-Blind Phase|Participant request-personal reason|0|||
146981923|NCT01620983|530096167|FG000|Overall Study|Lost to Follow-up|8|||
146937789|NCT02688153|529930703|FG000|Overall Study|Death|7|||
146937790|NCT02688153|529930704|FG001|Overall Study|Death|5|||
146937791|NCT02688153|529930703|FG000|Overall Study|Withdrawal by Subject|4|||
146937792|NCT02688153|529930704|FG001|Overall Study|Withdrawal by Subject|2|||
146937793|NCT02688153|529930703|FG000|Overall Study|Valve Explant|1|||
146937794|NCT02688153|529930704|FG001|Overall Study|Valve Explant|0|||
146937795|NCT02688153|529930703|FG000|Overall Study|Conversion to Commercial Valve|3|||
146937796|NCT02688153|529930704|FG001|Overall Study|Conversion to Commercial Valve|0|||
146937797|NCT00107172|529930705|FG000|Overall Study|Withdrawal by Subject|1|||
146937798|NCT00107172|529930706|FG001|Overall Study|Withdrawal by Subject|0|||
146937799|NCT00107172|529930705|FG000|Overall Study|Death|0|||
146937800|NCT00107172|529930706|FG001|Overall Study|Death|2|||
146937801|NCT00107172|529930705|FG000|Overall Study|Other Reason|4|||
146937802|NCT00107172|529930706|FG001|Overall Study|Other Reason|3|||
146937803|NCT03750240|529930708|FG000|Overall Study|Technical Difficulties|2|||
146937804|NCT03706040|529930709|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
146937805|NCT03706040|529930710|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
146937806|NCT03706040|529930711|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
146937807|NCT03706040|529930712|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
146937808|NCT03706040|529930713|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
146937809|NCT03706040|529930714|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
146937810|NCT03706040|529930715|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
146937811|NCT03706040|529930709|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
146937812|NCT03706040|529930710|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
146937813|NCT03706040|529930711|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
146937814|NCT03706040|529930712|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
146937815|NCT03706040|529930713|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
146937816|NCT03706040|529930714|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
146937817|NCT03706040|529930715|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
146937818|NCT03706040|529930709|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
146937819|NCT03706040|529930710|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
146937820|NCT03706040|529930711|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
146937821|NCT03706040|529930712|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
146788818|NCT04436276|529398071|FG022|Overall Study|Protocol Violation|0|||
146788819|NCT04436276|529398049|FG000|Overall Study|Withdrawal by Subject|25|||
146788820|NCT04436276|529398050|FG001|Overall Study|Withdrawal by Subject|22|||
146788821|NCT04436276|529398051|FG002|Overall Study|Withdrawal by Subject|24|||
146788822|NCT04436276|529398052|FG003|Overall Study|Withdrawal by Subject|23|||
146788823|NCT04436276|529398053|FG004|Overall Study|Withdrawal by Subject|14|||
146788824|NCT04436276|529398054|FG005|Overall Study|Withdrawal by Subject|0|||
146788825|NCT04436276|529398055|FG006|Overall Study|Withdrawal by Subject|0|||
146788826|NCT04436276|529398056|FG007|Overall Study|Withdrawal by Subject|1|||
146788827|NCT04436276|529398057|FG008|Overall Study|Withdrawal by Subject|0|||
146788828|NCT04436276|529398058|FG009|Overall Study|Withdrawal by Subject|1|||
146788829|NCT04436276|529398059|FG010|Overall Study|Withdrawal by Subject|17|||
146788830|NCT04436276|529398060|FG011|Overall Study|Withdrawal by Subject|7|||
146788831|NCT04436276|529398061|FG012|Overall Study|Withdrawal by Subject|10|||
146788832|NCT04436276|529398062|FG013|Overall Study|Withdrawal by Subject|6|||
146788833|NCT04436276|529398063|FG014|Overall Study|Withdrawal by Subject|20|||
146788834|NCT04436276|529398064|FG015|Overall Study|Withdrawal by Subject|6|||
146788835|NCT04436276|529398065|FG016|Overall Study|Withdrawal by Subject|11|||
146788836|NCT04436276|529398066|FG017|Overall Study|Withdrawal by Subject|4|||
146788837|NCT04436276|529398067|FG018|Overall Study|Withdrawal by Subject|14|||
146788838|NCT04436276|529398068|FG019|Overall Study|Withdrawal by Subject|24|||
146788839|NCT04436276|529398069|FG020|Overall Study|Withdrawal by Subject|24|||
146788840|NCT04436276|529398070|FG021|Overall Study|Withdrawal by Subject|16|||
146788841|NCT04436276|529398071|FG022|Overall Study|Withdrawal by Subject|14|||
146788842|NCT04436276|529398049|FG000|Overall Study|Other|3|||
146788843|NCT04436276|529398050|FG001|Overall Study|Other|2|||
146788844|NCT04436276|529398051|FG002|Overall Study|Other|5|||
146788845|NCT04436276|529398052|FG003|Overall Study|Other|9|||
146788846|NCT04436276|529398053|FG004|Overall Study|Other|23|||
146788847|NCT04436276|529398054|FG005|Overall Study|Other|1|||
146788848|NCT04436276|529398055|FG006|Overall Study|Other|0|||
146788849|NCT04436276|529398056|FG007|Overall Study|Other|0|||
146788850|NCT04436276|529398057|FG008|Overall Study|Other|0|||
146788851|NCT04436276|529398058|FG009|Overall Study|Other|0|||
146788852|NCT04436276|529398059|FG010|Overall Study|Other|3|||
146788853|NCT04436276|529398060|FG011|Overall Study|Other|1|||
146788854|NCT04436276|529398061|FG012|Overall Study|Other|1|||
146788855|NCT04436276|529398062|FG013|Overall Study|Other|2|||
146788856|NCT04436276|529398063|FG014|Overall Study|Other|3|||
146937822|NCT03706040|529930713|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
146937823|NCT03706040|529930714|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
146937824|NCT03706040|529930715|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
146937825|NCT03706040|529930709|FG000|Period A (Week 0 to Week 16)|Other|2|||
146788857|NCT04436276|529398064|FG015|Overall Study|Other|0|||
146937826|NCT03706040|529930710|FG001|Period A (Week 0 to Week 16)|Other|0|||
146937827|NCT03706040|529930711|FG002|Period A (Week 0 to Week 16)|Other|2|||
146937828|NCT03706040|529930712|FG003|Period A (Week 0 to Week 16)|Other|0|||
146937829|NCT03706040|529930713|FG004|Period A (Week 0 to Week 16)|Other|0|||
146937830|NCT03706040|529930714|FG005|Period A (Week 0 to Week 16)|Other|0|||
146937831|NCT03706040|529930715|FG006|Period A (Week 0 to Week 16)|Other|0|||
146937832|NCT03706040|529930709|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
146937833|NCT03706040|529930710|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
146937834|NCT03706040|529930711|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
146937835|NCT03706040|529930712|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
146731155|NCT00293267|529185940|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
146731156|NCT00293267|529185939|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
146731157|NCT00293267|529185940|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
146731158|NCT02182973|529185941|FG000|Overall Study|Withdrawal by Subject|3|||
146731159|NCT02182973|529185942|FG001|Overall Study|Withdrawal by Subject|0|||
146731160|NCT01235546|529185943|FG000|Overall Study|Staff error, medication not administered|1|||
146731161|NCT01235546|529185944|FG001|Overall Study|Staff error, medication not administered|0|||
146731162|NCT01235546|529185943|FG000|Overall Study|Protocol Violation|1|||
146731163|NCT01235546|529185944|FG001|Overall Study|Protocol Violation|1|||
146731164|NCT01123382|529185945|FG000|Overall Study|Withdrawal by Subject|1|||
146731165|NCT01123382|529185946|FG001|Overall Study|Withdrawal by Subject|4|||
146731166|NCT01123382|529185945|FG000|Overall Study|Lost to Follow-up|1|||
146731167|NCT01123382|529185946|FG001|Overall Study|Lost to Follow-up|2|||
146731168|NCT02740049|529185947|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
146731169|NCT02274857|529185948|FG000|Overall Study|Adverse Event|1|||
146731170|NCT02274857|529185949|FG001|Overall Study|Adverse Event|0|||
146731171|NCT02274857|529185948|FG000|Overall Study|Death|1|||
146731172|NCT02274857|529185949|FG001|Overall Study|Death|2|||
146731173|NCT02274857|529185948|FG000|Overall Study|Lost to Follow-up|3|||
146731174|NCT02274857|529185949|FG001|Overall Study|Lost to Follow-up|0|||
146731175|NCT02274857|529185948|FG000|Overall Study|Physician Decision|2|||
146731176|NCT02274857|529185949|FG001|Overall Study|Physician Decision|0|||
146731177|NCT02274857|529185948|FG000|Overall Study|Trial screen failure|0|||
146731178|NCT02274857|529185949|FG001|Overall Study|Trial screen failure|2|||
146731179|NCT02274857|529185948|FG000|Overall Study|Withdrawal by Subject|11|||
146731180|NCT02274857|529185949|FG001|Overall Study|Withdrawal by Subject|2|||
146731181|NCT02274857|529185948|FG000|Overall Study|Other|2|||
146731182|NCT02274857|529185949|FG001|Overall Study|Other|0|||
146731183|NCT02403180|529185952|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
146731184|NCT02403180|529185953|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
146731185|NCT02403180|529185952|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
146731186|NCT02403180|529185953|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
146731187|NCT03338829|529185956|FG000|Overall Study|Lost to Follow-up|4|||
146731188|NCT03338829|529185957|FG001|Overall Study|Lost to Follow-up|2|||
146731189|NCT03338829|529185958|FG002|Overall Study|Lost to Follow-up|4|||
146731190|NCT03338829|529185956|FG000|Overall Study|Pregnancy loss|1|||
146731191|NCT03338829|529185957|FG001|Overall Study|Pregnancy loss|1|||
146731192|NCT03338829|529185958|FG002|Overall Study|Pregnancy loss|0|||
146731193|NCT03338829|529185956|FG000|Overall Study|Protocol Violation|0|||
146731194|NCT03338829|529185957|FG001|Overall Study|Protocol Violation|1|||
146731195|NCT03338829|529185958|FG002|Overall Study|Protocol Violation|0|||
146731196|NCT02340026|529185959|FG000|Treatment Phase|Withdrawal by Subject|2|||
146731197|NCT02340026|529185960|FG001|Treatment Phase|Withdrawal by Subject|2|||
146731198|NCT02340026|529185959|FG000|Follow-up Phase|Lost to Follow-up|1|||
146731199|NCT02340026|529185960|FG001|Follow-up Phase|Lost to Follow-up|0|||
146731200|NCT04393441|529185970|FG000|Overall Study|Adverse Event|0|||
146731201|NCT04393441|529185971|FG001|Overall Study|Adverse Event|3|||
146731202|NCT04393441|529185970|FG000|Overall Study|Withdrawal by Subject|5|||
146731203|NCT04393441|529185971|FG001|Overall Study|Withdrawal by Subject|7|||
146731204|NCT04393441|529185970|FG000|Overall Study|Lost to Follow-up|0|||
146731205|NCT04393441|529185971|FG001|Overall Study|Lost to Follow-up|2|||
146731206|NCT04393441|529185970|FG000|Overall Study|Protocol Deviation|2|||
146731207|NCT04393441|529185971|FG001|Overall Study|Protocol Deviation|1|||
146731208|NCT04393441|529185970|FG000|Overall Study|Reason not Specified|1|||
146731209|NCT04393441|529185971|FG001|Overall Study|Reason not Specified|1|||
146731210|NCT02782169|529185972|FG000|Overall Study|Lost to Follow-up|1|||
146731211|NCT02782169|529185973|FG001|Overall Study|Lost to Follow-up|2|||
146731212|NCT04003610|529185974|FG000|Overall Study|Lost to Follow-up|0|||
146731213|NCT04003610|529185975|FG001|Overall Study|Lost to Follow-up|1|||
146731214|NCT04003610|529185976|FG002|Overall Study|Lost to Follow-up|0|||
146731215|NCT04003610|529185974|FG000|Overall Study|Death|0|||
146731216|NCT04003610|529185975|FG001|Overall Study|Death|0|||
146731217|NCT04003610|529185976|FG002|Overall Study|Death|3|||
146731218|NCT04003610|529185974|FG000|Overall Study|Study Terminated by Sponsor|0|||
146731219|NCT04003610|529185975|FG001|Overall Study|Study Terminated by Sponsor|0|||
146731220|NCT04003610|529185976|FG002|Overall Study|Study Terminated by Sponsor|3|||
146731221|NCT00771810|529185977|FG000|Overall Study|Adverse Event|3|||
146788858|NCT04436276|529398065|FG016|Overall Study|Other|0|||
146788859|NCT04436276|529398066|FG017|Overall Study|Other|6|||
146788860|NCT04436276|529398067|FG018|Overall Study|Other|1|||
146788861|NCT04436276|529398068|FG019|Overall Study|Other|0|||
146788862|NCT04436276|529398069|FG020|Overall Study|Other|2|||
146788863|NCT04436276|529398070|FG021|Overall Study|Other|2|||
146788864|NCT04436276|529398071|FG022|Overall Study|Other|60|||
146788865|NCT00324805|529398072|FG000|Overall Study|Adverse Event|62|||
146788866|NCT00324805|529398073|FG001|Overall Study|Adverse Event|203|||
146788867|NCT00324805|529398072|FG000|Overall Study|Progression|7|||
146788868|NCT00324805|529398073|FG001|Overall Study|Progression|35|||
146788869|NCT00324805|529398072|FG000|Overall Study|Withdrawal by Subject|51|||
146788870|NCT00324805|529398073|FG001|Overall Study|Withdrawal by Subject|174|||
146788871|NCT00324805|529398072|FG000|Overall Study|Death|6|||
146788872|NCT00324805|529398073|FG001|Overall Study|Death|9|||
146788873|NCT00324805|529398072|FG000|Overall Study|Alternative therapy|4|||
146788874|NCT00324805|529398073|FG001|Overall Study|Alternative therapy|8|||
146788875|NCT00324805|529398072|FG000|Overall Study|Other complicating disease|1|||
146788876|NCT00324805|529398073|FG001|Overall Study|Other complicating disease|9|||
146788877|NCT00324805|529398072|FG000|Overall Study|Other reasons|7|||
146788878|NCT00324805|529398073|FG001|Overall Study|Other reasons|26|||
146788879|NCT00324805|529398072|FG000|Overall Study|Other|0|||
146788880|NCT00324805|529398073|FG001|Overall Study|Other|2|||
146788881|NCT00324805|529398072|FG000|Overall Study|Did not start therapy|12|||
146788882|NCT00324805|529398073|FG001|Overall Study|Did not start therapy|17|||
146788883|NCT03931174|529398075|FG000|Providers|Staff left organization|26|||
146788884|NCT03931174|529398076|FG001|Providers|Staff left organization|25|||
146788885|NCT03931174|529398075|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
146788886|NCT03931174|529398076|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
146788887|NCT03931174|529398075|FG000|Providers|Lost to Follow-up|4|||
146788888|NCT03931174|529398076|FG001|Providers|Lost to Follow-up|4|||
146788889|NCT03931174|529398075|FG000|Patients|Post-consent screening failure|1|||
146788890|NCT03931174|529398076|FG001|Patients|Post-consent screening failure|1|||
146788891|NCT03931174|529398075|FG000|Patients|Death|1|||
146788892|NCT03931174|529398076|FG001|Patients|Death|1|||
146788893|NCT03931174|529398075|FG000|Patients|Lost to Follow-up|60|||
146788894|NCT03931174|529398076|FG001|Patients|Lost to Follow-up|89|||
146788895|NCT03322267|529398077|FG000|Overall Study|Lack of Efficacy|11|||
146788896|NCT03322267|529398077|FG000|Overall Study|Adverse Event|1|||
146788897|NCT03322267|529398077|FG000|Overall Study|Withdrawal by Subject|2|||
146788898|NCT05792085|529398078|FG000|Overall Study|Death|0|||
146788899|NCT05792085|529398079|FG001|Overall Study|Death|0|||
146788900|NCT05792085|529398080|FG002|Overall Study|Death|0|||
146788901|NCT05792085|529398081|FG003|Overall Study|Death|0|||
146788902|NCT05792085|529398082|FG004|Overall Study|Death|1|||
146788903|NCT05228457|529398085|FG000|Overall Study|Withdrawal by Subject|1|||
146788904|NCT05228457|529398086|FG001|Overall Study|Withdrawal by Subject|1|||
146788905|NCT03213691|529398091|FG000|Overall Study|Adverse Event|2|||
146788906|NCT03213691|529398091|FG000|Overall Study|Death|3|||
146788907|NCT03213691|529398091|FG000|Overall Study|Physician Decision|1|||
146937836|NCT03706040|529930713|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
146788908|NCT03213691|529398091|FG000|Overall Study|Progressive Disease|14|||
146788909|NCT03213691|529398091|FG000|Overall Study|Ineligible|1|||
146788910|NCT03161028|529398094|FG000|Overall Study|Withdrawal by Subject|6|||
146788911|NCT03161028|529398095|FG001|Overall Study|Withdrawal by Subject|4|||
146788912|NCT03161028|529398094|FG000|Overall Study|Adverse Event|5|||
146788913|NCT03161028|529398095|FG001|Overall Study|Adverse Event|1|||
146788914|NCT03161028|529398094|FG000|Overall Study|Study drug side effects|2|||
146788915|NCT03161028|529398095|FG001|Overall Study|Study drug side effects|2|||
146788916|NCT03161028|529398094|FG000|Overall Study|Administrative PD/UP|4|||
146937837|NCT03706040|529930714|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
146937838|NCT03706040|529930715|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
146937839|NCT03706040|529930709|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
146937840|NCT03706040|529930710|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
146937841|NCT03706040|529930711|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
146937842|NCT03706040|529930712|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
146937843|NCT03706040|529930713|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
146788917|NCT03161028|529398095|FG001|Overall Study|Administrative PD/UP|2|||
146788918|NCT03161028|529398094|FG000|Overall Study|Lost to Follow-up|2|||
146788919|NCT03161028|529398095|FG001|Overall Study|Lost to Follow-up|0|||
146788920|NCT03161028|529398094|FG000|Overall Study|Unable to comply with procedures|1|||
146788921|NCT03161028|529398095|FG001|Overall Study|Unable to comply with procedures|1|||
146788922|NCT03492216|529398096|FG000|Overall Study|Death|1|||
146788923|NCT03492216|529398097|FG001|Overall Study|Death|0|||
146788924|NCT03492216|529398098|FG002|Overall Study|Death|4|||
146937844|NCT03706040|529930714|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
146788925|NCT03492216|529398099|FG003|Overall Study|Death|0|||
146788926|NCT03492216|529398096|FG000|Overall Study|Withdrawal by Subject|5|||
146788927|NCT03492216|529398097|FG001|Overall Study|Withdrawal by Subject|3|||
146788928|NCT03492216|529398098|FG002|Overall Study|Withdrawal by Subject|1|||
146788929|NCT03492216|529398099|FG003|Overall Study|Withdrawal by Subject|1|||
146788930|NCT03492216|529398096|FG000|Overall Study|Lost to Follow-up|9|||
146788931|NCT03492216|529398097|FG001|Overall Study|Lost to Follow-up|2|||
146788932|NCT03492216|529398098|FG002|Overall Study|Lost to Follow-up|7|||
146788933|NCT03492216|529398099|FG003|Overall Study|Lost to Follow-up|8|||
146788934|NCT03492216|529398096|FG000|Overall Study|Moved|5|||
146788935|NCT03492216|529398097|FG001|Overall Study|Moved|3|||
146788936|NCT03492216|529398098|FG002|Overall Study|Moved|3|||
146788937|NCT03492216|529398099|FG003|Overall Study|Moved|5|||
146788938|NCT03492216|529398096|FG000|Overall Study|Too ill|0|||
146788939|NCT03492216|529398097|FG001|Overall Study|Too ill|1|||
146788940|NCT03492216|529398098|FG002|Overall Study|Too ill|0|||
146788941|NCT03492216|529398099|FG003|Overall Study|Too ill|0|||
146788942|NCT03492216|529398096|FG000|Overall Study|Incarcerated|0|||
146788943|NCT03492216|529398097|FG001|Overall Study|Incarcerated|0|||
146788944|NCT03492216|529398098|FG002|Overall Study|Incarcerated|2|||
146788945|NCT03492216|529398099|FG003|Overall Study|Incarcerated|0|||
146788946|NCT04797897|529398102|FG000|Overall Study|Study Termination by Sponsor|1|||
146788947|NCT04797897|529398103|FG001|Overall Study|Study Termination by Sponsor|1|||
146788948|NCT01799265|529398105|FG000|Overall Study|Lost to Follow-up|1|||
146788949|NCT01799265|529398106|FG001|Overall Study|Lost to Follow-up|0|||
146788950|NCT01799265|529398105|FG000|Overall Study|Protocol Violation|2|||
146788951|NCT01799265|529398106|FG001|Overall Study|Protocol Violation|1|||
146788952|NCT01799265|529398105|FG000|Overall Study|inadequate sleep study|0|||
146788953|NCT01799265|529398106|FG001|Overall Study|inadequate sleep study|2|||
146788954|NCT03774082|529398110|FG000|Overall Study|Death|6|||
146788955|NCT03774082|529398111|FG001|Overall Study|Death|3|||
146788956|NCT03774082|529398112|FG002|Overall Study|Death|2|||
146788957|NCT03774082|529398110|FG000|Overall Study|Subject decision|0|||
146788958|NCT03774082|529398111|FG001|Overall Study|Subject decision|3|||
146788959|NCT03774082|529398112|FG002|Overall Study|Subject decision|0|||
146788960|NCT03774082|529398110|FG000|Overall Study|Lost to Follow-up|2|||
146788961|NCT03774082|529398111|FG001|Overall Study|Lost to Follow-up|0|||
146788962|NCT03774082|529398112|FG002|Overall Study|Lost to Follow-up|0|||
146788963|NCT03774082|529398110|FG000|Overall Study|Guardian decision|0|||
146788964|NCT03774082|529398111|FG001|Overall Study|Guardian decision|0|||
146788965|NCT03774082|529398112|FG002|Overall Study|Guardian decision|1|||
146788966|NCT03774082|529398110|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
146788967|NCT03774082|529398111|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
146788968|NCT03774082|529398112|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
146788969|NCT05030233|529398113|FG000|Overall Study|withdrawn for transfer|1|||
146788970|NCT05030233|529398114|FG001|Overall Study|withdrawn for transfer|0|||
146788971|NCT04728347|529399686|FG000|Overall Study|Sponsor decision|0|||
146788972|NCT04728347|529399687|FG001|Overall Study|Sponsor decision|0|||
146788973|NCT04728347|529399688|FG002|Overall Study|Sponsor decision|1|||
146788974|NCT04728347|529399689|FG003|Overall Study|Sponsor decision|0|||
146788975|NCT01186367|529399693|FG000|Overall Study|Lost to Follow-up|7|||
146788976|NCT01186367|529399694|FG001|Overall Study|Lost to Follow-up|4|||
146788977|NCT01186367|529399695|FG002|Overall Study|Lost to Follow-up|7|||
146788978|NCT01186367|529399693|FG000|Overall Study|Did not receive study treatment|0|||
146788979|NCT01186367|529399694|FG001|Overall Study|Did not receive study treatment|1|||
146788980|NCT01186367|529399695|FG002|Overall Study|Did not receive study treatment|0|||
146788981|NCT03867500|529399696|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
146788982|NCT01098812|529399697|FG000|Overall Study|Death|2|||
146788983|NCT01098812|529399698|FG001|Overall Study|Death|0|||
146788984|NCT01098812|529399699|FG002|Overall Study|Death|1|||
146788985|NCT01098812|529399697|FG000|Overall Study|Lost to Follow-up|0|||
146788986|NCT01098812|529399698|FG001|Overall Study|Lost to Follow-up|1|||
146788987|NCT01098812|529399699|FG002|Overall Study|Lost to Follow-up|0|||
146788988|NCT01539083|529399717|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
146788989|NCT01539083|529399718|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
146788990|NCT01539083|529399719|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
146788991|NCT01539083|529399717|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
146788992|NCT01539083|529399718|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
146788993|NCT01539083|529399719|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
146788994|NCT01539083|529399717|FG000|Before Randomization (VCD Induction)|Death|6|||
146788995|NCT01539083|529399718|FG001|Before Randomization (VCD Induction)|Death|0|||
146788996|NCT01539083|529399719|FG002|Before Randomization (VCD Induction)|Death|0|||
146788997|NCT01539083|529399717|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
146788998|NCT01539083|529399718|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
146788999|NCT01539083|529399719|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
146937845|NCT03706040|529930715|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
146937846|NCT03706040|529930709|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
146789000|NCT01539083|529399717|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
146789001|NCT01539083|529399718|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
146789002|NCT01539083|529399719|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
146789003|NCT01539083|529399717|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
146789004|NCT01539083|529399718|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
146789005|NCT01539083|529399719|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
146789006|NCT01539083|529399717|FG000|Before Randomization (VCD Induction)|Other|5|||
146789007|NCT01539083|529399718|FG001|Before Randomization (VCD Induction)|Other|0|||
146789008|NCT01539083|529399719|FG002|Before Randomization (VCD Induction)|Other|0|||
146789009|NCT01539083|529399717|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
146789010|NCT01539083|529399718|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
146789011|NCT01539083|529399719|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
146789012|NCT01539083|529399717|FG000|After Randomization (TP and VTP)|Other|0|||
146789013|NCT01539083|529399718|FG001|After Randomization (TP and VTP)|Other|1|||
146937847|NCT03706040|529930710|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
146789014|NCT01539083|529399719|FG002|After Randomization (TP and VTP)|Other|1|||
146789015|NCT01539083|529399717|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
146789016|NCT01539083|529399718|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
146789017|NCT01539083|529399719|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
146789018|NCT01539083|529399717|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
146789019|NCT01539083|529399718|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
146789020|NCT01539083|529399719|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
146789021|NCT01539083|529399717|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
146789022|NCT01539083|529399718|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
146789023|NCT01539083|529399719|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
146789024|NCT01539083|529399717|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
146789025|NCT01539083|529399718|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
146789026|NCT01539083|529399719|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
146789027|NCT01539083|529399717|FG000|After Randomization (TP and VTP)|Death|0|||
146789028|NCT01539083|529399718|FG001|After Randomization (TP and VTP)|Death|6|||
146789029|NCT01539083|529399719|FG002|After Randomization (TP and VTP)|Death|11|||
146789030|NCT05499377|529399728|FG000|Overall Study|Withdrawal by Subject|2|||
146789031|NCT05499377|529399729|FG001|Overall Study|Withdrawal by Subject|0|||
146789032|NCT05499377|529399728|FG000|Overall Study|Physician Decision|1|||
146789033|NCT05499377|529399729|FG001|Overall Study|Physician Decision|0|||
146789034|NCT04149704|529399730|FG000|Three Month Follow-up|Death|2|||
146789035|NCT04149704|529399731|FG001|Three Month Follow-up|Death|0|||
146789036|NCT04149704|529399732|FG002|Three Month Follow-up|Death|0|||
146789037|NCT04149704|529399733|FG003|Three Month Follow-up|Death|0|||
146789038|NCT04149704|529399730|FG000|Three Month Follow-up|Lost to Follow-up|1|||
146789039|NCT04149704|529399731|FG001|Three Month Follow-up|Lost to Follow-up|4|||
146789040|NCT04149704|529399732|FG002|Three Month Follow-up|Lost to Follow-up|5|||
146789041|NCT04149704|529399733|FG003|Three Month Follow-up|Lost to Follow-up|5|||
146789042|NCT04149704|529399730|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
146789043|NCT04149704|529399731|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
146789044|NCT04149704|529399732|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
146789045|NCT04149704|529399733|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
146789046|NCT04149704|529399730|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
146789047|NCT04149704|529399731|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
146789048|NCT04149704|529399732|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
146789049|NCT04149704|529399733|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
146789050|NCT04632992|529399740|FG000|Overall Study|Adverse Event|0|||
146789051|NCT04632992|529399741|FG001|Overall Study|Adverse Event|0|||
146789052|NCT04632992|529399742|FG002|Overall Study|Adverse Event|0|||
146789053|NCT04632992|529399743|FG003|Overall Study|Adverse Event|0|||
146789054|NCT04632992|529399744|FG004|Overall Study|Adverse Event|0|||
146789055|NCT04632992|529399745|FG005|Overall Study|Adverse Event|0|||
146789056|NCT04632992|529399746|FG006|Overall Study|Adverse Event|0|||
146789057|NCT04632992|529399747|FG007|Overall Study|Adverse Event|0|||
146789058|NCT04632992|529399748|FG008|Overall Study|Adverse Event|0|||
146789059|NCT04632992|529399749|FG009|Overall Study|Adverse Event|0|||
146789060|NCT04632992|529399750|FG010|Overall Study|Adverse Event|0|||
146937848|NCT03706040|529930711|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
146937849|NCT03706040|529930712|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
146937850|NCT03706040|529930713|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
146937851|NCT03706040|529930714|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
146937852|NCT03706040|529930715|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
146789061|NCT04632992|529399751|FG011|Overall Study|Adverse Event|0|||
146789062|NCT04632992|529399752|FG012|Overall Study|Adverse Event|1|||
146789063|NCT04632992|529399753|FG013|Overall Study|Adverse Event|0|||
146789064|NCT04632992|529399740|FG000|Overall Study|Death|17|||
146789065|NCT04632992|529399741|FG001|Overall Study|Death|1|||
146789066|NCT04632992|529399742|FG002|Overall Study|Death|14|||
146789067|NCT04632992|529399743|FG003|Overall Study|Death|14|||
146789068|NCT04632992|529399744|FG004|Overall Study|Death|13|||
146789069|NCT04632992|529399745|FG005|Overall Study|Death|6|||
146789070|NCT04632992|529399746|FG006|Overall Study|Death|7|||
146789071|NCT04632992|529399747|FG007|Overall Study|Death|12|||
146789072|NCT04632992|529399748|FG008|Overall Study|Death|15|||
146789073|NCT04632992|529399749|FG009|Overall Study|Death|20|||
146789074|NCT04632992|529399750|FG010|Overall Study|Death|8|||
146789075|NCT04632992|529399751|FG011|Overall Study|Death|2|||
146789076|NCT04632992|529399752|FG012|Overall Study|Death|10|||
146789077|NCT04632992|529399753|FG013|Overall Study|Death|1|||
146789078|NCT04632992|529399740|FG000|Overall Study|Lost to Follow-up|1|||
146789079|NCT04632992|529399741|FG001|Overall Study|Lost to Follow-up|0|||
146789080|NCT04632992|529399742|FG002|Overall Study|Lost to Follow-up|1|||
146789081|NCT04632992|529399743|FG003|Overall Study|Lost to Follow-up|0|||
146789082|NCT04632992|529399744|FG004|Overall Study|Lost to Follow-up|2|||
146789083|NCT04632992|529399745|FG005|Overall Study|Lost to Follow-up|0|||
146789084|NCT04632992|529399746|FG006|Overall Study|Lost to Follow-up|1|||
146789085|NCT04632992|529399747|FG007|Overall Study|Lost to Follow-up|1|||
146789086|NCT04632992|529399748|FG008|Overall Study|Lost to Follow-up|1|||
146789087|NCT04632992|529399749|FG009|Overall Study|Lost to Follow-up|1|||
146789088|NCT04632992|529399750|FG010|Overall Study|Lost to Follow-up|2|||
146789089|NCT04632992|529399751|FG011|Overall Study|Lost to Follow-up|0|||
146789090|NCT04632992|529399752|FG012|Overall Study|Lost to Follow-up|0|||
146789091|NCT04632992|529399753|FG013|Overall Study|Lost to Follow-up|0|||
146789092|NCT04632992|529399740|FG000|Overall Study|Reason not Specified|2|||
146789093|NCT04632992|529399741|FG001|Overall Study|Reason not Specified|0|||
146789094|NCT04632992|529399742|FG002|Overall Study|Reason not Specified|1|||
146789095|NCT04632992|529399743|FG003|Overall Study|Reason not Specified|1|||
146789096|NCT04632992|529399744|FG004|Overall Study|Reason not Specified|0|||
146789097|NCT04632992|529399745|FG005|Overall Study|Reason not Specified|0|||
146789098|NCT04632992|529399746|FG006|Overall Study|Reason not Specified|0|||
146789099|NCT04632992|529399747|FG007|Overall Study|Reason not Specified|0|||
146789100|NCT04632992|529399748|FG008|Overall Study|Reason not Specified|0|||
146789101|NCT04632992|529399749|FG009|Overall Study|Reason not Specified|0|||
146789102|NCT04632992|529399750|FG010|Overall Study|Reason not Specified|1|||
146789103|NCT04632992|529399751|FG011|Overall Study|Reason not Specified|0|||
146789104|NCT04632992|529399752|FG012|Overall Study|Reason not Specified|0|||
146789105|NCT04632992|529399753|FG013|Overall Study|Reason not Specified|0|||
146789106|NCT04632992|529399740|FG000|Overall Study|Physician Decision|0|||
146789107|NCT04632992|529399741|FG001|Overall Study|Physician Decision|0|||
146789108|NCT04632992|529399742|FG002|Overall Study|Physician Decision|0|||
146789109|NCT04632992|529399743|FG003|Overall Study|Physician Decision|2|||
146789110|NCT04632992|529399744|FG004|Overall Study|Physician Decision|1|||
146789111|NCT04632992|529399745|FG005|Overall Study|Physician Decision|0|||
146789112|NCT04632992|529399746|FG006|Overall Study|Physician Decision|0|||
146789113|NCT04632992|529399747|FG007|Overall Study|Physician Decision|0|||
146789114|NCT04632992|529399748|FG008|Overall Study|Physician Decision|0|||
146789115|NCT04632992|529399749|FG009|Overall Study|Physician Decision|0|||
146789116|NCT04632992|529399750|FG010|Overall Study|Physician Decision|0|||
146789117|NCT04632992|529399751|FG011|Overall Study|Physician Decision|0|||
146789118|NCT04632992|529399752|FG012|Overall Study|Physician Decision|3|||
146789119|NCT04632992|529399753|FG013|Overall Study|Physician Decision|0|||
146789120|NCT04632992|529399740|FG000|Overall Study|Progressive Disease|0|||
146789121|NCT04632992|529399741|FG001|Overall Study|Progressive Disease|0|||
146789122|NCT04632992|529399742|FG002|Overall Study|Progressive Disease|0|||
146789123|NCT04632992|529399743|FG003|Overall Study|Progressive Disease|0|||
146789124|NCT04632992|529399744|FG004|Overall Study|Progressive Disease|1|||
146789125|NCT04632992|529399745|FG005|Overall Study|Progressive Disease|0|||
146789126|NCT04632992|529399746|FG006|Overall Study|Progressive Disease|0|||
146789127|NCT04632992|529399747|FG007|Overall Study|Progressive Disease|0|||
146789128|NCT04632992|529399748|FG008|Overall Study|Progressive Disease|0|||
146789129|NCT04632992|529399749|FG009|Overall Study|Progressive Disease|1|||
146789130|NCT04632992|529399750|FG010|Overall Study|Progressive Disease|1|||
146789131|NCT04632992|529399751|FG011|Overall Study|Progressive Disease|0|||
146789132|NCT04632992|529399752|FG012|Overall Study|Progressive Disease|2|||
146789133|NCT04632992|529399753|FG013|Overall Study|Progressive Disease|0|||
146789134|NCT04632992|529399740|FG000|Overall Study|Withdrawal by Subject|4|||
146789135|NCT04632992|529399741|FG001|Overall Study|Withdrawal by Subject|1|||
146789136|NCT04632992|529399742|FG002|Overall Study|Withdrawal by Subject|5|||
146789137|NCT04632992|529399743|FG003|Overall Study|Withdrawal by Subject|4|||
146789138|NCT04632992|529399744|FG004|Overall Study|Withdrawal by Subject|3|||
146789139|NCT04632992|529399745|FG005|Overall Study|Withdrawal by Subject|3|||
146789140|NCT04632992|529399746|FG006|Overall Study|Withdrawal by Subject|0|||
146789141|NCT04632992|529399747|FG007|Overall Study|Withdrawal by Subject|5|||
146789142|NCT04632992|529399748|FG008|Overall Study|Withdrawal by Subject|0|||
146789143|NCT04632992|529399749|FG009|Overall Study|Withdrawal by Subject|2|||
146789144|NCT04632992|529399750|FG010|Overall Study|Withdrawal by Subject|8|||
146789145|NCT04632992|529399751|FG011|Overall Study|Withdrawal by Subject|0|||
146789146|NCT04632992|529399752|FG012|Overall Study|Withdrawal by Subject|1|||
146789147|NCT04632992|529399753|FG013|Overall Study|Withdrawal by Subject|1|||
146789148|NCT02268253|529399754|FG000|Stage 1|Withdrawal by Subject|1|||
146789149|NCT02268253|529399755|FG001|Stage 1|Withdrawal by Subject|0|||
146789150|NCT02268253|529399756|FG002|Stage 1|Withdrawal by Subject|0|||
146789151|NCT02268253|529399757|FG003|Stage 1|Withdrawal by Subject|0|||
146789152|NCT02268253|529399758|FG004|Stage 1|Withdrawal by Subject|0|||
146789153|NCT02268253|529399759|FG005|Stage 1|Withdrawal by Subject|0|||
146789154|NCT02268253|529399760|FG006|Stage 1|Withdrawal by Subject|0|||
146789155|NCT02268253|529399754|FG000|Stage 1|Death|0|||
146789156|NCT02268253|529399755|FG001|Stage 1|Death|2|||
146789157|NCT02268253|529399756|FG002|Stage 1|Death|2|||
146789158|NCT02268253|529399757|FG003|Stage 1|Death|2|||
146789159|NCT02268253|529399758|FG004|Stage 1|Death|1|||
146789160|NCT02268253|529399759|FG005|Stage 1|Death|1|||
146789161|NCT02268253|529399760|FG006|Stage 1|Death|0|||
146789162|NCT02268253|529399754|FG000|Stage 2|Disease Recurrence/ Progression|0|||
146789163|NCT02268253|529399755|FG001|Stage 2|Disease Recurrence/ Progression|0|||
146789164|NCT02268253|529399756|FG002|Stage 2|Disease Recurrence/ Progression|1|||
146789165|NCT02268253|529399757|FG003|Stage 2|Disease Recurrence/ Progression|0|||
146789166|NCT02268253|529399758|FG004|Stage 2|Disease Recurrence/ Progression|0|||
146789167|NCT02268253|529399759|FG005|Stage 2|Disease Recurrence/ Progression|0|||
146789168|NCT02268253|529399760|FG006|Stage 2|Disease Recurrence/ Progression|0|||
146789169|NCT02268253|529399754|FG000|Stage 2|Withdrawal by Subject|0|||
146789170|NCT02268253|529399755|FG001|Stage 2|Withdrawal by Subject|0|||
146789171|NCT02268253|529399756|FG002|Stage 2|Withdrawal by Subject|2|||
146789172|NCT02268253|529399757|FG003|Stage 2|Withdrawal by Subject|0|||
146789173|NCT02268253|529399758|FG004|Stage 2|Withdrawal by Subject|0|||
146789174|NCT02268253|529399759|FG005|Stage 2|Withdrawal by Subject|2|||
146789175|NCT02268253|529399760|FG006|Stage 2|Withdrawal by Subject|0|||
146789176|NCT02268253|529399754|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
146789177|NCT02268253|529399755|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
146789178|NCT02268253|529399756|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
146789179|NCT02268253|529399757|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
146789180|NCT02268253|529399758|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
146789181|NCT02268253|529399759|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
146789182|NCT02268253|529399760|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
146789183|NCT02268253|529399754|FG000|Stage 2|Death|0|||
146789184|NCT02268253|529399755|FG001|Stage 2|Death|0|||
146789185|NCT02268253|529399756|FG002|Stage 2|Death|19|||
146789186|NCT02268253|529399757|FG003|Stage 2|Death|0|||
146789187|NCT02268253|529399758|FG004|Stage 2|Death|0|||
146789188|NCT02268253|529399759|FG005|Stage 2|Death|20|||
146789189|NCT02268253|529399760|FG006|Stage 2|Death|1|||
146789190|NCT02268253|529399754|FG000|Stage 2|Lost to Follow-up|0|||
146789191|NCT02268253|529399755|FG001|Stage 2|Lost to Follow-up|0|||
146789192|NCT02268253|529399756|FG002|Stage 2|Lost to Follow-up|0|||
146789193|NCT02268253|529399757|FG003|Stage 2|Lost to Follow-up|0|||
146789194|NCT02268253|529399758|FG004|Stage 2|Lost to Follow-up|0|||
146789195|NCT02268253|529399759|FG005|Stage 2|Lost to Follow-up|4|||
146789196|NCT02268253|529399760|FG006|Stage 2|Lost to Follow-up|0|||
146789197|NCT02268253|529399754|FG000|Stage 2|Transferred to Hospice|0|||
146789198|NCT02268253|529399755|FG001|Stage 2|Transferred to Hospice|0|||
146789199|NCT02268253|529399756|FG002|Stage 2|Transferred to Hospice|0|||
146789200|NCT02268253|529399757|FG003|Stage 2|Transferred to Hospice|0|||
146789201|NCT02268253|529399758|FG004|Stage 2|Transferred to Hospice|0|||
146789202|NCT02268253|529399759|FG005|Stage 2|Transferred to Hospice|2|||
146789203|NCT02268253|529399760|FG006|Stage 2|Transferred to Hospice|0|||
146789204|NCT02268253|529399754|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
146789205|NCT02268253|529399755|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
146789206|NCT02268253|529399756|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
146789207|NCT02268253|529399757|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
146789208|NCT02268253|529399758|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
146789209|NCT02268253|529399759|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
146789210|NCT02268253|529399760|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
146789211|NCT02268253|529399754|FG000|Stage 3A|Withdrawal by Subject|0|||
146789212|NCT02268253|529399755|FG001|Stage 3A|Withdrawal by Subject|0|||
146789213|NCT02268253|529399756|FG002|Stage 3A|Withdrawal by Subject|2|||
146789214|NCT02268253|529399757|FG003|Stage 3A|Withdrawal by Subject|0|||
146789215|NCT02268253|529399758|FG004|Stage 3A|Withdrawal by Subject|0|||
146789216|NCT02268253|529399759|FG005|Stage 3A|Withdrawal by Subject|0|||
146789217|NCT02268253|529399760|FG006|Stage 3A|Withdrawal by Subject|0|||
146789218|NCT02268253|529399754|FG000|Stage 3A|Physician Decision|0|||
146789219|NCT02268253|529399755|FG001|Stage 3A|Physician Decision|0|||
146789220|NCT02268253|529399756|FG002|Stage 3A|Physician Decision|2|||
146789221|NCT02268253|529399757|FG003|Stage 3A|Physician Decision|0|||
146789222|NCT02268253|529399758|FG004|Stage 3A|Physician Decision|0|||
146789223|NCT02268253|529399759|FG005|Stage 3A|Physician Decision|0|||
146789224|NCT02268253|529399760|FG006|Stage 3A|Physician Decision|0|||
146789225|NCT02268253|529399754|FG000|Stage 3A|Study Terminated by Sponsor|0|||
146789226|NCT02268253|529399755|FG001|Stage 3A|Study Terminated by Sponsor|0|||
146937853|NCT03706040|529930709|FG000|Period B (Week 16 to Week 52)|Other|0|||
146937854|NCT03706040|529930710|FG001|Period B (Week 16 to Week 52)|Other|0|||
146937855|NCT03706040|529930711|FG002|Period B (Week 16 to Week 52)|Other|0|||
146731222|NCT00771810|529185978|FG001|Overall Study|Adverse Event|0|||
146731223|NCT00771810|529185979|FG002|Overall Study|Adverse Event|2|||
146731224|NCT00771810|529185977|FG000|Overall Study|Lost to Follow-up|0|||
146731225|NCT00771810|529185978|FG001|Overall Study|Lost to Follow-up|0|||
146731226|NCT00771810|529185979|FG002|Overall Study|Lost to Follow-up|1|||
146731227|NCT00771810|529185977|FG000|Overall Study|Physician Decision|1|||
146731228|NCT00771810|529185978|FG001|Overall Study|Physician Decision|2|||
146731229|NCT00771810|529185979|FG002|Overall Study|Physician Decision|2|||
146731230|NCT00771810|529185977|FG000|Overall Study|Protocol Violation|0|||
146731231|NCT00771810|529185978|FG001|Overall Study|Protocol Violation|1|||
146731232|NCT00771810|529185979|FG002|Overall Study|Protocol Violation|1|||
146731233|NCT00771810|529185977|FG000|Overall Study|Withdrawal by Subject|1|||
146731234|NCT00771810|529185978|FG001|Overall Study|Withdrawal by Subject|2|||
146731235|NCT00771810|529185979|FG002|Overall Study|Withdrawal by Subject|0|||
146731236|NCT00771810|529185977|FG000|Overall Study|Other|0|||
146731237|NCT00771810|529185978|FG001|Overall Study|Other|0|||
146731238|NCT00771810|529185979|FG002|Overall Study|Other|1|||
146731239|NCT04751942|529185985|FG000|Overall Study|Lost to Follow-up|9|||
146731240|NCT04751942|529185986|FG001|Overall Study|Lost to Follow-up|6|||
146731241|NCT00724152|529185990|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
146731242|NCT00724152|529185991|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
146731243|NCT00724152|529185992|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
146731244|NCT00724152|529185990|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
146731245|NCT00724152|529185991|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
146731246|NCT00724152|529185992|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
146731247|NCT03266770|529185993|FG000|Overall Study|Physician Decision|3|||
146731248|NCT03266770|529185993|FG000|Overall Study|Insufficient study supplies|1|||
146731249|NCT03266770|529185993|FG000|Overall Study|Adverse Event|1|||
146731250|NCT02657031|529185997|FG000|Overall Study|Adverse Event|1|||
146731251|NCT02657031|529185998|FG001|Overall Study|Adverse Event|2|||
146731252|NCT03078816|529185999|FG000|Overall Study|Withdrawal by Subject|1|||
146731253|NCT02114151|529186000|FG000|Overall Study|Death|1|||
146731254|NCT02114151|529186000|FG000|Overall Study|Lost to Follow-up|1|||
146731255|NCT02114151|529186000|FG000|Overall Study|Withdrawal by Subject|5|||
146731256|NCT02638948|529186003|FG000|Overall Study|Withdrawal by Subject|4|||
146731257|NCT02638948|529186004|FG001|Overall Study|Withdrawal by Subject|5|||
146731258|NCT02638948|529186005|FG002|Overall Study|Withdrawal by Subject|3|||
146731259|NCT02638948|529186006|FG003|Overall Study|Withdrawal by Subject|1|||
146731260|NCT02638948|529186003|FG000|Overall Study|Administrative Reason by Sponsor|0|||
146731261|NCT02638948|529186004|FG001|Overall Study|Administrative Reason by Sponsor|1|||
146731262|NCT02638948|529186005|FG002|Overall Study|Administrative Reason by Sponsor|0|||
146731263|NCT02638948|529186006|FG003|Overall Study|Administrative Reason by Sponsor|4|||
146731264|NCT02638948|529186003|FG000|Overall Study|Adverse Event|0|||
146731265|NCT02638948|529186004|FG001|Overall Study|Adverse Event|0|||
146731266|NCT02638948|529186005|FG002|Overall Study|Adverse Event|1|||
146731267|NCT02638948|529186006|FG003|Overall Study|Adverse Event|1|||
146731268|NCT02638948|529186003|FG000|Overall Study|Lack of Efficacy|1|||
146731269|NCT02638948|529186004|FG001|Overall Study|Lack of Efficacy|1|||
146731270|NCT02638948|529186005|FG002|Overall Study|Lack of Efficacy|0|||
146731271|NCT02638948|529186006|FG003|Overall Study|Lack of Efficacy|0|||
146731272|NCT02638948|529186003|FG000|Overall Study|Lost to Follow-up|0|||
146731273|NCT02638948|529186004|FG001|Overall Study|Lost to Follow-up|0|||
146731274|NCT02638948|529186005|FG002|Overall Study|Lost to Follow-up|1|||
146731275|NCT02638948|529186006|FG003|Overall Study|Lost to Follow-up|1|||
146731276|NCT02638948|529186003|FG000|Overall Study|Poor/Non-Compliance|0|||
146731277|NCT02638948|529186004|FG001|Overall Study|Poor/Non-Compliance|2|||
146731278|NCT02638948|529186005|FG002|Overall Study|Poor/Non-Compliance|1|||
146731279|NCT02638948|529186006|FG003|Overall Study|Poor/Non-Compliance|0|||
146731280|NCT02638948|529186003|FG000|Overall Study|Participant no longer met study criteria|0|||
146731281|NCT02638948|529186004|FG001|Overall Study|Participant no longer met study criteria|1|||
146731282|NCT02638948|529186005|FG002|Overall Study|Participant no longer met study criteria|0|||
146731283|NCT02638948|529186006|FG003|Overall Study|Participant no longer met study criteria|0|||
146731284|NCT02638948|529186003|FG000|Overall Study|Other than specified above|4|||
146731285|NCT02638948|529186004|FG001|Overall Study|Other than specified above|1|||
146731286|NCT02638948|529186005|FG002|Overall Study|Other than specified above|1|||
146731287|NCT02638948|529186006|FG003|Overall Study|Other than specified above|1|||
146731288|NCT01218126|529186011|FG000|Overall Study|Adverse Event|8|||
146731289|NCT01218126|529186012|FG001|Overall Study|Adverse Event|10|||
146731290|NCT01218126|529186013|FG002|Overall Study|Adverse Event|12|||
146731291|NCT01218126|529186014|FG003|Overall Study|Adverse Event|16|||
146731292|NCT01218126|529186011|FG000|Overall Study|Lack of Efficacy|7|||
146731293|NCT01218126|529186012|FG001|Overall Study|Lack of Efficacy|2|||
146731294|NCT01218126|529186013|FG002|Overall Study|Lack of Efficacy|2|||
146731295|NCT01218126|529186014|FG003|Overall Study|Lack of Efficacy|6|||
146789227|NCT02268253|529399756|FG002|Stage 3A|Study Terminated by Sponsor|2|||
146789228|NCT02268253|529399757|FG003|Stage 3A|Study Terminated by Sponsor|0|||
146789229|NCT02268253|529399758|FG004|Stage 3A|Study Terminated by Sponsor|0|||
146789230|NCT02268253|529399759|FG005|Stage 3A|Study Terminated by Sponsor|0|||
146789231|NCT02268253|529399760|FG006|Stage 3A|Study Terminated by Sponsor|0|||
146789232|NCT02268253|529399754|FG000|Stage 3A|Lost to Follow-up|0|||
146789233|NCT02268253|529399755|FG001|Stage 3A|Lost to Follow-up|0|||
146789234|NCT02268253|529399756|FG002|Stage 3A|Lost to Follow-up|1|||
146789235|NCT02268253|529399757|FG003|Stage 3A|Lost to Follow-up|0|||
146789236|NCT02268253|529399758|FG004|Stage 3A|Lost to Follow-up|0|||
146789237|NCT02268253|529399759|FG005|Stage 3A|Lost to Follow-up|0|||
146789238|NCT02268253|529399760|FG006|Stage 3A|Lost to Follow-up|0|||
146789239|NCT02268253|529399754|FG000|Stage 3A|Death|0|||
146789240|NCT02268253|529399755|FG001|Stage 3A|Death|0|||
146789241|NCT02268253|529399756|FG002|Stage 3A|Death|5|||
146789242|NCT02268253|529399757|FG003|Stage 3A|Death|0|||
146789243|NCT02268253|529399758|FG004|Stage 3A|Death|0|||
146789244|NCT02268253|529399759|FG005|Stage 3A|Death|0|||
146789245|NCT02268253|529399760|FG006|Stage 3A|Death|0|||
146789246|NCT05714761|529399761|FG000|Overall Study|Lost to Follow-up|3|||
146789247|NCT05714761|529399761|FG000|Overall Study|Withdrawal by Subject|3|||
146789248|NCT05714761|529399761|FG000|Overall Study|unblinding of sensor data|1|||
146789249|NCT05714761|529399761|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
146789250|NCT05714761|529399761|FG000|Overall Study|did not return second CGM sensor|4|||
146789251|NCT02146378|529399763|FG000|Overall Study|No information of administration|2|||
146789252|NCT03603600|529399772|FG000|Overall Study|Withdrawal by Subject|5|||
146789253|NCT03603600|529399773|FG001|Overall Study|Withdrawal by Subject|7|||
146789254|NCT03603600|529399772|FG000|Overall Study|Lost to Follow-up|2|||
146789255|NCT03603600|529399773|FG001|Overall Study|Lost to Follow-up|3|||
146789256|NCT03603600|529399772|FG000|Overall Study|Death|3|||
146789257|NCT03603600|529399773|FG001|Overall Study|Death|1|||
146789258|NCT03603600|529399772|FG000|Overall Study|Physician Decision|2|||
146789259|NCT03603600|529399773|FG001|Overall Study|Physician Decision|1|||
146789260|NCT03603600|529399772|FG000|Overall Study|Other reason|1|||
146789261|NCT03603600|529399773|FG001|Overall Study|Other reason|0|||
146789262|NCT04973254|529399774|FG000|Overall Study|Not adherent|0|||
146789263|NCT04973254|529399775|FG001|Overall Study|Not adherent|1|||
146789264|NCT04973254|529399776|FG002|Overall Study|Not adherent|0|||
146789265|NCT05089019|529399777|FG000|Period 1|Withdrawal by Subject|0|||
146789266|NCT05089019|529399778|FG001|Period 1|Withdrawal by Subject|1|||
146789267|NCT05089019|529399777|FG000|Washout Period|Adverse Event|3|||
146789268|NCT05089019|529399778|FG001|Washout Period|Adverse Event|4|||
146789269|NCT05089019|529399777|FG000|Washout Period|Lost to Follow-up|1|||
146789270|NCT05089019|529399778|FG001|Washout Period|Lost to Follow-up|0|||
146789271|NCT05089019|529399777|FG000|Washout Period|Physician Decision|2|||
146789272|NCT05089019|529399778|FG001|Washout Period|Physician Decision|0|||
146789273|NCT05089019|529399777|FG000|Washout Period|Withdrawal by Subject|6|||
146789274|NCT05089019|529399778|FG001|Washout Period|Withdrawal by Subject|3|||
146789275|NCT05089019|529399777|FG000|Period 2|Adverse Event|4|||
146789276|NCT05089019|529399778|FG001|Period 2|Adverse Event|2|||
146789277|NCT05089019|529399777|FG000|Period 2|Lost to Follow-up|1|||
146789278|NCT05089019|529399778|FG001|Period 2|Lost to Follow-up|0|||
146789279|NCT05089019|529399777|FG000|Period 2|Withdrawal by Subject|0|||
146789280|NCT05089019|529399778|FG001|Period 2|Withdrawal by Subject|1|||
146789281|NCT01943409|529399784|FG000|Overall Study|resumed oral/entral|24|||
146789282|NCT01943409|529399785|FG001|Overall Study|resumed oral/entral|20|||
146789283|NCT01943409|529399784|FG000|Overall Study|Protocol Violation|14|||
146789284|NCT01943409|529399785|FG001|Overall Study|Protocol Violation|24|||
146789285|NCT01943409|529399784|FG000|Overall Study|Death|3|||
146789286|NCT01943409|529399785|FG001|Overall Study|Death|1|||
146789287|NCT01943409|529399784|FG000|Overall Study|Withdrawal by Subject|4|||
146937856|NCT03706040|529930712|FG003|Period B (Week 16 to Week 52)|Other|4|||
146789288|NCT01943409|529399785|FG001|Overall Study|Withdrawal by Subject|3|||
146789289|NCT04542317|529399786|FG000|Overall Study|Care recipients passed away|18|||
146789290|NCT04542317|529399787|FG001|Overall Study|Care recipients passed away|13|||
146937857|NCT03706040|529930713|FG004|Period B (Week 16 to Week 52)|Other|5|||
146789291|NCT04542317|529399786|FG000|Overall Study|No longer a primary caregiver|5|||
146937858|NCT03706040|529930714|FG005|Period B (Week 16 to Week 52)|Other|23|||
146937859|NCT03706040|529930715|FG006|Period B (Week 16 to Week 52)|Other|17|||
146937860|NCT00927758|529930716|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
146789292|NCT04542317|529399787|FG001|Overall Study|No longer a primary caregiver|1|||
146789293|NCT04542317|529399786|FG000|Overall Study|Withdrawal by Subject|4|||
146937861|NCT00927758|529930717|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
146981924|NCT01620983|530096168|FG001|Overall Study|Lost to Follow-up|4|||
146789294|NCT04542317|529399787|FG001|Overall Study|Withdrawal by Subject|2|||
146789295|NCT04542317|529399786|FG000|Overall Study|Caregivers passed away|0|||
146789296|NCT04542317|529399787|FG001|Overall Study|Caregivers passed away|2|||
146789297|NCT03496168|529399792|FG000|Overall Study|Other Reasons|1|||
146789298|NCT03496168|529399792|FG000|Overall Study|Adverse Event|1|||
146789299|NCT05543629|529399795|FG000|Overall Study|Death|1|||
146937862|NCT00927758|529930718|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
146937863|NCT00927758|529930719|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
146937864|NCT00927758|529930720|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
146937865|NCT00927758|529930721|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
146937866|NCT00927758|529930716|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
146937867|NCT00927758|529930717|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
146937868|NCT00927758|529930718|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
146937869|NCT00927758|529930719|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
146937870|NCT00927758|529930720|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
146937871|NCT00927758|529930721|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
146937872|NCT00439725|529930723|FG000|Treatment Period|Withdrawal by Subject|22|||
146937873|NCT00439725|529930724|FG001|Treatment Period|Withdrawal by Subject|19|||
146937874|NCT00439725|529930723|FG000|Treatment Period|Study terminated by sponsor|156|||
146731296|NCT01218126|529186011|FG000|Overall Study|Protocol Violation|5|||
146731297|NCT01218126|529186012|FG001|Overall Study|Protocol Violation|2|||
146731298|NCT01218126|529186013|FG002|Overall Study|Protocol Violation|2|||
146731299|NCT01218126|529186014|FG003|Overall Study|Protocol Violation|3|||
146731300|NCT01218126|529186011|FG000|Overall Study|Protocol-defined stopping criteria|1|||
146731301|NCT01218126|529186012|FG001|Overall Study|Protocol-defined stopping criteria|1|||
146731302|NCT01218126|529186013|FG002|Overall Study|Protocol-defined stopping criteria|0|||
146731303|NCT01218126|529186014|FG003|Overall Study|Protocol-defined stopping criteria|0|||
146731304|NCT01218126|529186011|FG000|Overall Study|Lost to Follow-up|0|||
146731305|NCT01218126|529186012|FG001|Overall Study|Lost to Follow-up|0|||
146731306|NCT01218126|529186013|FG002|Overall Study|Lost to Follow-up|0|||
146731307|NCT01218126|529186014|FG003|Overall Study|Lost to Follow-up|2|||
146731308|NCT01218126|529186011|FG000|Overall Study|Physician Decision|1|||
146731309|NCT01218126|529186012|FG001|Overall Study|Physician Decision|2|||
146731310|NCT01218126|529186013|FG002|Overall Study|Physician Decision|4|||
146731311|NCT01218126|529186014|FG003|Overall Study|Physician Decision|2|||
146731312|NCT01218126|529186011|FG000|Overall Study|Withdrawal by Subject|2|||
146731313|NCT01218126|529186012|FG001|Overall Study|Withdrawal by Subject|5|||
146731314|NCT01218126|529186013|FG002|Overall Study|Withdrawal by Subject|4|||
146731315|NCT01218126|529186014|FG003|Overall Study|Withdrawal by Subject|6|||
146731316|NCT01860703|529186017|FG000|Overall Study|Adverse Event|1|||
146731317|NCT01860703|529186018|FG001|Overall Study|Adverse Event|4|||
146731318|NCT01860703|529186019|FG002|Overall Study|Adverse Event|0|||
146731319|NCT01860703|529186020|FG003|Overall Study|Adverse Event|2|||
146731320|NCT01860703|529186017|FG000|Overall Study|Withdrawal by Subject|0|||
146731321|NCT01860703|529186018|FG001|Overall Study|Withdrawal by Subject|1|||
146731322|NCT01860703|529186019|FG002|Overall Study|Withdrawal by Subject|0|||
146731323|NCT01860703|529186020|FG003|Overall Study|Withdrawal by Subject|0|||
146731324|NCT01860703|529186017|FG000|Overall Study|Personal reason|1|||
146731325|NCT01860703|529186018|FG001|Overall Study|Personal reason|0|||
146731326|NCT01860703|529186019|FG002|Overall Study|Personal reason|1|||
146731327|NCT01860703|529186020|FG003|Overall Study|Personal reason|0|||
146731328|NCT00696410|529186022|FG000|Overall Study|Lost to Follow-up|2|||
146731329|NCT00696410|529186023|FG001|Overall Study|Lost to Follow-up|0|||
146731330|NCT00696410|529186022|FG000|Overall Study|Withdrawal by Subject|8|||
146731331|NCT00696410|529186023|FG001|Overall Study|Withdrawal by Subject|0|||
146731332|NCT00696410|529186022|FG000|Overall Study|Physician Decision|3|||
146731333|NCT00696410|529186023|FG001|Overall Study|Physician Decision|0|||
146731334|NCT03184792|529186027|FG000|Overall Study|Pandemic|2|||
146731335|NCT03184792|529186028|FG001|Overall Study|Pandemic|2|||
146731336|NCT02134587|529186030|FG000|Overall Study|Did not completed all meetings|30|||
146731337|NCT00657618|529186035|FG000|Overall Study|Adverse Event|32|||
146731338|NCT00657618|529186035|FG000|Overall Study|Withdrawal by Subject|8|||
146731339|NCT00657618|529186035|FG000|Overall Study|negative for leishmaniasis|2|||
146731340|NCT00657618|529186035|FG000|Overall Study|didn't start due to schedule conflicts|1|||
146731341|NCT05774197|529186036|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
146731342|NCT05073133|529186038|FG000|Overall Study|Death|2|||
146731343|NCT05002218|529186039|FG000|Overall Study|Lost to Follow-up|5|||
146731344|NCT05002218|529186040|FG001|Overall Study|Lost to Follow-up|6|||
146731345|NCT04120233|529186041|FG000|Overall Study|Adverse Event|0|||
146731346|NCT04120233|529186042|FG001|Overall Study|Adverse Event|0|||
146731347|NCT04120233|529186043|FG002|Overall Study|Adverse Event|0|||
146731348|NCT04120233|529186044|FG003|Overall Study|Adverse Event|0|||
146731349|NCT04120233|529186045|FG004|Overall Study|Adverse Event|1|||
146731350|NCT04120233|529186046|FG005|Overall Study|Adverse Event|0|||
146731351|NCT04981678|529186047|FG000|Overall Study|Lost to Follow-up|0|||
146731352|NCT04981678|529186048|FG001|Overall Study|Lost to Follow-up|1|||
146731353|NCT01345630|529187165|FG000|Overall Study|Adverse Event|22|||
146731354|NCT01345630|529187166|FG001|Overall Study|Adverse Event|23|||
146937875|NCT00439725|529930724|FG001|Treatment Period|Study terminated by sponsor|148|||
146981925|NCT01620983|530096169|FG002|Overall Study|Lost to Follow-up|9|||
146731355|NCT01345630|529187165|FG000|Overall Study|Lost to Follow-up|17|||
146731356|NCT01345630|529187166|FG001|Overall Study|Lost to Follow-up|16|||
146789300|NCT05543629|529399796|FG001|Overall Study|Death|0|||
146789301|NCT05543629|529399797|FG002|Overall Study|Death|1|||
146789302|NCT05543629|529399798|FG003|Overall Study|Death|0|||
146789303|NCT05543629|529399799|FG004|Overall Study|Death|0|||
146789304|NCT05543629|529399800|FG005|Overall Study|Death|1|||
146789305|NCT05543629|529399801|FG006|Overall Study|Death|2|||
146789306|NCT05543629|529399802|FG007|Overall Study|Death|2|||
146789307|NCT05543629|529399795|FG000|Overall Study|Other Reasons|0|||
146789308|NCT05543629|529399796|FG001|Overall Study|Other Reasons|0|||
146789309|NCT05543629|529399797|FG002|Overall Study|Other Reasons|0|||
146789310|NCT05543629|529399798|FG003|Overall Study|Other Reasons|0|||
146789311|NCT05543629|529399799|FG004|Overall Study|Other Reasons|1|||
146789312|NCT05543629|529399800|FG005|Overall Study|Other Reasons|0|||
146789313|NCT05543629|529399801|FG006|Overall Study|Other Reasons|0|||
146789314|NCT05543629|529399802|FG007|Overall Study|Other Reasons|0|||
146789315|NCT05543629|529399795|FG000|Overall Study|Physician Decision|0|||
146789316|NCT05543629|529399796|FG001|Overall Study|Physician Decision|0|||
146789317|NCT05543629|529399797|FG002|Overall Study|Physician Decision|3|||
146789318|NCT05543629|529399798|FG003|Overall Study|Physician Decision|0|||
146789319|NCT05543629|529399799|FG004|Overall Study|Physician Decision|0|||
146789320|NCT05543629|529399800|FG005|Overall Study|Physician Decision|0|||
146789321|NCT05543629|529399801|FG006|Overall Study|Physician Decision|1|||
146789322|NCT05543629|529399802|FG007|Overall Study|Physician Decision|0|||
146789323|NCT05543629|529399795|FG000|Overall Study|Study terminated by Sponsor|1|||
146789324|NCT05543629|529399796|FG001|Overall Study|Study terminated by Sponsor|0|||
146789325|NCT05543629|529399797|FG002|Overall Study|Study terminated by Sponsor|0|||
146789326|NCT05543629|529399798|FG003|Overall Study|Study terminated by Sponsor|1|||
146789327|NCT05543629|529399799|FG004|Overall Study|Study terminated by Sponsor|0|||
146789328|NCT05543629|529399800|FG005|Overall Study|Study terminated by Sponsor|4|||
146789329|NCT05543629|529399801|FG006|Overall Study|Study terminated by Sponsor|1|||
146789330|NCT05543629|529399802|FG007|Overall Study|Study terminated by Sponsor|0|||
146789331|NCT05543629|529399795|FG000|Overall Study|Withdrawal by Subject|1|||
146789332|NCT05543629|529399796|FG001|Overall Study|Withdrawal by Subject|1|||
146789333|NCT05543629|529399797|FG002|Overall Study|Withdrawal by Subject|0|||
146789334|NCT05543629|529399798|FG003|Overall Study|Withdrawal by Subject|2|||
146789335|NCT05543629|529399799|FG004|Overall Study|Withdrawal by Subject|1|||
146789336|NCT05543629|529399800|FG005|Overall Study|Withdrawal by Subject|1|||
146789337|NCT05543629|529399801|FG006|Overall Study|Withdrawal by Subject|1|||
146789338|NCT05543629|529399802|FG007|Overall Study|Withdrawal by Subject|1|||
146789339|NCT05543629|529399795|FG000|Overall Study|Not Reported|2|||
146789340|NCT05543629|529399796|FG001|Overall Study|Not Reported|2|||
146789341|NCT05543629|529399797|FG002|Overall Study|Not Reported|0|||
146789342|NCT05543629|529399798|FG003|Overall Study|Not Reported|0|||
146789343|NCT05543629|529399799|FG004|Overall Study|Not Reported|1|||
146789344|NCT05543629|529399800|FG005|Overall Study|Not Reported|1|||
146789345|NCT05543629|529399801|FG006|Overall Study|Not Reported|3|||
146789346|NCT05543629|529399802|FG007|Overall Study|Not Reported|0|||
146789347|NCT03313076|529399803|FG000|Overall Study|Withdrawal by Subject|2|||
146789348|NCT03313076|529399804|FG001|Overall Study|Withdrawal by Subject|0|||
146789349|NCT03313076|529399805|FG002|Overall Study|Withdrawal by Subject|0|||
146789350|NCT03313076|529399806|FG003|Overall Study|Withdrawal by Subject|0|||
146789351|NCT03313076|529399803|FG000|Overall Study|Lost to Follow-up|0|||
146789352|NCT03313076|529399804|FG001|Overall Study|Lost to Follow-up|2|||
146789353|NCT03313076|529399805|FG002|Overall Study|Lost to Follow-up|2|||
146789354|NCT03313076|529399806|FG003|Overall Study|Lost to Follow-up|2|||
146789355|NCT05869383|529399807|FG000|Overall Study|Withdrawal by Subject|2|||
146789356|NCT05869383|529399808|FG001|Overall Study|Withdrawal by Subject|0|||
146789357|NCT04948697|529399822|FG000|Overall Study|Progressive disease|27|||
146789358|NCT04948697|529399823|FG001|Overall Study|Progressive disease|18|||
146789359|NCT04948697|529399822|FG000|Overall Study|Adverse Event|14|||
146789360|NCT04948697|529399823|FG001|Overall Study|Adverse Event|4|||
146731357|NCT01345630|529187165|FG000|Overall Study|Protocol Violation|4|||
146731358|NCT01345630|529187166|FG001|Overall Study|Protocol Violation|1|||
146731359|NCT01345630|529187165|FG000|Overall Study|Medication error without associated AE|0|||
146731360|NCT01345630|529187166|FG001|Overall Study|Medication error without associated AE|1|||
146731361|NCT01345630|529187165|FG000|Overall Study|Study terminated by sponsor|254|||
146731362|NCT01345630|529187166|FG001|Overall Study|Study terminated by sponsor|285|||
146731363|NCT01345630|529187165|FG000|Overall Study|Other reasons|6|||
146731364|NCT01345630|529187166|FG001|Overall Study|Other reasons|8|||
146731365|NCT01345630|529187165|FG000|Overall Study|Withdrawn due to pregnancy|1|||
146731366|NCT01345630|529187166|FG001|Overall Study|Withdrawn due to pregnancy|2|||
146731367|NCT01345630|529187165|FG000|Overall Study|No longer willing to participate|9|||
146789361|NCT04948697|529399822|FG000|Overall Study|Participant moved to long term extension study|7|||
146789362|NCT04948697|529399823|FG001|Overall Study|Participant moved to long term extension study|4|||
146789363|NCT04948697|529399822|FG000|Overall Study|Withdrawal by Subject|10|||
146789364|NCT04948697|529399823|FG001|Overall Study|Withdrawal by Subject|0|||
146789365|NCT04948697|529399822|FG000|Overall Study|Closed by Sponsor|3|||
146789366|NCT04948697|529399823|FG001|Overall Study|Closed by Sponsor|2|||
146789367|NCT04948697|529399822|FG000|Overall Study|Physician Decision|0|||
146789368|NCT04948697|529399823|FG001|Overall Study|Physician Decision|2|||
146789369|NCT04948697|529399822|FG000|Overall Study|Lost to Follow-up|0|||
146789370|NCT04948697|529399823|FG001|Overall Study|Lost to Follow-up|1|||
146789371|NCT04948697|529399822|FG000|Overall Study|Other-Miscellaneous|1|||
146789372|NCT04948697|529399823|FG001|Overall Study|Other-Miscellaneous|0|||
146789373|NCT04948697|529399822|FG000|Overall Study|Randomized but not treated|0|||
146789374|NCT04948697|529399823|FG001|Overall Study|Randomized but not treated|1|||
146789375|NCT04599062|529399825|FG000|Overall Study|Physician Decision|1|||
146789376|NCT04599062|529399826|FG001|Overall Study|Physician Decision|0|||
146789377|NCT01175356|529399829|FG000|Overall Study|Death|1|||
146789378|NCT01175356|529399829|FG000|Overall Study|Lack of Efficacy|12|||
146789379|NCT01175356|529399829|FG000|Overall Study|Lost to Follow-up|1|||
146789380|NCT01175356|529399829|FG000|Overall Study|Physician Decision|23|||
146789381|NCT01175356|529399829|FG000|Overall Study|Ineligible|1|||
146789382|NCT01175356|529399829|FG000|Overall Study|Treatment Slot Not Available|18|||
146789383|NCT01175356|529399829|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
146789384|NCT01175356|529399829|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
146789385|NCT01175356|529399829|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
146789386|NCT01175356|529399829|FG000|Overall Study|Inadequate stem cell for transplant|1|||
146789387|NCT01175356|529399829|FG000|Overall Study|Initiation other tx prior to completion|9|||
146789388|NCT03852472|529399830|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
146789389|NCT03852472|529399831|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
146789390|NCT03852472|529399832|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
146789391|NCT03852472|529399833|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
146789392|NCT03852472|529399834|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
146789393|NCT03852472|529399830|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
146789394|NCT03852472|529399831|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
146789395|NCT03852472|529399832|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
146789396|NCT03852472|529399833|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
146789397|NCT03852472|529399834|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
146789398|NCT03852472|529399830|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
146789399|NCT03852472|529399831|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
146789400|NCT03852472|529399832|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
146789401|NCT03852472|529399833|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
146789402|NCT03852472|529399834|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
146789403|NCT03852472|529399830|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
146789404|NCT03852472|529399831|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
146789405|NCT03852472|529399832|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
146789406|NCT03852472|529399833|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
146789407|NCT03852472|529399834|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
146789408|NCT03852472|529399830|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
146789409|NCT03852472|529399831|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
146789410|NCT03852472|529399832|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
146789411|NCT03852472|529399833|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
146789412|NCT03852472|529399834|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
146789413|NCT03852472|529399830|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
146789414|NCT03852472|529399831|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
146789415|NCT03852472|529399832|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
146789416|NCT03852472|529399833|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
146789417|NCT03852472|529399834|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
146789418|NCT03852472|529399830|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
146789419|NCT03852472|529399831|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
146789420|NCT03852472|529399832|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
146789421|NCT03852472|529399833|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
146789422|NCT03852472|529399834|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
146789423|NCT03852472|529399830|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
146789424|NCT03852472|529399831|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
146789425|NCT03852472|529399832|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
146789426|NCT03852472|529399833|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
146789427|NCT03852472|529399834|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
146789428|NCT03852472|529399830|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
146789429|NCT03852472|529399831|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
146789430|NCT03852472|529399832|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
146789431|NCT03852472|529399833|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
146789432|NCT03852472|529399834|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
146789433|NCT03852472|529399830|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
146789434|NCT03852472|529399831|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
146789435|NCT03852472|529399832|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
146981926|NCT01620983|530096167|FG000|Overall Study|Withdrawal by Subject|6|||
146937876|NCT00439725|529930723|FG000|Treatment Period|Site closed by investigator|1|||
146937877|NCT00439725|529930724|FG001|Treatment Period|Site closed by investigator|2|||
146937878|NCT00439725|529930723|FG000|Treatment Period|Adverse Event|39|||
146937879|NCT00439725|529930724|FG001|Treatment Period|Adverse Event|18|||
146937880|NCT00439725|529930723|FG000|Treatment Period|Physician Decision|1|||
146937881|NCT00439725|529930724|FG001|Treatment Period|Physician Decision|1|||
146937882|NCT00439725|529930723|FG000|Treatment Period|Protocol Violation|2|||
146937883|NCT00439725|529930724|FG001|Treatment Period|Protocol Violation|1|||
146937884|NCT00439725|529930723|FG000|Treatment Period|Clinical endpoint reached|6|||
146937885|NCT00439725|529930724|FG001|Treatment Period|Clinical endpoint reached|50|||
146731368|NCT01345630|529187166|FG001|Overall Study|No longer willing to participate|12|||
146731369|NCT01345630|529187165|FG000|Overall Study|Insufficient clinical response|48|||
146731370|NCT01345630|529187166|FG001|Overall Study|Insufficient clinical response|11|||
146731371|NCT01289418|529187167|FG000|Day 8 Survey|email address invalid|283|||
146731372|NCT01289418|529187167|FG000|Day 8 Survey|participants did not complete the survey|1935|||
146731373|NCT01289418|529187167|FG000|Day 29 Survey|email address invalid|283|||
146731374|NCT01289418|529187167|FG000|Day 29 Survey|participants did not complete the survey|2185|||
146731375|NCT01352585|529187169|FG000|Overall Study|Adverse Event|2|||
146731376|NCT01352585|529187170|FG001|Overall Study|Adverse Event|1|||
146731377|NCT01352585|529187169|FG000|Overall Study|Lost to Follow-up|1|||
146731378|NCT01352585|529187170|FG001|Overall Study|Lost to Follow-up|0|||
146731379|NCT01352585|529187169|FG000|Overall Study|Other|5|||
146731380|NCT01352585|529187170|FG001|Overall Study|Other|2|||
146731381|NCT02459262|529187190|FG000|Overall Study|Withdrawal by Subject|0|||
146731382|NCT02459262|529187191|FG001|Overall Study|Withdrawal by Subject|0|||
146731383|NCT02459262|529187192|FG002|Overall Study|Withdrawal by Subject|0|||
146731384|NCT02459262|529187193|FG003|Overall Study|Withdrawal by Subject|0|||
146731385|NCT02459262|529187194|FG004|Overall Study|Withdrawal by Subject|0|||
146731386|NCT02459262|529187195|FG005|Overall Study|Withdrawal by Subject|0|||
146731387|NCT02459262|529187196|FG006|Overall Study|Withdrawal by Subject|0|||
146731388|NCT02459262|529187197|FG007|Overall Study|Withdrawal by Subject|0|||
146731389|NCT02459262|529187198|FG008|Overall Study|Withdrawal by Subject|0|||
146731390|NCT02459262|529187199|FG009|Overall Study|Withdrawal by Subject|1|||
146731391|NCT02459262|529187200|FG010|Overall Study|Withdrawal by Subject|0|||
146731392|NCT00549757|529187207|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
146731393|NCT00549757|529187208|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
146731394|NCT00549757|529187207|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
146731395|NCT00549757|529187208|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
146731396|NCT00549757|529187207|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
146731397|NCT00549757|529187208|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
146731398|NCT00549757|529187207|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
146731399|NCT00549757|529187208|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
146731400|NCT00549757|529187207|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
146731401|NCT00549757|529187208|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
146731402|NCT00549757|529187207|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
146731403|NCT00549757|529187208|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
146731404|NCT00549757|529187207|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
146731405|NCT00549757|529187208|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
146731406|NCT00549757|529187207|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
146731407|NCT00549757|529187208|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
146731408|NCT00549757|529187207|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
146731409|NCT00549757|529187208|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
146731410|NCT00549757|529187207|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
146731411|NCT00549757|529187208|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
146731412|NCT00549757|529187207|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
146731413|NCT00549757|529187208|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
146731414|NCT00549757|529187207|FG000|Extension Period (in Average 9 Months)|Death|143|||
146731415|NCT00549757|529187208|FG001|Extension Period (in Average 9 Months)|Death|136|||
146731416|NCT00549757|529187207|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
146731417|NCT00549757|529187208|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
146731418|NCT00549757|529187207|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
146731419|NCT00549757|529187208|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
146731420|NCT00549757|529187207|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
146731421|NCT00549757|529187208|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
146731422|NCT01814748|529187211|FG000|Overall Study|Lost to Follow-up|1|||
146731423|NCT01814748|529187212|FG001|Overall Study|Lost to Follow-up|2|||
146731424|NCT01814748|529187211|FG000|Overall Study|Study site terminated by sponsor|1|||
146937886|NCT00439725|529930723|FG000|Treatment Period|Technical problems|1|||
146937887|NCT00439725|529930724|FG001|Treatment Period|Technical problems|0|||
146731425|NCT01814748|529187212|FG001|Overall Study|Study site terminated by sponsor|1|||
146937888|NCT00439725|529930723|FG000|Treatment Period|Lost to Follow-up|1|||
146937889|NCT00439725|529930724|FG001|Treatment Period|Lost to Follow-up|1|||
146937890|NCT00439725|529930723|FG000|Treatment Period|Participant convenience|1|||
146937891|NCT00439725|529930724|FG001|Treatment Period|Participant convenience|0|||
146937892|NCT00439725|529930723|FG000|Treatment Period|Protocol driven decision point|1|||
146937893|NCT00439725|529930724|FG001|Treatment Period|Protocol driven decision point|1|||
146937894|NCT00439725|529930723|FG000|Treatment Period|Death|1|||
146937895|NCT00439725|529930724|FG001|Treatment Period|Death|1|||
146937896|NCT00439725|529930723|FG000|Treatment Period|Participant did not receive treatment|4|||
146937897|NCT00439725|529930724|FG001|Treatment Period|Participant did not receive treatment|4|||
146937898|NCT00439725|529930723|FG000|Observational Period|Withdrawal by Subject|2|||
146937899|NCT00439725|529930724|FG001|Observational Period|Withdrawal by Subject|2|||
146937900|NCT00439725|529930723|FG000|Observational Period|Lost to Follow-up|0|||
146937901|NCT00439725|529930724|FG001|Observational Period|Lost to Follow-up|1|||
146937902|NCT00439725|529930723|FG000|Observational Period|Death|0|||
146937903|NCT00439725|529930724|FG001|Observational Period|Death|2|||
146937904|NCT00439725|529930723|FG000|Observational Period|Study termination by sponsor|1|||
146937905|NCT00439725|529930724|FG001|Observational Period|Study termination by sponsor|1|||
146937906|NCT00439725|529930723|FG000|Observational Period|Clinical endpoint reached|3|||
146937907|NCT00439725|529930724|FG001|Observational Period|Clinical endpoint reached|1|||
146937908|NCT00439725|529930723|FG000|Observational Period|Technical problems|1|||
146937909|NCT00439725|529930724|FG001|Observational Period|Technical problems|0|||
146937910|NCT00439725|529930723|FG000|Observational Period|Participant convenience|1|||
146937911|NCT00439725|529930724|FG001|Observational Period|Participant convenience|0|||
146937912|NCT03077243|529930725|FG000|Overall Study|Death|1|||
146937913|NCT03077243|529930726|FG001|Overall Study|Death|2|||
146937914|NCT03077243|529930727|FG002|Overall Study|Death|0|||
146937915|NCT03077243|529930728|FG003|Overall Study|Death|0|||
146937916|NCT03077243|529930725|FG000|Overall Study|Withdrawal by Subject|1|||
146937917|NCT03077243|529930726|FG001|Overall Study|Withdrawal by Subject|3|||
146937918|NCT03077243|529930727|FG002|Overall Study|Withdrawal by Subject|0|||
146937919|NCT03077243|529930728|FG003|Overall Study|Withdrawal by Subject|0|||
146937920|NCT03077243|529930725|FG000|Overall Study|Physician Decision|1|||
146937921|NCT03077243|529930726|FG001|Overall Study|Physician Decision|0|||
146937922|NCT03077243|529930727|FG002|Overall Study|Physician Decision|0|||
146937923|NCT03077243|529930728|FG003|Overall Study|Physician Decision|0|||
146937924|NCT03077243|529930725|FG000|Overall Study|Research at two study sites terminated early|0|||
146937925|NCT03077243|529930726|FG001|Overall Study|Research at two study sites terminated early|0|||
146937926|NCT03077243|529930727|FG002|Overall Study|Research at two study sites terminated early|0|||
146937927|NCT03077243|529930728|FG003|Overall Study|Research at two study sites terminated early|69|||
146937928|NCT01544478|529930729|FG000|Overall Study|Adverse Event|1|||
146937929|NCT01544478|529930729|FG000|Overall Study|Death|1|||
146937930|NCT01544478|529930729|FG000|Overall Study|Lost to Follow-up|48|||
146937931|NCT01544478|529930729|FG000|Overall Study|Physician Decision|15|||
146731426|NCT01814748|529187211|FG000|Overall Study|Withdrawal by Subject|6|||
146731427|NCT01814748|529187212|FG001|Overall Study|Withdrawal by Subject|4|||
146731428|NCT00330174|529187214|FG000|Overall Study|Withdrawal by Subject|7|||
146731429|NCT00330174|529187215|FG001|Overall Study|Withdrawal by Subject|7|||
146731430|NCT00330174|529187214|FG000|Overall Study|Lost to Follow-up|4|||
146731431|NCT00330174|529187215|FG001|Overall Study|Lost to Follow-up|1|||
146731432|NCT00330174|529187214|FG000|Overall Study|Clinical deterioration|1|||
146731433|NCT00330174|529187215|FG001|Overall Study|Clinical deterioration|2|||
146731434|NCT00330174|529187214|FG000|Overall Study|Excessive missed visits|3|||
146731435|NCT00330174|529187215|FG001|Overall Study|Excessive missed visits|8|||
146731436|NCT00330174|529187214|FG000|Overall Study|Miscellaneous reasons|7|||
146731437|NCT00330174|529187215|FG001|Overall Study|Miscellaneous reasons|1|||
146731438|NCT02316769|529187218|FG000|Overall Study|Physician Decision|1|||
146731439|NCT02316769|529187219|FG001|Overall Study|Physician Decision|0|||
146731440|NCT02316769|529187218|FG000|Overall Study|Withdrawal by Subject|1|||
146731441|NCT02316769|529187219|FG001|Overall Study|Withdrawal by Subject|0|||
146731442|NCT00645164|529187223|FG000|Overall Study|Lost to Follow-up|2|||
146731443|NCT00645164|529187223|FG000|Overall Study|Withdrawal by Subject|4|||
146731444|NCT00645164|529187223|FG000|Overall Study|Protocol Violation|1|||
146731445|NCT00386022|529187236|FG000|Plus Estrogen|Lost to Follow-up|2|||
146731446|NCT00386022|529187237|FG001|Plus Estrogen|Lost to Follow-up|0|||
146731447|NCT00386022|529187236|FG000|Plus Estrogen|Adverse Event|0|||
146731448|NCT00386022|529187237|FG001|Plus Estrogen|Adverse Event|1|||
146937932|NCT01544478|529930729|FG000|Overall Study|Pregnancy|1|||
146937933|NCT01544478|529930729|FG000|Overall Study|Withdrawal by Subject|52|||
146937934|NCT03984812|529930731|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146731449|NCT02495025|529187242|FG000|Overall Study|Lost to Follow-up|21|||
146731450|NCT02495025|529187243|FG001|Overall Study|Lost to Follow-up|14|||
146731451|NCT02495025|529187242|FG000|Overall Study|Withdrawal by Subject|5|||
146731452|NCT02495025|529187243|FG001|Overall Study|Withdrawal by Subject|0|||
146731453|NCT00265889|529187244|FG000|Overall Study|Physician Decision|1|||
146937935|NCT03984812|529930732|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146789436|NCT03852472|529399833|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
146789437|NCT03852472|529399834|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
146937936|NCT03984812|529930733|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
146937937|NCT03984812|529930734|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146937938|NCT03984812|529930735|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146937939|NCT03984812|529930736|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146937940|NCT03984812|529930737|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146937941|NCT03984812|529930738|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146937942|NCT03984812|529930739|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146937943|NCT03984812|529930740|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146937944|NCT03984812|529930741|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146937945|NCT04038385|529930742|FG000|Overall Study|Completed baseline assessment only|7|||
146937946|NCT04038385|529930743|FG001|Overall Study|Completed baseline assessment only|4|||
146937947|NCT04038385|529930742|FG000|Overall Study|Moved out of area|4|||
146937948|NCT04038385|529930743|FG001|Overall Study|Moved out of area|2|||
146937949|NCT04038385|529930742|FG000|Overall Study|Discontinued study involvement|6|||
146937950|NCT04038385|529930743|FG001|Overall Study|Discontinued study involvement|1|||
146937951|NCT03170258|529930757|FG000|Overall Study|Physician Decision|4|||
146937952|NCT03170258|529930758|FG001|Overall Study|Physician Decision|0|||
146937953|NCT03170258|529930757|FG000|Overall Study|Equipment issues|1|||
146937954|NCT03170258|529930758|FG001|Overall Study|Equipment issues|0|||
146937955|NCT03170258|529930757|FG000|Overall Study|Medication|1|||
146937956|NCT03170258|529930758|FG001|Overall Study|Medication|0|||
146937957|NCT03170258|529930757|FG000|Overall Study|Sleep issues|1|||
146937958|NCT03170258|529930758|FG001|Overall Study|Sleep issues|0|||
146937959|NCT01563107|529930759|FG000|Overall Study|Physician Decision|0|||
146937960|NCT01563107|529930760|FG001|Overall Study|Physician Decision|1|||
146937961|NCT01563107|529930761|FG002|Overall Study|Physician Decision|1|||
146937962|NCT01563107|529930762|FG003|Overall Study|Physician Decision|3|||
146937963|NCT01563107|529930759|FG000|Overall Study|Withdrawal by Subject|1|||
146937964|NCT01563107|529930760|FG001|Overall Study|Withdrawal by Subject|2|||
146937965|NCT01563107|529930761|FG002|Overall Study|Withdrawal by Subject|1|||
146937966|NCT01563107|529930762|FG003|Overall Study|Withdrawal by Subject|2|||
146937967|NCT02707601|529930763|FG000|Overall Study|Death|0|||
146937968|NCT02707601|529930764|FG001|Overall Study|Death|1|||
146937969|NCT02707601|529930763|FG000|Overall Study|Lack of Efficacy|0|||
146937970|NCT02707601|529930764|FG001|Overall Study|Lack of Efficacy|1|||
146937971|NCT02707601|529930763|FG000|Overall Study|Investigator's Discretion|1|||
146937972|NCT02707601|529930764|FG001|Overall Study|Investigator's Discretion|0|||
146937973|NCT02707601|529930763|FG000|Overall Study|Withdrew Consent|0|||
146937974|NCT02707601|529930764|FG001|Overall Study|Withdrew Consent|1|||
146937975|NCT02707601|529930763|FG000|Overall Study|Lost to Follow-up|1|||
146937976|NCT02707601|529930764|FG001|Overall Study|Lost to Follow-up|1|||
146789438|NCT03852472|529399830|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
146789439|NCT03852472|529399831|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
146789440|NCT03852472|529399832|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
146789441|NCT03852472|529399833|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
146789442|NCT03852472|529399834|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
146789443|NCT03852472|529399830|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
146789444|NCT03852472|529399831|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
146789445|NCT03852472|529399832|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
146789446|NCT03852472|529399833|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
146789447|NCT03852472|529399834|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
146789448|NCT03852472|529399830|FG000|Period 2 - Week 44|Adverse Event|0|||
146789449|NCT03852472|529399831|FG001|Period 2 - Week 44|Adverse Event|3|||
146789450|NCT03852472|529399832|FG002|Period 2 - Week 44|Adverse Event|1|||
146789451|NCT03852472|529399833|FG003|Period 2 - Week 44|Adverse Event|2|||
146937977|NCT02707601|529930763|FG000|Overall Study|Participants Randomized but Not Treated|2|||
146937978|NCT02707601|529930764|FG001|Overall Study|Participants Randomized but Not Treated|0|||
146937979|NCT03907969|529930766|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
146789452|NCT03852472|529399834|FG004|Period 2 - Week 44|Adverse Event|2|||
146789453|NCT03852472|529399830|FG000|Period 2 - Week 44|COVID-19 Related|0|||
146789454|NCT03852472|529399831|FG001|Period 2 - Week 44|COVID-19 Related|0|||
146789455|NCT03852472|529399832|FG002|Period 2 - Week 44|COVID-19 Related|0|||
146789456|NCT03852472|529399833|FG003|Period 2 - Week 44|COVID-19 Related|1|||
146937980|NCT03907969|529930767|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
146937981|NCT03907969|529930768|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
146937982|NCT03907969|529930769|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
146789457|NCT03852472|529399834|FG004|Period 2 - Week 44|COVID-19 Related|0|||
146937983|NCT03907969|529930770|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
146789458|NCT03852472|529399830|FG000|Period 2 - Week 44|Reason not stated|0|||
146789459|NCT03852472|529399831|FG001|Period 2 - Week 44|Reason not stated|0|||
146937984|NCT03907969|529930771|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
146731454|NCT00265889|529187244|FG000|Overall Study|Protocol Violation|1|||
146731455|NCT00265889|529187244|FG000|Overall Study|Insurance denied the request|3|||
146731456|NCT02778100|529187246|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
146731457|NCT02778100|529187247|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
146731458|NCT01515748|529187253|FG000|Overall Study|Withdrawal by Subject|32|||
146731459|NCT01515748|529187254|FG001|Overall Study|Withdrawal by Subject|41|||
146731460|NCT01515748|529187253|FG000|Overall Study|Lost to Follow-up|2|||
146731461|NCT01515748|529187254|FG001|Overall Study|Lost to Follow-up|4|||
146731462|NCT01515748|529187253|FG000|Overall Study|Other than specified above|5|||
146731463|NCT01515748|529187254|FG001|Overall Study|Other than specified above|10|||
146731464|NCT03221387|529187255|FG000|Overall Study|Lost to Follow-up|1|||
146731465|NCT03221387|529187255|FG000|Overall Study|Lung transplant|1|||
146731466|NCT02365519|529187256|FG000|Randomized and Treated|Adverse Event|0|||
146731467|NCT02365519|529187257|FG001|Randomized and Treated|Adverse Event|1|||
146731468|NCT02365519|529187258|FG002|Randomized and Treated|Adverse Event|0|||
146731469|NCT02365519|529187256|FG000|Randomized and Treated|Withdrawal by Subject|0|||
146731470|NCT02365519|529187257|FG001|Randomized and Treated|Withdrawal by Subject|1|||
146731471|NCT02365519|529187258|FG002|Randomized and Treated|Withdrawal by Subject|1|||
146731472|NCT01971723|529187259|FG000|Overall Study|Withdrawal by Subject|1|||
146731473|NCT01971723|529187260|FG001|Overall Study|Withdrawal by Subject|1|||
146731474|NCT01971723|529187259|FG000|Overall Study|Protocol Violation|1|||
146731475|NCT01971723|529187260|FG001|Overall Study|Protocol Violation|2|||
146731476|NCT03188055|529187264|FG000|Overall Study|Unavailable for training|0|||
146731477|NCT03188055|529187265|FG001|Overall Study|Unavailable for training|0|||
146731478|NCT03188055|529187266|FG002|Overall Study|Unavailable for training|19|||
146731479|NCT03188055|529187267|FG003|Overall Study|Unavailable for training|0|||
146731480|NCT03188055|529187268|FG004|Overall Study|Unavailable for training|0|||
146731481|NCT03188055|529187269|FG005|Overall Study|Unavailable for training|0|||
146731482|NCT03188055|529187264|FG000|Overall Study|Lost to Follow-up|0|||
146731483|NCT03188055|529187265|FG001|Overall Study|Lost to Follow-up|18|||
146731484|NCT03188055|529187266|FG002|Overall Study|Lost to Follow-up|0|||
146731485|NCT03188055|529187267|FG003|Overall Study|Lost to Follow-up|11|||
146731486|NCT03188055|529187268|FG004|Overall Study|Lost to Follow-up|0|||
146731487|NCT03188055|529187269|FG005|Overall Study|Lost to Follow-up|0|||
146731488|NCT03188055|529187264|FG000|Overall Study|Withdrawal by Subject|0|||
146731489|NCT03188055|529187265|FG001|Overall Study|Withdrawal by Subject|1|||
146731490|NCT03188055|529187266|FG002|Overall Study|Withdrawal by Subject|0|||
146731491|NCT03188055|529187267|FG003|Overall Study|Withdrawal by Subject|1|||
146731492|NCT03188055|529187268|FG004|Overall Study|Withdrawal by Subject|0|||
146731493|NCT03188055|529187269|FG005|Overall Study|Withdrawal by Subject|0|||
146731494|NCT03017079|529187270|FG000|Overall Study|Physician Decision|1|||
146731495|NCT03017079|529187271|FG001|Overall Study|Physician Decision|1|||
146731496|NCT03017079|529187270|FG000|Overall Study|Death|3|||
146731497|NCT03017079|529187271|FG001|Overall Study|Death|2|||
146731498|NCT03017079|529187270|FG000|Overall Study|Lack of Efficacy|2|||
146731499|NCT03017079|529187271|FG001|Overall Study|Lack of Efficacy|2|||
146731500|NCT03017079|529187270|FG000|Overall Study|Protocol Violation|0|||
146731501|NCT03017079|529187271|FG001|Overall Study|Protocol Violation|1|||
146731502|NCT03657277|529187272|FG000|Overall Study|Physician Decision|2|||
146731503|NCT03657277|529187272|FG000|Overall Study|Lost to Follow-up|1|||
146731504|NCT03657277|529187272|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
146731505|NCT04349280|529187273|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
146731506|NCT04349280|529187274|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
146731507|NCT04349280|529187273|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
146731508|NCT04349280|529187274|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
146731509|NCT04349280|529187273|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
146731510|NCT04349280|529187274|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
146731511|NCT02286089|529187277|FG000|Overall Study|Ongoing in Study|1|||
146731512|NCT02286089|529187278|FG001|Overall Study|Ongoing in Study|1|||
146731513|NCT02286089|529187279|FG002|Overall Study|Ongoing in Study|4|||
146731514|NCT02286089|529187280|FG003|Overall Study|Ongoing in Study|10|||
146731515|NCT02286089|529187277|FG000|Overall Study|Withdrawal by Subject|0|||
146731516|NCT02286089|529187278|FG001|Overall Study|Withdrawal by Subject|0|||
146731517|NCT02286089|529187279|FG002|Overall Study|Withdrawal by Subject|2|||
146731518|NCT02286089|529187280|FG003|Overall Study|Withdrawal by Subject|2|||
146731519|NCT01984697|529188745|FG000|Overall Study|Adverse Event|0|||
146731520|NCT01984697|529188746|FG001|Overall Study|Adverse Event|0|||
146731521|NCT01984697|529188747|FG002|Overall Study|Adverse Event|2|||
146731522|NCT01984697|529188748|FG003|Overall Study|Adverse Event|0|||
146731523|NCT01984697|529188749|FG004|Overall Study|Adverse Event|0|||
146731524|NCT01984697|529188745|FG000|Overall Study|Lost to Follow-up|14|||
146731525|NCT01984697|529188746|FG001|Overall Study|Lost to Follow-up|5|||
146731526|NCT01984697|529188747|FG002|Overall Study|Lost to Follow-up|10|||
146731527|NCT01984697|529188748|FG003|Overall Study|Lost to Follow-up|6|||
146731528|NCT01984697|529188749|FG004|Overall Study|Lost to Follow-up|21|||
146731529|NCT01984697|529188745|FG000|Overall Study|Physician Decision|3|||
146731530|NCT01984697|529188746|FG001|Overall Study|Physician Decision|0|||
146981927|NCT01620983|530096168|FG001|Overall Study|Withdrawal by Subject|8|||
146981928|NCT01620983|530096169|FG002|Overall Study|Withdrawal by Subject|1|||
146981929|NCT01620983|530096167|FG000|Overall Study|Death|2|||
146981930|NCT01620983|530096168|FG001|Overall Study|Death|0|||
146981931|NCT01620983|530096169|FG002|Overall Study|Death|0|||
146981932|NCT01620983|530096167|FG000|Overall Study|Physician Decision|3|||
146981933|NCT01620983|530096168|FG001|Overall Study|Physician Decision|10|||
146981934|NCT01620983|530096169|FG002|Overall Study|Physician Decision|5|||
146981935|NCT01724359|530096170|FG000|Overall Study|Adverse Event|10|||
146981936|NCT01724359|530096170|FG000|Overall Study|Death|1|||
146981937|NCT01724359|530096170|FG000|Overall Study|Other|20|||
146981938|NCT01335464|530096171|FG000|Overall Study|Adverse Event|15|||
146981939|NCT01335464|530096172|FG001|Overall Study|Adverse Event|25|||
146981940|NCT01335464|530096171|FG000|Overall Study|Non compliant with protocol|2|||
146981941|NCT01335464|530096172|FG001|Overall Study|Non compliant with protocol|0|||
146981942|NCT01335464|530096171|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
146981943|NCT01335464|530096172|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
146981944|NCT01335464|530096171|FG000|Overall Study|Not treated|2|||
146981945|NCT01335464|530096172|FG001|Overall Study|Not treated|0|||
146981946|NCT01335464|530096171|FG000|Overall Study|Reason other than those stated above|1|||
146981947|NCT01335464|530096172|FG001|Overall Study|Reason other than those stated above|1|||
146981948|NCT00871169|530096173|FG000|Overall Study|Protocol Violation|1|||
146981949|NCT00871169|530096173|FG000|Overall Study|Patient did not receive study treatment|2|||
146981950|NCT00252187|530096174|FG000|Overall Study|Adverse Event|3|||
146731531|NCT01984697|529188747|FG002|Overall Study|Physician Decision|0|||
146731532|NCT01984697|529188748|FG003|Overall Study|Physician Decision|1|||
146731533|NCT01984697|529188749|FG004|Overall Study|Physician Decision|0|||
146731534|NCT01984697|529188745|FG000|Overall Study|Protocol Violation|8|||
146731535|NCT01984697|529188746|FG001|Overall Study|Protocol Violation|5|||
146731536|NCT01984697|529188747|FG002|Overall Study|Protocol Violation|3|||
146937985|NCT03907969|529930772|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
146937986|NCT03907969|529930773|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
146937987|NCT03907969|529930774|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
146937988|NCT03907969|529930775|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
146937989|NCT03907969|529930776|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
146937990|NCT03907969|529930766|FG000|Monotherapy Part A|Progressive Disease|0|||
146937991|NCT03907969|529930767|FG001|Monotherapy Part A|Progressive Disease|1|||
146937992|NCT03907969|529930768|FG002|Monotherapy Part A|Progressive Disease|0|||
146937993|NCT03907969|529930769|FG003|Monotherapy Part A|Progressive Disease|0|||
146937994|NCT03907969|529930770|FG004|Monotherapy Part A|Progressive Disease|0|||
146937995|NCT03907969|529930771|FG005|Monotherapy Part A|Progressive Disease|1|||
146937996|NCT03907969|529930772|FG006|Monotherapy Part A|Progressive Disease|2|||
146937997|NCT03907969|529930773|FG007|Monotherapy Part A|Progressive Disease|0|||
146937998|NCT03907969|529930774|FG008|Monotherapy Part A|Progressive Disease|0|||
146937999|NCT03907969|529930775|FG009|Monotherapy Part A|Progressive Disease|0|||
146938000|NCT03907969|529930776|FG010|Monotherapy Part A|Progressive Disease|0|||
146938001|NCT03907969|529930766|FG000|Monotherapy Part A|Death|0|||
146938002|NCT03907969|529930767|FG001|Monotherapy Part A|Death|0|||
146938003|NCT03907969|529930768|FG002|Monotherapy Part A|Death|1|||
146938004|NCT03907969|529930769|FG003|Monotherapy Part A|Death|1|||
146938005|NCT03907969|529930770|FG004|Monotherapy Part A|Death|0|||
146938006|NCT03907969|529930771|FG005|Monotherapy Part A|Death|1|||
146938007|NCT03907969|529930772|FG006|Monotherapy Part A|Death|0|||
146938008|NCT03907969|529930773|FG007|Monotherapy Part A|Death|0|||
146938009|NCT03907969|529930774|FG008|Monotherapy Part A|Death|0|||
146938010|NCT03907969|529930775|FG009|Monotherapy Part A|Death|0|||
146938011|NCT03907969|529930776|FG010|Monotherapy Part A|Death|0|||
146938012|NCT03907969|529930766|FG000|Combination Therapy Part A|Adverse Event|0|||
146938013|NCT03907969|529930767|FG001|Combination Therapy Part A|Adverse Event|0|||
146938014|NCT03907969|529930768|FG002|Combination Therapy Part A|Adverse Event|0|||
146938015|NCT03907969|529930769|FG003|Combination Therapy Part A|Adverse Event|0|||
146938016|NCT03907969|529930770|FG004|Combination Therapy Part A|Adverse Event|0|||
146938017|NCT03907969|529930771|FG005|Combination Therapy Part A|Adverse Event|0|||
146938018|NCT03907969|529930772|FG006|Combination Therapy Part A|Adverse Event|0|||
146938019|NCT03907969|529930773|FG007|Combination Therapy Part A|Adverse Event|0|||
146938020|NCT03907969|529930774|FG008|Combination Therapy Part A|Adverse Event|0|||
146938021|NCT03907969|529930775|FG009|Combination Therapy Part A|Adverse Event|1|||
146938022|NCT03907969|529930776|FG010|Combination Therapy Part A|Adverse Event|1|||
146938023|NCT03907969|529930766|FG000|Combination Therapy Part A|Progressive disease|0|||
146938024|NCT03907969|529930767|FG001|Combination Therapy Part A|Progressive disease|0|||
146938025|NCT03907969|529930768|FG002|Combination Therapy Part A|Progressive disease|0|||
146938026|NCT03907969|529930769|FG003|Combination Therapy Part A|Progressive disease|0|||
146981951|NCT00252187|530096175|FG001|Overall Study|Adverse Event|1|||
146981952|NCT00252187|530096174|FG000|Overall Study|Withdrawal by Subject|1|||
146981953|NCT00252187|530096175|FG001|Overall Study|Withdrawal by Subject|0|||
146981954|NCT02280356|530096187|FG000|Overall Study|Not Treated|2|||
146981955|NCT02280356|530096187|FG000|Overall Study|Withdrawal by Subject|1|||
146981956|NCT02280356|530096187|FG000|Overall Study|Not evaluable|2|||
146938027|NCT03907969|529930770|FG004|Combination Therapy Part A|Progressive disease|0|||
146938028|NCT03907969|529930771|FG005|Combination Therapy Part A|Progressive disease|0|||
146938029|NCT03907969|529930772|FG006|Combination Therapy Part A|Progressive disease|0|||
146938030|NCT03907969|529930773|FG007|Combination Therapy Part A|Progressive disease|1|||
146938031|NCT03907969|529930774|FG008|Combination Therapy Part A|Progressive disease|0|||
146938032|NCT03907969|529930775|FG009|Combination Therapy Part A|Progressive disease|2|||
146938033|NCT03907969|529930776|FG010|Combination Therapy Part A|Progressive disease|3|||
146938034|NCT03907969|529930766|FG000|Combination Therapy Part A|Death|0|||
146938035|NCT03907969|529930767|FG001|Combination Therapy Part A|Death|0|||
146938036|NCT03907969|529930768|FG002|Combination Therapy Part A|Death|0|||
146938037|NCT03907969|529930769|FG003|Combination Therapy Part A|Death|0|||
146938038|NCT03907969|529930770|FG004|Combination Therapy Part A|Death|0|||
146938039|NCT03907969|529930771|FG005|Combination Therapy Part A|Death|0|||
146938040|NCT03907969|529930772|FG006|Combination Therapy Part A|Death|0|||
146938041|NCT03907969|529930773|FG007|Combination Therapy Part A|Death|0|||
146938042|NCT03907969|529930774|FG008|Combination Therapy Part A|Death|1|||
146938043|NCT03907969|529930775|FG009|Combination Therapy Part A|Death|0|||
146938044|NCT03907969|529930776|FG010|Combination Therapy Part A|Death|1|||
146938045|NCT03907969|529930766|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
146938046|NCT03907969|529930767|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
146938047|NCT03907969|529930768|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
146938048|NCT03907969|529930769|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
146938049|NCT03907969|529930770|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
146938050|NCT03907969|529930771|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
146938051|NCT03907969|529930772|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
146938052|NCT03907969|529930773|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
146938053|NCT03907969|529930774|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
146938054|NCT03907969|529930775|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
146938055|NCT03907969|529930776|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
146938056|NCT03907969|529930766|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
146938057|NCT03907969|529930767|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
146938058|NCT03907969|529930768|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
146938059|NCT03907969|529930769|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
146938060|NCT03907969|529930770|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
146938061|NCT03907969|529930771|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
146938062|NCT03907969|529930772|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
146938063|NCT03907969|529930773|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
146938064|NCT03907969|529930774|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
146938065|NCT03907969|529930775|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
146938066|NCT03907969|529930776|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
146938067|NCT03907969|529930766|FG000|Combination Therapy Part A|Physician Decision|0|||
146938068|NCT03907969|529930767|FG001|Combination Therapy Part A|Physician Decision|0|||
146938069|NCT03907969|529930768|FG002|Combination Therapy Part A|Physician Decision|0|||
146938070|NCT03907969|529930769|FG003|Combination Therapy Part A|Physician Decision|0|||
146938071|NCT03907969|529930770|FG004|Combination Therapy Part A|Physician Decision|0|||
146938072|NCT03907969|529930771|FG005|Combination Therapy Part A|Physician Decision|0|||
146938073|NCT03907969|529930772|FG006|Combination Therapy Part A|Physician Decision|0|||
146938074|NCT03907969|529930773|FG007|Combination Therapy Part A|Physician Decision|1|||
146938075|NCT03907969|529930774|FG008|Combination Therapy Part A|Physician Decision|0|||
146938076|NCT03907969|529930775|FG009|Combination Therapy Part A|Physician Decision|0|||
146938077|NCT03907969|529930776|FG010|Combination Therapy Part A|Physician Decision|1|||
146938078|NCT00063986|529930780|FG000|Overall Study|Withdrawal by Subject|1|||
146938079|NCT00063986|529930780|FG000|Overall Study|Ineligible|1|||
146938080|NCT00063986|529930780|FG000|Overall Study|Intra-operatively ineligible|4|||
146938081|NCT00247273|529930788|FG000|Overall Study|Adverse Event|85|||
146938082|NCT00247273|529930789|FG001|Overall Study|Adverse Event|80|||
146938083|NCT00247273|529930788|FG000|Overall Study|Physician Decision|6|||
146938084|NCT00247273|529930789|FG001|Overall Study|Physician Decision|3|||
146938085|NCT00247273|529930788|FG000|Overall Study|Lost to Follow-up|7|||
146938086|NCT00247273|529930789|FG001|Overall Study|Lost to Follow-up|7|||
146938087|NCT00247273|529930788|FG000|Overall Study|Withdrawal by Subject|46|||
146938088|NCT00247273|529930789|FG001|Overall Study|Withdrawal by Subject|47|||
146938089|NCT00247273|529930788|FG000|Overall Study|Did not take any study drug|2|||
146938090|NCT00247273|529930789|FG001|Overall Study|Did not take any study drug|0|||
146938091|NCT02580240|529930790|FG000|Overall Study|Physician Decision|2|||
146938092|NCT02580240|529930791|FG001|Overall Study|Physician Decision|0|||
146938093|NCT02954952|529930792|FG000|Overall Study|Withdrawal by Subject|1|||
146938094|NCT02954952|529930793|FG001|Overall Study|Withdrawal by Subject|0|||
146938095|NCT02954952|529930794|FG002|Overall Study|Withdrawal by Subject|0|||
146938096|NCT02954952|529930792|FG000|Overall Study|No data collected|0|||
146938097|NCT02954952|529930793|FG001|Overall Study|No data collected|1|||
146938098|NCT02954952|529930794|FG002|Overall Study|No data collected|0|||
146938099|NCT00810043|529930801|FG000|Overall Study|Withdrawal by Subject|1|||
146938100|NCT00810043|529930802|FG001|Overall Study|Withdrawal by Subject|0|||
146938101|NCT00810043|529930803|FG002|Overall Study|Withdrawal by Subject|2|||
146938102|NCT00810043|529930801|FG000|Overall Study|Lost to Follow-up|1|||
146938103|NCT00810043|529930802|FG001|Overall Study|Lost to Follow-up|0|||
146938104|NCT00810043|529930803|FG002|Overall Study|Lost to Follow-up|0|||
146938105|NCT00810043|529930801|FG000|Overall Study|Physician Decision|0|||
146938106|NCT00810043|529930802|FG001|Overall Study|Physician Decision|0|||
146938107|NCT00810043|529930803|FG002|Overall Study|Physician Decision|2|||
146938108|NCT00810043|529930801|FG000|Overall Study|Death|2|||
146938109|NCT00810043|529930802|FG001|Overall Study|Death|0|||
146938110|NCT00810043|529930803|FG002|Overall Study|Death|0|||
146938111|NCT00810043|529930801|FG000|Overall Study|Unrelated medical problem|0|||
146938112|NCT00810043|529930802|FG001|Overall Study|Unrelated medical problem|1|||
146938113|NCT00810043|529930803|FG002|Overall Study|Unrelated medical problem|0|||
146938114|NCT00810043|529930801|FG000|Overall Study|Non-medical problem|0|||
146938115|NCT00810043|529930802|FG001|Overall Study|Non-medical problem|0|||
146938116|NCT00810043|529930803|FG002|Overall Study|Non-medical problem|1|||
146938117|NCT00810043|529930801|FG000|Overall Study|No longer met enrollment criteria|0|||
146938118|NCT00810043|529930802|FG001|Overall Study|No longer met enrollment criteria|0|||
146938119|NCT00810043|529930803|FG002|Overall Study|No longer met enrollment criteria|3|||
146938120|NCT02001688|529930804|FG000|Overall Study|Withdrawal by Subject|0|||
146938121|NCT02001688|529930805|FG001|Overall Study|Withdrawal by Subject|0|||
146938122|NCT02001688|529930806|FG002|Overall Study|Withdrawal by Subject|1|||
146938123|NCT02001688|529930804|FG000|Overall Study|Adverse Event|0|||
146938124|NCT02001688|529930805|FG001|Overall Study|Adverse Event|1|||
146938125|NCT02001688|529930806|FG002|Overall Study|Adverse Event|0|||
146938126|NCT00445341|529930810|FG000|Overall Study|refused further treatment|1|||
146938127|NCT00445341|529930810|FG000|Overall Study|taken off treatment too early|1|||
146938128|NCT03051217|529930813|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
146938129|NCT03051217|529930814|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146938130|NCT03051217|529930815|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
146938131|NCT03051217|529930816|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146938132|NCT03051217|529930817|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146938133|NCT03051217|529930818|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146938134|NCT03051217|529930819|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146938135|NCT03051217|529930813|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
146938136|NCT03051217|529930814|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
146938137|NCT03051217|529930815|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
146938138|NCT03051217|529930816|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
146938139|NCT03051217|529930817|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
146938140|NCT03051217|529930818|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
146938141|NCT03051217|529930819|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
146938142|NCT03051217|529930813|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
146938143|NCT03051217|529930814|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
146938144|NCT03051217|529930815|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
146938145|NCT03051217|529930816|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146938146|NCT03051217|529930817|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146938147|NCT03051217|529930818|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146938148|NCT03051217|529930819|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146938149|NCT03051217|529930813|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
146938150|NCT03051217|529930814|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
146938151|NCT03051217|529930815|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
146938152|NCT03051217|529930816|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
146938153|NCT03051217|529930817|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
146938154|NCT03051217|529930818|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
146938155|NCT03051217|529930819|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
146938156|NCT03051217|529930813|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
146938157|NCT03051217|529930814|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
146938158|NCT03051217|529930815|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
146938159|NCT03051217|529930816|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
146938160|NCT03051217|529930817|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
146938161|NCT03051217|529930818|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
146938162|NCT03051217|529930819|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
146938163|NCT03051217|529930813|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
146938164|NCT03051217|529930814|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
146938165|NCT03051217|529930815|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
146938166|NCT03051217|529930816|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
146938167|NCT03051217|529930817|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
146938168|NCT03051217|529930818|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
146789460|NCT03852472|529399832|FG002|Period 2 - Week 44|Reason not stated|0|||
146789461|NCT03852472|529399833|FG003|Period 2 - Week 44|Reason not stated|0|||
146789462|NCT03852472|529399834|FG004|Period 2 - Week 44|Reason not stated|1|||
146789463|NCT05977530|529399835|FG000|Overall Study|Withdrawal by Subject|1|||
146789464|NCT05977530|529399835|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
146789465|NCT04719832|529399838|FG000|Overall Study|Adverse Event|2|||
146789466|NCT04719832|529399839|FG001|Overall Study|Adverse Event|0|||
146789467|NCT04719832|529399838|FG000|Overall Study|Lack of Efficacy|2|||
146789468|NCT04719832|529399839|FG001|Overall Study|Lack of Efficacy|4|||
146789469|NCT04719832|529399838|FG000|Overall Study|Lost to Follow-up|0|||
146789470|NCT04719832|529399839|FG001|Overall Study|Lost to Follow-up|2|||
146789471|NCT04719832|529399838|FG000|Overall Study|Physician Decision|0|||
146789472|NCT04719832|529399839|FG001|Overall Study|Physician Decision|1|||
146789473|NCT04719832|529399838|FG000|Overall Study|Pregnancy|1|||
146789474|NCT04719832|529399839|FG001|Overall Study|Pregnancy|1|||
146789475|NCT04719832|529399838|FG000|Overall Study|Withdrawal by Subject|5|||
146789476|NCT04719832|529399839|FG001|Overall Study|Withdrawal by Subject|5|||
146789477|NCT04719832|529399838|FG000|Overall Study|Randomized, not treated|0|||
146789478|NCT04719832|529399839|FG001|Overall Study|Randomized, not treated|2|||
146789479|NCT04719832|529399838|FG000|Overall Study|GCP violations|4|||
146789480|NCT04719832|529399839|FG001|Overall Study|GCP violations|7|||
146789481|NCT03058289|529399840|FG000|Overall Study|Radiographic Deterioration|0|||
146789482|NCT03058289|529399841|FG001|Overall Study|Radiographic Deterioration|3|||
146789483|NCT03058289|529399842|FG002|Overall Study|Radiographic Deterioration|1|||
146789484|NCT03058289|529399843|FG003|Overall Study|Radiographic Deterioration|2|||
146789485|NCT03058289|529399844|FG004|Overall Study|Radiographic Deterioration|6|||
146789486|NCT03058289|529399845|FG005|Overall Study|Radiographic Deterioration|3|||
146789487|NCT03058289|529399846|FG006|Overall Study|Radiographic Deterioration|0|||
146789488|NCT03058289|529399847|FG007|Overall Study|Radiographic Deterioration|4|||
146789489|NCT03058289|529399848|FG008|Overall Study|Radiographic Deterioration|2|||
146789490|NCT03058289|529399840|FG000|Overall Study|Adverse Event|2|||
146789491|NCT03058289|529399841|FG001|Overall Study|Adverse Event|0|||
146789492|NCT03058289|529399842|FG002|Overall Study|Adverse Event|1|||
146789493|NCT03058289|529399843|FG003|Overall Study|Adverse Event|3|||
146789494|NCT03058289|529399844|FG004|Overall Study|Adverse Event|1|||
146789495|NCT03058289|529399845|FG005|Overall Study|Adverse Event|0|||
146789496|NCT03058289|529399846|FG006|Overall Study|Adverse Event|1|||
146789497|NCT03058289|529399847|FG007|Overall Study|Adverse Event|3|||
146789498|NCT03058289|529399848|FG008|Overall Study|Adverse Event|0|||
146789499|NCT03058289|529399840|FG000|Overall Study|Withdrawal by Subject|0|||
146789500|NCT03058289|529399841|FG001|Overall Study|Withdrawal by Subject|0|||
146789501|NCT03058289|529399842|FG002|Overall Study|Withdrawal by Subject|0|||
146789502|NCT03058289|529399843|FG003|Overall Study|Withdrawal by Subject|2|||
146789503|NCT03058289|529399844|FG004|Overall Study|Withdrawal by Subject|0|||
146789504|NCT03058289|529399845|FG005|Overall Study|Withdrawal by Subject|2|||
146789505|NCT03058289|529399846|FG006|Overall Study|Withdrawal by Subject|0|||
146789506|NCT03058289|529399847|FG007|Overall Study|Withdrawal by Subject|4|||
146789507|NCT03058289|529399848|FG008|Overall Study|Withdrawal by Subject|1|||
146789508|NCT03058289|529399840|FG000|Overall Study|Physician Decision|1|||
146789509|NCT03058289|529399841|FG001|Overall Study|Physician Decision|0|||
146789510|NCT03058289|529399842|FG002|Overall Study|Physician Decision|0|||
146789511|NCT03058289|529399843|FG003|Overall Study|Physician Decision|2|||
146789512|NCT03058289|529399844|FG004|Overall Study|Physician Decision|1|||
146789513|NCT03058289|529399845|FG005|Overall Study|Physician Decision|0|||
146789514|NCT03058289|529399846|FG006|Overall Study|Physician Decision|2|||
146789515|NCT03058289|529399847|FG007|Overall Study|Physician Decision|3|||
146789516|NCT03058289|529399848|FG008|Overall Study|Physician Decision|0|||
146789517|NCT03058289|529399840|FG000|Overall Study|Clinical Deterioration|2|||
146789518|NCT03058289|529399841|FG001|Overall Study|Clinical Deterioration|0|||
146789519|NCT03058289|529399842|FG002|Overall Study|Clinical Deterioration|0|||
146789520|NCT03058289|529399843|FG003|Overall Study|Clinical Deterioration|2|||
146938169|NCT03051217|529930819|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
146938170|NCT03051217|529930813|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
146938171|NCT03051217|529930814|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
146938172|NCT03051217|529930815|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
146789521|NCT03058289|529399844|FG004|Overall Study|Clinical Deterioration|1|||
146789522|NCT03058289|529399845|FG005|Overall Study|Clinical Deterioration|1|||
146789523|NCT03058289|529399846|FG006|Overall Study|Clinical Deterioration|0|||
146789524|NCT03058289|529399847|FG007|Overall Study|Clinical Deterioration|3|||
146789525|NCT03058289|529399848|FG008|Overall Study|Clinical Deterioration|2|||
146789526|NCT03058289|529399840|FG000|Overall Study|Lost to Follow-up|0|||
146789527|NCT03058289|529399841|FG001|Overall Study|Lost to Follow-up|0|||
146789528|NCT03058289|529399842|FG002|Overall Study|Lost to Follow-up|0|||
146789529|NCT03058289|529399843|FG003|Overall Study|Lost to Follow-up|0|||
146789530|NCT03058289|529399844|FG004|Overall Study|Lost to Follow-up|1|||
146789531|NCT03058289|529399845|FG005|Overall Study|Lost to Follow-up|0|||
146789532|NCT03058289|529399846|FG006|Overall Study|Lost to Follow-up|0|||
146789533|NCT03058289|529399847|FG007|Overall Study|Lost to Follow-up|0|||
146789534|NCT03058289|529399848|FG008|Overall Study|Lost to Follow-up|0|||
146789535|NCT03058289|529399840|FG000|Overall Study|Refused Further Treatment|0|||
146789536|NCT03058289|529399841|FG001|Overall Study|Refused Further Treatment|0|||
146789537|NCT03058289|529399842|FG002|Overall Study|Refused Further Treatment|1|||
146789538|NCT03058289|529399843|FG003|Overall Study|Refused Further Treatment|0|||
146789539|NCT03058289|529399844|FG004|Overall Study|Refused Further Treatment|1|||
146789540|NCT03058289|529399845|FG005|Overall Study|Refused Further Treatment|0|||
146789541|NCT03058289|529399846|FG006|Overall Study|Refused Further Treatment|0|||
146789542|NCT03058289|529399847|FG007|Overall Study|Refused Further Treatment|0|||
146789543|NCT03058289|529399848|FG008|Overall Study|Refused Further Treatment|0|||
146789544|NCT03058289|529399840|FG000|Overall Study|Rapid Progression of Disease|0|||
146789545|NCT03058289|529399841|FG001|Overall Study|Rapid Progression of Disease|0|||
146789546|NCT03058289|529399842|FG002|Overall Study|Rapid Progression of Disease|0|||
146789547|NCT03058289|529399843|FG003|Overall Study|Rapid Progression of Disease|1|||
146789548|NCT03058289|529399844|FG004|Overall Study|Rapid Progression of Disease|0|||
146789549|NCT03058289|529399845|FG005|Overall Study|Rapid Progression of Disease|0|||
146789550|NCT03058289|529399846|FG006|Overall Study|Rapid Progression of Disease|0|||
146789551|NCT03058289|529399847|FG007|Overall Study|Rapid Progression of Disease|0|||
146789552|NCT03058289|529399848|FG008|Overall Study|Rapid Progression of Disease|0|||
146789553|NCT03084536|529399849|FG000|Overall Study|Determined to be ineligible|0|||
146789554|NCT03084536|529399850|FG001|Overall Study|Determined to be ineligible|0|||
146789555|NCT03084536|529399851|FG002|Overall Study|Determined to be ineligible|16|||
146789556|NCT03084536|529399849|FG000|Overall Study|Withdrawal by Subject|0|||
146789557|NCT03084536|529399850|FG001|Overall Study|Withdrawal by Subject|0|||
146789558|NCT03084536|529399851|FG002|Overall Study|Withdrawal by Subject|4|||
146789559|NCT03084536|529399849|FG000|Overall Study|Physician Decision|0|||
146789560|NCT03084536|529399850|FG001|Overall Study|Physician Decision|0|||
146789561|NCT03084536|529399851|FG002|Overall Study|Physician Decision|3|||
146789562|NCT03084536|529399849|FG000|Overall Study|Death|0|||
146789563|NCT03084536|529399850|FG001|Overall Study|Death|0|||
146789564|NCT03084536|529399851|FG002|Overall Study|Death|1|||
146789565|NCT03084536|529399849|FG000|Overall Study|Lost to Follow-up|0|||
146789566|NCT03084536|529399850|FG001|Overall Study|Lost to Follow-up|0|||
146789567|NCT03084536|529399851|FG002|Overall Study|Lost to Follow-up|1|||
146789568|NCT03084536|529399849|FG000|Overall Study|Protocol Violation|0|||
146789569|NCT03084536|529399850|FG001|Overall Study|Protocol Violation|0|||
146789570|NCT03084536|529399851|FG002|Overall Study|Protocol Violation|1|||
146789571|NCT03084536|529399849|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
146789572|NCT03084536|529399850|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
146789573|NCT03084536|529399851|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
146789574|NCT05192109|529399856|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
146789575|NCT05192109|529399857|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
146789576|NCT05192109|529399858|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
146789577|NCT05192109|529399859|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
146789578|NCT05192109|529399856|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
146789579|NCT05192109|529399857|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
146789580|NCT05192109|529399858|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
146789581|NCT05192109|529399859|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
146789582|NCT04515849|529399860|FG000|Overall Study|Adverse Event|0|||
146789583|NCT04515849|529399861|FG001|Overall Study|Adverse Event|0|||
146789584|NCT04515849|529399862|FG002|Overall Study|Adverse Event|0|||
146789585|NCT04515849|529399863|FG003|Overall Study|Adverse Event|1|||
146789586|NCT04515849|529399864|FG004|Overall Study|Adverse Event|2|||
146789587|NCT04515849|529399860|FG000|Overall Study|Death|2|||
146789588|NCT04515849|529399861|FG001|Overall Study|Death|0|||
146789589|NCT04515849|529399862|FG002|Overall Study|Death|0|||
146789590|NCT04515849|529399863|FG003|Overall Study|Death|0|||
146789591|NCT04515849|529399864|FG004|Overall Study|Death|0|||
146789592|NCT04515849|529399860|FG000|Overall Study|Other:family emergency|0|||
146789593|NCT04515849|529399861|FG001|Overall Study|Other:family emergency|0|||
146789594|NCT04515849|529399862|FG002|Overall Study|Other:family emergency|0|||
146789595|NCT04515849|529399863|FG003|Overall Study|Other:family emergency|1|||
146938173|NCT03051217|529930816|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
146938174|NCT03051217|529930817|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
146938175|NCT03051217|529930818|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
146938176|NCT03051217|529930819|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
146789596|NCT04515849|529399864|FG004|Overall Study|Other:family emergency|0|||
146938177|NCT03051217|529930813|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
146789597|NCT04515849|529399860|FG000|Overall Study|Other:randomised by error|0|||
146789598|NCT04515849|529399861|FG001|Overall Study|Other:randomised by error|1|||
146789599|NCT04515849|529399862|FG002|Overall Study|Other:randomised by error|0|||
146789600|NCT04515849|529399863|FG003|Overall Study|Other:randomised by error|0|||
146789601|NCT04515849|529399864|FG004|Overall Study|Other:randomised by error|0|||
146789602|NCT04515849|529399860|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
146789603|NCT04515849|529399861|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
146789604|NCT04515849|529399862|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
146789605|NCT04515849|529399863|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
146789606|NCT04515849|529399864|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
146789607|NCT04515849|529399860|FG000|Overall Study|Physician Decision|0|||
146789608|NCT04515849|529399861|FG001|Overall Study|Physician Decision|1|||
146789609|NCT04515849|529399862|FG002|Overall Study|Physician Decision|0|||
146789610|NCT04515849|529399863|FG003|Overall Study|Physician Decision|0|||
146789611|NCT04515849|529399864|FG004|Overall Study|Physician Decision|0|||
146789612|NCT04515849|529399860|FG000|Overall Study|Withdrawal by Subject|1|||
146789613|NCT04515849|529399861|FG001|Overall Study|Withdrawal by Subject|2|||
146789614|NCT04515849|529399862|FG002|Overall Study|Withdrawal by Subject|1|||
146789615|NCT04515849|529399863|FG003|Overall Study|Withdrawal by Subject|0|||
146789616|NCT04515849|529399864|FG004|Overall Study|Withdrawal by Subject|0|||
146789617|NCT04437615|529399872|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
146789618|NCT02696707|529401412|FG000|Per Protocol Population|Physician Decision|2|||
146789619|NCT02696707|529401413|FG001|Per Protocol Population|Physician Decision|1|||
146789620|NCT02696707|529401412|FG000|Per Protocol Population|Participant Decision|0|||
146789621|NCT02696707|529401413|FG001|Per Protocol Population|Participant Decision|2|||
146789622|NCT02696707|529401412|FG000|Completed Study as Planned|Reason = LVEF|2|||
146789623|NCT02696707|529401413|FG001|Completed Study as Planned|Reason = LVEF|2|||
146789624|NCT02696707|529401412|FG000|Completed Study as Planned|Protocol Violation|2|||
146789625|NCT02696707|529401413|FG001|Completed Study as Planned|Protocol Violation|6|||
146789626|NCT02696707|529401412|FG000|Completed Study as Planned|Metastatic disease|3|||
146789627|NCT02696707|529401413|FG001|Completed Study as Planned|Metastatic disease|0|||
146789628|NCT02696707|529401412|FG000|Completed Study as Planned|Location|1|||
146789629|NCT02696707|529401413|FG001|Completed Study as Planned|Location|1|||
146789630|NCT03869866|529401418|FG000|Overall Study|Protocol Violation|1|||
146789631|NCT03869866|529401418|FG000|Overall Study|Withdrawal by Subject|3|||
146789632|NCT06516705|529401419|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
146789633|NCT06516705|529401420|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
146789634|NCT06516705|529401419|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
146789635|NCT06516705|529401420|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
146789636|NCT06516705|529401419|FG000|T3 ( 3 Month After Education)|covid-19|1|||
146789637|NCT06516705|529401420|FG001|T3 ( 3 Month After Education)|covid-19|2|||
146789638|NCT06516705|529401419|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
146789639|NCT06516705|529401420|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
146789640|NCT06516705|529401419|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
146789641|NCT06516705|529401420|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
146789642|NCT06516705|529401419|FG000|T4 ( 6 Month After Education)|covid-19|3|||
146789643|NCT06516705|529401420|FG001|T4 ( 6 Month After Education)|covid-19|2|||
146789644|NCT06516705|529401419|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
146789645|NCT06516705|529401420|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
146789646|NCT05579899|529401421|FG000|Overall Study|Lost to Follow-up|3|||
146789647|NCT05579899|529401422|FG001|Overall Study|Lost to Follow-up|1|||
146789648|NCT05579899|529401421|FG000|Overall Study|Adverse Event|0|||
146789649|NCT05579899|529401422|FG001|Overall Study|Adverse Event|3|||
146789650|NCT05579899|529401421|FG000|Overall Study|Pregnancy|0|||
146789651|NCT05579899|529401422|FG001|Overall Study|Pregnancy|1|||
146789652|NCT05579899|529401421|FG000|Overall Study|Withdrawal by Subject|0|||
146789653|NCT05579899|529401422|FG001|Overall Study|Withdrawal by Subject|3|||
146789654|NCT05453773|529401423|FG000|Overall Study|Withdrawal by Subject|3|||
146789655|NCT05453773|529401423|FG000|Overall Study|Lost to Follow-up|3|||
146789656|NCT05453773|529401423|FG000|Overall Study|Difficult Blood Draw|3|||
146731537|NCT01984697|529188748|FG003|Overall Study|Protocol Violation|2|||
146731538|NCT01984697|529188749|FG004|Overall Study|Protocol Violation|0|||
146731539|NCT01984697|529188745|FG000|Overall Study|Withdrawal by Subject|15|||
146731540|NCT01984697|529188746|FG001|Overall Study|Withdrawal by Subject|21|||
146731541|NCT01984697|529188747|FG002|Overall Study|Withdrawal by Subject|13|||
146731542|NCT01984697|529188748|FG003|Overall Study|Withdrawal by Subject|11|||
146731543|NCT01984697|529188749|FG004|Overall Study|Withdrawal by Subject|13|||
146731544|NCT01984697|529188745|FG000|Overall Study|Missed last follow-up visit|1|||
146731545|NCT01984697|529188746|FG001|Overall Study|Missed last follow-up visit|0|||
146731546|NCT01984697|529188747|FG002|Overall Study|Missed last follow-up visit|0|||
146731547|NCT01984697|529188748|FG003|Overall Study|Missed last follow-up visit|0|||
146731548|NCT01984697|529188749|FG004|Overall Study|Missed last follow-up visit|0|||
146731549|NCT01984697|529188745|FG000|Overall Study|Death|0|||
146731550|NCT01984697|529188746|FG001|Overall Study|Death|0|||
146731551|NCT01984697|529188747|FG002|Overall Study|Death|0|||
146789657|NCT03023410|529401426|FG000|Overall Study|study termination|0|||
146789658|NCT03023410|529401427|FG001|Overall Study|study termination|1|||
146789659|NCT04963270|529401433|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
146789660|NCT04963270|529401434|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
146938178|NCT03051217|529930814|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
146938179|NCT03051217|529930815|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
146938180|NCT03051217|529930816|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
146938181|NCT03051217|529930817|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
146938182|NCT03051217|529930818|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
146938183|NCT03051217|529930819|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
146938184|NCT00641706|529930820|FG000|Overall Study|Adverse Event|2|||
146938185|NCT00641706|529930821|FG001|Overall Study|Adverse Event|1|||
146938186|NCT00641706|529930820|FG000|Overall Study|Withdrawal by Subject|6|||
146938187|NCT00641706|529930821|FG001|Overall Study|Withdrawal by Subject|1|||
146938188|NCT00641706|529930820|FG000|Overall Study|Clinical Decline|1|||
146938189|NCT00641706|529930821|FG001|Overall Study|Clinical Decline|0|||
146938190|NCT00641706|529930820|FG000|Overall Study|Lead Investigator Decision|0|||
146938191|NCT00641706|529930821|FG001|Overall Study|Lead Investigator Decision|1|||
146938192|NCT01675141|529930822|FG000|Overall Study|Lenalidomide outside NIH|3|||
146938193|NCT01675141|529930822|FG000|Overall Study|Withdrawal by Subject|3|||
146938194|NCT01675141|529930822|FG000|Overall Study|Physician Decision|4|||
146938195|NCT01675141|529930822|FG000|Overall Study|No treatment, per protocol|1|||
146938196|NCT00109772|529930823|FG000|Double-blind Treatment|Adverse Event|14|||
146938197|NCT00109772|529930824|FG001|Double-blind Treatment|Adverse Event|5|||
146938198|NCT00109772|529930823|FG000|Double-blind Treatment|Lack of Efficacy|1|||
146938199|NCT00109772|529930824|FG001|Double-blind Treatment|Lack of Efficacy|0|||
146938200|NCT00109772|529930823|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
146938201|NCT00109772|529930824|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
146938202|NCT00109772|529930823|FG000|Double-blind Treatment|Lost to Follow-up|2|||
146938203|NCT00109772|529930824|FG001|Double-blind Treatment|Lost to Follow-up|3|||
146938204|NCT00109772|529930823|FG000|Double-blind Treatment|Protocol Violation|0|||
146938205|NCT00109772|529930824|FG001|Double-blind Treatment|Protocol Violation|1|||
146938206|NCT00109772|529930823|FG000|Double-blind Treatment|Other|0|||
146938207|NCT00109772|529930824|FG001|Double-blind Treatment|Other|4|||
146938208|NCT00109772|529930823|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
146938209|NCT00109772|529930824|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
146938210|NCT00109772|529930823|FG000|Open-label Extension|Adverse Event|10|||
146938211|NCT00109772|529930824|FG001|Open-label Extension|Adverse Event|19|||
146938212|NCT00109772|529930823|FG000|Open-label Extension|Lack of Efficacy|19|||
146938213|NCT00109772|529930824|FG001|Open-label Extension|Lack of Efficacy|11|||
146938214|NCT00109772|529930823|FG000|Open-label Extension|Withdrawal by Subject|9|||
146938215|NCT00109772|529930824|FG001|Open-label Extension|Withdrawal by Subject|6|||
146938216|NCT00109772|529930823|FG000|Open-label Extension|Lost to Follow-up|1|||
146938217|NCT00109772|529930824|FG001|Open-label Extension|Lost to Follow-up|0|||
146938218|NCT00109772|529930823|FG000|Open-label Extension|Death|0|||
146938219|NCT00109772|529930824|FG001|Open-label Extension|Death|1|||
146938220|NCT00109772|529930823|FG000|Open-label Extension|Protocol Violation|2|||
146938221|NCT00109772|529930824|FG001|Open-label Extension|Protocol Violation|2|||
146938222|NCT00109772|529930823|FG000|Open-label Extension|Other|4|||
146938223|NCT00109772|529930824|FG001|Open-label Extension|Other|10|||
146938224|NCT00813917|529930827|FG000|Overall Study|Adverse Event|0|||
146938225|NCT00813917|529930828|FG001|Overall Study|Adverse Event|1|||
146938226|NCT00813917|529930827|FG000|Overall Study|Withdrawal by Subject|3|||
146938227|NCT00813917|529930828|FG001|Overall Study|Withdrawal by Subject|4|||
146938228|NCT00813917|529930827|FG000|Overall Study|Lost to Follow-up|3|||
146938229|NCT00813917|529930828|FG001|Overall Study|Lost to Follow-up|1|||
146938230|NCT05441540|529930829|FG000|Overall Study|Withdrawal by Subject|2|||
146938231|NCT01359046|529930830|FG000|Overall Study|Did not receive allocated intervention|6|||
146938232|NCT01359046|529930831|FG001|Overall Study|Did not receive allocated intervention|6|||
146938233|NCT01359046|529930830|FG000|Overall Study|Physician Decision|1|||
146938234|NCT01359046|529930831|FG001|Overall Study|Physician Decision|11|||
146938235|NCT04539262|529930837|FG000|Overall Study|Adverse Event|0|||
146938236|NCT04539262|529930838|FG001|Overall Study|Adverse Event|0|||
146620789|NCT05470985|528783428|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
146789661|NCT04963270|529401435|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
146938237|NCT04539262|529930839|FG002|Overall Study|Adverse Event|1|||
146938238|NCT04539262|529930840|FG003|Overall Study|Adverse Event|0|||
146938239|NCT04539262|529930841|FG004|Overall Study|Adverse Event|0|||
146938240|NCT04539262|529930842|FG005|Overall Study|Adverse Event|0|||
146938241|NCT04539262|529930843|FG006|Overall Study|Adverse Event|0|||
146938242|NCT04539262|529930844|FG007|Overall Study|Adverse Event|0|||
146938243|NCT04539262|529930837|FG000|Overall Study|Withdrew Consent|0|||
146938244|NCT04539262|529930838|FG001|Overall Study|Withdrew Consent|0|||
146938245|NCT04539262|529930839|FG002|Overall Study|Withdrew Consent|0|||
146731552|NCT01984697|529188748|FG003|Overall Study|Death|1|||
146731553|NCT01984697|529188749|FG004|Overall Study|Death|0|||
146731554|NCT01984697|529188745|FG000|Overall Study|Pregnancy|2|||
146731555|NCT01984697|529188746|FG001|Overall Study|Pregnancy|0|||
146731556|NCT01984697|529188747|FG002|Overall Study|Pregnancy|1|||
146731557|NCT01984697|529188748|FG003|Overall Study|Pregnancy|0|||
146731558|NCT01984697|529188749|FG004|Overall Study|Pregnancy|1|||
146731559|NCT03092375|529188756|FG000|Overall Study|Lack of Efficacy|0|||
146731560|NCT03092375|529188757|FG001|Overall Study|Lack of Efficacy|1|||
146731561|NCT03092375|529188758|FG002|Overall Study|Lack of Efficacy|1|||
146731562|NCT03092375|529188759|FG003|Overall Study|Lack of Efficacy|0|||
146731563|NCT00949715|529188760|FG000|Overall Study|Physician Decision|1|||
146731564|NCT00949715|529188761|FG001|Overall Study|Physician Decision|0|||
146731565|NCT00949715|529188760|FG000|Overall Study|Lost to Follow-up|1|||
146731566|NCT00949715|529188761|FG001|Overall Study|Lost to Follow-up|0|||
146731567|NCT00949715|529188760|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
146731568|NCT00949715|529188761|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
146731569|NCT00861614|529188762|FG000|Overall Study|Disease Progression|182|||
146731570|NCT00861614|529188763|FG001|Overall Study|Disease Progression|263|||
146731571|NCT00861614|529188762|FG000|Overall Study|Study Drug Toxicity|79|||
146731572|NCT00861614|529188763|FG001|Overall Study|Study Drug Toxicity|6|||
146731573|NCT00861614|529188762|FG000|Overall Study|Death|32|||
146731574|NCT00861614|529188763|FG001|Overall Study|Death|19|||
146731575|NCT00861614|529188762|FG000|Overall Study|Adverse Event|27|||
146731576|NCT00861614|529188763|FG001|Overall Study|Adverse Event|23|||
146731577|NCT00861614|529188762|FG000|Overall Study|Withdrawal by Subject|34|||
146731578|NCT00861614|529188763|FG001|Overall Study|Withdrawal by Subject|35|||
146731579|NCT00861614|529188762|FG000|Overall Study|Other|17|||
146731580|NCT00861614|529188763|FG001|Overall Study|Other|22|||
146731581|NCT02243280|529188764|FG000|Treated|Adverse Event|1|||
146731582|NCT02243280|529188765|FG001|Treated|Adverse Event|0|||
146731583|NCT02243280|529188766|FG002|Treated|Adverse Event|0|||
146731584|NCT02243280|529188767|FG003|Treated|Adverse Event|0|||
146731585|NCT02243280|529188768|FG004|Treated|Adverse Event|0|||
146731586|NCT02243280|529188769|FG005|Treated|Adverse Event|0|||
146731587|NCT02243280|529188770|FG006|Treated|Adverse Event|0|||
146731588|NCT02243280|529188771|FG007|Treated|Adverse Event|0|||
146731589|NCT02243280|529188772|FG008|Treated|Adverse Event|0|||
146731590|NCT02243280|529188773|FG009|Treated|Adverse Event|0|||
146731591|NCT02243280|529188774|FG010|Treated|Adverse Event|1|||
146731592|NCT02243280|529188764|FG000|Treated|Lost to Follow-up|0|||
146731593|NCT02243280|529188765|FG001|Treated|Lost to Follow-up|0|||
146731594|NCT02243280|529188766|FG002|Treated|Lost to Follow-up|0|||
146731595|NCT02243280|529188767|FG003|Treated|Lost to Follow-up|0|||
146731596|NCT02243280|529188768|FG004|Treated|Lost to Follow-up|0|||
146731597|NCT02243280|529188769|FG005|Treated|Lost to Follow-up|0|||
146731598|NCT02243280|529188770|FG006|Treated|Lost to Follow-up|0|||
146731599|NCT02243280|529188771|FG007|Treated|Lost to Follow-up|0|||
146731600|NCT02243280|529188772|FG008|Treated|Lost to Follow-up|1|||
146731601|NCT02243280|529188773|FG009|Treated|Lost to Follow-up|0|||
146731602|NCT02243280|529188774|FG010|Treated|Lost to Follow-up|2|||
146731603|NCT01807156|529188775|FG000|Overall Study|Physician Decision|1|||
146731604|NCT01493687|529188779|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
146731605|NCT01493687|529188780|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
146731606|NCT01493687|529188779|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
146731607|NCT01493687|529188780|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
146731608|NCT01493687|529188779|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
146731609|NCT01493687|529188780|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
146731610|NCT01493687|529188779|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
146731611|NCT01493687|529188780|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
146731612|NCT01493687|529188779|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
146789662|NCT04963270|529401436|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
146789663|NCT04963270|529401433|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
146731613|NCT01493687|529188780|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
146731614|NCT01493687|529188779|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
146731615|NCT01493687|529188780|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
146731616|NCT01493687|529188779|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
146731617|NCT01493687|529188780|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
146731618|NCT01493687|529188779|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
146731619|NCT01493687|529188780|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
146731620|NCT01493687|529188779|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
146731621|NCT01493687|529188780|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
146731622|NCT01493687|529188779|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
146731623|NCT01493687|529188780|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
146938246|NCT04539262|529930840|FG003|Overall Study|Withdrew Consent|1|||
146938247|NCT04539262|529930841|FG004|Overall Study|Withdrew Consent|0|||
146938248|NCT04539262|529930842|FG005|Overall Study|Withdrew Consent|0|||
146938249|NCT04539262|529930843|FG006|Overall Study|Withdrew Consent|0|||
146789664|NCT04963270|529401434|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
146789665|NCT04963270|529401435|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
146789666|NCT04963270|529401436|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
146789667|NCT04963270|529401433|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
146789668|NCT04963270|529401434|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
146789669|NCT04963270|529401435|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
146789670|NCT04963270|529401436|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
146789671|NCT04963270|529401433|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
146789672|NCT04963270|529401434|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
146789673|NCT04963270|529401435|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
146789674|NCT04963270|529401436|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
146789675|NCT04963270|529401433|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
146789676|NCT04963270|529401434|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
146789677|NCT04963270|529401435|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
146789678|NCT04963270|529401436|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
146789679|NCT04963270|529401433|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
146789680|NCT04963270|529401434|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
146789681|NCT04963270|529401435|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
146789682|NCT04963270|529401436|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
146789683|NCT04963270|529401433|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
146789684|NCT04963270|529401434|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
146789685|NCT04963270|529401435|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
146789686|NCT04963270|529401436|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
146789687|NCT04963270|529401433|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
146789688|NCT04963270|529401434|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
146789689|NCT04963270|529401435|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
146789690|NCT04963270|529401436|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
146789691|NCT04963270|529401433|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
146789692|NCT04963270|529401434|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
146789693|NCT04963270|529401435|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
146789694|NCT04963270|529401436|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
146789695|NCT04963270|529401433|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
146789696|NCT04963270|529401434|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
146789697|NCT04963270|529401435|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
146789698|NCT04963270|529401436|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
146789699|NCT04963270|529401433|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
146789700|NCT04963270|529401434|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
146789701|NCT04963270|529401435|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
146789702|NCT04963270|529401436|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
146789703|NCT04963270|529401433|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
146789704|NCT04963270|529401434|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
146789705|NCT04963270|529401435|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
146789706|NCT04963270|529401436|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
146789707|NCT04963270|529401433|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
146789708|NCT04963270|529401434|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
146789709|NCT04963270|529401435|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
146789710|NCT04963270|529401436|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
146789711|NCT04963270|529401433|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
146789712|NCT04963270|529401434|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
146789713|NCT04963270|529401435|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
146789714|NCT04963270|529401436|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
146789715|NCT04802967|529401437|FG000|Part B|Withdrawal by Subject|0|||
146789716|NCT04802967|529401438|FG001|Part B|Withdrawal by Subject|0|||
146789717|NCT04802967|529401439|FG002|Part B|Withdrawal by Subject|0|||
146789718|NCT04802967|529401440|FG003|Part B|Withdrawal by Subject|0|||
146789719|NCT04802967|529401441|FG004|Part B|Withdrawal by Subject|0|||
146789720|NCT04802967|529401442|FG005|Part B|Withdrawal by Subject|1|||
146789721|NCT04802967|529401443|FG006|Part B|Withdrawal by Subject|0|||
146789722|NCT04802967|529401444|FG007|Part B|Withdrawal by Subject|0|||
146789723|NCT04802967|529401445|FG008|Part B|Withdrawal by Subject|0|||
146789724|NCT04802967|529401446|FG009|Part B|Withdrawal by Subject|0|||
146789725|NCT04332926|529401456|FG000|Overall Study|Withdrawal by Subject|6|||
146789726|NCT04332926|529401456|FG000|Overall Study|Physician Decision|6|||
146789727|NCT04376502|529401459|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
146789728|NCT02547233|529401460|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
146789729|NCT02547233|529401461|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
146789730|NCT02547233|529401460|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
146789731|NCT02547233|529401461|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
146938250|NCT04539262|529930844|FG007|Overall Study|Withdrew Consent|0|||
146938251|NCT04539262|529930837|FG000|Overall Study|Randomized, Not treated|0|||
146938252|NCT04539262|529930838|FG001|Overall Study|Randomized, Not treated|1|||
146938253|NCT04539262|529930839|FG002|Overall Study|Randomized, Not treated|0|||
146938254|NCT04539262|529930840|FG003|Overall Study|Randomized, Not treated|0|||
146938255|NCT04539262|529930841|FG004|Overall Study|Randomized, Not treated|0|||
146938256|NCT04539262|529930842|FG005|Overall Study|Randomized, Not treated|0|||
146938257|NCT04539262|529930843|FG006|Overall Study|Randomized, Not treated|1|||
146938258|NCT04539262|529930844|FG007|Overall Study|Randomized, Not treated|0|||
146938259|NCT03673956|529930847|FG000|Overall Study|Lost to Follow-up|1|||
146938260|NCT03673956|529930848|FG001|Overall Study|Lost to Follow-up|0|||
146938261|NCT03673956|529930849|FG002|Overall Study|Lost to Follow-up|0|||
146938262|NCT03673956|529930850|FG003|Overall Study|Lost to Follow-up|0|||
146938263|NCT03673956|529930847|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
146938264|NCT03673956|529930848|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
146938265|NCT03673956|529930849|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
146938266|NCT03673956|529930850|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
146938267|NCT00802867|529930853|FG000|Overall Study|Lost to Follow-up|6|||
146938268|NCT00802867|529930853|FG000|Overall Study|Protocol Violation|6|||
146938269|NCT00802867|529930853|FG000|Overall Study|Withdrawal by Subject|1|||
146938270|NCT04075396|529930856|FG000|Overall Study|Death|11|||
146938271|NCT04075396|529930857|FG001|Overall Study|Death|9|||
146938272|NCT04075396|529930856|FG000|Overall Study|Withdrawal by Subject|1|||
146938273|NCT04075396|529930857|FG001|Overall Study|Withdrawal by Subject|2|||
146938274|NCT04075396|529930856|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
146938275|NCT04075396|529930857|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
146938276|NCT04075396|529930856|FG000|Overall Study|Enrolled but not-treated|0|||
146938277|NCT04075396|529930857|FG001|Overall Study|Enrolled but not-treated|1|||
146938278|NCT01156532|529930858|FG000|Overall Study|Family Reasons|1|||
146938279|NCT01156532|529930858|FG000|Overall Study|Lost to Follow-up|1|||
146938280|NCT00435994|529930859|FG000|Overall Study|Lost to Follow-up|7|||
146938281|NCT00435994|529930860|FG001|Overall Study|Lost to Follow-up|0|||
146938282|NCT00435994|529930861|FG002|Overall Study|Lost to Follow-up|0|||
146938283|NCT00628758|529930863|FG000|Overall Study|Adverse Event|2|||
146938284|NCT00628758|529930864|FG001|Overall Study|Adverse Event|3|||
146938285|NCT00628758|529930863|FG000|Overall Study|Withdrawal by Subject|6|||
146938286|NCT00628758|529930864|FG001|Overall Study|Withdrawal by Subject|3|||
146938287|NCT00628758|529930863|FG000|Overall Study|Death|1|||
146938288|NCT00628758|529930864|FG001|Overall Study|Death|0|||
146938289|NCT00628758|529930863|FG000|Overall Study|Protocol Violation|5|||
146938290|NCT00628758|529930864|FG001|Overall Study|Protocol Violation|1|||
146938291|NCT00628758|529930863|FG000|Overall Study|Lost to Follow-up|25|||
146938292|NCT00628758|529930864|FG001|Overall Study|Lost to Follow-up|31|||
146938293|NCT00628758|529930863|FG000|Overall Study|Pregnancy|2|||
146938294|NCT00628758|529930864|FG001|Overall Study|Pregnancy|2|||
146938295|NCT00628758|529930863|FG000|Overall Study|Investigator Moved|3|||
146938296|NCT00628758|529930864|FG001|Overall Study|Investigator Moved|0|||
146938297|NCT00628758|529930863|FG000|Overall Study|Treatment Failure|0|||
146938298|NCT00628758|529930864|FG001|Overall Study|Treatment Failure|2|||
146938299|NCT04179786|529930865|FG000|Overall Study|Withdrawal by Subject|8|||
146938300|NCT03310580|529930866|FG000|Overall Study|Adverse Event|0|||
146938301|NCT03310580|529930867|FG001|Overall Study|Adverse Event|1|||
146938302|NCT03310580|529930868|FG002|Overall Study|Adverse Event|0|||
146938303|NCT00376246|529930870|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
146938304|NCT00376246|529930871|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
146938305|NCT00376246|529930870|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
146938306|NCT00376246|529930871|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
146938307|NCT00376246|529930870|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
146938308|NCT00376246|529930871|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
146938309|NCT03205982|529930872|FG000|Overall Study|Lost to Follow-up|20|||
146938310|NCT03205982|529930873|FG001|Overall Study|Lost to Follow-up|19|||
146938311|NCT03205982|529930872|FG000|Overall Study|Withdrawal by Subject|4|||
146938312|NCT03205982|529930873|FG001|Overall Study|Withdrawal by Subject|3|||
146938313|NCT03205982|529930872|FG000|Overall Study|Withdrawal by PI|0|||
146938314|NCT03205982|529930873|FG001|Overall Study|Withdrawal by PI|1|||
146938315|NCT00994162|529930876|FG000|Overall Study|Withdrawal by Subject|1|||
146938316|NCT00994162|529930876|FG000|Overall Study|Lost to Follow-up|2|||
146981957|NCT03493698|530096188|FG000|Treatment Period C|Adverse Event|1|||
146981958|NCT03493698|530096188|FG000|Treatment Period C|Withdrawal by Subject|1|||
146938317|NCT00994162|529930876|FG000|Overall Study|Product Complaint|1|||
146938318|NCT00994162|529930876|FG000|Overall Study|Poor Compliance|5|||
146938319|NCT00994162|529930876|FG000|Overall Study|Lack of Response|3|||
146938320|NCT00994162|529930876|FG000|Overall Study|Discharged from Hospital|4|||
146938321|NCT00994162|529930876|FG000|Overall Study|Death|2|||
146789732|NCT02547233|529401460|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
146789733|NCT02547233|529401461|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
146789734|NCT02547233|529401460|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
146789735|NCT02547233|529401461|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
146789736|NCT02547233|529401460|FG000|12-month Follow-up|Withdrawal by Subject|10|||
146789737|NCT02547233|529401461|FG001|12-month Follow-up|Withdrawal by Subject|10|||
146789738|NCT02547233|529401460|FG000|12-month Follow-up|Lost to Follow-up|3|||
146789739|NCT02547233|529401461|FG001|12-month Follow-up|Lost to Follow-up|3|||
146789740|NCT02547233|529401460|FG000|12-month Follow-up|Lack of Efficacy|1|||
146789741|NCT02547233|529401461|FG001|12-month Follow-up|Lack of Efficacy|2|||
146789742|NCT02547233|529401460|FG000|12-month Follow-up|Protocol Violation|0|||
146789743|NCT02547233|529401461|FG001|12-month Follow-up|Protocol Violation|1|||
146789744|NCT02547233|529401460|FG000|12-month Follow-up|Other|0|||
146789745|NCT02547233|529401461|FG001|12-month Follow-up|Other|1|||
146789746|NCT06019559|529401462|FG000|Overall Study|Withdrawal by Subject|7|||
146789747|NCT06019559|529401463|FG001|Overall Study|Withdrawal by Subject|6|||
146789748|NCT06019559|529401464|FG002|Overall Study|Withdrawal by Subject|5|||
146789749|NCT06019559|529401462|FG000|Overall Study|Lost to Follow-up|2|||
146789750|NCT06019559|529401463|FG001|Overall Study|Lost to Follow-up|0|||
146789751|NCT06019559|529401464|FG002|Overall Study|Lost to Follow-up|3|||
146789752|NCT05949788|529401465|FG000|Overall Study|severe birth deformity|2|||
146789753|NCT05949788|529401466|FG001|Overall Study|severe birth deformity|7|||
146789754|NCT05949788|529401465|FG000|Overall Study|twin-twin transfusion syndrome|2|||
146789755|NCT05949788|529401466|FG001|Overall Study|twin-twin transfusion syndrome|7|||
146789756|NCT05949788|529401465|FG000|Overall Study|neonatal hemolytic disease|3|||
146789757|NCT05949788|529401466|FG001|Overall Study|neonatal hemolytic disease|8|||
146789758|NCT05949788|529401465|FG000|Overall Study|death within 14 days after birth|2|||
146789759|NCT05949788|529401466|FG001|Overall Study|death within 14 days after birth|6|||
146789760|NCT05949788|529401465|FG000|Overall Study|transfer to another hospital|2|||
146789761|NCT05949788|529401466|FG001|Overall Study|transfer to another hospital|6|||
146789762|NCT05213390|529401467|FG000|Overall Study|Withdrawal by Subject|2|||
146789763|NCT05213390|529401467|FG000|Overall Study|Lost to Follow-up|12|||
146789764|NCT05213390|529401467|FG000|Overall Study|Protocol Violation|9|||
146789765|NCT01824537|529401468|FG000|Overall Study|Lost to Follow-up|78|||
146789766|NCT01824537|529401469|FG001|Overall Study|Lost to Follow-up|87|||
146789767|NCT05362487|529401470|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
146789768|NCT06215521|529401472|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
146789769|NCT06215521|529401473|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
146789770|NCT06215521|529401474|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
146789771|NCT06215521|529401475|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
146789772|NCT06215521|529401476|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
146789773|NCT06215521|529401477|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
146789774|NCT04096040|529401478|FG000|Overall Study|Protocol Violation|12|||
146789775|NCT04096040|529401478|FG000|Overall Study|Non-compliant site|4|||
146789776|NCT04044768|529401481|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
146789777|NCT04044768|529401482|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
146789778|NCT03808818|529401487|FG000|Overall Study|Death|6|||
146789779|NCT03808818|529401488|FG001|Overall Study|Death|6|||
146789780|NCT03808818|529401487|FG000|Overall Study|Withdrawal by Subject|7|||
146789781|NCT03808818|529401488|FG001|Overall Study|Withdrawal by Subject|18|||
146789782|NCT03808818|529401487|FG000|Overall Study|Lost to Follow-up|31|||
146789783|NCT03808818|529401488|FG001|Overall Study|Lost to Follow-up|33|||
146789784|NCT05415722|529401489|FG000|Overall Study|Lost to Follow-up|0|||
146789785|NCT05415722|529401490|FG001|Overall Study|Lost to Follow-up|2|||
146789786|NCT05415722|529401491|FG002|Overall Study|Lost to Follow-up|0|||
146789787|NCT05415722|529401492|FG003|Overall Study|Lost to Follow-up|1|||
146789788|NCT05415722|529401493|FG004|Overall Study|Lost to Follow-up|0|||
146789789|NCT05415722|529401494|FG005|Overall Study|Lost to Follow-up|0|||
146789790|NCT05415722|529401495|FG006|Overall Study|Lost to Follow-up|1|||
146789791|NCT05415722|529401489|FG000|Overall Study|Physician Decision|0|||
146789792|NCT05415722|529401490|FG001|Overall Study|Physician Decision|0|||
146981959|NCT03361956|530096189|FG000|Overall Study|Adverse Event|1|||
146789793|NCT05415722|529401491|FG002|Overall Study|Physician Decision|0|||
146789794|NCT05415722|529401492|FG003|Overall Study|Physician Decision|1|||
146789795|NCT05415722|529401493|FG004|Overall Study|Physician Decision|0|||
146789796|NCT05415722|529401494|FG005|Overall Study|Physician Decision|0|||
146789797|NCT05415722|529401495|FG006|Overall Study|Physician Decision|1|||
146789798|NCT05415722|529401489|FG000|Overall Study|Protocol Violation|0|||
146789799|NCT05415722|529401490|FG001|Overall Study|Protocol Violation|0|||
146789800|NCT05415722|529401491|FG002|Overall Study|Protocol Violation|0|||
146789801|NCT05415722|529401492|FG003|Overall Study|Protocol Violation|1|||
146789802|NCT05415722|529401493|FG004|Overall Study|Protocol Violation|0|||
146789803|NCT05415722|529401494|FG005|Overall Study|Protocol Violation|0|||
146789804|NCT05415722|529401495|FG006|Overall Study|Protocol Violation|0|||
146789805|NCT05415722|529401489|FG000|Overall Study|Sponsor Discretion|0|||
146789806|NCT05415722|529401490|FG001|Overall Study|Sponsor Discretion|0|||
146938322|NCT00994162|529930876|FG000|Overall Study|Care Transferred to Another Physician|2|||
146938323|NCT00994162|529930876|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
146938324|NCT00994162|529930876|FG000|Overall Study|Physician Decision|2|||
146938325|NCT00994162|529930876|FG000|Overall Study|Surrounding Wound Erythematous|1|||
146938326|NCT00994162|529930876|FG000|Overall Study|Machine Losing Vaccum|1|||
146938327|NCT00994162|529930876|FG000|Overall Study|Patient Lived Too Far Away|1|||
146938328|NCT00994162|529930876|FG000|Overall Study|Above Knee Amputation|1|||
146938329|NCT00994162|529930876|FG000|Overall Study|Reason Not Reported By Site|1|||
146938330|NCT02983799|529930877|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
146938331|NCT02983799|529930878|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
146938332|NCT02983799|529930879|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
146938333|NCT02983799|529930880|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
146938334|NCT02983799|529930881|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
146938335|NCT02983799|529930877|FG000|Overall Study|Death|20|||
146938336|NCT02983799|529930878|FG001|Overall Study|Death|5|||
146938337|NCT02983799|529930879|FG002|Overall Study|Death|23|||
146938338|NCT02983799|529930880|FG003|Overall Study|Death|47|||
146938339|NCT02983799|529930881|FG004|Overall Study|Death|7|||
146938340|NCT02983799|529930877|FG000|Overall Study|Withdrawal by Subject|1|||
146938341|NCT02983799|529930878|FG001|Overall Study|Withdrawal by Subject|0|||
146938342|NCT02983799|529930879|FG002|Overall Study|Withdrawal by Subject|3|||
146938343|NCT02983799|529930880|FG003|Overall Study|Withdrawal by Subject|4|||
146938344|NCT02983799|529930881|FG004|Overall Study|Withdrawal by Subject|1|||
146938345|NCT02983799|529930877|FG000|Overall Study|Protocol Violation|0|||
146789807|NCT05415722|529401491|FG002|Overall Study|Sponsor Discretion|0|||
146789808|NCT05415722|529401492|FG003|Overall Study|Sponsor Discretion|0|||
146789809|NCT05415722|529401493|FG004|Overall Study|Sponsor Discretion|1|||
146789810|NCT05415722|529401494|FG005|Overall Study|Sponsor Discretion|1|||
146789811|NCT05415722|529401495|FG006|Overall Study|Sponsor Discretion|0|||
146789812|NCT05415722|529401489|FG000|Overall Study|Withdrawal by Subject|0|||
146789813|NCT05415722|529401490|FG001|Overall Study|Withdrawal by Subject|1|||
146789814|NCT05415722|529401491|FG002|Overall Study|Withdrawal by Subject|0|||
146789815|NCT05415722|529401492|FG003|Overall Study|Withdrawal by Subject|1|||
146789816|NCT05415722|529401493|FG004|Overall Study|Withdrawal by Subject|1|||
146789817|NCT05415722|529401494|FG005|Overall Study|Withdrawal by Subject|0|||
146789818|NCT05415722|529401495|FG006|Overall Study|Withdrawal by Subject|1|||
146789819|NCT04537715|529401501|FG000|Overall Study|Death|3|||
146789820|NCT04537715|529401502|FG001|Overall Study|Death|1|||
146789821|NCT04537715|529401501|FG000|Overall Study|Withdrawal by Subject|3|||
146789822|NCT04537715|529401502|FG001|Overall Study|Withdrawal by Subject|1|||
146789823|NCT04537715|529401501|FG000|Overall Study|Other|4|||
146789824|NCT04537715|529401502|FG001|Overall Study|Other|3|||
146789825|NCT04537715|529401501|FG000|Overall Study|Progressive disease|1|||
146789826|NCT04537715|529401502|FG001|Overall Study|Progressive disease|0|||
146789827|NCT02191618|529401503|FG000|Overall Study|Withdrawal by Subject|3|||
146789828|NCT02191618|529401503|FG000|Overall Study|Missed Visit|4|||
146789829|NCT03031470|529401504|FG000|Overall Study|Adverse Event|3|||
146789830|NCT03031470|529401505|FG001|Overall Study|Adverse Event|0|||
146789831|NCT03031470|529401504|FG000|Overall Study|Death|3|||
146789832|NCT03031470|529401505|FG001|Overall Study|Death|1|||
146789833|NCT03031470|529401504|FG000|Overall Study|Lost to Follow-up|1|||
146789834|NCT03031470|529401505|FG001|Overall Study|Lost to Follow-up|1|||
146789835|NCT03031470|529401504|FG000|Overall Study|Withdrawal by Subject|1|||
146789836|NCT03031470|529401505|FG001|Overall Study|Withdrawal by Subject|0|||
146789837|NCT03031470|529401504|FG000|Overall Study|Protocol entry criteria not met|0|||
146789838|NCT03031470|529401505|FG001|Overall Study|Protocol entry criteria not met|1|||
146789839|NCT03031470|529401504|FG000|Overall Study|Cancel the operation|0|||
146789840|NCT03031470|529401505|FG001|Overall Study|Cancel the operation|1|||
146789841|NCT02489903|529401508|FG000|Screening|Screen Failure|24|||
146789842|NCT02489903|529401509|FG001|Screening|Screen Failure|0|||
146789843|NCT02489903|529401510|FG002|Screening|Screen Failure|0|||
146789844|NCT02489903|529401511|FG003|Screening|Screen Failure|8|||
146789845|NCT02489903|529401508|FG000|Randomized and Received Treatment|Protocol Violation|0|||
146789846|NCT02489903|529401509|FG001|Randomized and Received Treatment|Protocol Violation|1|||
146789847|NCT02489903|529401510|FG002|Randomized and Received Treatment|Protocol Violation|0|||
146789848|NCT02489903|529401511|FG003|Randomized and Received Treatment|Protocol Violation|0|||
146789849|NCT02489903|529401508|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
146789850|NCT02489903|529401509|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
146789851|NCT02489903|529401510|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
146789852|NCT02489903|529401511|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
146789853|NCT02489903|529401508|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
146789854|NCT02489903|529401509|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
146789855|NCT02489903|529401510|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
146938346|NCT02983799|529930878|FG001|Overall Study|Protocol Violation|1|||
146938347|NCT02983799|529930879|FG002|Overall Study|Protocol Violation|0|||
146938348|NCT02983799|529930880|FG003|Overall Study|Protocol Violation|0|||
146981960|NCT03361956|530096190|FG001|Overall Study|Adverse Event|0|||
146731624|NCT01493687|529188779|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
146731625|NCT01493687|529188780|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
146731626|NCT01493687|529188779|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
146731627|NCT01493687|529188780|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
146731628|NCT01493687|529188779|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
146731629|NCT01493687|529188780|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
146731630|NCT01493687|529188779|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
146731631|NCT01493687|529188780|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
146731632|NCT01493687|529188779|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
146731633|NCT01493687|529188780|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
146731634|NCT02323646|529188784|FG000|Treatment Course 1|Adverse Event|1|||
146731635|NCT02323646|529188785|FG001|Treatment Course 1|Adverse Event|0|||
146731636|NCT02323646|529188786|FG002|Treatment Course 1|Adverse Event|1|||
146731637|NCT02323646|529188784|FG000|Treatment Course 1|Heavy Bleeding|1|||
146731638|NCT02323646|529188785|FG001|Treatment Course 1|Heavy Bleeding|1|||
146731639|NCT02323646|529188786|FG002|Treatment Course 1|Heavy Bleeding|0|||
146731640|NCT02323646|529188784|FG000|Treatment Course 1|Lost to Follow-up|1|||
146731641|NCT02323646|529188785|FG001|Treatment Course 1|Lost to Follow-up|0|||
146731642|NCT02323646|529188786|FG002|Treatment Course 1|Lost to Follow-up|2|||
146731643|NCT02323646|529188784|FG000|Treatment Course 1|Withdrawal by Subject|0|||
146731644|NCT02323646|529188785|FG001|Treatment Course 1|Withdrawal by Subject|2|||
146731645|NCT02323646|529188786|FG002|Treatment Course 1|Withdrawal by Subject|0|||
146731646|NCT02323646|529188784|FG000|Treatment Course 2|Adverse Event|1|||
146731647|NCT02323646|529188785|FG001|Treatment Course 2|Adverse Event|0|||
146731648|NCT02323646|529188786|FG002|Treatment Course 2|Adverse Event|1|||
146731649|NCT02323646|529188784|FG000|Treatment Course 2|Lost to Follow-up|0|||
146731650|NCT02323646|529188785|FG001|Treatment Course 2|Lost to Follow-up|0|||
146731651|NCT02323646|529188786|FG002|Treatment Course 2|Lost to Follow-up|1|||
146731652|NCT02323646|529188784|FG000|Treatment Course 2|Non-compliance|0|||
146731653|NCT02323646|529188785|FG001|Treatment Course 2|Non-compliance|1|||
146731654|NCT02323646|529188786|FG002|Treatment Course 2|Non-compliance|1|||
146731655|NCT00521144|529188787|FG000|Overall Study|Not Treated|0|||
146731656|NCT00521144|529188788|FG001|Overall Study|Not Treated|0|||
146731657|NCT00521144|529188789|FG002|Overall Study|Not Treated|0|||
146731658|NCT00521144|529188790|FG003|Overall Study|Not Treated|1|||
146731659|NCT00521144|529188791|FG004|Overall Study|Not Treated|0|||
146731660|NCT00521144|529188787|FG000|Overall Study|Adverse Event|0|||
146731661|NCT00521144|529188788|FG001|Overall Study|Adverse Event|1|||
146731662|NCT00521144|529188789|FG002|Overall Study|Adverse Event|0|||
146731663|NCT00521144|529188790|FG003|Overall Study|Adverse Event|0|||
146731664|NCT00521144|529188791|FG004|Overall Study|Adverse Event|1|||
146731665|NCT00521144|529188787|FG000|Overall Study|Progressive Disease|4|||
146731666|NCT00521144|529188788|FG001|Overall Study|Progressive Disease|2|||
146731667|NCT00521144|529188789|FG002|Overall Study|Progressive Disease|2|||
146731668|NCT00521144|529188790|FG003|Overall Study|Progressive Disease|0|||
146731669|NCT00521144|529188791|FG004|Overall Study|Progressive Disease|6|||
146731670|NCT01370525|529188792|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
146731671|NCT01370525|529188793|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
146731672|NCT01370525|529188792|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
146731673|NCT01370525|529188793|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146731674|NCT01370525|529188792|FG000|Overall Study|Adverse Event|0|||
146731675|NCT01370525|529188793|FG001|Overall Study|Adverse Event|1|||
146731676|NCT01370525|529188792|FG000|Overall Study|Protocol Violation|2|||
146731677|NCT01370525|529188793|FG001|Overall Study|Protocol Violation|1|||
146731678|NCT01370525|529188792|FG000|Overall Study|Lost to follow up|2|||
146731679|NCT01370525|529188793|FG001|Overall Study|Lost to follow up|6|||
146731680|NCT04791761|529188796|FG000|Overall Study|Lost to Follow-up|8|||
146731681|NCT04791761|529188797|FG001|Overall Study|Lost to Follow-up|6|||
146731682|NCT04791761|529188798|FG002|Overall Study|Lost to Follow-up|10|||
146731683|NCT04791761|529188796|FG000|Overall Study|Withdrawal by Subject|0|||
146731684|NCT04791761|529188797|FG001|Overall Study|Withdrawal by Subject|1|||
146731685|NCT04791761|529188798|FG002|Overall Study|Withdrawal by Subject|1|||
146731686|NCT04791761|529188796|FG000|Overall Study|Protocol Violation|0|||
146731687|NCT04791761|529188797|FG001|Overall Study|Protocol Violation|1|||
146731688|NCT04791761|529188798|FG002|Overall Study|Protocol Violation|1|||
146731689|NCT00180479|529188802|FG000|Overall Study|Death|4|||
146731690|NCT00180479|529188803|FG001|Overall Study|Death|2|||
146731691|NCT00180479|529188802|FG000|Overall Study|Lost to Follow-up|9|||
146731692|NCT00180479|529188803|FG001|Overall Study|Lost to Follow-up|7|||
146731693|NCT00180479|529188802|FG000|Overall Study|Withdrawal by Subject|3|||
146731694|NCT00180479|529188803|FG001|Overall Study|Withdrawal by Subject|3|||
146731695|NCT00180479|529188802|FG000|Overall Study|Informed consent not signed|0|||
146731696|NCT00180479|529188803|FG001|Overall Study|Informed consent not signed|1|||
146731697|NCT00526630|529188804|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
146731698|NCT00526630|529188805|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
146981961|NCT03361956|530096191|FG002|Overall Study|Adverse Event|1|||
146981962|NCT03361956|530096192|FG003|Overall Study|Adverse Event|1|||
146981963|NCT03361956|530096193|FG004|Overall Study|Adverse Event|0|||
146731699|NCT00526630|529188804|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
146731700|NCT00526630|529188805|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
146731701|NCT05168579|529188806|FG000|Overall Study|Lack of Consent|1|||
146731702|NCT05168579|529188807|FG001|Overall Study|Lack of Consent|0|||
146731703|NCT05168579|529188806|FG000|Overall Study|Conflicts with time|2|||
146731704|NCT05168579|529188807|FG001|Overall Study|Conflicts with time|0|||
146731705|NCT05168579|529188806|FG000|Overall Study|Time slots were full|3|||
146731706|NCT05168579|529188807|FG001|Overall Study|Time slots were full|0|||
146731707|NCT05168579|529188806|FG000|Overall Study|Lost to Follow-up|0|||
146731708|NCT05168579|529188807|FG001|Overall Study|Lost to Follow-up|15|||
146731709|NCT00840801|529188808|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
146731710|NCT00840801|529188809|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
146731711|NCT00840801|529188810|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
146731712|NCT00840801|529188808|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
146731713|NCT00840801|529188809|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
146731714|NCT00840801|529188810|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
146731715|NCT00840801|529188808|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
146731716|NCT00840801|529188809|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
146731717|NCT00840801|529188810|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
146731718|NCT00840801|529188808|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
146731719|NCT00840801|529188809|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
146731720|NCT00840801|529188810|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
146731721|NCT01242748|529188811|FG000|Overall Study|Adverse Event|10|||
146731722|NCT01242748|529188812|FG001|Overall Study|Adverse Event|5|||
146731723|NCT01242748|529188811|FG000|Overall Study|Lost to Follow-up|6|||
146731724|NCT01242748|529188812|FG001|Overall Study|Lost to Follow-up|2|||
146731725|NCT01242748|529188811|FG000|Overall Study|Physician Decision|3|||
146731726|NCT01242748|529188812|FG001|Overall Study|Physician Decision|2|||
146731727|NCT01242748|529188811|FG000|Overall Study|Protocol Violation|1|||
146731728|NCT01242748|529188812|FG001|Overall Study|Protocol Violation|0|||
146731729|NCT01242748|529188811|FG000|Overall Study|Withdrawal by Subject|10|||
146731730|NCT01242748|529188812|FG001|Overall Study|Withdrawal by Subject|2|||
146731731|NCT01242748|529188811|FG000|Overall Study|Miscellaneous reasons|8|||
146731732|NCT01242748|529188812|FG001|Overall Study|Miscellaneous reasons|3|||
146731733|NCT00335452|529188813|FG000|Overall Study|Death|156|||
146731734|NCT00335452|529188814|FG001|Overall Study|Death|144|||
146731735|NCT00335452|529188815|FG002|Overall Study|Death|158|||
146731736|NCT00335452|529188816|FG003|Overall Study|Death|129|||
146731737|NCT00335452|529188813|FG000|Overall Study|Lost to Follow-up|2|||
146731738|NCT00335452|529188814|FG001|Overall Study|Lost to Follow-up|3|||
146731739|NCT00335452|529188815|FG002|Overall Study|Lost to Follow-up|1|||
146731740|NCT00335452|529188816|FG003|Overall Study|Lost to Follow-up|2|||
146731741|NCT02736825|529188817|FG000|Overall Study|Lost to Follow-up|10|||
146731742|NCT02736825|529188818|FG001|Overall Study|Lost to Follow-up|11|||
146731743|NCT02736825|529188817|FG000|Overall Study|Early Termination|0|||
146731744|NCT02736825|529188818|FG001|Overall Study|Early Termination|1|||
146731745|NCT00790452|529188820|FG000|Overall Study|Drug supply issue|1|||
146731746|NCT00790452|529188821|FG001|Overall Study|Drug supply issue|0|||
146731747|NCT02940574|529188822|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
146731748|NCT02940574|529188823|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
146731749|NCT02940574|529188822|FG000|1-year Follow-up|Lost to Follow-up|3|||
146731750|NCT02940574|529188823|FG001|1-year Follow-up|Lost to Follow-up|4|||
146731751|NCT01750879|529188826|FG000|Overall Study|Adverse Event|8|||
146731752|NCT01750879|529188827|FG001|Overall Study|Adverse Event|0|||
146731753|NCT01750879|529188826|FG000|Overall Study|Lack of Efficacy|1|||
146731754|NCT01750879|529188827|FG001|Overall Study|Lack of Efficacy|0|||
146731755|NCT01750879|529188826|FG000|Overall Study|Withdrawal by Subject|1|||
146731756|NCT01750879|529188827|FG001|Overall Study|Withdrawal by Subject|0|||
146731757|NCT01750879|529188826|FG000|Overall Study|Did not complete per protocol|0|||
146731758|NCT01750879|529188827|FG001|Overall Study|Did not complete per protocol|3|||
146731759|NCT04810221|529188828|FG000|Overall Study|Physician Decision|3|||
146731760|NCT03642938|529188829|FG000|Overall Study|Withdrawal by Subject|0|||
146731761|NCT03642938|529188830|FG001|Overall Study|Withdrawal by Subject|0|||
146731762|NCT03642938|529188831|FG002|Overall Study|Withdrawal by Subject|0|||
146731763|NCT03642938|529188832|FG003|Overall Study|Withdrawal by Subject|1|||
146731764|NCT00105235|529188833|FG000|Overall Study|Death|4|||
146731765|NCT00105235|529188833|FG000|Overall Study|Physician Decision|1|||
146731766|NCT00105235|529188833|FG000|Overall Study|Withdrawal by Subject|2|||
146731767|NCT01964326|529188834|FG000|Overall Study|Adverse Event|48|||
146731768|NCT01964326|529188834|FG000|Overall Study|Death|2|||
146731769|NCT01964326|529188834|FG000|Overall Study|Protocol Violation|4|||
146731770|NCT01964326|529188834|FG000|Overall Study|Lost to Follow-up|88|||
146981964|NCT03361956|530096189|FG000|Overall Study|Other|0|||
146789856|NCT02489903|529401511|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
146789857|NCT02489903|529401508|FG000|Randomized and Received Treatment|Death|10|||
146789858|NCT02489903|529401509|FG001|Randomized and Received Treatment|Death|1|||
146789859|NCT02489903|529401510|FG002|Randomized and Received Treatment|Death|0|||
146789860|NCT02489903|529401511|FG003|Randomized and Received Treatment|Death|0|||
146789861|NCT03848065|529401512|FG000|Overall Study|Death|0|||
146789862|NCT03848065|529401513|FG001|Overall Study|Death|1|||
146789863|NCT03848065|529401514|FG002|Overall Study|Death|0|||
146789864|NCT03848065|529401512|FG000|Overall Study|Lost to Follow-up|0|||
146789865|NCT03848065|529401513|FG001|Overall Study|Lost to Follow-up|0|||
146789866|NCT03848065|529401514|FG002|Overall Study|Lost to Follow-up|1|||
146789867|NCT03848065|529401512|FG000|Overall Study|Physician Decision|0|||
146789868|NCT03848065|529401513|FG001|Overall Study|Physician Decision|0|||
146789869|NCT03848065|529401514|FG002|Overall Study|Physician Decision|1|||
146789870|NCT04568603|529401517|FG000|Overall Study|Physician Decision|1|||
146789871|NCT04564742|529401518|FG000|Overall Study|Lost to Follow-up|1|||
146789872|NCT04564742|529401519|FG001|Overall Study|Lost to Follow-up|0|||
146789873|NCT04564742|529401518|FG000|Overall Study|Consent Withdrawal|4|||
146789874|NCT04564742|529401519|FG001|Overall Study|Consent Withdrawal|4|||
146789875|NCT05126433|529401523|FG000|Overall Study|Withdrawal by Subject|3|||
146789876|NCT05126433|529401524|FG001|Overall Study|Withdrawal by Subject|0|||
146789877|NCT05126433|529401525|FG002|Overall Study|Withdrawal by Subject|4|||
146789878|NCT05126433|529401523|FG000|Overall Study|Death|9|||
146789879|NCT05126433|529401524|FG001|Overall Study|Death|3|||
146789880|NCT05126433|529401525|FG002|Overall Study|Death|5|||
146789881|NCT05126433|529401523|FG000|Overall Study|Study Terminated by sponsor|0|||
146789882|NCT05126433|529401524|FG001|Overall Study|Study Terminated by sponsor|1|||
146789883|NCT05126433|529401525|FG002|Overall Study|Study Terminated by sponsor|2|||
146789884|NCT05126433|529401523|FG000|Overall Study|Progressive Disease|1|||
146789885|NCT05126433|529401524|FG001|Overall Study|Progressive Disease|4|||
146789886|NCT05126433|529401525|FG002|Overall Study|Progressive Disease|3|||
146789887|NCT05126433|529401523|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
146789888|NCT05126433|529401524|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
146789889|NCT05126433|529401525|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
146789890|NCT05144009|529401526|FG000|Overall Study|Lost to Follow-up|0|||
146789891|NCT05144009|529401527|FG001|Overall Study|Lost to Follow-up|1|||
146789892|NCT05144009|529401526|FG000|Overall Study|Study Termination by the Sponsor|11|||
146789893|NCT05144009|529401527|FG001|Overall Study|Study Termination by the Sponsor|11|||
146789894|NCT05144009|529401526|FG000|Overall Study|Disease Progression|1|||
146789895|NCT05144009|529401527|FG001|Overall Study|Disease Progression|0|||
146789896|NCT05144009|529401526|FG000|Overall Study|Participant Decision|0|||
146789897|NCT05144009|529401527|FG001|Overall Study|Participant Decision|2|||
146789898|NCT05144009|529401526|FG000|Overall Study|Death|5|||
146789899|NCT05144009|529401527|FG001|Overall Study|Death|10|||
146789900|NCT00764751|529401528|FG000|Overall Study|Adverse Event|1|||
146789901|NCT00764751|529401529|FG001|Overall Study|Adverse Event|1|||
146789902|NCT00764751|529401528|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
146789903|NCT00764751|529401529|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
146789904|NCT05201079|529401533|FG000|Overall Study|Adverse Event|7|||
146789905|NCT05201079|529401534|FG001|Overall Study|Adverse Event|11|||
146789906|NCT05201079|529401533|FG000|Overall Study|Death|1|||
146789907|NCT05201079|529401534|FG001|Overall Study|Death|1|||
146789908|NCT05201079|529401533|FG000|Overall Study|Lack of Efficacy|0|||
146789909|NCT05201079|529401534|FG001|Overall Study|Lack of Efficacy|2|||
146789910|NCT05201079|529401533|FG000|Overall Study|Lost to Follow-up|0|||
146789911|NCT05201079|529401534|FG001|Overall Study|Lost to Follow-up|1|||
146789912|NCT05201079|529401533|FG000|Overall Study|Physician Decision|1|||
146789913|NCT05201079|529401534|FG001|Overall Study|Physician Decision|1|||
146789914|NCT05201079|529401533|FG000|Overall Study|Protocol Violation|1|||
146789915|NCT05201079|529401534|FG001|Overall Study|Protocol Violation|0|||
146789916|NCT05201079|529401533|FG000|Overall Study|Withdrawal by Subject|1|||
146789917|NCT05201079|529401534|FG001|Overall Study|Withdrawal by Subject|0|||
146789918|NCT05201079|529401533|FG000|Overall Study|Forbidden medication|9|||
146789919|NCT05201079|529401534|FG001|Overall Study|Forbidden medication|5|||
146620790|NCT05470985|528783427|FG000|Double Blind Treatment Period|Physician Decision|0|||
146789920|NCT05201079|529401533|FG000|Overall Study|Transfer to another hospital|0|||
146789921|NCT05201079|529401534|FG001|Overall Study|Transfer to another hospital|1|||
146789922|NCT05201079|529401533|FG000|Overall Study|Clinical condition|1|||
146789923|NCT05201079|529401534|FG001|Overall Study|Clinical condition|0|||
146789924|NCT05201079|529401533|FG000|Overall Study|SAE and sepsis|1|||
146789925|NCT05201079|529401534|FG001|Overall Study|SAE and sepsis|0|||
146789926|NCT04145440|529401535|FG000|Overall Study|Physician Decision|3|||
146789927|NCT04145440|529401536|FG001|Overall Study|Physician Decision|0|||
146789928|NCT04145440|529401535|FG000|Overall Study|Use of prohibited therapy|2|||
146789929|NCT04145440|529401536|FG001|Overall Study|Use of prohibited therapy|3|||
146789930|NCT05281562|529401539|FG000|Overall Study|Ineligible patient|1|||
146789931|NCT05281562|529401540|FG001|Overall Study|Ineligible patient|0|||
146789932|NCT01919554|529401549|FG000|Overall Study|Withdrawal by Subject|0|||
146789933|NCT01919554|529401550|FG001|Overall Study|Withdrawal by Subject|0|||
146789934|NCT01919554|529401551|FG002|Overall Study|Withdrawal by Subject|1|||
146789935|NCT01919554|529401552|FG003|Overall Study|Withdrawal by Subject|1|||
146789936|NCT04880863|529401553|FG000|Overall Study|Adverse Event|1|||
146789937|NCT04880863|529401553|FG000|Overall Study|Patient decision|2|||
146789938|NCT04880863|529401553|FG000|Overall Study|Confirmed Disease Progression|15|||
146789939|NCT04880863|529401553|FG000|Overall Study|Death|3|||
146789940|NCT04880863|529401553|FG000|Overall Study|Physician Decision|4|||
146789941|NCT04880863|529401553|FG000|Overall Study|Unconfirmed Disease Progression|4|||
146789942|NCT04880863|529401553|FG000|Overall Study|Withdrawal by Subject|2|||
146789943|NCT04880863|529401553|FG000|Overall Study|Study discontinuation by the sponsor|4|||
146789944|NCT04880863|529401553|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
146789945|NCT04880863|529401553|FG000|Overall Study|Not received study drug NAP|2|||
146789946|NCT04898673|529401554|FG000|Overall Study|Screenfail|1|||
146789947|NCT04898673|529401555|FG001|Overall Study|Screenfail|0|||
146789948|NCT01152450|529401556|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
146981965|NCT03361956|530096190|FG001|Overall Study|Other|0|||
146981966|NCT03361956|530096191|FG002|Overall Study|Other|0|||
146981967|NCT03361956|530096192|FG003|Overall Study|Other|1|||
146981968|NCT03361956|530096193|FG004|Overall Study|Other|0|||
146981969|NCT03361956|530096189|FG000|Overall Study|Withdrawal by Subject|2|||
146981970|NCT03361956|530096190|FG001|Overall Study|Withdrawal by Subject|2|||
146981971|NCT03361956|530096191|FG002|Overall Study|Withdrawal by Subject|2|||
146981972|NCT03361956|530096192|FG003|Overall Study|Withdrawal by Subject|0|||
146981973|NCT03361956|530096193|FG004|Overall Study|Withdrawal by Subject|3|||
146981974|NCT03361956|530096189|FG000|Overall Study|Disease Relapse|0|||
146981975|NCT03361956|530096190|FG001|Overall Study|Disease Relapse|0|||
146981976|NCT03361956|530096191|FG002|Overall Study|Disease Relapse|1|||
146981977|NCT03361956|530096192|FG003|Overall Study|Disease Relapse|0|||
146981978|NCT03361956|530096193|FG004|Overall Study|Disease Relapse|0|||
146981979|NCT03361956|530096189|FG000|Overall Study|Physician Decision|0|||
146981980|NCT03361956|530096190|FG001|Overall Study|Physician Decision|2|||
146981981|NCT03361956|530096191|FG002|Overall Study|Physician Decision|0|||
146981982|NCT03361956|530096192|FG003|Overall Study|Physician Decision|1|||
146981983|NCT03361956|530096193|FG004|Overall Study|Physician Decision|0|||
146981984|NCT03361956|530096189|FG000|Overall Study|Lost to Follow-up|0|||
146981985|NCT03361956|530096190|FG001|Overall Study|Lost to Follow-up|0|||
146981986|NCT03361956|530096191|FG002|Overall Study|Lost to Follow-up|1|||
146981987|NCT03361956|530096192|FG003|Overall Study|Lost to Follow-up|1|||
146981988|NCT03361956|530096193|FG004|Overall Study|Lost to Follow-up|2|||
146731771|NCT01964326|529188834|FG000|Overall Study|Withdrawal by Subject|87|||
146731772|NCT01964326|529188834|FG000|Overall Study|Pregnancy|1|||
146731773|NCT01964326|529188834|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
146731774|NCT01964326|529188834|FG000|Overall Study|Physician Decision|55|||
146731775|NCT01964326|529188834|FG000|Overall Study|Investigator Discretion|1|||
146731776|NCT01964326|529188834|FG000|Overall Study|Other|9|||
146731777|NCT01964326|529188834|FG000|Overall Study|Did not meet eligibility criteria|1|||
146731778|NCT02347657|529188835|FG000|Overall Study|Physician Decision|0|||
146731779|NCT02347657|529188836|FG001|Overall Study|Physician Decision|1|||
146731780|NCT02347657|529188835|FG000|Overall Study|Adverse Event|8|||
146731781|NCT02347657|529188836|FG001|Overall Study|Adverse Event|4|||
146731782|NCT02347657|529188835|FG000|Overall Study|Withdrawal by Subject|6|||
146731783|NCT02347657|529188836|FG001|Overall Study|Withdrawal by Subject|7|||
146731784|NCT02347657|529188835|FG000|Overall Study|Randomized but not treated|1|||
146731785|NCT02347657|529188836|FG001|Overall Study|Randomized but not treated|0|||
146731786|NCT02347657|529188835|FG000|Overall Study|Other|3|||
146731787|NCT02347657|529188836|FG001|Overall Study|Other|3|||
146731788|NCT01621880|529188843|FG000|Overall Study|Adverse Event|5|||
146731789|NCT01621880|529188844|FG001|Overall Study|Adverse Event|1|||
146731790|NCT01621880|529188843|FG000|Overall Study|Withdrawal by Subject|5|||
146731791|NCT01621880|529188844|FG001|Overall Study|Withdrawal by Subject|4|||
146731792|NCT01662063|529188845|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
146731793|NCT01662063|529188846|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
146731794|NCT01662063|529188847|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
146731795|NCT01662063|529188845|FG000|Overall Study|Lack of Efficacy|1|||
146731796|NCT01662063|529188846|FG001|Overall Study|Lack of Efficacy|6|||
146731797|NCT01662063|529188847|FG002|Overall Study|Lack of Efficacy|0|||
146731798|NCT01662063|529188845|FG000|Overall Study|Lost to Follow-up|0|||
146731799|NCT01662063|529188846|FG001|Overall Study|Lost to Follow-up|4|||
146731800|NCT01662063|529188847|FG002|Overall Study|Lost to Follow-up|0|||
146731801|NCT01662063|529188845|FG000|Overall Study|Protocol Violation|1|||
146789949|NCT01152450|529401557|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
146789950|NCT01152450|529401558|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
146789951|NCT01152450|529401559|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
146789952|NCT01152450|529401560|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
146981989|NCT00291330|530096195|FG000|Overall Study|Adverse Event|47|||
146981990|NCT00291330|530096196|FG001|Overall Study|Adverse Event|40|||
146981991|NCT00291330|530096195|FG000|Overall Study|Protocol Violation|13|||
146981992|NCT00291330|530096196|FG001|Overall Study|Protocol Violation|20|||
146789953|NCT01152450|529401561|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
146789954|NCT01152450|529401556|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
146789955|NCT01152450|529401557|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
146789956|NCT01152450|529401558|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
146789957|NCT01152450|529401559|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
146789958|NCT01152450|529401560|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
146789959|NCT01152450|529401561|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
146789960|NCT01152450|529401556|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
146789961|NCT01152450|529401557|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
146789962|NCT01152450|529401558|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
146789963|NCT01152450|529401559|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
146789964|NCT01152450|529401560|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
146789965|NCT01152450|529401561|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
146789966|NCT03365882|529401566|FG000|Randomization|Still Receiving Protocol Treatment|2|||
146789967|NCT03365882|529401567|FG001|Randomization|Still Receiving Protocol Treatment|0|||
146789968|NCT03365882|529401566|FG000|Randomization|Adverse Event|1|||
146789969|NCT03365882|529401567|FG001|Randomization|Adverse Event|2|||
146789970|NCT03365882|529401566|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
146938349|NCT02983799|529930881|FG004|Overall Study|Protocol Violation|1|||
146938350|NCT02983799|529930877|FG000|Overall Study|Lost to Follow-up|1|||
146938351|NCT02983799|529930878|FG001|Overall Study|Lost to Follow-up|0|||
146938352|NCT02983799|529930879|FG002|Overall Study|Lost to Follow-up|1|||
146938353|NCT02983799|529930880|FG003|Overall Study|Lost to Follow-up|0|||
146938354|NCT02983799|529930881|FG004|Overall Study|Lost to Follow-up|0|||
146938355|NCT03136367|529930892|FG000|T1 Consultation|discontinued mistakenly included|2|||
146938356|NCT03136367|529930893|FG001|T1 Consultation|discontinued mistakenly included|6|||
146938357|NCT03136367|529930894|FG002|T1 Consultation|discontinued mistakenly included|1|||
146938358|NCT03136367|529930892|FG000|T1 Consultation|Discontinued other|0|||
146938359|NCT03136367|529930893|FG001|T1 Consultation|Discontinued other|1|||
146938360|NCT03136367|529930894|FG002|T1 Consultation|Discontinued other|0|||
146938361|NCT03136367|529930892|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
146938362|NCT03136367|529930893|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
146938363|NCT03136367|529930894|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
146938364|NCT03136367|529930892|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
146938365|NCT03136367|529930893|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
146938366|NCT03136367|529930894|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
146938367|NCT03136367|529930892|FG000|T2 Post-consultation|Discontinued other|0|||
146938368|NCT03136367|529930893|FG001|T2 Post-consultation|Discontinued other|2|||
146938369|NCT03136367|529930894|FG002|T2 Post-consultation|Discontinued other|6|||
146938370|NCT03136367|529930892|FG000|T2 Post-consultation|Discontinued transferred care|0|||
146938371|NCT03136367|529930893|FG001|T2 Post-consultation|Discontinued transferred care|0|||
146938372|NCT03136367|529930894|FG002|T2 Post-consultation|Discontinued transferred care|3|||
146938373|NCT03136367|529930892|FG000|T2 Post-consultation|Discontinued lost contact|0|||
146938374|NCT03136367|529930893|FG001|T2 Post-consultation|Discontinued lost contact|1|||
146938375|NCT03136367|529930894|FG002|T2 Post-consultation|Discontinued lost contact|0|||
146938376|NCT03136367|529930892|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
146938377|NCT03136367|529930893|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
146938378|NCT03136367|529930894|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
146938379|NCT03136367|529930892|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
146938380|NCT03136367|529930893|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
146938381|NCT03136367|529930894|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
146938382|NCT03136367|529930892|FG000|T3 1 Week After Surgery|other discontinued|2|||
146938383|NCT03136367|529930893|FG001|T3 1 Week After Surgery|other discontinued|4|||
146938384|NCT03136367|529930894|FG002|T3 1 Week After Surgery|other discontinued|3|||
146938385|NCT03136367|529930892|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
146938386|NCT03136367|529930893|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
146938387|NCT03136367|529930894|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
146938388|NCT03136367|529930892|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
146938389|NCT03136367|529930893|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
146789971|NCT03365882|529401567|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
146938390|NCT03136367|529930894|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
146938391|NCT03136367|529930892|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
146938392|NCT03136367|529930893|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
146938393|NCT03136367|529930894|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
146938394|NCT03136367|529930892|FG000|T4 12 Weeks After Surgery|Death|0|||
146938395|NCT03136367|529930893|FG001|T4 12 Weeks After Surgery|Death|1|||
146938396|NCT03136367|529930894|FG002|T4 12 Weeks After Surgery|Death|3|||
146938397|NCT03136367|529930892|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
146981993|NCT00291330|530096195|FG000|Overall Study|Lost to Follow-up|16|||
146981994|NCT00291330|530096196|FG001|Overall Study|Lost to Follow-up|11|||
146789972|NCT03365882|529401566|FG000|Randomization|Progression/Relapse|21|||
146789973|NCT03365882|529401567|FG001|Randomization|Progression/Relapse|3|||
146789974|NCT03365882|529401566|FG000|Randomization|Death|1|||
146981995|NCT00291330|530096195|FG000|Overall Study|Withdrawal by Subject|22|||
146981996|NCT00291330|530096196|FG001|Overall Study|Withdrawal by Subject|25|||
146981997|NCT00291330|530096195|FG000|Overall Study|Other|3|||
146789975|NCT03365882|529401567|FG001|Randomization|Death|0|||
146789976|NCT03365882|529401566|FG000|Randomization|Other - Not Protocol Specified|1|||
146789977|NCT03365882|529401567|FG001|Randomization|Other - Not Protocol Specified|1|||
146789978|NCT03365882|529401566|FG000|Randomization|Major Protocol Deviation|0|||
146789979|NCT03365882|529401567|FG001|Randomization|Major Protocol Deviation|1|||
146789980|NCT03365882|529401566|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
146789981|NCT03365882|529401567|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
146789982|NCT03365882|529401566|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
146789983|NCT03365882|529401567|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
146789984|NCT03365882|529401566|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
146789985|NCT03365882|529401567|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
146789986|NCT03365882|529401566|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
146789987|NCT03365882|529401567|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
146789988|NCT04828005|529401568|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
146789989|NCT04828005|529401569|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
146789990|NCT04828005|529401570|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
146789991|NCT04828005|529401571|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
146789992|NCT04828005|529401568|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
146789993|NCT04828005|529401569|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
146789994|NCT04828005|529401570|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
146789995|NCT04828005|529401571|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
146789996|NCT04828005|529401568|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
146789997|NCT04828005|529401569|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
146789998|NCT04828005|529401570|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
146789999|NCT04828005|529401571|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
146790000|NCT04828005|529401568|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
146790001|NCT04828005|529401569|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
146790002|NCT04828005|529401570|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
146790003|NCT04828005|529401571|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
146790004|NCT04828005|529401568|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
146790005|NCT04828005|529401569|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
146790006|NCT04828005|529401570|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
146790007|NCT04828005|529401571|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
146790008|NCT04828005|529401568|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
146790009|NCT04828005|529401569|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
146790010|NCT04828005|529401570|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
146790011|NCT04828005|529401571|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
146790012|NCT04828005|529401568|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
146790013|NCT04828005|529401569|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
146790014|NCT04828005|529401570|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
146790015|NCT04828005|529401571|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
146790016|NCT04828005|529401568|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
146790017|NCT04828005|529401569|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
146790018|NCT04828005|529401570|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
146790019|NCT04828005|529401571|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
146790020|NCT04828005|529401568|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
146790021|NCT04828005|529401569|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
146790022|NCT04828005|529401570|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
146790023|NCT04828005|529401571|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
146790024|NCT06181227|529403434|FG000|Overall Study|Study terminated by sponsor|7|||
146790025|NCT06181227|529403435|FG001|Overall Study|Study terminated by sponsor|9|||
146790026|NCT00470704|529403438|FG000|Overall Study|Withdrawal by Subject|4|||
146790027|NCT00470704|529403439|FG001|Overall Study|Withdrawal by Subject|3|||
146790028|NCT00470704|529403438|FG000|Overall Study|Relapse/Progression|37|||
146790029|NCT00470704|529403439|FG001|Overall Study|Relapse/Progression|42|||
146790030|NCT00470704|529403438|FG000|Overall Study|toxicity|0|||
146790031|NCT00470704|529403439|FG001|Overall Study|toxicity|1|||
146790032|NCT02561247|529403440|FG000|Overall Study|Protocol Violation|1|||
146790033|NCT02561247|529403440|FG000|Overall Study|Withdrawal by Subject|1|||
146790034|NCT02561247|529403440|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
146790035|NCT01824875|529403442|FG000|Overall Study|Disease progression|22|||
146790036|NCT01824875|529403443|FG001|Overall Study|Disease progression|15|||
146790037|NCT01824875|529403442|FG000|Overall Study|Withdrawal by Subject|5|||
146790038|NCT01824875|529403443|FG001|Overall Study|Withdrawal by Subject|4|||
146790039|NCT01824875|529403442|FG000|Overall Study|Adverse Event|4|||
146620791|NCT05470985|528783428|FG001|Double Blind Treatment Period|Physician Decision|1|||
146790040|NCT01824875|529403443|FG001|Overall Study|Adverse Event|10|||
146790041|NCT01824875|529403442|FG000|Overall Study|Alternative therapy|3|||
146790042|NCT01824875|529403443|FG001|Overall Study|Alternative therapy|0|||
146790043|NCT01824875|529403442|FG000|Overall Study|Complicating disease|1|||
146790044|NCT01824875|529403443|FG001|Overall Study|Complicating disease|0|||
146790045|NCT01824875|529403442|FG000|Overall Study|Physician Decision|0|||
146790046|NCT01824875|529403443|FG001|Overall Study|Physician Decision|1|||
146790047|NCT01824875|529403442|FG000|Overall Study|Non-compliance|1|||
146790048|NCT01824875|529403443|FG001|Overall Study|Non-compliance|1|||
146790049|NCT01824875|529403442|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
146790050|NCT01824875|529403443|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
146790051|NCT01824875|529403442|FG000|Overall Study|Administrative issues|0|||
146790052|NCT01824875|529403443|FG001|Overall Study|Administrative issues|2|||
146790053|NCT01824875|529403442|FG000|Overall Study|Ineligible or never started treatment|9|||
146790054|NCT01824875|529403443|FG001|Overall Study|Ineligible or never started treatment|5|||
146790055|NCT01824875|529403442|FG000|Overall Study|Other|0|||
146790056|NCT01824875|529403443|FG001|Overall Study|Other|2|||
146790057|NCT04195698|529403446|FG000|Overall Study|Adverse Event|4|||
146790058|NCT04195698|529403447|FG001|Overall Study|Adverse Event|11|||
146790059|NCT04195698|529403446|FG000|Overall Study|Withdrawal by Subject|9|||
146790060|NCT04195698|529403447|FG001|Overall Study|Withdrawal by Subject|10|||
146790061|NCT04195698|529403446|FG000|Overall Study|Lost to Follow-up|5|||
146790062|NCT04195698|529403447|FG001|Overall Study|Lost to Follow-up|4|||
146790063|NCT04195698|529403446|FG000|Overall Study|Lack of Efficacy|2|||
146790064|NCT04195698|529403447|FG001|Overall Study|Lack of Efficacy|10|||
146790065|NCT04195698|529403446|FG000|Overall Study|Other|5|||
146790066|NCT04195698|529403447|FG001|Overall Study|Other|4|||
146790067|NCT05459688|529403448|FG000|Overall Study|Lost to Follow-up|6|||
146790068|NCT05459688|529403448|FG000|Overall Study|Physician Decision|1|||
146790069|NCT05459688|529403448|FG000|Overall Study|Withdrawal by Subject|19|||
146790070|NCT05459688|529403448|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
146790071|NCT01129102|529403449|FG000|Overall Study|No study drug treatment|2|||
146790072|NCT01129102|529403450|FG001|Overall Study|No study drug treatment|3|||
146790073|NCT01129102|529403451|FG002|Overall Study|No study drug treatment|1|||
146790074|NCT01129102|529403449|FG000|Overall Study|Withdrawal by Subject|2|||
146790075|NCT01129102|529403450|FG001|Overall Study|Withdrawal by Subject|0|||
146790076|NCT01129102|529403451|FG002|Overall Study|Withdrawal by Subject|3|||
146790077|NCT01129102|529403449|FG000|Overall Study|Protocol Violation|0|||
146790078|NCT01129102|529403450|FG001|Overall Study|Protocol Violation|1|||
146790079|NCT01129102|529403451|FG002|Overall Study|Protocol Violation|1|||
146790080|NCT01129102|529403449|FG000|Overall Study|Pregnancy|0|||
146790081|NCT01129102|529403450|FG001|Overall Study|Pregnancy|0|||
146790082|NCT01129102|529403451|FG002|Overall Study|Pregnancy|1|||
146790083|NCT01129102|529403449|FG000|Overall Study|Adverse Event|2|||
146790084|NCT01129102|529403450|FG001|Overall Study|Adverse Event|2|||
146790085|NCT01129102|529403451|FG002|Overall Study|Adverse Event|1|||
146790086|NCT01129102|529403449|FG000|Overall Study|Lost to Follow-up|2|||
146790087|NCT01129102|529403450|FG001|Overall Study|Lost to Follow-up|0|||
146790088|NCT01129102|529403451|FG002|Overall Study|Lost to Follow-up|0|||
146790089|NCT03379675|529403454|FG000|Overall Study|Lost to Follow-up|0|||
146790090|NCT03379675|529403455|FG001|Overall Study|Lost to Follow-up|1|||
146790091|NCT03379675|529403456|FG002|Overall Study|Lost to Follow-up|0|||
146790092|NCT03379675|529403454|FG000|Overall Study|Adverse Event|2|||
146790093|NCT03379675|529403455|FG001|Overall Study|Adverse Event|0|||
146790094|NCT03379675|529403456|FG002|Overall Study|Adverse Event|0|||
146790095|NCT03379675|529403454|FG000|Overall Study|Withdrawal by Subject|2|||
146790096|NCT03379675|529403455|FG001|Overall Study|Withdrawal by Subject|1|||
146790097|NCT03379675|529403456|FG002|Overall Study|Withdrawal by Subject|2|||
146790098|NCT02817776|529403457|FG000|Overall Study|Excluded|33|||
146790099|NCT02817776|529403457|FG000|Overall Study|Lost to Follow-up|20|||
146790100|NCT02817776|529403457|FG000|Overall Study|Withdrawal by Subject|33|||
146790101|NCT02817776|529403457|FG000|Overall Study|Death|2|||
146938398|NCT03136367|529930893|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
146938399|NCT03136367|529930894|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
146938400|NCT03136367|529930892|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
146938401|NCT03136367|529930893|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
146938402|NCT03136367|529930894|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
146938403|NCT03136367|529930892|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
146938404|NCT03136367|529930893|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
146938405|NCT03136367|529930894|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
146938406|NCT03136367|529930892|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
146938407|NCT03136367|529930893|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
146938408|NCT03136367|529930894|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
146938409|NCT03136367|529930892|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
146938410|NCT03136367|529930893|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
146938411|NCT03136367|529930894|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
146938412|NCT03136367|529930892|FG000|T5 1 Year After Surgery|Death|0|||
146938413|NCT03136367|529930893|FG001|T5 1 Year After Surgery|Death|0|||
146790102|NCT05540665|529403458|FG000|Overall Study|Study terminated by sponsor|6|||
146790103|NCT05540665|529403459|FG001|Overall Study|Study terminated by sponsor|6|||
146790104|NCT05540665|529403460|FG002|Overall Study|Study terminated by sponsor|7|||
146790105|NCT03462030|529403463|FG000|Overall Study|Withdrawal by Subject|1|||
146790106|NCT03462030|529403464|FG001|Overall Study|Withdrawal by Subject|1|||
146790107|NCT02675751|529403465|FG000|Overall Study|Lost to Follow-up|16|||
146790108|NCT03371381|529403466|FG000|Overall Study|Death|5|||
146790109|NCT03371381|529403466|FG000|Overall Study|Study terminated by sponsor|3|||
146790110|NCT03371381|529403466|FG000|Overall Study|Other|4|||
146790111|NCT02979327|529403467|FG000|First Intervention|Protocol Violation|1|||
146790112|NCT02979327|529403468|FG001|First Intervention|Protocol Violation|0|||
146790113|NCT01073566|529403469|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
146790114|NCT01073566|529403470|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
146790115|NCT05672069|529403474|FG000|Overall Study|Implant removal|1|||
146790116|NCT05672069|529403474|FG000|Overall Study|Lost to Follow-up|2|||
146790117|NCT03858634|529403477|FG000|Overall Study|Withdrawal by Subject|1|||
146790118|NCT03858634|529403478|FG001|Overall Study|Withdrawal by Subject|0|||
146790119|NCT03858634|529403477|FG000|Overall Study|Adverse Event|1|||
146790120|NCT03858634|529403478|FG001|Overall Study|Adverse Event|0|||
146790121|NCT03858634|529403477|FG000|Overall Study|Lost to Follow-up|0|||
146790122|NCT03858634|529403478|FG001|Overall Study|Lost to Follow-up|1|||
146790123|NCT03858634|529403477|FG000|Overall Study|Other, Not Specified|1|||
146790124|NCT03858634|529403478|FG001|Overall Study|Other, Not Specified|1|||
146790125|NCT03150173|529403479|FG000|Overall Study|Lost to Follow-up|13|||
146790126|NCT03150173|529403480|FG001|Overall Study|Lost to Follow-up|5|||
146790127|NCT03461276|529403482|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
146790128|NCT03461276|529403483|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
146790129|NCT03461276|529403482|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
146790130|NCT03461276|529403483|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
146790131|NCT03461276|529403482|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
146790132|NCT03461276|529403483|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
146790133|NCT03461276|529403482|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
146790134|NCT03461276|529403483|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
146790135|NCT03461276|529403482|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
146790136|NCT03461276|529403483|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
146790137|NCT03461276|529403482|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
146790138|NCT03461276|529403483|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
146790139|NCT03461276|529403482|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
146790140|NCT03461276|529403483|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
146790141|NCT03461276|529403482|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
146790142|NCT03461276|529403483|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
146790143|NCT03461276|529403482|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
146790144|NCT03461276|529403483|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
146790145|NCT03461276|529403482|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
146790146|NCT03461276|529403483|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
146790147|NCT01802788|529403485|FG000|Overall Study|Withdrawal by Subject|102|||
146790148|NCT01802788|529403486|FG001|Overall Study|Withdrawal by Subject|5|||
146790149|NCT01802788|529403485|FG000|Overall Study|Death|382|||
146938414|NCT03136367|529930894|FG002|T5 1 Year After Surgery|Death|1|||
146938415|NCT03136367|529930892|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
146938416|NCT03136367|529930893|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
146938417|NCT03136367|529930894|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
146938418|NCT03136367|529930892|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
146938419|NCT03136367|529930893|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
146938420|NCT03136367|529930894|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
146938421|NCT03136367|529930892|FG000|T5 1 Year After Surgery|study ended before due|31|||
146938422|NCT03136367|529930893|FG001|T5 1 Year After Surgery|study ended before due|103|||
146938423|NCT03136367|529930894|FG002|T5 1 Year After Surgery|study ended before due|110|||
146938424|NCT03136367|529930892|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
146938425|NCT03136367|529930893|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
146938426|NCT03136367|529930894|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
146938427|NCT03175562|529930898|FG000|Overall Study|Adverse Event|1|||
146938428|NCT03175562|529930898|FG000|Overall Study|Lost to Follow-up|3|||
146790150|NCT01802788|529403486|FG001|Overall Study|Death|18|||
146790151|NCT01802788|529403485|FG000|Overall Study|Lost to Follow-up|31|||
146790152|NCT01802788|529403486|FG001|Overall Study|Lost to Follow-up|2|||
146938429|NCT03175562|529930898|FG000|Overall Study|Withdrawal by Subject|7|||
146938430|NCT03175562|529930898|FG000|Overall Study|Other (Not Specified)|5|||
146790153|NCT01802788|529403485|FG000|Overall Study|Physician Decision|3|||
146790154|NCT01802788|529403486|FG001|Overall Study|Physician Decision|0|||
146790155|NCT01802788|529403485|FG000|Overall Study|Patient Non-Compliance|1|||
146790156|NCT01802788|529403486|FG001|Overall Study|Patient Non-Compliance|0|||
146790157|NCT01802788|529403485|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
146790158|NCT01802788|529403486|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
146790159|NCT01802788|529403485|FG000|Overall Study|Other Reasons|19|||
146790160|NCT01802788|529403486|FG001|Overall Study|Other Reasons|0|||
146790161|NCT02043678|529403487|FG000|Overall Study|Never treated|11|||
146790162|NCT02043678|529403488|FG001|Overall Study|Never treated|9|||
146790163|NCT02043678|529403487|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
146790164|NCT02043678|529403488|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
146790165|NCT02043678|529403487|FG000|Overall Study|AE without clinical PD|54|||
146790166|NCT02043678|529403488|FG001|Overall Study|AE without clinical PD|36|||
146790167|NCT02043678|529403487|FG000|Overall Study|Lost to Follow-up|1|||
146790168|NCT02043678|529403488|FG001|Overall Study|Lost to Follow-up|1|||
146790169|NCT02043678|529403487|FG000|Overall Study|Other|10|||
146790170|NCT02043678|529403488|FG001|Overall Study|Other|14|||
146790171|NCT02043678|529403487|FG000|Overall Study|Clinical PD|114|||
146790172|NCT02043678|529403488|FG001|Overall Study|Clinical PD|148|||
146790173|NCT02043678|529403487|FG000|Overall Study|Radiological PD|100|||
146790174|NCT02043678|529403488|FG001|Overall Study|Radiological PD|90|||
146790175|NCT02043678|529403487|FG000|Overall Study|Protocol-driven decision point|59|||
146790176|NCT02043678|529403488|FG001|Overall Study|Protocol-driven decision point|58|||
146790177|NCT02043678|529403487|FG000|Overall Study|Withdrawal by Subject|16|||
146790178|NCT02043678|529403488|FG001|Overall Study|Withdrawal by Subject|20|||
146790179|NCT02043678|529403487|FG000|Overall Study|Protocol Violation|1|||
146790180|NCT02043678|529403488|FG001|Overall Study|Protocol Violation|0|||
146790181|NCT02043678|529403487|FG000|Overall Study|Deterioration of general conditions|1|||
146790182|NCT02043678|529403488|FG001|Overall Study|Deterioration of general conditions|1|||
146790183|NCT02043678|529403487|FG000|Overall Study|Logistical difficulties|2|||
146790184|NCT02043678|529403488|FG001|Overall Study|Logistical difficulties|0|||
146790185|NCT02043678|529403487|FG000|Overall Study|Non-compliance with study drug|3|||
146790186|NCT02043678|529403488|FG001|Overall Study|Non-compliance with study drug|1|||
146790187|NCT02043678|529403487|FG000|Overall Study|Physician Decision|4|||
146790188|NCT02043678|529403488|FG001|Overall Study|Physician Decision|3|||
146790189|NCT02043678|529403487|FG000|Overall Study|Subject decision|0|||
146790190|NCT02043678|529403488|FG001|Overall Study|Subject decision|1|||
146790191|NCT02043678|529403487|FG000|Overall Study|Switching to other therapy|3|||
146790192|NCT02043678|529403488|FG001|Overall Study|Switching to other therapy|2|||
146790193|NCT02043678|529403487|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
146790194|NCT02043678|529403488|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
146790195|NCT02043678|529403487|FG000|Overall Study|Missing|1|||
146790196|NCT02043678|529403488|FG001|Overall Study|Missing|0|||
146790197|NCT02043678|529403487|FG000|Overall Study|Adverse Event|0|||
146790198|NCT02043678|529403488|FG001|Overall Study|Adverse Event|1|||
146790199|NCT03216057|529403489|FG000|Overall Study|Lost to Follow-up|2|||
146790200|NCT03216057|529403490|FG001|Overall Study|Lost to Follow-up|2|||
146790201|NCT03904147|529403495|FG000|Overall Study|Death|15|||
146790202|NCT03904147|529403496|FG001|Overall Study|Death|13|||
146790203|NCT03904147|529403497|FG002|Overall Study|Death|15|||
146790204|NCT03904147|529403495|FG000|Overall Study|Withdrawal by Subject|7|||
146790205|NCT03904147|529403496|FG001|Overall Study|Withdrawal by Subject|12|||
146790206|NCT03904147|529403497|FG002|Overall Study|Withdrawal by Subject|1|||
146790207|NCT03904147|529403495|FG000|Overall Study|1Y visit completed after 365 days|1|||
146790208|NCT03904147|529403496|FG001|Overall Study|1Y visit completed after 365 days|1|||
146790209|NCT03904147|529403497|FG002|Overall Study|1Y visit completed after 365 days|0|||
146790210|NCT05269667|529403498|FG000|Overall Study|Study Terminated by Sponsor|4|||
146790211|NCT05270408|529403502|FG000|Started Treatment|Withdrawal by Subject|0|||
146790212|NCT05270408|529403503|FG001|Started Treatment|Withdrawal by Subject|0|||
146790213|NCT05270408|529403504|FG002|Started Treatment|Withdrawal by Subject|3|||
146790214|NCT05270408|529403502|FG000|Started Treatment|Adverse Event|0|||
146938431|NCT01230749|529930899|FG000|Overall Study|Adverse Event|0|||
146938432|NCT01230749|529930900|FG001|Overall Study|Adverse Event|0|||
146731802|NCT01662063|529188846|FG001|Overall Study|Protocol Violation|0|||
146731803|NCT01662063|529188847|FG002|Overall Study|Protocol Violation|0|||
146731804|NCT01662063|529188845|FG000|Overall Study|Withdrawal by Subject|2|||
146731805|NCT01662063|529188846|FG001|Overall Study|Withdrawal by Subject|4|||
146731806|NCT01662063|529188847|FG002|Overall Study|Withdrawal by Subject|1|||
146731807|NCT01662063|529188845|FG000|Overall Study|Physician Decision|0|||
146731808|NCT01662063|529188846|FG001|Overall Study|Physician Decision|2|||
146731809|NCT01662063|529188847|FG002|Overall Study|Physician Decision|0|||
146731810|NCT01662063|529188845|FG000|Overall Study|Other|0|||
146731811|NCT01662063|529188846|FG001|Overall Study|Other|1|||
146731812|NCT01662063|529188847|FG002|Overall Study|Other|0|||
146731813|NCT01477853|529188854|FG000|Phase A|Adverse Event|1|||
146731814|NCT01477853|529188855|FG001|Phase A|Adverse Event|2|||
146731815|NCT01477853|529188856|FG002|Phase A|Adverse Event|2|||
146731816|NCT01477853|529188854|FG000|Phase A|Lost to Follow-up|4|||
146731817|NCT01477853|529188855|FG001|Phase A|Lost to Follow-up|3|||
146731818|NCT01477853|529188856|FG002|Phase A|Lost to Follow-up|2|||
146731819|NCT01477853|529188854|FG000|Phase A|Physician Decision|1|||
146731820|NCT01477853|529188855|FG001|Phase A|Physician Decision|0|||
146981998|NCT00291330|530096196|FG001|Overall Study|Other|1|||
146981999|NCT01829295|530096197|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
146982000|NCT01829295|530096198|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
146982001|NCT01829295|530096199|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
146982002|NCT01829295|530096200|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
146982003|NCT01829295|530096197|FG000|6-12 Months|Adverse Event|0|||
146982004|NCT01829295|530096198|FG001|6-12 Months|Adverse Event|0|||
146982005|NCT01829295|530096199|FG002|6-12 Months|Adverse Event|3|||
146982006|NCT01829295|530096200|FG003|6-12 Months|Adverse Event|2|||
146982007|NCT01829295|530096197|FG000|6-12 Months|Lost to Follow-up|2|||
146982008|NCT01829295|530096198|FG001|6-12 Months|Lost to Follow-up|0|||
146982009|NCT01829295|530096199|FG002|6-12 Months|Lost to Follow-up|0|||
146982010|NCT01829295|530096200|FG003|6-12 Months|Lost to Follow-up|0|||
146982011|NCT01829295|530096197|FG000|6-12 Months|Withdrawal by Subject|2|||
146982012|NCT01829295|530096198|FG001|6-12 Months|Withdrawal by Subject|2|||
146982013|NCT01829295|530096199|FG002|6-12 Months|Withdrawal by Subject|0|||
146982014|NCT01829295|530096200|FG003|6-12 Months|Withdrawal by Subject|0|||
146982015|NCT02629965|530096203|FG000|Period 1|Adverse Event|1|||
146982016|NCT02629965|530096204|FG001|Period 1|Adverse Event|0|||
146982017|NCT02629965|530096203|FG000|Period 1|Unexpected worsening of disease|2|||
146982018|NCT02629965|530096204|FG001|Period 1|Unexpected worsening of disease|0|||
146982019|NCT02629965|530096203|FG000|Period 1|Other than listed above|1|||
146982020|NCT02629965|530096204|FG001|Period 1|Other than listed above|2|||
146982021|NCT02629965|530096203|FG000|Period 2|Adverse Event|1|||
146982022|NCT02629965|530096204|FG001|Period 2|Adverse Event|0|||
146982023|NCT03443869|530096205|FG000|Overall Study|Death|3|||
146982024|NCT03443869|530096206|FG001|Overall Study|Death|3|||
146982025|NCT03443869|530096205|FG000|Overall Study|Withdrawal by Subject|34|||
146982026|NCT03443869|530096206|FG001|Overall Study|Withdrawal by Subject|22|||
146982027|NCT03443869|530096205|FG000|Overall Study|Lost to Follow-up|1|||
146982028|NCT03443869|530096206|FG001|Overall Study|Lost to Follow-up|2|||
146982029|NCT03443869|530096205|FG000|Overall Study|Physician Decision|3|||
146982030|NCT03443869|530096206|FG001|Overall Study|Physician Decision|3|||
146982031|NCT03443869|530096205|FG000|Overall Study|Other|4|||
146982032|NCT03443869|530096206|FG001|Overall Study|Other|4|||
146982033|NCT02390219|530096207|FG000|Overall Study|Death|1|||
146982034|NCT02390219|530096207|FG000|Overall Study|Physician Decision|1|||
146982035|NCT02390219|530096207|FG000|Overall Study|Adverse Event|6|||
146982036|NCT02390219|530096207|FG000|Overall Study|Withdrawal by Subject|1|||
146982037|NCT02390219|530096207|FG000|Overall Study|Lost to Follow-up|2|||
146982038|NCT02390219|530096207|FG000|Overall Study|Other|2|||
146982039|NCT00299728|530096208|FG000|Overall Study|Lost to Follow-up|0|||
146982040|NCT00299728|530096209|FG001|Overall Study|Lost to Follow-up|1|||
146982041|NCT00299728|530096208|FG000|Overall Study|Withdrawal by Subject|0|||
146982042|NCT00299728|530096209|FG001|Overall Study|Withdrawal by Subject|1|||
146982043|NCT00299728|530096208|FG000|Overall Study|Progressive disease|0|||
146982044|NCT00299728|530096209|FG001|Overall Study|Progressive disease|1|||
146982045|NCT02230085|530096210|FG000|Overall Study|Physician Decision|1|||
146982046|NCT02230085|530096210|FG000|Overall Study|Withdrawal by Subject|3|||
146982047|NCT00580983|530096211|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
146982048|NCT01360632|530096212|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
146982049|NCT01360632|530096213|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
146982050|NCT01360632|530096214|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
146982051|NCT01360632|530096215|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
146982052|NCT01360632|530096216|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
146982053|NCT01360632|530096212|FG000|Phase A (8 Weeks)|Adverse Event|60|||
146982054|NCT01360632|530096213|FG001|Phase A (8 Weeks)|Adverse Event|0|||
146982055|NCT01360632|530096214|FG002|Phase A (8 Weeks)|Adverse Event|0|||
146982056|NCT01360632|530096215|FG003|Phase A (8 Weeks)|Adverse Event|0|||
146982057|NCT01360632|530096216|FG004|Phase A (8 Weeks)|Adverse Event|0|||
146982058|NCT01360632|530096212|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
146982059|NCT01360632|530096213|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
146982060|NCT01360632|530096214|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
146982061|NCT01360632|530096215|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
146982062|NCT01360632|530096216|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
146982063|NCT01360632|530096212|FG000|Phase A (8 Weeks)|Physician Decision|10|||
146982064|NCT01360632|530096213|FG001|Phase A (8 Weeks)|Physician Decision|0|||
146982065|NCT01360632|530096214|FG002|Phase A (8 Weeks)|Physician Decision|0|||
146982066|NCT01360632|530096215|FG003|Phase A (8 Weeks)|Physician Decision|0|||
146982067|NCT01360632|530096216|FG004|Phase A (8 Weeks)|Physician Decision|0|||
146982068|NCT01360632|530096212|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
146982069|NCT01360632|530096213|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
146982070|NCT01360632|530096214|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
146982071|NCT01360632|530096215|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
146982072|NCT01360632|530096216|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
146982073|NCT01360632|530096212|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
146982074|NCT01360632|530096213|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
146982075|NCT01360632|530096214|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
146982076|NCT01360632|530096215|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
146790215|NCT05270408|529403503|FG001|Started Treatment|Adverse Event|0|||
146790216|NCT05270408|529403504|FG002|Started Treatment|Adverse Event|1|||
146790217|NCT05270408|529403502|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
146790218|NCT05270408|529403503|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
146790219|NCT05270408|529403504|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
146790220|NCT03768505|529403505|FG000|Overall Study|sponsor decision|76|||
146790221|NCT03768505|529403505|FG000|Overall Study|Death|35|||
146790222|NCT03768505|529403505|FG000|Overall Study|Other -Various|30|||
146790223|NCT03768505|529403505|FG000|Overall Study|Withdrawal by Subject|22|||
146790224|NCT03768505|529403505|FG000|Overall Study|Lost to Follow-up|6|||
146790225|NCT04032704|529403509|FG000|Part A|Withdrawal by Subject|0|||
146790226|NCT04032704|529403510|FG001|Part A|Withdrawal by Subject|0|||
146790227|NCT04032704|529403511|FG002|Part A|Withdrawal by Subject|3|||
146790228|NCT04032704|529403512|FG003|Part A|Withdrawal by Subject|0|||
146790229|NCT04032704|529403513|FG004|Part A|Withdrawal by Subject|1|||
146790230|NCT04032704|529403514|FG005|Part A|Withdrawal by Subject|7|||
146790231|NCT04032704|529403515|FG006|Part A|Withdrawal by Subject|0|||
146790232|NCT04032704|529403516|FG007|Part A|Withdrawal by Subject|0|||
146790233|NCT04032704|529403517|FG008|Part A|Withdrawal by Subject|0|||
146790234|NCT04032704|529403518|FG009|Part A|Withdrawal by Subject|0|||
146790235|NCT04032704|529403519|FG010|Part A|Withdrawal by Subject|0|||
146790236|NCT04032704|529403520|FG011|Part A|Withdrawal by Subject|0|||
146790237|NCT04032704|529403521|FG012|Part A|Withdrawal by Subject|0|||
146790238|NCT04032704|529403522|FG013|Part A|Withdrawal by Subject|0|||
146790239|NCT04032704|529403523|FG014|Part A|Withdrawal by Subject|0|||
146790240|NCT04032704|529403524|FG015|Part A|Withdrawal by Subject|0|||
146790241|NCT04032704|529403525|FG016|Part A|Withdrawal by Subject|0|||
146790242|NCT04032704|529403526|FG017|Part A|Withdrawal by Subject|0|||
146790243|NCT04032704|529403509|FG000|Part A|Lost to Follow-up|1|||
146790244|NCT04032704|529403510|FG001|Part A|Lost to Follow-up|0|||
146790245|NCT04032704|529403511|FG002|Part A|Lost to Follow-up|0|||
146790246|NCT04032704|529403512|FG003|Part A|Lost to Follow-up|0|||
146790247|NCT04032704|529403513|FG004|Part A|Lost to Follow-up|0|||
146790248|NCT04032704|529403514|FG005|Part A|Lost to Follow-up|0|||
146790249|NCT04032704|529403515|FG006|Part A|Lost to Follow-up|0|||
146790250|NCT04032704|529403516|FG007|Part A|Lost to Follow-up|0|||
146790251|NCT04032704|529403517|FG008|Part A|Lost to Follow-up|0|||
146790252|NCT04032704|529403518|FG009|Part A|Lost to Follow-up|0|||
146790253|NCT04032704|529403519|FG010|Part A|Lost to Follow-up|0|||
146790254|NCT04032704|529403520|FG011|Part A|Lost to Follow-up|0|||
146790255|NCT04032704|529403521|FG012|Part A|Lost to Follow-up|0|||
146790256|NCT04032704|529403522|FG013|Part A|Lost to Follow-up|0|||
146790257|NCT04032704|529403523|FG014|Part A|Lost to Follow-up|0|||
146790258|NCT04032704|529403524|FG015|Part A|Lost to Follow-up|0|||
146790259|NCT04032704|529403525|FG016|Part A|Lost to Follow-up|0|||
146790260|NCT04032704|529403526|FG017|Part A|Lost to Follow-up|0|||
146790261|NCT04032704|529403509|FG000|Part A|Death|9|||
146790262|NCT04032704|529403510|FG001|Part A|Death|2|||
146790263|NCT04032704|529403511|FG002|Part A|Death|10|||
146790264|NCT04032704|529403512|FG003|Part A|Death|7|||
146790265|NCT04032704|529403513|FG004|Part A|Death|4|||
146790266|NCT04032704|529403514|FG005|Part A|Death|5|||
146790267|NCT04032704|529403515|FG006|Part A|Death|0|||
146790268|NCT04032704|529403516|FG007|Part A|Death|0|||
146790269|NCT04032704|529403517|FG008|Part A|Death|0|||
146790270|NCT04032704|529403518|FG009|Part A|Death|0|||
146790271|NCT04032704|529403519|FG010|Part A|Death|0|||
146790272|NCT04032704|529403520|FG011|Part A|Death|0|||
146790273|NCT04032704|529403521|FG012|Part A|Death|0|||
146790274|NCT04032704|529403522|FG013|Part A|Death|0|||
146790275|NCT04032704|529403523|FG014|Part A|Death|0|||
146790276|NCT04032704|529403524|FG015|Part A|Death|0|||
146790277|NCT04032704|529403525|FG016|Part A|Death|0|||
146790278|NCT04032704|529403526|FG017|Part A|Death|0|||
146790279|NCT04032704|529403509|FG000|Part B|Other|0|||
146790280|NCT04032704|529403510|FG001|Part B|Other|0|||
146790281|NCT04032704|529403511|FG002|Part B|Other|0|||
146790282|NCT04032704|529403512|FG003|Part B|Other|0|||
146790283|NCT04032704|529403513|FG004|Part B|Other|0|||
146790284|NCT04032704|529403514|FG005|Part B|Other|0|||
146790285|NCT04032704|529403515|FG006|Part B|Other|0|||
146790286|NCT04032704|529403516|FG007|Part B|Other|1|||
146790287|NCT04032704|529403517|FG008|Part B|Other|2|||
146790288|NCT04032704|529403518|FG009|Part B|Other|1|||
146790289|NCT04032704|529403519|FG010|Part B|Other|1|||
146790290|NCT04032704|529403520|FG011|Part B|Other|1|||
146790291|NCT04032704|529403521|FG012|Part B|Other|5|||
146790292|NCT04032704|529403522|FG013|Part B|Other|13|||
146790293|NCT04032704|529403523|FG014|Part B|Other|0|||
146938433|NCT01230749|529930901|FG002|Overall Study|Adverse Event|0|||
146938434|NCT01230749|529930902|FG003|Overall Study|Adverse Event|1|||
146790294|NCT04032704|529403524|FG015|Part B|Other|0|||
146790295|NCT04032704|529403525|FG016|Part B|Other|0|||
146790296|NCT04032704|529403526|FG017|Part B|Other|0|||
146790297|NCT04032704|529403509|FG000|Part B|Study termination by Sponsor|0|||
146790298|NCT04032704|529403510|FG001|Part B|Study termination by Sponsor|0|||
146790299|NCT04032704|529403511|FG002|Part B|Study termination by Sponsor|0|||
146790300|NCT04032704|529403512|FG003|Part B|Study termination by Sponsor|0|||
146938435|NCT01230749|529930899|FG000|Overall Study|Physician Decision|0|||
146938436|NCT01230749|529930900|FG001|Overall Study|Physician Decision|0|||
146938437|NCT01230749|529930901|FG002|Overall Study|Physician Decision|1|||
146938438|NCT01230749|529930902|FG003|Overall Study|Physician Decision|0|||
146938439|NCT01230749|529930899|FG000|Overall Study|Withdrawal by Subject|0|||
146938440|NCT01230749|529930900|FG001|Overall Study|Withdrawal by Subject|1|||
146938441|NCT01230749|529930901|FG002|Overall Study|Withdrawal by Subject|0|||
146938442|NCT01230749|529930902|FG003|Overall Study|Withdrawal by Subject|0|||
146938443|NCT01230749|529930899|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
146938444|NCT01230749|529930900|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
146938445|NCT01230749|529930901|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
146938446|NCT01230749|529930902|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
146938447|NCT03366844|529932397|FG000|Overall Study|Physician Decision|1|||
146790301|NCT04032704|529403513|FG004|Part B|Study termination by Sponsor|0|||
146790302|NCT04032704|529403514|FG005|Part B|Study termination by Sponsor|0|||
146790303|NCT04032704|529403515|FG006|Part B|Study termination by Sponsor|0|||
146790304|NCT04032704|529403516|FG007|Part B|Study termination by Sponsor|0|||
146790305|NCT04032704|529403517|FG008|Part B|Study termination by Sponsor|1|||
146790306|NCT04032704|529403518|FG009|Part B|Study termination by Sponsor|0|||
146790307|NCT04032704|529403519|FG010|Part B|Study termination by Sponsor|0|||
146790308|NCT04032704|529403520|FG011|Part B|Study termination by Sponsor|0|||
146790309|NCT04032704|529403521|FG012|Part B|Study termination by Sponsor|0|||
146790310|NCT04032704|529403522|FG013|Part B|Study termination by Sponsor|0|||
146790311|NCT04032704|529403523|FG014|Part B|Study termination by Sponsor|0|||
146790312|NCT04032704|529403524|FG015|Part B|Study termination by Sponsor|0|||
146790313|NCT04032704|529403525|FG016|Part B|Study termination by Sponsor|0|||
146790314|NCT04032704|529403526|FG017|Part B|Study termination by Sponsor|0|||
146790315|NCT04032704|529403509|FG000|Part B|Withdrawal by Subject|0|||
146790316|NCT04032704|529403510|FG001|Part B|Withdrawal by Subject|0|||
146790317|NCT04032704|529403511|FG002|Part B|Withdrawal by Subject|0|||
146790318|NCT04032704|529403512|FG003|Part B|Withdrawal by Subject|0|||
146790319|NCT04032704|529403513|FG004|Part B|Withdrawal by Subject|0|||
146790320|NCT04032704|529403514|FG005|Part B|Withdrawal by Subject|0|||
146790321|NCT04032704|529403515|FG006|Part B|Withdrawal by Subject|3|||
146790322|NCT04032704|529403516|FG007|Part B|Withdrawal by Subject|2|||
146790323|NCT04032704|529403517|FG008|Part B|Withdrawal by Subject|2|||
146790324|NCT04032704|529403518|FG009|Part B|Withdrawal by Subject|1|||
146790325|NCT04032704|529403519|FG010|Part B|Withdrawal by Subject|4|||
146790326|NCT04032704|529403520|FG011|Part B|Withdrawal by Subject|6|||
146790327|NCT04032704|529403521|FG012|Part B|Withdrawal by Subject|2|||
146790328|NCT04032704|529403522|FG013|Part B|Withdrawal by Subject|1|||
146790329|NCT04032704|529403523|FG014|Part B|Withdrawal by Subject|0|||
146790330|NCT04032704|529403524|FG015|Part B|Withdrawal by Subject|1|||
146790331|NCT04032704|529403525|FG016|Part B|Withdrawal by Subject|0|||
146790332|NCT04032704|529403526|FG017|Part B|Withdrawal by Subject|0|||
146790333|NCT04032704|529403509|FG000|Part B|Lost to Follow-up|0|||
146790334|NCT04032704|529403510|FG001|Part B|Lost to Follow-up|0|||
146790335|NCT04032704|529403511|FG002|Part B|Lost to Follow-up|0|||
146790336|NCT04032704|529403512|FG003|Part B|Lost to Follow-up|0|||
146790337|NCT04032704|529403513|FG004|Part B|Lost to Follow-up|0|||
146790338|NCT04032704|529403514|FG005|Part B|Lost to Follow-up|0|||
146790339|NCT04032704|529403515|FG006|Part B|Lost to Follow-up|0|||
146790340|NCT04032704|529403516|FG007|Part B|Lost to Follow-up|0|||
146790341|NCT04032704|529403517|FG008|Part B|Lost to Follow-up|0|||
146790342|NCT04032704|529403518|FG009|Part B|Lost to Follow-up|0|||
146790343|NCT04032704|529403519|FG010|Part B|Lost to Follow-up|0|||
146790344|NCT04032704|529403520|FG011|Part B|Lost to Follow-up|1|||
146790345|NCT04032704|529403521|FG012|Part B|Lost to Follow-up|0|||
146790346|NCT04032704|529403522|FG013|Part B|Lost to Follow-up|0|||
146790347|NCT04032704|529403523|FG014|Part B|Lost to Follow-up|0|||
146790348|NCT04032704|529403524|FG015|Part B|Lost to Follow-up|0|||
146790349|NCT04032704|529403525|FG016|Part B|Lost to Follow-up|0|||
146790350|NCT04032704|529403526|FG017|Part B|Lost to Follow-up|0|||
146790351|NCT04032704|529403509|FG000|Part B|Death|0|||
146938448|NCT03366844|529932397|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
146790352|NCT04032704|529403510|FG001|Part B|Death|0|||
146938449|NCT02687711|529932400|FG000|Overall Study|Adverse Event|89|||
146938450|NCT02687711|529932400|FG000|Overall Study|Lack of Efficacy|70|||
146790353|NCT04032704|529403511|FG002|Part B|Death|0|||
146790354|NCT04032704|529403512|FG003|Part B|Death|0|||
146790355|NCT04032704|529403513|FG004|Part B|Death|0|||
146790356|NCT04032704|529403514|FG005|Part B|Death|0|||
146938451|NCT02687711|529932400|FG000|Overall Study|Lost to Follow-up|20|||
146790357|NCT04032704|529403515|FG006|Part B|Death|13|||
146790358|NCT04032704|529403516|FG007|Part B|Death|13|||
146790359|NCT04032704|529403517|FG008|Part B|Death|14|||
146790360|NCT04032704|529403518|FG009|Part B|Death|12|||
146790361|NCT04032704|529403519|FG010|Part B|Death|12|||
146790362|NCT04032704|529403520|FG011|Part B|Death|13|||
146790363|NCT04032704|529403521|FG012|Part B|Death|7|||
146790364|NCT04032704|529403522|FG013|Part B|Death|17|||
146790365|NCT04032704|529403523|FG014|Part B|Death|2|||
146790366|NCT04032704|529403524|FG015|Part B|Death|1|||
146790367|NCT04032704|529403525|FG016|Part B|Death|2|||
146790368|NCT04032704|529403526|FG017|Part B|Death|2|||
146790369|NCT05399459|529403530|FG000|Overall Study|Randomized but not treated|29|||
146790370|NCT05399459|529403531|FG001|Overall Study|Randomized but not treated|30|||
146790371|NCT05399459|529403532|FG002|Overall Study|Randomized but not treated|38|||
146790372|NCT05399459|529403530|FG000|Overall Study|Lost to Follow-up|1|||
146790373|NCT05399459|529403531|FG001|Overall Study|Lost to Follow-up|0|||
146790374|NCT05399459|529403532|FG002|Overall Study|Lost to Follow-up|0|||
146790375|NCT04992520|529403533|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
146790376|NCT04992520|529403534|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
146790377|NCT04992520|529403535|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
146790378|NCT04992520|529403536|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
146790379|NCT04992520|529403537|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
146790380|NCT04992520|529403538|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
146790381|NCT04992520|529403533|FG000|Part A: First Challenge|Non-compliance|0|||
146790382|NCT04992520|529403534|FG001|Part A: First Challenge|Non-compliance|0|||
146790383|NCT04992520|529403535|FG002|Part A: First Challenge|Non-compliance|0|||
146790384|NCT04992520|529403536|FG003|Part A: First Challenge|Non-compliance|1|||
146790385|NCT04992520|529403537|FG004|Part A: First Challenge|Non-compliance|0|||
146790386|NCT04992520|529403538|FG005|Part A: First Challenge|Non-compliance|0|||
146790387|NCT04992520|529403533|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
146790388|NCT04992520|529403534|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
146790389|NCT04992520|529403535|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
146790390|NCT04992520|529403536|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
146790391|NCT04992520|529403537|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
146790392|NCT04992520|529403538|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
146790393|NCT04992520|529403533|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
146790394|NCT04992520|529403534|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
146790395|NCT04992520|529403535|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
146790396|NCT04992520|529403536|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
146790397|NCT04992520|529403537|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
146790398|NCT04992520|529403538|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
146790399|NCT04103580|529403542|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
146790400|NCT04103580|529403543|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
146790401|NCT04103580|529403542|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
146790402|NCT04103580|529403543|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
146790403|NCT04103580|529403542|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
146790404|NCT04103580|529403543|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
146790405|NCT04103580|529403542|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
146790406|NCT04103580|529403543|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
146790407|NCT04103580|529403542|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
146790408|NCT04103580|529403543|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
146790409|NCT04103580|529403542|FG000|Phase 1 Active Caregiving|Other|3|||
146790410|NCT04103580|529403543|FG001|Phase 1 Active Caregiving|Other|3|||
146790411|NCT04103580|529403542|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
146790412|NCT04103580|529403543|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
146790413|NCT04103580|529403542|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
146790414|NCT04103580|529403543|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
146790415|NCT04103580|529403542|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
146790416|NCT04103580|529403543|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
146790417|NCT04103580|529403542|FG000|Phase 2 Bereavement|Other|8|||
146790418|NCT04103580|529403543|FG001|Phase 2 Bereavement|Other|6|||
146790419|NCT06457802|529403546|FG000|Overall Study|Early termination of study prior to participant completion|2|||
146790420|NCT06457802|529403547|FG001|Overall Study|Early termination of study prior to participant completion|2|||
146790421|NCT02601313|529403549|FG000|Overall Study|Death|2|||
146790422|NCT02601313|529403550|FG001|Overall Study|Death|41|||
146790423|NCT02601313|529403551|FG002|Overall Study|Death|6|||
146790424|NCT02601313|529403549|FG000|Overall Study|Enrolled but never treated|0|||
146790425|NCT02601313|529403550|FG001|Overall Study|Enrolled but never treated|6|||
146790426|NCT02601313|529403551|FG002|Overall Study|Enrolled but never treated|3|||
146938452|NCT02687711|529932400|FG000|Overall Study|Consent withdrawn|15|||
146938453|NCT02687711|529932400|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
146938454|NCT02687711|529932400|FG000|Overall Study|Too expensive|4|||
146938455|NCT02687711|529932400|FG000|Overall Study|Participant moved abroad|1|||
146790427|NCT02601313|529403549|FG000|Overall Study|Enrolled, did not initiate AC|4|||
146790428|NCT02601313|529403550|FG001|Overall Study|Enrolled, did not initiate AC|0|||
146790429|NCT02601313|529403551|FG002|Overall Study|Enrolled, did not initiate AC|0|||
146790430|NCT02601313|529403549|FG000|Overall Study|Full consent withdrawal|0|||
146938456|NCT02687711|529932400|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
146938457|NCT02687711|529932400|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
146938458|NCT02687711|529932400|FG000|Overall Study|Disliked taste|1|||
146938459|NCT02687711|529932400|FG000|Overall Study|Low mood|1|||
146938460|NCT02687711|529932400|FG000|Overall Study|Side effects|1|||
146731821|NCT01477853|529188856|FG002|Phase A|Physician Decision|1|||
146731822|NCT01477853|529188854|FG000|Phase A|Study terminated by sponsor|37|||
146731823|NCT01477853|529188855|FG001|Phase A|Study terminated by sponsor|40|||
146731824|NCT01477853|529188856|FG002|Phase A|Study terminated by sponsor|39|||
146731825|NCT01477853|529188854|FG000|Phase B|Lost to Follow-up|0|||
146731826|NCT01477853|529188855|FG001|Phase B|Lost to Follow-up|1|||
146938461|NCT02687711|529932400|FG000|Overall Study|Change of Hospital|1|||
146938462|NCT02687711|529932400|FG000|Overall Study|Liver Encephalopathy|1|||
146731827|NCT01477853|529188856|FG002|Phase B|Lost to Follow-up|0|||
146731828|NCT01477853|529188854|FG000|Phase B|Study terminated by sponsor|12|||
146731829|NCT01477853|529188855|FG001|Phase B|Study terminated by sponsor|10|||
146731830|NCT01477853|529188856|FG002|Phase B|Study terminated by sponsor|11|||
146731831|NCT00677352|529188862|FG000|Treatment Phase|Adverse Event|14|||
146731832|NCT00677352|529188863|FG001|Treatment Phase|Adverse Event|22|||
146731833|NCT00677352|529188862|FG000|Treatment Phase|Lack of Efficacy|2|||
146731834|NCT00677352|529188863|FG001|Treatment Phase|Lack of Efficacy|3|||
146731835|NCT00677352|529188862|FG000|Treatment Phase|Lost to Follow-up|0|||
146731836|NCT00677352|529188863|FG001|Treatment Phase|Lost to Follow-up|1|||
146731837|NCT00677352|529188862|FG000|Treatment Phase|Withdrawal by Subject|7|||
146731838|NCT00677352|529188863|FG001|Treatment Phase|Withdrawal by Subject|7|||
146731839|NCT00677352|529188862|FG000|Treatment Phase|Physician Decision|1|||
146731840|NCT00677352|529188863|FG001|Treatment Phase|Physician Decision|0|||
146731841|NCT00677352|529188862|FG000|Treatment Phase|Pregnancy|0|||
146731842|NCT00677352|529188863|FG001|Treatment Phase|Pregnancy|1|||
146731843|NCT00677352|529188862|FG000|Treatment Phase|Protocol Violation|1|||
146731844|NCT00677352|529188863|FG001|Treatment Phase|Protocol Violation|1|||
146731845|NCT00677352|529188862|FG000|Treatment Phase|Transference or work related matter|0|||
146731846|NCT00677352|529188863|FG001|Treatment Phase|Transference or work related matter|5|||
146731847|NCT00677352|529188862|FG000|Treatment Phase|Not treated|0|||
146731848|NCT00677352|529188863|FG001|Treatment Phase|Not treated|2|||
146731849|NCT00677352|529188862|FG000|Tapering Phase|Adverse Event|1|||
146731850|NCT00677352|529188863|FG001|Tapering Phase|Adverse Event|5|||
146731851|NCT00677352|529188862|FG000|Tapering Phase|Withdrawal by Subject|5|||
146731852|NCT00677352|529188863|FG001|Tapering Phase|Withdrawal by Subject|3|||
146731853|NCT00677352|529188862|FG000|Tapering Phase|Pregnancy|0|||
146731854|NCT00677352|529188863|FG001|Tapering Phase|Pregnancy|1|||
146731855|NCT00677352|529188862|FG000|Tapering Phase|Job transfer|0|||
146731856|NCT00677352|529188863|FG001|Tapering Phase|Job transfer|1|||
146731857|NCT04044456|529188866|FG000|Overall Study|Lost to Follow-up|4|||
146731858|NCT04044456|529188867|FG001|Overall Study|Lost to Follow-up|1|||
146731859|NCT04044456|529188866|FG000|Overall Study|Withdrawal by Subject|1|||
146731860|NCT04044456|529188867|FG001|Overall Study|Withdrawal by Subject|0|||
146731861|NCT01972529|529188868|FG000|Overall Study|Adverse Event|0|||
146731862|NCT01972529|529188869|FG001|Overall Study|Adverse Event|1|||
146731863|NCT01972529|529188870|FG002|Overall Study|Adverse Event|0|||
146731864|NCT01972529|529188871|FG003|Overall Study|Adverse Event|0|||
146731865|NCT01972529|529188868|FG000|Overall Study|Lost to Follow-up|1|||
146731866|NCT01972529|529188869|FG001|Overall Study|Lost to Follow-up|0|||
146731867|NCT01972529|529188870|FG002|Overall Study|Lost to Follow-up|0|||
146731868|NCT01972529|529188871|FG003|Overall Study|Lost to Follow-up|0|||
146731869|NCT01972529|529188868|FG000|Overall Study|Participant Choice|0|||
146731870|NCT01972529|529188869|FG001|Overall Study|Participant Choice|1|||
146731871|NCT01972529|529188870|FG002|Overall Study|Participant Choice|0|||
146731872|NCT01972529|529188871|FG003|Overall Study|Participant Choice|0|||
146731873|NCT01972529|529188868|FG000|Overall Study|Withdrawl of Consent|1|||
146731874|NCT01972529|529188869|FG001|Overall Study|Withdrawl of Consent|2|||
146731875|NCT01972529|529188870|FG002|Overall Study|Withdrawl of Consent|0|||
146731876|NCT01972529|529188871|FG003|Overall Study|Withdrawl of Consent|1|||
146731877|NCT01972529|529188868|FG000|Overall Study|Other|0|||
146731878|NCT01972529|529188869|FG001|Overall Study|Other|0|||
146731879|NCT01972529|529188870|FG002|Overall Study|Other|0|||
146731880|NCT01972529|529188871|FG003|Overall Study|Other|2|||
146938463|NCT02687711|529932400|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
146731881|NCT01972529|529188868|FG000|Overall Study|Not treated|0|||
146731882|NCT01972529|529188869|FG001|Overall Study|Not treated|1|||
146731883|NCT01972529|529188870|FG002|Overall Study|Not treated|2|||
146731884|NCT01972529|529188871|FG003|Overall Study|Not treated|1|||
146731885|NCT01201811|529188872|FG000|Overall Study|Adverse Event|6|||
146731886|NCT01201811|529188872|FG000|Overall Study|Disease progression|3|||
146731887|NCT01201811|529188872|FG000|Overall Study|Withdrawal by Subject|3|||
146731888|NCT01201811|529188872|FG000|Overall Study|Death|4|||
146731889|NCT01201811|529188872|FG000|Overall Study|Treatment Failure|2|||
146731890|NCT01201811|529188872|FG000|Overall Study|Physician Decision|1|||
146731891|NCT00715429|529188873|FG000|Overall Study|Did not complete the study diary|0|||
146731892|NCT00715429|529188874|FG001|Overall Study|Did not complete the study diary|1|||
146731893|NCT04899245|529188875|FG000|Overall Study|Withdrawal by Subject|3|||
146731894|NCT04899245|529188876|FG001|Overall Study|Withdrawal by Subject|5|||
146731895|NCT04899245|529188877|FG002|Overall Study|Withdrawal by Subject|2|||
146731896|NCT04899245|529188875|FG000|Overall Study|No longer eligible - Left staff position|0|||
146731897|NCT04899245|529188876|FG001|Overall Study|No longer eligible - Left staff position|0|||
146731898|NCT04899245|529188877|FG002|Overall Study|No longer eligible - Left staff position|1|||
146731899|NCT04899245|529188875|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
146731900|NCT04899245|529188876|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
146731901|NCT04899245|529188877|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
146731902|NCT04899245|529188875|FG000|Overall Study|No longer eligible - Moved away from area|2|||
146731903|NCT04899245|529188876|FG001|Overall Study|No longer eligible - Moved away from area|2|||
146731904|NCT04899245|529188877|FG002|Overall Study|No longer eligible - Moved away from area|0|||
146731905|NCT01666808|529188881|FG000|Overall Study|Lost to Follow-up|9|||
146731906|NCT01666808|529188882|FG001|Overall Study|Lost to Follow-up|15|||
146731907|NCT01666808|529188881|FG000|Overall Study|Withdrawal by Subject|3|||
146731908|NCT01666808|529188882|FG001|Overall Study|Withdrawal by Subject|1|||
146731909|NCT01666808|529188881|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
146731910|NCT01666808|529188882|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
146731911|NCT03933826|529188883|FG000|Overall Study|Withdrawal by Subject|8|||
146731912|NCT03933826|529188884|FG001|Overall Study|Withdrawal by Subject|1|||
146731913|NCT03933826|529188883|FG000|Overall Study|Death|19|||
146731914|NCT03933826|529188884|FG001|Overall Study|Death|11|||
146731915|NCT03933826|529188883|FG000|Overall Study|Lost to Follow-up|41|||
146731916|NCT03933826|529188884|FG001|Overall Study|Lost to Follow-up|13|||
146731917|NCT01648348|529188888|FG000|Overall Study|Cancel|1|||
146731918|NCT01648348|529188889|FG001|Overall Study|Cancel|0|||
146731919|NCT01648348|529188890|FG002|Overall Study|Cancel|0|||
146731920|NCT01648348|529188891|FG003|Overall Study|Cancel|0|||
146731921|NCT01648348|529188892|FG004|Overall Study|Cancel|3|||
146731922|NCT01648348|529188893|FG005|Overall Study|Cancel|6|||
146731923|NCT01648348|529188888|FG000|Overall Study|Replaced for MTD analysis|1|||
146731924|NCT01648348|529188889|FG001|Overall Study|Replaced for MTD analysis|0|||
146731925|NCT01648348|529188890|FG002|Overall Study|Replaced for MTD analysis|1|||
146731926|NCT01648348|529188891|FG003|Overall Study|Replaced for MTD analysis|0|||
146731927|NCT01648348|529188892|FG004|Overall Study|Replaced for MTD analysis|0|||
146731928|NCT01648348|529188893|FG005|Overall Study|Replaced for MTD analysis|0|||
146731929|NCT01338025|529188898|FG000|Overall Study|Unexpected closure of study|10|||
146731930|NCT01338025|529188899|FG001|Overall Study|Unexpected closure of study|9|||
146731931|NCT01338025|529188898|FG000|Overall Study|Withdrawal by Subject|0|||
146731932|NCT01338025|529188899|FG001|Overall Study|Withdrawal by Subject|2|||
146731933|NCT01338025|529188898|FG000|Overall Study|Found ineligible after starting|1|||
146731934|NCT01338025|529188899|FG001|Overall Study|Found ineligible after starting|0|||
146731935|NCT03779906|529188902|FG000|Overall Study|Lost to Follow-up|7|||
146731936|NCT03779906|529188902|FG000|Overall Study|COVID pandemic|1|||
146731937|NCT02553460|529188903|FG000|Overall Study|Death|3|||
146938464|NCT02687711|529932400|FG000|Overall Study|Withdrawn due to intake interruption|1|||
146938465|NCT02687711|529932400|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
146938466|NCT02687711|529932400|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
146938467|NCT02687711|529932400|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
146938468|NCT00191386|529932401|FG000|Overall Study|Adverse Event|16|||
146938469|NCT00191386|529932401|FG000|Overall Study|Lost to Follow-up|1|||
146938470|NCT00191386|529932401|FG000|Overall Study|Entry Criteria Exclusion|3|||
146938471|NCT00191386|529932401|FG000|Overall Study|Protocol Violation|18|||
146938472|NCT00191386|529932401|FG000|Overall Study|Withdrawal by Subject|96|||
146938473|NCT00191386|529932401|FG000|Overall Study|Physician Decision|11|||
146938474|NCT00191386|529932401|FG000|Overall Study|Lack of Efficacy|15|||
146938475|NCT02038790|529932402|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
146938476|NCT02038790|529932403|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
146938477|NCT02431793|529932404|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
146938478|NCT02431793|529932405|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
146938479|NCT02431793|529932406|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
146938480|NCT02431793|529932404|FG000|Overall Study|Withdrawal by Subject|7|||
146938481|NCT02431793|529932405|FG001|Overall Study|Withdrawal by Subject|5|||
146938482|NCT02431793|529932406|FG002|Overall Study|Withdrawal by Subject|5|||
146938483|NCT02431793|529932404|FG000|Overall Study|Lost to Follow-up|101|||
146938484|NCT02431793|529932405|FG001|Overall Study|Lost to Follow-up|122|||
146938485|NCT02431793|529932406|FG002|Overall Study|Lost to Follow-up|104|||
146938486|NCT00792701|529932409|FG000|Overall Study|Adverse Event|0|||
146731938|NCT02553460|529188903|FG000|Overall Study|Withdrawal by Subject|1|||
146731939|NCT02553460|529188903|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
146731940|NCT02553460|529188903|FG000|Overall Study|Relapse or Transplant|14|||
146938487|NCT00792701|529932410|FG001|Overall Study|Adverse Event|22|||
146731941|NCT02553460|529188903|FG000|Overall Study|No response to treatment|2|||
146731942|NCT02553460|529188903|FG000|Overall Study|CAR T cells|2|||
146731943|NCT04737109|529190736|FG000|Study Treatment|Disease Progression|5|||
146731944|NCT04737109|529190737|FG001|Study Treatment|Disease Progression|0|||
146731945|NCT04737109|529190738|FG002|Study Treatment|Disease Progression|0|||
146731946|NCT04737109|529190739|FG003|Study Treatment|Disease Progression|0|||
146731947|NCT04737109|529190736|FG000|Study Treatment|Death on study|1|||
146731948|NCT04737109|529190737|FG001|Study Treatment|Death on study|0|||
146731949|NCT04737109|529190738|FG002|Study Treatment|Death on study|0|||
146731950|NCT04737109|529190739|FG003|Study Treatment|Death on study|0|||
146731951|NCT01582789|529190741|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
146731952|NCT01582789|529190742|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
146731953|NCT02276066|529190743|FG000|Overall Study|Lost to Follow-up|21|||
146731954|NCT02276066|529190744|FG001|Overall Study|Lost to Follow-up|11|||
146731955|NCT05050578|529190745|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
146731956|NCT05050578|529190746|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
146731957|NCT05050578|529190745|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
146731958|NCT05050578|529190746|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
146731959|NCT05050578|529190745|FG000|Period 2, 30 Days|Protocol Violation|0|||
146731960|NCT05050578|529190746|FG001|Period 2, 30 Days|Protocol Violation|1|||
146731961|NCT03386032|529190748|FG000|Overall Study|Lack of Efficacy|6|||
146731962|NCT03386032|529190749|FG001|Overall Study|Lack of Efficacy|2|||
146731963|NCT03386032|529190750|FG002|Overall Study|Lack of Efficacy|0|||
146731964|NCT03386032|529190748|FG000|Overall Study|Adverse Event|2|||
146731965|NCT03386032|529190749|FG001|Overall Study|Adverse Event|2|||
146731966|NCT03386032|529190750|FG002|Overall Study|Adverse Event|0|||
146731967|NCT03386032|529190748|FG000|Overall Study|Withdrawal by Subject|1|||
146731968|NCT03386032|529190749|FG001|Overall Study|Withdrawal by Subject|0|||
146731969|NCT03386032|529190750|FG002|Overall Study|Withdrawal by Subject|0|||
146731970|NCT03386032|529190748|FG000|Overall Study|Lost to Follow-up|9|||
146731971|NCT03386032|529190749|FG001|Overall Study|Lost to Follow-up|3|||
146731972|NCT03386032|529190750|FG002|Overall Study|Lost to Follow-up|0|||
146731973|NCT02710292|529190755|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
146731974|NCT02710292|529190756|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
146731975|NCT02710292|529190755|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
146731976|NCT02710292|529190756|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
146731977|NCT03122119|529190757|FG000|Overall Study|Did not meet eligibility critria|1|||
146731978|NCT02364180|529190763|FG000|Overall Study|Screen Fail|1|||
146731979|NCT01783418|529190764|FG000|Overall Study|Withdrawal by Subject|1|||
146731980|NCT01783418|529190765|FG001|Overall Study|Withdrawal by Subject|0|||
146731981|NCT00089141|529190766|FG000|Overall Study|Termination of trial|18|||
146731982|NCT00089141|529190767|FG001|Overall Study|Termination of trial|24|||
146731983|NCT00508261|529190768|FG000|Overall Study|Other|0|||
146731984|NCT00508261|529190769|FG001|Overall Study|Other|1|||
146731985|NCT00508261|529190770|FG002|Overall Study|Other|1|||
146731986|NCT00508261|529190771|FG003|Overall Study|Other|0|||
146731987|NCT00508261|529190768|FG000|Overall Study|Serious Adverse Event|0|||
146731988|NCT00508261|529190769|FG001|Overall Study|Serious Adverse Event|1|||
146731989|NCT00508261|529190770|FG002|Overall Study|Serious Adverse Event|0|||
146731990|NCT00508261|529190771|FG003|Overall Study|Serious Adverse Event|0|||
146731991|NCT00508261|529190768|FG000|Overall Study|Withdrawal by Subject|3|||
146731992|NCT00508261|529190769|FG001|Overall Study|Withdrawal by Subject|4|||
146731993|NCT00508261|529190770|FG002|Overall Study|Withdrawal by Subject|4|||
146731994|NCT00508261|529190771|FG003|Overall Study|Withdrawal by Subject|0|||
146731995|NCT00508261|529190768|FG000|Overall Study|Migrated/ moved from study area|0|||
146731996|NCT00508261|529190769|FG001|Overall Study|Migrated/ moved from study area|1|||
146731997|NCT00508261|529190770|FG002|Overall Study|Migrated/ moved from study area|0|||
146731998|NCT00508261|529190771|FG003|Overall Study|Migrated/ moved from study area|0|||
146731999|NCT00508261|529190768|FG000|Overall Study|Lost to Follow-up|0|||
146732000|NCT00508261|529190769|FG001|Overall Study|Lost to Follow-up|1|||
146732001|NCT00508261|529190770|FG002|Overall Study|Lost to Follow-up|1|||
146732002|NCT00508261|529190771|FG003|Overall Study|Lost to Follow-up|1|||
146732003|NCT02093663|529190774|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
146732004|NCT02093663|529190775|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
146732005|NCT02093663|529190776|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
146732006|NCT02093663|529190777|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
146732007|NCT02093663|529190778|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
146732008|NCT02093663|529190774|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
146732009|NCT02093663|529190775|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
146732010|NCT02093663|529190776|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
146732011|NCT02093663|529190777|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
146732012|NCT02093663|529190778|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
146732013|NCT02093663|529190774|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
146732014|NCT02093663|529190775|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
146790431|NCT02601313|529403550|FG001|Overall Study|Full consent withdrawal|3|||
146790432|NCT02601313|529403551|FG002|Overall Study|Full consent withdrawal|2|||
146790433|NCT02601313|529403549|FG000|Overall Study|Lost to Follow-up|0|||
146790434|NCT02601313|529403550|FG001|Overall Study|Lost to Follow-up|1|||
146790435|NCT02601313|529403551|FG002|Overall Study|Lost to Follow-up|1|||
146790436|NCT05239455|529403552|FG000|Overall Study|Adverse Event|1|||
146790437|NCT05239455|529403552|FG000|Overall Study|Sponsor Decision|5|||
146790438|NCT05239455|529403552|FG000|Overall Study|Incomplete Blood Collection|1|||
146790439|NCT03800654|529403553|FG000|Overall Study|Time constraints|3|||
146790440|NCT03800654|529403554|FG001|Overall Study|Time constraints|3|||
146790441|NCT03800654|529403555|FG002|Overall Study|Time constraints|3|||
146938488|NCT00792701|529932409|FG000|Overall Study|Ineligible|1|||
146938489|NCT00792701|529932410|FG001|Overall Study|Ineligible|3|||
146938490|NCT00792701|529932409|FG000|Overall Study|Withdrawal by Subject|1|||
146938491|NCT00792701|529932410|FG001|Overall Study|Withdrawal by Subject|19|||
146938492|NCT00792701|529932409|FG000|Overall Study|Not protocol specified|17|||
146938493|NCT00792701|529932410|FG001|Overall Study|Not protocol specified|0|||
146938494|NCT00615914|529932411|FG000|Overall Study|Adverse Event|274|||
146938495|NCT00615914|529932411|FG000|Overall Study|Death|20|||
146938496|NCT00615914|529932411|FG000|Overall Study|Lack of Efficacy|59|||
146938497|NCT00615914|529932411|FG000|Overall Study|Lost to Follow-up|187|||
146938498|NCT00615914|529932411|FG000|Overall Study|Withdrawal by Subject|16|||
146938499|NCT00615914|529932411|FG000|Overall Study|Physician Decision|4|||
146938500|NCT00615914|529932411|FG000|Overall Study|No data was collected.|65|||
146938501|NCT00615914|529932411|FG000|Overall Study|No treatment|2|||
146938502|NCT00615914|529932411|FG000|Overall Study|Irregularly enrolled patients|10|||
146938503|NCT01809197|529932412|FG000|Overall Study|Lost to Follow-up|4|||
146938504|NCT01809197|529932413|FG001|Overall Study|Lost to Follow-up|2|||
146938505|NCT01809197|529932412|FG000|Overall Study|Adverse Event|2|||
146938506|NCT01809197|529932413|FG001|Overall Study|Adverse Event|3|||
146938507|NCT01809197|529932412|FG000|Overall Study|Failed slit lamp exam|1|||
146938508|NCT01809197|529932413|FG001|Overall Study|Failed slit lamp exam|0|||
146938509|NCT01809197|529932412|FG000|Overall Study|Non-Compliance|1|||
146938510|NCT01809197|529932413|FG001|Overall Study|Non-Compliance|1|||
146938511|NCT01809197|529932412|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
146938512|NCT01809197|529932413|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
146938513|NCT01809197|529932412|FG000|Overall Study|Withdrawal by Subject|1|||
146938514|NCT01809197|529932413|FG001|Overall Study|Withdrawal by Subject|1|||
146938515|NCT01809197|529932412|FG000|Overall Study|Product not available|0|||
146938516|NCT01809197|529932413|FG001|Overall Study|Product not available|1|||
146938517|NCT03228394|529932414|FG000|Overall Study|Lost to Follow-up|0|||
146938518|NCT03228394|529932415|FG001|Overall Study|Lost to Follow-up|0|||
146938519|NCT03228394|529932416|FG002|Overall Study|Lost to Follow-up|1|||
146938520|NCT03228394|529932417|FG003|Overall Study|Lost to Follow-up|1|||
146938521|NCT03228394|529932418|FG004|Overall Study|Lost to Follow-up|0|||
146938522|NCT03228394|529932419|FG005|Overall Study|Lost to Follow-up|0|||
146938523|NCT03228394|529932420|FG006|Overall Study|Lost to Follow-up|2|||
146938524|NCT03228394|529932421|FG007|Overall Study|Lost to Follow-up|0|||
146938525|NCT03228394|529932414|FG000|Overall Study|Withdrawal by Subject|0|||
146938526|NCT03228394|529932415|FG001|Overall Study|Withdrawal by Subject|0|||
146938527|NCT03228394|529932416|FG002|Overall Study|Withdrawal by Subject|1|||
146938528|NCT03228394|529932417|FG003|Overall Study|Withdrawal by Subject|0|||
146938529|NCT03228394|529932418|FG004|Overall Study|Withdrawal by Subject|0|||
146938530|NCT03228394|529932419|FG005|Overall Study|Withdrawal by Subject|0|||
146790442|NCT03800654|529403553|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
146790443|NCT03800654|529403554|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
146790444|NCT03800654|529403555|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
146790445|NCT03800654|529403553|FG000|Overall Study|Lost to Follow-up|2|||
146790446|NCT03800654|529403554|FG001|Overall Study|Lost to Follow-up|1|||
146790447|NCT03800654|529403555|FG002|Overall Study|Lost to Follow-up|6|||
146790448|NCT03800654|529403553|FG000|Overall Study|Medical Health Issue|0|||
146790449|NCT03800654|529403554|FG001|Overall Study|Medical Health Issue|0|||
146938531|NCT03228394|529932420|FG006|Overall Study|Withdrawal by Subject|1|||
146938532|NCT03228394|529932421|FG007|Overall Study|Withdrawal by Subject|3|||
146938533|NCT03228394|529932414|FG000|Overall Study|Protocol Violation|0|||
146790450|NCT03800654|529403555|FG002|Overall Study|Medical Health Issue|1|||
146790451|NCT03800654|529403553|FG000|Overall Study|Personal Issues|0|||
146938534|NCT03228394|529932415|FG001|Overall Study|Protocol Violation|0|||
146938535|NCT03228394|529932416|FG002|Overall Study|Protocol Violation|0|||
146790452|NCT03800654|529403554|FG001|Overall Study|Personal Issues|2|||
146790453|NCT03800654|529403555|FG002|Overall Study|Personal Issues|0|||
146938536|NCT03228394|529932417|FG003|Overall Study|Protocol Violation|1|||
146938537|NCT03228394|529932418|FG004|Overall Study|Protocol Violation|0|||
146938538|NCT03228394|529932419|FG005|Overall Study|Protocol Violation|0|||
146938539|NCT03228394|529932420|FG006|Overall Study|Protocol Violation|0|||
146938540|NCT03228394|529932421|FG007|Overall Study|Protocol Violation|0|||
146938541|NCT03228394|529932414|FG000|Overall Study|Physician Decision|0|||
146938542|NCT03228394|529932415|FG001|Overall Study|Physician Decision|0|||
146938543|NCT03228394|529932416|FG002|Overall Study|Physician Decision|0|||
146938544|NCT03228394|529932417|FG003|Overall Study|Physician Decision|0|||
146938545|NCT03228394|529932418|FG004|Overall Study|Physician Decision|0|||
146938546|NCT03228394|529932419|FG005|Overall Study|Physician Decision|0|||
146938547|NCT03228394|529932420|FG006|Overall Study|Physician Decision|1|||
146938548|NCT03228394|529932421|FG007|Overall Study|Physician Decision|0|||
146938549|NCT03228394|529932414|FG000|Overall Study|Noncompliance|0|||
146938550|NCT03228394|529932415|FG001|Overall Study|Noncompliance|0|||
146938551|NCT03228394|529932416|FG002|Overall Study|Noncompliance|0|||
146938552|NCT03228394|529932417|FG003|Overall Study|Noncompliance|0|||
146938553|NCT03228394|529932418|FG004|Overall Study|Noncompliance|0|||
146938554|NCT03228394|529932419|FG005|Overall Study|Noncompliance|0|||
146938555|NCT03228394|529932420|FG006|Overall Study|Noncompliance|1|||
146938556|NCT03228394|529932421|FG007|Overall Study|Noncompliance|0|||
146938557|NCT00294684|529932426|FG000|Overall Study|Lost to Follow-up|5|||
146938558|NCT00294684|529932427|FG001|Overall Study|Lost to Follow-up|8|||
146938559|NCT02443805|529932428|FG000|Overall Study|Adverse Event|100|||
146938560|NCT02443805|529932429|FG001|Overall Study|Adverse Event|18|||
146938561|NCT02443805|529932428|FG000|Overall Study|Withdrawal by Subject|73|||
146938562|NCT02443805|529932429|FG001|Overall Study|Withdrawal by Subject|74|||
146938563|NCT02443805|529932428|FG000|Overall Study|Lost to Follow-up|19|||
146938564|NCT02443805|529932429|FG001|Overall Study|Lost to Follow-up|14|||
146938565|NCT02443805|529932428|FG000|Overall Study|Pregnancy|6|||
146938566|NCT02443805|529932429|FG001|Overall Study|Pregnancy|5|||
146938567|NCT02443805|529932428|FG000|Overall Study|Protocol Violation|2|||
146938568|NCT02443805|529932429|FG001|Overall Study|Protocol Violation|4|||
146938569|NCT02443805|529932428|FG000|Overall Study|Lack of Efficacy|1|||
146938570|NCT02443805|529932429|FG001|Overall Study|Lack of Efficacy|1|||
146790454|NCT03800654|529403553|FG000|Overall Study|Protocol Violation|0|||
146790455|NCT03800654|529403554|FG001|Overall Study|Protocol Violation|1|||
146790456|NCT03800654|529403555|FG002|Overall Study|Protocol Violation|0|||
146790457|NCT03459729|529403556|FG000|Overall Study|Physician Decision|2|||
146790458|NCT05704543|529403558|FG000|Overall Study|Withdrawal by Subject|1|||
146790459|NCT05704543|529403559|FG001|Overall Study|Withdrawal by Subject|1|||
146790460|NCT05704543|529403560|FG002|Overall Study|Withdrawal by Subject|0|||
146790461|NCT05704543|529403561|FG003|Overall Study|Withdrawal by Subject|2|||
146790462|NCT05704543|529403558|FG000|Overall Study|Lost to Follow-up|1|||
146790463|NCT05704543|529403559|FG001|Overall Study|Lost to Follow-up|2|||
146790464|NCT05704543|529403560|FG002|Overall Study|Lost to Follow-up|0|||
146790465|NCT05704543|529403561|FG003|Overall Study|Lost to Follow-up|0|||
146790466|NCT02151981|529403562|FG000|Overall Study|Death|184|||
146790467|NCT02151981|529403563|FG001|Overall Study|Death|88|||
146790468|NCT02151981|529403562|FG000|Overall Study|Lost to Follow-up|7|||
146790469|NCT02151981|529403563|FG001|Overall Study|Lost to Follow-up|1|||
146790470|NCT02151981|529403562|FG000|Overall Study|Withdrawal by Subject|27|||
146790471|NCT02151981|529403563|FG001|Overall Study|Withdrawal by Subject|21|||
146790472|NCT02151981|529403562|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146790473|NCT02151981|529403563|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146790474|NCT02151981|529403562|FG000|Overall Study|Other reasons|1|||
146790475|NCT02151981|529403563|FG001|Overall Study|Other reasons|2|||
146790476|NCT05576155|529403571|FG000|Overall Study|Withdrawal by Subject|1|||
146790477|NCT05576155|529403572|FG001|Overall Study|Withdrawal by Subject|1|||
146790478|NCT04081103|529403573|FG000|Overall Study|Adverse Event|1|||
146790479|NCT04081103|529403574|FG001|Overall Study|Adverse Event|1|||
146790480|NCT04081103|529403575|FG002|Overall Study|Adverse Event|1|||
146790481|NCT04081103|529403573|FG000|Overall Study|Physician Decision|0|||
146790482|NCT04081103|529403574|FG001|Overall Study|Physician Decision|0|||
146790483|NCT04081103|529403575|FG002|Overall Study|Physician Decision|1|||
146790484|NCT03287817|529405046|FG000|Overall Study|Progressive disease|4|||
146790485|NCT03287817|529405047|FG001|Overall Study|Progressive disease|2|||
146790486|NCT03287817|529405048|FG002|Overall Study|Progressive disease|3|||
146790487|NCT03287817|529405049|FG003|Overall Study|Progressive disease|10|||
146790488|NCT03287817|529405050|FG004|Overall Study|Progressive disease|8|||
146790489|NCT03287817|529405046|FG000|Overall Study|Death|0|||
146790490|NCT03287817|529405047|FG001|Overall Study|Death|0|||
146790491|NCT03287817|529405048|FG002|Overall Study|Death|2|||
146790492|NCT03287817|529405049|FG003|Overall Study|Death|3|||
146790493|NCT03287817|529405050|FG004|Overall Study|Death|4|||
146938571|NCT02443805|529932428|FG000|Overall Study|Non-compliance with study drug|6|||
146938572|NCT02443805|529932429|FG001|Overall Study|Non-compliance with study drug|4|||
146938573|NCT02443805|529932428|FG000|Overall Study|Withdrawal by parent/guardian|3|||
146938574|NCT02443805|529932429|FG001|Overall Study|Withdrawal by parent/guardian|5|||
146938575|NCT02443805|529932428|FG000|Overall Study|Any other reason not above-mentioned|3|||
146790494|NCT03287817|529405046|FG000|Overall Study|Physician Decision|0|||
146790495|NCT03287817|529405047|FG001|Overall Study|Physician Decision|0|||
146790496|NCT03287817|529405048|FG002|Overall Study|Physician Decision|0|||
146790497|NCT03287817|529405049|FG003|Overall Study|Physician Decision|1|||
146790498|NCT03287817|529405050|FG004|Overall Study|Physician Decision|0|||
146938576|NCT02443805|529932429|FG001|Overall Study|Any other reason not above-mentioned|2|||
146938577|NCT00968708|529932430|FG000|Overall Study|Adverse Event|169|||
146790499|NCT03287817|529405046|FG000|Overall Study|Withdrawal by Subject|0|||
146790500|NCT03287817|529405047|FG001|Overall Study|Withdrawal by Subject|0|||
146790501|NCT03287817|529405048|FG002|Overall Study|Withdrawal by Subject|0|||
146790502|NCT03287817|529405049|FG003|Overall Study|Withdrawal by Subject|0|||
146790503|NCT03287817|529405050|FG004|Overall Study|Withdrawal by Subject|4|||
146790504|NCT05543915|529405051|FG000|Overall Study|Lost to Follow-up|0|||
146790505|NCT05543915|529405052|FG001|Overall Study|Lost to Follow-up|1|||
146790506|NCT04987320|529405053|FG000|Overall Study|Withdrawal by Subject|0|||
146790507|NCT04987320|529405054|FG001|Overall Study|Withdrawal by Subject|1|||
146790508|NCT00085735|529405055|FG000|Overall Study|Adverse Event|1|||
146790509|NCT00085735|529405056|FG001|Overall Study|Adverse Event|0|||
146790510|NCT00085735|529405057|FG002|Overall Study|Adverse Event|0|||
146790511|NCT00085735|529405058|FG003|Overall Study|Adverse Event|0|||
146790512|NCT00085735|529405059|FG004|Overall Study|Adverse Event|0|||
146790513|NCT00085735|529405060|FG005|Overall Study|Adverse Event|0|||
146790514|NCT00085735|529405055|FG000|Overall Study|Lack of Efficacy|2|||
146790515|NCT00085735|529405056|FG001|Overall Study|Lack of Efficacy|4|||
146790516|NCT00085735|529405057|FG002|Overall Study|Lack of Efficacy|6|||
146790517|NCT00085735|529405058|FG003|Overall Study|Lack of Efficacy|3|||
146790518|NCT00085735|529405059|FG004|Overall Study|Lack of Efficacy|4|||
146790519|NCT00085735|529405060|FG005|Overall Study|Lack of Efficacy|3|||
146790520|NCT00085735|529405055|FG000|Overall Study|Lost to Follow-up|0|||
146790521|NCT00085735|529405056|FG001|Overall Study|Lost to Follow-up|1|||
146790522|NCT00085735|529405057|FG002|Overall Study|Lost to Follow-up|0|||
146790523|NCT00085735|529405058|FG003|Overall Study|Lost to Follow-up|0|||
146790524|NCT00085735|529405059|FG004|Overall Study|Lost to Follow-up|1|||
146790525|NCT00085735|529405060|FG005|Overall Study|Lost to Follow-up|0|||
146790526|NCT00085735|529405055|FG000|Overall Study|Physician Decision|2|||
146790527|NCT00085735|529405056|FG001|Overall Study|Physician Decision|3|||
146790528|NCT00085735|529405057|FG002|Overall Study|Physician Decision|2|||
146790529|NCT00085735|529405058|FG003|Overall Study|Physician Decision|3|||
146790530|NCT00085735|529405059|FG004|Overall Study|Physician Decision|11|||
146790531|NCT00085735|529405060|FG005|Overall Study|Physician Decision|8|||
146790532|NCT00085735|529405055|FG000|Overall Study|Protocol Violation|1|||
146790533|NCT00085735|529405056|FG001|Overall Study|Protocol Violation|0|||
146790534|NCT00085735|529405057|FG002|Overall Study|Protocol Violation|0|||
146790535|NCT00085735|529405058|FG003|Overall Study|Protocol Violation|0|||
146790536|NCT00085735|529405059|FG004|Overall Study|Protocol Violation|0|||
146790537|NCT00085735|529405060|FG005|Overall Study|Protocol Violation|0|||
146790538|NCT00085735|529405055|FG000|Overall Study|Withdrawal by Subject|1|||
146790539|NCT00085735|529405056|FG001|Overall Study|Withdrawal by Subject|0|||
146790540|NCT00085735|529405057|FG002|Overall Study|Withdrawal by Subject|4|||
146790541|NCT00085735|529405058|FG003|Overall Study|Withdrawal by Subject|5|||
146790542|NCT00085735|529405059|FG004|Overall Study|Withdrawal by Subject|7|||
146790543|NCT00085735|529405060|FG005|Overall Study|Withdrawal by Subject|8|||
146790544|NCT00085735|529405055|FG000|Overall Study|Patient ineligible|1|||
146790545|NCT00085735|529405056|FG001|Overall Study|Patient ineligible|0|||
146790546|NCT00085735|529405057|FG002|Overall Study|Patient ineligible|3|||
146790547|NCT00085735|529405058|FG003|Overall Study|Patient ineligible|7|||
146790548|NCT00085735|529405059|FG004|Overall Study|Patient ineligible|17|||
146790549|NCT00085735|529405060|FG005|Overall Study|Patient ineligible|8|||
146790550|NCT00085735|529405055|FG000|Overall Study|Excess residual disease|2|||
146790551|NCT00085735|529405056|FG001|Overall Study|Excess residual disease|2|||
146790552|NCT00085735|529405057|FG002|Overall Study|Excess residual disease|1|||
146790553|NCT00085735|529405058|FG003|Overall Study|Excess residual disease|1|||
146790554|NCT00085735|529405059|FG004|Overall Study|Excess residual disease|1|||
146790555|NCT00085735|529405060|FG005|Overall Study|Excess residual disease|4|||
146790556|NCT00085735|529405055|FG000|Overall Study|Reason not documented|1|||
146790557|NCT00085735|529405056|FG001|Overall Study|Reason not documented|0|||
146790558|NCT00085735|529405057|FG002|Overall Study|Reason not documented|1|||
146790559|NCT00085735|529405058|FG003|Overall Study|Reason not documented|0|||
146938578|NCT00968708|529932431|FG001|Overall Study|Adverse Event|150|||
146938579|NCT00968708|529932430|FG000|Overall Study|Major Protocol Deviation|0|||
146938580|NCT00968708|529932431|FG001|Overall Study|Major Protocol Deviation|1|||
146790560|NCT00085735|529405059|FG004|Overall Study|Reason not documented|1|||
146790561|NCT00085735|529405060|FG005|Overall Study|Reason not documented|0|||
146790562|NCT00085735|529405055|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
146790563|NCT00085735|529405056|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
146790564|NCT00085735|529405057|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
146790565|NCT00085735|529405058|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
146790566|NCT00085735|529405059|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
146790567|NCT00085735|529405060|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
146938581|NCT00968708|529932430|FG000|Overall Study|Lost to Follow-up|19|||
146790568|NCT00433329|529405061|FG000|Overall Study|Adverse Event|9|||
146790569|NCT00433329|529405061|FG000|Overall Study|Death|4|||
146790570|NCT00433329|529405061|FG000|Overall Study|Withdrew consent|3|||
146790571|NCT00433329|529405061|FG000|Overall Study|Discontinued sildenafil|2|||
146938582|NCT00968708|529932431|FG001|Overall Study|Lost to Follow-up|11|||
146790572|NCT00433329|529405061|FG000|Overall Study|Moved out of state|1|||
146790573|NCT00433329|529405061|FG000|Overall Study|Lost to Follow-up|1|||
146790574|NCT00433329|529405061|FG000|Overall Study|Physician Decision|1|||
146790575|NCT03381196|529405064|FG000|Overall Study|Withdrawal by Subject|7|||
146790576|NCT03381196|529405065|FG001|Overall Study|Withdrawal by Subject|7|||
146790577|NCT03381196|529405064|FG000|Overall Study|Other|0|||
146790578|NCT03381196|529405065|FG001|Overall Study|Other|1|||
146790579|NCT03381196|529405064|FG000|Overall Study|Lost to Follow-up|5|||
146790580|NCT03381196|529405065|FG001|Overall Study|Lost to Follow-up|4|||
146790581|NCT03381196|529405064|FG000|Overall Study|Death|0|||
146790582|NCT03381196|529405065|FG001|Overall Study|Death|1|||
146790583|NCT03381196|529405064|FG000|Overall Study|Adverse Event|1|||
146790584|NCT03381196|529405065|FG001|Overall Study|Adverse Event|0|||
146790585|NCT03381196|529405064|FG000|Overall Study|Randomized, not treated|3|||
146790586|NCT03381196|529405065|FG001|Overall Study|Randomized, not treated|6|||
146790587|NCT02359890|529405066|FG000|Overall Study|Not meeting eligibility|4|||
146790588|NCT02359890|529405066|FG000|Overall Study|Never treated with study catheter|6|||
146790589|NCT03628924|529405067|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
146790590|NCT03628924|529405068|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
146790591|NCT03628924|529405069|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
146790592|NCT03628924|529405070|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
146790593|NCT03628924|529405071|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
146790594|NCT03628924|529405072|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
146790595|NCT03628924|529405073|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
146790596|NCT03628924|529405067|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146790597|NCT03628924|529405068|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146790598|NCT03628924|529405069|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
146790599|NCT03628924|529405070|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146790600|NCT03628924|529405071|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146790601|NCT03628924|529405072|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146790602|NCT03628924|529405073|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146790603|NCT03628924|529405067|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
146790604|NCT03628924|529405068|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
146790605|NCT03628924|529405069|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
146790606|NCT03628924|529405070|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
146790607|NCT03628924|529405071|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
146790608|NCT03628924|529405072|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
146790609|NCT03628924|529405073|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
146790610|NCT03628924|529405067|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
146790611|NCT03628924|529405068|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
146790612|NCT03628924|529405069|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
146790613|NCT03628924|529405070|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
146790614|NCT03628924|529405071|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
146790615|NCT03628924|529405072|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
146790616|NCT03628924|529405073|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
146790617|NCT03628924|529405067|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
146790618|NCT03628924|529405068|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
146790619|NCT03628924|529405069|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
146790620|NCT03628924|529405070|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
146790621|NCT03628924|529405071|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
146790622|NCT03628924|529405072|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
146790623|NCT03628924|529405073|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
146790624|NCT03628924|529405067|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
146790625|NCT03628924|529405068|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
146790626|NCT03628924|529405069|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
146790627|NCT03628924|529405070|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
146790628|NCT03628924|529405071|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
146790629|NCT03628924|529405072|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
146790630|NCT03628924|529405073|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
146790631|NCT03628924|529405067|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
146790632|NCT03628924|529405068|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
146790633|NCT03628924|529405069|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
146790634|NCT03628924|529405070|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
146790635|NCT03628924|529405071|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
146938583|NCT00968708|529932430|FG000|Overall Study|Voluntary Withdrawal|104|||
146938584|NCT00968708|529932431|FG001|Overall Study|Voluntary Withdrawal|101|||
146938585|NCT00968708|529932430|FG000|Overall Study|Investigator Discretion|0|||
146790636|NCT03628924|529405072|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
146790637|NCT03628924|529405073|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
146790638|NCT03628924|529405067|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
146790639|NCT03628924|529405068|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
146790640|NCT03628924|529405069|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
146790641|NCT03628924|529405070|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
146790642|NCT03628924|529405071|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
146790643|NCT03628924|529405072|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
146790644|NCT03628924|529405073|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
146790645|NCT03628924|529405067|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
146790646|NCT03628924|529405068|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
146790647|NCT03628924|529405069|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
146790648|NCT03628924|529405070|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
146790649|NCT03628924|529405071|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
146790650|NCT03628924|529405072|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
146790651|NCT03628924|529405073|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
146790652|NCT03628924|529405067|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
146790653|NCT03628924|529405068|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
146790654|NCT03628924|529405069|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
146790655|NCT03628924|529405070|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
146790656|NCT03628924|529405071|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
146790657|NCT03628924|529405072|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
146790658|NCT03628924|529405073|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
146790659|NCT04499924|529405077|FG000|Overall Study|Study termination by sponsor|4|||
146790660|NCT04499924|529405078|FG001|Overall Study|Study termination by sponsor|6|||
146790661|NCT04499924|529405077|FG000|Overall Study|Withdrawal by Subject|1|||
146790662|NCT04499924|529405078|FG001|Overall Study|Withdrawal by Subject|3|||
146790663|NCT03011333|529405081|FG000|Overall Study|Lost to Follow-up|0|||
146790664|NCT03011333|529405082|FG001|Overall Study|Lost to Follow-up|1|||
146790665|NCT03011333|529405083|FG002|Overall Study|Lost to Follow-up|0|||
146790666|NCT03011333|529405084|FG003|Overall Study|Lost to Follow-up|1|||
146790667|NCT03011333|529405085|FG004|Overall Study|Lost to Follow-up|4|||
146790668|NCT03011333|529405086|FG005|Overall Study|Lost to Follow-up|4|||
146790669|NCT03011333|529405087|FG006|Overall Study|Lost to Follow-up|5|||
146790670|NCT04413708|529405088|FG000|Overall Study|Lost to Follow-up|1|||
146790671|NCT04413708|529405089|FG001|Overall Study|Lost to Follow-up|2|||
146790672|NCT02861300|529405092|FG000|Overall Study|Death|0|||
146790673|NCT02861300|529405093|FG001|Overall Study|Death|0|||
146790674|NCT02861300|529405094|FG002|Overall Study|Death|0|||
146790675|NCT02861300|529405095|FG003|Overall Study|Death|0|||
146790676|NCT02861300|529405096|FG004|Overall Study|Death|0|||
146790677|NCT02861300|529405097|FG005|Overall Study|Death|0|||
146790678|NCT02861300|529405098|FG006|Overall Study|Death|24|||
146790679|NCT02861300|529405092|FG000|Overall Study|Delay in treatment|0|||
146790680|NCT02861300|529405093|FG001|Overall Study|Delay in treatment|0|||
146790681|NCT02861300|529405094|FG002|Overall Study|Delay in treatment|0|||
146790682|NCT02861300|529405095|FG003|Overall Study|Delay in treatment|0|||
146790683|NCT02861300|529405096|FG004|Overall Study|Delay in treatment|0|||
146790684|NCT02861300|529405097|FG005|Overall Study|Delay in treatment|1|||
146790685|NCT02861300|529405098|FG006|Overall Study|Delay in treatment|0|||
146790686|NCT02861300|529405092|FG000|Overall Study|Disease Progression|0|||
146790687|NCT02861300|529405093|FG001|Overall Study|Disease Progression|1|||
146790688|NCT02861300|529405094|FG002|Overall Study|Disease Progression|0|||
146790689|NCT02861300|529405095|FG003|Overall Study|Disease Progression|0|||
146790690|NCT02861300|529405096|FG004|Overall Study|Disease Progression|0|||
146790691|NCT02861300|529405097|FG005|Overall Study|Disease Progression|0|||
146790692|NCT02861300|529405098|FG006|Overall Study|Disease Progression|2|||
146790693|NCT02861300|529405092|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
146790694|NCT02861300|529405093|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
146790695|NCT02861300|529405094|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
146790696|NCT02861300|529405095|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
146732015|NCT02093663|529190776|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
146732016|NCT02093663|529190777|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
146732017|NCT02093663|529190778|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
146732018|NCT02093663|529190774|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
146732019|NCT02093663|529190775|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
146732020|NCT02093663|529190776|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
146732021|NCT02093663|529190777|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
146732022|NCT02093663|529190778|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
146732023|NCT02093663|529190774|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
146732024|NCT02093663|529190775|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
146732025|NCT02093663|529190776|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
146790697|NCT02861300|529405096|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
146790698|NCT02861300|529405097|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
146790699|NCT02861300|529405098|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
146790700|NCT02861300|529405092|FG000|Overall Study|Clinical Complications|0|||
146790701|NCT02861300|529405093|FG001|Overall Study|Clinical Complications|0|||
146790702|NCT02861300|529405094|FG002|Overall Study|Clinical Complications|0|||
146790703|NCT02861300|529405095|FG003|Overall Study|Clinical Complications|0|||
146790704|NCT02861300|529405096|FG004|Overall Study|Clinical Complications|0|||
146790705|NCT02861300|529405097|FG005|Overall Study|Clinical Complications|0|||
146790706|NCT02861300|529405098|FG006|Overall Study|Clinical Complications|1|||
146790707|NCT03133546|529405104|FG000|Overall Study|Death|46|||
146790708|NCT03133546|529405105|FG001|Overall Study|Death|43|||
146790709|NCT03133546|529405104|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
146790710|NCT03133546|529405105|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
146790711|NCT01501955|529405109|FG000|Overall Study|Withdrawal by Subject|1|||
146790712|NCT01501955|529405110|FG001|Overall Study|Withdrawal by Subject|0|||
146790713|NCT01501955|529405109|FG000|Overall Study|Adverse Event|1|||
146790714|NCT01501955|529405110|FG001|Overall Study|Adverse Event|3|||
146790715|NCT05034328|529405111|FG000|Overall Study|Protocol Violation|1|||
146790716|NCT05034328|529405112|FG001|Overall Study|Protocol Violation|0|||
146790717|NCT05034328|529405111|FG000|Overall Study|Lost to Follow-up|0|||
146790718|NCT05034328|529405112|FG001|Overall Study|Lost to Follow-up|10|||
146790719|NCT02993159|529405113|FG000|Overall Study|Withdrawal by Subject|1|||
146790720|NCT02993159|529405114|FG001|Overall Study|Withdrawal by Subject|3|||
146790721|NCT02993159|529405113|FG000|Overall Study|Protocol Violation|1|||
146790722|NCT02993159|529405114|FG001|Overall Study|Protocol Violation|0|||
146790723|NCT02993159|529405113|FG000|Overall Study|Opted out of surgery|2|||
146790724|NCT02993159|529405114|FG001|Overall Study|Opted out of surgery|0|||
146790725|NCT02993159|529405113|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
146790726|NCT02993159|529405114|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
146790727|NCT02993159|529405113|FG000|Overall Study|Physician Decision|0|||
146790728|NCT02993159|529405114|FG001|Overall Study|Physician Decision|1|||
146790729|NCT02231164|529405116|FG000|Overall Study|Adverse Event|1|||
146790730|NCT02231164|529405117|FG001|Overall Study|Adverse Event|1|||
146790731|NCT02231164|529405116|FG000|Overall Study|Lack of Efficacy|4|||
146790732|NCT02231164|529405117|FG001|Overall Study|Lack of Efficacy|3|||
146790733|NCT02231164|529405116|FG000|Overall Study|Withdrawal by Subject|1|||
146790734|NCT02231164|529405117|FG001|Overall Study|Withdrawal by Subject|2|||
146790735|NCT03625167|529405118|FG000|Overall Study|Protocol Violation|5|||
146790736|NCT06103188|529405120|FG000|Overall Study|Lost to Follow-up|1|||
146790737|NCT06103188|529405121|FG001|Overall Study|Lost to Follow-up|6|||
146790738|NCT06103188|529405122|FG002|Overall Study|Lost to Follow-up|4|||
146790739|NCT02969707|529405127|FG000|Overall Study|Withdrawal by Subject|6|||
146790740|NCT02969707|529405128|FG001|Overall Study|Withdrawal by Subject|5|||
146790741|NCT02969707|529405127|FG000|Overall Study|Severe anxiety|0|||
146790742|NCT02969707|529405128|FG001|Overall Study|Severe anxiety|1|||
146790743|NCT02969707|529405127|FG000|Overall Study|Positive toxicology screen|0|||
146790744|NCT02969707|529405128|FG001|Overall Study|Positive toxicology screen|2|||
146790745|NCT02969707|529405127|FG000|Overall Study|Claustrophobia|2|||
146790746|NCT02969707|529405128|FG001|Overall Study|Claustrophobia|2|||
146790747|NCT02969707|529405127|FG000|Overall Study|Non-compliance|1|||
146790748|NCT02969707|529405128|FG001|Overall Study|Non-compliance|2|||
146790749|NCT05583578|529405131|FG000|Overall Study|Withdrawal by Subject|2|||
146790750|NCT05583578|529405132|FG001|Overall Study|Withdrawal by Subject|0|||
146790751|NCT04313972|529405133|FG000|Overall Study|Withdrawal by Subject|0|||
146790752|NCT04313972|529405134|FG001|Overall Study|Withdrawal by Subject|1|||
146790753|NCT04314713|529405136|FG000|Overall Study|Lost to Follow-up|0|||
146790754|NCT04314713|529405137|FG001|Overall Study|Lost to Follow-up|0|||
146790755|NCT04314713|529405138|FG002|Overall Study|Lost to Follow-up|0|||
146790756|NCT04314713|529405139|FG003|Overall Study|Lost to Follow-up|1|||
146790757|NCT04314713|529405140|FG004|Overall Study|Lost to Follow-up|0|||
146790758|NCT04314713|529405141|FG005|Overall Study|Lost to Follow-up|0|||
146790759|NCT00248287|529405142|FG000|Overall Study|Adverse Event|11|||
146790760|NCT00248287|529405143|FG001|Overall Study|Adverse Event|10|||
146790761|NCT00248287|529405142|FG000|Overall Study|Death|1|||
146790762|NCT00248287|529405143|FG001|Overall Study|Death|0|||
146790763|NCT00248287|529405142|FG000|Overall Study|Lost to Follow-up|0|||
146790764|NCT00248287|529405143|FG001|Overall Study|Lost to Follow-up|1|||
146790765|NCT00248287|529405142|FG000|Overall Study|Investigator Request|4|||
146790766|NCT00248287|529405143|FG001|Overall Study|Investigator Request|3|||
146790767|NCT00248287|529405142|FG000|Overall Study|Patient Request|5|||
146790768|NCT00248287|529405143|FG001|Overall Study|Patient Request|3|||
146790769|NCT00248287|529405142|FG000|Overall Study|Other|3|||
146790770|NCT00248287|529405143|FG001|Overall Study|Other|2|||
146790771|NCT04248725|529405146|FG000|Post-Treatment|Lost to Follow-up|6|||
146790772|NCT04248725|529405147|FG001|Post-Treatment|Lost to Follow-up|5|||
146790773|NCT04248725|529405146|FG000|6-Month Follow Up|Lost to Follow-up|9|||
146790774|NCT04248725|529405147|FG001|6-Month Follow Up|Lost to Follow-up|8|||
146790775|NCT04524442|529405156|FG000|Overall Study|Subject Decision|1|||
146790776|NCT01544114|529405171|FG000|Overall Study|Withdrawal by Subject|0|||
146790777|NCT01544114|529405172|FG001|Overall Study|Withdrawal by Subject|0|||
146790778|NCT01544114|529405173|FG002|Overall Study|Withdrawal by Subject|3|||
146790779|NCT01544114|529405171|FG000|Overall Study|Lost to Follow-up|0|||
146790780|NCT01544114|529405172|FG001|Overall Study|Lost to Follow-up|2|||
146790781|NCT01544114|529405173|FG002|Overall Study|Lost to Follow-up|0|||
146790782|NCT01544114|529405171|FG000|Overall Study|Adverse Event|1|||
146790783|NCT01544114|529405172|FG001|Overall Study|Adverse Event|1|||
146790784|NCT01544114|529405173|FG002|Overall Study|Adverse Event|2|||
146790785|NCT01544114|529405171|FG000|Overall Study|Protocol Violation|0|||
146790786|NCT01544114|529405172|FG001|Overall Study|Protocol Violation|1|||
146790787|NCT01544114|529405173|FG002|Overall Study|Protocol Violation|0|||
146790788|NCT06182033|529405176|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
146790789|NCT06182033|529405177|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
146790790|NCT06182033|529405176|FG000|Overall Study|Target child relocation|1|||
146790791|NCT06182033|529405177|FG001|Overall Study|Target child relocation|1|||
146790792|NCT06182033|529405176|FG000|Overall Study|Withdrawal by Subject|1|||
146790793|NCT06182033|529405177|FG001|Overall Study|Withdrawal by Subject|0|||
146790794|NCT04830800|529405188|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
146790795|NCT04830800|529405189|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
146790796|NCT04830800|529405190|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
146790797|NCT04830800|529405191|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
146790798|NCT04830800|529405192|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
146790799|NCT03701763|529405193|FG000|Placebo-controlled Phase|Adverse Event|1|||
146790800|NCT03701763|529405194|FG001|Placebo-controlled Phase|Adverse Event|5|||
146790801|NCT03701763|529405195|FG002|Placebo-controlled Phase|Adverse Event|0|||
146790802|NCT03701763|529405196|FG003|Placebo-controlled Phase|Adverse Event|0|||
146790803|NCT03701763|529405193|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
146790804|NCT03701763|529405194|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
146790805|NCT03701763|529405195|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
146790806|NCT03701763|529405196|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
146790807|NCT03701763|529405193|FG000|Placebo-controlled Phase|Miscellaneous|2|||
146790808|NCT03701763|529405194|FG001|Placebo-controlled Phase|Miscellaneous|0|||
146790809|NCT03701763|529405195|FG002|Placebo-controlled Phase|Miscellaneous|0|||
146790810|NCT03701763|529405196|FG003|Placebo-controlled Phase|Miscellaneous|0|||
146790811|NCT03701763|529405193|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
146790812|NCT03701763|529405194|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
146790813|NCT03701763|529405195|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
146790814|NCT03701763|529405196|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
146790815|NCT03701763|529405193|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
146790816|NCT03701763|529405194|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
146790817|NCT03701763|529405195|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
146790818|NCT03701763|529405196|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
146790819|NCT03701763|529405193|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
146790820|NCT03701763|529405194|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
146790821|NCT03701763|529405195|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
146790822|NCT03701763|529405196|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
146790823|NCT03701763|529405193|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
146790824|NCT03701763|529405194|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
146790825|NCT03701763|529405195|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
146790826|NCT03701763|529405196|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
146790827|NCT03701763|529405193|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
146790828|NCT03701763|529405194|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
146790829|NCT03701763|529405195|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
146790830|NCT03701763|529405196|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
146790831|NCT03701763|529405193|FG000|Apremilast Extension Phase|Adverse Event|0|||
146790832|NCT03701763|529405194|FG001|Apremilast Extension Phase|Adverse Event|0|||
146790833|NCT03701763|529405195|FG002|Apremilast Extension Phase|Adverse Event|3|||
146938586|NCT00968708|529932431|FG001|Overall Study|Investigator Discretion|1|||
146938587|NCT00968708|529932430|FG000|Overall Study|Other|26|||
146938588|NCT00968708|529932431|FG001|Overall Study|Other|34|||
146790834|NCT03701763|529405196|FG003|Apremilast Extension Phase|Adverse Event|1|||
146790835|NCT03701763|529405193|FG000|Apremilast Extension Phase|Miscellaneous|0|||
146790836|NCT03701763|529405194|FG001|Apremilast Extension Phase|Miscellaneous|0|||
146790837|NCT03701763|529405195|FG002|Apremilast Extension Phase|Miscellaneous|2|||
146790838|NCT03701763|529405196|FG003|Apremilast Extension Phase|Miscellaneous|1|||
146790839|NCT03701763|529405193|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
146790840|NCT03701763|529405194|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
146790841|NCT03701763|529405195|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
146938589|NCT02708966|529932432|FG000|Overall Study|Lost to Follow-up|2|||
146790842|NCT03701763|529405196|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
146790843|NCT03701763|529405193|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
146790844|NCT03701763|529405194|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
146790845|NCT03701763|529405195|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
146790846|NCT03701763|529405196|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
146790847|NCT03701763|529405193|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
146790848|NCT03701763|529405194|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
146790849|NCT03701763|529405195|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
146790850|NCT03701763|529405196|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
146790851|NCT03701763|529405193|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
146790852|NCT03701763|529405194|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
146790853|NCT03701763|529405195|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
146790854|NCT03701763|529405196|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
146790855|NCT03701763|529405193|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
146790856|NCT03701763|529405194|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
146790857|NCT03701763|529405195|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
146790858|NCT03701763|529405196|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
146790859|NCT03701763|529405193|FG000|14-Week Observational Follow-up Phase|Other|0|||
146790860|NCT03701763|529405194|FG001|14-Week Observational Follow-up Phase|Other|0|||
146790861|NCT03701763|529405195|FG002|14-Week Observational Follow-up Phase|Other|1|||
146790862|NCT03701763|529405196|FG003|14-Week Observational Follow-up Phase|Other|0|||
146790863|NCT03701763|529405193|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
146790864|NCT03701763|529405194|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
146790865|NCT03701763|529405195|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
146790866|NCT03701763|529405196|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
146790867|NCT03701763|529405193|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
146790868|NCT03701763|529405194|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
146790869|NCT03701763|529405195|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
146790870|NCT03701763|529405196|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
146790871|NCT04200456|529405197|FG000|Overall Study|Physician Decision|0|||
146790872|NCT04200456|529405198|FG001|Overall Study|Physician Decision|1|||
146790873|NCT04200456|529405197|FG000|Overall Study|Withdrawal by Subject|2|||
146790874|NCT04200456|529405198|FG001|Overall Study|Withdrawal by Subject|2|||
146790875|NCT04200456|529405197|FG000|Overall Study|Lack of Efficacy|1|||
146790876|NCT04200456|529405198|FG001|Overall Study|Lack of Efficacy|1|||
146790877|NCT04200456|529405197|FG000|Overall Study|Adverse event, non-fatal|0|||
146790878|NCT04200456|529405198|FG001|Overall Study|Adverse event, non-fatal|1|||
146790879|NCT04200456|529405197|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
146790880|NCT04200456|529405198|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
146790881|NCT03785964|529405199|FG000|Overall Study|Adverse Event|14|||
146790882|NCT03785964|529405200|FG001|Overall Study|Adverse Event|1|||
146790883|NCT03785964|529405199|FG000|Overall Study|Unqualified Clinical Progression|1|||
146790884|NCT03785964|529405200|FG001|Overall Study|Unqualified Clinical Progression|1|||
146790885|NCT03785964|529405199|FG000|Overall Study|Participant non-compliance|1|||
146790886|NCT03785964|529405200|FG001|Overall Study|Participant non-compliance|1|||
146790887|NCT03785964|529405199|FG000|Overall Study|Not treated|1|||
146790888|NCT03785964|529405200|FG001|Overall Study|Not treated|0|||
146790889|NCT03785964|529405199|FG000|Overall Study|Other reason|5|||
146790890|NCT03785964|529405200|FG001|Overall Study|Other reason|11|||
146790891|NCT03785964|529405199|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
146790892|NCT03785964|529405200|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
146790893|NCT05251909|529407353|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
146790894|NCT05251909|529407354|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
146790895|NCT03257410|529407355|FG000|Overall Study|Adverse Event|2|||
146790896|NCT03257410|529407356|FG001|Overall Study|Adverse Event|3|||
146790897|NCT03257410|529407355|FG000|Overall Study|Protocol Violation|1|||
146790898|NCT03257410|529407356|FG001|Overall Study|Protocol Violation|2|||
146790899|NCT03257410|529407355|FG000|Overall Study|Lost to Follow-up|1|||
146938590|NCT02708966|529932433|FG001|Overall Study|Lost to Follow-up|2|||
146790900|NCT03257410|529407356|FG001|Overall Study|Lost to Follow-up|0|||
146790901|NCT03257410|529407355|FG000|Overall Study|Withdrawal by Subject|1|||
146790902|NCT03257410|529407356|FG001|Overall Study|Withdrawal by Subject|2|||
146790903|NCT03257410|529407355|FG000|Overall Study|Physician Decision|1|||
146790904|NCT03257410|529407356|FG001|Overall Study|Physician Decision|1|||
146790905|NCT03257410|529407355|FG000|Overall Study|Renal transplantation|2|||
146790906|NCT03257410|529407356|FG001|Overall Study|Renal transplantation|0|||
146938591|NCT03407170|529932436|FG000|Overall Study|Adverse Event|1|||
146938592|NCT00126672|529932438|FG000|Overall Study|Adverse Event|4|||
146938593|NCT00126672|529932438|FG000|Overall Study|Lost to Follow-up|4|||
146790907|NCT03257410|529407355|FG000|Overall Study|Switch to peritoneal dialysis|1|||
146790908|NCT03257410|529407356|FG001|Overall Study|Switch to peritoneal dialysis|0|||
146790909|NCT03257410|529407355|FG000|Overall Study|Death|3|||
146790910|NCT03257410|529407356|FG001|Overall Study|Death|2|||
146790911|NCT03257410|529407355|FG000|Overall Study|Change to another dialysis center|2|||
146790912|NCT03257410|529407356|FG001|Overall Study|Change to another dialysis center|2|||
146790913|NCT03257410|529407355|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
146790914|NCT03257410|529407356|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
146790915|NCT03257410|529407355|FG000|Overall Study|Miscellaneous|2|||
146790916|NCT03257410|529407356|FG001|Overall Study|Miscellaneous|2|||
146790917|NCT03257410|529407355|FG000|Overall Study|Other|0|||
146790918|NCT03257410|529407356|FG001|Overall Study|Other|1|||
146790919|NCT02598388|529407357|FG000|Overall Study|Lost to Follow-up|1|||
146790920|NCT02598388|529407358|FG001|Overall Study|Lost to Follow-up|0|||
146790921|NCT02598388|529407359|FG002|Overall Study|Lost to Follow-up|1|||
146790922|NCT02598388|529407360|FG003|Overall Study|Lost to Follow-up|0|||
146790923|NCT02598388|529407361|FG004|Overall Study|Lost to Follow-up|5|||
146790924|NCT02598388|529407362|FG005|Overall Study|Lost to Follow-up|1|||
146790925|NCT02598388|529407363|FG006|Overall Study|Lost to Follow-up|2|||
146790926|NCT02598388|529407364|FG007|Overall Study|Lost to Follow-up|1|||
146790927|NCT02598388|529407365|FG008|Overall Study|Lost to Follow-up|0|||
146790928|NCT02598388|529407366|FG009|Overall Study|Lost to Follow-up|0|||
146790929|NCT02598388|529407367|FG010|Overall Study|Lost to Follow-up|1|||
146790930|NCT02598388|529407368|FG011|Overall Study|Lost to Follow-up|0|||
146790931|NCT02598388|529407357|FG000|Overall Study|Withdrawal by Subject|0|||
146790932|NCT02598388|529407358|FG001|Overall Study|Withdrawal by Subject|0|||
146790933|NCT02598388|529407359|FG002|Overall Study|Withdrawal by Subject|0|||
146790934|NCT02598388|529407360|FG003|Overall Study|Withdrawal by Subject|0|||
146790935|NCT02598388|529407361|FG004|Overall Study|Withdrawal by Subject|2|||
146790936|NCT02598388|529407362|FG005|Overall Study|Withdrawal by Subject|0|||
146790937|NCT02598388|529407363|FG006|Overall Study|Withdrawal by Subject|2|||
146790938|NCT02598388|529407364|FG007|Overall Study|Withdrawal by Subject|0|||
146790939|NCT02598388|529407365|FG008|Overall Study|Withdrawal by Subject|0|||
146790940|NCT02598388|529407366|FG009|Overall Study|Withdrawal by Subject|1|||
146790941|NCT02598388|529407367|FG010|Overall Study|Withdrawal by Subject|0|||
146790942|NCT02598388|529407368|FG011|Overall Study|Withdrawal by Subject|0|||
146790943|NCT02598388|529407357|FG000|Overall Study|Other|0|||
146790944|NCT02598388|529407358|FG001|Overall Study|Other|0|||
146790945|NCT02598388|529407359|FG002|Overall Study|Other|1|||
146790946|NCT02598388|529407360|FG003|Overall Study|Other|0|||
146790947|NCT02598388|529407361|FG004|Overall Study|Other|3|||
146790948|NCT02598388|529407362|FG005|Overall Study|Other|0|||
146790949|NCT02598388|529407363|FG006|Overall Study|Other|1|||
146790950|NCT02598388|529407364|FG007|Overall Study|Other|0|||
146790951|NCT02598388|529407365|FG008|Overall Study|Other|0|||
146790952|NCT02598388|529407366|FG009|Overall Study|Other|0|||
146790953|NCT02598388|529407367|FG010|Overall Study|Other|0|||
146790954|NCT02598388|529407368|FG011|Overall Study|Other|0|||
146790955|NCT05256017|529407372|FG000|Treatment Period|Withdrawal by Subject|1|||
146790956|NCT05256017|529407373|FG001|Treatment Period|Withdrawal by Subject|1|||
146790957|NCT05256017|529407372|FG000|Follow-up|Lost to Follow-up|7|||
146790958|NCT05256017|529407373|FG001|Follow-up|Lost to Follow-up|1|||
146790959|NCT05256017|529407372|FG000|Follow-up|Withdrawal by Subject|1|||
146790960|NCT05256017|529407373|FG001|Follow-up|Withdrawal by Subject|0|||
146790961|NCT05256017|529407372|FG000|Follow-up|Death|0|||
146790962|NCT05256017|529407373|FG001|Follow-up|Death|1|||
146790963|NCT06132282|529407376|FG000|Overall Study|Lost to Follow-up|31|||
146790964|NCT04663737|529407387|FG000|Overall Study|Withdrawal by Subject|2|||
146790965|NCT04663737|529407388|FG001|Overall Study|Withdrawal by Subject|0|||
146790966|NCT04016662|529407389|FG000|Run-In Phase|Death|1|||
146790967|NCT04016662|529407389|FG000|Run-In Phase|Withdrawal by Subject|11|||
146790968|NCT04016662|529407389|FG000|Run-In Phase|Not meeting screening eligibility|9|||
146790969|NCT04016662|529407389|FG000|Run-In Phase|Physician Decision|3|||
146790970|NCT04016662|529407389|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
146790971|NCT04016662|529407389|FG000|PLGS (12 Weeks)|Death|1|||
146790972|NCT04016662|529407389|FG000|SAP (12 Weeks)|Death|1|||
146790973|NCT03907878|529407390|FG000|Treatment Period|Withdrawal by Subject|5|||
146790974|NCT03907878|529407390|FG000|Treatment Period|Adverse Event|4|||
146790975|NCT03907878|529407390|FG000|Treatment Period|Lack of Efficacy|1|||
146790976|NCT03907878|529407390|FG000|Treatment Period|Protocol Violation|1|||
146790977|NCT03907878|529407390|FG000|Follow-up Period|Adverse Event|3|||
146790978|NCT03907878|529407390|FG000|Follow-up Period|Withdrawal by Subject|3|||
146790979|NCT02841579|529407398|FG000|Overall Study|Death|1|||
146790980|NCT02841579|529407398|FG000|Overall Study|Adverse Event|1|||
146938594|NCT01001234|529932441|FG000|Overall Study|Withdrawal by Subject|2|||
146790981|NCT02841579|529407398|FG000|Overall Study|Lack of Efficacy|9|||
146790982|NCT02998268|529407399|FG000|Overall Study|Adverse Event|0|||
146790983|NCT02998268|529407400|FG001|Overall Study|Adverse Event|2|||
146790984|NCT02998268|529407399|FG000|Overall Study|Withdrawal by Subject|0|||
146790985|NCT02998268|529407400|FG001|Overall Study|Withdrawal by Subject|1|||
146790986|NCT04225273|529407401|FG000|Overall Study|Lost to Follow-up|3|||
146790987|NCT03652389|529407402|FG000|Overall Study|Lost to Follow-up|1|||
146790988|NCT03652389|529407403|FG001|Overall Study|Lost to Follow-up|5|||
146790989|NCT03652389|529407402|FG000|Overall Study|Withdrawal by Subject|5|||
146790990|NCT03652389|529407403|FG001|Overall Study|Withdrawal by Subject|1|||
146790991|NCT03652389|529407402|FG000|Overall Study|New diagnosis|2|||
146790992|NCT03652389|529407403|FG001|Overall Study|New diagnosis|0|||
146790993|NCT02815566|529407404|FG000|Overall Study|Adverse Event|1|||
146790994|NCT02815566|529407405|FG001|Overall Study|Adverse Event|1|||
146790995|NCT02815566|529407404|FG000|Overall Study|Withdrawal by Subject|1|||
146790996|NCT02815566|529407405|FG001|Overall Study|Withdrawal by Subject|0|||
146790997|NCT02815566|529407404|FG000|Overall Study|Lost to Follow-up|0|||
146790998|NCT02815566|529407405|FG001|Overall Study|Lost to Follow-up|1|||
146790999|NCT03020199|529407406|FG000|Treatment Period|Adverse Event|0|||
146791000|NCT03020199|529407407|FG001|Treatment Period|Adverse Event|2|||
146791001|NCT03020199|529407406|FG000|Treatment Period|Lack of Efficacy|1|||
146791002|NCT03020199|529407407|FG001|Treatment Period|Lack of Efficacy|6|||
146791003|NCT03020199|529407406|FG000|Treatment Period|Lost to Follow-up|1|||
146791004|NCT03020199|529407407|FG001|Treatment Period|Lost to Follow-up|6|||
146791005|NCT03020199|529407406|FG000|Treatment Period|Physician Decision|0|||
146791006|NCT03020199|529407407|FG001|Treatment Period|Physician Decision|1|||
146791007|NCT03020199|529407406|FG000|Treatment Period|Subject/guardian decision|8|||
146791008|NCT03020199|529407407|FG001|Treatment Period|Subject/guardian decision|15|||
146791009|NCT03020199|529407406|FG000|Treatment Period|Subjects not treated|3|||
146791010|NCT03020199|529407407|FG001|Treatment Period|Subjects not treated|4|||
146791011|NCT03020199|529407406|FG000|Follow-up Period|Disease relapse|32|||
146791012|NCT03020199|529407407|FG001|Follow-up Period|Disease relapse|7|||
146791013|NCT03020199|529407406|FG000|Follow-up Period|Lack of Efficacy|1|||
146791014|NCT03020199|529407407|FG001|Follow-up Period|Lack of Efficacy|2|||
146791015|NCT03020199|529407406|FG000|Follow-up Period|Lost to Follow-up|4|||
146791016|NCT03020199|529407407|FG001|Follow-up Period|Lost to Follow-up|6|||
146791017|NCT03020199|529407406|FG000|Follow-up Period|Physician Decision|2|||
146791018|NCT03020199|529407407|FG001|Follow-up Period|Physician Decision|2|||
146791019|NCT03020199|529407406|FG000|Follow-up Period|Protocol Violation|1|||
146791020|NCT03020199|529407407|FG001|Follow-up Period|Protocol Violation|2|||
146791021|NCT03020199|529407406|FG000|Follow-up Period|Study terminated by Sponsor|6|||
146791022|NCT03020199|529407407|FG001|Follow-up Period|Study terminated by Sponsor|3|||
146791023|NCT03020199|529407406|FG000|Follow-up Period|Subject/guardian decision|14|||
146791024|NCT03020199|529407407|FG001|Follow-up Period|Subject/guardian decision|9|||
146791025|NCT05877976|529407408|FG000|Overall Study|Lost to Follow-up|31|||
146791026|NCT02714257|529407422|FG000|Overall Study|Withdrawal by Subject|6|||
146791027|NCT02714257|529407423|FG001|Overall Study|Withdrawal by Subject|11|||
146791028|NCT02714257|529407422|FG000|Overall Study|Death|3|||
146791029|NCT02714257|529407423|FG001|Overall Study|Death|4|||
146791030|NCT02714257|529407422|FG000|Overall Study|Lost to Follow-up|1|||
146791031|NCT02714257|529407423|FG001|Overall Study|Lost to Follow-up|6|||
146791032|NCT04568486|529407426|FG000|Overall Study|Withdrawal by Subject|26|||
146791033|NCT04568486|529407426|FG000|Overall Study|Lost to Follow-up|7|||
146791034|NCT01210807|529407427|FG000|Overall Study|Lost to Follow-up|1|||
146791035|NCT01210807|529407428|FG001|Overall Study|Lost to Follow-up|2|||
146791036|NCT01210807|529407427|FG000|Overall Study|Not implanted bilaterally|2|||
146791037|NCT01210807|529407428|FG001|Overall Study|Not implanted bilaterally|1|||
146791038|NCT05477186|529407431|FG000|Overall Study|Vaccine not administered|0|||
146791039|NCT05477186|529407432|FG001|Overall Study|Vaccine not administered|2|||
146791040|NCT05477186|529407433|FG002|Overall Study|Vaccine not administered|1|||
146791041|NCT05477186|529407434|FG003|Overall Study|Vaccine not administered|0|||
146791042|NCT05477186|529407435|FG004|Overall Study|Vaccine not administered|1|||
146791043|NCT05477186|529407436|FG005|Overall Study|Vaccine not administered|0|||
146791044|NCT05477186|529407437|FG006|Overall Study|Vaccine not administered|0|||
146791045|NCT05477186|529407431|FG000|Overall Study|Withdrawal by Subject|1|||
146791046|NCT05477186|529407432|FG001|Overall Study|Withdrawal by Subject|0|||
146791047|NCT05477186|529407433|FG002|Overall Study|Withdrawal by Subject|0|||
146791048|NCT05477186|529407434|FG003|Overall Study|Withdrawal by Subject|0|||
146791049|NCT05477186|529407435|FG004|Overall Study|Withdrawal by Subject|0|||
146791050|NCT05477186|529407436|FG005|Overall Study|Withdrawal by Subject|1|||
146791051|NCT05477186|529407437|FG006|Overall Study|Withdrawal by Subject|0|||
146791052|NCT05477186|529407431|FG000|Overall Study|Lost to Follow-up|1|||
146938595|NCT01001234|529932442|FG001|Overall Study|Withdrawal by Subject|0|||
146791053|NCT05477186|529407432|FG001|Overall Study|Lost to Follow-up|0|||
146791054|NCT05477186|529407433|FG002|Overall Study|Lost to Follow-up|2|||
146791055|NCT05477186|529407434|FG003|Overall Study|Lost to Follow-up|1|||
146791056|NCT05477186|529407435|FG004|Overall Study|Lost to Follow-up|1|||
146791057|NCT05477186|529407436|FG005|Overall Study|Lost to Follow-up|0|||
146791058|NCT05477186|529407437|FG006|Overall Study|Lost to Follow-up|2|||
146791059|NCT05496231|529407443|FG000|Overall Study|Adverse Event|1|||
146791060|NCT05496231|529407444|FG001|Overall Study|Adverse Event|1|||
146791061|NCT05496231|529407445|FG002|Overall Study|Adverse Event|0|||
146938596|NCT01001234|529932443|FG002|Overall Study|Withdrawal by Subject|3|||
146938597|NCT01001234|529932444|FG003|Overall Study|Withdrawal by Subject|0|||
146938598|NCT01001234|529932445|FG004|Overall Study|Withdrawal by Subject|0|||
146938599|NCT01001234|529932441|FG000|Overall Study|Protocol Violation|34|||
146938600|NCT01001234|529932442|FG001|Overall Study|Protocol Violation|3|||
146938601|NCT01001234|529932443|FG002|Overall Study|Protocol Violation|19|||
146938602|NCT01001234|529932444|FG003|Overall Study|Protocol Violation|18|||
146938603|NCT01001234|529932445|FG004|Overall Study|Protocol Violation|0|||
146938604|NCT01001234|529932441|FG000|Overall Study|Lost to Follow-up|0|||
146938605|NCT01001234|529932442|FG001|Overall Study|Lost to Follow-up|0|||
146938606|NCT01001234|529932443|FG002|Overall Study|Lost to Follow-up|1|||
146938607|NCT01001234|529932444|FG003|Overall Study|Lost to Follow-up|2|||
146938608|NCT01001234|529932445|FG004|Overall Study|Lost to Follow-up|0|||
146938609|NCT01001234|529932441|FG000|Overall Study|Physician Decision|1|||
146938610|NCT01001234|529932442|FG001|Overall Study|Physician Decision|0|||
146938611|NCT01001234|529932443|FG002|Overall Study|Physician Decision|0|||
146938612|NCT01001234|529932444|FG003|Overall Study|Physician Decision|0|||
146938613|NCT01001234|529932445|FG004|Overall Study|Physician Decision|0|||
146938614|NCT01001234|529932441|FG000|Overall Study|Not Treated: Adverse Event|1|||
146938615|NCT01001234|529932442|FG001|Overall Study|Not Treated: Adverse Event|0|||
146938616|NCT01001234|529932443|FG002|Overall Study|Not Treated: Adverse Event|0|||
146938617|NCT01001234|529932444|FG003|Overall Study|Not Treated: Adverse Event|0|||
146938618|NCT01001234|529932445|FG004|Overall Study|Not Treated: Adverse Event|0|||
146938619|NCT01001234|529932441|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
146938620|NCT01001234|529932442|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
146938621|NCT01001234|529932443|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
146938622|NCT01001234|529932444|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
146938623|NCT01001234|529932445|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
146938624|NCT01001234|529932441|FG000|Overall Study|Not Treated: Protocol Violation|3|||
146938625|NCT01001234|529932442|FG001|Overall Study|Not Treated: Protocol Violation|0|||
146938626|NCT01001234|529932443|FG002|Overall Study|Not Treated: Protocol Violation|0|||
146938627|NCT01001234|529932444|FG003|Overall Study|Not Treated: Protocol Violation|0|||
146938628|NCT01001234|529932445|FG004|Overall Study|Not Treated: Protocol Violation|0|||
146938629|NCT01001234|529932441|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
146938630|NCT01001234|529932442|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
146938631|NCT01001234|529932443|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
146938632|NCT01001234|529932444|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
146938633|NCT01001234|529932445|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
146938634|NCT01001234|529932441|FG000|Overall Study|Not Treated: Pregnancy|3|||
146938635|NCT01001234|529932442|FG001|Overall Study|Not Treated: Pregnancy|0|||
146938636|NCT01001234|529932443|FG002|Overall Study|Not Treated: Pregnancy|0|||
146938637|NCT01001234|529932444|FG003|Overall Study|Not Treated: Pregnancy|0|||
146938638|NCT01001234|529932445|FG004|Overall Study|Not Treated: Pregnancy|0|||
146938639|NCT01001234|529932441|FG000|Overall Study|Not Treated: Physician Decision|37|||
146938640|NCT01001234|529932442|FG001|Overall Study|Not Treated: Physician Decision|4|||
146938641|NCT01001234|529932443|FG002|Overall Study|Not Treated: Physician Decision|0|||
146938642|NCT01001234|529932444|FG003|Overall Study|Not Treated: Physician Decision|0|||
146938643|NCT01001234|529932445|FG004|Overall Study|Not Treated: Physician Decision|0|||
146938644|NCT01001234|529932441|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
146938645|NCT01001234|529932442|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
146938646|NCT01001234|529932443|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
146938647|NCT01001234|529932444|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
146938648|NCT01001234|529932445|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
146791062|NCT05496231|529407446|FG003|Overall Study|Adverse Event|4|||
146791063|NCT05496231|529407443|FG000|Overall Study|Withdrawal by Subject|5|||
146791064|NCT05496231|529407444|FG001|Overall Study|Withdrawal by Subject|5|||
146791065|NCT05496231|529407445|FG002|Overall Study|Withdrawal by Subject|4|||
146791066|NCT05496231|529407446|FG003|Overall Study|Withdrawal by Subject|11|||
146791067|NCT05496231|529407443|FG000|Overall Study|Migrated/moved from the study area|3|||
146791068|NCT05496231|529407444|FG001|Overall Study|Migrated/moved from the study area|5|||
146791069|NCT05496231|529407445|FG002|Overall Study|Migrated/moved from the study area|3|||
146791070|NCT05496231|529407446|FG003|Overall Study|Migrated/moved from the study area|3|||
146791071|NCT05496231|529407443|FG000|Overall Study|Lost to Follow-up|13|||
146791072|NCT05496231|529407444|FG001|Overall Study|Lost to Follow-up|6|||
146791073|NCT05496231|529407445|FG002|Overall Study|Lost to Follow-up|11|||
146938649|NCT01851863|529932449|FG000|Overall Study|Did not receive study medication|2|||
146938650|NCT01851863|529932450|FG001|Overall Study|Did not receive study medication|5|||
146938651|NCT01851863|529932451|FG002|Overall Study|Did not receive study medication|3|||
146938652|NCT01851863|529932452|FG003|Overall Study|Did not receive study medication|0|||
146938653|NCT01851863|529932449|FG000|Overall Study|Lost to Follow-up|3|||
146791074|NCT05496231|529407446|FG003|Overall Study|Lost to Follow-up|6|||
146791075|NCT05496231|529407443|FG000|Overall Study|Other|9|||
146791076|NCT05496231|529407444|FG001|Overall Study|Other|7|||
146791077|NCT05496231|529407445|FG002|Overall Study|Other|7|||
146791078|NCT05496231|529407446|FG003|Overall Study|Other|8|||
146791079|NCT05526430|529407449|FG000|Overall Study|Withdrawal by Subject|0|||
146791080|NCT05526430|529407450|FG001|Overall Study|Withdrawal by Subject|2|||
146791081|NCT05526430|529407451|FG002|Overall Study|Withdrawal by Subject|0|||
146791082|NCT05526430|529407452|FG003|Overall Study|Withdrawal by Subject|0|||
146791083|NCT02305888|529407461|FG000|Overall Study|Lost to Follow-up|0|||
146791084|NCT02305888|529407462|FG001|Overall Study|Lost to Follow-up|0|||
146791085|NCT02305888|529407463|FG002|Overall Study|Lost to Follow-up|1|||
146791086|NCT02305888|529407461|FG000|Overall Study|Adverse Event|0|||
146791087|NCT02305888|529407462|FG001|Overall Study|Adverse Event|1|||
146791088|NCT02305888|529407463|FG002|Overall Study|Adverse Event|0|||
146791089|NCT05940194|529407468|FG000|Overall Study|Adverse Event|0|||
146791090|NCT05940194|529407469|FG001|Overall Study|Adverse Event|1|||
146791091|NCT05940194|529407470|FG002|Overall Study|Adverse Event|0|||
146791092|NCT05940194|529407468|FG000|Overall Study|Migrated/Moved from the study area|2|||
146791093|NCT05940194|529407469|FG001|Overall Study|Migrated/Moved from the study area|2|||
146791094|NCT05940194|529407470|FG002|Overall Study|Migrated/Moved from the study area|4|||
146791095|NCT04914676|529407471|FG000|Overall Study|Study termination|3|||
146791096|NCT04914676|529407472|FG001|Overall Study|Study termination|0|||
146791097|NCT03024437|529407473|FG000|Overall Study|Adverse Event|0|||
146791098|NCT03024437|529407474|FG001|Overall Study|Adverse Event|1|||
146791099|NCT03024437|529407475|FG002|Overall Study|Adverse Event|3|||
146791100|NCT03024437|529407476|FG003|Overall Study|Adverse Event|5|||
146791101|NCT03024437|529407477|FG004|Overall Study|Adverse Event|0|||
146791102|NCT03024437|529407473|FG000|Overall Study|Physician Decision|1|||
146791103|NCT03024437|529407474|FG001|Overall Study|Physician Decision|0|||
146791104|NCT03024437|529407475|FG002|Overall Study|Physician Decision|0|||
146791105|NCT03024437|529407476|FG003|Overall Study|Physician Decision|1|||
146791106|NCT03024437|529407477|FG004|Overall Study|Physician Decision|0|||
146791107|NCT03024437|529407473|FG000|Overall Study|Disease progression, relapse|1|||
146791108|NCT03024437|529407474|FG001|Overall Study|Disease progression, relapse|0|||
146791109|NCT03024437|529407475|FG002|Overall Study|Disease progression, relapse|0|||
146791110|NCT03024437|529407476|FG003|Overall Study|Disease progression, relapse|3|||
146791111|NCT03024437|529407477|FG004|Overall Study|Disease progression, relapse|0|||
146791112|NCT03024437|529407473|FG000|Overall Study|Disease progression, refractory disease|4|||
146791113|NCT03024437|529407474|FG001|Overall Study|Disease progression, refractory disease|4|||
146791114|NCT03024437|529407475|FG002|Overall Study|Disease progression, refractory disease|2|||
146791115|NCT03024437|529407476|FG003|Overall Study|Disease progression, refractory disease|2|||
146791116|NCT03024437|529407477|FG004|Overall Study|Disease progression, refractory disease|1|||
146791117|NCT03024437|529407473|FG000|Overall Study|Newly diagnosed cancer|0|||
146791118|NCT03024437|529407474|FG001|Overall Study|Newly diagnosed cancer|0|||
146791119|NCT03024437|529407475|FG002|Overall Study|Newly diagnosed cancer|0|||
146791120|NCT03024437|529407476|FG003|Overall Study|Newly diagnosed cancer|1|||
146791121|NCT03024437|529407477|FG004|Overall Study|Newly diagnosed cancer|0|||
146791122|NCT03024437|529407473|FG000|Overall Study|Moved out of state|0|||
146791123|NCT03024437|529407474|FG001|Overall Study|Moved out of state|1|||
146791124|NCT03024437|529407475|FG002|Overall Study|Moved out of state|0|||
146791125|NCT03024437|529407476|FG003|Overall Study|Moved out of state|0|||
146791126|NCT03024437|529407477|FG004|Overall Study|Moved out of state|0|||
146791127|NCT03024437|529407473|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
146791128|NCT03024437|529407474|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
146791129|NCT03024437|529407475|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
146791130|NCT03024437|529407476|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
146791131|NCT03024437|529407477|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
146791132|NCT03085810|529407478|FG000|Main Study|Withdrawal by Subject|77|||
146791133|NCT03085810|529407479|FG001|Main Study|Withdrawal by Subject|0|||
146791134|NCT03085810|529407480|FG002|Main Study|Withdrawal by Subject|0|||
146791135|NCT03085810|529407478|FG000|Main Study|Terminated By Sponsor|14|||
146791136|NCT03085810|529407479|FG001|Main Study|Terminated By Sponsor|0|||
146791137|NCT03085810|529407480|FG002|Main Study|Terminated By Sponsor|0|||
146791138|NCT03085810|529407478|FG000|Main Study|Protocol Violation|15|||
146791139|NCT03085810|529407479|FG001|Main Study|Protocol Violation|0|||
146791140|NCT03085810|529407480|FG002|Main Study|Protocol Violation|0|||
146791141|NCT03085810|529407478|FG000|Main Study|Physician Decision|13|||
146791142|NCT03085810|529407479|FG001|Main Study|Physician Decision|0|||
146791143|NCT03085810|529407480|FG002|Main Study|Physician Decision|0|||
146791144|NCT03085810|529407478|FG000|Main Study|Lost to Follow-up|17|||
146791145|NCT03085810|529407479|FG001|Main Study|Lost to Follow-up|0|||
146791146|NCT03085810|529407480|FG002|Main Study|Lost to Follow-up|0|||
146791147|NCT03085810|529407478|FG000|Main Study|Adverse Event|25|||
146791148|NCT03085810|529407479|FG001|Main Study|Adverse Event|0|||
146791149|NCT03085810|529407480|FG002|Main Study|Adverse Event|0|||
146791150|NCT03085810|529407478|FG000|Main Study|Pregnancy|7|||
146791151|NCT03085810|529407479|FG001|Main Study|Pregnancy|0|||
146791152|NCT03085810|529407480|FG002|Main Study|Pregnancy|0|||
146791153|NCT03085810|529407478|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
146732026|NCT02093663|529190777|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
146732027|NCT02093663|529190778|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
146732028|NCT02093663|529190774|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
146732029|NCT02093663|529190775|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
146732030|NCT02093663|529190776|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
146732031|NCT02093663|529190777|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
146732032|NCT02093663|529190778|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
146732033|NCT02093663|529190774|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
146732034|NCT02093663|529190775|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
146732035|NCT02093663|529190776|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
146732036|NCT02093663|529190777|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
146732037|NCT02093663|529190778|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
146732038|NCT02093663|529190774|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
146732039|NCT02093663|529190775|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
146732040|NCT02093663|529190776|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
146732041|NCT02093663|529190777|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
146732042|NCT02093663|529190778|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
146732043|NCT02093663|529190774|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
146732044|NCT02093663|529190775|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
146732045|NCT02093663|529190776|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
146732046|NCT02093663|529190777|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
146732047|NCT02093663|529190778|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
146732048|NCT00508404|529190779|FG000|Overall Study|Ongoing at Data Cut-off|12|||
146732049|NCT00508404|529190779|FG000|Overall Study|Adverse Event|2|||
146732050|NCT00508404|529190779|FG000|Overall Study|Death|16|||
146732051|NCT00508404|529190779|FG000|Overall Study|Physician Decision|2|||
146732052|NCT00508404|529190779|FG000|Overall Study|Withdrawal by Subject|3|||
146732053|NCT00508404|529190779|FG000|Overall Study|Protocol-specified Criteria|2|||
146732054|NCT00508404|529190779|FG000|Overall Study|Lost to Follow-up|2|||
146732055|NCT00508404|529190779|FG000|Overall Study|Other - Not Specified|3|||
146732056|NCT01424930|529190781|FG000|Overall Study|Adverse Event|0|||
146732057|NCT01424930|529190782|FG001|Overall Study|Adverse Event|1|||
146732058|NCT01424930|529190781|FG000|Overall Study|Death|1|||
146732059|NCT01424930|529190782|FG001|Overall Study|Death|0|||
146732060|NCT01424930|529190781|FG000|Overall Study|Progressive Disease|3|||
146732061|NCT01424930|529190782|FG001|Overall Study|Progressive Disease|6|||
146732062|NCT01424930|529190781|FG000|Overall Study|Screen Failure|0|||
146732063|NCT01424930|529190782|FG001|Overall Study|Screen Failure|1|||
146732064|NCT01424930|529190781|FG000|Overall Study|Reason not specified|0|||
146732065|NCT01424930|529190782|FG001|Overall Study|Reason not specified|6|||
146732066|NCT01197508|529190787|FG000|Overall Study|Withdrawal by Subject|8|||
146732067|NCT01197508|529190788|FG001|Overall Study|Withdrawal by Subject|7|||
146732068|NCT01197508|529190789|FG002|Overall Study|Withdrawal by Subject|15|||
146732069|NCT01197508|529190790|FG003|Overall Study|Withdrawal by Subject|4|||
146732070|NCT01197508|529190787|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
146732071|NCT01197508|529190788|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
146732072|NCT01197508|529190789|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
146732073|NCT01197508|529190790|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
146732074|NCT01197508|529190787|FG000|Overall Study|Adverse Event|10|||
146732075|NCT01197508|529190788|FG001|Overall Study|Adverse Event|13|||
146732076|NCT01197508|529190789|FG002|Overall Study|Adverse Event|23|||
146732077|NCT01197508|529190790|FG003|Overall Study|Adverse Event|3|||
146732078|NCT01197508|529190787|FG000|Overall Study|Severe non-compliance to protocol|0|||
146732079|NCT01197508|529190788|FG001|Overall Study|Severe non-compliance to protocol|3|||
146732080|NCT01197508|529190789|FG002|Overall Study|Severe non-compliance to protocol|1|||
146732081|NCT01197508|529190790|FG003|Overall Study|Severe non-compliance to protocol|3|||
146732082|NCT01197508|529190787|FG000|Overall Study|Condition under investigation worsened|1|||
146732083|NCT01197508|529190788|FG001|Overall Study|Condition under investigation worsened|1|||
146732084|NCT01197508|529190789|FG002|Overall Study|Condition under investigation worsened|1|||
146732085|NCT01197508|529190790|FG003|Overall Study|Condition under investigation worsened|1|||
146732086|NCT01197508|529190787|FG000|Overall Study|Lack of Efficacy|1|||
146732087|NCT01197508|529190788|FG001|Overall Study|Lack of Efficacy|2|||
146732088|NCT01197508|529190789|FG002|Overall Study|Lack of Efficacy|2|||
146732089|NCT01197508|529190790|FG003|Overall Study|Lack of Efficacy|1|||
146732090|NCT01197508|529190787|FG000|Overall Study|Study-specific withdrawal criteria|0|||
146732091|NCT01197508|529190788|FG001|Overall Study|Study-specific withdrawal criteria|0|||
146732092|NCT01197508|529190789|FG002|Overall Study|Study-specific withdrawal criteria|1|||
146732093|NCT01197508|529190790|FG003|Overall Study|Study-specific withdrawal criteria|2|||
146732094|NCT01197508|529190787|FG000|Overall Study|Lost to Follow-up|1|||
146732095|NCT01197508|529190788|FG001|Overall Study|Lost to Follow-up|1|||
146732096|NCT01197508|529190789|FG002|Overall Study|Lost to Follow-up|2|||
146732097|NCT01197508|529190790|FG003|Overall Study|Lost to Follow-up|0|||
146732098|NCT01197508|529190787|FG000|Overall Study|Other|2|||
146791154|NCT03085810|529407479|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
146791155|NCT03085810|529407480|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
146791156|NCT03085810|529407478|FG000|Main Study|Lack of Efficacy|10|||
146791157|NCT03085810|529407479|FG001|Main Study|Lack of Efficacy|0|||
146791158|NCT03085810|529407480|FG002|Main Study|Lack of Efficacy|0|||
146791159|NCT03085810|529407478|FG000|Main Study|Death|12|||
146791160|NCT03085810|529407479|FG001|Main Study|Death|0|||
146791161|NCT03085810|529407480|FG002|Main Study|Death|0|||
146791162|NCT03085810|529407478|FG000|Main Study|Disease progression|1|||
146791163|NCT03085810|529407479|FG001|Main Study|Disease progression|0|||
146791164|NCT03085810|529407480|FG002|Main Study|Disease progression|0|||
146791165|NCT03085810|529407478|FG000|Main Study|Site Closure|3|||
146791166|NCT03085810|529407479|FG001|Main Study|Site Closure|0|||
146791167|NCT03085810|529407480|FG002|Main Study|Site Closure|0|||
146791168|NCT03085810|529407478|FG000|Main Study|Planned pregnancy|17|||
146791169|NCT03085810|529407479|FG001|Main Study|Planned pregnancy|0|||
146791170|NCT03085810|529407480|FG002|Main Study|Planned pregnancy|0|||
146791171|NCT03085810|529407478|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
146791172|NCT03085810|529407479|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
146791173|NCT03085810|529407480|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
146791174|NCT03085810|529407478|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
146791175|NCT03085810|529407479|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
146791176|NCT03085810|529407480|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
146791177|NCT03085810|529407478|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
146791178|NCT03085810|529407479|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
146791179|NCT03085810|529407480|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
146791180|NCT03085810|529407478|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
146791181|NCT03085810|529407479|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
146791182|NCT03085810|529407480|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
146791183|NCT04625465|529407483|FG000|Overall Study|Lost to Follow-up|2|||
146791184|NCT04625465|529407484|FG001|Overall Study|Lost to Follow-up|2|||
146791185|NCT04625465|529407485|FG002|Overall Study|Lost to Follow-up|1|||
146791186|NCT04625465|529407486|FG003|Overall Study|Lost to Follow-up|0|||
146791187|NCT04625465|529407487|FG004|Overall Study|Lost to Follow-up|0|||
146791188|NCT04625465|529407488|FG005|Overall Study|Lost to Follow-up|2|||
146791189|NCT04625465|529407489|FG006|Overall Study|Lost to Follow-up|0|||
146791190|NCT04625465|529407490|FG007|Overall Study|Lost to Follow-up|0|||
146791191|NCT04625465|529407483|FG000|Overall Study|Death|1|||
146791192|NCT04625465|529407484|FG001|Overall Study|Death|0|||
146791193|NCT04625465|529407485|FG002|Overall Study|Death|0|||
146791194|NCT04625465|529407486|FG003|Overall Study|Death|0|||
146791195|NCT04625465|529407487|FG004|Overall Study|Death|0|||
146791196|NCT04625465|529407488|FG005|Overall Study|Death|0|||
146791197|NCT04625465|529407489|FG006|Overall Study|Death|0|||
146791198|NCT04625465|529407490|FG007|Overall Study|Death|0|||
146791199|NCT04625465|529407483|FG000|Overall Study|Withdrawal by Subject|1|||
146791200|NCT04625465|529407484|FG001|Overall Study|Withdrawal by Subject|0|||
146791201|NCT04625465|529407485|FG002|Overall Study|Withdrawal by Subject|4|||
146791202|NCT04625465|529407486|FG003|Overall Study|Withdrawal by Subject|4|||
146791203|NCT04625465|529407487|FG004|Overall Study|Withdrawal by Subject|4|||
146791204|NCT04625465|529407488|FG005|Overall Study|Withdrawal by Subject|0|||
146791205|NCT04625465|529407489|FG006|Overall Study|Withdrawal by Subject|0|||
146791206|NCT04625465|529407490|FG007|Overall Study|Withdrawal by Subject|0|||
146791207|NCT05566639|529407498|FG000|Overall Study|Adverse Event|1|||
146791208|NCT05566639|529407499|FG001|Overall Study|Adverse Event|1|||
146791209|NCT05566639|529407498|FG000|Overall Study|Serious Adverse Event|1|||
146791210|NCT05566639|529407499|FG001|Overall Study|Serious Adverse Event|3|||
146791211|NCT05566639|529407498|FG000|Overall Study|Death|44|||
146791212|NCT05566639|529407499|FG001|Overall Study|Death|45|||
146791213|NCT05566639|529407498|FG000|Overall Study|Lost to Follow-up|467|||
146791214|NCT05566639|529407499|FG001|Overall Study|Lost to Follow-up|461|||
146791215|NCT05566639|529407498|FG000|Overall Study|Physician Decision|45|||
146791216|NCT05566639|529407499|FG001|Overall Study|Physician Decision|44|||
146791217|NCT05566639|529407498|FG000|Overall Study|Protocol Deviation|4|||
146791218|NCT05566639|529407499|FG001|Overall Study|Protocol Deviation|4|||
146791219|NCT05566639|529407498|FG000|Overall Study|Withdrawal by Subject|277|||
146791220|NCT05566639|529407499|FG001|Overall Study|Withdrawal by Subject|271|||
146791221|NCT05566639|529407498|FG000|Overall Study|Other Than Specified|52|||
146791222|NCT05566639|529407499|FG001|Overall Study|Other Than Specified|64|||
146791223|NCT04054193|529407507|FG000|Cycle 1|Physician Decision|1|||
146791224|NCT04054193|529407507|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
146791225|NCT04054193|529407507|FG000|Cycle 1|Allocated but not treated|3|||
146791226|NCT04054193|529407507|FG000|Cycles 2-3|Physician Decision|2|||
146791227|NCT04054193|529407507|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
146791228|NCT04054193|529407507|FG000|Cycles 2-3|Various reasons|17|||
146791229|NCT05436262|529407510|FG000|Pre-Randomization|Withdrawal by Subject|1|||
146791230|NCT05436262|529407511|FG001|Pre-Randomization|Withdrawal by Subject|0|||
146791231|NCT05436262|529407512|FG002|Pre-Randomization|Withdrawal by Subject|0|||
146791232|NCT05436262|529407510|FG000|Randomization|Withdrawal by Subject|0|||
146791233|NCT05436262|529407511|FG001|Randomization|Withdrawal by Subject|1|||
146791234|NCT05436262|529407512|FG002|Randomization|Withdrawal by Subject|0|||
146791235|NCT03710603|529407513|FG000|Overall Study|Adverse Event|1|||
146791236|NCT03710603|529407514|FG001|Overall Study|Adverse Event|0|||
146791237|NCT03710603|529407513|FG000|Overall Study|Death|44|||
146791238|NCT03710603|529407514|FG001|Overall Study|Death|34|||
146791239|NCT03710603|529407513|FG000|Overall Study|Lost to Follow-up|3|||
146791240|NCT03710603|529407514|FG001|Overall Study|Lost to Follow-up|5|||
146791241|NCT03710603|529407513|FG000|Overall Study|Withdrawal by Subject|11|||
146791242|NCT03710603|529407514|FG001|Overall Study|Withdrawal by Subject|10|||
146791243|NCT04753697|529407515|FG000|Induction Phase|Withdrawal by Subject|12|||
146791244|NCT04753697|529407516|FG001|Induction Phase|Withdrawal by Subject|5|||
146791245|NCT04753697|529407517|FG002|Induction Phase|Withdrawal by Subject|6|||
146791246|NCT04753697|529407515|FG000|Induction Phase|Physician Decision|1|||
146791247|NCT04753697|529407516|FG001|Induction Phase|Physician Decision|0|||
146791248|NCT04753697|529407517|FG002|Induction Phase|Physician Decision|0|||
146791249|NCT04753697|529407515|FG000|Induction Phase|Lost to Follow-up|2|||
146791250|NCT04753697|529407516|FG001|Induction Phase|Lost to Follow-up|2|||
146791251|NCT04753697|529407517|FG002|Induction Phase|Lost to Follow-up|1|||
146791252|NCT04753697|529407515|FG000|Induction Phase|Lack of Efficacy|1|||
146791253|NCT04753697|529407516|FG001|Induction Phase|Lack of Efficacy|0|||
146791254|NCT04753697|529407517|FG002|Induction Phase|Lack of Efficacy|0|||
146791255|NCT04753697|529407515|FG000|Maintenance Phase|Physician Decision|0|||
146791256|NCT04753697|529407516|FG001|Maintenance Phase|Physician Decision|0|||
146791257|NCT04753697|529407517|FG002|Maintenance Phase|Physician Decision|1|||
146791258|NCT04753697|529407515|FG000|Maintenance Phase|Withdrawal by Subject|3|||
146791259|NCT04753697|529407516|FG001|Maintenance Phase|Withdrawal by Subject|4|||
146791260|NCT04753697|529407517|FG002|Maintenance Phase|Withdrawal by Subject|6|||
146791261|NCT04753697|529407515|FG000|Maintenance Phase|Lost to Follow-up|2|||
146791262|NCT04753697|529407516|FG001|Maintenance Phase|Lost to Follow-up|2|||
146791263|NCT04753697|529407517|FG002|Maintenance Phase|Lost to Follow-up|0|||
146791264|NCT04753697|529407515|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
146791265|NCT04753697|529407516|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
146791266|NCT04753697|529407517|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
146791267|NCT04753697|529407515|FG000|Maintenance Phase|Adverse Event|0|||
146791268|NCT04753697|529407516|FG001|Maintenance Phase|Adverse Event|1|||
146791269|NCT04753697|529407517|FG002|Maintenance Phase|Adverse Event|1|||
146791270|NCT04753697|529407515|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
146791271|NCT04753697|529407516|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
146791272|NCT04753697|529407517|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
146791273|NCT02626533|529407518|FG000|Overall Study|Protocol Violation|14|||
146791274|NCT02626533|529407518|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
146791275|NCT02626533|529407518|FG000|Overall Study|Withdrawal by Subject|1|||
146791276|NCT05070728|529407523|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
146791277|NCT05070728|529407524|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
146791278|NCT05446168|529407525|FG000|Overall Study|Physician Decision|0|||
146791279|NCT05446168|529407526|FG001|Overall Study|Physician Decision|1|||
146791280|NCT02733159|529407528|FG000|Overall Study|Adverse Event|1|||
146791281|NCT02733159|529407528|FG000|Overall Study|Lack of disease progression|1|||
146791282|NCT03854227|529409369|FG000|Overall Study|Adverse Event|0|||
146791283|NCT03854227|529409370|FG001|Overall Study|Adverse Event|0|||
146791284|NCT03854227|529409371|FG002|Overall Study|Adverse Event|0|||
146791285|NCT03854227|529409372|FG003|Overall Study|Adverse Event|1|||
146791286|NCT03854227|529409373|FG004|Overall Study|Adverse Event|0|||
146791287|NCT03854227|529409374|FG005|Overall Study|Adverse Event|0|||
146791288|NCT03854227|529409375|FG006|Overall Study|Adverse Event|1|||
146791289|NCT03854227|529409376|FG007|Overall Study|Adverse Event|0|||
146791290|NCT03854227|529409377|FG008|Overall Study|Adverse Event|0|||
146791291|NCT03854227|529409378|FG009|Overall Study|Adverse Event|3|||
146791292|NCT03854227|529409379|FG010|Overall Study|Adverse Event|0|||
146791293|NCT03854227|529409380|FG011|Overall Study|Adverse Event|1|||
146791294|NCT03854227|529409369|FG000|Overall Study|Death|0|||
146791295|NCT03854227|529409370|FG001|Overall Study|Death|0|||
146791296|NCT03854227|529409371|FG002|Overall Study|Death|0|||
146791297|NCT03854227|529409372|FG003|Overall Study|Death|0|||
146791298|NCT03854227|529409373|FG004|Overall Study|Death|0|||
146791299|NCT03854227|529409374|FG005|Overall Study|Death|1|||
146791300|NCT03854227|529409375|FG006|Overall Study|Death|0|||
146791301|NCT03854227|529409376|FG007|Overall Study|Death|0|||
146791302|NCT03854227|529409377|FG008|Overall Study|Death|0|||
146791303|NCT03854227|529409378|FG009|Overall Study|Death|1|||
146791304|NCT03854227|529409379|FG010|Overall Study|Death|0|||
146791305|NCT03854227|529409380|FG011|Overall Study|Death|1|||
146791306|NCT03854227|529409369|FG000|Overall Study|Physician Decision|0|||
146791307|NCT03854227|529409370|FG001|Overall Study|Physician Decision|0|||
146791308|NCT03854227|529409371|FG002|Overall Study|Physician Decision|0|||
146791309|NCT03854227|529409372|FG003|Overall Study|Physician Decision|0|||
146791310|NCT03854227|529409373|FG004|Overall Study|Physician Decision|0|||
146791311|NCT03854227|529409374|FG005|Overall Study|Physician Decision|1|||
146791312|NCT03854227|529409375|FG006|Overall Study|Physician Decision|0|||
146791313|NCT03854227|529409376|FG007|Overall Study|Physician Decision|0|||
146791314|NCT03854227|529409377|FG008|Overall Study|Physician Decision|1|||
146791315|NCT03854227|529409378|FG009|Overall Study|Physician Decision|1|||
146791316|NCT03854227|529409379|FG010|Overall Study|Physician Decision|0|||
146938654|NCT01851863|529932450|FG001|Overall Study|Lost to Follow-up|4|||
146791317|NCT03854227|529409380|FG011|Overall Study|Physician Decision|1|||
146791318|NCT03854227|529409369|FG000|Overall Study|Progressive disease|1|||
146791319|NCT03854227|529409370|FG001|Overall Study|Progressive disease|1|||
146791320|NCT03854227|529409371|FG002|Overall Study|Progressive disease|1|||
146791321|NCT03854227|529409372|FG003|Overall Study|Progressive disease|2|||
146791322|NCT03854227|529409373|FG004|Overall Study|Progressive disease|3|||
146791323|NCT03854227|529409374|FG005|Overall Study|Progressive disease|1|||
146791324|NCT03854227|529409375|FG006|Overall Study|Progressive disease|2|||
146791325|NCT03854227|529409376|FG007|Overall Study|Progressive disease|5|||
146791326|NCT03854227|529409377|FG008|Overall Study|Progressive disease|2|||
146791327|NCT03854227|529409378|FG009|Overall Study|Progressive disease|5|||
146791328|NCT03854227|529409379|FG010|Overall Study|Progressive disease|1|||
146791329|NCT03854227|529409380|FG011|Overall Study|Progressive disease|6|||
146791330|NCT03854227|529409369|FG000|Overall Study|Study terminated by sponsor|0|||
146791331|NCT03854227|529409370|FG001|Overall Study|Study terminated by sponsor|0|||
146791332|NCT03854227|529409371|FG002|Overall Study|Study terminated by sponsor|0|||
146791333|NCT03854227|529409372|FG003|Overall Study|Study terminated by sponsor|0|||
146791334|NCT03854227|529409373|FG004|Overall Study|Study terminated by sponsor|0|||
146791335|NCT03854227|529409374|FG005|Overall Study|Study terminated by sponsor|0|||
146791336|NCT03854227|529409375|FG006|Overall Study|Study terminated by sponsor|0|||
146791337|NCT03854227|529409376|FG007|Overall Study|Study terminated by sponsor|0|||
146791338|NCT03854227|529409377|FG008|Overall Study|Study terminated by sponsor|0|||
146791339|NCT03854227|529409378|FG009|Overall Study|Study terminated by sponsor|1|||
146791340|NCT03854227|529409379|FG010|Overall Study|Study terminated by sponsor|0|||
146791341|NCT03854227|529409380|FG011|Overall Study|Study terminated by sponsor|0|||
146791342|NCT03854227|529409369|FG000|Overall Study|Withdrawal by Subject|0|||
146791343|NCT03854227|529409370|FG001|Overall Study|Withdrawal by Subject|0|||
146791344|NCT03854227|529409371|FG002|Overall Study|Withdrawal by Subject|1|||
146791345|NCT03854227|529409372|FG003|Overall Study|Withdrawal by Subject|0|||
146791346|NCT03854227|529409373|FG004|Overall Study|Withdrawal by Subject|0|||
146791347|NCT03854227|529409374|FG005|Overall Study|Withdrawal by Subject|0|||
146791348|NCT03854227|529409375|FG006|Overall Study|Withdrawal by Subject|0|||
146791349|NCT03854227|529409376|FG007|Overall Study|Withdrawal by Subject|0|||
146791350|NCT03854227|529409377|FG008|Overall Study|Withdrawal by Subject|0|||
146791351|NCT03854227|529409378|FG009|Overall Study|Withdrawal by Subject|1|||
146791352|NCT03854227|529409379|FG010|Overall Study|Withdrawal by Subject|1|||
146791353|NCT03854227|529409380|FG011|Overall Study|Withdrawal by Subject|0|||
146791354|NCT03854227|529409369|FG000|Overall Study|Disease relapse|0|||
146791355|NCT03854227|529409370|FG001|Overall Study|Disease relapse|0|||
146791356|NCT03854227|529409371|FG002|Overall Study|Disease relapse|0|||
146791357|NCT03854227|529409372|FG003|Overall Study|Disease relapse|0|||
146791358|NCT03854227|529409373|FG004|Overall Study|Disease relapse|0|||
146791359|NCT03854227|529409374|FG005|Overall Study|Disease relapse|0|||
146791360|NCT03854227|529409375|FG006|Overall Study|Disease relapse|0|||
146791361|NCT03854227|529409376|FG007|Overall Study|Disease relapse|0|||
146791362|NCT03854227|529409377|FG008|Overall Study|Disease relapse|1|||
146791363|NCT03854227|529409378|FG009|Overall Study|Disease relapse|0|||
146791364|NCT03854227|529409379|FG010|Overall Study|Disease relapse|0|||
146938655|NCT01851863|529932451|FG002|Overall Study|Lost to Follow-up|2|||
146938656|NCT01851863|529932452|FG003|Overall Study|Lost to Follow-up|3|||
146938657|NCT02076334|529932453|FG000|Overall Study|Protocol Violation|1|||
146938658|NCT02076334|529932454|FG001|Overall Study|Protocol Violation|0|||
146938659|NCT02076334|529932455|FG002|Overall Study|Protocol Violation|0|||
146938660|NCT02076334|529932456|FG003|Overall Study|Protocol Violation|0|||
146938661|NCT02076334|529932453|FG000|Overall Study|Lost to Follow-up|0|||
146938662|NCT02076334|529932454|FG001|Overall Study|Lost to Follow-up|1|||
146938663|NCT02076334|529932455|FG002|Overall Study|Lost to Follow-up|1|||
146938664|NCT02076334|529932456|FG003|Overall Study|Lost to Follow-up|0|||
146938665|NCT02076334|529932453|FG000|Overall Study|muscle soreness|0|||
146938666|NCT02076334|529932454|FG001|Overall Study|muscle soreness|0|||
146791365|NCT03854227|529409380|FG011|Overall Study|Disease relapse|0|||
146791366|NCT03854227|529409369|FG000|Overall Study|Global deterioration of health status|0|||
146791367|NCT03854227|529409370|FG001|Overall Study|Global deterioration of health status|0|||
146791368|NCT03854227|529409371|FG002|Overall Study|Global deterioration of health status|0|||
146791369|NCT03854227|529409372|FG003|Overall Study|Global deterioration of health status|0|||
146938667|NCT02076334|529932455|FG002|Overall Study|muscle soreness|0|||
146938668|NCT02076334|529932456|FG003|Overall Study|muscle soreness|1|||
146791370|NCT03854227|529409373|FG004|Overall Study|Global deterioration of health status|0|||
146791371|NCT03854227|529409374|FG005|Overall Study|Global deterioration of health status|1|||
146791372|NCT03854227|529409375|FG006|Overall Study|Global deterioration of health status|0|||
146791373|NCT03854227|529409376|FG007|Overall Study|Global deterioration of health status|1|||
146791374|NCT03854227|529409377|FG008|Overall Study|Global deterioration of health status|0|||
146791375|NCT03854227|529409378|FG009|Overall Study|Global deterioration of health status|0|||
146791376|NCT03854227|529409379|FG010|Overall Study|Global deterioration of health status|0|||
146791377|NCT03854227|529409380|FG011|Overall Study|Global deterioration of health status|0|||
146791378|NCT03854227|529409369|FG000|Overall Study|Refused further treatment|0|||
146791379|NCT03854227|529409370|FG001|Overall Study|Refused further treatment|0|||
146791380|NCT03854227|529409371|FG002|Overall Study|Refused further treatment|0|||
146791381|NCT03854227|529409372|FG003|Overall Study|Refused further treatment|0|||
146791382|NCT03854227|529409373|FG004|Overall Study|Refused further treatment|0|||
146791383|NCT03854227|529409374|FG005|Overall Study|Refused further treatment|0|||
146791384|NCT03854227|529409375|FG006|Overall Study|Refused further treatment|0|||
146791385|NCT03854227|529409376|FG007|Overall Study|Refused further treatment|0|||
146791386|NCT03854227|529409377|FG008|Overall Study|Refused further treatment|0|||
146791387|NCT03854227|529409378|FG009|Overall Study|Refused further treatment|1|||
146791388|NCT03854227|529409379|FG010|Overall Study|Refused further treatment|0|||
146791389|NCT03854227|529409380|FG011|Overall Study|Refused further treatment|1|||
146791390|NCT03854227|529409369|FG000|Overall Study|Other|0|||
146791391|NCT03854227|529409370|FG001|Overall Study|Other|0|||
146791392|NCT03854227|529409371|FG002|Overall Study|Other|0|||
146791393|NCT03854227|529409372|FG003|Overall Study|Other|0|||
146791394|NCT03854227|529409373|FG004|Overall Study|Other|0|||
146791395|NCT03854227|529409374|FG005|Overall Study|Other|0|||
146791396|NCT03854227|529409375|FG006|Overall Study|Other|0|||
146791397|NCT03854227|529409376|FG007|Overall Study|Other|0|||
146791398|NCT03854227|529409377|FG008|Overall Study|Other|1|||
146791399|NCT03854227|529409378|FG009|Overall Study|Other|1|||
146791400|NCT03854227|529409379|FG010|Overall Study|Other|0|||
146791401|NCT03854227|529409380|FG011|Overall Study|Other|0|||
146791402|NCT03668236|529409381|FG000|90-day Follow-up|Withdrawal by Subject|3|||
146791403|NCT03668236|529409382|FG001|90-day Follow-up|Withdrawal by Subject|2|||
146791404|NCT03668236|529409381|FG000|90-day Follow-up|Lost to Follow-up|3|||
146791405|NCT03668236|529409382|FG001|90-day Follow-up|Lost to Follow-up|1|||
146791406|NCT03668236|529409381|FG000|Baseline Characteristics|Lost to Follow-up|9|||
146791407|NCT03668236|529409382|FG001|Baseline Characteristics|Lost to Follow-up|5|||
146791408|NCT03668236|529409381|FG000|1-year Follow-up|Withdrawal by Subject|17|||
146791409|NCT03668236|529409382|FG001|1-year Follow-up|Withdrawal by Subject|15|||
146791410|NCT03748953|529409383|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
146791411|NCT03748953|529409384|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
146791412|NCT03748953|529409383|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
146791413|NCT03748953|529409384|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
146791414|NCT03748953|529409383|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
146791415|NCT03748953|529409384|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
146791416|NCT03748953|529409383|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
146791417|NCT03748953|529409384|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
146791418|NCT03748953|529409383|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
146791419|NCT03748953|529409384|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
146791420|NCT02276885|529409385|FG000|Overall Study|Withdrawal by Subject|2|||
146791421|NCT02276885|529409386|FG001|Overall Study|Withdrawal by Subject|0|||
146791422|NCT02276885|529409385|FG000|Overall Study|Lost to Follow-up|5|||
146791423|NCT02276885|529409386|FG001|Overall Study|Lost to Follow-up|2|||
146791424|NCT01574274|529409387|FG000|Overall Study|Ineligible|0|||
146791425|NCT01574274|529409388|FG001|Overall Study|Ineligible|1|||
146791426|NCT01574274|529409387|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
146791427|NCT01574274|529409388|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
146791428|NCT01574274|529409387|FG000|Overall Study|Ph+ B-ALL|3|||
146791429|NCT01574274|529409388|FG001|Overall Study|Ph+ B-ALL|4|||
146791430|NCT01574274|529409387|FG000|Overall Study|Induction Death|2|||
146791431|NCT01574274|529409388|FG001|Overall Study|Induction Death|0|||
146791432|NCT01574274|529409387|FG000|Overall Study|Induction Failure|4|||
146791433|NCT01574274|529409388|FG001|Overall Study|Induction Failure|1|||
146791434|NCT01574274|529409387|FG000|Overall Study|Adverse Event|16|||
146791435|NCT01574274|529409388|FG001|Overall Study|Adverse Event|13|||
146791436|NCT01574274|529409387|FG000|Overall Study|Remission Death|1|||
146791437|NCT01574274|529409388|FG001|Overall Study|Remission Death|0|||
146791438|NCT01574274|529409387|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
146791439|NCT01574274|529409388|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
146791440|NCT01574274|529409387|FG000|Overall Study|Other, unknown|3|||
146791441|NCT01574274|529409388|FG001|Overall Study|Other, unknown|2|||
146791442|NCT04676763|529409389|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
146791443|NCT04676763|529409390|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
146791444|NCT04676763|529409391|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
146791445|NCT04676763|529409389|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
146938669|NCT03379376|529932457|FG000|Overall Study|Lost to Follow-up|2|||
146791446|NCT04676763|529409390|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
146791447|NCT04676763|529409391|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
146982077|NCT01360632|530096216|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
146791448|NCT04676763|529409389|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
146791449|NCT04676763|529409390|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
146791450|NCT04676763|529409391|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
146791451|NCT01593917|529409392|FG000|Overall Study|Death|67|||
146791452|NCT01593917|529409392|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
146791453|NCT01593917|529409392|FG000|Overall Study|Withdrawal by Subject|23|||
146791454|NCT01593917|529409392|FG000|Overall Study|Lost to Follow-up|12|||
146791455|NCT01593917|529409392|FG000|Overall Study|Protocol Violation|5|||
146791456|NCT01593917|529409392|FG000|Overall Study|Physician Decision|3|||
146791457|NCT03656510|529409401|FG000|Overall Study|Lost to Follow-up|1|||
146791458|NCT03656510|529409402|FG001|Overall Study|Lost to Follow-up|0|||
146791459|NCT03656510|529409403|FG002|Overall Study|Lost to Follow-up|0|||
146791460|NCT03656510|529409404|FG003|Overall Study|Lost to Follow-up|0|||
146791461|NCT03656510|529409405|FG004|Overall Study|Lost to Follow-up|0|||
146791462|NCT03656510|529409406|FG005|Overall Study|Lost to Follow-up|0|||
146791463|NCT03656510|529409401|FG000|Overall Study|Withdrawal by Subject|1|||
146791464|NCT03656510|529409402|FG001|Overall Study|Withdrawal by Subject|1|||
146791465|NCT03656510|529409403|FG002|Overall Study|Withdrawal by Subject|0|||
146791466|NCT03656510|529409404|FG003|Overall Study|Withdrawal by Subject|1|||
146791467|NCT03656510|529409405|FG004|Overall Study|Withdrawal by Subject|0|||
146791468|NCT03656510|529409406|FG005|Overall Study|Withdrawal by Subject|0|||
146791469|NCT03974178|529409409|FG000|Overall Study|Death|0|||
146791470|NCT03974178|529409410|FG001|Overall Study|Death|1|||
146791471|NCT03899259|529409414|FG000|Overall Study|Adverse Event|5|||
146791472|NCT03899259|529409415|FG001|Overall Study|Adverse Event|4|||
146791473|NCT03899259|529409416|FG002|Overall Study|Adverse Event|6|||
146791474|NCT03899259|529409414|FG000|Overall Study|Lack of Efficacy|5|||
146791475|NCT03899259|529409415|FG001|Overall Study|Lack of Efficacy|0|||
146791476|NCT03899259|529409416|FG002|Overall Study|Lack of Efficacy|2|||
146791477|NCT03899259|529409414|FG000|Overall Study|Pregnancy|3|||
146791478|NCT03899259|529409415|FG001|Overall Study|Pregnancy|0|||
146791479|NCT03899259|529409416|FG002|Overall Study|Pregnancy|1|||
146791480|NCT03899259|529409414|FG000|Overall Study|Physician Decision|0|||
146791481|NCT03899259|529409415|FG001|Overall Study|Physician Decision|1|||
146791482|NCT03899259|529409416|FG002|Overall Study|Physician Decision|0|||
146791483|NCT03899259|529409414|FG000|Overall Study|Protocol Deviation|1|||
146791484|NCT03899259|529409415|FG001|Overall Study|Protocol Deviation|1|||
146791485|NCT03899259|529409416|FG002|Overall Study|Protocol Deviation|1|||
146791486|NCT03899259|529409414|FG000|Overall Study|Withdrawal by Subject|8|||
146791487|NCT03899259|529409415|FG001|Overall Study|Withdrawal by Subject|10|||
146791488|NCT03899259|529409416|FG002|Overall Study|Withdrawal by Subject|12|||
146791489|NCT03899259|529409414|FG000|Overall Study|Lost to Follow-up|5|||
146791490|NCT03899259|529409415|FG001|Overall Study|Lost to Follow-up|6|||
146791491|NCT03899259|529409416|FG002|Overall Study|Lost to Follow-up|2|||
146791492|NCT03899259|529409414|FG000|Overall Study|Lack of Adherence|1|||
146791493|NCT03899259|529409415|FG001|Overall Study|Lack of Adherence|0|||
146791494|NCT03899259|529409416|FG002|Overall Study|Lack of Adherence|0|||
146791495|NCT03899259|529409414|FG000|Overall Study|Screen Failure|1|||
146791496|NCT03899259|529409415|FG001|Overall Study|Screen Failure|0|||
146791497|NCT03899259|529409416|FG002|Overall Study|Screen Failure|0|||
146791498|NCT03899259|529409414|FG000|Overall Study|Ongoing Study Participation|127|||
146791499|NCT03899259|529409415|FG001|Overall Study|Ongoing Study Participation|134|||
146791500|NCT03899259|529409416|FG002|Overall Study|Ongoing Study Participation|210|||
146791501|NCT05670587|529409417|FG000|Overall Study|Withdrawal by Subject|3|||
146791502|NCT01733316|529409421|FG000|RP103 Phase|Non-compliance|1|||
146791503|NCT01733316|529409421|FG000|Long Term Extension Phase|Adverse Event|1|||
146791504|NCT01733316|529409421|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
146791505|NCT01733316|529409421|FG000|Long Term Extension Phase|Sponsor Decision|2|||
146791506|NCT04508309|529409422|FG000|Overall Study|Death|0|||
146791507|NCT04508309|529409423|FG001|Overall Study|Death|0|||
146791508|NCT04508309|529409424|FG002|Overall Study|Death|0|||
146791509|NCT04508309|529409425|FG003|Overall Study|Death|0|||
146791510|NCT04508309|529409426|FG004|Overall Study|Death|1|||
146791511|NCT04508309|529409422|FG000|Overall Study|Lost to Follow-up|0|||
146791512|NCT04508309|529409423|FG001|Overall Study|Lost to Follow-up|0|||
146791513|NCT04508309|529409424|FG002|Overall Study|Lost to Follow-up|1|||
146791514|NCT04508309|529409425|FG003|Overall Study|Lost to Follow-up|1|||
146791515|NCT04508309|529409426|FG004|Overall Study|Lost to Follow-up|0|||
146791516|NCT04508309|529409422|FG000|Overall Study|Withdrawal by Subject|0|||
146791517|NCT04508309|529409423|FG001|Overall Study|Withdrawal by Subject|0|||
146982078|NCT01360632|530096212|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
146791518|NCT04508309|529409424|FG002|Overall Study|Withdrawal by Subject|0|||
146791519|NCT04508309|529409425|FG003|Overall Study|Withdrawal by Subject|0|||
146791520|NCT04508309|529409426|FG004|Overall Study|Withdrawal by Subject|1|||
146791521|NCT05139810|529409427|FG000|Overall Study|Voluntary Withdrawal|2|||
146732099|NCT01197508|529190788|FG001|Overall Study|Other|3|||
146732100|NCT01197508|529190789|FG002|Overall Study|Other|2|||
146732101|NCT01197508|529190790|FG003|Overall Study|Other|2|||
146732102|NCT03286751|529190791|FG000|Washout Period 1|Withdrawal by Subject|0|||
146732103|NCT03286751|529190792|FG001|Washout Period 1|Withdrawal by Subject|0|||
146732104|NCT03286751|529190793|FG002|Washout Period 1|Withdrawal by Subject|0|||
146732105|NCT03286751|529190794|FG003|Washout Period 1|Withdrawal by Subject|0|||
146732106|NCT03286751|529190795|FG004|Washout Period 1|Withdrawal by Subject|1|||
146732107|NCT03286751|529190796|FG005|Washout Period 1|Withdrawal by Subject|0|||
146732108|NCT03286751|529190791|FG000|Washout Period 2|Personal Reasons|0|||
146732109|NCT03286751|529190792|FG001|Washout Period 2|Personal Reasons|1|||
146732110|NCT03286751|529190793|FG002|Washout Period 2|Personal Reasons|0|||
146732111|NCT03286751|529190794|FG003|Washout Period 2|Personal Reasons|0|||
146732112|NCT03286751|529190795|FG004|Washout Period 2|Personal Reasons|0|||
146732113|NCT03286751|529190796|FG005|Washout Period 2|Personal Reasons|0|||
146732114|NCT03286751|529190791|FG000|Washout Period 5|Adverse Event|0|||
146732115|NCT03286751|529190792|FG001|Washout Period 5|Adverse Event|0|||
146732116|NCT03286751|529190793|FG002|Washout Period 5|Adverse Event|0|||
146732117|NCT03286751|529190794|FG003|Washout Period 5|Adverse Event|0|||
146732118|NCT03286751|529190795|FG004|Washout Period 5|Adverse Event|1|||
146732119|NCT03286751|529190796|FG005|Washout Period 5|Adverse Event|0|||
146732120|NCT01078155|529190797|FG000|Overall Study|Adverse Event|7|||
146732121|NCT01078155|529190797|FG000|Overall Study|Lack of Efficacy|16|||
146732122|NCT01078155|529190797|FG000|Overall Study|Participant's Decision|6|||
146732123|NCT01078155|529190797|FG000|Overall Study|Lost to Follow-up|15|||
146732124|NCT01119768|529190798|FG000|Treatment Period|Lack of Efficacy|18|||
146732125|NCT01119768|529190799|FG001|Treatment Period|Lack of Efficacy|25|||
146732126|NCT01059643|529190800|FG000|Overall Study|Adverse Event|3|||
146732127|NCT01059643|529190800|FG000|Overall Study|Withdrawal by Subject|2|||
146732128|NCT01059643|529190800|FG000|Overall Study|Physician Decision|1|||
146732129|NCT01820559|529190801|FG000|Overall Study|Adverse Event|4|||
146732130|NCT01820559|529190802|FG001|Overall Study|Adverse Event|6|||
146732131|NCT01820559|529190803|FG002|Overall Study|Adverse Event|13|||
146732132|NCT01820559|529190801|FG000|Overall Study|Withdrawal by Subject|1|||
146732133|NCT01820559|529190802|FG001|Overall Study|Withdrawal by Subject|2|||
146732134|NCT01820559|529190803|FG002|Overall Study|Withdrawal by Subject|5|||
146732135|NCT01820559|529190801|FG000|Overall Study|Protocol Violation|2|||
146732136|NCT01820559|529190802|FG001|Overall Study|Protocol Violation|1|||
146732137|NCT01820559|529190803|FG002|Overall Study|Protocol Violation|3|||
146732138|NCT01820559|529190801|FG000|Overall Study|Subject's non-compliance|1|||
146732139|NCT01820559|529190802|FG001|Overall Study|Subject's non-compliance|0|||
146732140|NCT01820559|529190803|FG002|Overall Study|Subject's non-compliance|2|||
146732141|NCT01820559|529190801|FG000|Overall Study|Lost to Follow-up|3|||
146732142|NCT01820559|529190802|FG001|Overall Study|Lost to Follow-up|2|||
146732143|NCT01820559|529190803|FG002|Overall Study|Lost to Follow-up|2|||
146732144|NCT01820559|529190801|FG000|Overall Study|At sponsor request|0|||
146732145|NCT01820559|529190802|FG001|Overall Study|At sponsor request|0|||
146732146|NCT01820559|529190803|FG002|Overall Study|At sponsor request|1|||
146732147|NCT01820559|529190801|FG000|Overall Study|Lack of Efficacy|3|||
146732148|NCT01820559|529190802|FG001|Overall Study|Lack of Efficacy|2|||
146732149|NCT01820559|529190803|FG002|Overall Study|Lack of Efficacy|3|||
146732150|NCT00166296|529190805|FG000|Overall Study|Withdrawal by Subject|1|||
146732151|NCT00166296|529190806|FG001|Overall Study|Withdrawal by Subject|3|||
146732152|NCT00166296|529190805|FG000|Overall Study|Adverse Event|2|||
146732153|NCT00166296|529190806|FG001|Overall Study|Adverse Event|4|||
146732154|NCT00166296|529190805|FG000|Overall Study|Lost to Follow-up|4|||
146732155|NCT00166296|529190806|FG001|Overall Study|Lost to Follow-up|2|||
146732156|NCT04035200|529190812|FG000|Overall Study|Lost to Follow-up|0|||
146732157|NCT04035200|529190813|FG001|Overall Study|Lost to Follow-up|1|||
146732158|NCT04035200|529190814|FG002|Overall Study|Lost to Follow-up|0|||
146732159|NCT04035200|529190812|FG000|Overall Study|Withdrawal by Subject|1|||
146732160|NCT04035200|529190813|FG001|Overall Study|Withdrawal by Subject|4|||
146732161|NCT04035200|529190814|FG002|Overall Study|Withdrawal by Subject|4|||
146732162|NCT04035200|529190812|FG000|Overall Study|COVID-19|1|||
146732163|NCT04035200|529190813|FG001|Overall Study|COVID-19|0|||
146732164|NCT04035200|529190814|FG002|Overall Study|COVID-19|0|||
146938670|NCT03379376|529932457|FG000|Overall Study|Did not wish to complete follow up|1|||
146938671|NCT03379376|529932457|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
146732165|NCT04035200|529190812|FG000|Overall Study|Early Termination|0|||
146938672|NCT03379376|529932457|FG000|Overall Study|Death|1|||
146938673|NCT01611298|529932458|FG000|Overall Study|Relapsed|2|||
146732166|NCT04035200|529190813|FG001|Overall Study|Early Termination|1|||
146732167|NCT04035200|529190814|FG002|Overall Study|Early Termination|0|||
146732168|NCT04035200|529190812|FG000|Overall Study|Non-compliance|0|||
146732169|NCT04035200|529190813|FG001|Overall Study|Non-compliance|1|||
146732170|NCT04035200|529190814|FG002|Overall Study|Non-compliance|0|||
146732171|NCT02277990|529190815|FG000|Overall Study|Death|170|||
146732172|NCT02277990|529190816|FG001|Overall Study|Death|188|||
146732173|NCT02277990|529190815|FG000|Overall Study|Withdrawal by Subject|64|||
146732174|NCT02277990|529190816|FG001|Overall Study|Withdrawal by Subject|53|||
146732175|NCT02277990|529190815|FG000|Overall Study|Physician Decision|40|||
146732176|NCT02277990|529190816|FG001|Overall Study|Physician Decision|34|||
146732177|NCT02277990|529190815|FG000|Overall Study|Lost to Follow-up|66|||
146732178|NCT02277990|529190816|FG001|Overall Study|Lost to Follow-up|69|||
146732179|NCT02277990|529190815|FG000|Overall Study|Had other reason|26|||
146732180|NCT02277990|529190816|FG001|Overall Study|Had other reason|32|||
146732181|NCT03351738|529190817|FG000|Overall Study|Withdrawal by Subject|0|||
146732182|NCT03351738|529190818|FG001|Overall Study|Withdrawal by Subject|1|||
146732183|NCT03351738|529190819|FG002|Overall Study|Withdrawal by Subject|0|||
146732184|NCT03351738|529190820|FG003|Overall Study|Withdrawal by Subject|1|||
146732185|NCT03351738|529190821|FG004|Overall Study|Withdrawal by Subject|0|||
146732186|NCT03351738|529190822|FG005|Overall Study|Withdrawal by Subject|0|||
146732187|NCT05479604|529190827|FG000|Overall Study|Lost to Follow-up|1|||
146732188|NCT05479604|529190828|FG001|Overall Study|Lost to Follow-up|5|||
146732189|NCT03138733|529190831|FG000|Overall Study|Death|17|||
146732190|NCT03138733|529190832|FG001|Overall Study|Death|18|||
146732191|NCT03138733|529190831|FG000|Overall Study|Withdrawal by Subject|11|||
146732192|NCT03138733|529190832|FG001|Overall Study|Withdrawal by Subject|6|||
146732193|NCT03138733|529190831|FG000|Overall Study|Lost to Follow-up|3|||
146732194|NCT03138733|529190832|FG001|Overall Study|Lost to Follow-up|2|||
146732195|NCT03138733|529190831|FG000|Overall Study|Adverse Event|1|||
146732196|NCT03138733|529190832|FG001|Overall Study|Adverse Event|0|||
146732197|NCT03138733|529190831|FG000|Overall Study|Protocol Violation|1|||
146732198|NCT03138733|529190832|FG001|Overall Study|Protocol Violation|3|||
146732199|NCT03138733|529190831|FG000|Overall Study|Administrative or logistical reason|1|||
146732200|NCT03138733|529190832|FG001|Overall Study|Administrative or logistical reason|0|||
146732201|NCT03138733|529190831|FG000|Overall Study|The patient was transferred to another hospital|1|||
146732202|NCT03138733|529190832|FG001|Overall Study|The patient was transferred to another hospital|0|||
146732203|NCT03641313|529190838|FG000|Overall Study|Death|1|||
146732204|NCT03641313|529190838|FG000|Overall Study|Withdrawal by Subject|2|||
146732205|NCT03641313|529190838|FG000|Overall Study|Declining health|1|||
146732206|NCT03641313|529190838|FG000|Overall Study|Adverse Event|1|||
146732207|NCT03033225|529190839|FG000|Overall Study|Withdrawal by Subject|5|||
146732208|NCT00946296|529190840|FG000|Overall Study|Physician Decision|3|||
146732209|NCT00946296|529190841|FG001|Overall Study|Physician Decision|0|||
146732210|NCT03434678|529190844|FG000|Overall Study|Withdrawal by Subject|13|||
146732211|NCT03434678|529190845|FG001|Overall Study|Withdrawal by Subject|13|||
146732212|NCT03434678|529190844|FG000|Overall Study|Found to be ineligible post randomization|2|||
146732213|NCT03434678|529190845|FG001|Overall Study|Found to be ineligible post randomization|1|||
146732214|NCT06060457|529190848|FG000|Overall Study|Adverse Event|1|||
146732215|NCT06060457|529190849|FG001|Overall Study|Adverse Event|1|||
146732216|NCT06060457|529190848|FG000|Overall Study|Death|2|||
146732217|NCT06060457|529190849|FG001|Overall Study|Death|2|||
146732218|NCT06060457|529190848|FG000|Overall Study|Lost to Follow-up|17|||
146732219|NCT06060457|529190849|FG001|Overall Study|Lost to Follow-up|19|||
146732220|NCT06060457|529190848|FG000|Overall Study|Physician Decision|0|||
146732221|NCT06060457|529190849|FG001|Overall Study|Physician Decision|1|||
146732222|NCT06060457|529190848|FG000|Overall Study|Protocol Violation|1|||
146732223|NCT06060457|529190849|FG001|Overall Study|Protocol Violation|1|||
146732224|NCT06060457|529190848|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
146732225|NCT06060457|529190849|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
146732226|NCT06060457|529190848|FG000|Overall Study|Withdrawal by Subject|12|||
146732227|NCT06060457|529190849|FG001|Overall Study|Withdrawal by Subject|15|||
146732228|NCT06060457|529190848|FG000|Overall Study|Other Than Specified|2|||
146732229|NCT06060457|529190849|FG001|Overall Study|Other Than Specified|1|||
146732230|NCT02061202|529190850|FG000|Overall Study|Lost to Follow-up|1|||
146732231|NCT02061202|529190851|FG001|Overall Study|Lost to Follow-up|1|||
146732232|NCT01533493|529190852|FG000|Overall Study|Adverse Event|2|||
146732233|NCT01533493|529190853|FG001|Overall Study|Adverse Event|1|||
146732234|NCT01533493|529190852|FG000|Overall Study|Withdrawal by Subject|1|||
146732235|NCT01533493|529190853|FG001|Overall Study|Withdrawal by Subject|2|||
146732236|NCT01533493|529190852|FG000|Overall Study|Lost to Follow-up|2|||
146732237|NCT01533493|529190853|FG001|Overall Study|Lost to Follow-up|0|||
146732238|NCT05614089|529190859|FG000|Overall Study|Pregnancy|5|||
146732239|NCT05614089|529190860|FG001|Overall Study|Pregnancy|2|||
146732240|NCT05614089|529190859|FG000|Overall Study|Lost to Follow-up|5|||
146732241|NCT05614089|529190860|FG001|Overall Study|Lost to Follow-up|1|||
146732242|NCT05614089|529190859|FG000|Overall Study|Death|0|||
146732243|NCT05614089|529190860|FG001|Overall Study|Death|1|||
146732244|NCT05614089|529190859|FG000|Overall Study|Adverse Event|1|||
146732245|NCT05614089|529190860|FG001|Overall Study|Adverse Event|0|||
146732246|NCT05163522|529190861|FG000|Overall Study|Withdrawal by Subject|0|||
146732247|NCT05163522|529190862|FG001|Overall Study|Withdrawal by Subject|0|||
146732248|NCT05163522|529190863|FG002|Overall Study|Withdrawal by Subject|1|||
146982079|NCT01360632|530096213|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
146982080|NCT01360632|530096214|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
146732249|NCT05163522|529190864|FG003|Overall Study|Withdrawal by Subject|0|||
146732250|NCT05163522|529190865|FG004|Overall Study|Withdrawal by Subject|0|||
146938674|NCT01296698|529932461|FG000|Overall Study|Adverse Event|1|||
146938675|NCT01296698|529932462|FG001|Overall Study|Adverse Event|0|||
146732251|NCT05163522|529190866|FG005|Overall Study|Withdrawal by Subject|0|||
146732252|NCT05163522|529190867|FG006|Overall Study|Withdrawal by Subject|0|||
146732253|NCT05163522|529190868|FG007|Overall Study|Withdrawal by Subject|0|||
146732254|NCT05163522|529190869|FG008|Overall Study|Withdrawal by Subject|0|||
146732255|NCT05163522|529190870|FG009|Overall Study|Withdrawal by Subject|0|||
146732256|NCT05163522|529190871|FG010|Overall Study|Withdrawal by Subject|0|||
146732257|NCT02521285|529190873|FG000|Overall Study|Lost to Follow-up|1|||
146732258|NCT02521285|529190874|FG001|Overall Study|Lost to Follow-up|1|||
146732259|NCT02521285|529190873|FG000|Overall Study|Withdrawal by Subject|1|||
146732260|NCT02521285|529190874|FG001|Overall Study|Withdrawal by Subject|1|||
146732261|NCT02521285|529190873|FG000|Overall Study|Adverse Event|0|||
146732262|NCT02521285|529190874|FG001|Overall Study|Adverse Event|1|||
146732263|NCT05701995|529190876|FG000|Pre-Treatment|Randomization Error|1|||
146732264|NCT05701995|529190877|FG001|Pre-Treatment|Randomization Error|1|||
146732265|NCT05701995|529190876|FG000|Treatment|Withdrawal by Subject|8|||
146732266|NCT05701995|529190877|FG001|Treatment|Withdrawal by Subject|4|||
146732267|NCT05701995|529190876|FG000|Treatment|Lost to Follow-up|2|||
146732268|NCT05701995|529190877|FG001|Treatment|Lost to Follow-up|3|||
146732269|NCT05701995|529190876|FG000|Treatment|Adverse Event|3|||
146732270|NCT05701995|529190877|FG001|Treatment|Adverse Event|1|||
146732271|NCT05701995|529190876|FG000|Treatment|Other Reason|1|||
146732272|NCT05701995|529190877|FG001|Treatment|Other Reason|1|||
146732273|NCT05701995|529190876|FG000|Treatment|Death|1|||
146732274|NCT05701995|529190877|FG001|Treatment|Death|0|||
146732275|NCT05701995|529190876|FG000|Treatment|Physician Decision|0|||
146732276|NCT05701995|529190877|FG001|Treatment|Physician Decision|1|||
146732277|NCT00689026|529190887|FG000|Overall Study|Withdrawal by Subject|13|||
146732278|NCT00689026|529190888|FG001|Overall Study|Withdrawal by Subject|6|||
146732279|NCT04992546|529190889|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
146732280|NCT04992546|529190889|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
146732281|NCT04992546|529190889|FG000|Open-Label Treatment Period|Adverse Event|3|||
146732282|NCT04992546|529190889|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
146732283|NCT02703922|529190890|FG000|Overall Study|Death|5|||
146732284|NCT02703922|529190891|FG001|Overall Study|Death|8|||
146732285|NCT02703922|529190890|FG000|Overall Study|Lost to Follow-up|10|||
146732286|NCT02703922|529190891|FG001|Overall Study|Lost to Follow-up|10|||
146732287|NCT00500903|529190893|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
146732288|NCT00500903|529190894|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
146732289|NCT00500903|529190895|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
146732290|NCT00500903|529190893|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
146732291|NCT00500903|529190894|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
146732292|NCT00500903|529190895|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
146732293|NCT00500903|529190893|FG000|Overall Study|Progressive Disease|41|||
146732294|NCT00500903|529190894|FG001|Overall Study|Progressive Disease|2|||
146732295|NCT00500903|529190895|FG002|Overall Study|Progressive Disease|15|||
146732296|NCT00500903|529190893|FG000|Overall Study|Patient Declined Further Treatment|0|||
146732297|NCT00500903|529190894|FG001|Overall Study|Patient Declined Further Treatment|0|||
146732298|NCT00500903|529190895|FG002|Overall Study|Patient Declined Further Treatment|3|||
146732299|NCT00500903|529190893|FG000|Overall Study|Symptomatic Deterioration|2|||
146732300|NCT00500903|529190894|FG001|Overall Study|Symptomatic Deterioration|0|||
146732301|NCT00500903|529190895|FG002|Overall Study|Symptomatic Deterioration|0|||
146732302|NCT00500903|529190893|FG000|Overall Study|Reason Not Specified|10|||
146732303|NCT00500903|529190894|FG001|Overall Study|Reason Not Specified|0|||
146732304|NCT00500903|529190895|FG002|Overall Study|Reason Not Specified|2|||
146732305|NCT00717860|529190896|FG000|Overall Study|Clinical adverse experience|5|||
146732306|NCT00717860|529190897|FG001|Overall Study|Clinical adverse experience|9|||
146732307|NCT00717860|529190896|FG000|Overall Study|Laboratory adverse experience|2|||
146732308|NCT00717860|529190897|FG001|Overall Study|Laboratory adverse experience|2|||
146732309|NCT00717860|529190896|FG000|Overall Study|Lack of Efficacy|7|||
146732310|NCT00717860|529190897|FG001|Overall Study|Lack of Efficacy|13|||
146732311|NCT00717860|529190896|FG000|Overall Study|Discontinued for other reason|6|||
146732312|NCT00717860|529190897|FG001|Overall Study|Discontinued for other reason|1|||
146732313|NCT00717860|529190896|FG000|Overall Study|Withdrew consent|7|||
146732314|NCT00717860|529190897|FG001|Overall Study|Withdrew consent|3|||
146938676|NCT01296698|529932461|FG000|Overall Study|Death|1|||
146732315|NCT04058353|529190898|FG000|Overall Study|Adverse Event|2|||
146732316|NCT04058353|529190899|FG001|Overall Study|Adverse Event|1|||
146732317|NCT04058353|529190898|FG000|Overall Study|Physician Decision|1|||
146732318|NCT04058353|529190899|FG001|Overall Study|Physician Decision|0|||
146732319|NCT04058353|529190898|FG000|Overall Study|Other|1|||
146732320|NCT04058353|529190899|FG001|Overall Study|Other|0|||
146732321|NCT03419364|529190905|FG000|Overall Study|Delivery due to maternal condition|2|||
146732322|NCT03419364|529190906|FG001|Overall Study|Delivery due to maternal condition|0|||
146732323|NCT03419364|529190907|FG002|Overall Study|Delivery due to maternal condition|0|||
146938677|NCT01296698|529932462|FG001|Overall Study|Death|0|||
146732324|NCT00552084|529190908|FG000|Overall Study|Adverse Event|2|||
146732325|NCT00552084|529190909|FG001|Overall Study|Adverse Event|3|||
146732326|NCT00552084|529190908|FG000|Overall Study|Withdrawal by Subject|4|||
146732327|NCT00552084|529190909|FG001|Overall Study|Withdrawal by Subject|5|||
146732328|NCT00552084|529190908|FG000|Overall Study|Protocol Violation|1|||
146732329|NCT00552084|529190909|FG001|Overall Study|Protocol Violation|0|||
146732330|NCT00552084|529190908|FG000|Overall Study|change in anti-arrythmic drug|1|||
146732331|NCT00552084|529190909|FG001|Overall Study|change in anti-arrythmic drug|1|||
146732332|NCT02901626|529192311|FG000|Overall Study|Lost to Follow-up|1|||
146732333|NCT02901626|529192312|FG001|Overall Study|Lost to Follow-up|1|||
146732334|NCT04082884|529192313|FG000|Overall Study|Withdrawal by Subject|1|||
146732335|NCT04857034|529192315|FG000|Placebo-Controlled Period|Request to discontinue|2|||
146732336|NCT04857034|529192316|FG001|Placebo-Controlled Period|Request to discontinue|2|||
146732337|NCT04857034|529192317|FG002|Placebo-Controlled Period|Request to discontinue|0|||
146732338|NCT04857034|529192318|FG003|Placebo-Controlled Period|Request to discontinue|0|||
146732339|NCT04857034|529192319|FG004|Placebo-Controlled Period|Request to discontinue|0|||
146732340|NCT04857034|529192315|FG000|Placebo-Controlled Period|withdrew consent|1|||
146732341|NCT04857034|529192316|FG001|Placebo-Controlled Period|withdrew consent|1|||
146732342|NCT04857034|529192317|FG002|Placebo-Controlled Period|withdrew consent|2|||
146732343|NCT04857034|529192318|FG003|Placebo-Controlled Period|withdrew consent|0|||
146732344|NCT04857034|529192319|FG004|Placebo-Controlled Period|withdrew consent|0|||
146732345|NCT04857034|529192315|FG000|Placebo-Controlled Period|Pregnancy|1|||
146732346|NCT04857034|529192316|FG001|Placebo-Controlled Period|Pregnancy|1|||
146732347|NCT04857034|529192317|FG002|Placebo-Controlled Period|Pregnancy|0|||
146732348|NCT04857034|529192318|FG003|Placebo-Controlled Period|Pregnancy|0|||
146732349|NCT04857034|529192319|FG004|Placebo-Controlled Period|Pregnancy|0|||
146732350|NCT04857034|529192315|FG000|Placebo-Controlled Period|Ongoing study period|0|||
146732351|NCT04857034|529192316|FG001|Placebo-Controlled Period|Ongoing study period|1|||
146732352|NCT04857034|529192317|FG002|Placebo-Controlled Period|Ongoing study period|0|||
146732353|NCT04857034|529192318|FG003|Placebo-Controlled Period|Ongoing study period|0|||
146732354|NCT04857034|529192319|FG004|Placebo-Controlled Period|Ongoing study period|0|||
146732355|NCT04857034|529192315|FG000|Active Treatment Period|Lack of Efficacy|1|||
146732356|NCT04857034|529192316|FG001|Active Treatment Period|Lack of Efficacy|0|||
146732357|NCT04857034|529192317|FG002|Active Treatment Period|Lack of Efficacy|0|||
146732358|NCT04857034|529192318|FG003|Active Treatment Period|Lack of Efficacy|0|||
146732359|NCT04857034|529192319|FG004|Active Treatment Period|Lack of Efficacy|0|||
146732360|NCT04857034|529192315|FG000|Active Treatment Period|request to discontinue|0|||
146732361|NCT04857034|529192316|FG001|Active Treatment Period|request to discontinue|1|||
146732362|NCT04857034|529192317|FG002|Active Treatment Period|request to discontinue|0|||
146732363|NCT04857034|529192318|FG003|Active Treatment Period|request to discontinue|1|||
146732364|NCT04857034|529192319|FG004|Active Treatment Period|request to discontinue|0|||
146732365|NCT04857034|529192315|FG000|Active Treatment Period|administrative reason by sponsor|1|||
146732366|NCT04857034|529192316|FG001|Active Treatment Period|administrative reason by sponsor|5|||
146938678|NCT01296698|529932461|FG000|Overall Study|Lost to Follow-up|19|||
146938679|NCT01296698|529932462|FG001|Overall Study|Lost to Follow-up|1|||
146938680|NCT01296698|529932461|FG000|Overall Study|Withdrawal by Subject|12|||
146620792|NCT05470985|528783427|FG000|Long Term Extension|Adverse Event|0|||
146620793|NCT05470985|528783428|FG001|Long Term Extension|Adverse Event|1|||
146620794|NCT05470985|528783427|FG000|Long Term Extension|Study terminated by sponsor|2|||
146620795|NCT05470985|528783428|FG001|Long Term Extension|Study terminated by sponsor|0|||
146620796|NCT01917747|528783429|FG000|Overall Study|Withdrawal by Subject|1|||
146620797|NCT01917747|528783430|FG001|Overall Study|Withdrawal by Subject|2|||
146620798|NCT01917747|528783429|FG000|Overall Study|Lost to Follow-up|18|||
146620799|NCT01917747|528783430|FG001|Overall Study|Lost to Follow-up|9|||
146620800|NCT02741245|528783432|FG000|Overall Study|Adverse Event|0|||
146620801|NCT02741245|528783433|FG001|Overall Study|Adverse Event|0|||
146620802|NCT02741245|528783434|FG002|Overall Study|Adverse Event|0|||
146620803|NCT02741245|528783435|FG003|Overall Study|Adverse Event|2|||
146620804|NCT02741245|528783436|FG004|Overall Study|Adverse Event|2|||
146620805|NCT02741245|528783432|FG000|Overall Study|Protocol Violation|0|||
146620806|NCT02741245|528783433|FG001|Overall Study|Protocol Violation|1|||
146620807|NCT02741245|528783434|FG002|Overall Study|Protocol Violation|0|||
146620808|NCT02741245|528783435|FG003|Overall Study|Protocol Violation|1|||
146620809|NCT02741245|528783436|FG004|Overall Study|Protocol Violation|0|||
146620810|NCT02741245|528783432|FG000|Overall Study|Withdrawal by Subject|0|||
146620811|NCT02741245|528783433|FG001|Overall Study|Withdrawal by Subject|0|||
146620812|NCT02741245|528783434|FG002|Overall Study|Withdrawal by Subject|0|||
146620813|NCT02741245|528783435|FG003|Overall Study|Withdrawal by Subject|1|||
146620814|NCT02741245|528783436|FG004|Overall Study|Withdrawal by Subject|0|||
146620815|NCT01787461|528783438|FG000|Overall Study|Adverse Event|4|||
146620816|NCT01787461|528783439|FG001|Overall Study|Adverse Event|3|||
146620817|NCT01787461|528783438|FG000|Overall Study|Lost to Follow-up|3|||
146620818|NCT01787461|528783439|FG001|Overall Study|Lost to Follow-up|2|||
146620819|NCT01787461|528783438|FG000|Overall Study|No longer met eligibility criteria|1|||
146732367|NCT04857034|529192317|FG002|Active Treatment Period|administrative reason by sponsor|0|||
146732368|NCT04857034|529192318|FG003|Active Treatment Period|administrative reason by sponsor|2|||
146732369|NCT04857034|529192319|FG004|Active Treatment Period|administrative reason by sponsor|2|||
146732370|NCT04857034|529192315|FG000|Active Treatment Period|other reasons|1|||
146732371|NCT04857034|529192316|FG001|Active Treatment Period|other reasons|1|||
146732372|NCT04857034|529192317|FG002|Active Treatment Period|other reasons|0|||
146732373|NCT04857034|529192318|FG003|Active Treatment Period|other reasons|0|||
146732374|NCT04857034|529192319|FG004|Active Treatment Period|other reasons|1|||
146732375|NCT04857034|529192315|FG000|Active Treatment Period|Ongoing Study Period|2|||
146732376|NCT04857034|529192316|FG001|Active Treatment Period|Ongoing Study Period|4|||
146732377|NCT04857034|529192317|FG002|Active Treatment Period|Ongoing Study Period|0|||
146732378|NCT04857034|529192318|FG003|Active Treatment Period|Ongoing Study Period|1|||
146732379|NCT04857034|529192319|FG004|Active Treatment Period|Ongoing Study Period|0|||
146732380|NCT00387894|529192320|FG000|Overall Study|Withdrawal by Subject|1|||
146732381|NCT00659490|529192321|FG000|Overall Study|Lost to Follow-up|2|||
146732382|NCT00659490|529192322|FG001|Overall Study|Lost to Follow-up|0|||
146732383|NCT00659490|529192323|FG002|Overall Study|Lost to Follow-up|1|||
146732384|NCT05674890|529192324|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
146732385|NCT05674890|529192325|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
146732386|NCT05674890|529192324|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
146732387|NCT05674890|529192325|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
146732388|NCT05674890|529192324|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
146732389|NCT05674890|529192325|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
146732390|NCT00827541|529192326|FG000|Overall Study|Exitus|1|||
146732391|NCT00827541|529192327|FG001|Overall Study|Exitus|8|||
146732392|NCT00827541|529192326|FG000|Overall Study|Other|1|||
146732393|NCT00827541|529192327|FG001|Overall Study|Other|3|||
146732394|NCT00827541|529192326|FG000|Overall Study|Pathogen not susceptible|1|||
146732395|NCT00827541|529192327|FG001|Overall Study|Pathogen not susceptible|0|||
146732396|NCT00827541|529192326|FG000|Overall Study|Lack of effectiveness|1|||
146732397|NCT00827541|529192327|FG001|Overall Study|Lack of effectiveness|0|||
146732398|NCT01649232|529192328|FG000|Overall Study|Physician Decision|2|||
146732399|NCT01649232|529192329|FG001|Overall Study|Physician Decision|0|||
146732400|NCT02421666|529192330|FG000|6-month Follow-up|Lost to Follow-up|8|||
146732401|NCT02421666|529192331|FG001|6-month Follow-up|Lost to Follow-up|7|||
146732402|NCT02421666|529192330|FG000|6-month Follow-up|Withdrawal by Subject|5|||
146732403|NCT02421666|529192331|FG001|6-month Follow-up|Withdrawal by Subject|6|||
146732404|NCT02421666|529192330|FG000|12-month Follow-up|Lost to Follow-up|5|||
146732405|NCT02421666|529192331|FG001|12-month Follow-up|Lost to Follow-up|5|||
146732406|NCT02421666|529192330|FG000|12-month Follow-up|Withdrawal by Subject|6|||
146732407|NCT02421666|529192331|FG001|12-month Follow-up|Withdrawal by Subject|11|||
146732408|NCT00246337|529192332|FG000|Overall Study|Lost to Follow-up|3|||
146732409|NCT00246337|529192333|FG001|Overall Study|Lost to Follow-up|0|||
146732410|NCT00246337|529192334|FG002|Overall Study|Lost to Follow-up|0|||
146732411|NCT00246337|529192335|FG003|Overall Study|Lost to Follow-up|0|||
146732412|NCT00246337|529192336|FG004|Overall Study|Lost to Follow-up|2|||
146732413|NCT00246337|529192337|FG005|Overall Study|Lost to Follow-up|2|||
146732414|NCT00246337|529192338|FG006|Overall Study|Lost to Follow-up|1|||
146732415|NCT00246337|529192339|FG007|Overall Study|Lost to Follow-up|2|||
146732416|NCT00246337|529192340|FG008|Overall Study|Lost to Follow-up|0|||
146732417|NCT00246337|529192332|FG000|Overall Study|Protocol Violation|1|||
146732418|NCT00246337|529192333|FG001|Overall Study|Protocol Violation|0|||
146732419|NCT00246337|529192334|FG002|Overall Study|Protocol Violation|0|||
146732420|NCT00246337|529192335|FG003|Overall Study|Protocol Violation|0|||
146732421|NCT00246337|529192336|FG004|Overall Study|Protocol Violation|1|||
146732422|NCT00246337|529192337|FG005|Overall Study|Protocol Violation|0|||
146732423|NCT00246337|529192338|FG006|Overall Study|Protocol Violation|1|||
146732424|NCT00246337|529192339|FG007|Overall Study|Protocol Violation|1|||
146732425|NCT00246337|529192340|FG008|Overall Study|Protocol Violation|0|||
146732426|NCT00246337|529192332|FG000|Overall Study|Withdrawal by Subject|2|||
146732427|NCT00246337|529192333|FG001|Overall Study|Withdrawal by Subject|0|||
146732428|NCT00246337|529192334|FG002|Overall Study|Withdrawal by Subject|0|||
146732429|NCT00246337|529192335|FG003|Overall Study|Withdrawal by Subject|0|||
146732430|NCT00246337|529192336|FG004|Overall Study|Withdrawal by Subject|0|||
146732431|NCT00246337|529192337|FG005|Overall Study|Withdrawal by Subject|0|||
146732432|NCT00246337|529192338|FG006|Overall Study|Withdrawal by Subject|1|||
146732433|NCT00246337|529192339|FG007|Overall Study|Withdrawal by Subject|1|||
146732434|NCT00246337|529192340|FG008|Overall Study|Withdrawal by Subject|0|||
146732435|NCT00246337|529192332|FG000|Overall Study|Lack of Qualifying Event|8|||
146732436|NCT00246337|529192333|FG001|Overall Study|Lack of Qualifying Event|2|||
146732437|NCT00246337|529192334|FG002|Overall Study|Lack of Qualifying Event|1|||
146732438|NCT00246337|529192335|FG003|Overall Study|Lack of Qualifying Event|1|||
146732439|NCT00246337|529192336|FG004|Overall Study|Lack of Qualifying Event|1|||
146732440|NCT00246337|529192337|FG005|Overall Study|Lack of Qualifying Event|3|||
146732441|NCT00246337|529192338|FG006|Overall Study|Lack of Qualifying Event|3|||
146732442|NCT00246337|529192339|FG007|Overall Study|Lack of Qualifying Event|2|||
146732443|NCT00246337|529192340|FG008|Overall Study|Lack of Qualifying Event|5|||
146732444|NCT00246337|529192332|FG000|Overall Study|Site Terminated|10|||
146732445|NCT00246337|529192333|FG001|Overall Study|Site Terminated|0|||
146732446|NCT00246337|529192334|FG002|Overall Study|Site Terminated|0|||
146938681|NCT01296698|529932462|FG001|Overall Study|Withdrawal by Subject|0|||
146938682|NCT01296698|529932461|FG000|Overall Study|Difficulty Contacting Subject|2|||
146938683|NCT01296698|529932462|FG001|Overall Study|Difficulty Contacting Subject|0|||
146732447|NCT00246337|529192335|FG003|Overall Study|Site Terminated|0|||
146732448|NCT00246337|529192336|FG004|Overall Study|Site Terminated|0|||
146732449|NCT00246337|529192337|FG005|Overall Study|Site Terminated|7|||
146732450|NCT00246337|529192338|FG006|Overall Study|Site Terminated|1|||
146732451|NCT00246337|529192339|FG007|Overall Study|Site Terminated|6|||
146732452|NCT00246337|529192340|FG008|Overall Study|Site Terminated|2|||
146732453|NCT00246337|529192332|FG000|Overall Study|Abnormal baseline lab values|7|||
146732454|NCT00246337|529192333|FG001|Overall Study|Abnormal baseline lab values|0|||
146732455|NCT00246337|529192334|FG002|Overall Study|Abnormal baseline lab values|2|||
146732456|NCT00246337|529192335|FG003|Overall Study|Abnormal baseline lab values|0|||
146732457|NCT00246337|529192336|FG004|Overall Study|Abnormal baseline lab values|0|||
146732458|NCT00246337|529192337|FG005|Overall Study|Abnormal baseline lab values|2|||
146732459|NCT00246337|529192338|FG006|Overall Study|Abnormal baseline lab values|2|||
146732460|NCT00246337|529192339|FG007|Overall Study|Abnormal baseline lab values|0|||
146732461|NCT00246337|529192340|FG008|Overall Study|Abnormal baseline lab values|4|||
146732462|NCT00246337|529192332|FG000|Overall Study|Overwhelmed|0|||
146732463|NCT00246337|529192333|FG001|Overall Study|Overwhelmed|0|||
146732464|NCT00246337|529192334|FG002|Overall Study|Overwhelmed|0|||
146732465|NCT00246337|529192335|FG003|Overall Study|Overwhelmed|0|||
146732466|NCT00246337|529192336|FG004|Overall Study|Overwhelmed|0|||
146732467|NCT00246337|529192337|FG005|Overall Study|Overwhelmed|1|||
146732468|NCT00246337|529192338|FG006|Overall Study|Overwhelmed|0|||
146732469|NCT00246337|529192339|FG007|Overall Study|Overwhelmed|0|||
146732470|NCT00246337|529192340|FG008|Overall Study|Overwhelmed|0|||
146732471|NCT00246337|529192332|FG000|Overall Study|Protocol Violator|1|||
146732472|NCT00246337|529192333|FG001|Overall Study|Protocol Violator|0|||
146732473|NCT00246337|529192334|FG002|Overall Study|Protocol Violator|0|||
146732474|NCT00246337|529192335|FG003|Overall Study|Protocol Violator|0|||
146732475|NCT00246337|529192336|FG004|Overall Study|Protocol Violator|0|||
146732476|NCT00246337|529192337|FG005|Overall Study|Protocol Violator|0|||
146732477|NCT00246337|529192338|FG006|Overall Study|Protocol Violator|0|||
146732478|NCT00246337|529192339|FG007|Overall Study|Protocol Violator|0|||
146732479|NCT00246337|529192340|FG008|Overall Study|Protocol Violator|0|||
146732480|NCT00246337|529192332|FG000|Overall Study|Reported as completing trial in error|0|||
146732481|NCT00246337|529192333|FG001|Overall Study|Reported as completing trial in error|0|||
146732482|NCT00246337|529192334|FG002|Overall Study|Reported as completing trial in error|0|||
146732483|NCT00246337|529192335|FG003|Overall Study|Reported as completing trial in error|0|||
146732484|NCT00246337|529192336|FG004|Overall Study|Reported as completing trial in error|0|||
146732485|NCT00246337|529192337|FG005|Overall Study|Reported as completing trial in error|0|||
146732486|NCT00246337|529192338|FG006|Overall Study|Reported as completing trial in error|0|||
146732487|NCT00246337|529192339|FG007|Overall Study|Reported as completing trial in error|1|||
146732488|NCT00246337|529192340|FG008|Overall Study|Reported as completing trial in error|0|||
146732489|NCT01226511|529192345|FG000|Acute Treatment Period|Adverse Event|7|||
146732490|NCT01226511|529192346|FG001|Acute Treatment Period|Adverse Event|6|||
146732491|NCT01226511|529192345|FG000|Acute Treatment Period|Lack of Efficacy|2|||
146732492|NCT01226511|529192346|FG001|Acute Treatment Period|Lack of Efficacy|1|||
146732493|NCT01226511|529192345|FG000|Acute Treatment Period|Lost to Follow-up|3|||
146732494|NCT01226511|529192346|FG001|Acute Treatment Period|Lost to Follow-up|6|||
146732495|NCT01226511|529192345|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
146732496|NCT01226511|529192346|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
146732497|NCT01226511|529192345|FG000|Acute Treatment Period|Protocol Violation|5|||
146732498|NCT01226511|529192346|FG001|Acute Treatment Period|Protocol Violation|5|||
146732499|NCT01226511|529192345|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
146732500|NCT01226511|529192346|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
146732501|NCT01226511|529192345|FG000|Extension Treatment Period|Adverse Event|8|||
146732502|NCT01226511|529192346|FG001|Extension Treatment Period|Adverse Event|8|||
146732503|NCT01226511|529192345|FG000|Extension Treatment Period|Lack of Efficacy|3|||
146732504|NCT01226511|529192346|FG001|Extension Treatment Period|Lack of Efficacy|2|||
146732505|NCT01226511|529192345|FG000|Extension Treatment Period|Lost to Follow-up|4|||
146732506|NCT01226511|529192346|FG001|Extension Treatment Period|Lost to Follow-up|3|||
146732507|NCT01226511|529192345|FG000|Extension Treatment Period|Protocol Violation|2|||
146732508|NCT01226511|529192346|FG001|Extension Treatment Period|Protocol Violation|2|||
146732509|NCT01226511|529192345|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
146732510|NCT01226511|529192346|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
146938684|NCT01296698|529932461|FG000|Overall Study|Study Terminated by Sponsor|209|||
146938685|NCT01296698|529932462|FG001|Overall Study|Study Terminated by Sponsor|12|||
146732511|NCT01226511|529192345|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
146732512|NCT01226511|529192346|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
146732513|NCT01226511|529192345|FG000|Extension Treatment Period|Sponsor Decision|1|||
146732514|NCT01226511|529192346|FG001|Extension Treatment Period|Sponsor Decision|1|||
146732515|NCT01226511|529192345|FG000|Taper Period|Adverse Event|1|||
146732516|NCT01226511|529192346|FG001|Taper Period|Adverse Event|0|||
146732517|NCT01226511|529192345|FG000|Taper Period|Lost to Follow-up|2|||
146732518|NCT01226511|529192346|FG001|Taper Period|Lost to Follow-up|2|||
146732519|NCT01226511|529192345|FG000|Taper Period|Protocol Violation|1|||
146732520|NCT01226511|529192346|FG001|Taper Period|Protocol Violation|0|||
146732521|NCT01226511|529192345|FG000|Taper Period|Parent/Caregiver Decision|1|||
146732522|NCT01226511|529192346|FG001|Taper Period|Parent/Caregiver Decision|1|||
146732523|NCT00106184|529192357|FG000|Overall Study|Withdrawal by Subject|3|||
146732524|NCT00106184|529192358|FG001|Overall Study|Withdrawal by Subject|2|||
146732525|NCT02313909|529192359|FG000|Overall Study|Consent withdrawn by participant|33|||
146732526|NCT02313909|529192360|FG001|Overall Study|Consent withdrawn by participant|33|||
146732527|NCT02313909|529192359|FG000|Overall Study|Lost to Follow-up|24|||
146732528|NCT02313909|529192360|FG001|Overall Study|Lost to Follow-up|17|||
146732529|NCT05292534|529192366|FG000|Overall Study|Protocol Violation|3|||
146732530|NCT05292534|529192367|FG001|Overall Study|Protocol Violation|4|||
146732531|NCT05292534|529192366|FG000|Overall Study|Withdrawal by Subject|0|||
146732532|NCT05292534|529192367|FG001|Overall Study|Withdrawal by Subject|1|||
146732533|NCT00643123|529192368|FG000|Overall Study|Lost to Follow-up|4|||
146732534|NCT00643123|529192369|FG001|Overall Study|Lost to Follow-up|0|||
146732535|NCT00643123|529192368|FG000|Overall Study|Withdrawal by Subject|1|||
146732536|NCT00643123|529192369|FG001|Overall Study|Withdrawal by Subject|1|||
146732537|NCT01538472|529192370|FG000|Overall Study|Disease Progression|3|||
146732538|NCT01538472|529192370|FG000|Overall Study|Death|1|||
146732539|NCT02309112|529192371|FG000|Overall Study|Withdrawal by Subject|1|||
146732540|NCT02309112|529192372|FG001|Overall Study|Withdrawal by Subject|0|||
146732541|NCT02309112|529192373|FG002|Overall Study|Withdrawal by Subject|1|||
146732542|NCT02309112|529192371|FG000|Overall Study|Lost to Follow-up|0|||
146732543|NCT02309112|529192372|FG001|Overall Study|Lost to Follow-up|1|||
146732544|NCT02309112|529192373|FG002|Overall Study|Lost to Follow-up|0|||
146732545|NCT02133872|529192374|FG000|Overall Study|Withdrawal by Subject|5|||
146732546|NCT02133872|529192375|FG001|Overall Study|Withdrawal by Subject|3|||
146732547|NCT02133872|529192376|FG002|Overall Study|Withdrawal by Subject|0|||
146732548|NCT02923739|529192377|FG000|Overall Study|Withdrawal by Subject|2|||
146732549|NCT02923739|529192378|FG001|Overall Study|Withdrawal by Subject|0|||
146732550|NCT02923739|529192379|FG002|Overall Study|Withdrawal by Subject|0|||
146732551|NCT02923739|529192380|FG003|Overall Study|Withdrawal by Subject|0|||
146732552|NCT02923739|529192377|FG000|Overall Study|Failed Screening|3|||
146732553|NCT02923739|529192378|FG001|Overall Study|Failed Screening|0|||
146732554|NCT02923739|529192379|FG002|Overall Study|Failed Screening|0|||
146732555|NCT02923739|529192380|FG003|Overall Study|Failed Screening|0|||
146732556|NCT00948974|529192385|FG000|Overall Study|Lost to Follow-up|23|||
146791522|NCT05139810|529409428|FG001|Overall Study|Voluntary Withdrawal|1|||
146791523|NCT05139810|529409429|FG002|Overall Study|Voluntary Withdrawal|0|||
146791524|NCT05139810|529409427|FG000|Overall Study|Pregnancy|1|||
146791525|NCT05139810|529409428|FG001|Overall Study|Pregnancy|0|||
146791526|NCT05139810|529409429|FG002|Overall Study|Pregnancy|0|||
146791527|NCT05139810|529409427|FG000|Overall Study|Roll Over to CS7|19|||
146791528|NCT05139810|529409428|FG001|Overall Study|Roll Over to CS7|44|||
146791529|NCT05139810|529409429|FG002|Overall Study|Roll Over to CS7|20|||
146791530|NCT03240016|529409430|FG000|Overall Study|Adverse Event|9|||
146791531|NCT03240016|529409430|FG000|Overall Study|Withdrawal by Subject|7|||
146982081|NCT01360632|530096215|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
146732557|NCT00948974|529192386|FG001|Overall Study|Lost to Follow-up|20|||
146732558|NCT02857426|529192394|FG000|Overall Study|Disease progression|34|||
146732559|NCT02857426|529192395|FG001|Overall Study|Disease progression|13|||
146732560|NCT02857426|529192394|FG000|Overall Study|Study drug toxicity|4|||
146732561|NCT02857426|529192395|FG001|Overall Study|Study drug toxicity|1|||
146732562|NCT02857426|529192394|FG000|Overall Study|Death|1|||
146732563|NCT02857426|529192395|FG001|Overall Study|Death|0|||
146732564|NCT02857426|529192394|FG000|Overall Study|Adverse event unrelated to study drug|6|||
146732565|NCT02857426|529192395|FG001|Overall Study|Adverse event unrelated to study drug|2|||
146732566|NCT02857426|529192394|FG000|Overall Study|Participant withdrew consent|1|||
146732567|NCT02857426|529192395|FG001|Overall Study|Participant withdrew consent|1|||
146732568|NCT02857426|529192394|FG000|Overall Study|Maximum clinical benefit|1|||
146732569|NCT02857426|529192395|FG001|Overall Study|Maximum clinical benefit|0|||
146732570|NCT02857426|529192394|FG000|Overall Study|Completed treatment|0|||
146732571|NCT02857426|529192395|FG001|Overall Study|Completed treatment|2|||
146732572|NCT02634788|529192399|FG000|Overall Study|Adverse Event|0|||
146732573|NCT02634788|529192400|FG001|Overall Study|Adverse Event|8|||
146791532|NCT03240016|529409430|FG000|Overall Study|Death|1|||
146791533|NCT03240016|529409430|FG000|Overall Study|Physician Decision|2|||
146732574|NCT02634788|529192401|FG002|Overall Study|Adverse Event|3|||
146791534|NCT05200403|529409431|FG000|Overall Study|Withdrawal by Subject|4|||
146732575|NCT02634788|529192402|FG003|Overall Study|Adverse Event|1|||
146732576|NCT02634788|529192399|FG000|Overall Study|Lack of Efficacy|4|||
146732577|NCT02634788|529192400|FG001|Overall Study|Lack of Efficacy|0|||
146732578|NCT02634788|529192401|FG002|Overall Study|Lack of Efficacy|1|||
146732579|NCT02634788|529192402|FG003|Overall Study|Lack of Efficacy|4|||
146732580|NCT02634788|529192399|FG000|Overall Study|Lost to Follow-up|0|||
146732581|NCT02634788|529192400|FG001|Overall Study|Lost to Follow-up|1|||
146732582|NCT02634788|529192401|FG002|Overall Study|Lost to Follow-up|0|||
146732583|NCT02634788|529192402|FG003|Overall Study|Lost to Follow-up|0|||
146732584|NCT02634788|529192399|FG000|Overall Study|Withdrawal by Subject|0|||
146732585|NCT02634788|529192400|FG001|Overall Study|Withdrawal by Subject|1|||
146732586|NCT02634788|529192401|FG002|Overall Study|Withdrawal by Subject|1|||
146732587|NCT02634788|529192402|FG003|Overall Study|Withdrawal by Subject|0|||
146732588|NCT00758459|529192403|FG000|Overall Study|Adverse Event|3|||
146732589|NCT00758459|529192404|FG001|Overall Study|Adverse Event|2|||
146732590|NCT00758459|529192403|FG000|Overall Study|Protocol Violation|0|||
146732591|NCT00758459|529192404|FG001|Overall Study|Protocol Violation|1|||
146732592|NCT00758459|529192403|FG000|Overall Study|Withdrawal by Subject|0|||
146732593|NCT00758459|529192404|FG001|Overall Study|Withdrawal by Subject|1|||
146791535|NCT05200403|529409432|FG001|Overall Study|Withdrawal by Subject|2|||
146791536|NCT05200403|529409433|FG002|Overall Study|Withdrawal by Subject|6|||
146791537|NCT05299723|529409434|FG000|Overall Study|Withdrawal by Subject|0|||
146791538|NCT05299723|529409435|FG001|Overall Study|Withdrawal by Subject|2|||
146791539|NCT05299723|529409436|FG002|Overall Study|Withdrawal by Subject|0|||
146791540|NCT05546411|529409437|FG000|Overall Study|Progressive Disease|1|||
146791541|NCT05546411|529409438|FG001|Overall Study|Progressive Disease|0|||
146791542|NCT05546411|529409437|FG000|Overall Study|Adverse Event|0|||
146791543|NCT05546411|529409438|FG001|Overall Study|Adverse Event|1|||
146791544|NCT05546411|529409437|FG000|Overall Study|Metastatic disease|1|||
146791545|NCT05546411|529409438|FG001|Overall Study|Metastatic disease|0|||
146791546|NCT02606422|529409439|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
146791547|NCT02606422|529409440|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
146791548|NCT02606422|529409439|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
146791549|NCT02606422|529409440|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
146791550|NCT02606422|529409439|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
146791551|NCT02606422|529409440|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
146791552|NCT02606422|529409439|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
146791553|NCT02606422|529409440|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
146791554|NCT02966873|529409441|FG000|Overall Study|Lost to Follow-up|16|||
146791555|NCT02966873|529409442|FG001|Overall Study|Lost to Follow-up|15|||
146791556|NCT03235544|529409443|FG000|Overall Study|Death|11|||
146791557|NCT03235544|529409444|FG001|Overall Study|Death|31|||
146791558|NCT03235544|529409445|FG002|Overall Study|Death|19|||
146791559|NCT03235544|529409446|FG003|Overall Study|Death|34|||
146791560|NCT03235544|529409443|FG000|Overall Study|Lost to Follow-up|0|||
146791561|NCT03235544|529409444|FG001|Overall Study|Lost to Follow-up|1|||
146791562|NCT03235544|529409445|FG002|Overall Study|Lost to Follow-up|1|||
146791563|NCT03235544|529409446|FG003|Overall Study|Lost to Follow-up|1|||
146791564|NCT03235544|529409443|FG000|Overall Study|Withdrawal by Subject|0|||
146791565|NCT03235544|529409444|FG001|Overall Study|Withdrawal by Subject|3|||
146791566|NCT03235544|529409445|FG002|Overall Study|Withdrawal by Subject|1|||
146791567|NCT03235544|529409446|FG003|Overall Study|Withdrawal by Subject|5|||
146791568|NCT03235544|529409443|FG000|Overall Study|Disease Progression|0|||
146982082|NCT01360632|530096216|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
146732594|NCT02831257|529192406|FG000|Overall Study|Lack of Efficacy|3|||
146732595|NCT02831257|529192406|FG000|Overall Study|Adverse Event|2|||
146791569|NCT03235544|529409444|FG001|Overall Study|Disease Progression|1|||
146791570|NCT03235544|529409445|FG002|Overall Study|Disease Progression|0|||
146791571|NCT03235544|529409446|FG003|Overall Study|Disease Progression|2|||
146791572|NCT03235544|529409443|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
146791573|NCT03235544|529409444|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
146791574|NCT03235544|529409445|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
146791575|NCT03235544|529409446|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
146791576|NCT03235544|529409443|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
146791577|NCT03235544|529409444|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
146791578|NCT03235544|529409445|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
146791579|NCT03235544|529409446|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
146791580|NCT00950742|529409447|FG000|Overall Study|Other Adverse Event|1|||
146791581|NCT00950742|529409448|FG001|Overall Study|Other Adverse Event|0|||
146791582|NCT00950742|529409447|FG000|Overall Study|Withdrawal by Subject|3|||
146732596|NCT02831257|529192406|FG000|Overall Study|Physician Decision|1|||
146732597|NCT02831257|529192406|FG000|Overall Study|Withdrawal by Subject|6|||
146732598|NCT00611858|529192407|FG000|Overall Study|Adverse Event|2|||
146732599|NCT00611858|529192407|FG000|Overall Study|Withdrawal by Subject|2|||
146791583|NCT00950742|529409448|FG001|Overall Study|Withdrawal by Subject|0|||
146791584|NCT00950742|529409447|FG000|Overall Study|Progressive Disease|6|||
146791585|NCT00950742|529409448|FG001|Overall Study|Progressive Disease|2|||
146791586|NCT00950742|529409447|FG000|Overall Study|Dose limiting toxicity|6|||
146791587|NCT00950742|529409448|FG001|Overall Study|Dose limiting toxicity|0|||
146791588|NCT01456949|529409450|FG000|Enrollment|PI death- incomplete data|6|||
146791589|NCT01456949|529409450|FG000|Enrollment|Death|1|||
146791590|NCT01456949|529409450|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
146791591|NCT01456949|529409450|FG000|Enrollment|Physician Decision|10|||
146791592|NCT01456949|529409450|FG000|Enrollment|Withdrawal by Subject|7|||
146791593|NCT01456949|529409450|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
146791594|NCT01456949|529409450|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
146791595|NCT01456949|529409450|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
146791596|NCT01456949|529409450|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
146791597|NCT01456949|529409450|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
146791598|NCT01456949|529409450|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
146791599|NCT01456949|529409450|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
146791600|NCT01456949|529409450|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
146791601|NCT05002088|529409451|FG000|Overall Study|Withdrawal by Subject|9|||
146791602|NCT05002088|529409452|FG001|Overall Study|Withdrawal by Subject|0|||
146791603|NCT05002088|529409451|FG000|Overall Study|Lost to Follow-up|0|||
146791604|NCT05002088|529409452|FG001|Overall Study|Lost to Follow-up|1|||
146791605|NCT05002088|529409451|FG000|Overall Study|Death|16|||
146791606|NCT05002088|529409452|FG001|Overall Study|Death|2|||
146791607|NCT05002088|529409451|FG000|Overall Study|Protocol Violation|25|||
146791608|NCT05002088|529409452|FG001|Overall Study|Protocol Violation|7|||
146791609|NCT04068181|529409454|FG000|Overall Study|Death|17|||
146791610|NCT04068181|529409455|FG001|Overall Study|Death|12|||
146791611|NCT04068181|529409456|FG002|Overall Study|Death|4|||
146791612|NCT04068181|529409457|FG003|Overall Study|Death|7|||
146791613|NCT04068181|529409454|FG000|Overall Study|Lost to Follow-up|1|||
146791614|NCT04068181|529409455|FG001|Overall Study|Lost to Follow-up|0|||
146791615|NCT04068181|529409456|FG002|Overall Study|Lost to Follow-up|0|||
146791616|NCT04068181|529409457|FG003|Overall Study|Lost to Follow-up|0|||
146791617|NCT04068181|529409454|FG000|Overall Study|Withdrawal of consent from study|3|||
146791618|NCT04068181|529409455|FG001|Overall Study|Withdrawal of consent from study|0|||
146791619|NCT04068181|529409456|FG002|Overall Study|Withdrawal of consent from study|0|||
146791620|NCT04068181|529409457|FG003|Overall Study|Withdrawal of consent from study|0|||
146791621|NCT02723591|529409458|FG000|Overall Study|Adverse Event|48|||
146791622|NCT02723591|529409459|FG001|Overall Study|Adverse Event|40|||
146791623|NCT02723591|529409458|FG000|Overall Study|Death|2|||
146791624|NCT02723591|529409459|FG001|Overall Study|Death|2|||
146791625|NCT02723591|529409458|FG000|Overall Study|Lack of Efficacy|4|||
146791626|NCT02723591|529409459|FG001|Overall Study|Lack of Efficacy|3|||
146791627|NCT02723591|529409458|FG000|Overall Study|Lost to Follow-up|1|||
146791628|NCT02723591|529409459|FG001|Overall Study|Lost to Follow-up|7|||
146791629|NCT02723591|529409458|FG000|Overall Study|Protocol Violation|20|||
146791630|NCT02723591|529409459|FG001|Overall Study|Protocol Violation|23|||
146791631|NCT02723591|529409458|FG000|Overall Study|Withdrawal by Subject|4|||
146791632|NCT02723591|529409459|FG001|Overall Study|Withdrawal by Subject|8|||
146791633|NCT02723591|529409458|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
146791634|NCT02723591|529409459|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
146791635|NCT02723591|529409458|FG000|Overall Study|Miscellaneous|5|||
146791636|NCT02723591|529409459|FG001|Overall Study|Miscellaneous|6|||
146791637|NCT03599661|529409460|FG000|Overall Study|Lost to Follow-up|9|||
146791638|NCT03691935|529409461|FG000|Overall Study|Physician Decision|2|||
146791639|NCT03691935|529409462|FG001|Overall Study|Physician Decision|1|||
146791640|NCT03691935|529409461|FG000|Overall Study|Adverse Event|3|||
146791641|NCT03691935|529409462|FG001|Overall Study|Adverse Event|0|||
146791642|NCT03905798|529409468|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
146791643|NCT06473662|529409469|FG000|Overall Study|Withdrawal by Subject|1|||
146791644|NCT06473662|529409470|FG001|Overall Study|Withdrawal by Subject|6|||
146938686|NCT03639987|529932465|FG000|Overall Study|Study terminated by sponsor|26|||
146938687|NCT03639987|529932466|FG001|Overall Study|Study terminated by sponsor|25|||
146938688|NCT03639987|529932465|FG000|Overall Study|Lost to Follow-up|0|||
146938689|NCT03639987|529932466|FG001|Overall Study|Lost to Follow-up|1|||
146938690|NCT04294095|529932478|FG000|Overall Study|Adverse Event|1|||
146938691|NCT04294095|529932479|FG001|Overall Study|Adverse Event|0|||
146938692|NCT02224638|529932482|FG000|Overall Study|Adverse Event|1|||
146938693|NCT02224638|529932483|FG001|Overall Study|Adverse Event|1|||
146938694|NCT01406652|529932484|FG000|Overall Study|Lost-to-follow-up|3|||
146938695|NCT01406652|529932485|FG001|Overall Study|Lost-to-follow-up|4|||
146938696|NCT01406652|529932484|FG000|Overall Study|Withdrawal by Subject|2|||
146791645|NCT06473662|529409471|FG002|Overall Study|Withdrawal by Subject|5|||
146791646|NCT06473662|529409469|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
146938697|NCT01406652|529932485|FG001|Overall Study|Withdrawal by Subject|2|||
146938698|NCT01406652|529932484|FG000|Overall Study|Insufficient follow-up|5|||
146791647|NCT06473662|529409470|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
146791648|NCT06473662|529409471|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
146791649|NCT06473662|529409469|FG000|Overall Study|Starting HbA1c below 7%|0|||
146791650|NCT06473662|529409470|FG001|Overall Study|Starting HbA1c below 7%|1|||
146791651|NCT06473662|529409471|FG002|Overall Study|Starting HbA1c below 7%|1|||
146791652|NCT06473662|529409469|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
146791653|NCT06473662|529409470|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
146791654|NCT06473662|529409471|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
146791655|NCT06473662|529409469|FG000|Overall Study|Did not take medication|2|||
146791656|NCT06473662|529409470|FG001|Overall Study|Did not take medication|3|||
146791657|NCT06473662|529409471|FG002|Overall Study|Did not take medication|2|||
146791658|NCT03463044|529409474|FG000|Overall Study|Lost to Follow-up|0|||
146791659|NCT03463044|529409475|FG001|Overall Study|Lost to Follow-up|0|||
146791660|NCT03463044|529409476|FG002|Overall Study|Lost to Follow-up|0|||
146791661|NCT03463044|529409477|FG003|Overall Study|Lost to Follow-up|0|||
146791662|NCT03463044|529409478|FG004|Overall Study|Lost to Follow-up|0|||
146791663|NCT03463044|529409479|FG005|Overall Study|Lost to Follow-up|0|||
146791664|NCT03463044|529409480|FG006|Overall Study|Lost to Follow-up|0|||
146791665|NCT03463044|529409481|FG007|Overall Study|Lost to Follow-up|1|||
146791666|NCT03463044|529409482|FG008|Overall Study|Lost to Follow-up|0|||
146791667|NCT04079218|529409483|FG000|Overall Study|Death|1|||
146791668|NCT04079218|529409484|FG001|Overall Study|Death|0|||
146791669|NCT04079218|529409483|FG000|Overall Study|Withdrawal by Subject|3|||
146791670|NCT04079218|529409484|FG001|Overall Study|Withdrawal by Subject|0|||
146791671|NCT04079218|529409483|FG000|Overall Study|Physician Decision|4|||
146791672|NCT04079218|529409484|FG001|Overall Study|Physician Decision|0|||
146791673|NCT04079218|529409483|FG000|Overall Study|Lost to Follow-up|0|||
146791674|NCT04079218|529409484|FG001|Overall Study|Lost to Follow-up|1|||
146791675|NCT05907174|529409489|FG000|3-Month Assessment|Withdrawal by Subject|0|||
146791676|NCT05907174|529409490|FG001|3-Month Assessment|Withdrawal by Subject|0|||
146791677|NCT05907174|529409491|FG002|3-Month Assessment|Withdrawal by Subject|0|||
146791678|NCT05907174|529409492|FG003|3-Month Assessment|Withdrawal by Subject|1|||
146791679|NCT05907174|529409489|FG000|3-Month Assessment|Lost to Follow-up|1|||
146791680|NCT05907174|529409490|FG001|3-Month Assessment|Lost to Follow-up|1|||
146791681|NCT05907174|529409491|FG002|3-Month Assessment|Lost to Follow-up|1|||
146791682|NCT05907174|529409492|FG003|3-Month Assessment|Lost to Follow-up|1|||
146791683|NCT05907174|529409489|FG000|6-Month Assessment|Death|0|||
146791684|NCT05907174|529409490|FG001|6-Month Assessment|Death|0|||
146791685|NCT05907174|529409491|FG002|6-Month Assessment|Death|3|||
146791686|NCT05907174|529409492|FG003|6-Month Assessment|Death|0|||
146791687|NCT05907174|529409489|FG000|6-Month Assessment|Withdrawal by Subject|0|||
146732600|NCT02753595|529192408|FG000|Overall Study|Sponsor termination|2|||
146732601|NCT02753595|529192409|FG001|Overall Study|Sponsor termination|2|||
146732602|NCT01570868|529192410|FG000|Overall Study|Adverse Event|8|||
146732603|NCT01570868|529192411|FG001|Overall Study|Adverse Event|1|||
146732604|NCT01570868|529192410|FG000|Overall Study|FDA Recommendation|23|||
146732605|NCT01570868|529192411|FG001|Overall Study|FDA Recommendation|3|||
146732606|NCT01570868|529192410|FG000|Overall Study|Physician Decision|10|||
146732607|NCT01570868|529192411|FG001|Overall Study|Physician Decision|4|||
146732608|NCT01570868|529192410|FG000|Overall Study|Lost to Follow-up|1|||
146732609|NCT01570868|529192411|FG001|Overall Study|Lost to Follow-up|0|||
146732610|NCT01570868|529192410|FG000|Overall Study|Withdrawal by Subject|1|||
146732611|NCT01570868|529192411|FG001|Overall Study|Withdrawal by Subject|0|||
146732612|NCT03937219|529192415|FG000|Overall Study|Death|223|||
146732613|NCT03937219|529192416|FG001|Overall Study|Death|211|||
146732614|NCT03937219|529192415|FG000|Overall Study|Withdrawal by Subject|17|||
146732615|NCT03937219|529192416|FG001|Overall Study|Withdrawal by Subject|25|||
146732616|NCT03937219|529192415|FG000|Overall Study|Lost to Follow-up|3|||
146732617|NCT03937219|529192416|FG001|Overall Study|Lost to Follow-up|4|||
146791688|NCT05907174|529409490|FG001|6-Month Assessment|Withdrawal by Subject|0|||
146791689|NCT05907174|529409491|FG002|6-Month Assessment|Withdrawal by Subject|1|||
146791690|NCT05907174|529409492|FG003|6-Month Assessment|Withdrawal by Subject|1|||
146791691|NCT05907174|529409489|FG000|6-Month Assessment|Lost to Follow-up|0|||
146791692|NCT05907174|529409490|FG001|6-Month Assessment|Lost to Follow-up|1|||
146982083|NCT01360632|530096212|FG000|Phase B (6 Weeks)|Adverse Event|0|||
146732618|NCT02515279|529192419|FG000|Overall Study|Adverse Event|7|||
146982084|NCT01360632|530096213|FG001|Phase B (6 Weeks)|Adverse Event|3|||
146732619|NCT02515279|529192419|FG000|Overall Study|Lack of Efficacy|31|||
146732620|NCT02515279|529192419|FG000|Overall Study|Lost to Follow-up|9|||
146732621|NCT02515279|529192419|FG000|Overall Study|Withdrawal by Subject|18|||
146732622|NCT02515279|529192419|FG000|Overall Study|End-of-treatment visit not attended|17|||
146791693|NCT05907174|529409491|FG002|6-Month Assessment|Lost to Follow-up|1|||
146791694|NCT05907174|529409492|FG003|6-Month Assessment|Lost to Follow-up|1|||
146791695|NCT04498390|529409493|FG000|Overall Study|Adverse Event|0|||
146791696|NCT04498390|529409494|FG001|Overall Study|Adverse Event|0|||
146791697|NCT04498390|529409495|FG002|Overall Study|Adverse Event|1|||
146791698|NCT04498390|529409496|FG003|Overall Study|Adverse Event|0|||
146791699|NCT04498390|529409497|FG004|Overall Study|Adverse Event|0|||
146982085|NCT01360632|530096214|FG002|Phase B (6 Weeks)|Adverse Event|9|||
146982086|NCT01360632|530096215|FG003|Phase B (6 Weeks)|Adverse Event|3|||
146982087|NCT01360632|530096216|FG004|Phase B (6 Weeks)|Adverse Event|0|||
146982088|NCT01360632|530096212|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
146982089|NCT01360632|530096213|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
146982090|NCT01360632|530096214|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
146982091|NCT01360632|530096215|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
146982092|NCT01360632|530096216|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
146982093|NCT01360632|530096212|FG000|Phase B (6 Weeks)|Physician Decision|0|||
146982094|NCT01360632|530096213|FG001|Phase B (6 Weeks)|Physician Decision|0|||
146982095|NCT01360632|530096214|FG002|Phase B (6 Weeks)|Physician Decision|0|||
146982096|NCT01360632|530096215|FG003|Phase B (6 Weeks)|Physician Decision|1|||
146982097|NCT01360632|530096216|FG004|Phase B (6 Weeks)|Physician Decision|0|||
146982098|NCT01360632|530096212|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
146982099|NCT01360632|530096213|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
146982100|NCT01360632|530096214|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
146982101|NCT01360632|530096215|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
146982102|NCT01360632|530096216|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
146982103|NCT01360632|530096212|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
146982104|NCT01360632|530096213|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
146982105|NCT01360632|530096214|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
146982106|NCT01360632|530096215|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
146982107|NCT01360632|530096216|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
146982108|NCT01360632|530096212|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
146732623|NCT02515279|529192419|FG000|Overall Study|Other|22|||
146732624|NCT01800968|529192420|FG000|Overall Study|Death|23|||
146732625|NCT01800968|529192421|FG001|Overall Study|Death|16|||
146732626|NCT01800968|529192420|FG000|Overall Study|Lost to Follow-up|5|||
146732627|NCT01800968|529192421|FG001|Overall Study|Lost to Follow-up|7|||
146732628|NCT01800968|529192420|FG000|Overall Study|Withdrawal by Subject|7|||
146732629|NCT01800968|529192421|FG001|Overall Study|Withdrawal by Subject|9|||
146732630|NCT01800968|529192420|FG000|Overall Study|Physician Decision|1|||
146732631|NCT01800968|529192421|FG001|Overall Study|Physician Decision|0|||
146732632|NCT03185481|529192423|FG000|Overall Study|Adverse Event|1|||
146732633|NCT03185481|529192423|FG000|Overall Study|Study Terminated by Sponsor|4|||
146732634|NCT00701038|529192429|FG000|Overall Study|study amended pilot group of patients|4|||
146732635|NCT00701038|529192430|FG001|Overall Study|study amended pilot group of patients|4|||
146732636|NCT03371940|529192436|FG000|Overall Study|Withdrawal by Subject|8|||
146732637|NCT03371940|529192437|FG001|Overall Study|Withdrawal by Subject|1|||
146732638|NCT03371940|529192438|FG002|Overall Study|Withdrawal by Subject|3|||
146732639|NCT03371940|529192439|FG003|Overall Study|Withdrawal by Subject|4|||
146732640|NCT05099926|529192442|FG000|Overall Study|Lost to Follow-up|1|||
146732641|NCT00504426|529192445|FG000|Overall Study|Adverse Event|0|||
146732642|NCT00504426|529192446|FG001|Overall Study|Adverse Event|0|||
146732643|NCT00504426|529192447|FG002|Overall Study|Adverse Event|2|||
146732644|NCT00504426|529192448|FG003|Overall Study|Adverse Event|0|||
146732645|NCT00504426|529192445|FG000|Overall Study|Protocol Violation|1|||
146732646|NCT00504426|529192446|FG001|Overall Study|Protocol Violation|1|||
146732647|NCT00504426|529192447|FG002|Overall Study|Protocol Violation|2|||
146732648|NCT00504426|529192448|FG003|Overall Study|Protocol Violation|0|||
146732649|NCT00504426|529192445|FG000|Overall Study|Withdrawal by Subject|2|||
146732650|NCT00504426|529192446|FG001|Overall Study|Withdrawal by Subject|0|||
146732651|NCT00504426|529192447|FG002|Overall Study|Withdrawal by Subject|0|||
146732652|NCT00504426|529192448|FG003|Overall Study|Withdrawal by Subject|0|||
146732653|NCT00031486|529192454|FG000|Overall Study|Adverse Event|1|||
146732654|NCT00031486|529192455|FG001|Overall Study|Adverse Event|0|||
146732655|NCT00031486|529192454|FG000|Overall Study|Lost to Follow-up|0|||
146732656|NCT00031486|529192455|FG001|Overall Study|Lost to Follow-up|1|||
146732657|NCT00031486|529192454|FG000|Overall Study|Withdrawal by Subject|3|||
146732658|NCT00031486|529192455|FG001|Overall Study|Withdrawal by Subject|2|||
146732659|NCT00031486|529192454|FG000|Overall Study|Death|0|||
146732660|NCT00031486|529192455|FG001|Overall Study|Death|3|||
146732661|NCT00031486|529192454|FG000|Overall Study|Non-compliant|0|||
146732662|NCT00031486|529192455|FG001|Overall Study|Non-compliant|4|||
146732663|NCT00031486|529192454|FG000|Overall Study|Did not meet eligibility requirement|2|||
146982109|NCT01360632|530096213|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
146982110|NCT01360632|530096214|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
146732664|NCT00031486|529192455|FG001|Overall Study|Did not meet eligibility requirement|1|||
146732665|NCT00031486|529192454|FG000|Overall Study|Other|1|||
146732666|NCT00031486|529192455|FG001|Overall Study|Other|1|||
146732667|NCT03685591|529192456|FG000|Overall Study|Global Deterioration of Health Status|0|||
146732668|NCT03685591|529192457|FG001|Overall Study|Global Deterioration of Health Status|0|||
146732669|NCT03685591|529192458|FG002|Overall Study|Global Deterioration of Health Status|0|||
146732670|NCT03685591|529192459|FG003|Overall Study|Global Deterioration of Health Status|1|||
146732671|NCT03685591|529192460|FG004|Overall Study|Global Deterioration of Health Status|2|||
146732672|NCT03685591|529192461|FG005|Overall Study|Global Deterioration of Health Status|4|||
146732673|NCT03685591|529192462|FG006|Overall Study|Global Deterioration of Health Status|1|||
146732674|NCT03685591|529192463|FG007|Overall Study|Global Deterioration of Health Status|1|||
146732675|NCT03685591|529192464|FG008|Overall Study|Global Deterioration of Health Status|0|||
146732676|NCT03685591|529192456|FG000|Overall Study|Progressive Disease|1|||
146732677|NCT03685591|529192457|FG001|Overall Study|Progressive Disease|1|||
146732678|NCT03685591|529192458|FG002|Overall Study|Progressive Disease|0|||
146732679|NCT03685591|529192459|FG003|Overall Study|Progressive Disease|3|||
146732680|NCT03685591|529192460|FG004|Overall Study|Progressive Disease|5|||
146732681|NCT03685591|529192461|FG005|Overall Study|Progressive Disease|4|||
146732682|NCT03685591|529192462|FG006|Overall Study|Progressive Disease|3|||
146732683|NCT03685591|529192463|FG007|Overall Study|Progressive Disease|2|||
146732684|NCT03685591|529192464|FG008|Overall Study|Progressive Disease|1|||
146732685|NCT03685591|529192456|FG000|Overall Study|Other|0|||
146732686|NCT03685591|529192457|FG001|Overall Study|Other|0|||
146732687|NCT03685591|529192458|FG002|Overall Study|Other|1|||
146732688|NCT03685591|529192459|FG003|Overall Study|Other|0|||
146732689|NCT03685591|529192460|FG004|Overall Study|Other|2|||
146732690|NCT03685591|529192461|FG005|Overall Study|Other|3|||
146732691|NCT03685591|529192462|FG006|Overall Study|Other|0|||
146732692|NCT03685591|529192463|FG007|Overall Study|Other|0|||
146732693|NCT03685591|529192464|FG008|Overall Study|Other|0|||
146732694|NCT03685591|529192456|FG000|Overall Study|Withdrawal by Subject|0|||
146732695|NCT03685591|529192457|FG001|Overall Study|Withdrawal by Subject|0|||
146732696|NCT03685591|529192458|FG002|Overall Study|Withdrawal by Subject|0|||
146732697|NCT03685591|529192459|FG003|Overall Study|Withdrawal by Subject|0|||
146732698|NCT03685591|529192460|FG004|Overall Study|Withdrawal by Subject|3|||
146732699|NCT03685591|529192461|FG005|Overall Study|Withdrawal by Subject|2|||
146732700|NCT03685591|529192462|FG006|Overall Study|Withdrawal by Subject|0|||
146732701|NCT03685591|529192463|FG007|Overall Study|Withdrawal by Subject|0|||
146732702|NCT03685591|529192464|FG008|Overall Study|Withdrawal by Subject|1|||
146732703|NCT03685591|529192456|FG000|Overall Study|Adverse Event|0|||
146732704|NCT03685591|529192457|FG001|Overall Study|Adverse Event|0|||
146732705|NCT03685591|529192458|FG002|Overall Study|Adverse Event|0|||
146732706|NCT03685591|529192459|FG003|Overall Study|Adverse Event|1|||
146732707|NCT03685591|529192460|FG004|Overall Study|Adverse Event|1|||
146791700|NCT04498390|529409493|FG000|Overall Study|Withdrawal by Subject|0|||
146791701|NCT04498390|529409494|FG001|Overall Study|Withdrawal by Subject|0|||
146791702|NCT04498390|529409495|FG002|Overall Study|Withdrawal by Subject|0|||
146791703|NCT04498390|529409496|FG003|Overall Study|Withdrawal by Subject|1|||
146791704|NCT04498390|529409497|FG004|Overall Study|Withdrawal by Subject|0|||
146791705|NCT03478956|529409505|FG000|Randomized Treatment Period|Adverse Event|1|||
146791706|NCT03478956|529409506|FG001|Randomized Treatment Period|Adverse Event|0|||
146791707|NCT03478956|529409507|FG002|Randomized Treatment Period|Adverse Event|0|||
146791708|NCT03478956|529409508|FG003|Randomized Treatment Period|Adverse Event|0|||
146791709|NCT03478956|529409505|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
146791710|NCT03478956|529409506|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
146791711|NCT03478956|529409507|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
146791712|NCT03478956|529409508|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
146938699|NCT01406652|529932485|FG001|Overall Study|Insufficient follow-up|4|||
146938700|NCT01406652|529932484|FG000|Overall Study|Infection not sure|10|||
146938701|NCT01406652|529932485|FG001|Overall Study|Infection not sure|10|||
146938702|NCT00861380|529932486|FG000|Overall Study|Withdrawal Information not recorded|8427|||
146938703|NCT00861380|529932487|FG001|Overall Study|Withdrawal Information not recorded|9112|||
146938704|NCT00861380|529932488|FG002|Overall Study|Withdrawal Information not recorded|8872|||
146938705|NCT00861380|529932489|FG003|Overall Study|Withdrawal Information not recorded|3689|||
146938706|NCT00861380|529932490|FG004|Overall Study|Withdrawal Information not recorded|1812|||
146938707|NCT00861380|529932491|FG005|Overall Study|Withdrawal Information not recorded|6249|||
146938708|NCT00861380|529932492|FG006|Overall Study|Withdrawal Information not recorded|3020|||
146938709|NCT01998399|529932494|FG000|Overall Study|Lost to Follow-up|1|||
146938710|NCT01998399|529932495|FG001|Overall Study|Lost to Follow-up|3|||
146938711|NCT01998399|529932494|FG000|Overall Study|Death|4|||
146938712|NCT01998399|529932495|FG001|Overall Study|Death|2|||
146938713|NCT01998399|529932494|FG000|Overall Study|Study stopped before dosing completed|3|||
146938714|NCT01998399|529932495|FG001|Overall Study|Study stopped before dosing completed|3|||
146732708|NCT03685591|529192461|FG005|Overall Study|Adverse Event|4|||
146791713|NCT03478956|529409505|FG000|Open Label Extension Period|Adverse Event|0|||
146791714|NCT03478956|529409506|FG001|Open Label Extension Period|Adverse Event|0|||
146732709|NCT03685591|529192462|FG006|Overall Study|Adverse Event|0|||
146732710|NCT03685591|529192463|FG007|Overall Study|Adverse Event|1|||
146732711|NCT03685591|529192464|FG008|Overall Study|Adverse Event|1|||
146732712|NCT01685138|529192467|FG000|Overall Study|Lost to Follow-up|1|||
146732713|NCT01685138|529192467|FG000|Overall Study|Protocol Violation|1|||
146732714|NCT01685138|529192467|FG000|Overall Study|No longer requires treatment|1|||
146732715|NCT01685138|529192467|FG000|Overall Study|Subject/guardian decision|2|||
146732716|NCT01685138|529192467|FG000|Overall Study|Physician Decision|6|||
146791715|NCT03478956|529409507|FG002|Open Label Extension Period|Adverse Event|4|||
146938715|NCT01998399|529932494|FG000|Overall Study|Withdrawal by Subject|0|||
146791716|NCT03478956|529409508|FG003|Open Label Extension Period|Adverse Event|0|||
146982111|NCT01360632|530096215|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
146982112|NCT01360632|530096216|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
146791717|NCT03478956|529409505|FG000|Open Label Extension Period|Lack of Efficacy|0|||
146791718|NCT03478956|529409506|FG001|Open Label Extension Period|Lack of Efficacy|0|||
146791719|NCT03478956|529409507|FG002|Open Label Extension Period|Lack of Efficacy|8|||
146791720|NCT03478956|529409508|FG003|Open Label Extension Period|Lack of Efficacy|0|||
146791721|NCT03478956|529409505|FG000|Open Label Extension Period|Reason Not Provided|0|||
146791722|NCT03478956|529409506|FG001|Open Label Extension Period|Reason Not Provided|0|||
146732717|NCT01685138|529192467|FG000|Overall Study|Death|10|||
146732718|NCT01685138|529192467|FG000|Overall Study|Adverse Event|18|||
146732719|NCT01685138|529192467|FG000|Overall Study|Progressive disease|53|||
146732720|NCT02068495|529192468|FG000|Overall Study|Case Report Forms Uncollected|60|||
146732721|NCT02068495|529192468|FG000|Overall Study|Protocol Deviation|49|||
146732722|NCT03988166|529192469|FG000|Overall Study|Lost to Follow-up|2|||
146732723|NCT03988166|529192469|FG000|Overall Study|Death|1|||
146732724|NCT02220894|529192471|FG000|Overall Study|Adverse Event|127|||
146732725|NCT02220894|529192472|FG001|Overall Study|Adverse Event|74|||
146732726|NCT02220894|529192471|FG000|Overall Study|Death|418|||
146791723|NCT03478956|529409507|FG002|Open Label Extension Period|Reason Not Provided|1|||
146791724|NCT03478956|529409508|FG003|Open Label Extension Period|Reason Not Provided|0|||
146791725|NCT03478956|529409505|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
146791726|NCT03478956|529409506|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
146732727|NCT02220894|529192472|FG001|Overall Study|Death|508|||
146732728|NCT02220894|529192471|FG000|Overall Study|Lost to Follow-up|0|||
146938716|NCT01998399|529932495|FG001|Overall Study|Withdrawal by Subject|1|||
146938717|NCT01455415|529932510|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
146938718|NCT01455415|529932511|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
146938719|NCT01455415|529932510|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
146938720|NCT01455415|529932511|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
146938721|NCT01455415|529932510|FG000|Period 1|Drug Error not Associated to AE|0|||
146938722|NCT01455415|529932511|FG001|Period 1|Drug Error not Associated to AE|1|||
146938723|NCT01455415|529932510|FG000|Period 1|AE Not Related to Study Drug|2|||
146938724|NCT01455415|529932511|FG001|Period 1|AE Not Related to Study Drug|6|||
146938725|NCT01455415|529932510|FG000|Period 1|Withdrawal by Subject|4|||
146938726|NCT01455415|529932511|FG001|Period 1|Withdrawal by Subject|5|||
146938727|NCT01455415|529932510|FG000|Period 1|Unspecified Reason|1|||
146938728|NCT01455415|529932511|FG001|Period 1|Unspecified Reason|1|||
146938729|NCT01455415|529932510|FG000|Period 1|Protocol Violation|0|||
146938730|NCT01455415|529932511|FG001|Period 1|Protocol Violation|2|||
146938731|NCT01455415|529932510|FG000|Washout|AE Related to Study Drug|2|||
146938732|NCT01455415|529932511|FG001|Washout|AE Related to Study Drug|0|||
146938733|NCT01455415|529932510|FG000|Washout|Lost to Follow-up|1|||
146938734|NCT01455415|529932511|FG001|Washout|Lost to Follow-up|0|||
146938735|NCT01455415|529932510|FG000|Washout|Drug Error not Associated to AE|2|||
146938736|NCT01455415|529932511|FG001|Washout|Drug Error not Associated to AE|1|||
146938737|NCT01455415|529932510|FG000|Washout|AE Not Related to Study Drug|2|||
146938738|NCT01455415|529932511|FG001|Washout|AE Not Related to Study Drug|3|||
146938739|NCT01455415|529932510|FG000|Washout|Unspecified Reason|1|||
146938740|NCT01455415|529932511|FG001|Washout|Unspecified Reason|2|||
146938741|NCT01455415|529932510|FG000|Washout|Protocol Violation|0|||
146938742|NCT01455415|529932511|FG001|Washout|Protocol Violation|1|||
146938743|NCT01455415|529932510|FG000|Period 2|AE Related to Study Drug|1|||
146938744|NCT01455415|529932511|FG001|Period 2|AE Related to Study Drug|2|||
146732729|NCT02220894|529192472|FG001|Overall Study|Lost to Follow-up|4|||
146732730|NCT02220894|529192471|FG000|Overall Study|Site Terminated by Sponsor|2|||
146791727|NCT03478956|529409507|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
146791728|NCT03478956|529409508|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
146791729|NCT03478956|529409505|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
146938745|NCT01455415|529932510|FG000|Period 2|Lost to Follow-up|2|||
146938746|NCT01455415|529932511|FG001|Period 2|Lost to Follow-up|1|||
146938747|NCT01455415|529932510|FG000|Period 2|AE Not Related to Study Drug|2|||
146938748|NCT01455415|529932511|FG001|Period 2|AE Not Related to Study Drug|1|||
146982113|NCT01360632|530096212|FG000|Phase A+|Lost to Follow-up|0|||
146732731|NCT02220894|529192472|FG001|Overall Study|Site Terminated by Sponsor|0|||
146732732|NCT02220894|529192471|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
146791730|NCT03478956|529409506|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
146938749|NCT01455415|529932510|FG000|Period 2|Lack of Efficacy|2|||
146938750|NCT01455415|529932511|FG001|Period 2|Lack of Efficacy|0|||
146938751|NCT01455415|529932510|FG000|Period 2|Withdrawal by Subject|2|||
146938752|NCT01455415|529932511|FG001|Period 2|Withdrawal by Subject|3|||
146938753|NCT01455415|529932510|FG000|Period 2|Unspecified Reason|2|||
146938754|NCT01455415|529932511|FG001|Period 2|Unspecified Reason|3|||
146732733|NCT02220894|529192472|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
146938755|NCT01455415|529932510|FG000|Period 2|Protocol Violation|2|||
146938756|NCT01455415|529932511|FG001|Period 2|Protocol Violation|0|||
146982114|NCT01360632|530096213|FG001|Phase A+|Lost to Follow-up|0|||
146732734|NCT02220894|529192471|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146732735|NCT02220894|529192472|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146732736|NCT02220894|529192471|FG000|Overall Study|Withdrawal by Subject|10|||
146732737|NCT02220894|529192472|FG001|Overall Study|Withdrawal by Subject|9|||
146732738|NCT01728792|529194122|FG000|Overall Study|Withdrawal of Consent|1|||
146732739|NCT01728792|529194123|FG001|Overall Study|Withdrawal of Consent|1|||
146732740|NCT01728792|529194124|FG002|Overall Study|Withdrawal of Consent|0|||
146732741|NCT01728792|529194125|FG003|Overall Study|Withdrawal of Consent|1|||
146732742|NCT01728792|529194126|FG004|Overall Study|Withdrawal of Consent|0|||
146732743|NCT01728792|529194122|FG000|Overall Study|Lost to Follow-up|2|||
146732744|NCT01728792|529194123|FG001|Overall Study|Lost to Follow-up|1|||
146732745|NCT01728792|529194124|FG002|Overall Study|Lost to Follow-up|4|||
146732746|NCT01728792|529194125|FG003|Overall Study|Lost to Follow-up|2|||
146732747|NCT01728792|529194126|FG004|Overall Study|Lost to Follow-up|0|||
146732748|NCT03559218|529194127|FG000|Overall Study|Withdrawal by Subject|1|||
146791731|NCT03478956|529409507|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
146791732|NCT03478956|529409508|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
146791733|NCT03478956|529409505|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
146791734|NCT03478956|529409506|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
146791735|NCT03478956|529409507|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
146791736|NCT03478956|529409508|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
146791737|NCT01346540|529409510|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
146791738|NCT01346540|529409511|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
146791739|NCT01346540|529409510|FG000|Overall Study|Adverse Event|0|||
146791740|NCT01346540|529409511|FG001|Overall Study|Adverse Event|4|||
146791741|NCT04690582|529409512|FG000|Overall Study|Withdrawal by Subject|6|||
146791742|NCT04690582|529409513|FG001|Overall Study|Withdrawal by Subject|4|||
146791743|NCT04858451|529411200|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
146791744|NCT04858451|529411201|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
146791745|NCT04858451|529411202|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
146791746|NCT04858451|529411203|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
146791747|NCT04858451|529411204|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
146791748|NCT04858451|529411205|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
146982115|NCT01360632|530096214|FG002|Phase A+|Lost to Follow-up|0|||
146982116|NCT01360632|530096215|FG003|Phase A+|Lost to Follow-up|0|||
146982117|NCT01360632|530096216|FG004|Phase A+|Lost to Follow-up|2|||
146982118|NCT01360632|530096212|FG000|Phase A+|Adverse Event|0|||
146982119|NCT01360632|530096213|FG001|Phase A+|Adverse Event|0|||
146982120|NCT01360632|530096214|FG002|Phase A+|Adverse Event|0|||
146982121|NCT01360632|530096215|FG003|Phase A+|Adverse Event|0|||
146982122|NCT01360632|530096216|FG004|Phase A+|Adverse Event|2|||
146982123|NCT01360632|530096212|FG000|Phase A+|Met Withdrawal Criteria|0|||
146982124|NCT01360632|530096213|FG001|Phase A+|Met Withdrawal Criteria|0|||
146982125|NCT01360632|530096214|FG002|Phase A+|Met Withdrawal Criteria|0|||
146982126|NCT01360632|530096215|FG003|Phase A+|Met Withdrawal Criteria|0|||
146982127|NCT01360632|530096216|FG004|Phase A+|Met Withdrawal Criteria|7|||
146982128|NCT01360632|530096212|FG000|Phase A+|Physician Decision|0|||
146982129|NCT01360632|530096213|FG001|Phase A+|Physician Decision|0|||
146982130|NCT01360632|530096214|FG002|Phase A+|Physician Decision|0|||
146982131|NCT01360632|530096215|FG003|Phase A+|Physician Decision|0|||
146982132|NCT01360632|530096216|FG004|Phase A+|Physician Decision|3|||
146982133|NCT01360632|530096212|FG000|Phase A+|Withdrawal by Subject|0|||
146982134|NCT01360632|530096213|FG001|Phase A+|Withdrawal by Subject|0|||
146982135|NCT01360632|530096214|FG002|Phase A+|Withdrawal by Subject|0|||
146982136|NCT01360632|530096215|FG003|Phase A+|Withdrawal by Subject|0|||
146982137|NCT01360632|530096216|FG004|Phase A+|Withdrawal by Subject|8|||
146982138|NCT01360632|530096212|FG000|Phase A+|Protocol Deviation|0|||
146982139|NCT01360632|530096213|FG001|Phase A+|Protocol Deviation|0|||
146982140|NCT01360632|530096214|FG002|Phase A+|Protocol Deviation|0|||
146982141|NCT01360632|530096215|FG003|Phase A+|Protocol Deviation|0|||
146982142|NCT01360632|530096216|FG004|Phase A+|Protocol Deviation|3|||
146982143|NCT01298596|530096217|FG000|Overall Study|Withdrawal by Subject|1|||
146982144|NCT01298596|530096218|FG001|Overall Study|Withdrawal by Subject|1|||
146982145|NCT01298596|530096217|FG000|Overall Study|Death|5|||
146982146|NCT01298596|530096218|FG001|Overall Study|Death|3|||
146982147|NCT01298596|530096217|FG000|Overall Study|Lost to Follow-up|6|||
146982148|NCT01298596|530096218|FG001|Overall Study|Lost to Follow-up|14|||
146732749|NCT03559218|529194128|FG001|Overall Study|Withdrawal by Subject|0|||
146732750|NCT04277455|529194129|FG000|Overall Study|Lost to Follow-up|1|||
146791749|NCT04858451|529411206|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
146791750|NCT04858451|529411207|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
146982149|NCT01298596|530096217|FG000|Overall Study|Referred for further management|16|||
146732751|NCT01679301|529194132|FG000|Screening Period|screen failure|3|||
146732752|NCT01679301|529194133|FG001|Screening Period|screen failure|0|||
146732753|NCT01679301|529194134|FG002|Screening Period|screen failure|0|||
146732754|NCT01564368|529194136|FG000|Overall Study|Ineligible|18|||
146982150|NCT01298596|530096218|FG001|Overall Study|Referred for further management|15|||
146791751|NCT04858451|529411208|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
146791752|NCT04858451|529411200|FG000|Part 2|Discontinued|0|||
146791753|NCT04858451|529411201|FG001|Part 2|Discontinued|0|||
146791754|NCT04858451|529411202|FG002|Part 2|Discontinued|0|||
146791755|NCT04858451|529411203|FG003|Part 2|Discontinued|0|||
146791756|NCT04858451|529411204|FG004|Part 2|Discontinued|0|||
146791757|NCT04858451|529411205|FG005|Part 2|Discontinued|0|||
146791758|NCT04858451|529411206|FG006|Part 2|Discontinued|0|||
146791759|NCT04858451|529411207|FG007|Part 2|Discontinued|0|||
146791760|NCT04858451|529411208|FG008|Part 2|Discontinued|63|||
146791761|NCT03314454|529411209|FG000|Overall Study|Protocol Violation|1|||
146791762|NCT04119843|529411210|FG000|Overall Study|Adverse Event|3|||
146791763|NCT04119843|529411210|FG000|Overall Study|Death|1|||
146791764|NCT04233216|529411212|FG000|Overall Study|Lost to Follow-up|1|||
146791765|NCT04233216|529411213|FG001|Overall Study|Lost to Follow-up|0|||
146732755|NCT01564368|529194136|FG000|Overall Study|Not Randomized in Parent study|116|||
146732756|NCT01564368|529194136|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
146791766|NCT04233216|529411214|FG002|Overall Study|Lost to Follow-up|2|||
146791767|NCT04233216|529411215|FG003|Overall Study|Lost to Follow-up|0|||
146791768|NCT04233216|529411212|FG000|Overall Study|Physician Decision|0|||
146791769|NCT04233216|529411213|FG001|Overall Study|Physician Decision|3|||
146791770|NCT04233216|529411214|FG002|Overall Study|Physician Decision|0|||
146791771|NCT04233216|529411215|FG003|Overall Study|Physician Decision|2|||
146791772|NCT04233216|529411212|FG000|Overall Study|Withdrawal by Subject|0|||
146938757|NCT01455415|529932510|FG000|Follow-up|AE Related to Study Drug|0|||
146732757|NCT01564368|529194136|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
146732758|NCT01802437|529194140|FG000|Overall Study|Lost to Follow-up|1|||
146732759|NCT01802437|529194141|FG001|Overall Study|Lost to Follow-up|0|||
146732760|NCT01802437|529194140|FG000|Overall Study|Withdrawal by Subject|3|||
146732761|NCT01802437|529194141|FG001|Overall Study|Withdrawal by Subject|4|||
146732762|NCT02228967|529194142|FG000|Overall Study|Lost to Follow-up|146|||
146732763|NCT02228967|529194143|FG001|Overall Study|Lost to Follow-up|142|||
146732764|NCT02228967|529194142|FG000|Overall Study|Withdrawal by Subject|13|||
146732765|NCT02228967|529194143|FG001|Overall Study|Withdrawal by Subject|18|||
146732766|NCT00520975|529194144|FG000|Overall Study|Disease progression|31|||
146732767|NCT00520975|529194145|FG001|Overall Study|Disease progression|23|||
146732768|NCT00520975|529194144|FG000|Overall Study|Adverse Event|7|||
146732769|NCT00520975|529194145|FG001|Overall Study|Adverse Event|10|||
146732770|NCT00520975|529194144|FG000|Overall Study|Death|0|||
146732771|NCT00520975|529194145|FG001|Overall Study|Death|2|||
146732772|NCT00520975|529194144|FG000|Overall Study|Withdrawal by Subject|3|||
146732773|NCT00520975|529194145|FG001|Overall Study|Withdrawal by Subject|5|||
146732774|NCT00520975|529194144|FG000|Overall Study|Other therapy|2|||
146732775|NCT00520975|529194145|FG001|Overall Study|Other therapy|4|||
146938758|NCT01455415|529932511|FG001|Follow-up|AE Related to Study Drug|1|||
146938759|NCT01455415|529932510|FG000|Follow-up|Lack of Efficacy|0|||
146938760|NCT01455415|529932511|FG001|Follow-up|Lack of Efficacy|1|||
146938761|NCT01455415|529932510|FG000|Follow-up|Withdrawal by Subject|2|||
146938762|NCT01455415|529932511|FG001|Follow-up|Withdrawal by Subject|0|||
146938763|NCT01455415|529932510|FG000|Follow-up|Unspecified Reason|1|||
146938764|NCT01455415|529932511|FG001|Follow-up|Unspecified Reason|0|||
146938765|NCT00631540|529932521|FG000|Overall Study|Withdrawal by Subject|5|||
146938766|NCT00631540|529932521|FG000|Overall Study|Death|4|||
146938767|NCT00631540|529932521|FG000|Overall Study|Lost to Follow-up|2|||
146938768|NCT00631540|529932521|FG000|Overall Study|Core Lab Data Unavailable|3|||
146938769|NCT00795509|529932522|FG000|Overall Study|Protocol Violation|31|||
146938770|NCT00970268|529932523|FG000|Overall Study|Withdrawal by Subject|12|||
146938771|NCT00970268|529932524|FG001|Overall Study|Withdrawal by Subject|19|||
146938772|NCT00970268|529932523|FG000|Overall Study|Adverse Event|15|||
146938773|NCT00970268|529932524|FG001|Overall Study|Adverse Event|12|||
146938774|NCT00970268|529932523|FG000|Overall Study|Lack of Efficacy|3|||
146938775|NCT00970268|529932524|FG001|Overall Study|Lack of Efficacy|6|||
146732776|NCT00520975|529194144|FG000|Overall Study|Other reasons|4|||
146732777|NCT00520975|529194145|FG001|Overall Study|Other reasons|2|||
146732778|NCT00520975|529194144|FG000|Overall Study|Not start protocol therapy|1|||
146791773|NCT04233216|529411213|FG001|Overall Study|Withdrawal by Subject|2|||
146791774|NCT04233216|529411214|FG002|Overall Study|Withdrawal by Subject|1|||
146938776|NCT00970268|529932523|FG000|Overall Study|Protocol Violation|4|||
146938777|NCT00970268|529932524|FG001|Overall Study|Protocol Violation|7|||
146938778|NCT00970268|529932523|FG000|Overall Study|Other Reason|3|||
146732779|NCT00520975|529194145|FG001|Overall Study|Not start protocol therapy|2|||
146732780|NCT00238433|529194147|FG000|Overall Study|Screen failure|1|||
146732781|NCT00238433|529194147|FG000|Overall Study|Lost to Follow-up|1|||
146732782|NCT00238433|529194147|FG000|Overall Study|Death|1|||
146732783|NCT00409682|529194153|FG000|Open-label Induction Period|Adverse Event|1|||
146791775|NCT04233216|529411215|FG003|Overall Study|Withdrawal by Subject|0|||
146791776|NCT04231149|529411216|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
146791777|NCT04231149|529411217|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
146938779|NCT00970268|529932524|FG001|Overall Study|Other Reason|1|||
146938780|NCT00970268|529932523|FG000|Overall Study|COPD Exacerbation|4|||
146791778|NCT04231149|529411218|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
146791779|NCT04231149|529411219|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
146791780|NCT04231149|529411220|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
146791781|NCT03252847|529411221|FG000|Overall Study|Withdrawal by Subject|0|||
146791782|NCT03252847|529411222|FG001|Overall Study|Withdrawal by Subject|0|||
146791783|NCT03252847|529411223|FG002|Overall Study|Withdrawal by Subject|1|||
146791784|NCT03252847|529411224|FG003|Overall Study|Withdrawal by Subject|0|||
146791785|NCT03252847|529411225|FG004|Overall Study|Withdrawal by Subject|0|||
146791786|NCT03252847|529411226|FG005|Overall Study|Withdrawal by Subject|0|||
146791787|NCT03252847|529411227|FG006|Overall Study|Withdrawal by Subject|0|||
146791788|NCT03252847|529411221|FG000|Overall Study|Other: Patient decision|0|||
146791789|NCT03252847|529411222|FG001|Overall Study|Other: Patient decision|0|||
146791790|NCT03252847|529411223|FG002|Overall Study|Other: Patient decision|0|||
146791791|NCT03252847|529411224|FG003|Overall Study|Other: Patient decision|0|||
146791792|NCT03252847|529411225|FG004|Overall Study|Other: Patient decision|1|||
146791793|NCT03252847|529411226|FG005|Overall Study|Other: Patient decision|0|||
146791794|NCT03252847|529411227|FG006|Overall Study|Other: Patient decision|0|||
146791795|NCT05808257|529411230|FG000|Overall Study|Lost to Follow-up|8|||
146791796|NCT05808257|529411231|FG001|Overall Study|Lost to Follow-up|8|||
146791797|NCT03819153|529411252|FG000|Overall Study|Withdrawal by Subject|20|||
146791798|NCT03819153|529411253|FG001|Overall Study|Withdrawal by Subject|28|||
146791799|NCT03819153|529411252|FG000|Overall Study|Lost to Follow-up|23|||
146791800|NCT03819153|529411253|FG001|Overall Study|Lost to Follow-up|30|||
146791801|NCT05374798|529411263|FG000|Overall Study|Lost to Follow-up|2|||
146791802|NCT05374798|529411263|FG000|Overall Study|Withdrawal by Subject|2|||
146791803|NCT05374798|529411263|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
146791804|NCT04471246|529411264|FG000|Overall Study|Lost to Follow-up|2|||
146791805|NCT04471246|529411265|FG001|Overall Study|Lost to Follow-up|2|||
146791806|NCT05764525|529411266|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
146791807|NCT05764525|529411267|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
146791808|NCT05764525|529411266|FG000|Overall Study|Withdrawal by Subject|4|||
146791809|NCT05764525|529411267|FG001|Overall Study|Withdrawal by Subject|8|||
146791810|NCT05764525|529411266|FG000|Overall Study|Physician Decision|1|||
146791811|NCT05764525|529411267|FG001|Overall Study|Physician Decision|0|||
146791812|NCT03334630|529411268|FG000|Overall Study|Withdrawal by Subject|7|||
146791813|NCT03334630|529411269|FG001|Overall Study|Withdrawal by Subject|7|||
146791814|NCT03334630|529411268|FG000|Overall Study|Lost to Follow-up|3|||
146791815|NCT03334630|529411269|FG001|Overall Study|Lost to Follow-up|1|||
146791816|NCT03334630|529411268|FG000|Overall Study|Adverse Event|0|||
146791817|NCT03334630|529411269|FG001|Overall Study|Adverse Event|1|||
146791818|NCT03334630|529411268|FG000|Overall Study|Physician Decision|1|||
146791819|NCT03334630|529411269|FG001|Overall Study|Physician Decision|1|||
146791820|NCT03334630|529411268|FG000|Overall Study|Enrollment closed|2|||
146791821|NCT03334630|529411269|FG001|Overall Study|Enrollment closed|1|||
146791822|NCT03334630|529411268|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
146791823|NCT03334630|529411269|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
146791824|NCT03334630|529411268|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
146791825|NCT03334630|529411269|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
146791826|NCT05093842|529411276|FG000|Overall Study|Pregnancy loss|1|||
146791827|NCT05093842|529411277|FG001|Overall Study|Pregnancy loss|1|||
146791828|NCT05093842|529411276|FG000|Overall Study|Lost to Follow-up|6|||
146791829|NCT05093842|529411277|FG001|Overall Study|Lost to Follow-up|0|||
146791830|NCT05093842|529411276|FG000|Overall Study|Physician Decision|0|||
146791831|NCT05093842|529411277|FG001|Overall Study|Physician Decision|1|||
146791832|NCT03910478|529411283|FG000|Overall Study|Death|13|||
146791833|NCT03910478|529411284|FG001|Overall Study|Death|6|||
146791834|NCT03910478|529411283|FG000|Overall Study|Withdrawal by Subject|23|||
146791835|NCT03910478|529411284|FG001|Overall Study|Withdrawal by Subject|2|||
146791836|NCT03910478|529411283|FG000|Overall Study|Physician Decision|5|||
146791837|NCT03910478|529411284|FG001|Overall Study|Physician Decision|0|||
146791838|NCT03910478|529411283|FG000|Overall Study|Protocol Violation|1|||
146791839|NCT03910478|529411284|FG001|Overall Study|Protocol Violation|0|||
146791840|NCT03910478|529411283|FG000|Overall Study|Failure to meet continuation criteria|2|||
146982151|NCT04128696|530096219|FG000|Overall Study|Lost to Follow-up|3|||
146982152|NCT04128696|530096220|FG001|Overall Study|Lost to Follow-up|7|||
146791841|NCT03910478|529411284|FG001|Overall Study|Failure to meet continuation criteria|0|||
146791842|NCT03910478|529411283|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
146791843|NCT03910478|529411284|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
146982153|NCT04128696|530096219|FG000|Overall Study|Withdrawal by Subject|12|||
146791844|NCT01275677|529411287|FG000|Overall Study|Not at risk for recurrence.|1|||
146791845|NCT01275677|529411288|FG001|Overall Study|Not at risk for recurrence.|1|||
146791846|NCT01275677|529411287|FG000|Overall Study|No follow-up|26|||
146791847|NCT01275677|529411288|FG001|Overall Study|No follow-up|37|||
146791848|NCT01275677|529411287|FG000|Overall Study|No clinical follow up.|1|||
146791849|NCT01275677|529411288|FG001|Overall Study|No clinical follow up.|4|||
146791850|NCT03987022|529411289|FG000|Overall Study|Lost to Follow-up|2|||
146791851|NCT03987022|529411290|FG001|Overall Study|Lost to Follow-up|2|||
146791852|NCT03987022|529411289|FG000|Overall Study|Withdrawal by Subject|1|||
146791853|NCT03987022|529411290|FG001|Overall Study|Withdrawal by Subject|0|||
146791854|NCT04800211|529411291|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
146938781|NCT00970268|529932524|FG001|Overall Study|COPD Exacerbation|2|||
146938782|NCT00970268|529932523|FG000|Overall Study|Lost to Follow-up|1|||
146791855|NCT04800211|529411292|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
146791856|NCT04800211|529411293|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
146791857|NCT04800211|529411291|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
146791858|NCT04800211|529411292|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
146791859|NCT04800211|529411293|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
146791860|NCT04800211|529411291|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
146791861|NCT04800211|529411292|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
146791862|NCT04800211|529411293|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
146791863|NCT04800211|529411291|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
146791864|NCT04800211|529411292|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
146791865|NCT04800211|529411293|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
146791866|NCT04800211|529411291|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
146791867|NCT04800211|529411292|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
146791868|NCT04800211|529411293|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
146791869|NCT04800211|529411291|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
146791870|NCT04800211|529411292|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
146791871|NCT04800211|529411293|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
146791872|NCT04800211|529411291|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
146791873|NCT04800211|529411292|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
146791874|NCT04800211|529411293|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
146791875|NCT04800211|529411291|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
146791876|NCT04800211|529411292|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
146791877|NCT04800211|529411293|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
146791878|NCT04800211|529411291|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
146791879|NCT04800211|529411292|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
146791880|NCT04800211|529411293|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
146791881|NCT04800211|529411291|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
146791882|NCT04800211|529411292|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
146791883|NCT04800211|529411293|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
146791884|NCT04800211|529411291|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
146791885|NCT04800211|529411292|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
146791886|NCT04800211|529411293|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
146791887|NCT03734679|529411305|FG000|Overall Study|Missed Visit|1|||
146791888|NCT03088878|529411318|FG000|Overall Study|Adverse Event|0|||
146732784|NCT00409682|529194154|FG001|Open-label Induction Period|Adverse Event|0|||
146732785|NCT00409682|529194155|FG002|Open-label Induction Period|Adverse Event|0|||
146732786|NCT00409682|529194153|FG000|Open-label Induction Period|Lack of Efficacy|1|||
146732787|NCT00409682|529194154|FG001|Open-label Induction Period|Lack of Efficacy|0|||
146732788|NCT00409682|529194155|FG002|Open-label Induction Period|Lack of Efficacy|0|||
146732789|NCT00409682|529194153|FG000|Open-label Induction Period|Protocol Violation|1|||
146732790|NCT00409682|529194154|FG001|Open-label Induction Period|Protocol Violation|0|||
146732791|NCT00409682|529194155|FG002|Open-label Induction Period|Protocol Violation|0|||
146732792|NCT00409682|529194153|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
146732793|NCT00409682|529194154|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
146732794|NCT00409682|529194155|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
146732795|NCT00409682|529194153|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
146732796|NCT00409682|529194154|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
146732797|NCT00409682|529194155|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
146732798|NCT00409682|529194153|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
146732799|NCT00409682|529194154|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
146791889|NCT03088878|529411319|FG001|Overall Study|Adverse Event|0|||
146791890|NCT03088878|529411320|FG002|Overall Study|Adverse Event|0|||
146791891|NCT03088878|529411321|FG003|Overall Study|Adverse Event|0|||
146791892|NCT03088878|529411322|FG004|Overall Study|Adverse Event|4|||
146791893|NCT03088878|529411323|FG005|Overall Study|Adverse Event|2|||
146791894|NCT03088878|529411324|FG006|Overall Study|Adverse Event|1|||
146791895|NCT03088878|529411325|FG007|Overall Study|Adverse Event|0|||
146791896|NCT03088878|529411326|FG008|Overall Study|Adverse Event|0|||
146791897|NCT03088878|529411327|FG009|Overall Study|Adverse Event|0|||
146791898|NCT03088878|529411328|FG010|Overall Study|Adverse Event|0|||
146732800|NCT00409682|529194155|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
146791899|NCT03088878|529411329|FG011|Overall Study|Adverse Event|0|||
146732801|NCT00409682|529194153|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
146732802|NCT00409682|529194154|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
146732803|NCT00409682|529194155|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
146732804|NCT00409682|529194153|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
146732805|NCT00409682|529194154|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
146732806|NCT00409682|529194155|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
146732807|NCT00409682|529194153|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
146732808|NCT00409682|529194154|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
146732809|NCT00409682|529194155|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
146732810|NCT00409682|529194153|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
146732811|NCT00409682|529194154|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
146732812|NCT00409682|529194155|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
146732813|NCT01896869|529194157|FG000|Overall Study|Withdrawal by Subject|0|||
146732814|NCT01896869|529194158|FG001|Overall Study|Withdrawal by Subject|6|||
146732815|NCT01896869|529194157|FG000|Overall Study|Lost to Follow-up|1|||
146732816|NCT01896869|529194158|FG001|Overall Study|Lost to Follow-up|0|||
146732817|NCT04710927|529194166|FG000|Overall Study|Lost to Follow-up|7|||
146732818|NCT04710927|529194167|FG001|Overall Study|Lost to Follow-up|6|||
146732819|NCT04710927|529194168|FG002|Overall Study|Lost to Follow-up|5|||
146732820|NCT00118716|529194170|FG000|Overall Study|Adverse Event|2|||
146732821|NCT00118716|529194171|FG001|Overall Study|Adverse Event|7|||
146732822|NCT00118716|529194170|FG000|Overall Study|Protocol Violation|5|||
146732823|NCT00118716|529194171|FG001|Overall Study|Protocol Violation|4|||
146732824|NCT00118716|529194170|FG000|Overall Study|Withdrawal by Subject|0|||
146732825|NCT00118716|529194171|FG001|Overall Study|Withdrawal by Subject|1|||
146732826|NCT00118716|529194170|FG000|Overall Study|Exacerbation|2|||
146732827|NCT00118716|529194171|FG001|Overall Study|Exacerbation|2|||
146732828|NCT00118716|529194170|FG000|Overall Study|Discontinued by sponsor|1|||
146732829|NCT00118716|529194171|FG001|Overall Study|Discontinued by sponsor|1|||
146732830|NCT00118716|529194170|FG000|Overall Study|Non-compliance|1|||
146732831|NCT00118716|529194171|FG001|Overall Study|Non-compliance|3|||
146732832|NCT00118716|529194170|FG000|Overall Study|misrandomized|1|||
146732833|NCT00118716|529194171|FG001|Overall Study|misrandomized|1|||
146732834|NCT00118716|529194170|FG000|Overall Study|Expired drug use|1|||
146732835|NCT00118716|529194171|FG001|Overall Study|Expired drug use|2|||
146732836|NCT00118716|529194170|FG000|Overall Study|Investigator discretion|0|||
146732837|NCT00118716|529194171|FG001|Overall Study|Investigator discretion|1|||
146732838|NCT00855062|529194172|FG000|Step1|Early Study Closure|5|||
146732839|NCT00855062|529194173|FG001|Step1|Early Study Closure|7|||
146732840|NCT00855062|529194172|FG000|Step1|Adverse Event|1|||
146732841|NCT00855062|529194173|FG001|Step1|Adverse Event|1|||
146732842|NCT00855062|529194172|FG000|Step1|Protocol Violation|1|||
146732843|NCT00855062|529194173|FG001|Step1|Protocol Violation|0|||
146732844|NCT00855062|529194172|FG000|Step1|Pregnancy|1|||
146732845|NCT00855062|529194173|FG001|Step1|Pregnancy|0|||
146732846|NCT00855062|529194172|FG000|Step1|Withdrawal by Subject|2|||
146732847|NCT00855062|529194173|FG001|Step1|Withdrawal by Subject|3|||
146732848|NCT00855062|529194172|FG000|Step2|Early Study Closure|6|||
146732849|NCT00855062|529194173|FG001|Step2|Early Study Closure|2|||
146732850|NCT00855062|529194172|FG000|Step2|Adverse Event|0|||
146732851|NCT00855062|529194173|FG001|Step2|Adverse Event|3|||
146732852|NCT00855062|529194172|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
146732853|NCT00855062|529194173|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
146732854|NCT00454571|529194179|FG000|Overall Study|Adverse Event|2|||
146732855|NCT00454571|529194180|FG001|Overall Study|Adverse Event|0|||
146732856|NCT00454571|529194179|FG000|Overall Study|Physician Decision|0|||
146732857|NCT00454571|529194180|FG001|Overall Study|Physician Decision|1|||
146732858|NCT00454571|529194179|FG000|Overall Study|Protocol Violation|1|||
146732859|NCT00454571|529194180|FG001|Overall Study|Protocol Violation|0|||
146732860|NCT00454571|529194179|FG000|Overall Study|Withdrawal by Subject|10|||
146732861|NCT00454571|529194180|FG001|Overall Study|Withdrawal by Subject|5|||
146732862|NCT01376323|529194181|FG000|Overall Study|Adverse Event|1|||
146732863|NCT01376323|529194182|FG001|Overall Study|Adverse Event|0|||
146732864|NCT01376323|529194183|FG002|Overall Study|Adverse Event|0|||
146732865|NCT01376323|529194184|FG003|Overall Study|Adverse Event|2|||
146732866|NCT01376323|529194185|FG004|Overall Study|Adverse Event|0|||
146732867|NCT01376323|529194181|FG000|Overall Study|Lost to Follow-up|0|||
146732868|NCT01376323|529194182|FG001|Overall Study|Lost to Follow-up|0|||
146732869|NCT01376323|529194183|FG002|Overall Study|Lost to Follow-up|0|||
146732870|NCT01376323|529194184|FG003|Overall Study|Lost to Follow-up|2|||
146732871|NCT01376323|529194185|FG004|Overall Study|Lost to Follow-up|0|||
146732872|NCT01376323|529194181|FG000|Overall Study|Physician Decision|1|||
146732873|NCT01376323|529194182|FG001|Overall Study|Physician Decision|0|||
146732874|NCT01376323|529194183|FG002|Overall Study|Physician Decision|2|||
146732875|NCT01376323|529194184|FG003|Overall Study|Physician Decision|1|||
146732876|NCT01376323|529194185|FG004|Overall Study|Physician Decision|1|||
146732877|NCT01376323|529194181|FG000|Overall Study|Withdrawal by Subject|0|||
146732878|NCT01376323|529194182|FG001|Overall Study|Withdrawal by Subject|1|||
146732879|NCT01376323|529194183|FG002|Overall Study|Withdrawal by Subject|1|||
146732880|NCT01376323|529194184|FG003|Overall Study|Withdrawal by Subject|0|||
146732881|NCT01376323|529194185|FG004|Overall Study|Withdrawal by Subject|0|||
146732882|NCT04681729|529194186|FG000|Overall Study|Lack of Efficacy|2|||
146732883|NCT04681729|529194187|FG001|Overall Study|Lack of Efficacy|2|||
146732884|NCT04681729|529194186|FG000|Overall Study|Withdrawal by Subject|8|||
146732885|NCT04681729|529194187|FG001|Overall Study|Withdrawal by Subject|9|||
146732886|NCT02436811|529194188|FG000|Overall Study|Lost to Follow-up|2|||
146732887|NCT02436811|529194189|FG001|Overall Study|Lost to Follow-up|9|||
146732888|NCT02436811|529194190|FG002|Overall Study|Lost to Follow-up|7|||
146732889|NCT03595332|529194191|FG000|Overall Study|Lost to Follow-up|16|||
146732890|NCT03595332|529194192|FG001|Overall Study|Lost to Follow-up|22|||
146732891|NCT03595332|529194191|FG000|Overall Study|Unable to retrieve ID from school|0|||
146732892|NCT03595332|529194192|FG001|Overall Study|Unable to retrieve ID from school|2|||
146732893|NCT02227875|529194193|FG000|Overall Study|Protocol Violation|10|||
146732894|NCT02227875|529194194|FG001|Overall Study|Protocol Violation|7|||
146732895|NCT02227875|529194193|FG000|Overall Study|Other|1|||
146732896|NCT02227875|529194194|FG001|Overall Study|Other|3|||
146732897|NCT02227875|529194193|FG000|Overall Study|Physician Decision|1|||
146732898|NCT02227875|529194194|FG001|Overall Study|Physician Decision|0|||
146732899|NCT02227875|529194193|FG000|Overall Study|Adverse Event|3|||
146732900|NCT02227875|529194194|FG001|Overall Study|Adverse Event|0|||
146732901|NCT02227875|529194193|FG000|Overall Study|Withdrawal by Subject|12|||
146732902|NCT02227875|529194194|FG001|Overall Study|Withdrawal by Subject|13|||
146732903|NCT02227875|529194193|FG000|Overall Study|Lost to Follow-up|10|||
146732904|NCT02227875|529194194|FG001|Overall Study|Lost to Follow-up|10|||
146732905|NCT04209725|529194195|FG000|Overall Study|Adverse Event|1|||
146732906|NCT02657317|529194198|FG000|Overall Study|Withdrawal by Subject|2|||
146732907|NCT02657317|529194199|FG001|Overall Study|Withdrawal by Subject|0|||
146732908|NCT02657317|529194198|FG000|Overall Study|Lost to Follow-up|3|||
146732909|NCT02657317|529194199|FG001|Overall Study|Lost to Follow-up|3|||
146732910|NCT02856113|529194200|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
146732911|NCT02856113|529194201|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
146732912|NCT02856113|529194200|FG000|Overall Study|Significant Protocol Deviation|1|||
146732913|NCT02856113|529194201|FG001|Overall Study|Significant Protocol Deviation|0|||
146732914|NCT02856113|529194200|FG000|Overall Study|Lost to Follow-up|3|||
146732915|NCT02856113|529194201|FG001|Overall Study|Lost to Follow-up|5|||
146732916|NCT02856113|529194200|FG000|Overall Study|Voluntary Withdrawal|3|||
146732917|NCT02856113|529194201|FG001|Overall Study|Voluntary Withdrawal|5|||
146732918|NCT02856113|529194200|FG000|Overall Study|Pregnancy|0|||
146732919|NCT02856113|529194201|FG001|Overall Study|Pregnancy|1|||
146732920|NCT02856113|529194200|FG000|Overall Study|Principal Investigator Discretion|2|||
146732921|NCT02856113|529194201|FG001|Overall Study|Principal Investigator Discretion|1|||
146732922|NCT02856113|529194200|FG000|Overall Study|Randomized but not Treated|1|||
146732923|NCT02856113|529194201|FG001|Overall Study|Randomized but not Treated|0|||
146732924|NCT02856113|529194200|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
146732925|NCT02856113|529194201|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
146732926|NCT03494166|529194202|FG000|Overall Study|Death|0|||
146732927|NCT03494166|529194203|FG001|Overall Study|Death|0|||
146732928|NCT03494166|529194204|FG002|Overall Study|Death|0|||
146732929|NCT03494166|529194205|FG003|Overall Study|Death|1|||
146732930|NCT03494166|529194206|FG004|Overall Study|Death|3|||
146732931|NCT03494166|529194207|FG005|Overall Study|Death|0|||
146732932|NCT03494166|529194202|FG000|Overall Study|Lost to Follow-up|2|||
146732933|NCT03494166|529194203|FG001|Overall Study|Lost to Follow-up|2|||
146732934|NCT03494166|529194204|FG002|Overall Study|Lost to Follow-up|2|||
146732935|NCT03494166|529194205|FG003|Overall Study|Lost to Follow-up|2|||
146732936|NCT03494166|529194206|FG004|Overall Study|Lost to Follow-up|14|||
146732937|NCT03494166|529194207|FG005|Overall Study|Lost to Follow-up|0|||
146732938|NCT03494166|529194202|FG000|Overall Study|Withdrawal by Subject|10|||
146938783|NCT00970268|529932524|FG001|Overall Study|Lost to Follow-up|2|||
146732939|NCT03494166|529194203|FG001|Overall Study|Withdrawal by Subject|7|||
146732940|NCT03494166|529194204|FG002|Overall Study|Withdrawal by Subject|0|||
146732941|NCT03494166|529194205|FG003|Overall Study|Withdrawal by Subject|5|||
146732942|NCT03494166|529194206|FG004|Overall Study|Withdrawal by Subject|3|||
146732943|NCT03494166|529194207|FG005|Overall Study|Withdrawal by Subject|17|||
146732944|NCT03494166|529194202|FG000|Overall Study|Screen failure|1|||
146732945|NCT03494166|529194203|FG001|Overall Study|Screen failure|0|||
146732946|NCT03494166|529194204|FG002|Overall Study|Screen failure|0|||
146938784|NCT00970268|529932523|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
146732947|NCT03494166|529194205|FG003|Overall Study|Screen failure|0|||
146732948|NCT03494166|529194206|FG004|Overall Study|Screen failure|1|||
146732949|NCT03494166|529194207|FG005|Overall Study|Screen failure|0|||
146732950|NCT01960725|529194208|FG000|Overall Study|Lost to Follow-up|4|||
146732951|NCT01960725|529194209|FG001|Overall Study|Lost to Follow-up|3|||
146732952|NCT01960725|529194208|FG000|Overall Study|Withdrawal by Subject|1|||
146732953|NCT01960725|529194209|FG001|Overall Study|Withdrawal by Subject|0|||
146732954|NCT01960725|529194208|FG000|Overall Study|unable to obtain blood sample|1|||
146732955|NCT01960725|529194209|FG001|Overall Study|unable to obtain blood sample|2|||
146732956|NCT00855595|529194211|FG000|Overall Study|Withdrawal by Subject|1|||
146732957|NCT00855595|529194212|FG001|Overall Study|Withdrawal by Subject|2|||
146732958|NCT00855595|529194211|FG000|Overall Study|Lost to Follow-up|3|||
146732959|NCT00855595|529194212|FG001|Overall Study|Lost to Follow-up|3|||
146732960|NCT00855595|529194211|FG000|Overall Study|Adverse Event|1|||
146732961|NCT00855595|529194212|FG001|Overall Study|Adverse Event|1|||
146732962|NCT00855595|529194211|FG000|Overall Study|patient moved out of state|1|||
146732963|NCT00855595|529194212|FG001|Overall Study|patient moved out of state|0|||
146732964|NCT00855595|529194211|FG000|Overall Study|patient left country|0|||
146732965|NCT00855595|529194212|FG001|Overall Study|patient left country|1|||
146732966|NCT01780935|529194213|FG000|Overall Study|Admin problems due to early termination|321|||
146732967|NCT01780935|529194214|FG001|Overall Study|Admin problems due to early termination|309|||
146732968|NCT01780935|529194213|FG000|Overall Study|Adverse Event|2|||
146732969|NCT01780935|529194214|FG001|Overall Study|Adverse Event|4|||
146732970|NCT01780935|529194213|FG000|Overall Study|Death|1|||
146732971|NCT01780935|529194214|FG001|Overall Study|Death|6|||
146732972|NCT01780935|529194213|FG000|Overall Study|Lost to Follow-up|2|||
146732973|NCT01780935|529194214|FG001|Overall Study|Lost to Follow-up|6|||
146732974|NCT01780935|529194213|FG000|Overall Study|Physician Decision|1|||
146732975|NCT01780935|529194214|FG001|Overall Study|Physician Decision|1|||
146732976|NCT01780935|529194213|FG000|Overall Study|Protocol deviation|0|||
146732977|NCT01780935|529194214|FG001|Overall Study|Protocol deviation|1|||
146732978|NCT01780935|529194213|FG000|Overall Study|Patient withdrew consent|8|||
146732979|NCT01780935|529194214|FG001|Overall Study|Patient withdrew consent|9|||
146732980|NCT01844284|529194215|FG000|Overall Study|Lost to Follow-up|12|||
146732981|NCT01844284|529194216|FG001|Overall Study|Lost to Follow-up|7|||
146732982|NCT02755597|529194218|FG000|Overall Study|Withdrew consent|27|||
146732983|NCT02755597|529194219|FG001|Overall Study|Withdrew consent|11|||
146732984|NCT02755597|529194218|FG000|Overall Study|Lost to Follow-up|1|||
146732985|NCT02755597|529194219|FG001|Overall Study|Lost to Follow-up|0|||
146732986|NCT02755597|529194218|FG000|Overall Study|Death|78|||
146732987|NCT02755597|529194219|FG001|Overall Study|Death|36|||
146732988|NCT02755597|529194218|FG000|Overall Study|Study terminated by Sponsor|67|||
146732989|NCT02755597|529194219|FG001|Overall Study|Study terminated by Sponsor|47|||
146732990|NCT02755597|529194218|FG000|Overall Study|Other, not specified|20|||
146732991|NCT02755597|529194219|FG001|Overall Study|Other, not specified|3|||
146732992|NCT02755597|529194218|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
146732993|NCT02755597|529194219|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
146732994|NCT01591382|529194220|FG000|Overall Study|Discharged Prior to Study Completion|2|||
146732995|NCT01591382|529194221|FG001|Overall Study|Discharged Prior to Study Completion|1|||
146732996|NCT01591382|529194220|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
146732997|NCT01591382|529194221|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
146732998|NCT01089374|529194222|FG000|Overall Study|Lost to Follow-up|3|||
146732999|NCT01089374|529194223|FG001|Overall Study|Lost to Follow-up|0|||
146733000|NCT01089374|529194222|FG000|Overall Study|Withdrawal by Subject|1|||
146733001|NCT01089374|529194223|FG001|Overall Study|Withdrawal by Subject|0|||
146733002|NCT01089374|529194222|FG000|Overall Study|Study closed early - low accrual|6|||
146733003|NCT01089374|529194223|FG001|Overall Study|Study closed early - low accrual|0|||
146733004|NCT04252742|529194231|FG000|Overall Study|Decision by sponsor|0|||
146733005|NCT04252742|529194232|FG001|Overall Study|Decision by sponsor|2|||
146733006|NCT04252742|529194231|FG000|Overall Study|Withdrawal by Subject|15|||
146733007|NCT04252742|529194232|FG001|Overall Study|Withdrawal by Subject|9|||
146733008|NCT04252742|529194231|FG000|Overall Study|Lost to Follow-up|0|||
146733009|NCT04252742|529194232|FG001|Overall Study|Lost to Follow-up|1|||
146733010|NCT04179032|529194233|FG000|Part B (Up to Week 52)|Adverse Event|1|||
146733011|NCT04179032|529194233|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
146733012|NCT04179032|529194233|FG000|Access Extension Phase|Ongoing|11|||
146733013|NCT00698646|529194240|FG000|Overall Study|Adverse Event|8|||
146733014|NCT00698646|529194241|FG001|Overall Study|Adverse Event|7|||
146733015|NCT00698646|529194242|FG002|Overall Study|Adverse Event|8|||
146791900|NCT03088878|529411330|FG012|Overall Study|Adverse Event|5|||
146733016|NCT00698646|529194240|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
146733017|NCT00698646|529194241|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
146733018|NCT00698646|529194242|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
146733019|NCT00698646|529194240|FG000|Overall Study|Protocol Deviation|6|||
146733020|NCT00698646|529194241|FG001|Overall Study|Protocol Deviation|2|||
146733021|NCT00698646|529194242|FG002|Overall Study|Protocol Deviation|3|||
146733022|NCT00698646|529194240|FG000|Overall Study|Withdrawal by Subject|10|||
146733023|NCT00698646|529194241|FG001|Overall Study|Withdrawal by Subject|11|||
146733024|NCT00698646|529194242|FG002|Overall Study|Withdrawal by Subject|8|||
146733025|NCT00698646|529194240|FG000|Overall Study|Lost to Follow-up|0|||
146733026|NCT00698646|529194241|FG001|Overall Study|Lost to Follow-up|0|||
146733027|NCT00698646|529194242|FG002|Overall Study|Lost to Follow-up|2|||
146733028|NCT00698646|529194240|FG000|Overall Study|Administrative problems|1|||
146733029|NCT00698646|529194241|FG001|Overall Study|Administrative problems|0|||
146791901|NCT03088878|529411331|FG013|Overall Study|Adverse Event|3|||
146733030|NCT00698646|529194242|FG002|Overall Study|Administrative problems|1|||
146733031|NCT02390531|529194248|FG000|Overall Study|Death|0|||
146733032|NCT02390531|529194249|FG001|Overall Study|Death|2|||
146733033|NCT02390531|529194250|FG002|Overall Study|Death|0|||
146733034|NCT02390531|529194251|FG003|Overall Study|Death|1|||
146733035|NCT02390531|529194252|FG004|Overall Study|Death|0|||
146733036|NCT02390531|529194253|FG005|Overall Study|Death|0|||
146733037|NCT02390531|529194254|FG006|Overall Study|Death|0|||
146733038|NCT02390531|529194255|FG007|Overall Study|Death|1|||
146733039|NCT02390531|529194248|FG000|Overall Study|Protocol Violation|0|||
146733040|NCT02390531|529194249|FG001|Overall Study|Protocol Violation|0|||
146733041|NCT02390531|529194250|FG002|Overall Study|Protocol Violation|0|||
146733042|NCT02390531|529194251|FG003|Overall Study|Protocol Violation|0|||
146733043|NCT02390531|529194252|FG004|Overall Study|Protocol Violation|1|||
146733044|NCT02390531|529194253|FG005|Overall Study|Protocol Violation|0|||
146733045|NCT02390531|529194254|FG006|Overall Study|Protocol Violation|2|||
146733046|NCT02390531|529194255|FG007|Overall Study|Protocol Violation|0|||
146733047|NCT00511875|529194256|FG000|Overall Study|Lost to Follow-up|4|||
146733048|NCT00511875|529194257|FG001|Overall Study|Lost to Follow-up|0|||
146733049|NCT00511875|529194256|FG000|Overall Study|Missing variables|1|||
146733050|NCT00511875|529194257|FG001|Overall Study|Missing variables|0|||
146733051|NCT02618616|529194258|FG000|Overall Study|Lack of Efficacy|4|||
146733052|NCT02618616|529194259|FG001|Overall Study|Lack of Efficacy|0|||
146733053|NCT02618616|529194258|FG000|Overall Study|Pregnancy|0|||
146733054|NCT02618616|529194259|FG001|Overall Study|Pregnancy|1|||
146733055|NCT02618616|529194258|FG000|Overall Study|Adverse Event|8|||
146733056|NCT02618616|529194259|FG001|Overall Study|Adverse Event|0|||
146733057|NCT02618616|529194258|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
146733058|NCT02618616|529194259|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
146733059|NCT02618616|529194258|FG000|Overall Study|Consent withdrawn by subject|8|||
146733060|NCT02618616|529194259|FG001|Overall Study|Consent withdrawn by subject|5|||
146733061|NCT02618616|529194258|FG000|Overall Study|Lost to Follow-up|0|||
146733062|NCT02618616|529194259|FG001|Overall Study|Lost to Follow-up|1|||
146733063|NCT01951638|529194260|FG000|Treatment Period|Protocol Violation|0|||
146733064|NCT01951638|529194261|FG001|Treatment Period|Protocol Violation|0|||
146733065|NCT01951638|529194262|FG002|Treatment Period|Protocol Violation|0|||
146733066|NCT01951638|529194263|FG003|Treatment Period|Protocol Violation|2|||
146733067|NCT01951638|529194264|FG004|Treatment Period|Protocol Violation|0|||
146733068|NCT01951638|529194260|FG000|Treatment Period|Protocol-driven decision point|1|||
146733069|NCT01951638|529194261|FG001|Treatment Period|Protocol-driven decision point|3|||
146733070|NCT01951638|529194262|FG002|Treatment Period|Protocol-driven decision point|0|||
146733071|NCT01951638|529194263|FG003|Treatment Period|Protocol-driven decision point|0|||
146733072|NCT01951638|529194264|FG004|Treatment Period|Protocol-driven decision point|0|||
146733073|NCT01951638|529194260|FG000|Treatment Period|Logistical difficulties|0|||
146733074|NCT01951638|529194261|FG001|Treatment Period|Logistical difficulties|1|||
146733075|NCT01951638|529194262|FG002|Treatment Period|Logistical difficulties|1|||
146733076|NCT01951638|529194263|FG003|Treatment Period|Logistical difficulties|0|||
146733077|NCT01951638|529194264|FG004|Treatment Period|Logistical difficulties|0|||
146733078|NCT01951638|529194260|FG000|Treatment Period|Withdrawal by Subject|9|||
146733079|NCT01951638|529194261|FG001|Treatment Period|Withdrawal by Subject|6|||
146733080|NCT01951638|529194262|FG002|Treatment Period|Withdrawal by Subject|4|||
146733081|NCT01951638|529194263|FG003|Treatment Period|Withdrawal by Subject|5|||
146791902|NCT03088878|529411318|FG000|Overall Study|Clinical Progression|0|||
146791903|NCT03088878|529411319|FG001|Overall Study|Clinical Progression|0|||
146791904|NCT03088878|529411320|FG002|Overall Study|Clinical Progression|0|||
146791905|NCT03088878|529411321|FG003|Overall Study|Clinical Progression|0|||
146791906|NCT03088878|529411322|FG004|Overall Study|Clinical Progression|2|||
146982154|NCT04128696|530096220|FG001|Overall Study|Withdrawal by Subject|11|||
146733082|NCT01951638|529194264|FG004|Treatment Period|Withdrawal by Subject|4|||
146733083|NCT01951638|529194260|FG000|Treatment Period|Death|0|||
146733084|NCT01951638|529194261|FG001|Treatment Period|Death|0|||
146733085|NCT01951638|529194262|FG002|Treatment Period|Death|0|||
146733086|NCT01951638|529194263|FG003|Treatment Period|Death|3|||
146733087|NCT01951638|529194264|FG004|Treatment Period|Death|1|||
146733088|NCT01951638|529194260|FG000|Treatment Period|Adverse Event|3|||
146733089|NCT01951638|529194261|FG001|Treatment Period|Adverse Event|4|||
146733090|NCT01951638|529194262|FG002|Treatment Period|Adverse Event|8|||
146733091|NCT01951638|529194263|FG003|Treatment Period|Adverse Event|6|||
146733092|NCT01951638|529194264|FG004|Treatment Period|Adverse Event|5|||
146791907|NCT03088878|529411323|FG005|Overall Study|Clinical Progression|0|||
146982155|NCT04128696|530096219|FG000|Overall Study|Study Closed/Terminated|26|||
146733093|NCT01951638|529194260|FG000|Follow-up Period|Protocol Violation|0|||
146733094|NCT01951638|529194261|FG001|Follow-up Period|Protocol Violation|0|||
146733095|NCT01951638|529194262|FG002|Follow-up Period|Protocol Violation|0|||
146733096|NCT01951638|529194263|FG003|Follow-up Period|Protocol Violation|1|||
146733097|NCT01951638|529194264|FG004|Follow-up Period|Protocol Violation|0|||
146733098|NCT01951638|529194260|FG000|Follow-up Period|Logistical difficulties|0|||
146733099|NCT01951638|529194261|FG001|Follow-up Period|Logistical difficulties|2|||
146791908|NCT03088878|529411324|FG006|Overall Study|Clinical Progression|0|||
146791909|NCT03088878|529411325|FG007|Overall Study|Clinical Progression|0|||
146791910|NCT03088878|529411326|FG008|Overall Study|Clinical Progression|0|||
146791911|NCT03088878|529411327|FG009|Overall Study|Clinical Progression|0|||
146791912|NCT03088878|529411328|FG010|Overall Study|Clinical Progression|0|||
146791913|NCT03088878|529411329|FG011|Overall Study|Clinical Progression|0|||
146791914|NCT03088878|529411330|FG012|Overall Study|Clinical Progression|0|||
146791915|NCT03088878|529411331|FG013|Overall Study|Clinical Progression|0|||
146791916|NCT03088878|529411318|FG000|Overall Study|Death|0|||
146791917|NCT03088878|529411319|FG001|Overall Study|Death|0|||
146791918|NCT03088878|529411320|FG002|Overall Study|Death|0|||
146791919|NCT03088878|529411321|FG003|Overall Study|Death|0|||
146791920|NCT03088878|529411322|FG004|Overall Study|Death|2|||
146791921|NCT03088878|529411323|FG005|Overall Study|Death|0|||
146791922|NCT03088878|529411324|FG006|Overall Study|Death|0|||
146791923|NCT03088878|529411325|FG007|Overall Study|Death|0|||
146791924|NCT03088878|529411326|FG008|Overall Study|Death|0|||
146791925|NCT03088878|529411327|FG009|Overall Study|Death|0|||
146791926|NCT03088878|529411328|FG010|Overall Study|Death|0|||
146791927|NCT03088878|529411329|FG011|Overall Study|Death|1|||
146791928|NCT03088878|529411330|FG012|Overall Study|Death|0|||
146791929|NCT03088878|529411331|FG013|Overall Study|Death|0|||
146791930|NCT03088878|529411318|FG000|Overall Study|Disease Progression|1|||
146791931|NCT03088878|529411319|FG001|Overall Study|Disease Progression|2|||
146791932|NCT03088878|529411320|FG002|Overall Study|Disease Progression|3|||
146791933|NCT03088878|529411321|FG003|Overall Study|Disease Progression|0|||
146791934|NCT03088878|529411322|FG004|Overall Study|Disease Progression|3|||
146791935|NCT03088878|529411323|FG005|Overall Study|Disease Progression|0|||
146791936|NCT03088878|529411324|FG006|Overall Study|Disease Progression|0|||
146791937|NCT03088878|529411325|FG007|Overall Study|Disease Progression|0|||
146791938|NCT03088878|529411326|FG008|Overall Study|Disease Progression|0|||
146791939|NCT03088878|529411327|FG009|Overall Study|Disease Progression|0|||
146791940|NCT03088878|529411328|FG010|Overall Study|Disease Progression|0|||
146791941|NCT03088878|529411329|FG011|Overall Study|Disease Progression|0|||
146791942|NCT03088878|529411330|FG012|Overall Study|Disease Progression|1|||
146791943|NCT03088878|529411331|FG013|Overall Study|Disease Progression|1|||
146791944|NCT03088878|529411318|FG000|Overall Study|Initiation of Alternative Treatment|0|||
146791945|NCT03088878|529411319|FG001|Overall Study|Initiation of Alternative Treatment|0|||
146791946|NCT03088878|529411320|FG002|Overall Study|Initiation of Alternative Treatment|0|||
146791947|NCT03088878|529411321|FG003|Overall Study|Initiation of Alternative Treatment|1|||
146791948|NCT03088878|529411322|FG004|Overall Study|Initiation of Alternative Treatment|0|||
146791949|NCT03088878|529411323|FG005|Overall Study|Initiation of Alternative Treatment|0|||
146791950|NCT03088878|529411324|FG006|Overall Study|Initiation of Alternative Treatment|0|||
146791951|NCT03088878|529411325|FG007|Overall Study|Initiation of Alternative Treatment|1|||
146791952|NCT03088878|529411326|FG008|Overall Study|Initiation of Alternative Treatment|1|||
146791953|NCT03088878|529411327|FG009|Overall Study|Initiation of Alternative Treatment|0|||
146791954|NCT03088878|529411328|FG010|Overall Study|Initiation of Alternative Treatment|0|||
146791955|NCT03088878|529411329|FG011|Overall Study|Initiation of Alternative Treatment|0|||
146791956|NCT03088878|529411330|FG012|Overall Study|Initiation of Alternative Treatment|0|||
146791957|NCT03088878|529411331|FG013|Overall Study|Initiation of Alternative Treatment|0|||
146791958|NCT03088878|529411318|FG000|Overall Study|Withdrawal by Subject|0|||
146791959|NCT03088878|529411319|FG001|Overall Study|Withdrawal by Subject|0|||
146791960|NCT03088878|529411320|FG002|Overall Study|Withdrawal by Subject|0|||
146791961|NCT03088878|529411321|FG003|Overall Study|Withdrawal by Subject|1|||
146791962|NCT03088878|529411322|FG004|Overall Study|Withdrawal by Subject|4|||
146791963|NCT03088878|529411323|FG005|Overall Study|Withdrawal by Subject|1|||
146791964|NCT03088878|529411324|FG006|Overall Study|Withdrawal by Subject|1|||
146791965|NCT03088878|529411325|FG007|Overall Study|Withdrawal by Subject|0|||
146791966|NCT03088878|529411326|FG008|Overall Study|Withdrawal by Subject|1|||
146791967|NCT03088878|529411327|FG009|Overall Study|Withdrawal by Subject|2|||
146791968|NCT03088878|529411328|FG010|Overall Study|Withdrawal by Subject|0|||
146791969|NCT03088878|529411329|FG011|Overall Study|Withdrawal by Subject|2|||
146791970|NCT03088878|529411330|FG012|Overall Study|Withdrawal by Subject|1|||
146791971|NCT03088878|529411331|FG013|Overall Study|Withdrawal by Subject|0|||
146791972|NCT03088878|529411318|FG000|Overall Study|Terminated by Sponsor|2|||
146791973|NCT03088878|529411319|FG001|Overall Study|Terminated by Sponsor|1|||
146791974|NCT03088878|529411320|FG002|Overall Study|Terminated by Sponsor|0|||
146791975|NCT03088878|529411321|FG003|Overall Study|Terminated by Sponsor|1|||
146791976|NCT03088878|529411322|FG004|Overall Study|Terminated by Sponsor|6|||
146791977|NCT03088878|529411323|FG005|Overall Study|Terminated by Sponsor|0|||
146791978|NCT03088878|529411324|FG006|Overall Study|Terminated by Sponsor|0|||
146791979|NCT03088878|529411325|FG007|Overall Study|Terminated by Sponsor|0|||
146791980|NCT03088878|529411326|FG008|Overall Study|Terminated by Sponsor|0|||
146791981|NCT03088878|529411327|FG009|Overall Study|Terminated by Sponsor|0|||
146791982|NCT03088878|529411328|FG010|Overall Study|Terminated by Sponsor|3|||
146791983|NCT03088878|529411329|FG011|Overall Study|Terminated by Sponsor|13|||
146791984|NCT03088878|529411330|FG012|Overall Study|Terminated by Sponsor|2|||
146791985|NCT03088878|529411331|FG013|Overall Study|Terminated by Sponsor|1|||
146791986|NCT03088878|529411318|FG000|Overall Study|Completed 2 years of Treatment|0|||
146791987|NCT03088878|529411319|FG001|Overall Study|Completed 2 years of Treatment|0|||
146791988|NCT03088878|529411320|FG002|Overall Study|Completed 2 years of Treatment|0|||
146791989|NCT03088878|529411321|FG003|Overall Study|Completed 2 years of Treatment|0|||
146791990|NCT03088878|529411322|FG004|Overall Study|Completed 2 years of Treatment|0|||
146791991|NCT03088878|529411323|FG005|Overall Study|Completed 2 years of Treatment|0|||
146791992|NCT03088878|529411324|FG006|Overall Study|Completed 2 years of Treatment|1|||
146791993|NCT03088878|529411325|FG007|Overall Study|Completed 2 years of Treatment|0|||
146791994|NCT03088878|529411326|FG008|Overall Study|Completed 2 years of Treatment|0|||
146791995|NCT03088878|529411327|FG009|Overall Study|Completed 2 years of Treatment|1|||
146791996|NCT03088878|529411328|FG010|Overall Study|Completed 2 years of Treatment|0|||
146791997|NCT03088878|529411329|FG011|Overall Study|Completed 2 years of Treatment|0|||
146791998|NCT03088878|529411330|FG012|Overall Study|Completed 2 years of Treatment|8|||
146791999|NCT03088878|529411331|FG013|Overall Study|Completed 2 years of Treatment|3|||
146792000|NCT03088878|529411318|FG000|Overall Study|Physician Decision|0|||
146792001|NCT03088878|529411319|FG001|Overall Study|Physician Decision|0|||
146792002|NCT03088878|529411320|FG002|Overall Study|Physician Decision|0|||
146792003|NCT03088878|529411321|FG003|Overall Study|Physician Decision|0|||
146792004|NCT03088878|529411322|FG004|Overall Study|Physician Decision|0|||
146792005|NCT03088878|529411323|FG005|Overall Study|Physician Decision|0|||
146792006|NCT03088878|529411324|FG006|Overall Study|Physician Decision|0|||
146792007|NCT03088878|529411325|FG007|Overall Study|Physician Decision|2|||
146792008|NCT03088878|529411326|FG008|Overall Study|Physician Decision|1|||
146792009|NCT03088878|529411327|FG009|Overall Study|Physician Decision|0|||
146792010|NCT03088878|529411328|FG010|Overall Study|Physician Decision|0|||
146792011|NCT03088878|529411329|FG011|Overall Study|Physician Decision|0|||
146792012|NCT03088878|529411330|FG012|Overall Study|Physician Decision|0|||
146792013|NCT03088878|529411331|FG013|Overall Study|Physician Decision|1|||
146792014|NCT03088878|529411318|FG000|Overall Study|COVID Related noncompliance|0|||
146792015|NCT03088878|529411319|FG001|Overall Study|COVID Related noncompliance|0|||
146792016|NCT03088878|529411320|FG002|Overall Study|COVID Related noncompliance|0|||
146792017|NCT03088878|529411321|FG003|Overall Study|COVID Related noncompliance|0|||
146792018|NCT03088878|529411322|FG004|Overall Study|COVID Related noncompliance|0|||
146792019|NCT03088878|529411323|FG005|Overall Study|COVID Related noncompliance|0|||
146792020|NCT03088878|529411324|FG006|Overall Study|COVID Related noncompliance|0|||
146792021|NCT03088878|529411325|FG007|Overall Study|COVID Related noncompliance|0|||
146792022|NCT03088878|529411326|FG008|Overall Study|COVID Related noncompliance|0|||
146792023|NCT03088878|529411327|FG009|Overall Study|COVID Related noncompliance|0|||
146792024|NCT03088878|529411328|FG010|Overall Study|COVID Related noncompliance|0|||
146792025|NCT03088878|529411329|FG011|Overall Study|COVID Related noncompliance|0|||
146792026|NCT03088878|529411330|FG012|Overall Study|COVID Related noncompliance|0|||
146792027|NCT03088878|529411331|FG013|Overall Study|COVID Related noncompliance|1|||
146792028|NCT03088878|529411318|FG000|Overall Study|Drug or Study Noncompliance|0|||
146792029|NCT03088878|529411319|FG001|Overall Study|Drug or Study Noncompliance|0|||
146792030|NCT03088878|529411320|FG002|Overall Study|Drug or Study Noncompliance|0|||
146792031|NCT03088878|529411321|FG003|Overall Study|Drug or Study Noncompliance|0|||
146792032|NCT03088878|529411322|FG004|Overall Study|Drug or Study Noncompliance|0|||
146792033|NCT03088878|529411323|FG005|Overall Study|Drug or Study Noncompliance|0|||
146792034|NCT03088878|529411324|FG006|Overall Study|Drug or Study Noncompliance|0|||
146792035|NCT03088878|529411325|FG007|Overall Study|Drug or Study Noncompliance|0|||
146792036|NCT03088878|529411326|FG008|Overall Study|Drug or Study Noncompliance|0|||
146792037|NCT03088878|529411327|FG009|Overall Study|Drug or Study Noncompliance|0|||
146792038|NCT03088878|529411328|FG010|Overall Study|Drug or Study Noncompliance|0|||
146792039|NCT03088878|529411329|FG011|Overall Study|Drug or Study Noncompliance|0|||
146792040|NCT03088878|529411330|FG012|Overall Study|Drug or Study Noncompliance|1|||
146792041|NCT03088878|529411331|FG013|Overall Study|Drug or Study Noncompliance|0|||
146792042|NCT02724969|529411332|FG000|Overall Study|Lost to Follow-up|12|||
146792043|NCT02724969|529411333|FG001|Overall Study|Lost to Follow-up|6|||
146792044|NCT02724969|529411332|FG000|Overall Study|Withdrawal by Subject|3|||
146792045|NCT02724969|529411333|FG001|Overall Study|Withdrawal by Subject|3|||
146792046|NCT02724969|529411332|FG000|Overall Study|Infant demise|0|||
146792047|NCT02724969|529411333|FG001|Overall Study|Infant demise|2|||
146792048|NCT03362476|529411334|FG000|Overall Study|Withdrawal by Subject|0|||
146792049|NCT03362476|529411335|FG001|Overall Study|Withdrawal by Subject|1|||
146792050|NCT01236781|529411339|FG000|Overall Study|Ineligible|2|||
146792051|NCT01236781|529411340|FG001|Overall Study|Ineligible|1|||
146792052|NCT01236781|529411339|FG000|Overall Study|Did not complete study imaging|5|||
146792053|NCT01236781|529411340|FG001|Overall Study|Did not complete study imaging|0|||
146792054|NCT04577963|529411341|FG000|Part 2|Death|0|||
146792055|NCT04577963|529411342|FG001|Part 2|Death|1|||
146792056|NCT04577963|529411343|FG002|Part 2|Death|8|||
146792057|NCT04577963|529411344|FG003|Part 2|Death|0|||
146792058|NCT04577963|529411345|FG004|Part 2|Death|20|||
146792059|NCT04577963|529411341|FG000|Part 2|Lost to Follow-up|0|||
146792060|NCT04577963|529411342|FG001|Part 2|Lost to Follow-up|0|||
146792061|NCT04577963|529411343|FG002|Part 2|Lost to Follow-up|0|||
146733100|NCT01951638|529194262|FG002|Follow-up Period|Logistical difficulties|0|||
146733101|NCT01951638|529194263|FG003|Follow-up Period|Logistical difficulties|0|||
146733102|NCT01951638|529194264|FG004|Follow-up Period|Logistical difficulties|1|||
146733103|NCT01951638|529194260|FG000|Follow-up Period|Withdrawal by Subject|1|||
146733104|NCT01951638|529194261|FG001|Follow-up Period|Withdrawal by Subject|5|||
146733105|NCT01951638|529194262|FG002|Follow-up Period|Withdrawal by Subject|2|||
146733106|NCT01951638|529194263|FG003|Follow-up Period|Withdrawal by Subject|1|||
146733107|NCT01951638|529194264|FG004|Follow-up Period|Withdrawal by Subject|2|||
146733108|NCT01951638|529194260|FG000|Follow-up Period|Lost to Follow-up|0|||
146733109|NCT01951638|529194261|FG001|Follow-up Period|Lost to Follow-up|1|||
146733110|NCT01951638|529194262|FG002|Follow-up Period|Lost to Follow-up|0|||
146733111|NCT01951638|529194263|FG003|Follow-up Period|Lost to Follow-up|1|||
146733112|NCT01951638|529194264|FG004|Follow-up Period|Lost to Follow-up|0|||
146733113|NCT01951638|529194260|FG000|Follow-up Period|Death|1|||
146733114|NCT01951638|529194261|FG001|Follow-up Period|Death|0|||
146733115|NCT01951638|529194262|FG002|Follow-up Period|Death|1|||
146733116|NCT01951638|529194263|FG003|Follow-up Period|Death|4|||
146733117|NCT01951638|529194264|FG004|Follow-up Period|Death|1|||
146733118|NCT01951638|529194260|FG000|Follow-up Period|Adverse Event|0|||
146733119|NCT01951638|529194261|FG001|Follow-up Period|Adverse Event|1|||
146733120|NCT01951638|529194262|FG002|Follow-up Period|Adverse Event|2|||
146733121|NCT01951638|529194263|FG003|Follow-up Period|Adverse Event|1|||
146733122|NCT01951638|529194264|FG004|Follow-up Period|Adverse Event|1|||
146733123|NCT04225988|529194268|FG000|Overall Study|Withdrawal by Subject|2|||
146733124|NCT04225988|529194269|FG001|Overall Study|Withdrawal by Subject|0|||
146733125|NCT00766675|529195884|FG000|Overall Study|Adverse Event|16|||
146733126|NCT00766675|529195884|FG000|Overall Study|Lost to Follow-up|2|||
146733127|NCT00766675|529195884|FG000|Overall Study|Withdrawal by Subject|11|||
146733128|NCT00766675|529195884|FG000|Overall Study|Protocol Violation|8|||
146733129|NCT00766675|529195884|FG000|Overall Study|Participant took prohibited medication|1|||
146733130|NCT00766675|529195884|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
146733131|NCT00766675|529195884|FG000|Overall Study|Insufficient therapy|1|||
146733132|NCT03308825|529195885|FG000|Overall Study|Lost to Follow-up|2|||
146733133|NCT03308825|529195886|FG001|Overall Study|Lost to Follow-up|2|||
146733134|NCT03308825|529195887|FG002|Overall Study|Lost to Follow-up|1|||
146733135|NCT03308825|529195888|FG003|Overall Study|Lost to Follow-up|0|||
146733136|NCT03308825|529195885|FG000|Overall Study|Protocol Violation|0|||
146733137|NCT03308825|529195886|FG001|Overall Study|Protocol Violation|2|||
146733138|NCT03308825|529195887|FG002|Overall Study|Protocol Violation|0|||
146733139|NCT03308825|529195888|FG003|Overall Study|Protocol Violation|0|||
146733140|NCT02044848|529195889|FG000|Overall Study|Administrative Problems|2|||
146733141|NCT02044848|529195890|FG001|Overall Study|Administrative Problems|3|||
146733142|NCT00045708|529195891|FG000|Phase 1|early progressive disease|0|||
146733143|NCT00045708|529195892|FG001|Phase 1|early progressive disease|1|||
146733144|NCT00045708|529195893|FG002|Phase 1|early progressive disease|0|||
146733145|NCT00685945|529195895|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
146733146|NCT03183388|529195896|FG000|Overall Study|Lost to Follow-up|3|||
146733147|NCT03183388|529195897|FG001|Overall Study|Lost to Follow-up|5|||
146733148|NCT03183388|529195896|FG000|Overall Study|Physician Decision|1|||
146733149|NCT03183388|529195897|FG001|Overall Study|Physician Decision|4|||
146733150|NCT03183388|529195896|FG000|Overall Study|Withdrawal by Subject|4|||
146733151|NCT03183388|529195897|FG001|Overall Study|Withdrawal by Subject|1|||
146733152|NCT03183388|529195896|FG000|Overall Study|Moved|1|||
146733153|NCT03183388|529195897|FG001|Overall Study|Moved|0|||
146733154|NCT03183388|529195896|FG000|Overall Study|Met Exclusion Criteria|2|||
146733155|NCT03183388|529195897|FG001|Overall Study|Met Exclusion Criteria|2|||
146733156|NCT03183388|529195896|FG000|Overall Study|COVID Pandemic Related|2|||
146733157|NCT03183388|529195897|FG001|Overall Study|COVID Pandemic Related|4|||
146733158|NCT01493960|529195900|FG000|Overall Study|Adverse Event|0|||
146733159|NCT01493960|529195901|FG001|Overall Study|Adverse Event|1|||
146733160|NCT01493960|529195900|FG000|Overall Study|Lack of Efficacy|15|||
146733161|NCT01493960|529195901|FG001|Overall Study|Lack of Efficacy|9|||
146733162|NCT01493960|529195900|FG000|Overall Study|Protocol Violation|3|||
146733163|NCT01493960|529195901|FG001|Overall Study|Protocol Violation|0|||
146733164|NCT01493960|529195900|FG000|Overall Study|Withdrawal by Subject|10|||
146733165|NCT01493960|529195901|FG001|Overall Study|Withdrawal by Subject|4|||
146733166|NCT01493960|529195900|FG000|Overall Study|Non-specified|4|||
146733167|NCT01493960|529195901|FG001|Overall Study|Non-specified|4|||
146733168|NCT01679236|529195906|FG000|Overall Study|Lost to Follow-up|15|||
146733169|NCT01679236|529195907|FG001|Overall Study|Lost to Follow-up|15|||
146733170|NCT03935217|529195910|FG000|Overall Study|Adverse Event|1|||
146733171|NCT03935217|529195911|FG001|Overall Study|Adverse Event|0|||
146733172|NCT03935217|529195910|FG000|Overall Study|Lost to Follow-up|0|||
146733173|NCT03935217|529195911|FG001|Overall Study|Lost to Follow-up|1|||
146733174|NCT03935217|529195910|FG000|Overall Study|Withdrawal by Subject|0|||
146733175|NCT03935217|529195911|FG001|Overall Study|Withdrawal by Subject|2|||
146733176|NCT00847405|529195912|FG000|First Intervention|Adverse Event|0|||
146733177|NCT00847405|529195913|FG001|First Intervention|Adverse Event|1|||
146733178|NCT00847405|529195912|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
146733179|NCT00847405|529195913|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
146733180|NCT02259517|529195914|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
146733181|NCT02259517|529195915|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
146733182|NCT02259517|529195916|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
146733183|NCT02259517|529195914|FG000|Overall Study|Withdrawal by Subject|0|||
146733184|NCT02259517|529195915|FG001|Overall Study|Withdrawal by Subject|0|||
146733185|NCT02259517|529195916|FG002|Overall Study|Withdrawal by Subject|3|||
146733196|NCT02305381|529195919|FG000|Overall Study|Unclassified|5|||
146733197|NCT02305381|529195920|FG001|Overall Study|Unclassified|5|||
146792062|NCT04577963|529411344|FG003|Part 2|Lost to Follow-up|0|||
146792063|NCT04577963|529411345|FG004|Part 2|Lost to Follow-up|2|||
146792064|NCT04577963|529411341|FG000|Part 2|Withdrawal by Subject|0|||
146792065|NCT04577963|529411342|FG001|Part 2|Withdrawal by Subject|0|||
146792066|NCT04577963|529411343|FG002|Part 2|Withdrawal by Subject|0|||
146792067|NCT04577963|529411344|FG003|Part 2|Withdrawal by Subject|0|||
146792068|NCT04577963|529411345|FG004|Part 2|Withdrawal by Subject|10|||
146792069|NCT04577963|529411341|FG000|Part 2|Progressive disease|0|||
146792070|NCT04577963|529411342|FG001|Part 2|Progressive disease|0|||
146792071|NCT04577963|529411343|FG002|Part 2|Progressive disease|0|||
146792072|NCT04577963|529411344|FG003|Part 2|Progressive disease|0|||
146792073|NCT04577963|529411345|FG004|Part 2|Progressive disease|2|||
146792074|NCT04577963|529411341|FG000|Part 2|Investigator decision|0|||
146792075|NCT04577963|529411342|FG001|Part 2|Investigator decision|0|||
146792076|NCT04577963|529411343|FG002|Part 2|Investigator decision|0|||
146792077|NCT04577963|529411344|FG003|Part 2|Investigator decision|0|||
146792078|NCT04577963|529411345|FG004|Part 2|Investigator decision|1|||
146792079|NCT04577963|529411341|FG000|Part 2|Sponsor terminated study|0|||
146733198|NCT02305381|529195921|FG002|Overall Study|Unclassified|7|||
146733199|NCT00514683|529195922|FG000|Overall Study|Not treated|2|||
146733200|NCT00514683|529195923|FG001|Overall Study|Not treated|1|||
146733201|NCT00514683|529195924|FG002|Overall Study|Not treated|0|||
146733202|NCT00514683|529195925|FG003|Overall Study|Not treated|0|||
146733203|NCT00514683|529195926|FG004|Overall Study|Not treated|1|||
146733204|NCT00514683|529195922|FG000|Overall Study|Adverse Event|21|||
146733205|NCT00514683|529195923|FG001|Overall Study|Adverse Event|20|||
146733206|NCT00514683|529195924|FG002|Overall Study|Adverse Event|15|||
146733207|NCT00514683|529195925|FG003|Overall Study|Adverse Event|13|||
146733208|NCT00514683|529195926|FG004|Overall Study|Adverse Event|27|||
146733209|NCT00514683|529195922|FG000|Overall Study|Protocol Violation|1|||
146733210|NCT00514683|529195923|FG001|Overall Study|Protocol Violation|1|||
146733211|NCT00514683|529195924|FG002|Overall Study|Protocol Violation|0|||
146733212|NCT00514683|529195925|FG003|Overall Study|Protocol Violation|1|||
146733213|NCT00514683|529195926|FG004|Overall Study|Protocol Violation|0|||
146733214|NCT00514683|529195922|FG000|Overall Study|Withdrawal by Subject|2|||
146733215|NCT00514683|529195923|FG001|Overall Study|Withdrawal by Subject|2|||
146733216|NCT00514683|529195924|FG002|Overall Study|Withdrawal by Subject|1|||
146733217|NCT00514683|529195925|FG003|Overall Study|Withdrawal by Subject|0|||
146733218|NCT00514683|529195926|FG004|Overall Study|Withdrawal by Subject|4|||
146733219|NCT00514683|529195922|FG000|Overall Study|Reason other than listed above|0|||
146733220|NCT00514683|529195923|FG001|Overall Study|Reason other than listed above|1|||
146733221|NCT00514683|529195924|FG002|Overall Study|Reason other than listed above|2|||
146733222|NCT00514683|529195925|FG003|Overall Study|Reason other than listed above|0|||
146733223|NCT00514683|529195926|FG004|Overall Study|Reason other than listed above|1|||
146733224|NCT04998604|529195933|FG000|Overall Study|Adverse Event|3|||
146733225|NCT04998604|529195934|FG001|Overall Study|Adverse Event|2|||
146733226|NCT04998604|529195933|FG000|Overall Study|Withdrawal by Subject|2|||
146733227|NCT04998604|529195934|FG001|Overall Study|Withdrawal by Subject|4|||
146733228|NCT04998604|529195933|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
146733229|NCT04998604|529195934|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
146733230|NCT00642902|529195935|FG000|Overall Study|Adverse Event|0|||
146733231|NCT00642902|529195936|FG001|Overall Study|Adverse Event|1|||
146733232|NCT00642902|529195937|FG002|Overall Study|Adverse Event|3|||
146792080|NCT04577963|529411342|FG001|Part 2|Sponsor terminated study|0|||
146792081|NCT04577963|529411343|FG002|Part 2|Sponsor terminated study|3|||
146792082|NCT04577963|529411344|FG003|Part 2|Sponsor terminated study|1|||
146792083|NCT04577963|529411345|FG004|Part 2|Sponsor terminated study|4|||
146733233|NCT00642902|529195938|FG003|Overall Study|Adverse Event|1|||
146733234|NCT00642902|529195935|FG000|Overall Study|Lost to Follow-up|1|||
146733235|NCT00642902|529195936|FG001|Overall Study|Lost to Follow-up|1|||
146733236|NCT00642902|529195937|FG002|Overall Study|Lost to Follow-up|0|||
146733237|NCT00642902|529195938|FG003|Overall Study|Lost to Follow-up|0|||
146733238|NCT00642902|529195935|FG000|Overall Study|Lack of Efficacy|0|||
146733239|NCT00642902|529195936|FG001|Overall Study|Lack of Efficacy|3|||
146733240|NCT00642902|529195937|FG002|Overall Study|Lack of Efficacy|3|||
146733241|NCT00642902|529195938|FG003|Overall Study|Lack of Efficacy|0|||
146733242|NCT00642902|529195935|FG000|Overall Study|Death|1|||
146733243|NCT00642902|529195936|FG001|Overall Study|Death|0|||
146733244|NCT00642902|529195937|FG002|Overall Study|Death|0|||
146733245|NCT00642902|529195938|FG003|Overall Study|Death|0|||
146733246|NCT00642902|529195935|FG000|Overall Study|Premature termination of clinical trial|37|||
146733247|NCT00642902|529195936|FG001|Overall Study|Premature termination of clinical trial|32|||
146733248|NCT00642902|529195937|FG002|Overall Study|Premature termination of clinical trial|35|||
146733249|NCT00642902|529195938|FG003|Overall Study|Premature termination of clinical trial|35|||
146733250|NCT00642902|529195935|FG000|Overall Study|Randomized, but not treated|0|||
146733251|NCT00642902|529195936|FG001|Overall Study|Randomized, but not treated|0|||
146733252|NCT00642902|529195937|FG002|Overall Study|Randomized, but not treated|1|||
146733253|NCT00642902|529195938|FG003|Overall Study|Randomized, but not treated|0|||
146733254|NCT00642902|529195935|FG000|Overall Study|Other|1|||
146733255|NCT00642902|529195936|FG001|Overall Study|Other|5|||
146733256|NCT00642902|529195937|FG002|Overall Study|Other|1|||
146733257|NCT00642902|529195938|FG003|Overall Study|Other|4|||
146733258|NCT00429663|529195939|FG000|Overall Study|Lost to Follow-up|24|||
146733259|NCT00429663|529195940|FG001|Overall Study|Lost to Follow-up|31|||
146733260|NCT00429663|529195939|FG000|Overall Study|Physician Decision|6|||
146733261|NCT00429663|529195940|FG001|Overall Study|Physician Decision|3|||
146733262|NCT00429663|529195939|FG000|Overall Study|Withdrawal by Subject|2|||
146733263|NCT00429663|529195940|FG001|Overall Study|Withdrawal by Subject|5|||
146733264|NCT00429663|529195939|FG000|Overall Study|Death|4|||
146733265|NCT00429663|529195940|FG001|Overall Study|Death|0|||
146733266|NCT03953898|529195946|FG000|Overall Study|Lack of Efficacy|8|||
146733267|NCT03953898|529195946|FG000|Overall Study|Death|3|||
146733268|NCT03953898|529195946|FG000|Overall Study|Withdrawal by Subject|2|||
146733269|NCT03953898|529195946|FG000|Overall Study|Adverse Event|1|||
146733270|NCT03261271|529195947|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
146733271|NCT03261271|529195948|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
146733272|NCT03420781|529195949|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
146733273|NCT03420781|529195950|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
146733274|NCT03420781|529195951|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
146733275|NCT03420781|529195952|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
146733276|NCT03420781|529195953|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
146733277|NCT03420781|529195949|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
146733278|NCT03420781|529195950|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
146733279|NCT03420781|529195951|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
146733280|NCT03420781|529195952|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
146733281|NCT03420781|529195953|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
146733282|NCT03420781|529195949|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
146733283|NCT03420781|529195950|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
146733284|NCT03420781|529195951|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
146733285|NCT03420781|529195952|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
146733286|NCT03420781|529195953|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
146733287|NCT03420781|529195949|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
146733288|NCT03420781|529195950|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
146733289|NCT03420781|529195951|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
146733290|NCT03420781|529195952|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
146733291|NCT03420781|529195953|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
146733292|NCT03420781|529195949|FG000|Treatment Period (40 Weeks)|Death|2|||
146733293|NCT03420781|529195950|FG001|Treatment Period (40 Weeks)|Death|2|||
146733294|NCT03420781|529195951|FG002|Treatment Period (40 Weeks)|Death|0|||
146733295|NCT03420781|529195952|FG003|Treatment Period (40 Weeks)|Death|0|||
146733296|NCT03420781|529195953|FG004|Treatment Period (40 Weeks)|Death|0|||
146733297|NCT03420781|529195949|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
146733298|NCT03420781|529195950|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
146733299|NCT03420781|529195951|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
146733300|NCT03420781|529195952|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
146733301|NCT03420781|529195953|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
146792084|NCT02709161|529411346|FG000|Overall Study|Withdrawal by Subject|1|||
146792085|NCT02709161|529411347|FG001|Overall Study|Withdrawal by Subject|0|||
146733302|NCT03420781|529195949|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
146733303|NCT03420781|529195950|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
146733304|NCT03420781|529195951|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
146792086|NCT05167864|529411350|FG000|Overall Study|Lost to Follow-up|7|||
146733305|NCT03420781|529195952|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
146733306|NCT03420781|529195953|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
146733307|NCT03420781|529195949|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
146733308|NCT03420781|529195950|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
146733309|NCT03420781|529195951|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
146733310|NCT03420781|529195952|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
146733311|NCT03420781|529195953|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
146733312|NCT03420781|529195949|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
146733313|NCT03420781|529195950|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
146733314|NCT03420781|529195951|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
146733315|NCT03420781|529195952|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
146733316|NCT03420781|529195953|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
146733317|NCT03420781|529195949|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
146733318|NCT03420781|529195950|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
146733319|NCT03420781|529195951|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
146733320|NCT03420781|529195952|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
146733321|NCT03420781|529195953|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
146733322|NCT03420781|529195949|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
146733323|NCT03420781|529195950|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
146733324|NCT03420781|529195951|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
146733325|NCT03420781|529195952|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
146733326|NCT03420781|529195953|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
146733327|NCT03420781|529195949|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
146733328|NCT03420781|529195950|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
146733329|NCT03420781|529195951|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
146733330|NCT03420781|529195952|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
146733331|NCT03420781|529195953|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
146733332|NCT03420781|529195949|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
146733333|NCT03420781|529195950|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
146733334|NCT03420781|529195951|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
146733335|NCT03420781|529195952|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
146733336|NCT03420781|529195953|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
146792087|NCT05167864|529411351|FG001|Overall Study|Lost to Follow-up|6|||
146792088|NCT05167864|529411352|FG002|Overall Study|Lost to Follow-up|7|||
146792089|NCT05167864|529411353|FG003|Overall Study|Lost to Follow-up|9|||
146792090|NCT04059185|529411356|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
146792091|NCT04059185|529411357|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
146792092|NCT04059185|529411358|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
146792093|NCT04059185|529411356|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
146792094|NCT04059185|529411357|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
146792095|NCT04059185|529411358|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
146792096|NCT04059185|529411356|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
146792097|NCT04059185|529411357|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
146792098|NCT04059185|529411358|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
146792099|NCT04059185|529411356|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
146792100|NCT04059185|529411357|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
146792101|NCT04059185|529411358|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
146792102|NCT04059185|529411356|FG000|Longitudinal Assessment-Adults Only|Death|4|||
146792103|NCT04059185|529411357|FG001|Longitudinal Assessment-Adults Only|Death|4|||
146792104|NCT04059185|529411358|FG002|Longitudinal Assessment-Adults Only|Death|3|||
146792105|NCT04587453|529411366|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
146792106|NCT04587453|529411367|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
146792107|NCT05309291|529411378|FG000|Overall Study|Adverse Event|0|||
146792108|NCT05309291|529411379|FG001|Overall Study|Adverse Event|1|||
146792109|NCT05209152|529411380|FG000|Overall Study|Sponsor decision|1|||
146792110|NCT05209152|529411381|FG001|Overall Study|Sponsor decision|2|||
146792111|NCT05209152|529411380|FG000|Overall Study|Death|3|||
146792112|NCT05209152|529411381|FG001|Overall Study|Death|1|||
146792113|NCT04857723|529411383|FG000|Overall Study|Withdrawal by Subject|2|||
146792114|NCT04171141|529413070|FG000|Overall Study|Adverse Event|0|||
146792115|NCT04171141|529413071|FG001|Overall Study|Adverse Event|0|||
146792116|NCT04171141|529413072|FG002|Overall Study|Adverse Event|2|||
146792117|NCT04171141|529413073|FG003|Overall Study|Adverse Event|0|||
146792118|NCT04171141|529413074|FG004|Overall Study|Adverse Event|0|||
146982156|NCT04128696|530096220|FG001|Overall Study|Study Closed/Terminated|38|||
146792119|NCT04171141|529413075|FG005|Overall Study|Adverse Event|0|||
146792120|NCT04171141|529413076|FG006|Overall Study|Adverse Event|0|||
146792121|NCT04171141|529413077|FG007|Overall Study|Adverse Event|0|||
146733337|NCT05267600|529195954|FG000|Overall Study|Adverse Event|1|||
146733338|NCT05267600|529195955|FG001|Overall Study|Adverse Event|4|||
146733339|NCT05267600|529195954|FG000|Overall Study|Death|1|||
146733340|NCT05267600|529195955|FG001|Overall Study|Death|2|||
146733341|NCT05267600|529195954|FG000|Overall Study|Lack of Efficacy|1|||
146733342|NCT05267600|529195955|FG001|Overall Study|Lack of Efficacy|2|||
146792122|NCT04171141|529413078|FG008|Overall Study|Adverse Event|0|||
146792123|NCT04171141|529413079|FG009|Overall Study|Adverse Event|0|||
146733343|NCT05267600|529195954|FG000|Overall Study|Lost to Follow-up|3|||
146733344|NCT05267600|529195955|FG001|Overall Study|Lost to Follow-up|0|||
146733345|NCT05267600|529195954|FG000|Overall Study|Physician Decision|4|||
146733346|NCT05267600|529195955|FG001|Overall Study|Physician Decision|0|||
146733347|NCT05267600|529195954|FG000|Overall Study|Treatment Unblinded|0|||
146733348|NCT05267600|529195955|FG001|Overall Study|Treatment Unblinded|1|||
146733349|NCT05267600|529195954|FG000|Overall Study|Withdrawal by Subject|5|||
146733350|NCT05267600|529195955|FG001|Overall Study|Withdrawal by Subject|4|||
146733351|NCT04067401|529195956|FG000|Overall Study|Withdrawal by Subject|7|||
146733352|NCT04067401|529195957|FG001|Overall Study|Withdrawal by Subject|0|||
146733353|NCT04067401|529195956|FG000|Overall Study|no data provided|1|||
146792124|NCT04171141|529413080|FG010|Overall Study|Adverse Event|0|||
146792125|NCT04171141|529413081|FG011|Overall Study|Adverse Event|0|||
146792126|NCT04171141|529413082|FG012|Overall Study|Adverse Event|0|||
146792127|NCT04171141|529413083|FG013|Overall Study|Adverse Event|2|||
146792128|NCT04171141|529413084|FG014|Overall Study|Adverse Event|0|||
146792129|NCT04171141|529413085|FG015|Overall Study|Adverse Event|0|||
146792130|NCT04171141|529413070|FG000|Overall Study|Physician Decision|0|||
146792131|NCT04171141|529413071|FG001|Overall Study|Physician Decision|0|||
146792132|NCT04171141|529413072|FG002|Overall Study|Physician Decision|0|||
146792133|NCT04171141|529413073|FG003|Overall Study|Physician Decision|0|||
146733354|NCT04067401|529195957|FG001|Overall Study|no data provided|0|||
146733355|NCT01889186|529195959|FG000|Overall Study|Adverse event- not related to progression|18|||
146733356|NCT01889186|529195960|FG001|Overall Study|Adverse event- not related to progression|5|||
146733357|NCT01889186|529195959|FG000|Overall Study|Adverse event- related to progression|7|||
146733358|NCT01889186|529195960|FG001|Overall Study|Adverse event- related to progression|2|||
146733359|NCT01889186|529195959|FG000|Overall Study|COVID-19 logistical restrictions|1|||
146733360|NCT01889186|529195960|FG001|Overall Study|COVID-19 logistical restrictions|0|||
146733361|NCT01889186|529195959|FG000|Overall Study|Investigator request|1|||
146733362|NCT01889186|529195960|FG001|Overall Study|Investigator request|1|||
146733363|NCT01889186|529195959|FG000|Overall Study|Progressive disease- Richter's|12|||
146792134|NCT04171141|529413074|FG004|Overall Study|Physician Decision|1|||
146792135|NCT04171141|529413075|FG005|Overall Study|Physician Decision|0|||
146792136|NCT04171141|529413076|FG006|Overall Study|Physician Decision|0|||
146792137|NCT04171141|529413077|FG007|Overall Study|Physician Decision|0|||
146792138|NCT04171141|529413078|FG008|Overall Study|Physician Decision|0|||
146792139|NCT04171141|529413079|FG009|Overall Study|Physician Decision|0|||
146792140|NCT04171141|529413080|FG010|Overall Study|Physician Decision|0|||
146792141|NCT04171141|529413081|FG011|Overall Study|Physician Decision|0|||
146792142|NCT04171141|529413082|FG012|Overall Study|Physician Decision|0|||
146792143|NCT04171141|529413083|FG013|Overall Study|Physician Decision|0|||
146792144|NCT04171141|529413084|FG014|Overall Study|Physician Decision|0|||
146792145|NCT04171141|529413085|FG015|Overall Study|Physician Decision|1|||
146792146|NCT04171141|529413070|FG000|Overall Study|Progressive disease|2|||
146792147|NCT04171141|529413071|FG001|Overall Study|Progressive disease|3|||
146733364|NCT01889186|529195960|FG001|Overall Study|Progressive disease- Richter's|7|||
146733365|NCT01889186|529195959|FG000|Overall Study|Progressive disease per protocol|46|||
146733366|NCT01889186|529195960|FG001|Overall Study|Progressive disease per protocol|17|||
146733367|NCT01889186|529195959|FG000|Overall Study|Stem cell transplant|2|||
146733368|NCT01889186|529195960|FG001|Overall Study|Stem cell transplant|1|||
146733369|NCT01889186|529195959|FG000|Overall Study|Withdrew consent|2|||
146733370|NCT01889186|529195960|FG001|Overall Study|Withdrew consent|3|||
146733371|NCT01889186|529195959|FG000|Overall Study|Other, not specified|18|||
146733372|NCT01889186|529195960|FG001|Overall Study|Other, not specified|15|||
146733373|NCT02110901|529195961|FG000|Overall Study|Death|6|||
146733374|NCT02110901|529195962|FG001|Overall Study|Death|3|||
146792148|NCT04171141|529413072|FG002|Overall Study|Progressive disease|4|||
146792149|NCT04171141|529413073|FG003|Overall Study|Progressive disease|7|||
146938785|NCT00970268|529932524|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
146792150|NCT04171141|529413074|FG004|Overall Study|Progressive disease|1|||
146938786|NCT01079195|529932525|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
146938787|NCT01079195|529932525|FG000|Overall Study|No Documentation Available|437|||
146733375|NCT02110901|529195961|FG000|Overall Study|Lost to Follow-up|12|||
146733376|NCT02110901|529195962|FG001|Overall Study|Lost to Follow-up|8|||
146733377|NCT02110901|529195961|FG000|Overall Study|Withdrawal by Subject|7|||
146733378|NCT02110901|529195962|FG001|Overall Study|Withdrawal by Subject|3|||
146733379|NCT02110901|529195961|FG000|Overall Study|received a kidney transplant|5|||
146733380|NCT02110901|529195962|FG001|Overall Study|received a kidney transplant|0|||
146792151|NCT04171141|529413075|FG005|Overall Study|Progressive disease|8|||
146792152|NCT04171141|529413076|FG006|Overall Study|Progressive disease|4|||
146792153|NCT04171141|529413077|FG007|Overall Study|Progressive disease|6|||
146792154|NCT04171141|529413078|FG008|Overall Study|Progressive disease|7|||
146733381|NCT01058304|529195975|FG000|Overall Study|Withdrawal by Subject|8|||
146733382|NCT01058304|529195976|FG001|Overall Study|Withdrawal by Subject|5|||
146733383|NCT01058304|529195975|FG000|Overall Study|Lost to Follow-up|13|||
146733384|NCT01058304|529195976|FG001|Overall Study|Lost to Follow-up|16|||
146733385|NCT01058304|529195975|FG000|Overall Study|Developed exclusion criterion|6|||
146733386|NCT01058304|529195976|FG001|Overall Study|Developed exclusion criterion|12|||
146733387|NCT02496767|529195977|FG000|Open-label Lead-in Phase|Adverse Event|176|||
146733388|NCT02496767|529195978|FG001|Open-label Lead-in Phase|Adverse Event|0|||
146733389|NCT02496767|529195979|FG002|Open-label Lead-in Phase|Adverse Event|0|||
146733390|NCT02496767|529195980|FG003|Open-label Lead-in Phase|Adverse Event|0|||
146733391|NCT02496767|529195981|FG004|Open-label Lead-in Phase|Adverse Event|0|||
146733392|NCT02496767|529195982|FG005|Open-label Lead-in Phase|Adverse Event|0|||
146733393|NCT02496767|529195983|FG006|Open-label Lead-in Phase|Adverse Event|0|||
146733394|NCT02496767|529195984|FG007|Open-label Lead-in Phase|Adverse Event|0|||
146733395|NCT02496767|529195977|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
146733396|NCT02496767|529195978|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
146733397|NCT02496767|529195979|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
146733398|NCT02496767|529195980|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
146733399|NCT02496767|529195981|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
146733400|NCT02496767|529195982|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
146733401|NCT02496767|529195983|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
146733402|NCT02496767|529195984|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
146733403|NCT02496767|529195977|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
146733404|NCT02496767|529195978|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
146733405|NCT02496767|529195979|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
146733406|NCT02496767|529195980|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
146733407|NCT02496767|529195981|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
146733408|NCT02496767|529195982|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
146733409|NCT02496767|529195983|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
146733410|NCT02496767|529195984|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
146733411|NCT02496767|529195977|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
146733412|NCT02496767|529195978|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
146733413|NCT02496767|529195979|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
146733414|NCT02496767|529195980|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
146733415|NCT02496767|529195981|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
146733416|NCT02496767|529195982|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
146733417|NCT02496767|529195983|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
146733418|NCT02496767|529195984|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
146733419|NCT02496767|529195977|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
146733420|NCT02496767|529195978|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
146733421|NCT02496767|529195979|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
146733422|NCT02496767|529195980|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
146733423|NCT02496767|529195981|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
146733424|NCT02496767|529195982|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
146733425|NCT02496767|529195983|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
146733426|NCT02496767|529195984|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
146733427|NCT02496767|529195977|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
146733428|NCT02496767|529195978|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
146733429|NCT02496767|529195979|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
146733430|NCT02496767|529195980|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
146733431|NCT02496767|529195981|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
146733432|NCT02496767|529195982|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
146733433|NCT02496767|529195983|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
146733434|NCT02496767|529195984|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
146733435|NCT02496767|529195977|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
146733436|NCT02496767|529195978|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
146733437|NCT02496767|529195979|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
146733438|NCT02496767|529195980|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
146733439|NCT02496767|529195981|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
146733440|NCT02496767|529195982|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
146733441|NCT02496767|529195983|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
146733442|NCT02496767|529195984|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
146733443|NCT02496767|529195977|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
146733444|NCT02496767|529195978|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
146733445|NCT02496767|529195979|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
146733446|NCT02496767|529195980|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
146733447|NCT02496767|529195981|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
146792155|NCT04171141|529413079|FG009|Overall Study|Progressive disease|3|||
146938788|NCT01079195|529932525|FG000|Overall Study|Adverse Event|157|||
146733448|NCT02496767|529195982|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
146733449|NCT02496767|529195983|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
146733450|NCT02496767|529195984|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
146733451|NCT02496767|529195977|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
146733452|NCT02496767|529195978|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
146733453|NCT02496767|529195979|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
146733454|NCT02496767|529195980|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
146733455|NCT02496767|529195981|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
146733456|NCT02496767|529195982|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
146733457|NCT02496767|529195983|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
146733458|NCT02496767|529195984|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
146733459|NCT02496767|529195977|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146733460|NCT02496767|529195978|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
146733461|NCT02496767|529195979|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146733462|NCT02496767|529195980|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
146733463|NCT02496767|529195981|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
146733464|NCT02496767|529195982|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146733465|NCT02496767|529195983|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146733466|NCT02496767|529195984|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146733467|NCT02496767|529195977|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
146733468|NCT02496767|529195978|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
146733469|NCT02496767|529195979|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
146733470|NCT02496767|529195980|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
146733471|NCT02496767|529195981|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
146733472|NCT02496767|529195982|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
146733473|NCT02496767|529195983|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
146733474|NCT02496767|529195984|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
146733475|NCT02496767|529195977|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
146733476|NCT02496767|529195978|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
146733477|NCT02496767|529195979|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
146733478|NCT02496767|529195980|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
146733479|NCT02496767|529195981|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
146733480|NCT02496767|529195982|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
146733481|NCT02496767|529195983|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
146733482|NCT02496767|529195984|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
146733483|NCT02496767|529195977|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
146733484|NCT02496767|529195978|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
146733485|NCT02496767|529195979|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
146733486|NCT02496767|529195980|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
146733487|NCT02496767|529195981|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
146733488|NCT02496767|529195982|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
146733489|NCT02496767|529195983|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
146733490|NCT02496767|529195984|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
146733491|NCT02496767|529195977|FG000|Double-blind, Withdrawal Phase|Death|0|||
146733492|NCT02496767|529195978|FG001|Double-blind, Withdrawal Phase|Death|0|||
146733493|NCT02496767|529195979|FG002|Double-blind, Withdrawal Phase|Death|0|||
146733494|NCT02496767|529195980|FG003|Double-blind, Withdrawal Phase|Death|0|||
146733495|NCT02496767|529195981|FG004|Double-blind, Withdrawal Phase|Death|0|||
146733496|NCT02496767|529195982|FG005|Double-blind, Withdrawal Phase|Death|0|||
146733497|NCT02496767|529195983|FG006|Double-blind, Withdrawal Phase|Death|1|||
146733498|NCT02496767|529195984|FG007|Double-blind, Withdrawal Phase|Death|2|||
146733499|NCT02496767|529195977|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
146733500|NCT02496767|529195978|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
146733501|NCT02496767|529195979|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
146733502|NCT02496767|529195980|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
146733503|NCT02496767|529195981|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
146733504|NCT02496767|529195982|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
146733505|NCT02496767|529195983|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
146733506|NCT02496767|529195984|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
146733507|NCT02889133|529195985|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
146733508|NCT02889133|529195986|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
146733509|NCT02889133|529195985|FG000|Completed Primary Outcome|Manufacturing error|3|||
146733510|NCT02889133|529195986|FG001|Completed Primary Outcome|Manufacturing error|8|||
146733511|NCT02889133|529195985|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
146733512|NCT02889133|529195986|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
146733513|NCT02889133|529195985|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
146733514|NCT02889133|529195986|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
146733515|NCT02889133|529195985|FG000|Completed Primary Outcome|Protocol Violation|1|||
146733516|NCT02889133|529195986|FG001|Completed Primary Outcome|Protocol Violation|0|||
146733517|NCT02889133|529195985|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
146733518|NCT02889133|529195986|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
146733519|NCT02889133|529195985|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
146733520|NCT02889133|529195986|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
146733521|NCT02889133|529195985|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
146733522|NCT02889133|529195986|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
146733523|NCT02889133|529195985|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
146733524|NCT02889133|529195986|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
146733525|NCT02889133|529195985|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
146733526|NCT02889133|529195986|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
146733527|NCT04711603|529195987|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
146733528|NCT04711603|529195988|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
146733529|NCT04711603|529195989|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
146733530|NCT04711603|529195990|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
146733531|NCT04711603|529195987|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
146733532|NCT04711603|529195988|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
146733533|NCT04711603|529195989|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
146733534|NCT04711603|529195990|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
146733535|NCT04711603|529195987|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
146733536|NCT04711603|529195988|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
146733537|NCT04711603|529195989|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
146733538|NCT04711603|529195990|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
146733539|NCT04711603|529195987|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
146733540|NCT04711603|529195988|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
146733541|NCT04711603|529195989|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
146733542|NCT04711603|529195990|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
146733543|NCT04711603|529195987|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
146733544|NCT04711603|529195988|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
146733545|NCT04711603|529195989|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
146733546|NCT04711603|529195990|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
146733547|NCT04711603|529195987|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
146733548|NCT04711603|529195988|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
146733549|NCT04711603|529195989|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
146733550|NCT04711603|529195990|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
146733551|NCT04711603|529195987|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
146733552|NCT04711603|529195988|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
146733553|NCT04711603|529195989|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
146733554|NCT04711603|529195990|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
146733555|NCT04711603|529195987|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
146733556|NCT04711603|529195988|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
146733557|NCT04711603|529195989|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
146733558|NCT04711603|529195990|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
146733559|NCT04711603|529195987|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
146733560|NCT04711603|529195988|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
146733561|NCT04711603|529195989|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
146733562|NCT04711603|529195990|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
146733563|NCT04711603|529195987|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
146733564|NCT04711603|529195988|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
146733565|NCT04711603|529195989|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
146733566|NCT04711603|529195990|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
146733567|NCT04711603|529195987|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
146733568|NCT04711603|529195988|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
146733569|NCT04711603|529195989|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
146733570|NCT04711603|529195990|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
146733571|NCT04711603|529195987|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
146733572|NCT04711603|529195988|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
146733573|NCT04711603|529195989|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
146733574|NCT04711603|529195990|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
146733575|NCT02597036|529195993|FG000|Overall Study|Progressive Disease|0|||
146733576|NCT02597036|529195994|FG001|Overall Study|Progressive Disease|0|||
146733577|NCT02597036|529195995|FG002|Overall Study|Progressive Disease|0|||
146733578|NCT02597036|529195996|FG003|Overall Study|Progressive Disease|0|||
146733579|NCT02597036|529195997|FG004|Overall Study|Progressive Disease|1|||
146733580|NCT02597036|529195998|FG005|Overall Study|Progressive Disease|1|||
146733581|NCT02597036|529195999|FG006|Overall Study|Progressive Disease|1|||
146733582|NCT02597036|529196000|FG007|Overall Study|Progressive Disease|0|||
146733583|NCT02597036|529196001|FG008|Overall Study|Progressive Disease|0|||
146733584|NCT02597036|529196002|FG009|Overall Study|Progressive Disease|0|||
146733585|NCT02597036|529196003|FG010|Overall Study|Progressive Disease|0|||
146733586|NCT02597036|529196004|FG011|Overall Study|Progressive Disease|0|||
146733587|NCT02597036|529195993|FG000|Overall Study|Adverse Event|0|||
146733588|NCT02597036|529195994|FG001|Overall Study|Adverse Event|0|||
146733589|NCT02597036|529195995|FG002|Overall Study|Adverse Event|0|||
146733590|NCT02597036|529195996|FG003|Overall Study|Adverse Event|0|||
146733591|NCT02597036|529195997|FG004|Overall Study|Adverse Event|0|||
146733592|NCT02597036|529195998|FG005|Overall Study|Adverse Event|0|||
146733593|NCT02597036|529195999|FG006|Overall Study|Adverse Event|0|||
146733594|NCT02597036|529196000|FG007|Overall Study|Adverse Event|1|||
146733595|NCT02597036|529196001|FG008|Overall Study|Adverse Event|0|||
146733596|NCT02597036|529196002|FG009|Overall Study|Adverse Event|0|||
146733597|NCT02597036|529196003|FG010|Overall Study|Adverse Event|0|||
146733598|NCT02597036|529196004|FG011|Overall Study|Adverse Event|1|||
146733599|NCT02597036|529195993|FG000|Overall Study|Death|0|||
146733600|NCT02597036|529195994|FG001|Overall Study|Death|0|||
146733601|NCT02597036|529195995|FG002|Overall Study|Death|0|||
146733602|NCT02597036|529195996|FG003|Overall Study|Death|0|||
146733603|NCT02597036|529195997|FG004|Overall Study|Death|0|||
146733604|NCT02597036|529195998|FG005|Overall Study|Death|0|||
146733605|NCT02597036|529195999|FG006|Overall Study|Death|0|||
146733606|NCT02597036|529196000|FG007|Overall Study|Death|0|||
146733607|NCT02597036|529196001|FG008|Overall Study|Death|0|||
146733608|NCT02597036|529196002|FG009|Overall Study|Death|1|||
146733609|NCT02597036|529196003|FG010|Overall Study|Death|1|||
146733610|NCT02597036|529196004|FG011|Overall Study|Death|0|||
146733611|NCT02597036|529195993|FG000|Overall Study|Lost to Follow-up|0|||
146733612|NCT02597036|529195994|FG001|Overall Study|Lost to Follow-up|0|||
146733613|NCT02597036|529195995|FG002|Overall Study|Lost to Follow-up|0|||
146733614|NCT02597036|529195996|FG003|Overall Study|Lost to Follow-up|0|||
146733615|NCT02597036|529195997|FG004|Overall Study|Lost to Follow-up|0|||
146733616|NCT02597036|529195998|FG005|Overall Study|Lost to Follow-up|0|||
146733617|NCT02597036|529195999|FG006|Overall Study|Lost to Follow-up|0|||
146733618|NCT02597036|529196000|FG007|Overall Study|Lost to Follow-up|0|||
146733619|NCT02597036|529196001|FG008|Overall Study|Lost to Follow-up|0|||
146733620|NCT02597036|529196002|FG009|Overall Study|Lost to Follow-up|0|||
146733621|NCT02597036|529196003|FG010|Overall Study|Lost to Follow-up|1|||
146733622|NCT02597036|529196004|FG011|Overall Study|Lost to Follow-up|0|||
146733623|NCT02597036|529195993|FG000|Overall Study|Withdrawal by Subject|0|||
146733624|NCT02597036|529195994|FG001|Overall Study|Withdrawal by Subject|0|||
146733625|NCT02597036|529195995|FG002|Overall Study|Withdrawal by Subject|0|||
146733626|NCT02597036|529195996|FG003|Overall Study|Withdrawal by Subject|0|||
146733627|NCT02597036|529195997|FG004|Overall Study|Withdrawal by Subject|0|||
146733628|NCT02597036|529195998|FG005|Overall Study|Withdrawal by Subject|0|||
146733629|NCT02597036|529195999|FG006|Overall Study|Withdrawal by Subject|0|||
146733630|NCT02597036|529196000|FG007|Overall Study|Withdrawal by Subject|0|||
146733631|NCT02597036|529196001|FG008|Overall Study|Withdrawal by Subject|0|||
146733632|NCT02597036|529196002|FG009|Overall Study|Withdrawal by Subject|0|||
146733633|NCT02597036|529196003|FG010|Overall Study|Withdrawal by Subject|0|||
146733634|NCT02597036|529196004|FG011|Overall Study|Withdrawal by Subject|1|||
146733635|NCT06351371|529196005|FG000|Overall Study|Mutation Status Not Confirmed|9|||
146733636|NCT06351371|529196005|FG000|Overall Study|Ineligible|1|||
146733637|NCT06351371|529196005|FG000|Overall Study|Adverse Event|4|||
146733638|NCT06351371|529196005|FG000|Overall Study|Death|1|||
146733639|NCT06351371|529196005|FG000|Overall Study|Disease progression|14|||
146733640|NCT06351371|529196005|FG000|Overall Study|Withdrawal by Subject|3|||
146733641|NCT06351371|529196005|FG000|Overall Study|Physician Decision|3|||
146733642|NCT04359784|529196007|FG000|Overall Study|Death|2|||
146733643|NCT03217747|529196015|FG000|Overall Study|Adverse Event|0|||
146733644|NCT03217747|529196016|FG001|Overall Study|Adverse Event|1|||
146733645|NCT03217747|529196017|FG002|Overall Study|Adverse Event|0|||
146733646|NCT03217747|529196018|FG003|Overall Study|Adverse Event|0|||
146733647|NCT03217747|529196019|FG004|Overall Study|Adverse Event|0|||
146733648|NCT03217747|529196020|FG005|Overall Study|Adverse Event|0|||
146938789|NCT01079195|529932525|FG000|Overall Study|Reason Unknown|39|||
146733649|NCT03217747|529196021|FG006|Overall Study|Adverse Event|0|||
146733650|NCT03217747|529196022|FG007|Overall Study|Adverse Event|0|||
146733651|NCT03217747|529196023|FG008|Overall Study|Adverse Event|0|||
146733652|NCT03217747|529196024|FG009|Overall Study|Adverse Event|0|||
146733653|NCT03217747|529196025|FG010|Overall Study|Adverse Event|0|||
146733654|NCT03217747|529196026|FG011|Overall Study|Adverse Event|0|||
146733655|NCT03217747|529196027|FG012|Overall Study|Adverse Event|1|||
146733656|NCT03217747|529196028|FG013|Overall Study|Adverse Event|1|||
146733657|NCT03217747|529196015|FG000|Overall Study|Death|0|||
146733658|NCT03217747|529196016|FG001|Overall Study|Death|0|||
146733659|NCT03217747|529196017|FG002|Overall Study|Death|0|||
146733660|NCT03217747|529196018|FG003|Overall Study|Death|0|||
146733661|NCT03217747|529196019|FG004|Overall Study|Death|0|||
146733662|NCT03217747|529196020|FG005|Overall Study|Death|0|||
146733663|NCT03217747|529196021|FG006|Overall Study|Death|0|||
146733664|NCT03217747|529196022|FG007|Overall Study|Death|0|||
146733665|NCT03217747|529196023|FG008|Overall Study|Death|1|||
146733666|NCT03217747|529196024|FG009|Overall Study|Death|0|||
146733667|NCT03217747|529196025|FG010|Overall Study|Death|0|||
146733668|NCT03217747|529196026|FG011|Overall Study|Death|0|||
146733669|NCT03217747|529196027|FG012|Overall Study|Death|0|||
146733670|NCT03217747|529196028|FG013|Overall Study|Death|0|||
146733671|NCT03217747|529196015|FG000|Overall Study|Lack of Efficacy|12|||
146733672|NCT03217747|529196016|FG001|Overall Study|Lack of Efficacy|6|||
146733673|NCT03217747|529196017|FG002|Overall Study|Lack of Efficacy|15|||
146733674|NCT03217747|529196018|FG003|Overall Study|Lack of Efficacy|11|||
146733675|NCT03217747|529196019|FG004|Overall Study|Lack of Efficacy|3|||
146733676|NCT03217747|529196020|FG005|Overall Study|Lack of Efficacy|14|||
146733677|NCT03217747|529196021|FG006|Overall Study|Lack of Efficacy|10|||
146733678|NCT03217747|529196022|FG007|Overall Study|Lack of Efficacy|4|||
146733679|NCT03217747|529196023|FG008|Overall Study|Lack of Efficacy|2|||
146733680|NCT03217747|529196024|FG009|Overall Study|Lack of Efficacy|7|||
146733681|NCT03217747|529196025|FG010|Overall Study|Lack of Efficacy|3|||
146733682|NCT03217747|529196026|FG011|Overall Study|Lack of Efficacy|1|||
146733683|NCT03217747|529196027|FG012|Overall Study|Lack of Efficacy|3|||
146733684|NCT03217747|529196028|FG013|Overall Study|Lack of Efficacy|1|||
146733685|NCT03217747|529196015|FG000|Overall Study|Withdrawal by Subject|2|||
146733686|NCT03217747|529196016|FG001|Overall Study|Withdrawal by Subject|1|||
146733687|NCT03217747|529196017|FG002|Overall Study|Withdrawal by Subject|1|||
146733688|NCT03217747|529196018|FG003|Overall Study|Withdrawal by Subject|1|||
146733689|NCT03217747|529196019|FG004|Overall Study|Withdrawal by Subject|1|||
146733690|NCT03217747|529196020|FG005|Overall Study|Withdrawal by Subject|2|||
146733691|NCT03217747|529196021|FG006|Overall Study|Withdrawal by Subject|1|||
146733692|NCT03217747|529196022|FG007|Overall Study|Withdrawal by Subject|0|||
146733693|NCT03217747|529196023|FG008|Overall Study|Withdrawal by Subject|0|||
146733694|NCT03217747|529196024|FG009|Overall Study|Withdrawal by Subject|0|||
146733695|NCT03217747|529196025|FG010|Overall Study|Withdrawal by Subject|0|||
146733696|NCT03217747|529196026|FG011|Overall Study|Withdrawal by Subject|1|||
146733697|NCT03217747|529196027|FG012|Overall Study|Withdrawal by Subject|0|||
146733698|NCT03217747|529196028|FG013|Overall Study|Withdrawal by Subject|1|||
146733699|NCT03217747|529196015|FG000|Overall Study|Toxicity and progression|1|||
146733700|NCT03217747|529196016|FG001|Overall Study|Toxicity and progression|0|||
146733701|NCT03217747|529196017|FG002|Overall Study|Toxicity and progression|0|||
146733702|NCT03217747|529196018|FG003|Overall Study|Toxicity and progression|0|||
146733703|NCT03217747|529196019|FG004|Overall Study|Toxicity and progression|0|||
146733704|NCT03217747|529196020|FG005|Overall Study|Toxicity and progression|0|||
146733705|NCT03217747|529196021|FG006|Overall Study|Toxicity and progression|0|||
146733706|NCT03217747|529196022|FG007|Overall Study|Toxicity and progression|0|||
146733707|NCT03217747|529196023|FG008|Overall Study|Toxicity and progression|0|||
146733708|NCT03217747|529196024|FG009|Overall Study|Toxicity and progression|0|||
146733709|NCT03217747|529196025|FG010|Overall Study|Toxicity and progression|0|||
146733710|NCT03217747|529196026|FG011|Overall Study|Toxicity and progression|0|||
146733711|NCT03217747|529196027|FG012|Overall Study|Toxicity and progression|0|||
146733712|NCT03217747|529196028|FG013|Overall Study|Toxicity and progression|0|||
146733713|NCT03217747|529196015|FG000|Overall Study|Removal of sole target lesion|1|||
146733714|NCT03217747|529196016|FG001|Overall Study|Removal of sole target lesion|0|||
146733715|NCT03217747|529196017|FG002|Overall Study|Removal of sole target lesion|0|||
146733716|NCT03217747|529196018|FG003|Overall Study|Removal of sole target lesion|0|||
146733717|NCT03217747|529196019|FG004|Overall Study|Removal of sole target lesion|0|||
146733718|NCT03217747|529196020|FG005|Overall Study|Removal of sole target lesion|0|||
146733719|NCT03217747|529196021|FG006|Overall Study|Removal of sole target lesion|0|||
146733720|NCT03217747|529196022|FG007|Overall Study|Removal of sole target lesion|0|||
146733721|NCT03217747|529196023|FG008|Overall Study|Removal of sole target lesion|0|||
146733722|NCT03217747|529196024|FG009|Overall Study|Removal of sole target lesion|0|||
146733723|NCT03217747|529196025|FG010|Overall Study|Removal of sole target lesion|0|||
146733724|NCT03217747|529196026|FG011|Overall Study|Removal of sole target lesion|0|||
146733725|NCT03217747|529196027|FG012|Overall Study|Removal of sole target lesion|0|||
146733726|NCT03217747|529196028|FG013|Overall Study|Removal of sole target lesion|0|||
146733727|NCT03217747|529196015|FG000|Overall Study|Stroke|0|||
146733728|NCT03217747|529196016|FG001|Overall Study|Stroke|0|||
146733729|NCT03217747|529196017|FG002|Overall Study|Stroke|0|||
146733730|NCT03217747|529196018|FG003|Overall Study|Stroke|0|||
146733731|NCT03217747|529196019|FG004|Overall Study|Stroke|0|||
146733732|NCT03217747|529196020|FG005|Overall Study|Stroke|1|||
146733733|NCT03217747|529196021|FG006|Overall Study|Stroke|0|||
146733734|NCT03217747|529196022|FG007|Overall Study|Stroke|0|||
146733735|NCT03217747|529196023|FG008|Overall Study|Stroke|0|||
146733736|NCT03217747|529196024|FG009|Overall Study|Stroke|0|||
146733737|NCT03217747|529196025|FG010|Overall Study|Stroke|0|||
146733738|NCT03217747|529196026|FG011|Overall Study|Stroke|1|||
146733739|NCT03217747|529196027|FG012|Overall Study|Stroke|0|||
146792156|NCT04171141|529413080|FG010|Overall Study|Progressive disease|4|||
146792157|NCT04171141|529413081|FG011|Overall Study|Progressive disease|3|||
146792158|NCT04171141|529413082|FG012|Overall Study|Progressive disease|4|||
146792159|NCT04171141|529413083|FG013|Overall Study|Progressive disease|2|||
146792160|NCT04171141|529413084|FG014|Overall Study|Progressive disease|4|||
146982157|NCT04128696|530096219|FG000|Overall Study|Physician Decision|2|||
146792161|NCT04171141|529413085|FG015|Overall Study|Progressive disease|1|||
146792162|NCT04171141|529413070|FG000|Overall Study|Withdrawal by Subject|0|||
146792163|NCT04171141|529413071|FG001|Overall Study|Withdrawal by Subject|0|||
146792164|NCT04171141|529413072|FG002|Overall Study|Withdrawal by Subject|0|||
146792165|NCT04171141|529413073|FG003|Overall Study|Withdrawal by Subject|1|||
146792166|NCT04171141|529413074|FG004|Overall Study|Withdrawal by Subject|0|||
146792167|NCT04171141|529413075|FG005|Overall Study|Withdrawal by Subject|0|||
146792168|NCT04171141|529413076|FG006|Overall Study|Withdrawal by Subject|1|||
146792169|NCT04171141|529413077|FG007|Overall Study|Withdrawal by Subject|0|||
146792170|NCT04171141|529413078|FG008|Overall Study|Withdrawal by Subject|0|||
146792171|NCT04171141|529413079|FG009|Overall Study|Withdrawal by Subject|1|||
146792172|NCT04171141|529413080|FG010|Overall Study|Withdrawal by Subject|0|||
146792173|NCT04171141|529413081|FG011|Overall Study|Withdrawal by Subject|0|||
146982158|NCT04128696|530096220|FG001|Overall Study|Physician Decision|3|||
146982159|NCT02173301|530096221|FG000|Overall Study|Adverse Event|7|||
146982160|NCT02173301|530096222|FG001|Overall Study|Adverse Event|8|||
146982161|NCT02173301|530096223|FG002|Overall Study|Adverse Event|13|||
146982162|NCT02173301|530096224|FG003|Overall Study|Adverse Event|5|||
146982163|NCT02173301|530096221|FG000|Overall Study|Withdrawal by Subject|8|||
146733740|NCT03217747|529196028|FG013|Overall Study|Stroke|0|||
146733741|NCT03996291|529196029|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
146733742|NCT03996291|529196030|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
146733743|NCT03996291|529196031|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
146733744|NCT03996291|529196032|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
146733745|NCT03996291|529196033|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
146733746|NCT03996291|529196034|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
146733747|NCT03996291|529196035|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
146733748|NCT03996291|529196036|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
146733749|NCT03996291|529196029|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
146733750|NCT03996291|529196030|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
146733751|NCT03996291|529196031|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
146733752|NCT03996291|529196032|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
146733753|NCT03996291|529196033|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
146733754|NCT03996291|529196034|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
146733755|NCT03996291|529196035|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
146733756|NCT03996291|529196036|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
146733757|NCT03996291|529196029|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
146733758|NCT03996291|529196030|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
146733759|NCT03996291|529196031|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
146733760|NCT03996291|529196032|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
146733761|NCT03996291|529196033|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
146733762|NCT03996291|529196034|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
146733763|NCT03996291|529196035|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
146733764|NCT03996291|529196036|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
146733765|NCT03996291|529196029|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
146733766|NCT03996291|529196030|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
146733767|NCT03996291|529196031|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
146733768|NCT03996291|529196032|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
146733769|NCT03996291|529196033|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
146733770|NCT03996291|529196034|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
146733771|NCT03996291|529196035|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
146733772|NCT03996291|529196036|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
146733773|NCT03996291|529196029|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
146982164|NCT02173301|530096222|FG001|Overall Study|Withdrawal by Subject|10|||
146733774|NCT03996291|529196030|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
146733775|NCT03996291|529196031|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
146733776|NCT03996291|529196032|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
146733777|NCT03996291|529196033|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
146792174|NCT04171141|529413082|FG012|Overall Study|Withdrawal by Subject|0|||
146792175|NCT04171141|529413083|FG013|Overall Study|Withdrawal by Subject|0|||
146792176|NCT04171141|529413084|FG014|Overall Study|Withdrawal by Subject|0|||
146733778|NCT03996291|529196034|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
146792177|NCT04171141|529413085|FG015|Overall Study|Withdrawal by Subject|0|||
146792178|NCT04171141|529413070|FG000|Overall Study|Global deterioration of health status|0|||
146792179|NCT04171141|529413071|FG001|Overall Study|Global deterioration of health status|0|||
146982165|NCT02173301|530096223|FG002|Overall Study|Withdrawal by Subject|4|||
146982166|NCT02173301|530096224|FG003|Overall Study|Withdrawal by Subject|8|||
146733779|NCT03996291|529196035|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
146733780|NCT03996291|529196036|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
146733781|NCT03248375|529196037|FG000|Overall Study|Lost to Follow-up|5|||
146733782|NCT04098250|529196038|FG000|Overall Study|Withdrawal by Subject|1|||
146733783|NCT04098250|529196039|FG001|Overall Study|Withdrawal by Subject|0|||
146733784|NCT04098250|529196038|FG000|Overall Study|Lost to Follow-up|0|||
146733785|NCT04098250|529196039|FG001|Overall Study|Lost to Follow-up|1|||
146733786|NCT00394355|529196040|FG000|Overall Study|Adverse Event|10|||
146733787|NCT00394355|529196041|FG001|Overall Study|Adverse Event|6|||
146733788|NCT00394355|529196042|FG002|Overall Study|Adverse Event|7|||
146733789|NCT00394355|529196043|FG003|Overall Study|Adverse Event|8|||
146733790|NCT00394355|529196040|FG000|Overall Study|Did not meet protocol eligibility|1|||
146733791|NCT00394355|529196041|FG001|Overall Study|Did not meet protocol eligibility|5|||
146733792|NCT00394355|529196042|FG002|Overall Study|Did not meet protocol eligibility|4|||
146733793|NCT00394355|529196043|FG003|Overall Study|Did not meet protocol eligibility|2|||
146733794|NCT00394355|529196040|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
146733795|NCT00394355|529196041|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
146733796|NCT00394355|529196042|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
146733797|NCT00394355|529196043|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
146733798|NCT00394355|529196040|FG000|Overall Study|Subject withdrawal - related to drug|1|||
146733799|NCT00394355|529196041|FG001|Overall Study|Subject withdrawal - related to drug|0|||
146733800|NCT00394355|529196042|FG002|Overall Study|Subject withdrawal - related to drug|0|||
146733801|NCT00394355|529196043|FG003|Overall Study|Subject withdrawal - related to drug|0|||
146733802|NCT00394355|529196040|FG000|Overall Study|Lost to Follow-up|7|||
146733803|NCT00394355|529196041|FG001|Overall Study|Lost to Follow-up|5|||
146733804|NCT00394355|529196042|FG002|Overall Study|Lost to Follow-up|4|||
146733805|NCT00394355|529196043|FG003|Overall Study|Lost to Follow-up|3|||
146733806|NCT00394355|529196040|FG000|Overall Study|Noncompliance with protocol|4|||
146733807|NCT00394355|529196041|FG001|Overall Study|Noncompliance with protocol|3|||
146733808|NCT00394355|529196042|FG002|Overall Study|Noncompliance with protocol|10|||
146733809|NCT00394355|529196043|FG003|Overall Study|Noncompliance with protocol|8|||
146733810|NCT00394355|529196040|FG000|Overall Study|Administrative|0|||
146733811|NCT00394355|529196041|FG001|Overall Study|Administrative|1|||
146733812|NCT00394355|529196042|FG002|Overall Study|Administrative|1|||
146733813|NCT00394355|529196043|FG003|Overall Study|Administrative|1|||
146733814|NCT00394355|529196040|FG000|Overall Study|Lack of Efficacy|0|||
146733815|NCT00394355|529196041|FG001|Overall Study|Lack of Efficacy|0|||
146733816|NCT00394355|529196042|FG002|Overall Study|Lack of Efficacy|2|||
146733817|NCT00394355|529196043|FG003|Overall Study|Lack of Efficacy|3|||
146733818|NCT02686034|529196046|FG000|Run-In Period 1|Eligibility|12|||
146733819|NCT02686034|529196047|FG001|Run-In Period 1|Eligibility|10|||
146733820|NCT02686034|529196046|FG000|Run-In Period 1|Withdrawal by Subject|4|||
146733821|NCT02686034|529196047|FG001|Run-In Period 1|Withdrawal by Subject|3|||
146733822|NCT02686034|529196046|FG000|Run-In Period 1|Lost to Follow-up|4|||
146733823|NCT02686034|529196047|FG001|Run-In Period 1|Lost to Follow-up|4|||
146733824|NCT02686034|529196046|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
146733825|NCT02686034|529196047|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
146733826|NCT02686034|529196046|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
146733827|NCT02686034|529196047|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
146733828|NCT02686034|529196046|FG000|Randomized Controlled Period 2|Adverse Event|0|||
146733829|NCT02686034|529196047|FG001|Randomized Controlled Period 2|Adverse Event|2|||
146733830|NCT02686034|529196046|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
146733831|NCT02686034|529196047|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
146733832|NCT02686034|529196046|FG000|Open Label Period 3|Lost to Follow-up|0|||
146733833|NCT02686034|529196047|FG001|Open Label Period 3|Lost to Follow-up|1|||
146733834|NCT00941798|529196050|FG000|Overall Study|Withdrawal by Subject|72|||
146733835|NCT00941798|529196051|FG001|Overall Study|Withdrawal by Subject|74|||
146733836|NCT00941798|529196050|FG000|Overall Study|Adverse Event|43|||
146733837|NCT00941798|529196051|FG001|Overall Study|Adverse Event|23|||
146733838|NCT00941798|529196050|FG000|Overall Study|Lost to Follow-up|29|||
146733839|NCT00941798|529196051|FG001|Overall Study|Lost to Follow-up|23|||
146733840|NCT00941798|529196050|FG000|Overall Study|Protocol Violation|17|||
146733841|NCT00941798|529196051|FG001|Overall Study|Protocol Violation|20|||
146792180|NCT04171141|529413072|FG002|Overall Study|Global deterioration of health status|0|||
146792181|NCT04171141|529413073|FG003|Overall Study|Global deterioration of health status|1|||
146792182|NCT04171141|529413074|FG004|Overall Study|Global deterioration of health status|0|||
146733842|NCT00941798|529196050|FG000|Overall Study|Administrative problems|13|||
146733843|NCT00941798|529196051|FG001|Overall Study|Administrative problems|23|||
146733844|NCT00941798|529196050|FG000|Overall Study|Lack of Efficacy|10|||
146733845|NCT00941798|529196051|FG001|Overall Study|Lack of Efficacy|17|||
146938790|NCT01079195|529932525|FG000|Overall Study|Withdrawal by Subject|18|||
146733846|NCT00941798|529196050|FG000|Overall Study|Patient's inability to use device|6|||
146733847|NCT00941798|529196051|FG001|Overall Study|Patient's inability to use device|1|||
146733848|NCT00941798|529196050|FG000|Overall Study|Abnormal test procedure results|3|||
146733849|NCT00941798|529196051|FG001|Overall Study|Abnormal test procedure results|1|||
146733850|NCT00941798|529196050|FG000|Overall Study|Abnormal laboratory values|1|||
146733851|NCT00941798|529196051|FG001|Overall Study|Abnormal laboratory values|2|||
146733852|NCT00941798|529196050|FG000|Overall Study|Death|0|||
146733853|NCT00941798|529196051|FG001|Overall Study|Death|1|||
146733854|NCT04179721|529196054|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
146733855|NCT04179721|529196055|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
146733856|NCT04179721|529196054|FG000|Overall Study|Lost to Follow-up|0|||
146733857|NCT04179721|529196055|FG001|Overall Study|Lost to Follow-up|1|||
146733858|NCT01489189|529196056|FG000|Overall Study|Withdrawal by Subject|20|||
146733859|NCT01489189|529196057|FG001|Overall Study|Withdrawal by Subject|23|||
146733860|NCT01489189|529196056|FG000|Overall Study|Death|10|||
146733861|NCT01489189|529196057|FG001|Overall Study|Death|8|||
146733862|NCT01489189|529196056|FG000|Overall Study|Missed Visit|1|||
146733863|NCT01489189|529196057|FG001|Overall Study|Missed Visit|4|||
146733864|NCT00856167|529196061|FG000|Period 1|Withdrawal by Subject|1|||
146733865|NCT00856167|529196062|FG001|Period 1|Withdrawal by Subject|4|||
146733866|NCT00856167|529196063|FG002|Period 1|Withdrawal by Subject|0|||
146733867|NCT00856167|529196064|FG003|Period 1|Withdrawal by Subject|0|||
146733868|NCT00856167|529196061|FG000|Period 1|Lost to Follow-up|2|||
146733869|NCT00856167|529196062|FG001|Period 1|Lost to Follow-up|1|||
146733870|NCT00856167|529196063|FG002|Period 1|Lost to Follow-up|0|||
146733871|NCT00856167|529196064|FG003|Period 1|Lost to Follow-up|0|||
146733872|NCT00856167|529196061|FG000|Period 2|Lost to Follow-up|0|||
146733873|NCT00856167|529196062|FG001|Period 2|Lost to Follow-up|0|||
146733874|NCT00856167|529196063|FG002|Period 2|Lost to Follow-up|3|||
146733875|NCT00856167|529196064|FG003|Period 2|Lost to Follow-up|1|||
146733876|NCT00856167|529196061|FG000|Period 2|Withdrawal by Subject|0|||
146733877|NCT00856167|529196062|FG001|Period 2|Withdrawal by Subject|0|||
146733878|NCT00856167|529196063|FG002|Period 2|Withdrawal by Subject|2|||
146733879|NCT00856167|529196064|FG003|Period 2|Withdrawal by Subject|4|||
146733880|NCT00284141|529197178|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
146733881|NCT00284141|529197178|FG000|Overall Study|Adverse Event|19|||
146733882|NCT00284141|529197178|FG000|Overall Study|Participant's request|9|||
146733883|NCT00284141|529197178|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
146733884|NCT00284141|529197178|FG000|Overall Study|Clinical deterioration / death|2|||
146733885|NCT00284141|529197178|FG000|Overall Study|General decline|1|||
146733886|NCT00284141|529197178|FG000|Overall Study|Pneumonia|1|||
146733887|NCT00284141|529197178|FG000|Overall Study|Did not take study medication|2|||
146733888|NCT00284141|529197178|FG000|Overall Study|Ongoing treatment|2|||
146733889|NCT01160484|529197188|FG000|Overall Study|Lack of Efficacy|9|||
146733890|NCT01160484|529197188|FG000|Overall Study|Adverse Event|6|||
146733891|NCT01160484|529197188|FG000|Overall Study|Withdrawal by Subject|2|||
146733892|NCT01160484|529197188|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
146733893|NCT01782742|529197189|FG000|Double-blind Treatment Phase|Adverse Event|1|||
146733894|NCT01782742|529197190|FG001|Double-blind Treatment Phase|Adverse Event|0|||
146733895|NCT00803101|529197191|FG000|Overall Study|Death / Serious Adverse Event|4|||
146733896|NCT00803101|529197192|FG001|Overall Study|Death / Serious Adverse Event|6|||
146733897|NCT00803101|529197191|FG000|Overall Study|Withdrawal by Subject|6|||
146733898|NCT00803101|529197192|FG001|Overall Study|Withdrawal by Subject|4|||
146733899|NCT00803101|529197191|FG000|Overall Study|Lost to Follow-up|2|||
146733900|NCT00803101|529197192|FG001|Overall Study|Lost to Follow-up|2|||
146733901|NCT00803101|529197191|FG000|Overall Study|Protocol Violation|1|||
146733902|NCT00803101|529197192|FG001|Overall Study|Protocol Violation|7|||
146733903|NCT00803101|529197191|FG000|Overall Study|Surgery finished outside protocol window|1|||
146733904|NCT00803101|529197192|FG001|Overall Study|Surgery finished outside protocol window|1|||
146733905|NCT00803101|529197191|FG000|Overall Study|Patient died outside SAE report period|1|||
146733906|NCT00803101|529197192|FG001|Overall Study|Patient died outside SAE report period|0|||
146733907|NCT00803101|529197191|FG000|Overall Study|Patient did not attend scheduled visit|2|||
146733908|NCT00803101|529197192|FG001|Overall Study|Patient did not attend scheduled visit|1|||
146733909|NCT00803101|529197191|FG000|Overall Study|Patient did not have surgery|1|||
146733910|NCT00803101|529197192|FG001|Overall Study|Patient did not have surgery|1|||
146733911|NCT02790073|529197195|FG000|Overall Study|Death|1|||
146733912|NCT02790073|529197195|FG000|Overall Study|Withdrawal from HD|1|||
146733913|NCT02790073|529197195|FG000|Overall Study|Withdrawal by Subject|1|||
146733914|NCT04170686|529197196|FG000|Screening|Physician Decision|12|||
146938791|NCT01079195|529932525|FG000|Overall Study|Financial Reasons|15|||
146733915|NCT04170686|529197197|FG001|Screening|Physician Decision|13|||
146938792|NCT01079195|529932525|FG000|Overall Study|Lack of Effectiveness|12|||
146938793|NCT01079195|529932525|FG000|Overall Study|Physician Decision|4|||
146733916|NCT04170686|529197196|FG000|Randomization and Treatment|Lost to Follow-up|26|||
146733917|NCT04170686|529197197|FG001|Randomization and Treatment|Lost to Follow-up|15|||
146733918|NCT03328143|529197198|FG000|Overall Study|Declined|3|||
146733919|NCT03328143|529197198|FG000|Overall Study|Required increased sedation|4|||
146733920|NCT03328143|529197198|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
146733921|NCT03328143|529197198|FG000|Overall Study|Surgery cancelled|1|||
146733922|NCT02882282|529197199|FG000|Overall Study|Adverse Event|1|||
146733923|NCT02882282|529197200|FG001|Overall Study|Adverse Event|0|||
146733924|NCT02487498|529197201|FG000|Period: Period 1|Adverse Event|2|||
146733925|NCT02487498|529197202|FG001|Period: Period 1|Adverse Event|4|||
146733926|NCT02487498|529197201|FG000|Period: Period 1|Subject/guardian decision|2|||
146733927|NCT02487498|529197202|FG001|Period: Period 1|Subject/guardian decision|4|||
146733928|NCT02487498|529197201|FG000|Period: Period 1|Lost to Follow-up|0|||
146733929|NCT02487498|529197202|FG001|Period: Period 1|Lost to Follow-up|2|||
146733930|NCT02487498|529197201|FG000|Period: Period 1|Lack of Efficacy|1|||
146733931|NCT02487498|529197202|FG001|Period: Period 1|Lack of Efficacy|0|||
146733932|NCT02487498|529197201|FG000|Period: Period 1|Physician Decision|0|||
146733933|NCT02487498|529197202|FG001|Period: Period 1|Physician Decision|1|||
146733934|NCT02487498|529197201|FG000|Period: Period 1|Protocol deviation|1|||
146733935|NCT02487498|529197202|FG001|Period: Period 1|Protocol deviation|0|||
146733936|NCT02487498|529197201|FG000|Period: Washout|Subject/guardian decision|0|||
146733937|NCT02487498|529197202|FG001|Period: Washout|Subject/guardian decision|5|||
146733938|NCT02487498|529197201|FG000|Period: Washout|Lack of Efficacy|1|||
146733939|NCT02487498|529197202|FG001|Period: Washout|Lack of Efficacy|1|||
146733940|NCT02487498|529197201|FG000|Period: Washout|Physician Decision|1|||
146733941|NCT02487498|529197202|FG001|Period: Washout|Physician Decision|0|||
146733942|NCT02487498|529197201|FG000|Period: Washout|Non-compliance with study treatment|0|||
146733943|NCT02487498|529197202|FG001|Period: Washout|Non-compliance with study treatment|1|||
146733944|NCT02487498|529197201|FG000|Period: Period 2|Adverse Event|2|||
146733945|NCT02487498|529197202|FG001|Period: Period 2|Adverse Event|2|||
146733946|NCT02487498|529197201|FG000|Period: Period 2|Subject/guardian decision|2|||
146733947|NCT02487498|529197202|FG001|Period: Period 2|Subject/guardian decision|1|||
146733948|NCT02487498|529197201|FG000|Period: Period 2|Lost to Follow-up|1|||
146733949|NCT02487498|529197202|FG001|Period: Period 2|Lost to Follow-up|1|||
146733950|NCT02487498|529197201|FG000|Period: Period 2|Death|0|||
146733951|NCT02487498|529197202|FG001|Period: Period 2|Death|1|||
146733952|NCT02487498|529197201|FG000|Period: Period 2|Physician Decision|1|||
146733953|NCT02487498|529197202|FG001|Period: Period 2|Physician Decision|0|||
146733954|NCT00676130|529197203|FG000|Overall Study|Lost to Follow-up|0|||
146733955|NCT00676130|529197204|FG001|Overall Study|Lost to Follow-up|1|||
146733956|NCT00676130|529197203|FG000|Overall Study|Found ineligible|3|||
146733957|NCT00676130|529197204|FG001|Overall Study|Found ineligible|2|||
146733958|NCT00676130|529197203|FG000|Overall Study|Withdrawal by Subject|0|||
146733959|NCT00676130|529197204|FG001|Overall Study|Withdrawal by Subject|1|||
146733960|NCT00331344|529197209|FG000|Phase I|Adverse Event|0|||
146733961|NCT00331344|529197210|FG001|Phase I|Adverse Event|0|||
146733962|NCT00331344|529197211|FG002|Phase I|Adverse Event|0|||
146733963|NCT00331344|529197212|FG003|Phase I|Adverse Event|1|||
146733964|NCT00331344|529197213|FG004|Phase I|Adverse Event|2|||
146733965|NCT00331344|529197214|FG005|Phase I|Adverse Event|2|||
146733966|NCT00331344|529197215|FG006|Phase I|Adverse Event|0|||
146733967|NCT00331344|529197216|FG007|Phase I|Adverse Event|1|||
146733968|NCT00331344|529197217|FG008|Phase I|Adverse Event|0|||
146733969|NCT00331344|529197209|FG000|Phase II|Death|0|||
146733970|NCT00331344|529197210|FG001|Phase II|Death|0|||
146733971|NCT00331344|529197211|FG002|Phase II|Death|0|||
146733972|NCT00331344|529197212|FG003|Phase II|Death|0|||
146733973|NCT00331344|529197213|FG004|Phase II|Death|0|||
146733974|NCT00331344|529197214|FG005|Phase II|Death|0|||
146733975|NCT00331344|529197215|FG006|Phase II|Death|0|||
146733976|NCT00331344|529197216|FG007|Phase II|Death|0|||
146733977|NCT00331344|529197217|FG008|Phase II|Death|4|||
146733978|NCT04538144|529197218|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
146938794|NCT01079195|529932525|FG000|Overall Study|Improved Status of Participant|4|||
146938795|NCT01079195|529932525|FG000|Overall Study|No Follow-up Documentation Available|4|||
146938796|NCT01079195|529932525|FG000|Overall Study|Non-compliance|2|||
146938797|NCT02091921|529932531|FG000|Overall Study|Adverse Event|3|||
146733979|NCT04538144|529197219|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
146733980|NCT04538144|529197220|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
146733981|NCT04538144|529197221|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
146733982|NCT01181726|529197224|FG000|First Intervention|Adverse Event|1|||
146733983|NCT01181726|529197225|FG001|First Intervention|Adverse Event|0|||
146733984|NCT02696564|529197229|FG000|Overall Study|Death|1|||
146733985|NCT02696564|529197230|FG001|Overall Study|Death|2|||
146733986|NCT02696564|529197229|FG000|Overall Study|Withdrawal by Subject|3|||
146938798|NCT03307629|529932532|FG000|Overall Study|Withdrawal by Subject|0|||
146733987|NCT02696564|529197230|FG001|Overall Study|Withdrawal by Subject|2|||
146733988|NCT02696564|529197229|FG000|Overall Study|Lost to Follow-up|3|||
146733989|NCT02696564|529197230|FG001|Overall Study|Lost to Follow-up|3|||
146733990|NCT02696564|529197229|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
146733991|NCT02696564|529197230|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
146733992|NCT02696564|529197229|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
146733993|NCT02696564|529197230|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
146733994|NCT02696564|529197229|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
146733995|NCT02696564|529197230|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
146733996|NCT02696564|529197229|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
146733997|NCT02696564|529197230|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
146733998|NCT02696564|529197229|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
146733999|NCT02696564|529197230|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
146734000|NCT03633929|529197231|FG000|Overall Study|Lost to Follow-up|1|||
146734001|NCT03633929|529197231|FG000|Overall Study|Did not login to software. Did not participate|3|||
146734002|NCT01520402|529197232|FG000|Overall Study|Withdrawal by Subject|2|||
146734003|NCT01520402|529197232|FG000|Overall Study|Physician Decision|3|||
146734004|NCT01722162|529197233|FG000|Overall Study|Withdrawal by Subject|1|||
146734005|NCT01722162|529197234|FG001|Overall Study|Withdrawal by Subject|1|||
146734006|NCT01722162|529197233|FG000|Overall Study|Found ineligible|1|||
146734007|NCT01722162|529197234|FG001|Overall Study|Found ineligible|0|||
146734008|NCT01722162|529197233|FG000|Overall Study|Unrelated to study adverse event|2|||
146734009|NCT01722162|529197234|FG001|Overall Study|Unrelated to study adverse event|2|||
146734010|NCT01722162|529197233|FG000|Overall Study|Adverse Event|1|||
146734011|NCT01722162|529197234|FG001|Overall Study|Adverse Event|1|||
146734012|NCT01722162|529197233|FG000|Overall Study|Insurance denial post enrollment|0|||
146734013|NCT01722162|529197234|FG001|Overall Study|Insurance denial post enrollment|1|||
146734014|NCT01722162|529197233|FG000|Overall Study|Noncompliance|0|||
146734015|NCT01722162|529197234|FG001|Overall Study|Noncompliance|1|||
146734016|NCT02487810|529197235|FG000|Overall Study|Withdrawal by Subject|1|||
146734017|NCT02487810|529197236|FG001|Overall Study|Withdrawal by Subject|0|||
146734018|NCT00077064|529197239|FG000|Overall Study|Adverse Event|0|||
146792183|NCT04171141|529413075|FG005|Overall Study|Global deterioration of health status|2|||
146792184|NCT04171141|529413076|FG006|Overall Study|Global deterioration of health status|1|||
146734019|NCT00077064|529197240|FG001|Overall Study|Adverse Event|4|||
146792185|NCT04171141|529413077|FG007|Overall Study|Global deterioration of health status|0|||
146792186|NCT04171141|529413078|FG008|Overall Study|Global deterioration of health status|1|||
146792187|NCT04171141|529413079|FG009|Overall Study|Global deterioration of health status|0|||
146792188|NCT04171141|529413080|FG010|Overall Study|Global deterioration of health status|0|||
146792189|NCT04171141|529413081|FG011|Overall Study|Global deterioration of health status|0|||
146792190|NCT04171141|529413082|FG012|Overall Study|Global deterioration of health status|0|||
146792191|NCT04171141|529413083|FG013|Overall Study|Global deterioration of health status|0|||
146792192|NCT04171141|529413084|FG014|Overall Study|Global deterioration of health status|1|||
146792193|NCT04171141|529413085|FG015|Overall Study|Global deterioration of health status|1|||
146792194|NCT03663569|529413088|FG000|Overall Study|Discontinuation of study|11|||
146792195|NCT03663569|529413088|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
146792196|NCT03663569|529413088|FG000|Overall Study|Deceased patient|6|||
146792197|NCT03663569|529413088|FG000|Overall Study|Lost to Follow-up|18|||
146792198|NCT03663569|529413088|FG000|Overall Study|Withdrawal of consent|5|||
146792199|NCT03663569|529413088|FG000|Overall Study|Patient's request|11|||
146792200|NCT03663569|529413088|FG000|Overall Study|Adverse Event|4|||
146792201|NCT03663569|529413088|FG000|Overall Study|Not come to second visit|3|||
146792202|NCT03663569|529413088|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
146792203|NCT03663569|529413088|FG000|Overall Study|Serious adverse event|1|||
146938799|NCT03307629|529932533|FG001|Overall Study|Withdrawal by Subject|0|||
146938800|NCT03307629|529932534|FG002|Overall Study|Withdrawal by Subject|0|||
146938801|NCT03307629|529932535|FG003|Overall Study|Withdrawal by Subject|2|||
146734020|NCT00077064|529197239|FG000|Overall Study|Patient refusal|0|||
146734021|NCT00077064|529197240|FG001|Overall Study|Patient refusal|2|||
146734022|NCT01281202|529197244|FG000|Overall Study|Adverse Event|2|||
146734023|NCT01281202|529197245|FG001|Overall Study|Adverse Event|0|||
146734024|NCT01281202|529197244|FG000|Overall Study|Withdrawal by Subject|2|||
146734025|NCT01281202|529197245|FG001|Overall Study|Withdrawal by Subject|2|||
146938802|NCT03307629|529932532|FG000|Overall Study|Disease Progression|0|||
146938803|NCT03307629|529932533|FG001|Overall Study|Disease Progression|0|||
146938804|NCT03307629|529932534|FG002|Overall Study|Disease Progression|0|||
146938805|NCT03307629|529932535|FG003|Overall Study|Disease Progression|3|||
146938806|NCT03307629|529932532|FG000|Overall Study|Death|0|||
146734026|NCT01281202|529197244|FG000|Overall Study|Protocol Violation|11|||
146734027|NCT01281202|529197245|FG001|Overall Study|Protocol Violation|10|||
146734028|NCT01281202|529197244|FG000|Overall Study|Administrative|2|||
146938807|NCT03307629|529932533|FG001|Overall Study|Death|3|||
146938808|NCT03307629|529932534|FG002|Overall Study|Death|0|||
146938809|NCT03307629|529932535|FG003|Overall Study|Death|1|||
146734029|NCT01281202|529197245|FG001|Overall Study|Administrative|8|||
146734030|NCT01281202|529197244|FG000|Overall Study|Lost to Follow-up|11|||
146792204|NCT04979442|529413091|FG000|Overall Study|Death|43|||
146734031|NCT01281202|529197245|FG001|Overall Study|Lost to Follow-up|13|||
146734032|NCT01281202|529197244|FG000|Overall Study|Incarceration|0|||
146734033|NCT01281202|529197245|FG001|Overall Study|Incarceration|3|||
146734034|NCT03759834|529197246|FG000|Overall Study|Withdrawal by Subject|1|||
146734035|NCT00633464|529197247|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
146734036|NCT00633464|529197248|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
146734037|NCT00633464|529197247|FG000|Overall Study|Never Treated (Randomized in error)|0|||
146734038|NCT00633464|529197248|FG001|Overall Study|Never Treated (Randomized in error)|1|||
146734039|NCT02612064|529197249|FG000|Overall Study|Withdrawal by Subject|1|||
146734040|NCT02612064|529197250|FG001|Overall Study|Withdrawal by Subject|1|||
146734041|NCT02612064|529197249|FG000|Overall Study|Other|0|||
146734042|NCT02612064|529197250|FG001|Overall Study|Other|2|||
146734043|NCT05805657|529197255|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
146734044|NCT05805657|529197256|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
146734045|NCT03764072|529197257|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
146734046|NCT03764072|529197258|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
146734047|NCT03764072|529197259|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
146734048|NCT03764072|529197260|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
146734049|NCT03764072|529197261|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
146734050|NCT03764072|529197262|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
146734051|NCT03764072|529197257|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
146734052|NCT03764072|529197258|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
146734053|NCT03764072|529197259|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
146734054|NCT03764072|529197260|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
146734055|NCT03764072|529197261|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
146734056|NCT03764072|529197262|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
146734057|NCT03764072|529197257|FG000|Overall Study|Lost to Follow-up|0|||
146734058|NCT03764072|529197258|FG001|Overall Study|Lost to Follow-up|0|||
146734059|NCT03764072|529197259|FG002|Overall Study|Lost to Follow-up|0|||
146734060|NCT03764072|529197260|FG003|Overall Study|Lost to Follow-up|0|||
146734061|NCT03764072|529197261|FG004|Overall Study|Lost to Follow-up|1|||
146734062|NCT03764072|529197262|FG005|Overall Study|Lost to Follow-up|0|||
146734063|NCT00459342|529197264|FG000|Overall Study|Not eligible|1|||
146734064|NCT00542880|529197265|FG000|Period 1|Eligibility criteria not fulfilled|2|||
146734065|NCT00542880|529197266|FG001|Period 1|Eligibility criteria not fulfilled|6|||
146734066|NCT00542880|529197265|FG000|Period 1|Adverse Event|2|||
146734067|NCT00542880|529197266|FG001|Period 1|Adverse Event|2|||
146734068|NCT00542880|529197265|FG000|Period 1|Development of study-specific criteria|1|||
146734069|NCT00542880|529197266|FG001|Period 1|Development of study-specific criteria|2|||
146734070|NCT00542880|529197265|FG000|Period 1|Withdrawal by Subject|1|||
146734071|NCT00542880|529197266|FG001|Period 1|Withdrawal by Subject|1|||
146734072|NCT00542880|529197265|FG000|Period 1|Protocol Violation|0|||
146734073|NCT00542880|529197266|FG001|Period 1|Protocol Violation|1|||
146734074|NCT00542880|529197265|FG000|Period 2|Adverse Event|5|||
146734075|NCT00542880|529197266|FG001|Period 2|Adverse Event|7|||
146734076|NCT00542880|529197265|FG000|Period 2|Eligibility not fulfilled|0|||
146734077|NCT00542880|529197266|FG001|Period 2|Eligibility not fulfilled|1|||
146734078|NCT00542880|529197265|FG000|Period 2|Discontinuation criteria|2|||
146734079|NCT00542880|529197266|FG001|Period 2|Discontinuation criteria|0|||
146734080|NCT00542880|529197265|FG000|Period 2|Severe non-compliance|0|||
146734081|NCT00542880|529197266|FG001|Period 2|Severe non-compliance|1|||
146734082|NCT00542880|529197265|FG000|Period 2|Other|0|||
146734083|NCT00542880|529197266|FG001|Period 2|Other|1|||
146734084|NCT00542880|529197265|FG000|Period 3|Adverse Event|0|||
146734085|NCT00542880|529197266|FG001|Period 3|Adverse Event|2|||
146734086|NCT00696384|529197267|FG000|Open Label Phase|Adverse Event|27|||
146734087|NCT00696384|529197268|FG001|Open Label Phase|Adverse Event|0|||
146734088|NCT00696384|529197269|FG002|Open Label Phase|Adverse Event|0|||
146734089|NCT00696384|529197267|FG000|Open Label Phase|Protocol Violation|18|||
146734090|NCT00696384|529197268|FG001|Open Label Phase|Protocol Violation|0|||
146734091|NCT00696384|529197269|FG002|Open Label Phase|Protocol Violation|0|||
146734092|NCT00696384|529197267|FG000|Open Label Phase|Lost to Follow-up|24|||
146734093|NCT00696384|529197268|FG001|Open Label Phase|Lost to Follow-up|0|||
146734094|NCT00696384|529197269|FG002|Open Label Phase|Lost to Follow-up|0|||
146734095|NCT00696384|529197267|FG000|Open Label Phase|Withdrawal by Subject|37|||
146734096|NCT00696384|529197268|FG001|Open Label Phase|Withdrawal by Subject|0|||
146734097|NCT00696384|529197269|FG002|Open Label Phase|Withdrawal by Subject|0|||
146734098|NCT00696384|529197267|FG000|Open Label Phase|Other|6|||
146734099|NCT00696384|529197268|FG001|Open Label Phase|Other|0|||
146734100|NCT00696384|529197269|FG002|Open Label Phase|Other|0|||
146734101|NCT00696384|529197267|FG000|Open Label Phase|Lack of Efficacy|3|||
146734102|NCT00696384|529197268|FG001|Open Label Phase|Lack of Efficacy|0|||
146734103|NCT00696384|529197269|FG002|Open Label Phase|Lack of Efficacy|0|||
146734104|NCT00696384|529197267|FG000|Open Label Phase|Physician Decision|4|||
146982167|NCT02173301|530096221|FG000|Overall Study|Lost to Follow-up|4|||
146734105|NCT00696384|529197268|FG001|Open Label Phase|Physician Decision|0|||
146734106|NCT00696384|529197269|FG002|Open Label Phase|Physician Decision|0|||
146734107|NCT00696384|529197267|FG000|Double Blind Phase|Adverse Event|0|||
146734108|NCT00696384|529197268|FG001|Double Blind Phase|Adverse Event|2|||
146734109|NCT00696384|529197269|FG002|Double Blind Phase|Adverse Event|2|||
146734110|NCT00696384|529197267|FG000|Double Blind Phase|Lost to Follow-up|0|||
146734111|NCT00696384|529197268|FG001|Double Blind Phase|Lost to Follow-up|2|||
146734112|NCT00696384|529197269|FG002|Double Blind Phase|Lost to Follow-up|1|||
146734113|NCT00696384|529197267|FG000|Double Blind Phase|Withdrawal by Subject|0|||
146734114|NCT00696384|529197268|FG001|Double Blind Phase|Withdrawal by Subject|4|||
146734115|NCT00696384|529197269|FG002|Double Blind Phase|Withdrawal by Subject|3|||
146734116|NCT00696384|529197267|FG000|Double Blind Phase|Lack of Efficacy|0|||
146734117|NCT00696384|529197268|FG001|Double Blind Phase|Lack of Efficacy|1|||
146734118|NCT00696384|529197269|FG002|Double Blind Phase|Lack of Efficacy|0|||
146734119|NCT00696384|529197267|FG000|Double Blind Phase|Physician Decision|0|||
146734120|NCT00696384|529197268|FG001|Double Blind Phase|Physician Decision|2|||
146734121|NCT00696384|529197269|FG002|Double Blind Phase|Physician Decision|0|||
146734122|NCT01678131|529197270|FG000|Overall Study|Adverse Event|0|||
146734123|NCT01678131|529197271|FG001|Overall Study|Adverse Event|1|||
146734124|NCT01678131|529197272|FG002|Overall Study|Adverse Event|0|||
146734125|NCT01678131|529197270|FG000|Overall Study|Withdrawal by Subject|0|||
146734126|NCT01678131|529197271|FG001|Overall Study|Withdrawal by Subject|0|||
146734127|NCT01678131|529197272|FG002|Overall Study|Withdrawal by Subject|2|||
146734128|NCT00558064|529197273|FG000|Overall Study|Adverse Event|3|||
146734129|NCT00558064|529197274|FG001|Overall Study|Adverse Event|2|||
146734130|NCT00558064|529197273|FG000|Overall Study|Lack of Efficacy|0|||
146734131|NCT00558064|529197274|FG001|Overall Study|Lack of Efficacy|1|||
146734132|NCT00558064|529197273|FG000|Overall Study|Protocol Violation|1|||
146734133|NCT00558064|529197274|FG001|Overall Study|Protocol Violation|0|||
146734134|NCT00558064|529197273|FG000|Overall Study|Lost to Follow-up|0|||
146734135|NCT00558064|529197274|FG001|Overall Study|Lost to Follow-up|1|||
146734136|NCT00558064|529197273|FG000|Overall Study|Withdrawal by Subject|0|||
146734137|NCT00558064|529197274|FG001|Overall Study|Withdrawal by Subject|1|||
146734138|NCT00558064|529197273|FG000|Overall Study|No visit within allowance period|1|||
146734139|NCT00558064|529197274|FG001|Overall Study|No visit within allowance period|0|||
146734140|NCT02027402|529197276|FG000|Overall Study|Withdrawal by Subject|4|||
146734141|NCT02027402|529197277|FG001|Overall Study|Withdrawal by Subject|1|||
146734142|NCT00982930|529197278|FG000|Overall Study|Adverse Event|1|||
146734143|NCT00982930|529197278|FG000|Overall Study|Withdrawal by Subject|1|||
146734144|NCT00982930|529197278|FG000|Overall Study|Administrative Problems|2|||
146734145|NCT00112580|529197279|FG000|Overall Study|Adverse Event|1|||
146734146|NCT00112580|529197280|FG001|Overall Study|Adverse Event|2|||
146734147|NCT00112580|529197279|FG000|Overall Study|Disease progression|5|||
146734148|NCT00112580|529197280|FG001|Overall Study|Disease progression|16|||
146734149|NCT00112580|529197279|FG000|Overall Study|Participant withdrew consent|2|||
146734150|NCT00112580|529197280|FG001|Overall Study|Participant withdrew consent|1|||
146734151|NCT05597722|529197283|FG000|Overall Study|Study was terminated|6|||
146734152|NCT05597722|529197284|FG001|Overall Study|Study was terminated|1|||
146734153|NCT00404495|529197285|FG000|Overall Study|Death|37|||
146734154|NCT00404495|529197286|FG001|Overall Study|Death|11|||
146734155|NCT00404495|529197285|FG000|Overall Study|Lost to Follow-up|5|||
146734156|NCT00404495|529197286|FG001|Overall Study|Lost to Follow-up|0|||
146734157|NCT00404495|529197285|FG000|Overall Study|Other|1|||
146734158|NCT00404495|529197286|FG001|Overall Study|Other|0|||
146734159|NCT00404495|529197285|FG000|Overall Study|Withdrawal by Subject|1|||
146734160|NCT00404495|529197286|FG001|Overall Study|Withdrawal by Subject|0|||
146734161|NCT03904043|529197289|FG000|Overall Study|Adverse Event|1|||
146734162|NCT03904043|529197290|FG001|Overall Study|Adverse Event|1|||
146734163|NCT03904043|529197289|FG000|Overall Study|Withdrawal by Subject|1|||
146734164|NCT03904043|529197290|FG001|Overall Study|Withdrawal by Subject|0|||
146734165|NCT03904043|529197289|FG000|Overall Study|Non-compliance|1|||
146734166|NCT03904043|529197290|FG001|Overall Study|Non-compliance|0|||
146734167|NCT03904043|529197289|FG000|Overall Study|Did not start treatment|1|||
146734168|NCT03904043|529197290|FG001|Overall Study|Did not start treatment|0|||
146734169|NCT05619003|529197291|FG000|Overall Study|Adverse Event|1|||
146734170|NCT03538951|529197292|FG000|Overall Study|Withdrawal by Subject|1|||
146734171|NCT03538951|529197293|FG001|Overall Study|Withdrawal by Subject|2|||
146734172|NCT03444376|529197298|FG000|Part A|Disease relapse or Progression|1|||
146734173|NCT03444376|529197298|FG000|Part A|Withdrawal by Subject|2|||
146734174|NCT03444376|529197298|FG000|Part A|Adverse Event|1|||
146734175|NCT03444376|529197298|FG000|Part B|Disease relapse or Progression|18|||
146734176|NCT03444376|529197298|FG000|Part B|Withdrawal by Subject|2|||
146734177|NCT03444376|529197298|FG000|Part B|Adverse Event|2|||
146734178|NCT03444376|529197298|FG000|Part B|Physician Decision|1|||
146982168|NCT02173301|530096222|FG001|Overall Study|Lost to Follow-up|4|||
146734179|NCT03444376|529197298|FG000|Part C|Disease relapse or Progression|43|||
146734180|NCT03444376|529197298|FG000|Part C|Withdrawal by Subject|5|||
146734181|NCT03444376|529197298|FG000|Part C|Adverse Event|2|||
146734182|NCT03444376|529197298|FG000|Part C|Physician Decision|2|||
146734183|NCT03444376|529197298|FG000|Part C|Death|1|||
146734184|NCT01529008|529199153|FG000|Bone Marrow Harvesting|Physician Decision|1|||
146734185|NCT01529008|529199154|FG001|Bone Marrow Harvesting|Physician Decision|1|||
146734186|NCT01529008|529199153|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
146734187|NCT01529008|529199154|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
146734188|NCT01529008|529199153|FG000|Treatment|Adverse Event|6|||
146734189|NCT01529008|529199154|FG001|Treatment|Adverse Event|0|||
146734190|NCT01529008|529199153|FG000|Treatment|Other|3|||
146734191|NCT01529008|529199154|FG001|Treatment|Other|1|||
146734192|NCT01529008|529199153|FG000|Efficacy Analysis|Protocol Violation|2|||
146734193|NCT01529008|529199154|FG001|Efficacy Analysis|Protocol Violation|0|||
146734194|NCT01529008|529199153|FG000|Efficacy Analysis|Physician Decision|0|||
146734195|NCT01529008|529199154|FG001|Efficacy Analysis|Physician Decision|1|||
146734196|NCT01529008|529199153|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
146734197|NCT01529008|529199154|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
146734198|NCT00332332|529199155|FG000|Overall Study|Adverse Event|13|||
146734199|NCT00332332|529199155|FG000|Overall Study|Death|1|||
146734200|NCT00332332|529199155|FG000|Overall Study|Withdrawal by Subject|8|||
146734201|NCT00332332|529199155|FG000|Overall Study|Physician Decision|1|||
146734202|NCT00332332|529199155|FG000|Overall Study|Lost to Follow-up|3|||
146792205|NCT04979442|529413092|FG001|Overall Study|Death|30|||
146792206|NCT04979442|529413091|FG000|Overall Study|Withdrawal by Subject|8|||
146792207|NCT04979442|529413092|FG001|Overall Study|Withdrawal by Subject|13|||
146792208|NCT04979442|529413091|FG000|Overall Study|Physician Decision|1|||
146792209|NCT04979442|529413092|FG001|Overall Study|Physician Decision|1|||
146792210|NCT04979442|529413091|FG000|Overall Study|Lost to Follow-up|0|||
146792211|NCT04979442|529413092|FG001|Overall Study|Lost to Follow-up|2|||
146792212|NCT04979442|529413091|FG000|Overall Study|do not want to continue|0|||
146792213|NCT04979442|529413092|FG001|Overall Study|do not want to continue|1|||
146792214|NCT04298983|529413093|FG000|Overall Study|Adverse Event|4|||
146792215|NCT04298983|529413093|FG000|Overall Study|Lack of Efficacy|3|||
146792216|NCT04005794|529413094|FG000|Overall Study|Lost to Follow-up|0|||
146792217|NCT04005794|529413095|FG001|Overall Study|Lost to Follow-up|4|||
146792218|NCT04005794|529413096|FG002|Overall Study|Lost to Follow-up|0|||
146792219|NCT04042233|529413097|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
146792220|NCT04042233|529413098|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
146792221|NCT04042233|529413097|FG000|Overall Study|Protocol Violation|0|||
146792222|NCT04042233|529413098|FG001|Overall Study|Protocol Violation|2|||
146734203|NCT00332332|529199155|FG000|Overall Study|Protocol deviation|4|||
146734204|NCT00332332|529199155|FG000|Overall Study|Noncompliance|2|||
146734205|NCT00332332|529199155|FG000|Overall Study|Disease progression|2|||
146734206|NCT00332332|529199155|FG000|Overall Study|Other|18|||
146734207|NCT00332332|529199155|FG000|Overall Study|Did not receive study treatment|16|||
146734208|NCT01382602|529199156|FG000|Overall Study|Protocol Violation|0|||
146734209|NCT01382602|529199157|FG001|Overall Study|Protocol Violation|3|||
146734210|NCT01382602|529199156|FG000|Overall Study|Withdrawal by Subject|0|||
146734211|NCT01382602|529199157|FG001|Overall Study|Withdrawal by Subject|1|||
146734212|NCT04425902|529199162|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
146734213|NCT01191840|529199163|FG000|Overall Study|withdrew consent|2|||
146734214|NCT01191840|529199164|FG001|Overall Study|withdrew consent|1|||
146792223|NCT04907851|529413099|FG000|Overall Study|Consent withdrawn|1|||
146792224|NCT04907851|529413100|FG001|Overall Study|Consent withdrawn|2|||
146792225|NCT04907851|529413101|FG002|Overall Study|Consent withdrawn|0|||
146792226|NCT04907851|529413099|FG000|Overall Study|Death|5|||
146792227|NCT04907851|529413100|FG001|Overall Study|Death|15|||
146792228|NCT04907851|529413101|FG002|Overall Study|Death|10|||
146792229|NCT03766685|529413102|FG000|Overall Study|Lost to Follow-up|1|||
146792230|NCT03766685|529413103|FG001|Overall Study|Lost to Follow-up|1|||
146792231|NCT03766685|529413104|FG002|Overall Study|Lost to Follow-up|0|||
146792232|NCT03766685|529413105|FG003|Overall Study|Lost to Follow-up|0|||
146792233|NCT03766685|529413102|FG000|Overall Study|Adverse Event, not fatal|0|||
146734215|NCT01191840|529199163|FG000|Overall Study|Subject discontinued treatment|1|||
146734216|NCT01191840|529199164|FG001|Overall Study|Subject discontinued treatment|2|||
146734217|NCT01191840|529199163|FG000|Overall Study|Lost to Follow-up|4|||
146792234|NCT03766685|529413103|FG001|Overall Study|Adverse Event, not fatal|1|||
146792235|NCT03766685|529413104|FG002|Overall Study|Adverse Event, not fatal|0|||
146792236|NCT03766685|529413105|FG003|Overall Study|Adverse Event, not fatal|1|||
146792237|NCT03766685|529413102|FG000|Overall Study|Withdrawal by Subject|0|||
146792238|NCT03766685|529413103|FG001|Overall Study|Withdrawal by Subject|2|||
146734218|NCT01191840|529199164|FG001|Overall Study|Lost to Follow-up|6|||
146734219|NCT01191840|529199163|FG000|Overall Study|Non Staph Infection|4|||
146734220|NCT01191840|529199164|FG001|Overall Study|Non Staph Infection|3|||
146734221|NCT01191840|529199163|FG000|Overall Study|ineligible at enrollment|1|||
146734222|NCT01191840|529199164|FG001|Overall Study|ineligible at enrollment|0|||
146792239|NCT03766685|529413104|FG002|Overall Study|Withdrawal by Subject|0|||
146792240|NCT03766685|529413105|FG003|Overall Study|Withdrawal by Subject|0|||
146792241|NCT03766685|529413102|FG000|Overall Study|Protocol Violation|0|||
146792242|NCT03766685|529413103|FG001|Overall Study|Protocol Violation|1|||
146792243|NCT03766685|529413104|FG002|Overall Study|Protocol Violation|0|||
146734223|NCT01191840|529199163|FG000|Overall Study|IRB approval lapse|0|||
146734224|NCT01191840|529199164|FG001|Overall Study|IRB approval lapse|2|||
146734225|NCT01191840|529199163|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
146734226|NCT01191840|529199164|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
146734227|NCT01191840|529199163|FG000|Overall Study|Withdrawal by Subject|2|||
146734228|NCT01191840|529199164|FG001|Overall Study|Withdrawal by Subject|0|||
146734229|NCT04669600|529199165|FG000|Overall Study|Withdrawal by Subject|1|||
146734230|NCT04669600|529199165|FG000|Overall Study|Other|6|||
146734231|NCT00710606|529199168|FG000|Overall Study|Adverse Event|0|||
146734232|NCT00710606|529199169|FG001|Overall Study|Adverse Event|2|||
146734233|NCT01373931|529199181|FG000|Lead-in Period|Adverse Event|2|||
146734234|NCT01373931|529199182|FG001|Lead-in Period|Adverse Event|0|||
146734235|NCT01373931|529199181|FG000|Period 1|Adverse Event|2|||
146734236|NCT01373931|529199182|FG001|Period 1|Adverse Event|0|||
146734237|NCT01373931|529199181|FG000|Period 1|Withdrawal by Subject|0|||
146734238|NCT01373931|529199182|FG001|Period 1|Withdrawal by Subject|2|||
146734239|NCT01682213|529199188|FG000|Overall Study|Withdrawal by Subject|2|||
146734240|NCT01995539|529199189|FG000|Overall Study|Screening Failure|1|||
146734241|NCT01995539|529199189|FG000|Overall Study|Withdrawal by Investigator|15|||
146734242|NCT01995539|529199189|FG000|Overall Study|Withdrawal by Subject|11|||
146734243|NCT01995539|529199189|FG000|Overall Study|Lost to Follow-up|5|||
146734244|NCT01995539|529199189|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
146734245|NCT01264380|529199190|FG000|Period C|Disease Progression|0|||
146734246|NCT01264380|529199191|FG001|Period C|Disease Progression|0|||
146734247|NCT01264380|529199192|FG002|Period C|Disease Progression|4|||
146734248|NCT01264380|529199190|FG000|Period C|Death|0|||
146734249|NCT01264380|529199191|FG001|Period C|Death|0|||
146734250|NCT01264380|529199192|FG002|Period C|Death|2|||
146734251|NCT01264380|529199190|FG000|Period C|Follow-up for survival status|0|||
146734252|NCT01264380|529199191|FG001|Period C|Follow-up for survival status|0|||
146734253|NCT01264380|529199192|FG002|Period C|Follow-up for survival status|6|||
146734254|NCT01264380|529199190|FG000|Period C|Withdrawal by Subject|0|||
146734255|NCT01264380|529199191|FG001|Period C|Withdrawal by Subject|0|||
146734256|NCT01264380|529199192|FG002|Period C|Withdrawal by Subject|1|||
146734257|NCT01264380|529199190|FG000|Period C|Adverse Event|0|||
146734258|NCT01264380|529199191|FG001|Period C|Adverse Event|0|||
146734259|NCT01264380|529199192|FG002|Period C|Adverse Event|1|||
146734260|NCT01147822|529199193|FG000|Overall Study|Lost to Follow-up|14|||
146734261|NCT01147822|529199194|FG001|Overall Study|Lost to Follow-up|6|||
146734262|NCT01147822|529199193|FG000|Overall Study|Withdrawal by Subject|10|||
146734263|NCT01147822|529199194|FG001|Overall Study|Withdrawal by Subject|16|||
146734264|NCT01147822|529199193|FG000|Overall Study|Physician Decision|9|||
146734265|NCT01147822|529199194|FG001|Overall Study|Physician Decision|8|||
146734266|NCT01147822|529199193|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
146734267|NCT01147822|529199194|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
146734268|NCT01147822|529199193|FG000|Overall Study|Protocol Violation|1|||
146734269|NCT01147822|529199194|FG001|Overall Study|Protocol Violation|1|||
146734270|NCT00261495|529199198|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
146734271|NCT00261495|529199199|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
146734272|NCT00261495|529199198|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
146734273|NCT00261495|529199199|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
146734274|NCT00261495|529199198|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
146734275|NCT00261495|529199199|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
146734276|NCT00261495|529199198|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
146734277|NCT00261495|529199199|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
146734278|NCT00261495|529199198|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
146734279|NCT00261495|529199199|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
146734280|NCT00261495|529199198|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
146734281|NCT00261495|529199199|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
146734282|NCT00261495|529199198|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
146734283|NCT00261495|529199199|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
146734284|NCT00261495|529199198|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
146734285|NCT00261495|529199199|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
146734286|NCT00261495|529199198|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
146734287|NCT00261495|529199199|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
146734288|NCT00261495|529199198|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
146734289|NCT00261495|529199199|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
146734290|NCT00261495|529199198|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
146734291|NCT00261495|529199199|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
146734292|NCT00261495|529199198|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
146734293|NCT00261495|529199199|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
146734294|NCT00261495|529199198|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
146734295|NCT00261495|529199199|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
146734296|NCT00261495|529199198|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
146734297|NCT00261495|529199199|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
146734298|NCT00261495|529199198|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
146734299|NCT00261495|529199199|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
146734300|NCT00261495|529199198|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
146734301|NCT00261495|529199199|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
146734302|NCT00261495|529199198|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
146734303|NCT00261495|529199199|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
146734304|NCT00261495|529199198|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
146734305|NCT00261495|529199199|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
146734306|NCT00261495|529199198|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
146734307|NCT00261495|529199199|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
146734308|NCT00261495|529199198|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
146734309|NCT00261495|529199199|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
146734310|NCT00261495|529199198|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
146734311|NCT00261495|529199199|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146734312|NCT03474107|529199200|FG000|Overall Study|Adverse Event|42|||
146734313|NCT03474107|529199201|FG001|Overall Study|Adverse Event|46|||
146734314|NCT03474107|529199200|FG000|Overall Study|Death|2|||
146734315|NCT03474107|529199201|FG001|Overall Study|Death|2|||
146734316|NCT03474107|529199200|FG000|Overall Study|Lost to Follow-up|0|||
146734317|NCT03474107|529199201|FG001|Overall Study|Lost to Follow-up|1|||
146734318|NCT03474107|529199200|FG000|Overall Study|Progressive Disease|177|||
146734319|NCT03474107|529199201|FG001|Overall Study|Progressive Disease|180|||
146734320|NCT03474107|529199200|FG000|Overall Study|Protocol Violation|1|||
146734321|NCT03474107|529199201|FG001|Overall Study|Protocol Violation|1|||
146734322|NCT03474107|529199200|FG000|Overall Study|Withdrawal by Subject|15|||
146734323|NCT03474107|529199201|FG001|Overall Study|Withdrawal by Subject|27|||
146734324|NCT03474107|529199200|FG000|Overall Study|Physician Decision|7|||
146734325|NCT03474107|529199201|FG001|Overall Study|Physician Decision|22|||
146734326|NCT03474107|529199200|FG000|Overall Study|Miscellaneous|1|||
146734327|NCT03474107|529199201|FG001|Overall Study|Miscellaneous|6|||
146734328|NCT01932697|529199202|FG000|Overall Study|Received a different amount of tx|1|||
146734329|NCT01932697|529199203|FG001|Overall Study|Received a different amount of tx|0|||
146734330|NCT01932697|529199202|FG000|Overall Study|Ineligible|1|||
146734331|NCT01932697|529199203|FG001|Overall Study|Ineligible|0|||
146734332|NCT01330316|529199204|FG000|Overall Study|Adverse Event|2|||
146734333|NCT01330316|529199205|FG001|Overall Study|Adverse Event|2|||
146734334|NCT01330316|529199204|FG000|Overall Study|Lack of Efficacy|0|||
146734335|NCT01330316|529199205|FG001|Overall Study|Lack of Efficacy|10|||
146734336|NCT01330316|529199204|FG000|Overall Study|Lost to Follow-up|0|||
146734337|NCT01330316|529199205|FG001|Overall Study|Lost to Follow-up|1|||
146734338|NCT01330316|529199204|FG000|Overall Study|Withdrawal by Subject|0|||
146734339|NCT01330316|529199205|FG001|Overall Study|Withdrawal by Subject|1|||
146734340|NCT01330316|529199204|FG000|Overall Study|other than above|0|||
146734341|NCT01330316|529199205|FG001|Overall Study|other than above|1|||
146734342|NCT01337986|529199206|FG000|Overall Study|Adverse Event|2|||
146734343|NCT01337986|529199207|FG001|Overall Study|Adverse Event|2|||
146734344|NCT01337986|529199206|FG000|Overall Study|Lost to Follow-up|1|||
146734345|NCT01337986|529199207|FG001|Overall Study|Lost to Follow-up|0|||
146734346|NCT01337986|529199206|FG000|Overall Study|Protocol Violation|0|||
146734347|NCT01337986|529199207|FG001|Overall Study|Protocol Violation|3|||
146734348|NCT02798211|529199209|FG000|Period 1|Adverse Event|1|||
146734349|NCT02798211|529199210|FG001|Period 1|Adverse Event|1|||
146734350|NCT02798211|529199211|FG002|Period 1|Adverse Event|0|||
146734351|NCT02798211|529199212|FG003|Period 1|Adverse Event|0|||
146734352|NCT02798211|529199213|FG004|Period 1|Adverse Event|0|||
146734353|NCT02798211|529199214|FG005|Period 1|Adverse Event|0|||
146734354|NCT02798211|529199209|FG000|Period 1|Lost to Follow-up|2|||
146734355|NCT02798211|529199210|FG001|Period 1|Lost to Follow-up|1|||
146734356|NCT02798211|529199211|FG002|Period 1|Lost to Follow-up|0|||
146734357|NCT02798211|529199212|FG003|Period 1|Lost to Follow-up|0|||
146734358|NCT02798211|529199213|FG004|Period 1|Lost to Follow-up|0|||
146734359|NCT02798211|529199214|FG005|Period 1|Lost to Follow-up|0|||
146734360|NCT02798211|529199209|FG000|Period 1|Protocol Violation|0|||
146734361|NCT02798211|529199210|FG001|Period 1|Protocol Violation|0|||
146792244|NCT03766685|529413105|FG003|Overall Study|Protocol Violation|0|||
146734362|NCT02798211|529199211|FG002|Period 1|Protocol Violation|2|||
146734363|NCT02798211|529199212|FG003|Period 1|Protocol Violation|0|||
146734364|NCT02798211|529199213|FG004|Period 1|Protocol Violation|0|||
146734365|NCT02798211|529199214|FG005|Period 1|Protocol Violation|0|||
146734366|NCT02798211|529199209|FG000|Period 1|Withdrawal by Subject|1|||
146734367|NCT02798211|529199210|FG001|Period 1|Withdrawal by Subject|1|||
146734368|NCT02798211|529199211|FG002|Period 1|Withdrawal by Subject|0|||
146734369|NCT02798211|529199212|FG003|Period 1|Withdrawal by Subject|0|||
146734370|NCT02798211|529199213|FG004|Period 1|Withdrawal by Subject|0|||
146734371|NCT02798211|529199214|FG005|Period 1|Withdrawal by Subject|0|||
146734372|NCT02798211|529199209|FG000|Period 1|Death|0|||
146734373|NCT02798211|529199210|FG001|Period 1|Death|0|||
146734374|NCT02798211|529199211|FG002|Period 1|Death|1|||
146938810|NCT02483078|529932536|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
146938811|NCT02483078|529932537|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
146938812|NCT02483078|529932536|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
146938813|NCT02483078|529932537|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
146938814|NCT02483078|529932536|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
146938815|NCT02483078|529932537|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
146938816|NCT02483078|529932536|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
146938817|NCT02483078|529932537|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
146938818|NCT02483078|529932536|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
146938819|NCT02483078|529932537|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
146938820|NCT02483078|529932536|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
146938821|NCT02483078|529932537|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
146938822|NCT02853032|529932542|FG000|Overall Study|Adverse Event|4|||
146938823|NCT02853032|529932543|FG001|Overall Study|Adverse Event|0|||
146938824|NCT02853032|529932542|FG000|Overall Study|Withdrawal by Subject|3|||
146938825|NCT02853032|529932543|FG001|Overall Study|Withdrawal by Subject|1|||
146938826|NCT02853032|529932542|FG000|Overall Study|Requested to withdraw from all treatment|2|||
146938827|NCT02853032|529932543|FG001|Overall Study|Requested to withdraw from all treatment|2|||
146938828|NCT04876599|529932544|FG000|Overall Study|Missed|2|||
146938829|NCT04876599|529932545|FG001|Overall Study|Missed|0|||
146938830|NCT04876599|529932544|FG000|Overall Study|Declined|2|||
146938831|NCT04876599|529932545|FG001|Overall Study|Declined|3|||
146938832|NCT02146833|529932546|FG000|Overall Study|Death|10|||
146938833|NCT02146833|529932546|FG000|Overall Study|No longer consented to study treatment|1|||
146938834|NCT03726333|529932547|FG000|Overall Study|Progressive Disease|0|||
146938835|NCT03726333|529932548|FG001|Overall Study|Progressive Disease|0|||
146938836|NCT03726333|529932549|FG002|Overall Study|Progressive Disease|1|||
146938837|NCT03726333|529932550|FG003|Overall Study|Progressive Disease|0|||
146938838|NCT03726333|529932551|FG004|Overall Study|Progressive Disease|0|||
146938839|NCT02971007|529934295|FG000|Overall Study|Adverse Event|1|||
146938840|NCT02971007|529934296|FG001|Overall Study|Adverse Event|0|||
146938841|NCT02971007|529934297|FG002|Overall Study|Adverse Event|0|||
146938842|NCT02971007|529934295|FG000|Overall Study|Lost to Follow-up|0|||
146938843|NCT02971007|529934296|FG001|Overall Study|Lost to Follow-up|1|||
146938844|NCT02971007|529934297|FG002|Overall Study|Lost to Follow-up|1|||
146938845|NCT02971007|529934295|FG000|Overall Study|Withdrawal by Subject|0|||
146938846|NCT02971007|529934296|FG001|Overall Study|Withdrawal by Subject|1|||
146938847|NCT02971007|529934297|FG002|Overall Study|Withdrawal by Subject|0|||
146938848|NCT02971007|529934295|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
146938849|NCT02971007|529934296|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
146938850|NCT02971007|529934297|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
146938851|NCT02971007|529934295|FG000|Overall Study|Patient discontinued study drug|0|||
146938852|NCT02971007|529934296|FG001|Overall Study|Patient discontinued study drug|1|||
146938853|NCT02971007|529934297|FG002|Overall Study|Patient discontinued study drug|0|||
146938854|NCT01419015|529934299|FG000|Overall Study|Death|2|||
146938855|NCT00653328|529934300|FG000|Overall Study|Withdrawal by Subject|1|||
146938856|NCT00653328|529934300|FG000|Overall Study|Adverse Event|2|||
146938857|NCT00653328|529934300|FG000|Overall Study|Disease progression|10|||
146938858|NCT00653328|529934300|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
146938859|NCT02911519|529934301|FG000|Overall Study|Lost to Follow-up|2|||
146938860|NCT02911519|529934302|FG001|Overall Study|Lost to Follow-up|2|||
146938861|NCT02911519|529934301|FG000|Overall Study|Death|0|||
146938862|NCT02911519|529934302|FG001|Overall Study|Death|2|||
146938863|NCT01237223|529934303|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
146938864|NCT01237223|529934304|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
146938865|NCT01237223|529934305|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
146938866|NCT01237223|529934306|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
146938867|NCT01237223|529934307|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
146938868|NCT01237223|529934308|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
146938869|NCT01237223|529934303|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
146938870|NCT01237223|529934304|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
146938871|NCT01237223|529934305|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
146938872|NCT01237223|529934306|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
146938873|NCT01237223|529934307|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
146938874|NCT01237223|529934308|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
146938875|NCT01237223|529934303|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
146938876|NCT01237223|529934304|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
146938877|NCT01237223|529934305|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
146938878|NCT01237223|529934306|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
146938879|NCT01237223|529934307|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
146982169|NCT02173301|530096223|FG002|Overall Study|Lost to Follow-up|2|||
146734375|NCT02798211|529199212|FG003|Period 1|Death|0|||
146734376|NCT02798211|529199213|FG004|Period 1|Death|0|||
146792245|NCT03766685|529413102|FG000|Overall Study|Non-compliance|0|||
146792246|NCT03766685|529413103|FG001|Overall Study|Non-compliance|2|||
146792247|NCT03766685|529413104|FG002|Overall Study|Non-compliance|0|||
146792248|NCT03766685|529413105|FG003|Overall Study|Non-compliance|0|||
146734377|NCT02798211|529199214|FG005|Period 1|Death|0|||
146734378|NCT02798211|529199209|FG000|Period 1|Withdrawal of Informed Consent|2|||
146734379|NCT02798211|529199210|FG001|Period 1|Withdrawal of Informed Consent|7|||
146734380|NCT02798211|529199211|FG002|Period 1|Withdrawal of Informed Consent|3|||
146734381|NCT02798211|529199212|FG003|Period 1|Withdrawal of Informed Consent|0|||
146734382|NCT02798211|529199213|FG004|Period 1|Withdrawal of Informed Consent|0|||
146734383|NCT02798211|529199214|FG005|Period 1|Withdrawal of Informed Consent|0|||
146734384|NCT02798211|529199209|FG000|Period 2|Withdrawal by Subject|2|||
146734385|NCT02798211|529199210|FG001|Period 2|Withdrawal by Subject|0|||
146734386|NCT02798211|529199211|FG002|Period 2|Withdrawal by Subject|0|||
146734387|NCT02798211|529199212|FG003|Period 2|Withdrawal by Subject|0|||
146734388|NCT02798211|529199213|FG004|Period 2|Withdrawal by Subject|2|||
146734389|NCT02798211|529199214|FG005|Period 2|Withdrawal by Subject|2|||
146734390|NCT02798211|529199209|FG000|Period 2|Adverse Event|5|||
146734391|NCT02798211|529199210|FG001|Period 2|Adverse Event|0|||
146734392|NCT02798211|529199211|FG002|Period 2|Adverse Event|0|||
146734393|NCT02798211|529199212|FG003|Period 2|Adverse Event|0|||
146734394|NCT02798211|529199213|FG004|Period 2|Adverse Event|1|||
146734395|NCT02798211|529199214|FG005|Period 2|Adverse Event|0|||
146734396|NCT02798211|529199209|FG000|Period 2|Lack of Efficacy|1|||
146734397|NCT02798211|529199210|FG001|Period 2|Lack of Efficacy|0|||
146734398|NCT02798211|529199211|FG002|Period 2|Lack of Efficacy|0|||
146734399|NCT02798211|529199212|FG003|Period 2|Lack of Efficacy|1|||
146734400|NCT02798211|529199213|FG004|Period 2|Lack of Efficacy|0|||
146734401|NCT02798211|529199214|FG005|Period 2|Lack of Efficacy|1|||
146734402|NCT02798211|529199209|FG000|Period 2|Lost to Follow-up|3|||
146734403|NCT02798211|529199210|FG001|Period 2|Lost to Follow-up|0|||
146734404|NCT02798211|529199211|FG002|Period 2|Lost to Follow-up|0|||
146734405|NCT02798211|529199212|FG003|Period 2|Lost to Follow-up|0|||
146734406|NCT02798211|529199213|FG004|Period 2|Lost to Follow-up|2|||
146734407|NCT02798211|529199214|FG005|Period 2|Lost to Follow-up|0|||
146734408|NCT02798211|529199209|FG000|Period 2|Physician Decision|1|||
146734409|NCT02798211|529199210|FG001|Period 2|Physician Decision|0|||
146734410|NCT02798211|529199211|FG002|Period 2|Physician Decision|0|||
146734411|NCT02798211|529199212|FG003|Period 2|Physician Decision|1|||
146734412|NCT02798211|529199213|FG004|Period 2|Physician Decision|1|||
146734413|NCT02798211|529199214|FG005|Period 2|Physician Decision|0|||
146734414|NCT02798211|529199209|FG000|Period 2|Pregnancy|0|||
146734415|NCT02798211|529199210|FG001|Period 2|Pregnancy|0|||
146734416|NCT02798211|529199211|FG002|Period 2|Pregnancy|0|||
146734417|NCT02798211|529199212|FG003|Period 2|Pregnancy|2|||
146734418|NCT02798211|529199213|FG004|Period 2|Pregnancy|0|||
146734419|NCT02798211|529199214|FG005|Period 2|Pregnancy|0|||
146734420|NCT02798211|529199209|FG000|Period 2|Technical problems|1|||
146734421|NCT02798211|529199210|FG001|Period 2|Technical problems|0|||
146734422|NCT02798211|529199211|FG002|Period 2|Technical problems|0|||
146734423|NCT02798211|529199212|FG003|Period 2|Technical problems|1|||
146734424|NCT02798211|529199213|FG004|Period 2|Technical problems|0|||
146734425|NCT02798211|529199214|FG005|Period 2|Technical problems|0|||
146734426|NCT02798211|529199209|FG000|Period 2|Withdrawal of Informed Consent|1|||
146734427|NCT02798211|529199210|FG001|Period 2|Withdrawal of Informed Consent|0|||
146734428|NCT02798211|529199211|FG002|Period 2|Withdrawal of Informed Consent|0|||
146938880|NCT01237223|529934308|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
146734429|NCT02798211|529199212|FG003|Period 2|Withdrawal of Informed Consent|2|||
146734430|NCT02798211|529199213|FG004|Period 2|Withdrawal of Informed Consent|2|||
146734431|NCT02798211|529199214|FG005|Period 2|Withdrawal of Informed Consent|3|||
146792249|NCT02116530|529413106|FG000|Overall Study|Withdrawal by Subject|1|||
146792250|NCT02116530|529413107|FG001|Overall Study|Withdrawal by Subject|2|||
146792251|NCT02116530|529413106|FG000|Overall Study|Adverse Event|4|||
146792252|NCT02116530|529413107|FG001|Overall Study|Adverse Event|0|||
146792253|NCT02116530|529413106|FG000|Overall Study|Physician Decision|1|||
146792254|NCT02116530|529413107|FG001|Overall Study|Physician Decision|0|||
146792255|NCT02116530|529413106|FG000|Overall Study|Lost to Follow-up|1|||
146792256|NCT02116530|529413107|FG001|Overall Study|Lost to Follow-up|0|||
146982170|NCT02173301|530096224|FG003|Overall Study|Lost to Follow-up|2|||
146734432|NCT03299686|529199217|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
146734433|NCT03299686|529199218|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
146734434|NCT03299686|529199217|FG000|Treatment Epoch|Physician Decision|1|||
146734435|NCT03299686|529199218|FG001|Treatment Epoch|Physician Decision|0|||
146734436|NCT03299686|529199217|FG000|Treatment Epoch|Adverse Event|8|||
146734437|NCT03299686|529199218|FG001|Treatment Epoch|Adverse Event|4|||
146734438|NCT03299686|529199217|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
146734439|NCT03299686|529199218|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
146734440|NCT02709005|529199219|FG000|Overall Study|Lost to Follow-up|1|||
146792257|NCT02116530|529413106|FG000|Overall Study|Other Medical Problems|2|||
146792258|NCT02116530|529413107|FG001|Overall Study|Other Medical Problems|2|||
146792259|NCT02927236|529413110|FG000|Characterization Phase|Physician Decision|0|||
146792260|NCT02927236|529413111|FG001|Characterization Phase|Physician Decision|3|||
146792261|NCT02927236|529413112|FG002|Characterization Phase|Physician Decision|0|||
146792262|NCT02927236|529413113|FG003|Characterization Phase|Physician Decision|2|||
146792263|NCT02927236|529413110|FG000|Characterization Phase|Lost to Follow-up|0|||
146792264|NCT02927236|529413111|FG001|Characterization Phase|Lost to Follow-up|0|||
146792265|NCT02927236|529413112|FG002|Characterization Phase|Lost to Follow-up|0|||
146792266|NCT02927236|529413113|FG003|Characterization Phase|Lost to Follow-up|3|||
146792267|NCT02927236|529413110|FG000|Characterization Phase|Withdrawal by Subject|1|||
146792268|NCT02927236|529413111|FG001|Characterization Phase|Withdrawal by Subject|0|||
146792269|NCT02927236|529413112|FG002|Characterization Phase|Withdrawal by Subject|0|||
146792270|NCT02927236|529413113|FG003|Characterization Phase|Withdrawal by Subject|1|||
146792271|NCT02927236|529413110|FG000|Treatment Phase|Adverse Event|1|||
146792272|NCT02927236|529413111|FG001|Treatment Phase|Adverse Event|0|||
146792273|NCT02927236|529413112|FG002|Treatment Phase|Adverse Event|1|||
146792274|NCT02927236|529413113|FG003|Treatment Phase|Adverse Event|1|||
146792275|NCT02927236|529413110|FG000|Treatment Phase|Protocol Violation|3|||
146792276|NCT02927236|529413111|FG001|Treatment Phase|Protocol Violation|0|||
146792277|NCT02927236|529413112|FG002|Treatment Phase|Protocol Violation|0|||
146792278|NCT02927236|529413113|FG003|Treatment Phase|Protocol Violation|1|||
146792279|NCT02927236|529413110|FG000|Treatment Phase|Lost to Follow-up|1|||
146792280|NCT02927236|529413111|FG001|Treatment Phase|Lost to Follow-up|0|||
146792281|NCT02927236|529413112|FG002|Treatment Phase|Lost to Follow-up|0|||
146792282|NCT02927236|529413113|FG003|Treatment Phase|Lost to Follow-up|0|||
146792283|NCT02927236|529413110|FG000|Follow-up Phase|Lost to Follow-up|1|||
146792284|NCT02927236|529413111|FG001|Follow-up Phase|Lost to Follow-up|0|||
146792285|NCT02927236|529413112|FG002|Follow-up Phase|Lost to Follow-up|1|||
146792286|NCT02927236|529413113|FG003|Follow-up Phase|Lost to Follow-up|0|||
146792287|NCT05297565|529413114|FG000|Overall Study|Other Reasons|0|||
146792288|NCT05297565|529413115|FG001|Overall Study|Other Reasons|1|||
146792289|NCT05297565|529413114|FG000|Overall Study|Physician Decision|0|||
146792290|NCT05297565|529413115|FG001|Overall Study|Physician Decision|1|||
146792291|NCT05297565|529413114|FG000|Overall Study|Disease recurrence|1|||
146792292|NCT05297565|529413115|FG001|Overall Study|Disease recurrence|0|||
146792293|NCT05029622|529413118|FG000|Overall Study|Lost to Follow-up|1|||
146792294|NCT04850898|529413123|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
146792295|NCT04850898|529413124|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
146792296|NCT04770402|529413131|FG000|Overall Study|Lost to Follow-up|1|||
146792297|NCT04770402|529413132|FG001|Overall Study|Lost to Follow-up|2|||
146792298|NCT04770402|529413131|FG000|Overall Study|Non-compliance|1|||
146792299|NCT04770402|529413132|FG001|Overall Study|Non-compliance|0|||
146792300|NCT04770402|529413131|FG000|Overall Study|Withdrawal by Subject|0|||
146792301|NCT04770402|529413132|FG001|Overall Study|Withdrawal by Subject|1|||
146792302|NCT04117347|529413135|FG000|Overall Study|Adverse Event|0|||
146792303|NCT04117347|529413136|FG001|Overall Study|Adverse Event|0|||
146792304|NCT04117347|529413137|FG002|Overall Study|Adverse Event|1|||
146792305|NCT04117347|529413135|FG000|Overall Study|No time for study|0|||
146792306|NCT04117347|529413136|FG001|Overall Study|No time for study|2|||
146982171|NCT02173301|530096221|FG000|Overall Study|Protocol Violation|0|||
146734441|NCT02709005|529199220|FG001|Overall Study|Lost to Follow-up|1|||
146734442|NCT02709005|529199219|FG000|Overall Study|Withdrawal by Subject|3|||
146734443|NCT02709005|529199220|FG001|Overall Study|Withdrawal by Subject|0|||
146734444|NCT00499863|529199226|FG000|Overall Study|Lack of Efficacy|21|||
146734445|NCT00499863|529199227|FG001|Overall Study|Lack of Efficacy|27|||
146734446|NCT00499863|529199226|FG000|Overall Study|Protocol Violation|12|||
146734447|NCT00499863|529199227|FG001|Overall Study|Protocol Violation|7|||
146734448|NCT00499863|529199226|FG000|Overall Study|Withdrawal by Subject|6|||
146734449|NCT00499863|529199227|FG001|Overall Study|Withdrawal by Subject|4|||
146734450|NCT00499863|529199226|FG000|Overall Study|Adverse Event|8|||
146734451|NCT00499863|529199227|FG001|Overall Study|Adverse Event|2|||
146734452|NCT00499863|529199226|FG000|Overall Study|Sponsor decision|2|||
146734453|NCT00499863|529199227|FG001|Overall Study|Sponsor decision|2|||
146734454|NCT00499863|529199226|FG000|Overall Study|Lost to Follow-up|1|||
146734455|NCT00499863|529199227|FG001|Overall Study|Lost to Follow-up|1|||
146734456|NCT00691132|529199228|FG000|Overall Study|Adverse Event|2|||
146734457|NCT00691132|529199229|FG001|Overall Study|Adverse Event|3|||
146734458|NCT00691132|529199228|FG000|Overall Study|Withdrawal by Subject|10|||
146734459|NCT00691132|529199229|FG001|Overall Study|Withdrawal by Subject|10|||
146734460|NCT00860067|529199232|FG000|Overall Study|Lost to Follow-up|46|||
146734461|NCT00860067|529199233|FG001|Overall Study|Lost to Follow-up|9|||
146982172|NCT02173301|530096222|FG001|Overall Study|Protocol Violation|1|||
146734462|NCT00860067|529199234|FG002|Overall Study|Lost to Follow-up|9|||
146792307|NCT04117347|529413137|FG002|Overall Study|No time for study|0|||
146792308|NCT04117347|529413135|FG000|Overall Study|Family emergency|1|||
146792309|NCT04117347|529413136|FG001|Overall Study|Family emergency|0|||
146792310|NCT04117347|529413137|FG002|Overall Study|Family emergency|0|||
146792311|NCT03511664|529413139|FG000|Overall Study|Death|457|||
146792312|NCT03511664|529413140|FG001|Overall Study|Death|201|||
146982173|NCT02173301|530096223|FG002|Overall Study|Protocol Violation|0|||
146982174|NCT02173301|530096224|FG003|Overall Study|Protocol Violation|0|||
146982175|NCT02173301|530096221|FG000|Overall Study|Physician Decision|0|||
146982176|NCT02173301|530096222|FG001|Overall Study|Physician Decision|0|||
146982177|NCT02173301|530096223|FG002|Overall Study|Physician Decision|1|||
146982178|NCT02173301|530096224|FG003|Overall Study|Physician Decision|0|||
146982179|NCT02173301|530096221|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
146982180|NCT02173301|530096222|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
146982181|NCT02173301|530096223|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
146982182|NCT02173301|530096224|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
146982183|NCT03740100|530096225|FG000|Overall Study|Adverse Event|1|||
146982184|NCT03740100|530096225|FG000|Overall Study|Death|1|||
146982185|NCT03120520|530096226|FG000|Overall Study|Lost to Follow-up|1|||
146982186|NCT03120520|530096227|FG001|Overall Study|Lost to Follow-up|1|||
146982187|NCT03120520|530096228|FG002|Overall Study|Lost to Follow-up|1|||
146982188|NCT03120520|530096229|FG003|Overall Study|Lost to Follow-up|1|||
146982189|NCT03120520|530096226|FG000|Overall Study|Withdrawal by Subject|3|||
146982190|NCT03120520|530096227|FG001|Overall Study|Withdrawal by Subject|2|||
146982191|NCT03120520|530096228|FG002|Overall Study|Withdrawal by Subject|3|||
146982192|NCT03120520|530096229|FG003|Overall Study|Withdrawal by Subject|2|||
146982193|NCT03120520|530096226|FG000|Overall Study|Other|0|||
146982194|NCT03120520|530096227|FG001|Overall Study|Other|1|||
146982195|NCT03120520|530096228|FG002|Overall Study|Other|0|||
146982196|NCT03120520|530096229|FG003|Overall Study|Other|0|||
146982197|NCT02123459|530096233|FG000|Washout Period (1 Day)|Adverse Event|1|||
146982198|NCT02123459|530096234|FG001|Washout Period (1 Day)|Adverse Event|0|||
146982199|NCT03387059|530096235|FG000|Overall Study|Study termination|5|||
146982200|NCT03387059|530096236|FG001|Overall Study|Study termination|4|||
146982201|NCT00254397|530096237|FG000|Overall Study|Disease Progression|4|||
146982202|NCT00254397|530096238|FG001|Overall Study|Disease Progression|1|||
146982203|NCT00254397|530096239|FG002|Overall Study|Disease Progression|16|||
146982204|NCT00254397|530096240|FG003|Overall Study|Disease Progression|23|||
146982205|NCT00254397|530096237|FG000|Overall Study|Non-Compliant|0|||
146982206|NCT00254397|530096238|FG001|Overall Study|Non-Compliant|0|||
146982207|NCT00254397|530096239|FG002|Overall Study|Non-Compliant|0|||
146982208|NCT00254397|530096240|FG003|Overall Study|Non-Compliant|1|||
146982209|NCT00254397|530096237|FG000|Overall Study|Adverse Event|2|||
146982210|NCT00254397|530096238|FG001|Overall Study|Adverse Event|0|||
146982211|NCT00254397|530096239|FG002|Overall Study|Adverse Event|3|||
146982212|NCT00254397|530096240|FG003|Overall Study|Adverse Event|1|||
146982213|NCT02806232|530097890|FG000|Overall Study|Lost to Follow-up|1|||
146982214|NCT02806232|530097891|FG001|Overall Study|Lost to Follow-up|2|||
146982215|NCT02806232|530097892|FG002|Overall Study|Lost to Follow-up|1|||
146982216|NCT02806232|530097893|FG003|Overall Study|Lost to Follow-up|0|||
146982217|NCT02806232|530097894|FG004|Overall Study|Lost to Follow-up|0|||
146982218|NCT02806232|530097895|FG005|Overall Study|Lost to Follow-up|1|||
146792313|NCT03511664|529413141|FG002|Overall Study|Death|21|||
146938881|NCT01237223|529934303|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
146938882|NCT01237223|529934304|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
146938883|NCT01237223|529934305|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
146938884|NCT01237223|529934306|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
146938885|NCT01237223|529934307|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
146938886|NCT01237223|529934308|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
146938887|NCT01237223|529934303|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
146938888|NCT01237223|529934304|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
146938889|NCT01237223|529934305|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
146938890|NCT01237223|529934306|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
146938891|NCT01237223|529934307|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
146938892|NCT01237223|529934308|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
146938893|NCT01237223|529934303|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
146938894|NCT01237223|529934304|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
146938895|NCT01237223|529934305|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
146982219|NCT02806232|530097896|FG006|Overall Study|Lost to Follow-up|0|||
146982220|NCT02806232|530097897|FG007|Overall Study|Lost to Follow-up|0|||
146982221|NCT02806232|530097898|FG008|Overall Study|Lost to Follow-up|0|||
146982222|NCT02806232|530097890|FG000|Overall Study|Withdrawal by Subject|0|||
146982223|NCT02806232|530097891|FG001|Overall Study|Withdrawal by Subject|2|||
146982224|NCT02806232|530097892|FG002|Overall Study|Withdrawal by Subject|0|||
146982225|NCT02806232|530097893|FG003|Overall Study|Withdrawal by Subject|0|||
146982226|NCT02806232|530097894|FG004|Overall Study|Withdrawal by Subject|2|||
146792314|NCT03511664|529413139|FG000|Overall Study|Withdrew consent|40|||
146982227|NCT02806232|530097895|FG005|Overall Study|Withdrawal by Subject|1|||
146982228|NCT02806232|530097896|FG006|Overall Study|Withdrawal by Subject|0|||
146792315|NCT03511664|529413140|FG001|Overall Study|Withdrew consent|63|||
146792316|NCT03511664|529413141|FG002|Overall Study|Withdrew consent|3|||
146792317|NCT03511664|529413139|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
146792318|NCT03511664|529413140|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
146792319|NCT03511664|529413141|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
146792320|NCT03511664|529413139|FG000|Overall Study|Lost to Follow-up|8|||
146792321|NCT03511664|529413140|FG001|Overall Study|Lost to Follow-up|5|||
146792322|NCT03511664|529413141|FG002|Overall Study|Lost to Follow-up|0|||
146792323|NCT03511664|529413139|FG000|Overall Study|Physician Decision|2|||
146792324|NCT03511664|529413140|FG001|Overall Study|Physician Decision|1|||
146792325|NCT03511664|529413141|FG002|Overall Study|Physician Decision|0|||
146792326|NCT03511664|529413139|FG000|Overall Study|Patient non-compliance|1|||
146792327|NCT03511664|529413140|FG001|Overall Study|Patient non-compliance|0|||
146792328|NCT03511664|529413141|FG002|Overall Study|Patient non-compliance|0|||
146792329|NCT01946789|529413142|FG000|Overall Study|Death|0|||
146792330|NCT01946789|529413143|FG001|Overall Study|Death|2|||
146792331|NCT01946789|529413144|FG002|Overall Study|Death|1|||
146792332|NCT01946789|529413145|FG003|Overall Study|Death|1|||
146792333|NCT01946789|529413146|FG004|Overall Study|Death|1|||
146792334|NCT01946789|529413147|FG005|Overall Study|Death|1|||
146792335|NCT01946789|529413148|FG006|Overall Study|Death|3|||
146792336|NCT01946789|529413149|FG007|Overall Study|Death|1|||
146792337|NCT01946789|529413150|FG008|Overall Study|Death|2|||
146792338|NCT01946789|529413142|FG000|Overall Study|Progressive Disease|0|||
146792339|NCT01946789|529413143|FG001|Overall Study|Progressive Disease|0|||
146792340|NCT01946789|529413144|FG002|Overall Study|Progressive Disease|1|||
146792341|NCT01946789|529413145|FG003|Overall Study|Progressive Disease|0|||
146792342|NCT01946789|529413146|FG004|Overall Study|Progressive Disease|0|||
146792343|NCT01946789|529413147|FG005|Overall Study|Progressive Disease|2|||
146792344|NCT01946789|529413148|FG006|Overall Study|Progressive Disease|0|||
146792345|NCT01946789|529413149|FG007|Overall Study|Progressive Disease|0|||
146792346|NCT01946789|529413150|FG008|Overall Study|Progressive Disease|0|||
146792347|NCT01946789|529413142|FG000|Overall Study|Withdrawal by Subject|0|||
146792348|NCT01946789|529413143|FG001|Overall Study|Withdrawal by Subject|0|||
146792349|NCT01946789|529413144|FG002|Overall Study|Withdrawal by Subject|0|||
146792350|NCT01946789|529413145|FG003|Overall Study|Withdrawal by Subject|2|||
146792351|NCT01946789|529413146|FG004|Overall Study|Withdrawal by Subject|1|||
146792352|NCT01946789|529413147|FG005|Overall Study|Withdrawal by Subject|0|||
146792353|NCT01946789|529413148|FG006|Overall Study|Withdrawal by Subject|1|||
146792354|NCT01946789|529413149|FG007|Overall Study|Withdrawal by Subject|0|||
146792355|NCT01946789|529413150|FG008|Overall Study|Withdrawal by Subject|0|||
146792356|NCT04707625|529413169|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
146792357|NCT05485779|529413172|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
146792358|NCT05485779|529413173|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
146792359|NCT05485779|529413174|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
146792360|NCT05485779|529413175|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
146792361|NCT05485779|529413176|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
146792362|NCT05485779|529413177|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
146792363|NCT05485779|529413178|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
146792364|NCT05485779|529413179|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
146792365|NCT05485779|529413180|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
146792366|NCT05485779|529413181|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
146734463|NCT00860067|529199232|FG000|Overall Study|Withdrawal by Subject|4|||
146734464|NCT00860067|529199233|FG001|Overall Study|Withdrawal by Subject|0|||
146734465|NCT00860067|529199234|FG002|Overall Study|Withdrawal by Subject|0|||
146734466|NCT00860067|529199232|FG000|Overall Study|Pregnancy|1|||
146734467|NCT00860067|529199233|FG001|Overall Study|Pregnancy|0|||
146734468|NCT00860067|529199234|FG002|Overall Study|Pregnancy|0|||
146734469|NCT01282801|529199235|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
146792367|NCT05485779|529413182|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
146792368|NCT05485779|529413172|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
146792369|NCT05485779|529413173|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
146792370|NCT05485779|529413174|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
146792371|NCT05485779|529413175|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
146792372|NCT05485779|529413176|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
146792373|NCT05485779|529413177|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
146792374|NCT05485779|529413178|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
146792375|NCT05485779|529413179|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
146792376|NCT05485779|529413180|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
146734470|NCT01282801|529199236|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
146734471|NCT01498822|529199237|FG000|Overall Study|Protocol Violation|8|||
146734472|NCT01498822|529199238|FG001|Overall Study|Protocol Violation|4|||
146734473|NCT01498822|529199237|FG000|Overall Study|Other Reason|5|||
146792377|NCT05485779|529413181|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
146792378|NCT05485779|529413182|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
146848444|NCT00291642|529615686|FG003|Overall Study|Patient missed visit|0|||
146792379|NCT05485779|529413172|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146792380|NCT05485779|529413173|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146792381|NCT05485779|529413174|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146792382|NCT05485779|529413175|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
146792383|NCT05485779|529413176|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146792384|NCT05485779|529413177|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146792385|NCT05485779|529413178|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146792386|NCT05485779|529413179|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146792387|NCT05485779|529413180|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146792388|NCT05485779|529413181|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146792389|NCT05485779|529413182|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146792390|NCT03030261|529413184|FG000|Overall Study|Still receiving continuation therapy|5|||
146792391|NCT05293171|529413187|FG000|Washout 5 to 7 Days|Adverse Event|1|||
146792392|NCT05293171|529413188|FG001|Washout 5 to 7 Days|Adverse Event|1|||
146792393|NCT05293171|529413189|FG002|Washout 5 to 7 Days|Adverse Event|0|||
146792394|NCT05293171|529413190|FG003|Washout 5 to 7 Days|Adverse Event|0|||
146792395|NCT05293171|529413191|FG004|Washout 5 to 7 Days|Adverse Event|0|||
146792396|NCT05293171|529413192|FG005|Washout 5 to 7 Days|Adverse Event|0|||
146792397|NCT05293171|529413193|FG006|Washout 5 to 7 Days|Adverse Event|0|||
146792398|NCT05293171|529413194|FG007|Washout 5 to 7 Days|Adverse Event|0|||
146792399|NCT05293171|529413195|FG008|Washout 5 to 7 Days|Adverse Event|0|||
146792400|NCT05293171|529413196|FG009|Washout 5 to 7 Days|Adverse Event|0|||
146792401|NCT05293171|529413197|FG010|Washout 5 to 7 Days|Adverse Event|0|||
146792402|NCT05293171|529413198|FG011|Washout 5 to 7 Days|Adverse Event|0|||
146792403|NCT05293171|529413187|FG000|Washout 5 to 7 Days|Adverse Event|0|||
146792404|NCT05293171|529413188|FG001|Washout 5 to 7 Days|Adverse Event|0|||
146792405|NCT05293171|529413189|FG002|Washout 5 to 7 Days|Adverse Event|0|||
146792406|NCT05293171|529413190|FG003|Washout 5 to 7 Days|Adverse Event|0|||
146792407|NCT05293171|529413191|FG004|Washout 5 to 7 Days|Adverse Event|0|||
146792408|NCT05293171|529413192|FG005|Washout 5 to 7 Days|Adverse Event|1|||
146792409|NCT05293171|529413193|FG006|Washout 5 to 7 Days|Adverse Event|0|||
146792410|NCT05293171|529413194|FG007|Washout 5 to 7 Days|Adverse Event|0|||
146792411|NCT05293171|529413195|FG008|Washout 5 to 7 Days|Adverse Event|0|||
146792412|NCT05293171|529413196|FG009|Washout 5 to 7 Days|Adverse Event|0|||
146792413|NCT05293171|529413197|FG010|Washout 5 to 7 Days|Adverse Event|0|||
146792414|NCT05293171|529413198|FG011|Washout 5 to 7 Days|Adverse Event|0|||
146792415|NCT02052882|529413199|FG000|Overall Study|Not treated|11|||
146792416|NCT02052882|529413199|FG000|Overall Study|Protocol Violation|1|||
146792417|NCT02052882|529413199|FG000|Overall Study|Inadequate testing|1|||
146792418|NCT05170841|529413202|FG000|Single Dose Phase|Adverse Event|1|||
146792419|NCT05170841|529413203|FG001|Single Dose Phase|Adverse Event|2|||
146792420|NCT05170841|529413204|FG002|Single Dose Phase|Adverse Event|0|||
146792421|NCT05170841|529413205|FG003|Single Dose Phase|Adverse Event|2|||
146792422|NCT05170841|529413202|FG000|Multiple Dose Phase|Adverse Event|1|||
146792423|NCT05170841|529413203|FG001|Multiple Dose Phase|Adverse Event|2|||
146792424|NCT05170841|529413204|FG002|Multiple Dose Phase|Adverse Event|1|||
146792425|NCT05170841|529413205|FG003|Multiple Dose Phase|Adverse Event|4|||
146792426|NCT05170841|529413202|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
146792427|NCT05170841|529413203|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
146792428|NCT05170841|529413204|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
146792429|NCT05170841|529413205|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
146792430|NCT02240238|529413208|FG000|Phase 1|Adverse Event|0|||
146792431|NCT02240238|529413209|FG001|Phase 1|Adverse Event|0|||
146792432|NCT02240238|529413210|FG002|Phase 1|Adverse Event|0|||
146792433|NCT02240238|529413211|FG003|Phase 1|Adverse Event|0|||
146792434|NCT02240238|529413212|FG004|Phase 1|Adverse Event|0|||
146792435|NCT02240238|529413213|FG005|Phase 1|Adverse Event|0|||
146792436|NCT02240238|529413214|FG006|Phase 1|Adverse Event|3|||
146792437|NCT02240238|529413215|FG007|Phase 1|Adverse Event|1|||
146792438|NCT02240238|529413216|FG008|Phase 1|Adverse Event|0|||
146792439|NCT02240238|529413217|FG009|Phase 1|Adverse Event|0|||
146792440|NCT02240238|529413218|FG010|Phase 1|Adverse Event|0|||
146792441|NCT02240238|529413219|FG011|Phase 1|Adverse Event|0|||
146792442|NCT02240238|529413208|FG000|Phase 1|Death|0|||
146792443|NCT02240238|529413209|FG001|Phase 1|Death|0|||
146792444|NCT02240238|529413210|FG002|Phase 1|Death|0|||
146792445|NCT02240238|529413211|FG003|Phase 1|Death|0|||
146792446|NCT02240238|529413212|FG004|Phase 1|Death|0|||
146792447|NCT02240238|529413213|FG005|Phase 1|Death|1|||
146792448|NCT02240238|529413214|FG006|Phase 1|Death|0|||
146792449|NCT02240238|529413215|FG007|Phase 1|Death|0|||
146792450|NCT02240238|529413216|FG008|Phase 1|Death|0|||
146792451|NCT02240238|529413217|FG009|Phase 1|Death|0|||
146792452|NCT02240238|529413218|FG010|Phase 1|Death|0|||
146792453|NCT02240238|529413219|FG011|Phase 1|Death|0|||
146792454|NCT02240238|529413208|FG000|Phase 1|Sponsor termination|0|||
146792455|NCT02240238|529413209|FG001|Phase 1|Sponsor termination|0|||
146792456|NCT02240238|529413210|FG002|Phase 1|Sponsor termination|0|||
146792457|NCT02240238|529413211|FG003|Phase 1|Sponsor termination|0|||
146792458|NCT02240238|529413212|FG004|Phase 1|Sponsor termination|0|||
146792459|NCT02240238|529413213|FG005|Phase 1|Sponsor termination|1|||
146792460|NCT02240238|529413214|FG006|Phase 1|Sponsor termination|0|||
146792461|NCT02240238|529413215|FG007|Phase 1|Sponsor termination|0|||
146792462|NCT02240238|529413216|FG008|Phase 1|Sponsor termination|0|||
146792463|NCT02240238|529413217|FG009|Phase 1|Sponsor termination|0|||
146792464|NCT02240238|529413218|FG010|Phase 1|Sponsor termination|0|||
146792465|NCT02240238|529413219|FG011|Phase 1|Sponsor termination|0|||
146792466|NCT02240238|529413208|FG000|Phase 1|Withdrawal by Subject|0|||
146792467|NCT02240238|529413209|FG001|Phase 1|Withdrawal by Subject|0|||
146792468|NCT02240238|529413210|FG002|Phase 1|Withdrawal by Subject|0|||
146792469|NCT02240238|529413211|FG003|Phase 1|Withdrawal by Subject|0|||
146792470|NCT02240238|529413212|FG004|Phase 1|Withdrawal by Subject|0|||
146792471|NCT02240238|529413213|FG005|Phase 1|Withdrawal by Subject|2|||
146792472|NCT02240238|529413214|FG006|Phase 1|Withdrawal by Subject|0|||
146792473|NCT02240238|529413215|FG007|Phase 1|Withdrawal by Subject|0|||
146792474|NCT02240238|529413216|FG008|Phase 1|Withdrawal by Subject|0|||
146792475|NCT02240238|529413217|FG009|Phase 1|Withdrawal by Subject|0|||
146792476|NCT02240238|529413218|FG010|Phase 1|Withdrawal by Subject|0|||
146792477|NCT02240238|529413219|FG011|Phase 1|Withdrawal by Subject|0|||
146792478|NCT02240238|529413208|FG000|Phase 1|Physician Decision|0|||
146792479|NCT02240238|529413209|FG001|Phase 1|Physician Decision|0|||
146792480|NCT02240238|529413210|FG002|Phase 1|Physician Decision|0|||
146792481|NCT02240238|529413211|FG003|Phase 1|Physician Decision|0|||
146792482|NCT02240238|529413212|FG004|Phase 1|Physician Decision|0|||
146792483|NCT02240238|529413213|FG005|Phase 1|Physician Decision|2|||
146792484|NCT02240238|529413214|FG006|Phase 1|Physician Decision|0|||
146792485|NCT02240238|529413215|FG007|Phase 1|Physician Decision|0|||
146792486|NCT02240238|529413216|FG008|Phase 1|Physician Decision|0|||
146792487|NCT02240238|529413217|FG009|Phase 1|Physician Decision|0|||
146792488|NCT02240238|529413218|FG010|Phase 1|Physician Decision|0|||
146792489|NCT02240238|529413219|FG011|Phase 1|Physician Decision|0|||
146792490|NCT02240238|529413208|FG000|Phase 2|Adverse Event|0|||
146792491|NCT02240238|529413209|FG001|Phase 2|Adverse Event|0|||
146792492|NCT02240238|529413210|FG002|Phase 2|Adverse Event|0|||
146792493|NCT02240238|529413211|FG003|Phase 2|Adverse Event|0|||
146792494|NCT02240238|529413212|FG004|Phase 2|Adverse Event|0|||
146792495|NCT02240238|529413213|FG005|Phase 2|Adverse Event|0|||
146792496|NCT02240238|529413214|FG006|Phase 2|Adverse Event|0|||
146792497|NCT02240238|529413215|FG007|Phase 2|Adverse Event|0|||
146792498|NCT02240238|529413216|FG008|Phase 2|Adverse Event|0|||
146792499|NCT02240238|529413217|FG009|Phase 2|Adverse Event|7|||
146792500|NCT02240238|529413218|FG010|Phase 2|Adverse Event|14|||
146792501|NCT02240238|529413219|FG011|Phase 2|Adverse Event|2|||
146792502|NCT02240238|529413208|FG000|Phase 2|Death|0|||
146792503|NCT02240238|529413209|FG001|Phase 2|Death|0|||
146792504|NCT02240238|529413210|FG002|Phase 2|Death|0|||
146792505|NCT02240238|529413211|FG003|Phase 2|Death|0|||
146792506|NCT02240238|529413212|FG004|Phase 2|Death|0|||
146792507|NCT02240238|529413213|FG005|Phase 2|Death|0|||
146792508|NCT02240238|529413214|FG006|Phase 2|Death|0|||
146792509|NCT02240238|529413215|FG007|Phase 2|Death|0|||
146792510|NCT02240238|529413216|FG008|Phase 2|Death|0|||
146792511|NCT02240238|529413217|FG009|Phase 2|Death|3|||
146792512|NCT02240238|529413218|FG010|Phase 2|Death|2|||
146792513|NCT02240238|529413219|FG011|Phase 2|Death|1|||
146792514|NCT02240238|529413208|FG000|Phase 2|Disease progression|0|||
146792515|NCT02240238|529413209|FG001|Phase 2|Disease progression|0|||
146792516|NCT02240238|529413210|FG002|Phase 2|Disease progression|0|||
146792517|NCT02240238|529413211|FG003|Phase 2|Disease progression|0|||
146792518|NCT02240238|529413212|FG004|Phase 2|Disease progression|0|||
146792519|NCT02240238|529413213|FG005|Phase 2|Disease progression|0|||
146792520|NCT02240238|529413214|FG006|Phase 2|Disease progression|0|||
146792521|NCT02240238|529413215|FG007|Phase 2|Disease progression|0|||
146792522|NCT02240238|529413216|FG008|Phase 2|Disease progression|0|||
146792523|NCT02240238|529413217|FG009|Phase 2|Disease progression|5|||
146792524|NCT02240238|529413218|FG010|Phase 2|Disease progression|11|||
146792525|NCT02240238|529413219|FG011|Phase 2|Disease progression|1|||
146792526|NCT02240238|529413208|FG000|Phase 2|Withdrawal by Subject|0|||
146792527|NCT02240238|529413209|FG001|Phase 2|Withdrawal by Subject|0|||
146792528|NCT02240238|529413210|FG002|Phase 2|Withdrawal by Subject|0|||
146792529|NCT02240238|529413211|FG003|Phase 2|Withdrawal by Subject|0|||
146792530|NCT02240238|529413212|FG004|Phase 2|Withdrawal by Subject|0|||
146792531|NCT02240238|529413213|FG005|Phase 2|Withdrawal by Subject|0|||
146792532|NCT02240238|529413214|FG006|Phase 2|Withdrawal by Subject|0|||
146792533|NCT02240238|529413215|FG007|Phase 2|Withdrawal by Subject|0|||
146792534|NCT02240238|529413216|FG008|Phase 2|Withdrawal by Subject|0|||
146792535|NCT02240238|529413217|FG009|Phase 2|Withdrawal by Subject|1|||
146792536|NCT02240238|529413218|FG010|Phase 2|Withdrawal by Subject|1|||
146792537|NCT02240238|529413219|FG011|Phase 2|Withdrawal by Subject|0|||
146792538|NCT02240238|529413208|FG000|Phase 2|Physician Decision|0|||
146792539|NCT02240238|529413209|FG001|Phase 2|Physician Decision|0|||
146792540|NCT02240238|529413210|FG002|Phase 2|Physician Decision|0|||
146792541|NCT02240238|529413211|FG003|Phase 2|Physician Decision|0|||
146792542|NCT02240238|529413212|FG004|Phase 2|Physician Decision|0|||
146792543|NCT02240238|529413213|FG005|Phase 2|Physician Decision|0|||
146792544|NCT02240238|529413214|FG006|Phase 2|Physician Decision|0|||
146792545|NCT02240238|529413215|FG007|Phase 2|Physician Decision|0|||
146792546|NCT02240238|529413216|FG008|Phase 2|Physician Decision|0|||
146792547|NCT02240238|529413217|FG009|Phase 2|Physician Decision|1|||
146792548|NCT02240238|529413218|FG010|Phase 2|Physician Decision|3|||
146792549|NCT02240238|529413219|FG011|Phase 2|Physician Decision|0|||
146792550|NCT02240238|529413208|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146792551|NCT02240238|529413209|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146792552|NCT02240238|529413210|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146792553|NCT02240238|529413211|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146792554|NCT02240238|529413212|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146792555|NCT02240238|529413213|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146792556|NCT02240238|529413214|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146792557|NCT02240238|529413215|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146792558|NCT02240238|529413216|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146792559|NCT02240238|529413217|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
146792560|NCT02240238|529413218|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146792561|NCT02240238|529413219|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146792562|NCT02240238|529413208|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146792563|NCT02240238|529413209|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146792564|NCT02240238|529413210|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146792565|NCT02240238|529413211|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146792566|NCT02240238|529413212|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146792567|NCT02240238|529413213|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146792568|NCT02240238|529413214|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146792569|NCT02240238|529413215|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146792570|NCT02240238|529413216|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146792571|NCT02240238|529413217|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
146792572|NCT02240238|529413218|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146792573|NCT02240238|529413219|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146792574|NCT02240238|529413208|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146792575|NCT02240238|529413209|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146792576|NCT02240238|529413210|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146792577|NCT02240238|529413211|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146792578|NCT02240238|529413212|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146792579|NCT02240238|529413213|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146792580|NCT02240238|529413214|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146792581|NCT02240238|529413215|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146792582|NCT02240238|529413216|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146792583|NCT02240238|529413217|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146792584|NCT02240238|529413218|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
146792585|NCT02240238|529413219|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146792586|NCT02240238|529413208|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146792587|NCT02240238|529413209|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146792588|NCT02240238|529413210|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146792589|NCT02240238|529413211|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146792590|NCT02240238|529413212|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146792591|NCT02240238|529413213|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146792592|NCT02240238|529413214|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146792593|NCT02240238|529413215|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146792594|NCT02240238|529413216|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146792595|NCT02240238|529413217|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146792596|NCT02240238|529413218|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
146792597|NCT02240238|529413219|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146792598|NCT02240238|529413208|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146792599|NCT02240238|529413209|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146938896|NCT01237223|529934306|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
146938897|NCT01237223|529934307|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
146938898|NCT01237223|529934308|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
146938899|NCT01237223|529934303|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
146938900|NCT01237223|529934304|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
146962308|NCT01049360|530021580|FG006|Period 1|Did not meet inc/exc criteria|0|||
146734474|NCT01498822|529199238|FG001|Overall Study|Other Reason|2|||
146734475|NCT01498822|529199237|FG000|Overall Study|Lack of Efficacy|7|||
146734476|NCT01498822|529199238|FG001|Overall Study|Lack of Efficacy|2|||
146734477|NCT01498822|529199237|FG000|Overall Study|AE, non-serious non-fatal|8|||
146734478|NCT01498822|529199238|FG001|Overall Study|AE, non-serious non-fatal|17|||
146734479|NCT01498822|529199237|FG000|Overall Study|SAE, non-fatal|2|||
146734480|NCT01498822|529199238|FG001|Overall Study|SAE, non-fatal|2|||
146734481|NCT01498822|529199237|FG000|Overall Study|Adverse Event, serious fatal|1|||
146734482|NCT01498822|529199238|FG001|Overall Study|Adverse Event, serious fatal|1|||
146734483|NCT01498822|529199237|FG000|Overall Study|Withdrawal by Subject|15|||
146734484|NCT01498822|529199238|FG001|Overall Study|Withdrawal by Subject|25|||
146734485|NCT01498822|529199237|FG000|Overall Study|Lost to Follow-up|8|||
146734486|NCT01498822|529199238|FG001|Overall Study|Lost to Follow-up|3|||
146734487|NCT04707196|529199239|FG000|Overall Study|Withdrawal by Subject|9|||
146734488|NCT04707196|529199240|FG001|Overall Study|Withdrawal by Subject|6|||
146734489|NCT04707196|529199239|FG000|Overall Study|Lost to Follow-up|1|||
146734490|NCT04707196|529199240|FG001|Overall Study|Lost to Follow-up|0|||
146734491|NCT04707196|529199239|FG000|Overall Study|Protocol Violation|4|||
146734492|NCT04707196|529199240|FG001|Overall Study|Protocol Violation|1|||
146734493|NCT04707196|529199239|FG000|Overall Study|Adverse Event|2|||
146734494|NCT04707196|529199240|FG001|Overall Study|Adverse Event|2|||
146734495|NCT04707196|529199239|FG000|Overall Study|Death|3|||
146734496|NCT04707196|529199240|FG001|Overall Study|Death|1|||
146734497|NCT04707196|529199239|FG000|Overall Study|Non-compliance with study drug|1|||
146734498|NCT04707196|529199240|FG001|Overall Study|Non-compliance with study drug|0|||
146734499|NCT04707196|529199239|FG000|Overall Study|Progressive disease|9|||
146734500|NCT04707196|529199240|FG001|Overall Study|Progressive disease|10|||
146734501|NCT01862796|529199241|FG000|Overall Study|Prohibited medications|0|||
146734502|NCT01862796|529199242|FG001|Overall Study|Prohibited medications|0|||
146734503|NCT01862796|529199243|FG002|Overall Study|Prohibited medications|1|||
146734504|NCT03333928|529199244|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
146734505|NCT03333928|529199245|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
146734506|NCT03333928|529199246|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
146734507|NCT03333928|529199244|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
146734508|NCT03333928|529199245|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
146734509|NCT03333928|529199246|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
146734510|NCT03333928|529199244|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
146734511|NCT03333928|529199245|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
146734512|NCT03333928|529199246|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
146734513|NCT03333928|529199244|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
146734514|NCT03333928|529199245|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
146734515|NCT03333928|529199246|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
146734516|NCT03333928|529199244|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
146734517|NCT03333928|529199245|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
146734518|NCT03333928|529199246|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
146734519|NCT03333928|529199244|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
146734520|NCT03333928|529199245|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
146734521|NCT03333928|529199246|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
146734522|NCT03333928|529199244|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
146734523|NCT03333928|529199245|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
146734524|NCT03333928|529199246|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
146734525|NCT03333928|529199244|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
146734526|NCT03333928|529199245|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
146734527|NCT03333928|529199246|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
146734528|NCT01375205|529199257|FG000|Overall Study|Lost to Follow-up|15|||
146734529|NCT01375205|529199258|FG001|Overall Study|Lost to Follow-up|12|||
146734530|NCT01375205|529199257|FG000|Overall Study|Withdrawal by Subject|6|||
146734531|NCT01375205|529199258|FG001|Overall Study|Withdrawal by Subject|1|||
146734539|NCT01148862|529199260|FG000|Second Intervention|Withdrawal by Subject|0|||
146734540|NCT01148862|529199261|FG001|Second Intervention|Withdrawal by Subject|2|||
146734541|NCT03815019|529199262|FG000|Overall Study|Withdrawal by Subject|6|||
146734542|NCT03815019|529199263|FG001|Overall Study|Withdrawal by Subject|8|||
146792600|NCT02240238|529413210|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146792601|NCT02240238|529413211|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146792602|NCT02240238|529413212|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146792603|NCT02240238|529413213|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146792604|NCT02240238|529413214|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146792605|NCT02240238|529413215|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146792606|NCT02240238|529413216|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146792607|NCT02240238|529413217|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146792608|NCT02240238|529413218|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
146792609|NCT02240238|529413219|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146792610|NCT02240238|529413208|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146792611|NCT02240238|529413209|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146792612|NCT02240238|529413210|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146792613|NCT02240238|529413211|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146792614|NCT02240238|529413212|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146792615|NCT02240238|529413213|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146792616|NCT02240238|529413214|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146792617|NCT02240238|529413215|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146792618|NCT02240238|529413216|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146792619|NCT02240238|529413217|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146792620|NCT02240238|529413218|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
146792621|NCT02240238|529413219|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146792622|NCT02240238|529413208|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146792623|NCT02240238|529413209|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146792624|NCT02240238|529413210|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146792625|NCT02240238|529413211|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146792626|NCT02240238|529413212|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146792627|NCT02240238|529413213|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146792628|NCT02240238|529413214|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146792629|NCT02240238|529413215|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146792630|NCT02240238|529413216|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146792631|NCT02240238|529413217|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146792632|NCT02240238|529413218|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
146792633|NCT02240238|529413219|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146792634|NCT02240238|529413208|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146792635|NCT02240238|529413209|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146792636|NCT02240238|529413210|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146792637|NCT02240238|529413211|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146792638|NCT02240238|529413212|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146792639|NCT02240238|529413213|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146792640|NCT02240238|529413214|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146792641|NCT02240238|529413215|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146792642|NCT02240238|529413216|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146792643|NCT02240238|529413217|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146792644|NCT02240238|529413218|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146792645|NCT02240238|529413219|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
146792646|NCT05216406|529413234|FG000|Overall Study|Lost to Follow-up|8|||
146792647|NCT05216406|529413235|FG001|Overall Study|Lost to Follow-up|9|||
146792648|NCT04270942|529413239|FG000|Overall Study|Death|1|||
146792649|NCT03672916|529413247|FG000|Overall Study|Death|6|||
146792650|NCT03672916|529413247|FG000|Overall Study|Lost to Follow-up|29|||
146792651|NCT03672916|529413247|FG000|Overall Study|Adverse Event|6|||
146792652|NCT03672916|529413247|FG000|Overall Study|Withdrawal by Subject|11|||
146792653|NCT04797195|529413248|FG000|Overall Study|Death|8|||
146792654|NCT04797195|529413249|FG001|Overall Study|Death|15|||
146792655|NCT04797195|529413248|FG000|Overall Study|Change from PD|15|||
146792656|NCT04797195|529413249|FG001|Overall Study|Change from PD|15|||
146792657|NCT04797195|529413248|FG000|Overall Study|Withdrawal by Subject|3|||
146792658|NCT04797195|529413249|FG001|Overall Study|Withdrawal by Subject|2|||
146792659|NCT05623228|529413251|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
146792660|NCT05623228|529413252|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
146792661|NCT05623228|529413253|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
146792662|NCT05623228|529413254|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
146792663|NCT05623228|529413255|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
146982229|NCT02806232|530097897|FG007|Overall Study|Withdrawal by Subject|0|||
146982230|NCT02806232|530097898|FG008|Overall Study|Withdrawal by Subject|0|||
146982231|NCT01133821|530097899|FG000|Overall Study|Lost to Follow-up|8|||
146734543|NCT05398796|529199264|FG000|Overall Study|Participant moved from the area|0|||
146734544|NCT05398796|529199265|FG001|Overall Study|Participant moved from the area|1|||
146734545|NCT05398796|529199266|FG002|Overall Study|Participant moved from the area|0|||
146734546|NCT05398796|529199267|FG003|Overall Study|Participant moved from the area|0|||
146734547|NCT04270747|529199269|FG000|Through Week 16|Adverse Event|1|||
146734548|NCT04270747|529199270|FG001|Through Week 16|Adverse Event|2|||
146734549|NCT04270747|529199271|FG002|Through Week 16|Adverse Event|0|||
146734550|NCT04270747|529199269|FG000|Through Week 16|Death|0|||
146734551|NCT04270747|529199270|FG001|Through Week 16|Death|2|||
146734552|NCT04270747|529199271|FG002|Through Week 16|Death|0|||
146734553|NCT04270747|529199269|FG000|Through Week 16|Consent Withdrawn|3|||
146734554|NCT04270747|529199270|FG001|Through Week 16|Consent Withdrawn|3|||
146734555|NCT04270747|529199271|FG002|Through Week 16|Consent Withdrawn|0|||
146734556|NCT04270747|529199269|FG000|Through Week 16|Physician Decision|1|||
146734557|NCT04270747|529199270|FG001|Through Week 16|Physician Decision|1|||
146734558|NCT04270747|529199271|FG002|Through Week 16|Physician Decision|0|||
146734559|NCT04270747|529199269|FG000|Through Week 16|Lost to Follow-up|2|||
146734560|NCT04270747|529199270|FG001|Through Week 16|Lost to Follow-up|0|||
146734561|NCT04270747|529199271|FG002|Through Week 16|Lost to Follow-up|0|||
146734562|NCT04270747|529199269|FG000|Through Week 16|Protocol Violation|1|||
146734563|NCT04270747|529199270|FG001|Through Week 16|Protocol Violation|2|||
146734564|NCT04270747|529199271|FG002|Through Week 16|Protocol Violation|0|||
146734565|NCT04270747|529199269|FG000|Through Week 16|Protocol Specified Criteria|6|||
146734566|NCT04270747|529199270|FG001|Through Week 16|Protocol Specified Criteria|7|||
146734567|NCT04270747|529199271|FG002|Through Week 16|Protocol Specified Criteria|0|||
146734568|NCT04270747|529199269|FG000|Through Week 16|Miscellaneous|1|||
146734569|NCT04270747|529199270|FG001|Through Week 16|Miscellaneous|1|||
146734570|NCT04270747|529199271|FG002|Through Week 16|Miscellaneous|0|||
146734571|NCT04270747|529199269|FG000|Post Week 16|Adverse Event|7|||
146734572|NCT04270747|529199270|FG001|Post Week 16|Adverse Event|5|||
146734573|NCT04270747|529199271|FG002|Post Week 16|Adverse Event|1|||
146734574|NCT04270747|529199269|FG000|Post Week 16|Death|2|||
146734575|NCT04270747|529199270|FG001|Post Week 16|Death|0|||
146734576|NCT04270747|529199271|FG002|Post Week 16|Death|2|||
146734577|NCT04270747|529199269|FG000|Post Week 16|Consent Withdrawn|4|||
146734578|NCT04270747|529199270|FG001|Post Week 16|Consent Withdrawn|3|||
146734579|NCT04270747|529199271|FG002|Post Week 16|Consent Withdrawn|6|||
146734580|NCT04270747|529199269|FG000|Post Week 16|Physician Decision|3|||
146734581|NCT04270747|529199270|FG001|Post Week 16|Physician Decision|1|||
146734582|NCT04270747|529199271|FG002|Post Week 16|Physician Decision|1|||
146734583|NCT04270747|529199269|FG000|Post Week 16|Lost to Follow-up|2|||
146734584|NCT04270747|529199270|FG001|Post Week 16|Lost to Follow-up|1|||
146734585|NCT04270747|529199271|FG002|Post Week 16|Lost to Follow-up|0|||
146734586|NCT04270747|529199269|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
146734587|NCT04270747|529199270|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
146734588|NCT04270747|529199271|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
146734589|NCT04270747|529199269|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
146734590|NCT04270747|529199270|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
146734591|NCT04270747|529199271|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
146734592|NCT04270747|529199269|FG000|Post Week 16|Miscellaneous|1|||
146734593|NCT04270747|529199270|FG001|Post Week 16|Miscellaneous|0|||
146734594|NCT04270747|529199271|FG002|Post Week 16|Miscellaneous|1|||
146734595|NCT05960097|529199272|FG000|Overall Study|Lost to Follow-up|3|||
146734596|NCT05960097|529199273|FG001|Overall Study|Lost to Follow-up|1|||
146734597|NCT05960097|529199274|FG002|Overall Study|Lost to Follow-up|1|||
146734598|NCT05960097|529199275|FG003|Overall Study|Lost to Follow-up|2|||
146734599|NCT05960097|529199276|FG004|Overall Study|Lost to Follow-up|1|||
146734600|NCT05960097|529199277|FG005|Overall Study|Lost to Follow-up|1|||
146734601|NCT05960097|529199278|FG006|Overall Study|Lost to Follow-up|2|||
146734602|NCT05960097|529199279|FG007|Overall Study|Lost to Follow-up|3|||
146734603|NCT05960097|529199272|FG000|Overall Study|Physician Decision|0|||
146734604|NCT05960097|529199273|FG001|Overall Study|Physician Decision|0|||
146734605|NCT05960097|529199274|FG002|Overall Study|Physician Decision|0|||
146734606|NCT05960097|529199275|FG003|Overall Study|Physician Decision|0|||
146734607|NCT05960097|529199276|FG004|Overall Study|Physician Decision|0|||
146734608|NCT05960097|529199277|FG005|Overall Study|Physician Decision|0|||
146734609|NCT05960097|529199278|FG006|Overall Study|Physician Decision|1|||
146734610|NCT05960097|529199279|FG007|Overall Study|Physician Decision|0|||
146734611|NCT05960097|529199272|FG000|Overall Study|Withdrawal by Subject|1|||
146734612|NCT05960097|529199273|FG001|Overall Study|Withdrawal by Subject|0|||
146734613|NCT05960097|529199274|FG002|Overall Study|Withdrawal by Subject|0|||
146734614|NCT05960097|529199275|FG003|Overall Study|Withdrawal by Subject|1|||
146982232|NCT01133821|530097900|FG001|Overall Study|Lost to Follow-up|11|||
146734615|NCT05960097|529199276|FG004|Overall Study|Withdrawal by Subject|1|||
146734616|NCT05960097|529199277|FG005|Overall Study|Withdrawal by Subject|0|||
146792664|NCT05623228|529413256|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
146792665|NCT05623228|529413257|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
146792666|NCT05623228|529413258|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
146792667|NCT05623228|529413251|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
146792668|NCT05623228|529413252|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
146792669|NCT05623228|529413253|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
146792670|NCT05623228|529413254|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
146792671|NCT05623228|529413255|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
146792672|NCT05623228|529413256|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
146792673|NCT05623228|529413257|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
146792674|NCT05623228|529413258|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
146792675|NCT04737330|529413260|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
146792676|NCT04737330|529413261|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
146792677|NCT04737330|529413260|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
146792678|NCT04737330|529413261|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
146792679|NCT04737330|529413260|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
146792680|NCT04737330|529413261|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
146792681|NCT04737330|529413260|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
146792682|NCT04737330|529413261|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
146792683|NCT04737330|529413260|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
146792684|NCT04737330|529413261|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
146792685|NCT04737330|529413260|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
146792686|NCT04737330|529413261|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
146792687|NCT02823145|529413262|FG000|Enrollment|Other|1|||
146792688|NCT02823145|529413263|FG001|Enrollment|Other|0|||
146792689|NCT02823145|529413262|FG000|Treatment|Adverse Event|0|||
146792690|NCT02823145|529413263|FG001|Treatment|Adverse Event|11|||
146792691|NCT02823145|529413262|FG000|Treatment|Death|0|||
146792692|NCT02823145|529413263|FG001|Treatment|Death|3|||
146792693|NCT02823145|529413262|FG000|Treatment|Family Decision|0|||
146792694|NCT02823145|529413263|FG001|Treatment|Family Decision|1|||
146792695|NCT02823145|529413262|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
146792696|NCT02823145|529413263|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
146792697|NCT02823145|529413262|FG000|Treatment|Lack of Efficacy|0|||
146792698|NCT02823145|529413263|FG001|Treatment|Lack of Efficacy|48|||
146792699|NCT02823145|529413262|FG000|Treatment|Non-Compliance With E-Diary|0|||
146792700|NCT02823145|529413263|FG001|Treatment|Non-Compliance With E-Diary|1|||
146792701|NCT02823145|529413262|FG000|Treatment|Physician Decision|0|||
146792702|NCT02823145|529413263|FG001|Treatment|Physician Decision|2|||
146792703|NCT02823145|529413262|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
146792704|NCT02823145|529413263|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
146792705|NCT02823145|529413262|FG000|Treatment|Subject needed to take prohibited medication|0|||
146792706|NCT02823145|529413263|FG001|Treatment|Subject needed to take prohibited medication|1|||
146792707|NCT02823145|529413262|FG000|Treatment|Subject transferred to direct access programme|0|||
146792708|NCT02823145|529413263|FG001|Treatment|Subject transferred to direct access programme|1|||
146792709|NCT02823145|529413262|FG000|Treatment|Switching to commercially available drug|0|||
146792710|NCT02823145|529413263|FG001|Treatment|Switching to commercially available drug|11|||
146792711|NCT02823145|529413262|FG000|Treatment|Transitioned to commercial supply of medication|0|||
146792712|NCT02823145|529413263|FG001|Treatment|Transitioned to commercial supply of medication|1|||
146792713|NCT02823145|529413262|FG000|Treatment|Withdrawal By Caregiver|0|||
146792714|NCT02823145|529413263|FG001|Treatment|Withdrawal By Caregiver|1|||
146792715|NCT02823145|529413262|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
146792716|NCT02823145|529413263|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
146792717|NCT02823145|529413262|FG000|Treatment|Withdrawal by Subject|0|||
146792718|NCT02823145|529413263|FG001|Treatment|Withdrawal by Subject|16|||
146792719|NCT02823145|529413262|FG000|Treatment|Reason unknown|0|||
146792720|NCT02823145|529413263|FG001|Treatment|Reason unknown|1|||
146792721|NCT04741776|529413264|FG000|Overall Study|Withdrawal by Subject|7|||
146792722|NCT04741776|529413265|FG001|Overall Study|Withdrawal by Subject|10|||
146792723|NCT04741776|529413266|FG002|Overall Study|Withdrawal by Subject|10|||
146792724|NCT04741776|529413267|FG003|Overall Study|Withdrawal by Subject|17|||
146792725|NCT04741776|529413264|FG000|Overall Study|Death|0|||
146792726|NCT04741776|529413265|FG001|Overall Study|Death|0|||
146792727|NCT04741776|529413266|FG002|Overall Study|Death|1|||
146792728|NCT04741776|529413267|FG003|Overall Study|Death|0|||
146792729|NCT02852655|529413268|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
146792730|NCT02852655|529413269|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
146792731|NCT02852655|529413270|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
146792732|NCT02852655|529413268|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
146792733|NCT02852655|529413269|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
146982233|NCT01133821|530097899|FG000|Overall Study|Withdrawal by Subject|8|||
146982234|NCT01133821|530097900|FG001|Overall Study|Withdrawal by Subject|3|||
146982235|NCT01133821|530097899|FG000|Overall Study|preferred other treatment|1|||
146982236|NCT01133821|530097900|FG001|Overall Study|preferred other treatment|1|||
146982237|NCT01133821|530097899|FG000|Overall Study|Protocol Violation|0|||
146982238|NCT01133821|530097900|FG001|Overall Study|Protocol Violation|1|||
146734617|NCT05960097|529199278|FG006|Overall Study|Withdrawal by Subject|0|||
146734618|NCT05960097|529199279|FG007|Overall Study|Withdrawal by Subject|0|||
146734619|NCT05960097|529199272|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
146734620|NCT05960097|529199273|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
146734621|NCT05960097|529199274|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
146734622|NCT05960097|529199275|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
146734623|NCT05960097|529199276|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
146734624|NCT05960097|529199277|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
146734625|NCT05960097|529199278|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
146734626|NCT05960097|529199279|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
146734627|NCT01784068|529199280|FG000|NTCS Phase|Adverse Event|5|||
146734628|NCT01784068|529199281|FG001|NTCS Phase|Adverse Event|0|||
146734629|NCT01784068|529199280|FG000|NTCS Phase|Physician Decision|2|||
146734630|NCT01784068|529199281|FG001|NTCS Phase|Physician Decision|0|||
146734631|NCT01784068|529199280|FG000|NTCS Phase|Patient/guardian decision|3|||
146734632|NCT01784068|529199281|FG001|NTCS Phase|Patient/guardian decision|0|||
146734633|NCT01784068|529199280|FG000|NTCS Phase|Death|2|||
146734634|NCT01784068|529199281|FG001|NTCS Phase|Death|0|||
146734635|NCT01784068|529199280|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
146734636|NCT01784068|529199281|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
146734637|NCT01784068|529199280|FG000|TFR Phase|Physician Decision|0|||
146734638|NCT01784068|529199281|FG001|TFR Phase|Physician Decision|1|||
146734639|NCT01784068|529199280|FG000|TFR Phase|Patient/guardian decision|0|||
146734640|NCT01784068|529199281|FG001|TFR Phase|Patient/guardian decision|3|||
146734641|NCT01784068|529199280|FG000|TFR Phase|Death|0|||
146734642|NCT01784068|529199281|FG001|TFR Phase|Death|1|||
146734643|NCT01784068|529199280|FG000|TFR Phase|Lack of Efficacy|0|||
146734644|NCT01784068|529199281|FG001|TFR Phase|Lack of Efficacy|88|||
146734645|NCT02063828|529199284|FG000|Overall Study|Withdrawal by Subject|4|||
146734646|NCT02063828|529199285|FG001|Overall Study|Withdrawal by Subject|6|||
146734647|NCT02063828|529199286|FG002|Overall Study|Withdrawal by Subject|3|||
146734648|NCT02063828|529199284|FG000|Overall Study|Death|0|||
146734649|NCT02063828|529199285|FG001|Overall Study|Death|0|||
146734650|NCT02063828|529199286|FG002|Overall Study|Death|1|||
146734651|NCT03483038|529199287|FG000|Overall Study|Subjects still in follow-up|18|||
146734652|NCT04987762|529199288|FG000|Overall Study|Study was Terminated by Sponsor|103|||
146734653|NCT01064297|529199289|FG000|Overall Study|Lost to Follow-up|791|||
146734654|NCT01064297|529199290|FG001|Overall Study|Lost to Follow-up|48|||
146734655|NCT01064297|529199291|FG002|Overall Study|Lost to Follow-up|133|||
146734656|NCT00316173|529199306|FG000|Run-in Phase|Adverse Event|1|||
146734657|NCT00316173|529199307|FG001|Run-in Phase|Adverse Event|0|||
146734658|NCT00316173|529199306|FG000|Run-in Phase|Protocol Violation|1|||
146734659|NCT00316173|529199307|FG001|Run-in Phase|Protocol Violation|0|||
146734660|NCT00316173|529199306|FG000|Run-in Phase|Study Follow-up Stopped|5|||
146734661|NCT00316173|529199307|FG001|Run-in Phase|Study Follow-up Stopped|0|||
146734662|NCT00316173|529199306|FG000|Treatment Phase|Adverse Event|0|||
146734663|NCT00316173|529199307|FG001|Treatment Phase|Adverse Event|1|||
146734664|NCT00316173|529199306|FG000|Treatment Phase|Lack of Efficacy|0|||
146734665|NCT00316173|529199307|FG001|Treatment Phase|Lack of Efficacy|3|||
146734666|NCT00316173|529199306|FG000|Treatment Phase|Lost to Follow-up|0|||
146734667|NCT00316173|529199307|FG001|Treatment Phase|Lost to Follow-up|3|||
146734668|NCT00316173|529199306|FG000|Treatment Phase|Withdrawal by Subject|0|||
146734669|NCT00316173|529199307|FG001|Treatment Phase|Withdrawal by Subject|1|||
146734670|NCT00316173|529199306|FG000|Treatment Phase|Study Follow-up Stopped|0|||
146734671|NCT00316173|529199307|FG001|Treatment Phase|Study Follow-up Stopped|34|||
146734672|NCT04108000|529199310|FG000|Overall Study|Death of patient|1|||
146734673|NCT04108000|529199311|FG001|Overall Study|Death of patient|0|||
146734674|NCT04108000|529199312|FG002|Overall Study|Death of patient|1|||
146734675|NCT04108000|529199313|FG003|Overall Study|Death of patient|0|||
146734676|NCT04108000|529199310|FG000|Overall Study|Withdrawal by Subject|2|||
146734677|NCT04108000|529199311|FG001|Overall Study|Withdrawal by Subject|2|||
146734678|NCT04108000|529199312|FG002|Overall Study|Withdrawal by Subject|0|||
146792734|NCT02852655|529413270|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
146734679|NCT04108000|529199313|FG003|Overall Study|Withdrawal by Subject|0|||
146734680|NCT04108000|529199310|FG000|Overall Study|Death of surrogate partner|0|||
146734681|NCT04108000|529199311|FG001|Overall Study|Death of surrogate partner|1|||
146734682|NCT04108000|529199312|FG002|Overall Study|Death of surrogate partner|0|||
146734683|NCT04108000|529199313|FG003|Overall Study|Death of surrogate partner|1|||
146982239|NCT01133821|530097899|FG000|Overall Study|Refused participation|1|||
146792735|NCT02852655|529413268|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
146792736|NCT02852655|529413269|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
146792737|NCT02852655|529413270|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
146792738|NCT02852655|529413268|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
146792739|NCT02852655|529413269|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
146792740|NCT02852655|529413270|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
146792741|NCT02852655|529413268|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
146792742|NCT02852655|529413269|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
146792743|NCT02852655|529413270|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
146792744|NCT02852655|529413268|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
146792745|NCT02852655|529413269|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
146792746|NCT02852655|529413270|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
146792747|NCT02852655|529413268|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
146792748|NCT02852655|529413269|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
146792749|NCT02852655|529413270|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
146792750|NCT02852655|529413268|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
146792751|NCT02852655|529413269|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
146792752|NCT02852655|529413270|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
146792753|NCT02852655|529413268|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
146792754|NCT02852655|529413269|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
146792755|NCT02852655|529413270|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
146792756|NCT03221426|529413275|FG000|Overall Study|Ongoing in study|212|||
146792757|NCT03221426|529413276|FG001|Overall Study|Ongoing in study|193|||
146792758|NCT03221426|529413277|FG002|Overall Study|Ongoing in study|61|||
146792759|NCT03221426|529413278|FG003|Overall Study|Ongoing in study|55|||
146792760|NCT03221426|529413275|FG000|Overall Study|Withdrawal by Subject|12|||
146792761|NCT03221426|529413276|FG001|Overall Study|Withdrawal by Subject|4|||
146792762|NCT03221426|529413277|FG002|Overall Study|Withdrawal by Subject|2|||
146792763|NCT03221426|529413278|FG003|Overall Study|Withdrawal by Subject|3|||
146792764|NCT03221426|529413275|FG000|Overall Study|Lost to Follow-up|4|||
146792765|NCT03221426|529413276|FG001|Overall Study|Lost to Follow-up|1|||
146792766|NCT03221426|529413277|FG002|Overall Study|Lost to Follow-up|1|||
146792767|NCT03221426|529413278|FG003|Overall Study|Lost to Follow-up|0|||
146792768|NCT03221426|529413275|FG000|Overall Study|Death|174|||
146792769|NCT03221426|529413276|FG001|Overall Study|Death|204|||
146792770|NCT03221426|529413277|FG002|Overall Study|Death|36|||
146792771|NCT03221426|529413278|FG003|Overall Study|Death|45|||
146792772|NCT00104676|529415590|FG000|Overall Study|Death|3|||
146792773|NCT00104676|529415591|FG001|Overall Study|Death|2|||
146792774|NCT00104676|529415590|FG000|Overall Study|Withdrawal by Subject|0|||
146792775|NCT00104676|529415591|FG001|Overall Study|Withdrawal by Subject|2|||
146792776|NCT00104676|529415590|FG000|Overall Study|treatment interruption|4|||
146792777|NCT00104676|529415591|FG001|Overall Study|treatment interruption|10|||
146792778|NCT05622812|529415592|FG000|Overall Study|Withdrawal by Subject|1|||
146792779|NCT05622812|529415593|FG001|Overall Study|Withdrawal by Subject|4|||
146792780|NCT05622812|529415592|FG000|Overall Study|Lost to Follow-up|2|||
146792781|NCT05622812|529415593|FG001|Overall Study|Lost to Follow-up|1|||
146792782|NCT01959607|529415594|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
146734684|NCT05559866|529199314|FG000|Overall Study|Withdrawal by Subject|1|||
146734685|NCT05559866|529199315|FG001|Overall Study|Withdrawal by Subject|0|||
146734686|NCT07018999|529199317|FG000|Overall Study|Protocol Violation|0|||
146734687|NCT07018999|529199318|FG001|Overall Study|Protocol Violation|1|||
146734688|NCT07018999|529199317|FG000|Overall Study|Incomplete data entry|4|||
146734689|NCT07018999|529199318|FG001|Overall Study|Incomplete data entry|7|||
146734690|NCT06027619|529199319|FG000|Overall Study|Adverse Event|0|||
146734691|NCT06027619|529199320|FG001|Overall Study|Adverse Event|0|||
146734692|NCT06027619|529199321|FG002|Overall Study|Adverse Event|1|||
146734693|NCT01392300|529200901|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
146734694|NCT01392300|529200902|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
146734695|NCT01392300|529200903|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
146734696|NCT01392300|529200901|FG000|Main Period (MP)|Withdrawal by Subject|5|||
146734697|NCT01392300|529200902|FG001|Main Period (MP)|Withdrawal by Subject|1|||
146734698|NCT01392300|529200903|FG002|Main Period (MP)|Withdrawal by Subject|0|||
146734699|NCT01392300|529200901|FG000|Main Period (MP)|Lost to Follow-up|3|||
146734700|NCT01392300|529200902|FG001|Main Period (MP)|Lost to Follow-up|3|||
146734701|NCT01392300|529200903|FG002|Main Period (MP)|Lost to Follow-up|0|||
146734702|NCT01392300|529200901|FG000|Main Period (MP)|Non-compliance|1|||
146792783|NCT01959607|529415595|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
146792784|NCT01959607|529415596|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
146792785|NCT01959607|529415597|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
146792786|NCT03913442|529415598|FG000|Overall Study|Adverse Event|0|||
146792787|NCT03913442|529415599|FG001|Overall Study|Adverse Event|3|||
146792788|NCT03913442|529415598|FG000|Overall Study|Withdrawal by Subject|5|||
146734703|NCT01392300|529200902|FG001|Main Period (MP)|Non-compliance|0|||
146734704|NCT01392300|529200903|FG002|Main Period (MP)|Non-compliance|0|||
146734705|NCT01392300|529200901|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
146734706|NCT01392300|529200902|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
146734707|NCT01392300|529200903|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
146734708|NCT01392300|529200901|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
146734709|NCT01392300|529200902|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
146734710|NCT01392300|529200903|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
146734711|NCT01392300|529200901|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
146734712|NCT01392300|529200902|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
146734713|NCT01392300|529200903|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
146734714|NCT01392300|529200901|FG000|Open Label Extension (OLEX) Period|Death|0|||
146734715|NCT01392300|529200902|FG001|Open Label Extension (OLEX) Period|Death|0|||
146734716|NCT01392300|529200903|FG002|Open Label Extension (OLEX) Period|Death|4|||
146734717|NCT01392300|529200901|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
146734718|NCT01392300|529200902|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
146734719|NCT01392300|529200903|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
146734720|NCT01392300|529200901|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
146734721|NCT01392300|529200902|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
146734722|NCT01392300|529200903|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
146734723|NCT01392300|529200901|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
146734724|NCT01392300|529200902|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
146734725|NCT01392300|529200903|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
146734726|NCT05056870|529200908|FG000|Period 1|Site COVID-19 Related|3|||
146734727|NCT05056870|529200909|FG001|Period 1|Site COVID-19 Related|3|||
146734728|NCT05056870|529200908|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
146734729|NCT05056870|529200909|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
146734730|NCT05056870|529200908|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
146734731|NCT05056870|529200909|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
146734732|NCT05056870|529200908|FG000|Period 2|COVID-19 Related|1|||
146734733|NCT05056870|529200909|FG001|Period 2|COVID-19 Related|0|||
146734734|NCT05056870|529200908|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
146734735|NCT05056870|529200909|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
146734736|NCT00742079|529200910|FG000|Overall Study|Lost to Follow-up|0|||
146734737|NCT00742079|529200911|FG001|Overall Study|Lost to Follow-up|1|||
146734738|NCT02799472|529200917|FG000|Overall Study|Withdrawal by Subject|2|||
146734739|NCT02799472|529200918|FG001|Overall Study|Withdrawal by Subject|4|||
146734740|NCT02799472|529200917|FG000|Overall Study|Lack of Efficacy|2|||
146734741|NCT02799472|529200918|FG001|Overall Study|Lack of Efficacy|0|||
146734742|NCT02799472|529200917|FG000|Overall Study|Lost to Follow-up|0|||
146734743|NCT02799472|529200918|FG001|Overall Study|Lost to Follow-up|1|||
146734744|NCT02287584|529200919|FG000|the Double-blind Phase|Adverse Event|17|||
146734745|NCT02287584|529200920|FG001|the Double-blind Phase|Adverse Event|17|||
146734746|NCT02287584|529200921|FG002|the Double-blind Phase|Adverse Event|12|||
146734747|NCT02287584|529200922|FG003|the Double-blind Phase|Adverse Event|0|||
146734748|NCT02287584|529200923|FG004|the Double-blind Phase|Adverse Event|0|||
146734749|NCT02287584|529200924|FG005|the Double-blind Phase|Adverse Event|0|||
146734750|NCT02287584|529200919|FG000|the Double-blind Phase|Lack of Efficacy|18|||
146734751|NCT02287584|529200920|FG001|the Double-blind Phase|Lack of Efficacy|8|||
146734752|NCT02287584|529200921|FG002|the Double-blind Phase|Lack of Efficacy|8|||
146734753|NCT02287584|529200922|FG003|the Double-blind Phase|Lack of Efficacy|0|||
146734754|NCT02287584|529200923|FG004|the Double-blind Phase|Lack of Efficacy|0|||
146734755|NCT02287584|529200924|FG005|the Double-blind Phase|Lack of Efficacy|0|||
146734756|NCT02287584|529200919|FG000|the Double-blind Phase|Lost to Follow-up|0|||
146734757|NCT02287584|529200920|FG001|the Double-blind Phase|Lost to Follow-up|1|||
146734758|NCT02287584|529200921|FG002|the Double-blind Phase|Lost to Follow-up|1|||
146734759|NCT02287584|529200922|FG003|the Double-blind Phase|Lost to Follow-up|0|||
146734760|NCT02287584|529200923|FG004|the Double-blind Phase|Lost to Follow-up|0|||
146734761|NCT02287584|529200924|FG005|the Double-blind Phase|Lost to Follow-up|0|||
146734762|NCT02287584|529200919|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
146734763|NCT02287584|529200920|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
146734764|NCT02287584|529200921|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
146734765|NCT02287584|529200922|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
146734766|NCT02287584|529200923|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
146734767|NCT02287584|529200924|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
146734768|NCT02287584|529200919|FG000|the Double-blind Phase|Pregnancy|0|||
146734769|NCT02287584|529200920|FG001|the Double-blind Phase|Pregnancy|1|||
146734770|NCT02287584|529200921|FG002|the Double-blind Phase|Pregnancy|0|||
146734771|NCT02287584|529200922|FG003|the Double-blind Phase|Pregnancy|0|||
146734772|NCT02287584|529200923|FG004|the Double-blind Phase|Pregnancy|0|||
146734773|NCT02287584|529200924|FG005|the Double-blind Phase|Pregnancy|0|||
146734774|NCT02287584|529200919|FG000|the Double-blind Phase|Protocol Violation|0|||
146734775|NCT02287584|529200920|FG001|the Double-blind Phase|Protocol Violation|3|||
146734776|NCT02287584|529200921|FG002|the Double-blind Phase|Protocol Violation|0|||
146734777|NCT02287584|529200922|FG003|the Double-blind Phase|Protocol Violation|0|||
146734778|NCT02287584|529200923|FG004|the Double-blind Phase|Protocol Violation|0|||
146734779|NCT02287584|529200924|FG005|the Double-blind Phase|Protocol Violation|0|||
146734780|NCT02287584|529200919|FG000|the Double-blind Phase|other reasons|0|||
146734781|NCT02287584|529200920|FG001|the Double-blind Phase|other reasons|0|||
146734782|NCT02287584|529200921|FG002|the Double-blind Phase|other reasons|1|||
146734783|NCT02287584|529200922|FG003|the Double-blind Phase|other reasons|0|||
146734784|NCT02287584|529200923|FG004|the Double-blind Phase|other reasons|0|||
146734785|NCT02287584|529200924|FG005|the Double-blind Phase|other reasons|0|||
146734786|NCT02287584|529200919|FG000|the Open-label Phase|Did not receive drug|0|||
146734787|NCT02287584|529200920|FG001|the Open-label Phase|Did not receive drug|0|||
146734788|NCT02287584|529200921|FG002|the Open-label Phase|Did not receive drug|0|||
146734789|NCT02287584|529200922|FG003|the Open-label Phase|Did not receive drug|7|||
146734790|NCT02287584|529200923|FG004|the Open-label Phase|Did not receive drug|6|||
146734791|NCT02287584|529200924|FG005|the Open-label Phase|Did not receive drug|4|||
146734792|NCT02287584|529200919|FG000|the Open-label Phase|Adverse Event|0|||
146734793|NCT02287584|529200920|FG001|the Open-label Phase|Adverse Event|0|||
146734794|NCT02287584|529200921|FG002|the Open-label Phase|Adverse Event|0|||
146734795|NCT02287584|529200922|FG003|the Open-label Phase|Adverse Event|15|||
146734796|NCT02287584|529200923|FG004|the Open-label Phase|Adverse Event|12|||
146734797|NCT02287584|529200924|FG005|the Open-label Phase|Adverse Event|16|||
146734798|NCT02287584|529200919|FG000|the Open-label Phase|Lack of Efficacy|0|||
146734799|NCT02287584|529200920|FG001|the Open-label Phase|Lack of Efficacy|0|||
146734800|NCT02287584|529200921|FG002|the Open-label Phase|Lack of Efficacy|0|||
146734801|NCT02287584|529200922|FG003|the Open-label Phase|Lack of Efficacy|8|||
146734802|NCT02287584|529200923|FG004|the Open-label Phase|Lack of Efficacy|3|||
146734803|NCT02287584|529200924|FG005|the Open-label Phase|Lack of Efficacy|7|||
146734804|NCT02287584|529200919|FG000|the Open-label Phase|Lost to Follow-up|0|||
146734805|NCT02287584|529200920|FG001|the Open-label Phase|Lost to Follow-up|0|||
146734806|NCT02287584|529200921|FG002|the Open-label Phase|Lost to Follow-up|0|||
146734807|NCT02287584|529200922|FG003|the Open-label Phase|Lost to Follow-up|4|||
146734808|NCT02287584|529200923|FG004|the Open-label Phase|Lost to Follow-up|1|||
146734809|NCT02287584|529200924|FG005|the Open-label Phase|Lost to Follow-up|2|||
146734810|NCT02287584|529200919|FG000|the Open-label Phase|Withdrawal by Subject|0|||
146734811|NCT02287584|529200920|FG001|the Open-label Phase|Withdrawal by Subject|0|||
146734812|NCT02287584|529200921|FG002|the Open-label Phase|Withdrawal by Subject|0|||
146734813|NCT02287584|529200922|FG003|the Open-label Phase|Withdrawal by Subject|18|||
146734814|NCT02287584|529200923|FG004|the Open-label Phase|Withdrawal by Subject|29|||
146734815|NCT02287584|529200924|FG005|the Open-label Phase|Withdrawal by Subject|21|||
146734816|NCT02287584|529200919|FG000|the Open-label Phase|non-compliance|0|||
146734817|NCT02287584|529200920|FG001|the Open-label Phase|non-compliance|0|||
146734818|NCT02287584|529200921|FG002|the Open-label Phase|non-compliance|0|||
146734819|NCT02287584|529200922|FG003|the Open-label Phase|non-compliance|2|||
146734820|NCT02287584|529200923|FG004|the Open-label Phase|non-compliance|5|||
146734821|NCT02287584|529200924|FG005|the Open-label Phase|non-compliance|1|||
146734822|NCT02287584|529200919|FG000|the Open-label Phase|other reasons|0|||
146734823|NCT02287584|529200920|FG001|the Open-label Phase|other reasons|0|||
146734824|NCT02287584|529200921|FG002|the Open-label Phase|other reasons|0|||
146734825|NCT02287584|529200922|FG003|the Open-label Phase|other reasons|3|||
146734826|NCT02287584|529200923|FG004|the Open-label Phase|other reasons|6|||
146734827|NCT02287584|529200924|FG005|the Open-label Phase|other reasons|6|||
146734828|NCT01492686|529200927|FG000|Double-blind Phase|Adverse Event|0|||
146734829|NCT01492686|529200928|FG001|Double-blind Phase|Adverse Event|2|||
146734830|NCT01492686|529200927|FG000|Double-blind Phase|Physician Decision|0|||
146734831|NCT01492686|529200928|FG001|Double-blind Phase|Physician Decision|1|||
146734832|NCT01492686|529200927|FG000|Double-blind Phase|Withdrawal by Subject|0|||
146734833|NCT01492686|529200928|FG001|Double-blind Phase|Withdrawal by Subject|2|||
146734834|NCT01492686|529200927|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
146734835|NCT01492686|529200928|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
146734836|NCT01492686|529200927|FG000|Open-label Phase|Adverse Event|1|||
146734837|NCT01492686|529200928|FG001|Open-label Phase|Adverse Event|2|||
146734838|NCT01492686|529200927|FG000|Open-label Phase|Physician Decision|1|||
146734839|NCT01492686|529200928|FG001|Open-label Phase|Physician Decision|0|||
146734840|NCT01492686|529200927|FG000|Open-label Phase|Withdrawal by Subject|6|||
146734841|NCT01492686|529200928|FG001|Open-label Phase|Withdrawal by Subject|7|||
146734842|NCT01492686|529200927|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
146734843|NCT01492686|529200928|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
146734844|NCT03430063|529200930|FG000|Overall Study|Adverse Event|0|||
146734845|NCT03430063|529200931|FG001|Overall Study|Adverse Event|1|||
146734846|NCT03430063|529200932|FG002|Overall Study|Adverse Event|0|||
146734847|NCT03430063|529200930|FG000|Overall Study|Death|3|||
146734848|NCT03430063|529200931|FG001|Overall Study|Death|2|||
146734849|NCT03430063|529200932|FG002|Overall Study|Death|3|||
146734850|NCT03430063|529200930|FG000|Overall Study|Lost to Follow-up|0|||
146734851|NCT03430063|529200931|FG001|Overall Study|Lost to Follow-up|1|||
146734852|NCT03430063|529200932|FG002|Overall Study|Lost to Follow-up|0|||
146734853|NCT03430063|529200930|FG000|Overall Study|Withdrawal by Subject|0|||
146734854|NCT03430063|529200931|FG001|Overall Study|Withdrawal by Subject|0|||
146734855|NCT03430063|529200932|FG002|Overall Study|Withdrawal by Subject|1|||
146734856|NCT03430063|529200930|FG000|Overall Study|Withdrawal of consent|3|||
146734857|NCT03430063|529200931|FG001|Overall Study|Withdrawal of consent|1|||
146734858|NCT03430063|529200932|FG002|Overall Study|Withdrawal of consent|2|||
146734859|NCT03430063|529200930|FG000|Overall Study|Progressive disease|1|||
146734860|NCT03430063|529200931|FG001|Overall Study|Progressive disease|2|||
146734861|NCT03430063|529200932|FG002|Overall Study|Progressive disease|1|||
146734862|NCT03430063|529200930|FG000|Overall Study|Other un-specified|1|||
146734863|NCT03430063|529200931|FG001|Overall Study|Other un-specified|1|||
146734864|NCT03430063|529200932|FG002|Overall Study|Other un-specified|0|||
146734865|NCT03430063|529200930|FG000|Overall Study|Randomized, but never treated|0|||
146734866|NCT03430063|529200931|FG001|Overall Study|Randomized, but never treated|0|||
146734867|NCT03430063|529200932|FG002|Overall Study|Randomized, but never treated|1|||
146734868|NCT03124199|529200933|FG000|Overall Study|Lost to Follow-up|4|||
146734869|NCT03086018|529200934|FG000|Final Testing for End of Trial|Adverse Event|1|||
146734870|NCT03086018|529200934|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
146734871|NCT01782872|529200935|FG000|Overall Study|Protocol Violation|0|||
146734872|NCT01782872|529200936|FG001|Overall Study|Protocol Violation|0|||
146734873|NCT01782872|529200937|FG002|Overall Study|Protocol Violation|0|||
146734874|NCT01782872|529200938|FG003|Overall Study|Protocol Violation|1|||
146734875|NCT01782872|529200935|FG000|Overall Study|Withdrawal by Subject|0|||
146734876|NCT01782872|529200936|FG001|Overall Study|Withdrawal by Subject|1|||
146734877|NCT01782872|529200937|FG002|Overall Study|Withdrawal by Subject|0|||
146734878|NCT01782872|529200938|FG003|Overall Study|Withdrawal by Subject|0|||
146734879|NCT01892345|529200939|FG000|Overall Study|Adverse Event|0|||
146734880|NCT01892345|529200940|FG001|Overall Study|Adverse Event|2|||
146734881|NCT01892345|529200939|FG000|Overall Study|Death|1|||
146734882|NCT01892345|529200940|FG001|Overall Study|Death|0|||
146734883|NCT01892345|529200939|FG000|Overall Study|Lost to Follow-up|3|||
146734884|NCT01892345|529200940|FG001|Overall Study|Lost to Follow-up|0|||
146734885|NCT01892345|529200939|FG000|Overall Study|Withdrawal by Subject|12|||
146734886|NCT01892345|529200940|FG001|Overall Study|Withdrawal by Subject|1|||
146734887|NCT03505476|529200941|FG000|Overall Study|Physician Decision|18|||
146734888|NCT03505476|529200941|FG000|Overall Study|Device Malfunctioned|101|||
146734889|NCT03505476|529200941|FG000|Overall Study|Data Corrupt|6|||
146734890|NCT03505476|529200941|FG000|Overall Study|Device application insufficiant|3|||
146734891|NCT02748694|529200942|FG000|Overall Study|Voluntary Withdrawal|0|||
146734892|NCT02748694|529200943|FG001|Overall Study|Voluntary Withdrawal|0|||
146734893|NCT02748694|529200944|FG002|Overall Study|Voluntary Withdrawal|0|||
146734894|NCT02748694|529200945|FG003|Overall Study|Voluntary Withdrawal|0|||
146734895|NCT02748694|529200946|FG004|Overall Study|Voluntary Withdrawal|0|||
146734896|NCT02748694|529200947|FG005|Overall Study|Voluntary Withdrawal|0|||
146734897|NCT02748694|529200948|FG006|Overall Study|Voluntary Withdrawal|0|||
146734898|NCT02748694|529200949|FG007|Overall Study|Voluntary Withdrawal|0|||
146734899|NCT02748694|529200950|FG008|Overall Study|Voluntary Withdrawal|0|||
146734900|NCT02748694|529200951|FG009|Overall Study|Voluntary Withdrawal|0|||
146734901|NCT02748694|529200952|FG010|Overall Study|Voluntary Withdrawal|0|||
146734902|NCT02748694|529200953|FG011|Overall Study|Voluntary Withdrawal|0|||
146734903|NCT02748694|529200954|FG012|Overall Study|Voluntary Withdrawal|0|||
146734904|NCT02748694|529200955|FG013|Overall Study|Voluntary Withdrawal|0|||
146734905|NCT02748694|529200956|FG014|Overall Study|Voluntary Withdrawal|2|||
146734906|NCT00659984|529200959|FG000|Overall Study|Adverse Event|1|||
146734907|NCT04026165|529200962|FG000|Run-in Placebo Period|Enrollment Error|13|||
146734908|NCT04026165|529200963|FG001|Run-in Placebo Period|Enrollment Error|0|||
146734909|NCT04026165|529200964|FG002|Run-in Placebo Period|Enrollment Error|0|||
146734910|NCT04026165|529200965|FG003|Run-in Placebo Period|Enrollment Error|0|||
146734911|NCT04026165|529200962|FG000|Run-in Placebo Period|Run-in Failure|4|||
146734912|NCT04026165|529200963|FG001|Run-in Placebo Period|Run-in Failure|0|||
146734913|NCT04026165|529200964|FG002|Run-in Placebo Period|Run-in Failure|0|||
146734914|NCT04026165|529200965|FG003|Run-in Placebo Period|Run-in Failure|0|||
146734915|NCT04026165|529200962|FG000|Run-in Placebo Period|Protocol Violation|2|||
146734916|NCT04026165|529200963|FG001|Run-in Placebo Period|Protocol Violation|0|||
146734917|NCT04026165|529200964|FG002|Run-in Placebo Period|Protocol Violation|0|||
146734918|NCT04026165|529200965|FG003|Run-in Placebo Period|Protocol Violation|0|||
146734919|NCT04026165|529200962|FG000|Run-in Placebo Period|Withdrew Consent|2|||
146734920|NCT04026165|529200963|FG001|Run-in Placebo Period|Withdrew Consent|0|||
146734921|NCT04026165|529200964|FG002|Run-in Placebo Period|Withdrew Consent|0|||
146734922|NCT04026165|529200965|FG003|Run-in Placebo Period|Withdrew Consent|0|||
146734923|NCT04026165|529200962|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
146734924|NCT04026165|529200963|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
146734925|NCT04026165|529200964|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
146734926|NCT04026165|529200965|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
146792789|NCT03913442|529415599|FG001|Overall Study|Withdrawal by Subject|5|||
146792790|NCT03913442|529415598|FG000|Overall Study|Terminations|2|||
146792791|NCT03913442|529415599|FG001|Overall Study|Terminations|1|||
146792792|NCT03913442|529415598|FG000|Overall Study|Lost to Follow-up|2|||
146792793|NCT03913442|529415599|FG001|Overall Study|Lost to Follow-up|2|||
146792794|NCT02433379|529415600|FG000|Overall Study|Screen Failures|55|||
146792795|NCT02433379|529415600|FG000|Overall Study|Death|57|||
146792796|NCT02433379|529415600|FG000|Overall Study|Total Withdrawals|209|||
146792797|NCT03952338|529415601|FG000|Overall Study|Lost to Follow-up|11|||
146792798|NCT03952338|529415602|FG001|Overall Study|Lost to Follow-up|17|||
146792799|NCT03952338|529415601|FG000|Overall Study|Withdrawal by Subject|1|||
146792800|NCT03952338|529415602|FG001|Overall Study|Withdrawal by Subject|1|||
146792801|NCT03952338|529415601|FG000|Overall Study|Protocol Violation|1|||
146792802|NCT03952338|529415602|FG001|Overall Study|Protocol Violation|0|||
146792803|NCT00592852|529415603|FG000|Overall Study|Non-compliance|1|||
146792804|NCT00592852|529415603|FG000|Overall Study|Adverse Event|3|||
146792805|NCT00592852|529415603|FG000|Overall Study|Found ineligible|1|||
146792806|NCT00592852|529415603|FG000|Overall Study|Withdrawal by Subject|1|||
146792807|NCT05274074|529415612|FG000|Overall Study|Lost to Follow-up|2|||
146792808|NCT05274074|529415613|FG001|Overall Study|Lost to Follow-up|3|||
146792809|NCT05274074|529415612|FG000|Overall Study|Withdrawal by Subject|1|||
146792810|NCT05274074|529415613|FG001|Overall Study|Withdrawal by Subject|2|||
146792811|NCT03687086|529415614|FG000|Overall Study|Withdrawal by Subject|3|||
146792812|NCT03687086|529415615|FG001|Overall Study|Withdrawal by Subject|4|||
146792813|NCT03687086|529415614|FG000|Overall Study|Lost to Follow-up|1|||
146792814|NCT03687086|529415615|FG001|Overall Study|Lost to Follow-up|1|||
146792815|NCT03687086|529415614|FG000|Overall Study|Death|1|||
146792816|NCT03687086|529415615|FG001|Overall Study|Death|0|||
146792817|NCT03687086|529415614|FG000|Overall Study|Incomplete assessment|0|||
146792818|NCT03687086|529415615|FG001|Overall Study|Incomplete assessment|2|||
146792819|NCT02505984|529415616|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
146792820|NCT02505984|529415617|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
146792821|NCT02505984|529415616|FG000|Overall Study|Unreliable self-report data|1|||
146792822|NCT02505984|529415617|FG001|Overall Study|Unreliable self-report data|0|||
146792823|NCT02505984|529415616|FG000|Overall Study|Study blind opened during assessment|0|||
146792824|NCT02505984|529415617|FG001|Overall Study|Study blind opened during assessment|1|||
146792825|NCT02505984|529415616|FG000|Overall Study|Noncompliance with study protocol|0|||
146792826|NCT02505984|529415617|FG001|Overall Study|Noncompliance with study protocol|1|||
146792827|NCT05194956|529415618|FG000|Washout Period|Withdrawal by Subject|0|||
146792828|NCT05194956|529415619|FG001|Washout Period|Withdrawal by Subject|2|||
146792829|NCT02593773|529415630|FG000|Overall Study|Voluntary Withdrawal|3|||
146792830|NCT02593773|529415630|FG000|Overall Study|Study Terminated by Sponsor|31|||
146792831|NCT02593773|529415630|FG000|Overall Study|Death|1|||
146792832|NCT01828099|529415633|FG000|Treatment Period|Adverse Event|24|||
146792833|NCT01828099|529415634|FG001|Treatment Period|Adverse Event|23|||
146792834|NCT01828099|529415633|FG000|Treatment Period|Death|10|||
146792835|NCT01828099|529415634|FG001|Treatment Period|Death|12|||
146792836|NCT01828099|529415633|FG000|Treatment Period|Lost to Follow-up|2|||
146792837|NCT01828099|529415634|FG001|Treatment Period|Lost to Follow-up|1|||
146792838|NCT01828099|529415633|FG000|Treatment Period|Non-compliance with study treatment|1|||
146792839|NCT01828099|529415634|FG001|Treatment Period|Non-compliance with study treatment|0|||
146792840|NCT01828099|529415633|FG000|Treatment Period|Physician Decision|17|||
146792841|NCT01828099|529415634|FG001|Treatment Period|Physician Decision|16|||
146792842|NCT01828099|529415633|FG000|Treatment Period|Progressive disease|99|||
146792843|NCT01828099|529415634|FG001|Treatment Period|Progressive disease|107|||
146792844|NCT01828099|529415633|FG000|Treatment Period|Subject/guardian decision|22|||
146792845|NCT01828099|529415634|FG001|Treatment Period|Subject/guardian decision|26|||
146792846|NCT01828099|529415633|FG000|Treatment Period|Study terminated by Sponsor|13|||
146792847|NCT01828099|529415634|FG001|Treatment Period|Study terminated by Sponsor|1|||
146792848|NCT01828099|529415633|FG000|Treatment Period|Protocol deviation|1|||
146792849|NCT01828099|529415634|FG001|Treatment Period|Protocol deviation|0|||
146792850|NCT01828099|529415633|FG000|Treatment Period|No longer requires treatment|0|||
146792851|NCT01828099|529415634|FG001|Treatment Period|No longer requires treatment|1|||
146792852|NCT01828099|529415633|FG000|Extension-treatment Phase|Adverse Event|0|||
146792853|NCT01828099|529415634|FG001|Extension-treatment Phase|Adverse Event|17|||
146792854|NCT01828099|529415633|FG000|Extension-treatment Phase|Death|0|||
146792855|NCT01828099|529415634|FG001|Extension-treatment Phase|Death|11|||
146792856|NCT01828099|529415633|FG000|Extension-treatment Phase|Physician Decision|0|||
146792857|NCT01828099|529415634|FG001|Extension-treatment Phase|Physician Decision|5|||
146792858|NCT01828099|529415633|FG000|Extension-treatment Phase|Progressive disease|0|||
146792859|NCT01828099|529415634|FG001|Extension-treatment Phase|Progressive disease|54|||
146792860|NCT01828099|529415633|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
146792861|NCT01828099|529415634|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
146792862|NCT01828099|529415633|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
146792863|NCT01828099|529415634|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
146792864|NCT05934942|529415639|FG000|Run-in Period|Not treated|1|||
146792865|NCT05934942|529415639|FG000|Run-in Period|Withdrawal by Subject|1|||
146792866|NCT05645757|529415640|FG000|Overall Study|Enrolled but treatment not administered|0|||
146792867|NCT05645757|529415641|FG001|Overall Study|Enrolled but treatment not administered|0|||
146792868|NCT05645757|529415642|FG002|Overall Study|Enrolled but treatment not administered|0|||
146792869|NCT05645757|529415643|FG003|Overall Study|Enrolled but treatment not administered|0|||
146792870|NCT05645757|529415644|FG004|Overall Study|Enrolled but treatment not administered|1|||
146792871|NCT05645757|529415645|FG005|Overall Study|Enrolled but treatment not administered|1|||
146792872|NCT05645757|529415646|FG006|Overall Study|Enrolled but treatment not administered|0|||
146792873|NCT05645757|529415647|FG007|Overall Study|Enrolled but treatment not administered|0|||
146792874|NCT03924635|529415648|FG000|Overall Study|Withdrawal by Subject|2|||
146792875|NCT03924635|529415649|FG001|Overall Study|Withdrawal by Subject|4|||
146792876|NCT00539591|529415650|FG000|Overall Study|Toxicity|3|||
146792877|NCT00539591|529415651|FG001|Overall Study|Toxicity|0|||
146792878|NCT00539591|529415652|FG002|Overall Study|Toxicity|0|||
146792879|NCT00539591|529415650|FG000|Overall Study|Disease progression|2|||
146792880|NCT00539591|529415651|FG001|Overall Study|Disease progression|2|||
146792881|NCT00539591|529415652|FG002|Overall Study|Disease progression|3|||
146792882|NCT04362254|529415653|FG000|Overall Study|Adverse Event|1|||
146792883|NCT04362254|529415653|FG000|Overall Study|Protocol Violation|1|||
146792884|NCT04362254|529415653|FG000|Overall Study|Due to early termination of the trial|10|||
146792885|NCT04568434|529415654|FG000|Overall Study|Voluntary Withdrawal|0|||
146792886|NCT04568434|529415655|FG001|Overall Study|Voluntary Withdrawal|1|||
146792887|NCT04568434|529415656|FG002|Overall Study|Voluntary Withdrawal|1|||
146792888|NCT04568434|529415654|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
146792889|NCT04568434|529415655|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
146792890|NCT04568434|529415656|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
146792891|NCT04568434|529415654|FG000|Overall Study|Investigator Judgement|1|||
146792892|NCT04568434|529415655|FG001|Overall Study|Investigator Judgement|0|||
146792893|NCT04568434|529415656|FG002|Overall Study|Investigator Judgement|0|||
146792894|NCT05469464|529415657|FG000|Overall Study|Withdrawal by Subject|8|||
146792895|NCT05469464|529415658|FG001|Overall Study|Withdrawal by Subject|7|||
146792896|NCT05469464|529415659|FG002|Overall Study|Withdrawal by Subject|4|||
146792897|NCT05469464|529415660|FG003|Overall Study|Withdrawal by Subject|5|||
146792898|NCT05469464|529415657|FG000|Overall Study|Adverse Event|8|||
146792899|NCT05469464|529415658|FG001|Overall Study|Adverse Event|14|||
146792900|NCT05469464|529415659|FG002|Overall Study|Adverse Event|13|||
146792901|NCT05469464|529415660|FG003|Overall Study|Adverse Event|2|||
146792902|NCT05469464|529415657|FG000|Overall Study|Lost to Follow-up|2|||
146792903|NCT05469464|529415658|FG001|Overall Study|Lost to Follow-up|5|||
146792904|NCT05469464|529415659|FG002|Overall Study|Lost to Follow-up|3|||
146792905|NCT05469464|529415660|FG003|Overall Study|Lost to Follow-up|3|||
146792906|NCT05469464|529415657|FG000|Overall Study|Lack of Efficacy|4|||
146792907|NCT05469464|529415658|FG001|Overall Study|Lack of Efficacy|1|||
146792908|NCT05469464|529415659|FG002|Overall Study|Lack of Efficacy|2|||
146792909|NCT05469464|529415660|FG003|Overall Study|Lack of Efficacy|2|||
146792910|NCT05469464|529415657|FG000|Overall Study|Physician Decision|0|||
146792911|NCT05469464|529415658|FG001|Overall Study|Physician Decision|0|||
146792912|NCT05469464|529415659|FG002|Overall Study|Physician Decision|0|||
146792913|NCT05469464|529415660|FG003|Overall Study|Physician Decision|1|||
146792914|NCT01928394|529415661|FG000|Treatment Period|Disease progression|17|||
146792915|NCT01928394|529415662|FG001|Treatment Period|Disease progression|2|||
146792916|NCT01928394|529415663|FG002|Treatment Period|Disease progression|12|||
146792917|NCT01928394|529415664|FG003|Treatment Period|Disease progression|48|||
146792918|NCT01928394|529415665|FG004|Treatment Period|Disease progression|3|||
146792919|NCT01928394|529415666|FG005|Treatment Period|Disease progression|25|||
146792920|NCT01928394|529415667|FG006|Treatment Period|Disease progression|38|||
146792921|NCT01928394|529415668|FG007|Treatment Period|Disease progression|16|||
146792922|NCT01928394|529415669|FG008|Treatment Period|Disease progression|3|||
146792923|NCT01928394|529415670|FG009|Treatment Period|Disease progression|11|||
146792924|NCT01928394|529415671|FG010|Treatment Period|Disease progression|22|||
146792925|NCT01928394|529415672|FG011|Treatment Period|Disease progression|73|||
146792926|NCT01928394|529415673|FG012|Treatment Period|Disease progression|38|||
146792927|NCT01928394|529415674|FG013|Treatment Period|Disease progression|118|||
146792928|NCT01928394|529415675|FG014|Treatment Period|Disease progression|59|||
146792929|NCT01928394|529415676|FG015|Treatment Period|Disease progression|1|||
146792930|NCT01928394|529415677|FG016|Treatment Period|Disease progression|43|||
146792931|NCT01928394|529415678|FG017|Treatment Period|Disease progression|56|||
146792932|NCT01928394|529415679|FG018|Treatment Period|Disease progression|50|||
146792933|NCT01928394|529415680|FG019|Treatment Period|Disease progression|71|||
146792934|NCT01928394|529415681|FG020|Treatment Period|Disease progression|30|||
146792935|NCT01928394|529415682|FG021|Treatment Period|Disease progression|31|||
146792936|NCT01928394|529415683|FG022|Treatment Period|Disease progression|31|||
146792937|NCT01928394|529415661|FG000|Treatment Period|Study drug toxicity|1|||
146792938|NCT01928394|529415662|FG001|Treatment Period|Study drug toxicity|1|||
146792939|NCT01928394|529415663|FG002|Treatment Period|Study drug toxicity|3|||
146792940|NCT01928394|529415664|FG003|Treatment Period|Study drug toxicity|3|||
146792941|NCT01928394|529415665|FG004|Treatment Period|Study drug toxicity|0|||
146792942|NCT01928394|529415666|FG005|Treatment Period|Study drug toxicity|9|||
146792943|NCT01928394|529415667|FG006|Treatment Period|Study drug toxicity|7|||
146792944|NCT01928394|529415668|FG007|Treatment Period|Study drug toxicity|1|||
146792945|NCT01928394|529415669|FG008|Treatment Period|Study drug toxicity|0|||
146792946|NCT01928394|529415670|FG009|Treatment Period|Study drug toxicity|5|||
146792947|NCT01928394|529415671|FG010|Treatment Period|Study drug toxicity|2|||
146792948|NCT01928394|529415672|FG011|Treatment Period|Study drug toxicity|3|||
146792949|NCT01928394|529415673|FG012|Treatment Period|Study drug toxicity|7|||
146792950|NCT01928394|529415674|FG013|Treatment Period|Study drug toxicity|5|||
146792951|NCT01928394|529415675|FG014|Treatment Period|Study drug toxicity|12|||
146792952|NCT01928394|529415676|FG015|Treatment Period|Study drug toxicity|0|||
146792953|NCT01928394|529415677|FG016|Treatment Period|Study drug toxicity|3|||
146792954|NCT01928394|529415678|FG017|Treatment Period|Study drug toxicity|3|||
146792955|NCT01928394|529415679|FG018|Treatment Period|Study drug toxicity|12|||
146792956|NCT01928394|529415680|FG019|Treatment Period|Study drug toxicity|15|||
146792957|NCT01928394|529415681|FG020|Treatment Period|Study drug toxicity|4|||
146792958|NCT01928394|529415682|FG021|Treatment Period|Study drug toxicity|7|||
146792959|NCT01928394|529415683|FG022|Treatment Period|Study drug toxicity|4|||
146792960|NCT01928394|529415661|FG000|Treatment Period|AE unrelated to study drug|0|||
146792961|NCT01928394|529415662|FG001|Treatment Period|AE unrelated to study drug|0|||
146792962|NCT01928394|529415663|FG002|Treatment Period|AE unrelated to study drug|2|||
146792963|NCT01928394|529415664|FG003|Treatment Period|AE unrelated to study drug|3|||
146792964|NCT01928394|529415665|FG004|Treatment Period|AE unrelated to study drug|0|||
146792965|NCT01928394|529415666|FG005|Treatment Period|AE unrelated to study drug|5|||
146792966|NCT01928394|529415667|FG006|Treatment Period|AE unrelated to study drug|1|||
146792967|NCT01928394|529415668|FG007|Treatment Period|AE unrelated to study drug|0|||
146792968|NCT01928394|529415669|FG008|Treatment Period|AE unrelated to study drug|0|||
146792969|NCT01928394|529415670|FG009|Treatment Period|AE unrelated to study drug|2|||
146792970|NCT01928394|529415671|FG010|Treatment Period|AE unrelated to study drug|0|||
146792971|NCT01928394|529415672|FG011|Treatment Period|AE unrelated to study drug|12|||
146792972|NCT01928394|529415673|FG012|Treatment Period|AE unrelated to study drug|6|||
146792973|NCT01928394|529415674|FG013|Treatment Period|AE unrelated to study drug|13|||
146792974|NCT01928394|529415675|FG014|Treatment Period|AE unrelated to study drug|6|||
146792975|NCT01928394|529415676|FG015|Treatment Period|AE unrelated to study drug|1|||
146792976|NCT01928394|529415677|FG016|Treatment Period|AE unrelated to study drug|1|||
146792977|NCT01928394|529415678|FG017|Treatment Period|AE unrelated to study drug|6|||
146792978|NCT01928394|529415679|FG018|Treatment Period|AE unrelated to study drug|3|||
146792979|NCT01928394|529415680|FG019|Treatment Period|AE unrelated to study drug|5|||
146792980|NCT01928394|529415681|FG020|Treatment Period|AE unrelated to study drug|1|||
146792981|NCT01928394|529415682|FG021|Treatment Period|AE unrelated to study drug|1|||
146792982|NCT01928394|529415683|FG022|Treatment Period|AE unrelated to study drug|0|||
146792983|NCT01928394|529415661|FG000|Treatment Period|Participant request to stop therapy|0|||
146792984|NCT01928394|529415662|FG001|Treatment Period|Participant request to stop therapy|0|||
146792985|NCT01928394|529415663|FG002|Treatment Period|Participant request to stop therapy|0|||
146792986|NCT01928394|529415664|FG003|Treatment Period|Participant request to stop therapy|0|||
146792987|NCT01928394|529415665|FG004|Treatment Period|Participant request to stop therapy|0|||
146792988|NCT01928394|529415666|FG005|Treatment Period|Participant request to stop therapy|3|||
146792989|NCT01928394|529415667|FG006|Treatment Period|Participant request to stop therapy|3|||
146792990|NCT01928394|529415668|FG007|Treatment Period|Participant request to stop therapy|0|||
146792991|NCT01928394|529415669|FG008|Treatment Period|Participant request to stop therapy|0|||
146792992|NCT01928394|529415670|FG009|Treatment Period|Participant request to stop therapy|0|||
146792993|NCT01928394|529415671|FG010|Treatment Period|Participant request to stop therapy|3|||
146792994|NCT01928394|529415672|FG011|Treatment Period|Participant request to stop therapy|2|||
146982240|NCT01133821|530097900|FG001|Overall Study|Refused participation|3|||
146982241|NCT01267266|530097905|FG000|Enrollment Phase|Withdrawal by Subject|2|||
146982242|NCT01267266|530097906|FG001|Enrollment Phase|Withdrawal by Subject|0|||
146792995|NCT01928394|529415673|FG012|Treatment Period|Participant request to stop therapy|1|||
146792996|NCT01928394|529415674|FG013|Treatment Period|Participant request to stop therapy|2|||
146792997|NCT01928394|529415675|FG014|Treatment Period|Participant request to stop therapy|4|||
146792998|NCT01928394|529415676|FG015|Treatment Period|Participant request to stop therapy|0|||
146792999|NCT01928394|529415677|FG016|Treatment Period|Participant request to stop therapy|1|||
146793000|NCT01928394|529415678|FG017|Treatment Period|Participant request to stop therapy|3|||
146982243|NCT01267266|530097905|FG000|Lead-in Phase|Lack of Efficacy|20|||
146793001|NCT01928394|529415679|FG018|Treatment Period|Participant request to stop therapy|1|||
146793002|NCT01928394|529415680|FG019|Treatment Period|Participant request to stop therapy|1|||
146793003|NCT01928394|529415681|FG020|Treatment Period|Participant request to stop therapy|3|||
146938901|NCT01237223|529934305|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
146938902|NCT01237223|529934306|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
146938903|NCT01237223|529934307|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
146938904|NCT01237223|529934308|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
146938905|NCT01237223|529934303|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
146734927|NCT04026165|529200962|FG000|Run-in SEL Period|Run-in Failure|0|||
146734928|NCT04026165|529200963|FG001|Run-in SEL Period|Run-in Failure|26|||
146734929|NCT04026165|529200964|FG002|Run-in SEL Period|Run-in Failure|0|||
146734930|NCT04026165|529200965|FG003|Run-in SEL Period|Run-in Failure|0|||
146734931|NCT04026165|529200962|FG000|Run-in SEL Period|Withdrew Consent|0|||
146734932|NCT04026165|529200963|FG001|Run-in SEL Period|Withdrew Consent|10|||
146734933|NCT04026165|529200964|FG002|Run-in SEL Period|Withdrew Consent|0|||
146734934|NCT04026165|529200965|FG003|Run-in SEL Period|Withdrew Consent|0|||
146734935|NCT04026165|529200962|FG000|Run-in SEL Period|Enrollment Error|0|||
146734936|NCT04026165|529200963|FG001|Run-in SEL Period|Enrollment Error|4|||
146734937|NCT04026165|529200964|FG002|Run-in SEL Period|Enrollment Error|0|||
146734938|NCT04026165|529200965|FG003|Run-in SEL Period|Enrollment Error|0|||
146734939|NCT04026165|529200962|FG000|Run-in SEL Period|Protocol Violation|0|||
146734940|NCT04026165|529200963|FG001|Run-in SEL Period|Protocol Violation|3|||
146734941|NCT04026165|529200964|FG002|Run-in SEL Period|Protocol Violation|0|||
146734942|NCT04026165|529200965|FG003|Run-in SEL Period|Protocol Violation|0|||
146734943|NCT04026165|529200962|FG000|Run-in SEL Period|Investigator's Discretion|0|||
146734944|NCT04026165|529200963|FG001|Run-in SEL Period|Investigator's Discretion|2|||
146734945|NCT04026165|529200964|FG002|Run-in SEL Period|Investigator's Discretion|0|||
146734946|NCT04026165|529200965|FG003|Run-in SEL Period|Investigator's Discretion|0|||
146734947|NCT04026165|529200962|FG000|Run-in SEL Period|Death|0|||
146734948|NCT04026165|529200963|FG001|Run-in SEL Period|Death|1|||
146734949|NCT04026165|529200964|FG002|Run-in SEL Period|Death|0|||
146734950|NCT04026165|529200965|FG003|Run-in SEL Period|Death|0|||
146734951|NCT04026165|529200962|FG000|Randomized Period|Withdrew Consent|0|||
146734952|NCT04026165|529200963|FG001|Randomized Period|Withdrew Consent|0|||
146734953|NCT04026165|529200964|FG002|Randomized Period|Withdrew Consent|5|||
146734954|NCT04026165|529200965|FG003|Randomized Period|Withdrew Consent|8|||
146734955|NCT04026165|529200962|FG000|Randomized Period|Death|0|||
146734956|NCT04026165|529200963|FG001|Randomized Period|Death|0|||
146734957|NCT04026165|529200964|FG002|Randomized Period|Death|5|||
146734958|NCT04026165|529200965|FG003|Randomized Period|Death|7|||
146734959|NCT04026165|529200962|FG000|Randomized Period|Investigator's Discretion|0|||
146734960|NCT04026165|529200963|FG001|Randomized Period|Investigator's Discretion|0|||
146734961|NCT04026165|529200964|FG002|Randomized Period|Investigator's Discretion|2|||
146734962|NCT04026165|529200965|FG003|Randomized Period|Investigator's Discretion|2|||
146734963|NCT04026165|529200962|FG000|Randomized Period|Lost to Follow-up|0|||
146734964|NCT04026165|529200963|FG001|Randomized Period|Lost to Follow-up|0|||
146734965|NCT04026165|529200964|FG002|Randomized Period|Lost to Follow-up|2|||
146734966|NCT04026165|529200965|FG003|Randomized Period|Lost to Follow-up|2|||
146734967|NCT01059630|529200966|FG000|Overall Study|Death|100|||
146734968|NCT01059630|529200967|FG001|Overall Study|Death|84|||
146734969|NCT01059630|529200966|FG000|Overall Study|Lost to Follow-up|4|||
146734970|NCT01059630|529200967|FG001|Overall Study|Lost to Follow-up|1|||
146734971|NCT01059630|529200966|FG000|Overall Study|Physician Decision|2|||
146734972|NCT01059630|529200967|FG001|Overall Study|Physician Decision|4|||
146734973|NCT01059630|529200966|FG000|Overall Study|Withdrawal by Subject|21|||
146734974|NCT01059630|529200967|FG001|Overall Study|Withdrawal by Subject|14|||
146734975|NCT03170375|529200968|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
146734976|NCT03170375|529200969|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
146734977|NCT03170375|529200970|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
146734978|NCT03170375|529200968|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
146734979|NCT03170375|529200969|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
146734980|NCT03170375|529200970|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
146734981|NCT00441701|529200971|FG000|Overall Study|Adverse Event|3|||
146734982|NCT00441701|529200972|FG001|Overall Study|Adverse Event|2|||
146734983|NCT00441701|529200973|FG002|Overall Study|Adverse Event|1|||
146734984|NCT00441701|529200974|FG003|Overall Study|Adverse Event|0|||
146734985|NCT00441701|529200975|FG004|Overall Study|Adverse Event|2|||
146734986|NCT00441701|529200976|FG005|Overall Study|Adverse Event|2|||
146734987|NCT00441701|529200977|FG006|Overall Study|Adverse Event|0|||
146734988|NCT00441701|529200978|FG007|Overall Study|Adverse Event|0|||
146734989|NCT00441701|529200979|FG008|Overall Study|Adverse Event|0|||
146734990|NCT00441701|529200980|FG009|Overall Study|Adverse Event|0|||
146734991|NCT00441701|529200971|FG000|Overall Study|Lack of Efficacy|2|||
146734992|NCT00441701|529200972|FG001|Overall Study|Lack of Efficacy|0|||
146734993|NCT00441701|529200973|FG002|Overall Study|Lack of Efficacy|2|||
146938906|NCT01237223|529934304|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
146734994|NCT00441701|529200974|FG003|Overall Study|Lack of Efficacy|2|||
146734995|NCT00441701|529200975|FG004|Overall Study|Lack of Efficacy|0|||
146734996|NCT00441701|529200976|FG005|Overall Study|Lack of Efficacy|1|||
146982244|NCT01267266|530097906|FG001|Lead-in Phase|Lack of Efficacy|0|||
146982245|NCT01267266|530097905|FG000|Lead-in Phase|Adverse Event|2|||
146982246|NCT01267266|530097906|FG001|Lead-in Phase|Adverse Event|0|||
146982247|NCT01267266|530097905|FG000|Lead-in Phase|Withdrawal by Subject|1|||
146982248|NCT01267266|530097906|FG001|Lead-in Phase|Withdrawal by Subject|0|||
146982249|NCT01335477|530097908|FG000|Overall Study|Adverse Event|30|||
146982250|NCT01335477|530097909|FG001|Overall Study|Adverse Event|42|||
146982251|NCT01335477|530097908|FG000|Overall Study|Non compliant with protocol|0|||
146982252|NCT01335477|530097909|FG001|Overall Study|Non compliant with protocol|2|||
146982253|NCT01335477|530097908|FG000|Overall Study|Lost to Follow-up|1|||
146982254|NCT01335477|530097909|FG001|Overall Study|Lost to Follow-up|2|||
146982255|NCT01335477|530097908|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
146982256|NCT01335477|530097909|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
146982257|NCT01335477|530097908|FG000|Overall Study|Not treated|1|||
146982258|NCT01335477|530097909|FG001|Overall Study|Not treated|2|||
146982259|NCT01335477|530097908|FG000|Overall Study|Reason other than those stated above|2|||
146982260|NCT01335477|530097909|FG001|Overall Study|Reason other than those stated above|2|||
146982261|NCT02038634|530097911|FG000|Overall Study|Lost to Follow-up|0|||
146982262|NCT02038634|530097912|FG001|Overall Study|Lost to Follow-up|1|||
146982263|NCT01034137|530097914|FG000|Overall Study|Adverse Event|9|||
146982264|NCT01034137|530097915|FG001|Overall Study|Adverse Event|10|||
146982265|NCT01034137|530097916|FG002|Overall Study|Adverse Event|8|||
146982266|NCT01034137|530097914|FG000|Overall Study|Withdrawal by Subject|4|||
146982267|NCT01034137|530097915|FG001|Overall Study|Withdrawal by Subject|3|||
146982268|NCT01034137|530097916|FG002|Overall Study|Withdrawal by Subject|3|||
146982269|NCT01034137|530097914|FG000|Overall Study|Lack of Efficacy|9|||
146982270|NCT01034137|530097915|FG001|Overall Study|Lack of Efficacy|4|||
146982271|NCT01034137|530097916|FG002|Overall Study|Lack of Efficacy|13|||
146982272|NCT01034137|530097914|FG000|Overall Study|Protocol Violation|2|||
146982273|NCT01034137|530097915|FG001|Overall Study|Protocol Violation|2|||
146982274|NCT01034137|530097916|FG002|Overall Study|Protocol Violation|1|||
146982275|NCT01034137|530097914|FG000|Overall Study|Refused treatment or did not cooperate|2|||
146982276|NCT01034137|530097915|FG001|Overall Study|Refused treatment or did not cooperate|0|||
146982277|NCT01034137|530097916|FG002|Overall Study|Refused treatment or did not cooperate|1|||
146982278|NCT01034137|530097914|FG000|Overall Study|Administrative or other|2|||
146982279|NCT01034137|530097915|FG001|Overall Study|Administrative or other|3|||
146982280|NCT01034137|530097916|FG002|Overall Study|Administrative or other|4|||
146982281|NCT03572933|530097917|FG000|Overall Study|Adverse Event|4|||
146982282|NCT03572933|530097918|FG001|Overall Study|Adverse Event|1|||
146938907|NCT01237223|529934305|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
146938908|NCT01237223|529934306|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
146938909|NCT01237223|529934307|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
146938910|NCT01237223|529934308|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
146938911|NCT01237223|529934303|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
146938912|NCT01237223|529934304|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
146938913|NCT01237223|529934305|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
146938914|NCT01237223|529934306|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
146938915|NCT01237223|529934307|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
146938916|NCT01237223|529934308|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
146982283|NCT03572933|530097917|FG000|Overall Study|Withdrawal by Subject|0|||
146982284|NCT03572933|530097918|FG001|Overall Study|Withdrawal by Subject|1|||
146982285|NCT02049359|530097923|FG000|Overall Study|Lost to Follow-up|26|||
146982286|NCT02049359|530097924|FG001|Overall Study|Lost to Follow-up|19|||
146982287|NCT01405950|530097925|FG000|Overall Study|Withdrawal by Subject|1|||
146982288|NCT01405950|530097926|FG001|Overall Study|Withdrawal by Subject|0|||
146982289|NCT01405950|530097927|FG002|Overall Study|Withdrawal by Subject|0|||
146982290|NCT01405950|530097928|FG003|Overall Study|Withdrawal by Subject|0|||
146982291|NCT01381900|530097929|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
146982292|NCT01381900|530097930|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
146982293|NCT01381900|530097931|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
146982294|NCT01381900|530097929|FG000|Overall Study|Adverse Event|4|||
146982295|NCT01381900|530097930|FG001|Overall Study|Adverse Event|6|||
146982296|NCT01381900|530097931|FG002|Overall Study|Adverse Event|7|||
146982297|NCT01381900|530097929|FG000|Overall Study|Noncompliance with study drug|0|||
146982298|NCT01381900|530097930|FG001|Overall Study|Noncompliance with study drug|0|||
146982299|NCT01381900|530097931|FG002|Overall Study|Noncompliance with study drug|1|||
146982300|NCT01381900|530097929|FG000|Overall Study|Physician Decision|0|||
146982301|NCT01381900|530097930|FG001|Overall Study|Physician Decision|1|||
146982302|NCT01381900|530097931|FG002|Overall Study|Physician Decision|1|||
146982303|NCT01381900|530097929|FG000|Overall Study|Protocol Violation|0|||
146982304|NCT01381900|530097930|FG001|Overall Study|Protocol Violation|1|||
146982305|NCT01381900|530097931|FG002|Overall Study|Protocol Violation|1|||
146982306|NCT01381900|530097929|FG000|Overall Study|Withdrawal by Subject|0|||
146982307|NCT01381900|530097930|FG001|Overall Study|Withdrawal by Subject|0|||
146734997|NCT00441701|529200977|FG006|Overall Study|Lack of Efficacy|0|||
146734998|NCT00441701|529200978|FG007|Overall Study|Lack of Efficacy|0|||
146734999|NCT00441701|529200979|FG008|Overall Study|Lack of Efficacy|0|||
146735000|NCT00441701|529200980|FG009|Overall Study|Lack of Efficacy|0|||
146735001|NCT00441701|529200971|FG000|Overall Study|Withdrawal by Subject|0|||
146735002|NCT00441701|529200972|FG001|Overall Study|Withdrawal by Subject|2|||
146735003|NCT00441701|529200973|FG002|Overall Study|Withdrawal by Subject|1|||
146735004|NCT00441701|529200974|FG003|Overall Study|Withdrawal by Subject|1|||
146735005|NCT00441701|529200975|FG004|Overall Study|Withdrawal by Subject|0|||
146735006|NCT00441701|529200976|FG005|Overall Study|Withdrawal by Subject|0|||
146735007|NCT00441701|529200977|FG006|Overall Study|Withdrawal by Subject|0|||
146735008|NCT00441701|529200978|FG007|Overall Study|Withdrawal by Subject|0|||
146735009|NCT00441701|529200979|FG008|Overall Study|Withdrawal by Subject|0|||
146735010|NCT00441701|529200980|FG009|Overall Study|Withdrawal by Subject|0|||
146735011|NCT00621543|529200984|FG000|Overall Study|Lost to Follow-up|23|||
146735012|NCT01287611|529200989|FG000|Overall Study|Lost to Follow-up|29|||
146735013|NCT01287611|529200990|FG001|Overall Study|Lost to Follow-up|16|||
146735014|NCT01287611|529200989|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
146735015|NCT01287611|529200990|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
146735016|NCT02192970|529200991|FG000|Overall Study|Lost to Follow-up|6|||
146735017|NCT02192970|529200992|FG001|Overall Study|Lost to Follow-up|0|||
146735018|NCT00763958|529200993|FG000|Overall Study|did not meet final criteria|4|||
146735019|NCT00763958|529200994|FG001|Overall Study|did not meet final criteria|4|||
146735020|NCT00763958|529200993|FG000|Overall Study|Lost to Follow-up|10|||
146735021|NCT00763958|529200994|FG001|Overall Study|Lost to Follow-up|2|||
146735022|NCT00763958|529200993|FG000|Overall Study|Believed they were receiving placebo|0|||
146735023|NCT00763958|529200994|FG001|Overall Study|Believed they were receiving placebo|5|||
146735024|NCT01060553|529200995|FG000|Overall Study|Lost to Follow-up|3|||
146735025|NCT01060553|529200996|FG001|Overall Study|Lost to Follow-up|5|||
146735026|NCT01060553|529200995|FG000|Overall Study|Withdrawal by Subject|5|||
146735027|NCT01060553|529200996|FG001|Overall Study|Withdrawal by Subject|5|||
146735028|NCT01060553|529200995|FG000|Overall Study|Lack of Efficacy|1|||
146735029|NCT01060553|529200996|FG001|Overall Study|Lack of Efficacy|0|||
146735030|NCT01462162|529200998|FG000|Overall Study|Adverse Event|5|||
146735031|NCT01462162|529200998|FG000|Overall Study|Lack of Efficacy|4|||
146735032|NCT01462162|529200998|FG000|Overall Study|Abnormal laboratory parameters|1|||
146735033|NCT01462162|529200998|FG000|Overall Study|Other|2|||
146735034|NCT04404478|529200999|FG000|Overall Study|Withdrawal by Subject|1|||
146793004|NCT01928394|529415682|FG021|Treatment Period|Participant request to stop therapy|1|||
146793005|NCT01928394|529415683|FG022|Treatment Period|Participant request to stop therapy|3|||
146793006|NCT01928394|529415661|FG000|Treatment Period|Participant withdrew consent|0|||
146793007|NCT01928394|529415662|FG001|Treatment Period|Participant withdrew consent|0|||
146793008|NCT01928394|529415663|FG002|Treatment Period|Participant withdrew consent|1|||
146793009|NCT01928394|529415664|FG003|Treatment Period|Participant withdrew consent|1|||
146793010|NCT01928394|529415665|FG004|Treatment Period|Participant withdrew consent|0|||
146793011|NCT01928394|529415666|FG005|Treatment Period|Participant withdrew consent|1|||
146793012|NCT01928394|529415667|FG006|Treatment Period|Participant withdrew consent|0|||
146793013|NCT01928394|529415668|FG007|Treatment Period|Participant withdrew consent|1|||
146793014|NCT01928394|529415669|FG008|Treatment Period|Participant withdrew consent|0|||
146793015|NCT01928394|529415670|FG009|Treatment Period|Participant withdrew consent|0|||
146793016|NCT01928394|529415671|FG010|Treatment Period|Participant withdrew consent|1|||
146793017|NCT01928394|529415672|FG011|Treatment Period|Participant withdrew consent|1|||
146793018|NCT01928394|529415673|FG012|Treatment Period|Participant withdrew consent|1|||
146793019|NCT01928394|529415674|FG013|Treatment Period|Participant withdrew consent|0|||
146793020|NCT01928394|529415675|FG014|Treatment Period|Participant withdrew consent|2|||
146793021|NCT01928394|529415676|FG015|Treatment Period|Participant withdrew consent|0|||
146793022|NCT01928394|529415677|FG016|Treatment Period|Participant withdrew consent|2|||
146793023|NCT01928394|529415678|FG017|Treatment Period|Participant withdrew consent|1|||
146793024|NCT01928394|529415679|FG018|Treatment Period|Participant withdrew consent|1|||
146793025|NCT01928394|529415680|FG019|Treatment Period|Participant withdrew consent|1|||
146793026|NCT01928394|529415681|FG020|Treatment Period|Participant withdrew consent|0|||
146793027|NCT01928394|529415682|FG021|Treatment Period|Participant withdrew consent|2|||
146793028|NCT01928394|529415683|FG022|Treatment Period|Participant withdrew consent|0|||
146938917|NCT01237223|529934303|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
146938918|NCT01237223|529934304|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
146938919|NCT01237223|529934305|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
146938920|NCT01237223|529934306|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
146735035|NCT04404478|529201000|FG001|Overall Study|Withdrawal by Subject|3|||
146735036|NCT03485911|529201001|FG000|Part 1|Perceived lack of efficacy|1|||
146735037|NCT03485911|529201002|FG001|Part 1|Perceived lack of efficacy|1|||
146735038|NCT03485911|529201003|FG002|Part 1|Perceived lack of efficacy|2|||
146793029|NCT01928394|529415661|FG000|Treatment Period|Poor/non-compliance|0|||
146793030|NCT01928394|529415662|FG001|Treatment Period|Poor/non-compliance|0|||
146982308|NCT01381900|530097931|FG002|Overall Study|Withdrawal by Subject|1|||
146982309|NCT01381900|530097929|FG000|Overall Study|Early withdraw|3|||
146982310|NCT01381900|530097930|FG001|Overall Study|Early withdraw|1|||
146982311|NCT01381900|530097931|FG002|Overall Study|Early withdraw|1|||
146982312|NCT01772368|530097932|FG000|Overall Study|Adverse Event|1|||
146982313|NCT01772368|530097932|FG000|Overall Study|Withdrawal by Subject|3|||
146982314|NCT01772368|530097932|FG000|Overall Study|Protocol Violation|2|||
146982315|NCT01772368|530097932|FG000|Overall Study|Other|1|||
146982316|NCT03347695|530097939|FG000|Overall Study|Death|0|||
146982317|NCT03347695|530097940|FG001|Overall Study|Death|4|||
146982318|NCT03347695|530097939|FG000|Overall Study|Lost to Follow-up|0|||
146982319|NCT03347695|530097940|FG001|Overall Study|Lost to Follow-up|1|||
146982320|NCT00671879|530097943|FG000|Overall Study|Withdrawal by Subject|0|||
146982321|NCT00671879|530097944|FG001|Overall Study|Withdrawal by Subject|4|||
146982322|NCT00671879|530097945|FG002|Overall Study|Withdrawal by Subject|6|||
146982323|NCT04633837|530097946|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
146982324|NCT04633837|530097947|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
146982325|NCT02668783|530097948|FG000|Overall Study|Pregnancy|0|||
146982326|NCT02668783|530097949|FG001|Overall Study|Pregnancy|1|||
146982327|NCT02668783|530097948|FG000|Overall Study|Protocol Violation|2|||
146982328|NCT02668783|530097949|FG001|Overall Study|Protocol Violation|1|||
146982329|NCT02668783|530097948|FG000|Overall Study|Study terminated by sponsor|9|||
146982330|NCT02668783|530097949|FG001|Overall Study|Study terminated by sponsor|10|||
146982331|NCT02668783|530097948|FG000|Overall Study|Subject moved|1|||
146982332|NCT02668783|530097949|FG001|Overall Study|Subject moved|0|||
146982333|NCT02668783|530097948|FG000|Overall Study|Withdrawal by Subject|1|||
146982334|NCT02668783|530097949|FG001|Overall Study|Withdrawal by Subject|0|||
146982335|NCT02884206|530097950|FG000|Valsartan Run-in Period|Death|1|||
146982336|NCT02884206|530097951|FG001|Valsartan Run-in Period|Death|0|||
146982337|NCT02884206|530097952|FG002|Valsartan Run-in Period|Death|0|||
146982338|NCT02884206|530097950|FG000|Valsartan Run-in Period|Adverse Event|31|||
146982339|NCT02884206|530097951|FG001|Valsartan Run-in Period|Adverse Event|0|||
146982340|NCT02884206|530097952|FG002|Valsartan Run-in Period|Adverse Event|0|||
146982341|NCT02884206|530097950|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
146982342|NCT02884206|530097951|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
146982343|NCT02884206|530097952|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
146982344|NCT02884206|530097950|FG000|Valsartan Run-in Period|Protocol deviation|4|||
146982345|NCT02884206|530097951|FG001|Valsartan Run-in Period|Protocol deviation|0|||
146982346|NCT02884206|530097952|FG002|Valsartan Run-in Period|Protocol deviation|0|||
146982347|NCT02884206|530097950|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
146982348|NCT02884206|530097951|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
146982349|NCT02884206|530097952|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
146982350|NCT02884206|530097950|FG000|Valsartan Run-in Period|Physician Decision|1|||
146982351|NCT02884206|530097951|FG001|Valsartan Run-in Period|Physician Decision|0|||
146982352|NCT02884206|530097952|FG002|Valsartan Run-in Period|Physician Decision|0|||
146982353|NCT02884206|530097950|FG000|LCZ696 Run-in Period|Adverse Event|38|||
146982354|NCT02884206|530097951|FG001|LCZ696 Run-in Period|Adverse Event|0|||
146982355|NCT02884206|530097952|FG002|LCZ696 Run-in Period|Adverse Event|0|||
146982356|NCT02884206|530097950|FG000|LCZ696 Run-in Period|Death|2|||
146982357|NCT02884206|530097951|FG001|LCZ696 Run-in Period|Death|0|||
146982358|NCT02884206|530097952|FG002|LCZ696 Run-in Period|Death|0|||
146982359|NCT02884206|530097950|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
146982360|NCT02884206|530097951|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
146982361|NCT02884206|530097952|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
146982362|NCT02884206|530097950|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
146982363|NCT02884206|530097951|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
146982364|NCT02884206|530097952|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
146982365|NCT02884206|530097950|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
146982366|NCT02884206|530097951|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
146982367|NCT02884206|530097952|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
146982368|NCT02884206|530097950|FG000|LCZ696 Run-in Period|Physician Decision|1|||
146982369|NCT02884206|530097951|FG001|LCZ696 Run-in Period|Physician Decision|0|||
146982370|NCT02884206|530097952|FG002|LCZ696 Run-in Period|Physician Decision|0|||
146982371|NCT02884206|530097950|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
146982372|NCT02884206|530097951|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
146982373|NCT02884206|530097952|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
146982374|NCT02884206|530097950|FG000|Double-Blind Period|Death|0|||
146982375|NCT02884206|530097951|FG001|Double-Blind Period|Death|28|||
146982376|NCT02884206|530097952|FG002|Double-Blind Period|Death|39|||
146982377|NCT02884206|530097950|FG000|Double-Blind Period|Patient/guardian decision|0|||
146982378|NCT02884206|530097951|FG001|Double-Blind Period|Patient/guardian decision|10|||
146982379|NCT02884206|530097952|FG002|Double-Blind Period|Patient/guardian decision|13|||
146982380|NCT02884206|530097950|FG000|Double-Blind Period|Lost to Follow-up|0|||
146982381|NCT02884206|530097951|FG001|Double-Blind Period|Lost to Follow-up|4|||
146982382|NCT02884206|530097952|FG002|Double-Blind Period|Lost to Follow-up|4|||
146793031|NCT01928394|529415663|FG002|Treatment Period|Poor/non-compliance|0|||
146793032|NCT01928394|529415664|FG003|Treatment Period|Poor/non-compliance|1|||
146938921|NCT01237223|529934307|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
146938922|NCT01237223|529934308|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
146938923|NCT00064077|529934316|FG000|Overall Study|Improper prior treatment|1|||
146735039|NCT03485911|529201004|FG003|Part 1|Perceived lack of efficacy|0|||
146735040|NCT03485911|529201001|FG000|Part 1|Subject withdrew consent|0|||
146735041|NCT03485911|529201002|FG001|Part 1|Subject withdrew consent|1|||
146735042|NCT03485911|529201003|FG002|Part 1|Subject withdrew consent|0|||
146735043|NCT03485911|529201004|FG003|Part 1|Subject withdrew consent|1|||
146735044|NCT03485911|529201001|FG000|Part 1|Lab abnormalities/AEs|3|||
146735045|NCT03485911|529201002|FG001|Part 1|Lab abnormalities/AEs|1|||
146735046|NCT03485911|529201003|FG002|Part 1|Lab abnormalities/AEs|1|||
146735047|NCT03485911|529201004|FG003|Part 1|Lab abnormalities/AEs|0|||
146735048|NCT03485911|529201001|FG000|Part 1|Withdrew Consent prior to dosing|0|||
146735049|NCT03485911|529201002|FG001|Part 1|Withdrew Consent prior to dosing|0|||
146735050|NCT03485911|529201003|FG002|Part 1|Withdrew Consent prior to dosing|0|||
146735051|NCT03485911|529201004|FG003|Part 1|Withdrew Consent prior to dosing|1|||
146735052|NCT03485911|529201001|FG000|Part 1|Other NOS|0|||
146735053|NCT03485911|529201002|FG001|Part 1|Other NOS|0|||
146735054|NCT03485911|529201003|FG002|Part 1|Other NOS|0|||
146735055|NCT03485911|529201004|FG003|Part 1|Other NOS|1|||
146735056|NCT03485911|529201001|FG000|Part 2|Perceived lack of efficacy|5|||
146735057|NCT03485911|529201002|FG001|Part 2|Perceived lack of efficacy|3|||
146735058|NCT03485911|529201003|FG002|Part 2|Perceived lack of efficacy|0|||
146735059|NCT03485911|529201004|FG003|Part 2|Perceived lack of efficacy|2|||
146735060|NCT03485911|529201001|FG000|Part 2|Subject withdrew consent|1|||
146735061|NCT03485911|529201002|FG001|Part 2|Subject withdrew consent|0|||
146735062|NCT03485911|529201003|FG002|Part 2|Subject withdrew consent|2|||
146735063|NCT03485911|529201004|FG003|Part 2|Subject withdrew consent|1|||
146735064|NCT03485911|529201001|FG000|Part 2|Lab abnormalities/AEs|1|||
146735065|NCT03485911|529201002|FG001|Part 2|Lab abnormalities/AEs|2|||
146735066|NCT03485911|529201003|FG002|Part 2|Lab abnormalities/AEs|0|||
146735067|NCT03485911|529201004|FG003|Part 2|Lab abnormalities/AEs|0|||
146735068|NCT03485911|529201001|FG000|Part 2|Other NOS|0|||
146735069|NCT03485911|529201002|FG001|Part 2|Other NOS|1|||
146735070|NCT03485911|529201003|FG002|Part 2|Other NOS|0|||
146735071|NCT03485911|529201004|FG003|Part 2|Other NOS|0|||
146735072|NCT03485911|529201001|FG000|Part 2|Intercurrent illness/new medical condition|1|||
146735073|NCT03485911|529201002|FG001|Part 2|Intercurrent illness/new medical condition|0|||
146735074|NCT03485911|529201003|FG002|Part 2|Intercurrent illness/new medical condition|0|||
146735075|NCT03485911|529201004|FG003|Part 2|Intercurrent illness/new medical condition|0|||
146735076|NCT03485911|529201001|FG000|Part 2|Investigator judgement|1|||
146735077|NCT03485911|529201002|FG001|Part 2|Investigator judgement|0|||
146735078|NCT03485911|529201003|FG002|Part 2|Investigator judgement|0|||
146735079|NCT03485911|529201004|FG003|Part 2|Investigator judgement|0|||
146735080|NCT03485911|529201001|FG000|Part 3|Perceived lack of efficacy|2|||
146735081|NCT03485911|529201002|FG001|Part 3|Perceived lack of efficacy|2|||
146735082|NCT03485911|529201003|FG002|Part 3|Perceived lack of efficacy|2|||
146735083|NCT03485911|529201004|FG003|Part 3|Perceived lack of efficacy|0|||
146735084|NCT03485911|529201001|FG000|Part 3|Subject withdrew consent|1|||
146735085|NCT03485911|529201002|FG001|Part 3|Subject withdrew consent|4|||
146735086|NCT03485911|529201003|FG002|Part 3|Subject withdrew consent|0|||
146735087|NCT03485911|529201004|FG003|Part 3|Subject withdrew consent|1|||
146735088|NCT03485911|529201001|FG000|Part 3|Lab abnormalities/AEs|1|||
146735089|NCT03485911|529201002|FG001|Part 3|Lab abnormalities/AEs|1|||
146735090|NCT03485911|529201003|FG002|Part 3|Lab abnormalities/AEs|0|||
146735091|NCT03485911|529201004|FG003|Part 3|Lab abnormalities/AEs|2|||
146735092|NCT03485911|529201001|FG000|Part 3|Other NOS|1|||
146735093|NCT03485911|529201002|FG001|Part 3|Other NOS|1|||
146735094|NCT03485911|529201003|FG002|Part 3|Other NOS|0|||
146735095|NCT03485911|529201004|FG003|Part 3|Other NOS|0|||
146735096|NCT03485911|529201001|FG000|Part 3|Intercurrent illness/new medical condition|0|||
146735097|NCT03485911|529201002|FG001|Part 3|Intercurrent illness/new medical condition|1|||
146735098|NCT03485911|529201003|FG002|Part 3|Intercurrent illness/new medical condition|1|||
146735099|NCT03485911|529201004|FG003|Part 3|Intercurrent illness/new medical condition|0|||
146735100|NCT03485911|529201001|FG000|Part 3|Sponsor discontinuation|1|||
146735101|NCT03485911|529201002|FG001|Part 3|Sponsor discontinuation|0|||
146735102|NCT03485911|529201003|FG002|Part 3|Sponsor discontinuation|0|||
146735103|NCT03485911|529201004|FG003|Part 3|Sponsor discontinuation|0|||
146735104|NCT03485911|529201001|FG000|Part 3|Berotralstat provided by alternative means|13|||
146735105|NCT03485911|529201002|FG001|Part 3|Berotralstat provided by alternative means|13|||
146735106|NCT03485911|529201003|FG002|Part 3|Berotralstat provided by alternative means|7|||
146735107|NCT03485911|529201004|FG003|Part 3|Berotralstat provided by alternative means|7|||
146735108|NCT01674621|529201005|FG000|Overall Study|Adverse Event|3|||
146735109|NCT01674621|529201006|FG001|Overall Study|Adverse Event|2|||
146735110|NCT01674621|529201007|FG002|Overall Study|Adverse Event|5|||
146938924|NCT00064077|529934317|FG001|Overall Study|Improper prior treatment|0|||
146735111|NCT01674621|529201008|FG003|Overall Study|Adverse Event|5|||
146735112|NCT01674621|529201009|FG004|Overall Study|Adverse Event|1|||
146793033|NCT01928394|529415665|FG004|Treatment Period|Poor/non-compliance|0|||
146793034|NCT01928394|529415666|FG005|Treatment Period|Poor/non-compliance|0|||
146938925|NCT00064077|529934318|FG002|Overall Study|Improper prior treatment|0|||
146938926|NCT00064077|529934319|FG003|Overall Study|Improper prior treatment|0|||
146938927|NCT00064077|529934316|FG000|Overall Study|Poor risk|2|||
146938928|NCT00064077|529934317|FG001|Overall Study|Poor risk|0|||
146938929|NCT00064077|529934318|FG002|Overall Study|Poor risk|1|||
146938930|NCT00064077|529934319|FG003|Overall Study|Poor risk|1|||
146938931|NCT00064077|529934316|FG000|Overall Study|Pathology|10|||
146938932|NCT00064077|529934317|FG001|Overall Study|Pathology|7|||
146938933|NCT00064077|529934318|FG002|Overall Study|Pathology|3|||
146938934|NCT00064077|529934319|FG003|Overall Study|Pathology|4|||
146938935|NCT00064077|529934316|FG000|Overall Study|No surgery|0|||
146938936|NCT00064077|529934317|FG001|Overall Study|No surgery|0|||
146938937|NCT00064077|529934318|FG002|Overall Study|No surgery|1|||
146938938|NCT00064077|529934319|FG003|Overall Study|No surgery|0|||
146938939|NCT00064077|529934316|FG000|Overall Study|No tumor|0|||
146938940|NCT00064077|529934317|FG001|Overall Study|No tumor|0|||
146938941|NCT00064077|529934318|FG002|Overall Study|No tumor|1|||
146938942|NCT00064077|529934319|FG003|Overall Study|No tumor|0|||
146938943|NCT00064077|529934316|FG000|Overall Study|Other reasons|2|||
146938944|NCT00064077|529934317|FG001|Overall Study|Other reasons|2|||
146938945|NCT00064077|529934318|FG002|Overall Study|Other reasons|1|||
146938946|NCT00064077|529934319|FG003|Overall Study|Other reasons|2|||
146938947|NCT00879437|529934324|FG000|Overall Study|Protocol Violation|0|||
146938948|NCT00879437|529934325|FG001|Overall Study|Protocol Violation|1|||
146938949|NCT00879437|529934324|FG000|Overall Study|Death|1|||
146938950|NCT00879437|529934325|FG001|Overall Study|Death|0|||
146938951|NCT00268463|529934326|FG000|Overall Study|study terminated due to low accrual|10|||
146938952|NCT00268463|529934327|FG001|Overall Study|study terminated due to low accrual|12|||
146938953|NCT03000686|529934328|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
146938954|NCT03000686|529934329|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
146938955|NCT03000686|529934330|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
146938956|NCT03000686|529934331|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
146938957|NCT02920450|529934332|FG000|Overall Study|Death|1|||
146938958|NCT02920450|529934333|FG001|Overall Study|Death|0|||
146938959|NCT02920450|529934334|FG002|Overall Study|Death|0|||
146938960|NCT02920450|529934335|FG003|Overall Study|Death|0|||
146938961|NCT02920450|529934332|FG000|Overall Study|Withdrawal by Subject|1|||
146938962|NCT02920450|529934333|FG001|Overall Study|Withdrawal by Subject|0|||
146938963|NCT02920450|529934334|FG002|Overall Study|Withdrawal by Subject|0|||
146938964|NCT02920450|529934335|FG003|Overall Study|Withdrawal by Subject|0|||
146938965|NCT00770224|529934340|FG000|Step 1: Induction|Adverse Event|3|||
146938966|NCT00770224|529934341|FG001|Step 1: Induction|Adverse Event|0|||
146938967|NCT00770224|529934340|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
146938968|NCT00770224|529934341|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
146938969|NCT00770224|529934340|FG000|Step 1: Induction|Other reason not protocol specified|2|||
146938970|NCT00770224|529934341|FG001|Step 1: Induction|Other reason not protocol specified|0|||
146938971|NCT00770224|529934340|FG000|Step 1: Induction|Ineligible|2|||
146938972|NCT00770224|529934341|FG001|Step 1: Induction|Ineligible|0|||
146938973|NCT00770224|529934340|FG000|Step 1: Induction|No protocol treatment given|1|||
146938974|NCT00770224|529934341|FG001|Step 1: Induction|No protocol treatment given|0|||
146938975|NCT00770224|529934340|FG000|Step 2: Maintenance|Adverse Event|0|||
146938976|NCT00770224|529934341|FG001|Step 2: Maintenance|Adverse Event|10|||
146938977|NCT00770224|529934340|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
146938978|NCT00770224|529934341|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
146938979|NCT00770224|529934340|FG000|Step 2: Maintenance|Progression/relapse|0|||
146938980|NCT00770224|529934341|FG001|Step 2: Maintenance|Progression/relapse|1|||
146938981|NCT00770224|529934340|FG000|Step 2: Maintenance|Death|0|||
146938982|NCT00770224|529934341|FG001|Step 2: Maintenance|Death|2|||
146938983|NCT00770224|529934340|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
146938984|NCT00770224|529934341|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
146938985|NCT00770224|529934340|FG000|Step 2: Maintenance|Ineligible|0|||
146793035|NCT01928394|529415667|FG006|Treatment Period|Poor/non-compliance|0|||
146938986|NCT00770224|529934341|FG001|Step 2: Maintenance|Ineligible|2|||
146938987|NCT01112982|529934342|FG000|Overall Study|Withdrawal by Subject|1|||
146793036|NCT01928394|529415668|FG007|Treatment Period|Poor/non-compliance|0|||
146793037|NCT01928394|529415669|FG008|Treatment Period|Poor/non-compliance|0|||
146938988|NCT01112982|529934342|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
146938989|NCT00918346|529934348|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
146938990|NCT00918346|529934349|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
146938991|NCT03238352|529934350|FG000|Overall Study|Lost to Follow-up|0|||
146938992|NCT03238352|529934351|FG001|Overall Study|Lost to Follow-up|2|||
146938993|NCT03238352|529934352|FG002|Overall Study|Lost to Follow-up|1|||
146938994|NCT03238352|529934350|FG000|Overall Study|Withdrawal by Subject|0|||
146938995|NCT03238352|529934351|FG001|Overall Study|Withdrawal by Subject|1|||
146938996|NCT03238352|529934352|FG002|Overall Study|Withdrawal by Subject|0|||
146938997|NCT00928512|529934353|FG000|Overall Study|Adverse Event|4|||
146793038|NCT01928394|529415670|FG009|Treatment Period|Poor/non-compliance|0|||
146793039|NCT01928394|529415671|FG010|Treatment Period|Poor/non-compliance|0|||
146793040|NCT01928394|529415672|FG011|Treatment Period|Poor/non-compliance|0|||
146793041|NCT01928394|529415673|FG012|Treatment Period|Poor/non-compliance|1|||
146793042|NCT01928394|529415674|FG013|Treatment Period|Poor/non-compliance|0|||
146793043|NCT01928394|529415675|FG014|Treatment Period|Poor/non-compliance|1|||
146793044|NCT01928394|529415676|FG015|Treatment Period|Poor/non-compliance|0|||
146793045|NCT01928394|529415677|FG016|Treatment Period|Poor/non-compliance|0|||
146793046|NCT01928394|529415678|FG017|Treatment Period|Poor/non-compliance|1|||
146793047|NCT01928394|529415679|FG018|Treatment Period|Poor/non-compliance|0|||
146793048|NCT01928394|529415680|FG019|Treatment Period|Poor/non-compliance|1|||
146793049|NCT01928394|529415681|FG020|Treatment Period|Poor/non-compliance|0|||
146982383|NCT02884206|530097950|FG000|Double-Blind Period|Physician Decision|0|||
146735113|NCT01674621|529201005|FG000|Overall Study|Inability to Complete Study Procedures|0|||
146735114|NCT01674621|529201006|FG001|Overall Study|Inability to Complete Study Procedures|0|||
146735115|NCT01674621|529201007|FG002|Overall Study|Inability to Complete Study Procedures|0|||
146735116|NCT01674621|529201008|FG003|Overall Study|Inability to Complete Study Procedures|0|||
146735117|NCT01674621|529201009|FG004|Overall Study|Inability to Complete Study Procedures|2|||
146735118|NCT01674621|529201005|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
146735119|NCT01674621|529201006|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
146735120|NCT01674621|529201007|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
146735121|NCT01674621|529201008|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
146735122|NCT01674621|529201009|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
146735123|NCT01674621|529201005|FG000|Overall Study|Withdrawal by Subject|2|||
146735124|NCT01674621|529201006|FG001|Overall Study|Withdrawal by Subject|5|||
146735125|NCT01674621|529201007|FG002|Overall Study|Withdrawal by Subject|2|||
146735126|NCT01674621|529201008|FG003|Overall Study|Withdrawal by Subject|0|||
146735127|NCT01674621|529201009|FG004|Overall Study|Withdrawal by Subject|1|||
146735128|NCT01674621|529201005|FG000|Overall Study|Other than specified|0|||
146735129|NCT01674621|529201006|FG001|Overall Study|Other than specified|1|||
146735130|NCT01674621|529201007|FG002|Overall Study|Other than specified|0|||
146735131|NCT01674621|529201008|FG003|Overall Study|Other than specified|0|||
146735132|NCT01674621|529201009|FG004|Overall Study|Other than specified|2|||
146735133|NCT03056534|529201012|FG000|Overall Study|Participant withdrew consent|8|||
146735134|NCT03056534|529201012|FG000|Overall Study|Participant not able to return|6|||
146735135|NCT03056534|529201012|FG000|Overall Study|Lost to Follow-up|37|||
146735136|NCT03056534|529201012|FG000|Overall Study|Investigator judgment|1|||
146735137|NCT03056534|529201012|FG000|Overall Study|Death|4|||
146735138|NCT03056534|529201012|FG000|Overall Study|Adverse Event|1|||
146735139|NCT03056534|529201012|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
146735140|NCT02675465|529201013|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
146735141|NCT02675465|529201014|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
146735142|NCT02675465|529201015|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
146735143|NCT02675465|529201016|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
146735144|NCT02675465|529201017|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
146735145|NCT02675465|529201018|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
146735146|NCT02675465|529201013|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
146735147|NCT02675465|529201014|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
146735148|NCT02675465|529201015|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
146735149|NCT02675465|529201016|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
146735150|NCT02675465|529201017|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
146735151|NCT02675465|529201018|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
146735152|NCT02675465|529201013|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
146735153|NCT02675465|529201014|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
146735154|NCT02675465|529201015|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
146735155|NCT02675465|529201016|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
146735156|NCT02675465|529201017|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
146735157|NCT02675465|529201018|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
146735158|NCT02675465|529201013|FG000|Stage 4: Long Term Extension|Death|0|||
146735159|NCT02675465|529201014|FG001|Stage 4: Long Term Extension|Death|0|||
146735160|NCT02675465|529201015|FG002|Stage 4: Long Term Extension|Death|0|||
146735161|NCT02675465|529201016|FG003|Stage 4: Long Term Extension|Death|1|||
146735162|NCT02675465|529201017|FG004|Stage 4: Long Term Extension|Death|0|||
146735163|NCT02675465|529201018|FG005|Stage 4: Long Term Extension|Death|0|||
146735164|NCT05031078|529201019|FG000|Overall Study|Withdrawal by Subject|0|||
146735165|NCT05031078|529201020|FG001|Overall Study|Withdrawal by Subject|1|||
146735166|NCT05031078|529201021|FG002|Overall Study|Withdrawal by Subject|0|||
146735167|NCT00728962|529201025|FG000|Implant Placement Surgery|Adverse Event|8|||
146735168|NCT00728962|529201025|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
146735169|NCT00728962|529201025|FG000|Implant Placement Surgery|Protocol Violation|1|||
146793050|NCT01928394|529415682|FG021|Treatment Period|Poor/non-compliance|0|||
146793051|NCT01928394|529415683|FG022|Treatment Period|Poor/non-compliance|0|||
146793052|NCT01928394|529415661|FG000|Treatment Period|other reason|0|||
146793053|NCT01928394|529415662|FG001|Treatment Period|other reason|0|||
146793054|NCT01928394|529415663|FG002|Treatment Period|other reason|0|||
146793055|NCT01928394|529415664|FG003|Treatment Period|other reason|0|||
146793056|NCT01928394|529415665|FG004|Treatment Period|other reason|0|||
146793057|NCT01928394|529415666|FG005|Treatment Period|other reason|0|||
146793058|NCT01928394|529415667|FG006|Treatment Period|other reason|0|||
146793059|NCT01928394|529415668|FG007|Treatment Period|other reason|0|||
146793060|NCT01928394|529415669|FG008|Treatment Period|other reason|0|||
146793061|NCT01928394|529415670|FG009|Treatment Period|other reason|0|||
146793062|NCT01928394|529415671|FG010|Treatment Period|other reason|1|||
146793063|NCT01928394|529415672|FG011|Treatment Period|other reason|1|||
146793064|NCT01928394|529415673|FG012|Treatment Period|other reason|1|||
146793065|NCT01928394|529415674|FG013|Treatment Period|other reason|0|||
146793066|NCT01928394|529415675|FG014|Treatment Period|other reason|1|||
146793067|NCT01928394|529415676|FG015|Treatment Period|other reason|0|||
146793068|NCT01928394|529415677|FG016|Treatment Period|other reason|0|||
146793069|NCT01928394|529415678|FG017|Treatment Period|other reason|0|||
146793070|NCT01928394|529415679|FG018|Treatment Period|other reason|2|||
146793071|NCT01928394|529415680|FG019|Treatment Period|other reason|2|||
146793072|NCT01928394|529415681|FG020|Treatment Period|other reason|0|||
146793073|NCT01928394|529415682|FG021|Treatment Period|other reason|0|||
146793074|NCT01928394|529415683|FG022|Treatment Period|other reason|0|||
146793075|NCT01928394|529415661|FG000|Treatment Period|Maximum clinical benefit|0|||
146793076|NCT01928394|529415662|FG001|Treatment Period|Maximum clinical benefit|0|||
146793077|NCT01928394|529415663|FG002|Treatment Period|Maximum clinical benefit|0|||
146793078|NCT01928394|529415664|FG003|Treatment Period|Maximum clinical benefit|0|||
146793079|NCT01928394|529415665|FG004|Treatment Period|Maximum clinical benefit|0|||
146793080|NCT01928394|529415666|FG005|Treatment Period|Maximum clinical benefit|0|||
146793081|NCT01928394|529415667|FG006|Treatment Period|Maximum clinical benefit|0|||
146793082|NCT01928394|529415668|FG007|Treatment Period|Maximum clinical benefit|0|||
146793083|NCT01928394|529415669|FG008|Treatment Period|Maximum clinical benefit|0|||
146793084|NCT01928394|529415670|FG009|Treatment Period|Maximum clinical benefit|0|||
146793085|NCT01928394|529415671|FG010|Treatment Period|Maximum clinical benefit|1|||
146793086|NCT01928394|529415672|FG011|Treatment Period|Maximum clinical benefit|1|||
146793087|NCT01928394|529415673|FG012|Treatment Period|Maximum clinical benefit|0|||
146793088|NCT01928394|529415674|FG013|Treatment Period|Maximum clinical benefit|0|||
146793089|NCT01928394|529415675|FG014|Treatment Period|Maximum clinical benefit|1|||
146793090|NCT01928394|529415676|FG015|Treatment Period|Maximum clinical benefit|0|||
146793091|NCT01928394|529415677|FG016|Treatment Period|Maximum clinical benefit|0|||
146793092|NCT01928394|529415678|FG017|Treatment Period|Maximum clinical benefit|1|||
146793093|NCT01928394|529415679|FG018|Treatment Period|Maximum clinical benefit|1|||
146793094|NCT01928394|529415680|FG019|Treatment Period|Maximum clinical benefit|0|||
146793095|NCT01928394|529415681|FG020|Treatment Period|Maximum clinical benefit|2|||
146793096|NCT01928394|529415682|FG021|Treatment Period|Maximum clinical benefit|0|||
146793097|NCT01928394|529415683|FG022|Treatment Period|Maximum clinical benefit|0|||
146793098|NCT01928394|529415661|FG000|Treatment Period|Lost to Follow-up|0|||
146793099|NCT01928394|529415662|FG001|Treatment Period|Lost to Follow-up|0|||
146793100|NCT01928394|529415663|FG002|Treatment Period|Lost to Follow-up|0|||
146793101|NCT01928394|529415664|FG003|Treatment Period|Lost to Follow-up|0|||
146793102|NCT01928394|529415665|FG004|Treatment Period|Lost to Follow-up|0|||
146793103|NCT01928394|529415666|FG005|Treatment Period|Lost to Follow-up|0|||
146793104|NCT01928394|529415667|FG006|Treatment Period|Lost to Follow-up|0|||
146793105|NCT01928394|529415668|FG007|Treatment Period|Lost to Follow-up|0|||
146793106|NCT01928394|529415669|FG008|Treatment Period|Lost to Follow-up|0|||
146793107|NCT01928394|529415670|FG009|Treatment Period|Lost to Follow-up|0|||
146793108|NCT01928394|529415671|FG010|Treatment Period|Lost to Follow-up|0|||
146793109|NCT01928394|529415672|FG011|Treatment Period|Lost to Follow-up|0|||
146793110|NCT01928394|529415673|FG012|Treatment Period|Lost to Follow-up|0|||
146793111|NCT01928394|529415674|FG013|Treatment Period|Lost to Follow-up|0|||
146793112|NCT01928394|529415675|FG014|Treatment Period|Lost to Follow-up|0|||
146793113|NCT01928394|529415676|FG015|Treatment Period|Lost to Follow-up|0|||
146938998|NCT00928512|529934354|FG001|Overall Study|Adverse Event|3|||
146938999|NCT00928512|529934355|FG002|Overall Study|Adverse Event|2|||
146793114|NCT01928394|529415677|FG016|Treatment Period|Lost to Follow-up|0|||
146793115|NCT01928394|529415678|FG017|Treatment Period|Lost to Follow-up|0|||
146793116|NCT01928394|529415679|FG018|Treatment Period|Lost to Follow-up|0|||
146793117|NCT01928394|529415680|FG019|Treatment Period|Lost to Follow-up|0|||
146793118|NCT01928394|529415681|FG020|Treatment Period|Lost to Follow-up|0|||
146793119|NCT01928394|529415682|FG021|Treatment Period|Lost to Follow-up|0|||
146793120|NCT01928394|529415683|FG022|Treatment Period|Lost to Follow-up|1|||
146793121|NCT01928394|529415661|FG000|Treatment Period|Death|0|||
146793122|NCT01928394|529415662|FG001|Treatment Period|Death|0|||
146793123|NCT01928394|529415663|FG002|Treatment Period|Death|0|||
146793124|NCT01928394|529415664|FG003|Treatment Period|Death|0|||
146793125|NCT01928394|529415665|FG004|Treatment Period|Death|0|||
146793126|NCT01928394|529415666|FG005|Treatment Period|Death|0|||
146793127|NCT01928394|529415667|FG006|Treatment Period|Death|0|||
146793128|NCT01928394|529415668|FG007|Treatment Period|Death|0|||
146793129|NCT01928394|529415669|FG008|Treatment Period|Death|0|||
146793130|NCT01928394|529415670|FG009|Treatment Period|Death|0|||
146793131|NCT01928394|529415671|FG010|Treatment Period|Death|0|||
146793132|NCT01928394|529415672|FG011|Treatment Period|Death|0|||
146793133|NCT01928394|529415673|FG012|Treatment Period|Death|0|||
146793134|NCT01928394|529415674|FG013|Treatment Period|Death|1|||
146793135|NCT01928394|529415675|FG014|Treatment Period|Death|2|||
146793136|NCT01928394|529415676|FG015|Treatment Period|Death|0|||
146793137|NCT01928394|529415677|FG016|Treatment Period|Death|0|||
146793138|NCT01928394|529415678|FG017|Treatment Period|Death|0|||
146793139|NCT01928394|529415679|FG018|Treatment Period|Death|0|||
146793140|NCT01928394|529415680|FG019|Treatment Period|Death|0|||
146793141|NCT01928394|529415681|FG020|Treatment Period|Death|0|||
146793142|NCT01928394|529415682|FG021|Treatment Period|Death|0|||
146793143|NCT01928394|529415683|FG022|Treatment Period|Death|0|||
146793144|NCT01928394|529415661|FG000|Follow-up Period|Participant withdrew consent|3|||
146793145|NCT01928394|529415662|FG001|Follow-up Period|Participant withdrew consent|0|||
146793146|NCT01928394|529415663|FG002|Follow-up Period|Participant withdrew consent|1|||
146793147|NCT01928394|529415664|FG003|Follow-up Period|Participant withdrew consent|4|||
146793148|NCT01928394|529415665|FG004|Follow-up Period|Participant withdrew consent|0|||
146793149|NCT01928394|529415666|FG005|Follow-up Period|Participant withdrew consent|2|||
146793150|NCT01928394|529415667|FG006|Follow-up Period|Participant withdrew consent|5|||
146793151|NCT01928394|529415668|FG007|Follow-up Period|Participant withdrew consent|1|||
146793152|NCT01928394|529415669|FG008|Follow-up Period|Participant withdrew consent|0|||
146793153|NCT01928394|529415670|FG009|Follow-up Period|Participant withdrew consent|0|||
146793154|NCT01928394|529415671|FG010|Follow-up Period|Participant withdrew consent|5|||
146793155|NCT01928394|529415672|FG011|Follow-up Period|Participant withdrew consent|8|||
146793156|NCT01928394|529415673|FG012|Follow-up Period|Participant withdrew consent|2|||
146793157|NCT01928394|529415674|FG013|Follow-up Period|Participant withdrew consent|12|||
146793158|NCT01928394|529415675|FG014|Follow-up Period|Participant withdrew consent|7|||
146793159|NCT01928394|529415676|FG015|Follow-up Period|Participant withdrew consent|0|||
146793160|NCT01928394|529415677|FG016|Follow-up Period|Participant withdrew consent|5|||
146793161|NCT01928394|529415678|FG017|Follow-up Period|Participant withdrew consent|3|||
146793162|NCT01928394|529415679|FG018|Follow-up Period|Participant withdrew consent|2|||
146793163|NCT01928394|529415680|FG019|Follow-up Period|Participant withdrew consent|7|||
146939000|NCT00928512|529934356|FG003|Overall Study|Adverse Event|8|||
146939001|NCT00928512|529934357|FG004|Overall Study|Adverse Event|6|||
146939002|NCT00928512|529934353|FG000|Overall Study|Lack of Efficacy|2|||
146939003|NCT00928512|529934354|FG001|Overall Study|Lack of Efficacy|0|||
146939004|NCT00928512|529934355|FG002|Overall Study|Lack of Efficacy|4|||
146939005|NCT00928512|529934356|FG003|Overall Study|Lack of Efficacy|7|||
146939006|NCT00928512|529934357|FG004|Overall Study|Lack of Efficacy|3|||
146939007|NCT00928512|529934353|FG000|Overall Study|Protocol Violation|0|||
146939008|NCT00928512|529934354|FG001|Overall Study|Protocol Violation|1|||
146939009|NCT00928512|529934355|FG002|Overall Study|Protocol Violation|0|||
146939010|NCT00928512|529934356|FG003|Overall Study|Protocol Violation|1|||
146939011|NCT00928512|529934357|FG004|Overall Study|Protocol Violation|3|||
146939012|NCT00928512|529934353|FG000|Overall Study|Withdrawal by Subject|3|||
146939013|NCT00928512|529934354|FG001|Overall Study|Withdrawal by Subject|0|||
146939014|NCT00928512|529934355|FG002|Overall Study|Withdrawal by Subject|3|||
146939015|NCT00928512|529934356|FG003|Overall Study|Withdrawal by Subject|4|||
146939016|NCT00928512|529934357|FG004|Overall Study|Withdrawal by Subject|0|||
146939017|NCT00928512|529934353|FG000|Overall Study|Lost to Follow-up|1|||
146939018|NCT00928512|529934354|FG001|Overall Study|Lost to Follow-up|1|||
146939019|NCT00928512|529934355|FG002|Overall Study|Lost to Follow-up|2|||
146939020|NCT00928512|529934356|FG003|Overall Study|Lost to Follow-up|1|||
146939021|NCT00928512|529934357|FG004|Overall Study|Lost to Follow-up|3|||
146939022|NCT00928512|529934353|FG000|Overall Study|Administrative Problems|0|||
146939023|NCT00928512|529934354|FG001|Overall Study|Administrative Problems|1|||
146939024|NCT00928512|529934355|FG002|Overall Study|Administrative Problems|0|||
146939025|NCT00928512|529934356|FG003|Overall Study|Administrative Problems|0|||
146939026|NCT00928512|529934357|FG004|Overall Study|Administrative Problems|0|||
146939027|NCT00729326|529934362|FG000|Overall Study|Lost to Follow-up|2|||
146939028|NCT00729326|529934363|FG001|Overall Study|Lost to Follow-up|0|||
146939029|NCT00729326|529934362|FG000|Overall Study|Physician Decision|0|||
146939030|NCT00729326|529934363|FG001|Overall Study|Physician Decision|1|||
146982384|NCT02884206|530097951|FG001|Double-Blind Period|Physician Decision|2|||
146793164|NCT01928394|529415681|FG020|Follow-up Period|Participant withdrew consent|4|||
146939031|NCT00729326|529934362|FG000|Overall Study|Protocol Violation|3|||
146939032|NCT00729326|529934363|FG001|Overall Study|Protocol Violation|2|||
146939033|NCT00729326|529934362|FG000|Overall Study|Subject Decision|4|||
146939034|NCT00729326|529934363|FG001|Overall Study|Subject Decision|4|||
146939035|NCT00729326|529934362|FG000|Overall Study|Sponsor Decision|1|||
146793165|NCT01928394|529415682|FG021|Follow-up Period|Participant withdrew consent|6|||
146793166|NCT01928394|529415683|FG022|Follow-up Period|Participant withdrew consent|2|||
146939036|NCT00729326|529934363|FG001|Overall Study|Sponsor Decision|2|||
146939037|NCT01235728|529934366|FG000|Overall Study|Protocol Violation|0|||
146793167|NCT01928394|529415661|FG000|Follow-up Period|Death|0|||
146793168|NCT01928394|529415662|FG001|Follow-up Period|Death|0|||
146793169|NCT01928394|529415663|FG002|Follow-up Period|Death|2|||
146793170|NCT01928394|529415664|FG003|Follow-up Period|Death|6|||
146793171|NCT01928394|529415665|FG004|Follow-up Period|Death|0|||
146793172|NCT01928394|529415666|FG005|Follow-up Period|Death|6|||
146793173|NCT01928394|529415667|FG006|Follow-up Period|Death|6|||
146793174|NCT01928394|529415668|FG007|Follow-up Period|Death|2|||
146793175|NCT01928394|529415669|FG008|Follow-up Period|Death|1|||
146793176|NCT01928394|529415670|FG009|Follow-up Period|Death|2|||
146793177|NCT01928394|529415671|FG010|Follow-up Period|Death|4|||
146793178|NCT01928394|529415672|FG011|Follow-up Period|Death|12|||
146793179|NCT01928394|529415673|FG012|Follow-up Period|Death|11|||
146793180|NCT01928394|529415674|FG013|Follow-up Period|Death|25|||
146793181|NCT01928394|529415675|FG014|Follow-up Period|Death|18|||
146793182|NCT01928394|529415676|FG015|Follow-up Period|Death|0|||
146793183|NCT01928394|529415677|FG016|Follow-up Period|Death|6|||
146793184|NCT01928394|529415678|FG017|Follow-up Period|Death|5|||
146793185|NCT01928394|529415679|FG018|Follow-up Period|Death|13|||
146793186|NCT01928394|529415680|FG019|Follow-up Period|Death|13|||
146793187|NCT01928394|529415681|FG020|Follow-up Period|Death|5|||
146793188|NCT01928394|529415682|FG021|Follow-up Period|Death|3|||
146793189|NCT01928394|529415683|FG022|Follow-up Period|Death|2|||
146793190|NCT01928394|529415661|FG000|Follow-up Period|other reason|0|||
146793191|NCT01928394|529415662|FG001|Follow-up Period|other reason|0|||
146793192|NCT01928394|529415663|FG002|Follow-up Period|other reason|0|||
146793193|NCT01928394|529415664|FG003|Follow-up Period|other reason|0|||
146793194|NCT01928394|529415665|FG004|Follow-up Period|other reason|0|||
146793195|NCT01928394|529415666|FG005|Follow-up Period|other reason|0|||
146793196|NCT01928394|529415667|FG006|Follow-up Period|other reason|1|||
146793197|NCT01928394|529415668|FG007|Follow-up Period|other reason|3|||
146793198|NCT01928394|529415669|FG008|Follow-up Period|other reason|0|||
146793199|NCT01928394|529415670|FG009|Follow-up Period|other reason|0|||
146793200|NCT01928394|529415671|FG010|Follow-up Period|other reason|2|||
146793201|NCT01928394|529415672|FG011|Follow-up Period|other reason|1|||
146793202|NCT01928394|529415673|FG012|Follow-up Period|other reason|0|||
146793203|NCT01928394|529415674|FG013|Follow-up Period|other reason|1|||
146793204|NCT01928394|529415675|FG014|Follow-up Period|other reason|4|||
146793205|NCT01928394|529415676|FG015|Follow-up Period|other reason|0|||
146793206|NCT01928394|529415677|FG016|Follow-up Period|other reason|2|||
146793207|NCT01928394|529415678|FG017|Follow-up Period|other reason|0|||
146793208|NCT01928394|529415679|FG018|Follow-up Period|other reason|1|||
146793209|NCT01928394|529415680|FG019|Follow-up Period|other reason|1|||
146793210|NCT01928394|529415681|FG020|Follow-up Period|other reason|0|||
146793211|NCT01928394|529415682|FG021|Follow-up Period|other reason|0|||
146793212|NCT01928394|529415683|FG022|Follow-up Period|other reason|1|||
146793213|NCT01928394|529415661|FG000|Follow-up Period|Lost to Follow-up|0|||
146793214|NCT01928394|529415662|FG001|Follow-up Period|Lost to Follow-up|0|||
146793215|NCT01928394|529415663|FG002|Follow-up Period|Lost to Follow-up|0|||
146793216|NCT01928394|529415664|FG003|Follow-up Period|Lost to Follow-up|0|||
146793217|NCT01928394|529415665|FG004|Follow-up Period|Lost to Follow-up|0|||
146793218|NCT01928394|529415666|FG005|Follow-up Period|Lost to Follow-up|0|||
146793219|NCT01928394|529415667|FG006|Follow-up Period|Lost to Follow-up|0|||
146793220|NCT01928394|529415668|FG007|Follow-up Period|Lost to Follow-up|0|||
146793221|NCT01928394|529415669|FG008|Follow-up Period|Lost to Follow-up|0|||
146793222|NCT01928394|529415670|FG009|Follow-up Period|Lost to Follow-up|0|||
146793223|NCT01928394|529415671|FG010|Follow-up Period|Lost to Follow-up|0|||
146793224|NCT01928394|529415672|FG011|Follow-up Period|Lost to Follow-up|1|||
146793225|NCT01928394|529415673|FG012|Follow-up Period|Lost to Follow-up|1|||
146793226|NCT01928394|529415674|FG013|Follow-up Period|Lost to Follow-up|0|||
146793227|NCT01928394|529415675|FG014|Follow-up Period|Lost to Follow-up|1|||
146793228|NCT01928394|529415676|FG015|Follow-up Period|Lost to Follow-up|0|||
146793229|NCT01928394|529415677|FG016|Follow-up Period|Lost to Follow-up|1|||
146793230|NCT01928394|529415678|FG017|Follow-up Period|Lost to Follow-up|0|||
146793231|NCT01928394|529415679|FG018|Follow-up Period|Lost to Follow-up|0|||
146793232|NCT01928394|529415680|FG019|Follow-up Period|Lost to Follow-up|0|||
146793233|NCT01928394|529415681|FG020|Follow-up Period|Lost to Follow-up|0|||
146939038|NCT01235728|529934367|FG001|Overall Study|Protocol Violation|0|||
146793234|NCT01928394|529415682|FG021|Follow-up Period|Lost to Follow-up|0|||
146793235|NCT01928394|529415683|FG022|Follow-up Period|Lost to Follow-up|1|||
146793236|NCT02038777|529415684|FG000|Overall Study|Death|0|||
146793237|NCT02038777|529415685|FG001|Overall Study|Death|2|||
146793238|NCT02038777|529415686|FG002|Overall Study|Death|0|||
146793239|NCT02038777|529415687|FG003|Overall Study|Death|1|||
146793240|NCT02038777|529415688|FG004|Overall Study|Death|2|||
146793241|NCT02038777|529415689|FG005|Overall Study|Death|4|||
146793242|NCT02038777|529415690|FG006|Overall Study|Death|0|||
146793243|NCT02038777|529415691|FG007|Overall Study|Death|11|||
146793244|NCT02038777|529415684|FG000|Overall Study|Lost to Follow-up|0|||
146793245|NCT02038777|529415685|FG001|Overall Study|Lost to Follow-up|0|||
146793246|NCT02038777|529415686|FG002|Overall Study|Lost to Follow-up|0|||
146793247|NCT02038777|529415687|FG003|Overall Study|Lost to Follow-up|1|||
146982385|NCT02884206|530097952|FG002|Double-Blind Period|Physician Decision|0|||
146982386|NCT02884206|530097950|FG000|Double-Blind Period|Adverse Event|0|||
146982387|NCT02884206|530097951|FG001|Double-Blind Period|Adverse Event|0|||
146982388|NCT02884206|530097952|FG002|Double-Blind Period|Adverse Event|3|||
146982389|NCT02884206|530097950|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
146982390|NCT02884206|530097951|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
146982391|NCT02884206|530097952|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
146982392|NCT00112489|530097953|FG000|Overall Study|Refused further treatment|8|||
146982393|NCT00112489|530097953|FG000|Overall Study|Adverse Event|12|||
146982394|NCT00112489|530097953|FG000|Overall Study|Death|2|||
146982395|NCT00112489|530097953|FG000|Overall Study|Other, Not Specified|9|||
146982396|NCT00112489|530097953|FG000|Overall Study|Patient never treated|2|||
146982397|NCT00112489|530097953|FG000|Overall Study|Ineligible|7|||
146982398|NCT02231710|530097954|FG000|Overall Study|Physician Decision|1|||
146982399|NCT00124020|530097957|FG000|Overall Study|Death|67|||
146982400|NCT00124020|530097958|FG001|Overall Study|Death|71|||
146982401|NCT00124020|530097957|FG000|Overall Study|Withdrawal by Subject|13|||
146982402|NCT00124020|530097958|FG001|Overall Study|Withdrawal by Subject|11|||
146982403|NCT00124020|530097957|FG000|Overall Study|Lost to Follow-up|5|||
146982404|NCT00124020|530097958|FG001|Overall Study|Lost to Follow-up|8|||
146982405|NCT00124020|530097957|FG000|Overall Study|Other|1|||
146982406|NCT00124020|530097958|FG001|Overall Study|Other|1|||
146982407|NCT00124020|530097957|FG000|Overall Study|Transfer to another hospital|2|||
146982408|NCT00124020|530097958|FG001|Overall Study|Transfer to another hospital|0|||
146982409|NCT00268346|530097959|FG000|Overall Study|Adverse Event|0|||
146982410|NCT00268346|530097960|FG001|Overall Study|Adverse Event|1|||
146982411|NCT00268346|530097959|FG000|Overall Study|Death|0|||
146982412|NCT00268346|530097960|FG001|Overall Study|Death|1|||
146982413|NCT00268346|530097959|FG000|Overall Study|Withdrawal by Subject|0|||
146982414|NCT00268346|530097960|FG001|Overall Study|Withdrawal by Subject|1|||
146982415|NCT01799590|530097961|FG000|Overall Study|Adverse Event|13|||
146982416|NCT01799590|530097962|FG001|Overall Study|Adverse Event|7|||
146982417|NCT01799590|530097963|FG002|Overall Study|Adverse Event|5|||
146982418|NCT01799590|530097961|FG000|Overall Study|Pregnancy|2|||
146982419|NCT01799590|530097962|FG001|Overall Study|Pregnancy|0|||
146982420|NCT01799590|530097963|FG002|Overall Study|Pregnancy|0|||
146982421|NCT01799590|530097961|FG000|Overall Study|Lack of Efficacy|3|||
146982422|NCT01799590|530097962|FG001|Overall Study|Lack of Efficacy|1|||
146982423|NCT01799590|530097963|FG002|Overall Study|Lack of Efficacy|3|||
146982424|NCT01799590|530097961|FG000|Overall Study|Participants convenience|4|||
146982425|NCT01799590|530097962|FG001|Overall Study|Participants convenience|4|||
146982426|NCT01799590|530097963|FG002|Overall Study|Participants convenience|2|||
146982427|NCT01799590|530097961|FG000|Overall Study|Aggravation of complications|0|||
146982428|NCT01799590|530097962|FG001|Overall Study|Aggravation of complications|1|||
146982429|NCT01799590|530097963|FG002|Overall Study|Aggravation of complications|1|||
146982430|NCT01799590|530097961|FG000|Overall Study|Using drugs with restricted days of use|0|||
146982431|NCT01799590|530097962|FG001|Overall Study|Using drugs with restricted days of use|3|||
146982432|NCT01799590|530097963|FG002|Overall Study|Using drugs with restricted days of use|2|||
146982433|NCT01799590|530097961|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
146982434|NCT01799590|530097962|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
146982435|NCT01799590|530097963|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
146982436|NCT01799590|530097961|FG000|Overall Study|Other|3|||
146982437|NCT01799590|530097962|FG001|Overall Study|Other|0|||
146982438|NCT01799590|530097963|FG002|Overall Study|Other|1|||
146982439|NCT00294723|530097966|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
146982440|NCT00294723|530097967|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
146982441|NCT00294723|530097968|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
146982442|NCT00294723|530097966|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
146982443|NCT00294723|530097967|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
146793248|NCT02038777|529415688|FG004|Overall Study|Lost to Follow-up|0|||
146793249|NCT02038777|529415689|FG005|Overall Study|Lost to Follow-up|0|||
146793250|NCT02038777|529415690|FG006|Overall Study|Lost to Follow-up|0|||
146793251|NCT02038777|529415691|FG007|Overall Study|Lost to Follow-up|0|||
146793252|NCT02038777|529415684|FG000|Overall Study|Other|0|||
146982444|NCT00294723|530097968|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
146982445|NCT00294723|530097966|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
146982446|NCT00294723|530097967|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
146982447|NCT00294723|530097968|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
146793253|NCT02038777|529415685|FG001|Overall Study|Other|1|||
146793254|NCT02038777|529415686|FG002|Overall Study|Other|0|||
146982448|NCT00294723|530097966|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
146793255|NCT02038777|529415687|FG003|Overall Study|Other|2|||
146982449|NCT00294723|530097967|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
146982450|NCT00294723|530097968|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
146982451|NCT00294723|530097966|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
146793256|NCT02038777|529415688|FG004|Overall Study|Other|1|||
146735170|NCT00728962|529201025|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
146735171|NCT00728962|529201025|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
146735172|NCT04954586|529201026|FG000|Overall Study|Withdrawal by Subject|5|||
146735173|NCT00532155|529201027|FG000|Overall Study|Adverse Event|66|||
146735174|NCT00532155|529201028|FG001|Overall Study|Adverse Event|123|||
146735175|NCT00532155|529201027|FG000|Overall Study|Lack of Efficacy|332|||
146735176|NCT00532155|529201028|FG001|Overall Study|Lack of Efficacy|255|||
146735177|NCT00532155|529201027|FG000|Overall Study|Protocol Violation|1|||
146735178|NCT00532155|529201028|FG001|Overall Study|Protocol Violation|3|||
146735179|NCT00532155|529201027|FG000|Overall Study|Lost to Follow-up|2|||
146735180|NCT00532155|529201028|FG001|Overall Study|Lost to Follow-up|0|||
146735181|NCT00532155|529201027|FG000|Overall Study|Physician Decision|16|||
146735182|NCT00532155|529201028|FG001|Overall Study|Physician Decision|15|||
146735183|NCT00532155|529201027|FG000|Overall Study|Withdrawal by Subject|23|||
146735184|NCT00532155|529201028|FG001|Overall Study|Withdrawal by Subject|44|||
146735185|NCT00532155|529201027|FG000|Overall Study|Consent withdrawn|5|||
146735186|NCT00532155|529201028|FG001|Overall Study|Consent withdrawn|7|||
146735187|NCT00532155|529201027|FG000|Overall Study|Moved|1|||
146735188|NCT00532155|529201028|FG001|Overall Study|Moved|0|||
146735189|NCT00532155|529201027|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
146735190|NCT00532155|529201028|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
146735191|NCT00532155|529201027|FG000|Overall Study|Occurence of a second cancer|0|||
146735192|NCT00532155|529201028|FG001|Overall Study|Occurence of a second cancer|1|||
146735193|NCT00532155|529201027|FG000|Overall Study|Occurence of a secondary cancer|0|||
146735194|NCT00532155|529201028|FG001|Overall Study|Occurence of a secondary cancer|1|||
146735195|NCT00532155|529201027|FG000|Overall Study|Promotor ended study|1|||
146735196|NCT00532155|529201028|FG001|Overall Study|Promotor ended study|0|||
146735197|NCT00532155|529201027|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
146735198|NCT00532155|529201028|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
146735199|NCT00532155|529201027|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
146735200|NCT00532155|529201028|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
146735201|NCT00532155|529201027|FG000|Overall Study|Study stopped|1|||
146735202|NCT00532155|529201028|FG001|Overall Study|Study stopped|0|||
146735203|NCT00532155|529201027|FG000|Overall Study|Study terminated by sponsor|1|||
146735204|NCT00532155|529201028|FG001|Overall Study|Study terminated by sponsor|0|||
146735205|NCT00532155|529201027|FG000|Overall Study|Study termination stop further treatment|4|||
146735206|NCT00532155|529201028|FG001|Overall Study|Study termination stop further treatment|0|||
146735207|NCT00532155|529201027|FG000|Overall Study|Did not receive study medication|2|||
146735208|NCT00532155|529201028|FG001|Overall Study|Did not receive study medication|6|||
146735209|NCT02134925|529201029|FG000|Overall Study|Withdrawal by Subject|1|||
146735210|NCT02134925|529201030|FG001|Overall Study|Withdrawal by Subject|0|||
146735211|NCT02134925|529201029|FG000|Overall Study|Cancel|1|||
146735212|NCT02134925|529201030|FG001|Overall Study|Cancel|6|||
146735213|NCT04027348|529201031|FG000|Overall Study|Adverse Event|2|||
146735214|NCT02158884|529201032|FG000|Baseline Assessment|Missed performance assessment|3|||
146735215|NCT02158884|529201032|FG000|Baseline Assessment|Missed SMFA|1|||
146735216|NCT02158884|529201032|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
146735217|NCT02158884|529201032|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
146735218|NCT02158884|529201032|FG000|6 Month Assessment|Missed SMFA|20|||
146735219|NCT02158884|529201032|FG000|12 Month Assessment|Missed SMFA|17|||
146735220|NCT03750006|529201036|FG000|Overall Study|Withdrawal by Subject|8|||
146735221|NCT03750006|529201036|FG000|Overall Study|COVID PANDEMIC|11|||
146735222|NCT01108458|529202860|FG000|Overall Study|Withdrawal by Subject|1|||
146735223|NCT05044325|529202868|FG000|Part A:Treatment Period 1|Adverse Event|0|||
146735224|NCT05044325|529202869|FG001|Part A:Treatment Period 1|Adverse Event|0|||
146735225|NCT05044325|529202870|FG002|Part A:Treatment Period 1|Adverse Event|0|||
146735226|NCT05044325|529202871|FG003|Part A:Treatment Period 1|Adverse Event|0|||
146735227|NCT05044325|529202872|FG004|Part A:Treatment Period 1|Adverse Event|0|||
146735228|NCT05044325|529202873|FG005|Part A:Treatment Period 1|Adverse Event|1|||
146735229|NCT05044325|529202874|FG006|Part A:Treatment Period 1|Adverse Event|0|||
146735230|NCT05044325|529202875|FG007|Part A:Treatment Period 1|Adverse Event|1|||
146735231|NCT05044325|529202876|FG008|Part A:Treatment Period 1|Adverse Event|0|||
146735232|NCT05044325|529202877|FG009|Part A:Treatment Period 1|Adverse Event|0|||
146735233|NCT05044325|529202868|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
146735234|NCT05044325|529202869|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
146735235|NCT05044325|529202870|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
146735236|NCT05044325|529202871|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
146735237|NCT05044325|529202872|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
146735238|NCT05044325|529202873|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
146735239|NCT05044325|529202874|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
146735240|NCT05044325|529202875|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
146735241|NCT05044325|529202876|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
146793257|NCT02038777|529415689|FG005|Overall Study|Other|0|||
146793258|NCT02038777|529415690|FG006|Overall Study|Other|0|||
146793259|NCT02038777|529415691|FG007|Overall Study|Other|0|||
146793260|NCT02038777|529415684|FG000|Overall Study|Randomized but not treated|0|||
146793261|NCT02038777|529415685|FG001|Overall Study|Randomized but not treated|1|||
146793262|NCT02038777|529415686|FG002|Overall Study|Randomized but not treated|0|||
146793263|NCT02038777|529415687|FG003|Overall Study|Randomized but not treated|0|||
146793264|NCT02038777|529415688|FG004|Overall Study|Randomized but not treated|0|||
146793265|NCT02038777|529415689|FG005|Overall Study|Randomized but not treated|0|||
146793266|NCT02038777|529415690|FG006|Overall Study|Randomized but not treated|0|||
146793267|NCT02038777|529415691|FG007|Overall Study|Randomized but not treated|0|||
146793268|NCT02038777|529415684|FG000|Overall Study|Started Chemotherapy|1|||
146793269|NCT02038777|529415685|FG001|Overall Study|Started Chemotherapy|0|||
146793270|NCT02038777|529415686|FG002|Overall Study|Started Chemotherapy|3|||
146793271|NCT02038777|529415687|FG003|Overall Study|Started Chemotherapy|0|||
146793272|NCT02038777|529415688|FG004|Overall Study|Started Chemotherapy|0|||
146793273|NCT02038777|529415689|FG005|Overall Study|Started Chemotherapy|0|||
146793274|NCT02038777|529415690|FG006|Overall Study|Started Chemotherapy|0|||
146793275|NCT02038777|529415691|FG007|Overall Study|Started Chemotherapy|0|||
146793276|NCT02038777|529415684|FG000|Overall Study|participation terminated by sponsor|0|||
146793277|NCT02038777|529415685|FG001|Overall Study|participation terminated by sponsor|0|||
146793278|NCT02038777|529415686|FG002|Overall Study|participation terminated by sponsor|0|||
146793279|NCT02038777|529415687|FG003|Overall Study|participation terminated by sponsor|0|||
146793280|NCT02038777|529415688|FG004|Overall Study|participation terminated by sponsor|0|||
146793281|NCT02038777|529415689|FG005|Overall Study|participation terminated by sponsor|0|||
146793282|NCT02038777|529415690|FG006|Overall Study|participation terminated by sponsor|1|||
146793283|NCT02038777|529415691|FG007|Overall Study|participation terminated by sponsor|1|||
146793284|NCT04299464|529415692|FG000|Overall Study|Adverse Event|1|||
146793285|NCT04299464|529415693|FG001|Overall Study|Adverse Event|0|||
146793286|NCT04299464|529415694|FG002|Overall Study|Adverse Event|2|||
146793287|NCT04299464|529415692|FG000|Overall Study|Non-compliance with Study Drug|1|||
146793288|NCT04299464|529415693|FG001|Overall Study|Non-compliance with Study Drug|0|||
146793289|NCT04299464|529415694|FG002|Overall Study|Non-compliance with Study Drug|0|||
146793290|NCT04299464|529415692|FG000|Overall Study|Reason not Specified|0|||
146793291|NCT04299464|529415693|FG001|Overall Study|Reason not Specified|1|||
146793292|NCT04299464|529415694|FG002|Overall Study|Reason not Specified|3|||
146793293|NCT04299464|529415692|FG000|Overall Study|Physician Decision|0|||
146793294|NCT04299464|529415693|FG001|Overall Study|Physician Decision|1|||
146793295|NCT04299464|529415694|FG002|Overall Study|Physician Decision|1|||
146793296|NCT04299464|529415692|FG000|Overall Study|Withdrawal by Subject|0|||
146793297|NCT04299464|529415693|FG001|Overall Study|Withdrawal by Subject|2|||
146793298|NCT04299464|529415694|FG002|Overall Study|Withdrawal by Subject|1|||
146793299|NCT04826471|529415695|FG000|Overall Study|Lost to Follow-up|2|||
146793300|NCT04826471|529415695|FG000|Overall Study|Protocol Violation|3|||
146793301|NCT04826471|529415695|FG000|Overall Study|Withdrawal by Subject|1|||
146793302|NCT05370040|529415702|FG000|Overall Study|Lost to Follow-up|0|||
146793303|NCT05370040|529415703|FG001|Overall Study|Lost to Follow-up|0|||
146793304|NCT05370040|529415704|FG002|Overall Study|Lost to Follow-up|1|||
146793305|NCT05370040|529415705|FG003|Overall Study|Lost to Follow-up|0|||
146793306|NCT05370040|529415706|FG004|Overall Study|Lost to Follow-up|1|||
146793307|NCT05370040|529415707|FG005|Overall Study|Lost to Follow-up|0|||
146793308|NCT04971109|529415711|FG000|Overall Study|Adverse Event|4|||
146793309|NCT04971109|529415712|FG001|Overall Study|Adverse Event|3|||
146793310|NCT04971109|529415711|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
146793311|NCT04971109|529415712|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
146793312|NCT04971109|529415711|FG000|Overall Study|Lost to Follow-up|8|||
146793313|NCT04971109|529415712|FG001|Overall Study|Lost to Follow-up|2|||
146793314|NCT04971109|529415711|FG000|Overall Study|Physician Decision|5|||
146793315|NCT04971109|529415712|FG001|Overall Study|Physician Decision|0|||
146793316|NCT04971109|529415711|FG000|Overall Study|Protocol Violation|0|||
146793317|NCT04971109|529415712|FG001|Overall Study|Protocol Violation|1|||
146793318|NCT04971109|529415711|FG000|Overall Study|Withdrawal by Subject|18|||
146793319|NCT04971109|529415712|FG001|Overall Study|Withdrawal by Subject|3|||
146793320|NCT04971109|529415711|FG000|Overall Study|Subject was randomized in error|1|||
146793321|NCT04971109|529415712|FG001|Overall Study|Subject was randomized in error|0|||
146793322|NCT03209973|529415713|FG000|Overall Study|Withdrawal by Subject|7|||
146793323|NCT03209973|529415713|FG000|Overall Study|Lost to Follow-up|2|||
146793324|NCT03209973|529415713|FG000|Overall Study|Death|8|||
146793325|NCT03209973|529415713|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
146793326|NCT03209973|529415713|FG000|Overall Study|Sponsor Decision|18|||
146793327|NCT03209973|529415713|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
146793328|NCT03209973|529415713|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
146793329|NCT05123586|529415715|FG000|Overall Study|Physician Decision|1|||
146793330|NCT05123586|529415716|FG001|Overall Study|Physician Decision|1|||
146793331|NCT05123586|529415715|FG000|Overall Study|Withdrawal by Subject|0|||
146793332|NCT05123586|529415716|FG001|Overall Study|Withdrawal by Subject|3|||
146939039|NCT01235728|529934368|FG002|Overall Study|Protocol Violation|0|||
146982452|NCT00294723|530097967|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
146982453|NCT00294723|530097968|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
146735242|NCT05044325|529202877|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
146735243|NCT05044325|529202868|FG000|Part A:Treatment Period 1|Physician Decision|0|||
146735244|NCT05044325|529202869|FG001|Part A:Treatment Period 1|Physician Decision|0|||
146735245|NCT05044325|529202870|FG002|Part A:Treatment Period 1|Physician Decision|0|||
146735246|NCT05044325|529202871|FG003|Part A:Treatment Period 1|Physician Decision|0|||
146735247|NCT05044325|529202872|FG004|Part A:Treatment Period 1|Physician Decision|0|||
146735248|NCT05044325|529202873|FG005|Part A:Treatment Period 1|Physician Decision|0|||
146735249|NCT05044325|529202874|FG006|Part A:Treatment Period 1|Physician Decision|1|||
146735250|NCT05044325|529202875|FG007|Part A:Treatment Period 1|Physician Decision|0|||
146735251|NCT05044325|529202876|FG008|Part A:Treatment Period 1|Physician Decision|0|||
146735252|NCT05044325|529202877|FG009|Part A:Treatment Period 1|Physician Decision|0|||
146735253|NCT05044325|529202868|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146735254|NCT05044325|529202869|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146735255|NCT05044325|529202870|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
146735256|NCT05044325|529202871|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146735257|NCT05044325|529202872|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146735258|NCT05044325|529202873|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146735259|NCT05044325|529202874|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146735260|NCT05044325|529202875|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146735261|NCT05044325|529202876|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146735262|NCT05044325|529202877|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146735263|NCT05044325|529202868|FG000|Part A:Treatment Period 2|Adverse Event|0|||
146735264|NCT05044325|529202869|FG001|Part A:Treatment Period 2|Adverse Event|1|||
146735265|NCT05044325|529202870|FG002|Part A:Treatment Period 2|Adverse Event|0|||
146735266|NCT05044325|529202871|FG003|Part A:Treatment Period 2|Adverse Event|0|||
146735267|NCT05044325|529202872|FG004|Part A:Treatment Period 2|Adverse Event|1|||
146735268|NCT05044325|529202873|FG005|Part A:Treatment Period 2|Adverse Event|1|||
146735269|NCT05044325|529202874|FG006|Part A:Treatment Period 2|Adverse Event|0|||
146735270|NCT05044325|529202875|FG007|Part A:Treatment Period 2|Adverse Event|0|||
146735271|NCT05044325|529202876|FG008|Part A:Treatment Period 2|Adverse Event|0|||
146735272|NCT05044325|529202877|FG009|Part A:Treatment Period 2|Adverse Event|0|||
146735273|NCT05044325|529202868|FG000|Part A:Treatment Period 2|Physician Decision|0|||
146735274|NCT05044325|529202869|FG001|Part A:Treatment Period 2|Physician Decision|0|||
146735275|NCT05044325|529202870|FG002|Part A:Treatment Period 2|Physician Decision|0|||
146735276|NCT05044325|529202871|FG003|Part A:Treatment Period 2|Physician Decision|0|||
146735277|NCT05044325|529202872|FG004|Part A:Treatment Period 2|Physician Decision|0|||
146735278|NCT05044325|529202873|FG005|Part A:Treatment Period 2|Physician Decision|1|||
146735279|NCT05044325|529202874|FG006|Part A:Treatment Period 2|Physician Decision|0|||
146735280|NCT05044325|529202875|FG007|Part A:Treatment Period 2|Physician Decision|0|||
146735281|NCT05044325|529202876|FG008|Part A:Treatment Period 2|Physician Decision|0|||
146735282|NCT05044325|529202877|FG009|Part A:Treatment Period 2|Physician Decision|0|||
146735283|NCT05044325|529202868|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
146735284|NCT05044325|529202869|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
146735285|NCT05044325|529202870|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
146735286|NCT05044325|529202871|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
146735287|NCT05044325|529202872|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
146735288|NCT05044325|529202873|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
146735289|NCT05044325|529202874|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
146735290|NCT05044325|529202875|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
146735291|NCT05044325|529202876|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
146735292|NCT05044325|529202877|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
146735293|NCT00755222|529202878|FG000|Overall Study|Withdrawal by Subject|4|||
146735294|NCT00755222|529202879|FG001|Overall Study|Withdrawal by Subject|2|||
146735295|NCT00755222|529202878|FG000|Overall Study|Adverse Event|2|||
146735296|NCT00755222|529202879|FG001|Overall Study|Adverse Event|0|||
146735297|NCT00755222|529202878|FG000|Overall Study|Protocol Violation|2|||
146735298|NCT00755222|529202879|FG001|Overall Study|Protocol Violation|0|||
146735299|NCT02243202|529202880|FG000|Overall Study|Adverse Event|5|||
146735300|NCT02243202|529202881|FG001|Overall Study|Adverse Event|6|||
146735301|NCT02243202|529202882|FG002|Overall Study|Adverse Event|10|||
146735302|NCT02243202|529202883|FG003|Overall Study|Adverse Event|4|||
146735303|NCT02243202|529202880|FG000|Overall Study|Lost to Follow-up|9|||
146735304|NCT02243202|529202881|FG001|Overall Study|Lost to Follow-up|9|||
146735305|NCT02243202|529202882|FG002|Overall Study|Lost to Follow-up|14|||
146735306|NCT02243202|529202883|FG003|Overall Study|Lost to Follow-up|11|||
146735307|NCT02243202|529202880|FG000|Overall Study|Protocol Violation|3|||
146735308|NCT02243202|529202881|FG001|Overall Study|Protocol Violation|1|||
146735309|NCT02243202|529202882|FG002|Overall Study|Protocol Violation|2|||
146735310|NCT02243202|529202883|FG003|Overall Study|Protocol Violation|1|||
146939040|NCT01235728|529934369|FG003|Overall Study|Protocol Violation|1|||
146939041|NCT01235728|529934370|FG004|Overall Study|Protocol Violation|0|||
146939042|NCT01235728|529934371|FG005|Overall Study|Protocol Violation|0|||
146939043|NCT01235728|529934372|FG006|Overall Study|Protocol Violation|0|||
146939044|NCT01235728|529934373|FG007|Overall Study|Protocol Violation|0|||
146939045|NCT00996593|529934374|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
146939046|NCT00996593|529934374|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
146939047|NCT00996593|529934374|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
146939048|NCT00996593|529934374|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
146939049|NCT00996593|529934374|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
146939050|NCT00996593|529934374|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
146939051|NCT00996593|529934374|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
146939052|NCT00996593|529934374|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
146939053|NCT00996593|529934374|FG000|Long-Term Follow-Up|Site Closed|1|||
146939054|NCT01202760|529934375|FG000|Overall Study|Entry Criteria Not Met|0|||
146939055|NCT01202760|529934376|FG001|Overall Study|Entry Criteria Not Met|3|||
146939056|NCT01202760|529934377|FG002|Overall Study|Entry Criteria Not Met|1|||
146939057|NCT01202760|529934375|FG000|Overall Study|Adverse Event|11|||
146939058|NCT01202760|529934376|FG001|Overall Study|Adverse Event|9|||
146939059|NCT01202760|529934377|FG002|Overall Study|Adverse Event|10|||
146939060|NCT01202760|529934375|FG000|Overall Study|Death|2|||
146939061|NCT01202760|529934376|FG001|Overall Study|Death|1|||
146939062|NCT01202760|529934377|FG002|Overall Study|Death|0|||
146939063|NCT01202760|529934375|FG000|Overall Study|Lack of Efficacy|6|||
146939064|NCT01202760|529934376|FG001|Overall Study|Lack of Efficacy|8|||
146939065|NCT01202760|529934377|FG002|Overall Study|Lack of Efficacy|7|||
146939066|NCT01202760|529934375|FG000|Overall Study|Lost to Follow-up|0|||
146939067|NCT01202760|529934376|FG001|Overall Study|Lost to Follow-up|2|||
146939068|NCT01202760|529934377|FG002|Overall Study|Lost to Follow-up|1|||
146939069|NCT01202760|529934375|FG000|Overall Study|Parent / Caregiver Decision|0|||
146939070|NCT01202760|529934376|FG001|Overall Study|Parent / Caregiver Decision|1|||
146939071|NCT01202760|529934377|FG002|Overall Study|Parent / Caregiver Decision|0|||
146939072|NCT01202760|529934375|FG000|Overall Study|Withdrawal by Subject|17|||
146939073|NCT01202760|529934376|FG001|Overall Study|Withdrawal by Subject|18|||
146939074|NCT01202760|529934377|FG002|Overall Study|Withdrawal by Subject|14|||
146939075|NCT01202760|529934375|FG000|Overall Study|Physician Decision|0|||
146939076|NCT01202760|529934376|FG001|Overall Study|Physician Decision|1|||
146939077|NCT01202760|529934377|FG002|Overall Study|Physician Decision|0|||
146939078|NCT01202760|529934375|FG000|Overall Study|Protocol Violation|7|||
146939079|NCT01202760|529934376|FG001|Overall Study|Protocol Violation|5|||
146939080|NCT01202760|529934377|FG002|Overall Study|Protocol Violation|2|||
146939081|NCT01202760|529934375|FG000|Overall Study|Sponsor Decision|4|||
146939082|NCT01202760|529934376|FG001|Overall Study|Sponsor Decision|4|||
146939083|NCT01202760|529934377|FG002|Overall Study|Sponsor Decision|0|||
146939084|NCT00871572|529934378|FG000|Overall Study|Adverse Event|0|||
146939085|NCT00871572|529934379|FG001|Overall Study|Adverse Event|2|||
146939086|NCT00871572|529934380|FG002|Overall Study|Adverse Event|0|||
146939087|NCT00871572|529934381|FG003|Overall Study|Adverse Event|3|||
146939088|NCT00871572|529934378|FG000|Overall Study|Investigator Decision|0|||
146982454|NCT00294723|530097966|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
146735311|NCT02243202|529202880|FG000|Overall Study|Withdrawal by Subject|7|||
146735312|NCT02243202|529202881|FG001|Overall Study|Withdrawal by Subject|6|||
146735313|NCT02243202|529202882|FG002|Overall Study|Withdrawal by Subject|4|||
146735314|NCT02243202|529202883|FG003|Overall Study|Withdrawal by Subject|4|||
146735315|NCT02243202|529202880|FG000|Overall Study|Other|1|||
146735316|NCT02243202|529202881|FG001|Overall Study|Other|3|||
146735317|NCT02243202|529202882|FG002|Overall Study|Other|1|||
146735318|NCT02243202|529202883|FG003|Overall Study|Other|2|||
146735319|NCT02243202|529202880|FG000|Overall Study|Randomized but not received treatment|0|||
146735320|NCT02243202|529202881|FG001|Overall Study|Randomized but not received treatment|0|||
146735321|NCT02243202|529202882|FG002|Overall Study|Randomized but not received treatment|0|||
146735322|NCT02243202|529202883|FG003|Overall Study|Randomized but not received treatment|1|||
146735323|NCT04382924|529202884|FG000|Overall Study|Death|2|||
146735324|NCT04382924|529202885|FG001|Overall Study|Death|5|||
146735325|NCT04382924|529202886|FG002|Overall Study|Death|4|||
146735326|NCT04382924|529202884|FG000|Overall Study|Protocol Violation|0|||
146735327|NCT04382924|529202885|FG001|Overall Study|Protocol Violation|1|||
146735328|NCT04382924|529202886|FG002|Overall Study|Protocol Violation|1|||
146735329|NCT04382924|529202884|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
146735330|NCT04382924|529202885|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
146735331|NCT04382924|529202886|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
146735332|NCT04382924|529202884|FG000|Overall Study|Withdrawal by Subject|6|||
146735333|NCT04382924|529202885|FG001|Overall Study|Withdrawal by Subject|3|||
146735334|NCT04382924|529202886|FG002|Overall Study|Withdrawal by Subject|6|||
146735335|NCT04207840|529202890|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
146735336|NCT04207840|529202891|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
146793333|NCT01651403|529415726|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
146793334|NCT01651403|529415727|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
146793335|NCT01651403|529415726|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
146793336|NCT01651403|529415727|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
146793337|NCT01651403|529415726|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
146793338|NCT01651403|529415727|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
146793339|NCT01651403|529415726|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
146793340|NCT01651403|529415727|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
146793341|NCT01651403|529415726|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
146793342|NCT01651403|529415727|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
146793343|NCT01651403|529415726|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
146793344|NCT01651403|529415727|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
146793345|NCT05090683|529415730|FG000|Overall Study|Lost to Follow-up|10|||
146793346|NCT05090683|529415731|FG001|Overall Study|Lost to Follow-up|2|||
146793347|NCT05090683|529415730|FG000|Overall Study|Withdrawal by Subject|15|||
146793348|NCT05090683|529415731|FG001|Overall Study|Withdrawal by Subject|0|||
146793349|NCT04032847|529415732|FG000|Overall Study|Study termination by sponsor|8|||
146793350|NCT04032847|529415733|FG001|Overall Study|Study termination by sponsor|0|||
146793351|NCT04032847|529415734|FG002|Overall Study|Study termination by sponsor|4|||
146793352|NCT04032847|529415732|FG000|Overall Study|Death|12|||
146793353|NCT04032847|529415733|FG001|Overall Study|Death|0|||
146793354|NCT04032847|529415734|FG002|Overall Study|Death|0|||
146793355|NCT04032847|529415732|FG000|Overall Study|Progressive disease|2|||
146793356|NCT04032847|529415733|FG001|Overall Study|Progressive disease|0|||
146793357|NCT04032847|529415734|FG002|Overall Study|Progressive disease|1|||
146793358|NCT03325985|529415735|FG000|Overall Study|Lost to Follow-up|122|||
146793359|NCT03325985|529415736|FG001|Overall Study|Lost to Follow-up|26|||
146793360|NCT03325985|529415737|FG002|Overall Study|Lost to Follow-up|141|||
146793361|NCT03325985|529415738|FG003|Overall Study|Lost to Follow-up|28|||
146793362|NCT03325985|529415735|FG000|Overall Study|Death|99|||
146793363|NCT03325985|529415736|FG001|Overall Study|Death|36|||
146793364|NCT03325985|529415737|FG002|Overall Study|Death|94|||
146793365|NCT03325985|529415738|FG003|Overall Study|Death|32|||
146793366|NCT03213665|529415739|FG000|Overall Study|Adverse Event|1|||
146793367|NCT03213665|529415739|FG000|Overall Study|Physician Decision|2|||
146793368|NCT03213665|529415739|FG000|Overall Study|Withdrawal by Subject|3|||
146793369|NCT03213665|529415739|FG000|Overall Study|Progressive Disease|13|||
146939089|NCT00871572|529934379|FG001|Overall Study|Investigator Decision|1|||
146939090|NCT00871572|529934380|FG002|Overall Study|Investigator Decision|0|||
146939091|NCT00871572|529934381|FG003|Overall Study|Investigator Decision|1|||
146939092|NCT00871572|529934378|FG000|Overall Study|Lost to Follow-up|0|||
146939093|NCT00871572|529934379|FG001|Overall Study|Lost to Follow-up|1|||
146939094|NCT00871572|529934380|FG002|Overall Study|Lost to Follow-up|0|||
146939095|NCT00871572|529934381|FG003|Overall Study|Lost to Follow-up|1|||
146982455|NCT00294723|530097967|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
146982456|NCT00294723|530097968|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
146793370|NCT03056573|529415740|FG000|Overall Study|Death|2|||
146939096|NCT00871572|529934378|FG000|Overall Study|Protocol Violation|0|||
146939097|NCT00871572|529934379|FG001|Overall Study|Protocol Violation|0|||
146939098|NCT00871572|529934380|FG002|Overall Study|Protocol Violation|1|||
146735337|NCT04207840|529202892|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
146735338|NCT04207840|529202890|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
146735339|NCT04207840|529202891|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
146735340|NCT04207840|529202892|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
146735341|NCT02173054|529202893|FG000|Overall Study|lack of compliance|1|||
146735342|NCT02173054|529202894|FG001|Overall Study|lack of compliance|0|||
146735343|NCT02173054|529202895|FG002|Overall Study|lack of compliance|0|||
146735344|NCT02173054|529202893|FG000|Overall Study|Withdrawal by Subject|0|||
146735345|NCT02173054|529202894|FG001|Overall Study|Withdrawal by Subject|0|||
146735346|NCT02173054|529202895|FG002|Overall Study|Withdrawal by Subject|1|||
146735347|NCT01114204|529202896|FG000|Overall Study|Adverse Event|3|||
146735348|NCT01114204|529202897|FG001|Overall Study|Adverse Event|2|||
146793371|NCT03056573|529415741|FG001|Overall Study|Death|4|||
146793372|NCT03056573|529415740|FG000|Overall Study|Withdrawal by Subject|2|||
146793373|NCT03056573|529415741|FG001|Overall Study|Withdrawal by Subject|0|||
146793374|NCT03056573|529415740|FG000|Overall Study|Lost to Follow-up|1|||
146793375|NCT03056573|529415741|FG001|Overall Study|Lost to Follow-up|1|||
146735349|NCT01114204|529202896|FG000|Overall Study|Lost to Follow-up|1|||
146735350|NCT01114204|529202897|FG001|Overall Study|Lost to Follow-up|0|||
146793376|NCT00323856|529415742|FG000|Overall Study|Withdrawal by Subject|1|||
146939099|NCT00871572|529934381|FG003|Overall Study|Protocol Violation|1|||
146939100|NCT00871572|529934378|FG000|Overall Study|Sponsor Decision|1|||
146793377|NCT00323856|529415742|FG000|Overall Study|Was uncooperative and noncompliant|1|||
146793378|NCT00323856|529415742|FG000|Overall Study|Reason not specified|1|||
146793379|NCT00323856|529415742|FG000|Overall Study|Missing|2|||
146793380|NCT04086121|529415743|FG000|Overall Study|Other than listed|8|||
146793381|NCT04086121|529415743|FG000|Overall Study|Withdrawal by Subject|3|||
146793382|NCT04086121|529415743|FG000|Overall Study|Lost to Follow-up|2|||
146793383|NCT04086121|529415743|FG000|Overall Study|Adverse Event|1|||
146793384|NCT05292391|529415746|FG000|Overall Study|Lost to Follow-up|0|||
146793385|NCT05292391|529415747|FG001|Overall Study|Lost to Follow-up|0|||
146793386|NCT05292391|529415748|FG002|Overall Study|Lost to Follow-up|0|||
146793387|NCT05292391|529415749|FG003|Overall Study|Lost to Follow-up|1|||
146793388|NCT05292391|529415750|FG004|Overall Study|Lost to Follow-up|0|||
146793389|NCT05809453|529417384|FG000|Overall Study|Withdrawal by Subject|1|||
146793390|NCT05809453|529417385|FG001|Overall Study|Withdrawal by Subject|0|||
146793391|NCT05809453|529417386|FG002|Overall Study|Withdrawal by Subject|0|||
146793392|NCT05809453|529417387|FG003|Overall Study|Withdrawal by Subject|0|||
146793393|NCT03916185|529417391|FG000|Overall Study|Lost to Follow-up|0|||
146793394|NCT03916185|529417392|FG001|Overall Study|Lost to Follow-up|1|||
146793395|NCT03916185|529417393|FG002|Overall Study|Lost to Follow-up|0|||
146793396|NCT03916185|529417394|FG003|Overall Study|Lost to Follow-up|0|||
146793397|NCT03916185|529417391|FG000|Overall Study|Moved|1|||
146793398|NCT03916185|529417392|FG001|Overall Study|Moved|0|||
146793399|NCT03916185|529417393|FG002|Overall Study|Moved|0|||
146793400|NCT03916185|529417394|FG003|Overall Study|Moved|1|||
146793401|NCT03916185|529417391|FG000|Overall Study|Not Able to Get to Clinic|1|||
146793402|NCT03916185|529417392|FG001|Overall Study|Not Able to Get to Clinic|0|||
146793403|NCT03916185|529417393|FG002|Overall Study|Not Able to Get to Clinic|0|||
146793404|NCT03916185|529417394|FG003|Overall Study|Not Able to Get to Clinic|0|||
146793405|NCT02844465|529417398|FG000|Overall Study|Screen Failure|36|||
146793406|NCT02844465|529417398|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
146793407|NCT02844465|529417398|FG000|Overall Study|Withdrawal by Subject|5|||
146793408|NCT02844465|529417398|FG000|Overall Study|Lost to Follow-up|1|||
146793409|NCT02844465|529417398|FG000|Overall Study|Retreatment|1|||
146793410|NCT05671653|529417399|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
146793411|NCT05671653|529417400|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
146793412|NCT05671653|529417401|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
146793413|NCT05671653|529417402|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
146793414|NCT05671653|529417403|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
146793415|NCT05671653|529417404|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
146793416|NCT05671653|529417405|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
146793417|NCT05671653|529417406|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
146793418|NCT05671653|529417407|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
146793419|NCT05671653|529417408|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
146793420|NCT05671653|529417409|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
146793421|NCT05671653|529417410|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
146793422|NCT05671653|529417411|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
146793423|NCT05671653|529417399|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146793424|NCT05671653|529417400|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146793425|NCT05671653|529417401|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146793426|NCT05671653|529417402|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146793427|NCT05671653|529417403|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146793428|NCT05671653|529417404|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
146793429|NCT05671653|529417405|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146793430|NCT05671653|529417406|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146793431|NCT05671653|529417407|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146793432|NCT05671653|529417408|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146793433|NCT05671653|529417409|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146793434|NCT05671653|529417410|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146793435|NCT05671653|529417411|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146793436|NCT05671653|529417399|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146793437|NCT05671653|529417400|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146793438|NCT05671653|529417401|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146793439|NCT05671653|529417402|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146793440|NCT05671653|529417403|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146793441|NCT05671653|529417404|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
146793442|NCT05671653|529417405|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146793443|NCT05671653|529417406|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146793444|NCT05671653|529417407|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146793445|NCT05671653|529417408|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146793446|NCT05671653|529417409|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146793447|NCT05671653|529417410|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146793448|NCT05671653|529417411|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146793449|NCT05671653|529417399|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146793450|NCT05671653|529417400|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146793451|NCT05671653|529417401|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146793452|NCT05671653|529417402|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146793453|NCT05671653|529417403|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146793454|NCT05671653|529417404|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146939101|NCT00871572|529934379|FG001|Overall Study|Sponsor Decision|0|||
146735351|NCT01114204|529202896|FG000|Overall Study|Withdrawal by Subject|10|||
146735352|NCT01114204|529202897|FG001|Overall Study|Withdrawal by Subject|6|||
146735353|NCT01114204|529202896|FG000|Overall Study|Death|1|||
146735354|NCT01114204|529202897|FG001|Overall Study|Death|0|||
146735355|NCT01114204|529202896|FG000|Overall Study|Other-Personal reasons|2|||
146735356|NCT01114204|529202897|FG001|Overall Study|Other-Personal reasons|0|||
146735357|NCT01114204|529202896|FG000|Overall Study|Other-Medical monitor request|1|||
146735358|NCT01114204|529202897|FG001|Overall Study|Other-Medical monitor request|0|||
146735359|NCT01114204|529202896|FG000|Overall Study|Other-Participant request|2|||
146735360|NCT01114204|529202897|FG001|Overall Study|Other-Participant request|0|||
146735361|NCT01114204|529202896|FG000|Overall Study|Other-Protocol Violation|1|||
146735362|NCT01114204|529202897|FG001|Overall Study|Other-Protocol Violation|0|||
146735363|NCT00991341|529202902|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
146735364|NCT00991341|529202903|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
146735365|NCT00991341|529202902|FG000|Overall Study|Death|3|||
146735366|NCT00991341|529202903|FG001|Overall Study|Death|0|||
146735367|NCT00991341|529202902|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
146735368|NCT00991341|529202903|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
146735369|NCT00991341|529202902|FG000|Overall Study|Physician Decision|1|||
146735370|NCT00991341|529202903|FG001|Overall Study|Physician Decision|2|||
146735371|NCT00991341|529202902|FG000|Overall Study|Withdrawal by Subject|3|||
146735372|NCT00991341|529202903|FG001|Overall Study|Withdrawal by Subject|4|||
146735373|NCT03010462|529202918|FG000|Overall Study|Withdrawal by Subject|3|||
146735374|NCT03010462|529202919|FG001|Overall Study|Withdrawal by Subject|1|||
146735375|NCT02007434|529202922|FG000|Overall Study|Lost to Follow-up|0|||
146735376|NCT02007434|529202923|FG001|Overall Study|Lost to Follow-up|1|||
146735377|NCT02007434|529202924|FG002|Overall Study|Lost to Follow-up|0|||
146735378|NCT02007434|529202925|FG003|Overall Study|Lost to Follow-up|0|||
146735379|NCT02007434|529202926|FG004|Overall Study|Lost to Follow-up|0|||
146735380|NCT02007434|529202927|FG005|Overall Study|Lost to Follow-up|0|||
146735381|NCT02007434|529202928|FG006|Overall Study|Lost to Follow-up|0|||
146735382|NCT02007434|529202929|FG007|Overall Study|Lost to Follow-up|0|||
146735383|NCT02007434|529202922|FG000|Overall Study|Non-compliance|1|||
146793455|NCT05671653|529417405|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146793456|NCT05671653|529417406|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146793457|NCT05671653|529417407|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
146793458|NCT05671653|529417408|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146793459|NCT05671653|529417409|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146793460|NCT05671653|529417410|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146793461|NCT05671653|529417411|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146793462|NCT05671653|529417399|FG000|Cohort 2 Period 2|Adverse Event|0|||
146793463|NCT05671653|529417400|FG001|Cohort 2 Period 2|Adverse Event|0|||
146793464|NCT05671653|529417401|FG002|Cohort 2 Period 2|Adverse Event|0|||
146793465|NCT05671653|529417402|FG003|Cohort 2 Period 2|Adverse Event|0|||
146793466|NCT05671653|529417403|FG004|Cohort 2 Period 2|Adverse Event|0|||
146793467|NCT05671653|529417404|FG005|Cohort 2 Period 2|Adverse Event|0|||
146793468|NCT05671653|529417405|FG006|Cohort 2 Period 2|Adverse Event|0|||
146793469|NCT05671653|529417406|FG007|Cohort 2 Period 2|Adverse Event|0|||
146793470|NCT05671653|529417407|FG008|Cohort 2 Period 2|Adverse Event|0|||
146793471|NCT05671653|529417408|FG009|Cohort 2 Period 2|Adverse Event|0|||
146793472|NCT05671653|529417409|FG010|Cohort 2 Period 2|Adverse Event|1|||
146793473|NCT05671653|529417410|FG011|Cohort 2 Period 2|Adverse Event|0|||
146793474|NCT05671653|529417411|FG012|Cohort 2 Period 2|Adverse Event|0|||
146793475|NCT05671653|529417399|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
146793476|NCT05671653|529417400|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
146793477|NCT05671653|529417401|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
146793478|NCT05671653|529417402|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
146793479|NCT05671653|529417403|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
146793480|NCT05671653|529417404|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
146939102|NCT00871572|529934380|FG002|Overall Study|Sponsor Decision|0|||
146939103|NCT00871572|529934381|FG003|Overall Study|Sponsor Decision|0|||
146793481|NCT05671653|529417405|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
146939104|NCT00871572|529934378|FG000|Overall Study|Withdrawal by Subject|1|||
146735384|NCT02007434|529202923|FG001|Overall Study|Non-compliance|0|||
146735385|NCT02007434|529202924|FG002|Overall Study|Non-compliance|1|||
146735386|NCT02007434|529202925|FG003|Overall Study|Non-compliance|0|||
146735387|NCT02007434|529202926|FG004|Overall Study|Non-compliance|0|||
146735388|NCT02007434|529202927|FG005|Overall Study|Non-compliance|0|||
146735389|NCT02007434|529202928|FG006|Overall Study|Non-compliance|0|||
146735390|NCT02007434|529202929|FG007|Overall Study|Non-compliance|0|||
146735391|NCT04074590|529202932|FG000|Overall Study|Adverse Event|1|||
146735392|NCT04074590|529202933|FG001|Overall Study|Adverse Event|0|||
146793482|NCT05671653|529417406|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
146793483|NCT05671653|529417407|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
146793484|NCT05671653|529417408|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
146793485|NCT05671653|529417409|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
146793486|NCT05671653|529417410|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
146793487|NCT05671653|529417411|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
146793488|NCT05671653|529417399|FG000|Cohort 2 Period 2|Pregnancy|0|||
146793489|NCT05671653|529417400|FG001|Cohort 2 Period 2|Pregnancy|0|||
146793490|NCT05671653|529417401|FG002|Cohort 2 Period 2|Pregnancy|0|||
146793491|NCT05671653|529417402|FG003|Cohort 2 Period 2|Pregnancy|0|||
146793492|NCT05671653|529417403|FG004|Cohort 2 Period 2|Pregnancy|0|||
146793493|NCT05671653|529417404|FG005|Cohort 2 Period 2|Pregnancy|0|||
146793494|NCT05671653|529417405|FG006|Cohort 2 Period 2|Pregnancy|0|||
146793495|NCT05671653|529417406|FG007|Cohort 2 Period 2|Pregnancy|0|||
146793496|NCT05671653|529417407|FG008|Cohort 2 Period 2|Pregnancy|0|||
146793497|NCT05671653|529417408|FG009|Cohort 2 Period 2|Pregnancy|0|||
146793498|NCT05671653|529417409|FG010|Cohort 2 Period 2|Pregnancy|1|||
146793499|NCT05671653|529417410|FG011|Cohort 2 Period 2|Pregnancy|0|||
146939105|NCT00871572|529934379|FG001|Overall Study|Withdrawal by Subject|2|||
146939106|NCT00871572|529934380|FG002|Overall Study|Withdrawal by Subject|3|||
146939107|NCT00871572|529934381|FG003|Overall Study|Withdrawal by Subject|1|||
146939108|NCT01654523|529934382|FG000|Overall Study|Withdrawal by Subject|1|||
146939109|NCT04354155|529934385|FG000|Overall Study|Withdrawal by Subject|1|||
146939110|NCT04354155|529934385|FG000|Overall Study|Did not meet criteria for study intervention|1|||
146939111|NCT01686958|529934386|FG000|Overall Study|Withdrawal by Subject|1|||
146939112|NCT00587301|529934396|FG000|Overall Study|Screen Failure|9|||
146939113|NCT00587301|529934396|FG000|Overall Study|Lost to Follow-up|22|||
146939114|NCT00587301|529934396|FG000|Overall Study|Withdrawal by Subject|7|||
146939115|NCT00587301|529934396|FG000|Overall Study|Protocol Violation|7|||
146939116|NCT00351819|529934397|FG000|Overall Study|Lost to Follow-up|4|||
146939117|NCT00351819|529934398|FG001|Overall Study|Lost to Follow-up|4|||
146939118|NCT00351819|529934397|FG000|Overall Study|Withdrawal by Subject|0|||
146939119|NCT00351819|529934398|FG001|Overall Study|Withdrawal by Subject|4|||
146939120|NCT00351819|529934397|FG000|Overall Study|Elevated PSA|1|||
146939121|NCT00351819|529934398|FG001|Overall Study|Elevated PSA|1|||
146939122|NCT00351819|529934397|FG000|Overall Study|Traumatic ankle fracture|1|||
146939123|NCT00351819|529934398|FG001|Overall Study|Traumatic ankle fracture|0|||
146939124|NCT00351819|529934397|FG000|Overall Study|Unprofessional behavior|1|||
146939125|NCT00351819|529934398|FG001|Overall Study|Unprofessional behavior|0|||
146939126|NCT00351819|529934397|FG000|Overall Study|Non-compliance|0|||
146939127|NCT00351819|529934398|FG001|Overall Study|Non-compliance|1|||
146939128|NCT00351819|529934397|FG000|Overall Study|Incarcerated|0|||
146939129|NCT00351819|529934398|FG001|Overall Study|Incarcerated|1|||
146939130|NCT00351819|529934397|FG000|Overall Study|Enrolled in another trial|0|||
146939131|NCT00351819|529934398|FG001|Overall Study|Enrolled in another trial|1|||
146939132|NCT01400139|529934399|FG000|HYD Core Study|Adverse Event|210|||
146939133|NCT01400139|529934399|FG000|HYD Core Study|Lack of Efficacy|59|||
146939134|NCT01400139|529934399|FG000|HYD Core Study|Withdrawal by Subject|114|||
146939135|NCT01400139|529934399|FG000|HYD Core Study|Lost to Follow-up|39|||
146939136|NCT01400139|529934399|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
146939137|NCT01400139|529934399|FG000|HYD Core Study|Administrative|56|||
146939138|NCT01400139|529934399|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
146939139|NCT01400139|529934399|FG000|HYD Extension Period|Adverse Event|8|||
146939140|NCT01400139|529934399|FG000|HYD Extension Period|Withdrawal by Subject|5|||
146939141|NCT01400139|529934399|FG000|HYD Extension Period|Administrative|10|||
146939142|NCT00418717|529934400|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
146939143|NCT00418717|529934400|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
146939144|NCT00249795|529934402|FG000|Overall Study|Not treated|16|||
146939145|NCT00249795|529934403|FG001|Overall Study|Not treated|14|||
146939146|NCT00249795|529934402|FG000|Overall Study|Symptomatic hypotension|127|||
146939147|NCT00249795|529934403|FG001|Overall Study|Symptomatic hypotension|64|||
146939148|NCT00249795|529934402|FG000|Overall Study|Other Serious Adverse Event|84|||
146939149|NCT00249795|529934403|FG001|Overall Study|Other Serious Adverse Event|93|||
146939150|NCT00249795|529934402|FG000|Overall Study|Qualifying condition not present|26|||
146939151|NCT00249795|529934403|FG001|Overall Study|Qualifying condition not present|29|||
146939152|NCT00249795|529934402|FG000|Overall Study|Withdrawal by Subject|678|||
146939153|NCT00249795|529934403|FG001|Overall Study|Withdrawal by Subject|742|||
146793500|NCT05671653|529417411|FG012|Cohort 2 Period 2|Pregnancy|0|||
146793501|NCT05671653|529417399|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
146939154|NCT00249795|529934402|FG000|Overall Study|Thromboembolic / outcome event|39|||
146939155|NCT00249795|529934403|FG001|Overall Study|Thromboembolic / outcome event|45|||
146939156|NCT00249795|529934402|FG000|Overall Study|Oral anticoagulant required|2|||
146939157|NCT00249795|529934403|FG001|Overall Study|Oral anticoagulant required|0|||
146939158|NCT00249795|529934402|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
146939159|NCT00249795|529934403|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
146939160|NCT00249795|529934402|FG000|Overall Study|Non-compliance|71|||
146939161|NCT00249795|529934403|FG001|Overall Study|Non-compliance|69|||
146793502|NCT05671653|529417400|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
146793503|NCT05671653|529417401|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
146793504|NCT05671653|529417402|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
146793505|NCT05671653|529417403|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
146793506|NCT05671653|529417404|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
146793507|NCT05671653|529417405|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
146793508|NCT05671653|529417406|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
146793509|NCT05671653|529417407|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
146793510|NCT05671653|529417408|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
146793511|NCT05671653|529417409|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
146793512|NCT05671653|529417410|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
146793513|NCT05671653|529417411|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
146793514|NCT05671653|529417399|FG000|Cohort 2 Period 2|Other|0|||
146793515|NCT05671653|529417400|FG001|Cohort 2 Period 2|Other|0|||
146793516|NCT05671653|529417401|FG002|Cohort 2 Period 2|Other|0|||
146793517|NCT05671653|529417402|FG003|Cohort 2 Period 2|Other|0|||
146793518|NCT05671653|529417403|FG004|Cohort 2 Period 2|Other|0|||
146793519|NCT05671653|529417404|FG005|Cohort 2 Period 2|Other|0|||
146793520|NCT05671653|529417405|FG006|Cohort 2 Period 2|Other|0|||
146793521|NCT05671653|529417406|FG007|Cohort 2 Period 2|Other|0|||
146793522|NCT05671653|529417407|FG008|Cohort 2 Period 2|Other|0|||
146793523|NCT05671653|529417408|FG009|Cohort 2 Period 2|Other|0|||
146793524|NCT05671653|529417409|FG010|Cohort 2 Period 2|Other|1|||
146793525|NCT05671653|529417410|FG011|Cohort 2 Period 2|Other|0|||
146793526|NCT05671653|529417411|FG012|Cohort 2 Period 2|Other|0|||
146793527|NCT05671653|529417399|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146793528|NCT05671653|529417400|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146793529|NCT05671653|529417401|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146793530|NCT05671653|529417402|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146793531|NCT05671653|529417403|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146793532|NCT05671653|529417404|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146793533|NCT05671653|529417405|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146793534|NCT05671653|529417406|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146793535|NCT05671653|529417407|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146793536|NCT05671653|529417408|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146793537|NCT05671653|529417409|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146939162|NCT00249795|529934402|FG000|Overall Study|Study drug intolerance|3|||
146735393|NCT04074590|529202932|FG000|Overall Study|Physician Decision|1|||
146735394|NCT04074590|529202933|FG001|Overall Study|Physician Decision|0|||
146735395|NCT04074590|529202932|FG000|Overall Study|Withdrawal by Subject|2|||
146735396|NCT04074590|529202933|FG001|Overall Study|Withdrawal by Subject|0|||
146735397|NCT03745222|529202946|FG000|Overall Study|Withdrawal by Subject|0|||
146735398|NCT03745222|529202947|FG001|Overall Study|Withdrawal by Subject|1|||
146735399|NCT03745222|529202948|FG002|Overall Study|Withdrawal by Subject|0|||
146735400|NCT00792103|529202949|FG000|Overall Study|Enrolled, not treated|15|||
146735401|NCT00792103|529202949|FG000|Overall Study|Lost to Follow-up|17|||
146939163|NCT00249795|529934403|FG001|Overall Study|Study drug intolerance|3|||
146939164|NCT00249795|529934402|FG000|Overall Study|Other adverse events (non-serious)|188|||
146939165|NCT00249795|529934403|FG001|Overall Study|Other adverse events (non-serious)|159|||
146939166|NCT00249795|529934402|FG000|Overall Study|Physician withdrew consent|71|||
146939167|NCT00249795|529934403|FG001|Overall Study|Physician withdrew consent|63|||
146939168|NCT00249795|529934402|FG000|Overall Study|Surgery / procedure|4|||
146939169|NCT00249795|529934403|FG001|Overall Study|Surgery / procedure|5|||
146939170|NCT00249795|529934402|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
146939171|NCT00249795|529934403|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
146939172|NCT00249795|529934402|FG000|Overall Study|Lightheadedness / dizziness|15|||
146939173|NCT00249795|529934403|FG001|Overall Study|Lightheadedness / dizziness|11|||
146939174|NCT00249795|529934402|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
146939175|NCT00249795|529934403|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
146735402|NCT00792103|529202949|FG000|Overall Study|Adverse Event|25|||
146735403|NCT00792103|529202949|FG000|Overall Study|Withdrawal by Subject|52|||
146735404|NCT00792103|529202949|FG000|Overall Study|Protocol Violation|10|||
146735405|NCT00792103|529202949|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
146735406|NCT02535364|529202950|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
146735407|NCT02535364|529202950|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
146735408|NCT02535364|529202950|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
146939176|NCT00249795|529934402|FG000|Overall Study|Other contraindicated medication|1|||
146939177|NCT00249795|529934403|FG001|Overall Study|Other contraindicated medication|1|||
146939178|NCT00249795|529934402|FG000|Overall Study|Event related to cardiac condition|17|||
146735409|NCT02535364|529202950|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
146735410|NCT02535364|529202950|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
146735411|NCT02535364|529202950|FG000|Part B Screening|Death|2|||
146735412|NCT02535364|529202950|FG000|Part B Screening|Physician Decision|1|||
146735413|NCT02535364|529202950|FG000|Part B Screening|Withdrawal by Subject|1|||
146793538|NCT05671653|529417410|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
146793539|NCT05671653|529417411|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146793540|NCT01197378|529417415|FG000|Overall Study|Adverse Event|3|||
146735414|NCT02535364|529202950|FG000|Part B Screening|Adverse Event|1|||
146735415|NCT02535364|529202950|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
146735416|NCT02535364|529202950|FG000|Study Treatment|Death|1|||
146735417|NCT02535364|529202950|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
146735418|NCT02535364|529202950|FG000|12-Month Follow-up Period|Disease progression|22|||
146735419|NCT02535364|529202950|FG000|12-Month Follow-up Period|Death|5|||
146735420|NCT02535364|529202950|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
146735421|NCT02535364|529202950|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
146735422|NCT02535364|529202950|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
146735423|NCT00571701|529202951|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
146735424|NCT00571701|529202952|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
146735425|NCT00571701|529202951|FG000|First Intervention 12 Months|Death|1|||
146735426|NCT00571701|529202952|FG001|First Intervention 12 Months|Death|0|||
146735427|NCT00571701|529202951|FG000|Second Intervention 12 Months|Adverse Event|0|||
146735428|NCT00571701|529202952|FG001|Second Intervention 12 Months|Adverse Event|1|||
146735429|NCT00571701|529202951|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
146735430|NCT00571701|529202952|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
146735431|NCT04766086|529202955|FG000|Overall Study|Lost to Follow-up|3|||
146735432|NCT04766086|529202956|FG001|Overall Study|Lost to Follow-up|5|||
146735433|NCT04766086|529202957|FG002|Overall Study|Lost to Follow-up|3|||
146735434|NCT04766086|529202955|FG000|Overall Study|Withdrawal by Subject|1|||
146735435|NCT04766086|529202956|FG001|Overall Study|Withdrawal by Subject|1|||
146735436|NCT04766086|529202957|FG002|Overall Study|Withdrawal by Subject|2|||
146735437|NCT04766086|529202955|FG000|Overall Study|Other|0|||
146735438|NCT04766086|529202956|FG001|Overall Study|Other|0|||
146735439|NCT04766086|529202957|FG002|Overall Study|Other|1|||
146735440|NCT01959347|529202960|FG000|Overall Study|Protocol Violation|9|||
146735441|NCT01959347|529202961|FG001|Overall Study|Protocol Violation|7|||
146793541|NCT01197378|529417415|FG000|Overall Study|Withdrawal by Subject|1|||
146793542|NCT01197378|529417415|FG000|Overall Study|Physician Decision|1|||
146793543|NCT01197378|529417415|FG000|Overall Study|Other|2|||
146793544|NCT06232590|529417422|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
146793545|NCT06232590|529417423|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
146793546|NCT02589795|529417425|FG000|Overall Study|Lost to Follow-up|1|||
146793547|NCT02589795|529417426|FG001|Overall Study|Lost to Follow-up|0|||
146793548|NCT02589795|529417427|FG002|Overall Study|Lost to Follow-up|0|||
146793549|NCT02589795|529417425|FG000|Overall Study|Withdrawal by Subject|0|||
146793550|NCT02589795|529417426|FG001|Overall Study|Withdrawal by Subject|0|||
146793551|NCT02589795|529417427|FG002|Overall Study|Withdrawal by Subject|2|||
146793552|NCT02589795|529417425|FG000|Overall Study|Protocol Violation|0|||
146793553|NCT02589795|529417426|FG001|Overall Study|Protocol Violation|0|||
146793554|NCT02589795|529417427|FG002|Overall Study|Protocol Violation|1|||
146793555|NCT04909801|529417428|FG000|Overall Study|Lack of Efficacy|2|||
146793556|NCT04909801|529417429|FG001|Overall Study|Lack of Efficacy|1|||
146793557|NCT04909801|529417428|FG000|Overall Study|Adverse Event|1|||
146793558|NCT04909801|529417429|FG001|Overall Study|Adverse Event|2|||
146793559|NCT04909801|529417428|FG000|Overall Study|Participant request to discontinue study treatment|1|||
146793560|NCT04909801|529417429|FG001|Overall Study|Participant request to discontinue study treatment|2|||
146793561|NCT04909801|529417428|FG000|Overall Study|Withdrawal by Subject|2|||
146793562|NCT04909801|529417429|FG001|Overall Study|Withdrawal by Subject|1|||
146793563|NCT04909801|529417428|FG000|Overall Study|other reasons|1|||
146793564|NCT04909801|529417429|FG001|Overall Study|other reasons|1|||
146793565|NCT04550221|529417432|FG000|Overall Study|Lost to Follow-up|0|||
146793566|NCT04550221|529417433|FG001|Overall Study|Lost to Follow-up|4|||
146793567|NCT04550221|529417432|FG000|Overall Study|Withdrawn|3|||
146793568|NCT04550221|529417433|FG001|Overall Study|Withdrawn|0|||
146793569|NCT04550221|529417432|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
146793570|NCT04550221|529417433|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
146793571|NCT04811040|529417434|FG000|Overall Study|Lost to Follow-up|2|||
146793572|NCT04811040|529417435|FG001|Overall Study|Lost to Follow-up|0|||
146793573|NCT04811040|529417436|FG002|Overall Study|Lost to Follow-up|0|||
146793574|NCT04811040|529417437|FG003|Overall Study|Lost to Follow-up|0|||
146793575|NCT04811040|529417434|FG000|Overall Study|Withdrew consent|1|||
146793576|NCT04811040|529417435|FG001|Overall Study|Withdrew consent|1|||
146793577|NCT04811040|529417436|FG002|Overall Study|Withdrew consent|0|||
146735442|NCT03541044|529202962|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
146735443|NCT03541044|529202963|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
146735444|NCT03541044|529202962|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
146735445|NCT03541044|529202963|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
146735446|NCT04581200|529202966|FG000|Overall Study|Lost to Follow-up|6|||
146793578|NCT04811040|529417437|FG003|Overall Study|Withdrew consent|0|||
146793579|NCT04447040|529417439|FG000|Overall Study|Lost to Follow-up|2|||
146793580|NCT04447040|529417440|FG001|Overall Study|Lost to Follow-up|1|||
146793581|NCT04447040|529417441|FG002|Overall Study|Lost to Follow-up|3|||
146793582|NCT04447040|529417442|FG003|Overall Study|Lost to Follow-up|3|||
146793583|NCT04447040|529417443|FG004|Overall Study|Lost to Follow-up|1|||
146793584|NCT04447040|529417444|FG005|Overall Study|Lost to Follow-up|3|||
146793585|NCT04447040|529417439|FG000|Overall Study|Withdrawal by Subject|0|||
146793586|NCT04447040|529417440|FG001|Overall Study|Withdrawal by Subject|1|||
146793587|NCT04447040|529417441|FG002|Overall Study|Withdrawal by Subject|1|||
146793588|NCT04447040|529417442|FG003|Overall Study|Withdrawal by Subject|1|||
146793589|NCT04447040|529417443|FG004|Overall Study|Withdrawal by Subject|0|||
146793590|NCT04447040|529417444|FG005|Overall Study|Withdrawal by Subject|0|||
146793591|NCT01208662|529417445|FG000|Induction and Consolidation|Disease Progression|23|||
146793592|NCT01208662|529417446|FG001|Induction and Consolidation|Disease Progression|13|||
146793593|NCT01208662|529417447|FG002|Induction and Consolidation|Disease Progression|0|||
146793594|NCT01208662|529417445|FG000|Induction and Consolidation|Adverse Event|16|||
146793595|NCT01208662|529417446|FG001|Induction and Consolidation|Adverse Event|18|||
146793596|NCT01208662|529417447|FG002|Induction and Consolidation|Adverse Event|2|||
146793597|NCT01208662|529417445|FG000|Induction and Consolidation|MD or Participant Decision|16|||
146793598|NCT01208662|529417446|FG001|Induction and Consolidation|MD or Participant Decision|34|||
146793599|NCT01208662|529417447|FG002|Induction and Consolidation|MD or Participant Decision|4|||
146793600|NCT01208662|529417445|FG000|Induction and Consolidation|Death|1|||
146793601|NCT01208662|529417446|FG001|Induction and Consolidation|Death|3|||
146793602|NCT01208662|529417447|FG002|Induction and Consolidation|Death|1|||
146793603|NCT01208662|529417445|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
146793604|NCT01208662|529417446|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
146793605|NCT01208662|529417447|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
146793606|NCT01208662|529417445|FG000|Maintenance|Disease Progression|156|||
146793607|NCT01208662|529417446|FG001|Maintenance|Disease Progression|102|||
146793608|NCT01208662|529417447|FG002|Maintenance|Disease Progression|0|||
146793609|NCT01208662|529417445|FG000|Maintenance|Adverse Event|12|||
146793610|NCT01208662|529417446|FG001|Maintenance|Adverse Event|28|||
146793611|NCT01208662|529417447|FG002|Maintenance|Adverse Event|0|||
146793612|NCT01208662|529417445|FG000|Maintenance|MD or Participant Decision|24|||
146793613|NCT01208662|529417446|FG001|Maintenance|MD or Participant Decision|36|||
146793614|NCT01208662|529417447|FG002|Maintenance|MD or Participant Decision|0|||
146793615|NCT01208662|529417445|FG000|Maintenance|Death|0|||
146793616|NCT01208662|529417446|FG001|Maintenance|Death|3|||
146793617|NCT01208662|529417447|FG002|Maintenance|Death|0|||
146793618|NCT01208662|529417445|FG000|Maintenance|Discontinued for other reasons|21|||
146939179|NCT00249795|529934403|FG001|Overall Study|Event related to cardiac condition|16|||
146735447|NCT04581200|529202967|FG001|Overall Study|Lost to Follow-up|5|||
146735448|NCT03131960|529202968|FG000|Overall Study|Adverse Event|0|||
146735449|NCT03131960|529202969|FG001|Overall Study|Adverse Event|1|||
146735450|NCT01215357|529202973|FG000|Overall Study|Withdrawal by Subject|3|||
146735451|NCT01215357|529202973|FG000|Overall Study|Protocol Violation|9|||
146735452|NCT01859793|529202974|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
146735453|NCT01859793|529202975|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
146735454|NCT01859793|529202974|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
146735455|NCT01859793|529202975|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
146735456|NCT01859793|529202974|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
146735457|NCT01859793|529202975|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
146735458|NCT01859793|529202974|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
146735459|NCT01859793|529202975|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
146735460|NCT01597505|529202985|FG000|Overall Study|Physician Decision|5|||
146735461|NCT01597505|529202986|FG001|Overall Study|Physician Decision|0|||
146735462|NCT01597505|529202985|FG000|Overall Study|Adverse Event|19|||
146735463|NCT01597505|529202986|FG001|Overall Study|Adverse Event|7|||
146735464|NCT01597505|529202985|FG000|Overall Study|Lost to Follow-up|4|||
146735465|NCT01597505|529202986|FG001|Overall Study|Lost to Follow-up|2|||
146735466|NCT01597505|529202985|FG000|Overall Study|Withdrawal by Subject|10|||
146735467|NCT01597505|529202986|FG001|Overall Study|Withdrawal by Subject|18|||
146735468|NCT01597505|529202985|FG000|Overall Study|Other|5|||
146735469|NCT01597505|529202986|FG001|Overall Study|Other|6|||
146735470|NCT01597505|529202985|FG000|Overall Study|Missing|1|||
146735471|NCT01597505|529202986|FG001|Overall Study|Missing|0|||
146735472|NCT03728972|529202987|FG000|Overall Study|Death|1|||
146735473|NCT03728972|529202988|FG001|Overall Study|Death|0|||
146735474|NCT03728972|529202987|FG000|Overall Study|Lack of Efficacy|1|||
146735475|NCT03728972|529202988|FG001|Overall Study|Lack of Efficacy|0|||
146735476|NCT03728972|529202987|FG000|Overall Study|Physician Decision|3|||
146735477|NCT03728972|529202988|FG001|Overall Study|Physician Decision|0|||
146735478|NCT03728972|529202987|FG000|Overall Study|Disease progression|4|||
146735479|NCT03728972|529202988|FG001|Overall Study|Disease progression|3|||
146735480|NCT04543188|529202989|FG000|Phase 1a|Adverse Event|0|||
146735481|NCT04543188|529202990|FG001|Phase 1a|Adverse Event|0|||
146793619|NCT01208662|529417446|FG001|Maintenance|Discontinued for other reasons|31|||
146793620|NCT01208662|529417447|FG002|Maintenance|Discontinued for other reasons|0|||
146793621|NCT01208662|529417445|FG000|Maintenance|Still on Treatment|78|||
146793622|NCT01208662|529417446|FG001|Maintenance|Still on Treatment|89|||
146793623|NCT01208662|529417447|FG002|Maintenance|Still on Treatment|0|||
146735482|NCT04543188|529202991|FG002|Phase 1a|Adverse Event|0|||
146735483|NCT04543188|529202992|FG003|Phase 1a|Adverse Event|1|||
146735484|NCT04543188|529202993|FG004|Phase 1a|Adverse Event|0|||
146735485|NCT04543188|529202994|FG005|Phase 1a|Adverse Event|0|||
146735486|NCT04543188|529202995|FG006|Phase 1a|Adverse Event|1|||
146735487|NCT04543188|529202996|FG007|Phase 1a|Adverse Event|0|||
146735488|NCT04543188|529202997|FG008|Phase 1a|Adverse Event|0|||
146735489|NCT04543188|529202998|FG009|Phase 1a|Adverse Event|0|||
146735490|NCT04543188|529202999|FG010|Phase 1a|Adverse Event|0|||
146735491|NCT04543188|529203000|FG011|Phase 1a|Adverse Event|0|||
146735492|NCT04543188|529203001|FG012|Phase 1a|Adverse Event|0|||
146735493|NCT04543188|529203002|FG013|Phase 1a|Adverse Event|0|||
146735494|NCT04543188|529203003|FG014|Phase 1a|Adverse Event|0|||
146735495|NCT04543188|529202989|FG000|Phase 1a|Other (Death)|0|||
146735496|NCT04543188|529202990|FG001|Phase 1a|Other (Death)|1|||
146735497|NCT04543188|529202991|FG002|Phase 1a|Other (Death)|0|||
146735498|NCT04543188|529202992|FG003|Phase 1a|Other (Death)|0|||
146735499|NCT04543188|529202993|FG004|Phase 1a|Other (Death)|1|||
146735500|NCT04543188|529202994|FG005|Phase 1a|Other (Death)|0|||
146735501|NCT04543188|529202995|FG006|Phase 1a|Other (Death)|0|||
146735502|NCT04543188|529202996|FG007|Phase 1a|Other (Death)|0|||
146735503|NCT04543188|529202997|FG008|Phase 1a|Other (Death)|0|||
146735504|NCT04543188|529202998|FG009|Phase 1a|Other (Death)|1|||
146735505|NCT04543188|529202999|FG010|Phase 1a|Other (Death)|0|||
146735506|NCT04543188|529203000|FG011|Phase 1a|Other (Death)|0|||
146735507|NCT04543188|529203001|FG012|Phase 1a|Other (Death)|0|||
146735508|NCT04543188|529203002|FG013|Phase 1a|Other (Death)|0|||
146735509|NCT04543188|529203003|FG014|Phase 1a|Other (Death)|0|||
146735510|NCT04543188|529202989|FG000|Phase 1a|Lost to Follow-up|0|||
146735511|NCT04543188|529202990|FG001|Phase 1a|Lost to Follow-up|0|||
146735512|NCT04543188|529202991|FG002|Phase 1a|Lost to Follow-up|0|||
146735513|NCT04543188|529202992|FG003|Phase 1a|Lost to Follow-up|0|||
146735514|NCT04543188|529202993|FG004|Phase 1a|Lost to Follow-up|0|||
146735515|NCT04543188|529202994|FG005|Phase 1a|Lost to Follow-up|0|||
146735516|NCT04543188|529202995|FG006|Phase 1a|Lost to Follow-up|0|||
146735517|NCT04543188|529202996|FG007|Phase 1a|Lost to Follow-up|0|||
146735518|NCT04543188|529202997|FG008|Phase 1a|Lost to Follow-up|0|||
146735519|NCT04543188|529202998|FG009|Phase 1a|Lost to Follow-up|0|||
146735520|NCT04543188|529202999|FG010|Phase 1a|Lost to Follow-up|1|||
146735521|NCT04543188|529203000|FG011|Phase 1a|Lost to Follow-up|0|||
146735522|NCT04543188|529203001|FG012|Phase 1a|Lost to Follow-up|0|||
146735523|NCT04543188|529203002|FG013|Phase 1a|Lost to Follow-up|0|||
146735524|NCT04543188|529203003|FG014|Phase 1a|Lost to Follow-up|0|||
146735525|NCT04543188|529202989|FG000|Phase 1a|Progressive Disease|2|||
146735526|NCT04543188|529202990|FG001|Phase 1a|Progressive Disease|2|||
146735527|NCT04543188|529202991|FG002|Phase 1a|Progressive Disease|3|||
146735528|NCT04543188|529202992|FG003|Phase 1a|Progressive Disease|1|||
146735529|NCT04543188|529202993|FG004|Phase 1a|Progressive Disease|4|||
146735530|NCT04543188|529202994|FG005|Phase 1a|Progressive Disease|2|||
146735531|NCT04543188|529202995|FG006|Phase 1a|Progressive Disease|3|||
146735532|NCT04543188|529202996|FG007|Phase 1a|Progressive Disease|4|||
146735533|NCT04543188|529202997|FG008|Phase 1a|Progressive Disease|1|||
146735534|NCT04543188|529202998|FG009|Phase 1a|Progressive Disease|0|||
146735535|NCT04543188|529202999|FG010|Phase 1a|Progressive Disease|4|||
146735536|NCT04543188|529203000|FG011|Phase 1a|Progressive Disease|0|||
146735537|NCT04543188|529203001|FG012|Phase 1a|Progressive Disease|0|||
146735538|NCT04543188|529203002|FG013|Phase 1a|Progressive Disease|0|||
146735539|NCT04543188|529203003|FG014|Phase 1a|Progressive Disease|0|||
146735540|NCT04543188|529202989|FG000|Phase 1a|Study terminated by sponsor|0|||
146735541|NCT04543188|529202990|FG001|Phase 1a|Study terminated by sponsor|0|||
146735542|NCT04543188|529202991|FG002|Phase 1a|Study terminated by sponsor|0|||
146735543|NCT04543188|529202992|FG003|Phase 1a|Study terminated by sponsor|0|||
146939180|NCT00249795|529934402|FG000|Overall Study|Patient not wish to continue after May08|4|||
146939181|NCT00249795|529934403|FG001|Overall Study|Patient not wish to continue after May08|6|||
146735544|NCT04543188|529202993|FG004|Phase 1a|Study terminated by sponsor|1|||
146735545|NCT04543188|529202994|FG005|Phase 1a|Study terminated by sponsor|0|||
146735546|NCT04543188|529202995|FG006|Phase 1a|Study terminated by sponsor|0|||
146735547|NCT04543188|529202996|FG007|Phase 1a|Study terminated by sponsor|0|||
146735548|NCT04543188|529202997|FG008|Phase 1a|Study terminated by sponsor|0|||
146735549|NCT04543188|529202998|FG009|Phase 1a|Study terminated by sponsor|0|||
146735550|NCT04543188|529202999|FG010|Phase 1a|Study terminated by sponsor|1|||
146735551|NCT04543188|529203000|FG011|Phase 1a|Study terminated by sponsor|0|||
146735552|NCT04543188|529203001|FG012|Phase 1a|Study terminated by sponsor|0|||
146735553|NCT04543188|529203002|FG013|Phase 1a|Study terminated by sponsor|0|||
146735554|NCT04543188|529203003|FG014|Phase 1a|Study terminated by sponsor|0|||
146735555|NCT04543188|529202989|FG000|Phase 1a|Withdrawal by Subject|0|||
146735556|NCT04543188|529202990|FG001|Phase 1a|Withdrawal by Subject|0|||
146735557|NCT04543188|529202991|FG002|Phase 1a|Withdrawal by Subject|0|||
146735558|NCT04543188|529202992|FG003|Phase 1a|Withdrawal by Subject|0|||
146735559|NCT04543188|529202993|FG004|Phase 1a|Withdrawal by Subject|3|||
146735560|NCT04543188|529202994|FG005|Phase 1a|Withdrawal by Subject|0|||
146735561|NCT04543188|529202995|FG006|Phase 1a|Withdrawal by Subject|0|||
146735562|NCT04543188|529202996|FG007|Phase 1a|Withdrawal by Subject|0|||
146735563|NCT04543188|529202997|FG008|Phase 1a|Withdrawal by Subject|1|||
146735564|NCT04543188|529202998|FG009|Phase 1a|Withdrawal by Subject|1|||
146735565|NCT04543188|529202999|FG010|Phase 1a|Withdrawal by Subject|2|||
146735566|NCT04543188|529203000|FG011|Phase 1a|Withdrawal by Subject|0|||
146735567|NCT04543188|529203001|FG012|Phase 1a|Withdrawal by Subject|0|||
146735568|NCT04543188|529203002|FG013|Phase 1a|Withdrawal by Subject|0|||
146735569|NCT04543188|529203003|FG014|Phase 1a|Withdrawal by Subject|0|||
146735570|NCT04543188|529202989|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
146735571|NCT04543188|529202990|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
146735572|NCT04543188|529202991|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
146735573|NCT04543188|529202992|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
146735574|NCT04543188|529202993|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
146735575|NCT04543188|529202994|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
146735576|NCT04543188|529202995|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
146735577|NCT04543188|529202996|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
146735578|NCT04543188|529202997|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
146735579|NCT04543188|529202998|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
146735580|NCT04543188|529202999|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
146735581|NCT04543188|529203000|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
146735582|NCT04543188|529203001|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
146735583|NCT04543188|529203002|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
146735584|NCT04543188|529203003|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
146735585|NCT04543188|529202989|FG000|Phase 1a|Other|0|||
146735586|NCT04543188|529202990|FG001|Phase 1a|Other|0|||
146735587|NCT04543188|529202991|FG002|Phase 1a|Other|0|||
146735588|NCT04543188|529202992|FG003|Phase 1a|Other|0|||
146735589|NCT04543188|529202993|FG004|Phase 1a|Other|0|||
146793624|NCT04076618|529417448|FG000|Overall Study|Lost to Follow-up|2|||
146793625|NCT04076618|529417449|FG001|Overall Study|Lost to Follow-up|1|||
146793626|NCT04076618|529417450|FG002|Overall Study|Lost to Follow-up|3|||
146793627|NCT04076618|529417448|FG000|Overall Study|Withdrawal by Subject|3|||
146793628|NCT04076618|529417449|FG001|Overall Study|Withdrawal by Subject|1|||
146793629|NCT04076618|529417450|FG002|Overall Study|Withdrawal by Subject|2|||
146793630|NCT04076618|529417448|FG000|Overall Study|Relocated out of state|0|||
146793631|NCT04076618|529417449|FG001|Overall Study|Relocated out of state|2|||
146793632|NCT04076618|529417450|FG002|Overall Study|Relocated out of state|0|||
146793633|NCT04076618|529417448|FG000|Overall Study|COVID concerns|0|||
146793634|NCT04076618|529417449|FG001|Overall Study|COVID concerns|1|||
146793635|NCT04076618|529417450|FG002|Overall Study|COVID concerns|0|||
146793636|NCT04076618|529417448|FG000|Overall Study|Adverse Event|0|||
146793637|NCT04076618|529417449|FG001|Overall Study|Adverse Event|0|||
146793638|NCT04076618|529417450|FG002|Overall Study|Adverse Event|2|||
146793639|NCT00321048|529417451|FG000|Overall Study|Withdrawal by Subject|6|||
146793640|NCT00321048|529417452|FG001|Overall Study|Withdrawal by Subject|8|||
146793641|NCT04024020|529417457|FG000|Overall Study|Withdrawal by Subject|2|||
146793642|NCT04024020|529417458|FG001|Overall Study|Withdrawal by Subject|2|||
146793643|NCT00746096|529417467|FG000|Overall Study|Adverse Event|1|||
146793644|NCT00746096|529417468|FG001|Overall Study|Adverse Event|0|||
146793645|NCT00746096|529417467|FG000|Overall Study|Withdrawal by Subject|5|||
146793646|NCT00746096|529417468|FG001|Overall Study|Withdrawal by Subject|1|||
146793647|NCT00746096|529417467|FG000|Overall Study|Lost to Follow-up|2|||
146793648|NCT00746096|529417468|FG001|Overall Study|Lost to Follow-up|1|||
146793649|NCT00746096|529417467|FG000|Overall Study|Protocol Violation|1|||
146793650|NCT00746096|529417468|FG001|Overall Study|Protocol Violation|0|||
146793651|NCT00746096|529417467|FG000|Overall Study|No study drug treatment|1|||
146793652|NCT00746096|529417468|FG001|Overall Study|No study drug treatment|1|||
146793653|NCT02296684|529417469|FG000|Overall Study|Withdrawal by Subject|0|||
146793654|NCT02296684|529417470|FG001|Overall Study|Withdrawal by Subject|1|||
146793655|NCT02296684|529417471|FG002|Overall Study|Withdrawal by Subject|1|||
146793656|NCT02296684|529417469|FG000|Overall Study|Death|2|||
146793657|NCT02296684|529417470|FG001|Overall Study|Death|0|||
146735590|NCT04543188|529202994|FG005|Phase 1a|Other|0|||
146735591|NCT04543188|529202995|FG006|Phase 1a|Other|0|||
146735592|NCT04543188|529202996|FG007|Phase 1a|Other|0|||
146735593|NCT04543188|529202997|FG008|Phase 1a|Other|0|||
146735594|NCT04543188|529202998|FG009|Phase 1a|Other|1|||
146735595|NCT04543188|529202999|FG010|Phase 1a|Other|0|||
146735596|NCT04543188|529203000|FG011|Phase 1a|Other|0|||
146735597|NCT04543188|529203001|FG012|Phase 1a|Other|0|||
146793658|NCT02296684|529417471|FG002|Overall Study|Death|0|||
146793659|NCT03571581|529417472|FG000|Overall Study|Death|2|||
146793660|NCT03571581|529417472|FG000|Overall Study|Withdrawal by Subject|2|||
146793661|NCT03295721|529417477|FG000|Overall Study|Adverse Event|1|||
146793662|NCT03295721|529417478|FG001|Overall Study|Adverse Event|0|||
146793663|NCT03295721|529417479|FG002|Overall Study|Adverse Event|0|||
146793664|NCT03295721|529417477|FG000|Overall Study|Lost to Follow-up|1|||
146793665|NCT03295721|529417478|FG001|Overall Study|Lost to Follow-up|1|||
146793666|NCT03295721|529417479|FG002|Overall Study|Lost to Follow-up|1|||
146793667|NCT03295721|529417477|FG000|Overall Study|Withdrawal by Subject|1|||
146982457|NCT00294723|530097966|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
146982458|NCT00294723|530097967|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
146982459|NCT00294723|530097968|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
146793668|NCT03295721|529417478|FG001|Overall Study|Withdrawal by Subject|0|||
146793669|NCT03295721|529417479|FG002|Overall Study|Withdrawal by Subject|1|||
146793670|NCT03295721|529417477|FG000|Overall Study|Death|0|||
146793671|NCT03295721|529417478|FG001|Overall Study|Death|0|||
146793672|NCT03295721|529417479|FG002|Overall Study|Death|1|||
146793673|NCT00429364|529417482|FG000|Overall Study|Withdrawal by Subject|11|||
146793674|NCT00429364|529417483|FG001|Overall Study|Withdrawal by Subject|5|||
146793675|NCT00429364|529417482|FG000|Overall Study|Physician Decision|4|||
146793676|NCT00429364|529417483|FG001|Overall Study|Physician Decision|2|||
146793677|NCT00429364|529417482|FG000|Overall Study|Lost to Follow-up|7|||
146793678|NCT00429364|529417483|FG001|Overall Study|Lost to Follow-up|6|||
146793679|NCT00429364|529417482|FG000|Overall Study|Death|0|||
146793680|NCT00429364|529417483|FG001|Overall Study|Death|1|||
146793681|NCT00429364|529417482|FG000|Overall Study|Underwent aortic root surgery|10|||
146793682|NCT00429364|529417483|FG001|Overall Study|Underwent aortic root surgery|18|||
146793683|NCT00429364|529417482|FG000|Overall Study|Pregnancy|0|||
146793684|NCT00429364|529417483|FG001|Overall Study|Pregnancy|1|||
146793685|NCT04871529|529417484|FG000|Overall Study|Withdrawal by Subject|0|||
146793686|NCT04871529|529417485|FG001|Overall Study|Withdrawal by Subject|1|||
146793687|NCT04871529|529417484|FG000|Overall Study|Death|0|||
146793688|NCT04871529|529417485|FG001|Overall Study|Death|1|||
146793689|NCT04871529|529417484|FG000|Overall Study|Not protocol specified|0|||
146793690|NCT04871529|529417485|FG001|Overall Study|Not protocol specified|1|||
146793691|NCT05184452|529417486|FG000|Overall Study|Lost to Follow-up|0|||
146793692|NCT05184452|529417487|FG001|Overall Study|Lost to Follow-up|0|||
146793693|NCT05184452|529417488|FG002|Overall Study|Lost to Follow-up|0|||
146793694|NCT05184452|529417489|FG003|Overall Study|Lost to Follow-up|0|||
146793695|NCT05184452|529417490|FG004|Overall Study|Lost to Follow-up|0|||
146793696|NCT05184452|529417491|FG005|Overall Study|Lost to Follow-up|2|||
146793697|NCT05184452|529417492|FG006|Overall Study|Lost to Follow-up|0|||
146793698|NCT05184452|529417493|FG007|Overall Study|Lost to Follow-up|0|||
146793699|NCT05184452|529417494|FG008|Overall Study|Lost to Follow-up|0|||
146793700|NCT05184452|529417495|FG009|Overall Study|Lost to Follow-up|1|||
146793701|NCT05184452|529417486|FG000|Overall Study|Withdrawal by Subject|0|||
146793702|NCT05184452|529417487|FG001|Overall Study|Withdrawal by Subject|0|||
146793703|NCT05184452|529417488|FG002|Overall Study|Withdrawal by Subject|0|||
146793704|NCT05184452|529417489|FG003|Overall Study|Withdrawal by Subject|0|||
146793705|NCT05184452|529417490|FG004|Overall Study|Withdrawal by Subject|0|||
146793706|NCT05184452|529417491|FG005|Overall Study|Withdrawal by Subject|1|||
146793707|NCT05184452|529417492|FG006|Overall Study|Withdrawal by Subject|0|||
146793708|NCT05184452|529417493|FG007|Overall Study|Withdrawal by Subject|0|||
146793709|NCT05184452|529417494|FG008|Overall Study|Withdrawal by Subject|0|||
146793710|NCT05184452|529417495|FG009|Overall Study|Withdrawal by Subject|1|||
146793711|NCT05586490|529417496|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
146793712|NCT05586490|529417497|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
146793713|NCT05586490|529417498|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
146793714|NCT05586490|529417499|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
146793715|NCT05586490|529417500|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
146793716|NCT05586490|529417496|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
146793717|NCT05586490|529417497|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
146939182|NCT00249795|529934402|FG000|Overall Study|Site not agree to continue after May08|1|||
146939183|NCT00249795|529934403|FG001|Overall Study|Site not agree to continue after May08|1|||
146939184|NCT00249795|529934402|FG000|Overall Study|Lost to Follow-up|0|||
146939185|NCT00249795|529934403|FG001|Overall Study|Lost to Follow-up|2|||
146939186|NCT00249795|529934402|FG000|Overall Study|Missing|0|||
146939187|NCT00249795|529934403|FG001|Overall Study|Missing|1|||
146939188|NCT00719537|529934406|FG000|Overall Study|Withdrawal by Subject|1|||
146939189|NCT00719537|529934407|FG001|Overall Study|Withdrawal by Subject|0|||
146982460|NCT00294723|530097966|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
146982461|NCT00294723|530097967|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
146982462|NCT00294723|530097968|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
146982463|NCT00294723|530097966|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
146793718|NCT05586490|529417498|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
146793719|NCT05586490|529417499|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
146793720|NCT05586490|529417500|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
146793721|NCT05586490|529417496|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
146793722|NCT05586490|529417497|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
146793723|NCT05586490|529417498|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
146793724|NCT05586490|529417499|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
146793725|NCT05586490|529417500|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
146793726|NCT03034356|529417501|FG000|Baseline|Lost to Follow-up|2|||
146793727|NCT03034356|529417502|FG001|Baseline|Lost to Follow-up|4|||
146793728|NCT03034356|529417501|FG000|Baseline|Withdrawal by Subject|2|||
146793729|NCT03034356|529417502|FG001|Baseline|Withdrawal by Subject|0|||
146793730|NCT03034356|529417501|FG000|Baseline|Physician Decision|0|||
146793731|NCT03034356|529417502|FG001|Baseline|Physician Decision|1|||
146793732|NCT03034356|529417501|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
146793733|NCT03034356|529417502|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
146793734|NCT03034356|529417501|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
146793735|NCT03034356|529417502|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
146793736|NCT03034356|529417501|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
146793737|NCT03034356|529417502|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
146793738|NCT03034356|529417501|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
146793739|NCT03034356|529417502|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
146793740|NCT02684227|529417504|FG000|Overall Study|Adverse Event|1|||
146793741|NCT02684227|529417505|FG001|Overall Study|Adverse Event|7|||
146793742|NCT02684227|529417504|FG000|Overall Study|Death|0|||
146793743|NCT02684227|529417505|FG001|Overall Study|Death|2|||
146793744|NCT02684227|529417504|FG000|Overall Study|Withdrawal by Subject|0|||
146793745|NCT02684227|529417505|FG001|Overall Study|Withdrawal by Subject|1|||
146793746|NCT02684227|529417504|FG000|Overall Study|Progressive Disease|0|||
146793747|NCT02684227|529417505|FG001|Overall Study|Progressive Disease|2|||
146793748|NCT04689256|529417506|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
146793749|NCT04689256|529417507|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
146793750|NCT05267470|529417510|FG000|Overall Study|Decision by sponsor|0|||
146793751|NCT05267470|529417511|FG001|Overall Study|Decision by sponsor|3|||
146793752|NCT05267470|529417512|FG002|Overall Study|Decision by sponsor|19|||
146793753|NCT05267470|529417513|FG003|Overall Study|Decision by sponsor|7|||
146793754|NCT05267470|529417514|FG004|Overall Study|Decision by sponsor|3|||
146793755|NCT05267470|529417510|FG000|Overall Study|Withdrawal by Subject|1|||
146793756|NCT05267470|529417511|FG001|Overall Study|Withdrawal by Subject|1|||
146793757|NCT05267470|529417512|FG002|Overall Study|Withdrawal by Subject|2|||
146793758|NCT05267470|529417513|FG003|Overall Study|Withdrawal by Subject|2|||
146793759|NCT05267470|529417514|FG004|Overall Study|Withdrawal by Subject|0|||
146793760|NCT05267470|529417510|FG000|Overall Study|Death|3|||
146793761|NCT05267470|529417511|FG001|Overall Study|Death|5|||
146793762|NCT05267470|529417512|FG002|Overall Study|Death|8|||
146793763|NCT05267470|529417513|FG003|Overall Study|Death|18|||
146793764|NCT05267470|529417514|FG004|Overall Study|Death|1|||
146793765|NCT05267470|529417510|FG000|Overall Study|Lost to Follow-up|0|||
146793766|NCT05267470|529417511|FG001|Overall Study|Lost to Follow-up|0|||
146793767|NCT05267470|529417512|FG002|Overall Study|Lost to Follow-up|0|||
146793768|NCT05267470|529417513|FG003|Overall Study|Lost to Follow-up|1|||
146793769|NCT05267470|529417514|FG004|Overall Study|Lost to Follow-up|0|||
146793770|NCT05828017|529417515|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
146793771|NCT04428203|529417516|FG000|Overall Study|Adverse Event|1|||
146793772|NCT04428203|529417517|FG001|Overall Study|Adverse Event|0|||
146793773|NCT04428203|529417518|FG002|Overall Study|Adverse Event|0|||
146793774|NCT04428203|529417516|FG000|Overall Study|Withdrawal by Subject|1|||
146793775|NCT04428203|529417517|FG001|Overall Study|Withdrawal by Subject|0|||
146793776|NCT04428203|529417518|FG002|Overall Study|Withdrawal by Subject|1|||
146793777|NCT04571619|529417519|FG000|Phase 1|Death|22|||
146793778|NCT04571619|529417520|FG001|Phase 1|Death|18|||
146793779|NCT04571619|529417519|FG000|Phase 1|Withdrawal by Subject|7|||
146793780|NCT04571619|529417520|FG001|Phase 1|Withdrawal by Subject|2|||
146793781|NCT04571619|529417519|FG000|Phase 2|Death|13|||
146793782|NCT04571619|529417520|FG001|Phase 2|Death|16|||
146939190|NCT00719537|529934406|FG000|Overall Study|Lost to Follow-up|0|||
146939191|NCT00719537|529934407|FG001|Overall Study|Lost to Follow-up|1|||
146939192|NCT01142193|529934410|FG000|Overall Study|Adverse Event|12|||
146939193|NCT01142193|529934411|FG001|Overall Study|Adverse Event|4|||
146939194|NCT01142193|529934410|FG000|Overall Study|Lack of Efficacy|2|||
146939195|NCT01142193|529934411|FG001|Overall Study|Lack of Efficacy|1|||
146939196|NCT01142193|529934410|FG000|Overall Study|Physician Decision|1|||
146793783|NCT04571619|529417519|FG000|Phase 2|Withdrawal by Subject|6|||
146793784|NCT04571619|529417520|FG001|Phase 2|Withdrawal by Subject|4|||
146793785|NCT02361216|529417521|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
146793786|NCT02361216|529417522|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
146793787|NCT02361216|529417521|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
146793788|NCT02361216|529417522|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
146793789|NCT02361216|529417521|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
146793790|NCT02361216|529417522|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
146793791|NCT02361216|529417521|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
146793792|NCT02361216|529417522|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
146793793|NCT02361216|529417521|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
146793794|NCT02361216|529417522|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
146982464|NCT00294723|530097967|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
146982465|NCT00294723|530097968|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
146982466|NCT00294723|530097966|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
146982467|NCT00294723|530097967|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
146982468|NCT00294723|530097968|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
146982469|NCT00294723|530097966|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
146982470|NCT00294723|530097967|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
146982471|NCT00294723|530097968|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
146982472|NCT00294723|530097966|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
146982473|NCT00294723|530097967|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
146982474|NCT00294723|530097968|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
146982475|NCT00752791|530097969|FG000|Overall Study|Adverse Event|7|||
146982476|NCT00752791|530097969|FG000|Overall Study|Withdrawal by Subject|1|||
146982477|NCT00752791|530097969|FG000|Overall Study|Physician Decision|1|||
146982478|NCT00752791|530097969|FG000|Overall Study|Death|1|||
146982479|NCT00752791|530097969|FG000|Overall Study|Renal transplant|3|||
146982480|NCT00752791|530097969|FG000|Overall Study|Switched to hemodialysis|2|||
146982481|NCT00752791|530097969|FG000|Overall Study|Protocol deviation|1|||
146982482|NCT03341507|530097970|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
146982483|NCT02927847|530097971|FG000|Overall Study|Lost to Follow-up|1|||
146982484|NCT02927847|530097972|FG001|Overall Study|Lost to Follow-up|0|||
146982485|NCT02927847|530097971|FG000|Overall Study|Withdrawal by Subject|4|||
146982486|NCT02927847|530097972|FG001|Overall Study|Withdrawal by Subject|2|||
146982487|NCT02927847|530097971|FG000|Overall Study|PI withdrawn due to missed visits|1|||
146982488|NCT02927847|530097972|FG001|Overall Study|PI withdrawn due to missed visits|1|||
146982489|NCT01755858|530097975|FG000|Overall Study|Adverse Event|1|||
146982490|NCT01755858|530097976|FG001|Overall Study|Adverse Event|1|||
146982491|NCT03255031|530097977|FG000|Overall Study|Adverse Event|5|||
146982492|NCT03255031|530097978|FG001|Overall Study|Adverse Event|3|||
146982493|NCT03255031|530097977|FG000|Overall Study|Physician Decision|2|||
146982494|NCT03255031|530097978|FG001|Overall Study|Physician Decision|1|||
146982495|NCT03255031|530097977|FG000|Overall Study|Withdrawal by Subject|9|||
146982496|NCT03255031|530097978|FG001|Overall Study|Withdrawal by Subject|3|||
146982497|NCT01809314|530097979|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
146982498|NCT01809314|530097979|FG000|Overall Study|Adverse Event|6|||
146982499|NCT01809314|530097979|FG000|Overall Study|Insufficient Therapeutic Response|14|||
146982500|NCT01809314|530097979|FG000|Overall Study|Lost to Follow-up|724|||
146982501|NCT01092702|530097980|FG000|Overall Study|Withdrawal by Subject|7|||
146982502|NCT01092702|530097980|FG000|Overall Study|Lost to Follow-up|2|||
146982503|NCT03567057|530097981|FG000|Overall Study|Adverse Event|56|||
146982504|NCT03567057|530097982|FG001|Overall Study|Adverse Event|53|||
146982505|NCT03567057|530097983|FG002|Overall Study|Adverse Event|28|||
146982506|NCT03567057|530097981|FG000|Overall Study|Withdrawal by Subject|22|||
146982507|NCT03567057|530097982|FG001|Overall Study|Withdrawal by Subject|24|||
146982508|NCT03567057|530097983|FG002|Overall Study|Withdrawal by Subject|13|||
146982509|NCT03567057|530097981|FG000|Overall Study|Lost to Follow-up|3|||
146982510|NCT03567057|530097982|FG001|Overall Study|Lost to Follow-up|5|||
146982511|NCT03567057|530097983|FG002|Overall Study|Lost to Follow-up|2|||
146982512|NCT03567057|530097981|FG000|Overall Study|COVID-19 pandemic|4|||
146982513|NCT03567057|530097982|FG001|Overall Study|COVID-19 pandemic|3|||
146982514|NCT03567057|530097983|FG002|Overall Study|COVID-19 pandemic|0|||
146793795|NCT02361216|529417521|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
146793796|NCT02361216|529417522|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
146848445|NCT00291642|529615687|FG004|Overall Study|Patient missed visit|0|||
146848446|NCT00291642|529615683|FG000|Overall Study|Intake of prohibited medication|1|||
146848447|NCT00291642|529615684|FG001|Overall Study|Intake of prohibited medication|0|||
146848448|NCT00291642|529615685|FG002|Overall Study|Intake of prohibited medication|0|||
146848449|NCT00291642|529615686|FG003|Overall Study|Intake of prohibited medication|0|||
146848450|NCT00291642|529615687|FG004|Overall Study|Intake of prohibited medication|0|||
146848451|NCT00735475|529615688|FG000|Overall Study|Adverse Event|0|||
146848452|NCT00735475|529615689|FG001|Overall Study|Adverse Event|1|||
146848453|NCT00735475|529615688|FG000|Overall Study|Death|1|||
146848454|NCT00735475|529615689|FG001|Overall Study|Death|1|||
146848455|NCT00735475|529615688|FG000|Overall Study|Lost to Follow-up|3|||
146848456|NCT00735475|529615689|FG001|Overall Study|Lost to Follow-up|3|||
146848457|NCT00735475|529615688|FG000|Overall Study|Physician Decision|0|||
146848458|NCT00735475|529615689|FG001|Overall Study|Physician Decision|1|||
146848459|NCT00735475|529615688|FG000|Overall Study|Withdrawal by Subject|4|||
146848460|NCT00735475|529615689|FG001|Overall Study|Withdrawal by Subject|5|||
146848461|NCT00548262|529615690|FG000|Overall Study|Death|21|||
146848462|NCT00548262|529615690|FG000|Overall Study|Adverse Event|2|||
146848463|NCT00548262|529615690|FG000|Overall Study|Lack of Efficacy|4|||
146848464|NCT00548262|529615690|FG000|Overall Study|Lost to Follow-up|1|||
146848465|NCT00548262|529615690|FG000|Overall Study|Other|3|||
146939197|NCT01142193|529934411|FG001|Overall Study|Physician Decision|1|||
146939198|NCT01142193|529934410|FG000|Overall Study|Withdrawal by Subject|4|||
146939199|NCT01142193|529934411|FG001|Overall Study|Withdrawal by Subject|3|||
146939200|NCT01142193|529934410|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
146939201|NCT01142193|529934411|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
146939202|NCT01142193|529934410|FG000|Overall Study|Other|1|||
146939203|NCT01142193|529934411|FG001|Overall Study|Other|2|||
146939204|NCT01425749|529934412|FG000|Overall Study|progression of melanoma|0|||
146939205|NCT01425749|529934413|FG001|Overall Study|progression of melanoma|1|||
146939206|NCT02910219|529934414|FG000|Overall Study|Withdrawal by Subject|1|||
146939207|NCT02910219|529934415|FG001|Overall Study|Withdrawal by Subject|1|||
146939208|NCT02762708|529934419|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
146939209|NCT02762708|529934420|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
146939210|NCT02762708|529934421|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
146939211|NCT02762708|529934422|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
146939212|NCT01468701|529934428|FG000|Overall Study|Not eligible|91|||
146939213|NCT01468701|529934429|FG001|Overall Study|Not eligible|140|||
146939214|NCT01468701|529934430|FG002|Overall Study|Not eligible|29|||
146939215|NCT01468701|529934431|FG003|Overall Study|Not eligible|12|||
146939216|NCT01468701|529934432|FG004|Overall Study|Not eligible|22|||
146939217|NCT01468701|529934433|FG005|Overall Study|Not eligible|2|||
146939218|NCT01468701|529934434|FG006|Overall Study|Not eligible|39|||
146939219|NCT01468701|529934435|FG007|Overall Study|Not eligible|1|||
146939220|NCT01468701|529934436|FG008|Overall Study|Not eligible|40|||
146793797|NCT02460458|529418933|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
146793798|NCT02460458|529418933|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
146793799|NCT02460458|529418933|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
146793800|NCT02460458|529418933|FG000|First Prospective Phase|Lost to Follow-up|84|||
146793801|NCT02460458|529418933|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
146793802|NCT03220035|529418934|FG000|Overall Study|Adverse Event|1|||
146793803|NCT03220035|529418934|FG000|Overall Study|Protocol Violation|1|||
146793804|NCT03220035|529418934|FG000|Overall Study|Progressive Disease|2|||
146793805|NCT00696111|529418935|FG000|Overall Study|Withdrawal by Subject|17|||
146793806|NCT05299073|529418936|FG000|Overall Study|Withdrawal by Subject|0|||
146793807|NCT05299073|529418937|FG001|Overall Study|Withdrawal by Subject|0|||
146793808|NCT05299073|529418938|FG002|Overall Study|Withdrawal by Subject|1|||
146793809|NCT05299073|529418936|FG000|Overall Study|Adverse Event|0|||
146793810|NCT05299073|529418937|FG001|Overall Study|Adverse Event|1|||
146793811|NCT05299073|529418938|FG002|Overall Study|Adverse Event|0|||
146793812|NCT05299073|529418936|FG000|Overall Study|Lost to Follow-up|0|||
146793813|NCT05299073|529418937|FG001|Overall Study|Lost to Follow-up|1|||
146793814|NCT05299073|529418938|FG002|Overall Study|Lost to Follow-up|0|||
146793815|NCT05452460|529418939|FG000|Overall Study|Lost to Follow-up|3|||
146793816|NCT05452460|529418940|FG001|Overall Study|Lost to Follow-up|3|||
146793817|NCT05452460|529418939|FG000|Overall Study|Did not receive intervention|1|||
146793818|NCT05452460|529418940|FG001|Overall Study|Did not receive intervention|0|||
146793819|NCT04433208|529418941|FG000|Overall Study|Withdrawal by Subject|0|||
146793820|NCT04433208|529418942|FG001|Overall Study|Withdrawal by Subject|1|||
146793821|NCT04433208|529418943|FG002|Overall Study|Withdrawal by Subject|1|||
146793822|NCT04433208|529418944|FG003|Overall Study|Withdrawal by Subject|0|||
146793823|NCT04433208|529418945|FG004|Overall Study|Withdrawal by Subject|2|||
146793824|NCT04433208|529418946|FG005|Overall Study|Withdrawal by Subject|1|||
146793825|NCT04433208|529418941|FG000|Overall Study|Lost to Follow-up|0|||
146793826|NCT04433208|529418942|FG001|Overall Study|Lost to Follow-up|0|||
146793827|NCT04433208|529418943|FG002|Overall Study|Lost to Follow-up|0|||
146793828|NCT04433208|529418944|FG003|Overall Study|Lost to Follow-up|0|||
146793829|NCT04433208|529418945|FG004|Overall Study|Lost to Follow-up|0|||
146793830|NCT04433208|529418946|FG005|Overall Study|Lost to Follow-up|1|||
146793831|NCT03676192|529418951|FG000|Induction Study Period|Adverse Event|21|||
146793832|NCT03676192|529418952|FG001|Induction Study Period|Adverse Event|20|||
146793833|NCT03676192|529418951|FG000|Induction Study Period|Death|23|||
146793834|NCT03676192|529418952|FG001|Induction Study Period|Death|20|||
146793835|NCT03676192|529418951|FG000|Induction Study Period|Lost to Follow-up|3|||
146793836|NCT03676192|529418952|FG001|Induction Study Period|Lost to Follow-up|3|||
146939221|NCT01468701|529934437|FG009|Overall Study|Not eligible|126|||
146939222|NCT01468701|529934438|FG010|Overall Study|Not eligible|39|||
146939223|NCT01468701|529934439|FG011|Overall Study|Not eligible|33|||
146939224|NCT01468701|529934440|FG012|Overall Study|Not eligible|1|||
146793837|NCT03676192|529418951|FG000|Induction Study Period|Physician Decision|6|||
146793838|NCT03676192|529418952|FG001|Induction Study Period|Physician Decision|3|||
146793839|NCT03676192|529418951|FG000|Induction Study Period|Progressive Disease|32|||
146793840|NCT03676192|529418952|FG001|Induction Study Period|Progressive Disease|21|||
146793841|NCT03676192|529418951|FG000|Induction Study Period|Protocol Violation|1|||
146793842|NCT03676192|529418952|FG001|Induction Study Period|Protocol Violation|2|||
146793843|NCT03676192|529418951|FG000|Induction Study Period|Withdrawal by Subject|20|||
146793844|NCT03676192|529418952|FG001|Induction Study Period|Withdrawal by Subject|15|||
146793845|NCT04778397|529418954|FG000|Overall Study|Death|59|||
146793846|NCT04778397|529418955|FG001|Overall Study|Death|54|||
146793847|NCT04778397|529418956|FG002|Overall Study|Death|11|||
146793848|NCT04778397|529418957|FG003|Overall Study|Death|9|||
146793849|NCT04778397|529418954|FG000|Overall Study|Study Terminated by Sponsor|34|||
146793850|NCT04778397|529418955|FG001|Overall Study|Study Terminated by Sponsor|42|||
146793851|NCT04778397|529418956|FG002|Overall Study|Study Terminated by Sponsor|15|||
146793852|NCT04778397|529418957|FG003|Overall Study|Study Terminated by Sponsor|12|||
146793853|NCT04778397|529418954|FG000|Overall Study|Withdrew Consent|5|||
146793854|NCT04778397|529418955|FG001|Overall Study|Withdrew Consent|4|||
146793855|NCT04778397|529418956|FG002|Overall Study|Withdrew Consent|1|||
146793856|NCT04778397|529418957|FG003|Overall Study|Withdrew Consent|1|||
146793857|NCT04778397|529418954|FG000|Overall Study|Reason Not Specified|1|||
146793858|NCT04778397|529418955|FG001|Overall Study|Reason Not Specified|3|||
146793859|NCT04778397|529418956|FG002|Overall Study|Reason Not Specified|0|||
146793860|NCT04778397|529418957|FG003|Overall Study|Reason Not Specified|2|||
146793861|NCT04778397|529418954|FG000|Overall Study|Lost to Follow-up|2|||
146793862|NCT04778397|529418955|FG001|Overall Study|Lost to Follow-up|1|||
146793863|NCT04778397|529418956|FG002|Overall Study|Lost to Follow-up|0|||
146793864|NCT04778397|529418957|FG003|Overall Study|Lost to Follow-up|1|||
146793865|NCT01627574|529418959|FG000|Overall Study|Withdrawal by Subject|8|||
146793866|NCT01627574|529418960|FG001|Overall Study|Withdrawal by Subject|5|||
146793867|NCT01627574|529418959|FG000|Overall Study|Lost to Follow-up|13|||
146793868|NCT01627574|529418960|FG001|Overall Study|Lost to Follow-up|13|||
146793869|NCT03249090|529418970|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
146793870|NCT03249090|529418971|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
146793871|NCT03249090|529418970|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
146793872|NCT03249090|529418971|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
146793873|NCT03249090|529418970|FG000|3 Month Time Point|Voluntary withdrawal|6|||
146793874|NCT03249090|529418971|FG001|3 Month Time Point|Voluntary withdrawal|3|||
146793875|NCT03249090|529418970|FG000|3 Month Time Point|Changed oncology practice|4|||
146793876|NCT03249090|529418971|FG001|3 Month Time Point|Changed oncology practice|2|||
146793877|NCT03249090|529418970|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
146793878|NCT03249090|529418971|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
146793879|NCT03249090|529418970|FG000|12 Month Time Point|Voluntary withdrawal|35|||
146793880|NCT03249090|529418971|FG001|12 Month Time Point|Voluntary withdrawal|4|||
146793881|NCT03249090|529418970|FG000|12 Month Time Point|Changed oncology practice|20|||
146793882|NCT03249090|529418971|FG001|12 Month Time Point|Changed oncology practice|9|||
146793883|NCT04359654|529418974|FG000|Overall Study|Withdrawal by Subject|1|||
146793884|NCT04359654|529418975|FG001|Overall Study|Withdrawal by Subject|0|||
146793885|NCT04359654|529418974|FG000|Overall Study|Adverse Event|0|||
146793886|NCT04359654|529418975|FG001|Overall Study|Adverse Event|1|||
146793887|NCT06122194|529418976|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
146793888|NCT06122194|529418977|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
146793889|NCT06122194|529418978|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
146793890|NCT06122194|529418979|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
146793891|NCT04314778|529418980|FG000|Overall Study|Lost to Follow-up|5|||
146793892|NCT04314778|529418981|FG001|Overall Study|Lost to Follow-up|3|||
146793893|NCT05218096|529418982|FG000|Primary Evaluation|Withdrawal by Subject|0|||
146793894|NCT05218096|529418983|FG001|Primary Evaluation|Withdrawal by Subject|0|||
146793895|NCT05218096|529418984|FG002|Primary Evaluation|Withdrawal by Subject|2|||
146793896|NCT05218096|529418985|FG003|Primary Evaluation|Withdrawal by Subject|0|||
146793897|NCT05218096|529418986|FG004|Primary Evaluation|Withdrawal by Subject|0|||
146793898|NCT05218096|529418982|FG000|Primary Evaluation|Physician Decision|1|||
146793899|NCT05218096|529418983|FG001|Primary Evaluation|Physician Decision|0|||
146793900|NCT05218096|529418984|FG002|Primary Evaluation|Physician Decision|0|||
146793901|NCT05218096|529418985|FG003|Primary Evaluation|Physician Decision|0|||
146793902|NCT05218096|529418986|FG004|Primary Evaluation|Physician Decision|0|||
146939225|NCT01468701|529934441|FG013|Overall Study|Not eligible|19|||
146939226|NCT01468701|529934442|FG014|Overall Study|Not eligible|1|||
146939227|NCT01468701|529934443|FG015|Overall Study|Not eligible|32|||
146939228|NCT01468701|529934444|FG016|Overall Study|Not eligible|0|||
146939229|NCT01468701|529934428|FG000|Overall Study|Lost to Follow-up|306|||
146939230|NCT01468701|529934429|FG001|Overall Study|Lost to Follow-up|0|||
146793903|NCT05218096|529418982|FG000|Extended Treatment|Clinical Deterioration|1|||
146793904|NCT05218096|529418983|FG001|Extended Treatment|Clinical Deterioration|1|||
146793905|NCT05218096|529418984|FG002|Extended Treatment|Clinical Deterioration|0|||
146793906|NCT05218096|529418985|FG003|Extended Treatment|Clinical Deterioration|0|||
146793907|NCT05218096|529418986|FG004|Extended Treatment|Clinical Deterioration|0|||
146793908|NCT05218096|529418982|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
146793909|NCT05218096|529418983|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
146793910|NCT05218096|529418984|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
146793911|NCT05218096|529418985|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
146793912|NCT05218096|529418986|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
146793913|NCT05218096|529418982|FG000|Extended Treatment|Withdrawal by Subject|1|||
146939231|NCT01468701|529934430|FG002|Overall Study|Lost to Follow-up|0|||
146939232|NCT01468701|529934431|FG003|Overall Study|Lost to Follow-up|0|||
146939233|NCT01468701|529934432|FG004|Overall Study|Lost to Follow-up|0|||
146939234|NCT01468701|529934433|FG005|Overall Study|Lost to Follow-up|0|||
146939235|NCT01468701|529934434|FG006|Overall Study|Lost to Follow-up|0|||
146939236|NCT01468701|529934435|FG007|Overall Study|Lost to Follow-up|0|||
146939237|NCT01468701|529934436|FG008|Overall Study|Lost to Follow-up|215|||
146939238|NCT01468701|529934437|FG009|Overall Study|Lost to Follow-up|309|||
146939239|NCT01468701|529934438|FG010|Overall Study|Lost to Follow-up|224|||
146939240|NCT01468701|529934439|FG011|Overall Study|Lost to Follow-up|212|||
146939241|NCT01468701|529934440|FG012|Overall Study|Lost to Follow-up|11|||
146939242|NCT01468701|529934441|FG013|Overall Study|Lost to Follow-up|164|||
146939243|NCT01468701|529934442|FG014|Overall Study|Lost to Follow-up|17|||
146939244|NCT01468701|529934443|FG015|Overall Study|Lost to Follow-up|127|||
146939245|NCT01468701|529934444|FG016|Overall Study|Lost to Follow-up|1|||
146939246|NCT01468701|529934428|FG000|Overall Study|Withdrawal by Subject|165|||
146939247|NCT01468701|529934429|FG001|Overall Study|Withdrawal by Subject|0|||
146939248|NCT01468701|529934430|FG002|Overall Study|Withdrawal by Subject|0|||
146939249|NCT01468701|529934431|FG003|Overall Study|Withdrawal by Subject|0|||
146939250|NCT01468701|529934432|FG004|Overall Study|Withdrawal by Subject|0|||
146939251|NCT01468701|529934433|FG005|Overall Study|Withdrawal by Subject|0|||
146939252|NCT01468701|529934434|FG006|Overall Study|Withdrawal by Subject|0|||
146939253|NCT01468701|529934435|FG007|Overall Study|Withdrawal by Subject|0|||
146939254|NCT01468701|529934436|FG008|Overall Study|Withdrawal by Subject|83|||
146939255|NCT01468701|529934437|FG009|Overall Study|Withdrawal by Subject|88|||
146939256|NCT01468701|529934438|FG010|Overall Study|Withdrawal by Subject|100|||
146939257|NCT01468701|529934439|FG011|Overall Study|Withdrawal by Subject|114|||
146939258|NCT01468701|529934440|FG012|Overall Study|Withdrawal by Subject|9|||
146939259|NCT01468701|529934441|FG013|Overall Study|Withdrawal by Subject|47|||
146939260|NCT01468701|529934442|FG014|Overall Study|Withdrawal by Subject|6|||
146939261|NCT01468701|529934443|FG015|Overall Study|Withdrawal by Subject|31|||
146939262|NCT01468701|529934444|FG016|Overall Study|Withdrawal by Subject|0|||
146939263|NCT01468701|529934428|FG000|Overall Study|Other reasons than listed|437|||
146939264|NCT01468701|529934429|FG001|Overall Study|Other reasons than listed|0|||
146939265|NCT01468701|529934430|FG002|Overall Study|Other reasons than listed|0|||
146939266|NCT01468701|529934431|FG003|Overall Study|Other reasons than listed|0|||
146939267|NCT01468701|529934432|FG004|Overall Study|Other reasons than listed|0|||
146939268|NCT01468701|529934433|FG005|Overall Study|Other reasons than listed|0|||
146939269|NCT01468701|529934434|FG006|Overall Study|Other reasons than listed|0|||
146939270|NCT01468701|529934435|FG007|Overall Study|Other reasons than listed|0|||
146939271|NCT01468701|529934436|FG008|Overall Study|Other reasons than listed|318|||
146939272|NCT01468701|529934437|FG009|Overall Study|Other reasons than listed|658|||
146939273|NCT01468701|529934438|FG010|Overall Study|Other reasons than listed|433|||
146939274|NCT01468701|529934439|FG011|Overall Study|Other reasons than listed|504|||
146939275|NCT01468701|529934440|FG012|Overall Study|Other reasons than listed|28|||
146939276|NCT01468701|529934441|FG013|Overall Study|Other reasons than listed|239|||
146939277|NCT01468701|529934442|FG014|Overall Study|Other reasons than listed|39|||
146939278|NCT01468701|529934443|FG015|Overall Study|Other reasons than listed|172|||
146939279|NCT01468701|529934444|FG016|Overall Study|Other reasons than listed|0|||
146939280|NCT01468701|529934428|FG000|Overall Study|No end of study case report form|0|||
146939281|NCT01468701|529934429|FG001|Overall Study|No end of study case report form|0|||
146939282|NCT01468701|529934430|FG002|Overall Study|No end of study case report form|0|||
146939283|NCT01468701|529934431|FG003|Overall Study|No end of study case report form|0|||
146939284|NCT01468701|529934432|FG004|Overall Study|No end of study case report form|0|||
146793914|NCT05218096|529418983|FG001|Extended Treatment|Withdrawal by Subject|3|||
146793915|NCT05218096|529418984|FG002|Extended Treatment|Withdrawal by Subject|0|||
146793916|NCT05218096|529418985|FG003|Extended Treatment|Withdrawal by Subject|2|||
146793917|NCT05218096|529418986|FG004|Extended Treatment|Withdrawal by Subject|2|||
146793918|NCT05218096|529418982|FG000|Extended Treatment|Lack of Efficacy|3|||
146793919|NCT05218096|529418983|FG001|Extended Treatment|Lack of Efficacy|0|||
146793920|NCT05218096|529418984|FG002|Extended Treatment|Lack of Efficacy|0|||
146793921|NCT05218096|529418985|FG003|Extended Treatment|Lack of Efficacy|0|||
146793922|NCT05218096|529418986|FG004|Extended Treatment|Lack of Efficacy|0|||
146793923|NCT05218096|529418982|FG000|Extended Treatment|Physician Decision|0|||
146793924|NCT05218096|529418983|FG001|Extended Treatment|Physician Decision|1|||
146793925|NCT05218096|529418984|FG002|Extended Treatment|Physician Decision|0|||
146939285|NCT01468701|529934433|FG005|Overall Study|No end of study case report form|0|||
146939286|NCT01468701|529934434|FG006|Overall Study|No end of study case report form|0|||
146939287|NCT01468701|529934435|FG007|Overall Study|No end of study case report form|0|||
146939288|NCT01468701|529934436|FG008|Overall Study|No end of study case report form|4|||
146939289|NCT01468701|529934437|FG009|Overall Study|No end of study case report form|1|||
146939290|NCT01468701|529934438|FG010|Overall Study|No end of study case report form|2|||
146939291|NCT01468701|529934439|FG011|Overall Study|No end of study case report form|3|||
146939292|NCT01468701|529934440|FG012|Overall Study|No end of study case report form|0|||
146939293|NCT01468701|529934441|FG013|Overall Study|No end of study case report form|1|||
146793926|NCT05218096|529418985|FG003|Extended Treatment|Physician Decision|0|||
146793927|NCT05218096|529418986|FG004|Extended Treatment|Physician Decision|0|||
146793928|NCT05218096|529418982|FG000|Open-label Extension|Adverse Event|1|||
146939294|NCT01468701|529934442|FG014|Overall Study|No end of study case report form|0|||
146939295|NCT01468701|529934443|FG015|Overall Study|No end of study case report form|0|||
146939296|NCT01468701|529934444|FG016|Overall Study|No end of study case report form|0|||
146939297|NCT01468701|529934428|FG000|Overall Study|Not being followed up|0|||
146939298|NCT01468701|529934429|FG001|Overall Study|Not being followed up|4963|||
146939299|NCT01468701|529934430|FG002|Overall Study|Not being followed up|1755|||
146939300|NCT01468701|529934431|FG003|Overall Study|Not being followed up|703|||
146939301|NCT01468701|529934432|FG004|Overall Study|Not being followed up|1714|||
146939302|NCT01468701|529934433|FG005|Overall Study|Not being followed up|126|||
146939303|NCT01468701|529934434|FG006|Overall Study|Not being followed up|1170|||
146939304|NCT01468701|529934435|FG007|Overall Study|Not being followed up|4|||
146939305|NCT01468701|529934436|FG008|Overall Study|Not being followed up|0|||
146939306|NCT01468701|529934437|FG009|Overall Study|Not being followed up|0|||
146939307|NCT01468701|529934438|FG010|Overall Study|Not being followed up|0|||
146939308|NCT01468701|529934439|FG011|Overall Study|Not being followed up|0|||
146939309|NCT01468701|529934440|FG012|Overall Study|Not being followed up|0|||
146939310|NCT01468701|529934441|FG013|Overall Study|Not being followed up|0|||
146939311|NCT01468701|529934442|FG014|Overall Study|Not being followed up|0|||
146939312|NCT01468701|529934443|FG015|Overall Study|Not being followed up|0|||
146939313|NCT01468701|529934444|FG016|Overall Study|Not being followed up|0|||
146939314|NCT01068717|529934445|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
146939315|NCT01068717|529934446|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
146939316|NCT01068717|529934447|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
146939317|NCT01068717|529934448|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
146939318|NCT02679781|529934449|FG000|Overall Study|Lost to Follow-up|1|||
146939319|NCT02679781|529934450|FG001|Overall Study|Lost to Follow-up|2|||
146939320|NCT02679781|529934449|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
146939321|NCT02679781|529934450|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
146939322|NCT01822223|529934453|FG000|Overall Study|Death|0|||
146939323|NCT01822223|529934454|FG001|Overall Study|Death|1|||
146939324|NCT04209400|529934455|FG000|Overall Study|Withdrawal by Subject|0|||
146939325|NCT04209400|529934456|FG001|Overall Study|Withdrawal by Subject|1|||
146939326|NCT05200455|529934457|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
146939327|NCT01602549|529934460|FG000|Overall Study|Protocol Violation|0|||
146939328|NCT01602549|529934461|FG001|Overall Study|Protocol Violation|1|||
146939329|NCT01602549|529934460|FG000|Overall Study|Withdrawal by Subject|1|||
146939330|NCT01602549|529934461|FG001|Overall Study|Withdrawal by Subject|0|||
146939331|NCT00807014|529934462|FG000|Overall Study|Participant Considered Disease Cured|13|||
146939332|NCT00807014|529934463|FG001|Overall Study|Participant Considered Disease Cured|2|||
146939333|NCT00807014|529934462|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
146939334|NCT00807014|529934463|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
146939335|NCT00807014|529934462|FG000|Overall Study|Protocol Violation|2|||
146939336|NCT00807014|529934463|FG001|Overall Study|Protocol Violation|8|||
146939337|NCT00807014|529934462|FG000|Overall Study|Adverse Event|0|||
146939338|NCT00807014|529934463|FG001|Overall Study|Adverse Event|2|||
146939339|NCT00807014|529934462|FG000|Overall Study|Lost to Follow-up|9|||
146939340|NCT00807014|529934463|FG001|Overall Study|Lost to Follow-up|7|||
146939341|NCT00807014|529934462|FG000|Overall Study|Recovery|1|||
146939342|NCT00807014|529934463|FG001|Overall Study|Recovery|0|||
146939343|NCT00807014|529934462|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
146939344|NCT00807014|529934463|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
146939345|NCT03700736|529934466|FG000|Overall Study|Pregnancy|1|||
146939346|NCT03700736|529934467|FG001|Overall Study|Pregnancy|1|||
146939347|NCT03700736|529934466|FG000|Overall Study|Withdrawal by Subject|2|||
146939348|NCT03700736|529934467|FG001|Overall Study|Withdrawal by Subject|6|||
146939349|NCT03682055|529936916|FG000|Overall Study|Lack of Efficacy|1|||
146939350|NCT03682055|529936917|FG001|Overall Study|Lack of Efficacy|2|||
146939351|NCT03682055|529936918|FG002|Overall Study|Lack of Efficacy|1|||
146939352|NCT03682055|529936919|FG003|Overall Study|Lack of Efficacy|2|||
146939353|NCT03682055|529936920|FG004|Overall Study|Lack of Efficacy|1|||
146939354|NCT03682055|529936921|FG005|Overall Study|Lack of Efficacy|3|||
146939355|NCT03682055|529936916|FG000|Overall Study|Withdrawal by Subject|0|||
146939356|NCT03682055|529936917|FG001|Overall Study|Withdrawal by Subject|0|||
146939357|NCT03682055|529936918|FG002|Overall Study|Withdrawal by Subject|0|||
146939358|NCT03682055|529936919|FG003|Overall Study|Withdrawal by Subject|0|||
146939359|NCT03682055|529936920|FG004|Overall Study|Withdrawal by Subject|0|||
146939360|NCT03682055|529936921|FG005|Overall Study|Withdrawal by Subject|1|||
146939361|NCT03682055|529936916|FG000|Overall Study|Termination of Study by Sponsor|0|||
146939362|NCT03682055|529936917|FG001|Overall Study|Termination of Study by Sponsor|0|||
146793929|NCT05218096|529418983|FG001|Open-label Extension|Adverse Event|0|||
146939363|NCT03682055|529936918|FG002|Overall Study|Termination of Study by Sponsor|0|||
146939364|NCT03682055|529936919|FG003|Overall Study|Termination of Study by Sponsor|0|||
146939365|NCT03682055|529936920|FG004|Overall Study|Termination of Study by Sponsor|0|||
146939366|NCT03682055|529936921|FG005|Overall Study|Termination of Study by Sponsor|3|||
146939367|NCT01826448|529936922|FG000|Overall Study|Adverse Event|1|||
146939368|NCT01826448|529936923|FG001|Overall Study|Adverse Event|3|||
146793930|NCT05218096|529418984|FG002|Open-label Extension|Adverse Event|0|||
146793931|NCT05218096|529418985|FG003|Open-label Extension|Adverse Event|0|||
146793932|NCT05218096|529418986|FG004|Open-label Extension|Adverse Event|1|||
146793933|NCT05218096|529418982|FG000|Open-label Extension|Pregnancy|0|||
146793934|NCT05218096|529418983|FG001|Open-label Extension|Pregnancy|0|||
146793935|NCT05218096|529418984|FG002|Open-label Extension|Pregnancy|0|||
146793936|NCT05218096|529418985|FG003|Open-label Extension|Pregnancy|0|||
146793937|NCT05218096|529418986|FG004|Open-label Extension|Pregnancy|1|||
146793938|NCT05218096|529418982|FG000|Open-label Extension|Lack of Efficacy|1|||
146793939|NCT05218096|529418983|FG001|Open-label Extension|Lack of Efficacy|2|||
146793940|NCT05218096|529418984|FG002|Open-label Extension|Lack of Efficacy|0|||
146793941|NCT05218096|529418985|FG003|Open-label Extension|Lack of Efficacy|0|||
146793942|NCT05218096|529418986|FG004|Open-label Extension|Lack of Efficacy|0|||
146793943|NCT05218096|529418982|FG000|Open-label Extension|Lost to Follow-up|1|||
146793944|NCT05218096|529418983|FG001|Open-label Extension|Lost to Follow-up|0|||
146793945|NCT05218096|529418984|FG002|Open-label Extension|Lost to Follow-up|0|||
146793946|NCT05218096|529418985|FG003|Open-label Extension|Lost to Follow-up|0|||
146793947|NCT05218096|529418986|FG004|Open-label Extension|Lost to Follow-up|0|||
146793948|NCT05218096|529418982|FG000|Open-label Extension|Death|0|||
146793949|NCT05218096|529418983|FG001|Open-label Extension|Death|0|||
146793950|NCT05218096|529418984|FG002|Open-label Extension|Death|0|||
146793951|NCT05218096|529418985|FG003|Open-label Extension|Death|1|||
146793952|NCT05218096|529418986|FG004|Open-label Extension|Death|0|||
146793953|NCT05218096|529418982|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
146793954|NCT05218096|529418983|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
146793955|NCT05218096|529418984|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
146793956|NCT05218096|529418985|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
146793957|NCT05218096|529418986|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
146793958|NCT05863156|529418988|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
146793959|NCT05863156|529418989|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
146793960|NCT05863156|529418990|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
146793961|NCT03655028|529418993|FG000|12-weeks Follow up|Death|1|||
146793962|NCT03655028|529418994|FG001|12-weeks Follow up|Death|0|||
146793963|NCT03655028|529418993|FG000|12-weeks Follow up|Physician Decision|3|||
146793964|NCT03655028|529418994|FG001|12-weeks Follow up|Physician Decision|3|||
146793965|NCT03655028|529418993|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
146793966|NCT03655028|529418994|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
146793967|NCT03655028|529418993|FG000|12-weeks Follow up|Lost to Follow-up|4|||
146793968|NCT03655028|529418994|FG001|12-weeks Follow up|Lost to Follow-up|4|||
146793969|NCT03655028|529418993|FG000|24-weeks|Lost to Follow-up|1|||
146793970|NCT03655028|529418994|FG001|24-weeks|Lost to Follow-up|1|||
146793971|NCT03655028|529418993|FG000|24-weeks|Death|0|||
146793972|NCT03655028|529418994|FG001|24-weeks|Death|1|||
146793973|NCT03513302|529418995|FG000|First Intervention (14 Days)|Screen failure|15|||
146793974|NCT03513302|529418996|FG001|First Intervention (14 Days)|Screen failure|16|||
146793975|NCT05256654|529418997|FG000|Overall Study|Adverse Event|0|||
146793976|NCT05256654|529418998|FG001|Overall Study|Adverse Event|0|||
146793977|NCT05256654|529418999|FG002|Overall Study|Adverse Event|1|||
146793978|NCT05256654|529419000|FG003|Overall Study|Adverse Event|0|||
146793979|NCT05256654|529418997|FG000|Overall Study|Lost to Follow-up|0|||
146793980|NCT05256654|529418998|FG001|Overall Study|Lost to Follow-up|0|||
146793981|NCT05256654|529418999|FG002|Overall Study|Lost to Follow-up|0|||
146793982|NCT05256654|529419000|FG003|Overall Study|Lost to Follow-up|1|||
146793983|NCT05256654|529418997|FG000|Overall Study|Withdrawal by Subject|1|||
146793984|NCT05256654|529418998|FG001|Overall Study|Withdrawal by Subject|2|||
146793985|NCT05256654|529418999|FG002|Overall Study|Withdrawal by Subject|1|||
146793986|NCT05256654|529419000|FG003|Overall Study|Withdrawal by Subject|3|||
146793987|NCT05256654|529418997|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
146939369|NCT01826448|529936922|FG000|Overall Study|Disease progression|2|||
146793988|NCT05256654|529418998|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
146793989|NCT05256654|529418999|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
146793990|NCT05256654|529419000|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
146793991|NCT05256654|529418997|FG000|Overall Study|Other|0|||
146939370|NCT01826448|529936923|FG001|Overall Study|Disease progression|4|||
146939371|NCT01826448|529936922|FG000|Overall Study|Withdrawal by Subject|1|||
146793992|NCT05256654|529418998|FG001|Overall Study|Other|0|||
146793993|NCT05256654|529418999|FG002|Overall Study|Other|0|||
146793994|NCT05256654|529419000|FG003|Overall Study|Other|1|||
146939372|NCT01826448|529936923|FG001|Overall Study|Withdrawal by Subject|0|||
146939373|NCT01826448|529936922|FG000|Overall Study|Physician Decision|0|||
146939374|NCT01826448|529936923|FG001|Overall Study|Physician Decision|1|||
146939375|NCT01826448|529936922|FG000|Overall Study|2 active cancers|0|||
146939376|NCT01826448|529936923|FG001|Overall Study|2 active cancers|1|||
146939377|NCT00880100|529936924|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
146939378|NCT00880100|529936924|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
146939379|NCT00880100|529936924|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
146939380|NCT00402285|529936926|FG000|Overall Study|insufficient RNA quality|7|||
146939381|NCT00402285|529936927|FG001|Overall Study|insufficient RNA quality|6|||
146939382|NCT00402285|529936928|FG002|Overall Study|insufficient RNA quality|2|||
146939383|NCT02431702|529936929|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
146939384|NCT02431702|529936930|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
146939385|NCT02431702|529936931|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
146939386|NCT02431702|529936932|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
146939387|NCT02431702|529936933|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
146939388|NCT02431702|529936934|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
146939389|NCT02431702|529936935|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
146939390|NCT02431702|529936929|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
146939391|NCT02431702|529936930|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
146939392|NCT02431702|529936931|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
146939393|NCT02431702|529936932|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
146939394|NCT02431702|529936933|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
146939395|NCT02431702|529936934|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
146939396|NCT02431702|529936935|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
146939397|NCT02431702|529936929|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
146939398|NCT02431702|529936930|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
146939399|NCT02431702|529936931|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
146939400|NCT02431702|529936932|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
146939401|NCT02431702|529936933|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
146939402|NCT02431702|529936934|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
146939403|NCT02431702|529936935|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
146939404|NCT02431702|529936929|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
146939405|NCT02431702|529936930|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
146939406|NCT02431702|529936931|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
146939407|NCT02431702|529936932|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
146939408|NCT02431702|529936933|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
146939409|NCT02431702|529936934|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
146939410|NCT02431702|529936935|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
146939411|NCT02431702|529936929|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
146939412|NCT02431702|529936930|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
146939413|NCT02431702|529936931|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
146939414|NCT02431702|529936932|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
146939415|NCT02431702|529936933|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
146939416|NCT02431702|529936934|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
146939417|NCT02431702|529936935|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
146939418|NCT02431702|529936929|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
146939419|NCT02431702|529936930|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
146939420|NCT02431702|529936931|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
146939421|NCT02431702|529936932|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
146939422|NCT02431702|529936933|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
146939423|NCT02431702|529936934|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
146939424|NCT02431702|529936935|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
146939425|NCT02431702|529936929|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
146939426|NCT02431702|529936930|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
146939427|NCT02431702|529936931|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
146939428|NCT02431702|529936932|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
146939429|NCT02431702|529936933|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
146939430|NCT02431702|529936934|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
146939431|NCT02431702|529936935|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
146939432|NCT02431702|529936929|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
146939433|NCT02431702|529936930|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
146939434|NCT02431702|529936931|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
146939435|NCT02431702|529936932|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
146982515|NCT03567057|530097981|FG000|Overall Study|Non-compliance with study drug|4|||
146982516|NCT03567057|530097982|FG001|Overall Study|Non-compliance with study drug|2|||
146982517|NCT03567057|530097983|FG002|Overall Study|Non-compliance with study drug|0|||
146982518|NCT03567057|530097981|FG000|Overall Study|Lack of Efficacy|3|||
146982519|NCT03567057|530097982|FG001|Overall Study|Lack of Efficacy|0|||
146982520|NCT03567057|530097983|FG002|Overall Study|Lack of Efficacy|1|||
146793995|NCT04862416|529419009|FG000|Overall Study|Withdrawal by Subject|0|||
146793996|NCT04862416|529419010|FG001|Overall Study|Withdrawal by Subject|1|||
146793997|NCT04862416|529419011|FG002|Overall Study|Withdrawal by Subject|0|||
146793998|NCT04862416|529419012|FG003|Overall Study|Withdrawal by Subject|1|||
146793999|NCT04862416|529419013|FG004|Overall Study|Withdrawal by Subject|0|||
146794000|NCT04862416|529419014|FG005|Overall Study|Withdrawal by Subject|0|||
146794001|NCT04862416|529419015|FG006|Overall Study|Withdrawal by Subject|0|||
146794002|NCT04862416|529419016|FG007|Overall Study|Withdrawal by Subject|0|||
146794003|NCT03852550|529419017|FG000|Overall Study|Lost to Follow-up|4|||
146794004|NCT03852550|529419018|FG001|Overall Study|Lost to Follow-up|3|||
146794005|NCT03852550|529419017|FG000|Overall Study|Only parent outcomes completed|0|||
146794006|NCT03852550|529419018|FG001|Overall Study|Only parent outcomes completed|1|||
146794007|NCT03852550|529419017|FG000|Overall Study|Withdrawal by Subject|1|||
146794008|NCT03852550|529419018|FG001|Overall Study|Withdrawal by Subject|0|||
146794009|NCT04295512|529419021|FG000|Overall Study|Lack of family response to schedule assessment|0|||
146794010|NCT04295512|529419022|FG001|Overall Study|Lack of family response to schedule assessment|0|||
146794011|NCT04295512|529419023|FG002|Overall Study|Lack of family response to schedule assessment|0|||
146794012|NCT04295512|529419024|FG003|Overall Study|Lack of family response to schedule assessment|2|||
146794013|NCT04295512|529419021|FG000|Overall Study|Therapist did not refer eligible family|7|||
146794014|NCT04295512|529419022|FG001|Overall Study|Therapist did not refer eligible family|7|||
146794015|NCT04295512|529419023|FG002|Overall Study|Therapist did not refer eligible family|0|||
146794016|NCT04295512|529419024|FG003|Overall Study|Therapist did not refer eligible family|0|||
146794017|NCT01009788|529419035|FG000|Overall Study|Withdrawal by Subject|1|||
146794018|NCT01009788|529419036|FG001|Overall Study|Withdrawal by Subject|0|||
146794019|NCT01309672|529419038|FG000|Overall Study|Lack of Efficacy|20|||
146794020|NCT01309672|529419038|FG000|Overall Study|Other|9|||
146794021|NCT01309672|529419038|FG000|Overall Study|Adverse Event|5|||
146794022|NCT01309672|529419038|FG000|Overall Study|Withdrawal by Subject|3|||
146794023|NCT01254864|529419041|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
146794024|NCT01254864|529419042|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
146794025|NCT01254864|529419043|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
146794026|NCT01254864|529419041|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
146794027|NCT01254864|529419042|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
146794028|NCT01254864|529419043|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
146794029|NCT01254864|529419041|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
146794030|NCT01254864|529419042|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
146794031|NCT01254864|529419043|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
146794032|NCT01254864|529419041|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
146794033|NCT01254864|529419042|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
146794034|NCT01254864|529419043|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
146794035|NCT01254864|529419041|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
146794036|NCT01254864|529419042|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
146794037|NCT01254864|529419043|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
146794038|NCT01254864|529419041|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
146794039|NCT01254864|529419042|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
146794040|NCT01254864|529419043|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
146794041|NCT01254864|529419041|FG000|Randomization Phase|Adverse Event|0|||
146794042|NCT01254864|529419042|FG001|Randomization Phase|Adverse Event|5|||
146794043|NCT01254864|529419043|FG002|Randomization Phase|Adverse Event|17|||
146794044|NCT01254864|529419041|FG000|Randomization Phase|Death|0|||
146794045|NCT01254864|529419042|FG001|Randomization Phase|Death|1|||
146794046|NCT01254864|529419043|FG002|Randomization Phase|Death|0|||
146794047|NCT01254864|529419041|FG000|Randomization Phase|Lost to Follow-up|0|||
146794048|NCT01254864|529419042|FG001|Randomization Phase|Lost to Follow-up|0|||
146794049|NCT01254864|529419043|FG002|Randomization Phase|Lost to Follow-up|1|||
146794050|NCT01254864|529419041|FG000|Randomization Phase|Physician Decision|0|||
146794051|NCT01254864|529419042|FG001|Randomization Phase|Physician Decision|20|||
146794052|NCT01254864|529419043|FG002|Randomization Phase|Physician Decision|25|||
146794053|NCT01254864|529419041|FG000|Randomization Phase|Withdrawal by Subject|0|||
146982521|NCT03567057|530097981|FG000|Overall Study|Death|1|||
146794054|NCT01254864|529419042|FG001|Randomization Phase|Withdrawal by Subject|4|||
146794055|NCT01254864|529419043|FG002|Randomization Phase|Withdrawal by Subject|2|||
146794056|NCT01254864|529419041|FG000|Randomization Phase|Non-Compliance|0|||
146794057|NCT01254864|529419042|FG001|Randomization Phase|Non-Compliance|1|||
146794058|NCT01254864|529419043|FG002|Randomization Phase|Non-Compliance|0|||
146794059|NCT01254864|529419041|FG000|Randomization Phase|Comorbidities|0|||
146794060|NCT01254864|529419042|FG001|Randomization Phase|Comorbidities|2|||
146982522|NCT03567057|530097982|FG001|Overall Study|Death|0|||
146982523|NCT03567057|530097983|FG002|Overall Study|Death|0|||
146794061|NCT01254864|529419043|FG002|Randomization Phase|Comorbidities|1|||
146794062|NCT04141891|529419045|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
146794063|NCT04141891|529419046|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
146794064|NCT04141891|529419045|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
146794065|NCT04141891|529419046|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
146794066|NCT04141891|529419045|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
146794067|NCT04141891|529419046|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
146794068|NCT04141891|529419045|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
146794069|NCT04141891|529419046|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
146794070|NCT04141891|529419045|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
146794071|NCT04141891|529419046|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
146794072|NCT04141891|529419045|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
146794073|NCT04141891|529419046|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
146794074|NCT04141891|529419045|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
146794075|NCT04141891|529419046|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
146794076|NCT04141891|529419045|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
146794077|NCT04141891|529419046|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
146794078|NCT04141891|529419045|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
146794079|NCT04141891|529419046|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
146794080|NCT04141891|529419045|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
146794081|NCT04141891|529419046|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
146794082|NCT04141891|529419045|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
146794083|NCT04141891|529419046|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
146794084|NCT04141891|529419045|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
146794085|NCT04141891|529419046|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
146794086|NCT04141891|529419045|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
146794087|NCT04141891|529419046|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
146794088|NCT04141891|529419045|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
146794089|NCT04141891|529419046|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
146794090|NCT03626220|529419047|FG000|Overall Study|Withdrawal by Subject|2|||
146794091|NCT03626220|529419048|FG001|Overall Study|Withdrawal by Subject|0|||
146794092|NCT04625725|529419049|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
146794093|NCT04625725|529419050|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
146794094|NCT04625725|529419051|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
146794095|NCT04625725|529419052|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
146794096|NCT04625725|529419053|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
146794097|NCT04625725|529419054|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
146794098|NCT04625725|529419049|FG000|Provent Main Study|Withdrawal by Subject|242|||
146794099|NCT04625725|529419050|FG001|Provent Main Study|Withdrawal by Subject|144|||
146794100|NCT04625725|529419051|FG002|Provent Main Study|Withdrawal by Subject|0|||
146794101|NCT04625725|529419052|FG003|Provent Main Study|Withdrawal by Subject|0|||
146794102|NCT04625725|529419053|FG004|Provent Main Study|Withdrawal by Subject|0|||
146794103|NCT04625725|529419054|FG005|Provent Main Study|Withdrawal by Subject|0|||
146794104|NCT04625725|529419049|FG000|Provent Main Study|Physician Decision|5|||
146794105|NCT04625725|529419050|FG001|Provent Main Study|Physician Decision|0|||
146794106|NCT04625725|529419051|FG002|Provent Main Study|Physician Decision|0|||
146794107|NCT04625725|529419052|FG003|Provent Main Study|Physician Decision|0|||
146794108|NCT04625725|529419053|FG004|Provent Main Study|Physician Decision|0|||
146794109|NCT04625725|529419054|FG005|Provent Main Study|Physician Decision|0|||
146794110|NCT04625725|529419049|FG000|Provent Main Study|Protocol Violation|1|||
146794111|NCT04625725|529419050|FG001|Provent Main Study|Protocol Violation|0|||
146794112|NCT04625725|529419051|FG002|Provent Main Study|Protocol Violation|0|||
146794113|NCT04625725|529419052|FG003|Provent Main Study|Protocol Violation|0|||
146794114|NCT04625725|529419053|FG004|Provent Main Study|Protocol Violation|0|||
146794115|NCT04625725|529419054|FG005|Provent Main Study|Protocol Violation|0|||
146794116|NCT04625725|529419049|FG000|Provent Main Study|Lost to Follow-up|357|||
146794117|NCT04625725|529419050|FG001|Provent Main Study|Lost to Follow-up|200|||
146794118|NCT04625725|529419051|FG002|Provent Main Study|Lost to Follow-up|0|||
146794119|NCT04625725|529419052|FG003|Provent Main Study|Lost to Follow-up|0|||
146794120|NCT04625725|529419053|FG004|Provent Main Study|Lost to Follow-up|0|||
146794121|NCT04625725|529419054|FG005|Provent Main Study|Lost to Follow-up|0|||
146794122|NCT04625725|529419049|FG000|Provent Main Study|Death|22|||
146794123|NCT04625725|529419050|FG001|Provent Main Study|Death|10|||
146794124|NCT04625725|529419051|FG002|Provent Main Study|Death|0|||
146939436|NCT02431702|529936933|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
146939437|NCT02431702|529936934|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
146939438|NCT02431702|529936935|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
146982524|NCT03567057|530097981|FG000|Overall Study|Physician Decision|1|||
146794125|NCT04625725|529419052|FG003|Provent Main Study|Death|0|||
146794126|NCT04625725|529419053|FG004|Provent Main Study|Death|0|||
146939439|NCT02431702|529936929|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
146939440|NCT02431702|529936930|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
146939441|NCT02431702|529936931|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
146939442|NCT02431702|529936932|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
146939443|NCT02431702|529936933|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
146939444|NCT02431702|529936934|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
146939445|NCT02431702|529936935|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
146982525|NCT03567057|530097982|FG001|Overall Study|Physician Decision|0|||
146794127|NCT04625725|529419054|FG005|Provent Main Study|Death|0|||
146794128|NCT04625725|529419049|FG000|Provent Main Study|Adverse Event|2|||
146794129|NCT04625725|529419050|FG001|Provent Main Study|Adverse Event|1|||
146794130|NCT04625725|529419051|FG002|Provent Main Study|Adverse Event|0|||
146794131|NCT04625725|529419052|FG003|Provent Main Study|Adverse Event|0|||
146794132|NCT04625725|529419053|FG004|Provent Main Study|Adverse Event|0|||
146794133|NCT04625725|529419054|FG005|Provent Main Study|Adverse Event|0|||
146794134|NCT04625725|529419049|FG000|Provent Main Study|Participants dosed in sub-study|310|||
146794135|NCT04625725|529419050|FG001|Provent Main Study|Participants dosed in sub-study|193|||
146794136|NCT04625725|529419051|FG002|Provent Main Study|Participants dosed in sub-study|0|||
146794137|NCT04625725|529419052|FG003|Provent Main Study|Participants dosed in sub-study|0|||
146794138|NCT04625725|529419053|FG004|Provent Main Study|Participants dosed in sub-study|0|||
146794139|NCT04625725|529419054|FG005|Provent Main Study|Participants dosed in sub-study|0|||
146794140|NCT04625725|529419049|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
146794141|NCT04625725|529419050|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
146794142|NCT04625725|529419051|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
146794143|NCT04625725|529419052|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
146794144|NCT04625725|529419053|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
146794145|NCT04625725|529419054|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
146794146|NCT04625725|529419049|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
146794147|NCT04625725|529419050|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
146794148|NCT04625725|529419051|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
146794149|NCT04625725|529419052|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
146794150|NCT04625725|529419053|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
146794151|NCT04625725|529419054|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
146794152|NCT04625725|529419049|FG000|Provent Main Study|INCARCERATION|3|||
146794153|NCT04625725|529419050|FG001|Provent Main Study|INCARCERATION|0|||
146794154|NCT04625725|529419051|FG002|Provent Main Study|INCARCERATION|0|||
146794155|NCT04625725|529419052|FG003|Provent Main Study|INCARCERATION|0|||
146794156|NCT04625725|529419053|FG004|Provent Main Study|INCARCERATION|0|||
146794157|NCT04625725|529419054|FG005|Provent Main Study|INCARCERATION|0|||
146794158|NCT04625725|529419049|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
146794159|NCT04625725|529419050|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
146794160|NCT04625725|529419051|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
146794161|NCT04625725|529419052|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
146794162|NCT04625725|529419053|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
146794163|NCT04625725|529419054|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
146794164|NCT04625725|529419049|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
146794165|NCT04625725|529419050|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
146794166|NCT04625725|529419051|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
146794167|NCT04625725|529419052|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
146794168|NCT04625725|529419053|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
146794169|NCT04625725|529419054|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
146794170|NCT04625725|529419049|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
146794171|NCT04625725|529419050|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
146794172|NCT04625725|529419051|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
146794173|NCT04625725|529419052|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
146794174|NCT04625725|529419053|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
146794175|NCT04625725|529419054|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
146794176|NCT04625725|529419049|FG000|Provent Main Study|MISSING REASON|0|||
146794177|NCT04625725|529419050|FG001|Provent Main Study|MISSING REASON|1|||
146794178|NCT04625725|529419051|FG002|Provent Main Study|MISSING REASON|0|||
146794179|NCT04625725|529419052|FG003|Provent Main Study|MISSING REASON|0|||
146794180|NCT04625725|529419053|FG004|Provent Main Study|MISSING REASON|0|||
146794181|NCT04625725|529419054|FG005|Provent Main Study|MISSING REASON|0|||
146982526|NCT03567057|530097983|FG002|Overall Study|Physician Decision|0|||
146982527|NCT03567057|530097981|FG000|Overall Study|Unstable medical condition|1|||
146794182|NCT04625725|529419049|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
146794183|NCT04625725|529419050|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
146794184|NCT04625725|529419051|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
146794185|NCT04625725|529419052|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
146794186|NCT04625725|529419053|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
146939446|NCT02431702|529936929|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
146939447|NCT02431702|529936930|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
146794187|NCT04625725|529419054|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
146794188|NCT04625725|529419049|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
146794189|NCT04625725|529419050|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
146794190|NCT04625725|529419051|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
146794191|NCT04625725|529419052|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
146794192|NCT04625725|529419053|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
146794193|NCT04625725|529419054|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
146794194|NCT04625725|529419049|FG000|Provent Sub Study|Lost to Follow-up|0|||
146794195|NCT04625725|529419050|FG001|Provent Sub Study|Lost to Follow-up|0|||
146794196|NCT04625725|529419051|FG002|Provent Sub Study|Lost to Follow-up|20|||
146794197|NCT04625725|529419052|FG003|Provent Sub Study|Lost to Follow-up|10|||
146794198|NCT04625725|529419053|FG004|Provent Sub Study|Lost to Follow-up|6|||
146794199|NCT04625725|529419054|FG005|Provent Sub Study|Lost to Follow-up|4|||
146794200|NCT04625725|529419049|FG000|Provent Sub Study|Death|0|||
146794201|NCT04625725|529419050|FG001|Provent Sub Study|Death|0|||
146794202|NCT04625725|529419051|FG002|Provent Sub Study|Death|8|||
146794203|NCT04625725|529419052|FG003|Provent Sub Study|Death|5|||
146794204|NCT04625725|529419053|FG004|Provent Sub Study|Death|0|||
146794205|NCT04625725|529419054|FG005|Provent Sub Study|Death|1|||
146794206|NCT04625725|529419049|FG000|Provent Sub Study|Adverse Event|0|||
146794207|NCT04625725|529419050|FG001|Provent Sub Study|Adverse Event|0|||
146794208|NCT04625725|529419051|FG002|Provent Sub Study|Adverse Event|0|||
146794209|NCT04625725|529419052|FG003|Provent Sub Study|Adverse Event|0|||
146794210|NCT04625725|529419053|FG004|Provent Sub Study|Adverse Event|0|||
146794211|NCT04625725|529419054|FG005|Provent Sub Study|Adverse Event|1|||
146794212|NCT04625725|529419049|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
146794213|NCT04625725|529419050|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
146794214|NCT04625725|529419051|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
146794215|NCT04625725|529419052|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
146794216|NCT04625725|529419053|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
146794217|NCT04625725|529419054|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
146794218|NCT04625725|529419049|FG000|Provent Sub Study|Withdrawal by Subject|0|||
146794219|NCT04625725|529419050|FG001|Provent Sub Study|Withdrawal by Subject|0|||
146794220|NCT04625725|529419051|FG002|Provent Sub Study|Withdrawal by Subject|11|||
146794221|NCT04625725|529419052|FG003|Provent Sub Study|Withdrawal by Subject|13|||
146794222|NCT04625725|529419053|FG004|Provent Sub Study|Withdrawal by Subject|5|||
146794223|NCT04625725|529419054|FG005|Provent Sub Study|Withdrawal by Subject|6|||
146794224|NCT04625725|529419049|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
146794225|NCT04625725|529419050|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
146794226|NCT04625725|529419051|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
146794227|NCT04625725|529419052|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
146794228|NCT04625725|529419053|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
146794229|NCT04625725|529419054|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
146794230|NCT05565820|529419062|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
146794231|NCT05565820|529419063|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
146794232|NCT05565820|529419062|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
146794233|NCT05565820|529419063|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
146794234|NCT03556293|529419066|FG000|Overall Study|Ineligible for analysis|1904|||
146794235|NCT03556293|529419067|FG001|Overall Study|Ineligible for analysis|1471|||
146794236|NCT03556293|529419068|FG002|Overall Study|Ineligible for analysis|1091|||
146794237|NCT03556293|529419069|FG003|Overall Study|Ineligible for analysis|1269|||
146794238|NCT05104463|529419070|FG000|Overall Study|Adverse Event|1|||
146794239|NCT05104463|529419071|FG001|Overall Study|Adverse Event|1|||
146794240|NCT05104463|529419070|FG000|Overall Study|Lost to Follow-up|1|||
146794241|NCT05104463|529419071|FG001|Overall Study|Lost to Follow-up|1|||
146794242|NCT05104463|529419070|FG000|Overall Study|Physician Decision|1|||
146794243|NCT05104463|529419071|FG001|Overall Study|Physician Decision|0|||
146939448|NCT02431702|529936931|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
146939449|NCT02431702|529936932|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
146939450|NCT02431702|529936933|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
146939451|NCT02431702|529936934|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
146939452|NCT02431702|529936935|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
146794244|NCT05104463|529419070|FG000|Overall Study|Protocol Violation|0|||
146794245|NCT05104463|529419071|FG001|Overall Study|Protocol Violation|2|||
146794246|NCT05104463|529419070|FG000|Overall Study|Withdrawal by Subject|1|||
146794247|NCT05104463|529419071|FG001|Overall Study|Withdrawal by Subject|1|||
146794248|NCT04132518|529419076|FG000|Overall Study|Prematurely withdrawn from the study|0|||
146794249|NCT04132518|529419077|FG001|Overall Study|Prematurely withdrawn from the study|9|||
146794250|NCT04132518|529419078|FG002|Overall Study|Prematurely withdrawn from the study|1|||
146794251|NCT05425420|529419080|FG000|Overall Study|Physician Decision|1|||
146794252|NCT05425420|529419080|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
146794253|NCT04056611|529419081|FG000|Overall Study|Physician Decision|1|||
146794254|NCT02631746|529419084|FG000|Overall Study|Lack of Efficacy|3|||
146794255|NCT04183283|529420907|FG000|Period 1|Withdrawal by Subject|0|||
146794256|NCT04183283|529420908|FG001|Period 1|Withdrawal by Subject|1|||
146794257|NCT04183283|529420909|FG002|Period 1|Withdrawal by Subject|0|||
146794258|NCT04183283|529420910|FG003|Period 1|Withdrawal by Subject|0|||
146794259|NCT04183283|529420907|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
146794260|NCT04183283|529420908|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
146794261|NCT04183283|529420909|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
146794262|NCT04183283|529420910|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
146794263|NCT03386578|529420911|FG000|PK Component|Lost to Follow-up|0|||
146794264|NCT03386578|529420912|FG001|PK Component|Lost to Follow-up|1|||
146794265|NCT03386578|529420913|FG002|PK Component|Lost to Follow-up|0|||
146794266|NCT03386578|529420914|FG003|PK Component|Lost to Follow-up|0|||
146794267|NCT03386578|529420915|FG004|PK Component|Lost to Follow-up|0|||
146794268|NCT03386578|529420916|FG005|PK Component|Lost to Follow-up|0|||
146794269|NCT03386578|529420917|FG006|PK Component|Lost to Follow-up|1|||
146794270|NCT03386578|529420918|FG007|PK Component|Lost to Follow-up|0|||
146794271|NCT03386578|529420919|FG008|PK Component|Lost to Follow-up|0|||
146794272|NCT03386578|529420920|FG009|PK Component|Lost to Follow-up|0|||
146794273|NCT03386578|529420911|FG000|PK Component|Stillbirth/Abortion|0|||
146794274|NCT03386578|529420912|FG001|PK Component|Stillbirth/Abortion|0|||
146794275|NCT03386578|529420913|FG002|PK Component|Stillbirth/Abortion|0|||
146794276|NCT03386578|529420914|FG003|PK Component|Stillbirth/Abortion|0|||
146794277|NCT03386578|529420915|FG004|PK Component|Stillbirth/Abortion|0|||
146794278|NCT03386578|529420916|FG005|PK Component|Stillbirth/Abortion|2|||
146794279|NCT03386578|529420917|FG006|PK Component|Stillbirth/Abortion|0|||
146794280|NCT03386578|529420918|FG007|PK Component|Stillbirth/Abortion|0|||
146794281|NCT03386578|529420919|FG008|PK Component|Stillbirth/Abortion|0|||
146794282|NCT03386578|529420920|FG009|PK Component|Stillbirth/Abortion|0|||
146794283|NCT03386578|529420911|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
146794284|NCT03386578|529420912|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
146794285|NCT03386578|529420913|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
146794286|NCT03386578|529420914|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
146794287|NCT03386578|529420915|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
146794288|NCT03386578|529420916|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
146794289|NCT03386578|529420917|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
146794290|NCT03386578|529420918|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
146794291|NCT03386578|529420919|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
146794292|NCT03386578|529420920|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
146794293|NCT03386578|529420911|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
146794294|NCT03386578|529420912|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
146794295|NCT03386578|529420913|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
146794296|NCT03386578|529420914|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
146794297|NCT03386578|529420915|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
146794298|NCT03386578|529420916|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
146794299|NCT03386578|529420917|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
146794300|NCT03386578|529420918|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
146794301|NCT03386578|529420919|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
146794302|NCT03386578|529420920|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
146794303|NCT03386578|529420911|FG000|PrEP Comparison Component Step 1|Death|0|||
146794304|NCT03386578|529420912|FG001|PrEP Comparison Component Step 1|Death|0|||
146794305|NCT03386578|529420913|FG002|PrEP Comparison Component Step 1|Death|1|||
146794306|NCT03386578|529420914|FG003|PrEP Comparison Component Step 1|Death|0|||
146794307|NCT03386578|529420915|FG004|PrEP Comparison Component Step 1|Death|0|||
146794308|NCT03386578|529420916|FG005|PrEP Comparison Component Step 1|Death|0|||
146794309|NCT03386578|529420917|FG006|PrEP Comparison Component Step 1|Death|0|||
146794310|NCT03386578|529420918|FG007|PrEP Comparison Component Step 1|Death|9|||
146794311|NCT03386578|529420919|FG008|PrEP Comparison Component Step 1|Death|5|||
146794312|NCT03386578|529420920|FG009|PrEP Comparison Component Step 1|Death|0|||
146794313|NCT03386578|529420911|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
146794314|NCT03386578|529420912|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
146794315|NCT03386578|529420913|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
146794316|NCT03386578|529420914|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
146794317|NCT03386578|529420915|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
146794318|NCT03386578|529420916|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
146794319|NCT03386578|529420917|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
146794320|NCT03386578|529420918|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
146982528|NCT03567057|530097982|FG001|Overall Study|Unstable medical condition|0|||
146794321|NCT03386578|529420919|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
146794322|NCT03386578|529420920|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
146794323|NCT03386578|529420911|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
146794324|NCT03386578|529420912|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
146794325|NCT03386578|529420913|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
146794326|NCT03386578|529420914|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
146794327|NCT03386578|529420915|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
146794328|NCT03386578|529420916|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
146794329|NCT03386578|529420917|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
146794330|NCT03386578|529420918|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
146794331|NCT03386578|529420919|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
146794332|NCT03386578|529420920|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
146794333|NCT03386578|529420911|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
146794334|NCT03386578|529420912|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
146794335|NCT03386578|529420913|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
146794336|NCT03386578|529420914|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
146794337|NCT03386578|529420915|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
146794338|NCT03386578|529420916|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
146794339|NCT03386578|529420917|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
146794340|NCT03386578|529420918|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
146794341|NCT03386578|529420919|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
146794342|NCT03386578|529420920|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
146794343|NCT02424617|529420921|FG000|Overall Study|Adverse Event|0|||
146794344|NCT02424617|529420922|FG001|Overall Study|Adverse Event|1|||
146794345|NCT02424617|529420923|FG002|Overall Study|Adverse Event|0|||
146794346|NCT02424617|529420924|FG003|Overall Study|Adverse Event|0|||
146794347|NCT02424617|529420921|FG000|Overall Study|Investigator Decision|0|||
146794348|NCT02424617|529420922|FG001|Overall Study|Investigator Decision|0|||
146794349|NCT02424617|529420923|FG002|Overall Study|Investigator Decision|0|||
146794350|NCT02424617|529420924|FG003|Overall Study|Investigator Decision|1|||
146794351|NCT02424617|529420921|FG000|Overall Study|Withdrawal by Subject|1|||
146794352|NCT02424617|529420922|FG001|Overall Study|Withdrawal by Subject|1|||
146794353|NCT02424617|529420923|FG002|Overall Study|Withdrawal by Subject|0|||
146794354|NCT02424617|529420924|FG003|Overall Study|Withdrawal by Subject|1|||
146794355|NCT02424617|529420921|FG000|Overall Study|Progressive Disease|7|||
146794356|NCT02424617|529420922|FG001|Overall Study|Progressive Disease|6|||
146794357|NCT02424617|529420923|FG002|Overall Study|Progressive Disease|11|||
146794358|NCT02424617|529420924|FG003|Overall Study|Progressive Disease|10|||
146794359|NCT02424617|529420921|FG000|Overall Study|Other|0|||
146794360|NCT02424617|529420922|FG001|Overall Study|Other|0|||
146794361|NCT02424617|529420923|FG002|Overall Study|Other|0|||
146794362|NCT02424617|529420924|FG003|Overall Study|Other|1|||
146794363|NCT02694822|529420925|FG000|Phase 1|Death|2|||
146794364|NCT02694822|529420926|FG001|Phase 1|Death|1|||
146794365|NCT02694822|529420927|FG002|Phase 1|Death|6|||
146794366|NCT02694822|529420928|FG003|Phase 1|Death|6|||
146794367|NCT02694822|529420929|FG004|Phase 1|Death|3|||
146794368|NCT02694822|529420930|FG005|Phase 1|Death|0|||
146794369|NCT02694822|529420925|FG000|Phase 1|Withdrawal by Subject|2|||
146794370|NCT02694822|529420926|FG001|Phase 1|Withdrawal by Subject|2|||
146794371|NCT02694822|529420927|FG002|Phase 1|Withdrawal by Subject|4|||
146794372|NCT02694822|529420928|FG003|Phase 1|Withdrawal by Subject|8|||
146794373|NCT02694822|529420929|FG004|Phase 1|Withdrawal by Subject|1|||
146794374|NCT02694822|529420930|FG005|Phase 1|Withdrawal by Subject|0|||
146794375|NCT02694822|529420925|FG000|Phase 2|Death|0|||
146794376|NCT02694822|529420926|FG001|Phase 2|Death|0|||
146794377|NCT02694822|529420927|FG002|Phase 2|Death|0|||
146794378|NCT02694822|529420928|FG003|Phase 2|Death|0|||
146794379|NCT02694822|529420929|FG004|Phase 2|Death|0|||
146794380|NCT02694822|529420930|FG005|Phase 2|Death|26|||
146794381|NCT02694822|529420925|FG000|Phase 2|Withdrawal by Subject|0|||
146794382|NCT02694822|529420926|FG001|Phase 2|Withdrawal by Subject|0|||
146794383|NCT02694822|529420927|FG002|Phase 2|Withdrawal by Subject|0|||
146794384|NCT02694822|529420928|FG003|Phase 2|Withdrawal by Subject|0|||
146794385|NCT02694822|529420929|FG004|Phase 2|Withdrawal by Subject|0|||
146794386|NCT02694822|529420930|FG005|Phase 2|Withdrawal by Subject|13|||
146794387|NCT02694822|529420925|FG000|Phase 2|Administrative Study Closure|0|||
146794388|NCT02694822|529420926|FG001|Phase 2|Administrative Study Closure|0|||
146794389|NCT02694822|529420927|FG002|Phase 2|Administrative Study Closure|0|||
146794390|NCT02694822|529420928|FG003|Phase 2|Administrative Study Closure|0|||
146794391|NCT02694822|529420929|FG004|Phase 2|Administrative Study Closure|0|||
146794392|NCT02694822|529420930|FG005|Phase 2|Administrative Study Closure|2|||
146794393|NCT02694822|529420925|FG000|Phase 2|Lost to Follow-up|0|||
146794394|NCT02694822|529420926|FG001|Phase 2|Lost to Follow-up|0|||
146794395|NCT02694822|529420927|FG002|Phase 2|Lost to Follow-up|0|||
146794396|NCT02694822|529420928|FG003|Phase 2|Lost to Follow-up|0|||
146794397|NCT02694822|529420929|FG004|Phase 2|Lost to Follow-up|0|||
146794398|NCT02694822|529420930|FG005|Phase 2|Lost to Follow-up|1|||
146794399|NCT02694822|529420925|FG000|Phase 2|Participant Transferred to Another Site|0|||
146794400|NCT02694822|529420926|FG001|Phase 2|Participant Transferred to Another Site|0|||
146794401|NCT02694822|529420927|FG002|Phase 2|Participant Transferred to Another Site|0|||
146794402|NCT02694822|529420928|FG003|Phase 2|Participant Transferred to Another Site|0|||
146794403|NCT02694822|529420929|FG004|Phase 2|Participant Transferred to Another Site|0|||
146794404|NCT02694822|529420930|FG005|Phase 2|Participant Transferred to Another Site|1|||
146794405|NCT01868997|529420931|FG000|Overall Study|Adverse Event|2|||
146794406|NCT01868997|529420932|FG001|Overall Study|Adverse Event|5|||
146794407|NCT01868997|529420931|FG000|Overall Study|Lack of Efficacy|2|||
146794408|NCT01868997|529420932|FG001|Overall Study|Lack of Efficacy|0|||
146794409|NCT01868997|529420931|FG000|Overall Study|Other|3|||
146794410|NCT01868997|529420932|FG001|Overall Study|Other|1|||
146794411|NCT01960452|529420933|FG000|Overall Study|Withdrawal by Subject|2|||
146794412|NCT01960452|529420934|FG001|Overall Study|Withdrawal by Subject|1|||
146794413|NCT01960452|529420933|FG000|Overall Study|Sleep apnea in Night 1|1|||
146794414|NCT01960452|529420934|FG001|Overall Study|Sleep apnea in Night 1|0|||
146794415|NCT01960452|529420933|FG000|Overall Study|Poor Sleep in Night 1|0|||
146794416|NCT01960452|529420934|FG001|Overall Study|Poor Sleep in Night 1|2|||
146794417|NCT01960452|529420933|FG000|Overall Study|No Sex/Age Match Night 1|1|||
146794418|NCT01960452|529420934|FG001|Overall Study|No Sex/Age Match Night 1|0|||
146794419|NCT01960452|529420933|FG000|Overall Study|No Sex/Age Match Night 2|0|||
146794420|NCT01960452|529420934|FG001|Overall Study|No Sex/Age Match Night 2|2|||
146794421|NCT01960452|529420933|FG000|Overall Study|Technical Difficulties Night 2|2|||
146794422|NCT01960452|529420934|FG001|Overall Study|Technical Difficulties Night 2|0|||
146794423|NCT04066205|529420937|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
146794424|NCT04066205|529420938|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
146794425|NCT04066205|529420937|FG000|T2 Immediate Post-Intervention|did not respond|5|||
146794426|NCT04066205|529420938|FG001|T2 Immediate Post-Intervention|did not respond|3|||
146794427|NCT04294641|529420940|FG000|Overall Study|Screen failure|4|||
146794428|NCT04730739|529420941|FG000|Overall Study|Death|1|||
146794429|NCT03308877|529420942|FG000|Overall Study|Lost to Follow-up|32|||
146794430|NCT03308877|529420943|FG001|Overall Study|Lost to Follow-up|28|||
146794431|NCT05646355|529420951|FG000|Overall Study|Lost to Follow-up|1|||
146794432|NCT05646355|529420952|FG001|Overall Study|Lost to Follow-up|0|||
146794433|NCT05646355|529420951|FG000|Overall Study|translated materials not available for pilot|2|||
146794434|NCT05646355|529420952|FG001|Overall Study|translated materials not available for pilot|0|||
146794435|NCT05646355|529420951|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
146794436|NCT05646355|529420952|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
146794437|NCT03523572|529420955|FG000|Dose Escalation|Progressive disease|1|||
146794438|NCT03523572|529420956|FG001|Dose Escalation|Progressive disease|0|||
146794439|NCT03523572|529420957|FG002|Dose Escalation|Progressive disease|0|||
146794440|NCT03523572|529420958|FG003|Dose Escalation|Progressive disease|0|||
146794441|NCT03523572|529420959|FG004|Dose Escalation|Progressive disease|0|||
146794442|NCT03523572|529420960|FG005|Dose Escalation|Progressive disease|0|||
146794443|NCT03523572|529420955|FG000|Dose Escalation|Clinical Progression|0|||
146794444|NCT03523572|529420956|FG001|Dose Escalation|Clinical Progression|1|||
146794445|NCT03523572|529420957|FG002|Dose Escalation|Clinical Progression|0|||
146794446|NCT03523572|529420958|FG003|Dose Escalation|Clinical Progression|0|||
146794447|NCT03523572|529420959|FG004|Dose Escalation|Clinical Progression|0|||
146794448|NCT03523572|529420960|FG005|Dose Escalation|Clinical Progression|0|||
146794449|NCT03523572|529420955|FG000|Dose Escalation|Adverse Event|2|||
146794450|NCT03523572|529420956|FG001|Dose Escalation|Adverse Event|0|||
146794451|NCT03523572|529420957|FG002|Dose Escalation|Adverse Event|0|||
146794452|NCT03523572|529420958|FG003|Dose Escalation|Adverse Event|0|||
146794453|NCT03523572|529420959|FG004|Dose Escalation|Adverse Event|0|||
146794454|NCT03523572|529420960|FG005|Dose Escalation|Adverse Event|0|||
146794455|NCT03523572|529420955|FG000|Dose Escalation|Physician Decision|1|||
146794456|NCT03523572|529420956|FG001|Dose Escalation|Physician Decision|1|||
146794457|NCT03523572|529420957|FG002|Dose Escalation|Physician Decision|0|||
146794458|NCT03523572|529420958|FG003|Dose Escalation|Physician Decision|0|||
146794459|NCT03523572|529420959|FG004|Dose Escalation|Physician Decision|0|||
146794460|NCT03523572|529420960|FG005|Dose Escalation|Physician Decision|0|||
146794461|NCT03523572|529420955|FG000|Dose Expansion|Progressive Disease|0|||
146794462|NCT03523572|529420956|FG001|Dose Expansion|Progressive Disease|0|||
146982529|NCT03567057|530097983|FG002|Overall Study|Unstable medical condition|0|||
146982530|NCT03567057|530097981|FG000|Overall Study|Medical history event|0|||
146794463|NCT03523572|529420957|FG002|Dose Expansion|Progressive Disease|9|||
146794464|NCT03523572|529420958|FG003|Dose Expansion|Progressive Disease|11|||
146794465|NCT03523572|529420959|FG004|Dose Expansion|Progressive Disease|15|||
146982531|NCT03567057|530097982|FG001|Overall Study|Medical history event|0|||
146939453|NCT02431702|529936929|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
146939454|NCT02431702|529936930|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
146939455|NCT02431702|529936931|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
146939456|NCT02431702|529936932|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
146939457|NCT02431702|529936933|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
146939458|NCT02431702|529936934|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
146939459|NCT02431702|529936935|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
146939460|NCT02431702|529936929|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
146939461|NCT02431702|529936930|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
146939462|NCT02431702|529936931|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
146939463|NCT02431702|529936932|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
146939464|NCT02431702|529936933|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
146939465|NCT02431702|529936934|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
146939466|NCT02431702|529936935|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
146939467|NCT02431702|529936929|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
146939468|NCT02431702|529936930|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
146939469|NCT02431702|529936931|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
146939470|NCT02431702|529936932|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
146939471|NCT02431702|529936933|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
146939472|NCT02431702|529936934|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
146939473|NCT02431702|529936935|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
146939474|NCT02431702|529936929|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
146939475|NCT02431702|529936930|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
146939476|NCT02431702|529936931|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
146939477|NCT02431702|529936932|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
146939478|NCT02431702|529936933|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
146939479|NCT02431702|529936934|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
146939480|NCT02431702|529936935|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
146939481|NCT02431702|529936929|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
146939482|NCT02431702|529936930|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
146939483|NCT02431702|529936931|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
146939484|NCT02431702|529936932|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
146939485|NCT02431702|529936933|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
146939486|NCT02431702|529936934|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
146939487|NCT02431702|529936935|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
146939488|NCT03551626|529936936|FG000|Overall Study|Adverse Event|88|||
146939489|NCT03551626|529936936|FG000|Overall Study|Disease relapse|18|||
146939490|NCT03551626|529936936|FG000|Overall Study|Withdrawal of informed consent|6|||
146939491|NCT03551626|529936936|FG000|Overall Study|Patient decision|5|||
146939492|NCT03551626|529936936|FG000|Overall Study|Physician Decision|4|||
146939493|NCT03551626|529936936|FG000|Overall Study|Lost to Follow-up|3|||
146939494|NCT03551626|529936936|FG000|Overall Study|Pregnancy|1|||
146939495|NCT03551626|529936936|FG000|Overall Study|Protocol deviation|1|||
146939496|NCT03551626|529936936|FG000|Overall Study|Technical problems|1|||
146939497|NCT01017549|529936939|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
146939498|NCT01017549|529936939|FG000|One-year Follow-up|Lost to Follow-up|2|||
146939499|NCT01017549|529936939|FG000|One-year Follow-up|Withdrawal by Subject|5|||
146939500|NCT01017549|529936939|FG000|5 Year Follow-up|Lost to Follow-up|9|||
146939501|NCT01017549|529936939|FG000|5 Year Follow-up|Mastectomy|3|||
146939502|NCT00443846|529936940|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
146939503|NCT00443846|529936941|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
146939504|NCT00443846|529936940|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
146939505|NCT00443846|529936941|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
146939506|NCT00443846|529936940|FG000|Overall Study|Adverse Event|0|||
146939507|NCT00443846|529936941|FG001|Overall Study|Adverse Event|1|||
146939508|NCT00443846|529936940|FG000|Overall Study|Personal reason|8|||
146939509|NCT00443846|529936941|FG001|Overall Study|Personal reason|3|||
146939510|NCT00443846|529936940|FG000|Overall Study|Lost to Follow-up|1|||
146939511|NCT00443846|529936941|FG001|Overall Study|Lost to Follow-up|2|||
146939512|NCT02980692|529936946|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
146939513|NCT02980692|529936947|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
146939514|NCT02980692|529936948|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
146939515|NCT02980692|529936949|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
146939516|NCT02980692|529936950|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
146939517|NCT02980692|529936946|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
146939518|NCT02980692|529936947|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
146939519|NCT02980692|529936948|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
146939520|NCT02980692|529936949|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
146794466|NCT03523572|529420960|FG005|Dose Expansion|Progressive Disease|2|||
146794467|NCT03523572|529420955|FG000|Dose Expansion|Clinical Progression|0|||
146794468|NCT03523572|529420956|FG001|Dose Expansion|Clinical Progression|0|||
146794469|NCT03523572|529420957|FG002|Dose Expansion|Clinical Progression|2|||
146794470|NCT03523572|529420958|FG003|Dose Expansion|Clinical Progression|2|||
146794471|NCT03523572|529420959|FG004|Dose Expansion|Clinical Progression|2|||
146794472|NCT03523572|529420960|FG005|Dose Expansion|Clinical Progression|0|||
146794473|NCT03523572|529420955|FG000|Dose Expansion|Adverse Event|0|||
146794474|NCT03523572|529420956|FG001|Dose Expansion|Adverse Event|0|||
146794475|NCT03523572|529420957|FG002|Dose Expansion|Adverse Event|10|||
146794476|NCT03523572|529420958|FG003|Dose Expansion|Adverse Event|1|||
146794477|NCT03523572|529420959|FG004|Dose Expansion|Adverse Event|5|||
146794478|NCT03523572|529420960|FG005|Dose Expansion|Adverse Event|2|||
146794479|NCT03523572|529420955|FG000|Dose Expansion|Withdrawal by Subject|0|||
146939521|NCT02980692|529936950|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
146939522|NCT02980692|529936946|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
146939523|NCT02980692|529936947|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
146939524|NCT02980692|529936948|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
146939525|NCT02980692|529936949|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
146939526|NCT02980692|529936950|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
146939527|NCT02980692|529936946|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
146939528|NCT02980692|529936947|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
146939529|NCT02980692|529936948|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
146939530|NCT02980692|529936949|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
146939531|NCT02980692|529936950|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
146939532|NCT02980692|529936946|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
146939533|NCT02980692|529936947|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
146939534|NCT02980692|529936948|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
146939535|NCT02980692|529936949|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
146939536|NCT02980692|529936950|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
146939537|NCT02980692|529936946|FG000|Double Blind Placebo Controlled Period|Other|1|||
146939538|NCT02980692|529936947|FG001|Double Blind Placebo Controlled Period|Other|0|||
146939539|NCT02980692|529936948|FG002|Double Blind Placebo Controlled Period|Other|0|||
146939540|NCT02980692|529936949|FG003|Double Blind Placebo Controlled Period|Other|0|||
146939541|NCT02980692|529936950|FG004|Double Blind Placebo Controlled Period|Other|1|||
146735598|NCT04543188|529203002|FG013|Phase 1a|Other|0|||
146735599|NCT04543188|529203003|FG014|Phase 1a|Other|0|||
146735600|NCT04543188|529202989|FG000|Phase 1b|Adverse Event|0|||
146735601|NCT04543188|529202990|FG001|Phase 1b|Adverse Event|0|||
146735602|NCT04543188|529202991|FG002|Phase 1b|Adverse Event|0|||
146735603|NCT04543188|529202992|FG003|Phase 1b|Adverse Event|0|||
146735604|NCT04543188|529202993|FG004|Phase 1b|Adverse Event|0|||
146735605|NCT04543188|529202994|FG005|Phase 1b|Adverse Event|0|||
146735606|NCT04543188|529202995|FG006|Phase 1b|Adverse Event|0|||
146735607|NCT04543188|529202996|FG007|Phase 1b|Adverse Event|0|||
146735608|NCT04543188|529202997|FG008|Phase 1b|Adverse Event|0|||
146735609|NCT04543188|529202998|FG009|Phase 1b|Adverse Event|0|||
146735610|NCT04543188|529202999|FG010|Phase 1b|Adverse Event|0|||
146735611|NCT04543188|529203000|FG011|Phase 1b|Adverse Event|0|||
146735612|NCT04543188|529203001|FG012|Phase 1b|Adverse Event|0|||
146735613|NCT04543188|529203002|FG013|Phase 1b|Adverse Event|0|||
146735614|NCT04543188|529203003|FG014|Phase 1b|Adverse Event|2|||
146735615|NCT04543188|529202989|FG000|Phase 1b|Other (Death)|0|||
146735616|NCT04543188|529202990|FG001|Phase 1b|Other (Death)|0|||
146735617|NCT04543188|529202991|FG002|Phase 1b|Other (Death)|0|||
146735618|NCT04543188|529202992|FG003|Phase 1b|Other (Death)|0|||
146735619|NCT04543188|529202993|FG004|Phase 1b|Other (Death)|0|||
146735620|NCT04543188|529202994|FG005|Phase 1b|Other (Death)|0|||
146735621|NCT04543188|529202995|FG006|Phase 1b|Other (Death)|0|||
146735622|NCT04543188|529202996|FG007|Phase 1b|Other (Death)|0|||
146735623|NCT04543188|529202997|FG008|Phase 1b|Other (Death)|0|||
146735624|NCT04543188|529202998|FG009|Phase 1b|Other (Death)|0|||
146735625|NCT04543188|529202999|FG010|Phase 1b|Other (Death)|0|||
146735626|NCT04543188|529203000|FG011|Phase 1b|Other (Death)|0|||
146735627|NCT04543188|529203001|FG012|Phase 1b|Other (Death)|1|||
146735628|NCT04543188|529203002|FG013|Phase 1b|Other (Death)|0|||
146735629|NCT04543188|529203003|FG014|Phase 1b|Other (Death)|1|||
146735630|NCT04543188|529202989|FG000|Phase 1b|Progressive Disease|0|||
146735631|NCT04543188|529202990|FG001|Phase 1b|Progressive Disease|0|||
146735632|NCT04543188|529202991|FG002|Phase 1b|Progressive Disease|0|||
146735633|NCT04543188|529202992|FG003|Phase 1b|Progressive Disease|0|||
146735634|NCT04543188|529202993|FG004|Phase 1b|Progressive Disease|0|||
146735635|NCT04543188|529202994|FG005|Phase 1b|Progressive Disease|0|||
146735636|NCT04543188|529202995|FG006|Phase 1b|Progressive Disease|0|||
146735637|NCT04543188|529202996|FG007|Phase 1b|Progressive Disease|0|||
146735638|NCT04543188|529202997|FG008|Phase 1b|Progressive Disease|0|||
146982532|NCT03567057|530097983|FG002|Overall Study|Medical history event|1|||
146982533|NCT03567057|530097981|FG000|Overall Study|Other|0|||
146982534|NCT03567057|530097982|FG001|Overall Study|Other|0|||
146982535|NCT03567057|530097983|FG002|Overall Study|Other|1|||
146982536|NCT00490061|530097984|FG000|Overall Study|Physician Decision|1|||
146982537|NCT01580020|530097985|FG000|Overall Study|Lack of Efficacy|0|||
146982538|NCT01580020|530097986|FG001|Overall Study|Lack of Efficacy|5|||
146982539|NCT01580020|530097987|FG002|Overall Study|Lack of Efficacy|0|||
146982540|NCT01580020|530097988|FG003|Overall Study|Lack of Efficacy|1|||
146982541|NCT01580020|530097985|FG000|Overall Study|Withdrawal by Subject|0|||
146982542|NCT01580020|530097986|FG001|Overall Study|Withdrawal by Subject|1|||
146982543|NCT01580020|530097987|FG002|Overall Study|Withdrawal by Subject|1|||
146982544|NCT01580020|530097988|FG003|Overall Study|Withdrawal by Subject|0|||
146939542|NCT02980692|529936946|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
146939543|NCT02980692|529936947|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
146939544|NCT02980692|529936948|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
146939545|NCT02980692|529936949|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
146939546|NCT02980692|529936950|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
146939547|NCT02980692|529936946|FG000|Double-blind Follow-up Period|Adverse Event|0|||
146939548|NCT02980692|529936947|FG001|Double-blind Follow-up Period|Adverse Event|0|||
146939549|NCT02980692|529936948|FG002|Double-blind Follow-up Period|Adverse Event|0|||
146939550|NCT02980692|529936949|FG003|Double-blind Follow-up Period|Adverse Event|1|||
146939551|NCT02980692|529936950|FG004|Double-blind Follow-up Period|Adverse Event|1|||
146939552|NCT02980692|529936946|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
146939553|NCT02980692|529936947|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
146939554|NCT02980692|529936948|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
146939555|NCT02980692|529936949|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
146939556|NCT02980692|529936950|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
146939557|NCT02980692|529936946|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
146939558|NCT02980692|529936947|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
146939559|NCT02980692|529936948|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
146939560|NCT02980692|529936949|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
146939561|NCT02980692|529936950|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
146939562|NCT02980692|529936946|FG000|Double-blind Follow-up Period|Pregnancy|0|||
146939563|NCT02980692|529936947|FG001|Double-blind Follow-up Period|Pregnancy|0|||
146939564|NCT02980692|529936948|FG002|Double-blind Follow-up Period|Pregnancy|1|||
146939565|NCT02980692|529936949|FG003|Double-blind Follow-up Period|Pregnancy|1|||
146939566|NCT02980692|529936950|FG004|Double-blind Follow-up Period|Pregnancy|0|||
146939567|NCT02980692|529936946|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
146939568|NCT02980692|529936947|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
146939569|NCT02980692|529936948|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
146939570|NCT02980692|529936949|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
146939571|NCT02980692|529936950|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
146939572|NCT02980692|529936946|FG000|Double-blind Follow-up Period|Other|0|||
146939573|NCT02980692|529936947|FG001|Double-blind Follow-up Period|Other|0|||
146939574|NCT02980692|529936948|FG002|Double-blind Follow-up Period|Other|1|||
146939575|NCT02980692|529936949|FG003|Double-blind Follow-up Period|Other|1|||
146939576|NCT02980692|529936950|FG004|Double-blind Follow-up Period|Other|3|||
146939577|NCT03862495|529936955|FG000|Overall Study|Lost to Follow-up|37|||
146939578|NCT03862495|529936956|FG001|Overall Study|Lost to Follow-up|35|||
146939579|NCT04397796|529936957|FG000|Overall Study|Death|3|||
146939580|NCT04397796|529936958|FG001|Overall Study|Death|1|||
146939581|NCT01057862|529936959|FG000|Overall Study|Withdrawal by Subject|1|||
146939582|NCT01057862|529936960|FG001|Overall Study|Withdrawal by Subject|2|||
146939583|NCT03363165|529936963|FG000|3-month Follow-up|Death|0|||
146939584|NCT03363165|529936964|FG001|3-month Follow-up|Death|1|||
146939585|NCT03363165|529936963|FG000|6-month Follow-up|Death|0|||
146982545|NCT01580020|530097985|FG000|Overall Study|Adverse Event|1|||
146982546|NCT01580020|530097986|FG001|Overall Study|Adverse Event|1|||
146982547|NCT01580020|530097987|FG002|Overall Study|Adverse Event|1|||
146735639|NCT04543188|529202998|FG009|Phase 1b|Progressive Disease|0|||
146735640|NCT04543188|529202999|FG010|Phase 1b|Progressive Disease|0|||
146735641|NCT04543188|529203000|FG011|Phase 1b|Progressive Disease|0|||
146735642|NCT04543188|529203001|FG012|Phase 1b|Progressive Disease|2|||
146982548|NCT01580020|530097988|FG003|Overall Study|Adverse Event|1|||
146982549|NCT01580020|530097985|FG000|Overall Study|Administrative Problems|0|||
146982550|NCT01580020|530097986|FG001|Overall Study|Administrative Problems|0|||
146735643|NCT04543188|529203002|FG013|Phase 1b|Progressive Disease|1|||
146735644|NCT04543188|529203003|FG014|Phase 1b|Progressive Disease|5|||
146735645|NCT04543188|529202989|FG000|Phase 1b|Study Terminated By Sponsor|0|||
146735646|NCT04543188|529202990|FG001|Phase 1b|Study Terminated By Sponsor|0|||
146794480|NCT03523572|529420956|FG001|Dose Expansion|Withdrawal by Subject|0|||
146794481|NCT03523572|529420957|FG002|Dose Expansion|Withdrawal by Subject|1|||
146794482|NCT03523572|529420958|FG003|Dose Expansion|Withdrawal by Subject|1|||
146794483|NCT03523572|529420959|FG004|Dose Expansion|Withdrawal by Subject|0|||
146794484|NCT03523572|529420960|FG005|Dose Expansion|Withdrawal by Subject|0|||
146794485|NCT03523572|529420955|FG000|Dose Expansion|Physician Decision|0|||
146794486|NCT03523572|529420956|FG001|Dose Expansion|Physician Decision|0|||
146794487|NCT03523572|529420957|FG002|Dose Expansion|Physician Decision|1|||
146794488|NCT03523572|529420958|FG003|Dose Expansion|Physician Decision|0|||
146794489|NCT03523572|529420959|FG004|Dose Expansion|Physician Decision|1|||
146794490|NCT03523572|529420960|FG005|Dose Expansion|Physician Decision|0|||
146794491|NCT03523572|529420955|FG000|Dose Expansion|Miscellaneous|0|||
146794492|NCT03523572|529420956|FG001|Dose Expansion|Miscellaneous|0|||
146794493|NCT03523572|529420957|FG002|Dose Expansion|Miscellaneous|0|||
146794494|NCT03523572|529420958|FG003|Dose Expansion|Miscellaneous|0|||
146794495|NCT03523572|529420959|FG004|Dose Expansion|Miscellaneous|3|||
146794496|NCT03523572|529420960|FG005|Dose Expansion|Miscellaneous|0|||
146794497|NCT04685135|529420966|FG000|Overall Study|Death|126|||
146794498|NCT04685135|529420967|FG001|Overall Study|Death|53|||
146794499|NCT04685135|529420966|FG000|Overall Study|Withdrawal by Subject|12|||
146794500|NCT04685135|529420967|FG001|Overall Study|Withdrawal by Subject|16|||
146794501|NCT02315703|529420968|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
146794502|NCT02315703|529420969|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
146794503|NCT02315703|529420970|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
146794504|NCT02315703|529420971|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
146794505|NCT02315703|529420972|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
146794506|NCT02315703|529420973|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
146794507|NCT02315703|529420974|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
146794508|NCT02315703|529420975|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
146794509|NCT02315703|529420968|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
146794510|NCT02315703|529420969|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
146794511|NCT02315703|529420970|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
146794512|NCT02315703|529420971|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
146794513|NCT02315703|529420972|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
146794514|NCT02315703|529420973|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
146794515|NCT02315703|529420974|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
146794516|NCT02315703|529420975|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
146794517|NCT02315703|529420968|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
146794518|NCT02315703|529420969|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
146794519|NCT02315703|529420970|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
146794520|NCT02315703|529420971|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
146794521|NCT02315703|529420972|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
146735647|NCT04543188|529202991|FG002|Phase 1b|Study Terminated By Sponsor|0|||
146735648|NCT04543188|529202992|FG003|Phase 1b|Study Terminated By Sponsor|0|||
146735649|NCT04543188|529202993|FG004|Phase 1b|Study Terminated By Sponsor|0|||
146735650|NCT04543188|529202994|FG005|Phase 1b|Study Terminated By Sponsor|0|||
146735651|NCT04543188|529202995|FG006|Phase 1b|Study Terminated By Sponsor|0|||
146735652|NCT04543188|529202996|FG007|Phase 1b|Study Terminated By Sponsor|0|||
146735653|NCT04543188|529202997|FG008|Phase 1b|Study Terminated By Sponsor|0|||
146735654|NCT04543188|529202998|FG009|Phase 1b|Study Terminated By Sponsor|0|||
146735655|NCT04543188|529202999|FG010|Phase 1b|Study Terminated By Sponsor|0|||
146735656|NCT04543188|529203000|FG011|Phase 1b|Study Terminated By Sponsor|1|||
146735657|NCT04543188|529203001|FG012|Phase 1b|Study Terminated By Sponsor|1|||
146735658|NCT04543188|529203002|FG013|Phase 1b|Study Terminated By Sponsor|0|||
146735659|NCT04543188|529203003|FG014|Phase 1b|Study Terminated By Sponsor|1|||
146735660|NCT04543188|529202989|FG000|Phase 1b|Withdrawal by Subject|0|||
146735661|NCT04543188|529202990|FG001|Phase 1b|Withdrawal by Subject|0|||
146735662|NCT04543188|529202991|FG002|Phase 1b|Withdrawal by Subject|0|||
146735663|NCT04543188|529202992|FG003|Phase 1b|Withdrawal by Subject|0|||
146735664|NCT04543188|529202993|FG004|Phase 1b|Withdrawal by Subject|0|||
146735665|NCT04543188|529202994|FG005|Phase 1b|Withdrawal by Subject|0|||
146735666|NCT04543188|529202995|FG006|Phase 1b|Withdrawal by Subject|0|||
146735667|NCT04543188|529202996|FG007|Phase 1b|Withdrawal by Subject|0|||
146735668|NCT04543188|529202997|FG008|Phase 1b|Withdrawal by Subject|0|||
146735669|NCT04543188|529202998|FG009|Phase 1b|Withdrawal by Subject|0|||
146735670|NCT04543188|529202999|FG010|Phase 1b|Withdrawal by Subject|0|||
146735671|NCT04543188|529203000|FG011|Phase 1b|Withdrawal by Subject|0|||
146735672|NCT04543188|529203001|FG012|Phase 1b|Withdrawal by Subject|0|||
146735673|NCT04543188|529203002|FG013|Phase 1b|Withdrawal by Subject|0|||
146735674|NCT04543188|529203003|FG014|Phase 1b|Withdrawal by Subject|2|||
146735675|NCT02487472|529203004|FG000|Overall Study|Did not complete telephonic interviews|9|||
146735676|NCT02487472|529203004|FG000|Overall Study|Other|2|||
146735677|NCT01313286|529203009|FG000|Period 1|Withdrawal by Subject|2|||
146735678|NCT01313286|529203010|FG001|Period 1|Withdrawal by Subject|0|||
146794522|NCT02315703|529420973|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
146794523|NCT02315703|529420974|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
146794524|NCT02315703|529420975|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
146794525|NCT02315703|529420968|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
146794526|NCT02315703|529420969|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
146794527|NCT02315703|529420970|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
146794528|NCT02315703|529420971|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
146794529|NCT02315703|529420972|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
146794530|NCT02315703|529420973|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
146794531|NCT02315703|529420974|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
146794532|NCT02315703|529420975|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
146794533|NCT02315703|529420968|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
146794534|NCT02315703|529420969|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
146794535|NCT02315703|529420970|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
146794536|NCT02315703|529420971|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
146794537|NCT02315703|529420972|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
146794538|NCT02315703|529420973|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
146794539|NCT02315703|529420974|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
146794540|NCT02315703|529420975|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
146794541|NCT02315703|529420968|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
146794542|NCT02315703|529420969|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
146794543|NCT02315703|529420970|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
146794544|NCT02315703|529420971|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
146794545|NCT02315703|529420972|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
146794546|NCT02315703|529420973|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
146794547|NCT02315703|529420974|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
146794548|NCT02315703|529420975|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
146794549|NCT02315703|529420968|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
146794550|NCT02315703|529420969|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
146794551|NCT02315703|529420970|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
146794552|NCT02315703|529420971|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
146794553|NCT02315703|529420972|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
146794554|NCT02315703|529420973|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
146794555|NCT02315703|529420974|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
146794556|NCT02315703|529420975|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
146794557|NCT02315703|529420968|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
146794558|NCT02315703|529420969|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
146794559|NCT02315703|529420970|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
146794560|NCT02315703|529420971|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
146794561|NCT02315703|529420972|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
146794562|NCT02315703|529420973|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
146794563|NCT02315703|529420974|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
146794564|NCT02315703|529420975|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
146794565|NCT02315703|529420968|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
146794566|NCT02315703|529420969|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
146794567|NCT02315703|529420970|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
146794568|NCT02315703|529420971|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
146794569|NCT02315703|529420972|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
146794570|NCT02315703|529420973|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
146794571|NCT02315703|529420974|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
146794572|NCT02315703|529420975|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
146794573|NCT03711474|529420976|FG000|Overall Study|Physician Decision|2|||
146794574|NCT03711474|529420977|FG001|Overall Study|Physician Decision|0|||
146794575|NCT05974501|529420978|FG000|Overall Study|Physician Decision|0|||
146794576|NCT05974501|529420979|FG001|Overall Study|Physician Decision|1|||
146794577|NCT03625115|529420980|FG000|Overall Study|Withdrawal by Subject|4|||
146794578|NCT03625115|529420981|FG001|Overall Study|Withdrawal by Subject|7|||
146794579|NCT03625115|529420980|FG000|Overall Study|Lost to Follow-up|17|||
146794580|NCT03625115|529420981|FG001|Overall Study|Lost to Follow-up|24|||
146794581|NCT04197336|529420982|FG000|Overall Study|Withdrawal by Subject|1|||
146794582|NCT04304144|529420983|FG000|DLT Observation Period|Physician Decision|0|||
146794583|NCT04304144|529420984|FG001|DLT Observation Period|Physician Decision|1|||
146794584|NCT04304144|529420985|FG002|DLT Observation Period|Physician Decision|0|||
146794585|NCT04304144|529420986|FG003|DLT Observation Period|Physician Decision|0|||
146794586|NCT04304144|529420983|FG000|Continued Treatment Period|Adverse Event|0|||
146794587|NCT04304144|529420984|FG001|Continued Treatment Period|Adverse Event|1|||
146794588|NCT04304144|529420985|FG002|Continued Treatment Period|Adverse Event|0|||
146794589|NCT04304144|529420986|FG003|Continued Treatment Period|Adverse Event|0|||
146794590|NCT04304144|529420983|FG000|Continued Treatment Period|Death|0|||
146794591|NCT04304144|529420984|FG001|Continued Treatment Period|Death|0|||
146794592|NCT04304144|529420985|FG002|Continued Treatment Period|Death|1|||
146794593|NCT04304144|529420986|FG003|Continued Treatment Period|Death|2|||
146794594|NCT04304144|529420983|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
146794595|NCT04304144|529420984|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
146794596|NCT04304144|529420985|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
146794597|NCT04304144|529420986|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
146794598|NCT04304144|529420983|FG000|Continued Treatment Period|Other than specified|2|||
146794599|NCT04304144|529420984|FG001|Continued Treatment Period|Other than specified|0|||
146794600|NCT04304144|529420985|FG002|Continued Treatment Period|Other than specified|1|||
146794601|NCT04304144|529420986|FG003|Continued Treatment Period|Other than specified|1|||
146794602|NCT04101357|529420987|FG000|Overall Study|Death|1|||
146794603|NCT04101357|529420988|FG001|Overall Study|Death|1|||
146794604|NCT04101357|529420989|FG002|Overall Study|Death|1|||
146794605|NCT04101357|529420990|FG003|Overall Study|Death|2|||
146794606|NCT04101357|529420991|FG004|Overall Study|Death|4|||
146794607|NCT04101357|529420992|FG005|Overall Study|Death|11|||
146794608|NCT04101357|529420993|FG006|Overall Study|Death|4|||
146794609|NCT04101357|529420994|FG007|Overall Study|Death|4|||
146794610|NCT04101357|529420995|FG008|Overall Study|Death|5|||
146794611|NCT04101357|529420996|FG009|Overall Study|Death|2|||
146794612|NCT04101357|529420997|FG010|Overall Study|Death|3|||
146794613|NCT04101357|529420987|FG000|Overall Study|Trial closure|0|||
146794614|NCT04101357|529420988|FG001|Overall Study|Trial closure|0|||
146794615|NCT04101357|529420989|FG002|Overall Study|Trial closure|0|||
146794616|NCT04101357|529420990|FG003|Overall Study|Trial closure|0|||
146794617|NCT04101357|529420991|FG004|Overall Study|Trial closure|0|||
146794618|NCT04101357|529420992|FG005|Overall Study|Trial closure|2|||
146794619|NCT04101357|529420993|FG006|Overall Study|Trial closure|2|||
146794620|NCT04101357|529420994|FG007|Overall Study|Trial closure|0|||
146794621|NCT04101357|529420995|FG008|Overall Study|Trial closure|0|||
146794622|NCT04101357|529420996|FG009|Overall Study|Trial closure|0|||
146794623|NCT04101357|529420997|FG010|Overall Study|Trial closure|1|||
146794624|NCT04101357|529420987|FG000|Overall Study|Lost to Follow-up|0|||
146794625|NCT04101357|529420988|FG001|Overall Study|Lost to Follow-up|0|||
146794626|NCT04101357|529420989|FG002|Overall Study|Lost to Follow-up|0|||
146794627|NCT04101357|529420990|FG003|Overall Study|Lost to Follow-up|1|||
146794628|NCT04101357|529420991|FG004|Overall Study|Lost to Follow-up|0|||
146794629|NCT04101357|529420992|FG005|Overall Study|Lost to Follow-up|0|||
146794630|NCT04101357|529420993|FG006|Overall Study|Lost to Follow-up|0|||
146794631|NCT04101357|529420994|FG007|Overall Study|Lost to Follow-up|1|||
146794632|NCT04101357|529420995|FG008|Overall Study|Lost to Follow-up|0|||
146794633|NCT04101357|529420996|FG009|Overall Study|Lost to Follow-up|0|||
146794634|NCT04101357|529420997|FG010|Overall Study|Lost to Follow-up|0|||
146794635|NCT04101357|529420987|FG000|Overall Study|Withdrawal by Subject|1|||
146794636|NCT04101357|529420988|FG001|Overall Study|Withdrawal by Subject|0|||
146794637|NCT04101357|529420989|FG002|Overall Study|Withdrawal by Subject|0|||
146794638|NCT04101357|529420990|FG003|Overall Study|Withdrawal by Subject|0|||
146794639|NCT04101357|529420991|FG004|Overall Study|Withdrawal by Subject|0|||
146794640|NCT04101357|529420992|FG005|Overall Study|Withdrawal by Subject|0|||
146794641|NCT04101357|529420993|FG006|Overall Study|Withdrawal by Subject|0|||
146794642|NCT04101357|529420994|FG007|Overall Study|Withdrawal by Subject|0|||
146794643|NCT04101357|529420995|FG008|Overall Study|Withdrawal by Subject|1|||
146794644|NCT04101357|529420996|FG009|Overall Study|Withdrawal by Subject|1|||
146794645|NCT04101357|529420997|FG010|Overall Study|Withdrawal by Subject|0|||
146794646|NCT04101357|529420987|FG000|Overall Study|Other|0|||
146794647|NCT04101357|529420988|FG001|Overall Study|Other|0|||
146794648|NCT04101357|529420989|FG002|Overall Study|Other|0|||
146794649|NCT04101357|529420990|FG003|Overall Study|Other|0|||
146794650|NCT04101357|529420991|FG004|Overall Study|Other|0|||
146794651|NCT04101357|529420992|FG005|Overall Study|Other|1|||
146794652|NCT04101357|529420993|FG006|Overall Study|Other|2|||
146794653|NCT04101357|529420994|FG007|Overall Study|Other|1|||
146794654|NCT04101357|529420995|FG008|Overall Study|Other|0|||
146794655|NCT04101357|529420996|FG009|Overall Study|Other|0|||
146794656|NCT04101357|529420997|FG010|Overall Study|Other|0|||
146794657|NCT04101357|529420987|FG000|Overall Study|Enrolled but not treated|0|||
146794658|NCT04101357|529420988|FG001|Overall Study|Enrolled but not treated|0|||
146939586|NCT03363165|529936964|FG001|6-month Follow-up|Death|1|||
146794659|NCT04101357|529420989|FG002|Overall Study|Enrolled but not treated|0|||
146939587|NCT03363165|529936963|FG000|6-month Follow-up|Withdrawal by Subject|1|||
146794660|NCT04101357|529420990|FG003|Overall Study|Enrolled but not treated|0|||
146794661|NCT04101357|529420991|FG004|Overall Study|Enrolled but not treated|0|||
146794662|NCT04101357|529420992|FG005|Overall Study|Enrolled but not treated|1|||
146939588|NCT03363165|529936964|FG001|6-month Follow-up|Withdrawal by Subject|1|||
146794663|NCT04101357|529420993|FG006|Overall Study|Enrolled but not treated|1|||
146939589|NCT03363165|529936963|FG000|12-month Follow-up|Death|1|||
146794664|NCT04101357|529420994|FG007|Overall Study|Enrolled but not treated|0|||
146794665|NCT04101357|529420995|FG008|Overall Study|Enrolled but not treated|0|||
146794666|NCT04101357|529420996|FG009|Overall Study|Enrolled but not treated|0|||
146939590|NCT03363165|529936964|FG001|12-month Follow-up|Death|1|||
146982551|NCT01580020|530097987|FG002|Overall Study|Administrative Problems|1|||
146982552|NCT01580020|530097988|FG003|Overall Study|Administrative Problems|0|||
146982553|NCT01580020|530097985|FG000|Overall Study|Lost to Follow-up|0|||
146982554|NCT01580020|530097986|FG001|Overall Study|Lost to Follow-up|0|||
146982555|NCT01580020|530097987|FG002|Overall Study|Lost to Follow-up|1|||
146982556|NCT01580020|530097988|FG003|Overall Study|Lost to Follow-up|0|||
146982557|NCT00591253|530097990|FG000|Overall Study|Adverse Event|3|||
146982558|NCT00591253|530097991|FG001|Overall Study|Adverse Event|3|||
146982559|NCT00591253|530097992|FG002|Overall Study|Adverse Event|1|||
146982560|NCT00591253|530097990|FG000|Overall Study|Protocol Violation|2|||
146982561|NCT00591253|530097991|FG001|Overall Study|Protocol Violation|2|||
146982562|NCT00591253|530097992|FG002|Overall Study|Protocol Violation|2|||
146982563|NCT00591253|530097990|FG000|Overall Study|Lost to Follow-up|2|||
146982564|NCT00591253|530097991|FG001|Overall Study|Lost to Follow-up|4|||
146982565|NCT00591253|530097992|FG002|Overall Study|Lost to Follow-up|0|||
146794667|NCT04101357|529420997|FG010|Overall Study|Enrolled but not treated|0|||
146982566|NCT00591253|530097990|FG000|Overall Study|Withdrawal by Subject|1|||
146982567|NCT00591253|530097991|FG001|Overall Study|Withdrawal by Subject|7|||
146982568|NCT00591253|530097992|FG002|Overall Study|Withdrawal by Subject|6|||
146982569|NCT00591253|530097990|FG000|Overall Study|Lack of Efficacy|1|||
146982570|NCT00591253|530097991|FG001|Overall Study|Lack of Efficacy|0|||
146982571|NCT00591253|530097992|FG002|Overall Study|Lack of Efficacy|3|||
146982572|NCT00591253|530097990|FG000|Overall Study|Other|5|||
146982573|NCT00591253|530097991|FG001|Overall Study|Other|5|||
146982574|NCT00591253|530097992|FG002|Overall Study|Other|3|||
146982575|NCT01841359|530097993|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
146982576|NCT01841359|530097993|FG000|Overall Study|Concommitant medical issues|2|||
146982577|NCT01841359|530097993|FG000|Overall Study|Adverse Event|3|||
146982578|NCT01841359|530097993|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
146982579|NCT01875445|530097996|FG000|Overall Study|Lost to Follow-up|5|||
146982580|NCT01875445|530097997|FG001|Overall Study|Lost to Follow-up|0|||
146982581|NCT01875445|530097996|FG000|Overall Study|Withdrawal by Subject|2|||
146982582|NCT01875445|530097997|FG001|Overall Study|Withdrawal by Subject|0|||
146982583|NCT01102777|530097998|FG000|Overall Study|Death|2|||
146982584|NCT01102777|530097999|FG001|Overall Study|Death|6|||
146982585|NCT01102777|530097998|FG000|Overall Study|Lost to Follow-up|7|||
146982586|NCT01102777|530097999|FG001|Overall Study|Lost to Follow-up|10|||
146982587|NCT01752920|530098004|FG000|Overall Study|Adverse Event|1|||
146982588|NCT01752920|530098005|FG001|Overall Study|Adverse Event|0|||
146982589|NCT01752920|530098006|FG002|Overall Study|Adverse Event|5|||
146982590|NCT01752920|530098007|FG003|Overall Study|Adverse Event|10|||
146982591|NCT01752920|530098004|FG000|Overall Study|Clinical Disease Progression|6|||
146982592|NCT01752920|530098005|FG001|Overall Study|Clinical Disease Progression|4|||
146982593|NCT01752920|530098006|FG002|Overall Study|Clinical Disease Progression|1|||
146982594|NCT01752920|530098007|FG003|Overall Study|Clinical Disease Progression|13|||
146982595|NCT01752920|530098004|FG000|Overall Study|Physician Decision|1|||
146982596|NCT01752920|530098005|FG001|Overall Study|Physician Decision|0|||
146982597|NCT01752920|530098006|FG002|Overall Study|Physician Decision|0|||
146982598|NCT01752920|530098007|FG003|Overall Study|Physician Decision|3|||
146982599|NCT01752920|530098004|FG000|Overall Study|Radiographic Disease Progression|20|||
146982600|NCT01752920|530098005|FG001|Overall Study|Radiographic Disease Progression|7|||
146982601|NCT01752920|530098006|FG002|Overall Study|Radiographic Disease Progression|12|||
146982602|NCT01752920|530098007|FG003|Overall Study|Radiographic Disease Progression|29|||
146982603|NCT01752920|530098004|FG000|Overall Study|Study Terminated by Sponsor|0|||
146982604|NCT01752920|530098005|FG001|Overall Study|Study Terminated by Sponsor|0|||
146982605|NCT01752920|530098006|FG002|Overall Study|Study Terminated by Sponsor|0|||
146982606|NCT01752920|530098007|FG003|Overall Study|Study Terminated by Sponsor|1|||
146982607|NCT01752920|530098004|FG000|Overall Study|Withdrawal by Subject|0|||
146982608|NCT01752920|530098005|FG001|Overall Study|Withdrawal by Subject|1|||
146982609|NCT01752920|530098006|FG002|Overall Study|Withdrawal by Subject|0|||
146794668|NCT05868382|529420998|FG000|Overall Study|Lost to Follow-up|5|||
146794669|NCT05868382|529420999|FG001|Overall Study|Lost to Follow-up|0|||
146794670|NCT05868382|529421000|FG002|Overall Study|Lost to Follow-up|6|||
146794671|NCT05868382|529421001|FG003|Overall Study|Lost to Follow-up|4|||
146794672|NCT05868382|529421002|FG004|Overall Study|Lost to Follow-up|2|||
146794673|NCT05868382|529421003|FG005|Overall Study|Lost to Follow-up|6|||
146794674|NCT05868382|529420998|FG000|Overall Study|Withdrawal by Subject|1|||
146794675|NCT05868382|529420999|FG001|Overall Study|Withdrawal by Subject|0|||
146794676|NCT05868382|529421000|FG002|Overall Study|Withdrawal by Subject|0|||
146794677|NCT05868382|529421001|FG003|Overall Study|Withdrawal by Subject|0|||
146794678|NCT05868382|529421002|FG004|Overall Study|Withdrawal by Subject|1|||
146794679|NCT05868382|529421003|FG005|Overall Study|Withdrawal by Subject|0|||
146982610|NCT01752920|530098007|FG003|Overall Study|Withdrawal by Subject|1|||
146982611|NCT01752920|530098004|FG000|Overall Study|Lack of clinical benefit|1|||
146982612|NCT01752920|530098005|FG001|Overall Study|Lack of clinical benefit|1|||
146982613|NCT01752920|530098006|FG002|Overall Study|Lack of clinical benefit|1|||
146982614|NCT01752920|530098007|FG003|Overall Study|Lack of clinical benefit|1|||
146794680|NCT04585815|529421004|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
146794681|NCT04585815|529421005|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
146794682|NCT04585815|529421006|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
146794683|NCT04585815|529421007|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
146794684|NCT04585815|529421008|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
146794685|NCT04585815|529421009|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
146794686|NCT04585815|529421010|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
146794687|NCT04585815|529421004|FG000|Sub-study A- Treatment Phase|Death|0|||
146794688|NCT04585815|529421005|FG001|Sub-study A- Treatment Phase|Death|1|||
146794689|NCT04585815|529421006|FG002|Sub-study A- Treatment Phase|Death|0|||
146939591|NCT03363165|529936963|FG000|12-month Follow-up|Withdrawal by Subject|1|||
146939592|NCT03363165|529936964|FG001|12-month Follow-up|Withdrawal by Subject|1|||
146939593|NCT02255760|529936965|FG000|Overall Study|Lost to Follow-up|0|||
146939594|NCT02255760|529936966|FG001|Overall Study|Lost to Follow-up|1|||
146939595|NCT02255760|529936967|FG002|Overall Study|Lost to Follow-up|0|||
146939596|NCT02255760|529936968|FG003|Overall Study|Lost to Follow-up|0|||
146794690|NCT04585815|529421007|FG003|Sub-study A- Treatment Phase|Death|0|||
146794691|NCT04585815|529421008|FG004|Sub-study A- Treatment Phase|Death|0|||
146794692|NCT04585815|529421009|FG005|Sub-study A- Treatment Phase|Death|0|||
146794693|NCT04585815|529421010|FG006|Sub-study A- Treatment Phase|Death|0|||
146794694|NCT04585815|529421004|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
146794695|NCT04585815|529421005|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
146794696|NCT04585815|529421006|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
146794697|NCT04585815|529421007|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
146794698|NCT04585815|529421008|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
146794699|NCT04585815|529421009|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
146794700|NCT04585815|529421010|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
146794701|NCT04585815|529421004|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
146794702|NCT04585815|529421005|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
146794703|NCT04585815|529421006|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
146794704|NCT04585815|529421007|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
146794705|NCT04585815|529421008|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
146794706|NCT04585815|529421009|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
146794707|NCT04585815|529421010|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
146794708|NCT04585815|529421004|FG000|Sub-study A- Treatment Phase|Other|1|||
146794709|NCT04585815|529421005|FG001|Sub-study A- Treatment Phase|Other|0|||
146794710|NCT04585815|529421006|FG002|Sub-study A- Treatment Phase|Other|0|||
146794711|NCT04585815|529421007|FG003|Sub-study A- Treatment Phase|Other|0|||
146794712|NCT04585815|529421008|FG004|Sub-study A- Treatment Phase|Other|0|||
146794713|NCT04585815|529421009|FG005|Sub-study A- Treatment Phase|Other|0|||
146794714|NCT04585815|529421010|FG006|Sub-study A- Treatment Phase|Other|0|||
146794715|NCT04585815|529421004|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
146794716|NCT04585815|529421005|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
146794717|NCT04585815|529421006|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
146794718|NCT04585815|529421007|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
146794719|NCT04585815|529421008|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
146794720|NCT04585815|529421009|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
146794721|NCT04585815|529421010|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
146794722|NCT04585815|529421004|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
146794723|NCT04585815|529421005|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
146939597|NCT02255760|529936969|FG004|Overall Study|Lost to Follow-up|0|||
146939598|NCT00618813|529936970|FG000|Overall Study|Lack of Efficacy|1|||
146939599|NCT00618813|529936970|FG000|Overall Study|Physician Decision|2|||
146939600|NCT00618813|529936970|FG000|Overall Study|Withdrawal by Subject|1|||
146939601|NCT00003838|529936971|FG000|Overall Study|Death|0|||
146939602|NCT00003838|529936972|FG001|Overall Study|Death|12|||
146939603|NCT00003838|529936973|FG002|Overall Study|Death|7|||
146939604|NCT00003838|529936971|FG000|Overall Study|Lost to Follow-up|0|||
146939605|NCT00003838|529936972|FG001|Overall Study|Lost to Follow-up|1|||
146939606|NCT00003838|529936973|FG002|Overall Study|Lost to Follow-up|1|||
146939607|NCT00003838|529936971|FG000|Overall Study|Disease Progression|0|||
146794724|NCT04585815|529421006|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
146794725|NCT04585815|529421007|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
146794726|NCT04585815|529421008|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
146794727|NCT04585815|529421009|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
146939608|NCT00003838|529936972|FG001|Overall Study|Disease Progression|12|||
146982615|NCT01738581|530098008|FG000|Overall Study|Lost to Follow-up|1|||
146982616|NCT01738581|530098009|FG001|Overall Study|Lost to Follow-up|0|||
146939609|NCT00003838|529936973|FG002|Overall Study|Disease Progression|0|||
146939610|NCT00425113|529936974|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
146939611|NCT00425113|529936975|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
146939612|NCT00425113|529936974|FG000|Overall Study|diagnosis of abdominal TB|0|||
146794728|NCT04585815|529421010|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
146794729|NCT04585815|529421004|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
146794730|NCT04585815|529421005|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
146794731|NCT04585815|529421006|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
146794732|NCT04585815|529421007|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
146794733|NCT04585815|529421008|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
146794734|NCT04585815|529421009|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
146794735|NCT04585815|529421010|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
146794736|NCT04585815|529421004|FG000|Sub-study B- Treatment Phase|Death|0|||
146794737|NCT04585815|529421005|FG001|Sub-study B- Treatment Phase|Death|0|||
146794738|NCT04585815|529421006|FG002|Sub-study B- Treatment Phase|Death|0|||
146794739|NCT04585815|529421007|FG003|Sub-study B- Treatment Phase|Death|1|||
146794740|NCT04585815|529421008|FG004|Sub-study B- Treatment Phase|Death|0|||
146794741|NCT04585815|529421009|FG005|Sub-study B- Treatment Phase|Death|0|||
146794742|NCT04585815|529421010|FG006|Sub-study B- Treatment Phase|Death|0|||
146794743|NCT04585815|529421004|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
146794744|NCT04585815|529421005|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
146794745|NCT04585815|529421006|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
146794746|NCT04585815|529421007|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
146794747|NCT04585815|529421008|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
146794748|NCT04585815|529421009|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
146794749|NCT04585815|529421010|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
146794750|NCT04585815|529421004|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
146794751|NCT04585815|529421005|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
146794752|NCT04585815|529421006|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
146794753|NCT04585815|529421007|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
146794754|NCT04585815|529421008|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
146794755|NCT04585815|529421009|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
146794756|NCT04585815|529421010|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
146794757|NCT04585815|529421004|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
146794758|NCT04585815|529421005|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
146794759|NCT04585815|529421006|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
146794760|NCT04585815|529421007|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
146794761|NCT04585815|529421008|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
146794762|NCT04585815|529421009|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
146794763|NCT04585815|529421010|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
146794764|NCT04585815|529421004|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
146794765|NCT04585815|529421005|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
146794766|NCT04585815|529421006|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
146794767|NCT04585815|529421007|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
146794768|NCT04585815|529421008|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
146794769|NCT04585815|529421009|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
146794770|NCT04585815|529421010|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
146794771|NCT04585815|529421004|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
146794772|NCT04585815|529421005|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
146794773|NCT04585815|529421006|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
146794774|NCT04585815|529421007|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
146794775|NCT04585815|529421008|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
146794776|NCT04585815|529421009|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
146794777|NCT04585815|529421010|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
146794778|NCT04585815|529421004|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
146794779|NCT04585815|529421005|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
146794780|NCT04585815|529421006|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
146794781|NCT04585815|529421007|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
146794782|NCT04585815|529421008|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
146794783|NCT04585815|529421009|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
146794784|NCT04585815|529421010|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
146794785|NCT04585815|529421004|FG000|Sub-study B- Follow-up Phase|Death|0|||
146794786|NCT04585815|529421005|FG001|Sub-study B- Follow-up Phase|Death|0|||
146794787|NCT04585815|529421006|FG002|Sub-study B- Follow-up Phase|Death|1|||
146939613|NCT00425113|529936975|FG001|Overall Study|diagnosis of abdominal TB|1|||
146939614|NCT00425113|529936974|FG000|Overall Study|missing study drug more than 14 days|0|||
146939615|NCT00425113|529936975|FG001|Overall Study|missing study drug more than 14 days|1|||
146939616|NCT00425113|529936974|FG000|Overall Study|Withdrawal by Subject|1|||
146939617|NCT00425113|529936975|FG001|Overall Study|Withdrawal by Subject|0|||
146962309|NCT01049360|530021581|FG007|Period 1|Did not meet inc/exc criteria|1|||
146794788|NCT04585815|529421007|FG003|Sub-study B- Follow-up Phase|Death|3|||
146794789|NCT04585815|529421008|FG004|Sub-study B- Follow-up Phase|Death|0|||
146794790|NCT04585815|529421009|FG005|Sub-study B- Follow-up Phase|Death|0|||
146794791|NCT04585815|529421010|FG006|Sub-study B- Follow-up Phase|Death|1|||
146794792|NCT02497950|529421013|FG000|Overall Study|Death|209|||
146794793|NCT02497950|529421013|FG000|Overall Study|Transplanted|85|||
146794794|NCT02497950|529421013|FG000|Overall Study|Explanted|8|||
146794795|NCT02497950|529421013|FG000|Overall Study|Device Permanently Deactivated|4|||
146794796|NCT02497950|529421013|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
146794797|NCT02497950|529421013|FG000|Overall Study|Lost to Follow-up|6|||
146794798|NCT02497950|529421013|FG000|Overall Study|Withdrawal by Subject|2|||
146794799|NCT02497950|529421013|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
146794800|NCT02497950|529421013|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
146794801|NCT04660539|529421014|FG000|Overall Study|Adverse Event|10|||
146794802|NCT04660539|529421014|FG000|Overall Study|Lack of Efficacy|4|||
146794803|NCT04660539|529421014|FG000|Overall Study|Lost to Follow-up|5|||
146794804|NCT04660539|529421014|FG000|Overall Study|Non-Compliance With Study Drug|3|||
146794805|NCT04660539|529421014|FG000|Overall Study|Reason not Specified|12|||
146794806|NCT04660539|529421014|FG000|Overall Study|Pregnancy|2|||
146794807|NCT04660539|529421014|FG000|Overall Study|Protocol Violation|2|||
146794808|NCT04660539|529421014|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
146794809|NCT04660539|529421014|FG000|Overall Study|Withdrawal by Subject|21|||
146794810|NCT05618587|529421015|FG000|Overall Study|Lost to Follow-up|2|||
146794811|NCT05618587|529421016|FG001|Overall Study|Lost to Follow-up|0|||
146794812|NCT03756662|529421020|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
146794813|NCT05207956|529421027|FG000|Overall Study|Lost to follow up|1|||
146794814|NCT05207956|529421028|FG001|Overall Study|Lost to follow up|2|||
146794815|NCT01828112|529421031|FG000|Treatment Phase|Adverse Event|7|||
146794816|NCT01828112|529421032|FG001|Treatment Phase|Adverse Event|8|||
146794817|NCT01828112|529421033|FG002|Treatment Phase|Adverse Event|0|||
146794818|NCT01828112|529421031|FG000|Treatment Phase|Death|9|||
146794819|NCT01828112|529421032|FG001|Treatment Phase|Death|5|||
146794820|NCT01828112|529421033|FG002|Treatment Phase|Death|0|||
146794821|NCT01828112|529421031|FG000|Treatment Phase|No longer required treatment|0|||
146794822|NCT01828112|529421032|FG001|Treatment Phase|No longer required treatment|1|||
146794823|NCT01828112|529421033|FG002|Treatment Phase|No longer required treatment|0|||
146794824|NCT01828112|529421031|FG000|Treatment Phase|Physician Decision|6|||
146794825|NCT01828112|529421032|FG001|Treatment Phase|Physician Decision|7|||
146794826|NCT01828112|529421033|FG002|Treatment Phase|Physician Decision|0|||
146794827|NCT01828112|529421031|FG000|Treatment Phase|Pregnancy|1|||
146794828|NCT01828112|529421032|FG001|Treatment Phase|Pregnancy|0|||
146794829|NCT01828112|529421033|FG002|Treatment Phase|Pregnancy|0|||
146794830|NCT01828112|529421031|FG000|Treatment Phase|Progressive disease|79|||
146794831|NCT01828112|529421032|FG001|Treatment Phase|Progressive disease|87|||
146794832|NCT01828112|529421033|FG002|Treatment Phase|Progressive disease|0|||
146794833|NCT01828112|529421031|FG000|Treatment Phase|Study terminated by sponsor|1|||
146794834|NCT01828112|529421032|FG001|Treatment Phase|Study terminated by sponsor|0|||
146794835|NCT01828112|529421033|FG002|Treatment Phase|Study terminated by sponsor|0|||
146794836|NCT01828112|529421031|FG000|Treatment Phase|Subject/guardian decision|12|||
146794837|NCT01828112|529421032|FG001|Treatment Phase|Subject/guardian decision|8|||
146794838|NCT01828112|529421033|FG002|Treatment Phase|Subject/guardian decision|0|||
146794839|NCT01828112|529421031|FG000|Extension Treatment Phase|Adverse Event|0|||
146794840|NCT01828112|529421032|FG001|Extension Treatment Phase|Adverse Event|0|||
146794841|NCT01828112|529421033|FG002|Extension Treatment Phase|Adverse Event|6|||
146794842|NCT01828112|529421031|FG000|Extension Treatment Phase|Death|0|||
146794843|NCT01828112|529421032|FG001|Extension Treatment Phase|Death|0|||
146794844|NCT01828112|529421033|FG002|Extension Treatment Phase|Death|17|||
146794845|NCT01828112|529421031|FG000|Extension Treatment Phase|Physician Decision|0|||
146794846|NCT01828112|529421032|FG001|Extension Treatment Phase|Physician Decision|0|||
146794847|NCT01828112|529421033|FG002|Extension Treatment Phase|Physician Decision|5|||
146794848|NCT01828112|529421031|FG000|Extension Treatment Phase|Progressive disease|0|||
146794849|NCT01828112|529421032|FG001|Extension Treatment Phase|Progressive disease|0|||
146794850|NCT01828112|529421033|FG002|Extension Treatment Phase|Progressive disease|46|||
146794851|NCT01828112|529421031|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
146794852|NCT01828112|529421032|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
146794853|NCT01828112|529421033|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
146794854|NCT01828112|529421031|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
146794855|NCT01828112|529421032|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
146794856|NCT01828112|529421033|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
146794857|NCT04308681|529421039|FG000|Pre-Treatment|Not reported|1|||
146794858|NCT04308681|529421040|FG001|Pre-Treatment|Not reported|1|||
146794859|NCT04308681|529421041|FG002|Pre-Treatment|Not reported|0|||
146794860|NCT04308681|529421042|FG003|Pre-Treatment|Not reported|0|||
146794861|NCT04308681|529421043|FG004|Pre-Treatment|Not reported|0|||
146794862|NCT04308681|529421044|FG005|Pre-Treatment|Not reported|2|||
146794863|NCT04308681|529421045|FG006|Pre-Treatment|Not reported|0|||
146794864|NCT04308681|529421046|FG007|Pre-Treatment|Not reported|0|||
146794865|NCT04308681|529421039|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
146939618|NCT04737759|529936976|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
146939619|NCT04737759|529936977|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
146939620|NCT04737759|529936976|FG000|Overall Study|Death|2|||
146939621|NCT04737759|529936977|FG001|Overall Study|Death|0|||
146939622|NCT04737759|529936976|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
146939623|NCT04737759|529936977|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
146939624|NCT04737759|529936976|FG000|Overall Study|Lost to Follow-up|4|||
146939625|NCT04737759|529936977|FG001|Overall Study|Lost to Follow-up|12|||
146939626|NCT01484561|529936978|FG000|Overall Study|Lack of Efficacy|3|||
146939627|NCT01484561|529936979|FG001|Overall Study|Lack of Efficacy|1|||
146939628|NCT01484561|529936978|FG000|Overall Study|Lost to Follow-up|1|||
146939629|NCT01484561|529936979|FG001|Overall Study|Lost to Follow-up|0|||
146939630|NCT01484561|529936978|FG000|Overall Study|Withdrawal by Subject|3|||
146939631|NCT01484561|529936979|FG001|Overall Study|Withdrawal by Subject|0|||
146939632|NCT01484561|529936978|FG000|Overall Study|Other|1|||
146939633|NCT01484561|529936979|FG001|Overall Study|Other|1|||
146939634|NCT01484561|529936978|FG000|Overall Study|Adverse Event|1|||
146794866|NCT04308681|529421040|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
146794867|NCT04308681|529421041|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
146794868|NCT04308681|529421042|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
146794869|NCT04308681|529421043|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
146794870|NCT04308681|529421044|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
146794871|NCT04308681|529421045|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
146794872|NCT04308681|529421046|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
146794873|NCT04308681|529421039|FG000|Treatment up to Week 26|Other reasons|2|||
146794874|NCT04308681|529421040|FG001|Treatment up to Week 26|Other reasons|0|||
146794875|NCT04308681|529421041|FG002|Treatment up to Week 26|Other reasons|0|||
146794876|NCT04308681|529421042|FG003|Treatment up to Week 26|Other reasons|0|||
146794877|NCT04308681|529421043|FG004|Treatment up to Week 26|Other reasons|1|||
146794878|NCT04308681|529421044|FG005|Treatment up to Week 26|Other reasons|1|||
146794879|NCT04308681|529421045|FG006|Treatment up to Week 26|Other reasons|0|||
146794880|NCT04308681|529421046|FG007|Treatment up to Week 26|Other reasons|0|||
146794881|NCT04308681|529421039|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
146794882|NCT04308681|529421040|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
146794883|NCT04308681|529421041|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
146794884|NCT04308681|529421042|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
146794885|NCT04308681|529421043|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
146794886|NCT04308681|529421044|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
146794887|NCT04308681|529421045|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
146794888|NCT04308681|529421046|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
146794889|NCT04308681|529421039|FG000|Treatment up to Week 26|Adverse Event|6|||
146794890|NCT04308681|529421040|FG001|Treatment up to Week 26|Adverse Event|5|||
146794891|NCT04308681|529421041|FG002|Treatment up to Week 26|Adverse Event|5|||
146794892|NCT04308681|529421042|FG003|Treatment up to Week 26|Adverse Event|0|||
146794893|NCT04308681|529421043|FG004|Treatment up to Week 26|Adverse Event|6|||
146794894|NCT04308681|529421044|FG005|Treatment up to Week 26|Adverse Event|1|||
146794895|NCT04308681|529421045|FG006|Treatment up to Week 26|Adverse Event|0|||
146794896|NCT04308681|529421046|FG007|Treatment up to Week 26|Adverse Event|0|||
146794897|NCT04308681|529421039|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
146794898|NCT04308681|529421040|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
146794899|NCT04308681|529421041|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
146794900|NCT04308681|529421042|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
146794901|NCT04308681|529421043|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
146794902|NCT04308681|529421044|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
146794903|NCT04308681|529421045|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
146794904|NCT04308681|529421046|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
146794905|NCT04308681|529421039|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
146794906|NCT04308681|529421040|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
146794907|NCT04308681|529421041|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
146794908|NCT04308681|529421042|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
146794909|NCT04308681|529421043|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
146794910|NCT04308681|529421044|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
146794911|NCT04308681|529421045|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
146794912|NCT04308681|529421046|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
146794913|NCT04308681|529421039|FG000|OTE - 26 Weeks|Death|0|||
146794914|NCT04308681|529421040|FG001|OTE - 26 Weeks|Death|1|||
146794915|NCT04308681|529421041|FG002|OTE - 26 Weeks|Death|0|||
146794916|NCT04308681|529421042|FG003|OTE - 26 Weeks|Death|0|||
146794917|NCT04308681|529421043|FG004|OTE - 26 Weeks|Death|0|||
146794918|NCT04308681|529421044|FG005|OTE - 26 Weeks|Death|0|||
146794919|NCT04308681|529421045|FG006|OTE - 26 Weeks|Death|1|||
146794920|NCT04308681|529421046|FG007|OTE - 26 Weeks|Death|0|||
146794921|NCT04308681|529421039|FG000|OTE - 26 Weeks|Adverse Event|0|||
146794922|NCT04308681|529421040|FG001|OTE - 26 Weeks|Adverse Event|2|||
146794923|NCT04308681|529421041|FG002|OTE - 26 Weeks|Adverse Event|8|||
146794924|NCT04308681|529421042|FG003|OTE - 26 Weeks|Adverse Event|3|||
146794925|NCT04308681|529421043|FG004|OTE - 26 Weeks|Adverse Event|0|||
146794926|NCT04308681|529421044|FG005|OTE - 26 Weeks|Adverse Event|1|||
146794927|NCT04308681|529421045|FG006|OTE - 26 Weeks|Adverse Event|2|||
146794928|NCT04308681|529421046|FG007|OTE - 26 Weeks|Adverse Event|0|||
146794929|NCT04308681|529421039|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
146794930|NCT04308681|529421040|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
146794931|NCT04308681|529421041|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
146794932|NCT04308681|529421042|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
146794933|NCT04308681|529421043|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
146794934|NCT04308681|529421044|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
146794935|NCT04308681|529421045|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
146794936|NCT04308681|529421046|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
146794937|NCT05873556|529421047|FG000|Overall Study|Lost to Follow-up|4|||
146794938|NCT05873556|529421048|FG001|Overall Study|Lost to Follow-up|1|||
146794939|NCT03606408|529421049|FG000|Overall Study|Adverse Event|13|||
146794940|NCT03606408|529421049|FG000|Overall Study|Withdrawal by Subject|7|||
146794941|NCT03606408|529421049|FG000|Overall Study|Physician Decision|4|||
146794942|NCT03606408|529421049|FG000|Overall Study|Lack of Efficacy|2|||
146794943|NCT03606408|529421049|FG000|Overall Study|Death|1|||
146794944|NCT03606408|529421049|FG000|Overall Study|new therapy for study indication|1|||
146794945|NCT04862234|529421055|FG000|Overall Study|Surgery cancellation|1|||
146794946|NCT04862234|529421056|FG001|Overall Study|Surgery cancellation|2|||
146794947|NCT04862234|529421055|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
146794948|NCT04862234|529421056|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
146794949|NCT04862234|529421055|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
146794950|NCT04862234|529421056|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
146794951|NCT03292484|529421057|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
146794952|NCT03292484|529421057|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
146794953|NCT03292484|529421057|FG000|Overall Study|Protocol Violation|2|||
146794954|NCT03292484|529421057|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
146794955|NCT03292484|529421057|FG000|Overall Study|Sponsor decision|349|||
146794956|NCT03292484|529421057|FG000|Overall Study|Lost to Follow-up|7|||
146794957|NCT03292484|529421057|FG000|Overall Study|Coronavirus Disease 2019|1|||
146794958|NCT03292484|529421057|FG000|Overall Study|Other|20|||
146794959|NCT05069896|529421059|FG000|Overall Study|Adverse Event|0|||
146794960|NCT05069896|529421060|FG001|Overall Study|Adverse Event|1|||
146794961|NCT05069896|529421061|FG002|Overall Study|Adverse Event|1|||
146794962|NCT05069896|529421062|FG003|Overall Study|Adverse Event|0|||
146794963|NCT05069896|529421063|FG004|Overall Study|Adverse Event|0|||
146794964|NCT05069896|529421064|FG005|Overall Study|Adverse Event|0|||
146794965|NCT05069896|529421059|FG000|Overall Study|Lost to Follow-up|0|||
146794966|NCT05069896|529421060|FG001|Overall Study|Lost to Follow-up|0|||
146794967|NCT05069896|529421061|FG002|Overall Study|Lost to Follow-up|1|||
146794968|NCT05069896|529421062|FG003|Overall Study|Lost to Follow-up|0|||
146794969|NCT05069896|529421063|FG004|Overall Study|Lost to Follow-up|1|||
146794970|NCT05069896|529421064|FG005|Overall Study|Lost to Follow-up|2|||
146794971|NCT04068831|529421065|FG000|Overall Study|Disease Progression|10|||
146794972|NCT04068831|529421066|FG001|Overall Study|Disease Progression|8|||
146794973|NCT02839265|529421068|FG000|Overall Study|Screen Failure|2|||
146794974|NCT02839265|529421068|FG000|Overall Study|Death|1|||
146794975|NCT02839265|529421068|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
146794976|NCT04167553|529421071|FG000|Overall Study|Withdrawal by Subject|1|||
146794977|NCT04167553|529421072|FG001|Overall Study|Withdrawal by Subject|0|||
146982617|NCT00210626|530098010|FG000|Overall Study|Adverse Event|1|||
146982618|NCT00210626|530098011|FG001|Overall Study|Adverse Event|2|||
146982619|NCT00210626|530098010|FG000|Overall Study|Protocol Violation|1|||
146982620|NCT00210626|530098011|FG001|Overall Study|Protocol Violation|5|||
146982621|NCT00210626|530098010|FG000|Overall Study|Lost to Follow-up|11|||
146982622|NCT00210626|530098011|FG001|Overall Study|Lost to Follow-up|11|||
146982623|NCT00210626|530098010|FG000|Overall Study|Death|1|||
146982624|NCT00210626|530098011|FG001|Overall Study|Death|0|||
146982625|NCT00210626|530098010|FG000|Overall Study|Withdrawal by Subject|29|||
146982626|NCT00210626|530098011|FG001|Overall Study|Withdrawal by Subject|20|||
146982627|NCT00210626|530098010|FG000|Overall Study|Physician Decision|0|||
146982628|NCT00210626|530098011|FG001|Overall Study|Physician Decision|2|||
146794978|NCT04167553|529421073|FG002|Overall Study|Withdrawal by Subject|1|||
146794979|NCT04167553|529421074|FG003|Overall Study|Withdrawal by Subject|2|||
146794980|NCT04167553|529421075|FG004|Overall Study|Withdrawal by Subject|1|||
146794981|NCT04167553|529421076|FG005|Overall Study|Withdrawal by Subject|0|||
146982629|NCT00210626|530098010|FG000|Overall Study|Sponser Request|1|||
146794982|NCT04167553|529421077|FG006|Overall Study|Withdrawal by Subject|0|||
146982630|NCT00210626|530098011|FG001|Overall Study|Sponser Request|0|||
146982631|NCT00210626|530098010|FG000|Overall Study|Other|4|||
146982632|NCT00210626|530098011|FG001|Overall Study|Other|5|||
146982633|NCT00771901|530098012|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
146982634|NCT00771901|530098013|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
146982635|NCT00771901|530098014|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
146982636|NCT02862535|530098015|FG000|Overall Study|Death|7|||
146982637|NCT02862535|530098016|FG001|Overall Study|Death|3|||
146982638|NCT02862535|530098017|FG002|Overall Study|Death|2|||
146982639|NCT02862535|530098018|FG003|Overall Study|Death|5|||
146982640|NCT02862535|530098015|FG000|Overall Study|Study Terminated by Sponsor|1|||
146982641|NCT02862535|530098016|FG001|Overall Study|Study Terminated by Sponsor|3|||
146982642|NCT02862535|530098017|FG002|Overall Study|Study Terminated by Sponsor|8|||
146982643|NCT02862535|530098018|FG003|Overall Study|Study Terminated by Sponsor|5|||
146982644|NCT02862535|530098015|FG000|Overall Study|Enrolled, not Treated|1|||
146794983|NCT04167553|529421071|FG000|Overall Study|Physician Decision|0|||
146794984|NCT04167553|529421072|FG001|Overall Study|Physician Decision|0|||
146794985|NCT04167553|529421073|FG002|Overall Study|Physician Decision|0|||
146794986|NCT04167553|529421074|FG003|Overall Study|Physician Decision|0|||
146794987|NCT04167553|529421075|FG004|Overall Study|Physician Decision|2|||
146794988|NCT04167553|529421076|FG005|Overall Study|Physician Decision|2|||
146794989|NCT04167553|529421077|FG006|Overall Study|Physician Decision|0|||
146794990|NCT04167553|529421071|FG000|Overall Study|Lost to Follow-up|0|||
146794991|NCT04167553|529421072|FG001|Overall Study|Lost to Follow-up|0|||
146794992|NCT04167553|529421073|FG002|Overall Study|Lost to Follow-up|2|||
146794993|NCT04167553|529421074|FG003|Overall Study|Lost to Follow-up|0|||
146794994|NCT04167553|529421075|FG004|Overall Study|Lost to Follow-up|0|||
146794995|NCT04167553|529421076|FG005|Overall Study|Lost to Follow-up|0|||
146794996|NCT04167553|529421077|FG006|Overall Study|Lost to Follow-up|0|||
146794997|NCT05660434|529421079|FG000|Overall Study|Never obtained study materials|2|||
146794998|NCT05660434|529421080|FG001|Overall Study|Never obtained study materials|1|||
146794999|NCT04479761|529421095|FG000|Overall Study|could not perform the balance tasks|1|||
146795000|NCT04479761|529421096|FG001|Overall Study|could not perform the balance tasks|0|||
146795001|NCT04479761|529421097|FG002|Overall Study|could not perform the balance tasks|0|||
146795002|NCT04479761|529421095|FG000|Overall Study|Adverse Event|1|||
146795003|NCT04479761|529421096|FG001|Overall Study|Adverse Event|0|||
146795004|NCT04479761|529421097|FG002|Overall Study|Adverse Event|0|||
146795005|NCT04479761|529421095|FG000|Overall Study|one control did not meet screening criteria|0|||
146795006|NCT04479761|529421096|FG001|Overall Study|one control did not meet screening criteria|0|||
146795007|NCT04479761|529421097|FG002|Overall Study|one control did not meet screening criteria|1|||
146795008|NCT04479761|529421095|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
146795009|NCT04479761|529421096|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
146795010|NCT04479761|529421097|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
146795011|NCT03106740|529422174|FG000|Overall Study|Lost to Follow-up|2|||
146795012|NCT03106740|529422175|FG001|Overall Study|Lost to Follow-up|2|||
146795013|NCT03106740|529422174|FG000|Overall Study|Withdrawal by Subject|2|||
146795014|NCT03106740|529422175|FG001|Overall Study|Withdrawal by Subject|4|||
146795015|NCT03106740|529422174|FG000|Overall Study|Physician Decision|0|||
146795016|NCT03106740|529422175|FG001|Overall Study|Physician Decision|1|||
146795017|NCT03106740|529422174|FG000|Overall Study|Partial data|1|||
146795018|NCT03106740|529422175|FG001|Overall Study|Partial data|0|||
146795019|NCT04565990|529422176|FG000|Overall Study|Death|5|||
146795020|NCT04565990|529422176|FG000|Overall Study|Lost to Follow-up|1|||
146795021|NCT04565990|529422176|FG000|Overall Study|Withdrawal by Subject|1|||
146795022|NCT04797858|529422177|FG000|Overall Study|Withdrawal by Subject|0|||
146795023|NCT04797858|529422178|FG001|Overall Study|Withdrawal by Subject|1|||
146795024|NCT04797858|529422177|FG000|Overall Study|Excluded due to administrative error|7|||
146795025|NCT04797858|529422178|FG001|Overall Study|Excluded due to administrative error|8|||
146795026|NCT05269966|529422189|FG000|Overall Study|Adverse Event|4|||
146795027|NCT05269966|529422189|FG000|Overall Study|Withdrawal by Subject|1|||
146795028|NCT05269966|529422189|FG000|Overall Study|Lost to Follow-up|4|||
146795029|NCT05269966|529422189|FG000|Overall Study|Physician Decision|1|||
146795030|NCT03476343|529422205|FG000|Overall Study|Clinical exam moved to another scanner|7|||
146795031|NCT03476343|529422205|FG000|Overall Study|Clinical order cancelled|4|||
146795032|NCT03476343|529422205|FG000|Overall Study|Neonate did not settle down for the scan|1|||
146795033|NCT05147116|529422206|FG000|Overall Study|Withdrawal by Subject|0|||
146795034|NCT05147116|529422207|FG001|Overall Study|Withdrawal by Subject|1|||
146795035|NCT05204654|529422210|FG000|Overall Study|Study terminated due to time restraint|2|||
146795036|NCT05204654|529422211|FG001|Overall Study|Study terminated due to time restraint|2|||
146795037|NCT01221948|529422212|FG000|Overall Study|Physician Decision|5|||
146795038|NCT01221948|529422212|FG000|Overall Study|Withdrawal by Subject|2|||
146795039|NCT01221948|529422212|FG000|Overall Study|not disclosed|2|||
146982645|NCT02862535|530098016|FG001|Overall Study|Enrolled, not Treated|0|||
146982646|NCT02862535|530098017|FG002|Overall Study|Enrolled, not Treated|0|||
146795040|NCT01221948|529422212|FG000|Overall Study|Death|1|||
146795041|NCT01221948|529422212|FG000|Overall Study|Protocol Violation|4|||
146795042|NCT02446236|529422213|FG000|Overall Study|Screen Failure|1|||
146795043|NCT02446236|529422214|FG001|Overall Study|Screen Failure|0|||
146795044|NCT02446236|529422215|FG002|Overall Study|Screen Failure|1|||
146795045|NCT02446236|529422213|FG000|Overall Study|Actively Receiving Therapy|0|||
146795046|NCT02446236|529422214|FG001|Overall Study|Actively Receiving Therapy|0|||
146795047|NCT02446236|529422215|FG002|Overall Study|Actively Receiving Therapy|1|||
146795048|NCT05290493|529422220|FG000|Overall Study|Withdrawal by Subject|2|||
146795049|NCT05290493|529422221|FG001|Overall Study|Withdrawal by Subject|2|||
146795050|NCT05290493|529422220|FG000|Overall Study|Adverse Event|1|||
146795051|NCT05290493|529422221|FG001|Overall Study|Adverse Event|0|||
146795052|NCT05012163|529422225|FG000|Overall Study|Protocol Violation|0|||
146795053|NCT05012163|529422226|FG001|Overall Study|Protocol Violation|0|||
146795054|NCT05012163|529422227|FG002|Overall Study|Protocol Violation|1|||
146795055|NCT05012163|529422228|FG003|Overall Study|Protocol Violation|1|||
146795056|NCT04003246|529422231|FG000|Overall Study|Death|9|||
146795057|NCT03673501|529422241|FG000|Overall Study|Participants ongoing.|36|||
146795058|NCT03673501|529422242|FG001|Overall Study|Participants ongoing.|24|||
146795059|NCT05237284|529422243|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
146795060|NCT05237284|529422244|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
146795061|NCT05237284|529422245|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
146795062|NCT05237284|529422246|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
146795063|NCT05237284|529422243|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
146795064|NCT05237284|529422244|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
146795065|NCT05237284|529422245|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
146795066|NCT05237284|529422246|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
146795067|NCT05237284|529422243|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
146795068|NCT05237284|529422244|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
146795069|NCT05237284|529422245|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
146795070|NCT05237284|529422246|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
146795071|NCT05237284|529422243|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
146795072|NCT05237284|529422244|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
146795073|NCT05237284|529422245|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
146795074|NCT05237284|529422246|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
146795075|NCT05237284|529422243|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
146795076|NCT05237284|529422244|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
146795077|NCT05237284|529422245|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
146795078|NCT05237284|529422246|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
146795079|NCT05237284|529422243|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
146795080|NCT05237284|529422244|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
146795081|NCT05237284|529422245|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
146795082|NCT05237284|529422246|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
146795083|NCT05237284|529422243|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
146795084|NCT05237284|529422244|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
146795085|NCT05237284|529422245|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
146795086|NCT05237284|529422246|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
146795087|NCT05237284|529422243|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
146795088|NCT05237284|529422244|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
146795089|NCT05237284|529422245|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
146795090|NCT05237284|529422246|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
146795091|NCT05237284|529422243|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
146795092|NCT05237284|529422244|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
146795093|NCT05237284|529422245|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
146795094|NCT05237284|529422246|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
146795095|NCT04599634|529422247|FG000|Overall Study|Dose limiting toxicity|0|||
146795096|NCT04599634|529422248|FG001|Overall Study|Dose limiting toxicity|0|||
146795097|NCT04599634|529422249|FG002|Overall Study|Dose limiting toxicity|2|||
146795098|NCT04599634|529422250|FG003|Overall Study|Dose limiting toxicity|0|||
146795099|NCT03714815|529422251|FG000|Overall Study|Physician Decision|2|||
146795100|NCT03714815|529422251|FG000|Overall Study|Withdrawal by Subject|2|||
146795101|NCT03714815|529422251|FG000|Overall Study|Death|11|||
146795102|NCT03733925|529422256|FG000|Overall Study|Lost to Follow-up|1|||
146795103|NCT03733925|529422256|FG000|Overall Study|Withdrawal by Subject|2|||
146795104|NCT03733925|529422256|FG000|Overall Study|Adverse Event|2|||
146795105|NCT03733925|529422256|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146795106|NCT03213873|529422257|FG000|Overall Study|Withdrawal by Subject|8|||
146795107|NCT03213873|529422258|FG001|Overall Study|Withdrawal by Subject|9|||
146795108|NCT03213873|529422257|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
146795109|NCT03213873|529422258|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
146795110|NCT03213873|529422257|FG000|Overall Study|Lost to Follow-up|0|||
146939635|NCT01484561|529936979|FG001|Overall Study|Adverse Event|4|||
146939636|NCT03371251|529936980|FG000|Overall Study|Withdrawal by Subject|1|||
146939637|NCT03371251|529936981|FG001|Overall Study|Withdrawal by Subject|0|||
146939638|NCT03371251|529936982|FG002|Overall Study|Withdrawal by Subject|1|||
146939639|NCT03371251|529936983|FG003|Overall Study|Withdrawal by Subject|0|||
146939640|NCT03371251|529936984|FG004|Overall Study|Withdrawal by Subject|2|||
146939641|NCT03371251|529936985|FG005|Overall Study|Withdrawal by Subject|2|||
146939642|NCT03371251|529936980|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
146939643|NCT03371251|529936981|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
146939644|NCT03371251|529936982|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
146939645|NCT03371251|529936983|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
146939646|NCT03371251|529936984|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
146939647|NCT03371251|529936985|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
146939648|NCT03371251|529936980|FG000|Overall Study|Adverse Event|0|||
146939649|NCT03371251|529936981|FG001|Overall Study|Adverse Event|0|||
146795111|NCT03213873|529422258|FG001|Overall Study|Lost to Follow-up|2|||
146795112|NCT04709419|529422265|FG000|Overall Study|Physician Decision|1|||
146795113|NCT04709419|529422266|FG001|Overall Study|Physician Decision|0|||
146795114|NCT05683340|529422267|FG000|Overall Study|Adverse Event|1|||
146795115|NCT05683340|529422268|FG001|Overall Study|Adverse Event|1|||
146795116|NCT05683340|529422267|FG000|Overall Study|Protocol Violation|1|||
146795117|NCT05683340|529422268|FG001|Overall Study|Protocol Violation|0|||
146795118|NCT05683340|529422267|FG000|Overall Study|Withdrawal by Subject|0|||
146795119|NCT05683340|529422268|FG001|Overall Study|Withdrawal by Subject|2|||
146795120|NCT02224144|529422269|FG000|Overall Study|Lost to Follow-up|3|||
146795121|NCT02224144|529422270|FG001|Overall Study|Lost to Follow-up|1|||
146795122|NCT02224144|529422269|FG000|Overall Study|Death|2|||
146795123|NCT02224144|529422270|FG001|Overall Study|Death|0|||
146795124|NCT02224144|529422269|FG000|Overall Study|Withdrawal by Subject|0|||
146795125|NCT02224144|529422270|FG001|Overall Study|Withdrawal by Subject|1|||
146795126|NCT03505008|529422271|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
146795127|NCT03505008|529422272|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
146795128|NCT03505008|529422273|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
146795129|NCT03505008|529422274|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
146795130|NCT03505008|529422271|FG000|Before Week 24 Randomization|Adverse Event|10|||
146795131|NCT03505008|529422272|FG001|Before Week 24 Randomization|Adverse Event|0|||
146795132|NCT03505008|529422273|FG002|Before Week 24 Randomization|Adverse Event|0|||
146795133|NCT03505008|529422274|FG003|Before Week 24 Randomization|Adverse Event|0|||
146795134|NCT03505008|529422271|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
146795135|NCT03505008|529422272|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
146795136|NCT03505008|529422273|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
146795137|NCT03505008|529422274|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
146795138|NCT03505008|529422271|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
146795139|NCT03505008|529422272|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
146795140|NCT03505008|529422273|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
146795141|NCT03505008|529422274|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
146795142|NCT03505008|529422271|FG000|Before Week 24 Randomization|Physician Decision|2|||
146795143|NCT03505008|529422272|FG001|Before Week 24 Randomization|Physician Decision|0|||
146795144|NCT03505008|529422273|FG002|Before Week 24 Randomization|Physician Decision|0|||
146795145|NCT03505008|529422274|FG003|Before Week 24 Randomization|Physician Decision|0|||
146795146|NCT03505008|529422271|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
146795147|NCT03505008|529422272|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
146795148|NCT03505008|529422273|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
146795149|NCT03505008|529422274|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
146795150|NCT03505008|529422271|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
146795151|NCT03505008|529422272|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
146795152|NCT03505008|529422273|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
146795153|NCT03505008|529422274|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
146795154|NCT03505008|529422271|FG000|Before Week 24 Randomization|Complication|1|||
146795155|NCT03505008|529422272|FG001|Before Week 24 Randomization|Complication|0|||
146795156|NCT03505008|529422273|FG002|Before Week 24 Randomization|Complication|0|||
146795157|NCT03505008|529422274|FG003|Before Week 24 Randomization|Complication|0|||
146795158|NCT03505008|529422271|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
146795159|NCT03505008|529422272|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
146939650|NCT03371251|529936982|FG002|Overall Study|Adverse Event|0|||
146795160|NCT03505008|529422273|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
146795161|NCT03505008|529422274|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
146795162|NCT03505008|529422271|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
146795163|NCT03505008|529422272|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
146795164|NCT03505008|529422273|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
146795165|NCT03505008|529422274|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
146795166|NCT03505008|529422271|FG000|After Week 24 Randomization|Adverse Event|0|||
146795167|NCT03505008|529422272|FG001|After Week 24 Randomization|Adverse Event|1|||
146795168|NCT03505008|529422273|FG002|After Week 24 Randomization|Adverse Event|2|||
146795169|NCT03505008|529422274|FG003|After Week 24 Randomization|Adverse Event|2|||
146795170|NCT03505008|529422271|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
146795171|NCT03505008|529422272|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
146795172|NCT03505008|529422273|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
146795173|NCT03505008|529422274|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
146795174|NCT03505008|529422271|FG000|After Week 24 Randomization|Protocol Violation|0|||
146795175|NCT03505008|529422272|FG001|After Week 24 Randomization|Protocol Violation|0|||
146795176|NCT03505008|529422273|FG002|After Week 24 Randomization|Protocol Violation|1|||
146795177|NCT03505008|529422274|FG003|After Week 24 Randomization|Protocol Violation|0|||
146795178|NCT03824366|529422277|FG000|Overall Study|Death|1|||
146795179|NCT03824366|529422277|FG000|Overall Study|Previously unidentified metal artifact|1|||
146795180|NCT03824366|529422277|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
146795181|NCT03824366|529422277|FG000|Overall Study|Withdrawal by Subject|1|||
146795182|NCT04544007|529422280|FG000|Overall Study|Withdrawal by Subject|1|||
146795183|NCT04544007|529422280|FG000|Overall Study|Confirmed Progressive Disease|1|||
146795184|NCT02988661|529422285|FG000|Overall Study|Death|2|||
146795185|NCT02988661|529422286|FG001|Overall Study|Death|18|||
146795186|NCT02988661|529422285|FG000|Overall Study|Lost to Follow-up|0|||
146795187|NCT02988661|529422286|FG001|Overall Study|Lost to Follow-up|33|||
146795188|NCT02988661|529422285|FG000|Overall Study|Withdrawal by Subject|0|||
146795189|NCT02988661|529422286|FG001|Overall Study|Withdrawal by Subject|6|||
146795190|NCT02988661|529422285|FG000|Overall Study|Unable to complete the 18-month survey|1|||
146795191|NCT02988661|529422286|FG001|Overall Study|Unable to complete the 18-month survey|27|||
146795192|NCT02323880|529422289|FG000|Overall Study|Adverse Event|2|||
146795193|NCT02323880|529422290|FG001|Overall Study|Adverse Event|0|||
146795194|NCT02323880|529422291|FG002|Overall Study|Adverse Event|1|||
146795195|NCT02323880|529422292|FG003|Overall Study|Adverse Event|1|||
146795196|NCT02323880|529422293|FG004|Overall Study|Adverse Event|1|||
146795197|NCT02323880|529422294|FG005|Overall Study|Adverse Event|0|||
146795198|NCT02323880|529422295|FG006|Overall Study|Adverse Event|1|||
146795199|NCT02323880|529422296|FG007|Overall Study|Adverse Event|0|||
146795200|NCT02323880|529422289|FG000|Overall Study|Death|0|||
146795201|NCT02323880|529422290|FG001|Overall Study|Death|0|||
146795202|NCT02323880|529422291|FG002|Overall Study|Death|0|||
146795203|NCT02323880|529422292|FG003|Overall Study|Death|0|||
146795204|NCT02323880|529422293|FG004|Overall Study|Death|0|||
146795205|NCT02323880|529422294|FG005|Overall Study|Death|1|||
146795206|NCT02323880|529422295|FG006|Overall Study|Death|0|||
146795207|NCT02323880|529422296|FG007|Overall Study|Death|0|||
146795208|NCT02323880|529422289|FG000|Overall Study|Lack of Efficacy|4|||
146795209|NCT02323880|529422290|FG001|Overall Study|Lack of Efficacy|11|||
146795210|NCT02323880|529422291|FG002|Overall Study|Lack of Efficacy|5|||
146795211|NCT02323880|529422292|FG003|Overall Study|Lack of Efficacy|5|||
146795212|NCT02323880|529422293|FG004|Overall Study|Lack of Efficacy|4|||
146795213|NCT02323880|529422294|FG005|Overall Study|Lack of Efficacy|8|||
146795214|NCT02323880|529422295|FG006|Overall Study|Lack of Efficacy|4|||
146795215|NCT02323880|529422296|FG007|Overall Study|Lack of Efficacy|6|||
146795216|NCT02323880|529422289|FG000|Overall Study|Physician Decision|0|||
146795217|NCT02323880|529422290|FG001|Overall Study|Physician Decision|0|||
146795218|NCT02323880|529422291|FG002|Overall Study|Physician Decision|0|||
146795219|NCT02323880|529422292|FG003|Overall Study|Physician Decision|0|||
146795220|NCT02323880|529422293|FG004|Overall Study|Physician Decision|1|||
146795221|NCT02323880|529422294|FG005|Overall Study|Physician Decision|1|||
146795222|NCT02323880|529422295|FG006|Overall Study|Physician Decision|1|||
146795223|NCT02323880|529422296|FG007|Overall Study|Physician Decision|0|||
146795224|NCT02323880|529422289|FG000|Overall Study|Withdrawal by Subject|0|||
146795225|NCT02323880|529422290|FG001|Overall Study|Withdrawal by Subject|2|||
146795226|NCT02323880|529422291|FG002|Overall Study|Withdrawal by Subject|0|||
146795227|NCT02323880|529422292|FG003|Overall Study|Withdrawal by Subject|0|||
146795228|NCT02323880|529422293|FG004|Overall Study|Withdrawal by Subject|0|||
146795229|NCT02323880|529422294|FG005|Overall Study|Withdrawal by Subject|0|||
146795230|NCT02323880|529422295|FG006|Overall Study|Withdrawal by Subject|0|||
146795231|NCT02323880|529422296|FG007|Overall Study|Withdrawal by Subject|0|||
146795232|NCT04414722|529423850|FG000|Overall Study|Lost to Follow-up|3|||
146795233|NCT04414722|529423851|FG001|Overall Study|Lost to Follow-up|4|||
146795234|NCT04414722|529423852|FG002|Overall Study|Lost to Follow-up|3|||
146795235|NCT04414722|529423853|FG003|Overall Study|Lost to Follow-up|2|||
146795236|NCT04414722|529423854|FG004|Overall Study|Lost to Follow-up|3|||
146795237|NCT04414722|529423850|FG000|Overall Study|Withdrawal by Subject|6|||
146795238|NCT04414722|529423851|FG001|Overall Study|Withdrawal by Subject|3|||
146795239|NCT04414722|529423852|FG002|Overall Study|Withdrawal by Subject|1|||
146795240|NCT04414722|529423853|FG003|Overall Study|Withdrawal by Subject|5|||
146795241|NCT04414722|529423854|FG004|Overall Study|Withdrawal by Subject|1|||
146939651|NCT03371251|529936983|FG003|Overall Study|Adverse Event|0|||
146939652|NCT03371251|529936984|FG004|Overall Study|Adverse Event|1|||
146939653|NCT03371251|529936985|FG005|Overall Study|Adverse Event|0|||
146939654|NCT03371251|529936980|FG000|Overall Study|Decision by Sponsor|0|||
146939655|NCT03371251|529936981|FG001|Overall Study|Decision by Sponsor|0|||
146939656|NCT03371251|529936982|FG002|Overall Study|Decision by Sponsor|0|||
146939657|NCT03371251|529936983|FG003|Overall Study|Decision by Sponsor|0|||
146939658|NCT03371251|529936984|FG004|Overall Study|Decision by Sponsor|2|||
146939659|NCT03371251|529936985|FG005|Overall Study|Decision by Sponsor|0|||
146939660|NCT00291187|529936986|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
146939661|NCT00291187|529936987|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
146939662|NCT00291187|529936988|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
146939663|NCT00291187|529936989|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
146939664|NCT04362813|529936990|FG000|Overall Study|Death|12|||
146939665|NCT04362813|529936991|FG001|Overall Study|Death|16|||
146939666|NCT04362813|529936990|FG000|Overall Study|Withdrawal by Subject|3|||
146939667|NCT04362813|529936991|FG001|Overall Study|Withdrawal by Subject|1|||
146939668|NCT04362813|529936990|FG000|Overall Study|Protocol Violation|0|||
146939669|NCT04362813|529936991|FG001|Overall Study|Protocol Violation|3|||
146939670|NCT04362813|529936990|FG000|Overall Study|Lost to Follow-up|1|||
146939671|NCT04362813|529936991|FG001|Overall Study|Lost to Follow-up|1|||
146939672|NCT04362813|529936990|FG000|Overall Study|Enrolled but did not receive treatment|2|||
146939673|NCT04362813|529936991|FG001|Overall Study|Enrolled but did not receive treatment|4|||
146939674|NCT00961116|529936992|FG000|Washout Period of 7 Days|Adverse Event|1|||
146939675|NCT00961116|529936993|FG001|Washout Period of 7 Days|Adverse Event|1|||
146939676|NCT00961116|529936992|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
146939677|NCT00961116|529936993|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
146939678|NCT00961116|529936992|FG000|Washout Period of 7 Days|Protocol Violation|0|||
146939679|NCT00961116|529936993|FG001|Washout Period of 7 Days|Protocol Violation|1|||
146939680|NCT01981109|529936997|FG000|Overall Study|Death|36|||
146939681|NCT01981109|529936997|FG000|Overall Study|Withdrawal by Subject|40|||
146939682|NCT01981109|529936997|FG000|Overall Study|Lost to Follow-up|9|||
146939683|NCT01981109|529936997|FG000|Overall Study|No Discontinuation Documentation|37|||
146939684|NCT01981109|529936997|FG000|Overall Study|Study Termination|100|||
146939685|NCT01981109|529936997|FG000|Overall Study|No data available|2|||
146939686|NCT02023268|529936998|FG000|Overall Study|Lack of Efficacy|0|||
146939687|NCT02023268|529936999|FG001|Overall Study|Lack of Efficacy|1|||
146939688|NCT02023268|529936998|FG000|Overall Study|Adverse Event|0|||
146939689|NCT02023268|529936999|FG001|Overall Study|Adverse Event|2|||
146939690|NCT02023268|529936998|FG000|Overall Study|Withdrawal by Subject|0|||
146939691|NCT02023268|529936999|FG001|Overall Study|Withdrawal by Subject|1|||
146939692|NCT00615459|529937000|FG000|Period I|Adverse Event|2|||
146939693|NCT00615459|529937001|FG001|Period I|Adverse Event|0|||
146939694|NCT00615459|529937002|FG002|Period I|Adverse Event|1|||
146939695|NCT00615459|529937003|FG003|Period I|Adverse Event|0|||
146939696|NCT00615459|529937000|FG000|Period I|Subject withdrew consent|1|||
146939697|NCT00615459|529937001|FG001|Period I|Subject withdrew consent|0|||
146939698|NCT00615459|529937002|FG002|Period I|Subject withdrew consent|0|||
146939699|NCT00615459|529937003|FG003|Period I|Subject withdrew consent|1|||
146939700|NCT00615459|529937000|FG000|Period I|Abnormal test procedure results|1|||
146939701|NCT00615459|529937001|FG001|Period I|Abnormal test procedure results|1|||
146939702|NCT00615459|529937002|FG002|Period I|Abnormal test procedure results|1|||
146939703|NCT00615459|529937003|FG003|Period I|Abnormal test procedure results|0|||
146939704|NCT00615459|529937000|FG000|Period II|Adverse Event|1|||
146939705|NCT00615459|529937001|FG001|Period II|Adverse Event|0|||
146939706|NCT00615459|529937002|FG002|Period II|Adverse Event|0|||
146939707|NCT00615459|529937003|FG003|Period II|Adverse Event|0|||
146939708|NCT00615459|529937000|FG000|Period II|Lost to Follow-up|0|||
146939709|NCT00615459|529937001|FG001|Period II|Lost to Follow-up|0|||
146939710|NCT00615459|529937002|FG002|Period II|Lost to Follow-up|0|||
146939711|NCT00615459|529937003|FG003|Period II|Lost to Follow-up|1|||
146939712|NCT00615459|529937000|FG000|Period III|Adverse Event|0|||
146939713|NCT00615459|529937001|FG001|Period III|Adverse Event|1|||
146939714|NCT00615459|529937002|FG002|Period III|Adverse Event|0|||
146939715|NCT00615459|529937003|FG003|Period III|Adverse Event|0|||
146939716|NCT00615459|529937000|FG000|Period III|Administrative problems|0|||
146939717|NCT00615459|529937001|FG001|Period III|Administrative problems|1|||
146939718|NCT00615459|529937002|FG002|Period III|Administrative problems|1|||
146939719|NCT00615459|529937003|FG003|Period III|Administrative problems|0|||
146939720|NCT00615459|529937000|FG000|Period III|Unsatisfactory therapeutic effect|0|||
146939721|NCT00615459|529937001|FG001|Period III|Unsatisfactory therapeutic effect|1|||
146939722|NCT00615459|529937002|FG002|Period III|Unsatisfactory therapeutic effect|0|||
146939723|NCT00615459|529937003|FG003|Period III|Unsatisfactory therapeutic effect|0|||
146939724|NCT04153929|529937004|FG000|Overall Study|Other than listed|2|||
146939725|NCT04153929|529937005|FG001|Overall Study|Other than listed|2|||
146939726|NCT04153929|529937006|FG002|Overall Study|Other than listed|0|||
146939727|NCT04153929|529937007|FG003|Overall Study|Other than listed|1|||
146939728|NCT04153929|529937008|FG004|Overall Study|Other than listed|0|||
146939729|NCT04153929|529937009|FG005|Overall Study|Other than listed|2|||
146939730|NCT04153929|529937010|FG006|Overall Study|Other than listed|2|||
146939731|NCT04153929|529937011|FG007|Overall Study|Other than listed|1|||
146939732|NCT04153929|529937004|FG000|Overall Study|Lost to Follow-up|2|||
146939733|NCT04153929|529937005|FG001|Overall Study|Lost to Follow-up|1|||
146939734|NCT04153929|529937006|FG002|Overall Study|Lost to Follow-up|0|||
146939735|NCT04153929|529937007|FG003|Overall Study|Lost to Follow-up|1|||
146939736|NCT04153929|529937008|FG004|Overall Study|Lost to Follow-up|1|||
146939737|NCT04153929|529937009|FG005|Overall Study|Lost to Follow-up|0|||
146939738|NCT04153929|529937010|FG006|Overall Study|Lost to Follow-up|0|||
146939739|NCT04153929|529937011|FG007|Overall Study|Lost to Follow-up|0|||
146939740|NCT04153929|529937004|FG000|Overall Study|Withdrawal by Subject|3|||
146939741|NCT04153929|529937005|FG001|Overall Study|Withdrawal by Subject|1|||
146939742|NCT04153929|529937006|FG002|Overall Study|Withdrawal by Subject|0|||
146939743|NCT04153929|529937007|FG003|Overall Study|Withdrawal by Subject|3|||
146939744|NCT04153929|529937008|FG004|Overall Study|Withdrawal by Subject|1|||
146939745|NCT04153929|529937009|FG005|Overall Study|Withdrawal by Subject|0|||
146939746|NCT04153929|529937010|FG006|Overall Study|Withdrawal by Subject|1|||
146939747|NCT04153929|529937011|FG007|Overall Study|Withdrawal by Subject|0|||
146939748|NCT04153929|529937004|FG000|Overall Study|Protocol Violation|0|||
146939749|NCT04153929|529937005|FG001|Overall Study|Protocol Violation|0|||
146939750|NCT04153929|529937006|FG002|Overall Study|Protocol Violation|0|||
146939751|NCT04153929|529937007|FG003|Overall Study|Protocol Violation|0|||
146939752|NCT04153929|529937008|FG004|Overall Study|Protocol Violation|0|||
146939753|NCT04153929|529937009|FG005|Overall Study|Protocol Violation|0|||
146939754|NCT04153929|529937010|FG006|Overall Study|Protocol Violation|1|||
146939755|NCT04153929|529937011|FG007|Overall Study|Protocol Violation|2|||
146939756|NCT04153929|529937004|FG000|Overall Study|Adverse Event|3|||
146939757|NCT04153929|529937005|FG001|Overall Study|Adverse Event|5|||
146939758|NCT04153929|529937006|FG002|Overall Study|Adverse Event|5|||
146939759|NCT04153929|529937007|FG003|Overall Study|Adverse Event|11|||
146939760|NCT04153929|529937008|FG004|Overall Study|Adverse Event|15|||
146939761|NCT04153929|529937009|FG005|Overall Study|Adverse Event|4|||
146939762|NCT04153929|529937010|FG006|Overall Study|Adverse Event|8|||
146939763|NCT04153929|529937011|FG007|Overall Study|Adverse Event|2|||
146939764|NCT04153929|529937004|FG000|Overall Study|Not treated|1|||
146939765|NCT04153929|529937005|FG001|Overall Study|Not treated|0|||
146939766|NCT04153929|529937006|FG002|Overall Study|Not treated|0|||
146939767|NCT04153929|529937007|FG003|Overall Study|Not treated|0|||
146939768|NCT04153929|529937008|FG004|Overall Study|Not treated|0|||
146939769|NCT04153929|529937009|FG005|Overall Study|Not treated|0|||
146939770|NCT04153929|529937010|FG006|Overall Study|Not treated|1|||
146939771|NCT04153929|529937011|FG007|Overall Study|Not treated|0|||
146939772|NCT04083794|529937012|FG000|Overall Study|Lost to Follow-up|9|||
146939773|NCT01975675|529937013|FG000|Overall Study|Death|0|||
146939774|NCT01975675|529937014|FG001|Overall Study|Death|1|||
146939775|NCT01975675|529937015|FG002|Overall Study|Death|0|||
146939776|NCT01975675|529937016|FG003|Overall Study|Death|0|||
146939777|NCT00224003|529937017|FG000|Overall Study|Adverse Event|1|||
146939778|NCT00224003|529937017|FG000|Overall Study|Protocol Violation|2|||
146939779|NCT00224003|529937017|FG000|Overall Study|Withdrawal by Subject|1|||
146939780|NCT00224003|529937017|FG000|Overall Study|unk|3|||
146939781|NCT02810951|529937018|FG000|Overall Study|Adverse Event|1|||
146939782|NCT03199638|529937019|FG000|Overall Study|inability to drink glutamine during regularly|0|||
146939783|NCT03199638|529937020|FG001|Overall Study|inability to drink glutamine during regularly|2|||
146939784|NCT01575899|529937021|FG000|Overall Study|Lost to Follow-up|3|||
146939785|NCT01575899|529937022|FG001|Overall Study|Lost to Follow-up|4|||
146939786|NCT01575899|529937023|FG002|Overall Study|Lost to Follow-up|2|||
146939787|NCT01575899|529937021|FG000|Overall Study|Protocol Violation|2|||
146939788|NCT01575899|529937022|FG001|Overall Study|Protocol Violation|1|||
146939789|NCT01575899|529937023|FG002|Overall Study|Protocol Violation|0|||
146939790|NCT03097029|529937024|FG000|Overall Study|Withdrawal by Subject|1|||
146939791|NCT02807844|529937025|FG000|Overall Study|Physician Decision|0|||
146939792|NCT02807844|529937026|FG001|Overall Study|Physician Decision|0|||
146939793|NCT02807844|529937027|FG002|Overall Study|Physician Decision|0|||
146939794|NCT02807844|529937028|FG003|Overall Study|Physician Decision|0|||
146939795|NCT02807844|529937029|FG004|Overall Study|Physician Decision|0|||
146939796|NCT02807844|529937030|FG005|Overall Study|Physician Decision|0|||
146939797|NCT02807844|529937031|FG006|Overall Study|Physician Decision|3|||
146939798|NCT02807844|529937032|FG007|Overall Study|Physician Decision|0|||
146939799|NCT02807844|529937033|FG008|Overall Study|Physician Decision|1|||
146939800|NCT02807844|529937034|FG009|Overall Study|Physician Decision|2|||
146939801|NCT02807844|529937025|FG000|Overall Study|Death|0|||
146939802|NCT02807844|529937026|FG001|Overall Study|Death|0|||
146939803|NCT02807844|529937027|FG002|Overall Study|Death|2|||
146939804|NCT02807844|529937028|FG003|Overall Study|Death|4|||
146939805|NCT02807844|529937029|FG004|Overall Study|Death|1|||
146939806|NCT02807844|529937030|FG005|Overall Study|Death|2|||
146939807|NCT02807844|529937031|FG006|Overall Study|Death|1|||
146939808|NCT02807844|529937032|FG007|Overall Study|Death|2|||
146939809|NCT02807844|529937033|FG008|Overall Study|Death|0|||
146939810|NCT02807844|529937034|FG009|Overall Study|Death|1|||
146795242|NCT04414722|529423850|FG000|Overall Study|Physician Decision|0|||
146795243|NCT04414722|529423851|FG001|Overall Study|Physician Decision|1|||
146795244|NCT04414722|529423852|FG002|Overall Study|Physician Decision|2|||
146795245|NCT04414722|529423853|FG003|Overall Study|Physician Decision|0|||
146795246|NCT04414722|529423854|FG004|Overall Study|Physician Decision|0|||
146795247|NCT04414722|529423850|FG000|Overall Study|Non-participatory|0|||
146795248|NCT04414722|529423851|FG001|Overall Study|Non-participatory|1|||
146795249|NCT04414722|529423852|FG002|Overall Study|Non-participatory|1|||
146795250|NCT04414722|529423853|FG003|Overall Study|Non-participatory|0|||
146795251|NCT04414722|529423854|FG004|Overall Study|Non-participatory|0|||
146795252|NCT04766892|529423856|FG000|Overall Study|Withdrawal by Subject|1|||
146795253|NCT04766892|529423856|FG000|Overall Study|Lost to Follow-up|1|||
146795254|NCT04766892|529423856|FG000|Overall Study|Adverse Event|3|||
146795255|NCT04766892|529423856|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
146795256|NCT05906784|529423857|FG000|Overall Study|Lost to Follow-up|2|||
146795257|NCT05906784|529423858|FG001|Overall Study|Lost to Follow-up|1|||
146795258|NCT05906784|529423859|FG002|Overall Study|Lost to Follow-up|1|||
146795259|NCT05906784|529423860|FG003|Overall Study|Lost to Follow-up|1|||
146795260|NCT03442309|529423861|FG000|Overall Study|Lost to Follow-up|1676|||
146795261|NCT03442309|529423862|FG001|Overall Study|Lost to Follow-up|1642|||
146795262|NCT05524402|529423875|FG000|Overall Study|Withdrawal by Subject|3|||
146795263|NCT05524402|529423876|FG001|Overall Study|Withdrawal by Subject|1|||
146795264|NCT05524402|529423875|FG000|Overall Study|Lost to Follow-up|2|||
146795265|NCT05524402|529423876|FG001|Overall Study|Lost to Follow-up|1|||
146795266|NCT03381586|529423877|FG000|Overall Study|Adverse Event|1|||
146795267|NCT03381586|529423878|FG001|Overall Study|Adverse Event|1|||
146795268|NCT03381586|529423877|FG000|Overall Study|Protocol Violation|1|||
146795269|NCT03381586|529423878|FG001|Overall Study|Protocol Violation|0|||
146795270|NCT03381586|529423877|FG000|Overall Study|Withdrawal by Subject|1|||
146795271|NCT03381586|529423878|FG001|Overall Study|Withdrawal by Subject|2|||
146795272|NCT05280574|529423884|FG000|Overall Study|Withdrawal by Subject|0|||
146795273|NCT05280574|529423885|FG001|Overall Study|Withdrawal by Subject|2|||
146795274|NCT05280574|529423886|FG002|Overall Study|Withdrawal by Subject|0|||
146795275|NCT03276676|529423889|FG000|Overall Study|Withdrawal by Subject|2|||
146795276|NCT03276676|529423890|FG001|Overall Study|Withdrawal by Subject|1|||
146795277|NCT02962076|529423892|FG000|Overall Study|MHED tracer not available|5|||
146795278|NCT02962076|529423892|FG000|Overall Study|Protocol Violation|1|||
146795279|NCT02962076|529423892|FG000|Overall Study|Physician Decision|1|||
146795280|NCT02780700|529423893|FG000|Overall Study|Progressive disease|1|||
146795281|NCT03926130|529423894|FG000|Overall Study|Adverse Event|9|||
146795282|NCT03926130|529423895|FG001|Overall Study|Adverse Event|11|||
146795283|NCT03926130|529423896|FG002|Overall Study|Adverse Event|2|||
146939811|NCT02807844|529937025|FG000|Overall Study|Withdrawal by Subject|0|||
146939812|NCT02807844|529937026|FG001|Overall Study|Withdrawal by Subject|0|||
146795284|NCT03926130|529423897|FG003|Overall Study|Adverse Event|0|||
146795285|NCT03926130|529423894|FG000|Overall Study|Death|2|||
146795286|NCT03926130|529423895|FG001|Overall Study|Death|0|||
146795287|NCT03926130|529423896|FG002|Overall Study|Death|1|||
146795288|NCT03926130|529423897|FG003|Overall Study|Death|0|||
146795289|NCT03926130|529423894|FG000|Overall Study|Lack of Efficacy|14|||
146795290|NCT03926130|529423895|FG001|Overall Study|Lack of Efficacy|11|||
146795291|NCT03926130|529423896|FG002|Overall Study|Lack of Efficacy|7|||
146795292|NCT03926130|529423897|FG003|Overall Study|Lack of Efficacy|1|||
146795293|NCT03926130|529423894|FG000|Overall Study|Lost to Follow-up|0|||
146795294|NCT03926130|529423895|FG001|Overall Study|Lost to Follow-up|7|||
146795295|NCT03926130|529423896|FG002|Overall Study|Lost to Follow-up|1|||
146795296|NCT03926130|529423897|FG003|Overall Study|Lost to Follow-up|0|||
146795297|NCT03926130|529423894|FG000|Overall Study|As Reported by Investigator|2|||
146795298|NCT03926130|529423895|FG001|Overall Study|As Reported by Investigator|6|||
146795299|NCT03926130|529423896|FG002|Overall Study|As Reported by Investigator|6|||
146795300|NCT03926130|529423897|FG003|Overall Study|As Reported by Investigator|0|||
146795301|NCT03926130|529423894|FG000|Overall Study|Physician Decision|3|||
146795302|NCT03926130|529423895|FG001|Overall Study|Physician Decision|2|||
146795303|NCT03926130|529423896|FG002|Overall Study|Physician Decision|1|||
146795304|NCT03926130|529423897|FG003|Overall Study|Physician Decision|0|||
146795305|NCT03926130|529423894|FG000|Overall Study|Pregnancy|2|||
146795306|NCT03926130|529423895|FG001|Overall Study|Pregnancy|2|||
146795307|NCT03926130|529423896|FG002|Overall Study|Pregnancy|1|||
146795308|NCT03926130|529423897|FG003|Overall Study|Pregnancy|0|||
146795309|NCT03926130|529423894|FG000|Overall Study|Withdrawal by Subject|20|||
146795310|NCT03926130|529423895|FG001|Overall Study|Withdrawal by Subject|28|||
146795311|NCT03926130|529423896|FG002|Overall Study|Withdrawal by Subject|18|||
146795312|NCT03926130|529423897|FG003|Overall Study|Withdrawal by Subject|1|||
146795313|NCT03926130|529423894|FG000|Overall Study|Non-Compliance|1|||
146795314|NCT03926130|529423895|FG001|Overall Study|Non-Compliance|1|||
146795315|NCT03926130|529423896|FG002|Overall Study|Non-Compliance|0|||
146795316|NCT03926130|529423897|FG003|Overall Study|Non-Compliance|0|||
146795317|NCT03926130|529423894|FG000|Overall Study|Disposition Not Captured|0|||
146939813|NCT02807844|529937027|FG002|Overall Study|Withdrawal by Subject|2|||
146939814|NCT02807844|529937028|FG003|Overall Study|Withdrawal by Subject|1|||
146982647|NCT02862535|530098018|FG003|Overall Study|Enrolled, not Treated|1|||
146982648|NCT04147715|530098019|FG000|Overall Study|Adverse Event|0|||
146982649|NCT04147715|530098020|FG001|Overall Study|Adverse Event|0|||
146982650|NCT04147715|530098021|FG002|Overall Study|Adverse Event|0|||
146982651|NCT04147715|530098022|FG003|Overall Study|Adverse Event|0|||
146982652|NCT04147715|530098023|FG004|Overall Study|Adverse Event|0|||
146982653|NCT04147715|530098024|FG005|Overall Study|Adverse Event|0|||
146982654|NCT04147715|530098025|FG006|Overall Study|Adverse Event|0|||
146982655|NCT04147715|530098026|FG007|Overall Study|Adverse Event|2|||
146982656|NCT04147715|530098027|FG008|Overall Study|Adverse Event|1|||
146982657|NCT04147715|530098028|FG009|Overall Study|Adverse Event|0|||
146982658|NCT04147715|530098029|FG010|Overall Study|Adverse Event|0|||
146982659|NCT04147715|530098030|FG011|Overall Study|Adverse Event|0|||
146982660|NCT02418910|530098032|FG000|Overall Study|Lost to Follow-up|3|||
146982661|NCT02418910|530098032|FG000|Overall Study|Withdrawal by Subject|4|||
146982662|NCT02472977|530098036|FG000|Overall Study|Disease progression|4|||
146982663|NCT02472977|530098037|FG001|Overall Study|Disease progression|25|||
146982664|NCT02472977|530098038|FG002|Overall Study|Disease progression|6|||
146982665|NCT02472977|530098036|FG000|Overall Study|Withdrawal by Subject|0|||
146982666|NCT02472977|530098037|FG001|Overall Study|Withdrawal by Subject|1|||
146982667|NCT02472977|530098038|FG002|Overall Study|Withdrawal by Subject|0|||
146982668|NCT02472977|530098036|FG000|Overall Study|Study drug toxicity|2|||
146982669|NCT02472977|530098037|FG001|Overall Study|Study drug toxicity|0|||
146982670|NCT02472977|530098038|FG002|Overall Study|Study drug toxicity|2|||
146982671|NCT02472977|530098036|FG000|Overall Study|Subject request to discontinue treatment|0|||
146982672|NCT02472977|530098037|FG001|Overall Study|Subject request to discontinue treatment|1|||
146982673|NCT02472977|530098038|FG002|Overall Study|Subject request to discontinue treatment|0|||
146982674|NCT00566709|530098041|FG000|Overall Study|Protocol Violation|5|||
146982675|NCT00566709|530098042|FG001|Overall Study|Protocol Violation|0|||
146982676|NCT01806597|530099779|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
146982677|NCT01806597|530099780|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
146982678|NCT01806597|530099781|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
146982679|NCT01806597|530099782|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
146982680|NCT01806597|530099783|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
146982681|NCT01806597|530099784|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
146982682|NCT01806597|530099779|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
146982683|NCT01806597|530099780|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
146982684|NCT01806597|530099781|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
146982685|NCT01806597|530099782|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
146982686|NCT01806597|530099783|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
146982687|NCT01806597|530099784|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
146982688|NCT01806597|530099779|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
146982689|NCT01806597|530099780|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
146982690|NCT01806597|530099781|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
146982691|NCT01806597|530099782|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
146982692|NCT01806597|530099783|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
146982693|NCT01806597|530099784|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
146982694|NCT01806597|530099779|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
146982695|NCT01806597|530099780|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
146982696|NCT01806597|530099781|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
146982697|NCT01806597|530099782|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
146982698|NCT01806597|530099783|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
146982699|NCT01806597|530099784|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
146982700|NCT01806597|530099779|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
146982701|NCT01806597|530099780|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
146982702|NCT01806597|530099781|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
146982703|NCT01806597|530099782|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
146982704|NCT01806597|530099783|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
146982705|NCT01806597|530099784|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
146982706|NCT01806597|530099779|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
146982707|NCT01806597|530099780|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
146982708|NCT01806597|530099781|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
146982709|NCT01806597|530099782|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
146982710|NCT01806597|530099783|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
146982711|NCT01806597|530099784|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
146982712|NCT01806597|530099779|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
146982713|NCT01806597|530099780|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
146982714|NCT01806597|530099781|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
146982715|NCT01806597|530099782|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
146982716|NCT01806597|530099783|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
146982717|NCT01806597|530099784|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
146982718|NCT01806597|530099779|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
146982719|NCT01806597|530099780|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
146982720|NCT01806597|530099781|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
146982721|NCT01806597|530099782|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
146982722|NCT01806597|530099783|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
146982723|NCT01806597|530099784|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
146982724|NCT01806597|530099779|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
146982725|NCT01806597|530099780|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
146982726|NCT01806597|530099781|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
146982727|NCT01806597|530099782|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
146982728|NCT01806597|530099783|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
146982729|NCT01806597|530099784|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
146982730|NCT01806597|530099779|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
146982731|NCT01806597|530099780|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
146982732|NCT01806597|530099781|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
146982733|NCT01806597|530099782|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
146982734|NCT01806597|530099783|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
146982735|NCT01806597|530099784|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
146982736|NCT01806597|530099779|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
146982737|NCT01806597|530099780|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
146982738|NCT01806597|530099781|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
146982739|NCT01806597|530099782|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
146982740|NCT01806597|530099783|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
146982741|NCT01806597|530099784|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
146982742|NCT01806597|530099779|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
146982743|NCT01806597|530099780|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
146982744|NCT01806597|530099781|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
146939815|NCT02807844|529937029|FG004|Overall Study|Withdrawal by Subject|1|||
146939816|NCT02807844|529937030|FG005|Overall Study|Withdrawal by Subject|0|||
146939817|NCT02807844|529937031|FG006|Overall Study|Withdrawal by Subject|1|||
146939818|NCT02807844|529937032|FG007|Overall Study|Withdrawal by Subject|0|||
146939819|NCT02807844|529937033|FG008|Overall Study|Withdrawal by Subject|0|||
146939820|NCT02807844|529937034|FG009|Overall Study|Withdrawal by Subject|0|||
146939821|NCT02807844|529937025|FG000|Overall Study|Progressive disease|5|||
146939822|NCT02807844|529937026|FG001|Overall Study|Progressive disease|12|||
146939823|NCT02807844|529937027|FG002|Overall Study|Progressive disease|8|||
146939824|NCT02807844|529937028|FG003|Overall Study|Progressive disease|8|||
146939825|NCT02807844|529937029|FG004|Overall Study|Progressive disease|3|||
146939826|NCT02807844|529937030|FG005|Overall Study|Progressive disease|8|||
146939827|NCT02807844|529937031|FG006|Overall Study|Progressive disease|14|||
146939828|NCT02807844|529937032|FG007|Overall Study|Progressive disease|17|||
146939829|NCT02807844|529937033|FG008|Overall Study|Progressive disease|19|||
146939830|NCT02807844|529937034|FG009|Overall Study|Progressive disease|15|||
146939831|NCT02807844|529937025|FG000|Overall Study|Adverse Event|1|||
146939832|NCT02807844|529937026|FG001|Overall Study|Adverse Event|0|||
146939833|NCT02807844|529937027|FG002|Overall Study|Adverse Event|0|||
146939834|NCT02807844|529937028|FG003|Overall Study|Adverse Event|0|||
146939835|NCT02807844|529937029|FG004|Overall Study|Adverse Event|1|||
146939836|NCT02807844|529937030|FG005|Overall Study|Adverse Event|1|||
146939837|NCT02807844|529937031|FG006|Overall Study|Adverse Event|1|||
146939838|NCT02807844|529937032|FG007|Overall Study|Adverse Event|1|||
146939839|NCT02807844|529937033|FG008|Overall Study|Adverse Event|1|||
146939840|NCT02807844|529937034|FG009|Overall Study|Adverse Event|2|||
146939841|NCT00709124|529937035|FG000|Overall Study|Death|3|||
146939842|NCT00709124|529937036|FG001|Overall Study|Death|1|||
146939843|NCT00709124|529937035|FG000|Overall Study|encephalopathy; can't do assessment|1|||
146939844|NCT00709124|529937036|FG001|Overall Study|encephalopathy; can't do assessment|0|||
146939845|NCT00373490|529937037|FG000|Overall Study|Adverse Event|0|||
146939846|NCT00373490|529937038|FG001|Overall Study|Adverse Event|1|||
146939847|NCT00373490|529937037|FG000|Overall Study|Lack of Efficacy|9|||
146939848|NCT00373490|529937038|FG001|Overall Study|Lack of Efficacy|4|||
146939849|NCT00373490|529937037|FG000|Overall Study|Withdrawal by Subject|0|||
146939850|NCT00373490|529937038|FG001|Overall Study|Withdrawal by Subject|1|||
146939851|NCT00753688|529937045|FG000|Overall Study|Death|102|||
146939852|NCT00753688|529937046|FG001|Overall Study|Death|203|||
146939853|NCT00753688|529937045|FG000|Overall Study|Missing|4|||
146939854|NCT00753688|529937046|FG001|Overall Study|Missing|9|||
146939855|NCT00753688|529937045|FG000|Overall Study|Participant Withdrew Consent|2|||
146939856|NCT00753688|529937046|FG001|Overall Study|Participant Withdrew Consent|2|||
146939857|NCT00753688|529937045|FG000|Overall Study|Ongoing - in Follow-up|15|||
146939858|NCT00753688|529937046|FG001|Overall Study|Ongoing - in Follow-up|31|||
146939859|NCT00753688|529937045|FG000|Overall Study|Adverse Event|0|||
146982745|NCT01806597|530099782|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
146982746|NCT01806597|530099783|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
146982747|NCT01806597|530099784|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
146982748|NCT01806597|530099779|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
146982749|NCT01806597|530099780|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
146982750|NCT01806597|530099781|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
146982751|NCT01806597|530099782|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
146982752|NCT01806597|530099783|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
146982753|NCT01806597|530099784|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
146982754|NCT01806597|530099779|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
146982755|NCT01806597|530099780|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
146982756|NCT01806597|530099781|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
146982757|NCT01806597|530099782|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
146982758|NCT01806597|530099783|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
146982759|NCT01806597|530099784|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
146982760|NCT01806597|530099779|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
146982761|NCT01806597|530099780|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
146982762|NCT01806597|530099781|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
146982763|NCT01806597|530099782|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
146982764|NCT01806597|530099783|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
146982765|NCT01806597|530099784|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
146982766|NCT01806597|530099779|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
146982767|NCT01806597|530099780|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
146982768|NCT01806597|530099781|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
146982769|NCT01806597|530099782|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
146795318|NCT03926130|529423895|FG001|Overall Study|Disposition Not Captured|2|||
146795319|NCT03926130|529423896|FG002|Overall Study|Disposition Not Captured|1|||
146795320|NCT03926130|529423897|FG003|Overall Study|Disposition Not Captured|0|||
146795321|NCT03583333|529423898|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
146795322|NCT03583333|529423899|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
146795323|NCT03583333|529423898|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
146795324|NCT03583333|529423899|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
146795325|NCT03583333|529423898|FG000|Overall Study|Withdrawal by Subject|9|||
146795326|NCT03583333|529423899|FG001|Overall Study|Withdrawal by Subject|5|||
146795327|NCT03583333|529423898|FG000|Overall Study|Physician Decision|3|||
146795328|NCT03583333|529423899|FG001|Overall Study|Physician Decision|2|||
146795329|NCT03583333|529423898|FG000|Overall Study|Death|12|||
146982770|NCT01806597|530099783|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
146982771|NCT01806597|530099784|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
146982772|NCT01806597|530099779|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
146982773|NCT01806597|530099780|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
146795330|NCT03583333|529423899|FG001|Overall Study|Death|7|||
146982774|NCT01806597|530099781|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
146982775|NCT01806597|530099782|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
146982776|NCT01806597|530099783|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
146982777|NCT01806597|530099784|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
146982778|NCT01806597|530099779|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
146982779|NCT01806597|530099780|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
146982780|NCT01806597|530099781|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
146982781|NCT01806597|530099782|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
146982782|NCT01806597|530099783|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
146982783|NCT01806597|530099784|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
146982784|NCT01806597|530099779|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
146982785|NCT01806597|530099780|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
146982786|NCT01806597|530099781|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
146982787|NCT01806597|530099782|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
146982788|NCT01806597|530099783|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
146982789|NCT01806597|530099784|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
146982790|NCT02482805|530099785|FG000|Overall Study|Lost to Follow-up|4|||
146982791|NCT02482805|530099786|FG001|Overall Study|Lost to Follow-up|4|||
146982792|NCT02482805|530099787|FG002|Overall Study|Lost to Follow-up|0|||
146795331|NCT03640286|529423916|FG000|Overall Study|Adverse Event|6|||
146795332|NCT03640286|529423917|FG001|Overall Study|Adverse Event|6|||
146795333|NCT03640286|529423916|FG000|Overall Study|Lost to Follow-up|3|||
146795334|NCT03640286|529423917|FG001|Overall Study|Lost to Follow-up|6|||
146795335|NCT03640286|529423916|FG000|Overall Study|Pregnancy|1|||
146795336|NCT03640286|529423917|FG001|Overall Study|Pregnancy|0|||
146795337|NCT03640286|529423916|FG000|Overall Study|Withdrawal by Subject|10|||
146795338|NCT03640286|529423917|FG001|Overall Study|Withdrawal by Subject|10|||
146795339|NCT03640286|529423916|FG000|Overall Study|Non-compliance|4|||
146795340|NCT03640286|529423917|FG001|Overall Study|Non-compliance|10|||
146982793|NCT01144663|530099788|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
146982794|NCT01144663|530099789|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
146982795|NCT01144663|530099790|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
146982796|NCT01144663|530099791|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
146982797|NCT01144663|530099788|FG000|Primary Vaccination Phase|Adverse Event|1|||
146982798|NCT01144663|530099789|FG001|Primary Vaccination Phase|Adverse Event|0|||
146982799|NCT01144663|530099790|FG002|Primary Vaccination Phase|Adverse Event|0|||
146982800|NCT01144663|530099791|FG003|Primary Vaccination Phase|Adverse Event|1|||
146982801|NCT01144663|530099788|FG000|Primary Vaccination Phase|Protocol Violation|2|||
146982802|NCT01144663|530099789|FG001|Primary Vaccination Phase|Protocol Violation|0|||
146982803|NCT01144663|530099790|FG002|Primary Vaccination Phase|Protocol Violation|1|||
146982804|NCT01144663|530099791|FG003|Primary Vaccination Phase|Protocol Violation|0|||
146982805|NCT01144663|530099788|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
146982806|NCT01144663|530099789|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
146982807|NCT01144663|530099790|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
146982808|NCT01144663|530099791|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
146982809|NCT01144663|530099788|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
146982810|NCT01144663|530099789|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
146982811|NCT01144663|530099790|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
146982812|NCT01144663|530099791|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
146982813|NCT01144663|530099788|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
146795341|NCT03640286|529423916|FG000|Overall Study|Medication change|1|||
146795342|NCT03640286|529423917|FG001|Overall Study|Medication change|0|||
146795343|NCT03640286|529423916|FG000|Overall Study|Other|1|||
146795344|NCT03640286|529423917|FG001|Overall Study|Other|2|||
146795345|NCT03640286|529423916|FG000|Overall Study|Joined another lifestyle program|0|||
146795346|NCT03640286|529423917|FG001|Overall Study|Joined another lifestyle program|1|||
146795347|NCT03181516|529423918|FG000|Overall Study|Withdrawal by Subject|14|||
146795348|NCT03181516|529423919|FG001|Overall Study|Withdrawal by Subject|7|||
146795349|NCT03181516|529423918|FG000|Overall Study|Lost to Follow-up|2|||
146795350|NCT03181516|529423919|FG001|Overall Study|Lost to Follow-up|2|||
146795351|NCT04580914|529423920|FG000|Overall Study|Withdrawal by Subject|6|||
146795352|NCT04580914|529423920|FG000|Overall Study|Lost to Follow-up|2|||
146795353|NCT02998528|529423926|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
146795354|NCT02998528|529423927|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
146795355|NCT02998528|529423928|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
146795356|NCT02998528|529423926|FG000|Randomization Period|Participant withdrew consent|0|||
146939860|NCT00753688|529937046|FG001|Overall Study|Adverse Event|1|||
146939861|NCT00108953|529937047|FG000|Follow-up|Death|18|||
146939862|NCT00108953|529937048|FG001|Follow-up|Death|26|||
146795357|NCT02998528|529423927|FG001|Randomization Period|Participant withdrew consent|3|||
146795358|NCT02998528|529423928|FG002|Randomization Period|Participant withdrew consent|0|||
146795359|NCT02998528|529423926|FG000|Randomization Period|Participant no longer meets study criteria|1|||
146795360|NCT02998528|529423927|FG001|Randomization Period|Participant no longer meets study criteria|3|||
146795361|NCT02998528|529423928|FG002|Randomization Period|Participant no longer meets study criteria|2|||
146795362|NCT02998528|529423926|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
146795363|NCT02998528|529423927|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
146939863|NCT00108953|529937047|FG000|Follow-up|Lost to Follow-up|1|||
146939864|NCT00108953|529937048|FG001|Follow-up|Lost to Follow-up|1|||
146939865|NCT00108953|529937047|FG000|Follow-up|Study terminated by sponsor|10|||
146939866|NCT00108953|529937048|FG001|Follow-up|Study terminated by sponsor|6|||
146939867|NCT03803202|529937051|FG000|Overall Study|Other|0|||
146939868|NCT03803202|529937052|FG001|Overall Study|Other|1|||
146939869|NCT03803202|529937053|FG002|Overall Study|Other|0|||
146939870|NCT03803202|529937054|FG003|Overall Study|Other|0|||
146939871|NCT03803202|529937055|FG004|Overall Study|Other|0|||
146795364|NCT02998528|529423928|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
146795365|NCT02998528|529423926|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
146795366|NCT02998528|529423927|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
146795367|NCT02998528|529423928|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
146795368|NCT02998528|529423926|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
146795369|NCT02998528|529423927|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
146939872|NCT03803202|529937056|FG005|Overall Study|Other|0|||
146939873|NCT03803202|529937057|FG006|Overall Study|Other|0|||
146939874|NCT03803202|529937058|FG007|Overall Study|Other|0|||
146939875|NCT03803202|529937059|FG008|Overall Study|Other|0|||
146939876|NCT03803202|529937051|FG000|Overall Study|Death|0|||
146795370|NCT02998528|529423928|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
146795371|NCT02998528|529423926|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
146795372|NCT02998528|529423927|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
146795373|NCT02998528|529423928|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
146795374|NCT02998528|529423926|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
146795375|NCT02998528|529423927|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
146795376|NCT02998528|529423928|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
146795377|NCT02998528|529423926|FG000|Neoadjuvant Treatment Period|Death|1|||
146795378|NCT02998528|529423927|FG001|Neoadjuvant Treatment Period|Death|0|||
146795379|NCT02998528|529423928|FG002|Neoadjuvant Treatment Period|Death|0|||
146795380|NCT02998528|529423926|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
146795381|NCT02998528|529423927|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
146795382|NCT02998528|529423928|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
146795383|NCT02998528|529423926|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
146795384|NCT02998528|529423927|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
146795385|NCT02998528|529423928|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
146795386|NCT02998528|529423926|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
146795387|NCT02998528|529423927|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
146795388|NCT02998528|529423928|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
146795389|NCT02998528|529423926|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
146795390|NCT02998528|529423927|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
146795391|NCT02998528|529423928|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
146795392|NCT02998528|529423926|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
146795393|NCT02998528|529423927|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
146795394|NCT02998528|529423928|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
146795395|NCT02998528|529423926|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
146795396|NCT02998528|529423927|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
146795397|NCT02998528|529423928|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
146795398|NCT03485729|529423931|FG000|Overall Study|Withdrawal by Subject|0|||
146795399|NCT03485729|529423932|FG001|Overall Study|Withdrawal by Subject|0|||
146795400|NCT03485729|529423933|FG002|Overall Study|Withdrawal by Subject|1|||
146795401|NCT03485729|529423931|FG000|Overall Study|Disease progression|8|||
146795402|NCT03485729|529423932|FG001|Overall Study|Disease progression|13|||
146795403|NCT03485729|529423933|FG002|Overall Study|Disease progression|1|||
146795404|NCT03485729|529423931|FG000|Overall Study|Hospice care|1|||
146795405|NCT03485729|529423932|FG001|Overall Study|Hospice care|0|||
146795406|NCT03485729|529423933|FG002|Overall Study|Hospice care|0|||
146795407|NCT03485729|529423931|FG000|Overall Study|Poor performance status|1|||
146795408|NCT03485729|529423932|FG001|Overall Study|Poor performance status|0|||
146795409|NCT03485729|529423933|FG002|Overall Study|Poor performance status|0|||
146795410|NCT03485729|529423931|FG000|Overall Study|Illness|0|||
146795411|NCT03485729|529423932|FG001|Overall Study|Illness|1|||
146795412|NCT03485729|529423933|FG002|Overall Study|Illness|0|||
146795413|NCT05035654|529423934|FG000|Overall Study|Physician Decision|0|||
146795414|NCT05035654|529423935|FG001|Overall Study|Physician Decision|1|||
146795415|NCT05035654|529423936|FG002|Overall Study|Physician Decision|0|||
146795416|NCT05035654|529423934|FG000|Overall Study|Adverse Event|0|||
146795417|NCT05035654|529423935|FG001|Overall Study|Adverse Event|1|||
146795418|NCT05035654|529423936|FG002|Overall Study|Adverse Event|0|||
146795419|NCT05035654|529423934|FG000|Overall Study|Withdrawal by Subject|0|||
146795420|NCT05035654|529423935|FG001|Overall Study|Withdrawal by Subject|0|||
146795421|NCT05035654|529423936|FG002|Overall Study|Withdrawal by Subject|4|||
146795422|NCT05035654|529423934|FG000|Overall Study|Bilateral Dislodgement|1|||
146795423|NCT05035654|529423935|FG001|Overall Study|Bilateral Dislodgement|0|||
146795424|NCT05035654|529423936|FG002|Overall Study|Bilateral Dislodgement|0|||
146795425|NCT05856435|529423940|FG000|Overall Study|Lost to Follow-up|6|||
146795426|NCT04934072|529423941|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
146795427|NCT04934072|529423942|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
146795428|NCT04934072|529423943|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
146795429|NCT04934072|529423944|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
146939877|NCT03803202|529937052|FG001|Overall Study|Death|0|||
146939878|NCT03803202|529937053|FG002|Overall Study|Death|0|||
146939879|NCT03803202|529937054|FG003|Overall Study|Death|0|||
146795430|NCT04934072|529423945|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
146795431|NCT04934072|529423941|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
146795432|NCT04934072|529423942|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
146795433|NCT04934072|529423943|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
146795434|NCT04934072|529423944|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
146795435|NCT04934072|529423945|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
146795436|NCT04934072|529423941|FG000|Day 0 to Week 52|Other|3|||
146795437|NCT04934072|529423942|FG001|Day 0 to Week 52|Other|1|||
146795438|NCT04934072|529423943|FG002|Day 0 to Week 52|Other|0|||
146795439|NCT04934072|529423944|FG003|Day 0 to Week 52|Other|0|||
146795440|NCT04934072|529423945|FG004|Day 0 to Week 52|Other|0|||
146795441|NCT04934072|529423941|FG000|Day 0 to Week 52|Adverse Event|1|||
146795442|NCT04934072|529423942|FG001|Day 0 to Week 52|Adverse Event|3|||
146795443|NCT04934072|529423943|FG002|Day 0 to Week 52|Adverse Event|0|||
146795444|NCT04934072|529423944|FG003|Day 0 to Week 52|Adverse Event|0|||
146795445|NCT04934072|529423945|FG004|Day 0 to Week 52|Adverse Event|0|||
146795446|NCT04934072|529423941|FG000|Week 52 to Week 78|Adverse Event|0|||
146795447|NCT04934072|529423942|FG001|Week 52 to Week 78|Adverse Event|0|||
146795448|NCT04934072|529423943|FG002|Week 52 to Week 78|Adverse Event|0|||
146795449|NCT04934072|529423944|FG003|Week 52 to Week 78|Adverse Event|1|||
146795450|NCT04934072|529423945|FG004|Week 52 to Week 78|Adverse Event|1|||
146795451|NCT04934072|529423941|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
146620820|NCT01787461|528783439|FG001|Overall Study|No longer met eligibility criteria|0|||
146620821|NCT01787461|528783438|FG000|Overall Study|Withdrawal by Subject|3|||
146620822|NCT01787461|528783439|FG001|Overall Study|Withdrawal by Subject|4|||
146620823|NCT01787461|528783438|FG000|Overall Study|Protocol Violation|3|||
146620824|NCT01787461|528783439|FG001|Overall Study|Protocol Violation|0|||
146620825|NCT00152503|528783440|FG000|Overall Study|Adverse Event|4|||
146620826|NCT03253679|528783441|FG000|Overall Study|Screen Failure|1|||
146795452|NCT04934072|529423942|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
146795453|NCT04934072|529423943|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
146795454|NCT04934072|529423944|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
146795455|NCT04934072|529423945|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
146795456|NCT04934072|529423941|FG000|Week 52 to Week 78|Other|0|||
146795457|NCT04934072|529423942|FG001|Week 52 to Week 78|Other|0|||
146795458|NCT04934072|529423943|FG002|Week 52 to Week 78|Other|1|||
146795459|NCT04934072|529423944|FG003|Week 52 to Week 78|Other|0|||
146795460|NCT04934072|529423945|FG004|Week 52 to Week 78|Other|0|||
146795461|NCT02828358|529423948|FG000|Overall Study|Physician Decision|7|||
146795462|NCT02828358|529423949|FG001|Overall Study|Physician Decision|1|||
146795463|NCT02828358|529423948|FG000|Overall Study|Treatment Failure|6|||
146795464|NCT02828358|529423949|FG001|Overall Study|Treatment Failure|0|||
146795465|NCT02828358|529423948|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
146795466|NCT02828358|529423949|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
146795467|NCT02828358|529423948|FG000|Overall Study|Refusal of further protocol therapy|2|||
146795468|NCT02828358|529423949|FG001|Overall Study|Refusal of further protocol therapy|0|||
146795469|NCT02828358|529423948|FG000|Overall Study|Relapse|25|||
146795470|NCT02828358|529423949|FG001|Overall Study|Relapse|0|||
146795471|NCT02828358|529423948|FG000|Overall Study|Still on therapy|5|||
146795472|NCT02828358|529423949|FG001|Overall Study|Still on therapy|0|||
146795473|NCT02413489|529423950|FG000|Overall Study|Death|11|||
146795474|NCT02413489|529423951|FG001|Overall Study|Death|3|||
146795475|NCT02413489|529423952|FG002|Overall Study|Death|4|||
146795476|NCT02413489|529423950|FG000|Overall Study|Withdrawal by Subject|2|||
146795477|NCT02413489|529423951|FG001|Overall Study|Withdrawal by Subject|0|||
146795478|NCT02413489|529423952|FG002|Overall Study|Withdrawal by Subject|0|||
146795479|NCT02413489|529423950|FG000|Overall Study|Study Terminated By Sponsor|2|||
146795480|NCT02413489|529423951|FG001|Overall Study|Study Terminated By Sponsor|13|||
146795481|NCT02413489|529423952|FG002|Overall Study|Study Terminated By Sponsor|1|||
146795482|NCT05285137|529423953|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
146795483|NCT05285137|529423954|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
146795484|NCT05285137|529423955|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
146795485|NCT05285137|529423956|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
146795486|NCT05285137|529423957|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
146795487|NCT05285137|529423958|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
146795488|NCT05285137|529423959|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
146795489|NCT05285137|529423960|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
146795490|NCT05285137|529423961|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
146795491|NCT05285137|529423953|FG000|Overall Study|Lost to Follow-up|0|||
146795492|NCT05285137|529423954|FG001|Overall Study|Lost to Follow-up|0|||
146795493|NCT05285137|529423955|FG002|Overall Study|Lost to Follow-up|1|||
146795494|NCT05285137|529423956|FG003|Overall Study|Lost to Follow-up|3|||
146795495|NCT05285137|529423957|FG004|Overall Study|Lost to Follow-up|0|||
146795496|NCT05285137|529423958|FG005|Overall Study|Lost to Follow-up|0|||
146795497|NCT05285137|529423959|FG006|Overall Study|Lost to Follow-up|1|||
146795498|NCT05285137|529423960|FG007|Overall Study|Lost to Follow-up|0|||
146795499|NCT05285137|529423961|FG008|Overall Study|Lost to Follow-up|0|||
146795500|NCT05285137|529423953|FG000|Overall Study|Physician Decision|0|||
146795501|NCT05285137|529423954|FG001|Overall Study|Physician Decision|1|||
146620827|NCT04816214|528783442|FG000|Overall Study|Progressive Disease|4|||
146620828|NCT04816214|528783443|FG001|Overall Study|Progressive Disease|0|||
146795502|NCT05285137|529423955|FG002|Overall Study|Physician Decision|0|||
146795503|NCT05285137|529423956|FG003|Overall Study|Physician Decision|0|||
146795504|NCT05285137|529423957|FG004|Overall Study|Physician Decision|0|||
146795505|NCT05285137|529423958|FG005|Overall Study|Physician Decision|0|||
146795506|NCT05285137|529423959|FG006|Overall Study|Physician Decision|0|||
146795507|NCT05285137|529423960|FG007|Overall Study|Physician Decision|0|||
146939880|NCT03803202|529937055|FG004|Overall Study|Death|0|||
146939881|NCT03803202|529937056|FG005|Overall Study|Death|1|||
146939882|NCT03803202|529937057|FG006|Overall Study|Death|0|||
146939883|NCT03803202|529937058|FG007|Overall Study|Death|0|||
146939884|NCT03803202|529937059|FG008|Overall Study|Death|0|||
146939885|NCT03803202|529937051|FG000|Overall Study|Withdrawal by Subject|0|||
146939886|NCT03803202|529937052|FG001|Overall Study|Withdrawal by Subject|0|||
146939887|NCT03803202|529937053|FG002|Overall Study|Withdrawal by Subject|1|||
146939888|NCT03803202|529937054|FG003|Overall Study|Withdrawal by Subject|0|||
146939889|NCT03803202|529937055|FG004|Overall Study|Withdrawal by Subject|0|||
146939890|NCT03803202|529937056|FG005|Overall Study|Withdrawal by Subject|0|||
146939891|NCT03803202|529937057|FG006|Overall Study|Withdrawal by Subject|0|||
146939892|NCT03803202|529937058|FG007|Overall Study|Withdrawal by Subject|1|||
146939893|NCT03803202|529937059|FG008|Overall Study|Withdrawal by Subject|0|||
146939894|NCT03803202|529937051|FG000|Overall Study|Lost to Follow-up|0|||
146939895|NCT03803202|529937052|FG001|Overall Study|Lost to Follow-up|0|||
146939896|NCT03803202|529937053|FG002|Overall Study|Lost to Follow-up|0|||
146939897|NCT03803202|529937054|FG003|Overall Study|Lost to Follow-up|1|||
146939898|NCT03803202|529937055|FG004|Overall Study|Lost to Follow-up|1|||
146939899|NCT03803202|529937056|FG005|Overall Study|Lost to Follow-up|0|||
146939900|NCT03803202|529937057|FG006|Overall Study|Lost to Follow-up|1|||
146939901|NCT03803202|529937058|FG007|Overall Study|Lost to Follow-up|0|||
146939902|NCT03803202|529937059|FG008|Overall Study|Lost to Follow-up|0|||
146939903|NCT01125293|529937060|FG000|Overall Study|Disease Progression|1|||
146939904|NCT01125293|529937061|FG001|Overall Study|Disease Progression|3|||
146939905|NCT01125293|529937062|FG002|Overall Study|Disease Progression|4|||
146939906|NCT01125293|529937063|FG003|Overall Study|Disease Progression|3|||
146939907|NCT01125293|529937064|FG004|Overall Study|Disease Progression|5|||
146939908|NCT01125293|529937065|FG005|Overall Study|Disease Progression|12|||
146939909|NCT01125293|529937060|FG000|Overall Study|Adverse Event|1|||
146939910|NCT01125293|529937061|FG001|Overall Study|Adverse Event|0|||
146939911|NCT01125293|529937062|FG002|Overall Study|Adverse Event|0|||
146939912|NCT01125293|529937063|FG003|Overall Study|Adverse Event|0|||
146939913|NCT01125293|529937064|FG004|Overall Study|Adverse Event|2|||
146939914|NCT01125293|529937065|FG005|Overall Study|Adverse Event|8|||
146939915|NCT01125293|529937060|FG000|Overall Study|Symptomatic Deterioration|1|||
146939916|NCT01125293|529937061|FG001|Overall Study|Symptomatic Deterioration|0|||
146939917|NCT01125293|529937062|FG002|Overall Study|Symptomatic Deterioration|0|||
146939918|NCT01125293|529937063|FG003|Overall Study|Symptomatic Deterioration|0|||
146939919|NCT01125293|529937064|FG004|Overall Study|Symptomatic Deterioration|0|||
146939920|NCT01125293|529937065|FG005|Overall Study|Symptomatic Deterioration|0|||
146939921|NCT01125293|529937060|FG000|Overall Study|Death|0|||
146939922|NCT01125293|529937061|FG001|Overall Study|Death|0|||
146939923|NCT01125293|529937062|FG002|Overall Study|Death|0|||
146939924|NCT01125293|529937063|FG003|Overall Study|Death|0|||
146939925|NCT01125293|529937064|FG004|Overall Study|Death|1|||
146939926|NCT01125293|529937065|FG005|Overall Study|Death|0|||
146939927|NCT01125293|529937060|FG000|Overall Study|Withdrawal by Subject|0|||
146939928|NCT01125293|529937061|FG001|Overall Study|Withdrawal by Subject|0|||
146939929|NCT01125293|529937062|FG002|Overall Study|Withdrawal by Subject|0|||
146939930|NCT01125293|529937063|FG003|Overall Study|Withdrawal by Subject|0|||
146939931|NCT01125293|529937064|FG004|Overall Study|Withdrawal by Subject|2|||
146939932|NCT01125293|529937065|FG005|Overall Study|Withdrawal by Subject|1|||
146939933|NCT01125293|529937060|FG000|Overall Study|Physician Decision|0|||
146939934|NCT01125293|529937061|FG001|Overall Study|Physician Decision|0|||
146939935|NCT01125293|529937062|FG002|Overall Study|Physician Decision|0|||
146939936|NCT01125293|529937063|FG003|Overall Study|Physician Decision|0|||
146939937|NCT01125293|529937064|FG004|Overall Study|Physician Decision|0|||
146939938|NCT01125293|529937065|FG005|Overall Study|Physician Decision|2|||
146939939|NCT00260429|529937070|FG000|Overall Study|failure to follow appointments|1|||
146939940|NCT00260429|529937071|FG001|Overall Study|failure to follow appointments|0|||
146939941|NCT00260429|529937070|FG000|Overall Study|scheduled hand surgery|1|||
146939942|NCT00260429|529937071|FG001|Overall Study|scheduled hand surgery|0|||
146939943|NCT00659126|529937072|FG000|Overall Study|Adverse Event|2|||
146939944|NCT00659126|529937073|FG001|Overall Study|Adverse Event|2|||
146939945|NCT00659126|529937072|FG000|Overall Study|Screen failure|1|||
146939946|NCT00659126|529937073|FG001|Overall Study|Screen failure|1|||
146939947|NCT00659126|529937072|FG000|Overall Study|Technical problems with MRI|0|||
146939948|NCT00659126|529937073|FG001|Overall Study|Technical problems with MRI|1|||
146939949|NCT02228564|529937074|FG000|Overall Study|Withdrawal by Subject|10|||
146939950|NCT02228564|529937074|FG000|Overall Study|Death|11|||
146939951|NCT02228564|529937074|FG000|Overall Study|Physician Decision|5|||
146939952|NCT02228564|529937074|FG000|Overall Study|Lost to Follow-up|17|||
146939953|NCT02228564|529937074|FG000|Overall Study|Other|6|||
146939954|NCT02633046|529937078|FG000|Overall Study|Adverse Event|8|||
146939955|NCT02633046|529937078|FG000|Overall Study|Physician Decision|7|||
146939956|NCT02633046|529937078|FG000|Overall Study|Withdrawal by Subject|8|||
146939957|NCT02633046|529937078|FG000|Overall Study|Increased proteinuria|2|||
146939958|NCT02633046|529937078|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
146795508|NCT05285137|529423961|FG008|Overall Study|Physician Decision|0|||
146795509|NCT05285137|529423953|FG000|Overall Study|Pregnancy|0|||
146795510|NCT05285137|529423954|FG001|Overall Study|Pregnancy|0|||
146795511|NCT05285137|529423955|FG002|Overall Study|Pregnancy|0|||
146795512|NCT05285137|529423956|FG003|Overall Study|Pregnancy|0|||
146795513|NCT05285137|529423957|FG004|Overall Study|Pregnancy|0|||
146795514|NCT05285137|529423958|FG005|Overall Study|Pregnancy|0|||
146795515|NCT05285137|529423959|FG006|Overall Study|Pregnancy|1|||
146795516|NCT05285137|529423960|FG007|Overall Study|Pregnancy|0|||
146795517|NCT05285137|529423961|FG008|Overall Study|Pregnancy|0|||
146795518|NCT05285137|529423953|FG000|Overall Study|Withdrawal by Subject|0|||
146795519|NCT05285137|529423954|FG001|Overall Study|Withdrawal by Subject|1|||
146795520|NCT05285137|529423955|FG002|Overall Study|Withdrawal by Subject|2|||
146795521|NCT05285137|529423956|FG003|Overall Study|Withdrawal by Subject|1|||
146795522|NCT05285137|529423957|FG004|Overall Study|Withdrawal by Subject|0|||
146795523|NCT05285137|529423958|FG005|Overall Study|Withdrawal by Subject|0|||
146795524|NCT05285137|529423959|FG006|Overall Study|Withdrawal by Subject|0|||
146795525|NCT05285137|529423960|FG007|Overall Study|Withdrawal by Subject|0|||
146795526|NCT05285137|529423961|FG008|Overall Study|Withdrawal by Subject|1|||
146795527|NCT03717935|529423966|FG000|Overall Study|Withdrawal by Subject|0|||
146795528|NCT03717935|529423967|FG001|Overall Study|Withdrawal by Subject|2|||
146795529|NCT01820611|529423968|FG000|Overall Study|Death|8|||
146795530|NCT01820611|529423968|FG000|Overall Study|Adverse Event|1|||
146795531|NCT01820611|529423968|FG000|Overall Study|Withdrawal by Subject|9|||
146795532|NCT05736458|529423969|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
146795533|NCT05736458|529423970|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
146795534|NCT05736458|529423971|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
146795535|NCT05736458|529423969|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
146795536|NCT05736458|529423970|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
146795537|NCT05736458|529423971|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
146795538|NCT05736458|529423969|FG000|TMS/fMRI #1|Physician Decision|0|||
146795539|NCT05736458|529423970|FG001|TMS/fMRI #1|Physician Decision|0|||
146795540|NCT05736458|529423971|FG002|TMS/fMRI #1|Physician Decision|2|||
146795541|NCT05736458|529423969|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
146795542|NCT05736458|529423970|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
146795543|NCT05736458|529423971|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
146795544|NCT01199133|529423976|FG000|Year 1|Adverse Event|16|||
146795545|NCT01199133|529423977|FG001|Year 1|Adverse Event|4|||
146795546|NCT01199133|529423976|FG000|Year 1|Withdrawal by Subject|8|||
146795547|NCT01199133|529423977|FG001|Year 1|Withdrawal by Subject|4|||
146795548|NCT01199133|529423976|FG000|Year 1|Any other reason not above-mentioned|6|||
146795549|NCT01199133|529423977|FG001|Year 1|Any other reason not above-mentioned|7|||
146795550|NCT01199133|529423976|FG000|Year 2|Adverse Event|1|||
146795551|NCT01199133|529423977|FG001|Year 2|Adverse Event|0|||
146795552|NCT01199133|529423976|FG000|Year 2|Withdrawal by Subject|1|||
146795553|NCT01199133|529423977|FG001|Year 2|Withdrawal by Subject|1|||
146795554|NCT01199133|529423976|FG000|Year 2|Any other reason not above-mentioned|1|||
146795555|NCT01199133|529423977|FG001|Year 2|Any other reason not above-mentioned|2|||
146795556|NCT05100628|529423978|FG000|Overall Study|Progressive Disease|1|||
146795557|NCT05100628|529423979|FG001|Overall Study|Progressive Disease|0|||
146795558|NCT05100628|529423980|FG002|Overall Study|Progressive Disease|0|||
146795559|NCT05100628|529423981|FG003|Overall Study|Progressive Disease|0|||
146795560|NCT05100628|529423978|FG000|Overall Study|Study Terminated by Sponsor|0|||
146939959|NCT02633046|529937078|FG000|Overall Study|Mutual decision patient and physician|1|||
146939960|NCT02758613|529937079|FG000|Treatment|Physician and Sponsor Decision|1|||
146939961|NCT02758613|529937080|FG001|Treatment|Physician and Sponsor Decision|0|||
146939962|NCT02758613|529937081|FG002|Treatment|Physician and Sponsor Decision|0|||
146939963|NCT02758613|529937082|FG003|Treatment|Physician and Sponsor Decision|0|||
146939964|NCT02758613|529937079|FG000|Treatment|Withdrawal by Subject|1|||
146939965|NCT02758613|529937080|FG001|Treatment|Withdrawal by Subject|0|||
146939966|NCT02758613|529937081|FG002|Treatment|Withdrawal by Subject|1|||
146939967|NCT02758613|529937082|FG003|Treatment|Withdrawal by Subject|0|||
146939968|NCT01496274|529937083|FG000|Overall Study|Protocol Violation|0|||
146795561|NCT05100628|529423979|FG001|Overall Study|Study Terminated by Sponsor|0|||
146795562|NCT05100628|529423980|FG002|Overall Study|Study Terminated by Sponsor|3|||
146795563|NCT05100628|529423981|FG003|Overall Study|Study Terminated by Sponsor|0|||
146939969|NCT01496274|529937084|FG001|Overall Study|Protocol Violation|1|||
146795564|NCT05100628|529423978|FG000|Overall Study|unkown|0|||
146939970|NCT01496274|529937083|FG000|Overall Study|Adverse Event|1|||
146939971|NCT01496274|529937084|FG001|Overall Study|Adverse Event|1|||
146939972|NCT01496274|529937083|FG000|Overall Study|Withdrawal by Subject|2|||
146939973|NCT01496274|529937084|FG001|Overall Study|Withdrawal by Subject|0|||
146795565|NCT05100628|529423979|FG001|Overall Study|unkown|1|||
146795566|NCT05100628|529423980|FG002|Overall Study|unkown|0|||
146795567|NCT05100628|529423981|FG003|Overall Study|unkown|0|||
146795568|NCT02575950|529423984|FG000|Overall Study|Withdrawal by Subject|0|||
146795569|NCT02575950|529423985|FG001|Overall Study|Withdrawal by Subject|0|||
146795570|NCT02575950|529423986|FG002|Overall Study|Withdrawal by Subject|0|||
146795571|NCT02575950|529423987|FG003|Overall Study|Withdrawal by Subject|2|||
146939974|NCT01496274|529937083|FG000|Overall Study|Lost to Follow-up|0|||
146939975|NCT01496274|529937084|FG001|Overall Study|Lost to Follow-up|3|||
146939976|NCT03549429|529937087|FG000|Overall Study|Protocol Violation|5|||
146939977|NCT03549429|529937088|FG001|Overall Study|Protocol Violation|3|||
146939978|NCT02096042|529937089|FG000|Overall Study|Disease Progression|1|||
146939979|NCT02096042|529937090|FG001|Overall Study|Disease Progression|0|||
146939980|NCT02096042|529937091|FG002|Overall Study|Disease Progression|0|||
146939981|NCT00701441|529937093|FG000|Overall Study|failure in cpap compliance|0|||
146939982|NCT00701441|529937094|FG001|Overall Study|failure in cpap compliance|4|||
146939983|NCT01225172|529937098|FG000|Overall Study|Subject decision to stop|1|||
146939984|NCT01225172|529937099|FG001|Overall Study|Subject decision to stop|0|||
146939985|NCT01225172|529937098|FG000|Overall Study|Subject request to discontinue treatment|3|||
146939986|NCT01225172|529937099|FG001|Overall Study|Subject request to discontinue treatment|1|||
146939987|NCT01225172|529937098|FG000|Overall Study|Subject no longer meets study criteria|1|||
146939988|NCT01225172|529937099|FG001|Overall Study|Subject no longer meets study criteria|0|||
146939989|NCT01225172|529937098|FG000|Overall Study|Withdrawal by Subject|1|||
146939990|NCT01225172|529937099|FG001|Overall Study|Withdrawal by Subject|0|||
146939991|NCT03693404|529937101|FG000|Overall Study|Withdrawal by Subject|1|||
146939992|NCT03693404|529937102|FG001|Overall Study|Withdrawal by Subject|0|||
146939993|NCT03693404|529937101|FG000|Overall Study|Lost to Follow-up|0|||
146939994|NCT03693404|529937102|FG001|Overall Study|Lost to Follow-up|5|||
146939995|NCT03693404|529937101|FG000|Overall Study|Excluded from Analysis|0|||
146939996|NCT03693404|529937102|FG001|Overall Study|Excluded from Analysis|1|||
146795572|NCT02575950|529423984|FG000|Overall Study|Lost to Follow-up|0|||
146795573|NCT02575950|529423985|FG001|Overall Study|Lost to Follow-up|1|||
146795574|NCT02575950|529423986|FG002|Overall Study|Lost to Follow-up|0|||
146795575|NCT02575950|529423987|FG003|Overall Study|Lost to Follow-up|3|||
146795576|NCT04271046|529423988|FG000|Overall Study|Death|0|||
146795577|NCT04271046|529423989|FG001|Overall Study|Death|2|||
146795578|NCT04271046|529423990|FG002|Overall Study|Death|0|||
146795579|NCT04271046|529423991|FG003|Overall Study|Death|2|||
146795580|NCT04271046|529423988|FG000|Overall Study|Lost to Follow-up|12|||
146795581|NCT04271046|529423989|FG001|Overall Study|Lost to Follow-up|12|||
146795582|NCT04271046|529423990|FG002|Overall Study|Lost to Follow-up|11|||
146795583|NCT04271046|529423991|FG003|Overall Study|Lost to Follow-up|11|||
146795584|NCT04271046|529423988|FG000|Overall Study|Patient with Dementia Died|2|||
146795585|NCT04271046|529423989|FG001|Overall Study|Patient with Dementia Died|0|||
146795586|NCT04271046|529423990|FG002|Overall Study|Patient with Dementia Died|2|||
146795587|NCT04271046|529423991|FG003|Overall Study|Patient with Dementia Died|0|||
146939997|NCT00892957|529937103|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
146939998|NCT00892957|529937104|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
146939999|NCT00892957|529937103|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
146940000|NCT00892957|529937104|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
146940001|NCT01410799|529937118|FG000|Overall Study|PI decision|13|||
146940002|NCT01280812|529939096|FG000|Overall Study|Withdrawal by Subject|2|||
146940003|NCT01280812|529939097|FG001|Overall Study|Withdrawal by Subject|1|||
146940004|NCT01280812|529939098|FG002|Overall Study|Withdrawal by Subject|0|||
146940005|NCT01280812|529939096|FG000|Overall Study|Lost to Follow-up|1|||
146940006|NCT01280812|529939097|FG001|Overall Study|Lost to Follow-up|1|||
146940007|NCT01280812|529939098|FG002|Overall Study|Lost to Follow-up|1|||
146940008|NCT00446641|529939099|FG000|Overall Study|Withdrawal by Subject|8|||
146940009|NCT00446641|529939100|FG001|Overall Study|Withdrawal by Subject|3|||
146940010|NCT00446641|529939099|FG000|Overall Study|poor compliance|8|||
146940011|NCT00446641|529939100|FG001|Overall Study|poor compliance|6|||
146940012|NCT00446641|529939099|FG000|Overall Study|Lost to Follow-up|1|||
146940013|NCT00446641|529939100|FG001|Overall Study|Lost to Follow-up|1|||
146940014|NCT00086385|529939103|FG000|Overall Study|Death|2|||
146940015|NCT00086385|529939104|FG001|Overall Study|Death|2|||
146940016|NCT00086385|529939105|FG002|Overall Study|Death|1|||
146795588|NCT04271046|529423988|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
146795589|NCT04271046|529423989|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
146795590|NCT04271046|529423990|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
146795591|NCT04271046|529423991|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
146795592|NCT04230681|529423992|FG000|Overall Study|Physician Decision|2|||
146795593|NCT04230681|529423993|FG001|Overall Study|Physician Decision|3|||
146940017|NCT00086385|529939106|FG003|Overall Study|Death|1|||
146940018|NCT03424044|529939111|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
146982814|NCT01144663|530099789|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
146795594|NCT04230681|529423992|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
146940019|NCT03424044|529939112|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
146940020|NCT03424044|529939113|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
146940021|NCT03424044|529939114|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
146940022|NCT03424044|529939115|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
146940023|NCT03424044|529939116|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
146982815|NCT01144663|530099790|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
146982816|NCT01144663|530099791|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
146982817|NCT01144663|530099788|FG000|Primary Vaccination Phase|Other|0|||
146982818|NCT01144663|530099789|FG001|Primary Vaccination Phase|Other|1|||
146982819|NCT01144663|530099790|FG002|Primary Vaccination Phase|Other|0|||
146982820|NCT01144663|530099791|FG003|Primary Vaccination Phase|Other|2|||
146982821|NCT01144663|530099788|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
146982822|NCT01144663|530099789|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
146982823|NCT01144663|530099790|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
146982824|NCT01144663|530099791|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
146982825|NCT01144663|530099788|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
146982826|NCT01144663|530099789|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
146982827|NCT01144663|530099790|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
146982828|NCT01144663|530099791|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
146982829|NCT01144663|530099788|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
146982830|NCT01144663|530099789|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
146982831|NCT01144663|530099790|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
146982832|NCT01144663|530099791|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
146982833|NCT01144663|530099788|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
146982834|NCT01144663|530099789|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
146982835|NCT01144663|530099790|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
146982836|NCT01144663|530099791|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
146982837|NCT01144663|530099788|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
146982838|NCT01144663|530099789|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
146982839|NCT01144663|530099790|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
146982840|NCT01144663|530099791|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
146982841|NCT01144663|530099788|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
146982842|NCT01144663|530099789|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
146982843|NCT01144663|530099790|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
146982844|NCT01144663|530099791|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
146982845|NCT00387712|530099806|FG000|Overall Study|Physician Decision|6|||
146982846|NCT00387712|530099807|FG001|Overall Study|Physician Decision|4|||
146982847|NCT00387712|530099806|FG000|Overall Study|Lost to Follow-up|17|||
146982848|NCT00387712|530099807|FG001|Overall Study|Lost to Follow-up|20|||
146982849|NCT00387712|530099806|FG000|Overall Study|Withdrawal by Subject|6|||
146982850|NCT00387712|530099807|FG001|Overall Study|Withdrawal by Subject|12|||
146982851|NCT02040428|530099808|FG000|Overall Study|Death|4|||
146982852|NCT02040428|530099809|FG001|Overall Study|Death|3|||
146982853|NCT02040428|530099808|FG000|Overall Study|Withdrawal by Subject|1|||
146982854|NCT02040428|530099809|FG001|Overall Study|Withdrawal by Subject|1|||
146982855|NCT01927757|530099821|FG000|Overall Study|Withdrawal by Subject|14|||
146982856|NCT01927757|530099821|FG000|Overall Study|Lost to Follow-up|2|||
146982857|NCT01927757|530099821|FG000|Overall Study|Decision by Sponsor|2|||
146982858|NCT01927757|530099821|FG000|Overall Study|Other|1|||
146982859|NCT01927757|530099821|FG000|Overall Study|Ethical Reasons|4|||
146982860|NCT01399723|530099822|FG000|Overall Study|Lost to Follow-up|0|||
146982861|NCT01399723|530099823|FG001|Overall Study|Lost to Follow-up|1|||
146982862|NCT01464827|530099824|FG000|Overall Study|Adverse Event|0|||
146982863|NCT01464827|530099825|FG001|Overall Study|Adverse Event|0|||
146982864|NCT01464827|530099826|FG002|Overall Study|Adverse Event|0|||
146982865|NCT01464827|530099827|FG003|Overall Study|Adverse Event|0|||
146982866|NCT01464827|530099828|FG004|Overall Study|Adverse Event|0|||
146982867|NCT01464827|530099829|FG005|Overall Study|Adverse Event|0|||
146982868|NCT01464827|530099830|FG006|Overall Study|Adverse Event|0|||
146982869|NCT01464827|530099831|FG007|Overall Study|Adverse Event|0|||
146982870|NCT01464827|530099832|FG008|Overall Study|Adverse Event|0|||
146982871|NCT01464827|530099833|FG009|Overall Study|Adverse Event|0|||
146982872|NCT01464827|530099834|FG010|Overall Study|Adverse Event|0|||
146982873|NCT01464827|530099835|FG011|Overall Study|Adverse Event|0|||
146982874|NCT01464827|530099836|FG012|Overall Study|Adverse Event|1|||
146982875|NCT01464827|530099837|FG013|Overall Study|Adverse Event|0|||
146982876|NCT01464827|530099824|FG000|Overall Study|Withdrawal by Subject|1|||
146982877|NCT01464827|530099825|FG001|Overall Study|Withdrawal by Subject|0|||
146982878|NCT01464827|530099826|FG002|Overall Study|Withdrawal by Subject|0|||
146982879|NCT01464827|530099827|FG003|Overall Study|Withdrawal by Subject|0|||
146982880|NCT01464827|530099828|FG004|Overall Study|Withdrawal by Subject|1|||
146982881|NCT01464827|530099829|FG005|Overall Study|Withdrawal by Subject|0|||
146982882|NCT01464827|530099830|FG006|Overall Study|Withdrawal by Subject|0|||
146982883|NCT01464827|530099831|FG007|Overall Study|Withdrawal by Subject|1|||
146982884|NCT01464827|530099832|FG008|Overall Study|Withdrawal by Subject|0|||
146982885|NCT01464827|530099833|FG009|Overall Study|Withdrawal by Subject|0|||
146982886|NCT01464827|530099834|FG010|Overall Study|Withdrawal by Subject|0|||
146982887|NCT01464827|530099835|FG011|Overall Study|Withdrawal by Subject|0|||
146982888|NCT01464827|530099836|FG012|Overall Study|Withdrawal by Subject|0|||
146795595|NCT04230681|529423993|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
146795596|NCT04230681|529423992|FG000|Overall Study|IV inadvertently removed|0|||
146795597|NCT04230681|529423993|FG001|Overall Study|IV inadvertently removed|1|||
146795598|NCT02668692|529425019|FG000|Overall Study|Adverse Event|1|||
146795599|NCT02668692|529425020|FG001|Overall Study|Adverse Event|0|||
146795600|NCT05976334|529425021|FG000|Part B|Death|0|||
146795601|NCT05976334|529425022|FG001|Part B|Death|1|||
146795602|NCT05976334|529425021|FG000|Part B|Study Terminated by Sponsor|0|||
146795603|NCT05976334|529425022|FG001|Part B|Study Terminated by Sponsor|1|||
146795604|NCT05976334|529425021|FG000|Part B|Reason Not Specified|0|||
146795605|NCT05976334|529425022|FG001|Part B|Reason Not Specified|1|||
146795606|NCT05363163|529425023|FG000|Overall Study|Withdrawal by Subject|13|||
146795607|NCT05838027|529425025|FG000|Overall Study|Lost to Follow-up|5|||
146795608|NCT05838027|529425026|FG001|Overall Study|Lost to Follow-up|1|||
146795609|NCT05838027|529425025|FG000|Overall Study|Withdrawal by Subject|1|||
146795610|NCT05838027|529425026|FG001|Overall Study|Withdrawal by Subject|0|||
146795611|NCT04820322|529425027|FG000|Overall Study|Adverse Event|1|||
146795612|NCT04820322|529425028|FG001|Overall Study|Adverse Event|0|||
146795613|NCT03156465|529425029|FG000|Overall Study|Withdrawal by Subject|2|||
146795614|NCT05715528|529425033|FG000|Overall Study|Randomized but never treated|11|||
146795615|NCT05715528|529425034|FG001|Overall Study|Randomized but never treated|13|||
146795616|NCT05715528|529425033|FG000|Overall Study|Withdrew consent|7|||
146795617|NCT05715528|529425034|FG001|Overall Study|Withdrew consent|15|||
146795618|NCT05715528|529425033|FG000|Overall Study|Lost to Follow-up|5|||
146795619|NCT05715528|529425034|FG001|Overall Study|Lost to Follow-up|13|||
146795620|NCT05715528|529425033|FG000|Overall Study|Investigator's discretion|3|||
146795621|NCT05715528|529425034|FG001|Overall Study|Investigator's discretion|1|||
146795622|NCT05715528|529425033|FG000|Overall Study|Protocol Violation|2|||
146795623|NCT05715528|529425034|FG001|Overall Study|Protocol Violation|0|||
146795624|NCT05715528|529425033|FG000|Overall Study|Non-compliance with study drug|0|||
146795625|NCT05715528|529425034|FG001|Overall Study|Non-compliance with study drug|1|||
146795626|NCT03118518|529425035|FG000|Overall Study|Early Exit after treatment|2|||
146795627|NCT03118518|529425036|FG001|Overall Study|Early Exit after treatment|8|||
146795628|NCT03118518|529425035|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
146795629|NCT03118518|529425036|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
146795630|NCT04880733|529425037|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
146795631|NCT04880733|529425038|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
146795632|NCT04880733|529425039|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
146795633|NCT04880733|529425037|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
146795634|NCT04880733|529425038|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
146795635|NCT04880733|529425039|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
146795636|NCT04880733|529425037|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
146795637|NCT04880733|529425038|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
146795638|NCT04880733|529425039|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
146795639|NCT04880733|529425037|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
146795640|NCT04880733|529425038|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
146795641|NCT04880733|529425039|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
146795642|NCT04880733|529425037|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
146795643|NCT04880733|529425038|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
146795644|NCT04880733|529425039|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
146795645|NCT05533190|529425041|FG000|Overall Study|Lost to Follow-up|19|||
146795646|NCT05533190|529425042|FG001|Overall Study|Lost to Follow-up|7|||
146795647|NCT05533190|529425041|FG000|Overall Study|Failed to download app|1|||
146795648|NCT05533190|529425042|FG001|Overall Study|Failed to download app|0|||
146940024|NCT03424044|529939117|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
146940025|NCT03424044|529939118|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
146940026|NCT03424044|529939119|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
146940027|NCT03424044|529939111|FG000|First Intervention (76 Hours)|Adverse Event|0|||
146940028|NCT03424044|529939112|FG001|First Intervention (76 Hours)|Adverse Event|0|||
146940029|NCT03424044|529939113|FG002|First Intervention (76 Hours)|Adverse Event|0|||
146940030|NCT03424044|529939114|FG003|First Intervention (76 Hours)|Adverse Event|0|||
146982889|NCT01464827|530099837|FG013|Overall Study|Withdrawal by Subject|0|||
146795649|NCT05533190|529425041|FG000|Overall Study|Thought app was a scam|1|||
146795650|NCT05533190|529425042|FG001|Overall Study|Thought app was a scam|0|||
146795651|NCT05533190|529425041|FG000|Overall Study|Withdrawal by Subject|2|||
146795652|NCT05533190|529425042|FG001|Overall Study|Withdrawal by Subject|0|||
146795653|NCT03213678|529425051|FG000|Overall Study|Death|1|||
146795654|NCT03213678|529425051|FG000|Overall Study|Physician Decision|1|||
146795655|NCT03213678|529425051|FG000|Overall Study|Progressive disease|16|||
146795656|NCT04218851|529425052|FG000|Overall Study|Death|1|||
146795657|NCT04218851|529425053|FG001|Overall Study|Death|3|||
146940031|NCT03424044|529939115|FG004|First Intervention (76 Hours)|Adverse Event|1|||
146795658|NCT03174275|529425054|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
146795659|NCT03174275|529425054|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
146795660|NCT03174275|529425054|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
146795661|NCT03174275|529425054|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
146795662|NCT03174275|529425054|FG000|Adjuvant Chemotherapy|Progression|1|||
146795663|NCT03174275|529425054|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
146795664|NCT03174275|529425054|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
146795665|NCT03174275|529425054|FG000|Adjuvant Durvalumab|Progression|1|||
146795666|NCT03174275|529425054|FG000|Adjuvant Durvalumab|Adverse Event|3|||
146795667|NCT03174275|529425054|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
146795668|NCT03174275|529425054|FG000|Adjuvant Radiotherapy|Progression|1|||
146795669|NCT03174275|529425054|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
146795670|NCT05970861|529425055|FG000|Overall Study|Physician Decision|4|||
146795671|NCT05970861|529425056|FG001|Overall Study|Physician Decision|4|||
146795672|NCT05970861|529425055|FG000|Overall Study|Lost to Follow-up|4|||
146795673|NCT05970861|529425056|FG001|Overall Study|Lost to Follow-up|3|||
146795674|NCT04456296|529425057|FG000|Overall Study|Withdrawal by Subject|14|||
146795675|NCT04456296|529425058|FG001|Overall Study|Withdrawal by Subject|21|||
146795676|NCT04456296|529425059|FG002|Overall Study|Withdrawal by Subject|21|||
146795677|NCT04456296|529425057|FG000|Overall Study|Adverse Event|2|||
146795678|NCT04456296|529425058|FG001|Overall Study|Adverse Event|2|||
146795679|NCT04456296|529425059|FG002|Overall Study|Adverse Event|2|||
146795680|NCT04456296|529425057|FG000|Overall Study|Death|1|||
146795681|NCT04456296|529425058|FG001|Overall Study|Death|0|||
146795682|NCT04456296|529425059|FG002|Overall Study|Death|0|||
146795683|NCT04456296|529425057|FG000|Overall Study|Lost to Follow-up|3|||
146795684|NCT04456296|529425058|FG001|Overall Study|Lost to Follow-up|5|||
146795685|NCT04456296|529425059|FG002|Overall Study|Lost to Follow-up|6|||
146795686|NCT04456296|529425057|FG000|Overall Study|Other than specified|0|||
146795687|NCT04456296|529425058|FG001|Overall Study|Other than specified|1|||
146795688|NCT04456296|529425059|FG002|Overall Study|Other than specified|4|||
146795689|NCT04456296|529425057|FG000|Overall Study|Randomized, not treated|2|||
146795690|NCT04456296|529425058|FG001|Overall Study|Randomized, not treated|1|||
146795691|NCT04456296|529425059|FG002|Overall Study|Randomized, not treated|0|||
146795692|NCT03988621|529425064|FG000|Overall Study|Lost to Follow-up|16|||
146795693|NCT03988621|529425065|FG001|Overall Study|Lost to Follow-up|17|||
146795694|NCT03988621|529425064|FG000|Overall Study|Withdrawal by Subject|14|||
146795695|NCT03988621|529425065|FG001|Overall Study|Withdrawal by Subject|7|||
146795696|NCT03988621|529425064|FG000|Overall Study|Patient Lost to Follow Up|15|||
146795697|NCT03988621|529425065|FG001|Overall Study|Patient Lost to Follow Up|15|||
146795698|NCT03988621|529425064|FG000|Overall Study|Patient death|1|||
146795699|NCT03988621|529425065|FG001|Overall Study|Patient death|5|||
146795700|NCT05013385|529425066|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
146795701|NCT04247802|529425067|FG000|Overall Study|Withdrawal by Subject|1|||
146795702|NCT04247802|529425068|FG001|Overall Study|Withdrawal by Subject|3|||
146795703|NCT04247802|529425067|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
146795704|NCT04247802|529425068|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
146795705|NCT01447719|529425071|FG000|Overall Study|Image acquisition failure|2|||
146795706|NCT01447719|529425071|FG000|Overall Study|Invalid image or not imaged|3|||
146795707|NCT01447719|529425071|FG000|Overall Study|Subject still living at end of study|79|||
146795708|NCT01447719|529425071|FG000|Overall Study|Withdrawal by Subject|2|||
146795709|NCT01447719|529425071|FG000|Overall Study|Family withdrew autopsy consent|7|||
146795710|NCT03252288|529425073|FG000|Overall Study|Death|1|||
146795711|NCT03252288|529425074|FG001|Overall Study|Death|0|||
146795712|NCT03252288|529425075|FG002|Overall Study|Death|0|||
146795713|NCT03252288|529425073|FG000|Overall Study|Death|11|||
146795714|NCT03252288|529425074|FG001|Overall Study|Death|0|||
146795715|NCT03252288|529425075|FG002|Overall Study|Death|0|||
146795716|NCT03252288|529425073|FG000|Overall Study|Withdrawal by Subject|2|||
146795717|NCT03252288|529425074|FG001|Overall Study|Withdrawal by Subject|0|||
146795718|NCT03252288|529425075|FG002|Overall Study|Withdrawal by Subject|0|||
146795719|NCT03252288|529425073|FG000|Overall Study|Lost to Follow-up|79|||
146795720|NCT03252288|529425074|FG001|Overall Study|Lost to Follow-up|0|||
146795721|NCT03252288|529425075|FG002|Overall Study|Lost to Follow-up|0|||
146795722|NCT03252288|529425073|FG000|Overall Study|Loss of baseline data on tablets|6|||
146795723|NCT03252288|529425074|FG001|Overall Study|Loss of baseline data on tablets|0|||
146795724|NCT03252288|529425075|FG002|Overall Study|Loss of baseline data on tablets|0|||
146795725|NCT02905331|529425077|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
146795726|NCT02905331|529425078|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
146795727|NCT02905331|529425079|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
146795728|NCT02905331|529425077|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
146795729|NCT02905331|529425078|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
146795730|NCT02905331|529425079|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
146795731|NCT02905331|529425077|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
146795732|NCT02905331|529425078|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
146795733|NCT02905331|529425079|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
146795734|NCT02905331|529425077|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
146795735|NCT02905331|529425078|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
146795736|NCT02905331|529425079|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
146795737|NCT02905331|529425077|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
146795738|NCT02905331|529425078|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
146795739|NCT02905331|529425079|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
146795740|NCT02641730|529425080|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
146795741|NCT02641730|529425081|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
146795742|NCT02641730|529425082|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
146795743|NCT02641730|529425083|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
146795744|NCT02641730|529425084|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
146795745|NCT02641730|529425080|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
146795746|NCT02641730|529425081|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
146795747|NCT02641730|529425082|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
146795748|NCT02641730|529425083|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
146795749|NCT02641730|529425084|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
146795750|NCT02641730|529425080|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
146795751|NCT02641730|529425081|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
146795752|NCT02641730|529425082|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
146795753|NCT02641730|529425083|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
146795754|NCT02641730|529425084|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
146795755|NCT02641730|529425080|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
146795756|NCT02641730|529425081|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
146795757|NCT02641730|529425082|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
146795758|NCT02641730|529425083|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
146795759|NCT02641730|529425084|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
146795760|NCT02641730|529425080|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
146795761|NCT02641730|529425081|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
146795762|NCT02641730|529425082|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
146795763|NCT02641730|529425083|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
146795764|NCT02641730|529425084|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
146795765|NCT02641730|529425080|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
146795766|NCT02641730|529425081|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
146795767|NCT02641730|529425082|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
146795768|NCT02641730|529425083|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
146795769|NCT02641730|529425084|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
146795770|NCT05460871|529425085|FG000|Overall Study|Withdrawal by Subject|1|||
146795771|NCT05460871|529425086|FG001|Overall Study|Withdrawal by Subject|2|||
146795772|NCT00721149|529425087|FG000|Overall Study|Physician Decision|1|||
146795773|NCT05158504|529425088|FG000|Overall Study|Lost to Follow-up|2|||
146795774|NCT05158504|529425089|FG001|Overall Study|Lost to Follow-up|3|||
146795775|NCT03606512|529425092|FG000|Overall Study|Lost to Follow-up|0|||
146795776|NCT03606512|529425093|FG001|Overall Study|Lost to Follow-up|1|||
146795777|NCT03606512|529425092|FG000|Overall Study|'moved from study area|0|||
146795778|NCT03606512|529425093|FG001|Overall Study|'moved from study area|1|||
146795779|NCT05513937|529425094|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
146795780|NCT05513937|529425095|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
146795781|NCT05513937|529425096|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
146795782|NCT05513937|529425097|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
146795783|NCT05513937|529425094|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
146795784|NCT05513937|529425095|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
146795785|NCT05513937|529425096|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
146795786|NCT05513937|529425097|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
146795787|NCT05513937|529425094|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
146795788|NCT05513937|529425095|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
146795789|NCT05513937|529425096|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
146795790|NCT05513937|529425097|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
146795791|NCT05513937|529425094|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
146795792|NCT05513937|529425095|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
146795793|NCT05513937|529425096|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
146795794|NCT05513937|529425097|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
146795795|NCT05513937|529425094|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
146795796|NCT05513937|529425095|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
146795797|NCT05513937|529425096|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
146795798|NCT05513937|529425097|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
146982890|NCT01464827|530099824|FG000|Overall Study|Lost to Follow-up|0|||
146982891|NCT01464827|530099825|FG001|Overall Study|Lost to Follow-up|2|||
146982892|NCT01464827|530099826|FG002|Overall Study|Lost to Follow-up|0|||
146982893|NCT01464827|530099827|FG003|Overall Study|Lost to Follow-up|2|||
146982894|NCT01464827|530099828|FG004|Overall Study|Lost to Follow-up|3|||
146982895|NCT01464827|530099829|FG005|Overall Study|Lost to Follow-up|1|||
146982896|NCT01464827|530099830|FG006|Overall Study|Lost to Follow-up|2|||
146982897|NCT01464827|530099831|FG007|Overall Study|Lost to Follow-up|2|||
146982898|NCT01464827|530099832|FG008|Overall Study|Lost to Follow-up|0|||
146982899|NCT01464827|530099833|FG009|Overall Study|Lost to Follow-up|0|||
146982900|NCT01464827|530099834|FG010|Overall Study|Lost to Follow-up|0|||
146982901|NCT01464827|530099835|FG011|Overall Study|Lost to Follow-up|1|||
146982902|NCT01464827|530099836|FG012|Overall Study|Lost to Follow-up|0|||
146982903|NCT01464827|530099837|FG013|Overall Study|Lost to Follow-up|1|||
146982904|NCT01464827|530099824|FG000|Overall Study|Other|2|||
146982905|NCT01464827|530099825|FG001|Overall Study|Other|3|||
146982906|NCT01464827|530099826|FG002|Overall Study|Other|0|||
146982907|NCT01464827|530099827|FG003|Overall Study|Other|2|||
146982908|NCT01464827|530099828|FG004|Overall Study|Other|3|||
146982909|NCT01464827|530099829|FG005|Overall Study|Other|0|||
146982910|NCT01464827|530099830|FG006|Overall Study|Other|1|||
146982911|NCT01464827|530099831|FG007|Overall Study|Other|0|||
146982912|NCT01464827|530099832|FG008|Overall Study|Other|3|||
146982913|NCT01464827|530099833|FG009|Overall Study|Other|1|||
146982914|NCT01464827|530099834|FG010|Overall Study|Other|2|||
146982915|NCT01464827|530099835|FG011|Overall Study|Other|0|||
146982916|NCT01464827|530099836|FG012|Overall Study|Other|1|||
146982917|NCT01464827|530099837|FG013|Overall Study|Other|0|||
146982918|NCT01464827|530099824|FG000|Overall Study|Not Treated|0|||
146982919|NCT01464827|530099825|FG001|Overall Study|Not Treated|2|||
146982920|NCT01464827|530099826|FG002|Overall Study|Not Treated|0|||
146982921|NCT01464827|530099827|FG003|Overall Study|Not Treated|0|||
146982922|NCT01464827|530099828|FG004|Overall Study|Not Treated|1|||
146982923|NCT01464827|530099829|FG005|Overall Study|Not Treated|0|||
146982924|NCT01464827|530099830|FG006|Overall Study|Not Treated|1|||
146982925|NCT01464827|530099831|FG007|Overall Study|Not Treated|0|||
146982926|NCT01464827|530099832|FG008|Overall Study|Not Treated|0|||
146982927|NCT01464827|530099833|FG009|Overall Study|Not Treated|2|||
146982928|NCT01464827|530099834|FG010|Overall Study|Not Treated|0|||
146982929|NCT01464827|530099835|FG011|Overall Study|Not Treated|1|||
146982930|NCT01464827|530099836|FG012|Overall Study|Not Treated|0|||
146982931|NCT01464827|530099837|FG013|Overall Study|Not Treated|2|||
146982932|NCT04604184|530099847|FG000|Overall Study|Adverse Event|5|||
146982933|NCT04604184|530099848|FG001|Overall Study|Adverse Event|5|||
146982934|NCT04604184|530099847|FG000|Overall Study|Death|2|||
146982935|NCT04604184|530099848|FG001|Overall Study|Death|1|||
146982936|NCT04604184|530099847|FG000|Overall Study|Withdrawal by Subject|1|||
146982937|NCT04604184|530099848|FG001|Overall Study|Withdrawal by Subject|3|||
146982938|NCT04604184|530099847|FG000|Overall Study|Not treated|2|||
146795799|NCT05513937|529425094|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
146795800|NCT05513937|529425095|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
146795801|NCT05513937|529425096|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
146795802|NCT05513937|529425097|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
146795803|NCT02846545|529425098|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
146795804|NCT02846545|529425099|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
146795805|NCT02846545|529425098|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
146795806|NCT02846545|529425099|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
146795807|NCT02846545|529425098|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
146795808|NCT02846545|529425099|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
146795809|NCT02846545|529425098|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
146795810|NCT02846545|529425099|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
146795811|NCT02846545|529425098|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
146795812|NCT02846545|529425099|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
146982939|NCT04604184|530099848|FG001|Overall Study|Not treated|2|||
146982940|NCT04604184|530099847|FG000|Overall Study|Due to sponsor decision|9|||
146982941|NCT04604184|530099848|FG001|Overall Study|Due to sponsor decision|7|||
146982942|NCT04604184|530099847|FG000|Overall Study|Physician Decision|0|||
146982943|NCT04604184|530099848|FG001|Overall Study|Physician Decision|1|||
146982944|NCT04604184|530099847|FG000|Overall Study|Transfer to healthcare|1|||
146982945|NCT04604184|530099848|FG001|Overall Study|Transfer to healthcare|0|||
146982946|NCT01769378|530099849|FG000|Overall Study|Adverse Event|10|||
146982947|NCT01769378|530099850|FG001|Overall Study|Adverse Event|0|||
146982948|NCT01769378|530099849|FG000|Overall Study|Entry criteria not met|1|||
146982949|NCT01769378|530099850|FG001|Overall Study|Entry criteria not met|0|||
146982950|NCT01769378|530099849|FG000|Overall Study|Protocol Violation|1|||
146982951|NCT01769378|530099850|FG001|Overall Study|Protocol Violation|1|||
146982952|NCT01769378|530099849|FG000|Overall Study|Withdrawal by Subject|10|||
146982953|NCT01769378|530099850|FG001|Overall Study|Withdrawal by Subject|3|||
146982954|NCT01769378|530099849|FG000|Overall Study|Sponsor Decision|1|||
146982955|NCT01769378|530099850|FG001|Overall Study|Sponsor Decision|0|||
146795813|NCT03993392|529425104|FG000|Overall Study|Withdrawal by Subject|3|||
146795814|NCT03993392|529425104|FG000|Overall Study|Lost to Follow-up|2|||
146795815|NCT03993392|529425104|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
146795816|NCT05654662|529425106|FG000|Overall Study|Withdrawal by Subject|1|||
146795817|NCT05654662|529425107|FG001|Overall Study|Withdrawal by Subject|0|||
146795818|NCT05654662|529425106|FG000|Overall Study|A death in the family|1|||
146795819|NCT05654662|529425107|FG001|Overall Study|A death in the family|0|||
146795820|NCT05962814|529425108|FG000|Overall Study|failed eligibility|1|||
146795821|NCT03057054|529425109|FG000|Overall Study|Death|4|||
146795822|NCT03057054|529425110|FG001|Overall Study|Death|4|||
146795823|NCT03057054|529425109|FG000|Overall Study|Withdrawal by Subject|6|||
146795824|NCT03057054|529425110|FG001|Overall Study|Withdrawal by Subject|3|||
146795825|NCT03057054|529425109|FG000|Overall Study|Ineligible|1|||
146795826|NCT03057054|529425110|FG001|Overall Study|Ineligible|1|||
146795831|NCT06262477|529426656|FG000|Overall Study|Withdrawal by Subject|1|||
146795832|NCT06262477|529426657|FG001|Overall Study|Withdrawal by Subject|0|||
146795833|NCT06262477|529426656|FG000|Overall Study|Adverse Event|0|||
146795834|NCT06262477|529426657|FG001|Overall Study|Adverse Event|1|||
146795835|NCT06262477|529426656|FG000|Overall Study|Lost to Follow-up|0|||
146795836|NCT06262477|529426657|FG001|Overall Study|Lost to Follow-up|1|||
146795837|NCT01064440|529426658|FG000|Overall Study|Lost to Follow-up|1|||
146795838|NCT01064440|529426659|FG001|Overall Study|Lost to Follow-up|1|||
146795839|NCT01064440|529426660|FG002|Overall Study|Lost to Follow-up|1|||
146795840|NCT01064440|529426658|FG000|Overall Study|Non-compliance|0|||
146795841|NCT01064440|529426659|FG001|Overall Study|Non-compliance|1|||
146795842|NCT01064440|529426660|FG002|Overall Study|Non-compliance|0|||
146795843|NCT01064440|529426658|FG000|Overall Study|Death|1|||
146795844|NCT01064440|529426659|FG001|Overall Study|Death|0|||
146795845|NCT01064440|529426660|FG002|Overall Study|Death|1|||
146795846|NCT01064440|529426658|FG000|Overall Study|Withdrawal by Subject|0|||
146795847|NCT01064440|529426659|FG001|Overall Study|Withdrawal by Subject|1|||
146795848|NCT01064440|529426660|FG002|Overall Study|Withdrawal by Subject|1|||
146795849|NCT01064440|529426658|FG000|Overall Study|Other: amputation|1|||
146795850|NCT01064440|529426659|FG001|Overall Study|Other: amputation|0|||
146795851|NCT01064440|529426660|FG002|Overall Study|Other: amputation|0|||
146795852|NCT04108130|529426661|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
146795853|NCT04108130|529426662|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
146795854|NCT04108130|529426661|FG000|Overall Study|Consent Withdrawn|9|||
146795855|NCT04108130|529426662|FG001|Overall Study|Consent Withdrawn|6|||
146795856|NCT04108130|529426661|FG000|Overall Study|Surgery Cancelled|4|||
146940032|NCT03424044|529939116|FG005|First Intervention (76 Hours)|Adverse Event|0|||
146940033|NCT03424044|529939117|FG006|First Intervention (76 Hours)|Adverse Event|0|||
146940034|NCT03424044|529939118|FG007|First Intervention (76 Hours)|Adverse Event|0|||
146940035|NCT03424044|529939119|FG008|First Intervention (76 Hours)|Adverse Event|0|||
146940036|NCT03424044|529939111|FG000|First Intervention (76 Hours)|device issues|0|||
146940037|NCT03424044|529939112|FG001|First Intervention (76 Hours)|device issues|0|||
146940038|NCT03424044|529939113|FG002|First Intervention (76 Hours)|device issues|0|||
146940039|NCT03424044|529939114|FG003|First Intervention (76 Hours)|device issues|0|||
146940040|NCT03424044|529939115|FG004|First Intervention (76 Hours)|device issues|0|||
146940041|NCT03424044|529939116|FG005|First Intervention (76 Hours)|device issues|0|||
146940042|NCT03424044|529939117|FG006|First Intervention (76 Hours)|device issues|1|||
146940043|NCT03424044|529939118|FG007|First Intervention (76 Hours)|device issues|1|||
146940044|NCT03424044|529939119|FG008|First Intervention (76 Hours)|device issues|1|||
146940045|NCT03424044|529939111|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
146940046|NCT03424044|529939112|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
146795857|NCT04108130|529426662|FG001|Overall Study|Surgery Cancelled|4|||
146795858|NCT04108130|529426661|FG000|Overall Study|Found Ineligible for Study|4|||
146795859|NCT04108130|529426662|FG001|Overall Study|Found Ineligible for Study|3|||
146795860|NCT04108130|529426661|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
146795861|NCT04108130|529426662|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
146795862|NCT04108130|529426661|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
146795863|NCT04108130|529426662|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
146795864|NCT05507333|529426663|FG000|Overall Study|Protocol Violation|1|||
146795865|NCT05247034|529426668|FG000|Overall Study|Lost to Follow-up|3|||
146795866|NCT05247034|529426669|FG001|Overall Study|Lost to Follow-up|2|||
146795867|NCT05247034|529426668|FG000|Overall Study|Organizational problems when attending appointments|1|||
146795868|NCT05247034|529426669|FG001|Overall Study|Organizational problems when attending appointments|0|||
146795869|NCT04136912|529426674|FG000|Overall Study|Operational reasons|0|||
146795870|NCT04136912|529426675|FG001|Overall Study|Operational reasons|0|||
146940047|NCT03424044|529939113|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
146940048|NCT03424044|529939114|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
146940049|NCT03424044|529939115|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
146795871|NCT04136912|529426676|FG002|Overall Study|Operational reasons|2|||
146795872|NCT04615273|529426677|FG000|Overall Study|Withdrawal by Subject|3|||
146795873|NCT04615273|529426678|FG001|Overall Study|Withdrawal by Subject|1|||
146795874|NCT04615273|529426679|FG002|Overall Study|Withdrawal by Subject|2|||
146795875|NCT04615273|529426677|FG000|Overall Study|Adverse Event|1|||
146795876|NCT04615273|529426678|FG001|Overall Study|Adverse Event|0|||
146795877|NCT04615273|529426679|FG002|Overall Study|Adverse Event|1|||
146795878|NCT04615273|529426677|FG000|Overall Study|Lost to Follow-up|0|||
146795879|NCT04615273|529426678|FG001|Overall Study|Lost to Follow-up|1|||
146795880|NCT04615273|529426679|FG002|Overall Study|Lost to Follow-up|0|||
146795881|NCT04615273|529426677|FG000|Overall Study|Physician Decision|0|||
146795882|NCT04615273|529426678|FG001|Overall Study|Physician Decision|0|||
146795883|NCT04615273|529426679|FG002|Overall Study|Physician Decision|1|||
146795884|NCT04615273|529426677|FG000|Overall Study|Other|0|||
146795885|NCT04615273|529426678|FG001|Overall Study|Other|1|||
146795886|NCT04615273|529426679|FG002|Overall Study|Other|0|||
146795887|NCT04615273|529426677|FG000|Overall Study|Randomized but not treated|1|||
146795888|NCT04615273|529426678|FG001|Overall Study|Randomized but not treated|3|||
146795889|NCT04615273|529426679|FG002|Overall Study|Randomized but not treated|1|||
146795890|NCT04999111|529426684|FG000|Overall Study|Lost to Follow-up|21|||
146795891|NCT04999111|529426685|FG001|Overall Study|Lost to Follow-up|16|||
146795892|NCT04999111|529426686|FG002|Overall Study|Lost to Follow-up|2|||
146795893|NCT04999111|529426687|FG003|Overall Study|Lost to Follow-up|26|||
146795894|NCT04999111|529426688|FG004|Overall Study|Lost to Follow-up|30|||
146795895|NCT04999111|529426689|FG005|Overall Study|Lost to Follow-up|6|||
146795896|NCT04999111|529426684|FG000|Overall Study|Physician Decision|1|||
146795897|NCT04999111|529426685|FG001|Overall Study|Physician Decision|3|||
146795898|NCT04999111|529426686|FG002|Overall Study|Physician Decision|0|||
146795899|NCT04999111|529426687|FG003|Overall Study|Physician Decision|1|||
146795900|NCT04999111|529426688|FG004|Overall Study|Physician Decision|2|||
146795901|NCT04999111|529426689|FG005|Overall Study|Physician Decision|0|||
146795902|NCT04999111|529426684|FG000|Overall Study|Withdrawal by Subject|23|||
146795903|NCT04999111|529426685|FG001|Overall Study|Withdrawal by Subject|29|||
146795904|NCT04999111|529426686|FG002|Overall Study|Withdrawal by Subject|15|||
146795905|NCT04999111|529426687|FG003|Overall Study|Withdrawal by Subject|30|||
146795906|NCT04999111|529426688|FG004|Overall Study|Withdrawal by Subject|35|||
146795907|NCT04999111|529426689|FG005|Overall Study|Withdrawal by Subject|10|||
146795908|NCT04999111|529426684|FG000|Overall Study|Other|6|||
146795909|NCT04999111|529426685|FG001|Overall Study|Other|6|||
146795910|NCT04999111|529426686|FG002|Overall Study|Other|3|||
146795911|NCT04999111|529426687|FG003|Overall Study|Other|8|||
146795912|NCT04999111|529426688|FG004|Overall Study|Other|8|||
146795913|NCT04999111|529426689|FG005|Overall Study|Other|5|||
146795914|NCT04999111|529426684|FG000|Overall Study|Non-compliance with study schedule|1|||
146795915|NCT04999111|529426685|FG001|Overall Study|Non-compliance with study schedule|0|||
146795916|NCT04999111|529426686|FG002|Overall Study|Non-compliance with study schedule|0|||
146795917|NCT04999111|529426687|FG003|Overall Study|Non-compliance with study schedule|1|||
146795918|NCT04999111|529426688|FG004|Overall Study|Non-compliance with study schedule|1|||
146795919|NCT04999111|529426689|FG005|Overall Study|Non-compliance with study schedule|1|||
146795920|NCT04999111|529426684|FG000|Overall Study|Randomized but not vaccinated|1|||
146795921|NCT04999111|529426685|FG001|Overall Study|Randomized but not vaccinated|2|||
146795922|NCT04999111|529426686|FG002|Overall Study|Randomized but not vaccinated|0|||
146795923|NCT04999111|529426687|FG003|Overall Study|Randomized but not vaccinated|3|||
146795924|NCT04999111|529426688|FG004|Overall Study|Randomized but not vaccinated|3|||
146795925|NCT04999111|529426689|FG005|Overall Study|Randomized but not vaccinated|0|||
146795926|NCT04999111|529426684|FG000|Overall Study|Adverse Event|1|||
146795927|NCT04999111|529426685|FG001|Overall Study|Adverse Event|1|||
146982956|NCT01769378|530099849|FG000|Overall Study|Lost to Follow-up|2|||
146982957|NCT01769378|530099850|FG001|Overall Study|Lost to Follow-up|0|||
146982958|NCT01090765|530099851|FG000|Overall Study|Patient withdrew consent|0|||
146982959|NCT01090765|530099852|FG001|Overall Study|Patient withdrew consent|0|||
146795928|NCT04999111|529426686|FG002|Overall Study|Adverse Event|0|||
146795929|NCT04999111|529426687|FG003|Overall Study|Adverse Event|0|||
146795930|NCT04999111|529426688|FG004|Overall Study|Adverse Event|0|||
146795931|NCT04999111|529426689|FG005|Overall Study|Adverse Event|0|||
146795932|NCT04999111|529426684|FG000|Overall Study|Initiated prohibited medication|0|||
146795933|NCT04999111|529426685|FG001|Overall Study|Initiated prohibited medication|0|||
146795934|NCT04999111|529426686|FG002|Overall Study|Initiated prohibited medication|0|||
146795935|NCT04999111|529426687|FG003|Overall Study|Initiated prohibited medication|0|||
146795936|NCT04999111|529426688|FG004|Overall Study|Initiated prohibited medication|1|||
146795937|NCT04999111|529426689|FG005|Overall Study|Initiated prohibited medication|0|||
146795938|NCT02437136|529426695|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
146795939|NCT02437136|529426696|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
146795940|NCT02437136|529426697|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
146795941|NCT02437136|529426698|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
146982960|NCT01090765|530099853|FG002|Overall Study|Patient withdrew consent|0|||
146795942|NCT02437136|529426699|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
146795943|NCT02437136|529426700|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
146982961|NCT01090765|530099854|FG003|Overall Study|Patient withdrew consent|0|||
146982962|NCT01090765|530099855|FG004|Overall Study|Patient withdrew consent|1|||
146982963|NCT01090765|530099856|FG005|Overall Study|Patient withdrew consent|1|||
146982964|NCT01090765|530099851|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
146982965|NCT01090765|530099852|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
146982966|NCT01090765|530099853|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
146982967|NCT01090765|530099854|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
146982968|NCT01090765|530099855|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
146982969|NCT01090765|530099856|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
146982970|NCT01090765|530099851|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
146982971|NCT01090765|530099852|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
146982972|NCT01090765|530099853|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
146982973|NCT01090765|530099854|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
146982974|NCT01090765|530099855|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
146982975|NCT01090765|530099856|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
146982976|NCT01977092|530099857|FG000|Overall Study|Death|3|||
146982977|NCT01977092|530099858|FG001|Overall Study|Death|4|||
146982978|NCT01977092|530099857|FG000|Overall Study|Lost to Follow-up|23|||
146982979|NCT01977092|530099858|FG001|Overall Study|Lost to Follow-up|14|||
146982980|NCT01977092|530099857|FG000|Overall Study|Withdrawal by Subject|2|||
146982981|NCT01977092|530099858|FG001|Overall Study|Withdrawal by Subject|1|||
146982982|NCT01977092|530099857|FG000|Overall Study|In prison|3|||
146982983|NCT01977092|530099858|FG001|Overall Study|In prison|11|||
146982984|NCT00678392|530099859|FG000|Overall Study|Adverse Event|0|||
146982985|NCT00678392|530099860|FG001|Overall Study|Adverse Event|6|||
146982986|NCT00678392|530099859|FG000|Overall Study|Death|280|||
146982987|NCT00678392|530099860|FG001|Overall Study|Death|269|||
146982988|NCT00678392|530099859|FG000|Overall Study|Lost to Follow-up|15|||
146982989|NCT00678392|530099860|FG001|Overall Study|Lost to Follow-up|13|||
146982990|NCT00678392|530099859|FG000|Overall Study|Objective Progression or Relapse|3|||
146982991|NCT00678392|530099860|FG001|Overall Study|Objective Progression or Relapse|8|||
146982992|NCT00678392|530099859|FG000|Overall Study|Sponsor's Decision|1|||
146982993|NCT00678392|530099860|FG001|Overall Study|Sponsor's Decision|2|||
146982994|NCT00678392|530099859|FG000|Overall Study|Withdrawal by Subject|4|||
146982995|NCT00678392|530099860|FG001|Overall Study|Withdrawal by Subject|4|||
146982996|NCT00678392|530099859|FG000|Overall Study|Randomized But Not Treated|2|||
146982997|NCT00678392|530099860|FG001|Overall Study|Randomized But Not Treated|7|||
146982998|NCT00678392|530099859|FG000|Overall Study|Other|56|||
146982999|NCT00678392|530099860|FG001|Overall Study|Other|53|||
146983000|NCT01958281|530099861|FG000|Overall Study|Lack of Efficacy|5|||
146983001|NCT01958281|530099862|FG001|Overall Study|Lack of Efficacy|2|||
146983002|NCT01958281|530099863|FG002|Overall Study|Lack of Efficacy|0|||
146983003|NCT01958281|530099861|FG000|Overall Study|Adverse Event|0|||
146983004|NCT01958281|530099862|FG001|Overall Study|Adverse Event|2|||
146983005|NCT01958281|530099863|FG002|Overall Study|Adverse Event|0|||
146795944|NCT02437136|529426701|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
146795945|NCT02437136|529426695|FG000|Expansion (Phase 2)|Death|0|||
146795946|NCT02437136|529426696|FG001|Expansion (Phase 2)|Death|0|||
146795947|NCT02437136|529426697|FG002|Expansion (Phase 2)|Death|0|||
146795948|NCT02437136|529426698|FG003|Expansion (Phase 2)|Death|6|||
146795949|NCT02437136|529426699|FG004|Expansion (Phase 2)|Death|37|||
146795950|NCT02437136|529426700|FG005|Expansion (Phase 2)|Death|29|||
146795951|NCT02437136|529426701|FG006|Expansion (Phase 2)|Death|24|||
146795952|NCT02437136|529426695|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
146795953|NCT02437136|529426696|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
146795954|NCT02437136|529426697|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
146795955|NCT02437136|529426698|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
146983006|NCT01958281|530099861|FG000|Overall Study|Withdrew Consent|1|||
146983007|NCT01958281|530099862|FG001|Overall Study|Withdrew Consent|0|||
146983008|NCT01958281|530099863|FG002|Overall Study|Withdrew Consent|0|||
146795956|NCT02437136|529426699|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
146983009|NCT02784106|530099866|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
146983010|NCT02784106|530099867|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
146795957|NCT02437136|529426700|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
146795958|NCT02437136|529426701|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
146795959|NCT02437136|529426695|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
146983011|NCT02784106|530099868|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
146983012|NCT02784106|530099869|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
146983013|NCT02784106|530099866|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
146983014|NCT02784106|530099867|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
146983015|NCT02784106|530099868|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146795960|NCT02437136|529426696|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
146795961|NCT02437136|529426697|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
146983016|NCT02784106|530099869|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146795962|NCT02437136|529426698|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
146795963|NCT02437136|529426699|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
146795964|NCT02437136|529426700|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
146795965|NCT02437136|529426701|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
146795966|NCT01314105|529426702|FG000|Overall Study|Progressive Disease|6|||
146795967|NCT01314105|529426703|FG001|Overall Study|Progressive Disease|10|||
146795968|NCT01314105|529426702|FG000|Overall Study|Refused to continue taking medication|0|||
146795969|NCT01314105|529426703|FG001|Overall Study|Refused to continue taking medication|1|||
146795970|NCT01314105|529426702|FG000|Overall Study|Other Adverse Event|1|||
146795971|NCT01314105|529426703|FG001|Overall Study|Other Adverse Event|1|||
146795972|NCT02056834|529426706|FG000|Overall Study|Lost to Follow-up|7|||
146795973|NCT04526886|529426708|FG000|Overall Study|Physician Decision|4|||
146795974|NCT03484819|529426718|FG000|Overall Study|Death|2|||
146795975|NCT03484819|529426718|FG000|Overall Study|Adverse Event|2|||
146795976|NCT03484819|529426718|FG000|Overall Study|Physician Decision|1|||
146795977|NCT03484819|529426718|FG000|Overall Study|Withdrawal by Subject|2|||
146795978|NCT03484819|529426718|FG000|Overall Study|Disease Progression|4|||
146795979|NCT03484819|529426718|FG000|Overall Study|Complicating Condition|1|||
146795980|NCT02990338|529426719|FG000|Overall Study|Randomized and not treated|4|||
146795981|NCT02990338|529426720|FG001|Overall Study|Randomized and not treated|2|||
146795982|NCT02990338|529426719|FG000|Overall Study|Adverse Event|23|||
146795983|NCT02990338|529426720|FG001|Overall Study|Adverse Event|22|||
146795984|NCT02990338|529426719|FG000|Overall Study|Progressive disease|118|||
146795985|NCT02990338|529426720|FG001|Overall Study|Progressive disease|107|||
146795986|NCT02990338|529426719|FG000|Overall Study|Poor compliance to protocol|0|||
146795987|NCT02990338|529426720|FG001|Overall Study|Poor compliance to protocol|1|||
146795988|NCT02990338|529426719|FG000|Overall Study|Withdrawal by Subject|6|||
146795989|NCT02990338|529426720|FG001|Overall Study|Withdrawal by Subject|8|||
146795990|NCT02990338|529426719|FG000|Overall Study|Physician's decision|2|||
146795991|NCT02990338|529426720|FG001|Overall Study|Physician's decision|6|||
146795992|NCT02990338|529426719|FG000|Overall Study|Treatment extension study|0|||
146795993|NCT02990338|529426720|FG001|Overall Study|Treatment extension study|6|||
146795994|NCT02990338|529426719|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
146795995|NCT02990338|529426720|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
146795996|NCT02990338|529426719|FG000|Overall Study|Continue with therapy available commercially|0|||
146795997|NCT02990338|529426720|FG001|Overall Study|Continue with therapy available commercially|1|||
146795998|NCT04186819|529426721|FG000|Overall Study|Adverse Event|1|||
146795999|NCT04186819|529426721|FG000|Overall Study|Lost to Follow-up|1|||
146796000|NCT04186819|529426721|FG000|Overall Study|Opted for EBRT|1|||
146796001|NCT04186819|529426721|FG000|Overall Study|Opted SBRT|1|||
146796002|NCT04186819|529426721|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
146796003|NCT04186819|529426721|FG000|Overall Study|Physician Decision|1|||
146796004|NCT04186819|529426721|FG000|Overall Study|RP Delayed|1|||
146796005|NCT04186819|529426721|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
146796006|NCT04186819|529426721|FG000|Overall Study|Subject declined for financial reasons|1|||
146796007|NCT04186819|529426721|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
146796008|NCT04186819|529426721|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
146796009|NCT04186819|529426721|FG000|Overall Study|The subject opted for other treatment option|2|||
146796010|NCT04186819|529426721|FG000|Overall Study|The subject opted for other treatment options|1|||
146796011|NCT04186819|529426721|FG000|Overall Study|Withdrawal by Subject|3|||
146796012|NCT04186819|529426721|FG000|Overall Study|Reason not specified|1|||
146796013|NCT05900154|529426722|FG000|Follow-Up Period|Lost to Follow-up|1|||
146796014|NCT05900154|529426723|FG001|Follow-Up Period|Lost to Follow-up|2|||
146796015|NCT05900154|529426724|FG002|Follow-Up Period|Lost to Follow-up|1|||
146796016|NCT05900154|529426725|FG003|Follow-Up Period|Lost to Follow-up|0|||
146796017|NCT05900154|529426726|FG004|Follow-Up Period|Lost to Follow-up|1|||
146796018|NCT05900154|529426727|FG005|Follow-Up Period|Lost to Follow-up|1|||
146796019|NCT04102111|529426736|FG000|Overall Study|Withdrawal by Subject|2|||
146796020|NCT04102111|529426737|FG001|Overall Study|Withdrawal by Subject|3|||
146796021|NCT04102111|529426736|FG000|Overall Study|Adverse Event|1|||
146796022|NCT04102111|529426737|FG001|Overall Study|Adverse Event|1|||
146796023|NCT04102111|529426736|FG000|Overall Study|Study terminated by sponsor|1|||
146796024|NCT04102111|529426737|FG001|Overall Study|Study terminated by sponsor|3|||
146796025|NCT02542631|529426738|FG000|Overall Study|Adverse Event|1|||
146796026|NCT02542631|529426739|FG001|Overall Study|Adverse Event|1|||
146796027|NCT02542631|529426738|FG000|Overall Study|Sponsor Termination|1|||
146796028|NCT02542631|529426739|FG001|Overall Study|Sponsor Termination|0|||
146796029|NCT02542631|529426738|FG000|Overall Study|Withdrawal by Subject|11|||
146796030|NCT02542631|529426739|FG001|Overall Study|Withdrawal by Subject|16|||
146796031|NCT02542631|529426738|FG000|Overall Study|Protocol Violation|1|||
146796032|NCT02542631|529426739|FG001|Overall Study|Protocol Violation|1|||
146796033|NCT02542631|529426738|FG000|Overall Study|Physician Decision|6|||
146796034|NCT02542631|529426739|FG001|Overall Study|Physician Decision|4|||
146796035|NCT02542631|529426738|FG000|Overall Study|Lost to Follow-up|6|||
146796036|NCT02542631|529426739|FG001|Overall Study|Lost to Follow-up|5|||
146796037|NCT02542631|529426738|FG000|Overall Study|Death|1|||
146796038|NCT02542631|529426739|FG001|Overall Study|Death|2|||
146796039|NCT02542631|529426738|FG000|Overall Study|Other|2|||
146796040|NCT02542631|529426739|FG001|Overall Study|Other|1|||
146796041|NCT02542631|529426738|FG000|Overall Study|Used Prohibited Medication|2|||
146796042|NCT02542631|529426739|FG001|Overall Study|Used Prohibited Medication|1|||
146796043|NCT03334695|529426740|FG000|Overall Study|Lost to Follow-up|3|||
146796044|NCT03334695|529426741|FG001|Overall Study|Lost to Follow-up|3|||
146796045|NCT03334695|529426740|FG000|Overall Study|Physician Decision|1|||
146796046|NCT03334695|529426741|FG001|Overall Study|Physician Decision|2|||
146796047|NCT03334695|529426740|FG000|Overall Study|Protocol Violation|0|||
146796048|NCT03334695|529426741|FG001|Overall Study|Protocol Violation|1|||
146796049|NCT02938923|529426742|FG000|Overall Study|Death|1|||
146796050|NCT02938923|529426743|FG001|Overall Study|Death|0|||
146796051|NCT02938923|529426744|FG002|Overall Study|Death|0|||
146796052|NCT02938923|529426742|FG000|Overall Study|Physician Decision|0|||
146796053|NCT02938923|529426743|FG001|Overall Study|Physician Decision|2|||
146796054|NCT02938923|529426744|FG002|Overall Study|Physician Decision|0|||
146796055|NCT02938923|529426742|FG000|Overall Study|Withdrawal by Subject|0|||
146796056|NCT02938923|529426743|FG001|Overall Study|Withdrawal by Subject|1|||
146796057|NCT02938923|529426744|FG002|Overall Study|Withdrawal by Subject|1|||
146796058|NCT04583280|529426747|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
146796059|NCT04583280|529426748|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
146796060|NCT04614948|529426749|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
146796061|NCT04614948|529426750|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
146796062|NCT04614948|529426751|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
146796063|NCT04614948|529426749|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
146796064|NCT04614948|529426750|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
146796065|NCT04614948|529426751|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
146796066|NCT04614948|529426749|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
146796067|NCT04614948|529426750|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
146796068|NCT04614948|529426751|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
146796069|NCT04614948|529426749|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
146796070|NCT04614948|529426750|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
146796071|NCT04614948|529426751|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
146796072|NCT04614948|529426749|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
146796073|NCT04614948|529426750|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
146796074|NCT04614948|529426751|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
146796075|NCT04614948|529426749|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
146796076|NCT04614948|529426750|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
146796077|NCT04614948|529426751|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
146796078|NCT04614948|529426749|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
146796079|NCT04614948|529426750|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
146796080|NCT04614948|529426751|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
146796081|NCT04614948|529426749|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
146796082|NCT04614948|529426750|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
146796083|NCT04614948|529426751|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
146796084|NCT04614948|529426749|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
146796085|NCT04614948|529426750|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
146796086|NCT04614948|529426751|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
146796087|NCT04614948|529426749|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
146796088|NCT04614948|529426750|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
146796089|NCT04614948|529426751|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
146796090|NCT04614948|529426749|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
146796091|NCT04614948|529426750|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
146796092|NCT04614948|529426751|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
146796093|NCT04614948|529426749|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
146796094|NCT04614948|529426750|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
146796095|NCT04614948|529426751|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
146796096|NCT04614948|529426749|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
146796097|NCT04614948|529426750|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
146796098|NCT04614948|529426751|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
146796099|NCT04614948|529426749|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
146983017|NCT02784106|530099866|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
146796100|NCT04614948|529426750|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
146796101|NCT04614948|529426751|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
146796102|NCT04614948|529426749|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
146796103|NCT04614948|529426750|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
146983018|NCT02784106|530099867|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
146983019|NCT02784106|530099868|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
146940050|NCT03424044|529939116|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
146940051|NCT03424044|529939117|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
146940052|NCT03424044|529939118|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
146940053|NCT03424044|529939119|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
146940054|NCT03424044|529939111|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
146940055|NCT03424044|529939112|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
146940056|NCT03424044|529939113|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
146940057|NCT03424044|529939114|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
146940058|NCT03424044|529939115|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
146940059|NCT03424044|529939116|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
146940060|NCT03424044|529939117|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
146940061|NCT03424044|529939118|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
146940062|NCT03424044|529939119|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
146940063|NCT00784459|529939123|FG000|Overall Study|Adverse Event|0|||
146940064|NCT00784459|529939124|FG001|Overall Study|Adverse Event|2|||
146940065|NCT01376388|529939125|FG000|Overall Study|Adverse Event|13|||
146940066|NCT01376388|529939125|FG000|Overall Study|Lack of Efficacy|2|||
146940067|NCT01376388|529939125|FG000|Overall Study|Withdrawal by Subject|3|||
146940068|NCT02471586|529939134|FG000|Overall Study|Lost to Follow-up|3|||
146940069|NCT02471586|529939135|FG001|Overall Study|Lost to Follow-up|8|||
146940070|NCT02471586|529939136|FG002|Overall Study|Lost to Follow-up|4|||
146940071|NCT02471586|529939134|FG000|Overall Study|Death|2|||
146940072|NCT02471586|529939135|FG001|Overall Study|Death|2|||
146940073|NCT02471586|529939136|FG002|Overall Study|Death|0|||
146940074|NCT03805971|529939147|FG000|Overall Study|Withdrawal by Subject|1|||
146940075|NCT03805971|529939147|FG000|Overall Study|Protocol Violation|2|||
146940076|NCT04839393|529939148|FG000|Overall Study|Adverse Event|0|||
146940077|NCT04839393|529939149|FG001|Overall Study|Adverse Event|0|||
146940078|NCT04839393|529939150|FG002|Overall Study|Adverse Event|2|||
146940079|NCT04839393|529939148|FG000|Overall Study|Withdrawal by participant|0|||
146940080|NCT04839393|529939149|FG001|Overall Study|Withdrawal by participant|0|||
146940081|NCT04839393|529939150|FG002|Overall Study|Withdrawal by participant|1|||
146940082|NCT00254163|529939151|FG000|Overall Study|Adverse Event|29|||
146940083|NCT00254163|529939152|FG001|Overall Study|Adverse Event|26|||
146940084|NCT00254163|529939151|FG000|Overall Study|Patient request/withdrew consent|6|||
146940085|NCT00254163|529939152|FG001|Overall Study|Patient request/withdrew consent|4|||
146940086|NCT00254163|529939151|FG000|Overall Study|Investigator request|1|||
146940087|NCT00254163|529939152|FG001|Overall Study|Investigator request|3|||
146940088|NCT00254163|529939151|FG000|Overall Study|Failed entry|1|||
146940089|NCT00254163|529939152|FG001|Overall Study|Failed entry|3|||
146940090|NCT00254163|529939151|FG000|Overall Study|Progressive disease|0|||
146940091|NCT00254163|529939152|FG001|Overall Study|Progressive disease|1|||
146940092|NCT00254163|529939151|FG000|Overall Study|Death|0|||
146940093|NCT00254163|529939152|FG001|Overall Study|Death|1|||
146940094|NCT00254163|529939151|FG000|Overall Study|Other|8|||
146940095|NCT00254163|529939152|FG001|Overall Study|Other|8|||
146940096|NCT01510028|529939158|FG000|Overall Study|Lack of Efficacy|1|||
146940097|NCT01510028|529939159|FG001|Overall Study|Lack of Efficacy|0|||
146940098|NCT01510028|529939160|FG002|Overall Study|Lack of Efficacy|0|||
146940099|NCT01510028|529939161|FG003|Overall Study|Lack of Efficacy|0|||
146940100|NCT00633893|529939162|FG000|Overall Study|Death|1|||
146940101|NCT00633893|529939163|FG001|Overall Study|Death|3|||
146940102|NCT00633893|529939164|FG002|Overall Study|Death|9|||
146940103|NCT00633893|529939162|FG000|Overall Study|Adverse Event|65|||
146940104|NCT00633893|529939163|FG001|Overall Study|Adverse Event|58|||
146940105|NCT00633893|529939164|FG002|Overall Study|Adverse Event|126|||
146940106|NCT00633893|529939162|FG000|Overall Study|Withdrawal by Subject|7|||
146940107|NCT00633893|529939163|FG001|Overall Study|Withdrawal by Subject|12|||
146940108|NCT00633893|529939164|FG002|Overall Study|Withdrawal by Subject|6|||
146940109|NCT00633893|529939162|FG000|Overall Study|Lost to Follow-up|2|||
146940110|NCT00633893|529939163|FG001|Overall Study|Lost to Follow-up|4|||
146940111|NCT00633893|529939164|FG002|Overall Study|Lost to Follow-up|8|||
146940112|NCT00633893|529939162|FG000|Overall Study|Poor/non-compliance|5|||
146940113|NCT00633893|529939163|FG001|Overall Study|Poor/non-compliance|12|||
146940114|NCT00633893|529939164|FG002|Overall Study|Poor/non-compliance|3|||
146940115|NCT00633893|529939162|FG000|Overall Study|Pregnancy|2|||
146940116|NCT00633893|529939163|FG001|Overall Study|Pregnancy|1|||
146940117|NCT00633893|529939164|FG002|Overall Study|Pregnancy|1|||
146940118|NCT00633893|529939162|FG000|Overall Study|Not meet/no longer meets criteria|4|||
146940119|NCT00633893|529939163|FG001|Overall Study|Not meet/no longer meets criteria|6|||
146940120|NCT00633893|529939164|FG002|Overall Study|Not meet/no longer meets criteria|4|||
146940121|NCT00633893|529939162|FG000|Overall Study|Other|28|||
146940122|NCT00633893|529939163|FG001|Overall Study|Other|33|||
146940123|NCT00633893|529939164|FG002|Overall Study|Other|31|||
146940124|NCT02741310|529939165|FG000|Overall Study|Sponsor Decision|2|||
146940125|NCT02741310|529939166|FG001|Overall Study|Sponsor Decision|2|||
146940126|NCT05091918|529939167|FG000|Overall Study|Adverse Event|1|||
146940127|NCT05091918|529939167|FG000|Overall Study|Withdrawal by Subject|81|||
146796104|NCT04614948|529426751|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
146796105|NCT04614948|529426749|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
146796106|NCT04614948|529426750|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
146796107|NCT04614948|529426751|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
146796108|NCT04614948|529426749|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
146796109|NCT04614948|529426750|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
146796110|NCT04614948|529426751|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
146796111|NCT04614948|529426749|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
146796112|NCT04614948|529426750|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
146796113|NCT04614948|529426751|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
146796114|NCT04614948|529426749|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
146796115|NCT04614948|529426750|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
146796116|NCT04614948|529426751|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
146796117|NCT04614948|529426749|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
146796118|NCT04614948|529426750|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
146796119|NCT04614948|529426751|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
146796120|NCT04614948|529426749|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
146796121|NCT04614948|529426750|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
146796122|NCT04614948|529426751|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
146796123|NCT04614948|529426749|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
146796124|NCT04614948|529426750|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
146796125|NCT04614948|529426751|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
146796126|NCT04614948|529426749|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
146796127|NCT04614948|529426750|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
146796128|NCT04614948|529426751|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
146796129|NCT01570361|529426752|FG000|Overall Study|Subject discontinued|1|||
146796130|NCT01570361|529426753|FG001|Overall Study|Subject discontinued|2|||
146796131|NCT01570361|529426752|FG000|Overall Study|Sponsor closing the study|51|||
146796132|NCT01570361|529426753|FG001|Overall Study|Sponsor closing the study|50|||
146796133|NCT01570361|529426752|FG000|Overall Study|Subject excluded|5|||
146796134|NCT01570361|529426753|FG001|Overall Study|Subject excluded|3|||
146796135|NCT01570361|529426752|FG000|Overall Study|Subject withdrew consent|14|||
146796136|NCT01570361|529426753|FG001|Overall Study|Subject withdrew consent|9|||
146796137|NCT01570361|529426752|FG000|Overall Study|Adverse Event|2|||
146796138|NCT01570361|529426753|FG001|Overall Study|Adverse Event|1|||
146796139|NCT01570361|529426752|FG000|Overall Study|Lost to Follow-up|4|||
146796140|NCT01570361|529426753|FG001|Overall Study|Lost to Follow-up|4|||
146796141|NCT01570361|529426752|FG000|Overall Study|Death|5|||
146796142|NCT01570361|529426753|FG001|Overall Study|Death|4|||
146796143|NCT01570361|529426752|FG000|Overall Study|Other|0|||
146796144|NCT01570361|529426753|FG001|Overall Study|Other|2|||
146796145|NCT04129554|529426754|FG000|Overall Study|Withdrawal by Subject|4|||
146796146|NCT04129554|529426755|FG001|Overall Study|Withdrawal by Subject|3|||
146796147|NCT04129554|529426754|FG000|Overall Study|Other|0|||
146796148|NCT04129554|529426755|FG001|Overall Study|Other|2|||
146796149|NCT04633538|529426758|FG000|Overall Study|Death|1|||
146796150|NCT04633538|529426758|FG000|Overall Study|Lost to Follow-up|3|||
146796151|NCT04633538|529426758|FG000|Overall Study|Withdrawal by Subject|1|||
146796152|NCT02938520|529426759|FG000|Overall Study|On-going at the time of analysis|258|||
146796153|NCT02938520|529426760|FG001|Overall Study|On-going at the time of analysis|261|||
146796154|NCT02938520|529426759|FG000|Overall Study|Physician Decision|2|||
146796155|NCT02938520|529426760|FG001|Overall Study|Physician Decision|5|||
146796156|NCT02938520|529426759|FG000|Overall Study|Lost to Follow-up|2|||
146796157|NCT02938520|529426760|FG001|Overall Study|Lost to Follow-up|2|||
146796158|NCT02938520|529426759|FG000|Overall Study|Withdrawal by Subject|7|||
146796159|NCT02938520|529426760|FG001|Overall Study|Withdrawal by Subject|7|||
146796160|NCT02938520|529426759|FG000|Overall Study|Protocol Violation|0|||
146796161|NCT02938520|529426760|FG001|Overall Study|Protocol Violation|1|||
146796162|NCT02938520|529426759|FG000|Overall Study|Lack of Efficacy|5|||
146796163|NCT02938520|529426760|FG001|Overall Study|Lack of Efficacy|3|||
146796164|NCT02938520|529426759|FG000|Overall Study|Adverse Event|9|||
146796165|NCT02938520|529426760|FG001|Overall Study|Adverse Event|4|||
146796166|NCT03245840|529426761|FG000|Overall Study|Adverse Event|6|||
146796167|NCT03245840|529426762|FG001|Overall Study|Adverse Event|0|||
146796168|NCT03245840|529426761|FG000|Overall Study|Death|2|||
146796169|NCT03245840|529426762|FG001|Overall Study|Death|0|||
146796170|NCT03245840|529426761|FG000|Overall Study|Withdrawal by Subject|31|||
146796171|NCT03245840|529426762|FG001|Overall Study|Withdrawal by Subject|1|||
146796172|NCT03245840|529426761|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
146796173|NCT03245840|529426762|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146796174|NCT03245840|529426761|FG000|Overall Study|Physician Decision|4|||
146796175|NCT03245840|529426762|FG001|Overall Study|Physician Decision|1|||
146796176|NCT03245840|529426761|FG000|Overall Study|Study Terminated by Sponsor|56|||
146796177|NCT03245840|529426762|FG001|Overall Study|Study Terminated by Sponsor|6|||
146796178|NCT03245840|529426761|FG000|Overall Study|Site Terminated by Sponsor|4|||
146796179|NCT03245840|529426762|FG001|Overall Study|Site Terminated by Sponsor|0|||
146796180|NCT03245840|529426761|FG000|Overall Study|Lost to Follow-up|12|||
146796181|NCT03245840|529426762|FG001|Overall Study|Lost to Follow-up|2|||
146796182|NCT03245840|529426761|FG000|Overall Study|Pregnancy|2|||
146796183|NCT03245840|529426762|FG001|Overall Study|Pregnancy|0|||
146796184|NCT03245840|529426761|FG000|Overall Study|Non-Compliance with Study Drug|2|||
146796185|NCT03245840|529426762|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146796186|NCT03245840|529426761|FG000|Overall Study|Not treated|1|||
146796187|NCT03245840|529426762|FG001|Overall Study|Not treated|1|||
146796188|NCT02518048|529426767|FG000|Overall Study|Withdrawal by Subject|1|||
146796189|NCT02585323|529428296|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
146796190|NCT02585323|529428297|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
146796191|NCT02585323|529428296|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
146796192|NCT02585323|529428297|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
146796193|NCT02585323|529428296|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
146796194|NCT02585323|529428297|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
146796195|NCT02585323|529428296|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
146796196|NCT02585323|529428297|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
146796197|NCT01130883|529428298|FG000|Overall Study|Patient Noncompliance|6|||
146796198|NCT01130883|529428298|FG000|Overall Study|Reason Unknown|1|||
146796199|NCT01130883|529428298|FG000|Overall Study|Adverse Event|3|||
146796200|NCT01880515|529428301|FG000|Overall Study|Lost to Follow-up|3|||
146796201|NCT01880515|529428302|FG001|Overall Study|Lost to Follow-up|2|||
146796202|NCT01880515|529428301|FG000|Overall Study|Disease Progression|5|||
146796203|NCT01880515|529428302|FG001|Overall Study|Disease Progression|7|||
146796204|NCT03972150|529428303|FG000|Overall Study|Adverse Event|0|||
146796205|NCT03972150|529428304|FG001|Overall Study|Adverse Event|1|||
146796206|NCT03972150|529428305|FG002|Overall Study|Adverse Event|1|||
146796207|NCT03972150|529428306|FG003|Overall Study|Adverse Event|0|||
146796208|NCT03972150|529428307|FG004|Overall Study|Adverse Event|0|||
146796209|NCT03972150|529428303|FG000|Overall Study|Progressive disease|3|||
146796210|NCT03972150|529428304|FG001|Overall Study|Progressive disease|5|||
146796211|NCT03972150|529428305|FG002|Overall Study|Progressive disease|2|||
146796212|NCT03972150|529428306|FG003|Overall Study|Progressive disease|2|||
146796213|NCT03972150|529428307|FG004|Overall Study|Progressive disease|3|||
146796214|NCT03505710|529428308|FG000|Overall Study|Progressive Disease|24|||
146796215|NCT03505710|529428309|FG001|Overall Study|Progressive Disease|17|||
146796216|NCT03505710|529428310|FG002|Overall Study|Progressive Disease|43|||
146796217|NCT03505710|529428308|FG000|Overall Study|Clinical Progression|6|||
146796218|NCT03505710|529428309|FG001|Overall Study|Clinical Progression|8|||
146796219|NCT03505710|529428310|FG002|Overall Study|Clinical Progression|3|||
146796220|NCT03505710|529428308|FG000|Overall Study|Adverse Event|12|||
146796221|NCT03505710|529428309|FG001|Overall Study|Adverse Event|6|||
146796222|NCT03505710|529428310|FG002|Overall Study|Adverse Event|28|||
146796223|NCT03505710|529428308|FG000|Overall Study|Withdrawal by Subject|1|||
146796224|NCT03505710|529428309|FG001|Overall Study|Withdrawal by Subject|3|||
146940128|NCT01100658|529939168|FG000|Overall Study|Withdrawal by Subject|1|||
146940129|NCT01784211|529939172|FG000|Part A (Days 1-15)|Adverse Event|1|||
146940130|NCT01784211|529939173|FG001|Part A (Days 1-15)|Adverse Event|1|||
146940131|NCT01784211|529939174|FG002|Part A (Days 1-15)|Adverse Event|0|||
146940132|NCT01784211|529939175|FG003|Part A (Days 1-15)|Adverse Event|0|||
146940133|NCT01784211|529939176|FG004|Part A (Days 1-15)|Adverse Event|0|||
146940134|NCT01784211|529939177|FG005|Part A (Days 1-15)|Adverse Event|0|||
146940135|NCT01784211|529939172|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
146940136|NCT01784211|529939173|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
146940137|NCT01784211|529939174|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
146940138|NCT01784211|529939175|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
146940139|NCT01784211|529939176|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
146940140|NCT01784211|529939177|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
146796225|NCT03505710|529428310|FG002|Overall Study|Withdrawal by Subject|7|||
146796226|NCT03505710|529428308|FG000|Overall Study|Physician Decision|1|||
146796227|NCT03505710|529428309|FG001|Overall Study|Physician Decision|1|||
146796228|NCT03505710|529428310|FG002|Overall Study|Physician Decision|2|||
146940141|NCT00239356|529939180|FG000|Overall Study|Lack of Efficacy|1|||
146940142|NCT00239356|529939181|FG001|Overall Study|Lack of Efficacy|0|||
146940143|NCT00239356|529939180|FG000|Overall Study|Adverse Event|6|||
146940144|NCT00239356|529939181|FG001|Overall Study|Adverse Event|0|||
146940145|NCT00239356|529939180|FG000|Overall Study|Withdrawal by Subject|15|||
146796229|NCT03505710|529428308|FG000|Overall Study|Death|4|||
146796230|NCT03505710|529428309|FG001|Overall Study|Death|5|||
146796231|NCT03505710|529428310|FG002|Overall Study|Death|6|||
146796232|NCT03505710|529428308|FG000|Overall Study|Other Reasons|1|||
146796233|NCT03505710|529428309|FG001|Overall Study|Other Reasons|1|||
146796234|NCT03505710|529428310|FG002|Overall Study|Other Reasons|1|||
146796235|NCT03505710|529428308|FG000|Overall Study|Study Terminated by Sponsor|0|||
146796236|NCT03505710|529428309|FG001|Overall Study|Study Terminated by Sponsor|0|||
146796237|NCT03505710|529428310|FG002|Overall Study|Study Terminated by Sponsor|1|||
146796238|NCT03981926|529428313|FG000|Overall Study|Lost to Follow-up|5|||
146796239|NCT03981926|529428314|FG001|Overall Study|Lost to Follow-up|9|||
146796240|NCT06262347|529428315|FG000|Overall Study|Lost to Follow-up|4|||
146796241|NCT06262347|529428316|FG001|Overall Study|Lost to Follow-up|3|||
146796242|NCT06262347|529428315|FG000|Overall Study|Withdrawal by Subject|0|||
146796243|NCT06262347|529428316|FG001|Overall Study|Withdrawal by Subject|1|||
146796244|NCT03677141|529428317|FG000|Overall Study|Death|2|||
146796245|NCT03677141|529428318|FG001|Overall Study|Death|1|||
146796246|NCT03677141|529428319|FG002|Overall Study|Death|6|||
146796247|NCT03677141|529428320|FG003|Overall Study|Death|9|||
146796248|NCT03677141|529428321|FG004|Overall Study|Death|5|||
146796249|NCT03677141|529428322|FG005|Overall Study|Death|3|||
146796250|NCT03677141|529428317|FG000|Overall Study|Lost to Follow-up|0|||
146796251|NCT03677141|529428318|FG001|Overall Study|Lost to Follow-up|0|||
146796252|NCT03677141|529428319|FG002|Overall Study|Lost to Follow-up|0|||
146796253|NCT03677141|529428320|FG003|Overall Study|Lost to Follow-up|2|||
146796254|NCT03677141|529428321|FG004|Overall Study|Lost to Follow-up|0|||
146796255|NCT03677141|529428322|FG005|Overall Study|Lost to Follow-up|0|||
146796256|NCT03677141|529428317|FG000|Overall Study|Screen failure or enrolled in error|0|||
146796257|NCT03677141|529428318|FG001|Overall Study|Screen failure or enrolled in error|0|||
146796258|NCT03677141|529428319|FG002|Overall Study|Screen failure or enrolled in error|0|||
146796259|NCT03677141|529428320|FG003|Overall Study|Screen failure or enrolled in error|0|||
146796260|NCT03677141|529428321|FG004|Overall Study|Screen failure or enrolled in error|2|||
146796261|NCT03677141|529428322|FG005|Overall Study|Screen failure or enrolled in error|0|||
146796262|NCT03677141|529428317|FG000|Overall Study|Physician Decision|0|||
146796263|NCT03677141|529428318|FG001|Overall Study|Physician Decision|0|||
146796264|NCT03677141|529428319|FG002|Overall Study|Physician Decision|0|||
146796265|NCT03677141|529428320|FG003|Overall Study|Physician Decision|0|||
146796266|NCT03677141|529428321|FG004|Overall Study|Physician Decision|1|||
146796267|NCT03677141|529428322|FG005|Overall Study|Physician Decision|0|||
146796268|NCT03677141|529428317|FG000|Overall Study|Withdrawal by Subject|0|||
146796269|NCT03677141|529428318|FG001|Overall Study|Withdrawal by Subject|0|||
146796270|NCT03677141|529428319|FG002|Overall Study|Withdrawal by Subject|1|||
146796271|NCT03677141|529428320|FG003|Overall Study|Withdrawal by Subject|1|||
146796272|NCT03677141|529428321|FG004|Overall Study|Withdrawal by Subject|1|||
146796273|NCT03677141|529428322|FG005|Overall Study|Withdrawal by Subject|0|||
146796274|NCT06106022|529428334|FG000|Overall Study|Lost to Follow-up|1|||
146796275|NCT06106022|529428335|FG001|Overall Study|Lost to Follow-up|0|||
146796276|NCT06106022|529428334|FG000|Overall Study|Voluntary Withdrawal|0|||
146796277|NCT06106022|529428335|FG001|Overall Study|Voluntary Withdrawal|2|||
146796278|NCT04089865|529428337|FG000|Overall Study|Withdrawal by Subject|2|||
146796279|NCT04089865|529428338|FG001|Overall Study|Withdrawal by Subject|2|||
146796280|NCT04089865|529428339|FG002|Overall Study|Withdrawal by Subject|7|||
146796281|NCT04089865|529428340|FG003|Overall Study|Withdrawal by Subject|2|||
146796282|NCT03580356|529428360|FG000|Treatment Period|Withdrawal by Subject|13|||
146796283|NCT03580356|529428361|FG001|Treatment Period|Withdrawal by Subject|0|||
146796284|NCT03580356|529428362|FG002|Treatment Period|Withdrawal by Subject|13|||
146796285|NCT03580356|529428363|FG003|Treatment Period|Withdrawal by Subject|1|||
146796286|NCT03580356|529428364|FG004|Treatment Period|Withdrawal by Subject|17|||
146796287|NCT03580356|529428365|FG005|Treatment Period|Withdrawal by Subject|0|||
146796288|NCT03580356|529428366|FG006|Treatment Period|Withdrawal by Subject|5|||
146796289|NCT03580356|529428367|FG007|Treatment Period|Withdrawal by Subject|0|||
146796290|NCT03580356|529428360|FG000|Treatment Period|Adverse Event|10|||
146796291|NCT03580356|529428361|FG001|Treatment Period|Adverse Event|0|||
146796292|NCT03580356|529428362|FG002|Treatment Period|Adverse Event|13|||
146796293|NCT03580356|529428363|FG003|Treatment Period|Adverse Event|0|||
146796294|NCT03580356|529428364|FG004|Treatment Period|Adverse Event|5|||
146796295|NCT03580356|529428365|FG005|Treatment Period|Adverse Event|0|||
146796296|NCT03580356|529428366|FG006|Treatment Period|Adverse Event|8|||
146796297|NCT03580356|529428367|FG007|Treatment Period|Adverse Event|0|||
146796298|NCT03580356|529428360|FG000|Treatment Period|Protocol Violation|5|||
146796299|NCT03580356|529428361|FG001|Treatment Period|Protocol Violation|0|||
146796300|NCT03580356|529428362|FG002|Treatment Period|Protocol Violation|6|||
146796301|NCT03580356|529428363|FG003|Treatment Period|Protocol Violation|1|||
146796302|NCT03580356|529428364|FG004|Treatment Period|Protocol Violation|9|||
146796303|NCT03580356|529428365|FG005|Treatment Period|Protocol Violation|1|||
146796304|NCT03580356|529428366|FG006|Treatment Period|Protocol Violation|1|||
146796305|NCT03580356|529428367|FG007|Treatment Period|Protocol Violation|0|||
146796306|NCT03580356|529428360|FG000|Treatment Period|Lack of Efficacy|6|||
146796307|NCT03580356|529428361|FG001|Treatment Period|Lack of Efficacy|0|||
146796308|NCT03580356|529428362|FG002|Treatment Period|Lack of Efficacy|2|||
146796309|NCT03580356|529428363|FG003|Treatment Period|Lack of Efficacy|0|||
146796310|NCT03580356|529428364|FG004|Treatment Period|Lack of Efficacy|3|||
146796311|NCT03580356|529428365|FG005|Treatment Period|Lack of Efficacy|0|||
146796312|NCT03580356|529428366|FG006|Treatment Period|Lack of Efficacy|3|||
146796313|NCT03580356|529428367|FG007|Treatment Period|Lack of Efficacy|0|||
146796314|NCT03580356|529428360|FG000|Treatment Period|Pregnancy|1|||
146796315|NCT03580356|529428361|FG001|Treatment Period|Pregnancy|0|||
146796316|NCT03580356|529428362|FG002|Treatment Period|Pregnancy|7|||
146796317|NCT03580356|529428363|FG003|Treatment Period|Pregnancy|0|||
146796318|NCT03580356|529428364|FG004|Treatment Period|Pregnancy|2|||
146796319|NCT03580356|529428365|FG005|Treatment Period|Pregnancy|0|||
146796320|NCT03580356|529428366|FG006|Treatment Period|Pregnancy|1|||
146796321|NCT03580356|529428367|FG007|Treatment Period|Pregnancy|0|||
146796322|NCT03580356|529428360|FG000|Treatment Period|Physician Decision|2|||
146796323|NCT03580356|529428361|FG001|Treatment Period|Physician Decision|0|||
146796324|NCT03580356|529428362|FG002|Treatment Period|Physician Decision|1|||
146796325|NCT03580356|529428363|FG003|Treatment Period|Physician Decision|0|||
146796326|NCT03580356|529428364|FG004|Treatment Period|Physician Decision|4|||
146796327|NCT03580356|529428365|FG005|Treatment Period|Physician Decision|0|||
146796328|NCT03580356|529428366|FG006|Treatment Period|Physician Decision|2|||
146796329|NCT03580356|529428367|FG007|Treatment Period|Physician Decision|0|||
146796330|NCT03580356|529428360|FG000|Treatment Period|Lost to Follow-up|1|||
146796331|NCT03580356|529428361|FG001|Treatment Period|Lost to Follow-up|1|||
146796332|NCT03580356|529428362|FG002|Treatment Period|Lost to Follow-up|1|||
146796333|NCT03580356|529428363|FG003|Treatment Period|Lost to Follow-up|0|||
146796334|NCT03580356|529428364|FG004|Treatment Period|Lost to Follow-up|3|||
146796335|NCT03580356|529428365|FG005|Treatment Period|Lost to Follow-up|0|||
146796336|NCT03580356|529428366|FG006|Treatment Period|Lost to Follow-up|1|||
146796337|NCT03580356|529428367|FG007|Treatment Period|Lost to Follow-up|0|||
146796338|NCT03580356|529428360|FG000|Treatment Period|Death|0|||
146796339|NCT03580356|529428361|FG001|Treatment Period|Death|0|||
146796340|NCT03580356|529428362|FG002|Treatment Period|Death|1|||
146796341|NCT03580356|529428363|FG003|Treatment Period|Death|0|||
146796342|NCT03580356|529428364|FG004|Treatment Period|Death|0|||
146796343|NCT03580356|529428365|FG005|Treatment Period|Death|0|||
146796344|NCT03580356|529428366|FG006|Treatment Period|Death|0|||
146796345|NCT03580356|529428367|FG007|Treatment Period|Death|0|||
146796346|NCT03580356|529428360|FG000|Treatment Period|Technical problems|0|||
146796347|NCT03580356|529428361|FG001|Treatment Period|Technical problems|0|||
146796348|NCT03580356|529428362|FG002|Treatment Period|Technical problems|0|||
146796349|NCT03580356|529428363|FG003|Treatment Period|Technical problems|0|||
146796350|NCT03580356|529428364|FG004|Treatment Period|Technical problems|1|||
146796351|NCT03580356|529428365|FG005|Treatment Period|Technical problems|0|||
146796352|NCT03580356|529428366|FG006|Treatment Period|Technical problems|0|||
146796353|NCT03580356|529428367|FG007|Treatment Period|Technical problems|0|||
146796354|NCT03580356|529428360|FG000|Treatment Period|Misrandomized, no treatment|0|||
146796355|NCT03580356|529428361|FG001|Treatment Period|Misrandomized, no treatment|0|||
146796356|NCT03580356|529428362|FG002|Treatment Period|Misrandomized, no treatment|1|||
146796357|NCT03580356|529428363|FG003|Treatment Period|Misrandomized, no treatment|0|||
146796358|NCT03580356|529428364|FG004|Treatment Period|Misrandomized, no treatment|2|||
146796359|NCT03580356|529428365|FG005|Treatment Period|Misrandomized, no treatment|0|||
146796360|NCT03580356|529428366|FG006|Treatment Period|Misrandomized, no treatment|0|||
146796361|NCT03580356|529428367|FG007|Treatment Period|Misrandomized, no treatment|0|||
146796362|NCT03580356|529428360|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
146796363|NCT03580356|529428361|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
146796364|NCT03580356|529428362|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
146796365|NCT03580356|529428363|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
146796366|NCT03580356|529428364|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
146796367|NCT03580356|529428365|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
146796368|NCT03580356|529428366|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
146796369|NCT03580356|529428367|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
146796370|NCT03580356|529428360|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
146796371|NCT03580356|529428361|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
146796372|NCT03580356|529428362|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
146796373|NCT03580356|529428363|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
146796374|NCT03580356|529428364|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
146796375|NCT03580356|529428365|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
146796376|NCT03580356|529428366|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
146796377|NCT03580356|529428367|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
146796378|NCT03580356|529428360|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
146796379|NCT03580356|529428361|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
146796380|NCT03580356|529428362|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
146796381|NCT03580356|529428363|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
146796382|NCT03580356|529428364|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
146796383|NCT03580356|529428365|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
146796384|NCT03580356|529428366|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
146796385|NCT03580356|529428367|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
146796386|NCT03580356|529428360|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
146796387|NCT03580356|529428361|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
146796388|NCT03580356|529428362|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
146796389|NCT03580356|529428363|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
146796390|NCT03580356|529428364|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
146796391|NCT03580356|529428365|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
146796392|NCT03580356|529428366|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
146796393|NCT03580356|529428367|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
146796394|NCT03580356|529428360|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
146796395|NCT03580356|529428361|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
146796396|NCT03580356|529428362|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
146796397|NCT03580356|529428363|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
146796398|NCT03580356|529428364|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
146796399|NCT03580356|529428365|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
146796400|NCT03580356|529428366|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
146796401|NCT03580356|529428367|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
146796402|NCT03580356|529428360|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
146796403|NCT03580356|529428361|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
146796404|NCT03580356|529428362|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
146796405|NCT03580356|529428363|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
146796406|NCT03580356|529428364|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
146796407|NCT03580356|529428365|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
146796408|NCT03580356|529428366|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
146796409|NCT03580356|529428367|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
146796410|NCT03580356|529428360|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
146796411|NCT03580356|529428361|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
146796412|NCT03580356|529428362|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
146796413|NCT03580356|529428363|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
146796414|NCT03580356|529428364|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
146796415|NCT03580356|529428365|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
146796416|NCT03580356|529428366|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
146796417|NCT03580356|529428367|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
146796418|NCT02834390|529428368|FG000|Induction Phase|Progressive disease|0|||
146796419|NCT02834390|529428369|FG001|Induction Phase|Progressive disease|1|||
146796420|NCT02834390|529428368|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
146796421|NCT02834390|529428369|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
146796422|NCT02834390|529428368|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
146796423|NCT02834390|529428369|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
146796424|NCT02834390|529428368|FG000|Consolidation Phase|Physician Decision|1|||
146796425|NCT02834390|529428369|FG001|Consolidation Phase|Physician Decision|1|||
146796426|NCT03536884|529428375|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
146796427|NCT03536884|529428376|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
146796428|NCT03536884|529428377|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146796429|NCT03536884|529428378|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146796430|NCT03536884|529428379|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146796431|NCT03536884|529428380|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146796432|NCT03536884|529428381|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146796433|NCT03536884|529428382|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146796434|NCT03536884|529428383|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146796435|NCT03536884|529428384|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146796436|NCT03536884|529428385|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146796437|NCT03536884|529428386|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146796438|NCT03536884|529428375|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146796439|NCT03536884|529428376|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
146796440|NCT03536884|529428377|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146796441|NCT03536884|529428378|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146796442|NCT03536884|529428379|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146796443|NCT03536884|529428380|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146796444|NCT03536884|529428381|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146796445|NCT03536884|529428382|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146796446|NCT03536884|529428383|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146796447|NCT03536884|529428384|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146796448|NCT03536884|529428385|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146796449|NCT03536884|529428386|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146796450|NCT03536884|529428375|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
146796451|NCT03536884|529428376|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
146796452|NCT03536884|529428377|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146940146|NCT00239356|529939181|FG001|Overall Study|Withdrawal by Subject|6|||
146940147|NCT00239356|529939180|FG000|Overall Study|Lost to Follow-up|3|||
146940148|NCT00239356|529939181|FG001|Overall Study|Lost to Follow-up|0|||
146796453|NCT03536884|529428378|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146796454|NCT03536884|529428379|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146796455|NCT03536884|529428380|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146796456|NCT03536884|529428381|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146796457|NCT03536884|529428382|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146796458|NCT03536884|529428383|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146796459|NCT03536884|529428384|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146796460|NCT03536884|529428385|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146796461|NCT03536884|529428386|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146796462|NCT03536884|529428375|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146796463|NCT03536884|529428376|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
146796464|NCT03536884|529428377|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146796465|NCT03536884|529428378|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146796466|NCT03536884|529428379|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146796467|NCT03536884|529428380|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146796468|NCT03536884|529428381|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146796469|NCT03536884|529428382|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146796470|NCT03536884|529428383|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146796471|NCT03536884|529428384|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146796472|NCT03536884|529428385|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146796473|NCT03536884|529428386|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146796474|NCT03536884|529428375|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146796475|NCT03536884|529428376|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
146796476|NCT03536884|529428377|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146796477|NCT03536884|529428378|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146796478|NCT03536884|529428379|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146796479|NCT03536884|529428380|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146796480|NCT03536884|529428381|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146796481|NCT03536884|529428382|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146796482|NCT03536884|529428383|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146796483|NCT03536884|529428384|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146796484|NCT03536884|529428385|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146796485|NCT03536884|529428386|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146796486|NCT03536884|529428375|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146796487|NCT03536884|529428376|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
146796488|NCT03536884|529428377|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146796489|NCT03536884|529428378|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146796490|NCT03536884|529428379|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146796491|NCT03536884|529428380|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146796492|NCT03536884|529428381|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146796493|NCT03536884|529428382|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146796494|NCT03536884|529428383|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146796495|NCT03536884|529428384|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146796496|NCT03536884|529428385|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146796497|NCT03536884|529428386|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146796498|NCT03536884|529428375|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
146796499|NCT03536884|529428376|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
146796500|NCT03536884|529428377|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
146796501|NCT03536884|529428378|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
146796502|NCT03536884|529428379|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
146796503|NCT03536884|529428380|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
146796504|NCT03536884|529428381|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
146796505|NCT03536884|529428382|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
146796506|NCT03536884|529428383|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
146796507|NCT03536884|529428384|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
146796508|NCT03536884|529428385|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
146796509|NCT03536884|529428386|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
146796510|NCT03536884|529428375|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146796511|NCT03536884|529428376|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146940149|NCT00239356|529939180|FG000|Overall Study|poor/non-compliance|2|||
146940150|NCT00239356|529939181|FG001|Overall Study|poor/non-compliance|0|||
146940151|NCT00239356|529939180|FG000|Overall Study|Pregnancy|1|||
146796512|NCT03536884|529428377|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
146796513|NCT03536884|529428378|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
146796514|NCT03536884|529428379|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
146796515|NCT03536884|529428380|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146796516|NCT03536884|529428381|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146796517|NCT03536884|529428382|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146796518|NCT03536884|529428383|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146796519|NCT03536884|529428384|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146796520|NCT03536884|529428385|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146796521|NCT03536884|529428386|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146796522|NCT03536884|529428375|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146796523|NCT03536884|529428376|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146796524|NCT03536884|529428377|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146796525|NCT03536884|529428378|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
146796526|NCT03536884|529428379|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
146796527|NCT03536884|529428380|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146796528|NCT03536884|529428381|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146796529|NCT03536884|529428382|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146796530|NCT03536884|529428383|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146796531|NCT03536884|529428384|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146796532|NCT03536884|529428385|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146796533|NCT03536884|529428386|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146796534|NCT03536884|529428375|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146796535|NCT03536884|529428376|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146796536|NCT03536884|529428377|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
146796537|NCT03536884|529428378|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
146796538|NCT03536884|529428379|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
146796539|NCT03536884|529428380|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146796540|NCT03536884|529428381|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146796541|NCT03536884|529428382|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146796542|NCT03536884|529428383|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146796543|NCT03536884|529428384|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146796544|NCT03536884|529428385|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146796545|NCT03536884|529428386|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146796546|NCT03536884|529428375|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146796547|NCT03536884|529428376|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146796548|NCT03536884|529428377|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
146796549|NCT03536884|529428378|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
146796550|NCT03536884|529428379|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
146796551|NCT03536884|529428380|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146796552|NCT03536884|529428381|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146796553|NCT03536884|529428382|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146796554|NCT03536884|529428383|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146796555|NCT03536884|529428384|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146796556|NCT03536884|529428385|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146796557|NCT03536884|529428386|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146796558|NCT03536884|529428375|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
146796559|NCT03536884|529428376|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
146796560|NCT03536884|529428377|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
146796561|NCT03536884|529428378|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
146796562|NCT03536884|529428379|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
146796563|NCT03536884|529428380|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
146796564|NCT03536884|529428381|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
146796565|NCT03536884|529428382|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
146796566|NCT03536884|529428383|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
146796567|NCT03536884|529428384|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
146796568|NCT03536884|529428385|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
146796569|NCT03536884|529428386|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
146796570|NCT03536884|529428375|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
146940152|NCT00239356|529939181|FG001|Overall Study|Pregnancy|0|||
146940153|NCT00239356|529939180|FG000|Overall Study|Administrative reason|0|||
146940154|NCT00239356|529939181|FG001|Overall Study|Administrative reason|1|||
146940155|NCT00239356|529939180|FG000|Overall Study|Drug available on market|11|||
146796571|NCT03536884|529428376|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
146796572|NCT03536884|529428377|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
146796573|NCT03536884|529428378|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
146796574|NCT03536884|529428379|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
146796575|NCT03536884|529428380|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
146940156|NCT00239356|529939181|FG001|Overall Study|Drug available on market|2|||
146940157|NCT02044822|529939182|FG000|Overall Study|Study Terminated by Sponsor|77|||
146940158|NCT02044822|529939182|FG000|Overall Study|Investigator's Discretion|10|||
146796576|NCT03536884|529428381|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
146796577|NCT03536884|529428382|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
146796578|NCT03536884|529428383|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
146796579|NCT03536884|529428384|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
146796580|NCT03536884|529428385|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
146796581|NCT03536884|529428386|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
146796582|NCT03536884|529428375|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146796583|NCT03536884|529428376|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146796584|NCT03536884|529428377|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146796585|NCT03536884|529428378|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146796586|NCT03536884|529428379|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146796587|NCT03536884|529428380|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
146796588|NCT03536884|529428381|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146796589|NCT03536884|529428382|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
146796590|NCT03536884|529428383|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146796591|NCT03536884|529428384|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146796592|NCT03536884|529428385|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146796593|NCT03536884|529428386|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146796594|NCT03536884|529428375|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146796595|NCT03536884|529428376|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146796596|NCT03536884|529428377|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146796597|NCT03536884|529428378|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146796598|NCT03536884|529428379|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146796599|NCT03536884|529428380|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
146796600|NCT03536884|529428381|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146796601|NCT03536884|529428382|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
146796602|NCT03536884|529428383|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
146796603|NCT03536884|529428384|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146796604|NCT03536884|529428385|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146796605|NCT03536884|529428386|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146796606|NCT03536884|529428375|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
146796607|NCT03536884|529428376|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
146796608|NCT03536884|529428377|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
146796609|NCT03536884|529428378|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
146796610|NCT03536884|529428379|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
146796611|NCT03536884|529428380|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
146796612|NCT03536884|529428381|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
146796613|NCT03536884|529428382|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
146796614|NCT03536884|529428383|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
146796615|NCT03536884|529428384|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
146796616|NCT03536884|529428385|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
146796617|NCT03536884|529428386|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
146796618|NCT03536884|529428375|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146796619|NCT03536884|529428376|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146796620|NCT03536884|529428377|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146796621|NCT03536884|529428378|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146796622|NCT03536884|529428379|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146796623|NCT03536884|529428380|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
146796624|NCT03536884|529428381|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146796625|NCT03536884|529428382|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146796626|NCT03536884|529428383|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146796627|NCT03536884|529428384|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146796628|NCT03536884|529428385|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146796629|NCT03536884|529428386|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146796630|NCT03536884|529428375|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146796631|NCT03536884|529428376|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146796632|NCT03536884|529428377|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146796633|NCT03536884|529428378|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146796634|NCT03536884|529428379|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146940159|NCT02044822|529939182|FG000|Overall Study|Withdrew Consent|3|||
146940160|NCT02044822|529939182|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
146796635|NCT03536884|529428380|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146796636|NCT03536884|529428381|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
146796637|NCT03536884|529428382|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146796638|NCT03536884|529428383|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146796639|NCT03536884|529428384|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146796640|NCT03536884|529428385|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146796641|NCT03536884|529428386|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146796642|NCT03536884|529428375|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146796643|NCT03536884|529428376|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146796644|NCT03536884|529428377|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146796645|NCT03536884|529428378|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146796646|NCT03536884|529428379|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146796647|NCT03536884|529428380|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146796648|NCT03536884|529428381|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
146796649|NCT03536884|529428382|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146796650|NCT03536884|529428383|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146796651|NCT03536884|529428384|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146796652|NCT03536884|529428385|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146796653|NCT03536884|529428386|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146796654|NCT03536884|529428375|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
146796655|NCT03536884|529428376|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
146796656|NCT03536884|529428377|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
146796657|NCT03536884|529428378|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
146796658|NCT03536884|529428379|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
146796659|NCT03536884|529428380|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
146796660|NCT03536884|529428381|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
146796661|NCT03536884|529428382|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
146796662|NCT03536884|529428383|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
146796663|NCT03536884|529428384|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
146796664|NCT03536884|529428385|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
146796665|NCT03536884|529428386|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
146796666|NCT03536884|529428375|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146796667|NCT03536884|529428376|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146796668|NCT03536884|529428377|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146796669|NCT03536884|529428378|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146796670|NCT03536884|529428379|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146796671|NCT03536884|529428380|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146796672|NCT03536884|529428381|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146796673|NCT03536884|529428382|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146796674|NCT03536884|529428383|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
146796675|NCT03536884|529428384|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146796676|NCT03536884|529428385|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146796677|NCT03536884|529428386|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146796678|NCT03536884|529428375|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146796679|NCT03536884|529428376|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146796680|NCT03536884|529428377|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146796681|NCT03536884|529428378|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146796682|NCT03536884|529428379|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146796683|NCT03536884|529428380|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146796684|NCT03536884|529428381|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146796685|NCT03536884|529428382|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146796686|NCT03536884|529428383|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146796687|NCT03536884|529428384|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
146796688|NCT03536884|529428385|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
146796689|NCT03536884|529428386|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
146796690|NCT03536884|529428375|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
146796691|NCT03536884|529428376|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
146796692|NCT03536884|529428377|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
146796693|NCT03536884|529428378|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
146796694|NCT03536884|529428379|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
146796695|NCT03536884|529428380|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
146796696|NCT03536884|529428381|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
146940161|NCT02044822|529939182|FG000|Overall Study|Lost to Follow-up|1|||
146796697|NCT03536884|529428382|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
146796698|NCT03536884|529428383|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
146796699|NCT03536884|529428384|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
146796700|NCT03536884|529428385|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
146940162|NCT03417505|529939183|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
146940163|NCT03417505|529939184|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
146940164|NCT00391807|529939192|FG000|Overall Study|Did not receive study medication|23|||
146940165|NCT00391807|529939192|FG000|Overall Study|Adverse Event|177|||
146940166|NCT00391807|529939192|FG000|Overall Study|Pregnancy|25|||
146940167|NCT00391807|529939192|FG000|Overall Study|Lost to Follow-up|227|||
146940168|NCT00391807|529939192|FG000|Overall Study|Withdrawal by Subject|147|||
146940169|NCT00391807|529939192|FG000|Overall Study|Protocol Violation|20|||
146940170|NCT00391807|529939192|FG000|Overall Study|Various|96|||
146940171|NCT03725293|529939198|FG000|Overall Study|Physician Decision|9|||
146940172|NCT03725293|529939199|FG001|Overall Study|Physician Decision|6|||
146940173|NCT03725293|529939198|FG000|Overall Study|alternative vascular access needs|1|||
146940174|NCT03725293|529939199|FG001|Overall Study|alternative vascular access needs|2|||
146940175|NCT03725293|529939198|FG000|Overall Study|venous anatomy screen failures|2|||
146940176|NCT03725293|529939199|FG001|Overall Study|venous anatomy screen failures|1|||
146940177|NCT04583969|529939200|FG000|Overall Study|Death|31|||
146940178|NCT04583969|529939201|FG001|Overall Study|Death|38|||
146940179|NCT04583969|529939200|FG000|Overall Study|Lost to Follow-up|16|||
146940180|NCT04583969|529939201|FG001|Overall Study|Lost to Follow-up|13|||
146940181|NCT04583969|529939200|FG000|Overall Study|Protocol Violation|1|||
146940182|NCT04583969|529939201|FG001|Overall Study|Protocol Violation|0|||
146940183|NCT04583969|529939200|FG000|Overall Study|Withdrawal by Subject|3|||
146940184|NCT04583969|529939201|FG001|Overall Study|Withdrawal by Subject|3|||
146940185|NCT04583969|529939200|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
146940186|NCT04583969|529939201|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
146940187|NCT04583969|529939200|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
146940188|NCT04583969|529939201|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
146940189|NCT04583969|529939200|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
146940190|NCT04583969|529939201|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
146940191|NCT04583969|529939200|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
146940192|NCT04583969|529939201|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
146940193|NCT04583969|529939200|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
146940194|NCT04583969|529939201|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
146940195|NCT02143141|529939202|FG000|Overall Study|pain scores at 24 hours not collected|1|||
146940196|NCT02143141|529939203|FG001|Overall Study|pain scores at 24 hours not collected|0|||
146940197|NCT01819506|529939204|FG000|Overall Study|Physician Decision|5|||
146940198|NCT01819506|529939205|FG001|Overall Study|Physician Decision|2|||
146940199|NCT01819506|529939204|FG000|Overall Study|Withdrawal by Subject|3|||
146940200|NCT01819506|529939205|FG001|Overall Study|Withdrawal by Subject|3|||
146940201|NCT00114218|529939208|FG000|Overall Study|Wrong Cell Type|2|||
146940202|NCT00114218|529939208|FG000|Overall Study|Wrong Primary|1|||
146940203|NCT00114218|529939208|FG000|Overall Study|Never Treated|1|||
146940204|NCT01963780|529939210|FG000|Overall Study|Death|7|||
146940205|NCT02142504|529939211|FG000|Overall Study|Protocol Violation|2|||
146940206|NCT02142504|529939212|FG001|Overall Study|Protocol Violation|1|||
146940207|NCT02142504|529939213|FG002|Overall Study|Protocol Violation|2|||
146940208|NCT02142504|529939211|FG000|Overall Study|Adverse Event|2|||
146940209|NCT02142504|529939212|FG001|Overall Study|Adverse Event|3|||
146940210|NCT02142504|529939213|FG002|Overall Study|Adverse Event|4|||
146940211|NCT02142504|529939211|FG000|Overall Study|Lost to Follow-up|12|||
146940212|NCT02142504|529939212|FG001|Overall Study|Lost to Follow-up|19|||
146940213|NCT02142504|529939213|FG002|Overall Study|Lost to Follow-up|17|||
146940214|NCT02142504|529939211|FG000|Overall Study|Withdrawal by Subject|7|||
146940215|NCT02142504|529939212|FG001|Overall Study|Withdrawal by Subject|9|||
146940216|NCT02142504|529939213|FG002|Overall Study|Withdrawal by Subject|11|||
146940217|NCT02142504|529939211|FG000|Overall Study|Pregnancy|4|||
146940218|NCT02142504|529939212|FG001|Overall Study|Pregnancy|4|||
146940219|NCT02142504|529939213|FG002|Overall Study|Pregnancy|2|||
146940220|NCT02142504|529939211|FG000|Overall Study|Physician Decision|0|||
146940221|NCT02142504|529939212|FG001|Overall Study|Physician Decision|1|||
146940222|NCT02142504|529939213|FG002|Overall Study|Physician Decision|3|||
146940223|NCT02142504|529939211|FG000|Overall Study|Reason Not Specified|4|||
146940224|NCT02142504|529939212|FG001|Overall Study|Reason Not Specified|5|||
146940225|NCT02142504|529939213|FG002|Overall Study|Reason Not Specified|4|||
146940226|NCT02925312|529939214|FG000|Overall Study|Lost to Follow-up|25|||
146940227|NCT02925312|529939215|FG001|Overall Study|Lost to Follow-up|0|||
146940228|NCT02925312|529939214|FG000|Overall Study|Adverse Event|2|||
146796701|NCT03536884|529428386|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
146796702|NCT03536884|529428375|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146796703|NCT03536884|529428376|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146940229|NCT02925312|529939215|FG001|Overall Study|Adverse Event|0|||
146940230|NCT04114539|529939218|FG000|Overall Study|Adverse Event|14|||
146940231|NCT04114539|529939218|FG000|Overall Study|Lost to Follow-up|2|||
146940232|NCT04114539|529939218|FG000|Overall Study|Non-compliance with Protocol|2|||
146796704|NCT03536884|529428377|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146940233|NCT04114539|529939218|FG000|Overall Study|Non-compliance with Study Drug|1|||
146940234|NCT04114539|529939218|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
146940235|NCT04114539|529939218|FG000|Overall Study|Withdrew consent|10|||
146940236|NCT04114539|529939218|FG000|Overall Study|Others not specified|5|||
146983020|NCT02784106|530099869|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
146983021|NCT02784106|530099866|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
146983022|NCT02784106|530099867|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
146983023|NCT02784106|530099868|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
146983024|NCT02784106|530099869|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
146983025|NCT02784106|530099866|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
146983026|NCT02784106|530099867|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
146983027|NCT02784106|530099868|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
146983028|NCT02784106|530099869|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
146983029|NCT02784106|530099866|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
146983030|NCT02784106|530099867|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
146983031|NCT02784106|530099868|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
146983032|NCT02784106|530099869|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
146983033|NCT01418352|530099882|FG000|Overall Study|Lost to Follow-up|2|||
146983034|NCT01418352|530099883|FG001|Overall Study|Lost to Follow-up|0|||
146983035|NCT01418352|530099884|FG002|Overall Study|Lost to Follow-up|0|||
146983036|NCT01418352|530099885|FG003|Overall Study|Lost to Follow-up|0|||
146983037|NCT01418352|530099882|FG000|Overall Study|Adverse Event|0|||
146983038|NCT01418352|530099883|FG001|Overall Study|Adverse Event|1|||
146983039|NCT01418352|530099884|FG002|Overall Study|Adverse Event|0|||
146983040|NCT01418352|530099885|FG003|Overall Study|Adverse Event|0|||
146983041|NCT01418352|530099882|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
146983042|NCT01418352|530099883|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
146983043|NCT01418352|530099884|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
146983044|NCT01418352|530099885|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
146983045|NCT01418352|530099882|FG000|Overall Study|Subject Withdrew Consent|0|||
146983046|NCT01418352|530099883|FG001|Overall Study|Subject Withdrew Consent|1|||
146983047|NCT01418352|530099884|FG002|Overall Study|Subject Withdrew Consent|2|||
146983048|NCT01418352|530099885|FG003|Overall Study|Subject Withdrew Consent|1|||
146983049|NCT01418352|530099882|FG000|Overall Study|Protocol Deviation|0|||
146983050|NCT01418352|530099883|FG001|Overall Study|Protocol Deviation|0|||
146983051|NCT01418352|530099884|FG002|Overall Study|Protocol Deviation|1|||
146983052|NCT01418352|530099885|FG003|Overall Study|Protocol Deviation|0|||
146983053|NCT01418352|530099882|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
146796705|NCT03536884|529428378|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146796706|NCT03536884|529428379|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146796707|NCT03536884|529428380|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146796708|NCT03536884|529428381|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146796709|NCT03536884|529428382|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146796710|NCT03536884|529428383|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146796711|NCT03536884|529428384|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146796712|NCT03536884|529428385|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
146796713|NCT03536884|529428386|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146796714|NCT03536884|529428375|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146796715|NCT03536884|529428376|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146796716|NCT03536884|529428377|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146796717|NCT03536884|529428378|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146796718|NCT03536884|529428379|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146796719|NCT03536884|529428380|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146796720|NCT03536884|529428381|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146796721|NCT03536884|529428382|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146796722|NCT03536884|529428383|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146796723|NCT03536884|529428384|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146796724|NCT03536884|529428385|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146796725|NCT03536884|529428386|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
146796726|NCT03536884|529428375|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146796727|NCT03536884|529428376|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146796728|NCT03536884|529428377|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146796729|NCT03536884|529428378|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146796730|NCT03536884|529428379|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146796731|NCT03536884|529428380|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146796732|NCT03536884|529428381|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146796733|NCT03536884|529428382|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146983054|NCT01418352|530099883|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
146983055|NCT01418352|530099884|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
146796734|NCT03536884|529428383|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146796735|NCT03536884|529428384|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146796736|NCT03536884|529428385|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146796737|NCT03536884|529428386|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
146796738|NCT02909686|529428409|FG000|Overall Study|Physician Decision|3|||
146796739|NCT02909686|529428409|FG000|Overall Study|Withdrawal by Subject|2|||
146796740|NCT00844415|529428412|FG000|Overall Study|Withdrawal by Subject|1|||
146796741|NCT02473445|529428413|FG000|Overall Study|Withdrawal by Subject|2|||
146796742|NCT02473445|529428413|FG000|Overall Study|Sponsor Decision|20|||
146796743|NCT03015532|529428414|FG000|Overall Study|Adverse Event|0|||
146796744|NCT03015532|529428415|FG001|Overall Study|Adverse Event|0|||
146796745|NCT03015532|529428416|FG002|Overall Study|Adverse Event|0|||
146796746|NCT03015532|529428417|FG003|Overall Study|Adverse Event|0|||
146796747|NCT03015532|529428418|FG004|Overall Study|Adverse Event|0|||
146796748|NCT03015532|529428419|FG005|Overall Study|Adverse Event|2|||
146796749|NCT03015532|529428420|FG006|Overall Study|Adverse Event|1|||
146796750|NCT03015532|529428421|FG007|Overall Study|Adverse Event|0|||
146796751|NCT03015532|529428414|FG000|Overall Study|Withdrawal by Subject|0|||
146796752|NCT03015532|529428415|FG001|Overall Study|Withdrawal by Subject|0|||
146796753|NCT03015532|529428416|FG002|Overall Study|Withdrawal by Subject|0|||
146796754|NCT03015532|529428417|FG003|Overall Study|Withdrawal by Subject|0|||
146796755|NCT03015532|529428418|FG004|Overall Study|Withdrawal by Subject|0|||
146796756|NCT03015532|529428419|FG005|Overall Study|Withdrawal by Subject|0|||
146796757|NCT03015532|529428420|FG006|Overall Study|Withdrawal by Subject|1|||
146796758|NCT03015532|529428421|FG007|Overall Study|Withdrawal by Subject|0|||
146796759|NCT04778410|529428422|FG000|Safety Run-in Period|Death|5|||
146796760|NCT04778410|529428423|FG001|Safety Run-in Period|Death|6|||
146796761|NCT04778410|529428424|FG002|Safety Run-in Period|Death|0|||
146796762|NCT04778410|529428425|FG003|Safety Run-in Period|Death|0|||
146796763|NCT04778410|529428426|FG004|Safety Run-in Period|Death|0|||
146796764|NCT04778410|529428427|FG005|Safety Run-in Period|Death|0|||
146796765|NCT04778410|529428422|FG000|Phase 2 Period|Death|0|||
146796766|NCT04778410|529428423|FG001|Phase 2 Period|Death|0|||
146796767|NCT04778410|529428424|FG002|Phase 2 Period|Death|0|||
146796768|NCT04778410|529428425|FG003|Phase 2 Period|Death|5|||
146796769|NCT04778410|529428426|FG004|Phase 2 Period|Death|18|||
146796770|NCT04778410|529428427|FG005|Phase 2 Period|Death|0|||
146796771|NCT04778410|529428422|FG000|Phase 2 Period|Lost to Follow-up|0|||
146796772|NCT04778410|529428423|FG001|Phase 2 Period|Lost to Follow-up|0|||
146796773|NCT04778410|529428424|FG002|Phase 2 Period|Lost to Follow-up|0|||
146796774|NCT04778410|529428425|FG003|Phase 2 Period|Lost to Follow-up|1|||
146796775|NCT04778410|529428426|FG004|Phase 2 Period|Lost to Follow-up|1|||
146796776|NCT04778410|529428427|FG005|Phase 2 Period|Lost to Follow-up|0|||
146796777|NCT04778410|529428422|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
146796778|NCT04778410|529428423|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
146796779|NCT04778410|529428424|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
146796780|NCT04778410|529428425|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
146796781|NCT04778410|529428426|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
146796782|NCT04778410|529428427|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
146796783|NCT04778410|529428422|FG000|Phase 2 Period|Withdrew Consent|0|||
146796784|NCT04778410|529428423|FG001|Phase 2 Period|Withdrew Consent|0|||
146796785|NCT04778410|529428424|FG002|Phase 2 Period|Withdrew Consent|0|||
146796786|NCT04778410|529428425|FG003|Phase 2 Period|Withdrew Consent|0|||
146796787|NCT04778410|529428426|FG004|Phase 2 Period|Withdrew Consent|2|||
146796788|NCT04778410|529428427|FG005|Phase 2 Period|Withdrew Consent|0|||
146796789|NCT02944968|529428431|FG000|Overall Study|Subject excluded before study procedure|1|||
146796790|NCT02944968|529428431|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
146796791|NCT00631475|529428432|FG000|Overall Study|Death|18|||
146796792|NCT00631475|529428432|FG000|Overall Study|Adverse Event|14|||
146796793|NCT00631475|529428432|FG000|Overall Study|Withdrew consent|5|||
146796794|NCT00631475|529428432|FG000|Overall Study|Preparation for lung transplant|8|||
146796795|NCT00303459|529428433|FG000|Overall Study|Death|33|||
146796796|NCT00303459|529428434|FG001|Overall Study|Death|44|||
146796797|NCT00303459|529428433|FG000|Overall Study|Withdrawal of consent|32|||
146796798|NCT00303459|529428434|FG001|Overall Study|Withdrawal of consent|26|||
146796799|NCT00303459|529428433|FG000|Overall Study|Lost to Follow-up|5|||
146796800|NCT00303459|529428434|FG001|Overall Study|Lost to Follow-up|4|||
146796801|NCT00303459|529428433|FG000|Overall Study|Administrative reason|7|||
146796802|NCT00303459|529428434|FG001|Overall Study|Administrative reason|7|||
146796803|NCT00303459|529428433|FG000|Overall Study|Decision by the investigator|5|||
146796804|NCT00303459|529428434|FG001|Overall Study|Decision by the investigator|7|||
146796805|NCT00303459|529428433|FG000|Overall Study|Lung transplantation|1|||
146796806|NCT00303459|529428434|FG001|Overall Study|Lung transplantation|1|||
146796807|NCT03691298|529428437|FG000|Overall Study|Lost to Follow-up|8|||
146796808|NCT03691298|529428437|FG000|Overall Study|Sponsor terminated study|2|||
146796809|NCT02492711|529428441|FG000|Overall Study|Adverse Event|9|||
146796810|NCT02492711|529428442|FG001|Overall Study|Adverse Event|9|||
146796811|NCT02492711|529428443|FG002|Overall Study|Adverse Event|2|||
146796812|NCT02492711|529428441|FG000|Overall Study|Death|3|||
146796813|NCT02492711|529428442|FG001|Overall Study|Death|3|||
146796814|NCT02492711|529428443|FG002|Overall Study|Death|0|||
146796815|NCT02492711|529428441|FG000|Overall Study|Withdrawal by Subject|10|||
146796816|NCT02492711|529428442|FG001|Overall Study|Withdrawal by Subject|16|||
146796817|NCT02492711|529428443|FG002|Overall Study|Withdrawal by Subject|5|||
146796818|NCT02492711|529428441|FG000|Overall Study|Physician Decision|10|||
146796819|NCT02492711|529428442|FG001|Overall Study|Physician Decision|6|||
146796820|NCT02492711|529428443|FG002|Overall Study|Physician Decision|4|||
146796821|NCT02492711|529428441|FG000|Overall Study|Lost to Follow-up|0|||
146796822|NCT02492711|529428442|FG001|Overall Study|Lost to Follow-up|0|||
146796823|NCT02492711|529428443|FG002|Overall Study|Lost to Follow-up|1|||
146796824|NCT02492711|529428441|FG000|Overall Study|study treatment delay|2|||
146796825|NCT02492711|529428442|FG001|Overall Study|study treatment delay|1|||
146796826|NCT02492711|529428443|FG002|Overall Study|study treatment delay|0|||
146796827|NCT02492711|529428441|FG000|Overall Study|change in chemotherapy|0|||
146796828|NCT02492711|529428442|FG001|Overall Study|change in chemotherapy|1|||
146796829|NCT02492711|529428443|FG002|Overall Study|change in chemotherapy|0|||
146796830|NCT02492711|529428441|FG000|Overall Study|never treated|2|||
146796831|NCT02492711|529428442|FG001|Overall Study|never treated|4|||
146796832|NCT02492711|529428443|FG002|Overall Study|never treated|0|||
146796833|NCT02492711|529428441|FG000|Overall Study|Other|0|||
146796834|NCT02492711|529428442|FG001|Overall Study|Other|0|||
146796835|NCT02492711|529428443|FG002|Overall Study|Other|1|||
146796836|NCT03663205|529428444|FG000|Overall Study|Death|144|||
146796837|NCT03663205|529428445|FG001|Overall Study|Death|69|||
146796838|NCT03663205|529428444|FG000|Overall Study|Sponsor decision|53|||
146796839|NCT03663205|529428445|FG001|Overall Study|Sponsor decision|19|||
146796840|NCT03663205|529428444|FG000|Overall Study|Withdrawal by Subject|8|||
146796841|NCT03663205|529428445|FG001|Overall Study|Withdrawal by Subject|11|||
146796842|NCT03663205|529428444|FG000|Overall Study|Lost to Follow-up|7|||
146796843|NCT03663205|529428445|FG001|Overall Study|Lost to Follow-up|9|||
146796844|NCT03663205|529428444|FG000|Overall Study|Transferred to long term extension study|11|||
146796845|NCT03663205|529428445|FG001|Overall Study|Transferred to long term extension study|3|||
146796846|NCT05890105|529428448|FG000|Overall Study|Adverse Event|1|||
146796847|NCT05890105|529428449|FG001|Overall Study|Adverse Event|0|||
146796848|NCT05890105|529428450|FG002|Overall Study|Adverse Event|0|||
146796849|NCT05890105|529428448|FG000|Overall Study|Other|1|||
146796850|NCT05890105|529428449|FG001|Overall Study|Other|2|||
146796851|NCT05890105|529428450|FG002|Overall Study|Other|0|||
146796852|NCT04505410|529428451|FG000|Overall Study|Adverse Event|2|||
146796853|NCT04505410|529428452|FG001|Overall Study|Adverse Event|0|||
146796854|NCT04505410|529428451|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
146796855|NCT04505410|529428452|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
146796856|NCT04505410|529428451|FG000|Overall Study|did not want to follow diet|1|||
146796857|NCT04505410|529428452|FG001|Overall Study|did not want to follow diet|0|||
146796858|NCT04505410|529428451|FG000|Overall Study|flare up of ulcerative colitis|0|||
146796859|NCT04505410|529428452|FG001|Overall Study|flare up of ulcerative colitis|1|||
146796860|NCT04505410|529428451|FG000|Overall Study|Lost to Follow-up|0|||
146796861|NCT04505410|529428452|FG001|Overall Study|Lost to Follow-up|2|||
146796862|NCT04505410|529428451|FG000|Overall Study|Lost to Follow-up|1|||
146796863|NCT04505410|529428452|FG001|Overall Study|Lost to Follow-up|0|||
146796864|NCT04505410|529428451|FG000|Overall Study|initiated another diet on their own|0|||
146796865|NCT04505410|529428452|FG001|Overall Study|initiated another diet on their own|2|||
146796866|NCT05123027|529428457|FG000|Overall Study|Lost to Follow-up|17|||
146796867|NCT05123027|529428458|FG001|Overall Study|Lost to Follow-up|22|||
146796868|NCT05123027|529428457|FG000|Overall Study|Incarceration|3|||
146796869|NCT05123027|529428458|FG001|Overall Study|Incarceration|4|||
146796870|NCT05123027|529428457|FG000|Overall Study|Death|2|||
146796871|NCT05123027|529428458|FG001|Overall Study|Death|2|||
146796872|NCT05123027|529428457|FG000|Overall Study|Other|2|||
146796873|NCT05123027|529428458|FG001|Overall Study|Other|0|||
146983056|NCT01418352|530099885|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
146796874|NCT05311176|529430176|FG000|Overall Study|Death|6|||
146796875|NCT05311176|529430176|FG000|Overall Study|Sponsor discontinued the study|1|||
146796876|NCT05464069|529430177|FG000|Overall Study|Protocol Violation|3|||
146796877|NCT05464069|529430178|FG001|Overall Study|Protocol Violation|2|||
146796878|NCT05524116|529430184|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
146796879|NCT05524116|529430185|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
146796880|NCT05524116|529430184|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
146796881|NCT05524116|529430185|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
146796882|NCT05524116|529430184|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
146796883|NCT05524116|529430185|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
146983057|NCT01401478|530099887|FG000|Overall Study|Study drug not available|6|||
146796884|NCT05524116|529430184|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
146796885|NCT05524116|529430185|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
146796886|NCT05524116|529430184|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
146796887|NCT05524116|529430185|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
146796888|NCT05552508|529430187|FG000|Overall Study|Adverse Event|3|||
146796889|NCT04605159|529430188|FG000|Overall Study|Adverse Event|6|||
146796890|NCT04605159|529430189|FG001|Overall Study|Adverse Event|3|||
146796891|NCT04605159|529430190|FG002|Overall Study|Adverse Event|21|||
146796892|NCT04605159|529430191|FG003|Overall Study|Adverse Event|4|||
146796893|NCT04605159|529430188|FG000|Overall Study|Lost to Follow-up|74|||
146796894|NCT04605159|529430189|FG001|Overall Study|Lost to Follow-up|45|||
146796895|NCT04605159|529430190|FG002|Overall Study|Lost to Follow-up|119|||
146796896|NCT04605159|529430191|FG003|Overall Study|Lost to Follow-up|80|||
146796897|NCT04605159|529430188|FG000|Overall Study|Protocol Violation|4|||
146796898|NCT04605159|529430189|FG001|Overall Study|Protocol Violation|5|||
146796899|NCT04605159|529430190|FG002|Overall Study|Protocol Violation|2|||
146796900|NCT04605159|529430191|FG003|Overall Study|Protocol Violation|0|||
146796901|NCT04605159|529430188|FG000|Overall Study|Withdrawal by Subject|66|||
146796902|NCT04605159|529430189|FG001|Overall Study|Withdrawal by Subject|37|||
146796903|NCT04605159|529430190|FG002|Overall Study|Withdrawal by Subject|68|||
146796904|NCT04605159|529430191|FG003|Overall Study|Withdrawal by Subject|50|||
146796905|NCT04605159|529430188|FG000|Overall Study|Migrated / moved from the study area|32|||
146796906|NCT04605159|529430189|FG001|Overall Study|Migrated / moved from the study area|22|||
146796907|NCT04605159|529430190|FG002|Overall Study|Migrated / moved from the study area|41|||
146796908|NCT04605159|529430191|FG003|Overall Study|Migrated / moved from the study area|21|||
146796909|NCT04605159|529430188|FG000|Overall Study|Other|1|||
146796910|NCT04605159|529430189|FG001|Overall Study|Other|2|||
146796911|NCT04605159|529430190|FG002|Overall Study|Other|7|||
146796912|NCT04605159|529430191|FG003|Overall Study|Other|3|||
146796913|NCT05424380|529430195|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
146796914|NCT05424380|529430196|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
146796915|NCT05424380|529430197|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
146796916|NCT05424380|529430198|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
146796917|NCT05424380|529430199|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
146796918|NCT05424380|529430200|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
146796919|NCT05424380|529430195|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
146796920|NCT05424380|529430196|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
146796921|NCT05424380|529430197|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
146796922|NCT05424380|529430198|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
146796923|NCT05424380|529430199|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
146796924|NCT05424380|529430200|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
146796925|NCT05424380|529430195|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
146796926|NCT05424380|529430196|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
146796927|NCT05424380|529430197|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
146796928|NCT05424380|529430198|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
146796929|NCT05424380|529430199|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
146796930|NCT05424380|529430200|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
146796931|NCT05424380|529430195|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
146796932|NCT05424380|529430196|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
146796933|NCT05424380|529430197|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
146796934|NCT05424380|529430198|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
146796935|NCT05424380|529430199|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
146796936|NCT05424380|529430200|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
146796937|NCT05424380|529430195|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
146796938|NCT05424380|529430196|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
146796939|NCT05424380|529430197|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
146796940|NCT05424380|529430198|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
146796941|NCT05424380|529430199|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
146796942|NCT05424380|529430200|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
146796943|NCT05424380|529430195|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
146796944|NCT05424380|529430196|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
146796945|NCT05424380|529430197|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
146796946|NCT05424380|529430198|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
146796947|NCT05424380|529430199|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
146796948|NCT05424380|529430200|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
146940237|NCT04114539|529939218|FG000|Overall Study|Investigator Decision|2|||
146940238|NCT00617591|529939219|FG000|Overall Study|Withdrew consent during Induction|4|||
146940239|NCT00617591|529939219|FG000|Overall Study|Withdrew consent during Maintenance|6|||
146940240|NCT04285853|529939223|FG000|Overall Study|Withdrawal by Subject|1|||
146796949|NCT05424380|529430195|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
146796950|NCT05424380|529430196|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
146796951|NCT05424380|529430197|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
146796952|NCT05424380|529430198|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
146796953|NCT05424380|529430199|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
146796954|NCT05424380|529430200|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
146796955|NCT05424380|529430195|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
146796956|NCT05424380|529430196|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
146796957|NCT05424380|529430197|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
146796958|NCT05424380|529430198|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
146796959|NCT05424380|529430199|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
146796960|NCT05424380|529430200|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
146796961|NCT05424380|529430195|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146796962|NCT05424380|529430196|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146796963|NCT05424380|529430197|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146796964|NCT05424380|529430198|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
146796965|NCT05424380|529430199|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146796966|NCT05424380|529430200|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146796967|NCT05424380|529430195|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
146796968|NCT05424380|529430196|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
146796969|NCT05424380|529430197|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
146796970|NCT05424380|529430198|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
146796971|NCT05424380|529430199|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
146796972|NCT05424380|529430200|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
146796973|NCT05424380|529430195|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
146796974|NCT05424380|529430196|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
146796975|NCT05424380|529430197|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
146796976|NCT05424380|529430198|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
146796977|NCT05424380|529430199|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
146796978|NCT05424380|529430200|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
146796979|NCT05424380|529430195|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
146796980|NCT05424380|529430196|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
146796981|NCT05424380|529430197|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
146796982|NCT05424380|529430198|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
146796983|NCT05424380|529430199|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
146796984|NCT05424380|529430200|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
146796985|NCT05424380|529430195|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146796986|NCT05424380|529430196|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146796987|NCT05424380|529430197|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146796988|NCT05424380|529430198|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146796989|NCT05424380|529430199|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
146796990|NCT05424380|529430200|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146796991|NCT05424380|529430195|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
146796992|NCT05424380|529430196|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
146796993|NCT05424380|529430197|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
146796994|NCT05424380|529430198|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
146796995|NCT05424380|529430199|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
146796996|NCT05424380|529430200|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
146796997|NCT03914469|529430205|FG000|Overall Study|Lost to Follow-up|1|||
146796998|NCT03914469|529430206|FG001|Overall Study|Lost to Follow-up|4|||
146796999|NCT00677365|529430208|FG000|Overall Study|Adverse Event|2|||
146797000|NCT00677365|529430209|FG001|Overall Study|Adverse Event|1|||
146797001|NCT00677365|529430210|FG002|Overall Study|Adverse Event|1|||
146797002|NCT00677365|529430211|FG003|Overall Study|Adverse Event|2|||
146797003|NCT00677365|529430208|FG000|Overall Study|Withdrawal by Subject|0|||
146797004|NCT00677365|529430209|FG001|Overall Study|Withdrawal by Subject|0|||
146797005|NCT00677365|529430210|FG002|Overall Study|Withdrawal by Subject|1|||
146797006|NCT00677365|529430211|FG003|Overall Study|Withdrawal by Subject|0|||
146797007|NCT00677365|529430208|FG000|Overall Study|Other reason|0|||
146797008|NCT00677365|529430209|FG001|Overall Study|Other reason|0|||
146797009|NCT00677365|529430210|FG002|Overall Study|Other reason|0|||
146797010|NCT00677365|529430211|FG003|Overall Study|Other reason|1|||
146797011|NCT05422885|529430212|FG000|Overall Study|Lost to Follow-up|1|||
146797012|NCT05422885|529430212|FG000|Overall Study|Withdrawal by Subject|2|||
146797013|NCT01121588|529430213|FG000|Overall Study|Death|5|||
146797014|NCT01121588|529430214|FG001|Overall Study|Death|3|||
146797015|NCT01121588|529430215|FG002|Overall Study|Death|13|||
146797016|NCT01121588|529430213|FG000|Overall Study|Study Terminated by Sponsor|1|||
146797017|NCT01121588|529430214|FG001|Overall Study|Study Terminated by Sponsor|1|||
146797018|NCT01121588|529430215|FG002|Overall Study|Study Terminated by Sponsor|0|||
146797019|NCT01121588|529430213|FG000|Overall Study|Participant Refused Further Followup|2|||
146797020|NCT01121588|529430214|FG001|Overall Study|Participant Refused Further Followup|0|||
146797021|NCT01121588|529430215|FG002|Overall Study|Participant Refused Further Followup|2|||
146797022|NCT01121588|529430213|FG000|Overall Study|Lost to Follow-up|0|||
146797023|NCT01121588|529430214|FG001|Overall Study|Lost to Follow-up|1|||
146797024|NCT01121588|529430215|FG002|Overall Study|Lost to Follow-up|1|||
146797025|NCT01121588|529430213|FG000|Overall Study|Non-Specified Reasons|9|||
146797026|NCT01121588|529430214|FG001|Overall Study|Non-Specified Reasons|4|||
146797027|NCT01121588|529430215|FG002|Overall Study|Non-Specified Reasons|2|||
146797028|NCT00942877|529430216|FG000|Overall Study|Refused further treatment|1|||
146797029|NCT00942877|529430217|FG001|Overall Study|Refused further treatment|1|||
146797030|NCT00942877|529430216|FG000|Overall Study|Patient was not treated|1|||
146797031|NCT00942877|529430217|FG001|Overall Study|Patient was not treated|0|||
146797032|NCT00942877|529430216|FG000|Overall Study|Adverse Event|1|||
146797033|NCT00942877|529430217|FG001|Overall Study|Adverse Event|0|||
146797034|NCT00942877|529430216|FG000|Overall Study|Progressive disease|42|||
146797035|NCT00942877|529430217|FG001|Overall Study|Progressive disease|3|||
146797036|NCT01385202|529430220|FG000|Overall Study|Lost to Follow-up|6|||
146797037|NCT01385202|529430220|FG000|Overall Study|Not Eligible|11|||
146797038|NCT01385202|529430220|FG000|Overall Study|Withdrawn|1|||
146797039|NCT02874742|529430221|FG000|Overall Study|Death|0|||
146797040|NCT02874742|529430222|FG001|Overall Study|Death|1|||
146797041|NCT02874742|529430223|FG002|Overall Study|Death|0|||
146797042|NCT02874742|529430221|FG000|Overall Study|Lost to Follow-up|5|||
146797043|NCT02874742|529430222|FG001|Overall Study|Lost to Follow-up|4|||
146797044|NCT02874742|529430223|FG002|Overall Study|Lost to Follow-up|1|||
146797045|NCT02874742|529430221|FG000|Overall Study|Withdrawal by Subject|17|||
146797046|NCT02874742|529430222|FG001|Overall Study|Withdrawal by Subject|8|||
146797047|NCT02874742|529430223|FG002|Overall Study|Withdrawal by Subject|0|||
146797048|NCT02874742|529430221|FG000|Overall Study|Other|4|||
146797049|NCT02874742|529430222|FG001|Overall Study|Other|1|||
146797050|NCT02874742|529430223|FG002|Overall Study|Other|0|||
146797051|NCT02874742|529430221|FG000|Overall Study|Progressive Disease|1|||
146797052|NCT02874742|529430222|FG001|Overall Study|Progressive Disease|0|||
146797053|NCT02874742|529430223|FG002|Overall Study|Progressive Disease|0|||
146797054|NCT02874742|529430221|FG000|Overall Study|Screen Failure|0|||
146797055|NCT02874742|529430222|FG001|Overall Study|Screen Failure|2|||
146797056|NCT02874742|529430223|FG002|Overall Study|Screen Failure|0|||
146797057|NCT04424316|529430235|FG000|Overall Study|Adverse Event|0|||
146797058|NCT04424316|529430236|FG001|Overall Study|Adverse Event|1|||
146797059|NCT04424316|529430237|FG002|Overall Study|Adverse Event|0|||
146797060|NCT04424316|529430238|FG003|Overall Study|Adverse Event|0|||
146797061|NCT04424316|529430235|FG000|Overall Study|Death|1|||
146797062|NCT04424316|529430236|FG001|Overall Study|Death|0|||
146797063|NCT04424316|529430237|FG002|Overall Study|Death|8|||
146983058|NCT01401478|530099887|FG000|Overall Study|Adverse Event|5|||
146983059|NCT01401478|530099887|FG000|Overall Study|Hyperphosphatemia|5|||
146983060|NCT01401478|530099887|FG000|Overall Study|Lost to Follow-up|5|||
146983061|NCT01401478|530099887|FG000|Overall Study|Kidney transplantation|3|||
146983062|NCT01401478|530099887|FG000|Overall Study|Withdrawal by Subject|3|||
146983063|NCT01401478|530099887|FG000|Overall Study|Blood samples not available|1|||
146983064|NCT01401478|530099887|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
146983065|NCT01401478|530099887|FG000|Overall Study|Low intact parathyroid hormone|1|||
146983066|NCT01401478|530099887|FG000|Overall Study|Serious adverse event|1|||
146983067|NCT01814137|530099888|FG000|Overall Study|Adverse Event|0|||
146983068|NCT01814137|530099889|FG001|Overall Study|Adverse Event|1|||
146983069|NCT01814137|530099888|FG000|Overall Study|Withdrawal by Subject|2|||
146983070|NCT01814137|530099889|FG001|Overall Study|Withdrawal by Subject|2|||
146983071|NCT01814137|530099888|FG000|Overall Study|Physician Decision|1|||
146983072|NCT01814137|530099889|FG001|Overall Study|Physician Decision|1|||
146983073|NCT01814137|530099888|FG000|Overall Study|Unclassified|2|||
146983074|NCT01814137|530099889|FG001|Overall Study|Unclassified|1|||
146797064|NCT04424316|529430238|FG003|Overall Study|Death|14|||
146983075|NCT01952574|530099890|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
146983076|NCT01952574|530099891|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
146983077|NCT01952574|530099892|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
146983078|NCT01952574|530099893|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
146983079|NCT01952574|530099894|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146983080|NCT01952574|530099895|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146983081|NCT01952574|530099896|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146983082|NCT01952574|530099890|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
146983083|NCT01952574|530099891|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
146797065|NCT04424316|529430235|FG000|Overall Study|Lost to Follow-up|93|||
146797066|NCT04424316|529430236|FG001|Overall Study|Lost to Follow-up|88|||
146797067|NCT04424316|529430237|FG002|Overall Study|Lost to Follow-up|224|||
146797068|NCT04424316|529430238|FG003|Overall Study|Lost to Follow-up|211|||
146797069|NCT04424316|529430235|FG000|Overall Study|No longer met eligibility criteria|1|||
146983084|NCT01952574|530099892|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
146797070|NCT04424316|529430236|FG001|Overall Study|No longer met eligibility criteria|0|||
146797071|NCT04424316|529430237|FG002|Overall Study|No longer met eligibility criteria|0|||
146797072|NCT04424316|529430238|FG003|Overall Study|No longer met eligibility criteria|0|||
146797073|NCT04424316|529430235|FG000|Overall Study|Other|15|||
146797074|NCT04424316|529430236|FG001|Overall Study|Other|11|||
146797075|NCT04424316|529430237|FG002|Overall Study|Other|34|||
146797076|NCT04424316|529430238|FG003|Overall Study|Other|45|||
146797077|NCT04424316|529430235|FG000|Overall Study|Physician Decision|1|||
146797078|NCT04424316|529430236|FG001|Overall Study|Physician Decision|0|||
146797079|NCT04424316|529430237|FG002|Overall Study|Physician Decision|1|||
146797080|NCT04424316|529430238|FG003|Overall Study|Physician Decision|1|||
146797081|NCT04424316|529430235|FG000|Overall Study|Protocol Violation|0|||
146797082|NCT04424316|529430236|FG001|Overall Study|Protocol Violation|1|||
146797083|NCT04424316|529430237|FG002|Overall Study|Protocol Violation|0|||
146797084|NCT04424316|529430238|FG003|Overall Study|Protocol Violation|0|||
146797085|NCT04424316|529430235|FG000|Overall Study|Withdrawal by Subject|71|||
146797086|NCT04424316|529430236|FG001|Overall Study|Withdrawal by Subject|77|||
146797087|NCT04424316|529430237|FG002|Overall Study|Withdrawal by Subject|0|||
146797088|NCT04424316|529430238|FG003|Overall Study|Withdrawal by Subject|0|||
146797089|NCT04424316|529430235|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146797090|NCT04424316|529430236|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146797091|NCT04424316|529430237|FG002|Overall Study|Withdrawal by parent/guardian|74|||
146797092|NCT04424316|529430238|FG003|Overall Study|Withdrawal by parent/guardian|81|||
146797093|NCT04424316|529430235|FG000|Overall Study|Randomized but not vaccinated|13|||
146797094|NCT04424316|529430236|FG001|Overall Study|Randomized but not vaccinated|21|||
146797095|NCT04424316|529430237|FG002|Overall Study|Randomized but not vaccinated|0|||
146797096|NCT04424316|529430238|FG003|Overall Study|Randomized but not vaccinated|0|||
146797097|NCT04424316|529430235|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
146797098|NCT04424316|529430236|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
146797099|NCT04424316|529430237|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
146797100|NCT04424316|529430238|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
146797101|NCT05070741|529430239|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
146797102|NCT03582033|529430240|FG000|Part A|Other|0|||
146797103|NCT03582033|529430241|FG001|Part A|Other|0|||
146797104|NCT03582033|529430242|FG002|Part A|Other|0|||
146797105|NCT03582033|529430243|FG003|Part A|Other|0|||
146797106|NCT03582033|529430244|FG004|Part A|Other|2|||
146797107|NCT03582033|529430245|FG005|Part A|Other|0|||
146797108|NCT03582033|529430246|FG006|Part A|Other|0|||
146797109|NCT03582033|529430247|FG007|Part A|Other|0|||
146797110|NCT03582033|529430248|FG008|Part A|Other|0|||
146797111|NCT03582033|529430249|FG009|Part A|Other|0|||
146797112|NCT03582033|529430240|FG000|Part A|Death|1|||
146797113|NCT03582033|529430241|FG001|Part A|Death|1|||
146797114|NCT03582033|529430242|FG002|Part A|Death|2|||
146797115|NCT03582033|529430243|FG003|Part A|Death|4|||
146797116|NCT03582033|529430244|FG004|Part A|Death|11|||
146797117|NCT03582033|529430245|FG005|Part A|Death|0|||
146797118|NCT03582033|529430246|FG006|Part A|Death|0|||
146797119|NCT03582033|529430247|FG007|Part A|Death|0|||
146797120|NCT03582033|529430248|FG008|Part A|Death|0|||
146797121|NCT03582033|529430249|FG009|Part A|Death|0|||
146797122|NCT03582033|529430240|FG000|Part A|Lost to Follow-up|0|||
146797123|NCT03582033|529430241|FG001|Part A|Lost to Follow-up|0|||
146797124|NCT03582033|529430242|FG002|Part A|Lost to Follow-up|0|||
146797125|NCT03582033|529430243|FG003|Part A|Lost to Follow-up|0|||
146797126|NCT03582033|529430244|FG004|Part A|Lost to Follow-up|1|||
146797127|NCT03582033|529430245|FG005|Part A|Lost to Follow-up|0|||
146797128|NCT03582033|529430246|FG006|Part A|Lost to Follow-up|0|||
146797129|NCT03582033|529430247|FG007|Part A|Lost to Follow-up|0|||
146797130|NCT03582033|529430248|FG008|Part A|Lost to Follow-up|0|||
146797131|NCT03582033|529430249|FG009|Part A|Lost to Follow-up|0|||
146797132|NCT03582033|529430240|FG000|Part A|Study terminated by sponsor|0|||
146797133|NCT03582033|529430241|FG001|Part A|Study terminated by sponsor|0|||
146797134|NCT03582033|529430242|FG002|Part A|Study terminated by sponsor|0|||
146797135|NCT03582033|529430243|FG003|Part A|Study terminated by sponsor|2|||
146797136|NCT03582033|529430244|FG004|Part A|Study terminated by sponsor|1|||
146797137|NCT03582033|529430245|FG005|Part A|Study terminated by sponsor|0|||
146797138|NCT03582033|529430246|FG006|Part A|Study terminated by sponsor|0|||
146797139|NCT03582033|529430247|FG007|Part A|Study terminated by sponsor|0|||
146797140|NCT03582033|529430248|FG008|Part A|Study terminated by sponsor|0|||
146797141|NCT03582033|529430249|FG009|Part A|Study terminated by sponsor|0|||
146797142|NCT03582033|529430240|FG000|Part A|Withdrawal by Subject|1|||
146797143|NCT03582033|529430241|FG001|Part A|Withdrawal by Subject|1|||
146797144|NCT03582033|529430242|FG002|Part A|Withdrawal by Subject|0|||
146983085|NCT01952574|530099893|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
146797145|NCT03582033|529430243|FG003|Part A|Withdrawal by Subject|1|||
146797146|NCT03582033|529430244|FG004|Part A|Withdrawal by Subject|7|||
146797147|NCT03582033|529430245|FG005|Part A|Withdrawal by Subject|0|||
146797148|NCT03582033|529430246|FG006|Part A|Withdrawal by Subject|0|||
146797149|NCT03582033|529430247|FG007|Part A|Withdrawal by Subject|0|||
146797150|NCT03582033|529430248|FG008|Part A|Withdrawal by Subject|0|||
146797151|NCT03582033|529430249|FG009|Part A|Withdrawal by Subject|0|||
146797152|NCT03582033|529430240|FG000|Part B|Death|0|||
146797153|NCT03582033|529430241|FG001|Part B|Death|0|||
146797154|NCT03582033|529430242|FG002|Part B|Death|0|||
146797155|NCT03582033|529430243|FG003|Part B|Death|0|||
146797156|NCT03582033|529430244|FG004|Part B|Death|0|||
146797157|NCT03582033|529430245|FG005|Part B|Death|2|||
146797158|NCT03582033|529430246|FG006|Part B|Death|0|||
146797159|NCT03582033|529430247|FG007|Part B|Death|0|||
146797160|NCT03582033|529430248|FG008|Part B|Death|0|||
146797161|NCT03582033|529430249|FG009|Part B|Death|0|||
146797162|NCT03582033|529430240|FG000|Part B|Study terminated by sponsor|0|||
146797163|NCT03582033|529430241|FG001|Part B|Study terminated by sponsor|0|||
146797164|NCT03582033|529430242|FG002|Part B|Study terminated by sponsor|0|||
146797165|NCT03582033|529430243|FG003|Part B|Study terminated by sponsor|0|||
146797166|NCT03582033|529430244|FG004|Part B|Study terminated by sponsor|0|||
146797167|NCT03582033|529430245|FG005|Part B|Study terminated by sponsor|12|||
146797168|NCT03582033|529430246|FG006|Part B|Study terminated by sponsor|0|||
146797169|NCT03582033|529430247|FG007|Part B|Study terminated by sponsor|0|||
146797170|NCT03582033|529430248|FG008|Part B|Study terminated by sponsor|0|||
146797171|NCT03582033|529430249|FG009|Part B|Study terminated by sponsor|0|||
146797172|NCT03582033|529430240|FG000|Part B|Withdrawal by Subject|0|||
146797173|NCT03582033|529430241|FG001|Part B|Withdrawal by Subject|0|||
146797174|NCT03582033|529430242|FG002|Part B|Withdrawal by Subject|0|||
146797175|NCT03582033|529430243|FG003|Part B|Withdrawal by Subject|0|||
146797176|NCT03582033|529430244|FG004|Part B|Withdrawal by Subject|0|||
146797177|NCT03582033|529430245|FG005|Part B|Withdrawal by Subject|6|||
146797178|NCT03582033|529430246|FG006|Part B|Withdrawal by Subject|0|||
146797179|NCT03582033|529430247|FG007|Part B|Withdrawal by Subject|0|||
146797180|NCT03582033|529430248|FG008|Part B|Withdrawal by Subject|0|||
146797181|NCT03582033|529430249|FG009|Part B|Withdrawal by Subject|0|||
146797182|NCT03582033|529430240|FG000|Part C|Other|0|||
146797183|NCT03582033|529430241|FG001|Part C|Other|0|||
146797184|NCT03582033|529430242|FG002|Part C|Other|0|||
146797185|NCT03582033|529430243|FG003|Part C|Other|0|||
146797186|NCT03582033|529430244|FG004|Part C|Other|0|||
146797187|NCT03582033|529430245|FG005|Part C|Other|0|||
146797188|NCT03582033|529430246|FG006|Part C|Other|2|||
146797189|NCT03582033|529430247|FG007|Part C|Other|0|||
146797190|NCT03582033|529430248|FG008|Part C|Other|0|||
146797191|NCT03582033|529430249|FG009|Part C|Other|0|||
146797192|NCT03582033|529430240|FG000|Part C|Death|0|||
146797193|NCT03582033|529430241|FG001|Part C|Death|0|||
146797194|NCT03582033|529430242|FG002|Part C|Death|0|||
146797195|NCT03582033|529430243|FG003|Part C|Death|0|||
146797196|NCT03582033|529430244|FG004|Part C|Death|0|||
146797197|NCT03582033|529430245|FG005|Part C|Death|0|||
146797198|NCT03582033|529430246|FG006|Part C|Death|6|||
146797199|NCT03582033|529430247|FG007|Part C|Death|1|||
146797200|NCT03582033|529430248|FG008|Part C|Death|2|||
146797201|NCT03582033|529430249|FG009|Part C|Death|0|||
146797202|NCT03582033|529430240|FG000|Part C|Study terminated by sponsor|0|||
146797203|NCT03582033|529430241|FG001|Part C|Study terminated by sponsor|0|||
146797204|NCT03582033|529430242|FG002|Part C|Study terminated by sponsor|0|||
146797205|NCT03582033|529430243|FG003|Part C|Study terminated by sponsor|0|||
146797206|NCT03582033|529430244|FG004|Part C|Study terminated by sponsor|0|||
146797207|NCT03582033|529430245|FG005|Part C|Study terminated by sponsor|0|||
146797208|NCT03582033|529430246|FG006|Part C|Study terminated by sponsor|3|||
146797209|NCT03582033|529430247|FG007|Part C|Study terminated by sponsor|3|||
146797210|NCT03582033|529430248|FG008|Part C|Study terminated by sponsor|2|||
146797211|NCT03582033|529430249|FG009|Part C|Study terminated by sponsor|0|||
146797212|NCT03582033|529430240|FG000|Part C|Withdrawal by Subject|0|||
146797213|NCT03582033|529430241|FG001|Part C|Withdrawal by Subject|0|||
146797214|NCT03582033|529430242|FG002|Part C|Withdrawal by Subject|0|||
146797215|NCT03582033|529430243|FG003|Part C|Withdrawal by Subject|0|||
146797216|NCT03582033|529430244|FG004|Part C|Withdrawal by Subject|0|||
146797217|NCT03582033|529430245|FG005|Part C|Withdrawal by Subject|0|||
146797218|NCT03582033|529430246|FG006|Part C|Withdrawal by Subject|1|||
146797219|NCT03582033|529430247|FG007|Part C|Withdrawal by Subject|2|||
146797220|NCT03582033|529430248|FG008|Part C|Withdrawal by Subject|1|||
146797221|NCT03582033|529430249|FG009|Part C|Withdrawal by Subject|0|||
146797222|NCT03582033|529430240|FG000|Part D|Death|0|||
146797223|NCT03582033|529430241|FG001|Part D|Death|0|||
146797224|NCT03582033|529430242|FG002|Part D|Death|0|||
146797225|NCT03582033|529430243|FG003|Part D|Death|0|||
146797226|NCT03582033|529430244|FG004|Part D|Death|0|||
146797227|NCT03582033|529430245|FG005|Part D|Death|0|||
146797228|NCT03582033|529430246|FG006|Part D|Death|0|||
146797229|NCT03582033|529430247|FG007|Part D|Death|0|||
146797230|NCT03582033|529430248|FG008|Part D|Death|0|||
146797231|NCT03582033|529430249|FG009|Part D|Death|1|||
146797232|NCT03582033|529430240|FG000|Part D|Study terminated by sponsor|0|||
146797233|NCT03582033|529430241|FG001|Part D|Study terminated by sponsor|0|||
146797234|NCT03582033|529430242|FG002|Part D|Study terminated by sponsor|0|||
146797235|NCT03582033|529430243|FG003|Part D|Study terminated by sponsor|0|||
146797236|NCT03582033|529430244|FG004|Part D|Study terminated by sponsor|0|||
146797237|NCT03582033|529430245|FG005|Part D|Study terminated by sponsor|0|||
146797238|NCT03582033|529430246|FG006|Part D|Study terminated by sponsor|0|||
146797239|NCT03582033|529430247|FG007|Part D|Study terminated by sponsor|0|||
146797240|NCT03582033|529430248|FG008|Part D|Study terminated by sponsor|0|||
146797241|NCT03582033|529430249|FG009|Part D|Study terminated by sponsor|4|||
146797242|NCT06010836|529430250|FG000|Overall Study|Lost to Follow-up|2|||
146797243|NCT06010836|529430251|FG001|Overall Study|Lost to Follow-up|2|||
146797244|NCT06010836|529430250|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
146797245|NCT06010836|529430251|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
146797246|NCT06010836|529430250|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
146797247|NCT06010836|529430251|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
146797248|NCT06010836|529430250|FG000|Overall Study|Did not receive intervention discussion|0|||
146797249|NCT06010836|529430251|FG001|Overall Study|Did not receive intervention discussion|4|||
146940241|NCT04285853|529939224|FG001|Overall Study|Withdrawal by Subject|0|||
146940242|NCT04285853|529939223|FG000|Overall Study|Lost to Follow-up|9|||
146940243|NCT04285853|529939224|FG001|Overall Study|Lost to Follow-up|5|||
146940244|NCT01072448|529939225|FG000|Overall Study|Adverse Event|9|||
146940245|NCT01072448|529939226|FG001|Overall Study|Adverse Event|10|||
146940246|NCT01072448|529939225|FG000|Overall Study|Subject withdrew consent|4|||
146940247|NCT01072448|529939226|FG001|Overall Study|Subject withdrew consent|9|||
146940248|NCT01072448|529939225|FG000|Overall Study|Protocol deviation|3|||
146940249|NCT01072448|529939226|FG001|Overall Study|Protocol deviation|4|||
146940250|NCT01072448|529939225|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146940251|NCT01072448|529939226|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146940252|NCT01072448|529939225|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146940253|NCT01072448|529939226|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
146940254|NCT01072448|529939225|FG000|Overall Study|Lost to Follow-up|1|||
146940255|NCT01072448|529939226|FG001|Overall Study|Lost to Follow-up|1|||
146940256|NCT01072448|529939225|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146940257|NCT01072448|529939226|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146940258|NCT01072448|529939225|FG000|Overall Study|Death|0|||
146940259|NCT01072448|529939226|FG001|Overall Study|Death|2|||
146940260|NCT01203787|529939234|FG000|Overall Study|Death|12|||
146940261|NCT01203787|529939235|FG001|Overall Study|Death|10|||
146940262|NCT01203787|529939234|FG000|Overall Study|Withdrawal by Subject|6|||
146940263|NCT01203787|529939235|FG001|Overall Study|Withdrawal by Subject|2|||
146940264|NCT01203787|529939234|FG000|Overall Study|Lost to Follow-up|2|||
146940265|NCT01203787|529939235|FG001|Overall Study|Lost to Follow-up|0|||
146940266|NCT01203787|529939234|FG000|Overall Study|Adverse Event|11|||
146940267|NCT01203787|529939235|FG001|Overall Study|Adverse Event|15|||
146940268|NCT03404518|529939236|FG000|Overall Study|Lost to Follow-up|28|||
146940269|NCT03404518|529939237|FG001|Overall Study|Lost to Follow-up|30|||
146940270|NCT03404518|529939236|FG000|Overall Study|Protocol Violation|13|||
146940271|NCT03404518|529939237|FG001|Overall Study|Protocol Violation|6|||
146940272|NCT02079519|529939238|FG000|Overall Study|Disease Progression|9|||
146940273|NCT02079519|529939238|FG000|Overall Study|Adverse Event|1|||
146940274|NCT01576406|529939239|FG000|Overall Study|Lost to Follow-up|1|||
146940275|NCT01576406|529939240|FG001|Overall Study|Lost to Follow-up|2|||
146940276|NCT01576406|529939241|FG002|Overall Study|Lost to Follow-up|0|||
146940277|NCT01576406|529939242|FG003|Overall Study|Lost to Follow-up|0|||
146940278|NCT01576406|529939243|FG004|Overall Study|Lost to Follow-up|0|||
146940279|NCT01576406|529939244|FG005|Overall Study|Lost to Follow-up|0|||
146940280|NCT01576406|529939239|FG000|Overall Study|Death|3|||
146940281|NCT01576406|529939240|FG001|Overall Study|Death|4|||
146940282|NCT01576406|529939241|FG002|Overall Study|Death|8|||
146940283|NCT01576406|529939242|FG003|Overall Study|Death|5|||
146940284|NCT01576406|529939243|FG004|Overall Study|Death|7|||
146940285|NCT01576406|529939244|FG005|Overall Study|Death|9|||
146940286|NCT01576406|529939239|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
146940287|NCT01576406|529939240|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
146940288|NCT01576406|529939241|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
146940289|NCT01576406|529939242|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
146940290|NCT01576406|529939243|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
146940291|NCT01576406|529939244|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
146940292|NCT01576406|529939239|FG000|Overall Study|Withdrawal the consent|2|||
146940293|NCT01576406|529939240|FG001|Overall Study|Withdrawal the consent|2|||
146940294|NCT01576406|529939241|FG002|Overall Study|Withdrawal the consent|5|||
146940295|NCT01576406|529939242|FG003|Overall Study|Withdrawal the consent|1|||
146940296|NCT01576406|529939243|FG004|Overall Study|Withdrawal the consent|1|||
146940297|NCT01576406|529939244|FG005|Overall Study|Withdrawal the consent|3|||
146940298|NCT01576406|529939239|FG000|Overall Study|Other|0|||
146940299|NCT01576406|529939240|FG001|Overall Study|Other|0|||
146940300|NCT01576406|529939241|FG002|Overall Study|Other|2|||
146940301|NCT01576406|529939242|FG003|Overall Study|Other|2|||
146940302|NCT01576406|529939243|FG004|Overall Study|Other|0|||
146940303|NCT01576406|529939244|FG005|Overall Study|Other|0|||
146940304|NCT00651313|529939245|FG000|Overall Study|Adverse Event|0|||
146940305|NCT00651313|529939246|FG001|Overall Study|Adverse Event|1|||
146940306|NCT00651313|529939245|FG000|Overall Study|Withdrawal by Subject|3|||
146983086|NCT01952574|530099894|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
146983087|NCT01952574|530099895|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
146797250|NCT05953740|529430259|FG000|Period 1|Physician Decision|0|||
146797251|NCT05953740|529430260|FG001|Period 1|Physician Decision|1|||
146797252|NCT05953740|529430261|FG002|Period 1|Physician Decision|0|||
146797253|NCT05953740|529430262|FG003|Period 1|Physician Decision|0|||
146797254|NCT05953740|529430263|FG004|Period 1|Physician Decision|0|||
146797255|NCT05953740|529430264|FG005|Period 1|Physician Decision|0|||
146797256|NCT05953740|529430265|FG006|Period 1|Physician Decision|0|||
146797257|NCT05953740|529430266|FG007|Period 1|Physician Decision|0|||
146797258|NCT05953740|529430259|FG000|Period 2|Withdrawal by Subject|0|||
146797259|NCT05953740|529430260|FG001|Period 2|Withdrawal by Subject|1|||
146797260|NCT05953740|529430261|FG002|Period 2|Withdrawal by Subject|1|||
146797261|NCT05953740|529430262|FG003|Period 2|Withdrawal by Subject|0|||
146797262|NCT05953740|529430263|FG004|Period 2|Withdrawal by Subject|0|||
146797263|NCT05953740|529430264|FG005|Period 2|Withdrawal by Subject|0|||
146797264|NCT05953740|529430265|FG006|Period 2|Withdrawal by Subject|0|||
146797265|NCT05953740|529430266|FG007|Period 2|Withdrawal by Subject|0|||
146797266|NCT04206787|529430267|FG000|Overall Study|Other than listed|2|||
146797267|NCT04206787|529430267|FG000|Overall Study|Investigator decision|1|||
146797268|NCT04206787|529430267|FG000|Overall Study|Death|25|||
146797269|NCT04206787|529430267|FG000|Overall Study|Lost to Follow-up|9|||
146797270|NCT04206787|529430267|FG000|Overall Study|Withdrawal of consent|9|||
146797271|NCT02865538|529430272|FG000|Overall Study|Withdrawal by Subject|0|||
146797272|NCT02865538|529430273|FG001|Overall Study|Withdrawal by Subject|0|||
146797273|NCT02865538|529430274|FG002|Overall Study|Withdrawal by Subject|1|||
146797274|NCT02865538|529430275|FG003|Overall Study|Withdrawal by Subject|0|||
146797275|NCT02865538|529430276|FG004|Overall Study|Withdrawal by Subject|0|||
146797276|NCT02865538|529430272|FG000|Overall Study|Lost to Follow-up|1|||
146797277|NCT02865538|529430273|FG001|Overall Study|Lost to Follow-up|0|||
146797278|NCT02865538|529430274|FG002|Overall Study|Lost to Follow-up|0|||
146797279|NCT02865538|529430275|FG003|Overall Study|Lost to Follow-up|0|||
146797280|NCT02865538|529430276|FG004|Overall Study|Lost to Follow-up|0|||
146797281|NCT04451772|529431597|FG000|Overall Study|Adverse Event|1|||
146797282|NCT04451772|529431598|FG001|Overall Study|Adverse Event|0|||
146797283|NCT04451772|529431599|FG002|Overall Study|Adverse Event|1|||
146797284|NCT04451772|529431600|FG003|Overall Study|Adverse Event|1|||
146797285|NCT04451772|529431601|FG004|Overall Study|Adverse Event|0|||
146797286|NCT04451772|529431602|FG005|Overall Study|Adverse Event|3|||
146797287|NCT04451772|529431597|FG000|Overall Study|Withdrawal by Subject|2|||
146797288|NCT04451772|529431598|FG001|Overall Study|Withdrawal by Subject|7|||
146797289|NCT04451772|529431599|FG002|Overall Study|Withdrawal by Subject|2|||
146797290|NCT04451772|529431600|FG003|Overall Study|Withdrawal by Subject|1|||
146797291|NCT04451772|529431601|FG004|Overall Study|Withdrawal by Subject|1|||
146797292|NCT04451772|529431602|FG005|Overall Study|Withdrawal by Subject|0|||
146797293|NCT04451772|529431597|FG000|Overall Study|Other, not specified|1|||
146797294|NCT04451772|529431598|FG001|Overall Study|Other, not specified|2|||
146797295|NCT04451772|529431599|FG002|Overall Study|Other, not specified|1|||
146797296|NCT04451772|529431600|FG003|Overall Study|Other, not specified|0|||
146797297|NCT04451772|529431601|FG004|Overall Study|Other, not specified|0|||
146797298|NCT04451772|529431602|FG005|Overall Study|Other, not specified|1|||
146797299|NCT04451772|529431597|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
146797300|NCT04451772|529431598|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
146797301|NCT04451772|529431599|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
146797302|NCT04451772|529431600|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
146797303|NCT04451772|529431601|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
146797304|NCT04451772|529431602|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
146797305|NCT04311632|529431603|FG000|Overall Study|Withdrawal by Subject|0|||
146983088|NCT01952574|530099896|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
146983089|NCT01952574|530099890|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
146983090|NCT01952574|530099891|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
146797306|NCT04311632|529431604|FG001|Overall Study|Withdrawal by Subject|0|||
146797307|NCT04311632|529431605|FG002|Overall Study|Withdrawal by Subject|1|||
146797308|NCT04632225|529431606|FG000|Overall Study|Withdrawal by Subject|2|||
146797309|NCT04632225|529431607|FG001|Overall Study|Withdrawal by Subject|2|||
146797310|NCT02278211|529431608|FG000|Overall Study|Unable to analyse PET scan|2|||
146797311|NCT03858517|529431609|FG000|Overall Study|Adverse Event|1|||
146797312|NCT03858517|529431609|FG000|Overall Study|Lost to Follow-up|1|||
146797313|NCT03858517|529431609|FG000|Overall Study|removed for being incarcerated|1|||
146983091|NCT01952574|530099892|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
146983092|NCT01952574|530099893|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
146983093|NCT01952574|530099894|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
146797314|NCT03858517|529431609|FG000|Overall Study|Sponsor Closure|48|||
146797315|NCT04804540|529431610|FG000|Overall Study|Adverse Event|26|||
146797316|NCT04804540|529431611|FG001|Overall Study|Adverse Event|13|||
146797317|NCT05172232|529431612|FG000|Overall Study|Lost to Follow-up|3|||
146797318|NCT02997202|529431614|FG000|Overall Study|Miscellaneous|2|||
146797319|NCT02997202|529431615|FG001|Overall Study|Miscellaneous|2|||
146797320|NCT02997202|529431614|FG000|Overall Study|Withdrawal by Subject|8|||
146797321|NCT02997202|529431615|FG001|Overall Study|Withdrawal by Subject|12|||
146797322|NCT02997202|529431614|FG000|Overall Study|Lost to Follow-up|5|||
146797323|NCT02997202|529431615|FG001|Overall Study|Lost to Follow-up|3|||
146797324|NCT02997202|529431614|FG000|Overall Study|Death|41|||
146797325|NCT02997202|529431615|FG001|Overall Study|Death|45|||
146797326|NCT04629339|529431621|FG000|Overall Study|Death|1|||
146797327|NCT04629339|529431622|FG001|Overall Study|Death|0|||
146797328|NCT04629339|529431623|FG002|Overall Study|Death|2|||
146797329|NCT04629339|529431624|FG003|Overall Study|Death|2|||
146797330|NCT04629339|529431625|FG004|Overall Study|Death|0|||
146797331|NCT04629339|529431621|FG000|Overall Study|Disease Progression|0|||
146797332|NCT04629339|529431622|FG001|Overall Study|Disease Progression|0|||
146797333|NCT04629339|529431623|FG002|Overall Study|Disease Progression|1|||
146797334|NCT04629339|529431624|FG003|Overall Study|Disease Progression|1|||
146797335|NCT04629339|529431625|FG004|Overall Study|Disease Progression|0|||
146797336|NCT04629339|529431621|FG000|Overall Study|Lost to Follow-up|0|||
146797337|NCT04629339|529431622|FG001|Overall Study|Lost to Follow-up|0|||
146797338|NCT04629339|529431623|FG002|Overall Study|Lost to Follow-up|0|||
146797339|NCT04629339|529431624|FG003|Overall Study|Lost to Follow-up|1|||
146797340|NCT04629339|529431625|FG004|Overall Study|Lost to Follow-up|0|||
146797341|NCT04629339|529431621|FG000|Overall Study|Physician Decision|0|||
146797342|NCT04629339|529431622|FG001|Overall Study|Physician Decision|1|||
146797343|NCT04629339|529431623|FG002|Overall Study|Physician Decision|0|||
146797344|NCT04629339|529431624|FG003|Overall Study|Physician Decision|0|||
146797345|NCT04629339|529431625|FG004|Overall Study|Physician Decision|0|||
146797346|NCT04629339|529431621|FG000|Overall Study|Study Terminated by Sponsor|0|||
146797347|NCT04629339|529431622|FG001|Overall Study|Study Terminated by Sponsor|0|||
146797348|NCT04629339|529431623|FG002|Overall Study|Study Terminated by Sponsor|0|||
146797349|NCT04629339|529431624|FG003|Overall Study|Study Terminated by Sponsor|1|||
146797350|NCT04629339|529431625|FG004|Overall Study|Study Terminated by Sponsor|0|||
146797351|NCT04629339|529431621|FG000|Overall Study|Withdrawal by Subject|0|||
146797352|NCT04629339|529431622|FG001|Overall Study|Withdrawal by Subject|0|||
146797353|NCT04629339|529431623|FG002|Overall Study|Withdrawal by Subject|2|||
146797354|NCT04629339|529431624|FG003|Overall Study|Withdrawal by Subject|2|||
146797355|NCT04629339|529431625|FG004|Overall Study|Withdrawal by Subject|0|||
146797356|NCT04158739|529431630|FG000|Overall Study|Adverse Event|1|||
146797357|NCT04158739|529431631|FG001|Overall Study|Adverse Event|0|||
146797358|NCT04158739|529431630|FG000|Overall Study|Death|0|||
146797359|NCT04158739|529431631|FG001|Overall Study|Death|1|||
146797360|NCT04158739|529431630|FG000|Overall Study|Lack of Efficacy|3|||
146797361|NCT04158739|529431631|FG001|Overall Study|Lack of Efficacy|7|||
146797362|NCT04158739|529431630|FG000|Overall Study|Physician Decision|0|||
146797363|NCT04158739|529431631|FG001|Overall Study|Physician Decision|1|||
146797364|NCT04158739|529431630|FG000|Overall Study|Withdrawal by Subject|3|||
146797365|NCT04158739|529431631|FG001|Overall Study|Withdrawal by Subject|0|||
146797366|NCT04084574|529431634|FG000|Overall Study|Lost to Follow-up|1|||
146797367|NCT04084574|529431635|FG001|Overall Study|Lost to Follow-up|0|||
146797368|NCT04084574|529431634|FG000|Overall Study|Physician Decision|1|||
146797369|NCT04084574|529431635|FG001|Overall Study|Physician Decision|0|||
146797370|NCT04084574|529431634|FG000|Overall Study|Relocated out of state|1|||
146797371|NCT04084574|529431635|FG001|Overall Study|Relocated out of state|0|||
146797372|NCT02782676|529431636|FG000|Overall Study|Lost to Follow-up|0|||
146797373|NCT02782676|529431637|FG001|Overall Study|Lost to Follow-up|1|||
146983094|NCT01952574|530099895|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
146983095|NCT01952574|530099896|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
146983096|NCT01952574|530099890|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
146797374|NCT00964392|529431638|FG000|Overall Study|Withdrawal by Subject|4|||
146983097|NCT01952574|530099891|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
146983098|NCT01952574|530099892|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
146983099|NCT01952574|530099893|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
146983100|NCT01952574|530099894|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
146983101|NCT01952574|530099895|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
146983102|NCT01952574|530099896|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
146797375|NCT00964392|529431639|FG001|Overall Study|Withdrawal by Subject|6|||
146797376|NCT00964392|529431638|FG000|Overall Study|Lost to Follow-up|4|||
146797377|NCT00964392|529431639|FG001|Overall Study|Lost to Follow-up|10|||
146797378|NCT00964392|529431638|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
146797379|NCT00964392|529431639|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
146797380|NCT00964392|529431638|FG000|Overall Study|Not completed|44|||
146797381|NCT00964392|529431639|FG001|Overall Study|Not completed|168|||
146797382|NCT04055012|529431640|FG000|Overall Study|Withdrawal by Subject|1|||
146797383|NCT04055012|529431641|FG001|Overall Study|Withdrawal by Subject|3|||
146797384|NCT04055012|529431642|FG002|Overall Study|Withdrawal by Subject|1|||
146797385|NCT04055012|529431643|FG003|Overall Study|Withdrawal by Subject|0|||
146797386|NCT04055012|529431640|FG000|Overall Study|Metformin Recall|1|||
146797387|NCT04055012|529431641|FG001|Overall Study|Metformin Recall|1|||
146797388|NCT04055012|529431642|FG002|Overall Study|Metformin Recall|1|||
146797389|NCT04055012|529431643|FG003|Overall Study|Metformin Recall|0|||
146797390|NCT03652272|529431644|FG000|3 Month|Withdrawal by Subject|1|||
146797391|NCT03652272|529431645|FG001|3 Month|Withdrawal by Subject|1|||
146797392|NCT03652272|529431644|FG000|3 Month|Lost to Follow-up|16|||
146797393|NCT03652272|529431645|FG001|3 Month|Lost to Follow-up|14|||
146797394|NCT02326974|529431646|FG000|Overall Study|Withdrawal by Subject|2|||
146797395|NCT02326974|529431646|FG000|Overall Study|failed heterogenity evaluation|5|||
146797396|NCT02577354|529431647|FG000|Overall Study|Lack of Efficacy|4|||
146797397|NCT02577354|529431648|FG001|Overall Study|Lack of Efficacy|4|||
146797398|NCT02577354|529431647|FG000|Overall Study|Lost to Follow-up|3|||
146797399|NCT02577354|529431648|FG001|Overall Study|Lost to Follow-up|1|||
146797400|NCT02577354|529431647|FG000|Overall Study|Missed Visit|4|||
146797401|NCT02577354|529431648|FG001|Overall Study|Missed Visit|3|||
146797402|NCT02577354|529431647|FG000|Overall Study|Adverse Event|4|||
146797403|NCT02577354|529431648|FG001|Overall Study|Adverse Event|5|||
146797404|NCT04214834|529431654|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
146797405|NCT04214834|529431655|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
146797406|NCT04924400|529431658|FG000|Overall Study|Lost to Follow-up|3|||
146797407|NCT04924400|529431659|FG001|Overall Study|Lost to Follow-up|0|||
146797408|NCT04109066|529431660|FG000|Pre-treatment|Participant withdrew consent|2|||
146797409|NCT04109066|529431661|FG001|Pre-treatment|Participant withdrew consent|0|||
146797410|NCT04109066|529431660|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
146797411|NCT04109066|529431661|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
146797412|NCT04109066|529431660|FG000|Treatment|Lack of Efficacy|2|||
146797413|NCT04109066|529431661|FG001|Treatment|Lack of Efficacy|4|||
146797414|NCT04109066|529431660|FG000|Treatment|Adverse Event|23|||
146797415|NCT04109066|529431661|FG001|Treatment|Adverse Event|7|||
146797416|NCT04109066|529431660|FG000|Treatment|Participant request to discontinue Study treatment|15|||
146797417|NCT04109066|529431661|FG001|Treatment|Participant request to discontinue Study treatment|14|||
146797418|NCT04109066|529431660|FG000|Treatment|Withdrawal by Subject|8|||
146797419|NCT04109066|529431661|FG001|Treatment|Withdrawal by Subject|8|||
146797420|NCT04109066|529431660|FG000|Treatment|Death|3|||
146797421|NCT04109066|529431661|FG001|Treatment|Death|0|||
146797422|NCT04109066|529431660|FG000|Treatment|Participant no longer meets study criteria|2|||
146797423|NCT04109066|529431661|FG001|Treatment|Participant no longer meets study criteria|2|||
146797424|NCT04109066|529431660|FG000|Treatment|Administrative reasons by sponsor|2|||
146797425|NCT04109066|529431661|FG001|Treatment|Administrative reasons by sponsor|3|||
146797426|NCT04109066|529431660|FG000|Treatment|Other reasons|17|||
146797427|NCT04109066|529431661|FG001|Treatment|Other reasons|23|||
146797428|NCT04109066|529431660|FG000|Treatment|Disease Progression|4|||
146797429|NCT04109066|529431661|FG001|Treatment|Disease Progression|7|||
146797430|NCT04109066|529431660|FG000|Treatment|Study drug toxicity|12|||
146797431|NCT04109066|529431661|FG001|Treatment|Study drug toxicity|5|||
146797432|NCT04109066|529431660|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
146797433|NCT04109066|529431661|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
146797434|NCT04109066|529431660|FG000|Treatment|Disease Recurrence|0|||
146797435|NCT04109066|529431661|FG001|Treatment|Disease Recurrence|2|||
146797436|NCT04109066|529431660|FG000|Treatment|Not reported|4|||
146797437|NCT04109066|529431661|FG001|Treatment|Not reported|8|||
146797438|NCT03812614|529431662|FG000|Intervention|Withdrawal by Subject|7|||
146797439|NCT03812614|529431663|FG001|Intervention|Withdrawal by Subject|2|||
146797440|NCT03812614|529431664|FG002|Intervention|Withdrawal by Subject|7|||
146797441|NCT03812614|529431665|FG003|Intervention|Withdrawal by Subject|2|||
146797442|NCT03812614|529431662|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
146797443|NCT03812614|529431663|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
146797444|NCT03812614|529431664|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
146797445|NCT03812614|529431665|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
146797446|NCT03812614|529431662|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
146797447|NCT03812614|529431663|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
146797448|NCT03812614|529431664|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
146797449|NCT03812614|529431665|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
146797450|NCT03812614|529431662|FG000|6-month Follow-up|Lost to Follow-up|0|||
146797451|NCT03812614|529431663|FG001|6-month Follow-up|Lost to Follow-up|0|||
146797452|NCT03812614|529431664|FG002|6-month Follow-up|Lost to Follow-up|12|||
146797453|NCT03812614|529431665|FG003|6-month Follow-up|Lost to Follow-up|8|||
146797454|NCT03812614|529431662|FG000|12-month Follow-up|Lost to Follow-up|18|||
146797455|NCT03812614|529431663|FG001|12-month Follow-up|Lost to Follow-up|17|||
146797456|NCT03812614|529431664|FG002|12-month Follow-up|Lost to Follow-up|5|||
146797457|NCT03812614|529431665|FG003|12-month Follow-up|Lost to Follow-up|2|||
146983103|NCT01952574|530099890|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
146983104|NCT01952574|530099891|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
146983105|NCT01952574|530099892|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
146983106|NCT01952574|530099893|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
146983107|NCT01952574|530099894|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
146983108|NCT01952574|530099895|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
146983109|NCT01952574|530099896|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
146983110|NCT01952574|530099890|FG000|Open-label Treatment Phase|Missing|0|||
146983111|NCT01952574|530099891|FG001|Open-label Treatment Phase|Missing|0|||
146983112|NCT01952574|530099892|FG002|Open-label Treatment Phase|Missing|0|||
146983113|NCT01952574|530099893|FG003|Open-label Treatment Phase|Missing|0|||
146983114|NCT01952574|530099894|FG004|Open-label Treatment Phase|Missing|4|||
146983115|NCT01952574|530099895|FG005|Open-label Treatment Phase|Missing|0|||
146983116|NCT01952574|530099896|FG006|Open-label Treatment Phase|Missing|0|||
146983117|NCT01952574|530099890|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
146983118|NCT01952574|530099891|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
146983119|NCT01952574|530099892|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
146983120|NCT01952574|530099893|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
146983121|NCT01952574|530099894|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
146983122|NCT01952574|530099895|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
146983123|NCT01952574|530099896|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
146983124|NCT01952574|530099890|FG000|Open-label Treatment Phase|Death|0|||
146983125|NCT01952574|530099891|FG001|Open-label Treatment Phase|Death|0|||
146983126|NCT01952574|530099892|FG002|Open-label Treatment Phase|Death|0|||
146983127|NCT01952574|530099893|FG003|Open-label Treatment Phase|Death|0|||
146983128|NCT01952574|530099894|FG004|Open-label Treatment Phase|Death|1|||
146983129|NCT01952574|530099895|FG005|Open-label Treatment Phase|Death|0|||
146983130|NCT01952574|530099896|FG006|Open-label Treatment Phase|Death|0|||
146983131|NCT01952574|530099890|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
146983132|NCT01952574|530099891|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
146983133|NCT01952574|530099892|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
146983134|NCT01952574|530099893|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
146983135|NCT01952574|530099894|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
146983136|NCT01952574|530099895|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
146983137|NCT01952574|530099896|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
146983138|NCT01952574|530099890|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
146983139|NCT01952574|530099891|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
146983140|NCT01952574|530099892|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
146983141|NCT01952574|530099893|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
146983142|NCT01952574|530099894|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
146983143|NCT01952574|530099895|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
146983144|NCT01952574|530099896|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
146983145|NCT00770991|530099900|FG000|Overall Study|Physician Decision|2|||
146983146|NCT00770991|530099901|FG001|Overall Study|Physician Decision|0|||
146983147|NCT00770991|530099900|FG000|Overall Study|Withdrawal by Subject|1|||
146983148|NCT00770991|530099901|FG001|Overall Study|Withdrawal by Subject|0|||
146983149|NCT00770991|530099900|FG000|Overall Study|Adverse Event|1|||
146983150|NCT00770991|530099901|FG001|Overall Study|Adverse Event|5|||
146983151|NCT00770991|530099900|FG000|Overall Study|Pregnancy|1|||
146983152|NCT00770991|530099901|FG001|Overall Study|Pregnancy|0|||
146983153|NCT02444533|530099903|FG000|Overall Study|Not able to complete forms|0|||
146983154|NCT02444533|530099904|FG001|Overall Study|Not able to complete forms|2|||
146983155|NCT02444533|530099903|FG000|Overall Study|Only gave post-procedure complications|2|||
146983156|NCT02444533|530099904|FG001|Overall Study|Only gave post-procedure complications|2|||
146983157|NCT00886483|530099909|FG000|Overall Study|Lost to Follow-up|0|||
146983158|NCT00886483|530099910|FG001|Overall Study|Lost to Follow-up|1|||
146797458|NCT05205161|529431666|FG000|Overall Study|Study terminated by sponsor|3|||
146983159|NCT00886483|530099909|FG000|Overall Study|Pursue medications|1|||
146983160|NCT00886483|530099910|FG001|Overall Study|Pursue medications|2|||
146983161|NCT00886483|530099909|FG000|Overall Study|Distance to center, poor grades|1|||
146983162|NCT00886483|530099910|FG001|Overall Study|Distance to center, poor grades|0|||
146983163|NCT02168270|530099912|FG000|Overall Study|Lack of Efficacy|4|||
146983164|NCT00593333|530099913|FG000|Overall Study|Lost to Follow-up|10|||
146983165|NCT00593333|530099914|FG001|Overall Study|Lost to Follow-up|11|||
146983166|NCT02175966|530099915|FG000|Follow-up Period|Lack of Efficacy|10|||
146983167|NCT02175966|530099916|FG001|Follow-up Period|Lack of Efficacy|6|||
146983168|NCT01086215|530099921|FG000|Overall Study|Death|14|||
146983169|NCT01086215|530099922|FG001|Overall Study|Death|8|||
146983170|NCT01086215|530099923|FG002|Overall Study|Death|8|||
146983171|NCT01086215|530099924|FG003|Overall Study|Death|1|||
146983172|NCT01086215|530099921|FG000|Overall Study|Lost to Follow-up|22|||
146983173|NCT01086215|530099922|FG001|Overall Study|Lost to Follow-up|39|||
146983174|NCT01086215|530099923|FG002|Overall Study|Lost to Follow-up|18|||
146983175|NCT01086215|530099924|FG003|Overall Study|Lost to Follow-up|2|||
146983176|NCT01965652|530099925|FG000|Overall Study|Adverse Event|40|||
146797459|NCT05205161|529431667|FG001|Overall Study|Study terminated by sponsor|3|||
146797460|NCT05205161|529431668|FG002|Overall Study|Study terminated by sponsor|1|||
146797461|NCT05652010|529431669|FG000|First Intervention|Withdrawal by Subject|0|||
146797462|NCT05652010|529431670|FG001|First Intervention|Withdrawal by Subject|1|||
146797463|NCT05652010|529431669|FG000|Second Intervention|Withdrawal by Subject|1|||
146797464|NCT05652010|529431670|FG001|Second Intervention|Withdrawal by Subject|0|||
146797465|NCT05451693|529431672|FG000|Overall Study|Withdrawal by Subject|1|||
146797466|NCT05451693|529431673|FG001|Overall Study|Withdrawal by Subject|1|||
146797467|NCT05741294|529431674|FG000|Overall Study|Lost to Follow-up|3|||
146797468|NCT05741294|529431674|FG000|Overall Study|Protocol deviation|3|||
146797469|NCT05741294|529431674|FG000|Overall Study|Withdrawal by Subject|1|||
146797470|NCT04707768|529431689|FG000|Overall Study|Adverse Event|9|||
146797471|NCT04707768|529431690|FG001|Overall Study|Adverse Event|18|||
146797472|NCT04707768|529431691|FG002|Overall Study|Adverse Event|3|||
146797473|NCT04707768|529431689|FG000|Overall Study|Investigator's Discretion|8|||
146797474|NCT04707768|529431690|FG001|Overall Study|Investigator's Discretion|4|||
146797475|NCT04707768|529431691|FG002|Overall Study|Investigator's Discretion|3|||
146797476|NCT04707768|529431689|FG000|Overall Study|Withdrawal by Subject|6|||
146797477|NCT04707768|529431690|FG001|Overall Study|Withdrawal by Subject|8|||
146797478|NCT04707768|529431691|FG002|Overall Study|Withdrawal by Subject|2|||
146797479|NCT04707768|529431689|FG000|Overall Study|Lack of Efficacy|1|||
146797480|NCT04707768|529431690|FG001|Overall Study|Lack of Efficacy|3|||
146797481|NCT04707768|529431691|FG002|Overall Study|Lack of Efficacy|0|||
146797482|NCT04707768|529431689|FG000|Overall Study|Lost to Follow-up|0|||
146797483|NCT04707768|529431690|FG001|Overall Study|Lost to Follow-up|0|||
146797484|NCT04707768|529431691|FG002|Overall Study|Lost to Follow-up|3|||
146797485|NCT04707768|529431689|FG000|Overall Study|Death|13|||
146797486|NCT04707768|529431690|FG001|Overall Study|Death|11|||
146797487|NCT04707768|529431691|FG002|Overall Study|Death|13|||
146797488|NCT04707768|529431689|FG000|Overall Study|Protocol Violation|2|||
146797489|NCT04707768|529431690|FG001|Overall Study|Protocol Violation|1|||
146797490|NCT04707768|529431691|FG002|Overall Study|Protocol Violation|0|||
146797491|NCT04707768|529431689|FG000|Overall Study|Non Compliance with Study Drug|1|||
146797492|NCT04707768|529431690|FG001|Overall Study|Non Compliance with Study Drug|0|||
146797493|NCT04707768|529431691|FG002|Overall Study|Non Compliance with Study Drug|0|||
146797494|NCT04707768|529431689|FG000|Overall Study|Transplant|4|||
146797495|NCT04707768|529431690|FG001|Overall Study|Transplant|4|||
146797496|NCT04707768|529431691|FG002|Overall Study|Transplant|8|||
146797497|NCT04707768|529431689|FG000|Overall Study|Other|9|||
146797498|NCT04707768|529431690|FG001|Overall Study|Other|5|||
146797499|NCT04707768|529431691|FG002|Overall Study|Other|2|||
146797500|NCT02510235|529431692|FG000|Overall Study|Withdrawal by Subject|1|||
146797501|NCT02510235|529431693|FG001|Overall Study|Withdrawal by Subject|0|||
146797502|NCT05008055|529431694|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
146797503|NCT05008055|529431695|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
146797504|NCT05008055|529431696|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
146797505|NCT03011034|529431701|FG000|Overall Study|Adverse Event|1|||
146797506|NCT03011034|529431702|FG001|Overall Study|Adverse Event|0|||
146797507|NCT03735979|529431704|FG000|Overall Study|Lost to Follow-up|1|||
146797508|NCT03735979|529431705|FG001|Overall Study|Lost to Follow-up|12|||
146797509|NCT03735979|529431706|FG002|Overall Study|Lost to Follow-up|14|||
146797510|NCT03735979|529431704|FG000|Overall Study|Withdrawal by Subject|1|||
146797511|NCT03735979|529431705|FG001|Overall Study|Withdrawal by Subject|5|||
146797512|NCT03735979|529431706|FG002|Overall Study|Withdrawal by Subject|2|||
146797513|NCT03735979|529431704|FG000|Overall Study|Not due to the above reasons|1|||
146797514|NCT03735979|529431705|FG001|Overall Study|Not due to the above reasons|0|||
146797515|NCT03735979|529431706|FG002|Overall Study|Not due to the above reasons|0|||
146797516|NCT01438853|529431709|FG000|Overall Study|Death|0|||
146797517|NCT01438853|529431710|FG001|Overall Study|Death|0|||
146797518|NCT01438853|529431711|FG002|Overall Study|Death|0|||
146797519|NCT01438853|529431712|FG003|Overall Study|Death|1|||
146797520|NCT01438853|529431709|FG000|Overall Study|Withdrawal by Subject|0|||
146797521|NCT01438853|529431710|FG001|Overall Study|Withdrawal by Subject|0|||
146797522|NCT01438853|529431711|FG002|Overall Study|Withdrawal by Subject|1|||
146797523|NCT01438853|529431712|FG003|Overall Study|Withdrawal by Subject|0|||
146797524|NCT03165955|529431713|FG000|Treatment|Withdrawal by Subject|3|||
146797525|NCT03165955|529431713|FG000|Treatment|Death|1|||
146797526|NCT03165955|529431713|FG000|Treatment|Adverse Event|1|||
146797527|NCT03165955|529431713|FG000|Treatment|Progressive disease|3|||
146797528|NCT04761198|529431716|FG000|Overall Study|Progressive Disease|1|||
146797529|NCT04761198|529431717|FG001|Overall Study|Progressive Disease|0|||
146797530|NCT04761198|529431718|FG002|Overall Study|Progressive Disease|0|||
146797531|NCT04761198|529431719|FG003|Overall Study|Progressive Disease|1|||
146940307|NCT00651313|529939246|FG001|Overall Study|Withdrawal by Subject|1|||
146797532|NCT04761198|529431720|FG004|Overall Study|Progressive Disease|4|||
146797533|NCT04761198|529431721|FG005|Overall Study|Progressive Disease|1|||
146797534|NCT04761198|529431722|FG006|Overall Study|Progressive Disease|2|||
146940308|NCT00651313|529939245|FG000|Overall Study|Lost to Follow-up|1|||
146797535|NCT04761198|529431716|FG000|Overall Study|Protocol Violation|0|||
146797536|NCT04761198|529431717|FG001|Overall Study|Protocol Violation|0|||
146797537|NCT04761198|529431718|FG002|Overall Study|Protocol Violation|0|||
146797538|NCT04761198|529431719|FG003|Overall Study|Protocol Violation|0|||
146797539|NCT04761198|529431720|FG004|Overall Study|Protocol Violation|1|||
146797540|NCT04761198|529431721|FG005|Overall Study|Protocol Violation|0|||
146797541|NCT04761198|529431722|FG006|Overall Study|Protocol Violation|0|||
146797542|NCT04761198|529431716|FG000|Overall Study|Death|2|||
146797543|NCT04761198|529431717|FG001|Overall Study|Death|1|||
146797544|NCT04761198|529431718|FG002|Overall Study|Death|2|||
146797545|NCT04761198|529431719|FG003|Overall Study|Death|5|||
146797546|NCT04761198|529431720|FG004|Overall Study|Death|14|||
146797547|NCT04761198|529431721|FG005|Overall Study|Death|2|||
146797548|NCT04761198|529431722|FG006|Overall Study|Death|5|||
146797549|NCT04761198|529431716|FG000|Overall Study|Lost to Follow-up|0|||
146797550|NCT04761198|529431717|FG001|Overall Study|Lost to Follow-up|0|||
146797551|NCT04761198|529431718|FG002|Overall Study|Lost to Follow-up|0|||
146797552|NCT04761198|529431719|FG003|Overall Study|Lost to Follow-up|0|||
146797553|NCT04761198|529431720|FG004|Overall Study|Lost to Follow-up|1|||
146797554|NCT04761198|529431721|FG005|Overall Study|Lost to Follow-up|0|||
146797555|NCT04761198|529431722|FG006|Overall Study|Lost to Follow-up|0|||
146797556|NCT04761198|529431716|FG000|Overall Study|Withdrawal by Subject|2|||
146797557|NCT04761198|529431717|FG001|Overall Study|Withdrawal by Subject|0|||
146797558|NCT04761198|529431718|FG002|Overall Study|Withdrawal by Subject|1|||
146797559|NCT04761198|529431719|FG003|Overall Study|Withdrawal by Subject|0|||
146797560|NCT04761198|529431720|FG004|Overall Study|Withdrawal by Subject|2|||
146797561|NCT04761198|529431721|FG005|Overall Study|Withdrawal by Subject|0|||
146797562|NCT04761198|529431722|FG006|Overall Study|Withdrawal by Subject|1|||
146797563|NCT04761198|529431716|FG000|Overall Study|Study Terminated by Sponsor|6|||
146797564|NCT04761198|529431717|FG001|Overall Study|Study Terminated by Sponsor|0|||
146797565|NCT04761198|529431718|FG002|Overall Study|Study Terminated by Sponsor|5|||
146797566|NCT04761198|529431719|FG003|Overall Study|Study Terminated by Sponsor|3|||
146797567|NCT04761198|529431720|FG004|Overall Study|Study Terminated by Sponsor|10|||
146797568|NCT04761198|529431721|FG005|Overall Study|Study Terminated by Sponsor|1|||
146797569|NCT04761198|529431722|FG006|Overall Study|Study Terminated by Sponsor|2|||
146797570|NCT02994927|529431723|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146797571|NCT02994927|529431724|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146797572|NCT02994927|529431723|FG000|Overall Study|Did not meet eligibility criteria|0|||
146797573|NCT02994927|529431724|FG001|Overall Study|Did not meet eligibility criteria|1|||
146797574|NCT02994927|529431723|FG000|Overall Study|Physician Decision|4|||
146797575|NCT02994927|529431724|FG001|Overall Study|Physician Decision|3|||
146797576|NCT02994927|529431723|FG000|Overall Study|Death|4|||
146797577|NCT02994927|529431724|FG001|Overall Study|Death|2|||
146797578|NCT02994927|529431723|FG000|Overall Study|Adverse Event|2|||
146797579|NCT02994927|529431724|FG001|Overall Study|Adverse Event|1|||
146797580|NCT02994927|529431723|FG000|Overall Study|Withdrawal by Subject|3|||
146797581|NCT02994927|529431724|FG001|Overall Study|Withdrawal by Subject|6|||
146797582|NCT02994927|529431723|FG000|Overall Study|Lost to Follow-up|2|||
146797583|NCT02994927|529431724|FG001|Overall Study|Lost to Follow-up|1|||
146797584|NCT00626795|529431725|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
146797585|NCT00626795|529431726|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
146797586|NCT00626795|529431727|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
146797587|NCT00626795|529431725|FG000|Blinded Treatment|Lack of Efficacy|2|||
146797588|NCT00626795|529431726|FG001|Blinded Treatment|Lack of Efficacy|0|||
146797589|NCT00626795|529431727|FG002|Blinded Treatment|Lack of Efficacy|0|||
146797590|NCT00626795|529431725|FG000|Blinded Treatment|Unacceptable adverse event|0|||
146797591|NCT00626795|529431726|FG001|Blinded Treatment|Unacceptable adverse event|0|||
146797592|NCT00626795|529431727|FG002|Blinded Treatment|Unacceptable adverse event|1|||
146797593|NCT00626795|529431725|FG000|Blinded Treatment|Protocol Violation|0|||
146797594|NCT00626795|529431726|FG001|Blinded Treatment|Protocol Violation|1|||
146797595|NCT00626795|529431727|FG002|Blinded Treatment|Protocol Violation|1|||
146797596|NCT00626795|529431725|FG000|Blinded Treatment|Withdrawal by Subject|1|||
146797597|NCT00626795|529431726|FG001|Blinded Treatment|Withdrawal by Subject|1|||
146797598|NCT00626795|529431727|FG002|Blinded Treatment|Withdrawal by Subject|0|||
146797599|NCT00626795|529431725|FG000|Blinded Treatment|Other reasons|2|||
146797600|NCT00626795|529431726|FG001|Blinded Treatment|Other reasons|0|||
146797601|NCT00626795|529431727|FG002|Blinded Treatment|Other reasons|2|||
146797602|NCT00626795|529431725|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
146797603|NCT00626795|529431726|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
146797604|NCT00626795|529431727|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
146797605|NCT03533257|529431735|FG000|Overall Study|Adverse Event|4|||
146797606|NCT03533257|529431736|FG001|Overall Study|Adverse Event|2|||
146797607|NCT03533257|529431735|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
146797608|NCT03533257|529431736|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
146797609|NCT05525104|529431737|FG000|Overall Study|Failed caudal analgesia|1|||
146797610|NCT05525104|529431738|FG001|Overall Study|Failed caudal analgesia|3|||
146797611|NCT05525104|529431737|FG000|Overall Study|Premedication needed|0|||
146797612|NCT05525104|529431738|FG001|Overall Study|Premedication needed|1|||
146797613|NCT05525104|529431737|FG000|Overall Study|Protocol Violation|10|||
146797614|NCT05525104|529431738|FG001|Overall Study|Protocol Violation|0|||
146797615|NCT05525104|529431737|FG000|Overall Study|Cancelled operation|1|||
146797616|NCT05525104|529431738|FG001|Overall Study|Cancelled operation|0|||
146797617|NCT02039401|529431739|FG000|Overall Study|Adverse Event|0|||
146797618|NCT02039401|529431740|FG001|Overall Study|Adverse Event|1|||
146797619|NCT04678856|529431741|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
146797620|NCT04678856|529431742|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
146797621|NCT04678856|529431741|FG000|Overall Study|Withdrawal by Subject|5|||
146797622|NCT04678856|529431742|FG001|Overall Study|Withdrawal by Subject|1|||
146797623|NCT04389957|529432576|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
146797624|NCT04389957|529432577|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
146797625|NCT04389957|529432578|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
146797626|NCT04389957|529432579|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
146797627|NCT04389957|529432580|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
146797628|NCT05405985|529432583|FG000|Overall Study|Withdrawal by Subject|1|||
146797629|NCT05405985|529432584|FG001|Overall Study|Withdrawal by Subject|0|||
146797630|NCT01917084|529432585|FG000|Overall Study|Withdrawal by Subject|1|||
146797631|NCT03571386|529432586|FG000|Overall Study|scheduling conflict|4|||
146797632|NCT03571386|529432587|FG001|Overall Study|scheduling conflict|0|||
146797633|NCT03571386|529432586|FG000|Overall Study|Withdrawal by Subject|15|||
146797634|NCT03571386|529432587|FG001|Overall Study|Withdrawal by Subject|5|||
146797635|NCT06037668|529432594|FG000|Overall Study|Lost to Follow-up|1|||
146797636|NCT06037668|529432595|FG001|Overall Study|Lost to Follow-up|1|||
146797637|NCT06037668|529432594|FG000|Overall Study|Protocol Violation|1|||
146797638|NCT06037668|529432595|FG001|Overall Study|Protocol Violation|0|||
146797639|NCT06037668|529432594|FG000|Overall Study|Withdrawal by Subject|1|||
146797640|NCT06037668|529432595|FG001|Overall Study|Withdrawal by Subject|0|||
146797641|NCT06037668|529432594|FG000|Overall Study|Other Study Discontinuation Reason|1|||
146797642|NCT06037668|529432595|FG001|Overall Study|Other Study Discontinuation Reason|0|||
146797643|NCT05224544|529432596|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
146797644|NCT05224544|529432597|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
146797645|NCT01828021|529432598|FG000|Overall Study|Adverse Event|5|||
146797646|NCT01828021|529432598|FG000|Overall Study|Lack of Efficacy|17|||
146797647|NCT01828021|529432598|FG000|Overall Study|Withdrawal by Subject|2|||
146797648|NCT01828021|529432598|FG000|Overall Study|Ileal obstruction, unrelated|1|||
146797649|NCT04881461|529432599|FG000|Overall Study|Adverse Event|2|||
146797650|NCT04881461|529432600|FG001|Overall Study|Adverse Event|4|||
146797651|NCT04881461|529432599|FG000|Overall Study|Withdrawal by Subject|19|||
146797652|NCT04881461|529432600|FG001|Overall Study|Withdrawal by Subject|19|||
146797653|NCT04881461|529432599|FG000|Overall Study|Lost to Follow-up|4|||
146797654|NCT04881461|529432600|FG001|Overall Study|Lost to Follow-up|4|||
146797655|NCT04881461|529432599|FG000|Overall Study|Lack of Efficacy|1|||
146797656|NCT04881461|529432600|FG001|Overall Study|Lack of Efficacy|0|||
146797657|NCT04881461|529432599|FG000|Overall Study|"Reason stated as other in CRF"|1|||
146797658|NCT04881461|529432600|FG001|Overall Study|"Reason stated as other in CRF"|2|||
146797659|NCT03681262|529432607|FG000|Overall Study|Continuing on study|3|||
146797660|NCT03681262|529432608|FG001|Overall Study|Continuing on study|3|||
146797661|NCT03681262|529432607|FG000|Overall Study|Lost to Follow-up|1|||
146797662|NCT03681262|529432608|FG001|Overall Study|Lost to Follow-up|0|||
146797663|NCT04163991|529432622|FG000|Overall Study|Adverse Event|0|||
146797664|NCT04163991|529432623|FG001|Overall Study|Adverse Event|0|||
146797665|NCT04163991|529432624|FG002|Overall Study|Adverse Event|0|||
146797666|NCT04163991|529432625|FG003|Overall Study|Adverse Event|1|||
146797667|NCT04163991|529432626|FG004|Overall Study|Adverse Event|0|||
146797668|NCT04163991|529432622|FG000|Overall Study|Death|0|||
146797669|NCT04163991|529432623|FG001|Overall Study|Death|0|||
146797670|NCT04163991|529432624|FG002|Overall Study|Death|1|||
146797671|NCT04163991|529432625|FG003|Overall Study|Death|0|||
146797672|NCT04163991|529432626|FG004|Overall Study|Death|0|||
146797673|NCT04163991|529432622|FG000|Overall Study|Lost to Follow-up|0|||
146797674|NCT04163991|529432623|FG001|Overall Study|Lost to Follow-up|1|||
146797675|NCT04163991|529432624|FG002|Overall Study|Lost to Follow-up|0|||
146797676|NCT04163991|529432625|FG003|Overall Study|Lost to Follow-up|0|||
146797677|NCT04163991|529432626|FG004|Overall Study|Lost to Follow-up|0|||
146797678|NCT04163991|529432622|FG000|Overall Study|Withdrawal by Subject|1|||
146797679|NCT04163991|529432623|FG001|Overall Study|Withdrawal by Subject|1|||
146797680|NCT04163991|529432624|FG002|Overall Study|Withdrawal by Subject|3|||
146797681|NCT04163991|529432625|FG003|Overall Study|Withdrawal by Subject|1|||
146797682|NCT04163991|529432626|FG004|Overall Study|Withdrawal by Subject|1|||
146797683|NCT04163991|529432622|FG000|Overall Study|Other, Not Specified|0|||
146797684|NCT04163991|529432623|FG001|Overall Study|Other, Not Specified|1|||
146797685|NCT04163991|529432624|FG002|Overall Study|Other, Not Specified|1|||
146797686|NCT04163991|529432625|FG003|Overall Study|Other, Not Specified|1|||
146797687|NCT04163991|529432626|FG004|Overall Study|Other, Not Specified|0|||
146797688|NCT03372057|529432627|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
146797689|NCT03372057|529432628|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
146797690|NCT03372057|529432629|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
146797691|NCT03372057|529432627|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
146797692|NCT03372057|529432628|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
146797693|NCT03372057|529432629|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
146797694|NCT03372057|529432627|FG000|Dose Optimization Phase|Death|16|||
146797695|NCT03372057|529432628|FG001|Dose Optimization Phase|Death|11|||
146797696|NCT03372057|529432629|FG002|Dose Optimization Phase|Death|0|||
146797697|NCT03372057|529432627|FG000|Expansion Phase|Withdrawal by Subject|0|||
146797698|NCT03372057|529432628|FG001|Expansion Phase|Withdrawal by Subject|0|||
146797699|NCT03372057|529432629|FG002|Expansion Phase|Withdrawal by Subject|4|||
146797700|NCT03372057|529432627|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
146797701|NCT03372057|529432628|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
146797702|NCT03372057|529432629|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
146797703|NCT03372057|529432627|FG000|Expansion Phase|Death|0|||
146797704|NCT03372057|529432628|FG001|Expansion Phase|Death|0|||
146797705|NCT03372057|529432629|FG002|Expansion Phase|Death|78|||
146797706|NCT03372057|529432627|FG000|Expansion Phase|Progressive Disease|0|||
146797707|NCT03372057|529432628|FG001|Expansion Phase|Progressive Disease|0|||
146797708|NCT03372057|529432629|FG002|Expansion Phase|Progressive Disease|1|||
146797709|NCT03372057|529432627|FG000|Expansion Phase|Adverse Event|0|||
146797710|NCT03372057|529432628|FG001|Expansion Phase|Adverse Event|0|||
146797711|NCT03372057|529432629|FG002|Expansion Phase|Adverse Event|1|||
146797712|NCT03880955|529432630|FG000|Overall Study|Adverse Event|1|||
146797713|NCT03880955|529432630|FG000|Overall Study|Death|1|||
146797714|NCT03880955|529432630|FG000|Overall Study|Lost to Follow-up|12|||
146797715|NCT03880955|529432630|FG000|Overall Study|Withdrawal by Subject|4|||
146797716|NCT03880955|529432630|FG000|Overall Study|Missing- Study Site Closed|27|||
146797717|NCT00450216|529432631|FG000|Overall Study|Adverse Event|38|||
146797718|NCT00450216|529432632|FG001|Overall Study|Adverse Event|23|||
146797719|NCT00450216|529432631|FG000|Overall Study|Withdrawal by Subject|48|||
146797720|NCT00450216|529432632|FG001|Overall Study|Withdrawal by Subject|26|||
146797721|NCT00450216|529432631|FG000|Overall Study|Lost to Follow-up|16|||
146797722|NCT00450216|529432632|FG001|Overall Study|Lost to Follow-up|9|||
146797723|NCT00450216|529432631|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
146797724|NCT00450216|529432632|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
146797725|NCT00450216|529432631|FG000|Overall Study|misc|21|||
146797726|NCT00450216|529432632|FG001|Overall Study|misc|20|||
146797727|NCT05112900|529432636|FG000|Overall Study|Withdrawal by Subject|960|||
146797728|NCT05112900|529432637|FG001|Overall Study|Withdrawal by Subject|921|||
146797729|NCT05112900|529432638|FG002|Overall Study|Withdrawal by Subject|968|||
146797730|NCT00319111|529432639|FG000|Overall Study|Adverse Event|20|||
146797731|NCT00319111|529432639|FG000|Overall Study|Withdrawal of consent|11|||
146797732|NCT00319111|529432639|FG000|Overall Study|Death|9|||
146797733|NCT00319111|529432639|FG000|Overall Study|Lack of clinical improvement|4|||
146797734|NCT00319111|529432639|FG000|Overall Study|Administrative|2|||
146797735|NCT00319111|529432639|FG000|Overall Study|Treatment failure|1|||
146797736|NCT02919917|529432642|FG000|Overall Study|Withdrawal by Subject|4|||
146797737|NCT02919917|529432643|FG001|Overall Study|Withdrawal by Subject|8|||
146797738|NCT04743973|529432645|FG000|Overall Study|Withdrawal by Subject|5|||
146797739|NCT04330040|529432646|FG000|Overall Study|Other: Adverse event|5|||
146797740|NCT04330040|529432647|FG001|Overall Study|Other: Adverse event|0|||
146797741|NCT04330040|529432648|FG002|Overall Study|Other: Adverse event|0|||
146797742|NCT04330040|529432646|FG000|Overall Study|Disease progression|38|||
146797743|NCT04330040|529432647|FG001|Overall Study|Disease progression|10|||
146797744|NCT04330040|529432648|FG002|Overall Study|Disease progression|0|||
146797745|NCT04330040|529432646|FG000|Overall Study|Physician Decision|5|||
146797746|NCT04330040|529432647|FG001|Overall Study|Physician Decision|3|||
146797747|NCT04330040|529432648|FG002|Overall Study|Physician Decision|0|||
146797748|NCT04330040|529432646|FG000|Overall Study|Lost to Follow-up|1|||
146797749|NCT04330040|529432647|FG001|Overall Study|Lost to Follow-up|1|||
146797750|NCT04330040|529432648|FG002|Overall Study|Lost to Follow-up|0|||
146797751|NCT04330040|529432646|FG000|Overall Study|Death|2|||
146983177|NCT01965652|530099926|FG001|Overall Study|Adverse Event|37|||
146797752|NCT04330040|529432647|FG001|Overall Study|Death|1|||
146797753|NCT04330040|529432648|FG002|Overall Study|Death|0|||
146797754|NCT04330040|529432646|FG000|Overall Study|Withdrawal by Subject|3|||
146797755|NCT04330040|529432647|FG001|Overall Study|Withdrawal by Subject|3|||
146797756|NCT04330040|529432648|FG002|Overall Study|Withdrawal by Subject|0|||
146797757|NCT04330040|529432646|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
146797758|NCT04330040|529432647|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
146797759|NCT04330040|529432648|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
146797760|NCT04330040|529432646|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
146797761|NCT04330040|529432647|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
146797762|NCT04330040|529432648|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
146797763|NCT04330040|529432646|FG000|Overall Study|Other: Disease progression|1|||
146797764|NCT04330040|529432647|FG001|Overall Study|Other: Disease progression|0|||
146797765|NCT04330040|529432648|FG002|Overall Study|Other: Disease progression|0|||
146797766|NCT04330040|529432646|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
146797767|NCT04330040|529432647|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
146797768|NCT04330040|529432648|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
146797769|NCT04330040|529432646|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
146797770|NCT04330040|529432647|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
146797771|NCT04330040|529432648|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
146797772|NCT04330040|529432646|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
146797773|NCT04330040|529432647|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
146797774|NCT04330040|529432648|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
146797775|NCT02461134|529432650|FG000|Overall Study|Adverse Event|1|||
146797776|NCT04499521|529432653|FG000|Overall Study|Disease Progression|1|||
146797777|NCT04499521|529432654|FG001|Overall Study|Disease Progression|0|||
146797778|NCT03734029|529432655|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
146797779|NCT03734029|529432656|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
146797780|NCT03734029|529432655|FG000|Overall Study|Adverse Event|60|||
146797781|NCT03734029|529432656|FG001|Overall Study|Adverse Event|14|||
146797782|NCT03734029|529432655|FG000|Overall Study|Withdrawal by Subject|12|||
146797783|NCT03734029|529432656|FG001|Overall Study|Withdrawal by Subject|11|||
146797784|NCT03734029|529432655|FG000|Overall Study|Clinical progression by investigator|10|||
146797785|NCT03734029|529432656|FG001|Overall Study|Clinical progression by investigator|8|||
146797786|NCT03734029|529432655|FG000|Overall Study|Death|5|||
146797787|NCT03734029|529432656|FG001|Overall Study|Death|2|||
146797788|NCT03734029|529432655|FG000|Overall Study|Physician Decision|4|||
146797789|NCT03734029|529432656|FG001|Overall Study|Physician Decision|3|||
146797790|NCT03734029|529432655|FG000|Overall Study|Other|2|||
146797791|NCT03734029|529432656|FG001|Overall Study|Other|0|||
146797792|NCT03734029|529432655|FG000|Overall Study|Lost to Follow-up|0|||
146797793|NCT03734029|529432656|FG001|Overall Study|Lost to Follow-up|1|||
146797794|NCT03734029|529432655|FG000|Overall Study|Randomized, but not treated|2|||
146797795|NCT03734029|529432656|FG001|Overall Study|Randomized, but not treated|12|||
146797796|NCT04427007|529433442|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
146797797|NCT04427007|529433443|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
146797798|NCT04165213|529433454|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
146797799|NCT04165213|529433455|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
146797800|NCT04165213|529433454|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
146797801|NCT04165213|529433455|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
146797802|NCT04165213|529433454|FG000|Clinician Enrollment|Termination from site|0|||
146797803|NCT04165213|529433455|FG001|Clinician Enrollment|Termination from site|1|||
146797804|NCT04165213|529433454|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
146797805|NCT04165213|529433455|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
146797806|NCT04165213|529433454|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
146797807|NCT04165213|529433455|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
146797808|NCT04165213|529433454|FG000|Caregiver Enrollment|Physician Decision|1|||
146797809|NCT04165213|529433455|FG001|Caregiver Enrollment|Physician Decision|0|||
146797810|NCT04165213|529433454|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
146797811|NCT04165213|529433455|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
146797812|NCT04165213|529433454|FG000|Caregiver Enrollment|PLWD death|2|||
146797813|NCT04165213|529433455|FG001|Caregiver Enrollment|PLWD death|0|||
146797814|NCT04165213|529433454|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
146797815|NCT04165213|529433455|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
146797816|NCT04165213|529433454|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
146797817|NCT04165213|529433455|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
146797818|NCT04165213|529433454|FG000|PLWD Enrollment|Lost to Follow-up|1|||
146797819|NCT04165213|529433455|FG001|PLWD Enrollment|Lost to Follow-up|1|||
146797820|NCT04165213|529433454|FG000|PLWD Enrollment|Physician Decision|1|||
146797821|NCT04165213|529433455|FG001|PLWD Enrollment|Physician Decision|0|||
146797822|NCT04165213|529433454|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
146797823|NCT04165213|529433455|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
146797824|NCT04165213|529433454|FG000|PLWD Enrollment|Death|2|||
146797825|NCT04165213|529433455|FG001|PLWD Enrollment|Death|0|||
146797826|NCT04165213|529433454|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
146797827|NCT04165213|529433455|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
146797828|NCT04464564|529433456|FG000|Period A (Placebo lead-in)|Other|5|||
146797829|NCT04464564|529433457|FG001|Period A (Placebo lead-in)|Other|0|||
146797830|NCT04464564|529433458|FG002|Period A (Placebo lead-in)|Other|0|||
146983178|NCT01965652|530099925|FG000|Overall Study|Withdrawal by Subject|62|||
146983179|NCT01965652|530099926|FG001|Overall Study|Withdrawal by Subject|69|||
146983180|NCT01965652|530099925|FG000|Overall Study|Lost to Follow-up|53|||
146983181|NCT01965652|530099926|FG001|Overall Study|Lost to Follow-up|40|||
146983182|NCT01965652|530099925|FG000|Overall Study|Protocol Violation|34|||
146983183|NCT01965652|530099926|FG001|Overall Study|Protocol Violation|38|||
146983184|NCT01965652|530099925|FG000|Overall Study|Death|3|||
146983185|NCT01965652|530099926|FG001|Overall Study|Death|4|||
146983186|NCT01965652|530099925|FG000|Overall Study|Other - Miscellaneous|18|||
146983187|NCT01965652|530099926|FG001|Overall Study|Other - Miscellaneous|21|||
146983188|NCT01965652|530099925|FG000|Overall Study|Pregnancy|0|||
146983189|NCT01965652|530099926|FG001|Overall Study|Pregnancy|1|||
146983190|NCT01121900|530099929|FG000|First Intervention Period|Adverse Event|1|||
146983191|NCT01121900|530099930|FG001|First Intervention Period|Adverse Event|1|||
146940309|NCT00651313|529939246|FG001|Overall Study|Lost to Follow-up|1|||
146940310|NCT00651313|529939245|FG000|Overall Study|Adminstrative Discontinuation|2|||
146940311|NCT00651313|529939246|FG001|Overall Study|Adminstrative Discontinuation|3|||
146940312|NCT00676208|529939248|FG000|Overall Study|Lost to Follow-up|0|||
146940313|NCT00676208|529939249|FG001|Overall Study|Lost to Follow-up|2|||
146940314|NCT00676208|529939248|FG000|Overall Study|Incomplete data|2|||
146940315|NCT00676208|529939249|FG001|Overall Study|Incomplete data|4|||
146940316|NCT00669032|529939250|FG000|Overall Study|Lost to Follow-up|6|||
146940317|NCT00669032|529939251|FG001|Overall Study|Lost to Follow-up|5|||
146940318|NCT00669032|529939250|FG000|Overall Study|Lack of Efficacy|8|||
146940319|NCT00669032|529939251|FG001|Overall Study|Lack of Efficacy|19|||
146983192|NCT01121900|530099929|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
146983193|NCT01121900|530099930|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
146983194|NCT03469271|530099931|FG000|Overall Study|Withdrawal by Subject|2|||
146983195|NCT03469271|530099932|FG001|Overall Study|Withdrawal by Subject|0|||
146983196|NCT03469271|530099933|FG002|Overall Study|Withdrawal by Subject|0|||
146983197|NCT03469271|530099934|FG003|Overall Study|Withdrawal by Subject|1|||
146983198|NCT01328054|530099937|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
146983199|NCT01328054|530099938|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
146983200|NCT01328054|530099937|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
146983201|NCT01328054|530099938|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
146983202|NCT01328054|530099937|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
146983203|NCT01328054|530099938|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
146940320|NCT00669032|529939250|FG000|Overall Study|Withdrawal by Subject|12|||
146940321|NCT00669032|529939251|FG001|Overall Study|Withdrawal by Subject|13|||
146940322|NCT00669032|529939250|FG000|Overall Study|Adverse Event|12|||
146940323|NCT00669032|529939251|FG001|Overall Study|Adverse Event|16|||
146940324|NCT00669032|529939250|FG000|Overall Study|Physician Decision|1|||
146940325|NCT00669032|529939251|FG001|Overall Study|Physician Decision|1|||
146940326|NCT00669032|529939250|FG000|Overall Study|No fulfilment of the selection criteria|5|||
146940327|NCT00669032|529939251|FG001|Overall Study|No fulfilment of the selection criteria|5|||
146940328|NCT01607073|529939252|FG000|Overall Study|Adverse Event|1|||
146940329|NCT00642018|529939253|FG000|Overall Study|Adverse Event|11|||
146940330|NCT00642018|529939254|FG001|Overall Study|Adverse Event|36|||
146940331|NCT00642018|529939253|FG000|Overall Study|Withdrawal by Subject|4|||
146940332|NCT00642018|529939254|FG001|Overall Study|Withdrawal by Subject|10|||
146940333|NCT00642018|529939253|FG000|Overall Study|Progressive Disease|13|||
146940334|NCT00642018|529939254|FG001|Overall Study|Progressive Disease|18|||
146940335|NCT00642018|529939253|FG000|Overall Study|Physician Decision|0|||
146983204|NCT03760510|530099939|FG000|Overall Study|Not ventilated for 24 hours|105|||
146797831|NCT04464564|529433459|FG003|Period A (Placebo lead-in)|Other|0|||
146797832|NCT04464564|529433456|FG000|Period B (Randomization Period)|Adverse Event|0|||
146797833|NCT04464564|529433457|FG001|Period B (Randomization Period)|Adverse Event|1|||
146797834|NCT04464564|529433458|FG002|Period B (Randomization Period)|Adverse Event|2|||
146797835|NCT04464564|529433459|FG003|Period B (Randomization Period)|Adverse Event|8|||
146797836|NCT04464564|529433456|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
146797837|NCT04464564|529433457|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
146797838|NCT04464564|529433458|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
146797839|NCT04464564|529433459|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
146797840|NCT04464564|529433456|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
146797841|NCT04464564|529433457|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
146797842|NCT04464564|529433458|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
146940336|NCT00642018|529939254|FG001|Overall Study|Physician Decision|10|||
146940337|NCT00642018|529939253|FG000|Overall Study|Protocol Violation|0|||
146940338|NCT00642018|529939254|FG001|Overall Study|Protocol Violation|1|||
146940339|NCT00642018|529939253|FG000|Overall Study|Death|0|||
146983205|NCT03760510|530099940|FG001|Overall Study|Not ventilated for 24 hours|97|||
146983206|NCT00871728|530099941|FG000|Overall Study|Adverse Event|1|||
146940340|NCT00642018|529939254|FG001|Overall Study|Death|3|||
146940341|NCT00642018|529939253|FG000|Overall Study|Entry Criteria Not Met|0|||
146940342|NCT00642018|529939254|FG001|Overall Study|Entry Criteria Not Met|1|||
146940343|NCT04126031|529939255|FG000|Part A|Withdrawal by Subject|0|||
146797843|NCT04464564|529433459|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
146797844|NCT04464564|529433456|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
146797845|NCT04464564|529433457|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
146797846|NCT04464564|529433458|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
146797847|NCT04464564|529433459|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
146797848|NCT04464564|529433456|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
146797849|NCT04464564|529433457|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
146797850|NCT04464564|529433458|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
146797851|NCT04464564|529433459|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
146797852|NCT04464564|529433456|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
146797853|NCT04464564|529433457|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
146797854|NCT04464564|529433458|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
146797855|NCT04464564|529433459|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
146797856|NCT04464564|529433456|FG000|Period B (Randomization Period)|Reason not Specified|0|||
146797857|NCT04464564|529433457|FG001|Period B (Randomization Period)|Reason not Specified|3|||
146797858|NCT04464564|529433458|FG002|Period B (Randomization Period)|Reason not Specified|3|||
146797859|NCT04464564|529433459|FG003|Period B (Randomization Period)|Reason not Specified|3|||
146797860|NCT04282980|529433462|FG000|Overall Study|Remained on treatment|6|||
146797861|NCT04282980|529433462|FG000|Overall Study|Survival follow-up|11|||
146797862|NCT04282980|529433462|FG000|Overall Study|Withdrawal of informed consent|1|||
146797863|NCT04282980|529433462|FG000|Overall Study|Lost to Follow-up|1|||
146797864|NCT05007080|529433463|FG000|Overall Study|Lost to Follow-up|0|||
146797865|NCT05007080|529433464|FG001|Overall Study|Lost to Follow-up|1|||
146797866|NCT05007080|529433465|FG002|Overall Study|Lost to Follow-up|0|||
146797867|NCT05007080|529433466|FG003|Overall Study|Lost to Follow-up|1|||
146797868|NCT05007080|529433467|FG004|Overall Study|Lost to Follow-up|1|||
146797869|NCT05007080|529433468|FG005|Overall Study|Lost to Follow-up|1|||
146797870|NCT05007080|529433463|FG000|Overall Study|Death|0|||
146797871|NCT05007080|529433464|FG001|Overall Study|Death|1|||
146797872|NCT05007080|529433465|FG002|Overall Study|Death|0|||
146797873|NCT05007080|529433466|FG003|Overall Study|Death|0|||
146797874|NCT05007080|529433467|FG004|Overall Study|Death|0|||
146797875|NCT05007080|529433468|FG005|Overall Study|Death|0|||
146797876|NCT05007080|529433463|FG000|Overall Study|Withdrawal by Subject|1|||
146797877|NCT05007080|529433464|FG001|Overall Study|Withdrawal by Subject|2|||
146797878|NCT05007080|529433465|FG002|Overall Study|Withdrawal by Subject|0|||
146797879|NCT05007080|529433466|FG003|Overall Study|Withdrawal by Subject|2|||
146797880|NCT05007080|529433467|FG004|Overall Study|Withdrawal by Subject|1|||
146797881|NCT05007080|529433468|FG005|Overall Study|Withdrawal by Subject|1|||
146797882|NCT05007080|529433463|FG000|Overall Study|Other|1|||
146797883|NCT05007080|529433464|FG001|Overall Study|Other|0|||
146797884|NCT05007080|529433465|FG002|Overall Study|Other|1|||
146797885|NCT05007080|529433466|FG003|Overall Study|Other|1|||
146797886|NCT05007080|529433467|FG004|Overall Study|Other|0|||
146797887|NCT05007080|529433468|FG005|Overall Study|Other|2|||
146797888|NCT05007080|529433463|FG000|Overall Study|Randomized not vaccinated|0|||
146797889|NCT05007080|529433464|FG001|Overall Study|Randomized not vaccinated|0|||
146797890|NCT05007080|529433465|FG002|Overall Study|Randomized not vaccinated|0|||
146797891|NCT05007080|529433466|FG003|Overall Study|Randomized not vaccinated|0|||
146797892|NCT05007080|529433467|FG004|Overall Study|Randomized not vaccinated|0|||
146797893|NCT05007080|529433468|FG005|Overall Study|Randomized not vaccinated|1|||
146797894|NCT04173247|529433472|FG000|Overall Study|Withdrawal by Subject|0|||
146797895|NCT04173247|529433473|FG001|Overall Study|Withdrawal by Subject|2|||
146797896|NCT04173247|529433472|FG000|Overall Study|Death|1|||
146797897|NCT04173247|529433473|FG001|Overall Study|Death|0|||
146797898|NCT04173247|529433472|FG000|Overall Study|Physician Decision|1|||
146797899|NCT04173247|529433473|FG001|Overall Study|Physician Decision|0|||
146940344|NCT04126031|529939256|FG001|Part A|Withdrawal by Subject|0|||
146940345|NCT04126031|529939257|FG002|Part A|Withdrawal by Subject|1|||
146940346|NCT04126031|529939258|FG003|Part A|Withdrawal by Subject|0|||
146940347|NCT04126031|529939259|FG004|Part A|Withdrawal by Subject|0|||
146940348|NCT04126031|529939260|FG005|Part A|Withdrawal by Subject|0|||
146940349|NCT04126031|529939255|FG000|Part A|Other|1|||
146940350|NCT04126031|529939256|FG001|Part A|Other|0|||
146797900|NCT03370913|529433474|FG000|Overall Study|Death|1|||
146797901|NCT03370913|529433474|FG000|Overall Study|Lost to Follow-up|1|||
146797902|NCT04631016|529433477|FG000|Overall Study|Adverse Event|3|||
146797903|NCT04631016|529433478|FG001|Overall Study|Adverse Event|0|||
146940351|NCT04126031|529939257|FG002|Part A|Other|0|||
146940352|NCT04126031|529939258|FG003|Part A|Other|0|||
146983207|NCT00871728|530099941|FG000|Overall Study|Protocol Violation|7|||
146797904|NCT04631016|529433477|FG000|Overall Study|Withdrawal by Subject|5|||
146797905|NCT04631016|529433478|FG001|Overall Study|Withdrawal by Subject|4|||
146940353|NCT04126031|529939259|FG004|Part A|Other|0|||
146940354|NCT04126031|529939260|FG005|Part A|Other|0|||
146940355|NCT04126031|529939255|FG000|Part B|Adverse Event|0|||
146940356|NCT04126031|529939256|FG001|Part B|Adverse Event|0|||
146797906|NCT04631016|529433477|FG000|Overall Study|Reason unspecified|1|||
146797907|NCT04631016|529433478|FG001|Overall Study|Reason unspecified|0|||
146797908|NCT04631016|529433477|FG000|Overall Study|Failure to meet randomization criteria|2|||
146797909|NCT04631016|529433478|FG001|Overall Study|Failure to meet randomization criteria|1|||
146797910|NCT04967599|529433479|FG000|Overall Study|Lost to Follow-up|35|||
146797911|NCT04967599|529433480|FG001|Overall Study|Lost to Follow-up|19|||
146797912|NCT04967599|529433481|FG002|Overall Study|Lost to Follow-up|23|||
146797913|NCT04490109|529433482|FG000|Overall Study|Lost to Follow-up|3|||
146797914|NCT04490109|529433483|FG001|Overall Study|Lost to Follow-up|10|||
146797915|NCT04490109|529433484|FG002|Overall Study|Lost to Follow-up|4|||
146797916|NCT04490109|529433482|FG000|Overall Study|Withdrawal by Subject|8|||
146797917|NCT04490109|529433483|FG001|Overall Study|Withdrawal by Subject|6|||
146797918|NCT04490109|529433484|FG002|Overall Study|Withdrawal by Subject|9|||
146797919|NCT04490109|529433482|FG000|Overall Study|Physician Decision|0|||
146797920|NCT04490109|529433483|FG001|Overall Study|Physician Decision|2|||
146797921|NCT04490109|529433484|FG002|Overall Study|Physician Decision|3|||
146797922|NCT04490109|529433482|FG000|Overall Study|Adverse Event|2|||
146797923|NCT04490109|529433483|FG001|Overall Study|Adverse Event|1|||
146797924|NCT04490109|529433484|FG002|Overall Study|Adverse Event|0|||
146797925|NCT04490109|529433482|FG000|Overall Study|Significant Non-Compliance|2|||
146797926|NCT04490109|529433483|FG001|Overall Study|Significant Non-Compliance|4|||
146797927|NCT04490109|529433484|FG002|Overall Study|Significant Non-Compliance|4|||
146797928|NCT04490109|529433482|FG000|Overall Study|Significant Clinical Event|0|||
146797929|NCT04490109|529433483|FG001|Overall Study|Significant Clinical Event|1|||
146797930|NCT04490109|529433484|FG002|Overall Study|Significant Clinical Event|0|||
146797931|NCT04490109|529433482|FG000|Overall Study|Other Reason|4|||
146797932|NCT04490109|529433483|FG001|Overall Study|Other Reason|1|||
146797933|NCT04490109|529433484|FG002|Overall Study|Other Reason|1|||
146797934|NCT03817983|529433485|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
146797935|NCT03817983|529433486|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
146797936|NCT03817983|529433487|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
146797937|NCT03744676|529433488|FG000|Pre-Treatment Phase|Disease related complications|2|||
146797938|NCT03744676|529433488|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
146797939|NCT03744676|529433488|FG000|Pre-Treatment Phase|Death|7|||
146797940|NCT03744676|529433488|FG000|Pre-Treatment Phase|Other Reasons|7|||
146797941|NCT03744676|529433488|FG000|Treatment Phase|Participant withdrew consent|8|||
146797942|NCT03744676|529433488|FG000|Treatment Phase|Death|33|||
146797943|NCT03744676|529433488|FG000|Treatment Phase|other reasons|6|||
146797944|NCT04078152|529433489|FG000|Overall Study|Other|83|||
146797945|NCT04078152|529433490|FG001|Overall Study|Other|22|||
146797946|NCT04078152|529433491|FG002|Overall Study|Other|25|||
146797947|NCT04078152|529433489|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
146797948|NCT04078152|529433490|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
146797949|NCT04078152|529433491|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
146797950|NCT04078152|529433489|FG000|Overall Study|Withdrawal by Subject|5|||
146797951|NCT04078152|529433490|FG001|Overall Study|Withdrawal by Subject|0|||
146797952|NCT04078152|529433491|FG002|Overall Study|Withdrawal by Subject|1|||
146797953|NCT04078152|529433489|FG000|Overall Study|Death|10|||
146797954|NCT04078152|529433490|FG001|Overall Study|Death|2|||
146797955|NCT04078152|529433491|FG002|Overall Study|Death|12|||
146797956|NCT04078152|529433489|FG000|Overall Study|Adverse Event|1|||
146797957|NCT04078152|529433490|FG001|Overall Study|Adverse Event|0|||
146797958|NCT04078152|529433491|FG002|Overall Study|Adverse Event|0|||
146797959|NCT02624050|529433497|FG000|Overall Study|Physician Decision|4|||
146797960|NCT02624050|529433498|FG001|Overall Study|Physician Decision|0|||
146797961|NCT02624050|529433497|FG000|Overall Study|Protocol Violation|2|||
146797962|NCT02624050|529433498|FG001|Overall Study|Protocol Violation|0|||
146797963|NCT03279978|529433500|FG000|Overall Study|Withdrawal by Subject|0|||
146797964|NCT03279978|529433501|FG001|Overall Study|Withdrawal by Subject|1|||
146797965|NCT03279978|529433502|FG002|Overall Study|Withdrawal by Subject|0|||
146797966|NCT03279978|529433503|FG003|Overall Study|Withdrawal by Subject|0|||
146797967|NCT03279978|529433504|FG004|Overall Study|Withdrawal by Subject|0|||
146797968|NCT03279978|529433505|FG005|Overall Study|Withdrawal by Subject|0|||
146797969|NCT03279978|529433506|FG006|Overall Study|Withdrawal by Subject|0|||
146797970|NCT03279978|529433507|FG007|Overall Study|Withdrawal by Subject|0|||
146797971|NCT03279978|529433508|FG008|Overall Study|Withdrawal by Subject|0|||
146797972|NCT03279978|529433509|FG009|Overall Study|Withdrawal by Subject|1|||
146797973|NCT03279978|529433500|FG000|Overall Study|Lost to Follow-up|1|||
146797974|NCT03279978|529433501|FG001|Overall Study|Lost to Follow-up|0|||
146797975|NCT03279978|529433502|FG002|Overall Study|Lost to Follow-up|1|||
146797976|NCT03279978|529433503|FG003|Overall Study|Lost to Follow-up|0|||
146797977|NCT03279978|529433504|FG004|Overall Study|Lost to Follow-up|0|||
146797978|NCT03279978|529433505|FG005|Overall Study|Lost to Follow-up|0|||
146797979|NCT03279978|529433506|FG006|Overall Study|Lost to Follow-up|0|||
146797980|NCT03279978|529433507|FG007|Overall Study|Lost to Follow-up|0|||
146797981|NCT03279978|529433508|FG008|Overall Study|Lost to Follow-up|0|||
146797982|NCT03279978|529433509|FG009|Overall Study|Lost to Follow-up|0|||
146797983|NCT03279978|529433500|FG000|Overall Study|Other than stated above|0|||
146797984|NCT03279978|529433501|FG001|Overall Study|Other than stated above|0|||
146797985|NCT03279978|529433502|FG002|Overall Study|Other than stated above|0|||
146797986|NCT03279978|529433503|FG003|Overall Study|Other than stated above|0|||
146797987|NCT03279978|529433504|FG004|Overall Study|Other than stated above|0|||
146797988|NCT03279978|529433505|FG005|Overall Study|Other than stated above|0|||
146797989|NCT03279978|529433506|FG006|Overall Study|Other than stated above|1|||
146797990|NCT03279978|529433507|FG007|Overall Study|Other than stated above|0|||
146797991|NCT03279978|529433508|FG008|Overall Study|Other than stated above|0|||
146797992|NCT03279978|529433509|FG009|Overall Study|Other than stated above|0|||
146797993|NCT03493542|529433510|FG000|Base Study|Withdrawal by Subject|0|||
146797994|NCT03493542|529433511|FG001|Base Study|Withdrawal by Subject|4|||
146797995|NCT03493542|529433512|FG002|Base Study|Withdrawal by Subject|0|||
146797996|NCT03493542|529433510|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
146797997|NCT03493542|529433511|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
146797998|NCT03493542|529433512|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
146797999|NCT03493542|529433510|FG000|Extension Study|Withdrawal by Subject|0|||
146798000|NCT03493542|529433511|FG001|Extension Study|Withdrawal by Subject|0|||
146798001|NCT03493542|529433512|FG002|Extension Study|Withdrawal by Subject|25|||
146798002|NCT01756300|529433518|FG000|Overall Study|Death|1|||
146798003|NCT01756300|529433518|FG000|Overall Study|Withdrawal by Subject|1|||
146798004|NCT04244175|529434226|FG000|Overall Study|Adverse Event|3|||
146798005|NCT04244175|529434227|FG001|Overall Study|Adverse Event|2|||
146798006|NCT04244175|529434228|FG002|Overall Study|Adverse Event|5|||
146798007|NCT04244175|529434226|FG000|Overall Study|Lack of Efficacy|1|||
146798008|NCT04244175|529434227|FG001|Overall Study|Lack of Efficacy|0|||
146798009|NCT04244175|529434228|FG002|Overall Study|Lack of Efficacy|1|||
146798010|NCT04244175|529434226|FG000|Overall Study|Lost to Follow-up|1|||
146798011|NCT04244175|529434227|FG001|Overall Study|Lost to Follow-up|0|||
146798012|NCT04244175|529434228|FG002|Overall Study|Lost to Follow-up|0|||
146798013|NCT04244175|529434226|FG000|Overall Study|Non-compliance with study drug|1|||
146798014|NCT04244175|529434227|FG001|Overall Study|Non-compliance with study drug|0|||
146798015|NCT04244175|529434228|FG002|Overall Study|Non-compliance with study drug|1|||
146798016|NCT04244175|529434226|FG000|Overall Study|Protocol deviation|0|||
146798017|NCT04244175|529434227|FG001|Overall Study|Protocol deviation|1|||
146798018|NCT04244175|529434228|FG002|Overall Study|Protocol deviation|0|||
146798019|NCT04244175|529434226|FG000|Overall Study|Withdrawal by Subject|1|||
146798020|NCT04244175|529434227|FG001|Overall Study|Withdrawal by Subject|3|||
146798021|NCT04244175|529434228|FG002|Overall Study|Withdrawal by Subject|1|||
146798022|NCT04244175|529434226|FG000|Overall Study|Other, not specified|0|||
146798023|NCT04244175|529434227|FG001|Overall Study|Other, not specified|1|||
146798024|NCT04244175|529434228|FG002|Overall Study|Other, not specified|2|||
146798025|NCT02095691|529434229|FG000|Overall Study|Physician Decision|1|||
146798026|NCT00887198|529434230|FG000|Randomized Period|Ongoing|42|||
146798027|NCT00887198|529434231|FG001|Randomized Period|Ongoing|0|||
146798028|NCT00887198|529434232|FG002|Randomized Period|Ongoing|0|||
146798029|NCT00887198|529434230|FG000|Randomized Period|Adverse Event|50|||
146798030|NCT00887198|529434231|FG001|Randomized Period|Adverse Event|33|||
146798031|NCT00887198|529434232|FG002|Randomized Period|Adverse Event|0|||
146798032|NCT00887198|529434230|FG000|Randomized Period|Lost to Follow-up|1|||
146798033|NCT00887198|529434231|FG001|Randomized Period|Lost to Follow-up|0|||
146798034|NCT00887198|529434232|FG002|Randomized Period|Lost to Follow-up|0|||
146798035|NCT00887198|529434230|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
146798036|NCT00887198|529434231|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
146798037|NCT00887198|529434232|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
146798038|NCT00887198|529434230|FG000|Randomized Period|Withdrawal by Subject|41|||
146798039|NCT00887198|529434231|FG001|Randomized Period|Withdrawal by Subject|56|||
146798040|NCT00887198|529434232|FG002|Randomized Period|Withdrawal by Subject|0|||
146798041|NCT00887198|529434230|FG000|Randomized Period|Progressive disease|366|||
146940357|NCT04126031|529939257|FG002|Part B|Adverse Event|0|||
146940358|NCT04126031|529939258|FG003|Part B|Adverse Event|0|||
146940359|NCT04126031|529939259|FG004|Part B|Adverse Event|0|||
146940360|NCT04126031|529939260|FG005|Part B|Adverse Event|2|||
146940361|NCT04126031|529939255|FG000|Part B|Pre-existing hypertransaminasemia|0|||
146940362|NCT04126031|529939256|FG001|Part B|Pre-existing hypertransaminasemia|0|||
146940363|NCT04126031|529939257|FG002|Part B|Pre-existing hypertransaminasemia|0|||
146940364|NCT04126031|529939258|FG003|Part B|Pre-existing hypertransaminasemia|0|||
146940365|NCT04126031|529939259|FG004|Part B|Pre-existing hypertransaminasemia|1|||
146940366|NCT04126031|529939260|FG005|Part B|Pre-existing hypertransaminasemia|0|||
146798042|NCT00887198|529434231|FG001|Randomized Period|Progressive disease|370|||
146798043|NCT00887198|529434232|FG002|Randomized Period|Progressive disease|0|||
146798044|NCT00887198|529434230|FG000|Randomized Period|Other|42|||
146798045|NCT00887198|529434231|FG001|Randomized Period|Other|30|||
146798046|NCT00887198|529434232|FG002|Randomized Period|Other|0|||
146798047|NCT00887198|529434230|FG000|Randomized Period|Randomized, Not treated|4|||
146798048|NCT00887198|529434231|FG001|Randomized Period|Randomized, Not treated|2|||
146798049|NCT00887198|529434232|FG002|Randomized Period|Randomized, Not treated|0|||
146940367|NCT01946412|529939261|FG000|Overall Study|Adverse Event|1|||
146798050|NCT00887198|529434230|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
146798051|NCT00887198|529434231|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
146798052|NCT00887198|529434232|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
146798053|NCT00887198|529434230|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
146798054|NCT00887198|529434231|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
146798055|NCT00887198|529434232|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
146798056|NCT00887198|529434230|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
146798057|NCT00887198|529434231|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
146798058|NCT00887198|529434232|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
146798059|NCT00887198|529434230|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
146798060|NCT00887198|529434231|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
146798061|NCT00887198|529434232|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
146798062|NCT00887198|529434230|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
146798063|NCT00887198|529434231|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
146798064|NCT00887198|529434232|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
146798065|NCT00887198|529434230|FG000|Cross Over (Placebo to AA)|Other|0|||
146798066|NCT00887198|529434231|FG001|Cross Over (Placebo to AA)|Other|0|||
146798067|NCT00887198|529434232|FG002|Cross Over (Placebo to AA)|Other|19|||
146798068|NCT05147584|529434233|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
146798069|NCT05830799|529434239|FG000|Overall Study|Withdrawal by Subject|1|||
146798070|NCT02163694|529434240|FG000|Overall Study|Adverse event- related to progression|4|||
146940368|NCT01946412|529939261|FG000|Overall Study|Non-Compliance|1|||
146940369|NCT01946412|529939261|FG000|Overall Study|Continued with commercial Kalydeco|2|||
146940370|NCT01946412|529939261|FG000|Overall Study|Difficulty in swallowing|1|||
146940371|NCT00617656|529939262|FG000|Overall Study|Inclusion error|4|||
146940372|NCT00617656|529939263|FG001|Overall Study|Inclusion error|4|||
146798071|NCT02163694|529434241|FG001|Overall Study|Adverse event- related to progression|10|||
146798072|NCT02163694|529434240|FG000|Overall Study|Adverse event- not related to progression|7|||
146798073|NCT02163694|529434241|FG001|Overall Study|Adverse event- not related to progression|22|||
146798074|NCT02163694|529434240|FG000|Overall Study|Withdrew consent|13|||
146798075|NCT02163694|529434241|FG001|Overall Study|Withdrew consent|28|||
146798076|NCT02163694|529434240|FG000|Overall Study|Lost to Follow-up|2|||
146798077|NCT02163694|529434241|FG001|Overall Study|Lost to Follow-up|2|||
146798078|NCT02163694|529434240|FG000|Overall Study|Sponsor discontinued study|3|||
146798079|NCT02163694|529434241|FG001|Overall Study|Sponsor discontinued study|29|||
146798080|NCT02163694|529434240|FG000|Overall Study|Progressive disease per protocol|125|||
146798081|NCT02163694|529434241|FG001|Overall Study|Progressive disease per protocol|224|||
146798082|NCT02163694|529434240|FG000|Overall Study|Other, not specified|17|||
146798083|NCT02163694|529434241|FG001|Overall Study|Other, not specified|22|||
146798084|NCT02163694|529434240|FG000|Overall Study|Randomized but Not Treated|1|||
146798085|NCT02163694|529434241|FG001|Overall Study|Randomized but Not Treated|0|||
146798086|NCT02163694|529434240|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
146798087|NCT02163694|529434241|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
146798088|NCT03884101|529434242|FG000|Overall Study|Participant Ongoing in Study|202|||
146798089|NCT03884101|529434243|FG001|Overall Study|Participant Ongoing in Study|186|||
146798090|NCT03884101|529434242|FG000|Overall Study|Death|212|||
146798091|NCT03884101|529434243|FG001|Overall Study|Death|224|||
146798092|NCT03884101|529434242|FG000|Overall Study|Lost to Follow-up|0|||
146798093|NCT03884101|529434243|FG001|Overall Study|Lost to Follow-up|1|||
146798094|NCT03884101|529434242|FG000|Overall Study|Withdrawal by Subject|6|||
146798095|NCT03884101|529434243|FG001|Overall Study|Withdrawal by Subject|11|||
146798096|NCT04369911|529434246|FG000|Overall Study|Lost to Follow-up|3|||
146798097|NCT04369911|529434247|FG001|Overall Study|Lost to Follow-up|3|||
146798098|NCT04369911|529434246|FG000|Overall Study|Withdrawal by Subject|1|||
146798099|NCT04369911|529434247|FG001|Overall Study|Withdrawal by Subject|2|||
146798100|NCT05454514|529434250|FG000|Overall Study|Withdrawal by Subject|4|||
146798101|NCT05541484|529434253|FG000|Overall Study|Withdrawal by Subject|1|||
146798102|NCT05541484|529434254|FG001|Overall Study|Withdrawal by Subject|0|||
146798103|NCT05785130|529434257|FG000|Overall Study|Withdrawal by Subject|1|||
146798104|NCT05785130|529434258|FG001|Overall Study|Withdrawal by Subject|0|||
146798105|NCT05785130|529434257|FG000|Overall Study|Lack of Efficacy|0|||
146798106|NCT05785130|529434258|FG001|Overall Study|Lack of Efficacy|1|||
146798107|NCT04157517|529434259|FG000|Overall Study|Death|1|||
146798108|NCT04157517|529434260|FG001|Overall Study|Death|2|||
146798109|NCT04157517|529434261|FG002|Overall Study|Death|2|||
146798110|NCT04157517|529434262|FG003|Overall Study|Death|3|||
146798111|NCT04157517|529434263|FG004|Overall Study|Death|3|||
146798112|NCT04157517|529434264|FG005|Overall Study|Death|4|||
146798113|NCT04157517|529434265|FG006|Overall Study|Death|1|||
146798114|NCT04157517|529434266|FG007|Overall Study|Death|2|||
146798115|NCT04157517|529434267|FG008|Overall Study|Death|4|||
146798116|NCT04157517|529434268|FG009|Overall Study|Death|0|||
146798117|NCT04157517|529434259|FG000|Overall Study|Withdrawal by Subject|1|||
146798118|NCT04157517|529434260|FG001|Overall Study|Withdrawal by Subject|1|||
146798119|NCT04157517|529434261|FG002|Overall Study|Withdrawal by Subject|1|||
146798120|NCT04157517|529434262|FG003|Overall Study|Withdrawal by Subject|0|||
146798121|NCT04157517|529434263|FG004|Overall Study|Withdrawal by Subject|0|||
146798122|NCT04157517|529434264|FG005|Overall Study|Withdrawal by Subject|1|||
146798123|NCT04157517|529434265|FG006|Overall Study|Withdrawal by Subject|0|||
146798124|NCT04157517|529434266|FG007|Overall Study|Withdrawal by Subject|0|||
146798125|NCT04157517|529434267|FG008|Overall Study|Withdrawal by Subject|1|||
146798126|NCT04157517|529434268|FG009|Overall Study|Withdrawal by Subject|0|||
146798127|NCT04157517|529434259|FG000|Overall Study|Other|1|||
146798128|NCT04157517|529434260|FG001|Overall Study|Other|0|||
146798129|NCT04157517|529434261|FG002|Overall Study|Other|0|||
146798130|NCT04157517|529434262|FG003|Overall Study|Other|0|||
146798131|NCT04157517|529434263|FG004|Overall Study|Other|0|||
146798132|NCT04157517|529434264|FG005|Overall Study|Other|1|||
146798133|NCT04157517|529434265|FG006|Overall Study|Other|2|||
146798134|NCT04157517|529434266|FG007|Overall Study|Other|7|||
146798135|NCT04157517|529434267|FG008|Overall Study|Other|7|||
146798136|NCT04157517|529434268|FG009|Overall Study|Other|0|||
146798137|NCT04159519|529434273|FG000|Overall Study|Adverse Event|1|||
146798138|NCT04159519|529434274|FG001|Overall Study|Adverse Event|1|||
146798139|NCT04159519|529434273|FG000|Overall Study|Lack of Efficacy|1|||
146798140|NCT04159519|529434274|FG001|Overall Study|Lack of Efficacy|0|||
146798141|NCT04159519|529434273|FG000|Overall Study|Discontinued from study|1|||
146798142|NCT04159519|529434274|FG001|Overall Study|Discontinued from study|0|||
146798143|NCT04159519|529434273|FG000|Overall Study|Protocol Violation|1|||
146798144|NCT04159519|529434274|FG001|Overall Study|Protocol Violation|1|||
146798145|NCT04159519|529434273|FG000|Overall Study|Withdrawal by Subject|4|||
146798146|NCT04159519|529434274|FG001|Overall Study|Withdrawal by Subject|4|||
146798147|NCT04780581|529434275|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
146798148|NCT04780581|529434276|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
146798149|NCT04780581|529434275|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
146798150|NCT04780581|529434276|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
146798151|NCT01651000|529434277|FG000|Overall Study|Adverse Event|2|||
146798152|NCT01651000|529434278|FG001|Overall Study|Adverse Event|8|||
146798153|NCT01651000|529434277|FG000|Overall Study|Lost to Follow-up|3|||
146798154|NCT01651000|529434278|FG001|Overall Study|Lost to Follow-up|2|||
146798155|NCT01651000|529434277|FG000|Overall Study|Protocol Violation|0|||
146798156|NCT01651000|529434278|FG001|Overall Study|Protocol Violation|3|||
146798157|NCT01651000|529434277|FG000|Overall Study|Withdrawal by Subject|2|||
146798158|NCT01651000|529434278|FG001|Overall Study|Withdrawal by Subject|10|||
146798159|NCT01651000|529434277|FG000|Overall Study|Subject noncompliance|0|||
146798160|NCT01651000|529434278|FG001|Overall Study|Subject noncompliance|3|||
146798161|NCT01651000|529434277|FG000|Overall Study|Lack of Efficacy|1|||
146798162|NCT01651000|529434278|FG001|Overall Study|Lack of Efficacy|1|||
146798163|NCT01651000|529434277|FG000|Overall Study|Physician Decision|1|||
146798164|NCT01651000|529434278|FG001|Overall Study|Physician Decision|0|||
146798165|NCT01651000|529434277|FG000|Overall Study|Administrative reason|1|||
146798166|NCT01651000|529434278|FG001|Overall Study|Administrative reason|0|||
146798167|NCT01651000|529434277|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
146798168|NCT01651000|529434278|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
146798169|NCT02765412|529434279|FG000|Overall Study|Death|482|||
146798170|NCT02765412|529434280|FG001|Overall Study|Death|855|||
146798171|NCT03781089|529434936|FG000|Overall Study|Constipation|1|||
146798172|NCT03781089|529434937|FG001|Overall Study|Constipation|0|||
146798173|NCT03781089|529434936|FG000|Overall Study|Positive pregnancy test|0|||
146798174|NCT03781089|529434937|FG001|Overall Study|Positive pregnancy test|1|||
146798175|NCT03417284|529434938|FG000|Overall Study|Inadequate supply on study drug|1|||
146798176|NCT03417284|529434939|FG001|Overall Study|Inadequate supply on study drug|0|||
146798177|NCT03417284|529434940|FG002|Overall Study|Inadequate supply on study drug|0|||
146798178|NCT03417284|529434941|FG003|Overall Study|Inadequate supply on study drug|0|||
146798179|NCT03417284|529434938|FG000|Overall Study|Disease Progression|0|||
146798180|NCT03417284|529434939|FG001|Overall Study|Disease Progression|0|||
146798181|NCT03417284|529434940|FG002|Overall Study|Disease Progression|1|||
146798182|NCT03417284|529434941|FG003|Overall Study|Disease Progression|0|||
146798183|NCT03636490|529434942|FG000|Overall Study|Dropped out or incomplete data|141|||
146798184|NCT02246127|529434943|FG000|First Course Treatment|Adverse Event|9|||
146798185|NCT02246127|529434944|FG001|First Course Treatment|Adverse Event|7|||
146940373|NCT00617656|529939264|FG002|Overall Study|Inclusion error|0|||
146940374|NCT00617656|529939265|FG003|Overall Study|Inclusion error|0|||
146940375|NCT00617656|529939262|FG000|Overall Study|Missing data|44|||
146798186|NCT02246127|529434943|FG000|First Course Treatment|Withdrawal by Subject|6|||
146798187|NCT02246127|529434944|FG001|First Course Treatment|Withdrawal by Subject|7|||
146798188|NCT02246127|529434943|FG000|First Course Treatment|Physician Decision|9|||
146798189|NCT02246127|529434944|FG001|First Course Treatment|Physician Decision|9|||
146798190|NCT02246127|529434943|FG000|First Course Treatment|Death|3|||
146798191|NCT02246127|529434944|FG001|First Course Treatment|Death|3|||
146798192|NCT02246127|529434943|FG000|First Course Treatment|Not reported reasons|6|||
146798193|NCT02246127|529434944|FG001|First Course Treatment|Not reported reasons|7|||
146983208|NCT00871728|530099941|FG000|Overall Study|Lost to Follow-up|2|||
146798194|NCT02246127|529434943|FG000|First Course Treatment|Not treated|3|||
146798195|NCT02246127|529434944|FG001|First Course Treatment|Not treated|3|||
146798196|NCT03635567|529434945|FG000|Overall Study|Lost to Follow-up|4|||
146798197|NCT03635567|529434946|FG001|Overall Study|Lost to Follow-up|1|||
146798198|NCT03635567|529434945|FG000|Overall Study|Withdrawal by Subject|11|||
146798199|NCT03635567|529434946|FG001|Overall Study|Withdrawal by Subject|16|||
146798200|NCT03635567|529434945|FG000|Overall Study|Sponsor Decision|99|||
146798201|NCT03635567|529434946|FG001|Overall Study|Sponsor Decision|57|||
146798202|NCT03635567|529434945|FG000|Overall Study|Death|194|||
146798203|NCT03635567|529434946|FG001|Overall Study|Death|235|||
146798204|NCT04560179|529434951|FG000|Overall Study|Physician Decision|1|||
146798205|NCT04560179|529434952|FG001|Overall Study|Physician Decision|0|||
146798206|NCT04560179|529434953|FG002|Overall Study|Physician Decision|0|||
146798207|NCT04560179|529434954|FG003|Overall Study|Physician Decision|0|||
146798208|NCT04560179|529434955|FG004|Overall Study|Physician Decision|0|||
146798209|NCT04560179|529434951|FG000|Overall Study|Adverse Event|0|||
146798210|NCT04560179|529434952|FG001|Overall Study|Adverse Event|0|||
146798211|NCT04560179|529434953|FG002|Overall Study|Adverse Event|0|||
146798212|NCT04560179|529434954|FG003|Overall Study|Adverse Event|1|||
146798213|NCT04560179|529434955|FG004|Overall Study|Adverse Event|0|||
146798214|NCT04214418|529434958|FG000|Overall Study|Withdrawal by Subject|1|||
146798215|NCT04214418|529434959|FG001|Overall Study|Withdrawal by Subject|0|||
146798216|NCT04214418|529434960|FG002|Overall Study|Withdrawal by Subject|0|||
146798217|NCT04214418|529434961|FG003|Overall Study|Withdrawal by Subject|0|||
146798218|NCT04214418|529434962|FG004|Overall Study|Withdrawal by Subject|0|||
146798219|NCT04214418|529434963|FG005|Overall Study|Withdrawal by Subject|0|||
146798220|NCT04214418|529434958|FG000|Overall Study|Adverse Event|0|||
146798221|NCT04214418|529434959|FG001|Overall Study|Adverse Event|2|||
146798222|NCT04214418|529434960|FG002|Overall Study|Adverse Event|0|||
146798223|NCT04214418|529434961|FG003|Overall Study|Adverse Event|0|||
146798224|NCT04214418|529434962|FG004|Overall Study|Adverse Event|0|||
146798225|NCT04214418|529434963|FG005|Overall Study|Adverse Event|0|||
146798226|NCT04214418|529434958|FG000|Overall Study|Death|1|||
146798227|NCT04214418|529434959|FG001|Overall Study|Death|0|||
146798228|NCT04214418|529434960|FG002|Overall Study|Death|0|||
146798229|NCT04214418|529434961|FG003|Overall Study|Death|0|||
146798230|NCT04214418|529434962|FG004|Overall Study|Death|0|||
146798231|NCT04214418|529434963|FG005|Overall Study|Death|0|||
146798232|NCT03248479|529434966|FG000|Overall Study|Death|12|||
146798233|NCT03248479|529434967|FG001|Overall Study|Death|44|||
146798234|NCT03248479|529434968|FG002|Overall Study|Death|1|||
146798235|NCT03248479|529434969|FG003|Overall Study|Death|72|||
146798236|NCT03248479|529434970|FG004|Overall Study|Death|17|||
146798237|NCT03248479|529434971|FG005|Overall Study|Death|6|||
146798238|NCT03248479|529434972|FG006|Overall Study|Death|1|||
146798239|NCT03248479|529434973|FG007|Overall Study|Death|14|||
146798240|NCT03248479|529434974|FG008|Overall Study|Death|3|||
146798241|NCT03248479|529434975|FG009|Overall Study|Death|7|||
146798242|NCT03248479|529434976|FG010|Overall Study|Death|3|||
146798243|NCT03248479|529434977|FG011|Overall Study|Death|1|||
146798244|NCT03248479|529434978|FG012|Overall Study|Death|1|||
146798245|NCT03248479|529434966|FG000|Overall Study|Study terminated by sponsor|12|||
146798246|NCT03248479|529434967|FG001|Overall Study|Study terminated by sponsor|15|||
146798247|NCT03248479|529434968|FG002|Overall Study|Study terminated by sponsor|0|||
146798248|NCT03248479|529434969|FG003|Overall Study|Study terminated by sponsor|5|||
146798249|NCT03248479|529434970|FG004|Overall Study|Study terminated by sponsor|0|||
146798250|NCT03248479|529434971|FG005|Overall Study|Study terminated by sponsor|0|||
146798251|NCT03248479|529434972|FG006|Overall Study|Study terminated by sponsor|0|||
146798252|NCT03248479|529434973|FG007|Overall Study|Study terminated by sponsor|1|||
146798253|NCT03248479|529434974|FG008|Overall Study|Study terminated by sponsor|1|||
146798254|NCT03248479|529434975|FG009|Overall Study|Study terminated by sponsor|0|||
146798255|NCT03248479|529434976|FG010|Overall Study|Study terminated by sponsor|5|||
146798256|NCT03248479|529434977|FG011|Overall Study|Study terminated by sponsor|4|||
146798257|NCT03248479|529434978|FG012|Overall Study|Study terminated by sponsor|0|||
146798258|NCT03248479|529434966|FG000|Overall Study|Consent withdrawn|6|||
146798259|NCT03248479|529434967|FG001|Overall Study|Consent withdrawn|3|||
146798260|NCT03248479|529434968|FG002|Overall Study|Consent withdrawn|0|||
146798261|NCT03248479|529434969|FG003|Overall Study|Consent withdrawn|9|||
146798262|NCT03248479|529434970|FG004|Overall Study|Consent withdrawn|1|||
146798263|NCT03248479|529434971|FG005|Overall Study|Consent withdrawn|0|||
146798264|NCT03248479|529434972|FG006|Overall Study|Consent withdrawn|0|||
146798265|NCT03248479|529434973|FG007|Overall Study|Consent withdrawn|1|||
146798266|NCT03248479|529434974|FG008|Overall Study|Consent withdrawn|0|||
146798267|NCT03248479|529434975|FG009|Overall Study|Consent withdrawn|3|||
146798268|NCT03248479|529434976|FG010|Overall Study|Consent withdrawn|1|||
146798269|NCT03248479|529434977|FG011|Overall Study|Consent withdrawn|0|||
146798270|NCT03248479|529434978|FG012|Overall Study|Consent withdrawn|1|||
146798271|NCT03248479|529434966|FG000|Overall Study|Lost to Follow-up|2|||
146798272|NCT03248479|529434967|FG001|Overall Study|Lost to Follow-up|1|||
146798273|NCT03248479|529434968|FG002|Overall Study|Lost to Follow-up|0|||
146798274|NCT03248479|529434969|FG003|Overall Study|Lost to Follow-up|0|||
146798275|NCT03248479|529434970|FG004|Overall Study|Lost to Follow-up|0|||
146798276|NCT03248479|529434971|FG005|Overall Study|Lost to Follow-up|0|||
146798277|NCT03248479|529434972|FG006|Overall Study|Lost to Follow-up|0|||
146798278|NCT03248479|529434973|FG007|Overall Study|Lost to Follow-up|0|||
146798279|NCT03248479|529434974|FG008|Overall Study|Lost to Follow-up|0|||
146798280|NCT03248479|529434975|FG009|Overall Study|Lost to Follow-up|0|||
146798281|NCT03248479|529434976|FG010|Overall Study|Lost to Follow-up|0|||
146798282|NCT03248479|529434977|FG011|Overall Study|Lost to Follow-up|0|||
146798283|NCT03248479|529434978|FG012|Overall Study|Lost to Follow-up|1|||
146798284|NCT03248479|529434966|FG000|Overall Study|Not reported|0|||
146798285|NCT03248479|529434967|FG001|Overall Study|Not reported|0|||
146798286|NCT03248479|529434968|FG002|Overall Study|Not reported|0|||
146798287|NCT03248479|529434969|FG003|Overall Study|Not reported|1|||
146798288|NCT03248479|529434970|FG004|Overall Study|Not reported|1|||
146798289|NCT03248479|529434971|FG005|Overall Study|Not reported|0|||
146798290|NCT03248479|529434972|FG006|Overall Study|Not reported|0|||
146798291|NCT03248479|529434973|FG007|Overall Study|Not reported|1|||
146798292|NCT03248479|529434974|FG008|Overall Study|Not reported|1|||
146798293|NCT03248479|529434975|FG009|Overall Study|Not reported|0|||
146798294|NCT03248479|529434976|FG010|Overall Study|Not reported|0|||
146798295|NCT03248479|529434977|FG011|Overall Study|Not reported|0|||
146798296|NCT03248479|529434978|FG012|Overall Study|Not reported|0|||
146798297|NCT04679389|529434979|FG000|Overall Study|Adverse Event|1|||
146798298|NCT04679389|529434980|FG001|Overall Study|Adverse Event|0|||
146798299|NCT04679389|529434979|FG000|Overall Study|Protocol Violation|2|||
146798300|NCT04679389|529434980|FG001|Overall Study|Protocol Violation|0|||
146798301|NCT04679389|529434979|FG000|Overall Study|Physician Decision|3|||
146798302|NCT04679389|529434980|FG001|Overall Study|Physician Decision|5|||
146798303|NCT04679389|529434979|FG000|Overall Study|Withdrawal by Subject|5|||
146798304|NCT04679389|529434980|FG001|Overall Study|Withdrawal by Subject|7|||
146798305|NCT01475786|529435001|FG000|Overall Study|Adverse Event|0|||
146798306|NCT01475786|529435002|FG001|Overall Study|Adverse Event|1|||
146798307|NCT01475786|529435003|FG002|Overall Study|Adverse Event|0|||
146798308|NCT01475786|529435001|FG000|Overall Study|Lost to Follow-up|1|||
146798309|NCT01475786|529435002|FG001|Overall Study|Lost to Follow-up|2|||
146798310|NCT01475786|529435003|FG002|Overall Study|Lost to Follow-up|1|||
146798311|NCT01475786|529435001|FG000|Overall Study|Withdrawal by Subject|0|||
146798312|NCT01475786|529435002|FG001|Overall Study|Withdrawal by Subject|1|||
146798313|NCT01475786|529435003|FG002|Overall Study|Withdrawal by Subject|1|||
146798314|NCT01475786|529435001|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
146798315|NCT01475786|529435002|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
146798316|NCT01475786|529435003|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
146798317|NCT01897441|529435004|FG000|Overall Study|Lost to Follow-up|0|||
146798318|NCT01897441|529435005|FG001|Overall Study|Lost to Follow-up|0|||
146798319|NCT01897441|529435006|FG002|Overall Study|Lost to Follow-up|1|||
146798320|NCT01897441|529435007|FG003|Overall Study|Lost to Follow-up|0|||
146798321|NCT01897441|529435008|FG004|Overall Study|Lost to Follow-up|0|||
146798322|NCT01897441|529435009|FG005|Overall Study|Lost to Follow-up|0|||
146798323|NCT01897441|529435004|FG000|Overall Study|Withdrawal by Subject|0|||
146798324|NCT01897441|529435005|FG001|Overall Study|Withdrawal by Subject|0|||
146798325|NCT01897441|529435006|FG002|Overall Study|Withdrawal by Subject|0|||
146798326|NCT01897441|529435007|FG003|Overall Study|Withdrawal by Subject|0|||
146798327|NCT01897441|529435008|FG004|Overall Study|Withdrawal by Subject|1|||
146798328|NCT01897441|529435009|FG005|Overall Study|Withdrawal by Subject|0|||
146798329|NCT01897441|529435004|FG000|Overall Study|Withdrawn by Provider|0|||
146798330|NCT01897441|529435005|FG001|Overall Study|Withdrawn by Provider|2|||
146798331|NCT01897441|529435006|FG002|Overall Study|Withdrawn by Provider|0|||
146798332|NCT01897441|529435007|FG003|Overall Study|Withdrawn by Provider|0|||
146798333|NCT01897441|529435008|FG004|Overall Study|Withdrawn by Provider|0|||
146798334|NCT01897441|529435009|FG005|Overall Study|Withdrawn by Provider|0|||
146798335|NCT04633278|529435594|FG000|Overall Study|Adverse Event|1|||
146798336|NCT04633278|529435595|FG001|Overall Study|Adverse Event|0|||
146798337|NCT04633278|529435594|FG000|Overall Study|Withdrawal by Subject|1|||
146798338|NCT04633278|529435595|FG001|Overall Study|Withdrawal by Subject|0|||
146798339|NCT04633278|529435594|FG000|Overall Study|Death|11|||
146798340|NCT04633278|529435595|FG001|Overall Study|Death|7|||
146798341|NCT04633278|529435594|FG000|Overall Study|Sponsor Decision|3|||
146798342|NCT04633278|529435595|FG001|Overall Study|Sponsor Decision|0|||
146798343|NCT04633278|529435594|FG000|Overall Study|Not Listed|1|||
146798344|NCT04633278|529435595|FG001|Overall Study|Not Listed|0|||
146798345|NCT00942734|529435604|FG000|Overall Study|Adverse Event|2|||
146798346|NCT00942734|529435604|FG000|Overall Study|Protocol Violation|3|||
146798347|NCT00942734|529435604|FG000|Overall Study|Disease Progression|2|||
146798348|NCT00942734|529435604|FG000|Overall Study|Physician Decision|1|||
146798349|NCT04496752|529435615|FG000|Second Assessment|Lost to Follow-up|3|||
146798350|NCT04496752|529435616|FG001|Second Assessment|Lost to Follow-up|3|||
146798351|NCT04496752|529435615|FG000|Second Assessment|Adverse Event|2|||
146798352|NCT04496752|529435616|FG001|Second Assessment|Adverse Event|0|||
146798353|NCT03662022|529435617|FG000|Year 1 2019|prevalent case|83|||
146798354|NCT03662022|529435618|FG001|Year 1 2019|prevalent case|116|||
146798355|NCT03662022|529435619|FG002|Year 1 2019|prevalent case|158|||
146798356|NCT03662022|529435620|FG003|Year 1 2019|prevalent case|99|||
146798357|NCT03662022|529435617|FG000|Year 2 2020|incident case|18|||
146798358|NCT03662022|529435618|FG001|Year 2 2020|incident case|18|||
146798359|NCT03662022|529435619|FG002|Year 2 2020|incident case|16|||
146798360|NCT03662022|529435620|FG003|Year 2 2020|incident case|26|||
146798361|NCT03662022|529435617|FG000|Year 2 2020|other case|18|||
146798362|NCT03662022|529435618|FG001|Year 2 2020|other case|16|||
146798363|NCT03662022|529435619|FG002|Year 2 2020|other case|16|||
146798364|NCT03662022|529435620|FG003|Year 2 2020|other case|24|||
146798365|NCT03662022|529435617|FG000|Year 2 2020|Lost to Follow-up|1633|||
146798366|NCT03662022|529435618|FG001|Year 2 2020|Lost to Follow-up|1183|||
146798367|NCT03662022|529435619|FG002|Year 2 2020|Lost to Follow-up|1381|||
146798368|NCT03662022|529435620|FG003|Year 2 2020|Lost to Follow-up|2858|||
146798369|NCT03662022|529435617|FG000|Year 3 2021|incident case|24|||
146798370|NCT03662022|529435618|FG001|Year 3 2021|incident case|27|||
146798371|NCT03662022|529435619|FG002|Year 3 2021|incident case|24|||
146798372|NCT03662022|529435620|FG003|Year 3 2021|incident case|11|||
146798373|NCT03662022|529435617|FG000|Year 3 2021|other case|4|||
146798374|NCT03662022|529435618|FG001|Year 3 2021|other case|15|||
146798375|NCT03662022|529435619|FG002|Year 3 2021|other case|10|||
146798376|NCT03662022|529435620|FG003|Year 3 2021|other case|14|||
146798377|NCT03662022|529435617|FG000|Year 3 2021|Lost to Follow-up|179|||
146798378|NCT03662022|529435618|FG001|Year 3 2021|Lost to Follow-up|244|||
146798379|NCT03662022|529435619|FG002|Year 3 2021|Lost to Follow-up|480|||
146798380|NCT03662022|529435620|FG003|Year 3 2021|Lost to Follow-up|477|||
146798381|NCT03662022|529435617|FG000|Year 4 2022|incident case|25|||
146798382|NCT03662022|529435618|FG001|Year 4 2022|incident case|41|||
146798383|NCT03662022|529435619|FG002|Year 4 2022|incident case|28|||
146798384|NCT03662022|529435620|FG003|Year 4 2022|incident case|7|||
146798385|NCT03662022|529435617|FG000|Year 4 2022|other case|8|||
146798386|NCT03662022|529435618|FG001|Year 4 2022|other case|19|||
146798387|NCT03662022|529435619|FG002|Year 4 2022|other case|13|||
146798388|NCT03662022|529435620|FG003|Year 4 2022|other case|7|||
146798389|NCT03662022|529435617|FG000|Year 4 2022|Lost to Follow-up|986|||
146798390|NCT03662022|529435618|FG001|Year 4 2022|Lost to Follow-up|1079|||
146798391|NCT03662022|529435619|FG002|Year 4 2022|Lost to Follow-up|1236|||
146798392|NCT03662022|529435620|FG003|Year 4 2022|Lost to Follow-up|1826|||
146798393|NCT03547271|529435625|FG000|Overall Study|Adverse Event|1|||
146798394|NCT03547271|529435626|FG001|Overall Study|Adverse Event|1|||
146798395|NCT03547271|529435627|FG002|Overall Study|Adverse Event|0|||
146798396|NCT03547271|529435628|FG003|Overall Study|Adverse Event|0|||
146798397|NCT03547271|529435625|FG000|Overall Study|Protocol deviation|5|||
146798398|NCT03547271|529435626|FG001|Overall Study|Protocol deviation|7|||
146798399|NCT03547271|529435627|FG002|Overall Study|Protocol deviation|3|||
146798400|NCT03547271|529435628|FG003|Overall Study|Protocol deviation|0|||
146798401|NCT03547271|529435625|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
146798402|NCT03547271|529435626|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
146798403|NCT03547271|529435627|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
146798404|NCT03547271|529435628|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
146798405|NCT03547271|529435625|FG000|Overall Study|Lost to Follow-up|3|||
146798406|NCT03547271|529435626|FG001|Overall Study|Lost to Follow-up|3|||
146798407|NCT03547271|529435627|FG002|Overall Study|Lost to Follow-up|1|||
146798408|NCT03547271|529435628|FG003|Overall Study|Lost to Follow-up|0|||
146798409|NCT04795245|529435633|FG000|Overall Study|Unkown reason|7|||
146940376|NCT00617656|529939263|FG001|Overall Study|Missing data|30|||
146940377|NCT00617656|529939264|FG002|Overall Study|Missing data|13|||
146940378|NCT00617656|529939265|FG003|Overall Study|Missing data|6|||
146940379|NCT00617656|529939262|FG000|Overall Study|Withdrawal by Subject|0|||
146798410|NCT04795245|529435633|FG000|Overall Study|Death|17|||
146798411|NCT04795245|529435633|FG000|Overall Study|Other than listed|19|||
146798412|NCT04795245|529435633|FG000|Overall Study|Adverse Event|143|||
146940380|NCT00617656|529939263|FG001|Overall Study|Withdrawal by Subject|2|||
146940381|NCT00617656|529939264|FG002|Overall Study|Withdrawal by Subject|0|||
146940382|NCT00617656|529939265|FG003|Overall Study|Withdrawal by Subject|0|||
146798413|NCT04795245|529435633|FG000|Overall Study|Progressive disease|512|||
146798414|NCT04795245|529435633|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
146798415|NCT03904576|529435634|FG000|Washout Period|Protocol Violation|1|||
146798416|NCT03904576|529435635|FG001|Washout Period|Protocol Violation|1|||
146798417|NCT05718687|529435636|FG000|Overall Study|Withdrawal by Subject|3|||
146798418|NCT03418740|529435637|FG000|Overall Study|Lost to Follow-up|13|||
146798419|NCT03418740|529435637|FG000|Overall Study|Scheduling Issues|7|||
146798420|NCT03418740|529435637|FG000|Overall Study|Withdrawal by Subject|2|||
146798421|NCT03418740|529435637|FG000|Overall Study|Unable to Continue Consent|1|||
146798422|NCT05215054|529435638|FG000|Overall Study|Lost to Follow-up|1|||
146798423|NCT05215054|529435639|FG001|Overall Study|Lost to Follow-up|1|||
146798424|NCT05215054|529435638|FG000|Overall Study|Protocol Violation|1|||
146798425|NCT05215054|529435639|FG001|Overall Study|Protocol Violation|1|||
146798426|NCT05215054|529435638|FG000|Overall Study|Withdrawal by Subject|4|||
146798427|NCT05215054|529435639|FG001|Overall Study|Withdrawal by Subject|4|||
146798428|NCT01499368|529435640|FG000|Overall Study|Did not meet I/E criteria|8|||
146798429|NCT01499368|529435641|FG001|Overall Study|Did not meet I/E criteria|4|||
146798430|NCT01499368|529435642|FG002|Overall Study|Did not meet I/E criteria|4|||
146798431|NCT01499368|529435640|FG000|Overall Study|Prohibited Concomitant medication|1|||
146798432|NCT01499368|529435641|FG001|Overall Study|Prohibited Concomitant medication|1|||
146798433|NCT01499368|529435642|FG002|Overall Study|Prohibited Concomitant medication|0|||
146798434|NCT01499368|529435640|FG000|Overall Study|Withdrawal by Subject|11|||
146798435|NCT01499368|529435641|FG001|Overall Study|Withdrawal by Subject|10|||
146798436|NCT01499368|529435642|FG002|Overall Study|Withdrawal by Subject|8|||
146798437|NCT01499368|529435640|FG000|Overall Study|Lost to Follow-up|3|||
146798438|NCT01499368|529435641|FG001|Overall Study|Lost to Follow-up|2|||
146798439|NCT01499368|529435642|FG002|Overall Study|Lost to Follow-up|5|||
146798440|NCT01499368|529435640|FG000|Overall Study|Adverse Event|4|||
146798441|NCT01499368|529435641|FG001|Overall Study|Adverse Event|0|||
146798442|NCT01499368|529435642|FG002|Overall Study|Adverse Event|2|||
146798443|NCT01499368|529435640|FG000|Overall Study|Physician Decision|0|||
146798444|NCT01499368|529435641|FG001|Overall Study|Physician Decision|1|||
146798445|NCT01499368|529435642|FG002|Overall Study|Physician Decision|0|||
146798446|NCT01499368|529435640|FG000|Overall Study|Deviation from visit window|0|||
146798447|NCT01499368|529435641|FG001|Overall Study|Deviation from visit window|0|||
146798448|NCT01499368|529435642|FG002|Overall Study|Deviation from visit window|1|||
146798449|NCT01499368|529435640|FG000|Overall Study|Error of Prescriptions|0|||
146798450|NCT01499368|529435641|FG001|Overall Study|Error of Prescriptions|0|||
146798451|NCT01499368|529435642|FG002|Overall Study|Error of Prescriptions|1|||
146798452|NCT03990883|529435643|FG000|Blinded Treatment Phase|Adverse Event|1|||
146798453|NCT03990883|529435644|FG001|Blinded Treatment Phase|Adverse Event|1|||
146798454|NCT03990883|529435645|FG002|Blinded Treatment Phase|Adverse Event|0|||
146798455|NCT03990883|529435643|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
146798456|NCT03990883|529435644|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
146798457|NCT03990883|529435645|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
146798458|NCT03990883|529435643|FG000|Blinded Treatment Phase|Physician Decision|1|||
146798459|NCT03990883|529435644|FG001|Blinded Treatment Phase|Physician Decision|0|||
146798460|NCT03990883|529435645|FG002|Blinded Treatment Phase|Physician Decision|0|||
146798461|NCT03990883|529435643|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
146798462|NCT03990883|529435644|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
146798463|NCT03990883|529435645|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
146798464|NCT03990883|529435643|FG000|Blinded Treatment Phase|COVID-19|3|||
146798465|NCT03990883|529435644|FG001|Blinded Treatment Phase|COVID-19|2|||
146798466|NCT03990883|529435645|FG002|Blinded Treatment Phase|COVID-19|0|||
146798467|NCT03990883|529435643|FG000|Blinded Treatment Phase|Personal Reasons|6|||
146798468|NCT03990883|529435644|FG001|Blinded Treatment Phase|Personal Reasons|3|||
146798469|NCT03990883|529435645|FG002|Blinded Treatment Phase|Personal Reasons|0|||
146798470|NCT03990883|529435643|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
146798471|NCT03990883|529435644|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
146798472|NCT03990883|529435645|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
146798473|NCT03990883|529435643|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
146798474|NCT03990883|529435644|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
146798475|NCT03990883|529435645|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
146798476|NCT03990883|529435643|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
146798477|NCT03990883|529435644|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
146798478|NCT03990883|529435645|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
146798479|NCT02076009|529436500|FG000|Overall Study|Death|172|||
146798480|NCT02076009|529436501|FG001|Overall Study|Death|153|||
146798481|NCT02076009|529436500|FG000|Overall Study|Withdrawal by Subject|16|||
146798482|NCT02076009|529436501|FG001|Overall Study|Withdrawal by Subject|12|||
146798483|NCT02076009|529436500|FG000|Overall Study|Lost to Follow-up|4|||
146798484|NCT02076009|529436501|FG001|Overall Study|Lost to Follow-up|2|||
146798485|NCT02076009|529436500|FG000|Overall Study|Progressive Disease|1|||
146798486|NCT02076009|529436501|FG001|Overall Study|Progressive Disease|0|||
146798487|NCT02076009|529436500|FG000|Overall Study|Physician Decision|0|||
146798488|NCT02076009|529436501|FG001|Overall Study|Physician Decision|1|||
146798489|NCT02076009|529436500|FG000|Overall Study|End of data collection|90|||
146798490|NCT02076009|529436501|FG001|Overall Study|End of data collection|118|||
146940383|NCT00131664|529939266|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
146940384|NCT00131664|529939267|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
146940385|NCT00131664|529939268|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
146798491|NCT05988398|529436505|FG000|Overall Study|Lack of time|21|||
146798492|NCT05988398|529436506|FG001|Overall Study|Lack of time|0|||
146798493|NCT05988398|529436505|FG000|Overall Study|Absent from school|0|||
146798494|NCT05988398|529436506|FG001|Overall Study|Absent from school|38|||
146798495|NCT05988398|529436505|FG000|Overall Study|Chose not to participate|0|||
146940386|NCT00131664|529939269|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
146940387|NCT00131664|529939270|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
146798496|NCT05988398|529436506|FG001|Overall Study|Chose not to participate|42|||
146798497|NCT05988398|529436505|FG000|Overall Study|Other commitments (e.g., sports)|0|||
146798498|NCT05988398|529436506|FG001|Overall Study|Other commitments (e.g., sports)|25|||
146798499|NCT04408755|529436507|FG000|Period A (Placebo lead-in)|Other|11|||
146798500|NCT04408755|529436508|FG001|Period A (Placebo lead-in)|Other|0|||
146798501|NCT04408755|529436509|FG002|Period A (Placebo lead-in)|Other|0|||
146798502|NCT04408755|529436510|FG003|Period A (Placebo lead-in)|Other|0|||
146798503|NCT04408755|529436507|FG000|Period B (Randomization Period)|Adverse Event|0|||
146798504|NCT04408755|529436508|FG001|Period B (Randomization Period)|Adverse Event|3|||
146798505|NCT04408755|529436509|FG002|Period B (Randomization Period)|Adverse Event|0|||
146798506|NCT04408755|529436510|FG003|Period B (Randomization Period)|Adverse Event|1|||
146798507|NCT04408755|529436507|FG000|Period B (Randomization Period)|Death|0|||
146798508|NCT04408755|529436508|FG001|Period B (Randomization Period)|Death|0|||
146798509|NCT04408755|529436509|FG002|Period B (Randomization Period)|Death|1|||
146798510|NCT04408755|529436510|FG003|Period B (Randomization Period)|Death|0|||
146798511|NCT04408755|529436507|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
146798512|NCT04408755|529436508|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
146798513|NCT04408755|529436509|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
146798514|NCT04408755|529436510|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
146798515|NCT04408755|529436507|FG000|Period B (Randomization Period)|Physician Decision|0|||
146798516|NCT04408755|529436508|FG001|Period B (Randomization Period)|Physician Decision|0|||
146798517|NCT04408755|529436509|FG002|Period B (Randomization Period)|Physician Decision|1|||
146798518|NCT04408755|529436510|FG003|Period B (Randomization Period)|Physician Decision|0|||
146798519|NCT04408755|529436507|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
146798520|NCT04408755|529436508|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
146798521|NCT04408755|529436509|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
146798522|NCT04408755|529436510|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
146798523|NCT04408755|529436507|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
146798524|NCT04408755|529436508|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
146798525|NCT04408755|529436509|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
146798526|NCT04408755|529436510|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
146798527|NCT04408755|529436507|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
146798528|NCT04408755|529436508|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
146798529|NCT04408755|529436509|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
146798530|NCT04408755|529436510|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
146798531|NCT04408755|529436507|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
146798532|NCT04408755|529436508|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
146798533|NCT04408755|529436509|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
146798534|NCT04408755|529436510|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
146798535|NCT04408755|529436507|FG000|Period B (Randomization Period)|Reason not Specified|0|||
146798536|NCT04408755|529436508|FG001|Period B (Randomization Period)|Reason not Specified|1|||
146798537|NCT04408755|529436509|FG002|Period B (Randomization Period)|Reason not Specified|0|||
146798538|NCT04408755|529436510|FG003|Period B (Randomization Period)|Reason not Specified|2|||
146940388|NCT00131664|529939271|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
146940389|NCT00131664|529939266|FG000|First Period (First 6 Months)|Death|0|||
146940390|NCT00131664|529939267|FG001|First Period (First 6 Months)|Death|1|||
146940391|NCT00131664|529939268|FG002|First Period (First 6 Months)|Death|0|||
146940392|NCT00131664|529939269|FG003|First Period (First 6 Months)|Death|0|||
146940393|NCT00131664|529939270|FG004|First Period (First 6 Months)|Death|0|||
146940394|NCT00131664|529939271|FG005|First Period (First 6 Months)|Death|0|||
146940395|NCT00131664|529939266|FG000|First Period (First 6 Months)|Protocol Violation|2|||
146940396|NCT00131664|529939267|FG001|First Period (First 6 Months)|Protocol Violation|2|||
146940397|NCT00131664|529939268|FG002|First Period (First 6 Months)|Protocol Violation|1|||
146940398|NCT00131664|529939269|FG003|First Period (First 6 Months)|Protocol Violation|0|||
146940399|NCT00131664|529939270|FG004|First Period (First 6 Months)|Protocol Violation|0|||
146798539|NCT06655818|529436511|FG000|Overall Study|Withdrawal by Subject|1|||
146798540|NCT00319046|529436512|FG000|Overall Study|withdrawal of subject's consent|7|||
146798541|NCT00319046|529436512|FG000|Overall Study|administrative reason|1|||
146940400|NCT00131664|529939271|FG005|First Period (First 6 Months)|Protocol Violation|0|||
146940401|NCT00131664|529939266|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
146940402|NCT00131664|529939267|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
146940403|NCT00131664|529939268|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
146940404|NCT00131664|529939269|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
146940405|NCT00131664|529939270|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
146798542|NCT00412607|529436513|FG000|Overall Study|Withdrawal by Subject|9|||
146798543|NCT00412607|529436513|FG000|Overall Study|Lost to Follow-up|19|||
146798544|NCT00412607|529436513|FG000|Overall Study|Death|61|||
146798545|NCT00412607|529436513|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
146940406|NCT00131664|529939271|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
146798546|NCT04675034|529436516|FG000|Overall Study|Lost to Follow-up|1|||
146798547|NCT04675034|529436517|FG001|Overall Study|Lost to Follow-up|1|||
146798548|NCT04675034|529436518|FG002|Overall Study|Lost to Follow-up|0|||
146798549|NCT04675034|529436519|FG003|Overall Study|Lost to Follow-up|2|||
146798550|NCT04675034|529436520|FG004|Overall Study|Lost to Follow-up|0|||
146798551|NCT04675034|529436516|FG000|Overall Study|Protocol Violation|1|||
146798552|NCT04675034|529436517|FG001|Overall Study|Protocol Violation|0|||
146798553|NCT04675034|529436518|FG002|Overall Study|Protocol Violation|0|||
146798554|NCT04675034|529436519|FG003|Overall Study|Protocol Violation|1|||
146798555|NCT04675034|529436520|FG004|Overall Study|Protocol Violation|3|||
146798556|NCT04675034|529436516|FG000|Overall Study|Withdrawal by Subject|9|||
146798557|NCT04675034|529436517|FG001|Overall Study|Withdrawal by Subject|3|||
146798558|NCT04675034|529436518|FG002|Overall Study|Withdrawal by Subject|4|||
146798559|NCT04675034|529436519|FG003|Overall Study|Withdrawal by Subject|8|||
146798560|NCT04675034|529436520|FG004|Overall Study|Withdrawal by Subject|6|||
146798561|NCT05836012|529436523|FG000|Overall Study|Lost to Follow-up|1|||
146798562|NCT05836012|529436524|FG001|Overall Study|Lost to Follow-up|0|||
146798563|NCT05836012|529436523|FG000|Overall Study|Withdrawal by Subject|1|||
146798564|NCT05836012|529436524|FG001|Overall Study|Withdrawal by Subject|3|||
146798565|NCT05836012|529436523|FG000|Overall Study|Reason not included in pre-specified categories|2|||
146798566|NCT05836012|529436524|FG001|Overall Study|Reason not included in pre-specified categories|1|||
146798567|NCT05985395|529436525|FG000|Overall Study|Physician Decision|2|||
146798568|NCT05985395|529436526|FG001|Overall Study|Physician Decision|1|||
146798569|NCT05985395|529436525|FG000|Overall Study|Withdrawal by Subject|1|||
146798570|NCT05985395|529436526|FG001|Overall Study|Withdrawal by Subject|0|||
146798571|NCT04908930|529436529|FG000|Overall Study|Lost to Follow-up|1|||
146798572|NCT04908930|529436530|FG001|Overall Study|Lost to Follow-up|1|||
146798573|NCT04908930|529436531|FG002|Overall Study|Lost to Follow-up|0|||
146798574|NCT04908930|529436532|FG003|Overall Study|Lost to Follow-up|0|||
146798575|NCT04908930|529436533|FG004|Overall Study|Lost to Follow-up|0|||
146798576|NCT04908930|529436529|FG000|Overall Study|hardware in mouth|1|||
146798577|NCT04908930|529436530|FG001|Overall Study|hardware in mouth|1|||
146798578|NCT04908930|529436531|FG002|Overall Study|hardware in mouth|0|||
146798579|NCT04908930|529436532|FG003|Overall Study|hardware in mouth|0|||
146798580|NCT04908930|529436533|FG004|Overall Study|hardware in mouth|0|||
146798581|NCT04908930|529436529|FG000|Overall Study|wrong team|1|||
146798582|NCT04908930|529436530|FG001|Overall Study|wrong team|0|||
146798583|NCT04908930|529436531|FG002|Overall Study|wrong team|0|||
146798584|NCT04908930|529436532|FG003|Overall Study|wrong team|0|||
146798585|NCT04908930|529436533|FG004|Overall Study|wrong team|0|||
146798586|NCT04908930|529436529|FG000|Overall Study|quit team|2|||
146798587|NCT04908930|529436530|FG001|Overall Study|quit team|4|||
146798588|NCT04908930|529436531|FG002|Overall Study|quit team|0|||
146798589|NCT04908930|529436532|FG003|Overall Study|quit team|0|||
146798590|NCT04908930|529436533|FG004|Overall Study|quit team|0|||
146798591|NCT04908930|529436529|FG000|Overall Study|Withdrawal by Subject|1|||
146798592|NCT04908930|529436530|FG001|Overall Study|Withdrawal by Subject|2|||
146798593|NCT04908930|529436531|FG002|Overall Study|Withdrawal by Subject|0|||
146798594|NCT04908930|529436532|FG003|Overall Study|Withdrawal by Subject|0|||
146798595|NCT04908930|529436533|FG004|Overall Study|Withdrawal by Subject|0|||
146798596|NCT04908930|529436529|FG000|Overall Study|parent not liking program|0|||
146798597|NCT04908930|529436530|FG001|Overall Study|parent not liking program|1|||
146798598|NCT04908930|529436531|FG002|Overall Study|parent not liking program|0|||
146798599|NCT04908930|529436532|FG003|Overall Study|parent not liking program|0|||
146798600|NCT04908930|529436533|FG004|Overall Study|parent not liking program|0|||
146798601|NCT02777593|529436536|FG000|Overall Study|Still in study|1|||
146798602|NCT02777593|529436537|FG001|Overall Study|Still in study|32|||
146798603|NCT02777593|529436538|FG002|Overall Study|Still in study|3|||
146798604|NCT02777593|529436539|FG003|Overall Study|Still in study|6|||
146798605|NCT02777593|529436540|FG004|Overall Study|Still in study|5|||
146798606|NCT02777593|529436536|FG000|Overall Study|Death|21|||
146798607|NCT02777593|529436537|FG001|Overall Study|Death|28|||
146798608|NCT02777593|529436538|FG002|Overall Study|Death|0|||
146798609|NCT02777593|529436539|FG003|Overall Study|Death|5|||
146798610|NCT02777593|529436540|FG004|Overall Study|Death|0|||
146798611|NCT02777593|529436536|FG000|Overall Study|Withdrawal by Subject|8|||
146798612|NCT02777593|529436537|FG001|Overall Study|Withdrawal by Subject|4|||
146798613|NCT02777593|529436538|FG002|Overall Study|Withdrawal by Subject|1|||
146798614|NCT02777593|529436539|FG003|Overall Study|Withdrawal by Subject|1|||
146798615|NCT02777593|529436540|FG004|Overall Study|Withdrawal by Subject|0|||
146798616|NCT02777593|529436536|FG000|Overall Study|Lost to Follow-up|8|||
146798617|NCT02777593|529436537|FG001|Overall Study|Lost to Follow-up|16|||
146798618|NCT02777593|529436538|FG002|Overall Study|Lost to Follow-up|5|||
146798619|NCT02777593|529436539|FG003|Overall Study|Lost to Follow-up|0|||
146798620|NCT02777593|529436540|FG004|Overall Study|Lost to Follow-up|1|||
146798621|NCT02777593|529436536|FG000|Overall Study|Physician Decision|2|||
146798622|NCT02777593|529436537|FG001|Overall Study|Physician Decision|2|||
146798623|NCT02777593|529436538|FG002|Overall Study|Physician Decision|0|||
146798624|NCT02777593|529436539|FG003|Overall Study|Physician Decision|0|||
146798625|NCT02777593|529436540|FG004|Overall Study|Physician Decision|0|||
146798626|NCT02777593|529436536|FG000|Overall Study|Discontinued due to Other|1|||
146798627|NCT02777593|529436537|FG001|Overall Study|Discontinued due to Other|0|||
146798628|NCT02777593|529436538|FG002|Overall Study|Discontinued due to Other|0|||
146798629|NCT02777593|529436539|FG003|Overall Study|Discontinued due to Other|0|||
146798630|NCT02777593|529436540|FG004|Overall Study|Discontinued due to Other|0|||
146798631|NCT06065735|529436543|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
146798632|NCT06065735|529436544|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
146798633|NCT06065735|529436545|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
146798634|NCT06065735|529436543|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
146798635|NCT06065735|529436544|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
146798636|NCT06065735|529436545|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
146798637|NCT06065735|529436543|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
146798638|NCT06065735|529436544|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
146798639|NCT06065735|529436545|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
146798640|NCT06065735|529436543|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
146798641|NCT06065735|529436544|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
146798642|NCT06065735|529436545|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
146798643|NCT06065735|529436543|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
146798644|NCT06065735|529436544|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
146798645|NCT06065735|529436545|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
146798646|NCT02532621|529436546|FG000|Overall Study|Death|3|||
146798647|NCT02532621|529436546|FG000|Overall Study|Lost to Follow-up|3|||
146798648|NCT02532621|529436546|FG000|Overall Study|Withdrawal by Subject|6|||
146798649|NCT02532621|529436546|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
146798650|NCT02532621|529436546|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
146798651|NCT03522298|529436547|FG000|Overall Study|Adverse Event|1|||
146798652|NCT03522298|529436548|FG001|Overall Study|Adverse Event|0|||
146798653|NCT03522298|529436549|FG002|Overall Study|Adverse Event|0|||
146798654|NCT03522298|529436550|FG003|Overall Study|Adverse Event|1|||
146798655|NCT03522298|529436547|FG000|Overall Study|Death|2|||
146798656|NCT03522298|529436548|FG001|Overall Study|Death|4|||
146798657|NCT03522298|529436549|FG002|Overall Study|Death|8|||
146798658|NCT03522298|529436550|FG003|Overall Study|Death|8|||
146798659|NCT03522298|529436547|FG000|Overall Study|Patient decision|0|||
146798660|NCT03522298|529436548|FG001|Overall Study|Patient decision|2|||
146798661|NCT03522298|529436549|FG002|Overall Study|Patient decision|2|||
146798662|NCT03522298|529436550|FG003|Overall Study|Patient decision|2|||
146798663|NCT02933489|529436553|FG000|Overall Study|Ineligible|3|||
146798664|NCT02933489|529436554|FG001|Overall Study|Ineligible|3|||
146798665|NCT02933489|529436553|FG000|Overall Study|Withdrawal by Subject|27|||
146798666|NCT02933489|529436554|FG001|Overall Study|Withdrawal by Subject|18|||
146798667|NCT02933489|529436553|FG000|Overall Study|Unable to complete exams (other)|14|||
146798668|NCT02933489|529436554|FG001|Overall Study|Unable to complete exams (other)|7|||
146798669|NCT05485935|529436555|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
146798670|NCT05485935|529436556|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
146798671|NCT05485935|529436555|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
146798672|NCT05485935|529436556|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
146798673|NCT05485935|529436555|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
146798674|NCT05485935|529436556|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
146798675|NCT05485935|529436555|FG000|Period 2 (T2 and V3)|loss of contact|0|||
146798676|NCT05485935|529436556|FG001|Period 2 (T2 and V3)|loss of contact|1|||
146798677|NCT04093869|529436558|FG000|Overall Study|Death|0|||
146798678|NCT04093869|529436559|FG001|Overall Study|Death|1|||
146798679|NCT04093869|529436558|FG000|Overall Study|Withdrawal by Subject|1|||
146798680|NCT04093869|529436559|FG001|Overall Study|Withdrawal by Subject|0|||
146798681|NCT03250676|529436564|FG000|Overall Study|Adverse Event|0|||
146798682|NCT03250676|529436565|FG001|Overall Study|Adverse Event|0|||
146798683|NCT03250676|529436566|FG002|Overall Study|Adverse Event|0|||
146798684|NCT03250676|529436567|FG003|Overall Study|Adverse Event|1|||
146798685|NCT03250676|529436568|FG004|Overall Study|Adverse Event|2|||
146798686|NCT03250676|529436569|FG005|Overall Study|Adverse Event|9|||
146798687|NCT03250676|529436564|FG000|Overall Study|Withdrawal by Subject|1|||
146798688|NCT03250676|529436565|FG001|Overall Study|Withdrawal by Subject|0|||
146798689|NCT03250676|529436566|FG002|Overall Study|Withdrawal by Subject|0|||
146798690|NCT03250676|529436567|FG003|Overall Study|Withdrawal by Subject|1|||
146798691|NCT03250676|529436568|FG004|Overall Study|Withdrawal by Subject|1|||
146798692|NCT03250676|529436569|FG005|Overall Study|Withdrawal by Subject|2|||
146798693|NCT03250676|529436564|FG000|Overall Study|Physician Decision|0|||
146798694|NCT03250676|529436565|FG001|Overall Study|Physician Decision|0|||
146798695|NCT03250676|529436566|FG002|Overall Study|Physician Decision|0|||
146798696|NCT03250676|529436567|FG003|Overall Study|Physician Decision|2|||
146798697|NCT03250676|529436568|FG004|Overall Study|Physician Decision|0|||
146798698|NCT03250676|529436569|FG005|Overall Study|Physician Decision|3|||
146798699|NCT03250676|529436564|FG000|Overall Study|Withdrawal of consent|0|||
146798700|NCT03250676|529436565|FG001|Overall Study|Withdrawal of consent|0|||
146798701|NCT03250676|529436566|FG002|Overall Study|Withdrawal of consent|2|||
146798702|NCT03250676|529436567|FG003|Overall Study|Withdrawal of consent|0|||
146798703|NCT03250676|529436568|FG004|Overall Study|Withdrawal of consent|0|||
146798704|NCT03250676|529436569|FG005|Overall Study|Withdrawal of consent|2|||
146798705|NCT03250676|529436564|FG000|Overall Study|Other|1|||
146798706|NCT03250676|529436565|FG001|Overall Study|Other|0|||
146798707|NCT03250676|529436566|FG002|Overall Study|Other|0|||
146798708|NCT03250676|529436567|FG003|Overall Study|Other|0|||
146798709|NCT03250676|529436568|FG004|Overall Study|Other|0|||
146798710|NCT03250676|529436569|FG005|Overall Study|Other|0|||
146798711|NCT03250676|529436564|FG000|Overall Study|Disease progression|4|||
146798712|NCT03250676|529436565|FG001|Overall Study|Disease progression|12|||
146798713|NCT03250676|529436566|FG002|Overall Study|Disease progression|9|||
146798714|NCT03250676|529436567|FG003|Overall Study|Disease progression|7|||
146798715|NCT03250676|529436568|FG004|Overall Study|Disease progression|4|||
146798716|NCT03250676|529436569|FG005|Overall Study|Disease progression|88|||
146798717|NCT04626427|529436570|FG000|Overall Study|Death|1|||
146798718|NCT04626427|529436570|FG000|Overall Study|Withdrawal by Subject|1|||
146798719|NCT04626427|529436570|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
146798720|NCT04626427|529436570|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
146798721|NCT02325154|529436571|FG000|Overall Study|Physician Decision|1|||
146798722|NCT01265537|529436572|FG000|Overall Study|Adverse Event|2|||
146798723|NCT01265537|529436573|FG001|Overall Study|Adverse Event|1|||
146798724|NCT01265537|529436572|FG000|Overall Study|Physician Decision|0|||
146798725|NCT01265537|529436573|FG001|Overall Study|Physician Decision|1|||
146798726|NCT04595331|529437569|FG000|Overall Study|Withdrawal by Subject|0|||
146798727|NCT04595331|529437570|FG001|Overall Study|Withdrawal by Subject|1|||
146798728|NCT04595331|529437569|FG000|Overall Study|Lost to Follow-up|0|||
146798729|NCT04595331|529437570|FG001|Overall Study|Lost to Follow-up|5|||
146798730|NCT04595331|529437569|FG000|Overall Study|Medical reason|0|||
146798731|NCT04595331|529437570|FG001|Overall Study|Medical reason|1|||
146798732|NCT05412004|529437572|FG000|Overall Study|Adverse Event|0|||
146798733|NCT05412004|529437573|FG001|Overall Study|Adverse Event|2|||
146798734|NCT05412004|529437574|FG002|Overall Study|Adverse Event|1|||
146798735|NCT05412004|529437575|FG003|Overall Study|Adverse Event|5|||
146798736|NCT05412004|529437572|FG000|Overall Study|Assigned Treatment by Mistake|5|||
146798737|NCT05412004|529437573|FG001|Overall Study|Assigned Treatment by Mistake|10|||
146798738|NCT05412004|529437574|FG002|Overall Study|Assigned Treatment by Mistake|2|||
146798739|NCT05412004|529437575|FG003|Overall Study|Assigned Treatment by Mistake|5|||
146798740|NCT05412004|529437572|FG000|Overall Study|Lost to Follow-up|3|||
146798741|NCT05412004|529437573|FG001|Overall Study|Lost to Follow-up|0|||
146798742|NCT05412004|529437574|FG002|Overall Study|Lost to Follow-up|0|||
146798743|NCT05412004|529437575|FG003|Overall Study|Lost to Follow-up|0|||
146798744|NCT05412004|529437572|FG000|Overall Study|Patient could not travel to site|0|||
146798745|NCT05412004|529437573|FG001|Overall Study|Patient could not travel to site|1|||
146798746|NCT05412004|529437574|FG002|Overall Study|Patient could not travel to site|0|||
146798747|NCT05412004|529437575|FG003|Overall Study|Patient could not travel to site|0|||
146798748|NCT05412004|529437572|FG000|Overall Study|Physician Decision|0|||
146798749|NCT05412004|529437573|FG001|Overall Study|Physician Decision|1|||
146798750|NCT05412004|529437574|FG002|Overall Study|Physician Decision|0|||
146798751|NCT05412004|529437575|FG003|Overall Study|Physician Decision|0|||
146798752|NCT05412004|529437572|FG000|Overall Study|Pregnancy|0|||
146798753|NCT05412004|529437573|FG001|Overall Study|Pregnancy|1|||
146798754|NCT05412004|529437574|FG002|Overall Study|Pregnancy|0|||
146798755|NCT05412004|529437575|FG003|Overall Study|Pregnancy|0|||
146798756|NCT05412004|529437572|FG000|Overall Study|Protocol Violation|1|||
146798757|NCT05412004|529437573|FG001|Overall Study|Protocol Violation|0|||
146798758|NCT05412004|529437574|FG002|Overall Study|Protocol Violation|0|||
146798759|NCT05412004|529437575|FG003|Overall Study|Protocol Violation|0|||
146798760|NCT05412004|529437572|FG000|Overall Study|Withdrawal by Subject|4|||
146940407|NCT00131664|529939266|FG000|First Period (First 6 Months)|Adverse Event|9|||
146798761|NCT05412004|529437573|FG001|Overall Study|Withdrawal by Subject|19|||
146798762|NCT05412004|529437574|FG002|Overall Study|Withdrawal by Subject|4|||
146798763|NCT05412004|529437575|FG003|Overall Study|Withdrawal by Subject|14|||
146798764|NCT05412004|529437572|FG000|Overall Study|Screen Failure|0|||
146798765|NCT05412004|529437573|FG001|Overall Study|Screen Failure|0|||
146798766|NCT05412004|529437574|FG002|Overall Study|Screen Failure|0|||
146798767|NCT05412004|529437575|FG003|Overall Study|Screen Failure|1|||
146798768|NCT05412004|529437572|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
146798769|NCT05412004|529437573|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
146798770|NCT05412004|529437574|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
146798771|NCT05412004|529437575|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
146798772|NCT04644029|529437576|FG000|Overall Study|Death|1|||
146798773|NCT04644029|529437577|FG001|Overall Study|Death|0|||
146798774|NCT04644029|529437576|FG000|Overall Study|Physician Decision|1|||
146798775|NCT04644029|529437577|FG001|Overall Study|Physician Decision|2|||
146798776|NCT04644029|529437576|FG000|Overall Study|Withdrawal by Subject|21|||
146798777|NCT04644029|529437577|FG001|Overall Study|Withdrawal by Subject|19|||
146798778|NCT04644029|529437576|FG000|Overall Study|Lost to Follow-up|31|||
146798779|NCT04644029|529437577|FG001|Overall Study|Lost to Follow-up|34|||
146798780|NCT04644029|529437576|FG000|Overall Study|Study Terminated by Sponsor|308|||
146798781|NCT04644029|529437577|FG001|Overall Study|Study Terminated by Sponsor|309|||
146798782|NCT04644029|529437576|FG000|Overall Study|Randomized in Error|2|||
146798783|NCT04644029|529437577|FG001|Overall Study|Randomized in Error|1|||
146798784|NCT04644029|529437576|FG000|Overall Study|Other|0|||
146798785|NCT04644029|529437577|FG001|Overall Study|Other|1|||
146798786|NCT05020353|529437578|FG000|Overall Study|Protocol Violation|7|||
146798787|NCT05020353|529437578|FG000|Overall Study|Withdrawal by Subject|33|||
146798788|NCT05132400|529437579|FG000|Overall Study|Withdrawal by Subject|14|||
146798789|NCT05132400|529437580|FG001|Overall Study|Withdrawal by Subject|8|||
146798790|NCT05132400|529437579|FG000|Overall Study|Lost to Follow-up|132|||
146798791|NCT05132400|529437580|FG001|Overall Study|Lost to Follow-up|121|||
146798792|NCT02611687|529437582|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
146798793|NCT02611687|529437583|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
146798794|NCT03934931|529437584|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
146798795|NCT03934931|529437585|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
146798796|NCT03934931|529437586|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
146798797|NCT03786926|529437594|FG000|Overall Study|Adverse Event|0|||
146798798|NCT03786926|529437595|FG001|Overall Study|Adverse Event|0|||
146798799|NCT03786926|529437596|FG002|Overall Study|Adverse Event|0|||
146798800|NCT03786926|529437597|FG003|Overall Study|Adverse Event|0|||
146798801|NCT03786926|529437598|FG004|Overall Study|Adverse Event|0|||
146798802|NCT03786926|529437599|FG005|Overall Study|Adverse Event|0|||
146798803|NCT03786926|529437600|FG006|Overall Study|Adverse Event|0|||
146798804|NCT03786926|529437601|FG007|Overall Study|Adverse Event|1|||
146798805|NCT03786926|529437602|FG008|Overall Study|Adverse Event|1|||
146798806|NCT03786926|529437603|FG009|Overall Study|Adverse Event|0|||
146798807|NCT03786926|529437604|FG010|Overall Study|Adverse Event|1|||
146798808|NCT03786926|529437594|FG000|Overall Study|Progressive disease|3|||
146798809|NCT03786926|529437595|FG001|Overall Study|Progressive disease|0|||
146798810|NCT03786926|529437596|FG002|Overall Study|Progressive disease|3|||
146798811|NCT03786926|529437597|FG003|Overall Study|Progressive disease|1|||
146798812|NCT03786926|529437598|FG004|Overall Study|Progressive disease|2|||
146798813|NCT03786926|529437599|FG005|Overall Study|Progressive disease|2|||
146798814|NCT03786926|529437600|FG006|Overall Study|Progressive disease|1|||
146798815|NCT03786926|529437601|FG007|Overall Study|Progressive disease|6|||
146798816|NCT03786926|529437602|FG008|Overall Study|Progressive disease|1|||
146798817|NCT03786926|529437603|FG009|Overall Study|Progressive disease|1|||
146798818|NCT03786926|529437604|FG010|Overall Study|Progressive disease|1|||
146798819|NCT03786926|529437594|FG000|Overall Study|Death|0|||
146798820|NCT03786926|529437595|FG001|Overall Study|Death|1|||
146798821|NCT03786926|529437596|FG002|Overall Study|Death|1|||
146798822|NCT03786926|529437597|FG003|Overall Study|Death|0|||
146798823|NCT03786926|529437598|FG004|Overall Study|Death|0|||
146798824|NCT03786926|529437599|FG005|Overall Study|Death|0|||
146798825|NCT03786926|529437600|FG006|Overall Study|Death|0|||
146798826|NCT03786926|529437601|FG007|Overall Study|Death|0|||
146798827|NCT03786926|529437602|FG008|Overall Study|Death|0|||
146798828|NCT03786926|529437603|FG009|Overall Study|Death|1|||
146798829|NCT03786926|529437604|FG010|Overall Study|Death|2|||
146798830|NCT03786926|529437594|FG000|Overall Study|Physician Decision|0|||
146798831|NCT03786926|529437595|FG001|Overall Study|Physician Decision|1|||
146798832|NCT03786926|529437596|FG002|Overall Study|Physician Decision|0|||
146798833|NCT03786926|529437597|FG003|Overall Study|Physician Decision|1|||
146798834|NCT03786926|529437598|FG004|Overall Study|Physician Decision|2|||
146798835|NCT03786926|529437599|FG005|Overall Study|Physician Decision|0|||
146798836|NCT03786926|529437600|FG006|Overall Study|Physician Decision|0|||
146798837|NCT03786926|529437601|FG007|Overall Study|Physician Decision|2|||
146798838|NCT03786926|529437602|FG008|Overall Study|Physician Decision|1|||
146798839|NCT03786926|529437603|FG009|Overall Study|Physician Decision|1|||
146798840|NCT03786926|529437604|FG010|Overall Study|Physician Decision|0|||
146798841|NCT03786926|529437594|FG000|Overall Study|Withdrawal by Subject|0|||
146798842|NCT03786926|529437595|FG001|Overall Study|Withdrawal by Subject|1|||
146798843|NCT03786926|529437596|FG002|Overall Study|Withdrawal by Subject|1|||
146798844|NCT03786926|529437597|FG003|Overall Study|Withdrawal by Subject|0|||
146798845|NCT03786926|529437598|FG004|Overall Study|Withdrawal by Subject|0|||
146798846|NCT03786926|529437599|FG005|Overall Study|Withdrawal by Subject|0|||
146798847|NCT03786926|529437600|FG006|Overall Study|Withdrawal by Subject|1|||
146798848|NCT03786926|529437601|FG007|Overall Study|Withdrawal by Subject|0|||
146798849|NCT03786926|529437602|FG008|Overall Study|Withdrawal by Subject|1|||
146798850|NCT03786926|529437603|FG009|Overall Study|Withdrawal by Subject|0|||
146798851|NCT03786926|529437604|FG010|Overall Study|Withdrawal by Subject|1|||
146798852|NCT03786926|529437594|FG000|Overall Study|Study terminated by Sponsor|0|||
146798853|NCT03786926|529437595|FG001|Overall Study|Study terminated by Sponsor|0|||
146798854|NCT03786926|529437596|FG002|Overall Study|Study terminated by Sponsor|0|||
146798855|NCT03786926|529437597|FG003|Overall Study|Study terminated by Sponsor|0|||
146798856|NCT03786926|529437598|FG004|Overall Study|Study terminated by Sponsor|1|||
146798857|NCT03786926|529437599|FG005|Overall Study|Study terminated by Sponsor|0|||
146798858|NCT03786926|529437600|FG006|Overall Study|Study terminated by Sponsor|0|||
146798859|NCT03786926|529437601|FG007|Overall Study|Study terminated by Sponsor|4|||
146798860|NCT03786926|529437602|FG008|Overall Study|Study terminated by Sponsor|0|||
146798861|NCT03786926|529437603|FG009|Overall Study|Study terminated by Sponsor|0|||
146798862|NCT03786926|529437604|FG010|Overall Study|Study terminated by Sponsor|0|||
146798863|NCT03786926|529437594|FG000|Overall Study|Anti-neoplasm treatment|0|||
146798864|NCT03786926|529437595|FG001|Overall Study|Anti-neoplasm treatment|0|||
146798865|NCT03786926|529437596|FG002|Overall Study|Anti-neoplasm treatment|0|||
146798866|NCT03786926|529437597|FG003|Overall Study|Anti-neoplasm treatment|0|||
146798867|NCT03786926|529437598|FG004|Overall Study|Anti-neoplasm treatment|1|||
146798868|NCT03786926|529437599|FG005|Overall Study|Anti-neoplasm treatment|0|||
146798869|NCT03786926|529437600|FG006|Overall Study|Anti-neoplasm treatment|1|||
146798870|NCT03786926|529437601|FG007|Overall Study|Anti-neoplasm treatment|0|||
146798871|NCT03786926|529437602|FG008|Overall Study|Anti-neoplasm treatment|0|||
146798872|NCT03786926|529437603|FG009|Overall Study|Anti-neoplasm treatment|0|||
146798873|NCT03786926|529437604|FG010|Overall Study|Anti-neoplasm treatment|0|||
146798874|NCT03786926|529437594|FG000|Overall Study|Other|0|||
146798875|NCT03786926|529437595|FG001|Overall Study|Other|0|||
146798876|NCT03786926|529437596|FG002|Overall Study|Other|0|||
146798877|NCT03786926|529437597|FG003|Overall Study|Other|1|||
146798878|NCT03786926|529437598|FG004|Overall Study|Other|0|||
146798879|NCT03786926|529437599|FG005|Overall Study|Other|1|||
146798880|NCT03786926|529437600|FG006|Overall Study|Other|0|||
146798881|NCT03786926|529437601|FG007|Overall Study|Other|0|||
146798882|NCT03786926|529437602|FG008|Overall Study|Other|2|||
146798883|NCT03786926|529437603|FG009|Overall Study|Other|0|||
146798884|NCT03786926|529437604|FG010|Overall Study|Other|0|||
146798885|NCT05875701|529437609|FG000|Overall Study|Lost to Follow-up|2|||
146798886|NCT05875701|529437610|FG001|Overall Study|Lost to Follow-up|0|||
146798887|NCT05875701|529437609|FG000|Overall Study|Withdrawal by Subject|1|||
146798888|NCT05875701|529437610|FG001|Overall Study|Withdrawal by Subject|1|||
146798889|NCT03884439|529437624|FG000|Overall Study|No informed consent for publication of study results|38|||
146798890|NCT03884439|529437624|FG000|Overall Study|Contract violation/deficiency|7|||
146798891|NCT02806726|529437632|FG000|Overall Study|Lost to Follow-up|1|||
146798892|NCT05129501|529437635|FG000|Overall Study|Lost to Follow-up|54|||
146798893|NCT05129501|529437636|FG001|Overall Study|Lost to Follow-up|41|||
146798894|NCT03092674|529437637|FG000|Overall Study|Adverse Event or Side Effects|1|||
146798895|NCT03092674|529437638|FG001|Overall Study|Adverse Event or Side Effects|4|||
146798896|NCT03092674|529437639|FG002|Overall Study|Adverse Event or Side Effects|4|||
146798897|NCT03092674|529437637|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
146798898|NCT03092674|529437638|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
146798899|NCT03092674|529437639|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
146798900|NCT03092674|529437637|FG000|Overall Study|Progression/Relapse|5|||
146798901|NCT03092674|529437638|FG001|Overall Study|Progression/Relapse|4|||
146798902|NCT03092674|529437639|FG002|Overall Study|Progression/Relapse|8|||
146798903|NCT03092674|529437637|FG000|Overall Study|Death|4|||
146798904|NCT03092674|529437638|FG001|Overall Study|Death|8|||
146798905|NCT03092674|529437639|FG002|Overall Study|Death|2|||
146798906|NCT03092674|529437637|FG000|Overall Study|Other - Not Protocol Specified|11|||
146798907|NCT03092674|529437638|FG001|Overall Study|Other - Not Protocol Specified|8|||
146798908|NCT03092674|529437639|FG002|Overall Study|Other - Not Protocol Specified|8|||
146798909|NCT01527188|529437640|FG000|Overall Study|Adverse Event|5|||
146798910|NCT01527188|529437641|FG001|Overall Study|Adverse Event|5|||
146798911|NCT01527188|529437642|FG002|Overall Study|Adverse Event|11|||
146798912|NCT01527188|529437643|FG003|Overall Study|Adverse Event|0|||
146798913|NCT01527188|529437640|FG000|Overall Study|Withdrawal by Subject|3|||
146940408|NCT00131664|529939267|FG001|First Period (First 6 Months)|Adverse Event|4|||
146940409|NCT00131664|529939268|FG002|First Period (First 6 Months)|Adverse Event|5|||
146940410|NCT00131664|529939269|FG003|First Period (First 6 Months)|Adverse Event|0|||
146940411|NCT00131664|529939270|FG004|First Period (First 6 Months)|Adverse Event|0|||
146940412|NCT00131664|529939271|FG005|First Period (First 6 Months)|Adverse Event|0|||
146940413|NCT00131664|529939266|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
146940414|NCT00131664|529939267|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
146798914|NCT01527188|529437641|FG001|Overall Study|Withdrawal by Subject|6|||
146798915|NCT01527188|529437642|FG002|Overall Study|Withdrawal by Subject|4|||
146798916|NCT01527188|529437643|FG003|Overall Study|Withdrawal by Subject|4|||
146798917|NCT01527188|529437640|FG000|Overall Study|Any other reason not above-mentioned|6|||
146798918|NCT01527188|529437641|FG001|Overall Study|Any other reason not above-mentioned|7|||
146798919|NCT01527188|529437642|FG002|Overall Study|Any other reason not above-mentioned|8|||
146940415|NCT00131664|529939268|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
146798920|NCT01527188|529437643|FG003|Overall Study|Any other reason not above-mentioned|8|||
146798921|NCT03982186|529437646|FG000|Overall Study|Lost to Follow-up|0|||
146798922|NCT03982186|529437647|FG001|Overall Study|Lost to Follow-up|1|||
146798923|NCT03982186|529437648|FG002|Overall Study|Lost to Follow-up|2|||
146940416|NCT00131664|529939269|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
146940417|NCT00131664|529939270|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
146940418|NCT00131664|529939271|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
146940419|NCT00131664|529939266|FG000|First Period (First 6 Months)|Administrative reasons|2|||
146940420|NCT00131664|529939267|FG001|First Period (First 6 Months)|Administrative reasons|0|||
146940421|NCT00131664|529939268|FG002|First Period (First 6 Months)|Administrative reasons|5|||
146940422|NCT00131664|529939269|FG003|First Period (First 6 Months)|Administrative reasons|0|||
146940423|NCT00131664|529939270|FG004|First Period (First 6 Months)|Administrative reasons|0|||
146940424|NCT00131664|529939271|FG005|First Period (First 6 Months)|Administrative reasons|0|||
146940425|NCT00131664|529939266|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
146940426|NCT00131664|529939267|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
146940427|NCT00131664|529939268|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
146940428|NCT00131664|529939269|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
146940429|NCT00131664|529939270|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
146940430|NCT00131664|529939271|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
146940431|NCT00131664|529939266|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
146940432|NCT00131664|529939267|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
146940433|NCT00131664|529939268|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
146940434|NCT00131664|529939269|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
146940435|NCT00131664|529939270|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
146940436|NCT00131664|529939271|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
146940437|NCT00131664|529939266|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
146940438|NCT00131664|529939267|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
146940439|NCT00131664|529939268|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
146940440|NCT00131664|529939269|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
146940441|NCT00131664|529939270|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
146940442|NCT00131664|529939271|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
146940443|NCT00131664|529939266|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
146940444|NCT00131664|529939267|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
146940445|NCT00131664|529939268|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
146940446|NCT00131664|529939269|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
146940447|NCT00131664|529939270|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
146940448|NCT00131664|529939271|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
146940449|NCT00131664|529939266|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
146940450|NCT00131664|529939267|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
146940451|NCT00131664|529939268|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
146940452|NCT00131664|529939269|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
146940453|NCT00131664|529939270|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
146940454|NCT00131664|529939271|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
146940455|NCT00131664|529939266|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
146940456|NCT00131664|529939267|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
146940457|NCT00131664|529939268|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
146940458|NCT00131664|529939269|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
146940459|NCT00131664|529939270|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
146940460|NCT00131664|529939271|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
146940461|NCT00959894|529941330|FG000|Overall Study|Lost to Follow-up|10|||
146940462|NCT00959894|529941330|FG000|Overall Study|Adverse Event|3|||
146940463|NCT00959894|529941330|FG000|Overall Study|Withdrawal by Subject|1|||
146940464|NCT00959894|529941330|FG000|Overall Study|Need for contraindicated medication|1|||
146940465|NCT00959894|529941330|FG000|Overall Study|Subject moved out of town|1|||
146940466|NCT00323310|529941331|FG000|Overall Study|Withdrawal by Subject|1|||
146940467|NCT00323310|529941331|FG000|Overall Study|a parent refused blood draw|1|||
146940468|NCT00323310|529941331|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
146940469|NCT03565991|529941333|FG000|Overall Study|Other|11|||
146940470|NCT03565991|529941334|FG001|Overall Study|Other|0|||
146940471|NCT03565991|529941333|FG000|Overall Study|Global deterioration of health status|14|||
146940472|NCT03565991|529941334|FG001|Overall Study|Global deterioration of health status|4|||
146940473|NCT03565991|529941333|FG000|Overall Study|Withdrawal by Subject|2|||
146940474|NCT03565991|529941334|FG001|Overall Study|Withdrawal by Subject|6|||
146940475|NCT03565991|529941333|FG000|Overall Study|Progressive disease|121|||
146940476|NCT03565991|529941334|FG001|Overall Study|Progressive disease|29|||
146940477|NCT03565991|529941333|FG000|Overall Study|Death|3|||
146940478|NCT03565991|529941334|FG001|Overall Study|Death|0|||
146940479|NCT03565991|529941333|FG000|Overall Study|Adverse Event|7|||
146940480|NCT03565991|529941334|FG001|Overall Study|Adverse Event|2|||
146940481|NCT02009930|529941342|FG000|Overall Study|withdrawn|5|||
146940482|NCT02959970|529941345|FG000|Overall Study|Adverse Event|1|||
146940483|NCT02959970|529941346|FG001|Overall Study|Adverse Event|0|||
146940484|NCT02959970|529941345|FG000|Overall Study|Withdrawal by Subject|0|||
146940485|NCT02959970|529941346|FG001|Overall Study|Withdrawal by Subject|2|||
146940486|NCT02959970|529941345|FG000|Overall Study|Lost to Follow-up|1|||
146940487|NCT02959970|529941346|FG001|Overall Study|Lost to Follow-up|5|||
146940488|NCT00666536|529941347|FG000|Overall Study|Adverse Event|9|||
146940489|NCT00666536|529941348|FG001|Overall Study|Adverse Event|19|||
146940490|NCT00666536|529941347|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146940491|NCT00666536|529941348|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146940492|NCT00666536|529941347|FG000|Overall Study|Protocol deviation(s)|8|||
146940493|NCT00666536|529941348|FG001|Overall Study|Protocol deviation(s)|6|||
146940494|NCT00666536|529941347|FG000|Overall Study|Withdrawal by Subject|10|||
146940495|NCT00666536|529941348|FG001|Overall Study|Withdrawal by Subject|9|||
146940496|NCT00666536|529941347|FG000|Overall Study|Lost to Follow-up|4|||
146940497|NCT00666536|529941348|FG001|Overall Study|Lost to Follow-up|3|||
146940498|NCT01495689|529941352|FG000|Overall Study|Death|0|||
146940499|NCT01495689|529941353|FG001|Overall Study|Death|1|||
146940500|NCT01495689|529941352|FG000|Overall Study|Withdrawal by Subject|3|||
146940501|NCT01495689|529941353|FG001|Overall Study|Withdrawal by Subject|0|||
146940502|NCT01495689|529941352|FG000|Overall Study|Lost to Follow-up|7|||
146940503|NCT01495689|529941353|FG001|Overall Study|Lost to Follow-up|6|||
146940504|NCT05516134|529941354|FG000|Overall Study|Lost to Follow-up|1|||
146940505|NCT05516134|529941355|FG001|Overall Study|Lost to Follow-up|0|||
146940506|NCT05516134|529941356|FG002|Overall Study|Lost to Follow-up|0|||
146940507|NCT01355497|529941369|FG000|Overall Study|Death|19|||
146940508|NCT01355497|529941370|FG001|Overall Study|Death|18|||
146940509|NCT01355497|529941369|FG000|Overall Study|Lost to Follow-up|3|||
146940510|NCT01355497|529941370|FG001|Overall Study|Lost to Follow-up|0|||
146940511|NCT01355497|529941369|FG000|Overall Study|Protocol Violation|0|||
146940512|NCT01355497|529941370|FG001|Overall Study|Protocol Violation|1|||
146940513|NCT01355497|529941369|FG000|Overall Study|other-not provided|9|||
146940514|NCT01355497|529941370|FG001|Overall Study|other-not provided|4|||
146940515|NCT01355497|529941369|FG000|Overall Study|Withdrawal by Subject|12|||
146940516|NCT01355497|529941370|FG001|Overall Study|Withdrawal by Subject|20|||
146940517|NCT01355497|529941369|FG000|Overall Study|noncompliance|1|||
146940518|NCT01355497|529941370|FG001|Overall Study|noncompliance|2|||
146940519|NCT01355497|529941369|FG000|Overall Study|progressive disease|11|||
146940520|NCT01355497|529941370|FG001|Overall Study|progressive disease|8|||
146940521|NCT01355497|529941369|FG000|Overall Study|Adverse Event|11|||
146940522|NCT01355497|529941370|FG001|Overall Study|Adverse Event|10|||
146940523|NCT01001572|529941372|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
146940524|NCT01001572|529941373|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
146940525|NCT01001572|529941374|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
146940526|NCT01001572|529941372|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
146940527|NCT01001572|529941373|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
146940528|NCT01001572|529941374|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
146940529|NCT01001572|529941372|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
146940530|NCT01001572|529941373|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
146940531|NCT01001572|529941374|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
146940532|NCT01001572|529941372|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
146940533|NCT01001572|529941373|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
146940534|NCT01001572|529941374|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
146940535|NCT01001572|529941372|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
146940536|NCT01001572|529941373|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
146940537|NCT01001572|529941374|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
146940538|NCT01001572|529941372|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
146940539|NCT01001572|529941373|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
146940540|NCT01001572|529941374|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
146940541|NCT01001572|529941372|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
146940542|NCT01001572|529941373|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
146940543|NCT01001572|529941374|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
146940544|NCT01001572|529941372|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
146798924|NCT03982186|529437649|FG003|Overall Study|Lost to Follow-up|1|||
146798925|NCT03982186|529437650|FG004|Overall Study|Lost to Follow-up|1|||
146940545|NCT01001572|529941373|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
146940546|NCT01001572|529941374|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
146940547|NCT01001572|529941372|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
146940548|NCT01001572|529941373|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
146940549|NCT01001572|529941374|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
146798926|NCT03982186|529437651|FG005|Overall Study|Lost to Follow-up|0|||
146940550|NCT01001572|529941372|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
146940551|NCT01001572|529941373|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
146620829|NCT04816214|528783444|FG002|Overall Study|Progressive Disease|0|||
146940552|NCT01001572|529941374|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
146940553|NCT01001572|529941372|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
146940554|NCT01001572|529941373|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
146940555|NCT01001572|529941374|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
146940556|NCT01001572|529941372|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
146940557|NCT01001572|529941373|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
146940558|NCT01001572|529941374|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
146940559|NCT01001572|529941372|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
146940560|NCT01001572|529941373|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
146940561|NCT01001572|529941374|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
146940562|NCT01001572|529941372|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146940563|NCT01001572|529941373|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146940564|NCT01001572|529941374|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
146940565|NCT01094808|529941375|FG000|Overall Study|Withdrawal by Subject|1|||
146940566|NCT01094808|529941376|FG001|Overall Study|Withdrawal by Subject|1|||
146940567|NCT01094808|529941377|FG002|Overall Study|Withdrawal by Subject|0|||
146940568|NCT00369278|529941378|FG000|Overall Study|Adverse Event|14|||
146940569|NCT00369278|529941379|FG001|Overall Study|Adverse Event|11|||
146940570|NCT00369278|529941378|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146940571|NCT00369278|529941379|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
146940572|NCT00369278|529941378|FG000|Overall Study|Protocol Violation|2|||
146940573|NCT00369278|529941379|FG001|Overall Study|Protocol Violation|1|||
146940574|NCT00369278|529941378|FG000|Overall Study|Withdrawal by Subject|2|||
146940575|NCT00369278|529941379|FG001|Overall Study|Withdrawal by Subject|2|||
146940576|NCT00369278|529941378|FG000|Overall Study|Lost to Follow-up|1|||
146940577|NCT00369278|529941379|FG001|Overall Study|Lost to Follow-up|0|||
146940578|NCT00369278|529941378|FG000|Overall Study|Graft loss|1|||
146940579|NCT00369278|529941379|FG001|Overall Study|Graft loss|2|||
146940580|NCT02025530|529941382|FG000|Overall Study|No longer met elligibility criteria|5|||
146940581|NCT02025530|529941383|FG001|Overall Study|No longer met elligibility criteria|1|||
146940582|NCT01444898|529941390|FG000|Overall Study|Withdrawal by Subject|1|||
146940583|NCT03235726|529941391|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146940584|NCT03235726|529941392|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146940585|NCT03235726|529941393|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146940586|NCT03235726|529941394|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146940587|NCT03235726|529941395|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
146940588|NCT03235726|529941396|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146940589|NCT03235726|529941397|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146940590|NCT03235726|529941398|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146940591|NCT03235726|529941399|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146940592|NCT03235726|529941400|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146940593|NCT03235726|529941391|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146940594|NCT03235726|529941392|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146940595|NCT03235726|529941393|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146940596|NCT03235726|529941394|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146940597|NCT03235726|529941395|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
146940598|NCT03235726|529941396|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146940599|NCT03235726|529941397|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146940600|NCT03235726|529941398|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146940601|NCT03235726|529941399|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146940602|NCT03235726|529941400|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146798927|NCT03982186|529437646|FG000|Overall Study|Physician Decision|0|||
146798928|NCT03982186|529437647|FG001|Overall Study|Physician Decision|1|||
146798929|NCT03982186|529437648|FG002|Overall Study|Physician Decision|0|||
146798930|NCT03982186|529437649|FG003|Overall Study|Physician Decision|0|||
146798931|NCT03982186|529437650|FG004|Overall Study|Physician Decision|0|||
146798932|NCT03982186|529437651|FG005|Overall Study|Physician Decision|0|||
146798933|NCT03982186|529437646|FG000|Overall Study|Withdrawal by Subject|3|||
146798934|NCT03982186|529437647|FG001|Overall Study|Withdrawal by Subject|4|||
146798935|NCT03982186|529437648|FG002|Overall Study|Withdrawal by Subject|1|||
146940603|NCT00990249|529941409|FG000|Overall Study|Disease Progression|8|||
146940604|NCT00990249|529941409|FG000|Overall Study|Non-Compliance|1|||
146940605|NCT00990249|529941409|FG000|Overall Study|Death|2|||
146940606|NCT00990249|529941409|FG000|Overall Study|Not treated|2|||
146940607|NCT02873208|529941412|FG000|Overall Study|Withdrawal by Subject|36|||
146798936|NCT03982186|529437649|FG003|Overall Study|Withdrawal by Subject|7|||
146798937|NCT03982186|529437650|FG004|Overall Study|Withdrawal by Subject|2|||
146798938|NCT03982186|529437651|FG005|Overall Study|Withdrawal by Subject|0|||
146798939|NCT03982186|529437646|FG000|Overall Study|Randomized and not treated|0|||
146798940|NCT03982186|529437647|FG001|Overall Study|Randomized and not treated|0|||
146798941|NCT03982186|529437648|FG002|Overall Study|Randomized and not treated|0|||
146798942|NCT03982186|529437649|FG003|Overall Study|Randomized and not treated|1|||
146798943|NCT03982186|529437650|FG004|Overall Study|Randomized and not treated|0|||
146798944|NCT03982186|529437651|FG005|Overall Study|Randomized and not treated|0|||
146798945|NCT01553149|529437652|FG000|Overall Study|Adverse Event|0|||
146798946|NCT01553149|529437653|FG001|Overall Study|Adverse Event|9|||
146798947|NCT01553149|529437652|FG000|Overall Study|Physician Decision|5|||
146798948|NCT01553149|529437653|FG001|Overall Study|Physician Decision|10|||
146798949|NCT01553149|529437652|FG000|Overall Study|Ineligible|0|||
146798950|NCT01553149|529437653|FG001|Overall Study|Ineligible|1|||
146798951|NCT05866926|529437654|FG000|Overall Study|Death|16|||
146798952|NCT05866926|529437655|FG001|Overall Study|Death|9|||
146798953|NCT05866926|529437654|FG000|Overall Study|Lost to Follow-up|0|||
146798954|NCT05866926|529437655|FG001|Overall Study|Lost to Follow-up|1|||
146798955|NCT05866926|529437654|FG000|Overall Study|Adverse Event|1|||
146798956|NCT05866926|529437655|FG001|Overall Study|Adverse Event|0|||
146798957|NCT05866926|529437654|FG000|Overall Study|Withdrawal by Subject|5|||
146798958|NCT05866926|529437655|FG001|Overall Study|Withdrawal by Subject|1|||
146798959|NCT05866926|529437654|FG000|Overall Study|Disease progression|1|||
146798960|NCT05866926|529437655|FG001|Overall Study|Disease progression|0|||
146798961|NCT05866926|529437654|FG000|Overall Study|other causes|2|||
146798962|NCT05866926|529437655|FG001|Overall Study|other causes|1|||
146798963|NCT03512301|529438248|FG000|Overall Study|Protocol Violation|2|||
146798964|NCT03512301|529438248|FG000|Overall Study|Did Not Qualify|3|||
146798965|NCT03512301|529438248|FG000|Overall Study|Age-ineligible|1|||
146798966|NCT03512301|529438248|FG000|Overall Study|Inadequate fluency with the English language|3|||
146798967|NCT00739908|529438255|FG000|Overall Study|Adverse Event|5|||
146940608|NCT02873208|529941412|FG000|Overall Study|Lost to Follow-up|22|||
146940609|NCT02873208|529941412|FG000|Overall Study|Adverse Event|15|||
146940610|NCT02873208|529941412|FG000|Overall Study|Non-compliance with study drug|12|||
146940611|NCT02873208|529941412|FG000|Overall Study|Protocol Violation|8|||
146940612|NCT02873208|529941412|FG000|Overall Study|Pregnancy|2|||
146940613|NCT02873208|529941412|FG000|Overall Study|Incarceration|1|||
146940614|NCT02873208|529941412|FG000|Overall Study|Lack of Efficacy|1|||
146940615|NCT02873208|529941412|FG000|Overall Study|Physician Decision|1|||
146940616|NCT00415584|529941413|FG000|Overall Study|Withdrawal by Subject|1|||
146940617|NCT00563368|529941414|FG000|Overall Study|Lost to Follow-up|14|||
146940618|NCT00563368|529941415|FG001|Overall Study|Lost to Follow-up|14|||
146940619|NCT00563368|529941416|FG002|Overall Study|Lost to Follow-up|12|||
146940620|NCT00563368|529941417|FG003|Overall Study|Lost to Follow-up|6|||
146940621|NCT00563368|529941418|FG004|Overall Study|Lost to Follow-up|9|||
146940622|NCT00563368|529941419|FG005|Overall Study|Lost to Follow-up|8|||
146940623|NCT00563368|529941420|FG006|Overall Study|Lost to Follow-up|9|||
146940624|NCT00563368|529941414|FG000|Overall Study|Adverse Event|3|||
146940625|NCT00563368|529941415|FG001|Overall Study|Adverse Event|4|||
146940626|NCT00563368|529941416|FG002|Overall Study|Adverse Event|5|||
146940627|NCT00563368|529941417|FG003|Overall Study|Adverse Event|9|||
146940628|NCT00563368|529941418|FG004|Overall Study|Adverse Event|6|||
146940629|NCT00563368|529941419|FG005|Overall Study|Adverse Event|10|||
146940630|NCT00563368|529941420|FG006|Overall Study|Adverse Event|17|||
146940631|NCT00563368|529941414|FG000|Overall Study|Withdrawal by Subject|11|||
146940632|NCT00563368|529941415|FG001|Overall Study|Withdrawal by Subject|6|||
146940633|NCT00563368|529941416|FG002|Overall Study|Withdrawal by Subject|5|||
146940634|NCT00563368|529941417|FG003|Overall Study|Withdrawal by Subject|7|||
146940635|NCT00563368|529941418|FG004|Overall Study|Withdrawal by Subject|8|||
146940636|NCT00563368|529941419|FG005|Overall Study|Withdrawal by Subject|5|||
146940637|NCT00563368|529941420|FG006|Overall Study|Withdrawal by Subject|4|||
146940638|NCT00563368|529941414|FG000|Overall Study|protocol non-compliance|1|||
146940639|NCT00563368|529941415|FG001|Overall Study|protocol non-compliance|1|||
146940640|NCT00563368|529941416|FG002|Overall Study|protocol non-compliance|2|||
146940641|NCT00563368|529941417|FG003|Overall Study|protocol non-compliance|1|||
146940642|NCT00563368|529941418|FG004|Overall Study|protocol non-compliance|0|||
146940643|NCT00563368|529941419|FG005|Overall Study|protocol non-compliance|1|||
146940644|NCT00563368|529941420|FG006|Overall Study|protocol non-compliance|3|||
146940645|NCT00563368|529941414|FG000|Overall Study|Pregnancy|1|||
146940646|NCT00563368|529941415|FG001|Overall Study|Pregnancy|0|||
146940647|NCT00563368|529941416|FG002|Overall Study|Pregnancy|1|||
146940648|NCT00563368|529941417|FG003|Overall Study|Pregnancy|2|||
146940649|NCT00563368|529941418|FG004|Overall Study|Pregnancy|1|||
146940650|NCT00563368|529941419|FG005|Overall Study|Pregnancy|2|||
146940651|NCT00563368|529941420|FG006|Overall Study|Pregnancy|0|||
146798968|NCT00739908|529438256|FG001|Overall Study|Adverse Event|6|||
146798969|NCT00739908|529438255|FG000|Overall Study|Withdrawal by Subject|4|||
146798970|NCT00739908|529438256|FG001|Overall Study|Withdrawal by Subject|2|||
146798971|NCT00739908|529438255|FG000|Overall Study|Lost to Follow-up|14|||
146798972|NCT00739908|529438256|FG001|Overall Study|Lost to Follow-up|9|||
146798973|NCT00739908|529438255|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
146798974|NCT00739908|529438256|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
146798975|NCT00739908|529438255|FG000|Overall Study|Non-Compliance With Study Medication|0|||
146798976|NCT00739908|529438256|FG001|Overall Study|Non-Compliance With Study Medication|3|||
146798977|NCT00739908|529438255|FG000|Overall Study|Lack of Efficacy|0|||
146798978|NCT00739908|529438256|FG001|Overall Study|Lack of Efficacy|1|||
146798979|NCT00739908|529438255|FG000|Overall Study|Relocation|0|||
146798980|NCT00739908|529438256|FG001|Overall Study|Relocation|1|||
146798981|NCT05157841|529438257|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
146798982|NCT05157841|529438258|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
146798983|NCT05157841|529438259|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
146798984|NCT05157841|529438257|FG000|Part A (14 Days)|Adverse Event|1|||
146798985|NCT05157841|529438258|FG001|Part A (14 Days)|Adverse Event|0|||
146798986|NCT05157841|529438259|FG002|Part A (14 Days)|Adverse Event|0|||
146798987|NCT05157841|529438257|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
146798988|NCT05157841|529438258|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
146798989|NCT05157841|529438259|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
146798990|NCT02075554|529438263|FG000|Overall Study|Lost to Follow-up|7|||
146798991|NCT02075554|529438263|FG000|Overall Study|Withdrawal by Subject|5|||
146798992|NCT02075554|529438263|FG000|Overall Study|Physician Decision|3|||
146798993|NCT04933474|529438269|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
146798994|NCT04933474|529438270|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
146798995|NCT04933474|529438269|FG000|Overall Study|Lost to Follow-up|19|||
146940652|NCT00563368|529941414|FG000|Overall Study|requirement for restricted medication|0|||
146940653|NCT00563368|529941415|FG001|Overall Study|requirement for restricted medication|0|||
146940654|NCT00563368|529941416|FG002|Overall Study|requirement for restricted medication|2|||
146940655|NCT00563368|529941417|FG003|Overall Study|requirement for restricted medication|0|||
146940656|NCT00563368|529941418|FG004|Overall Study|requirement for restricted medication|0|||
146940657|NCT00563368|529941419|FG005|Overall Study|requirement for restricted medication|0|||
146940658|NCT00563368|529941420|FG006|Overall Study|requirement for restricted medication|0|||
146940659|NCT00563368|529941414|FG000|Overall Study|Other|5|||
146940660|NCT00563368|529941415|FG001|Overall Study|Other|5|||
146940661|NCT00563368|529941416|FG002|Overall Study|Other|3|||
146940662|NCT00563368|529941417|FG003|Overall Study|Other|4|||
146940663|NCT00563368|529941418|FG004|Overall Study|Other|4|||
146940664|NCT00563368|529941419|FG005|Overall Study|Other|4|||
146940665|NCT00563368|529941420|FG006|Overall Study|Other|0|||
146940666|NCT01061567|529941421|FG000|Overall Study|Adverse Event|32|||
146940667|NCT01061567|529941421|FG000|Overall Study|Death|2|||
146940668|NCT01061567|529941421|FG000|Overall Study|Lack of Efficacy|3|||
146940669|NCT01061567|529941421|FG000|Overall Study|Lost to Follow-up|24|||
146940670|NCT01061567|529941421|FG000|Overall Study|Protocol Violation|1|||
146940671|NCT01061567|529941421|FG000|Overall Study|Withdrawal by Subject|11|||
146940672|NCT01061567|529941421|FG000|Overall Study|Other reason than stated above|3|||
146940673|NCT01831804|529941422|FG000|Overall Study|Adverse Event|0|||
146940674|NCT01831804|529941423|FG001|Overall Study|Adverse Event|0|||
146940675|NCT01831804|529941424|FG002|Overall Study|Adverse Event|0|||
146940676|NCT01831804|529941425|FG003|Overall Study|Adverse Event|0|||
146940677|NCT01831804|529941426|FG004|Overall Study|Adverse Event|0|||
146940678|NCT01831804|529941427|FG005|Overall Study|Adverse Event|0|||
146940679|NCT01831804|529941428|FG006|Overall Study|Adverse Event|1|||
146940680|NCT01831804|529941429|FG007|Overall Study|Adverse Event|0|||
146940681|NCT01831804|529941430|FG008|Overall Study|Adverse Event|1|||
146940682|NCT01831804|529941422|FG000|Overall Study|Protocol Violation|0|||
146940683|NCT01831804|529941423|FG001|Overall Study|Protocol Violation|0|||
146940684|NCT01831804|529941424|FG002|Overall Study|Protocol Violation|2|||
146940685|NCT01831804|529941425|FG003|Overall Study|Protocol Violation|0|||
146940686|NCT01831804|529941426|FG004|Overall Study|Protocol Violation|0|||
146940687|NCT01831804|529941427|FG005|Overall Study|Protocol Violation|0|||
146940688|NCT01831804|529941428|FG006|Overall Study|Protocol Violation|0|||
146940689|NCT01831804|529941429|FG007|Overall Study|Protocol Violation|0|||
146940690|NCT01831804|529941430|FG008|Overall Study|Protocol Violation|0|||
146940691|NCT01831804|529941422|FG000|Overall Study|Protocol defined stopping criteria|1|||
146940692|NCT01831804|529941423|FG001|Overall Study|Protocol defined stopping criteria|1|||
146940693|NCT01831804|529941424|FG002|Overall Study|Protocol defined stopping criteria|3|||
146940694|NCT01831804|529941425|FG003|Overall Study|Protocol defined stopping criteria|0|||
146940695|NCT01831804|529941426|FG004|Overall Study|Protocol defined stopping criteria|1|||
146798996|NCT04933474|529438270|FG001|Overall Study|Lost to Follow-up|9|||
146940696|NCT01831804|529941427|FG005|Overall Study|Protocol defined stopping criteria|0|||
146798997|NCT04933474|529438269|FG000|Overall Study|Life Burden - unable to participate|6|||
146940697|NCT01831804|529941428|FG006|Overall Study|Protocol defined stopping criteria|0|||
146940698|NCT01831804|529941429|FG007|Overall Study|Protocol defined stopping criteria|0|||
146940699|NCT01831804|529941430|FG008|Overall Study|Protocol defined stopping criteria|0|||
146940700|NCT01831804|529941422|FG000|Overall Study|Lost to Follow-up|0|||
146940701|NCT01831804|529941423|FG001|Overall Study|Lost to Follow-up|0|||
146940702|NCT01831804|529941424|FG002|Overall Study|Lost to Follow-up|1|||
146940703|NCT01831804|529941425|FG003|Overall Study|Lost to Follow-up|0|||
146940704|NCT01831804|529941426|FG004|Overall Study|Lost to Follow-up|0|||
146798998|NCT04933474|529438270|FG001|Overall Study|Life Burden - unable to participate|2|||
146798999|NCT04933474|529438269|FG000|Overall Study|Disease Burden - unable to participate|4|||
146799000|NCT04933474|529438270|FG001|Overall Study|Disease Burden - unable to participate|1|||
146799001|NCT04933474|529438269|FG000|Overall Study|Surgery/Hospitalization|1|||
146799002|NCT04933474|529438270|FG001|Overall Study|Surgery/Hospitalization|2|||
146799003|NCT04933474|529438269|FG000|Overall Study|Dissatisfied with Intervention|1|||
146799004|NCT04933474|529438270|FG001|Overall Study|Dissatisfied with Intervention|1|||
146799005|NCT04933474|529438269|FG000|Overall Study|Withdrew interest in participation|1|||
146799006|NCT04933474|529438270|FG001|Overall Study|Withdrew interest in participation|0|||
146799007|NCT04933474|529438269|FG000|Overall Study|Had previously enrolled in the study|0|||
146799008|NCT04933474|529438270|FG001|Overall Study|Had previously enrolled in the study|1|||
146799009|NCT01773993|529438271|FG000|Overall Study|No Visit After Treatment|35|||
146799010|NCT04993677|529438272|FG000|Overall Study|Lost to Follow-up|1|||
146799011|NCT04993677|529438273|FG001|Overall Study|Lost to Follow-up|0|||
146799012|NCT04993677|529438274|FG002|Overall Study|Lost to Follow-up|0|||
146799013|NCT04993677|529438275|FG003|Overall Study|Lost to Follow-up|0|||
146799014|NCT04993677|529438272|FG000|Overall Study|Death|11|||
146799015|NCT04993677|529438273|FG001|Overall Study|Death|8|||
146799016|NCT04993677|529438274|FG002|Overall Study|Death|3|||
146799017|NCT04993677|529438275|FG003|Overall Study|Death|1|||
146799018|NCT04993677|529438272|FG000|Overall Study|Subject withdrawal of consent|4|||
146799019|NCT04993677|529438273|FG001|Overall Study|Subject withdrawal of consent|3|||
146799020|NCT04993677|529438274|FG002|Overall Study|Subject withdrawal of consent|0|||
146799021|NCT04993677|529438275|FG003|Overall Study|Subject withdrawal of consent|2|||
146799022|NCT04993677|529438272|FG000|Overall Study|Study termination by sponsor|3|||
146799023|NCT04993677|529438273|FG001|Overall Study|Study termination by sponsor|25|||
146799024|NCT04993677|529438274|FG002|Overall Study|Study termination by sponsor|3|||
146799025|NCT04993677|529438275|FG003|Overall Study|Study termination by sponsor|3|||
146799026|NCT04993677|529438272|FG000|Overall Study|Other|2|||
146799027|NCT04993677|529438273|FG001|Overall Study|Other|3|||
146799028|NCT04993677|529438274|FG002|Overall Study|Other|3|||
146799029|NCT04993677|529438275|FG003|Overall Study|Other|2|||
146799030|NCT04174170|529438276|FG000|Placebo Run-in Period|Not Randomized|38|||
146799031|NCT04174170|529438277|FG001|Placebo Run-in Period|Not Randomized|0|||
146799032|NCT04174170|529438278|FG002|Placebo Run-in Period|Not Randomized|0|||
146799033|NCT04174170|529438279|FG003|Placebo Run-in Period|Not Randomized|0|||
146799034|NCT04174170|529438276|FG000|Double Blind Treatment Period|Adverse Event|0|||
146799035|NCT04174170|529438277|FG001|Double Blind Treatment Period|Adverse Event|9|||
146799036|NCT04174170|529438278|FG002|Double Blind Treatment Period|Adverse Event|9|||
146799037|NCT04174170|529438279|FG003|Double Blind Treatment Period|Adverse Event|8|||
146799038|NCT04174170|529438276|FG000|Double Blind Treatment Period|Death|0|||
146799039|NCT04174170|529438277|FG001|Double Blind Treatment Period|Death|1|||
146799040|NCT04174170|529438278|FG002|Double Blind Treatment Period|Death|0|||
146799041|NCT04174170|529438279|FG003|Double Blind Treatment Period|Death|0|||
146799042|NCT04174170|529438276|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
146799043|NCT04174170|529438277|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
146799044|NCT04174170|529438278|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
146799045|NCT04174170|529438279|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
146799046|NCT04174170|529438276|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
146799047|NCT04174170|529438277|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
146799048|NCT04174170|529438278|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
146799049|NCT04174170|529438279|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
146799050|NCT04174170|529438276|FG000|Double Blind Treatment Period|Physician Decision|0|||
146799051|NCT04174170|529438277|FG001|Double Blind Treatment Period|Physician Decision|1|||
146799052|NCT04174170|529438278|FG002|Double Blind Treatment Period|Physician Decision|0|||
146799053|NCT04174170|529438279|FG003|Double Blind Treatment Period|Physician Decision|1|||
146799054|NCT04174170|529438276|FG000|Double Blind Treatment Period|Pregnancy|0|||
146799055|NCT04174170|529438277|FG001|Double Blind Treatment Period|Pregnancy|1|||
146799056|NCT04174170|529438278|FG002|Double Blind Treatment Period|Pregnancy|0|||
146799057|NCT04174170|529438279|FG003|Double Blind Treatment Period|Pregnancy|1|||
146799058|NCT04174170|529438276|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
146799059|NCT04174170|529438277|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
146799060|NCT04174170|529438278|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
146799061|NCT04174170|529438279|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
146799062|NCT04174170|529438276|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
146799063|NCT04174170|529438277|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
146799064|NCT04174170|529438278|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
146799065|NCT04174170|529438279|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
146799066|NCT04174170|529438276|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
146940705|NCT01831804|529941427|FG005|Overall Study|Lost to Follow-up|0|||
146940706|NCT01831804|529941428|FG006|Overall Study|Lost to Follow-up|0|||
146620830|NCT04816214|528783442|FG000|Overall Study|Death|1|||
146799067|NCT04174170|529438277|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
146799068|NCT04174170|529438278|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
146799069|NCT04174170|529438279|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
146799070|NCT04664881|529438280|FG000|Overall Study|Withdrawal by Subject|1|||
146799071|NCT04664881|529438281|FG001|Overall Study|Withdrawal by Subject|8|||
146799072|NCT04664881|529438280|FG000|Overall Study|Physician Decision|0|||
146799073|NCT04664881|529438281|FG001|Overall Study|Physician Decision|5|||
146799074|NCT04664881|529438280|FG000|Overall Study|Lost to Follow-up|1|||
146799075|NCT04664881|529438281|FG001|Overall Study|Lost to Follow-up|0|||
146799076|NCT04772534|529438290|FG000|Overall Study|Physician Decision|1|||
146799077|NCT04772534|529438291|FG001|Overall Study|Physician Decision|0|||
146799078|NCT04772534|529438292|FG002|Overall Study|Physician Decision|0|||
146799079|NCT04772534|529438290|FG000|Overall Study|Withdrawal by Subject|3|||
146799080|NCT04772534|529438291|FG001|Overall Study|Withdrawal by Subject|0|||
146799081|NCT04772534|529438292|FG002|Overall Study|Withdrawal by Subject|1|||
146799082|NCT04194450|529438293|FG000|Overall Study|not eligible|1|||
146799083|NCT04194450|529438294|FG001|Overall Study|not eligible|0|||
146799084|NCT00308997|529438298|FG000|Overall Study|Subject feigned clinical data|0|||
146799085|NCT00308997|529438299|FG001|Overall Study|Subject feigned clinical data|1|||
146799086|NCT00308997|529438298|FG000|Overall Study|Unable to tolerate intervention|1|||
146799087|NCT00308997|529438299|FG001|Overall Study|Unable to tolerate intervention|0|||
146799088|NCT04490356|529438300|FG000|Overall Study|Lost to Follow-up|1|||
146799089|NCT03733626|529438301|FG000|Overall Study|Physician Decision|4|||
146799090|NCT03733626|529438302|FG001|Overall Study|Physician Decision|4|||
146799091|NCT03816397|529438303|FG000|Overall Study|Censored at interim analysis date.|13|||
146799092|NCT03816397|529438304|FG001|Overall Study|Censored at interim analysis date.|6|||
146799093|NCT03816397|529438303|FG000|Overall Study|Withdrawal by Subject|1|||
146799094|NCT03816397|529438304|FG001|Overall Study|Withdrawal by Subject|1|||
146799095|NCT01220531|529438313|FG000|Overall Study|Death|7|||
146799096|NCT01220531|529438313|FG000|Overall Study|Lost to Follow-up|1|||
146799097|NCT00709956|529438314|FG000|Overall Study|Withdrawal by Subject|1|||
146799098|NCT00709956|529438315|FG001|Overall Study|Withdrawal by Subject|1|||
146799099|NCT00709956|529438314|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
146799100|NCT00709956|529438315|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
146799101|NCT01105091|529438316|FG000|Overall Study|Death|2|||
146799102|NCT01105091|529438317|FG001|Overall Study|Death|0|||
146799103|NCT03215706|529438318|FG000|Randomization|Adverse Event unrelated to study drug|1|||
146799104|NCT03215706|529438319|FG001|Randomization|Adverse Event unrelated to study drug|0|||
146799105|NCT03215706|529438318|FG000|Randomization|participant withdrew consent|1|||
146799106|NCT03215706|529438319|FG001|Randomization|participant withdrew consent|3|||
146799107|NCT03215706|529438318|FG000|Randomization|no longer meets study criteria|1|||
146799108|NCT03215706|529438319|FG001|Randomization|no longer meets study criteria|4|||
146799109|NCT03215706|529438318|FG000|Randomization|other reasons|0|||
146799110|NCT03215706|529438319|FG001|Randomization|other reasons|2|||
146799111|NCT03215706|529438318|FG000|Treatment Period|Disease Progression|150|||
146799112|NCT03215706|529438319|FG001|Treatment Period|Disease Progression|142|||
146799113|NCT03215706|529438318|FG000|Treatment Period|Study Drug Toxicity|53|||
146799114|NCT03215706|529438319|FG001|Treatment Period|Study Drug Toxicity|21|||
146799115|NCT03215706|529438318|FG000|Treatment Period|Death|2|||
146799116|NCT03215706|529438319|FG001|Treatment Period|Death|1|||
146799117|NCT03215706|529438318|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
146799118|NCT03215706|529438319|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
146799119|NCT03215706|529438318|FG000|Treatment Period|Request to D/C treatment|1|||
146799120|NCT03215706|529438319|FG001|Treatment Period|Request to D/C treatment|6|||
146799121|NCT03215706|529438318|FG000|Treatment Period|Participant withdrew consent|3|||
146799122|NCT03215706|529438319|FG001|Treatment Period|Participant withdrew consent|4|||
146799123|NCT03215706|529438318|FG000|Treatment Period|Lost to Follow-up|0|||
146799124|NCT03215706|529438319|FG001|Treatment Period|Lost to Follow-up|1|||
146799125|NCT03215706|529438318|FG000|Treatment Period|Other Reasons|4|||
146799126|NCT03215706|529438319|FG001|Treatment Period|Other Reasons|5|||
146799127|NCT03215706|529438318|FG000|Treatment Period|Ongoing in the treatment period|105|||
146799128|NCT03215706|529438319|FG001|Treatment Period|Ongoing in the treatment period|43|||
146799129|NCT05267639|529439176|FG000|Overall Study|Withdrawal by Subject|1|||
146799130|NCT05267639|529439177|FG001|Overall Study|Withdrawal by Subject|0|||
146799131|NCT03705793|529439189|FG000|Overall Study|Lost to Follow-up|3|||
146799132|NCT03705793|529439190|FG001|Overall Study|Lost to Follow-up|4|||
146799133|NCT03705793|529439189|FG000|Overall Study|Withdrawal by Subject|2|||
146799134|NCT03705793|529439190|FG001|Overall Study|Withdrawal by Subject|1|||
146799135|NCT00447980|529439191|FG000|Overall Study|Withdrawal by Subject|1|||
146799136|NCT00447980|529439192|FG001|Overall Study|Withdrawal by Subject|1|||
146940707|NCT01831804|529941429|FG007|Overall Study|Lost to Follow-up|0|||
146940708|NCT01831804|529941430|FG008|Overall Study|Lost to Follow-up|1|||
146940709|NCT01831804|529941422|FG000|Overall Study|Investigator discretion|0|||
146940710|NCT01831804|529941423|FG001|Overall Study|Investigator discretion|0|||
146799137|NCT00447980|529439193|FG002|Overall Study|Withdrawal by Subject|4|||
146799138|NCT00447980|529439194|FG003|Overall Study|Withdrawal by Subject|4|||
146799139|NCT00447980|529439191|FG000|Overall Study|Lost to Follow-up|1|||
146799140|NCT00447980|529439192|FG001|Overall Study|Lost to Follow-up|1|||
146799141|NCT00447980|529439193|FG002|Overall Study|Lost to Follow-up|0|||
146799142|NCT00447980|529439194|FG003|Overall Study|Lost to Follow-up|0|||
146799143|NCT00447980|529439191|FG000|Overall Study|Did not proceed with surgery|3|||
146799144|NCT00447980|529439192|FG001|Overall Study|Did not proceed with surgery|3|||
146799145|NCT00447980|529439193|FG002|Overall Study|Did not proceed with surgery|2|||
146799146|NCT00447980|529439194|FG003|Overall Study|Did not proceed with surgery|2|||
146799147|NCT02720068|529439195|FG000|Overall Study|Adverse Event|0|||
146799148|NCT02720068|529439196|FG001|Overall Study|Adverse Event|0|||
146799149|NCT02720068|529439197|FG002|Overall Study|Adverse Event|0|||
146799150|NCT02720068|529439198|FG003|Overall Study|Adverse Event|0|||
146799151|NCT02720068|529439199|FG004|Overall Study|Adverse Event|0|||
146799152|NCT02720068|529439200|FG005|Overall Study|Adverse Event|0|||
146799153|NCT02720068|529439201|FG006|Overall Study|Adverse Event|0|||
146799154|NCT02720068|529439202|FG007|Overall Study|Adverse Event|0|||
146799155|NCT02720068|529439203|FG008|Overall Study|Adverse Event|0|||
146799156|NCT02720068|529439204|FG009|Overall Study|Adverse Event|0|||
146799157|NCT02720068|529439205|FG010|Overall Study|Adverse Event|0|||
146799158|NCT02720068|529439206|FG011|Overall Study|Adverse Event|1|||
146799159|NCT02720068|529439207|FG012|Overall Study|Adverse Event|0|||
146799160|NCT02720068|529439208|FG013|Overall Study|Adverse Event|0|||
146799161|NCT02720068|529439209|FG014|Overall Study|Adverse Event|0|||
146799162|NCT02720068|529439210|FG015|Overall Study|Adverse Event|0|||
146799163|NCT02720068|529439211|FG016|Overall Study|Adverse Event|0|||
146799164|NCT02720068|529439212|FG017|Overall Study|Adverse Event|0|||
146799165|NCT02720068|529439195|FG000|Overall Study|Death|1|||
146799166|NCT02720068|529439196|FG001|Overall Study|Death|3|||
146799167|NCT02720068|529439197|FG002|Overall Study|Death|2|||
146799168|NCT02720068|529439198|FG003|Overall Study|Death|1|||
146799169|NCT02720068|529439199|FG004|Overall Study|Death|2|||
146799170|NCT02720068|529439200|FG005|Overall Study|Death|1|||
146799171|NCT02720068|529439201|FG006|Overall Study|Death|2|||
146799172|NCT02720068|529439202|FG007|Overall Study|Death|2|||
146799173|NCT02720068|529439203|FG008|Overall Study|Death|3|||
146799174|NCT02720068|529439204|FG009|Overall Study|Death|1|||
146799175|NCT02720068|529439205|FG010|Overall Study|Death|20|||
146799176|NCT02720068|529439206|FG011|Overall Study|Death|166|||
146799177|NCT02720068|529439207|FG012|Overall Study|Death|34|||
146799178|NCT02720068|529439208|FG013|Overall Study|Death|30|||
146799179|NCT02720068|529439209|FG014|Overall Study|Death|45|||
146799180|NCT02720068|529439210|FG015|Overall Study|Death|16|||
146799181|NCT02720068|529439211|FG016|Overall Study|Death|20|||
146799182|NCT02720068|529439212|FG017|Overall Study|Death|28|||
146799183|NCT02720068|529439195|FG000|Overall Study|Lost to Follow-up|0|||
146799184|NCT02720068|529439196|FG001|Overall Study|Lost to Follow-up|0|||
146799185|NCT02720068|529439197|FG002|Overall Study|Lost to Follow-up|0|||
146799186|NCT02720068|529439198|FG003|Overall Study|Lost to Follow-up|0|||
146799187|NCT02720068|529439199|FG004|Overall Study|Lost to Follow-up|0|||
146799188|NCT02720068|529439200|FG005|Overall Study|Lost to Follow-up|0|||
146799189|NCT02720068|529439201|FG006|Overall Study|Lost to Follow-up|0|||
146799190|NCT02720068|529439202|FG007|Overall Study|Lost to Follow-up|0|||
146799191|NCT02720068|529439203|FG008|Overall Study|Lost to Follow-up|0|||
146799192|NCT02720068|529439204|FG009|Overall Study|Lost to Follow-up|0|||
146799193|NCT02720068|529439205|FG010|Overall Study|Lost to Follow-up|0|||
146799194|NCT02720068|529439206|FG011|Overall Study|Lost to Follow-up|1|||
146799195|NCT02720068|529439207|FG012|Overall Study|Lost to Follow-up|0|||
146799196|NCT02720068|529439208|FG013|Overall Study|Lost to Follow-up|1|||
146799197|NCT02720068|529439209|FG014|Overall Study|Lost to Follow-up|2|||
146799198|NCT02720068|529439210|FG015|Overall Study|Lost to Follow-up|0|||
146799199|NCT02720068|529439211|FG016|Overall Study|Lost to Follow-up|0|||
146799200|NCT02720068|529439212|FG017|Overall Study|Lost to Follow-up|1|||
146799201|NCT02720068|529439195|FG000|Overall Study|Physician Decision|0|||
146799202|NCT02720068|529439196|FG001|Overall Study|Physician Decision|0|||
146799203|NCT02720068|529439197|FG002|Overall Study|Physician Decision|0|||
146799204|NCT02720068|529439198|FG003|Overall Study|Physician Decision|1|||
146799205|NCT02720068|529439199|FG004|Overall Study|Physician Decision|0|||
146799206|NCT02720068|529439200|FG005|Overall Study|Physician Decision|0|||
146799207|NCT02720068|529439201|FG006|Overall Study|Physician Decision|0|||
146799208|NCT02720068|529439202|FG007|Overall Study|Physician Decision|0|||
146799209|NCT02720068|529439203|FG008|Overall Study|Physician Decision|0|||
146799210|NCT02720068|529439204|FG009|Overall Study|Physician Decision|0|||
146799211|NCT02720068|529439205|FG010|Overall Study|Physician Decision|0|||
146799212|NCT02720068|529439206|FG011|Overall Study|Physician Decision|1|||
146799213|NCT02720068|529439207|FG012|Overall Study|Physician Decision|0|||
146799214|NCT02720068|529439208|FG013|Overall Study|Physician Decision|0|||
146799215|NCT02720068|529439209|FG014|Overall Study|Physician Decision|0|||
146799216|NCT02720068|529439210|FG015|Overall Study|Physician Decision|0|||
146799217|NCT02720068|529439211|FG016|Overall Study|Physician Decision|0|||
146799218|NCT02720068|529439212|FG017|Overall Study|Physician Decision|1|||
146799219|NCT02720068|529439195|FG000|Overall Study|Progressive Disease|2|||
146799220|NCT02720068|529439196|FG001|Overall Study|Progressive Disease|3|||
146799221|NCT02720068|529439197|FG002|Overall Study|Progressive Disease|1|||
146799222|NCT02720068|529439198|FG003|Overall Study|Progressive Disease|1|||
146799223|NCT02720068|529439199|FG004|Overall Study|Progressive Disease|1|||
146799224|NCT02720068|529439200|FG005|Overall Study|Progressive Disease|2|||
146799225|NCT02720068|529439201|FG006|Overall Study|Progressive Disease|1|||
146799226|NCT02720068|529439202|FG007|Overall Study|Progressive Disease|1|||
146799227|NCT02720068|529439203|FG008|Overall Study|Progressive Disease|0|||
146799228|NCT02720068|529439204|FG009|Overall Study|Progressive Disease|1|||
146799229|NCT02720068|529439205|FG010|Overall Study|Progressive Disease|0|||
146799230|NCT02720068|529439206|FG011|Overall Study|Progressive Disease|4|||
146799231|NCT02720068|529439207|FG012|Overall Study|Progressive Disease|1|||
146799232|NCT02720068|529439208|FG013|Overall Study|Progressive Disease|0|||
146799233|NCT02720068|529439209|FG014|Overall Study|Progressive Disease|0|||
146799234|NCT02720068|529439210|FG015|Overall Study|Progressive Disease|0|||
146799235|NCT02720068|529439211|FG016|Overall Study|Progressive Disease|0|||
146799236|NCT02720068|529439212|FG017|Overall Study|Progressive Disease|0|||
146799237|NCT02720068|529439195|FG000|Overall Study|Sponsor Decision|0|||
146799238|NCT02720068|529439196|FG001|Overall Study|Sponsor Decision|0|||
146799239|NCT02720068|529439197|FG002|Overall Study|Sponsor Decision|0|||
146799240|NCT02720068|529439198|FG003|Overall Study|Sponsor Decision|0|||
146799241|NCT02720068|529439199|FG004|Overall Study|Sponsor Decision|0|||
146799242|NCT02720068|529439200|FG005|Overall Study|Sponsor Decision|0|||
146799243|NCT02720068|529439201|FG006|Overall Study|Sponsor Decision|0|||
146799244|NCT02720068|529439202|FG007|Overall Study|Sponsor Decision|0|||
146799245|NCT02720068|529439203|FG008|Overall Study|Sponsor Decision|0|||
146799246|NCT02720068|529439204|FG009|Overall Study|Sponsor Decision|0|||
146799247|NCT02720068|529439205|FG010|Overall Study|Sponsor Decision|0|||
146799248|NCT02720068|529439206|FG011|Overall Study|Sponsor Decision|6|||
146799249|NCT02720068|529439207|FG012|Overall Study|Sponsor Decision|3|||
146799250|NCT02720068|529439208|FG013|Overall Study|Sponsor Decision|2|||
146799251|NCT02720068|529439209|FG014|Overall Study|Sponsor Decision|4|||
146799252|NCT02720068|529439210|FG015|Overall Study|Sponsor Decision|4|||
146799253|NCT02720068|529439211|FG016|Overall Study|Sponsor Decision|0|||
146799254|NCT02720068|529439212|FG017|Overall Study|Sponsor Decision|8|||
146799255|NCT02720068|529439195|FG000|Overall Study|Withdrawal by Subject|0|||
146799256|NCT02720068|529439196|FG001|Overall Study|Withdrawal by Subject|0|||
146799257|NCT02720068|529439197|FG002|Overall Study|Withdrawal by Subject|0|||
146799258|NCT02720068|529439198|FG003|Overall Study|Withdrawal by Subject|0|||
146799259|NCT02720068|529439199|FG004|Overall Study|Withdrawal by Subject|0|||
146799260|NCT02720068|529439200|FG005|Overall Study|Withdrawal by Subject|0|||
146799261|NCT02720068|529439201|FG006|Overall Study|Withdrawal by Subject|0|||
146799262|NCT02720068|529439202|FG007|Overall Study|Withdrawal by Subject|0|||
146799263|NCT02720068|529439203|FG008|Overall Study|Withdrawal by Subject|0|||
146799264|NCT02720068|529439204|FG009|Overall Study|Withdrawal by Subject|1|||
146799265|NCT02720068|529439205|FG010|Overall Study|Withdrawal by Subject|0|||
146799266|NCT02720068|529439206|FG011|Overall Study|Withdrawal by Subject|27|||
146799267|NCT02720068|529439207|FG012|Overall Study|Withdrawal by Subject|2|||
146799268|NCT02720068|529439208|FG013|Overall Study|Withdrawal by Subject|8|||
146799269|NCT02720068|529439209|FG014|Overall Study|Withdrawal by Subject|7|||
146799270|NCT02720068|529439210|FG015|Overall Study|Withdrawal by Subject|0|||
146799271|NCT02720068|529439211|FG016|Overall Study|Withdrawal by Subject|0|||
146799272|NCT02720068|529439212|FG017|Overall Study|Withdrawal by Subject|2|||
146799273|NCT02720068|529439195|FG000|Overall Study|Protocol Violation|0|||
146799274|NCT02720068|529439196|FG001|Overall Study|Protocol Violation|0|||
146799275|NCT02720068|529439197|FG002|Overall Study|Protocol Violation|0|||
146799276|NCT02720068|529439198|FG003|Overall Study|Protocol Violation|0|||
146799277|NCT02720068|529439199|FG004|Overall Study|Protocol Violation|0|||
146799278|NCT02720068|529439200|FG005|Overall Study|Protocol Violation|0|||
146799279|NCT02720068|529439201|FG006|Overall Study|Protocol Violation|0|||
146799280|NCT02720068|529439202|FG007|Overall Study|Protocol Violation|0|||
146799281|NCT02720068|529439203|FG008|Overall Study|Protocol Violation|0|||
146799282|NCT02720068|529439204|FG009|Overall Study|Protocol Violation|0|||
146799283|NCT02720068|529439205|FG010|Overall Study|Protocol Violation|1|||
146799284|NCT02720068|529439206|FG011|Overall Study|Protocol Violation|0|||
146799285|NCT02720068|529439207|FG012|Overall Study|Protocol Violation|0|||
146799286|NCT02720068|529439208|FG013|Overall Study|Protocol Violation|0|||
146799287|NCT02720068|529439209|FG014|Overall Study|Protocol Violation|1|||
146799288|NCT02720068|529439210|FG015|Overall Study|Protocol Violation|0|||
146799289|NCT02720068|529439211|FG016|Overall Study|Protocol Violation|1|||
146799290|NCT02720068|529439212|FG017|Overall Study|Protocol Violation|0|||
146799291|NCT02467270|529439225|FG000|Overall Study|Participants Never Treated|0|||
146799292|NCT02467270|529439226|FG001|Overall Study|Participants Never Treated|1|||
146799293|NCT02467270|529439227|FG002|Overall Study|Participants Never Treated|0|||
146799294|NCT02467270|529439225|FG000|Overall Study|Ongoing|50|||
146799295|NCT02467270|529439226|FG001|Overall Study|Ongoing|41|||
146799296|NCT02467270|529439227|FG002|Overall Study|Ongoing|43|||
146799297|NCT02467270|529439225|FG000|Overall Study|Adverse Event|16|||
146799298|NCT02467270|529439226|FG001|Overall Study|Adverse Event|15|||
146799299|NCT02467270|529439227|FG002|Overall Study|Adverse Event|14|||
146799300|NCT02467270|529439225|FG000|Overall Study|Progressive Disease|7|||
146799301|NCT02467270|529439226|FG001|Overall Study|Progressive Disease|7|||
146799302|NCT02467270|529439227|FG002|Overall Study|Progressive Disease|4|||
146799303|NCT02467270|529439225|FG000|Overall Study|Death|2|||
146799304|NCT02467270|529439226|FG001|Overall Study|Death|0|||
146799305|NCT02467270|529439227|FG002|Overall Study|Death|2|||
146799306|NCT02467270|529439225|FG000|Overall Study|Lack of Efficacy|12|||
146799307|NCT02467270|529439226|FG001|Overall Study|Lack of Efficacy|18|||
146799308|NCT02467270|529439227|FG002|Overall Study|Lack of Efficacy|23|||
146799309|NCT02467270|529439225|FG000|Overall Study|Non-compliance With Study Drug|0|||
146799310|NCT02467270|529439226|FG001|Overall Study|Non-compliance With Study Drug|2|||
146799311|NCT02467270|529439227|FG002|Overall Study|Non-compliance With Study Drug|1|||
146799312|NCT02467270|529439225|FG000|Overall Study|Lost to Follow-up|2|||
146799313|NCT02467270|529439226|FG001|Overall Study|Lost to Follow-up|1|||
146799314|NCT02467270|529439227|FG002|Overall Study|Lost to Follow-up|0|||
146799315|NCT02467270|529439225|FG000|Overall Study|Pregnancy|0|||
146799316|NCT02467270|529439226|FG001|Overall Study|Pregnancy|1|||
146799317|NCT02467270|529439227|FG002|Overall Study|Pregnancy|0|||
146799318|NCT02467270|529439225|FG000|Overall Study|Physician Decision|0|||
146799319|NCT02467270|529439226|FG001|Overall Study|Physician Decision|4|||
146799320|NCT02467270|529439227|FG002|Overall Study|Physician Decision|1|||
146799321|NCT02467270|529439225|FG000|Overall Study|Withdrawal by Subject|4|||
146799322|NCT02467270|529439226|FG001|Overall Study|Withdrawal by Subject|3|||
146799323|NCT02467270|529439227|FG002|Overall Study|Withdrawal by Subject|5|||
146799324|NCT02467270|529439225|FG000|Overall Study|Reason not Specified|1|||
146799325|NCT02467270|529439226|FG001|Overall Study|Reason not Specified|2|||
146799326|NCT02467270|529439227|FG002|Overall Study|Reason not Specified|1|||
146799327|NCT04281498|529439262|FG000|Overall Study|Progression of disease|1|||
146799328|NCT04281498|529439262|FG000|Overall Study|Planned SCT|1|||
146799329|NCT04281498|529439262|FG000|Overall Study|Alternative Treatment|1|||
146799330|NCT03142009|529439265|FG000|Overall Study|Lost to Follow-up|45|||
146799331|NCT03142009|529439266|FG001|Overall Study|Lost to Follow-up|30|||
146799332|NCT03587805|529439267|FG000|Overall Study|Adverse Event|72|||
146799333|NCT03587805|529439267|FG000|Overall Study|Death|1|||
146799334|NCT03587805|529439267|FG000|Overall Study|Lost to Follow-up|78|||
146799335|NCT03587805|529439267|FG000|Overall Study|Withdrawal by Subject|105|||
146799336|NCT03587805|529439267|FG000|Overall Study|Lack of Efficacy|119|||
146799337|NCT03587805|529439267|FG000|Overall Study|Reason unknown|26|||
146799338|NCT03587805|529439267|FG000|Overall Study|COVID_19 pandemic|4|||
146799339|NCT03587805|529439267|FG000|Overall Study|Various reasons|121|||
146799340|NCT03587805|529439267|FG000|Overall Study|Withdrawal by parent/guardian|3|||
146799341|NCT03008382|529439268|FG000|Overall Study|Withdrawal by Subject|2|||
146799342|NCT03008382|529439269|FG001|Overall Study|Withdrawal by Subject|5|||
146799343|NCT03008382|529439270|FG002|Overall Study|Withdrawal by Subject|2|||
146799344|NCT03008382|529439271|FG003|Overall Study|Withdrawal by Subject|0|||
146799345|NCT03008382|529439268|FG000|Overall Study|Protocol Violation|1|||
146799346|NCT03008382|529439269|FG001|Overall Study|Protocol Violation|0|||
146799347|NCT03008382|529439270|FG002|Overall Study|Protocol Violation|0|||
146799348|NCT03008382|529439271|FG003|Overall Study|Protocol Violation|0|||
146799349|NCT03008382|529439268|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
146799350|NCT03008382|529439269|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
146799351|NCT03008382|529439270|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
146799352|NCT03008382|529439271|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
146799353|NCT03008382|529439268|FG000|Overall Study|Lost to Follow-up|0|||
146799354|NCT03008382|529439269|FG001|Overall Study|Lost to Follow-up|0|||
146799355|NCT03008382|529439270|FG002|Overall Study|Lost to Follow-up|1|||
146799356|NCT03008382|529439271|FG003|Overall Study|Lost to Follow-up|0|||
146799357|NCT03008382|529439268|FG000|Overall Study|Screenfail|0|||
146799358|NCT03008382|529439269|FG001|Overall Study|Screenfail|0|||
146799359|NCT03008382|529439270|FG002|Overall Study|Screenfail|2|||
146799360|NCT03008382|529439271|FG003|Overall Study|Screenfail|0|||
146799361|NCT05180539|529439913|FG000|Overall Study|Lost to Follow-up|27|||
146799362|NCT05180539|529439914|FG001|Overall Study|Lost to Follow-up|30|||
146799363|NCT00994643|529439917|FG000|Overall Study|Withdrawal by Subject|1|||
146799364|NCT04518943|529439919|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
146799365|NCT04518943|529439920|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
146799366|NCT04518943|529439921|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
146799367|NCT04518943|529439922|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
146799368|NCT04518943|529439923|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
146799369|NCT04518943|529439924|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
146799370|NCT04518943|529439925|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
146799371|NCT04518943|529439926|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
146799372|NCT04518943|529439927|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
146799373|NCT04518943|529439928|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
146799374|NCT04518943|529439929|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
146799375|NCT04518943|529439930|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
146799376|NCT04518943|529439931|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
146799377|NCT04518943|529439932|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
146799378|NCT04518943|529439933|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
146799379|NCT04518943|529439934|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
146799380|NCT00968149|529439935|FG000|Overall Study|Adverse Event|5|||
146799381|NCT00968149|529439936|FG001|Overall Study|Adverse Event|1|||
146799382|NCT00968149|529439935|FG000|Overall Study|Lack of Efficacy|0|||
146799383|NCT00968149|529439936|FG001|Overall Study|Lack of Efficacy|4|||
146799384|NCT00968149|529439935|FG000|Overall Study|Lost to Follow-up|0|||
146799385|NCT00968149|529439936|FG001|Overall Study|Lost to Follow-up|1|||
146799386|NCT00968149|529439935|FG000|Overall Study|Protocol Violation|4|||
146799387|NCT00968149|529439936|FG001|Overall Study|Protocol Violation|0|||
146799388|NCT00968149|529439935|FG000|Overall Study|Withdrawal by Subject|2|||
146799389|NCT00968149|529439936|FG001|Overall Study|Withdrawal by Subject|0|||
146799390|NCT04757753|529439937|FG000|Overall Study|Lost to Follow-up|7|||
146799391|NCT04757753|529439938|FG001|Overall Study|Lost to Follow-up|7|||
146799392|NCT04757753|529439937|FG000|Overall Study|Withdrawal by Subject|0|||
146799393|NCT04757753|529439938|FG001|Overall Study|Withdrawal by Subject|3|||
146799394|NCT04757753|529439937|FG000|Overall Study|Endodontic treatment failure|1|||
146799395|NCT04757753|529439938|FG001|Overall Study|Endodontic treatment failure|2|||
146799396|NCT04757753|529439937|FG000|Overall Study|Tooth fracture/extraction|3|||
146799397|NCT04757753|529439938|FG001|Overall Study|Tooth fracture/extraction|0|||
146799398|NCT03333915|529439941|FG000|Overall Study|Lost to Follow-up|0|||
146799399|NCT03333915|529439942|FG001|Overall Study|Lost to Follow-up|0|||
146799400|NCT03333915|529439943|FG002|Overall Study|Lost to Follow-up|1|||
146799401|NCT03333915|529439944|FG003|Overall Study|Lost to Follow-up|0|||
146799402|NCT03333915|529439945|FG004|Overall Study|Lost to Follow-up|0|||
146799403|NCT03333915|529439941|FG000|Overall Study|Disease Progression|0|||
146799404|NCT03333915|529439942|FG001|Overall Study|Disease Progression|1|||
146799405|NCT03333915|529439943|FG002|Overall Study|Disease Progression|0|||
146799406|NCT03333915|529439944|FG003|Overall Study|Disease Progression|0|||
146799407|NCT03333915|529439945|FG004|Overall Study|Disease Progression|0|||
146799408|NCT03333915|529439941|FG000|Overall Study|Death|0|||
146799409|NCT03333915|529439942|FG001|Overall Study|Death|0|||
146799410|NCT03333915|529439943|FG002|Overall Study|Death|0|||
146799411|NCT03333915|529439944|FG003|Overall Study|Death|37|||
146799412|NCT03333915|529439945|FG004|Overall Study|Death|18|||
146799413|NCT03333915|529439941|FG000|Overall Study|Sponsor's Decision|0|||
146799414|NCT03333915|529439942|FG001|Overall Study|Sponsor's Decision|0|||
146799415|NCT03333915|529439943|FG002|Overall Study|Sponsor's Decision|0|||
146799416|NCT03333915|529439944|FG003|Overall Study|Sponsor's Decision|48|||
146799417|NCT03333915|529439945|FG004|Overall Study|Sponsor's Decision|4|||
146799418|NCT03333915|529439941|FG000|Overall Study|Withdrawal by Subject|0|||
146799419|NCT03333915|529439942|FG001|Overall Study|Withdrawal by Subject|0|||
146799420|NCT03333915|529439943|FG002|Overall Study|Withdrawal by Subject|0|||
146799421|NCT03333915|529439944|FG003|Overall Study|Withdrawal by Subject|5|||
146799422|NCT03333915|529439945|FG004|Overall Study|Withdrawal by Subject|1|||
146799423|NCT03872466|529439948|FG000|Overall Study|Withdrawal by Subject|1|||
146799424|NCT03872466|529439949|FG001|Overall Study|Withdrawal by Subject|0|||
146799425|NCT03872466|529439948|FG000|Overall Study|Physician Decision|2|||
146799426|NCT03872466|529439949|FG001|Overall Study|Physician Decision|0|||
146799427|NCT01778686|529439950|FG000|Overall Study|Adverse Event|0|||
146799428|NCT01778686|529439951|FG001|Overall Study|Adverse Event|0|||
146799429|NCT01778686|529439952|FG002|Overall Study|Adverse Event|1|||
146799430|NCT04012567|529439953|FG000|Overall Study|Lost to Follow-up|0|||
146799431|NCT04012567|529439954|FG001|Overall Study|Lost to Follow-up|1|||
146799432|NCT04012567|529439953|FG000|Overall Study|Withdrawal by Subject|1|||
146799433|NCT04012567|529439954|FG001|Overall Study|Withdrawal by Subject|0|||
146799434|NCT06059443|529439955|FG000|Overall Study|Withdrawal by Subject|2|||
146799435|NCT06059443|529439956|FG001|Overall Study|Withdrawal by Subject|0|||
146799436|NCT06059443|529439955|FG000|Overall Study|Lost to Follow-up|2|||
146799437|NCT06059443|529439956|FG001|Overall Study|Lost to Follow-up|2|||
146799438|NCT05771467|529439957|FG000|Overall Study|Lost to Follow-up|6|||
146799439|NCT05771467|529439958|FG001|Overall Study|Lost to Follow-up|3|||
146799440|NCT04940624|529439964|FG000|Overall Study|Adverse Event|4|||
146799441|NCT04940624|529439965|FG001|Overall Study|Adverse Event|11|||
146799442|NCT04940624|529439964|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146799443|NCT04940624|529439965|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
146799444|NCT04940624|529439964|FG000|Overall Study|Physician Decision|1|||
146799445|NCT04940624|529439965|FG001|Overall Study|Physician Decision|0|||
146799446|NCT04940624|529439964|FG000|Overall Study|Lost to Follow-up|1|||
146799447|NCT04940624|529439965|FG001|Overall Study|Lost to Follow-up|0|||
146799448|NCT04940624|529439964|FG000|Overall Study|Reason Not Specified|1|||
146799449|NCT04940624|529439965|FG001|Overall Study|Reason Not Specified|0|||
146799450|NCT02206828|529439966|FG000|Overall Study|Lost to Follow-up|7|||
146799451|NCT00945724|529439967|FG000|Overall Study|Withdrawal by Subject|2|||
146799452|NCT00945724|529439967|FG000|Overall Study|Physician Decision|1|||
146799453|NCT00945724|529439967|FG000|Overall Study|Adverse Event|5|||
146799454|NCT00945724|529439967|FG000|Overall Study|Second malignancy|1|||
146799455|NCT00113360|529440547|FG000|Overall Study|Adverse Event|3|||
146799456|NCT00113360|529440547|FG000|Overall Study|Subject required surgery|1|||
146799457|NCT00113360|529440547|FG000|Overall Study|Did not meet eligibility criteria|3|||
146799458|NCT02231749|529440553|FG000|Overall Study|Disease progression|229|||
146799459|NCT02231749|529440554|FG001|Overall Study|Disease progression|297|||
146799460|NCT02231749|529440553|FG000|Overall Study|Study Drug Toxicity|134|||
146799461|NCT02231749|529440554|FG001|Overall Study|Study Drug Toxicity|63|||
146799462|NCT02231749|529440553|FG000|Overall Study|Death|1|||
146799463|NCT02231749|529440554|FG001|Overall Study|Death|1|||
146799464|NCT02231749|529440553|FG000|Overall Study|AE unrelated to Study drug|32|||
146799465|NCT02231749|529440554|FG001|Overall Study|AE unrelated to Study drug|31|||
146799466|NCT02231749|529440553|FG000|Overall Study|Participant's request to discontinue|10|||
146799467|NCT02231749|529440554|FG001|Overall Study|Participant's request to discontinue|21|||
146799468|NCT02231749|529440553|FG000|Overall Study|Participant withdrew Consent|8|||
146799469|NCT02231749|529440554|FG001|Overall Study|Participant withdrew Consent|15|||
146799470|NCT02231749|529440553|FG000|Overall Study|Lost to Follow-up|1|||
146799471|NCT02231749|529440554|FG001|Overall Study|Lost to Follow-up|2|||
146799472|NCT02231749|529440553|FG000|Overall Study|Maximum Clinical Benefit|5|||
146799473|NCT02231749|529440554|FG001|Overall Study|Maximum Clinical Benefit|8|||
146799474|NCT02231749|529440553|FG000|Overall Study|Poor/Non-Compliance|0|||
146799475|NCT02231749|529440554|FG001|Overall Study|Poor/Non-Compliance|3|||
146799476|NCT02231749|529440553|FG000|Overall Study|Pregnancy|1|||
146799477|NCT02231749|529440554|FG001|Overall Study|Pregnancy|0|||
146799478|NCT02231749|529440553|FG000|Overall Study|other|0|||
146799479|NCT02231749|529440554|FG001|Overall Study|other|8|||
146799480|NCT02231749|529440553|FG000|Overall Study|No longer meets Study Criteria|1|||
146799481|NCT02231749|529440554|FG001|Overall Study|No longer meets Study Criteria|0|||
146799482|NCT03705390|529440555|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
146799483|NCT03705390|529440555|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
146799484|NCT02989662|529440557|FG000|Overall Study|Lost to Follow-up|0|||
146799485|NCT02989662|529440558|FG001|Overall Study|Lost to Follow-up|0|||
146799486|NCT02989662|529440559|FG002|Overall Study|Lost to Follow-up|0|||
146799487|NCT02989662|529440560|FG003|Overall Study|Lost to Follow-up|2|||
146799488|NCT02989662|529440557|FG000|Overall Study|Physician Decision|3|||
146799489|NCT02989662|529440558|FG001|Overall Study|Physician Decision|0|||
146799490|NCT02989662|529440559|FG002|Overall Study|Physician Decision|0|||
146799491|NCT02989662|529440560|FG003|Overall Study|Physician Decision|0|||
146799492|NCT02989662|529440557|FG000|Overall Study|Withdrawal by Subject|1|||
146799493|NCT02989662|529440558|FG001|Overall Study|Withdrawal by Subject|0|||
146799494|NCT02989662|529440559|FG002|Overall Study|Withdrawal by Subject|0|||
146799495|NCT02989662|529440560|FG003|Overall Study|Withdrawal by Subject|0|||
146799496|NCT00328783|529440561|FG000|Overall Study|Could not tolerate ABC|21|||
146799497|NCT00328783|529440561|FG000|Overall Study|No heart in RT field|4|||
146799498|NCT00328783|529440561|FG000|Overall Study|Withdrawal by Subject|1|||
146799499|NCT00357682|529440562|FG000|Overall Study|Did not receive allocated Treatment|10|||
146799500|NCT00357682|529440563|FG001|Overall Study|Did not receive allocated Treatment|9|||
146799501|NCT00357682|529440564|FG002|Overall Study|Did not receive allocated Treatment|9|||
146799502|NCT00357682|529440565|FG003|Overall Study|Did not receive allocated Treatment|10|||
146799503|NCT00357682|529440562|FG000|Overall Study|Withdrew consent|6|||
146799504|NCT00357682|529440563|FG001|Overall Study|Withdrew consent|6|||
146799505|NCT00357682|529440564|FG002|Overall Study|Withdrew consent|5|||
146799506|NCT00357682|529440565|FG003|Overall Study|Withdrew consent|5|||
146799507|NCT00357682|529440562|FG000|Overall Study|Lost to Follow-up|39|||
146799508|NCT00357682|529440563|FG001|Overall Study|Lost to Follow-up|33|||
146799509|NCT00357682|529440564|FG002|Overall Study|Lost to Follow-up|26|||
146799510|NCT00357682|529440565|FG003|Overall Study|Lost to Follow-up|35|||
146799511|NCT00357682|529440562|FG000|Overall Study|Adverse Event|24|||
146799512|NCT00357682|529440563|FG001|Overall Study|Adverse Event|32|||
146799513|NCT00357682|529440564|FG002|Overall Study|Adverse Event|22|||
146799514|NCT00357682|529440565|FG003|Overall Study|Adverse Event|27|||
146799515|NCT00357682|529440562|FG000|Overall Study|Physician Decision|32|||
146799516|NCT00357682|529440563|FG001|Overall Study|Physician Decision|20|||
146799517|NCT00357682|529440564|FG002|Overall Study|Physician Decision|24|||
146799518|NCT00357682|529440565|FG003|Overall Study|Physician Decision|30|||
146799519|NCT00357682|529440562|FG000|Overall Study|Patient decision|73|||
146799520|NCT00357682|529440563|FG001|Overall Study|Patient decision|80|||
146799521|NCT00357682|529440564|FG002|Overall Study|Patient decision|51|||
146940711|NCT01831804|529941424|FG002|Overall Study|Investigator discretion|0|||
146940712|NCT01831804|529941425|FG003|Overall Study|Investigator discretion|0|||
146799522|NCT00357682|529440565|FG003|Overall Study|Patient decision|59|||
146799523|NCT00357682|529440562|FG000|Overall Study|Other reason|157|||
146799524|NCT00357682|529440563|FG001|Overall Study|Other reason|130|||
146620831|NCT04816214|528783443|FG001|Overall Study|Death|0|||
146799525|NCT00357682|529440564|FG002|Overall Study|Other reason|114|||
146799526|NCT00357682|529440565|FG003|Overall Study|Other reason|99|||
146799527|NCT03660930|529440567|FG000|Overall Study|Adverse Event|0|||
146940713|NCT01831804|529941426|FG004|Overall Study|Investigator discretion|1|||
146940714|NCT01831804|529941427|FG005|Overall Study|Investigator discretion|0|||
146940715|NCT01831804|529941428|FG006|Overall Study|Investigator discretion|0|||
146940716|NCT01831804|529941429|FG007|Overall Study|Investigator discretion|1|||
146940717|NCT01831804|529941430|FG008|Overall Study|Investigator discretion|0|||
146799528|NCT03660930|529440568|FG001|Overall Study|Adverse Event|0|||
146799529|NCT03660930|529440569|FG002|Overall Study|Adverse Event|0|||
146799530|NCT03660930|529440570|FG003|Overall Study|Adverse Event|2|||
146799531|NCT03660930|529440571|FG004|Overall Study|Adverse Event|0|||
146799532|NCT03660930|529440572|FG005|Overall Study|Adverse Event|1|||
146799533|NCT03660930|529440573|FG006|Overall Study|Adverse Event|0|||
146799534|NCT03660930|529440574|FG007|Overall Study|Adverse Event|0|||
146799535|NCT03660930|529440567|FG000|Overall Study|Withdrawal by Subject|0|||
146799536|NCT03660930|529440568|FG001|Overall Study|Withdrawal by Subject|0|||
146799537|NCT03660930|529440569|FG002|Overall Study|Withdrawal by Subject|0|||
146799538|NCT03660930|529440570|FG003|Overall Study|Withdrawal by Subject|0|||
146799539|NCT03660930|529440571|FG004|Overall Study|Withdrawal by Subject|0|||
146799540|NCT03660930|529440572|FG005|Overall Study|Withdrawal by Subject|1|||
146799541|NCT03660930|529440573|FG006|Overall Study|Withdrawal by Subject|0|||
146799542|NCT03660930|529440574|FG007|Overall Study|Withdrawal by Subject|0|||
146799543|NCT02656706|529440577|FG000|Overall Study|Insurance Denial|1|||
146799544|NCT03725332|529440578|FG000|Overall Study|Adverse Event|5|||
146799545|NCT03725332|529440579|FG001|Overall Study|Adverse Event|10|||
146799546|NCT03725332|529440578|FG000|Overall Study|Death|1|||
146799547|NCT03725332|529440579|FG001|Overall Study|Death|3|||
146799548|NCT03725332|529440578|FG000|Overall Study|Lost to Follow-up|43|||
146799549|NCT03725332|529440579|FG001|Overall Study|Lost to Follow-up|122|||
146799550|NCT03725332|529440578|FG000|Overall Study|Withdrawal by Subject|0|||
146799551|NCT03725332|529440579|FG001|Overall Study|Withdrawal by Subject|1|||
146799552|NCT03725332|529440578|FG000|Overall Study|Duplicate enrollment|0|||
146799553|NCT03725332|529440579|FG001|Overall Study|Duplicate enrollment|1|||
146799554|NCT03725332|529440578|FG000|Overall Study|Did not consent|0|||
146799555|NCT03725332|529440579|FG001|Overall Study|Did not consent|1|||
146799556|NCT03242915|529440586|FG000|Overall Study|Adverse Event|5|||
146799557|NCT03242915|529440587|FG001|Overall Study|Adverse Event|1|||
146799558|NCT03242915|529440586|FG000|Overall Study|Withdrawal by Subject|0|||
146799559|NCT03242915|529440587|FG001|Overall Study|Withdrawal by Subject|2|||
146799560|NCT03242915|529440586|FG000|Overall Study|Physician Decision|4|||
146799561|NCT03242915|529440587|FG001|Overall Study|Physician Decision|1|||
146799562|NCT02726386|529440588|FG000|Overall Study|Adverse Event|17|||
146799563|NCT02726386|529440589|FG001|Overall Study|Adverse Event|20|||
146799564|NCT02726386|529440588|FG000|Overall Study|Withdrawal by Subject|14|||
146799565|NCT02726386|529440589|FG001|Overall Study|Withdrawal by Subject|28|||
146799566|NCT02726386|529440588|FG000|Overall Study|Other reasons|7|||
146799567|NCT02726386|529440589|FG001|Overall Study|Other reasons|8|||
146799568|NCT03201939|529440592|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
146799569|NCT03201939|529440593|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
146799570|NCT05424718|529440607|FG000|Overall Study|Lost to Follow-up|5|||
146799571|NCT05424718|529440608|FG001|Overall Study|Lost to Follow-up|4|||
146799572|NCT04046549|529440609|FG000|Overall Study|Adverse Event|1|||
146799573|NCT04046549|529440609|FG000|Overall Study|Physician Decision|1|||
146799574|NCT04046549|529440609|FG000|Overall Study|Withdrawal by Subject|3|||
146799575|NCT04046549|529440609|FG000|Overall Study|Other, Not Specified|5|||
146799576|NCT04039113|529440626|FG000|Overall Study|Withdrawal by Subject|8|||
146799577|NCT04039113|529440627|FG001|Overall Study|Withdrawal by Subject|11|||
146799578|NCT04039113|529440626|FG000|Overall Study|Lost to Follow-up|1|||
146799579|NCT04039113|529440627|FG001|Overall Study|Lost to Follow-up|1|||
146799580|NCT04039113|529440626|FG000|Overall Study|Adverse Event|2|||
146799581|NCT04039113|529440627|FG001|Overall Study|Adverse Event|2|||
146799582|NCT04039113|529440626|FG000|Overall Study|Death|2|||
146799583|NCT04039113|529440627|FG001|Overall Study|Death|4|||
146799584|NCT04039113|529440626|FG000|Overall Study|Site Closure|6|||
146799585|NCT04039113|529440627|FG001|Overall Study|Site Closure|0|||
146799586|NCT04039113|529440626|FG000|Overall Study|Failure to meet randomisation criteria|4|||
146799587|NCT04039113|529440627|FG001|Overall Study|Failure to meet randomisation criteria|0|||
146799588|NCT00353496|529440628|FG000|Overall Study|Adverse Event|1|||
146799589|NCT00353496|529440629|FG001|Overall Study|Adverse Event|0|||
146799590|NCT00353496|529440628|FG000|Overall Study|Protocol Violation|2|||
146799591|NCT00353496|529440629|FG001|Overall Study|Protocol Violation|2|||
146799592|NCT00353496|529440628|FG000|Overall Study|Withdrawal by Subject|3|||
146799593|NCT00353496|529440629|FG001|Overall Study|Withdrawal by Subject|4|||
146940718|NCT01831804|529941422|FG000|Overall Study|Withdrew Consent|0|||
146799594|NCT00353496|529440628|FG000|Overall Study|Physician Decision|6|||
146799595|NCT00353496|529440629|FG001|Overall Study|Physician Decision|9|||
146799596|NCT00353496|529440628|FG000|Overall Study|Not otherwise specified|4|||
146799597|NCT00353496|529440629|FG001|Overall Study|Not otherwise specified|2|||
146799598|NCT04129164|529441149|FG000|Overall Study|Non-compliance with procedures|0|||
146940719|NCT01831804|529941423|FG001|Overall Study|Withdrew Consent|1|||
146940720|NCT01831804|529941424|FG002|Overall Study|Withdrew Consent|0|||
146940721|NCT01831804|529941425|FG003|Overall Study|Withdrew Consent|0|||
146940722|NCT01831804|529941426|FG004|Overall Study|Withdrew Consent|0|||
146940723|NCT01831804|529941427|FG005|Overall Study|Withdrew Consent|0|||
146940724|NCT01831804|529941428|FG006|Overall Study|Withdrew Consent|0|||
146940725|NCT01831804|529941429|FG007|Overall Study|Withdrew Consent|2|||
146940726|NCT01831804|529941430|FG008|Overall Study|Withdrew Consent|0|||
146940727|NCT01505114|529941440|FG000|Overall Study|Withdrawal by Subject|5|||
146940728|NCT01505114|529941441|FG001|Overall Study|Withdrawal by Subject|4|||
146940729|NCT01505114|529941442|FG002|Overall Study|Withdrawal by Subject|4|||
146940730|NCT01505114|529941443|FG003|Overall Study|Withdrawal by Subject|7|||
146940731|NCT01505114|529941440|FG000|Overall Study|Death|1|||
146940732|NCT01505114|529941441|FG001|Overall Study|Death|0|||
146940733|NCT01505114|529941442|FG002|Overall Study|Death|0|||
146940734|NCT01505114|529941443|FG003|Overall Study|Death|1|||
146940735|NCT01505114|529941440|FG000|Overall Study|unable to adhere to visit schedule|3|||
146940736|NCT01505114|529941441|FG001|Overall Study|unable to adhere to visit schedule|2|||
146940737|NCT01505114|529941442|FG002|Overall Study|unable to adhere to visit schedule|3|||
146940738|NCT01505114|529941443|FG003|Overall Study|unable to adhere to visit schedule|3|||
146940739|NCT01505114|529941440|FG000|Overall Study|Lost to Follow-up|11|||
146940740|NCT01505114|529941441|FG001|Overall Study|Lost to Follow-up|5|||
146940741|NCT01505114|529941442|FG002|Overall Study|Lost to Follow-up|8|||
146940742|NCT01505114|529941443|FG003|Overall Study|Lost to Follow-up|7|||
146940743|NCT01505114|529941440|FG000|Overall Study|relocated|4|||
146940744|NCT01505114|529941441|FG001|Overall Study|relocated|2|||
146940745|NCT01505114|529941442|FG002|Overall Study|relocated|2|||
146940746|NCT01505114|529941443|FG003|Overall Study|relocated|3|||
146940747|NCT01505114|529941440|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
146940748|NCT01505114|529941441|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
146940749|NCT01505114|529941442|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
146940750|NCT01505114|529941443|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
146940751|NCT01505114|529941440|FG000|Overall Study|staff safety concerns|0|||
146940752|NCT01505114|529941441|FG001|Overall Study|staff safety concerns|0|||
146940753|NCT01505114|529941442|FG002|Overall Study|staff safety concerns|0|||
146940754|NCT01505114|529941443|FG003|Overall Study|staff safety concerns|1|||
146940755|NCT01505114|529941440|FG000|Overall Study|investigator decision|1|||
146940756|NCT01505114|529941441|FG001|Overall Study|investigator decision|0|||
146940757|NCT01505114|529941442|FG002|Overall Study|investigator decision|1|||
146940758|NCT01505114|529941443|FG003|Overall Study|investigator decision|0|||
146940759|NCT01040845|529941444|FG000|Overall Study|Withdrawal by Subject|1|||
146940760|NCT01040845|529941445|FG001|Overall Study|Withdrawal by Subject|1|||
146940761|NCT01040845|529941444|FG000|Overall Study|Physician Decision|1|||
146940762|NCT01040845|529941445|FG001|Overall Study|Physician Decision|0|||
146940763|NCT04445688|529941447|FG000|Washout (One Week)|Adverse Event|2|||
146940764|NCT04445688|529941447|FG000|Washout (One Week)|Withdrawal by Subject|1|||
146940765|NCT01749800|529941454|FG000|Overall Study|not meeting inclusion criteria|3|||
146940766|NCT01749800|529941455|FG001|Overall Study|not meeting inclusion criteria|0|||
146940767|NCT01749800|529941456|FG002|Overall Study|not meeting inclusion criteria|0|||
146940768|NCT01749800|529941454|FG000|Overall Study|Withdrawal by Subject|0|||
146940769|NCT01749800|529941455|FG001|Overall Study|Withdrawal by Subject|1|||
146940770|NCT01749800|529941456|FG002|Overall Study|Withdrawal by Subject|0|||
146940771|NCT01000025|529941460|FG000|Overall Study|Adverse Event|43|||
146940772|NCT01000025|529941461|FG001|Overall Study|Adverse Event|2|||
146940773|NCT01000025|529941460|FG000|Overall Study|Withdrawal by Subject|13|||
146940774|NCT01000025|529941461|FG001|Overall Study|Withdrawal by Subject|8|||
146940775|NCT01000025|529941460|FG000|Overall Study|Death|23|||
146940776|NCT01000025|529941461|FG001|Overall Study|Death|13|||
146940777|NCT01000025|529941460|FG000|Overall Study|Lack of Efficacy|363|||
146940778|NCT01000025|529941461|FG001|Overall Study|Lack of Efficacy|208|||
146940779|NCT01000025|529941460|FG000|Overall Study|Intercurrent Illness|26|||
146940780|NCT01000025|529941461|FG001|Overall Study|Intercurrent Illness|7|||
146940781|NCT04423757|529941462|FG000|Overall Study|Adverse Event|2|||
146940782|NCT04423757|529941463|FG001|Overall Study|Adverse Event|0|||
146940783|NCT04423757|529941462|FG000|Overall Study|Not treated|1|||
146940784|NCT04423757|529941463|FG001|Overall Study|Not treated|1|||
146940785|NCT02738580|529941464|FG000|Overall Study|Adverse Event|1|||
146940786|NCT02738580|529941465|FG001|Overall Study|Adverse Event|0|||
146940787|NCT02738580|529941464|FG000|Overall Study|Lack of Efficacy|3|||
146940788|NCT02738580|529941465|FG001|Overall Study|Lack of Efficacy|2|||
146940789|NCT02738580|529941464|FG000|Overall Study|Withdrawal by Subject|0|||
146940790|NCT02738580|529941465|FG001|Overall Study|Withdrawal by Subject|1|||
146940791|NCT02738580|529941464|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
146940792|NCT02738580|529941465|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
146940793|NCT01250756|529941468|FG000|Infant Series|Withdrawal by Subject|4|||
146940794|NCT01250756|529941469|FG001|Infant Series|Withdrawal by Subject|5|||
146620832|NCT04816214|528783444|FG002|Overall Study|Death|0|||
146940795|NCT01250756|529941468|FG000|Infant Series|Randomized, Not Vaccinated|2|||
146799599|NCT04129164|529441150|FG001|Overall Study|Non-compliance with procedures|0|||
146799600|NCT04129164|529441151|FG002|Overall Study|Non-compliance with procedures|2|||
146799601|NCT04129164|529441152|FG003|Overall Study|Non-compliance with procedures|0|||
146799602|NCT04129164|529441149|FG000|Overall Study|Adverse Event|0|||
146799603|NCT04129164|529441150|FG001|Overall Study|Adverse Event|0|||
146799604|NCT04129164|529441151|FG002|Overall Study|Adverse Event|2|||
146799605|NCT04129164|529441152|FG003|Overall Study|Adverse Event|0|||
146799606|NCT04129164|529441149|FG000|Overall Study|Pregnancy|0|||
146799607|NCT04129164|529441150|FG001|Overall Study|Pregnancy|0|||
146799608|NCT04129164|529441151|FG002|Overall Study|Pregnancy|0|||
146799609|NCT04129164|529441152|FG003|Overall Study|Pregnancy|1|||
146799610|NCT04129164|529441149|FG000|Overall Study|Withdrawal by Subject|3|||
146799611|NCT04129164|529441150|FG001|Overall Study|Withdrawal by Subject|2|||
146799612|NCT04129164|529441151|FG002|Overall Study|Withdrawal by Subject|4|||
146799613|NCT04129164|529441152|FG003|Overall Study|Withdrawal by Subject|6|||
146799614|NCT04129164|529441149|FG000|Overall Study|Death|0|||
146799615|NCT04129164|529441150|FG001|Overall Study|Death|1|||
146799616|NCT04129164|529441151|FG002|Overall Study|Death|0|||
146799617|NCT04129164|529441152|FG003|Overall Study|Death|0|||
146799618|NCT04129164|529441149|FG000|Overall Study|Lost to Follow-up|0|||
146799619|NCT04129164|529441150|FG001|Overall Study|Lost to Follow-up|1|||
146799620|NCT04129164|529441151|FG002|Overall Study|Lost to Follow-up|0|||
146799621|NCT04129164|529441152|FG003|Overall Study|Lost to Follow-up|0|||
146799622|NCT04174560|529441165|FG000|Overall Study|Lost to Follow-up|1|||
146799623|NCT04174560|529441166|FG001|Overall Study|Lost to Follow-up|0|||
146799624|NCT04174560|529441167|FG002|Overall Study|Lost to Follow-up|0|||
146799625|NCT04174560|529441168|FG003|Overall Study|Lost to Follow-up|0|||
146799626|NCT04174560|529441165|FG000|Overall Study|Withdrawal by Subject|0|||
146799627|NCT04174560|529441166|FG001|Overall Study|Withdrawal by Subject|0|||
146799628|NCT04174560|529441167|FG002|Overall Study|Withdrawal by Subject|2|||
146799629|NCT04174560|529441168|FG003|Overall Study|Withdrawal by Subject|0|||
146799630|NCT03782116|529441172|FG000|Completed Intervetion|Lost to Follow-up|11|||
146799631|NCT03782116|529441173|FG001|Completed Intervetion|Lost to Follow-up|7|||
146799632|NCT03782116|529441172|FG000|Completed Intervetion|Withdrawal by Subject|6|||
146799633|NCT03782116|529441173|FG001|Completed Intervetion|Withdrawal by Subject|5|||
146940796|NCT01250756|529941469|FG001|Infant Series|Randomized, Not Vaccinated|2|||
146940797|NCT01250756|529941468|FG000|Infant Series|Other|22|||
146940798|NCT01250756|529941469|FG001|Infant Series|Other|0|||
146940799|NCT01250756|529941468|FG000|After Infant Series|Adverse Event|5|||
146940800|NCT01250756|529941469|FG001|After Infant Series|Adverse Event|2|||
146940801|NCT01250756|529941468|FG000|After Infant Series|Withdrawal by Subject|4|||
146940802|NCT01250756|529941469|FG001|After Infant Series|Withdrawal by Subject|1|||
146940803|NCT01250756|529941468|FG000|After Infant Series|Other|2|||
146940804|NCT01250756|529941469|FG001|After Infant Series|Other|1|||
146940805|NCT01250756|529941468|FG000|Toddler Dose|Adverse Event|0|||
146940806|NCT01250756|529941469|FG001|Toddler Dose|Adverse Event|1|||
146940807|NCT01250756|529941468|FG000|After Toddler Dose|Adverse Event|0|||
146940808|NCT01250756|529941469|FG001|After Toddler Dose|Adverse Event|1|||
146940809|NCT02999100|529941470|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
146940810|NCT02999100|529941471|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
146940811|NCT02999100|529941472|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
146940812|NCT02999100|529941473|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
146940813|NCT02999100|529941474|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
146940814|NCT02999100|529941475|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
146940815|NCT02999100|529941470|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
146940816|NCT02999100|529941471|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
146940817|NCT02999100|529941472|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
146940818|NCT02999100|529941473|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
146940819|NCT02999100|529941474|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
146940820|NCT02999100|529941475|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
146940821|NCT02999100|529941470|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
146940822|NCT02999100|529941471|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
146940823|NCT02999100|529941472|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
146940824|NCT02999100|529941473|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
146799634|NCT03782116|529441172|FG000|Included in Analysis|Protocol Violation|5|||
146940825|NCT02999100|529941474|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
146940826|NCT02999100|529941475|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
146940827|NCT03595384|529941476|FG000|Overall Study|Other time commitments|8|||
146940828|NCT03595384|529941476|FG000|Overall Study|Changes to session time|7|||
146940829|NCT03595384|529941476|FG000|Overall Study|Relocation out of country|1|||
146940830|NCT00293241|529941477|FG000|Overall Study|Lost to Follow-up|9|||
146940831|NCT00293241|529941478|FG001|Overall Study|Lost to Follow-up|16|||
146940832|NCT00293241|529941477|FG000|Overall Study|Physician Decision|23|||
146940833|NCT00293241|529941478|FG001|Overall Study|Physician Decision|17|||
146799635|NCT03782116|529441173|FG001|Included in Analysis|Protocol Violation|5|||
146799636|NCT05934292|529441174|FG000|Overall Study|Lost to Follow-up|0|||
146940834|NCT00293241|529941477|FG000|Overall Study|Withdrawal by Subject|4|||
146940835|NCT00293241|529941478|FG001|Overall Study|Withdrawal by Subject|8|||
146940836|NCT01270958|529941480|FG000|Overall Study|Lost to Follow-up|2|||
146940837|NCT01270958|529941480|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
146940838|NCT00166517|529941484|FG000|Overall Study|Lost to Follow-up|1|||
146940839|NCT00166517|529941485|FG001|Overall Study|Lost to Follow-up|0|||
146940840|NCT00166517|529941484|FG000|Overall Study|Protocol Violation|4|||
146940841|NCT00166517|529941485|FG001|Overall Study|Protocol Violation|1|||
146940842|NCT00166517|529941484|FG000|Overall Study|Withdrawal by Subject|0|||
146940843|NCT00166517|529941485|FG001|Overall Study|Withdrawal by Subject|1|||
146940844|NCT03094611|529941489|FG000|Overall Study|Lack of Efficacy|1|||
146940845|NCT03094611|529941489|FG000|Overall Study|Stem Cell Transplant|1|||
146940846|NCT02186561|529941490|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
146940847|NCT02186561|529941490|FG000|Enrollment|Enrollment Cap Reached|5|||
146940848|NCT02186561|529941490|FG000|Enrollment|Insurance Denial|2|||
146940849|NCT02186561|529941490|FG000|Enrollment|Withdrawal by Subject|2|||
146940850|NCT02186561|529941490|FG000|Enrollment|Investigator Withdrew Consent|1|||
146940851|NCT02186561|529941490|FG000|30-Day Post Index Procedure Visit|Death|1|||
146940852|NCT02186561|529941490|FG000|1- Year Post Index Procedure Visit|Death|1|||
146940853|NCT02186561|529941490|FG000|1- Year Post Index Procedure Visit|Missed|1|||
146940854|NCT00842361|529941491|FG000|Overall Study|Protocol Violation|1|||
146940855|NCT00842361|529941492|FG001|Overall Study|Protocol Violation|0|||
146940856|NCT00842361|529941491|FG000|Overall Study|Unclassified|0|||
146940857|NCT00842361|529941492|FG001|Overall Study|Unclassified|2|||
146940858|NCT02460978|529941494|FG000|Overall Study|Adverse Event|17|||
146940859|NCT02460978|529941495|FG001|Overall Study|Adverse Event|11|||
146940860|NCT02460978|529941496|FG002|Overall Study|Adverse Event|11|||
146940861|NCT02460978|529941494|FG000|Overall Study|Withdrawal by Subject|5|||
146940862|NCT02460978|529941495|FG001|Overall Study|Withdrawal by Subject|5|||
146940863|NCT02460978|529941496|FG002|Overall Study|Withdrawal by Subject|14|||
146940864|NCT02460978|529941494|FG000|Overall Study|Lost to Follow-up|2|||
146799637|NCT05934292|529441175|FG001|Overall Study|Lost to Follow-up|0|||
146799638|NCT05934292|529441176|FG002|Overall Study|Lost to Follow-up|1|||
146799639|NCT05934292|529441177|FG003|Overall Study|Lost to Follow-up|0|||
146799640|NCT04479787|529441178|FG000|Through 6 Months|Withdrawal by Subject|16|||
146799641|NCT04479787|529441179|FG001|Through 6 Months|Withdrawal by Subject|14|||
146799642|NCT04479787|529441178|FG000|Through 6 Months|Unsuccessful Trial|17|||
146799643|NCT04479787|529441179|FG001|Through 6 Months|Unsuccessful Trial|0|||
146799644|NCT04479787|529441178|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
146799645|NCT04479787|529441179|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
146799646|NCT04479787|529441178|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
146799647|NCT04479787|529441179|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
146799648|NCT04479787|529441178|FG000|Through 6 Months|Lost to Follow-up|3|||
146799649|NCT04479787|529441179|FG001|Through 6 Months|Lost to Follow-up|2|||
146799650|NCT04479787|529441178|FG000|Through 6 Months|Death|3|||
146799651|NCT04479787|529441179|FG001|Through 6 Months|Death|0|||
146799652|NCT04479787|529441178|FG000|Through 6 Months|Inclusion/Exclusion|2|||
146799653|NCT04479787|529441179|FG001|Through 6 Months|Inclusion/Exclusion|1|||
146799654|NCT04479787|529441178|FG000|Through 6 Months|Subject Became Pregnant|1|||
146799655|NCT04479787|529441179|FG001|Through 6 Months|Subject Became Pregnant|1|||
146799656|NCT04479787|529441178|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
146799657|NCT04479787|529441179|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
146799658|NCT04479787|529441178|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
146799659|NCT04479787|529441179|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
146799660|NCT04479787|529441178|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
146799661|NCT04479787|529441179|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
146799662|NCT04479787|529441178|FG000|After 6 Months|Withdrawal by Subject|3|||
146799663|NCT04479787|529441179|FG001|After 6 Months|Withdrawal by Subject|13|||
146799664|NCT04479787|529441178|FG000|After 6 Months|Unsuccessful Trial|0|||
146799665|NCT04479787|529441179|FG001|After 6 Months|Unsuccessful Trial|7|||
146799666|NCT04479787|529441178|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
146799667|NCT04479787|529441179|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
146799668|NCT04479787|529441178|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
146799669|NCT04479787|529441179|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
146799670|NCT04479787|529441178|FG000|After 6 Months|Death|2|||
146799671|NCT04479787|529441179|FG001|After 6 Months|Death|0|||
146799672|NCT04479787|529441178|FG000|After 6 Months|Lost to Follow-up|1|||
146799673|NCT04479787|529441179|FG001|After 6 Months|Lost to Follow-up|1|||
146799674|NCT04479787|529441178|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
146799675|NCT04479787|529441179|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
146799676|NCT04479787|529441178|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
146799677|NCT04479787|529441179|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
146940865|NCT02460978|529941495|FG001|Overall Study|Lost to Follow-up|3|||
146940866|NCT02460978|529941496|FG002|Overall Study|Lost to Follow-up|1|||
146799678|NCT04479787|529441178|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
146799679|NCT04479787|529441179|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
146799680|NCT04479787|529441178|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
146799681|NCT04479787|529441179|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
146799682|NCT05714059|529441182|FG000|Overall Study|Withdrawal by Subject|2|||
146799683|NCT05714059|529441183|FG001|Overall Study|Withdrawal by Subject|2|||
146799684|NCT05714059|529441182|FG000|Overall Study|Adverse Event|0|||
146799685|NCT05714059|529441183|FG001|Overall Study|Adverse Event|1|||
146799686|NCT05714059|529441182|FG000|Overall Study|Lost to Follow-up|0|||
146799687|NCT05714059|529441183|FG001|Overall Study|Lost to Follow-up|1|||
146799688|NCT05714059|529441182|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
146799689|NCT05714059|529441183|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
146799690|NCT05714059|529441182|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
146799691|NCT05714059|529441183|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
146799692|NCT04899674|529441184|FG000|Test|Adverse Event|1|||
146799693|NCT03774472|529441185|FG000|Overall Study|Physician Decision|1|||
146799694|NCT03774472|529441186|FG001|Overall Study|Physician Decision|0|||
146799695|NCT03774472|529441187|FG002|Overall Study|Physician Decision|0|||
146799696|NCT03774472|529441185|FG000|Overall Study|Progression prior to 4 weeks|0|||
146799697|NCT03774472|529441186|FG001|Overall Study|Progression prior to 4 weeks|1|||
146799698|NCT03774472|529441187|FG002|Overall Study|Progression prior to 4 weeks|0|||
146799699|NCT03774472|529441185|FG000|Overall Study|Withdrawal by Subject|0|||
146799700|NCT03774472|529441186|FG001|Overall Study|Withdrawal by Subject|1|||
146799701|NCT03774472|529441187|FG002|Overall Study|Withdrawal by Subject|0|||
146799702|NCT03150862|529441189|FG000|Overall Study|Death|2|||
146799703|NCT03150862|529441190|FG001|Overall Study|Death|7|||
146799704|NCT03150862|529441191|FG002|Overall Study|Death|8|||
146799705|NCT03150862|529441192|FG003|Overall Study|Death|27|||
146799706|NCT03150862|529441193|FG004|Overall Study|Death|4|||
146799707|NCT03150862|529441194|FG005|Overall Study|Death|8|||
146799708|NCT03150862|529441195|FG006|Overall Study|Death|6|||
146799709|NCT03150862|529441196|FG007|Overall Study|Death|21|||
146799710|NCT03150862|529441189|FG000|Overall Study|Withdrawal by Subject|1|||
146799711|NCT03150862|529441190|FG001|Overall Study|Withdrawal by Subject|1|||
146799712|NCT03150862|529441191|FG002|Overall Study|Withdrawal by Subject|0|||
146799713|NCT03150862|529441192|FG003|Overall Study|Withdrawal by Subject|3|||
146799714|NCT03150862|529441193|FG004|Overall Study|Withdrawal by Subject|1|||
146799715|NCT03150862|529441194|FG005|Overall Study|Withdrawal by Subject|1|||
146799716|NCT03150862|529441195|FG006|Overall Study|Withdrawal by Subject|1|||
146799717|NCT03150862|529441196|FG007|Overall Study|Withdrawal by Subject|3|||
146799718|NCT03150862|529441189|FG000|Overall Study|Lost to Follow-up|0|||
146799719|NCT03150862|529441190|FG001|Overall Study|Lost to Follow-up|0|||
146799720|NCT03150862|529441191|FG002|Overall Study|Lost to Follow-up|1|||
146799721|NCT03150862|529441192|FG003|Overall Study|Lost to Follow-up|0|||
146799722|NCT03150862|529441193|FG004|Overall Study|Lost to Follow-up|0|||
146799723|NCT03150862|529441194|FG005|Overall Study|Lost to Follow-up|0|||
146799724|NCT03150862|529441195|FG006|Overall Study|Lost to Follow-up|0|||
146799725|NCT03150862|529441196|FG007|Overall Study|Lost to Follow-up|2|||
146799726|NCT03150862|529441189|FG000|Overall Study|Sponsor's decision|0|||
146799727|NCT03150862|529441190|FG001|Overall Study|Sponsor's decision|0|||
146799728|NCT03150862|529441191|FG002|Overall Study|Sponsor's decision|0|||
146799729|NCT03150862|529441192|FG003|Overall Study|Sponsor's decision|10|||
146799730|NCT03150862|529441193|FG004|Overall Study|Sponsor's decision|3|||
146799731|NCT03150862|529441194|FG005|Overall Study|Sponsor's decision|0|||
146799732|NCT03150862|529441195|FG006|Overall Study|Sponsor's decision|1|||
146799733|NCT03150862|529441196|FG007|Overall Study|Sponsor's decision|1|||
146799734|NCT03150862|529441189|FG000|Overall Study|Change in Methylation status|0|||
146799735|NCT03150862|529441190|FG001|Overall Study|Change in Methylation status|0|||
146799736|NCT03150862|529441191|FG002|Overall Study|Change in Methylation status|0|||
146799737|NCT03150862|529441192|FG003|Overall Study|Change in Methylation status|0|||
146799738|NCT03150862|529441193|FG004|Overall Study|Change in Methylation status|1|||
146799739|NCT03150862|529441194|FG005|Overall Study|Change in Methylation status|0|||
146799740|NCT03150862|529441195|FG006|Overall Study|Change in Methylation status|0|||
146799741|NCT03150862|529441196|FG007|Overall Study|Change in Methylation status|0|||
146799742|NCT03150862|529441189|FG000|Overall Study|Roll over in to Long Term Extension|0|||
146799743|NCT03150862|529441190|FG001|Overall Study|Roll over in to Long Term Extension|0|||
146799744|NCT03150862|529441191|FG002|Overall Study|Roll over in to Long Term Extension|0|||
146799745|NCT03150862|529441192|FG003|Overall Study|Roll over in to Long Term Extension|0|||
146799746|NCT03150862|529441193|FG004|Overall Study|Roll over in to Long Term Extension|0|||
146799747|NCT03150862|529441194|FG005|Overall Study|Roll over in to Long Term Extension|0|||
146799748|NCT03150862|529441195|FG006|Overall Study|Roll over in to Long Term Extension|0|||
146799749|NCT03150862|529441196|FG007|Overall Study|Roll over in to Long Term Extension|1|||
146799750|NCT03150862|529441189|FG000|Overall Study|Progressive Disease|0|||
146799751|NCT03150862|529441190|FG001|Overall Study|Progressive Disease|0|||
146799752|NCT03150862|529441191|FG002|Overall Study|Progressive Disease|0|||
146799753|NCT03150862|529441192|FG003|Overall Study|Progressive Disease|0|||
146799754|NCT03150862|529441193|FG004|Overall Study|Progressive Disease|0|||
146799755|NCT03150862|529441194|FG005|Overall Study|Progressive Disease|0|||
146799756|NCT03150862|529441195|FG006|Overall Study|Progressive Disease|0|||
146799757|NCT03150862|529441196|FG007|Overall Study|Progressive Disease|2|||
146799758|NCT05039021|529441650|FG000|Overall Study|Death|1|||
146799759|NCT05039021|529441650|FG000|Overall Study|Lost to Follow-up|3|||
146799760|NCT02719574|529441651|FG000|Phase 1 (Dose Escalation)|Other|0|||
146799761|NCT02719574|529441652|FG001|Phase 1 (Dose Escalation)|Other|2|||
146799762|NCT02719574|529441653|FG002|Phase 1 (Dose Escalation)|Other|1|||
146799763|NCT02719574|529441654|FG003|Phase 1 (Dose Escalation)|Other|2|||
146799764|NCT02719574|529441655|FG004|Phase 1 (Dose Escalation)|Other|2|||
146799765|NCT02719574|529441656|FG005|Phase 1 (Dose Escalation)|Other|0|||
146799766|NCT02719574|529441657|FG006|Phase 1 (Dose Escalation)|Other|0|||
146799767|NCT02719574|529441658|FG007|Phase 1 (Dose Escalation)|Other|0|||
146799768|NCT02719574|529441659|FG008|Phase 1 (Dose Escalation)|Other|0|||
146799769|NCT02719574|529441660|FG009|Phase 1 (Dose Escalation)|Other|0|||
146799770|NCT02719574|529441661|FG010|Phase 1 (Dose Escalation)|Other|0|||
146799771|NCT02719574|529441662|FG011|Phase 1 (Dose Escalation)|Other|0|||
146799772|NCT02719574|529441663|FG012|Phase 1 (Dose Escalation)|Other|0|||
146799773|NCT02719574|529441664|FG013|Phase 1 (Dose Escalation)|Other|0|||
146799774|NCT02719574|529441665|FG014|Phase 1 (Dose Escalation)|Other|0|||
146799775|NCT02719574|529441666|FG015|Phase 1 (Dose Escalation)|Other|0|||
146799776|NCT02719574|529441667|FG016|Phase 1 (Dose Escalation)|Other|0|||
146799777|NCT02719574|529441651|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
146799778|NCT02719574|529441652|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
146799779|NCT02719574|529441653|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
146799780|NCT02719574|529441654|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
146799781|NCT02719574|529441655|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
146799782|NCT02719574|529441656|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
146799783|NCT02719574|529441657|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146799784|NCT02719574|529441658|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146799785|NCT02719574|529441659|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146799786|NCT02719574|529441660|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146799787|NCT02719574|529441661|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146799788|NCT02719574|529441662|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146799789|NCT02719574|529441663|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146799790|NCT02719574|529441664|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146799791|NCT02719574|529441665|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146799792|NCT02719574|529441666|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146799793|NCT02719574|529441667|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146799794|NCT02719574|529441651|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146799795|NCT02719574|529441652|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
146799796|NCT02719574|529441653|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
146799797|NCT02719574|529441654|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146799798|NCT02719574|529441655|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
146799799|NCT02719574|529441656|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
146799800|NCT02719574|529441657|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146799801|NCT02719574|529441658|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146799802|NCT02719574|529441659|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146799803|NCT02719574|529441660|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146799804|NCT02719574|529441661|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146799805|NCT02719574|529441662|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146799806|NCT02719574|529441663|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146799807|NCT02719574|529441664|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146799808|NCT02719574|529441665|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146799809|NCT02719574|529441666|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146799810|NCT02719574|529441667|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146799811|NCT02719574|529441651|FG000|Phase 1 (Dose Escalation)|Death|2|||
146799812|NCT02719574|529441652|FG001|Phase 1 (Dose Escalation)|Death|1|||
146799813|NCT02719574|529441653|FG002|Phase 1 (Dose Escalation)|Death|1|||
146799814|NCT02719574|529441654|FG003|Phase 1 (Dose Escalation)|Death|0|||
146799815|NCT02719574|529441655|FG004|Phase 1 (Dose Escalation)|Death|0|||
146799816|NCT02719574|529441656|FG005|Phase 1 (Dose Escalation)|Death|0|||
146799817|NCT02719574|529441657|FG006|Phase 1 (Dose Escalation)|Death|0|||
146799818|NCT02719574|529441658|FG007|Phase 1 (Dose Escalation)|Death|0|||
146799819|NCT02719574|529441659|FG008|Phase 1 (Dose Escalation)|Death|0|||
146799820|NCT02719574|529441660|FG009|Phase 1 (Dose Escalation)|Death|0|||
146799821|NCT02719574|529441661|FG010|Phase 1 (Dose Escalation)|Death|0|||
146799822|NCT02719574|529441662|FG011|Phase 1 (Dose Escalation)|Death|0|||
146799823|NCT02719574|529441663|FG012|Phase 1 (Dose Escalation)|Death|0|||
146799824|NCT02719574|529441664|FG013|Phase 1 (Dose Escalation)|Death|0|||
146799825|NCT02719574|529441665|FG014|Phase 1 (Dose Escalation)|Death|0|||
146799826|NCT02719574|529441666|FG015|Phase 1 (Dose Escalation)|Death|0|||
146799827|NCT02719574|529441667|FG016|Phase 1 (Dose Escalation)|Death|0|||
146799828|NCT02719574|529441651|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
146799829|NCT02719574|529441652|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
146799830|NCT02719574|529441653|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
146799831|NCT02719574|529441654|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
146799832|NCT02719574|529441655|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
146799833|NCT02719574|529441656|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
146799834|NCT02719574|529441657|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
146799835|NCT02719574|529441658|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
146799836|NCT02719574|529441659|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
146799837|NCT02719574|529441660|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
146799838|NCT02719574|529441661|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
146799839|NCT02719574|529441662|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
146799840|NCT02719574|529441663|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
146799841|NCT02719574|529441664|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
146799842|NCT02719574|529441665|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
146799843|NCT02719574|529441666|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
146799844|NCT02719574|529441667|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
146799845|NCT02719574|529441651|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
146799846|NCT02719574|529441652|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
146799847|NCT02719574|529441653|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
146799848|NCT02719574|529441654|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
146799849|NCT02719574|529441655|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
146799850|NCT02719574|529441656|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
146799851|NCT02719574|529441657|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
146799852|NCT02719574|529441658|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
146799853|NCT02719574|529441659|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
146799854|NCT02719574|529441660|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
146799855|NCT02719574|529441661|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
146799856|NCT02719574|529441662|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
146799857|NCT02719574|529441663|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
146799858|NCT02719574|529441664|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
146799859|NCT02719574|529441665|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
146799860|NCT02719574|529441666|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
146799861|NCT02719574|529441667|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
146799862|NCT02719574|529441651|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146799863|NCT02719574|529441652|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146799864|NCT02719574|529441653|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
146799865|NCT02719574|529441654|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146983209|NCT00871728|530099941|FG000|Overall Study|Failed to Visit Hospital|4|||
146983210|NCT00871728|530099941|FG000|Overall Study|Participant Non-compliance|1|||
146983211|NCT00871728|530099941|FG000|Overall Study|Withdrawal of Informed Consent|5|||
146983212|NCT03775681|530099949|FG000|Overall Study|Physician Decision|3|||
146983213|NCT00616928|530099950|FG000|Overall Study|Adverse Event|6|||
146983214|NCT00616928|530099951|FG001|Overall Study|Adverse Event|3|||
146983215|NCT00616928|530099952|FG002|Overall Study|Adverse Event|2|||
146983216|NCT00616928|530099953|FG003|Overall Study|Adverse Event|2|||
146983217|NCT00616928|530099950|FG000|Overall Study|Other|51|||
146983218|NCT00616928|530099951|FG001|Overall Study|Other|8|||
146983219|NCT00616928|530099952|FG002|Overall Study|Other|15|||
146983220|NCT00616928|530099953|FG003|Overall Study|Other|5|||
146983221|NCT00616928|530099950|FG000|Overall Study|Lost to Follow-up|5|||
146983222|NCT00616928|530099951|FG001|Overall Study|Lost to Follow-up|7|||
146983223|NCT00616928|530099952|FG002|Overall Study|Lost to Follow-up|0|||
146983224|NCT00616928|530099953|FG003|Overall Study|Lost to Follow-up|0|||
146983225|NCT00895583|530099954|FG000|Overall Study|Adverse Event|28|||
146983226|NCT00895583|530099955|FG001|Overall Study|Adverse Event|4|||
146983227|NCT00895583|530099954|FG000|Overall Study|Death|2|||
146983228|NCT00895583|530099955|FG001|Overall Study|Death|1|||
146983229|NCT00895583|530099954|FG000|Overall Study|Physician Decision|3|||
146983230|NCT00895583|530099955|FG001|Overall Study|Physician Decision|1|||
146983231|NCT00895583|530099954|FG000|Overall Study|Lost to Follow-up|1|||
146983232|NCT00895583|530099955|FG001|Overall Study|Lost to Follow-up|3|||
146983233|NCT00895583|530099954|FG000|Overall Study|Protocol Violation|1|||
146983234|NCT00895583|530099955|FG001|Overall Study|Protocol Violation|0|||
146983235|NCT00895583|530099954|FG000|Overall Study|Withdrawal by Subject|4|||
146983236|NCT00895583|530099955|FG001|Overall Study|Withdrawal by Subject|2|||
146799866|NCT02719574|529441655|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146799867|NCT02719574|529441656|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146983237|NCT00895583|530099954|FG000|Overall Study|Lack of Efficacy|5|||
146983238|NCT00895583|530099955|FG001|Overall Study|Lack of Efficacy|0|||
146983239|NCT00895583|530099954|FG000|Overall Study|Other|0|||
146983240|NCT00895583|530099955|FG001|Overall Study|Other|1|||
146983241|NCT03529955|530099956|FG000|Overall Study|Adverse Event|1|||
146983242|NCT03529955|530099956|FG000|Overall Study|Lack of Efficacy|1|||
146983243|NCT03016078|530099962|FG000|Overall Study|Protocol Violation|1|||
146983244|NCT03016078|530099962|FG000|Overall Study|Protocol Violation|1|||
146983245|NCT02378506|530099963|FG000|Overall Study|Lack of Efficacy|3|||
146983246|NCT02378506|530099963|FG000|Overall Study|Withdrawal by Subject|4|||
146983247|NCT02378506|530099963|FG000|Overall Study|Protocol Violation|2|||
146983248|NCT02378506|530099963|FG000|Overall Study|Death|1|||
146799868|NCT02719574|529441657|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146799869|NCT02719574|529441658|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146799870|NCT02719574|529441659|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146799871|NCT02719574|529441660|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146799872|NCT02719574|529441661|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146799873|NCT02719574|529441662|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146799874|NCT02719574|529441663|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146799875|NCT02719574|529441664|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146799876|NCT02719574|529441665|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146799877|NCT02719574|529441666|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146799878|NCT02719574|529441667|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146799879|NCT02719574|529441651|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146799880|NCT02719574|529441652|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146940867|NCT02460978|529941494|FG000|Overall Study|Protocol Violation|1|||
146940868|NCT02460978|529941495|FG001|Overall Study|Protocol Violation|1|||
146940869|NCT02460978|529941496|FG002|Overall Study|Protocol Violation|1|||
146940870|NCT02460978|529941494|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
146940871|NCT02460978|529941495|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
146940872|NCT02460978|529941496|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
146940873|NCT02460978|529941494|FG000|Overall Study|Pregnancy|0|||
146940874|NCT02460978|529941495|FG001|Overall Study|Pregnancy|0|||
146940875|NCT02460978|529941496|FG002|Overall Study|Pregnancy|2|||
146940876|NCT00588523|529941500|FG000|Overall Study|Not treated|3|||
146940877|NCT01459068|529941505|FG000|Overall Study|Withdrawal by Subject|8|||
146940878|NCT01459068|529941506|FG001|Overall Study|Withdrawal by Subject|18|||
146940879|NCT01459068|529941505|FG000|Overall Study|Lost to Follow-up|31|||
146940880|NCT01459068|529941506|FG001|Overall Study|Lost to Follow-up|15|||
146940881|NCT01459068|529941505|FG000|Overall Study|Death|0|||
146940882|NCT01459068|529941506|FG001|Overall Study|Death|1|||
146940883|NCT02023112|529941507|FG000|Overall Study|Withdrawal by Subject|2|||
146940884|NCT02023112|529941508|FG001|Overall Study|Withdrawal by Subject|1|||
146940885|NCT01313078|529941509|FG000|Overall Study|Death|1|||
146940886|NCT01313078|529941509|FG000|Overall Study|Discontinued study drug|1|||
146940887|NCT01313078|529941509|FG000|Overall Study|Withdrawal by Subject|1|||
146940888|NCT03136484|529941510|FG000|Overall Study|Withdrawal by Subject|19|||
146940889|NCT03136484|529941511|FG001|Overall Study|Withdrawal by Subject|14|||
146940890|NCT03136484|529941510|FG000|Overall Study|Lost to Follow-up|7|||
146940891|NCT03136484|529941511|FG001|Overall Study|Lost to Follow-up|8|||
146940892|NCT03136484|529941510|FG000|Overall Study|Death|1|||
146940893|NCT03136484|529941511|FG001|Overall Study|Death|0|||
146940894|NCT01449955|529941514|FG000|Overall Study|Withdrawal by Subject|1|||
146940895|NCT01449955|529941515|FG001|Overall Study|Withdrawal by Subject|2|||
146940896|NCT01601470|529941516|FG000|Period 2 - LCZ696|Physician Decision|1|||
146940897|NCT03627494|529941519|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
146940898|NCT03627494|529941520|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
146940899|NCT03627494|529941521|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
146940900|NCT03627494|529941522|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
146940901|NCT03627494|529941523|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
146940902|NCT03627494|529941524|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
146940903|NCT03627494|529941525|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
146940904|NCT03627494|529941526|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
146940905|NCT03627494|529941527|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
146940906|NCT03627494|529941528|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
146940907|NCT03627494|529941529|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
146940908|NCT03627494|529941530|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
146940909|NCT03627494|529941519|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
146940910|NCT03627494|529941520|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
146940911|NCT03627494|529941521|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
146940912|NCT03627494|529941522|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
146940913|NCT03627494|529941523|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
146940914|NCT03627494|529941524|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
146940915|NCT03627494|529941525|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
146940916|NCT03627494|529941526|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
146940917|NCT03627494|529941527|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
146940918|NCT03627494|529941528|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
146940919|NCT03627494|529941529|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
146940920|NCT03627494|529941530|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
146799881|NCT02719574|529441653|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146799882|NCT02719574|529441654|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146940921|NCT03627494|529941519|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
146940922|NCT03627494|529941520|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
146799883|NCT02719574|529441655|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146940923|NCT03627494|529941521|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
146940924|NCT03627494|529941522|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
146940925|NCT03627494|529941523|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
146983249|NCT02378506|530099963|FG000|Overall Study|Adverse Event|14|||
146983250|NCT02378506|530099963|FG000|Overall Study|Randomized But Not Treated|1|||
146983251|NCT01070394|530099966|FG000|Overall Study|Adverse Event|6|||
146983252|NCT01070394|530099966|FG000|Overall Study|Withdrawal by Subject|1|||
146983253|NCT01715415|530099978|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
146983254|NCT01715415|530099979|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
146983255|NCT01715415|530099978|FG000|Double-blind Treatment|Adverse Event|3|||
146983256|NCT01715415|530099979|FG001|Double-blind Treatment|Adverse Event|0|||
146983257|NCT01715415|530099978|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
146983258|NCT01715415|530099979|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
146983259|NCT01715415|530099978|FG000|Double-blind Treatment|Other|1|||
146983260|NCT01715415|530099979|FG001|Double-blind Treatment|Other|0|||
146983261|NCT01715415|530099978|FG000|Open-label Treatment|Adverse Event|0|||
146983262|NCT01715415|530099979|FG001|Open-label Treatment|Adverse Event|1|||
146983263|NCT01715415|530099978|FG000|Open-label Treatment|Subject Noncompliant|0|||
146983264|NCT01715415|530099979|FG001|Open-label Treatment|Subject Noncompliant|1|||
146983265|NCT01015612|530099980|FG000|Overall Study|Death|113|||
146983266|NCT01015612|530099980|FG000|Overall Study|Withdrawal by Subject|40|||
146983267|NCT03586830|530099981|FG000|Overall Study|Site terminated by Sponsor|1|||
146983268|NCT03586830|530099982|FG001|Overall Study|Site terminated by Sponsor|4|||
146983269|NCT03586830|530099983|FG002|Overall Study|Site terminated by Sponsor|3|||
146983270|NCT03586830|530099984|FG003|Overall Study|Site terminated by Sponsor|3|||
146983271|NCT03586830|530099981|FG000|Overall Study|Lost to Follow-up|0|||
146983272|NCT03586830|530099982|FG001|Overall Study|Lost to Follow-up|2|||
146983273|NCT03586830|530099983|FG002|Overall Study|Lost to Follow-up|2|||
146983274|NCT03586830|530099984|FG003|Overall Study|Lost to Follow-up|1|||
146983275|NCT03586830|530099981|FG000|Overall Study|Withdrawal by Subject|1|||
146983276|NCT03586830|530099982|FG001|Overall Study|Withdrawal by Subject|0|||
146983277|NCT03586830|530099983|FG002|Overall Study|Withdrawal by Subject|3|||
146983278|NCT03586830|530099984|FG003|Overall Study|Withdrawal by Subject|1|||
146983279|NCT02497391|530101801|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
146983280|NCT02497391|530101802|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
146983281|NCT02497391|530101803|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
146983282|NCT02497391|530101804|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
146983283|NCT02497391|530101805|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
146983284|NCT02497391|530101806|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
146983285|NCT02497391|530101801|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
146983286|NCT02497391|530101802|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
146983287|NCT02497391|530101803|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
146983288|NCT02497391|530101804|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
146983289|NCT02497391|530101805|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
146983290|NCT02497391|530101806|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
146983291|NCT02497391|530101801|FG000|Period 3 (14 Days)|Adverse Event|0|||
146983292|NCT02497391|530101802|FG001|Period 3 (14 Days)|Adverse Event|1|||
146983293|NCT02497391|530101803|FG002|Period 3 (14 Days)|Adverse Event|0|||
146983294|NCT02497391|530101804|FG003|Period 3 (14 Days)|Adverse Event|0|||
146983295|NCT02497391|530101805|FG004|Period 3 (14 Days)|Adverse Event|0|||
146983296|NCT02497391|530101806|FG005|Period 3 (14 Days)|Adverse Event|0|||
146799884|NCT02719574|529441656|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146799885|NCT02719574|529441657|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
146799886|NCT02719574|529441658|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
146799887|NCT02719574|529441659|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
146799888|NCT02719574|529441660|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146799889|NCT02719574|529441661|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146799890|NCT02719574|529441662|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146799891|NCT02719574|529441663|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146983297|NCT02497391|530101801|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
146983298|NCT02497391|530101802|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
146983299|NCT02497391|530101803|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
146983300|NCT02497391|530101804|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
146983301|NCT02497391|530101805|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
146983302|NCT02497391|530101806|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
146983303|NCT02497391|530101801|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
146983304|NCT02497391|530101802|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
146983305|NCT02497391|530101803|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
146983306|NCT02497391|530101804|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
146983307|NCT02497391|530101805|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
146983308|NCT02497391|530101806|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
146799892|NCT02719574|529441664|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146799893|NCT02719574|529441665|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146983309|NCT01664052|530101807|FG000|Phase 1|No device placement|6|||
146983310|NCT01664052|530101808|FG001|Phase 1|No device placement|0|||
146983311|NCT01664052|530101807|FG000|Phase 1|No HSG 1 hr post placement|1|||
146983312|NCT01664052|530101808|FG001|Phase 1|No HSG 1 hr post placement|0|||
146983313|NCT01664052|530101807|FG000|Phase 2|No device placement|0|||
146983314|NCT01664052|530101808|FG001|Phase 2|No device placement|4|||
146799894|NCT02719574|529441666|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146799895|NCT02719574|529441667|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146799896|NCT02719574|529441651|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146799897|NCT02719574|529441652|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146799898|NCT02719574|529441653|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146799899|NCT02719574|529441654|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146799900|NCT02719574|529441655|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146799901|NCT02719574|529441656|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146799902|NCT02719574|529441657|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
146799903|NCT02719574|529441658|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
146799904|NCT02719574|529441659|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146799905|NCT02719574|529441660|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146799906|NCT02719574|529441661|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146799907|NCT02719574|529441662|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146799908|NCT02719574|529441663|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146799909|NCT02719574|529441664|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146799910|NCT02719574|529441665|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146799911|NCT02719574|529441666|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146799912|NCT02719574|529441667|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146799913|NCT02719574|529441651|FG000|Phase 1 (Dose Expansion)|Death|0|||
146799914|NCT02719574|529441652|FG001|Phase 1 (Dose Expansion)|Death|0|||
146799915|NCT02719574|529441653|FG002|Phase 1 (Dose Expansion)|Death|0|||
146799916|NCT02719574|529441654|FG003|Phase 1 (Dose Expansion)|Death|0|||
146799917|NCT02719574|529441655|FG004|Phase 1 (Dose Expansion)|Death|0|||
146799918|NCT02719574|529441656|FG005|Phase 1 (Dose Expansion)|Death|0|||
146799919|NCT02719574|529441657|FG006|Phase 1 (Dose Expansion)|Death|1|||
146799920|NCT02719574|529441658|FG007|Phase 1 (Dose Expansion)|Death|6|||
146799921|NCT02719574|529441659|FG008|Phase 1 (Dose Expansion)|Death|0|||
146799922|NCT02719574|529441660|FG009|Phase 1 (Dose Expansion)|Death|0|||
146799923|NCT02719574|529441661|FG010|Phase 1 (Dose Expansion)|Death|0|||
146799924|NCT02719574|529441662|FG011|Phase 1 (Dose Expansion)|Death|0|||
146799925|NCT02719574|529441663|FG012|Phase 1 (Dose Expansion)|Death|0|||
146799926|NCT02719574|529441664|FG013|Phase 1 (Dose Expansion)|Death|0|||
146799927|NCT02719574|529441665|FG014|Phase 1 (Dose Expansion)|Death|0|||
146799928|NCT02719574|529441666|FG015|Phase 1 (Dose Expansion)|Death|0|||
146799929|NCT02719574|529441667|FG016|Phase 1 (Dose Expansion)|Death|0|||
146799930|NCT02719574|529441651|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
146799931|NCT02719574|529441652|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
146799932|NCT02719574|529441653|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
146799933|NCT02719574|529441654|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
146799934|NCT02719574|529441655|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
146799935|NCT02719574|529441656|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
146799936|NCT02719574|529441657|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
146799937|NCT02719574|529441658|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
146799938|NCT02719574|529441659|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
146799939|NCT02719574|529441660|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
146799940|NCT02719574|529441661|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
146799941|NCT02719574|529441662|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
146799942|NCT02719574|529441663|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
146799943|NCT02719574|529441664|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
146799944|NCT02719574|529441665|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
146799945|NCT02719574|529441666|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
146799946|NCT02719574|529441667|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
146799947|NCT02719574|529441651|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
146799948|NCT02719574|529441652|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
146799949|NCT02719574|529441653|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
146799950|NCT02719574|529441654|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
146799951|NCT02719574|529441655|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
146799952|NCT02719574|529441656|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
146799953|NCT02719574|529441657|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
146799954|NCT02719574|529441658|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
146799955|NCT02719574|529441659|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
146799956|NCT02719574|529441660|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
146799957|NCT02719574|529441661|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
146940926|NCT03627494|529941524|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
146799958|NCT02719574|529441662|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
146799959|NCT02719574|529441663|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
146799960|NCT02719574|529441664|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
146799961|NCT02719574|529441665|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
146799962|NCT02719574|529441666|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
146799963|NCT02719574|529441667|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
146799964|NCT02719574|529441651|FG000|Phase 1 (Dose Expansion)|Other|0|||
146799965|NCT02719574|529441652|FG001|Phase 1 (Dose Expansion)|Other|0|||
146799966|NCT02719574|529441653|FG002|Phase 1 (Dose Expansion)|Other|0|||
146799967|NCT02719574|529441654|FG003|Phase 1 (Dose Expansion)|Other|0|||
146940927|NCT03627494|529941525|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
146799968|NCT02719574|529441655|FG004|Phase 1 (Dose Expansion)|Other|0|||
146799969|NCT02719574|529441656|FG005|Phase 1 (Dose Expansion)|Other|0|||
146799970|NCT02719574|529441657|FG006|Phase 1 (Dose Expansion)|Other|1|||
146799971|NCT02719574|529441658|FG007|Phase 1 (Dose Expansion)|Other|7|||
146799972|NCT02719574|529441659|FG008|Phase 1 (Dose Expansion)|Other|0|||
146799973|NCT02719574|529441660|FG009|Phase 1 (Dose Expansion)|Other|0|||
146799974|NCT02719574|529441661|FG010|Phase 1 (Dose Expansion)|Other|0|||
146799975|NCT02719574|529441662|FG011|Phase 1 (Dose Expansion)|Other|0|||
146799976|NCT02719574|529441663|FG012|Phase 1 (Dose Expansion)|Other|0|||
146799977|NCT02719574|529441664|FG013|Phase 1 (Dose Expansion)|Other|0|||
146799978|NCT02719574|529441665|FG014|Phase 1 (Dose Expansion)|Other|0|||
146799979|NCT02719574|529441666|FG015|Phase 1 (Dose Expansion)|Other|0|||
146799980|NCT02719574|529441667|FG016|Phase 1 (Dose Expansion)|Other|0|||
146799981|NCT02719574|529441651|FG000|Phase 2|Protocol Defined Disease Progression|0|||
146799982|NCT02719574|529441652|FG001|Phase 2|Protocol Defined Disease Progression|0|||
146799983|NCT02719574|529441653|FG002|Phase 2|Protocol Defined Disease Progression|0|||
146799984|NCT02719574|529441654|FG003|Phase 2|Protocol Defined Disease Progression|0|||
146799985|NCT02719574|529441655|FG004|Phase 2|Protocol Defined Disease Progression|0|||
146799986|NCT02719574|529441656|FG005|Phase 2|Protocol Defined Disease Progression|0|||
146799987|NCT02719574|529441657|FG006|Phase 2|Protocol Defined Disease Progression|0|||
146799988|NCT02719574|529441658|FG007|Phase 2|Protocol Defined Disease Progression|0|||
146799989|NCT02719574|529441659|FG008|Phase 2|Protocol Defined Disease Progression|0|||
146799990|NCT02719574|529441660|FG009|Phase 2|Protocol Defined Disease Progression|65|||
146799991|NCT02719574|529441661|FG010|Phase 2|Protocol Defined Disease Progression|8|||
146799992|NCT02719574|529441662|FG011|Phase 2|Protocol Defined Disease Progression|2|||
146799993|NCT02719574|529441663|FG012|Phase 2|Protocol Defined Disease Progression|4|||
146799994|NCT02719574|529441664|FG013|Phase 2|Protocol Defined Disease Progression|9|||
146799995|NCT02719574|529441665|FG014|Phase 2|Protocol Defined Disease Progression|11|||
146799996|NCT02719574|529441666|FG015|Phase 2|Protocol Defined Disease Progression|3|||
146799997|NCT02719574|529441667|FG016|Phase 2|Protocol Defined Disease Progression|4|||
146799998|NCT02719574|529441651|FG000|Phase 2|Adverse Event|0|||
146799999|NCT02719574|529441652|FG001|Phase 2|Adverse Event|0|||
146800000|NCT02719574|529441653|FG002|Phase 2|Adverse Event|0|||
146800001|NCT02719574|529441654|FG003|Phase 2|Adverse Event|0|||
146800002|NCT02719574|529441655|FG004|Phase 2|Adverse Event|0|||
146800003|NCT02719574|529441656|FG005|Phase 2|Adverse Event|0|||
146800004|NCT02719574|529441657|FG006|Phase 2|Adverse Event|0|||
146800005|NCT02719574|529441658|FG007|Phase 2|Adverse Event|0|||
146800006|NCT02719574|529441659|FG008|Phase 2|Adverse Event|0|||
146800007|NCT02719574|529441660|FG009|Phase 2|Adverse Event|27|||
146800008|NCT02719574|529441661|FG010|Phase 2|Adverse Event|0|||
146800009|NCT02719574|529441662|FG011|Phase 2|Adverse Event|1|||
146800010|NCT02719574|529441663|FG012|Phase 2|Adverse Event|1|||
146800011|NCT02719574|529441664|FG013|Phase 2|Adverse Event|1|||
146800012|NCT02719574|529441665|FG014|Phase 2|Adverse Event|2|||
146800013|NCT02719574|529441666|FG015|Phase 2|Adverse Event|2|||
146800014|NCT02719574|529441667|FG016|Phase 2|Adverse Event|3|||
146800015|NCT02719574|529441651|FG000|Phase 2|Other|0|||
146800016|NCT02719574|529441652|FG001|Phase 2|Other|0|||
146800017|NCT02719574|529441653|FG002|Phase 2|Other|0|||
146800018|NCT02719574|529441654|FG003|Phase 2|Other|0|||
146800019|NCT02719574|529441655|FG004|Phase 2|Other|0|||
146800020|NCT02719574|529441656|FG005|Phase 2|Other|0|||
146800021|NCT02719574|529441657|FG006|Phase 2|Other|0|||
146800022|NCT02719574|529441658|FG007|Phase 2|Other|0|||
146800023|NCT02719574|529441659|FG008|Phase 2|Other|0|||
146800024|NCT02719574|529441660|FG009|Phase 2|Other|20|||
146800025|NCT02719574|529441661|FG010|Phase 2|Other|7|||
146800026|NCT02719574|529441662|FG011|Phase 2|Other|0|||
146800027|NCT02719574|529441663|FG012|Phase 2|Other|5|||
146800028|NCT02719574|529441664|FG013|Phase 2|Other|7|||
146800029|NCT02719574|529441665|FG014|Phase 2|Other|0|||
146800030|NCT02719574|529441666|FG015|Phase 2|Other|1|||
146800031|NCT02719574|529441667|FG016|Phase 2|Other|4|||
146800032|NCT02719574|529441651|FG000|Phase 2|Transplant|0|||
146800033|NCT02719574|529441652|FG001|Phase 2|Transplant|0|||
146800034|NCT02719574|529441653|FG002|Phase 2|Transplant|0|||
146940928|NCT03627494|529941526|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
146800035|NCT02719574|529441654|FG003|Phase 2|Transplant|0|||
146800036|NCT02719574|529441655|FG004|Phase 2|Transplant|0|||
146800037|NCT02719574|529441656|FG005|Phase 2|Transplant|0|||
146800038|NCT02719574|529441657|FG006|Phase 2|Transplant|0|||
146800039|NCT02719574|529441658|FG007|Phase 2|Transplant|0|||
146800040|NCT02719574|529441659|FG008|Phase 2|Transplant|0|||
146800041|NCT02719574|529441660|FG009|Phase 2|Transplant|15|||
146800042|NCT02719574|529441661|FG010|Phase 2|Transplant|2|||
146800043|NCT02719574|529441662|FG011|Phase 2|Transplant|0|||
146800044|NCT02719574|529441663|FG012|Phase 2|Transplant|6|||
146800045|NCT02719574|529441664|FG013|Phase 2|Transplant|1|||
146800046|NCT02719574|529441665|FG014|Phase 2|Transplant|1|||
146800047|NCT02719574|529441666|FG015|Phase 2|Transplant|0|||
146800048|NCT02719574|529441667|FG016|Phase 2|Transplant|0|||
146800049|NCT02719574|529441651|FG000|Phase 2|Death|0|||
146983315|NCT03740698|530101809|FG000|Overall Study|Physician Decision|0|||
146983316|NCT03740698|530101810|FG001|Overall Study|Physician Decision|1|||
146983317|NCT03740698|530101811|FG002|Overall Study|Physician Decision|1|||
146983318|NCT01466686|530101815|FG000|Overall Study|Withdrawal by Subject|1|||
146983319|NCT00633152|530101820|FG000|Overall Study|Adverse Event|1|||
146983320|NCT00633152|530101821|FG001|Overall Study|Adverse Event|0|||
146983321|NCT00633152|530101820|FG000|Overall Study|Randomized, did not receive study drug|5|||
146983322|NCT00633152|530101821|FG001|Overall Study|Randomized, did not receive study drug|2|||
146800050|NCT02719574|529441652|FG001|Phase 2|Death|0|||
146800051|NCT02719574|529441653|FG002|Phase 2|Death|0|||
146800052|NCT02719574|529441654|FG003|Phase 2|Death|0|||
146800053|NCT02719574|529441655|FG004|Phase 2|Death|0|||
146800054|NCT02719574|529441656|FG005|Phase 2|Death|0|||
146800055|NCT02719574|529441657|FG006|Phase 2|Death|0|||
146800056|NCT02719574|529441658|FG007|Phase 2|Death|0|||
146800057|NCT02719574|529441659|FG008|Phase 2|Death|0|||
146800058|NCT02719574|529441660|FG009|Phase 2|Death|14|||
146800059|NCT02719574|529441661|FG010|Phase 2|Death|0|||
146800060|NCT02719574|529441662|FG011|Phase 2|Death|0|||
146800061|NCT02719574|529441663|FG012|Phase 2|Death|1|||
146800062|NCT02719574|529441664|FG013|Phase 2|Death|1|||
146800063|NCT02719574|529441665|FG014|Phase 2|Death|2|||
146800064|NCT02719574|529441666|FG015|Phase 2|Death|0|||
146800065|NCT02719574|529441667|FG016|Phase 2|Death|0|||
146800066|NCT02719574|529441651|FG000|Phase 2|Investigator Decision|0|||
146800067|NCT02719574|529441652|FG001|Phase 2|Investigator Decision|0|||
146800068|NCT02719574|529441653|FG002|Phase 2|Investigator Decision|0|||
146940929|NCT03627494|529941527|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
146940930|NCT03627494|529941528|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
146940931|NCT03627494|529941529|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
146940932|NCT03627494|529941530|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
146940933|NCT02578992|529943257|FG000|Overall Study|equipment not available or malfunction|3|||
146940934|NCT02578992|529943258|FG001|Overall Study|equipment not available or malfunction|3|||
146940935|NCT00405275|529943259|FG000|Overall Study|Death|1|||
146940936|NCT00405275|529943260|FG001|Overall Study|Death|0|||
146940937|NCT00405275|529943259|FG000|Overall Study|Lost to Follow-up|5|||
146940938|NCT00405275|529943260|FG001|Overall Study|Lost to Follow-up|1|||
146940939|NCT00405275|529943259|FG000|Overall Study|Withdrawal by Subject|7|||
146940940|NCT00405275|529943260|FG001|Overall Study|Withdrawal by Subject|9|||
146940941|NCT00405275|529943259|FG000|Overall Study|Unwilling to continue|10|||
146940942|NCT00405275|529943260|FG001|Overall Study|Unwilling to continue|9|||
146940943|NCT01308853|529943263|FG000|Overall Study|Adverse Event|1|||
146940944|NCT01308853|529943263|FG000|Overall Study|Lost to Follow-up|2|||
146940945|NCT01308853|529943263|FG000|Overall Study|Insertion of permanent implants|1|||
146940946|NCT00693420|529943266|FG000|Overall Study|Adverse Event|4|||
146940947|NCT00693420|529943267|FG001|Overall Study|Adverse Event|4|||
146940948|NCT00693420|529943266|FG000|Overall Study|Lost to Follow-up|0|||
146940949|NCT00693420|529943267|FG001|Overall Study|Lost to Follow-up|3|||
146940950|NCT00693420|529943266|FG000|Overall Study|Withdrawal by Subject|1|||
146940951|NCT00693420|529943267|FG001|Overall Study|Withdrawal by Subject|0|||
146940952|NCT00693420|529943266|FG000|Overall Study|Protocol Violation|0|||
146940953|NCT00693420|529943267|FG001|Overall Study|Protocol Violation|2|||
146940954|NCT00693420|529943266|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
146940955|NCT00693420|529943267|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
146940956|NCT00693420|529943266|FG000|Overall Study|Personal Reasons|1|||
146940957|NCT00693420|529943267|FG001|Overall Study|Personal Reasons|4|||
146940958|NCT02853123|529943271|FG000|Treatment Period 1|Adverse Event|0|||
146940959|NCT02853123|529943272|FG001|Treatment Period 1|Adverse Event|3|||
146940960|NCT02853123|529943271|FG000|Washout Period|Worsening of COPD|0|||
146940961|NCT02853123|529943272|FG001|Washout Period|Worsening of COPD|3|||
146940962|NCT02853123|529943271|FG000|Washout Period|Adverse Event|1|||
146940963|NCT02853123|529943272|FG001|Washout Period|Adverse Event|0|||
146940964|NCT01473355|529943273|FG000|Overall Study|Protocol Violation|2|||
146940965|NCT01473355|529943273|FG000|Overall Study|Adverse Event|2|||
146940966|NCT01473355|529943273|FG000|Overall Study|Lost to Follow-up|2|||
146940967|NCT03250624|529943274|FG000|Overall Study|Lack of Efficacy|1|||
146940968|NCT03250624|529943275|FG001|Overall Study|Lack of Efficacy|4|||
146940969|NCT03250624|529943274|FG000|Overall Study|Adverse Event|0|||
146940970|NCT03250624|529943275|FG001|Overall Study|Adverse Event|1|||
146940971|NCT03250624|529943274|FG000|Overall Study|Other|1|||
146940972|NCT03250624|529943275|FG001|Overall Study|Other|2|||
146800069|NCT02719574|529441654|FG003|Phase 2|Investigator Decision|0|||
146800070|NCT02719574|529441655|FG004|Phase 2|Investigator Decision|0|||
146800071|NCT02719574|529441656|FG005|Phase 2|Investigator Decision|0|||
146800072|NCT02719574|529441657|FG006|Phase 2|Investigator Decision|0|||
146800073|NCT02719574|529441658|FG007|Phase 2|Investigator Decision|0|||
146800074|NCT02719574|529441659|FG008|Phase 2|Investigator Decision|0|||
146800075|NCT02719574|529441660|FG009|Phase 2|Investigator Decision|6|||
146800076|NCT02719574|529441661|FG010|Phase 2|Investigator Decision|1|||
146800077|NCT02719574|529441662|FG011|Phase 2|Investigator Decision|2|||
146940973|NCT00106249|529943277|FG000|Overall Study|Lost to Follow-up|3|||
146983323|NCT00633152|530101820|FG000|Overall Study|Withdrawal by Subject|1|||
146800078|NCT02719574|529441663|FG012|Phase 2|Investigator Decision|3|||
146800079|NCT02719574|529441664|FG013|Phase 2|Investigator Decision|1|||
146800080|NCT02719574|529441665|FG014|Phase 2|Investigator Decision|3|||
146800081|NCT02719574|529441666|FG015|Phase 2|Investigator Decision|2|||
146800082|NCT02719574|529441667|FG016|Phase 2|Investigator Decision|0|||
146800083|NCT02719574|529441651|FG000|Phase 2|Withdrawal by Subject|0|||
146800084|NCT02719574|529441652|FG001|Phase 2|Withdrawal by Subject|0|||
146800085|NCT02719574|529441653|FG002|Phase 2|Withdrawal by Subject|0|||
146800086|NCT02719574|529441654|FG003|Phase 2|Withdrawal by Subject|0|||
146800087|NCT02719574|529441655|FG004|Phase 2|Withdrawal by Subject|0|||
146800088|NCT02719574|529441656|FG005|Phase 2|Withdrawal by Subject|0|||
146800089|NCT02719574|529441657|FG006|Phase 2|Withdrawal by Subject|0|||
146800090|NCT02719574|529441658|FG007|Phase 2|Withdrawal by Subject|0|||
146800091|NCT02719574|529441659|FG008|Phase 2|Withdrawal by Subject|0|||
146800092|NCT02719574|529441660|FG009|Phase 2|Withdrawal by Subject|5|||
146800093|NCT02719574|529441661|FG010|Phase 2|Withdrawal by Subject|0|||
146800094|NCT02719574|529441662|FG011|Phase 2|Withdrawal by Subject|0|||
146800095|NCT02719574|529441663|FG012|Phase 2|Withdrawal by Subject|0|||
146800096|NCT02719574|529441664|FG013|Phase 2|Withdrawal by Subject|1|||
146800097|NCT02719574|529441665|FG014|Phase 2|Withdrawal by Subject|1|||
146800098|NCT02719574|529441666|FG015|Phase 2|Withdrawal by Subject|2|||
146800099|NCT02719574|529441667|FG016|Phase 2|Withdrawal by Subject|0|||
146800100|NCT02719574|529441651|FG000|Phase 2|Protocol Violation|0|||
146800101|NCT02719574|529441652|FG001|Phase 2|Protocol Violation|0|||
146800102|NCT02719574|529441653|FG002|Phase 2|Protocol Violation|0|||
146800103|NCT02719574|529441654|FG003|Phase 2|Protocol Violation|0|||
146800104|NCT02719574|529441655|FG004|Phase 2|Protocol Violation|0|||
146800105|NCT02719574|529441656|FG005|Phase 2|Protocol Violation|0|||
146800106|NCT02719574|529441657|FG006|Phase 2|Protocol Violation|0|||
146800107|NCT02719574|529441658|FG007|Phase 2|Protocol Violation|0|||
146800108|NCT02719574|529441659|FG008|Phase 2|Protocol Violation|0|||
146800109|NCT02719574|529441660|FG009|Phase 2|Protocol Violation|1|||
146800110|NCT02719574|529441661|FG010|Phase 2|Protocol Violation|0|||
146800111|NCT02719574|529441662|FG011|Phase 2|Protocol Violation|0|||
146800112|NCT02719574|529441663|FG012|Phase 2|Protocol Violation|0|||
146800113|NCT02719574|529441664|FG013|Phase 2|Protocol Violation|0|||
146800114|NCT02719574|529441665|FG014|Phase 2|Protocol Violation|0|||
146800115|NCT02719574|529441666|FG015|Phase 2|Protocol Violation|0|||
146800116|NCT02719574|529441667|FG016|Phase 2|Protocol Violation|0|||
146800117|NCT00495677|529441672|FG000|Stage 1 (25 Days)|Adverse Event|0|||
146800118|NCT00495677|529441673|FG001|Stage 1 (25 Days)|Adverse Event|0|||
146800119|NCT00495677|529441674|FG002|Stage 1 (25 Days)|Adverse Event|1|||
146800120|NCT00495677|529441675|FG003|Stage 1 (25 Days)|Adverse Event|0|||
146800121|NCT00495677|529441676|FG004|Stage 1 (25 Days)|Adverse Event|0|||
146800122|NCT00495677|529441677|FG005|Stage 1 (25 Days)|Adverse Event|0|||
146800123|NCT00495677|529441678|FG006|Stage 1 (25 Days)|Adverse Event|0|||
146800124|NCT03653364|529441683|FG000|Overall Study|Withdrawal by Subject|1|||
146800125|NCT03653364|529441683|FG000|Overall Study|Enrolled in Error|1|||
146800126|NCT03653364|529441683|FG000|Overall Study|Death|1|||
146800127|NCT03983382|529441686|FG000|Overall Study|Death|1|||
146800128|NCT03983382|529441686|FG000|Overall Study|Lost to Follow-up|3|||
146800129|NCT03983382|529441686|FG000|Overall Study|Physician Decision|2|||
146800130|NCT03983382|529441686|FG000|Overall Study|Withdrawal by Subject|10|||
146800131|NCT03983382|529441686|FG000|Overall Study|Change in cancer treatment|2|||
146800132|NCT04908514|529441695|FG000|Overall Study|Lost to Follow-up|2|||
146800133|NCT04908514|529441695|FG000|Overall Study|Withdrawal by Subject|1|||
146800134|NCT02566889|529442847|FG000|Overall Study|Withdrawal by Subject|3|||
146800135|NCT02566889|529442848|FG001|Overall Study|Withdrawal by Subject|1|||
146940974|NCT00106249|529943278|FG001|Overall Study|Lost to Follow-up|2|||
146940975|NCT02809118|529943281|FG000|Overall Study|Withdrawal by Subject|0|||
146940976|NCT02809118|529943282|FG001|Overall Study|Withdrawal by Subject|1|||
146940977|NCT02809118|529943283|FG002|Overall Study|Withdrawal by Subject|1|||
146800136|NCT02566889|529442847|FG000|Overall Study|Adverse Event|4|||
146940978|NCT01235338|529943284|FG000|Overall Study|Adverse Event|3|||
146940979|NCT01235338|529943285|FG001|Overall Study|Adverse Event|2|||
146800137|NCT02566889|529442848|FG001|Overall Study|Adverse Event|2|||
146800138|NCT02566889|529442847|FG000|Overall Study|Other|6|||
146800139|NCT02566889|529442848|FG001|Overall Study|Other|2|||
146800140|NCT03140670|529442849|FG000|Overall Study|Withdrawal by Subject|2|||
146800141|NCT03140670|529442849|FG000|Overall Study|Lost to Follow-up|1|||
146940980|NCT01235338|529943284|FG000|Overall Study|Protocol Violation|1|||
146800142|NCT03140670|529442849|FG000|Overall Study|Physician Decision|1|||
146800143|NCT00220805|529442850|FG000|Overall Study|Adverse Event|1|||
146800144|NCT00220805|529442851|FG001|Overall Study|Adverse Event|3|||
146800145|NCT00220805|529442850|FG000|Overall Study|Withdrawal by Subject|3|||
146800146|NCT00220805|529442851|FG001|Overall Study|Withdrawal by Subject|0|||
146800147|NCT00220805|529442850|FG000|Overall Study|Lack of Efficacy|1|||
146800148|NCT00220805|529442851|FG001|Overall Study|Lack of Efficacy|0|||
146800149|NCT00220805|529442850|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
146940981|NCT01235338|529943285|FG001|Overall Study|Protocol Violation|1|||
146983324|NCT00633152|530101821|FG001|Overall Study|Withdrawal by Subject|1|||
146983325|NCT00633152|530101820|FG000|Overall Study|Lost to Follow-up|4|||
146983326|NCT00633152|530101821|FG001|Overall Study|Lost to Follow-up|1|||
146800150|NCT00220805|529442851|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
146800151|NCT02325466|529442852|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
146800152|NCT02325466|529442853|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
146800153|NCT02325466|529442854|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
146800154|NCT02325466|529442852|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
146800155|NCT02325466|529442853|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
146800156|NCT02325466|529442854|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
146800157|NCT02325466|529442852|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
146800158|NCT02325466|529442853|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
146983327|NCT00633152|530101820|FG000|Overall Study|Miscellaneous Other|3|||
146983328|NCT00633152|530101821|FG001|Overall Study|Miscellaneous Other|2|||
146983329|NCT05216978|530101823|FG000|Overall Study|Withdrawal by Subject|3|||
146800159|NCT02325466|529442854|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
146800160|NCT02325466|529442852|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
146800161|NCT02325466|529442853|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
146800162|NCT02325466|529442854|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
146800163|NCT02325466|529442852|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
146800164|NCT02325466|529442853|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
146800165|NCT02325466|529442854|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
146800166|NCT02325466|529442852|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
146800167|NCT02325466|529442853|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
146800168|NCT02325466|529442854|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
146983330|NCT05216978|530101823|FG000|Overall Study|Lost to Follow-up|5|||
146983331|NCT00658320|530101825|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
146983332|NCT00658320|530101826|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
146983333|NCT00658320|530101825|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
146983334|NCT00658320|530101826|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
146983335|NCT00658320|530101825|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
146983336|NCT00658320|530101826|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
146983337|NCT00658320|530101825|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
146983338|NCT00658320|530101826|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
146983339|NCT02410252|530101836|FG000|Overall Study|Withdrawal by Subject|4|||
146983340|NCT02410252|530101836|FG000|Overall Study|Physician Decision|2|||
146983341|NCT01007916|530101846|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
146983342|NCT01007916|530101847|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
146983343|NCT01007916|530101846|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
146983344|NCT01007916|530101847|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
146983345|NCT02961920|530101851|FG000|Overall Study|did not achive stydy protocol schedule|1|||
146983346|NCT02961920|530101852|FG001|Overall Study|did not achive stydy protocol schedule|1|||
146983347|NCT03907280|530101855|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
146983348|NCT03907280|530101856|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
146983349|NCT03907280|530101857|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
146983350|NCT04480463|530101860|FG000|Overall Study|Death|0|||
146983351|NCT04480463|530101861|FG001|Overall Study|Death|1|||
146983352|NCT04480463|530101860|FG000|Overall Study|Adverse Event|6|||
146983353|NCT04480463|530101861|FG001|Overall Study|Adverse Event|8|||
146983354|NCT04480463|530101860|FG000|Overall Study|Lost to Follow-up|3|||
146983355|NCT04480463|530101861|FG001|Overall Study|Lost to Follow-up|2|||
146983356|NCT04480463|530101860|FG000|Overall Study|Physician Decision|2|||
146983357|NCT04480463|530101861|FG001|Overall Study|Physician Decision|5|||
146983358|NCT04480463|530101860|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
146983359|NCT04480463|530101861|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
146983360|NCT04480463|530101860|FG000|Overall Study|Protocol Violation|2|||
146800169|NCT02325466|529442852|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
146800170|NCT02325466|529442853|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
146800171|NCT02325466|529442854|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
146800172|NCT02325466|529442852|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
146800173|NCT02325466|529442853|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
146800174|NCT02325466|529442854|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
146800175|NCT02325466|529442852|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
146983361|NCT04480463|530101861|FG001|Overall Study|Protocol Violation|1|||
146983362|NCT04480463|530101860|FG000|Overall Study|Withdrawal by Subject|6|||
146983363|NCT04480463|530101861|FG001|Overall Study|Withdrawal by Subject|7|||
146800176|NCT02325466|529442853|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
146800177|NCT02325466|529442854|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
146800178|NCT03699163|529442855|FG000|Overall Study|Physician Decision|12|||
146800179|NCT03699163|529442856|FG001|Overall Study|Physician Decision|0|||
146800180|NCT03699163|529442855|FG000|Overall Study|failed QC measures|205|||
146800181|NCT03699163|529442856|FG001|Overall Study|failed QC measures|206|||
146800182|NCT01964300|529442862|FG000|Overall Study|Ineligible after enrollment|0|||
146800183|NCT01964300|529442863|FG001|Overall Study|Ineligible after enrollment|1|||
146800184|NCT01964300|529442862|FG000|Overall Study|Adverse Event|1|||
146800185|NCT01964300|529442863|FG001|Overall Study|Adverse Event|1|||
146800186|NCT01964300|529442862|FG000|Overall Study|Lack of Efficacy|3|||
146800187|NCT01964300|529442863|FG001|Overall Study|Lack of Efficacy|5|||
146800188|NCT01964300|529442862|FG000|Overall Study|Withdrawal by Subject|0|||
146800189|NCT01964300|529442863|FG001|Overall Study|Withdrawal by Subject|1|||
146800190|NCT01964300|529442862|FG000|Overall Study|To receive alternative therapy|1|||
146800191|NCT01964300|529442863|FG001|Overall Study|To receive alternative therapy|2|||
146800192|NCT01964300|529442862|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
146800193|NCT01964300|529442863|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
146800194|NCT01964300|529442862|FG000|Overall Study|Weight criteria not met|0|||
146800195|NCT01964300|529442863|FG001|Overall Study|Weight criteria not met|1|||
146800196|NCT00557492|529442864|FG000|Overall Study|Change in health insurance|1|||
146800197|NCT02111096|529442866|FG000|Overall Study|Adverse Event|4|||
146800198|NCT02111096|529442867|FG001|Overall Study|Adverse Event|1|||
146800199|NCT02111096|529442868|FG002|Overall Study|Adverse Event|2|||
146800200|NCT02111096|529442866|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146800201|NCT02111096|529442867|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146800202|NCT02111096|529442868|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146800203|NCT02111096|529442866|FG000|Overall Study|Lost to Follow Up|1|||
146800204|NCT02111096|529442867|FG001|Overall Study|Lost to Follow Up|1|||
146800205|NCT02111096|529442868|FG002|Overall Study|Lost to Follow Up|1|||
146800206|NCT02111096|529442866|FG000|Overall Study|Physician Decision|0|||
146800207|NCT02111096|529442867|FG001|Overall Study|Physician Decision|1|||
146800208|NCT02111096|529442868|FG002|Overall Study|Physician Decision|0|||
146800209|NCT02111096|529442866|FG000|Overall Study|Protocol Violation|1|||
146800210|NCT02111096|529442867|FG001|Overall Study|Protocol Violation|0|||
146800211|NCT02111096|529442868|FG002|Overall Study|Protocol Violation|1|||
146800212|NCT02111096|529442866|FG000|Overall Study|Terminated by Sponsor|53|||
146800213|NCT02111096|529442867|FG001|Overall Study|Terminated by Sponsor|35|||
146800214|NCT02111096|529442868|FG002|Overall Study|Terminated by Sponsor|54|||
146800215|NCT02111096|529442866|FG000|Overall Study|Withdrawal by Subject|4|||
146800216|NCT02111096|529442867|FG001|Overall Study|Withdrawal by Subject|2|||
146800217|NCT02111096|529442868|FG002|Overall Study|Withdrawal by Subject|8|||
146800218|NCT03621735|529442869|FG000|Overall Study|Withdrawal by Subject|13|||
146800219|NCT03621735|529442870|FG001|Overall Study|Withdrawal by Subject|13|||
146800220|NCT03875313|529442876|FG000|Overall Study|Withdrawal by Subject|1|||
146800221|NCT03875313|529442877|FG001|Overall Study|Withdrawal by Subject|3|||
146800222|NCT03875313|529442878|FG002|Overall Study|Withdrawal by Subject|0|||
146800223|NCT03875313|529442879|FG003|Overall Study|Withdrawal by Subject|0|||
146800224|NCT03875313|529442880|FG004|Overall Study|Withdrawal by Subject|0|||
146800225|NCT03875313|529442876|FG000|Overall Study|Death|0|||
146800226|NCT03875313|529442877|FG001|Overall Study|Death|0|||
146800227|NCT03875313|529442878|FG002|Overall Study|Death|0|||
146800228|NCT03875313|529442879|FG003|Overall Study|Death|0|||
146800229|NCT03875313|529442880|FG004|Overall Study|Death|1|||
146940982|NCT01235338|529943284|FG000|Overall Study|Withdrawal by Subject|5|||
146940983|NCT01235338|529943285|FG001|Overall Study|Withdrawal by Subject|0|||
146940984|NCT01235338|529943284|FG000|Overall Study|Exclusion criteria violations|1|||
146940985|NCT01235338|529943285|FG001|Overall Study|Exclusion criteria violations|1|||
146940986|NCT01235338|529943284|FG000|Overall Study|Positive drug screen|0|||
146800230|NCT03875313|529442876|FG000|Overall Study|Lost to Follow-up|0|||
146800231|NCT03875313|529442877|FG001|Overall Study|Lost to Follow-up|0|||
146800232|NCT03875313|529442878|FG002|Overall Study|Lost to Follow-up|0|||
146800233|NCT03875313|529442879|FG003|Overall Study|Lost to Follow-up|0|||
146800234|NCT03875313|529442880|FG004|Overall Study|Lost to Follow-up|1|||
146800235|NCT03875313|529442876|FG000|Overall Study|Study Termination by Sponsor|0|||
146800236|NCT03875313|529442877|FG001|Overall Study|Study Termination by Sponsor|1|||
146800237|NCT03875313|529442878|FG002|Overall Study|Study Termination by Sponsor|1|||
146800238|NCT03875313|529442879|FG003|Overall Study|Study Termination by Sponsor|0|||
146800239|NCT03875313|529442880|FG004|Overall Study|Study Termination by Sponsor|1|||
146800240|NCT03875313|529442876|FG000|Overall Study|New Anticancer Treatment|0|||
146800241|NCT03875313|529442877|FG001|Overall Study|New Anticancer Treatment|1|||
146800242|NCT03875313|529442878|FG002|Overall Study|New Anticancer Treatment|2|||
146800243|NCT03875313|529442879|FG003|Overall Study|New Anticancer Treatment|1|||
146940987|NCT01235338|529943285|FG001|Overall Study|Positive drug screen|1|||
146940988|NCT01235338|529943284|FG000|Overall Study|Prohibited meds|1|||
146800244|NCT03875313|529442880|FG004|Overall Study|New Anticancer Treatment|0|||
146940989|NCT01235338|529943285|FG001|Overall Study|Prohibited meds|0|||
146940990|NCT00509028|529943288|FG000|Overall Study|Adverse Event|2|||
146940991|NCT00509028|529943289|FG001|Overall Study|Adverse Event|0|||
146940992|NCT00509028|529943288|FG000|Overall Study|Withdrawal by Subject|4|||
146940993|NCT00509028|529943289|FG001|Overall Study|Withdrawal by Subject|3|||
146940994|NCT00509028|529943288|FG000|Overall Study|Lost to Follow-up|0|||
146940995|NCT00509028|529943289|FG001|Overall Study|Lost to Follow-up|1|||
146940996|NCT00509028|529943288|FG000|Overall Study|Protocol Violation|4|||
146940997|NCT00509028|529943289|FG001|Overall Study|Protocol Violation|2|||
146940998|NCT00509028|529943288|FG000|Overall Study|Non-compliance|2|||
146940999|NCT00509028|529943289|FG001|Overall Study|Non-compliance|1|||
146941000|NCT00948428|529943290|FG000|Overall Study|Withdrawal by Subject|6|||
146941001|NCT00948428|529943291|FG001|Overall Study|Withdrawal by Subject|12|||
146941002|NCT00948428|529943292|FG002|Overall Study|Withdrawal by Subject|7|||
146941003|NCT00948428|529943290|FG000|Overall Study|Adverse Event|6|||
146941004|NCT00948428|529943291|FG001|Overall Study|Adverse Event|3|||
146941005|NCT00948428|529943292|FG002|Overall Study|Adverse Event|0|||
146941006|NCT00948428|529943290|FG000|Overall Study|Lost to Follow-up|2|||
146941007|NCT00948428|529943291|FG001|Overall Study|Lost to Follow-up|1|||
146941008|NCT00948428|529943292|FG002|Overall Study|Lost to Follow-up|1|||
146941009|NCT00948428|529943290|FG000|Overall Study|Death|2|||
146941010|NCT00948428|529943291|FG001|Overall Study|Death|0|||
146941011|NCT00948428|529943292|FG002|Overall Study|Death|0|||
146941012|NCT00948428|529943290|FG000|Overall Study|Intercurrent Illness|1|||
146941013|NCT00948428|529943291|FG001|Overall Study|Intercurrent Illness|0|||
146941014|NCT00948428|529943292|FG002|Overall Study|Intercurrent Illness|0|||
146941015|NCT00948428|529943290|FG000|Overall Study|Non-compliance|1|||
146941016|NCT00948428|529943291|FG001|Overall Study|Non-compliance|2|||
146941017|NCT00948428|529943292|FG002|Overall Study|Non-compliance|0|||
146941018|NCT01843205|529943295|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
146941019|NCT01843205|529943296|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
146941020|NCT00517413|529943297|FG000|Overall Study|Adverse Event|7|||
146941021|NCT00517413|529943297|FG000|Overall Study|Death|13|||
146941022|NCT00517413|529943297|FG000|Overall Study|Protocol Violation|15|||
146941023|NCT00517413|529943297|FG000|Overall Study|Withdrawal by Subject|2|||
146941024|NCT00517413|529943297|FG000|Overall Study|Failure to return|1|||
146941025|NCT00517413|529943297|FG000|Overall Study|Other-Reasons|23|||
146941026|NCT00606177|529943298|FG000|Overall Study|Adverse Event|9|||
146941027|NCT00606177|529943299|FG001|Overall Study|Adverse Event|5|||
146941028|NCT00606177|529943298|FG000|Overall Study|Lack of Efficacy|3|||
146941029|NCT00606177|529943299|FG001|Overall Study|Lack of Efficacy|7|||
146941030|NCT00606177|529943298|FG000|Overall Study|Physician Decision|1|||
146941031|NCT00606177|529943299|FG001|Overall Study|Physician Decision|0|||
146941032|NCT00606177|529943298|FG000|Overall Study|Protocol Violation|1|||
146941033|NCT00606177|529943299|FG001|Overall Study|Protocol Violation|4|||
146941034|NCT00606177|529943298|FG000|Overall Study|Withdrawal by Subject|5|||
146941035|NCT00606177|529943299|FG001|Overall Study|Withdrawal by Subject|6|||
146941036|NCT00606177|529943298|FG000|Overall Study|Progression to depressive phase|6|||
146941037|NCT00606177|529943299|FG001|Overall Study|Progression to depressive phase|1|||
146941038|NCT00606177|529943298|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
146941039|NCT00606177|529943299|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
146941040|NCT00606177|529943298|FG000|Overall Study|Change of residence or other commitments|1|||
146941041|NCT00606177|529943299|FG001|Overall Study|Change of residence or other commitments|1|||
146941042|NCT00136357|529943300|FG000|Overall Study|Withdrawal by Subject|3|||
146941043|NCT00136357|529943301|FG001|Overall Study|Withdrawal by Subject|2|||
146941044|NCT02603172|529943307|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
146941045|NCT02603172|529943308|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
146941046|NCT02603172|529943309|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
146941047|NCT02603172|529943310|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
146941048|NCT02603172|529943311|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
146941049|NCT02603172|529943312|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
146941050|NCT02603172|529943313|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
146800245|NCT03875313|529442876|FG000|Overall Study|Other, Not Specified|2|||
146941051|NCT02603172|529943314|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
146800246|NCT03875313|529442877|FG001|Overall Study|Other, Not Specified|11|||
146800247|NCT03875313|529442878|FG002|Overall Study|Other, Not Specified|3|||
146941052|NCT00441727|529943317|FG000|Overall Study|Protocol Violation|19|||
146941053|NCT00441727|529943318|FG001|Overall Study|Protocol Violation|28|||
146941054|NCT00441727|529943319|FG002|Overall Study|Protocol Violation|32|||
146941055|NCT00441727|529943317|FG000|Overall Study|Adverse Event|26|||
146941056|NCT00441727|529943318|FG001|Overall Study|Adverse Event|33|||
146941057|NCT00441727|529943319|FG002|Overall Study|Adverse Event|28|||
146941058|NCT00441727|529943317|FG000|Overall Study|Lack of Efficacy|7|||
146800248|NCT03875313|529442879|FG003|Overall Study|Other, Not Specified|3|||
146941059|NCT00441727|529943318|FG001|Overall Study|Lack of Efficacy|8|||
146941060|NCT00441727|529943319|FG002|Overall Study|Lack of Efficacy|48|||
146941061|NCT00441727|529943317|FG000|Overall Study|Withdrawal by Subject|40|||
146941062|NCT00441727|529943318|FG001|Overall Study|Withdrawal by Subject|34|||
146941063|NCT00441727|529943319|FG002|Overall Study|Withdrawal by Subject|47|||
146941064|NCT00441727|529943317|FG000|Overall Study|Lost to Follow-up|5|||
146941065|NCT00441727|529943318|FG001|Overall Study|Lost to Follow-up|6|||
146941066|NCT00441727|529943319|FG002|Overall Study|Lost to Follow-up|5|||
146941067|NCT00441727|529943317|FG000|Overall Study|Safety Reasons|3|||
146941068|NCT00441727|529943318|FG001|Overall Study|Safety Reasons|1|||
146941069|NCT00441727|529943319|FG002|Overall Study|Safety Reasons|3|||
146941070|NCT00441727|529943317|FG000|Overall Study|Various reason specified|6|||
146941071|NCT00441727|529943318|FG001|Overall Study|Various reason specified|8|||
146941072|NCT00441727|529943319|FG002|Overall Study|Various reason specified|5|||
146941073|NCT02133001|529943320|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
146941074|NCT02133001|529943321|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
146941075|NCT02133001|529943320|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
146941076|NCT02133001|529943321|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
146941077|NCT02133001|529943320|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
146941078|NCT02133001|529943321|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
146941079|NCT02133001|529943320|FG000|Double Blind (Day 1-25)|Other|2|||
146941080|NCT02133001|529943321|FG001|Double Blind (Day 1-25)|Other|2|||
146941081|NCT02133001|529943320|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
146941082|NCT02133001|529943321|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
146941083|NCT02133001|529943320|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
146941084|NCT02133001|529943321|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
146941085|NCT02133001|529943320|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
146941086|NCT02133001|529943321|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
146941087|NCT02133001|529943320|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
146941088|NCT02133001|529943321|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
146941089|NCT04211961|529943322|FG000|Overall Study|Death|0|||
146941090|NCT04211961|529943323|FG001|Overall Study|Death|1|||
146941091|NCT04211961|529943322|FG000|Overall Study|Lost to Follow-up|0|||
146941092|NCT04211961|529943323|FG001|Overall Study|Lost to Follow-up|1|||
146941093|NCT04211961|529943322|FG000|Overall Study|Withdrawal by Subject|0|||
146941094|NCT04211961|529943323|FG001|Overall Study|Withdrawal by Subject|1|||
146941095|NCT03210220|529943324|FG000|Overall Study|Physician Decision|1|||
146941096|NCT03210220|529943325|FG001|Overall Study|Physician Decision|0|||
146941097|NCT00282568|529943326|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
146941098|NCT00282568|529943326|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
146941099|NCT00282568|529943326|FG000|Extended Treatment Period|Adverse Event|17|||
146941100|NCT00282568|529943326|FG000|Extended Treatment Period|Non-compliance|4|||
146941101|NCT00282568|529943326|FG000|Extended Treatment Period|Physician Decision|1|||
146941102|NCT00282568|529943326|FG000|Extended Treatment Period|Lost to Follow-up|2|||
146941103|NCT01548417|529943331|FG000|Overall Study|Withdrawal by Subject|0|||
146941104|NCT01548417|529943332|FG001|Overall Study|Withdrawal by Subject|2|||
146941105|NCT02640755|529943333|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
146941106|NCT02640755|529943334|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
146941107|NCT02640755|529943333|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
146941108|NCT02640755|529943334|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
146941109|NCT02640755|529943333|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
146941110|NCT02640755|529943334|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
146941111|NCT03434041|529943335|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
146941112|NCT03434041|529943336|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
146941113|NCT03434041|529943335|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
146941114|NCT03434041|529943336|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
146941115|NCT03434041|529943335|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
146941116|NCT03434041|529943336|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
146941117|NCT03434041|529943335|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
146941118|NCT03434041|529943336|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
146941119|NCT03434041|529943335|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
146941120|NCT03434041|529943336|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
146941121|NCT03434041|529943335|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
146941122|NCT03434041|529943336|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
146941123|NCT03434041|529943335|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
146941124|NCT03434041|529943336|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
146941125|NCT03434041|529943335|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
146941126|NCT03434041|529943336|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
146941127|NCT03434041|529943335|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
146941128|NCT03434041|529943336|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
146941129|NCT03434041|529943335|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
146941130|NCT03434041|529943336|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
146941131|NCT03434041|529943335|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
146983364|NCT04480463|530101860|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
146983365|NCT04480463|530101861|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
146983366|NCT04480463|530101860|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
146983367|NCT04480463|530101861|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
146983368|NCT04480463|530101860|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
146800249|NCT03875313|529442880|FG004|Overall Study|Other, Not Specified|1|||
146800250|NCT04121546|529442881|FG000|Overall Study|Lost to Follow-up|1|||
146800251|NCT04121546|529442882|FG001|Overall Study|Lost to Follow-up|3|||
146800252|NCT00686595|529442885|FG000|Overall Study|Adverse Event|3|||
146800253|NCT00686595|529442885|FG000|Overall Study|Protocol Violation|1|||
146800254|NCT00686595|529442885|FG000|Overall Study|Lost to Follow-up|1|||
146800255|NCT00686595|529442885|FG000|Overall Study|Lack of Efficacy|1|||
146800256|NCT00686595|529442885|FG000|Overall Study|Poor Compliance|1|||
146800257|NCT03286114|529442891|FG000|Overall Study|Adverse Event|6|||
146800258|NCT03286114|529442891|FG000|Overall Study|Death|3|||
146800259|NCT01260896|529442897|FG000|First Intervention|Withdrawn Due to Emesis|2|||
146800260|NCT01260896|529442898|FG001|First Intervention|Withdrawn Due to Emesis|0|||
146800261|NCT00982644|529442899|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
146800262|NCT00982644|529442900|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
146800263|NCT00982644|529442899|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
146800264|NCT00982644|529442900|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
146800265|NCT00982644|529442899|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
146800266|NCT00982644|529442900|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
146800267|NCT00982644|529442899|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
146800268|NCT00982644|529442900|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
146800269|NCT00982644|529442899|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
146800270|NCT00982644|529442900|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
146800271|NCT00982644|529442899|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
146800272|NCT00982644|529442900|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
146800273|NCT00982644|529442899|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
146800274|NCT00982644|529442900|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
146800275|NCT00982644|529442899|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
146800276|NCT00982644|529442900|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
146800277|NCT00982644|529442899|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
146800278|NCT00982644|529442900|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
146800279|NCT00982644|529442899|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
146800280|NCT00982644|529442900|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
146800281|NCT00943917|529442903|FG000|Stage I|Adverse Event|1|||
146800282|NCT00943917|529442904|FG001|Stage I|Adverse Event|2|||
146800283|NCT00943917|529442905|FG002|Stage I|Adverse Event|2|||
146800284|NCT00943917|529442906|FG003|Stage I|Adverse Event|0|||
146800285|NCT00943917|529442907|FG004|Stage I|Adverse Event|0|||
146800286|NCT00943917|529442908|FG005|Stage I|Adverse Event|0|||
146800287|NCT00943917|529442909|FG006|Stage I|Adverse Event|0|||
146800288|NCT00943917|529442910|FG007|Stage I|Adverse Event|0|||
146800289|NCT00943917|529442911|FG008|Stage I|Adverse Event|0|||
146800290|NCT00943917|529442912|FG009|Stage I|Adverse Event|0|||
146800291|NCT00943917|529442913|FG010|Stage I|Adverse Event|0|||
146800292|NCT00943917|529442914|FG011|Stage I|Adverse Event|0|||
146800293|NCT00943917|529442915|FG012|Stage I|Adverse Event|0|||
146800294|NCT00943917|529442916|FG013|Stage I|Adverse Event|0|||
146983369|NCT04480463|530101861|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
146983370|NCT04480463|530101860|FG000|Overall Study|Other|6|||
146983371|NCT04480463|530101861|FG001|Overall Study|Other|4|||
146983372|NCT00444795|530101862|FG000|Overall Study|Not Treated|1|||
146983373|NCT00444795|530101862|FG000|Overall Study|Treated Prior to the Contract Date|2|||
146800295|NCT00943917|529442917|FG014|Stage I|Adverse Event|0|||
146800296|NCT00943917|529442903|FG000|Stage I|Lost to Follow-up|0|||
146800297|NCT00943917|529442904|FG001|Stage I|Lost to Follow-up|0|||
146800298|NCT00943917|529442905|FG002|Stage I|Lost to Follow-up|1|||
146800299|NCT00943917|529442906|FG003|Stage I|Lost to Follow-up|0|||
146800300|NCT00943917|529442907|FG004|Stage I|Lost to Follow-up|0|||
146800301|NCT00943917|529442908|FG005|Stage I|Lost to Follow-up|0|||
146983374|NCT02322879|530101863|FG000|First Intervention|Physician Decision|1|||
146983375|NCT02322879|530101864|FG001|First Intervention|Physician Decision|0|||
146983376|NCT04081337|530101865|FG000|Overall Study|Adverse Event|0|||
146983377|NCT04081337|530101866|FG001|Overall Study|Adverse Event|1|||
146800302|NCT00943917|529442909|FG006|Stage I|Lost to Follow-up|0|||
146800303|NCT00943917|529442910|FG007|Stage I|Lost to Follow-up|0|||
146800304|NCT00943917|529442911|FG008|Stage I|Lost to Follow-up|0|||
146800305|NCT00943917|529442912|FG009|Stage I|Lost to Follow-up|0|||
146800306|NCT00943917|529442913|FG010|Stage I|Lost to Follow-up|0|||
146800307|NCT00943917|529442914|FG011|Stage I|Lost to Follow-up|0|||
146800308|NCT00943917|529442915|FG012|Stage I|Lost to Follow-up|0|||
146800309|NCT00943917|529442916|FG013|Stage I|Lost to Follow-up|0|||
146800310|NCT00943917|529442917|FG014|Stage I|Lost to Follow-up|0|||
146800311|NCT00943917|529442903|FG000|Stage I|hyperglycemia|0|||
146800312|NCT00943917|529442904|FG001|Stage I|hyperglycemia|0|||
146800313|NCT00943917|529442905|FG002|Stage I|hyperglycemia|1|||
146800314|NCT00943917|529442906|FG003|Stage I|hyperglycemia|0|||
146800315|NCT00943917|529442907|FG004|Stage I|hyperglycemia|0|||
146800316|NCT00943917|529442908|FG005|Stage I|hyperglycemia|0|||
146800317|NCT00943917|529442909|FG006|Stage I|hyperglycemia|0|||
146800318|NCT00943917|529442910|FG007|Stage I|hyperglycemia|0|||
146800319|NCT00943917|529442911|FG008|Stage I|hyperglycemia|0|||
146800320|NCT00943917|529442912|FG009|Stage I|hyperglycemia|0|||
146800321|NCT00943917|529442913|FG010|Stage I|hyperglycemia|0|||
146800322|NCT00943917|529442914|FG011|Stage I|hyperglycemia|0|||
146800323|NCT00943917|529442915|FG012|Stage I|hyperglycemia|0|||
146800324|NCT00943917|529442916|FG013|Stage I|hyperglycemia|0|||
146800325|NCT00943917|529442917|FG014|Stage I|hyperglycemia|0|||
146800326|NCT00943917|529442903|FG000|Stage I|A1C elevation|1|||
146800327|NCT00943917|529442904|FG001|Stage I|A1C elevation|0|||
146800328|NCT00943917|529442905|FG002|Stage I|A1C elevation|0|||
146800329|NCT00943917|529442906|FG003|Stage I|A1C elevation|0|||
146800330|NCT00943917|529442907|FG004|Stage I|A1C elevation|0|||
146800331|NCT00943917|529442908|FG005|Stage I|A1C elevation|0|||
146800332|NCT00943917|529442909|FG006|Stage I|A1C elevation|0|||
146800333|NCT00943917|529442910|FG007|Stage I|A1C elevation|0|||
146800334|NCT00943917|529442911|FG008|Stage I|A1C elevation|0|||
146800335|NCT00943917|529442912|FG009|Stage I|A1C elevation|0|||
146800336|NCT00943917|529442913|FG010|Stage I|A1C elevation|0|||
146800337|NCT00943917|529442914|FG011|Stage I|A1C elevation|0|||
146800338|NCT00943917|529442915|FG012|Stage I|A1C elevation|0|||
146800339|NCT00943917|529442916|FG013|Stage I|A1C elevation|0|||
146800340|NCT00943917|529442917|FG014|Stage I|A1C elevation|0|||
146800341|NCT00943917|529442903|FG000|Stage I|Withdrawal by Subject|2|||
146800342|NCT00943917|529442904|FG001|Stage I|Withdrawal by Subject|1|||
146800343|NCT00943917|529442905|FG002|Stage I|Withdrawal by Subject|2|||
146800344|NCT00943917|529442906|FG003|Stage I|Withdrawal by Subject|0|||
146800345|NCT00943917|529442907|FG004|Stage I|Withdrawal by Subject|0|||
146800346|NCT00943917|529442908|FG005|Stage I|Withdrawal by Subject|0|||
146800347|NCT00943917|529442909|FG006|Stage I|Withdrawal by Subject|0|||
146800348|NCT00943917|529442910|FG007|Stage I|Withdrawal by Subject|0|||
146800349|NCT00943917|529442911|FG008|Stage I|Withdrawal by Subject|0|||
146800350|NCT00943917|529442912|FG009|Stage I|Withdrawal by Subject|0|||
146800351|NCT00943917|529442913|FG010|Stage I|Withdrawal by Subject|0|||
146800352|NCT00943917|529442914|FG011|Stage I|Withdrawal by Subject|0|||
146800353|NCT00943917|529442915|FG012|Stage I|Withdrawal by Subject|0|||
146800354|NCT00943917|529442916|FG013|Stage I|Withdrawal by Subject|0|||
146800355|NCT00943917|529442917|FG014|Stage I|Withdrawal by Subject|0|||
146800356|NCT00943917|529442903|FG000|Stage II|Adverse Event|0|||
146800357|NCT00943917|529442904|FG001|Stage II|Adverse Event|0|||
146800358|NCT00943917|529442905|FG002|Stage II|Adverse Event|0|||
146800359|NCT00943917|529442906|FG003|Stage II|Adverse Event|0|||
146800360|NCT00943917|529442907|FG004|Stage II|Adverse Event|0|||
146800361|NCT00943917|529442908|FG005|Stage II|Adverse Event|1|||
146800362|NCT00943917|529442909|FG006|Stage II|Adverse Event|3|||
146800363|NCT00943917|529442910|FG007|Stage II|Adverse Event|0|||
146800364|NCT00943917|529442911|FG008|Stage II|Adverse Event|1|||
146800365|NCT00943917|529442912|FG009|Stage II|Adverse Event|0|||
146800366|NCT00943917|529442913|FG010|Stage II|Adverse Event|0|||
146800367|NCT00943917|529442914|FG011|Stage II|Adverse Event|0|||
146800368|NCT00943917|529442915|FG012|Stage II|Adverse Event|0|||
146800369|NCT00943917|529442916|FG013|Stage II|Adverse Event|0|||
146800370|NCT00943917|529442917|FG014|Stage II|Adverse Event|0|||
146800371|NCT00943917|529442903|FG000|Stage II|Withdrawal by Subject|0|||
146800372|NCT00943917|529442904|FG001|Stage II|Withdrawal by Subject|0|||
146800373|NCT00943917|529442905|FG002|Stage II|Withdrawal by Subject|0|||
146800374|NCT00943917|529442906|FG003|Stage II|Withdrawal by Subject|0|||
146800375|NCT00943917|529442907|FG004|Stage II|Withdrawal by Subject|0|||
146800376|NCT00943917|529442908|FG005|Stage II|Withdrawal by Subject|1|||
146800377|NCT00943917|529442909|FG006|Stage II|Withdrawal by Subject|0|||
146800378|NCT00943917|529442910|FG007|Stage II|Withdrawal by Subject|0|||
146800379|NCT00943917|529442911|FG008|Stage II|Withdrawal by Subject|0|||
146800380|NCT00943917|529442912|FG009|Stage II|Withdrawal by Subject|0|||
146800381|NCT00943917|529442913|FG010|Stage II|Withdrawal by Subject|0|||
146800382|NCT00943917|529442914|FG011|Stage II|Withdrawal by Subject|0|||
146800383|NCT00943917|529442915|FG012|Stage II|Withdrawal by Subject|0|||
146800384|NCT00943917|529442916|FG013|Stage II|Withdrawal by Subject|0|||
146800385|NCT00943917|529442917|FG014|Stage II|Withdrawal by Subject|0|||
146800386|NCT00943917|529442903|FG000|Stage II|Pregnancy|0|||
146800387|NCT00943917|529442904|FG001|Stage II|Pregnancy|0|||
146800388|NCT00943917|529442905|FG002|Stage II|Pregnancy|0|||
146800389|NCT00943917|529442906|FG003|Stage II|Pregnancy|0|||
146800390|NCT00943917|529442907|FG004|Stage II|Pregnancy|0|||
146800391|NCT00943917|529442908|FG005|Stage II|Pregnancy|1|||
146800392|NCT00943917|529442909|FG006|Stage II|Pregnancy|0|||
146800393|NCT00943917|529442910|FG007|Stage II|Pregnancy|0|||
146800394|NCT00943917|529442911|FG008|Stage II|Pregnancy|0|||
146800395|NCT00943917|529442912|FG009|Stage II|Pregnancy|0|||
146800396|NCT00943917|529442913|FG010|Stage II|Pregnancy|0|||
146800397|NCT00943917|529442914|FG011|Stage II|Pregnancy|0|||
146800398|NCT00943917|529442915|FG012|Stage II|Pregnancy|0|||
146800399|NCT00943917|529442916|FG013|Stage II|Pregnancy|0|||
146800400|NCT00943917|529442917|FG014|Stage II|Pregnancy|0|||
146800401|NCT00943917|529442903|FG000|Stage II Continuation|Adverse Event|0|||
146800402|NCT00943917|529442904|FG001|Stage II Continuation|Adverse Event|0|||
146800403|NCT00943917|529442905|FG002|Stage II Continuation|Adverse Event|0|||
146800404|NCT00943917|529442906|FG003|Stage II Continuation|Adverse Event|0|||
146800405|NCT00943917|529442907|FG004|Stage II Continuation|Adverse Event|0|||
146800406|NCT00943917|529442908|FG005|Stage II Continuation|Adverse Event|0|||
146800407|NCT00943917|529442909|FG006|Stage II Continuation|Adverse Event|0|||
146800408|NCT00943917|529442910|FG007|Stage II Continuation|Adverse Event|0|||
146800409|NCT00943917|529442911|FG008|Stage II Continuation|Adverse Event|0|||
146800410|NCT00943917|529442912|FG009|Stage II Continuation|Adverse Event|0|||
146800411|NCT00943917|529442913|FG010|Stage II Continuation|Adverse Event|0|||
146800412|NCT00943917|529442914|FG011|Stage II Continuation|Adverse Event|1|||
146800413|NCT00943917|529442915|FG012|Stage II Continuation|Adverse Event|2|||
146800414|NCT00943917|529442916|FG013|Stage II Continuation|Adverse Event|1|||
146800415|NCT00943917|529442917|FG014|Stage II Continuation|Adverse Event|1|||
146800416|NCT00943917|529442903|FG000|Stage II Continuation|Withdrawal by Subject|0|||
146800417|NCT00943917|529442904|FG001|Stage II Continuation|Withdrawal by Subject|0|||
146800418|NCT00943917|529442905|FG002|Stage II Continuation|Withdrawal by Subject|0|||
146800419|NCT00943917|529442906|FG003|Stage II Continuation|Withdrawal by Subject|0|||
146800420|NCT00943917|529442907|FG004|Stage II Continuation|Withdrawal by Subject|0|||
146800421|NCT00943917|529442908|FG005|Stage II Continuation|Withdrawal by Subject|0|||
146800422|NCT00943917|529442909|FG006|Stage II Continuation|Withdrawal by Subject|0|||
146800423|NCT00943917|529442910|FG007|Stage II Continuation|Withdrawal by Subject|0|||
146800424|NCT00943917|529442911|FG008|Stage II Continuation|Withdrawal by Subject|0|||
146800425|NCT00943917|529442912|FG009|Stage II Continuation|Withdrawal by Subject|0|||
146800426|NCT00943917|529442913|FG010|Stage II Continuation|Withdrawal by Subject|0|||
146800427|NCT00943917|529442914|FG011|Stage II Continuation|Withdrawal by Subject|0|||
146800428|NCT00943917|529442915|FG012|Stage II Continuation|Withdrawal by Subject|0|||
146800429|NCT00943917|529442916|FG013|Stage II Continuation|Withdrawal by Subject|1|||
146800430|NCT00943917|529442917|FG014|Stage II Continuation|Withdrawal by Subject|3|||
146800431|NCT00943917|529442903|FG000|Stage II Continuation|Protocol Violation|0|||
146800432|NCT00943917|529442904|FG001|Stage II Continuation|Protocol Violation|0|||
146800433|NCT00943917|529442905|FG002|Stage II Continuation|Protocol Violation|0|||
146800434|NCT00943917|529442906|FG003|Stage II Continuation|Protocol Violation|0|||
146800435|NCT00943917|529442907|FG004|Stage II Continuation|Protocol Violation|0|||
146800436|NCT00943917|529442908|FG005|Stage II Continuation|Protocol Violation|0|||
146800437|NCT00943917|529442909|FG006|Stage II Continuation|Protocol Violation|0|||
146800438|NCT00943917|529442910|FG007|Stage II Continuation|Protocol Violation|0|||
146800439|NCT00943917|529442911|FG008|Stage II Continuation|Protocol Violation|0|||
146800440|NCT00943917|529442912|FG009|Stage II Continuation|Protocol Violation|1|||
146800441|NCT00943917|529442913|FG010|Stage II Continuation|Protocol Violation|0|||
146800442|NCT00943917|529442914|FG011|Stage II Continuation|Protocol Violation|1|||
146800443|NCT00943917|529442915|FG012|Stage II Continuation|Protocol Violation|0|||
146800444|NCT00943917|529442916|FG013|Stage II Continuation|Protocol Violation|0|||
146800445|NCT00943917|529442917|FG014|Stage II Continuation|Protocol Violation|0|||
146800446|NCT00943917|529442903|FG000|Stage II Continuation|hypoglycemia|0|||
146800447|NCT00943917|529442904|FG001|Stage II Continuation|hypoglycemia|0|||
146800448|NCT00943917|529442905|FG002|Stage II Continuation|hypoglycemia|0|||
146800449|NCT00943917|529442906|FG003|Stage II Continuation|hypoglycemia|0|||
146800450|NCT00943917|529442907|FG004|Stage II Continuation|hypoglycemia|0|||
146800451|NCT00943917|529442908|FG005|Stage II Continuation|hypoglycemia|0|||
146800452|NCT00943917|529442909|FG006|Stage II Continuation|hypoglycemia|0|||
146800453|NCT00943917|529442910|FG007|Stage II Continuation|hypoglycemia|0|||
146800454|NCT00943917|529442911|FG008|Stage II Continuation|hypoglycemia|0|||
146800455|NCT00943917|529442912|FG009|Stage II Continuation|hypoglycemia|0|||
146800456|NCT00943917|529442913|FG010|Stage II Continuation|hypoglycemia|0|||
146800457|NCT00943917|529442914|FG011|Stage II Continuation|hypoglycemia|0|||
146962310|NCT01049360|530021582|FG008|Period 1|Did not meet inc/exc criteria|1|||
146800458|NCT00943917|529442915|FG012|Stage II Continuation|hypoglycemia|1|||
146800459|NCT00943917|529442916|FG013|Stage II Continuation|hypoglycemia|0|||
146800460|NCT00943917|529442917|FG014|Stage II Continuation|hypoglycemia|0|||
146800461|NCT00943917|529442903|FG000|Stage II Continuation|A1C elevation|0|||
146800462|NCT00943917|529442904|FG001|Stage II Continuation|A1C elevation|0|||
146800463|NCT00943917|529442905|FG002|Stage II Continuation|A1C elevation|0|||
146800464|NCT00943917|529442906|FG003|Stage II Continuation|A1C elevation|0|||
146800465|NCT00943917|529442907|FG004|Stage II Continuation|A1C elevation|0|||
146800466|NCT00943917|529442908|FG005|Stage II Continuation|A1C elevation|0|||
146800467|NCT00943917|529442909|FG006|Stage II Continuation|A1C elevation|0|||
146800468|NCT00943917|529442910|FG007|Stage II Continuation|A1C elevation|0|||
146800469|NCT00943917|529442911|FG008|Stage II Continuation|A1C elevation|0|||
146800470|NCT00943917|529442912|FG009|Stage II Continuation|A1C elevation|0|||
146800471|NCT00943917|529442913|FG010|Stage II Continuation|A1C elevation|0|||
146800472|NCT00943917|529442914|FG011|Stage II Continuation|A1C elevation|0|||
146800473|NCT00943917|529442915|FG012|Stage II Continuation|A1C elevation|0|||
146800474|NCT00943917|529442916|FG013|Stage II Continuation|A1C elevation|1|||
146800475|NCT00943917|529442917|FG014|Stage II Continuation|A1C elevation|0|||
146800476|NCT01171976|529442918|FG000|Overall Study|Protocol Violation|0|||
146800477|NCT01171976|529442919|FG001|Overall Study|Protocol Violation|0|||
146800478|NCT01171976|529442920|FG002|Overall Study|Protocol Violation|1|||
146800479|NCT01171976|529442918|FG000|Overall Study|Death|2|||
146800480|NCT01171976|529442919|FG001|Overall Study|Death|4|||
146800481|NCT01171976|529442920|FG002|Overall Study|Death|1|||
146800482|NCT01171976|529442918|FG000|Overall Study|Lost to Follow-up|4|||
146800483|NCT01171976|529442919|FG001|Overall Study|Lost to Follow-up|0|||
146800484|NCT01171976|529442920|FG002|Overall Study|Lost to Follow-up|2|||
146800485|NCT01171976|529442918|FG000|Overall Study|Withdrawal by Subject|1|||
146800486|NCT01171976|529442919|FG001|Overall Study|Withdrawal by Subject|5|||
146800487|NCT01171976|529442920|FG002|Overall Study|Withdrawal by Subject|6|||
146800488|NCT01171976|529442918|FG000|Overall Study|Abnormal test result|1|||
146800489|NCT01171976|529442919|FG001|Overall Study|Abnormal test result|0|||
146800490|NCT01171976|529442920|FG002|Overall Study|Abnormal test result|0|||
146800491|NCT01171976|529442918|FG000|Overall Study|Adverse Event|6|||
146800492|NCT01171976|529442919|FG001|Overall Study|Adverse Event|2|||
146800493|NCT01171976|529442920|FG002|Overall Study|Adverse Event|5|||
146800494|NCT00003222|529442925|FG000|Overall Study|Physician Decision|0|||
146800495|NCT00003222|529442926|FG001|Overall Study|Physician Decision|1|||
146800496|NCT03767335|529442938|FG000|Overall Study|Physician Decision|1|||
146800497|NCT03767335|529442939|FG001|Overall Study|Physician Decision|1|||
146800498|NCT03767335|529442940|FG002|Overall Study|Physician Decision|0|||
146800499|NCT03767335|529442938|FG000|Overall Study|Withdrawal by Subject|0|||
146800500|NCT03767335|529442939|FG001|Overall Study|Withdrawal by Subject|0|||
146800501|NCT03767335|529442940|FG002|Overall Study|Withdrawal by Subject|6|||
146800502|NCT03767335|529442938|FG000|Overall Study|Participant excluded from efficacy population|0|||
146800503|NCT03767335|529442939|FG001|Overall Study|Participant excluded from efficacy population|0|||
146800504|NCT03767335|529442940|FG002|Overall Study|Participant excluded from efficacy population|1|||
146800505|NCT03767335|529442938|FG000|Overall Study|Death|0|||
146800506|NCT03767335|529442939|FG001|Overall Study|Death|0|||
146800507|NCT03767335|529442940|FG002|Overall Study|Death|2|||
146800508|NCT03767335|529442938|FG000|Overall Study|Progressive Disease|2|||
146800509|NCT03767335|529442939|FG001|Overall Study|Progressive Disease|2|||
146800510|NCT03767335|529442940|FG002|Overall Study|Progressive Disease|2|||
146800511|NCT03767335|529442938|FG000|Overall Study|Disease progression needing additional medication|0|||
146800512|NCT03767335|529442939|FG001|Overall Study|Disease progression needing additional medication|0|||
146800513|NCT03767335|529442940|FG002|Overall Study|Disease progression needing additional medication|17|||
146800514|NCT03767335|529442938|FG000|Overall Study|Sponsor decision|0|||
146800515|NCT03767335|529442939|FG001|Overall Study|Sponsor decision|0|||
146800516|NCT03767335|529442940|FG002|Overall Study|Sponsor decision|2|||
146800517|NCT03767335|529442938|FG000|Overall Study|Other Medical Reasons|0|||
146800518|NCT03767335|529442939|FG001|Overall Study|Other Medical Reasons|0|||
146620833|NCT04816214|528783442|FG000|Overall Study|Study Terminated by Sponsor|1|||
146620834|NCT04816214|528783443|FG001|Overall Study|Study Terminated by Sponsor|0|||
146620835|NCT04816214|528783444|FG002|Overall Study|Study Terminated by Sponsor|0|||
146620836|NCT02586623|528783445|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
146620837|NCT02586623|528783446|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
146800519|NCT03767335|529442940|FG002|Overall Study|Other Medical Reasons|3|||
146800520|NCT01313559|529442941|FG000|Overall Study|Withdrawal by Subject|1|||
146800521|NCT01313559|529442942|FG001|Overall Study|Withdrawal by Subject|2|||
146800522|NCT01313559|529442941|FG000|Overall Study|Disease progression|1|||
146800523|NCT01313559|529442942|FG001|Overall Study|Disease progression|0|||
146800524|NCT01313559|529442941|FG000|Overall Study|Rising PSA|2|||
146800525|NCT01313559|529442942|FG001|Overall Study|Rising PSA|0|||
146800526|NCT02754596|529442943|FG000|Overall Study|Withdrawal by Subject|3|||
146800527|NCT02754596|529442944|FG001|Overall Study|Withdrawal by Subject|4|||
146800528|NCT02754596|529442945|FG002|Overall Study|Withdrawal by Subject|0|||
146800529|NCT02754596|529442943|FG000|Overall Study|Physician Decision|1|||
146800530|NCT02754596|529442944|FG001|Overall Study|Physician Decision|1|||
146800531|NCT02754596|529442945|FG002|Overall Study|Physician Decision|1|||
146800532|NCT02754596|529442943|FG000|Overall Study|Lost to Follow-up|1|||
146800533|NCT02754596|529442944|FG001|Overall Study|Lost to Follow-up|1|||
146800534|NCT02754596|529442945|FG002|Overall Study|Lost to Follow-up|2|||
146800535|NCT02754596|529442943|FG000|Overall Study|Death|0|||
146800536|NCT02754596|529442944|FG001|Overall Study|Death|2|||
146800537|NCT02754596|529442945|FG002|Overall Study|Death|0|||
146800538|NCT02754596|529442943|FG000|Overall Study|Adverse Event|1|||
146800539|NCT02754596|529442944|FG001|Overall Study|Adverse Event|0|||
146800540|NCT02754596|529442945|FG002|Overall Study|Adverse Event|1|||
146800541|NCT02754596|529442943|FG000|Overall Study|Other|1|||
146800542|NCT02754596|529442944|FG001|Overall Study|Other|0|||
146800543|NCT02754596|529442945|FG002|Overall Study|Other|0|||
146941132|NCT03434041|529943336|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
146941133|NCT02057068|529943339|FG000|Overall Study|Withdrawal by Subject|2|||
146941134|NCT02057068|529943340|FG001|Overall Study|Withdrawal by Subject|2|||
146941135|NCT02057068|529943339|FG000|Overall Study|Caregiver (CG) Health|0|||
146941136|NCT02057068|529943340|FG001|Overall Study|Caregiver (CG) Health|2|||
146941137|NCT02057068|529943339|FG000|Overall Study|Carepartner (CP) Health|4|||
146941138|NCT02057068|529943340|FG001|Overall Study|Carepartner (CP) Health|2|||
146941139|NCT02057068|529943339|FG000|Overall Study|Lost to Follow-up|2|||
146941140|NCT02057068|529943340|FG001|Overall Study|Lost to Follow-up|2|||
146941141|NCT03447821|529943344|FG000|Overall Study|Withdrawal by Subject|1|||
146941142|NCT03447821|529943345|FG001|Overall Study|Withdrawal by Subject|1|||
146941143|NCT03447821|529943346|FG002|Overall Study|Withdrawal by Subject|0|||
146941144|NCT03447821|529943344|FG000|Overall Study|Lost to Follow-up|0|||
146941145|NCT03447821|529943345|FG001|Overall Study|Lost to Follow-up|0|||
146941146|NCT03447821|529943346|FG002|Overall Study|Lost to Follow-up|1|||
146941147|NCT04685538|529943347|FG000|Overall Study|Adverse Event|0|||
146941148|NCT04685538|529943348|FG001|Overall Study|Adverse Event|1|||
146941149|NCT04685538|529943347|FG000|Overall Study|Lost to Follow-up|0|||
146941150|NCT04685538|529943348|FG001|Overall Study|Lost to Follow-up|2|||
146941151|NCT03168555|529943349|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
146941152|NCT03168555|529943349|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
146941153|NCT03168555|529943349|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
146941154|NCT03168555|529943349|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
146941155|NCT01732107|529943351|FG000|Overall Study|Adverse Event|2|||
146941156|NCT01732107|529943351|FG000|Overall Study|Disease Progression|8|||
146941157|NCT01732107|529943351|FG000|Overall Study|Physician Decision|1|||
146941158|NCT01732107|529943351|FG000|Overall Study|Withdrawal by Subject|2|||
146941159|NCT02959190|529943352|FG000|Open Label|Adverse Event|5|||
146941160|NCT02959190|529943353|FG001|Open Label|Adverse Event|7|||
146941161|NCT02959190|529943354|FG002|Open Label|Adverse Event|3|||
146941162|NCT02959190|529943355|FG003|Open Label|Adverse Event|4|||
146941163|NCT02959190|529943352|FG000|Open Label|Pregnancy|0|||
146941164|NCT02959190|529943353|FG001|Open Label|Pregnancy|1|||
146941165|NCT02959190|529943354|FG002|Open Label|Pregnancy|0|||
146941166|NCT02959190|529943355|FG003|Open Label|Pregnancy|0|||
146941167|NCT02959190|529943352|FG000|Open Label|Withdrawal by Subject|2|||
146941168|NCT02959190|529943353|FG001|Open Label|Withdrawal by Subject|8|||
146941169|NCT02959190|529943354|FG002|Open Label|Withdrawal by Subject|0|||
146941170|NCT02959190|529943355|FG003|Open Label|Withdrawal by Subject|0|||
146941171|NCT02959190|529943352|FG000|Open Label|Physician Decision|0|||
146941172|NCT02959190|529943353|FG001|Open Label|Physician Decision|0|||
146941173|NCT02959190|529943354|FG002|Open Label|Physician Decision|1|||
146941174|NCT02959190|529943355|FG003|Open Label|Physician Decision|0|||
146941175|NCT02959190|529943352|FG000|Open Label|Protocol Violation|0|||
146941176|NCT02959190|529943353|FG001|Open Label|Protocol Violation|0|||
146941177|NCT02959190|529943354|FG002|Open Label|Protocol Violation|0|||
146941178|NCT02959190|529943355|FG003|Open Label|Protocol Violation|2|||
146941179|NCT02959190|529943352|FG000|Post Treatment Follow Up|Adverse Event|1|||
146941180|NCT02959190|529943353|FG001|Post Treatment Follow Up|Adverse Event|1|||
146941181|NCT02959190|529943354|FG002|Post Treatment Follow Up|Adverse Event|0|||
146941182|NCT02959190|529943355|FG003|Post Treatment Follow Up|Adverse Event|0|||
146941183|NCT02959190|529943352|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
146941184|NCT02959190|529943353|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
146941185|NCT02959190|529943354|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
146941186|NCT02959190|529943355|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
146941187|NCT01235507|529943357|FG000|Overall Study|Adverse Event|1|||
146941188|NCT01235507|529943357|FG000|Overall Study|Withdrawal by Subject|1|||
146941189|NCT02017704|529943360|FG000|Overall Study|Withdrawal by Subject|2|||
146941190|NCT02017704|529943361|FG001|Overall Study|Withdrawal by Subject|0|||
146800544|NCT03213457|529442948|FG000|Screening Period|Withdrawal by Subject|0|||
146800545|NCT03213457|529442949|FG001|Screening Period|Withdrawal by Subject|1|||
146941191|NCT01587274|529943362|FG000|Overall Study|Lost to Follow-up|4|||
146941192|NCT01587274|529943363|FG001|Overall Study|Lost to Follow-up|5|||
146941193|NCT01587274|529943364|FG002|Overall Study|Lost to Follow-up|3|||
146941194|NCT01421069|529943365|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
146941195|NCT01421069|529943365|FG000|Parent Study|Failed to return|3|||
146941196|NCT01421069|529943365|FG000|Parent Study|Withdrawal by Subject|1|||
146941197|NCT01421069|529943365|FG000|Parent Study|Lost to Follow-up|2|||
146941198|NCT01421069|529943365|FG000|Parent Study|Lack of Efficacy|1|||
146800546|NCT03213457|529442950|FG002|Screening Period|Withdrawal by Subject|0|||
146941199|NCT01421069|529943365|FG000|Overall Period for Extension Study|Other|2|||
146941200|NCT01421069|529943365|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
146941201|NCT01421069|529943365|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
146941202|NCT01421069|529943365|FG000|Overall Period for Extension Study|Pregnancy|1|||
146800547|NCT03213457|529442948|FG000|Screening Period|Other|1|||
146800548|NCT03213457|529442949|FG001|Screening Period|Other|0|||
146800549|NCT03213457|529442950|FG002|Screening Period|Other|0|||
146800550|NCT03213457|529442948|FG000|Double-Blind Period|Adverse Event|3|||
146800551|NCT03213457|529442949|FG001|Double-Blind Period|Adverse Event|2|||
146800552|NCT03213457|529442950|FG002|Double-Blind Period|Adverse Event|7|||
146941203|NCT01421069|529943365|FG000|Overall Period for Extension Study|Adverse Event|1|||
146800553|NCT03213457|529442948|FG000|Double-Blind Period|Withdrawal by Subject|14|||
146800554|NCT03213457|529442949|FG001|Double-Blind Period|Withdrawal by Subject|2|||
146800555|NCT03213457|529442950|FG002|Double-Blind Period|Withdrawal by Subject|14|||
146800556|NCT03213457|529442948|FG000|Double-Blind Period|Lost to Follow-up|2|||
146800557|NCT03213457|529442949|FG001|Double-Blind Period|Lost to Follow-up|3|||
146800558|NCT03213457|529442950|FG002|Double-Blind Period|Lost to Follow-up|9|||
146800559|NCT03213457|529442948|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
146800560|NCT03213457|529442949|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
146800561|NCT03213457|529442950|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
146800562|NCT03213457|529442948|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
146800563|NCT03213457|529442949|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
146800564|NCT03213457|529442950|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
146800565|NCT03213457|529442948|FG000|Double-Blind Period|Pregnancy|5|||
146800566|NCT03213457|529442949|FG001|Double-Blind Period|Pregnancy|0|||
146800567|NCT03213457|529442950|FG002|Double-Blind Period|Pregnancy|0|||
146800568|NCT03213457|529442948|FG000|Double-Blind Period|Other|10|||
146800569|NCT03213457|529442949|FG001|Double-Blind Period|Other|3|||
146800570|NCT03213457|529442950|FG002|Double-Blind Period|Other|17|||
146800571|NCT03213457|529442948|FG000|Open-Label Period|Adverse Event|1|||
146800572|NCT03213457|529442949|FG001|Open-Label Period|Adverse Event|2|||
146800573|NCT03213457|529442950|FG002|Open-Label Period|Adverse Event|2|||
146800574|NCT03213457|529442948|FG000|Open-Label Period|Withdrawal by Subject|12|||
146800575|NCT03213457|529442949|FG001|Open-Label Period|Withdrawal by Subject|5|||
146800576|NCT03213457|529442950|FG002|Open-Label Period|Withdrawal by Subject|24|||
146800577|NCT03213457|529442948|FG000|Open-Label Period|Lost to Follow-up|1|||
146800578|NCT03213457|529442949|FG001|Open-Label Period|Lost to Follow-up|2|||
146800579|NCT03213457|529442950|FG002|Open-Label Period|Lost to Follow-up|8|||
146800580|NCT03213457|529442948|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
146800581|NCT03213457|529442949|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
146800582|NCT03213457|529442950|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
146800583|NCT03213457|529442948|FG000|Open-Label Period|Non-compliance with study procedures|1|||
146800584|NCT03213457|529442949|FG001|Open-Label Period|Non-compliance with study procedures|1|||
146800585|NCT03213457|529442950|FG002|Open-Label Period|Non-compliance with study procedures|2|||
146800586|NCT03213457|529442948|FG000|Open-Label Period|Exclusionary medications|0|||
146800587|NCT03213457|529442949|FG001|Open-Label Period|Exclusionary medications|0|||
146800588|NCT03213457|529442950|FG002|Open-Label Period|Exclusionary medications|1|||
146941204|NCT01421069|529943365|FG000|Overall Period for Extension Study|Protocol Violation|1|||
146941205|NCT01421069|529943365|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
146800589|NCT03213457|529442948|FG000|Open-Label Period|Other|1|||
146800590|NCT03213457|529442949|FG001|Open-Label Period|Other|1|||
146800591|NCT03213457|529442950|FG002|Open-Label Period|Other|6|||
146800592|NCT03213457|529442948|FG000|Follow-Up Period|Adverse Event|16|||
146800593|NCT03213457|529442949|FG001|Follow-Up Period|Adverse Event|8|||
146800594|NCT03213457|529442950|FG002|Follow-Up Period|Adverse Event|37|||
146800595|NCT03213457|529442948|FG000|Follow-Up Period|Withdrawal by Subject|18|||
146800596|NCT03213457|529442949|FG001|Follow-Up Period|Withdrawal by Subject|11|||
146800597|NCT03213457|529442950|FG002|Follow-Up Period|Withdrawal by Subject|55|||
146800598|NCT03213457|529442948|FG000|Follow-Up Period|Lost to Follow-up|28|||
146800599|NCT03213457|529442949|FG001|Follow-Up Period|Lost to Follow-up|15|||
146800600|NCT03213457|529442950|FG002|Follow-Up Period|Lost to Follow-up|50|||
146800601|NCT03213457|529442948|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
146800602|NCT03213457|529442949|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
146800603|NCT03213457|529442950|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
146941206|NCT01421069|529943365|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
146941207|NCT01421069|529943365|FG000|Active Treatment Period|Other|1|||
146941208|NCT01421069|529943365|FG000|Active Treatment Period|No longer willing to participate in study|8|||
146800604|NCT03213457|529442948|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
146800605|NCT03213457|529442949|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
146800606|NCT03213457|529442950|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
146800607|NCT03213457|529442948|FG000|Follow-Up Period|Pregnancy|7|||
146941209|NCT01421069|529943365|FG000|Active Treatment Period|Insufficient clinical response|1|||
146800608|NCT03213457|529442949|FG001|Follow-Up Period|Pregnancy|0|||
146800609|NCT03213457|529442950|FG002|Follow-Up Period|Pregnancy|18|||
146983378|NCT04081337|530101865|FG000|Overall Study|Withdrawal by Subject|2|||
146983379|NCT04081337|530101866|FG001|Overall Study|Withdrawal by Subject|0|||
146983380|NCT04081337|530101865|FG000|Overall Study|Physician Decision|1|||
146983381|NCT04081337|530101866|FG001|Overall Study|Physician Decision|2|||
146983382|NCT04081337|530101865|FG000|Overall Study|Lost to Follow-up|1|||
146983383|NCT04081337|530101866|FG001|Overall Study|Lost to Follow-up|0|||
146983384|NCT00130520|530101867|FG000|Overall Study|Adverse Event|11|||
146983385|NCT00130520|530101867|FG000|Overall Study|Death|1|||
146983386|NCT00130520|530101867|FG000|Overall Study|Physician Decision|1|||
146983387|NCT00130520|530101867|FG000|Overall Study|Withdrawal by Subject|1|||
146983388|NCT00130520|530101867|FG000|Overall Study|Disease Progression|23|||
146983389|NCT00130520|530101867|FG000|Overall Study|Protocol non-compliance|1|||
146983390|NCT00130520|530101867|FG000|Overall Study|Did not meet re-treatment criteria|1|||
146983391|NCT03487796|530101868|FG000|Overall Study|Lost to Follow-up|18|||
146983392|NCT03487796|530101869|FG001|Overall Study|Lost to Follow-up|6|||
146983393|NCT00613574|530101872|FG000|Overall Study|Adverse Event|3|||
146983394|NCT00613574|530101872|FG000|Overall Study|Lost to Follow-up|2|||
146983395|NCT00613574|530101872|FG000|Overall Study|Other|1|||
146983396|NCT02711956|530101874|FG000|Overall Study|Adverse Event|0|||
146983397|NCT02711956|530101875|FG001|Overall Study|Adverse Event|0|||
146983398|NCT02711956|530101876|FG002|Overall Study|Adverse Event|0|||
146983399|NCT02711956|530101877|FG003|Overall Study|Adverse Event|1|||
146983400|NCT02711956|530101878|FG004|Overall Study|Adverse Event|2|||
146983401|NCT02711956|530101879|FG005|Overall Study|Adverse Event|0|||
146983402|NCT02711956|530101880|FG006|Overall Study|Adverse Event|0|||
146983403|NCT02711956|530101881|FG007|Overall Study|Adverse Event|1|||
146983404|NCT02711956|530101882|FG008|Overall Study|Adverse Event|1|||
146983405|NCT02711956|530101883|FG009|Overall Study|Adverse Event|1|||
146983406|NCT02711956|530101884|FG010|Overall Study|Adverse Event|1|||
146983407|NCT02711956|530101885|FG011|Overall Study|Adverse Event|0|||
146983408|NCT02711956|530101886|FG012|Overall Study|Adverse Event|0|||
146983409|NCT02711956|530101887|FG013|Overall Study|Adverse Event|0|||
146983410|NCT02711956|530101888|FG014|Overall Study|Adverse Event|2|||
146983411|NCT02711956|530101874|FG000|Overall Study|Physician Decision|0|||
146983412|NCT02711956|530101875|FG001|Overall Study|Physician Decision|0|||
146983413|NCT02711956|530101876|FG002|Overall Study|Physician Decision|0|||
146983414|NCT02711956|530101877|FG003|Overall Study|Physician Decision|2|||
146983415|NCT02711956|530101878|FG004|Overall Study|Physician Decision|0|||
146983416|NCT02711956|530101879|FG005|Overall Study|Physician Decision|0|||
146983417|NCT02711956|530101880|FG006|Overall Study|Physician Decision|0|||
146983418|NCT02711956|530101881|FG007|Overall Study|Physician Decision|0|||
146983419|NCT02711956|530101882|FG008|Overall Study|Physician Decision|0|||
146983420|NCT02711956|530101883|FG009|Overall Study|Physician Decision|0|||
146983421|NCT02711956|530101884|FG010|Overall Study|Physician Decision|0|||
146983422|NCT02711956|530101885|FG011|Overall Study|Physician Decision|0|||
146983423|NCT02711956|530101886|FG012|Overall Study|Physician Decision|0|||
146983424|NCT02711956|530101887|FG013|Overall Study|Physician Decision|0|||
146983425|NCT02711956|530101888|FG014|Overall Study|Physician Decision|0|||
146983426|NCT02711956|530101874|FG000|Overall Study|Withdrawal by Subject|0|||
146983427|NCT02711956|530101875|FG001|Overall Study|Withdrawal by Subject|0|||
146983428|NCT02711956|530101876|FG002|Overall Study|Withdrawal by Subject|0|||
146983429|NCT02711956|530101877|FG003|Overall Study|Withdrawal by Subject|0|||
146983430|NCT02711956|530101878|FG004|Overall Study|Withdrawal by Subject|0|||
146983431|NCT02711956|530101879|FG005|Overall Study|Withdrawal by Subject|0|||
146983432|NCT02711956|530101880|FG006|Overall Study|Withdrawal by Subject|1|||
146983433|NCT02711956|530101881|FG007|Overall Study|Withdrawal by Subject|0|||
146983434|NCT02711956|530101882|FG008|Overall Study|Withdrawal by Subject|0|||
146983435|NCT02711956|530101883|FG009|Overall Study|Withdrawal by Subject|0|||
146983436|NCT02711956|530101884|FG010|Overall Study|Withdrawal by Subject|0|||
146983437|NCT02711956|530101885|FG011|Overall Study|Withdrawal by Subject|1|||
146983438|NCT02711956|530101886|FG012|Overall Study|Withdrawal by Subject|6|||
146983439|NCT02711956|530101887|FG013|Overall Study|Withdrawal by Subject|0|||
146983440|NCT02711956|530101888|FG014|Overall Study|Withdrawal by Subject|1|||
146983441|NCT02711956|530101874|FG000|Overall Study|Clinical progression|1|||
146983442|NCT02711956|530101875|FG001|Overall Study|Clinical progression|0|||
146983443|NCT02711956|530101876|FG002|Overall Study|Clinical progression|0|||
146983444|NCT02711956|530101877|FG003|Overall Study|Clinical progression|0|||
146983445|NCT02711956|530101878|FG004|Overall Study|Clinical progression|0|||
146983446|NCT02711956|530101879|FG005|Overall Study|Clinical progression|0|||
146983447|NCT02711956|530101880|FG006|Overall Study|Clinical progression|1|||
146983448|NCT02711956|530101881|FG007|Overall Study|Clinical progression|0|||
146983449|NCT02711956|530101882|FG008|Overall Study|Clinical progression|1|||
146983450|NCT02711956|530101883|FG009|Overall Study|Clinical progression|0|||
146983451|NCT02711956|530101884|FG010|Overall Study|Clinical progression|0|||
146983452|NCT02711956|530101885|FG011|Overall Study|Clinical progression|2|||
146983453|NCT02711956|530101886|FG012|Overall Study|Clinical progression|4|||
146983454|NCT02711956|530101887|FG013|Overall Study|Clinical progression|1|||
146983455|NCT02711956|530101888|FG014|Overall Study|Clinical progression|1|||
146800610|NCT03213457|529442948|FG000|Follow-Up Period|Exclusionary medications|1|||
146800611|NCT03213457|529442949|FG001|Follow-Up Period|Exclusionary medications|1|||
146800612|NCT03213457|529442950|FG002|Follow-Up Period|Exclusionary medications|5|||
146800613|NCT03213457|529442948|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
146800614|NCT03213457|529442949|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
146800615|NCT03213457|529442950|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
146800616|NCT03213457|529442948|FG000|Follow-Up Period|Other|14|||
146800617|NCT03213457|529442949|FG001|Follow-Up Period|Other|10|||
146800618|NCT03213457|529442950|FG002|Follow-Up Period|Other|31|||
146800619|NCT02951052|529442951|FG000|Overall Study|Adverse Event|13|||
146800620|NCT02951052|529442952|FG001|Overall Study|Adverse Event|5|||
146800621|NCT02951052|529442951|FG000|Overall Study|Withdrawal by Subject|1|||
146800622|NCT02951052|529442952|FG001|Overall Study|Withdrawal by Subject|5|||
146800623|NCT02951052|529442951|FG000|Overall Study|Physician Decision|2|||
146800624|NCT02951052|529442952|FG001|Overall Study|Physician Decision|0|||
146800625|NCT02951052|529442951|FG000|Overall Study|Lost to Follow-up|1|||
146800626|NCT02951052|529442952|FG001|Overall Study|Lost to Follow-up|1|||
146800627|NCT02951052|529442951|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
146800628|NCT02951052|529442952|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
146800629|NCT02951052|529442951|FG000|Overall Study|Protocol Violation|5|||
146800630|NCT02951052|529442952|FG001|Overall Study|Protocol Violation|3|||
146800631|NCT02951052|529442951|FG000|Overall Study|Lack of Efficacy|3|||
146800632|NCT02951052|529442952|FG001|Overall Study|Lack of Efficacy|4|||
146800633|NCT02951052|529442951|FG000|Overall Study|Ongoing|1|||
146800634|NCT02951052|529442952|FG001|Overall Study|Ongoing|0|||
146800635|NCT04059406|529442957|FG000|Overall Study|Early Treatment Termination|5|||
146800636|NCT04059406|529442958|FG001|Overall Study|Early Treatment Termination|5|||
146800637|NCT04059406|529442959|FG002|Overall Study|Early Treatment Termination|15|||
146800638|NCT04755595|529442961|FG000|Overall Study|Lost to Follow-up|1|||
146800639|NCT00319696|529442962|FG000|Overall Study|Adverse Event|36|||
146800640|NCT00319696|529442962|FG000|Overall Study|withdrawal of consent|14|||
146800641|NCT00319696|529442962|FG000|Overall Study|administrative|7|||
146800642|NCT00319696|529442962|FG000|Overall Study|Lost to Follow-up|3|||
146800643|NCT00655499|529443610|FG000|Overall Study|not eligible|4|||
146800644|NCT03248492|529443613|FG000|Overall Study|Progressive Disease|24|||
146800645|NCT03248492|529443614|FG001|Overall Study|Progressive Disease|23|||
146800646|NCT03248492|529443615|FG002|Overall Study|Progressive Disease|11|||
146941210|NCT01421069|529943365|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
146800647|NCT03248492|529443616|FG003|Overall Study|Progressive Disease|66|||
146800648|NCT03248492|529443617|FG004|Overall Study|Progressive Disease|1|||
146800649|NCT03248492|529443613|FG000|Overall Study|Adverse Event|14|||
146800650|NCT03248492|529443614|FG001|Overall Study|Adverse Event|13|||
146800651|NCT03248492|529443615|FG002|Overall Study|Adverse Event|9|||
146800652|NCT03248492|529443616|FG003|Overall Study|Adverse Event|22|||
146800653|NCT03248492|529443617|FG004|Overall Study|Adverse Event|2|||
146800654|NCT03248492|529443613|FG000|Overall Study|Withdrawal by Subject|5|||
146800655|NCT03248492|529443614|FG001|Overall Study|Withdrawal by Subject|4|||
146800656|NCT03248492|529443615|FG002|Overall Study|Withdrawal by Subject|0|||
146800657|NCT03248492|529443616|FG003|Overall Study|Withdrawal by Subject|8|||
146800658|NCT03248492|529443617|FG004|Overall Study|Withdrawal by Subject|1|||
146800659|NCT03248492|529443613|FG000|Overall Study|Physician Decision|1|||
146800660|NCT03248492|529443614|FG001|Overall Study|Physician Decision|1|||
146800661|NCT03248492|529443615|FG002|Overall Study|Physician Decision|1|||
146800662|NCT03248492|529443616|FG003|Overall Study|Physician Decision|7|||
146800663|NCT03248492|529443617|FG004|Overall Study|Physician Decision|0|||
146800664|NCT03248492|529443613|FG000|Overall Study|Death|1|||
146800665|NCT03248492|529443614|FG001|Overall Study|Death|1|||
146800666|NCT03248492|529443615|FG002|Overall Study|Death|0|||
146800667|NCT03248492|529443616|FG003|Overall Study|Death|6|||
146800668|NCT03248492|529443617|FG004|Overall Study|Death|0|||
146800669|NCT03248492|529443613|FG000|Overall Study|Study Terminated by Sponsor|3|||
146941211|NCT01421069|529943365|FG000|Active Treatment Period|Pregnancy|1|||
146941212|NCT01421069|529943365|FG000|Active Treatment Period|Adverse Event|1|||
146941213|NCT01421069|529943365|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
146941214|NCT01421069|529943365|FG000|Active Treatment Period|Enrolled in observational period|29|||
146941215|NCT01421069|529943365|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
146800670|NCT03248492|529443614|FG001|Overall Study|Study Terminated by Sponsor|1|||
146800671|NCT03248492|529443615|FG002|Overall Study|Study Terminated by Sponsor|0|||
146800672|NCT03248492|529443616|FG003|Overall Study|Study Terminated by Sponsor|7|||
146800673|NCT03248492|529443617|FG004|Overall Study|Study Terminated by Sponsor|0|||
146800674|NCT03248492|529443613|FG000|Overall Study|Other|2|||
146800675|NCT03248492|529443614|FG001|Overall Study|Other|5|||
146800676|NCT03248492|529443615|FG002|Overall Study|Other|0|||
146800677|NCT03248492|529443616|FG003|Overall Study|Other|14|||
146800678|NCT03248492|529443617|FG004|Overall Study|Other|0|||
146800679|NCT04495621|529443618|FG000|Overall Study|Withdrawal by Subject|0|||
146800680|NCT04495621|529443619|FG001|Overall Study|Withdrawal by Subject|3|||
146800681|NCT04495621|529443618|FG000|Overall Study|Death|7|||
146800682|NCT04495621|529443619|FG001|Overall Study|Death|11|||
146800683|NCT04495621|529443618|FG000|Overall Study|Investigator Decision|0|||
146800684|NCT04495621|529443619|FG001|Overall Study|Investigator Decision|7|||
146800685|NCT04495621|529443618|FG000|Overall Study|Lost to Follow-up|0|||
146800686|NCT04495621|529443619|FG001|Overall Study|Lost to Follow-up|1|||
146800687|NCT05707351|529443622|FG000|Overall Study|Withdrawal by Subject|2|||
146800688|NCT05707351|529443622|FG000|Overall Study|Reason Not Specified|1|||
146800689|NCT05155306|529443634|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
146800690|NCT05155306|529443635|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
146800691|NCT05155306|529443636|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
146800692|NCT05155306|529443637|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
146800693|NCT05155306|529443634|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
146800694|NCT05155306|529443635|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
146800695|NCT05155306|529443636|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
146800696|NCT05155306|529443637|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
146800697|NCT04158141|529443638|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
146800698|NCT04158141|529443639|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
146800699|NCT04158141|529443640|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
146800700|NCT04158141|529443638|FG000|Step 1: Registration|Adverse Event|1|||
146800701|NCT04158141|529443639|FG001|Step 1: Registration|Adverse Event|0|||
146800702|NCT04158141|529443640|FG002|Step 1: Registration|Adverse Event|0|||
146800703|NCT04158141|529443638|FG000|Step 1: Registration|Withdrawal by Subject|1|||
146800704|NCT04158141|529443639|FG001|Step 1: Registration|Withdrawal by Subject|0|||
146941216|NCT01421069|529943365|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
146941217|NCT01421069|529943365|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
146941218|NCT01421069|529943365|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
146941219|NCT01421069|529943365|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
146941220|NCT01421069|529943365|FG000|2b. Retreatment Period|Protocol Violation|1|||
146941221|NCT01421069|529943365|FG000|Observational Period|Other|1|||
146941222|NCT01421069|529943365|FG000|Observational Period|No longer willing to participate in study|4|||
146941223|NCT01421069|529943365|FG000|Observational Period|Lost to Follow-up|3|||
146941224|NCT01641081|529943366|FG000|Period 1|Sponsor request (potential unblinding)|0|||
146941225|NCT01641081|529943367|FG001|Period 1|Sponsor request (potential unblinding)|0|||
146941226|NCT01641081|529943368|FG002|Period 1|Sponsor request (potential unblinding)|0|||
146941227|NCT01641081|529943369|FG003|Period 1|Sponsor request (potential unblinding)|0|||
146941228|NCT01641081|529943370|FG004|Period 1|Sponsor request (potential unblinding)|0|||
146941229|NCT01641081|529943371|FG005|Period 1|Sponsor request (potential unblinding)|0|||
146941230|NCT01641081|529943372|FG006|Period 1|Sponsor request (potential unblinding)|1|||
146941231|NCT01641081|529943373|FG007|Period 1|Sponsor request (potential unblinding)|0|||
146941232|NCT01641081|529943374|FG008|Period 1|Sponsor request (potential unblinding)|0|||
146941233|NCT01641081|529943375|FG009|Period 1|Sponsor request (potential unblinding)|0|||
146941234|NCT01641081|529943366|FG000|Period 1|Protocol Violation|0|||
146941235|NCT01641081|529943367|FG001|Period 1|Protocol Violation|0|||
146941236|NCT01641081|529943368|FG002|Period 1|Protocol Violation|0|||
146941237|NCT01641081|529943369|FG003|Period 1|Protocol Violation|0|||
146941238|NCT01641081|529943370|FG004|Period 1|Protocol Violation|1|||
146941239|NCT01641081|529943371|FG005|Period 1|Protocol Violation|0|||
146941240|NCT01641081|529943372|FG006|Period 1|Protocol Violation|0|||
146941241|NCT01641081|529943373|FG007|Period 1|Protocol Violation|1|||
146941242|NCT01641081|529943374|FG008|Period 1|Protocol Violation|0|||
146941243|NCT01641081|529943375|FG009|Period 1|Protocol Violation|0|||
146941244|NCT01641081|529943366|FG000|Period 1|Adverse Event|1|||
146941245|NCT01641081|529943367|FG001|Period 1|Adverse Event|0|||
146941246|NCT01641081|529943368|FG002|Period 1|Adverse Event|0|||
146941247|NCT01641081|529943369|FG003|Period 1|Adverse Event|0|||
146941248|NCT01641081|529943370|FG004|Period 1|Adverse Event|0|||
146941249|NCT01641081|529943371|FG005|Period 1|Adverse Event|0|||
146941250|NCT01641081|529943372|FG006|Period 1|Adverse Event|0|||
146941251|NCT01641081|529943373|FG007|Period 1|Adverse Event|2|||
146941252|NCT01641081|529943374|FG008|Period 1|Adverse Event|0|||
146941253|NCT01641081|529943375|FG009|Period 1|Adverse Event|0|||
146941254|NCT01641081|529943366|FG000|Period 2|Adverse Event|0|||
146941255|NCT01641081|529943367|FG001|Period 2|Adverse Event|0|||
146941256|NCT01641081|529943368|FG002|Period 2|Adverse Event|0|||
146941257|NCT01641081|529943369|FG003|Period 2|Adverse Event|0|||
146941258|NCT01641081|529943370|FG004|Period 2|Adverse Event|0|||
146941259|NCT01641081|529943371|FG005|Period 2|Adverse Event|1|||
146941260|NCT01641081|529943372|FG006|Period 2|Adverse Event|0|||
146941261|NCT01641081|529943373|FG007|Period 2|Adverse Event|0|||
146800705|NCT04158141|529443640|FG002|Step 1: Registration|Withdrawal by Subject|0|||
146800706|NCT04158141|529443638|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
146800707|NCT04158141|529443639|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
146941262|NCT01641081|529943374|FG008|Period 2|Adverse Event|0|||
146941263|NCT01641081|529943375|FG009|Period 2|Adverse Event|0|||
146941264|NCT01641081|529943366|FG000|Period 2|Withdrawal by Subject|0|||
146941265|NCT01641081|529943367|FG001|Period 2|Withdrawal by Subject|0|||
146941266|NCT01641081|529943368|FG002|Period 2|Withdrawal by Subject|0|||
146800708|NCT04158141|529443640|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
146800709|NCT04121741|529443641|FG000|Overall Study|Protocol Violation|1|||
146800710|NCT04121741|529443642|FG001|Overall Study|Protocol Violation|0|||
146800711|NCT04121741|529443643|FG002|Overall Study|Protocol Violation|0|||
146800712|NCT04121741|529443644|FG003|Overall Study|Protocol Violation|0|||
146800713|NCT04121741|529443645|FG004|Overall Study|Protocol Violation|0|||
146800714|NCT04121741|529443646|FG005|Overall Study|Protocol Violation|0|||
146800715|NCT01084863|529443647|FG000|Main Study Treatment Period|Disease progression|11|||
146800716|NCT01084863|529443648|FG001|Main Study Treatment Period|Disease progression|7|||
146800717|NCT01084863|529443647|FG000|Main Study Treatment Period|Adverse Event|5|||
146800718|NCT01084863|529443648|FG001|Main Study Treatment Period|Adverse Event|3|||
146800719|NCT01084863|529443647|FG000|Main Study Treatment Period|Other Reason|0|||
146800720|NCT01084863|529443648|FG001|Main Study Treatment Period|Other Reason|1|||
146800721|NCT01084863|529443647|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
146800722|NCT01084863|529443648|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
146800723|NCT01084863|529443647|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
146800724|NCT01084863|529443648|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
146800725|NCT01084863|529443647|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
146800726|NCT01084863|529443648|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
146800727|NCT01084863|529443647|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
146800728|NCT01084863|529443648|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
146800729|NCT01084863|529443647|FG000|Treatment Period Beyond Cycle 8|Other|0|||
146800730|NCT01084863|529443648|FG001|Treatment Period Beyond Cycle 8|Other|1|||
146800731|NCT01084863|529443647|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
146800732|NCT01084863|529443648|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
146800733|NCT04505722|529443649|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
146800734|NCT04505722|529443650|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
146800735|NCT04505722|529443651|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
146800736|NCT04505722|529443649|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
146800737|NCT04505722|529443650|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
146800738|NCT04505722|529443651|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
146800739|NCT04505722|529443649|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
146800740|NCT04505722|529443650|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
146800741|NCT04505722|529443651|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
146800742|NCT04505722|529443649|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
146800743|NCT04505722|529443650|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
146800744|NCT04505722|529443651|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
146800745|NCT04505722|529443649|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
146800746|NCT04505722|529443650|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
146800747|NCT04505722|529443651|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
146800748|NCT04505722|529443649|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
146800749|NCT04505722|529443650|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
146800750|NCT04505722|529443651|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
146800751|NCT04505722|529443649|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
146800752|NCT04505722|529443650|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
146800753|NCT04505722|529443651|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
146800754|NCT04505722|529443649|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
146800755|NCT04505722|529443650|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
146800756|NCT04505722|529443651|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
146800757|NCT04505722|529443649|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
146800758|NCT04505722|529443650|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
146800759|NCT04505722|529443651|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
146800760|NCT04505722|529443649|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
146800761|NCT04505722|529443650|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
146800762|NCT04505722|529443651|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
146800763|NCT04505722|529443649|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
146800764|NCT04505722|529443650|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
146800765|NCT04505722|529443651|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
146800766|NCT04505722|529443649|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
146800767|NCT04505722|529443650|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
146800768|NCT04505722|529443651|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
146800769|NCT04505722|529443649|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
146800770|NCT04505722|529443650|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
146800771|NCT04505722|529443651|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
146800772|NCT04505722|529443649|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
146800773|NCT04505722|529443650|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
146800774|NCT04505722|529443651|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
146800775|NCT04505722|529443649|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
146800776|NCT04505722|529443650|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
146800777|NCT04505722|529443651|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
146800778|NCT03473223|529443652|FG000|Overall Study|Lost to Follow-up|1|||
146800779|NCT03473223|529443653|FG001|Overall Study|Lost to Follow-up|1|||
146800780|NCT03473223|529443652|FG000|Overall Study|Withdrawal by Subject|47|||
146800781|NCT03473223|529443653|FG001|Overall Study|Withdrawal by Subject|42|||
146800782|NCT03473223|529443652|FG000|Overall Study|Indirect contact|32|||
146800783|NCT03473223|529443653|FG001|Overall Study|Indirect contact|29|||
146800784|NCT03473223|529443652|FG000|Overall Study|Other (Not specified)|32|||
146800785|NCT03473223|529443653|FG001|Overall Study|Other (Not specified)|20|||
146800786|NCT05827068|529443654|FG000|Overall Study|Lost to Follow-up|1|||
146800787|NCT05827068|529443655|FG001|Overall Study|Lost to Follow-up|4|||
146800788|NCT05827068|529443656|FG002|Overall Study|Lost to Follow-up|1|||
146800789|NCT05827068|529443657|FG003|Overall Study|Lost to Follow-up|1|||
146800790|NCT05827068|529443658|FG004|Overall Study|Lost to Follow-up|2|||
146800791|NCT05827068|529443659|FG005|Overall Study|Lost to Follow-up|4|||
146800792|NCT05827068|529443660|FG006|Overall Study|Lost to Follow-up|1|||
146800793|NCT05827068|529443654|FG000|Overall Study|Withdrawal by Subject|4|||
146800794|NCT05827068|529443655|FG001|Overall Study|Withdrawal by Subject|0|||
146800795|NCT05827068|529443656|FG002|Overall Study|Withdrawal by Subject|1|||
146800796|NCT05827068|529443657|FG003|Overall Study|Withdrawal by Subject|2|||
146800797|NCT05827068|529443658|FG004|Overall Study|Withdrawal by Subject|3|||
146800798|NCT05827068|529443659|FG005|Overall Study|Withdrawal by Subject|0|||
146800799|NCT05827068|529443660|FG006|Overall Study|Withdrawal by Subject|1|||
146800800|NCT05827068|529443654|FG000|Overall Study|Physician Decision|0|||
146800801|NCT05827068|529443655|FG001|Overall Study|Physician Decision|0|||
146800802|NCT05827068|529443656|FG002|Overall Study|Physician Decision|0|||
146800803|NCT05827068|529443657|FG003|Overall Study|Physician Decision|0|||
146800804|NCT05827068|529443658|FG004|Overall Study|Physician Decision|1|||
146800805|NCT05827068|529443659|FG005|Overall Study|Physician Decision|0|||
146800806|NCT05827068|529443660|FG006|Overall Study|Physician Decision|1|||
146800807|NCT05827068|529443654|FG000|Overall Study|Other Than Specified|0|||
146800808|NCT05827068|529443655|FG001|Overall Study|Other Than Specified|1|||
146800809|NCT05827068|529443656|FG002|Overall Study|Other Than Specified|0|||
146800810|NCT05827068|529443657|FG003|Overall Study|Other Than Specified|0|||
146800811|NCT05827068|529443658|FG004|Overall Study|Other Than Specified|0|||
146800812|NCT05827068|529443659|FG005|Overall Study|Other Than Specified|0|||
146800813|NCT05827068|529443660|FG006|Overall Study|Other Than Specified|0|||
146800814|NCT00319020|529443661|FG000|Overall Study|Death|2|||
146800815|NCT00319020|529443662|FG001|Overall Study|Death|2|||
146800816|NCT00319020|529443661|FG000|Overall Study|Withdrawal by Subject|4|||
146800817|NCT00319020|529443662|FG001|Overall Study|Withdrawal by Subject|1|||
146800818|NCT00319020|529443661|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
146800819|NCT00319020|529443662|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
146800820|NCT00319020|529443661|FG000|Overall Study|Administrative reason|0|||
146800821|NCT00319020|529443662|FG001|Overall Study|Administrative reason|5|||
146800822|NCT00319020|529443661|FG000|Overall Study|Disease progression|0|||
146800823|NCT00319020|529443662|FG001|Overall Study|Disease progression|2|||
146800824|NCT00319020|529443661|FG000|Overall Study|Transplant|0|||
146800825|NCT00319020|529443662|FG001|Overall Study|Transplant|1|||
146800826|NCT00319020|529443661|FG000|Overall Study|Treatment failure|0|||
146800827|NCT00319020|529443662|FG001|Overall Study|Treatment failure|1|||
146800828|NCT00319020|529443661|FG000|Overall Study|Adverse Event|0|||
146800829|NCT00319020|529443662|FG001|Overall Study|Adverse Event|1|||
146800830|NCT01288443|529444338|FG000|Overall Study|Adverse Event|0|||
146800831|NCT01288443|529444339|FG001|Overall Study|Adverse Event|0|||
146800832|NCT01288443|529444340|FG002|Overall Study|Adverse Event|1|||
146800833|NCT01288443|529444341|FG003|Overall Study|Adverse Event|1|||
146800834|NCT01288443|529444342|FG004|Overall Study|Adverse Event|3|||
146800835|NCT01288443|529444343|FG005|Overall Study|Adverse Event|1|||
146800836|NCT01288443|529444338|FG000|Overall Study|Poor compliance to protocol|0|||
146800837|NCT01288443|529444339|FG001|Overall Study|Poor compliance to protocol|0|||
146941267|NCT01641081|529943369|FG003|Period 2|Withdrawal by Subject|1|||
146941268|NCT01641081|529943370|FG004|Period 2|Withdrawal by Subject|0|||
146941269|NCT01641081|529943371|FG005|Period 2|Withdrawal by Subject|0|||
146941270|NCT01641081|529943372|FG006|Period 2|Withdrawal by Subject|2|||
146800838|NCT01288443|529444340|FG002|Overall Study|Poor compliance to protocol|0|||
146800839|NCT01288443|529444341|FG003|Overall Study|Poor compliance to protocol|0|||
146800840|NCT01288443|529444342|FG004|Overall Study|Poor compliance to protocol|0|||
146800841|NCT01288443|529444343|FG005|Overall Study|Poor compliance to protocol|1|||
146800842|NCT01288443|529444338|FG000|Overall Study|Participant Moved|0|||
146800843|NCT01288443|529444339|FG001|Overall Study|Participant Moved|0|||
146800844|NCT01288443|529444340|FG002|Overall Study|Participant Moved|0|||
146800845|NCT01288443|529444341|FG003|Overall Study|Participant Moved|1|||
146800846|NCT01288443|529444342|FG004|Overall Study|Participant Moved|2|||
146800847|NCT01288443|529444343|FG005|Overall Study|Participant Moved|1|||
146941271|NCT01641081|529943373|FG007|Period 2|Withdrawal by Subject|0|||
146800848|NCT01288443|529444338|FG000|Overall Study|Consent withdrawn by Participant|0|||
146800849|NCT01288443|529444339|FG001|Overall Study|Consent withdrawn by Participant|0|||
146800850|NCT01288443|529444340|FG002|Overall Study|Consent withdrawn by Participant|0|||
146800851|NCT01288443|529444341|FG003|Overall Study|Consent withdrawn by Participant|0|||
146800852|NCT01288443|529444342|FG004|Overall Study|Consent withdrawn by Participant|0|||
146800853|NCT01288443|529444343|FG005|Overall Study|Consent withdrawn by Participant|1|||
146800854|NCT01288443|529444338|FG000|Overall Study|Lost to Follow-up|0|||
146800855|NCT01288443|529444339|FG001|Overall Study|Lost to Follow-up|1|||
146800856|NCT01288443|529444340|FG002|Overall Study|Lost to Follow-up|0|||
146800857|NCT01288443|529444341|FG003|Overall Study|Lost to Follow-up|0|||
146800858|NCT01288443|529444342|FG004|Overall Study|Lost to Follow-up|0|||
146800859|NCT01288443|529444343|FG005|Overall Study|Lost to Follow-up|0|||
146800860|NCT01288443|529444338|FG000|Overall Study|Study drug auto-injector administration|0|||
146800861|NCT01288443|529444339|FG001|Overall Study|Study drug auto-injector administration|0|||
146800862|NCT01288443|529444340|FG002|Overall Study|Study drug auto-injector administration|0|||
146800863|NCT01288443|529444341|FG003|Overall Study|Study drug auto-injector administration|0|||
146800864|NCT01288443|529444342|FG004|Overall Study|Study drug auto-injector administration|1|||
146800865|NCT01288443|529444343|FG005|Overall Study|Study drug auto-injector administration|1|||
146800866|NCT01288443|529444338|FG000|Overall Study|Other than above|0|||
146800867|NCT01288443|529444339|FG001|Overall Study|Other than above|0|||
146800868|NCT01288443|529444340|FG002|Overall Study|Other than above|0|||
146800869|NCT01288443|529444341|FG003|Overall Study|Other than above|2|||
146800870|NCT01288443|529444342|FG004|Overall Study|Other than above|1|||
146800871|NCT01288443|529444343|FG005|Overall Study|Other than above|0|||
146800872|NCT01596972|529444344|FG000|Overall Study|Physician Decision|1|||
146800873|NCT01596972|529444345|FG001|Overall Study|Physician Decision|9|||
146800874|NCT01596972|529444344|FG000|Overall Study|Lost to Follow-up|0|||
146800875|NCT01596972|529444345|FG001|Overall Study|Lost to Follow-up|4|||
146800876|NCT01596972|529444344|FG000|Overall Study|Withdrawal by Subject|0|||
146800877|NCT01596972|529444345|FG001|Overall Study|Withdrawal by Subject|1|||
146800878|NCT01639131|529444347|FG000|Overall Study|Disease Progression|6|||
146800879|NCT02285270|529444349|FG000|Overall Study|Lost to Follow-up|1|||
146800880|NCT02285270|529444349|FG000|Overall Study|Physician Decision|3|||
146800881|NCT02285270|529444349|FG000|Overall Study|Determined to be ineligible|1|||
146800882|NCT00439270|529444350|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
146800883|NCT00439270|529444351|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
146800884|NCT00439270|529444352|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
146800885|NCT00439270|529444353|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
146800886|NCT00439270|529444354|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
146800887|NCT00439270|529444350|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
146800888|NCT00439270|529444351|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
146800889|NCT00439270|529444352|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
146800890|NCT00439270|529444353|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
146800891|NCT00439270|529444354|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
146800892|NCT00439270|529444350|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
146800893|NCT00439270|529444351|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
146800894|NCT00439270|529444352|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
146800895|NCT00439270|529444353|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
146800896|NCT00439270|529444354|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
146800897|NCT00439270|529444350|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
146800898|NCT00439270|529444351|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
146800899|NCT00439270|529444352|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
146800900|NCT00439270|529444353|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
146800901|NCT00439270|529444354|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
146800902|NCT00439270|529444350|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
146800903|NCT00439270|529444351|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
146800904|NCT00439270|529444352|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
146800905|NCT00439270|529444353|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
146800906|NCT00439270|529444354|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
146800907|NCT00439270|529444350|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
146800908|NCT00439270|529444351|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
146800909|NCT00439270|529444352|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
146800910|NCT00439270|529444353|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
146800911|NCT00439270|529444354|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
146941272|NCT01641081|529943374|FG008|Period 2|Withdrawal by Subject|0|||
146941273|NCT01641081|529943375|FG009|Period 2|Withdrawal by Subject|0|||
146941274|NCT01641081|529943366|FG000|Period 2|Protocol Violation|1|||
146941275|NCT01641081|529943367|FG001|Period 2|Protocol Violation|0|||
146941276|NCT01641081|529943368|FG002|Period 2|Protocol Violation|0|||
146941277|NCT01641081|529943369|FG003|Period 2|Protocol Violation|0|||
146941278|NCT01641081|529943370|FG004|Period 2|Protocol Violation|0|||
146941279|NCT01641081|529943371|FG005|Period 2|Protocol Violation|0|||
146941280|NCT01641081|529943372|FG006|Period 2|Protocol Violation|0|||
146941281|NCT01641081|529943373|FG007|Period 2|Protocol Violation|0|||
146941282|NCT01641081|529943374|FG008|Period 2|Protocol Violation|0|||
146941283|NCT01641081|529943375|FG009|Period 2|Protocol Violation|0|||
146941284|NCT01641081|529943366|FG000|Period 3|Adverse Event|0|||
146941285|NCT01641081|529943367|FG001|Period 3|Adverse Event|0|||
146941286|NCT01641081|529943368|FG002|Period 3|Adverse Event|1|||
146800912|NCT00439270|529444350|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
146983456|NCT02711956|530101874|FG000|Overall Study|Radiographic progression|1|||
146983457|NCT02711956|530101875|FG001|Overall Study|Radiographic progression|1|||
146983458|NCT02711956|530101876|FG002|Overall Study|Radiographic progression|2|||
146983459|NCT02711956|530101877|FG003|Overall Study|Radiographic progression|0|||
146800913|NCT00439270|529444351|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
146800914|NCT00439270|529444352|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
146800915|NCT00439270|529444353|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
146800916|NCT00439270|529444354|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
146800917|NCT00439270|529444350|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
146800918|NCT00439270|529444351|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
146800919|NCT00439270|529444352|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
146800920|NCT00439270|529444353|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
146800921|NCT00439270|529444354|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
146800922|NCT00439270|529444350|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
146800923|NCT00439270|529444351|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
146941287|NCT01641081|529943369|FG003|Period 3|Adverse Event|0|||
146941288|NCT01641081|529943370|FG004|Period 3|Adverse Event|0|||
146941289|NCT01641081|529943371|FG005|Period 3|Adverse Event|0|||
146941290|NCT01641081|529943372|FG006|Period 3|Adverse Event|0|||
146941291|NCT01641081|529943373|FG007|Period 3|Adverse Event|0|||
146941292|NCT01641081|529943374|FG008|Period 3|Adverse Event|0|||
146941293|NCT01641081|529943375|FG009|Period 3|Adverse Event|0|||
146941294|NCT01641081|529943366|FG000|Period 3|Withdrawal by Subject|0|||
146941295|NCT01641081|529943367|FG001|Period 3|Withdrawal by Subject|0|||
146941296|NCT01641081|529943368|FG002|Period 3|Withdrawal by Subject|0|||
146941297|NCT01641081|529943369|FG003|Period 3|Withdrawal by Subject|0|||
146941298|NCT01641081|529943370|FG004|Period 3|Withdrawal by Subject|0|||
146941299|NCT01641081|529943371|FG005|Period 3|Withdrawal by Subject|0|||
146941300|NCT01641081|529943372|FG006|Period 3|Withdrawal by Subject|0|||
146941301|NCT01641081|529943373|FG007|Period 3|Withdrawal by Subject|0|||
146941302|NCT01641081|529943374|FG008|Period 3|Withdrawal by Subject|1|||
146941303|NCT01641081|529943375|FG009|Period 3|Withdrawal by Subject|0|||
146941304|NCT01641081|529943366|FG000|Period 4|Adverse Event|0|||
146941305|NCT01641081|529943367|FG001|Period 4|Adverse Event|1|||
146941306|NCT01641081|529943368|FG002|Period 4|Adverse Event|0|||
146941307|NCT01641081|529943369|FG003|Period 4|Adverse Event|1|||
146941308|NCT01641081|529943370|FG004|Period 4|Adverse Event|0|||
146941309|NCT01641081|529943371|FG005|Period 4|Adverse Event|0|||
146941310|NCT01641081|529943372|FG006|Period 4|Adverse Event|0|||
146941311|NCT01641081|529943373|FG007|Period 4|Adverse Event|0|||
146941312|NCT01641081|529943374|FG008|Period 4|Adverse Event|0|||
146941313|NCT01641081|529943375|FG009|Period 4|Adverse Event|0|||
146941314|NCT01641081|529943366|FG000|Period 5|Adverse Event|0|||
146941315|NCT01641081|529943367|FG001|Period 5|Adverse Event|0|||
146941316|NCT01641081|529943368|FG002|Period 5|Adverse Event|2|||
146941317|NCT01641081|529943369|FG003|Period 5|Adverse Event|0|||
146941318|NCT01641081|529943370|FG004|Period 5|Adverse Event|0|||
146941319|NCT01641081|529943371|FG005|Period 5|Adverse Event|0|||
146941320|NCT01641081|529943372|FG006|Period 5|Adverse Event|0|||
146941321|NCT01641081|529943373|FG007|Period 5|Adverse Event|0|||
146941322|NCT01641081|529943374|FG008|Period 5|Adverse Event|0|||
146941323|NCT01641081|529943375|FG009|Period 5|Adverse Event|0|||
146941324|NCT03383614|529943377|FG000|Overall Study|Withdrawal by Subject|0|||
146941325|NCT03383614|529943378|FG001|Overall Study|Withdrawal by Subject|1|||
146941326|NCT03383614|529943379|FG002|Overall Study|Withdrawal by Subject|0|||
146941327|NCT03383614|529943380|FG003|Overall Study|Withdrawal by Subject|0|||
146941328|NCT02709109|529943382|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
146941329|NCT02709109|529943383|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
146941330|NCT02709109|529943384|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
146941331|NCT02709109|529943385|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
146941332|NCT02709109|529943382|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
146941333|NCT02709109|529943383|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
146941334|NCT02709109|529943384|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
146941335|NCT02709109|529943385|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
146941336|NCT02709109|529943382|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
146941337|NCT02709109|529943383|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
146941338|NCT02709109|529943384|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
146941339|NCT02709109|529943385|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
146941340|NCT02709109|529943382|FG000|Washout Period (28 Days)|Other|2|||
146941341|NCT02709109|529943383|FG001|Washout Period (28 Days)|Other|2|||
146941342|NCT02709109|529943384|FG002|Washout Period (28 Days)|Other|3|||
146941343|NCT02709109|529943385|FG003|Washout Period (28 Days)|Other|0|||
146941344|NCT02709109|529943382|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
146800924|NCT00439270|529444352|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
146800925|NCT00439270|529444353|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
146800926|NCT00439270|529444354|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
146800927|NCT00439270|529444350|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
146800928|NCT00439270|529444351|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
146800929|NCT00439270|529444352|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
146800930|NCT00439270|529444353|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
146800931|NCT00439270|529444354|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
146800932|NCT04334317|529444355|FG000|Overall Study|Adverse Event|1|||
146800933|NCT04334317|529444356|FG001|Overall Study|Adverse Event|2|||
146800934|NCT04334317|529444357|FG002|Overall Study|Adverse Event|0|||
146800935|NCT04334317|529444358|FG003|Overall Study|Adverse Event|0|||
146800936|NCT04334317|529444355|FG000|Overall Study|Protocol Deviation|0|||
146800937|NCT04334317|529444356|FG001|Overall Study|Protocol Deviation|1|||
146800938|NCT04334317|529444357|FG002|Overall Study|Protocol Deviation|0|||
146800939|NCT04334317|529444358|FG003|Overall Study|Protocol Deviation|0|||
146800940|NCT04334317|529444355|FG000|Overall Study|Withdrawal by Subject|2|||
146800941|NCT04334317|529444356|FG001|Overall Study|Withdrawal by Subject|2|||
146800942|NCT04334317|529444357|FG002|Overall Study|Withdrawal by Subject|0|||
146800943|NCT04334317|529444358|FG003|Overall Study|Withdrawal by Subject|0|||
146800944|NCT03183050|529444360|FG000|Overall Study|Lost to Follow-up|23|||
146800945|NCT02797132|529444361|FG000|Part A (15 Days)|Adverse Event|1|||
146800946|NCT02797132|529444361|FG000|Part B (24 Weeks)|Adverse Event|3|||
146800947|NCT01315132|529444362|FG000|Overall Study|not treated due to disease progression|1|||
146800948|NCT01371994|529444374|FG000|Overall Study|Adverse Event|3|||
146800949|NCT01371994|529444375|FG001|Overall Study|Adverse Event|6|||
146800950|NCT01371994|529444374|FG000|Overall Study|Lack of Efficacy|3|||
146800951|NCT01371994|529444375|FG001|Overall Study|Lack of Efficacy|0|||
146800952|NCT01371994|529444374|FG000|Overall Study|Withdrawal by Subject|13|||
146800953|NCT01371994|529444375|FG001|Overall Study|Withdrawal by Subject|7|||
146800954|NCT01371994|529444374|FG000|Overall Study|Lost to Follow-up|1|||
146800955|NCT01371994|529444375|FG001|Overall Study|Lost to Follow-up|1|||
146800956|NCT01371994|529444374|FG000|Overall Study|Protocol Violation|24|||
146800957|NCT01371994|529444375|FG001|Overall Study|Protocol Violation|17|||
146800958|NCT01371994|529444374|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
146800959|NCT01371994|529444375|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
146800960|NCT01371994|529444374|FG000|Overall Study|Physician Decision|1|||
146800961|NCT01371994|529444375|FG001|Overall Study|Physician Decision|1|||
146800962|NCT01371994|529444374|FG000|Overall Study|Miscellaneous Reasons|6|||
146800963|NCT01371994|529444375|FG001|Overall Study|Miscellaneous Reasons|4|||
146800964|NCT00087685|529444376|FG000|Overall Study|Adverse Event|5|||
146800965|NCT00087685|529444376|FG000|Overall Study|Non-Compliance|1|||
146800966|NCT00087685|529444376|FG000|Overall Study|Progressive Disease|5|||
146800967|NCT00087685|529444376|FG000|Overall Study|Withdrawal by Subject|3|||
146800968|NCT04018495|529444377|FG000|Overall Study|Physician Decision|1|||
146800969|NCT03275285|529444381|FG000|Overall Study|Ongoing|45|||
146800970|NCT03275285|529444382|FG001|Overall Study|Ongoing|69|||
146800971|NCT02500576|529444384|FG000|Overall Study|Adverse Event|0|||
146800972|NCT02500576|529444385|FG001|Overall Study|Adverse Event|1|||
146800973|NCT02500576|529444384|FG000|Overall Study|Death|2|||
146800974|NCT02500576|529444385|FG001|Overall Study|Death|1|||
146800975|NCT02500576|529444384|FG000|Overall Study|Lack of Efficacy|5|||
146800976|NCT02500576|529444385|FG001|Overall Study|Lack of Efficacy|5|||
146800977|NCT02500576|529444384|FG000|Overall Study|Withdrawal by Subject|1|||
146800978|NCT02500576|529444385|FG001|Overall Study|Withdrawal by Subject|1|||
146800979|NCT01983683|529444391|FG000|Overall Study|Withdrawal by Subject|14|||
146800980|NCT01983683|529444392|FG001|Overall Study|Withdrawal by Subject|18|||
146800981|NCT01983683|529444391|FG000|Overall Study|Death|11|||
146800982|NCT01983683|529444392|FG001|Overall Study|Death|15|||
146941345|NCT02709109|529943383|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
146800983|NCT01983683|529444391|FG000|Overall Study|Physician Decision|8|||
146800984|NCT01983683|529444392|FG001|Overall Study|Physician Decision|9|||
146800985|NCT01983683|529444391|FG000|Overall Study|Lost to Follow-up|4|||
146941346|NCT02709109|529943384|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
146800986|NCT01983683|529444392|FG001|Overall Study|Lost to Follow-up|8|||
146800987|NCT01983683|529444391|FG000|Overall Study|Sponsor Decision|1|||
146800988|NCT01983683|529444392|FG001|Overall Study|Sponsor Decision|1|||
146800989|NCT04926740|529444395|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
146800990|NCT04926740|529444396|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
146800991|NCT04926740|529444395|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
146800992|NCT04926740|529444396|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
146800993|NCT04980300|529444397|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
146800994|NCT04980300|529444398|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
146800995|NCT04980300|529444397|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
146941347|NCT02709109|529943385|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
146800996|NCT04980300|529444398|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
146800997|NCT04980300|529444397|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
146800998|NCT04980300|529444398|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
146800999|NCT04980300|529444397|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
146801000|NCT04980300|529444398|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
146801001|NCT04530487|529445166|FG000|Overall Study|Death|1|||
146801002|NCT04977583|529445167|FG000|Overall Study|Lost to Follow-up|8|||
146801003|NCT04977583|529445168|FG001|Overall Study|Lost to Follow-up|4|||
146801004|NCT04977583|529445169|FG002|Overall Study|Lost to Follow-up|13|||
146801005|NCT04977583|529445167|FG000|Overall Study|Withdrawal by Subject|3|||
146801006|NCT04977583|529445168|FG001|Overall Study|Withdrawal by Subject|2|||
146801007|NCT04977583|529445169|FG002|Overall Study|Withdrawal by Subject|1|||
146801008|NCT01574716|529445173|FG000|Part 1|Death|3|||
146801009|NCT01574716|529445174|FG001|Part 1|Death|1|||
146801010|NCT01574716|529445175|FG002|Part 1|Death|8|||
146801011|NCT01574716|529445176|FG003|Part 1|Death|0|||
146801012|NCT01574716|529445177|FG004|Part 1|Death|0|||
146801013|NCT01574716|529445173|FG000|Part 1|Discontinuation of study by sponsor|0|||
146801014|NCT01574716|529445174|FG001|Part 1|Discontinuation of study by sponsor|0|||
146801015|NCT01574716|529445175|FG002|Part 1|Discontinuation of study by sponsor|1|||
146801016|NCT01574716|529445176|FG003|Part 1|Discontinuation of study by sponsor|0|||
146801017|NCT01574716|529445177|FG004|Part 1|Discontinuation of study by sponsor|0|||
146801018|NCT01574716|529445173|FG000|Part 1|Withdrawal by Subject|0|||
146801019|NCT01574716|529445174|FG001|Part 1|Withdrawal by Subject|2|||
146801020|NCT01574716|529445175|FG002|Part 1|Withdrawal by Subject|0|||
146801021|NCT01574716|529445176|FG003|Part 1|Withdrawal by Subject|0|||
146801022|NCT01574716|529445177|FG004|Part 1|Withdrawal by Subject|0|||
146801023|NCT01574716|529445173|FG000|Part 1|Lost to Follow-up|0|||
146801024|NCT01574716|529445174|FG001|Part 1|Lost to Follow-up|1|||
146801025|NCT01574716|529445175|FG002|Part 1|Lost to Follow-up|0|||
146801026|NCT01574716|529445176|FG003|Part 1|Lost to Follow-up|0|||
146801027|NCT01574716|529445177|FG004|Part 1|Lost to Follow-up|0|||
146801028|NCT01574716|529445173|FG000|Part 2|Progressive disease|0|||
146801029|NCT01574716|529445174|FG001|Part 2|Progressive disease|0|||
146801030|NCT01574716|529445175|FG002|Part 2|Progressive disease|0|||
146801031|NCT01574716|529445176|FG003|Part 2|Progressive disease|1|||
146801032|NCT01574716|529445177|FG004|Part 2|Progressive disease|0|||
146801033|NCT01574716|529445173|FG000|Part 2|Death|0|||
146801034|NCT01574716|529445174|FG001|Part 2|Death|0|||
146801035|NCT01574716|529445175|FG002|Part 2|Death|0|||
146801036|NCT01574716|529445176|FG003|Part 2|Death|76|||
146801037|NCT01574716|529445177|FG004|Part 2|Death|35|||
146801038|NCT01574716|529445173|FG000|Part 2|Discontinuation of study by sponsor|0|||
146801039|NCT01574716|529445174|FG001|Part 2|Discontinuation of study by sponsor|0|||
146801040|NCT01574716|529445175|FG002|Part 2|Discontinuation of study by sponsor|0|||
146801041|NCT01574716|529445176|FG003|Part 2|Discontinuation of study by sponsor|51|||
146801042|NCT01574716|529445177|FG004|Part 2|Discontinuation of study by sponsor|31|||
146801043|NCT01574716|529445173|FG000|Part 2|Withdrawal by Subject|0|||
146801044|NCT01574716|529445174|FG001|Part 2|Withdrawal by Subject|0|||
146801045|NCT01574716|529445175|FG002|Part 2|Withdrawal by Subject|0|||
146801046|NCT01574716|529445176|FG003|Part 2|Withdrawal by Subject|5|||
146801047|NCT01574716|529445177|FG004|Part 2|Withdrawal by Subject|4|||
146801048|NCT01574716|529445173|FG000|Part 2|Brain metastases|0|||
146801049|NCT01574716|529445174|FG001|Part 2|Brain metastases|0|||
146801050|NCT01574716|529445175|FG002|Part 2|Brain metastases|0|||
146801051|NCT01574716|529445176|FG003|Part 2|Brain metastases|1|||
146801052|NCT01574716|529445177|FG004|Part 2|Brain metastases|0|||
146801053|NCT01574716|529445173|FG000|Part 2|Lost to Follow-up|0|||
146801054|NCT01574716|529445174|FG001|Part 2|Lost to Follow-up|0|||
146801055|NCT01574716|529445175|FG002|Part 2|Lost to Follow-up|0|||
146801056|NCT01574716|529445176|FG003|Part 2|Lost to Follow-up|3|||
146801057|NCT01574716|529445177|FG004|Part 2|Lost to Follow-up|0|||
146801058|NCT01268306|529445181|FG000|Overall Study|Lost to Follow-up|1|||
146801059|NCT03709706|529445182|FG000|Overall Study|Adverse Event|0|||
146801060|NCT03709706|529445183|FG001|Overall Study|Adverse Event|1|||
146801061|NCT03709706|529445182|FG000|Overall Study|Physician Decision|14|||
146801062|NCT03709706|529445183|FG001|Overall Study|Physician Decision|8|||
146801063|NCT03709706|529445182|FG000|Overall Study|Withdrawal by Subject|2|||
146801064|NCT03709706|529445183|FG001|Overall Study|Withdrawal by Subject|1|||
146801065|NCT03709706|529445182|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
146801066|NCT03709706|529445183|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
146801067|NCT01105975|529445184|FG000|Overall Study|Adverse Event|2|||
146801068|NCT01105975|529445185|FG001|Overall Study|Adverse Event|1|||
146801069|NCT01105975|529445186|FG002|Overall Study|Adverse Event|5|||
146801070|NCT01105975|529445187|FG003|Overall Study|Adverse Event|1|||
146801071|NCT01105975|529445188|FG004|Overall Study|Adverse Event|0|||
146801072|NCT01105975|529445189|FG005|Overall Study|Adverse Event|1|||
146801073|NCT01105975|529445190|FG006|Overall Study|Adverse Event|2|||
146801074|NCT01105975|529445191|FG007|Overall Study|Adverse Event|4|||
146801075|NCT01105975|529445192|FG008|Overall Study|Adverse Event|1|||
146801076|NCT01105975|529445193|FG009|Overall Study|Adverse Event|4|||
146983460|NCT02711956|530101878|FG004|Overall Study|Radiographic progression|1|||
146983461|NCT02711956|530101879|FG005|Overall Study|Radiographic progression|0|||
146983462|NCT02711956|530101880|FG006|Overall Study|Radiographic progression|0|||
146983463|NCT02711956|530101881|FG007|Overall Study|Radiographic progression|0|||
146801077|NCT01105975|529445184|FG000|Overall Study|Withdrawal by Subject|2|||
146941348|NCT02709109|529943382|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
146941349|NCT02709109|529943383|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
146941350|NCT02709109|529943384|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
146941351|NCT02709109|529943385|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
146941352|NCT02709109|529943382|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
146941353|NCT02709109|529943383|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
146941354|NCT02709109|529943384|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
146941355|NCT02709109|529943385|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
146941356|NCT02709109|529943382|FG000|Treatment Period 2 (28 Days)|Other|0|||
146941357|NCT02709109|529943383|FG001|Treatment Period 2 (28 Days)|Other|0|||
146941358|NCT02709109|529943384|FG002|Treatment Period 2 (28 Days)|Other|1|||
146941359|NCT02709109|529943385|FG003|Treatment Period 2 (28 Days)|Other|0|||
146941360|NCT01928082|529943387|FG000|Overall Study|Study terminated.|1|||
146941361|NCT01815580|529943389|FG000|Overall Study|Lost to Follow-up|4|||
146941362|NCT01815580|529943390|FG001|Overall Study|Lost to Follow-up|7|||
146941363|NCT01815580|529943389|FG000|Overall Study|Withdrawal by Subject|3|||
146941364|NCT01815580|529943390|FG001|Overall Study|Withdrawal by Subject|4|||
146941365|NCT01815580|529943389|FG000|Overall Study|Excluded from analysis|5|||
146941366|NCT01815580|529943390|FG001|Overall Study|Excluded from analysis|4|||
146941367|NCT01015820|529943391|FG000|Overall Study|Suboptimal measurements|1|||
146941368|NCT01015820|529943392|FG001|Overall Study|Suboptimal measurements|0|||
146941369|NCT01176240|529943395|FG000|Study 306A|Lack of Efficacy|2|||
146941370|NCT01176240|529943396|FG001|Study 306A|Lack of Efficacy|1|||
146941371|NCT01176240|529943395|FG000|Study 306A|Protocol Violation|0|||
146941372|NCT01176240|529943396|FG001|Study 306A|Protocol Violation|1|||
146941373|NCT01176240|529943395|FG000|Study 306A|Withdrawal by Subject|0|||
146941374|NCT01176240|529943396|FG001|Study 306A|Withdrawal by Subject|1|||
146941375|NCT01176240|529943395|FG000|Study 306A|Stop due to diverse problems|1|||
146941376|NCT01176240|529943396|FG001|Study 306A|Stop due to diverse problems|0|||
146941377|NCT01176240|529943395|FG000|Study 306B|Lack of Efficacy|5|||
146941378|NCT01176240|529943396|FG001|Study 306B|Lack of Efficacy|3|||
146941379|NCT01176240|529943395|FG000|Study 306B|Adverse Event|10|||
146941380|NCT01176240|529943396|FG001|Study 306B|Adverse Event|5|||
146941381|NCT01176240|529943395|FG000|Study 306B|Protocol Violation|2|||
146941382|NCT01176240|529943396|FG001|Study 306B|Protocol Violation|3|||
146941383|NCT01176240|529943395|FG000|Study 306B|Withdrawal by Subject|4|||
146941384|NCT01176240|529943396|FG001|Study 306B|Withdrawal by Subject|1|||
146941385|NCT01176240|529943395|FG000|Study 306B|Physician Decision|2|||
146941386|NCT01176240|529943396|FG001|Study 306B|Physician Decision|1|||
146941387|NCT01176240|529943395|FG000|Study 306B|Supine Hypertension|1|||
146941388|NCT01176240|529943396|FG001|Study 306B|Supine Hypertension|2|||
146941389|NCT01176240|529943395|FG000|Study 306B|Lost to Follow-up|0|||
146941390|NCT01176240|529943396|FG001|Study 306B|Lost to Follow-up|1|||
146941391|NCT01176240|529943395|FG000|Study 306B|withdrew prior to dosing|2|||
146941392|NCT01176240|529943396|FG001|Study 306B|withdrew prior to dosing|1|||
146941393|NCT02650895|529943402|FG000|Overall Study|Withdrawal by Subject|0|||
146941394|NCT02650895|529943403|FG001|Overall Study|Withdrawal by Subject|1|||
146941395|NCT02650895|529943404|FG002|Overall Study|Withdrawal by Subject|0|||
146941396|NCT02650895|529943405|FG003|Overall Study|Withdrawal by Subject|0|||
146941397|NCT02650895|529943406|FG004|Overall Study|Withdrawal by Subject|0|||
146941398|NCT02650895|529943407|FG005|Overall Study|Withdrawal by Subject|0|||
146941399|NCT03906136|529945880|FG000|Overall Study|Adverse Event|1|||
146941400|NCT03906136|529945881|FG001|Overall Study|Adverse Event|0|||
146941401|NCT03906136|529945880|FG000|Overall Study|Lost to Follow-up|7|||
146983464|NCT02711956|530101882|FG008|Overall Study|Radiographic progression|2|||
146983465|NCT02711956|530101883|FG009|Overall Study|Radiographic progression|1|||
146801078|NCT01105975|529445185|FG001|Overall Study|Withdrawal by Subject|2|||
146801079|NCT01105975|529445186|FG002|Overall Study|Withdrawal by Subject|2|||
146941402|NCT03906136|529945881|FG001|Overall Study|Lost to Follow-up|4|||
146941403|NCT03906136|529945880|FG000|Overall Study|Physician Decision|1|||
146941404|NCT03906136|529945881|FG001|Overall Study|Physician Decision|0|||
146941405|NCT03906136|529945880|FG000|Overall Study|Withdrawal by Subject|3|||
146941406|NCT03906136|529945881|FG001|Overall Study|Withdrawal by Subject|7|||
146941407|NCT02371980|529945890|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
146941408|NCT02371980|529945891|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
146941409|NCT02371980|529945892|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
146941410|NCT02371980|529945893|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
146941411|NCT02371980|529945894|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
146941412|NCT02371980|529945890|FG000|Open-label Period|Significant Protocol Deviation|19|||
146941413|NCT02371980|529945891|FG001|Open-label Period|Significant Protocol Deviation|0|||
146801080|NCT01105975|529445187|FG003|Overall Study|Withdrawal by Subject|0|||
146801081|NCT01105975|529445188|FG004|Overall Study|Withdrawal by Subject|4|||
146801082|NCT01105975|529445189|FG005|Overall Study|Withdrawal by Subject|1|||
146801083|NCT01105975|529445190|FG006|Overall Study|Withdrawal by Subject|2|||
146801084|NCT01105975|529445191|FG007|Overall Study|Withdrawal by Subject|1|||
146801085|NCT01105975|529445192|FG008|Overall Study|Withdrawal by Subject|0|||
146801086|NCT01105975|529445193|FG009|Overall Study|Withdrawal by Subject|3|||
146983466|NCT02711956|530101884|FG010|Overall Study|Radiographic progression|0|||
146983467|NCT02711956|530101885|FG011|Overall Study|Radiographic progression|5|||
146983468|NCT02711956|530101886|FG012|Overall Study|Radiographic progression|3|||
146801087|NCT01105975|529445184|FG000|Overall Study|Lost to Follow-up|1|||
146801088|NCT01105975|529445185|FG001|Overall Study|Lost to Follow-up|0|||
146801089|NCT01105975|529445186|FG002|Overall Study|Lost to Follow-up|0|||
146801090|NCT01105975|529445187|FG003|Overall Study|Lost to Follow-up|1|||
146801091|NCT01105975|529445188|FG004|Overall Study|Lost to Follow-up|1|||
146801092|NCT01105975|529445189|FG005|Overall Study|Lost to Follow-up|0|||
146801093|NCT01105975|529445190|FG006|Overall Study|Lost to Follow-up|0|||
146801094|NCT01105975|529445191|FG007|Overall Study|Lost to Follow-up|0|||
146801095|NCT01105975|529445192|FG008|Overall Study|Lost to Follow-up|1|||
146801096|NCT01105975|529445193|FG009|Overall Study|Lost to Follow-up|0|||
146801097|NCT01105975|529445184|FG000|Overall Study|Physician Decision|0|||
146801098|NCT01105975|529445185|FG001|Overall Study|Physician Decision|0|||
146801099|NCT01105975|529445186|FG002|Overall Study|Physician Decision|0|||
146801100|NCT01105975|529445187|FG003|Overall Study|Physician Decision|0|||
146801101|NCT01105975|529445188|FG004|Overall Study|Physician Decision|0|||
146801102|NCT01105975|529445189|FG005|Overall Study|Physician Decision|0|||
146801103|NCT01105975|529445190|FG006|Overall Study|Physician Decision|2|||
146801104|NCT01105975|529445191|FG007|Overall Study|Physician Decision|0|||
146801105|NCT01105975|529445192|FG008|Overall Study|Physician Decision|0|||
146801106|NCT01105975|529445193|FG009|Overall Study|Physician Decision|0|||
146801107|NCT01105975|529445184|FG000|Overall Study|Protocol Violation|0|||
146801108|NCT01105975|529445185|FG001|Overall Study|Protocol Violation|2|||
146801109|NCT01105975|529445186|FG002|Overall Study|Protocol Violation|2|||
146801110|NCT01105975|529445187|FG003|Overall Study|Protocol Violation|0|||
146801111|NCT01105975|529445188|FG004|Overall Study|Protocol Violation|1|||
146801112|NCT01105975|529445189|FG005|Overall Study|Protocol Violation|1|||
146801113|NCT01105975|529445190|FG006|Overall Study|Protocol Violation|1|||
146801114|NCT01105975|529445191|FG007|Overall Study|Protocol Violation|1|||
146801115|NCT01105975|529445192|FG008|Overall Study|Protocol Violation|2|||
146801116|NCT01105975|529445193|FG009|Overall Study|Protocol Violation|2|||
146801117|NCT01105975|529445184|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
146801118|NCT01105975|529445185|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
146801119|NCT01105975|529445186|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
146801120|NCT01105975|529445187|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
146801121|NCT01105975|529445188|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
146801122|NCT01105975|529445189|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
146801123|NCT01105975|529445190|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
146801124|NCT01105975|529445191|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
146801125|NCT01105975|529445192|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
146801126|NCT01105975|529445193|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
146801127|NCT02502526|529445195|FG000|Overall Study|Lost to Follow-up|2|||
146801128|NCT02502526|529445196|FG001|Overall Study|Lost to Follow-up|2|||
146801129|NCT02502526|529445197|FG002|Overall Study|Lost to Follow-up|3|||
146801130|NCT02502526|529445195|FG000|Overall Study|Withdrawal by Subject|0|||
146801131|NCT02502526|529445196|FG001|Overall Study|Withdrawal by Subject|1|||
146801132|NCT02502526|529445197|FG002|Overall Study|Withdrawal by Subject|1|||
146801133|NCT02502526|529445195|FG000|Overall Study|Disqualified due to cataract grading|0|||
146801134|NCT02502526|529445196|FG001|Overall Study|Disqualified due to cataract grading|0|||
146801135|NCT02502526|529445197|FG002|Overall Study|Disqualified due to cataract grading|1|||
146801136|NCT02502526|529445195|FG000|Overall Study|Enrollment suspension|4|||
146801137|NCT02502526|529445196|FG001|Overall Study|Enrollment suspension|1|||
146801138|NCT02502526|529445197|FG002|Overall Study|Enrollment suspension|1|||
146801139|NCT00640159|529445200|FG000|Overall Study|Lost to Follow-up|2|||
146801140|NCT00112359|529445201|FG000|Overall Study|Unrelated adverse event|16|||
146801141|NCT00112359|529445202|FG001|Overall Study|Unrelated adverse event|8|||
146801142|NCT00112359|529445201|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
146801143|NCT00112359|529445202|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
146801144|NCT00112359|529445201|FG000|Overall Study|Related adverse event|5|||
146801145|NCT00112359|529445202|FG001|Overall Study|Related adverse event|3|||
146801146|NCT00112359|529445201|FG000|Overall Study|Lost to Follow-up|0|||
146801147|NCT00112359|529445202|FG001|Overall Study|Lost to Follow-up|1|||
146801148|NCT00112359|529445201|FG000|Overall Study|Personal/administrative|1|||
146801149|NCT00112359|529445202|FG001|Overall Study|Personal/administrative|1|||
146801150|NCT00112359|529445201|FG000|Overall Study|Other|3|||
146801151|NCT00112359|529445202|FG001|Overall Study|Other|0|||
146801152|NCT01218009|529445203|FG000|Overall Study|Protocol Violation|2|||
146801153|NCT01218009|529445204|FG001|Overall Study|Protocol Violation|1|||
146801154|NCT01218009|529445203|FG000|Overall Study|Withdrawal by Subject|3|||
146801155|NCT01218009|529445204|FG001|Overall Study|Withdrawal by Subject|1|||
146801156|NCT01218009|529445203|FG000|Overall Study|Sponsor terminated study|161|||
146801157|NCT01218009|529445204|FG001|Overall Study|Sponsor terminated study|163|||
146801158|NCT03170882|529445205|FG000|Overall Study|Death|17|||
146801159|NCT03170882|529445206|FG001|Overall Study|Death|29|||
146801160|NCT03170882|529445205|FG000|Overall Study|Lost to Follow-up|0|||
146801161|NCT03170882|529445206|FG001|Overall Study|Lost to Follow-up|1|||
146620838|NCT02586623|528783447|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
146620839|NCT02586623|528783445|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
146620840|NCT02586623|528783446|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
146620841|NCT02586623|528783447|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
146620842|NCT02586623|528783445|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
146620843|NCT02586623|528783446|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
146620844|NCT02586623|528783447|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
146620845|NCT02586623|528783445|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
146620846|NCT02586623|528783446|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
146941414|NCT02371980|529945892|FG002|Open-label Period|Significant Protocol Deviation|0|||
146941415|NCT02371980|529945893|FG003|Open-label Period|Significant Protocol Deviation|0|||
146941416|NCT02371980|529945894|FG004|Open-label Period|Significant Protocol Deviation|0|||
146941417|NCT02371980|529945890|FG000|Open-label Period|Noncompliance with Study Drug|10|||
146941418|NCT02371980|529945891|FG001|Open-label Period|Noncompliance with Study Drug|0|||
146941419|NCT02371980|529945892|FG002|Open-label Period|Noncompliance with Study Drug|0|||
146941420|NCT02371980|529945893|FG003|Open-label Period|Noncompliance with Study Drug|0|||
146801162|NCT03170882|529445205|FG000|Overall Study|Withdrawal by Subject|4|||
146801163|NCT03170882|529445206|FG001|Overall Study|Withdrawal by Subject|7|||
146801164|NCT03170882|529445205|FG000|Overall Study|Reason not Specified|28|||
146801165|NCT03170882|529445206|FG001|Overall Study|Reason not Specified|36|||
146801166|NCT05521516|529445212|FG000|Overall Study|Withdrawal by Subject|1|||
146801167|NCT05521516|529445213|FG001|Overall Study|Withdrawal by Subject|1|||
146801168|NCT04305327|529445214|FG000|Overall Study|Study early termination|2|||
146801169|NCT04305327|529445215|FG001|Overall Study|Study early termination|5|||
146801170|NCT04305327|529445216|FG002|Overall Study|Study early termination|2|||
146801171|NCT04305327|529445217|FG003|Overall Study|Study early termination|2|||
146801172|NCT04305327|529445214|FG000|Overall Study|Withdrawal by Subject|0|||
146801173|NCT04305327|529445215|FG001|Overall Study|Withdrawal by Subject|1|||
146801174|NCT04305327|529445216|FG002|Overall Study|Withdrawal by Subject|0|||
146801175|NCT04305327|529445217|FG003|Overall Study|Withdrawal by Subject|0|||
146801176|NCT00115934|529445218|FG000|Overall Study|Lost to Follow-up|1|||
146801177|NCT00115934|529445219|FG001|Overall Study|Lost to Follow-up|0|||
146801178|NCT00115934|529445218|FG000|Overall Study|Did not receive intervention|3|||
146801179|NCT00115934|529445219|FG001|Overall Study|Did not receive intervention|2|||
146801180|NCT00747565|529445220|FG000|Overall Study|Withdrawal by Subject|10|||
146801181|NCT00747565|529445221|FG001|Overall Study|Withdrawal by Subject|6|||
146801182|NCT00747565|529445220|FG000|Overall Study|Lost to Follow-up|4|||
146801183|NCT00747565|529445221|FG001|Overall Study|Lost to Follow-up|1|||
146801184|NCT04882917|529445229|FG000|Overall Study|Adverse Event|0|||
146801185|NCT04882917|529445230|FG001|Overall Study|Adverse Event|1|||
146801186|NCT04882917|529445231|FG002|Overall Study|Adverse Event|2|||
146801187|NCT04882917|529445232|FG003|Overall Study|Adverse Event|2|||
146801188|NCT04882917|529445229|FG000|Overall Study|Withdrawal by Subject|1|||
146801189|NCT04882917|529445230|FG001|Overall Study|Withdrawal by Subject|0|||
146801190|NCT04882917|529445231|FG002|Overall Study|Withdrawal by Subject|2|||
146801191|NCT04882917|529445232|FG003|Overall Study|Withdrawal by Subject|1|||
146801192|NCT04882917|529445229|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
146801193|NCT04882917|529445230|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
146801194|NCT04882917|529445231|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
146801195|NCT04882917|529445232|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
146801196|NCT00227266|529445233|FG000|Overall Study|Withdrawal by Subject|0|||
146801197|NCT00227266|529445234|FG001|Overall Study|Withdrawal by Subject|0|||
146801198|NCT00227266|529445235|FG002|Overall Study|Withdrawal by Subject|1|||
146801199|NCT00227266|529445233|FG000|Overall Study|Protocol Violation|1|||
146801200|NCT00227266|529445234|FG001|Overall Study|Protocol Violation|0|||
146801201|NCT00227266|529445235|FG002|Overall Study|Protocol Violation|1|||
146801202|NCT00227266|529445233|FG000|Overall Study|Excessive weight gain|0|||
146801203|NCT00227266|529445234|FG001|Overall Study|Excessive weight gain|0|||
146801204|NCT00227266|529445235|FG002|Overall Study|Excessive weight gain|2|||
146801205|NCT00210106|529446205|FG000|Overall Study|Death|1|||
146801206|NCT00210106|529446205|FG000|Overall Study|Protocol Violation|13|||
146801207|NCT03876457|529446209|FG000|Overall Study|Lost to Follow-up|1|||
146801208|NCT03876457|529446210|FG001|Overall Study|Lost to Follow-up|3|||
146801209|NCT02422615|529446211|FG000|Treatment Period|Progressive disease|314|||
146801210|NCT02422615|529446212|FG001|Treatment Period|Progressive disease|200|||
146801211|NCT02422615|529446211|FG000|Treatment Period|Adverse Event|51|||
146801212|NCT02422615|529446212|FG001|Treatment Period|Adverse Event|9|||
146801213|NCT02422615|529446211|FG000|Treatment Period|Physician Decision|32|||
146801214|NCT02422615|529446212|FG001|Treatment Period|Physician Decision|8|||
146801215|NCT02422615|529446211|FG000|Treatment Period|Subject/guardian decision|38|||
146801216|NCT02422615|529446212|FG001|Treatment Period|Subject/guardian decision|8|||
146801217|NCT02422615|529446211|FG000|Treatment Period|Death|2|||
146801218|NCT02422615|529446212|FG001|Treatment Period|Death|1|||
146801219|NCT02422615|529446211|FG000|Treatment Period|Technical problems|0|||
146801220|NCT02422615|529446212|FG001|Treatment Period|Technical problems|1|||
146801221|NCT02422615|529446211|FG000|Treatment Period|Protocol deviation|1|||
146801222|NCT02422615|529446212|FG001|Treatment Period|Protocol deviation|1|||
146801223|NCT02422615|529446211|FG000|Treatment Period|Study terminated as per protocol|46|||
146801224|NCT02422615|529446212|FG001|Treatment Period|Study terminated as per protocol|14|||
146801225|NCT02422615|529446211|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
146801226|NCT02422615|529446212|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146801227|NCT02422615|529446211|FG000|Post-treatment Efficacy Follow-up|Death|2|||
146801228|NCT02422615|529446212|FG001|Post-treatment Efficacy Follow-up|Death|1|||
146801229|NCT02422615|529446211|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
146801230|NCT02422615|529446212|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
146801231|NCT02422615|529446211|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
146801232|NCT02422615|529446212|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
146801233|NCT02422615|529446211|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
146801234|NCT02422615|529446212|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
146801235|NCT02422615|529446211|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
146801236|NCT02422615|529446212|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
146801237|NCT01036724|529446213|FG000|Overall Study|Adverse Event|1|||
146801238|NCT01036724|529446214|FG001|Overall Study|Adverse Event|2|||
146801239|NCT01036724|529446213|FG000|Overall Study|Lack of Efficacy|1|||
146801240|NCT01036724|529446214|FG001|Overall Study|Lack of Efficacy|1|||
146801241|NCT01036724|529446213|FG000|Overall Study|Protocol Violation|4|||
146801242|NCT01036724|529446214|FG001|Overall Study|Protocol Violation|5|||
146801243|NCT00945321|529446216|FG000|Period 1|Adverse Event|0|||
146801244|NCT00945321|529446217|FG001|Period 1|Adverse Event|0|||
146801245|NCT00945321|529446218|FG002|Period 1|Adverse Event|0|||
146801246|NCT00945321|529446219|FG003|Period 1|Adverse Event|0|||
146801247|NCT00945321|529446220|FG004|Period 1|Adverse Event|1|||
146801248|NCT00945321|529446221|FG005|Period 1|Adverse Event|0|||
146801249|NCT00945321|529446216|FG000|Period 4|Lost to Follow-up|0|||
146801250|NCT00945321|529446217|FG001|Period 4|Lost to Follow-up|0|||
146801251|NCT00945321|529446218|FG002|Period 4|Lost to Follow-up|0|||
146801252|NCT00945321|529446219|FG003|Period 4|Lost to Follow-up|0|||
146801253|NCT00945321|529446220|FG004|Period 4|Lost to Follow-up|0|||
146801254|NCT00945321|529446221|FG005|Period 4|Lost to Follow-up|1|||
146801255|NCT02438137|529446222|FG000|Overall Study|Lost to Follow-up|3|||
146801256|NCT02438137|529446223|FG001|Overall Study|Lost to Follow-up|2|||
146801257|NCT02438137|529446222|FG000|Overall Study|Adverse Event|1|||
146801258|NCT02438137|529446223|FG001|Overall Study|Adverse Event|0|||
146801259|NCT02438137|529446222|FG000|Overall Study|Withdrawal by Subject|4|||
146801260|NCT02438137|529446223|FG001|Overall Study|Withdrawal by Subject|3|||
146801261|NCT02438137|529446222|FG000|Overall Study|Physician Decision|0|||
146801262|NCT02438137|529446223|FG001|Overall Study|Physician Decision|1|||
146801263|NCT00692913|529446224|FG000|Overall Study|Adverse Event|8|||
146801264|NCT00692913|529446225|FG001|Overall Study|Adverse Event|4|||
146801265|NCT00692913|529446224|FG000|Overall Study|Lost to Follow-up|3|||
146801266|NCT00692913|529446225|FG001|Overall Study|Lost to Follow-up|5|||
146801267|NCT00692913|529446224|FG000|Overall Study|Physician Decision|2|||
146801268|NCT00692913|529446225|FG001|Overall Study|Physician Decision|0|||
146801269|NCT00692913|529446224|FG000|Overall Study|Protocol Violation|1|||
146801270|NCT00692913|529446225|FG001|Overall Study|Protocol Violation|1|||
146801271|NCT00692913|529446224|FG000|Overall Study|Withdrawal by Subject|15|||
146801272|NCT00692913|529446225|FG001|Overall Study|Withdrawal by Subject|20|||
146801273|NCT04017611|529446226|FG000|Overall Study|Withdrawn prior to completion|1|||
146801274|NCT02291913|529446227|FG000|Overall Study|Progressive Disease|32|||
146801275|NCT02291913|529446227|FG000|Overall Study|Adverse Event|11|||
146801276|NCT02291913|529446227|FG000|Overall Study|Death|2|||
146801277|NCT02291913|529446227|FG000|Overall Study|Physician Decision|1|||
146801278|NCT02291913|529446227|FG000|Overall Study|Withdrawal by Subject|1|||
146801279|NCT02291913|529446227|FG000|Overall Study|Protocol Violation|1|||
146801280|NCT01637402|529446236|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
146801281|NCT01637402|529446237|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
146801282|NCT01637402|529446236|FG000|Standard Dose Regimen|Adverse Event|1|||
146801283|NCT01637402|529446237|FG001|Standard Dose Regimen|Adverse Event|0|||
146801284|NCT01637402|529446236|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
146801285|NCT01637402|529446237|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
146941421|NCT02371980|529945894|FG004|Open-label Period|Noncompliance with Study Drug|0|||
146941422|NCT02371980|529945890|FG000|Open-label Period|Lost to Follow-up|55|||
146941423|NCT02371980|529945891|FG001|Open-label Period|Lost to Follow-up|0|||
146983469|NCT02711956|530101887|FG013|Overall Study|Radiographic progression|0|||
146983470|NCT02711956|530101888|FG014|Overall Study|Radiographic progression|1|||
146983471|NCT02711956|530101874|FG000|Overall Study|PSA progression with clinical progression|0|||
146983472|NCT02711956|530101875|FG001|Overall Study|PSA progression with clinical progression|0|||
146983473|NCT02711956|530101876|FG002|Overall Study|PSA progression with clinical progression|0|||
146983474|NCT02711956|530101877|FG003|Overall Study|PSA progression with clinical progression|0|||
146983475|NCT02711956|530101878|FG004|Overall Study|PSA progression with clinical progression|1|||
146983476|NCT02711956|530101879|FG005|Overall Study|PSA progression with clinical progression|0|||
146983477|NCT02711956|530101880|FG006|Overall Study|PSA progression with clinical progression|0|||
146983478|NCT02711956|530101881|FG007|Overall Study|PSA progression with clinical progression|0|||
146983479|NCT02711956|530101882|FG008|Overall Study|PSA progression with clinical progression|0|||
146983480|NCT02711956|530101883|FG009|Overall Study|PSA progression with clinical progression|0|||
146983481|NCT02711956|530101884|FG010|Overall Study|PSA progression with clinical progression|0|||
146983482|NCT02711956|530101885|FG011|Overall Study|PSA progression with clinical progression|0|||
146983483|NCT02711956|530101886|FG012|Overall Study|PSA progression with clinical progression|1|||
146983484|NCT02711956|530101887|FG013|Overall Study|PSA progression with clinical progression|1|||
146983485|NCT02711956|530101888|FG014|Overall Study|PSA progression with clinical progression|0|||
146983486|NCT02711956|530101874|FG000|Overall Study|PSA progression with radiographic progression|0|||
146983487|NCT02711956|530101875|FG001|Overall Study|PSA progression with radiographic progression|1|||
146983488|NCT02711956|530101876|FG002|Overall Study|PSA progression with radiographic progression|0|||
146983489|NCT02711956|530101877|FG003|Overall Study|PSA progression with radiographic progression|0|||
146983490|NCT02711956|530101878|FG004|Overall Study|PSA progression with radiographic progression|0|||
146983491|NCT02711956|530101879|FG005|Overall Study|PSA progression with radiographic progression|2|||
146983492|NCT02711956|530101880|FG006|Overall Study|PSA progression with radiographic progression|2|||
146983493|NCT02711956|530101881|FG007|Overall Study|PSA progression with radiographic progression|1|||
146983494|NCT02711956|530101882|FG008|Overall Study|PSA progression with radiographic progression|0|||
146983495|NCT02711956|530101883|FG009|Overall Study|PSA progression with radiographic progression|1|||
146983496|NCT02711956|530101884|FG010|Overall Study|PSA progression with radiographic progression|0|||
146983497|NCT02711956|530101885|FG011|Overall Study|PSA progression with radiographic progression|1|||
146983498|NCT02711956|530101886|FG012|Overall Study|PSA progression with radiographic progression|2|||
146983499|NCT02711956|530101887|FG013|Overall Study|PSA progression with radiographic progression|3|||
146983500|NCT02711956|530101888|FG014|Overall Study|PSA progression with radiographic progression|3|||
146983501|NCT05487456|530101889|FG000|Overall Study|Withdrawal by Subject|0|||
146983502|NCT05487456|530101890|FG001|Overall Study|Withdrawal by Subject|0|||
146983503|NCT05487456|530101891|FG002|Overall Study|Withdrawal by Subject|1|||
146983504|NCT05487456|530101892|FG003|Overall Study|Withdrawal by Subject|0|||
146983505|NCT01625377|530101895|FG000|Overall Study|Death|1|||
146983506|NCT01625377|530101896|FG001|Overall Study|Death|1|||
146983507|NCT01625377|530101895|FG000|Overall Study|Administrative Problem|1|||
146983508|NCT01625377|530101896|FG001|Overall Study|Administrative Problem|1|||
146983509|NCT01625377|530101895|FG000|Overall Study|Protocol Violation|0|||
146983510|NCT01625377|530101896|FG001|Overall Study|Protocol Violation|3|||
146983511|NCT01625377|530101895|FG000|Overall Study|Adverse Event|3|||
146983512|NCT01625377|530101896|FG001|Overall Study|Adverse Event|16|||
146983513|NCT01625377|530101895|FG000|Overall Study|Graft loss|1|||
146983514|NCT01625377|530101896|FG001|Overall Study|Graft loss|0|||
146983515|NCT01625377|530101895|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146983516|NCT01625377|530101896|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146983517|NCT01625377|530101895|FG000|Overall Study|Abnormal laboratory values|1|||
146983518|NCT01625377|530101896|FG001|Overall Study|Abnormal laboratory values|0|||
146983519|NCT02043366|530101897|FG000|Overall Study|Lost to Follow-up|2|||
146983520|NCT02043366|530101898|FG001|Overall Study|Lost to Follow-up|2|||
146983521|NCT02043366|530101899|FG002|Overall Study|Lost to Follow-up|2|||
146983522|NCT02043366|530101900|FG003|Overall Study|Lost to Follow-up|2|||
146983523|NCT02043366|530101901|FG004|Overall Study|Lost to Follow-up|2|||
146983524|NCT02043366|530101902|FG005|Overall Study|Lost to Follow-up|2|||
146983525|NCT01489956|530101905|FG000|Overall Study|Lost to Follow-up|1|||
146983526|NCT01489956|530101906|FG001|Overall Study|Lost to Follow-up|0|||
146983527|NCT01489956|530101907|FG002|Overall Study|Lost to Follow-up|0|||
146983528|NCT01489956|530101905|FG000|Overall Study|Withdrawal by Subject|0|||
146983529|NCT01489956|530101906|FG001|Overall Study|Withdrawal by Subject|0|||
146983530|NCT01489956|530101907|FG002|Overall Study|Withdrawal by Subject|1|||
146983531|NCT00718159|530101910|FG000|Overall Study|Progressive Disease|3|||
146983532|NCT00718159|530101911|FG001|Overall Study|Progressive Disease|3|||
146983533|NCT00718159|530101912|FG002|Overall Study|Progressive Disease|2|||
146983534|NCT00718159|530101913|FG003|Overall Study|Progressive Disease|0|||
146983535|NCT00718159|530101914|FG004|Overall Study|Progressive Disease|6|||
146983536|NCT00718159|530101915|FG005|Overall Study|Progressive Disease|0|||
146983537|NCT00718159|530101916|FG006|Overall Study|Progressive Disease|0|||
146983538|NCT00718159|530101910|FG000|Overall Study|Death due to Adverse Event|0|||
146983539|NCT00718159|530101911|FG001|Overall Study|Death due to Adverse Event|0|||
146983540|NCT00718159|530101912|FG002|Overall Study|Death due to Adverse Event|0|||
146983541|NCT00718159|530101913|FG003|Overall Study|Death due to Adverse Event|2|||
146983542|NCT00718159|530101914|FG004|Overall Study|Death due to Adverse Event|2|||
146983543|NCT00718159|530101915|FG005|Overall Study|Death due to Adverse Event|0|||
146983544|NCT00718159|530101916|FG006|Overall Study|Death due to Adverse Event|0|||
146983545|NCT00718159|530101910|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
146983546|NCT00718159|530101911|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
146983547|NCT00718159|530101912|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
146983548|NCT00718159|530101913|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
146983549|NCT00718159|530101914|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
146983550|NCT00718159|530101915|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
146983551|NCT00718159|530101916|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
146983552|NCT00718159|530101910|FG000|Overall Study|Investigator Decision|0|||
146983553|NCT00718159|530101911|FG001|Overall Study|Investigator Decision|0|||
146983554|NCT00718159|530101912|FG002|Overall Study|Investigator Decision|0|||
146983555|NCT00718159|530101913|FG003|Overall Study|Investigator Decision|0|||
146983556|NCT00718159|530101914|FG004|Overall Study|Investigator Decision|0|||
146983557|NCT00718159|530101915|FG005|Overall Study|Investigator Decision|1|||
146983558|NCT00718159|530101916|FG006|Overall Study|Investigator Decision|1|||
146983559|NCT00782509|530101917|FG000|Overall Study|Adverse Event|20|||
146983560|NCT00782509|530101918|FG001|Overall Study|Adverse Event|10|||
146983561|NCT00782509|530101919|FG002|Overall Study|Adverse Event|20|||
146983562|NCT00782509|530101917|FG000|Overall Study|Lost to Follow-up|1|||
146983563|NCT00782509|530101918|FG001|Overall Study|Lost to Follow-up|2|||
146983564|NCT00782509|530101919|FG002|Overall Study|Lost to Follow-up|3|||
146983565|NCT00782509|530101917|FG000|Overall Study|Withdrawal by Subject|3|||
146983566|NCT00782509|530101918|FG001|Overall Study|Withdrawal by Subject|5|||
146983567|NCT00782509|530101919|FG002|Overall Study|Withdrawal by Subject|8|||
146983568|NCT00782509|530101917|FG000|Overall Study|Non compliance with protocol|2|||
146983569|NCT00782509|530101918|FG001|Overall Study|Non compliance with protocol|0|||
146983570|NCT00782509|530101919|FG002|Overall Study|Non compliance with protocol|0|||
146983571|NCT00782509|530101917|FG000|Overall Study|Other reasons not stated above|5|||
146983572|NCT00782509|530101918|FG001|Overall Study|Other reasons not stated above|2|||
146983573|NCT00782509|530101919|FG002|Overall Study|Other reasons not stated above|3|||
146983574|NCT00782509|530101917|FG000|Overall Study|Lack of Efficacy|10|||
146983575|NCT00782509|530101918|FG001|Overall Study|Lack of Efficacy|5|||
146983576|NCT00782509|530101919|FG002|Overall Study|Lack of Efficacy|2|||
146983577|NCT00175019|530101920|FG000|Overall Study|Adverse Event|54|||
146983578|NCT00175019|530101921|FG001|Overall Study|Adverse Event|22|||
146983579|NCT00175019|530101922|FG002|Overall Study|Adverse Event|2|||
146983580|NCT00175019|530101920|FG000|Overall Study|Protocol Violation|6|||
146983581|NCT00175019|530101921|FG001|Overall Study|Protocol Violation|3|||
146983582|NCT00175019|530101922|FG002|Overall Study|Protocol Violation|3|||
146983583|NCT00175019|530101920|FG000|Overall Study|Lost to Follow-up|42|||
146983584|NCT00175019|530101921|FG001|Overall Study|Lost to Follow-up|39|||
146983585|NCT00175019|530101922|FG002|Overall Study|Lost to Follow-up|9|||
146983586|NCT00175019|530101920|FG000|Overall Study|Did not continue under Amendment 4|1|||
146983587|NCT00175019|530101921|FG001|Overall Study|Did not continue under Amendment 4|1|||
146983588|NCT00175019|530101922|FG002|Overall Study|Did not continue under Amendment 4|2|||
146983589|NCT00175019|530101920|FG000|Overall Study|Personal Reason(s)|39|||
146983590|NCT00175019|530101921|FG001|Overall Study|Personal Reason(s)|31|||
146983591|NCT00175019|530101922|FG002|Overall Study|Personal Reason(s)|8|||
146983592|NCT00175019|530101920|FG000|Overall Study|Therapeutic Failure|10|||
146801286|NCT01637402|529446236|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
146801287|NCT01637402|529446237|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
146801288|NCT01637402|529446236|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
146801289|NCT01637402|529446237|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
146801290|NCT01637402|529446236|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
146801291|NCT01637402|529446237|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
146801292|NCT04876417|529446240|FG000|Overall Study|Lost to Follow-up|5|||
146801293|NCT04876417|529446241|FG001|Overall Study|Lost to Follow-up|8|||
146801294|NCT04876417|529446242|FG002|Overall Study|Lost to Follow-up|0|||
146801295|NCT04876417|529446243|FG003|Overall Study|Lost to Follow-up|0|||
146801296|NCT04868617|529446244|FG000|Overall Study|Death|1|||
146801297|NCT04868617|529446245|FG001|Overall Study|Death|0|||
146801298|NCT04868617|529446244|FG000|Overall Study|Adverse Event|1|||
146801299|NCT04868617|529446245|FG001|Overall Study|Adverse Event|0|||
146801300|NCT04868617|529446244|FG000|Overall Study|Withdrawal by Subject|1|||
146801301|NCT04868617|529446245|FG001|Overall Study|Withdrawal by Subject|0|||
146801302|NCT04868617|529446244|FG000|Overall Study|Device deficiency|1|||
146801303|NCT04868617|529446245|FG001|Overall Study|Device deficiency|0|||
146801304|NCT01342367|529446246|FG000|Overall Study|Death|1|||
146801305|NCT01342367|529446247|FG001|Overall Study|Death|0|||
146801306|NCT01342367|529446246|FG000|Overall Study|Withdrawal by Subject|1|||
146983593|NCT00175019|530101921|FG001|Overall Study|Therapeutic Failure|38|||
146983594|NCT00175019|530101922|FG002|Overall Study|Therapeutic Failure|22|||
146983595|NCT00175019|530101920|FG000|Overall Study|Gout Flare|2|||
146801307|NCT01342367|529446247|FG001|Overall Study|Withdrawal by Subject|2|||
146801308|NCT02964741|529446248|FG000|Overall Study|Protocol Violation|1|||
146801309|NCT02964741|529446249|FG001|Overall Study|Protocol Violation|0|||
146801310|NCT02964741|529446250|FG002|Overall Study|Protocol Violation|0|||
146801311|NCT02964741|529446248|FG000|Overall Study|Withdrawal by Subject|0|||
146801312|NCT02964741|529446249|FG001|Overall Study|Withdrawal by Subject|1|||
146801313|NCT02964741|529446250|FG002|Overall Study|Withdrawal by Subject|0|||
146801314|NCT02964741|529446248|FG000|Overall Study|claustrophobia|1|||
146801315|NCT02964741|529446249|FG001|Overall Study|claustrophobia|0|||
146801316|NCT02964741|529446250|FG002|Overall Study|claustrophobia|0|||
146801317|NCT01074294|529446254|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
146801318|NCT01074294|529446255|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
146801319|NCT01074294|529446256|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
146801320|NCT01074294|529446257|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
146801321|NCT01074294|529446254|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
146801322|NCT01074294|529446255|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
146801323|NCT01074294|529446256|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
146801324|NCT01074294|529446257|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
146801325|NCT01074294|529446254|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
146801326|NCT01074294|529446255|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
146801327|NCT01074294|529446256|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
146801328|NCT01074294|529446257|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
146801329|NCT01074294|529446254|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
146801330|NCT01074294|529446255|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
146801331|NCT01074294|529446256|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
146801332|NCT01074294|529446257|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
146801333|NCT01074294|529446254|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
146801334|NCT01074294|529446255|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
146801335|NCT01074294|529446256|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
146801336|NCT01074294|529446257|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
146801337|NCT01074294|529446254|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
146801338|NCT01074294|529446255|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
146801339|NCT01074294|529446256|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
146801340|NCT01074294|529446257|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
146801341|NCT01074294|529446254|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
146801342|NCT01074294|529446255|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
146801343|NCT01074294|529446256|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
146801344|NCT01074294|529446257|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
146801345|NCT01074294|529446254|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
146801346|NCT01074294|529446255|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
146801347|NCT01074294|529446256|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
146801348|NCT01074294|529446257|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
146801349|NCT01074294|529446254|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
146801350|NCT01074294|529446255|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
146801351|NCT01074294|529446256|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
146801352|NCT01074294|529446257|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
146801353|NCT01074294|529446254|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
146801354|NCT01074294|529446255|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
146801355|NCT01074294|529446256|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
146801356|NCT01074294|529446257|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
146801357|NCT01074294|529446254|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
146801358|NCT01074294|529446255|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
146801359|NCT01074294|529446256|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
146801360|NCT01074294|529446257|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
146801361|NCT01074294|529446254|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
146801362|NCT01074294|529446255|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
146801363|NCT01074294|529446256|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
146801364|NCT01074294|529446257|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
146801365|NCT01074294|529446254|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
146801366|NCT01074294|529446255|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
146801367|NCT01074294|529446256|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
146801368|NCT01074294|529446257|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
146801369|NCT00312208|529446264|FG000|Overall Study|Adverse Event|97|||
146801370|NCT00312208|529446265|FG001|Overall Study|Adverse Event|61|||
146801371|NCT00312208|529446264|FG000|Overall Study|Protocol Violation|5|||
146801372|NCT00312208|529446265|FG001|Overall Study|Protocol Violation|3|||
146801373|NCT00312208|529446264|FG000|Overall Study|Death|2|||
146801374|NCT00312208|529446265|FG001|Overall Study|Death|1|||
146801375|NCT00312208|529446264|FG000|Overall Study|Lack of Efficacy|7|||
146801376|NCT00312208|529446265|FG001|Overall Study|Lack of Efficacy|4|||
146801377|NCT00312208|529446264|FG000|Overall Study|Lost to Follow-up|3|||
146801378|NCT00312208|529446265|FG001|Overall Study|Lost to Follow-up|5|||
146801379|NCT00312208|529446264|FG000|Overall Study|Withdrawal by Subject|53|||
146801380|NCT00312208|529446265|FG001|Overall Study|Withdrawal by Subject|42|||
146801381|NCT00312208|529446264|FG000|Overall Study|Other|5|||
146801382|NCT00312208|529446265|FG001|Overall Study|Other|7|||
146801383|NCT02284113|529446266|FG000|Overall Study|Adverse Event|1|||
146801384|NCT02284113|529446267|FG001|Overall Study|Adverse Event|0|||
146801385|NCT02284113|529446266|FG000|Overall Study|non-compliance|0|||
146801386|NCT02284113|529446267|FG001|Overall Study|non-compliance|1|||
146801387|NCT02284113|529446266|FG000|Overall Study|Withdrawal by Subject|0|||
146801388|NCT02284113|529446267|FG001|Overall Study|Withdrawal by Subject|1|||
146801389|NCT02284113|529446266|FG000|Overall Study|not provided|0|||
146801390|NCT02284113|529446267|FG001|Overall Study|not provided|1|||
146801391|NCT02284113|529446266|FG000|Overall Study|surgery cancelled|2|||
146801392|NCT02284113|529446267|FG001|Overall Study|surgery cancelled|0|||
146801393|NCT04191824|529446268|FG000|Overall Study|Death|13|||
146801394|NCT04191824|529446269|FG001|Overall Study|Death|12|||
146801395|NCT04191824|529446268|FG000|Overall Study|Lost to Follow-up|456|||
146801396|NCT04191824|529446269|FG001|Overall Study|Lost to Follow-up|435|||
146801397|NCT04191824|529446268|FG000|Overall Study|Physician Decision|2|||
146801398|NCT04191824|529446269|FG001|Overall Study|Physician Decision|1|||
146801399|NCT04191824|529446268|FG000|Overall Study|Protocol Violation|0|||
146801400|NCT04191824|529446269|FG001|Overall Study|Protocol Violation|2|||
146801401|NCT04191824|529446268|FG000|Overall Study|Withdrawal by Subject|16|||
146801402|NCT04191824|529446269|FG001|Overall Study|Withdrawal by Subject|18|||
146801403|NCT04191824|529446268|FG000|Overall Study|Early site closure|24|||
146801404|NCT04191824|529446269|FG001|Overall Study|Early site closure|22|||
146801405|NCT01324310|529446270|FG000|Overall Study|Adverse Event|1|||
146801406|NCT01324310|529446270|FG000|Overall Study|Disease Progression|1|||
146801407|NCT01830595|529446287|FG000|First Period|Withdrawal by Subject|1|||
146801408|NCT01830595|529446288|FG001|First Period|Withdrawal by Subject|3|||
146801409|NCT01830595|529446287|FG000|Washout|Withdrawal by Subject|2|||
146801410|NCT01830595|529446288|FG001|Washout|Withdrawal by Subject|2|||
146801411|NCT05018143|529446289|FG000|Overall Study|Lost to Follow-up|5|||
146801412|NCT05018143|529446290|FG001|Overall Study|Lost to Follow-up|4|||
146801413|NCT05018143|529446289|FG000|Overall Study|Withdrawal by Subject|0|||
146801414|NCT05018143|529446290|FG001|Overall Study|Withdrawal by Subject|1|||
146801415|NCT05116774|529446291|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
146801416|NCT05116774|529446292|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
146801417|NCT05116774|529446291|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
146801418|NCT05116774|529446292|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
146801419|NCT05116774|529446291|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
146801420|NCT05116774|529446292|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
146801421|NCT05116774|529446291|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
146801422|NCT05116774|529446292|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
146801423|NCT05601882|529446293|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
146801424|NCT05601882|529446294|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
146801425|NCT05601882|529446295|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
146801426|NCT05601882|529446296|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
146801427|NCT05601882|529446293|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
146801428|NCT05601882|529446294|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
146801429|NCT05601882|529446295|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
146801430|NCT05601882|529446296|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
146801431|NCT05601882|529446293|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
146801432|NCT05601882|529446294|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
146801433|NCT05601882|529446295|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
146801434|NCT05601882|529446296|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
146801435|NCT05601882|529446293|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
146801436|NCT05601882|529446294|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
146801437|NCT05601882|529446295|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
146801438|NCT05601882|529446296|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
146801439|NCT05601882|529446293|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
146801440|NCT05601882|529446294|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
146801441|NCT05601882|529446295|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
146801442|NCT05601882|529446296|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
146801443|NCT05601882|529446293|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
146801444|NCT05601882|529446294|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
146801445|NCT05601882|529446295|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
146801446|NCT05601882|529446296|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
146801447|NCT05464732|529446306|FG000|Overall Study|Lost to Follow-up|0|||
146801448|NCT05464732|529446307|FG001|Overall Study|Lost to Follow-up|1|||
146983596|NCT00175019|530101921|FG001|Overall Study|Gout Flare|3|||
146983597|NCT00175019|530101922|FG002|Overall Study|Gout Flare|0|||
146983598|NCT00175019|530101920|FG000|Overall Study|Reason Not Specified|40|||
146983599|NCT00175019|530101921|FG001|Overall Study|Reason Not Specified|34|||
146983600|NCT00175019|530101922|FG002|Overall Study|Reason Not Specified|11|||
146983601|NCT01405820|530101923|FG000|Randomized Treatment Period|Adverse Event|3|||
146983602|NCT01405820|530101924|FG001|Randomized Treatment Period|Adverse Event|3|||
146983603|NCT01405820|530101925|FG002|Randomized Treatment Period|Adverse Event|3|||
146983604|NCT01405820|530101926|FG003|Randomized Treatment Period|Adverse Event|0|||
146983605|NCT01405820|530101927|FG004|Randomized Treatment Period|Adverse Event|2|||
146983606|NCT01405820|530101928|FG005|Randomized Treatment Period|Adverse Event|1|||
146983607|NCT01405820|530101923|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
146983608|NCT01405820|530101924|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
146983609|NCT01405820|530101925|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
146983610|NCT01405820|530101926|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
146983611|NCT01405820|530101927|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
146983612|NCT01405820|530101928|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
146983613|NCT01405820|530101923|FG000|Randomized Treatment Period|Other|2|||
146983614|NCT01405820|530101924|FG001|Randomized Treatment Period|Other|2|||
146983615|NCT01405820|530101925|FG002|Randomized Treatment Period|Other|1|||
146983616|NCT01405820|530101926|FG003|Randomized Treatment Period|Other|1|||
146983617|NCT01405820|530101927|FG004|Randomized Treatment Period|Other|0|||
146983618|NCT01405820|530101928|FG005|Randomized Treatment Period|Other|0|||
146983619|NCT01405820|530101923|FG000|Randomized Treatment Period|Physician Decision|0|||
146983620|NCT01405820|530101924|FG001|Randomized Treatment Period|Physician Decision|2|||
146983621|NCT01405820|530101925|FG002|Randomized Treatment Period|Physician Decision|1|||
146983622|NCT01405820|530101926|FG003|Randomized Treatment Period|Physician Decision|0|||
146983623|NCT01405820|530101927|FG004|Randomized Treatment Period|Physician Decision|0|||
146983624|NCT01405820|530101928|FG005|Randomized Treatment Period|Physician Decision|0|||
146983625|NCT01405820|530101923|FG000|Randomized Treatment Period|Rescue|0|||
146983626|NCT01405820|530101924|FG001|Randomized Treatment Period|Rescue|1|||
146983627|NCT01405820|530101925|FG002|Randomized Treatment Period|Rescue|13|||
146983628|NCT01405820|530101926|FG003|Randomized Treatment Period|Rescue|10|||
146983629|NCT01405820|530101927|FG004|Randomized Treatment Period|Rescue|8|||
146983630|NCT01405820|530101928|FG005|Randomized Treatment Period|Rescue|8|||
146983631|NCT01405820|530101923|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
146983632|NCT01405820|530101924|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
146983633|NCT01405820|530101925|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
146983634|NCT01405820|530101926|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
146983635|NCT01405820|530101927|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
146983636|NCT01405820|530101928|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
146983637|NCT01405820|530101923|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
146801449|NCT05464732|529446306|FG000|Overall Study|Adverse Event|1|||
146801450|NCT05464732|529446307|FG001|Overall Study|Adverse Event|0|||
146801451|NCT03959423|529446311|FG000|Overall Study|Withdrawal by Subject|2|||
146801452|NCT03959423|529446312|FG001|Overall Study|Withdrawal by Subject|3|||
146801453|NCT03959423|529446311|FG000|Overall Study|Physician Decision|0|||
146801454|NCT03959423|529446312|FG001|Overall Study|Physician Decision|1|||
146801455|NCT03959423|529446311|FG000|Overall Study|Lost to Follow-up|1|||
146801456|NCT03959423|529446312|FG001|Overall Study|Lost to Follow-up|0|||
146801457|NCT03959423|529446311|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
146801458|NCT03959423|529446312|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146801459|NCT05864209|529447195|FG000|Overall Study|Lost to Follow-up|2|||
146801460|NCT05864209|529447196|FG001|Overall Study|Lost to Follow-up|3|||
146801461|NCT02722434|529447199|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
146801462|NCT02722434|529447200|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
146801463|NCT02722434|529447199|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
146801464|NCT02722434|529447200|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
146983638|NCT01405820|530101924|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
146983639|NCT01405820|530101925|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
146801465|NCT00146172|529447202|FG000|Overall Study|Adverse Event|0|||
146801466|NCT00146172|529447203|FG001|Overall Study|Adverse Event|0|||
146801467|NCT00146172|529447204|FG002|Overall Study|Adverse Event|1|||
146983640|NCT01405820|530101926|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
146983641|NCT01405820|530101927|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
146983642|NCT01405820|530101928|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
146983643|NCT01405820|530101923|FG000|Randomized Treatment Period|Death|0|||
146983644|NCT01405820|530101924|FG001|Randomized Treatment Period|Death|0|||
146983645|NCT01405820|530101925|FG002|Randomized Treatment Period|Death|0|||
146983646|NCT01405820|530101926|FG003|Randomized Treatment Period|Death|1|||
146983647|NCT01405820|530101927|FG004|Randomized Treatment Period|Death|0|||
146983648|NCT01405820|530101928|FG005|Randomized Treatment Period|Death|0|||
146801468|NCT00146172|529447205|FG003|Overall Study|Adverse Event|1|||
146983649|NCT01405820|530101923|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
146801469|NCT00146172|529447206|FG004|Overall Study|Adverse Event|0|||
146801470|NCT00146172|529447207|FG005|Overall Study|Adverse Event|2|||
146801471|NCT00146172|529447208|FG006|Overall Study|Adverse Event|3|||
146801472|NCT00146172|529447209|FG007|Overall Study|Adverse Event|10|||
146801473|NCT00146172|529447202|FG000|Overall Study|Lost to Follow-up|0|||
146801474|NCT00146172|529447203|FG001|Overall Study|Lost to Follow-up|0|||
146801475|NCT00146172|529447204|FG002|Overall Study|Lost to Follow-up|0|||
146801476|NCT00146172|529447205|FG003|Overall Study|Lost to Follow-up|0|||
146801477|NCT00146172|529447206|FG004|Overall Study|Lost to Follow-up|0|||
146801478|NCT00146172|529447207|FG005|Overall Study|Lost to Follow-up|0|||
146801479|NCT00146172|529447208|FG006|Overall Study|Lost to Follow-up|0|||
146801480|NCT00146172|529447209|FG007|Overall Study|Lost to Follow-up|1|||
146801481|NCT00146172|529447202|FG000|Overall Study|Disease Progression|2|||
146801482|NCT00146172|529447203|FG001|Overall Study|Disease Progression|4|||
146801483|NCT00146172|529447204|FG002|Overall Study|Disease Progression|2|||
146801484|NCT00146172|529447205|FG003|Overall Study|Disease Progression|5|||
146801485|NCT00146172|529447206|FG004|Overall Study|Disease Progression|2|||
146801486|NCT00146172|529447207|FG005|Overall Study|Disease Progression|2|||
146801487|NCT00146172|529447208|FG006|Overall Study|Disease Progression|1|||
146801488|NCT00146172|529447209|FG007|Overall Study|Disease Progression|22|||
146801489|NCT00146172|529447202|FG000|Overall Study|Death|0|||
146801490|NCT00146172|529447203|FG001|Overall Study|Death|0|||
146801491|NCT00146172|529447204|FG002|Overall Study|Death|0|||
146801492|NCT00146172|529447205|FG003|Overall Study|Death|0|||
146801493|NCT00146172|529447206|FG004|Overall Study|Death|0|||
146801494|NCT00146172|529447207|FG005|Overall Study|Death|0|||
146801495|NCT00146172|529447208|FG006|Overall Study|Death|1|||
146801496|NCT00146172|529447209|FG007|Overall Study|Death|0|||
146801497|NCT00146172|529447202|FG000|Overall Study|Physician Decision|0|||
146801498|NCT00146172|529447203|FG001|Overall Study|Physician Decision|0|||
146801499|NCT00146172|529447204|FG002|Overall Study|Physician Decision|0|||
146801500|NCT00146172|529447205|FG003|Overall Study|Physician Decision|0|||
146801501|NCT00146172|529447206|FG004|Overall Study|Physician Decision|0|||
146801502|NCT00146172|529447207|FG005|Overall Study|Physician Decision|0|||
146801503|NCT00146172|529447208|FG006|Overall Study|Physician Decision|0|||
146801504|NCT00146172|529447209|FG007|Overall Study|Physician Decision|1|||
146801505|NCT00146172|529447202|FG000|Overall Study|Withdrawal by Subject|0|||
146801506|NCT00146172|529447203|FG001|Overall Study|Withdrawal by Subject|0|||
146801507|NCT00146172|529447204|FG002|Overall Study|Withdrawal by Subject|0|||
146801508|NCT00146172|529447205|FG003|Overall Study|Withdrawal by Subject|0|||
146801509|NCT00146172|529447206|FG004|Overall Study|Withdrawal by Subject|0|||
146801510|NCT00146172|529447207|FG005|Overall Study|Withdrawal by Subject|1|||
146801511|NCT00146172|529447208|FG006|Overall Study|Withdrawal by Subject|1|||
146801512|NCT00146172|529447209|FG007|Overall Study|Withdrawal by Subject|4|||
146801513|NCT00146172|529447202|FG000|Overall Study|Symptomatic Deterioration|1|||
146801514|NCT00146172|529447203|FG001|Overall Study|Symptomatic Deterioration|0|||
146801515|NCT00146172|529447204|FG002|Overall Study|Symptomatic Deterioration|1|||
146801516|NCT00146172|529447205|FG003|Overall Study|Symptomatic Deterioration|0|||
146801517|NCT00146172|529447206|FG004|Overall Study|Symptomatic Deterioration|1|||
146801518|NCT00146172|529447207|FG005|Overall Study|Symptomatic Deterioration|2|||
146801519|NCT00146172|529447208|FG006|Overall Study|Symptomatic Deterioration|0|||
146801520|NCT00146172|529447209|FG007|Overall Study|Symptomatic Deterioration|2|||
146801521|NCT00786864|529447210|FG000|Overall Study|Lost to Follow-up|0|||
146801522|NCT00786864|529447211|FG001|Overall Study|Lost to Follow-up|1|||
146801523|NCT00786864|529447210|FG000|Overall Study|Sustained serious back injury|1|||
146801524|NCT00786864|529447211|FG001|Overall Study|Sustained serious back injury|0|||
146801525|NCT01500200|529447223|FG000|Stage 1|Adverse Event|1|||
146801526|NCT01500200|529447224|FG001|Stage 1|Adverse Event|4|||
146801527|NCT01500200|529447225|FG002|Stage 1|Adverse Event|5|||
146801528|NCT01500200|529447226|FG003|Stage 1|Adverse Event|0|||
146801529|NCT01500200|529447227|FG004|Stage 1|Adverse Event|0|||
146801530|NCT01500200|529447228|FG005|Stage 1|Adverse Event|0|||
146801531|NCT01500200|529447223|FG000|Stage 1|Lost to Follow-up|2|||
146801532|NCT01500200|529447224|FG001|Stage 1|Lost to Follow-up|2|||
146801533|NCT01500200|529447225|FG002|Stage 1|Lost to Follow-up|1|||
146801534|NCT01500200|529447226|FG003|Stage 1|Lost to Follow-up|0|||
146801535|NCT01500200|529447227|FG004|Stage 1|Lost to Follow-up|0|||
146801536|NCT01500200|529447228|FG005|Stage 1|Lost to Follow-up|0|||
146801537|NCT01500200|529447223|FG000|Stage 1|Withdrawal by Subject|3|||
146801538|NCT01500200|529447224|FG001|Stage 1|Withdrawal by Subject|0|||
146801539|NCT01500200|529447225|FG002|Stage 1|Withdrawal by Subject|0|||
146801540|NCT01500200|529447226|FG003|Stage 1|Withdrawal by Subject|0|||
146801541|NCT01500200|529447227|FG004|Stage 1|Withdrawal by Subject|0|||
146801542|NCT01500200|529447228|FG005|Stage 1|Withdrawal by Subject|0|||
146801543|NCT01500200|529447223|FG000|Stage 1|Noncompliance with Study Drug|1|||
146801544|NCT01500200|529447224|FG001|Stage 1|Noncompliance with Study Drug|0|||
146801545|NCT01500200|529447225|FG002|Stage 1|Noncompliance with Study Drug|0|||
146801546|NCT01500200|529447226|FG003|Stage 1|Noncompliance with Study Drug|0|||
146801547|NCT01500200|529447227|FG004|Stage 1|Noncompliance with Study Drug|0|||
146801548|NCT01500200|529447228|FG005|Stage 1|Noncompliance with Study Drug|0|||
146801549|NCT01500200|529447223|FG000|Stage 1|Physician Decision|1|||
146801550|NCT01500200|529447224|FG001|Stage 1|Physician Decision|0|||
146801551|NCT01500200|529447225|FG002|Stage 1|Physician Decision|0|||
146801552|NCT01500200|529447226|FG003|Stage 1|Physician Decision|0|||
146801553|NCT01500200|529447227|FG004|Stage 1|Physician Decision|0|||
146801554|NCT01500200|529447228|FG005|Stage 1|Physician Decision|0|||
146801555|NCT01500200|529447223|FG000|Stage 2|Adverse Event|0|||
146801556|NCT01500200|529447224|FG001|Stage 2|Adverse Event|0|||
146801557|NCT01500200|529447225|FG002|Stage 2|Adverse Event|0|||
146801558|NCT01500200|529447226|FG003|Stage 2|Adverse Event|0|||
146801559|NCT01500200|529447227|FG004|Stage 2|Adverse Event|5|||
146801560|NCT01500200|529447228|FG005|Stage 2|Adverse Event|4|||
146801561|NCT00623194|529447229|FG000|Overall Study|Lack of Efficacy|1|||
146801562|NCT00623194|529447229|FG000|Overall Study|Protocol Violation|3|||
146801563|NCT00623194|529447229|FG000|Overall Study|Unclassified|1|||
146801564|NCT01952366|529447230|FG000|Overall Study|Death|22|||
146801565|NCT01952366|529447230|FG000|Overall Study|Withdrawal by Subject|9|||
146801566|NCT04860505|529447231|FG000|Overall Study|Lost to Follow-up|2|||
146801567|NCT00857766|529447232|FG000|Overall Study|Adverse Event|13|||
146801568|NCT00857766|529447233|FG001|Overall Study|Adverse Event|12|||
146801569|NCT00857766|529447232|FG000|Overall Study|Protocol Violation|11|||
146801570|NCT00857766|529447233|FG001|Overall Study|Protocol Violation|11|||
146801571|NCT00857766|529447232|FG000|Overall Study|Lost to Follow-up|1|||
146801572|NCT00857766|529447233|FG001|Overall Study|Lost to Follow-up|0|||
146801573|NCT00857766|529447232|FG000|Overall Study|Investigator Discretion|2|||
146801574|NCT00857766|529447233|FG001|Overall Study|Investigator Discretion|3|||
146801575|NCT00857766|529447232|FG000|Overall Study|Participant Withdrew Consent|4|||
146801576|NCT00857766|529447233|FG001|Overall Study|Participant Withdrew Consent|4|||
146801577|NCT01988402|529447234|FG000|Overall Study|Adverse Event|1|||
146801578|NCT01988402|529447235|FG001|Overall Study|Adverse Event|2|||
146801579|NCT01988402|529447234|FG000|Overall Study|Withdrawal by Subject|1|||
146801580|NCT01988402|529447235|FG001|Overall Study|Withdrawal by Subject|0|||
146801581|NCT01961609|529447236|FG000|Initiation|Missing|3|||
146801582|NCT01961609|529447237|FG001|Initiation|Missing|2|||
146801583|NCT01961609|529447238|FG002|Initiation|Missing|0|||
146801584|NCT01961609|529447239|FG003|Initiation|Missing|0|||
146801585|NCT01961609|529447236|FG000|Initiation|Protocol deviation|1|||
146801586|NCT01961609|529447237|FG001|Initiation|Protocol deviation|0|||
146801587|NCT01961609|529447238|FG002|Initiation|Protocol deviation|0|||
146801588|NCT01961609|529447239|FG003|Initiation|Protocol deviation|0|||
146801589|NCT01961609|529447236|FG000|Initiation|Death|0|||
146801590|NCT01961609|529447237|FG001|Initiation|Death|1|||
146801591|NCT01961609|529447238|FG002|Initiation|Death|0|||
146801592|NCT01961609|529447239|FG003|Initiation|Death|0|||
146801593|NCT01961609|529447236|FG000|Initiation|Administrative problems|1|||
146801594|NCT01961609|529447237|FG001|Initiation|Administrative problems|0|||
146801595|NCT01961609|529447238|FG002|Initiation|Administrative problems|0|||
146801596|NCT01961609|529447239|FG003|Initiation|Administrative problems|0|||
146801597|NCT01961609|529447236|FG000|Initiation|Withdrawal by Subject|1|||
146801598|NCT01961609|529447237|FG001|Initiation|Withdrawal by Subject|2|||
146801599|NCT01961609|529447238|FG002|Initiation|Withdrawal by Subject|0|||
146801600|NCT01961609|529447239|FG003|Initiation|Withdrawal by Subject|0|||
146801601|NCT01961609|529447236|FG000|Initiation|Lack of Efficacy|2|||
146801602|NCT01961609|529447237|FG001|Initiation|Lack of Efficacy|1|||
146801603|NCT01961609|529447238|FG002|Initiation|Lack of Efficacy|0|||
146801604|NCT01961609|529447239|FG003|Initiation|Lack of Efficacy|0|||
146801605|NCT01961609|529447236|FG000|Initiation|Abnormal lab values|0|||
146801606|NCT01961609|529447237|FG001|Initiation|Abnormal lab values|1|||
146801607|NCT01961609|529447238|FG002|Initiation|Abnormal lab values|0|||
146801608|NCT01961609|529447239|FG003|Initiation|Abnormal lab values|0|||
146801609|NCT01961609|529447236|FG000|Initiation|Adverse Event|3|||
146801610|NCT01961609|529447237|FG001|Initiation|Adverse Event|5|||
146801611|NCT01961609|529447238|FG002|Initiation|Adverse Event|0|||
146801612|NCT01961609|529447239|FG003|Initiation|Adverse Event|0|||
146801613|NCT01961609|529447236|FG000|Initiation|Randomized but not treated|1|||
146801614|NCT01961609|529447237|FG001|Initiation|Randomized but not treated|1|||
146801615|NCT01961609|529447238|FG002|Initiation|Randomized but not treated|0|||
146801616|NCT01961609|529447239|FG003|Initiation|Randomized but not treated|0|||
146801617|NCT01961609|529447236|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
146941424|NCT02371980|529945892|FG002|Open-label Period|Lost to Follow-up|0|||
146801618|NCT01961609|529447237|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
146801619|NCT01961609|529447238|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
146801620|NCT01961609|529447239|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
146801621|NCT01961609|529447236|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
146801622|NCT01961609|529447237|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
146801623|NCT01961609|529447238|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
146801624|NCT01961609|529447239|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
146801625|NCT01961609|529447236|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
146941425|NCT02371980|529945893|FG003|Open-label Period|Lost to Follow-up|0|||
146801626|NCT01961609|529447237|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
146801627|NCT01961609|529447238|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
146801628|NCT01961609|529447239|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
146801629|NCT01961609|529447236|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
146801630|NCT01961609|529447237|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
146801631|NCT01961609|529447238|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
146801632|NCT01961609|529447239|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
146801633|NCT01961609|529447236|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
146801634|NCT01961609|529447237|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
146801635|NCT01961609|529447238|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
146801636|NCT01961609|529447239|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
146801637|NCT01961609|529447236|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
146801638|NCT01961609|529447237|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
146801639|NCT01961609|529447238|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
146801640|NCT01961609|529447239|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
146801641|NCT01961609|529447236|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
146801642|NCT01961609|529447237|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
146801643|NCT01961609|529447238|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
146801644|NCT01961609|529447239|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
146801645|NCT01961609|529447236|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
146801646|NCT01961609|529447237|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
146801647|NCT01961609|529447238|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
146801648|NCT01961609|529447239|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
146801649|NCT01961609|529447236|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
146801650|NCT01961609|529447237|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
146801651|NCT01961609|529447238|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
146801652|NCT01961609|529447239|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
146801653|NCT01961609|529447236|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
146801654|NCT01961609|529447237|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
146801655|NCT01961609|529447238|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
146801656|NCT01961609|529447239|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
146801657|NCT01961609|529447236|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
146801658|NCT01961609|529447237|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
146801659|NCT01961609|529447238|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
146801660|NCT01961609|529447239|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
146801661|NCT01961609|529447236|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
146801662|NCT01961609|529447237|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
146801663|NCT01961609|529447238|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
146801664|NCT01961609|529447239|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
146801665|NCT01212744|529447242|FG000|Overall Study|Withdrawal by Subject|1|||
146801666|NCT02167451|529447244|FG000|Overall Study|Withdrawal by Subject|1|||
146801667|NCT00571649|529447245|FG000|Treatment Period|Adverse Event|438|||
146801668|NCT00571649|529447246|FG001|Treatment Period|Adverse Event|385|||
146801669|NCT00571649|529447245|FG000|Treatment Period|Clinical endpoint reached|50|||
146801670|NCT00571649|529447246|FG001|Treatment Period|Clinical endpoint reached|56|||
146801671|NCT00571649|529447245|FG000|Treatment Period|Withdrawal by Subject|285|||
146801672|NCT00571649|529447246|FG001|Treatment Period|Withdrawal by Subject|255|||
146801673|NCT00571649|529447245|FG000|Treatment Period|Death|76|||
146801674|NCT00571649|529447246|FG001|Treatment Period|Death|59|||
146801675|NCT00571649|529447245|FG000|Treatment Period|Physician Decision|8|||
146801676|NCT00571649|529447246|FG001|Treatment Period|Physician Decision|9|||
146801677|NCT00571649|529447245|FG000|Treatment Period|Lost to Follow-up|43|||
146801678|NCT00571649|529447246|FG001|Treatment Period|Lost to Follow-up|41|||
146801679|NCT00571649|529447245|FG000|Treatment Period|Non-compliant with study medication|88|||
146801680|NCT00571649|529447246|FG001|Treatment Period|Non-compliant with study medication|89|||
146801681|NCT00571649|529447245|FG000|Treatment Period|Patient convenience|11|||
146801682|NCT00571649|529447246|FG001|Treatment Period|Patient convenience|13|||
146801683|NCT00571649|529447245|FG000|Treatment Period|Protocol Violation|90|||
146801684|NCT00571649|529447246|FG001|Treatment Period|Protocol Violation|92|||
146801685|NCT00571649|529447245|FG000|Treatment Period|Technical problems|3|||
146801686|NCT00571649|529447246|FG001|Treatment Period|Technical problems|5|||
146801687|NCT00571649|529447245|FG000|Follow-up Period|Adverse Event|46|||
146801688|NCT00571649|529447246|FG001|Follow-up Period|Adverse Event|40|||
146801689|NCT00571649|529447245|FG000|Follow-up Period|Clinical endpoint reached|5|||
146801690|NCT00571649|529447246|FG001|Follow-up Period|Clinical endpoint reached|2|||
146801691|NCT00571649|529447245|FG000|Follow-up Period|Withdrawal by Subject|119|||
146801692|NCT00571649|529447246|FG001|Follow-up Period|Withdrawal by Subject|115|||
146801693|NCT00571649|529447245|FG000|Follow-up Period|Death|132|||
146801694|NCT00571649|529447246|FG001|Follow-up Period|Death|133|||
146941426|NCT02371980|529945894|FG004|Open-label Period|Lost to Follow-up|0|||
146941427|NCT02371980|529945890|FG000|Open-label Period|Voluntary Withdrawal|91|||
146801695|NCT00571649|529447245|FG000|Follow-up Period|Physician Decision|7|||
146801696|NCT00571649|529447246|FG001|Follow-up Period|Physician Decision|13|||
146801697|NCT00571649|529447245|FG000|Follow-up Period|Lost to Follow-up|95|||
146801698|NCT00571649|529447246|FG001|Follow-up Period|Lost to Follow-up|92|||
146801699|NCT00571649|529447245|FG000|Follow-up Period|Patient convenience|136|||
146801700|NCT00571649|529447246|FG001|Follow-up Period|Patient convenience|121|||
146801701|NCT00571649|529447245|FG000|Follow-up Period|Protocol Violation|5|||
146801702|NCT00571649|529447246|FG001|Follow-up Period|Protocol Violation|12|||
146801703|NCT01218659|529447247|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
146801704|NCT01218659|529447248|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
146801705|NCT01218659|529447249|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
146801706|NCT01218659|529447247|FG000|18-Month Randomized Period|Did not receive study drug|0|||
146801707|NCT01218659|529447248|FG001|18-Month Randomized Period|Did not receive study drug|3|||
146801708|NCT01218659|529447249|FG002|18-Month Randomized Period|Did not receive study drug|0|||
146801709|NCT01218659|529447247|FG000|12-Month OLE|Withdrawal by Subject|0|||
146801710|NCT01218659|529447248|FG001|12-Month OLE|Withdrawal by Subject|0|||
146801711|NCT01218659|529447249|FG002|12-Month OLE|Withdrawal by Subject|2|||
146801712|NCT01218659|529447247|FG000|12-Month OLE|Physician Decision|0|||
146801713|NCT01218659|529447248|FG001|12-Month OLE|Physician Decision|0|||
146801714|NCT01218659|529447249|FG002|12-Month OLE|Physician Decision|1|||
146801715|NCT01218659|529447247|FG000|12-Month OLE|Lost to Follow-up|0|||
146801716|NCT01218659|529447248|FG001|12-Month OLE|Lost to Follow-up|0|||
146801717|NCT01218659|529447249|FG002|12-Month OLE|Lost to Follow-up|1|||
146801718|NCT01218659|529447247|FG000|12-Month OLE|Pregnancy|0|||
146801719|NCT01218659|529447248|FG001|12-Month OLE|Pregnancy|0|||
146801720|NCT01218659|529447249|FG002|12-Month OLE|Pregnancy|1|||
146801721|NCT01218659|529447247|FG000|12-Month OLE|Lack of Efficacy|0|||
146801722|NCT01218659|529447248|FG001|12-Month OLE|Lack of Efficacy|0|||
146801723|NCT01218659|529447249|FG002|12-Month OLE|Lack of Efficacy|1|||
146801724|NCT01218659|529447247|FG000|12-Month OLE|Declined to participate in the OLE|0|||
146801725|NCT01218659|529447248|FG001|12-Month OLE|Declined to participate in the OLE|0|||
146801726|NCT01218659|529447249|FG002|12-Month OLE|Declined to participate in the OLE|4|||
146801727|NCT00811941|529447250|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
146801728|NCT00811941|529447251|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
146801729|NCT00811941|529447250|FG000|All Treated Patients|Adverse Event|2|||
146801730|NCT00811941|529447251|FG001|All Treated Patients|Adverse Event|43|||
146801731|NCT00811941|529447250|FG000|All Treated Patients|Lack of Efficacy|2|||
146801732|NCT00811941|529447251|FG001|All Treated Patients|Lack of Efficacy|3|||
146801733|NCT00811941|529447250|FG000|All Treated Patients|Non-compliance|1|||
146801734|NCT00811941|529447251|FG001|All Treated Patients|Non-compliance|8|||
146801735|NCT00811941|529447250|FG000|All Treated Patients|Protocol Violation|5|||
146801736|NCT00811941|529447251|FG001|All Treated Patients|Protocol Violation|17|||
146801737|NCT00811941|529447250|FG000|All Treated Patients|Withdrawal by Subject|35|||
146801738|NCT00811941|529447251|FG001|All Treated Patients|Withdrawal by Subject|94|||
146801739|NCT00811941|529447250|FG000|All Treated Patients|Lost to Follow-up|3|||
146801740|NCT00811941|529447251|FG001|All Treated Patients|Lost to Follow-up|12|||
146801741|NCT00811941|529447250|FG000|All Treated Patients|Other Reason|4|||
146801742|NCT00811941|529447251|FG001|All Treated Patients|Other Reason|14|||
146801743|NCT03885232|529447252|FG000|Overall Study|Lost to Follow-up|74|||
146801744|NCT03885232|529447253|FG001|Overall Study|Lost to Follow-up|32|||
146801745|NCT03885232|529447252|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
146801746|NCT03885232|529447253|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
146801747|NCT02397096|529447254|FG000|Day 1 to Week 24|Adverse Event|7|||
146801748|NCT02397096|529447255|FG001|Day 1 to Week 24|Adverse Event|1|||
146801749|NCT02397096|529447254|FG000|Day 1 to Week 24|Death|1|||
146801750|NCT02397096|529447255|FG001|Day 1 to Week 24|Death|0|||
146801751|NCT02397096|529447254|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
146941428|NCT02371980|529945891|FG001|Open-label Period|Voluntary Withdrawal|0|||
146941429|NCT02371980|529945892|FG002|Open-label Period|Voluntary Withdrawal|0|||
146941430|NCT02371980|529945893|FG003|Open-label Period|Voluntary Withdrawal|0|||
146941431|NCT02371980|529945894|FG004|Open-label Period|Voluntary Withdrawal|0|||
146801752|NCT02397096|529447255|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
146801753|NCT02397096|529447254|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
146801754|NCT02397096|529447255|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
146801755|NCT02397096|529447254|FG000|Day 1 to Week 24|Physician Decision|2|||
146801756|NCT02397096|529447255|FG001|Day 1 to Week 24|Physician Decision|3|||
146801757|NCT02397096|529447254|FG000|Day 1 to Week 24|Protocol Violation|1|||
146801758|NCT02397096|529447255|FG001|Day 1 to Week 24|Protocol Violation|4|||
146941432|NCT02371980|529945890|FG000|Open-label Period|Pregnancy|1|||
146801759|NCT02397096|529447254|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
146801760|NCT02397096|529447255|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
146801761|NCT02397096|529447254|FG000|Day 1 to Week 24|Randomized, not treated|3|||
146801762|NCT02397096|529447255|FG001|Day 1 to Week 24|Randomized, not treated|0|||
146801763|NCT02397096|529447254|FG000|Week 24 to Week 48|Adverse Event|6|||
146801764|NCT02397096|529447255|FG001|Week 24 to Week 48|Adverse Event|2|||
146941433|NCT02371980|529945891|FG001|Open-label Period|Pregnancy|0|||
146941434|NCT02371980|529945892|FG002|Open-label Period|Pregnancy|0|||
146941435|NCT02371980|529945893|FG003|Open-label Period|Pregnancy|0|||
146941436|NCT02371980|529945894|FG004|Open-label Period|Pregnancy|0|||
146941437|NCT02371980|529945890|FG000|Open-label Period|Lack of Efficacy|116|||
146941438|NCT02371980|529945891|FG001|Open-label Period|Lack of Efficacy|0|||
146801765|NCT02397096|529447254|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
146801766|NCT02397096|529447255|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
146801767|NCT02397096|529447254|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
146801768|NCT02397096|529447255|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
146801769|NCT02397096|529447254|FG000|Week 24 to Week 48|Physician Decision|2|||
146801770|NCT02397096|529447255|FG001|Week 24 to Week 48|Physician Decision|1|||
146801771|NCT02397096|529447254|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
146801772|NCT02397096|529447255|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
146801773|NCT02397096|529447254|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
146801774|NCT02397096|529447255|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
146801775|NCT02397096|529447254|FG000|Study Extension 1|Adverse Event|7|||
146801776|NCT02397096|529447255|FG001|Study Extension 1|Adverse Event|5|||
146801777|NCT02397096|529447254|FG000|Study Extension 1|Death|1|||
146801778|NCT02397096|529447255|FG001|Study Extension 1|Death|0|||
146801779|NCT02397096|529447254|FG000|Study Extension 1|Lack of Efficacy|2|||
146801780|NCT02397096|529447255|FG001|Study Extension 1|Lack of Efficacy|5|||
146801781|NCT02397096|529447254|FG000|Study Extension 1|Lost to Follow-up|2|||
146801782|NCT02397096|529447255|FG001|Study Extension 1|Lost to Follow-up|3|||
146801783|NCT02397096|529447254|FG000|Study Extension 1|Non-compliance with study drug|3|||
146801784|NCT02397096|529447255|FG001|Study Extension 1|Non-compliance with study drug|0|||
146801785|NCT02397096|529447254|FG000|Study Extension 1|Physician Decision|4|||
146801786|NCT02397096|529447255|FG001|Study Extension 1|Physician Decision|2|||
146801787|NCT02397096|529447254|FG000|Study Extension 1|Pregnancy|1|||
146801788|NCT02397096|529447255|FG001|Study Extension 1|Pregnancy|0|||
146801789|NCT02397096|529447254|FG000|Study Extension 1|Protocol Violation|0|||
146801790|NCT02397096|529447255|FG001|Study Extension 1|Protocol Violation|1|||
146801791|NCT02397096|529447254|FG000|Study Extension 1|Withdrawal by Subject|21|||
146801792|NCT02397096|529447255|FG001|Study Extension 1|Withdrawal by Subject|7|||
146801793|NCT02397096|529447254|FG000|Study Extension 2|Adverse Event|3|||
146801794|NCT02397096|529447255|FG001|Study Extension 2|Adverse Event|3|||
146801795|NCT02397096|529447254|FG000|Study Extension 2|Availability of study medication locally|152|||
146801796|NCT02397096|529447255|FG001|Study Extension 2|Availability of study medication locally|64|||
146801797|NCT02397096|529447254|FG000|Study Extension 2|Death|2|||
146801798|NCT02397096|529447255|FG001|Study Extension 2|Death|0|||
146801799|NCT02397096|529447254|FG000|Study Extension 2|Lack of Efficacy|1|||
146801800|NCT02397096|529447255|FG001|Study Extension 2|Lack of Efficacy|0|||
146801801|NCT02397096|529447254|FG000|Study Extension 2|Lost to Follow-up|2|||
146801802|NCT02397096|529447255|FG001|Study Extension 2|Lost to Follow-up|1|||
146801803|NCT02397096|529447254|FG000|Study Extension 2|Non-compliance with study drug|1|||
146801804|NCT02397096|529447255|FG001|Study Extension 2|Non-compliance with study drug|0|||
146801805|NCT02397096|529447254|FG000|Study Extension 2|Physician Decision|2|||
146801806|NCT02397096|529447255|FG001|Study Extension 2|Physician Decision|5|||
146801807|NCT02397096|529447254|FG000|Study Extension 2|Pregnancy|1|||
146801808|NCT02397096|529447255|FG001|Study Extension 2|Pregnancy|0|||
146801809|NCT02397096|529447254|FG000|Study Extension 2|Withdrawal by Subject|10|||
146801810|NCT02397096|529447255|FG001|Study Extension 2|Withdrawal by Subject|3|||
146801811|NCT02397096|529447254|FG000|Study Extension 3|Adverse Event|1|||
146801812|NCT02397096|529447255|FG001|Study Extension 3|Adverse Event|0|||
146801813|NCT02397096|529447254|FG000|Study Extension 3|Availability of study medication locally|11|||
146801814|NCT02397096|529447255|FG001|Study Extension 3|Availability of study medication locally|3|||
146801815|NCT02397096|529447254|FG000|Study Extension 3|Lost to Follow-up|1|||
146801816|NCT02397096|529447255|FG001|Study Extension 3|Lost to Follow-up|0|||
146801817|NCT02397096|529447254|FG000|Study Extension 3|Withdrawal by Subject|2|||
146801818|NCT02397096|529447255|FG001|Study Extension 3|Withdrawal by Subject|1|||
146801819|NCT03840902|529447256|FG000|Overall Study|Randomized but not treated|1|||
146801820|NCT03840902|529447257|FG001|Overall Study|Randomized but not treated|1|||
146801821|NCT06688357|529447261|FG000|Overall Study|Adverse Event|0|||
146801822|NCT06688357|529447262|FG001|Overall Study|Adverse Event|1|||
146801823|NCT03222609|529447265|FG000|Overall Study|Withdrew consent|2|||
146941439|NCT02371980|529945892|FG002|Open-label Period|Lack of Efficacy|0|||
146801824|NCT03222609|529447266|FG001|Overall Study|Withdrew consent|3|||
146801825|NCT03222609|529447267|FG002|Overall Study|Withdrew consent|4|||
146801826|NCT03222609|529447268|FG003|Overall Study|Withdrew consent|2|||
146801827|NCT03222609|529447265|FG000|Overall Study|Lost to Follow-up|1|||
146801828|NCT03222609|529447266|FG001|Overall Study|Lost to Follow-up|0|||
146941440|NCT02371980|529945893|FG003|Open-label Period|Lack of Efficacy|0|||
146801829|NCT03222609|529447267|FG002|Overall Study|Lost to Follow-up|0|||
146801830|NCT03222609|529447268|FG003|Overall Study|Lost to Follow-up|0|||
146801831|NCT03222609|529447265|FG000|Overall Study|Death|16|||
146941441|NCT02371980|529945894|FG004|Open-label Period|Lack of Efficacy|0|||
146941442|NCT02371980|529945890|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
146983650|NCT01405820|530101924|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
146983651|NCT01405820|530101925|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
146983652|NCT01405820|530101926|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
146983653|NCT01405820|530101927|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
146983654|NCT01405820|530101928|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
146983655|NCT01405820|530101923|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
146983656|NCT01405820|530101924|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
146983657|NCT01405820|530101925|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
146983658|NCT01405820|530101926|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
146983659|NCT01405820|530101927|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
146983660|NCT01405820|530101928|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
146983661|NCT01405820|530101923|FG000|Open-Label Treatment Period|Other|1|||
146983662|NCT01405820|530101924|FG001|Open-Label Treatment Period|Other|1|||
146983663|NCT01405820|530101925|FG002|Open-Label Treatment Period|Other|1|||
146983664|NCT01405820|530101926|FG003|Open-Label Treatment Period|Other|1|||
146983665|NCT01405820|530101927|FG004|Open-Label Treatment Period|Other|1|||
146983666|NCT01405820|530101928|FG005|Open-Label Treatment Period|Other|1|||
146983667|NCT01405820|530101923|FG000|Open-Label Treatment Period|Physician Decision|0|||
146983668|NCT01405820|530101924|FG001|Open-Label Treatment Period|Physician Decision|0|||
146983669|NCT01405820|530101925|FG002|Open-Label Treatment Period|Physician Decision|1|||
146983670|NCT01405820|530101926|FG003|Open-Label Treatment Period|Physician Decision|2|||
146983671|NCT01405820|530101927|FG004|Open-Label Treatment Period|Physician Decision|1|||
146983672|NCT01405820|530101928|FG005|Open-Label Treatment Period|Physician Decision|0|||
146983673|NCT01405820|530101923|FG000|Open-Label Treatment Period|Adverse Event|0|||
146983674|NCT01405820|530101924|FG001|Open-Label Treatment Period|Adverse Event|0|||
146983675|NCT01405820|530101925|FG002|Open-Label Treatment Period|Adverse Event|0|||
146983676|NCT01405820|530101926|FG003|Open-Label Treatment Period|Adverse Event|1|||
146983677|NCT01405820|530101927|FG004|Open-Label Treatment Period|Adverse Event|0|||
146983678|NCT01405820|530101928|FG005|Open-Label Treatment Period|Adverse Event|0|||
146983679|NCT03222141|530101929|FG000|Overall Study|Death|15|||
146983680|NCT03222141|530101929|FG000|Overall Study|Lost to Follow-up|3|||
146983681|NCT00441584|530101930|FG000|Overall Study|Lack of Efficacy|79|||
146983682|NCT00441584|530101930|FG000|Overall Study|Withdrawal by Subject|8|||
146983683|NCT00441584|530101930|FG000|Overall Study|Adverse Event|6|||
146983684|NCT00441584|530101930|FG000|Overall Study|Protocol Violation|5|||
146983685|NCT00441584|530101930|FG000|Overall Study|Lost to Follow-up|4|||
146983686|NCT00441584|530101930|FG000|Overall Study|Failure to meet eligibility criteria|3|||
146983687|NCT00619619|530101931|FG000|Overall Study|Physician Decision|0|||
146983688|NCT00619619|530101932|FG001|Overall Study|Physician Decision|0|||
146983689|NCT00619619|530101933|FG002|Overall Study|Physician Decision|1|||
146983690|NCT00619619|530101934|FG003|Overall Study|Physician Decision|0|||
146983691|NCT00619619|530101935|FG004|Overall Study|Physician Decision|0|||
146983692|NCT00619619|530101936|FG005|Overall Study|Physician Decision|0|||
146983693|NCT00619619|530101937|FG006|Overall Study|Physician Decision|0|||
146983694|NCT00619619|530101938|FG007|Overall Study|Physician Decision|0|||
146983695|NCT00619619|530101931|FG000|Overall Study|Protocol Violation|0|||
146983696|NCT00619619|530101932|FG001|Overall Study|Protocol Violation|0|||
146983697|NCT00619619|530101933|FG002|Overall Study|Protocol Violation|0|||
146983698|NCT00619619|530101934|FG003|Overall Study|Protocol Violation|1|||
146983699|NCT00619619|530101935|FG004|Overall Study|Protocol Violation|0|||
146801832|NCT03222609|529447266|FG001|Overall Study|Death|13|||
146801833|NCT03222609|529447267|FG002|Overall Study|Death|9|||
146801834|NCT03222609|529447268|FG003|Overall Study|Death|6|||
146801835|NCT03222609|529447265|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
146801836|NCT03222609|529447266|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
146801837|NCT03222609|529447267|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
146983700|NCT00619619|530101936|FG005|Overall Study|Protocol Violation|0|||
146983701|NCT00619619|530101937|FG006|Overall Study|Protocol Violation|1|||
146801838|NCT03222609|529447268|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
146801839|NCT05139992|529447269|FG000|Overall Study|Withdrawal by Subject|12|||
146801840|NCT05139992|529447269|FG000|Overall Study|Lost to Follow-up|6|||
146801841|NCT03834740|529447270|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
146983702|NCT00619619|530101938|FG007|Overall Study|Protocol Violation|1|||
146983703|NCT00619619|530101931|FG000|Overall Study|Adverse Event|0|||
146983704|NCT00619619|530101932|FG001|Overall Study|Adverse Event|0|||
146983705|NCT00619619|530101933|FG002|Overall Study|Adverse Event|0|||
146983706|NCT00619619|530101934|FG003|Overall Study|Adverse Event|0|||
146983707|NCT00619619|530101935|FG004|Overall Study|Adverse Event|2|||
146983708|NCT00619619|530101936|FG005|Overall Study|Adverse Event|0|||
146983709|NCT00619619|530101937|FG006|Overall Study|Adverse Event|0|||
146983710|NCT00619619|530101938|FG007|Overall Study|Adverse Event|2|||
146983711|NCT01798485|530101940|FG000|Overall Study|Adverse Event|32|||
146983712|NCT01798485|530101941|FG001|Overall Study|Adverse Event|40|||
146983713|NCT01798485|530101940|FG000|Overall Study|Withdrawal by Subject|27|||
146983714|NCT01798485|530101941|FG001|Overall Study|Withdrawal by Subject|31|||
146983715|NCT01798485|530101940|FG000|Overall Study|Lost to Follow-up|0|||
146941443|NCT02371980|529945891|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
146941444|NCT02371980|529945892|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
146941445|NCT02371980|529945893|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
146941446|NCT02371980|529945894|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
146941447|NCT02371980|529945890|FG000|Open-label Period|Reason not Specified|9|||
146941448|NCT02371980|529945891|FG001|Open-label Period|Reason not Specified|0|||
146941449|NCT02371980|529945892|FG002|Open-label Period|Reason not Specified|0|||
146941450|NCT02371980|529945893|FG003|Open-label Period|Reason not Specified|0|||
146941451|NCT02371980|529945894|FG004|Open-label Period|Reason not Specified|0|||
146941452|NCT02371980|529945890|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
146941453|NCT02371980|529945891|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
146941454|NCT02371980|529945892|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
146941455|NCT02371980|529945893|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
146941456|NCT02371980|529945894|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
146941457|NCT02371980|529945890|FG000|Double-blind Period|Significant Protocol Deviation|0|||
146941458|NCT02371980|529945891|FG001|Double-blind Period|Significant Protocol Deviation|2|||
146941459|NCT02371980|529945892|FG002|Double-blind Period|Significant Protocol Deviation|7|||
146941460|NCT02371980|529945893|FG003|Double-blind Period|Significant Protocol Deviation|3|||
146941461|NCT02371980|529945894|FG004|Double-blind Period|Significant Protocol Deviation|3|||
146801842|NCT03834740|529447271|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
146801843|NCT03834740|529447272|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
146801844|NCT03593226|529447273|FG000|Overall Study|Disease progression|6|||
146801845|NCT03593226|529447274|FG001|Overall Study|Disease progression|13|||
146801846|NCT03593226|529447275|FG002|Overall Study|Disease progression|5|||
146801847|NCT03593226|529447276|FG003|Overall Study|Disease progression|6|||
146801848|NCT03593226|529447273|FG000|Overall Study|Adverse Event|0|||
146801849|NCT03593226|529447274|FG001|Overall Study|Adverse Event|1|||
146801850|NCT03593226|529447275|FG002|Overall Study|Adverse Event|0|||
146801851|NCT03593226|529447276|FG003|Overall Study|Adverse Event|0|||
146801852|NCT03593226|529447273|FG000|Overall Study|Withdrawal by Subject|0|||
146801853|NCT03593226|529447274|FG001|Overall Study|Withdrawal by Subject|4|||
146801854|NCT03593226|529447275|FG002|Overall Study|Withdrawal by Subject|1|||
146801855|NCT03593226|529447276|FG003|Overall Study|Withdrawal by Subject|0|||
146801856|NCT03593226|529447273|FG000|Overall Study|Physician Decision|0|||
146801857|NCT03593226|529447274|FG001|Overall Study|Physician Decision|1|||
146801858|NCT03593226|529447275|FG002|Overall Study|Physician Decision|0|||
146801859|NCT03593226|529447276|FG003|Overall Study|Physician Decision|0|||
146801860|NCT03593226|529447273|FG000|Overall Study|Clinical disease progression|0|||
146801861|NCT03593226|529447274|FG001|Overall Study|Clinical disease progression|0|||
146801862|NCT03593226|529447275|FG002|Overall Study|Clinical disease progression|1|||
146801863|NCT03593226|529447276|FG003|Overall Study|Clinical disease progression|0|||
146801864|NCT03891758|529447277|FG000|Overall Study|Adverse Event|2|||
146801865|NCT03891758|529447278|FG001|Overall Study|Adverse Event|0|||
146801866|NCT03891758|529447277|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146801867|NCT03891758|529447278|FG001|Overall Study|Withdrawal by parent/guardian|2|||
146801868|NCT03777657|529447279|FG000|Overall Study|Death|397|||
146801869|NCT03777657|529447280|FG001|Overall Study|Death|431|||
146801870|NCT03777657|529447279|FG000|Overall Study|Study Closed by Sponsor|77|||
146801871|NCT03777657|529447280|FG001|Overall Study|Study Closed by Sponsor|38|||
146801872|NCT03777657|529447279|FG000|Overall Study|Withdrawal by Subject|20|||
146801873|NCT03777657|529447280|FG001|Overall Study|Withdrawal by Subject|17|||
146801874|NCT03777657|529447279|FG000|Overall Study|Lost to Follow-up|6|||
146801875|NCT03777657|529447280|FG001|Overall Study|Lost to Follow-up|10|||
146801876|NCT03789110|529447281|FG000|Overall Study|Adverse Event|2|||
146801877|NCT03789110|529447281|FG000|Overall Study|Physician Decision|1|||
146801878|NCT03789110|529447281|FG000|Overall Study|Withdrawal by Subject|2|||
146801879|NCT03789110|529447281|FG000|Overall Study|Lack of Efficacy|22|||
146801880|NCT03789110|529447281|FG000|Overall Study|still on treatment|3|||
146801881|NCT03691493|529447282|FG000|Overall Study|Withdrawal by Subject|1|||
146801882|NCT02678689|529447284|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
146801883|NCT02678689|529447285|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
146801884|NCT02549352|529447286|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
146801885|NCT02549352|529447287|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
146801886|NCT02549352|529447286|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
146941462|NCT02371980|529945890|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
146941463|NCT02371980|529945891|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
146801887|NCT02549352|529447287|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
146801888|NCT02549352|529447286|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
146801889|NCT02549352|529447287|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
146801890|NCT02549352|529447286|FG000|12-month Follow-up|Withdrawal by Subject|4|||
146941464|NCT02371980|529945892|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
146941465|NCT02371980|529945893|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
146801891|NCT02549352|529447287|FG001|12-month Follow-up|Withdrawal by Subject|5|||
146801892|NCT02549352|529447286|FG000|12-month Follow-up|Lost to Follow-up|3|||
146801893|NCT02549352|529447287|FG001|12-month Follow-up|Lost to Follow-up|2|||
146801894|NCT02549352|529447286|FG000|12-month Follow-up|Death|0|||
146801895|NCT02549352|529447287|FG001|12-month Follow-up|Death|1|||
146801896|NCT02549352|529447286|FG000|12-month Follow-up|Protocol Violation|0|||
146801897|NCT02549352|529447287|FG001|12-month Follow-up|Protocol Violation|1|||
146801898|NCT02549352|529447286|FG000|12-month Follow-up|Other|1|||
146801899|NCT02549352|529447287|FG001|12-month Follow-up|Other|3|||
146801900|NCT05704725|529447288|FG000|Overall Study|Lost to Follow-up|0|||
146801901|NCT05704725|529447289|FG001|Overall Study|Lost to Follow-up|1|||
146801902|NCT05704725|529447288|FG000|Overall Study|Withdrawal by Subject|1|||
146801903|NCT05704725|529447289|FG001|Overall Study|Withdrawal by Subject|0|||
146801904|NCT01470144|529447290|FG000|Overall Study|Adverse Event|2|||
146801905|NCT01470144|529447290|FG000|Overall Study|Death|1|||
146801906|NCT01470144|529447290|FG000|Overall Study|Lung transplant|6|||
146801907|NCT01470144|529447290|FG000|Overall Study|Patient's and investigator's decision|1|||
146801908|NCT00593840|529447291|FG000|Overall Study|Withdrawal by Subject|1|||
146801909|NCT04503681|529448427|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
146801910|NCT04503681|529448428|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
146801911|NCT03752684|529448429|FG000|Overall Study|Lost to Follow-up|4|||
146801912|NCT03352713|529448432|FG000|Overall Study|Lost to Follow-up|8|||
146801913|NCT03352713|529448432|FG000|Overall Study|Withdrawn by investigator|5|||
146801914|NCT03352713|529448432|FG000|Overall Study|Completed 0 EMAs|8|||
146801915|NCT03352713|529448432|FG000|Overall Study|Device incompatible/stolen|5|||
146801916|NCT01812759|529448433|FG000|Overall Study|Physician Decision|0|||
146801917|NCT01812759|529448434|FG001|Overall Study|Physician Decision|0|||
146801918|NCT01812759|529448435|FG002|Overall Study|Physician Decision|1|||
146801919|NCT00536120|529448436|FG000|Overall Study|Lost to Follow-up|1|||
146801920|NCT00536120|529448437|FG001|Overall Study|Lost to Follow-up|0|||
146801921|NCT00536120|529448436|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
146801922|NCT00536120|529448437|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
146801923|NCT00536120|529448436|FG000|Overall Study|Non-compliance|1|||
146801924|NCT00536120|529448437|FG001|Overall Study|Non-compliance|0|||
146801925|NCT00536120|529448436|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
146801926|NCT00536120|529448437|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
146801927|NCT00536120|529448436|FG000|Overall Study|Steroid Use|0|||
146801928|NCT00536120|529448437|FG001|Overall Study|Steroid Use|2|||
146801929|NCT00536120|529448436|FG000|Overall Study|Missed Study Visit|0|||
146801930|NCT00536120|529448437|FG001|Overall Study|Missed Study Visit|1|||
146801931|NCT04559698|529448438|FG000|Overall Study|Lost to Follow-up|14|||
146801932|NCT04559698|529448439|FG001|Overall Study|Lost to Follow-up|15|||
146801933|NCT04559698|529448438|FG000|Overall Study|Withdrawal by Subject|0|||
146801934|NCT04559698|529448439|FG001|Overall Study|Withdrawal by Subject|1|||
146801935|NCT03437733|529448440|FG000|Overall Study|Eligibility criteria not met|0|||
146801936|NCT03437733|529448441|FG001|Overall Study|Eligibility criteria not met|3|||
146801937|NCT01982682|529448442|FG000|Overall Study|Physician Decision|1|||
146801938|NCT02760654|529448443|FG000|Overall Study|Lost to Follow-up|3|||
146801939|NCT02760654|529448444|FG001|Overall Study|Lost to Follow-up|3|||
146801940|NCT02760654|529448443|FG000|Overall Study|Withdrawal by Subject|4|||
146801941|NCT02760654|529448444|FG001|Overall Study|Withdrawal by Subject|3|||
146801942|NCT01184326|529448445|FG000|Overall Study|Adverse Event|1|||
146801943|NCT01184326|529448446|FG001|Overall Study|Adverse Event|2|||
146801944|NCT01184326|529448447|FG002|Overall Study|Adverse Event|0|||
146801945|NCT01184326|529448445|FG000|Overall Study|Death|0|||
146801946|NCT01184326|529448446|FG001|Overall Study|Death|0|||
146801947|NCT01184326|529448447|FG002|Overall Study|Death|1|||
146801948|NCT01184326|529448445|FG000|Overall Study|Withdrawal by Subject|0|||
146801949|NCT01184326|529448446|FG001|Overall Study|Withdrawal by Subject|0|||
146801950|NCT01184326|529448447|FG002|Overall Study|Withdrawal by Subject|1|||
146801951|NCT01184326|529448445|FG000|Overall Study|Physician Decision|1|||
146801952|NCT01184326|529448446|FG001|Overall Study|Physician Decision|1|||
146801953|NCT01184326|529448447|FG002|Overall Study|Physician Decision|0|||
146801954|NCT01184326|529448445|FG000|Overall Study|Disease Progression|1|||
146801955|NCT01184326|529448446|FG001|Overall Study|Disease Progression|3|||
146941466|NCT02371980|529945894|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
146941467|NCT02371980|529945890|FG000|Double-blind Period|Lost to Follow-up|0|||
146941468|NCT02371980|529945891|FG001|Double-blind Period|Lost to Follow-up|8|||
146801956|NCT01184326|529448447|FG002|Overall Study|Disease Progression|12|||
146801957|NCT01084694|529448448|FG000|Overall Study|Withdrawal by Subject|2|||
146801958|NCT01084694|529448449|FG001|Overall Study|Withdrawal by Subject|1|||
146801959|NCT01084694|529448448|FG000|Overall Study|Death|2|||
146801960|NCT01084694|529448449|FG001|Overall Study|Death|12|||
146801961|NCT01084694|529448448|FG000|Overall Study|eligibility not maintained|2|||
146801962|NCT01084694|529448449|FG001|Overall Study|eligibility not maintained|7|||
146941469|NCT02371980|529945892|FG002|Double-blind Period|Lost to Follow-up|8|||
146801963|NCT00605306|529448450|FG000|Overall Study|Adverse Event|0|||
146801964|NCT00605306|529448451|FG001|Overall Study|Adverse Event|1|||
146801965|NCT01750684|529448452|FG000|Overall Study|Death|1|||
146801966|NCT01750684|529448453|FG001|Overall Study|Death|0|||
146801967|NCT01750684|529448452|FG000|Overall Study|Non-compliance with Study Drug|0|||
146801968|NCT01750684|529448453|FG001|Overall Study|Non-compliance with Study Drug|1|||
146801969|NCT01750684|529448452|FG000|Overall Study|Withdrawn by Sponsor|0|||
146801970|NCT01750684|529448453|FG001|Overall Study|Withdrawn by Sponsor|1|||
146801971|NCT01750684|529448452|FG000|Overall Study|Protocol Violation|1|||
146801972|NCT01750684|529448453|FG001|Overall Study|Protocol Violation|0|||
146801973|NCT02185794|529448456|FG000|Overall Study|Enrolled but Never Dosed|1|||
146801974|NCT02185794|529448457|FG001|Overall Study|Enrolled but Never Dosed|6|||
146801975|NCT02185794|529448458|FG002|Overall Study|Enrolled but Never Dosed|3|||
146801976|NCT02185794|529448459|FG003|Overall Study|Enrolled but Never Dosed|1|||
146801977|NCT02185794|529448460|FG004|Overall Study|Enrolled but Never Dosed|1|||
146801978|NCT02185794|529448461|FG005|Overall Study|Enrolled but Never Dosed|0|||
146801979|NCT02185794|529448456|FG000|Overall Study|Investigator's Discretion|1|||
146801980|NCT02185794|529448457|FG001|Overall Study|Investigator's Discretion|0|||
146801981|NCT02185794|529448458|FG002|Overall Study|Investigator's Discretion|1|||
146801982|NCT02185794|529448459|FG003|Overall Study|Investigator's Discretion|2|||
146801983|NCT02185794|529448460|FG004|Overall Study|Investigator's Discretion|2|||
146801984|NCT02185794|529448461|FG005|Overall Study|Investigator's Discretion|15|||
146801985|NCT02185794|529448456|FG000|Overall Study|Withdrew Consent|2|||
146801986|NCT02185794|529448457|FG001|Overall Study|Withdrew Consent|5|||
146801987|NCT02185794|529448458|FG002|Overall Study|Withdrew Consent|10|||
146801988|NCT02185794|529448459|FG003|Overall Study|Withdrew Consent|2|||
146801989|NCT02185794|529448460|FG004|Overall Study|Withdrew Consent|0|||
146801990|NCT02185794|529448461|FG005|Overall Study|Withdrew Consent|0|||
146801991|NCT02185794|529448456|FG000|Overall Study|Lost to Follow-up|1|||
146801992|NCT02185794|529448457|FG001|Overall Study|Lost to Follow-up|2|||
146801993|NCT02185794|529448458|FG002|Overall Study|Lost to Follow-up|2|||
146801994|NCT02185794|529448459|FG003|Overall Study|Lost to Follow-up|3|||
146801995|NCT02185794|529448460|FG004|Overall Study|Lost to Follow-up|0|||
146801996|NCT02185794|529448461|FG005|Overall Study|Lost to Follow-up|1|||
146801997|NCT00336505|529448462|FG000|Overall Study|Adverse Event|10|||
146801998|NCT00336505|529448463|FG001|Overall Study|Adverse Event|9|||
146801999|NCT00336505|529448462|FG000|Overall Study|Lack of Efficacy|8|||
146802000|NCT00336505|529448463|FG001|Overall Study|Lack of Efficacy|4|||
146802001|NCT00336505|529448462|FG000|Overall Study|Lost to Follow-up|7|||
146802002|NCT00336505|529448463|FG001|Overall Study|Lost to Follow-up|4|||
146802003|NCT00336505|529448462|FG000|Overall Study|Withdrawal by Subject|5|||
146802004|NCT00336505|529448463|FG001|Overall Study|Withdrawal by Subject|3|||
146802005|NCT00336505|529448462|FG000|Overall Study|Other|7|||
146802006|NCT00336505|529448463|FG001|Overall Study|Other|7|||
146802007|NCT01092416|529448464|FG000|Enrollment|Atherectomy device not inserted|3|||
146802008|NCT01092416|529448464|FG000|30-Day Follow-up|Death|2|||
146802009|NCT01092416|529448464|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
146802010|NCT01092416|529448464|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
146802011|NCT01092416|529448464|FG000|12-Month Follow-up|Death|16|||
146802012|NCT01092416|529448464|FG000|12-Month Follow-up|Lost to Follow-up|4|||
146802013|NCT01092416|529448464|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
146802014|NCT01092416|529448464|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
146802015|NCT01092416|529448464|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
146802016|NCT00366249|529448465|FG000|Overall Study|Adverse Event|53|||
146802017|NCT00366249|529448466|FG001|Overall Study|Adverse Event|28|||
146802018|NCT00366249|529448465|FG000|Overall Study|Death|0|||
146802019|NCT00366249|529448466|FG001|Overall Study|Death|1|||
146802020|NCT00366249|529448465|FG000|Overall Study|Physician Decision|5|||
146802021|NCT00366249|529448466|FG001|Overall Study|Physician Decision|2|||
146802022|NCT00366249|529448465|FG000|Overall Study|Lost to Follow-up|2|||
146802023|NCT00366249|529448466|FG001|Overall Study|Lost to Follow-up|0|||
146802024|NCT00366249|529448465|FG000|Overall Study|Protocol Violation|1|||
146802025|NCT00366249|529448466|FG001|Overall Study|Protocol Violation|2|||
146802026|NCT00366249|529448465|FG000|Overall Study|Withdrawal by Subject|18|||
146802027|NCT00366249|529448466|FG001|Overall Study|Withdrawal by Subject|4|||
146802028|NCT00366249|529448465|FG000|Overall Study|Lack of Efficacy|21|||
146802029|NCT00366249|529448466|FG001|Overall Study|Lack of Efficacy|21|||
146802030|NCT00366249|529448465|FG000|Overall Study|Most due to osteomylitis status|31|||
146802031|NCT00366249|529448466|FG001|Overall Study|Most due to osteomylitis status|20|||
146802032|NCT01561300|529448467|FG000|Run in on Placebo|Adverse Event|1|||
146802033|NCT01561300|529448468|FG001|Run in on Placebo|Adverse Event|0|||
146802034|NCT00777049|529448469|FG000|Overall Study|Withdrawal by Subject|1|||
146802035|NCT00777049|529448470|FG001|Overall Study|Withdrawal by Subject|0|||
146802036|NCT00777049|529448469|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
146802037|NCT00777049|529448470|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
146802038|NCT00246805|529448471|FG000|Phase 1|Lost to Follow-up|1|||
146802039|NCT00246805|529448472|FG001|Phase 1|Lost to Follow-up|0|||
146802040|NCT03478969|529448473|FG000|Overall Study|Withdrawal by Subject|4|||
146802041|NCT03478969|529448474|FG001|Overall Study|Withdrawal by Subject|7|||
146802042|NCT03478969|529448475|FG002|Overall Study|Withdrawal by Subject|6|||
146802043|NCT03478969|529448473|FG000|Overall Study|Adverse Event|2|||
146802044|NCT03478969|529448474|FG001|Overall Study|Adverse Event|0|||
146802045|NCT03478969|529448475|FG002|Overall Study|Adverse Event|1|||
146802046|NCT03478969|529448473|FG000|Overall Study|Pregnancy|1|||
146802047|NCT03478969|529448474|FG001|Overall Study|Pregnancy|0|||
146802048|NCT03478969|529448475|FG002|Overall Study|Pregnancy|0|||
146802049|NCT03478969|529448473|FG000|Overall Study|Personal Reasons|1|||
146802050|NCT03478969|529448474|FG001|Overall Study|Personal Reasons|0|||
146802051|NCT03478969|529448475|FG002|Overall Study|Personal Reasons|1|||
146802052|NCT03478969|529448473|FG000|Overall Study|Covid-19|1|||
146802053|NCT03478969|529448474|FG001|Overall Study|Covid-19|4|||
146802054|NCT03478969|529448475|FG002|Overall Study|Covid-19|3|||
146802055|NCT03478969|529448473|FG000|Overall Study|Multiple Reasons|0|||
146802056|NCT03478969|529448474|FG001|Overall Study|Multiple Reasons|1|||
146941470|NCT02371980|529945893|FG003|Double-blind Period|Lost to Follow-up|6|||
146941471|NCT02371980|529945894|FG004|Double-blind Period|Lost to Follow-up|5|||
146941472|NCT02371980|529945890|FG000|Double-blind Period|Voluntary Withdrawal|0|||
146941473|NCT02371980|529945891|FG001|Double-blind Period|Voluntary Withdrawal|12|||
146941474|NCT02371980|529945892|FG002|Double-blind Period|Voluntary Withdrawal|8|||
146941475|NCT02371980|529945893|FG003|Double-blind Period|Voluntary Withdrawal|9|||
146941476|NCT02371980|529945894|FG004|Double-blind Period|Voluntary Withdrawal|11|||
146941477|NCT02371980|529945890|FG000|Double-blind Period|Relapse|0|||
146941478|NCT02371980|529945891|FG001|Double-blind Period|Relapse|50|||
146941479|NCT02371980|529945892|FG002|Double-blind Period|Relapse|25|||
146941480|NCT02371980|529945893|FG003|Double-blind Period|Relapse|25|||
146941481|NCT02371980|529945894|FG004|Double-blind Period|Relapse|26|||
146941482|NCT02371980|529945890|FG000|Double-blind Period|Reason not Specified|0|||
146941483|NCT02371980|529945891|FG001|Double-blind Period|Reason not Specified|3|||
146941484|NCT02371980|529945892|FG002|Double-blind Period|Reason not Specified|3|||
146941485|NCT02371980|529945893|FG003|Double-blind Period|Reason not Specified|2|||
146941486|NCT02371980|529945894|FG004|Double-blind Period|Reason not Specified|1|||
146941487|NCT02371980|529945890|FG000|Double-blind Period|Missing|0|||
146941488|NCT02371980|529945891|FG001|Double-blind Period|Missing|1|||
146941489|NCT02371980|529945892|FG002|Double-blind Period|Missing|0|||
146941490|NCT02371980|529945893|FG003|Double-blind Period|Missing|0|||
146941491|NCT02371980|529945894|FG004|Double-blind Period|Missing|0|||
146941492|NCT00922974|529945895|FG000|Phase II Component|Protocol Violation|2|||
146941493|NCT00922974|529945896|FG001|Phase II Component|Protocol Violation|0|||
146941494|NCT00922974|529945895|FG000|Phase II Component|Not evaluable for treatment review|5|||
146941495|NCT00922974|529945896|FG001|Phase II Component|Not evaluable for treatment review|0|||
146941496|NCT00922974|529945895|FG000|Phase III Component|Protocol Violation|8|||
146941497|NCT00922974|529945896|FG001|Phase III Component|Protocol Violation|6|||
146941498|NCT02944513|529945897|FG000|Overall Study|Withdrawal by Subject|4|||
146941499|NCT02944513|529945898|FG001|Overall Study|Withdrawal by Subject|1|||
146941500|NCT00937326|529945899|FG000|Overall Study|Adverse Event|0|||
146941501|NCT00937326|529945900|FG001|Overall Study|Adverse Event|3|||
146941502|NCT00937326|529945901|FG002|Overall Study|Adverse Event|1|||
146941503|NCT00937326|529945902|FG003|Overall Study|Adverse Event|1|||
146941504|NCT00937326|529945903|FG004|Overall Study|Adverse Event|2|||
146941505|NCT00937326|529945899|FG000|Overall Study|Death|0|||
146941506|NCT00937326|529945900|FG001|Overall Study|Death|0|||
146941507|NCT00937326|529945901|FG002|Overall Study|Death|1|||
146941508|NCT00937326|529945902|FG003|Overall Study|Death|0|||
146941509|NCT00937326|529945903|FG004|Overall Study|Death|0|||
146941510|NCT00937326|529945899|FG000|Overall Study|Withdrawal by Subject|3|||
146941511|NCT00937326|529945900|FG001|Overall Study|Withdrawal by Subject|4|||
146941512|NCT00937326|529945901|FG002|Overall Study|Withdrawal by Subject|1|||
146941513|NCT00937326|529945902|FG003|Overall Study|Withdrawal by Subject|4|||
146802057|NCT03478969|529448475|FG002|Overall Study|Multiple Reasons|1|||
146802058|NCT03478969|529448473|FG000|Overall Study|Eligibility Criteria|0|||
146802059|NCT03478969|529448474|FG001|Overall Study|Eligibility Criteria|0|||
146802060|NCT03478969|529448475|FG002|Overall Study|Eligibility Criteria|5|||
146941514|NCT00937326|529945903|FG004|Overall Study|Withdrawal by Subject|3|||
146941515|NCT00937326|529945899|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
146941516|NCT00937326|529945900|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
146941517|NCT00937326|529945901|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
146941518|NCT00937326|529945902|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
146941519|NCT00937326|529945903|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
146802061|NCT03478969|529448473|FG000|Overall Study|Lost to Follow-up|0|||
146941520|NCT00790218|529945904|FG000|Overall Study|Death|1|||
146941521|NCT00790218|529945905|FG001|Overall Study|Death|0|||
146941522|NCT00790218|529945906|FG002|Overall Study|Death|0|||
146941523|NCT02443155|529945907|FG000|Overall Study|Adverse Event|3|||
146802062|NCT03478969|529448474|FG001|Overall Study|Lost to Follow-up|0|||
146802063|NCT03478969|529448475|FG002|Overall Study|Lost to Follow-up|1|||
146802064|NCT01185600|529448476|FG000|Overall Study|Adverse Event|1|||
146802065|NCT01185600|529448477|FG001|Overall Study|Adverse Event|1|||
146941524|NCT02443155|529945908|FG001|Overall Study|Adverse Event|4|||
146941525|NCT02443155|529945909|FG002|Overall Study|Adverse Event|1|||
146802066|NCT01185600|529448476|FG000|Overall Study|Death|0|||
146802067|NCT01185600|529448477|FG001|Overall Study|Death|1|||
146802068|NCT01185600|529448476|FG000|Overall Study|Lost to Follow-up|0|||
146802069|NCT01185600|529448477|FG001|Overall Study|Lost to Follow-up|5|||
146802070|NCT01185600|529448476|FG000|Overall Study|Physician Decision|29|||
146802071|NCT01185600|529448477|FG001|Overall Study|Physician Decision|35|||
146802072|NCT01185600|529448476|FG000|Overall Study|Withdrawal by Subject|1|||
146802073|NCT01185600|529448477|FG001|Overall Study|Withdrawal by Subject|1|||
146802074|NCT01185600|529448476|FG000|Overall Study|Hold by DSMB|1|||
146802075|NCT01185600|529448477|FG001|Overall Study|Hold by DSMB|2|||
146802076|NCT00724126|529448478|FG000|Overall Study|Adverse Event|2|||
146802077|NCT00724126|529448479|FG001|Overall Study|Adverse Event|0|||
146802078|NCT00724126|529448478|FG000|Overall Study|Withdrawal by Subject|8|||
146802079|NCT00724126|529448479|FG001|Overall Study|Withdrawal by Subject|6|||
146802080|NCT00724126|529448478|FG000|Overall Study|Lost to Follow-up|6|||
146802081|NCT00724126|529448479|FG001|Overall Study|Lost to Follow-up|6|||
146802082|NCT00724126|529448478|FG000|Overall Study|Noncompliance|2|||
146802083|NCT00724126|529448479|FG001|Overall Study|Noncompliance|1|||
146802084|NCT00724126|529448478|FG000|Overall Study|Subject randomized although ineligible|1|||
146802085|NCT00724126|529448479|FG001|Overall Study|Subject randomized although ineligible|1|||
146802086|NCT00724126|529448478|FG000|Overall Study|Subject had to leave vicinity of site|0|||
146802087|NCT00724126|529448479|FG001|Overall Study|Subject had to leave vicinity of site|1|||
146802088|NCT00739934|529448481|FG000|Voriconazole IV|Adverse Event|6|||
146802089|NCT00739934|529448481|FG000|Voriconazole Oral|Other|3|||
146802090|NCT01579318|529448484|FG000|Overall Study|Disease Progression|1|||
146802091|NCT03066609|529448491|FG000|INDUCTION|Pregnancy|0|||
146802092|NCT03066609|529448492|FG001|INDUCTION|Pregnancy|0|||
146802093|NCT03066609|529448493|FG002|INDUCTION|Pregnancy|1|||
146802094|NCT03066609|529448494|FG003|INDUCTION|Pregnancy|0|||
146802095|NCT03066609|529448491|FG000|INDUCTION|Lack of Efficacy|0|||
146802096|NCT03066609|529448492|FG001|INDUCTION|Lack of Efficacy|0|||
146802097|NCT03066609|529448493|FG002|INDUCTION|Lack of Efficacy|1|||
146802098|NCT03066609|529448494|FG003|INDUCTION|Lack of Efficacy|0|||
146802099|NCT03066609|529448491|FG000|INDUCTION|Adverse Event|2|||
146802100|NCT03066609|529448492|FG001|INDUCTION|Adverse Event|2|||
146802101|NCT03066609|529448493|FG002|INDUCTION|Adverse Event|0|||
146802102|NCT03066609|529448494|FG003|INDUCTION|Adverse Event|0|||
146802103|NCT03066609|529448491|FG000|MAINTENANCE|Adverse Event|0|||
146802104|NCT03066609|529448492|FG001|MAINTENANCE|Adverse Event|0|||
146802105|NCT03066609|529448493|FG002|MAINTENANCE|Adverse Event|0|||
146802106|NCT03066609|529448494|FG003|MAINTENANCE|Adverse Event|1|||
146802107|NCT03066609|529448491|FG000|MAINTENANCE|Withdrawal by Subject|4|||
146802108|NCT03066609|529448492|FG001|MAINTENANCE|Withdrawal by Subject|2|||
146802109|NCT03066609|529448493|FG002|MAINTENANCE|Withdrawal by Subject|1|||
146802110|NCT03066609|529448494|FG003|MAINTENANCE|Withdrawal by Subject|1|||
146802111|NCT03066609|529448491|FG000|MAINTENANCE|Lost to Follow-up|0|||
146802112|NCT03066609|529448492|FG001|MAINTENANCE|Lost to Follow-up|1|||
146802113|NCT03066609|529448493|FG002|MAINTENANCE|Lost to Follow-up|1|||
146802114|NCT03066609|529448494|FG003|MAINTENANCE|Lost to Follow-up|0|||
146802115|NCT03066609|529448491|FG000|MAINTENANCE|Pregnancy|1|||
146802116|NCT03066609|529448492|FG001|MAINTENANCE|Pregnancy|0|||
146802117|NCT03066609|529448493|FG002|MAINTENANCE|Pregnancy|0|||
146802118|NCT03066609|529448494|FG003|MAINTENANCE|Pregnancy|0|||
146802119|NCT03066609|529448491|FG000|MAINTENANCE|Lack of Efficacy|2|||
146802120|NCT03066609|529448492|FG001|MAINTENANCE|Lack of Efficacy|1|||
146802121|NCT03066609|529448493|FG002|MAINTENANCE|Lack of Efficacy|0|||
146802122|NCT03066609|529448494|FG003|MAINTENANCE|Lack of Efficacy|1|||
146802123|NCT03066609|529448491|FG000|OVERALL STUDY|Adverse Event|2|||
146802124|NCT03066609|529448492|FG001|OVERALL STUDY|Adverse Event|2|||
146802125|NCT03066609|529448493|FG002|OVERALL STUDY|Adverse Event|0|||
146802126|NCT03066609|529448494|FG003|OVERALL STUDY|Adverse Event|1|||
146802127|NCT03066609|529448491|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
146802128|NCT03066609|529448492|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
146802129|NCT03066609|529448493|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
146802130|NCT03066609|529448494|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
146802131|NCT03066609|529448491|FG000|OVERALL STUDY|Lost to Follow-up|1|||
146802132|NCT03066609|529448492|FG001|OVERALL STUDY|Lost to Follow-up|1|||
146802133|NCT03066609|529448493|FG002|OVERALL STUDY|Lost to Follow-up|1|||
146802134|NCT03066609|529448494|FG003|OVERALL STUDY|Lost to Follow-up|1|||
146802135|NCT03066609|529448491|FG000|OVERALL STUDY|Pregnancy|1|||
146802136|NCT03066609|529448492|FG001|OVERALL STUDY|Pregnancy|0|||
146802137|NCT03066609|529448493|FG002|OVERALL STUDY|Pregnancy|1|||
146802138|NCT03066609|529448494|FG003|OVERALL STUDY|Pregnancy|0|||
146802139|NCT03066609|529448491|FG000|OVERALL STUDY|Lack of Efficacy|2|||
146802140|NCT03066609|529448492|FG001|OVERALL STUDY|Lack of Efficacy|1|||
146802141|NCT03066609|529448493|FG002|OVERALL STUDY|Lack of Efficacy|1|||
146802142|NCT03066609|529448494|FG003|OVERALL STUDY|Lack of Efficacy|1|||
146802143|NCT03066609|529448491|FG000|OVERALL STUDY|discontinued follow up|0|||
146802144|NCT03066609|529448492|FG001|OVERALL STUDY|discontinued follow up|2|||
146802145|NCT03066609|529448493|FG002|OVERALL STUDY|discontinued follow up|0|||
146802146|NCT03066609|529448494|FG003|OVERALL STUDY|discontinued follow up|0|||
146802147|NCT03355573|529448495|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
146802148|NCT03355573|529448495|FG000|Overall Study|Sponsor's decision|1|||
146802149|NCT03355573|529448495|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
146802150|NCT03355573|529448495|FG000|Overall Study|PI's decision|2|||
146802151|NCT03355573|529448495|FG000|Overall Study|Withdrawal by Subject|23|||
146802152|NCT03355573|529448495|FG000|Overall Study|Lost to Follow-up|4|||
146802153|NCT03355573|529448495|FG000|Overall Study|Lack of Efficacy|2|||
146802154|NCT03355573|529448495|FG000|Overall Study|Adverse Event, non-fatal|17|||
146802155|NCT03355573|529448495|FG000|Overall Study|Adverse Event, serious fatal|2|||
146802156|NCT01566890|529448496|FG000|Overall Study|Adverse Event|1|||
146802157|NCT01566890|529448497|FG001|Overall Study|Adverse Event|0|||
146802158|NCT01566890|529448498|FG002|Overall Study|Adverse Event|0|||
146802159|NCT01566890|529448499|FG003|Overall Study|Adverse Event|0|||
146802160|NCT01566890|529448500|FG004|Overall Study|Adverse Event|0|||
146802161|NCT01566890|529448496|FG000|Overall Study|Withdrawal by Subject|3|||
146802162|NCT01566890|529448497|FG001|Overall Study|Withdrawal by Subject|1|||
146802163|NCT01566890|529448498|FG002|Overall Study|Withdrawal by Subject|1|||
146802164|NCT01566890|529448499|FG003|Overall Study|Withdrawal by Subject|1|||
146802165|NCT01566890|529448500|FG004|Overall Study|Withdrawal by Subject|0|||
146802166|NCT01566890|529448496|FG000|Overall Study|Screen failure|6|||
146802167|NCT01566890|529448497|FG001|Overall Study|Screen failure|0|||
146802168|NCT01566890|529448498|FG002|Overall Study|Screen failure|1|||
146802169|NCT01566890|529448499|FG003|Overall Study|Screen failure|1|||
146802170|NCT01566890|529448500|FG004|Overall Study|Screen failure|0|||
146802171|NCT01566890|529448496|FG000|Overall Study|Incomplete CEU data|1|||
146802172|NCT01566890|529448497|FG001|Overall Study|Incomplete CEU data|3|||
146802173|NCT01566890|529448498|FG002|Overall Study|Incomplete CEU data|5|||
146802174|NCT01566890|529448499|FG003|Overall Study|Incomplete CEU data|8|||
146802175|NCT01566890|529448500|FG004|Overall Study|Incomplete CEU data|0|||
146802176|NCT01566890|529448496|FG000|Overall Study|Lost to Follow-up|0|||
146802177|NCT01566890|529448497|FG001|Overall Study|Lost to Follow-up|0|||
146802178|NCT01566890|529448498|FG002|Overall Study|Lost to Follow-up|4|||
146802179|NCT01566890|529448499|FG003|Overall Study|Lost to Follow-up|4|||
146802180|NCT01566890|529448500|FG004|Overall Study|Lost to Follow-up|0|||
146802181|NCT01566890|529448496|FG000|Overall Study|Other|0|||
146802182|NCT01566890|529448497|FG001|Overall Study|Other|0|||
146802183|NCT01566890|529448498|FG002|Overall Study|Other|0|||
146802184|NCT01566890|529448499|FG003|Overall Study|Other|0|||
146802185|NCT01566890|529448500|FG004|Overall Study|Other|7|||
146802186|NCT00523419|529448511|FG000|Overall Study|Adverse Event|1|||
146802187|NCT00523419|529448511|FG000|Overall Study|Withdrawal by Subject|1|||
146802188|NCT00523419|529448511|FG000|Overall Study|Physician Decision|2|||
146802189|NCT00523419|529448511|FG000|Overall Study|Progressive Disease|22|||
146802190|NCT00523419|529448511|FG000|Overall Study|Death due to Study Disease|4|||
146802191|NCT00523419|529448511|FG000|Overall Study|Death due to Adverse Event|2|||
146802192|NCT01211184|529448512|FG000|Overall Study|Withdrawal by Subject|0|||
146802193|NCT01211184|529448513|FG001|Overall Study|Withdrawal by Subject|2|||
146802194|NCT01211184|529448514|FG002|Overall Study|Withdrawal by Subject|1|||
146802195|NCT01421667|529448515|FG000|Overall Study|Withdrawal by Subject|0|||
146802196|NCT01421667|529448516|FG001|Overall Study|Withdrawal by Subject|1|||
146802197|NCT01421667|529448517|FG002|Overall Study|Withdrawal by Subject|2|||
146802198|NCT01421667|529448518|FG003|Overall Study|Withdrawal by Subject|1|||
146802199|NCT01421667|529448515|FG000|Overall Study|Lost to Follow-up|0|||
146802200|NCT01421667|529448516|FG001|Overall Study|Lost to Follow-up|1|||
146802201|NCT01421667|529448517|FG002|Overall Study|Lost to Follow-up|0|||
146802202|NCT01421667|529448518|FG003|Overall Study|Lost to Follow-up|0|||
146802203|NCT00822120|529448519|FG000|Initial Registration|Adverse Event|1|||
146802204|NCT00822120|529448520|FG001|Initial Registration|Adverse Event|0|||
146802205|NCT00822120|529448521|FG002|Initial Registration|Adverse Event|0|||
146802206|NCT00822120|529448522|FG003|Initial Registration|Adverse Event|0|||
146802207|NCT00822120|529448523|FG004|Initial Registration|Adverse Event|0|||
146802208|NCT00822120|529448524|FG005|Initial Registration|Adverse Event|0|||
146802209|NCT00822120|529448519|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
146802210|NCT00822120|529448520|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
146802211|NCT00822120|529448521|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
146802212|NCT00822120|529448522|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
146802213|NCT00822120|529448523|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
146802214|NCT00822120|529448524|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
146802215|NCT00822120|529448519|FG000|Initial Registration|Reasons not Protocol Specified|2|||
146802216|NCT00822120|529448520|FG001|Initial Registration|Reasons not Protocol Specified|0|||
146802217|NCT00822120|529448521|FG002|Initial Registration|Reasons not Protocol Specified|0|||
146802218|NCT00822120|529448522|FG003|Initial Registration|Reasons not Protocol Specified|0|||
146802219|NCT00822120|529448523|FG004|Initial Registration|Reasons not Protocol Specified|0|||
146802220|NCT00822120|529448524|FG005|Initial Registration|Reasons not Protocol Specified|0|||
146802221|NCT00822120|529448519|FG000|Initial Registration|Ineligible|22|||
146802222|NCT00822120|529448520|FG001|Initial Registration|Ineligible|1|||
146802223|NCT00822120|529448521|FG002|Initial Registration|Ineligible|0|||
146802224|NCT00822120|529448522|FG003|Initial Registration|Ineligible|0|||
146802225|NCT00822120|529448523|FG004|Initial Registration|Ineligible|0|||
146802226|NCT00822120|529448524|FG005|Initial Registration|Ineligible|0|||
146802227|NCT00822120|529448519|FG000|PET-directed Therapy|Adverse Event|0|||
146802228|NCT00822120|529448520|FG001|PET-directed Therapy|Adverse Event|0|||
146802229|NCT00822120|529448521|FG002|PET-directed Therapy|Adverse Event|0|||
146802230|NCT00822120|529448522|FG003|PET-directed Therapy|Adverse Event|1|||
146802231|NCT00822120|529448523|FG004|PET-directed Therapy|Adverse Event|0|||
146802232|NCT00822120|529448524|FG005|PET-directed Therapy|Adverse Event|0|||
146802233|NCT00822120|529448519|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
146802234|NCT00822120|529448520|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
146802235|NCT00822120|529448521|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
146802236|NCT00822120|529448522|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
146802237|NCT00822120|529448523|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
146802238|NCT00822120|529448524|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
146802239|NCT00822120|529448519|FG000|PET-directed Therapy|Death|0|||
146802240|NCT00822120|529448520|FG001|PET-directed Therapy|Death|0|||
146802241|NCT00822120|529448521|FG002|PET-directed Therapy|Death|0|||
146802242|NCT00822120|529448522|FG003|PET-directed Therapy|Death|2|||
146802243|NCT00822120|529448523|FG004|PET-directed Therapy|Death|0|||
146802244|NCT00822120|529448524|FG005|PET-directed Therapy|Death|0|||
146802245|NCT00822120|529448519|FG000|PET-directed Therapy|Protocol Violation|0|||
146802246|NCT00822120|529448520|FG001|PET-directed Therapy|Protocol Violation|0|||
146802247|NCT00822120|529448521|FG002|PET-directed Therapy|Protocol Violation|0|||
146802248|NCT00822120|529448522|FG003|PET-directed Therapy|Protocol Violation|6|||
146802249|NCT00822120|529448523|FG004|PET-directed Therapy|Protocol Violation|0|||
146802250|NCT00822120|529448524|FG005|PET-directed Therapy|Protocol Violation|0|||
146802251|NCT04060212|529448526|FG000|Overall Study|Withdrawal by Subject|7|||
146802252|NCT03802994|529448530|FG000|Overall Study|Lost to Follow-up|0|||
146802253|NCT03802994|529448531|FG001|Overall Study|Lost to Follow-up|2|||
146802254|NCT03802994|529448532|FG002|Overall Study|Lost to Follow-up|3|||
146802255|NCT03802994|529448533|FG003|Overall Study|Lost to Follow-up|2|||
146802256|NCT03802994|529448534|FG004|Overall Study|Lost to Follow-up|2|||
146802257|NCT02646618|529448535|FG000|Overall Study|Lost to Follow-up|10|||
146802258|NCT02646618|529448536|FG001|Overall Study|Lost to Follow-up|14|||
146802259|NCT00918203|529448538|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
146802260|NCT00918203|529448539|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
146802261|NCT00918203|529448540|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
146802262|NCT00918203|529448538|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
146802263|NCT00918203|529448539|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
146802264|NCT00918203|529448540|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
146802265|NCT00918203|529448538|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
146802266|NCT00918203|529448539|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
146802267|NCT00918203|529448540|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
146802268|NCT00918203|529448538|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
146802269|NCT00918203|529448539|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
146802270|NCT00918203|529448540|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
146802271|NCT00701701|529448543|FG000|Overall Study|Withdrawal by Subject|0|||
146802272|NCT00701701|529448544|FG001|Overall Study|Withdrawal by Subject|1|||
146802273|NCT00701701|529448543|FG000|Overall Study|Adverse Event|0|||
146802274|NCT00701701|529448544|FG001|Overall Study|Adverse Event|1|||
146802275|NCT00589875|529448545|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
146941526|NCT02443155|529945910|FG003|Overall Study|Adverse Event|2|||
146941527|NCT02443155|529945907|FG000|Overall Study|Unclassified|0|||
146941528|NCT02443155|529945908|FG001|Overall Study|Unclassified|0|||
146941529|NCT02443155|529945909|FG002|Overall Study|Unclassified|2|||
146941530|NCT02443155|529945910|FG003|Overall Study|Unclassified|1|||
146941531|NCT02443155|529945907|FG000|Overall Study|Withdrawal by Subject|4|||
146802276|NCT00589875|529448545|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
146802277|NCT03357952|529448548|FG000|Overall Study|Withdrawal by Subject|0|||
146802278|NCT03357952|529448549|FG001|Overall Study|Withdrawal by Subject|1|||
146802279|NCT03357952|529448548|FG000|Overall Study|Sponsor Decision|9|||
146802280|NCT03357952|529448549|FG001|Overall Study|Sponsor Decision|0|||
146802281|NCT01208974|529448550|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
146802282|NCT01208974|529448551|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
146802283|NCT01208974|529448552|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
146802284|NCT01208974|529448553|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
146802285|NCT01208974|529448550|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
146802286|NCT01208974|529448551|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
146802287|NCT01208974|529448552|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
146941532|NCT02443155|529945908|FG001|Overall Study|Withdrawal by Subject|7|||
146802288|NCT01208974|529448553|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
146802289|NCT01208974|529448550|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
146802290|NCT01208974|529448551|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
146802291|NCT01208974|529448552|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
146802292|NCT01208974|529448553|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
146802293|NCT04517435|529448570|FG000|Overall Study|Withdrawal by Subject|0|||
146802294|NCT04517435|529448571|FG001|Overall Study|Withdrawal by Subject|0|||
146802295|NCT04517435|529448572|FG002|Overall Study|Withdrawal by Subject|1|||
146802296|NCT04517435|529448570|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
146802297|NCT04517435|529448571|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
146802298|NCT04517435|529448572|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
146802299|NCT06191679|529448573|FG000|Baseline|Lost to Follow-up|1|||
146802300|NCT06191679|529448574|FG001|Baseline|Lost to Follow-up|0|||
146802301|NCT06191679|529448575|FG002|Baseline|Lost to Follow-up|1|||
146802302|NCT06191679|529448576|FG003|Baseline|Lost to Follow-up|0|||
146802303|NCT06191679|529448573|FG000|Allocation to Group|Withdrawal by Subject|0|||
146802304|NCT06191679|529448574|FG001|Allocation to Group|Withdrawal by Subject|1|||
146802305|NCT06191679|529448575|FG002|Allocation to Group|Withdrawal by Subject|2|||
146802306|NCT06191679|529448576|FG003|Allocation to Group|Withdrawal by Subject|0|||
146802307|NCT06191679|529448573|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
146802308|NCT06191679|529448574|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
146802309|NCT06191679|529448575|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
146802310|NCT06191679|529448576|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
146802311|NCT06191679|529448573|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
146802312|NCT06191679|529448574|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
146802313|NCT06191679|529448575|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
146802314|NCT06191679|529448576|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
146802315|NCT06191679|529448573|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
146802316|NCT06191679|529448574|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
146802317|NCT06191679|529448575|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
146802318|NCT06191679|529448576|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
146802319|NCT03459196|529450519|FG000|Overall Study|Subject didn't receive study catheter|2|||
146802320|NCT04989816|529450521|FG000|Overall Study|Death|77|||
146802321|NCT04989816|529450521|FG000|Overall Study|Lost to Follow-up|3|||
146802322|NCT04213807|529450527|FG000|Overall Study|Physician Decision|0|||
146802323|NCT04213807|529450528|FG001|Overall Study|Physician Decision|0|||
146802324|NCT04213807|529450529|FG002|Overall Study|Physician Decision|1|||
146802325|NCT01128595|529450532|FG000|Treatment Period 3|Withdrawal by Subject|0|||
146802326|NCT01128595|529450533|FG001|Treatment Period 3|Withdrawal by Subject|1|||
146802327|NCT01128595|529450534|FG002|Treatment Period 3|Withdrawal by Subject|0|||
146802328|NCT01128595|529450535|FG003|Treatment Period 3|Withdrawal by Subject|0|||
146802329|NCT00372775|529450536|FG000|Overall Study|Adverse Event|8|||
146802330|NCT00372775|529450536|FG000|Overall Study|Death|15|||
146802331|NCT00372775|529450536|FG000|Overall Study|Objective progression or relapse|30|||
146802332|NCT00372775|529450536|FG000|Overall Study|Global deterioration of health status|6|||
146802333|NCT00372775|529450536|FG000|Overall Study|Withdrawal by Subject|1|||
146802334|NCT00372775|529450536|FG000|Overall Study|Other|1|||
146802335|NCT00372775|529450536|FG000|Overall Study|Not Treated|2|||
146802336|NCT00890591|529450539|FG000|Overall Study|Lack of Efficacy|20|||
146802337|NCT01436175|529450542|FG000|Overall Study|Adverse Event|111|||
146802338|NCT01436175|529450542|FG000|Overall Study|Protocol Violation|49|||
146802339|NCT01436175|529450542|FG000|Overall Study|Withdrawal by Subject|108|||
146802340|NCT01436175|529450542|FG000|Overall Study|Lost to Follow-up|89|||
146802341|NCT01436175|529450542|FG000|Overall Study|Lack of Efficacy|24|||
146802342|NCT01436175|529450542|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
146802343|NCT01436175|529450542|FG000|Overall Study|Other|826|||
146802344|NCT05405244|529450543|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
146802345|NCT05405244|529450544|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
146802346|NCT05405244|529450543|FG000|Washout (2 Weeks)|Adverse Event|2|||
146802347|NCT05405244|529450544|FG001|Washout (2 Weeks)|Adverse Event|0|||
146802348|NCT05405244|529450543|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
146802349|NCT05405244|529450544|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
146802350|NCT03418922|529450545|FG000|Overall Study|Withdrawal by Subject|0|||
146802351|NCT03418922|529450546|FG001|Overall Study|Withdrawal by Subject|2|||
146802352|NCT03418922|529450545|FG000|Overall Study|Adverse Event|2|||
146802353|NCT03418922|529450546|FG001|Overall Study|Adverse Event|2|||
146802354|NCT03418922|529450545|FG000|Overall Study|Death|0|||
146802355|NCT03418922|529450546|FG001|Overall Study|Death|1|||
146802356|NCT03418922|529450545|FG000|Overall Study|Physician Decision|0|||
146802357|NCT03418922|529450546|FG001|Overall Study|Physician Decision|1|||
146802358|NCT03577106|529450547|FG000|Overall Study|Withdrawal by Subject|3|||
146802359|NCT03601715|529450550|FG000|Second Intervention|Lost to Follow-up|1|||
146802360|NCT03601715|529450551|FG001|Second Intervention|Lost to Follow-up|1|||
146802361|NCT03601715|529450552|FG002|Second Intervention|Lost to Follow-up|0|||
146802362|NCT02347332|529450553|FG000|Overall Study|Not treated|5|||
146802363|NCT02347332|529450554|FG001|Overall Study|Not treated|2|||
146802364|NCT02347332|529450553|FG000|Overall Study|Progressive disease|141|||
146802365|NCT02347332|529450554|FG001|Overall Study|Progressive disease|159|||
146802366|NCT02347332|529450553|FG000|Overall Study|Adverse Event|50|||
146802367|NCT02347332|529450554|FG001|Overall Study|Adverse Event|41|||
146802368|NCT02347332|529450553|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
146802369|NCT02347332|529450554|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
146802370|NCT02347332|529450553|FG000|Overall Study|Protocol Violation|1|||
146802371|NCT02347332|529450554|FG001|Overall Study|Protocol Violation|1|||
146802372|NCT02347332|529450553|FG000|Overall Study|Lost to Follow-up|2|||
146802373|NCT02347332|529450554|FG001|Overall Study|Lost to Follow-up|1|||
146802374|NCT02347332|529450553|FG000|Overall Study|Physician Decision|4|||
146802375|NCT02347332|529450554|FG001|Overall Study|Physician Decision|3|||
146802376|NCT02347332|529450553|FG000|Overall Study|Withdrawal by Subject|20|||
146802377|NCT02347332|529450554|FG001|Overall Study|Withdrawal by Subject|14|||
146802378|NCT02347332|529450553|FG000|Overall Study|Protocol requirement|1|||
146802379|NCT02347332|529450554|FG001|Overall Study|Protocol requirement|1|||
146802380|NCT02347332|529450553|FG000|Overall Study|Switch Post-Trial program|0|||
146802381|NCT02347332|529450554|FG001|Overall Study|Switch Post-Trial program|1|||
146802382|NCT01478594|529450556|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
146802383|NCT01478594|529450557|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
146802384|NCT01478594|529450556|FG000|Overall Study|Death|45|||
146802385|NCT01478594|529450557|FG001|Overall Study|Death|18|||
146802386|NCT01478594|529450556|FG000|Overall Study|Lost to Follow-up|3|||
146802387|NCT01478594|529450557|FG001|Overall Study|Lost to Follow-up|1|||
146802388|NCT01478594|529450556|FG000|Overall Study|Withdrawal by Subject|9|||
146802389|NCT01478594|529450557|FG001|Overall Study|Withdrawal by Subject|3|||
146802390|NCT01478594|529450556|FG000|Overall Study|Study Closed by Sponsor|8|||
146802391|NCT01478594|529450557|FG001|Overall Study|Study Closed by Sponsor|5|||
146802392|NCT01313884|529450559|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
146802393|NCT01970007|529450560|FG000|Overall Study|Death|5|||
146802394|NCT01970007|529450560|FG000|Overall Study|Withdrawal by Subject|23|||
146802395|NCT01970007|529450560|FG000|Overall Study|Lost to Follow-up|24|||
146802396|NCT01970007|529450560|FG000|Overall Study|"Other endpoint"|3|||
146802397|NCT02854436|529450561|FG000|Overall Study|Adverse Event|1|||
146802398|NCT02854436|529450561|FG000|Overall Study|Death|208|||
146802399|NCT02854436|529450561|FG000|Overall Study|Lost to Follow-up|5|||
146802400|NCT02854436|529450561|FG000|Overall Study|Withdrawal by Subject|24|||
146802401|NCT02854436|529450561|FG000|Overall Study|Other|45|||
146802402|NCT02854436|529450561|FG000|Overall Study|Physician Decision|6|||
146802403|NCT04250194|529450562|FG000|Overall Study|Declined to schedule biopsy|6|||
146802404|NCT04250194|529450563|FG001|Overall Study|Declined to schedule biopsy|10|||
146802405|NCT04250194|529450562|FG000|Overall Study|Medically Unfit for Biopsy|2|||
146802406|NCT04250194|529450563|FG001|Overall Study|Medically Unfit for Biopsy|1|||
146802407|NCT04250194|529450562|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
146802408|NCT04250194|529450563|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
146802409|NCT04250194|529450562|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
146802410|NCT04250194|529450563|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
146802411|NCT04250194|529450562|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
146802412|NCT04250194|529450563|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
146802413|NCT01499849|529450566|FG000|Overall Study|Adverse Event|28|||
146802414|NCT01499849|529450567|FG001|Overall Study|Adverse Event|32|||
146802415|NCT01499849|529450566|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
146802416|NCT01499849|529450567|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
146802417|NCT01499849|529450566|FG000|Overall Study|Withdrawal by Subject|43|||
146802418|NCT01499849|529450567|FG001|Overall Study|Withdrawal by Subject|43|||
146802419|NCT01499849|529450566|FG000|Overall Study|Death|5|||
146802420|NCT01499849|529450567|FG001|Overall Study|Death|7|||
146802421|NCT01499849|529450566|FG000|Overall Study|Disease Progression|11|||
146802422|NCT01499849|529450567|FG001|Overall Study|Disease Progression|10|||
146802423|NCT01499849|529450566|FG000|Overall Study|Protocol Violation|11|||
146802424|NCT01499849|529450567|FG001|Overall Study|Protocol Violation|11|||
146802425|NCT01499849|529450566|FG000|Overall Study|Physician Decision|20|||
146802426|NCT01499849|529450567|FG001|Overall Study|Physician Decision|19|||
146802427|NCT01499849|529450566|FG000|Overall Study|Lack of Efficacy|3|||
146802428|NCT01499849|529450567|FG001|Overall Study|Lack of Efficacy|4|||
146802429|NCT01499849|529450566|FG000|Overall Study|Lost to Follow-up|6|||
146802430|NCT01499849|529450567|FG001|Overall Study|Lost to Follow-up|3|||
146802431|NCT01499849|529450566|FG000|Overall Study|Other Reasons|27|||
146802432|NCT01499849|529450567|FG001|Overall Study|Other Reasons|30|||
146802433|NCT00174252|529450568|FG000|Overall Study|Protocol Violation|2|||
146802434|NCT00622700|529450574|FG000|Core Treatment Period|Randomized but Not Treated|0|||
146983716|NCT01798485|530101941|FG001|Overall Study|Lost to Follow-up|3|||
146802435|NCT00622700|529450575|FG001|Core Treatment Period|Randomized but Not Treated|2|||
146802436|NCT00622700|529450576|FG002|Core Treatment Period|Randomized but Not Treated|2|||
146802437|NCT00622700|529450577|FG003|Core Treatment Period|Randomized but Not Treated|0|||
146802438|NCT00622700|529450578|FG004|Core Treatment Period|Randomized but Not Treated|0|||
146802439|NCT00622700|529450579|FG005|Core Treatment Period|Randomized but Not Treated|0|||
146802440|NCT00622700|529450580|FG006|Core Treatment Period|Randomized but Not Treated|0|||
146802441|NCT00622700|529450574|FG000|Core Treatment Period|Adverse Event|18|||
146802442|NCT00622700|529450575|FG001|Core Treatment Period|Adverse Event|25|||
146802443|NCT00622700|529450576|FG002|Core Treatment Period|Adverse Event|18|||
146802444|NCT00622700|529450577|FG003|Core Treatment Period|Adverse Event|0|||
146802445|NCT00622700|529450578|FG004|Core Treatment Period|Adverse Event|0|||
146802446|NCT00622700|529450579|FG005|Core Treatment Period|Adverse Event|0|||
146802447|NCT00622700|529450580|FG006|Core Treatment Period|Adverse Event|0|||
146802448|NCT00622700|529450574|FG000|Core Treatment Period|Lack of Efficacy|19|||
146802449|NCT00622700|529450575|FG001|Core Treatment Period|Lack of Efficacy|6|||
146802450|NCT00622700|529450576|FG002|Core Treatment Period|Lack of Efficacy|12|||
146802451|NCT00622700|529450577|FG003|Core Treatment Period|Lack of Efficacy|0|||
146802452|NCT00622700|529450578|FG004|Core Treatment Period|Lack of Efficacy|0|||
146802453|NCT00622700|529450579|FG005|Core Treatment Period|Lack of Efficacy|0|||
146802454|NCT00622700|529450580|FG006|Core Treatment Period|Lack of Efficacy|0|||
146802455|NCT00622700|529450574|FG000|Core Treatment Period|Lost to Follow-up|1|||
146802456|NCT00622700|529450575|FG001|Core Treatment Period|Lost to Follow-up|1|||
146802457|NCT00622700|529450576|FG002|Core Treatment Period|Lost to Follow-up|1|||
146802458|NCT00622700|529450577|FG003|Core Treatment Period|Lost to Follow-up|0|||
146802459|NCT00622700|529450578|FG004|Core Treatment Period|Lost to Follow-up|0|||
146802460|NCT00622700|529450579|FG005|Core Treatment Period|Lost to Follow-up|0|||
146802461|NCT00622700|529450580|FG006|Core Treatment Period|Lost to Follow-up|0|||
146802462|NCT00622700|529450574|FG000|Core Treatment Period|Death|1|||
146802463|NCT00622700|529450575|FG001|Core Treatment Period|Death|0|||
146802464|NCT00622700|529450576|FG002|Core Treatment Period|Death|0|||
146802465|NCT00622700|529450577|FG003|Core Treatment Period|Death|0|||
146802466|NCT00622700|529450578|FG004|Core Treatment Period|Death|0|||
146802467|NCT00622700|529450579|FG005|Core Treatment Period|Death|0|||
146802468|NCT00622700|529450580|FG006|Core Treatment Period|Death|0|||
146802469|NCT00622700|529450574|FG000|Core Treatment Period|Progressive Disease|3|||
146802470|NCT00622700|529450575|FG001|Core Treatment Period|Progressive Disease|1|||
146802471|NCT00622700|529450576|FG002|Core Treatment Period|Progressive Disease|0|||
146802472|NCT00622700|529450577|FG003|Core Treatment Period|Progressive Disease|0|||
146802473|NCT00622700|529450578|FG004|Core Treatment Period|Progressive Disease|0|||
146802474|NCT00622700|529450579|FG005|Core Treatment Period|Progressive Disease|0|||
146802475|NCT00622700|529450580|FG006|Core Treatment Period|Progressive Disease|0|||
146802476|NCT00622700|529450574|FG000|Core Treatment Period|Withdrawal by Subject|12|||
146802477|NCT00622700|529450575|FG001|Core Treatment Period|Withdrawal by Subject|18|||
146802478|NCT00622700|529450576|FG002|Core Treatment Period|Withdrawal by Subject|15|||
146802479|NCT00622700|529450577|FG003|Core Treatment Period|Withdrawal by Subject|0|||
146802480|NCT00622700|529450578|FG004|Core Treatment Period|Withdrawal by Subject|0|||
146802481|NCT00622700|529450579|FG005|Core Treatment Period|Withdrawal by Subject|0|||
146802482|NCT00622700|529450580|FG006|Core Treatment Period|Withdrawal by Subject|0|||
146802483|NCT00622700|529450574|FG000|Core Treatment Period|Other than specified above|2|||
146802484|NCT00622700|529450575|FG001|Core Treatment Period|Other than specified above|2|||
146802485|NCT00622700|529450576|FG002|Core Treatment Period|Other than specified above|5|||
146802486|NCT00622700|529450577|FG003|Core Treatment Period|Other than specified above|0|||
146802487|NCT00622700|529450578|FG004|Core Treatment Period|Other than specified above|0|||
146802488|NCT00622700|529450579|FG005|Core Treatment Period|Other than specified above|0|||
146802489|NCT00622700|529450580|FG006|Core Treatment Period|Other than specified above|0|||
146802490|NCT00622700|529450574|FG000|Extension Treatment Period|Adverse Event|0|||
146802491|NCT00622700|529450575|FG001|Extension Treatment Period|Adverse Event|0|||
146802492|NCT00622700|529450576|FG002|Extension Treatment Period|Adverse Event|0|||
146802493|NCT00622700|529450577|FG003|Extension Treatment Period|Adverse Event|5|||
146802494|NCT00622700|529450578|FG004|Extension Treatment Period|Adverse Event|9|||
146802495|NCT00622700|529450579|FG005|Extension Treatment Period|Adverse Event|6|||
146802496|NCT00622700|529450580|FG006|Extension Treatment Period|Adverse Event|8|||
146802497|NCT00622700|529450574|FG000|Extension Treatment Period|Lack of Efficacy|0|||
146802498|NCT00622700|529450575|FG001|Extension Treatment Period|Lack of Efficacy|0|||
146802499|NCT00622700|529450576|FG002|Extension Treatment Period|Lack of Efficacy|0|||
146802500|NCT00622700|529450577|FG003|Extension Treatment Period|Lack of Efficacy|2|||
146802501|NCT00622700|529450578|FG004|Extension Treatment Period|Lack of Efficacy|8|||
146802502|NCT00622700|529450579|FG005|Extension Treatment Period|Lack of Efficacy|1|||
146802503|NCT00622700|529450580|FG006|Extension Treatment Period|Lack of Efficacy|9|||
146802504|NCT00622700|529450574|FG000|Extension Treatment Period|Protocol Violation|0|||
146802505|NCT00622700|529450575|FG001|Extension Treatment Period|Protocol Violation|0|||
146802506|NCT00622700|529450576|FG002|Extension Treatment Period|Protocol Violation|0|||
146802507|NCT00622700|529450577|FG003|Extension Treatment Period|Protocol Violation|0|||
146983717|NCT01798485|530101940|FG000|Overall Study|Physician Decision|14|||
146983718|NCT01798485|530101941|FG001|Overall Study|Physician Decision|10|||
146802508|NCT00622700|529450578|FG004|Extension Treatment Period|Protocol Violation|0|||
146802509|NCT00622700|529450579|FG005|Extension Treatment Period|Protocol Violation|2|||
146802510|NCT00622700|529450580|FG006|Extension Treatment Period|Protocol Violation|0|||
146802511|NCT00622700|529450574|FG000|Extension Treatment Period|Lost to Follow-up|0|||
146802512|NCT00622700|529450575|FG001|Extension Treatment Period|Lost to Follow-up|0|||
146802513|NCT00622700|529450576|FG002|Extension Treatment Period|Lost to Follow-up|0|||
146802514|NCT00622700|529450577|FG003|Extension Treatment Period|Lost to Follow-up|0|||
146802515|NCT00622700|529450578|FG004|Extension Treatment Period|Lost to Follow-up|1|||
146802516|NCT00622700|529450579|FG005|Extension Treatment Period|Lost to Follow-up|0|||
146802517|NCT00622700|529450580|FG006|Extension Treatment Period|Lost to Follow-up|0|||
146802518|NCT00622700|529450574|FG000|Extension Treatment Period|Progressive Disease|0|||
146802519|NCT00622700|529450575|FG001|Extension Treatment Period|Progressive Disease|0|||
146802520|NCT00622700|529450576|FG002|Extension Treatment Period|Progressive Disease|0|||
146802521|NCT00622700|529450577|FG003|Extension Treatment Period|Progressive Disease|1|||
146802522|NCT00622700|529450578|FG004|Extension Treatment Period|Progressive Disease|2|||
146802523|NCT00622700|529450579|FG005|Extension Treatment Period|Progressive Disease|0|||
146802524|NCT00622700|529450580|FG006|Extension Treatment Period|Progressive Disease|2|||
146802525|NCT00622700|529450574|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
146802526|NCT00622700|529450575|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
146802527|NCT00622700|529450576|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
146802528|NCT00622700|529450577|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
146802529|NCT00622700|529450578|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
146802530|NCT00622700|529450579|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
146802531|NCT00622700|529450580|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
146802532|NCT00622700|529450574|FG000|Extension Treatment Period|Missing|0|||
146802533|NCT00622700|529450575|FG001|Extension Treatment Period|Missing|0|||
146802534|NCT00622700|529450576|FG002|Extension Treatment Period|Missing|0|||
146802535|NCT00622700|529450577|FG003|Extension Treatment Period|Missing|2|||
146802536|NCT00622700|529450578|FG004|Extension Treatment Period|Missing|3|||
146802537|NCT00622700|529450579|FG005|Extension Treatment Period|Missing|1|||
146802538|NCT00622700|529450580|FG006|Extension Treatment Period|Missing|0|||
146802539|NCT00622700|529450574|FG000|Extension Treatment Period|Other than specified above|0|||
146802540|NCT00622700|529450575|FG001|Extension Treatment Period|Other than specified above|0|||
146802541|NCT00622700|529450576|FG002|Extension Treatment Period|Other than specified above|0|||
146802542|NCT00622700|529450577|FG003|Extension Treatment Period|Other than specified above|0|||
146802543|NCT00622700|529450578|FG004|Extension Treatment Period|Other than specified above|0|||
146802544|NCT00622700|529450579|FG005|Extension Treatment Period|Other than specified above|1|||
146802545|NCT00622700|529450580|FG006|Extension Treatment Period|Other than specified above|1|||
146802546|NCT00942266|529450581|FG000|Overall Study|Withdrawal by Subject|1|||
146802547|NCT00942266|529450582|FG001|Overall Study|Withdrawal by Subject|0|||
146802548|NCT00942266|529450581|FG000|Overall Study|Adverse Event|2|||
146802549|NCT00942266|529450582|FG001|Overall Study|Adverse Event|1|||
146802550|NCT00942266|529450581|FG000|Overall Study|Disease Progression|38|||
146802551|NCT00942266|529450582|FG001|Overall Study|Disease Progression|11|||
146802552|NCT00942266|529450581|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
146802553|NCT00942266|529450582|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
146802554|NCT00942266|529450581|FG000|Overall Study|Intercurrent illness|0|||
146802555|NCT00942266|529450582|FG001|Overall Study|Intercurrent illness|1|||
146802556|NCT00942266|529450581|FG000|Overall Study|Physician Decision|2|||
146802557|NCT00942266|529450582|FG001|Overall Study|Physician Decision|0|||
146802558|NCT00942266|529450581|FG000|Overall Study|medical deterioration (pneumonia)|0|||
146802559|NCT00942266|529450582|FG001|Overall Study|medical deterioration (pneumonia)|1|||
146802560|NCT03611556|529450583|FG000|Overall Study|Death|7|||
146802561|NCT03611556|529450584|FG001|Overall Study|Death|7|||
146802562|NCT03611556|529450585|FG002|Overall Study|Death|3|||
146802563|NCT03611556|529450586|FG003|Overall Study|Death|8|||
146802564|NCT03611556|529450587|FG004|Overall Study|Death|47|||
146802565|NCT03611556|529450588|FG005|Overall Study|Death|32|||
146802566|NCT03611556|529450589|FG006|Overall Study|Death|53|||
146802567|NCT03611556|529450583|FG000|Overall Study|Withdrawal by Subject|0|||
146802568|NCT03611556|529450584|FG001|Overall Study|Withdrawal by Subject|0|||
146802569|NCT03611556|529450585|FG002|Overall Study|Withdrawal by Subject|0|||
146802570|NCT03611556|529450586|FG003|Overall Study|Withdrawal by Subject|0|||
146983719|NCT01798485|530101940|FG000|Overall Study|Objective Disease Progression|152|||
146983720|NCT01798485|530101941|FG001|Overall Study|Objective Disease Progression|106|||
146983721|NCT01798485|530101940|FG000|Overall Study|Death|25|||
146802571|NCT03611556|529450587|FG004|Overall Study|Withdrawal by Subject|4|||
146802572|NCT03611556|529450588|FG005|Overall Study|Withdrawal by Subject|2|||
146802573|NCT03611556|529450589|FG006|Overall Study|Withdrawal by Subject|4|||
146983722|NCT01798485|530101941|FG001|Overall Study|Death|22|||
146983723|NCT01798485|530101940|FG000|Overall Study|Sponsor Decision|61|||
146802574|NCT03611556|529450583|FG000|Overall Study|Sponsor decision|0|||
146802575|NCT03611556|529450584|FG001|Overall Study|Sponsor decision|0|||
146802576|NCT03611556|529450585|FG002|Overall Study|Sponsor decision|0|||
146802577|NCT03611556|529450586|FG003|Overall Study|Sponsor decision|0|||
146802578|NCT03611556|529450587|FG004|Overall Study|Sponsor decision|9|||
146802579|NCT03611556|529450588|FG005|Overall Study|Sponsor decision|4|||
146802580|NCT03611556|529450589|FG006|Overall Study|Sponsor decision|12|||
146802581|NCT03611556|529450583|FG000|Overall Study|Reasons|0|||
146802582|NCT03611556|529450584|FG001|Overall Study|Reasons|0|||
146802583|NCT03611556|529450585|FG002|Overall Study|Reasons|0|||
146802584|NCT03611556|529450586|FG003|Overall Study|Reasons|0|||
146802585|NCT03611556|529450587|FG004|Overall Study|Reasons|2|||
146802586|NCT03611556|529450588|FG005|Overall Study|Reasons|0|||
146802587|NCT03611556|529450589|FG006|Overall Study|Reasons|1|||
146802588|NCT02844439|529450595|FG000|Overall Study|Withdrawal by Subject|1|||
146802589|NCT02844439|529450595|FG000|Overall Study|Lost to Follow-up|2|||
146802590|NCT02844439|529450595|FG000|Overall Study|Termination by Sponsor|4|||
146802591|NCT02844439|529450595|FG000|Overall Study|Death|28|||
146802592|NCT02844439|529450595|FG000|Overall Study|Other|5|||
146802593|NCT05580003|529450601|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802594|NCT05580003|529450602|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802595|NCT05580003|529450603|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802596|NCT05580003|529450604|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802597|NCT05580003|529450605|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802598|NCT05580003|529450606|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802599|NCT05580003|529450607|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
146802600|NCT05580003|529450608|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802601|NCT05580003|529450609|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802602|NCT05580003|529450610|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802603|NCT05580003|529450611|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802604|NCT05580003|529450612|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802605|NCT05580003|529450613|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802606|NCT05580003|529450614|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802607|NCT05580003|529450615|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802608|NCT05580003|529450616|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802609|NCT05580003|529450617|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802610|NCT05580003|529450618|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802611|NCT05580003|529450619|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802612|NCT05580003|529450620|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802613|NCT05580003|529450621|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802614|NCT05580003|529450622|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802615|NCT05580003|529450623|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802616|NCT05580003|529450624|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802617|NCT05580003|529450625|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802618|NCT05580003|529450626|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802619|NCT05580003|529450627|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802620|NCT05580003|529450628|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146802621|NCT05580003|529450601|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802622|NCT05580003|529450602|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802623|NCT05580003|529450603|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802624|NCT05580003|529450604|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802625|NCT05580003|529450605|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802626|NCT05580003|529450606|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
146802627|NCT05580003|529450607|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802628|NCT05580003|529450608|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802629|NCT05580003|529450609|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802630|NCT05580003|529450610|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802631|NCT05580003|529450611|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802632|NCT05580003|529450612|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802633|NCT05580003|529450613|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802634|NCT05580003|529450614|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802635|NCT05580003|529450615|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802636|NCT05580003|529450616|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802637|NCT05580003|529450617|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802638|NCT05580003|529450618|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802639|NCT05580003|529450619|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802640|NCT05580003|529450620|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802641|NCT05580003|529450621|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802642|NCT05580003|529450622|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802643|NCT05580003|529450623|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802644|NCT05580003|529450624|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802645|NCT05580003|529450625|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802646|NCT05580003|529450626|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802647|NCT05580003|529450627|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802648|NCT05580003|529450628|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146802649|NCT05580003|529450601|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802650|NCT05580003|529450602|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802651|NCT05580003|529450603|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802652|NCT05580003|529450604|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
146802653|NCT05580003|529450605|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802654|NCT05580003|529450606|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802655|NCT05580003|529450607|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802656|NCT05580003|529450608|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802657|NCT05580003|529450609|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802658|NCT05580003|529450610|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802659|NCT05580003|529450611|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802660|NCT05580003|529450612|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802661|NCT05580003|529450613|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802662|NCT05580003|529450614|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802663|NCT05580003|529450615|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802664|NCT05580003|529450616|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802665|NCT05580003|529450617|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802666|NCT05580003|529450618|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802667|NCT05580003|529450619|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802668|NCT05580003|529450620|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802669|NCT05580003|529450621|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802670|NCT05580003|529450622|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802671|NCT05580003|529450623|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802672|NCT05580003|529450624|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802673|NCT05580003|529450625|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802674|NCT05580003|529450626|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802675|NCT05580003|529450627|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802676|NCT05580003|529450628|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146802677|NCT05580003|529450601|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802678|NCT05580003|529450602|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
146802679|NCT05580003|529450603|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802680|NCT05580003|529450604|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802681|NCT05580003|529450605|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802682|NCT05580003|529450606|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802683|NCT05580003|529450607|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802684|NCT05580003|529450608|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802685|NCT05580003|529450609|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802686|NCT05580003|529450610|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802687|NCT05580003|529450611|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802688|NCT05580003|529450612|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802689|NCT05580003|529450613|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802690|NCT05580003|529450614|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802691|NCT05580003|529450615|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802692|NCT05580003|529450616|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802693|NCT05580003|529450617|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802694|NCT05580003|529450618|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802695|NCT05580003|529450619|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802696|NCT05580003|529450620|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802697|NCT05580003|529450621|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802698|NCT05580003|529450622|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802699|NCT05580003|529450623|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802700|NCT05580003|529450624|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802701|NCT05580003|529450625|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802702|NCT05580003|529450626|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802703|NCT05580003|529450627|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802704|NCT05580003|529450628|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146802705|NCT05580003|529450601|FG000|Part 2 (up to 10 Days)|Other|0|||
146802706|NCT05580003|529450602|FG001|Part 2 (up to 10 Days)|Other|0|||
146802707|NCT05580003|529450603|FG002|Part 2 (up to 10 Days)|Other|0|||
146802708|NCT05580003|529450604|FG003|Part 2 (up to 10 Days)|Other|0|||
146802709|NCT05580003|529450605|FG004|Part 2 (up to 10 Days)|Other|0|||
146802710|NCT05580003|529450606|FG005|Part 2 (up to 10 Days)|Other|0|||
146802711|NCT05580003|529450607|FG006|Part 2 (up to 10 Days)|Other|0|||
146802712|NCT05580003|529450608|FG007|Part 2 (up to 10 Days)|Other|0|||
146802713|NCT05580003|529450609|FG008|Part 2 (up to 10 Days)|Other|0|||
146802714|NCT05580003|529450610|FG009|Part 2 (up to 10 Days)|Other|1|||
146941533|NCT02443155|529945909|FG002|Overall Study|Withdrawal by Subject|3|||
146941534|NCT02443155|529945910|FG003|Overall Study|Withdrawal by Subject|9|||
146941535|NCT02443155|529945907|FG000|Overall Study|Pregnancy|3|||
146941536|NCT02443155|529945908|FG001|Overall Study|Pregnancy|1|||
146941537|NCT02443155|529945909|FG002|Overall Study|Pregnancy|1|||
146941538|NCT02443155|529945910|FG003|Overall Study|Pregnancy|2|||
146941539|NCT02443155|529945907|FG000|Overall Study|Lost to Follow-up|1|||
146941540|NCT02443155|529945908|FG001|Overall Study|Lost to Follow-up|2|||
146941541|NCT02443155|529945909|FG002|Overall Study|Lost to Follow-up|0|||
146941542|NCT02443155|529945910|FG003|Overall Study|Lost to Follow-up|1|||
146941543|NCT02443155|529945907|FG000|Overall Study|Protocol Violation|1|||
146941544|NCT02443155|529945908|FG001|Overall Study|Protocol Violation|0|||
146941545|NCT02443155|529945909|FG002|Overall Study|Protocol Violation|1|||
146941546|NCT02443155|529945910|FG003|Overall Study|Protocol Violation|1|||
146941547|NCT02443155|529945907|FG000|Overall Study|Death|0|||
146941548|NCT02443155|529945908|FG001|Overall Study|Death|0|||
146941549|NCT02443155|529945909|FG002|Overall Study|Death|1|||
146941550|NCT02443155|529945910|FG003|Overall Study|Death|0|||
146941551|NCT00731666|529945918|FG000|Overall Study|Adverse Event|2|||
146941552|NCT00731666|529945918|FG000|Overall Study|Lost to Follow-up|8|||
146941553|NCT00731666|529945918|FG000|Overall Study|Withdrawal by Subject|2|||
146941554|NCT00088595|529945919|FG000|Overall Study|Adverse Event|11|||
146941555|NCT00088595|529945919|FG000|Overall Study|Withdrawal by Subject|8|||
146941556|NCT00088595|529945919|FG000|Overall Study|Ongoing (After Core)|7|||
146941557|NCT00088595|529945919|FG000|Overall Study|New Cancer Therapy|2|||
146941558|NCT05283499|529945931|FG000|Overall Study|Did not receive intervention|1|||
146941559|NCT05283499|529945932|FG001|Overall Study|Did not receive intervention|2|||
146941560|NCT02408484|529945933|FG000|Overall Study|Withdrawal by Subject|3|||
146941561|NCT02408484|529945933|FG000|Overall Study|Not treated during study period|1|||
146941562|NCT02436915|529945934|FG000|Overall Study|Withdrawal by Subject|0|||
146941563|NCT02436915|529945935|FG001|Overall Study|Withdrawal by Subject|1|||
146941564|NCT01117181|529945937|FG000|Overall Study|Lost to Follow-up|1|||
146941565|NCT01117181|529945938|FG001|Overall Study|Lost to Follow-up|0|||
146941566|NCT01117181|529945937|FG000|Overall Study|Withdrawal by Subject|0|||
146941567|NCT01117181|529945938|FG001|Overall Study|Withdrawal by Subject|2|||
146941568|NCT00420342|529945944|FG000|Overall Study|Lost to Follow-up|1|||
146941569|NCT00420342|529945945|FG001|Overall Study|Lost to Follow-up|0|||
146941570|NCT00420342|529945946|FG002|Overall Study|Lost to Follow-up|1|||
146941571|NCT00420342|529945944|FG000|Overall Study|Withdrawal by Subject|0|||
146941572|NCT00420342|529945945|FG001|Overall Study|Withdrawal by Subject|2|||
146941573|NCT00420342|529945946|FG002|Overall Study|Withdrawal by Subject|0|||
146941574|NCT01599806|529945949|FG000|Overall Study|Lost to Follow-up|20|||
146941575|NCT01599806|529945950|FG001|Overall Study|Lost to Follow-up|20|||
146941576|NCT01599806|529945949|FG000|Overall Study|Withdrawal by Subject|12|||
146941577|NCT01599806|529945950|FG001|Overall Study|Withdrawal by Subject|12|||
146941578|NCT01599806|529945949|FG000|Overall Study|Other Eligibility criteria|11|||
146941579|NCT01599806|529945950|FG001|Overall Study|Other Eligibility criteria|9|||
146941580|NCT03006926|529945954|FG000|Overall Study|Adverse Event|0|||
146941581|NCT03006926|529945955|FG001|Overall Study|Adverse Event|27|||
146941582|NCT03006926|529945954|FG000|Overall Study|Withdrawal by Subject|0|||
146941583|NCT03006926|529945955|FG001|Overall Study|Withdrawal by Subject|1|||
146941584|NCT03006926|529945954|FG000|Overall Study|Radiological Disease Progression|0|||
146941585|NCT03006926|529945955|FG001|Overall Study|Radiological Disease Progression|52|||
146941586|NCT03006926|529945954|FG000|Overall Study|Clinical Disease Progression|0|||
146941587|NCT03006926|529945955|FG001|Overall Study|Clinical Disease Progression|10|||
146941588|NCT03006926|529945954|FG000|Overall Study|Other|0|||
146941589|NCT03006926|529945955|FG001|Overall Study|Other|8|||
146941590|NCT03689972|529945956|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
146941591|NCT03689972|529945957|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
146941592|NCT03689972|529945958|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
146941593|NCT03689972|529945959|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
146941594|NCT03689972|529945960|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
146941595|NCT03689972|529945956|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
146941596|NCT03689972|529945957|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
146941597|NCT03689972|529945958|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
146941598|NCT03689972|529945959|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
146941599|NCT03689972|529945960|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
146941600|NCT03689972|529945956|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
146941601|NCT03689972|529945957|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
146941602|NCT03689972|529945958|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
146941603|NCT03689972|529945959|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
146941604|NCT03689972|529945960|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
146941605|NCT03689972|529945956|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
146983724|NCT01798485|530101941|FG001|Overall Study|Sponsor Decision|54|||
146802715|NCT05580003|529450611|FG010|Part 2 (up to 10 Days)|Other|0|||
146802716|NCT05580003|529450612|FG011|Part 2 (up to 10 Days)|Other|0|||
146802717|NCT05580003|529450613|FG012|Part 2 (up to 10 Days)|Other|0|||
146802718|NCT05580003|529450614|FG013|Part 2 (up to 10 Days)|Other|0|||
146802719|NCT05580003|529450615|FG014|Part 2 (up to 10 Days)|Other|0|||
146802720|NCT05580003|529450616|FG015|Part 2 (up to 10 Days)|Other|0|||
146802721|NCT05580003|529450617|FG016|Part 2 (up to 10 Days)|Other|0|||
146802722|NCT05580003|529450618|FG017|Part 2 (up to 10 Days)|Other|0|||
146802723|NCT05580003|529450619|FG018|Part 2 (up to 10 Days)|Other|0|||
146802724|NCT05580003|529450620|FG019|Part 2 (up to 10 Days)|Other|0|||
146802725|NCT05580003|529450621|FG020|Part 2 (up to 10 Days)|Other|0|||
146802726|NCT05580003|529450622|FG021|Part 2 (up to 10 Days)|Other|0|||
146802727|NCT05580003|529450623|FG022|Part 2 (up to 10 Days)|Other|0|||
146802728|NCT05580003|529450624|FG023|Part 2 (up to 10 Days)|Other|0|||
146802729|NCT05580003|529450625|FG024|Part 2 (up to 10 Days)|Other|0|||
146802730|NCT05580003|529450626|FG025|Part 2 (up to 10 Days)|Other|0|||
146802731|NCT05580003|529450627|FG026|Part 2 (up to 10 Days)|Other|0|||
146802732|NCT05580003|529450628|FG027|Part 2 (up to 10 Days)|Other|0|||
146802733|NCT05580003|529450601|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802734|NCT05580003|529450602|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802735|NCT05580003|529450603|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802736|NCT05580003|529450604|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802737|NCT05580003|529450605|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802738|NCT05580003|529450606|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802739|NCT05580003|529450607|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802740|NCT05580003|529450608|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802741|NCT05580003|529450609|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802742|NCT05580003|529450610|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802743|NCT05580003|529450611|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802744|NCT05580003|529450612|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802745|NCT05580003|529450613|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802746|NCT05580003|529450614|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802747|NCT05580003|529450615|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802748|NCT05580003|529450616|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802749|NCT05580003|529450617|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802750|NCT05580003|529450618|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802751|NCT05580003|529450619|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802752|NCT05580003|529450620|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
146802753|NCT05580003|529450621|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802754|NCT05580003|529450622|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802755|NCT05580003|529450623|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802756|NCT05580003|529450624|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802757|NCT05580003|529450625|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802758|NCT05580003|529450626|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802759|NCT05580003|529450627|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802760|NCT05580003|529450628|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146802761|NCT05580003|529450601|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802762|NCT05580003|529450602|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802763|NCT05580003|529450603|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802764|NCT05580003|529450604|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802765|NCT05580003|529450605|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802766|NCT05580003|529450606|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802767|NCT05580003|529450607|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802768|NCT05580003|529450608|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802769|NCT05580003|529450609|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802770|NCT05580003|529450610|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802771|NCT05580003|529450611|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802772|NCT05580003|529450612|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802773|NCT05580003|529450613|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802774|NCT05580003|529450614|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802775|NCT05580003|529450615|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802776|NCT05580003|529450616|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802777|NCT05580003|529450617|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802778|NCT05580003|529450618|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802779|NCT05580003|529450619|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146983725|NCT01798485|530101940|FG000|Overall Study|Clinical Progression|35|||
146983726|NCT01798485|530101941|FG001|Overall Study|Clinical Progression|24|||
146983727|NCT02087046|530101942|FG000|Overall Study|Adverse Event|4|||
146802780|NCT05580003|529450620|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802781|NCT05580003|529450621|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
146802782|NCT05580003|529450622|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146983728|NCT02087046|530101942|FG000|Overall Study|Death|1|||
146802783|NCT05580003|529450623|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802784|NCT05580003|529450624|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802785|NCT05580003|529450625|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802786|NCT05580003|529450626|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802787|NCT05580003|529450627|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802788|NCT05580003|529450628|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146802789|NCT05580003|529450601|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802790|NCT05580003|529450602|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802791|NCT05580003|529450603|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802792|NCT05580003|529450604|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802793|NCT05580003|529450605|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802794|NCT05580003|529450606|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802795|NCT05580003|529450607|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802796|NCT05580003|529450608|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802797|NCT05580003|529450609|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802798|NCT05580003|529450610|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802799|NCT05580003|529450611|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802800|NCT05580003|529450612|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802801|NCT05580003|529450613|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802802|NCT05580003|529450614|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802803|NCT05580003|529450615|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802804|NCT05580003|529450616|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802805|NCT05580003|529450617|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802806|NCT05580003|529450618|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802807|NCT05580003|529450619|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802808|NCT05580003|529450620|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802809|NCT05580003|529450621|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802810|NCT05580003|529450622|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
146802811|NCT05580003|529450623|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802812|NCT05580003|529450624|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802813|NCT05580003|529450625|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802814|NCT05580003|529450626|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802815|NCT05580003|529450627|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802816|NCT05580003|529450628|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146802817|NCT05580003|529450601|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802818|NCT05580003|529450602|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802819|NCT05580003|529450603|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146941606|NCT03689972|529945957|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
146941607|NCT03689972|529945958|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
146941608|NCT03689972|529945959|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
146941609|NCT03689972|529945960|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
146941610|NCT03689972|529945956|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
146941611|NCT03689972|529945957|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
146802820|NCT05580003|529450604|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802821|NCT05580003|529450605|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802822|NCT05580003|529450606|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802823|NCT05580003|529450607|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802824|NCT05580003|529450608|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802825|NCT05580003|529450609|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802826|NCT05580003|529450610|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802827|NCT05580003|529450611|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802828|NCT05580003|529450612|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802829|NCT05580003|529450613|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802830|NCT05580003|529450614|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802831|NCT05580003|529450615|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802832|NCT05580003|529450616|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802833|NCT05580003|529450617|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802834|NCT05580003|529450618|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802835|NCT05580003|529450619|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802836|NCT05580003|529450620|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802837|NCT05580003|529450621|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146941612|NCT03689972|529945958|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
146983729|NCT02087046|530101942|FG000|Overall Study|Lost to Follow-up|3|||
146802838|NCT05580003|529450622|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802839|NCT05580003|529450623|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146941613|NCT03689972|529945959|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
146983730|NCT02087046|530101942|FG000|Overall Study|Withdrawal by Subject|2|||
146802840|NCT05580003|529450624|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802841|NCT05580003|529450625|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146983731|NCT02087046|530101942|FG000|Overall Study|Physician Decision|1|||
146802842|NCT05580003|529450626|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802843|NCT05580003|529450627|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146802844|NCT05580003|529450628|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
146802845|NCT05580003|529450601|FG000|Part 6 Period 2 (Day 1)|Other|0|||
146802846|NCT05580003|529450602|FG001|Part 6 Period 2 (Day 1)|Other|0|||
146802847|NCT05580003|529450603|FG002|Part 6 Period 2 (Day 1)|Other|0|||
146802848|NCT05580003|529450604|FG003|Part 6 Period 2 (Day 1)|Other|0|||
146802849|NCT05580003|529450605|FG004|Part 6 Period 2 (Day 1)|Other|0|||
146802850|NCT05580003|529450606|FG005|Part 6 Period 2 (Day 1)|Other|0|||
146802851|NCT05580003|529450607|FG006|Part 6 Period 2 (Day 1)|Other|0|||
146802852|NCT05580003|529450608|FG007|Part 6 Period 2 (Day 1)|Other|0|||
146802853|NCT05580003|529450609|FG008|Part 6 Period 2 (Day 1)|Other|0|||
146802854|NCT05580003|529450610|FG009|Part 6 Period 2 (Day 1)|Other|0|||
146802855|NCT05580003|529450611|FG010|Part 6 Period 2 (Day 1)|Other|0|||
146802856|NCT05580003|529450612|FG011|Part 6 Period 2 (Day 1)|Other|0|||
146802857|NCT05580003|529450613|FG012|Part 6 Period 2 (Day 1)|Other|0|||
146802858|NCT05580003|529450614|FG013|Part 6 Period 2 (Day 1)|Other|0|||
146802859|NCT05580003|529450615|FG014|Part 6 Period 2 (Day 1)|Other|0|||
146802860|NCT05580003|529450616|FG015|Part 6 Period 2 (Day 1)|Other|0|||
146802861|NCT05580003|529450617|FG016|Part 6 Period 2 (Day 1)|Other|0|||
146802862|NCT05580003|529450618|FG017|Part 6 Period 2 (Day 1)|Other|0|||
146802863|NCT05580003|529450619|FG018|Part 6 Period 2 (Day 1)|Other|0|||
146802864|NCT05580003|529450620|FG019|Part 6 Period 2 (Day 1)|Other|0|||
146802865|NCT05580003|529450621|FG020|Part 6 Period 2 (Day 1)|Other|0|||
146802866|NCT05580003|529450622|FG021|Part 6 Period 2 (Day 1)|Other|0|||
146802867|NCT05580003|529450623|FG022|Part 6 Period 2 (Day 1)|Other|0|||
146802868|NCT05580003|529450624|FG023|Part 6 Period 2 (Day 1)|Other|0|||
146802869|NCT05580003|529450625|FG024|Part 6 Period 2 (Day 1)|Other|1|||
146802870|NCT05580003|529450626|FG025|Part 6 Period 2 (Day 1)|Other|0|||
146802871|NCT05580003|529450627|FG026|Part 6 Period 2 (Day 1)|Other|0|||
146802872|NCT05580003|529450628|FG027|Part 6 Period 2 (Day 1)|Other|0|||
146802873|NCT03500549|529450629|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
146802874|NCT03500549|529450630|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
146802875|NCT03500549|529450629|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
146802876|NCT03500549|529450630|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
146802877|NCT04337931|529450634|FG000|Overall Study|Death|4|||
146802878|NCT04337931|529450635|FG001|Overall Study|Death|1|||
146802879|NCT04337931|529450636|FG002|Overall Study|Death|7|||
146802880|NCT04337931|529450634|FG000|Overall Study|Withdrawal by Subject|0|||
146802881|NCT04337931|529450635|FG001|Overall Study|Withdrawal by Subject|1|||
146802882|NCT04337931|529450636|FG002|Overall Study|Withdrawal by Subject|0|||
146802883|NCT04337931|529450634|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
146802884|NCT04337931|529450635|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
146802885|NCT04337931|529450636|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
146802886|NCT04337931|529450634|FG000|Overall Study|Study terminated by sponsor|3|||
146802887|NCT04337931|529450635|FG001|Overall Study|Study terminated by sponsor|6|||
146802888|NCT04337931|529450636|FG002|Overall Study|Study terminated by sponsor|2|||
146802889|NCT04337931|529450634|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
146802890|NCT04337931|529450635|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
146802891|NCT04337931|529450636|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
146802892|NCT04337931|529450634|FG000|Overall Study|Colorectal cancer treatment|1|||
146802893|NCT04337931|529450635|FG001|Overall Study|Colorectal cancer treatment|0|||
146802894|NCT04337931|529450636|FG002|Overall Study|Colorectal cancer treatment|0|||
146802895|NCT04337931|529450634|FG000|Overall Study|Participant decision|0|||
146802896|NCT04337931|529450635|FG001|Overall Study|Participant decision|1|||
146802897|NCT04337931|529450636|FG002|Overall Study|Participant decision|0|||
146802898|NCT01738438|529450637|FG000|Overall Study|Disease Progression|32|||
146802899|NCT01738438|529450637|FG000|Overall Study|Adverse Event|3|||
146802900|NCT04436289|529450638|FG000|Overall Study|Death prior to hospital discharge|8|||
146802901|NCT04436289|529450639|FG001|Overall Study|Death prior to hospital discharge|5|||
146802902|NCT04436289|529450640|FG002|Overall Study|Death prior to hospital discharge|0|||
146802903|NCT04436289|529450641|FG003|Overall Study|Death prior to hospital discharge|1|||
146802904|NCT04436289|529450638|FG000|Overall Study|Withdrawal by Subject|0|||
146802905|NCT04436289|529450639|FG001|Overall Study|Withdrawal by Subject|1|||
146802906|NCT04436289|529450640|FG002|Overall Study|Withdrawal by Subject|4|||
146941614|NCT03689972|529945960|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
146941615|NCT03689972|529945956|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
146941616|NCT03689972|529945957|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
146941617|NCT03689972|529945958|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
146802907|NCT04436289|529450641|FG003|Overall Study|Withdrawal by Subject|0|||
146802908|NCT04436289|529450638|FG000|Overall Study|Extended hospital stay|0|||
146802909|NCT04436289|529450639|FG001|Overall Study|Extended hospital stay|1|||
146802910|NCT04436289|529450640|FG002|Overall Study|Extended hospital stay|0|||
146802911|NCT04436289|529450641|FG003|Overall Study|Extended hospital stay|0|||
146802912|NCT04436289|529450638|FG000|Overall Study|Lost to Follow-up|0|||
146802913|NCT04436289|529450639|FG001|Overall Study|Lost to Follow-up|4|||
146802914|NCT04436289|529450640|FG002|Overall Study|Lost to Follow-up|1|||
146802915|NCT04436289|529450641|FG003|Overall Study|Lost to Follow-up|3|||
146802916|NCT01532999|529450642|FG000|Overall Study|Lost to Follow-up|14|||
146802917|NCT01532999|529450643|FG001|Overall Study|Lost to Follow-up|8|||
146802918|NCT01532999|529450642|FG000|Overall Study|Physician Decision|1|||
146802919|NCT01532999|529450643|FG001|Overall Study|Physician Decision|2|||
146802920|NCT01532999|529450642|FG000|Overall Study|Withdrawal by Subject|5|||
146802921|NCT01532999|529450643|FG001|Overall Study|Withdrawal by Subject|0|||
146802922|NCT01532999|529450642|FG000|Overall Study|Relocated|2|||
146802923|NCT01532999|529450643|FG001|Overall Study|Relocated|0|||
146802924|NCT01532999|529450642|FG000|Overall Study|should not have been randomized|1|||
146802925|NCT01532999|529450643|FG001|Overall Study|should not have been randomized|0|||
146802926|NCT01532999|529450642|FG000|Overall Study|substantial noncompliance|2|||
146802927|NCT01532999|529450643|FG001|Overall Study|substantial noncompliance|0|||
146802928|NCT01532999|529450642|FG000|Overall Study|no show for week 9 assessments|6|||
146802929|NCT01532999|529450643|FG001|Overall Study|no show for week 9 assessments|4|||
146941618|NCT03689972|529945959|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
146941619|NCT03689972|529945960|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
146941620|NCT03689972|529945956|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
146941621|NCT03689972|529945957|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
146941622|NCT03689972|529945958|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
146941623|NCT03689972|529945959|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
146941624|NCT03689972|529945960|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
146941625|NCT03689972|529945956|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
146941626|NCT03689972|529945957|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
146941627|NCT03689972|529945958|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
146941628|NCT03689972|529945959|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
146941629|NCT03689972|529945960|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
146941630|NCT03689972|529945956|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
146941631|NCT03689972|529945957|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
146941632|NCT03689972|529945958|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
146941633|NCT03689972|529945959|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
146941634|NCT03689972|529945960|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
146941635|NCT03689972|529945956|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
146941636|NCT03689972|529945957|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
146941637|NCT03689972|529945958|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
146941638|NCT03689972|529945959|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
146941639|NCT03689972|529945960|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
146941640|NCT03689972|529945956|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
146941641|NCT03689972|529945957|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
146941642|NCT03689972|529945958|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
146941643|NCT03689972|529945959|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
146941644|NCT03689972|529945960|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
146941645|NCT03689972|529945956|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
146941646|NCT03689972|529945957|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
146941647|NCT03689972|529945958|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
146941648|NCT03689972|529945959|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
146941649|NCT03689972|529945960|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
146941650|NCT03689972|529945956|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
146941651|NCT03689972|529945957|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
146941652|NCT03689972|529945958|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
146941653|NCT03689972|529945959|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
146941654|NCT03689972|529945960|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
146941655|NCT03689972|529945956|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
146941656|NCT03689972|529945957|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
146941657|NCT03689972|529945958|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
146941658|NCT03689972|529945959|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
146941659|NCT03689972|529945960|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
146941660|NCT03689972|529945956|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
146941661|NCT03689972|529945957|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
146941662|NCT03689972|529945958|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
146941663|NCT03689972|529945959|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
146802930|NCT01532999|529450642|FG000|Overall Study|Adverse Event|0|||
146802931|NCT01532999|529450643|FG001|Overall Study|Adverse Event|1|||
146802932|NCT01532999|529450642|FG000|Overall Study|incarcerated|0|||
146802933|NCT01532999|529450643|FG001|Overall Study|incarcerated|1|||
146802934|NCT01532999|529450642|FG000|Overall Study|New job|0|||
146802935|NCT01532999|529450643|FG001|Overall Study|New job|2|||
146802936|NCT02928172|529450644|FG000|Overall Study|Device did not record data|1|||
146802937|NCT02016872|529450645|FG000|Overall Study|Withdrawal by Subject|10|||
146802938|NCT02016872|529450645|FG000|Overall Study|Death Progression|2|||
146802939|NCT02016872|529450645|FG000|Overall Study|No FMISO scan|1|||
146802940|NCT02016872|529450645|FG000|Overall Study|Ineligible|2|||
146802941|NCT03280030|529450646|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
146802942|NCT03280030|529450647|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
146802943|NCT03280030|529450648|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
146802944|NCT03280030|529450646|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
146802945|NCT03280030|529450647|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
146802946|NCT03280030|529450648|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
146802947|NCT03280030|529450646|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
146802948|NCT03280030|529450647|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
146802949|NCT03280030|529450648|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
146802950|NCT03280030|529450646|FG000|Part 2 - Efficacy|Adverse Event|0|||
146802951|NCT03280030|529450647|FG001|Part 2 - Efficacy|Adverse Event|4|||
146802952|NCT03280030|529450648|FG002|Part 2 - Efficacy|Adverse Event|6|||
146802953|NCT03280030|529450646|FG000|Part 2 - Efficacy|Death|0|||
146802954|NCT03280030|529450647|FG001|Part 2 - Efficacy|Death|3|||
146802955|NCT03280030|529450648|FG002|Part 2 - Efficacy|Death|0|||
146802956|NCT03280030|529450646|FG000|Part 2 - Efficacy|Physician Decision|0|||
146802957|NCT03280030|529450647|FG001|Part 2 - Efficacy|Physician Decision|10|||
146802958|NCT03280030|529450648|FG002|Part 2 - Efficacy|Physician Decision|16|||
146802959|NCT03280030|529450646|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
146802960|NCT03280030|529450647|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
146802961|NCT03280030|529450648|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
146802962|NCT03280030|529450646|FG000|Part 2 - Efficacy|Progressive disease|0|||
146802963|NCT03280030|529450647|FG001|Part 2 - Efficacy|Progressive disease|7|||
146802964|NCT03280030|529450648|FG002|Part 2 - Efficacy|Progressive disease|5|||
146802965|NCT03211247|529450649|FG000|Overall Study|Adverse Event|8|||
146802966|NCT03211247|529450650|FG001|Overall Study|Adverse Event|0|||
146802967|NCT03211247|529450651|FG002|Overall Study|Adverse Event|1|||
146802968|NCT03211247|529450652|FG003|Overall Study|Adverse Event|0|||
146802969|NCT03211247|529450653|FG004|Overall Study|Adverse Event|0|||
146802970|NCT03211247|529450649|FG000|Overall Study|Lost to Follow-up|2|||
146802971|NCT03211247|529450650|FG001|Overall Study|Lost to Follow-up|1|||
146802972|NCT03211247|529450651|FG002|Overall Study|Lost to Follow-up|0|||
146802973|NCT03211247|529450652|FG003|Overall Study|Lost to Follow-up|0|||
146802974|NCT03211247|529450653|FG004|Overall Study|Lost to Follow-up|0|||
146802975|NCT03211247|529450649|FG000|Overall Study|Physician Decision|1|||
146802976|NCT03211247|529450650|FG001|Overall Study|Physician Decision|2|||
146802977|NCT03211247|529450651|FG002|Overall Study|Physician Decision|0|||
146802978|NCT03211247|529450652|FG003|Overall Study|Physician Decision|0|||
146802979|NCT03211247|529450653|FG004|Overall Study|Physician Decision|0|||
146802980|NCT03211247|529450649|FG000|Overall Study|Non-compliance with study drug|2|||
146802981|NCT03211247|529450650|FG001|Overall Study|Non-compliance with study drug|0|||
146802982|NCT03211247|529450651|FG002|Overall Study|Non-compliance with study drug|0|||
146802983|NCT03211247|529450652|FG003|Overall Study|Non-compliance with study drug|0|||
146802984|NCT03211247|529450653|FG004|Overall Study|Non-compliance with study drug|0|||
146802985|NCT03211247|529450649|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
146802986|NCT03211247|529450650|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
146802987|NCT03211247|529450651|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
146802988|NCT03211247|529450652|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
146802989|NCT03211247|529450653|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
146802990|NCT03211247|529450649|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
146802991|NCT03211247|529450650|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
146802992|NCT03211247|529450651|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
146802993|NCT03211247|529450652|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
146802994|NCT03211247|529450653|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
146802995|NCT03211247|529450649|FG000|Overall Study|Protocol Violation|0|||
146802996|NCT03211247|529450650|FG001|Overall Study|Protocol Violation|1|||
146802997|NCT03211247|529450651|FG002|Overall Study|Protocol Violation|0|||
146802998|NCT03211247|529450652|FG003|Overall Study|Protocol Violation|0|||
146802999|NCT03211247|529450653|FG004|Overall Study|Protocol Violation|0|||
146803000|NCT02415127|529450654|FG000|Overall Study|Adverse Event|1|||
146803001|NCT02415127|529450655|FG001|Overall Study|Adverse Event|0|||
146803002|NCT00545545|529450656|FG000|Overall Study|Progressive Neoplastic Disease|1|||
146803003|NCT00545545|529450657|FG001|Overall Study|Progressive Neoplastic Disease|5|||
146803004|NCT00545545|529450658|FG002|Overall Study|Progressive Neoplastic Disease|0|||
146803005|NCT00545545|529450659|FG003|Overall Study|Progressive Neoplastic Disease|4|||
146803006|NCT00545545|529450660|FG004|Overall Study|Progressive Neoplastic Disease|8|||
146803007|NCT00545545|529450661|FG005|Overall Study|Progressive Neoplastic Disease|7|||
146803008|NCT00545545|529450656|FG000|Overall Study|Withdrawal by Subject|0|||
146803009|NCT00545545|529450657|FG001|Overall Study|Withdrawal by Subject|1|||
146803010|NCT00545545|529450658|FG002|Overall Study|Withdrawal by Subject|0|||
146803011|NCT00545545|529450659|FG003|Overall Study|Withdrawal by Subject|0|||
146803012|NCT00545545|529450660|FG004|Overall Study|Withdrawal by Subject|0|||
146803013|NCT00545545|529450661|FG005|Overall Study|Withdrawal by Subject|0|||
146803014|NCT00545545|529450656|FG000|Overall Study|Physician Decision|1|||
146803015|NCT00545545|529450657|FG001|Overall Study|Physician Decision|0|||
146803016|NCT00545545|529450658|FG002|Overall Study|Physician Decision|0|||
146803017|NCT00545545|529450659|FG003|Overall Study|Physician Decision|0|||
146803018|NCT00545545|529450660|FG004|Overall Study|Physician Decision|0|||
146803019|NCT00545545|529450661|FG005|Overall Study|Physician Decision|1|||
146803020|NCT00545545|529450656|FG000|Overall Study|Irinotecan intolerance|1|||
146803021|NCT00545545|529450657|FG001|Overall Study|Irinotecan intolerance|1|||
146803022|NCT00545545|529450658|FG002|Overall Study|Irinotecan intolerance|0|||
146803023|NCT00545545|529450659|FG003|Overall Study|Irinotecan intolerance|0|||
146803024|NCT00545545|529450660|FG004|Overall Study|Irinotecan intolerance|0|||
146803025|NCT00545545|529450661|FG005|Overall Study|Irinotecan intolerance|0|||
146803026|NCT00545545|529450656|FG000|Overall Study|No target lesions to track post surgery|0|||
146803027|NCT00545545|529450657|FG001|Overall Study|No target lesions to track post surgery|0|||
146803028|NCT00545545|529450658|FG002|Overall Study|No target lesions to track post surgery|0|||
146803029|NCT00545545|529450659|FG003|Overall Study|No target lesions to track post surgery|0|||
146803030|NCT00545545|529450660|FG004|Overall Study|No target lesions to track post surgery|1|||
146803031|NCT00545545|529450661|FG005|Overall Study|No target lesions to track post surgery|1|||
146803032|NCT02761187|529450662|FG000|Overall Study|Too ill to Participate|13|||
146803033|NCT02761187|529450663|FG001|Overall Study|Too ill to Participate|8|||
146803034|NCT02761187|529450662|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
146803035|NCT02761187|529450663|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
146803036|NCT02761187|529450662|FG000|Overall Study|Patient withdrew consent|64|||
146803037|NCT02761187|529450663|FG001|Overall Study|Patient withdrew consent|58|||
146803038|NCT02761187|529450662|FG000|Overall Study|Physician discretion|4|||
146803039|NCT02761187|529450663|FG001|Overall Study|Physician discretion|8|||
146803040|NCT02761187|529450662|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
146803041|NCT02761187|529450663|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
146803042|NCT02761187|529450662|FG000|Overall Study|On Hospice|20|||
146803043|NCT02761187|529450663|FG001|Overall Study|On Hospice|26|||
146803044|NCT02761187|529450662|FG000|Overall Study|Deceased|474|||
146803045|NCT02761187|529450663|FG001|Overall Study|Deceased|642|||
146803046|NCT02761187|529450662|FG000|Overall Study|Lost to Follow-up|73|||
146803047|NCT02761187|529450663|FG001|Overall Study|Lost to Follow-up|63|||
146803048|NCT02761187|529450662|FG000|Overall Study|Due to study discontinued at site|100|||
146803049|NCT02761187|529450663|FG001|Overall Study|Due to study discontinued at site|85|||
146803050|NCT02761187|529450662|FG000|Overall Study|Reason not Specified|1484|||
146803051|NCT02761187|529450663|FG001|Overall Study|Reason not Specified|937|||
146803052|NCT04153890|529450664|FG000|Overall Study|Lost to Follow-up|9|||
146803053|NCT04153890|529450665|FG001|Overall Study|Lost to Follow-up|0|||
146803054|NCT04153890|529450666|FG002|Overall Study|Lost to Follow-up|9|||
146803055|NCT04153890|529450667|FG003|Overall Study|Lost to Follow-up|0|||
146803056|NCT04153890|529450664|FG000|Overall Study|Death|0|||
146803057|NCT04153890|529450665|FG001|Overall Study|Death|2|||
146803058|NCT04153890|529450666|FG002|Overall Study|Death|0|||
146803059|NCT04153890|529450667|FG003|Overall Study|Death|0|||
146803060|NCT04153890|529450664|FG000|Overall Study|Withdrawal by Subject|0|||
146803061|NCT04153890|529450665|FG001|Overall Study|Withdrawal by Subject|0|||
146803062|NCT04153890|529450666|FG002|Overall Study|Withdrawal by Subject|0|||
146803063|NCT04153890|529450667|FG003|Overall Study|Withdrawal by Subject|2|||
146803064|NCT03997474|529450670|FG000|Overall Study|Death|6|||
146803065|NCT03997474|529450671|FG001|Overall Study|Death|2|||
146803066|NCT03997474|529450672|FG002|Overall Study|Death|1|||
146803067|NCT03997474|529450670|FG000|Overall Study|Physician Decision|2|||
146803068|NCT03997474|529450671|FG001|Overall Study|Physician Decision|0|||
146803069|NCT03997474|529450672|FG002|Overall Study|Physician Decision|0|||
146803070|NCT03997474|529450670|FG000|Overall Study|study terminated by sponsor|1|||
146983732|NCT01107535|530101943|FG000|Overall Study|Death|5|||
146983733|NCT01155583|530101944|FG000|Phase I|Screen failure - did not start treatment|0|||
146983734|NCT01155583|530101945|FG001|Phase I|Screen failure - did not start treatment|0|||
146983735|NCT01155583|530101946|FG002|Phase I|Screen failure - did not start treatment|0|||
146803071|NCT03997474|529450671|FG001|Overall Study|study terminated by sponsor|0|||
146803072|NCT03997474|529450672|FG002|Overall Study|study terminated by sponsor|1|||
146803073|NCT05630833|529450674|FG000|Overall Study|Adverse Event|3|||
146803074|NCT05630833|529450675|FG001|Overall Study|Adverse Event|0|||
146803075|NCT05630833|529450674|FG000|Overall Study|Lack of Efficacy|0|||
146803076|NCT05630833|529450675|FG001|Overall Study|Lack of Efficacy|1|||
146803077|NCT05630833|529450674|FG000|Overall Study|Lost to Follow-up|1|||
146803078|NCT05630833|529450675|FG001|Overall Study|Lost to Follow-up|0|||
146803079|NCT05630833|529450674|FG000|Overall Study|Withdrawal by Subject|3|||
146803080|NCT05630833|529450675|FG001|Overall Study|Withdrawal by Subject|1|||
146803081|NCT03277989|529450676|FG000|Overall Study|Lost to Follow-up|6|||
146803082|NCT03277989|529450676|FG000|Overall Study|Adverse Event|6|||
146803083|NCT03277989|529450676|FG000|Overall Study|Withdrawal by Subject|3|||
146803084|NCT03277989|529450676|FG000|Overall Study|Didn't Receive Study Device|7|||
146803085|NCT03277989|529450676|FG000|Overall Study|Site Closure|26|||
146803086|NCT03277989|529450676|FG000|Overall Study|Sponsor Closure|107|||
146803087|NCT02798471|529450679|FG000|Overall Study|Adverse Event|7|||
146803088|NCT02798471|529450680|FG001|Overall Study|Adverse Event|2|||
146803089|NCT02798471|529450679|FG000|Overall Study|Physician Decision|3|||
146803090|NCT02798471|529450680|FG001|Overall Study|Physician Decision|7|||
146803091|NCT02798471|529450679|FG000|Overall Study|Death|2|||
146803092|NCT02798471|529450680|FG001|Overall Study|Death|3|||
146803093|NCT02798471|529450679|FG000|Overall Study|Lost to Follow-up|0|||
146803094|NCT02798471|529450680|FG001|Overall Study|Lost to Follow-up|1|||
146803095|NCT02798471|529450679|FG000|Overall Study|Other|5|||
146803096|NCT02798471|529450680|FG001|Overall Study|Other|3|||
146803097|NCT02798471|529450679|FG000|Overall Study|Subject withdrew consent|0|||
146803098|NCT02798471|529450680|FG001|Overall Study|Subject withdrew consent|6|||
146803099|NCT02798471|529450679|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
146803100|NCT02798471|529450680|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
146803101|NCT02798471|529450679|FG000|Overall Study|Randomized, but not treated|0|||
146803102|NCT02798471|529450680|FG001|Overall Study|Randomized, but not treated|2|||
146803103|NCT03083366|529452073|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
146803104|NCT03083366|529452074|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
146803105|NCT03083366|529452073|FG000|Enrollment Period|Lack of Efficacy|1|||
146803106|NCT03083366|529452074|FG001|Enrollment Period|Lack of Efficacy|0|||
146803107|NCT06056310|529452079|FG000|Overall Study|Other Reasons|2|||
146803108|NCT06056310|529452079|FG000|Overall Study|Sponsor Request|16|||
146803109|NCT02702843|529452080|FG000|Overall Study|Insufficient data to analyze|15|||
146803110|NCT02702843|529452081|FG001|Overall Study|Insufficient data to analyze|23|||
146803111|NCT00065182|529452086|FG000|Overall Study|Adverse Event|24|||
146803112|NCT00065182|529452087|FG001|Overall Study|Adverse Event|17|||
146803113|NCT00065182|529452086|FG000|Overall Study|Lost to Follow-up|0|||
146803114|NCT00065182|529452087|FG001|Overall Study|Lost to Follow-up|4|||
146803115|NCT00065182|529452086|FG000|Overall Study|Protocol Violation|3|||
146803116|NCT00065182|529452087|FG001|Overall Study|Protocol Violation|4|||
146803117|NCT00065182|529452086|FG000|Overall Study|Serious adverse events (SAE)|1|||
146803118|NCT00065182|529452087|FG001|Overall Study|Serious adverse events (SAE)|0|||
146803119|NCT00065182|529452086|FG000|Overall Study|Sponsor Decision|11|||
146803120|NCT00065182|529452087|FG001|Overall Study|Sponsor Decision|7|||
146803121|NCT00065182|529452086|FG000|Overall Study|Withdrawal by Subject|8|||
146803122|NCT00065182|529452087|FG001|Overall Study|Withdrawal by Subject|3|||
146803123|NCT00065182|529452086|FG000|Overall Study|No clinical benefit|1|||
146803124|NCT00065182|529452087|FG001|Overall Study|No clinical benefit|0|||
146803125|NCT00065182|529452086|FG000|Overall Study|Death|0|||
146803126|NCT00065182|529452087|FG001|Overall Study|Death|1|||
146803127|NCT00065182|529452086|FG000|Overall Study|Decline in Status|0|||
146803128|NCT00065182|529452087|FG001|Overall Study|Decline in Status|1|||
146803129|NCT02633215|529452088|FG000|Overall Study|Lost to Follow-up|2|||
146803130|NCT02633215|529452089|FG001|Overall Study|Lost to Follow-up|3|||
146803131|NCT00754325|529452090|FG000|Initial Treatment|Continuing Active Treatment|4|||
146803132|NCT00754325|529452091|FG001|Initial Treatment|Continuing Active Treatment|5|||
146803133|NCT00754325|529452090|FG000|Initial Treatment|Adverse Event|7|||
146803134|NCT00754325|529452091|FG001|Initial Treatment|Adverse Event|6|||
146803135|NCT00754325|529452090|FG000|Initial Treatment|Withdrawal by Subject|2|||
146803136|NCT00754325|529452091|FG001|Initial Treatment|Withdrawal by Subject|2|||
146803137|NCT00754325|529452090|FG000|Initial Treatment|Physician Decision|2|||
146803138|NCT00754325|529452091|FG001|Initial Treatment|Physician Decision|0|||
146803139|NCT00754325|529452090|FG000|Initial Treatment|Sponsor Request|0|||
146803140|NCT00754325|529452091|FG001|Initial Treatment|Sponsor Request|1|||
146803141|NCT00754325|529452090|FG000|Initial Treatment|Disease Progression|35|||
146803142|NCT00754325|529452091|FG001|Initial Treatment|Disease Progression|35|||
146803143|NCT03442777|529452092|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
146983736|NCT01155583|530101947|FG003|Phase I|Screen failure - did not start treatment|0|||
146983737|NCT01155583|530101948|FG004|Phase I|Screen failure - did not start treatment|1|||
146983738|NCT01155583|530101949|FG005|Phase I|Screen failure - did not start treatment|0|||
146803144|NCT03442777|529452093|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
146803145|NCT03442777|529452094|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
146803146|NCT03801148|529452095|FG000|Period 1 (2 Days)|Adverse Event|1|||
146803147|NCT03801148|529452096|FG001|Period 1 (2 Days)|Adverse Event|1|||
146803148|NCT03801148|529452097|FG002|Period 1 (2 Days)|Adverse Event|0|||
146983739|NCT01155583|530101950|FG006|Phase I|Screen failure - did not start treatment|0|||
146983740|NCT01155583|530101951|FG007|Phase I|Screen failure - did not start treatment|2|||
146803149|NCT03801148|529452098|FG003|Period 1 (2 Days)|Adverse Event|0|||
146803150|NCT03801148|529452095|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
146803151|NCT03801148|529452096|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
146803152|NCT03801148|529452097|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
146983741|NCT01155583|530101952|FG008|Phase I|Screen failure - did not start treatment|0|||
146983742|NCT01155583|530101944|FG000|Phase I|Withdrawal by Subject|0|||
146983743|NCT01155583|530101945|FG001|Phase I|Withdrawal by Subject|0|||
146983744|NCT01155583|530101946|FG002|Phase I|Withdrawal by Subject|0|||
146983745|NCT01155583|530101947|FG003|Phase I|Withdrawal by Subject|0|||
146983746|NCT01155583|530101948|FG004|Phase I|Withdrawal by Subject|0|||
146983747|NCT01155583|530101949|FG005|Phase I|Withdrawal by Subject|0|||
146983748|NCT01155583|530101950|FG006|Phase I|Withdrawal by Subject|0|||
146983749|NCT01155583|530101951|FG007|Phase I|Withdrawal by Subject|1|||
146983750|NCT01155583|530101952|FG008|Phase I|Withdrawal by Subject|0|||
146983751|NCT00585351|530101953|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
146983752|NCT00585351|530101954|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
146983753|NCT00585351|530101955|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
146983754|NCT00585351|530101956|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
146983755|NCT00585351|530101957|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
146983756|NCT00585351|530101958|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
146983757|NCT00585351|530101959|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
146983758|NCT00585351|530101960|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
146983759|NCT00585351|530101953|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
146803153|NCT03801148|529452098|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
146803154|NCT03801148|529452095|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
146803155|NCT03801148|529452096|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
146803156|NCT03801148|529452097|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
146803157|NCT03801148|529452098|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
146803158|NCT03801148|529452095|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
146803159|NCT03801148|529452096|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
146803160|NCT03801148|529452097|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
146803161|NCT03801148|529452098|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
146803162|NCT00609869|529452099|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
146803163|NCT00609869|529452099|FG000|Overall Study|Severe hematologic toxicity|1|||
146803164|NCT00609869|529452099|FG000|Overall Study|Withdrawal by Subject|1|||
146803165|NCT00609869|529452099|FG000|Overall Study|Seizures|1|||
146803166|NCT00609869|529452099|FG000|Overall Study|Severe tumor flare reaction|1|||
146803167|NCT00609869|529452099|FG000|Overall Study|Hepatitis B infection|1|||
146803168|NCT00609869|529452099|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
146803169|NCT00609869|529452099|FG000|Overall Study|Mantle cell: not evaluable|4|||
146803170|NCT01627561|529452100|FG000|Overall Study|Lost to Follow-up|1|||
146803171|NCT01627561|529452101|FG001|Overall Study|Lost to Follow-up|0|||
146803172|NCT01627561|529452100|FG000|Overall Study|Withdrawal by Subject|0|||
146803173|NCT01627561|529452101|FG001|Overall Study|Withdrawal by Subject|1|||
146803174|NCT01627561|529452100|FG000|Overall Study|Migrated/moved from study area|0|||
146803175|NCT01627561|529452101|FG001|Overall Study|Migrated/moved from study area|2|||
146803176|NCT00754065|529452112|FG000|Overall Study|Never received treatment|12|||
146803177|NCT00754065|529452113|FG001|Overall Study|Never received treatment|2|||
146803178|NCT00754065|529452112|FG000|Overall Study|Adverse Event|19|||
146803179|NCT00754065|529452113|FG001|Overall Study|Adverse Event|25|||
146803180|NCT00754065|529452112|FG000|Overall Study|Lost to Follow-up|7|||
146803181|NCT00754065|529452113|FG001|Overall Study|Lost to Follow-up|11|||
146803182|NCT00754065|529452112|FG000|Overall Study|Protocol Violation|12|||
146803183|NCT00754065|529452113|FG001|Overall Study|Protocol Violation|10|||
146803184|NCT00754065|529452112|FG000|Overall Study|Withdrawal by Subject|4|||
146803185|NCT00754065|529452113|FG001|Overall Study|Withdrawal by Subject|5|||
146803186|NCT00754065|529452112|FG000|Overall Study|Pregnancy|6|||
146803187|NCT00754065|529452113|FG001|Overall Study|Pregnancy|0|||
146803188|NCT00754065|529452112|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
146803189|NCT00754065|529452113|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
146803190|NCT04033445|529452114|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
146803191|NCT04033445|529452115|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
146803192|NCT04033445|529452116|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146803193|NCT04033445|529452117|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146803194|NCT04033445|529452118|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146803195|NCT04033445|529452119|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
146803196|NCT04033445|529452120|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
146803197|NCT04033445|529452121|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146803198|NCT04033445|529452122|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146803199|NCT04033445|529452123|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146803200|NCT04033445|529452124|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146803201|NCT04033445|529452125|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146803202|NCT04033445|529452126|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146983760|NCT00585351|530101954|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
146983761|NCT00585351|530101955|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
146983762|NCT00585351|530101956|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
146803203|NCT04033445|529452127|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146803204|NCT04033445|529452114|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146803205|NCT04033445|529452115|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146803206|NCT04033445|529452116|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146803207|NCT04033445|529452117|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146803208|NCT04033445|529452118|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146803209|NCT04033445|529452119|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
146803210|NCT04033445|529452120|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
146803211|NCT04033445|529452121|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146803212|NCT04033445|529452122|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146803213|NCT04033445|529452123|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146803214|NCT04033445|529452124|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146803215|NCT04033445|529452125|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146803216|NCT04033445|529452126|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146803217|NCT04033445|529452127|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146803218|NCT04033445|529452114|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
146803219|NCT04033445|529452115|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146803220|NCT04033445|529452116|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146803221|NCT04033445|529452117|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146803222|NCT04033445|529452118|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146803223|NCT04033445|529452119|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146803224|NCT04033445|529452120|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
146803225|NCT04033445|529452121|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146803226|NCT04033445|529452122|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146803227|NCT04033445|529452123|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146803228|NCT04033445|529452124|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146803229|NCT04033445|529452125|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146803230|NCT04033445|529452126|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146803231|NCT04033445|529452127|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146803232|NCT04033445|529452114|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146803233|NCT04033445|529452115|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146803234|NCT04033445|529452116|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146803235|NCT04033445|529452117|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146803236|NCT04033445|529452118|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146803237|NCT04033445|529452119|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
146803238|NCT04033445|529452120|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
146803239|NCT04033445|529452121|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146803240|NCT04033445|529452122|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146803241|NCT04033445|529452123|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146803242|NCT04033445|529452124|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146803243|NCT04033445|529452125|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146803244|NCT04033445|529452126|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146803245|NCT04033445|529452127|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146803246|NCT04033445|529452114|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146803247|NCT04033445|529452115|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146803248|NCT04033445|529452116|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146803249|NCT04033445|529452117|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146803250|NCT04033445|529452118|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146803251|NCT04033445|529452119|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146803252|NCT04033445|529452120|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
146803253|NCT04033445|529452121|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146803254|NCT04033445|529452122|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146803255|NCT04033445|529452123|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146803256|NCT04033445|529452124|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146803257|NCT04033445|529452125|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146803258|NCT04033445|529452126|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146803259|NCT04033445|529452127|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146803260|NCT04033445|529452114|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
146803261|NCT04033445|529452115|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
146941664|NCT03689972|529945960|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
146941665|NCT03689972|529945956|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
146941666|NCT03689972|529945957|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
146803262|NCT04033445|529452116|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
146803263|NCT04033445|529452117|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146803264|NCT04033445|529452118|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146803265|NCT04033445|529452119|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
146803266|NCT04033445|529452120|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
146803267|NCT04033445|529452121|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146803268|NCT04033445|529452122|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146803269|NCT04033445|529452123|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146803270|NCT04033445|529452124|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146803271|NCT04033445|529452125|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146803272|NCT04033445|529452126|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146803273|NCT04033445|529452127|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146803274|NCT04033445|529452114|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146803275|NCT04033445|529452115|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
146803276|NCT04033445|529452116|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146803277|NCT04033445|529452117|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146803278|NCT04033445|529452118|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146803279|NCT04033445|529452119|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
146803280|NCT04033445|529452120|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146803281|NCT04033445|529452121|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146803282|NCT04033445|529452122|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146803283|NCT04033445|529452123|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146803284|NCT04033445|529452124|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146803285|NCT04033445|529452125|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146803286|NCT04033445|529452126|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146803287|NCT04033445|529452127|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146803288|NCT04033445|529452114|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
146803289|NCT04033445|529452115|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146803290|NCT04033445|529452116|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146803291|NCT04033445|529452117|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146803292|NCT04033445|529452118|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146803293|NCT04033445|529452119|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
146803294|NCT04033445|529452120|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146941667|NCT03689972|529945958|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
146941668|NCT03689972|529945959|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
146941669|NCT03689972|529945960|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
146941670|NCT03689972|529945956|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
146941671|NCT03689972|529945957|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
146941672|NCT03689972|529945958|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
146941673|NCT03689972|529945959|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
146941674|NCT03689972|529945960|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
146941675|NCT03689972|529945956|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
146941676|NCT03689972|529945957|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
146941677|NCT03689972|529945958|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
146941678|NCT03689972|529945959|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
146941679|NCT03689972|529945960|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
146941680|NCT03689972|529945956|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
146941681|NCT03689972|529945957|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
146941682|NCT03689972|529945958|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
146941683|NCT03689972|529945959|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
146941684|NCT03689972|529945960|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
146941685|NCT02417064|529945961|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
146941686|NCT02417064|529945962|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
146941687|NCT02417064|529945963|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
146941688|NCT02417064|529945961|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
146941689|NCT02417064|529945962|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
146941690|NCT02417064|529945963|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
146941691|NCT02417064|529945961|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
146941692|NCT02417064|529945962|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
146941693|NCT02417064|529945963|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
146941694|NCT02417064|529945961|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
146941695|NCT02417064|529945962|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
146941696|NCT02417064|529945963|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
146983763|NCT00585351|530101957|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
146983764|NCT00585351|530101958|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
146941697|NCT02417064|529945961|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
146803295|NCT04033445|529452121|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146803296|NCT04033445|529452122|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146803297|NCT04033445|529452123|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146803298|NCT04033445|529452124|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146803299|NCT04033445|529452125|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146803300|NCT04033445|529452126|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146803301|NCT04033445|529452127|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146803302|NCT04033445|529452114|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146803303|NCT04033445|529452115|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146803304|NCT04033445|529452116|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146803305|NCT04033445|529452117|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
146803306|NCT04033445|529452118|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
146803307|NCT04033445|529452119|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146803308|NCT04033445|529452120|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146803309|NCT04033445|529452121|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
146803310|NCT04033445|529452122|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
146803311|NCT04033445|529452123|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146803312|NCT04033445|529452124|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146803313|NCT04033445|529452125|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146803314|NCT04033445|529452126|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146803315|NCT04033445|529452127|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146803316|NCT04033445|529452114|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146803317|NCT04033445|529452115|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146803318|NCT04033445|529452116|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146803319|NCT04033445|529452117|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146941698|NCT02417064|529945962|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
146941699|NCT02417064|529945963|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
146941700|NCT02417064|529945961|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
146941701|NCT02417064|529945962|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
146941702|NCT02417064|529945963|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
146941703|NCT02417064|529945961|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
146941704|NCT02417064|529945962|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
146941705|NCT02417064|529945963|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
146941706|NCT02417064|529945961|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
146941707|NCT02417064|529945962|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
146941708|NCT02417064|529945963|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
146941709|NCT02417064|529945961|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
146941710|NCT02417064|529945962|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
146941711|NCT02417064|529945963|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
146941712|NCT02417064|529945961|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
146941713|NCT02417064|529945962|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
146941714|NCT02417064|529945963|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
146941715|NCT02417064|529945961|FG000|Follow-up Phase (24 Weeks)|Other|2|||
146941716|NCT02417064|529945962|FG001|Follow-up Phase (24 Weeks)|Other|2|||
146941717|NCT02417064|529945963|FG002|Follow-up Phase (24 Weeks)|Other|3|||
146941718|NCT00732641|529945964|FG000|Overall Study|Relapse or Progressive Disease|65|||
146941719|NCT00732641|529945965|FG001|Overall Study|Relapse or Progressive Disease|101|||
146941720|NCT00732641|529945964|FG000|Overall Study|Serious Adverse Events|12|||
146941721|NCT00732641|529945965|FG001|Overall Study|Serious Adverse Events|3|||
146941722|NCT00732641|529945964|FG000|Overall Study|Physician Decision|6|||
146941723|NCT00732641|529945965|FG001|Overall Study|Physician Decision|0|||
146941724|NCT00732641|529945964|FG000|Overall Study|Withdrawal by Subject|4|||
146941725|NCT00732641|529945965|FG001|Overall Study|Withdrawal by Subject|2|||
146941726|NCT00732641|529945964|FG000|Overall Study|Unable to Complete|1|||
146941727|NCT00732641|529945965|FG001|Overall Study|Unable to Complete|1|||
146941728|NCT00732641|529945964|FG000|Overall Study|Other|18|||
146941729|NCT00732641|529945965|FG001|Overall Study|Other|5|||
146941730|NCT01192100|529945970|FG000|Overall Study|Withdrawal by Subject|0|||
146941731|NCT01192100|529945971|FG001|Overall Study|Withdrawal by Subject|0|||
146941732|NCT01192100|529945972|FG002|Overall Study|Withdrawal by Subject|0|||
146941733|NCT01192100|529945973|FG003|Overall Study|Withdrawal by Subject|0|||
146941734|NCT01192100|529945974|FG004|Overall Study|Withdrawal by Subject|1|||
146941735|NCT01192100|529945975|FG005|Overall Study|Withdrawal by Subject|0|||
146941736|NCT01192100|529945970|FG000|Overall Study|Protocol Violation|0|||
146941737|NCT01192100|529945971|FG001|Overall Study|Protocol Violation|0|||
146941738|NCT01192100|529945972|FG002|Overall Study|Protocol Violation|0|||
146941739|NCT01192100|529945973|FG003|Overall Study|Protocol Violation|1|||
146941740|NCT01192100|529945974|FG004|Overall Study|Protocol Violation|0|||
146941741|NCT01192100|529945975|FG005|Overall Study|Protocol Violation|0|||
146941742|NCT00865046|529945976|FG000|Overall Study|Lost to Follow-up|1|||
146941743|NCT00865046|529945977|FG001|Overall Study|Lost to Follow-up|4|||
146941744|NCT00865046|529945978|FG002|Overall Study|Lost to Follow-up|0|||
146941745|NCT00865046|529945976|FG000|Overall Study|Death|0|||
146941746|NCT00865046|529945977|FG001|Overall Study|Death|1|||
146803320|NCT04033445|529452118|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146803321|NCT04033445|529452119|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146803322|NCT04033445|529452120|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146803323|NCT04033445|529452121|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
146803324|NCT04033445|529452122|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
146803325|NCT04033445|529452123|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146803326|NCT04033445|529452124|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146803327|NCT04033445|529452125|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146803328|NCT04033445|529452126|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146803329|NCT04033445|529452127|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146803330|NCT04033445|529452114|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146803331|NCT04033445|529452115|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146803332|NCT04033445|529452116|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146803333|NCT04033445|529452117|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146803334|NCT04033445|529452118|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146803335|NCT04033445|529452119|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146803336|NCT04033445|529452120|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146803337|NCT04033445|529452121|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146803338|NCT04033445|529452122|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
146803339|NCT04033445|529452123|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146803340|NCT04033445|529452124|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146803341|NCT04033445|529452125|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146803342|NCT04033445|529452126|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146803343|NCT04033445|529452127|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146803344|NCT04033445|529452114|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146803345|NCT04033445|529452115|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146803346|NCT04033445|529452116|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146803347|NCT04033445|529452117|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
146803348|NCT04033445|529452118|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146803349|NCT04033445|529452119|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146803350|NCT04033445|529452120|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146803351|NCT04033445|529452121|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146803352|NCT04033445|529452122|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146803353|NCT04033445|529452123|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146803354|NCT04033445|529452124|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146803355|NCT04033445|529452125|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146803356|NCT04033445|529452126|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146803357|NCT04033445|529452127|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146803358|NCT04033445|529452114|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146803359|NCT04033445|529452115|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146803360|NCT04033445|529452116|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146803361|NCT04033445|529452117|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146803362|NCT04033445|529452118|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146803363|NCT04033445|529452119|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146803364|NCT04033445|529452120|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146803365|NCT04033445|529452121|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
146803366|NCT04033445|529452122|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
146803367|NCT04033445|529452123|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146803368|NCT04033445|529452124|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146803369|NCT04033445|529452125|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146803370|NCT04033445|529452126|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146803371|NCT04033445|529452127|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146803372|NCT04033445|529452114|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146803373|NCT04033445|529452115|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146803374|NCT04033445|529452116|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146803375|NCT04033445|529452117|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146803376|NCT04033445|529452118|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146803377|NCT04033445|529452119|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146803378|NCT04033445|529452120|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146941747|NCT00865046|529945978|FG002|Overall Study|Death|1|||
146941748|NCT00865046|529945976|FG000|Overall Study|Withdrawal by Subject|5|||
146941749|NCT00865046|529945977|FG001|Overall Study|Withdrawal by Subject|0|||
146941750|NCT00865046|529945978|FG002|Overall Study|Withdrawal by Subject|0|||
146941751|NCT02475629|529945979|FG000|Overall Study|Adverse Event|1|||
146941752|NCT02475629|529945979|FG000|Overall Study|Death|4|||
146941753|NCT02475629|529945979|FG000|Overall Study|Physician Decision|1|||
146803379|NCT04033445|529452121|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
146803380|NCT04033445|529452122|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146803381|NCT04033445|529452123|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146803382|NCT04033445|529452124|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146803383|NCT04033445|529452125|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146803384|NCT04033445|529452126|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146803385|NCT04033445|529452127|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146803386|NCT04033445|529452114|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146803387|NCT04033445|529452115|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146803388|NCT04033445|529452116|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146803389|NCT04033445|529452117|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146803390|NCT04033445|529452118|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146803391|NCT04033445|529452119|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146803392|NCT04033445|529452120|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146803393|NCT04033445|529452121|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
146803394|NCT04033445|529452122|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146803395|NCT04033445|529452123|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146803396|NCT04033445|529452124|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146803397|NCT04033445|529452125|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146803398|NCT04033445|529452126|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146803399|NCT04033445|529452127|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146803400|NCT04033445|529452114|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146803401|NCT04033445|529452115|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146803402|NCT04033445|529452116|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146803403|NCT04033445|529452117|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146803404|NCT04033445|529452118|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146803405|NCT04033445|529452119|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146803406|NCT04033445|529452120|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146803407|NCT04033445|529452121|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146803408|NCT04033445|529452122|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146803409|NCT04033445|529452123|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
146803410|NCT04033445|529452124|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
146803411|NCT04033445|529452125|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
146803412|NCT04033445|529452126|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
146803413|NCT04033445|529452127|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
146803414|NCT04033445|529452114|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146803415|NCT04033445|529452115|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146803416|NCT04033445|529452116|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146803417|NCT04033445|529452117|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146803418|NCT04033445|529452118|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146803419|NCT04033445|529452119|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146803420|NCT04033445|529452120|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146803421|NCT04033445|529452121|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146803422|NCT04033445|529452122|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146803423|NCT04033445|529452123|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
146803424|NCT04033445|529452124|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
146803425|NCT04033445|529452125|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
146803426|NCT04033445|529452126|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
146803427|NCT04033445|529452127|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
146803428|NCT04033445|529452114|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146803429|NCT04033445|529452115|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146803430|NCT04033445|529452116|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146803431|NCT04033445|529452117|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146803432|NCT04033445|529452118|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146803433|NCT04033445|529452119|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146803434|NCT04033445|529452120|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146803435|NCT04033445|529452121|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146803436|NCT04033445|529452122|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146803437|NCT04033445|529452123|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146803438|NCT04033445|529452124|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
146803439|NCT04033445|529452125|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
146803440|NCT04033445|529452126|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146803441|NCT04033445|529452127|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
146803442|NCT04033445|529452114|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146803443|NCT04033445|529452115|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146803444|NCT04033445|529452116|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146803445|NCT04033445|529452117|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146803446|NCT04033445|529452118|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146803447|NCT04033445|529452119|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146803448|NCT04033445|529452120|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146803449|NCT04033445|529452121|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146803450|NCT04033445|529452122|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146803451|NCT04033445|529452123|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146803452|NCT04033445|529452124|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
146803453|NCT04033445|529452125|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
146803454|NCT04033445|529452126|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
146803455|NCT04033445|529452127|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
146803456|NCT04033445|529452114|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146803457|NCT04033445|529452115|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146803458|NCT04033445|529452116|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146803459|NCT04033445|529452117|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146803460|NCT04033445|529452118|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146803461|NCT04033445|529452119|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146803462|NCT04033445|529452120|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146803463|NCT04033445|529452121|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146803464|NCT04033445|529452122|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146803465|NCT04033445|529452123|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
146803466|NCT04033445|529452124|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
146803467|NCT04033445|529452125|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
146803468|NCT04033445|529452126|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
146803469|NCT04033445|529452127|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
146803470|NCT04033445|529452114|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146803471|NCT04033445|529452115|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146803472|NCT04033445|529452116|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146803473|NCT04033445|529452117|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146803474|NCT04033445|529452118|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146803475|NCT04033445|529452119|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146803476|NCT04033445|529452120|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146803477|NCT04033445|529452121|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146803478|NCT04033445|529452122|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146803479|NCT04033445|529452123|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146803480|NCT04033445|529452124|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146803481|NCT04033445|529452125|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146803482|NCT04033445|529452126|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146803483|NCT04033445|529452127|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
146803484|NCT04033445|529452114|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
146803485|NCT04033445|529452115|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
146803486|NCT04033445|529452116|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
146803487|NCT04033445|529452117|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
146803488|NCT04033445|529452118|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
146803489|NCT04033445|529452119|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
146803490|NCT04033445|529452120|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
146803491|NCT04033445|529452121|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
146803492|NCT04033445|529452122|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
146803493|NCT04033445|529452123|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
146803494|NCT04033445|529452124|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
146803495|NCT04033445|529452125|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
146803496|NCT04033445|529452126|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
146803497|NCT04033445|529452127|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
146803498|NCT04033445|529452114|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146803499|NCT04033445|529452115|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146803500|NCT04033445|529452116|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146803501|NCT04033445|529452117|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146803502|NCT04033445|529452118|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146803503|NCT04033445|529452119|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146941754|NCT02475629|529945979|FG000|Overall Study|Withdrawal by Subject|1|||
146941755|NCT02475629|529945979|FG000|Overall Study|Lost to Follow-up|1|||
146941756|NCT02475629|529945979|FG000|Overall Study|Subject non-compliance|1|||
146803504|NCT04033445|529452120|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146803505|NCT04033445|529452121|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146803506|NCT04033445|529452122|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146803507|NCT04033445|529452123|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
146803508|NCT04033445|529452124|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146803509|NCT04033445|529452125|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
146803510|NCT04033445|529452126|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
146803511|NCT04033445|529452127|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146803512|NCT04353492|529452130|FG000|Overall Study|Subject decision|24|||
146803513|NCT04353492|529452130|FG000|Overall Study|Physician Decision|5|||
146803514|NCT04353492|529452130|FG000|Overall Study|Adverse Event|3|||
146803515|NCT04353492|529452130|FG000|Overall Study|Pregnancy|3|||
146803516|NCT04353492|529452130|FG000|Overall Study|Lost to Follow-up|2|||
146803517|NCT04353492|529452130|FG000|Overall Study|Protocol deviation|1|||
146803518|NCT04353492|529452130|FG000|Overall Study|Technical problems|1|||
146803519|NCT00776009|529452131|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
146803520|NCT00776009|529452132|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
146803521|NCT00776009|529452133|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
146803522|NCT00776009|529452134|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
146803523|NCT00776009|529452135|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
146803524|NCT00776009|529452136|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
146803525|NCT00776009|529452131|FG000|Period 1: First Intervention|Protocol Violation|0|||
146803526|NCT00776009|529452132|FG001|Period 1: First Intervention|Protocol Violation|1|||
146803527|NCT00776009|529452133|FG002|Period 1: First Intervention|Protocol Violation|0|||
146803528|NCT00776009|529452134|FG003|Period 1: First Intervention|Protocol Violation|0|||
146803529|NCT00776009|529452135|FG004|Period 1: First Intervention|Protocol Violation|1|||
146803530|NCT00776009|529452136|FG005|Period 1: First Intervention|Protocol Violation|0|||
146803531|NCT00776009|529452131|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
146803532|NCT00776009|529452132|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
146803533|NCT00776009|529452133|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
146803534|NCT00776009|529452134|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
146803535|NCT00776009|529452135|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
146803536|NCT00776009|529452136|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
146941757|NCT01095666|529945983|FG000|Overall Study|Lack of Efficacy|0|||
146941758|NCT01095666|529945984|FG001|Overall Study|Lack of Efficacy|0|||
146941759|NCT01095666|529945985|FG002|Overall Study|Lack of Efficacy|1|||
146941760|NCT01095666|529945983|FG000|Overall Study|Adverse Event|2|||
146941761|NCT01095666|529945984|FG001|Overall Study|Adverse Event|1|||
146941762|NCT01095666|529945985|FG002|Overall Study|Adverse Event|3|||
146620847|NCT02586623|528783447|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
146620848|NCT02586623|528783445|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
146620849|NCT02586623|528783446|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
146620850|NCT02586623|528783447|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
146620851|NCT02586623|528783445|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
146620852|NCT02586623|528783446|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
146620853|NCT02586623|528783447|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
146620854|NCT02586623|528783445|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
146620855|NCT02586623|528783446|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
146620856|NCT02586623|528783447|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
146620857|NCT02586623|528783445|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
146620858|NCT02586623|528783446|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
146620859|NCT02586623|528783447|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
146620860|NCT02586623|528783445|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
146620861|NCT02586623|528783446|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
146620862|NCT02586623|528783447|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
146620863|NCT02586623|528783445|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
146620864|NCT02586623|528783446|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
146620865|NCT02586623|528783447|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
146620866|NCT02586623|528783445|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
146620867|NCT02586623|528783446|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
146941763|NCT01095666|529945983|FG000|Overall Study|Lost to Follow-up|2|||
146620868|NCT02586623|528783447|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
146620869|NCT02586623|528783445|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
146620870|NCT02586623|528783446|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
146620871|NCT02586623|528783447|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
146620872|NCT02586623|528783445|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
146620873|NCT02586623|528783446|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
146620874|NCT02586623|528783447|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
146620875|NCT02586623|528783445|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
146620876|NCT02586623|528783446|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
146620877|NCT02586623|528783447|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
146620878|NCT02586623|528783445|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
146620879|NCT02586623|528783446|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
146620880|NCT02586623|528783447|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
146620881|NCT02586623|528783445|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
146620882|NCT02586623|528783446|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
146620883|NCT02586623|528783447|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
146620884|NCT02586623|528783445|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
146620885|NCT02586623|528783446|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
146620886|NCT02586623|528783447|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
146620887|NCT02586623|528783445|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
146620888|NCT02586623|528783446|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
146620889|NCT02586623|528783447|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
146620890|NCT02586623|528783445|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
146620891|NCT02586623|528783446|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
146620892|NCT02586623|528783447|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
146620893|NCT02586623|528783445|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
146620894|NCT02586623|528783446|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
146620895|NCT02586623|528783447|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
146620896|NCT02586623|528783445|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
146620897|NCT02586623|528783446|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
146620898|NCT02586623|528783447|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
146620899|NCT05051579|528783451|FG000|Overall Study|Withdrawal by Subject|3|||
146803537|NCT00776009|529452131|FG000|Period 2: Second Intervention|Protocol Violation|1|||
146803538|NCT00776009|529452132|FG001|Period 2: Second Intervention|Protocol Violation|0|||
146803539|NCT00776009|529452133|FG002|Period 2: Second Intervention|Protocol Violation|1|||
146803540|NCT00776009|529452134|FG003|Period 2: Second Intervention|Protocol Violation|0|||
146803541|NCT00776009|529452135|FG004|Period 2: Second Intervention|Protocol Violation|0|||
146803542|NCT00776009|529452136|FG005|Period 2: Second Intervention|Protocol Violation|0|||
146803543|NCT00776009|529452131|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
146803544|NCT00776009|529452132|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
146803545|NCT00776009|529452133|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
146803546|NCT00776009|529452134|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
146803547|NCT00776009|529452135|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
146620900|NCT05051579|528783452|FG001|Overall Study|Withdrawal by Subject|5|||
146620901|NCT05051579|528783453|FG002|Overall Study|Withdrawal by Subject|2|||
146620902|NCT05051579|528783454|FG003|Overall Study|Withdrawal by Subject|1|||
146620903|NCT05051579|528783455|FG004|Overall Study|Withdrawal by Subject|4|||
146620904|NCT05051579|528783456|FG005|Overall Study|Withdrawal by Subject|0|||
146620905|NCT05051579|528783457|FG006|Overall Study|Withdrawal by Subject|4|||
146620906|NCT05051579|528783451|FG000|Overall Study|Lost to Follow-up|1|||
146620907|NCT05051579|528783452|FG001|Overall Study|Lost to Follow-up|0|||
146620908|NCT05051579|528783453|FG002|Overall Study|Lost to Follow-up|0|||
146803548|NCT00776009|529452136|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
146803549|NCT00582972|529452137|FG000|Overall Study|Protocol Violation|2|||
146803550|NCT02101775|529452143|FG000|Overall Study|Adverse Event|4|||
146803551|NCT02101775|529452144|FG001|Overall Study|Adverse Event|0|||
146803552|NCT02101775|529452145|FG002|Overall Study|Adverse Event|0|||
146803553|NCT02101775|529452143|FG000|Overall Study|Admission to Hospital|0|||
146803554|NCT02101775|529452144|FG001|Overall Study|Admission to Hospital|1|||
146803555|NCT02101775|529452145|FG002|Overall Study|Admission to Hospital|0|||
146803556|NCT00293397|529452146|FG000|Overall Study|Death|2|||
146803557|NCT00503906|529452149|FG000|Overall Study|Withdrawal by Subject|1|||
146803558|NCT04035447|529452150|FG000|Treatment Period|Lost to Follow-up|6|||
146803559|NCT04035447|529452151|FG001|Treatment Period|Lost to Follow-up|5|||
146803560|NCT04035447|529452150|FG000|Treatment Period|Physician Decision|0|||
146803561|NCT04035447|529452151|FG001|Treatment Period|Physician Decision|2|||
146803562|NCT03304587|529452152|FG000|Overall Study|Headache after intervention|0|||
146803563|NCT03304587|529452153|FG001|Overall Study|Headache after intervention|1|||
146803564|NCT03304587|529452152|FG000|Overall Study|Withdrawal by Subject|1|||
146803565|NCT03304587|529452153|FG001|Overall Study|Withdrawal by Subject|0|||
146803566|NCT02029235|529452154|FG000|Overall Study|Non-compliance with study meds or diary|4|||
146803567|NCT02029235|529452155|FG001|Overall Study|Non-compliance with study meds or diary|1|||
146803568|NCT02107261|529452156|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
146803569|NCT02107261|529452157|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
146803570|NCT02107261|529452156|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
146803571|NCT02107261|529452157|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
146941764|NCT01095666|529945984|FG001|Overall Study|Lost to Follow-up|2|||
146941765|NCT01095666|529945985|FG002|Overall Study|Lost to Follow-up|0|||
146803572|NCT02408887|529452160|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
146803573|NCT02408887|529452161|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
146803574|NCT02408887|529452160|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
146803575|NCT02408887|529452161|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
146803576|NCT03333109|529452162|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
146803577|NCT03333109|529452163|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
146803578|NCT03333109|529452164|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
146803579|NCT03333109|529452162|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146803580|NCT03333109|529452163|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146803581|NCT03333109|529452164|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
146803582|NCT03333109|529452162|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
146803583|NCT03333109|529452163|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
146803584|NCT03333109|529452164|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
146803585|NCT03333109|529452162|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
146803586|NCT03333109|529452163|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
146803587|NCT03333109|529452164|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
146803588|NCT03333109|529452162|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
146803589|NCT03333109|529452163|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
146803590|NCT03333109|529452164|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
146803591|NCT03333109|529452162|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
146803592|NCT03333109|529452163|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
146803593|NCT03333109|529452164|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
146803594|NCT03333109|529452162|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
146803595|NCT03333109|529452163|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
146803596|NCT03333109|529452164|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
146803597|NCT03333109|529452162|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
146803598|NCT03333109|529452163|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
146803599|NCT03333109|529452164|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
146803600|NCT04088227|529452165|FG000|Overall Study|Withdrawal by Subject|1|||
146803601|NCT04088227|529452166|FG001|Overall Study|Withdrawal by Subject|0|||
146803602|NCT04088227|529452165|FG000|Overall Study|Surgery postponed >5weeks|1|||
146803603|NCT04088227|529452166|FG001|Overall Study|Surgery postponed >5weeks|0|||
146803604|NCT03160885|529452169|FG000|Initial Treatment Period|Not dosed|2|||
146803605|NCT03160885|529452170|FG001|Initial Treatment Period|Not dosed|0|||
146803606|NCT03160885|529452171|FG002|Initial Treatment Period|Not dosed|0|||
146803607|NCT03160885|529452172|FG003|Initial Treatment Period|Not dosed|0|||
146803608|NCT03160885|529452173|FG004|Initial Treatment Period|Not dosed|0|||
146803609|NCT03160885|529452174|FG005|Initial Treatment Period|Not dosed|0|||
146803610|NCT03160885|529452175|FG006|Initial Treatment Period|Not dosed|0|||
146803611|NCT03160885|529452169|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
146803612|NCT03160885|529452170|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
146803613|NCT03160885|529452171|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146803614|NCT03160885|529452172|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146620909|NCT05051579|528783454|FG003|Overall Study|Lost to Follow-up|0|||
146620910|NCT05051579|528783455|FG004|Overall Study|Lost to Follow-up|1|||
146620911|NCT05051579|528783456|FG005|Overall Study|Lost to Follow-up|0|||
146620912|NCT05051579|528783457|FG006|Overall Study|Lost to Follow-up|1|||
146620913|NCT05051579|528783451|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
146620914|NCT05051579|528783452|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
146620915|NCT05051579|528783453|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
146620916|NCT05051579|528783454|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
146620917|NCT05051579|528783455|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
146620918|NCT05051579|528783456|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
146803615|NCT03160885|529452173|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146803616|NCT03160885|529452174|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146803617|NCT03160885|529452175|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146941766|NCT01095666|529945983|FG000|Overall Study|Withdrawal by Subject|6|||
146941767|NCT01095666|529945984|FG001|Overall Study|Withdrawal by Subject|6|||
146941768|NCT01095666|529945985|FG002|Overall Study|Withdrawal by Subject|1|||
146620919|NCT05051579|528783457|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
146620920|NCT05051579|528783451|FG000|Overall Study|Adverse Event|2|||
146620921|NCT05051579|528783452|FG001|Overall Study|Adverse Event|1|||
146620922|NCT05051579|528783453|FG002|Overall Study|Adverse Event|0|||
146620923|NCT05051579|528783454|FG003|Overall Study|Adverse Event|4|||
146620924|NCT05051579|528783455|FG004|Overall Study|Adverse Event|1|||
146620925|NCT05051579|528783456|FG005|Overall Study|Adverse Event|2|||
146620926|NCT05051579|528783457|FG006|Overall Study|Adverse Event|0|||
146620927|NCT05051579|528783451|FG000|Overall Study|Inadvertent Enrollment|0|||
146620928|NCT05051579|528783452|FG001|Overall Study|Inadvertent Enrollment|0|||
146803618|NCT03160885|529452169|FG000|Open-label Treatment|Not dosed|0|||
146803619|NCT03160885|529452170|FG001|Open-label Treatment|Not dosed|0|||
146803620|NCT03160885|529452171|FG002|Open-label Treatment|Not dosed|0|||
146803621|NCT03160885|529452172|FG003|Open-label Treatment|Not dosed|0|||
146803622|NCT03160885|529452173|FG004|Open-label Treatment|Not dosed|0|||
146803623|NCT03160885|529452174|FG005|Open-label Treatment|Not dosed|0|||
146803624|NCT03160885|529452175|FG006|Open-label Treatment|Not dosed|2|||
146803625|NCT03160885|529452169|FG000|Open-label Treatment|Discontinued IMP|0|||
146803626|NCT03160885|529452170|FG001|Open-label Treatment|Discontinued IMP|0|||
146803627|NCT03160885|529452171|FG002|Open-label Treatment|Discontinued IMP|0|||
146803628|NCT03160885|529452172|FG003|Open-label Treatment|Discontinued IMP|0|||
146803629|NCT03160885|529452173|FG004|Open-label Treatment|Discontinued IMP|0|||
146803630|NCT03160885|529452174|FG005|Open-label Treatment|Discontinued IMP|0|||
146803631|NCT03160885|529452175|FG006|Open-label Treatment|Discontinued IMP|131|||
146803632|NCT03160885|529452169|FG000|Open-label Treatment|Completed Week 50|0|||
146803633|NCT03160885|529452170|FG001|Open-label Treatment|Completed Week 50|0|||
146803634|NCT03160885|529452171|FG002|Open-label Treatment|Completed Week 50|0|||
146803635|NCT03160885|529452172|FG003|Open-label Treatment|Completed Week 50|0|||
146620929|NCT05051579|528783453|FG002|Overall Study|Inadvertent Enrollment|0|||
146620930|NCT05051579|528783454|FG003|Overall Study|Inadvertent Enrollment|0|||
146620931|NCT05051579|528783455|FG004|Overall Study|Inadvertent Enrollment|0|||
146620932|NCT05051579|528783456|FG005|Overall Study|Inadvertent Enrollment|0|||
146620933|NCT05051579|528783457|FG006|Overall Study|Inadvertent Enrollment|1|||
146620934|NCT05051579|528783451|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
146620935|NCT05051579|528783452|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
146620936|NCT05051579|528783453|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
146620937|NCT05051579|528783454|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
146620938|NCT05051579|528783455|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
146620939|NCT05051579|528783456|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
146620940|NCT05051579|528783457|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
146620941|NCT05051579|528783451|FG000|Overall Study|Sponsor Decision|0|||
146620942|NCT05051579|528783452|FG001|Overall Study|Sponsor Decision|0|||
146620943|NCT05051579|528783453|FG002|Overall Study|Sponsor Decision|0|||
146620944|NCT05051579|528783454|FG003|Overall Study|Sponsor Decision|0|||
146620945|NCT05051579|528783455|FG004|Overall Study|Sponsor Decision|1|||
146620946|NCT05051579|528783456|FG005|Overall Study|Sponsor Decision|0|||
146620947|NCT05051579|528783457|FG006|Overall Study|Sponsor Decision|0|||
146620948|NCT05051579|528783451|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
146620949|NCT05051579|528783452|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
146620950|NCT05051579|528783453|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
146620951|NCT05051579|528783454|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
146620952|NCT05051579|528783455|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
146620953|NCT05051579|528783456|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
146620954|NCT05051579|528783457|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
146620955|NCT04332107|528783463|FG000|Day 3|Lost to Follow-up|23|||
146803636|NCT03160885|529452173|FG004|Open-label Treatment|Completed Week 50|0|||
146803637|NCT03160885|529452174|FG005|Open-label Treatment|Completed Week 50|0|||
146803638|NCT03160885|529452175|FG006|Open-label Treatment|Completed Week 50|4|||
146803639|NCT03160885|529452169|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
146803640|NCT03160885|529452170|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
146803641|NCT03160885|529452171|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
146803642|NCT03160885|529452172|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
146803643|NCT03160885|529452173|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
146803644|NCT03160885|529452174|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
146803645|NCT03160885|529452175|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
146803646|NCT03160885|529452169|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
146803647|NCT03160885|529452170|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
146803648|NCT03160885|529452171|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
146941769|NCT01095666|529945983|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
146941770|NCT01095666|529945984|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
146941771|NCT01095666|529945985|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
146803649|NCT03160885|529452172|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
146803650|NCT03160885|529452173|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
146803651|NCT03160885|529452174|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
146941772|NCT00841672|529945993|FG000|Overall Study|Adverse Event|7|||
146941773|NCT00841672|529945994|FG001|Overall Study|Adverse Event|16|||
146941774|NCT00841672|529945993|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146803652|NCT03160885|529452175|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
146803653|NCT03160885|529452169|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
146803654|NCT03160885|529452170|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
146803655|NCT03160885|529452171|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
146803656|NCT03160885|529452172|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
146803657|NCT03160885|529452173|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
146803658|NCT03160885|529452174|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
146803659|NCT03160885|529452175|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
146803660|NCT03160885|529452169|FG000|Maintenance Treatment Period|Completed Week 50|0|||
146803661|NCT03160885|529452170|FG001|Maintenance Treatment Period|Completed Week 50|0|||
146803662|NCT03160885|529452171|FG002|Maintenance Treatment Period|Completed Week 50|1|||
146803663|NCT03160885|529452172|FG003|Maintenance Treatment Period|Completed Week 50|0|||
146803664|NCT03160885|529452173|FG004|Maintenance Treatment Period|Completed Week 50|0|||
146620956|NCT04332107|528783464|FG001|Day 3|Lost to Follow-up|14|||
146620957|NCT04332107|528783463|FG000|Day 3|Missing outcome data|3|||
146620958|NCT04332107|528783464|FG001|Day 3|Missing outcome data|6|||
146620959|NCT04332107|528783463|FG000|Day 14|Lost to Follow-up|13|||
146620960|NCT04332107|528783464|FG001|Day 14|Lost to Follow-up|4|||
146620961|NCT04332107|528783463|FG000|Day 14|Missing outcome data|4|||
146620962|NCT04332107|528783464|FG001|Day 14|Missing outcome data|4|||
146620963|NCT04332107|528783463|FG000|Day 21|Lost to Follow-up|10|||
146620964|NCT04332107|528783464|FG001|Day 21|Lost to Follow-up|2|||
146620965|NCT00717249|528783465|FG000|Overall Study|Lens Discomfort|4|||
146620966|NCT00717249|528783466|FG001|Overall Study|Lens Discomfort|1|||
146620967|NCT00717249|528783465|FG000|Overall Study|Unsatisfactory visual Response|0|||
146620968|NCT00717249|528783466|FG001|Overall Study|Unsatisfactory visual Response|2|||
146620969|NCT00717249|528783465|FG000|Overall Study|Adverse Event|4|||
146620970|NCT00717249|528783466|FG001|Overall Study|Adverse Event|2|||
146620971|NCT00717249|528783465|FG000|Overall Study|Lost to Follow-up|2|||
146620972|NCT00717249|528783466|FG001|Overall Study|Lost to Follow-up|0|||
146620973|NCT00717249|528783465|FG000|Overall Study|Withdrawal by Subject|1|||
146620974|NCT00717249|528783466|FG001|Overall Study|Withdrawal by Subject|2|||
146620975|NCT00717249|528783465|FG000|Overall Study|Pregnancy|6|||
146620976|NCT00717249|528783466|FG001|Overall Study|Pregnancy|3|||
146620977|NCT00717249|528783465|FG000|Overall Study|Protocol Violation|0|||
146620978|NCT00717249|528783466|FG001|Overall Study|Protocol Violation|2|||
146620979|NCT00717249|528783465|FG000|Overall Study|Subject became Ineligible|1|||
146620980|NCT00717249|528783466|FG001|Overall Study|Subject became Ineligible|1|||
146620981|NCT00717249|528783465|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
146620982|NCT00717249|528783466|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
146620983|NCT00717249|528783465|FG000|Overall Study|Gastric Surgery|0|||
146803665|NCT03160885|529452174|FG005|Maintenance Treatment Period|Completed Week 50|0|||
146803666|NCT03160885|529452175|FG006|Maintenance Treatment Period|Completed Week 50|0|||
146803667|NCT05786612|529452176|FG000|Overall Study|Adverse Event|1|||
146803668|NCT05786612|529452177|FG001|Overall Study|Adverse Event|2|||
146803669|NCT05786612|529452176|FG000|Overall Study|one screening failure|0|||
146803670|NCT05786612|529452177|FG001|Overall Study|one screening failure|2|||
146803671|NCT05485805|529452183|FG000|Overall Study|Withdrawal by Subject|1|||
146803672|NCT05485805|529452184|FG001|Overall Study|Withdrawal by Subject|2|||
146803673|NCT05485805|529452185|FG002|Overall Study|Withdrawal by Subject|2|||
146803674|NCT05485805|529452186|FG003|Overall Study|Withdrawal by Subject|0|||
146803675|NCT05485805|529452187|FG004|Overall Study|Withdrawal by Subject|2|||
146803676|NCT05485805|529452183|FG000|Overall Study|Adverse Event|0|||
146803677|NCT05485805|529452184|FG001|Overall Study|Adverse Event|1|||
146803678|NCT05485805|529452185|FG002|Overall Study|Adverse Event|0|||
146803679|NCT05485805|529452186|FG003|Overall Study|Adverse Event|0|||
146803680|NCT05485805|529452187|FG004|Overall Study|Adverse Event|0|||
146803681|NCT05485805|529452183|FG000|Overall Study|Lost to Follow-up|1|||
146803682|NCT05485805|529452184|FG001|Overall Study|Lost to Follow-up|1|||
146941775|NCT00841672|529945994|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146941776|NCT00841672|529945993|FG000|Overall Study|Subject withdrew consent|2|||
146941777|NCT00841672|529945994|FG001|Overall Study|Subject withdrew consent|4|||
146620984|NCT00717249|528783466|FG001|Overall Study|Gastric Surgery|1|||
146620985|NCT00717249|528783465|FG000|Overall Study|Diagnosed with Diabetes|1|||
146620986|NCT00717249|528783466|FG001|Overall Study|Diagnosed with Diabetes|0|||
146620987|NCT00717249|528783465|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
146620988|NCT00717249|528783466|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
146620989|NCT00717249|528783465|FG000|Overall Study|Subject relocated|1|||
146620990|NCT00717249|528783466|FG001|Overall Study|Subject relocated|0|||
146620991|NCT00717249|528783465|FG000|Overall Study|Headaches|1|||
146803683|NCT05485805|529452185|FG002|Overall Study|Lost to Follow-up|3|||
146803684|NCT05485805|529452186|FG003|Overall Study|Lost to Follow-up|1|||
146803685|NCT05485805|529452187|FG004|Overall Study|Lost to Follow-up|0|||
146803686|NCT00490139|529452188|FG000|Overall Study|Lost to Follow-up|249|||
146803687|NCT00490139|529452189|FG001|Overall Study|Lost to Follow-up|216|||
146803688|NCT00490139|529452190|FG002|Overall Study|Lost to Follow-up|205|||
146803689|NCT00490139|529452191|FG003|Overall Study|Lost to Follow-up|229|||
146803690|NCT00490139|529452188|FG000|Overall Study|Withdrawal by Subject|333|||
146803691|NCT00490139|529452189|FG001|Overall Study|Withdrawal by Subject|322|||
146803692|NCT00490139|529452190|FG002|Overall Study|Withdrawal by Subject|396|||
146803693|NCT00490139|529452191|FG003|Overall Study|Withdrawal by Subject|295|||
146803694|NCT00490139|529452188|FG000|Overall Study|Patient did not sign ICF 12|169|||
146803695|NCT00490139|529452189|FG001|Overall Study|Patient did not sign ICF 12|176|||
146803696|NCT00490139|529452190|FG002|Overall Study|Patient did not sign ICF 12|139|||
146803697|NCT00490139|529452191|FG003|Overall Study|Patient did not sign ICF 12|167|||
146803698|NCT00490139|529452188|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
146803699|NCT00490139|529452189|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
146803700|NCT00490139|529452190|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
146803701|NCT00490139|529452191|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
146803702|NCT00490139|529452188|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
146803703|NCT00490139|529452189|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
146803704|NCT00490139|529452190|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
146620992|NCT00717249|528783466|FG001|Overall Study|Headaches|0|||
146620993|NCT00871871|528783467|FG000|Part I|Adverse Event|0|||
146620994|NCT00871871|528783468|FG001|Part I|Adverse Event|2|||
146620995|NCT00871871|528783469|FG002|Part I|Adverse Event|0|||
146620996|NCT00871871|528783470|FG003|Part I|Adverse Event|0|||
146620997|NCT00871871|528783467|FG000|Part I|Withdrawal by Subject|3|||
146620998|NCT00871871|528783468|FG001|Part I|Withdrawal by Subject|0|||
146620999|NCT00871871|528783469|FG002|Part I|Withdrawal by Subject|0|||
146621000|NCT00871871|528783470|FG003|Part I|Withdrawal by Subject|0|||
146621001|NCT00871871|528783467|FG000|Part I|Laboratory abnormality|0|||
146621002|NCT00871871|528783468|FG001|Part I|Laboratory abnormality|1|||
146621003|NCT00871871|528783469|FG002|Part I|Laboratory abnormality|0|||
146621004|NCT00871871|528783470|FG003|Part I|Laboratory abnormality|0|||
146621005|NCT00871871|528783467|FG000|Part II|Lack of Efficacy|0|||
146621006|NCT00871871|528783468|FG001|Part II|Lack of Efficacy|0|||
146621007|NCT00871871|528783469|FG002|Part II|Lack of Efficacy|1|||
146621008|NCT00871871|528783470|FG003|Part II|Lack of Efficacy|0|||
146621009|NCT00871871|528783467|FG000|Part II|Withdrawal by Subject|0|||
146621010|NCT00871871|528783468|FG001|Part II|Withdrawal by Subject|0|||
146621011|NCT00871871|528783469|FG002|Part II|Withdrawal by Subject|2|||
146621012|NCT00871871|528783470|FG003|Part II|Withdrawal by Subject|1|||
146621013|NCT00871871|528783467|FG000|Part II|Adverse Event|0|||
146621014|NCT00871871|528783468|FG001|Part II|Adverse Event|0|||
146621015|NCT00871871|528783469|FG002|Part II|Adverse Event|1|||
146621016|NCT00871871|528783470|FG003|Part II|Adverse Event|2|||
146621017|NCT00871871|528783467|FG000|Part II|Protocol Violation|0|||
146621018|NCT00871871|528783468|FG001|Part II|Protocol Violation|0|||
146621019|NCT00871871|528783469|FG002|Part II|Protocol Violation|0|||
146621020|NCT00871871|528783470|FG003|Part II|Protocol Violation|1|||
146621021|NCT03863509|528783471|FG000|Overall Study|COVID-19 shutdown period|0|||
146621022|NCT03863509|528783472|FG001|Overall Study|COVID-19 shutdown period|4|||
146621023|NCT03863509|528783473|FG002|Overall Study|COVID-19 shutdown period|0|||
146621024|NCT03863509|528783471|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
146621025|NCT03863509|528783472|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
146621026|NCT03863509|528783473|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
146621027|NCT03863509|528783471|FG000|Overall Study|Lost to Follow-up|8|||
146621028|NCT03863509|528783472|FG001|Overall Study|Lost to Follow-up|0|||
146621029|NCT03863509|528783473|FG002|Overall Study|Lost to Follow-up|2|||
146621030|NCT03863509|528783471|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
146621031|NCT03863509|528783472|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
146621032|NCT03863509|528783473|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
146621033|NCT03863509|528783471|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
146983765|NCT00585351|530101959|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
146983766|NCT00585351|530101960|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
146621034|NCT03863509|528783472|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
146621035|NCT03863509|528783473|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
146983767|NCT00585351|530101953|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
146983768|NCT00585351|530101954|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
146621036|NCT03799341|528783474|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
146621037|NCT03799341|528783475|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
146621038|NCT03799341|528783476|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
146621039|NCT03799341|528783474|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
146621040|NCT03799341|528783475|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
146621041|NCT03799341|528783476|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
146803705|NCT00490139|529452191|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
147013212|NCT02048813|530210052|FG000|Overall Study|Non-protocol therapy|0|||
146621042|NCT03799341|528783474|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
146621043|NCT03799341|528783475|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
146621044|NCT03799341|528783476|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
146621045|NCT03799341|528783474|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
146621046|NCT03799341|528783475|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
146621047|NCT03799341|528783476|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
146621048|NCT03799341|528783474|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
146621049|NCT03799341|528783475|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
146621050|NCT03799341|528783476|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
146621051|NCT03799341|528783474|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
146621052|NCT03799341|528783475|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
146621053|NCT03799341|528783476|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
146621054|NCT00990106|528783477|FG000|Overall Study|"too busy to continue"|1|||
146621055|NCT00990106|528783478|FG001|Overall Study|"too busy to continue"|2|||
146621056|NCT00990106|528783477|FG000|Overall Study|Lost to Follow-up|1|||
146621057|NCT00990106|528783478|FG001|Overall Study|Lost to Follow-up|3|||
146621058|NCT00990106|528783477|FG000|Overall Study|Withdrawal by Subject|2|||
146621059|NCT00990106|528783478|FG001|Overall Study|Withdrawal by Subject|1|||
146621060|NCT00990106|528783477|FG000|Overall Study|opted for open label prazosin|1|||
146621061|NCT00990106|528783478|FG001|Overall Study|opted for open label prazosin|1|||
146621062|NCT00990106|528783477|FG000|Overall Study|relocation/deployment|4|||
146621063|NCT00990106|528783478|FG001|Overall Study|relocation/deployment|1|||
146621064|NCT00990106|528783477|FG000|Overall Study|started exclusionary medication|0|||
146621065|NCT00990106|528783478|FG001|Overall Study|started exclusionary medication|1|||
146621066|NCT00990106|528783477|FG000|Overall Study|planned major surgery|0|||
146621067|NCT00990106|528783478|FG001|Overall Study|planned major surgery|1|||
146621068|NCT00990106|528783477|FG000|Overall Study|scheduling conflicts|0|||
146621069|NCT00990106|528783478|FG001|Overall Study|scheduling conflicts|2|||
146621070|NCT03100149|528783479|FG000|Overall Study|Adverse Event|0|||
146621071|NCT03100149|528783480|FG001|Overall Study|Adverse Event|1|||
146621072|NCT03100149|528783481|FG002|Overall Study|Adverse Event|0|||
146621073|NCT03100149|528783479|FG000|Overall Study|Participant Moved out of Country|0|||
146621074|NCT03100149|528783480|FG001|Overall Study|Participant Moved out of Country|0|||
146621075|NCT03100149|528783481|FG002|Overall Study|Participant Moved out of Country|1|||
146621076|NCT03100149|528783479|FG000|Overall Study|Withdrawal by Subject|0|||
146621077|NCT03100149|528783480|FG001|Overall Study|Withdrawal by Subject|3|||
146621078|NCT03100149|528783481|FG002|Overall Study|Withdrawal by Subject|1|||
146621079|NCT00445549|528784567|FG000|Overall Study|progressive disease|12|||
146621080|NCT01405768|528784574|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
146621081|NCT01405768|528784575|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
146621082|NCT02792231|528784578|FG000|Overall Study|Patient/guardian decision|32|||
146621083|NCT02792231|528784579|FG001|Overall Study|Patient/guardian decision|42|||
146621084|NCT02792231|528784578|FG000|Overall Study|Adverse Event|15|||
146621085|NCT02792231|528784579|FG001|Overall Study|Adverse Event|11|||
146621086|NCT02792231|528784578|FG000|Overall Study|Physician Decision|14|||
146621087|NCT02792231|528784579|FG001|Overall Study|Physician Decision|12|||
146621088|NCT02792231|528784578|FG000|Overall Study|Lack of Efficacy|7|||
146621089|NCT02792231|528784579|FG001|Overall Study|Lack of Efficacy|9|||
146621090|NCT02792231|528784578|FG000|Overall Study|Lost to Follow-up|9|||
146621091|NCT02792231|528784579|FG001|Overall Study|Lost to Follow-up|5|||
146621092|NCT02792231|528784578|FG000|Overall Study|Pregnancy|1|||
146621093|NCT02792231|528784579|FG001|Overall Study|Pregnancy|3|||
146621094|NCT02792231|528784578|FG000|Overall Study|Non-compliance with study treatment|2|||
146621095|NCT02792231|528784579|FG001|Overall Study|Non-compliance with study treatment|1|||
146621096|NCT02792231|528784578|FG000|Overall Study|Protocol deviation|2|||
146621097|NCT02792231|528784579|FG001|Overall Study|Protocol deviation|0|||
146621098|NCT02792231|528784578|FG000|Overall Study|Technical problems|0|||
146621099|NCT02792231|528784579|FG001|Overall Study|Technical problems|1|||
146621100|NCT05196828|528784580|FG000|Overall Study|Withdrawal by Subject|2|||
146621101|NCT05196828|528784581|FG001|Overall Study|Withdrawal by Subject|0|||
146621102|NCT05196828|528784580|FG000|Overall Study|Lost to Follow-up|0|||
146621103|NCT05196828|528784581|FG001|Overall Study|Lost to Follow-up|4|||
146621104|NCT05196828|528784580|FG000|Overall Study|Adverse Event|1|||
146621105|NCT05196828|528784581|FG001|Overall Study|Adverse Event|0|||
146621106|NCT04073186|528784582|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
146621107|NCT04073186|528784582|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
146621108|NCT04073186|528784582|FG000|First Wearing Cycle|Protocol Violation|1|||
146803706|NCT00490139|529452188|FG000|Overall Study|Other reasons as defined per protocol|98|||
146803707|NCT00490139|529452189|FG001|Overall Study|Other reasons as defined per protocol|84|||
146803708|NCT00490139|529452190|FG002|Overall Study|Other reasons as defined per protocol|82|||
146803709|NCT00490139|529452191|FG003|Overall Study|Other reasons as defined per protocol|105|||
146803710|NCT03664804|529452193|FG000|Overall Study|Withdrawal by Subject|7|||
146803711|NCT05529992|529452194|FG000|Overall Study|Withdrawal by Subject|1|||
146803712|NCT06140290|529452195|FG000|Period 1|Adverse Event|1|||
146803713|NCT06140290|529452196|FG001|Period 1|Adverse Event|0|||
146803714|NCT06140290|529452195|FG000|Period 2|Assigned but not treated|0|||
146803715|NCT06140290|529452196|FG001|Period 2|Assigned but not treated|1|||
146803716|NCT06140290|529452195|FG000|Period 2|Withdrawal by Subject|0|||
146621109|NCT04073186|528784582|FG000|First Wearing Cycle|Lens Discomfort|2|||
146621110|NCT04073186|528784582|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
146621111|NCT04073186|528784582|FG000|Second Wearing Cycle|Adverse Event|1|||
146621112|NCT00473434|528784583|FG000|Overall Study|Physician Decision|3|||
146621113|NCT00473434|528784583|FG000|Overall Study|Withdrawal by Subject|9|||
146621114|NCT00473434|528784583|FG000|Overall Study|Compliance|3|||
146621115|NCT00473434|528784583|FG000|Overall Study|Lack of Efficacy|3|||
146621116|NCT00473434|528784583|FG000|Overall Study|Adverse Event|3|||
146621117|NCT00473434|528784583|FG000|Overall Study|Patient was selling medication to others|1|||
146621118|NCT00473434|528784583|FG000|Overall Study|Safety evaluation|1|||
146621119|NCT00473434|528784583|FG000|Overall Study|Reason not specified|6|||
146621120|NCT00473434|528784583|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
146621121|NCT00473434|528784583|FG000|Overall Study|Switching to trial medication|1|||
146621122|NCT00473434|528784583|FG000|Overall Study|No longer required|1|||
146803717|NCT06140290|529452196|FG001|Period 2|Withdrawal by Subject|1|||
146803718|NCT05250115|529453186|FG000|Overall Study|Premature study end|40|||
146803719|NCT05250115|529453186|FG000|Overall Study|Adverse Event|8|||
146803720|NCT05250115|529453186|FG000|Overall Study|Lost to Follow-up|7|||
146803721|NCT05250115|529453186|FG000|Overall Study|Withdrawal by Subject|6|||
146803722|NCT05250115|529453186|FG000|Overall Study|Withdrawal of informed consent|1|||
146803723|NCT05250115|529453186|FG000|Overall Study|Other|7|||
146803724|NCT03758638|529453187|FG000|Overall Study|Pregnancy|17|||
146803725|NCT03758638|529453188|FG001|Overall Study|Pregnancy|25|||
146803726|NCT03758638|529453187|FG000|Overall Study|Lost to Follow-up|60|||
146803727|NCT03758638|529453188|FG001|Overall Study|Lost to Follow-up|54|||
146803728|NCT03758638|529453187|FG000|Overall Study|Protocol Violation|2|||
146803729|NCT03758638|529453188|FG001|Overall Study|Protocol Violation|0|||
146803730|NCT03758638|529453187|FG000|Overall Study|Withdrawal by Subject|8|||
146803731|NCT03758638|529453188|FG001|Overall Study|Withdrawal by Subject|2|||
146803732|NCT03758638|529453187|FG000|Overall Study|Providers not included in the primary outcome.|183|||
146803733|NCT03758638|529453188|FG001|Overall Study|Providers not included in the primary outcome.|128|||
146803734|NCT01314118|529453189|FG000|Overall Study|Adverse Event|9|||
146803735|NCT01314118|529453189|FG000|Overall Study|Progressive disease|27|||
146803736|NCT01314118|529453189|FG000|Overall Study|Physician Decision|11|||
146803737|NCT01314118|529453189|FG000|Overall Study|Death|4|||
146803738|NCT01314118|529453189|FG000|Overall Study|Protocol Violation|5|||
146803739|NCT01314118|529453189|FG000|Overall Study|Withdrawal by Subject|11|||
146803740|NCT01314118|529453189|FG000|Overall Study|Other|2|||
146803741|NCT01314118|529453189|FG000|Overall Study|Ongoing|62|||
146803742|NCT00790569|529453193|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
146803743|NCT00790569|529453194|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
146803744|NCT00790569|529453195|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
146803745|NCT00790569|529453193|FG000|End of Treatment (6 Month Interview)|Death|0|||
146803746|NCT00790569|529453194|FG001|End of Treatment (6 Month Interview)|Death|2|||
146803747|NCT00790569|529453195|FG002|End of Treatment (6 Month Interview)|Death|1|||
146803748|NCT00790569|529453193|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
146803749|NCT00790569|529453194|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
146803750|NCT00790569|529453195|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
146803751|NCT00790569|529453193|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
146803752|NCT00790569|529453194|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
146803753|NCT00790569|529453195|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
146803754|NCT00790569|529453193|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
146803755|NCT00790569|529453194|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
146803756|NCT00790569|529453195|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
146803757|NCT00790569|529453193|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
146803758|NCT00790569|529453194|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
146803759|NCT00790569|529453195|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
146803760|NCT03244800|529453196|FG000|Overall Study|Adverse Event|0|||
146803761|NCT03244800|529453197|FG001|Overall Study|Adverse Event|1|||
146941778|NCT00841672|529945993|FG000|Overall Study|Lost to Follow-up|1|||
146803762|NCT03244800|529453198|FG002|Overall Study|Adverse Event|0|||
146803763|NCT03244800|529453199|FG003|Overall Study|Adverse Event|1|||
146803764|NCT03244800|529453196|FG000|Overall Study|Withdrew treatment|0|||
146803765|NCT03244800|529453197|FG001|Overall Study|Withdrew treatment|0|||
146803766|NCT03244800|529453198|FG002|Overall Study|Withdrew treatment|0|||
146803767|NCT03244800|529453199|FG003|Overall Study|Withdrew treatment|1|||
146803768|NCT02941549|529453200|FG000|Overall Study|Adverse Event|1|||
146803769|NCT02941549|529453201|FG001|Overall Study|Adverse Event|0|||
146803770|NCT02941549|529453202|FG002|Overall Study|Adverse Event|0|||
146803771|NCT02941549|529453200|FG000|Overall Study|Withdrawal by Subject|2|||
146941779|NCT00841672|529945994|FG001|Overall Study|Lost to Follow-up|1|||
146803772|NCT02941549|529453201|FG001|Overall Study|Withdrawal by Subject|1|||
146803773|NCT02941549|529453202|FG002|Overall Study|Withdrawal by Subject|2|||
146621123|NCT00423657|528784584|FG000|Overall Study|Withdrew consent|10|||
146621124|NCT00423657|528784585|FG001|Overall Study|Withdrew consent|8|||
146621125|NCT00423657|528784584|FG000|Overall Study|Non-compliance|0|||
146621126|NCT00423657|528784585|FG001|Overall Study|Non-compliance|1|||
146621127|NCT00423657|528784584|FG000|Overall Study|Other|15|||
146621128|NCT00423657|528784585|FG001|Overall Study|Other|16|||
146621129|NCT00423657|528784584|FG000|Overall Study|Request of sponsor/investigator|1|||
146621130|NCT00423657|528784585|FG001|Overall Study|Request of sponsor/investigator|0|||
146621131|NCT02748863|528784586|FG000|Treatment Period 1|Adverse Event|0|||
146621132|NCT02748863|528784587|FG001|Treatment Period 1|Adverse Event|1|||
146621133|NCT02748863|528784588|FG002|Treatment Period 1|Adverse Event|0|||
146621134|NCT02748863|528784589|FG003|Treatment Period 1|Adverse Event|0|||
146621135|NCT02748863|528784590|FG004|Treatment Period 1|Adverse Event|0|||
146621136|NCT02748863|528784586|FG000|Treatment Period 1|Lack of Efficacy|0|||
146621137|NCT02748863|528784587|FG001|Treatment Period 1|Lack of Efficacy|0|||
146621138|NCT02748863|528784588|FG002|Treatment Period 1|Lack of Efficacy|1|||
146621139|NCT02748863|528784589|FG003|Treatment Period 1|Lack of Efficacy|0|||
146621140|NCT02748863|528784590|FG004|Treatment Period 1|Lack of Efficacy|0|||
146621141|NCT02748863|528784586|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146621142|NCT02748863|528784587|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146621143|NCT02748863|528784588|FG002|Treatment Period 1|Withdrawal by Subject|1|||
146621144|NCT02748863|528784589|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146621145|NCT02748863|528784590|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146621146|NCT02748863|528784586|FG000|Treatment Period 2|Lost to Follow-up|2|||
146621147|NCT02748863|528784587|FG001|Treatment Period 2|Lost to Follow-up|0|||
146621148|NCT02748863|528784588|FG002|Treatment Period 2|Lost to Follow-up|0|||
146621149|NCT02748863|528784589|FG003|Treatment Period 2|Lost to Follow-up|0|||
146621150|NCT02748863|528784590|FG004|Treatment Period 2|Lost to Follow-up|0|||
146621151|NCT02748863|528784586|FG000|Treatment Period 2|Adverse Event|3|||
146621152|NCT02748863|528784587|FG001|Treatment Period 2|Adverse Event|2|||
146621153|NCT02748863|528784588|FG002|Treatment Period 2|Adverse Event|0|||
146621154|NCT02748863|528784589|FG003|Treatment Period 2|Adverse Event|2|||
146621155|NCT02748863|528784590|FG004|Treatment Period 2|Adverse Event|0|||
146621156|NCT02748863|528784586|FG000|Treatment Period 2|Lack of Efficacy|0|||
146803774|NCT03451422|529453206|FG000|Overall Study|Lost to Follow-up|0|||
146803775|NCT03451422|529453207|FG001|Overall Study|Lost to Follow-up|0|||
146803776|NCT03451422|529453208|FG002|Overall Study|Lost to Follow-up|0|||
146803777|NCT03451422|529453209|FG003|Overall Study|Lost to Follow-up|0|||
146803778|NCT03451422|529453210|FG004|Overall Study|Lost to Follow-up|0|||
146803779|NCT03451422|529453211|FG005|Overall Study|Lost to Follow-up|1|||
146803780|NCT03451422|529453206|FG000|Overall Study|Decision by sponsor|1|||
146803781|NCT03451422|529453207|FG001|Overall Study|Decision by sponsor|0|||
146803782|NCT03451422|529453208|FG002|Overall Study|Decision by sponsor|1|||
146803783|NCT03451422|529453209|FG003|Overall Study|Decision by sponsor|0|||
146941780|NCT00841672|529945993|FG000|Overall Study|Administrative problems|9|||
146621157|NCT02748863|528784587|FG001|Treatment Period 2|Lack of Efficacy|1|||
146621158|NCT02748863|528784588|FG002|Treatment Period 2|Lack of Efficacy|0|||
146621159|NCT02748863|528784589|FG003|Treatment Period 2|Lack of Efficacy|0|||
146621160|NCT02748863|528784590|FG004|Treatment Period 2|Lack of Efficacy|0|||
146621161|NCT02748863|528784586|FG000|Treatment Period 2|Pregnancy|0|||
146621162|NCT02748863|528784587|FG001|Treatment Period 2|Pregnancy|0|||
146621163|NCT02748863|528784588|FG002|Treatment Period 2|Pregnancy|0|||
146621164|NCT02748863|528784589|FG003|Treatment Period 2|Pregnancy|0|||
146621165|NCT02748863|528784590|FG004|Treatment Period 2|Pregnancy|1|||
146621166|NCT02422498|528784591|FG000|Overall Study|Inevaluable|4|||
146621167|NCT03206216|528784592|FG000|Overall Study|Withdrawal by Subject|0|||
146941781|NCT00841672|529945994|FG001|Overall Study|Administrative problems|9|||
146941782|NCT00841672|529945993|FG000|Overall Study|Misrandomized|1|||
146941783|NCT00841672|529945994|FG001|Overall Study|Misrandomized|0|||
146941784|NCT00841672|529945993|FG000|Overall Study|Protocol Deviation|0|||
146621168|NCT03206216|528784593|FG001|Overall Study|Withdrawal by Subject|1|||
146621169|NCT00657046|528784594|FG000|Overall Study|Adverse Event|1|||
146621170|NCT00657046|528784595|FG001|Overall Study|Adverse Event|1|||
146621171|NCT00657046|528784596|FG002|Overall Study|Adverse Event|0|||
146621172|NCT00657046|528784594|FG000|Overall Study|Protocol Violation|2|||
146621173|NCT00657046|528784595|FG001|Overall Study|Protocol Violation|2|||
146941785|NCT00841672|529945994|FG001|Overall Study|Protocol Deviation|1|||
146941786|NCT01451398|529945995|FG000|Overall Study|Adverse Event|7|||
146621174|NCT00657046|528784596|FG002|Overall Study|Protocol Violation|0|||
146621175|NCT00657046|528784594|FG000|Overall Study|Withdrawal by Subject|1|||
146621176|NCT00657046|528784595|FG001|Overall Study|Withdrawal by Subject|0|||
146621177|NCT00657046|528784596|FG002|Overall Study|Withdrawal by Subject|0|||
146621178|NCT00657046|528784594|FG000|Overall Study|Death|0|||
146621179|NCT00657046|528784595|FG001|Overall Study|Death|0|||
146621180|NCT00657046|528784596|FG002|Overall Study|Death|1|||
146621181|NCT00657046|528784594|FG000|Overall Study|Surgery|0|||
146803784|NCT03451422|529453210|FG004|Overall Study|Decision by sponsor|0|||
146621182|NCT00657046|528784595|FG001|Overall Study|Surgery|0|||
146621183|NCT00657046|528784596|FG002|Overall Study|Surgery|1|||
146621184|NCT06237049|528784597|FG000|Overall Study|Death|0|||
146621185|NCT06237049|528784598|FG001|Overall Study|Death|0|||
146621186|NCT06237049|528784599|FG002|Overall Study|Death|0|||
146621187|NCT06237049|528784600|FG003|Overall Study|Death|1|||
146621188|NCT06237049|528784597|FG000|Overall Study|Lost to Follow-up|11|||
146621189|NCT06237049|528784598|FG001|Overall Study|Lost to Follow-up|5|||
146621190|NCT06237049|528784599|FG002|Overall Study|Lost to Follow-up|8|||
146621191|NCT06237049|528784600|FG003|Overall Study|Lost to Follow-up|8|||
146621192|NCT06237049|528784597|FG000|Overall Study|Protocol Violation|0|||
146621193|NCT06237049|528784598|FG001|Overall Study|Protocol Violation|1|||
146621194|NCT06237049|528784599|FG002|Overall Study|Protocol Violation|0|||
146621195|NCT06237049|528784600|FG003|Overall Study|Protocol Violation|1|||
146621196|NCT06237049|528784597|FG000|Overall Study|Withdrawal by Subject|4|||
146621197|NCT06237049|528784598|FG001|Overall Study|Withdrawal by Subject|2|||
146621198|NCT06237049|528784599|FG002|Overall Study|Withdrawal by Subject|1|||
146621199|NCT06237049|528784600|FG003|Overall Study|Withdrawal by Subject|0|||
146621200|NCT02525471|528784601|FG000|Overall Study|Screen Failure|6|||
146621201|NCT02525471|528784601|FG000|Overall Study|Withdrawal by Subject|4|||
146621202|NCT02525471|528784601|FG000|Overall Study|Death|1|||
146621203|NCT00844376|528784602|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
146621204|NCT00844376|528784603|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
146621205|NCT00988884|528784604|FG000|Overall Study|Adverse Event|0|||
146621206|NCT00988884|528784605|FG001|Overall Study|Adverse Event|1|||
146621207|NCT00988884|528784604|FG000|Overall Study|Lost to Follow-up|20|||
146621208|NCT00988884|528784605|FG001|Overall Study|Lost to Follow-up|16|||
146621209|NCT00988884|528784604|FG000|Overall Study|Protocol Violation|0|||
146621210|NCT00988884|528784605|FG001|Overall Study|Protocol Violation|1|||
146621211|NCT00988884|528784604|FG000|Overall Study|Withdrawal by Subject|15|||
146621212|NCT00988884|528784605|FG001|Overall Study|Withdrawal by Subject|18|||
146621213|NCT00468299|528784612|FG000|Overall Study|Withdrawal by Subject|0|||
146621214|NCT00468299|528784613|FG001|Overall Study|Withdrawal by Subject|1|||
146621215|NCT03546621|528784614|FG000|Overall Study|Withdrawal by Subject|0|||
146621216|NCT03546621|528784615|FG001|Overall Study|Withdrawal by Subject|1|||
146621217|NCT03546621|528784616|FG002|Overall Study|Withdrawal by Subject|2|||
146621218|NCT03546621|528784617|FG003|Overall Study|Withdrawal by Subject|1|||
146621219|NCT03546621|528784614|FG000|Overall Study|Lost to Follow-up|0|||
146621220|NCT03546621|528784615|FG001|Overall Study|Lost to Follow-up|1|||
146621221|NCT03546621|528784616|FG002|Overall Study|Lost to Follow-up|0|||
146621222|NCT03546621|528784617|FG003|Overall Study|Lost to Follow-up|0|||
146621223|NCT03546621|528784614|FG000|Overall Study|Adverse Event|0|||
146621224|NCT03546621|528784615|FG001|Overall Study|Adverse Event|1|||
146621225|NCT03546621|528784616|FG002|Overall Study|Adverse Event|0|||
146621226|NCT03546621|528784617|FG003|Overall Study|Adverse Event|1|||
146621227|NCT03546621|528784614|FG000|Overall Study|Progressive disease|0|||
146621228|NCT03546621|528784615|FG001|Overall Study|Progressive disease|0|||
146621229|NCT03546621|528784616|FG002|Overall Study|Progressive disease|0|||
146621230|NCT03546621|528784617|FG003|Overall Study|Progressive disease|1|||
146621231|NCT03318549|528784624|FG000|Overall Study|Withdrawal by Subject|5|||
146621232|NCT03318549|528784625|FG001|Overall Study|Withdrawal by Subject|19|||
146621233|NCT03318549|528784626|FG002|Overall Study|Withdrawal by Subject|2|||
146621234|NCT03318549|528784627|FG003|Overall Study|Withdrawal by Subject|0|||
146621235|NCT03318549|528784628|FG004|Overall Study|Withdrawal by Subject|0|||
146621236|NCT03318549|528784629|FG005|Overall Study|Withdrawal by Subject|0|||
146621237|NCT03318549|528784630|FG006|Overall Study|Withdrawal by Subject|0|||
146621238|NCT03318549|528784624|FG000|Overall Study|Physician Decision|0|||
146621239|NCT03318549|528784625|FG001|Overall Study|Physician Decision|4|||
146983769|NCT00585351|530101955|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
146983770|NCT00585351|530101956|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
146983771|NCT00585351|530101957|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
146621240|NCT03318549|528784626|FG002|Overall Study|Physician Decision|1|||
146983772|NCT00585351|530101958|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
146983773|NCT00585351|530101959|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
146621241|NCT03318549|528784627|FG003|Overall Study|Physician Decision|0|||
146621242|NCT03318549|528784628|FG004|Overall Study|Physician Decision|0|||
146621243|NCT03318549|528784629|FG005|Overall Study|Physician Decision|0|||
146621244|NCT03318549|528784630|FG006|Overall Study|Physician Decision|0|||
146621245|NCT03318549|528784624|FG000|Overall Study|Lost to Follow-up|0|||
146621246|NCT03318549|528784625|FG001|Overall Study|Lost to Follow-up|3|||
146621247|NCT03318549|528784626|FG002|Overall Study|Lost to Follow-up|3|||
146621248|NCT03318549|528784627|FG003|Overall Study|Lost to Follow-up|0|||
146621249|NCT03318549|528784628|FG004|Overall Study|Lost to Follow-up|0|||
146621250|NCT03318549|528784629|FG005|Overall Study|Lost to Follow-up|0|||
146621251|NCT03318549|528784630|FG006|Overall Study|Lost to Follow-up|0|||
146621252|NCT00539994|528784631|FG000|Overall Study|Lost to Follow-up|2|||
146621253|NCT00539994|528784632|FG001|Overall Study|Lost to Follow-up|1|||
146621254|NCT00539994|528784633|FG002|Overall Study|Lost to Follow-up|0|||
146621255|NCT00539994|528784631|FG000|Overall Study|Withdrawal by Subject|1|||
146621256|NCT00539994|528784632|FG001|Overall Study|Withdrawal by Subject|0|||
146621257|NCT00539994|528784633|FG002|Overall Study|Withdrawal by Subject|1|||
146621258|NCT00539994|528784631|FG000|Overall Study|Physician Decision|0|||
146621259|NCT00539994|528784632|FG001|Overall Study|Physician Decision|0|||
146621260|NCT00539994|528784633|FG002|Overall Study|Physician Decision|1|||
146621261|NCT03649074|528784639|FG000|Overall Study|Lost to Follow-up|2|||
146621262|NCT03649074|528784640|FG001|Overall Study|Lost to Follow-up|1|||
146621263|NCT03649074|528784639|FG000|Overall Study|Adverse Event|1|||
146621264|NCT03649074|528784640|FG001|Overall Study|Adverse Event|0|||
146621265|NCT03649074|528784639|FG000|Overall Study|Physician Decision|1|||
146621266|NCT03649074|528784640|FG001|Overall Study|Physician Decision|0|||
146621267|NCT03649074|528784639|FG000|Overall Study|Withdrawal by Subject|0|||
146621268|NCT03649074|528784640|FG001|Overall Study|Withdrawal by Subject|2|||
146621269|NCT03649074|528784639|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
146621270|NCT03649074|528784640|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
146621271|NCT03649074|528784639|FG000|Overall Study|Other|1|||
146621272|NCT03649074|528784640|FG001|Overall Study|Other|0|||
146621273|NCT03861273|528784647|FG000|Screening Phase (3 Weeks)|Other|1|||
146621274|NCT03861273|528784647|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
146621275|NCT03861273|528784647|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
146621276|NCT03861273|528784647|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
146621277|NCT03861273|528784647|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
146621278|NCT00191334|528784650|FG000|Overall Study|Adverse Event|4|||
146621279|NCT00191334|528784650|FG000|Overall Study|Disease Progression or Relapse|8|||
146621280|NCT00191334|528784650|FG000|Overall Study|Physician Decision|1|||
146621281|NCT00191334|528784650|FG000|Overall Study|Withdrawal by Subject|4|||
146621282|NCT01116648|528784651|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
146621283|NCT01116648|528784652|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
146621284|NCT01116648|528784653|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
146621285|NCT01116648|528784654|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
146621286|NCT01116648|528784655|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
146621287|NCT01116648|528784656|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
146621288|NCT01116648|528784657|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
146621289|NCT01116648|528784658|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
146621290|NCT01116648|528784659|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
146621291|NCT01116648|528784660|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
146621292|NCT01116648|528784661|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
146621293|NCT01116648|528784662|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
146621294|NCT01116648|528784663|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
146621295|NCT01116648|528784664|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
146621296|NCT01116648|528784665|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
146621297|NCT04539938|528784666|FG000|Overall Study|Death|30|||
146621298|NCT04539938|528784666|FG000|Overall Study|Withdrawal by Subject|4|||
146621299|NCT03064490|528784667|FG000|Overall Study|Physician Decision|5|||
146621300|NCT02926638|528784673|FG000|Overall Study|Progression|2|||
146621301|NCT02926638|528784674|FG001|Overall Study|Progression|5|||
146621302|NCT02926638|528784673|FG000|Overall Study|Ineligible|1|||
146621303|NCT02926638|528784674|FG001|Overall Study|Ineligible|0|||
146621304|NCT02926638|528784673|FG000|Overall Study|Not protocol specified|1|||
146621305|NCT02926638|528784674|FG001|Overall Study|Not protocol specified|0|||
146621306|NCT01871519|528784675|FG000|Overall Study|Death|26|||
146621307|NCT01871519|528784675|FG000|Overall Study|Lost to Follow-up|15|||
146621308|NCT01871519|528784675|FG000|Overall Study|Withdrawal by Subject|49|||
146621309|NCT00320515|528784676|FG000|Overall Study|Death|33|||
146621310|NCT00320515|528784676|FG000|Overall Study|Lost to Follow-up|6|||
146621311|NCT00320515|528784676|FG000|Overall Study|Physician Decision|2|||
146621312|NCT00320515|528784676|FG000|Overall Study|Withdrawal by Subject|8|||
146621313|NCT01063153|528784677|FG000|Overall Study|Found Ineligible During Screening|2|||
146621314|NCT01063153|528784678|FG001|Overall Study|Found Ineligible During Screening|0|||
146621315|NCT01063153|528784677|FG000|Overall Study|Lost to Follow-up|0|||
146621316|NCT01063153|528784678|FG001|Overall Study|Lost to Follow-up|7|||
146621317|NCT01063153|528784677|FG000|Overall Study|Withdrawal by Subject|0|||
146621318|NCT01063153|528784678|FG001|Overall Study|Withdrawal by Subject|1|||
146621319|NCT01063153|528784677|FG000|Overall Study|Physician Decision|0|||
146621320|NCT01063153|528784678|FG001|Overall Study|Physician Decision|4|||
146621321|NCT00350844|528784679|FG000|Overall Study|Lost to Follow-up|1|||
146621322|NCT01420926|528784680|FG000|Overall Study|Adverse Event|6|||
146621323|NCT01420926|528784681|FG001|Overall Study|Adverse Event|4|||
146621324|NCT01420926|528784680|FG000|Overall Study|Death|18|||
146621325|NCT01420926|528784681|FG001|Overall Study|Death|17|||
146621326|NCT01420926|528784680|FG000|Overall Study|Withdrawal by Subject|11|||
146621327|NCT01420926|528784681|FG001|Overall Study|Withdrawal by Subject|17|||
146621328|NCT01420926|528784680|FG000|Overall Study|Non-protocol treatment|17|||
146621329|NCT01420926|528784681|FG001|Overall Study|Non-protocol treatment|20|||
146621330|NCT01420926|528784680|FG000|Overall Study|Physician Decision|8|||
146621331|NCT01420926|528784681|FG001|Overall Study|Physician Decision|5|||
146621332|NCT00882440|528786098|FG000|Overall Study|Adverse Event|2|||
146621333|NCT00882440|528786099|FG001|Overall Study|Adverse Event|2|||
146621334|NCT00882440|528786100|FG002|Overall Study|Adverse Event|2|||
146621335|NCT00882440|528786101|FG003|Overall Study|Adverse Event|1|||
146621336|NCT00882440|528786102|FG004|Overall Study|Adverse Event|1|||
146621337|NCT00882440|528786103|FG005|Overall Study|Adverse Event|4|||
146621338|NCT00882440|528786104|FG006|Overall Study|Adverse Event|2|||
146621339|NCT00882440|528786098|FG000|Overall Study|Lack of Efficacy|3|||
146621340|NCT00882440|528786099|FG001|Overall Study|Lack of Efficacy|5|||
146621341|NCT00882440|528786100|FG002|Overall Study|Lack of Efficacy|2|||
146621342|NCT00882440|528786101|FG003|Overall Study|Lack of Efficacy|0|||
146621343|NCT00882440|528786102|FG004|Overall Study|Lack of Efficacy|0|||
146621344|NCT00882440|528786103|FG005|Overall Study|Lack of Efficacy|3|||
146621345|NCT00882440|528786104|FG006|Overall Study|Lack of Efficacy|0|||
146621346|NCT00882440|528786098|FG000|Overall Study|Lost to Follow-up|2|||
146621347|NCT00882440|528786099|FG001|Overall Study|Lost to Follow-up|0|||
146621348|NCT00882440|528786100|FG002|Overall Study|Lost to Follow-up|1|||
146621349|NCT00882440|528786101|FG003|Overall Study|Lost to Follow-up|1|||
146621350|NCT00882440|528786102|FG004|Overall Study|Lost to Follow-up|1|||
146621351|NCT00882440|528786103|FG005|Overall Study|Lost to Follow-up|0|||
146621352|NCT00882440|528786104|FG006|Overall Study|Lost to Follow-up|1|||
146621353|NCT00882440|528786098|FG000|Overall Study|Protocol Violation|0|||
146621354|NCT00882440|528786099|FG001|Overall Study|Protocol Violation|0|||
146803785|NCT03451422|529453211|FG005|Overall Study|Decision by sponsor|0|||
146803786|NCT03451422|529453206|FG000|Overall Study|Withdrawal by Subject|0|||
146803787|NCT03451422|529453207|FG001|Overall Study|Withdrawal by Subject|0|||
146803788|NCT03451422|529453208|FG002|Overall Study|Withdrawal by Subject|2|||
146803789|NCT03451422|529453209|FG003|Overall Study|Withdrawal by Subject|3|||
146803790|NCT03451422|529453210|FG004|Overall Study|Withdrawal by Subject|2|||
146621355|NCT00882440|528786100|FG002|Overall Study|Protocol Violation|1|||
146621356|NCT00882440|528786101|FG003|Overall Study|Protocol Violation|1|||
146621357|NCT00882440|528786102|FG004|Overall Study|Protocol Violation|1|||
146621358|NCT00882440|528786103|FG005|Overall Study|Protocol Violation|0|||
146621359|NCT00882440|528786104|FG006|Overall Study|Protocol Violation|0|||
146621360|NCT00882440|528786098|FG000|Overall Study|Withdrawal by Subject|2|||
146621361|NCT00882440|528786099|FG001|Overall Study|Withdrawal by Subject|1|||
146621362|NCT00882440|528786100|FG002|Overall Study|Withdrawal by Subject|1|||
146621363|NCT00882440|528786101|FG003|Overall Study|Withdrawal by Subject|0|||
146621364|NCT00882440|528786102|FG004|Overall Study|Withdrawal by Subject|6|||
146621365|NCT00882440|528786103|FG005|Overall Study|Withdrawal by Subject|0|||
146621366|NCT00882440|528786104|FG006|Overall Study|Withdrawal by Subject|1|||
146621367|NCT00882440|528786098|FG000|Overall Study|Patient Uncooperative|2|||
146621368|NCT00882440|528786099|FG001|Overall Study|Patient Uncooperative|0|||
146621369|NCT00882440|528786100|FG002|Overall Study|Patient Uncooperative|0|||
146621370|NCT00882440|528786101|FG003|Overall Study|Patient Uncooperative|0|||
146621371|NCT00882440|528786102|FG004|Overall Study|Patient Uncooperative|1|||
146621372|NCT00882440|528786103|FG005|Overall Study|Patient Uncooperative|0|||
146621373|NCT00882440|528786104|FG006|Overall Study|Patient Uncooperative|0|||
146621374|NCT01381016|528786106|FG000|Overall Study|Lost to Follow-up|1|||
146621375|NCT01381016|528786107|FG001|Overall Study|Lost to Follow-up|1|||
146621376|NCT01381016|528786106|FG000|Overall Study|Screen Failure|2|||
146621377|NCT01381016|528786107|FG001|Overall Study|Screen Failure|2|||
146621378|NCT01381016|528786106|FG000|Overall Study|Withdrawal by Subject|0|||
146621379|NCT01381016|528786107|FG001|Overall Study|Withdrawal by Subject|1|||
146621380|NCT01381016|528786106|FG000|Overall Study|Physician Decision|0|||
146621381|NCT01381016|528786107|FG001|Overall Study|Physician Decision|2|||
146621382|NCT01451723|528786117|FG000|Overall Study|study halted|6|||
146621383|NCT01451723|528786118|FG001|Overall Study|study halted|5|||
146621384|NCT01329263|528786119|FG000|Overall Study|Lost to Follow-up|4|||
146621385|NCT01329263|528786120|FG001|Overall Study|Lost to Follow-up|21|||
146621386|NCT01329263|528786119|FG000|Overall Study|Withdrawal by Subject|1|||
146621387|NCT01329263|528786120|FG001|Overall Study|Withdrawal by Subject|2|||
146941787|NCT01451398|529945996|FG001|Overall Study|Adverse Event|9|||
146621388|NCT01631435|528786122|FG000|Overall Study|Adverse Event|2|||
146621389|NCT01631435|528786122|FG000|Overall Study|Withdrawal by Subject|2|||
146621390|NCT01631435|528786122|FG000|Overall Study|incomplete study procedure|5|||
146621391|NCT00833040|528786123|FG000|Overall Study|Adverse Event|0|||
146941788|NCT01451398|529945995|FG000|Overall Study|Protocol Violation|1|||
146941789|NCT01451398|529945996|FG001|Overall Study|Protocol Violation|2|||
146621392|NCT00833040|528786124|FG001|Overall Study|Adverse Event|0|||
146621393|NCT00833040|528786125|FG002|Overall Study|Adverse Event|0|||
146803791|NCT03451422|529453211|FG005|Overall Study|Withdrawal by Subject|1|||
146941790|NCT01451398|529945995|FG000|Overall Study|Physician Decision|1|||
146621394|NCT00833040|528786126|FG003|Overall Study|Adverse Event|0|||
146621395|NCT00833040|528786127|FG004|Overall Study|Adverse Event|0|||
146621396|NCT00833040|528786128|FG005|Overall Study|Adverse Event|1|||
146621397|NCT00416624|528786131|FG000|Overall Study|Withdrawal by Subject|1|||
146621398|NCT00416624|528786132|FG001|Overall Study|Withdrawal by Subject|6|||
146621399|NCT00416624|528786133|FG002|Overall Study|Withdrawal by Subject|4|||
146621400|NCT00416624|528786134|FG003|Overall Study|Withdrawal by Subject|9|||
146621401|NCT00416624|528786131|FG000|Overall Study|Death|4|||
146621402|NCT00416624|528786132|FG001|Overall Study|Death|7|||
146621403|NCT00416624|528786133|FG002|Overall Study|Death|7|||
146621404|NCT00416624|528786134|FG003|Overall Study|Death|1|||
146621405|NCT00416624|528786131|FG000|Overall Study|Adverse Event|8|||
146621406|NCT00416624|528786132|FG001|Overall Study|Adverse Event|3|||
146621407|NCT00416624|528786133|FG002|Overall Study|Adverse Event|2|||
146621408|NCT00416624|528786134|FG003|Overall Study|Adverse Event|2|||
146621409|NCT00416624|528786131|FG000|Overall Study|Other|8|||
146621410|NCT00416624|528786132|FG001|Overall Study|Other|11|||
146621411|NCT00416624|528786133|FG002|Overall Study|Other|5|||
146621412|NCT00416624|528786134|FG003|Overall Study|Other|5|||
146621413|NCT00416624|528786131|FG000|Overall Study|Cancel|1|||
146621414|NCT00416624|528786132|FG001|Overall Study|Cancel|0|||
146621415|NCT00416624|528786133|FG002|Overall Study|Cancel|0|||
146621416|NCT00416624|528786134|FG003|Overall Study|Cancel|0|||
146621417|NCT01005251|528786135|FG000|Overall Study|Withdrawal by Subject|2|||
146621418|NCT01005251|528786136|FG001|Overall Study|Withdrawal by Subject|5|||
146621419|NCT01005251|528786137|FG002|Overall Study|Withdrawal by Subject|3|||
146621420|NCT01005251|528786138|FG003|Overall Study|Withdrawal by Subject|4|||
146621421|NCT01005251|528786139|FG004|Overall Study|Withdrawal by Subject|9|||
146621422|NCT01005251|528786135|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
146621423|NCT01005251|528786136|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146621424|NCT01005251|528786137|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
146621425|NCT01005251|528786138|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
146621426|NCT01005251|528786139|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
146621427|NCT01005251|528786135|FG000|Overall Study|Adverse Event|2|||
146621428|NCT01005251|528786136|FG001|Overall Study|Adverse Event|6|||
146621429|NCT01005251|528786137|FG002|Overall Study|Adverse Event|8|||
146621430|NCT01005251|528786138|FG003|Overall Study|Adverse Event|5|||
146621431|NCT01005251|528786139|FG004|Overall Study|Adverse Event|4|||
146621432|NCT01005251|528786135|FG000|Overall Study|Protocol Violation|1|||
146621433|NCT01005251|528786136|FG001|Overall Study|Protocol Violation|0|||
146621434|NCT01005251|528786137|FG002|Overall Study|Protocol Violation|0|||
146621435|NCT01005251|528786138|FG003|Overall Study|Protocol Violation|0|||
146621436|NCT01005251|528786139|FG004|Overall Study|Protocol Violation|2|||
146621437|NCT01005251|528786135|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
146621438|NCT01005251|528786136|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
146621439|NCT01005251|528786137|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
146621440|NCT01005251|528786138|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
146621441|NCT01005251|528786139|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
146621442|NCT01005251|528786135|FG000|Overall Study|Lost to Follow-up|1|||
146621443|NCT01005251|528786136|FG001|Overall Study|Lost to Follow-up|4|||
146621444|NCT01005251|528786137|FG002|Overall Study|Lost to Follow-up|2|||
146621445|NCT01005251|528786138|FG003|Overall Study|Lost to Follow-up|0|||
146621446|NCT01005251|528786139|FG004|Overall Study|Lost to Follow-up|0|||
146621447|NCT01005251|528786135|FG000|Overall Study|Physician Decision|0|||
146621448|NCT01005251|528786136|FG001|Overall Study|Physician Decision|0|||
146621449|NCT01005251|528786137|FG002|Overall Study|Physician Decision|0|||
146621450|NCT01005251|528786138|FG003|Overall Study|Physician Decision|0|||
146621451|NCT01005251|528786139|FG004|Overall Study|Physician Decision|2|||
146621452|NCT01005251|528786135|FG000|Overall Study|Patient moved|1|||
146621453|NCT01005251|528786136|FG001|Overall Study|Patient moved|0|||
146621454|NCT01005251|528786137|FG002|Overall Study|Patient moved|0|||
146621455|NCT01005251|528786138|FG003|Overall Study|Patient moved|0|||
146621456|NCT01005251|528786139|FG004|Overall Study|Patient moved|0|||
146621457|NCT01005251|528786135|FG000|Overall Study|Wrong drug dispensed|0|||
146621458|NCT01005251|528786136|FG001|Overall Study|Wrong drug dispensed|1|||
146621459|NCT01005251|528786137|FG002|Overall Study|Wrong drug dispensed|0|||
146621460|NCT01005251|528786138|FG003|Overall Study|Wrong drug dispensed|0|||
146621461|NCT01005251|528786139|FG004|Overall Study|Wrong drug dispensed|0|||
146621462|NCT01005251|528786135|FG000|Overall Study|Randomized in error|0|||
146621463|NCT01005251|528786136|FG001|Overall Study|Randomized in error|0|||
146621464|NCT01005251|528786137|FG002|Overall Study|Randomized in error|1|||
146621465|NCT01005251|528786138|FG003|Overall Study|Randomized in error|1|||
146621466|NCT01005251|528786139|FG004|Overall Study|Randomized in error|0|||
146621467|NCT01005251|528786135|FG000|Overall Study|Lack of Efficacy|0|||
146621468|NCT01005251|528786136|FG001|Overall Study|Lack of Efficacy|0|||
146621469|NCT01005251|528786137|FG002|Overall Study|Lack of Efficacy|1|||
146621470|NCT01005251|528786138|FG003|Overall Study|Lack of Efficacy|1|||
146621471|NCT01005251|528786139|FG004|Overall Study|Lack of Efficacy|0|||
146621472|NCT00962208|528786141|FG000|Overall Study|Could not achieve good vision|9|||
146621473|NCT00962208|528786142|FG001|Overall Study|Could not achieve good vision|0|||
146621474|NCT00962208|528786141|FG000|Overall Study|Contraindicated to continue study|5|||
146621475|NCT00962208|528786142|FG001|Overall Study|Contraindicated to continue study|1|||
146621476|NCT00962208|528786141|FG000|Overall Study|Lost to Follow-up|0|||
146621477|NCT00962208|528786142|FG001|Overall Study|Lost to Follow-up|9|||
146621478|NCT00657540|528786143|FG000|Overall Study|Lost to Follow-up|1|||
146621479|NCT00657540|528786144|FG001|Overall Study|Lost to Follow-up|4|||
146621480|NCT04245111|528786147|FG000|Overall Study|Lost to Follow-up|5|||
146621481|NCT04245111|528786148|FG001|Overall Study|Lost to Follow-up|1|||
146621482|NCT04245111|528786149|FG002|Overall Study|Lost to Follow-up|1|||
146621483|NCT06039579|528786152|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
146621484|NCT06039579|528786153|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
146621485|NCT06039579|528786154|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
146621486|NCT06039579|528786155|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
146621487|NCT06039579|528786156|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
146621488|NCT06039579|528786157|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
146621489|NCT06039579|528786158|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
146621490|NCT06039579|528786159|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
146621491|NCT02469623|528786164|FG000|Overall Study|Not consented for long-term follow-up|4|||
146621492|NCT02469623|528786164|FG000|Overall Study|Lost to Follow-up|4|||
146621493|NCT02469623|528786164|FG000|Overall Study|Withdrawal by Subject|2|||
146621494|NCT02469623|528786164|FG000|Overall Study|Death|3|||
146621495|NCT03309878|528786165|FG000|Overall Study|Adverse Event|1|||
146621496|NCT03309878|528786166|FG001|Overall Study|Adverse Event|0|||
146621497|NCT03309878|528786167|FG002|Overall Study|Adverse Event|0|||
146621498|NCT03309878|528786168|FG003|Overall Study|Adverse Event|0|||
146621499|NCT03309878|528786165|FG000|Overall Study|Did not maintain eligibility|2|||
146621500|NCT03309878|528786166|FG001|Overall Study|Did not maintain eligibility|1|||
146621501|NCT03309878|528786167|FG002|Overall Study|Did not maintain eligibility|0|||
146621502|NCT03309878|528786168|FG003|Overall Study|Did not maintain eligibility|0|||
146621503|NCT03309878|528786165|FG000|Overall Study|Withdrawal by Subject|0|||
146621504|NCT03309878|528786166|FG001|Overall Study|Withdrawal by Subject|1|||
146621505|NCT03309878|528786167|FG002|Overall Study|Withdrawal by Subject|0|||
146621506|NCT03309878|528786168|FG003|Overall Study|Withdrawal by Subject|0|||
146621507|NCT01096316|528786169|FG000|Overall Study|Lost to Follow-up|15|||
146621508|NCT01096316|528786170|FG001|Overall Study|Lost to Follow-up|9|||
146621509|NCT01884077|528786171|FG000|Overall Study|screen fail|0|||
146621510|NCT01884077|528786172|FG001|Overall Study|screen fail|2|||
146621511|NCT01884077|528786171|FG000|Overall Study|canceled surgery|2|||
146621512|NCT01884077|528786172|FG001|Overall Study|canceled surgery|0|||
146621513|NCT01884077|528786171|FG000|Overall Study|Lost to Follow-up|0|||
146621514|NCT01884077|528786172|FG001|Overall Study|Lost to Follow-up|4|||
146621515|NCT01884077|528786171|FG000|Overall Study|study closed|6|||
146621516|NCT01884077|528786172|FG001|Overall Study|study closed|4|||
146621517|NCT02836652|528786173|FG000|Overall Study|Death|3|||
146621518|NCT02836652|528786174|FG001|Overall Study|Death|3|||
146621519|NCT02836652|528786173|FG000|Overall Study|Transplant/Explant|3|||
146621520|NCT02836652|528786174|FG001|Overall Study|Transplant/Explant|4|||
146621521|NCT02836652|528786173|FG000|Overall Study|Withdrawn|9|||
146621522|NCT02836652|528786174|FG001|Overall Study|Withdrawn|9|||
146621523|NCT02836652|528786173|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
146621524|NCT02836652|528786174|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
146621525|NCT02349633|528786176|FG000|Overall Study|Death|0|||
146621526|NCT02349633|528786177|FG001|Overall Study|Death|1|||
146621527|NCT02349633|528786178|FG002|Overall Study|Death|0|||
146621528|NCT02349633|528786179|FG003|Overall Study|Death|0|||
146621529|NCT02349633|528786180|FG004|Overall Study|Death|0|||
146621530|NCT02349633|528786181|FG005|Overall Study|Death|1|||
146621531|NCT02349633|528786182|FG006|Overall Study|Death|1|||
146621532|NCT02349633|528786183|FG007|Overall Study|Death|1|||
146621533|NCT02349633|528786184|FG008|Overall Study|Death|0|||
146621534|NCT02349633|528786185|FG009|Overall Study|Death|1|||
146621535|NCT02349633|528786186|FG010|Overall Study|Death|0|||
146621536|NCT02349633|528786187|FG011|Overall Study|Death|0|||
146621537|NCT02349633|528786188|FG012|Overall Study|Death|0|||
146621538|NCT02349633|528786189|FG013|Overall Study|Death|0|||
146621539|NCT02349633|528786176|FG000|Overall Study|Withdrawal by Subject|0|||
146621540|NCT02349633|528786177|FG001|Overall Study|Withdrawal by Subject|0|||
146621541|NCT02349633|528786178|FG002|Overall Study|Withdrawal by Subject|0|||
146621542|NCT02349633|528786179|FG003|Overall Study|Withdrawal by Subject|1|||
146621543|NCT02349633|528786180|FG004|Overall Study|Withdrawal by Subject|0|||
146621544|NCT02349633|528786181|FG005|Overall Study|Withdrawal by Subject|0|||
146621545|NCT02349633|528786182|FG006|Overall Study|Withdrawal by Subject|0|||
146621546|NCT02349633|528786183|FG007|Overall Study|Withdrawal by Subject|2|||
146983774|NCT00585351|530101960|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
146621547|NCT02349633|528786184|FG008|Overall Study|Withdrawal by Subject|2|||
146621548|NCT02349633|528786185|FG009|Overall Study|Withdrawal by Subject|1|||
146621549|NCT02349633|528786186|FG010|Overall Study|Withdrawal by Subject|0|||
146621550|NCT02349633|528786187|FG011|Overall Study|Withdrawal by Subject|0|||
146621551|NCT02349633|528786188|FG012|Overall Study|Withdrawal by Subject|0|||
146621552|NCT02349633|528786189|FG013|Overall Study|Withdrawal by Subject|0|||
146621553|NCT02349633|528786176|FG000|Overall Study|Withdrawal of informed consent|0|||
146621554|NCT02349633|528786177|FG001|Overall Study|Withdrawal of informed consent|0|||
146621555|NCT02349633|528786178|FG002|Overall Study|Withdrawal of informed consent|0|||
146621556|NCT02349633|528786179|FG003|Overall Study|Withdrawal of informed consent|1|||
146621557|NCT02349633|528786180|FG004|Overall Study|Withdrawal of informed consent|1|||
146621558|NCT02349633|528786181|FG005|Overall Study|Withdrawal of informed consent|0|||
146621559|NCT02349633|528786182|FG006|Overall Study|Withdrawal of informed consent|0|||
146621560|NCT02349633|528786183|FG007|Overall Study|Withdrawal of informed consent|3|||
146621561|NCT02349633|528786184|FG008|Overall Study|Withdrawal of informed consent|0|||
146621562|NCT02349633|528786185|FG009|Overall Study|Withdrawal of informed consent|0|||
146621563|NCT02349633|528786186|FG010|Overall Study|Withdrawal of informed consent|0|||
146621564|NCT02349633|528786187|FG011|Overall Study|Withdrawal of informed consent|0|||
146621565|NCT02349633|528786188|FG012|Overall Study|Withdrawal of informed consent|0|||
146621566|NCT02349633|528786189|FG013|Overall Study|Withdrawal of informed consent|0|||
146621567|NCT02349633|528786176|FG000|Overall Study|Transition to compassionate use|0|||
146621568|NCT02349633|528786177|FG001|Overall Study|Transition to compassionate use|0|||
146621569|NCT02349633|528786178|FG002|Overall Study|Transition to compassionate use|0|||
146621570|NCT02349633|528786179|FG003|Overall Study|Transition to compassionate use|0|||
146621571|NCT02349633|528786180|FG004|Overall Study|Transition to compassionate use|1|||
146621572|NCT02349633|528786181|FG005|Overall Study|Transition to compassionate use|0|||
146621573|NCT02349633|528786182|FG006|Overall Study|Transition to compassionate use|0|||
146621574|NCT02349633|528786183|FG007|Overall Study|Transition to compassionate use|3|||
146621575|NCT02349633|528786184|FG008|Overall Study|Transition to compassionate use|0|||
146621576|NCT02349633|528786185|FG009|Overall Study|Transition to compassionate use|1|||
146621577|NCT02349633|528786186|FG010|Overall Study|Transition to compassionate use|0|||
146621578|NCT02349633|528786187|FG011|Overall Study|Transition to compassionate use|0|||
146621579|NCT02349633|528786188|FG012|Overall Study|Transition to compassionate use|0|||
146621580|NCT02349633|528786189|FG013|Overall Study|Transition to compassionate use|0|||
146621581|NCT02349633|528786176|FG000|Overall Study|Early termination of survival follow-up|0|||
146621582|NCT02349633|528786177|FG001|Overall Study|Early termination of survival follow-up|0|||
146621583|NCT02349633|528786178|FG002|Overall Study|Early termination of survival follow-up|0|||
146621584|NCT02349633|528786179|FG003|Overall Study|Early termination of survival follow-up|0|||
146621585|NCT02349633|528786180|FG004|Overall Study|Early termination of survival follow-up|0|||
146621586|NCT02349633|528786181|FG005|Overall Study|Early termination of survival follow-up|0|||
146621587|NCT02349633|528786182|FG006|Overall Study|Early termination of survival follow-up|0|||
146621588|NCT02349633|528786183|FG007|Overall Study|Early termination of survival follow-up|4|||
146621589|NCT02349633|528786184|FG008|Overall Study|Early termination of survival follow-up|0|||
146621590|NCT02349633|528786185|FG009|Overall Study|Early termination of survival follow-up|0|||
146621591|NCT02349633|528786186|FG010|Overall Study|Early termination of survival follow-up|0|||
146621592|NCT02349633|528786187|FG011|Overall Study|Early termination of survival follow-up|0|||
146621593|NCT02349633|528786188|FG012|Overall Study|Early termination of survival follow-up|0|||
146621594|NCT02349633|528786189|FG013|Overall Study|Early termination of survival follow-up|0|||
146621595|NCT02349633|528786176|FG000|Overall Study|Termination by sponsor|0|||
146621596|NCT02349633|528786177|FG001|Overall Study|Termination by sponsor|0|||
146621597|NCT02349633|528786178|FG002|Overall Study|Termination by sponsor|0|||
146621598|NCT02349633|528786179|FG003|Overall Study|Termination by sponsor|0|||
146621599|NCT02349633|528786180|FG004|Overall Study|Termination by sponsor|0|||
146621600|NCT02349633|528786181|FG005|Overall Study|Termination by sponsor|0|||
146621601|NCT02349633|528786182|FG006|Overall Study|Termination by sponsor|0|||
146621602|NCT02349633|528786183|FG007|Overall Study|Termination by sponsor|1|||
146621603|NCT02349633|528786184|FG008|Overall Study|Termination by sponsor|0|||
146621604|NCT02349633|528786185|FG009|Overall Study|Termination by sponsor|2|||
146621605|NCT02349633|528786186|FG010|Overall Study|Termination by sponsor|0|||
146621606|NCT02349633|528786187|FG011|Overall Study|Termination by sponsor|0|||
146621607|NCT02349633|528786188|FG012|Overall Study|Termination by sponsor|0|||
146621608|NCT02349633|528786189|FG013|Overall Study|Termination by sponsor|0|||
146941791|NCT01451398|529945996|FG001|Overall Study|Physician Decision|1|||
146941792|NCT01451398|529945995|FG000|Overall Study|Withdrawal by Subject|10|||
146941793|NCT01451398|529945996|FG001|Overall Study|Withdrawal by Subject|14|||
146941794|NCT01451398|529945995|FG000|Overall Study|Lost to Follow-up|6|||
146941795|NCT01451398|529945996|FG001|Overall Study|Lost to Follow-up|4|||
146621609|NCT02349633|528786176|FG000|Overall Study|Other|0|||
146621610|NCT02349633|528786177|FG001|Overall Study|Other|0|||
146621611|NCT02349633|528786178|FG002|Overall Study|Other|0|||
146621612|NCT02349633|528786179|FG003|Overall Study|Other|0|||
146621613|NCT02349633|528786180|FG004|Overall Study|Other|0|||
146621614|NCT02349633|528786181|FG005|Overall Study|Other|0|||
146621615|NCT02349633|528786182|FG006|Overall Study|Other|0|||
146621616|NCT02349633|528786183|FG007|Overall Study|Other|2|||
146941796|NCT01451398|529945995|FG000|Overall Study|Non-compliance with study drug|1|||
146621617|NCT02349633|528786184|FG008|Overall Study|Other|0|||
146621618|NCT02349633|528786185|FG009|Overall Study|Other|0|||
146621619|NCT02349633|528786186|FG010|Overall Study|Other|0|||
146941797|NCT01451398|529945996|FG001|Overall Study|Non-compliance with study drug|3|||
146941798|NCT01451398|529945995|FG000|Overall Study|Non-compliance with protocol|1|||
146621620|NCT02349633|528786187|FG011|Overall Study|Other|0|||
146983775|NCT00585351|530101953|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
146983776|NCT00585351|530101954|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
146983777|NCT00585351|530101955|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
146983778|NCT00585351|530101956|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
146983779|NCT00585351|530101957|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
146983780|NCT00585351|530101958|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
146983781|NCT00585351|530101959|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
146983782|NCT00585351|530101960|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
146983783|NCT00585351|530101953|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
146983784|NCT00585351|530101954|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
146983785|NCT00585351|530101955|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
146983786|NCT00585351|530101956|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
146621621|NCT02349633|528786188|FG012|Overall Study|Other|0|||
146941799|NCT01451398|529945996|FG001|Overall Study|Non-compliance with protocol|1|||
146941800|NCT01451398|529945995|FG000|Overall Study|Moved out of country|0|||
146941801|NCT01451398|529945996|FG001|Overall Study|Moved out of country|1|||
146941802|NCT01451398|529945995|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
146941803|NCT01451398|529945996|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
146941804|NCT01451398|529945995|FG000|Overall Study|Lack of Efficacy|0|||
146941805|NCT01451398|529945996|FG001|Overall Study|Lack of Efficacy|1|||
146941806|NCT00422669|529945997|FG000|Overall Study|The study was terminated early.|98|||
146941807|NCT00422669|529945998|FG001|Overall Study|The study was terminated early.|100|||
146941808|NCT00422669|529945999|FG002|Overall Study|The study was terminated early.|7|||
146941809|NCT03034057|529946006|FG000|Overall Study|Withdrawal by Subject|10|||
146941810|NCT03034057|529946006|FG000|Overall Study|Protocol Violation|1|||
146941811|NCT03034057|529946006|FG000|Overall Study|Not defined|2|||
146941812|NCT03034057|529946006|FG000|Overall Study|Lost to Follow-up|19|||
146941813|NCT03034057|529946006|FG000|Overall Study|Adverse Event|22|||
146941814|NCT03034057|529946006|FG000|Overall Study|Medication error without associated AE|1|||
146941815|NCT01814826|529946007|FG000|Overall Study|Other|3|||
146941816|NCT01814826|529946008|FG001|Overall Study|Other|5|||
146941817|NCT01814826|529946009|FG002|Overall Study|Other|0|||
146941818|NCT01814826|529946007|FG000|Overall Study|Death|29|||
146941819|NCT01814826|529946008|FG001|Overall Study|Death|24|||
146941820|NCT01814826|529946009|FG002|Overall Study|Death|3|||
146941821|NCT03339401|529946010|FG000|Overall Study|Death|2|||
146941822|NCT03339401|529946011|FG001|Overall Study|Death|1|||
146941823|NCT03339401|529946010|FG000|Overall Study|Withdrawal by Subject|2|||
146941824|NCT03339401|529946011|FG001|Overall Study|Withdrawal by Subject|0|||
146941825|NCT03339401|529946010|FG000|Overall Study|Study terminated|4|||
146941826|NCT03339401|529946011|FG001|Overall Study|Study terminated|3|||
146941827|NCT03339401|529946010|FG000|Overall Study|Investigator Decision|1|||
146941828|NCT03339401|529946011|FG001|Overall Study|Investigator Decision|0|||
146941829|NCT00718523|529946012|FG000|Overall Study|Withdrawal by Subject|5|||
146941830|NCT00718523|529946013|FG001|Overall Study|Withdrawal by Subject|7|||
146941831|NCT00718523|529946012|FG000|Overall Study|Death|13|||
146983787|NCT00585351|530101957|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
146983788|NCT00585351|530101958|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
146983789|NCT00585351|530101959|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
146621622|NCT02349633|528786189|FG013|Overall Study|Other|0|||
146621623|NCT00667628|528786195|FG000|Overall Study|Lost to Follow-up|1|||
146621624|NCT00667628|528786196|FG001|Overall Study|Lost to Follow-up|0|||
146621625|NCT00667628|528786195|FG000|Overall Study|Death|6|||
146621626|NCT00667628|528786196|FG001|Overall Study|Death|6|||
146621627|NCT00667628|528786195|FG000|Overall Study|Investigator Considers in Best Interest|1|||
146621628|NCT00667628|528786196|FG001|Overall Study|Investigator Considers in Best Interest|0|||
146621629|NCT00667628|528786195|FG000|Overall Study|Sponsor Terminated Study|17|||
146621630|NCT00667628|528786196|FG001|Overall Study|Sponsor Terminated Study|21|||
146621631|NCT04663321|528786197|FG000|Overall Study|Study terminated by Sponsor|2|||
146621632|NCT04663321|528786198|FG001|Overall Study|Study terminated by Sponsor|1|||
146621633|NCT04663321|528786199|FG002|Overall Study|Study terminated by Sponsor|2|||
146621634|NCT04663321|528786197|FG000|Overall Study|Withdrawal by Subject|10|||
146621635|NCT04663321|528786198|FG001|Overall Study|Withdrawal by Subject|3|||
146941832|NCT00718523|529946013|FG001|Overall Study|Death|17|||
146941833|NCT01042938|529946014|FG000|Overall Study|Withdrawal by Subject|1|||
146941834|NCT01042938|529946015|FG001|Overall Study|Withdrawal by Subject|1|||
146941835|NCT01042938|529946014|FG000|Overall Study|Protocol Violation|1|||
146941836|NCT01042938|529946015|FG001|Overall Study|Protocol Violation|1|||
146941837|NCT01042938|529946014|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
146941838|NCT01042938|529946015|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
146621636|NCT04663321|528786199|FG002|Overall Study|Withdrawal by Subject|2|||
146621637|NCT04663321|528786197|FG000|Overall Study|Not provided|0|||
146621638|NCT04663321|528786198|FG001|Overall Study|Not provided|0|||
146621639|NCT04663321|528786199|FG002|Overall Study|Not provided|1|||
146621640|NCT03360682|528786200|FG000|Overall Study|Adverse Event|3|||
146621641|NCT01962441|528786203|FG000|Randomized Period|Randomized but Never Treated|4|||
146621642|NCT01962441|528786204|FG001|Randomized Period|Randomized but Never Treated|2|||
146621643|NCT01962441|528786205|FG002|Randomized Period|Randomized but Never Treated|3|||
146621644|NCT01962441|528786203|FG000|Randomized Period|Lost to Follow-up|2|||
146621645|NCT01962441|528786204|FG001|Randomized Period|Lost to Follow-up|4|||
146621646|NCT01962441|528786205|FG002|Randomized Period|Lost to Follow-up|4|||
146621647|NCT01962441|528786203|FG000|Randomized Period|Withdrew Consent|3|||
146621648|NCT01962441|528786204|FG001|Randomized Period|Withdrew Consent|3|||
146621649|NCT01962441|528786205|FG002|Randomized Period|Withdrew Consent|2|||
146621650|NCT01962441|528786203|FG000|Randomized Period|Adverse Event|1|||
146621651|NCT01962441|528786204|FG001|Randomized Period|Adverse Event|1|||
146621652|NCT01962441|528786205|FG002|Randomized Period|Adverse Event|0|||
146621653|NCT01962441|528786203|FG000|Randomized Period|Death|0|||
146621654|NCT01962441|528786204|FG001|Randomized Period|Death|0|||
146621655|NCT01962441|528786205|FG002|Randomized Period|Death|2|||
146621656|NCT01962441|528786203|FG000|Randomized Period|Protocol Violation|0|||
146621657|NCT01962441|528786204|FG001|Randomized Period|Protocol Violation|1|||
146621658|NCT01962441|528786205|FG002|Randomized Period|Protocol Violation|0|||
146621659|NCT01962441|528786203|FG000|Retreatment Substudy|Lack of Efficacy|1|||
146621660|NCT01962441|528786204|FG001|Retreatment Substudy|Lack of Efficacy|0|||
146621661|NCT01962441|528786205|FG002|Retreatment Substudy|Lack of Efficacy|0|||
146621662|NCT01962441|528786203|FG000|Retreatment Substudy|Lost to Follow-up|1|||
146621663|NCT01962441|528786204|FG001|Retreatment Substudy|Lost to Follow-up|0|||
146621664|NCT01962441|528786205|FG002|Retreatment Substudy|Lost to Follow-up|0|||
146621665|NCT04862065|528786206|FG000|Screening|Protocol Violation|54|||
146621666|NCT04862065|528786207|FG001|Screening|Protocol Violation|0|||
146621667|NCT04862065|528786208|FG002|Screening|Protocol Violation|0|||
146621668|NCT04862065|528786206|FG000|Screening|Insufficient Sample|1|||
146621669|NCT04862065|528786207|FG001|Screening|Insufficient Sample|0|||
146621670|NCT04862065|528786208|FG002|Screening|Insufficient Sample|0|||
146621671|NCT04862065|528786206|FG000|Follow-Up|Lost to Follow-up|3|||
146621672|NCT04862065|528786207|FG001|Follow-Up|Lost to Follow-up|0|||
146621673|NCT04862065|528786208|FG002|Follow-Up|Lost to Follow-up|0|||
146621674|NCT01453140|528786209|FG000|Overall Study|Adverse Event|3|||
146621675|NCT00743249|528786210|FG000|Overall Study|Adverse Event|0|||
146621676|NCT00743249|528786211|FG001|Overall Study|Adverse Event|4|||
146621677|NCT00743249|528786210|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
146621678|NCT00743249|528786211|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
146621679|NCT00743249|528786210|FG000|Overall Study|Unsuccessful insertion of stent|2|||
146621680|NCT00743249|528786211|FG001|Overall Study|Unsuccessful insertion of stent|1|||
146621681|NCT00718510|528786212|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
146621682|NCT00718510|528786213|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
146621683|NCT00718510|528786212|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
146621684|NCT00718510|528786213|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
146621685|NCT02653326|528786217|FG000|Overall Study|Lost to Follow-up|10|||
146621686|NCT02653326|528786218|FG001|Overall Study|Lost to Follow-up|7|||
146621687|NCT00231777|528786221|FG000|Overall Study|Lost to Follow-up|3|||
146621688|NCT00231777|528786222|FG001|Overall Study|Lost to Follow-up|0|||
146621689|NCT00231777|528786221|FG000|Overall Study|Other|3|||
146621690|NCT00231777|528786222|FG001|Overall Study|Other|2|||
146621691|NCT01239381|528786225|FG000|Overall Study|Protocol Violation|1|||
146621692|NCT01239381|528786225|FG000|Overall Study|Withdrawal by Subject|1|||
146621693|NCT04678115|528786226|FG000|Overall Study|Lost to Follow-up|1|||
146621694|NCT04678115|528786227|FG001|Overall Study|Lost to Follow-up|0|||
146621695|NCT04621448|528786228|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
146621696|NCT04621448|528786229|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
146621697|NCT04621448|528786230|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
146621698|NCT04621448|528786231|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
146621699|NCT04621448|528786228|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
146621700|NCT04621448|528786229|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
146621701|NCT04621448|528786230|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
146621702|NCT04621448|528786231|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
146621703|NCT04621448|528786228|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
146621704|NCT04621448|528786229|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
146621705|NCT04621448|528786230|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
146621706|NCT04621448|528786231|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
146621707|NCT04621448|528786228|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
146621708|NCT04621448|528786229|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
146621709|NCT04621448|528786230|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
146621710|NCT04621448|528786231|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
146621711|NCT03550378|528786234|FG000|Overall Study|Death|0|||
146621712|NCT03550378|528786235|FG001|Overall Study|Death|1|||
146621713|NCT04486235|528786236|FG000|Overall Study|Pregnancy|1|||
146621714|NCT04486235|528786237|FG001|Overall Study|Pregnancy|0|||
146621715|NCT04486235|528786236|FG000|Overall Study|Lost to Follow-up|1|||
146621716|NCT04486235|528786237|FG001|Overall Study|Lost to Follow-up|0|||
146621717|NCT04590014|528786238|FG000|Overall Study|Withdrawal by Subject|1|||
146621718|NCT04590014|528786239|FG001|Overall Study|Withdrawal by Subject|0|||
146621719|NCT03935126|528786240|FG000|Overall Study|Study termination by sponsor|3|||
146621720|NCT01091675|528786241|FG000|Overall Study|Adverse Event|7|||
146621721|NCT01091675|528786241|FG000|Overall Study|Lack of Efficacy|27|||
146621722|NCT03040141|528786242|FG000|Overall Study|Death|1|||
146621723|NCT03040141|528786243|FG001|Overall Study|Death|2|||
146621724|NCT03040141|528786244|FG002|Overall Study|Death|3|||
146621725|NCT03040141|528786242|FG000|Overall Study|Withdrawal by Subject|3|||
146621726|NCT03040141|528786243|FG001|Overall Study|Withdrawal by Subject|1|||
146621727|NCT03040141|528786244|FG002|Overall Study|Withdrawal by Subject|1|||
146621728|NCT03040141|528786242|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
146621729|NCT03040141|528786243|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
146621730|NCT03040141|528786244|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
146621731|NCT03040141|528786242|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
146621732|NCT03040141|528786243|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
146621733|NCT03040141|528786244|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
146621734|NCT02426580|528787807|FG000|Overall Study|Death|2|||
146621735|NCT02426580|528787808|FG001|Overall Study|Death|2|||
146621736|NCT02426580|528787807|FG000|Overall Study|Lost to Follow-up|0|||
146621737|NCT02426580|528787808|FG001|Overall Study|Lost to Follow-up|9|||
146941839|NCT00856986|529946016|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
146941840|NCT00856986|529946017|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
146941841|NCT00856986|529946018|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
146941842|NCT00856986|529946019|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
146941843|NCT00856986|529946020|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
146941844|NCT00856986|529946016|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
146941845|NCT00856986|529946017|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
146941846|NCT00856986|529946018|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
146941847|NCT00856986|529946019|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
146941848|NCT00856986|529946020|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
146621738|NCT02426580|528787807|FG000|Overall Study|transfer to hemodialysis|5|||
146621739|NCT02426580|528787808|FG001|Overall Study|transfer to hemodialysis|5|||
146621740|NCT02426580|528787807|FG000|Overall Study|Kidney transplant|3|||
146621741|NCT02426580|528787808|FG001|Overall Study|Kidney transplant|0|||
146621742|NCT02426580|528787807|FG000|Overall Study|Allergic to egg white|1|||
146621743|NCT02426580|528787808|FG001|Overall Study|Allergic to egg white|0|||
146621744|NCT00383552|528787809|FG000|Overall Study|Adverse Event|7|||
146621745|NCT00383552|528787810|FG001|Overall Study|Adverse Event|6|||
146621746|NCT00383552|528787811|FG002|Overall Study|Adverse Event|9|||
146621747|NCT00383552|528787812|FG003|Overall Study|Adverse Event|6|||
146621748|NCT00383552|528787809|FG000|Overall Study|Lack of Efficacy|4|||
146621749|NCT00383552|528787810|FG001|Overall Study|Lack of Efficacy|13|||
146621750|NCT00383552|528787811|FG002|Overall Study|Lack of Efficacy|29|||
146621751|NCT00383552|528787812|FG003|Overall Study|Lack of Efficacy|42|||
146621752|NCT00383552|528787809|FG000|Overall Study|Lost to Follow-up|0|||
146621753|NCT00383552|528787810|FG001|Overall Study|Lost to Follow-up|1|||
146621754|NCT00383552|528787811|FG002|Overall Study|Lost to Follow-up|5|||
146621755|NCT00383552|528787812|FG003|Overall Study|Lost to Follow-up|1|||
146941849|NCT00856986|529946016|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
146941850|NCT00856986|529946017|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
146941851|NCT00856986|529946018|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
146941852|NCT00856986|529946019|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
146941853|NCT00856986|529946020|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
146941854|NCT00856986|529946016|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
146941855|NCT00856986|529946017|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
146941856|NCT00856986|529946018|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
146941857|NCT00856986|529946019|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
146941858|NCT00856986|529946020|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
146941859|NCT00856986|529946016|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
146941860|NCT00856986|529946017|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
146941861|NCT00856986|529946018|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
146941862|NCT00856986|529946019|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
146941863|NCT00856986|529946020|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
146941864|NCT00856986|529946016|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
146941865|NCT00856986|529946017|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
146941866|NCT00856986|529946018|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
146941867|NCT00856986|529946019|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
146621756|NCT00383552|528787809|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
146941868|NCT00856986|529946020|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
146941869|NCT00856986|529946016|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
146941870|NCT00856986|529946017|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
146983790|NCT00585351|530101960|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
146983791|NCT00585351|530101953|FG000|Enrollment Period (Intervention)|Death|0|||
146983792|NCT00585351|530101954|FG001|Enrollment Period (Intervention)|Death|0|||
146983793|NCT00585351|530101955|FG002|Enrollment Period (Intervention)|Death|0|||
146983794|NCT00585351|530101956|FG003|Enrollment Period (Intervention)|Death|0|||
146983795|NCT00585351|530101957|FG004|Enrollment Period (Intervention)|Death|1|||
146983796|NCT00585351|530101958|FG005|Enrollment Period (Intervention)|Death|0|||
146983797|NCT00585351|530101959|FG006|Enrollment Period (Intervention)|Death|1|||
146983798|NCT00585351|530101960|FG007|Enrollment Period (Intervention)|Death|0|||
146983799|NCT00585351|530101953|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
146983800|NCT00585351|530101954|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
146983801|NCT00585351|530101955|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
146983802|NCT00585351|530101956|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
146983803|NCT00585351|530101957|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
146983804|NCT00585351|530101958|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
146983805|NCT00585351|530101959|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
146983806|NCT00585351|530101960|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
146983807|NCT01001169|530101961|FG000|Overall Study|Withdrawal by Subject|2|||
146983808|NCT01001169|530101962|FG001|Overall Study|Withdrawal by Subject|1|||
146983809|NCT02536378|530101967|FG000|Overall Study|Physician Decision|0|||
146983810|NCT02536378|530101968|FG001|Overall Study|Physician Decision|2|||
146983811|NCT02536378|530101967|FG000|Overall Study|Withdrawal by Subject|0|||
146983812|NCT02536378|530101968|FG001|Overall Study|Withdrawal by Subject|1|||
146983813|NCT02536378|530101967|FG000|Overall Study|Death|1|||
146983814|NCT02536378|530101968|FG001|Overall Study|Death|2|||
146983815|NCT02536378|530101967|FG000|Overall Study|Patient refused further follow up|6|||
146983816|NCT02536378|530101968|FG001|Overall Study|Patient refused further follow up|2|||
146983817|NCT00602030|530101969|FG000|Lead-in Phase|Disease Progression|2|||
146983818|NCT00602030|530101970|FG001|Lead-in Phase|Disease Progression|3|||
146983819|NCT00602030|530101971|FG002|Lead-in Phase|Disease Progression|0|||
146983820|NCT00602030|530101972|FG003|Lead-in Phase|Disease Progression|0|||
146983821|NCT00602030|530101973|FG004|Lead-in Phase|Disease Progression|0|||
146983822|NCT00602030|530101969|FG000|Lead-in Phase|Adverse Event|0|||
146983823|NCT00602030|530101970|FG001|Lead-in Phase|Adverse Event|2|||
146983824|NCT00602030|530101971|FG002|Lead-in Phase|Adverse Event|0|||
146983825|NCT00602030|530101972|FG003|Lead-in Phase|Adverse Event|0|||
146983826|NCT00602030|530101973|FG004|Lead-in Phase|Adverse Event|0|||
146983827|NCT00602030|530101969|FG000|Double-blind Phase|Disease progression|0|||
146983828|NCT00602030|530101970|FG001|Double-blind Phase|Disease progression|0|||
146983829|NCT00602030|530101971|FG002|Double-blind Phase|Disease progression|33|||
146983830|NCT00602030|530101972|FG003|Double-blind Phase|Disease progression|30|||
146983831|NCT00602030|530101973|FG004|Double-blind Phase|Disease progression|0|||
146983832|NCT00602030|530101969|FG000|Double-blind Phase|Adverse Event|0|||
146983833|NCT00602030|530101970|FG001|Double-blind Phase|Adverse Event|0|||
146983834|NCT00602030|530101971|FG002|Double-blind Phase|Adverse Event|9|||
146983835|NCT00602030|530101972|FG003|Double-blind Phase|Adverse Event|18|||
146983836|NCT00602030|530101973|FG004|Double-blind Phase|Adverse Event|0|||
146983837|NCT00602030|530101969|FG000|Double-blind Phase|Consent withdrawal|0|||
146983838|NCT00602030|530101970|FG001|Double-blind Phase|Consent withdrawal|0|||
146983839|NCT00602030|530101971|FG002|Double-blind Phase|Consent withdrawal|4|||
146983840|NCT00602030|530101972|FG003|Double-blind Phase|Consent withdrawal|3|||
146983841|NCT00602030|530101973|FG004|Double-blind Phase|Consent withdrawal|0|||
146983842|NCT00602030|530101969|FG000|Double-blind Phase|Death|0|||
146621757|NCT00383552|528787810|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
146621758|NCT00383552|528787811|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
146621759|NCT00383552|528787812|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
146621760|NCT00383552|528787809|FG000|Overall Study|Did not wish to continue (related)|1|||
146621761|NCT00383552|528787810|FG001|Overall Study|Did not wish to continue (related)|0|||
146621762|NCT00383552|528787811|FG002|Overall Study|Did not wish to continue (related)|2|||
146621763|NCT00383552|528787812|FG003|Overall Study|Did not wish to continue (related)|3|||
146621764|NCT00383552|528787809|FG000|Overall Study|Noncompliance with the protocol|11|||
146621765|NCT00383552|528787810|FG001|Overall Study|Noncompliance with the protocol|6|||
146983843|NCT00602030|530101970|FG001|Double-blind Phase|Death|0|||
146983844|NCT00602030|530101971|FG002|Double-blind Phase|Death|3|||
146983845|NCT00602030|530101972|FG003|Double-blind Phase|Death|3|||
146983846|NCT00602030|530101973|FG004|Double-blind Phase|Death|0|||
146983847|NCT00602030|530101969|FG000|Double-blind Phase|Administrative decision|0|||
146983848|NCT00602030|530101970|FG001|Double-blind Phase|Administrative decision|0|||
146983849|NCT00602030|530101971|FG002|Double-blind Phase|Administrative decision|0|||
146983850|NCT00602030|530101972|FG003|Double-blind Phase|Administrative decision|2|||
146983851|NCT00602030|530101973|FG004|Double-blind Phase|Administrative decision|0|||
146621766|NCT00383552|528787811|FG002|Overall Study|Noncompliance with the protocol|8|||
146983852|NCT00602030|530101969|FG000|Double-blind Phase|Ineligibility|0|||
146983853|NCT00602030|530101970|FG001|Double-blind Phase|Ineligibility|0|||
146983854|NCT00602030|530101971|FG002|Double-blind Phase|Ineligibility|0|||
146983855|NCT00602030|530101972|FG003|Double-blind Phase|Ineligibility|1|||
146983856|NCT00602030|530101973|FG004|Double-blind Phase|Ineligibility|0|||
146983857|NCT00602030|530101969|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
146983858|NCT00602030|530101970|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
146983859|NCT00602030|530101971|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
146983860|NCT00602030|530101972|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
146983861|NCT00602030|530101973|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
146983862|NCT00602030|530101969|FG000|Double-blind Phase|Reason not specified|0|||
146983863|NCT00602030|530101970|FG001|Double-blind Phase|Reason not specified|0|||
146983864|NCT00602030|530101971|FG002|Double-blind Phase|Reason not specified|4|||
146983865|NCT00602030|530101972|FG003|Double-blind Phase|Reason not specified|2|||
146983866|NCT00602030|530101973|FG004|Double-blind Phase|Reason not specified|0|||
146983867|NCT00602030|530101969|FG000|Crossover Phase|Disease Progression|0|||
146983868|NCT00602030|530101970|FG001|Crossover Phase|Disease Progression|0|||
146983869|NCT00602030|530101971|FG002|Crossover Phase|Disease Progression|0|||
146983870|NCT00602030|530101972|FG003|Crossover Phase|Disease Progression|0|||
146983871|NCT00602030|530101973|FG004|Crossover Phase|Disease Progression|11|||
146983872|NCT00602030|530101969|FG000|Crossover Phase|Adverse Event|0|||
146983873|NCT00602030|530101970|FG001|Crossover Phase|Adverse Event|0|||
146983874|NCT00602030|530101971|FG002|Crossover Phase|Adverse Event|0|||
146983875|NCT00602030|530101972|FG003|Crossover Phase|Adverse Event|0|||
146983876|NCT00602030|530101973|FG004|Crossover Phase|Adverse Event|3|||
146983877|NCT00602030|530101969|FG000|Crossover Phase|Consent withdrawal|0|||
146983878|NCT00602030|530101970|FG001|Crossover Phase|Consent withdrawal|0|||
146983879|NCT00602030|530101971|FG002|Crossover Phase|Consent withdrawal|0|||
146983880|NCT00602030|530101972|FG003|Crossover Phase|Consent withdrawal|0|||
146983881|NCT00602030|530101973|FG004|Crossover Phase|Consent withdrawal|2|||
146983882|NCT00798889|530101974|FG000|Overall Study|Adverse Event|53|||
146983883|NCT00798889|530101974|FG000|Overall Study|Protocol Violation|2|||
146983884|NCT00798889|530101974|FG000|Overall Study|Withdrawal by Subject|31|||
146983885|NCT00798889|530101974|FG000|Overall Study|Lost to Follow-up|1|||
146983886|NCT00798889|530101974|FG000|Overall Study|Lack of Efficacy|213|||
146983887|NCT00798889|530101974|FG000|Overall Study|Decision of Sponsor|11|||
146983888|NCT00798889|530101974|FG000|Overall Study|Enrolled, Not treated|3|||
146983889|NCT05085964|530101975|FG000|Overall Study|Premature termination of study|21|||
146983890|NCT05085964|530101976|FG001|Overall Study|Premature termination of study|0|||
146983891|NCT03156270|530101981|FG000|Overall Study|Failed pre-treatment screening|1|||
146983892|NCT03156270|530101981|FG000|Overall Study|Lost to Follow-up|1|||
146983893|NCT00446654|530101982|FG000|Overall Study|Withdrawal by Subject|1|||
146983894|NCT00446654|530101983|FG001|Overall Study|Withdrawal by Subject|0|||
146983895|NCT00446654|530101982|FG000|Overall Study|Adverse Event|1|||
146983896|NCT00446654|530101983|FG001|Overall Study|Adverse Event|0|||
146983897|NCT02087059|530101985|FG000|Overall Study|Disease Progression|1|||
146983898|NCT02087059|530101985|FG000|Overall Study|Adverse Event|5|||
146983899|NCT02087059|530101985|FG000|Overall Study|Lost to Follow-up|1|||
146983900|NCT00947856|530101986|FG000|Treatment Period|Progressive Disease|33|||
146983901|NCT00947856|530101987|FG001|Treatment Period|Progressive Disease|12|||
146983902|NCT00947856|530101986|FG000|Treatment Period|Adverse Event|15|||
146983903|NCT00947856|530101987|FG001|Treatment Period|Adverse Event|9|||
146983904|NCT00947856|530101986|FG000|Treatment Period|Physician Decision|14|||
146983905|NCT00947856|530101987|FG001|Treatment Period|Physician Decision|6|||
146983906|NCT00947856|530101986|FG000|Treatment Period|Study Stopped by Sponsor|4|||
146983907|NCT00947856|530101987|FG001|Treatment Period|Study Stopped by Sponsor|4|||
146983908|NCT00947856|530101986|FG000|Treatment Period|Withdrawal by Subject|12|||
146983909|NCT00947856|530101987|FG001|Treatment Period|Withdrawal by Subject|1|||
146983910|NCT00947856|530101986|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
146983911|NCT00947856|530101987|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
146983912|NCT00947856|530101986|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
146983913|NCT00947856|530101987|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
146983914|NCT00947856|530101986|FG000|Follow-up Period|Lost to Follow-up|7|||
146983915|NCT00947856|530101987|FG001|Follow-up Period|Lost to Follow-up|0|||
146983916|NCT00947856|530101986|FG000|Follow-up Period|Patient unavailable for site visits|1|||
146983917|NCT00947856|530101987|FG001|Follow-up Period|Patient unavailable for site visits|0|||
146983918|NCT00947856|530101986|FG000|Follow-up Period|Withdrawal by Subject|1|||
146983919|NCT00947856|530101987|FG001|Follow-up Period|Withdrawal by Subject|0|||
146983920|NCT01261325|530101988|FG000|Overall Study|Lack of Efficacy|1|||
146983921|NCT01261325|530101989|FG001|Overall Study|Lack of Efficacy|1|||
146983922|NCT01261325|530101990|FG002|Overall Study|Lack of Efficacy|0|||
146983923|NCT01261325|530101988|FG000|Overall Study|Withdrawal by Subject|2|||
146983924|NCT01261325|530101989|FG001|Overall Study|Withdrawal by Subject|2|||
146983925|NCT01261325|530101990|FG002|Overall Study|Withdrawal by Subject|4|||
146983926|NCT01261325|530101988|FG000|Overall Study|SAE, non-fatal|1|||
146983927|NCT01261325|530101989|FG001|Overall Study|SAE, non-fatal|5|||
146983928|NCT01261325|530101990|FG002|Overall Study|SAE, non-fatal|1|||
146983929|NCT01261325|530101988|FG000|Overall Study|AE, non-serious non-fatal|9|||
146621767|NCT00383552|528787812|FG003|Overall Study|Noncompliance with the protocol|10|||
146621768|NCT00383552|528787809|FG000|Overall Study|Did not meet protocol eligibility|8|||
146621769|NCT00383552|528787810|FG001|Overall Study|Did not meet protocol eligibility|6|||
146621770|NCT00383552|528787811|FG002|Overall Study|Did not meet protocol eligibility|2|||
146621771|NCT00383552|528787812|FG003|Overall Study|Did not meet protocol eligibility|3|||
146621772|NCT00383552|528787809|FG000|Overall Study|Administrative|1|||
146621773|NCT00383552|528787810|FG001|Overall Study|Administrative|0|||
146621774|NCT00383552|528787811|FG002|Overall Study|Administrative|1|||
146621775|NCT00383552|528787812|FG003|Overall Study|Administrative|1|||
146621776|NCT00966654|528787813|FG000|Overall Study|Study was terminated,PI left institution|12|||
146621777|NCT01600326|528787816|FG000|Overall Study|Lost to Follow-up|1|||
146621778|NCT01600326|528787817|FG001|Overall Study|Lost to Follow-up|1|||
146621779|NCT04456504|528787818|FG000|Overall Study|Lost to Follow-up|2|||
146621780|NCT01393158|528787819|FG000|Overall Study|Adverse Event|1|||
146621781|NCT01393158|528787820|FG001|Overall Study|Adverse Event|0|||
146621782|NCT02173769|528787822|FG000|Overall Study|Protocol Violation|4|||
146621783|NCT02869633|528787823|FG000|Overall Study|Death|2|||
146621784|NCT02869633|528787824|FG001|Overall Study|Death|1|||
146621785|NCT02869633|528787823|FG000|Overall Study|Patient refused follow-up|1|||
146621786|NCT02869633|528787824|FG001|Overall Study|Patient refused follow-up|0|||
146621787|NCT02869633|528787823|FG000|Overall Study|Provider discretion|1|||
146621788|NCT02869633|528787824|FG001|Overall Study|Provider discretion|0|||
146621789|NCT02869633|528787823|FG000|Overall Study|Investigator decision|1|||
146621790|NCT02869633|528787824|FG001|Overall Study|Investigator decision|0|||
146621791|NCT02869633|528787823|FG000|Overall Study|Lost to Follow-up|0|||
146621792|NCT02869633|528787824|FG001|Overall Study|Lost to Follow-up|1|||
146621793|NCT02869633|528787823|FG000|Overall Study|Not eligible|6|||
146621794|NCT02869633|528787824|FG001|Overall Study|Not eligible|1|||
146621795|NCT02869633|528787823|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
146621796|NCT02869633|528787824|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
146621797|NCT02869633|528787823|FG000|Overall Study|Withdrawal by Subject|0|||
146621798|NCT02869633|528787824|FG001|Overall Study|Withdrawal by Subject|1|||
146621799|NCT04024891|528787825|FG000|Overall Study|Pregnancy|0|||
146621800|NCT04024891|528787826|FG001|Overall Study|Pregnancy|1|||
146621801|NCT01693029|528787827|FG000|Overall Study|Withdrawal by Subject|15|||
146621802|NCT01693029|528787828|FG001|Overall Study|Withdrawal by Subject|22|||
146621803|NCT01693029|528787827|FG000|Overall Study|Kidney transplantation|7|||
146621804|NCT01693029|528787828|FG001|Overall Study|Kidney transplantation|7|||
146621805|NCT01693029|528787827|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
146621806|NCT01693029|528787828|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
146621807|NCT01693029|528787827|FG000|Overall Study|Protocol Violation|6|||
146621808|NCT01693029|528787828|FG001|Overall Study|Protocol Violation|7|||
146621809|NCT01693029|528787827|FG000|Overall Study|Change in dialysis modality|2|||
146621810|NCT01693029|528787828|FG001|Overall Study|Change in dialysis modality|1|||
146621811|NCT01693029|528787827|FG000|Overall Study|Physician Decision|0|||
146621812|NCT01693029|528787828|FG001|Overall Study|Physician Decision|2|||
146621813|NCT01693029|528787827|FG000|Overall Study|Lost to Follow-up|0|||
146621814|NCT01693029|528787828|FG001|Overall Study|Lost to Follow-up|1|||
146621815|NCT01693029|528787827|FG000|Overall Study|Adverse Event|1|||
146621816|NCT01693029|528787828|FG001|Overall Study|Adverse Event|6|||
146621817|NCT01693029|528787827|FG000|Overall Study|Death|5|||
146621818|NCT01693029|528787828|FG001|Overall Study|Death|8|||
146621819|NCT01693029|528787827|FG000|Overall Study|Non-compliance|2|||
146621820|NCT01693029|528787828|FG001|Overall Study|Non-compliance|1|||
146621821|NCT00308139|528787829|FG000|Overall Study|Adverse Event|20|||
146621822|NCT00308139|528787830|FG001|Overall Study|Adverse Event|14|||
146621823|NCT00308139|528787829|FG000|Overall Study|Lost to Follow-up|13|||
146621824|NCT00308139|528787830|FG001|Overall Study|Lost to Follow-up|8|||
146621825|NCT00308139|528787829|FG000|Overall Study|Protocol Violation|3|||
146621826|NCT00308139|528787830|FG001|Overall Study|Protocol Violation|2|||
146621827|NCT00308139|528787829|FG000|Overall Study|Withdrawal of Consent|40|||
146621828|NCT00308139|528787830|FG001|Overall Study|Withdrawal of Consent|42|||
146621829|NCT00308139|528787829|FG000|Overall Study|Investigator Decision|11|||
146621830|NCT00308139|528787830|FG001|Overall Study|Investigator Decision|10|||
146621831|NCT00308139|528787829|FG000|Overall Study|Loss of Glucose Control|5|||
146621832|NCT00308139|528787830|FG001|Overall Study|Loss of Glucose Control|7|||
146621833|NCT00308139|528787829|FG000|Overall Study|Administrative|1|||
146621834|NCT00308139|528787830|FG001|Overall Study|Administrative|4|||
146621835|NCT00308139|528787829|FG000|Overall Study|Other|1|||
146621836|NCT00308139|528787830|FG001|Overall Study|Other|0|||
146621837|NCT02313766|528787833|FG000|Overall Study|surgery cancelled|1|||
146621838|NCT02313766|528787834|FG001|Overall Study|surgery cancelled|0|||
146621839|NCT02313766|528787835|FG002|Overall Study|surgery cancelled|0|||
146621840|NCT02313766|528787833|FG000|Overall Study|Lost to Follow-up|0|||
146621841|NCT02313766|528787834|FG001|Overall Study|Lost to Follow-up|2|||
146621842|NCT02313766|528787835|FG002|Overall Study|Lost to Follow-up|0|||
146621843|NCT02313766|528787833|FG000|Overall Study|Adverse Event|0|||
146621844|NCT02313766|528787834|FG001|Overall Study|Adverse Event|1|||
146621845|NCT02313766|528787835|FG002|Overall Study|Adverse Event|0|||
146621846|NCT00791388|528787839|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
146621847|NCT00791388|528787840|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
146621848|NCT00791388|528787841|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
146621849|NCT00791388|528787842|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
146621850|NCT00791388|528787843|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
146621851|NCT00791388|528787839|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
146621852|NCT00791388|528787840|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
146621853|NCT00791388|528787841|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
146621854|NCT00791388|528787842|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
146621855|NCT00791388|528787843|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
146621856|NCT00791388|528787839|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
146621857|NCT00791388|528787840|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
146621858|NCT00791388|528787841|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
146621859|NCT00791388|528787842|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
146621860|NCT00791388|528787843|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
146621861|NCT00141453|528787851|FG000|Overall Study|Protocol Violation|6|||
146621862|NCT00141453|528787852|FG001|Overall Study|Protocol Violation|5|||
146621863|NCT00443040|528787853|FG000|Overall Study|Withdrawal by Subject|1|||
146621864|NCT00443040|528787854|FG001|Overall Study|Withdrawal by Subject|0|||
146621865|NCT00443040|528787855|FG002|Overall Study|Withdrawal by Subject|0|||
146621866|NCT00443040|528787853|FG000|Overall Study|Converted to an open laparotomy|3|||
146621867|NCT00443040|528787854|FG001|Overall Study|Converted to an open laparotomy|0|||
146621868|NCT00443040|528787855|FG002|Overall Study|Converted to an open laparotomy|1|||
146621869|NCT02763644|528787858|FG000|Overall Study|Patient/guardian decision|1|||
146621870|NCT02763644|528787859|FG001|Overall Study|Patient/guardian decision|0|||
146621871|NCT02763644|528787858|FG000|Overall Study|Death|1|||
146621872|NCT02763644|528787859|FG001|Overall Study|Death|1|||
146621873|NCT02763644|528787858|FG000|Overall Study|Adverse Event|1|||
146621874|NCT02763644|528787859|FG001|Overall Study|Adverse Event|1|||
146621875|NCT02648204|528787860|FG000|Overall Study|Withdrawal by Subject|12|||
146621876|NCT02648204|528787861|FG001|Overall Study|Withdrawal by Subject|8|||
146621877|NCT02648204|528787862|FG002|Overall Study|Withdrawal by Subject|2|||
146621878|NCT02648204|528787863|FG003|Overall Study|Withdrawal by Subject|6|||
146621879|NCT02648204|528787860|FG000|Overall Study|Lost to Follow-up|5|||
146621880|NCT02648204|528787861|FG001|Overall Study|Lost to Follow-up|8|||
146621881|NCT02648204|528787862|FG002|Overall Study|Lost to Follow-up|4|||
146621882|NCT02648204|528787863|FG003|Overall Study|Lost to Follow-up|6|||
146621883|NCT02648204|528787860|FG000|Overall Study|Missing follow-up information|4|||
146621884|NCT02648204|528787861|FG001|Overall Study|Missing follow-up information|4|||
146621885|NCT02648204|528787862|FG002|Overall Study|Missing follow-up information|4|||
146621886|NCT02648204|528787863|FG003|Overall Study|Missing follow-up information|2|||
146621887|NCT02648204|528787860|FG000|Overall Study|Death|1|||
146621888|NCT02648204|528787861|FG001|Overall Study|Death|1|||
146621889|NCT02648204|528787862|FG002|Overall Study|Death|2|||
146621890|NCT02648204|528787863|FG003|Overall Study|Death|2|||
146621891|NCT02648204|528787860|FG000|Overall Study|Adverse Event|0|||
146621892|NCT02648204|528787861|FG001|Overall Study|Adverse Event|0|||
146621893|NCT02648204|528787862|FG002|Overall Study|Adverse Event|1|||
146621894|NCT02648204|528787863|FG003|Overall Study|Adverse Event|0|||
146621895|NCT01220167|528787868|FG000|Period 3|Urine positive for substance abuse|0|||
146621896|NCT01220167|528787869|FG001|Period 3|Urine positive for substance abuse|1|||
146621897|NCT01220167|528787870|FG002|Period 3|Urine positive for substance abuse|0|||
146621898|NCT01008943|528787871|FG000|Overall Study|Withdrawal by Subject|1|||
146621899|NCT02356159|528787872|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
146621900|NCT02356159|528787873|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
146621901|NCT02356159|528787874|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
146621902|NCT02356159|528787875|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
146621903|NCT02356159|528787876|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
146621904|NCT02356159|528787877|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
146621905|NCT06418152|528787878|FG000|Overall Study|Frequent DBS setting changes|1|||
146621906|NCT06418152|528787878|FG000|Overall Study|Withdrawal by Subject|2|||
146621907|NCT05789745|528787879|FG000|Overall Study|Withdrawal by Subject|0|||
146621908|NCT05789745|528787880|FG001|Overall Study|Withdrawal by Subject|0|||
146621909|NCT05789745|528787881|FG002|Overall Study|Withdrawal by Subject|0|||
146621910|NCT05789745|528787882|FG003|Overall Study|Withdrawal by Subject|0|||
146621911|NCT05789745|528787883|FG004|Overall Study|Withdrawal by Subject|1|||
146621912|NCT02055898|528787888|FG000|First Intervention (5 Days)|Physician Decision|2|||
146621913|NCT02055898|528787889|FG001|First Intervention (5 Days)|Physician Decision|0|||
146621914|NCT02055898|528787888|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
146621915|NCT02055898|528787889|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
146621916|NCT02201524|528787891|FG000|Overall Study|Adverse Event|0|||
146621917|NCT02201524|528787892|FG001|Overall Study|Adverse Event|2|||
146803792|NCT00918333|529453212|FG000|Overall Study|Drug not taken per protocol|1|||
146803793|NCT00918333|529453213|FG001|Overall Study|Drug not taken per protocol|0|||
146803794|NCT00918333|529453212|FG000|Overall Study|Inadequate amount of drugs provided|1|||
146621918|NCT02201524|528787893|FG002|Overall Study|Adverse Event|1|||
146621919|NCT02201524|528787894|FG003|Overall Study|Adverse Event|0|||
146621920|NCT02201524|528787891|FG000|Overall Study|Insufficient clinical response|1|||
146621921|NCT02201524|528787892|FG001|Overall Study|Insufficient clinical response|0|||
146621922|NCT02201524|528787893|FG002|Overall Study|Insufficient clinical response|0|||
146621923|NCT02201524|528787894|FG003|Overall Study|Insufficient clinical response|0|||
146621924|NCT02201524|528787891|FG000|Overall Study|Lost to Follow-up|0|||
146621925|NCT02201524|528787892|FG001|Overall Study|Lost to Follow-up|0|||
146621926|NCT02201524|528787893|FG002|Overall Study|Lost to Follow-up|2|||
146621927|NCT02201524|528787894|FG003|Overall Study|Lost to Follow-up|0|||
146621928|NCT02201524|528787891|FG000|Overall Study|No longer meets eligibility criteria|0|||
146621929|NCT02201524|528787892|FG001|Overall Study|No longer meets eligibility criteria|0|||
146621930|NCT02201524|528787893|FG002|Overall Study|No longer meets eligibility criteria|0|||
146621931|NCT02201524|528787894|FG003|Overall Study|No longer meets eligibility criteria|2|||
146621932|NCT02201524|528787891|FG000|Overall Study|Protocol Violation|0|||
146621933|NCT02201524|528787892|FG001|Overall Study|Protocol Violation|0|||
146621934|NCT02201524|528787893|FG002|Overall Study|Protocol Violation|0|||
146621935|NCT02201524|528787894|FG003|Overall Study|Protocol Violation|1|||
146621936|NCT02201524|528787891|FG000|Overall Study|Withdrawal by Subject|0|||
146621937|NCT02201524|528787892|FG001|Overall Study|Withdrawal by Subject|0|||
146621938|NCT02201524|528787893|FG002|Overall Study|Withdrawal by Subject|1|||
146621939|NCT02201524|528787894|FG003|Overall Study|Withdrawal by Subject|1|||
146621940|NCT02201524|528787891|FG000|Overall Study|Other|1|||
146621941|NCT02201524|528787892|FG001|Overall Study|Other|1|||
146621942|NCT02201524|528787893|FG002|Overall Study|Other|0|||
146621943|NCT02201524|528787894|FG003|Overall Study|Other|0|||
146621944|NCT02314052|528787895|FG000|Cycle One|Adverse Event|0|||
146621945|NCT02314052|528787896|FG001|Cycle One|Adverse Event|0|||
146621946|NCT02314052|528787897|FG002|Cycle One|Adverse Event|0|||
146621947|NCT02314052|528787898|FG003|Cycle One|Adverse Event|1|||
146621948|NCT02314052|528787899|FG004|Cycle One|Adverse Event|0|||
146621949|NCT02314052|528787900|FG005|Cycle One|Adverse Event|0|||
146621950|NCT01960140|528787906|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
146621951|NCT00686777|528787912|FG000|Overall Study|Adverse Event|2|||
146621952|NCT00686777|528787912|FG000|Overall Study|Pregnancy|1|||
146621953|NCT00686777|528787912|FG000|Overall Study|Withdrawal by Subject|2|||
146621954|NCT00686777|528787912|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
146621955|NCT00686777|528787912|FG000|Overall Study|No Visit|1|||
146621956|NCT00499681|528787913|FG000|Overall Study|toxicity|0|||
146621957|NCT00499681|528787914|FG001|Overall Study|toxicity|1|||
146621958|NCT00499681|528787913|FG000|Overall Study|disease progression|0|||
146621959|NCT00499681|528787914|FG001|Overall Study|disease progression|1|||
146621960|NCT00883779|528787915|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
146621961|NCT00883779|528787916|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
146621962|NCT00883779|528787915|FG000|Primary Study Treatment Phase|Disease progression|75|||
146621963|NCT00883779|528787916|FG001|Primary Study Treatment Phase|Disease progression|59|||
146621964|NCT00883779|528787915|FG000|Primary Study Treatment Phase|Adverse Event|16|||
146621965|NCT00883779|528787916|FG001|Primary Study Treatment Phase|Adverse Event|16|||
146621966|NCT00883779|528787915|FG000|Primary Study Treatment Phase|Death|2|||
146621967|NCT00883779|528787916|FG001|Primary Study Treatment Phase|Death|3|||
146621968|NCT00883779|528787915|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
146621969|NCT00883779|528787916|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
146621970|NCT00883779|528787915|FG000|Primary Study Treatment Phase|Other|3|||
146621971|NCT00883779|528787916|FG001|Primary Study Treatment Phase|Other|0|||
146621972|NCT00883779|528787915|FG000|Post-Study Treatment Phase|Adverse Event|2|||
146621973|NCT00883779|528787916|FG001|Post-Study Treatment Phase|Adverse Event|3|||
146621974|NCT00883779|528787915|FG000|Post-Study Treatment Phase|Death|1|||
146621975|NCT00883779|528787916|FG001|Post-Study Treatment Phase|Death|3|||
146621976|NCT00883779|528787915|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
146621977|NCT00883779|528787916|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
146621978|NCT00883779|528787915|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
146621979|NCT00883779|528787916|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
146621980|NCT00883779|528787915|FG000|Post-Study Treatment Phase|Disease progression|103|||
146621981|NCT00883779|528787916|FG001|Post-Study Treatment Phase|Disease progression|122|||
146621982|NCT00883779|528787915|FG000|Post-Study Treatment Phase|Other|3|||
146621983|NCT00883779|528787916|FG001|Post-Study Treatment Phase|Other|0|||
146621984|NCT00883779|528787915|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
146621985|NCT00883779|528787916|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
146803795|NCT00918333|529453213|FG001|Overall Study|Inadequate amount of drugs provided|4|||
146803796|NCT00918333|529453212|FG000|Overall Study|Ineligible|1|||
146803797|NCT00918333|529453213|FG001|Overall Study|Ineligible|0|||
146803798|NCT00918333|529453212|FG000|Overall Study|Withdrawal by Subject|0|||
146803799|NCT00918333|529453213|FG001|Overall Study|Withdrawal by Subject|1|||
146803800|NCT00263757|529453214|FG000|Overall Study|Withdrawal by Subject|5|||
146803801|NCT00263757|529453215|FG001|Overall Study|Withdrawal by Subject|4|||
146803802|NCT00263757|529453214|FG000|Overall Study|Screen failure|0|||
146803803|NCT00263757|529453215|FG001|Overall Study|Screen failure|1|||
146803804|NCT00263757|529453214|FG000|Overall Study|Adverse Event|3|||
146803805|NCT00263757|529453215|FG001|Overall Study|Adverse Event|3|||
146803806|NCT00713596|529453216|FG000|Overall Study|Study was terminated|2|||
146803807|NCT00713596|529453217|FG001|Overall Study|Study was terminated|3|||
146803808|NCT00713596|529453218|FG002|Overall Study|Study was terminated|2|||
146803809|NCT04545619|529453219|FG000|Overall Study|due to equipment challenges|1|||
146803810|NCT04384172|529453220|FG000|Overall Study|Lost to Follow-up|0|||
146803811|NCT04384172|529453221|FG001|Overall Study|Lost to Follow-up|2|||
146803812|NCT04384172|529453220|FG000|Overall Study|Pregnancy|1|||
146803813|NCT04384172|529453221|FG001|Overall Study|Pregnancy|0|||
146803814|NCT04384172|529453220|FG000|Overall Study|Withdrawal by Subject|0|||
146803815|NCT04384172|529453221|FG001|Overall Study|Withdrawal by Subject|1|||
146803816|NCT01759862|529453222|FG000|Overall Study|Physician Decision|3|||
146941871|NCT00856986|529946018|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
146941872|NCT00856986|529946019|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
146803817|NCT01759862|529453223|FG001|Overall Study|Physician Decision|1|||
146803818|NCT01759862|529453222|FG000|Overall Study|Adverse Event|0|||
146803819|NCT01759862|529453223|FG001|Overall Study|Adverse Event|1|||
146803820|NCT03631407|529453224|FG000|Overall Study|Withdrawal by Subject|3|||
146803821|NCT03631407|529453225|FG001|Overall Study|Withdrawal by Subject|2|||
146803822|NCT03631407|529453224|FG000|Overall Study|Sponsor Decision|0|||
146803823|NCT03631407|529453225|FG001|Overall Study|Sponsor Decision|2|||
146803824|NCT03631407|529453224|FG000|Overall Study|Death|16|||
146803825|NCT03631407|529453225|FG001|Overall Study|Death|16|||
146803826|NCT03631407|529453224|FG000|Overall Study|Randomized by mistake without study treatment|1|||
146803827|NCT03631407|529453225|FG001|Overall Study|Randomized by mistake without study treatment|0|||
146803828|NCT01437319|529453226|FG000|Phase I|Lost to Follow-up|2|||
146803829|NCT01437319|529453227|FG001|Phase I|Lost to Follow-up|0|||
146803830|NCT01437319|529453228|FG002|Phase I|Lost to Follow-up|0|||
146803831|NCT01437319|529453226|FG000|Phase I|Protocol Violation|1|||
146803832|NCT01437319|529453227|FG001|Phase I|Protocol Violation|0|||
146621986|NCT00883779|528787915|FG000|Off-study Phase|Death|185|||
146621987|NCT00883779|528787916|FG001|Off-study Phase|Death|174|||
146621988|NCT00883779|528787915|FG000|Off-study Phase|Refused treatment|1|||
146621989|NCT00883779|528787916|FG001|Off-study Phase|Refused treatment|1|||
146621990|NCT00883779|528787915|FG000|Off-study Phase|Failure to return|5|||
146621991|NCT00883779|528787916|FG001|Off-study Phase|Failure to return|6|||
146621992|NCT00883779|528787915|FG000|Off-study Phase|Other|18|||
146803833|NCT01437319|529453228|FG002|Phase I|Protocol Violation|0|||
146803834|NCT01437319|529453226|FG000|Phase I|Study related symptoms/complaints|27|||
146803835|NCT01437319|529453227|FG001|Phase I|Study related symptoms/complaints|0|||
146803836|NCT01437319|529453228|FG002|Phase I|Study related symptoms/complaints|0|||
146803837|NCT01437319|529453226|FG000|Phase I|Withdrawal by Subject|25|||
146803838|NCT01437319|529453227|FG001|Phase I|Withdrawal by Subject|0|||
146803839|NCT01437319|529453228|FG002|Phase I|Withdrawal by Subject|0|||
146803840|NCT01437319|529453226|FG000|Phase II|Withdrawal by Subject|0|||
146803841|NCT01437319|529453227|FG001|Phase II|Withdrawal by Subject|8|||
146803842|NCT01437319|529453228|FG002|Phase II|Withdrawal by Subject|16|||
146803843|NCT01437319|529453226|FG000|Phase II|Lost to Follow-up|0|||
146803844|NCT01437319|529453227|FG001|Phase II|Lost to Follow-up|7|||
146803845|NCT01437319|529453228|FG002|Phase II|Lost to Follow-up|2|||
146803846|NCT01437319|529453226|FG000|Phase II|Study related symptoms/complaints|0|||
146803847|NCT01437319|529453227|FG001|Phase II|Study related symptoms/complaints|28|||
146803848|NCT01437319|529453228|FG002|Phase II|Study related symptoms/complaints|19|||
146803849|NCT01437319|529453226|FG000|Phase II|Protocol Violation|0|||
146803850|NCT01437319|529453227|FG001|Phase II|Protocol Violation|1|||
146941873|NCT00856986|529946020|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
146941874|NCT00856986|529946016|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
146803851|NCT01437319|529453228|FG002|Phase II|Protocol Violation|0|||
146803852|NCT00983294|529453229|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
146803853|NCT00983294|529453229|FG000|Colchicine With Azithromycin|Adverse Event|1|||
146803854|NCT03473743|529453230|FG000|Overall Study|Withdrawal by Subject|0|||
146941875|NCT00856986|529946017|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
146941876|NCT00856986|529946018|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
146803855|NCT03473743|529453231|FG001|Overall Study|Withdrawal by Subject|0|||
146803856|NCT03473743|529453232|FG002|Overall Study|Withdrawal by Subject|0|||
146941877|NCT00856986|529946019|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
146941878|NCT00856986|529946020|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
146803857|NCT03473743|529453233|FG003|Overall Study|Withdrawal by Subject|0|||
146803858|NCT03473743|529453234|FG004|Overall Study|Withdrawal by Subject|0|||
146803859|NCT03473743|529453235|FG005|Overall Study|Withdrawal by Subject|0|||
146803860|NCT03473743|529453236|FG006|Overall Study|Withdrawal by Subject|0|||
146803861|NCT03473743|529453237|FG007|Overall Study|Withdrawal by Subject|3|||
146621993|NCT00883779|528787916|FG001|Off-study Phase|Other|21|||
146621994|NCT00739401|528787921|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
146621995|NCT00739401|528787921|FG000|Overall Study|Death|3|||
146621996|NCT00739401|528787921|FG000|Overall Study|Withdrawal by Subject|4|||
146621997|NCT04575155|528787922|FG000|2 Month|Withdrawal by Subject|1|||
146621998|NCT04575155|528787923|FG001|2 Month|Withdrawal by Subject|1|||
146621999|NCT04575155|528787922|FG000|2 Month|Lost to Follow-up|5|||
146622000|NCT04575155|528787923|FG001|2 Month|Lost to Follow-up|3|||
146622001|NCT04575155|528787922|FG000|2 Month|Ineligible|1|||
146803862|NCT03473743|529453230|FG000|Overall Study|Other|0|||
146803863|NCT03473743|529453231|FG001|Overall Study|Other|0|||
146803864|NCT03473743|529453232|FG002|Overall Study|Other|0|||
146803865|NCT03473743|529453233|FG003|Overall Study|Other|1|||
146803866|NCT03473743|529453234|FG004|Overall Study|Other|0|||
146803867|NCT03473743|529453235|FG005|Overall Study|Other|0|||
146803868|NCT03473743|529453236|FG006|Overall Study|Other|0|||
146803869|NCT03473743|529453237|FG007|Overall Study|Other|0|||
146803870|NCT03473743|529453230|FG000|Overall Study|Ongoing|0|||
146803871|NCT03473743|529453231|FG001|Overall Study|Ongoing|0|||
146803872|NCT03473743|529453232|FG002|Overall Study|Ongoing|6|||
146803873|NCT03473743|529453233|FG003|Overall Study|Ongoing|8|||
146803874|NCT03473743|529453234|FG004|Overall Study|Ongoing|1|||
146803875|NCT03473743|529453235|FG005|Overall Study|Ongoing|1|||
146803876|NCT03473743|529453236|FG006|Overall Study|Ongoing|22|||
146803877|NCT03473743|529453237|FG007|Overall Study|Ongoing|24|||
146803878|NCT03473743|529453230|FG000|Overall Study|Randomized but not treated|0|||
146803879|NCT03473743|529453231|FG001|Overall Study|Randomized but not treated|0|||
146803880|NCT03473743|529453232|FG002|Overall Study|Randomized but not treated|0|||
146803881|NCT03473743|529453233|FG003|Overall Study|Randomized but not treated|0|||
146803882|NCT03473743|529453234|FG004|Overall Study|Randomized but not treated|0|||
146622002|NCT04575155|528787923|FG001|2 Month|Ineligible|0|||
146622003|NCT03915717|528787926|FG000|Overall Study|EchoMark Not Implanted|6|||
146622004|NCT03748823|528787928|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
146622005|NCT03748823|528787929|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
146622006|NCT03748823|528787928|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
146622007|NCT03748823|528787929|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
146622008|NCT03748823|528787928|FG000|Extension Period|Withdrawal by Subject|9|||
146622009|NCT03748823|528787929|FG001|Extension Period|Withdrawal by Subject|12|||
146803883|NCT03473743|529453235|FG005|Overall Study|Randomized but not treated|0|||
146803884|NCT03473743|529453236|FG006|Overall Study|Randomized but not treated|1|||
146803885|NCT03473743|529453237|FG007|Overall Study|Randomized but not treated|1|||
146803886|NCT00980954|529453238|FG000|Overall Study|Protocol Violation|9|||
146803887|NCT00980954|529453239|FG001|Overall Study|Protocol Violation|15|||
146803888|NCT01458366|529453245|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
146803889|NCT01458366|529453246|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
146803890|NCT01458366|529453247|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
146803891|NCT01458366|529453248|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
146803892|NCT01458366|529453249|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
146803893|NCT01458366|529453245|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
146803894|NCT01458366|529453246|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
146803895|NCT01458366|529453247|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
146803896|NCT01458366|529453248|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
146803897|NCT01458366|529453249|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
146803898|NCT04647487|529453250|FG000|Overall Study|Protocol Deviation|0|||
146622010|NCT03748823|528787928|FG000|Extension Period|Death|2|||
146622011|NCT03748823|528787929|FG001|Extension Period|Death|2|||
146622012|NCT03748823|528787928|FG000|Extension Period|Other than Specified|0|||
146622013|NCT03748823|528787929|FG001|Extension Period|Other than Specified|1|||
146622014|NCT03748823|528787928|FG000|Extension Period|Protocol Violation|1|||
146622015|NCT03748823|528787929|FG001|Extension Period|Protocol Violation|0|||
146622016|NCT03748823|528787928|FG000|Extension Period|Lost to Follow-up|0|||
146622017|NCT03748823|528787929|FG001|Extension Period|Lost to Follow-up|1|||
146622018|NCT03748823|528787928|FG000|Extension Period|Lack of Efficacy|0|||
146803899|NCT04647487|529453251|FG001|Overall Study|Protocol Deviation|0|||
146803900|NCT04647487|529453252|FG002|Overall Study|Protocol Deviation|1|||
146803901|NCT04647487|529453250|FG000|Overall Study|Withdrawal by Subject|1|||
146941879|NCT00856986|529946016|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
146941880|NCT00856986|529946017|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
146941881|NCT00856986|529946018|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
146941882|NCT00856986|529946019|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
146941883|NCT00856986|529946020|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
146941884|NCT00856986|529946016|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
146941885|NCT00856986|529946017|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
146941886|NCT00856986|529946018|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
146941887|NCT00856986|529946019|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
146941888|NCT00856986|529946020|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
146941889|NCT00856986|529946016|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
146941890|NCT00856986|529946017|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
146622019|NCT03748823|528787929|FG001|Extension Period|Lack of Efficacy|1|||
146622020|NCT03748823|528787928|FG000|Extension Period|Physician Decision|1|||
146622021|NCT03748823|528787929|FG001|Extension Period|Physician Decision|2|||
146622022|NCT02903160|528787930|FG000|Overall Study|Adverse Event|2|||
146622023|NCT02903160|528787930|FG000|Overall Study|Death|1|||
146622024|NCT02903160|528787930|FG000|Overall Study|Lost to Follow-up|2|||
146622025|NCT02903160|528787930|FG000|Overall Study|Withdrawal by Subject|1|||
146622026|NCT02903160|528787930|FG000|Overall Study|Medical Insurance Barriers|1|||
146622027|NCT01664910|528787933|FG000|Overall Study|Adverse Event|0|||
146622028|NCT01664910|528787934|FG001|Overall Study|Adverse Event|0|||
146983930|NCT01261325|530101989|FG001|Overall Study|AE, non-serious non-fatal|15|||
146983931|NCT01261325|530101990|FG002|Overall Study|AE, non-serious non-fatal|13|||
146983932|NCT01261325|530101988|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
146983933|NCT01261325|530101989|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
146983934|NCT01261325|530101990|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
146983935|NCT01261325|530101988|FG000|Overall Study|Non Compliance|2|||
146983936|NCT01261325|530101989|FG001|Overall Study|Non Compliance|0|||
146622029|NCT01664910|528787935|FG002|Overall Study|Adverse Event|1|||
146622030|NCT00867165|528787940|FG000|Overall Study|Adverse Event|3|||
146622031|NCT00867165|528787941|FG001|Overall Study|Adverse Event|0|||
146622032|NCT00867165|528787940|FG000|Overall Study|Withdrawal by Subject|1|||
146622033|NCT00867165|528787941|FG001|Overall Study|Withdrawal by Subject|0|||
146803902|NCT04647487|529453251|FG001|Overall Study|Withdrawal by Subject|0|||
146803903|NCT04647487|529453252|FG002|Overall Study|Withdrawal by Subject|2|||
146803904|NCT02787005|529453253|FG000|Overall Study|Adverse Event|24|||
146803905|NCT02787005|529453254|FG001|Overall Study|Adverse Event|9|||
146803906|NCT02787005|529453255|FG002|Overall Study|Adverse Event|9|||
146803907|NCT02787005|529453256|FG003|Overall Study|Adverse Event|7|||
146803908|NCT02787005|529453257|FG004|Overall Study|Adverse Event|2|||
146803909|NCT02787005|529453253|FG000|Overall Study|Death|100|||
146803910|NCT02787005|529453254|FG001|Overall Study|Death|53|||
146803911|NCT02787005|529453255|FG002|Overall Study|Death|48|||
146803912|NCT02787005|529453256|FG003|Overall Study|Death|69|||
146803913|NCT02787005|529453257|FG004|Overall Study|Death|38|||
146803914|NCT02787005|529453253|FG000|Overall Study|Sponsor Decision|7|||
146803915|NCT02787005|529453254|FG001|Overall Study|Sponsor Decision|4|||
146803916|NCT02787005|529453255|FG002|Overall Study|Sponsor Decision|0|||
146803917|NCT02787005|529453256|FG003|Overall Study|Sponsor Decision|4|||
146803918|NCT02787005|529453257|FG004|Overall Study|Sponsor Decision|5|||
146803919|NCT02787005|529453253|FG000|Overall Study|Withdrawal by Subject|2|||
146622034|NCT02738008|528787942|FG000|Overall Study|Study Terminated by Sponsor|1|||
146622035|NCT02738008|528787943|FG001|Overall Study|Study Terminated by Sponsor|5|||
146622036|NCT02738008|528787944|FG002|Overall Study|Study Terminated by Sponsor|3|||
146622037|NCT02738008|528787942|FG000|Overall Study|Adverse Event|0|||
146622038|NCT02738008|528787943|FG001|Overall Study|Adverse Event|1|||
146622039|NCT02738008|528787944|FG002|Overall Study|Adverse Event|2|||
146622040|NCT00399516|528787945|FG000|Overall Study|Lost to Follow-up|2|||
146622041|NCT02734693|528787946|FG000|Overall Study|Adverse Event|1|||
146622042|NCT02734693|528787947|FG001|Overall Study|Adverse Event|3|||
146622043|NCT02734693|528787948|FG002|Overall Study|Adverse Event|3|||
146622044|NCT02734693|528787946|FG000|Overall Study|Lack of Efficacy|1|||
146622045|NCT02734693|528787947|FG001|Overall Study|Lack of Efficacy|0|||
146622046|NCT02734693|528787948|FG002|Overall Study|Lack of Efficacy|0|||
146622047|NCT02734693|528787946|FG000|Overall Study|Lost to Follow-up|2|||
146622048|NCT02734693|528787947|FG001|Overall Study|Lost to Follow-up|0|||
146622049|NCT02734693|528787948|FG002|Overall Study|Lost to Follow-up|0|||
146622050|NCT02734693|528787946|FG000|Overall Study|Protocol Violation|1|||
146622051|NCT02734693|528787947|FG001|Overall Study|Protocol Violation|0|||
146622052|NCT02734693|528787948|FG002|Overall Study|Protocol Violation|0|||
146622053|NCT02734693|528787946|FG000|Overall Study|Withdrawal by Subject|1|||
146622054|NCT02734693|528787947|FG001|Overall Study|Withdrawal by Subject|0|||
146622055|NCT02734693|528787948|FG002|Overall Study|Withdrawal by Subject|0|||
146622056|NCT00982735|528787949|FG000|Overall Study|Lost to Follow-up|6|||
146622057|NCT00982735|528787949|FG000|Overall Study|Patient ineligible for trial|224|||
146622058|NCT04879628|528787955|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
146622059|NCT04879628|528787956|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
146983937|NCT01261325|530101990|FG002|Overall Study|Non Compliance|0|||
146622060|NCT04879628|528787957|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
146622061|NCT04879628|528787958|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
146622062|NCT04879628|528787955|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
146983938|NCT01261325|530101988|FG000|Overall Study|Patient Randomized by Mistake|0|||
146983939|NCT01261325|530101989|FG001|Overall Study|Patient Randomized by Mistake|1|||
146622063|NCT04879628|528787956|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
146803920|NCT02787005|529453254|FG001|Overall Study|Withdrawal by Subject|1|||
146803921|NCT02787005|529453255|FG002|Overall Study|Withdrawal by Subject|1|||
146803922|NCT02787005|529453256|FG003|Overall Study|Withdrawal by Subject|0|||
146941891|NCT00856986|529946018|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
146941892|NCT00856986|529946019|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
146622064|NCT04879628|528787957|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
146622065|NCT04879628|528787958|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
146622066|NCT04879628|528787955|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
146622067|NCT04879628|528787956|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
146622068|NCT04879628|528787957|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
146622069|NCT04879628|528787958|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
146622070|NCT04879628|528787955|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
146622071|NCT04879628|528787956|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
146622072|NCT04879628|528787957|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
146622073|NCT04879628|528787958|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
146622074|NCT02775916|528787959|FG000|Overall Study|Adverse Event|1|||
146622075|NCT02775916|528787960|FG001|Overall Study|Adverse Event|0|||
146622076|NCT02775916|528787959|FG000|Overall Study|Subject/Guardian Decision|2|||
146622077|NCT02775916|528787960|FG001|Overall Study|Subject/Guardian Decision|0|||
146622078|NCT00948064|528789562|FG000|Phase I|No treatment received|1|||
146622079|NCT00948064|528789563|FG001|Phase I|No treatment received|0|||
146622080|NCT00948064|528789564|FG002|Phase I|No treatment received|0|||
146622081|NCT00948064|528789562|FG000|Phase II|Physician Decision|0|||
146622082|NCT00948064|528789563|FG001|Phase II|Physician Decision|0|||
146622083|NCT00948064|528789564|FG002|Phase II|Physician Decision|1|||
146622084|NCT00948064|528789562|FG000|Phase II|Withdrawal by Subject|0|||
146622085|NCT00948064|528789563|FG001|Phase II|Withdrawal by Subject|1|||
146622086|NCT00948064|528789564|FG002|Phase II|Withdrawal by Subject|0|||
146622087|NCT00644423|528789566|FG000|Overall Study|Lost to Follow-up|1|||
146622088|NCT00644423|528789567|FG001|Overall Study|Lost to Follow-up|1|||
146622089|NCT03096834|528789568|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
146622090|NCT03096834|528789569|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
146622091|NCT03096834|528789570|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
146622092|NCT03096834|528789571|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
146622093|NCT03096834|528789568|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
146622094|NCT03096834|528789569|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
146622095|NCT03096834|528789570|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
146622096|NCT03096834|528789571|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
146622097|NCT03096834|528789568|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
146622098|NCT03096834|528789569|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
146622099|NCT03096834|528789570|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
146622100|NCT03096834|528789571|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
146622101|NCT03096834|528789568|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
146622102|NCT03096834|528789569|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
146622103|NCT03096834|528789570|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
146622104|NCT03096834|528789571|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
146622105|NCT03096834|528789568|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
146622106|NCT03096834|528789569|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
146622107|NCT03096834|528789570|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
146622108|NCT03096834|528789571|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
146622109|NCT03096834|528789568|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
146622110|NCT03096834|528789569|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
146622111|NCT03096834|528789570|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
146622112|NCT03096834|528789571|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
146622113|NCT03096834|528789568|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
146622114|NCT03096834|528789569|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
146622115|NCT03096834|528789570|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
146622116|NCT03096834|528789571|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
146622117|NCT03096834|528789568|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
146622118|NCT03096834|528789569|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
146622119|NCT03096834|528789570|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
146622120|NCT03096834|528789571|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
146622121|NCT03096834|528789568|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
146622122|NCT03096834|528789569|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
146622123|NCT03096834|528789570|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
146622124|NCT03096834|528789571|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
146622125|NCT03096834|528789568|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
146622126|NCT03096834|528789569|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
146622127|NCT03096834|528789570|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
146622128|NCT03096834|528789571|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
146622129|NCT03096834|528789568|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
146622130|NCT03096834|528789569|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
146622131|NCT03096834|528789570|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
146622132|NCT03096834|528789571|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
146622133|NCT03096834|528789568|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
146622134|NCT03096834|528789569|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
146622135|NCT03096834|528789570|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
146622136|NCT03096834|528789571|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
146622137|NCT04233801|528789576|FG000|Overall Study|Other than listed|0|||
146622138|NCT04233801|528789577|FG001|Overall Study|Other than listed|0|||
146622139|NCT04233801|528789578|FG002|Overall Study|Other than listed|1|||
146622140|NCT04233801|528789576|FG000|Overall Study|Withdrawal by Subject|0|||
146622141|NCT04233801|528789577|FG001|Overall Study|Withdrawal by Subject|2|||
146622142|NCT04233801|528789578|FG002|Overall Study|Withdrawal by Subject|3|||
146622143|NCT00762359|528789579|FG000|Overall Study|Adverse Event|20|||
146622144|NCT00762359|528789580|FG001|Overall Study|Adverse Event|23|||
146622145|NCT00762359|528789579|FG000|Overall Study|Protocol Violation|21|||
146622146|NCT00762359|528789580|FG001|Overall Study|Protocol Violation|13|||
146622147|NCT00762359|528789579|FG000|Overall Study|Withdrawal by Subject|13|||
146803923|NCT02787005|529453257|FG004|Overall Study|Withdrawal by Subject|1|||
146803924|NCT02787005|529453253|FG000|Overall Study|Screen Failure|0|||
146803925|NCT02787005|529453254|FG001|Overall Study|Screen Failure|2|||
146803926|NCT02787005|529453255|FG002|Overall Study|Screen Failure|0|||
146803927|NCT02787005|529453256|FG003|Overall Study|Screen Failure|0|||
146803928|NCT02787005|529453257|FG004|Overall Study|Screen Failure|1|||
146803929|NCT02787005|529453253|FG000|Overall Study|Lost to Follow-up|0|||
146803930|NCT02787005|529453254|FG001|Overall Study|Lost to Follow-up|0|||
146803931|NCT02787005|529453255|FG002|Overall Study|Lost to Follow-up|0|||
146803932|NCT02787005|529453256|FG003|Overall Study|Lost to Follow-up|1|||
146803933|NCT02787005|529453257|FG004|Overall Study|Lost to Follow-up|0|||
146803934|NCT01753999|529453258|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
146803935|NCT01753999|529453259|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
146803936|NCT01753999|529453258|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
146803937|NCT01753999|529453259|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
146803938|NCT01753999|529453258|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
146803939|NCT01753999|529453259|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
146803940|NCT01753999|529453258|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
146803941|NCT01753999|529453259|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
146803942|NCT01753999|529453258|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
146803943|NCT01753999|529453259|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
146803944|NCT01753999|529453258|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
146803945|NCT01753999|529453259|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
146803946|NCT02392234|529453260|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
146803947|NCT02392234|529453261|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
146803948|NCT02392234|529453262|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
146803949|NCT02392234|529453263|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
146803950|NCT02392234|529453264|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
146803951|NCT02392234|529453265|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
146803952|NCT02392234|529453260|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
146803953|NCT02392234|529453261|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
146803954|NCT02392234|529453262|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
146803955|NCT02392234|529453263|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
146803956|NCT02392234|529453264|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
146803957|NCT02392234|529453265|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
146803958|NCT02392234|529453260|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
146803959|NCT02392234|529453261|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
146803960|NCT02392234|529453262|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
146803961|NCT02392234|529453263|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
146803962|NCT02392234|529453264|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
146803963|NCT02392234|529453265|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
146803964|NCT02392234|529453260|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
146803965|NCT02392234|529453261|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
146803966|NCT02392234|529453262|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
146803967|NCT02392234|529453263|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
146803968|NCT02392234|529453264|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
146803969|NCT02392234|529453265|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
146803970|NCT02392234|529453260|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
146803971|NCT02392234|529453261|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
146803972|NCT02392234|529453262|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
146803973|NCT02392234|529453263|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
146803974|NCT02392234|529453264|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
146622148|NCT00762359|528789580|FG001|Overall Study|Withdrawal by Subject|10|||
146803975|NCT02392234|529453265|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
146803976|NCT02392234|529453260|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
146803977|NCT02392234|529453261|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
146803978|NCT02392234|529453262|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
146803979|NCT02392234|529453263|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
146803980|NCT02392234|529453264|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
146803981|NCT02392234|529453265|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
146803982|NCT02392234|529453260|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
146803983|NCT02392234|529453261|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
146803984|NCT02392234|529453262|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
146803985|NCT02392234|529453263|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
146803986|NCT02392234|529453264|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
146803987|NCT02392234|529453265|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
146803988|NCT02392234|529453260|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
146803989|NCT02392234|529453261|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
146803990|NCT02392234|529453262|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
146803991|NCT02392234|529453263|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
146803992|NCT02392234|529453264|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
146803993|NCT02392234|529453265|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
146803994|NCT01387516|529453266|FG000|Overall Study|Lost to Follow-up|4|||
146803995|NCT01387516|529453267|FG001|Overall Study|Lost to Follow-up|4|||
146803996|NCT01387516|529453268|FG002|Overall Study|Lost to Follow-up|2|||
146803997|NCT01387516|529453269|FG003|Overall Study|Lost to Follow-up|3|||
146803998|NCT01387516|529453266|FG000|Overall Study|Withdrawal by Subject|1|||
146803999|NCT01387516|529453267|FG001|Overall Study|Withdrawal by Subject|1|||
146804000|NCT01387516|529453268|FG002|Overall Study|Withdrawal by Subject|2|||
146804001|NCT01387516|529453269|FG003|Overall Study|Withdrawal by Subject|0|||
146804002|NCT01387516|529453266|FG000|Overall Study|Death|0|||
146804003|NCT01387516|529453267|FG001|Overall Study|Death|0|||
146804004|NCT01387516|529453268|FG002|Overall Study|Death|0|||
146804005|NCT01387516|529453269|FG003|Overall Study|Death|1|||
146804006|NCT03170648|529453272|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
146804007|NCT03170648|529453272|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
146804008|NCT02052440|529453273|FG000|Overall Study|Withdrawal by Subject|0|||
146804009|NCT02052440|529453274|FG001|Overall Study|Withdrawal by Subject|1|||
146804010|NCT03509909|529453275|FG000|Overall Study|Withdrawal by Subject|16|||
146804011|NCT03509909|529453276|FG001|Overall Study|Withdrawal by Subject|9|||
146804012|NCT03509909|529453275|FG000|Overall Study|Lost to Follow-up|3|||
146804013|NCT03509909|529453276|FG001|Overall Study|Lost to Follow-up|4|||
146804014|NCT03509909|529453275|FG000|Overall Study|Adverse Event|2|||
146804015|NCT03509909|529453276|FG001|Overall Study|Adverse Event|0|||
146804016|NCT04325828|529453277|FG000|Overall Study|Ongoing|26|||
146804017|NCT05509816|529453278|FG000|Overall Study|Lost to Follow-up|1|||
146804018|NCT02130557|529453279|FG000|Overall Study|Withdrawal by Subject|12|||
146804019|NCT02130557|529453280|FG001|Overall Study|Withdrawal by Subject|12|||
146804020|NCT02130557|529453279|FG000|Overall Study|Investigator Request|0|||
146804021|NCT02130557|529453280|FG001|Overall Study|Investigator Request|2|||
146804022|NCT02130557|529453279|FG000|Overall Study|Deceased|14|||
146804023|NCT02130557|529453280|FG001|Overall Study|Deceased|14|||
146804024|NCT02130557|529453279|FG000|Overall Study|Lost to Follow-up|6|||
146804025|NCT02130557|529453280|FG001|Overall Study|Lost to Follow-up|7|||
146804026|NCT02130557|529453279|FG000|Overall Study|Other|2|||
146804027|NCT02130557|529453280|FG001|Overall Study|Other|1|||
146804028|NCT02130557|529453279|FG000|Overall Study|Missing|2|||
146804029|NCT02130557|529453280|FG001|Overall Study|Missing|1|||
146804030|NCT04066075|529453281|FG000|Overall Study|Lost to Follow-up|3|||
146804031|NCT04066075|529453282|FG001|Overall Study|Lost to Follow-up|3|||
146804032|NCT04066075|529453281|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
146804033|NCT04066075|529453282|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
146804034|NCT04066075|529453281|FG000|Overall Study|Withdrawal by Subject|2|||
146804035|NCT04066075|529453282|FG001|Overall Study|Withdrawal by Subject|2|||
146804036|NCT00309166|529453283|FG000|Overall Study|Adverse event, non-fatal|1|||
146804037|NCT00309166|529453284|FG001|Overall Study|Adverse event, non-fatal|0|||
146804038|NCT00309166|529453283|FG000|Overall Study|Withdrawal by Subject|4|||
146804039|NCT00309166|529453284|FG001|Overall Study|Withdrawal by Subject|3|||
146804040|NCT04801420|529453289|FG000|Overall Study|Other|1|||
146622149|NCT00762359|528789579|FG000|Overall Study|Lack of Efficacy|0|||
146804041|NCT04801420|529453290|FG001|Overall Study|Other|2|||
146804042|NCT04801420|529453291|FG002|Overall Study|Other|1|||
146804043|NCT04801420|529453289|FG000|Overall Study|Lost to Follow-up|7|||
146804044|NCT04801420|529453290|FG001|Overall Study|Lost to Follow-up|9|||
146804045|NCT04801420|529453291|FG002|Overall Study|Lost to Follow-up|10|||
146804046|NCT04801420|529453289|FG000|Overall Study|Moved from study area|0|||
146804047|NCT04801420|529453290|FG001|Overall Study|Moved from study area|1|||
146804048|NCT04801420|529453291|FG002|Overall Study|Moved from study area|1|||
146804049|NCT04801420|529453289|FG000|Overall Study|Withdrawal by Subject|5|||
146804050|NCT04801420|529453290|FG001|Overall Study|Withdrawal by Subject|1|||
146804051|NCT04801420|529453291|FG002|Overall Study|Withdrawal by Subject|4|||
146804052|NCT04801420|529453289|FG000|Overall Study|Individual stopping criteria reached|0|||
146804053|NCT04801420|529453290|FG001|Overall Study|Individual stopping criteria reached|1|||
146804054|NCT04801420|529453291|FG002|Overall Study|Individual stopping criteria reached|0|||
146804055|NCT04801420|529453289|FG000|Overall Study|Ongoing in the study|195|||
146804056|NCT04801420|529453290|FG001|Overall Study|Ongoing in the study|195|||
146804057|NCT04801420|529453291|FG002|Overall Study|Ongoing in the study|192|||
146941893|NCT00856986|529946020|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
146941894|NCT00856986|529946016|FG000|Main Period, Weeks 0-26|Unclassified|7|||
146941895|NCT00856986|529946017|FG001|Main Period, Weeks 0-26|Unclassified|6|||
146941896|NCT00856986|529946018|FG002|Main Period, Weeks 0-26|Unclassified|7|||
146804070|NCT01675492|529453294|FG000|Overall Study|study completed early - product approval|42|||
146804071|NCT05349838|529453295|FG000|Overall Study|Virological Failure|1|||
146804072|NCT05349838|529453296|FG001|Overall Study|Virological Failure|2|||
146804073|NCT05349838|529453295|FG000|Overall Study|Withdrawal by Subject|2|||
146804074|NCT05349838|529453296|FG001|Overall Study|Withdrawal by Subject|3|||
146804075|NCT05349838|529453295|FG000|Overall Study|Adverse Event|3|||
146804076|NCT05349838|529453296|FG001|Overall Study|Adverse Event|1|||
146804077|NCT05349838|529453295|FG000|Overall Study|Lost to Follow-up|1|||
146804078|NCT05349838|529453296|FG001|Overall Study|Lost to Follow-up|2|||
146804079|NCT05349838|529453295|FG000|Overall Study|Other reasons|5|||
146804080|NCT05349838|529453296|FG001|Overall Study|Other reasons|1|||
146804081|NCT00092534|529454811|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
146804082|NCT00092534|529454812|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
146804083|NCT00092534|529454813|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
146804084|NCT00092534|529454814|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
146804085|NCT00092534|529454815|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
146804086|NCT00092534|529454811|FG000|Base Study Vaccination Period|Adverse Event|3|||
146804087|NCT00092534|529454812|FG001|Base Study Vaccination Period|Adverse Event|1|||
146804088|NCT00092534|529454813|FG002|Base Study Vaccination Period|Adverse Event|0|||
146804089|NCT00092534|529454814|FG003|Base Study Vaccination Period|Adverse Event|0|||
146804090|NCT00092534|529454815|FG004|Base Study Vaccination Period|Adverse Event|0|||
146804091|NCT00092534|529454811|FG000|Base Study Vaccination Period|Death|5|||
146804092|NCT00092534|529454812|FG001|Base Study Vaccination Period|Death|4|||
146804093|NCT00092534|529454813|FG002|Base Study Vaccination Period|Death|0|||
146804094|NCT00092534|529454814|FG003|Base Study Vaccination Period|Death|0|||
146804095|NCT00092534|529454815|FG004|Base Study Vaccination Period|Death|0|||
146804096|NCT00092534|529454811|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
146804097|NCT00092534|529454812|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
146804098|NCT00092534|529454813|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
146804099|NCT00092534|529454814|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
146804100|NCT00092534|529454815|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
146804101|NCT00092534|529454811|FG000|Base Study Vaccination Period|Physician Decision|1|||
146804102|NCT00092534|529454812|FG001|Base Study Vaccination Period|Physician Decision|0|||
146804103|NCT00092534|529454813|FG002|Base Study Vaccination Period|Physician Decision|0|||
146804104|NCT00092534|529454814|FG003|Base Study Vaccination Period|Physician Decision|0|||
146804105|NCT00092534|529454815|FG004|Base Study Vaccination Period|Physician Decision|0|||
146804106|NCT00092534|529454811|FG000|Base Study Vaccination Period|Pregnancy|9|||
146804107|NCT00092534|529454812|FG001|Base Study Vaccination Period|Pregnancy|7|||
146804108|NCT00092534|529454813|FG002|Base Study Vaccination Period|Pregnancy|0|||
146804109|NCT00092534|529454814|FG003|Base Study Vaccination Period|Pregnancy|0|||
146804110|NCT00092534|529454815|FG004|Base Study Vaccination Period|Pregnancy|0|||
146941897|NCT00856986|529946019|FG003|Main Period, Weeks 0-26|Unclassified|0|||
146941898|NCT00856986|529946020|FG004|Main Period, Weeks 0-26|Unclassified|0|||
146941899|NCT00856986|529946016|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
146804111|NCT00092534|529454811|FG000|Base Study Vaccination Period|Protocol Violation|2|||
146804112|NCT00092534|529454812|FG001|Base Study Vaccination Period|Protocol Violation|1|||
146804113|NCT00092534|529454813|FG002|Base Study Vaccination Period|Protocol Violation|0|||
146804114|NCT00092534|529454814|FG003|Base Study Vaccination Period|Protocol Violation|0|||
146804115|NCT00092534|529454815|FG004|Base Study Vaccination Period|Protocol Violation|0|||
146804116|NCT00092534|529454811|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
146804117|NCT00092534|529454812|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
146804118|NCT00092534|529454813|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
146804119|NCT00092534|529454814|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
146804120|NCT00092534|529454815|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
146804121|NCT00092534|529454811|FG000|Base Study Vaccination Period|Moved|14|||
146804122|NCT00092534|529454812|FG001|Base Study Vaccination Period|Moved|12|||
146804123|NCT00092534|529454813|FG002|Base Study Vaccination Period|Moved|0|||
146804124|NCT00092534|529454814|FG003|Base Study Vaccination Period|Moved|0|||
146804125|NCT00092534|529454815|FG004|Base Study Vaccination Period|Moved|0|||
146804126|NCT00092534|529454811|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
146804127|NCT00092534|529454812|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
146804128|NCT00092534|529454813|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
146804129|NCT00092534|529454814|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
146804130|NCT00092534|529454815|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
146804131|NCT00092534|529454811|FG000|Base Study Vaccination Period|Travel|1|||
146804132|NCT00092534|529454812|FG001|Base Study Vaccination Period|Travel|0|||
146804133|NCT00092534|529454813|FG002|Base Study Vaccination Period|Travel|0|||
146804134|NCT00092534|529454814|FG003|Base Study Vaccination Period|Travel|0|||
146804135|NCT00092534|529454815|FG004|Base Study Vaccination Period|Travel|0|||
146804136|NCT00092534|529454811|FG000|Base Study Vaccination Period|Site Closed|0|||
146804137|NCT00092534|529454812|FG001|Base Study Vaccination Period|Site Closed|1|||
146804138|NCT00092534|529454813|FG002|Base Study Vaccination Period|Site Closed|0|||
146804139|NCT00092534|529454814|FG003|Base Study Vaccination Period|Site Closed|0|||
146804140|NCT00092534|529454815|FG004|Base Study Vaccination Period|Site Closed|0|||
146804141|NCT00092534|529454811|FG000|Base Study Follow-Up Period|Adverse Event|2|||
146804142|NCT00092534|529454812|FG001|Base Study Follow-Up Period|Adverse Event|4|||
146804143|NCT00092534|529454813|FG002|Base Study Follow-Up Period|Adverse Event|0|||
146804144|NCT00092534|529454814|FG003|Base Study Follow-Up Period|Adverse Event|0|||
146804145|NCT00092534|529454815|FG004|Base Study Follow-Up Period|Adverse Event|0|||
146804146|NCT00092534|529454811|FG000|Base Study Follow-Up Period|Death|2|||
146804147|NCT00092534|529454812|FG001|Base Study Follow-Up Period|Death|1|||
146804148|NCT00092534|529454813|FG002|Base Study Follow-Up Period|Death|0|||
146804149|NCT00092534|529454814|FG003|Base Study Follow-Up Period|Death|0|||
146804150|NCT00092534|529454815|FG004|Base Study Follow-Up Period|Death|0|||
146804151|NCT00092534|529454811|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
146804152|NCT00092534|529454812|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
146804153|NCT00092534|529454813|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
146804154|NCT00092534|529454814|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
146804155|NCT00092534|529454815|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
146804156|NCT00092534|529454811|FG000|Base Study Follow-Up Period|Pregnancy|6|||
146804157|NCT00092534|529454812|FG001|Base Study Follow-Up Period|Pregnancy|10|||
146804158|NCT00092534|529454813|FG002|Base Study Follow-Up Period|Pregnancy|0|||
146804159|NCT00092534|529454814|FG003|Base Study Follow-Up Period|Pregnancy|0|||
146804160|NCT00092534|529454815|FG004|Base Study Follow-Up Period|Pregnancy|0|||
146804161|NCT00092534|529454811|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
146804162|NCT00092534|529454812|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
146804163|NCT00092534|529454813|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
146804164|NCT00092534|529454814|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
146804165|NCT00092534|529454815|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
146804166|NCT00092534|529454811|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
146804167|NCT00092534|529454812|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
146804168|NCT00092534|529454813|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
146804169|NCT00092534|529454814|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
146804170|NCT00092534|529454815|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
146804171|NCT00092534|529454811|FG000|Base Study Follow-Up Period|Moved|62|||
146804172|NCT00092534|529454812|FG001|Base Study Follow-Up Period|Moved|58|||
146804173|NCT00092534|529454813|FG002|Base Study Follow-Up Period|Moved|0|||
146804174|NCT00092534|529454814|FG003|Base Study Follow-Up Period|Moved|0|||
146804175|NCT00092534|529454815|FG004|Base Study Follow-Up Period|Moved|0|||
146804176|NCT00092534|529454811|FG000|Base Study Follow-Up Period|Travel|10|||
146804177|NCT00092534|529454812|FG001|Base Study Follow-Up Period|Travel|7|||
146804178|NCT00092534|529454813|FG002|Base Study Follow-Up Period|Travel|0|||
146804179|NCT00092534|529454814|FG003|Base Study Follow-Up Period|Travel|0|||
146804180|NCT00092534|529454815|FG004|Base Study Follow-Up Period|Travel|0|||
146804181|NCT00092534|529454811|FG000|Base Study Follow-Up Period|Site Closed|0|||
146804182|NCT00092534|529454812|FG001|Base Study Follow-Up Period|Site Closed|2|||
146804183|NCT00092534|529454813|FG002|Base Study Follow-Up Period|Site Closed|0|||
146804184|NCT00092534|529454814|FG003|Base Study Follow-Up Period|Site Closed|0|||
146804185|NCT00092534|529454815|FG004|Base Study Follow-Up Period|Site Closed|0|||
146804186|NCT00092534|529454811|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
146804187|NCT00092534|529454812|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
146804188|NCT00092534|529454813|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
146804189|NCT00092534|529454814|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
146804190|NCT00092534|529454815|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
146804191|NCT00092534|529454811|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
146804192|NCT00092534|529454812|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
146804193|NCT00092534|529454813|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
146804194|NCT00092534|529454814|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
146804195|NCT00092534|529454815|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
146804196|NCT00092534|529454811|FG000|Base Study EXT|Lost to Follow-up|0|||
146804197|NCT00092534|529454812|FG001|Base Study EXT|Lost to Follow-up|0|||
146804198|NCT00092534|529454813|FG002|Base Study EXT|Lost to Follow-up|41|||
146804199|NCT00092534|529454814|FG003|Base Study EXT|Lost to Follow-up|0|||
146804200|NCT00092534|529454815|FG004|Base Study EXT|Lost to Follow-up|0|||
146804201|NCT00092534|529454811|FG000|Base Study EXT|Physician Decision|0|||
146804202|NCT00092534|529454812|FG001|Base Study EXT|Physician Decision|0|||
146804203|NCT00092534|529454813|FG002|Base Study EXT|Physician Decision|1|||
146804204|NCT00092534|529454814|FG003|Base Study EXT|Physician Decision|0|||
146804205|NCT00092534|529454815|FG004|Base Study EXT|Physician Decision|0|||
146804206|NCT00092534|529454811|FG000|Base Study EXT|Pregnancy|0|||
146804207|NCT00092534|529454812|FG001|Base Study EXT|Pregnancy|0|||
146804208|NCT00092534|529454813|FG002|Base Study EXT|Pregnancy|12|||
146804209|NCT00092534|529454814|FG003|Base Study EXT|Pregnancy|0|||
146804210|NCT00092534|529454815|FG004|Base Study EXT|Pregnancy|0|||
146804211|NCT00092534|529454811|FG000|Base Study EXT|Withdrawal by Subject|0|||
146804212|NCT00092534|529454812|FG001|Base Study EXT|Withdrawal by Subject|0|||
146804213|NCT00092534|529454813|FG002|Base Study EXT|Withdrawal by Subject|18|||
146804214|NCT00092534|529454814|FG003|Base Study EXT|Withdrawal by Subject|0|||
146804215|NCT00092534|529454815|FG004|Base Study EXT|Withdrawal by Subject|0|||
146804216|NCT00092534|529454811|FG000|Base Study EXT|Participant moved|0|||
146804217|NCT00092534|529454812|FG001|Base Study EXT|Participant moved|0|||
146804218|NCT00092534|529454813|FG002|Base Study EXT|Participant moved|6|||
146804219|NCT00092534|529454814|FG003|Base Study EXT|Participant moved|0|||
146804220|NCT00092534|529454815|FG004|Base Study EXT|Participant moved|0|||
146804221|NCT00092534|529454811|FG000|Base Study EXT|Travel|0|||
146804222|NCT00092534|529454812|FG001|Base Study EXT|Travel|0|||
146804223|NCT00092534|529454813|FG002|Base Study EXT|Travel|2|||
146804224|NCT00092534|529454814|FG003|Base Study EXT|Travel|0|||
146804225|NCT00092534|529454815|FG004|Base Study EXT|Travel|0|||
146804226|NCT00092534|529454811|FG000|Base Study EXT|Site closed|0|||
146804227|NCT00092534|529454812|FG001|Base Study EXT|Site closed|0|||
146804228|NCT00092534|529454813|FG002|Base Study EXT|Site closed|21|||
146804229|NCT00092534|529454814|FG003|Base Study EXT|Site closed|0|||
146804230|NCT00092534|529454815|FG004|Base Study EXT|Site closed|0|||
146804231|NCT00092534|529454811|FG000|Base Study EXT|Study ended|0|||
146804232|NCT00092534|529454812|FG001|Base Study EXT|Study ended|0|||
146804233|NCT00092534|529454813|FG002|Base Study EXT|Study ended|29|||
146804234|NCT00092534|529454814|FG003|Base Study EXT|Study ended|0|||
146804235|NCT00092534|529454815|FG004|Base Study EXT|Study ended|0|||
146804236|NCT00092534|529454811|FG000|Base Study EXT|Protocol Violation|0|||
146804237|NCT00092534|529454812|FG001|Base Study EXT|Protocol Violation|0|||
146804238|NCT00092534|529454813|FG002|Base Study EXT|Protocol Violation|15|||
146804239|NCT00092534|529454814|FG003|Base Study EXT|Protocol Violation|0|||
146804240|NCT00092534|529454815|FG004|Base Study EXT|Protocol Violation|0|||
146804241|NCT00092534|529454811|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
146804242|NCT00092534|529454812|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
146804243|NCT00092534|529454813|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
146804244|NCT00092534|529454814|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
146804245|NCT00092534|529454815|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
146941900|NCT00856986|529946017|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
146941901|NCT00856986|529946018|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
146941902|NCT00856986|529946019|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
146941903|NCT00856986|529946020|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
146941904|NCT00856986|529946016|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
146941905|NCT00856986|529946017|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
146941906|NCT00856986|529946018|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
146804246|NCT02036970|529454817|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
146804247|NCT02036970|529454818|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
146804248|NCT02036970|529454819|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
146622150|NCT00762359|528789580|FG001|Overall Study|Lack of Efficacy|4|||
146622151|NCT00762359|528789579|FG000|Overall Study|Institution closed|2|||
146983940|NCT01261325|530101990|FG002|Overall Study|Patient Randomized by Mistake|0|||
146622152|NCT00762359|528789580|FG001|Overall Study|Institution closed|3|||
146622153|NCT00762359|528789579|FG000|Overall Study|Physician Decision|2|||
146941907|NCT00856986|529946019|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
146941908|NCT00856986|529946020|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
146804249|NCT02036970|529454820|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
146804250|NCT02036970|529454821|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
146804251|NCT02036970|529454822|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
146804252|NCT02036970|529454823|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
146804253|NCT02036970|529454824|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
146804254|NCT02036970|529454825|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
146804255|NCT02036970|529454826|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
146983941|NCT01261325|530101988|FG000|Overall Study|Erroneously Randomized|1|||
146983942|NCT01261325|530101989|FG001|Overall Study|Erroneously Randomized|0|||
146983943|NCT01261325|530101990|FG002|Overall Study|Erroneously Randomized|0|||
146983944|NCT01261325|530101988|FG000|Overall Study|Screen Failure|1|||
146622154|NCT00762359|528789580|FG001|Overall Study|Physician Decision|3|||
146622155|NCT00762359|528789579|FG000|Overall Study|Removal|0|||
146622156|NCT00762359|528789580|FG001|Overall Study|Removal|1|||
146622157|NCT00762359|528789579|FG000|Overall Study|Withdrew consent|1|||
146983945|NCT01261325|530101989|FG001|Overall Study|Screen Failure|0|||
146983946|NCT01261325|530101990|FG002|Overall Study|Screen Failure|0|||
146983947|NCT01261325|530101988|FG000|Overall Study|Randomized in Error|0|||
146983948|NCT01261325|530101989|FG001|Overall Study|Randomized in Error|0|||
146983949|NCT01261325|530101990|FG002|Overall Study|Randomized in Error|1|||
146983950|NCT01261325|530101988|FG000|Overall Study|Protocol Violation|0|||
146983951|NCT01261325|530101989|FG001|Overall Study|Protocol Violation|3|||
146983952|NCT01261325|530101990|FG002|Overall Study|Protocol Violation|1|||
146983953|NCT01261325|530101988|FG000|Overall Study|Lost to Follow-up|0|||
146983954|NCT01261325|530101989|FG001|Overall Study|Lost to Follow-up|1|||
146622158|NCT00762359|528789580|FG001|Overall Study|Withdrew consent|0|||
146622159|NCT01690052|528789585|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
146622160|NCT01690052|528789586|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
146622161|NCT02421172|528789587|FG000|Period 1|Adverse Event|1|||
146622162|NCT02421172|528789588|FG001|Period 1|Adverse Event|0|||
146622163|NCT02421172|528789589|FG002|Period 1|Adverse Event|0|||
146622164|NCT02421172|528789590|FG003|Period 1|Adverse Event|0|||
146622165|NCT02421172|528789591|FG004|Period 1|Adverse Event|0|||
146622166|NCT02421172|528789587|FG000|Period 1|Lost to Follow-up|3|||
146622167|NCT02421172|528789588|FG001|Period 1|Lost to Follow-up|1|||
146622168|NCT02421172|528789589|FG002|Period 1|Lost to Follow-up|0|||
146622169|NCT02421172|528789590|FG003|Period 1|Lost to Follow-up|0|||
146622170|NCT02421172|528789591|FG004|Period 1|Lost to Follow-up|0|||
146622171|NCT02421172|528789587|FG000|Period 1|Patient/guardian decision|0|||
146622172|NCT02421172|528789588|FG001|Period 1|Patient/guardian decision|1|||
146622173|NCT02421172|528789589|FG002|Period 1|Patient/guardian decision|0|||
146622174|NCT02421172|528789590|FG003|Period 1|Patient/guardian decision|0|||
146622175|NCT02421172|528789591|FG004|Period 1|Patient/guardian decision|0|||
146622176|NCT02421172|528789587|FG000|Period 2|Adverse Event|0|||
146622177|NCT02421172|528789588|FG001|Period 2|Adverse Event|0|||
146622178|NCT02421172|528789589|FG002|Period 2|Adverse Event|4|||
146622179|NCT02421172|528789590|FG003|Period 2|Adverse Event|0|||
146622180|NCT02421172|528789591|FG004|Period 2|Adverse Event|0|||
146622181|NCT02421172|528789587|FG000|Period 2|Lost to Follow-up|0|||
146622182|NCT02421172|528789588|FG001|Period 2|Lost to Follow-up|0|||
146622183|NCT02421172|528789589|FG002|Period 2|Lost to Follow-up|0|||
146622184|NCT02421172|528789590|FG003|Period 2|Lost to Follow-up|1|||
146622185|NCT02421172|528789591|FG004|Period 2|Lost to Follow-up|0|||
146622186|NCT02421172|528789587|FG000|Period 2|Patient/guardian decision|0|||
146622187|NCT02421172|528789588|FG001|Period 2|Patient/guardian decision|0|||
146622188|NCT02421172|528789589|FG002|Period 2|Patient/guardian decision|3|||
146622189|NCT02421172|528789590|FG003|Period 2|Patient/guardian decision|2|||
146622190|NCT02421172|528789591|FG004|Period 2|Patient/guardian decision|1|||
146622191|NCT00928486|528789592|FG000|Overall Study|Adverse Event|2|||
146622192|NCT00928486|528789592|FG000|Overall Study|Disease Progression|7|||
146622193|NCT00928486|528789592|FG000|Overall Study|Withdrawal by Subject|1|||
146622194|NCT00683878|528789597|FG000|Overall Study|Lack of Efficacy|3|||
146622195|NCT00683878|528789598|FG001|Overall Study|Lack of Efficacy|0|||
146622196|NCT00683878|528789599|FG002|Overall Study|Lack of Efficacy|1|||
146622197|NCT00683878|528789597|FG000|Overall Study|Adverse Event|4|||
146622198|NCT00683878|528789598|FG001|Overall Study|Adverse Event|3|||
146622199|NCT00683878|528789599|FG002|Overall Study|Adverse Event|3|||
146983955|NCT01261325|530101990|FG002|Overall Study|Lost to Follow-up|3|||
146983956|NCT01261325|530101988|FG000|Overall Study|AE, serious fatal|0|||
146622200|NCT00683878|528789597|FG000|Overall Study|Withdrawal by Subject|9|||
146622201|NCT00683878|528789598|FG001|Overall Study|Withdrawal by Subject|8|||
146983957|NCT01261325|530101989|FG001|Overall Study|AE, serious fatal|0|||
146983958|NCT01261325|530101990|FG002|Overall Study|AE, serious fatal|2|||
146983959|NCT02330081|530102001|FG000|Overall Study|Adverse Event|1|||
146983960|NCT02330081|530102001|FG000|Overall Study|Donation did not meet criteria|1|||
146622202|NCT00683878|528789599|FG002|Overall Study|Withdrawal by Subject|6|||
146622203|NCT00683878|528789597|FG000|Overall Study|Death|0|||
146622204|NCT00683878|528789598|FG001|Overall Study|Death|1|||
146622205|NCT00683878|528789599|FG002|Overall Study|Death|0|||
146622206|NCT00683878|528789597|FG000|Overall Study|Lost to Follow-up|4|||
146622207|NCT00683878|528789598|FG001|Overall Study|Lost to Follow-up|2|||
146622208|NCT00683878|528789599|FG002|Overall Study|Lost to Follow-up|4|||
146622209|NCT00683878|528789597|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
146622210|NCT00683878|528789598|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
146622211|NCT00683878|528789599|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
146622212|NCT02891174|528789621|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
146622213|NCT02891174|528789622|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
146622214|NCT02891174|528789621|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
146622215|NCT02891174|528789622|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
146622216|NCT02891174|528789621|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
146622217|NCT02891174|528789622|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
146622218|NCT02891174|528789621|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
146622219|NCT02891174|528789622|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
146622220|NCT02891174|528789621|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
146622221|NCT02891174|528789622|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
146622222|NCT02891174|528789621|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
146622223|NCT02891174|528789622|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
146622224|NCT02891174|528789621|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
146622225|NCT02891174|528789622|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
146622226|NCT04235140|528789623|FG000|Overall Study|Adverse Event|2|||
146622227|NCT04235140|528789623|FG000|Overall Study|Lost to Follow-up|1|||
146622228|NCT04235140|528789623|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
146622229|NCT04235140|528789623|FG000|Overall Study|Commercial drug is available for participants|7|||
146622230|NCT01421017|528789624|FG000|Overall Study|Withdrawal by Subject|2|||
146622231|NCT01421017|528789625|FG001|Overall Study|Withdrawal by Subject|0|||
146622232|NCT01421017|528789626|FG002|Overall Study|Withdrawal by Subject|0|||
146622233|NCT01421017|528789624|FG000|Overall Study|POD|0|||
146622234|NCT01421017|528789625|FG001|Overall Study|POD|6|||
146622235|NCT01421017|528789626|FG002|Overall Study|POD|3|||
146804256|NCT02036970|529454817|FG000|Part 1: Day 1 Through Week 16|Death|0|||
146804257|NCT02036970|529454818|FG001|Part 1: Day 1 Through Week 16|Death|0|||
146804258|NCT02036970|529454819|FG002|Part 1: Day 1 Through Week 16|Death|0|||
146804259|NCT02036970|529454820|FG003|Part 1: Day 1 Through Week 16|Death|0|||
146622236|NCT00861705|528789631|FG000|Overall Study|Never Began Treatment|7|||
146622237|NCT00861705|528789632|FG001|Overall Study|Never Began Treatment|3|||
146622238|NCT00861705|528789633|FG002|Overall Study|Never Began Treatment|0|||
146622239|NCT00861705|528789634|FG003|Overall Study|Never Began Treatment|1|||
146622240|NCT00472108|528789635|FG000|Overall Study|Lost to Follow-up|0|||
146622241|NCT00472108|528789636|FG001|Overall Study|Lost to Follow-up|1|||
146622242|NCT00005906|528789637|FG000|Overall Study|Lack of Efficacy|3|||
146622243|NCT04551989|528789638|FG000|Overall Study|Adverse Event|4|||
146622244|NCT04551989|528789638|FG000|Overall Study|Protocol Violation|3|||
146622245|NCT04551989|528789638|FG000|Overall Study|Lost to Follow-up|1|||
146622246|NCT04551989|528789638|FG000|Overall Study|Physician Decision|3|||
146622247|NCT00088530|528789639|FG000|Overall Study|Progressive/Relapsed Disease|28|||
146622248|NCT00088530|528789640|FG001|Overall Study|Progressive/Relapsed Disease|39|||
146622249|NCT00088530|528789639|FG000|Overall Study|Adverse Event|15|||
146622250|NCT00088530|528789640|FG001|Overall Study|Adverse Event|9|||
146622251|NCT00088530|528789639|FG000|Overall Study|Withdrawal by Subject|2|||
146804260|NCT02036970|529454821|FG004|Part 1: Day 1 Through Week 16|Death|0|||
146804261|NCT02036970|529454822|FG005|Part 1: Day 1 Through Week 16|Death|0|||
146804262|NCT02036970|529454823|FG006|Part 1: Day 1 Through Week 16|Death|0|||
146622252|NCT00088530|528789640|FG001|Overall Study|Withdrawal by Subject|5|||
146622253|NCT00088530|528789639|FG000|Overall Study|Lost to Follow-up|2|||
146622254|NCT00088530|528789640|FG001|Overall Study|Lost to Follow-up|0|||
146622255|NCT00088530|528789639|FG000|Overall Study|Physician Decision|2|||
146622256|NCT00088530|528789640|FG001|Overall Study|Physician Decision|0|||
146622257|NCT00088530|528789639|FG000|Overall Study|Sponsor decision|0|||
146622258|NCT00088530|528789640|FG001|Overall Study|Sponsor decision|1|||
146622259|NCT00088530|528789639|FG000|Overall Study|Patient never treated|1|||
146622260|NCT00088530|528789640|FG001|Overall Study|Patient never treated|0|||
146622261|NCT02694744|528789641|FG000|Overall Study|Adverse Event|2|||
146622262|NCT02694744|528789642|FG001|Overall Study|Adverse Event|1|||
146622263|NCT02694744|528789641|FG000|Overall Study|Withdrawal by Subject|2|||
146622264|NCT02694744|528789642|FG001|Overall Study|Withdrawal by Subject|1|||
146622265|NCT02694744|528789641|FG000|Overall Study|Physician Decision|1|||
146622266|NCT02694744|528789642|FG001|Overall Study|Physician Decision|2|||
146622267|NCT02694744|528789641|FG000|Overall Study|Lost to Follow-up|1|||
146622268|NCT02694744|528789642|FG001|Overall Study|Lost to Follow-up|0|||
146622269|NCT02694744|528789641|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
146622270|NCT02694744|528789642|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
146622271|NCT01945021|528789643|FG000|Overall Study|Adverse Event|1|||
146622272|NCT01945021|528789643|FG000|Overall Study|Withdrawal of consent|12|||
146622273|NCT01945021|528789643|FG000|Overall Study|Lost to Follow-up|5|||
146622274|NCT01945021|528789643|FG000|Overall Study|Death|65|||
146622275|NCT02163902|528789644|FG000|Overall Study|Subject's Request|3|||
146622276|NCT02163902|528789645|FG001|Overall Study|Subject's Request|4|||
146622277|NCT02163902|528789644|FG000|Overall Study|Lost to Follow-up|6|||
146622278|NCT02163902|528789645|FG001|Overall Study|Lost to Follow-up|7|||
146622279|NCT02163902|528789644|FG000|Overall Study|Administrative Decision|2|||
146622280|NCT02163902|528789645|FG001|Overall Study|Administrative Decision|2|||
146622281|NCT02898454|528789646|FG000|Overall Study|Adverse Event|4|||
146622282|NCT02898454|528789647|FG001|Overall Study|Adverse Event|1|||
146622283|NCT02898454|528789648|FG002|Overall Study|Adverse Event|2|||
146622284|NCT02898454|528789646|FG000|Overall Study|Protocol Violation|1|||
146622285|NCT02898454|528789647|FG001|Overall Study|Protocol Violation|0|||
146622286|NCT02898454|528789648|FG002|Overall Study|Protocol Violation|1|||
146622287|NCT02898454|528789646|FG000|Overall Study|Lack of Efficacy|4|||
146622288|NCT02898454|528789647|FG001|Overall Study|Lack of Efficacy|1|||
146622289|NCT02898454|528789648|FG002|Overall Study|Lack of Efficacy|0|||
146622290|NCT02898454|528789646|FG000|Overall Study|Withdrawal by Subject|6|||
146622291|NCT02898454|528789647|FG001|Overall Study|Withdrawal by Subject|3|||
146622292|NCT02898454|528789648|FG002|Overall Study|Withdrawal by Subject|3|||
146622293|NCT02898454|528789646|FG000|Overall Study|Lost to Follow-up|1|||
146622294|NCT02898454|528789647|FG001|Overall Study|Lost to Follow-up|0|||
146622295|NCT02898454|528789648|FG002|Overall Study|Lost to Follow-up|0|||
146622296|NCT02898454|528789646|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
146622297|NCT02898454|528789647|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
146622298|NCT02898454|528789648|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
146622299|NCT00689390|528789649|FG000|Overall Study|Adverse Event|19|||
146622300|NCT00689390|528789650|FG001|Overall Study|Adverse Event|0|||
146622301|NCT00689390|528789649|FG000|Overall Study|Lost to Follow-up|179|||
146622302|NCT00689390|528789650|FG001|Overall Study|Lost to Follow-up|7|||
146941909|NCT00856986|529946016|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
146941910|NCT00856986|529946017|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
146941911|NCT00856986|529946018|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
146941912|NCT00856986|529946019|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
146622303|NCT00689390|528789649|FG000|Overall Study|Withdrawal by Subject|117|||
146622304|NCT00689390|528789650|FG001|Overall Study|Withdrawal by Subject|3|||
146622305|NCT00689390|528789649|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
146622306|NCT00689390|528789650|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
146622307|NCT00689390|528789649|FG000|Overall Study|Non-Compliance With Protocol|21|||
146622308|NCT00689390|528789650|FG001|Overall Study|Non-Compliance With Protocol|0|||
146622309|NCT00689390|528789649|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
146622310|NCT00689390|528789650|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
146622311|NCT00689390|528789649|FG000|Overall Study|Administrative|37|||
146622312|NCT00689390|528789650|FG001|Overall Study|Administrative|0|||
146622313|NCT02343263|528789651|FG000|Overall Study|Physician Decision|5|||
146622314|NCT02343263|528789652|FG001|Overall Study|Physician Decision|3|||
146622315|NCT02343263|528789653|FG002|Overall Study|Physician Decision|1|||
146622316|NCT04264442|528789657|FG000|Overall Study|Lack of Efficacy|6|||
146622317|NCT04264442|528789657|FG000|Overall Study|Lost to Follow-up|2|||
146622318|NCT04264442|528789657|FG000|Overall Study|Sponsor Decision|23|||
146622319|NCT04264442|528789657|FG000|Overall Study|Withdrawal by Subject|11|||
146622320|NCT04264442|528789657|FG000|Overall Study|Study Termination|5|||
146804263|NCT02036970|529454824|FG007|Part 1: Day 1 Through Week 16|Death|0|||
146804264|NCT02036970|529454825|FG008|Part 1: Day 1 Through Week 16|Death|1|||
146804265|NCT02036970|529454826|FG009|Part 1: Day 1 Through Week 16|Death|0|||
146804266|NCT02036970|529454817|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
146804267|NCT02036970|529454818|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
146622321|NCT01384734|528789659|FG000|Overall Study|Adverse Event|0|||
146622322|NCT01384734|528789660|FG001|Overall Study|Adverse Event|3|||
146622323|NCT01384734|528789661|FG002|Overall Study|Adverse Event|0|||
146622324|NCT01384734|528789662|FG003|Overall Study|Adverse Event|2|||
146622325|NCT01384734|528789663|FG004|Overall Study|Adverse Event|7|||
146622326|NCT01384734|528789659|FG000|Overall Study|Death|1|||
146622327|NCT01384734|528789660|FG001|Overall Study|Death|0|||
146622328|NCT01384734|528789661|FG002|Overall Study|Death|1|||
146622329|NCT01384734|528789662|FG003|Overall Study|Death|0|||
146622330|NCT01384734|528789663|FG004|Overall Study|Death|0|||
146622331|NCT01384734|528789659|FG000|Overall Study|Continuation criteria not met|0|||
146622332|NCT01384734|528789660|FG001|Overall Study|Continuation criteria not met|0|||
146622333|NCT01384734|528789661|FG002|Overall Study|Continuation criteria not met|1|||
146622334|NCT01384734|528789662|FG003|Overall Study|Continuation criteria not met|1|||
146622335|NCT01384734|528789663|FG004|Overall Study|Continuation criteria not met|0|||
146622336|NCT01384734|528789659|FG000|Overall Study|Lack of Efficacy|3|||
146622337|NCT01384734|528789660|FG001|Overall Study|Lack of Efficacy|7|||
146622338|NCT01384734|528789661|FG002|Overall Study|Lack of Efficacy|4|||
146622339|NCT01384734|528789662|FG003|Overall Study|Lack of Efficacy|4|||
146622340|NCT01384734|528789663|FG004|Overall Study|Lack of Efficacy|2|||
146622341|NCT01384734|528789659|FG000|Overall Study|Lost to Follow-up|5|||
146622342|NCT01384734|528789660|FG001|Overall Study|Lost to Follow-up|3|||
146622343|NCT01384734|528789661|FG002|Overall Study|Lost to Follow-up|3|||
146622344|NCT01384734|528789662|FG003|Overall Study|Lost to Follow-up|8|||
146622345|NCT01384734|528789663|FG004|Overall Study|Lost to Follow-up|5|||
146622346|NCT01384734|528789659|FG000|Overall Study|Non-compliance with study drug|1|||
146622347|NCT01384734|528789660|FG001|Overall Study|Non-compliance with study drug|2|||
146622348|NCT01384734|528789661|FG002|Overall Study|Non-compliance with study drug|6|||
146622349|NCT01384734|528789662|FG003|Overall Study|Non-compliance with study drug|0|||
146622350|NCT01384734|528789663|FG004|Overall Study|Non-compliance with study drug|2|||
146622351|NCT01384734|528789659|FG000|Overall Study|Pregnancy|0|||
146622352|NCT01384734|528789660|FG001|Overall Study|Pregnancy|1|||
146622353|NCT01384734|528789661|FG002|Overall Study|Pregnancy|0|||
146804268|NCT02036970|529454819|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
146804269|NCT02036970|529454820|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
146804270|NCT02036970|529454821|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
146804271|NCT02036970|529454822|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
146804272|NCT02036970|529454823|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
146804273|NCT02036970|529454824|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
146941913|NCT00856986|529946020|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
146941914|NCT00856986|529946016|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
146622354|NCT01384734|528789662|FG003|Overall Study|Pregnancy|0|||
146622355|NCT01384734|528789663|FG004|Overall Study|Pregnancy|1|||
146622356|NCT01384734|528789659|FG000|Overall Study|Sponsor terminated|0|||
146622357|NCT01384734|528789660|FG001|Overall Study|Sponsor terminated|0|||
146622358|NCT01384734|528789661|FG002|Overall Study|Sponsor terminated|0|||
146622359|NCT01384734|528789662|FG003|Overall Study|Sponsor terminated|0|||
146622360|NCT01384734|528789663|FG004|Overall Study|Sponsor terminated|1|||
146622361|NCT01384734|528789659|FG000|Overall Study|Withdrawal by Subject|5|||
146622362|NCT01384734|528789660|FG001|Overall Study|Withdrawal by Subject|5|||
146622363|NCT01384734|528789661|FG002|Overall Study|Withdrawal by Subject|6|||
146622364|NCT01384734|528789662|FG003|Overall Study|Withdrawal by Subject|7|||
146622365|NCT01384734|528789663|FG004|Overall Study|Withdrawal by Subject|9|||
146622366|NCT01384734|528789659|FG000|Overall Study|Investigator relocating|0|||
146622367|NCT01384734|528789660|FG001|Overall Study|Investigator relocating|2|||
146622368|NCT01384734|528789661|FG002|Overall Study|Investigator relocating|0|||
146622369|NCT01384734|528789662|FG003|Overall Study|Investigator relocating|3|||
146622370|NCT01384734|528789663|FG004|Overall Study|Investigator relocating|1|||
146622371|NCT01384734|528789659|FG000|Overall Study|Unable to come back for visit|1|||
146622372|NCT01384734|528789660|FG001|Overall Study|Unable to come back for visit|0|||
146622373|NCT01384734|528789661|FG002|Overall Study|Unable to come back for visit|1|||
146622374|NCT01384734|528789662|FG003|Overall Study|Unable to come back for visit|1|||
146622375|NCT01384734|528789663|FG004|Overall Study|Unable to come back for visit|0|||
146622376|NCT01384734|528789659|FG000|Overall Study|Prison|0|||
146622377|NCT01384734|528789660|FG001|Overall Study|Prison|0|||
146622378|NCT01384734|528789661|FG002|Overall Study|Prison|1|||
146622379|NCT01384734|528789662|FG003|Overall Study|Prison|0|||
146622380|NCT01384734|528789663|FG004|Overall Study|Prison|0|||
146622381|NCT01384734|528789659|FG000|Overall Study|As per Exclusion criteria|0|||
146622382|NCT01384734|528789660|FG001|Overall Study|As per Exclusion criteria|1|||
146622383|NCT01384734|528789661|FG002|Overall Study|As per Exclusion criteria|0|||
146622384|NCT01384734|528789662|FG003|Overall Study|As per Exclusion criteria|0|||
146622385|NCT01384734|528789663|FG004|Overall Study|As per Exclusion criteria|0|||
146622386|NCT01384734|528789659|FG000|Overall Study|Missed End of treatment visit|0|||
146941915|NCT00856986|529946017|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
146941916|NCT00856986|529946018|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
146941917|NCT00856986|529946019|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
146941918|NCT00856986|529946020|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
146941919|NCT00856986|529946016|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
146941920|NCT00856986|529946017|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
146941921|NCT00856986|529946018|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
146941922|NCT00856986|529946019|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
146941923|NCT00856986|529946020|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
146941924|NCT00856986|529946016|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
146941925|NCT00856986|529946017|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
146941926|NCT00856986|529946018|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
146622387|NCT01384734|528789660|FG001|Overall Study|Missed End of treatment visit|0|||
146622388|NCT01384734|528789661|FG002|Overall Study|Missed End of treatment visit|0|||
146622389|NCT01384734|528789662|FG003|Overall Study|Missed End of treatment visit|1|||
146622390|NCT01384734|528789663|FG004|Overall Study|Missed End of treatment visit|0|||
146622391|NCT01384734|528789659|FG000|Overall Study|Adhesion problem|0|||
146622392|NCT01384734|528789660|FG001|Overall Study|Adhesion problem|0|||
146622393|NCT01384734|528789661|FG002|Overall Study|Adhesion problem|0|||
146622394|NCT01384734|528789662|FG003|Overall Study|Adhesion problem|1|||
146622395|NCT01384734|528789663|FG004|Overall Study|Adhesion problem|0|||
146622396|NCT01384734|528789659|FG000|Overall Study|Early termination|0|||
146622397|NCT01384734|528789660|FG001|Overall Study|Early termination|0|||
146622398|NCT01384734|528789661|FG002|Overall Study|Early termination|0|||
146622399|NCT01384734|528789662|FG003|Overall Study|Early termination|0|||
146941927|NCT00856986|529946019|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
146941928|NCT00856986|529946020|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
146622400|NCT01384734|528789663|FG004|Overall Study|Early termination|1|||
146622401|NCT01384734|528789659|FG000|Overall Study|Physician Decision|1|||
146622402|NCT01384734|528789660|FG001|Overall Study|Physician Decision|0|||
146622403|NCT01384734|528789661|FG002|Overall Study|Physician Decision|0|||
146804274|NCT02036970|529454825|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
146804275|NCT02036970|529454826|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
146804276|NCT02036970|529454817|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
146804277|NCT02036970|529454818|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
146804278|NCT02036970|529454819|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
146804279|NCT02036970|529454820|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
146804280|NCT02036970|529454821|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
146804281|NCT02036970|529454822|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
146804282|NCT02036970|529454823|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
146804283|NCT02036970|529454824|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
146804284|NCT02036970|529454825|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
146804285|NCT02036970|529454826|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
146804286|NCT02036970|529454817|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146804287|NCT02036970|529454818|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146804288|NCT02036970|529454819|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146804289|NCT02036970|529454820|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
146804290|NCT02036970|529454821|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146804291|NCT02036970|529454822|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146804292|NCT02036970|529454823|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146804293|NCT02036970|529454824|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146804294|NCT02036970|529454825|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146804295|NCT02036970|529454826|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146804296|NCT02036970|529454817|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
146804297|NCT02036970|529454818|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
146804298|NCT02036970|529454819|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
146804299|NCT02036970|529454820|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
146804300|NCT02036970|529454821|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
146804301|NCT02036970|529454822|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
146804302|NCT02036970|529454823|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
146804303|NCT02036970|529454824|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
146804304|NCT02036970|529454825|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
146804305|NCT02036970|529454826|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
146804306|NCT02036970|529454817|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
146804307|NCT02036970|529454818|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
146804308|NCT02036970|529454819|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
146804309|NCT02036970|529454820|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
146804310|NCT02036970|529454821|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
146804311|NCT02036970|529454822|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
146804312|NCT02036970|529454823|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
146804313|NCT02036970|529454824|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
146804314|NCT02036970|529454825|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
146804315|NCT02036970|529454826|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
146804316|NCT02036970|529454817|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
146804317|NCT02036970|529454818|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
146804318|NCT02036970|529454819|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
146622404|NCT01384734|528789662|FG003|Overall Study|Physician Decision|0|||
146622405|NCT01384734|528789663|FG004|Overall Study|Physician Decision|0|||
146622406|NCT01290523|528789664|FG000|Overall Study|Death|3|||
146622407|NCT03071263|528789665|FG000|Overall Study|Adverse Event|1|||
146622408|NCT03071263|528789666|FG001|Overall Study|Adverse Event|3|||
146622409|NCT03071263|528789665|FG000|Overall Study|Withdrawal by Subject|1|||
146622410|NCT03071263|528789666|FG001|Overall Study|Withdrawal by Subject|3|||
146622411|NCT03071263|528789665|FG000|Overall Study|Physician Decision|1|||
146622412|NCT03071263|528789666|FG001|Overall Study|Physician Decision|0|||
146622413|NCT03071263|528789665|FG000|Overall Study|Participant moved to another city|0|||
146622414|NCT03071263|528789666|FG001|Overall Study|Participant moved to another city|1|||
146622415|NCT02922725|528789668|FG000|Overall Study|Withdrawal by Subject|1|||
146622416|NCT02922725|528789669|FG001|Overall Study|Withdrawal by Subject|0|||
146622417|NCT02922725|528789670|FG002|Overall Study|Withdrawal by Subject|0|||
146622418|NCT01300234|528789671|FG000|Overall Study|Adverse Event|1|||
146622419|NCT01300234|528789672|FG001|Overall Study|Adverse Event|1|||
146622420|NCT01300234|528789671|FG000|Overall Study|Protocol Violation|2|||
146622421|NCT01300234|528789672|FG001|Overall Study|Protocol Violation|3|||
146622422|NCT01300234|528789671|FG000|Overall Study|Withdrawal by Subject|5|||
146622423|NCT01300234|528789672|FG001|Overall Study|Withdrawal by Subject|9|||
146804319|NCT02036970|529454820|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
146804320|NCT02036970|529454821|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
146804321|NCT02036970|529454822|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
146804322|NCT02036970|529454823|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
146941929|NCT03032510|529946021|FG000|Overall Study|Adverse Event|5|||
146622424|NCT01300234|528789671|FG000|Overall Study|Lost to Follow-up|14|||
146622425|NCT01300234|528789672|FG001|Overall Study|Lost to Follow-up|12|||
146622426|NCT01300234|528789671|FG000|Overall Study|Pregnancy|2|||
146622427|NCT01300234|528789672|FG001|Overall Study|Pregnancy|1|||
146622428|NCT01300234|528789671|FG000|Overall Study|Participant reached stopping critera|2|||
146622429|NCT01300234|528789672|FG001|Overall Study|Participant reached stopping critera|0|||
146622430|NCT01300234|528789671|FG000|Overall Study|Participant stopped medication|1|||
146622431|NCT01300234|528789672|FG001|Overall Study|Participant stopped medication|1|||
146622432|NCT01300234|528789671|FG000|Overall Study|Participant refused return to hospital|1|||
146622433|NCT01300234|528789672|FG001|Overall Study|Participant refused return to hospital|0|||
146622434|NCT00360412|528789673|FG000|Overall Study|Adverse Event|37|||
146622435|NCT00360412|528789674|FG001|Overall Study|Adverse Event|65|||
146622436|NCT00360412|528789673|FG000|Overall Study|Protocol Violation|2|||
146622437|NCT00360412|528789674|FG001|Overall Study|Protocol Violation|5|||
146622438|NCT00360412|528789673|FG000|Overall Study|Patient withdrew consent|27|||
146622439|NCT00360412|528789674|FG001|Overall Study|Patient withdrew consent|52|||
146622440|NCT00360412|528789673|FG000|Overall Study|Lack of therapeutic efficacy|46|||
146622441|NCT00360412|528789674|FG001|Overall Study|Lack of therapeutic efficacy|61|||
146622442|NCT00360412|528789673|FG000|Overall Study|Physician Decision|2|||
146622443|NCT00360412|528789674|FG001|Overall Study|Physician Decision|4|||
146622444|NCT00360412|528789673|FG000|Overall Study|Other|5|||
146622445|NCT00360412|528789674|FG001|Overall Study|Other|6|||
146622446|NCT00360412|528789673|FG000|Overall Study|Study termination by Sponsor|214|||
146622447|NCT00360412|528789674|FG001|Overall Study|Study termination by Sponsor|469|||
146622448|NCT04612725|528789675|FG000|Overall Study|Adverse Event|1|||
146804323|NCT02036970|529454824|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
146804324|NCT02036970|529454825|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
146804325|NCT02036970|529454826|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
146804326|NCT02036970|529454817|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
146804327|NCT02036970|529454818|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
146804328|NCT02036970|529454819|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
146804329|NCT02036970|529454820|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
146804330|NCT02036970|529454821|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
146804331|NCT02036970|529454822|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
146804332|NCT02036970|529454823|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
146804333|NCT02036970|529454824|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
146804334|NCT02036970|529454825|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
146804335|NCT02036970|529454826|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
146804336|NCT01171898|529454831|FG000|Overall Study|Death|0|||
146804337|NCT01171898|529454832|FG001|Overall Study|Death|0|||
146804338|NCT01171898|529454833|FG002|Overall Study|Death|2|||
146804339|NCT01171898|529454834|FG003|Overall Study|Death|0|||
146804340|NCT01171898|529454831|FG000|Overall Study|Lost to Follow-up|0|||
146804341|NCT01171898|529454832|FG001|Overall Study|Lost to Follow-up|1|||
146804342|NCT01171898|529454833|FG002|Overall Study|Lost to Follow-up|1|||
146804343|NCT01171898|529454834|FG003|Overall Study|Lost to Follow-up|1|||
146804344|NCT01171898|529454831|FG000|Overall Study|Withdrawal by Subject|1|||
146804345|NCT01171898|529454832|FG001|Overall Study|Withdrawal by Subject|4|||
146804346|NCT01171898|529454833|FG002|Overall Study|Withdrawal by Subject|6|||
146804347|NCT01171898|529454834|FG003|Overall Study|Withdrawal by Subject|3|||
146804348|NCT01171898|529454831|FG000|Overall Study|Terminated by Sponsor|1|||
146804349|NCT01171898|529454832|FG001|Overall Study|Terminated by Sponsor|0|||
146804350|NCT01171898|529454833|FG002|Overall Study|Terminated by Sponsor|0|||
146804351|NCT01171898|529454834|FG003|Overall Study|Terminated by Sponsor|0|||
146804352|NCT01171898|529454831|FG000|Overall Study|Ongoing|1|||
146804353|NCT01171898|529454832|FG001|Overall Study|Ongoing|9|||
146804354|NCT01171898|529454833|FG002|Overall Study|Ongoing|3|||
146804355|NCT01171898|529454834|FG003|Overall Study|Ongoing|0|||
146804356|NCT01171898|529454831|FG000|Overall Study|Other|1|||
146804357|NCT01171898|529454832|FG001|Overall Study|Other|5|||
146804358|NCT01171898|529454833|FG002|Overall Study|Other|0|||
146804359|NCT01171898|529454834|FG003|Overall Study|Other|2|||
146804360|NCT05802173|529454835|FG000|Overall Study|Withdrawal by Subject|2|||
146804361|NCT05802173|529454836|FG001|Overall Study|Withdrawal by Subject|0|||
146804362|NCT05802173|529454837|FG002|Overall Study|Withdrawal by Subject|0|||
146804363|NCT05802173|529454835|FG000|Overall Study|Protocol Violation|1|||
146804364|NCT05802173|529454836|FG001|Overall Study|Protocol Violation|0|||
146804365|NCT05802173|529454837|FG002|Overall Study|Protocol Violation|0|||
146804366|NCT05802173|529454835|FG000|Overall Study|Lost to Follow-up|0|||
146804367|NCT05802173|529454836|FG001|Overall Study|Lost to Follow-up|6|||
146622449|NCT04612725|528789676|FG001|Overall Study|Adverse Event|3|||
146804368|NCT05802173|529454837|FG002|Overall Study|Lost to Follow-up|4|||
146804369|NCT05802173|529454835|FG000|Overall Study|non-compliance|0|||
146804370|NCT05802173|529454836|FG001|Overall Study|non-compliance|1|||
146804371|NCT05802173|529454837|FG002|Overall Study|non-compliance|0|||
146804372|NCT02932410|529454838|FG000|Overall Study|Death|7|||
146804373|NCT02932410|529454839|FG001|Overall Study|Death|6|||
146804374|NCT02932410|529454840|FG002|Overall Study|Death|0|||
146804375|NCT02932410|529454841|FG003|Overall Study|Death|0|||
146804376|NCT02932410|529454838|FG000|Overall Study|Lost to Follow-up|1|||
146804377|NCT02932410|529454839|FG001|Overall Study|Lost to Follow-up|2|||
146804378|NCT02932410|529454840|FG002|Overall Study|Lost to Follow-up|0|||
146804379|NCT02932410|529454841|FG003|Overall Study|Lost to Follow-up|0|||
146804380|NCT02932410|529454838|FG000|Overall Study|Parent/Subjects decision|6|||
146804381|NCT02932410|529454839|FG001|Overall Study|Parent/Subjects decision|6|||
146804382|NCT02932410|529454840|FG002|Overall Study|Parent/Subjects decision|1|||
146804383|NCT02932410|529454841|FG003|Overall Study|Parent/Subjects decision|0|||
146804384|NCT02932410|529454838|FG000|Overall Study|Physician Decision|0|||
146804385|NCT02932410|529454839|FG001|Overall Study|Physician Decision|1|||
146804386|NCT02932410|529454840|FG002|Overall Study|Physician Decision|0|||
146804387|NCT02932410|529454841|FG003|Overall Study|Physician Decision|0|||
146804388|NCT00360269|529454842|FG000|Overall Study|Lost to Follow-up|7|||
146804389|NCT00360269|529454843|FG001|Overall Study|Lost to Follow-up|9|||
146804390|NCT00360269|529454842|FG000|Overall Study|Physician Decision|1|||
146804391|NCT00360269|529454843|FG001|Overall Study|Physician Decision|2|||
146804392|NCT00360269|529454842|FG000|Overall Study|Adverse Event|1|||
146804393|NCT00360269|529454843|FG001|Overall Study|Adverse Event|0|||
146804394|NCT00360269|529454842|FG000|Overall Study|Withdrawal by Subject|1|||
146804395|NCT00360269|529454843|FG001|Overall Study|Withdrawal by Subject|1|||
146804396|NCT00048932|529454846|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
146804397|NCT00048932|529454847|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
146804398|NCT00048932|529454848|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
146804399|NCT00048932|529454846|FG000|Double Blind Period (DB)|Adverse Event|51|||
146804400|NCT00048932|529454847|FG001|Double Blind Period (DB)|Adverse Event|19|||
146804401|NCT00048932|529454848|FG002|Double Blind Period (DB)|Adverse Event|0|||
146804402|NCT00048932|529454846|FG000|Double Blind Period (DB)|Death|5|||
146804403|NCT00048932|529454847|FG001|Double Blind Period (DB)|Death|3|||
146804404|NCT00048932|529454848|FG002|Double Blind Period (DB)|Death|0|||
146804405|NCT00048932|529454846|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
146804406|NCT00048932|529454847|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
146804407|NCT00048932|529454848|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
146804408|NCT00048932|529454846|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
146804409|NCT00048932|529454847|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
146804410|NCT00048932|529454848|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
146804411|NCT00048932|529454846|FG000|Double Blind Period (DB)|Relocation|1|||
146804412|NCT00048932|529454847|FG001|Double Blind Period (DB)|Relocation|0|||
146804413|NCT00048932|529454848|FG002|Double Blind Period (DB)|Relocation|0|||
146804414|NCT00048932|529454846|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
146804415|NCT00048932|529454847|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
146804416|NCT00048932|529454848|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
146804417|NCT00048932|529454846|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
146804418|NCT00048932|529454847|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
146804419|NCT00048932|529454848|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
146804420|NCT00048932|529454846|FG000|Double Blind Period (DB)|Pregnancy|1|||
146804421|NCT00048932|529454847|FG001|Double Blind Period (DB)|Pregnancy|0|||
146804422|NCT00048932|529454848|FG002|Double Blind Period (DB)|Pregnancy|0|||
146804423|NCT00048932|529454846|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
146804424|NCT00048932|529454847|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
146804425|NCT00048932|529454848|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
146804426|NCT00048932|529454846|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
146804427|NCT00048932|529454847|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
146804428|NCT00048932|529454848|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
146804429|NCT00048932|529454846|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
146804430|NCT00048932|529454847|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
146804431|NCT00048932|529454848|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
146941930|NCT03032510|529946022|FG001|Overall Study|Adverse Event|2|||
146941931|NCT03032510|529946021|FG000|Overall Study|Lost to Follow-up|8|||
146941932|NCT03032510|529946022|FG001|Overall Study|Lost to Follow-up|7|||
146941933|NCT03032510|529946021|FG000|Overall Study|Withdrawal by Subject|8|||
146941934|NCT03032510|529946022|FG001|Overall Study|Withdrawal by Subject|7|||
146941935|NCT03032510|529946021|FG000|Overall Study|Subject noncompliance|4|||
146804432|NCT00048932|529454846|FG000|Open Label Period (OL)|Death|0|||
146804433|NCT00048932|529454847|FG001|Open Label Period (OL)|Death|0|||
146804434|NCT00048932|529454848|FG002|Open Label Period (OL)|Death|25|||
146804435|NCT00048932|529454846|FG000|Open Label Period (OL)|Adverse Event|0|||
146804436|NCT00048932|529454847|FG001|Open Label Period (OL)|Adverse Event|0|||
146804437|NCT00048932|529454848|FG002|Open Label Period (OL)|Adverse Event|103|||
146804438|NCT00048932|529454846|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
146804439|NCT00048932|529454847|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
146804440|NCT00048932|529454848|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
146804441|NCT00048932|529454846|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
146941936|NCT03032510|529946022|FG001|Overall Study|Subject noncompliance|2|||
146941937|NCT03032510|529946021|FG000|Overall Study|Physician Decision|2|||
146941938|NCT03032510|529946022|FG001|Overall Study|Physician Decision|0|||
146941939|NCT04018612|529946023|FG000|Overall Study|Withdrawal by Subject|1|||
146941940|NCT04018612|529946024|FG001|Overall Study|Withdrawal by Subject|0|||
146941941|NCT04018612|529946025|FG002|Overall Study|Withdrawal by Subject|1|||
146941942|NCT02671760|529946026|FG000|Overall Study|Lost to Follow-up|0|||
146941943|NCT02671760|529946027|FG001|Overall Study|Lost to Follow-up|1|||
146941944|NCT02671760|529946028|FG002|Overall Study|Lost to Follow-up|0|||
146941945|NCT02999191|529946029|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
146941946|NCT02999191|529946030|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
146941947|NCT02999191|529946031|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
146941948|NCT02566109|529946039|FG000|Overall Study|Withdrawal by Subject|1|||
146941949|NCT01993667|529946043|FG000|Overall Study|Insufficient data to analyze|16|||
146941950|NCT01993667|529946044|FG001|Overall Study|Insufficient data to analyze|16|||
146941951|NCT01993667|529946043|FG000|Overall Study|Insufficient altitude reached|3|||
146941952|NCT01993667|529946044|FG001|Overall Study|Insufficient altitude reached|1|||
146941953|NCT01993667|529946043|FG000|Overall Study|Lost to Follow-up|2|||
146941954|NCT01993667|529946044|FG001|Overall Study|Lost to Follow-up|2|||
146941955|NCT03619837|529946045|FG000|Screening|received organs from HCV-negative donors|47|||
146941956|NCT03619837|529946045|FG000|Screening|died on the wait-list|2|||
146941957|NCT03619837|529946045|FG000|Screening|remained on the wait list|40|||
146941958|NCT03619837|529946045|FG000|Screening|didn't meet eligibility criteria|3|||
146941959|NCT03619837|529946045|FG000|Screening|withdrew consent|2|||
146941960|NCT03619837|529946045|FG000|Screening|never listed for HCV-viremic donor|1|||
146941961|NCT03619837|529946045|FG000|Screening|developed exclusion criteria|2|||
146983961|NCT02330081|530102001|FG000|Overall Study|Protocol Violation|6|||
146983962|NCT02668302|530102007|FG000|Overall Study|Withdrawal by Subject|1|||
146804442|NCT00048932|529454847|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
146804443|NCT00048932|529454848|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
146804444|NCT00048932|529454846|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
146804445|NCT00048932|529454847|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
146804446|NCT00048932|529454848|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
146804447|NCT00048932|529454846|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
146804448|NCT00048932|529454847|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
146804449|NCT00048932|529454848|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
146804450|NCT00048932|529454846|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
146804451|NCT00048932|529454847|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
146804452|NCT00048932|529454848|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
146804453|NCT00048932|529454846|FG000|Open Label Period (OL)|Pregnancy|0|||
146804454|NCT00048932|529454847|FG001|Open Label Period (OL)|Pregnancy|0|||
146804455|NCT00048932|529454848|FG002|Open Label Period (OL)|Pregnancy|6|||
146804456|NCT00048932|529454846|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
146804457|NCT00048932|529454847|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
146804458|NCT00048932|529454848|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
146804459|NCT00048932|529454846|FG000|Open Label Period (OL)|Investigator Retiring|0|||
146804460|NCT00048932|529454847|FG001|Open Label Period (OL)|Investigator Retiring|0|||
146804461|NCT00048932|529454848|FG002|Open Label Period (OL)|Investigator Retiring|2|||
146804462|NCT00048932|529454846|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
146804463|NCT00048932|529454847|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
146804464|NCT00048932|529454848|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
146804465|NCT00048932|529454846|FG000|Open Label Period (OL)|Participant Relocated|0|||
146804466|NCT00048932|529454847|FG001|Open Label Period (OL)|Participant Relocated|0|||
146804467|NCT00048932|529454848|FG002|Open Label Period (OL)|Participant Relocated|6|||
146804468|NCT00048932|529454846|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
146804469|NCT00048932|529454847|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
146804470|NCT00048932|529454848|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
146804471|NCT00048932|529454846|FG000|Open Label Period (OL)|Site Closure|0|||
146804472|NCT00048932|529454847|FG001|Open Label Period (OL)|Site Closure|0|||
146804473|NCT00048932|529454848|FG002|Open Label Period (OL)|Site Closure|3|||
146804474|NCT00048932|529454846|FG000|Open Label Period (OL)|Trial Terminated|0|||
146804475|NCT00048932|529454847|FG001|Open Label Period (OL)|Trial Terminated|0|||
146804476|NCT00048932|529454848|FG002|Open Label Period (OL)|Trial Terminated|1|||
146941962|NCT03619837|529946045|FG000|Screening|excluded by the investigator due to non-compliance|1|||
146983963|NCT02668302|530102008|FG001|Overall Study|Withdrawal by Subject|0|||
146804477|NCT00048932|529454846|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
146804478|NCT00048932|529454847|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
146804479|NCT00048932|529454848|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
146804480|NCT00048932|529454846|FG000|Open Label Period (OL)|Patient Decision|0|||
146941963|NCT00981682|529946049|FG000|Overall Study|Adverse Event|48|||
146804481|NCT00048932|529454847|FG001|Open Label Period (OL)|Patient Decision|0|||
146941964|NCT00981682|529946049|FG000|Overall Study|Withdrawal by Subject|52|||
146941965|NCT00981682|529946049|FG000|Overall Study|Lost to Follow-up|14|||
146804482|NCT00048932|529454848|FG002|Open Label Period (OL)|Patient Decision|4|||
146804483|NCT00048932|529454846|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
146804484|NCT00048932|529454847|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
146804485|NCT00048932|529454848|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
146804486|NCT00048932|529454846|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
146804487|NCT00048932|529454847|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
146804488|NCT00048932|529454848|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
146804489|NCT00048932|529454846|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
146804490|NCT00048932|529454847|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
146804491|NCT00048932|529454848|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
146804492|NCT00048932|529454846|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
146804493|NCT00048932|529454847|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
146804494|NCT00048932|529454848|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
146804495|NCT00048932|529454846|FG000|Open Label Period (OL)|Investigator Decision|0|||
146804496|NCT00048932|529454847|FG001|Open Label Period (OL)|Investigator Decision|0|||
146804497|NCT00048932|529454848|FG002|Open Label Period (OL)|Investigator Decision|4|||
146804498|NCT00048932|529454846|FG000|Open Label Period (OL)|Site Staff Issues|0|||
146804499|NCT00048932|529454847|FG001|Open Label Period (OL)|Site Staff Issues|0|||
146804500|NCT00048932|529454848|FG002|Open Label Period (OL)|Site Staff Issues|2|||
146804501|NCT00048932|529454846|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
146804502|NCT00048932|529454847|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
146804503|NCT00048932|529454848|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
146804504|NCT00048932|529454846|FG000|Open Label Period (OL)|Participant Surgery|0|||
146804505|NCT00048932|529454847|FG001|Open Label Period (OL)|Participant Surgery|0|||
146804506|NCT00048932|529454848|FG002|Open Label Period (OL)|Participant Surgery|1|||
146804507|NCT02232737|529454849|FG000|Overall Study|Lost to Follow-up|18|||
146804508|NCT02232737|529454850|FG001|Overall Study|Lost to Follow-up|28|||
146804509|NCT02232737|529454851|FG002|Overall Study|Lost to Follow-up|33|||
146804510|NCT02232737|529454849|FG000|Overall Study|Personal reasons|7|||
146804511|NCT02232737|529454850|FG001|Overall Study|Personal reasons|8|||
146804512|NCT02232737|529454851|FG002|Overall Study|Personal reasons|14|||
146804513|NCT02232737|529454849|FG000|Overall Study|Adverse Event|6|||
146804514|NCT02232737|529454850|FG001|Overall Study|Adverse Event|3|||
146804515|NCT02232737|529454851|FG002|Overall Study|Adverse Event|8|||
146804516|NCT02232737|529454849|FG000|Overall Study|Incarcerated|2|||
146804517|NCT02232737|529454850|FG001|Overall Study|Incarcerated|1|||
146804518|NCT02232737|529454851|FG002|Overall Study|Incarcerated|2|||
146804519|NCT02232737|529454849|FG000|Overall Study|Withdrawal by Subject|0|||
146804520|NCT02232737|529454850|FG001|Overall Study|Withdrawal by Subject|1|||
146804521|NCT02232737|529454851|FG002|Overall Study|Withdrawal by Subject|2|||
146804522|NCT02232737|529454849|FG000|Overall Study|Death|0|||
146804523|NCT02232737|529454850|FG001|Overall Study|Death|1|||
146804524|NCT02232737|529454851|FG002|Overall Study|Death|1|||
146804525|NCT02232737|529454849|FG000|Overall Study|Physician Decision|1|||
146804526|NCT02232737|529454850|FG001|Overall Study|Physician Decision|3|||
146804527|NCT02232737|529454851|FG002|Overall Study|Physician Decision|1|||
146804528|NCT02232737|529454849|FG000|Overall Study|Protocol Violation|1|||
146804529|NCT02232737|529454850|FG001|Overall Study|Protocol Violation|0|||
146804530|NCT02232737|529454851|FG002|Overall Study|Protocol Violation|1|||
146804531|NCT02232737|529454849|FG000|Overall Study|Reason unknown|1|||
146804532|NCT02232737|529454850|FG001|Overall Study|Reason unknown|0|||
146804533|NCT02232737|529454851|FG002|Overall Study|Reason unknown|0|||
146804534|NCT02200705|529454854|FG000|Overall Study|Excluded|12|||
146804535|NCT02200705|529454854|FG000|Overall Study|Death|21|||
146804536|NCT02200705|529454854|FG000|Overall Study|Withdrawal by Subject|22|||
146804537|NCT02200705|529454854|FG000|Overall Study|Lost to Follow-up|13|||
146804538|NCT02200705|529454854|FG000|Overall Study|Physician Decision|5|||
146804539|NCT02200705|529454854|FG000|Overall Study|Adverse Event|2|||
146804540|NCT03738228|529454856|FG000|Overall Study|Never received study treatment|2|||
146804541|NCT03738228|529454857|FG001|Overall Study|Never received study treatment|2|||
146804542|NCT02866942|529454858|FG000|Overall Study|Invalid consent|1|||
146804543|NCT06212752|529454859|FG000|Overall Study|Death|5|||
146983964|NCT03558997|530102009|FG000|Overall Study|Adverse Event|0|||
146804544|NCT06212752|529454860|FG001|Overall Study|Death|3|||
146804545|NCT06212752|529454859|FG000|Overall Study|Participants ongoing|23|||
146804546|NCT06212752|529454860|FG001|Overall Study|Participants ongoing|8|||
146804547|NCT04162210|529454861|FG000|Overall Study|Lost to Follow-up|4|||
146804548|NCT04162210|529454862|FG001|Overall Study|Lost to Follow-up|1|||
146804549|NCT04162210|529454861|FG000|Overall Study|Withdrawal by Subject|17|||
146804550|NCT04162210|529454862|FG001|Overall Study|Withdrawal by Subject|9|||
146804551|NCT04162210|529454861|FG000|Overall Study|Ongoing|113|||
146804552|NCT04162210|529454862|FG001|Overall Study|Ongoing|59|||
146804553|NCT01641900|529454863|FG000|Overall Study|Withdrawal by Subject|2|||
146804554|NCT01641900|529454864|FG001|Overall Study|Withdrawal by Subject|2|||
146804555|NCT02568215|529454865|FG000|Overall Study|Death|1|||
146804556|NCT02568215|529454866|FG001|Overall Study|Death|2|||
146804557|NCT02568215|529454867|FG002|Overall Study|Death|0|||
146804558|NCT02568215|529454865|FG000|Overall Study|Physician Decision|2|||
146804559|NCT02568215|529454866|FG001|Overall Study|Physician Decision|2|||
146804560|NCT02568215|529454867|FG002|Overall Study|Physician Decision|2|||
146804561|NCT02568215|529454865|FG000|Overall Study|Lost to Follow-up|29|||
146804562|NCT02568215|529454866|FG001|Overall Study|Lost to Follow-up|32|||
146804563|NCT02568215|529454867|FG002|Overall Study|Lost to Follow-up|41|||
146804564|NCT02568215|529454865|FG000|Overall Study|Withdrawal by Subject|21|||
146804565|NCT02568215|529454866|FG001|Overall Study|Withdrawal by Subject|19|||
146804566|NCT02568215|529454867|FG002|Overall Study|Withdrawal by Subject|22|||
146804567|NCT02568215|529454865|FG000|Overall Study|Protocol Violation|1|||
146804568|NCT02568215|529454866|FG001|Overall Study|Protocol Violation|1|||
146804569|NCT02568215|529454867|FG002|Overall Study|Protocol Violation|0|||
146804570|NCT02568215|529454865|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
146804571|NCT02568215|529454866|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
146804572|NCT02568215|529454867|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
146804573|NCT02568215|529454865|FG000|Overall Study|Other|0|||
146804574|NCT02568215|529454866|FG001|Overall Study|Other|1|||
146804575|NCT02568215|529454867|FG002|Overall Study|Other|4|||
146804576|NCT00371345|529454868|FG000|Overall Study|Disease Progression|21|||
146804577|NCT00371345|529454869|FG001|Overall Study|Disease Progression|35|||
146804578|NCT00371345|529454868|FG000|Overall Study|Study Drug Toxicity|1|||
146804579|NCT00371345|529454869|FG001|Overall Study|Study Drug Toxicity|7|||
146941966|NCT00981682|529946049|FG000|Overall Study|Lack of Efficacy|13|||
146941967|NCT00981682|529946049|FG000|Overall Study|Protocol Violation|6|||
146804580|NCT00371345|529454868|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
146804581|NCT00371345|529454869|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
146804582|NCT00371345|529454868|FG000|Overall Study|Participant Request|1|||
146804583|NCT00371345|529454869|FG001|Overall Study|Participant Request|1|||
146804584|NCT00371345|529454868|FG000|Overall Study|Participant Withdrew Consent|0|||
146804585|NCT00371345|529454869|FG001|Overall Study|Participant Withdrew Consent|1|||
146804586|NCT02463448|529454873|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
146804587|NCT02463448|529454873|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
146804588|NCT02463448|529454873|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
146804589|NCT02463448|529454873|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
146804590|NCT01640951|529454874|FG000|Overall Study|Adverse Event|8|||
146804591|NCT01640951|529454875|FG001|Overall Study|Adverse Event|3|||
146804592|NCT01640951|529454876|FG002|Overall Study|Adverse Event|10|||
146804593|NCT01640951|529454877|FG003|Overall Study|Adverse Event|6|||
146804594|NCT01640951|529454878|FG004|Overall Study|Adverse Event|1|||
146804595|NCT01640951|529454879|FG005|Overall Study|Adverse Event|11|||
146804596|NCT01640951|529454880|FG006|Overall Study|Adverse Event|1|||
146804597|NCT01640951|529454881|FG007|Overall Study|Adverse Event|3|||
146804598|NCT01640951|529454874|FG000|Overall Study|Lack of Efficacy|20|||
146804599|NCT01640951|529454875|FG001|Overall Study|Lack of Efficacy|1|||
146804600|NCT01640951|529454876|FG002|Overall Study|Lack of Efficacy|7|||
146804601|NCT01640951|529454877|FG003|Overall Study|Lack of Efficacy|14|||
146804602|NCT01640951|529454878|FG004|Overall Study|Lack of Efficacy|0|||
146804603|NCT01640951|529454879|FG005|Overall Study|Lack of Efficacy|6|||
146804604|NCT01640951|529454880|FG006|Overall Study|Lack of Efficacy|5|||
146941968|NCT00981682|529946049|FG000|Overall Study|administrative|9|||
146941969|NCT01518309|529948004|FG000|Overall Study|Adverse Event|6|||
146804605|NCT01640951|529454881|FG007|Overall Study|Lack of Efficacy|6|||
146941970|NCT01518309|529948004|FG000|Overall Study|Death|6|||
146941971|NCT01518309|529948004|FG000|Overall Study|Lack of Efficacy|7|||
146941972|NCT01518309|529948004|FG000|Overall Study|Withdrawal by Subject|6|||
146941973|NCT01518309|529948004|FG000|Overall Study|Physician Decision|3|||
146941974|NCT01518309|529948004|FG000|Overall Study|Sponsor Decision|2|||
146941975|NCT01518309|529948004|FG000|Overall Study|Not in Predefined Categories|9|||
146941976|NCT00863317|529948005|FG000|Overall Study|Lost to Follow-up|8|||
146941977|NCT00863317|529948006|FG001|Overall Study|Lost to Follow-up|9|||
146941978|NCT00216086|529948009|FG000|Overall Study|Protocol Violation|1|||
146804606|NCT01640951|529454874|FG000|Overall Study|Lost to Follow-up|1|||
146804607|NCT01640951|529454875|FG001|Overall Study|Lost to Follow-up|0|||
146804608|NCT01640951|529454876|FG002|Overall Study|Lost to Follow-up|6|||
146804609|NCT01640951|529454877|FG003|Overall Study|Lost to Follow-up|2|||
146941979|NCT00216086|529948009|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
146941980|NCT00216086|529948009|FG000|Overall Study|Social Reasons|2|||
146804610|NCT01640951|529454878|FG004|Overall Study|Lost to Follow-up|2|||
146804611|NCT01640951|529454879|FG005|Overall Study|Lost to Follow-up|3|||
146804612|NCT01640951|529454880|FG006|Overall Study|Lost to Follow-up|1|||
146804613|NCT01640951|529454881|FG007|Overall Study|Lost to Follow-up|1|||
146804614|NCT01640951|529454874|FG000|Overall Study|Non-compliance with study treatment|0|||
146804615|NCT01640951|529454875|FG001|Overall Study|Non-compliance with study treatment|0|||
146804616|NCT01640951|529454876|FG002|Overall Study|Non-compliance with study treatment|1|||
146941981|NCT00809614|529948010|FG000|Overall Study|Lack of Efficacy|2|||
146941982|NCT00809614|529948011|FG001|Overall Study|Lack of Efficacy|3|||
146804617|NCT01640951|529454877|FG003|Overall Study|Non-compliance with study treatment|1|||
146804618|NCT01640951|529454878|FG004|Overall Study|Non-compliance with study treatment|1|||
146804619|NCT01640951|529454879|FG005|Overall Study|Non-compliance with study treatment|4|||
146804620|NCT01640951|529454880|FG006|Overall Study|Non-compliance with study treatment|1|||
146804621|NCT01640951|529454881|FG007|Overall Study|Non-compliance with study treatment|0|||
146804622|NCT01640951|529454874|FG000|Overall Study|Physician Decision|2|||
146804623|NCT01640951|529454875|FG001|Overall Study|Physician Decision|5|||
146804624|NCT01640951|529454876|FG002|Overall Study|Physician Decision|2|||
146804625|NCT01640951|529454877|FG003|Overall Study|Physician Decision|2|||
146804626|NCT01640951|529454878|FG004|Overall Study|Physician Decision|2|||
146804627|NCT01640951|529454879|FG005|Overall Study|Physician Decision|3|||
146804628|NCT01640951|529454880|FG006|Overall Study|Physician Decision|3|||
146804629|NCT01640951|529454881|FG007|Overall Study|Physician Decision|0|||
146804630|NCT01640951|529454874|FG000|Overall Study|Pregnancy|3|||
146804631|NCT01640951|529454875|FG001|Overall Study|Pregnancy|0|||
146804632|NCT01640951|529454876|FG002|Overall Study|Pregnancy|0|||
146804633|NCT01640951|529454877|FG003|Overall Study|Pregnancy|4|||
146804634|NCT01640951|529454878|FG004|Overall Study|Pregnancy|0|||
146804635|NCT01640951|529454879|FG005|Overall Study|Pregnancy|0|||
146804636|NCT01640951|529454880|FG006|Overall Study|Pregnancy|2|||
146804637|NCT01640951|529454881|FG007|Overall Study|Pregnancy|0|||
146804638|NCT01640951|529454874|FG000|Overall Study|Protocol Deviation|0|||
146804639|NCT01640951|529454875|FG001|Overall Study|Protocol Deviation|1|||
146804640|NCT01640951|529454876|FG002|Overall Study|Protocol Deviation|2|||
146804641|NCT01640951|529454877|FG003|Overall Study|Protocol Deviation|1|||
146804642|NCT01640951|529454878|FG004|Overall Study|Protocol Deviation|0|||
146804643|NCT01640951|529454879|FG005|Overall Study|Protocol Deviation|1|||
146804644|NCT01640951|529454880|FG006|Overall Study|Protocol Deviation|0|||
146804645|NCT01640951|529454881|FG007|Overall Study|Protocol Deviation|0|||
146804646|NCT01640951|529454874|FG000|Overall Study|Subject/Guardian decision|12|||
146804647|NCT01640951|529454875|FG001|Overall Study|Subject/Guardian decision|4|||
146804648|NCT01640951|529454876|FG002|Overall Study|Subject/Guardian decision|13|||
146804649|NCT01640951|529454877|FG003|Overall Study|Subject/Guardian decision|15|||
146804650|NCT01640951|529454878|FG004|Overall Study|Subject/Guardian decision|7|||
146804651|NCT01640951|529454879|FG005|Overall Study|Subject/Guardian decision|19|||
146804652|NCT01640951|529454880|FG006|Overall Study|Subject/Guardian decision|5|||
146804653|NCT01640951|529454881|FG007|Overall Study|Subject/Guardian decision|4|||
146804654|NCT01640951|529454874|FG000|Overall Study|Death|0|||
146804655|NCT01640951|529454875|FG001|Overall Study|Death|1|||
146804656|NCT01640951|529454876|FG002|Overall Study|Death|1|||
146804657|NCT01640951|529454877|FG003|Overall Study|Death|0|||
146804658|NCT01640951|529454878|FG004|Overall Study|Death|0|||
146804659|NCT01640951|529454879|FG005|Overall Study|Death|0|||
146804660|NCT01640951|529454880|FG006|Overall Study|Death|0|||
146804661|NCT01640951|529454881|FG007|Overall Study|Death|2|||
146804662|NCT04949542|529454882|FG000|Overall Study|Lost to Follow-up|4|||
146804663|NCT04949542|529454883|FG001|Overall Study|Lost to Follow-up|1|||
146804664|NCT01536093|529454884|FG000|Overall Study|Death|1|||
146804665|NCT01536093|529454885|FG001|Overall Study|Death|2|||
146804666|NCT01536093|529454884|FG000|Overall Study|absence of maternal colostrum|2|||
146804667|NCT01536093|529454885|FG001|Overall Study|absence of maternal colostrum|0|||
146804668|NCT01536093|529454884|FG000|Overall Study|Withdrawal by Subject|0|||
146804669|NCT01536093|529454885|FG001|Overall Study|Withdrawal by Subject|1|||
146804670|NCT02365597|529454886|FG000|Overall Study|Lost to Follow-up|0|||
146804671|NCT02365597|529454887|FG001|Overall Study|Lost to Follow-up|1|||
146804672|NCT02365597|529454888|FG002|Overall Study|Lost to Follow-up|0|||
146804673|NCT02365597|529454889|FG003|Overall Study|Lost to Follow-up|1|||
146804674|NCT02365597|529454886|FG000|Overall Study|Withdrawal by Subject|1|||
146804675|NCT02365597|529454887|FG001|Overall Study|Withdrawal by Subject|8|||
146804676|NCT02365597|529454888|FG002|Overall Study|Withdrawal by Subject|5|||
146804677|NCT02365597|529454889|FG003|Overall Study|Withdrawal by Subject|1|||
146804678|NCT02365597|529454886|FG000|Overall Study|Sponsor's decision|1|||
146804679|NCT02365597|529454887|FG001|Overall Study|Sponsor's decision|3|||
146804680|NCT02365597|529454888|FG002|Overall Study|Sponsor's decision|13|||
146804681|NCT02365597|529454889|FG003|Overall Study|Sponsor's decision|0|||
146804682|NCT02365597|529454886|FG000|Overall Study|Other|0|||
146804683|NCT02365597|529454887|FG001|Overall Study|Other|4|||
146804684|NCT02365597|529454888|FG002|Overall Study|Other|0|||
146804685|NCT02365597|529454889|FG003|Overall Study|Other|0|||
146804686|NCT02365597|529454886|FG000|Overall Study|Enrolled but not treated|0|||
146804687|NCT02365597|529454887|FG001|Overall Study|Enrolled but not treated|1|||
146804688|NCT02365597|529454888|FG002|Overall Study|Enrolled but not treated|1|||
146804689|NCT02365597|529454889|FG003|Overall Study|Enrolled but not treated|0|||
146804690|NCT02365597|529454886|FG000|Overall Study|Ongoing|0|||
146804691|NCT02365597|529454887|FG001|Overall Study|Ongoing|0|||
146804692|NCT02365597|529454888|FG002|Overall Study|Ongoing|0|||
146804693|NCT02365597|529454889|FG003|Overall Study|Ongoing|17|||
146804694|NCT02275611|529454890|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
146804695|NCT02275611|529454891|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
146804696|NCT02275611|529454892|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
146804697|NCT02275611|529454893|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
146804698|NCT00390884|529454901|FG000|Overall Study|Withdrawal by Subject|2|||
146804699|NCT00390884|529454902|FG001|Overall Study|Withdrawal by Subject|2|||
146804700|NCT04622332|529454903|FG000|Overall Study|Withdrawal by Subject|4|||
146804701|NCT04622332|529454904|FG001|Overall Study|Withdrawal by Subject|2|||
146804702|NCT04622332|529454903|FG000|Overall Study|Physician Decision|1|||
146804703|NCT04622332|529454904|FG001|Overall Study|Physician Decision|1|||
146804704|NCT04622332|529454903|FG000|Overall Study|Adverse Event|0|||
146804705|NCT04622332|529454904|FG001|Overall Study|Adverse Event|2|||
146804706|NCT04622332|529454903|FG000|Overall Study|Protocol Violation|0|||
146804707|NCT04622332|529454904|FG001|Overall Study|Protocol Violation|1|||
146804708|NCT05966155|529454905|FG000|Overall Study|Death|1|||
146804709|NCT05966155|529454906|FG001|Overall Study|Death|2|||
146804710|NCT05966155|529454905|FG000|Overall Study|Lost to Follow-up|63|||
146804711|NCT05966155|529454906|FG001|Overall Study|Lost to Follow-up|67|||
146804712|NCT05966155|529454905|FG000|Overall Study|Protocol Violation|1|||
146804713|NCT05966155|529454906|FG001|Overall Study|Protocol Violation|0|||
146804714|NCT05966155|529454905|FG000|Overall Study|Withdrawal by Subject|8|||
146804715|NCT05966155|529454906|FG001|Overall Study|Withdrawal by Subject|9|||
146804716|NCT05966155|529454905|FG000|Overall Study|Enrolled Erroneously|0|||
146804717|NCT05966155|529454906|FG001|Overall Study|Enrolled Erroneously|1|||
146804718|NCT05966155|529454905|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
146804719|NCT05966155|529454906|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
146804720|NCT05036278|529454909|FG000|Overall Study|Withdrawal by Subject|1|||
146804721|NCT05036278|529454909|FG000|Overall Study|Adverse Event|1|||
146804722|NCT01946204|529454914|FG000|Overall Study|Death|38|||
146804723|NCT01946204|529454915|FG001|Overall Study|Death|59|||
146804724|NCT01946204|529454914|FG000|Overall Study|Withdrawal by Subject|37|||
146804725|NCT01946204|529454915|FG001|Overall Study|Withdrawal by Subject|50|||
146804726|NCT01946204|529454914|FG000|Overall Study|Lost to Follow-up|3|||
146804727|NCT01946204|529454915|FG001|Overall Study|Lost to Follow-up|7|||
146804728|NCT01946204|529454914|FG000|Overall Study|Ongoing|316|||
146804729|NCT01946204|529454915|FG001|Overall Study|Ongoing|687|||
146804730|NCT01946204|529454914|FG000|Overall Study|Other|7|||
146804731|NCT01946204|529454915|FG001|Overall Study|Other|3|||
146804732|NCT03466411|529454916|FG000|Overall Study|Lost to Follow-up|0|||
146804733|NCT03466411|529454917|FG001|Overall Study|Lost to Follow-up|1|||
146804734|NCT03466411|529454918|FG002|Overall Study|Lost to Follow-up|1|||
146804735|NCT03466411|529454919|FG003|Overall Study|Lost to Follow-up|0|||
146804736|NCT03466411|529454920|FG004|Overall Study|Lost to Follow-up|0|||
146804737|NCT03466411|529454921|FG005|Overall Study|Lost to Follow-up|0|||
146804738|NCT03466411|529454922|FG006|Overall Study|Lost to Follow-up|1|||
146804739|NCT03466411|529454923|FG007|Overall Study|Lost to Follow-up|1|||
146804740|NCT03466411|529454924|FG008|Overall Study|Lost to Follow-up|0|||
146804741|NCT03466411|529454925|FG009|Overall Study|Lost to Follow-up|1|||
146804742|NCT03466411|529454926|FG010|Overall Study|Lost to Follow-up|1|||
146804743|NCT03466411|529454927|FG011|Overall Study|Lost to Follow-up|1|||
146804744|NCT03466411|529454928|FG012|Overall Study|Lost to Follow-up|0|||
146804745|NCT03466411|529454916|FG000|Overall Study|Withdrawal by Subject|14|||
146804746|NCT03466411|529454917|FG001|Overall Study|Withdrawal by Subject|7|||
146804747|NCT03466411|529454918|FG002|Overall Study|Withdrawal by Subject|8|||
146804748|NCT03466411|529454919|FG003|Overall Study|Withdrawal by Subject|4|||
146804749|NCT03466411|529454920|FG004|Overall Study|Withdrawal by Subject|6|||
146804750|NCT03466411|529454921|FG005|Overall Study|Withdrawal by Subject|3|||
146804751|NCT03466411|529454922|FG006|Overall Study|Withdrawal by Subject|6|||
146804752|NCT03466411|529454923|FG007|Overall Study|Withdrawal by Subject|9|||
146804753|NCT03466411|529454924|FG008|Overall Study|Withdrawal by Subject|6|||
146804754|NCT03466411|529454925|FG009|Overall Study|Withdrawal by Subject|11|||
146804755|NCT03466411|529454926|FG010|Overall Study|Withdrawal by Subject|14|||
146804756|NCT03466411|529454927|FG011|Overall Study|Withdrawal by Subject|12|||
146804757|NCT03466411|529454928|FG012|Overall Study|Withdrawal by Subject|7|||
146804758|NCT03466411|529454916|FG000|Overall Study|Other|1|||
146804759|NCT03466411|529454917|FG001|Overall Study|Other|1|||
146804760|NCT03466411|529454918|FG002|Overall Study|Other|0|||
146804761|NCT03466411|529454919|FG003|Overall Study|Other|1|||
146804762|NCT03466411|529454920|FG004|Overall Study|Other|2|||
146804763|NCT03466411|529454921|FG005|Overall Study|Other|0|||
146804764|NCT03466411|529454922|FG006|Overall Study|Other|0|||
146804765|NCT03466411|529454923|FG007|Overall Study|Other|0|||
146804766|NCT03466411|529454924|FG008|Overall Study|Other|0|||
146804767|NCT03466411|529454925|FG009|Overall Study|Other|1|||
146804768|NCT03466411|529454926|FG010|Overall Study|Other|2|||
146804769|NCT03466411|529454927|FG011|Overall Study|Other|0|||
146804770|NCT03466411|529454928|FG012|Overall Study|Other|0|||
146804771|NCT03466411|529454916|FG000|Overall Study|Randomized but not Treated|0|||
146804772|NCT03466411|529454917|FG001|Overall Study|Randomized but not Treated|0|||
146804773|NCT03466411|529454918|FG002|Overall Study|Randomized but not Treated|0|||
146804774|NCT03466411|529454919|FG003|Overall Study|Randomized but not Treated|0|||
146804775|NCT03466411|529454920|FG004|Overall Study|Randomized but not Treated|0|||
146804776|NCT03466411|529454921|FG005|Overall Study|Randomized but not Treated|0|||
146804777|NCT03466411|529454922|FG006|Overall Study|Randomized but not Treated|1|||
146804778|NCT03466411|529454923|FG007|Overall Study|Randomized but not Treated|0|||
146804779|NCT03466411|529454924|FG008|Overall Study|Randomized but not Treated|0|||
146804780|NCT03466411|529454925|FG009|Overall Study|Randomized but not Treated|0|||
146804781|NCT03466411|529454926|FG010|Overall Study|Randomized but not Treated|0|||
146804782|NCT03466411|529454927|FG011|Overall Study|Randomized but not Treated|0|||
146804783|NCT03466411|529454928|FG012|Overall Study|Randomized but not Treated|0|||
146804784|NCT00274261|529454941|FG000|Overall Study|Adverse Event|19|||
146804785|NCT00274261|529454942|FG001|Overall Study|Adverse Event|11|||
146804786|NCT00274261|529454941|FG000|Overall Study|Pregnancy|114|||
146804787|NCT00274261|529454942|FG001|Overall Study|Pregnancy|83|||
146804788|NCT00274261|529454941|FG000|Overall Study|Withdrawal by Subject|179|||
146804789|NCT00274261|529454942|FG001|Overall Study|Withdrawal by Subject|126|||
146804790|NCT00274261|529454941|FG000|Overall Study|Protocol Violation|71|||
146804791|NCT00274261|529454942|FG001|Overall Study|Protocol Violation|42|||
146804792|NCT00274261|529454941|FG000|Overall Study|Lost to Follow-up|106|||
146804793|NCT00274261|529454942|FG001|Overall Study|Lost to Follow-up|75|||
146804794|NCT03582475|529454943|FG000|Treatment Period|Withdrawal by Subject|0|||
146804795|NCT03582475|529454944|FG001|Treatment Period|Withdrawal by Subject|1|||
146804796|NCT03582475|529454943|FG000|Follow-up Period|Withdrawal by Subject|0|||
146804797|NCT03582475|529454944|FG001|Follow-up Period|Withdrawal by Subject|1|||
146804798|NCT02257736|529454945|FG000|Overall Study|Progressive disease|365|||
146804799|NCT02257736|529454946|FG001|Overall Study|Progressive disease|327|||
146804800|NCT02257736|529454945|FG000|Overall Study|Adverse Event|45|||
146804801|NCT02257736|529454946|FG001|Overall Study|Adverse Event|56|||
146804802|NCT02257736|529454945|FG000|Overall Study|Withdrawal by Subject|21|||
146804803|NCT02257736|529454946|FG001|Overall Study|Withdrawal by Subject|38|||
146804804|NCT02257736|529454945|FG000|Overall Study|Death|11|||
146804805|NCT02257736|529454946|FG001|Overall Study|Death|6|||
146804806|NCT02257736|529454945|FG000|Overall Study|Physician Decision|5|||
146804807|NCT02257736|529454946|FG001|Overall Study|Physician Decision|9|||
146804808|NCT02257736|529454945|FG000|Overall Study|Non-Compliance with study drug|1|||
146804809|NCT02257736|529454946|FG001|Overall Study|Non-Compliance with study drug|2|||
146804810|NCT02257736|529454945|FG000|Overall Study|Protocol Violation|1|||
146804811|NCT02257736|529454946|FG001|Overall Study|Protocol Violation|0|||
146804812|NCT02257736|529454945|FG000|Overall Study|Other|1|||
146804813|NCT02257736|529454946|FG001|Overall Study|Other|7|||
146804814|NCT02257736|529454945|FG000|Overall Study|Randomized, not treated|1|||
146804815|NCT02257736|529454946|FG001|Overall Study|Randomized, not treated|2|||
146804816|NCT03431350|529454947|FG000|Overall Study|ONGOING|0|||
146804817|NCT03431350|529454948|FG001|Overall Study|ONGOING|0|||
146804818|NCT03431350|529454949|FG002|Overall Study|ONGOING|2|||
146804819|NCT03431350|529454950|FG003|Overall Study|ONGOING|0|||
146804820|NCT03431350|529454951|FG004|Overall Study|ONGOING|1|||
146804821|NCT03431350|529454952|FG005|Overall Study|ONGOING|3|||
146804822|NCT03431350|529454953|FG006|Overall Study|ONGOING|0|||
146804823|NCT03431350|529454954|FG007|Overall Study|ONGOING|1|||
146804824|NCT03431350|529454955|FG008|Overall Study|ONGOING|3|||
146804825|NCT03431350|529454956|FG009|Overall Study|ONGOING|4|||
146804826|NCT03431350|529454957|FG010|Overall Study|ONGOING|2|||
146804827|NCT03431350|529454958|FG011|Overall Study|ONGOING|1|||
146804828|NCT03431350|529454947|FG000|Overall Study|Death|6|||
146804829|NCT03431350|529454948|FG001|Overall Study|Death|5|||
146804830|NCT03431350|529454949|FG002|Overall Study|Death|18|||
146804831|NCT03431350|529454950|FG003|Overall Study|Death|7|||
146804832|NCT03431350|529454951|FG004|Overall Study|Death|4|||
146804833|NCT03431350|529454952|FG005|Overall Study|Death|3|||
146804834|NCT03431350|529454953|FG006|Overall Study|Death|2|||
146804835|NCT03431350|529454954|FG007|Overall Study|Death|0|||
146804836|NCT03431350|529454955|FG008|Overall Study|Death|0|||
146804837|NCT03431350|529454956|FG009|Overall Study|Death|0|||
146804838|NCT03431350|529454957|FG010|Overall Study|Death|4|||
146804839|NCT03431350|529454958|FG011|Overall Study|Death|0|||
146804840|NCT03431350|529454947|FG000|Overall Study|Lost to Follow-up|0|||
146804841|NCT03431350|529454948|FG001|Overall Study|Lost to Follow-up|1|||
146804842|NCT03431350|529454949|FG002|Overall Study|Lost to Follow-up|0|||
146804843|NCT03431350|529454950|FG003|Overall Study|Lost to Follow-up|0|||
146804844|NCT03431350|529454951|FG004|Overall Study|Lost to Follow-up|0|||
146804845|NCT03431350|529454952|FG005|Overall Study|Lost to Follow-up|0|||
146804846|NCT03431350|529454953|FG006|Overall Study|Lost to Follow-up|0|||
146804847|NCT03431350|529454954|FG007|Overall Study|Lost to Follow-up|0|||
146804848|NCT03431350|529454955|FG008|Overall Study|Lost to Follow-up|0|||
146804849|NCT03431350|529454956|FG009|Overall Study|Lost to Follow-up|0|||
146804850|NCT03431350|529454957|FG010|Overall Study|Lost to Follow-up|0|||
146804851|NCT03431350|529454958|FG011|Overall Study|Lost to Follow-up|0|||
146804852|NCT03431350|529454947|FG000|Overall Study|Withdrawal by Subject|0|||
146804853|NCT03431350|529454948|FG001|Overall Study|Withdrawal by Subject|0|||
146804854|NCT03431350|529454949|FG002|Overall Study|Withdrawal by Subject|0|||
146804855|NCT03431350|529454950|FG003|Overall Study|Withdrawal by Subject|1|||
146804856|NCT03431350|529454951|FG004|Overall Study|Withdrawal by Subject|1|||
146804857|NCT03431350|529454952|FG005|Overall Study|Withdrawal by Subject|1|||
146804858|NCT03431350|529454953|FG006|Overall Study|Withdrawal by Subject|0|||
146804859|NCT03431350|529454954|FG007|Overall Study|Withdrawal by Subject|0|||
146804860|NCT03431350|529454955|FG008|Overall Study|Withdrawal by Subject|0|||
146804861|NCT03431350|529454956|FG009|Overall Study|Withdrawal by Subject|2|||
146804862|NCT03431350|529454957|FG010|Overall Study|Withdrawal by Subject|0|||
146804863|NCT03431350|529454958|FG011|Overall Study|Withdrawal by Subject|1|||
146804864|NCT03431350|529454947|FG000|Overall Study|Other|0|||
146804865|NCT03431350|529454948|FG001|Overall Study|Other|0|||
146804866|NCT03431350|529454949|FG002|Overall Study|Other|1|||
146804867|NCT03431350|529454950|FG003|Overall Study|Other|3|||
146804868|NCT03431350|529454951|FG004|Overall Study|Other|2|||
146804869|NCT03431350|529454952|FG005|Overall Study|Other|2|||
146804870|NCT03431350|529454953|FG006|Overall Study|Other|4|||
146804871|NCT03431350|529454954|FG007|Overall Study|Other|0|||
146804872|NCT03431350|529454955|FG008|Overall Study|Other|14|||
146804873|NCT03431350|529454956|FG009|Overall Study|Other|11|||
146804874|NCT03431350|529454957|FG010|Overall Study|Other|11|||
146804875|NCT03431350|529454958|FG011|Overall Study|Other|15|||
146804876|NCT03414684|529454959|FG000|First-course Treatment|Complete response|0|||
146804877|NCT03414684|529454960|FG001|First-course Treatment|Complete response|1|||
146804878|NCT03414684|529454959|FG000|First-course Treatment|Intercurrent illness|1|||
146804879|NCT03414684|529454960|FG001|First-course Treatment|Intercurrent illness|0|||
146804880|NCT03414684|529454959|FG000|First-course Treatment|Progressive Disease|31|||
146804881|NCT03414684|529454960|FG001|First-course Treatment|Progressive Disease|32|||
146804882|NCT03414684|529454959|FG000|First-course Treatment|Adverse Event|1|||
146804883|NCT03414684|529454960|FG001|First-course Treatment|Adverse Event|2|||
146804884|NCT03414684|529454959|FG000|First-course Treatment|Physician Decision|0|||
146804885|NCT03414684|529454960|FG001|First-course Treatment|Physician Decision|1|||
146804886|NCT03414684|529454959|FG000|First-course Treatment|Withdrawal by Subject|0|||
146804887|NCT03414684|529454960|FG001|First-course Treatment|Withdrawal by Subject|1|||
146804888|NCT03414684|529454959|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
146804889|NCT03414684|529454960|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
146804890|NCT03414684|529454959|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
146804891|NCT03414684|529454960|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
146804892|NCT03414684|529454959|FG000|First-course Treatment|Still on treatment|3|||
146804893|NCT03414684|529454960|FG001|First-course Treatment|Still on treatment|0|||
146804894|NCT03414684|529454959|FG000|First-course Treatment|Never started protocol therapy|2|||
146804895|NCT03414684|529454960|FG001|First-course Treatment|Never started protocol therapy|1|||
146804896|NCT03414684|529454959|FG000|Crossover Treatment|Progressive disease|0|||
146804897|NCT03414684|529454960|FG001|Crossover Treatment|Progressive disease|12|||
146804898|NCT03414684|529454959|FG000|Crossover Treatment|Adverse Event|0|||
146804899|NCT03414684|529454960|FG001|Crossover Treatment|Adverse Event|3|||
146804900|NCT03414684|529454959|FG000|Crossover Treatment|Physician Decision|0|||
146804901|NCT03414684|529454960|FG001|Crossover Treatment|Physician Decision|1|||
146804902|NCT03414684|529454959|FG000|Crossover Treatment|Still on treatment|0|||
146804903|NCT03414684|529454960|FG001|Crossover Treatment|Still on treatment|2|||
146804904|NCT02078648|529454961|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
146804905|NCT02078648|529454962|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
146804906|NCT02078648|529454961|FG000|Overall Study|Adverse Event|0|||
146804907|NCT02078648|529454962|FG001|Overall Study|Adverse Event|1|||
146804908|NCT02078648|529454961|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
146804909|NCT02078648|529454962|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
146804910|NCT02078648|529454961|FG000|Overall Study|Withdrawal by Subject|3|||
146804911|NCT02078648|529454962|FG001|Overall Study|Withdrawal by Subject|1|||
146804912|NCT02078648|529454961|FG000|Overall Study|Investigator Decision|5|||
146804913|NCT02078648|529454962|FG001|Overall Study|Investigator Decision|7|||
146804914|NCT02078648|529454961|FG000|Overall Study|Death|1|||
146804915|NCT02078648|529454962|FG001|Overall Study|Death|1|||
146804916|NCT02078648|529454961|FG000|Overall Study|Undefined|0|||
146804917|NCT02078648|529454962|FG001|Overall Study|Undefined|1|||
146804918|NCT05379270|529454963|FG000|Overall Study|Withdrawal by Subject|1|||
146804919|NCT05379270|529454964|FG001|Overall Study|Withdrawal by Subject|1|||
146804920|NCT04306367|529454970|FG000|Overall Study|Progression of Disease|9|||
146804921|NCT04306367|529454970|FG000|Overall Study|Adverse Event|3|||
146804922|NCT04306367|529454970|FG000|Overall Study|Withdrawal by Subject|1|||
146804923|NCT02401815|529454971|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146804924|NCT02401815|529454972|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146804925|NCT02401815|529454973|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146804926|NCT02401815|529454974|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
146804927|NCT02401815|529454975|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146804928|NCT02401815|529454976|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146804929|NCT02401815|529454977|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146804930|NCT02401815|529454978|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146804931|NCT02401815|529454979|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146804932|NCT02401815|529454980|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146804933|NCT02401815|529454971|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
146804934|NCT02401815|529454972|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
146804935|NCT02401815|529454973|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
146804936|NCT02401815|529454974|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
146804937|NCT02401815|529454975|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
146804938|NCT02401815|529454976|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
146804939|NCT02401815|529454977|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
146804940|NCT02401815|529454978|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
146804941|NCT02401815|529454979|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
146804942|NCT02401815|529454980|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
146804943|NCT02401815|529454971|FG000|Dose Escalation (up to 670 Days)|Death|1|||
146804944|NCT02401815|529454972|FG001|Dose Escalation (up to 670 Days)|Death|2|||
146804945|NCT02401815|529454973|FG002|Dose Escalation (up to 670 Days)|Death|3|||
146804946|NCT02401815|529454974|FG003|Dose Escalation (up to 670 Days)|Death|5|||
146804947|NCT02401815|529454975|FG004|Dose Escalation (up to 670 Days)|Death|4|||
146804948|NCT02401815|529454976|FG005|Dose Escalation (up to 670 Days)|Death|0|||
146804949|NCT02401815|529454977|FG006|Dose Escalation (up to 670 Days)|Death|0|||
146804950|NCT02401815|529454978|FG007|Dose Escalation (up to 670 Days)|Death|0|||
146804951|NCT02401815|529454979|FG008|Dose Escalation (up to 670 Days)|Death|0|||
146804952|NCT02401815|529454980|FG009|Dose Escalation (up to 670 Days)|Death|0|||
146804953|NCT02401815|529454971|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
146804954|NCT02401815|529454972|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
146804955|NCT02401815|529454973|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
146804956|NCT02401815|529454974|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
146804957|NCT02401815|529454975|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
146804958|NCT02401815|529454976|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
146804959|NCT02401815|529454977|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
146804960|NCT02401815|529454978|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
146804961|NCT02401815|529454979|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
146804962|NCT02401815|529454980|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
146804963|NCT02401815|529454971|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
146804964|NCT02401815|529454972|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
146804965|NCT02401815|529454973|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
146804966|NCT02401815|529454974|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
146804967|NCT02401815|529454975|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
146804968|NCT02401815|529454976|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
146804969|NCT02401815|529454977|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
146804970|NCT02401815|529454978|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
146804971|NCT02401815|529454979|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
146804972|NCT02401815|529454980|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
146804973|NCT02401815|529454971|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
146804974|NCT02401815|529454972|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
146804975|NCT02401815|529454973|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
146804976|NCT02401815|529454974|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
146804977|NCT02401815|529454975|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
146804978|NCT02401815|529454976|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
146804979|NCT02401815|529454977|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
146804980|NCT02401815|529454978|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
146804981|NCT02401815|529454979|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
146804982|NCT02401815|529454980|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
146804983|NCT02401815|529454971|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146804984|NCT02401815|529454972|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146804985|NCT02401815|529454973|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146804986|NCT02401815|529454974|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146804987|NCT02401815|529454975|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146804988|NCT02401815|529454976|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146804989|NCT02401815|529454977|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
146804990|NCT02401815|529454978|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146804991|NCT02401815|529454979|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146804992|NCT02401815|529454980|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146804993|NCT02401815|529454971|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
146804994|NCT02401815|529454972|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
146941983|NCT00809614|529948010|FG000|Overall Study|Withdrawal by Subject|1|||
146941984|NCT00809614|529948011|FG001|Overall Study|Withdrawal by Subject|1|||
146804995|NCT02401815|529454973|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
146804996|NCT02401815|529454974|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
146804997|NCT02401815|529454975|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
146804998|NCT02401815|529454976|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
146804999|NCT02401815|529454977|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
146805000|NCT02401815|529454978|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
146805001|NCT02401815|529454979|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
146805002|NCT02401815|529454980|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
146805003|NCT02401815|529454971|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146805004|NCT02401815|529454972|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146805005|NCT02401815|529454973|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146805006|NCT02401815|529454974|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146805007|NCT02401815|529454975|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146805008|NCT02401815|529454976|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
146805009|NCT02401815|529454977|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146805010|NCT02401815|529454978|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146805011|NCT02401815|529454979|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146805012|NCT02401815|529454980|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146805013|NCT02401815|529454971|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
146805014|NCT02401815|529454972|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
146805015|NCT02401815|529454973|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
146805016|NCT02401815|529454974|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
146805017|NCT02401815|529454975|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
146805018|NCT02401815|529454976|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
146805019|NCT02401815|529454977|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
146805020|NCT02401815|529454978|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
146805021|NCT02401815|529454979|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
146805022|NCT02401815|529454980|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
146805023|NCT02401815|529454971|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146805024|NCT02401815|529454972|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146805025|NCT02401815|529454973|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146805026|NCT02401815|529454974|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146805027|NCT02401815|529454975|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146805028|NCT02401815|529454976|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146805029|NCT02401815|529454977|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146805030|NCT02401815|529454978|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146805031|NCT02401815|529454979|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
146805032|NCT02401815|529454980|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
146805033|NCT02401815|529454971|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146805034|NCT02401815|529454972|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146805035|NCT02401815|529454973|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146805036|NCT02401815|529454974|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146805037|NCT02401815|529454975|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146805038|NCT02401815|529454976|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146805039|NCT02401815|529454977|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146805040|NCT02401815|529454978|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146805041|NCT02401815|529454979|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146805042|NCT02401815|529454980|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
146805043|NCT02401815|529454971|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146805044|NCT02401815|529454972|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146805045|NCT02401815|529454973|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146805046|NCT02401815|529454974|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146805047|NCT02401815|529454975|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146805048|NCT02401815|529454976|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146805049|NCT02401815|529454977|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146805050|NCT02401815|529454978|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146805051|NCT02401815|529454979|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
146805052|NCT02401815|529454980|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146805053|NCT02401815|529454971|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
146805054|NCT02401815|529454972|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
146805055|NCT02401815|529454973|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
146805056|NCT02401815|529454974|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
146805057|NCT02401815|529454975|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
146805058|NCT02401815|529454976|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
146805059|NCT02401815|529454977|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
146805060|NCT02401815|529454978|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
146805061|NCT02401815|529454979|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
146805062|NCT02401815|529454980|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
146805063|NCT00748709|529454981|FG000|Overall Study|Progressive disease|15|||
146805064|NCT00748709|529454981|FG000|Overall Study|Drug reducing Toxity|2|||
146805065|NCT00748709|529454981|FG000|Overall Study|Other Adverse Event|1|||
146805066|NCT00748709|529454981|FG000|Overall Study|Withdrawal by Subject|1|||
146805067|NCT00748709|529454981|FG000|Overall Study|Other Reasons|1|||
146805068|NCT02751528|529454986|FG000|Overall Study|Withdrawal by Subject|1|||
146805069|NCT02751528|529454986|FG000|Overall Study|Adverse Event|1|||
146805070|NCT04218357|529454987|FG000|1st Allocation|Withdrawal by Subject|1|||
146805071|NCT04218357|529454988|FG001|1st Allocation|Withdrawal by Subject|0|||
146805072|NCT04484623|529454990|FG000|Overall Study|Lost to Follow-up|0|||
146805073|NCT04484623|529454991|FG001|Overall Study|Lost to Follow-up|1|||
146805074|NCT04484623|529454990|FG000|Overall Study|Protocol Deviation|1|||
146805075|NCT04484623|529454991|FG001|Overall Study|Protocol Deviation|0|||
146805076|NCT04484623|529454990|FG000|Overall Study|Physician Decision|1|||
146805077|NCT04484623|529454991|FG001|Overall Study|Physician Decision|0|||
146805078|NCT04484623|529454990|FG000|Overall Study|Withdrawal by Subject|11|||
146805079|NCT04484623|529454991|FG001|Overall Study|Withdrawal by Subject|8|||
146805080|NCT04484623|529454990|FG000|Overall Study|Ongoing|94|||
146805081|NCT04484623|529454991|FG001|Overall Study|Ongoing|84|||
146805082|NCT05199571|529456394|FG000|Treatment Period|Participant decision|3|||
146805083|NCT05199571|529456394|FG000|Treatment Period|Physician Decision|1|||
146805084|NCT05199571|529456394|FG000|Post-treatment Follow up Period|Participant decision|3|||
146805085|NCT03367156|529456395|FG000|Overall Study|Lack of interest|3|||
146805086|NCT03367156|529456396|FG001|Overall Study|Lack of interest|1|||
146805087|NCT03367156|529456395|FG000|Overall Study|Death|2|||
146805088|NCT03367156|529456396|FG001|Overall Study|Death|0|||
146805089|NCT03367156|529456395|FG000|Overall Study|Lost to Follow-up|2|||
146805090|NCT03367156|529456396|FG001|Overall Study|Lost to Follow-up|1|||
146805091|NCT03367156|529456395|FG000|Overall Study|Became ineligible|1|||
146805092|NCT03367156|529456396|FG001|Overall Study|Became ineligible|2|||
146805093|NCT03367156|529456395|FG000|Overall Study|Hospitalization|1|||
146805094|NCT03367156|529456396|FG001|Overall Study|Hospitalization|0|||
146805095|NCT03367156|529456395|FG000|Overall Study|Concerned about Treatment|11|||
146805096|NCT03367156|529456396|FG001|Overall Study|Concerned about Treatment|3|||
146805097|NCT03367156|529456395|FG000|Overall Study|Started new treatment|4|||
146805098|NCT03367156|529456396|FG001|Overall Study|Started new treatment|1|||
146805099|NCT03762850|529456397|FG000|Overall Study|Death|0|||
146805100|NCT03762850|529456398|FG001|Overall Study|Death|1|||
146805101|NCT03762850|529456397|FG000|Overall Study|Lost to Follow-up|0|||
146805102|NCT03762850|529456398|FG001|Overall Study|Lost to Follow-up|1|||
146805103|NCT03762850|529456397|FG000|Overall Study|Physician Decision|0|||
146805104|NCT03762850|529456398|FG001|Overall Study|Physician Decision|1|||
146805105|NCT03762850|529456397|FG000|Overall Study|Withdrawal by Subject|4|||
146805106|NCT03762850|529456398|FG001|Overall Study|Withdrawal by Subject|9|||
146805107|NCT03002194|529456401|FG000|Overall Study|Lost to Follow-up|6|||
146805108|NCT03002194|529456401|FG000|Overall Study|Adverse Event|1|||
146805109|NCT03002194|529456401|FG000|Overall Study|Lack of Efficacy|1|||
146805110|NCT03002194|529456401|FG000|Overall Study|Withdrawal by Subject|2|||
146805111|NCT03021993|529456404|FG000|Overall Study|Withdrawal by Subject|4|||
146805112|NCT03021993|529456404|FG000|Overall Study|Physician Decision|1|||
146805113|NCT03021993|529456404|FG000|Overall Study|enrolled but were not treated|1|||
146805114|NCT03021993|529456404|FG000|Overall Study|Death|3|||
146805115|NCT00756574|529456405|FG000|Overall Study|Withdrawal by Subject|9|||
146805116|NCT00756574|529456406|FG001|Overall Study|Withdrawal by Subject|7|||
146805117|NCT00756574|529456405|FG000|Overall Study|Lost to Follow-up|4|||
146805118|NCT00756574|529456406|FG001|Overall Study|Lost to Follow-up|4|||
146805119|NCT03516812|529456409|FG000|Overall Study|Adverse Event|4|||
146805120|NCT03516812|529456409|FG000|Overall Study|Lack of Efficacy|2|||
146805121|NCT04795167|529456410|FG000|Overall Study|Death|1|||
146805122|NCT04795167|529456411|FG001|Overall Study|Death|18|||
146805123|NCT04795167|529456412|FG002|Overall Study|Death|1|||
146805124|NCT04795167|529456410|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
146805125|NCT04795167|529456411|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
146805126|NCT04795167|529456412|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
146805127|NCT03683576|529456418|FG000|Overall Study|Withdrawal by Subject|2|||
146805128|NCT03683576|529456419|FG001|Overall Study|Withdrawal by Subject|0|||
146805129|NCT03683576|529456420|FG002|Overall Study|Withdrawal by Subject|8|||
146805130|NCT03683576|529456421|FG003|Overall Study|Withdrawal by Subject|3|||
146805131|NCT03683576|529456418|FG000|Overall Study|Adverse Event|3|||
146805132|NCT03683576|529456419|FG001|Overall Study|Adverse Event|0|||
146805133|NCT03683576|529456420|FG002|Overall Study|Adverse Event|0|||
146805134|NCT03683576|529456421|FG003|Overall Study|Adverse Event|4|||
146805135|NCT03683576|529456418|FG000|Overall Study|Lack of Efficacy|1|||
146805136|NCT03683576|529456419|FG001|Overall Study|Lack of Efficacy|0|||
146805137|NCT03683576|529456420|FG002|Overall Study|Lack of Efficacy|1|||
146805138|NCT03683576|529456421|FG003|Overall Study|Lack of Efficacy|1|||
146805139|NCT03683576|529456418|FG000|Overall Study|Lost to Follow-up|0|||
146805140|NCT03683576|529456419|FG001|Overall Study|Lost to Follow-up|1|||
146805141|NCT03683576|529456420|FG002|Overall Study|Lost to Follow-up|2|||
146805142|NCT03683576|529456421|FG003|Overall Study|Lost to Follow-up|0|||
146805143|NCT03683576|529456418|FG000|Overall Study|Other, Not Specified|0|||
146805144|NCT03683576|529456419|FG001|Overall Study|Other, Not Specified|2|||
146805145|NCT03683576|529456420|FG002|Overall Study|Other, Not Specified|0|||
146805146|NCT03683576|529456421|FG003|Overall Study|Other, Not Specified|0|||
146805147|NCT03683576|529456418|FG000|Overall Study|Protocol Violation|0|||
146805148|NCT03683576|529456419|FG001|Overall Study|Protocol Violation|1|||
146805149|NCT03683576|529456420|FG002|Overall Study|Protocol Violation|1|||
146805150|NCT03683576|529456421|FG003|Overall Study|Protocol Violation|0|||
146805151|NCT02628626|529456423|FG000|Overall Study|Withdrawal by Subject|2|||
146805152|NCT02628626|529456424|FG001|Overall Study|Withdrawal by Subject|2|||
146805153|NCT02744066|529456425|FG000|Overall Study|Withdrawal by parent|0|||
146805154|NCT02744066|529456426|FG001|Overall Study|Withdrawal by parent|1|||
146805155|NCT02744066|529456425|FG000|Overall Study|Discharged from NICU prior to completion|0|||
146805156|NCT02744066|529456426|FG001|Overall Study|Discharged from NICU prior to completion|4|||
146805157|NCT05628103|529456427|FG000|Overall Study|Adverse Event|7|||
146805158|NCT05628103|529456427|FG000|Overall Study|Withdrawal by Subject|3|||
146805159|NCT05628103|529456427|FG000|Overall Study|Lost to Follow-up|3|||
146805160|NCT05628103|529456427|FG000|Overall Study|Lack of Efficacy|1|||
146805161|NCT05628103|529456427|FG000|Overall Study|Non-Compliance With Study Drug|4|||
146805162|NCT03492177|529456429|FG000|Overall Study|Adverse Event|1|||
146805163|NCT03492177|529456430|FG001|Overall Study|Adverse Event|0|||
146805164|NCT03492177|529456431|FG002|Overall Study|Adverse Event|0|||
146805165|NCT03492177|529456429|FG000|Overall Study|Death|3|||
146805166|NCT03492177|529456430|FG001|Overall Study|Death|0|||
146805167|NCT03492177|529456431|FG002|Overall Study|Death|3|||
146805168|NCT03492177|529456429|FG000|Overall Study|Lack of Efficacy|1|||
146805169|NCT03492177|529456430|FG001|Overall Study|Lack of Efficacy|2|||
146805170|NCT03492177|529456431|FG002|Overall Study|Lack of Efficacy|0|||
146805171|NCT03492177|529456429|FG000|Overall Study|Other|1|||
146805172|NCT03492177|529456430|FG001|Overall Study|Other|0|||
146805173|NCT03492177|529456431|FG002|Overall Study|Other|0|||
146805174|NCT03492177|529456429|FG000|Overall Study|Ongoing|16|||
146805175|NCT03492177|529456430|FG001|Overall Study|Ongoing|19|||
146805176|NCT03492177|529456431|FG002|Overall Study|Ongoing|17|||
146805177|NCT02499328|529456432|FG000|Overall Study|Withdrawal by Subject|1|||
146805178|NCT02499328|529456433|FG001|Overall Study|Withdrawal by Subject|1|||
146805179|NCT02499328|529456434|FG002|Overall Study|Withdrawal by Subject|5|||
146805180|NCT02499328|529456435|FG003|Overall Study|Withdrawal by Subject|3|||
146805181|NCT02499328|529456436|FG004|Overall Study|Withdrawal by Subject|5|||
146805182|NCT02499328|529456437|FG005|Overall Study|Withdrawal by Subject|0|||
146805183|NCT02499328|529456438|FG006|Overall Study|Withdrawal by Subject|0|||
146805184|NCT02499328|529456439|FG007|Overall Study|Withdrawal by Subject|0|||
146805185|NCT02499328|529456440|FG008|Overall Study|Withdrawal by Subject|2|||
146805186|NCT02499328|529456441|FG009|Overall Study|Withdrawal by Subject|2|||
146805187|NCT02499328|529456442|FG010|Overall Study|Withdrawal by Subject|0|||
146805188|NCT02499328|529456443|FG011|Overall Study|Withdrawal by Subject|3|||
146805189|NCT02499328|529456444|FG012|Overall Study|Withdrawal by Subject|7|||
146805190|NCT02499328|529456445|FG013|Overall Study|Withdrawal by Subject|3|||
146805191|NCT02499328|529456446|FG014|Overall Study|Withdrawal by Subject|1|||
146805192|NCT02499328|529456447|FG015|Overall Study|Withdrawal by Subject|0|||
146805193|NCT02499328|529456448|FG016|Overall Study|Withdrawal by Subject|0|||
146805194|NCT02499328|529456449|FG017|Overall Study|Withdrawal by Subject|3|||
146805195|NCT02499328|529456450|FG018|Overall Study|Withdrawal by Subject|0|||
146941985|NCT01080625|529948012|FG000|Overall Study|Physician Decision|0|||
146941986|NCT01080625|529948013|FG001|Overall Study|Physician Decision|2|||
146805196|NCT02499328|529456432|FG000|Overall Study|Lost to Follow-up|0|||
146805197|NCT02499328|529456433|FG001|Overall Study|Lost to Follow-up|1|||
146805198|NCT02499328|529456434|FG002|Overall Study|Lost to Follow-up|1|||
146805199|NCT02499328|529456435|FG003|Overall Study|Lost to Follow-up|2|||
146805200|NCT02499328|529456436|FG004|Overall Study|Lost to Follow-up|0|||
146941987|NCT01080625|529948014|FG002|Overall Study|Physician Decision|1|||
146941988|NCT01224106|529948015|FG000|Double-Blind Treatment Phase|Death|3|||
146805201|NCT02499328|529456437|FG005|Overall Study|Lost to Follow-up|0|||
146805202|NCT02499328|529456438|FG006|Overall Study|Lost to Follow-up|0|||
146805203|NCT02499328|529456439|FG007|Overall Study|Lost to Follow-up|2|||
146805204|NCT02499328|529456440|FG008|Overall Study|Lost to Follow-up|3|||
146941989|NCT01224106|529948016|FG001|Double-Blind Treatment Phase|Death|0|||
146805205|NCT02499328|529456441|FG009|Overall Study|Lost to Follow-up|0|||
146805206|NCT02499328|529456442|FG010|Overall Study|Lost to Follow-up|0|||
146805207|NCT02499328|529456443|FG011|Overall Study|Lost to Follow-up|0|||
146805208|NCT02499328|529456444|FG012|Overall Study|Lost to Follow-up|0|||
146805209|NCT02499328|529456445|FG013|Overall Study|Lost to Follow-up|0|||
146805210|NCT02499328|529456446|FG014|Overall Study|Lost to Follow-up|0|||
146805211|NCT02499328|529456447|FG015|Overall Study|Lost to Follow-up|0|||
146805212|NCT02499328|529456448|FG016|Overall Study|Lost to Follow-up|0|||
146805213|NCT02499328|529456449|FG017|Overall Study|Lost to Follow-up|0|||
146805214|NCT02499328|529456450|FG018|Overall Study|Lost to Follow-up|1|||
146805215|NCT02499328|529456432|FG000|Overall Study|Death|0|||
146805216|NCT02499328|529456433|FG001|Overall Study|Death|3|||
146805217|NCT02499328|529456434|FG002|Overall Study|Death|3|||
146805218|NCT02499328|529456435|FG003|Overall Study|Death|2|||
146805219|NCT02499328|529456436|FG004|Overall Study|Death|4|||
146805220|NCT02499328|529456437|FG005|Overall Study|Death|7|||
146805221|NCT02499328|529456438|FG006|Overall Study|Death|3|||
146805222|NCT02499328|529456439|FG007|Overall Study|Death|0|||
146805223|NCT02499328|529456440|FG008|Overall Study|Death|2|||
146805224|NCT02499328|529456441|FG009|Overall Study|Death|6|||
146805225|NCT02499328|529456442|FG010|Overall Study|Death|6|||
146805226|NCT02499328|529456443|FG011|Overall Study|Death|20|||
146805227|NCT02499328|529456444|FG012|Overall Study|Death|9|||
146805228|NCT02499328|529456445|FG013|Overall Study|Death|7|||
146805229|NCT02499328|529456446|FG014|Overall Study|Death|3|||
146805230|NCT02499328|529456447|FG015|Overall Study|Death|1|||
146805231|NCT02499328|529456448|FG016|Overall Study|Death|1|||
146805232|NCT02499328|529456449|FG017|Overall Study|Death|16|||
146805233|NCT02499328|529456450|FG018|Overall Study|Death|5|||
146805234|NCT02499328|529456432|FG000|Overall Study|"Other"|2|||
146805235|NCT02499328|529456433|FG001|Overall Study|"Other"|2|||
146805236|NCT02499328|529456434|FG002|Overall Study|"Other"|1|||
146805237|NCT02499328|529456435|FG003|Overall Study|"Other"|3|||
146805238|NCT02499328|529456436|FG004|Overall Study|"Other"|6|||
146805239|NCT02499328|529456437|FG005|Overall Study|"Other"|2|||
146805240|NCT02499328|529456438|FG006|Overall Study|"Other"|3|||
146805241|NCT02499328|529456439|FG007|Overall Study|"Other"|4|||
146805242|NCT02499328|529456440|FG008|Overall Study|"Other"|6|||
146805243|NCT02499328|529456441|FG009|Overall Study|"Other"|16|||
146805244|NCT02499328|529456442|FG010|Overall Study|"Other"|13|||
146805245|NCT02499328|529456443|FG011|Overall Study|"Other"|31|||
146805246|NCT02499328|529456444|FG012|Overall Study|"Other"|8|||
146805247|NCT02499328|529456445|FG013|Overall Study|"Other"|7|||
146805248|NCT02499328|529456446|FG014|Overall Study|"Other"|6|||
146805249|NCT02499328|529456447|FG015|Overall Study|"Other"|0|||
146805250|NCT02499328|529456448|FG016|Overall Study|"Other"|0|||
146805251|NCT02499328|529456449|FG017|Overall Study|"Other"|34|||
146805252|NCT02499328|529456450|FG018|Overall Study|"Other"|43|||
146805253|NCT02499328|529456432|FG000|Overall Study|Disease Progression|0|||
146805254|NCT02499328|529456433|FG001|Overall Study|Disease Progression|0|||
146805255|NCT02499328|529456434|FG002|Overall Study|Disease Progression|0|||
146805256|NCT02499328|529456435|FG003|Overall Study|Disease Progression|0|||
146805257|NCT02499328|529456436|FG004|Overall Study|Disease Progression|0|||
146805258|NCT02499328|529456437|FG005|Overall Study|Disease Progression|0|||
146805259|NCT02499328|529456438|FG006|Overall Study|Disease Progression|1|||
146805260|NCT02499328|529456439|FG007|Overall Study|Disease Progression|0|||
146805261|NCT02499328|529456440|FG008|Overall Study|Disease Progression|1|||
146805262|NCT02499328|529456441|FG009|Overall Study|Disease Progression|0|||
146805263|NCT02499328|529456442|FG010|Overall Study|Disease Progression|1|||
146805264|NCT02499328|529456443|FG011|Overall Study|Disease Progression|0|||
146805265|NCT02499328|529456444|FG012|Overall Study|Disease Progression|0|||
146805266|NCT02499328|529456445|FG013|Overall Study|Disease Progression|0|||
146805267|NCT02499328|529456446|FG014|Overall Study|Disease Progression|0|||
146941990|NCT01224106|529948017|FG002|Double-Blind Treatment Phase|Death|0|||
146941991|NCT01224106|529948018|FG003|Double-Blind Treatment Phase|Death|0|||
146805268|NCT02499328|529456447|FG015|Overall Study|Disease Progression|0|||
146805269|NCT02499328|529456448|FG016|Overall Study|Disease Progression|0|||
146805270|NCT02499328|529456449|FG017|Overall Study|Disease Progression|2|||
146805271|NCT02499328|529456450|FG018|Overall Study|Disease Progression|0|||
146805272|NCT02499328|529456432|FG000|Overall Study|Adverse Event|1|||
146805273|NCT02499328|529456433|FG001|Overall Study|Adverse Event|0|||
146805274|NCT02499328|529456434|FG002|Overall Study|Adverse Event|0|||
146805275|NCT02499328|529456435|FG003|Overall Study|Adverse Event|1|||
146805276|NCT02499328|529456436|FG004|Overall Study|Adverse Event|0|||
146805277|NCT02499328|529456437|FG005|Overall Study|Adverse Event|0|||
146805278|NCT02499328|529456438|FG006|Overall Study|Adverse Event|0|||
146805279|NCT02499328|529456439|FG007|Overall Study|Adverse Event|0|||
146805280|NCT02499328|529456440|FG008|Overall Study|Adverse Event|0|||
146805281|NCT02499328|529456441|FG009|Overall Study|Adverse Event|0|||
146805282|NCT02499328|529456442|FG010|Overall Study|Adverse Event|0|||
146805283|NCT02499328|529456443|FG011|Overall Study|Adverse Event|0|||
146805284|NCT02499328|529456444|FG012|Overall Study|Adverse Event|1|||
146805285|NCT02499328|529456445|FG013|Overall Study|Adverse Event|0|||
146805286|NCT02499328|529456446|FG014|Overall Study|Adverse Event|0|||
146805287|NCT02499328|529456447|FG015|Overall Study|Adverse Event|0|||
146805288|NCT02499328|529456448|FG016|Overall Study|Adverse Event|0|||
146805289|NCT02499328|529456449|FG017|Overall Study|Adverse Event|0|||
146805290|NCT02499328|529456450|FG018|Overall Study|Adverse Event|0|||
146805291|NCT01400958|529456453|FG000|Overall Study|Physician Decision|0|||
146805292|NCT01400958|529456454|FG001|Overall Study|Physician Decision|1|||
146805293|NCT01400958|529456453|FG000|Overall Study|Withdrawal by Subject|0|||
146805294|NCT01400958|529456454|FG001|Overall Study|Withdrawal by Subject|1|||
146805295|NCT01400958|529456453|FG000|Overall Study|Adverse Event|1|||
146805296|NCT01400958|529456454|FG001|Overall Study|Adverse Event|0|||
146805297|NCT03102034|529456455|FG000|Overall Study|Withdrawal by Subject|1|||
146805298|NCT03102034|529456456|FG001|Overall Study|Withdrawal by Subject|0|||
146805299|NCT05663866|529456461|FG000|Overall Study|Adverse Event|0|||
146805300|NCT05663866|529456462|FG001|Overall Study|Adverse Event|0|||
146805301|NCT05663866|529456463|FG002|Overall Study|Adverse Event|1|||
146805302|NCT05663866|529456464|FG003|Overall Study|Adverse Event|0|||
146805303|NCT05663866|529456461|FG000|Overall Study|Physician Decision|0|||
146805304|NCT05663866|529456462|FG001|Overall Study|Physician Decision|0|||
146805305|NCT05663866|529456463|FG002|Overall Study|Physician Decision|0|||
146805306|NCT05663866|529456464|FG003|Overall Study|Physician Decision|1|||
146805307|NCT05663866|529456461|FG000|Overall Study|Withdrawal by Subject|0|||
146805308|NCT05663866|529456462|FG001|Overall Study|Withdrawal by Subject|2|||
146805309|NCT05663866|529456463|FG002|Overall Study|Withdrawal by Subject|1|||
146805310|NCT05663866|529456464|FG003|Overall Study|Withdrawal by Subject|2|||
146805311|NCT05663866|529456461|FG000|Overall Study|Progressive disease|4|||
146805312|NCT05663866|529456462|FG001|Overall Study|Progressive disease|8|||
146805313|NCT05663866|529456463|FG002|Overall Study|Progressive disease|5|||
146805314|NCT05663866|529456464|FG003|Overall Study|Progressive disease|2|||
146805315|NCT05663866|529456461|FG000|Overall Study|Other|1|||
146805316|NCT05663866|529456462|FG001|Overall Study|Other|0|||
146805317|NCT05663866|529456463|FG002|Overall Study|Other|0|||
146805318|NCT05663866|529456464|FG003|Overall Study|Other|0|||
146805319|NCT05663866|529456461|FG000|Overall Study|Ongoing|1|||
146805320|NCT05663866|529456462|FG001|Overall Study|Ongoing|27|||
146805321|NCT05663866|529456463|FG002|Overall Study|Ongoing|6|||
146805322|NCT05663866|529456464|FG003|Overall Study|Ongoing|1|||
146805323|NCT03598907|529456467|FG000|Overall Study|Physician Decision|14|||
146805324|NCT03598907|529456468|FG001|Overall Study|Physician Decision|19|||
146805325|NCT05741528|529456469|FG000|Overall Study|Withdrawal by Subject|11|||
146805326|NCT05741528|529456469|FG000|Overall Study|Lost to Follow-up|3|||
146805327|NCT05741528|529456469|FG000|Overall Study|Adverse Event|2|||
146805328|NCT05741528|529456469|FG000|Overall Study|Non-Compliance With Study Drug|2|||
146805329|NCT05741528|529456469|FG000|Overall Study|Reason Not Specified|1|||
146805330|NCT03656718|529456472|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
146805331|NCT03656718|529456473|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
146805332|NCT03656718|529456474|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
146805333|NCT03656718|529456475|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
146805334|NCT03656718|529456476|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
146805335|NCT03656718|529456477|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
146805336|NCT03656718|529456478|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
146805337|NCT03656718|529456472|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
146805338|NCT03656718|529456473|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
146805339|NCT03656718|529456474|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
146805340|NCT03656718|529456475|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
146805341|NCT03656718|529456476|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
146805342|NCT03656718|529456477|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
146805343|NCT03656718|529456478|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
146805344|NCT03656718|529456472|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
146805345|NCT03656718|529456473|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
146805346|NCT03656718|529456474|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
146805347|NCT03656718|529456475|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
146805348|NCT03656718|529456476|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
146805349|NCT03656718|529456477|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
146805350|NCT03656718|529456478|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
146805351|NCT03656718|529456472|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
146805352|NCT03656718|529456473|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
146805353|NCT03656718|529456474|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
146941992|NCT01224106|529948019|FG004|Double-Blind Treatment Phase|Death|0|||
146941993|NCT01224106|529948015|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
146805354|NCT03656718|529456475|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
146805355|NCT03656718|529456476|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
146805356|NCT03656718|529456477|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
146805357|NCT03656718|529456478|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
146805358|NCT03656718|529456472|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
146941994|NCT01224106|529948016|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
146805359|NCT03656718|529456473|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
146805360|NCT03656718|529456474|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
146805361|NCT03656718|529456475|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
146805362|NCT03656718|529456476|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
146805363|NCT03656718|529456477|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
146805364|NCT03656718|529456478|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
146805365|NCT03656718|529456472|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
146805366|NCT03656718|529456473|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
146805367|NCT03656718|529456474|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
146805368|NCT03656718|529456475|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
146805369|NCT03656718|529456476|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
146805370|NCT03656718|529456477|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
146805371|NCT03656718|529456478|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
146805372|NCT03656718|529456472|FG000|Treatment Period Part C|Disease progression|0|||
146805373|NCT03656718|529456473|FG001|Treatment Period Part C|Disease progression|0|||
146805374|NCT03656718|529456474|FG002|Treatment Period Part C|Disease progression|0|||
146805375|NCT03656718|529456475|FG003|Treatment Period Part C|Disease progression|0|||
146805376|NCT03656718|529456476|FG004|Treatment Period Part C|Disease progression|12|||
146805377|NCT03656718|529456477|FG005|Treatment Period Part C|Disease progression|0|||
146805378|NCT03656718|529456478|FG006|Treatment Period Part C|Disease progression|0|||
146805379|NCT03656718|529456472|FG000|Treatment Period Part C|Death|0|||
146805380|NCT03656718|529456473|FG001|Treatment Period Part C|Death|0|||
146805381|NCT03656718|529456474|FG002|Treatment Period Part C|Death|0|||
146805382|NCT03656718|529456475|FG003|Treatment Period Part C|Death|0|||
146805383|NCT03656718|529456476|FG004|Treatment Period Part C|Death|1|||
146805384|NCT03656718|529456477|FG005|Treatment Period Part C|Death|0|||
146805385|NCT03656718|529456478|FG006|Treatment Period Part C|Death|0|||
146805386|NCT03656718|529456472|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
146805387|NCT03656718|529456473|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
146805388|NCT03656718|529456474|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
146805389|NCT03656718|529456475|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
146805390|NCT03656718|529456476|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
146805391|NCT03656718|529456477|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
146805392|NCT03656718|529456478|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
146805393|NCT03656718|529456472|FG000|Treatment Period Part C|Other reasons|0|||
146805394|NCT03656718|529456473|FG001|Treatment Period Part C|Other reasons|0|||
146805395|NCT03656718|529456474|FG002|Treatment Period Part C|Other reasons|0|||
146805396|NCT03656718|529456475|FG003|Treatment Period Part C|Other reasons|0|||
146805397|NCT03656718|529456476|FG004|Treatment Period Part C|Other reasons|1|||
146805398|NCT03656718|529456477|FG005|Treatment Period Part C|Other reasons|0|||
146805399|NCT03656718|529456478|FG006|Treatment Period Part C|Other reasons|0|||
146805400|NCT03656718|529456472|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
146805401|NCT03656718|529456473|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
146805402|NCT03656718|529456474|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
146805403|NCT03656718|529456475|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
146805404|NCT03656718|529456476|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
146805405|NCT03656718|529456477|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
146805406|NCT03656718|529456478|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
146805407|NCT00489307|529456481|FG000|Overall Study|Death|1|||
146941995|NCT01224106|529948017|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
146941996|NCT01224106|529948018|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
146805408|NCT00489307|529456482|FG001|Overall Study|Death|1|||
146805409|NCT00489307|529456481|FG000|Overall Study|Lost to Follow-up|2|||
146805410|NCT00489307|529456482|FG001|Overall Study|Lost to Follow-up|2|||
146805411|NCT00489307|529456481|FG000|Overall Study|Physician Decision|1|||
146805412|NCT00489307|529456482|FG001|Overall Study|Physician Decision|0|||
146805413|NCT00489307|529456481|FG000|Overall Study|Withdrawal by Subject|2|||
146805414|NCT00489307|529456482|FG001|Overall Study|Withdrawal by Subject|4|||
146805415|NCT00489307|529456481|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
146805416|NCT00489307|529456482|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
146805417|NCT00489307|529456481|FG000|Overall Study|Surgery after assignment|1|||
146805418|NCT00489307|529456482|FG001|Overall Study|Surgery after assignment|0|||
146805419|NCT00489307|529456481|FG000|Overall Study|Did not fill up the forms|2|||
146805420|NCT00489307|529456482|FG001|Overall Study|Did not fill up the forms|1|||
146805421|NCT00489307|529456481|FG000|Overall Study|Patient or family refusal|5|||
146805422|NCT00489307|529456482|FG001|Overall Study|Patient or family refusal|9|||
146941997|NCT01224106|529948019|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
146941998|NCT01224106|529948015|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
146941999|NCT01224106|529948016|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
146942000|NCT01224106|529948017|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
146942001|NCT01224106|529948018|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
146805423|NCT02307682|529456483|FG000|Overall Study|Adverse Event|9|||
146805424|NCT02307682|529456484|FG001|Overall Study|Adverse Event|8|||
146805425|NCT02307682|529456485|FG002|Overall Study|Adverse Event|12|||
146805426|NCT02307682|529456483|FG000|Overall Study|Lack of Efficacy|1|||
146805427|NCT02307682|529456484|FG001|Overall Study|Lack of Efficacy|0|||
146805428|NCT02307682|529456485|FG002|Overall Study|Lack of Efficacy|1|||
146805429|NCT02307682|529456483|FG000|Overall Study|Physician Decision|2|||
146805430|NCT02307682|529456484|FG001|Overall Study|Physician Decision|2|||
146805431|NCT02307682|529456485|FG002|Overall Study|Physician Decision|8|||
146805432|NCT02307682|529456483|FG000|Overall Study|Progressive Disease|1|||
146805433|NCT02307682|529456484|FG001|Overall Study|Progressive Disease|0|||
146805434|NCT02307682|529456485|FG002|Overall Study|Progressive Disease|0|||
146805435|NCT02307682|529456483|FG000|Overall Study|Withdrawal by Subject|26|||
146805436|NCT02307682|529456484|FG001|Overall Study|Withdrawal by Subject|34|||
146805437|NCT02307682|529456485|FG002|Overall Study|Withdrawal by Subject|23|||
146805438|NCT02307682|529456483|FG000|Overall Study|Death|9|||
146805439|NCT02307682|529456484|FG001|Overall Study|Death|7|||
146805440|NCT02307682|529456485|FG002|Overall Study|Death|12|||
146805441|NCT02307682|529456483|FG000|Overall Study|Lost to Follow-up|1|||
146805442|NCT02307682|529456484|FG001|Overall Study|Lost to Follow-up|5|||
146805443|NCT02307682|529456485|FG002|Overall Study|Lost to Follow-up|6|||
146805444|NCT02307682|529456483|FG000|Overall Study|Protocol Deviation|0|||
146805445|NCT02307682|529456484|FG001|Overall Study|Protocol Deviation|0|||
146805446|NCT02307682|529456485|FG002|Overall Study|Protocol Deviation|2|||
146805447|NCT02307682|529456483|FG000|Overall Study|Other|1|||
146805448|NCT02307682|529456484|FG001|Overall Study|Other|1|||
146805449|NCT02307682|529456485|FG002|Overall Study|Other|0|||
146805450|NCT02517268|529456488|FG000|Overall Study|Withdrawal by Subject|1|||
146805451|NCT02517268|529456489|FG001|Overall Study|Withdrawal by Subject|0|||
146805452|NCT04686266|529456490|FG000|Overall Study|Withdrawal by Subject|0|||
146805453|NCT04686266|529456491|FG001|Overall Study|Withdrawal by Subject|1|||
146805454|NCT03227861|529456494|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
146805455|NCT03227861|529456494|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
146805456|NCT03227861|529456494|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
146805457|NCT03227861|529456494|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
146805458|NCT03227861|529456494|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
146805459|NCT03227861|529456494|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
146805460|NCT03227861|529456494|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
146805461|NCT03227861|529456494|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
146805462|NCT03227861|529456494|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
146805463|NCT03227861|529456494|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
146805464|NCT05071430|529456498|FG000|Overall Study|Adverse Event|1|||
146805465|NCT05071430|529456499|FG001|Overall Study|Adverse Event|2|||
146805466|NCT05071430|529456498|FG000|Overall Study|Lost to Follow-up|4|||
146805467|NCT05071430|529456499|FG001|Overall Study|Lost to Follow-up|4|||
146805468|NCT05071430|529456498|FG000|Overall Study|Protocol Violation|1|||
146805469|NCT05071430|529456499|FG001|Overall Study|Protocol Violation|0|||
146805470|NCT05071430|529456498|FG000|Overall Study|Withdrawal by Subject|3|||
146805471|NCT05071430|529456499|FG001|Overall Study|Withdrawal by Subject|2|||
146805472|NCT05071430|529456498|FG000|Overall Study|Other|1|||
146805473|NCT05071430|529456499|FG001|Overall Study|Other|1|||
146805474|NCT01958021|529456500|FG000|Treatment|Progressive disease|206|||
146805475|NCT01958021|529456501|FG001|Treatment|Progressive disease|265|||
146805476|NCT01958021|529456500|FG000|Treatment|Adverse Event|38|||
146805477|NCT01958021|529456501|FG001|Treatment|Adverse Event|10|||
146805478|NCT01958021|529456500|FG000|Treatment|Subject/guardian decision|29|||
146805479|NCT01958021|529456501|FG001|Treatment|Subject/guardian decision|25|||
146805480|NCT01958021|529456500|FG000|Treatment|Physician Decision|28|||
146805481|NCT01958021|529456501|FG001|Treatment|Physician Decision|21|||
146805482|NCT01958021|529456500|FG000|Treatment|Death|6|||
146805483|NCT01958021|529456501|FG001|Treatment|Death|1|||
146805484|NCT01958021|529456500|FG000|Treatment|Protocol deviation|3|||
146805485|NCT01958021|529456501|FG001|Treatment|Protocol deviation|1|||
146805486|NCT01958021|529456500|FG000|Treatment|Sponsor decision|24|||
146805487|NCT01958021|529456501|FG001|Treatment|Sponsor decision|11|||
146805488|NCT01958021|529456500|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
146805489|NCT01958021|529456501|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146805490|NCT01958021|529456500|FG000|Post-treatment Efficacy Follow-up|Death|1|||
146805491|NCT01958021|529456501|FG001|Post-treatment Efficacy Follow-up|Death|0|||
146942002|NCT01224106|529948019|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
146805492|NCT01958021|529456500|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
146805493|NCT01958021|529456501|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146805494|NCT01958021|529456500|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
146805495|NCT01958021|529456501|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
146805496|NCT01958021|529456500|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
146805497|NCT01958021|529456501|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
146805498|NCT01958021|529456500|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
146805499|NCT01958021|529456501|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
146805500|NCT01958021|529456500|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
146805501|NCT01958021|529456501|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
146805502|NCT05810285|529456502|FG000|Overall Study|Death|4|||
146805503|NCT05810285|529456503|FG001|Overall Study|Death|21|||
146805504|NCT05810285|529456502|FG000|Overall Study|Adverse Event|18|||
146805505|NCT05810285|529456503|FG001|Overall Study|Adverse Event|16|||
146805506|NCT04649047|529456504|FG000|Overall Study|Withdrawal by Subject|3|||
146805507|NCT05886777|529456505|FG000|Overall Study|Lost to Follow-up|1|||
146805508|NCT05886777|529456506|FG001|Overall Study|Lost to Follow-up|0|||
146805509|NCT05886777|529456507|FG002|Overall Study|Lost to Follow-up|2|||
146805510|NCT05886777|529456508|FG003|Overall Study|Lost to Follow-up|1|||
146805511|NCT05886777|529456509|FG004|Overall Study|Lost to Follow-up|0|||
146805512|NCT05886777|529456510|FG005|Overall Study|Lost to Follow-up|2|||
146805513|NCT05886777|529456511|FG006|Overall Study|Lost to Follow-up|0|||
146805514|NCT05886777|529456505|FG000|Overall Study|Other|0|||
146805515|NCT05886777|529456506|FG001|Overall Study|Other|2|||
146805516|NCT05886777|529456507|FG002|Overall Study|Other|1|||
146805517|NCT05886777|529456508|FG003|Overall Study|Other|0|||
146805518|NCT05886777|529456509|FG004|Overall Study|Other|0|||
146805519|NCT05886777|529456510|FG005|Overall Study|Other|0|||
146805520|NCT05886777|529456511|FG006|Overall Study|Other|0|||
146805521|NCT05886777|529456505|FG000|Overall Study|Withdrawal by Subject|1|||
146805522|NCT05886777|529456506|FG001|Overall Study|Withdrawal by Subject|0|||
146805523|NCT05886777|529456507|FG002|Overall Study|Withdrawal by Subject|1|||
146805524|NCT05886777|529456508|FG003|Overall Study|Withdrawal by Subject|4|||
146805525|NCT05886777|529456509|FG004|Overall Study|Withdrawal by Subject|3|||
146805526|NCT05886777|529456510|FG005|Overall Study|Withdrawal by Subject|1|||
146805527|NCT05886777|529456511|FG006|Overall Study|Withdrawal by Subject|1|||
146805528|NCT05886777|529456505|FG000|Overall Study|Protocol Violation|0|||
146805529|NCT05886777|529456506|FG001|Overall Study|Protocol Violation|0|||
146805530|NCT05886777|529456507|FG002|Overall Study|Protocol Violation|1|||
146805531|NCT05886777|529456508|FG003|Overall Study|Protocol Violation|0|||
146805532|NCT05886777|529456509|FG004|Overall Study|Protocol Violation|0|||
146805533|NCT05886777|529456510|FG005|Overall Study|Protocol Violation|0|||
146805534|NCT05886777|529456511|FG006|Overall Study|Protocol Violation|0|||
146805535|NCT05886777|529456505|FG000|Overall Study|No longer met eligibility criteria|0|||
146805536|NCT05886777|529456506|FG001|Overall Study|No longer met eligibility criteria|1|||
146805537|NCT05886777|529456507|FG002|Overall Study|No longer met eligibility criteria|0|||
146805538|NCT05886777|529456508|FG003|Overall Study|No longer met eligibility criteria|0|||
146805539|NCT05886777|529456509|FG004|Overall Study|No longer met eligibility criteria|0|||
146805540|NCT05886777|529456510|FG005|Overall Study|No longer met eligibility criteria|0|||
146942003|NCT01224106|529948015|FG000|Double-Blind Treatment Phase|Other|0|||
146942004|NCT01224106|529948016|FG001|Double-Blind Treatment Phase|Other|0|||
146942005|NCT01224106|529948017|FG002|Double-Blind Treatment Phase|Other|1|||
146942006|NCT01224106|529948018|FG003|Double-Blind Treatment Phase|Other|0|||
146942007|NCT01224106|529948019|FG004|Double-Blind Treatment Phase|Other|0|||
146942008|NCT01224106|529948015|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
146942009|NCT01224106|529948016|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
146805541|NCT05886777|529456511|FG006|Overall Study|No longer met eligibility criteria|0|||
146805542|NCT03773107|529456512|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
146805543|NCT03773107|529456513|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
146805544|NCT03773107|529456514|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
146805545|NCT03773107|529456515|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
146805546|NCT07204444|529456518|FG000|Overall Study|Medical/Hospitalization|6|||
146805547|NCT07204444|529456519|FG001|Overall Study|Medical/Hospitalization|9|||
146805548|NCT07204444|529456520|FG002|Overall Study|Medical/Hospitalization|6|||
146805549|NCT07204444|529456518|FG000|Overall Study|Treatment Provider Issue|1|||
146805550|NCT07204444|529456519|FG001|Overall Study|Treatment Provider Issue|3|||
146805551|NCT07204444|529456520|FG002|Overall Study|Treatment Provider Issue|0|||
146805552|NCT07204444|529456518|FG000|Overall Study|Withdrawal by Subject|11|||
146805553|NCT07204444|529456519|FG001|Overall Study|Withdrawal by Subject|5|||
146805554|NCT07204444|529456520|FG002|Overall Study|Withdrawal by Subject|5|||
146805555|NCT07204444|529456518|FG000|Overall Study|Death|3|||
146805556|NCT07204444|529456519|FG001|Overall Study|Death|6|||
146805557|NCT07204444|529456520|FG002|Overall Study|Death|1|||
146805558|NCT07204444|529456518|FG000|Overall Study|Unable To Reach|29|||
146805559|NCT07204444|529456519|FG001|Overall Study|Unable To Reach|26|||
146805560|NCT07204444|529456520|FG002|Overall Study|Unable To Reach|17|||
146805561|NCT07204444|529456518|FG000|Overall Study|Protocol Deviation|3|||
146805562|NCT07204444|529456519|FG001|Overall Study|Protocol Deviation|2|||
146805563|NCT07204444|529456520|FG002|Overall Study|Protocol Deviation|0|||
146805564|NCT04083976|529457642|FG000|Overall Study|Lost to Follow-up|3|||
146805565|NCT04083976|529457643|FG001|Overall Study|Lost to Follow-up|0|||
146805566|NCT04083976|529457644|FG002|Overall Study|Lost to Follow-up|0|||
146805567|NCT04083976|529457645|FG003|Overall Study|Lost to Follow-up|1|||
146805568|NCT04083976|529457642|FG000|Overall Study|Withdrawal by Subject|16|||
146805569|NCT04083976|529457643|FG001|Overall Study|Withdrawal by Subject|1|||
146805570|NCT04083976|529457644|FG002|Overall Study|Withdrawal by Subject|9|||
146805571|NCT04083976|529457645|FG003|Overall Study|Withdrawal by Subject|0|||
146805572|NCT04083976|529457642|FG000|Overall Study|Sponsor Decision|14|||
146805573|NCT04083976|529457643|FG001|Overall Study|Sponsor Decision|0|||
146805574|NCT04083976|529457644|FG002|Overall Study|Sponsor Decision|0|||
146805575|NCT04083976|529457645|FG003|Overall Study|Sponsor Decision|7|||
146805576|NCT04083976|529457642|FG000|Overall Study|Other|1|||
146805577|NCT04083976|529457643|FG001|Overall Study|Other|0|||
146805578|NCT04083976|529457644|FG002|Overall Study|Other|1|||
146805579|NCT04083976|529457645|FG003|Overall Study|Other|0|||
146805580|NCT00512252|529457651|FG000|Overall Study|Lost to Follow-up|0|||
146805581|NCT00512252|529457652|FG001|Overall Study|Lost to Follow-up|0|||
146805582|NCT00512252|529457653|FG002|Overall Study|Lost to Follow-up|1|||
146805583|NCT00512252|529457651|FG000|Overall Study|Protocol Violation|0|||
146805584|NCT00512252|529457652|FG001|Overall Study|Protocol Violation|0|||
146805585|NCT00512252|529457653|FG002|Overall Study|Protocol Violation|1|||
146805586|NCT00512252|529457651|FG000|Overall Study|Death|0|||
146805587|NCT00512252|529457652|FG001|Overall Study|Death|0|||
146805588|NCT00512252|529457653|FG002|Overall Study|Death|1|||
146805589|NCT02357966|529457654|FG000|Overall Study|Death|0|||
146805590|NCT02357966|529457655|FG001|Overall Study|Death|0|||
146805591|NCT02357966|529457656|FG002|Overall Study|Death|1|||
146805592|NCT02357966|529457657|FG003|Overall Study|Death|0|||
146805593|NCT02357966|529457658|FG004|Overall Study|Death|2|||
146805594|NCT02357966|529457659|FG005|Overall Study|Death|0|||
146805595|NCT02357966|529457654|FG000|Overall Study|Physician Decision|1|||
146805596|NCT02357966|529457655|FG001|Overall Study|Physician Decision|0|||
146805597|NCT02357966|529457656|FG002|Overall Study|Physician Decision|0|||
146805598|NCT02357966|529457657|FG003|Overall Study|Physician Decision|0|||
146805599|NCT02357966|529457658|FG004|Overall Study|Physician Decision|1|||
146805600|NCT02357966|529457659|FG005|Overall Study|Physician Decision|0|||
146805601|NCT01779700|529457660|FG000|Overall Study|Adverse Event|4|||
146805602|NCT01779700|529457661|FG001|Overall Study|Adverse Event|3|||
146805603|NCT01779700|529457660|FG000|Overall Study|Withdrawal by Subject|0|||
146805604|NCT01779700|529457661|FG001|Overall Study|Withdrawal by Subject|2|||
146805605|NCT00442104|529457664|FG000|Overall Study|Adverse Event|5|||
146805606|NCT00442104|529457664|FG000|Overall Study|Death|2|||
146805607|NCT00442104|529457664|FG000|Overall Study|Lost to Follow-up|3|||
146805608|NCT00442104|529457664|FG000|Overall Study|Withdrawal by Subject|5|||
146805609|NCT00442104|529457664|FG000|Overall Study|Insufficient Clinical Response|10|||
146805610|NCT00442104|529457664|FG000|Overall Study|Other|21|||
146805611|NCT00442104|529457664|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
146805612|NCT04608409|529457665|FG000|Overall Study|Physician Decision|1|||
146805613|NCT04608409|529457666|FG001|Overall Study|Physician Decision|1|||
146805614|NCT04608409|529457667|FG002|Overall Study|Physician Decision|2|||
146805615|NCT04497415|529457668|FG000|Overall Study|Lost to Follow-up|43|||
146805616|NCT04497415|529457669|FG001|Overall Study|Lost to Follow-up|27|||
146805617|NCT00683800|529457671|FG000|Overall Study|Adverse Event|195|||
146805618|NCT00683800|529457672|FG001|Overall Study|Adverse Event|102|||
146805619|NCT00683800|529457671|FG000|Overall Study|Death|0|||
146805620|NCT00683800|529457672|FG001|Overall Study|Death|1|||
146805621|NCT00683800|529457671|FG000|Overall Study|Lost to Follow-up|57|||
146805622|NCT00683800|529457672|FG001|Overall Study|Lost to Follow-up|44|||
146805623|NCT00683800|529457671|FG000|Overall Study|Other|5|||
146805624|NCT00683800|529457672|FG001|Overall Study|Other|2|||
146805625|NCT00683800|529457671|FG000|Overall Study|Protocol Violation|13|||
146805626|NCT00683800|529457672|FG001|Overall Study|Protocol Violation|16|||
146805627|NCT00683800|529457671|FG000|Overall Study|Withdrawal by Subject|66|||
146942010|NCT01224106|529948017|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
146942011|NCT01224106|529948018|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
146805628|NCT00683800|529457672|FG001|Overall Study|Withdrawal by Subject|64|||
146805629|NCT00683800|529457671|FG000|Overall Study|Lack of Efficacy|61|||
146805630|NCT00683800|529457672|FG001|Overall Study|Lack of Efficacy|104|||
146805631|NCT00683800|529457671|FG000|Overall Study|Randomized, not treated|35|||
146805632|NCT00683800|529457672|FG001|Overall Study|Randomized, not treated|33|||
146805633|NCT03041233|529457675|FG000|Overall Study|Death|5|||
146805634|NCT03041233|529457675|FG000|Overall Study|Physician Decision|1|||
146942012|NCT01224106|529948019|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
146805635|NCT03041233|529457675|FG000|Overall Study|Lost to Follow-up|16|||
146805636|NCT03041233|529457675|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
146805637|NCT03041233|529457675|FG000|Overall Study|Sponsor Request|1|||
146805638|NCT03041233|529457675|FG000|Overall Study|Duplicate subject|1|||
146805639|NCT03041233|529457675|FG000|Overall Study|Re-ablation|1|||
146805640|NCT01588951|529457688|FG000|Overall Study|Ineligible in retrospect|0|||
146983965|NCT03558997|530102010|FG001|Overall Study|Adverse Event|2|||
146983966|NCT03558997|530102011|FG002|Overall Study|Adverse Event|5|||
146983967|NCT03558997|530102012|FG003|Overall Study|Adverse Event|1|||
146983968|NCT03558997|530102009|FG000|Overall Study|Physician Decision|0|||
146983969|NCT03558997|530102010|FG001|Overall Study|Physician Decision|0|||
146983970|NCT03558997|530102011|FG002|Overall Study|Physician Decision|1|||
146983971|NCT03558997|530102012|FG003|Overall Study|Physician Decision|0|||
146983972|NCT03558997|530102009|FG000|Overall Study|Withdrawal by Subject|1|||
146983973|NCT03558997|530102010|FG001|Overall Study|Withdrawal by Subject|0|||
146983974|NCT03558997|530102011|FG002|Overall Study|Withdrawal by Subject|1|||
146805641|NCT01588951|529457689|FG001|Overall Study|Ineligible in retrospect|0|||
146805642|NCT01588951|529457690|FG002|Overall Study|Ineligible in retrospect|1|||
146805643|NCT01593020|529457691|FG000|Overall Study|Adverse Event|1|||
146805644|NCT01593020|529457692|FG001|Overall Study|Adverse Event|1|||
146805645|NCT01593020|529457691|FG000|Overall Study|Death|0|||
146805646|NCT01593020|529457692|FG001|Overall Study|Death|1|||
146805647|NCT01593020|529457691|FG000|Overall Study|Ineligible|1|||
146805648|NCT01593020|529457692|FG001|Overall Study|Ineligible|0|||
146805649|NCT02350634|529457693|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
146805650|NCT02972359|529457709|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
146805651|NCT02972359|529457709|FG000|Overall Study|Lack of Efficacy|1|||
146805652|NCT02972359|529457709|FG000|Overall Study|Adverse Event|4|||
146805653|NCT02972359|529457709|FG000|Overall Study|Death|1|||
146805654|NCT02972359|529457709|FG000|Overall Study|Withdrawal by Subject|30|||
146805655|NCT02972359|529457709|FG000|Overall Study|Protocol Violation|1|||
146942013|NCT01224106|529948015|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
146942014|NCT01224106|529948016|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
146942015|NCT01224106|529948017|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
146942016|NCT01224106|529948018|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
146942017|NCT01224106|529948019|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
146942018|NCT01224106|529948015|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
146942019|NCT01224106|529948016|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146942020|NCT01224106|529948017|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
146942021|NCT01224106|529948018|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146942022|NCT01224106|529948019|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146942023|NCT01224106|529948015|FG000|Open-Label Extension (OLE) Phase|Death|0|||
146942024|NCT01224106|529948016|FG001|Open-Label Extension (OLE) Phase|Death|0|||
146942025|NCT01224106|529948017|FG002|Open-Label Extension (OLE) Phase|Death|0|||
146942026|NCT01224106|529948018|FG003|Open-Label Extension (OLE) Phase|Death|1|||
146942027|NCT01224106|529948019|FG004|Open-Label Extension (OLE) Phase|Death|3|||
146942028|NCT01224106|529948015|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
146942029|NCT01224106|529948016|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
146942030|NCT01224106|529948017|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
146942031|NCT01224106|529948018|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
146942032|NCT01224106|529948019|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
146942033|NCT01224106|529948015|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
146942034|NCT01224106|529948016|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
146942035|NCT01224106|529948017|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
146942036|NCT01224106|529948018|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
146942037|NCT01224106|529948019|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
146942038|NCT01224106|529948015|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
146942039|NCT01224106|529948016|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
146942040|NCT01224106|529948017|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
146942041|NCT01224106|529948018|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
146942042|NCT01224106|529948019|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
146942043|NCT01224106|529948015|FG000|Open-Label Extension (OLE) Phase|Other|0|||
146942044|NCT01224106|529948016|FG001|Open-Label Extension (OLE) Phase|Other|0|||
146805656|NCT02972359|529457709|FG000|Overall Study|Lost to Follow-up|26|||
146805657|NCT02972359|529457709|FG000|Overall Study|Other reasons|5|||
146942045|NCT01224106|529948017|FG002|Open-Label Extension (OLE) Phase|Other|0|||
146942046|NCT01224106|529948018|FG003|Open-Label Extension (OLE) Phase|Other|5|||
146942047|NCT01224106|529948019|FG004|Open-Label Extension (OLE) Phase|Other|3|||
146942048|NCT00364832|529948020|FG000|Core Period|Early Withdrawals|2|||
146942049|NCT00364832|529948021|FG001|Core Period|Early Withdrawals|2|||
146942050|NCT00364832|529948022|FG002|Core Period|Early Withdrawals|1|||
146942051|NCT00364832|529948023|FG003|Core Period|Early Withdrawals|1|||
146942052|NCT00364832|529948024|FG004|Core Period|Early Withdrawals|0|||
146942053|NCT00364832|529948025|FG005|Core Period|Early Withdrawals|0|||
146942054|NCT00364832|529948026|FG006|Core Period|Early Withdrawals|4|||
146942055|NCT00364832|529948027|FG007|Core Period|Early Withdrawals|1|||
146942056|NCT00364832|529948028|FG008|Core Period|Early Withdrawals|0|||
146983975|NCT03558997|530102012|FG003|Overall Study|Withdrawal by Subject|1|||
146983976|NCT03558997|530102009|FG000|Overall Study|Lost to Follow-up|0|||
146983977|NCT03558997|530102010|FG001|Overall Study|Lost to Follow-up|0|||
146805658|NCT02972359|529457709|FG000|Overall Study|Missing|1|||
146805659|NCT02063659|529457710|FG000|Double-Blind Treatment Period|Adverse Event|1|||
146805660|NCT02063659|529457711|FG001|Double-Blind Treatment Period|Adverse Event|2|||
146805661|NCT02063659|529457712|FG002|Double-Blind Treatment Period|Adverse Event|0|||
146805662|NCT02063659|529457713|FG003|Double-Blind Treatment Period|Adverse Event|0|||
146805663|NCT02063659|529457710|FG000|Double-Blind Treatment Period|Physician Decision|1|||
146805664|NCT02063659|529457711|FG001|Double-Blind Treatment Period|Physician Decision|0|||
146805665|NCT02063659|529457712|FG002|Double-Blind Treatment Period|Physician Decision|0|||
146805666|NCT02063659|529457713|FG003|Double-Blind Treatment Period|Physician Decision|0|||
146805667|NCT02063659|529457710|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
146805668|NCT02063659|529457711|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
146805669|NCT02063659|529457712|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
146805670|NCT02063659|529457713|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
146805671|NCT02063659|529457710|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
146805672|NCT02063659|529457711|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
146805673|NCT02063659|529457712|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
146805674|NCT02063659|529457713|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
146805675|NCT02063659|529457710|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
146805676|NCT02063659|529457711|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
146805677|NCT02063659|529457712|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
146805678|NCT02063659|529457713|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
146805679|NCT02063659|529457710|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
146805680|NCT02063659|529457711|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
146805681|NCT02063659|529457712|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
146805682|NCT02063659|529457713|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
146805683|NCT02063659|529457710|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
146805684|NCT02063659|529457711|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
146805685|NCT02063659|529457712|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
146805686|NCT02063659|529457713|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
146805687|NCT02063659|529457710|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
146805688|NCT02063659|529457711|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
146805689|NCT02063659|529457712|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
146805690|NCT02063659|529457713|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
146805691|NCT00914966|529457714|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
146805692|NCT00914966|529457714|FG000|Step 1: 1500 Units|Physician Decision|1|||
146805693|NCT00914966|529457714|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
146805694|NCT03488719|529457715|FG000|Overall Study|Adverse Event|0|||
146805695|NCT03488719|529457716|FG001|Overall Study|Adverse Event|4|||
146805696|NCT03488719|529457717|FG002|Overall Study|Adverse Event|2|||
146805697|NCT03488719|529457715|FG000|Overall Study|Other|0|||
146805698|NCT03488719|529457716|FG001|Overall Study|Other|0|||
146805699|NCT03488719|529457717|FG002|Overall Study|Other|5|||
146805700|NCT03477175|529457720|FG000|Overall Study|Unable to travel due to COVID-19|0|||
146805701|NCT03477175|529457721|FG001|Overall Study|Unable to travel due to COVID-19|1|||
146805702|NCT03477175|529457720|FG000|Overall Study|Physician Decision|1|||
146805703|NCT03477175|529457721|FG001|Overall Study|Physician Decision|0|||
146805704|NCT03477175|529457720|FG000|Overall Study|Transitioned to commercial drug|6|||
146805705|NCT03477175|529457721|FG001|Overall Study|Transitioned to commercial drug|6|||
146942057|NCT00364832|529948029|FG009|Core Period|Early Withdrawals|0|||
146942058|NCT00364832|529948030|FG010|Core Period|Early Withdrawals|0|||
146942059|NCT00364832|529948031|FG011|Core Period|Early Withdrawals|0|||
146942060|NCT00364832|529948020|FG000|Extension Year 1|Early Withdrawals|0|||
146942061|NCT00364832|529948021|FG001|Extension Year 1|Early Withdrawals|0|||
146942062|NCT00364832|529948022|FG002|Extension Year 1|Early Withdrawals|0|||
146942063|NCT00364832|529948023|FG003|Extension Year 1|Early Withdrawals|0|||
146942064|NCT00364832|529948024|FG004|Extension Year 1|Early Withdrawals|0|||
146942065|NCT00364832|529948025|FG005|Extension Year 1|Early Withdrawals|0|||
146942066|NCT00364832|529948026|FG006|Extension Year 1|Early Withdrawals|0|||
146942067|NCT00364832|529948027|FG007|Extension Year 1|Early Withdrawals|0|||
146942068|NCT00364832|529948028|FG008|Extension Year 1|Early Withdrawals|0|||
146942069|NCT00364832|529948029|FG009|Extension Year 1|Early Withdrawals|4|||
146942070|NCT00364832|529948030|FG010|Extension Year 1|Early Withdrawals|2|||
146942071|NCT00364832|529948031|FG011|Extension Year 1|Early Withdrawals|10|||
146805706|NCT03477175|529457720|FG000|Overall Study|Lost to Follow-up|1|||
146805707|NCT03477175|529457721|FG001|Overall Study|Lost to Follow-up|1|||
146805708|NCT03477175|529457720|FG000|Overall Study|Withdrawal by Subject|3|||
146805709|NCT03477175|529457721|FG001|Overall Study|Withdrawal by Subject|1|||
146942072|NCT00364832|529948020|FG000|Extension Year 2|Early Withdrawals|0|||
146622450|NCT04612725|528789677|FG002|Overall Study|Adverse Event|1|||
146942073|NCT00364832|529948021|FG001|Extension Year 2|Early Withdrawals|0|||
146942074|NCT00364832|529948022|FG002|Extension Year 2|Early Withdrawals|0|||
146942075|NCT00364832|529948023|FG003|Extension Year 2|Early Withdrawals|0|||
146805710|NCT03477175|529457720|FG000|Overall Study|Adverse Event|1|||
146805711|NCT03477175|529457721|FG001|Overall Study|Adverse Event|5|||
146805712|NCT03477175|529457720|FG000|Overall Study|Disease Progression|7|||
146805713|NCT03477175|529457721|FG001|Overall Study|Disease Progression|7|||
146805714|NCT03371017|529457722|FG000|Overall Study|Physician Decision|0|||
146805715|NCT03371017|529457723|FG001|Overall Study|Physician Decision|1|||
146805716|NCT03371017|529457722|FG000|Overall Study|Reason not Specified|0|||
146805717|NCT03371017|529457723|FG001|Overall Study|Reason not Specified|1|||
146805718|NCT03371017|529457722|FG000|Overall Study|Lost to Follow-up|13|||
146805719|NCT03371017|529457723|FG001|Overall Study|Lost to Follow-up|16|||
146805720|NCT03371017|529457722|FG000|Overall Study|Death|228|||
146805721|NCT03371017|529457723|FG001|Overall Study|Death|215|||
146805722|NCT03371017|529457722|FG000|Overall Study|Withdrawal by Subject|20|||
146805723|NCT03371017|529457723|FG001|Overall Study|Withdrawal by Subject|25|||
146805724|NCT03371017|529457722|FG000|Overall Study|Study Ended by Sponsor|37|||
146805725|NCT03371017|529457723|FG001|Overall Study|Study Ended by Sponsor|38|||
146805726|NCT03371017|529457722|FG000|Overall Study|Protocol Deviation|0|||
146805727|NCT03371017|529457723|FG001|Overall Study|Protocol Deviation|1|||
146805728|NCT04300023|529457724|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
146805729|NCT04300023|529457725|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
146805730|NCT01855750|529457726|FG000|Overall Study|Death|78|||
146805731|NCT01855750|529457727|FG001|Overall Study|Death|78|||
146805732|NCT01855750|529457726|FG000|Overall Study|Lost to Follow-up|9|||
146805733|NCT01855750|529457727|FG001|Overall Study|Lost to Follow-up|23|||
146805734|NCT01855750|529457726|FG000|Overall Study|Withdrawal by Subject|35|||
146805735|NCT01855750|529457727|FG001|Overall Study|Withdrawal by Subject|28|||
146805736|NCT01855750|529457726|FG000|Overall Study|Sponsor ends the study|297|||
146805737|NCT01855750|529457727|FG001|Overall Study|Sponsor ends the study|290|||
146805738|NCT05525572|529457728|FG000|Overall Study|Lost to Follow-up|2|||
146805739|NCT05025384|529457735|FG000|Overall Study|Physician Decision|5|||
146805740|NCT05025384|529457736|FG001|Overall Study|Physician Decision|6|||
146805741|NCT03425682|529457737|FG000|Overall Study|Lost to Follow-up|2|||
146805742|NCT03425682|529457738|FG001|Overall Study|Lost to Follow-up|4|||
146805743|NCT03425682|529457737|FG000|Overall Study|Withdrawal by Subject|0|||
146805744|NCT03425682|529457738|FG001|Overall Study|Withdrawal by Subject|3|||
146805745|NCT03425682|529457737|FG000|Overall Study|Subject did not meet I/E|4|||
146805746|NCT03425682|529457738|FG001|Overall Study|Subject did not meet I/E|10|||
146805747|NCT03610581|529457739|FG000|Overall Study|Study terminated by sponsor|2|||
146805748|NCT03610581|529457740|FG001|Overall Study|Study terminated by sponsor|0|||
146805749|NCT03610581|529457739|FG000|Overall Study|Other|0|||
146805750|NCT03610581|529457740|FG001|Overall Study|Other|1|||
146805751|NCT03610581|529457739|FG000|Overall Study|Withdrawal by Subject|1|||
146805752|NCT03610581|529457740|FG001|Overall Study|Withdrawal by Subject|0|||
146805753|NCT05470114|529457744|FG000|Overall Study|Withdrawal by Subject|1|||
146805754|NCT05470114|529457745|FG001|Overall Study|Withdrawal by Subject|0|||
146805755|NCT05470114|529457744|FG000|Overall Study|Lost to Follow-up|1|||
146805756|NCT05470114|529457745|FG001|Overall Study|Lost to Follow-up|0|||
146805757|NCT02488408|529457746|FG000|Part A|Adverse Event|2|||
146805758|NCT02488408|529457747|FG001|Part A|Adverse Event|0|||
146805759|NCT02488408|529457748|FG002|Part A|Adverse Event|0|||
146805760|NCT02488408|529457749|FG003|Part A|Adverse Event|0|||
146805761|NCT02488408|529457750|FG004|Part A|Adverse Event|0|||
146805762|NCT02488408|529457751|FG005|Part A|Adverse Event|0|||
146805763|NCT02488408|529457752|FG006|Part A|Adverse Event|0|||
146805764|NCT02488408|529457753|FG007|Part A|Adverse Event|0|||
146805765|NCT02488408|529457754|FG008|Part A|Adverse Event|0|||
146805766|NCT02488408|529457755|FG009|Part A|Adverse Event|0|||
146805767|NCT02488408|529457746|FG000|Part A|Death|1|||
146805768|NCT02488408|529457747|FG001|Part A|Death|5|||
146805769|NCT02488408|529457748|FG002|Part A|Death|0|||
146805770|NCT02488408|529457749|FG003|Part A|Death|0|||
146805771|NCT02488408|529457750|FG004|Part A|Death|3|||
146805772|NCT02488408|529457751|FG005|Part A|Death|0|||
146805773|NCT02488408|529457752|FG006|Part A|Death|0|||
146805774|NCT02488408|529457753|FG007|Part A|Death|0|||
146805775|NCT02488408|529457754|FG008|Part A|Death|0|||
146805776|NCT02488408|529457755|FG009|Part A|Death|0|||
146622451|NCT04612725|528789678|FG003|Overall Study|Adverse Event|0|||
146805777|NCT02488408|529457746|FG000|Part A|Disease Progression|2|||
146805778|NCT02488408|529457747|FG001|Part A|Disease Progression|8|||
146805779|NCT02488408|529457748|FG002|Part A|Disease Progression|2|||
146805780|NCT02488408|529457749|FG003|Part A|Disease Progression|3|||
146805781|NCT02488408|529457750|FG004|Part A|Disease Progression|4|||
146805782|NCT02488408|529457751|FG005|Part A|Disease Progression|0|||
146805783|NCT02488408|529457752|FG006|Part A|Disease Progression|0|||
146805784|NCT02488408|529457753|FG007|Part A|Disease Progression|0|||
146805785|NCT02488408|529457754|FG008|Part A|Disease Progression|0|||
146805786|NCT02488408|529457755|FG009|Part A|Disease Progression|0|||
146805787|NCT02488408|529457746|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
146805788|NCT02488408|529457747|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
146805789|NCT02488408|529457748|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
146983978|NCT03558997|530102011|FG002|Overall Study|Lost to Follow-up|1|||
146805790|NCT02488408|529457749|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
146805791|NCT02488408|529457750|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
146805792|NCT02488408|529457751|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
146805793|NCT02488408|529457752|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
146805794|NCT02488408|529457753|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
146805795|NCT02488408|529457754|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
146805796|NCT02488408|529457755|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
146805797|NCT02488408|529457746|FG000|Part A|Investigator Decision|0|||
146805798|NCT02488408|529457747|FG001|Part A|Investigator Decision|1|||
146805799|NCT02488408|529457748|FG002|Part A|Investigator Decision|1|||
146805800|NCT02488408|529457749|FG003|Part A|Investigator Decision|0|||
146805801|NCT02488408|529457750|FG004|Part A|Investigator Decision|0|||
146805802|NCT02488408|529457751|FG005|Part A|Investigator Decision|0|||
146805803|NCT02488408|529457752|FG006|Part A|Investigator Decision|0|||
146805804|NCT02488408|529457753|FG007|Part A|Investigator Decision|0|||
146805805|NCT02488408|529457754|FG008|Part A|Investigator Decision|0|||
146805806|NCT02488408|529457755|FG009|Part A|Investigator Decision|0|||
146805807|NCT02488408|529457746|FG000|Part A|Withdrawal by Subject|0|||
146805808|NCT02488408|529457747|FG001|Part A|Withdrawal by Subject|0|||
146805809|NCT02488408|529457748|FG002|Part A|Withdrawal by Subject|2|||
146805810|NCT02488408|529457749|FG003|Part A|Withdrawal by Subject|0|||
146805811|NCT02488408|529457750|FG004|Part A|Withdrawal by Subject|0|||
146805812|NCT02488408|529457751|FG005|Part A|Withdrawal by Subject|0|||
146805813|NCT02488408|529457752|FG006|Part A|Withdrawal by Subject|0|||
146805814|NCT02488408|529457753|FG007|Part A|Withdrawal by Subject|0|||
146805815|NCT02488408|529457754|FG008|Part A|Withdrawal by Subject|0|||
146805816|NCT02488408|529457755|FG009|Part A|Withdrawal by Subject|0|||
146805817|NCT02488408|529457746|FG000|Part A|Other|1|||
146805818|NCT02488408|529457747|FG001|Part A|Other|0|||
146805819|NCT02488408|529457748|FG002|Part A|Other|0|||
146805820|NCT02488408|529457749|FG003|Part A|Other|0|||
146805821|NCT02488408|529457750|FG004|Part A|Other|0|||
146805822|NCT02488408|529457751|FG005|Part A|Other|0|||
146805823|NCT02488408|529457752|FG006|Part A|Other|0|||
146805824|NCT02488408|529457753|FG007|Part A|Other|0|||
146805825|NCT02488408|529457754|FG008|Part A|Other|0|||
146805826|NCT02488408|529457755|FG009|Part A|Other|0|||
146805827|NCT02488408|529457746|FG000|Part B|Adverse Event|0|||
146805828|NCT02488408|529457747|FG001|Part B|Adverse Event|0|||
146805829|NCT02488408|529457748|FG002|Part B|Adverse Event|0|||
146805830|NCT02488408|529457749|FG003|Part B|Adverse Event|0|||
146805831|NCT02488408|529457750|FG004|Part B|Adverse Event|0|||
146805832|NCT02488408|529457751|FG005|Part B|Adverse Event|2|||
146805833|NCT02488408|529457752|FG006|Part B|Adverse Event|2|||
146805834|NCT02488408|529457753|FG007|Part B|Adverse Event|7|||
146805835|NCT02488408|529457754|FG008|Part B|Adverse Event|2|||
146805836|NCT02488408|529457755|FG009|Part B|Adverse Event|2|||
146805837|NCT02488408|529457746|FG000|Part B|Death|0|||
146805838|NCT02488408|529457747|FG001|Part B|Death|0|||
146805839|NCT02488408|529457748|FG002|Part B|Death|0|||
146805840|NCT02488408|529457749|FG003|Part B|Death|0|||
146805841|NCT02488408|529457750|FG004|Part B|Death|0|||
146805842|NCT02488408|529457751|FG005|Part B|Death|3|||
146805843|NCT02488408|529457752|FG006|Part B|Death|1|||
146805844|NCT02488408|529457753|FG007|Part B|Death|2|||
146942076|NCT00364832|529948024|FG004|Extension Year 2|Early Withdrawals|0|||
146942077|NCT00364832|529948025|FG005|Extension Year 2|Early Withdrawals|0|||
146942078|NCT00364832|529948026|FG006|Extension Year 2|Early Withdrawals|0|||
146942079|NCT00364832|529948027|FG007|Extension Year 2|Early Withdrawals|0|||
146942080|NCT00364832|529948028|FG008|Extension Year 2|Early Withdrawals|0|||
146942081|NCT00364832|529948029|FG009|Extension Year 2|Early Withdrawals|5|||
146942082|NCT00364832|529948030|FG010|Extension Year 2|Early Withdrawals|5|||
146942083|NCT00364832|529948031|FG011|Extension Year 2|Early Withdrawals|3|||
146622452|NCT04612725|528789679|FG004|Overall Study|Adverse Event|1|||
146805845|NCT02488408|529457754|FG008|Part B|Death|2|||
146805846|NCT02488408|529457755|FG009|Part B|Death|2|||
146805847|NCT02488408|529457746|FG000|Part B|Death due to Disease Progression|0|||
146805848|NCT02488408|529457747|FG001|Part B|Death due to Disease Progression|0|||
146805849|NCT02488408|529457748|FG002|Part B|Death due to Disease Progression|0|||
146805850|NCT02488408|529457749|FG003|Part B|Death due to Disease Progression|0|||
146805851|NCT02488408|529457750|FG004|Part B|Death due to Disease Progression|0|||
146805852|NCT02488408|529457751|FG005|Part B|Death due to Disease Progression|2|||
146805853|NCT02488408|529457752|FG006|Part B|Death due to Disease Progression|2|||
146942084|NCT00839436|529948038|FG000|Overall Study|Developed exclusionary condition|1|||
146805854|NCT02488408|529457753|FG007|Part B|Death due to Disease Progression|1|||
146805855|NCT02488408|529457754|FG008|Part B|Death due to Disease Progression|1|||
146805856|NCT02488408|529457755|FG009|Part B|Death due to Disease Progression|1|||
146805857|NCT02488408|529457746|FG000|Part B|Disease Progression|0|||
146805858|NCT02488408|529457747|FG001|Part B|Disease Progression|0|||
146805859|NCT02488408|529457748|FG002|Part B|Disease Progression|0|||
146805860|NCT02488408|529457749|FG003|Part B|Disease Progression|0|||
146942085|NCT00839436|529948039|FG001|Overall Study|Developed exclusionary condition|0|||
146942086|NCT00839436|529948040|FG002|Overall Study|Developed exclusionary condition|0|||
146942087|NCT00839436|529948038|FG000|Overall Study|Withdrawal by Subject|0|||
146942088|NCT00839436|529948039|FG001|Overall Study|Withdrawal by Subject|1|||
146942089|NCT00839436|529948040|FG002|Overall Study|Withdrawal by Subject|0|||
146942090|NCT00839436|529948038|FG000|Overall Study|Study drug no longer available|0|||
146942091|NCT00839436|529948039|FG001|Overall Study|Study drug no longer available|0|||
146942092|NCT00839436|529948040|FG002|Overall Study|Study drug no longer available|1|||
146942093|NCT01440972|529948041|FG000|Overall Study|Withdrawal by Subject|3|||
146942094|NCT01440972|529948042|FG001|Overall Study|Withdrawal by Subject|2|||
146942095|NCT03933215|529948043|FG000|Overall Study|Other|6|||
146942096|NCT03933215|529948043|FG000|Overall Study|Sponsor decision|5|||
146942097|NCT03933215|529948043|FG000|Overall Study|Protocol Violation|5|||
146942098|NCT03933215|529948043|FG000|Overall Study|Withdrawal by Subject|6|||
146942099|NCT03933215|529948043|FG000|Overall Study|Lost to Follow-up|6|||
146942100|NCT03933215|529948043|FG000|Overall Study|Enrolled but not treated|38|||
146942101|NCT05784129|529948044|FG000|Overall Study|Study terminated by sponsor|2|||
146942102|NCT05784129|529948045|FG001|Overall Study|Study terminated by sponsor|2|||
146805861|NCT02488408|529457750|FG004|Part B|Disease Progression|0|||
146805862|NCT02488408|529457751|FG005|Part B|Disease Progression|6|||
146805863|NCT02488408|529457752|FG006|Part B|Disease Progression|9|||
146805864|NCT02488408|529457753|FG007|Part B|Disease Progression|7|||
146805865|NCT02488408|529457754|FG008|Part B|Disease Progression|9|||
146805866|NCT02488408|529457755|FG009|Part B|Disease Progression|11|||
146805867|NCT02488408|529457746|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
146805868|NCT02488408|529457747|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
146805869|NCT02488408|529457748|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
146805870|NCT02488408|529457749|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
146805871|NCT02488408|529457750|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
146805872|NCT02488408|529457751|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
146805873|NCT02488408|529457752|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
146805874|NCT02488408|529457753|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
146805875|NCT02488408|529457754|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
146805876|NCT02488408|529457755|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
146805877|NCT02488408|529457746|FG000|Part B|Investigator Decision|0|||
146805878|NCT02488408|529457747|FG001|Part B|Investigator Decision|0|||
146805879|NCT02488408|529457748|FG002|Part B|Investigator Decision|0|||
146805880|NCT02488408|529457749|FG003|Part B|Investigator Decision|0|||
146805881|NCT02488408|529457750|FG004|Part B|Investigator Decision|0|||
146805882|NCT02488408|529457751|FG005|Part B|Investigator Decision|0|||
146805883|NCT02488408|529457752|FG006|Part B|Investigator Decision|1|||
146805884|NCT02488408|529457753|FG007|Part B|Investigator Decision|0|||
146805885|NCT02488408|529457754|FG008|Part B|Investigator Decision|2|||
146805886|NCT02488408|529457755|FG009|Part B|Investigator Decision|1|||
146805887|NCT00719888|529457756|FG000|Overall Study|Death|24|||
146805888|NCT00719888|529457757|FG001|Overall Study|Death|9|||
146805889|NCT00719888|529457756|FG000|Overall Study|Relapse|8|||
146805890|NCT00719888|529457757|FG001|Overall Study|Relapse|3|||
146805891|NCT00719888|529457756|FG000|Overall Study|Physician Decision|1|||
146942103|NCT00407550|529948046|FG000|Overall Study|Adverse Event|0|||
146942104|NCT00407550|529948047|FG001|Overall Study|Adverse Event|1|||
146942105|NCT00407550|529948046|FG000|Overall Study|Withdrawal by Subject|0|||
146942106|NCT00407550|529948047|FG001|Overall Study|Withdrawal by Subject|2|||
146942107|NCT00407550|529948046|FG000|Overall Study|Death|1|||
146942108|NCT00407550|529948047|FG001|Overall Study|Death|0|||
146942109|NCT00407550|529948046|FG000|Overall Study|Insurance or Other medical condition|2|||
146942110|NCT00407550|529948047|FG001|Overall Study|Insurance or Other medical condition|1|||
146942111|NCT02580591|529948049|FG000|Overall Study|Adverse Event|0|||
146942112|NCT02580591|529948050|FG001|Overall Study|Adverse Event|1|||
146942113|NCT02580591|529948051|FG002|Overall Study|Adverse Event|2|||
146942114|NCT02580591|529948052|FG003|Overall Study|Adverse Event|5|||
146942115|NCT02580591|529948049|FG000|Overall Study|Protocol Violation|3|||
146942116|NCT02580591|529948050|FG001|Overall Study|Protocol Violation|2|||
146942117|NCT02580591|529948051|FG002|Overall Study|Protocol Violation|1|||
146942118|NCT02580591|529948052|FG003|Overall Study|Protocol Violation|1|||
146942119|NCT02580591|529948049|FG000|Overall Study|Lost to Follow-up|5|||
146942120|NCT02580591|529948050|FG001|Overall Study|Lost to Follow-up|3|||
146942121|NCT02580591|529948051|FG002|Overall Study|Lost to Follow-up|3|||
146942122|NCT02580591|529948052|FG003|Overall Study|Lost to Follow-up|1|||
146942123|NCT02580591|529948049|FG000|Overall Study|Withdrawal by Subject|6|||
146942124|NCT02580591|529948050|FG001|Overall Study|Withdrawal by Subject|1|||
146942125|NCT02580591|529948051|FG002|Overall Study|Withdrawal by Subject|2|||
146805892|NCT00719888|529457757|FG001|Overall Study|Physician Decision|0|||
146805893|NCT00719888|529457756|FG000|Overall Study|Withdrawal by Subject|1|||
146805894|NCT00719888|529457757|FG001|Overall Study|Withdrawal by Subject|0|||
146805895|NCT05037513|529457758|FG000|Intervention Period|Lost to Follow-up|1|||
146805896|NCT05037513|529457759|FG001|Intervention Period|Lost to Follow-up|2|||
146942126|NCT02580591|529948052|FG003|Overall Study|Withdrawal by Subject|3|||
146942127|NCT02580591|529948049|FG000|Overall Study|Not treated|1|||
146805897|NCT05037513|529457758|FG000|Follow Up Period|Lost to Follow-up|16|||
146805898|NCT05037513|529457759|FG001|Follow Up Period|Lost to Follow-up|21|||
146805899|NCT05037513|529457758|FG000|Follow Up Period|Death|0|||
146805900|NCT05037513|529457759|FG001|Follow Up Period|Death|1|||
146805901|NCT05037513|529457758|FG000|Follow Up Period|Incarcerated|4|||
146805902|NCT05037513|529457759|FG001|Follow Up Period|Incarcerated|2|||
146805903|NCT04577651|529457760|FG000|Overall Study|Screen Failure|7|||
146805904|NCT04577651|529457760|FG000|Overall Study|Adverse Event|1|||
146805905|NCT04577651|529457760|FG000|Overall Study|Death|1|||
146805906|NCT04577651|529457760|FG000|Overall Study|Physician Decision|1|||
146805907|NCT04577651|529457760|FG000|Overall Study|Withdrawal by Subject|3|||
146805908|NCT02386098|529458911|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
146805909|NCT02386098|529458912|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
146805910|NCT02386098|529458913|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
146805911|NCT02386098|529458914|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
146805912|NCT02386098|529458915|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
146805913|NCT02386098|529458911|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
146805914|NCT02386098|529458912|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
146805915|NCT02386098|529458913|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
146805916|NCT02386098|529458914|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
146805917|NCT02386098|529458915|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
146805918|NCT02386098|529458911|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
146805919|NCT02386098|529458912|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
146805920|NCT02386098|529458913|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
146805921|NCT02386098|529458914|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
146805922|NCT02386098|529458915|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
146805923|NCT02386098|529458911|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
146805924|NCT02386098|529458912|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
146805925|NCT02386098|529458913|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
146805926|NCT02386098|529458914|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
146805927|NCT02386098|529458915|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
146805928|NCT02386098|529458911|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
146805929|NCT02386098|529458912|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
146805930|NCT02386098|529458913|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
146805931|NCT02386098|529458914|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
146805932|NCT02386098|529458915|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
146805933|NCT02386098|529458911|FG000|Stage 1 (96 Weeks)|Other|1|||
146805934|NCT02386098|529458912|FG001|Stage 1 (96 Weeks)|Other|0|||
146805935|NCT02386098|529458913|FG002|Stage 1 (96 Weeks)|Other|0|||
146805936|NCT02386098|529458914|FG003|Stage 1 (96 Weeks)|Other|0|||
146805937|NCT02386098|529458915|FG004|Stage 1 (96 Weeks)|Other|0|||
146805938|NCT02386098|529458911|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
146805939|NCT02386098|529458912|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
146805940|NCT02386098|529458913|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
146805941|NCT02386098|529458914|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
146805942|NCT02386098|529458915|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
146805943|NCT03861052|529458916|FG000|Overall Study|Adverse Event|1|||
146805944|NCT03861052|529458917|FG001|Overall Study|Adverse Event|1|||
146805945|NCT03861052|529458918|FG002|Overall Study|Adverse Event|2|||
146805946|NCT03861052|529458919|FG003|Overall Study|Adverse Event|4|||
146805947|NCT03861052|529458916|FG000|Overall Study|Lost to Follow-up|0|||
146805948|NCT03861052|529458917|FG001|Overall Study|Lost to Follow-up|0|||
146805949|NCT03861052|529458918|FG002|Overall Study|Lost to Follow-up|0|||
146805950|NCT03861052|529458919|FG003|Overall Study|Lost to Follow-up|1|||
146805951|NCT03861052|529458916|FG000|Overall Study|Physician Decision|0|||
146805952|NCT03861052|529458917|FG001|Overall Study|Physician Decision|1|||
146805953|NCT03861052|529458918|FG002|Overall Study|Physician Decision|0|||
146805954|NCT03861052|529458919|FG003|Overall Study|Physician Decision|0|||
146805955|NCT03861052|529458916|FG000|Overall Study|Withdrawal by Subject|2|||
146805956|NCT03861052|529458917|FG001|Overall Study|Withdrawal by Subject|5|||
146805957|NCT03861052|529458918|FG002|Overall Study|Withdrawal by Subject|3|||
146942128|NCT02580591|529948050|FG001|Overall Study|Not treated|1|||
146805958|NCT03861052|529458919|FG003|Overall Study|Withdrawal by Subject|0|||
146805959|NCT03861052|529458916|FG000|Overall Study|Relocation to other city|1|||
146805960|NCT03861052|529458917|FG001|Overall Study|Relocation to other city|0|||
146805961|NCT03861052|529458918|FG002|Overall Study|Relocation to other city|0|||
146805962|NCT03861052|529458919|FG003|Overall Study|Relocation to other city|0|||
146805963|NCT00705406|529458922|FG000|Overall Study|Lost to Follow-up|3|||
146942129|NCT02580591|529948051|FG002|Overall Study|Not treated|0|||
146805964|NCT00705406|529458923|FG001|Overall Study|Lost to Follow-up|3|||
146805965|NCT00705406|529458922|FG000|Overall Study|Did not receive study drug|1|||
146805966|NCT00705406|529458923|FG001|Overall Study|Did not receive study drug|2|||
146805967|NCT03712371|529458928|FG000|Overall Study|Lack of Efficacy|0|||
146805968|NCT03712371|529458929|FG001|Overall Study|Lack of Efficacy|0|||
146942130|NCT02580591|529948052|FG003|Overall Study|Not treated|0|||
146805969|NCT03712371|529458930|FG002|Overall Study|Lack of Efficacy|0|||
146805970|NCT03712371|529458931|FG003|Overall Study|Lack of Efficacy|1|||
146805971|NCT02362035|529458934|FG000|Overall Study|Death|67|||
146805972|NCT02362035|529458934|FG000|Overall Study|Lost to Follow-up|3|||
146805973|NCT02362035|529458934|FG000|Overall Study|Adverse Event|1|||
146805974|NCT02362035|529458934|FG000|Overall Study|Physician Decision|1|||
146805975|NCT02362035|529458934|FG000|Overall Study|Subject started another cancer therapy|10|||
146805976|NCT02362035|529458934|FG000|Overall Study|Study terminated by sponsor|45|||
146983979|NCT03558997|530102012|FG003|Overall Study|Lost to Follow-up|0|||
146805977|NCT02362035|529458934|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
146805978|NCT02362035|529458934|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
146805979|NCT02362035|529458934|FG000|Overall Study|Disease progression|11|||
146805980|NCT02362035|529458934|FG000|Overall Study|Withdrawal by Subject|20|||
146805981|NCT00229658|529458944|FG000|Overall Study|Administrative|2|||
146805982|NCT00229658|529458945|FG001|Overall Study|Administrative|1|||
146805983|NCT00229658|529458944|FG000|Overall Study|Investigator decision|13|||
146805984|NCT00229658|529458945|FG001|Overall Study|Investigator decision|10|||
146805985|NCT00229658|529458944|FG000|Overall Study|Other|80|||
146805986|NCT00229658|529458945|FG001|Overall Study|Other|60|||
146805987|NCT00229658|529458944|FG000|Overall Study|Lost to Follow-up|82|||
146805988|NCT00229658|529458945|FG001|Overall Study|Lost to Follow-up|55|||
146805989|NCT00229658|529458944|FG000|Overall Study|Serious Adverse Event|2|||
146805990|NCT00229658|529458945|FG001|Overall Study|Serious Adverse Event|2|||
146805991|NCT00229658|529458944|FG000|Overall Study|Withdrawal of consent|46|||
146805992|NCT00229658|529458945|FG001|Overall Study|Withdrawal of consent|39|||
146805993|NCT02157116|529458946|FG000|Overall Study|Withdrawal by Subject|4|||
146805994|NCT02157116|529458946|FG000|Overall Study|Physician Decision|3|||
146805995|NCT02157116|529458946|FG000|Overall Study|Failed Screening|2|||
146805996|NCT00975585|529458947|FG000|Overall Study|Adverse Event|0|||
146805997|NCT00975585|529458948|FG001|Overall Study|Adverse Event|4|||
146805998|NCT00975585|529458947|FG000|Overall Study|Lost to Follow-up|3|||
146805999|NCT00975585|529458948|FG001|Overall Study|Lost to Follow-up|5|||
146806000|NCT00975585|529458947|FG000|Overall Study|Withdrawal by Subject|2|||
146806001|NCT00975585|529458948|FG001|Overall Study|Withdrawal by Subject|1|||
146806002|NCT00975585|529458947|FG000|Overall Study|Lens issue|2|||
146806003|NCT00975585|529458948|FG001|Overall Study|Lens issue|2|||
146806004|NCT01953224|529458949|FG000|Overall Study|Lost to Follow-up|1|||
146806005|NCT01953224|529458950|FG001|Overall Study|Lost to Follow-up|1|||
146806006|NCT01953224|529458949|FG000|Overall Study|Withdrawal by Subject|1|||
146806007|NCT01953224|529458950|FG001|Overall Study|Withdrawal by Subject|2|||
146806008|NCT00205179|529458953|FG000|Overall Study|Death|0|||
146806009|NCT00205179|529458954|FG001|Overall Study|Death|2|||
146806010|NCT00205179|529458953|FG000|Overall Study|Physician Decision|1|||
146806011|NCT00205179|529458954|FG001|Overall Study|Physician Decision|1|||
146806012|NCT00205179|529458953|FG000|Overall Study|Adverse Event|1|||
146806013|NCT00205179|529458954|FG001|Overall Study|Adverse Event|1|||
146806014|NCT00463229|529458955|FG000|Overall Study|Lost to Follow-up|5|||
146806015|NCT00463229|529458956|FG001|Overall Study|Lost to Follow-up|7|||
146806016|NCT00463229|529458955|FG000|Overall Study|Death|4|||
146806017|NCT00463229|529458956|FG001|Overall Study|Death|3|||
146806018|NCT01767467|529458963|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
146806019|NCT01767467|529458964|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
146806020|NCT01767467|529458963|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
146806021|NCT01767467|529458964|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
146806022|NCT01767467|529458963|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
146806023|NCT01767467|529458964|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
146806024|NCT01767467|529458963|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
146806025|NCT01767467|529458964|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
146806026|NCT01767467|529458963|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
146806027|NCT01767467|529458964|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
146806028|NCT01767467|529458963|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
146806029|NCT01767467|529458964|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
146806030|NCT01767467|529458963|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
146806031|NCT01767467|529458964|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
146806032|NCT01767467|529458963|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
146806033|NCT01767467|529458964|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
146806034|NCT01767467|529458963|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
146806035|NCT01767467|529458964|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
146806036|NCT01767467|529458963|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
146806037|NCT01767467|529458964|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
146806038|NCT01767467|529458963|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
146806039|NCT01767467|529458964|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
146806040|NCT01767467|529458963|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
146983980|NCT01688037|530102015|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
146942131|NCT02580591|529948049|FG000|Overall Study|Other than specified|3|||
146942132|NCT02580591|529948050|FG001|Overall Study|Other than specified|2|||
146942133|NCT02580591|529948051|FG002|Overall Study|Other than specified|5|||
146942134|NCT02580591|529948052|FG003|Overall Study|Other than specified|2|||
146942135|NCT01266070|529948054|FG000|Overall Study|Adverse Event|3|||
146942136|NCT01266070|529948054|FG000|Overall Study|Protocol Violation|1|||
146942137|NCT01838213|529948055|FG000|Overall Study|Ineligible|166|||
146942138|NCT01838213|529948056|FG001|Overall Study|Ineligible|191|||
146942139|NCT04882072|529948057|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
146942140|NCT04882072|529948058|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
146942141|NCT04882072|529948057|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
146942142|NCT04882072|529948058|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
146942143|NCT04882072|529948057|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
146942144|NCT04882072|529948058|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
146806041|NCT01767467|529458964|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
146806042|NCT01767467|529458963|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
146806043|NCT01767467|529458964|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
146806044|NCT01767467|529458963|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
146806045|NCT01767467|529458964|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
146806046|NCT01359150|529458965|FG000|Overall Study|Lack of Efficacy|1|||
146806047|NCT01359150|529458966|FG001|Overall Study|Lack of Efficacy|1|||
146806048|NCT01359150|529458965|FG000|Overall Study|Withdrawal by Subject|1|||
146806049|NCT01359150|529458966|FG001|Overall Study|Withdrawal by Subject|1|||
146806050|NCT01359150|529458965|FG000|Overall Study|Adverse Event|4|||
146806051|NCT01359150|529458966|FG001|Overall Study|Adverse Event|3|||
146806052|NCT01359150|529458965|FG000|Overall Study|Other|1|||
146806053|NCT01359150|529458966|FG001|Overall Study|Other|0|||
146806054|NCT01787032|529458969|FG000|Overall Study|Protocol Violation|0|||
146806055|NCT01787032|529458970|FG001|Overall Study|Protocol Violation|0|||
146806056|NCT01787032|529458971|FG002|Overall Study|Protocol Violation|0|||
146806057|NCT01787032|529458972|FG003|Overall Study|Protocol Violation|0|||
146806058|NCT01787032|529458973|FG004|Overall Study|Protocol Violation|1|||
146806059|NCT01787032|529458974|FG005|Overall Study|Protocol Violation|1|||
146806060|NCT02040870|529458975|FG000|Overall Study|Completed treatment phase|6|||
146806061|NCT02040870|529458975|FG000|Overall Study|Adverse Event|7|||
146806062|NCT02040870|529458975|FG000|Overall Study|Progressive disease|58|||
146806063|NCT02040870|529458975|FG000|Overall Study|Physician Decision|6|||
146806064|NCT02040870|529458975|FG000|Overall Study|Subject/guardian decision|10|||
146806065|NCT02040870|529458975|FG000|Overall Study|Lost to Follow-up|3|||
146806066|NCT02040870|529458975|FG000|Overall Study|Death|13|||
146806067|NCT00853593|529458979|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
146806068|NCT00853593|529458979|FG000|Overall Study|Model 4396 lead not attempted|29|||
146806069|NCT00853593|529458979|FG000|Overall Study|Implant not attempted|4|||
146806070|NCT03890289|529458980|FG000|Overall Study|Adverse Event|1|||
146806071|NCT03890289|529458980|FG000|Overall Study|Physician Decision|1|||
146806072|NCT03890289|529458980|FG000|Overall Study|Lack of Efficacy|2|||
146806073|NCT02816398|529458981|FG000|Overall Study|Death|5|||
146806074|NCT02816398|529458981|FG000|Overall Study|Lack of Efficacy|8|||
146806075|NCT02816398|529458981|FG000|Overall Study|Lost to Follow-up|1|||
146806076|NCT03362190|529458982|FG000|Overall Study|Adverse Event|0|||
146806077|NCT03362190|529458983|FG001|Overall Study|Adverse Event|0|||
146806078|NCT03362190|529458984|FG002|Overall Study|Adverse Event|0|||
146806079|NCT03362190|529458985|FG003|Overall Study|Adverse Event|1|||
146806080|NCT03362190|529458982|FG000|Overall Study|Withdrawal by Subject|0|||
146806081|NCT03362190|529458983|FG001|Overall Study|Withdrawal by Subject|0|||
146806082|NCT03362190|529458984|FG002|Overall Study|Withdrawal by Subject|0|||
146942145|NCT03185819|529948059|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
146942146|NCT03185819|529948060|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
146942147|NCT03185819|529948061|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
146942148|NCT03185819|529948062|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
146806083|NCT03362190|529458985|FG003|Overall Study|Withdrawal by Subject|1|||
146806084|NCT00687219|529458986|FG000|Overall Study|Adverse Event|8|||
146806085|NCT00687219|529458986|FG000|Overall Study|Discontinuance criteria met|7|||
146806086|NCT00687219|529458986|FG000|Overall Study|HCV-RNA positive conversion|34|||
146806087|NCT00687219|529458986|FG000|Overall Study|Withdrawal by Subject|1|||
146806088|NCT00687219|529458986|FG000|Overall Study|Lack of Efficacy|1|||
146806089|NCT01367236|529458994|FG000|Overall Study|Withdrawal by Subject|3|||
146806090|NCT01367236|529458995|FG001|Overall Study|Withdrawal by Subject|1|||
146806091|NCT02235298|529458996|FG000|Overall Study|Lost to Follow-up|6|||
146942149|NCT03185819|529948059|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
146942150|NCT03185819|529948060|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
146806092|NCT02235298|529458997|FG001|Overall Study|Lost to Follow-up|5|||
146806093|NCT02235298|529458996|FG000|Overall Study|Adverse Event|2|||
146806094|NCT02235298|529458997|FG001|Overall Study|Adverse Event|2|||
146806095|NCT02235298|529458996|FG000|Overall Study|Withdrawal by Subject|0|||
146806096|NCT02235298|529458997|FG001|Overall Study|Withdrawal by Subject|1|||
146806097|NCT04038580|529459010|FG000|Washout 1|Death|0|||
146806098|NCT04038580|529459011|FG001|Washout 1|Death|0|||
146806099|NCT04038580|529459012|FG002|Washout 1|Death|0|||
146806100|NCT04038580|529459013|FG003|Washout 1|Death|1|||
146806101|NCT04038580|529459014|FG004|Washout 1|Death|0|||
146806102|NCT04038580|529459015|FG005|Washout 1|Death|0|||
146806103|NCT04038580|529459010|FG000|Washout 1|Withdrawal by Subject|0|||
146806104|NCT04038580|529459011|FG001|Washout 1|Withdrawal by Subject|0|||
146806105|NCT04038580|529459012|FG002|Washout 1|Withdrawal by Subject|0|||
146806106|NCT04038580|529459013|FG003|Washout 1|Withdrawal by Subject|0|||
146806107|NCT04038580|529459014|FG004|Washout 1|Withdrawal by Subject|1|||
146806108|NCT04038580|529459015|FG005|Washout 1|Withdrawal by Subject|0|||
146806109|NCT04038580|529459010|FG000|Wash-out 2|Withdrawal by Subject|1|||
146806110|NCT04038580|529459011|FG001|Wash-out 2|Withdrawal by Subject|0|||
146806111|NCT04038580|529459012|FG002|Wash-out 2|Withdrawal by Subject|0|||
146806112|NCT04038580|529459013|FG003|Wash-out 2|Withdrawal by Subject|2|||
146806113|NCT04038580|529459014|FG004|Wash-out 2|Withdrawal by Subject|0|||
146806114|NCT04038580|529459015|FG005|Wash-out 2|Withdrawal by Subject|1|||
146806115|NCT04038580|529459010|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
146806116|NCT04038580|529459011|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
146806117|NCT04038580|529459012|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
146806118|NCT04038580|529459013|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
146806119|NCT04038580|529459014|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
146806120|NCT04038580|529459015|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
146806121|NCT04038580|529459010|FG000|Wash-out 3|Withdrawal by Subject|1|||
146806122|NCT04038580|529459011|FG001|Wash-out 3|Withdrawal by Subject|0|||
146806123|NCT04038580|529459012|FG002|Wash-out 3|Withdrawal by Subject|2|||
146806124|NCT04038580|529459013|FG003|Wash-out 3|Withdrawal by Subject|0|||
146806125|NCT04038580|529459014|FG004|Wash-out 3|Withdrawal by Subject|0|||
146806126|NCT04038580|529459015|FG005|Wash-out 3|Withdrawal by Subject|0|||
146806127|NCT05251363|529459016|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
146806128|NCT05251363|529459016|FG000|Overall Study After Implant Period|Death|9|||
146806129|NCT05251363|529459016|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
146806130|NCT05251363|529459016|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
146806131|NCT05251363|529459016|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
146806132|NCT05251363|529459016|FG000|Overall Study After Implant Period|Physician Decision|1|||
146806133|NCT05251363|529459016|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
146806134|NCT00093496|529460166|FG000|Overall Study|Protocol Violation|1|||
146806135|NCT00093496|529460167|FG001|Overall Study|Protocol Violation|3|||
146806136|NCT01932970|529460168|FG000|Overall Study|Withdrawal by Subject|5|||
146806137|NCT01932970|529460168|FG000|Overall Study|Death|1|||
146806138|NCT01932970|529460168|FG000|Overall Study|Lost to Follow-up|2|||
146806139|NCT01932970|529460168|FG000|Overall Study|Protocol Specified Criteria|10|||
146806140|NCT00853580|529460169|FG000|Overall Study|Lost to Follow-up|3|||
146806141|NCT00853580|529460170|FG001|Overall Study|Lost to Follow-up|5|||
146806142|NCT00853580|529460169|FG000|Overall Study|Protocol Violation|2|||
146806143|NCT00853580|529460170|FG001|Overall Study|Protocol Violation|1|||
146806144|NCT00853580|529460169|FG000|Overall Study|Withdrawal by Subject|2|||
146806145|NCT00853580|529460170|FG001|Overall Study|Withdrawal by Subject|8|||
146806146|NCT00853580|529460169|FG000|Overall Study|Commenced contraindicated therapy|0|||
146806147|NCT00853580|529460170|FG001|Overall Study|Commenced contraindicated therapy|2|||
146806148|NCT01700205|529460171|FG000|Overall Study|Withdrawal by Subject|13|||
146806149|NCT01700205|529460172|FG001|Overall Study|Withdrawal by Subject|13|||
146806150|NCT01700205|529460171|FG000|Overall Study|Protocol Violation|2|||
146806151|NCT01700205|529460172|FG001|Overall Study|Protocol Violation|2|||
146806152|NCT01728324|529460173|FG000|Termination of DBV|Adverse Event|14|||
146806153|NCT01728324|529460174|FG001|Termination of DBV|Adverse Event|13|||
146806154|NCT01728324|529460175|FG002|Termination of DBV|Adverse Event|4|||
146806155|NCT01728324|529460173|FG000|Termination of DBV|Lack of Efficacy|14|||
146942151|NCT03185819|529948061|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
146942152|NCT03185819|529948062|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
146942153|NCT03185819|529948059|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
146806156|NCT01728324|529460174|FG001|Termination of DBV|Lack of Efficacy|12|||
146806157|NCT01728324|529460175|FG002|Termination of DBV|Lack of Efficacy|8|||
146806158|NCT01728324|529460173|FG000|Termination of DBV|Withdrawal by Subject|9|||
146806159|NCT01728324|529460174|FG001|Termination of DBV|Withdrawal by Subject|6|||
146806160|NCT01728324|529460175|FG002|Termination of DBV|Withdrawal by Subject|2|||
146806161|NCT01728324|529460173|FG000|Termination of DBV|Other than stated|1|||
146806162|NCT01728324|529460174|FG001|Termination of DBV|Other than stated|3|||
146806163|NCT01728324|529460175|FG002|Termination of DBV|Other than stated|0|||
146806164|NCT01728324|529460173|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
146806165|NCT01728324|529460174|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
146806166|NCT01728324|529460175|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
146806167|NCT01728324|529460173|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
146806168|NCT01728324|529460174|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
146806169|NCT01728324|529460175|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
146806170|NCT01728324|529460173|FG000|Termination of FDV|Adverse Event|14|||
146806171|NCT01728324|529460174|FG001|Termination of FDV|Adverse Event|13|||
146806172|NCT01728324|529460175|FG002|Termination of FDV|Adverse Event|4|||
146806173|NCT01728324|529460173|FG000|Termination of FDV|Lack of Efficacy|14|||
146806174|NCT01728324|529460174|FG001|Termination of FDV|Lack of Efficacy|12|||
146806175|NCT01728324|529460175|FG002|Termination of FDV|Lack of Efficacy|8|||
146806176|NCT01728324|529460173|FG000|Termination of FDV|Withdrawal by Subject|9|||
146806177|NCT01728324|529460174|FG001|Termination of FDV|Withdrawal by Subject|6|||
146806178|NCT01728324|529460175|FG002|Termination of FDV|Withdrawal by Subject|2|||
146806179|NCT01728324|529460173|FG000|Termination of FDV|Other than stated|1|||
146806180|NCT01728324|529460174|FG001|Termination of FDV|Other than stated|3|||
146806181|NCT01728324|529460175|FG002|Termination of FDV|Other than stated|0|||
146806182|NCT01728324|529460173|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
146806183|NCT01728324|529460174|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
146806184|NCT01728324|529460175|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
146806185|NCT01728324|529460173|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
146806186|NCT01728324|529460174|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
146806187|NCT01728324|529460175|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
146806188|NCT01728324|529460173|FG000|Termination of RBV|Adverse Event|15|||
146806189|NCT01728324|529460174|FG001|Termination of RBV|Adverse Event|16|||
146806190|NCT01728324|529460175|FG002|Termination of RBV|Adverse Event|5|||
146806191|NCT01728324|529460173|FG000|Termination of RBV|Lack of Efficacy|14|||
146806192|NCT01728324|529460174|FG001|Termination of RBV|Lack of Efficacy|11|||
146806193|NCT01728324|529460175|FG002|Termination of RBV|Lack of Efficacy|7|||
146806194|NCT01728324|529460173|FG000|Termination of RBV|Withdrawal by Subject|9|||
146806195|NCT01728324|529460174|FG001|Termination of RBV|Withdrawal by Subject|5|||
146806196|NCT01728324|529460175|FG002|Termination of RBV|Withdrawal by Subject|2|||
146806197|NCT01728324|529460173|FG000|Termination of RBV|Other than stated|1|||
146806198|NCT01728324|529460174|FG001|Termination of RBV|Other than stated|3|||
146806199|NCT01728324|529460175|FG002|Termination of RBV|Other than stated|1|||
146806200|NCT01728324|529460173|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
146806201|NCT01728324|529460174|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
146806202|NCT01728324|529460175|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
146806203|NCT01728324|529460173|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
146806204|NCT01728324|529460174|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
146806205|NCT01728324|529460175|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
146806206|NCT03113409|529460178|FG000|Overall Study|Withdrawal by Subject|5|||
146806207|NCT03113409|529460179|FG001|Overall Study|Withdrawal by Subject|0|||
146806208|NCT03113409|529460180|FG002|Overall Study|Withdrawal by Subject|0|||
146806209|NCT03335488|529460185|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
146806210|NCT03335488|529460186|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
146806211|NCT03335488|529460185|FG000|Safety Extension Period|Adverse Event|1|||
146806212|NCT03335488|529460186|FG001|Safety Extension Period|Adverse Event|0|||
146806213|NCT03335488|529460185|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
146806214|NCT03335488|529460186|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
146806215|NCT00388726|529460187|FG000|Overall Study|Adverse Event|50|||
146806216|NCT00388726|529460188|FG001|Overall Study|Adverse Event|24|||
146806217|NCT00388726|529460187|FG000|Overall Study|Progressive Disease|336|||
146806218|NCT00388726|529460188|FG001|Overall Study|Progressive Disease|153|||
146806219|NCT00388726|529460187|FG000|Overall Study|Clinical Progression|61|||
146806220|NCT00388726|529460188|FG001|Overall Study|Clinical Progression|36|||
146806221|NCT00388726|529460187|FG000|Overall Study|Withdrawal by Subject|10|||
146806222|NCT00388726|529460188|FG001|Overall Study|Withdrawal by Subject|7|||
146806223|NCT00388726|529460187|FG000|Overall Study|Administrative|6|||
146806224|NCT00388726|529460188|FG001|Overall Study|Administrative|9|||
146806225|NCT00388726|529460187|FG000|Overall Study|Physician Decision|18|||
146942154|NCT03185819|529948060|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
146942155|NCT03185819|529948061|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
146942156|NCT03185819|529948062|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
146942157|NCT03185819|529948059|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
146942158|NCT03185819|529948060|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
146942159|NCT03185819|529948061|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
146806226|NCT00388726|529460188|FG001|Overall Study|Physician Decision|13|||
146806227|NCT00388726|529460187|FG000|Overall Study|Death|3|||
146806228|NCT00388726|529460188|FG001|Overall Study|Death|2|||
146806229|NCT04971733|529460189|FG000|Overall Study|Adverse Event|1|||
146806230|NCT04971733|529460190|FG001|Overall Study|Adverse Event|1|||
146806231|NCT04971733|529460189|FG000|Overall Study|Subject choice|2|||
146806232|NCT04971733|529460190|FG001|Overall Study|Subject choice|0|||
146806233|NCT04971733|529460189|FG000|Overall Study|Withdrawal by Subject|1|||
146806234|NCT04971733|529460190|FG001|Overall Study|Withdrawal by Subject|0|||
146942160|NCT03185819|529948062|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
146942161|NCT03185819|529948059|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
146806235|NCT04971733|529460189|FG000|Overall Study|Other|1|||
146806236|NCT04971733|529460190|FG001|Overall Study|Other|0|||
146806237|NCT02406092|529460199|FG000|Overall Study|Screen failure|10|||
146806238|NCT02406092|529460200|FG001|Overall Study|Screen failure|7|||
146806239|NCT02406092|529460199|FG000|Overall Study|Death|22|||
146806240|NCT02406092|529460200|FG001|Overall Study|Death|5|||
146806241|NCT02406092|529460199|FG000|Overall Study|Lost to Follow-up|4|||
146806242|NCT02406092|529460200|FG001|Overall Study|Lost to Follow-up|1|||
146806243|NCT02406092|529460199|FG000|Overall Study|Adverse Event|1|||
146806244|NCT02406092|529460200|FG001|Overall Study|Adverse Event|0|||
146806245|NCT02406092|529460199|FG000|Overall Study|Withdrawal by Subject|1|||
146806246|NCT02406092|529460200|FG001|Overall Study|Withdrawal by Subject|0|||
146806247|NCT00600353|529460202|FG000|Overall Study|history of malignancy within 5 years|1|||
146806248|NCT00600353|529460203|FG001|Overall Study|history of malignancy within 5 years|0|||
146806249|NCT00600353|529460202|FG000|Overall Study|History of prepartive regimen|0|||
146806250|NCT00600353|529460203|FG001|Overall Study|History of prepartive regimen|1|||
146806251|NCT04941482|529460204|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
146806252|NCT04941482|529460205|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
146806253|NCT03229408|529460206|FG000|Overall Study|Withdrawal by Subject|4|||
146806254|NCT03229408|529460207|FG001|Overall Study|Withdrawal by Subject|1|||
146806255|NCT03229408|529460206|FG000|Overall Study|Adverse Event|2|||
146806256|NCT03229408|529460207|FG001|Overall Study|Adverse Event|0|||
146806257|NCT03229408|529460206|FG000|Overall Study|Pregnancy|0|||
146806258|NCT03229408|529460207|FG001|Overall Study|Pregnancy|1|||
146806259|NCT03229408|529460206|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
146806260|NCT03229408|529460207|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
146806261|NCT04200664|529460208|FG000|Overall Study|Withdrawal by Subject|1|||
146806262|NCT04200664|529460209|FG001|Overall Study|Withdrawal by Subject|0|||
146806263|NCT04200664|529460210|FG002|Overall Study|Withdrawal by Subject|0|||
146806264|NCT03745313|529460215|FG000|At 30 Days Follow-up|Death|2|||
146806265|NCT03745313|529460215|FG000|At 6 Months Follow-up|Death|1|||
146806266|NCT03745313|529460215|FG000|At 6 Months Follow-up|Missed Visit|1|||
146806267|NCT03745313|529460215|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
146806268|NCT03745313|529460215|FG000|At 1 Year Follow-up|Death|2|||
146806269|NCT03745313|529460215|FG000|At 1 Year Follow-up|Missed Visit|2|||
146806270|NCT03745313|529460215|FG000|At 2 Year Follow-up|Missed Visit|1|||
146806271|NCT03611075|529460217|FG000|Overall Study|Physician Decision|0|||
146806272|NCT03611075|529460218|FG001|Overall Study|Physician Decision|1|||
146806273|NCT03611075|529460219|FG002|Overall Study|Physician Decision|1|||
146806274|NCT03611075|529460220|FG003|Overall Study|Physician Decision|0|||
146806275|NCT03611075|529460221|FG004|Overall Study|Physician Decision|0|||
146806276|NCT03611075|529460222|FG005|Overall Study|Physician Decision|0|||
146806277|NCT03611075|529460223|FG006|Overall Study|Physician Decision|0|||
146806278|NCT03611075|529460224|FG007|Overall Study|Physician Decision|0|||
146806279|NCT03611075|529460225|FG008|Overall Study|Physician Decision|0|||
146806280|NCT03611075|529460217|FG000|Overall Study|Lost to Follow-up|1|||
146806281|NCT03611075|529460218|FG001|Overall Study|Lost to Follow-up|0|||
146806282|NCT03611075|529460219|FG002|Overall Study|Lost to Follow-up|0|||
146806283|NCT03611075|529460220|FG003|Overall Study|Lost to Follow-up|2|||
146806284|NCT03611075|529460221|FG004|Overall Study|Lost to Follow-up|0|||
146806285|NCT03611075|529460222|FG005|Overall Study|Lost to Follow-up|0|||
146806286|NCT03611075|529460223|FG006|Overall Study|Lost to Follow-up|0|||
146806287|NCT03611075|529460224|FG007|Overall Study|Lost to Follow-up|0|||
146806288|NCT03611075|529460225|FG008|Overall Study|Lost to Follow-up|0|||
146806289|NCT03611075|529460217|FG000|Overall Study|Withdrawal by Subject|0|||
146806290|NCT03611075|529460218|FG001|Overall Study|Withdrawal by Subject|1|||
146806291|NCT03611075|529460219|FG002|Overall Study|Withdrawal by Subject|1|||
146806292|NCT03611075|529460220|FG003|Overall Study|Withdrawal by Subject|1|||
146806293|NCT03611075|529460221|FG004|Overall Study|Withdrawal by Subject|0|||
146806294|NCT03611075|529460222|FG005|Overall Study|Withdrawal by Subject|0|||
146806295|NCT03611075|529460223|FG006|Overall Study|Withdrawal by Subject|1|||
146806296|NCT03611075|529460224|FG007|Overall Study|Withdrawal by Subject|0|||
146806297|NCT03611075|529460225|FG008|Overall Study|Withdrawal by Subject|0|||
146806298|NCT03611075|529460217|FG000|Overall Study|Reason unknown|0|||
146806299|NCT03611075|529460218|FG001|Overall Study|Reason unknown|0|||
146806300|NCT03611075|529460219|FG002|Overall Study|Reason unknown|0|||
146806301|NCT03611075|529460220|FG003|Overall Study|Reason unknown|1|||
146806302|NCT03611075|529460221|FG004|Overall Study|Reason unknown|0|||
146806303|NCT03611075|529460222|FG005|Overall Study|Reason unknown|0|||
146806304|NCT03611075|529460223|FG006|Overall Study|Reason unknown|1|||
146806305|NCT03611075|529460224|FG007|Overall Study|Reason unknown|0|||
146806306|NCT03611075|529460225|FG008|Overall Study|Reason unknown|0|||
146806307|NCT01701401|529460226|FG000|Overall Study|Randomized But Not Treated|3|||
146806308|NCT01701401|529460227|FG001|Overall Study|Randomized But Not Treated|1|||
146806309|NCT01701401|529460228|FG002|Overall Study|Randomized But Not Treated|0|||
146806310|NCT01701401|529460229|FG003|Overall Study|Randomized But Not Treated|1|||
146806311|NCT01701401|529460226|FG000|Overall Study|Lost to Follow-up|5|||
146806312|NCT01701401|529460227|FG001|Overall Study|Lost to Follow-up|5|||
146806313|NCT01701401|529460228|FG002|Overall Study|Lost to Follow-up|1|||
146806314|NCT01701401|529460229|FG003|Overall Study|Lost to Follow-up|3|||
146806315|NCT01701401|529460226|FG000|Overall Study|Withdrew Consent|0|||
146806316|NCT01701401|529460227|FG001|Overall Study|Withdrew Consent|3|||
146806317|NCT01701401|529460228|FG002|Overall Study|Withdrew Consent|1|||
146806318|NCT01701401|529460229|FG003|Overall Study|Withdrew Consent|2|||
146806319|NCT01701401|529460226|FG000|Overall Study|Lack of Efficacy|1|||
146806320|NCT01701401|529460227|FG001|Overall Study|Lack of Efficacy|0|||
146806321|NCT01701401|529460228|FG002|Overall Study|Lack of Efficacy|2|||
146806322|NCT01701401|529460229|FG003|Overall Study|Lack of Efficacy|0|||
146806323|NCT01701401|529460226|FG000|Overall Study|Adverse Event|1|||
146806324|NCT01701401|529460227|FG001|Overall Study|Adverse Event|0|||
146806325|NCT01701401|529460228|FG002|Overall Study|Adverse Event|0|||
146806326|NCT01701401|529460229|FG003|Overall Study|Adverse Event|0|||
146806327|NCT01701401|529460226|FG000|Overall Study|Protocol Violation|0|||
146806328|NCT01701401|529460227|FG001|Overall Study|Protocol Violation|0|||
146806329|NCT01701401|529460228|FG002|Overall Study|Protocol Violation|1|||
146806330|NCT01701401|529460229|FG003|Overall Study|Protocol Violation|0|||
146806331|NCT04827732|529460233|FG000|Overall Study|Did not start treatment|0|||
146806332|NCT04827732|529460234|FG001|Overall Study|Did not start treatment|1|||
146806333|NCT04827732|529460235|FG002|Overall Study|Did not start treatment|0|||
146806334|NCT04827732|529460236|FG003|Overall Study|Did not start treatment|1|||
146806335|NCT04021862|529460237|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
146806336|NCT04021862|529460238|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
146806337|NCT04021862|529460239|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
146806338|NCT04021862|529460240|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
146806339|NCT04021862|529460241|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
146806340|NCT04021862|529460242|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
146806341|NCT04021862|529460237|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
146806342|NCT04021862|529460238|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
146806343|NCT04021862|529460239|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
146806344|NCT04021862|529460240|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
146806345|NCT04021862|529460241|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
146806346|NCT04021862|529460242|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
146806347|NCT04021862|529460237|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
146806348|NCT04021862|529460238|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
146806349|NCT04021862|529460239|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
146806350|NCT04021862|529460240|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
146806351|NCT04021862|529460241|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
146806352|NCT04021862|529460242|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
146806353|NCT04021862|529460237|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
146806354|NCT04021862|529460238|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
146806355|NCT04021862|529460239|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
146806356|NCT04021862|529460240|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
146806357|NCT04021862|529460241|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
146806358|NCT04021862|529460242|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
146806359|NCT04021862|529460237|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
146806360|NCT04021862|529460238|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
146806361|NCT04021862|529460239|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
146806362|NCT04021862|529460240|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
146806363|NCT04021862|529460241|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
146806364|NCT04021862|529460242|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
146806365|NCT04057131|529460243|FG000|Overall Study|Protocol Violation|24|||
146806366|NCT03835754|529460244|FG000|Overall Study|Death|4|||
146806367|NCT02830204|529460245|FG000|Overall Study|Death|9|||
146806368|NCT02830204|529460245|FG000|Overall Study|Withdrawal by Subject|1|||
146806369|NCT04445831|529460248|FG000|Overall Study|Withdrawal by Subject|2|||
146983981|NCT01688037|530102016|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
146806370|NCT04445831|529460249|FG001|Overall Study|Withdrawal by Subject|1|||
146806371|NCT04445831|529460250|FG002|Overall Study|Withdrawal by Subject|1|||
146806372|NCT04445831|529460251|FG003|Overall Study|Withdrawal by Subject|0|||
146806373|NCT04445831|529460252|FG004|Overall Study|Withdrawal by Subject|0|||
146806374|NCT04445831|529460253|FG005|Overall Study|Withdrawal by Subject|0|||
146806375|NCT04445831|529460254|FG006|Overall Study|Withdrawal by Subject|0|||
146806376|NCT04445831|529460248|FG000|Overall Study|Subject withdrawal by caregiver|0|||
146806377|NCT04445831|529460249|FG001|Overall Study|Subject withdrawal by caregiver|1|||
146806378|NCT04445831|529460250|FG002|Overall Study|Subject withdrawal by caregiver|0|||
146806379|NCT04445831|529460251|FG003|Overall Study|Subject withdrawal by caregiver|0|||
146983982|NCT01688037|530102017|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
146806380|NCT04445831|529460252|FG004|Overall Study|Subject withdrawal by caregiver|0|||
146806381|NCT04445831|529460253|FG005|Overall Study|Subject withdrawal by caregiver|0|||
146806382|NCT04445831|529460254|FG006|Overall Study|Subject withdrawal by caregiver|0|||
146806383|NCT05613907|529460258|FG000|Overall Study|Lost to Follow-up|5|||
146806384|NCT05613907|529460258|FG000|Overall Study|Death|3|||
146806385|NCT05613907|529460258|FG000|Overall Study|Withdrawal by Subject|2|||
146806386|NCT04701203|529460277|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
146806387|NCT04701203|529460278|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
146806388|NCT04701203|529460279|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
146806389|NCT04701203|529460277|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
146806390|NCT04701203|529460278|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
146806391|NCT04701203|529460279|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
146806392|NCT04701203|529460277|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
146806393|NCT04701203|529460278|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
146806394|NCT04701203|529460279|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
146806395|NCT04701203|529460277|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
146806396|NCT04701203|529460278|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
146806397|NCT04701203|529460279|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
146806398|NCT00491894|529460281|FG000|Overall Study|Adverse Event|14|||
146806399|NCT00491894|529460281|FG000|Overall Study|Withdrawal by Subject|5|||
146806400|NCT00491894|529460281|FG000|Overall Study|Death|3|||
146806401|NCT00491894|529460281|FG000|Overall Study|Lost to Follow-up|3|||
146806402|NCT00491894|529460281|FG000|Overall Study|Lack of Efficacy|2|||
146806403|NCT00491894|529460281|FG000|Overall Study|Other-Failed to meet any criteria|2|||
146806404|NCT00491894|529460281|FG000|Overall Study|Physician Decision|2|||
146806405|NCT00491894|529460281|FG000|Overall Study|Protocol Violation|2|||
146806406|NCT00491894|529460281|FG000|Overall Study|Other-Intake of prohibited medication|1|||
146806407|NCT01563185|529460282|FG000|Overall Study|Withdrawal by Subject|1|||
146806408|NCT01563185|529460282|FG000|Overall Study|Non-Compliance with study drug|1|||
146806409|NCT05293717|529460284|FG000|Overall Study|Physician Decision|1|||
146806410|NCT02328014|529461802|FG000|Overall Study|Adverse Event|1|||
146806411|NCT02328014|529461803|FG001|Overall Study|Adverse Event|0|||
146806412|NCT02328014|529461804|FG002|Overall Study|Adverse Event|0|||
146806413|NCT02328014|529461805|FG003|Overall Study|Adverse Event|1|||
146806414|NCT02328014|529461802|FG000|Overall Study|Death|0|||
146806415|NCT02328014|529461803|FG001|Overall Study|Death|0|||
146806416|NCT02328014|529461804|FG002|Overall Study|Death|0|||
146806417|NCT02328014|529461805|FG003|Overall Study|Death|4|||
146806418|NCT02328014|529461802|FG000|Overall Study|Physician Decision|0|||
146806419|NCT02328014|529461803|FG001|Overall Study|Physician Decision|0|||
146806420|NCT02328014|529461804|FG002|Overall Study|Physician Decision|0|||
146806421|NCT02328014|529461805|FG003|Overall Study|Physician Decision|1|||
146806422|NCT02328014|529461802|FG000|Overall Study|Disease Progression|1|||
146806423|NCT02328014|529461803|FG001|Overall Study|Disease Progression|0|||
146806424|NCT02328014|529461804|FG002|Overall Study|Disease Progression|1|||
146806425|NCT02328014|529461805|FG003|Overall Study|Disease Progression|3|||
146806426|NCT02328014|529461802|FG000|Overall Study|Study Terminated by Sponsor|4|||
146806427|NCT02328014|529461803|FG001|Overall Study|Study Terminated by Sponsor|1|||
146806428|NCT02328014|529461804|FG002|Overall Study|Study Terminated by Sponsor|1|||
146806429|NCT02328014|529461805|FG003|Overall Study|Study Terminated by Sponsor|0|||
146806430|NCT02328014|529461802|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
146806431|NCT02328014|529461803|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
146806432|NCT02328014|529461804|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
146806433|NCT02328014|529461805|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
146806434|NCT02328014|529461802|FG000|Overall Study|Withdrawal by Subject|0|||
146806435|NCT02328014|529461803|FG001|Overall Study|Withdrawal by Subject|0|||
146806436|NCT02328014|529461804|FG002|Overall Study|Withdrawal by Subject|0|||
146806437|NCT02328014|529461805|FG003|Overall Study|Withdrawal by Subject|1|||
146806438|NCT05422339|529461806|FG000|Overall Study|Withdrawal by Subject|17|||
146806439|NCT05422339|529461807|FG001|Overall Study|Withdrawal by Subject|15|||
146806440|NCT04172675|529461808|FG000|Overall Study|Withdrawal by Subject|7|||
146806441|NCT04172675|529461809|FG001|Overall Study|Withdrawal by Subject|5|||
146806442|NCT04172675|529461810|FG002|Overall Study|Withdrawal by Subject|1|||
146806443|NCT04172675|529461811|FG003|Overall Study|Withdrawal by Subject|4|||
146806444|NCT05029284|529461818|FG000|Overall Study|Lost to Follow-up|1|||
146806445|NCT03070392|529461819|FG000|Overall Study|Not Treated|7|||
146806446|NCT03070392|529461820|FG001|Overall Study|Not Treated|0|||
146806447|NCT03070392|529461821|FG002|Overall Study|Not Treated|3|||
146806448|NCT03070392|529461822|FG003|Overall Study|Not Treated|12|||
146806449|NCT03070392|529461819|FG000|Overall Study|Death|3|||
146806450|NCT03070392|529461820|FG001|Overall Study|Death|0|||
146806451|NCT03070392|529461821|FG002|Overall Study|Death|0|||
146806452|NCT03070392|529461822|FG003|Overall Study|Death|1|||
146806453|NCT03070392|529461819|FG000|Overall Study|Withdrawal by Subject|7|||
146806454|NCT03070392|529461820|FG001|Overall Study|Withdrawal by Subject|0|||
146806455|NCT03070392|529461821|FG002|Overall Study|Withdrawal by Subject|0|||
146806456|NCT03070392|529461822|FG003|Overall Study|Withdrawal by Subject|3|||
146806457|NCT03070392|529461819|FG000|Overall Study|Physician Decision|1|||
146806458|NCT03070392|529461820|FG001|Overall Study|Physician Decision|0|||
146806459|NCT03070392|529461821|FG002|Overall Study|Physician Decision|0|||
146806460|NCT03070392|529461822|FG003|Overall Study|Physician Decision|2|||
146806461|NCT03070392|529461819|FG000|Overall Study|Progressive Disease|154|||
146806462|NCT03070392|529461820|FG001|Overall Study|Progressive Disease|6|||
146806463|NCT03070392|529461821|FG002|Overall Study|Progressive Disease|2|||
146806464|NCT03070392|529461822|FG003|Overall Study|Progressive Disease|70|||
146806465|NCT03070392|529461819|FG000|Overall Study|Adverse Event|6|||
146806466|NCT03070392|529461820|FG001|Overall Study|Adverse Event|1|||
146806467|NCT03070392|529461821|FG002|Overall Study|Adverse Event|1|||
146806468|NCT03070392|529461822|FG003|Overall Study|Adverse Event|3|||
146806469|NCT03070392|529461819|FG000|Overall Study|Alternate anticancer treatment|1|||
146806470|NCT03070392|529461820|FG001|Overall Study|Alternate anticancer treatment|0|||
146806471|NCT03070392|529461821|FG002|Overall Study|Alternate anticancer treatment|0|||
146806472|NCT03070392|529461822|FG003|Overall Study|Alternate anticancer treatment|1|||
146806473|NCT03070392|529461819|FG000|Overall Study|Ongoing|73|||
146806474|NCT03070392|529461820|FG001|Overall Study|Ongoing|0|||
146806475|NCT03070392|529461821|FG002|Overall Study|Ongoing|0|||
146806476|NCT03070392|529461822|FG003|Overall Study|Ongoing|11|||
146806477|NCT02972034|529461823|FG000|Overall Study|Death|11|||
146806478|NCT02972034|529461824|FG001|Overall Study|Death|1|||
146806479|NCT02972034|529461825|FG002|Overall Study|Death|3|||
146806480|NCT02972034|529461826|FG003|Overall Study|Death|3|||
146806481|NCT02972034|529461827|FG004|Overall Study|Death|2|||
146806482|NCT02972034|529461828|FG005|Overall Study|Death|2|||
146806483|NCT02972034|529461829|FG006|Overall Study|Death|3|||
146806484|NCT02972034|529461830|FG007|Overall Study|Death|4|||
146806485|NCT02972034|529461831|FG008|Overall Study|Death|8|||
146806486|NCT02972034|529461832|FG009|Overall Study|Death|11|||
146806487|NCT02972034|529461833|FG010|Overall Study|Death|3|||
146806488|NCT02972034|529461834|FG011|Overall Study|Death|2|||
146806489|NCT02972034|529461835|FG012|Overall Study|Death|11|||
146806490|NCT02972034|529461836|FG013|Overall Study|Death|10|||
146806491|NCT02972034|529461837|FG014|Overall Study|Death|9|||
146806492|NCT02972034|529461823|FG000|Overall Study|Lost to Follow-up|0|||
146806493|NCT02972034|529461824|FG001|Overall Study|Lost to Follow-up|0|||
146806494|NCT02972034|529461825|FG002|Overall Study|Lost to Follow-up|0|||
146806495|NCT02972034|529461826|FG003|Overall Study|Lost to Follow-up|0|||
146806496|NCT02972034|529461827|FG004|Overall Study|Lost to Follow-up|1|||
146806497|NCT02972034|529461828|FG005|Overall Study|Lost to Follow-up|0|||
146806498|NCT02972034|529461829|FG006|Overall Study|Lost to Follow-up|0|||
146806499|NCT02972034|529461830|FG007|Overall Study|Lost to Follow-up|1|||
146806500|NCT02972034|529461831|FG008|Overall Study|Lost to Follow-up|0|||
146806501|NCT02972034|529461832|FG009|Overall Study|Lost to Follow-up|0|||
146806502|NCT02972034|529461833|FG010|Overall Study|Lost to Follow-up|0|||
146806503|NCT02972034|529461834|FG011|Overall Study|Lost to Follow-up|0|||
146806504|NCT02972034|529461835|FG012|Overall Study|Lost to Follow-up|0|||
146806505|NCT02972034|529461836|FG013|Overall Study|Lost to Follow-up|0|||
146806506|NCT02972034|529461837|FG014|Overall Study|Lost to Follow-up|1|||
146806507|NCT02972034|529461823|FG000|Overall Study|Physician Decision|0|||
146806508|NCT02972034|529461824|FG001|Overall Study|Physician Decision|0|||
146806509|NCT02972034|529461825|FG002|Overall Study|Physician Decision|0|||
146806510|NCT02972034|529461826|FG003|Overall Study|Physician Decision|0|||
146806511|NCT02972034|529461827|FG004|Overall Study|Physician Decision|0|||
146806512|NCT02972034|529461828|FG005|Overall Study|Physician Decision|0|||
146806513|NCT02972034|529461829|FG006|Overall Study|Physician Decision|0|||
146806514|NCT02972034|529461830|FG007|Overall Study|Physician Decision|1|||
146806515|NCT02972034|529461831|FG008|Overall Study|Physician Decision|0|||
146806516|NCT02972034|529461832|FG009|Overall Study|Physician Decision|0|||
146806517|NCT02972034|529461833|FG010|Overall Study|Physician Decision|1|||
146806518|NCT02972034|529461834|FG011|Overall Study|Physician Decision|0|||
146806519|NCT02972034|529461835|FG012|Overall Study|Physician Decision|0|||
146806520|NCT02972034|529461836|FG013|Overall Study|Physician Decision|0|||
146806521|NCT02972034|529461837|FG014|Overall Study|Physician Decision|0|||
146806522|NCT02972034|529461823|FG000|Overall Study|Sponsor Decision|0|||
146806523|NCT02972034|529461824|FG001|Overall Study|Sponsor Decision|0|||
146942162|NCT03185819|529948060|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
146942163|NCT03185819|529948061|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
146806524|NCT02972034|529461825|FG002|Overall Study|Sponsor Decision|0|||
146806525|NCT02972034|529461826|FG003|Overall Study|Sponsor Decision|1|||
146806526|NCT02972034|529461827|FG004|Overall Study|Sponsor Decision|0|||
146942164|NCT03185819|529948062|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
146806527|NCT02972034|529461828|FG005|Overall Study|Sponsor Decision|0|||
146806528|NCT02972034|529461829|FG006|Overall Study|Sponsor Decision|1|||
146806529|NCT02972034|529461830|FG007|Overall Study|Sponsor Decision|1|||
146806530|NCT02972034|529461831|FG008|Overall Study|Sponsor Decision|1|||
146806531|NCT02972034|529461832|FG009|Overall Study|Sponsor Decision|2|||
146806532|NCT02972034|529461833|FG010|Overall Study|Sponsor Decision|2|||
146806533|NCT02972034|529461834|FG011|Overall Study|Sponsor Decision|0|||
146806534|NCT02972034|529461835|FG012|Overall Study|Sponsor Decision|1|||
146806535|NCT02972034|529461836|FG013|Overall Study|Sponsor Decision|0|||
146806536|NCT02972034|529461837|FG014|Overall Study|Sponsor Decision|1|||
146806537|NCT02972034|529461823|FG000|Overall Study|Withdrawal by Subject|3|||
146806538|NCT02972034|529461824|FG001|Overall Study|Withdrawal by Subject|0|||
146806539|NCT02972034|529461825|FG002|Overall Study|Withdrawal by Subject|0|||
146806540|NCT02972034|529461826|FG003|Overall Study|Withdrawal by Subject|0|||
146806541|NCT02972034|529461827|FG004|Overall Study|Withdrawal by Subject|1|||
146806542|NCT02972034|529461828|FG005|Overall Study|Withdrawal by Subject|1|||
146806543|NCT02972034|529461829|FG006|Overall Study|Withdrawal by Subject|0|||
146806544|NCT02972034|529461830|FG007|Overall Study|Withdrawal by Subject|0|||
146806545|NCT02972034|529461831|FG008|Overall Study|Withdrawal by Subject|1|||
146806546|NCT02972034|529461832|FG009|Overall Study|Withdrawal by Subject|1|||
146806547|NCT02972034|529461833|FG010|Overall Study|Withdrawal by Subject|2|||
146806548|NCT02972034|529461834|FG011|Overall Study|Withdrawal by Subject|1|||
146806549|NCT02972034|529461835|FG012|Overall Study|Withdrawal by Subject|1|||
146806550|NCT02972034|529461836|FG013|Overall Study|Withdrawal by Subject|1|||
146806551|NCT02972034|529461837|FG014|Overall Study|Withdrawal by Subject|0|||
146806552|NCT02972034|529461823|FG000|Overall Study|Screen Failure|0|||
146806553|NCT02972034|529461824|FG001|Overall Study|Screen Failure|0|||
146806554|NCT02972034|529461825|FG002|Overall Study|Screen Failure|0|||
146806555|NCT02972034|529461826|FG003|Overall Study|Screen Failure|0|||
146806556|NCT02972034|529461827|FG004|Overall Study|Screen Failure|0|||
146806557|NCT02972034|529461828|FG005|Overall Study|Screen Failure|0|||
146806558|NCT02972034|529461829|FG006|Overall Study|Screen Failure|0|||
146806559|NCT02972034|529461830|FG007|Overall Study|Screen Failure|0|||
146806560|NCT02972034|529461831|FG008|Overall Study|Screen Failure|0|||
146806561|NCT02972034|529461832|FG009|Overall Study|Screen Failure|0|||
146806562|NCT02972034|529461833|FG010|Overall Study|Screen Failure|0|||
146806563|NCT02972034|529461834|FG011|Overall Study|Screen Failure|0|||
146806564|NCT02972034|529461835|FG012|Overall Study|Screen Failure|1|||
146806565|NCT02972034|529461836|FG013|Overall Study|Screen Failure|0|||
146806566|NCT02972034|529461837|FG014|Overall Study|Screen Failure|0|||
146806567|NCT03009344|529461838|FG000|Overall Study|Lack of Efficacy|5|||
146806568|NCT03009344|529461838|FG000|Overall Study|Withdrawal by Subject|1|||
146806569|NCT03009344|529461838|FG000|Overall Study|Adverse Event|1|||
146806570|NCT00378898|529461839|FG000|Overall Study|Withdrawal by Subject|10|||
146806571|NCT00378898|529461840|FG001|Overall Study|Withdrawal by Subject|5|||
146806572|NCT00378898|529461839|FG000|Overall Study|Protocol Violation|1|||
146806573|NCT00378898|529461840|FG001|Overall Study|Protocol Violation|1|||
146806574|NCT02534233|529461846|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
146806575|NCT01278030|529461850|FG000|Overall Study|Withdrawal by Subject|8|||
146806576|NCT01278030|529461851|FG001|Overall Study|Withdrawal by Subject|4|||
146806577|NCT00458783|529461853|FG000|Overall Study|Protocol Violation|1228|||
146942165|NCT03185819|529948059|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
146806578|NCT00458783|529461854|FG001|Overall Study|Protocol Violation|1220|||
146806579|NCT01737398|529461855|FG000|Overall Study|Adverse event or SAE|16|||
146806580|NCT01737398|529461856|FG001|Overall Study|Adverse event or SAE|1|||
146806581|NCT01737398|529461855|FG000|Overall Study|Stopping rule met|2|||
146806582|NCT01737398|529461856|FG001|Overall Study|Stopping rule met|1|||
146806583|NCT01737398|529461855|FG000|Overall Study|Voluntary withdrawal|2|||
146806584|NCT01737398|529461856|FG001|Overall Study|Voluntary withdrawal|3|||
146806585|NCT01737398|529461855|FG000|Overall Study|Ineligibility|1|||
146806586|NCT01737398|529461856|FG001|Overall Study|Ineligibility|0|||
146806587|NCT01737398|529461855|FG000|Overall Study|Liver transplant|1|||
146806588|NCT01737398|529461856|FG001|Overall Study|Liver transplant|0|||
146806589|NCT01737398|529461855|FG000|Overall Study|Disease progression|2|||
146806590|NCT01737398|529461856|FG001|Overall Study|Disease progression|3|||
146806591|NCT01737398|529461855|FG000|Overall Study|Sponsor's decision|2|||
146806592|NCT01737398|529461856|FG001|Overall Study|Sponsor's decision|0|||
146806593|NCT03220724|529461860|FG000|Overall Study|Lost to Follow-up|2|||
146806594|NCT03220724|529461861|FG001|Overall Study|Lost to Follow-up|2|||
146806595|NCT03220724|529461862|FG002|Overall Study|Lost to Follow-up|0|||
146806596|NCT03220724|529461863|FG003|Overall Study|Lost to Follow-up|3|||
146806597|NCT03220724|529461864|FG004|Overall Study|Lost to Follow-up|1|||
146806598|NCT03220724|529461865|FG005|Overall Study|Lost to Follow-up|0|||
146806599|NCT03220724|529461866|FG006|Overall Study|Lost to Follow-up|2|||
146806600|NCT03220724|529461867|FG007|Overall Study|Lost to Follow-up|1|||
146806601|NCT03220724|529461868|FG008|Overall Study|Lost to Follow-up|0|||
146806602|NCT03220724|529461860|FG000|Overall Study|Withdrawal by Subject|1|||
146806603|NCT03220724|529461861|FG001|Overall Study|Withdrawal by Subject|0|||
146806604|NCT03220724|529461862|FG002|Overall Study|Withdrawal by Subject|1|||
146806605|NCT03220724|529461863|FG003|Overall Study|Withdrawal by Subject|0|||
146806606|NCT03220724|529461864|FG004|Overall Study|Withdrawal by Subject|0|||
146806607|NCT03220724|529461865|FG005|Overall Study|Withdrawal by Subject|0|||
146806608|NCT03220724|529461866|FG006|Overall Study|Withdrawal by Subject|0|||
146806609|NCT03220724|529461867|FG007|Overall Study|Withdrawal by Subject|0|||
146806610|NCT03220724|529461868|FG008|Overall Study|Withdrawal by Subject|0|||
146806611|NCT00019604|529461869|FG000|Overall Study|Death|1|||
146806612|NCT00019604|529461869|FG000|Overall Study|Progressive disease|23|||
146806613|NCT00019604|529461869|FG000|Overall Study|Refused treatment|1|||
146806614|NCT00019604|529461869|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
146806615|NCT00019604|529461869|FG000|Overall Study|Going to have liver transplant|1|||
146806616|NCT00019604|529461869|FG000|Overall Study|Move to a different study|1|||
146806617|NCT00019604|529461869|FG000|Overall Study|Non compliant on systemic CH|1|||
146806618|NCT00019604|529461869|FG000|Overall Study|Non compliant|1|||
146806619|NCT00019604|529461869|FG000|Overall Study|Resectable disease|1|||
146806620|NCT00019604|529461869|FG000|Overall Study|Started new chemo regimen|1|||
146806621|NCT00019604|529461869|FG000|Overall Study|Pt going to immunotherapy study|1|||
146806622|NCT00019604|529461869|FG000|Overall Study|Too much disease|1|||
146806623|NCT00019604|529461869|FG000|Overall Study|Unable to evaluate|1|||
146806624|NCT00019604|529461869|FG000|Overall Study|Details for other not available|4|||
146806625|NCT00454194|529461884|FG000|Overall Study|Adverse Event|7|||
146806626|NCT00454194|529461885|FG001|Overall Study|Adverse Event|2|||
146806627|NCT00454194|529461884|FG000|Overall Study|Withdrawal by Subject|12|||
146806628|NCT00454194|529461885|FG001|Overall Study|Withdrawal by Subject|8|||
146806629|NCT00454194|529461884|FG000|Overall Study|Other Medical Problems|1|||
146806630|NCT00454194|529461885|FG001|Overall Study|Other Medical Problems|2|||
146806631|NCT00454194|529461884|FG000|Overall Study|Other Unspecified Reason|2|||
146806632|NCT00454194|529461885|FG001|Overall Study|Other Unspecified Reason|2|||
146806633|NCT00586313|529461893|FG000|Overall Study|Lack of Efficacy|2|||
146806634|NCT03205566|529461895|FG000|Phase 1|Protocol Violation|1|||
146806635|NCT03205566|529461896|FG001|Phase 1|Protocol Violation|1|||
146806636|NCT03184987|529461897|FG000|Overall Study|Withdrawal by Subject|0|||
146806637|NCT03184987|529461898|FG001|Overall Study|Withdrawal by Subject|1|||
146806638|NCT03184987|529461899|FG002|Overall Study|Withdrawal by Subject|2|||
146806639|NCT03184987|529461897|FG000|Overall Study|Physician Decision|0|||
146806640|NCT03184987|529461898|FG001|Overall Study|Physician Decision|0|||
146806641|NCT03184987|529461899|FG002|Overall Study|Physician Decision|1|||
146806642|NCT03184987|529461897|FG000|Overall Study|Adverse Event|1|||
146806643|NCT03184987|529461898|FG001|Overall Study|Adverse Event|0|||
146806644|NCT03184987|529461899|FG002|Overall Study|Adverse Event|1|||
146806645|NCT01619059|529461906|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
146806646|NCT01619059|529461907|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
146806647|NCT01619059|529461906|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
146806648|NCT01619059|529461907|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
146806649|NCT01619059|529461906|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
146806650|NCT01619059|529461907|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
146806651|NCT01619059|529461906|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
146806652|NCT01619059|529461907|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
146806653|NCT01619059|529461906|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
146806654|NCT01619059|529461907|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
146806655|NCT01619059|529461906|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
146806656|NCT01619059|529461907|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
146806657|NCT01619059|529461906|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
146806658|NCT01619059|529461907|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
146806659|NCT01619059|529461906|FG000|Long-Term (LT) Treatment Period|Death|1|||
146806660|NCT01619059|529461907|FG001|Long-Term (LT) Treatment Period|Death|0|||
146806661|NCT01619059|529461906|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
146806662|NCT01619059|529461907|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
146806663|NCT01619059|529461906|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
146806664|NCT01619059|529461907|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
146806665|NCT01170208|529461908|FG000|Overall Study|Withdrawal by Subject|5|||
146806666|NCT01170208|529461909|FG001|Overall Study|Withdrawal by Subject|0|||
146806667|NCT01170208|529461910|FG002|Overall Study|Withdrawal by Subject|1|||
146806668|NCT01170208|529461908|FG000|Overall Study|Protocol Violation|1|||
146806669|NCT01170208|529461909|FG001|Overall Study|Protocol Violation|0|||
146806670|NCT01170208|529461910|FG002|Overall Study|Protocol Violation|1|||
146806671|NCT01160354|529461917|FG000|Overall Study|Death|0|||
146806672|NCT01160354|529461918|FG001|Overall Study|Death|1|||
146806673|NCT01160354|529461919|FG002|Overall Study|Death|1|||
146806674|NCT02743819|529461921|FG000|Overall Study|Lack of Efficacy|5|||
146806675|NCT02743819|529461921|FG000|Overall Study|Death|2|||
146806676|NCT02743819|529461921|FG000|Overall Study|Adverse Event|1|||
146806677|NCT03389802|529461922|FG000|Overall Study|Lack of Efficacy|3|||
146806678|NCT03389802|529461923|FG001|Overall Study|Lack of Efficacy|3|||
146806679|NCT03389802|529461924|FG002|Overall Study|Lack of Efficacy|13|||
146806680|NCT03389802|529461925|FG003|Overall Study|Lack of Efficacy|6|||
146806681|NCT03389802|529461926|FG004|Overall Study|Lack of Efficacy|1|||
146806682|NCT03389802|529461922|FG000|Overall Study|Adverse Event|0|||
146806683|NCT03389802|529461923|FG001|Overall Study|Adverse Event|0|||
146806684|NCT03389802|529461924|FG002|Overall Study|Adverse Event|1|||
146806685|NCT03389802|529461925|FG003|Overall Study|Adverse Event|0|||
146806686|NCT03389802|529461926|FG004|Overall Study|Adverse Event|4|||
146806687|NCT03389802|529461922|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
146806688|NCT03389802|529461923|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
146806689|NCT03389802|529461924|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
146806690|NCT03389802|529461925|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
146806691|NCT03389802|529461926|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
146806692|NCT01706159|529461927|FG000|Overall Study|Withdrawal Criteria|2|||
146806693|NCT01706159|529461928|FG001|Overall Study|Withdrawal Criteria|1|||
146806694|NCT01706159|529461927|FG000|Overall Study|Unclassified|6|||
146806695|NCT01706159|529461928|FG001|Overall Study|Unclassified|1|||
146806696|NCT02454959|529461930|FG000|Overall Study|Protocol-Specified Criteria|3|||
146806697|NCT02454959|529461930|FG000|Overall Study|Physician Decision|1|||
146806698|NCT02454959|529461930|FG000|Overall Study|Withdrawal by Subject|3|||
146806699|NCT02454959|529461930|FG000|Overall Study|Adverse Event|2|||
146806700|NCT00989196|529461931|FG000|Treatment Period|Lost to Follow-up|1|||
146806701|NCT00989196|529461932|FG001|Treatment Period|Lost to Follow-up|0|||
146806702|NCT02409680|529461933|FG000|Overall Study|Lost to Follow-up|15|||
146806703|NCT02409680|529461934|FG001|Overall Study|Lost to Follow-up|30|||
146806704|NCT03789656|529461935|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
146806705|NCT03789656|529461936|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
146806706|NCT03789656|529461937|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
146806707|NCT03789656|529461938|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
146806708|NCT03789656|529461939|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
146806709|NCT03789656|529461935|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
146806710|NCT03789656|529461936|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
146806711|NCT03789656|529461937|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
146806712|NCT03789656|529461938|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
146806713|NCT03789656|529461939|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
146806714|NCT03789656|529461935|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
146806715|NCT03789656|529461936|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
146806716|NCT03789656|529461937|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
146806717|NCT03789656|529461938|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
146806718|NCT03789656|529461939|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
146806719|NCT03789656|529461935|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
146806720|NCT03789656|529461936|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
146806721|NCT03789656|529461937|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
146806722|NCT03789656|529461938|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
146806723|NCT03789656|529461939|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
146806724|NCT05325294|529461944|FG000|Overall Study|Adverse Event|3|||
146806725|NCT05325294|529461945|FG001|Overall Study|Adverse Event|3|||
146806726|NCT05325294|529461944|FG000|Overall Study|Physician Decision|0|||
146806727|NCT05325294|529461945|FG001|Overall Study|Physician Decision|1|||
146806728|NCT05325294|529461944|FG000|Overall Study|Withdrawal by Subject|0|||
146806729|NCT05325294|529461945|FG001|Overall Study|Withdrawal by Subject|3|||
146806730|NCT05325294|529461944|FG000|Overall Study|Lost to Follow-up|1|||
146806731|NCT05325294|529461945|FG001|Overall Study|Lost to Follow-up|0|||
146806732|NCT05325294|529461944|FG000|Overall Study|Sponsor Request|0|||
146806733|NCT05325294|529461945|FG001|Overall Study|Sponsor Request|2|||
146806734|NCT02434328|529461947|FG000|Overall Study|Adverse Event|9|||
146806735|NCT02434328|529461948|FG001|Overall Study|Adverse Event|4|||
146806736|NCT02434328|529461947|FG000|Overall Study|Lack of Efficacy|0|||
146806737|NCT02434328|529461948|FG001|Overall Study|Lack of Efficacy|2|||
146806738|NCT02434328|529461947|FG000|Overall Study|Physician Decision|0|||
146806739|NCT02434328|529461948|FG001|Overall Study|Physician Decision|1|||
146806740|NCT02434328|529461947|FG000|Overall Study|Withdrawal by Subject|12|||
146806741|NCT02434328|529461948|FG001|Overall Study|Withdrawal by Subject|21|||
146806742|NCT02434328|529461947|FG000|Overall Study|Death|4|||
146806743|NCT02434328|529461948|FG001|Overall Study|Death|7|||
146806744|NCT02434328|529461947|FG000|Overall Study|Lost to Follow-up|1|||
146806745|NCT02434328|529461948|FG001|Overall Study|Lost to Follow-up|6|||
146806746|NCT02434328|529461947|FG000|Overall Study|Other|4|||
146806747|NCT02434328|529461948|FG001|Overall Study|Other|1|||
146806748|NCT03147287|529461949|FG000|Overall Study|Randomized Not Treated|2|||
146806749|NCT03147287|529461950|FG001|Overall Study|Randomized Not Treated|1|||
146806750|NCT03147287|529461951|FG002|Overall Study|Randomized Not Treated|1|||
146806751|NCT03147287|529461949|FG000|Overall Study|Progressive Disease RECIST|31|||
146806752|NCT03147287|529461950|FG001|Overall Study|Progressive Disease RECIST|72|||
146806753|NCT03147287|529461951|FG002|Overall Study|Progressive Disease RECIST|32|||
146806754|NCT03147287|529461949|FG000|Overall Study|Progressive Disease not RECIST|13|||
146806755|NCT03147287|529461950|FG001|Overall Study|Progressive Disease not RECIST|21|||
146806756|NCT03147287|529461951|FG002|Overall Study|Progressive Disease not RECIST|13|||
146806757|NCT03147287|529461949|FG000|Overall Study|Physician Decision|1|||
146942166|NCT03185819|529948060|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
146942167|NCT03185819|529948061|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
146806758|NCT03147287|529461950|FG001|Overall Study|Physician Decision|2|||
146806759|NCT03147287|529461951|FG002|Overall Study|Physician Decision|1|||
146806760|NCT03147287|529461949|FG000|Overall Study|Intercurrent illness|0|||
146806761|NCT03147287|529461950|FG001|Overall Study|Intercurrent illness|1|||
146806762|NCT03147287|529461951|FG002|Overall Study|Intercurrent illness|0|||
146806763|NCT03147287|529461949|FG000|Overall Study|Withdrawal by Subject|2|||
146806764|NCT03147287|529461950|FG001|Overall Study|Withdrawal by Subject|3|||
146806765|NCT03147287|529461951|FG002|Overall Study|Withdrawal by Subject|2|||
146806766|NCT03147287|529461949|FG000|Overall Study|Patient Non-Compliance|0|||
146806767|NCT03147287|529461950|FG001|Overall Study|Patient Non-Compliance|2|||
146806768|NCT03147287|529461951|FG002|Overall Study|Patient Non-Compliance|0|||
146806769|NCT03147287|529461949|FG000|Overall Study|Patient moved|0|||
146806770|NCT03147287|529461950|FG001|Overall Study|Patient moved|1|||
146806771|NCT03147287|529461951|FG002|Overall Study|Patient moved|0|||
146806772|NCT03147287|529461949|FG000|Overall Study|Arm A crossover without PD|1|||
146806773|NCT03147287|529461950|FG001|Overall Study|Arm A crossover without PD|0|||
146806774|NCT03147287|529461951|FG002|Overall Study|Arm A crossover without PD|0|||
146806775|NCT03147287|529461949|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
146806776|NCT03147287|529461950|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
146806777|NCT03147287|529461951|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
146806778|NCT00925548|529463448|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
146806779|NCT00925548|529463449|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
146806780|NCT02278796|529463450|FG000|Overall Study|Death|2|||
146806781|NCT02278796|529463451|FG001|Overall Study|Death|3|||
146806782|NCT03214081|529463452|FG000|Overall Study|Case Report Forms Uncollected|9|||
146806783|NCT03214081|529463452|FG000|Overall Study|Protocol Deviation|54|||
146806784|NCT02962284|529463453|FG000|Overall Study|Death|2|||
146806785|NCT02962284|529463454|FG001|Overall Study|Death|0|||
146806786|NCT02962284|529463453|FG000|Overall Study|Progressive disease|2|||
146806787|NCT02962284|529463454|FG001|Overall Study|Progressive disease|3|||
146806788|NCT02962284|529463453|FG000|Overall Study|Withdrawal by Subject|1|||
146806789|NCT02962284|529463454|FG001|Overall Study|Withdrawal by Subject|0|||
146806790|NCT02372799|529463457|FG000|Treatment Period|Adverse Event|3|||
146806791|NCT02372799|529463458|FG001|Treatment Period|Adverse Event|10|||
146806792|NCT02372799|529463459|FG002|Treatment Period|Adverse Event|6|||
146806793|NCT02372799|529463457|FG000|Treatment Period|Insufficient therapeutic response|2|||
146806794|NCT02372799|529463458|FG001|Treatment Period|Insufficient therapeutic response|2|||
146806795|NCT02372799|529463459|FG002|Treatment Period|Insufficient therapeutic response|0|||
146806796|NCT02372799|529463457|FG000|Treatment Period|Withdrawal by Subject|10|||
146806797|NCT02372799|529463458|FG001|Treatment Period|Withdrawal by Subject|10|||
146806798|NCT02372799|529463459|FG002|Treatment Period|Withdrawal by Subject|2|||
146806799|NCT02372799|529463457|FG000|Treatment Period|Lost to Follow-up|11|||
146806800|NCT02372799|529463458|FG001|Treatment Period|Lost to Follow-up|5|||
146806801|NCT02372799|529463459|FG002|Treatment Period|Lost to Follow-up|3|||
146806802|NCT02372799|529463457|FG000|Treatment Period|Protocol Violation|3|||
146806803|NCT02372799|529463458|FG001|Treatment Period|Protocol Violation|0|||
146806804|NCT02372799|529463459|FG002|Treatment Period|Protocol Violation|0|||
146806805|NCT02372799|529463457|FG000|Treatment Period|Non-compliance with study drug|4|||
146806806|NCT02372799|529463458|FG001|Treatment Period|Non-compliance with study drug|4|||
146806807|NCT02372799|529463459|FG002|Treatment Period|Non-compliance with study drug|4|||
146806808|NCT02372799|529463457|FG000|Treatment Period|Miscellaneous Reasons|1|||
146806809|NCT02372799|529463458|FG001|Treatment Period|Miscellaneous Reasons|1|||
146806810|NCT02372799|529463459|FG002|Treatment Period|Miscellaneous Reasons|0|||
146806811|NCT02372799|529463457|FG000|Down-taper Period|Lost to Follow-up|1|||
146806812|NCT02372799|529463458|FG001|Down-taper Period|Lost to Follow-up|2|||
146806813|NCT02372799|529463459|FG002|Down-taper Period|Lost to Follow-up|2|||
146806814|NCT00089609|529463460|FG000|Overall Study|Withdrawal by Subject|3|||
146806815|NCT00089609|529463461|FG001|Overall Study|Withdrawal by Subject|1|||
146806816|NCT05815342|529463463|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
146806817|NCT05815342|529463463|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
146806818|NCT05815342|529463463|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
146806819|NCT05815342|529463463|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
146806820|NCT05815342|529463463|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
146806821|NCT03116464|529463464|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
146806822|NCT00747006|529463465|FG000|Overall Study|Adverse Event|1|||
146806823|NCT00747006|529463466|FG001|Overall Study|Adverse Event|0|||
146806824|NCT00747006|529463467|FG002|Overall Study|Adverse Event|0|||
146806825|NCT00747006|529463465|FG000|Overall Study|Lost to Follow-up|0|||
146806826|NCT00747006|529463466|FG001|Overall Study|Lost to Follow-up|1|||
146806827|NCT00747006|529463467|FG002|Overall Study|Lost to Follow-up|0|||
146806828|NCT00747006|529463465|FG000|Overall Study|Physician Decision|2|||
146806829|NCT00747006|529463466|FG001|Overall Study|Physician Decision|0|||
146806830|NCT00747006|529463467|FG002|Overall Study|Physician Decision|1|||
146806831|NCT00357994|529463468|FG000|Overall Study|Adverse Event|1|||
146942168|NCT03185819|529948062|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
146806832|NCT00357994|529463469|FG001|Overall Study|Adverse Event|2|||
146806833|NCT00357994|529463468|FG000|Overall Study|Lack of Efficacy|0|||
146806834|NCT00357994|529463469|FG001|Overall Study|Lack of Efficacy|1|||
146806835|NCT00357994|529463468|FG000|Overall Study|Protocol Violation|1|||
146806836|NCT00357994|529463469|FG001|Overall Study|Protocol Violation|0|||
146806837|NCT00345046|529463472|FG000|Overall Study|Protocol Violation|1|||
146806838|NCT00345046|529463473|FG001|Overall Study|Protocol Violation|1|||
146806839|NCT00345046|529463474|FG002|Overall Study|Protocol Violation|2|||
146806840|NCT04652869|529463479|FG000|Overall Study|Withdrawal by Subject|0|||
146806841|NCT04652869|529463480|FG001|Overall Study|Withdrawal by Subject|2|||
146806842|NCT04652869|529463481|FG002|Overall Study|Withdrawal by Subject|0|||
146806843|NCT01372085|529463482|FG000|Washout Period 2|Physician Decision|0|||
146806844|NCT01372085|529463483|FG001|Washout Period 2|Physician Decision|0|||
146806845|NCT01372085|529463484|FG002|Washout Period 2|Physician Decision|0|||
146806846|NCT01372085|529463485|FG003|Washout Period 2|Physician Decision|0|||
146806847|NCT01372085|529463486|FG004|Washout Period 2|Physician Decision|1|||
146806848|NCT01372085|529463487|FG005|Washout Period 2|Physician Decision|0|||
146806849|NCT01372085|529463488|FG006|Washout Period 2|Physician Decision|0|||
146806850|NCT01372085|529463489|FG007|Washout Period 2|Physician Decision|0|||
146806851|NCT01372085|529463490|FG008|Washout Period 2|Physician Decision|0|||
146806852|NCT01372085|529463491|FG009|Washout Period 2|Physician Decision|0|||
146806853|NCT01372085|529463482|FG000|Washout Period 3|Withdrawal by Subject|0|||
146806854|NCT01372085|529463483|FG001|Washout Period 3|Withdrawal by Subject|0|||
146806855|NCT01372085|529463484|FG002|Washout Period 3|Withdrawal by Subject|0|||
146806856|NCT01372085|529463485|FG003|Washout Period 3|Withdrawal by Subject|0|||
146806857|NCT01372085|529463486|FG004|Washout Period 3|Withdrawal by Subject|0|||
146806858|NCT01372085|529463487|FG005|Washout Period 3|Withdrawal by Subject|2|||
146806859|NCT01372085|529463488|FG006|Washout Period 3|Withdrawal by Subject|0|||
146806860|NCT01372085|529463489|FG007|Washout Period 3|Withdrawal by Subject|0|||
146806861|NCT01372085|529463490|FG008|Washout Period 3|Withdrawal by Subject|0|||
146806862|NCT01372085|529463491|FG009|Washout Period 3|Withdrawal by Subject|0|||
146806863|NCT00562094|529463492|FG000|Overall Study|Lost to Follow-up|62|||
146806864|NCT03689946|529463493|FG000|Overall Study|Withdrawal by Subject|3|||
146806865|NCT03689946|529463493|FG000|Overall Study|Lost to Follow-up|3|||
146806866|NCT03689946|529463493|FG000|Overall Study|Data corruption|2|||
146806867|NCT01555138|529463494|FG000|Overall Study|Death|0|||
146806868|NCT01555138|529463495|FG001|Overall Study|Death|1|||
146806869|NCT01555138|529463494|FG000|Overall Study|Lost to Follow-up|1|||
146806870|NCT01555138|529463495|FG001|Overall Study|Lost to Follow-up|0|||
146806871|NCT01555138|529463494|FG000|Overall Study|Abnormal Lab reults|1|||
146806872|NCT01555138|529463495|FG001|Overall Study|Abnormal Lab reults|3|||
146806873|NCT01555138|529463494|FG000|Overall Study|Lack of Efficacy|2|||
146806874|NCT01555138|529463495|FG001|Overall Study|Lack of Efficacy|2|||
146806875|NCT01555138|529463494|FG000|Overall Study|Protocol Violation|5|||
146806876|NCT01555138|529463495|FG001|Overall Study|Protocol Violation|3|||
146806877|NCT01555138|529463494|FG000|Overall Study|Administrative problems|8|||
146806878|NCT01555138|529463495|FG001|Overall Study|Administrative problems|0|||
146806879|NCT01555138|529463494|FG000|Overall Study|Withdrawal by Subject|16|||
146806880|NCT01555138|529463495|FG001|Overall Study|Withdrawal by Subject|15|||
146806881|NCT01555138|529463494|FG000|Overall Study|Adverse Event|14|||
146806882|NCT01555138|529463495|FG001|Overall Study|Adverse Event|14|||
146806883|NCT01613417|529463496|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
146806884|NCT01613417|529463497|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
146806885|NCT03732807|529463501|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
146806886|NCT03732807|529463502|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
146806887|NCT03732807|529463503|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
146806888|NCT03732807|529463504|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
146806889|NCT03732807|529463505|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
146806890|NCT03732807|529463506|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
146806891|NCT03732807|529463507|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
146806892|NCT03732807|529463501|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
146806893|NCT03732807|529463502|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
146806894|NCT03732807|529463503|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
146806895|NCT03732807|529463504|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
146942169|NCT03185819|529948059|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
146942170|NCT03185819|529948060|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
146806896|NCT03732807|529463505|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
146806897|NCT03732807|529463506|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
146942171|NCT03185819|529948061|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
146942172|NCT03185819|529948062|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
146806898|NCT03732807|529463507|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
146806899|NCT03732807|529463501|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
146806900|NCT03732807|529463502|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
146806901|NCT03732807|529463503|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
146942173|NCT03185819|529948059|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
146942174|NCT03185819|529948060|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
146806902|NCT03732807|529463504|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
146806903|NCT03732807|529463505|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
146806904|NCT03732807|529463506|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
146806905|NCT03732807|529463507|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
146806906|NCT03732807|529463501|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
146806907|NCT03732807|529463502|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
146806908|NCT03732807|529463503|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
146806909|NCT03732807|529463504|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
146806910|NCT03732807|529463505|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
146806911|NCT03732807|529463506|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
146806912|NCT03732807|529463507|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
146806913|NCT03732807|529463501|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
146806914|NCT03732807|529463502|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
146806915|NCT03732807|529463503|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
146806916|NCT03732807|529463504|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
146806917|NCT03732807|529463505|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
146806918|NCT03732807|529463506|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
146806919|NCT03732807|529463507|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
146806920|NCT03732807|529463501|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
146806921|NCT03732807|529463502|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
146806922|NCT03732807|529463503|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
146806923|NCT03732807|529463504|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
146806924|NCT03732807|529463505|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
146806925|NCT03732807|529463506|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
146806926|NCT03732807|529463507|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
146806927|NCT03732807|529463501|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
146806928|NCT03732807|529463502|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
146806929|NCT03732807|529463503|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
146806930|NCT03732807|529463504|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
146806931|NCT03732807|529463505|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
146806932|NCT03732807|529463506|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
146806933|NCT03732807|529463507|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
146806934|NCT03732807|529463501|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
146806935|NCT03732807|529463502|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
146806936|NCT03732807|529463503|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
146806937|NCT03732807|529463504|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
146806938|NCT03732807|529463505|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
146806939|NCT03732807|529463506|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
146806940|NCT03732807|529463507|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
146806941|NCT03732807|529463501|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
146806942|NCT03732807|529463502|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
146806943|NCT03732807|529463503|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
146806944|NCT03732807|529463504|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
146806945|NCT03732807|529463505|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
146806946|NCT03732807|529463506|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
146806947|NCT03732807|529463507|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
146806948|NCT03732807|529463501|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
146806949|NCT03732807|529463502|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
146806950|NCT03732807|529463503|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
146806951|NCT03732807|529463504|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
146806952|NCT03732807|529463505|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
146806953|NCT03732807|529463506|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
146806954|NCT03732807|529463507|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
146806955|NCT03732807|529463501|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
146806956|NCT03732807|529463502|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
146806957|NCT03732807|529463503|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
146806958|NCT03732807|529463504|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
146806959|NCT03732807|529463505|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
146806960|NCT03732807|529463506|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
146806961|NCT03732807|529463507|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
146806962|NCT03732807|529463501|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
146806963|NCT03732807|529463502|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
146806964|NCT03732807|529463503|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
146806965|NCT03732807|529463504|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
146806966|NCT03732807|529463505|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
146806967|NCT03732807|529463506|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
146806968|NCT03732807|529463507|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
146806969|NCT03732807|529463501|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
146806970|NCT03732807|529463502|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
146806971|NCT03732807|529463503|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
146806972|NCT03732807|529463504|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
146806973|NCT03732807|529463505|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
146806974|NCT03732807|529463506|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
146806975|NCT03732807|529463507|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
146806976|NCT03732807|529463501|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
146806977|NCT03732807|529463502|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
146806978|NCT03732807|529463503|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
146806979|NCT03732807|529463504|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
146806980|NCT03732807|529463505|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
146806981|NCT03732807|529463506|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
146806982|NCT03732807|529463507|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
146806983|NCT00599196|529463508|FG000|Overall Study|Lack of Efficacy|22|||
146806984|NCT00599196|529463508|FG000|Overall Study|Adverse Event|93|||
146806985|NCT00599196|529463508|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
146806986|NCT00599196|529463508|FG000|Overall Study|Subject withdrew consent|43|||
146806987|NCT00599196|529463508|FG000|Overall Study|Study ended per sponsor|197|||
146806988|NCT00599196|529463508|FG000|Overall Study|Lost to Follow-up|17|||
146806989|NCT00599196|529463508|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
146806990|NCT00599196|529463508|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
146806991|NCT00599196|529463508|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
146806992|NCT00599196|529463508|FG000|Overall Study|Other: Pt Moved To Australia|1|||
146806993|NCT00599196|529463508|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
146806994|NCT00599196|529463508|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
146806995|NCT03274076|529463510|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
146806996|NCT03274076|529463511|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
146806997|NCT03274076|529463512|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
146806998|NCT03274076|529463513|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
146806999|NCT03274076|529463510|FG000|24 Weeks Open Label|Adverse Event|0|||
146807000|NCT03274076|529463511|FG001|24 Weeks Open Label|Adverse Event|0|||
146807001|NCT03274076|529463512|FG002|24 Weeks Open Label|Adverse Event|2|||
146807002|NCT03274076|529463513|FG003|24 Weeks Open Label|Adverse Event|0|||
146807003|NCT03274076|529463510|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
146807004|NCT03274076|529463511|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
146807005|NCT03274076|529463512|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
146807006|NCT03274076|529463513|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
146807007|NCT00641537|529463537|FG000|96-week Period|Adverse Event|0|||
146807008|NCT00641537|529463538|FG001|96-week Period|Adverse Event|1|||
146807009|NCT00641537|529463539|FG002|96-week Period|Adverse Event|3|||
146807010|NCT00641537|529463540|FG003|96-week Period|Adverse Event|0|||
146807011|NCT00641537|529463541|FG004|96-week Period|Adverse Event|2|||
146807012|NCT00641537|529463542|FG005|96-week Period|Adverse Event|0|||
146807013|NCT00641537|529463543|FG006|96-week Period|Adverse Event|0|||
146807014|NCT00641537|529463544|FG007|96-week Period|Adverse Event|0|||
146807015|NCT00641537|529463537|FG000|96-week Period|Lost to Follow-up|3|||
146807016|NCT00641537|529463538|FG001|96-week Period|Lost to Follow-up|1|||
146807017|NCT00641537|529463539|FG002|96-week Period|Lost to Follow-up|2|||
146807018|NCT00641537|529463540|FG003|96-week Period|Lost to Follow-up|2|||
146807019|NCT00641537|529463541|FG004|96-week Period|Lost to Follow-up|4|||
146807020|NCT00641537|529463542|FG005|96-week Period|Lost to Follow-up|0|||
146807021|NCT00641537|529463543|FG006|96-week Period|Lost to Follow-up|1|||
146807022|NCT00641537|529463544|FG007|96-week Period|Lost to Follow-up|0|||
146807023|NCT00641537|529463537|FG000|96-week Period|Protocol Violation|0|||
146807024|NCT00641537|529463538|FG001|96-week Period|Protocol Violation|1|||
146807025|NCT00641537|529463539|FG002|96-week Period|Protocol Violation|0|||
146807026|NCT00641537|529463540|FG003|96-week Period|Protocol Violation|1|||
146807027|NCT00641537|529463541|FG004|96-week Period|Protocol Violation|0|||
146807028|NCT00641537|529463542|FG005|96-week Period|Protocol Violation|1|||
146807029|NCT00641537|529463543|FG006|96-week Period|Protocol Violation|0|||
146807030|NCT00641537|529463544|FG007|96-week Period|Protocol Violation|0|||
146807031|NCT00641537|529463537|FG000|96-week Period|Death|2|||
146807032|NCT00641537|529463538|FG001|96-week Period|Death|0|||
146807033|NCT00641537|529463539|FG002|96-week Period|Death|1|||
146807034|NCT00641537|529463540|FG003|96-week Period|Death|0|||
146807035|NCT00641537|529463541|FG004|96-week Period|Death|0|||
146807036|NCT00641537|529463542|FG005|96-week Period|Death|0|||
146807037|NCT00641537|529463543|FG006|96-week Period|Death|0|||
146807038|NCT00641537|529463544|FG007|96-week Period|Death|0|||
146807039|NCT00641537|529463537|FG000|96-week Period|Other|4|||
146807040|NCT00641537|529463538|FG001|96-week Period|Other|7|||
146807041|NCT00641537|529463539|FG002|96-week Period|Other|14|||
146807042|NCT00641537|529463540|FG003|96-week Period|Other|9|||
146807043|NCT00641537|529463541|FG004|96-week Period|Other|11|||
146807044|NCT00641537|529463542|FG005|96-week Period|Other|6|||
146807045|NCT00641537|529463543|FG006|96-week Period|Other|4|||
146807046|NCT00641537|529463544|FG007|96-week Period|Other|6|||
146807047|NCT00641537|529463537|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
146807048|NCT00641537|529463538|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
146807049|NCT00641537|529463539|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
146807050|NCT00641537|529463540|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
146807051|NCT00641537|529463541|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
146807052|NCT00641537|529463542|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
146807053|NCT00641537|529463543|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
146807054|NCT00641537|529463544|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
146807055|NCT00641537|529463537|FG000|24-Week Supplemental Follow-up Period|Other|0|||
146807056|NCT00641537|529463538|FG001|24-Week Supplemental Follow-up Period|Other|2|||
146807057|NCT00641537|529463539|FG002|24-Week Supplemental Follow-up Period|Other|2|||
146807058|NCT00641537|529463540|FG003|24-Week Supplemental Follow-up Period|Other|1|||
146807059|NCT00641537|529463541|FG004|24-Week Supplemental Follow-up Period|Other|3|||
146807060|NCT00641537|529463542|FG005|24-Week Supplemental Follow-up Period|Other|0|||
146807061|NCT00641537|529463543|FG006|24-Week Supplemental Follow-up Period|Other|1|||
146807062|NCT00641537|529463544|FG007|24-Week Supplemental Follow-up Period|Other|1|||
146807063|NCT01801007|529463545|FG000|Overall Study|Adverse Event|2|||
146807064|NCT01801007|529463545|FG000|Overall Study|Lost to Follow-up|4|||
146807065|NCT01801007|529463545|FG000|Overall Study|Withdrawal by Subject|5|||
146807066|NCT00665392|529463546|FG000|Overall Study|not treated|1|||
146807067|NCT02426138|529463547|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
146807068|NCT02426138|529463548|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
146807069|NCT00553332|529463554|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
146807070|NCT03924869|529463567|FG000|Overall Study|Death|66|||
146807071|NCT03924869|529463568|FG001|Overall Study|Death|53|||
146807072|NCT03924869|529463567|FG000|Overall Study|Lost to Follow-up|2|||
146807073|NCT03924869|529463568|FG001|Overall Study|Lost to Follow-up|0|||
146807074|NCT03924869|529463567|FG000|Overall Study|Physician Decision|0|||
146807075|NCT03924869|529463568|FG001|Overall Study|Physician Decision|3|||
146807076|NCT03924869|529463567|FG000|Overall Study|Withdrawal by Subject|5|||
146807077|NCT03924869|529463568|FG001|Overall Study|Withdrawal by Subject|1|||
146807078|NCT03924869|529463567|FG000|Overall Study|Participants Ongoing|154|||
146807079|NCT03924869|529463568|FG001|Overall Study|Participants Ongoing|164|||
146807080|NCT04762277|529463571|FG000|Overall Study|Withdrawal by Subject|0|||
146807081|NCT04762277|529463572|FG001|Overall Study|Withdrawal by Subject|2|||
146807082|NCT04762277|529463571|FG000|Overall Study|Protocol Violation|0|||
146807083|NCT04762277|529463572|FG001|Overall Study|Protocol Violation|1|||
146807084|NCT04762277|529463571|FG000|Overall Study|Adverse Event|1|||
146807085|NCT04762277|529463572|FG001|Overall Study|Adverse Event|0|||
146807086|NCT05824559|529463573|FG000|Overall Study|Adverse Event|2|||
146807087|NCT05824559|529463573|FG000|Overall Study|Physician Decision|2|||
146807088|NCT05824559|529463573|FG000|Overall Study|Progressive Disease|16|||
146807089|NCT05824559|529463573|FG000|Overall Study|Study Terminated by Sponsor|1|||
146807090|NCT05824559|529463573|FG000|Overall Study|Withdrawal by Subject|2|||
146807091|NCT05366751|529463574|FG000|Overall Study|Adverse Event|25|||
146807092|NCT05366751|529463574|FG000|Overall Study|Physician Decision|3|||
146807093|NCT05366751|529463574|FG000|Overall Study|Lost to Follow-up|2|||
146807094|NCT05366751|529463574|FG000|Overall Study|Withdrawal by Subject|14|||
146807095|NCT05366751|529463574|FG000|Overall Study|Study Terminated by Sponsor|50|||
146807096|NCT05366751|529463574|FG000|Overall Study|Site Terminated by Sponsor|3|||
146807097|NCT01690624|529463577|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
146807098|NCT01690624|529463578|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
146807099|NCT01690624|529463579|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
146807100|NCT01690624|529463580|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
146807101|NCT01690624|529463577|FG000|Overall Study|Adverse event (other than DLT)|3|||
146807102|NCT01690624|529463578|FG001|Overall Study|Adverse event (other than DLT)|1|||
146807103|NCT01690624|529463579|FG002|Overall Study|Adverse event (other than DLT)|1|||
146807104|NCT01690624|529463580|FG003|Overall Study|Adverse event (other than DLT)|1|||
146807105|NCT01690624|529463577|FG000|Overall Study|Withdrawal by Subject|0|||
146807106|NCT01690624|529463578|FG001|Overall Study|Withdrawal by Subject|0|||
146807107|NCT01690624|529463579|FG002|Overall Study|Withdrawal by Subject|1|||
146807108|NCT01690624|529463580|FG003|Overall Study|Withdrawal by Subject|0|||
146807109|NCT01690624|529463577|FG000|Overall Study|Sponsor is ending trial|0|||
146807110|NCT01690624|529463578|FG001|Overall Study|Sponsor is ending trial|0|||
146807111|NCT01690624|529463579|FG002|Overall Study|Sponsor is ending trial|0|||
146807112|NCT01690624|529463580|FG003|Overall Study|Sponsor is ending trial|1|||
146807113|NCT01690624|529463577|FG000|Overall Study|Physician Decision|0|||
146807114|NCT01690624|529463578|FG001|Overall Study|Physician Decision|0|||
146807115|NCT01690624|529463579|FG002|Overall Study|Physician Decision|0|||
146807116|NCT01690624|529463580|FG003|Overall Study|Physician Decision|1|||
146807117|NCT01690624|529463577|FG000|Overall Study|Withdrawal by Subject|0|||
146807118|NCT01690624|529463578|FG001|Overall Study|Withdrawal by Subject|1|||
146942175|NCT03185819|529948061|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
146942176|NCT03185819|529948062|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
146942177|NCT03185819|529948059|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
146942178|NCT03185819|529948060|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
146942179|NCT03185819|529948061|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
146942180|NCT03185819|529948062|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
146942181|NCT03185819|529948059|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
146942182|NCT03185819|529948060|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
146942183|NCT03185819|529948061|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
146942184|NCT03185819|529948062|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
146942185|NCT03185819|529948059|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
146942186|NCT03185819|529948060|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
146942187|NCT03185819|529948061|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
146942188|NCT03185819|529948062|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
146942189|NCT03185819|529948059|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
146942190|NCT03185819|529948060|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
146942191|NCT03185819|529948061|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
146942192|NCT03185819|529948062|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
146942193|NCT03185819|529948059|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
146942194|NCT03185819|529948060|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
146942195|NCT03185819|529948061|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
146942196|NCT03185819|529948062|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
146942197|NCT03097133|529948063|FG000|Overall Study|Lost to Follow-up|3|||
146942198|NCT03097133|529948064|FG001|Overall Study|Lost to Follow-up|2|||
146807119|NCT01690624|529463579|FG002|Overall Study|Withdrawal by Subject|0|||
146807120|NCT01690624|529463580|FG003|Overall Study|Withdrawal by Subject|0|||
146807121|NCT01690624|529463577|FG000|Overall Study|Lack of Efficacy|1|||
146807122|NCT01690624|529463578|FG001|Overall Study|Lack of Efficacy|1|||
146807123|NCT01690624|529463579|FG002|Overall Study|Lack of Efficacy|3|||
146807124|NCT01690624|529463580|FG003|Overall Study|Lack of Efficacy|0|||
146807125|NCT04912856|529463584|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
146807126|NCT04912856|529463585|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
146807127|NCT04912856|529463584|FG000|Overall Study|Not reported in synoptic CSR.|0|||
146807128|NCT04912856|529463585|FG001|Overall Study|Not reported in synoptic CSR.|1|||
146807129|NCT00647387|529463588|FG000|Overall Study|Lost to Follow-up|6|||
146807130|NCT00647387|529463588|FG000|Overall Study|Unsuccessful implant|5|||
146807131|NCT00647387|529463588|FG000|Overall Study|Device explanted|3|||
146807132|NCT00647387|529463588|FG000|Overall Study|Other Reason|3|||
146807133|NCT00647387|529463588|FG000|Overall Study|Death|2|||
146807134|NCT03678688|529465213|FG000|Overall Study|Reason not Specified|0|||
146807135|NCT03678688|529465214|FG001|Overall Study|Reason not Specified|0|||
146807136|NCT03678688|529465215|FG002|Overall Study|Reason not Specified|3|||
146807137|NCT03678688|529465216|FG003|Overall Study|Reason not Specified|0|||
146807138|NCT03678688|529465217|FG004|Overall Study|Reason not Specified|1|||
146807139|NCT03678688|529465218|FG005|Overall Study|Reason not Specified|0|||
146807140|NCT03678688|529465219|FG006|Overall Study|Reason not Specified|0|||
146807141|NCT03678688|529465220|FG007|Overall Study|Reason not Specified|0|||
146807142|NCT03678688|529465221|FG008|Overall Study|Reason not Specified|0|||
146807143|NCT03678688|529465213|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
146807144|NCT03678688|529465214|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
146807145|NCT03678688|529465215|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
146807146|NCT03678688|529465216|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
146807147|NCT03678688|529465217|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
146807148|NCT03678688|529465218|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
146807149|NCT03678688|529465219|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
146807150|NCT03678688|529465220|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
146807151|NCT03678688|529465221|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
146807152|NCT03678688|529465213|FG000|Overall Study|Covid Related Adverse Event|0|||
146942199|NCT03097133|529948063|FG000|Overall Study|Withdrawal by Subject|2|||
146942200|NCT03097133|529948064|FG001|Overall Study|Withdrawal by Subject|5|||
146807153|NCT03678688|529465214|FG001|Overall Study|Covid Related Adverse Event|0|||
146807154|NCT03678688|529465215|FG002|Overall Study|Covid Related Adverse Event|0|||
146807155|NCT03678688|529465216|FG003|Overall Study|Covid Related Adverse Event|0|||
146807156|NCT03678688|529465217|FG004|Overall Study|Covid Related Adverse Event|0|||
146942201|NCT03097133|529948063|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
146983983|NCT01688037|530102015|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
146807157|NCT03678688|529465218|FG005|Overall Study|Covid Related Adverse Event|3|||
146942202|NCT03097133|529948064|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
146942203|NCT03097133|529948063|FG000|Overall Study|Other|3|||
146942204|NCT03097133|529948064|FG001|Overall Study|Other|2|||
146942205|NCT03097133|529948063|FG000|Overall Study|Adverse Event|1|||
146942206|NCT03097133|529948064|FG001|Overall Study|Adverse Event|0|||
146807158|NCT03678688|529465219|FG006|Overall Study|Covid Related Adverse Event|1|||
146807159|NCT03678688|529465220|FG007|Overall Study|Covid Related Adverse Event|1|||
146807160|NCT03678688|529465221|FG008|Overall Study|Covid Related Adverse Event|0|||
146807161|NCT03678688|529465213|FG000|Overall Study|Physician Decision|0|||
146807162|NCT03678688|529465214|FG001|Overall Study|Physician Decision|0|||
146807163|NCT03678688|529465215|FG002|Overall Study|Physician Decision|0|||
146807164|NCT03678688|529465216|FG003|Overall Study|Physician Decision|0|||
146807165|NCT03678688|529465217|FG004|Overall Study|Physician Decision|0|||
146807166|NCT03678688|529465218|FG005|Overall Study|Physician Decision|1|||
146807167|NCT03678688|529465219|FG006|Overall Study|Physician Decision|0|||
146807168|NCT03678688|529465220|FG007|Overall Study|Physician Decision|0|||
146807169|NCT03678688|529465221|FG008|Overall Study|Physician Decision|0|||
146807170|NCT03678688|529465213|FG000|Overall Study|Withdrawal by Subject|0|||
146807171|NCT03678688|529465214|FG001|Overall Study|Withdrawal by Subject|0|||
146942207|NCT02910089|529948067|FG000|Overall Study|Lost insurance eligibility|22|||
146807172|NCT03678688|529465215|FG002|Overall Study|Withdrawal by Subject|0|||
146807173|NCT03678688|529465216|FG003|Overall Study|Withdrawal by Subject|0|||
146807174|NCT03678688|529465217|FG004|Overall Study|Withdrawal by Subject|0|||
146807175|NCT03678688|529465218|FG005|Overall Study|Withdrawal by Subject|0|||
146807176|NCT03678688|529465219|FG006|Overall Study|Withdrawal by Subject|2|||
146807177|NCT03678688|529465220|FG007|Overall Study|Withdrawal by Subject|1|||
146807178|NCT03678688|529465221|FG008|Overall Study|Withdrawal by Subject|0|||
146807179|NCT01583166|529465224|FG000|Overall Study|Withdrawal by Subject|4|||
146807180|NCT01583166|529465225|FG001|Overall Study|Withdrawal by Subject|6|||
146807181|NCT02000752|529465228|FG000|Overall Study|Dystocic delivery|19|||
146807182|NCT02000752|529465229|FG001|Overall Study|Dystocic delivery|8|||
146807183|NCT02000752|529465228|FG000|Overall Study|Shift Changes|12|||
146807184|NCT02000752|529465229|FG001|Overall Study|Shift Changes|5|||
146807185|NCT00047385|529465235|FG000|Overall Study|Death before any screening|2|||
146807186|NCT00047385|529465236|FG001|Overall Study|Death before any screening|5|||
146807187|NCT00047385|529465235|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
146807188|NCT00047385|529465236|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
146807189|NCT00047385|529465235|FG000|Overall Study|Eligible for screening but had no screen|260|||
146807190|NCT00047385|529465236|FG001|Overall Study|Eligible for screening but had no screen|492|||
146807191|NCT03392194|529465237|FG000|Overall Study|Withdrawal by Subject|1|||
146807192|NCT03392194|529465238|FG001|Overall Study|Withdrawal by Subject|2|||
146807193|NCT03392194|529465237|FG000|Overall Study|Conflicts with personal schedule|1|||
146807194|NCT03392194|529465238|FG001|Overall Study|Conflicts with personal schedule|0|||
146807195|NCT03865732|529465239|FG000|Overall Study|Adverse Event|0|||
146807196|NCT03865732|529465240|FG001|Overall Study|Adverse Event|1|||
146807197|NCT01009645|529465244|FG000|Overall Study|Lost to Follow-up|2|||
146807198|NCT01009645|529465245|FG001|Overall Study|Lost to Follow-up|8|||
146807199|NCT01009645|529465246|FG002|Overall Study|Lost to Follow-up|4|||
146807200|NCT01009645|529465247|FG003|Overall Study|Lost to Follow-up|5|||
146807201|NCT00620854|529465248|FG000|Washout 1|Withdrawal by Subject|0|||
146807202|NCT00620854|529465249|FG001|Washout 1|Withdrawal by Subject|0|||
146807203|NCT00620854|529465250|FG002|Washout 1|Withdrawal by Subject|1|||
146807204|NCT00620854|529465251|FG003|Washout 1|Withdrawal by Subject|1|||
146807205|NCT00620854|529465252|FG004|Washout 1|Withdrawal by Subject|0|||
146807206|NCT00620854|529465253|FG005|Washout 1|Withdrawal by Subject|0|||
146807207|NCT03345979|529465254|FG000|Overall Study|Withdrawal by Subject|20|||
146807208|NCT03345979|529465255|FG001|Overall Study|Withdrawal by Subject|31|||
146807209|NCT03345979|529465254|FG000|Overall Study|Adverse Event|10|||
146807210|NCT03345979|529465255|FG001|Overall Study|Adverse Event|11|||
146807211|NCT03345979|529465254|FG000|Overall Study|Lost to Follow-up|8|||
146942208|NCT02910089|529948068|FG001|Overall Study|Lost insurance eligibility|16|||
146807212|NCT03345979|529465255|FG001|Overall Study|Lost to Follow-up|9|||
146807213|NCT03345979|529465254|FG000|Overall Study|Lack of Efficacy|4|||
146807214|NCT03345979|529465255|FG001|Overall Study|Lack of Efficacy|2|||
146807215|NCT03345979|529465254|FG000|Overall Study|Protocol Violation|1|||
146807216|NCT03345979|529465255|FG001|Overall Study|Protocol Violation|3|||
146942209|NCT02939976|529948069|FG000|Overall Study|Lost to Follow-up|7|||
146942210|NCT02939976|529948070|FG001|Overall Study|Lost to Follow-up|1|||
146942211|NCT02939976|529948071|FG002|Overall Study|Lost to Follow-up|1|||
146942212|NCT02939976|529948072|FG003|Overall Study|Lost to Follow-up|2|||
146942213|NCT02939976|529948069|FG000|Overall Study|Withdrawal by Subject|4|||
146942214|NCT02939976|529948070|FG001|Overall Study|Withdrawal by Subject|0|||
146942215|NCT02939976|529948071|FG002|Overall Study|Withdrawal by Subject|2|||
146807217|NCT03345979|529465254|FG000|Overall Study|Physician Decision|0|||
146807218|NCT03345979|529465255|FG001|Overall Study|Physician Decision|2|||
146807219|NCT00734578|529465257|FG000|Overall Study|Adverse Event|4|||
146807220|NCT00734578|529465258|FG001|Overall Study|Adverse Event|6|||
146807221|NCT00734578|529465259|FG002|Overall Study|Adverse Event|1|||
146807222|NCT00734578|529465257|FG000|Overall Study|Protocol Violation|8|||
146807223|NCT00734578|529465258|FG001|Overall Study|Protocol Violation|6|||
146807224|NCT00734578|529465259|FG002|Overall Study|Protocol Violation|3|||
146807225|NCT00734578|529465257|FG000|Overall Study|Withdrawal by Subject|7|||
146807226|NCT00734578|529465258|FG001|Overall Study|Withdrawal by Subject|8|||
146807227|NCT00734578|529465259|FG002|Overall Study|Withdrawal by Subject|11|||
146807228|NCT00734578|529465257|FG000|Overall Study|Lost to Follow-up|9|||
146807229|NCT00734578|529465258|FG001|Overall Study|Lost to Follow-up|3|||
146807230|NCT00734578|529465259|FG002|Overall Study|Lost to Follow-up|5|||
146807231|NCT00734578|529465257|FG000|Overall Study|Lack of Efficacy|3|||
146807232|NCT00734578|529465258|FG001|Overall Study|Lack of Efficacy|2|||
146807233|NCT00734578|529465259|FG002|Overall Study|Lack of Efficacy|5|||
146807234|NCT00734578|529465257|FG000|Overall Study|Randomized in error|1|||
146942216|NCT02939976|529948072|FG003|Overall Study|Withdrawal by Subject|4|||
146942217|NCT02939976|529948069|FG000|Overall Study|Due to early study closure|4|||
146942218|NCT02939976|529948070|FG001|Overall Study|Due to early study closure|3|||
146942219|NCT02939976|529948071|FG002|Overall Study|Due to early study closure|2|||
146942220|NCT02939976|529948072|FG003|Overall Study|Due to early study closure|3|||
146942221|NCT01585168|529948073|FG000|Overall Study|Lost to Follow-up|3|||
146942222|NCT01585168|529948074|FG001|Overall Study|Lost to Follow-up|1|||
146942223|NCT01585168|529948075|FG002|Overall Study|Lost to Follow-up|1|||
146983984|NCT01688037|530102016|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
146983985|NCT01688037|530102017|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
146983986|NCT01688037|530102015|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
146807235|NCT00734578|529465258|FG001|Overall Study|Randomized in error|0|||
146807236|NCT00734578|529465259|FG002|Overall Study|Randomized in error|0|||
146807237|NCT00734578|529465257|FG000|Overall Study|Exclusion criteria|1|||
146807238|NCT00734578|529465258|FG001|Overall Study|Exclusion criteria|0|||
146807239|NCT00734578|529465259|FG002|Overall Study|Exclusion criteria|0|||
146807240|NCT00999596|529465260|FG000|Overall Study|Statistical population not required|101|||
146807241|NCT02095145|529465261|FG000|Overall Study|Withdrawal by Subject|1|||
146807242|NCT02095145|529465262|FG001|Overall Study|Withdrawal by Subject|0|||
146807243|NCT02085941|529465264|FG000|Overall Study|Lack of Efficacy|1|||
146807244|NCT02085941|529465265|FG001|Overall Study|Lack of Efficacy|0|||
146807245|NCT02085941|529465264|FG000|Overall Study|Death|6|||
146807246|NCT02085941|529465265|FG001|Overall Study|Death|1|||
146807247|NCT02085941|529465264|FG000|Overall Study|Lost to Follow-up|1|||
146807248|NCT02085941|529465265|FG001|Overall Study|Lost to Follow-up|0|||
146807249|NCT02085941|529465264|FG000|Overall Study|Physician Decision|0|||
146807250|NCT02085941|529465265|FG001|Overall Study|Physician Decision|2|||
146807251|NCT01079806|529465271|FG000|Day 1 to Week 96|Adverse Event|0|||
146807252|NCT01079806|529465272|FG001|Day 1 to Week 96|Adverse Event|3|||
146807253|NCT01079806|529465271|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
146807254|NCT01079806|529465272|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
146807255|NCT01079806|529465271|FG000|Day 1 to Week 96|Pregnancy|0|||
146807256|NCT01079806|529465272|FG001|Day 1 to Week 96|Pregnancy|1|||
146807257|NCT01079806|529465271|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
146807258|NCT01079806|529465272|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
146807259|NCT01079806|529465271|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
146807260|NCT01079806|529465272|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
146807261|NCT01079806|529465271|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
146807262|NCT01079806|529465272|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
146807263|NCT01079806|529465271|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
146807264|NCT01079806|529465272|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
146807265|NCT01079806|529465271|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
146807266|NCT01079806|529465272|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
146807267|NCT01079806|529465271|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
146807268|NCT01079806|529465272|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
146807269|NCT01079806|529465271|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
146942224|NCT01585168|529948076|FG003|Overall Study|Lost to Follow-up|1|||
146942225|NCT02977507|529948078|FG000|Overall Study|Protocol Deviation|1|||
146807270|NCT01079806|529465272|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
146807271|NCT02788981|529465275|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
146807272|NCT02788981|529465276|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
146942226|NCT02977507|529948079|FG001|Overall Study|Protocol Deviation|0|||
146942227|NCT02977507|529948078|FG000|Overall Study|Lost to Follow-up|1|||
146942228|NCT02977507|529948079|FG001|Overall Study|Lost to Follow-up|0|||
146807273|NCT00249769|529465277|FG000|Overall Study|Withdrawal by Subject|1|||
146807274|NCT00249769|529465278|FG001|Overall Study|Withdrawal by Subject|10|||
146807275|NCT00249769|529465279|FG002|Overall Study|Withdrawal by Subject|6|||
146807276|NCT00249769|529465277|FG000|Overall Study|Migration from Study Area|1|||
146942229|NCT00481988|529948080|FG000|Overall Study|Withdrawal by Subject|1|||
146942230|NCT00481988|529948081|FG001|Overall Study|Withdrawal by Subject|1|||
146942231|NCT00654420|529948082|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
146942232|NCT00654420|529948083|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
146942233|NCT00654420|529948084|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
146942234|NCT00654420|529948085|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
146807277|NCT00249769|529465278|FG001|Overall Study|Migration from Study Area|3|||
146807278|NCT00249769|529465279|FG002|Overall Study|Migration from Study Area|14|||
146807279|NCT00249769|529465277|FG000|Overall Study|Miscellaneous|0|||
146807280|NCT00249769|529465278|FG001|Overall Study|Miscellaneous|2|||
146807281|NCT00249769|529465279|FG002|Overall Study|Miscellaneous|2|||
146807282|NCT00249769|529465277|FG000|Overall Study|Adverse Event|0|||
146807283|NCT00249769|529465278|FG001|Overall Study|Adverse Event|0|||
146807284|NCT00249769|529465279|FG002|Overall Study|Adverse Event|1|||
146807285|NCT00249769|529465277|FG000|Overall Study|Physician Decision|0|||
146807286|NCT00249769|529465278|FG001|Overall Study|Physician Decision|0|||
146807287|NCT00249769|529465279|FG002|Overall Study|Physician Decision|2|||
146807288|NCT00249769|529465277|FG000|Overall Study|Lost to Follow-up|0|||
146807289|NCT00249769|529465278|FG001|Overall Study|Lost to Follow-up|0|||
146807290|NCT00249769|529465279|FG002|Overall Study|Lost to Follow-up|3|||
146807291|NCT02022657|529465280|FG000|Overall Study|Withdrawal by Subject|2|||
146807292|NCT02022657|529465281|FG001|Overall Study|Withdrawal by Subject|0|||
146807293|NCT02022657|529465282|FG002|Overall Study|Withdrawal by Subject|1|||
146807294|NCT02022657|529465283|FG003|Overall Study|Withdrawal by Subject|0|||
146807295|NCT02022657|529465284|FG004|Overall Study|Withdrawal by Subject|0|||
146807296|NCT02022657|529465285|FG005|Overall Study|Withdrawal by Subject|0|||
146807297|NCT02022657|529465280|FG000|Overall Study|Physician Decision|0|||
146807298|NCT02022657|529465281|FG001|Overall Study|Physician Decision|0|||
146807299|NCT02022657|529465282|FG002|Overall Study|Physician Decision|0|||
146807300|NCT02022657|529465283|FG003|Overall Study|Physician Decision|0|||
146807301|NCT02022657|529465284|FG004|Overall Study|Physician Decision|0|||
146807302|NCT02022657|529465285|FG005|Overall Study|Physician Decision|1|||
146807303|NCT03739866|529465292|FG000|Overall Study|Lost to Follow-up|0|||
146807304|NCT03739866|529465293|FG001|Overall Study|Lost to Follow-up|0|||
146807305|NCT03739866|529465294|FG002|Overall Study|Lost to Follow-up|0|||
146807306|NCT03739866|529465295|FG003|Overall Study|Lost to Follow-up|1|||
146807307|NCT03739866|529465296|FG004|Overall Study|Lost to Follow-up|0|||
146807308|NCT03739866|529465297|FG005|Overall Study|Lost to Follow-up|0|||
146807309|NCT03739866|529465298|FG006|Overall Study|Lost to Follow-up|0|||
146807310|NCT03739866|529465299|FG007|Overall Study|Lost to Follow-up|0|||
146807311|NCT03739866|529465292|FG000|Overall Study|Enrolled but not treated|0|||
146807312|NCT03739866|529465293|FG001|Overall Study|Enrolled but not treated|0|||
146807313|NCT03739866|529465294|FG002|Overall Study|Enrolled but not treated|1|||
146807314|NCT03739866|529465295|FG003|Overall Study|Enrolled but not treated|0|||
146807315|NCT03739866|529465296|FG004|Overall Study|Enrolled but not treated|1|||
146807316|NCT03739866|529465297|FG005|Overall Study|Enrolled but not treated|0|||
146807317|NCT03739866|529465298|FG006|Overall Study|Enrolled but not treated|0|||
146807318|NCT03739866|529465299|FG007|Overall Study|Enrolled but not treated|0|||
146807319|NCT03057600|529465300|FG000|Overall Study|Adverse Event|0|||
146807320|NCT03057600|529465301|FG001|Overall Study|Adverse Event|0|||
146807321|NCT03057600|529465302|FG002|Overall Study|Adverse Event|4|||
146807322|NCT03057600|529465303|FG003|Overall Study|Adverse Event|0|||
146807323|NCT03057600|529465300|FG000|Overall Study|Radiologic Disease Progression|8|||
146807324|NCT03057600|529465301|FG001|Overall Study|Radiologic Disease Progression|7|||
146807325|NCT03057600|529465302|FG002|Overall Study|Radiologic Disease Progression|13|||
146807326|NCT03057600|529465303|FG003|Overall Study|Radiologic Disease Progression|10|||
146807327|NCT03057600|529465300|FG000|Overall Study|Symptomatic Deterioration|0|||
146807328|NCT03057600|529465301|FG001|Overall Study|Symptomatic Deterioration|1|||
146807329|NCT03057600|529465302|FG002|Overall Study|Symptomatic Deterioration|1|||
146807330|NCT03057600|529465303|FG003|Overall Study|Symptomatic Deterioration|0|||
146807331|NCT03057600|529465300|FG000|Overall Study|Investigator Decision|0|||
146807332|NCT03057600|529465301|FG001|Overall Study|Investigator Decision|0|||
146807333|NCT03057600|529465302|FG002|Overall Study|Investigator Decision|1|||
146807334|NCT03057600|529465303|FG003|Overall Study|Investigator Decision|0|||
146807335|NCT03057600|529465300|FG000|Overall Study|Study Termination by Sponsor|0|||
146807336|NCT03057600|529465301|FG001|Overall Study|Study Termination by Sponsor|0|||
146807337|NCT03057600|529465302|FG002|Overall Study|Study Termination by Sponsor|0|||
146807338|NCT03057600|529465303|FG003|Overall Study|Study Termination by Sponsor|2|||
146807339|NCT03057600|529465300|FG000|Overall Study|Withdrawal by Subject|0|||
146807340|NCT03057600|529465301|FG001|Overall Study|Withdrawal by Subject|1|||
146807341|NCT03057600|529465302|FG002|Overall Study|Withdrawal by Subject|0|||
146942235|NCT00654420|529948082|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
146807342|NCT03057600|529465303|FG003|Overall Study|Withdrawal by Subject|0|||
146807343|NCT03057600|529465300|FG000|Overall Study|Other, Not Specified|1|||
146807344|NCT03057600|529465301|FG001|Overall Study|Other, Not Specified|1|||
146807345|NCT03057600|529465302|FG002|Overall Study|Other, Not Specified|1|||
146807346|NCT03057600|529465303|FG003|Overall Study|Other, Not Specified|1|||
146807347|NCT02203799|529465304|FG000|Overall Study|Withdrawal by Subject|3|||
146807348|NCT01953692|529465307|FG000|Overall Study|Adverse Event|5|||
146807349|NCT01953692|529465308|FG001|Overall Study|Adverse Event|2|||
146942236|NCT00654420|529948083|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
146807350|NCT01953692|529465309|FG002|Overall Study|Adverse Event|4|||
146807351|NCT01953692|529465310|FG003|Overall Study|Adverse Event|2|||
146807352|NCT01953692|529465311|FG004|Overall Study|Adverse Event|1|||
146807353|NCT01953692|529465312|FG005|Overall Study|Adverse Event|2|||
146807354|NCT01953692|529465313|FG006|Overall Study|Adverse Event|0|||
146807355|NCT01953692|529465314|FG007|Overall Study|Adverse Event|0|||
146807356|NCT01953692|529465315|FG008|Overall Study|Adverse Event|0|||
146807357|NCT01953692|529465307|FG000|Overall Study|Clinical Progression|0|||
146807358|NCT01953692|529465308|FG001|Overall Study|Clinical Progression|15|||
146807359|NCT01953692|529465309|FG002|Overall Study|Clinical Progression|7|||
146807360|NCT01953692|529465310|FG003|Overall Study|Clinical Progression|5|||
146807361|NCT01953692|529465311|FG004|Overall Study|Clinical Progression|0|||
146807362|NCT01953692|529465312|FG005|Overall Study|Clinical Progression|7|||
146807363|NCT01953692|529465313|FG006|Overall Study|Clinical Progression|20|||
146807364|NCT01953692|529465314|FG007|Overall Study|Clinical Progression|3|||
146807365|NCT01953692|529465315|FG008|Overall Study|Clinical Progression|3|||
146807366|NCT01953692|529465307|FG000|Overall Study|Death|5|||
146807367|NCT01953692|529465308|FG001|Overall Study|Death|0|||
146807368|NCT01953692|529465309|FG002|Overall Study|Death|2|||
146807369|NCT01953692|529465310|FG003|Overall Study|Death|2|||
146807370|NCT01953692|529465311|FG004|Overall Study|Death|1|||
146807371|NCT01953692|529465312|FG005|Overall Study|Death|3|||
146807372|NCT01953692|529465313|FG006|Overall Study|Death|6|||
146807373|NCT01953692|529465314|FG007|Overall Study|Death|2|||
146807374|NCT01953692|529465315|FG008|Overall Study|Death|1|||
146807375|NCT01953692|529465307|FG000|Overall Study|Excluded Medication|1|||
146807376|NCT01953692|529465308|FG001|Overall Study|Excluded Medication|0|||
146807377|NCT01953692|529465309|FG002|Overall Study|Excluded Medication|0|||
146807378|NCT01953692|529465310|FG003|Overall Study|Excluded Medication|0|||
146807379|NCT01953692|529465311|FG004|Overall Study|Excluded Medication|0|||
146807380|NCT01953692|529465312|FG005|Overall Study|Excluded Medication|0|||
146807381|NCT01953692|529465313|FG006|Overall Study|Excluded Medication|0|||
146807382|NCT01953692|529465314|FG007|Overall Study|Excluded Medication|0|||
146807383|NCT01953692|529465315|FG008|Overall Study|Excluded Medication|0|||
146807384|NCT01953692|529465307|FG000|Overall Study|Lost to Follow-up|1|||
146807385|NCT01953692|529465308|FG001|Overall Study|Lost to Follow-up|0|||
146807386|NCT01953692|529465309|FG002|Overall Study|Lost to Follow-up|3|||
146807387|NCT01953692|529465310|FG003|Overall Study|Lost to Follow-up|1|||
146807388|NCT01953692|529465311|FG004|Overall Study|Lost to Follow-up|0|||
146807389|NCT01953692|529465312|FG005|Overall Study|Lost to Follow-up|1|||
146807390|NCT01953692|529465313|FG006|Overall Study|Lost to Follow-up|0|||
146807391|NCT01953692|529465314|FG007|Overall Study|Lost to Follow-up|0|||
146807392|NCT01953692|529465315|FG008|Overall Study|Lost to Follow-up|0|||
146807393|NCT01953692|529465307|FG000|Overall Study|Physician Decision|11|||
146807394|NCT01953692|529465308|FG001|Overall Study|Physician Decision|4|||
146807395|NCT01953692|529465309|FG002|Overall Study|Physician Decision|2|||
146807396|NCT01953692|529465310|FG003|Overall Study|Physician Decision|2|||
146807397|NCT01953692|529465311|FG004|Overall Study|Physician Decision|1|||
146807398|NCT01953692|529465312|FG005|Overall Study|Physician Decision|2|||
146807399|NCT01953692|529465313|FG006|Overall Study|Physician Decision|4|||
146807400|NCT01953692|529465314|FG007|Overall Study|Physician Decision|1|||
146807401|NCT01953692|529465315|FG008|Overall Study|Physician Decision|0|||
146807402|NCT01953692|529465307|FG000|Overall Study|Protocol Violation|0|||
146807403|NCT01953692|529465308|FG001|Overall Study|Protocol Violation|2|||
146807404|NCT01953692|529465309|FG002|Overall Study|Protocol Violation|1|||
146807405|NCT01953692|529465310|FG003|Overall Study|Protocol Violation|0|||
146807406|NCT01953692|529465311|FG004|Overall Study|Protocol Violation|0|||
146807407|NCT01953692|529465312|FG005|Overall Study|Protocol Violation|0|||
146807408|NCT01953692|529465313|FG006|Overall Study|Protocol Violation|0|||
146807409|NCT01953692|529465314|FG007|Overall Study|Protocol Violation|1|||
146807410|NCT01953692|529465315|FG008|Overall Study|Protocol Violation|0|||
146807411|NCT01953692|529465307|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
146807412|NCT01953692|529465308|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
146807413|NCT01953692|529465309|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
146807414|NCT01953692|529465310|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
146807415|NCT01953692|529465311|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
146807416|NCT01953692|529465312|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
146807417|NCT01953692|529465313|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
146807418|NCT01953692|529465314|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
146807419|NCT01953692|529465315|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
146807420|NCT01953692|529465307|FG000|Overall Study|Withdrawal by Subject|4|||
146807421|NCT01953692|529465308|FG001|Overall Study|Withdrawal by Subject|2|||
146807422|NCT01953692|529465309|FG002|Overall Study|Withdrawal by Subject|1|||
146807423|NCT01953692|529465310|FG003|Overall Study|Withdrawal by Subject|2|||
146807424|NCT01953692|529465311|FG004|Overall Study|Withdrawal by Subject|0|||
146807425|NCT01953692|529465312|FG005|Overall Study|Withdrawal by Subject|3|||
146807426|NCT01953692|529465313|FG006|Overall Study|Withdrawal by Subject|2|||
146807427|NCT01953692|529465314|FG007|Overall Study|Withdrawal by Subject|1|||
146807428|NCT01953692|529465315|FG008|Overall Study|Withdrawal by Subject|1|||
146807429|NCT02022670|529465316|FG000|Overall Study|Adverse Event|1|||
146807430|NCT02022670|529465317|FG001|Overall Study|Adverse Event|0|||
146807431|NCT02022670|529465318|FG002|Overall Study|Adverse Event|1|||
146807432|NCT02630966|529465327|FG000|Overall Study|Adverse Event|1|||
146807433|NCT02630966|529465328|FG001|Overall Study|Adverse Event|3|||
146807434|NCT02630966|529465327|FG000|Overall Study|Significant Protocol Deviation|0|||
146807435|NCT02630966|529465328|FG001|Overall Study|Significant Protocol Deviation|2|||
146807436|NCT02630966|529465327|FG000|Overall Study|Voluntary Withdrawal|1|||
146807437|NCT02630966|529465328|FG001|Overall Study|Voluntary Withdrawal|1|||
146807438|NCT02630966|529465327|FG000|Overall Study|Lack of Efficacy|0|||
146807439|NCT02630966|529465328|FG001|Overall Study|Lack of Efficacy|2|||
146807440|NCT04677738|529465329|FG000|Overall Study|Withdrawal by Subject|4|||
146807441|NCT04677738|529465330|FG001|Overall Study|Withdrawal by Subject|2|||
146807442|NCT03697603|529465333|FG000|Overall Study|Adverse Event|3|||
146807443|NCT03697603|529465334|FG001|Overall Study|Adverse Event|18|||
146807444|NCT03697603|529465335|FG002|Overall Study|Adverse Event|3|||
146807445|NCT03697603|529465333|FG000|Overall Study|Physician Decision|1|||
146807446|NCT03697603|529465334|FG001|Overall Study|Physician Decision|0|||
146807447|NCT03697603|529465335|FG002|Overall Study|Physician Decision|2|||
146807448|NCT03697603|529465333|FG000|Overall Study|Protocol Violation|3|||
146807449|NCT03697603|529465334|FG001|Overall Study|Protocol Violation|8|||
146807450|NCT03697603|529465335|FG002|Overall Study|Protocol Violation|5|||
146807451|NCT03697603|529465333|FG000|Overall Study|Withdrawal by Subject|5|||
146807452|NCT03697603|529465334|FG001|Overall Study|Withdrawal by Subject|1|||
146807453|NCT03697603|529465335|FG002|Overall Study|Withdrawal by Subject|1|||
146807454|NCT03697603|529465333|FG000|Overall Study|Protocol Violation|0|||
146807455|NCT03697603|529465334|FG001|Overall Study|Protocol Violation|0|||
146807456|NCT03697603|529465335|FG002|Overall Study|Protocol Violation|1|||
146807457|NCT01683409|529465338|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
146807458|NCT01683409|529465339|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
146807459|NCT01683409|529465340|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
146807460|NCT01683409|529465341|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
146807461|NCT01683409|529465342|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
146807462|NCT01683409|529465338|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
146807463|NCT01683409|529465339|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
146807464|NCT01683409|529465340|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
146807465|NCT01683409|529465341|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
146807466|NCT01683409|529465342|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
146807467|NCT01683409|529465338|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
146807468|NCT01683409|529465339|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
146807469|NCT01683409|529465340|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
146807470|NCT01683409|529465341|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
146807471|NCT01683409|529465342|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
146807472|NCT01683409|529465338|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
146807473|NCT01683409|529465339|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
146807474|NCT01683409|529465340|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
146807475|NCT01683409|529465341|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
146807476|NCT01683409|529465342|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
146807477|NCT01683409|529465338|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
146942237|NCT00654420|529948084|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
146942238|NCT00654420|529948085|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
146942239|NCT00654420|529948082|FG000|Phase II|Adverse Event|0|||
146942240|NCT00654420|529948083|FG001|Phase II|Adverse Event|0|||
146942241|NCT00654420|529948084|FG002|Phase II|Adverse Event|3|||
146942242|NCT00654420|529948085|FG003|Phase II|Adverse Event|3|||
146942243|NCT00654420|529948082|FG000|Phase II|Lost to Follow-up|0|||
146942244|NCT00654420|529948083|FG001|Phase II|Lost to Follow-up|0|||
146942245|NCT00654420|529948084|FG002|Phase II|Lost to Follow-up|0|||
146942246|NCT00654420|529948085|FG003|Phase II|Lost to Follow-up|1|||
146942247|NCT00654420|529948082|FG000|Phase II|Physician Decision|0|||
146942248|NCT00654420|529948083|FG001|Phase II|Physician Decision|0|||
146942249|NCT00654420|529948084|FG002|Phase II|Physician Decision|0|||
146942250|NCT00654420|529948085|FG003|Phase II|Physician Decision|4|||
146942251|NCT00654420|529948082|FG000|Phase II|Progressive Disease|0|||
146942252|NCT00654420|529948083|FG001|Phase II|Progressive Disease|0|||
146942253|NCT00654420|529948084|FG002|Phase II|Progressive Disease|29|||
146807478|NCT01683409|529465339|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
146807479|NCT01683409|529465340|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
146807480|NCT01683409|529465341|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
146942254|NCT00654420|529948085|FG003|Phase II|Progressive Disease|29|||
146942255|NCT00654420|529948082|FG000|Phase II|Withdrawal by Subject|0|||
146942256|NCT00654420|529948083|FG001|Phase II|Withdrawal by Subject|0|||
146942257|NCT00654420|529948084|FG002|Phase II|Withdrawal by Subject|4|||
146942258|NCT00654420|529948085|FG003|Phase II|Withdrawal by Subject|1|||
146942259|NCT00654420|529948082|FG000|Phase II|Missing Disposition Record|0|||
146807481|NCT01683409|529465342|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
146807482|NCT01683409|529465338|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
146807483|NCT01683409|529465339|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
146807484|NCT01683409|529465340|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
146807485|NCT01683409|529465341|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
146807486|NCT01683409|529465342|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
146807487|NCT01683409|529465338|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
146807488|NCT01683409|529465339|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
146807489|NCT01683409|529465340|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
146807490|NCT01683409|529465341|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
146807491|NCT01683409|529465342|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
146807492|NCT01683409|529465338|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
146807493|NCT01683409|529465339|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
146807494|NCT01683409|529465340|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
146807495|NCT01683409|529465341|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
146807496|NCT01683409|529465342|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
146807497|NCT01683409|529465338|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
146807498|NCT01683409|529465339|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
146807499|NCT01683409|529465340|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
146807500|NCT01683409|529465341|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
146807501|NCT01683409|529465342|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
146807502|NCT01683409|529465338|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
146807503|NCT01683409|529465339|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
146807504|NCT01683409|529465340|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
146807505|NCT01683409|529465341|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
146807506|NCT01683409|529465342|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
146807507|NCT01683409|529465338|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
146807508|NCT01683409|529465339|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
146807509|NCT01683409|529465340|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
146807510|NCT01683409|529465341|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
146807511|NCT01683409|529465342|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
146807512|NCT04218864|529465343|FG000|Overall Study|Lost to Follow-up|8|||
146807513|NCT04218864|529465344|FG001|Overall Study|Lost to Follow-up|4|||
146807514|NCT04218864|529465343|FG000|Overall Study|Withdrawal by Subject|1|||
146807515|NCT04218864|529465344|FG001|Overall Study|Withdrawal by Subject|3|||
146807516|NCT03520036|529465345|FG000|Overall Study|Adverse Event|1|||
146807517|NCT03520036|529465346|FG001|Overall Study|Adverse Event|2|||
146807518|NCT03520036|529465347|FG002|Overall Study|Adverse Event|0|||
146807519|NCT03520036|529465345|FG000|Overall Study|Protocol Violation|1|||
146807520|NCT03520036|529465346|FG001|Overall Study|Protocol Violation|0|||
146807521|NCT03520036|529465347|FG002|Overall Study|Protocol Violation|0|||
146807522|NCT03520036|529465345|FG000|Overall Study|Withdrawal by Subject|0|||
146942260|NCT00654420|529948083|FG001|Phase II|Missing Disposition Record|0|||
146942261|NCT00654420|529948084|FG002|Phase II|Missing Disposition Record|1|||
146942262|NCT00654420|529948085|FG003|Phase II|Missing Disposition Record|0|||
146942263|NCT00741260|529948106|FG000|Overall Study|Disease Progression|3|||
146942264|NCT00741260|529948107|FG001|Overall Study|Disease Progression|5|||
146942265|NCT00741260|529948108|FG002|Overall Study|Disease Progression|3|||
146942266|NCT00741260|529948109|FG003|Overall Study|Disease Progression|3|||
146942267|NCT00741260|529948110|FG004|Overall Study|Disease Progression|5|||
146942268|NCT00741260|529948111|FG005|Overall Study|Disease Progression|37|||
146942269|NCT00741260|529948112|FG006|Overall Study|Disease Progression|4|||
146942270|NCT00741260|529948106|FG000|Overall Study|Death|0|||
146942271|NCT00741260|529948107|FG001|Overall Study|Death|1|||
146807523|NCT03520036|529465346|FG001|Overall Study|Withdrawal by Subject|1|||
146807524|NCT03520036|529465347|FG002|Overall Study|Withdrawal by Subject|4|||
146807525|NCT03520036|529465345|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
146807526|NCT03520036|529465346|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
146807527|NCT03520036|529465347|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
146807528|NCT00467272|529465348|FG000|Overall Study|Pneumonia|2|||
146807529|NCT00467272|529465348|FG000|Overall Study|Thrombophlebitis|1|||
146807530|NCT00145470|529465351|FG000|Overall Study|Adverse Event|19|||
146807531|NCT00145470|529465352|FG001|Overall Study|Adverse Event|25|||
146942272|NCT00741260|529948108|FG002|Overall Study|Death|0|||
146942273|NCT00741260|529948109|FG003|Overall Study|Death|1|||
146942274|NCT00741260|529948110|FG004|Overall Study|Death|2|||
146942275|NCT00741260|529948111|FG005|Overall Study|Death|2|||
146942276|NCT00741260|529948112|FG006|Overall Study|Death|1|||
146942277|NCT00741260|529948106|FG000|Overall Study|Withdrawal by Subject|0|||
146942278|NCT00741260|529948107|FG001|Overall Study|Withdrawal by Subject|0|||
146942279|NCT00741260|529948108|FG002|Overall Study|Withdrawal by Subject|0|||
146942280|NCT00741260|529948109|FG003|Overall Study|Withdrawal by Subject|0|||
146942281|NCT00741260|529948110|FG004|Overall Study|Withdrawal by Subject|1|||
146942282|NCT00741260|529948111|FG005|Overall Study|Withdrawal by Subject|3|||
146807532|NCT00145470|529465351|FG000|Overall Study|Lack of Efficacy|27|||
146807533|NCT00145470|529465352|FG001|Overall Study|Lack of Efficacy|13|||
146807534|NCT00145470|529465351|FG000|Overall Study|Withdrawal by Subject|36|||
146807535|NCT00145470|529465352|FG001|Overall Study|Withdrawal by Subject|34|||
146807536|NCT00145470|529465351|FG000|Overall Study|Lost to Follow-up|21|||
146807537|NCT00145470|529465352|FG001|Overall Study|Lost to Follow-up|17|||
146807538|NCT00145470|529465351|FG000|Overall Study|Reason Not Reported|9|||
146807539|NCT00145470|529465352|FG001|Overall Study|Reason Not Reported|9|||
146807540|NCT00676091|529465353|FG000|Infant Series|Parent or legal guardian request|10|||
146807541|NCT00676091|529465354|FG001|Infant Series|Parent or legal guardian request|8|||
146807542|NCT00676091|529465353|FG000|Infant Series|Protocol Violation|6|||
146807543|NCT00676091|529465354|FG001|Infant Series|Protocol Violation|3|||
146807544|NCT00676091|529465353|FG000|Infant Series|Adverse Event|2|||
146807545|NCT00676091|529465354|FG001|Infant Series|Adverse Event|3|||
146807546|NCT00676091|529465353|FG000|Infant Series|Failed to return|1|||
146807547|NCT00676091|529465354|FG001|Infant Series|Failed to return|3|||
146807548|NCT00676091|529465353|FG000|Infant Series|Lost to Follow-up|1|||
146807549|NCT00676091|529465354|FG001|Infant Series|Lost to Follow-up|0|||
146807550|NCT00676091|529465353|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
146807551|NCT00676091|529465354|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
146807552|NCT00676091|529465353|FG000|After Infant Series|Adverse Event|0|||
146807553|NCT00676091|529465354|FG001|After Infant Series|Adverse Event|1|||
146807554|NCT00676091|529465353|FG000|After Infant Series|Protocol Violation|0|||
146807555|NCT00676091|529465354|FG001|After Infant Series|Protocol Violation|1|||
146807556|NCT00676091|529465353|FG000|After Infant Series|Failed to return|1|||
146807557|NCT00676091|529465354|FG001|After Infant Series|Failed to return|1|||
146807558|NCT00676091|529465353|FG000|Toddler Dose|Failed to return|2|||
146807559|NCT00676091|529465354|FG001|Toddler Dose|Failed to return|0|||
146807560|NCT00676091|529465353|FG000|Toddler Dose|Parent or legal guardian request|1|||
146807561|NCT00676091|529465354|FG001|Toddler Dose|Parent or legal guardian request|0|||
146807562|NCT00933270|529465357|FG000|Overall Study|Withdrawal by Subject|26|||
146807563|NCT00933270|529465357|FG000|Overall Study|Insufficient Follow-up|10|||
146807564|NCT00933270|529465357|FG000|Overall Study|Lost to Follow-up|14|||
146807565|NCT00933270|529465357|FG000|Overall Study|Adverse Event|1|||
146807566|NCT00933270|529465357|FG000|Overall Study|Missed Visit|2|||
146807567|NCT00933270|529465357|FG000|Overall Study|Death|24|||
146807568|NCT00933270|529465357|FG000|Overall Study|Moved or would not return|10|||
146807569|NCT03343704|529465358|FG000|Overall Study|Refused to complete follow up|0|||
146807570|NCT03343704|529465359|FG001|Overall Study|Refused to complete follow up|1|||
146807571|NCT03343704|529465358|FG000|Overall Study|Death|0|||
146807572|NCT03343704|529465359|FG001|Overall Study|Death|1|||
146807573|NCT03343704|529465358|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
146807574|NCT03343704|529465359|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
146807575|NCT05349721|529467080|FG000|Part A (24 Weeks)|Adverse Event|9|||
146807576|NCT05349721|529467081|FG001|Part A (24 Weeks)|Adverse Event|2|||
146807577|NCT05349721|529467080|FG000|Part A (24 Weeks)|Death|8|||
146807578|NCT05349721|529467081|FG001|Part A (24 Weeks)|Death|3|||
146807579|NCT05349721|529467080|FG000|Part A (24 Weeks)|Disease Progression|1|||
146807580|NCT05349721|529467081|FG001|Part A (24 Weeks)|Disease Progression|1|||
146807581|NCT05349721|529467080|FG000|Part A (24 Weeks)|Screen Failure|2|||
146807582|NCT05349721|529467081|FG001|Part A (24 Weeks)|Screen Failure|0|||
146807583|NCT05349721|529467080|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
146807584|NCT05349721|529467081|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
146807585|NCT05349721|529467080|FG000|Part A (24 Weeks)|Other Than Specified|5|||
146807586|NCT05349721|529467081|FG001|Part A (24 Weeks)|Other Than Specified|1|||
146807587|NCT05349721|529467080|FG000|Part B (28 Weeks)|Adverse Event|3|||
146807588|NCT05349721|529467081|FG001|Part B (28 Weeks)|Adverse Event|0|||
146807589|NCT05349721|529467080|FG000|Part B (28 Weeks)|Death|21|||
146807590|NCT05349721|529467081|FG001|Part B (28 Weeks)|Death|11|||
146807591|NCT05349721|529467080|FG000|Part B (28 Weeks)|Disease Progression|2|||
146807592|NCT05349721|529467081|FG001|Part B (28 Weeks)|Disease Progression|1|||
146807593|NCT05349721|529467080|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
146807594|NCT05349721|529467081|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
146807595|NCT05349721|529467080|FG000|Part B (28 Weeks)|Physician Decision|1|||
146807596|NCT05349721|529467081|FG001|Part B (28 Weeks)|Physician Decision|0|||
146807597|NCT05349721|529467080|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
146807598|NCT05349721|529467081|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
146807599|NCT05349721|529467080|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
146807600|NCT05349721|529467081|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
146807601|NCT05349721|529467080|FG000|Part B (28 Weeks)|Other Than Specified|4|||
146807602|NCT05349721|529467081|FG001|Part B (28 Weeks)|Other Than Specified|2|||
146807603|NCT05349721|529467080|FG000|Part C (108 Weeks)|Death|0|||
146807604|NCT05349721|529467081|FG001|Part C (108 Weeks)|Death|1|||
146807605|NCT05349721|529467080|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
146807606|NCT05349721|529467081|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
146807607|NCT05349721|529467080|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
146807608|NCT05349721|529467081|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
146807609|NCT05349721|529467080|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
146807610|NCT05349721|529467081|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
146807611|NCT03136159|529467083|FG000|Overall Study|chorioamnionitis|2|||
146807612|NCT03136159|529467084|FG001|Overall Study|chorioamnionitis|0|||
146807613|NCT03136159|529467083|FG000|Overall Study|vertical skin incision|1|||
146807614|NCT03136159|529467084|FG001|Overall Study|vertical skin incision|0|||
146807615|NCT03136159|529467083|FG000|Overall Study|additional dressing|1|||
146807616|NCT03136159|529467084|FG001|Overall Study|additional dressing|0|||
146807617|NCT03136159|529467083|FG000|Overall Study|never got dressing placed|1|||
146807618|NCT03136159|529467084|FG001|Overall Study|never got dressing placed|0|||
146807619|NCT03823703|529467085|FG000|Overall Study|Sponsor request|0|||
146807620|NCT03823703|529467086|FG001|Overall Study|Sponsor request|3|||
146807621|NCT03823703|529467087|FG002|Overall Study|Sponsor request|4|||
146807622|NCT03823703|529467085|FG000|Overall Study|Adverse Event|3|||
146807623|NCT03823703|529467086|FG001|Overall Study|Adverse Event|1|||
146807624|NCT03823703|529467087|FG002|Overall Study|Adverse Event|0|||
146807625|NCT03823703|529467085|FG000|Overall Study|Withdrawal by Subject|0|||
146807626|NCT03823703|529467086|FG001|Overall Study|Withdrawal by Subject|1|||
146807627|NCT03823703|529467087|FG002|Overall Study|Withdrawal by Subject|0|||
146807628|NCT03137459|529467088|FG000|2-month Assessment|Withdrawal by Subject|13|||
146807629|NCT03137459|529467089|FG001|2-month Assessment|Withdrawal by Subject|3|||
146807630|NCT03137459|529467088|FG000|2-month Assessment|Unable to reach|42|||
146807631|NCT03137459|529467089|FG001|2-month Assessment|Unable to reach|32|||
146807632|NCT03137459|529467088|FG000|2-month Assessment|Refused assessment|7|||
146807633|NCT03137459|529467089|FG001|2-month Assessment|Refused assessment|5|||
146807634|NCT03137459|529467088|FG000|2-month Assessment|Acutely ill|6|||
146807635|NCT03137459|529467089|FG001|2-month Assessment|Acutely ill|2|||
146807636|NCT03137459|529467088|FG000|4-month Assessment|Death|4|||
146807637|NCT03137459|529467089|FG001|4-month Assessment|Death|2|||
146807638|NCT03137459|529467088|FG000|4-month Assessment|Withdrawal by Subject|4|||
146807639|NCT03137459|529467089|FG001|4-month Assessment|Withdrawal by Subject|2|||
146807640|NCT03137459|529467088|FG000|4-month Assessment|Unable to reach|44|||
146807641|NCT03137459|529467089|FG001|4-month Assessment|Unable to reach|29|||
146807642|NCT03137459|529467088|FG000|4-month Assessment|Refused assessment|24|||
146807643|NCT03137459|529467089|FG001|4-month Assessment|Refused assessment|10|||
146807644|NCT03137459|529467088|FG000|4-month Assessment|Acutely ill|2|||
146807645|NCT03137459|529467089|FG001|4-month Assessment|Acutely ill|3|||
146807646|NCT03137459|529467088|FG000|6-months|Lost to Follow-up|14|||
146807647|NCT03137459|529467089|FG001|6-months|Lost to Follow-up|11|||
146807648|NCT03137459|529467088|FG000|6-months|Death|0|||
146807649|NCT03137459|529467089|FG001|6-months|Death|2|||
146807650|NCT03137459|529467088|FG000|6-months|Refused assessment|6|||
146807651|NCT03137459|529467089|FG001|6-months|Refused assessment|3|||
146807652|NCT03137459|529467088|FG000|6-months|Acutely ill|1|||
146807653|NCT03137459|529467089|FG001|6-months|Acutely ill|1|||
146807654|NCT00985088|529467090|FG000|Overall Study|Serious Adverse Event|1|||
146807655|NCT00985088|529467091|FG001|Overall Study|Serious Adverse Event|1|||
146807656|NCT00985088|529467092|FG002|Overall Study|Serious Adverse Event|0|||
146807657|NCT00985088|529467093|FG003|Overall Study|Serious Adverse Event|0|||
146807658|NCT00985088|529467094|FG004|Overall Study|Serious Adverse Event|0|||
146807659|NCT00985088|529467095|FG005|Overall Study|Serious Adverse Event|0|||
146807660|NCT00985088|529467096|FG006|Overall Study|Serious Adverse Event|0|||
146807661|NCT00985088|529467097|FG007|Overall Study|Serious Adverse Event|1|||
146807662|NCT00985088|529467090|FG000|Overall Study|Adverse Event|0|||
146807663|NCT00985088|529467091|FG001|Overall Study|Adverse Event|0|||
146807664|NCT00985088|529467092|FG002|Overall Study|Adverse Event|1|||
146807665|NCT00985088|529467093|FG003|Overall Study|Adverse Event|0|||
146807666|NCT00985088|529467094|FG004|Overall Study|Adverse Event|0|||
146807667|NCT00985088|529467095|FG005|Overall Study|Adverse Event|0|||
146807668|NCT00985088|529467096|FG006|Overall Study|Adverse Event|0|||
146942283|NCT00741260|529948112|FG006|Overall Study|Withdrawal by Subject|1|||
146942284|NCT00741260|529948106|FG000|Overall Study|Physician Decision|1|||
146942285|NCT00741260|529948107|FG001|Overall Study|Physician Decision|1|||
146942286|NCT00741260|529948108|FG002|Overall Study|Physician Decision|0|||
146942287|NCT00741260|529948109|FG003|Overall Study|Physician Decision|0|||
146807669|NCT00985088|529467097|FG007|Overall Study|Adverse Event|0|||
146807670|NCT00985088|529467090|FG000|Overall Study|Withdrawal by Subject|4|||
146807671|NCT00985088|529467091|FG001|Overall Study|Withdrawal by Subject|0|||
146807672|NCT00985088|529467092|FG002|Overall Study|Withdrawal by Subject|0|||
146807673|NCT00985088|529467093|FG003|Overall Study|Withdrawal by Subject|1|||
146807674|NCT00985088|529467094|FG004|Overall Study|Withdrawal by Subject|3|||
146807675|NCT00985088|529467095|FG005|Overall Study|Withdrawal by Subject|2|||
146807676|NCT00985088|529467096|FG006|Overall Study|Withdrawal by Subject|1|||
146807677|NCT00985088|529467097|FG007|Overall Study|Withdrawal by Subject|2|||
146942288|NCT00741260|529948110|FG004|Overall Study|Physician Decision|0|||
146807678|NCT00985088|529467090|FG000|Overall Study|Migrated/moved from study area|0|||
146942289|NCT00741260|529948111|FG005|Overall Study|Physician Decision|0|||
146807679|NCT00985088|529467091|FG001|Overall Study|Migrated/moved from study area|0|||
146807680|NCT00985088|529467092|FG002|Overall Study|Migrated/moved from study area|1|||
146807681|NCT00985088|529467093|FG003|Overall Study|Migrated/moved from study area|0|||
146807682|NCT00985088|529467094|FG004|Overall Study|Migrated/moved from study area|0|||
146807683|NCT00985088|529467095|FG005|Overall Study|Migrated/moved from study area|0|||
146807684|NCT00985088|529467096|FG006|Overall Study|Migrated/moved from study area|0|||
146807685|NCT00985088|529467097|FG007|Overall Study|Migrated/moved from study area|1|||
146807686|NCT00985088|529467090|FG000|Overall Study|Lost to Follow-up|6|||
146807687|NCT00985088|529467091|FG001|Overall Study|Lost to Follow-up|1|||
146807688|NCT00985088|529467092|FG002|Overall Study|Lost to Follow-up|2|||
146807689|NCT00985088|529467093|FG003|Overall Study|Lost to Follow-up|6|||
146807690|NCT00985088|529467094|FG004|Overall Study|Lost to Follow-up|6|||
146807691|NCT00985088|529467095|FG005|Overall Study|Lost to Follow-up|5|||
146807692|NCT00985088|529467096|FG006|Overall Study|Lost to Follow-up|3|||
146807693|NCT00985088|529467097|FG007|Overall Study|Lost to Follow-up|2|||
146807694|NCT01732757|529467098|FG000|Overall Study|Lost to Follow-up|1|||
146807695|NCT01732757|529467099|FG001|Overall Study|Lost to Follow-up|0|||
146807696|NCT01732757|529467100|FG002|Overall Study|Lost to Follow-up|0|||
146807697|NCT00491400|529467101|FG000|Overall Study|Withdrawal by Subject|5|||
146807698|NCT00491400|529467102|FG001|Overall Study|Withdrawal by Subject|4|||
146807699|NCT00887224|529467105|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
146807700|NCT00887224|529467106|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
146807701|NCT00887224|529467107|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
146807702|NCT00887224|529467105|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
146807703|NCT00887224|529467106|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
146807704|NCT00887224|529467107|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
146807705|NCT00887224|529467105|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
146807706|NCT00887224|529467106|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
146807707|NCT00887224|529467107|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
146807708|NCT00887224|529467105|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
146807709|NCT00887224|529467106|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
146807710|NCT00887224|529467107|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
146807711|NCT00887224|529467105|FG000|Open-label Response (OLR) Phase|Other|1|||
146807712|NCT00887224|529467106|FG001|Open-label Response (OLR) Phase|Other|0|||
146807713|NCT00887224|529467107|FG002|Open-label Response (OLR) Phase|Other|0|||
146807714|NCT00887224|529467105|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
146807715|NCT00887224|529467106|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
146807716|NCT00887224|529467107|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
146807717|NCT00887224|529467105|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
146807718|NCT00887224|529467106|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
146807719|NCT00887224|529467107|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
146807720|NCT00887224|529467105|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
146807721|NCT00887224|529467106|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
146807722|NCT00887224|529467107|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
146807723|NCT00887224|529467105|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
146807724|NCT00887224|529467106|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
146807725|NCT00887224|529467107|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
146807726|NCT00887224|529467105|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
146807727|NCT00887224|529467106|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
146807728|NCT00887224|529467107|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
146807729|NCT00887224|529467105|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
146807730|NCT00887224|529467106|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
146807731|NCT00887224|529467107|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
146807732|NCT00887224|529467105|FG000|Open-label Stability (OLS) Phase|Other|1|||
146807733|NCT00887224|529467106|FG001|Open-label Stability (OLS) Phase|Other|0|||
146807734|NCT00887224|529467107|FG002|Open-label Stability (OLS) Phase|Other|0|||
146807735|NCT00887224|529467105|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
146807736|NCT00887224|529467106|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
146807737|NCT00887224|529467107|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
146807738|NCT00887224|529467105|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
146807739|NCT00887224|529467106|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
146807740|NCT00887224|529467107|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
146807741|NCT00887224|529467105|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
146807742|NCT00887224|529467106|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
146807743|NCT00887224|529467107|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
146807744|NCT00887224|529467105|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
146807745|NCT00887224|529467106|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
146807746|NCT00887224|529467107|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
146807747|NCT00887224|529467105|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
146807748|NCT00887224|529467106|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
146942290|NCT00741260|529948112|FG006|Overall Study|Physician Decision|0|||
146942291|NCT00741260|529948106|FG000|Overall Study|Other|2|||
146942292|NCT00741260|529948107|FG001|Overall Study|Other|1|||
146807749|NCT00887224|529467107|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
146807750|NCT00887224|529467105|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
146807751|NCT00887224|529467106|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
146807752|NCT00887224|529467107|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
146807753|NCT00887224|529467105|FG000|OL Taper Phase / OL Follow Up|Other|30|||
146807754|NCT00887224|529467106|FG001|OL Taper Phase / OL Follow Up|Other|0|||
146807755|NCT00887224|529467107|FG002|OL Taper Phase / OL Follow Up|Other|0|||
146807756|NCT00887224|529467105|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
146807757|NCT00887224|529467106|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
146807758|NCT00887224|529467107|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
146807759|NCT00887224|529467105|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
146807760|NCT00887224|529467106|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
146807761|NCT00887224|529467107|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
146807762|NCT00887224|529467105|FG000|Double-blind (DB) Phase|Adverse Event|0|||
146807763|NCT00887224|529467106|FG001|Double-blind (DB) Phase|Adverse Event|7|||
146807764|NCT00887224|529467107|FG002|Double-blind (DB) Phase|Adverse Event|2|||
146807765|NCT00887224|529467105|FG000|Double-blind (DB) Phase|Failed to return|0|||
146807766|NCT00887224|529467106|FG001|Double-blind (DB) Phase|Failed to return|2|||
146807767|NCT00887224|529467107|FG002|Double-blind (DB) Phase|Failed to return|2|||
146807768|NCT00887224|529467105|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
146807769|NCT00887224|529467106|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
146807770|NCT00887224|529467107|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
146807771|NCT00887224|529467105|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
146807772|NCT00887224|529467106|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
146807773|NCT00887224|529467107|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
146807774|NCT00887224|529467105|FG000|Double-blind (DB) Phase|Other|0|||
146807775|NCT00887224|529467106|FG001|Double-blind (DB) Phase|Other|2|||
146807776|NCT00887224|529467107|FG002|Double-blind (DB) Phase|Other|0|||
146807777|NCT00887224|529467105|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
146807778|NCT00887224|529467106|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
146807779|NCT00887224|529467107|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
146807780|NCT00887224|529467105|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
146807781|NCT00887224|529467106|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
146807782|NCT00887224|529467107|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
146807783|NCT00887224|529467105|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
146807784|NCT00887224|529467106|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
146807785|NCT00887224|529467107|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
146807786|NCT00887224|529467105|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
146807787|NCT00887224|529467106|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
146807788|NCT00887224|529467107|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
146807789|NCT00887224|529467105|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
146807790|NCT00887224|529467106|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
146807791|NCT00887224|529467107|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
146807792|NCT00887224|529467105|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
146807793|NCT00887224|529467106|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
146807794|NCT00887224|529467107|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
146807795|NCT00887224|529467105|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
146807796|NCT00887224|529467106|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
146807797|NCT00887224|529467107|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
146807798|NCT00887224|529467105|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
146807799|NCT00887224|529467106|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
146807800|NCT00887224|529467107|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
146807801|NCT00887224|529467105|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
146807802|NCT00887224|529467106|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
146807803|NCT00887224|529467107|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
146807804|NCT01698918|529467110|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
146807805|NCT01698918|529467110|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
146807806|NCT01698918|529467110|FG000|First Line Treatment (Core+Extension)|Death|2|||
146807807|NCT01698918|529467110|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
146807808|NCT01698918|529467110|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
146807809|NCT01698918|529467110|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
146807810|NCT01698918|529467110|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
146807811|NCT01698918|529467110|FG000|Second Line Treatment (Core+Extension)|Death|1|||
146807812|NCT01698918|529467110|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
146807813|NCT01698918|529467110|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
146807814|NCT04693637|529467114|FG000|Overall Study|Death|4|||
146807815|NCT04693637|529467114|FG000|Overall Study|Withdrawal by Subject|3|||
146807816|NCT04693637|529467114|FG000|Overall Study|Physician Decision|2|||
146942293|NCT00741260|529948108|FG002|Overall Study|Other|1|||
146942294|NCT00741260|529948109|FG003|Overall Study|Other|2|||
146983987|NCT01688037|530102016|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
146983988|NCT01688037|530102017|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
146983989|NCT01688037|530102015|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
146983990|NCT01688037|530102016|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
146983991|NCT01688037|530102017|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
146807817|NCT04693637|529467114|FG000|Overall Study|Lost to Follow-up|1|||
146807818|NCT05553366|529467117|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
146807819|NCT05553366|529467118|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
146807820|NCT05553366|529467119|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
146807821|NCT05553366|529467117|FG000|Overall Study|Lost to Follow-up|3|||
146807822|NCT05553366|529467118|FG001|Overall Study|Lost to Follow-up|3|||
146807823|NCT05553366|529467119|FG002|Overall Study|Lost to Follow-up|3|||
146807824|NCT05553366|529467117|FG000|Overall Study|Other non-compliance|1|||
146807825|NCT05553366|529467118|FG001|Overall Study|Other non-compliance|1|||
146807826|NCT05553366|529467119|FG002|Overall Study|Other non-compliance|0|||
146807827|NCT05553366|529467117|FG000|Overall Study|Randomized but not dosed|0|||
146807828|NCT05553366|529467118|FG001|Overall Study|Randomized but not dosed|0|||
146807829|NCT05553366|529467119|FG002|Overall Study|Randomized but not dosed|2|||
146807830|NCT00795184|529467125|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
146807831|NCT00795184|529467126|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
146807832|NCT03781375|529467127|FG000|Double-blind Phase|Adverse Event|0|||
146807833|NCT03781375|529467128|FG001|Double-blind Phase|Adverse Event|1|||
146807834|NCT03781375|529467127|FG000|Double-blind Phase|Lack of Response|6|||
146807835|NCT03781375|529467128|FG001|Double-blind Phase|Lack of Response|2|||
146807836|NCT03781375|529467127|FG000|Double-blind Phase|Other|1|||
146807837|NCT03781375|529467128|FG001|Double-blind Phase|Other|3|||
146807838|NCT03781375|529467127|FG000|Open-label Phase|Protocol Issues|0|||
146807839|NCT03781375|529467128|FG001|Open-label Phase|Protocol Issues|1|||
146807840|NCT03781375|529467127|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
146807841|NCT03781375|529467128|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
146807842|NCT03781375|529467127|FG000|Open-label Phase|Other|2|||
146807843|NCT03781375|529467128|FG001|Open-label Phase|Other|2|||
146807844|NCT02079649|529467129|FG000|Overall Study|Lost to Follow-up|0|||
146807845|NCT02079649|529467130|FG001|Overall Study|Lost to Follow-up|0|||
146807846|NCT02079649|529467131|FG002|Overall Study|Lost to Follow-up|0|||
146807847|NCT02079649|529467132|FG003|Overall Study|Lost to Follow-up|1|||
146807848|NCT02079649|529467129|FG000|Overall Study|Withdrawal by Subject|0|||
146807849|NCT02079649|529467130|FG001|Overall Study|Withdrawal by Subject|0|||
146807850|NCT02079649|529467131|FG002|Overall Study|Withdrawal by Subject|0|||
146807851|NCT02079649|529467132|FG003|Overall Study|Withdrawal by Subject|1|||
146807852|NCT02079649|529467129|FG000|Overall Study|Randomization error (prior to treatment)|1|||
146807853|NCT02079649|529467130|FG001|Overall Study|Randomization error (prior to treatment)|0|||
146807854|NCT02079649|529467131|FG002|Overall Study|Randomization error (prior to treatment)|1|||
146807855|NCT02079649|529467132|FG003|Overall Study|Randomization error (prior to treatment)|0|||
146807856|NCT00836498|529467133|FG000|Overall Study|Adverse Event|1|||
146807857|NCT00836498|529467134|FG001|Overall Study|Adverse Event|0|||
146807858|NCT00836498|529467133|FG000|Overall Study|Lost to Follow-up|1|||
146807859|NCT00836498|529467134|FG001|Overall Study|Lost to Follow-up|0|||
146807860|NCT00836498|529467133|FG000|Overall Study|Withdrawal by Subject|2|||
146807861|NCT00836498|529467134|FG001|Overall Study|Withdrawal by Subject|1|||
146807862|NCT01034306|529467135|FG000|Overall Study|Adverse Event|1|||
146807863|NCT01034306|529467136|FG001|Overall Study|Adverse Event|0|||
146807864|NCT01034306|529467135|FG000|Overall Study|Lost to Follow-up|0|||
146807865|NCT01034306|529467136|FG001|Overall Study|Lost to Follow-up|1|||
146807866|NCT01034306|529467135|FG000|Overall Study|Withdrawal by Subject|2|||
146807867|NCT01034306|529467136|FG001|Overall Study|Withdrawal by Subject|2|||
146807868|NCT01034306|529467135|FG000|Overall Study|hospitalized and decided to stop|1|||
146807869|NCT01034306|529467136|FG001|Overall Study|hospitalized and decided to stop|0|||
146807870|NCT01034306|529467135|FG000|Overall Study|Noncomplience|1|||
146807871|NCT01034306|529467136|FG001|Overall Study|Noncomplience|0|||
146807872|NCT01968967|529467137|FG000|Treatment Period|Other|22|||
146807873|NCT01968967|529467138|FG001|Treatment Period|Other|22|||
146807874|NCT01968967|529467139|FG002|Treatment Period|Other|0|||
146807875|NCT01968967|529467140|FG003|Treatment Period|Other|0|||
146807876|NCT01968967|529467141|FG004|Treatment Period|Other|0|||
146807877|NCT01968967|529467137|FG000|Treatment Period|Withdrawal by Subject|71|||
146807878|NCT01968967|529467138|FG001|Treatment Period|Withdrawal by Subject|61|||
146807879|NCT01968967|529467139|FG002|Treatment Period|Withdrawal by Subject|0|||
146807880|NCT01968967|529467140|FG003|Treatment Period|Withdrawal by Subject|0|||
146807881|NCT01968967|529467141|FG004|Treatment Period|Withdrawal by Subject|0|||
146807882|NCT01968967|529467137|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
146807883|NCT01968967|529467138|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
146807884|NCT01968967|529467139|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
146807885|NCT01968967|529467140|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
146807886|NCT01968967|529467141|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
146807887|NCT01968967|529467137|FG000|Treatment Period|Lost to Follow-up|26|||
146807888|NCT01968967|529467138|FG001|Treatment Period|Lost to Follow-up|31|||
146807889|NCT01968967|529467139|FG002|Treatment Period|Lost to Follow-up|0|||
146807890|NCT01968967|529467140|FG003|Treatment Period|Lost to Follow-up|0|||
146807891|NCT01968967|529467141|FG004|Treatment Period|Lost to Follow-up|0|||
146807892|NCT01968967|529467137|FG000|Treatment Period|Protocol Violation|1|||
146807893|NCT01968967|529467138|FG001|Treatment Period|Protocol Violation|2|||
146807894|NCT01968967|529467139|FG002|Treatment Period|Protocol Violation|0|||
146807895|NCT01968967|529467140|FG003|Treatment Period|Protocol Violation|0|||
146807896|NCT01968967|529467141|FG004|Treatment Period|Protocol Violation|0|||
146807897|NCT01968967|529467137|FG000|Treatment Period|Adverse Event|9|||
146807898|NCT01968967|529467138|FG001|Treatment Period|Adverse Event|8|||
146807899|NCT01968967|529467139|FG002|Treatment Period|Adverse Event|0|||
146807900|NCT01968967|529467140|FG003|Treatment Period|Adverse Event|0|||
146807901|NCT01968967|529467141|FG004|Treatment Period|Adverse Event|0|||
146807902|NCT01968967|529467137|FG000|Treatment Period|Death|9|||
146807903|NCT01968967|529467138|FG001|Treatment Period|Death|2|||
146807904|NCT01968967|529467139|FG002|Treatment Period|Death|0|||
146807905|NCT01968967|529467140|FG003|Treatment Period|Death|0|||
146807906|NCT01968967|529467141|FG004|Treatment Period|Death|0|||
146807907|NCT01968967|529467137|FG000|Treatment Period|Randomized Not Treated|6|||
146807908|NCT01968967|529467138|FG001|Treatment Period|Randomized Not Treated|5|||
146807909|NCT01968967|529467139|FG002|Treatment Period|Randomized Not Treated|0|||
146807910|NCT01968967|529467140|FG003|Treatment Period|Randomized Not Treated|0|||
146807911|NCT01968967|529467141|FG004|Treatment Period|Randomized Not Treated|0|||
146807912|NCT01968967|529467137|FG000|Extension Period|Withdrew Consent|0|||
146807913|NCT01968967|529467138|FG001|Extension Period|Withdrew Consent|0|||
146807914|NCT01968967|529467139|FG002|Extension Period|Withdrew Consent|2|||
146807915|NCT01968967|529467140|FG003|Extension Period|Withdrew Consent|0|||
146807916|NCT01968967|529467141|FG004|Extension Period|Withdrew Consent|5|||
146807917|NCT03489369|529467142|FG000|Overall Study|Documented Progressive Disease|3|||
146807918|NCT03489369|529467143|FG001|Overall Study|Documented Progressive Disease|2|||
146807919|NCT03489369|529467144|FG002|Overall Study|Documented Progressive Disease|3|||
146807920|NCT03489369|529467145|FG003|Overall Study|Documented Progressive Disease|6|||
146807921|NCT03489369|529467142|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
146807922|NCT03489369|529467143|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
146807923|NCT03489369|529467144|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
146807924|NCT03489369|529467145|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
146807925|NCT02384382|529467152|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
146807926|NCT02384382|529467152|FG000|Overall Study|Death|1|||
146807927|NCT02384382|529467152|FG000|Overall Study|Adverse Event|1|||
146807928|NCT02384382|529467152|FG000|Overall Study|Disease progression|16|||
146807929|NCT02113449|529467153|FG000|Overall Study|Adverse Event|4|||
146807930|NCT01328496|529467154|FG000|Overall Study|Significant Change in Health Status|1|||
146807931|NCT01328496|529467155|FG001|Overall Study|Significant Change in Health Status|0|||
146807932|NCT02091752|529467158|FG000|Overall Study|Study terminated by Sponsor|2|||
146807933|NCT02091752|529467158|FG000|Overall Study|Adverse Event|1|||
146807934|NCT04029090|529467159|FG000|Overall Study|Protocol Violation|1|||
146807935|NCT04029090|529467160|FG001|Overall Study|Protocol Violation|0|||
146807936|NCT04029090|529467161|FG002|Overall Study|Protocol Violation|0|||
146807937|NCT04029090|529467159|FG000|Overall Study|Withdrawal by Subject|0|||
146807938|NCT04029090|529467160|FG001|Overall Study|Withdrawal by Subject|1|||
146807939|NCT04029090|529467161|FG002|Overall Study|Withdrawal by Subject|0|||
146807940|NCT01065779|529467162|FG000|Overall Study|Duplicate Investigation|1|||
146807941|NCT01065779|529467162|FG000|Overall Study|Investigation Before Contract Date|37|||
146807942|NCT01065779|529467162|FG000|Overall Study|Non-enrollment Period Administration|10|||
146807943|NCT01065779|529467162|FG000|Overall Study|Not Administered With Study Drug|17|||
146807944|NCT01065779|529467162|FG000|Overall Study|Failed to Follow-up|10|||
146807945|NCT01065779|529467162|FG000|Overall Study|Inclusion Criteria Violation|7|||
146807946|NCT02157948|529467163|FG000|Overall Study|Withdrawal by Subject|4|||
146807947|NCT02157948|529467164|FG001|Overall Study|Withdrawal by Subject|5|||
146807948|NCT02157948|529467163|FG000|Overall Study|Lost to Follow-up|3|||
146942295|NCT00741260|529948110|FG004|Overall Study|Other|1|||
146942296|NCT00741260|529948111|FG005|Overall Study|Other|3|||
146942297|NCT00741260|529948112|FG006|Overall Study|Other|1|||
146942298|NCT02565615|529948113|FG000|Overall Study|Death|0|||
146942299|NCT02565615|529948114|FG001|Overall Study|Death|1|||
146942300|NCT02565615|529948115|FG002|Overall Study|Death|0|||
146807949|NCT02157948|529467164|FG001|Overall Study|Lost to Follow-up|2|||
146807950|NCT02157948|529467163|FG000|Overall Study|Protocol Specified Criteria|2|||
146807951|NCT02157948|529467164|FG001|Overall Study|Protocol Specified Criteria|1|||
146807952|NCT02157948|529467163|FG000|Overall Study|Decision by Sponsor|0|||
146807953|NCT02157948|529467164|FG001|Overall Study|Decision by Sponsor|1|||
146807954|NCT01604824|529467166|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
146807955|NCT01604824|529467167|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
146942301|NCT02565615|529948116|FG003|Overall Study|Death|0|||
146942302|NCT02565615|529948117|FG004|Overall Study|Death|4|||
146807956|NCT01604824|529467168|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
146807957|NCT01604824|529467169|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
146807958|NCT01604824|529467170|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
146807959|NCT01604824|529467171|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
146807960|NCT01604824|529467166|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
146807961|NCT01604824|529467167|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
146807962|NCT01604824|529467168|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
146807963|NCT01604824|529467169|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
146807964|NCT01604824|529467170|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
146807965|NCT01604824|529467171|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
146807966|NCT03822832|529467176|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
146807967|NCT03822832|529467177|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
146807968|NCT03822832|529467176|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
146807969|NCT03822832|529467177|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
146807970|NCT03822832|529467176|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
146807971|NCT03822832|529467177|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
146807972|NCT03822832|529467176|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
146807973|NCT03822832|529467177|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
146807974|NCT03822832|529467176|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
146807975|NCT03822832|529467177|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
146807976|NCT03822832|529467176|FG000|Re-allocation|Not re-allocated to open label period|2|||
146807977|NCT03822832|529467177|FG001|Re-allocation|Not re-allocated to open label period|6|||
146807978|NCT03822832|529467176|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
146807979|NCT03822832|529467177|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
146807980|NCT03822832|529467176|FG000|Period 2 - Open Label Period|Adverse Event|0|||
146807981|NCT03822832|529467177|FG001|Period 2 - Open Label Period|Adverse Event|3|||
146807982|NCT04248803|529467182|FG000|Overall Study|Lost to Follow-up|7|||
146807983|NCT04248803|529467183|FG001|Overall Study|Lost to Follow-up|7|||
146807984|NCT04248803|529467184|FG002|Overall Study|Lost to Follow-up|7|||
146807985|NCT04248803|529467185|FG003|Overall Study|Lost to Follow-up|7|||
146807986|NCT04248803|529467186|FG004|Overall Study|Lost to Follow-up|7|||
146807987|NCT04248803|529467187|FG005|Overall Study|Lost to Follow-up|7|||
146807988|NCT05352230|529467188|FG000|First Intervention (3 Months)|study terminated|2|||
146807989|NCT05352230|529467189|FG001|First Intervention (3 Months)|study terminated|2|||
146807990|NCT04399837|529467191|FG000|Overall Study|Other than listed|0|||
146807991|NCT04399837|529467192|FG001|Overall Study|Other than listed|2|||
146807992|NCT04399837|529467193|FG002|Overall Study|Other than listed|2|||
146807993|NCT04399837|529467194|FG003|Overall Study|Other than listed|3|||
146807994|NCT04399837|529467191|FG000|Overall Study|Withdrawal by Subject|1|||
146807995|NCT04399837|529467192|FG001|Overall Study|Withdrawal by Subject|2|||
146807996|NCT04399837|529467193|FG002|Overall Study|Withdrawal by Subject|1|||
146807997|NCT04399837|529467194|FG003|Overall Study|Withdrawal by Subject|1|||
146807998|NCT00614614|529467201|FG000|Primary Vaccination Phase|Adverse Event|6|||
146807999|NCT00614614|529467202|FG001|Primary Vaccination Phase|Adverse Event|0|||
146808000|NCT00614614|529467203|FG002|Primary Vaccination Phase|Adverse Event|0|||
146808001|NCT00614614|529467204|FG003|Primary Vaccination Phase|Adverse Event|0|||
146808002|NCT00614614|529467205|FG004|Primary Vaccination Phase|Adverse Event|0|||
146808003|NCT00614614|529467201|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
146808004|NCT00614614|529467202|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
146808005|NCT00614614|529467203|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
146808006|NCT00614614|529467204|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
146808007|NCT00614614|529467205|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
146808008|NCT00614614|529467201|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
146808009|NCT00614614|529467202|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
146808010|NCT00614614|529467203|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
146808011|NCT00614614|529467204|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
146808012|NCT00614614|529467205|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
146808013|NCT00614614|529467201|FG000|Primary Vaccination Phase|Protocol Violation|9|||
146808014|NCT00614614|529467202|FG001|Primary Vaccination Phase|Protocol Violation|3|||
146808015|NCT00614614|529467203|FG002|Primary Vaccination Phase|Protocol Violation|0|||
146808016|NCT00614614|529467204|FG003|Primary Vaccination Phase|Protocol Violation|0|||
146808017|NCT00614614|529467205|FG004|Primary Vaccination Phase|Protocol Violation|0|||
146808018|NCT00614614|529467201|FG000|Primary Vaccination Phase|Other|4|||
146808019|NCT00614614|529467202|FG001|Primary Vaccination Phase|Other|0|||
146808020|NCT00614614|529467203|FG002|Primary Vaccination Phase|Other|0|||
146808021|NCT00614614|529467204|FG003|Primary Vaccination Phase|Other|0|||
146808022|NCT00614614|529467205|FG004|Primary Vaccination Phase|Other|0|||
146808023|NCT00614614|529467201|FG000|Booster Vaccination Phase|Adverse Event|0|||
146808024|NCT00614614|529467202|FG001|Booster Vaccination Phase|Adverse Event|0|||
146808025|NCT00614614|529467203|FG002|Booster Vaccination Phase|Adverse Event|1|||
146808026|NCT00614614|529467204|FG003|Booster Vaccination Phase|Adverse Event|1|||
146808027|NCT00614614|529467205|FG004|Booster Vaccination Phase|Adverse Event|0|||
146808028|NCT00614614|529467201|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
146808029|NCT00614614|529467202|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
146808030|NCT00614614|529467203|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
146808031|NCT00614614|529467204|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
146808032|NCT00614614|529467205|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
146808033|NCT00614614|529467201|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
146808034|NCT00614614|529467202|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
146808035|NCT00614614|529467203|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
146808036|NCT00614614|529467204|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
146808037|NCT00614614|529467205|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
146808038|NCT00614614|529467201|FG000|Booster Vaccination Phase|Protocol Violation|0|||
146808039|NCT00614614|529467202|FG001|Booster Vaccination Phase|Protocol Violation|0|||
146808040|NCT00614614|529467203|FG002|Booster Vaccination Phase|Protocol Violation|2|||
146808041|NCT00614614|529467204|FG003|Booster Vaccination Phase|Protocol Violation|3|||
146808042|NCT00614614|529467205|FG004|Booster Vaccination Phase|Protocol Violation|0|||
146808043|NCT00614614|529467201|FG000|Booster Vaccination Phase|Other|0|||
146808044|NCT00614614|529467202|FG001|Booster Vaccination Phase|Other|1|||
146808045|NCT00614614|529467203|FG002|Booster Vaccination Phase|Other|3|||
146808046|NCT00614614|529467204|FG003|Booster Vaccination Phase|Other|2|||
146808047|NCT00614614|529467205|FG004|Booster Vaccination Phase|Other|1|||
146808048|NCT04745676|529467206|FG000|Overall Study|Death|1|||
146808049|NCT04745676|529467207|FG001|Overall Study|Death|0|||
146808050|NCT04745676|529467208|FG002|Overall Study|Death|0|||
146808051|NCT05212285|529467209|FG000|Overall Study|Lack of Efficacy|12|||
146808052|NCT05212285|529467210|FG001|Overall Study|Lack of Efficacy|8|||
146808053|NCT05212285|529467209|FG000|Overall Study|Withdrawal by Subject|8|||
146808054|NCT05212285|529467210|FG001|Overall Study|Withdrawal by Subject|1|||
146808055|NCT05212285|529467209|FG000|Overall Study|Lost to Follow-up|13|||
146808056|NCT05212285|529467210|FG001|Overall Study|Lost to Follow-up|1|||
146808057|NCT05212285|529467209|FG000|Overall Study|miss data|21|||
146808058|NCT05212285|529467210|FG001|Overall Study|miss data|2|||
146808059|NCT03683030|529467211|FG000|Overall Study|Enrolled but screen failures|12|||
146808060|NCT03683030|529467212|FG001|Overall Study|Enrolled but screen failures|7|||
146808061|NCT03683030|529467211|FG000|Overall Study|Enrolled but no catheter inserted|11|||
146808062|NCT03683030|529467212|FG001|Overall Study|Enrolled but no catheter inserted|13|||
146808063|NCT03683030|529467211|FG000|Overall Study|Withdrawal by Subject|0|||
146808064|NCT03683030|529467212|FG001|Overall Study|Withdrawal by Subject|2|||
146808065|NCT03683030|529467211|FG000|Overall Study|Early termination by subject|1|||
146808066|NCT03683030|529467212|FG001|Overall Study|Early termination by subject|0|||
146808067|NCT03683030|529467211|FG000|Overall Study|Lost to Follow-up|0|||
146808068|NCT03683030|529467212|FG001|Overall Study|Lost to Follow-up|6|||
146808069|NCT03683030|529467211|FG000|Overall Study|Death|0|||
146808070|NCT03683030|529467212|FG001|Overall Study|Death|2|||
146808071|NCT03683030|529467211|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
146808072|NCT03683030|529467212|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
146808073|NCT02222493|529467215|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
146808074|NCT02222493|529467216|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
146808075|NCT02222493|529467215|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
146808076|NCT02222493|529467216|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
146808077|NCT02222493|529467215|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
146808078|NCT02222493|529467216|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
146808079|NCT02222493|529467215|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
146808080|NCT02222493|529467216|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
146808081|NCT02222493|529467215|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
146808082|NCT02222493|529467216|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
146808083|NCT02222493|529467215|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
146808084|NCT02222493|529467216|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
146808085|NCT02222493|529467215|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
146808086|NCT02222493|529467216|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
146808087|NCT02222493|529467215|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
146808088|NCT02222493|529467216|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
146808089|NCT02222493|529467215|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
146808090|NCT02222493|529467216|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
146808091|NCT02222493|529467215|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
146808092|NCT02222493|529467216|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
146808093|NCT02222493|529467215|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
146808094|NCT02222493|529467216|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
146808095|NCT02222493|529467215|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
146808096|NCT02222493|529467216|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
146942303|NCT02565615|529948113|FG000|Overall Study|Not willing to participate in study|2|||
146808097|NCT02222493|529467215|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
146808098|NCT02222493|529467216|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
146808099|NCT02222493|529467215|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
146808100|NCT02222493|529467216|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
146808101|NCT02222493|529467215|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
146808102|NCT02222493|529467216|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
146808103|NCT02222493|529467215|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
146808104|NCT02222493|529467216|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
146808105|NCT02222493|529467215|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
146808106|NCT02222493|529467216|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
146808107|NCT02222493|529467215|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
146808108|NCT02222493|529467216|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
146808109|NCT02222493|529467215|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
146808110|NCT02222493|529467216|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
146808111|NCT02222493|529467215|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
146808112|NCT02222493|529467216|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
146808113|NCT02222493|529467215|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
146808114|NCT02222493|529467216|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
146808115|NCT02222493|529467215|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
146808116|NCT02222493|529467216|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
146808117|NCT01000805|529467220|FG000|Overall Study|Adverse Event|21|||
146808118|NCT01000805|529467221|FG001|Overall Study|Adverse Event|9|||
146808119|NCT01000805|529467220|FG000|Overall Study|Lack of Efficacy|5|||
146808120|NCT01000805|529467221|FG001|Overall Study|Lack of Efficacy|16|||
146808121|NCT01000805|529467220|FG000|Overall Study|Lost to Follow-up|16|||
146808122|NCT01000805|529467221|FG001|Overall Study|Lost to Follow-up|21|||
146808123|NCT01000805|529467220|FG000|Overall Study|Physician Decision|0|||
146808124|NCT01000805|529467221|FG001|Overall Study|Physician Decision|1|||
146808125|NCT01000805|529467220|FG000|Overall Study|Protocol Violation|12|||
146808126|NCT01000805|529467221|FG001|Overall Study|Protocol Violation|8|||
146808127|NCT01000805|529467220|FG000|Overall Study|Withdrawal by Subject|16|||
146808128|NCT01000805|529467221|FG001|Overall Study|Withdrawal by Subject|6|||
146808129|NCT01000805|529467220|FG000|Overall Study|Sponsor Decision|0|||
146808130|NCT01000805|529467221|FG001|Overall Study|Sponsor Decision|1|||
146808131|NCT00302211|529467226|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
146808132|NCT00302211|529467227|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
146808133|NCT00302211|529467228|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
146808134|NCT00302211|529467229|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
146808135|NCT00302211|529467230|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
146808136|NCT00302211|529467226|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
146808137|NCT00302211|529467227|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
146808138|NCT00302211|529467228|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
146808139|NCT00302211|529467229|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
146808140|NCT00302211|529467230|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
146808141|NCT00302211|529467226|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
146808142|NCT00302211|529467227|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
146808143|NCT00302211|529467228|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
146808144|NCT00302211|529467229|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
146808145|NCT00302211|529467230|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
146808146|NCT00302211|529467226|FG000|Double Blind Period (New Patients)|Disease progression|0|||
146808147|NCT00302211|529467227|FG001|Double Blind Period (New Patients)|Disease progression|1|||
146808148|NCT00302211|529467228|FG002|Double Blind Period (New Patients)|Disease progression|1|||
146808149|NCT00302211|529467229|FG003|Double Blind Period (New Patients)|Disease progression|0|||
146808150|NCT00302211|529467230|FG004|Double Blind Period (New Patients)|Disease progression|0|||
146808151|NCT00302211|529467226|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
146808152|NCT00302211|529467227|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
146808153|NCT00302211|529467228|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
146808154|NCT00302211|529467229|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
146808155|NCT00302211|529467230|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
146808156|NCT00302211|529467226|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
146942304|NCT02565615|529948114|FG001|Overall Study|Not willing to participate in study|21|||
146808157|NCT00302211|529467227|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
146808158|NCT00302211|529467228|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
146808159|NCT00302211|529467229|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
146942305|NCT02565615|529948115|FG002|Overall Study|Not willing to participate in study|0|||
146942306|NCT02565615|529948116|FG003|Overall Study|Not willing to participate in study|1|||
146942307|NCT02565615|529948117|FG004|Overall Study|Not willing to participate in study|169|||
146942308|NCT02565615|529948113|FG000|Overall Study|Lost to Follow-up|0|||
146808160|NCT00302211|529467230|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
146808161|NCT00302211|529467226|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
146808162|NCT00302211|529467227|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
146808163|NCT00302211|529467228|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
146808164|NCT00302211|529467229|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
146808165|NCT00302211|529467230|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
146808166|NCT00302211|529467226|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
146808167|NCT00302211|529467227|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
146808168|NCT00302211|529467228|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
146808169|NCT00302211|529467229|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
146808170|NCT00302211|529467230|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
146808171|NCT00302211|529467226|FG000|Open Label-Patients From Double-Blind|Death|0|||
146808172|NCT00302211|529467227|FG001|Open Label-Patients From Double-Blind|Death|0|||
146808173|NCT00302211|529467228|FG002|Open Label-Patients From Double-Blind|Death|0|||
146808174|NCT00302211|529467229|FG003|Open Label-Patients From Double-Blind|Death|1|||
146808175|NCT00302211|529467230|FG004|Open Label-Patients From Double-Blind|Death|1|||
146808176|NCT00302211|529467226|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
146808177|NCT00302211|529467227|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
146808178|NCT00302211|529467228|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
146808179|NCT00302211|529467229|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
146808180|NCT00302211|529467230|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
146808181|NCT00302211|529467226|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
146808182|NCT00302211|529467227|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
146808183|NCT00302211|529467228|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
146808184|NCT00302211|529467229|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
146808185|NCT00302211|529467230|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
146808186|NCT00302211|529467226|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
146808187|NCT00302211|529467227|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
146808188|NCT00302211|529467228|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
146808189|NCT00302211|529467229|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
146808190|NCT00302211|529467230|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
146808191|NCT05432986|529467233|FG000|Overall Study|Withdrawal by Subject|2|||
146808192|NCT05432986|529467233|FG000|Overall Study|incomplete measurement|7|||
146808193|NCT01970878|529468704|FG000|Overall Study|Withdrawal by Subject|11|||
146808194|NCT01970878|529468705|FG001|Overall Study|Withdrawal by Subject|10|||
146808195|NCT01970878|529468706|FG002|Overall Study|Withdrawal by Subject|14|||
146808196|NCT01970878|529468707|FG003|Overall Study|Withdrawal by Subject|7|||
146808197|NCT01970878|529468704|FG000|Overall Study|Lost to Follow-up|1|||
146808198|NCT01970878|529468705|FG001|Overall Study|Lost to Follow-up|3|||
146808199|NCT01970878|529468706|FG002|Overall Study|Lost to Follow-up|2|||
146808200|NCT01970878|529468707|FG003|Overall Study|Lost to Follow-up|4|||
146808201|NCT01970878|529468704|FG000|Overall Study|Administrative Reasons|1|||
146808202|NCT01970878|529468705|FG001|Overall Study|Administrative Reasons|0|||
146808203|NCT01970878|529468706|FG002|Overall Study|Administrative Reasons|0|||
146808204|NCT01970878|529468707|FG003|Overall Study|Administrative Reasons|4|||
146808205|NCT01970878|529468704|FG000|Overall Study|Lack of Efficacy|2|||
146808206|NCT01970878|529468705|FG001|Overall Study|Lack of Efficacy|1|||
146808207|NCT01970878|529468706|FG002|Overall Study|Lack of Efficacy|2|||
146808208|NCT01970878|529468707|FG003|Overall Study|Lack of Efficacy|0|||
146808209|NCT01970878|529468704|FG000|Overall Study|Adverse Event|12|||
146808210|NCT01970878|529468705|FG001|Overall Study|Adverse Event|7|||
146808211|NCT01970878|529468706|FG002|Overall Study|Adverse Event|4|||
146808212|NCT01970878|529468707|FG003|Overall Study|Adverse Event|3|||
146808213|NCT01970878|529468704|FG000|Overall Study|Protocol Specified Criteria|10|||
146808214|NCT01970878|529468705|FG001|Overall Study|Protocol Specified Criteria|4|||
146808215|NCT01970878|529468706|FG002|Overall Study|Protocol Specified Criteria|3|||
146808216|NCT01970878|529468707|FG003|Overall Study|Protocol Specified Criteria|6|||
146942309|NCT02565615|529948114|FG001|Overall Study|Lost to Follow-up|4|||
146942310|NCT02565615|529948115|FG002|Overall Study|Lost to Follow-up|0|||
146942311|NCT02565615|529948116|FG003|Overall Study|Lost to Follow-up|1|||
146808217|NCT01970878|529468704|FG000|Overall Study|Physician Decision|0|||
146808218|NCT01970878|529468705|FG001|Overall Study|Physician Decision|1|||
146808219|NCT01970878|529468706|FG002|Overall Study|Physician Decision|1|||
146808220|NCT01970878|529468707|FG003|Overall Study|Physician Decision|0|||
146808221|NCT01970878|529468704|FG000|Overall Study|No Completion Status|0|||
146808222|NCT01970878|529468705|FG001|Overall Study|No Completion Status|1|||
146808223|NCT01970878|529468706|FG002|Overall Study|No Completion Status|0|||
146808224|NCT01970878|529468707|FG003|Overall Study|No Completion Status|0|||
146808225|NCT06571695|529468709|FG000|Overall Study|Lost to Follow-up|1|||
146808226|NCT06571695|529468710|FG001|Overall Study|Lost to Follow-up|6|||
146808227|NCT04921358|529468711|FG000|Overall Study|Withdrawal by Subject|6|||
146808228|NCT04921358|529468712|FG001|Overall Study|Withdrawal by Subject|13|||
146808229|NCT04921358|529468711|FG000|Overall Study|Lost to Follow-up|3|||
146808230|NCT04921358|529468712|FG001|Overall Study|Lost to Follow-up|6|||
146808231|NCT04921358|529468711|FG000|Overall Study|Study Terminated by Sponsor|86|||
146808232|NCT04921358|529468712|FG001|Overall Study|Study Terminated by Sponsor|89|||
146808233|NCT04921358|529468711|FG000|Overall Study|Death|92|||
146808234|NCT04921358|529468712|FG001|Overall Study|Death|82|||
146808235|NCT04926857|529468713|FG000|Overall Study|Withdrawal by Subject|40|||
146808236|NCT04926857|529468713|FG000|Overall Study|Death|9|||
146808237|NCT04926857|529468713|FG000|Overall Study|Study product no longer in use|44|||
146808238|NCT04926857|529468713|FG000|Overall Study|Inadequate data to address primary objective|16|||
146808239|NCT02637063|529468714|FG000|Overall Study|Lost to Follow-up|3|||
146808240|NCT02637063|529468715|FG001|Overall Study|Lost to Follow-up|2|||
146808241|NCT02637063|529468716|FG002|Overall Study|Lost to Follow-up|3|||
146808242|NCT02637063|529468714|FG000|Overall Study|Withdrawal by Subject|2|||
146808243|NCT02637063|529468715|FG001|Overall Study|Withdrawal by Subject|2|||
146808244|NCT02637063|529468716|FG002|Overall Study|Withdrawal by Subject|3|||
146808245|NCT02132949|529468721|FG000|Overall Study|Death|7|||
146808246|NCT02132949|529468722|FG001|Overall Study|Death|13|||
146808247|NCT02132949|529468721|FG000|Overall Study|Lost to Follow-up|14|||
146808248|NCT02132949|529468722|FG001|Overall Study|Lost to Follow-up|4|||
146808249|NCT02132949|529468721|FG000|Overall Study|Withdrawal by Subject|6|||
146808250|NCT02132949|529468722|FG001|Overall Study|Withdrawal by Subject|5|||
146808251|NCT02132949|529468721|FG000|Overall Study|Noncompliance|5|||
146808252|NCT02132949|529468722|FG001|Overall Study|Noncompliance|1|||
146808253|NCT02132949|529468721|FG000|Overall Study|Physician Decision|3|||
146808254|NCT02132949|529468722|FG001|Overall Study|Physician Decision|1|||
146808255|NCT02132949|529468721|FG000|Overall Study|Disease Progression|3|||
146808256|NCT02132949|529468722|FG001|Overall Study|Disease Progression|0|||
146808257|NCT02132949|529468721|FG000|Overall Study|Adverse Event|2|||
146808258|NCT02132949|529468722|FG001|Overall Study|Adverse Event|1|||
146808259|NCT02132949|529468721|FG000|Overall Study|Withdrew Prior to Treatment|1|||
146942312|NCT02565615|529948117|FG004|Overall Study|Lost to Follow-up|765|||
146942313|NCT02565615|529948113|FG000|Overall Study|Not meeting eligibility criteria|0|||
146942314|NCT02565615|529948114|FG001|Overall Study|Not meeting eligibility criteria|7|||
146942315|NCT02565615|529948115|FG002|Overall Study|Not meeting eligibility criteria|0|||
146942316|NCT02565615|529948116|FG003|Overall Study|Not meeting eligibility criteria|0|||
146942317|NCT02565615|529948117|FG004|Overall Study|Not meeting eligibility criteria|25|||
146942318|NCT02565615|529948113|FG000|Overall Study|Reason not defined|0|||
146942319|NCT02565615|529948114|FG001|Overall Study|Reason not defined|2|||
146942320|NCT02565615|529948115|FG002|Overall Study|Reason not defined|0|||
146942321|NCT02565615|529948116|FG003|Overall Study|Reason not defined|1|||
146942322|NCT02565615|529948117|FG004|Overall Study|Reason not defined|62|||
146942323|NCT02565615|529948113|FG000|Overall Study|Adverse Event|1|||
146942324|NCT02565615|529948114|FG001|Overall Study|Adverse Event|1|||
146942325|NCT02565615|529948115|FG002|Overall Study|Adverse Event|0|||
146942326|NCT02565615|529948116|FG003|Overall Study|Adverse Event|0|||
146942327|NCT02565615|529948117|FG004|Overall Study|Adverse Event|9|||
146942328|NCT02565615|529948113|FG000|Overall Study|Untreated|0|||
146942329|NCT02565615|529948114|FG001|Overall Study|Untreated|0|||
146942330|NCT02565615|529948115|FG002|Overall Study|Untreated|0|||
146942331|NCT02565615|529948116|FG003|Overall Study|Untreated|0|||
146942332|NCT02565615|529948117|FG004|Overall Study|Untreated|567|||
146942333|NCT05563714|529948121|FG000|Overall Study|Death|2|||
146942334|NCT05563714|529948122|FG001|Overall Study|Death|2|||
146942335|NCT05563714|529948123|FG002|Overall Study|Death|0|||
146942336|NCT05563714|529948124|FG003|Overall Study|Death|0|||
146942337|NCT05563714|529948121|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
146942338|NCT05563714|529948122|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
146942339|NCT05563714|529948123|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
146942340|NCT05563714|529948124|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
146942341|NCT05563714|529948121|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
146942342|NCT05563714|529948122|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
146942343|NCT05563714|529948123|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
146942344|NCT05563714|529948124|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
146942345|NCT05563714|529948121|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
146942346|NCT05563714|529948122|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
146808260|NCT02132949|529468722|FG001|Overall Study|Withdrew Prior to Treatment|2|||
146808261|NCT02132949|529468721|FG000|Overall Study|Reason Unspecified|0|||
146808262|NCT02132949|529468722|FG001|Overall Study|Reason Unspecified|1|||
146808263|NCT00745875|529468726|FG000|Overall Study|Continuing study treatment|4|||
146808264|NCT00745875|529468727|FG001|Overall Study|Continuing study treatment|4|||
146808265|NCT02310581|529468728|FG000|Overall Study|Adverse Event|1|||
146808266|NCT02310581|529468729|FG001|Overall Study|Adverse Event|1|||
146808267|NCT02310581|529468730|FG002|Overall Study|Adverse Event|1|||
146808268|NCT02310581|529468731|FG003|Overall Study|Adverse Event|0|||
146808269|NCT02310581|529468728|FG000|Overall Study|Withdrawal by Subject|2|||
146808270|NCT02310581|529468729|FG001|Overall Study|Withdrawal by Subject|1|||
146808271|NCT02310581|529468730|FG002|Overall Study|Withdrawal by Subject|0|||
146808272|NCT02310581|529468731|FG003|Overall Study|Withdrawal by Subject|1|||
146808273|NCT02824198|529468732|FG000|Overall Study|Non-compliance with the protocol|5|||
146808274|NCT02824198|529468733|FG001|Overall Study|Non-compliance with the protocol|1|||
146808275|NCT02824198|529468732|FG000|Overall Study|Lost to Follow-up|5|||
146808276|NCT02824198|529468733|FG001|Overall Study|Lost to Follow-up|2|||
146808277|NCT02824198|529468732|FG000|Overall Study|Withdrawal by Subject|5|||
146808278|NCT02824198|529468733|FG001|Overall Study|Withdrawal by Subject|0|||
146808279|NCT03883828|529468734|FG000|Overall Study|Did not start radiotherapy|1|||
146808280|NCT03883828|529468735|FG001|Overall Study|Did not start radiotherapy|2|||
146808281|NCT01256359|529468736|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
146808282|NCT01256359|529468737|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
146808283|NCT01256359|529468736|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
146808284|NCT01256359|529468737|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
146808285|NCT00487240|529468738|FG000|Overall Study|Withdrawal by Subject|12|||
146808286|NCT00487240|529468739|FG001|Overall Study|Withdrawal by Subject|6|||
146808287|NCT00487240|529468738|FG000|Overall Study|Lost to Follow-up|7|||
146808288|NCT00487240|529468739|FG001|Overall Study|Lost to Follow-up|6|||
146808289|NCT00487240|529468738|FG000|Overall Study|Adverse Event|0|||
146808290|NCT00487240|529468739|FG001|Overall Study|Adverse Event|4|||
146808291|NCT00487240|529468738|FG000|Overall Study|Protocol Violation|5|||
146808292|NCT00487240|529468739|FG001|Overall Study|Protocol Violation|5|||
146808293|NCT00487240|529468738|FG000|Overall Study|Entry Criteria Not Met|3|||
146808294|NCT00487240|529468739|FG001|Overall Study|Entry Criteria Not Met|4|||
146808295|NCT00487240|529468738|FG000|Overall Study|Sponsor Decision|2|||
146808296|NCT00487240|529468739|FG001|Overall Study|Sponsor Decision|1|||
146808297|NCT00487240|529468738|FG000|Overall Study|Physician Decision|2|||
146808298|NCT00487240|529468739|FG001|Overall Study|Physician Decision|0|||
146808299|NCT01019135|529468740|FG000|Overall Study|Did not receive allocated intervention|12|||
146808300|NCT01019135|529468741|FG001|Overall Study|Did not receive allocated intervention|6|||
146808301|NCT01019135|529468742|FG002|Overall Study|Did not receive allocated intervention|25|||
146808302|NCT01019135|529468740|FG000|Overall Study|Did not attend CR|8|||
146808303|NCT01019135|529468741|FG001|Overall Study|Did not attend CR|13|||
146808304|NCT01019135|529468742|FG002|Overall Study|Did not attend CR|6|||
146808305|NCT04237792|529468744|FG000|Treatment (Day 1)|Adverse Event|1|||
146808306|NCT04237792|529468745|FG001|Treatment (Day 1)|Adverse Event|0|||
146808307|NCT04237792|529468746|FG002|Treatment (Day 1)|Adverse Event|0|||
146808308|NCT04237792|529468747|FG003|Treatment (Day 1)|Adverse Event|0|||
146808309|NCT04237792|529468748|FG004|Treatment (Day 1)|Adverse Event|1|||
146808310|NCT04237792|529468749|FG005|Treatment (Day 1)|Adverse Event|1|||
146808311|NCT04237792|529468744|FG000|Treatment (Day 1)|Other|0|||
146808312|NCT04237792|529468745|FG001|Treatment (Day 1)|Other|0|||
146808313|NCT04237792|529468746|FG002|Treatment (Day 1)|Other|1|||
146808314|NCT04237792|529468747|FG003|Treatment (Day 1)|Other|0|||
146808315|NCT04237792|529468748|FG004|Treatment (Day 1)|Other|0|||
146808316|NCT04237792|529468749|FG005|Treatment (Day 1)|Other|1|||
146808317|NCT04237792|529468744|FG000|Treatment (Day 1)|Not treated|1|||
146808318|NCT04237792|529468745|FG001|Treatment (Day 1)|Not treated|1|||
146808319|NCT04237792|529468746|FG002|Treatment (Day 1)|Not treated|2|||
146808320|NCT04237792|529468747|FG003|Treatment (Day 1)|Not treated|1|||
146808321|NCT04237792|529468748|FG004|Treatment (Day 1)|Not treated|0|||
146808322|NCT04237792|529468749|FG005|Treatment (Day 1)|Not treated|1|||
146808323|NCT04885998|529468750|FG000|Overall Study|Withdrawal by Subject|0|||
146808324|NCT04885998|529468751|FG001|Overall Study|Withdrawal by Subject|2|||
146808325|NCT04885998|529468752|FG002|Overall Study|Withdrawal by Subject|0|||
146808326|NCT04885998|529468753|FG003|Overall Study|Withdrawal by Subject|3|||
146808327|NCT04885998|529468750|FG000|Overall Study|Lost to Follow-up|1|||
146808328|NCT04885998|529468751|FG001|Overall Study|Lost to Follow-up|1|||
146808329|NCT04885998|529468752|FG002|Overall Study|Lost to Follow-up|0|||
146808330|NCT04885998|529468753|FG003|Overall Study|Lost to Follow-up|0|||
146808331|NCT04885998|529468750|FG000|Overall Study|Death|2|||
146808332|NCT04885998|529468751|FG001|Overall Study|Death|1|||
146808333|NCT04885998|529468752|FG002|Overall Study|Death|2|||
146808334|NCT04885998|529468753|FG003|Overall Study|Death|2|||
146808335|NCT04885998|529468750|FG000|Overall Study|Decision by sponsor|1|||
146808336|NCT04885998|529468751|FG001|Overall Study|Decision by sponsor|1|||
146808337|NCT04885998|529468752|FG002|Overall Study|Decision by sponsor|0|||
146808338|NCT04885998|529468753|FG003|Overall Study|Decision by sponsor|0|||
146808339|NCT00910962|529468754|FG000|Overall Study|Adverse Event|5|||
146808340|NCT00910962|529468755|FG001|Overall Study|Adverse Event|20|||
146808341|NCT00910962|529468756|FG002|Overall Study|Adverse Event|17|||
146808342|NCT00910962|529468754|FG000|Overall Study|Protocol Violation|1|||
146808343|NCT00910962|529468755|FG001|Overall Study|Protocol Violation|3|||
146808344|NCT00910962|529468756|FG002|Overall Study|Protocol Violation|3|||
146808345|NCT00910962|529468754|FG000|Overall Study|Lost to Follow-up|0|||
146808346|NCT00910962|529468755|FG001|Overall Study|Lost to Follow-up|3|||
146808347|NCT00910962|529468756|FG002|Overall Study|Lost to Follow-up|1|||
146808348|NCT00910962|529468754|FG000|Overall Study|Physician Decision|0|||
146808349|NCT00910962|529468755|FG001|Overall Study|Physician Decision|6|||
146808350|NCT00910962|529468756|FG002|Overall Study|Physician Decision|6|||
146808351|NCT00910962|529468754|FG000|Overall Study|Withdrawal by Subject|25|||
146808352|NCT00910962|529468755|FG001|Overall Study|Withdrawal by Subject|32|||
146808353|NCT00910962|529468756|FG002|Overall Study|Withdrawal by Subject|32|||
146808354|NCT00910962|529468754|FG000|Overall Study|Reached defined stopping criteria|12|||
146808355|NCT00910962|529468755|FG001|Overall Study|Reached defined stopping criteria|14|||
146808356|NCT00910962|529468756|FG002|Overall Study|Reached defined stopping criteria|17|||
146808357|NCT01485887|529468758|FG000|Overall Study|Withdrawal by Subject|2|||
146808358|NCT01485887|529468758|FG000|Overall Study|Adverse Event|8|||
146808359|NCT01485887|529468758|FG000|Overall Study|Deterioration of primary disease|1|||
146808360|NCT01485887|529468758|FG000|Overall Study|Primary disease markedly improved|1|||
146942347|NCT05563714|529948123|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
146942348|NCT05563714|529948124|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
146983992|NCT01688037|530102015|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
146983993|NCT01688037|530102016|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
146983994|NCT01688037|530102017|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
146983995|NCT01688037|530102015|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
146983996|NCT01688037|530102016|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
146983997|NCT01688037|530102017|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
146983998|NCT01688037|530102015|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
146983999|NCT01688037|530102016|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
146984000|NCT01688037|530102017|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
146984001|NCT01688037|530102015|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
146984002|NCT01688037|530102016|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
146984003|NCT01688037|530102017|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
146942349|NCT05563714|529948121|FG000|Overall Study|Lost to Follow-up|22|||
146984004|NCT01688037|530102015|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
146984005|NCT01688037|530102016|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
146984006|NCT01688037|530102017|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
146984007|NCT01688037|530102015|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
146942350|NCT05563714|529948122|FG001|Overall Study|Lost to Follow-up|19|||
146942351|NCT05563714|529948123|FG002|Overall Study|Lost to Follow-up|0|||
146942352|NCT05563714|529948124|FG003|Overall Study|Lost to Follow-up|0|||
146942353|NCT02120352|529948130|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
146942354|NCT02120352|529948131|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
146942355|NCT02120352|529948132|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
146942356|NCT02120352|529948133|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
146942357|NCT02120352|529948134|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
146942358|NCT02120352|529948135|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
146942359|NCT02120352|529948136|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
146942360|NCT02120352|529948130|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
146942361|NCT02120352|529948131|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
146942362|NCT02120352|529948132|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
146942363|NCT02120352|529948133|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
146942364|NCT02120352|529948134|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
146942365|NCT02120352|529948135|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
146942366|NCT02120352|529948136|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
146942367|NCT02120352|529948130|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
146942368|NCT02120352|529948131|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
146942369|NCT02120352|529948132|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
146942370|NCT02120352|529948133|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
146984008|NCT01688037|530102016|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
146984009|NCT01688037|530102017|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
146984010|NCT02100956|530102018|FG000|At Least One Week Between Injections|Adverse Event|0|||
146808361|NCT02106884|529468763|FG000|Overall Study|Change of diagnosis/exclusion|0|||
146808362|NCT02106884|529468764|FG001|Overall Study|Change of diagnosis/exclusion|1|||
146808363|NCT04638816|529468770|FG000|Overall Study|Withdrawal by Subject|0|||
146942371|NCT02120352|529948134|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
146942372|NCT02120352|529948135|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
146942373|NCT02120352|529948136|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
146808364|NCT04638816|529468771|FG001|Overall Study|Withdrawal by Subject|1|||
146808365|NCT04638816|529468770|FG000|Overall Study|Lost to Follow-up|0|||
146808366|NCT04638816|529468771|FG001|Overall Study|Lost to Follow-up|1|||
146808367|NCT01822756|529468774|FG000|Overall Study|Adverse Event|0|||
146808368|NCT01822756|529468775|FG001|Overall Study|Adverse Event|0|||
146808369|NCT01822756|529468776|FG002|Overall Study|Adverse Event|0|||
146808370|NCT01822756|529468777|FG003|Overall Study|Adverse Event|2|||
146808371|NCT01822756|529468778|FG004|Overall Study|Adverse Event|0|||
146808372|NCT01822756|529468774|FG000|Overall Study|Disease progression|11|||
146808373|NCT01822756|529468775|FG001|Overall Study|Disease progression|1|||
146808374|NCT01822756|529468776|FG002|Overall Study|Disease progression|7|||
146808375|NCT01822756|529468777|FG003|Overall Study|Disease progression|2|||
146808376|NCT01822756|529468778|FG004|Overall Study|Disease progression|6|||
146808377|NCT01822756|529468774|FG000|Overall Study|Death|2|||
146808378|NCT01822756|529468775|FG001|Overall Study|Death|2|||
146808379|NCT01822756|529468776|FG002|Overall Study|Death|1|||
146808380|NCT01822756|529468777|FG003|Overall Study|Death|0|||
146808381|NCT01822756|529468778|FG004|Overall Study|Death|0|||
146808382|NCT01822756|529468774|FG000|Overall Study|Lost to Follow-up|1|||
146808383|NCT01822756|529468775|FG001|Overall Study|Lost to Follow-up|0|||
146808384|NCT01822756|529468776|FG002|Overall Study|Lost to Follow-up|1|||
146808385|NCT01822756|529468777|FG003|Overall Study|Lost to Follow-up|0|||
146808386|NCT01822756|529468778|FG004|Overall Study|Lost to Follow-up|1|||
146808387|NCT01822756|529468774|FG000|Overall Study|Physician Decision|0|||
146808388|NCT01822756|529468775|FG001|Overall Study|Physician Decision|1|||
146808389|NCT01822756|529468776|FG002|Overall Study|Physician Decision|0|||
146808390|NCT01822756|529468777|FG003|Overall Study|Physician Decision|0|||
146808391|NCT01822756|529468778|FG004|Overall Study|Physician Decision|0|||
146808392|NCT01822756|529468774|FG000|Overall Study|disease progression & patient preference|2|||
146808393|NCT01822756|529468775|FG001|Overall Study|disease progression & patient preference|0|||
146808394|NCT01822756|529468776|FG002|Overall Study|disease progression & patient preference|1|||
146808395|NCT01822756|529468777|FG003|Overall Study|disease progression & patient preference|0|||
146808396|NCT01822756|529468778|FG004|Overall Study|disease progression & patient preference|0|||
146808397|NCT02060487|529468794|FG000|Overall Study|Other|1|||
146808398|NCT02060487|529468795|FG001|Overall Study|Other|2|||
146808399|NCT02060487|529468796|FG002|Overall Study|Other|1|||
146808400|NCT02060487|529468794|FG000|Overall Study|Lack of Efficacy|0|||
146808401|NCT02060487|529468795|FG001|Overall Study|Lack of Efficacy|1|||
146808402|NCT02060487|529468796|FG002|Overall Study|Lack of Efficacy|0|||
146808403|NCT02060487|529468794|FG000|Overall Study|Withdrawal by Subject|3|||
146808404|NCT02060487|529468795|FG001|Overall Study|Withdrawal by Subject|10|||
146808405|NCT02060487|529468796|FG002|Overall Study|Withdrawal by Subject|4|||
146808406|NCT02060487|529468794|FG000|Overall Study|Study Terminated By Sponsor|87|||
146808407|NCT02060487|529468795|FG001|Overall Study|Study Terminated By Sponsor|89|||
146808408|NCT02060487|529468796|FG002|Overall Study|Study Terminated By Sponsor|100|||
146808409|NCT02060487|529468794|FG000|Overall Study|Randomized in error|1|||
146808410|NCT02060487|529468795|FG001|Overall Study|Randomized in error|0|||
146808411|NCT02060487|529468796|FG002|Overall Study|Randomized in error|0|||
146808412|NCT02060487|529468794|FG000|Overall Study|Protocol Violation|0|||
146808413|NCT02060487|529468795|FG001|Overall Study|Protocol Violation|1|||
146808414|NCT02060487|529468796|FG002|Overall Study|Protocol Violation|1|||
146808415|NCT02060487|529468794|FG000|Overall Study|Lost to Follow-up|3|||
146808416|NCT02060487|529468795|FG001|Overall Study|Lost to Follow-up|0|||
146808417|NCT02060487|529468796|FG002|Overall Study|Lost to Follow-up|2|||
146808418|NCT02060487|529468794|FG000|Overall Study|Death|34|||
146808419|NCT02060487|529468795|FG001|Overall Study|Death|25|||
146808420|NCT02060487|529468796|FG002|Overall Study|Death|19|||
146808421|NCT02060487|529468794|FG000|Overall Study|Adverse Event|0|||
146808422|NCT02060487|529468795|FG001|Overall Study|Adverse Event|0|||
146808423|NCT02060487|529468796|FG002|Overall Study|Adverse Event|1|||
146808424|NCT02309294|529468797|FG000|Overall Study|Withdrawal by Subject|2|||
146808425|NCT01227421|529468798|FG000|Overall Study|Lost to Follow-up|6|||
146808426|NCT01227421|529468799|FG001|Overall Study|Lost to Follow-up|7|||
146942374|NCT02120352|529948130|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
146808427|NCT01227421|529468800|FG002|Overall Study|Lost to Follow-up|5|||
146808428|NCT01227421|529468798|FG000|Overall Study|Adverse Event|2|||
146808429|NCT01227421|529468799|FG001|Overall Study|Adverse Event|7|||
146808430|NCT01227421|529468800|FG002|Overall Study|Adverse Event|2|||
146808431|NCT01227421|529468798|FG000|Overall Study|Withdrawal by Subject|1|||
146808432|NCT01227421|529468799|FG001|Overall Study|Withdrawal by Subject|2|||
146808433|NCT01227421|529468800|FG002|Overall Study|Withdrawal by Subject|1|||
146808434|NCT01227421|529468798|FG000|Overall Study|Protocol Violation|1|||
146942375|NCT02120352|529948131|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
146942376|NCT02120352|529948132|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
146808435|NCT01227421|529468799|FG001|Overall Study|Protocol Violation|1|||
146808436|NCT01227421|529468800|FG002|Overall Study|Protocol Violation|2|||
146808437|NCT01227421|529468798|FG000|Overall Study|Randomized in error|1|||
146808438|NCT01227421|529468799|FG001|Overall Study|Randomized in error|1|||
146808439|NCT01227421|529468800|FG002|Overall Study|Randomized in error|0|||
146808440|NCT01827839|529468803|FG000|Overall Study|Adverse Event|1|||
146808441|NCT01827839|529468803|FG000|Overall Study|Consent Withdrawal|2|||
146808442|NCT05426109|529468804|FG000|Overall Study|Withdrawal by Subject|0|||
146808443|NCT05426109|529468805|FG001|Overall Study|Withdrawal by Subject|1|||
146808444|NCT02542943|529468806|FG000|Overall Study|Lost to Follow-up|1|||
146808445|NCT02542943|529468807|FG001|Overall Study|Lost to Follow-up|0|||
146808446|NCT02542943|529468808|FG002|Overall Study|Lost to Follow-up|0|||
146808447|NCT02542943|529468806|FG000|Overall Study|Withdrawal by Subject|0|||
146808448|NCT02542943|529468807|FG001|Overall Study|Withdrawal by Subject|1|||
146808449|NCT02542943|529468808|FG002|Overall Study|Withdrawal by Subject|0|||
146808450|NCT03476798|529468809|FG000|Overall Study|Death|1|||
146808451|NCT03476798|529468809|FG000|Overall Study|Withdrawal by Subject|2|||
146808452|NCT03476798|529468809|FG000|Overall Study|Protocol Violation|2|||
146808453|NCT06269003|529468810|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
146808454|NCT06269003|529468811|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
146808455|NCT06269003|529468812|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
146808456|NCT06269003|529468813|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
146808457|NCT05865392|529468817|FG000|Overall Study|Withdrawal by Subject|4|||
146808458|NCT05865392|529468818|FG001|Overall Study|Withdrawal by Subject|0|||
146808459|NCT05865392|529468817|FG000|Overall Study|Didn't meet inclusion criteria|4|||
146808460|NCT05865392|529468818|FG001|Overall Study|Didn't meet inclusion criteria|0|||
146808461|NCT04447027|529468821|FG000|Dose Escalation|Withdrawal by Subject|1|||
146808462|NCT04447027|529468822|FG001|Dose Escalation|Withdrawal by Subject|4|||
146808463|NCT04447027|529468823|FG002|Dose Escalation|Withdrawal by Subject|3|||
146808464|NCT04447027|529468824|FG003|Dose Escalation|Withdrawal by Subject|3|||
146808465|NCT04447027|529468825|FG004|Dose Escalation|Withdrawal by Subject|1|||
146808466|NCT04447027|529468826|FG005|Dose Escalation|Withdrawal by Subject|0|||
146808467|NCT04447027|529468827|FG006|Dose Escalation|Withdrawal by Subject|0|||
146808468|NCT04447027|529468828|FG007|Dose Escalation|Withdrawal by Subject|0|||
146808469|NCT04447027|529468829|FG008|Dose Escalation|Withdrawal by Subject|0|||
146808470|NCT04447027|529468821|FG000|Dose Escalation|Refused further treatment|0|||
146808471|NCT04447027|529468822|FG001|Dose Escalation|Refused further treatment|1|||
146808472|NCT04447027|529468823|FG002|Dose Escalation|Refused further treatment|1|||
146808473|NCT04447027|529468824|FG003|Dose Escalation|Refused further treatment|0|||
146808474|NCT04447027|529468825|FG004|Dose Escalation|Refused further treatment|0|||
146808475|NCT04447027|529468826|FG005|Dose Escalation|Refused further treatment|0|||
146808476|NCT04447027|529468827|FG006|Dose Escalation|Refused further treatment|0|||
146808477|NCT04447027|529468828|FG007|Dose Escalation|Refused further treatment|0|||
146808478|NCT04447027|529468829|FG008|Dose Escalation|Refused further treatment|0|||
146808479|NCT04447027|529468821|FG000|Dose Expansion|Withdrawal by Subject|0|||
146808480|NCT04447027|529468822|FG001|Dose Expansion|Withdrawal by Subject|0|||
146808481|NCT04447027|529468823|FG002|Dose Expansion|Withdrawal by Subject|0|||
146808482|NCT04447027|529468824|FG003|Dose Expansion|Withdrawal by Subject|0|||
146808483|NCT04447027|529468825|FG004|Dose Expansion|Withdrawal by Subject|0|||
146808484|NCT04447027|529468826|FG005|Dose Expansion|Withdrawal by Subject|2|||
146808485|NCT04447027|529468827|FG006|Dose Expansion|Withdrawal by Subject|0|||
146808486|NCT04447027|529468828|FG007|Dose Expansion|Withdrawal by Subject|2|||
146808487|NCT04447027|529468829|FG008|Dose Expansion|Withdrawal by Subject|0|||
146808488|NCT04118894|529468832|FG000|Overall Study|Lost to Follow-up|21|||
146808489|NCT04118894|529468832|FG000|Overall Study|Withdrawal by Subject|10|||
146808490|NCT04118894|529468832|FG000|Overall Study|Adverse Event|4|||
146808491|NCT00551421|529470076|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
146808492|NCT00799409|529470078|FG000|Overall Study|Withdrawal by Subject|1|||
146808493|NCT00799409|529470079|FG001|Overall Study|Withdrawal by Subject|0|||
146808494|NCT00799409|529470080|FG002|Overall Study|Withdrawal by Subject|0|||
146808495|NCT00799409|529470078|FG000|Overall Study|Lost to Follow-up|1|||
146808496|NCT00799409|529470079|FG001|Overall Study|Lost to Follow-up|0|||
146808497|NCT00799409|529470080|FG002|Overall Study|Lost to Follow-up|0|||
146808498|NCT00799409|529470078|FG000|Overall Study|Optimal Dose Not Achieved|2|||
146808499|NCT00799409|529470079|FG001|Overall Study|Optimal Dose Not Achieved|0|||
146808500|NCT00799409|529470080|FG002|Overall Study|Optimal Dose Not Achieved|0|||
146942377|NCT02120352|529948133|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
146808501|NCT00799409|529470078|FG000|Overall Study|Failure to follow study protocol)|1|||
146808502|NCT00799409|529470079|FG001|Overall Study|Failure to follow study protocol)|0|||
146808503|NCT00799409|529470080|FG002|Overall Study|Failure to follow study protocol)|0|||
146808504|NCT00799409|529470078|FG000|Overall Study|Did not attend lab school day 1|1|||
146808505|NCT00799409|529470079|FG001|Overall Study|Did not attend lab school day 1|0|||
146808506|NCT00799409|529470080|FG002|Overall Study|Did not attend lab school day 1|0|||
146808507|NCT00799409|529470078|FG000|Overall Study|medication compliance|1|||
146808508|NCT00799409|529470079|FG001|Overall Study|medication compliance|0|||
146942378|NCT02120352|529948134|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
146942379|NCT02120352|529948135|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
146808509|NCT00799409|529470080|FG002|Overall Study|medication compliance|0|||
146808510|NCT04323800|529470082|FG000|Overall Study|Withdrawal by Subject|4|||
146808511|NCT04323800|529470083|FG001|Overall Study|Withdrawal by Subject|4|||
146984011|NCT02100956|530102019|FG001|At Least One Week Between Injections|Adverse Event|1|||
146984012|NCT01859702|530102020|FG000|Overall Study|Protocol deviation|3|||
146984013|NCT01859702|530102020|FG000|Overall Study|Adverse Event|2|||
146984014|NCT02034799|530103304|FG000|Overall Study|Withdrawal by Subject|0|||
146984015|NCT02034799|530103305|FG001|Overall Study|Withdrawal by Subject|2|||
146984016|NCT02034799|530103304|FG000|Overall Study|Lost to Follow-up|0|||
146984017|NCT02034799|530103305|FG001|Overall Study|Lost to Follow-up|1|||
146984018|NCT02034799|530103304|FG000|Overall Study|Death|2|||
146984019|NCT02034799|530103305|FG001|Overall Study|Death|1|||
146984020|NCT03433001|530103316|FG000|Overall Study|Lack of Efficacy|109|||
146808512|NCT04323800|529470082|FG000|Overall Study|Incomplete transfusion|1|||
146808513|NCT04323800|529470083|FG001|Overall Study|Incomplete transfusion|0|||
146808514|NCT04323800|529470082|FG000|Overall Study|Other|0|||
146808515|NCT04323800|529470083|FG001|Overall Study|Other|1|||
146808516|NCT04323800|529470082|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
146808517|NCT04323800|529470083|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
146808518|NCT00489554|529470084|FG000|Overall Study|Adverse Event|2|||
146808519|NCT00489554|529470084|FG000|Overall Study|Withdrawal by Subject|1|||
146808520|NCT00489554|529470084|FG000|Overall Study|Lost to Follow-up|1|||
146808521|NCT00731692|529470085|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
146808522|NCT00731692|529470086|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
146808523|NCT00731692|529470087|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
146808524|NCT00731692|529470085|FG000|Core Study (36 Months)|Physician Decision|1|||
146808525|NCT00731692|529470086|FG001|Core Study (36 Months)|Physician Decision|0|||
146808526|NCT00731692|529470087|FG002|Core Study (36 Months)|Physician Decision|2|||
146808527|NCT00731692|529470085|FG000|Core Study (36 Months)|Death|2|||
146808528|NCT00731692|529470086|FG001|Core Study (36 Months)|Death|1|||
146808529|NCT00731692|529470087|FG002|Core Study (36 Months)|Death|2|||
146808530|NCT00731692|529470085|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
146808531|NCT00731692|529470086|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
146808532|NCT00731692|529470087|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
146808533|NCT00731692|529470085|FG000|Core Study (36 Months)|Administrative|2|||
146808534|NCT00731692|529470086|FG001|Core Study (36 Months)|Administrative|2|||
146808535|NCT00731692|529470087|FG002|Core Study (36 Months)|Administrative|6|||
146808536|NCT00731692|529470085|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
146808537|NCT00731692|529470086|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
146808538|NCT00731692|529470087|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
146808539|NCT00731692|529470085|FG000|Core Study (36 Months)|Protocol Violation|4|||
146808540|NCT00731692|529470086|FG001|Core Study (36 Months)|Protocol Violation|5|||
146808541|NCT00731692|529470087|FG002|Core Study (36 Months)|Protocol Violation|8|||
146808542|NCT00731692|529470085|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
146808543|NCT00731692|529470086|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
146808544|NCT00731692|529470087|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
146808545|NCT00731692|529470085|FG000|Core Study (36 Months)|Adverse Event|25|||
146808546|NCT00731692|529470086|FG001|Core Study (36 Months)|Adverse Event|28|||
146808547|NCT00731692|529470087|FG002|Core Study (36 Months)|Adverse Event|29|||
146808548|NCT00731692|529470085|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
146808549|NCT00731692|529470086|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
146808550|NCT00731692|529470087|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
146808551|NCT00731692|529470085|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
146808552|NCT00731692|529470086|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
146808553|NCT00731692|529470087|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
146808554|NCT00731692|529470085|FG000|Extension Phase|Abnormal test procedure|0|||
146808555|NCT00731692|529470086|FG001|Extension Phase|Abnormal test procedure|0|||
146808556|NCT00731692|529470087|FG002|Extension Phase|Abnormal test procedure|1|||
146808557|NCT00731692|529470085|FG000|Extension Phase|Abnormal lab values|0|||
146808558|NCT00731692|529470086|FG001|Extension Phase|Abnormal lab values|0|||
146808559|NCT00731692|529470087|FG002|Extension Phase|Abnormal lab values|1|||
146808560|NCT00731692|529470085|FG000|Extension Phase|Lost to Follow-up|0|||
146808561|NCT00731692|529470086|FG001|Extension Phase|Lost to Follow-up|1|||
146808562|NCT00731692|529470087|FG002|Extension Phase|Lost to Follow-up|4|||
146984021|NCT03433001|530103316|FG000|Overall Study|Adverse Event|69|||
146622453|NCT04612725|528789675|FG000|Overall Study|Lost to Follow-up|0|||
146808563|NCT00731692|529470085|FG000|Extension Phase|Withdrawal by Subject|4|||
146808564|NCT00731692|529470086|FG001|Extension Phase|Withdrawal by Subject|5|||
146808565|NCT00731692|529470087|FG002|Extension Phase|Withdrawal by Subject|3|||
146808566|NCT00731692|529470085|FG000|Extension Phase|Adverse Event|1|||
146808567|NCT00731692|529470086|FG001|Extension Phase|Adverse Event|1|||
146808568|NCT00731692|529470087|FG002|Extension Phase|Adverse Event|15|||
146808569|NCT00597376|529470088|FG000|Overall Study|Withdrawal by Subject|4|||
146808570|NCT00597376|529470089|FG001|Overall Study|Withdrawal by Subject|3|||
146984022|NCT03433001|530103316|FG000|Overall Study|Withdrawal by Subject|10|||
146984023|NCT03433001|530103316|FG000|Overall Study|Death|12|||
146808571|NCT00597376|529470088|FG000|Overall Study|Adverse Event|4|||
146808572|NCT00597376|529470089|FG001|Overall Study|Adverse Event|1|||
146808573|NCT02634307|529470090|FG000|Overall Study|Adverse Event|50|||
146808574|NCT02634307|529470091|FG001|Overall Study|Adverse Event|24|||
146808575|NCT02634307|529470092|FG002|Overall Study|Adverse Event|14|||
146808576|NCT02634307|529470090|FG000|Overall Study|Lost to Follow-up|21|||
146808577|NCT02634307|529470091|FG001|Overall Study|Lost to Follow-up|5|||
146808578|NCT02634307|529470092|FG002|Overall Study|Lost to Follow-up|6|||
146808579|NCT02634307|529470090|FG000|Overall Study|Pregnancy|5|||
146808580|NCT02634307|529470091|FG001|Overall Study|Pregnancy|1|||
146808581|NCT02634307|529470092|FG002|Overall Study|Pregnancy|3|||
146808582|NCT02634307|529470090|FG000|Overall Study|Withdrawal by Subject|38|||
146808583|NCT02634307|529470091|FG001|Overall Study|Withdrawal by Subject|24|||
146808584|NCT02634307|529470092|FG002|Overall Study|Withdrawal by Subject|18|||
146808585|NCT02634307|529470090|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146808586|NCT02634307|529470091|FG001|Overall Study|Non-Compliance with Study Drug|2|||
146808587|NCT02634307|529470092|FG002|Overall Study|Non-Compliance with Study Drug|2|||
146808588|NCT02634307|529470090|FG000|Overall Study|Lack of Efficacy|1|||
146808589|NCT02634307|529470091|FG001|Overall Study|Lack of Efficacy|5|||
146808590|NCT02634307|529470092|FG002|Overall Study|Lack of Efficacy|3|||
146808591|NCT02634307|529470090|FG000|Overall Study|Physician Decision|7|||
146808592|NCT02634307|529470091|FG001|Overall Study|Physician Decision|5|||
146808593|NCT02634307|529470092|FG002|Overall Study|Physician Decision|5|||
146808594|NCT02634307|529470090|FG000|Overall Study|Reason not Specified|3|||
146808595|NCT02634307|529470091|FG001|Overall Study|Reason not Specified|5|||
146808596|NCT02634307|529470092|FG002|Overall Study|Reason not Specified|10|||
146808597|NCT01214200|529470097|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
146808598|NCT01214200|529470097|FG000|Overall Study|Withdrawal by Subject|2|||
146808599|NCT00667017|529470098|FG000|Overall Study|Withdrawal by Subject|1|||
146808600|NCT01823224|529470099|FG000|Overall Study|Lost to Follow-up|5|||
146808601|NCT01823224|529470100|FG001|Overall Study|Lost to Follow-up|6|||
146808602|NCT01823224|529470099|FG000|Overall Study|didn't qualify|1|||
146808603|NCT01823224|529470100|FG001|Overall Study|didn't qualify|2|||
146808604|NCT01823224|529470099|FG000|Overall Study|pharmacy error|0|||
146808605|NCT01823224|529470100|FG001|Overall Study|pharmacy error|1|||
146808606|NCT01823224|529470099|FG000|Overall Study|missed med dose|0|||
146808607|NCT01823224|529470100|FG001|Overall Study|missed med dose|1|||
146808608|NCT01823224|529470099|FG000|Overall Study|Withdrawal by Subject|0|||
146808609|NCT01823224|529470100|FG001|Overall Study|Withdrawal by Subject|1|||
146808610|NCT01532648|529470101|FG000|Overall Study|Lost to Follow-up|3|||
146808611|NCT01532648|529470102|FG001|Overall Study|Lost to Follow-up|4|||
146808612|NCT01532648|529470101|FG000|Overall Study|Lack of Efficacy|4|||
146808613|NCT01532648|529470102|FG001|Overall Study|Lack of Efficacy|1|||
146808614|NCT01532648|529470101|FG000|Overall Study|Protocol Violation|1|||
146808615|NCT01532648|529470102|FG001|Overall Study|Protocol Violation|1|||
146808616|NCT01532648|529470101|FG000|Overall Study|Adverse Event|12|||
146808617|NCT01532648|529470102|FG001|Overall Study|Adverse Event|9|||
146808618|NCT01532648|529470101|FG000|Overall Study|Withdrawal by Subject|16|||
146808619|NCT01532648|529470102|FG001|Overall Study|Withdrawal by Subject|2|||
146808620|NCT01833455|529470103|FG000|Overall Study|Withdrawal by Subject|1|||
146808621|NCT01833455|529470104|FG001|Overall Study|Withdrawal by Subject|0|||
146808622|NCT03960645|529470105|FG000|Overall Study|Protocol Violation|1|||
146808623|NCT03960645|529470106|FG001|Overall Study|Protocol Violation|0|||
146808624|NCT04938453|529470107|FG000|Washout Period 1|Adverse Event|1|||
146808625|NCT04938453|529470108|FG001|Washout Period 1|Adverse Event|0|||
146808626|NCT04938453|529470107|FG000|Washout Period 1|Physician Decision|0|||
146808627|NCT04938453|529470108|FG001|Washout Period 1|Physician Decision|1|||
146808628|NCT03292406|529470111|FG000|Overall Study|Progressive Disease|6|||
146808629|NCT03292406|529470112|FG001|Overall Study|Progressive Disease|3|||
146984024|NCT03433001|530103316|FG000|Overall Study|Lost to Follow-up|4|||
146808630|NCT03292406|529470113|FG002|Overall Study|Progressive Disease|4|||
146808631|NCT03292406|529470111|FG000|Overall Study|Adverse Event|7|||
146808632|NCT03292406|529470112|FG001|Overall Study|Adverse Event|1|||
146808633|NCT03292406|529470113|FG002|Overall Study|Adverse Event|4|||
146808634|NCT03292406|529470111|FG000|Overall Study|Withdrawal by Subject|0|||
146808635|NCT03292406|529470112|FG001|Overall Study|Withdrawal by Subject|7|||
146984025|NCT03433001|530103316|FG000|Overall Study|Other|25|||
146808636|NCT03292406|529470113|FG002|Overall Study|Withdrawal by Subject|2|||
146808637|NCT03292406|529470111|FG000|Overall Study|Protocol Violation|0|||
146808638|NCT03292406|529470112|FG001|Overall Study|Protocol Violation|1|||
146808639|NCT03292406|529470113|FG002|Overall Study|Protocol Violation|1|||
146808640|NCT03292406|529470111|FG000|Overall Study|Other|0|||
146808641|NCT03292406|529470112|FG001|Overall Study|Other|1|||
146808642|NCT03292406|529470113|FG002|Overall Study|Other|2|||
146808643|NCT00022672|529470115|FG000|Main Phase: 24 Months|Adverse Event|6|||
146808644|NCT00022672|529470116|FG001|Main Phase: 24 Months|Adverse Event|0|||
146808645|NCT00022672|529470115|FG000|Main Phase: 24 Months|Death|0|||
146808646|NCT00022672|529470116|FG001|Main Phase: 24 Months|Death|3|||
146808647|NCT00022672|529470115|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
146808648|NCT00022672|529470116|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
146808649|NCT00022672|529470115|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
146808650|NCT00022672|529470116|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
146808651|NCT00022672|529470115|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
146808652|NCT00022672|529470116|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
146808653|NCT00022672|529470115|FG000|Main Phase: 24 Months|Refused Treatment|3|||
146808654|NCT00022672|529470116|FG001|Main Phase: 24 Months|Refused Treatment|4|||
146808655|NCT00022672|529470115|FG000|Main Phase: 24 Months|Failure to Return|1|||
146808656|NCT00022672|529470116|FG001|Main Phase: 24 Months|Failure to Return|1|||
146808657|NCT00022672|529470115|FG000|Main Phase: 24 Months|Other|1|||
146808658|NCT00022672|529470116|FG001|Main Phase: 24 Months|Other|0|||
146808659|NCT00022672|529470115|FG000|Extension Phase|Adverse Event|1|||
146808660|NCT00022672|529470116|FG001|Extension Phase|Adverse Event|3|||
146808661|NCT00022672|529470115|FG000|Extension Phase|Death|0|||
146808662|NCT00022672|529470116|FG001|Extension Phase|Death|1|||
146808663|NCT00022672|529470115|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
146808664|NCT00022672|529470116|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
146808665|NCT00022672|529470115|FG000|Extension Phase|Refused Treatment|0|||
146808666|NCT00022672|529470116|FG001|Extension Phase|Refused Treatment|2|||
146808667|NCT00022672|529470115|FG000|Extension Phase|Other|1|||
146808668|NCT00022672|529470116|FG001|Extension Phase|Other|1|||
146808669|NCT00403494|529470117|FG000|Overall Study|Adverse Event|10|||
146808670|NCT00403494|529470118|FG001|Overall Study|Adverse Event|8|||
146808671|NCT00403494|529470117|FG000|Overall Study|Withdrew Consent|3|||
146808672|NCT00403494|529470118|FG001|Overall Study|Withdrew Consent|2|||
146808673|NCT00403494|529470117|FG000|Overall Study|Inappropriately enrolled|0|||
146808674|NCT00403494|529470118|FG001|Overall Study|Inappropriately enrolled|1|||
146808675|NCT00403494|529470117|FG000|Overall Study|Lost to Follow-up|0|||
146808676|NCT00403494|529470118|FG001|Overall Study|Lost to Follow-up|2|||
146808677|NCT00403494|529470117|FG000|Overall Study|Protocol noncompliance|0|||
146808678|NCT00403494|529470118|FG001|Overall Study|Protocol noncompliance|1|||
146942380|NCT02120352|529948136|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
146942381|NCT02120352|529948130|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
146942382|NCT02120352|529948131|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
146942383|NCT02120352|529948132|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
146942384|NCT02120352|529948133|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
146942385|NCT02120352|529948134|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
146808679|NCT00403494|529470117|FG000|Overall Study|Death|1|||
146808680|NCT00403494|529470118|FG001|Overall Study|Death|0|||
146808681|NCT00403494|529470117|FG000|Overall Study|Sponsor Request|1|||
146808682|NCT00403494|529470118|FG001|Overall Study|Sponsor Request|0|||
146808683|NCT04658784|529470125|FG000|6-month Follow-up|Lost to Follow-up|2|||
146808684|NCT04658784|529470126|FG001|6-month Follow-up|Lost to Follow-up|5|||
146808685|NCT02575365|529470127|FG000|Overall Study|Lost to Follow-up|4|||
146808686|NCT00670488|529470132|FG000|Overall Study|Adverse Event|0|||
146808687|NCT00670488|529470133|FG001|Overall Study|Adverse Event|7|||
146808688|NCT00670488|529470134|FG002|Overall Study|Adverse Event|0|||
146808689|NCT00670488|529470135|FG003|Overall Study|Adverse Event|3|||
146808690|NCT00670488|529470136|FG004|Overall Study|Adverse Event|1|||
146808691|NCT00670488|529470137|FG005|Overall Study|Adverse Event|1|||
146808692|NCT00670488|529470138|FG006|Overall Study|Adverse Event|5|||
146808693|NCT00670488|529470139|FG007|Overall Study|Adverse Event|1|||
146808694|NCT00670488|529470140|FG008|Overall Study|Adverse Event|0|||
146808695|NCT00670488|529470141|FG009|Overall Study|Adverse Event|1|||
146808696|NCT00670488|529470132|FG000|Overall Study|Physician Decision|1|||
146808697|NCT00670488|529470133|FG001|Overall Study|Physician Decision|9|||
146808698|NCT00670488|529470134|FG002|Overall Study|Physician Decision|0|||
146808699|NCT00670488|529470135|FG003|Overall Study|Physician Decision|1|||
146808700|NCT00670488|529470136|FG004|Overall Study|Physician Decision|0|||
146808701|NCT00670488|529470137|FG005|Overall Study|Physician Decision|0|||
146808702|NCT00670488|529470138|FG006|Overall Study|Physician Decision|0|||
146808703|NCT00670488|529470139|FG007|Overall Study|Physician Decision|0|||
146808704|NCT00670488|529470140|FG008|Overall Study|Physician Decision|0|||
146808705|NCT00670488|529470141|FG009|Overall Study|Physician Decision|0|||
146808706|NCT00670488|529470132|FG000|Overall Study|Progressive Disease|2|||
146942386|NCT02120352|529948135|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
146808707|NCT00670488|529470133|FG001|Overall Study|Progressive Disease|41|||
146808708|NCT00670488|529470134|FG002|Overall Study|Progressive Disease|3|||
146808709|NCT00670488|529470135|FG003|Overall Study|Progressive Disease|2|||
146808710|NCT00670488|529470136|FG004|Overall Study|Progressive Disease|2|||
146808711|NCT00670488|529470137|FG005|Overall Study|Progressive Disease|4|||
146808712|NCT00670488|529470138|FG006|Overall Study|Progressive Disease|11|||
146808713|NCT00670488|529470139|FG007|Overall Study|Progressive Disease|2|||
146808714|NCT00670488|529470140|FG008|Overall Study|Progressive Disease|2|||
146808715|NCT00670488|529470141|FG009|Overall Study|Progressive Disease|1|||
146808716|NCT00670488|529470132|FG000|Overall Study|Withdrawal by Subject|0|||
146808717|NCT00670488|529470133|FG001|Overall Study|Withdrawal by Subject|1|||
146808718|NCT00670488|529470134|FG002|Overall Study|Withdrawal by Subject|0|||
146808719|NCT00670488|529470135|FG003|Overall Study|Withdrawal by Subject|1|||
146808720|NCT00670488|529470136|FG004|Overall Study|Withdrawal by Subject|0|||
146808721|NCT00670488|529470137|FG005|Overall Study|Withdrawal by Subject|0|||
146808722|NCT00670488|529470138|FG006|Overall Study|Withdrawal by Subject|1|||
146808723|NCT00670488|529470139|FG007|Overall Study|Withdrawal by Subject|0|||
146808724|NCT00670488|529470140|FG008|Overall Study|Withdrawal by Subject|1|||
146808725|NCT00670488|529470141|FG009|Overall Study|Withdrawal by Subject|0|||
146808726|NCT02708498|529470142|FG000|Overall Study|Death|20|||
146808727|NCT02708498|529470143|FG001|Overall Study|Death|19|||
146808728|NCT02708498|529470144|FG002|Overall Study|Death|0|||
146808729|NCT02708498|529470145|FG003|Overall Study|Death|0|||
146808730|NCT02708498|529470146|FG004|Overall Study|Death|1|||
146808731|NCT02708498|529470147|FG005|Overall Study|Death|0|||
146808732|NCT02708498|529470148|FG006|Overall Study|Death|0|||
146808733|NCT02708498|529470149|FG007|Overall Study|Death|0|||
146808734|NCT02708498|529470142|FG000|Overall Study|Unknown reason, missing data|0|||
146808735|NCT02708498|529470143|FG001|Overall Study|Unknown reason, missing data|0|||
146808736|NCT02708498|529470144|FG002|Overall Study|Unknown reason, missing data|62|||
146808737|NCT02708498|529470145|FG003|Overall Study|Unknown reason, missing data|51|||
146808738|NCT02708498|529470146|FG004|Overall Study|Unknown reason, missing data|195|||
146808739|NCT02708498|529470147|FG005|Overall Study|Unknown reason, missing data|132|||
146808740|NCT02708498|529470148|FG006|Overall Study|Unknown reason, missing data|0|||
146808741|NCT02708498|529470149|FG007|Overall Study|Unknown reason, missing data|0|||
146808742|NCT00195819|529470150|FG000|Double-Blind|Withdrawal by Subject|1|||
146808743|NCT00195819|529470151|FG001|Double-Blind|Withdrawal by Subject|0|||
146808744|NCT00195819|529470150|FG000|Double-Blind|Moved|1|||
146808745|NCT00195819|529470151|FG001|Double-Blind|Moved|0|||
146808746|NCT00195819|529470150|FG000|Open-label|Adverse Event|0|||
146808747|NCT00195819|529470151|FG001|Open-label|Adverse Event|9|||
146808748|NCT00195819|529470150|FG000|Open-label|Lack of Efficacy|0|||
146808749|NCT00195819|529470151|FG001|Open-label|Lack of Efficacy|2|||
146808750|NCT00195819|529470150|FG000|Open-label|Pregnancy|0|||
146808751|NCT00195819|529470151|FG001|Open-label|Pregnancy|1|||
146808752|NCT00195819|529470150|FG000|Open-label|Protocol Violation|0|||
146808753|NCT00195819|529470151|FG001|Open-label|Protocol Violation|2|||
146808754|NCT00195819|529470150|FG000|Open-label|Moved|0|||
146808755|NCT00195819|529470151|FG001|Open-label|Moved|1|||
146808756|NCT00195819|529470150|FG000|Open-label|Withdrawal by Subject|0|||
146808757|NCT00195819|529470151|FG001|Open-label|Withdrawal by Subject|5|||
146808758|NCT01124045|529470152|FG000|Overall Study|Lost to Follow-up|0|||
146808759|NCT01124045|529470153|FG001|Overall Study|Lost to Follow-up|1|||
146808760|NCT01124045|529470152|FG000|Overall Study|Physician Decision|0|||
146808761|NCT01124045|529470153|FG001|Overall Study|Physician Decision|2|||
146808762|NCT03298087|529470154|FG000|Overall Study|Withdrawal by Subject|4|||
146808763|NCT01629589|529470155|FG000|Overall Study|Protocol Violation|4|||
146808764|NCT01629589|529470156|FG001|Overall Study|Protocol Violation|2|||
146808765|NCT01629589|529470155|FG000|Overall Study|Lost to Follow-up|2|||
146808766|NCT01629589|529470156|FG001|Overall Study|Lost to Follow-up|1|||
146808767|NCT01629589|529470155|FG000|Overall Study|Withdrawal by Subject|2|||
146808768|NCT01629589|529470156|FG001|Overall Study|Withdrawal by Subject|3|||
146808769|NCT01629589|529470155|FG000|Overall Study|Did not receive study vaccine|0|||
146808770|NCT01629589|529470156|FG001|Overall Study|Did not receive study vaccine|1|||
146808771|NCT00822900|529470157|FG000|Overall Study|Withdrawal by Subject|14|||
146808772|NCT00822900|529470158|FG001|Overall Study|Withdrawal by Subject|14|||
146808773|NCT00822900|529470157|FG000|Overall Study|Lost to Follow-up|9|||
146808774|NCT00822900|529470158|FG001|Overall Study|Lost to Follow-up|9|||
146808775|NCT00822900|529470157|FG000|Overall Study|Death|83|||
146808776|NCT00822900|529470158|FG001|Overall Study|Death|69|||
146808777|NCT00822900|529470157|FG000|Overall Study|Became a ward of the state|2|||
146808778|NCT00822900|529470158|FG001|Overall Study|Became a ward of the state|1|||
146808779|NCT02234141|529470159|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
146808780|NCT02234141|529470160|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
146808781|NCT02234141|529470161|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
146808782|NCT02234141|529470162|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
146808783|NCT02234141|529470163|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
146808784|NCT02234141|529470164|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
146808785|NCT02234141|529470165|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
146808786|NCT02234141|529470159|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
146808787|NCT02234141|529470160|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
146808788|NCT02234141|529470161|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
146808789|NCT02234141|529470162|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
146808790|NCT02234141|529470163|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
146808791|NCT02234141|529470164|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
146808792|NCT02234141|529470165|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
146808793|NCT02234141|529470159|FG000|Treatment Period (24 Weeks)|Death|1|||
146808794|NCT02234141|529470160|FG001|Treatment Period (24 Weeks)|Death|2|||
146808795|NCT02234141|529470161|FG002|Treatment Period (24 Weeks)|Death|0|||
146808796|NCT02234141|529470162|FG003|Treatment Period (24 Weeks)|Death|1|||
146942387|NCT02120352|529948136|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
146942388|NCT02120352|529948130|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
146942389|NCT02120352|529948131|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
146942390|NCT02120352|529948132|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
146942391|NCT02120352|529948133|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
146942392|NCT02120352|529948134|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
146942393|NCT02120352|529948135|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
146808797|NCT02234141|529470163|FG004|Treatment Period (24 Weeks)|Death|0|||
146808798|NCT02234141|529470164|FG005|Treatment Period (24 Weeks)|Death|0|||
146808799|NCT02234141|529470165|FG006|Treatment Period (24 Weeks)|Death|0|||
146808800|NCT02234141|529470159|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
146808801|NCT02234141|529470160|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
146808802|NCT02234141|529470161|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
146808803|NCT02234141|529470162|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
146808804|NCT02234141|529470163|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
146808805|NCT02234141|529470164|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
146808806|NCT02234141|529470165|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
146808807|NCT02234141|529470159|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
146808808|NCT02234141|529470160|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
146808809|NCT02234141|529470161|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
146808810|NCT02234141|529470162|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
146808811|NCT02234141|529470163|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
146808812|NCT02234141|529470164|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
146808813|NCT02234141|529470165|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
146808814|NCT02234141|529470159|FG000|Long-Term Treatment Period|Death|0|||
146808815|NCT02234141|529470160|FG001|Long-Term Treatment Period|Death|0|||
146808816|NCT02234141|529470161|FG002|Long-Term Treatment Period|Death|0|||
146808817|NCT02234141|529470162|FG003|Long-Term Treatment Period|Death|0|||
146808818|NCT02234141|529470163|FG004|Long-Term Treatment Period|Death|0|||
146808819|NCT02234141|529470164|FG005|Long-Term Treatment Period|Death|1|||
146808820|NCT02234141|529470165|FG006|Long-Term Treatment Period|Death|0|||
146808821|NCT02234141|529470159|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
146808822|NCT02234141|529470160|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
146808823|NCT02234141|529470161|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
146808824|NCT02234141|529470162|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
146808825|NCT02234141|529470163|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
146808826|NCT02234141|529470164|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
146808827|NCT02234141|529470165|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
146808828|NCT02234141|529470159|FG000|Long-Term Treatment Period|Adverse Event|4|||
146808829|NCT02234141|529470160|FG001|Long-Term Treatment Period|Adverse Event|0|||
146808830|NCT02234141|529470161|FG002|Long-Term Treatment Period|Adverse Event|5|||
146808831|NCT02234141|529470162|FG003|Long-Term Treatment Period|Adverse Event|0|||
146808832|NCT02234141|529470163|FG004|Long-Term Treatment Period|Adverse Event|1|||
146808833|NCT02234141|529470164|FG005|Long-Term Treatment Period|Adverse Event|1|||
146808834|NCT02234141|529470165|FG006|Long-Term Treatment Period|Adverse Event|1|||
146808835|NCT02234141|529470159|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
146808836|NCT02234141|529470160|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
146808837|NCT02234141|529470161|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
146808838|NCT02234141|529470162|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
146808839|NCT02234141|529470163|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
146808840|NCT02234141|529470164|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
146808841|NCT02234141|529470165|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
146808842|NCT02234141|529470159|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
146808843|NCT02234141|529470160|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
146808844|NCT02234141|529470161|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
146808845|NCT02234141|529470162|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
146808846|NCT02234141|529470163|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
146808847|NCT02234141|529470164|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
146808848|NCT02234141|529470165|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
146808849|NCT03418545|529470166|FG000|Overall Study|Withdrawal by Participant|2|||
146808850|NCT03418545|529470167|FG001|Overall Study|Withdrawal by Participant|4|||
146808851|NCT03418545|529470166|FG000|Overall Study|Lost to Follow-up|3|||
146808852|NCT03418545|529470167|FG001|Overall Study|Lost to Follow-up|5|||
146808853|NCT03418545|529470166|FG000|Overall Study|Reason Not Specified|0|||
146808854|NCT03418545|529470167|FG001|Overall Study|Reason Not Specified|1|||
146808855|NCT03418545|529470166|FG000|Overall Study|Missing Completion Status|0|||
146808856|NCT03418545|529470167|FG001|Overall Study|Missing Completion Status|1|||
146808857|NCT02251652|529470168|FG000|Overall Study|Withdrawal by Subject|1|||
146808858|NCT01074242|529470169|FG000|Overall Study|Case report before date of contract|40|||
146808859|NCT01074242|529470169|FG000|Overall Study|Lost to Follow-up|1|||
146808860|NCT01074242|529470169|FG000|Overall Study|Case report unclear|6|||
146808861|NCT01074242|529470169|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
146808862|NCT01074242|529470169|FG000|Overall Study|Duplicate Case Report Form|5|||
146808863|NCT00109031|529470170|FG000|Overall Study|Adverse Event|0|||
146808864|NCT00109031|529470171|FG001|Overall Study|Adverse Event|0|||
146808865|NCT00109031|529470172|FG002|Overall Study|Adverse Event|1|||
146808866|NCT00109031|529470173|FG003|Overall Study|Adverse Event|0|||
146808867|NCT00109031|529470170|FG000|Overall Study|Withdrawal by Subject|0|||
146808868|NCT00109031|529470171|FG001|Overall Study|Withdrawal by Subject|1|||
146808869|NCT00109031|529470172|FG002|Overall Study|Withdrawal by Subject|0|||
146808870|NCT00109031|529470173|FG003|Overall Study|Withdrawal by Subject|0|||
146808871|NCT00109031|529470170|FG000|Overall Study|Physician Decision|0|||
146808872|NCT00109031|529470171|FG001|Overall Study|Physician Decision|1|||
146808873|NCT00109031|529470172|FG002|Overall Study|Physician Decision|0|||
146808874|NCT00109031|529470173|FG003|Overall Study|Physician Decision|0|||
146808875|NCT00109031|529470170|FG000|Overall Study|Protocol Violation|0|||
146808876|NCT00109031|529470171|FG001|Overall Study|Protocol Violation|0|||
146808877|NCT00109031|529470172|FG002|Overall Study|Protocol Violation|1|||
146808878|NCT00109031|529470173|FG003|Overall Study|Protocol Violation|0|||
146808879|NCT01957163|529470174|FG000|Overall Study|Adverse Event|5|||
146808880|NCT01957163|529470175|FG001|Overall Study|Adverse Event|2|||
146808881|NCT01957163|529470176|FG002|Overall Study|Adverse Event|4|||
146808882|NCT01957163|529470174|FG000|Overall Study|Lack of Efficacy|5|||
146808883|NCT01957163|529470175|FG001|Overall Study|Lack of Efficacy|4|||
146808884|NCT01957163|529470176|FG002|Overall Study|Lack of Efficacy|9|||
146808885|NCT01957163|529470174|FG000|Overall Study|Protocol Violation|1|||
146808886|NCT01957163|529470175|FG001|Overall Study|Protocol Violation|2|||
146808887|NCT01957163|529470176|FG002|Overall Study|Protocol Violation|0|||
146808888|NCT01957163|529470174|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
146808889|NCT01957163|529470175|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
146808890|NCT01957163|529470176|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
146808891|NCT01957163|529470174|FG000|Overall Study|Lost to Follow-up|0|||
146808892|NCT01957163|529470175|FG001|Overall Study|Lost to Follow-up|1|||
146808893|NCT01957163|529470176|FG002|Overall Study|Lost to Follow-up|0|||
146808894|NCT01957163|529470174|FG000|Overall Study|Withdrawal by Subject|4|||
146808895|NCT01957163|529470175|FG001|Overall Study|Withdrawal by Subject|2|||
146808896|NCT01957163|529470176|FG002|Overall Study|Withdrawal by Subject|4|||
146808897|NCT00243867|529470181|FG000|Overall Study|Adverse Event|24|||
146808898|NCT00243867|529470182|FG001|Overall Study|Adverse Event|34|||
146808899|NCT00243867|529470181|FG000|Overall Study|Lack of Efficacy|115|||
146808900|NCT00243867|529470182|FG001|Overall Study|Lack of Efficacy|78|||
146808901|NCT00243867|529470181|FG000|Overall Study|Withdrawal by Subject|11|||
146808902|NCT00243867|529470182|FG001|Overall Study|Withdrawal by Subject|23|||
146808903|NCT00243867|529470181|FG000|Overall Study|Lost to Follow-up|2|||
146808904|NCT00243867|529470182|FG001|Overall Study|Lost to Follow-up|1|||
146808905|NCT00243867|529470181|FG000|Overall Study|Physician Decision|2|||
146808906|NCT00243867|529470182|FG001|Overall Study|Physician Decision|7|||
146808907|NCT00243867|529470181|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
146808908|NCT00243867|529470182|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
146808909|NCT05182606|529470188|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
146808910|NCT02686658|529470190|FG000|Overall Study|Adverse Event|0|||
146808911|NCT02686658|529470191|FG001|Overall Study|Adverse Event|0|||
146808912|NCT02686658|529470192|FG002|Overall Study|Adverse Event|1|||
146808913|NCT02686658|529470193|FG003|Overall Study|Adverse Event|1|||
146808914|NCT02686658|529470194|FG004|Overall Study|Adverse Event|2|||
146808915|NCT02686658|529470195|FG005|Overall Study|Adverse Event|1|||
146808916|NCT02686658|529470190|FG000|Overall Study|Investigator decision|0|||
146808917|NCT02686658|529470191|FG001|Overall Study|Investigator decision|0|||
146808918|NCT02686658|529470192|FG002|Overall Study|Investigator decision|0|||
146808919|NCT02686658|529470193|FG003|Overall Study|Investigator decision|1|||
146808920|NCT02686658|529470194|FG004|Overall Study|Investigator decision|2|||
146808921|NCT02686658|529470195|FG005|Overall Study|Investigator decision|1|||
146942394|NCT02120352|529948136|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
146808922|NCT02686658|529470190|FG000|Overall Study|Sponsor decision|1|||
146808923|NCT02686658|529470191|FG001|Overall Study|Sponsor decision|2|||
146942395|NCT02120352|529948130|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
146942396|NCT02120352|529948131|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
146808924|NCT02686658|529470192|FG002|Overall Study|Sponsor decision|1|||
146808925|NCT02686658|529470193|FG003|Overall Study|Sponsor decision|5|||
146808926|NCT02686658|529470194|FG004|Overall Study|Sponsor decision|13|||
146808927|NCT02686658|529470195|FG005|Overall Study|Sponsor decision|2|||
146808928|NCT02686658|529470190|FG000|Overall Study|Lost to Follow-up|0|||
146808929|NCT02686658|529470191|FG001|Overall Study|Lost to Follow-up|0|||
146808930|NCT02686658|529470192|FG002|Overall Study|Lost to Follow-up|2|||
146808931|NCT02686658|529470193|FG003|Overall Study|Lost to Follow-up|0|||
146808932|NCT02686658|529470194|FG004|Overall Study|Lost to Follow-up|0|||
146808933|NCT02686658|529470195|FG005|Overall Study|Lost to Follow-up|1|||
146808934|NCT02686658|529470190|FG000|Overall Study|Death|1|||
146808935|NCT02686658|529470191|FG001|Overall Study|Death|0|||
146808936|NCT02686658|529470192|FG002|Overall Study|Death|0|||
146808937|NCT02686658|529470193|FG003|Overall Study|Death|1|||
146808938|NCT02686658|529470194|FG004|Overall Study|Death|1|||
146808939|NCT02686658|529470195|FG005|Overall Study|Death|1|||
146808940|NCT02686658|529470190|FG000|Overall Study|Withdrawal by Subject|2|||
146808941|NCT02686658|529470191|FG001|Overall Study|Withdrawal by Subject|5|||
146808942|NCT02686658|529470192|FG002|Overall Study|Withdrawal by Subject|4|||
146808943|NCT02686658|529470193|FG003|Overall Study|Withdrawal by Subject|4|||
146808944|NCT02686658|529470194|FG004|Overall Study|Withdrawal by Subject|17|||
146808945|NCT02686658|529470195|FG005|Overall Study|Withdrawal by Subject|8|||
146808946|NCT02686658|529470190|FG000|Overall Study|Placed in hospice care|0|||
146808947|NCT02686658|529470191|FG001|Overall Study|Placed in hospice care|0|||
146808948|NCT02686658|529470192|FG002|Overall Study|Placed in hospice care|1|||
146808949|NCT02686658|529470193|FG003|Overall Study|Placed in hospice care|0|||
146808950|NCT02686658|529470194|FG004|Overall Study|Placed in hospice care|0|||
146808951|NCT02686658|529470195|FG005|Overall Study|Placed in hospice care|0|||
146808952|NCT02686658|529470190|FG000|Overall Study|Participant non-compliance|0|||
146808953|NCT02686658|529470191|FG001|Overall Study|Participant non-compliance|0|||
146808954|NCT02686658|529470192|FG002|Overall Study|Participant non-compliance|0|||
146808955|NCT02686658|529470193|FG003|Overall Study|Participant non-compliance|0|||
146808956|NCT02686658|529470194|FG004|Overall Study|Participant non-compliance|0|||
146808957|NCT02686658|529470195|FG005|Overall Study|Participant non-compliance|1|||
146984026|NCT02058628|530103317|FG000|Overall Study|Adverse Event|1|||
146984027|NCT02058628|530103318|FG001|Overall Study|Adverse Event|0|||
146984028|NCT02058628|530103317|FG000|Overall Study|Withdrawal by Subject|2|||
146984029|NCT02058628|530103318|FG001|Overall Study|Withdrawal by Subject|2|||
146984030|NCT02058628|530103317|FG000|Overall Study|Lost to Follow-up|2|||
146984031|NCT02058628|530103318|FG001|Overall Study|Lost to Follow-up|4|||
146984032|NCT02058628|530103317|FG000|Overall Study|Not in time schedule|0|||
146984033|NCT02058628|530103318|FG001|Overall Study|Not in time schedule|1|||
146984034|NCT02058628|530103317|FG000|Overall Study|The visit date was not in timeline|0|||
146984035|NCT02058628|530103318|FG001|Overall Study|The visit date was not in timeline|1|||
146984036|NCT02058628|530103317|FG000|Overall Study|A lot of time for study for participant|1|||
146984037|NCT02058628|530103318|FG001|Overall Study|A lot of time for study for participant|0|||
146984038|NCT02058628|530103317|FG000|Overall Study|Non compliance|1|||
146984039|NCT02058628|530103318|FG001|Overall Study|Non compliance|0|||
146808958|NCT02686658|529470190|FG000|Overall Study|Concern over coronavirus disease care|0|||
146808959|NCT02686658|529470191|FG001|Overall Study|Concern over coronavirus disease care|0|||
146808960|NCT02686658|529470192|FG002|Overall Study|Concern over coronavirus disease care|0|||
146808961|NCT02686658|529470193|FG003|Overall Study|Concern over coronavirus disease care|0|||
146808962|NCT02686658|529470194|FG004|Overall Study|Concern over coronavirus disease care|2|||
146808963|NCT02686658|529470195|FG005|Overall Study|Concern over coronavirus disease care|1|||
146808964|NCT02969356|529470203|FG000|Overall Study|Adverse Event|7|||
146808965|NCT02969356|529470203|FG000|Overall Study|Consent withdrawn|2|||
146808966|NCT02969356|529470203|FG000|Overall Study|Lost to Follow-up|3|||
146808967|NCT02969356|529470203|FG000|Overall Study|Did not need to be reinjected|6|||
146808968|NCT02969356|529470203|FG000|Overall Study|Personal reasons|5|||
146808969|NCT02556918|529471612|FG000|Overall Study|Protocol Violation|5|||
146808970|NCT02556918|529471613|FG001|Overall Study|Protocol Violation|6|||
146808971|NCT02556918|529471612|FG000|Overall Study|Withdrawal by Subject|4|||
146808972|NCT02556918|529471613|FG001|Overall Study|Withdrawal by Subject|4|||
146808973|NCT04511702|529471619|FG000|Overall Study|Lost to Follow-up|3|||
146808974|NCT04511702|529471620|FG001|Overall Study|Lost to Follow-up|0|||
146808975|NCT04511702|529471621|FG002|Overall Study|Lost to Follow-up|4|||
146808976|NCT04511702|529471619|FG000|Overall Study|Withdrawal by Subject|17|||
146808977|NCT04511702|529471620|FG001|Overall Study|Withdrawal by Subject|1|||
146808978|NCT04511702|529471621|FG002|Overall Study|Withdrawal by Subject|8|||
146808979|NCT04493424|529471622|FG000|Overall Study|Termination of the trial by the sponsor|89|||
146808980|NCT04493424|529471622|FG000|Overall Study|Withdrawal by Subject|9|||
146808981|NCT04493424|529471622|FG000|Overall Study|Lost to Follow-up|2|||
146808982|NCT04493424|529471622|FG000|Overall Study|Lack of Efficacy|3|||
146808983|NCT04493424|529471622|FG000|Overall Study|Adverse Event|5|||
146808984|NCT00108355|529471626|FG000|Overall Study|Peritonitis at index paracentesis|1|||
146808985|NCT00108355|529471627|FG001|Overall Study|Peritonitis at index paracentesis|1|||
146984040|NCT01452529|530103319|FG000|Run-in Period|Adverse Event|96|||
146984041|NCT01452529|530103320|FG001|Run-in Period|Adverse Event|0|||
146984042|NCT01452529|530103321|FG002|Run-in Period|Adverse Event|0|||
146808986|NCT00108355|529471626|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
146808987|NCT00108355|529471627|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
146808988|NCT04992273|529471628|FG000|Overall Study|Lost to Follow-up|0|||
146808989|NCT04992273|529471629|FG001|Overall Study|Lost to Follow-up|1|||
146808990|NCT01364597|529471630|FG000|Overall Study|Adverse Event|4|||
146808991|NCT01364597|529471631|FG001|Overall Study|Adverse Event|5|||
146808992|NCT01364597|529471632|FG002|Overall Study|Adverse Event|16|||
146808993|NCT01364597|529471633|FG003|Overall Study|Adverse Event|7|||
146808994|NCT01364597|529471630|FG000|Overall Study|Lack of Efficacy|4|||
146808995|NCT01364597|529471631|FG001|Overall Study|Lack of Efficacy|4|||
146808996|NCT01364597|529471632|FG002|Overall Study|Lack of Efficacy|23|||
146808997|NCT01364597|529471633|FG003|Overall Study|Lack of Efficacy|8|||
146808998|NCT01364597|529471630|FG000|Overall Study|Protocol Violation|0|||
146808999|NCT01364597|529471631|FG001|Overall Study|Protocol Violation|0|||
146809000|NCT01364597|529471632|FG002|Overall Study|Protocol Violation|2|||
146809001|NCT01364597|529471633|FG003|Overall Study|Protocol Violation|0|||
146809002|NCT01364597|529471630|FG000|Overall Study|Lost to Follow-up|0|||
146809003|NCT01364597|529471631|FG001|Overall Study|Lost to Follow-up|0|||
146809004|NCT01364597|529471632|FG002|Overall Study|Lost to Follow-up|5|||
146809005|NCT01364597|529471633|FG003|Overall Study|Lost to Follow-up|3|||
146809006|NCT01364597|529471630|FG000|Overall Study|Withdrawal by Subject|4|||
146809007|NCT01364597|529471631|FG001|Overall Study|Withdrawal by Subject|1|||
146809008|NCT01364597|529471632|FG002|Overall Study|Withdrawal by Subject|18|||
146809009|NCT01364597|529471633|FG003|Overall Study|Withdrawal by Subject|6|||
146809010|NCT01364597|529471630|FG000|Overall Study|Non compliance|1|||
146809011|NCT01364597|529471631|FG001|Overall Study|Non compliance|0|||
146809012|NCT01364597|529471632|FG002|Overall Study|Non compliance|1|||
146809013|NCT01364597|529471633|FG003|Overall Study|Non compliance|0|||
146809014|NCT01364597|529471630|FG000|Overall Study|Lack of compliance|1|||
146809015|NCT01364597|529471631|FG001|Overall Study|Lack of compliance|0|||
146809016|NCT01364597|529471632|FG002|Overall Study|Lack of compliance|0|||
146809017|NCT01364597|529471633|FG003|Overall Study|Lack of compliance|0|||
146809018|NCT01364597|529471630|FG000|Overall Study|End of treatment epilepsy|1|||
146809019|NCT01364597|529471631|FG001|Overall Study|End of treatment epilepsy|0|||
146809020|NCT01364597|529471632|FG002|Overall Study|End of treatment epilepsy|0|||
146809021|NCT01364597|529471633|FG003|Overall Study|End of treatment epilepsy|0|||
146809022|NCT01364597|529471630|FG000|Overall Study|No Seizures|1|||
146809023|NCT01364597|529471631|FG001|Overall Study|No Seizures|0|||
146809024|NCT01364597|529471632|FG002|Overall Study|No Seizures|0|||
146809025|NCT01364597|529471633|FG003|Overall Study|No Seizures|0|||
146809026|NCT01364597|529471630|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
146809027|NCT01364597|529471631|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
146809028|NCT01364597|529471632|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
146809029|NCT01364597|529471633|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
146809030|NCT01364597|529471630|FG000|Overall Study|Cure|1|||
146809031|NCT01364597|529471631|FG001|Overall Study|Cure|0|||
146809032|NCT01364597|529471632|FG002|Overall Study|Cure|0|||
146809033|NCT01364597|529471633|FG003|Overall Study|Cure|0|||
146809034|NCT01364597|529471630|FG000|Overall Study|Patient was moving|0|||
146809035|NCT01364597|529471631|FG001|Overall Study|Patient was moving|1|||
146809036|NCT01364597|529471632|FG002|Overall Study|Patient was moving|0|||
146809037|NCT01364597|529471633|FG003|Overall Study|Patient was moving|0|||
146809038|NCT01364597|529471630|FG000|Overall Study|Seizures resolved|0|||
146809039|NCT01364597|529471631|FG001|Overall Study|Seizures resolved|0|||
146809040|NCT01364597|529471632|FG002|Overall Study|Seizures resolved|1|||
146809041|NCT01364597|529471633|FG003|Overall Study|Seizures resolved|0|||
146809042|NCT01364597|529471630|FG000|Overall Study|Patient became seizure-free after surgery|0|||
146809043|NCT01364597|529471631|FG001|Overall Study|Patient became seizure-free after surgery|0|||
146809044|NCT01364597|529471632|FG002|Overall Study|Patient became seizure-free after surgery|1|||
146809045|NCT01364597|529471633|FG003|Overall Study|Patient became seizure-free after surgery|0|||
146809046|NCT01364597|529471630|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
146809047|NCT01364597|529471631|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
146809048|NCT01364597|529471632|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
146809049|NCT01364597|529471633|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
146809050|NCT01364597|529471630|FG000|Overall Study|Patient cured from Epilepsy|0|||
146942397|NCT02120352|529948132|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
146942398|NCT02120352|529948133|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
146942399|NCT02120352|529948134|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
146942400|NCT02120352|529948135|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
146809051|NCT01364597|529471631|FG001|Overall Study|Patient cured from Epilepsy|0|||
146809052|NCT01364597|529471632|FG002|Overall Study|Patient cured from Epilepsy|1|||
146809053|NCT01364597|529471633|FG003|Overall Study|Patient cured from Epilepsy|0|||
146942401|NCT02120352|529948136|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
146809054|NCT01364597|529471630|FG000|Overall Study|Investigator decision|0|||
146809055|NCT01364597|529471631|FG001|Overall Study|Investigator decision|0|||
146809056|NCT01364597|529471632|FG002|Overall Study|Investigator decision|1|||
146809057|NCT01364597|529471633|FG003|Overall Study|Investigator decision|0|||
146809058|NCT01364597|529471630|FG000|Overall Study|Sponsor recommended discontinuation|0|||
146809059|NCT01364597|529471631|FG001|Overall Study|Sponsor recommended discontinuation|0|||
146809060|NCT01364597|529471632|FG002|Overall Study|Sponsor recommended discontinuation|0|||
146809061|NCT01364597|529471633|FG003|Overall Study|Sponsor recommended discontinuation|1|||
146809062|NCT01364597|529471630|FG000|Overall Study|Parents went abroad with the patient|0|||
146809063|NCT01364597|529471631|FG001|Overall Study|Parents went abroad with the patient|0|||
146809064|NCT01364597|529471632|FG002|Overall Study|Parents went abroad with the patient|1|||
146809065|NCT01364597|529471633|FG003|Overall Study|Parents went abroad with the patient|0|||
146809066|NCT01364597|529471630|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
146809067|NCT01364597|529471631|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
146809068|NCT01364597|529471632|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
146809069|NCT01364597|529471633|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
146809070|NCT01364597|529471630|FG000|Overall Study|BRV administration dropout|0|||
146809071|NCT01364597|529471631|FG001|Overall Study|BRV administration dropout|0|||
146809072|NCT01364597|529471632|FG002|Overall Study|BRV administration dropout|1|||
146809073|NCT01364597|529471633|FG003|Overall Study|BRV administration dropout|0|||
146809074|NCT01364597|529471630|FG000|Overall Study|Dropout|0|||
146809075|NCT01364597|529471631|FG001|Overall Study|Dropout|0|||
146809076|NCT01364597|529471632|FG002|Overall Study|Dropout|3|||
146809077|NCT01364597|529471633|FG003|Overall Study|Dropout|1|||
146809078|NCT01364597|529471630|FG000|Overall Study|Unreliable subject|0|||
146809079|NCT01364597|529471631|FG001|Overall Study|Unreliable subject|0|||
146809080|NCT01364597|529471632|FG002|Overall Study|Unreliable subject|0|||
146809081|NCT01364597|529471633|FG003|Overall Study|Unreliable subject|1|||
146809082|NCT01364597|529471630|FG000|Overall Study|Other|0|||
146809083|NCT01364597|529471631|FG001|Overall Study|Other|0|||
146809084|NCT01364597|529471632|FG002|Overall Study|Other|0|||
146809085|NCT01364597|529471633|FG003|Overall Study|Other|1|||
146809086|NCT03493282|529471637|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
146809087|NCT03493282|529471638|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
146809088|NCT03493282|529471639|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
146809089|NCT03493282|529471637|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
146809090|NCT03493282|529471638|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
146809091|NCT03493282|529471639|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
146809092|NCT01380145|529471640|FG000|Overall Study|Progressive disease|4|||
146809093|NCT02698475|529471641|FG000|Main Study Period|Lack of Efficacy|1|||
146809094|NCT02698475|529471641|FG000|Main Study Period|Protocol Violation|2|||
146809095|NCT02698475|529471641|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
146809096|NCT02698475|529471641|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
146809097|NCT02698475|529471641|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
146809098|NCT02698475|529471641|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
146809099|NCT02698475|529471641|FG000|Long-Term Extension Period|Other|1|||
146809100|NCT02038049|529471642|FG000|Overall Study|Lost to Follow-up|1|||
146809101|NCT02038049|529471643|FG001|Overall Study|Lost to Follow-up|0|||
146809102|NCT02771366|529471644|FG000|Period 1|Withdrawal by Subject|0|||
146809103|NCT02771366|529471645|FG001|Period 1|Withdrawal by Subject|2|||
146809104|NCT02771366|529471644|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
146809105|NCT02771366|529471645|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
146809106|NCT00587171|529471648|FG000|Overall Study|Lost to Follow-up|1|||
146809107|NCT00587171|529471649|FG001|Overall Study|Lost to Follow-up|1|||
146942402|NCT02120352|529948130|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
146942403|NCT02120352|529948131|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
146942404|NCT02120352|529948132|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
146942405|NCT02120352|529948133|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
146942406|NCT02120352|529948134|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
146942407|NCT02120352|529948135|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
146942408|NCT02120352|529948136|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
146942409|NCT02120352|529948130|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
146942410|NCT02120352|529948131|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
146942411|NCT02120352|529948132|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
146942412|NCT02120352|529948133|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
146942413|NCT02120352|529948134|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
146942414|NCT02120352|529948135|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
146942415|NCT02120352|529948136|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
146942416|NCT02120352|529948130|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
146942417|NCT02120352|529948131|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
146942418|NCT02120352|529948132|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
146942419|NCT02120352|529948133|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
146942420|NCT02120352|529948134|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
146809108|NCT02148705|529471653|FG000|Overall Study|Death|2|||
146809109|NCT02148705|529471654|FG001|Overall Study|Death|0|||
146809110|NCT02148705|529471655|FG002|Overall Study|Death|0|||
146809111|NCT02148705|529471653|FG000|Overall Study|Lost to Follow-up|13|||
146809112|NCT02148705|529471654|FG001|Overall Study|Lost to Follow-up|4|||
146809113|NCT02148705|529471655|FG002|Overall Study|Lost to Follow-up|10|||
146809114|NCT02148705|529471653|FG000|Overall Study|Withdrawal by Subject|3|||
146809115|NCT02148705|529471654|FG001|Overall Study|Withdrawal by Subject|0|||
146809116|NCT02148705|529471655|FG002|Overall Study|Withdrawal by Subject|2|||
146809117|NCT02148705|529471653|FG000|Overall Study|Not Treated|0|||
146984043|NCT01452529|530103319|FG000|Run-in Period|Withdrawal by Subject|49|||
146984044|NCT01452529|530103320|FG001|Run-in Period|Withdrawal by Subject|0|||
146984045|NCT01452529|530103321|FG002|Run-in Period|Withdrawal by Subject|0|||
146984046|NCT01452529|530103319|FG000|Run-in Period|Lost to Follow-up|19|||
146984047|NCT01452529|530103320|FG001|Run-in Period|Lost to Follow-up|0|||
146984048|NCT01452529|530103321|FG002|Run-in Period|Lost to Follow-up|0|||
146984049|NCT01452529|530103319|FG000|Run-in Period|Lack of Efficacy|46|||
146984050|NCT01452529|530103320|FG001|Run-in Period|Lack of Efficacy|0|||
146984051|NCT01452529|530103321|FG002|Run-in Period|Lack of Efficacy|0|||
146984052|NCT01452529|530103319|FG000|Run-in Period|Confirmed or suspected diversion|23|||
146984053|NCT01452529|530103320|FG001|Run-in Period|Confirmed or suspected diversion|0|||
146984054|NCT01452529|530103321|FG002|Run-in Period|Confirmed or suspected diversion|0|||
146984055|NCT01452529|530103319|FG000|Run-in Period|Administrative|21|||
146984056|NCT01452529|530103320|FG001|Run-in Period|Administrative|0|||
146984057|NCT01452529|530103321|FG002|Run-in Period|Administrative|0|||
146984058|NCT01452529|530103319|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
146984059|NCT01452529|530103320|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
146984060|NCT01452529|530103321|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
146984061|NCT01452529|530103319|FG000|Double-blind (DB) Period|Adverse Event|0|||
146984062|NCT01452529|530103320|FG001|Double-blind (DB) Period|Adverse Event|18|||
146984063|NCT01452529|530103321|FG002|Double-blind (DB) Period|Adverse Event|11|||
146984064|NCT01452529|530103319|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
146984065|NCT01452529|530103320|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
146984066|NCT01452529|530103321|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
146984067|NCT01452529|530103319|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
146984068|NCT01452529|530103320|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
146984069|NCT01452529|530103321|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
146984070|NCT01452529|530103319|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
146984071|NCT01452529|530103320|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
146984072|NCT01452529|530103321|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
146984073|NCT01452529|530103319|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
146984074|NCT01452529|530103320|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
146984075|NCT01452529|530103321|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
146984076|NCT01452529|530103319|FG000|Double-blind (DB) Period|Administrative|0|||
146984077|NCT01452529|530103320|FG001|Double-blind (DB) Period|Administrative|11|||
146984078|NCT01452529|530103321|FG002|Double-blind (DB) Period|Administrative|7|||
146984079|NCT04527471|530103325|FG000|Overall Study|Adverse Event|1|||
146984080|NCT04527471|530103326|FG001|Overall Study|Adverse Event|0|||
146984081|NCT04527471|530103325|FG000|Overall Study|Lost to Follow-up|1|||
146984082|NCT04527471|530103326|FG001|Overall Study|Lost to Follow-up|0|||
146984083|NCT02891200|530103327|FG000|Overall Study|Lost to Follow-up|31|||
146984084|NCT02891200|530103328|FG001|Overall Study|Lost to Follow-up|36|||
146984085|NCT02891200|530103327|FG000|Overall Study|Death|10|||
146984086|NCT02891200|530103328|FG001|Overall Study|Death|9|||
146984087|NCT02891200|530103327|FG000|Overall Study|Withdrawal by Subject|1|||
146984088|NCT02891200|530103328|FG001|Overall Study|Withdrawal by Subject|4|||
146984089|NCT00988169|530103331|FG000|Overall Study|Withdrawal by Subject|1|||
146984090|NCT02637076|530103332|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
146984091|NCT02637076|530103333|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
146984092|NCT02637076|530103332|FG000|Overall Study|Withdrawal by Subject|0|||
146984093|NCT02637076|530103333|FG001|Overall Study|Withdrawal by Subject|4|||
146984094|NCT02295774|530103335|FG000|Overall Study|Physician Decision|1|||
146984095|NCT02295774|530103335|FG000|Overall Study|Withdrawal by Subject|2|||
146984096|NCT03083483|530103336|FG000|Overall Study|Adverse Event|1|||
146984097|NCT03083483|530103337|FG001|Overall Study|Adverse Event|1|||
146984098|NCT03083483|530103338|FG002|Overall Study|Adverse Event|1|||
146984099|NCT03083483|530103336|FG000|Overall Study|Lost to Follow-up|2|||
146984100|NCT03083483|530103337|FG001|Overall Study|Lost to Follow-up|1|||
146984101|NCT03083483|530103338|FG002|Overall Study|Lost to Follow-up|1|||
146984102|NCT03083483|530103336|FG000|Overall Study|technological issues|1|||
146984103|NCT03083483|530103337|FG001|Overall Study|technological issues|0|||
146984104|NCT03083483|530103338|FG002|Overall Study|technological issues|1|||
146984105|NCT01751412|530103339|FG000|Overall Study|Disease Progression Before Treatment|1|||
146984106|NCT00582036|530103340|FG000|Overall Study|Withdrawal by Subject|0|||
146984107|NCT00582036|530103341|FG001|Overall Study|Withdrawal by Subject|1|||
146984108|NCT03294538|530103344|FG000|Overall Study|Adverse Event|0|||
146984109|NCT03294538|530103345|FG001|Overall Study|Adverse Event|1|||
146984110|NCT03294538|530103346|FG002|Overall Study|Adverse Event|1|||
146984111|NCT03294538|530103344|FG000|Overall Study|Lost to Follow-up|1|||
146984112|NCT03294538|530103345|FG001|Overall Study|Lost to Follow-up|0|||
146984113|NCT03294538|530103346|FG002|Overall Study|Lost to Follow-up|0|||
146984114|NCT03294538|530103344|FG000|Overall Study|Outside of Visit Window|4|||
146984115|NCT03294538|530103345|FG001|Overall Study|Outside of Visit Window|4|||
146984116|NCT03294538|530103346|FG002|Overall Study|Outside of Visit Window|1|||
146809118|NCT02148705|529471654|FG001|Overall Study|Not Treated|1|||
146809119|NCT02148705|529471655|FG002|Overall Study|Not Treated|5|||
146809120|NCT01737021|529471658|FG000|Overall Study|Lost to Follow-up|5|||
146809121|NCT01737021|529471659|FG001|Overall Study|Lost to Follow-up|3|||
146809122|NCT01673594|529471660|FG000|Overall Study|Adverse Event|3|||
146809123|NCT01673594|529471661|FG001|Overall Study|Adverse Event|1|||
146809124|NCT01673594|529471660|FG000|Overall Study|Lost to Follow-up|1|||
146809125|NCT01673594|529471661|FG001|Overall Study|Lost to Follow-up|0|||
146809126|NCT01673594|529471660|FG000|Overall Study|Physician Decision|2|||
146809127|NCT01673594|529471661|FG001|Overall Study|Physician Decision|4|||
146809128|NCT01673594|529471660|FG000|Overall Study|Withdrawal by Subject|0|||
146809129|NCT01673594|529471661|FG001|Overall Study|Withdrawal by Subject|1|||
146809130|NCT02605174|529471665|FG000|Overall Study|Adverse Event|0|||
146809131|NCT02605174|529471666|FG001|Overall Study|Adverse Event|0|||
146809132|NCT02605174|529471667|FG002|Overall Study|Adverse Event|1|||
146809133|NCT02605174|529471668|FG003|Overall Study|Adverse Event|0|||
146809134|NCT02605174|529471669|FG004|Overall Study|Adverse Event|4|||
146809135|NCT02605174|529471670|FG005|Overall Study|Adverse Event|0|||
146809136|NCT02605174|529471671|FG006|Overall Study|Adverse Event|0|||
146809137|NCT02605174|529471665|FG000|Overall Study|Lost to Follow-up|20|||
146809138|NCT02605174|529471666|FG001|Overall Study|Lost to Follow-up|7|||
146809139|NCT02605174|529471667|FG002|Overall Study|Lost to Follow-up|27|||
146809140|NCT02605174|529471668|FG003|Overall Study|Lost to Follow-up|10|||
146809141|NCT02605174|529471669|FG004|Overall Study|Lost to Follow-up|20|||
146809142|NCT02605174|529471670|FG005|Overall Study|Lost to Follow-up|10|||
146942421|NCT02120352|529948135|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
146942422|NCT02120352|529948136|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
146942423|NCT02120352|529948130|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
146942424|NCT02120352|529948131|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
146942425|NCT02120352|529948132|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
146942426|NCT02120352|529948133|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
146942427|NCT02120352|529948134|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
146942428|NCT02120352|529948135|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
146942429|NCT02120352|529948136|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
146942430|NCT02120352|529948130|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
146942431|NCT02120352|529948131|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
146942432|NCT02120352|529948132|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
146942433|NCT02120352|529948133|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
146942434|NCT02120352|529948134|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
146942435|NCT02120352|529948135|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
146942436|NCT02120352|529948136|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
146942437|NCT02120352|529948130|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
146942438|NCT02120352|529948131|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
146942439|NCT02120352|529948132|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
146942440|NCT02120352|529948133|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
146942441|NCT02120352|529948134|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
146942442|NCT02120352|529948135|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
146942443|NCT02120352|529948136|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
146942444|NCT02120352|529948130|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
146942445|NCT02120352|529948131|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
146942446|NCT02120352|529948132|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
146942447|NCT02120352|529948133|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
146942448|NCT02120352|529948134|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
146942449|NCT02120352|529948135|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
146942450|NCT02120352|529948136|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
146942451|NCT02120352|529948130|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
146942452|NCT02120352|529948131|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
146942453|NCT02120352|529948132|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
146942454|NCT02120352|529948133|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
146942455|NCT02120352|529948134|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
146942456|NCT02120352|529948135|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
146942457|NCT02120352|529948136|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
146942458|NCT02120352|529948130|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
146809143|NCT02605174|529471671|FG006|Overall Study|Lost to Follow-up|29|||
146809144|NCT02605174|529471665|FG000|Overall Study|Protocol Violation|10|||
146809145|NCT02605174|529471666|FG001|Overall Study|Protocol Violation|4|||
146809146|NCT02605174|529471667|FG002|Overall Study|Protocol Violation|14|||
146809147|NCT02605174|529471668|FG003|Overall Study|Protocol Violation|6|||
146809148|NCT02605174|529471669|FG004|Overall Study|Protocol Violation|7|||
146809149|NCT02605174|529471670|FG005|Overall Study|Protocol Violation|7|||
146809150|NCT02605174|529471671|FG006|Overall Study|Protocol Violation|12|||
146809151|NCT02605174|529471665|FG000|Overall Study|Pregnancy|1|||
146809152|NCT02605174|529471666|FG001|Overall Study|Pregnancy|0|||
146809153|NCT02605174|529471667|FG002|Overall Study|Pregnancy|0|||
146809154|NCT02605174|529471668|FG003|Overall Study|Pregnancy|2|||
146809155|NCT02605174|529471669|FG004|Overall Study|Pregnancy|0|||
146809156|NCT02605174|529471670|FG005|Overall Study|Pregnancy|0|||
146809157|NCT02605174|529471671|FG006|Overall Study|Pregnancy|0|||
146809158|NCT02605174|529471665|FG000|Overall Study|Withdrawal by Subject|9|||
146809159|NCT02605174|529471666|FG001|Overall Study|Withdrawal by Subject|6|||
146809160|NCT02605174|529471667|FG002|Overall Study|Withdrawal by Subject|14|||
146809161|NCT02605174|529471668|FG003|Overall Study|Withdrawal by Subject|11|||
146809162|NCT02605174|529471669|FG004|Overall Study|Withdrawal by Subject|6|||
146809163|NCT02605174|529471670|FG005|Overall Study|Withdrawal by Subject|4|||
146809164|NCT02605174|529471671|FG006|Overall Study|Withdrawal by Subject|15|||
146809165|NCT02605174|529471665|FG000|Overall Study|Physician Decision|2|||
146809166|NCT02605174|529471666|FG001|Overall Study|Physician Decision|0|||
146809167|NCT02605174|529471667|FG002|Overall Study|Physician Decision|0|||
146809168|NCT02605174|529471668|FG003|Overall Study|Physician Decision|0|||
146809169|NCT02605174|529471669|FG004|Overall Study|Physician Decision|0|||
146809170|NCT02605174|529471670|FG005|Overall Study|Physician Decision|0|||
146809171|NCT02605174|529471671|FG006|Overall Study|Physician Decision|3|||
146809172|NCT02605174|529471665|FG000|Overall Study|Randomization Failure|22|||
146809173|NCT02605174|529471666|FG001|Overall Study|Randomization Failure|6|||
146809174|NCT02605174|529471667|FG002|Overall Study|Randomization Failure|20|||
146809175|NCT02605174|529471668|FG003|Overall Study|Randomization Failure|7|||
146809176|NCT02605174|529471669|FG004|Overall Study|Randomization Failure|16|||
146809177|NCT02605174|529471670|FG005|Overall Study|Randomization Failure|11|||
146809178|NCT02605174|529471671|FG006|Overall Study|Randomization Failure|30|||
146809179|NCT04250636|529471672|FG000|Overall Study|Lost to Follow-up|2|||
146809180|NCT01779050|529471674|FG000|Overall Study|Withdrawal by Subject|1|||
146809181|NCT01779050|529471675|FG001|Overall Study|Withdrawal by Subject|0|||
146809182|NCT01353274|529471676|FG000|Overall Study|No case report form (CRF) collected|28|||
146809183|NCT03737110|529471679|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
146809184|NCT03737110|529471680|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
146809185|NCT03737110|529471681|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
146809186|NCT03737110|529471682|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
146809187|NCT03737110|529471683|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
146809188|NCT03737110|529471684|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
146809189|NCT03737110|529471679|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
146809190|NCT03737110|529471680|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
146809191|NCT03737110|529471681|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
146809192|NCT03737110|529471682|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
146809193|NCT03737110|529471683|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
146809194|NCT03737110|529471684|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
146809195|NCT03737110|529471679|FG000|Run-in (RI) Period|Adverse Event|4|||
146809196|NCT03737110|529471680|FG001|Run-in (RI) Period|Adverse Event|0|||
146809197|NCT03737110|529471681|FG002|Run-in (RI) Period|Adverse Event|0|||
146809198|NCT03737110|529471682|FG003|Run-in (RI) Period|Adverse Event|0|||
146809199|NCT03737110|529471683|FG004|Run-in (RI) Period|Adverse Event|0|||
146809200|NCT03737110|529471684|FG005|Run-in (RI) Period|Adverse Event|0|||
146809201|NCT03737110|529471679|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
146809202|NCT03737110|529471680|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
146809203|NCT03737110|529471681|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
146809204|NCT03737110|529471682|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
146809205|NCT03737110|529471683|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
146809206|NCT03737110|529471684|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
146809207|NCT03737110|529471679|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
146809208|NCT03737110|529471680|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
146809209|NCT03737110|529471681|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
146809210|NCT03737110|529471682|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
146809211|NCT03737110|529471683|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
146809212|NCT03737110|529471684|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
146809213|NCT03737110|529471679|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
146809214|NCT03737110|529471680|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
146809215|NCT03737110|529471681|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
146809216|NCT03737110|529471682|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
146809217|NCT03737110|529471683|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
146809218|NCT03737110|529471684|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
146809219|NCT03737110|529471679|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
146809220|NCT03737110|529471680|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
146809221|NCT03737110|529471681|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
146809222|NCT03737110|529471682|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
146809223|NCT03737110|529471683|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
146809224|NCT03737110|529471684|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
146809225|NCT03737110|529471679|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
146809226|NCT03737110|529471680|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
146809227|NCT03737110|529471681|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
146809228|NCT03737110|529471682|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
146809229|NCT03737110|529471683|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
146809230|NCT03737110|529471684|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
146809231|NCT03648541|529471685|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
146809232|NCT03648541|529471686|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
146809233|NCT03648541|529471685|FG000|Re-induction Period Only|Lack of Efficacy|7|||
146809234|NCT03648541|529471686|FG001|Re-induction Period Only|Lack of Efficacy|0|||
146809235|NCT03648541|529471685|FG000|Maintenance Period Only|Missing|0|||
146809236|NCT03648541|529471686|FG001|Maintenance Period Only|Missing|1|||
146809237|NCT03648541|529471685|FG000|Maintenance Period Only|Other not listed below|0|||
146809238|NCT03648541|529471686|FG001|Maintenance Period Only|Other not listed below|4|||
146809239|NCT03648541|529471685|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
146809240|NCT03648541|529471686|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
146809241|NCT03648541|529471685|FG000|Maintenance Period Only|Protocol Violation|0|||
146809242|NCT03648541|529471686|FG001|Maintenance Period Only|Protocol Violation|1|||
146809243|NCT03648541|529471685|FG000|Maintenance Period Only|Lack of Efficacy|0|||
146809244|NCT03648541|529471686|FG001|Maintenance Period Only|Lack of Efficacy|18|||
146809245|NCT03648541|529471685|FG000|Maintenance Period Only|Adverse Event|0|||
146809246|NCT03648541|529471686|FG001|Maintenance Period Only|Adverse Event|4|||
146809247|NCT03648541|529471685|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
146809248|NCT03648541|529471686|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
146809249|NCT03052517|529471687|FG000|Overall Study|Study Terminated By Sponsor|928|||
146809250|NCT03052517|529471688|FG001|Overall Study|Study Terminated By Sponsor|938|||
146809251|NCT03052517|529471689|FG002|Overall Study|Study Terminated By Sponsor|296|||
146809252|NCT03052517|529471687|FG000|Overall Study|Subject/Guardian Decision|50|||
146809253|NCT03052517|529471688|FG001|Overall Study|Subject/Guardian Decision|45|||
146809254|NCT03052517|529471689|FG002|Overall Study|Subject/Guardian Decision|22|||
146809255|NCT03052517|529471687|FG000|Overall Study|Lack of Efficacy|23|||
146809256|NCT03052517|529471688|FG001|Overall Study|Lack of Efficacy|14|||
146809257|NCT03052517|529471689|FG002|Overall Study|Lack of Efficacy|7|||
146809258|NCT03052517|529471687|FG000|Overall Study|Adverse Event|6|||
146809259|NCT03052517|529471688|FG001|Overall Study|Adverse Event|5|||
146809260|NCT03052517|529471689|FG002|Overall Study|Adverse Event|0|||
146809261|NCT03052517|529471687|FG000|Overall Study|Physician Decision|4|||
146809262|NCT03052517|529471688|FG001|Overall Study|Physician Decision|5|||
146809263|NCT03052517|529471689|FG002|Overall Study|Physician Decision|1|||
146809264|NCT03052517|529471687|FG000|Overall Study|Death|3|||
146809265|NCT03052517|529471688|FG001|Overall Study|Death|0|||
146809266|NCT03052517|529471689|FG002|Overall Study|Death|1|||
146809267|NCT03052517|529471687|FG000|Overall Study|Lost to Follow-up|2|||
146809268|NCT03052517|529471688|FG001|Overall Study|Lost to Follow-up|4|||
146809269|NCT03052517|529471689|FG002|Overall Study|Lost to Follow-up|0|||
146809270|NCT03052517|529471687|FG000|Overall Study|Pregnancy|1|||
146809271|NCT03052517|529471688|FG001|Overall Study|Pregnancy|0|||
146809272|NCT03052517|529471689|FG002|Overall Study|Pregnancy|1|||
146809273|NCT03052517|529471687|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
146809274|NCT03052517|529471688|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
146809275|NCT03052517|529471689|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
146809276|NCT03052517|529471687|FG000|Overall Study|Technical Problems|0|||
146809277|NCT03052517|529471688|FG001|Overall Study|Technical Problems|1|||
146809278|NCT03052517|529471689|FG002|Overall Study|Technical Problems|0|||
146809279|NCT05260437|529471692|FG000|Overall Study|Lost to Follow-up|5|||
146809280|NCT05260437|529471693|FG001|Overall Study|Lost to Follow-up|2|||
146809281|NCT05260437|529471694|FG002|Overall Study|Lost to Follow-up|1|||
146809282|NCT05260437|529471695|FG003|Overall Study|Lost to Follow-up|2|||
146809283|NCT05260437|529471696|FG004|Overall Study|Lost to Follow-up|2|||
146809284|NCT05260437|529471692|FG000|Overall Study|Withdrawal by Subject|3|||
146809285|NCT05260437|529471693|FG001|Overall Study|Withdrawal by Subject|0|||
146809286|NCT05260437|529471694|FG002|Overall Study|Withdrawal by Subject|4|||
146809287|NCT05260437|529471695|FG003|Overall Study|Withdrawal by Subject|5|||
146809288|NCT05260437|529471696|FG004|Overall Study|Withdrawal by Subject|0|||
146809289|NCT05260437|529471692|FG000|Overall Study|Vaccine Not Administered|0|||
146809290|NCT05260437|529471693|FG001|Overall Study|Vaccine Not Administered|1|||
146809291|NCT05260437|529471694|FG002|Overall Study|Vaccine Not Administered|0|||
146809292|NCT05260437|529471695|FG003|Overall Study|Vaccine Not Administered|0|||
146809293|NCT05260437|529471696|FG004|Overall Study|Vaccine Not Administered|0|||
146809294|NCT01858688|529471697|FG000|Overall Study|Withdrawal by Subject|8|||
146984117|NCT02623959|530103349|FG000|Overall Study|Progression|0|||
146984118|NCT02623959|530103350|FG001|Overall Study|Progression|1|||
146809295|NCT01858688|529471697|FG000|Overall Study|Participant began another therapy|3|||
146809296|NCT01858688|529471697|FG000|Overall Study|Physician Decision|2|||
146809297|NCT01858688|529471697|FG000|Overall Study|Progressive Disease|2|||
146809298|NCT01858688|529471697|FG000|Overall Study|Reason not reproted|5|||
146809299|NCT01530334|529471699|FG000|Overall Study|Adverse Event|3|||
146809300|NCT01530334|529471699|FG000|Overall Study|unknown reason|1|||
146809301|NCT01530334|529471699|FG000|Overall Study|Progressive disease|47|||
146942459|NCT02120352|529948131|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
146942460|NCT02120352|529948132|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
146942461|NCT02120352|529948133|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
146942462|NCT02120352|529948134|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
146942463|NCT02120352|529948135|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
146942464|NCT02120352|529948136|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
146942465|NCT02120352|529948130|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
146942466|NCT02120352|529948131|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
146942467|NCT02120352|529948132|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
146942468|NCT02120352|529948133|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
146942469|NCT02120352|529948134|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
146942470|NCT02120352|529948135|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
146942471|NCT02120352|529948136|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
146809302|NCT01303510|529471700|FG000|Overall Study|Lost to Follow-up|1|||
146809303|NCT01303510|529471701|FG001|Overall Study|Lost to Follow-up|0|||
146809304|NCT00701415|529471702|FG000|Overall Study|Adverse Event|0|||
146809305|NCT00701415|529471703|FG001|Overall Study|Adverse Event|1|||
146809306|NCT00701415|529471702|FG000|Overall Study|Social/family issues and needle phobia|1|||
146809307|NCT00701415|529471703|FG001|Overall Study|Social/family issues and needle phobia|0|||
146809308|NCT02208843|529471706|FG000|Overall Study|Clinical symptoms of progression|2|||
146809309|NCT02208843|529471706|FG000|Overall Study|Progression disease according to RECIST|24|||
146809310|NCT02208843|529471706|FG000|Overall Study|Adverse Event|12|||
146809311|NCT02208843|529471706|FG000|Overall Study|Protocol Violation|1|||
146809312|NCT02208843|529471706|FG000|Overall Study|Withdrawal by Subject|1|||
146809313|NCT02208843|529471706|FG000|Overall Study|Switched to commercial afatinib|20|||
146809314|NCT03162614|529471711|FG000|Overall Study|Lost to Follow-up|2|||
146809315|NCT03162614|529471712|FG001|Overall Study|Lost to Follow-up|1|||
146809316|NCT03162614|529471713|FG002|Overall Study|Lost to Follow-up|1|||
146809317|NCT03162614|529471714|FG003|Overall Study|Lost to Follow-up|1|||
146809318|NCT03162614|529471715|FG004|Overall Study|Lost to Follow-up|2|||
146809319|NCT03162614|529471716|FG005|Overall Study|Lost to Follow-up|0|||
146809320|NCT03162614|529471711|FG000|Overall Study|Protocol Violation|0|||
146809321|NCT03162614|529471712|FG001|Overall Study|Protocol Violation|1|||
146809322|NCT03162614|529471713|FG002|Overall Study|Protocol Violation|0|||
146809323|NCT03162614|529471714|FG003|Overall Study|Protocol Violation|1|||
146809324|NCT03162614|529471715|FG004|Overall Study|Protocol Violation|0|||
146809325|NCT03162614|529471716|FG005|Overall Study|Protocol Violation|0|||
146809326|NCT03162614|529471711|FG000|Overall Study|Withdrawal by Subject|2|||
146809327|NCT03162614|529471712|FG001|Overall Study|Withdrawal by Subject|1|||
146809328|NCT03162614|529471713|FG002|Overall Study|Withdrawal by Subject|1|||
146809329|NCT03162614|529471714|FG003|Overall Study|Withdrawal by Subject|1|||
146809330|NCT03162614|529471715|FG004|Overall Study|Withdrawal by Subject|0|||
146809331|NCT03162614|529471716|FG005|Overall Study|Withdrawal by Subject|0|||
146809332|NCT03162614|529471711|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
146809333|NCT03162614|529471712|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
146809334|NCT03162614|529471713|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
146809335|NCT03162614|529471714|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
146809336|NCT03162614|529471715|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
146809337|NCT03162614|529471716|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
146809338|NCT01321073|529471721|FG000|Overall Study|Did not attempt implant|4|||
146809339|NCT01321073|529471721|FG000|Overall Study|Death|3|||
146809340|NCT04224272|529471728|FG000|Part 1 - Dose Finding|Death|4|||
146809341|NCT04224272|529471728|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
146809342|NCT04224272|529471728|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
146809343|NCT04224272|529471728|FG000|Part 2 - Dose Expansion|Death|10|||
146942472|NCT02120352|529948130|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
146809344|NCT04224272|529471728|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
146809345|NCT02609048|529471729|FG000|Overall Study|Adverse Event|3|||
146942473|NCT02120352|529948131|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
146942474|NCT02120352|529948132|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
146984119|NCT00415532|530103354|FG000|Treatment Period|Adverse Event|2|||
146622454|NCT04612725|528789676|FG001|Overall Study|Lost to Follow-up|1|||
146809346|NCT02609048|529471730|FG001|Overall Study|Adverse Event|0|||
146809347|NCT02609048|529471731|FG002|Overall Study|Adverse Event|0|||
146809348|NCT02609048|529471729|FG000|Overall Study|Randomized but never treated|1|||
146809349|NCT02609048|529471730|FG001|Overall Study|Randomized but never treated|1|||
146809350|NCT02609048|529471731|FG002|Overall Study|Randomized but never treated|1|||
146809351|NCT02609048|529471729|FG000|Overall Study|Withdrawal of informed consent|1|||
146809352|NCT02609048|529471730|FG001|Overall Study|Withdrawal of informed consent|0|||
146809353|NCT02609048|529471731|FG002|Overall Study|Withdrawal of informed consent|0|||
146809354|NCT02609048|529471729|FG000|Overall Study|Reason not specified|6|||
146809355|NCT02609048|529471730|FG001|Overall Study|Reason not specified|9|||
146809356|NCT02609048|529471731|FG002|Overall Study|Reason not specified|9|||
146809357|NCT04186247|529471732|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
146809358|NCT04186247|529471733|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
146809359|NCT04186247|529471734|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
146809360|NCT04186247|529471735|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
146809361|NCT04186247|529471736|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
146809362|NCT03769090|529473193|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
146809363|NCT03769090|529473194|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
146809364|NCT03769090|529473195|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
146809365|NCT03769090|529473193|FG000|Overall Study|Withdrawal by Subject|52|||
146809366|NCT03769090|529473194|FG001|Overall Study|Withdrawal by Subject|62|||
146809367|NCT03769090|529473195|FG002|Overall Study|Withdrawal by Subject|74|||
146809368|NCT03769090|529473193|FG000|Overall Study|Death|4|||
146809369|NCT03769090|529473194|FG001|Overall Study|Death|2|||
146809370|NCT03769090|529473195|FG002|Overall Study|Death|2|||
146809371|NCT03769090|529473193|FG000|Overall Study|Adverse Event|7|||
146809372|NCT03769090|529473194|FG001|Overall Study|Adverse Event|7|||
146809373|NCT03769090|529473195|FG002|Overall Study|Adverse Event|8|||
146809374|NCT03769090|529473193|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
146809375|NCT03769090|529473194|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
146809376|NCT03769090|529473195|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
146809377|NCT03769090|529473193|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
146809378|NCT03769090|529473194|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
146809379|NCT03769090|529473195|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
146809380|NCT03769090|529473193|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
146809381|NCT03769090|529473194|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
146809382|NCT03769090|529473195|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
146809383|NCT03769090|529473193|FG000|Overall Study|Protocol Violation|5|||
146809384|NCT03769090|529473194|FG001|Overall Study|Protocol Violation|6|||
146809385|NCT03769090|529473195|FG002|Overall Study|Protocol Violation|8|||
146809386|NCT03769090|529473193|FG000|Overall Study|Pregnancy|1|||
146809387|NCT03769090|529473194|FG001|Overall Study|Pregnancy|0|||
146809388|NCT03769090|529473195|FG002|Overall Study|Pregnancy|3|||
146809389|NCT03769090|529473193|FG000|Overall Study|Lost to Follow-up|19|||
146809390|NCT03769090|529473194|FG001|Overall Study|Lost to Follow-up|25|||
146809391|NCT03769090|529473195|FG002|Overall Study|Lost to Follow-up|21|||
146809392|NCT03769090|529473193|FG000|Overall Study|Condition under investigation worsened|2|||
146809393|NCT03769090|529473194|FG001|Overall Study|Condition under investigation worsened|0|||
146809394|NCT03769090|529473195|FG002|Overall Study|Condition under investigation worsened|1|||
146809395|NCT03769090|529473193|FG000|Overall Study|Lack of Efficacy|1|||
146809396|NCT03769090|529473194|FG001|Overall Study|Lack of Efficacy|2|||
146809397|NCT03769090|529473195|FG002|Overall Study|Lack of Efficacy|2|||
146809398|NCT03769090|529473193|FG000|Overall Study|Other reasons|8|||
146809399|NCT03769090|529473194|FG001|Overall Study|Other reasons|12|||
146809400|NCT03769090|529473195|FG002|Overall Study|Other reasons|15|||
146809401|NCT03964974|529473196|FG000|Overall Study|Lost to Follow-up|3|||
146809402|NCT03964974|529473197|FG001|Overall Study|Lost to Follow-up|2|||
146809403|NCT03964974|529473196|FG000|Overall Study|Withdrawal by Subject|0|||
146809404|NCT03964974|529473197|FG001|Overall Study|Withdrawal by Subject|3|||
146809405|NCT02713594|529473198|FG000|Overall Study|Withdrawal by Subject|32|||
146809406|NCT02713594|529473199|FG001|Overall Study|Withdrawal by Subject|22|||
146942475|NCT02120352|529948133|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
146942476|NCT02120352|529948134|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
146942477|NCT02120352|529948135|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
146942478|NCT02120352|529948136|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
146809407|NCT02713594|529473198|FG000|Overall Study|Lost to Follow-up|358|||
146809408|NCT02713594|529473199|FG001|Overall Study|Lost to Follow-up|374|||
146809409|NCT02660086|529473200|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
146809410|NCT02660086|529473201|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
146809411|NCT02660086|529473200|FG000|Overall Study- 12-month|Left full-time employment|12|||
146809412|NCT02660086|529473201|FG001|Overall Study- 12-month|Left full-time employment|20|||
146809413|NCT02660086|529473200|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
146809414|NCT02660086|529473201|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
146809415|NCT02660086|529473200|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
146942479|NCT02120352|529948130|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
146809416|NCT02660086|529473201|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
146809417|NCT02660086|529473200|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
146809418|NCT02660086|529473201|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
146809419|NCT02660086|529473200|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
146809420|NCT02660086|529473201|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
146809421|NCT05005247|529473207|FG000|Overall Study|Withdrawal by Subject|0|||
146809422|NCT05005247|529473208|FG001|Overall Study|Withdrawal by Subject|1|||
146809423|NCT05005247|529473209|FG002|Overall Study|Withdrawal by Subject|0|||
146809424|NCT01450007|529473210|FG000|Overall Study|Late exclusion before treatment|2|||
146809425|NCT01450007|529473211|FG001|Overall Study|Late exclusion before treatment|3|||
146809426|NCT01450007|529473212|FG002|Overall Study|Late exclusion before treatment|2|||
146809427|NCT01450007|529473210|FG000|Overall Study|Protocol Violation|0|||
146809428|NCT01450007|529473211|FG001|Overall Study|Protocol Violation|1|||
146809429|NCT01450007|529473212|FG002|Overall Study|Protocol Violation|1|||
146809430|NCT01450007|529473210|FG000|Overall Study|Adverse Event|0|||
146809431|NCT01450007|529473211|FG001|Overall Study|Adverse Event|1|||
146809432|NCT01450007|529473212|FG002|Overall Study|Adverse Event|0|||
146809433|NCT02958553|529473213|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
146809434|NCT02958553|529473213|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
146809435|NCT00273052|529473227|FG000|Overall Study|Withdrawal by Subject|16|||
146809436|NCT00273052|529473228|FG001|Overall Study|Withdrawal by Subject|19|||
146809437|NCT00273052|529473227|FG000|Overall Study|Adverse Event|21|||
146809438|NCT00273052|529473228|FG001|Overall Study|Adverse Event|19|||
146809439|NCT00273052|529473227|FG000|Overall Study|Protocol Violation|14|||
146809440|NCT00273052|529473228|FG001|Overall Study|Protocol Violation|18|||
146809441|NCT00273052|529473227|FG000|Overall Study|Lost to Follow-up|7|||
146809442|NCT00273052|529473228|FG001|Overall Study|Lost to Follow-up|25|||
146809443|NCT00273052|529473227|FG000|Overall Study|Lack of Efficacy|6|||
146809444|NCT00273052|529473228|FG001|Overall Study|Lack of Efficacy|4|||
146809445|NCT00273052|529473227|FG000|Overall Study|Non-Compliance|3|||
146809446|NCT00273052|529473228|FG001|Overall Study|Non-Compliance|1|||
146809447|NCT00273052|529473227|FG000|Overall Study|Other|2|||
146809448|NCT00273052|529473228|FG001|Overall Study|Other|0|||
146809449|NCT00273052|529473227|FG000|Overall Study|Worsening serum lipid levels|0|||
146809450|NCT00273052|529473228|FG001|Overall Study|Worsening serum lipid levels|2|||
146809451|NCT02224755|529473229|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
146809452|NCT02224755|529473230|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
146809453|NCT02224755|529473229|FG000|Two Year Follow up Post-implant|Death|103|||
146809454|NCT02224755|529473230|FG001|Two Year Follow up Post-implant|Death|98|||
146809455|NCT02224755|529473229|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
146809456|NCT02224755|529473230|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
146809457|NCT02224755|529473229|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
146809458|NCT02224755|529473230|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
146809459|NCT02224755|529473229|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
146809460|NCT02224755|529473230|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
146809461|NCT01951703|529473231|FG000|First Intervention|Withdrawal by Subject|1|||
146809462|NCT01951703|529473232|FG001|First Intervention|Withdrawal by Subject|0|||
146809463|NCT01951703|529473231|FG000|First Intervention|Subject was not compliant|1|||
146809464|NCT01951703|529473232|FG001|First Intervention|Subject was not compliant|1|||
146809465|NCT01951703|529473231|FG000|First Intervention|Physician Decision|1|||
146809466|NCT01951703|529473232|FG001|First Intervention|Physician Decision|0|||
146809467|NCT01951703|529473231|FG000|Second Intervention|Protocol Violation|0|||
146809468|NCT01951703|529473232|FG001|Second Intervention|Protocol Violation|1|||
146809469|NCT01951703|529473231|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
146809470|NCT01951703|529473232|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
146809471|NCT01852045|529473233|FG000|Overall Study|Adverse Event|1|||
146809472|NCT01852045|529473234|FG001|Overall Study|Adverse Event|0|||
146809473|NCT01852045|529473235|FG002|Overall Study|Adverse Event|0|||
146809474|NCT01852045|529473233|FG000|Overall Study|Lack of Efficacy|3|||
146809475|NCT01852045|529473234|FG001|Overall Study|Lack of Efficacy|0|||
146809476|NCT01852045|529473235|FG002|Overall Study|Lack of Efficacy|0|||
146809477|NCT01852045|529473233|FG000|Overall Study|Lost to Follow-up|0|||
146809478|NCT01852045|529473234|FG001|Overall Study|Lost to Follow-up|1|||
146809479|NCT01852045|529473235|FG002|Overall Study|Lost to Follow-up|1|||
146809480|NCT01852045|529473233|FG000|Overall Study|Withdrawal by Subject|1|||
146809481|NCT01852045|529473234|FG001|Overall Study|Withdrawal by Subject|0|||
146809482|NCT01852045|529473235|FG002|Overall Study|Withdrawal by Subject|1|||
146809483|NCT01852045|529473233|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146809484|NCT01852045|529473234|FG001|Overall Study|Other Miscellaneous Reasons|3|||
146809485|NCT01852045|529473235|FG002|Overall Study|Other Miscellaneous Reasons|2|||
146809486|NCT02827201|529473236|FG000|Overall Study|Death|1|||
146809487|NCT02827201|529473237|FG001|Overall Study|Death|2|||
146809488|NCT02827201|529473236|FG000|Overall Study|Patients not treated|1|||
146809489|NCT02827201|529473237|FG001|Overall Study|Patients not treated|1|||
146809490|NCT02736188|529473240|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
146809491|NCT02736188|529473240|FG000|Overall Study|Adverse Event|1|||
146809492|NCT02736188|529473240|FG000|Overall Study|Withdrawal by Subject|1|||
146809493|NCT02736188|529473240|FG000|Overall Study|Other|6|||
146809494|NCT00240994|529473241|FG000|Overall Study|Lost to Follow-up|1|||
146809495|NCT00240994|529473241|FG000|Overall Study|Protocol Violation|1|||
146809496|NCT00240994|529473241|FG000|Overall Study|Graft failure|1|||
146809497|NCT02630186|529473242|FG000|Overall Study|Withdrawal by Subject|1|||
146809498|NCT00439218|529473243|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
146809499|NCT03176407|529473244|FG000|Overall Study|Protocol Violation|1|||
146809500|NCT03176407|529473244|FG000|Overall Study|human failure|1|||
146809501|NCT03176407|529473244|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
146809502|NCT01428583|529473245|FG000|Overall Study|Adverse Event|75|||
146809503|NCT01428583|529473245|FG000|Overall Study|Withdrawal by Subject|51|||
146809504|NCT01428583|529473245|FG000|Overall Study|Lack of Efficacy|37|||
146809505|NCT01428583|529473245|FG000|Overall Study|Lost to Follow-up|17|||
146809506|NCT01428583|529473245|FG000|Overall Study|Death|1|||
146809507|NCT01428583|529473245|FG000|Overall Study|Pregnancy|1|||
146809508|NCT01428583|529473245|FG000|Overall Study|Protocol Violation|1|||
146809509|NCT01428583|529473245|FG000|Overall Study|Physician Decision|12|||
146809510|NCT01428583|529473245|FG000|Overall Study|Non-compliant|25|||
146809511|NCT01428583|529473245|FG000|Overall Study|Confirmed positive urine drug test|8|||
146809512|NCT01428583|529473245|FG000|Overall Study|Sponsor's request|3|||
146809513|NCT01428583|529473245|FG000|Overall Study|Other|6|||
146809514|NCT05124210|529473246|FG000|Overall Study|Lost to Follow-up|1|||
146809515|NCT05124210|529473247|FG001|Overall Study|Lost to Follow-up|0|||
146809516|NCT05124210|529473246|FG000|Overall Study|Withdrawal by Subject|1|||
146809517|NCT05124210|529473247|FG001|Overall Study|Withdrawal by Subject|0|||
146809518|NCT00768755|529473250|FG000|Phase 1|Death|6|||
146809519|NCT00768755|529473251|FG001|Phase 1|Death|0|||
146809520|NCT00768755|529473252|FG002|Phase 1|Death|0|||
146809521|NCT00768755|529473253|FG003|Phase 1|Death|0|||
146809522|NCT00768755|529473250|FG000|Phase 1|Other|4|||
146809523|NCT00768755|529473251|FG001|Phase 1|Other|0|||
146809524|NCT00768755|529473252|FG002|Phase 1|Other|0|||
146809525|NCT00768755|529473253|FG003|Phase 1|Other|0|||
146809526|NCT00768755|529473250|FG000|Phase 2|Death|0|||
146809527|NCT00768755|529473251|FG001|Phase 2|Death|37|||
146809528|NCT00768755|529473252|FG002|Phase 2|Death|48|||
146809529|NCT00768755|529473253|FG003|Phase 2|Death|31|||
146809530|NCT00768755|529473250|FG000|Phase 2|Protocol Violation|0|||
146809531|NCT00768755|529473251|FG001|Phase 2|Protocol Violation|2|||
146809532|NCT00768755|529473252|FG002|Phase 2|Protocol Violation|0|||
146809533|NCT00768755|529473253|FG003|Phase 2|Protocol Violation|1|||
146809534|NCT00768755|529473250|FG000|Phase 2|Lost to Follow-up|0|||
146809535|NCT00768755|529473251|FG001|Phase 2|Lost to Follow-up|1|||
146809536|NCT00768755|529473252|FG002|Phase 2|Lost to Follow-up|1|||
146809537|NCT00768755|529473253|FG003|Phase 2|Lost to Follow-up|4|||
146809538|NCT00768755|529473250|FG000|Phase 2|Withdrawal by Subject|0|||
146809539|NCT00768755|529473251|FG001|Phase 2|Withdrawal by Subject|1|||
146809540|NCT00768755|529473252|FG002|Phase 2|Withdrawal by Subject|0|||
146809541|NCT00768755|529473253|FG003|Phase 2|Withdrawal by Subject|1|||
146809542|NCT00768755|529473250|FG000|Phase 2|Other|0|||
146809543|NCT00768755|529473251|FG001|Phase 2|Other|1|||
146809544|NCT00768755|529473252|FG002|Phase 2|Other|2|||
146809545|NCT00768755|529473253|FG003|Phase 2|Other|4|||
146809546|NCT00768755|529473250|FG000|Phase 2|Study Terminated by Sponsor|0|||
146809547|NCT00768755|529473251|FG001|Phase 2|Study Terminated by Sponsor|13|||
146809548|NCT00768755|529473252|FG002|Phase 2|Study Terminated by Sponsor|7|||
146809549|NCT00768755|529473253|FG003|Phase 2|Study Terminated by Sponsor|14|||
146809550|NCT00768755|529473250|FG000|Phase 2|Randomized but not treated|0|||
146809551|NCT00768755|529473251|FG001|Phase 2|Randomized but not treated|0|||
146809552|NCT00768755|529473252|FG002|Phase 2|Randomized but not treated|0|||
146809553|NCT00768755|529473253|FG003|Phase 2|Randomized but not treated|2|||
146809554|NCT03142932|529473256|FG000|Overall Study|Lost to Follow-up|2|||
146809555|NCT03142932|529473257|FG001|Overall Study|Lost to Follow-up|11|||
146809556|NCT02128269|529473258|FG000|Treatment Period|Adverse Event|1|||
146809557|NCT02128269|529473258|FG000|Treatment Period|Physician Decision|1|||
146809558|NCT00878189|529473259|FG000|Overall Study|Death|0|||
146809559|NCT00878189|529473260|FG001|Overall Study|Death|1|||
146809560|NCT00878189|529473261|FG002|Overall Study|Death|0|||
146809561|NCT00878189|529473262|FG003|Overall Study|Death|1|||
146809562|NCT00878189|529473263|FG004|Overall Study|Death|0|||
146809563|NCT00878189|529473264|FG005|Overall Study|Death|0|||
146809564|NCT00878189|529473265|FG006|Overall Study|Death|0|||
146809565|NCT00878189|529473266|FG007|Overall Study|Death|0|||
146809566|NCT00878189|529473267|FG008|Overall Study|Death|1|||
146809567|NCT00878189|529473259|FG000|Overall Study|Participant Refused to Follow-up|0|||
146809568|NCT00878189|529473260|FG001|Overall Study|Participant Refused to Follow-up|0|||
146809569|NCT00878189|529473261|FG002|Overall Study|Participant Refused to Follow-up|0|||
146809570|NCT00878189|529473262|FG003|Overall Study|Participant Refused to Follow-up|0|||
146809571|NCT00878189|529473263|FG004|Overall Study|Participant Refused to Follow-up|0|||
146809572|NCT00878189|529473264|FG005|Overall Study|Participant Refused to Follow-up|4|||
146809573|NCT00878189|529473265|FG006|Overall Study|Participant Refused to Follow-up|0|||
146809574|NCT00878189|529473266|FG007|Overall Study|Participant Refused to Follow-up|0|||
146809575|NCT00878189|529473267|FG008|Overall Study|Participant Refused to Follow-up|0|||
146809576|NCT00878189|529473259|FG000|Overall Study|Other|3|||
146809577|NCT00878189|529473260|FG001|Overall Study|Other|2|||
146809578|NCT00878189|529473261|FG002|Overall Study|Other|4|||
146809579|NCT00878189|529473262|FG003|Overall Study|Other|7|||
146809580|NCT00878189|529473263|FG004|Overall Study|Other|4|||
146809581|NCT00878189|529473264|FG005|Overall Study|Other|18|||
146809582|NCT00878189|529473265|FG006|Overall Study|Other|15|||
146809583|NCT00878189|529473266|FG007|Overall Study|Other|3|||
146809584|NCT00878189|529473267|FG008|Overall Study|Other|4|||
146809585|NCT00878189|529473259|FG000|Overall Study|Lost to Follow-up|0|||
146809586|NCT00878189|529473260|FG001|Overall Study|Lost to Follow-up|0|||
146809587|NCT00878189|529473261|FG002|Overall Study|Lost to Follow-up|0|||
146809588|NCT00878189|529473262|FG003|Overall Study|Lost to Follow-up|0|||
146809589|NCT00878189|529473263|FG004|Overall Study|Lost to Follow-up|0|||
146809590|NCT00878189|529473264|FG005|Overall Study|Lost to Follow-up|1|||
146809591|NCT00878189|529473265|FG006|Overall Study|Lost to Follow-up|1|||
146809592|NCT00878189|529473266|FG007|Overall Study|Lost to Follow-up|0|||
146809593|NCT00878189|529473267|FG008|Overall Study|Lost to Follow-up|0|||
146809594|NCT00878189|529473259|FG000|Overall Study|Objection Progression or Relapse|0|||
146809595|NCT00878189|529473260|FG001|Overall Study|Objection Progression or Relapse|0|||
146809596|NCT00878189|529473261|FG002|Overall Study|Objection Progression or Relapse|0|||
146809597|NCT00878189|529473262|FG003|Overall Study|Objection Progression or Relapse|0|||
146809598|NCT00878189|529473263|FG004|Overall Study|Objection Progression or Relapse|0|||
146809599|NCT00878189|529473264|FG005|Overall Study|Objection Progression or Relapse|0|||
146809600|NCT00878189|529473265|FG006|Overall Study|Objection Progression or Relapse|0|||
146809601|NCT00878189|529473266|FG007|Overall Study|Objection Progression or Relapse|0|||
146809602|NCT00878189|529473267|FG008|Overall Study|Objection Progression or Relapse|3|||
146809603|NCT00638456|529473268|FG000|Overall Study|Withdrawal by Subject|6|||
146809604|NCT00638456|529473269|FG001|Overall Study|Withdrawal by Subject|2|||
146809605|NCT01640288|529473272|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
146809606|NCT01640288|529473273|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
146809607|NCT01640288|529473272|FG000|Overall Study|Screen Failure|20|||
146809608|NCT01640288|529473273|FG001|Overall Study|Screen Failure|18|||
146809609|NCT01640288|529473272|FG000|Overall Study|Withdrawn by PI|5|||
146809610|NCT01640288|529473273|FG001|Overall Study|Withdrawn by PI|0|||
146809611|NCT01640288|529473272|FG000|Overall Study|Withdrawal by Subject|1|||
146809612|NCT01640288|529473273|FG001|Overall Study|Withdrawal by Subject|0|||
146809613|NCT00787176|529473275|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
146809614|NCT00787176|529473276|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
146809615|NCT00787176|529473277|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
146809616|NCT00787176|529473278|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
146809617|NCT00895245|529473284|FG000|Overall Study|Lack of Efficacy|6|||
146809618|NCT02095678|529473285|FG000|Overall Study|Withdrawal by Subject|0|||
146809619|NCT02095678|529473286|FG001|Overall Study|Withdrawal by Subject|1|||
146809620|NCT02095678|529473285|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
146809621|NCT02095678|529473286|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
146809622|NCT02095678|529473285|FG000|Overall Study|lesion impacted by previous treatment|1|||
146809623|NCT02095678|529473286|FG001|Overall Study|lesion impacted by previous treatment|1|||
146809624|NCT02095678|529473285|FG000|Overall Study|No Confirmed Diagnosis|0|||
146809625|NCT02095678|529473286|FG001|Overall Study|No Confirmed Diagnosis|3|||
146809626|NCT02095678|529473285|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
146809627|NCT02095678|529473286|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
146809628|NCT02095678|529473285|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
146809629|NCT02095678|529473286|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
146942480|NCT02120352|529948131|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
146942481|NCT02120352|529948132|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
146942482|NCT02120352|529948133|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
146809630|NCT00681109|529473287|FG000|Overall Study|Lost to Follow-up|2|||
146809631|NCT00681109|529473288|FG001|Overall Study|Lost to Follow-up|6|||
146809632|NCT00681109|529473289|FG002|Overall Study|Lost to Follow-up|0|||
146809633|NCT04660799|529473290|FG000|Overall Study|Progressive Disease|1|||
146809634|NCT04660799|529473291|FG001|Overall Study|Progressive Disease|1|||
146809635|NCT04660799|529473290|FG000|Overall Study|Death|2|||
146809636|NCT04660799|529473291|FG001|Overall Study|Death|1|||
146809637|NCT04660799|529473290|FG000|Overall Study|Adverse Event|2|||
146809638|NCT04660799|529473291|FG001|Overall Study|Adverse Event|1|||
146809639|NCT04660799|529473290|FG000|Overall Study|Withdrawal by Subject|2|||
146809640|NCT04660799|529473291|FG001|Overall Study|Withdrawal by Subject|5|||
146809641|NCT02706483|529473292|FG000|Overall Study|Adverse Event|97|||
146942483|NCT02120352|529948134|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
146809642|NCT02706483|529473292|FG000|Overall Study|Death|1|||
146809643|NCT02706483|529473292|FG000|Overall Study|Lack of Efficacy|39|||
146809644|NCT02706483|529473292|FG000|Overall Study|Lost to Follow-up|101|||
146809645|NCT02706483|529473292|FG000|Overall Study|Non-compliance with study drug|15|||
146809646|NCT02706483|529473292|FG000|Overall Study|Physician Decision|6|||
146809647|NCT02706483|529473292|FG000|Overall Study|Pregnancy|6|||
146809648|NCT02706483|529473292|FG000|Overall Study|Protocol Violation|18|||
146809649|NCT02706483|529473292|FG000|Overall Study|Withdrawal by Subject|136|||
146809650|NCT02706483|529473292|FG000|Overall Study|Non-compliance with visits|6|||
146809651|NCT02706483|529473292|FG000|Overall Study|Site closure|4|||
146809652|NCT02706483|529473292|FG000|Overall Study|Subject moved|1|||
146809653|NCT03131713|529473293|FG000|Overall Study|Lost to Follow-up|5|||
146809654|NCT03131713|529473294|FG001|Overall Study|Lost to Follow-up|0|||
146809655|NCT01972776|529473305|FG000|Part 1|Withdrawal by Subject|0|||
146809656|NCT01972776|529473306|FG001|Part 1|Withdrawal by Subject|0|||
146809657|NCT01972776|529473307|FG002|Part 1|Withdrawal by Subject|1|||
146809658|NCT01972776|529473308|FG003|Part 1|Withdrawal by Subject|0|||
146809659|NCT01972776|529473309|FG004|Part 1|Withdrawal by Subject|0|||
146809660|NCT01972776|529473310|FG005|Part 1|Withdrawal by Subject|0|||
146809661|NCT01972776|529473305|FG000|Part 1|Adverse Event|0|||
146809662|NCT01972776|529473306|FG001|Part 1|Adverse Event|0|||
146809663|NCT01972776|529473307|FG002|Part 1|Adverse Event|1|||
146809664|NCT01972776|529473308|FG003|Part 1|Adverse Event|1|||
146809665|NCT01972776|529473309|FG004|Part 1|Adverse Event|0|||
146809666|NCT01972776|529473310|FG005|Part 1|Adverse Event|0|||
146809667|NCT01972776|529473305|FG000|Part 2|Adverse Event|0|||
146809668|NCT01972776|529473306|FG001|Part 2|Adverse Event|0|||
146809669|NCT01972776|529473307|FG002|Part 2|Adverse Event|0|||
146809670|NCT01972776|529473308|FG003|Part 2|Adverse Event|0|||
146809671|NCT01972776|529473309|FG004|Part 2|Adverse Event|3|||
146809672|NCT01972776|529473310|FG005|Part 2|Adverse Event|0|||
146809673|NCT01972776|529473305|FG000|Part 2|Administrative problems|0|||
146809674|NCT01972776|529473306|FG001|Part 2|Administrative problems|0|||
146809675|NCT01972776|529473307|FG002|Part 2|Administrative problems|0|||
146809676|NCT01972776|529473308|FG003|Part 2|Administrative problems|0|||
146809677|NCT01972776|529473309|FG004|Part 2|Administrative problems|10|||
146809678|NCT01972776|529473310|FG005|Part 2|Administrative problems|7|||
146809679|NCT02382640|529473320|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
146809680|NCT02382640|529473321|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
146809681|NCT02382640|529473322|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
146809682|NCT02382640|529473323|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
146809683|NCT01560429|529473324|FG000|Overall Study|Protocol Violation|3|||
146809684|NCT01560429|529473325|FG001|Overall Study|Protocol Violation|6|||
146809685|NCT01638000|529473329|FG000|Overall Study|Randomized but Never Received Drug|7|||
146809686|NCT01638000|529473330|FG001|Overall Study|Randomized but Never Received Drug|10|||
146809687|NCT01638000|529473329|FG000|Overall Study|Adverse Event|14|||
146809688|NCT01638000|529473330|FG001|Overall Study|Adverse Event|16|||
146809689|NCT01638000|529473329|FG000|Overall Study|Lack of Efficacy|5|||
146809690|NCT01638000|529473330|FG001|Overall Study|Lack of Efficacy|6|||
146809691|NCT01638000|529473329|FG000|Overall Study|Protocol Violation|11|||
146809692|NCT01638000|529473330|FG001|Overall Study|Protocol Violation|13|||
146809693|NCT01638000|529473329|FG000|Overall Study|Withdrawal by Subject|21|||
146809694|NCT01638000|529473330|FG001|Overall Study|Withdrawal by Subject|24|||
146809695|NCT01638000|529473329|FG000|Overall Study|Miscellaneous|2|||
146809696|NCT01638000|529473330|FG001|Overall Study|Miscellaneous|2|||
146809697|NCT05484661|529473331|FG000|Overall Study|Withdrawal by Subject|1|||
146809698|NCT05484661|529473332|FG001|Overall Study|Withdrawal by Subject|0|||
146809699|NCT00570505|529473335|FG000|Overall Study|Adverse Event|7|||
146809700|NCT00570505|529473335|FG000|Overall Study|Withdrawal by Subject|7|||
146809701|NCT00570505|529473335|FG000|Overall Study|Lost to Follow-up|23|||
146809702|NCT00570505|529473335|FG000|Overall Study|Other loss to follow-up|4|||
146809703|NCT05338476|529473336|FG000|Period 2|Adverse Event|0|||
146809704|NCT05338476|529473337|FG001|Period 2|Adverse Event|1|||
146809705|NCT02485925|529473338|FG000|Overall Study|Withdrawal by Subject|3|||
146809706|NCT02485925|529473338|FG000|Overall Study|Death|1|||
146809707|NCT02485925|529473338|FG000|Overall Study|Lost to Follow-up|11|||
146809708|NCT04924608|529475463|FG000|Overall Study|Adverse Event|10|||
146809709|NCT04924608|529475464|FG001|Overall Study|Adverse Event|6|||
146809710|NCT04924608|529475463|FG000|Overall Study|Lost to Follow-up|1|||
146809711|NCT04924608|529475464|FG001|Overall Study|Lost to Follow-up|1|||
146809712|NCT04924608|529475463|FG000|Overall Study|Ongoing at the data cut-off date|54|||
146809713|NCT04924608|529475464|FG001|Overall Study|Ongoing at the data cut-off date|60|||
146809714|NCT04924608|529475463|FG000|Overall Study|Progressive Disease|2|||
146809715|NCT04924608|529475464|FG001|Overall Study|Progressive Disease|0|||
146809716|NCT04924608|529475463|FG000|Overall Study|Withdrawal by Subject|3|||
146809717|NCT04924608|529475464|FG001|Overall Study|Withdrawal by Subject|6|||
146809718|NCT04924608|529475463|FG000|Overall Study|Other reason|1|||
146809719|NCT04924608|529475464|FG001|Overall Study|Other reason|1|||
146809720|NCT00949117|529475465|FG000|Overall Study|Lack of Efficacy|2|||
146809721|NCT00949117|529475466|FG001|Overall Study|Lack of Efficacy|3|||
146809722|NCT00949117|529475465|FG000|Overall Study|Protocol Violation|1|||
146809723|NCT00949117|529475466|FG001|Overall Study|Protocol Violation|1|||
146809724|NCT00949117|529475465|FG000|Overall Study|Adverse Event|0|||
146809725|NCT00949117|529475466|FG001|Overall Study|Adverse Event|1|||
146809726|NCT02014402|529475467|FG000|Overall Study|Adverse Event|1|||
146809727|NCT02014402|529475468|FG001|Overall Study|Adverse Event|0|||
146809728|NCT02014402|529475469|FG002|Overall Study|Adverse Event|0|||
146809729|NCT02014402|529475470|FG003|Overall Study|Adverse Event|0|||
146809730|NCT02014402|529475467|FG000|Overall Study|Withdrawal by Subject|1|||
146809731|NCT02014402|529475468|FG001|Overall Study|Withdrawal by Subject|2|||
146809732|NCT02014402|529475469|FG002|Overall Study|Withdrawal by Subject|2|||
146809733|NCT02014402|529475470|FG003|Overall Study|Withdrawal by Subject|1|||
146809734|NCT02014402|529475467|FG000|Overall Study|Subject did not have transportation|0|||
146809735|NCT02014402|529475468|FG001|Overall Study|Subject did not have transportation|1|||
146809736|NCT02014402|529475469|FG002|Overall Study|Subject did not have transportation|0|||
146809737|NCT02014402|529475470|FG003|Overall Study|Subject did not have transportation|0|||
146809738|NCT02014402|529475467|FG000|Overall Study|Lost to Follow-up|0|||
146809739|NCT02014402|529475468|FG001|Overall Study|Lost to Follow-up|0|||
146809740|NCT02014402|529475469|FG002|Overall Study|Lost to Follow-up|1|||
146809741|NCT02014402|529475470|FG003|Overall Study|Lost to Follow-up|2|||
146809742|NCT03928743|529475474|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
146809743|NCT03928743|529475475|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
146809744|NCT03928743|529475476|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
146809745|NCT03928743|529475474|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
146809746|NCT03928743|529475475|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
146809747|NCT03928743|529475476|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
146809748|NCT03928743|529475474|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
146809749|NCT03928743|529475475|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
146809750|NCT03928743|529475476|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
146809751|NCT03928743|529475474|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
146809752|NCT03928743|529475475|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
146809753|NCT03928743|529475476|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
146809754|NCT03928743|529475474|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
146809755|NCT03928743|529475475|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
146809756|NCT03928743|529475476|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
146809757|NCT03928743|529475474|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
146809758|NCT03928743|529475475|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
146809759|NCT03928743|529475476|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
146984120|NCT00415532|530103355|FG001|Treatment Period|Adverse Event|3|||
146984121|NCT00415532|530103354|FG000|Treatment Period|Death|2|||
146984122|NCT00415532|530103355|FG001|Treatment Period|Death|1|||
146984123|NCT00415532|530103354|FG000|Treatment Period|Lost to Follow-up|1|||
146984124|NCT00415532|530103355|FG001|Treatment Period|Lost to Follow-up|1|||
146984125|NCT00415532|530103354|FG000|Treatment Period|Protocol Violation|1|||
146984126|NCT00415532|530103355|FG001|Treatment Period|Protocol Violation|0|||
146984127|NCT00415532|530103354|FG000|Treatment Period|Withdrawal by Subject|6|||
146984128|NCT00415532|530103355|FG001|Treatment Period|Withdrawal by Subject|6|||
146984129|NCT00415532|530103354|FG000|Treatment Period|Other|2|||
146984130|NCT00415532|530103355|FG001|Treatment Period|Other|2|||
146984131|NCT00415532|530103354|FG000|Treatment Period|Ineligibility determined|1|||
146984132|NCT00415532|530103355|FG001|Treatment Period|Ineligibility determined|1|||
146984133|NCT00415532|530103354|FG000|Treatment Period|Noncompliance|1|||
146984134|NCT00415532|530103355|FG001|Treatment Period|Noncompliance|1|||
146809760|NCT03928743|529475474|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
146809761|NCT03928743|529475475|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
146809762|NCT03928743|529475476|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
146809763|NCT03928743|529475474|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
146809764|NCT03928743|529475475|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
146809765|NCT03928743|529475476|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
146809766|NCT03928743|529475474|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
146809767|NCT03928743|529475475|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
146809768|NCT03928743|529475476|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
146809769|NCT03928743|529475474|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
146809770|NCT03928743|529475475|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
146809771|NCT03928743|529475476|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
146809772|NCT03928743|529475474|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
146984135|NCT00415532|530103354|FG000|Treatment Period|Requirement for alternative therapy|1|||
146984136|NCT00415532|530103355|FG001|Treatment Period|Requirement for alternative therapy|0|||
146984137|NCT00415532|530103354|FG000|Safety Follow Up Period|Adverse Event|1|||
146984138|NCT00415532|530103355|FG001|Safety Follow Up Period|Adverse Event|3|||
146809773|NCT03928743|529475475|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
146809774|NCT03928743|529475476|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
146809775|NCT00703092|529475480|FG000|Overall Study|Withdrawal by Subject|2|||
146809776|NCT02007070|529475481|FG000|Overall Study|Adverse Event|4|||
146809777|NCT02007070|529475481|FG000|Overall Study|Clinical Progression|4|||
146809778|NCT02007070|529475481|FG000|Overall Study|Death|1|||
146809779|NCT02007070|529475481|FG000|Overall Study|Protocol Violation|2|||
146809780|NCT02007070|529475481|FG000|Overall Study|Physician Decision|1|||
146809781|NCT02007070|529475481|FG000|Overall Study|Progressive Disease|21|||
146809782|NCT01480258|529475482|FG000|Infant Series|Protocol Violation|2|||
146809783|NCT01480258|529475483|FG001|Infant Series|Protocol Violation|0|||
146809784|NCT01480258|529475482|FG000|Infant Series|Physician Decision|0|||
146809785|NCT01480258|529475483|FG001|Infant Series|Physician Decision|1|||
146809786|NCT01480258|529475482|FG000|Infant Series|Not Vaccinated|3|||
146809787|NCT01480258|529475483|FG001|Infant Series|Not Vaccinated|0|||
146809788|NCT01480258|529475482|FG000|Infant Series|Adverse Event|1|||
146809789|NCT01480258|529475483|FG001|Infant Series|Adverse Event|1|||
146809790|NCT01480258|529475482|FG000|Infant Series|Withdrawal by Subject|1|||
146809791|NCT01480258|529475483|FG001|Infant Series|Withdrawal by Subject|6|||
146809792|NCT01480258|529475482|FG000|Interim Period|Lost to Follow-up|0|||
146809793|NCT01480258|529475483|FG001|Interim Period|Lost to Follow-up|2|||
146809794|NCT01480258|529475482|FG000|Interim Period|Physician Decision|1|||
146809795|NCT01480258|529475483|FG001|Interim Period|Physician Decision|0|||
146809796|NCT01480258|529475482|FG000|Interim Period|Protocol Violation|0|||
146809797|NCT01480258|529475483|FG001|Interim Period|Protocol Violation|1|||
146809798|NCT01480258|529475482|FG000|Interim Period|Withdrawal by Subject|9|||
146809799|NCT01480258|529475483|FG001|Interim Period|Withdrawal by Subject|6|||
146809800|NCT00659373|529475485|FG000|Overall Study|Withdrawal by Subject|3|||
146809801|NCT00659373|529475486|FG001|Overall Study|Withdrawal by Subject|5|||
146809802|NCT00659373|529475485|FG000|Overall Study|Assessment Missed|2|||
146809803|NCT00659373|529475486|FG001|Overall Study|Assessment Missed|2|||
146809804|NCT03042767|529475487|FG000|Overall Study|Lost to Follow-up|1|||
146809805|NCT03042767|529475488|FG001|Overall Study|Lost to Follow-up|2|||
146809806|NCT01543204|529475489|FG000|Overall Study|Non-compliance|1|||
146809807|NCT01543204|529475489|FG000|Overall Study|Adverse Event|1|||
146809808|NCT01543204|529475489|FG000|Overall Study|Withdrawal by Subject|4|||
146809809|NCT01543204|529475489|FG000|Overall Study|Requirement for Alternative Therapy|1|||
146809810|NCT01543204|529475489|FG000|Overall Study|Lost to Follow-up|1|||
146809811|NCT01220999|529475490|FG000|Overall Study|Progressive disease|0|||
146809812|NCT01220999|529475491|FG001|Overall Study|Progressive disease|0|||
146809813|NCT01220999|529475492|FG002|Overall Study|Progressive disease|1|||
146809814|NCT01220999|529475493|FG003|Overall Study|Progressive disease|0|||
146809815|NCT01220999|529475494|FG004|Overall Study|Progressive disease|0|||
146809816|NCT03326856|529475496|FG000|Overall Study|Lost to Follow-up|1|||
146809817|NCT03326856|529475497|FG001|Overall Study|Lost to Follow-up|1|||
146809818|NCT03326856|529475498|FG002|Overall Study|Lost to Follow-up|0|||
146809819|NCT03326856|529475499|FG003|Overall Study|Lost to Follow-up|0|||
146809820|NCT03326856|529475500|FG004|Overall Study|Lost to Follow-up|0|||
146809821|NCT02037568|529475501|FG000|Overall Study|Withdrawal by Subject|17|||
146809822|NCT02037568|529475502|FG001|Overall Study|Withdrawal by Subject|24|||
146809823|NCT02037568|529475501|FG000|Overall Study|Lost to Follow-up|16|||
146809824|NCT02037568|529475502|FG001|Overall Study|Lost to Follow-up|13|||
146809825|NCT02037568|529475501|FG000|Overall Study|Screen Failure|3|||
146809826|NCT02037568|529475502|FG001|Overall Study|Screen Failure|1|||
146809827|NCT02037568|529475501|FG000|Overall Study|Patient did not receive transplant|0|||
146809828|NCT02037568|529475502|FG001|Overall Study|Patient did not receive transplant|1|||
146809829|NCT00721734|529475505|FG000|Overall Study|Progressive Disease|3|||
146809830|NCT00721734|529475506|FG001|Overall Study|Progressive Disease|10|||
146809831|NCT00721734|529475507|FG002|Overall Study|Progressive Disease|4|||
146809832|NCT00721734|529475508|FG003|Overall Study|Progressive Disease|5|||
146809833|NCT00721734|529475509|FG004|Overall Study|Progressive Disease|2|||
146809834|NCT00721734|529475505|FG000|Overall Study|Adverse Event|3|||
146809835|NCT00721734|529475506|FG001|Overall Study|Adverse Event|1|||
146809836|NCT00721734|529475507|FG002|Overall Study|Adverse Event|4|||
146809837|NCT00721734|529475508|FG003|Overall Study|Adverse Event|0|||
146809838|NCT00721734|529475509|FG004|Overall Study|Adverse Event|3|||
146809839|NCT00721734|529475505|FG000|Overall Study|Withdrawal by Subject|2|||
146809840|NCT00721734|529475506|FG001|Overall Study|Withdrawal by Subject|1|||
146809841|NCT00721734|529475507|FG002|Overall Study|Withdrawal by Subject|0|||
146809842|NCT00721734|529475508|FG003|Overall Study|Withdrawal by Subject|0|||
146809843|NCT00721734|529475509|FG004|Overall Study|Withdrawal by Subject|1|||
146809844|NCT00721734|529475505|FG000|Overall Study|Other|0|||
146809845|NCT00721734|529475506|FG001|Overall Study|Other|0|||
146809846|NCT00721734|529475507|FG002|Overall Study|Other|0|||
146809847|NCT00721734|529475508|FG003|Overall Study|Other|1|||
146809848|NCT00721734|529475509|FG004|Overall Study|Other|0|||
146809849|NCT01989689|529475512|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
146809850|NCT01989689|529475513|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
146809851|NCT01989689|529475512|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
146942484|NCT02120352|529948135|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
146942485|NCT02120352|529948136|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
146942486|NCT02120352|529948130|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
146942487|NCT02120352|529948131|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
146942488|NCT02120352|529948132|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
146942489|NCT02120352|529948133|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
146942490|NCT02120352|529948134|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
146942491|NCT02120352|529948135|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
146942492|NCT02120352|529948136|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
146942493|NCT02120352|529948130|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
146942494|NCT02120352|529948131|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
146942495|NCT02120352|529948132|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
146942496|NCT02120352|529948133|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
146942497|NCT02120352|529948134|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
146942498|NCT02120352|529948135|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
146942499|NCT02120352|529948136|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
146942500|NCT02120352|529948130|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
146942501|NCT02120352|529948131|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
146942502|NCT02120352|529948132|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
146942503|NCT02120352|529948133|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
146809852|NCT01989689|529475513|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
146809853|NCT02066636|529475514|FG000|Overall Study|Disease progression|51|||
146809854|NCT02066636|529475515|FG001|Overall Study|Disease progression|60|||
146809855|NCT02066636|529475516|FG002|Overall Study|Disease progression|700|||
146809856|NCT02066636|529475514|FG000|Overall Study|Study drug toxicity|13|||
146809857|NCT02066636|529475515|FG001|Overall Study|Study drug toxicity|2|||
146809858|NCT02066636|529475516|FG002|Overall Study|Study drug toxicity|58|||
146809859|NCT02066636|529475514|FG000|Overall Study|Death|4|||
146809860|NCT02066636|529475515|FG001|Overall Study|Death|2|||
146809861|NCT02066636|529475516|FG002|Overall Study|Death|158|||
146809862|NCT02066636|529475514|FG000|Overall Study|Adverse event unrelated to study drug|6|||
146809863|NCT02066636|529475515|FG001|Overall Study|Adverse event unrelated to study drug|4|||
146809864|NCT02066636|529475516|FG002|Overall Study|Adverse event unrelated to study drug|45|||
146809865|NCT02066636|529475514|FG000|Overall Study|Participant request to discontinue treatment|12|||
146809866|NCT02066636|529475515|FG001|Overall Study|Participant request to discontinue treatment|12|||
146809867|NCT02066636|529475516|FG002|Overall Study|Participant request to discontinue treatment|70|||
146809868|NCT02066636|529475514|FG000|Overall Study|Participant withdrew consent|10|||
146809869|NCT02066636|529475515|FG001|Overall Study|Participant withdrew consent|18|||
146809870|NCT02066636|529475516|FG002|Overall Study|Participant withdrew consent|61|||
146809871|NCT02066636|529475514|FG000|Overall Study|Lost to Follow-up|0|||
146809872|NCT02066636|529475515|FG001|Overall Study|Lost to Follow-up|2|||
146809873|NCT02066636|529475516|FG002|Overall Study|Lost to Follow-up|2|||
146809874|NCT02066636|529475514|FG000|Overall Study|Maximum clinical benefit|2|||
146809875|NCT02066636|529475515|FG001|Overall Study|Maximum clinical benefit|2|||
146809876|NCT02066636|529475516|FG002|Overall Study|Maximum clinical benefit|3|||
146809877|NCT02066636|529475514|FG000|Overall Study|Poor/non-compliance|2|||
146809878|NCT02066636|529475515|FG001|Overall Study|Poor/non-compliance|1|||
146809879|NCT02066636|529475516|FG002|Overall Study|Poor/non-compliance|1|||
146809880|NCT02066636|529475514|FG000|Overall Study|Participant no loner meets study criteria|3|||
146809881|NCT02066636|529475515|FG001|Overall Study|Participant no loner meets study criteria|2|||
146809882|NCT02066636|529475516|FG002|Overall Study|Participant no loner meets study criteria|28|||
146809883|NCT02066636|529475514|FG000|Overall Study|Administrative reasons by sponsor|8|||
146809884|NCT02066636|529475515|FG001|Overall Study|Administrative reasons by sponsor|5|||
146809885|NCT02066636|529475516|FG002|Overall Study|Administrative reasons by sponsor|0|||
146809886|NCT02066636|529475514|FG000|Overall Study|Other reasons|16|||
146809887|NCT02066636|529475515|FG001|Overall Study|Other reasons|15|||
146809888|NCT02066636|529475516|FG002|Overall Study|Other reasons|50|||
146809889|NCT00391170|529475517|FG000|Overall Study|Withdrawal by Subject|1|||
146809890|NCT00391170|529475518|FG001|Overall Study|Withdrawal by Subject|0|||
146809891|NCT00391170|529475517|FG000|Overall Study|Adverse Event|3|||
146809892|NCT00391170|529475518|FG001|Overall Study|Adverse Event|2|||
146809893|NCT00391170|529475517|FG000|Overall Study|Physician Decision|2|||
146809894|NCT00391170|529475518|FG001|Overall Study|Physician Decision|2|||
146809895|NCT03567616|529475525|FG000|Overall Study|Disease progression|4|||
146809896|NCT03567616|529475525|FG000|Overall Study|Withdrawal by Subject|1|||
146809897|NCT03567616|529475525|FG000|Overall Study|Physician Decision|1|||
146809898|NCT03567616|529475525|FG000|Overall Study|Death|1|||
146942504|NCT02120352|529948134|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
146942505|NCT02120352|529948135|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
146942506|NCT02120352|529948136|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
146942507|NCT02427100|529948137|FG000|Overall Study|Lost to Follow-up|0|||
146942508|NCT02427100|529948138|FG001|Overall Study|Lost to Follow-up|2|||
146984139|NCT00415532|530103354|FG000|Safety Follow Up Period|Death|3|||
146809899|NCT03567616|529475525|FG000|Overall Study|Adverse Event|1|||
146809900|NCT00526994|529475530|FG000|Overall Study|Lost to Follow-up|98|||
146809901|NCT00526994|529475531|FG001|Overall Study|Lost to Follow-up|108|||
146809902|NCT00526994|529475532|FG002|Overall Study|Lost to Follow-up|96|||
146809903|NCT00526994|529475530|FG000|Overall Study|Death|4|||
146809904|NCT00526994|529475531|FG001|Overall Study|Death|3|||
146809905|NCT00526994|529475532|FG002|Overall Study|Death|3|||
146809906|NCT00526994|529475530|FG000|Overall Study|Withdrawal by Subject|2|||
146809907|NCT00526994|529475531|FG001|Overall Study|Withdrawal by Subject|7|||
146809908|NCT00526994|529475532|FG002|Overall Study|Withdrawal by Subject|5|||
146809909|NCT00526994|529475530|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
146809910|NCT00526994|529475531|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
146809911|NCT00526994|529475532|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
146809912|NCT02833948|529475535|FG000|Overall Study|Death|2|||
146809913|NCT02833948|529475536|FG001|Overall Study|Death|3|||
146809914|NCT02833948|529475535|FG000|Overall Study|were not scanned|8|||
146809915|NCT02833948|529475536|FG001|Overall Study|were not scanned|13|||
146809916|NCT02833948|529475535|FG000|Overall Study|scans could not be evaluated|5|||
146809917|NCT02833948|529475536|FG001|Overall Study|scans could not be evaluated|2|||
146809918|NCT05169684|529475540|FG000|Overall Study|Adverse Event|1|||
146809919|NCT05169684|529475541|FG001|Overall Study|Adverse Event|3|||
146809920|NCT05169684|529475540|FG000|Overall Study|Physician Decision|0|||
146809921|NCT05169684|529475541|FG001|Overall Study|Physician Decision|1|||
146809922|NCT05169684|529475540|FG000|Overall Study|Progressive Disease|1|||
146809923|NCT05169684|529475541|FG001|Overall Study|Progressive Disease|1|||
146809924|NCT05169684|529475540|FG000|Overall Study|Participant request to discontinue treatment|0|||
146809925|NCT05169684|529475541|FG001|Overall Study|Participant request to discontinue treatment|1|||
146809926|NCT05169684|529475540|FG000|Overall Study|Other Reason|0|||
146809927|NCT05169684|529475541|FG001|Overall Study|Other Reason|1|||
146809928|NCT03539055|529475542|FG000|Overall Study|Death|4|||
146809929|NCT03539055|529475542|FG000|Overall Study|Lost to Follow-up|1|||
146809930|NCT03539055|529475542|FG000|Overall Study|Withdrawal by Subject|2|||
146809931|NCT03539055|529475542|FG000|Overall Study|Screen Fail|7|||
146809932|NCT03539055|529475542|FG000|Overall Study|Drug Intolerance|2|||
146809933|NCT00875706|529475546|FG000|Overall Study|Withdrawal by Subject|1|||
146809934|NCT00875706|529475547|FG001|Overall Study|Withdrawal by Subject|0|||
146809935|NCT00875706|529475548|FG002|Overall Study|Withdrawal by Subject|0|||
146809936|NCT03775213|529475549|FG000|Overall Study|Withdrawal by Subject|51|||
146809937|NCT03775213|529475550|FG001|Overall Study|Withdrawal by Subject|53|||
146809938|NCT03775213|529475549|FG000|Overall Study|Incomplete Survey|7|||
146809939|NCT03775213|529475550|FG001|Overall Study|Incomplete Survey|7|||
146809940|NCT00786188|529475551|FG000|Overall Study|Adverse Event|3|||
146809941|NCT00786188|529475552|FG001|Overall Study|Adverse Event|1|||
146809942|NCT00786188|529475551|FG000|Overall Study|Withdrawal by Subject|2|||
146809943|NCT00786188|529475552|FG001|Overall Study|Withdrawal by Subject|0|||
146809944|NCT05163353|529475556|FG000|Overall Study|Adverse Event|1|||
146809945|NCT05163353|529475557|FG001|Overall Study|Adverse Event|0|||
146809946|NCT05163353|529475556|FG000|Overall Study|Withdrawal by Subject|21|||
146809947|NCT05163353|529475557|FG001|Overall Study|Withdrawal by Subject|6|||
146809948|NCT05163353|529475556|FG000|Overall Study|Protocol Violation|0|||
146809949|NCT05163353|529475557|FG001|Overall Study|Protocol Violation|1|||
146809950|NCT05163353|529475556|FG000|Overall Study|Lost to Follow-up|13|||
146809951|NCT05163353|529475557|FG001|Overall Study|Lost to Follow-up|2|||
146809952|NCT06086028|529475559|FG000|Overall Study|Withdrawal by Subject|1|||
146809953|NCT06086028|529475560|FG001|Overall Study|Withdrawal by Subject|1|||
146809954|NCT06086028|529475559|FG000|Overall Study|Lost to Follow-up|2|||
146809955|NCT06086028|529475560|FG001|Overall Study|Lost to Follow-up|3|||
146809956|NCT00824408|529475561|FG000|Run-in Phase|Progressive disease|4|||
146984140|NCT00415532|530103355|FG001|Safety Follow Up Period|Death|0|||
146984141|NCT00415532|530103354|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
146984142|NCT00415532|530103355|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
146984143|NCT00415532|530103354|FG000|Safety Follow Up Period|Other|1|||
146809957|NCT00824408|529475562|FG001|Run-in Phase|Progressive disease|4|||
146809958|NCT00824408|529475563|FG002|Run-in Phase|Progressive disease|0|||
146809959|NCT00824408|529475564|FG003|Run-in Phase|Progressive disease|0|||
146809960|NCT00824408|529475565|FG004|Run-in Phase|Progressive disease|0|||
146809961|NCT00824408|529475561|FG000|Run-in Phase|Adverse Event|1|||
146809962|NCT00824408|529475562|FG001|Run-in Phase|Adverse Event|1|||
146809963|NCT00824408|529475563|FG002|Run-in Phase|Adverse Event|0|||
146809964|NCT00824408|529475564|FG003|Run-in Phase|Adverse Event|0|||
146809965|NCT00824408|529475565|FG004|Run-in Phase|Adverse Event|0|||
146809966|NCT00824408|529475561|FG000|Run-in Phase|Refused to continue medication|1|||
146984144|NCT00415532|530103355|FG001|Safety Follow Up Period|Other|4|||
146809967|NCT00824408|529475562|FG001|Run-in Phase|Refused to continue medication|0|||
146809968|NCT00824408|529475563|FG002|Run-in Phase|Refused to continue medication|0|||
146809969|NCT00824408|529475564|FG003|Run-in Phase|Refused to continue medication|0|||
146809970|NCT00824408|529475565|FG004|Run-in Phase|Refused to continue medication|0|||
146809971|NCT00824408|529475561|FG000|Run-in Phase|Other reason not defined above|0|||
146809972|NCT00824408|529475562|FG001|Run-in Phase|Other reason not defined above|1|||
146809973|NCT00824408|529475563|FG002|Run-in Phase|Other reason not defined above|0|||
146809974|NCT00824408|529475564|FG003|Run-in Phase|Other reason not defined above|0|||
146809975|NCT00824408|529475565|FG004|Run-in Phase|Other reason not defined above|0|||
146809976|NCT00824408|529475561|FG000|Randomized Phase|Not treated|0|||
146809977|NCT00824408|529475562|FG001|Randomized Phase|Not treated|0|||
146809978|NCT00824408|529475563|FG002|Randomized Phase|Not treated|1|||
146809979|NCT00824408|529475564|FG003|Randomized Phase|Not treated|1|||
146809980|NCT00824408|529475565|FG004|Randomized Phase|Not treated|1|||
146809981|NCT00824408|529475561|FG000|Randomized Phase|Progressive disease|0|||
146809982|NCT00824408|529475562|FG001|Randomized Phase|Progressive disease|0|||
146809983|NCT00824408|529475563|FG002|Randomized Phase|Progressive disease|25|||
146809984|NCT00824408|529475564|FG003|Randomized Phase|Progressive disease|36|||
146809985|NCT00824408|529475565|FG004|Randomized Phase|Progressive disease|34|||
146809986|NCT00824408|529475561|FG000|Randomized Phase|Adverse Event|0|||
146809987|NCT00824408|529475562|FG001|Randomized Phase|Adverse Event|0|||
146809988|NCT00824408|529475563|FG002|Randomized Phase|Adverse Event|4|||
146809989|NCT00824408|529475564|FG003|Randomized Phase|Adverse Event|5|||
146809990|NCT00824408|529475565|FG004|Randomized Phase|Adverse Event|5|||
146809991|NCT00824408|529475561|FG000|Randomized Phase|Refused to continue medication|0|||
146809992|NCT00824408|529475562|FG001|Randomized Phase|Refused to continue medication|0|||
146809993|NCT00824408|529475563|FG002|Randomized Phase|Refused to continue medication|2|||
146809994|NCT00824408|529475564|FG003|Randomized Phase|Refused to continue medication|2|||
146809995|NCT00824408|529475565|FG004|Randomized Phase|Refused to continue medication|2|||
146809996|NCT00824408|529475561|FG000|Randomized Phase|Other reason not defined above|0|||
146809997|NCT00824408|529475562|FG001|Randomized Phase|Other reason not defined above|0|||
146809998|NCT00824408|529475563|FG002|Randomized Phase|Other reason not defined above|4|||
146809999|NCT00824408|529475564|FG003|Randomized Phase|Other reason not defined above|2|||
146810000|NCT00824408|529475565|FG004|Randomized Phase|Other reason not defined above|4|||
146810001|NCT04821271|529475566|FG000|Period 1|Withdrawal by Subject|2|||
146810002|NCT04821271|529475567|FG001|Period 1|Withdrawal by Subject|0|||
146810003|NCT02521493|529475569|FG000|Overall Study|Death|3|||
146810004|NCT02521493|529475570|FG001|Overall Study|Death|4|||
146810005|NCT02521493|529475571|FG002|Overall Study|Death|1|||
146810006|NCT02521493|529475569|FG000|Overall Study|Physician Decision|19|||
146810007|NCT02521493|529475570|FG001|Overall Study|Physician Decision|1|||
146810008|NCT02521493|529475571|FG002|Overall Study|Physician Decision|2|||
146810009|NCT02521493|529475569|FG000|Overall Study|Withdrawal by Subject|3|||
146810010|NCT02521493|529475570|FG001|Overall Study|Withdrawal by Subject|0|||
146810011|NCT02521493|529475571|FG002|Overall Study|Withdrawal by Subject|0|||
146810012|NCT02521493|529475569|FG000|Overall Study|Ineligible|0|||
146810013|NCT02521493|529475570|FG001|Overall Study|Ineligible|1|||
146810014|NCT02521493|529475571|FG002|Overall Study|Ineligible|0|||
146810015|NCT02521493|529475569|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
146810016|NCT02521493|529475570|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
146810017|NCT02521493|529475571|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
146810018|NCT02521493|529475569|FG000|Overall Study|No MRD result|0|||
146810019|NCT02521493|529475570|FG001|Overall Study|No MRD result|0|||
146810020|NCT02521493|529475571|FG002|Overall Study|No MRD result|4|||
146810021|NCT04083781|529475572|FG000|Main Part|Physician Decision|0|||
146810022|NCT04083781|529475573|FG001|Main Part|Physician Decision|1|||
146810023|NCT04083781|529475574|FG002|Main Part|Physician Decision|2|||
146810024|NCT04083781|529475575|FG003|Main Part|Physician Decision|0|||
146810025|NCT04083781|529475572|FG000|Main Part|Death|1|||
146810026|NCT04083781|529475573|FG001|Main Part|Death|3|||
146810027|NCT04083781|529475574|FG002|Main Part|Death|1|||
146810028|NCT04083781|529475575|FG003|Main Part|Death|0|||
146810029|NCT04083781|529475572|FG000|Main Part|Withdrawal by Subject|5|||
146810030|NCT04083781|529475573|FG001|Main Part|Withdrawal by Subject|2|||
146810031|NCT04083781|529475574|FG002|Main Part|Withdrawal by Subject|3|||
146810032|NCT04083781|529475575|FG003|Main Part|Withdrawal by Subject|7|||
146810033|NCT04083781|529475572|FG000|Extension Part|Physician Decision|0|||
146810034|NCT04083781|529475573|FG001|Extension Part|Physician Decision|0|||
146810035|NCT04083781|529475574|FG002|Extension Part|Physician Decision|0|||
146810036|NCT04083781|529475575|FG003|Extension Part|Physician Decision|1|||
146810037|NCT04083781|529475572|FG000|Extension Part|Death|0|||
146810038|NCT04083781|529475573|FG001|Extension Part|Death|1|||
146810039|NCT04083781|529475574|FG002|Extension Part|Death|0|||
146810040|NCT04083781|529475575|FG003|Extension Part|Death|1|||
146810041|NCT04083781|529475572|FG000|Extension Part|Withdrawal by Subject|0|||
146810042|NCT04083781|529475573|FG001|Extension Part|Withdrawal by Subject|1|||
146810043|NCT04083781|529475574|FG002|Extension Part|Withdrawal by Subject|0|||
146810044|NCT04083781|529475575|FG003|Extension Part|Withdrawal by Subject|0|||
146810045|NCT04083781|529475572|FG000|Extension Part|Ongoing|13|||
146810046|NCT04083781|529475573|FG001|Extension Part|Ongoing|25|||
146810047|NCT04083781|529475574|FG002|Extension Part|Ongoing|15|||
146810048|NCT04083781|529475575|FG003|Extension Part|Ongoing|51|||
146810049|NCT02334215|529475578|FG000|Overall Study|Death|1|||
146810050|NCT02334215|529475579|FG001|Overall Study|Death|1|||
146810051|NCT02334215|529475580|FG002|Overall Study|Death|0|||
146810052|NCT02334215|529475578|FG000|Overall Study|Lost to Follow-up|1|||
146810053|NCT02334215|529475579|FG001|Overall Study|Lost to Follow-up|0|||
146810054|NCT02334215|529475580|FG002|Overall Study|Lost to Follow-up|4|||
146810055|NCT02334215|529475578|FG000|Overall Study|Withdrawal by Subject|2|||
146810056|NCT02334215|529475579|FG001|Overall Study|Withdrawal by Subject|2|||
146942509|NCT01610206|529948141|FG000|Overall Study|Adverse Event|10|||
146942510|NCT01610206|529948142|FG001|Overall Study|Adverse Event|30|||
146942511|NCT00924729|529948145|FG000|Overall Study|insufficient volume for analysis|1|||
146942512|NCT00924729|529948146|FG001|Overall Study|insufficient volume for analysis|0|||
146942513|NCT00924729|529948145|FG000|Overall Study|Protocol Violation|1|||
146942514|NCT00924729|529948146|FG001|Overall Study|Protocol Violation|0|||
146942515|NCT00196196|529948147|FG000|Overall Study|Withdrawal by Subject|2|||
146942516|NCT00196196|529948147|FG000|Overall Study|Did not have required condition (hydroce|5|||
146942517|NCT02917629|529948148|FG000|Overall Study|Withdrawal by Subject|0|||
146942518|NCT02917629|529948149|FG001|Overall Study|Withdrawal by Subject|1|||
146942519|NCT03271307|529948150|FG000|Overall Study|Lost to Follow-up|0|||
146942520|NCT03271307|529948151|FG001|Overall Study|Lost to Follow-up|0|||
146942521|NCT03271307|529948152|FG002|Overall Study|Lost to Follow-up|0|||
146942522|NCT03271307|529948153|FG003|Overall Study|Lost to Follow-up|28|||
146942523|NCT03271307|529948154|FG004|Overall Study|Lost to Follow-up|91|||
146942524|NCT00910728|529948155|FG000|Overall Study|Lack of Efficacy|2|||
146942525|NCT00910728|529948156|FG001|Overall Study|Lack of Efficacy|3|||
146942526|NCT00910728|529948157|FG002|Overall Study|Lack of Efficacy|1|||
146942527|NCT00910728|529948158|FG003|Overall Study|Lack of Efficacy|2|||
146942528|NCT00910728|529948159|FG004|Overall Study|Lack of Efficacy|1|||
146942529|NCT00910728|529948160|FG005|Overall Study|Lack of Efficacy|0|||
146942530|NCT00910728|529948161|FG006|Overall Study|Lack of Efficacy|2|||
146942531|NCT00910728|529948162|FG007|Overall Study|Lack of Efficacy|2|||
146942532|NCT00910728|529948163|FG008|Overall Study|Lack of Efficacy|2|||
146942533|NCT00910728|529948155|FG000|Overall Study|Withdrawal by Subject|0|||
146942534|NCT00910728|529948156|FG001|Overall Study|Withdrawal by Subject|0|||
146942535|NCT00910728|529948157|FG002|Overall Study|Withdrawal by Subject|0|||
146942536|NCT00910728|529948158|FG003|Overall Study|Withdrawal by Subject|0|||
146942537|NCT00910728|529948159|FG004|Overall Study|Withdrawal by Subject|3|||
146942538|NCT00910728|529948160|FG005|Overall Study|Withdrawal by Subject|1|||
146942539|NCT00910728|529948161|FG006|Overall Study|Withdrawal by Subject|2|||
146984145|NCT00415532|530103354|FG000|Safety Follow Up Period|Ineligibility determined|1|||
146984146|NCT00415532|530103355|FG001|Safety Follow Up Period|Ineligibility determined|1|||
146984147|NCT00415532|530103354|FG000|Safety Follow Up Period|Noncompliance|1|||
146810057|NCT02334215|529475580|FG002|Overall Study|Withdrawal by Subject|1|||
146810058|NCT02334215|529475578|FG000|Overall Study|Not released from incarceration on time|3|||
146810059|NCT02334215|529475579|FG001|Overall Study|Not released from incarceration on time|3|||
146810060|NCT02334215|529475580|FG002|Overall Study|Not released from incarceration on time|3|||
146810061|NCT02334215|529475578|FG000|Overall Study|Incarcerated|0|||
146810062|NCT02334215|529475579|FG001|Overall Study|Incarcerated|0|||
146810063|NCT02334215|529475580|FG002|Overall Study|Incarcerated|7|||
146810064|NCT05615363|529475581|FG000|Overall Study|Adverse Event|0|||
146810065|NCT05615363|529475582|FG001|Overall Study|Adverse Event|4|||
146810066|NCT05615363|529475583|FG002|Overall Study|Adverse Event|4|||
146810067|NCT05615363|529475584|FG003|Overall Study|Adverse Event|3|||
146810068|NCT05615363|529475585|FG004|Overall Study|Adverse Event|1|||
146810069|NCT05615363|529475581|FG000|Overall Study|Physician Decision|2|||
146810070|NCT05615363|529475582|FG001|Overall Study|Physician Decision|0|||
146810071|NCT05615363|529475583|FG002|Overall Study|Physician Decision|4|||
146810072|NCT05615363|529475584|FG003|Overall Study|Physician Decision|1|||
146810073|NCT05615363|529475585|FG004|Overall Study|Physician Decision|3|||
146810074|NCT05615363|529475581|FG000|Overall Study|Protocol Violation|2|||
146810075|NCT05615363|529475582|FG001|Overall Study|Protocol Violation|0|||
146810076|NCT05615363|529475583|FG002|Overall Study|Protocol Violation|0|||
146810077|NCT05615363|529475584|FG003|Overall Study|Protocol Violation|0|||
146810078|NCT05615363|529475585|FG004|Overall Study|Protocol Violation|1|||
146810079|NCT05615363|529475581|FG000|Overall Study|Withdrawal by Subject|0|||
146810080|NCT05615363|529475582|FG001|Overall Study|Withdrawal by Subject|0|||
146810081|NCT05615363|529475583|FG002|Overall Study|Withdrawal by Subject|1|||
146942540|NCT00910728|529948162|FG007|Overall Study|Withdrawal by Subject|0|||
146942541|NCT00910728|529948163|FG008|Overall Study|Withdrawal by Subject|0|||
146942542|NCT00910728|529948155|FG000|Overall Study|(not specified)|2|||
146810082|NCT05615363|529475584|FG003|Overall Study|Withdrawal by Subject|0|||
146810083|NCT05615363|529475585|FG004|Overall Study|Withdrawal by Subject|0|||
146942543|NCT00910728|529948156|FG001|Overall Study|(not specified)|0|||
146810084|NCT04602728|529475590|FG000|Overall Study|Lost to Follow-up|4|||
146942544|NCT00910728|529948157|FG002|Overall Study|(not specified)|1|||
146942545|NCT00910728|529948158|FG003|Overall Study|(not specified)|0|||
146942546|NCT00910728|529948159|FG004|Overall Study|(not specified)|1|||
146942547|NCT00910728|529948160|FG005|Overall Study|(not specified)|0|||
146942548|NCT00910728|529948161|FG006|Overall Study|(not specified)|0|||
146942549|NCT00910728|529948162|FG007|Overall Study|(not specified)|0|||
146810085|NCT04602728|529475591|FG001|Overall Study|Lost to Follow-up|4|||
146810086|NCT03905642|529475593|FG000|Overall Study|Withdrawal by Subject|3|||
146810087|NCT03905642|529475593|FG000|Overall Study|Pregnancy|1|||
146810088|NCT03905642|529475593|FG000|Overall Study|Adverse Event|1|||
146810089|NCT03905642|529475593|FG000|Overall Study|Lack of Efficacy|1|||
146810090|NCT03905642|529475593|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
146810091|NCT02159989|529475594|FG000|Overall Study|Adverse Event|1|||
146810092|NCT02159989|529475595|FG001|Overall Study|Adverse Event|0|||
146810093|NCT02159989|529475596|FG002|Overall Study|Adverse Event|0|||
146810094|NCT02159989|529475597|FG003|Overall Study|Adverse Event|0|||
146810095|NCT02159989|529475598|FG004|Overall Study|Adverse Event|1|||
146810096|NCT02159989|529475599|FG005|Overall Study|Adverse Event|0|||
146810097|NCT02159989|529475600|FG006|Overall Study|Adverse Event|1|||
146810098|NCT02159989|529475601|FG007|Overall Study|Adverse Event|2|||
146810099|NCT02159989|529475602|FG008|Overall Study|Adverse Event|0|||
146810100|NCT02159989|529475603|FG009|Overall Study|Adverse Event|2|||
146810101|NCT02159989|529475604|FG010|Overall Study|Adverse Event|1|||
146810102|NCT02159989|529475594|FG000|Overall Study|Death|0|||
146810103|NCT02159989|529475595|FG001|Overall Study|Death|0|||
146810104|NCT02159989|529475596|FG002|Overall Study|Death|0|||
146810105|NCT02159989|529475597|FG003|Overall Study|Death|0|||
146810106|NCT02159989|529475598|FG004|Overall Study|Death|0|||
146810107|NCT02159989|529475599|FG005|Overall Study|Death|0|||
146810108|NCT02159989|529475600|FG006|Overall Study|Death|0|||
146810109|NCT02159989|529475601|FG007|Overall Study|Death|0|||
146810110|NCT02159989|529475602|FG008|Overall Study|Death|0|||
146810111|NCT02159989|529475603|FG009|Overall Study|Death|0|||
146810112|NCT02159989|529475604|FG010|Overall Study|Death|1|||
146810113|NCT02159989|529475594|FG000|Overall Study|Lack of Efficacy|2|||
146810114|NCT02159989|529475595|FG001|Overall Study|Lack of Efficacy|3|||
146810115|NCT02159989|529475596|FG002|Overall Study|Lack of Efficacy|3|||
146810116|NCT02159989|529475597|FG003|Overall Study|Lack of Efficacy|0|||
146810117|NCT02159989|529475598|FG004|Overall Study|Lack of Efficacy|2|||
146810118|NCT02159989|529475599|FG005|Overall Study|Lack of Efficacy|3|||
146810119|NCT02159989|529475600|FG006|Overall Study|Lack of Efficacy|3|||
146810120|NCT02159989|529475601|FG007|Overall Study|Lack of Efficacy|1|||
146810121|NCT02159989|529475602|FG008|Overall Study|Lack of Efficacy|3|||
146810122|NCT02159989|529475603|FG009|Overall Study|Lack of Efficacy|6|||
146810123|NCT02159989|529475604|FG010|Overall Study|Lack of Efficacy|7|||
146810124|NCT02159989|529475594|FG000|Overall Study|Lost to Follow-up|0|||
146810125|NCT02159989|529475595|FG001|Overall Study|Lost to Follow-up|0|||
146810126|NCT02159989|529475596|FG002|Overall Study|Lost to Follow-up|0|||
146810127|NCT02159989|529475597|FG003|Overall Study|Lost to Follow-up|1|||
146810128|NCT02159989|529475598|FG004|Overall Study|Lost to Follow-up|0|||
146810129|NCT02159989|529475599|FG005|Overall Study|Lost to Follow-up|0|||
146810130|NCT02159989|529475600|FG006|Overall Study|Lost to Follow-up|0|||
146810131|NCT02159989|529475601|FG007|Overall Study|Lost to Follow-up|0|||
146810132|NCT02159989|529475602|FG008|Overall Study|Lost to Follow-up|0|||
146810133|NCT02159989|529475603|FG009|Overall Study|Lost to Follow-up|0|||
146810134|NCT02159989|529475604|FG010|Overall Study|Lost to Follow-up|1|||
146810135|NCT02159989|529475594|FG000|Overall Study|Withdrawal by Subject|2|||
146810136|NCT02159989|529475595|FG001|Overall Study|Withdrawal by Subject|0|||
146810137|NCT02159989|529475596|FG002|Overall Study|Withdrawal by Subject|0|||
146810138|NCT02159989|529475597|FG003|Overall Study|Withdrawal by Subject|2|||
146810139|NCT02159989|529475598|FG004|Overall Study|Withdrawal by Subject|1|||
146810140|NCT02159989|529475599|FG005|Overall Study|Withdrawal by Subject|0|||
146942550|NCT00910728|529948163|FG008|Overall Study|(not specified)|0|||
146942551|NCT00910728|529948155|FG000|Overall Study|Adverse Event|2|||
146942552|NCT00910728|529948156|FG001|Overall Study|Adverse Event|0|||
146942553|NCT00910728|529948157|FG002|Overall Study|Adverse Event|1|||
146942554|NCT00910728|529948158|FG003|Overall Study|Adverse Event|1|||
146942555|NCT00910728|529948159|FG004|Overall Study|Adverse Event|0|||
146810141|NCT02159989|529475600|FG006|Overall Study|Withdrawal by Subject|3|||
146810142|NCT02159989|529475601|FG007|Overall Study|Withdrawal by Subject|1|||
146810143|NCT02159989|529475602|FG008|Overall Study|Withdrawal by Subject|0|||
146810144|NCT02159989|529475603|FG009|Overall Study|Withdrawal by Subject|0|||
146810145|NCT02159989|529475604|FG010|Overall Study|Withdrawal by Subject|0|||
146810146|NCT02159989|529475594|FG000|Overall Study|New treatment|0|||
146810147|NCT02159989|529475595|FG001|Overall Study|New treatment|1|||
146810148|NCT02159989|529475596|FG002|Overall Study|New treatment|0|||
146810149|NCT02159989|529475597|FG003|Overall Study|New treatment|0|||
146810150|NCT02159989|529475598|FG004|Overall Study|New treatment|0|||
146810151|NCT02159989|529475599|FG005|Overall Study|New treatment|0|||
146810152|NCT02159989|529475600|FG006|Overall Study|New treatment|0|||
146942556|NCT00910728|529948160|FG005|Overall Study|Adverse Event|0|||
146810153|NCT02159989|529475601|FG007|Overall Study|New treatment|0|||
146810154|NCT02159989|529475602|FG008|Overall Study|New treatment|0|||
146810155|NCT02159989|529475603|FG009|Overall Study|New treatment|0|||
146810156|NCT02159989|529475604|FG010|Overall Study|New treatment|0|||
146810157|NCT02159989|529475594|FG000|Overall Study|Insurance Issues|0|||
146810158|NCT02159989|529475595|FG001|Overall Study|Insurance Issues|0|||
146810159|NCT02159989|529475596|FG002|Overall Study|Insurance Issues|0|||
146810160|NCT02159989|529475597|FG003|Overall Study|Insurance Issues|0|||
146810161|NCT02159989|529475598|FG004|Overall Study|Insurance Issues|0|||
146810162|NCT02159989|529475599|FG005|Overall Study|Insurance Issues|0|||
146810163|NCT02159989|529475600|FG006|Overall Study|Insurance Issues|0|||
146810164|NCT02159989|529475601|FG007|Overall Study|Insurance Issues|0|||
146810165|NCT02159989|529475602|FG008|Overall Study|Insurance Issues|0|||
146810166|NCT02159989|529475603|FG009|Overall Study|Insurance Issues|1|||
146810167|NCT02159989|529475604|FG010|Overall Study|Insurance Issues|0|||
146810168|NCT05289037|529475608|FG000|Overall Study|Withdrawal by Subject|7|||
146810169|NCT05289037|529475609|FG001|Overall Study|Withdrawal by Subject|0|||
146810170|NCT05289037|529475610|FG002|Overall Study|Withdrawal by Subject|3|||
146810171|NCT05289037|529475611|FG003|Overall Study|Withdrawal by Subject|3|||
146810172|NCT05289037|529475612|FG004|Overall Study|Withdrawal by Subject|1|||
146810173|NCT05289037|529475613|FG005|Overall Study|Withdrawal by Subject|5|||
146810174|NCT05289037|529475614|FG006|Overall Study|Withdrawal by Subject|2|||
146810175|NCT05289037|529475615|FG007|Overall Study|Withdrawal by Subject|1|||
146810176|NCT05289037|529475616|FG008|Overall Study|Withdrawal by Subject|2|||
146810177|NCT05289037|529475617|FG009|Overall Study|Withdrawal by Subject|2|||
146810178|NCT05289037|529475618|FG010|Overall Study|Withdrawal by Subject|1|||
146810179|NCT05289037|529475619|FG011|Overall Study|Withdrawal by Subject|0|||
146810180|NCT05289037|529475620|FG012|Overall Study|Withdrawal by Subject|1|||
146810181|NCT05289037|529475621|FG013|Overall Study|Withdrawal by Subject|2|||
146810182|NCT05289037|529475622|FG014|Overall Study|Withdrawal by Subject|0|||
146810183|NCT05289037|529475623|FG015|Overall Study|Withdrawal by Subject|3|||
146810184|NCT05289037|529475624|FG016|Overall Study|Withdrawal by Subject|3|||
146810185|NCT05289037|529475608|FG000|Overall Study|Lost to Follow-up|1|||
146810186|NCT05289037|529475609|FG001|Overall Study|Lost to Follow-up|4|||
146810187|NCT05289037|529475610|FG002|Overall Study|Lost to Follow-up|3|||
146810188|NCT05289037|529475611|FG003|Overall Study|Lost to Follow-up|3|||
146810189|NCT05289037|529475612|FG004|Overall Study|Lost to Follow-up|3|||
146810190|NCT05289037|529475613|FG005|Overall Study|Lost to Follow-up|2|||
146810191|NCT05289037|529475614|FG006|Overall Study|Lost to Follow-up|3|||
146810192|NCT05289037|529475615|FG007|Overall Study|Lost to Follow-up|2|||
146810193|NCT05289037|529475616|FG008|Overall Study|Lost to Follow-up|2|||
146810194|NCT05289037|529475617|FG009|Overall Study|Lost to Follow-up|1|||
146810195|NCT05289037|529475618|FG010|Overall Study|Lost to Follow-up|3|||
146810196|NCT05289037|529475619|FG011|Overall Study|Lost to Follow-up|4|||
146810197|NCT05289037|529475620|FG012|Overall Study|Lost to Follow-up|2|||
146810198|NCT05289037|529475621|FG013|Overall Study|Lost to Follow-up|7|||
146810199|NCT05289037|529475622|FG014|Overall Study|Lost to Follow-up|4|||
146810200|NCT05289037|529475623|FG015|Overall Study|Lost to Follow-up|6|||
146810201|NCT05289037|529475624|FG016|Overall Study|Lost to Follow-up|4|||
146810202|NCT05289037|529475608|FG000|Overall Study|Death|0|||
146810203|NCT05289037|529475609|FG001|Overall Study|Death|0|||
146810204|NCT05289037|529475610|FG002|Overall Study|Death|0|||
146810205|NCT05289037|529475611|FG003|Overall Study|Death|0|||
146810206|NCT05289037|529475612|FG004|Overall Study|Death|0|||
146810207|NCT05289037|529475613|FG005|Overall Study|Death|1|||
146810208|NCT05289037|529475614|FG006|Overall Study|Death|0|||
146810209|NCT05289037|529475615|FG007|Overall Study|Death|0|||
146810210|NCT05289037|529475616|FG008|Overall Study|Death|0|||
146810211|NCT05289037|529475617|FG009|Overall Study|Death|0|||
146810212|NCT05289037|529475618|FG010|Overall Study|Death|0|||
146810213|NCT05289037|529475619|FG011|Overall Study|Death|0|||
146810214|NCT05289037|529475620|FG012|Overall Study|Death|0|||
146810215|NCT05289037|529475621|FG013|Overall Study|Death|0|||
146810216|NCT05289037|529475622|FG014|Overall Study|Death|1|||
146810217|NCT05289037|529475623|FG015|Overall Study|Death|0|||
146810218|NCT05289037|529475624|FG016|Overall Study|Death|0|||
146810219|NCT05289037|529475608|FG000|Overall Study|Did not receive vaccine|0|||
146984148|NCT00415532|530103355|FG001|Safety Follow Up Period|Noncompliance|0|||
146810220|NCT05289037|529475609|FG001|Overall Study|Did not receive vaccine|3|||
146810221|NCT05289037|529475610|FG002|Overall Study|Did not receive vaccine|0|||
146810222|NCT05289037|529475611|FG003|Overall Study|Did not receive vaccine|0|||
146810223|NCT05289037|529475612|FG004|Overall Study|Did not receive vaccine|1|||
146810224|NCT05289037|529475613|FG005|Overall Study|Did not receive vaccine|1|||
146810225|NCT05289037|529475614|FG006|Overall Study|Did not receive vaccine|1|||
146810226|NCT05289037|529475615|FG007|Overall Study|Did not receive vaccine|0|||
146810227|NCT05289037|529475616|FG008|Overall Study|Did not receive vaccine|0|||
146810228|NCT05289037|529475617|FG009|Overall Study|Did not receive vaccine|0|||
146810229|NCT05289037|529475618|FG010|Overall Study|Did not receive vaccine|0|||
146810230|NCT05289037|529475619|FG011|Overall Study|Did not receive vaccine|0|||
146810231|NCT05289037|529475620|FG012|Overall Study|Did not receive vaccine|0|||
146810232|NCT05289037|529475621|FG013|Overall Study|Did not receive vaccine|0|||
146810233|NCT05289037|529475622|FG014|Overall Study|Did not receive vaccine|1|||
146810234|NCT05289037|529475623|FG015|Overall Study|Did not receive vaccine|0|||
146810235|NCT05289037|529475624|FG016|Overall Study|Did not receive vaccine|0|||
146810236|NCT05289037|529475608|FG000|Overall Study|Unable to make last visit|0|||
146810237|NCT05289037|529475609|FG001|Overall Study|Unable to make last visit|0|||
146810238|NCT05289037|529475610|FG002|Overall Study|Unable to make last visit|1|||
146810239|NCT05289037|529475611|FG003|Overall Study|Unable to make last visit|0|||
146810240|NCT05289037|529475612|FG004|Overall Study|Unable to make last visit|0|||
146810241|NCT05289037|529475613|FG005|Overall Study|Unable to make last visit|0|||
146810242|NCT05289037|529475614|FG006|Overall Study|Unable to make last visit|0|||
146810243|NCT05289037|529475615|FG007|Overall Study|Unable to make last visit|0|||
146810244|NCT05289037|529475616|FG008|Overall Study|Unable to make last visit|0|||
146810245|NCT05289037|529475617|FG009|Overall Study|Unable to make last visit|0|||
146810246|NCT05289037|529475618|FG010|Overall Study|Unable to make last visit|0|||
146810247|NCT05289037|529475619|FG011|Overall Study|Unable to make last visit|0|||
146810248|NCT05289037|529475620|FG012|Overall Study|Unable to make last visit|0|||
146810249|NCT05289037|529475621|FG013|Overall Study|Unable to make last visit|0|||
146810250|NCT05289037|529475622|FG014|Overall Study|Unable to make last visit|0|||
146810251|NCT05289037|529475623|FG015|Overall Study|Unable to make last visit|0|||
146810252|NCT05289037|529475624|FG016|Overall Study|Unable to make last visit|0|||
146810253|NCT05289037|529475608|FG000|Overall Study|Protocol deviation|0|||
146810254|NCT05289037|529475609|FG001|Overall Study|Protocol deviation|0|||
146810255|NCT05289037|529475610|FG002|Overall Study|Protocol deviation|0|||
146810256|NCT05289037|529475611|FG003|Overall Study|Protocol deviation|0|||
146810257|NCT05289037|529475612|FG004|Overall Study|Protocol deviation|0|||
146810258|NCT05289037|529475613|FG005|Overall Study|Protocol deviation|0|||
146810259|NCT05289037|529475614|FG006|Overall Study|Protocol deviation|0|||
146810260|NCT05289037|529475615|FG007|Overall Study|Protocol deviation|0|||
146810261|NCT05289037|529475616|FG008|Overall Study|Protocol deviation|0|||
146810262|NCT05289037|529475617|FG009|Overall Study|Protocol deviation|0|||
146810263|NCT05289037|529475618|FG010|Overall Study|Protocol deviation|0|||
146810264|NCT05289037|529475619|FG011|Overall Study|Protocol deviation|0|||
146810265|NCT05289037|529475620|FG012|Overall Study|Protocol deviation|0|||
146810266|NCT05289037|529475621|FG013|Overall Study|Protocol deviation|0|||
146810267|NCT05289037|529475622|FG014|Overall Study|Protocol deviation|0|||
146810268|NCT05289037|529475623|FG015|Overall Study|Protocol deviation|1|||
146810269|NCT05289037|529475624|FG016|Overall Study|Protocol deviation|0|||
146810270|NCT04937504|529475625|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
146810271|NCT04937504|529475626|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
146810272|NCT04937504|529475625|FG000|9 Months Assessment|Lost to Follow-up|3|||
146810273|NCT04937504|529475626|FG001|9 Months Assessment|Lost to Follow-up|2|||
146810274|NCT00070707|529477741|FG000|Overall Study|Adverse Event|1|||
146810275|NCT00070707|529477742|FG001|Overall Study|Adverse Event|2|||
146810276|NCT00070707|529477741|FG000|Overall Study|Lack of Efficacy|4|||
146810277|NCT00070707|529477742|FG001|Overall Study|Lack of Efficacy|1|||
146810278|NCT00070707|529477741|FG000|Overall Study|Protocol Violation|8|||
146810279|NCT00070707|529477742|FG001|Overall Study|Protocol Violation|4|||
146810280|NCT00070707|529477741|FG000|Overall Study|Unrelated to Study Medication|1|||
146810281|NCT00070707|529477742|FG001|Overall Study|Unrelated to Study Medication|0|||
146810282|NCT00670449|529477743|FG000|Overall Study|Adverse Event|6|||
146810283|NCT00670449|529477744|FG001|Overall Study|Adverse Event|2|||
146810284|NCT00670449|529477745|FG002|Overall Study|Adverse Event|8|||
146810285|NCT00670449|529477746|FG003|Overall Study|Adverse Event|5|||
146810286|NCT00670449|529477743|FG000|Overall Study|Protocol Deviation|1|||
146810287|NCT00670449|529477744|FG001|Overall Study|Protocol Deviation|2|||
146810288|NCT00670449|529477745|FG002|Overall Study|Protocol Deviation|0|||
146810289|NCT00670449|529477746|FG003|Overall Study|Protocol Deviation|1|||
146810290|NCT00670449|529477743|FG000|Overall Study|Administrative Problems|0|||
146810291|NCT00670449|529477744|FG001|Overall Study|Administrative Problems|2|||
146810292|NCT00670449|529477745|FG002|Overall Study|Administrative Problems|0|||
146810293|NCT00670449|529477746|FG003|Overall Study|Administrative Problems|1|||
146810294|NCT00670449|529477743|FG000|Overall Study|Subject Withdrew Consent|0|||
146810295|NCT00670449|529477744|FG001|Overall Study|Subject Withdrew Consent|2|||
146942557|NCT00910728|529948161|FG006|Overall Study|Adverse Event|2|||
146942558|NCT00910728|529948162|FG007|Overall Study|Adverse Event|1|||
146810296|NCT00670449|529477745|FG002|Overall Study|Subject Withdrew Consent|0|||
146810297|NCT00670449|529477746|FG003|Overall Study|Subject Withdrew Consent|1|||
146810298|NCT00670449|529477743|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
146810299|NCT00670449|529477744|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146810300|NCT00670449|529477745|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
146810301|NCT00670449|529477746|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146810302|NCT00670449|529477743|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
146810303|NCT00670449|529477744|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
146810304|NCT00670449|529477745|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
146810305|NCT00670449|529477746|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
146810306|NCT03690219|529477747|FG000|Overall Study|no injuries|9|||
146810307|NCT03690219|529477748|FG001|Overall Study|no injuries|20|||
146810308|NCT03690219|529477747|FG000|Overall Study|missing information|7|||
146810309|NCT03690219|529477748|FG001|Overall Study|missing information|7|||
146810310|NCT04809623|529477749|FG000|Overall Study|Study Terminated by Sponsor|1|||
146810311|NCT04809623|529477750|FG001|Overall Study|Study Terminated by Sponsor|0|||
146942559|NCT00910728|529948163|FG008|Overall Study|Adverse Event|1|||
146810312|NCT00413283|529477751|FG000|Overall Study|Withdrawal by Subject|1|||
146810313|NCT00413283|529477752|FG001|Overall Study|Withdrawal by Subject|0|||
146810314|NCT00413283|529477753|FG002|Overall Study|Withdrawal by Subject|0|||
146810315|NCT00413283|529477754|FG003|Overall Study|Withdrawal by Subject|1|||
146810316|NCT00413283|529477751|FG000|Overall Study|Death|0|||
146810317|NCT00413283|529477752|FG001|Overall Study|Death|0|||
146810318|NCT00413283|529477753|FG002|Overall Study|Death|1|||
146810319|NCT00413283|529477754|FG003|Overall Study|Death|1|||
146810320|NCT00413283|529477751|FG000|Overall Study|Adverse Event|0|||
146810321|NCT00413283|529477752|FG001|Overall Study|Adverse Event|0|||
146810322|NCT00413283|529477753|FG002|Overall Study|Adverse Event|0|||
146810323|NCT00413283|529477754|FG003|Overall Study|Adverse Event|1|||
146810324|NCT00413283|529477751|FG000|Overall Study|Ineligibility determined|0|||
146810325|NCT00413283|529477752|FG001|Overall Study|Ineligibility determined|0|||
146810326|NCT00413283|529477753|FG002|Overall Study|Ineligibility determined|0|||
146810327|NCT00413283|529477754|FG003|Overall Study|Ineligibility determined|1|||
146810328|NCT00413283|529477751|FG000|Overall Study|Protocol deviation|0|||
146810329|NCT00413283|529477752|FG001|Overall Study|Protocol deviation|1|||
146810330|NCT00413283|529477753|FG002|Overall Study|Protocol deviation|0|||
146810331|NCT00413283|529477754|FG003|Overall Study|Protocol deviation|0|||
146810332|NCT00413283|529477751|FG000|Overall Study|Requirement for alternative therapy|0|||
146810333|NCT00413283|529477752|FG001|Overall Study|Requirement for alternative therapy|2|||
146810334|NCT00413283|529477753|FG002|Overall Study|Requirement for alternative therapy|0|||
146810335|NCT00413283|529477754|FG003|Overall Study|Requirement for alternative therapy|0|||
146810336|NCT00413283|529477751|FG000|Overall Study|Other|0|||
146810337|NCT00413283|529477752|FG001|Overall Study|Other|0|||
146810338|NCT00413283|529477753|FG002|Overall Study|Other|1|||
146810339|NCT00413283|529477754|FG003|Overall Study|Other|0|||
146810340|NCT02002689|529477755|FG000|Overall Study|Disease Progression|7|||
146810341|NCT02002689|529477755|FG000|Overall Study|Adverse Event|3|||
146810342|NCT00671853|529477756|FG000|Overall Study|Lack of Efficacy|3|||
146810343|NCT00671853|529477757|FG001|Overall Study|Lack of Efficacy|7|||
146810344|NCT00671853|529477756|FG000|Overall Study|Adverse Event|7|||
146810345|NCT00671853|529477757|FG001|Overall Study|Adverse Event|1|||
146810346|NCT00671853|529477756|FG000|Overall Study|Withdrawal by Subject|1|||
146810347|NCT00671853|529477757|FG001|Overall Study|Withdrawal by Subject|5|||
146810348|NCT00671853|529477756|FG000|Overall Study|Lost to Follow-up|8|||
146810349|NCT00671853|529477757|FG001|Overall Study|Lost to Follow-up|8|||
146810350|NCT00671853|529477756|FG000|Overall Study|Physician Decision|0|||
146810351|NCT00671853|529477757|FG001|Overall Study|Physician Decision|2|||
146810352|NCT00671853|529477756|FG000|Overall Study|Non-adherence with study procedures|1|||
146810353|NCT00671853|529477757|FG001|Overall Study|Non-adherence with study procedures|4|||
146810354|NCT01185340|529477760|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
146810355|NCT01185340|529477761|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146810356|NCT01185340|529477762|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146810357|NCT01185340|529477763|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146810358|NCT01185340|529477760|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
146810359|NCT01185340|529477761|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146810360|NCT01185340|529477762|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146810361|NCT01185340|529477763|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146810362|NCT01185340|529477760|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
146810363|NCT01185340|529477761|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146942560|NCT03997760|529948164|FG000|Overall Study|Protocol Deviation|0|||
146942561|NCT03997760|529948165|FG001|Overall Study|Protocol Deviation|1|||
146942562|NCT03997760|529948166|FG002|Overall Study|Protocol Deviation|0|||
146942563|NCT03997760|529948167|FG003|Overall Study|Protocol Deviation|0|||
146942564|NCT05041062|529948170|FG000|Overall Study|Adverse Event|2|||
146942565|NCT01915095|529948171|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
146942566|NCT01915095|529948172|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
146942567|NCT01915095|529948173|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
146942568|NCT01915095|529948174|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
146942569|NCT01915095|529948175|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
146942570|NCT00361218|529948176|FG000|Overall Study|Lost to Follow-up|11|||
146810364|NCT01185340|529477762|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146810365|NCT01185340|529477763|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146810366|NCT01185340|529477760|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
146810367|NCT01185340|529477761|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146810368|NCT01185340|529477762|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146810369|NCT01185340|529477763|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146810370|NCT01185340|529477760|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
146810371|NCT01185340|529477761|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146810372|NCT01185340|529477762|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146810373|NCT01185340|529477763|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146942571|NCT00361218|529948176|FG000|Overall Study|Personal Reasons|7|||
146942572|NCT00361218|529948176|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
146942573|NCT01802515|529948180|FG000|Overall Study|Withdrawal by Subject|3|||
146942574|NCT01802515|529948181|FG001|Overall Study|Withdrawal by Subject|0|||
146942575|NCT01802515|529948182|FG002|Overall Study|Withdrawal by Subject|0|||
146942576|NCT01906476|529948183|FG000|Overall Study|Lost to Follow-up|17|||
146942577|NCT01906476|529948184|FG001|Overall Study|Lost to Follow-up|16|||
146942578|NCT01041404|529948187|FG000|Overall Study|Adverse Event|45|||
146942579|NCT01041404|529948188|FG001|Overall Study|Adverse Event|35|||
146942580|NCT01041404|529948187|FG000|Overall Study|Lack of Efficacy|200|||
146942581|NCT01041404|529948188|FG001|Overall Study|Lack of Efficacy|210|||
146942582|NCT01041404|529948187|FG000|Overall Study|Violation of Selection Criteria|0|||
146942583|NCT01041404|529948188|FG001|Overall Study|Violation of Selection Criteria|1|||
146942584|NCT01041404|529948187|FG000|Overall Study|Protocol Violation|4|||
146942585|NCT01041404|529948188|FG001|Overall Study|Protocol Violation|0|||
146942586|NCT01041404|529948187|FG000|Overall Study|Withdrawal by Subject|29|||
146942587|NCT01041404|529948188|FG001|Overall Study|Withdrawal by Subject|23|||
146942588|NCT01041404|529948187|FG000|Overall Study|Failure to Return|1|||
146942589|NCT01041404|529948188|FG001|Overall Study|Failure to Return|2|||
146942590|NCT01041404|529948187|FG000|Overall Study|Other|11|||
146942591|NCT01041404|529948188|FG001|Overall Study|Other|23|||
146942592|NCT01931150|529948189|FG000|Overall Study|Withdrawal by Subject|1|||
146942593|NCT01931150|529948190|FG001|Overall Study|Withdrawal by Subject|2|||
146942594|NCT04968353|529948193|FG000|Overall Study|Non-compliance|1|||
146942595|NCT04968353|529948194|FG001|Overall Study|Non-compliance|0|||
146942596|NCT04968353|529948195|FG002|Overall Study|Non-compliance|2|||
146942597|NCT04968353|529948196|FG003|Overall Study|Non-compliance|0|||
146942598|NCT01685203|529948197|FG000|Overall Study|Lost to Follow-up|3|||
146942599|NCT01685203|529948198|FG001|Overall Study|Lost to Follow-up|3|||
146942600|NCT01685203|529948199|FG002|Overall Study|Lost to Follow-up|0|||
146942601|NCT01685203|529948200|FG003|Overall Study|Lost to Follow-up|1|||
146942602|NCT01685203|529948201|FG004|Overall Study|Lost to Follow-up|0|||
146942603|NCT01685203|529948202|FG005|Overall Study|Lost to Follow-up|0|||
146942604|NCT01685203|529948203|FG006|Overall Study|Lost to Follow-up|0|||
146942605|NCT01685203|529948197|FG000|Overall Study|Adverse Event|0|||
146942606|NCT01685203|529948198|FG001|Overall Study|Adverse Event|0|||
146942607|NCT01685203|529948199|FG002|Overall Study|Adverse Event|0|||
146942608|NCT01685203|529948200|FG003|Overall Study|Adverse Event|0|||
146942609|NCT01685203|529948201|FG004|Overall Study|Adverse Event|0|||
146942610|NCT01685203|529948202|FG005|Overall Study|Adverse Event|2|||
146942611|NCT01685203|529948203|FG006|Overall Study|Adverse Event|0|||
146942612|NCT01685203|529948197|FG000|Overall Study|Adverse event and withdrew consent|1|||
146942613|NCT01685203|529948198|FG001|Overall Study|Adverse event and withdrew consent|0|||
146942614|NCT01685203|529948199|FG002|Overall Study|Adverse event and withdrew consent|0|||
146984149|NCT00415532|530103354|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
146984150|NCT00415532|530103355|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
146984151|NCT03687125|530103356|FG000|Overall Study|Progressive Disease|2|||
146984152|NCT03687125|530103357|FG001|Overall Study|Progressive Disease|1|||
146810374|NCT01185340|529477760|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
146810375|NCT01185340|529477761|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146810376|NCT01185340|529477762|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146810377|NCT01185340|529477763|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146810378|NCT01185340|529477760|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
146810379|NCT01185340|529477761|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146810380|NCT01185340|529477762|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146810381|NCT01185340|529477763|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146810382|NCT01185340|529477760|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
146810383|NCT01185340|529477761|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
146810384|NCT01185340|529477762|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
146810385|NCT01185340|529477763|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
146810386|NCT01185340|529477760|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
146810387|NCT01185340|529477761|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
146942615|NCT01685203|529948200|FG003|Overall Study|Adverse event and withdrew consent|0|||
146942616|NCT01685203|529948201|FG004|Overall Study|Adverse event and withdrew consent|0|||
146942617|NCT01685203|529948202|FG005|Overall Study|Adverse event and withdrew consent|0|||
146942618|NCT01685203|529948203|FG006|Overall Study|Adverse event and withdrew consent|0|||
146942619|NCT01685203|529948197|FG000|Overall Study|Patient's decision|0|||
146942620|NCT01685203|529948198|FG001|Overall Study|Patient's decision|0|||
146942621|NCT01685203|529948199|FG002|Overall Study|Patient's decision|0|||
146942622|NCT01685203|529948200|FG003|Overall Study|Patient's decision|0|||
146942623|NCT01685203|529948201|FG004|Overall Study|Patient's decision|0|||
146942624|NCT01685203|529948202|FG005|Overall Study|Patient's decision|1|||
146942625|NCT01685203|529948203|FG006|Overall Study|Patient's decision|0|||
146810388|NCT01185340|529477762|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
146942626|NCT02896192|529948204|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
146810389|NCT01185340|529477763|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
146810390|NCT01185340|529477760|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
146810391|NCT01185340|529477761|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
146810392|NCT01185340|529477762|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
146810393|NCT01185340|529477763|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
146810394|NCT01185340|529477760|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
146810395|NCT01185340|529477761|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
146810396|NCT01185340|529477762|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
146810397|NCT01185340|529477763|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
146810398|NCT01185340|529477760|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
146810399|NCT01185340|529477761|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
146810400|NCT01185340|529477762|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
146810401|NCT01185340|529477763|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
146810402|NCT01185340|529477760|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
146810403|NCT01185340|529477761|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
146810404|NCT01185340|529477762|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
146810405|NCT01185340|529477763|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
146810406|NCT01185340|529477760|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
146810407|NCT01185340|529477761|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
146810408|NCT01185340|529477762|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
146810409|NCT01185340|529477763|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
146810410|NCT01719172|529477764|FG000|Overall Study|Lost to Follow-up|1|||
146810411|NCT01719172|529477764|FG000|Overall Study|Death|1|||
146810412|NCT01848483|529477765|FG000|Overall Study|Death|2|||
146810413|NCT01848483|529477766|FG001|Overall Study|Death|1|||
146810414|NCT01848483|529477765|FG000|Overall Study|Lost to Follow-up|6|||
146810415|NCT01848483|529477766|FG001|Overall Study|Lost to Follow-up|8|||
146810416|NCT01848483|529477765|FG000|Overall Study|Withdrawal by Subject|1|||
146810417|NCT01848483|529477766|FG001|Overall Study|Withdrawal by Subject|0|||
146810418|NCT01848483|529477765|FG000|Overall Study|Incarceration|2|||
146810419|NCT01848483|529477766|FG001|Overall Study|Incarceration|2|||
146810420|NCT01148017|529477767|FG000|Overall Study|Withdrawal by Subject|31|||
146810421|NCT01148017|529477768|FG001|Overall Study|Withdrawal by Subject|14|||
146810422|NCT01148017|529477769|FG002|Overall Study|Withdrawal by Subject|0|||
146810423|NCT01148017|529477770|FG003|Overall Study|Withdrawal by Subject|0|||
146810424|NCT01148017|529477767|FG000|Overall Study|Lost to Follow-up|23|||
146810425|NCT01148017|529477768|FG001|Overall Study|Lost to Follow-up|10|||
146810426|NCT01148017|529477769|FG002|Overall Study|Lost to Follow-up|0|||
146810427|NCT01148017|529477770|FG003|Overall Study|Lost to Follow-up|0|||
146810428|NCT01148017|529477767|FG000|Overall Study|Inappropriate enrollment|1|||
146810429|NCT01148017|529477768|FG001|Overall Study|Inappropriate enrollment|0|||
146810430|NCT01148017|529477769|FG002|Overall Study|Inappropriate enrollment|0|||
146810431|NCT01148017|529477770|FG003|Overall Study|Inappropriate enrollment|0|||
146810432|NCT01148017|529477767|FG000|Overall Study|Administrative reason|22|||
146810433|NCT01148017|529477768|FG001|Overall Study|Administrative reason|9|||
146810434|NCT01148017|529477769|FG002|Overall Study|Administrative reason|0|||
146810435|NCT01148017|529477770|FG003|Overall Study|Administrative reason|0|||
146810436|NCT01148017|529477767|FG000|Overall Study|Unable to classify|3|||
146810437|NCT01148017|529477768|FG001|Overall Study|Unable to classify|1|||
146810438|NCT01148017|529477769|FG002|Overall Study|Unable to classify|0|||
146810439|NCT01148017|529477770|FG003|Overall Study|Unable to classify|0|||
146810440|NCT00246129|529477775|FG000|Overall Study|Lost to Follow-up|1|||
146810441|NCT00246129|529477776|FG001|Overall Study|Lost to Follow-up|0|||
146810442|NCT00246129|529477775|FG000|Overall Study|Death|2|||
146810443|NCT00246129|529477776|FG001|Overall Study|Death|1|||
146810444|NCT00246129|529477775|FG000|Overall Study|suffered primary non-function|1|||
146810445|NCT00246129|529477776|FG001|Overall Study|suffered primary non-function|0|||
146810446|NCT00246129|529477775|FG000|Overall Study|grafts failed|3|||
146810447|NCT00246129|529477776|FG001|Overall Study|grafts failed|1|||
146810448|NCT03740737|529477777|FG000|Overall Study|Protocol deviation|13|||
146810449|NCT03740737|529477778|FG001|Overall Study|Protocol deviation|0|||
146810450|NCT03740737|529477777|FG000|Overall Study|Adverse Event|2|||
146810451|NCT03740737|529477778|FG001|Overall Study|Adverse Event|0|||
146810452|NCT03740737|529477777|FG000|Overall Study|Lost to Follow-up|1|||
146810453|NCT03740737|529477778|FG001|Overall Study|Lost to Follow-up|0|||
146810454|NCT03740737|529477777|FG000|Overall Study|Randomization failure|1|||
146810455|NCT03740737|529477778|FG001|Overall Study|Randomization failure|0|||
146810456|NCT03740737|529477777|FG000|Overall Study|Participant withdrew consent|1|||
146810457|NCT03740737|529477778|FG001|Overall Study|Participant withdrew consent|0|||
146810458|NCT03740737|529477777|FG000|Overall Study|Participant withdrew from trial|2|||
146810459|NCT03740737|529477778|FG001|Overall Study|Participant withdrew from trial|1|||
146942627|NCT02896192|529948204|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
146942628|NCT02896192|529948204|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
146942629|NCT00383708|529948205|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
146942630|NCT00383708|529948205|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
146942631|NCT00383708|529948205|FG000|Run-in Period|Protocol Violation|4|||
146942632|NCT00383708|529948205|FG000|Run-in Period|Adverse Event|2|||
146942633|NCT00383708|529948205|FG000|Run-in Period|Claustrophobia|1|||
146942634|NCT00383708|529948205|FG000|Co-administration Period|Adverse Event|5|||
146942635|NCT00318370|529948206|FG000|Period 1|Lack of Efficacy|5|||
146810460|NCT03469258|529477779|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
146810461|NCT02236611|529477782|FG000|Overall Study|Adverse Event|10|||
146810462|NCT02236611|529477783|FG001|Overall Study|Adverse Event|16|||
146810463|NCT02236611|529477782|FG000|Overall Study|Lack of Efficacy|4|||
146810464|NCT02236611|529477783|FG001|Overall Study|Lack of Efficacy|7|||
146810465|NCT02236611|529477782|FG000|Overall Study|Lost to Follow-up|0|||
146810466|NCT02236611|529477783|FG001|Overall Study|Lost to Follow-up|2|||
146810467|NCT02236611|529477782|FG000|Overall Study|Protocol deviation|3|||
146810468|NCT02236611|529477783|FG001|Overall Study|Protocol deviation|5|||
146810469|NCT02236611|529477782|FG000|Overall Study|Withdrew consent|9|||
146810470|NCT02236611|529477783|FG001|Overall Study|Withdrew consent|4|||
146810471|NCT03041090|529477784|FG000|Overall Study|technical error|0|||
146810472|NCT03041090|529477785|FG001|Overall Study|technical error|3|||
146810473|NCT03403036|529477786|FG000|Overall Study|Lack of Efficacy|5|||
146810474|NCT01128959|529477787|FG000|Lead in Period|Adverse Event|3|||
146810475|NCT01128959|529477787|FG000|Treatment Period|Adverse Event|3|||
146810476|NCT01128959|529477787|FG000|Treatment Period|Withdrawal by Subject|1|||
146810477|NCT02338999|529477788|FG000|First Intervention|Withdrawal by Subject|3|||
146810478|NCT02338999|529477789|FG001|First Intervention|Withdrawal by Subject|1|||
146810479|NCT02338999|529477788|FG000|Washout Period|Withdrawal by Subject|0|||
146810480|NCT02338999|529477789|FG001|Washout Period|Withdrawal by Subject|2|||
146810481|NCT02338999|529477788|FG000|Second Intervention|Withdrawal by Subject|0|||
146810482|NCT02338999|529477789|FG001|Second Intervention|Withdrawal by Subject|2|||
146810483|NCT02701296|529477790|FG000|Overall Study|Incomplete Data|0|||
146810484|NCT02701296|529477791|FG001|Overall Study|Incomplete Data|2|||
146810485|NCT01409837|529477794|FG000|Overall Study|Withdrawal by Subject|2|||
146810486|NCT01409837|529477795|FG001|Overall Study|Withdrawal by Subject|1|||
146810487|NCT01409837|529477794|FG000|Overall Study|Lost to Follow-up|1|||
146810488|NCT01409837|529477795|FG001|Overall Study|Lost to Follow-up|0|||
146810489|NCT01409837|529477794|FG000|Overall Study|Physician Decision|0|||
146810490|NCT01409837|529477795|FG001|Overall Study|Physician Decision|1|||
146810491|NCT03490032|529477797|FG000|Overall Study|family issue (child custody)|1|||
146810492|NCT03490032|529477798|FG001|Overall Study|family issue (child custody)|0|||
146810493|NCT03490032|529477799|FG002|Overall Study|family issue (child custody)|0|||
146810494|NCT00308308|529477800|FG000|Overall Study|Adverse Event|17|||
146810495|NCT00308308|529477801|FG001|Overall Study|Adverse Event|2|||
146810496|NCT00308308|529477800|FG000|Overall Study|Lost to Follow-up|5|||
146942636|NCT00318370|529948207|FG001|Period 1|Lack of Efficacy|0|||
146942637|NCT00318370|529948208|FG002|Period 1|Lack of Efficacy|0|||
146942638|NCT00318370|529948206|FG000|Period 1|Physician Decision|1|||
146942639|NCT00318370|529948207|FG001|Period 1|Physician Decision|0|||
146942640|NCT00318370|529948208|FG002|Period 1|Physician Decision|0|||
146942641|NCT00318370|529948206|FG000|Period 1|Withdrawal by Subject|1|||
146942642|NCT00318370|529948207|FG001|Period 1|Withdrawal by Subject|0|||
146942643|NCT00318370|529948208|FG002|Period 1|Withdrawal by Subject|0|||
146942644|NCT00318370|529948206|FG000|Period 2|Adverse Event|0|||
146942645|NCT00318370|529948207|FG001|Period 2|Adverse Event|3|||
146942646|NCT00318370|529948208|FG002|Period 2|Adverse Event|0|||
146942647|NCT00318370|529948206|FG000|Period 2|Lack of Efficacy|0|||
146942648|NCT00318370|529948207|FG001|Period 2|Lack of Efficacy|5|||
146942649|NCT00318370|529948208|FG002|Period 2|Lack of Efficacy|0|||
146942650|NCT00318370|529948206|FG000|Period 2|Physician Decision|0|||
146942651|NCT00318370|529948207|FG001|Period 2|Physician Decision|1|||
146942652|NCT00318370|529948208|FG002|Period 2|Physician Decision|0|||
146942653|NCT00318370|529948206|FG000|Period 2|Withdrawal by Subject|0|||
146942654|NCT00318370|529948207|FG001|Period 2|Withdrawal by Subject|1|||
146942655|NCT00318370|529948208|FG002|Period 2|Withdrawal by Subject|0|||
146942656|NCT00318370|529948206|FG000|Period 2|Other|0|||
146942657|NCT00318370|529948207|FG001|Period 2|Other|1|||
146942658|NCT00318370|529948208|FG002|Period 2|Other|0|||
146942659|NCT00318370|529948206|FG000|Period 3|Adverse Event|0|||
146942660|NCT00318370|529948207|FG001|Period 3|Adverse Event|0|||
146810497|NCT00308308|529477801|FG001|Overall Study|Lost to Follow-up|5|||
146810498|NCT00308308|529477800|FG000|Overall Study|Physician Decision|15|||
146810499|NCT00308308|529477801|FG001|Overall Study|Physician Decision|7|||
146810500|NCT00308308|529477800|FG000|Overall Study|Protocol Violation|3|||
146810501|NCT00308308|529477801|FG001|Overall Study|Protocol Violation|14|||
146810502|NCT00308308|529477800|FG000|Overall Study|Withdrawal by Subject|47|||
146810503|NCT00308308|529477801|FG001|Overall Study|Withdrawal by Subject|19|||
146810504|NCT00308308|529477800|FG000|Overall Study|Various|7|||
146810505|NCT00308308|529477801|FG001|Overall Study|Various|5|||
146810506|NCT00308308|529477800|FG000|Overall Study|Randomized but not dosed|8|||
146942661|NCT00318370|529948208|FG002|Period 3|Adverse Event|1|||
146942662|NCT00318370|529948206|FG000|Period 3|Lack of Efficacy|0|||
146810507|NCT00308308|529477801|FG001|Overall Study|Randomized but not dosed|16|||
146810508|NCT00308308|529477800|FG000|Overall Study|Other|1|||
146810509|NCT00308308|529477801|FG001|Overall Study|Other|0|||
146810510|NCT01021748|529477804|FG000|Overall Study|Adverse Event|2|||
146810511|NCT01021748|529477805|FG001|Overall Study|Adverse Event|1|||
146810512|NCT01021748|529477806|FG002|Overall Study|Adverse Event|2|||
146810513|NCT01021748|529477807|FG003|Overall Study|Adverse Event|0|||
146810514|NCT01021748|529477808|FG004|Overall Study|Adverse Event|2|||
146810515|NCT01021748|529477809|FG005|Overall Study|Adverse Event|0|||
146810516|NCT01021748|529477810|FG006|Overall Study|Adverse Event|1|||
146810517|NCT01021748|529477811|FG007|Overall Study|Adverse Event|0|||
146810518|NCT01021748|529477812|FG008|Overall Study|Adverse Event|7|||
146810519|NCT01021748|529477804|FG000|Overall Study|Physician Decision|1|||
146810520|NCT01021748|529477805|FG001|Overall Study|Physician Decision|0|||
146810521|NCT01021748|529477806|FG002|Overall Study|Physician Decision|1|||
146810522|NCT01021748|529477807|FG003|Overall Study|Physician Decision|1|||
146810523|NCT01021748|529477808|FG004|Overall Study|Physician Decision|0|||
146810524|NCT01021748|529477809|FG005|Overall Study|Physician Decision|0|||
146810525|NCT01021748|529477810|FG006|Overall Study|Physician Decision|1|||
146810526|NCT01021748|529477811|FG007|Overall Study|Physician Decision|1|||
146810527|NCT01021748|529477812|FG008|Overall Study|Physician Decision|2|||
146810528|NCT01021748|529477804|FG000|Overall Study|Progressive Disease|3|||
146810529|NCT01021748|529477805|FG001|Overall Study|Progressive Disease|3|||
146810530|NCT01021748|529477806|FG002|Overall Study|Progressive Disease|4|||
146810531|NCT01021748|529477807|FG003|Overall Study|Progressive Disease|6|||
146810532|NCT01021748|529477808|FG004|Overall Study|Progressive Disease|7|||
146810533|NCT01021748|529477809|FG005|Overall Study|Progressive Disease|3|||
146810534|NCT01021748|529477810|FG006|Overall Study|Progressive Disease|0|||
146810535|NCT01021748|529477811|FG007|Overall Study|Progressive Disease|5|||
146810536|NCT01021748|529477812|FG008|Overall Study|Progressive Disease|6|||
146810537|NCT01021748|529477804|FG000|Overall Study|Withdrawal by Subject|0|||
146810538|NCT01021748|529477805|FG001|Overall Study|Withdrawal by Subject|0|||
146810539|NCT01021748|529477806|FG002|Overall Study|Withdrawal by Subject|0|||
146810540|NCT01021748|529477807|FG003|Overall Study|Withdrawal by Subject|0|||
146810541|NCT01021748|529477808|FG004|Overall Study|Withdrawal by Subject|0|||
146810542|NCT01021748|529477809|FG005|Overall Study|Withdrawal by Subject|0|||
146810543|NCT01021748|529477810|FG006|Overall Study|Withdrawal by Subject|1|||
146810544|NCT01021748|529477811|FG007|Overall Study|Withdrawal by Subject|0|||
146810545|NCT01021748|529477812|FG008|Overall Study|Withdrawal by Subject|1|||
146810546|NCT01021748|529477804|FG000|Overall Study|Not Treated|0|||
146810547|NCT01021748|529477805|FG001|Overall Study|Not Treated|1|||
146810548|NCT01021748|529477806|FG002|Overall Study|Not Treated|0|||
146810549|NCT01021748|529477807|FG003|Overall Study|Not Treated|0|||
146810550|NCT01021748|529477808|FG004|Overall Study|Not Treated|0|||
146810551|NCT01021748|529477809|FG005|Overall Study|Not Treated|0|||
146810552|NCT01021748|529477810|FG006|Overall Study|Not Treated|0|||
146810553|NCT01021748|529477811|FG007|Overall Study|Not Treated|0|||
146810554|NCT01021748|529477812|FG008|Overall Study|Not Treated|0|||
146810555|NCT01829711|529477813|FG000|Overall Study|Lost to Follow-up|2|||
146810556|NCT01829711|529477813|FG000|Overall Study|Withdrawal by Subject|3|||
146810557|NCT01829711|529477813|FG000|Overall Study|Death|4|||
146810558|NCT01829711|529477813|FG000|Overall Study|Started new therapies|17|||
146810559|NCT01829711|529477813|FG000|Overall Study|Adverse Event|3|||
146810560|NCT01829711|529477813|FG000|Overall Study|Due to progression of disease|13|||
146810561|NCT01829711|529477813|FG000|Overall Study|Due to lack of response|1|||
146810562|NCT02935673|529477816|FG000|Overall Study|Adverse Event|0|||
146810563|NCT02935673|529477817|FG001|Overall Study|Adverse Event|1|||
146810564|NCT02935673|529477818|FG002|Overall Study|Adverse Event|0|||
146810565|NCT02935673|529477816|FG000|Overall Study|Withdrawal by Subject|1|||
146810566|NCT02935673|529477817|FG001|Overall Study|Withdrawal by Subject|2|||
146810567|NCT02935673|529477818|FG002|Overall Study|Withdrawal by Subject|0|||
146810568|NCT04679675|529477819|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
146810569|NCT04679675|529477820|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
146810570|NCT04679675|529477821|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
146810571|NCT04679675|529477822|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
146810572|NCT04679675|529477819|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
146810573|NCT04679675|529477820|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
146942663|NCT00318370|529948207|FG001|Period 3|Lack of Efficacy|0|||
146942664|NCT00318370|529948208|FG002|Period 3|Lack of Efficacy|24|||
146942665|NCT00318370|529948206|FG000|Period 3|Death|0|||
146810574|NCT04679675|529477821|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
146810575|NCT04679675|529477822|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
146810576|NCT01228734|529477826|FG000|Overall Study|Randomized, but not treated|0|||
146810577|NCT01228734|529477827|FG001|Overall Study|Randomized, but not treated|4|||
146810578|NCT00089791|529477828|FG000|Overall Study|Physician Decision|6|||
146810579|NCT00089791|529477829|FG001|Overall Study|Physician Decision|3|||
146942666|NCT00318370|529948207|FG001|Period 3|Death|0|||
146810580|NCT00089791|529477828|FG000|Overall Study|Adverse Event|81|||
146810581|NCT00089791|529477829|FG001|Overall Study|Adverse Event|93|||
146810582|NCT00089791|529477828|FG000|Overall Study|Withdrawal by Subject|403|||
146810583|NCT00089791|529477829|FG001|Overall Study|Withdrawal by Subject|344|||
146810584|NCT00089791|529477828|FG000|Overall Study|Death|78|||
146810585|NCT00089791|529477829|FG001|Overall Study|Death|62|||
146810586|NCT00089791|529477828|FG000|Overall Study|Disease progression|7|||
146810587|NCT00089791|529477829|FG001|Overall Study|Disease progression|3|||
146810588|NCT00089791|529477828|FG000|Overall Study|Ineligibility determined|12|||
146810589|NCT00089791|529477829|FG001|Overall Study|Ineligibility determined|9|||
146810590|NCT00089791|529477828|FG000|Overall Study|Lost to Follow-up|57|||
146810591|NCT00089791|529477829|FG001|Overall Study|Lost to Follow-up|57|||
146810592|NCT00089791|529477828|FG000|Overall Study|Noncompliance|17|||
146810593|NCT00089791|529477829|FG001|Overall Study|Noncompliance|13|||
146810594|NCT00089791|529477828|FG000|Overall Study|Other|20|||
146810595|NCT00089791|529477829|FG001|Overall Study|Other|32|||
146810596|NCT00089791|529477828|FG000|Overall Study|Protocol deviation|12|||
146810597|NCT00089791|529477829|FG001|Overall Study|Protocol deviation|10|||
146810598|NCT00089791|529477828|FG000|Overall Study|Requirement for alternative therapy|7|||
146810599|NCT00089791|529477829|FG001|Overall Study|Requirement for alternative therapy|4|||
146810600|NCT02449902|529477832|FG000|Overall Study|Adverse Event|0|||
146810601|NCT02449902|529477833|FG001|Overall Study|Adverse Event|1|||
146810602|NCT02449902|529477832|FG000|Overall Study|Withdrawal by Subject|0|||
146810603|NCT02449902|529477833|FG001|Overall Study|Withdrawal by Subject|1|||
146810604|NCT02362789|529477837|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
146810605|NCT02362789|529477838|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
146810606|NCT02362789|529477839|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
146810607|NCT02362789|529477837|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
146810608|NCT02362789|529477838|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
146810609|NCT02362789|529477839|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
146810610|NCT02362789|529477837|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
146810611|NCT02362789|529477838|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
146810612|NCT02362789|529477839|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
146810613|NCT02362789|529477837|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
146810614|NCT02362789|529477838|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
146810615|NCT02362789|529477839|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
146810616|NCT02362789|529477837|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
146810617|NCT02362789|529477838|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
146810618|NCT02362789|529477839|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
146810619|NCT01365546|529477840|FG000|Overall Study|Withdrawal by Subject|1|||
146810620|NCT01365546|529477840|FG000|Overall Study|Screen failure|9|||
146810621|NCT01365546|529477840|FG000|Overall Study|Study termination|1|||
146810622|NCT03861234|529477842|FG000|Overall Study|Not treated|0|||
146810623|NCT03861234|529477843|FG001|Overall Study|Not treated|0|||
146810624|NCT03861234|529477844|FG002|Overall Study|Not treated|0|||
146810625|NCT03861234|529477845|FG003|Overall Study|Not treated|0|||
146810626|NCT03861234|529477846|FG004|Overall Study|Not treated|0|||
146810627|NCT03861234|529477847|FG005|Overall Study|Not treated|1|||
146810628|NCT03861234|529477848|FG006|Overall Study|Not treated|0|||
146810629|NCT03861234|529477849|FG007|Overall Study|Not treated|0|||
146810630|NCT03861234|529477842|FG000|Overall Study|Adverse Event|0|||
146810631|NCT03861234|529477843|FG001|Overall Study|Adverse Event|0|||
146810632|NCT03861234|529477844|FG002|Overall Study|Adverse Event|0|||
146810633|NCT03861234|529477845|FG003|Overall Study|Adverse Event|0|||
146810634|NCT03861234|529477846|FG004|Overall Study|Adverse Event|0|||
146810635|NCT03861234|529477847|FG005|Overall Study|Adverse Event|1|||
146810636|NCT03861234|529477848|FG006|Overall Study|Adverse Event|0|||
146810637|NCT03861234|529477849|FG007|Overall Study|Adverse Event|0|||
146810638|NCT03861234|529477842|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
146810639|NCT03861234|529477843|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
146810640|NCT03861234|529477844|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
146810641|NCT03861234|529477845|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
146942667|NCT00318370|529948208|FG002|Period 3|Death|1|||
146810642|NCT03861234|529477846|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
146810643|NCT03861234|529477847|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
146810644|NCT03861234|529477848|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
146810645|NCT03861234|529477849|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
146810646|NCT03861234|529477842|FG000|Overall Study|As per sponsor decision|0|||
146810647|NCT03861234|529477843|FG001|Overall Study|As per sponsor decision|0|||
146810648|NCT03861234|529477844|FG002|Overall Study|As per sponsor decision|0|||
146810649|NCT03861234|529477845|FG003|Overall Study|As per sponsor decision|0|||
146810650|NCT03861234|529477846|FG004|Overall Study|As per sponsor decision|0|||
146810651|NCT03861234|529477847|FG005|Overall Study|As per sponsor decision|0|||
146810652|NCT03861234|529477848|FG006|Overall Study|As per sponsor decision|1|||
146810653|NCT03861234|529477849|FG007|Overall Study|As per sponsor decision|0|||
146810654|NCT03861234|529477842|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
146810655|NCT03861234|529477843|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
146810656|NCT03861234|529477844|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
146810657|NCT03861234|529477845|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
146810658|NCT03861234|529477846|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
146810659|NCT03861234|529477847|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
146810660|NCT03861234|529477848|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
146810661|NCT03861234|529477849|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
146810662|NCT00621842|529477850|FG000|Overall Study|Adverse Event|6|||
146810663|NCT00621842|529477850|FG000|Overall Study|Withdrawal by Subject|7|||
146810664|NCT00621842|529477850|FG000|Overall Study|Protocol Violation|4|||
146810665|NCT00621842|529477850|FG000|Overall Study|Lack of Efficacy|2|||
146810666|NCT05074433|529477852|FG000|Overall Study|Adverse Event|0|||
146810667|NCT05074433|529477853|FG001|Overall Study|Adverse Event|2|||
146810668|NCT05074433|529477854|FG002|Overall Study|Adverse Event|0|||
146810669|NCT05074433|529477855|FG003|Overall Study|Adverse Event|1|||
146810670|NCT05074433|529477852|FG000|Overall Study|Sponsor Request|0|||
146810671|NCT05074433|529477853|FG001|Overall Study|Sponsor Request|1|||
146810672|NCT05074433|529477854|FG002|Overall Study|Sponsor Request|1|||
146810673|NCT05074433|529477855|FG003|Overall Study|Sponsor Request|0|||
146810674|NCT05074433|529477852|FG000|Overall Study|Death|1|||
146810675|NCT05074433|529477853|FG001|Overall Study|Death|0|||
146810676|NCT05074433|529477854|FG002|Overall Study|Death|0|||
146810677|NCT05074433|529477855|FG003|Overall Study|Death|0|||
146810678|NCT05074433|529477852|FG000|Overall Study|Lost to Follow-up|0|||
146810679|NCT05074433|529477853|FG001|Overall Study|Lost to Follow-up|0|||
146810680|NCT05074433|529477854|FG002|Overall Study|Lost to Follow-up|2|||
146810681|NCT05074433|529477855|FG003|Overall Study|Lost to Follow-up|0|||
146810682|NCT05074433|529477852|FG000|Overall Study|Subject Decision|8|||
146810683|NCT05074433|529477853|FG001|Overall Study|Subject Decision|6|||
146810684|NCT05074433|529477854|FG002|Overall Study|Subject Decision|4|||
146810685|NCT05074433|529477855|FG003|Overall Study|Subject Decision|5|||
146810686|NCT04397263|529477856|FG000|Overall Study|Withdrawal by Subject|2|||
146810687|NCT03026166|529477866|FG000|Overall Study|Death|22|||
146810688|NCT03026166|529477867|FG001|Overall Study|Death|7|||
146810689|NCT03026166|529477866|FG000|Overall Study|Physician Decision|2|||
146810690|NCT03026166|529477867|FG001|Overall Study|Physician Decision|0|||
146810691|NCT03026166|529477866|FG000|Overall Study|Withdrawal by Subject|1|||
146810692|NCT03026166|529477867|FG001|Overall Study|Withdrawal by Subject|2|||
146810693|NCT03026166|529477866|FG000|Overall Study|Lost to Follow-up|1|||
146810694|NCT03026166|529477867|FG001|Overall Study|Lost to Follow-up|0|||
146810695|NCT03026166|529477866|FG000|Overall Study|Study Terminated by Sponsor|3|||
146810696|NCT03026166|529477867|FG001|Overall Study|Study Terminated by Sponsor|3|||
146810697|NCT03026166|529477866|FG000|Overall Study|Other|1|||
146810698|NCT03026166|529477867|FG001|Overall Study|Other|0|||
146810699|NCT05270460|529477868|FG000|Overall Study|Adverse Event|0|||
146810700|NCT05270460|529477869|FG001|Overall Study|Adverse Event|1|||
146810701|NCT05270460|529477870|FG002|Overall Study|Adverse Event|0|||
146810702|NCT05270460|529477868|FG000|Overall Study|Early Termination|0|||
146810703|NCT05270460|529477869|FG001|Overall Study|Early Termination|1|||
146810704|NCT05270460|529477870|FG002|Overall Study|Early Termination|0|||
146810705|NCT00380250|529477871|FG000|Overall Study|Withdrawal by Subject|39|||
146810706|NCT00380250|529477872|FG001|Overall Study|Withdrawal by Subject|28|||
146810707|NCT00380250|529477871|FG000|Overall Study|Adverse Event|20|||
146810708|NCT00380250|529477872|FG001|Overall Study|Adverse Event|9|||
146810709|NCT00380250|529477871|FG000|Overall Study|Lack of Efficacy|10|||
146810710|NCT00380250|529477872|FG001|Overall Study|Lack of Efficacy|8|||
146810711|NCT00380250|529477871|FG000|Overall Study|Protocol Violation|15|||
146942668|NCT00318370|529948206|FG000|Period 3|Physician Decision|0|||
146810712|NCT00380250|529477872|FG001|Overall Study|Protocol Violation|5|||
146810713|NCT00380250|529477871|FG000|Overall Study|Lost to Follow-up|14|||
146810714|NCT00380250|529477872|FG001|Overall Study|Lost to Follow-up|5|||
146810715|NCT00380250|529477871|FG000|Overall Study|Physician Decision|1|||
146810716|NCT00380250|529477872|FG001|Overall Study|Physician Decision|0|||
146810717|NCT00680771|529477873|FG000|Overall Study|Withdrawal by Subject|1|||
146810718|NCT00680771|529477874|FG001|Overall Study|Withdrawal by Subject|0|||
146810719|NCT00680771|529477873|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
146942669|NCT00318370|529948207|FG001|Period 3|Physician Decision|0|||
146942670|NCT00318370|529948208|FG002|Period 3|Physician Decision|1|||
146810720|NCT00680771|529477874|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
146810721|NCT00680771|529477873|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
146810722|NCT00680771|529477874|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
146810723|NCT02691702|529477875|FG000|Overall Study|Adverse Event|1|||
146810724|NCT02691702|529477876|FG001|Overall Study|Adverse Event|0|||
146810725|NCT02691702|529477877|FG002|Overall Study|Adverse Event|0|||
146810726|NCT02691702|529477878|FG003|Overall Study|Adverse Event|0|||
146810727|NCT02691702|529477879|FG004|Overall Study|Adverse Event|0|||
146810728|NCT02691702|529477880|FG005|Overall Study|Adverse Event|0|||
146810729|NCT02691702|529477881|FG006|Overall Study|Adverse Event|0|||
146810730|NCT02691702|529477882|FG007|Overall Study|Adverse Event|0|||
146810731|NCT02691702|529477883|FG008|Overall Study|Adverse Event|1|||
146810732|NCT02691702|529477884|FG009|Overall Study|Adverse Event|0|||
146810733|NCT02691702|529477885|FG010|Overall Study|Adverse Event|1|||
146810734|NCT02691702|529477875|FG000|Overall Study|Lost to Follow-up|0|||
146810735|NCT02691702|529477876|FG001|Overall Study|Lost to Follow-up|0|||
146810736|NCT02691702|529477877|FG002|Overall Study|Lost to Follow-up|1|||
146810737|NCT02691702|529477878|FG003|Overall Study|Lost to Follow-up|0|||
146810738|NCT02691702|529477879|FG004|Overall Study|Lost to Follow-up|0|||
146810739|NCT02691702|529477880|FG005|Overall Study|Lost to Follow-up|2|||
146810740|NCT02691702|529477881|FG006|Overall Study|Lost to Follow-up|0|||
146810741|NCT02691702|529477882|FG007|Overall Study|Lost to Follow-up|0|||
146810742|NCT02691702|529477883|FG008|Overall Study|Lost to Follow-up|0|||
146810743|NCT02691702|529477884|FG009|Overall Study|Lost to Follow-up|0|||
146810744|NCT02691702|529477885|FG010|Overall Study|Lost to Follow-up|1|||
146810745|NCT02691702|529477875|FG000|Overall Study|Withdrawal by Subject|1|||
146810746|NCT02691702|529477876|FG001|Overall Study|Withdrawal by Subject|1|||
146810747|NCT02691702|529477877|FG002|Overall Study|Withdrawal by Subject|0|||
146810748|NCT02691702|529477878|FG003|Overall Study|Withdrawal by Subject|0|||
146810749|NCT02691702|529477879|FG004|Overall Study|Withdrawal by Subject|0|||
146810750|NCT02691702|529477880|FG005|Overall Study|Withdrawal by Subject|1|||
146810751|NCT02691702|529477881|FG006|Overall Study|Withdrawal by Subject|2|||
146810752|NCT02691702|529477882|FG007|Overall Study|Withdrawal by Subject|0|||
146810753|NCT02691702|529477883|FG008|Overall Study|Withdrawal by Subject|0|||
146810754|NCT02691702|529477884|FG009|Overall Study|Withdrawal by Subject|0|||
146810755|NCT02691702|529477885|FG010|Overall Study|Withdrawal by Subject|0|||
146810756|NCT02691702|529477875|FG000|Overall Study|Other|0|||
146810757|NCT02691702|529477876|FG001|Overall Study|Other|0|||
146810758|NCT02691702|529477877|FG002|Overall Study|Other|0|||
146810759|NCT02691702|529477878|FG003|Overall Study|Other|0|||
146810760|NCT02691702|529477879|FG004|Overall Study|Other|0|||
146810761|NCT02691702|529477880|FG005|Overall Study|Other|0|||
146810762|NCT02691702|529477881|FG006|Overall Study|Other|1|||
146942671|NCT00318370|529948206|FG000|Period 3|Withdrawal by Subject|0|||
146942672|NCT00318370|529948207|FG001|Period 3|Withdrawal by Subject|0|||
146942673|NCT00318370|529948208|FG002|Period 3|Withdrawal by Subject|3|||
146942674|NCT00318370|529948206|FG000|Period 3|Other|0|||
146942675|NCT00318370|529948207|FG001|Period 3|Other|0|||
146942676|NCT00318370|529948208|FG002|Period 3|Other|3|||
146942677|NCT01750840|529948212|FG000|Overall Study|Lost to Follow-up|4|||
146942678|NCT01997281|529948213|FG000|Overall Study|Withdrawal by Subject|1|||
146942679|NCT01997281|529948214|FG001|Overall Study|Withdrawal by Subject|0|||
146942680|NCT01696396|529949555|FG000|Overall Study|Withdrawal by Subject|19|||
146942681|NCT01696396|529949556|FG001|Overall Study|Withdrawal by Subject|5|||
146942682|NCT01696396|529949557|FG002|Overall Study|Withdrawal by Subject|19|||
146942683|NCT01696396|529949558|FG003|Overall Study|Withdrawal by Subject|11|||
146942684|NCT01696396|529949555|FG000|Overall Study|Decision by Sponsor|3|||
146942685|NCT01696396|529949556|FG001|Overall Study|Decision by Sponsor|1|||
146942686|NCT01696396|529949557|FG002|Overall Study|Decision by Sponsor|2|||
146942687|NCT01696396|529949558|FG003|Overall Study|Decision by Sponsor|2|||
146942688|NCT01696396|529949555|FG000|Overall Study|Lost to Follow-up|9|||
146942689|NCT01696396|529949556|FG001|Overall Study|Lost to Follow-up|1|||
146942690|NCT01696396|529949557|FG002|Overall Study|Lost to Follow-up|4|||
146942691|NCT01696396|529949558|FG003|Overall Study|Lost to Follow-up|1|||
146942692|NCT01696396|529949555|FG000|Overall Study|Death|0|||
146942693|NCT01696396|529949556|FG001|Overall Study|Death|0|||
146810763|NCT02691702|529477882|FG007|Overall Study|Other|0|||
146942694|NCT01696396|529949557|FG002|Overall Study|Death|1|||
146942695|NCT01696396|529949558|FG003|Overall Study|Death|0|||
146942696|NCT02712008|529949559|FG000|Baseline (Day 1) up to Week 12|Death|3|||
146942697|NCT02712008|529949560|FG001|Baseline (Day 1) up to Week 12|Death|0|||
146942698|NCT02712008|529949561|FG002|Baseline (Day 1) up to Week 12|Death|0|||
146942699|NCT02712008|529949562|FG003|Baseline (Day 1) up to Week 12|Death|0|||
146810764|NCT02691702|529477883|FG008|Overall Study|Other|1|||
146810765|NCT02691702|529477884|FG009|Overall Study|Other|0|||
146810766|NCT02691702|529477885|FG010|Overall Study|Other|0|||
146810767|NCT02691702|529477875|FG000|Overall Study|Protocol Violation|0|||
146810768|NCT02691702|529477876|FG001|Overall Study|Protocol Violation|0|||
146810769|NCT02691702|529477877|FG002|Overall Study|Protocol Violation|0|||
146810770|NCT02691702|529477878|FG003|Overall Study|Protocol Violation|0|||
146942700|NCT02712008|529949563|FG004|Baseline (Day 1) up to Week 12|Death|0|||
146942701|NCT02712008|529949564|FG005|Baseline (Day 1) up to Week 12|Death|0|||
146942702|NCT02712008|529949565|FG006|Baseline (Day 1) up to Week 12|Death|0|||
146942703|NCT02712008|529949566|FG007|Baseline (Day 1) up to Week 12|Death|0|||
146942704|NCT02712008|529949559|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146810771|NCT02691702|529477879|FG004|Overall Study|Protocol Violation|0|||
146810772|NCT02691702|529477880|FG005|Overall Study|Protocol Violation|0|||
146810773|NCT02691702|529477881|FG006|Overall Study|Protocol Violation|0|||
146984153|NCT03687125|530103356|FG000|Overall Study|Protocol Violation|1|||
146810774|NCT02691702|529477882|FG007|Overall Study|Protocol Violation|0|||
146810775|NCT02691702|529477883|FG008|Overall Study|Protocol Violation|0|||
146810776|NCT02691702|529477884|FG009|Overall Study|Protocol Violation|2|||
146810777|NCT02691702|529477885|FG010|Overall Study|Protocol Violation|0|||
146810778|NCT05613088|529477886|FG000|Treatment|Ongoing Study Treatment|9|||
146810779|NCT05613088|529477887|FG001|Treatment|Ongoing Study Treatment|2|||
146810780|NCT05613088|529477886|FG000|Treatment|Adverse Event|3|||
146810781|NCT05613088|529477887|FG001|Treatment|Adverse Event|1|||
146810782|NCT05613088|529477886|FG000|Treatment|Other Reasons|0|||
146810783|NCT05613088|529477887|FG001|Treatment|Other Reasons|1|||
146810784|NCT05613088|529477886|FG000|Treatment|Progressive Disease|58|||
146810785|NCT05613088|529477887|FG001|Treatment|Progressive Disease|26|||
146810786|NCT05613088|529477886|FG000|Treatment|Withdrawal by Subject|0|||
146810787|NCT05613088|529477887|FG001|Treatment|Withdrawal by Subject|4|||
146810788|NCT01668719|529477888|FG000|Phase I|On treatment|1|||
146810789|NCT01668719|529477889|FG001|Phase I|On treatment|0|||
146810790|NCT01668719|529477890|FG002|Phase I|On treatment|0|||
146810791|NCT01668719|529477888|FG000|Phase I|Adverse Event|2|||
146810792|NCT01668719|529477889|FG001|Phase I|Adverse Event|0|||
146810793|NCT01668719|529477890|FG002|Phase I|Adverse Event|0|||
146810794|NCT01668719|529477888|FG000|Phase I|Progression/relapse|1|||
146810795|NCT01668719|529477889|FG001|Phase I|Progression/relapse|0|||
146810796|NCT01668719|529477890|FG002|Phase I|Progression/relapse|0|||
146810797|NCT01668719|529477888|FG000|Phase I|not protocol specified|2|||
146810798|NCT01668719|529477889|FG001|Phase I|not protocol specified|0|||
146810799|NCT01668719|529477890|FG002|Phase I|not protocol specified|0|||
146810800|NCT01668719|529477888|FG000|Phase II|On treatment|0|||
146810801|NCT01668719|529477889|FG001|Phase II|On treatment|4|||
146810802|NCT01668719|529477890|FG002|Phase II|On treatment|3|||
146810803|NCT01668719|529477888|FG000|Phase II|Adverse Event|0|||
146810804|NCT01668719|529477889|FG001|Phase II|Adverse Event|18|||
146810805|NCT01668719|529477890|FG002|Phase II|Adverse Event|18|||
146810806|NCT01668719|529477888|FG000|Phase II|Refusal unrelated to adverse event|0|||
146942705|NCT02712008|529949560|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
146942706|NCT02712008|529949561|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
146942707|NCT02712008|529949562|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146942708|NCT02712008|529949563|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146942709|NCT02712008|529949564|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146942710|NCT02712008|529949565|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146942711|NCT02712008|529949566|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146942712|NCT02712008|529949559|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
146942713|NCT02712008|529949560|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146942714|NCT02712008|529949561|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
146942715|NCT02712008|529949562|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146942716|NCT02712008|529949563|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146942717|NCT02712008|529949564|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146942718|NCT02712008|529949565|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146942719|NCT02712008|529949566|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146942720|NCT02712008|529949559|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
146942721|NCT02712008|529949560|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
146942722|NCT02712008|529949561|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
146942723|NCT02712008|529949562|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
146942724|NCT02712008|529949563|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
146942725|NCT02712008|529949564|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
146942726|NCT02712008|529949565|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
146942727|NCT02712008|529949566|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
146942728|NCT02712008|529949559|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
146942729|NCT02712008|529949560|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
146942730|NCT02712008|529949561|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
146942731|NCT02712008|529949562|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
146942732|NCT02712008|529949563|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
146942733|NCT02712008|529949564|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
146942734|NCT02712008|529949565|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
146942735|NCT02712008|529949566|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
146942736|NCT02712008|529949559|FG000|From Week 12 up to Week 36|Adverse Event|0|||
146942737|NCT02712008|529949560|FG001|From Week 12 up to Week 36|Adverse Event|0|||
146942738|NCT02712008|529949561|FG002|From Week 12 up to Week 36|Adverse Event|0|||
146984154|NCT03687125|530103357|FG001|Overall Study|Protocol Violation|0|||
146810807|NCT01668719|529477889|FG001|Phase II|Refusal unrelated to adverse event|4|||
146810808|NCT01668719|529477890|FG002|Phase II|Refusal unrelated to adverse event|1|||
146810809|NCT01668719|529477888|FG000|Phase II|Progression/relapse|0|||
146810810|NCT01668719|529477889|FG001|Phase II|Progression/relapse|13|||
146810811|NCT01668719|529477890|FG002|Phase II|Progression/relapse|17|||
146810812|NCT01668719|529477888|FG000|Phase II|Death|0|||
146810813|NCT01668719|529477889|FG001|Phase II|Death|0|||
146810814|NCT01668719|529477890|FG002|Phase II|Death|2|||
146810815|NCT01668719|529477888|FG000|Phase II|not protocol specified|0|||
146984155|NCT01992107|530103358|FG000|Overall Study|Administrative reasons|2|||
146984156|NCT01992107|530103359|FG001|Overall Study|Administrative reasons|0|||
146984157|NCT01992107|530103360|FG002|Overall Study|Administrative reasons|0|||
146984158|NCT01992107|530103358|FG000|Overall Study|Adverse Event|0|||
146984159|NCT01992107|530103359|FG001|Overall Study|Adverse Event|1|||
146984160|NCT01992107|530103360|FG002|Overall Study|Adverse Event|0|||
146984161|NCT01992107|530103358|FG000|Overall Study|Lost to Follow-up|46|||
146984162|NCT01992107|530103359|FG001|Overall Study|Lost to Follow-up|22|||
146984163|NCT01992107|530103360|FG002|Overall Study|Lost to Follow-up|26|||
146984164|NCT01992107|530103358|FG000|Overall Study|noncompliance and were unavailable|7|||
146984165|NCT01992107|530103359|FG001|Overall Study|noncompliance and were unavailable|3|||
146984166|NCT01992107|530103360|FG002|Overall Study|noncompliance and were unavailable|2|||
146984167|NCT01992107|530103358|FG000|Overall Study|Withdrawal by Subject|13|||
146984168|NCT01992107|530103359|FG001|Overall Study|Withdrawal by Subject|7|||
146984169|NCT01992107|530103360|FG002|Overall Study|Withdrawal by Subject|8|||
146984170|NCT02022007|530103361|FG000|Overall Study|Withdrawal by Subject|1|||
146984171|NCT02022007|530103362|FG001|Overall Study|Withdrawal by Subject|1|||
146984172|NCT02022007|530103363|FG002|Overall Study|Withdrawal by Subject|1|||
146984173|NCT02022007|530103361|FG000|Overall Study|Noncompliant|0|||
146984174|NCT02022007|530103362|FG001|Overall Study|Noncompliant|0|||
146984175|NCT02022007|530103363|FG002|Overall Study|Noncompliant|1|||
146984176|NCT01214603|530103364|FG000|Overall Study|Adverse Event|0|||
146984177|NCT01214603|530103365|FG001|Overall Study|Adverse Event|0|||
146984178|NCT01214603|530103366|FG002|Overall Study|Adverse Event|1|||
146984179|NCT01214603|530103364|FG000|Overall Study|Death|1|||
146810816|NCT01668719|529477889|FG001|Phase II|not protocol specified|13|||
146810817|NCT01668719|529477890|FG002|Phase II|not protocol specified|7|||
146810818|NCT03205488|529477893|FG000|Overall Study|Adverse Event|1|||
146810819|NCT03205488|529477894|FG001|Overall Study|Adverse Event|2|||
146810820|NCT03205488|529477895|FG002|Overall Study|Adverse Event|4|||
146810821|NCT03205488|529477893|FG000|Overall Study|Protocol Violation|0|||
146810822|NCT03205488|529477894|FG001|Overall Study|Protocol Violation|0|||
146810823|NCT03205488|529477895|FG002|Overall Study|Protocol Violation|1|||
146810824|NCT03652610|529477896|FG000|Overall Study|Lost to Follow-up|1|||
146810825|NCT03652610|529477897|FG001|Overall Study|Lost to Follow-up|0|||
146810826|NCT03652610|529477896|FG000|Overall Study|Withdrawal by Subject|3|||
146810827|NCT03652610|529477897|FG001|Overall Study|Withdrawal by Subject|5|||
146810828|NCT00326183|529477898|FG000|Overall Study|Lost to Follow-up|104|||
146810829|NCT00326183|529477899|FG001|Overall Study|Lost to Follow-up|56|||
146810830|NCT00326183|529477898|FG000|Overall Study|Protocol Violation|6|||
146810831|NCT00326183|529477899|FG001|Overall Study|Protocol Violation|3|||
146810832|NCT00326183|529477898|FG000|Overall Study|Withdrawal by Subject|35|||
146810833|NCT00326183|529477899|FG001|Overall Study|Withdrawal by Subject|7|||
146810834|NCT00326183|529477898|FG000|Overall Study|Subject Moved|7|||
146810835|NCT00326183|529477899|FG001|Overall Study|Subject Moved|4|||
146810836|NCT00326183|529477898|FG000|Overall Study|Other|47|||
146810837|NCT00326183|529477899|FG001|Overall Study|Other|13|||
146810838|NCT00326183|529477898|FG000|Overall Study|Adverse Event|1|||
146810839|NCT00326183|529477899|FG001|Overall Study|Adverse Event|0|||
146810840|NCT01218594|529477900|FG000|Overall Study|Death|1|||
146810841|NCT01218594|529477900|FG000|Overall Study|Withdrawal by Subject|3|||
146810842|NCT01218594|529477900|FG000|Overall Study|Adverse Event|2|||
146810843|NCT01218594|529477900|FG000|Overall Study|Physician Decision|6|||
146810844|NCT02203032|529477902|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
146810845|NCT02203032|529477903|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
146810846|NCT02203032|529477904|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
146810847|NCT02203032|529477905|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
146810848|NCT02203032|529477902|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
146810849|NCT02203032|529477903|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
146810850|NCT02203032|529477904|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
146810851|NCT02203032|529477905|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
146810852|NCT02203032|529477902|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
146810853|NCT02203032|529477903|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
146810854|NCT02203032|529477904|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
146984180|NCT01214603|530103365|FG001|Overall Study|Death|0|||
146984181|NCT01214603|530103366|FG002|Overall Study|Death|0|||
146810855|NCT02203032|529477905|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
146810856|NCT02203032|529477902|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
146810857|NCT02203032|529477903|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
146984182|NCT01214603|530103364|FG000|Overall Study|Progressive Disease|4|||
146810858|NCT02203032|529477904|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
146810859|NCT02203032|529477905|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
146984183|NCT01214603|530103365|FG001|Overall Study|Progressive Disease|1|||
146984184|NCT01214603|530103366|FG002|Overall Study|Progressive Disease|3|||
146984185|NCT01507896|530103367|FG000|Overall Study|Withdrawal by Subject|1|||
146984186|NCT01507896|530103367|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
146810860|NCT02203032|529477902|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
146810861|NCT02203032|529477903|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
146810862|NCT02203032|529477904|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
146810863|NCT02203032|529477905|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
146810864|NCT02203032|529477902|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
146810865|NCT02203032|529477903|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
146810866|NCT02203032|529477904|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
146810867|NCT02203032|529477905|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
146810868|NCT02203032|529477902|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
146810869|NCT02203032|529477903|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
146810870|NCT02203032|529477904|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
146810871|NCT02203032|529477905|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
146810872|NCT02203032|529477902|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
146810873|NCT02203032|529477903|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
146810874|NCT02203032|529477904|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
146810875|NCT02203032|529477905|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
146810876|NCT02203032|529477902|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
146810877|NCT02203032|529477903|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
146810878|NCT02203032|529477904|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
146810879|NCT02203032|529477905|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
146810880|NCT02203032|529477902|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
146810881|NCT02203032|529477903|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
146810882|NCT02203032|529477904|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
146810883|NCT02203032|529477905|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
146810884|NCT02203032|529477902|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
146810885|NCT02203032|529477903|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
146810886|NCT02203032|529477904|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
146810887|NCT02203032|529477905|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
146810888|NCT02203032|529477902|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
146810889|NCT02203032|529477903|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
146810890|NCT02203032|529477904|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
146810891|NCT02203032|529477905|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
146810892|NCT02241785|529477906|FG000|Overall Study|Sponsor Termination|43|||
146810893|NCT02241785|529477906|FG000|Overall Study|Withdrawal by Subject|1|||
146810894|NCT02241785|529477906|FG000|Overall Study|Lost to Follow-up|2|||
146810895|NCT02241785|529477906|FG000|Overall Study|Adverse Event|1|||
146810896|NCT04748341|529477909|FG000|Overall Study|Lost to Follow-up|1|||
146810897|NCT04748341|529477910|FG001|Overall Study|Lost to Follow-up|1|||
146810898|NCT00452114|529477911|FG000|Overall Study|Physician Decision|3|||
146810899|NCT00452114|529477912|FG001|Overall Study|Physician Decision|3|||
146810900|NCT04197713|529477913|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
146810901|NCT04197713|529477914|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
146810902|NCT02831049|529477928|FG000|Overall Study|Lost to Follow-up|0|||
146810903|NCT02831049|529477929|FG001|Overall Study|Lost to Follow-up|0|||
146810904|NCT02831049|529477930|FG002|Overall Study|Lost to Follow-up|1|||
146810905|NCT02831049|529477928|FG000|Overall Study|Withdrawal by Subject|0|||
146810906|NCT02831049|529477929|FG001|Overall Study|Withdrawal by Subject|1|||
146810907|NCT02831049|529477930|FG002|Overall Study|Withdrawal by Subject|1|||
146810908|NCT02831049|529477928|FG000|Overall Study|Pandemic shutdown|1|||
146810909|NCT02831049|529477929|FG001|Overall Study|Pandemic shutdown|0|||
146810910|NCT02831049|529477930|FG002|Overall Study|Pandemic shutdown|0|||
146810911|NCT04535414|529477932|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
146810912|NCT04535414|529477933|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
146810913|NCT04535414|529477932|FG000|Overall Study|Cancelled appointment|1|||
146810914|NCT04535414|529477933|FG001|Overall Study|Cancelled appointment|0|||
146810915|NCT04535414|529477932|FG000|Overall Study|cancelled - food in stomach|2|||
146810916|NCT04535414|529477933|FG001|Overall Study|cancelled - food in stomach|0|||
146810917|NCT04535414|529477932|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
146810918|NCT04535414|529477933|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
146810919|NCT04535414|529477932|FG000|Overall Study|Withdrawal by Subject|0|||
146810920|NCT04535414|529477933|FG001|Overall Study|Withdrawal by Subject|1|||
146810921|NCT03662659|529477934|FG000|Pre-treatment|Participant no longer met study criteria|1|||
146810922|NCT03662659|529477935|FG001|Pre-treatment|Participant no longer met study criteria|1|||
146810923|NCT03662659|529477934|FG000|Pre-treatment|Other reasons|1|||
146942739|NCT02712008|529949562|FG003|From Week 12 up to Week 36|Adverse Event|0|||
146810924|NCT03662659|529477935|FG001|Pre-treatment|Other reasons|0|||
146810925|NCT03662659|529477934|FG000|Treatment|Completed Treatment|0|||
146810926|NCT03662659|529477935|FG001|Treatment|Completed Treatment|2|||
146810927|NCT03662659|529477934|FG000|Treatment|Disease Progression|85|||
146942740|NCT02712008|529949563|FG004|From Week 12 up to Week 36|Adverse Event|1|||
146810928|NCT03662659|529477935|FG001|Treatment|Disease Progression|97|||
146810929|NCT03662659|529477934|FG000|Treatment|Study Drug Toxicity|19|||
146810930|NCT03662659|529477935|FG001|Treatment|Study Drug Toxicity|9|||
146810931|NCT03662659|529477934|FG000|Treatment|Death|11|||
146810932|NCT03662659|529477935|FG001|Treatment|Death|9|||
146810933|NCT03662659|529477934|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
146810934|NCT03662659|529477935|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
146810935|NCT03662659|529477934|FG000|Treatment|Withdrawal by Subject|1|||
146810936|NCT03662659|529477935|FG001|Treatment|Withdrawal by Subject|1|||
146810937|NCT03662659|529477934|FG000|Treatment|Poor/Non-compliance|1|||
146810938|NCT03662659|529477935|FG001|Treatment|Poor/Non-compliance|0|||
146810939|NCT03662659|529477934|FG000|Treatment|Participant no longer meets study criteria|1|||
146810940|NCT03662659|529477935|FG001|Treatment|Participant no longer meets study criteria|0|||
146810941|NCT03662659|529477934|FG000|Treatment|Other reasons|10|||
146810942|NCT03662659|529477935|FG001|Treatment|Other reasons|8|||
146810943|NCT03662659|529477934|FG000|Treatment|Administrative reasons by sponsor|1|||
146810944|NCT03662659|529477935|FG001|Treatment|Administrative reasons by sponsor|0|||
146810945|NCT03662659|529477934|FG000|Treatment|maximum clinical benefit|0|||
146810946|NCT03662659|529477935|FG001|Treatment|maximum clinical benefit|2|||
146810947|NCT01668355|529479494|FG000|Overall Study|Death|3|||
146810948|NCT01668355|529479495|FG001|Overall Study|Death|1|||
146810949|NCT01668355|529479494|FG000|Overall Study|Withdrawal by Subject|6|||
146810950|NCT01668355|529479495|FG001|Overall Study|Withdrawal by Subject|1|||
146810951|NCT01277302|529479499|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
146810952|NCT01277302|529479500|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
146810953|NCT01277302|529479501|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
146810954|NCT01277302|529479499|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
146810955|NCT01277302|529479500|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
146810956|NCT01277302|529479501|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
146810957|NCT01277302|529479499|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
146810958|NCT01277302|529479500|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
146810959|NCT01277302|529479501|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
146810960|NCT01277302|529479499|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
146810961|NCT01277302|529479500|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
146810962|NCT01277302|529479501|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
146810963|NCT01277302|529479499|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
146810964|NCT01277302|529479500|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
146810965|NCT01277302|529479501|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
146810966|NCT01277302|529479499|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
146810967|NCT01277302|529479500|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
146810968|NCT01277302|529479501|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
146810969|NCT01277302|529479499|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
146810970|NCT01277302|529479500|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
146810971|NCT01277302|529479501|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
146810972|NCT01277302|529479499|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
146810973|NCT01277302|529479500|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
146810974|NCT01277302|529479501|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
146810975|NCT01277302|529479499|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
146810976|NCT01277302|529479500|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
146810977|NCT01277302|529479501|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
146810978|NCT02710669|529479504|FG000|Overall Study|Physician Decision|2|||
146810979|NCT02710669|529479505|FG001|Overall Study|Physician Decision|1|||
146810980|NCT02710669|529479506|FG002|Overall Study|Physician Decision|0|||
146810981|NCT02710669|529479504|FG000|Overall Study|Institutional delays (including COVID)|2|||
146810982|NCT02710669|529479505|FG001|Overall Study|Institutional delays (including COVID)|2|||
146810983|NCT02710669|529479506|FG002|Overall Study|Institutional delays (including COVID)|0|||
146810984|NCT02710669|529479504|FG000|Overall Study|arrived in afib/aflutter|10|||
146810985|NCT02710669|529479505|FG001|Overall Study|arrived in afib/aflutter|8|||
146810986|NCT02710669|529479506|FG002|Overall Study|arrived in afib/aflutter|2|||
146810987|NCT01190124|529479508|FG000|Overall Study|Death|3|||
146810988|NCT01190124|529479509|FG001|Overall Study|Death|0|||
146810989|NCT01190124|529479510|FG002|Overall Study|Death|0|||
146622455|NCT04612725|528789677|FG002|Overall Study|Lost to Follow-up|0|||
146810990|NCT01190124|529479508|FG000|Overall Study|Therapeutic Failure|12|||
146810991|NCT01190124|529479509|FG001|Overall Study|Therapeutic Failure|0|||
146810992|NCT01190124|529479510|FG002|Overall Study|Therapeutic Failure|1|||
146810993|NCT01190124|529479508|FG000|Overall Study|Lost to Follow-up|2|||
146810994|NCT01190124|529479509|FG001|Overall Study|Lost to Follow-up|0|||
146810995|NCT01190124|529479510|FG002|Overall Study|Lost to Follow-up|0|||
146810996|NCT01523392|529479511|FG000|Treatment Period 1|Withdrawal by Subject|2|||
146810997|NCT01523392|529479512|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146810998|NCT01523392|529479511|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
146810999|NCT01523392|529479512|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
146811000|NCT01523392|529479511|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
146811001|NCT01523392|529479512|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
146811002|NCT03851094|529479515|FG000|Overall Study|Withdrawal by Subject|0|||
146942741|NCT02712008|529949564|FG005|From Week 12 up to Week 36|Adverse Event|0|||
146942742|NCT02712008|529949565|FG006|From Week 12 up to Week 36|Adverse Event|0|||
146942743|NCT02712008|529949566|FG007|From Week 12 up to Week 36|Adverse Event|2|||
146942744|NCT02712008|529949559|FG000|From Week 12 up to Week 36|Death|1|||
146942745|NCT02712008|529949560|FG001|From Week 12 up to Week 36|Death|0|||
146942746|NCT02712008|529949561|FG002|From Week 12 up to Week 36|Death|0|||
146942747|NCT02712008|529949562|FG003|From Week 12 up to Week 36|Death|0|||
146942748|NCT02712008|529949563|FG004|From Week 12 up to Week 36|Death|0|||
146942749|NCT02712008|529949564|FG005|From Week 12 up to Week 36|Death|0|||
146942750|NCT02712008|529949565|FG006|From Week 12 up to Week 36|Death|1|||
146942751|NCT02712008|529949566|FG007|From Week 12 up to Week 36|Death|0|||
146942752|NCT02712008|529949559|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
146942753|NCT02712008|529949560|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
146942754|NCT02712008|529949561|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
146942755|NCT02712008|529949562|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
146942756|NCT02712008|529949563|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
146942757|NCT02712008|529949564|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
146942758|NCT02712008|529949565|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
146942759|NCT02712008|529949566|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
146942760|NCT02712008|529949559|FG000|From Week 12 up to Week 36|Physician Decision|0|||
146942761|NCT02712008|529949560|FG001|From Week 12 up to Week 36|Physician Decision|0|||
146942762|NCT02712008|529949561|FG002|From Week 12 up to Week 36|Physician Decision|0|||
146942763|NCT02712008|529949562|FG003|From Week 12 up to Week 36|Physician Decision|1|||
146942764|NCT02712008|529949563|FG004|From Week 12 up to Week 36|Physician Decision|1|||
146942765|NCT02712008|529949564|FG005|From Week 12 up to Week 36|Physician Decision|0|||
146942766|NCT02712008|529949565|FG006|From Week 12 up to Week 36|Physician Decision|0|||
146942767|NCT02712008|529949566|FG007|From Week 12 up to Week 36|Physician Decision|0|||
146942768|NCT02712008|529949559|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
146942769|NCT02712008|529949560|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
146942770|NCT02712008|529949561|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
146942771|NCT02712008|529949562|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
146942772|NCT02712008|529949563|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
146811003|NCT03851094|529479516|FG001|Overall Study|Withdrawal by Subject|1|||
146811004|NCT03851094|529479515|FG000|Overall Study|Participant lost device|0|||
146811005|NCT03851094|529479516|FG001|Overall Study|Participant lost device|1|||
146811006|NCT03851094|529479515|FG000|Overall Study|Participant returned device|0|||
146811007|NCT03851094|529479516|FG001|Overall Study|Participant returned device|2|||
146811008|NCT01332266|529479517|FG000|Phase 1b|Death|3|||
146811009|NCT01332266|529479518|FG001|Phase 1b|Death|3|||
146811010|NCT01332266|529479519|FG002|Phase 1b|Death|2|||
146811011|NCT01332266|529479520|FG003|Phase 1b|Death|0|||
146811012|NCT01332266|529479521|FG004|Phase 1b|Death|0|||
146811013|NCT01332266|529479517|FG000|Phase 1b|Lost to Follow-up|0|||
146811014|NCT01332266|529479518|FG001|Phase 1b|Lost to Follow-up|1|||
146811015|NCT01332266|529479519|FG002|Phase 1b|Lost to Follow-up|0|||
146811016|NCT01332266|529479520|FG003|Phase 1b|Lost to Follow-up|0|||
146811017|NCT01332266|529479521|FG004|Phase 1b|Lost to Follow-up|0|||
146811018|NCT01332266|529479517|FG000|Phase 1b|Withdrawal by Subject|1|||
146811019|NCT01332266|529479518|FG001|Phase 1b|Withdrawal by Subject|1|||
146811020|NCT01332266|529479519|FG002|Phase 1b|Withdrawal by Subject|1|||
146811021|NCT01332266|529479520|FG003|Phase 1b|Withdrawal by Subject|0|||
146811022|NCT01332266|529479521|FG004|Phase 1b|Withdrawal by Subject|0|||
146811023|NCT01332266|529479517|FG000|Phase 2|Death|0|||
146811024|NCT01332266|529479518|FG001|Phase 2|Death|0|||
146811025|NCT01332266|529479519|FG002|Phase 2|Death|0|||
146811026|NCT01332266|529479520|FG003|Phase 2|Death|33|||
146811027|NCT01332266|529479521|FG004|Phase 2|Death|36|||
146942773|NCT02712008|529949564|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
146942774|NCT02712008|529949565|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
146942775|NCT02712008|529949566|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
146942776|NCT01731990|529949567|FG000|Overall Study|Adverse Event|1|||
146811028|NCT01332266|529479517|FG000|Phase 2|Lost to Follow-up|0|||
146811029|NCT01332266|529479518|FG001|Phase 2|Lost to Follow-up|0|||
146811030|NCT01332266|529479519|FG002|Phase 2|Lost to Follow-up|0|||
146811031|NCT01332266|529479520|FG003|Phase 2|Lost to Follow-up|2|||
146811032|NCT01332266|529479521|FG004|Phase 2|Lost to Follow-up|0|||
146811033|NCT01332266|529479517|FG000|Phase 2|Physician Decision|0|||
146811034|NCT01332266|529479518|FG001|Phase 2|Physician Decision|0|||
146811035|NCT01332266|529479519|FG002|Phase 2|Physician Decision|0|||
146942777|NCT01731990|529949568|FG001|Overall Study|Adverse Event|5|||
146811036|NCT01332266|529479520|FG003|Phase 2|Physician Decision|3|||
146811037|NCT01332266|529479521|FG004|Phase 2|Physician Decision|1|||
146811038|NCT01332266|529479517|FG000|Phase 2|Symptomatic deterioration|0|||
146811039|NCT01332266|529479518|FG001|Phase 2|Symptomatic deterioration|0|||
146811040|NCT01332266|529479519|FG002|Phase 2|Symptomatic deterioration|0|||
146811041|NCT01332266|529479520|FG003|Phase 2|Symptomatic deterioration|0|||
146811042|NCT01332266|529479521|FG004|Phase 2|Symptomatic deterioration|1|||
146811043|NCT01332266|529479517|FG000|Phase 2|Progression Disease|0|||
146811044|NCT01332266|529479518|FG001|Phase 2|Progression Disease|0|||
146811045|NCT01332266|529479519|FG002|Phase 2|Progression Disease|0|||
146811046|NCT01332266|529479520|FG003|Phase 2|Progression Disease|2|||
146811047|NCT01332266|529479521|FG004|Phase 2|Progression Disease|1|||
146811048|NCT01332266|529479517|FG000|Phase 2|Withdrawal by Subject|0|||
146811049|NCT01332266|529479518|FG001|Phase 2|Withdrawal by Subject|0|||
146811050|NCT01332266|529479519|FG002|Phase 2|Withdrawal by Subject|0|||
146811051|NCT01332266|529479520|FG003|Phase 2|Withdrawal by Subject|2|||
146811052|NCT01332266|529479521|FG004|Phase 2|Withdrawal by Subject|2|||
146811053|NCT01536704|529479524|FG000|Washout Period 1|Withdrawal by Subject|1|||
146811054|NCT01536704|529479525|FG001|Washout Period 1|Withdrawal by Subject|2|||
146811055|NCT01536704|529479526|FG002|Washout Period 1|Withdrawal by Subject|0|||
146811056|NCT01536704|529479527|FG003|Washout Period 1|Withdrawal by Subject|0|||
146811057|NCT01536704|529479524|FG000|Washout Period 2|Adverse Event|1|||
146811058|NCT01536704|529479525|FG001|Washout Period 2|Adverse Event|0|||
146811059|NCT01536704|529479526|FG002|Washout Period 2|Adverse Event|0|||
146811060|NCT01536704|529479527|FG003|Washout Period 2|Adverse Event|0|||
146811061|NCT01536704|529479524|FG000|Washout Period 2|Withdrawal by Subject|0|||
146811062|NCT01536704|529479525|FG001|Washout Period 2|Withdrawal by Subject|0|||
146811063|NCT01536704|529479526|FG002|Washout Period 2|Withdrawal by Subject|0|||
146811064|NCT01536704|529479527|FG003|Washout Period 2|Withdrawal by Subject|1|||
146811065|NCT01536704|529479524|FG000|Period 3|Adverse Event|0|||
146811066|NCT01536704|529479525|FG001|Period 3|Adverse Event|0|||
146811067|NCT01536704|529479526|FG002|Period 3|Adverse Event|0|||
146811068|NCT01536704|529479527|FG003|Period 3|Adverse Event|1|||
146811069|NCT01536704|529479524|FG000|Washout Period 3|Adverse Event|0|||
146811070|NCT01536704|529479525|FG001|Washout Period 3|Adverse Event|0|||
146811071|NCT01536704|529479526|FG002|Washout Period 3|Adverse Event|1|||
146811072|NCT01536704|529479527|FG003|Washout Period 3|Adverse Event|0|||
146811073|NCT02392507|529479528|FG000|Induction Regimen|Death|3|||
146811074|NCT02392507|529479528|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
146811075|NCT02392507|529479528|FG000|Induction Regimen|Physician Decision|1|||
146942778|NCT01731990|529949567|FG000|Overall Study|Withdrawal by Subject|1|||
146942779|NCT01731990|529949568|FG001|Overall Study|Withdrawal by Subject|1|||
146942780|NCT01731990|529949567|FG000|Overall Study|Protocol deviation|1|||
146942781|NCT01731990|529949568|FG001|Overall Study|Protocol deviation|2|||
146942782|NCT01731990|529949567|FG000|Overall Study|Death|1|||
146942783|NCT01731990|529949568|FG001|Overall Study|Death|0|||
146942784|NCT02177786|529949573|FG000|Overall Study|Withdrew Consent|2|||
146942785|NCT02177786|529949574|FG001|Overall Study|Withdrew Consent|6|||
146942786|NCT02177786|529949575|FG002|Overall Study|Withdrew Consent|9|||
146942787|NCT02177786|529949576|FG003|Overall Study|Withdrew Consent|5|||
146942788|NCT02177786|529949573|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
146942789|NCT02177786|529949574|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
146942790|NCT02177786|529949575|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
146942791|NCT02177786|529949576|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
146942792|NCT02177786|529949573|FG000|Overall Study|Adverse Event|1|||
146942793|NCT02177786|529949574|FG001|Overall Study|Adverse Event|1|||
146942794|NCT02177786|529949575|FG002|Overall Study|Adverse Event|2|||
146942795|NCT02177786|529949576|FG003|Overall Study|Adverse Event|3|||
146942796|NCT02177786|529949573|FG000|Overall Study|Death|1|||
146942797|NCT02177786|529949574|FG001|Overall Study|Death|1|||
146942798|NCT02177786|529949575|FG002|Overall Study|Death|1|||
146811076|NCT02392507|529479528|FG000|Induction Regimen|Withdrawal by Subject|2|||
146811077|NCT02392507|529479528|FG000|Maintenance Regimen|Death|1|||
146811078|NCT02392507|529479528|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
146811079|NCT01802333|529479529|FG000|Overall Study|Ineligible|2|||
146811080|NCT01802333|529479530|FG001|Overall Study|Ineligible|6|||
146811081|NCT01802333|529479531|FG002|Overall Study|Ineligible|8|||
146811082|NCT01802333|529479529|FG000|Overall Study|Adverse Event|1|||
146811083|NCT01802333|529479530|FG001|Overall Study|Adverse Event|8|||
146811084|NCT01802333|529479531|FG002|Overall Study|Adverse Event|8|||
146811085|NCT01802333|529479529|FG000|Overall Study|Withdrawal by Subject|6|||
146811086|NCT01802333|529479530|FG001|Overall Study|Withdrawal by Subject|6|||
146984187|NCT01821625|530103378|FG000|Overall Study|Withdrawal by Subject|2|||
146811087|NCT01802333|529479531|FG002|Overall Study|Withdrawal by Subject|5|||
146811088|NCT01802333|529479529|FG000|Overall Study|Progression/relapse|1|||
146811089|NCT01802333|529479530|FG001|Overall Study|Progression/relapse|3|||
146811090|NCT01802333|529479531|FG002|Overall Study|Progression/relapse|0|||
146811091|NCT01802333|529479529|FG000|Overall Study|Death|7|||
146811092|NCT01802333|529479530|FG001|Overall Study|Death|14|||
146811093|NCT01802333|529479531|FG002|Overall Study|Death|13|||
146942799|NCT02177786|529949576|FG003|Overall Study|Death|1|||
146942800|NCT02177786|529949573|FG000|Overall Study|Lost to Follow-up|0|||
146942801|NCT02177786|529949574|FG001|Overall Study|Lost to Follow-up|0|||
146811094|NCT01802333|529479529|FG000|Overall Study|Other - not protocol specified|32|||
146811095|NCT01802333|529479530|FG001|Overall Study|Other - not protocol specified|22|||
146811096|NCT01802333|529479531|FG002|Overall Study|Other - not protocol specified|24|||
146811097|NCT01802333|529479529|FG000|Overall Study|Did not start treatment|0|||
146811098|NCT01802333|529479530|FG001|Overall Study|Did not start treatment|2|||
146811099|NCT01802333|529479531|FG002|Overall Study|Did not start treatment|5|||
146811100|NCT02067663|529479533|FG000|Overall Study|Lost to Follow-up|13|||
146811101|NCT02067663|529479534|FG001|Overall Study|Lost to Follow-up|14|||
146811102|NCT00486954|529479539|FG000|Pilot Part|Adverse Event|4|||
146811103|NCT00486954|529479540|FG001|Pilot Part|Adverse Event|0|||
146811104|NCT00486954|529479541|FG002|Pilot Part|Adverse Event|5|||
146811105|NCT00486954|529479542|FG003|Pilot Part|Adverse Event|0|||
146811106|NCT00486954|529479543|FG004|Pilot Part|Adverse Event|0|||
146811107|NCT00486954|529479539|FG000|Pilot Part|Disease Progression|2|||
146811108|NCT00486954|529479540|FG001|Pilot Part|Disease Progression|0|||
146811109|NCT00486954|529479541|FG002|Pilot Part|Disease Progression|1|||
146811110|NCT00486954|529479542|FG003|Pilot Part|Disease Progression|0|||
146811111|NCT00486954|529479543|FG004|Pilot Part|Disease Progression|0|||
146811112|NCT00486954|529479539|FG000|Randomized Part|Lost to Follow-up|0|||
146811113|NCT00486954|529479540|FG001|Randomized Part|Lost to Follow-up|0|||
146811114|NCT00486954|529479541|FG002|Randomized Part|Lost to Follow-up|0|||
146811115|NCT00486954|529479542|FG003|Randomized Part|Lost to Follow-up|0|||
146811116|NCT00486954|529479543|FG004|Randomized Part|Lost to Follow-up|1|||
146811117|NCT00486954|529479539|FG000|Randomized Part|Withdrawal by Subject|0|||
146811118|NCT00486954|529479540|FG001|Randomized Part|Withdrawal by Subject|0|||
146811119|NCT00486954|529479541|FG002|Randomized Part|Withdrawal by Subject|0|||
146811120|NCT00486954|529479542|FG003|Randomized Part|Withdrawal by Subject|1|||
146811121|NCT00486954|529479543|FG004|Randomized Part|Withdrawal by Subject|0|||
146811122|NCT00486954|529479539|FG000|Randomized Part|Sponsor Terminated Study|0|||
146811123|NCT00486954|529479540|FG001|Randomized Part|Sponsor Terminated Study|0|||
146811124|NCT00486954|529479541|FG002|Randomized Part|Sponsor Terminated Study|0|||
146811125|NCT00486954|529479542|FG003|Randomized Part|Sponsor Terminated Study|19|||
146811126|NCT00486954|529479543|FG004|Randomized Part|Sponsor Terminated Study|13|||
146811127|NCT03236779|529479544|FG000|Overall Study|Lost to Follow-up|13|||
146811128|NCT03236779|529479545|FG001|Overall Study|Lost to Follow-up|21|||
146811129|NCT01836523|529479550|FG000|Overall Study|Adverse Event|15|||
146811130|NCT01836523|529479551|FG001|Overall Study|Adverse Event|41|||
146811131|NCT01836523|529479552|FG002|Overall Study|Adverse Event|49|||
146811132|NCT01836523|529479553|FG003|Overall Study|Adverse Event|14|||
146811133|NCT01836523|529479550|FG000|Overall Study|Protocol Violation|6|||
146811134|NCT01836523|529479551|FG001|Overall Study|Protocol Violation|3|||
146811135|NCT01836523|529479552|FG002|Overall Study|Protocol Violation|2|||
146811136|NCT01836523|529479553|FG003|Overall Study|Protocol Violation|4|||
146811137|NCT01836523|529479550|FG000|Overall Study|Met Withdrawal Criteria|13|||
146811138|NCT01836523|529479551|FG001|Overall Study|Met Withdrawal Criteria|13|||
146811139|NCT01836523|529479552|FG002|Overall Study|Met Withdrawal Criteria|21|||
146811140|NCT01836523|529479553|FG003|Overall Study|Met Withdrawal Criteria|27|||
146811141|NCT01836523|529479550|FG000|Overall Study|Unclassified|17|||
146811142|NCT01836523|529479551|FG001|Overall Study|Unclassified|28|||
146811143|NCT01836523|529479552|FG002|Overall Study|Unclassified|19|||
146811144|NCT01836523|529479553|FG003|Overall Study|Unclassified|29|||
146811145|NCT04070105|529479557|FG000|Overall Study|Lost to Follow-up|0|||
146942802|NCT02177786|529949575|FG002|Overall Study|Lost to Follow-up|2|||
146811146|NCT04070105|529479558|FG001|Overall Study|Lost to Follow-up|0|||
146811147|NCT04070105|529479559|FG002|Overall Study|Lost to Follow-up|0|||
146811148|NCT04070105|529479560|FG003|Overall Study|Lost to Follow-up|0|||
146811149|NCT04070105|529479561|FG004|Overall Study|Lost to Follow-up|0|||
146811150|NCT04070105|529479562|FG005|Overall Study|Lost to Follow-up|1|||
146811151|NCT00624377|529479565|FG000|Overall Study|Lost to Follow-up|355|||
146811152|NCT00624377|529479565|FG000|Overall Study|Withdrawal by Subject|100|||
146811153|NCT00624377|529479565|FG000|Overall Study|Adverse Event|14|||
146942803|NCT02177786|529949576|FG003|Overall Study|Lost to Follow-up|2|||
146942804|NCT02177786|529949573|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146811154|NCT00624377|529479565|FG000|Overall Study|Other|91|||
146811155|NCT00624377|529479565|FG000|Overall Study|Non-evaluable population|84|||
146811156|NCT02245620|529479569|FG000|Overall Study|Physician Decision|1|||
146811157|NCT02245620|529479570|FG001|Overall Study|Physician Decision|1|||
146811158|NCT01102426|529479571|FG000|Overall Study|Randomized but not treated|4|||
146811159|NCT01102426|529479572|FG001|Overall Study|Randomized but not treated|1|||
146811160|NCT01102426|529479571|FG000|Overall Study|Adverse Events (treatment-related)|15|||
146811161|NCT01102426|529479572|FG001|Overall Study|Adverse Events (treatment-related)|8|||
146811162|NCT01102426|529479571|FG000|Overall Study|Physician Decision|9|||
146811163|NCT01102426|529479572|FG001|Overall Study|Physician Decision|6|||
146811164|NCT01102426|529479571|FG000|Overall Study|Progressive Disease|85|||
146811165|NCT01102426|529479572|FG001|Overall Study|Progressive Disease|44|||
146811166|NCT01102426|529479571|FG000|Overall Study|Adverse Events (unrelated to|9|||
146811167|NCT01102426|529479572|FG001|Overall Study|Adverse Events (unrelated to|1|||
146811168|NCT01102426|529479571|FG000|Overall Study|Patient Refusal|24|||
146811169|NCT01102426|529479572|FG001|Overall Study|Patient Refusal|12|||
146811170|NCT01102426|529479571|FG000|Overall Study|Death (due to adverse events|0|||
146811171|NCT01102426|529479572|FG001|Overall Study|Death (due to adverse events|1|||
146811172|NCT01102426|529479571|FG000|Overall Study|Death (non-related to the study|19|||
146811173|NCT01102426|529479572|FG001|Overall Study|Death (non-related to the study|8|||
146811174|NCT03909100|529479573|FG000|Overall Study|Protocol Deviation|2|||
146811175|NCT03909100|529479573|FG000|Overall Study|Technical Problems|4|||
146811176|NCT03909100|529479573|FG000|Overall Study|Withdrawal by Subject|4|||
146811177|NCT03909100|529479573|FG000|Overall Study|Lost to Follow-up|1|||
146811178|NCT03909100|529479573|FG000|Overall Study|Reason not Specified|4|||
146811179|NCT03259568|529479574|FG000|Overall Study|Participant performance was low|3|||
146811180|NCT04248868|529479577|FG000|Overall Study|Death|1|||
146811181|NCT04248868|529479577|FG000|Overall Study|Lost to Follow-up|3|||
146811182|NCT04248868|529479577|FG000|Overall Study|Protocol Violation|2|||
146811183|NCT03128099|529479578|FG000|Overall Study|High dose task was too long|0|||
146811184|NCT03128099|529479579|FG001|Overall Study|High dose task was too long|4|||
146811185|NCT03128099|529479580|FG002|Overall Study|High dose task was too long|0|||
146811186|NCT03128099|529479578|FG000|Overall Study|Participant got a full time job.|1|||
146811187|NCT03128099|529479579|FG001|Overall Study|Participant got a full time job.|0|||
146811188|NCT03128099|529479580|FG002|Overall Study|Participant got a full time job.|0|||
146811189|NCT03128099|529479578|FG000|Overall Study|Became homeless and lost contact|1|||
146811190|NCT03128099|529479579|FG001|Overall Study|Became homeless and lost contact|0|||
146811191|NCT03128099|529479580|FG002|Overall Study|Became homeless and lost contact|0|||
146811192|NCT03128099|529479578|FG000|Overall Study|Did not complete all the assessments|0|||
146811193|NCT03128099|529479579|FG001|Overall Study|Did not complete all the assessments|0|||
146811194|NCT03128099|529479580|FG002|Overall Study|Did not complete all the assessments|1|||
146811195|NCT00148122|529479581|FG000|Overall Study|Withdrawal by Subject|2|||
146811196|NCT00274287|529479584|FG000|Overall Study|Withdrawal by Subject|1|||
146811197|NCT00274287|529479584|FG000|Overall Study|subject non-compliance|1|||
146811198|NCT03200574|529479585|FG000|Overall Study|Death|4|||
146811199|NCT03200574|529479585|FG000|Overall Study|Withdrawal by Subject|8|||
146811200|NCT03200574|529479585|FG000|Overall Study|Long-Term need for anticoagulation|1|||
146811201|NCT03200574|529479585|FG000|Overall Study|Relocation|2|||
146811202|NCT03200574|529479585|FG000|Overall Study|Lost to Follow-up|2|||
146811203|NCT00705159|529479589|FG000|Overall Study|Withdrawal by Subject|0|||
146811204|NCT00705159|529479590|FG001|Overall Study|Withdrawal by Subject|1|||
146811205|NCT00705159|529479591|FG002|Overall Study|Withdrawal by Subject|1|||
146811206|NCT00705159|529479592|FG003|Overall Study|Withdrawal by Subject|1|||
146811207|NCT00705159|529479589|FG000|Overall Study|Protocol Violation|0|||
146811208|NCT00705159|529479590|FG001|Overall Study|Protocol Violation|1|||
146811209|NCT00705159|529479591|FG002|Overall Study|Protocol Violation|0|||
146811210|NCT00705159|529479592|FG003|Overall Study|Protocol Violation|0|||
146811211|NCT00705159|529479589|FG000|Overall Study|Adverse Event|0|||
146811212|NCT00705159|529479590|FG001|Overall Study|Adverse Event|0|||
146811213|NCT00705159|529479591|FG002|Overall Study|Adverse Event|1|||
146811214|NCT00705159|529479592|FG003|Overall Study|Adverse Event|0|||
146811215|NCT00705159|529479589|FG000|Overall Study|Lost to Follow-up|0|||
146811216|NCT00705159|529479590|FG001|Overall Study|Lost to Follow-up|0|||
146811217|NCT00705159|529479591|FG002|Overall Study|Lost to Follow-up|3|||
146811218|NCT00705159|529479592|FG003|Overall Study|Lost to Follow-up|2|||
146811219|NCT00705159|529479589|FG000|Overall Study|Screen Failure|0|||
146811220|NCT00705159|529479590|FG001|Overall Study|Screen Failure|0|||
146811221|NCT00705159|529479591|FG002|Overall Study|Screen Failure|0|||
146811222|NCT00705159|529479592|FG003|Overall Study|Screen Failure|1|||
146811223|NCT03035942|529479593|FG000|Overall Study|Adverse Event|8|||
146811224|NCT03035942|529479594|FG001|Overall Study|Adverse Event|4|||
146811225|NCT03035942|529479595|FG002|Overall Study|Adverse Event|5|||
146811226|NCT02538094|529479596|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
146811227|NCT02538094|529479597|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
146811228|NCT02538094|529479596|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
146811229|NCT02538094|529479597|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
146811230|NCT01989104|529479598|FG000|Overall Study|Withdrawal by Subject|3|||
146811231|NCT01989104|529479599|FG001|Overall Study|Withdrawal by Subject|0|||
146811232|NCT01989104|529479600|FG002|Overall Study|Withdrawal by Subject|0|||
146811233|NCT01989104|529479601|FG003|Overall Study|Withdrawal by Subject|0|||
146811234|NCT01989104|529479602|FG004|Overall Study|Withdrawal by Subject|0|||
146811235|NCT01860079|529479603|FG000|Overall Study|Physician Decision|14|||
146811236|NCT01860079|529479604|FG001|Overall Study|Physician Decision|22|||
146811237|NCT03803475|529479611|FG000|Overall Study|Physician Decision|1|||
146811238|NCT01880736|529479612|FG000|Overall Study|Adverse Event|0|||
146811239|NCT01880736|529479613|FG001|Overall Study|Adverse Event|0|||
146811240|NCT01880736|529479614|FG002|Overall Study|Adverse Event|0|||
146811241|NCT01880736|529479615|FG003|Overall Study|Adverse Event|1|||
146811242|NCT01880736|529479612|FG000|Overall Study|Withdrawal Criteria|1|||
146811243|NCT01880736|529479613|FG001|Overall Study|Withdrawal Criteria|2|||
146811244|NCT01880736|529479614|FG002|Overall Study|Withdrawal Criteria|1|||
146811245|NCT01880736|529479615|FG003|Overall Study|Withdrawal Criteria|5|||
146984188|NCT01821625|530103378|FG000|Overall Study|Lack of Efficacy|2|||
146811246|NCT01263496|529479619|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
146811247|NCT01263496|529479620|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
146811248|NCT01263496|529479621|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
146811249|NCT01263496|529479622|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
146811250|NCT01263496|529479623|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
146811251|NCT01263496|529479624|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
146811252|NCT01263496|529479625|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
146811253|NCT01263496|529479626|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
146811254|NCT01263496|529479627|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
146811255|NCT01263496|529479619|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146811256|NCT01263496|529479620|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146811257|NCT01263496|529479621|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146811258|NCT01263496|529479622|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
146811259|NCT01263496|529479623|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
146811260|NCT01263496|529479624|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146811261|NCT01263496|529479625|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146811262|NCT01263496|529479626|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146811263|NCT01263496|529479627|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146811264|NCT01263496|529479619|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
146811265|NCT01263496|529479620|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
146811266|NCT01263496|529479621|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
146811267|NCT01263496|529479622|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
146811268|NCT01263496|529479623|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
146811269|NCT01263496|529479624|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
146811270|NCT01263496|529479625|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
146811271|NCT01263496|529479626|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
146811272|NCT01263496|529479627|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
146811273|NCT01263496|529479619|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146811274|NCT01263496|529479620|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
146811275|NCT01263496|529479621|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146811276|NCT01263496|529479622|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146811277|NCT01263496|529479623|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146811278|NCT01263496|529479624|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146811279|NCT01263496|529479625|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146811280|NCT01263496|529479626|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146811281|NCT01263496|529479627|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146811282|NCT01263496|529479619|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
146811283|NCT01263496|529479620|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
146811284|NCT01263496|529479621|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
146811285|NCT01263496|529479622|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
146811286|NCT01263496|529479623|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
146811287|NCT01263496|529479624|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
146811288|NCT01263496|529479625|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
146811289|NCT01263496|529479626|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
146811290|NCT01263496|529479627|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
146811291|NCT01263496|529479619|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
146811292|NCT01263496|529479620|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
146811293|NCT01263496|529479621|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
146811294|NCT01263496|529479622|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
146811295|NCT01263496|529479623|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
146811296|NCT01263496|529479624|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
146811297|NCT01263496|529479625|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
146811298|NCT01263496|529479626|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
146811299|NCT01263496|529479627|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
146811300|NCT01263496|529479619|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146811301|NCT01263496|529479620|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146811302|NCT01263496|529479621|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146811303|NCT01263496|529479622|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146811304|NCT01263496|529479623|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146811305|NCT01263496|529479624|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146811306|NCT01263496|529479625|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146811307|NCT01263496|529479626|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
146811308|NCT01263496|529479627|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146811309|NCT05995977|529479631|FG000|Overall Study|Withdrawal by Subject|1|||
146811310|NCT05995977|529479632|FG001|Overall Study|Withdrawal by Subject|4|||
146811311|NCT05995977|529479631|FG000|Overall Study|Lost to Follow-up|2|||
146811312|NCT05995977|529479632|FG001|Overall Study|Lost to Follow-up|0|||
146811313|NCT04181788|529479633|FG000|TREATMENT|Adverse Event|0|||
146811314|NCT04181788|529479634|FG001|TREATMENT|Adverse Event|2|||
146811315|NCT04181788|529479635|FG002|TREATMENT|Adverse Event|1|||
146811316|NCT04181788|529479636|FG003|TREATMENT|Adverse Event|0|||
146811317|NCT04181788|529479637|FG004|TREATMENT|Adverse Event|1|||
146811318|NCT04181788|529479638|FG005|TREATMENT|Adverse Event|3|||
146811319|NCT04181788|529479633|FG000|TREATMENT|Death|0|||
146811320|NCT04181788|529479634|FG001|TREATMENT|Death|0|||
146811321|NCT04181788|529479635|FG002|TREATMENT|Death|0|||
146811322|NCT04181788|529479636|FG003|TREATMENT|Death|0|||
146811323|NCT04181788|529479637|FG004|TREATMENT|Death|8|||
146811324|NCT04181788|529479638|FG005|TREATMENT|Death|8|||
146811325|NCT04181788|529479633|FG000|TREATMENT|Physician Decision|0|||
146811326|NCT04181788|529479634|FG001|TREATMENT|Physician Decision|0|||
146811327|NCT04181788|529479635|FG002|TREATMENT|Physician Decision|0|||
146811328|NCT04181788|529479636|FG003|TREATMENT|Physician Decision|0|||
146811329|NCT04181788|529479637|FG004|TREATMENT|Physician Decision|0|||
146811330|NCT04181788|529479638|FG005|TREATMENT|Physician Decision|1|||
146811331|NCT04181788|529479633|FG000|TREATMENT|Progressive disease|3|||
146811332|NCT04181788|529479634|FG001|TREATMENT|Progressive disease|3|||
146811333|NCT04181788|529479635|FG002|TREATMENT|Progressive disease|5|||
146811334|NCT04181788|529479636|FG003|TREATMENT|Progressive disease|7|||
146811335|NCT04181788|529479637|FG004|TREATMENT|Progressive disease|20|||
146811336|NCT04181788|529479638|FG005|TREATMENT|Progressive disease|38|||
146811337|NCT04181788|529479633|FG000|TREATMENT|Global deterioration of health status|0|||
146811338|NCT04181788|529479634|FG001|TREATMENT|Global deterioration of health status|2|||
146811339|NCT04181788|529479635|FG002|TREATMENT|Global deterioration of health status|0|||
146811340|NCT04181788|529479636|FG003|TREATMENT|Global deterioration of health status|0|||
146811341|NCT04181788|529479637|FG004|TREATMENT|Global deterioration of health status|2|||
146811342|NCT04181788|529479638|FG005|TREATMENT|Global deterioration of health status|8|||
146811343|NCT04181788|529479633|FG000|TREATMENT|Withdrawal by Subject|1|||
146811344|NCT04181788|529479634|FG001|TREATMENT|Withdrawal by Subject|2|||
146811345|NCT04181788|529479635|FG002|TREATMENT|Withdrawal by Subject|0|||
146811346|NCT04181788|529479636|FG003|TREATMENT|Withdrawal by Subject|0|||
146811347|NCT04181788|529479637|FG004|TREATMENT|Withdrawal by Subject|3|||
146811348|NCT04181788|529479638|FG005|TREATMENT|Withdrawal by Subject|5|||
146811349|NCT04181788|529479633|FG000|TREATMENT|Other unspecified|0|||
146811350|NCT04181788|529479634|FG001|TREATMENT|Other unspecified|0|||
146811351|NCT04181788|529479635|FG002|TREATMENT|Other unspecified|0|||
146811352|NCT04181788|529479636|FG003|TREATMENT|Other unspecified|0|||
146811353|NCT04181788|529479637|FG004|TREATMENT|Other unspecified|0|||
146811354|NCT04181788|529479638|FG005|TREATMENT|Other unspecified|2|||
146811355|NCT04181788|529479633|FG000|TREATMENT|Ongoing|0|||
146811356|NCT04181788|529479634|FG001|TREATMENT|Ongoing|3|||
146811357|NCT04181788|529479635|FG002|TREATMENT|Ongoing|0|||
146811358|NCT04181788|529479636|FG003|TREATMENT|Ongoing|5|||
146811359|NCT04181788|529479637|FG004|TREATMENT|Ongoing|7|||
146811360|NCT04181788|529479638|FG005|TREATMENT|Ongoing|15|||
146811361|NCT04181788|529479633|FG000|FOLLOW-UP|Death|0|||
146811362|NCT04181788|529479634|FG001|FOLLOW-UP|Death|0|||
146811363|NCT04181788|529479635|FG002|FOLLOW-UP|Death|1|||
146942805|NCT02177786|529949574|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146942806|NCT02177786|529949575|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146942807|NCT02177786|529949576|FG003|Overall Study|Non-Compliance with Study Drug|1|||
146942808|NCT02177786|529949573|FG000|Overall Study|Protocol Violation|0|||
146942809|NCT02177786|529949574|FG001|Overall Study|Protocol Violation|0|||
146942810|NCT02177786|529949575|FG002|Overall Study|Protocol Violation|2|||
146942811|NCT02177786|529949576|FG003|Overall Study|Protocol Violation|0|||
146811364|NCT04181788|529479636|FG003|FOLLOW-UP|Death|2|||
146811365|NCT04181788|529479637|FG004|FOLLOW-UP|Death|8|||
146811366|NCT04181788|529479638|FG005|FOLLOW-UP|Death|20|||
146942812|NCT02177786|529949573|FG000|Overall Study|Progressive Disease|0|||
146942813|NCT02177786|529949574|FG001|Overall Study|Progressive Disease|1|||
146942814|NCT02177786|529949575|FG002|Overall Study|Progressive Disease|0|||
146811367|NCT04181788|529479633|FG000|FOLLOW-UP|Lost to Follow-up|0|||
146811368|NCT04181788|529479634|FG001|FOLLOW-UP|Lost to Follow-up|0|||
146811369|NCT04181788|529479635|FG002|FOLLOW-UP|Lost to Follow-up|0|||
146942815|NCT02177786|529949576|FG003|Overall Study|Progressive Disease|0|||
146942816|NCT02177786|529949573|FG000|Overall Study|Missing study completion status|0|||
146942817|NCT02177786|529949574|FG001|Overall Study|Missing study completion status|1|||
146811370|NCT04181788|529479636|FG003|FOLLOW-UP|Lost to Follow-up|0|||
146811371|NCT04181788|529479637|FG004|FOLLOW-UP|Lost to Follow-up|0|||
146811372|NCT04181788|529479638|FG005|FOLLOW-UP|Lost to Follow-up|2|||
146811373|NCT04181788|529479633|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
146811374|NCT04181788|529479634|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
146811375|NCT04181788|529479635|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
146811376|NCT04181788|529479636|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
146811377|NCT04181788|529479637|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
146811378|NCT04181788|529479638|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
146811379|NCT04181788|529479633|FG000|FOLLOW-UP|Other unspecified|0|||
146811380|NCT04181788|529479634|FG001|FOLLOW-UP|Other unspecified|1|||
146942818|NCT02177786|529949575|FG002|Overall Study|Missing study completion status|0|||
146811381|NCT04181788|529479635|FG002|FOLLOW-UP|Other unspecified|0|||
146811382|NCT04181788|529479636|FG003|FOLLOW-UP|Other unspecified|0|||
146811383|NCT04181788|529479637|FG004|FOLLOW-UP|Other unspecified|0|||
146811384|NCT04181788|529479638|FG005|FOLLOW-UP|Other unspecified|3|||
146811385|NCT04181788|529479633|FG000|FOLLOW-UP|Ongoing|0|||
146811386|NCT04181788|529479634|FG001|FOLLOW-UP|Ongoing|0|||
146811387|NCT04181788|529479635|FG002|FOLLOW-UP|Ongoing|1|||
146811388|NCT04181788|529479636|FG003|FOLLOW-UP|Ongoing|3|||
146811389|NCT04181788|529479637|FG004|FOLLOW-UP|Ongoing|2|||
146811390|NCT04181788|529479638|FG005|FOLLOW-UP|Ongoing|2|||
146811391|NCT01276509|529481462|FG000|Overall Study|Adverse Event|9|||
146811392|NCT01276509|529481463|FG001|Overall Study|Adverse Event|8|||
146811393|NCT01276509|529481464|FG002|Overall Study|Adverse Event|4|||
146811394|NCT01276509|529481465|FG003|Overall Study|Adverse Event|3|||
146811395|NCT01276509|529481462|FG000|Overall Study|Lack of Efficacy|2|||
146811396|NCT01276509|529481463|FG001|Overall Study|Lack of Efficacy|1|||
146811397|NCT01276509|529481464|FG002|Overall Study|Lack of Efficacy|1|||
146811398|NCT01276509|529481465|FG003|Overall Study|Lack of Efficacy|2|||
146811399|NCT01276509|529481462|FG000|Overall Study|Pregnancy|1|||
146811400|NCT01276509|529481463|FG001|Overall Study|Pregnancy|0|||
146811401|NCT01276509|529481464|FG002|Overall Study|Pregnancy|0|||
146811402|NCT01276509|529481465|FG003|Overall Study|Pregnancy|0|||
146811403|NCT01276509|529481462|FG000|Overall Study|Withdrawal by Subject|1|||
146811404|NCT01276509|529481463|FG001|Overall Study|Withdrawal by Subject|2|||
146811405|NCT01276509|529481464|FG002|Overall Study|Withdrawal by Subject|0|||
146811406|NCT01276509|529481465|FG003|Overall Study|Withdrawal by Subject|0|||
146811407|NCT01276509|529481462|FG000|Overall Study|Other|0|||
146811408|NCT01276509|529481463|FG001|Overall Study|Other|1|||
146811409|NCT01276509|529481464|FG002|Overall Study|Other|0|||
146811410|NCT01276509|529481465|FG003|Overall Study|Other|0|||
146811411|NCT00535626|529481469|FG000|Overall Study|Death|15|||
146811412|NCT00535626|529481469|FG000|Overall Study|Lost to Follow-up|29|||
146811413|NCT00535626|529481469|FG000|Overall Study|Withdrawal by Subject|20|||
146811414|NCT00535626|529481469|FG000|Overall Study|Removal/revision of study component|8|||
146811415|NCT00535626|529481469|FG000|Overall Study|Subject terminated|31|||
146811416|NCT00535626|529481469|FG000|Overall Study|Unable to return|2|||
146811417|NCT02830893|529481470|FG000|Overall Study|Relocation to out of the country|1|||
146811418|NCT02830893|529481471|FG001|Overall Study|Relocation to out of the country|0|||
146811419|NCT02830893|529481470|FG000|Overall Study|Lost to Follow-up|0|||
146811420|NCT02830893|529481471|FG001|Overall Study|Lost to Follow-up|2|||
146811421|NCT02830893|529481470|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
146811422|NCT02830893|529481471|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
146811423|NCT01567852|529481472|FG000|Overall Study|Withdrawal by Subject|3|||
146811424|NCT01567852|529481473|FG001|Overall Study|Withdrawal by Subject|6|||
146811425|NCT01567852|529481472|FG000|Overall Study|ECT discontinued|1|||
146811426|NCT01567852|529481473|FG001|Overall Study|ECT discontinued|1|||
146811427|NCT03332589|529481474|FG000|Overall Study|Lack of Efficacy|2|||
146811428|NCT03332589|529481475|FG001|Overall Study|Lack of Efficacy|0|||
146811429|NCT03332589|529481476|FG002|Overall Study|Lack of Efficacy|0|||
146811430|NCT03332589|529481474|FG000|Overall Study|Adverse Event|1|||
146811431|NCT03332589|529481475|FG001|Overall Study|Adverse Event|0|||
146811432|NCT03332589|529481476|FG002|Overall Study|Adverse Event|0|||
146811433|NCT03332589|529481474|FG000|Overall Study|Death|1|||
146811434|NCT03332589|529481475|FG001|Overall Study|Death|0|||
146811435|NCT03332589|529481476|FG002|Overall Study|Death|0|||
146811436|NCT00443820|529481477|FG000|Overall Study|Adverse Event|1|||
146811437|NCT00443820|529481478|FG001|Overall Study|Adverse Event|1|||
146811438|NCT00443820|529481479|FG002|Overall Study|Adverse Event|0|||
146811439|NCT00443820|529481480|FG003|Overall Study|Adverse Event|0|||
146811440|NCT00443820|529481477|FG000|Overall Study|Lack of Efficacy|3|||
146811441|NCT00443820|529481478|FG001|Overall Study|Lack of Efficacy|2|||
146811442|NCT00443820|529481479|FG002|Overall Study|Lack of Efficacy|1|||
146811443|NCT00443820|529481480|FG003|Overall Study|Lack of Efficacy|1|||
146811444|NCT00443820|529481477|FG000|Overall Study|Protocol Violation|2|||
146811445|NCT00443820|529481478|FG001|Overall Study|Protocol Violation|1|||
146811446|NCT00443820|529481479|FG002|Overall Study|Protocol Violation|2|||
146811447|NCT00443820|529481480|FG003|Overall Study|Protocol Violation|1|||
146811448|NCT00443820|529481477|FG000|Overall Study|Withdrawal by Subject|6|||
146811449|NCT00443820|529481478|FG001|Overall Study|Withdrawal by Subject|7|||
146811450|NCT00443820|529481479|FG002|Overall Study|Withdrawal by Subject|8|||
146811451|NCT00443820|529481480|FG003|Overall Study|Withdrawal by Subject|9|||
146811452|NCT00443820|529481477|FG000|Overall Study|Lost to Follow-up|9|||
146811453|NCT00443820|529481478|FG001|Overall Study|Lost to Follow-up|8|||
146811454|NCT00443820|529481479|FG002|Overall Study|Lost to Follow-up|6|||
146811455|NCT00443820|529481480|FG003|Overall Study|Lost to Follow-up|5|||
146811456|NCT00443820|529481477|FG000|Overall Study|Administrative problems|0|||
146811457|NCT00443820|529481478|FG001|Overall Study|Administrative problems|0|||
146811458|NCT00443820|529481479|FG002|Overall Study|Administrative problems|0|||
146811459|NCT00443820|529481480|FG003|Overall Study|Administrative problems|1|||
146811460|NCT00443820|529481477|FG000|Overall Study|Death|0|||
146811461|NCT00443820|529481478|FG001|Overall Study|Death|0|||
146811462|NCT00443820|529481479|FG002|Overall Study|Death|1|||
146811463|NCT00443820|529481480|FG003|Overall Study|Death|0|||
146811464|NCT01808534|529481490|FG000|Overall Study|Disease progression|3|||
146811465|NCT01808534|529481490|FG000|Overall Study|Physician Decision|1|||
146811466|NCT02354417|529481491|FG000|Overall Study|Physician Decision|1|||
146811467|NCT01377844|529481492|FG000|Overall Study|Withdrawal by Subject|25|||
146811468|NCT01377844|529481493|FG001|Overall Study|Withdrawal by Subject|28|||
146811469|NCT01377844|529481492|FG000|Overall Study|Protocol Violation|2|||
146811470|NCT01377844|529481493|FG001|Overall Study|Protocol Violation|3|||
146811471|NCT01377844|529481492|FG000|Overall Study|Adverse Event|3|||
146811472|NCT01377844|529481493|FG001|Overall Study|Adverse Event|0|||
146811473|NCT01377844|529481492|FG000|Overall Study|Physician Decision|6|||
146811474|NCT01377844|529481493|FG001|Overall Study|Physician Decision|3|||
146811475|NCT01377844|529481492|FG000|Overall Study|Study terminated by Sponsor|0|||
146811476|NCT01377844|529481493|FG001|Overall Study|Study terminated by Sponsor|1|||
146811477|NCT02202317|529481499|FG000|Overall Study|Lost to Follow-up|1|||
146811478|NCT00569166|529481501|FG000|Overall Study|Withdrawal by Subject|7|||
146811479|NCT00569166|529481502|FG001|Overall Study|Withdrawal by Subject|5|||
146811480|NCT00569166|529481503|FG002|Overall Study|Withdrawal by Subject|3|||
146811481|NCT00569166|529481501|FG000|Overall Study|Lost to Follow-up|2|||
146811482|NCT00569166|529481502|FG001|Overall Study|Lost to Follow-up|1|||
146811483|NCT00569166|529481503|FG002|Overall Study|Lost to Follow-up|1|||
146811484|NCT00484198|529481505|FG000|Overall Study|Participant Withdrew Consent|12|||
146811485|NCT00484198|529481506|FG001|Overall Study|Participant Withdrew Consent|21|||
146811486|NCT00484198|529481507|FG002|Overall Study|Participant Withdrew Consent|47|||
146811487|NCT00484198|529481508|FG003|Overall Study|Participant Withdrew Consent|59|||
146811488|NCT00484198|529481505|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
146811489|NCT00484198|529481506|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
146811490|NCT00484198|529481507|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
146811491|NCT00484198|529481508|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
146811492|NCT00484198|529481505|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
146811493|NCT00484198|529481506|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
146811494|NCT00484198|529481507|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
146811495|NCT00484198|529481508|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
146811496|NCT00484198|529481505|FG000|Overall Study|Adverse Event|3|||
146811497|NCT00484198|529481506|FG001|Overall Study|Adverse Event|11|||
146811498|NCT00484198|529481507|FG002|Overall Study|Adverse Event|32|||
146811499|NCT00484198|529481508|FG003|Overall Study|Adverse Event|31|||
146811500|NCT00484198|529481505|FG000|Overall Study|Protocol Violation|0|||
146811501|NCT00484198|529481506|FG001|Overall Study|Protocol Violation|5|||
146811502|NCT00484198|529481507|FG002|Overall Study|Protocol Violation|6|||
146811503|NCT00484198|529481508|FG003|Overall Study|Protocol Violation|8|||
146811504|NCT00484198|529481505|FG000|Overall Study|Other|7|||
146811505|NCT00484198|529481506|FG001|Overall Study|Other|10|||
146811506|NCT00484198|529481507|FG002|Overall Study|Other|31|||
146811507|NCT00484198|529481508|FG003|Overall Study|Other|28|||
146811508|NCT01853384|529481509|FG000|Randomized|Adverse Event|5|||
146811509|NCT01853384|529481510|FG001|Randomized|Adverse Event|3|||
146811510|NCT01853384|529481509|FG000|Randomized|Death|1|||
146811511|NCT01853384|529481510|FG001|Randomized|Death|2|||
146811512|NCT01853384|529481509|FG000|Randomized|Lost to Follow-up|1|||
146811513|NCT01853384|529481510|FG001|Randomized|Lost to Follow-up|1|||
146811514|NCT01853384|529481509|FG000|Randomized|Withdrawal by Subject|5|||
146811515|NCT01853384|529481510|FG001|Randomized|Withdrawal by Subject|3|||
146811516|NCT01853384|529481509|FG000|Randomized|Sponsor Decision|47|||
146811517|NCT01853384|529481510|FG001|Randomized|Sponsor Decision|34|||
146811518|NCT01853384|529481509|FG000|Randomized|Other|3|||
146811519|NCT01853384|529481510|FG001|Randomized|Other|3|||
146811520|NCT01853384|529481509|FG000|Completed Follow up Visit 1|Early Termination|13|||
146811521|NCT01853384|529481510|FG001|Completed Follow up Visit 1|Early Termination|9|||
146942819|NCT02177786|529949576|FG003|Overall Study|Missing study completion status|0|||
146942820|NCT01305941|529949577|FG000|Overall Study|Adverse Event|6|||
146942821|NCT01305941|529949577|FG000|Overall Study|Clinical decline|2|||
146942822|NCT01305941|529949577|FG000|Overall Study|Withdrawal by Subject|1|||
146942823|NCT01305941|529949577|FG000|Overall Study|Death|1|||
146811522|NCT01853384|529481509|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
146811523|NCT01853384|529481510|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
146811524|NCT01853384|529481509|FG000|Completed Follow up Visit 2|Adverse Event|1|||
146811525|NCT01853384|529481510|FG001|Completed Follow up Visit 2|Adverse Event|0|||
146811526|NCT01853384|529481509|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
146811527|NCT01853384|529481510|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
146811528|NCT01853384|529481509|FG000|Completed Follow up Visit 2|Death|1|||
146811529|NCT01853384|529481510|FG001|Completed Follow up Visit 2|Death|0|||
146811530|NCT01853384|529481509|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
146811531|NCT01853384|529481510|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
146811532|NCT01947491|529481511|FG000|Overall Study|Lost to Follow-up|5|||
146942824|NCT03950440|529949578|FG000|Overall Study|Death|8|||
146942825|NCT03950440|529949579|FG001|Overall Study|Death|2|||
146942826|NCT03950440|529949580|FG002|Overall Study|Death|1|||
146942827|NCT02892734|529949581|FG000|Treatment on Study|Progressive Disease|2|||
146942828|NCT02892734|529949581|FG000|Follow up for 2 Years|Death|2|||
146942829|NCT02892734|529949581|FG000|Follow up for 2 Years|Study closed early|1|||
146942830|NCT02043509|529949582|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
146942831|NCT02043509|529949583|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
146942832|NCT02043509|529949582|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
146942833|NCT02043509|529949583|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
146942834|NCT02043509|529949582|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
146942835|NCT02043509|529949583|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
146942836|NCT02043509|529949582|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
146942837|NCT02043509|529949583|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
146942838|NCT00608244|529949588|FG000|Overall Study|Adverse Event|1|||
146942839|NCT00608244|529949588|FG000|Overall Study|Low trough levels|1|||
146942840|NCT01957215|529949593|FG000|Overall Study|Adverse Event|2|||
146942841|NCT01957215|529949594|FG001|Overall Study|Adverse Event|2|||
146942842|NCT01957215|529949593|FG000|Overall Study|Lost to Follow-up|3|||
146942843|NCT01957215|529949594|FG001|Overall Study|Lost to Follow-up|3|||
146942844|NCT01957215|529949593|FG000|Overall Study|Protocol Violation|1|||
146942845|NCT01957215|529949594|FG001|Overall Study|Protocol Violation|2|||
146942846|NCT01957215|529949593|FG000|Overall Study|Withdrawal by Subject|7|||
146942847|NCT01957215|529949594|FG001|Overall Study|Withdrawal by Subject|5|||
146942848|NCT03597503|529949602|FG000|Overall Study|Withdrawal by Subject|0|||
146942849|NCT03597503|529949603|FG001|Overall Study|Withdrawal by Subject|2|||
146942850|NCT03597503|529949602|FG000|Overall Study|Lost to Follow-up|1|||
146942851|NCT03597503|529949603|FG001|Overall Study|Lost to Follow-up|2|||
146942852|NCT03597503|529949602|FG000|Overall Study|Protocol Violation|1|||
146942853|NCT03597503|529949603|FG001|Overall Study|Protocol Violation|0|||
146942854|NCT00688623|529949608|FG000|Overall Study|Adverse Event|22|||
146942855|NCT00688623|529949608|FG000|Overall Study|abnormal lab value|1|||
146942856|NCT00688623|529949608|FG000|Overall Study|Withdrawal by Subject|4|||
146942857|NCT00688623|529949608|FG000|Overall Study|Death|3|||
146942858|NCT00688623|529949608|FG000|Overall Study|disease progression|23|||
146942859|NCT00688623|529949608|FG000|Overall Study|Protocol Violation|2|||
146942860|NCT02000219|529949609|FG000|14-Week Study Period|Physician Decision|1|||
146942861|NCT02000219|529949609|FG000|14-Week Study Period|Adverse Event|1|||
146942862|NCT02000219|529949609|FG000|14-Week Study Period|Underwent transplantation|1|||
146942863|NCT02000219|529949609|FG000|Continuation Period|Withdrawal by Subject|1|||
146942864|NCT02000219|529949609|FG000|Continuation Period|Had liver transplant|2|||
146942865|NCT02000219|529949609|FG000|Continuation Period|Non-compliance with study drug|2|||
146942866|NCT02667236|529949610|FG000|Overall Study|Adverse Event|1|||
146942867|NCT02667236|529949611|FG001|Overall Study|Adverse Event|1|||
146942868|NCT02667236|529949610|FG000|Overall Study|Withdrawal by Subject|2|||
146942869|NCT02667236|529949611|FG001|Overall Study|Withdrawal by Subject|0|||
146942870|NCT04402385|529949616|FG000|Overall Study|Withdrawal by Subject|4|||
146942871|NCT04402385|529949617|FG001|Overall Study|Withdrawal by Subject|4|||
146942872|NCT04402385|529949616|FG000|Overall Study|Lost to Follow-up|1|||
146942873|NCT04402385|529949617|FG001|Overall Study|Lost to Follow-up|1|||
146942874|NCT04402385|529949616|FG000|Overall Study|Physician Decision|0|||
146942875|NCT04402385|529949617|FG001|Overall Study|Physician Decision|1|||
146942876|NCT00608894|529949618|FG000|Overall Study|Withdrawal by Subject|0|||
146942877|NCT00608894|529949619|FG001|Overall Study|Withdrawal by Subject|2|||
146942878|NCT03654560|529949620|FG000|Overall Study|Death|3|||
146942879|NCT03654560|529949621|FG001|Overall Study|Death|1|||
146942880|NCT03654560|529949620|FG000|Overall Study|Lost to Follow-up|1|||
146942881|NCT03654560|529949621|FG001|Overall Study|Lost to Follow-up|0|||
146942882|NCT03938636|529949622|FG000|Overall Study|Protocol Violation|0|||
146942883|NCT03938636|529949623|FG001|Overall Study|Protocol Violation|1|||
146942884|NCT03938636|529949624|FG002|Overall Study|Protocol Violation|1|||
146942885|NCT03938636|529949622|FG000|Overall Study|Subject withdrew due to death in family|0|||
146942886|NCT03938636|529949623|FG001|Overall Study|Subject withdrew due to death in family|1|||
146942887|NCT03938636|529949624|FG002|Overall Study|Subject withdrew due to death in family|0|||
146942888|NCT03938636|529949622|FG000|Overall Study|Missed visit|0|||
146942889|NCT03938636|529949623|FG001|Overall Study|Missed visit|1|||
146942890|NCT03938636|529949624|FG002|Overall Study|Missed visit|0|||
146942891|NCT03938636|529949622|FG000|Overall Study|Adverse Event|0|||
146942892|NCT03938636|529949623|FG001|Overall Study|Adverse Event|0|||
146942893|NCT03938636|529949624|FG002|Overall Study|Adverse Event|1|||
146942894|NCT03938636|529949622|FG000|Overall Study|Lost to Follow-up|0|||
146942895|NCT03938636|529949623|FG001|Overall Study|Lost to Follow-up|0|||
146942896|NCT03938636|529949624|FG002|Overall Study|Lost to Follow-up|1|||
146942897|NCT02579863|529949625|FG000|Overall Study|Final Disposition Unknown|2|||
146942898|NCT02579863|529949626|FG001|Overall Study|Final Disposition Unknown|1|||
146942899|NCT02579863|529949625|FG000|Overall Study|Adverse Event|18|||
146942900|NCT02579863|529949626|FG001|Overall Study|Adverse Event|11|||
146942901|NCT02579863|529949625|FG000|Overall Study|Death|31|||
146942902|NCT02579863|529949626|FG001|Overall Study|Death|29|||
146942903|NCT02579863|529949625|FG000|Overall Study|Lost to Follow-up|2|||
146942904|NCT02579863|529949626|FG001|Overall Study|Lost to Follow-up|1|||
146942905|NCT02579863|529949625|FG000|Overall Study|Physician Decision|1|||
146942906|NCT02579863|529949626|FG001|Overall Study|Physician Decision|2|||
146942907|NCT02579863|529949625|FG000|Overall Study|Screen Failure|0|||
146942908|NCT02579863|529949626|FG001|Overall Study|Screen Failure|2|||
146942909|NCT02579863|529949625|FG000|Overall Study|Study Terminated at Selected Sites|82|||
146942910|NCT02579863|529949626|FG001|Overall Study|Study Terminated at Selected Sites|88|||
146942911|NCT02579863|529949625|FG000|Overall Study|Withdrawal by Subject|20|||
146942912|NCT02579863|529949626|FG001|Overall Study|Withdrawal by Subject|20|||
146942913|NCT00038142|529949627|FG000|Overall Study|Ineligible|1|||
146942914|NCT00038142|529949628|FG001|Overall Study|Ineligible|0|||
146942915|NCT00038142|529949627|FG000|Overall Study|Progressive Disease|11|||
146942916|NCT00038142|529949628|FG001|Overall Study|Progressive Disease|7|||
146942917|NCT00038142|529949627|FG000|Overall Study|Death|1|||
146942918|NCT00038142|529949628|FG001|Overall Study|Death|0|||
146942919|NCT00038142|529949627|FG000|Overall Study|Adverse Event|1|||
146942920|NCT00038142|529949628|FG001|Overall Study|Adverse Event|0|||
146942921|NCT00038142|529949627|FG000|Overall Study|Unknown Reason|8|||
146942922|NCT00038142|529949628|FG001|Overall Study|Unknown Reason|0|||
146942923|NCT00446797|529949631|FG000|Overall Study|Lack of Efficacy|0|||
146942924|NCT00446797|529949632|FG001|Overall Study|Lack of Efficacy|2|||
146942925|NCT00446797|529949631|FG000|Overall Study|Lost to Follow-up|5|||
146942926|NCT00446797|529949632|FG001|Overall Study|Lost to Follow-up|3|||
146942927|NCT00446797|529949631|FG000|Overall Study|Withdrawal by Subject|2|||
146942928|NCT00446797|529949632|FG001|Overall Study|Withdrawal by Subject|2|||
146942929|NCT00446797|529949631|FG000|Overall Study|Protocol Violation|1|||
146942930|NCT00446797|529949632|FG001|Overall Study|Protocol Violation|3|||
146942931|NCT00446797|529949631|FG000|Overall Study|subject entered at another site|0|||
146942932|NCT00446797|529949632|FG001|Overall Study|subject entered at another site|1|||
146942933|NCT00446797|529949631|FG000|Overall Study|did not meet entrance criteria|0|||
146942934|NCT00446797|529949632|FG001|Overall Study|did not meet entrance criteria|1|||
146942935|NCT03745989|529949635|FG000|Overall Study|Death|3|||
146942936|NCT03745989|529949636|FG001|Overall Study|Death|7|||
146942937|NCT03745989|529949637|FG002|Overall Study|Death|4|||
146942938|NCT03745989|529949635|FG000|Overall Study|Lost to Follow-up|0|||
146942939|NCT03745989|529949636|FG001|Overall Study|Lost to Follow-up|2|||
146942940|NCT03745989|529949637|FG002|Overall Study|Lost to Follow-up|0|||
146942941|NCT03745989|529949635|FG000|Overall Study|Sponsor Decision|0|||
146942942|NCT03745989|529949636|FG001|Overall Study|Sponsor Decision|2|||
146942943|NCT03745989|529949637|FG002|Overall Study|Sponsor Decision|8|||
146942944|NCT03745989|529949635|FG000|Overall Study|Withdrawal by Subject|0|||
146942945|NCT03745989|529949636|FG001|Overall Study|Withdrawal by Subject|1|||
146942946|NCT03745989|529949637|FG002|Overall Study|Withdrawal by Subject|3|||
146942947|NCT02918318|529949642|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
146942948|NCT02918318|529949643|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
146942949|NCT02918318|529949644|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
146942950|NCT02918318|529949645|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
146942951|NCT02918318|529949646|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
146942952|NCT02918318|529949642|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
146942953|NCT02918318|529949643|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
146942954|NCT02918318|529949644|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
146942955|NCT02918318|529949645|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
146942956|NCT02918318|529949646|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
146942957|NCT02918318|529949642|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
146984189|NCT01821625|530103378|FG000|Overall Study|Adverse Event|1|||
146984190|NCT01821625|530103378|FG000|Overall Study|Medical contraindication|1|||
146984191|NCT00321711|530103385|FG000|Part A|Adverse Event|3|||
146984192|NCT00321711|530103386|FG001|Part A|Adverse Event|3|||
146984193|NCT00321711|530103387|FG002|Part A|Adverse Event|2|||
146984194|NCT00321711|530103388|FG003|Part A|Adverse Event|0|||
146984195|NCT00321711|530103389|FG004|Part A|Adverse Event|0|||
146942958|NCT02918318|529949643|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
146984196|NCT00321711|530103385|FG000|Part A|Withdrawal by Subject|1|||
146984197|NCT00321711|530103386|FG001|Part A|Withdrawal by Subject|1|||
146984198|NCT00321711|530103387|FG002|Part A|Withdrawal by Subject|1|||
146942959|NCT02918318|529949644|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
146942960|NCT02918318|529949645|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
146942961|NCT02918318|529949646|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
146942962|NCT02918318|529949642|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
146942963|NCT02918318|529949643|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
146942964|NCT02918318|529949644|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
146942965|NCT02918318|529949645|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
146942966|NCT02918318|529949646|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
146942967|NCT02918318|529949642|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
146984199|NCT00321711|530103388|FG003|Part A|Withdrawal by Subject|0|||
146942968|NCT02918318|529949643|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
146942969|NCT02918318|529949644|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
146942970|NCT02918318|529949645|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
146942971|NCT02918318|529949646|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
146942972|NCT02918318|529949642|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
146942973|NCT02918318|529949643|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
146942974|NCT02918318|529949644|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
146942975|NCT02918318|529949645|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
146942976|NCT02918318|529949646|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
146942977|NCT02918318|529949642|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
146942978|NCT02918318|529949643|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
146942979|NCT02918318|529949644|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
146942980|NCT02918318|529949645|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
146942981|NCT02918318|529949646|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
146942982|NCT02918318|529949642|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
146942983|NCT02918318|529949643|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
146942984|NCT02918318|529949644|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
146942985|NCT02918318|529949645|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
146942986|NCT02918318|529949646|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
146942987|NCT02918318|529949642|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
146942988|NCT02918318|529949643|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
146942989|NCT02918318|529949644|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
146942990|NCT02918318|529949645|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
146942991|NCT02918318|529949646|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
146942992|NCT02918318|529949642|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
146942993|NCT02918318|529949643|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
146942994|NCT02918318|529949644|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
146942995|NCT02918318|529949645|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
146942996|NCT02918318|529949646|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
146942997|NCT02918318|529949642|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
146942998|NCT02918318|529949643|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
146942999|NCT02918318|529949644|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
146943000|NCT02918318|529949645|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
146943001|NCT02918318|529949646|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
146943002|NCT02918318|529949642|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
146943003|NCT02918318|529949643|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
146943004|NCT02918318|529949644|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
146943005|NCT02918318|529949645|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
146943006|NCT02918318|529949646|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
146943007|NCT00732238|529949647|FG000|Overall Study|Bacteremia|4|||
146943008|NCT00732238|529949648|FG001|Overall Study|Bacteremia|1|||
146943009|NCT00732238|529949647|FG000|Overall Study|Asymptomatic bacteriuria|1|||
146943010|NCT00732238|529949648|FG001|Overall Study|Asymptomatic bacteriuria|0|||
146943011|NCT04080752|529949649|FG000|Overall Study|Adverse Event|2|||
146943012|NCT04080752|529949650|FG001|Overall Study|Adverse Event|3|||
146943013|NCT04080752|529949649|FG000|Overall Study|Lack of Efficacy|1|||
146943014|NCT04080752|529949650|FG001|Overall Study|Lack of Efficacy|0|||
146943015|NCT04080752|529949649|FG000|Overall Study|Lost to Follow-up|1|||
146811533|NCT01947491|529481512|FG001|Overall Study|Lost to Follow-up|3|||
146811534|NCT01947491|529481513|FG002|Overall Study|Lost to Follow-up|1|||
146811535|NCT01947491|529481514|FG003|Overall Study|Lost to Follow-up|2|||
146811536|NCT01947491|529481511|FG000|Overall Study|Lack of Efficacy|1|||
146811537|NCT01947491|529481512|FG001|Overall Study|Lack of Efficacy|0|||
146811538|NCT01947491|529481513|FG002|Overall Study|Lack of Efficacy|0|||
146811539|NCT01947491|529481514|FG003|Overall Study|Lack of Efficacy|1|||
146811540|NCT01947491|529481511|FG000|Overall Study|Protocol Violation|1|||
146811541|NCT01947491|529481512|FG001|Overall Study|Protocol Violation|0|||
146811542|NCT01947491|529481513|FG002|Overall Study|Protocol Violation|0|||
146811543|NCT01947491|529481514|FG003|Overall Study|Protocol Violation|0|||
146811544|NCT01947491|529481511|FG000|Overall Study|Withdrawal by Subject|1|||
146943016|NCT04080752|529949650|FG001|Overall Study|Lost to Follow-up|0|||
146943017|NCT04080752|529949649|FG000|Overall Study|Pregnancy|0|||
146943018|NCT04080752|529949650|FG001|Overall Study|Pregnancy|1|||
146943019|NCT04080752|529949649|FG000|Overall Study|Withdrawal by Subject|7|||
146943020|NCT04080752|529949650|FG001|Overall Study|Withdrawal by Subject|0|||
146943021|NCT04080752|529949649|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146943022|NCT04080752|529949650|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146811545|NCT01947491|529481512|FG001|Overall Study|Withdrawal by Subject|1|||
146943023|NCT04080752|529949649|FG000|Overall Study|Other|2|||
146943024|NCT04080752|529949650|FG001|Overall Study|Other|1|||
146943025|NCT01194414|529949651|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
146943026|NCT01194414|529949652|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
146943027|NCT01194414|529949653|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
146943028|NCT01194414|529949654|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
146943029|NCT01194414|529949651|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
146943030|NCT01194414|529949652|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
146943031|NCT01194414|529949653|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
146943032|NCT01194414|529949654|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
146943033|NCT01194414|529949651|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
146943034|NCT01194414|529949652|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
146943035|NCT01194414|529949653|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
146943036|NCT01194414|529949654|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
146943037|NCT01194414|529949651|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
146943038|NCT01194414|529949652|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
146943039|NCT01194414|529949653|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
146943040|NCT01194414|529949654|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
146943041|NCT01194414|529949651|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
146943042|NCT01194414|529949652|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
146943043|NCT01194414|529949653|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
146943044|NCT01194414|529949654|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
146943045|NCT01194414|529949651|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
146943046|NCT01194414|529949652|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
146943047|NCT01194414|529949653|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
146943048|NCT01194414|529949654|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
146943049|NCT01194414|529949651|FG000|24 Weeks Double Blind Period|Other|0|||
146943050|NCT01194414|529949652|FG001|24 Weeks Double Blind Period|Other|1|||
146943051|NCT01194414|529949653|FG002|24 Weeks Double Blind Period|Other|0|||
146943052|NCT01194414|529949654|FG003|24 Weeks Double Blind Period|Other|0|||
146943053|NCT01194414|529949651|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
146943054|NCT01194414|529949652|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
146943055|NCT01194414|529949653|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
146943056|NCT01194414|529949654|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
146943057|NCT01194414|529949651|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
146943058|NCT01194414|529949652|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
146943059|NCT01194414|529949653|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
146943060|NCT01194414|529949654|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
146943061|NCT01194414|529949651|FG000|24 Weeks Double Blind Period|Death|0|||
146943062|NCT01194414|529949652|FG001|24 Weeks Double Blind Period|Death|1|||
146943063|NCT01194414|529949653|FG002|24 Weeks Double Blind Period|Death|0|||
146943064|NCT01194414|529949654|FG003|24 Weeks Double Blind Period|Death|0|||
146943065|NCT01194414|529949651|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
146943066|NCT01194414|529949652|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
146943067|NCT01194414|529949653|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
146943068|NCT01194414|529949654|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
146943069|NCT01194414|529949651|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
146943070|NCT01194414|529949652|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
146943071|NCT01194414|529949653|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
146943072|NCT01194414|529949654|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
146943073|NCT01194414|529949651|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
146943074|NCT01194414|529949652|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
146943075|NCT01194414|529949653|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
146943076|NCT01194414|529949654|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
146943077|NCT01194414|529949651|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
146943078|NCT01194414|529949652|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
146943079|NCT01194414|529949653|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
146943080|NCT01194414|529949654|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
146943081|NCT01194414|529949651|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
146943082|NCT01194414|529949652|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
146943083|NCT01194414|529949653|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
146943084|NCT01194414|529949654|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
146943085|NCT01194414|529949651|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
146943086|NCT01194414|529949652|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
146943087|NCT01194414|529949653|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
146943088|NCT01194414|529949654|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
146943089|NCT01194414|529949651|FG000|72 Weeks Open Label Extension|Other|2|||
146943090|NCT01194414|529949652|FG001|72 Weeks Open Label Extension|Other|1|||
146943091|NCT01194414|529949653|FG002|72 Weeks Open Label Extension|Other|0|||
146943092|NCT01194414|529949654|FG003|72 Weeks Open Label Extension|Other|0|||
146943093|NCT01194414|529949651|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
146943094|NCT01194414|529949652|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
146943095|NCT01194414|529949653|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
146943096|NCT01194414|529949654|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
146943097|NCT01194414|529949651|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
146943098|NCT01194414|529949652|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
146943099|NCT01194414|529949653|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
146943100|NCT01194414|529949654|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
146943101|NCT01194414|529949651|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
146943102|NCT01194414|529949652|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
146943103|NCT01194414|529949653|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
146943104|NCT01194414|529949654|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
146943105|NCT01194414|529949651|FG000|72 Weeks Open Label Extension|Death|1|||
146943106|NCT01194414|529949652|FG001|72 Weeks Open Label Extension|Death|2|||
146943107|NCT01194414|529949653|FG002|72 Weeks Open Label Extension|Death|0|||
146943108|NCT01194414|529949654|FG003|72 Weeks Open Label Extension|Death|2|||
146943109|NCT03605836|529949655|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
146943110|NCT03605836|529949656|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
146943111|NCT03605836|529949657|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
146943112|NCT03605836|529949658|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
146943113|NCT03605836|529949655|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
146943114|NCT03605836|529949656|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
146943115|NCT03605836|529949657|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
146943116|NCT03605836|529949658|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
146943117|NCT03605836|529949655|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
146943118|NCT03605836|529949656|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
146943119|NCT03605836|529949657|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
146943120|NCT03605836|529949658|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
146943121|NCT03605836|529949655|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
146943122|NCT03605836|529949656|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
146943123|NCT03605836|529949657|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
146943124|NCT03605836|529949658|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
146943125|NCT03605836|529949655|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
146943126|NCT03605836|529949656|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
146943127|NCT03605836|529949657|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
146943128|NCT03605836|529949658|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
146943129|NCT03605836|529949655|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
146943130|NCT03605836|529949656|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
146943131|NCT03605836|529949657|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
146943132|NCT03605836|529949658|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
146943133|NCT03605836|529949655|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
146943134|NCT03605836|529949656|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
146943135|NCT03605836|529949657|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
146943136|NCT03605836|529949658|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
146943137|NCT03605836|529949655|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
146943138|NCT03605836|529949656|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
146943139|NCT03605836|529949657|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
146943140|NCT03605836|529949658|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
146943141|NCT03605836|529949655|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
146943142|NCT03605836|529949656|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
146943143|NCT03605836|529949657|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
146943144|NCT03605836|529949658|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
146943145|NCT03605836|529949655|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
146943146|NCT03605836|529949656|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
146943147|NCT03605836|529949657|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
146943148|NCT03605836|529949658|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
146943149|NCT03605836|529949655|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
146943150|NCT03605836|529949656|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
146943151|NCT03605836|529949657|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
146943152|NCT03605836|529949658|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
146943153|NCT03605836|529949655|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
146811546|NCT01947491|529481513|FG002|Overall Study|Withdrawal by Subject|1|||
146943154|NCT03605836|529949656|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
146984200|NCT00321711|530103389|FG004|Part A|Withdrawal by Subject|0|||
146811547|NCT01947491|529481514|FG003|Overall Study|Withdrawal by Subject|0|||
146811548|NCT01947491|529481511|FG000|Overall Study|Worsening of condition|0|||
146943155|NCT03605836|529949657|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
146943156|NCT03605836|529949658|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
146943157|NCT03605836|529949655|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
146943158|NCT03605836|529949656|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
146943159|NCT03605836|529949657|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
146943160|NCT03605836|529949658|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
146943161|NCT03605836|529949655|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
146943162|NCT03605836|529949656|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
146943163|NCT03605836|529949657|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
146943164|NCT03605836|529949658|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
146943165|NCT03605836|529949655|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
146943166|NCT03605836|529949656|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
146943167|NCT03605836|529949657|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
146943168|NCT03605836|529949658|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
146943169|NCT03605836|529949655|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
146943170|NCT03605836|529949656|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
146943171|NCT03605836|529949657|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
146943172|NCT03605836|529949658|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
146943173|NCT03605836|529949655|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
146943174|NCT03605836|529949656|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
146943175|NCT03605836|529949657|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
146943176|NCT03605836|529949658|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
146943177|NCT03605836|529949655|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
146943178|NCT03605836|529949656|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
146943179|NCT03605836|529949657|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
146943180|NCT03605836|529949658|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
146943181|NCT03605836|529949655|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
146943182|NCT03605836|529949656|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
146943183|NCT03605836|529949657|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
146943184|NCT03605836|529949658|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
146943185|NCT03605836|529949655|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
146943186|NCT03605836|529949656|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
146943187|NCT03605836|529949657|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
146943188|NCT03605836|529949658|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
146943189|NCT03605836|529949655|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
146943190|NCT03605836|529949656|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
146943191|NCT03605836|529949657|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
146943192|NCT03605836|529949658|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
146943193|NCT03605836|529949655|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
146943194|NCT03605836|529949656|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
146943195|NCT03605836|529949657|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
146943196|NCT03605836|529949658|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
146943197|NCT01929707|529949664|FG000|Intervention Period 1|Lost to Follow-up|0|||
146943198|NCT01929707|529949665|FG001|Intervention Period 1|Lost to Follow-up|0|||
146943199|NCT01929707|529949666|FG002|Intervention Period 1|Lost to Follow-up|0|||
146943200|NCT01929707|529949667|FG003|Intervention Period 1|Lost to Follow-up|1|||
146943201|NCT01929707|529949668|FG004|Intervention Period 1|Lost to Follow-up|0|||
146943202|NCT01929707|529949669|FG005|Intervention Period 1|Lost to Follow-up|0|||
146943203|NCT01929707|529949670|FG006|Intervention Period 1|Lost to Follow-up|0|||
146943204|NCT01929707|529949671|FG007|Intervention Period 1|Lost to Follow-up|0|||
146943205|NCT01929707|529949664|FG000|Intervention Period 1|Withdrawal by Subject|0|||
146984201|NCT00321711|530103385|FG000|Part A|Disease progression|0|||
146984202|NCT00321711|530103386|FG001|Part A|Disease progression|1|||
146984203|NCT00321711|530103387|FG002|Part A|Disease progression|0|||
146811549|NCT01947491|529481512|FG001|Overall Study|Worsening of condition|1|||
146811550|NCT01947491|529481513|FG002|Overall Study|Worsening of condition|0|||
146811551|NCT01947491|529481514|FG003|Overall Study|Worsening of condition|0|||
146811552|NCT01947491|529481511|FG000|Overall Study|Adverse Event|0|||
146811553|NCT01947491|529481512|FG001|Overall Study|Adverse Event|1|||
146811554|NCT01947491|529481513|FG002|Overall Study|Adverse Event|0|||
146811555|NCT01947491|529481514|FG003|Overall Study|Adverse Event|2|||
146811556|NCT00704340|529481515|FG000|Overall Study|Lost to Follow-up|2|||
146811557|NCT00704340|529481516|FG001|Overall Study|Lost to Follow-up|1|||
146811558|NCT00704340|529481515|FG000|Overall Study|Death|0|||
146811559|NCT00704340|529481516|FG001|Overall Study|Death|1|||
146811560|NCT00929526|529481517|FG000|Overall Study|Withdrawal by Subject|1|||
146943206|NCT01929707|529949665|FG001|Intervention Period 1|Withdrawal by Subject|0|||
146811561|NCT00929526|529481518|FG001|Overall Study|Withdrawal by Subject|11|||
146811562|NCT00929526|529481517|FG000|Overall Study|Lost to Follow-up|8|||
146811563|NCT00929526|529481518|FG001|Overall Study|Lost to Follow-up|12|||
146811564|NCT00929526|529481517|FG000|Overall Study|Other|8|||
146811565|NCT00929526|529481518|FG001|Overall Study|Other|6|||
146811566|NCT00403845|529481519|FG000|Treatment Period 1|Subject withdrew consent|1|||
146811567|NCT00403845|529481520|FG001|Treatment Period 1|Subject withdrew consent|0|||
146811568|NCT00403845|529481521|FG002|Treatment Period 1|Subject withdrew consent|0|||
146811569|NCT00403845|529481522|FG003|Treatment Period 1|Subject withdrew consent|0|||
146811570|NCT00403845|529481519|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
146811571|NCT00403845|529481520|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
146811572|NCT00403845|529481521|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
146811573|NCT00403845|529481522|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
146811574|NCT00403845|529481519|FG000|Treatment Period 2|Subject withdrew consent|1|||
146811575|NCT00403845|529481520|FG001|Treatment Period 2|Subject withdrew consent|0|||
146811576|NCT00403845|529481521|FG002|Treatment Period 2|Subject withdrew consent|0|||
146811577|NCT00403845|529481522|FG003|Treatment Period 2|Subject withdrew consent|0|||
146811578|NCT00403845|529481519|FG000|Treatment Period 3|Subject withdrew consent|0|||
146811579|NCT00403845|529481520|FG001|Treatment Period 3|Subject withdrew consent|0|||
146811580|NCT00403845|529481521|FG002|Treatment Period 3|Subject withdrew consent|0|||
146811581|NCT00403845|529481522|FG003|Treatment Period 3|Subject withdrew consent|1|||
146811582|NCT00403845|529481519|FG000|Treatment Period 3|Adverse Event|0|||
146811583|NCT00403845|529481520|FG001|Treatment Period 3|Adverse Event|0|||
146811584|NCT00403845|529481521|FG002|Treatment Period 3|Adverse Event|0|||
146811585|NCT00403845|529481522|FG003|Treatment Period 3|Adverse Event|1|||
146811586|NCT03316170|529481523|FG000|Overall Study|Death|1|||
146811587|NCT03316170|529481524|FG001|Overall Study|Death|0|||
146811588|NCT03316170|529481523|FG000|Overall Study|Lost to Follow-up|6|||
146811589|NCT03316170|529481524|FG001|Overall Study|Lost to Follow-up|7|||
146811590|NCT02169414|529481525|FG000|Overall Study|Withdrawal by Subject|1|||
146811591|NCT02169414|529481526|FG001|Overall Study|Withdrawal by Subject|0|||
146811592|NCT02169414|529481527|FG002|Overall Study|Withdrawal by Subject|0|||
146811593|NCT02169414|529481528|FG003|Overall Study|Withdrawal by Subject|0|||
146811594|NCT02169414|529481525|FG000|Overall Study|Adverse Event|0|||
146811595|NCT02169414|529481526|FG001|Overall Study|Adverse Event|1|||
146811596|NCT02169414|529481527|FG002|Overall Study|Adverse Event|0|||
146811597|NCT02169414|529481528|FG003|Overall Study|Adverse Event|0|||
146811598|NCT00578344|529481529|FG000|Overall Study|Insurance problems|1|||
146811599|NCT00578344|529481529|FG000|Overall Study|Graft failure|1|||
146811600|NCT03374254|529481532|FG000|Overall Study|Death|5|||
146811601|NCT03374254|529481533|FG001|Overall Study|Death|16|||
146811602|NCT03374254|529481534|FG002|Overall Study|Death|13|||
146811603|NCT03374254|529481535|FG003|Overall Study|Death|11|||
146811604|NCT03374254|529481536|FG004|Overall Study|Death|9|||
146811605|NCT03374254|529481537|FG005|Overall Study|Death|12|||
146811606|NCT03374254|529481538|FG006|Overall Study|Death|11|||
146811607|NCT03374254|529481539|FG007|Overall Study|Death|6|||
146811608|NCT03374254|529481540|FG008|Overall Study|Death|7|||
146811609|NCT03374254|529481532|FG000|Overall Study|Lost to Follow-up|0|||
146811610|NCT03374254|529481533|FG001|Overall Study|Lost to Follow-up|0|||
146811611|NCT03374254|529481534|FG002|Overall Study|Lost to Follow-up|0|||
146811612|NCT03374254|529481535|FG003|Overall Study|Lost to Follow-up|0|||
146811613|NCT03374254|529481536|FG004|Overall Study|Lost to Follow-up|0|||
146811614|NCT03374254|529481537|FG005|Overall Study|Lost to Follow-up|0|||
146811615|NCT03374254|529481538|FG006|Overall Study|Lost to Follow-up|2|||
146811616|NCT03374254|529481539|FG007|Overall Study|Lost to Follow-up|0|||
146811617|NCT03374254|529481540|FG008|Overall Study|Lost to Follow-up|0|||
146811618|NCT03374254|529481532|FG000|Overall Study|Sponsor Decision|1|||
146811619|NCT03374254|529481533|FG001|Overall Study|Sponsor Decision|0|||
146811620|NCT03374254|529481534|FG002|Overall Study|Sponsor Decision|2|||
146943207|NCT01929707|529949666|FG002|Intervention Period 1|Withdrawal by Subject|0|||
146943208|NCT01929707|529949667|FG003|Intervention Period 1|Withdrawal by Subject|2|||
146943209|NCT01929707|529949668|FG004|Intervention Period 1|Withdrawal by Subject|0|||
146943210|NCT01929707|529949669|FG005|Intervention Period 1|Withdrawal by Subject|0|||
146943211|NCT01929707|529949670|FG006|Intervention Period 1|Withdrawal by Subject|0|||
146811621|NCT03374254|529481535|FG003|Overall Study|Sponsor Decision|3|||
146811622|NCT03374254|529481536|FG004|Overall Study|Sponsor Decision|2|||
146811623|NCT03374254|529481537|FG005|Overall Study|Sponsor Decision|3|||
146811624|NCT03374254|529481538|FG006|Overall Study|Sponsor Decision|3|||
146811625|NCT03374254|529481539|FG007|Overall Study|Sponsor Decision|3|||
146811626|NCT03374254|529481540|FG008|Overall Study|Sponsor Decision|4|||
146811627|NCT03374254|529481532|FG000|Overall Study|Withdrawal by Subject|0|||
146811628|NCT03374254|529481533|FG001|Overall Study|Withdrawal by Subject|0|||
146943212|NCT01929707|529949671|FG007|Intervention Period 1|Withdrawal by Subject|0|||
146811629|NCT03374254|529481534|FG002|Overall Study|Withdrawal by Subject|0|||
146811630|NCT03374254|529481535|FG003|Overall Study|Withdrawal by Subject|2|||
146811631|NCT03374254|529481536|FG004|Overall Study|Withdrawal by Subject|0|||
146984204|NCT00321711|530103388|FG003|Part A|Disease progression|0|||
146943213|NCT01929707|529949664|FG000|Intervention Period 2|Withdrawal by Subject|0|||
146943214|NCT01929707|529949665|FG001|Intervention Period 2|Withdrawal by Subject|0|||
146943215|NCT01929707|529949666|FG002|Intervention Period 2|Withdrawal by Subject|0|||
146943216|NCT01929707|529949667|FG003|Intervention Period 2|Withdrawal by Subject|0|||
146943217|NCT01929707|529949668|FG004|Intervention Period 2|Withdrawal by Subject|0|||
146943218|NCT01929707|529949669|FG005|Intervention Period 2|Withdrawal by Subject|2|||
146943219|NCT01929707|529949670|FG006|Intervention Period 2|Withdrawal by Subject|0|||
146943220|NCT01929707|529949671|FG007|Intervention Period 2|Withdrawal by Subject|0|||
146943221|NCT00431496|529949678|FG000|Overall Study|Adverse Event|3|||
146943222|NCT00431496|529949678|FG000|Overall Study|Lost to Follow-up|1|||
146943223|NCT00431496|529949678|FG000|Overall Study|Withdrawal by Subject|2|||
146943224|NCT00431496|529949678|FG000|Overall Study|Protocol-specified criteria|5|||
146943225|NCT02343952|529949679|FG000|Study Treatment|Disease Progression|23|||
146943226|NCT02343952|529949679|FG000|Study Treatment|Death|3|||
146943227|NCT02343952|529949679|FG000|Study Treatment|Adverse Event|19|||
146943228|NCT02343952|529949679|FG000|Study Treatment|Withdrawal by Subject|7|||
146943229|NCT02343952|529949679|FG000|Study Treatment|other complicating Diseases|1|||
146943230|NCT02343952|529949679|FG000|Follow up|Withdrawal by Subject|3|||
146943231|NCT02343952|529949679|FG000|Follow up|Death|33|||
146943232|NCT02343952|529949679|FG000|Follow up|Patient does not meet eligibility for study.|1|||
146943233|NCT02343952|529949679|FG000|Follow up|Research department closed by the practice.|5|||
146943234|NCT02343952|529949679|FG000|Follow up|Patient went home to Russia|1|||
146943235|NCT02343952|529949679|FG000|Follow up|Disease Progression|1|||
146943236|NCT02343952|529949679|FG000|Follow up|study terminated|1|||
146943237|NCT02067533|529949680|FG000|Overall Study|Lost to Follow-up|4|||
146943238|NCT02067533|529949681|FG001|Overall Study|Lost to Follow-up|2|||
146943239|NCT00845845|529949682|FG000|Overall Study|Lost to Follow-up|0|||
146943240|NCT00845845|529949683|FG001|Overall Study|Lost to Follow-up|4|||
146943241|NCT00560794|529949686|FG000|Overall Study|Adverse Event|2|||
146943242|NCT00560794|529949686|FG000|Overall Study|Patient was not Compliant|1|||
146943243|NCT00560794|529949686|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
146943244|NCT00560794|529949686|FG000|Overall Study|Hematological Relapse|1|||
146943245|NCT00560794|529949686|FG000|Overall Study|Received Bone Marrow Transplant|6|||
146943246|NCT00880607|529949690|FG000|Overall Study|Physician Decision|2|||
146943247|NCT00880607|529949691|FG001|Overall Study|Physician Decision|2|||
146943248|NCT00880607|529949690|FG000|Overall Study|Protocol Violation|2|||
146943249|NCT00880607|529949691|FG001|Overall Study|Protocol Violation|1|||
146943250|NCT00880607|529949690|FG000|Overall Study|surgery did not extend past L1 level|3|||
146943251|NCT00880607|529949691|FG001|Overall Study|surgery did not extend past L1 level|0|||
146943252|NCT04507360|529951555|FG000|Week 1|Lost to Follow-up|0|||
146943253|NCT04507360|529951556|FG001|Week 1|Lost to Follow-up|0|||
146943254|NCT04507360|529951557|FG002|Week 1|Lost to Follow-up|0|||
146943255|NCT04507360|529951558|FG003|Week 1|Lost to Follow-up|0|||
146943256|NCT04507360|529951559|FG004|Week 1|Lost to Follow-up|0|||
146943257|NCT04507360|529951560|FG005|Week 1|Lost to Follow-up|0|||
146943258|NCT04507360|529951561|FG006|Week 1|Lost to Follow-up|0|||
146943259|NCT04507360|529951562|FG007|Week 1|Lost to Follow-up|0|||
146943260|NCT04507360|529951563|FG008|Week 1|Lost to Follow-up|72|||
146943261|NCT04507360|529951564|FG009|Week 1|Lost to Follow-up|22|||
146984205|NCT00321711|530103389|FG004|Part A|Disease progression|0|||
146984206|NCT00321711|530103385|FG000|Part A|Requirement for alternative therapy|0|||
146984207|NCT00321711|530103386|FG001|Part A|Requirement for alternative therapy|2|||
146984208|NCT00321711|530103387|FG002|Part A|Requirement for alternative therapy|1|||
146984209|NCT00321711|530103388|FG003|Part A|Requirement for alternative therapy|0|||
146811632|NCT03374254|529481537|FG005|Overall Study|Withdrawal by Subject|1|||
146811633|NCT03374254|529481538|FG006|Overall Study|Withdrawal by Subject|0|||
146811634|NCT03374254|529481539|FG007|Overall Study|Withdrawal by Subject|0|||
146811635|NCT03374254|529481540|FG008|Overall Study|Withdrawal by Subject|0|||
146811636|NCT04803734|529481541|FG000|Overall Study|Withdrawal by Subject|0|||
146943262|NCT04507360|529951565|FG010|Week 1|Lost to Follow-up|10|||
146943263|NCT04507360|529951555|FG000|Week 2|Lost to Follow-up|0|||
146943264|NCT04507360|529951556|FG001|Week 2|Lost to Follow-up|0|||
146943265|NCT04507360|529951557|FG002|Week 2|Lost to Follow-up|0|||
146943266|NCT04507360|529951558|FG003|Week 2|Lost to Follow-up|0|||
146984210|NCT00321711|530103389|FG004|Part A|Requirement for alternative therapy|0|||
146984211|NCT00321711|530103385|FG000|Part A|Physician Decision|0|||
146943267|NCT04507360|529951559|FG004|Week 2|Lost to Follow-up|0|||
146943268|NCT04507360|529951560|FG005|Week 2|Lost to Follow-up|0|||
146943269|NCT04507360|529951561|FG006|Week 2|Lost to Follow-up|0|||
146943270|NCT04507360|529951562|FG007|Week 2|Lost to Follow-up|0|||
146811637|NCT04803734|529481542|FG001|Overall Study|Withdrawal by Subject|1|||
146811638|NCT04803734|529481541|FG000|Overall Study|Protocol Violation|0|||
146943271|NCT04507360|529951563|FG008|Week 2|Lost to Follow-up|121|||
146943272|NCT04507360|529951564|FG009|Week 2|Lost to Follow-up|85|||
146943273|NCT04507360|529951565|FG010|Week 2|Lost to Follow-up|82|||
146943274|NCT04507360|529951555|FG000|Week 3|Lost to Follow-up|0|||
146943275|NCT04507360|529951556|FG001|Week 3|Lost to Follow-up|0|||
146943276|NCT04507360|529951557|FG002|Week 3|Lost to Follow-up|0|||
146943277|NCT04507360|529951558|FG003|Week 3|Lost to Follow-up|0|||
146943278|NCT04507360|529951559|FG004|Week 3|Lost to Follow-up|0|||
146943279|NCT04507360|529951560|FG005|Week 3|Lost to Follow-up|0|||
146943280|NCT04507360|529951561|FG006|Week 3|Lost to Follow-up|0|||
146943281|NCT04507360|529951562|FG007|Week 3|Lost to Follow-up|0|||
146943282|NCT04507360|529951563|FG008|Week 3|Lost to Follow-up|123|||
146943283|NCT04507360|529951564|FG009|Week 3|Lost to Follow-up|92|||
146943284|NCT04507360|529951565|FG010|Week 3|Lost to Follow-up|84|||
146943285|NCT04507360|529951555|FG000|Week 4|Lost to Follow-up|0|||
146943286|NCT04507360|529951556|FG001|Week 4|Lost to Follow-up|0|||
146943287|NCT04507360|529951557|FG002|Week 4|Lost to Follow-up|0|||
146943288|NCT04507360|529951558|FG003|Week 4|Lost to Follow-up|0|||
146943289|NCT04507360|529951559|FG004|Week 4|Lost to Follow-up|0|||
146943290|NCT04507360|529951560|FG005|Week 4|Lost to Follow-up|0|||
146943291|NCT04507360|529951561|FG006|Week 4|Lost to Follow-up|0|||
146943292|NCT04507360|529951562|FG007|Week 4|Lost to Follow-up|0|||
146943293|NCT04507360|529951563|FG008|Week 4|Lost to Follow-up|131|||
146943294|NCT04507360|529951564|FG009|Week 4|Lost to Follow-up|115|||
146943295|NCT04507360|529951565|FG010|Week 4|Lost to Follow-up|102|||
146943296|NCT04507360|529951555|FG000|Week 5|Lost to Follow-up|0|||
146943297|NCT04507360|529951556|FG001|Week 5|Lost to Follow-up|0|||
146943298|NCT04507360|529951557|FG002|Week 5|Lost to Follow-up|0|||
146943299|NCT04507360|529951558|FG003|Week 5|Lost to Follow-up|0|||
146943300|NCT04507360|529951559|FG004|Week 5|Lost to Follow-up|0|||
146943301|NCT04507360|529951560|FG005|Week 5|Lost to Follow-up|0|||
146943302|NCT04507360|529951561|FG006|Week 5|Lost to Follow-up|0|||
146943303|NCT04507360|529951562|FG007|Week 5|Lost to Follow-up|0|||
146943304|NCT04507360|529951563|FG008|Week 5|Lost to Follow-up|103|||
146943305|NCT04507360|529951564|FG009|Week 5|Lost to Follow-up|135|||
146943306|NCT04507360|529951565|FG010|Week 5|Lost to Follow-up|143|||
146943307|NCT04507360|529951555|FG000|Week 8|Lost to Follow-up|0|||
146943308|NCT04507360|529951556|FG001|Week 8|Lost to Follow-up|0|||
146943309|NCT04507360|529951557|FG002|Week 8|Lost to Follow-up|0|||
146943310|NCT04507360|529951558|FG003|Week 8|Lost to Follow-up|0|||
146943311|NCT04507360|529951559|FG004|Week 8|Lost to Follow-up|0|||
146943312|NCT04507360|529951560|FG005|Week 8|Lost to Follow-up|0|||
146943313|NCT04507360|529951561|FG006|Week 8|Lost to Follow-up|0|||
146943314|NCT04507360|529951562|FG007|Week 8|Lost to Follow-up|0|||
146943315|NCT04507360|529951563|FG008|Week 8|Lost to Follow-up|139|||
146943316|NCT04507360|529951564|FG009|Week 8|Lost to Follow-up|145|||
146943317|NCT04507360|529951565|FG010|Week 8|Lost to Follow-up|152|||
146943318|NCT01131078|529951570|FG000|Overall Study|Adverse Event|22|||
146943319|NCT01131078|529951571|FG001|Overall Study|Adverse Event|12|||
146943320|NCT01131078|529951572|FG002|Overall Study|Adverse Event|17|||
146943321|NCT01131078|529951570|FG000|Overall Study|Progressive Disease|58|||
146943322|NCT01131078|529951571|FG001|Overall Study|Progressive Disease|77|||
146943323|NCT01131078|529951572|FG002|Overall Study|Progressive Disease|71|||
146943324|NCT01131078|529951570|FG000|Overall Study|Protocol Violation|1|||
146943325|NCT01131078|529951571|FG001|Overall Study|Protocol Violation|0|||
146943326|NCT01131078|529951572|FG002|Overall Study|Protocol Violation|0|||
146943327|NCT01131078|529951570|FG000|Overall Study|Lost to Follow-up|1|||
146943328|NCT01131078|529951571|FG001|Overall Study|Lost to Follow-up|1|||
146943329|NCT01131078|529951572|FG002|Overall Study|Lost to Follow-up|1|||
146943330|NCT01131078|529951570|FG000|Overall Study|Withdrawal by Subject|2|||
146943331|NCT01131078|529951571|FG001|Overall Study|Withdrawal by Subject|4|||
146943332|NCT01131078|529951572|FG002|Overall Study|Withdrawal by Subject|3|||
146943333|NCT01131078|529951570|FG000|Overall Study|Non-compliance|3|||
146943334|NCT01131078|529951571|FG001|Overall Study|Non-compliance|0|||
146943335|NCT01131078|529951572|FG002|Overall Study|Non-compliance|0|||
146943336|NCT01131078|529951570|FG000|Overall Study|Physician Decision|10|||
146943337|NCT01131078|529951571|FG001|Overall Study|Physician Decision|6|||
146943338|NCT01131078|529951572|FG002|Overall Study|Physician Decision|8|||
146943339|NCT01131078|529951570|FG000|Overall Study|Death|4|||
146943340|NCT01131078|529951571|FG001|Overall Study|Death|0|||
146943341|NCT01131078|529951572|FG002|Overall Study|Death|2|||
146943342|NCT01131078|529951570|FG000|Overall Study|Other|0|||
146943343|NCT01131078|529951571|FG001|Overall Study|Other|1|||
146943344|NCT01131078|529951572|FG002|Overall Study|Other|0|||
146943345|NCT04315298|529951573|FG000|Overall Study|Withdrawal by Subject|0|||
146943346|NCT04315298|529951574|FG001|Overall Study|Withdrawal by Subject|0|||
146943347|NCT04315298|529951575|FG002|Overall Study|Withdrawal by Subject|0|||
146984212|NCT00321711|530103386|FG001|Part A|Physician Decision|1|||
146622456|NCT04612725|528789678|FG003|Overall Study|Lost to Follow-up|0|||
146943348|NCT04315298|529951576|FG003|Overall Study|Withdrawal by Subject|2|||
146943349|NCT04315298|529951577|FG004|Overall Study|Withdrawal by Subject|2|||
146943350|NCT04315298|529951578|FG005|Overall Study|Withdrawal by Subject|2|||
146943351|NCT04315298|529951579|FG006|Overall Study|Withdrawal by Subject|0|||
146943352|NCT04315298|529951580|FG007|Overall Study|Withdrawal by Subject|1|||
146943353|NCT04315298|529951581|FG008|Overall Study|Withdrawal by Subject|1|||
146943354|NCT04315298|529951582|FG009|Overall Study|Withdrawal by Subject|1|||
146943355|NCT04315298|529951583|FG010|Overall Study|Withdrawal by Subject|0|||
146943356|NCT04315298|529951584|FG011|Overall Study|Withdrawal by Subject|0|||
146943357|NCT04315298|529951585|FG012|Overall Study|Withdrawal by Subject|0|||
146943358|NCT04315298|529951586|FG013|Overall Study|Withdrawal by Subject|0|||
146984213|NCT00321711|530103387|FG002|Part A|Physician Decision|3|||
146943359|NCT04315298|529951587|FG014|Overall Study|Withdrawal by Subject|0|||
146943360|NCT04315298|529951588|FG015|Overall Study|Withdrawal by Subject|0|||
146943361|NCT04315298|529951589|FG016|Overall Study|Withdrawal by Subject|0|||
146943362|NCT04315298|529951590|FG017|Overall Study|Withdrawal by Subject|0|||
146943363|NCT04315298|529951591|FG018|Overall Study|Withdrawal by Subject|0|||
146943364|NCT04315298|529951573|FG000|Overall Study|Physician Decision|0|||
146943365|NCT04315298|529951574|FG001|Overall Study|Physician Decision|0|||
146943366|NCT04315298|529951575|FG002|Overall Study|Physician Decision|0|||
146943367|NCT04315298|529951576|FG003|Overall Study|Physician Decision|0|||
146943368|NCT04315298|529951577|FG004|Overall Study|Physician Decision|1|||
146943369|NCT04315298|529951578|FG005|Overall Study|Physician Decision|0|||
146943370|NCT04315298|529951579|FG006|Overall Study|Physician Decision|0|||
146943371|NCT04315298|529951580|FG007|Overall Study|Physician Decision|0|||
146943372|NCT04315298|529951581|FG008|Overall Study|Physician Decision|0|||
146943373|NCT04315298|529951582|FG009|Overall Study|Physician Decision|0|||
146943374|NCT04315298|529951583|FG010|Overall Study|Physician Decision|0|||
146943375|NCT04315298|529951584|FG011|Overall Study|Physician Decision|0|||
146943376|NCT04315298|529951585|FG012|Overall Study|Physician Decision|0|||
146943377|NCT04315298|529951586|FG013|Overall Study|Physician Decision|0|||
146943378|NCT04315298|529951587|FG014|Overall Study|Physician Decision|0|||
146943379|NCT04315298|529951588|FG015|Overall Study|Physician Decision|0|||
146943380|NCT04315298|529951589|FG016|Overall Study|Physician Decision|0|||
146943381|NCT04315298|529951590|FG017|Overall Study|Physician Decision|0|||
146943382|NCT04315298|529951591|FG018|Overall Study|Physician Decision|0|||
146943383|NCT04315298|529951573|FG000|Overall Study|Lost to Follow-up|5|||
146943384|NCT04315298|529951574|FG001|Overall Study|Lost to Follow-up|10|||
146943385|NCT04315298|529951575|FG002|Overall Study|Lost to Follow-up|6|||
146943386|NCT04315298|529951576|FG003|Overall Study|Lost to Follow-up|8|||
146943387|NCT04315298|529951577|FG004|Overall Study|Lost to Follow-up|12|||
146943388|NCT04315298|529951578|FG005|Overall Study|Lost to Follow-up|13|||
146943389|NCT04315298|529951579|FG006|Overall Study|Lost to Follow-up|9|||
146943390|NCT04315298|529951580|FG007|Overall Study|Lost to Follow-up|16|||
146943391|NCT04315298|529951581|FG008|Overall Study|Lost to Follow-up|14|||
146943392|NCT04315298|529951582|FG009|Overall Study|Lost to Follow-up|0|||
146943393|NCT04315298|529951583|FG010|Overall Study|Lost to Follow-up|2|||
146943394|NCT04315298|529951584|FG011|Overall Study|Lost to Follow-up|1|||
146943395|NCT04315298|529951585|FG012|Overall Study|Lost to Follow-up|0|||
146943396|NCT04315298|529951586|FG013|Overall Study|Lost to Follow-up|0|||
146943397|NCT04315298|529951587|FG014|Overall Study|Lost to Follow-up|0|||
146943398|NCT04315298|529951588|FG015|Overall Study|Lost to Follow-up|2|||
146943399|NCT04315298|529951589|FG016|Overall Study|Lost to Follow-up|0|||
146943400|NCT04315298|529951590|FG017|Overall Study|Lost to Follow-up|0|||
146943401|NCT04315298|529951591|FG018|Overall Study|Lost to Follow-up|0|||
146943402|NCT04315298|529951573|FG000|Overall Study|Death|24|||
146943403|NCT04315298|529951574|FG001|Overall Study|Death|60|||
146943404|NCT04315298|529951575|FG002|Overall Study|Death|49|||
146943405|NCT04315298|529951576|FG003|Overall Study|Death|59|||
146943406|NCT04315298|529951577|FG004|Overall Study|Death|70|||
146943407|NCT04315298|529951578|FG005|Overall Study|Death|114|||
146943408|NCT04315298|529951579|FG006|Overall Study|Death|9|||
146943409|NCT04315298|529951580|FG007|Overall Study|Death|12|||
146943410|NCT04315298|529951581|FG008|Overall Study|Death|21|||
146943411|NCT04315298|529951582|FG009|Overall Study|Death|16|||
146943412|NCT04315298|529951583|FG010|Overall Study|Death|40|||
146943413|NCT04315298|529951584|FG011|Overall Study|Death|40|||
146943414|NCT04315298|529951585|FG012|Overall Study|Death|3|||
146943415|NCT04315298|529951586|FG013|Overall Study|Death|4|||
146943416|NCT04315298|529951587|FG014|Overall Study|Death|6|||
146943417|NCT04315298|529951588|FG015|Overall Study|Death|4|||
146943418|NCT04315298|529951589|FG016|Overall Study|Death|3|||
146943419|NCT04315298|529951590|FG017|Overall Study|Death|1|||
146943420|NCT04315298|529951591|FG018|Overall Study|Death|0|||
146943421|NCT01199198|529951592|FG000|Overall Study|Adverse Event|3|||
146943422|NCT01199198|529951593|FG001|Overall Study|Adverse Event|0|||
146943423|NCT01199198|529951592|FG000|Overall Study|Lost to Follow-up|1|||
146943424|NCT01199198|529951593|FG001|Overall Study|Lost to Follow-up|5|||
146943425|NCT01199198|529951592|FG000|Overall Study|Withdrawal by Subject|1|||
146943426|NCT01199198|529951593|FG001|Overall Study|Withdrawal by Subject|2|||
146943427|NCT01199198|529951592|FG000|Overall Study|ICU Transfer|1|||
146943428|NCT01199198|529951593|FG001|Overall Study|ICU Transfer|2|||
146984214|NCT00321711|530103388|FG003|Part A|Physician Decision|0|||
146943429|NCT01199198|529951592|FG000|Overall Study|Hospice-care transfer|1|||
146943430|NCT01199198|529951593|FG001|Overall Study|Hospice-care transfer|2|||
146943431|NCT00736385|529951594|FG000|Overall Study|Withdrawal by Subject|2|||
146943432|NCT00736385|529951595|FG001|Overall Study|Withdrawal by Subject|2|||
146943433|NCT00736385|529951594|FG000|Overall Study|Adverse Event|0|||
146943434|NCT00736385|529951595|FG001|Overall Study|Adverse Event|1|||
146943435|NCT01183104|529951596|FG000|Overall Study|Adverse Event|8|||
146943436|NCT01183104|529951597|FG001|Overall Study|Adverse Event|6|||
146943437|NCT01183104|529951596|FG000|Overall Study|Death|0|||
146943438|NCT01183104|529951597|FG001|Overall Study|Death|1|||
146943439|NCT01183104|529951596|FG000|Overall Study|Lost to Follow-up|14|||
146943440|NCT01183104|529951597|FG001|Overall Study|Lost to Follow-up|7|||
146943441|NCT01183104|529951596|FG000|Overall Study|Physician Decision|5|||
146943442|NCT01183104|529951597|FG001|Overall Study|Physician Decision|8|||
146943443|NCT01183104|529951596|FG000|Overall Study|Withdrawal by Subject|6|||
146943444|NCT01183104|529951597|FG001|Overall Study|Withdrawal by Subject|11|||
146943445|NCT01183104|529951596|FG000|Overall Study|Nonparticipation in Extension Study|39|||
146943446|NCT01183104|529951597|FG001|Overall Study|Nonparticipation in Extension Study|50|||
146943447|NCT01183104|529951596|FG000|Overall Study|Did not receive study drug|5|||
146943448|NCT01183104|529951597|FG001|Overall Study|Did not receive study drug|9|||
146943449|NCT03267511|529951598|FG000|Overall Study|Lost to Follow-up|0|||
146943450|NCT03267511|529951599|FG001|Overall Study|Lost to Follow-up|0|||
146943451|NCT03267511|529951600|FG002|Overall Study|Lost to Follow-up|0|||
146943452|NCT03267511|529951601|FG003|Overall Study|Lost to Follow-up|1|||
146943453|NCT01594749|529951602|FG000|Overall Study|Adverse Event|2|||
146943454|NCT01594749|529951603|FG001|Overall Study|Adverse Event|1|||
146943455|NCT01594749|529951602|FG000|Overall Study|Withdrawal by Subject|2|||
146943456|NCT01594749|529951603|FG001|Overall Study|Withdrawal by Subject|2|||
146943457|NCT01594749|529951602|FG000|Overall Study|Protocol Violation|2|||
146943458|NCT01594749|529951603|FG001|Overall Study|Protocol Violation|0|||
146943459|NCT01594749|529951602|FG000|Overall Study|Physician Decision|1|||
146943460|NCT01594749|529951603|FG001|Overall Study|Physician Decision|1|||
146943461|NCT01594749|529951602|FG000|Overall Study|Non-compliance with Protocol|0|||
146943462|NCT01594749|529951603|FG001|Overall Study|Non-compliance with Protocol|1|||
146943463|NCT01594749|529951602|FG000|Overall Study|Lost to Follow-up|1|||
146943464|NCT01594749|529951603|FG001|Overall Study|Lost to Follow-up|0|||
146943465|NCT01594749|529951602|FG000|Overall Study|Death|9|||
146943466|NCT01594749|529951603|FG001|Overall Study|Death|3|||
146943467|NCT01594749|529951602|FG000|Overall Study|Not Treated|4|||
146943468|NCT01594749|529951603|FG001|Overall Study|Not Treated|10|||
146943469|NCT01594749|529951602|FG000|Overall Study|Lost Source Documentation|1|||
146943470|NCT01594749|529951603|FG001|Overall Study|Lost Source Documentation|0|||
146943471|NCT00364351|529951604|FG000|Overall Study|Adverse Event|90|||
146943472|NCT00364351|529951605|FG001|Overall Study|Adverse Event|44|||
146943473|NCT00364351|529951604|FG000|Overall Study|Condition under investigation worsened|469|||
146943474|NCT00364351|529951605|FG001|Overall Study|Condition under investigation worsened|497|||
146943475|NCT00364351|529951604|FG000|Overall Study|Prohibited concomitant medication|0|||
146943476|NCT00364351|529951605|FG001|Overall Study|Prohibited concomitant medication|2|||
146943477|NCT00364351|529951604|FG000|Overall Study|Lost to Follow-up|1|||
146943478|NCT00364351|529951605|FG001|Overall Study|Lost to Follow-up|1|||
146943479|NCT00364351|529951604|FG000|Overall Study|Withdrawal by Subject|30|||
146943480|NCT00364351|529951605|FG001|Overall Study|Withdrawal by Subject|29|||
146943481|NCT00364351|529951604|FG000|Overall Study|Incorrect enrollment|1|||
146943482|NCT00364351|529951605|FG001|Overall Study|Incorrect enrollment|1|||
146943483|NCT00364351|529951604|FG000|Overall Study|Sponsor decision|1|||
146943484|NCT00364351|529951605|FG001|Overall Study|Sponsor decision|0|||
146943485|NCT00364351|529951604|FG000|Overall Study|Poor treatment compliance|0|||
146943486|NCT00364351|529951605|FG001|Overall Study|Poor treatment compliance|3|||
146943487|NCT00364351|529951604|FG000|Overall Study|Investigator error|0|||
146943488|NCT00364351|529951605|FG001|Overall Study|Investigator error|2|||
146943489|NCT00364351|529951604|FG000|Overall Study|Patient could not travel to site|0|||
146943490|NCT00364351|529951605|FG001|Overall Study|Patient could not travel to site|1|||
146943491|NCT00364351|529951604|FG000|Overall Study|Randomised treatment not started|0|||
146943492|NCT00364351|529951605|FG001|Overall Study|Randomised treatment not started|3|||
146943493|NCT00653068|529951606|FG000|Overall Study|Death|9|||
146943494|NCT00653068|529951606|FG000|Overall Study|Lack of Efficacy|34|||
146943495|NCT00653068|529951606|FG000|Overall Study|Physician Decision|4|||
146943496|NCT00653068|529951606|FG000|Overall Study|Withdrawal by Subject|1|||
146943497|NCT00653068|529951606|FG000|Overall Study|Ineligible|2|||
146943498|NCT00634751|529951607|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
146943499|NCT00634751|529951608|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
146943500|NCT00634751|529951609|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
146943501|NCT00634751|529951610|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
146943502|NCT00634751|529951607|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
146943503|NCT00634751|529951608|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
146943504|NCT00634751|529951609|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
146943505|NCT00634751|529951610|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
146943506|NCT00634751|529951607|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
146943507|NCT00634751|529951608|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
146943508|NCT00634751|529951609|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
146943509|NCT00634751|529951610|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
146943510|NCT00209092|529951615|FG000|Overall Study|Progression of disease|7|||
146943511|NCT00209092|529951616|FG001|Overall Study|Progression of disease|1|||
146943512|NCT00209092|529951615|FG000|Overall Study|Adverse Event|0|||
146943513|NCT00209092|529951616|FG001|Overall Study|Adverse Event|1|||
146943514|NCT00209092|529951615|FG000|Overall Study|Withdrawal by Subject|1|||
146943515|NCT00209092|529951616|FG001|Overall Study|Withdrawal by Subject|0|||
146943516|NCT01119963|529951620|FG000|Overall Study|Lost to Follow-up|1|||
146943517|NCT01119963|529951621|FG001|Overall Study|Lost to Follow-up|1|||
146943518|NCT04072575|529951633|FG000|Overall Study|Physician Decision|1|||
146943519|NCT04072575|529951633|FG000|Overall Study|Adverse Event|7|||
146943520|NCT04072575|529951633|FG000|Overall Study|Withdrawal by Subject|14|||
146943521|NCT04072575|529951633|FG000|Overall Study|Other|2|||
146943522|NCT02498392|529951634|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
146943523|NCT02498392|529951635|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
146943524|NCT02498392|529951634|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
146943525|NCT02498392|529951635|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
146943526|NCT02498392|529951634|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
146943527|NCT02498392|529951635|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
146943528|NCT02498392|529951634|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
146943529|NCT02498392|529951635|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
146943530|NCT02498392|529951634|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
146943531|NCT02498392|529951635|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
146943532|NCT02498392|529951634|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
146943533|NCT02498392|529951635|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
146943534|NCT02473289|529951636|FG000|Overall Study|Adverse Event|2|||
146943535|NCT02473289|529951637|FG001|Overall Study|Adverse Event|3|||
146943536|NCT02473289|529951636|FG000|Overall Study|Lost to Follow-up|1|||
146943537|NCT02473289|529951637|FG001|Overall Study|Lost to Follow-up|1|||
146943538|NCT02473289|529951636|FG000|Overall Study|Protocol Violation|0|||
146943539|NCT02473289|529951637|FG001|Overall Study|Protocol Violation|1|||
146943540|NCT02473289|529951636|FG000|Overall Study|Withdrawal of consent|6|||
146943541|NCT02473289|529951637|FG001|Overall Study|Withdrawal of consent|7|||
146943542|NCT02473289|529951636|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
146943543|NCT02473289|529951637|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
146943544|NCT02473289|529951636|FG000|Overall Study|Other|2|||
146943545|NCT02473289|529951637|FG001|Overall Study|Other|0|||
146943546|NCT02244619|529951638|FG000|Overall Study|Did not receive study intervention|8|||
146943547|NCT02244619|529951639|FG001|Overall Study|Did not receive study intervention|21|||
146943548|NCT03135262|529951640|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
146943549|NCT03135262|529951641|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
146943550|NCT03135262|529951642|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
146943551|NCT03135262|529951643|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
146943552|NCT03135262|529951644|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
146943553|NCT03135262|529951640|FG000|Overall Study|Progression of disease|0|||
146943554|NCT03135262|529951641|FG001|Overall Study|Progression of disease|0|||
146943555|NCT03135262|529951642|FG002|Overall Study|Progression of disease|0|||
146943556|NCT03135262|529951643|FG003|Overall Study|Progression of disease|1|||
146943557|NCT03135262|529951644|FG004|Overall Study|Progression of disease|0|||
146943558|NCT03135262|529951640|FG000|Overall Study|Death|6|||
146943559|NCT03135262|529951641|FG001|Overall Study|Death|2|||
146943560|NCT03135262|529951642|FG002|Overall Study|Death|2|||
146943561|NCT03135262|529951643|FG003|Overall Study|Death|2|||
146943562|NCT03135262|529951644|FG004|Overall Study|Death|0|||
146943563|NCT03135262|529951640|FG000|Overall Study|Withdrawal by Subject|0|||
146943564|NCT03135262|529951641|FG001|Overall Study|Withdrawal by Subject|0|||
146943565|NCT03135262|529951642|FG002|Overall Study|Withdrawal by Subject|1|||
146943566|NCT03135262|529951643|FG003|Overall Study|Withdrawal by Subject|0|||
146943567|NCT03135262|529951644|FG004|Overall Study|Withdrawal by Subject|1|||
146943568|NCT03135262|529951640|FG000|Overall Study|Study terminated by sponsor|2|||
146943569|NCT03135262|529951641|FG001|Overall Study|Study terminated by sponsor|4|||
146943570|NCT03135262|529951642|FG002|Overall Study|Study terminated by sponsor|4|||
146943571|NCT03135262|529951643|FG003|Overall Study|Study terminated by sponsor|3|||
146943572|NCT03135262|529951644|FG004|Overall Study|Study terminated by sponsor|0|||
146943573|NCT02728206|529951646|FG000|Overall Study|Death|1|||
146943574|NCT01782885|529951649|FG000|Overall Study|Lost to Follow-up|4|||
146943575|NCT01782885|529951650|FG001|Overall Study|Lost to Follow-up|6|||
146943576|NCT00633360|529951654|FG000|Overall Study|Lost to Follow-up|1|||
146943577|NCT00633360|529951655|FG001|Overall Study|Lost to Follow-up|1|||
146943578|NCT00633360|529951654|FG000|Overall Study|Adverse Event|3|||
146943579|NCT00633360|529951655|FG001|Overall Study|Adverse Event|1|||
146943580|NCT00633360|529951654|FG000|Overall Study|Protocol Violation|0|||
146943581|NCT00633360|529951655|FG001|Overall Study|Protocol Violation|1|||
146943582|NCT01098032|529951656|FG000|Overall Study|Withdrawal by Subject|1|||
146943583|NCT01098032|529951657|FG001|Overall Study|Withdrawal by Subject|1|||
146943584|NCT00610207|529951659|FG000|Overall Study|Lost to Follow-up|3|||
146811639|NCT04803734|529481542|FG001|Overall Study|Protocol Violation|1|||
146943585|NCT03236506|529951668|FG000|Overall Study|Death|1|||
146943586|NCT03236506|529951669|FG001|Overall Study|Death|1|||
146811640|NCT02309515|529481544|FG000|Overall Study|Withdrawal by Subject|0|||
146811641|NCT02309515|529481545|FG001|Overall Study|Withdrawal by Subject|1|||
146811642|NCT00749944|529481553|FG000|Overall Study|Lost to Follow-up|2|||
146811643|NCT00749944|529481554|FG001|Overall Study|Lost to Follow-up|1|||
146811644|NCT00749944|529481553|FG000|Overall Study|Other|1|||
146811645|NCT00749944|529481554|FG001|Overall Study|Other|0|||
146811646|NCT00749944|529481553|FG000|Overall Study|Withdrawal by Subject|2|||
146811647|NCT00749944|529481554|FG001|Overall Study|Withdrawal by Subject|0|||
146811648|NCT02547974|529481555|FG000|Overall Study|Withdrawal by Subject|1|||
146811649|NCT02547974|529481556|FG001|Overall Study|Withdrawal by Subject|0|||
146811650|NCT02547974|529481557|FG002|Overall Study|Withdrawal by Subject|0|||
146811651|NCT02547974|529481558|FG003|Overall Study|Withdrawal by Subject|0|||
146811652|NCT00923078|529481562|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
146811653|NCT00923078|529481563|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
146811654|NCT00923078|529481564|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
146811655|NCT00923078|529481562|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
146811656|NCT00923078|529481563|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
146811657|NCT00923078|529481564|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
146811658|NCT01999335|529481565|FG000|Overall Study|Discontinued before receiving treatment|0|||
146811659|NCT01999335|529481566|FG001|Overall Study|Discontinued before receiving treatment|0|||
146811660|NCT01999335|529481567|FG002|Overall Study|Discontinued before receiving treatment|0|||
146811661|NCT01999335|529481568|FG003|Overall Study|Discontinued before receiving treatment|0|||
146811662|NCT01999335|529481569|FG004|Overall Study|Discontinued before receiving treatment|2|||
146811663|NCT04766996|529481570|FG000|Overall Study|Withdrawal by Subject|1|||
146811664|NCT04766996|529481571|FG001|Overall Study|Withdrawal by Subject|0|||
146811665|NCT04766996|529481572|FG002|Overall Study|Withdrawal by Subject|13|||
146811666|NCT01393964|529481585|FG000|Overall Study|Disease Progression|4|||
146811667|NCT01393964|529481586|FG001|Overall Study|Disease Progression|3|||
146811668|NCT01393964|529481587|FG002|Overall Study|Disease Progression|5|||
146811669|NCT01393964|529481585|FG000|Overall Study|Study drug toxicity|1|||
146811670|NCT01393964|529481586|FG001|Overall Study|Study drug toxicity|0|||
146811671|NCT01393964|529481587|FG002|Overall Study|Study drug toxicity|0|||
146811672|NCT01393964|529481585|FG000|Overall Study|Withdrawal by Subject|0|||
146811673|NCT01393964|529481586|FG001|Overall Study|Withdrawal by Subject|0|||
146811674|NCT01393964|529481587|FG002|Overall Study|Withdrawal by Subject|1|||
146811675|NCT01393964|529481585|FG000|Overall Study|Adverse event unrelated to study drug|0|||
146811676|NCT01393964|529481586|FG001|Overall Study|Adverse event unrelated to study drug|3|||
146811677|NCT01393964|529481587|FG002|Overall Study|Adverse event unrelated to study drug|0|||
146811678|NCT01393964|529481585|FG000|Overall Study|Subject request stop study treatment|0|||
146811679|NCT01393964|529481586|FG001|Overall Study|Subject request stop study treatment|1|||
146811680|NCT01393964|529481587|FG002|Overall Study|Subject request stop study treatment|0|||
146811681|NCT01393964|529481585|FG000|Overall Study|Subject decided to move to transplant|1|||
146811682|NCT01393964|529481586|FG001|Overall Study|Subject decided to move to transplant|0|||
146811683|NCT01393964|529481587|FG002|Overall Study|Subject decided to move to transplant|0|||
146811684|NCT01393964|529481585|FG000|Overall Study|Subject switched to commercial supply|1|||
146811685|NCT01393964|529481586|FG001|Overall Study|Subject switched to commercial supply|0|||
146811686|NCT01393964|529481587|FG002|Overall Study|Subject switched to commercial supply|2|||
146811687|NCT01393964|529481585|FG000|Overall Study|Subject plateaued in terms of effect|1|||
146811688|NCT01393964|529481586|FG001|Overall Study|Subject plateaued in terms of effect|0|||
146811689|NCT01393964|529481587|FG002|Overall Study|Subject plateaued in terms of effect|0|||
146811690|NCT01393964|529481585|FG000|Overall Study|Investigator removed subject from study|0|||
146811691|NCT01393964|529481586|FG001|Overall Study|Investigator removed subject from study|1|||
146811692|NCT01393964|529481587|FG002|Overall Study|Investigator removed subject from study|0|||
146811693|NCT01393964|529481585|FG000|Overall Study|Subject converted to roll-over study|0|||
146811694|NCT01393964|529481586|FG001|Overall Study|Subject converted to roll-over study|1|||
146811695|NCT01393964|529481587|FG002|Overall Study|Subject converted to roll-over study|0|||
146811696|NCT01393964|529481585|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
146811697|NCT01393964|529481586|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
146943587|NCT03236506|529951670|FG002|Overall Study|Death|1|||
146943588|NCT03236506|529951668|FG000|Overall Study|Withdrawal by Subject|3|||
146943589|NCT03236506|529951669|FG001|Overall Study|Withdrawal by Subject|3|||
146622457|NCT04612725|528789679|FG004|Overall Study|Lost to Follow-up|0|||
146622458|NCT04612725|528789675|FG000|Overall Study|Physician Decision|2|||
146622459|NCT04612725|528789676|FG001|Overall Study|Physician Decision|0|||
146622460|NCT04612725|528789677|FG002|Overall Study|Physician Decision|0|||
146622461|NCT04612725|528789678|FG003|Overall Study|Physician Decision|0|||
146622462|NCT04612725|528789679|FG004|Overall Study|Physician Decision|0|||
146622463|NCT04612725|528789675|FG000|Overall Study|Study terminated by sponsor|3|||
146622464|NCT04612725|528789676|FG001|Overall Study|Study terminated by sponsor|1|||
146622465|NCT04612725|528789677|FG002|Overall Study|Study terminated by sponsor|2|||
146622466|NCT04612725|528789678|FG003|Overall Study|Study terminated by sponsor|4|||
146622467|NCT04612725|528789679|FG004|Overall Study|Study terminated by sponsor|5|||
146622468|NCT04612725|528789675|FG000|Overall Study|Withdrawal by Subject|8|||
146622469|NCT04612725|528789676|FG001|Overall Study|Withdrawal by Subject|3|||
146943590|NCT03236506|529951670|FG002|Overall Study|Withdrawal by Subject|4|||
146943591|NCT03236506|529951668|FG000|Overall Study|Did not initiate treatment|2|||
146943592|NCT03236506|529951669|FG001|Overall Study|Did not initiate treatment|1|||
146943593|NCT03236506|529951670|FG002|Overall Study|Did not initiate treatment|2|||
146943594|NCT01594411|529951683|FG000|Overall Study|Lost to Follow-up|2|||
146943595|NCT00437203|529951686|FG000|Overall Study|Death|0|||
146943596|NCT00437203|529951687|FG001|Overall Study|Death|0|||
146943597|NCT00437203|529951688|FG002|Overall Study|Death|1|||
146943598|NCT00437203|529951689|FG003|Overall Study|Death|0|||
146943599|NCT00437203|529951690|FG004|Overall Study|Death|0|||
146943600|NCT00437203|529951691|FG005|Overall Study|Death|0|||
146943601|NCT00437203|529951692|FG006|Overall Study|Death|0|||
146943602|NCT00437203|529951693|FG007|Overall Study|Death|1|||
146943603|NCT00437203|529951694|FG008|Overall Study|Death|0|||
146943604|NCT00437203|529951695|FG009|Overall Study|Death|1|||
146943605|NCT00437203|529951686|FG000|Overall Study|Adverse Event|1|||
146943606|NCT00437203|529951687|FG001|Overall Study|Adverse Event|1|||
146943607|NCT00437203|529951688|FG002|Overall Study|Adverse Event|0|||
146943608|NCT00437203|529951689|FG003|Overall Study|Adverse Event|0|||
146943609|NCT00437203|529951690|FG004|Overall Study|Adverse Event|0|||
146943610|NCT00437203|529951691|FG005|Overall Study|Adverse Event|0|||
146943611|NCT00437203|529951692|FG006|Overall Study|Adverse Event|0|||
146943612|NCT00437203|529951693|FG007|Overall Study|Adverse Event|1|||
146622470|NCT04612725|528789677|FG002|Overall Study|Withdrawal by Subject|5|||
146622471|NCT04612725|528789678|FG003|Overall Study|Withdrawal by Subject|1|||
146622472|NCT04612725|528789679|FG004|Overall Study|Withdrawal by Subject|9|||
146622473|NCT04612725|528789675|FG000|Overall Study|Other|0|||
146622474|NCT04612725|528789676|FG001|Overall Study|Other|0|||
146622475|NCT04612725|528789677|FG002|Overall Study|Other|0|||
146622476|NCT04612725|528789678|FG003|Overall Study|Other|0|||
146622477|NCT04612725|528789679|FG004|Overall Study|Other|1|||
146622478|NCT02354235|528789680|FG000|Overall Study|Adverse Event|2|||
146622479|NCT02354235|528789681|FG001|Overall Study|Adverse Event|2|||
146622480|NCT02354235|528789680|FG000|Overall Study|Physician Decision|0|||
146622481|NCT02354235|528789681|FG001|Overall Study|Physician Decision|1|||
146622482|NCT02354235|528789680|FG000|Overall Study|Withdrawal by Subject|1|||
146622483|NCT02354235|528789681|FG001|Overall Study|Withdrawal by Subject|3|||
146984215|NCT00321711|530103389|FG004|Part A|Physician Decision|0|||
146984216|NCT00321711|530103385|FG000|Part A|Other|1|||
146622484|NCT02354235|528789680|FG000|Overall Study|Conflict with the stopping criteria|0|||
146622485|NCT02354235|528789681|FG001|Overall Study|Conflict with the stopping criteria|1|||
146622486|NCT03069352|528789682|FG000|Overall Study|Ongoing|12|||
146622487|NCT03069352|528789683|FG001|Overall Study|Ongoing|40|||
146622488|NCT02621424|528789684|FG000|Overall Study|Withdrawal by Subject|1|||
146622489|NCT02621424|528789685|FG001|Overall Study|Withdrawal by Subject|2|||
146622490|NCT05148234|528789687|FG000|Phase I|Ineligible|0|||
146622491|NCT05148234|528789688|FG001|Phase I|Ineligible|0|||
146622492|NCT05148234|528789689|FG002|Phase I|Ineligible|0|||
146622493|NCT05148234|528789690|FG003|Phase I|Ineligible|0|||
146622494|NCT05148234|528789691|FG004|Phase I|Ineligible|0|||
146622495|NCT05148234|528789692|FG005|Phase I|Ineligible|0|||
146622496|NCT05148234|528789693|FG006|Phase I|Ineligible|0|||
146622497|NCT05148234|528789694|FG007|Phase I|Ineligible|1|||
146622498|NCT05148234|528789687|FG000|Phase I|Company closed the trial.|0|||
146622499|NCT05148234|528789688|FG001|Phase I|Company closed the trial.|1|||
146622500|NCT05148234|528789689|FG002|Phase I|Company closed the trial.|0|||
146622501|NCT05148234|528789690|FG003|Phase I|Company closed the trial.|0|||
146622502|NCT05148234|528789691|FG004|Phase I|Company closed the trial.|0|||
146622503|NCT05148234|528789692|FG005|Phase I|Company closed the trial.|0|||
146622504|NCT05148234|528789693|FG006|Phase I|Company closed the trial.|0|||
146622505|NCT05148234|528789694|FG007|Phase I|Company closed the trial.|0|||
146622506|NCT01928927|528789695|FG000|Overall Study|Lost to Follow-up|1|||
146622507|NCT01928927|528789696|FG001|Overall Study|Lost to Follow-up|0|||
146622508|NCT01928927|528789695|FG000|Overall Study|Withdrawal by Subject|1|||
146943613|NCT00437203|529951694|FG008|Overall Study|Adverse Event|0|||
146943614|NCT00437203|529951695|FG009|Overall Study|Adverse Event|1|||
146943615|NCT00437203|529951686|FG000|Overall Study|Study terminated by sponsor|0|||
146984217|NCT00321711|530103386|FG001|Part A|Other|2|||
146622509|NCT01928927|528789696|FG001|Overall Study|Withdrawal by Subject|1|||
146622510|NCT04158583|528789697|FG000|Overall Study|Withdrawal by Subject|1|||
146622511|NCT04158583|528789698|FG001|Overall Study|Withdrawal by Subject|1|||
146622512|NCT04158583|528789699|FG002|Overall Study|Withdrawal by Subject|0|||
146622513|NCT04158583|528789700|FG003|Overall Study|Withdrawal by Subject|0|||
146622514|NCT04158583|528789701|FG004|Overall Study|Withdrawal by Subject|1|||
146622515|NCT04158583|528789702|FG005|Overall Study|Withdrawal by Subject|0|||
146622516|NCT04158583|528789703|FG006|Overall Study|Withdrawal by Subject|0|||
146943616|NCT00437203|529951687|FG001|Overall Study|Study terminated by sponsor|0|||
146943617|NCT00437203|529951688|FG002|Overall Study|Study terminated by sponsor|0|||
146622517|NCT04158583|528789704|FG007|Overall Study|Withdrawal by Subject|0|||
146943618|NCT00437203|529951689|FG003|Overall Study|Study terminated by sponsor|0|||
146984218|NCT00321711|530103387|FG002|Part A|Other|3|||
146984219|NCT00321711|530103388|FG003|Part A|Other|0|||
146943619|NCT00437203|529951690|FG004|Overall Study|Study terminated by sponsor|0|||
146943620|NCT00437203|529951691|FG005|Overall Study|Study terminated by sponsor|0|||
146943621|NCT00437203|529951692|FG006|Overall Study|Study terminated by sponsor|0|||
146943622|NCT00437203|529951693|FG007|Overall Study|Study terminated by sponsor|0|||
146943623|NCT00437203|529951694|FG008|Overall Study|Study terminated by sponsor|1|||
146943624|NCT00437203|529951695|FG009|Overall Study|Study terminated by sponsor|0|||
146943625|NCT00437203|529951686|FG000|Overall Study|Objective progression or relapse|5|||
146943626|NCT00437203|529951687|FG001|Overall Study|Objective progression or relapse|6|||
146943627|NCT00437203|529951688|FG002|Overall Study|Objective progression or relapse|2|||
146943628|NCT00437203|529951689|FG003|Overall Study|Objective progression or relapse|3|||
146943629|NCT00437203|529951690|FG004|Overall Study|Objective progression or relapse|3|||
146943630|NCT00437203|529951691|FG005|Overall Study|Objective progression or relapse|3|||
146943631|NCT00437203|529951692|FG006|Overall Study|Objective progression or relapse|6|||
146943632|NCT00437203|529951693|FG007|Overall Study|Objective progression or relapse|1|||
146943633|NCT00437203|529951694|FG008|Overall Study|Objective progression or relapse|2|||
146943634|NCT00437203|529951695|FG009|Overall Study|Objective progression or relapse|2|||
146943635|NCT00437203|529951686|FG000|Overall Study|Other|0|||
146943636|NCT00437203|529951687|FG001|Overall Study|Other|1|||
146943637|NCT00437203|529951688|FG002|Overall Study|Other|0|||
146943638|NCT00437203|529951689|FG003|Overall Study|Other|0|||
146943639|NCT00437203|529951690|FG004|Overall Study|Other|0|||
146943640|NCT00437203|529951691|FG005|Overall Study|Other|0|||
146943641|NCT00437203|529951692|FG006|Overall Study|Other|1|||
146943642|NCT00437203|529951693|FG007|Overall Study|Other|0|||
146943643|NCT00437203|529951694|FG008|Overall Study|Other|0|||
146943644|NCT00437203|529951695|FG009|Overall Study|Other|0|||
146943645|NCT00479167|529951696|FG000|Overall Study|Withdrawal by Subject|1|||
146943646|NCT01570309|529951699|FG000|Overall Study|Withdrawal by Subject|3|||
146943647|NCT01570309|529951700|FG001|Overall Study|Withdrawal by Subject|3|||
146943648|NCT04857892|529951701|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
146943649|NCT04857892|529951702|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
146943650|NCT04857892|529951703|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
146943651|NCT04857892|529951704|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
146943652|NCT04857892|529951705|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
146943653|NCT04857892|529951701|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
146943654|NCT04857892|529951702|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
146943655|NCT04857892|529951703|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
146943656|NCT04857892|529951704|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
146943657|NCT04857892|529951705|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
146943658|NCT04857892|529951701|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
146943659|NCT04857892|529951702|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
146943660|NCT04857892|529951703|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
146943661|NCT04857892|529951704|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
146943662|NCT04857892|529951705|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
146943663|NCT00368472|529951710|FG000|Overall Study|Adverse Event|22|||
146943664|NCT00368472|529951710|FG000|Overall Study|Medication non-compliance|4|||
146943665|NCT00368472|529951710|FG000|Overall Study|Protocol Violation|2|||
146943666|NCT00368472|529951710|FG000|Overall Study|Request of Investigator or Sponsor|3|||
146943667|NCT00368472|529951710|FG000|Overall Study|Withdrawal by Subject|40|||
146943668|NCT00368472|529951710|FG000|Overall Study|Diary non-compliance|1|||
146943669|NCT00368472|529951710|FG000|Overall Study|Other|32|||
146943670|NCT00368472|529951710|FG000|Overall Study|Missing Final Disposition Date|1|||
146943671|NCT02384993|529951714|FG000|Overall Study|Adverse Event|0|||
146943672|NCT02384993|529951715|FG001|Overall Study|Adverse Event|1|||
146943673|NCT04095793|529951716|FG000|Overall Study|Adverse Event|3|||
146943674|NCT04095793|529951716|FG000|Overall Study|Study Terminated by Sponsor|103|||
146943675|NCT04095793|529951716|FG000|Overall Study|Withdrawal by Subject|4|||
146943676|NCT01004159|529953251|FG000|Overall Study|Adverse Event|2|||
146943677|NCT01004159|529953251|FG000|Overall Study|Disease Progression|18|||
146943678|NCT04483544|529953253|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
146943679|NCT04483544|529953253|FG000|Post-Treatment|Admitted to hospice|2|||
146943680|NCT04483544|529953253|FG000|Post-Treatment|Study terminated|3|||
146943681|NCT01977040|529953255|FG000|Overall Study|Vasa previa not confirmed|2|||
146943682|NCT01685060|529953256|FG000|Overall Study|Rollover patients|16|||
146943683|NCT01685060|529953256|FG000|Overall Study|Adverse Event|12|||
146943684|NCT01685060|529953256|FG000|Overall Study|Progressive disease|69|||
146943685|NCT01685060|529953256|FG000|Overall Study|Physician Decision|14|||
146943686|NCT01685060|529953256|FG000|Overall Study|Subject/guardian decision|20|||
146622518|NCT04158583|528789705|FG008|Overall Study|Withdrawal by Subject|2|||
146943687|NCT01685060|529953256|FG000|Overall Study|Lost to Follow-up|1|||
146943688|NCT01685060|529953256|FG000|Overall Study|Death|8|||
146943689|NCT02828644|529953257|FG000|Overall Study|Lost to Follow-up|23|||
146943690|NCT02828644|529953258|FG001|Overall Study|Lost to Follow-up|22|||
146943691|NCT02996110|529953259|FG000|Pre-Treatment|Other Reasons|0|||
146943692|NCT02996110|529953260|FG001|Pre-Treatment|Other Reasons|1|||
146943693|NCT02996110|529953261|FG002|Pre-Treatment|Other Reasons|0|||
146943694|NCT02996110|529953262|FG003|Pre-Treatment|Other Reasons|0|||
146943695|NCT02996110|529953263|FG004|Pre-Treatment|Other Reasons|1|||
146943696|NCT02996110|529953259|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
146943697|NCT02996110|529953260|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
146943698|NCT02996110|529953261|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
146943699|NCT02996110|529953262|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
146943700|NCT02996110|529953263|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
146943701|NCT02996110|529953259|FG000|Track 1|Disease Progression|15|||
146943702|NCT02996110|529953260|FG001|Track 1|Disease Progression|17|||
146943703|NCT02996110|529953261|FG002|Track 1|Disease Progression|0|||
146943704|NCT02996110|529953262|FG003|Track 1|Disease Progression|0|||
146943705|NCT02996110|529953263|FG004|Track 1|Disease Progression|0|||
146943706|NCT02996110|529953259|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
146943707|NCT02996110|529953260|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
146943708|NCT02996110|529953261|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
146943709|NCT02996110|529953262|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
146943710|NCT02996110|529953263|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
146943711|NCT02996110|529953259|FG000|Track 1|Study Drug Toxicity|5|||
146943712|NCT02996110|529953260|FG001|Track 1|Study Drug Toxicity|3|||
146943713|NCT02996110|529953261|FG002|Track 1|Study Drug Toxicity|0|||
146943714|NCT02996110|529953262|FG003|Track 1|Study Drug Toxicity|0|||
146943715|NCT02996110|529953263|FG004|Track 1|Study Drug Toxicity|0|||
146943716|NCT02996110|529953259|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
146943717|NCT02996110|529953260|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
146943718|NCT02996110|529953261|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
146943719|NCT02996110|529953262|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
146943720|NCT02996110|529953263|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
146943721|NCT02996110|529953259|FG000|Track 1|Administrative Reason by Sponsor|0|||
146943722|NCT02996110|529953260|FG001|Track 1|Administrative Reason by Sponsor|1|||
146943723|NCT02996110|529953261|FG002|Track 1|Administrative Reason by Sponsor|0|||
146943724|NCT02996110|529953262|FG003|Track 1|Administrative Reason by Sponsor|0|||
146943725|NCT02996110|529953263|FG004|Track 1|Administrative Reason by Sponsor|0|||
146943726|NCT02996110|529953259|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
146943727|NCT02996110|529953260|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
146943728|NCT02996110|529953261|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
146943729|NCT02996110|529953262|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
146943730|NCT02996110|529953263|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
146943731|NCT02996110|529953259|FG000|Track 2|Disease Progression|33|||
146943732|NCT02996110|529953260|FG001|Track 2|Disease Progression|26|||
146943733|NCT02996110|529953261|FG002|Track 2|Disease Progression|19|||
146943734|NCT02996110|529953262|FG003|Track 2|Disease Progression|16|||
146943735|NCT02996110|529953263|FG004|Track 2|Disease Progression|15|||
146943736|NCT02996110|529953259|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
146943737|NCT02996110|529953260|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
146943738|NCT02996110|529953261|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
146943739|NCT02996110|529953262|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
146943740|NCT02996110|529953263|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
146943741|NCT02996110|529953259|FG000|Track 2|Death|0|||
146943742|NCT02996110|529953260|FG001|Track 2|Death|0|||
146943743|NCT02996110|529953261|FG002|Track 2|Death|1|||
146943744|NCT02996110|529953262|FG003|Track 2|Death|0|||
146943745|NCT02996110|529953263|FG004|Track 2|Death|1|||
146943746|NCT02996110|529953259|FG000|Track 2|Study Drug Toxicity|4|||
146943747|NCT02996110|529953260|FG001|Track 2|Study Drug Toxicity|1|||
146943748|NCT02996110|529953261|FG002|Track 2|Study Drug Toxicity|4|||
146943749|NCT02996110|529953262|FG003|Track 2|Study Drug Toxicity|1|||
146943750|NCT02996110|529953263|FG004|Track 2|Study Drug Toxicity|0|||
146943751|NCT02996110|529953259|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
146943752|NCT02996110|529953260|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
146984220|NCT00321711|530103389|FG004|Part A|Other|0|||
146984221|NCT00321711|530103385|FG000|Part A|Protocol deviation|0|||
146943753|NCT02996110|529953261|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
146943754|NCT02996110|529953262|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
146943755|NCT02996110|529953263|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
146943756|NCT02996110|529953259|FG000|Track 2|Participant Withdrew Consent|1|||
146943757|NCT02996110|529953260|FG001|Track 2|Participant Withdrew Consent|2|||
146943758|NCT02996110|529953261|FG002|Track 2|Participant Withdrew Consent|3|||
146943759|NCT02996110|529953262|FG003|Track 2|Participant Withdrew Consent|1|||
146943760|NCT02996110|529953263|FG004|Track 2|Participant Withdrew Consent|1|||
146943761|NCT02996110|529953259|FG000|Track 2|Other Reasons|0|||
146943762|NCT02996110|529953260|FG001|Track 2|Other Reasons|0|||
146943763|NCT02996110|529953261|FG002|Track 2|Other Reasons|1|||
146943764|NCT02996110|529953262|FG003|Track 2|Other Reasons|0|||
146943765|NCT02996110|529953263|FG004|Track 2|Other Reasons|1|||
146984222|NCT00321711|530103386|FG001|Part A|Protocol deviation|0|||
146622519|NCT04158583|528789706|FG009|Overall Study|Withdrawal by Subject|0|||
146622520|NCT04158583|528789697|FG000|Overall Study|Study Terminated by Sponsor|0|||
146622521|NCT04158583|528789698|FG001|Overall Study|Study Terminated by Sponsor|0|||
146622522|NCT04158583|528789699|FG002|Overall Study|Study Terminated by Sponsor|0|||
146622523|NCT04158583|528789700|FG003|Overall Study|Study Terminated by Sponsor|1|||
146622524|NCT04158583|528789701|FG004|Overall Study|Study Terminated by Sponsor|0|||
146622525|NCT04158583|528789702|FG005|Overall Study|Study Terminated by Sponsor|0|||
146622526|NCT04158583|528789703|FG006|Overall Study|Study Terminated by Sponsor|0|||
146622527|NCT04158583|528789704|FG007|Overall Study|Study Terminated by Sponsor|0|||
146622528|NCT04158583|528789705|FG008|Overall Study|Study Terminated by Sponsor|0|||
146622529|NCT04158583|528789706|FG009|Overall Study|Study Terminated by Sponsor|0|||
146622530|NCT04158583|528789697|FG000|Overall Study|Progressive Disease|1|||
146622531|NCT04158583|528789698|FG001|Overall Study|Progressive Disease|0|||
146622532|NCT04158583|528789699|FG002|Overall Study|Progressive Disease|3|||
146622533|NCT04158583|528789700|FG003|Overall Study|Progressive Disease|5|||
146622534|NCT04158583|528789701|FG004|Overall Study|Progressive Disease|0|||
146622535|NCT04158583|528789702|FG005|Overall Study|Progressive Disease|1|||
146622536|NCT04158583|528789703|FG006|Overall Study|Progressive Disease|6|||
146622537|NCT04158583|528789704|FG007|Overall Study|Progressive Disease|2|||
146622538|NCT04158583|528789705|FG008|Overall Study|Progressive Disease|1|||
146622539|NCT04158583|528789706|FG009|Overall Study|Progressive Disease|2|||
146622540|NCT04158583|528789697|FG000|Overall Study|Lost to Follow-up|0|||
146622541|NCT04158583|528789698|FG001|Overall Study|Lost to Follow-up|0|||
146622542|NCT04158583|528789699|FG002|Overall Study|Lost to Follow-up|1|||
146622543|NCT04158583|528789700|FG003|Overall Study|Lost to Follow-up|1|||
146622544|NCT04158583|528789701|FG004|Overall Study|Lost to Follow-up|1|||
146622545|NCT04158583|528789702|FG005|Overall Study|Lost to Follow-up|0|||
146622546|NCT04158583|528789703|FG006|Overall Study|Lost to Follow-up|0|||
146622547|NCT04158583|528789704|FG007|Overall Study|Lost to Follow-up|0|||
146622548|NCT04158583|528789705|FG008|Overall Study|Lost to Follow-up|0|||
146622549|NCT04158583|528789706|FG009|Overall Study|Lost to Follow-up|0|||
146622550|NCT04158583|528789697|FG000|Overall Study|Due To Patient Status|0|||
146622551|NCT04158583|528789698|FG001|Overall Study|Due To Patient Status|0|||
146622552|NCT04158583|528789699|FG002|Overall Study|Due To Patient Status|0|||
146622553|NCT04158583|528789700|FG003|Overall Study|Due To Patient Status|0|||
146622554|NCT04158583|528789701|FG004|Overall Study|Due To Patient Status|0|||
146622555|NCT04158583|528789702|FG005|Overall Study|Due To Patient Status|0|||
146622556|NCT04158583|528789703|FG006|Overall Study|Due To Patient Status|0|||
146622557|NCT04158583|528789704|FG007|Overall Study|Due To Patient Status|0|||
146622558|NCT04158583|528789705|FG008|Overall Study|Due To Patient Status|1|||
146622559|NCT04158583|528789706|FG009|Overall Study|Due To Patient Status|0|||
146622560|NCT04158583|528789697|FG000|Overall Study|Death|3|||
146622561|NCT04158583|528789698|FG001|Overall Study|Death|4|||
146622562|NCT04158583|528789699|FG002|Overall Study|Death|2|||
146622563|NCT04158583|528789700|FG003|Overall Study|Death|2|||
146622564|NCT04158583|528789701|FG004|Overall Study|Death|4|||
146622565|NCT04158583|528789702|FG005|Overall Study|Death|3|||
146622566|NCT04158583|528789703|FG006|Overall Study|Death|5|||
146622567|NCT04158583|528789704|FG007|Overall Study|Death|2|||
146622568|NCT04158583|528789705|FG008|Overall Study|Death|0|||
146622569|NCT04158583|528789706|FG009|Overall Study|Death|1|||
146622570|NCT04158583|528789697|FG000|Overall Study|Clinical Progression Disease|0|||
146622571|NCT04158583|528789698|FG001|Overall Study|Clinical Progression Disease|0|||
146622572|NCT04158583|528789699|FG002|Overall Study|Clinical Progression Disease|0|||
146622573|NCT04158583|528789700|FG003|Overall Study|Clinical Progression Disease|1|||
146622574|NCT04158583|528789701|FG004|Overall Study|Clinical Progression Disease|0|||
146943766|NCT00524043|529953264|FG000|Overall Study|Lack of Efficacy|15|||
146943767|NCT00524043|529953265|FG001|Overall Study|Lack of Efficacy|13|||
146943768|NCT00524043|529953266|FG002|Overall Study|Lack of Efficacy|14|||
146943769|NCT00524043|529953264|FG000|Overall Study|Withdrawal by Subject|5|||
146943770|NCT00524043|529953265|FG001|Overall Study|Withdrawal by Subject|7|||
146943771|NCT00524043|529953266|FG002|Overall Study|Withdrawal by Subject|7|||
146943772|NCT00524043|529953264|FG000|Overall Study|Adverse Event|5|||
146622575|NCT04158583|528789702|FG005|Overall Study|Clinical Progression Disease|0|||
146622576|NCT04158583|528789703|FG006|Overall Study|Clinical Progression Disease|0|||
146622577|NCT04158583|528789704|FG007|Overall Study|Clinical Progression Disease|0|||
146622578|NCT04158583|528789705|FG008|Overall Study|Clinical Progression Disease|0|||
146622579|NCT04158583|528789706|FG009|Overall Study|Clinical Progression Disease|0|||
146622580|NCT04158583|528789697|FG000|Overall Study|Clinical Progression|0|||
146622581|NCT04158583|528789698|FG001|Overall Study|Clinical Progression|0|||
146622582|NCT04158583|528789699|FG002|Overall Study|Clinical Progression|0|||
146622583|NCT04158583|528789700|FG003|Overall Study|Clinical Progression|0|||
146622584|NCT04158583|528789701|FG004|Overall Study|Clinical Progression|1|||
146622585|NCT04158583|528789702|FG005|Overall Study|Clinical Progression|0|||
146622586|NCT04158583|528789703|FG006|Overall Study|Clinical Progression|2|||
146622587|NCT04158583|528789704|FG007|Overall Study|Clinical Progression|0|||
146943773|NCT00524043|529953265|FG001|Overall Study|Adverse Event|2|||
146943774|NCT00524043|529953266|FG002|Overall Study|Adverse Event|7|||
146943775|NCT00524043|529953264|FG000|Overall Study|Lost to Follow-up|3|||
146943776|NCT00524043|529953265|FG001|Overall Study|Lost to Follow-up|5|||
146943777|NCT00524043|529953266|FG002|Overall Study|Lost to Follow-up|3|||
146943778|NCT00524043|529953264|FG000|Overall Study|Various (eg, incarceration)|2|||
146943779|NCT00524043|529953265|FG001|Overall Study|Various (eg, incarceration)|1|||
146943780|NCT00524043|529953266|FG002|Overall Study|Various (eg, incarceration)|0|||
146943781|NCT01536418|529953273|FG000|Overall Study|Protocol Violation|2|||
146943782|NCT01536418|529953274|FG001|Overall Study|Protocol Violation|3|||
146943783|NCT01536418|529953273|FG000|Overall Study|Physician Decision|1|||
146943784|NCT01536418|529953274|FG001|Overall Study|Physician Decision|3|||
146943785|NCT01536418|529953273|FG000|Overall Study|Study closed/terminated|41|||
146943786|NCT01536418|529953274|FG001|Overall Study|Study closed/terminated|37|||
146943787|NCT01536418|529953273|FG000|Overall Study|Lack of Efficacy|10|||
146943788|NCT01536418|529953274|FG001|Overall Study|Lack of Efficacy|16|||
146943789|NCT01536418|529953273|FG000|Overall Study|Adverse Event|9|||
146943790|NCT01536418|529953274|FG001|Overall Study|Adverse Event|4|||
146943791|NCT01536418|529953273|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
146943792|NCT01536418|529953274|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
146943793|NCT01536418|529953273|FG000|Overall Study|Withdrawal by Subject|5|||
146943794|NCT01536418|529953274|FG001|Overall Study|Withdrawal by Subject|3|||
146943795|NCT02658149|529953279|FG000|Overall Study|Physician Decision|1|||
146943796|NCT02658149|529953280|FG001|Overall Study|Physician Decision|0|||
146943797|NCT00711412|529953283|FG000|Induction Treatment|Death|2|||
146943798|NCT00711412|529953283|FG000|Induction Treatment|Adverse Event|1|||
146943799|NCT00711412|529953283|FG000|Induction Treatment|Other|1|||
146943800|NCT00711412|529953283|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
146943801|NCT00711412|529953283|FG000|Evaluated for Combination Treatment|Death|1|||
146943802|NCT00711412|529953283|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
146943803|NCT00711412|529953283|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
146943804|NCT00711412|529953283|FG000|Combination Treatment|Progressive Disease|1|||
146943805|NCT00711412|529953283|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
146943806|NCT00711412|529953283|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
146943807|NCT00711412|529953283|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
146943808|NCT00711412|529953283|FG000|Evaluation for Response and Surgery|Death|1|||
146943809|NCT00711412|529953283|FG000|Survival Follow up Until Death|Other|12|||
146943810|NCT04097028|529953288|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
146943811|NCT04097028|529953288|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
146943812|NCT04097028|529953288|FG000|Overall Study|Disease Progression prior to Surgery|2|||
146943813|NCT04097028|529953288|FG000|Overall Study|Adverse Event prior to Surgery|1|||
146943814|NCT03687827|529953289|FG000|Treatment Period 1|Death|0|||
146943815|NCT03687827|529953290|FG001|Treatment Period 1|Death|1|||
146943816|NCT03687827|529953289|FG000|Treatment Period 1|Lost to Follow-up|2|||
146943817|NCT03687827|529953290|FG001|Treatment Period 1|Lost to Follow-up|2|||
146943818|NCT03687827|529953289|FG000|Treatment Period 1|Physician Decision|5|||
146943819|NCT03687827|529953290|FG001|Treatment Period 1|Physician Decision|2|||
146943820|NCT03687827|529953289|FG000|Treatment Period 1|Withdrawal by Subject|7|||
146943821|NCT03687827|529953290|FG001|Treatment Period 1|Withdrawal by Subject|3|||
146943822|NCT03687827|529953289|FG000|Treatment Period 2|Physician Decision|4|||
146943823|NCT03687827|529953290|FG001|Treatment Period 2|Physician Decision|1|||
146943824|NCT03687827|529953289|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146943825|NCT03687827|529953290|FG001|Treatment Period 2|Withdrawal by Subject|2|||
146943826|NCT01156363|529953291|FG000|Overall Study|Adverse Event|6|||
146943827|NCT01156363|529953291|FG000|Overall Study|Insufficient Therapeutic Response|5|||
146943828|NCT01156363|529953291|FG000|Overall Study|Failure to Return|1|||
146943829|NCT01156363|529953291|FG000|Overall Study|Refused Treatment|4|||
146943830|NCT01156363|529953291|FG000|Overall Study|Other|6|||
146943831|NCT03285490|529953292|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
146984223|NCT00321711|530103387|FG002|Part A|Protocol deviation|1|||
146984224|NCT00321711|530103388|FG003|Part A|Protocol deviation|0|||
146984225|NCT00321711|530103389|FG004|Part A|Protocol deviation|0|||
146943832|NCT03285490|529953293|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
146943833|NCT03285490|529953292|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
146943834|NCT03285490|529953293|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
146984226|NCT00321711|530103385|FG000|Part B|Noncompliance|0|||
146943835|NCT00735072|529953299|FG000|Overall Study|interrupted study med during ARV change|1|||
146984227|NCT00321711|530103386|FG001|Part B|Noncompliance|0|||
146984228|NCT00321711|530103387|FG002|Part B|Noncompliance|0|||
146984229|NCT00321711|530103388|FG003|Part B|Noncompliance|0|||
146984230|NCT00321711|530103389|FG004|Part B|Noncompliance|1|||
146984231|NCT00321711|530103385|FG000|Part B|Adverse Event|0|||
146943836|NCT00735072|529953300|FG001|Overall Study|interrupted study med during ARV change|0|||
146943837|NCT00735072|529953299|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
146943838|NCT00735072|529953300|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
146943839|NCT00911144|529953301|FG000|Overall Study|Withdrawal by Subject|16|||
146984232|NCT00321711|530103386|FG001|Part B|Adverse Event|0|||
146943840|NCT00911144|529953302|FG001|Overall Study|Withdrawal by Subject|5|||
146943841|NCT01291511|529953303|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
146943842|NCT01291511|529953304|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
146943843|NCT01291511|529953303|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
146943844|NCT01291511|529953304|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
146943845|NCT01291511|529953303|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
146943846|NCT01291511|529953304|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
146943847|NCT01291511|529953303|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
146943848|NCT01291511|529953304|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
146943849|NCT01291511|529953303|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
146943850|NCT01291511|529953304|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
146943851|NCT01291511|529953303|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
146943852|NCT01291511|529953304|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
146943853|NCT01291511|529953303|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
146943854|NCT01291511|529953304|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
146943855|NCT01291511|529953303|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
146943856|NCT01291511|529953304|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
146943857|NCT01291511|529953303|FG000|Cross-Titration and Stabilization Phase|Death|1|||
146943858|NCT01291511|529953304|FG001|Cross-Titration and Stabilization Phase|Death|0|||
146943859|NCT01291511|529953303|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
146943860|NCT01291511|529953304|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
146943861|NCT01291511|529953303|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
146943862|NCT01291511|529953304|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
146943863|NCT01291511|529953303|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
146943864|NCT01291511|529953304|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
146943865|NCT01291511|529953303|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
146943866|NCT01291511|529953304|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
146943867|NCT01291511|529953303|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
146943868|NCT01291511|529953304|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
146943869|NCT01291511|529953303|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
146943870|NCT01291511|529953304|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
146943871|NCT01291511|529953303|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
146943872|NCT01291511|529953304|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
146943873|NCT01291511|529953303|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
146943874|NCT01291511|529953304|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
146943875|NCT01291511|529953303|FG000|Double-blind Relapse Prevention Phase|Death|1|||
146943876|NCT01291511|529953304|FG001|Double-blind Relapse Prevention Phase|Death|0|||
146943877|NCT00047008|529953307|FG000|Overall Study|Withdrawn consent|2|||
146943878|NCT00047008|529953308|FG001|Overall Study|Withdrawn consent|3|||
146943879|NCT00047008|529953307|FG000|Overall Study|Ineligible|9|||
146943880|NCT00047008|529953308|FG001|Overall Study|Ineligible|8|||
146943881|NCT00429572|529953309|FG000|Overall Study|Disease progression|1|||
146943882|NCT02773368|529953310|FG000|Overall Study|Lost to Follow-up|4|||
146943883|NCT02773368|529953311|FG001|Overall Study|Lost to Follow-up|1|||
146943884|NCT02773368|529953310|FG000|Overall Study|Withdrawal by Subject|5|||
146943885|NCT02773368|529953311|FG001|Overall Study|Withdrawal by Subject|1|||
146943886|NCT02773368|529953310|FG000|Overall Study|Unclassified|1|||
146943887|NCT02773368|529953311|FG001|Overall Study|Unclassified|1|||
146943888|NCT02773368|529953310|FG000|Overall Study|Missing|0|||
146943889|NCT02773368|529953311|FG001|Overall Study|Missing|1|||
146943890|NCT01929018|529953314|FG000|Overall Study|Lost to Follow-up|1|||
146943891|NCT01929018|529953315|FG001|Overall Study|Lost to Follow-up|0|||
146943892|NCT01929018|529953314|FG000|Overall Study|Hospitalization|0|||
146943893|NCT01929018|529953315|FG001|Overall Study|Hospitalization|1|||
146943894|NCT01366534|529953318|FG000|Overall Study|Lost to Follow-up|1|||
146943895|NCT01366534|529953319|FG001|Overall Study|Lost to Follow-up|0|||
146943896|NCT01366534|529953320|FG002|Overall Study|Lost to Follow-up|0|||
146943897|NCT01366534|529953318|FG000|Overall Study|Migrated|1|||
146943898|NCT01366534|529953319|FG001|Overall Study|Migrated|1|||
146943899|NCT01366534|529953320|FG002|Overall Study|Migrated|0|||
146943900|NCT01366534|529953318|FG000|Overall Study|Declined challenged|0|||
146943901|NCT01366534|529953319|FG001|Overall Study|Declined challenged|1|||
146943902|NCT01366534|529953320|FG002|Overall Study|Declined challenged|0|||
146943903|NCT01047436|529953322|FG000|Overall Study|Protocol Violation|1|||
146943904|NCT01047436|529953323|FG001|Overall Study|Protocol Violation|0|||
146943905|NCT01678313|529953326|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
146943906|NCT01678313|529953327|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
146943907|NCT01678313|529953326|FG000|Completed the 3-month Therapy|Physician Decision|3|||
146943908|NCT01678313|529953327|FG001|Completed the 3-month Therapy|Physician Decision|4|||
146943909|NCT01678313|529953326|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
146943910|NCT01678313|529953327|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
146943911|NCT01678313|529953326|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
146943912|NCT01678313|529953327|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
146943913|NCT02635867|529953330|FG000|Overall Study|Lost to Follow-up|4|||
146943914|NCT02635867|529953331|FG001|Overall Study|Lost to Follow-up|3|||
146943915|NCT02635867|529953332|FG002|Overall Study|Lost to Follow-up|3|||
146943916|NCT02635867|529953333|FG003|Overall Study|Lost to Follow-up|4|||
146943917|NCT02635867|529953334|FG004|Overall Study|Lost to Follow-up|1|||
146943918|NCT02565576|529953337|FG000|Overall Study|abnormal lab value|2|||
146943919|NCT02565576|529953338|FG001|Overall Study|abnormal lab value|0|||
146943920|NCT02565576|529953337|FG000|Overall Study|subject / guardian decision|1|||
146943921|NCT02565576|529953338|FG001|Overall Study|subject / guardian decision|3|||
146943922|NCT02565576|529953337|FG000|Overall Study|Lost to Follow-up|1|||
146943923|NCT02565576|529953338|FG001|Overall Study|Lost to Follow-up|0|||
146943924|NCT02565576|529953337|FG000|Overall Study|Death|0|||
146943925|NCT02565576|529953338|FG001|Overall Study|Death|2|||
146943926|NCT02565576|529953337|FG000|Overall Study|Adverse Event|1|||
146943927|NCT02565576|529953338|FG001|Overall Study|Adverse Event|0|||
146943928|NCT00939341|529953339|FG000|Overall Study|Adverse Event|15|||
146943929|NCT00939341|529953339|FG000|Overall Study|Pregnancy|1|||
146943930|NCT00939341|529953339|FG000|Overall Study|Lost to Follow-up|23|||
146943931|NCT00939341|529953339|FG000|Overall Study|Withdrawal by Subject|13|||
146943932|NCT00939341|529953339|FG000|Overall Study|Protocol Violation|6|||
146943933|NCT00939341|529953339|FG000|Overall Study|Incorrect enrolment|8|||
146943934|NCT00246376|529953342|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
146943935|NCT00246376|529953343|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
146943936|NCT00246376|529953344|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
146943937|NCT00246376|529953345|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
146943938|NCT00246376|529953346|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
146943939|NCT00246376|529953342|FG000|Overall Study|Adverse Event|2|||
146943940|NCT00246376|529953343|FG001|Overall Study|Adverse Event|3|||
146943941|NCT00246376|529953344|FG002|Overall Study|Adverse Event|1|||
146943942|NCT00246376|529953345|FG003|Overall Study|Adverse Event|3|||
146943943|NCT00246376|529953346|FG004|Overall Study|Adverse Event|1|||
146943944|NCT00246376|529953342|FG000|Overall Study|Lost to Follow-up|2|||
146943945|NCT00246376|529953343|FG001|Overall Study|Lost to Follow-up|11|||
146943946|NCT00246376|529953344|FG002|Overall Study|Lost to Follow-up|11|||
146943947|NCT00246376|529953345|FG003|Overall Study|Lost to Follow-up|16|||
146943948|NCT00246376|529953346|FG004|Overall Study|Lost to Follow-up|13|||
146943949|NCT01872897|529953347|FG000|Overall Study|Withdrawal by Subject|1|||
146943950|NCT01872897|529953348|FG001|Overall Study|Withdrawal by Subject|0|||
146943951|NCT02418585|529953351|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
146943952|NCT02418585|529953352|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
146943953|NCT02418585|529953351|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
146943954|NCT02418585|529953352|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
146943955|NCT02418585|529953351|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
146943956|NCT02418585|529953352|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
146943957|NCT02418585|529953351|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
146943958|NCT02418585|529953352|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
146943959|NCT02418585|529953351|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
146943960|NCT02418585|529953352|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
146943961|NCT02418585|529953351|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
146943962|NCT02418585|529953352|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
146943963|NCT02418585|529953351|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
146943964|NCT02418585|529953352|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
146943965|NCT02418585|529953351|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
146622588|NCT04158583|528789705|FG008|Overall Study|Clinical Progression|0|||
146943966|NCT02418585|529953352|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
146943967|NCT02418585|529953351|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
146943968|NCT02418585|529953352|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
146943969|NCT02418585|529953351|FG000|Follow-up Phase (24 Weeks)|Other|3|||
146943970|NCT02418585|529953352|FG001|Follow-up Phase (24 Weeks)|Other|2|||
146943971|NCT02040857|529953353|FG000|Overall Study|Adverse Event|14|||
146943972|NCT02040857|529953353|FG000|Overall Study|Physician Decision|5|||
146943973|NCT02040857|529953353|FG000|Overall Study|Withdrawal by Subject|31|||
146943974|NCT02040857|529953353|FG000|Overall Study|patient non-compliance|3|||
146943975|NCT02040857|529953353|FG000|Overall Study|Lost to Follow-up|2|||
146943976|NCT02040857|529953353|FG000|Overall Study|recurrence|4|||
146943977|NCT02040857|529953353|FG000|Overall Study|ineligible|1|||
146943978|NCT04159701|529953354|FG000|Period 1: Treatment Period|Pregnancy|1|||
146943979|NCT04159701|529953355|FG001|Period 1: Treatment Period|Pregnancy|0|||
146943980|NCT04159701|529953354|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
146943981|NCT04159701|529953355|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
146943982|NCT04159701|529953354|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
146943983|NCT04159701|529953355|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
146943984|NCT04159701|529953354|FG000|Washout Period|site terminated by sponsor|0|||
146943985|NCT04159701|529953355|FG001|Washout Period|site terminated by sponsor|1|||
146943986|NCT04159701|529953354|FG000|Washout Period|study terminated by sponsor|10|||
146943987|NCT04159701|529953355|FG001|Washout Period|study terminated by sponsor|3|||
146943988|NCT04159701|529953354|FG000|Washout Period|Withdrawal by Subject|1|||
146943989|NCT04159701|529953355|FG001|Washout Period|Withdrawal by Subject|0|||
146943990|NCT04159701|529953354|FG000|Washout Period|Inadvertent Enrollment|1|||
146943991|NCT04159701|529953355|FG001|Washout Period|Inadvertent Enrollment|0|||
146943992|NCT04159701|529953354|FG000|Washout Period|Miscellaneous|1|||
146943993|NCT04159701|529953355|FG001|Washout Period|Miscellaneous|0|||
146943994|NCT04159701|529953354|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
146943995|NCT04159701|529953355|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
146943996|NCT04159701|529953354|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
146943997|NCT04159701|529953355|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
146943998|NCT04159701|529953354|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
146943999|NCT04159701|529953355|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
146944000|NCT04159701|529953354|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
146944001|NCT04159701|529953355|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
146944002|NCT04159701|529953354|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
146944003|NCT04159701|529953355|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
146944004|NCT01849562|529953365|FG000|Overall Study|Lost to Follow-up|1|||
146944005|NCT01849562|529953366|FG001|Overall Study|Lost to Follow-up|0|||
146944006|NCT01849562|529953367|FG002|Overall Study|Lost to Follow-up|0|||
146944007|NCT01849562|529953365|FG000|Overall Study|Non-compliance with Study Drug|1|||
146944008|NCT01849562|529953366|FG001|Overall Study|Non-compliance with Study Drug|0|||
146944009|NCT01849562|529953367|FG002|Overall Study|Non-compliance with Study Drug|0|||
146944010|NCT01024920|529953368|FG000|Overall Study|Progressive disease|47|||
146944011|NCT01024920|529953369|FG001|Overall Study|Progressive disease|25|||
146944012|NCT01024920|529953368|FG000|Overall Study|Adverse Event|8|||
146944013|NCT01024920|529953369|FG001|Overall Study|Adverse Event|4|||
146944014|NCT01024920|529953368|FG000|Overall Study|Lost to Follow-up|0|||
146944015|NCT01024920|529953369|FG001|Overall Study|Lost to Follow-up|1|||
146944016|NCT01024920|529953368|FG000|Overall Study|Patient refusal to continue|4|||
146944017|NCT01024920|529953369|FG001|Overall Study|Patient refusal to continue|0|||
146944018|NCT01024920|529953368|FG000|Overall Study|Other than listed|5|||
146944019|NCT01024920|529953369|FG001|Overall Study|Other than listed|1|||
146944020|NCT01024920|529953368|FG000|Overall Study|Not treated|3|||
146944021|NCT01024920|529953369|FG001|Overall Study|Not treated|0|||
146944022|NCT01024920|529953368|FG000|Overall Study|Protocol Violation|0|||
146944023|NCT01024920|529953369|FG001|Overall Study|Protocol Violation|1|||
146944024|NCT00329784|529953370|FG000|Overall Study|Lost to Follow-up|0|||
146944025|NCT00329784|529953371|FG001|Overall Study|Lost to Follow-up|1|||
146944026|NCT00329784|529953372|FG002|Overall Study|Lost to Follow-up|0|||
146944027|NCT00329784|529953373|FG003|Overall Study|Lost to Follow-up|0|||
146944028|NCT00329784|529953370|FG000|Overall Study|Withdrawal by Subject|4|||
146944029|NCT00329784|529953371|FG001|Overall Study|Withdrawal by Subject|2|||
146944030|NCT00329784|529953372|FG002|Overall Study|Withdrawal by Subject|0|||
146944031|NCT00329784|529953373|FG003|Overall Study|Withdrawal by Subject|0|||
146944032|NCT00329784|529953370|FG000|Overall Study|Other|1|||
146944033|NCT00329784|529953371|FG001|Overall Study|Other|2|||
146944034|NCT00329784|529953372|FG002|Overall Study|Other|0|||
146944035|NCT00329784|529953373|FG003|Overall Study|Other|0|||
146944036|NCT03152110|529953384|FG000|Overall Study|Withdrawal by Subject|3|||
146944037|NCT01634100|529953385|FG000|Overall Study|Withdrawal by Subject|1|||
146944038|NCT01634100|529953386|FG001|Overall Study|Withdrawal by Subject|0|||
146944039|NCT01634100|529953387|FG002|Overall Study|Withdrawal by Subject|1|||
146944040|NCT01634100|529953388|FG003|Overall Study|Withdrawal by Subject|0|||
146944041|NCT01634100|529953389|FG004|Overall Study|Withdrawal by Subject|0|||
146944042|NCT01634100|529953390|FG005|Overall Study|Withdrawal by Subject|0|||
146944043|NCT00471276|529953391|FG000|Overall Study|Death|2|||
146944044|NCT00471276|529953391|FG000|Overall Study|Adverse Event|16|||
146944045|NCT00471276|529953391|FG000|Overall Study|Protocol Violation|1|||
146944046|NCT00471276|529953391|FG000|Overall Study|Objective progression or relapse|54|||
146944047|NCT00471276|529953391|FG000|Overall Study|Global deterioration of health status|1|||
146944048|NCT00471276|529953391|FG000|Overall Study|Other|3|||
146944049|NCT00471276|529953391|FG000|Overall Study|Refused treatment|6|||
146944050|NCT00179517|529953392|FG000|Overall Study|Withdrawal by Subject|2|||
146944051|NCT00179517|529953393|FG001|Overall Study|Withdrawal by Subject|1|||
146944052|NCT00023712|529953394|FG000|Overall Study|Not platinum sensitive|1|||
146944053|NCT00023712|529953395|FG001|Overall Study|Not platinum sensitive|0|||
146944054|NCT00023712|529953394|FG000|Overall Study|Never treated|1|||
146944055|NCT00023712|529953395|FG001|Overall Study|Never treated|1|||
146944056|NCT00565812|529953396|FG000|Overall Study|Death|2|||
146944057|NCT00565812|529953397|FG001|Overall Study|Death|1|||
146944058|NCT00565812|529953398|FG002|Overall Study|Death|3|||
146944059|NCT00565812|529953396|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
146944060|NCT00565812|529953397|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
146944061|NCT00565812|529953398|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
146944062|NCT00565812|529953396|FG000|Overall Study|Lost to Follow-up|10|||
146944063|NCT00565812|529953397|FG001|Overall Study|Lost to Follow-up|8|||
146944064|NCT00565812|529953398|FG002|Overall Study|Lost to Follow-up|8|||
146944065|NCT00565812|529953396|FG000|Overall Study|Withdrawal by Subject|58|||
146944066|NCT00565812|529953397|FG001|Overall Study|Withdrawal by Subject|47|||
146944067|NCT00565812|529953398|FG002|Overall Study|Withdrawal by Subject|48|||
146944068|NCT00565812|529953396|FG000|Overall Study|Work Schedule|5|||
146944069|NCT00565812|529953397|FG001|Overall Study|Work Schedule|3|||
146944070|NCT00565812|529953398|FG002|Overall Study|Work Schedule|1|||
146944071|NCT00565812|529953396|FG000|Overall Study|Protocol Violation|2|||
146944072|NCT00565812|529953397|FG001|Overall Study|Protocol Violation|6|||
146944073|NCT00565812|529953398|FG002|Overall Study|Protocol Violation|4|||
146944074|NCT00565812|529953396|FG000|Overall Study|Adverse Event|41|||
146944075|NCT00565812|529953397|FG001|Overall Study|Adverse Event|54|||
146944076|NCT00565812|529953398|FG002|Overall Study|Adverse Event|40|||
146944077|NCT00565812|529953396|FG000|Overall Study|Jury Duty|1|||
146944078|NCT00565812|529953397|FG001|Overall Study|Jury Duty|0|||
146944079|NCT00565812|529953398|FG002|Overall Study|Jury Duty|0|||
146944080|NCT00565812|529953396|FG000|Overall Study|Relocated Out of Area|5|||
146944081|NCT00565812|529953397|FG001|Overall Study|Relocated Out of Area|8|||
146944082|NCT00565812|529953398|FG002|Overall Study|Relocated Out of Area|9|||
146944083|NCT00565812|529953396|FG000|Overall Study|Sponsor Decision|1|||
146944084|NCT00565812|529953397|FG001|Overall Study|Sponsor Decision|5|||
146944085|NCT00565812|529953398|FG002|Overall Study|Sponsor Decision|1|||
146944086|NCT00565812|529953396|FG000|Overall Study|Domestic Reasons|7|||
146944087|NCT00565812|529953397|FG001|Overall Study|Domestic Reasons|1|||
146944088|NCT00565812|529953398|FG002|Overall Study|Domestic Reasons|3|||
146944089|NCT00565812|529953396|FG000|Overall Study|Research Site Closure|6|||
146944090|NCT00565812|529953397|FG001|Overall Study|Research Site Closure|1|||
146944091|NCT00565812|529953398|FG002|Overall Study|Research Site Closure|8|||
146944092|NCT00565812|529953396|FG000|Overall Study|Surgical Intervention|0|||
146944093|NCT00565812|529953397|FG001|Overall Study|Surgical Intervention|1|||
146944094|NCT00565812|529953398|FG002|Overall Study|Surgical Intervention|2|||
146944095|NCT00565812|529953396|FG000|Overall Study|Low Compliance|1|||
146944096|NCT00565812|529953397|FG001|Overall Study|Low Compliance|0|||
146944097|NCT00565812|529953398|FG002|Overall Study|Low Compliance|1|||
146944098|NCT00565812|529953396|FG000|Overall Study|Follow-up Visit Not Completed|2|||
146944099|NCT00565812|529953397|FG001|Overall Study|Follow-up Visit Not Completed|0|||
146944100|NCT00565812|529953398|FG002|Overall Study|Follow-up Visit Not Completed|1|||
146944101|NCT00565812|529953396|FG000|Overall Study|Physician Decision|2|||
146944102|NCT00565812|529953397|FG001|Overall Study|Physician Decision|0|||
146944103|NCT00565812|529953398|FG002|Overall Study|Physician Decision|0|||
146944104|NCT00044213|529953400|FG000|Overall Study|Withdrawal by Subject|50|||
146944105|NCT00044213|529953401|FG001|Overall Study|Withdrawal by Subject|65|||
146944106|NCT00044213|529953402|FG002|Overall Study|Withdrawal by Subject|91|||
146944107|NCT00044213|529953403|FG003|Overall Study|Withdrawal by Subject|83|||
146944108|NCT00044213|529953400|FG000|Overall Study|Death|42|||
146944109|NCT00044213|529953401|FG001|Overall Study|Death|42|||
146944110|NCT00044213|529953402|FG002|Overall Study|Death|42|||
146944111|NCT00044213|529953403|FG003|Overall Study|Death|49|||
146944112|NCT00044213|529953400|FG000|Overall Study|Lost to Follow-up|8|||
146944113|NCT00044213|529953401|FG001|Overall Study|Lost to Follow-up|5|||
146944114|NCT00044213|529953402|FG002|Overall Study|Lost to Follow-up|5|||
146944115|NCT00044213|529953403|FG003|Overall Study|Lost to Follow-up|4|||
146944116|NCT01167153|529953410|FG000|Overall Study|Non-effective therapy|1|||
146944117|NCT01167153|529953411|FG001|Overall Study|Non-effective therapy|4|||
146944118|NCT01167153|529953410|FG000|Overall Study|AE including clinical laboratory AE|2|||
146944119|NCT01167153|529953411|FG001|Overall Study|AE including clinical laboratory AE|8|||
146944120|NCT01167153|529953410|FG000|Overall Study|Hypotension|1|||
146944121|NCT01167153|529953411|FG001|Overall Study|Hypotension|0|||
146944122|NCT01167153|529953410|FG000|Overall Study|Lost to Follow-up|7|||
146944123|NCT01167153|529953411|FG001|Overall Study|Lost to Follow-up|9|||
146944124|NCT01167153|529953410|FG000|Overall Study|Non-compliance to concomitant medication|0|||
146944125|NCT01167153|529953411|FG001|Overall Study|Non-compliance to concomitant medication|2|||
146944126|NCT01167153|529953410|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
146944127|NCT01167153|529953411|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
146944128|NCT01167153|529953410|FG000|Overall Study|Withdrawal consent|1|||
146944129|NCT01167153|529953411|FG001|Overall Study|Withdrawal consent|1|||
146944130|NCT01167153|529953410|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
146944131|NCT01167153|529953411|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
146944132|NCT00098865|529956280|FG000|Overall Study|Progressive Disease|6|||
146944133|NCT00098865|529956280|FG000|Overall Study|Adverse Event|2|||
146944134|NCT00098865|529956280|FG000|Overall Study|Alternative Therapy|1|||
146944135|NCT03050307|529956281|FG000|Overall Study|Adverse Event|4|||
146944136|NCT03050307|529956282|FG001|Overall Study|Adverse Event|2|||
146944137|NCT03050307|529956281|FG000|Overall Study|Significant Protocol Deviation|0|||
146944138|NCT03050307|529956282|FG001|Overall Study|Significant Protocol Deviation|1|||
146944139|NCT03050307|529956281|FG000|Overall Study|Lost to Follow-up|0|||
146944140|NCT03050307|529956282|FG001|Overall Study|Lost to Follow-up|1|||
146622589|NCT04158583|528789706|FG009|Overall Study|Clinical Progression|0|||
146622590|NCT04158583|528789697|FG000|Overall Study|Clinical Deterioration|0|||
146944141|NCT03050307|529956281|FG000|Overall Study|Voluntary Withdrawal|3|||
146944142|NCT03050307|529956282|FG001|Overall Study|Voluntary Withdrawal|4|||
146944143|NCT03050307|529956281|FG000|Overall Study|Reason not Specified|1|||
146944144|NCT03050307|529956282|FG001|Overall Study|Reason not Specified|1|||
146622591|NCT04158583|528789698|FG001|Overall Study|Clinical Deterioration|0|||
146622592|NCT04158583|528789699|FG002|Overall Study|Clinical Deterioration|0|||
146622593|NCT04158583|528789700|FG003|Overall Study|Clinical Deterioration|1|||
146622594|NCT04158583|528789701|FG004|Overall Study|Clinical Deterioration|0|||
146622595|NCT04158583|528789702|FG005|Overall Study|Clinical Deterioration|0|||
146622596|NCT04158583|528789703|FG006|Overall Study|Clinical Deterioration|0|||
146622597|NCT04158583|528789704|FG007|Overall Study|Clinical Deterioration|0|||
146622598|NCT04158583|528789705|FG008|Overall Study|Clinical Deterioration|0|||
146622599|NCT04158583|528789706|FG009|Overall Study|Clinical Deterioration|1|||
146622600|NCT03409796|528791042|FG000|Overall Study|Adverse Event|2|||
146622601|NCT03409796|528791043|FG001|Overall Study|Adverse Event|0|||
146622602|NCT03409796|528791042|FG000|Overall Study|Other|0|||
146622603|NCT03409796|528791043|FG001|Overall Study|Other|1|||
146622604|NCT01453049|528791057|FG000|Overall Study|Protocol Violation|2|||
146622605|NCT01453049|528791058|FG001|Overall Study|Protocol Violation|5|||
146622606|NCT01453049|528791057|FG000|Overall Study|Lost to Follow-up|2|||
146622607|NCT01453049|528791058|FG001|Overall Study|Lost to Follow-up|1|||
146622608|NCT01453049|528791057|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
146622609|NCT01453049|528791058|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
146622610|NCT01453049|528791057|FG000|Overall Study|Withdrawal by Subject|1|||
146622611|NCT01453049|528791058|FG001|Overall Study|Withdrawal by Subject|0|||
146622612|NCT01453049|528791057|FG000|Overall Study|Randomized in Error|1|||
146622613|NCT01453049|528791058|FG001|Overall Study|Randomized in Error|0|||
146622614|NCT03287791|528791063|FG000|Overall Study|Insufficient Therapeutic Response|0|||
146622615|NCT03287791|528791064|FG001|Overall Study|Insufficient Therapeutic Response|0|||
146622616|NCT03287791|528791065|FG002|Overall Study|Insufficient Therapeutic Response|1|||
146622617|NCT03287791|528791063|FG000|Overall Study|Adverse Event|0|||
146622618|NCT03287791|528791064|FG001|Overall Study|Adverse Event|4|||
146622619|NCT03287791|528791065|FG002|Overall Study|Adverse Event|3|||
146622620|NCT03287791|528791063|FG000|Overall Study|Withdrawal by Subject|12|||
146622621|NCT03287791|528791064|FG001|Overall Study|Withdrawal by Subject|12|||
146622622|NCT03287791|528791065|FG002|Overall Study|Withdrawal by Subject|17|||
146622623|NCT03287791|528791063|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
146622624|NCT03287791|528791064|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
146622625|NCT03287791|528791065|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
146622626|NCT03287791|528791063|FG000|Overall Study|Lost to Follow-up|8|||
146622627|NCT03287791|528791064|FG001|Overall Study|Lost to Follow-up|14|||
146622628|NCT03287791|528791065|FG002|Overall Study|Lost to Follow-up|11|||
146622629|NCT03287791|528791063|FG000|Overall Study|Protocol Violation|7|||
146622630|NCT03287791|528791064|FG001|Overall Study|Protocol Violation|2|||
146622631|NCT03287791|528791065|FG002|Overall Study|Protocol Violation|1|||
146622632|NCT03287791|528791063|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
146622633|NCT03287791|528791064|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
146622634|NCT03287791|528791065|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
146622635|NCT03287791|528791063|FG000|Overall Study|Too much time between 2 visits|0|||
146622636|NCT03287791|528791064|FG001|Overall Study|Too much time between 2 visits|1|||
146622637|NCT03287791|528791065|FG002|Overall Study|Too much time between 2 visits|0|||
146622638|NCT03287791|528791063|FG000|Overall Study|Non-compliance|0|||
146622639|NCT03287791|528791064|FG001|Overall Study|Non-compliance|1|||
146622640|NCT03287791|528791065|FG002|Overall Study|Non-compliance|0|||
146622641|NCT03287791|528791063|FG000|Overall Study|Did not meet inclusion criteria|1|||
146622642|NCT03287791|528791064|FG001|Overall Study|Did not meet inclusion criteria|0|||
146622643|NCT03287791|528791065|FG002|Overall Study|Did not meet inclusion criteria|0|||
146622644|NCT03095651|528791067|FG000|Overall Study|Lost to Follow-up|1|||
146622645|NCT03095651|528791068|FG001|Overall Study|Lost to Follow-up|1|||
146622646|NCT03095651|528791069|FG002|Overall Study|Lost to Follow-up|0|||
146622647|NCT03095651|528791070|FG003|Overall Study|Lost to Follow-up|1|||
146622648|NCT03095651|528791071|FG004|Overall Study|Lost to Follow-up|0|||
146622649|NCT03095651|528791072|FG005|Overall Study|Lost to Follow-up|0|||
146622650|NCT03095651|528791073|FG006|Overall Study|Lost to Follow-up|0|||
146622651|NCT03095651|528791074|FG007|Overall Study|Lost to Follow-up|0|||
146622652|NCT03095651|528791067|FG000|Overall Study|Withdrawal by Subject|0|||
146622653|NCT03095651|528791068|FG001|Overall Study|Withdrawal by Subject|0|||
146622654|NCT03095651|528791069|FG002|Overall Study|Withdrawal by Subject|0|||
146622655|NCT03095651|528791070|FG003|Overall Study|Withdrawal by Subject|0|||
146622656|NCT03095651|528791071|FG004|Overall Study|Withdrawal by Subject|0|||
146622657|NCT03095651|528791072|FG005|Overall Study|Withdrawal by Subject|1|||
146944145|NCT00439309|529956283|FG000|Follow-Up|Death|1|||
146944146|NCT00439309|529956284|FG001|Follow-Up|Death|0|||
146944147|NCT00439309|529956283|FG000|Follow-Up|Lost to Follow-up|2|||
146944148|NCT00439309|529956284|FG001|Follow-Up|Lost to Follow-up|0|||
146944149|NCT00439309|529956283|FG000|Follow-Up|Withdrawal by Subject|0|||
146944150|NCT00439309|529956284|FG001|Follow-Up|Withdrawal by Subject|1|||
146944151|NCT00439309|529956283|FG000|Follow-Up|Late response by subject|0|||
146944152|NCT00439309|529956284|FG001|Follow-Up|Late response by subject|1|||
146944153|NCT00430027|529956286|FG000|Overall Study|Study terminated|8|||
146944154|NCT00464620|529956287|FG000|Overall Study|Physician Decision|1|||
146944155|NCT00464620|529956288|FG001|Overall Study|Physician Decision|0|||
146944156|NCT00464620|529956289|FG002|Overall Study|Physician Decision|0|||
146944157|NCT00464620|529956287|FG000|Overall Study|Withdrawal by Subject|1|||
146944158|NCT00464620|529956288|FG001|Overall Study|Withdrawal by Subject|0|||
146944159|NCT00464620|529956289|FG002|Overall Study|Withdrawal by Subject|3|||
146944160|NCT00464620|529956287|FG000|Overall Study|Ineligible sarcoma subtype|0|||
146944161|NCT00464620|529956288|FG001|Overall Study|Ineligible sarcoma subtype|2|||
146944162|NCT00464620|529956289|FG002|Overall Study|Ineligible sarcoma subtype|2|||
146944163|NCT00464620|529956287|FG000|Overall Study|Use of prohibited concomitant medication|0|||
146944164|NCT00464620|529956288|FG001|Overall Study|Use of prohibited concomitant medication|0|||
146944165|NCT00464620|529956289|FG002|Overall Study|Use of prohibited concomitant medication|2|||
146944166|NCT01998906|529956290|FG000|Overall Study|Participants ongoing in follow-up|77|||
146944167|NCT01998906|529956291|FG001|Overall Study|Participants ongoing in follow-up|60|||
146944168|NCT01998906|529956292|FG002|Overall Study|Participants ongoing in follow-up|58|||
146944169|NCT01998906|529956290|FG000|Overall Study|Death|21|||
146944170|NCT01998906|529956291|FG001|Overall Study|Death|30|||
146944171|NCT01998906|529956292|FG002|Overall Study|Death|17|||
146944172|NCT01998906|529956290|FG000|Overall Study|Lack of Efficacy|10|||
146944173|NCT01998906|529956291|FG001|Overall Study|Lack of Efficacy|9|||
146944174|NCT01998906|529956292|FG002|Overall Study|Lack of Efficacy|8|||
146944175|NCT01998906|529956290|FG000|Overall Study|Failure to return|0|||
146944176|NCT01998906|529956291|FG001|Overall Study|Failure to return|2|||
146944177|NCT01998906|529956292|FG002|Overall Study|Failure to return|4|||
146944178|NCT01998906|529956290|FG000|Overall Study|Violation of Selection Criteria|0|||
146944179|NCT01998906|529956291|FG001|Overall Study|Violation of Selection Criteria|0|||
146944180|NCT01998906|529956292|FG002|Overall Study|Violation of Selection Criteria|1|||
146944181|NCT01998906|529956290|FG000|Overall Study|Withdrawal by Subject|1|||
146944182|NCT01998906|529956291|FG001|Overall Study|Withdrawal by Subject|4|||
146944183|NCT01998906|529956292|FG002|Overall Study|Withdrawal by Subject|3|||
146944184|NCT01998906|529956290|FG000|Overall Study|Administrative/Other|2|||
146944185|NCT01998906|529956291|FG001|Overall Study|Administrative/Other|1|||
146944186|NCT01998906|529956292|FG002|Overall Study|Administrative/Other|3|||
146944187|NCT01998906|529956290|FG000|Overall Study|Other|3|||
146944188|NCT01998906|529956291|FG001|Overall Study|Other|8|||
146944189|NCT01998906|529956292|FG002|Overall Study|Other|4|||
146944190|NCT01572844|529956293|FG000|Overall Study|Physician Decision|1|||
146944191|NCT01572844|529956294|FG001|Overall Study|Physician Decision|1|||
146944192|NCT01131130|529956299|FG000|Period 1 - Baseline|Pregnancy|1|||
146944193|NCT01131130|529956299|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
146944194|NCT02437162|529956304|FG000|Overall Study|Protocol Violation|0|||
146944195|NCT02437162|529956305|FG001|Overall Study|Protocol Violation|1|||
146944196|NCT02437162|529956306|FG002|Overall Study|Protocol Violation|0|||
146944197|NCT02437162|529956304|FG000|Overall Study|Randomized but not treated|0|||
146944198|NCT02437162|529956305|FG001|Overall Study|Randomized but not treated|0|||
146944199|NCT02437162|529956306|FG002|Overall Study|Randomized but not treated|1|||
146944200|NCT02437162|529956304|FG000|Overall Study|Study discontinued by Sponsor|93|||
146944201|NCT02437162|529956305|FG001|Overall Study|Study discontinued by Sponsor|98|||
146944202|NCT02437162|529956306|FG002|Overall Study|Study discontinued by Sponsor|97|||
146944203|NCT02437162|529956304|FG000|Overall Study|Withdrawal by Subject|13|||
146944204|NCT02437162|529956305|FG001|Overall Study|Withdrawal by Subject|7|||
146944205|NCT02437162|529956306|FG002|Overall Study|Withdrawal by Subject|9|||
146944206|NCT02437162|529956304|FG000|Overall Study|Adverse Event|0|||
146944207|NCT02437162|529956305|FG001|Overall Study|Adverse Event|1|||
146944208|NCT02437162|529956306|FG002|Overall Study|Adverse Event|0|||
146944209|NCT02437162|529956304|FG000|Overall Study|Lost to Follow-up|1|||
146944210|NCT02437162|529956305|FG001|Overall Study|Lost to Follow-up|0|||
146944211|NCT02437162|529956306|FG002|Overall Study|Lost to Follow-up|1|||
146944212|NCT02437162|529956304|FG000|Overall Study|Death|0|||
146944213|NCT02437162|529956305|FG001|Overall Study|Death|1|||
146944214|NCT02437162|529956306|FG002|Overall Study|Death|0|||
146944215|NCT02437162|529956304|FG000|Overall Study|Other|0|||
146944216|NCT02437162|529956305|FG001|Overall Study|Other|0|||
146944217|NCT02437162|529956306|FG002|Overall Study|Other|1|||
146944218|NCT03981744|529956307|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
146944219|NCT03981744|529956308|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
146944220|NCT03981744|529956309|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
146944221|NCT03981744|529956310|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
146944222|NCT03981744|529956307|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
146944223|NCT03981744|529956308|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
146944224|NCT03981744|529956309|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
146944225|NCT03981744|529956310|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
146944226|NCT03981744|529956307|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
146944227|NCT03981744|529956308|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
146944228|NCT03981744|529956309|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
146944229|NCT03981744|529956310|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
146944230|NCT02782104|529956311|FG000|Overall Study|Other|215|||
146944231|NCT02782104|529956311|FG000|Overall Study|Induction Day 28 Non Responder|9|||
146944232|NCT02782104|529956311|FG000|Overall Study|Non-Compliance with Study Drug|2|||
146944233|NCT02782104|529956311|FG000|Overall Study|Death|8|||
146944234|NCT02782104|529956311|FG000|Overall Study|Pregnancy|6|||
146944235|NCT02782104|529956311|FG000|Overall Study|Withdrawal by Subject|63|||
146944236|NCT02782104|529956311|FG000|Overall Study|Protocol Violation|7|||
146944237|NCT02782104|529956311|FG000|Overall Study|Lack of Efficacy|61|||
146944238|NCT02782104|529956311|FG000|Overall Study|Lost to Follow-up|23|||
146944239|NCT02782104|529956311|FG000|Overall Study|Adverse Event|74|||
146944240|NCT04338321|529956312|FG000|Overall Study|Adverse Event|4|||
146944241|NCT04338321|529956313|FG001|Overall Study|Adverse Event|10|||
146944242|NCT04338321|529956312|FG000|Overall Study|Death|1|||
146944243|NCT04338321|529956313|FG001|Overall Study|Death|1|||
146944244|NCT04338321|529956312|FG000|Overall Study|Lost to Follow-up|4|||
146944245|NCT04338321|529956313|FG001|Overall Study|Lost to Follow-up|9|||
146944246|NCT04338321|529956312|FG000|Overall Study|Withdrawal by Subject|45|||
146944247|NCT04338321|529956313|FG001|Overall Study|Withdrawal by Subject|69|||
146944248|NCT04338321|529956312|FG000|Overall Study|Physician Decision|5|||
146944249|NCT04338321|529956313|FG001|Overall Study|Physician Decision|9|||
146944250|NCT04338321|529956312|FG000|Overall Study|Other|3|||
146944251|NCT04338321|529956313|FG001|Overall Study|Other|10|||
146944252|NCT03464136|529956314|FG000|Overall Study|Lost to Follow-up|5|||
146944253|NCT03464136|529956315|FG001|Overall Study|Lost to Follow-up|8|||
146944254|NCT03464136|529956314|FG000|Overall Study|Withdrawal by Subject|16|||
146944255|NCT03464136|529956315|FG001|Overall Study|Withdrawal by Subject|13|||
146944256|NCT03464136|529956314|FG000|Overall Study|Death|1|||
146944257|NCT03464136|529956315|FG001|Overall Study|Death|0|||
146944258|NCT03464136|529956314|FG000|Overall Study|Other|8|||
146944259|NCT03464136|529956315|FG001|Overall Study|Other|4|||
146944260|NCT02438787|529956316|FG000|Overall Study|Adverse Event|1|||
146944261|NCT02438787|529956317|FG001|Overall Study|Adverse Event|0|||
146944262|NCT02438787|529956318|FG002|Overall Study|Adverse Event|2|||
146944263|NCT02438787|529956316|FG000|Overall Study|Lack of Efficacy|1|||
146944264|NCT02438787|529956317|FG001|Overall Study|Lack of Efficacy|2|||
146944265|NCT02438787|529956318|FG002|Overall Study|Lack of Efficacy|0|||
146944266|NCT02438787|529956316|FG000|Overall Study|Lost to Follow-up|0|||
146944267|NCT02438787|529956317|FG001|Overall Study|Lost to Follow-up|1|||
146944268|NCT02438787|529956318|FG002|Overall Study|Lost to Follow-up|0|||
146944269|NCT02438787|529956316|FG000|Overall Study|Protocol Violation|0|||
146944270|NCT02438787|529956317|FG001|Overall Study|Protocol Violation|0|||
146944271|NCT02438787|529956318|FG002|Overall Study|Protocol Violation|1|||
146944272|NCT02438787|529956316|FG000|Overall Study|Withdrawal by Subject|15|||
146944273|NCT02438787|529956317|FG001|Overall Study|Withdrawal by Subject|7|||
146944274|NCT02438787|529956318|FG002|Overall Study|Withdrawal by Subject|10|||
146944275|NCT02438787|529956316|FG000|Overall Study|Study discontinued by sponsor|64|||
146944276|NCT02438787|529956317|FG001|Overall Study|Study discontinued by sponsor|72|||
146944277|NCT02438787|529956318|FG002|Overall Study|Study discontinued by sponsor|69|||
146944278|NCT02438787|529956316|FG000|Overall Study|Other|0|||
146944279|NCT02438787|529956317|FG001|Overall Study|Other|1|||
146944280|NCT02438787|529956318|FG002|Overall Study|Other|0|||
146944281|NCT02438787|529956316|FG000|Overall Study|Site terminated by sponsor|0|||
146944282|NCT02438787|529956317|FG001|Overall Study|Site terminated by sponsor|0|||
146944283|NCT02438787|529956318|FG002|Overall Study|Site terminated by sponsor|1|||
146944284|NCT03412565|529956319|FG000|Overall Study|Lost to Follow-up|0|||
146944285|NCT03412565|529956320|FG001|Overall Study|Lost to Follow-up|0|||
146944286|NCT03412565|529956321|FG002|Overall Study|Lost to Follow-up|1|||
146944287|NCT03412565|529956322|FG003|Overall Study|Lost to Follow-up|0|||
146944288|NCT03412565|529956319|FG000|Overall Study|Physician Decision|0|||
146944289|NCT03412565|529956320|FG001|Overall Study|Physician Decision|0|||
146944290|NCT03412565|529956321|FG002|Overall Study|Physician Decision|0|||
146944291|NCT03412565|529956322|FG003|Overall Study|Physician Decision|1|||
146944292|NCT03412565|529956319|FG000|Overall Study|Withdrawal by Subject|0|||
146944293|NCT03412565|529956320|FG001|Overall Study|Withdrawal by Subject|4|||
146944294|NCT03412565|529956321|FG002|Overall Study|Withdrawal by Subject|5|||
146944295|NCT03412565|529956322|FG003|Overall Study|Withdrawal by Subject|5|||
146944296|NCT03412565|529956319|FG000|Overall Study|Death|1|||
146944297|NCT03412565|529956320|FG001|Overall Study|Death|3|||
146944298|NCT03412565|529956321|FG002|Overall Study|Death|4|||
146944299|NCT03412565|529956322|FG003|Overall Study|Death|5|||
146944300|NCT03412565|529956319|FG000|Overall Study|Data collection ended|0|||
146984233|NCT00321711|530103387|FG002|Part B|Adverse Event|0|||
146622658|NCT03095651|528791073|FG006|Overall Study|Withdrawal by Subject|0|||
146622659|NCT03095651|528791074|FG007|Overall Study|Withdrawal by Subject|0|||
146622660|NCT02210000|528791075|FG000|Overall Study|Study Terminated|11|||
146622661|NCT02210000|528791076|FG001|Overall Study|Study Terminated|12|||
146622662|NCT02210000|528791075|FG000|Overall Study|Withdrawal by Subject|7|||
146622663|NCT02210000|528791076|FG001|Overall Study|Withdrawal by Subject|1|||
146622664|NCT02210000|528791075|FG000|Overall Study|Adverse Event|1|||
146622665|NCT02210000|528791076|FG001|Overall Study|Adverse Event|5|||
146622666|NCT02210000|528791075|FG000|Overall Study|Lost to Follow-up|0|||
146622667|NCT02210000|528791076|FG001|Overall Study|Lost to Follow-up|2|||
146622668|NCT02210000|528791075|FG000|Overall Study|Physician Decision|0|||
146622669|NCT02210000|528791076|FG001|Overall Study|Physician Decision|1|||
146622670|NCT00866177|528791077|FG000|Overall Study|Withdrawal by Subject|1|||
146622671|NCT00866177|528791077|FG000|Overall Study|Not Treated|151|||
146622672|NCT03585660|528791078|FG000|Overall Study|operator error|1|||
146622673|NCT03585660|528791078|FG000|Overall Study|technical error|2|||
146622674|NCT03585660|528791078|FG000|Overall Study|hip prosthesis|2|||
146622675|NCT03585660|528791078|FG000|Overall Study|did not undergo biopsy|8|||
146622676|NCT03585660|528791078|FG000|Overall Study|scanner problem|2|||
146622677|NCT05635461|528791079|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
146622678|NCT05635461|528791080|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
146622679|NCT05635461|528791081|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
146622680|NCT05635461|528791082|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
146622681|NCT05635461|528791083|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
146622682|NCT05635461|528791084|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
146622683|NCT05635461|528791079|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
146622684|NCT05635461|528791080|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
146944301|NCT03412565|529956320|FG001|Overall Study|Data collection ended|41|||
146622685|NCT05635461|528791081|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
146622686|NCT05635461|528791082|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
146622687|NCT05635461|528791083|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
146622688|NCT05635461|528791084|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
146622689|NCT05635461|528791079|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
146622690|NCT05635461|528791080|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
146622691|NCT05635461|528791081|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
146622692|NCT05635461|528791082|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
146622693|NCT05635461|528791083|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
146622694|NCT05635461|528791084|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
146622695|NCT01620060|528791086|FG000|Overall Study|Adverse Event|9|||
146622696|NCT01620060|528791086|FG000|Overall Study|Protocol Violation|1|||
146622697|NCT01620060|528791086|FG000|Overall Study|Withdrawal by Subject|1|||
146622698|NCT01620060|528791086|FG000|Overall Study|Did not comply with Study Produre|1|||
146622699|NCT01620060|528791086|FG000|Overall Study|Family emergency|1|||
146622700|NCT01620060|528791086|FG000|Overall Study|Per Sponsor Decision|2|||
146622701|NCT02269124|528791087|FG000|Overall Study|Lost to Follow-up|1|||
146622702|NCT02269124|528791088|FG001|Overall Study|Lost to Follow-up|0|||
146622703|NCT02269124|528791087|FG000|Overall Study|Withdrawal by Subject|0|||
146622704|NCT02269124|528791088|FG001|Overall Study|Withdrawal by Subject|2|||
146622705|NCT03452540|528791089|FG000|Overall Study|Adverse Event|1|||
146622706|NCT03452540|528791089|FG000|Overall Study|Withdrawal by Subject|1|||
146622707|NCT03452540|528791089|FG000|Overall Study|Other SAE and AE|2|||
146622708|NCT01582061|528791090|FG000|Overall Study|Lack of Efficacy|3|||
146622709|NCT01582061|528791091|FG001|Overall Study|Lack of Efficacy|23|||
146622710|NCT01582061|528791090|FG000|Overall Study|Adverse Event|12|||
146622711|NCT01582061|528791091|FG001|Overall Study|Adverse Event|8|||
146622712|NCT01582061|528791090|FG000|Overall Study|Withdrawal by Subject|10|||
146622713|NCT01582061|528791091|FG001|Overall Study|Withdrawal by Subject|4|||
146622714|NCT01582061|528791090|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146622715|NCT01582061|528791091|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146622716|NCT01582061|528791090|FG000|Overall Study|Death|0|||
146622717|NCT01582061|528791091|FG001|Overall Study|Death|1|||
146944302|NCT03412565|529956321|FG002|Overall Study|Data collection ended|41|||
146944303|NCT03412565|529956322|FG003|Overall Study|Data collection ended|40|||
146622718|NCT01582061|528791090|FG000|Overall Study|condition no longer requires study drug|1|||
146622719|NCT01582061|528791091|FG001|Overall Study|condition no longer requires study drug|0|||
146622720|NCT01582061|528791090|FG000|Overall Study|Lost to Follow-up|1|||
146622721|NCT01582061|528791091|FG001|Overall Study|Lost to Follow-up|0|||
146622722|NCT04664153|528791092|FG000|Overall Study|Lack of Efficacy|0|||
146622723|NCT04664153|528791093|FG001|Overall Study|Lack of Efficacy|0|||
146622724|NCT04664153|528791094|FG002|Overall Study|Lack of Efficacy|1|||
146622725|NCT04664153|528791095|FG003|Overall Study|Lack of Efficacy|0|||
146622726|NCT04664153|528791092|FG000|Overall Study|Physician Decision|0|||
146622727|NCT04664153|528791093|FG001|Overall Study|Physician Decision|0|||
146622728|NCT04664153|528791094|FG002|Overall Study|Physician Decision|1|||
146622729|NCT04664153|528791095|FG003|Overall Study|Physician Decision|0|||
146622730|NCT04664153|528791092|FG000|Overall Study|Withdrawal by Subject|3|||
146622731|NCT04664153|528791093|FG001|Overall Study|Withdrawal by Subject|2|||
146622732|NCT04664153|528791094|FG002|Overall Study|Withdrawal by Subject|1|||
146622733|NCT04664153|528791095|FG003|Overall Study|Withdrawal by Subject|2|||
146622734|NCT04664153|528791092|FG000|Overall Study|Other|0|||
146622735|NCT04664153|528791093|FG001|Overall Study|Other|1|||
146622736|NCT04664153|528791094|FG002|Overall Study|Other|0|||
146622737|NCT04664153|528791095|FG003|Overall Study|Other|0|||
146622738|NCT04664153|528791092|FG000|Overall Study|Adverse Event|4|||
146622739|NCT04664153|528791093|FG001|Overall Study|Adverse Event|0|||
146622740|NCT04664153|528791094|FG002|Overall Study|Adverse Event|1|||
146622741|NCT04664153|528791095|FG003|Overall Study|Adverse Event|0|||
146622742|NCT01600885|528791096|FG000|First Period|Adverse Event|1|||
146622743|NCT01600885|528791097|FG001|First Period|Adverse Event|1|||
146622744|NCT01600885|528791096|FG000|First Period|moved out of area|1|||
146622745|NCT01600885|528791097|FG001|First Period|moved out of area|0|||
146622746|NCT00642356|528791098|FG000|Overall Study|Adverse Event|1|||
146622747|NCT00642356|528791099|FG001|Overall Study|Adverse Event|0|||
146622748|NCT00642356|528791098|FG000|Overall Study|Protocol Violation|0|||
146622749|NCT00642356|528791099|FG001|Overall Study|Protocol Violation|3|||
146622750|NCT00642356|528791098|FG000|Overall Study|Lack of Efficacy|1|||
146622751|NCT00642356|528791099|FG001|Overall Study|Lack of Efficacy|0|||
146622752|NCT01009060|528791106|FG000|Overall Study|Adverse Event|1|||
146622753|NCT01009060|528791107|FG001|Overall Study|Adverse Event|2|||
146622754|NCT01009060|528791106|FG000|Overall Study|Protocol Violation|0|||
146622755|NCT01009060|528791107|FG001|Overall Study|Protocol Violation|1|||
146622756|NCT01009060|528791106|FG000|Overall Study|Lost to Follow-up|1|||
146622757|NCT01009060|528791107|FG001|Overall Study|Lost to Follow-up|0|||
146622758|NCT01009060|528791106|FG000|Overall Study|Physician Decision|1|||
146622759|NCT01009060|528791107|FG001|Overall Study|Physician Decision|1|||
146622760|NCT01009060|528791106|FG000|Overall Study|Withdrawal by Subject|1|||
146622761|NCT01009060|528791107|FG001|Overall Study|Withdrawal by Subject|1|||
146622762|NCT04201431|528791108|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
146622763|NCT04201431|528791109|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
146622764|NCT04201431|528791110|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
146622765|NCT00667888|528791113|FG000|Overall Study|Death|1|||
146622766|NCT00667888|528791114|FG001|Overall Study|Death|1|||
146622767|NCT00667888|528791113|FG000|Overall Study|Withdrawal by Subject|6|||
146622768|NCT00667888|528791114|FG001|Overall Study|Withdrawal by Subject|3|||
146622769|NCT00667888|528791113|FG000|Overall Study|Proceed with other treatment|3|||
146622770|NCT00667888|528791114|FG001|Overall Study|Proceed with other treatment|3|||
146622771|NCT00667888|528791113|FG000|Overall Study|Ineligible after SIM|0|||
146622772|NCT00667888|528791114|FG001|Overall Study|Ineligible after SIM|2|||
146622773|NCT02140047|528791115|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146622774|NCT02140047|528791116|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146622775|NCT02140047|528791117|FG002|Overall Study|Withdrawal by parent/guardian|0|||
146622776|NCT02174731|528791118|FG000|Overall Study|Participant decision|67|||
146622777|NCT02174731|528791119|FG001|Overall Study|Participant decision|64|||
146622778|NCT02174731|528791118|FG000|Overall Study|Incorrect enrolment before randomization|0|||
146622779|NCT02174731|528791119|FG001|Overall Study|Incorrect enrolment before randomization|1|||
146622780|NCT02174731|528791118|FG000|Overall Study|Missing|2|||
146622781|NCT02174731|528791119|FG001|Overall Study|Missing|0|||
146622782|NCT00079040|528791120|FG000|Overall Study|Withdrew before treatment|1|||
146622783|NCT00079040|528791120|FG000|Overall Study|Ineligible|1|||
146622784|NCT03119259|528791121|FG000|Overall Study|Withdrawn as no longer eligible|1|||
146622785|NCT03119259|528791122|FG001|Overall Study|Withdrawn as no longer eligible|0|||
146622786|NCT03119259|528791121|FG000|Overall Study|Withdrawal by Subject|4|||
146622787|NCT03119259|528791122|FG001|Overall Study|Withdrawal by Subject|2|||
146622788|NCT03119259|528791121|FG000|Overall Study|Lost to Follow-up|0|||
146622789|NCT03119259|528791122|FG001|Overall Study|Lost to Follow-up|1|||
146622790|NCT00325897|528791123|FG000|Overall Study|Lost to Follow-up|12|||
146622791|NCT00325897|528791124|FG001|Overall Study|Lost to Follow-up|13|||
146622792|NCT03535974|528791125|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
146622793|NCT03535974|528791126|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
146622794|NCT03535974|528791127|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
146622795|NCT03535974|528791125|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
146622796|NCT03535974|528791126|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
146622797|NCT03535974|528791127|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
146622798|NCT04059549|528791128|FG000|Overall Study|Withdrawal by Subject|2|||
146622799|NCT04059549|528791129|FG001|Overall Study|Withdrawal by Subject|0|||
146622800|NCT00549640|528791130|FG000|Overall Study|Withdrawal by Subject|6|||
146622801|NCT00549640|528791131|FG001|Overall Study|Withdrawal by Subject|12|||
146622802|NCT00549640|528791130|FG000|Overall Study|Adverse Event|5|||
146622803|NCT00549640|528791131|FG001|Overall Study|Adverse Event|0|||
146622804|NCT00549640|528791130|FG000|Overall Study|Lost to Follow-up|7|||
146622805|NCT00549640|528791131|FG001|Overall Study|Lost to Follow-up|4|||
146622806|NCT00626275|528791134|FG000|Part A - Treatment Period 1|Adverse Event|1|||
146944304|NCT03375203|529956323|FG000|Overall Study|Protocol Violation|0|||
146944305|NCT03375203|529956324|FG001|Overall Study|Protocol Violation|0|||
146944306|NCT03375203|529956325|FG002|Overall Study|Protocol Violation|1|||
146944307|NCT03375203|529956326|FG003|Overall Study|Protocol Violation|0|||
146944308|NCT03375203|529956327|FG004|Overall Study|Protocol Violation|0|||
146944309|NCT03375203|529956323|FG000|Overall Study|Adverse Event|2|||
146944310|NCT03375203|529956324|FG001|Overall Study|Adverse Event|3|||
146944311|NCT03375203|529956325|FG002|Overall Study|Adverse Event|0|||
146944312|NCT03375203|529956326|FG003|Overall Study|Adverse Event|2|||
146944313|NCT03375203|529956327|FG004|Overall Study|Adverse Event|2|||
146944314|NCT03375203|529956323|FG000|Overall Study|Withdrawal by Subject|3|||
146944315|NCT03375203|529956324|FG001|Overall Study|Withdrawal by Subject|0|||
146944316|NCT03375203|529956325|FG002|Overall Study|Withdrawal by Subject|1|||
146944317|NCT03375203|529956326|FG003|Overall Study|Withdrawal by Subject|0|||
146944318|NCT03375203|529956327|FG004|Overall Study|Withdrawal by Subject|2|||
146944319|NCT03375203|529956323|FG000|Overall Study|Non-compliance with study drug|1|||
146944320|NCT03375203|529956324|FG001|Overall Study|Non-compliance with study drug|0|||
146944321|NCT03375203|529956325|FG002|Overall Study|Non-compliance with study drug|0|||
146944322|NCT03375203|529956326|FG003|Overall Study|Non-compliance with study drug|0|||
146944323|NCT03375203|529956327|FG004|Overall Study|Non-compliance with study drug|0|||
146944324|NCT03375203|529956323|FG000|Overall Study|Randomized, not treated.|0|||
146944325|NCT03375203|529956324|FG001|Overall Study|Randomized, not treated.|1|||
146944326|NCT03375203|529956325|FG002|Overall Study|Randomized, not treated.|0|||
146944327|NCT03375203|529956326|FG003|Overall Study|Randomized, not treated.|0|||
146944328|NCT03375203|529956327|FG004|Overall Study|Randomized, not treated.|0|||
146944329|NCT03107793|529956328|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
146944330|NCT03107793|529956329|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
146944331|NCT03107793|529956330|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
146944332|NCT03107793|529956331|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
146944333|NCT03107793|529956332|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
146944334|NCT03107793|529956328|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
146944335|NCT03107793|529956329|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
146944336|NCT03107793|529956330|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
146944337|NCT03107793|529956331|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
146944338|NCT03107793|529956332|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
146944339|NCT03107793|529956328|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
146944340|NCT03107793|529956329|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
146944341|NCT03107793|529956330|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
146944342|NCT03107793|529956331|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
146944343|NCT03107793|529956332|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
146944344|NCT03107793|529956328|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
146944345|NCT03107793|529956329|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146944346|NCT03107793|529956330|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146944347|NCT03107793|529956331|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146944348|NCT03107793|529956332|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146944349|NCT03107793|529956328|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
146944350|NCT03107793|529956329|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
146944351|NCT03107793|529956330|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
146944352|NCT03107793|529956331|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
146944353|NCT03107793|529956332|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
146944354|NCT03107793|529956328|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
146944355|NCT03107793|529956329|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
146944356|NCT03107793|529956330|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
146944357|NCT03107793|529956331|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
146944358|NCT03107793|529956332|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
146944359|NCT03107793|529956328|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
146944360|NCT03107793|529956329|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
146944361|NCT03107793|529956330|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
146944362|NCT03107793|529956331|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
146622807|NCT00626275|528791135|FG001|Part A - Treatment Period 1|Adverse Event|0|||
146944363|NCT03107793|529956332|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
146984234|NCT00321711|530103388|FG003|Part B|Adverse Event|2|||
146984235|NCT00321711|530103389|FG004|Part B|Adverse Event|1|||
146944364|NCT03107793|529956328|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
146944365|NCT03107793|529956329|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
146944366|NCT03107793|529956330|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
146944367|NCT03107793|529956331|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
146944368|NCT03107793|529956332|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
146944369|NCT03107793|529956328|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
146944370|NCT03107793|529956329|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
146944371|NCT03107793|529956330|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
146984236|NCT00321711|530103385|FG000|Part B|Disease progression|0|||
146622808|NCT00626275|528791136|FG002|Part A - Treatment Period 1|Adverse Event|0|||
146622809|NCT00626275|528791137|FG003|Part A - Treatment Period 1|Adverse Event|0|||
146622810|NCT00626275|528791138|FG004|Part A - Treatment Period 1|Adverse Event|0|||
146622811|NCT00626275|528791139|FG005|Part A - Treatment Period 1|Adverse Event|0|||
146622812|NCT00626275|528791140|FG006|Part A - Treatment Period 1|Adverse Event|0|||
146622813|NCT00626275|528791141|FG007|Part A - Treatment Period 1|Adverse Event|0|||
146622814|NCT00626275|528791134|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
146622815|NCT00626275|528791135|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
146622816|NCT00626275|528791136|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
146622817|NCT00626275|528791137|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
146622818|NCT00626275|528791138|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
146622819|NCT00626275|528791139|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
146622820|NCT00626275|528791140|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
146622821|NCT00626275|528791141|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
146622822|NCT00626275|528791134|FG000|Part B|Lost to Follow-up|0|||
146622823|NCT00626275|528791135|FG001|Part B|Lost to Follow-up|0|||
146622824|NCT00626275|528791136|FG002|Part B|Lost to Follow-up|0|||
146622825|NCT00626275|528791137|FG003|Part B|Lost to Follow-up|0|||
146622826|NCT00626275|528791138|FG004|Part B|Lost to Follow-up|0|||
146622827|NCT00626275|528791139|FG005|Part B|Lost to Follow-up|0|||
146622828|NCT00626275|528791140|FG006|Part B|Lost to Follow-up|1|||
146622829|NCT00626275|528791141|FG007|Part B|Lost to Follow-up|0|||
146622830|NCT00626275|528791134|FG000|Part B|Withdrawal by Subject|0|||
146622831|NCT00626275|528791135|FG001|Part B|Withdrawal by Subject|0|||
146622832|NCT00626275|528791136|FG002|Part B|Withdrawal by Subject|0|||
146622833|NCT00626275|528791137|FG003|Part B|Withdrawal by Subject|0|||
146622834|NCT00626275|528791138|FG004|Part B|Withdrawal by Subject|0|||
146622835|NCT00626275|528791139|FG005|Part B|Withdrawal by Subject|0|||
146622836|NCT00626275|528791140|FG006|Part B|Withdrawal by Subject|0|||
146622837|NCT00626275|528791141|FG007|Part B|Withdrawal by Subject|1|||
146622838|NCT01362348|528791142|FG000|Overall Study|Protocol-defined stopping criteria|9|||
146622839|NCT01362348|528791142|FG000|Overall Study|Study closed/terminated|5|||
146622840|NCT02675907|528791143|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
146622841|NCT02675907|528791144|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
146622842|NCT02675907|528791143|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
146622843|NCT02675907|528791144|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
146622844|NCT02675907|528791143|FG000|Study Overall|Lack of Efficacy|1|||
146622845|NCT02675907|528791144|FG001|Study Overall|Lack of Efficacy|0|||
146622846|NCT02675907|528791143|FG000|Study Overall|Withdrawal by Subject|2|||
146622847|NCT02675907|528791144|FG001|Study Overall|Withdrawal by Subject|2|||
146622848|NCT02675907|528791143|FG000|Study Overall|Lost to Follow-up|0|||
146622849|NCT02675907|528791144|FG001|Study Overall|Lost to Follow-up|2|||
146622850|NCT01611792|528791145|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
146622851|NCT01611792|528791146|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
146622852|NCT01611792|528791145|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
146622853|NCT01611792|528791146|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
146622854|NCT03289208|528791151|FG000|Overall Study|Adverse Event|1|||
146622855|NCT03289208|528791152|FG001|Overall Study|Adverse Event|0|||
146622856|NCT03289208|528791153|FG002|Overall Study|Adverse Event|0|||
146622857|NCT00647296|528791154|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
146622858|NCT00647296|528791155|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
146622859|NCT00647296|528791156|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
146622860|NCT00647296|528791157|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
146622861|NCT00647296|528791154|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
146984237|NCT00321711|530103386|FG001|Part B|Disease progression|0|||
146984238|NCT00321711|530103387|FG002|Part B|Disease progression|0|||
146622862|NCT00647296|528791155|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
146622863|NCT00647296|528791156|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
146622864|NCT00647296|528791157|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
146622865|NCT00647296|528791154|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
146622866|NCT00647296|528791155|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
146622867|NCT00647296|528791156|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
146622868|NCT00647296|528791157|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
146622869|NCT00647296|528791154|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
146622870|NCT00647296|528791155|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
146622871|NCT00647296|528791156|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
146622872|NCT00647296|528791157|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
146622873|NCT00647296|528791154|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
146622874|NCT00647296|528791155|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
146622875|NCT00647296|528791156|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
146622876|NCT00647296|528791157|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
146622877|NCT00647296|528791154|FG000|Part 2: 4-week Placebo Washout|Death|3|||
146984239|NCT00321711|530103388|FG003|Part B|Disease progression|1|||
146944372|NCT03107793|529956331|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
146944373|NCT03107793|529956332|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
146944374|NCT03107793|529956328|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
146944375|NCT03107793|529956329|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
146944376|NCT03107793|529956330|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
146944377|NCT03107793|529956331|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
146944378|NCT03107793|529956332|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
146944379|NCT03107793|529956328|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146944380|NCT03107793|529956329|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
146944381|NCT03107793|529956330|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146944382|NCT03107793|529956331|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146944383|NCT03107793|529956332|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146944384|NCT03107793|529956328|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
146944385|NCT03107793|529956329|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
146944386|NCT03107793|529956330|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
146944387|NCT03107793|529956331|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
146944388|NCT03107793|529956332|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
146944389|NCT03107793|529956328|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
146944390|NCT03107793|529956329|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
146944391|NCT03107793|529956330|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
146944392|NCT03107793|529956331|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
146944393|NCT03107793|529956332|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
146944394|NCT03107793|529956328|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
146944395|NCT03107793|529956329|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
146944396|NCT03107793|529956330|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
146944397|NCT03107793|529956331|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
146944398|NCT03107793|529956332|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
146944399|NCT03107793|529956328|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
146944400|NCT03107793|529956329|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
146944401|NCT03107793|529956330|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
146944402|NCT03107793|529956331|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
146944403|NCT03107793|529956332|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
146944404|NCT03107793|529956328|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
146944405|NCT03107793|529956329|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
146944406|NCT03107793|529956330|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
146944407|NCT03107793|529956331|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
146944408|NCT03107793|529956332|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
146944409|NCT03107793|529956328|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
146944410|NCT03107793|529956329|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
146944411|NCT03107793|529956330|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
146944412|NCT03107793|529956331|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
146944413|NCT03107793|529956332|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
146944414|NCT03107793|529956328|FG000|Extension Period (Week 48- Week 104)|Death|0|||
146944415|NCT03107793|529956329|FG001|Extension Period (Week 48- Week 104)|Death|0|||
146944416|NCT03107793|529956330|FG002|Extension Period (Week 48- Week 104)|Death|0|||
146944417|NCT03107793|529956331|FG003|Extension Period (Week 48- Week 104)|Death|0|||
146944418|NCT03107793|529956332|FG004|Extension Period (Week 48- Week 104)|Death|1|||
146944419|NCT03107793|529956328|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
146944420|NCT03107793|529956329|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
146944421|NCT03107793|529956330|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
146944422|NCT03107793|529956331|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
146944423|NCT03107793|529956332|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
146944424|NCT03107793|529956328|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
146944425|NCT03107793|529956329|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
146944426|NCT03107793|529956330|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
146944427|NCT03107793|529956331|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
146944428|NCT03107793|529956332|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
146944429|NCT03107793|529956328|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
146944430|NCT03107793|529956329|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
146944431|NCT03107793|529956330|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
146944432|NCT03107793|529956331|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
146944433|NCT03107793|529956332|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
146944434|NCT03107793|529956328|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
146944435|NCT03107793|529956329|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
146944436|NCT03107793|529956330|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
146622878|NCT00647296|528791155|FG001|Part 2: 4-week Placebo Washout|Death|0|||
146622879|NCT00647296|528791156|FG002|Part 2: 4-week Placebo Washout|Death|0|||
146622880|NCT00647296|528791157|FG003|Part 2: 4-week Placebo Washout|Death|0|||
146622881|NCT00647296|528791154|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
146622882|NCT00647296|528791155|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
146622883|NCT00647296|528791156|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
146622884|NCT00647296|528791157|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
146622885|NCT00647296|528791154|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
146622886|NCT00647296|528791155|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
146622887|NCT00647296|528791156|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
146622888|NCT00647296|528791157|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
146622889|NCT00647296|528791154|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
146622890|NCT00647296|528791155|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
146622891|NCT00647296|528791156|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
146622892|NCT00647296|528791157|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
146622893|NCT00647296|528791154|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
146622894|NCT00647296|528791155|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
146622895|NCT00647296|528791156|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
146622896|NCT00647296|528791157|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
146622897|NCT00647296|528791154|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
146622898|NCT00647296|528791155|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
146622899|NCT00647296|528791156|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
146622900|NCT00647296|528791157|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
146622901|NCT00550407|528791158|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
146622902|NCT00550407|528791159|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
146622903|NCT00550407|528791160|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
146622904|NCT00550407|528791158|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
146622905|NCT00550407|528791159|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
146622906|NCT00550407|528791160|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
146622907|NCT00550407|528791158|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
146622908|NCT00550407|528791159|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
146622909|NCT00550407|528791160|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
146622910|NCT00550407|528791158|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
146622911|NCT00550407|528791159|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
146622912|NCT00550407|528791160|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
146622913|NCT00550407|528791158|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
146622914|NCT00550407|528791159|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
146622915|NCT00550407|528791160|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
146622916|NCT00550407|528791158|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
146622917|NCT00550407|528791159|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
146622918|NCT00550407|528791160|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
146622919|NCT00550407|528791158|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
146622920|NCT00550407|528791159|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
146622921|NCT00550407|528791160|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
146622922|NCT00550407|528791158|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
146622923|NCT00550407|528791159|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
146622924|NCT00550407|528791160|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
146622925|NCT00550407|528791158|FG000|26-Week Randomized Phase|Adverse Event|0|||
146622926|NCT00550407|528791159|FG001|26-Week Randomized Phase|Adverse Event|5|||
146622927|NCT00550407|528791160|FG002|26-Week Randomized Phase|Adverse Event|2|||
146622928|NCT00550407|528791158|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
146622929|NCT00550407|528791159|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
146622930|NCT00550407|528791160|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
146622931|NCT00550407|528791158|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
146622932|NCT00550407|528791159|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
146622933|NCT00550407|528791160|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
146622934|NCT00550407|528791158|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
146622935|NCT00550407|528791159|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
146622936|NCT00550407|528791160|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
146622937|NCT00584415|528791161|FG000|Overall Study|Adverse Event|7|||
146944437|NCT03107793|529956331|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
146622938|NCT00556894|528791162|FG000|Overall Study|Adverse Event|2|||
146622939|NCT00556894|528791163|FG001|Overall Study|Adverse Event|3|||
146622940|NCT00556894|528791164|FG002|Overall Study|Adverse Event|3|||
146944438|NCT03107793|529956332|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
146622941|NCT00556894|528791162|FG000|Overall Study|Death|1|||
146622942|NCT00556894|528791163|FG001|Overall Study|Death|0|||
146622943|NCT00556894|528791164|FG002|Overall Study|Death|0|||
146622944|NCT00556894|528791162|FG000|Overall Study|regulatory decision in Bulgaria|10|||
146622945|NCT00556894|528791163|FG001|Overall Study|regulatory decision in Bulgaria|14|||
146622946|NCT00556894|528791164|FG002|Overall Study|regulatory decision in Bulgaria|13|||
146622947|NCT00556894|528791162|FG000|Overall Study|Change in therapy|2|||
146622948|NCT00556894|528791163|FG001|Overall Study|Change in therapy|1|||
146622949|NCT00556894|528791164|FG002|Overall Study|Change in therapy|2|||
146622950|NCT00556894|528791162|FG000|Overall Study|Withdrawal by Subject|1|||
146622951|NCT00556894|528791163|FG001|Overall Study|Withdrawal by Subject|1|||
146622952|NCT00556894|528791164|FG002|Overall Study|Withdrawal by Subject|1|||
146622953|NCT03883581|528791165|FG000|Overall Study|Withdrawal by Subject|4|||
146622954|NCT04750642|528791169|FG000|Overall Study|Adverse Event|1|||
146622955|NCT04750642|528791170|FG001|Overall Study|Adverse Event|0|||
146622956|NCT04750642|528791169|FG000|Overall Study|Withdrawal by Subject|0|||
146622957|NCT04750642|528791170|FG001|Overall Study|Withdrawal by Subject|1|||
146622958|NCT04750642|528791169|FG000|Overall Study|Protocol Violation|0|||
146622959|NCT04750642|528791170|FG001|Overall Study|Protocol Violation|1|||
146622960|NCT00410956|528791171|FG000|Overall Study|Adverse Event|1|||
146622961|NCT00410956|528791171|FG000|Overall Study|Death|2|||
146622962|NCT00410956|528791171|FG000|Overall Study|Lack of Efficacy|10|||
146622963|NCT00410956|528791171|FG000|Overall Study|Physician Decision|6|||
146622964|NCT01650194|528791173|FG000|Overall Study|Progressive Disease (PD)|35|||
146622965|NCT01650194|528791173|FG000|Overall Study|Withdrawal by Subject|2|||
146622966|NCT01650194|528791173|FG000|Overall Study|Miscellaneous|10|||
146622967|NCT00740220|528792738|FG000|Overall Study|screen failures (non-COPD patients)|9|||
146622968|NCT01908426|528792743|FG000|Overall Study|Adverse Event|98|||
146622969|NCT01908426|528792744|FG001|Overall Study|Adverse Event|11|||
146622970|NCT01908426|528792743|FG000|Overall Study|Clinical Deterioration|72|||
146622971|NCT01908426|528792744|FG001|Overall Study|Clinical Deterioration|38|||
146622972|NCT01908426|528792743|FG000|Overall Study|Lack of Efficacy|3|||
146622973|NCT01908426|528792744|FG001|Overall Study|Lack of Efficacy|0|||
146622974|NCT01908426|528792743|FG000|Overall Study|Lost to Follow-up|0|||
146622975|NCT01908426|528792744|FG001|Overall Study|Lost to Follow-up|1|||
146622976|NCT01908426|528792743|FG000|Overall Study|Physician Decision|3|||
146622977|NCT01908426|528792744|FG001|Overall Study|Physician Decision|3|||
146622978|NCT01908426|528792743|FG000|Overall Study|Withdrawal by Subject|11|||
146622979|NCT01908426|528792744|FG001|Overall Study|Withdrawal by Subject|6|||
146622980|NCT01908426|528792743|FG000|Overall Study|Progressive Disease|206|||
146622981|NCT01908426|528792744|FG001|Overall Study|Progressive Disease|152|||
146622982|NCT01908426|528792743|FG000|Overall Study|Protocol Violation|1|||
146622983|NCT01908426|528792744|FG001|Overall Study|Protocol Violation|0|||
146622984|NCT01908426|528792743|FG000|Overall Study|No Study Treatment Given|3|||
146622985|NCT01908426|528792744|FG001|Overall Study|No Study Treatment Given|0|||
146622986|NCT03346434|528792745|FG000|Overall Study|Randomized in Error|0|||
146622987|NCT03346434|528792746|FG001|Overall Study|Randomized in Error|0|||
146622988|NCT03346434|528792747|FG002|Overall Study|Randomized in Error|0|||
146622989|NCT03346434|528792748|FG003|Overall Study|Randomized in Error|0|||
146622990|NCT03346434|528792749|FG004|Overall Study|Randomized in Error|1|||
146622991|NCT03346434|528792750|FG005|Overall Study|Randomized in Error|0|||
146622992|NCT03346434|528792745|FG000|Overall Study|Withdrawal by Subject|0|||
146622993|NCT03346434|528792746|FG001|Overall Study|Withdrawal by Subject|0|||
146622994|NCT03346434|528792747|FG002|Overall Study|Withdrawal by Subject|1|||
146622995|NCT03346434|528792748|FG003|Overall Study|Withdrawal by Subject|0|||
146622996|NCT03346434|528792749|FG004|Overall Study|Withdrawal by Subject|1|||
146622997|NCT03346434|528792750|FG005|Overall Study|Withdrawal by Subject|0|||
146622998|NCT03346434|528792745|FG000|Overall Study|Lost to Follow-up|0|||
146622999|NCT03346434|528792746|FG001|Overall Study|Lost to Follow-up|0|||
146623000|NCT03346434|528792747|FG002|Overall Study|Lost to Follow-up|0|||
146623001|NCT03346434|528792748|FG003|Overall Study|Lost to Follow-up|0|||
146623002|NCT03346434|528792749|FG004|Overall Study|Lost to Follow-up|1|||
146623003|NCT03346434|528792750|FG005|Overall Study|Lost to Follow-up|1|||
146623004|NCT03346434|528792745|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
146623005|NCT03346434|528792746|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
146623006|NCT03346434|528792747|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
146623007|NCT03346434|528792748|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
146623008|NCT03346434|528792749|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
146623009|NCT03346434|528792750|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
146623010|NCT04416204|528792754|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
146623011|NCT04416204|528792755|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
146623012|NCT04416204|528792756|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
146623013|NCT04416204|528792757|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
146623014|NCT00812708|528792758|FG000|Overall Study|Device could not be implanted|2|||
146623015|NCT00812708|528792758|FG000|Overall Study|Lack of medical insurance|1|||
146623016|NCT00812708|528792758|FG000|Overall Study|Switched to another study|1|||
146623017|NCT00812708|528792758|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
146623018|NCT00812708|528792758|FG000|Overall Study|Signed consent but later withdrew|3|||
146623019|NCT03224130|528792764|FG000|Overall Study|consent issue|0|||
146623020|NCT03224130|528792765|FG001|Overall Study|consent issue|1|||
146623021|NCT02587520|528792768|FG000|Overall Study|Protocol Violation|2|||
146623022|NCT02587520|528792769|FG001|Overall Study|Protocol Violation|0|||
146623023|NCT02587520|528792770|FG002|Overall Study|Protocol Violation|0|||
146623024|NCT02587520|528792771|FG003|Overall Study|Protocol Violation|2|||
146623025|NCT02587520|528792772|FG004|Overall Study|Protocol Violation|0|||
146623026|NCT02587520|528792773|FG005|Overall Study|Protocol Violation|1|||
146623027|NCT02587520|528792774|FG006|Overall Study|Protocol Violation|1|||
146623028|NCT02587520|528792775|FG007|Overall Study|Protocol Violation|1|||
146623029|NCT02587520|528792776|FG008|Overall Study|Protocol Violation|3|||
146623030|NCT02587520|528792777|FG009|Overall Study|Protocol Violation|3|||
146623031|NCT02587520|528792778|FG010|Overall Study|Protocol Violation|1|||
146623032|NCT02587520|528792779|FG011|Overall Study|Protocol Violation|2|||
146623033|NCT02587520|528792780|FG012|Overall Study|Protocol Violation|0|||
146623034|NCT02587520|528792781|FG013|Overall Study|Protocol Violation|0|||
146623035|NCT02587520|528792782|FG014|Overall Study|Protocol Violation|0|||
146623036|NCT02587520|528792783|FG015|Overall Study|Protocol Violation|0|||
146623037|NCT02587520|528792784|FG016|Overall Study|Protocol Violation|0|||
146623038|NCT02587520|528792785|FG017|Overall Study|Protocol Violation|0|||
146623039|NCT02587520|528792768|FG000|Overall Study|Adverse Event|0|||
146623040|NCT02587520|528792769|FG001|Overall Study|Adverse Event|0|||
146623041|NCT02587520|528792770|FG002|Overall Study|Adverse Event|0|||
146623042|NCT02587520|528792771|FG003|Overall Study|Adverse Event|0|||
146623043|NCT02587520|528792772|FG004|Overall Study|Adverse Event|0|||
146623044|NCT02587520|528792773|FG005|Overall Study|Adverse Event|0|||
146623045|NCT02587520|528792774|FG006|Overall Study|Adverse Event|0|||
146623046|NCT02587520|528792775|FG007|Overall Study|Adverse Event|0|||
146623047|NCT02587520|528792776|FG008|Overall Study|Adverse Event|0|||
146623048|NCT02587520|528792777|FG009|Overall Study|Adverse Event|0|||
146623049|NCT02587520|528792778|FG010|Overall Study|Adverse Event|0|||
146623050|NCT02587520|528792779|FG011|Overall Study|Adverse Event|1|||
146623051|NCT02587520|528792780|FG012|Overall Study|Adverse Event|0|||
146623052|NCT02587520|528792781|FG013|Overall Study|Adverse Event|0|||
146623053|NCT02587520|528792782|FG014|Overall Study|Adverse Event|0|||
146623054|NCT02587520|528792783|FG015|Overall Study|Adverse Event|0|||
146623055|NCT02587520|528792784|FG016|Overall Study|Adverse Event|0|||
146623056|NCT02587520|528792785|FG017|Overall Study|Adverse Event|0|||
146623057|NCT02587520|528792768|FG000|Overall Study|Withdrawal by Subject|0|||
146623058|NCT02587520|528792769|FG001|Overall Study|Withdrawal by Subject|0|||
146623059|NCT02587520|528792770|FG002|Overall Study|Withdrawal by Subject|1|||
146623060|NCT02587520|528792771|FG003|Overall Study|Withdrawal by Subject|1|||
146623061|NCT02587520|528792772|FG004|Overall Study|Withdrawal by Subject|0|||
146623062|NCT02587520|528792773|FG005|Overall Study|Withdrawal by Subject|1|||
146623063|NCT02587520|528792774|FG006|Overall Study|Withdrawal by Subject|1|||
146623064|NCT02587520|528792775|FG007|Overall Study|Withdrawal by Subject|0|||
146623065|NCT02587520|528792776|FG008|Overall Study|Withdrawal by Subject|0|||
146623066|NCT02587520|528792777|FG009|Overall Study|Withdrawal by Subject|0|||
146623067|NCT02587520|528792778|FG010|Overall Study|Withdrawal by Subject|0|||
146623068|NCT02587520|528792779|FG011|Overall Study|Withdrawal by Subject|0|||
146623069|NCT02587520|528792780|FG012|Overall Study|Withdrawal by Subject|0|||
146623070|NCT02587520|528792781|FG013|Overall Study|Withdrawal by Subject|1|||
146623071|NCT02587520|528792782|FG014|Overall Study|Withdrawal by Subject|0|||
146623072|NCT02587520|528792783|FG015|Overall Study|Withdrawal by Subject|0|||
146623073|NCT02587520|528792784|FG016|Overall Study|Withdrawal by Subject|0|||
146623074|NCT02587520|528792785|FG017|Overall Study|Withdrawal by Subject|0|||
146623075|NCT02587520|528792768|FG000|Overall Study|Lost to Follow-up|0|||
146623076|NCT02587520|528792769|FG001|Overall Study|Lost to Follow-up|2|||
146623077|NCT02587520|528792770|FG002|Overall Study|Lost to Follow-up|0|||
146623078|NCT02587520|528792771|FG003|Overall Study|Lost to Follow-up|2|||
146623079|NCT02587520|528792772|FG004|Overall Study|Lost to Follow-up|0|||
146623080|NCT02587520|528792773|FG005|Overall Study|Lost to Follow-up|1|||
146623081|NCT02587520|528792774|FG006|Overall Study|Lost to Follow-up|1|||
146623082|NCT02587520|528792775|FG007|Overall Study|Lost to Follow-up|1|||
146623083|NCT02587520|528792776|FG008|Overall Study|Lost to Follow-up|0|||
146623084|NCT02587520|528792777|FG009|Overall Study|Lost to Follow-up|2|||
146623085|NCT02587520|528792778|FG010|Overall Study|Lost to Follow-up|2|||
146623086|NCT02587520|528792779|FG011|Overall Study|Lost to Follow-up|1|||
146623087|NCT02587520|528792780|FG012|Overall Study|Lost to Follow-up|0|||
146623088|NCT02587520|528792781|FG013|Overall Study|Lost to Follow-up|0|||
146623089|NCT02587520|528792782|FG014|Overall Study|Lost to Follow-up|0|||
146623090|NCT02587520|528792783|FG015|Overall Study|Lost to Follow-up|0|||
146984240|NCT00321711|530103389|FG004|Part B|Disease progression|0|||
146623091|NCT02587520|528792784|FG016|Overall Study|Lost to Follow-up|0|||
146623092|NCT02587520|528792785|FG017|Overall Study|Lost to Follow-up|0|||
146623093|NCT04516746|528792786|FG000|Overall Study|Randomized but not Treated|51|||
146623094|NCT04516746|528792787|FG001|Overall Study|Randomized but not Treated|19|||
146623095|NCT04516746|528792786|FG000|Overall Study|Adverse Event|0|||
146984241|NCT00321711|530103385|FG000|Part B|Physician Decision|0|||
146944439|NCT03107793|529956328|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
146944440|NCT03107793|529956329|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
146944441|NCT03107793|529956330|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
146944442|NCT03107793|529956331|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
146944443|NCT03107793|529956332|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
146944444|NCT03107793|529956328|FG000|Extension Period (Week 48- Week 104)|Other|0|||
146944445|NCT03107793|529956329|FG001|Extension Period (Week 48- Week 104)|Other|0|||
146944446|NCT03107793|529956330|FG002|Extension Period (Week 48- Week 104)|Other|0|||
146944447|NCT03107793|529956331|FG003|Extension Period (Week 48- Week 104)|Other|1|||
146944448|NCT03107793|529956332|FG004|Extension Period (Week 48- Week 104)|Other|3|||
146944449|NCT03107793|529956328|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
146944450|NCT03107793|529956329|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
146944451|NCT03107793|529956330|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
146944452|NCT03107793|529956331|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
146944453|NCT03107793|529956332|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
146944454|NCT04599972|529956342|FG000|Overall Study|Withdrawal by Subject|6|||
146944455|NCT04599972|529956343|FG001|Overall Study|Withdrawal by Subject|1|||
146944456|NCT04599972|529956342|FG000|Overall Study|Adverse Event|1|||
146944457|NCT04599972|529956343|FG001|Overall Study|Adverse Event|1|||
146944458|NCT04599972|529956342|FG000|Overall Study|Lost to Follow-up|1|||
146944459|NCT04599972|529956343|FG001|Overall Study|Lost to Follow-up|6|||
146944460|NCT04599972|529956342|FG000|Overall Study|Protocol Violation|1|||
146944461|NCT04599972|529956343|FG001|Overall Study|Protocol Violation|0|||
146944462|NCT04599972|529956342|FG000|Overall Study|Other reason|1|||
146944463|NCT04599972|529956343|FG001|Overall Study|Other reason|0|||
146944464|NCT00638690|529956344|FG000|Overall Study|Death|655|||
146944465|NCT00638690|529956345|FG001|Overall Study|Death|335|||
146944466|NCT00638690|529956344|FG000|Overall Study|Withdrawal by Subject|22|||
146944467|NCT00638690|529956345|FG001|Overall Study|Withdrawal by Subject|5|||
146944468|NCT00638690|529956344|FG000|Overall Study|Lost to Follow-up|4|||
146944469|NCT00638690|529956345|FG001|Overall Study|Lost to Follow-up|2|||
146944470|NCT02348840|529956346|FG000|Overall Study|Withdrawal by Subject|2|||
146623096|NCT04516746|528792787|FG001|Overall Study|Adverse Event|1|||
146623097|NCT04516746|528792786|FG000|Overall Study|Death|62|||
146623098|NCT04516746|528792787|FG001|Overall Study|Death|32|||
146623099|NCT04516746|528792786|FG000|Overall Study|Lost to Follow-up|3431|||
146623100|NCT04516746|528792787|FG001|Overall Study|Lost to Follow-up|1831|||
146623101|NCT04516746|528792786|FG000|Overall Study|Withdrawal by Subject|1946|||
146623102|NCT04516746|528792787|FG001|Overall Study|Withdrawal by Subject|1696|||
146623103|NCT04516746|528792786|FG000|Overall Study|Physician Decision|10|||
146623104|NCT04516746|528792787|FG001|Overall Study|Physician Decision|8|||
146623105|NCT04516746|528792786|FG000|Overall Study|Other|35|||
146623106|NCT04516746|528792787|FG001|Overall Study|Other|16|||
146623107|NCT00768989|528792788|FG000|Prior to Week 24|Withdrawal by Subject|1|||
146623108|NCT00768989|528792789|FG001|Prior to Week 24|Withdrawal by Subject|0|||
146623109|NCT00768989|528792788|FG000|Prior to Week 24|Adverse Event|3|||
146623110|NCT00768989|528792789|FG001|Prior to Week 24|Adverse Event|0|||
146623111|NCT00768989|528792788|FG000|Prior to Week 24|Lost to Follow-up|0|||
146623112|NCT00768989|528792789|FG001|Prior to Week 24|Lost to Follow-up|1|||
146623113|NCT00768989|528792788|FG000|Prior to Week 24|Protocol Violation|0|||
146623114|NCT00768989|528792789|FG001|Prior to Week 24|Protocol Violation|2|||
146623115|NCT00768989|528792788|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
146623116|NCT00768989|528792789|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
146623117|NCT00768989|528792788|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
146623118|NCT00768989|528792789|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
146623119|NCT00768989|528792788|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
146623120|NCT00768989|528792789|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
146623121|NCT00768989|528792788|FG000|On or After Week 36|Lack of Efficacy|1|||
146623122|NCT00768989|528792789|FG001|On or After Week 36|Lack of Efficacy|0|||
146623123|NCT00768989|528792788|FG000|On or After Week 36|Adverse Event|0|||
146623124|NCT00768989|528792789|FG001|On or After Week 36|Adverse Event|1|||
146623125|NCT00768989|528792788|FG000|On or After Week 36|Lost to Follow-up|1|||
146623126|NCT00768989|528792789|FG001|On or After Week 36|Lost to Follow-up|0|||
146944471|NCT02348840|529956347|FG001|Overall Study|Withdrawal by Subject|1|||
146944472|NCT02348840|529956348|FG002|Overall Study|Withdrawal by Subject|0|||
146623127|NCT00768989|528792788|FG000|On or After Week 36|Poor Compliance|1|||
146623128|NCT00768989|528792789|FG001|On or After Week 36|Poor Compliance|0|||
146623129|NCT00768989|528792788|FG000|On or After Week 36|Protocol Violation|1|||
146623130|NCT00768989|528792789|FG001|On or After Week 36|Protocol Violation|0|||
146944473|NCT02348840|529956349|FG003|Overall Study|Withdrawal by Subject|0|||
146944474|NCT00373880|529956350|FG000|Overall Study|Physician Decision|3|||
146944475|NCT00373880|529956350|FG000|Overall Study|Arrested|1|||
146944476|NCT00373880|529956350|FG000|Overall Study|Protocol Violation|14|||
146623131|NCT00768989|528792788|FG000|On or After Week 36|Did not attend termination visit|2|||
146984242|NCT00321711|530103386|FG001|Part B|Physician Decision|0|||
146984243|NCT00321711|530103387|FG002|Part B|Physician Decision|0|||
146984244|NCT00321711|530103388|FG003|Part B|Physician Decision|1|||
146984245|NCT00321711|530103389|FG004|Part B|Physician Decision|2|||
146984246|NCT00321711|530103385|FG000|Part B|Death|0|||
146984247|NCT00321711|530103386|FG001|Part B|Death|0|||
146984248|NCT00321711|530103387|FG002|Part B|Death|0|||
146984249|NCT00321711|530103388|FG003|Part B|Death|2|||
146984250|NCT00321711|530103389|FG004|Part B|Death|1|||
146984251|NCT01186978|530103390|FG000|Overall Study|Withdrawal by Subject|1|||
146984252|NCT01227668|530103391|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
146984253|NCT01227668|530103392|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
146984254|NCT01227668|530103391|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
146984255|NCT01227668|530103392|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
146984256|NCT01227668|530103391|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
146984257|NCT01227668|530103392|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
146984258|NCT01227668|530103391|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
146984259|NCT01227668|530103392|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
146984260|NCT01227668|530103391|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
146984261|NCT01227668|530103392|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
146984262|NCT01227668|530103391|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
146984263|NCT01227668|530103392|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
146984264|NCT01227668|530103391|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
146984265|NCT01227668|530103392|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
146984266|NCT01227668|530103391|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
146984267|NCT01227668|530103392|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
146984268|NCT01227668|530103391|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
146984269|NCT01227668|530103392|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
146984270|NCT01227668|530103391|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
146984271|NCT01227668|530103392|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
146984272|NCT01227668|530103391|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
146984273|NCT01227668|530103392|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
146984274|NCT01227668|530103391|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
146984275|NCT01227668|530103392|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
146984276|NCT02115256|530103397|FG000|Overall Study|Withdrawal by Subject|0|||
146984277|NCT02115256|530103398|FG001|Overall Study|Withdrawal by Subject|1|||
146984278|NCT01626859|530103401|FG000|Overall Study|Adverse Event|1|||
146623132|NCT00768989|528792789|FG001|On or After Week 36|Did not attend termination visit|0|||
146623133|NCT00768989|528792788|FG000|On or After Week 36|Sponsor Termination|45|||
146623134|NCT00768989|528792789|FG001|On or After Week 36|Sponsor Termination|26|||
146623135|NCT00435409|528792795|FG000|Overall Study|Protocol Violation|1|||
146623136|NCT00435409|528792796|FG001|Overall Study|Protocol Violation|2|||
146623137|NCT00435409|528792797|FG002|Overall Study|Protocol Violation|0|||
146623138|NCT00435409|528792795|FG000|Overall Study|Lost to Follow-up|1|||
146623139|NCT00435409|528792796|FG001|Overall Study|Lost to Follow-up|2|||
146623140|NCT00435409|528792797|FG002|Overall Study|Lost to Follow-up|0|||
146623141|NCT00435409|528792795|FG000|Overall Study|Death|8|||
146623142|NCT00435409|528792796|FG001|Overall Study|Death|6|||
146623143|NCT00435409|528792797|FG002|Overall Study|Death|6|||
146623144|NCT00435409|528792795|FG000|Overall Study|Objective progression or relapse|158|||
146623145|NCT00435409|528792796|FG001|Overall Study|Objective progression or relapse|93|||
146623146|NCT00435409|528792797|FG002|Overall Study|Objective progression or relapse|58|||
146623147|NCT00435409|528792795|FG000|Overall Study|Global deterioration of health status|0|||
146623148|NCT00435409|528792796|FG001|Overall Study|Global deterioration of health status|0|||
146623149|NCT00435409|528792797|FG002|Overall Study|Global deterioration of health status|4|||
146623150|NCT00435409|528792795|FG000|Overall Study|Withdrawal by Subject|8|||
146623151|NCT00435409|528792796|FG001|Overall Study|Withdrawal by Subject|7|||
146623152|NCT00435409|528792797|FG002|Overall Study|Withdrawal by Subject|1|||
146623153|NCT00435409|528792795|FG000|Overall Study|Other|45|||
146623154|NCT00435409|528792796|FG001|Overall Study|Other|30|||
146623155|NCT00435409|528792797|FG002|Overall Study|Other|1|||
146623156|NCT00435409|528792795|FG000|Overall Study|Adverse Event|0|||
146623157|NCT00435409|528792796|FG001|Overall Study|Adverse Event|0|||
146623158|NCT00435409|528792797|FG002|Overall Study|Adverse Event|8|||
146623159|NCT00435409|528792795|FG000|Overall Study|Sponsor decision|0|||
146623160|NCT00435409|528792796|FG001|Overall Study|Sponsor decision|3|||
146623161|NCT00435409|528792797|FG002|Overall Study|Sponsor decision|0|||
146623162|NCT03661723|528792802|FG000|Overall Study|Disease Progression|4|||
146623163|NCT03661723|528792803|FG001|Overall Study|Disease Progression|24|||
146984279|NCT01626859|530103402|FG001|Overall Study|Adverse Event|3|||
146984280|NCT01626859|530103403|FG002|Overall Study|Adverse Event|2|||
146984281|NCT01626859|530103401|FG000|Overall Study|Physician Decision|0|||
146984282|NCT01626859|530103402|FG001|Overall Study|Physician Decision|1|||
146984283|NCT01626859|530103403|FG002|Overall Study|Physician Decision|0|||
146984284|NCT01626859|530103401|FG000|Overall Study|Withdrawal by Subject|1|||
146623164|NCT03661723|528792804|FG002|Overall Study|Disease Progression|4|||
146623165|NCT03661723|528792805|FG003|Overall Study|Disease Progression|19|||
146623166|NCT03661723|528792802|FG000|Overall Study|Withdrawal by Subject|1|||
146623167|NCT03661723|528792803|FG001|Overall Study|Withdrawal by Subject|0|||
146623168|NCT03661723|528792804|FG002|Overall Study|Withdrawal by Subject|2|||
146623169|NCT03661723|528792805|FG003|Overall Study|Withdrawal by Subject|4|||
146623170|NCT03661723|528792802|FG000|Overall Study|Physician Decision|1|||
146623171|NCT03661723|528792803|FG001|Overall Study|Physician Decision|0|||
146623172|NCT03661723|528792804|FG002|Overall Study|Physician Decision|0|||
146623173|NCT03661723|528792805|FG003|Overall Study|Physician Decision|0|||
146623174|NCT03661723|528792802|FG000|Overall Study|Clinical Deterioration|0|||
146623175|NCT03661723|528792803|FG001|Overall Study|Clinical Deterioration|0|||
146623176|NCT03661723|528792804|FG002|Overall Study|Clinical Deterioration|0|||
146623177|NCT03661723|528792805|FG003|Overall Study|Clinical Deterioration|1|||
146623178|NCT03562195|528792808|FG000|Overall Study|Adverse Event|0|||
146623179|NCT03562195|528792809|FG001|Overall Study|Adverse Event|6|||
146623180|NCT03562195|528792808|FG000|Overall Study|Lack of Efficacy|0|||
146623181|NCT03562195|528792809|FG001|Overall Study|Lack of Efficacy|5|||
146623182|NCT03562195|528792808|FG000|Overall Study|Protocol Violation|0|||
146623183|NCT03562195|528792809|FG001|Overall Study|Protocol Violation|1|||
146623184|NCT03562195|528792808|FG000|Overall Study|Lost to Follow-up|0|||
146623185|NCT03562195|528792809|FG001|Overall Study|Lost to Follow-up|1|||
146623186|NCT03562195|528792808|FG000|Overall Study|Physician Decision|1|||
146623187|NCT03562195|528792809|FG001|Overall Study|Physician Decision|0|||
146623188|NCT03562195|528792808|FG000|Overall Study|Withdrawal by Subject|3|||
146623189|NCT03562195|528792809|FG001|Overall Study|Withdrawal by Subject|0|||
146623190|NCT02529852|528792810|FG000|Overall Study|Withdrawal by Subject|2|||
146623191|NCT00117637|528792811|FG000|First Intervention (Period 1)|Adverse Event|11|||
146623192|NCT00117637|528792812|FG001|First Intervention (Period 1)|Adverse Event|16|||
146623193|NCT00117637|528792811|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
146623194|NCT00117637|528792812|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
146623195|NCT00117637|528792811|FG000|First Intervention (Period 1)|Protocol Violation|1|||
146623196|NCT00117637|528792812|FG001|First Intervention (Period 1)|Protocol Violation|0|||
146623197|NCT00117637|528792811|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
146623198|NCT00117637|528792812|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
146623199|NCT00117637|528792811|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
146623200|NCT00117637|528792812|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
146623201|NCT00117637|528792811|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
146623202|NCT00117637|528792812|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
146623203|NCT00117637|528792811|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
146623204|NCT00117637|528792812|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
146623205|NCT00117637|528792811|FG000|First Intervention (Period 1)|reason not reported|0|||
146623206|NCT00117637|528792812|FG001|First Intervention (Period 1)|reason not reported|1|||
146623207|NCT00117637|528792811|FG000|Second Intervention (Period 2)|Adverse Event|0|||
146623208|NCT00117637|528792812|FG001|Second Intervention (Period 2)|Adverse Event|9|||
146623209|NCT00117637|528792811|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
146623210|NCT00117637|528792812|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
146623211|NCT00117637|528792811|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
146623212|NCT00117637|528792812|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
146623213|NCT00117637|528792811|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
146623214|NCT00117637|528792812|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
146623215|NCT00117637|528792811|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
146623216|NCT00117637|528792812|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
146623217|NCT00117637|528792811|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
146623218|NCT00117637|528792812|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
146623219|NCT00117637|528792811|FG000|Second Intervention (Period 2)|reason not reported|1|||
146623220|NCT00117637|528792812|FG001|Second Intervention (Period 2)|reason not reported|0|||
146623221|NCT00614575|528792813|FG000|Overall Study|Adverse Event|106|||
146623222|NCT00614575|528792813|FG000|Overall Study|Lost to Follow-up|55|||
146623223|NCT00614575|528792813|FG000|Overall Study|Lack of Efficacy|14|||
146623224|NCT00614575|528792813|FG000|Overall Study|Withdrawal by Subject|6|||
146623225|NCT00614575|528792813|FG000|Overall Study|Death|3|||
146623226|NCT00614575|528792813|FG000|Overall Study|Physician Decision|2|||
146623227|NCT00614575|528792813|FG000|Overall Study|No data were collected.|18|||
146623228|NCT00614575|528792813|FG000|Overall Study|Irregularly enrolled patients|23|||
146623229|NCT00614575|528792813|FG000|Overall Study|No treatment|1|||
146623230|NCT01045460|528792817|FG000|Overall Study|Physician Decision|3|||
146623231|NCT01045460|528792818|FG001|Overall Study|Physician Decision|2|||
146623232|NCT01045460|528792817|FG000|Overall Study|Lost to Follow-up|0|||
146623233|NCT01045460|528792818|FG001|Overall Study|Lost to Follow-up|1|||
146623234|NCT01045460|528792817|FG000|Overall Study|Lack of Efficacy|3|||
146623235|NCT01045460|528792818|FG001|Overall Study|Lack of Efficacy|0|||
146623236|NCT00097500|528792819|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
146623237|NCT00097500|528792820|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
146623238|NCT00097500|528792819|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
146623239|NCT00097500|528792820|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
146623240|NCT00097500|528792819|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
146623241|NCT00097500|528792820|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
146623242|NCT00097500|528792819|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
146623243|NCT00097500|528792820|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
146623244|NCT00097500|528792819|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
146623245|NCT00097500|528792820|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
146623246|NCT00097500|528792819|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
146623247|NCT00097500|528792820|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
146623248|NCT00097500|528792819|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
146623249|NCT00097500|528792820|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
146623250|NCT00524485|528792824|FG000|Overall Study|Withdrawal by Subject|5|||
146623251|NCT00300755|528792834|FG000|Overall Study|Adverse Event|1|||
146623252|NCT00300755|528792835|FG001|Overall Study|Adverse Event|2|||
146623253|NCT00300755|528792836|FG002|Overall Study|Adverse Event|1|||
146623254|NCT00300755|528792834|FG000|Overall Study|Withdrawal by Subject|0|||
146623255|NCT00300755|528792835|FG001|Overall Study|Withdrawal by Subject|2|||
146623256|NCT00300755|528792836|FG002|Overall Study|Withdrawal by Subject|0|||
146623257|NCT00300755|528792834|FG000|Overall Study|Protocol Violation|0|||
146623258|NCT00300755|528792835|FG001|Overall Study|Protocol Violation|0|||
146623259|NCT00300755|528792836|FG002|Overall Study|Protocol Violation|1|||
146623260|NCT04571944|528792837|FG000|Overall Study|Death|1|||
146623261|NCT04571944|528792838|FG001|Overall Study|Death|0|||
146623262|NCT04571944|528792837|FG000|Overall Study|Withdrawal by Subject|3|||
146623263|NCT04571944|528792838|FG001|Overall Study|Withdrawal by Subject|0|||
146623264|NCT04571944|528792837|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
146623265|NCT04571944|528792838|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
146623266|NCT04079296|528792841|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
146623267|NCT04079296|528792842|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
146623268|NCT04079296|528792843|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
146623269|NCT04079296|528792844|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
146623270|NCT04079296|528792845|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
146623271|NCT04079296|528792841|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
146623272|NCT04079296|528792842|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
146623273|NCT04079296|528792843|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
146623274|NCT04079296|528792844|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
146623275|NCT04079296|528792845|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
146623276|NCT04079296|528792841|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
146623277|NCT04079296|528792842|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
146623278|NCT04079296|528792843|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
146623279|NCT04079296|528792844|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
146623280|NCT04079296|528792845|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
146623281|NCT04079296|528792841|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
146623282|NCT04079296|528792842|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
146623283|NCT04079296|528792843|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
146623284|NCT04079296|528792844|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
146623285|NCT04079296|528792845|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
146623286|NCT04079296|528792841|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
146623287|NCT04079296|528792842|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
146623288|NCT04079296|528792843|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
146623289|NCT04079296|528792844|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
146623290|NCT04079296|528792845|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
146623291|NCT04079296|528792841|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
146623292|NCT04079296|528792842|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
146623293|NCT04079296|528792843|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
146623294|NCT04079296|528792844|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
146623295|NCT04079296|528792845|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
146623296|NCT04079296|528792841|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
146623297|NCT04079296|528792842|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
146623298|NCT04079296|528792843|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
146623299|NCT04079296|528792844|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
146623300|NCT04079296|528792845|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
146623301|NCT04079296|528792841|FG000|Dose Expansion Phase (168 Days)|Death|0|||
146623302|NCT04079296|528792842|FG001|Dose Expansion Phase (168 Days)|Death|0|||
146623303|NCT04079296|528792843|FG002|Dose Expansion Phase (168 Days)|Death|0|||
146623304|NCT04079296|528792844|FG003|Dose Expansion Phase (168 Days)|Death|1|||
146984285|NCT01626859|530103402|FG001|Overall Study|Withdrawal by Subject|4|||
146984286|NCT01626859|530103403|FG002|Overall Study|Withdrawal by Subject|2|||
146984287|NCT02826603|530103404|FG000|Overall Study|Adverse Event|17|||
146984288|NCT02826603|530103405|FG001|Overall Study|Adverse Event|9|||
146984289|NCT02826603|530103404|FG000|Overall Study|Lack of Efficacy|4|||
146984290|NCT02826603|530103405|FG001|Overall Study|Lack of Efficacy|9|||
146984291|NCT02826603|530103404|FG000|Overall Study|Lost to Follow-up|13|||
146623305|NCT04079296|528792845|FG004|Dose Expansion Phase (168 Days)|Death|0|||
146623306|NCT01919229|528792847|FG000|Overall Study|Subject/guardian decision|0|||
146623307|NCT01919229|528792848|FG001|Overall Study|Subject/guardian decision|0|||
146623308|NCT01919229|528792849|FG002|Overall Study|Subject/guardian decision|1|||
146623309|NCT01011673|528792850|FG000|Randomized|Secondary headache|2|||
146623310|NCT01011673|528792851|FG001|Randomized|Secondary headache|1|||
146623311|NCT01011673|528792850|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
146623312|NCT01011673|528792851|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
146623313|NCT03261336|528792853|FG000|Overall Study|Adverse Event|1|||
146623314|NCT00292942|528792855|FG000|Overall Study|Withdrawal by Subject|0|||
146623315|NCT00292942|528792856|FG001|Overall Study|Withdrawal by Subject|0|||
146623316|NCT00292942|528792857|FG002|Overall Study|Withdrawal by Subject|1|||
146623317|NCT00292942|528792858|FG003|Overall Study|Withdrawal by Subject|0|||
146623318|NCT00292942|528792855|FG000|Overall Study|Adverse Event|0|||
146623319|NCT00292942|528792856|FG001|Overall Study|Adverse Event|0|||
146623320|NCT00292942|528792857|FG002|Overall Study|Adverse Event|0|||
146623321|NCT00292942|528792858|FG003|Overall Study|Adverse Event|1|||
146623322|NCT00644358|528792859|FG000|Overall Study|Adverse Event|124|||
146623323|NCT00644358|528792859|FG000|Overall Study|Lost to Follow-up|105|||
146623324|NCT00644358|528792859|FG000|Overall Study|Consent Withdrawal|64|||
146623325|NCT00644358|528792859|FG000|Overall Study|Lack of Effectiveness|39|||
146623326|NCT00644358|528792859|FG000|Overall Study|Protocol Violation|5|||
146623327|NCT00644358|528792859|FG000|Overall Study|Noncompliance|14|||
146623328|NCT00644358|528792859|FG000|Overall Study|Other Unspecified|11|||
146623329|NCT00651924|528792865|FG000|Overall Study|Withdrawal by PI|0|||
146623330|NCT00651924|528792866|FG001|Overall Study|Withdrawal by PI|2|||
146623331|NCT00651924|528792865|FG000|Overall Study|Withdrawal by Subject|0|||
146623332|NCT00651924|528792866|FG001|Overall Study|Withdrawal by Subject|5|||
146623333|NCT00758771|528792867|FG000|Overall Study|Withdrawal by Subject|1|||
146623334|NCT00758771|528792868|FG001|Overall Study|Withdrawal by Subject|1|||
146623335|NCT00758771|528792867|FG000|Overall Study|Did not meet eligibility criteria|2|||
146623336|NCT00758771|528792868|FG001|Overall Study|Did not meet eligibility criteria|4|||
146623337|NCT00960063|528792869|FG000|Overall Study|Adverse Event|1|||
146623338|NCT00960063|528792870|FG001|Overall Study|Adverse Event|0|||
146623339|NCT00960063|528792871|FG002|Overall Study|Adverse Event|0|||
146623340|NCT00960063|528792869|FG000|Overall Study|Progression of Disease|0|||
146623341|NCT00960063|528792870|FG001|Overall Study|Progression of Disease|0|||
146623342|NCT00960063|528792871|FG002|Overall Study|Progression of Disease|3|||
146623343|NCT01759420|528792872|FG000|Overall Study|Screen failure|5|||
146623344|NCT01759420|528792872|FG000|Overall Study|Inaccurate EKG machine readings|1|||
146623345|NCT01129622|528792873|FG000|Overall Study|Withdrawal by Subject|2|||
146623346|NCT02051764|528792874|FG000|Overall Study|Study terminated by sponsor|0|||
146623347|NCT02051764|528792875|FG001|Overall Study|Study terminated by sponsor|7|||
146623348|NCT00591006|528792876|FG000|Overall Study|Withdrawal by Subject|0|||
146623349|NCT00591006|528792877|FG001|Overall Study|Withdrawal by Subject|0|||
146623350|NCT00591006|528792878|FG002|Overall Study|Withdrawal by Subject|0|||
146623351|NCT00591006|528792879|FG003|Overall Study|Withdrawal by Subject|0|||
146623352|NCT00591006|528792880|FG004|Overall Study|Withdrawal by Subject|0|||
146623353|NCT00591006|528792881|FG005|Overall Study|Withdrawal by Subject|0|||
146623354|NCT00591006|528792882|FG006|Overall Study|Withdrawal by Subject|0|||
146623355|NCT00591006|528792883|FG007|Overall Study|Withdrawal by Subject|0|||
146623356|NCT00591006|528792884|FG008|Overall Study|Withdrawal by Subject|0|||
146623357|NCT00591006|528792885|FG009|Overall Study|Withdrawal by Subject|0|||
146623358|NCT00591006|528792886|FG010|Overall Study|Withdrawal by Subject|0|||
146623359|NCT00591006|528792887|FG011|Overall Study|Withdrawal by Subject|0|||
146623360|NCT00591006|528792888|FG012|Overall Study|Withdrawal by Subject|0|||
146623361|NCT00591006|528792889|FG013|Overall Study|Withdrawal by Subject|0|||
146623362|NCT00591006|528792890|FG014|Overall Study|Withdrawal by Subject|0|||
146623363|NCT00591006|528792891|FG015|Overall Study|Withdrawal by Subject|1|||
146623364|NCT00591006|528792892|FG016|Overall Study|Withdrawal by Subject|0|||
146984292|NCT02826603|530103405|FG001|Overall Study|Lost to Follow-up|12|||
146623365|NCT00591006|528792893|FG017|Overall Study|Withdrawal by Subject|0|||
146623366|NCT00591006|528792894|FG018|Overall Study|Withdrawal by Subject|0|||
146623367|NCT00591006|528792895|FG019|Overall Study|Withdrawal by Subject|0|||
146623368|NCT00591006|528792896|FG020|Overall Study|Withdrawal by Subject|0|||
146623369|NCT00591006|528792897|FG021|Overall Study|Withdrawal by Subject|0|||
146623370|NCT00591006|528792898|FG022|Overall Study|Withdrawal by Subject|0|||
146623371|NCT00591006|528792899|FG023|Overall Study|Withdrawal by Subject|1|||
146623372|NCT00591006|528792876|FG000|Overall Study|Adverse Event|0|||
146984293|NCT02826603|530103404|FG000|Overall Study|Noncompliance with treatment|0|||
146623373|NCT00591006|528792877|FG001|Overall Study|Adverse Event|0|||
146623374|NCT00591006|528792878|FG002|Overall Study|Adverse Event|0|||
146623375|NCT00591006|528792879|FG003|Overall Study|Adverse Event|0|||
146623376|NCT00591006|528792880|FG004|Overall Study|Adverse Event|0|||
146623377|NCT00591006|528792881|FG005|Overall Study|Adverse Event|0|||
146623378|NCT00591006|528792882|FG006|Overall Study|Adverse Event|0|||
146623379|NCT00591006|528792883|FG007|Overall Study|Adverse Event|0|||
146623380|NCT00591006|528792884|FG008|Overall Study|Adverse Event|0|||
146623381|NCT00591006|528792885|FG009|Overall Study|Adverse Event|0|||
146623382|NCT00591006|528792886|FG010|Overall Study|Adverse Event|0|||
146623383|NCT00591006|528792887|FG011|Overall Study|Adverse Event|0|||
146623384|NCT00591006|528792888|FG012|Overall Study|Adverse Event|0|||
146623385|NCT00591006|528792889|FG013|Overall Study|Adverse Event|0|||
146623386|NCT00591006|528792890|FG014|Overall Study|Adverse Event|0|||
146623387|NCT00591006|528792891|FG015|Overall Study|Adverse Event|0|||
146623388|NCT00591006|528792892|FG016|Overall Study|Adverse Event|0|||
146623389|NCT00591006|528792893|FG017|Overall Study|Adverse Event|0|||
146623390|NCT00591006|528792894|FG018|Overall Study|Adverse Event|0|||
146623391|NCT00591006|528792895|FG019|Overall Study|Adverse Event|0|||
146623392|NCT00591006|528792896|FG020|Overall Study|Adverse Event|0|||
146623393|NCT00591006|528792897|FG021|Overall Study|Adverse Event|0|||
146623394|NCT00591006|528792898|FG022|Overall Study|Adverse Event|1|||
146623395|NCT00591006|528792899|FG023|Overall Study|Adverse Event|0|||
146623396|NCT05190120|528792902|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
146623397|NCT05190120|528792903|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
146623398|NCT05190120|528792904|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
146623399|NCT05190120|528792905|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
146623400|NCT05190120|528792902|FG000|Overall Study|Lost to Follow-up|5|||
146623401|NCT05190120|528792903|FG001|Overall Study|Lost to Follow-up|0|||
146623402|NCT05190120|528792904|FG002|Overall Study|Lost to Follow-up|2|||
146623403|NCT05190120|528792905|FG003|Overall Study|Lost to Follow-up|3|||
146623404|NCT03062358|528792907|FG000|Overall Study|Death|269|||
146623405|NCT03062358|528792908|FG001|Overall Study|Death|145|||
146623406|NCT03062358|528792907|FG000|Overall Study|Withdrawal by Subject|2|||
146623407|NCT03062358|528792908|FG001|Overall Study|Withdrawal by Subject|1|||
146623408|NCT03062358|528792907|FG000|Overall Study|Sponsor Decision|29|||
146623409|NCT03062358|528792908|FG001|Overall Study|Sponsor Decision|7|||
146735679|NCT02036645|529203011|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146735680|NCT02036645|529203012|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146735681|NCT02036645|529203013|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146735682|NCT02036645|529203014|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146735683|NCT02036645|529203015|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146735684|NCT02036645|529203016|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146735685|NCT02036645|529203017|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
146735686|NCT02036645|529203018|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146735687|NCT02036645|529203019|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146735688|NCT02036645|529203020|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146735689|NCT02036645|529203021|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146735690|NCT02036645|529203022|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146735691|NCT02036645|529203011|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146735692|NCT02036645|529203012|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146735693|NCT02036645|529203013|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146735694|NCT02036645|529203014|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
146735695|NCT02036645|529203015|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146735696|NCT02036645|529203016|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146735697|NCT02036645|529203017|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146735698|NCT02036645|529203018|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146735699|NCT02036645|529203019|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146735700|NCT02036645|529203020|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146735701|NCT02036645|529203021|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146735702|NCT02036645|529203022|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146735703|NCT03881696|529203030|FG000|Overall Study|Adverse Event|2|||
146735704|NCT03881696|529203031|FG001|Overall Study|Adverse Event|0|||
146735705|NCT03881696|529203030|FG000|Overall Study|Withdrawal by Subject|2|||
146735706|NCT03881696|529203031|FG001|Overall Study|Withdrawal by Subject|0|||
146735707|NCT03881696|529203030|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
146735708|NCT03881696|529203031|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
146944477|NCT01347073|529956351|FG000|Overall Study|Adverse Event|1|||
146735709|NCT03881696|529203030|FG000|Overall Study|Failure to meet continuation criteria|1|||
146735710|NCT03881696|529203031|FG001|Overall Study|Failure to meet continuation criteria|0|||
146735711|NCT02202434|529205143|FG000|Overall Study|Death|70|||
146735712|NCT02202434|529205144|FG001|Overall Study|Death|39|||
146735713|NCT02202434|529205145|FG002|Overall Study|Death|13|||
146735714|NCT02202434|529205146|FG003|Overall Study|Death|27|||
146735715|NCT02202434|529205143|FG000|Overall Study|Lost to Follow-up|1|||
146735716|NCT02202434|529205144|FG001|Overall Study|Lost to Follow-up|1|||
146735717|NCT02202434|529205145|FG002|Overall Study|Lost to Follow-up|1|||
146735718|NCT02202434|529205146|FG003|Overall Study|Lost to Follow-up|0|||
146735719|NCT02202434|529205143|FG000|Overall Study|Physician Decision|2|||
146735720|NCT02202434|529205144|FG001|Overall Study|Physician Decision|3|||
146735721|NCT02202434|529205145|FG002|Overall Study|Physician Decision|0|||
146735722|NCT02202434|529205146|FG003|Overall Study|Physician Decision|0|||
146735723|NCT02202434|529205143|FG000|Overall Study|Withdrawal by Subject|13|||
146735724|NCT02202434|529205144|FG001|Overall Study|Withdrawal by Subject|14|||
146735725|NCT02202434|529205145|FG002|Overall Study|Withdrawal by Subject|1|||
146735726|NCT02202434|529205146|FG003|Overall Study|Withdrawal by Subject|4|||
146735727|NCT02202434|529205143|FG000|Overall Study|Completed Study|1|||
146735728|NCT02202434|529205144|FG001|Overall Study|Completed Study|0|||
146735729|NCT02202434|529205145|FG002|Overall Study|Completed Study|0|||
146735730|NCT02202434|529205146|FG003|Overall Study|Completed Study|0|||
146735731|NCT02202434|529205143|FG000|Overall Study|Visit Missed|21|||
146735732|NCT02202434|529205144|FG001|Overall Study|Visit Missed|12|||
146735733|NCT02202434|529205145|FG002|Overall Study|Visit Missed|0|||
146735734|NCT02202434|529205146|FG003|Overall Study|Visit Missed|5|||
146811698|NCT01393964|529481587|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
146811699|NCT04492475|529481590|FG000|Overall Study|Enrolled but not treated|8|||
146811700|NCT04492475|529481591|FG001|Overall Study|Enrolled but not treated|8|||
146811701|NCT04492475|529481590|FG000|Overall Study|Withdrawal by Subject|4|||
146811702|NCT04492475|529481591|FG001|Overall Study|Withdrawal by Subject|0|||
146811703|NCT04492475|529481590|FG000|Overall Study|Became ineligible after enrollment|2|||
146811704|NCT04492475|529481591|FG001|Overall Study|Became ineligible after enrollment|0|||
146811705|NCT03938272|529481600|FG000|Overall Study|Withdrawal by Subject|1|||
146811706|NCT03938272|529481601|FG001|Overall Study|Withdrawal by Subject|0|||
146811707|NCT03938272|529481600|FG000|Overall Study|Physician Decision|0|||
146811708|NCT03938272|529481601|FG001|Overall Study|Physician Decision|2|||
146811709|NCT03938272|529481600|FG000|Overall Study|Study termination by sponsor|10|||
146811710|NCT03938272|529481601|FG001|Overall Study|Study termination by sponsor|8|||
146811711|NCT01323790|529481609|FG000|Overall Study|Other|3|||
146811712|NCT01323790|529481610|FG001|Overall Study|Other|2|||
146811713|NCT01323790|529481611|FG002|Overall Study|Other|1|||
146811714|NCT01323790|529481609|FG000|Overall Study|Lost to Follow-up|11|||
146811715|NCT01323790|529481610|FG001|Overall Study|Lost to Follow-up|9|||
146811716|NCT01323790|529481611|FG002|Overall Study|Lost to Follow-up|9|||
146811717|NCT01323790|529481609|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
146811718|NCT01323790|529481610|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
146811719|NCT01323790|529481611|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
146811720|NCT01323790|529481609|FG000|Overall Study|Lack of Efficacy|3|||
146811721|NCT01323790|529481610|FG001|Overall Study|Lack of Efficacy|0|||
146811722|NCT01323790|529481611|FG002|Overall Study|Lack of Efficacy|3|||
146811723|NCT01323790|529481609|FG000|Overall Study|Adverse Event|11|||
146811724|NCT01323790|529481610|FG001|Overall Study|Adverse Event|24|||
146811725|NCT01323790|529481611|FG002|Overall Study|Adverse Event|12|||
146811726|NCT01323790|529481609|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
146811727|NCT01323790|529481610|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
146811728|NCT01323790|529481611|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
146811729|NCT01323790|529481609|FG000|Overall Study|Withdrawal by Subject|23|||
146811730|NCT01323790|529481610|FG001|Overall Study|Withdrawal by Subject|20|||
146811731|NCT01323790|529481611|FG002|Overall Study|Withdrawal by Subject|13|||
146811732|NCT01323790|529481609|FG000|Overall Study|Did Not Receive Treatment|2|||
146811733|NCT01323790|529481610|FG001|Overall Study|Did Not Receive Treatment|0|||
146811734|NCT01323790|529481611|FG002|Overall Study|Did Not Receive Treatment|1|||
146811735|NCT01323790|529481609|FG000|Overall Study|Severe non-compliance with protocol|2|||
146811736|NCT01323790|529481610|FG001|Overall Study|Severe non-compliance with protocol|2|||
146811737|NCT01323790|529481611|FG002|Overall Study|Severe non-compliance with protocol|2|||
146811738|NCT00266656|529481615|FG000|Overall Study|Death|1|||
146811739|NCT00266656|529481616|FG001|Overall Study|Death|0|||
146811740|NCT00266656|529481615|FG000|Overall Study|Lost to Follow-up|4|||
146811741|NCT00266656|529481616|FG001|Overall Study|Lost to Follow-up|1|||
146811742|NCT00266656|529481615|FG000|Overall Study|Withdrawal by Subject|4|||
146811743|NCT00266656|529481616|FG001|Overall Study|Withdrawal by Subject|2|||
146811744|NCT00266656|529481615|FG000|Overall Study|Did Not Reach Final Height|4|||
146811745|NCT00266656|529481616|FG001|Overall Study|Did Not Reach Final Height|8|||
146811746|NCT00266656|529481615|FG000|Overall Study|Parent/Caregiver Decision|1|||
146811747|NCT00266656|529481616|FG001|Overall Study|Parent/Caregiver Decision|2|||
146984294|NCT02826603|530103405|FG001|Overall Study|Noncompliance with treatment|2|||
146811748|NCT03242863|529481619|FG000|Study Week 1|Withdrawal by Subject|0|||
146811749|NCT03242863|529481620|FG001|Study Week 1|Withdrawal by Subject|1|||
146984295|NCT02826603|530103404|FG000|Overall Study|Physician Decision|1|||
146735735|NCT02202434|529205143|FG000|Overall Study|Other|1|||
146735736|NCT02202434|529205144|FG001|Overall Study|Other|0|||
146811750|NCT03242863|529481621|FG002|Study Week 1|Withdrawal by Subject|0|||
146811751|NCT03242863|529481622|FG003|Study Week 1|Withdrawal by Subject|0|||
146811752|NCT03242863|529481623|FG004|Study Week 1|Withdrawal by Subject|3|||
146811753|NCT03242863|529481624|FG005|Study Week 1|Withdrawal by Subject|0|||
146811754|NCT04852978|529481625|FG000|Overall Study|Physician Decision|0|||
146811755|NCT04852978|529481626|FG001|Overall Study|Physician Decision|1|||
146811756|NCT04852978|529481627|FG002|Overall Study|Physician Decision|0|||
146811757|NCT04852978|529481628|FG003|Overall Study|Physician Decision|0|||
146811758|NCT04852978|529481629|FG004|Overall Study|Physician Decision|0|||
146811759|NCT04852978|529481630|FG005|Overall Study|Physician Decision|0|||
146811760|NCT04852978|529481631|FG006|Overall Study|Physician Decision|0|||
146811761|NCT04852978|529481632|FG007|Overall Study|Physician Decision|2|||
146811762|NCT04852978|529481633|FG008|Overall Study|Physician Decision|0|||
146811763|NCT04852978|529481625|FG000|Overall Study|Sponsor request|0|||
146811764|NCT04852978|529481626|FG001|Overall Study|Sponsor request|0|||
146811765|NCT04852978|529481627|FG002|Overall Study|Sponsor request|1|||
146811766|NCT04852978|529481628|FG003|Overall Study|Sponsor request|0|||
146811767|NCT04852978|529481629|FG004|Overall Study|Sponsor request|0|||
146811768|NCT04852978|529481630|FG005|Overall Study|Sponsor request|0|||
146811769|NCT04852978|529481631|FG006|Overall Study|Sponsor request|0|||
146811770|NCT04852978|529481632|FG007|Overall Study|Sponsor request|0|||
146811771|NCT04852978|529481633|FG008|Overall Study|Sponsor request|0|||
146811772|NCT04852978|529481625|FG000|Overall Study|Death|0|||
146811773|NCT04852978|529481626|FG001|Overall Study|Death|0|||
146811774|NCT04852978|529481627|FG002|Overall Study|Death|0|||
146811775|NCT04852978|529481628|FG003|Overall Study|Death|0|||
146811776|NCT04852978|529481629|FG004|Overall Study|Death|0|||
146811777|NCT04852978|529481630|FG005|Overall Study|Death|0|||
146811778|NCT04852978|529481631|FG006|Overall Study|Death|1|||
146811779|NCT04852978|529481632|FG007|Overall Study|Death|0|||
146811780|NCT04852978|529481633|FG008|Overall Study|Death|0|||
146811781|NCT04852978|529481625|FG000|Overall Study|Lost to Follow-up|3|||
146811782|NCT04852978|529481626|FG001|Overall Study|Lost to Follow-up|2|||
146811783|NCT04852978|529481627|FG002|Overall Study|Lost to Follow-up|2|||
146811784|NCT04852978|529481628|FG003|Overall Study|Lost to Follow-up|0|||
146811785|NCT04852978|529481629|FG004|Overall Study|Lost to Follow-up|2|||
146811786|NCT04852978|529481630|FG005|Overall Study|Lost to Follow-up|4|||
146811787|NCT04852978|529481631|FG006|Overall Study|Lost to Follow-up|1|||
146811788|NCT04852978|529481632|FG007|Overall Study|Lost to Follow-up|2|||
146811789|NCT04852978|529481633|FG008|Overall Study|Lost to Follow-up|2|||
146811790|NCT04852978|529481625|FG000|Overall Study|Withdrawal by Subject|4|||
146811791|NCT04852978|529481626|FG001|Overall Study|Withdrawal by Subject|2|||
146811792|NCT04852978|529481627|FG002|Overall Study|Withdrawal by Subject|2|||
146811793|NCT04852978|529481628|FG003|Overall Study|Withdrawal by Subject|1|||
146811794|NCT04852978|529481629|FG004|Overall Study|Withdrawal by Subject|5|||
146811795|NCT04852978|529481630|FG005|Overall Study|Withdrawal by Subject|3|||
146811796|NCT04852978|529481631|FG006|Overall Study|Withdrawal by Subject|2|||
146811797|NCT04852978|529481632|FG007|Overall Study|Withdrawal by Subject|2|||
146811798|NCT04852978|529481633|FG008|Overall Study|Withdrawal by Subject|1|||
146811799|NCT00215943|529483052|FG000|Overall Study|Disease Progression|3|||
146811800|NCT00215943|529483053|FG001|Overall Study|Disease Progression|5|||
146811801|NCT00215943|529483052|FG000|Overall Study|Alternate therapy|0|||
146811802|NCT00215943|529483053|FG001|Overall Study|Alternate therapy|1|||
146811803|NCT00215943|529483052|FG000|Overall Study|Adverse Event|3|||
146811804|NCT00215943|529483053|FG001|Overall Study|Adverse Event|6|||
146811805|NCT00215943|529483052|FG000|Overall Study|Other disease|0|||
146811806|NCT00215943|529483053|FG001|Overall Study|Other disease|1|||
146811807|NCT00215943|529483052|FG000|Overall Study|Other complications|3|||
146811808|NCT00215943|529483053|FG001|Overall Study|Other complications|1|||
146811809|NCT04633200|529483054|FG000|Overall Study|Lost to Follow-up|3|||
146811810|NCT04633200|529483055|FG001|Overall Study|Lost to Follow-up|5|||
146811811|NCT02507297|529483056|FG000|Overall Study|Withdrawal by Subject|1|||
146811812|NCT02507297|529483057|FG001|Overall Study|Withdrawal by Subject|0|||
146811813|NCT02507297|529483056|FG000|Overall Study|Lost to Follow-up|0|||
146811814|NCT02507297|529483057|FG001|Overall Study|Lost to Follow-up|1|||
146811815|NCT02092285|529483058|FG000|Induction Phase|Adverse Event|7|||
146811816|NCT02092285|529483058|FG000|Induction Phase|Physician Decision|4|||
146811817|NCT02092285|529483058|FG000|Induction Phase|Pregnancy|1|||
146811818|NCT02092285|529483058|FG000|Induction Phase|Relapse/Recurrence|7|||
146811819|NCT02092285|529483058|FG000|Induction Phase|Withdrawal by Subject|2|||
146811820|NCT02092285|529483058|FG000|Induction Phase|Lack of Efficacy|14|||
146811821|NCT02092285|529483058|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
146811822|NCT02092285|529483058|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
146811823|NCT02092285|529483058|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
146944478|NCT01347073|529956351|FG000|Overall Study|Liver Transplant|1|||
146811824|NCT02092285|529483058|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
146811825|NCT02092285|529483058|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
146811826|NCT02092285|529483058|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
146811827|NCT02092285|529483058|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
146811828|NCT02092285|529483058|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
146811829|NCT02092285|529483058|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
146811830|NCT00087516|529483059|FG000|Overall Study|Adverse Event|10|||
146811831|NCT00087516|529483060|FG001|Overall Study|Adverse Event|10|||
146811832|NCT00087516|529483061|FG002|Overall Study|Adverse Event|3|||
146811833|NCT00087516|529483062|FG003|Overall Study|Adverse Event|6|||
146811834|NCT00087516|529483059|FG000|Overall Study|Lack of Efficacy|82|||
146811835|NCT00087516|529483060|FG001|Overall Study|Lack of Efficacy|80|||
146811836|NCT00087516|529483061|FG002|Overall Study|Lack of Efficacy|39|||
146811837|NCT00087516|529483062|FG003|Overall Study|Lack of Efficacy|29|||
146811838|NCT00087516|529483059|FG000|Overall Study|Lost to Follow-up|8|||
146811839|NCT00087516|529483060|FG001|Overall Study|Lost to Follow-up|6|||
146811840|NCT00087516|529483061|FG002|Overall Study|Lost to Follow-up|5|||
146811841|NCT00087516|529483062|FG003|Overall Study|Lost to Follow-up|5|||
146811842|NCT00087516|529483059|FG000|Overall Study|Protocol Violation|4|||
146811843|NCT00087516|529483060|FG001|Overall Study|Protocol Violation|8|||
146811844|NCT00087516|529483061|FG002|Overall Study|Protocol Violation|3|||
146811845|NCT00087516|529483062|FG003|Overall Study|Protocol Violation|6|||
146811846|NCT00087516|529483059|FG000|Overall Study|Withdrawal by Subject|16|||
146811847|NCT00087516|529483060|FG001|Overall Study|Withdrawal by Subject|27|||
146811848|NCT00087516|529483061|FG002|Overall Study|Withdrawal by Subject|11|||
146811849|NCT00087516|529483062|FG003|Overall Study|Withdrawal by Subject|12|||
146811850|NCT00087516|529483059|FG000|Overall Study|Site terminated|0|||
146811851|NCT00087516|529483060|FG001|Overall Study|Site terminated|2|||
146811852|NCT00087516|529483061|FG002|Overall Study|Site terminated|1|||
146811853|NCT00087516|529483062|FG003|Overall Study|Site terminated|0|||
146811854|NCT00087516|529483059|FG000|Overall Study|Protocol specified discontinuation|35|||
146811855|NCT00087516|529483060|FG001|Overall Study|Protocol specified discontinuation|33|||
146811856|NCT00087516|529483061|FG002|Overall Study|Protocol specified discontinuation|33|||
146811857|NCT00087516|529483062|FG003|Overall Study|Protocol specified discontinuation|26|||
146811858|NCT00087516|529483059|FG000|Overall Study|Patient moved|3|||
146811859|NCT00087516|529483060|FG001|Overall Study|Patient moved|2|||
146811860|NCT00087516|529483061|FG002|Overall Study|Patient moved|1|||
146811861|NCT00087516|529483062|FG003|Overall Study|Patient moved|0|||
146811862|NCT00087516|529483059|FG000|Overall Study|Patient was non-compliant|3|||
146811863|NCT00087516|529483060|FG001|Overall Study|Patient was non-compliant|1|||
146811864|NCT00087516|529483061|FG002|Overall Study|Patient was non-compliant|0|||
146811865|NCT00087516|529483062|FG003|Overall Study|Patient was non-compliant|0|||
146811866|NCT00087516|529483059|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
146811867|NCT00087516|529483060|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
146811868|NCT00087516|529483061|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
146811869|NCT00087516|529483062|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
146811870|NCT00087516|529483059|FG000|Overall Study|Other|0|||
146811871|NCT00087516|529483060|FG001|Overall Study|Other|0|||
146811872|NCT00087516|529483061|FG002|Overall Study|Other|1|||
146811873|NCT00087516|529483062|FG003|Overall Study|Other|0|||
146811874|NCT00278395|529483063|FG000|Overall Study|Adverse Event|2|||
146811875|NCT00278395|529483063|FG000|Overall Study|Nonevaluable|1|||
146811876|NCT01686152|529483066|FG000|Overall Study|Withdrawal by Subject|11|||
146811877|NCT01686152|529483067|FG001|Overall Study|Withdrawal by Subject|11|||
146811878|NCT01686152|529483068|FG002|Overall Study|Withdrawal by Subject|3|||
146811879|NCT01686152|529483066|FG000|Overall Study|Drug Code Unblinded|0|||
146811880|NCT01686152|529483067|FG001|Overall Study|Drug Code Unblinded|1|||
146811881|NCT01686152|529483068|FG002|Overall Study|Drug Code Unblinded|0|||
146811882|NCT01686152|529483066|FG000|Overall Study|Protocol Violation|6|||
146811883|NCT01686152|529483067|FG001|Overall Study|Protocol Violation|1|||
146811884|NCT01686152|529483068|FG002|Overall Study|Protocol Violation|0|||
146811885|NCT01686152|529483066|FG000|Overall Study|Adverse Event|12|||
146811886|NCT01686152|529483067|FG001|Overall Study|Adverse Event|11|||
146811887|NCT01686152|529483068|FG002|Overall Study|Adverse Event|0|||
146811888|NCT01686152|529483066|FG000|Overall Study|Lack of Efficacy|0|||
146811889|NCT01686152|529483067|FG001|Overall Study|Lack of Efficacy|0|||
146811890|NCT01686152|529483068|FG002|Overall Study|Lack of Efficacy|1|||
146811891|NCT01686152|529483066|FG000|Overall Study|IP Non-compliance|5|||
146811892|NCT01686152|529483067|FG001|Overall Study|IP Non-compliance|5|||
146811893|NCT01686152|529483068|FG002|Overall Study|IP Non-compliance|0|||
146811894|NCT01686152|529483066|FG000|Overall Study|Lost to Follow-up|7|||
146811895|NCT01686152|529483067|FG001|Overall Study|Lost to Follow-up|6|||
146811896|NCT01686152|529483068|FG002|Overall Study|Lost to Follow-up|5|||
146811897|NCT02784834|529483072|FG000|Overall Study|Lack of Efficacy|1|||
146811898|NCT02143713|529483073|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
146811899|NCT02143713|529483074|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
146811900|NCT02143713|529483075|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
146811901|NCT02143713|529483076|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
146811902|NCT02143713|529483073|FG000|Treatment Period (6 Months)|Adverse Event|7|||
146811903|NCT02143713|529483074|FG001|Treatment Period (6 Months)|Adverse Event|8|||
146811904|NCT02143713|529483075|FG002|Treatment Period (6 Months)|Adverse Event|8|||
146811905|NCT02143713|529483076|FG003|Treatment Period (6 Months)|Adverse Event|9|||
146811906|NCT02143713|529483073|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
146811907|NCT02143713|529483074|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
146811908|NCT02143713|529483075|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
146811909|NCT02143713|529483076|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
146811910|NCT02143713|529483073|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
146811911|NCT02143713|529483074|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
146811912|NCT02143713|529483075|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
146811913|NCT02143713|529483076|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
146811914|NCT02143713|529483073|FG000|Treatment Period (6 Months)|Pregnancy|0|||
146811915|NCT02143713|529483074|FG001|Treatment Period (6 Months)|Pregnancy|2|||
146811916|NCT02143713|529483075|FG002|Treatment Period (6 Months)|Pregnancy|2|||
146811917|NCT02143713|529483076|FG003|Treatment Period (6 Months)|Pregnancy|0|||
146811918|NCT02143713|529483073|FG000|Treatment Period (6 Months)|Non-compliance|1|||
146811919|NCT02143713|529483074|FG001|Treatment Period (6 Months)|Non-compliance|0|||
146811920|NCT02143713|529483075|FG002|Treatment Period (6 Months)|Non-compliance|0|||
146811921|NCT02143713|529483076|FG003|Treatment Period (6 Months)|Non-compliance|3|||
146811922|NCT02143713|529483073|FG000|Treatment Period (6 Months)|Other|3|||
146811923|NCT02143713|529483074|FG001|Treatment Period (6 Months)|Other|0|||
146811924|NCT02143713|529483075|FG002|Treatment Period (6 Months)|Other|3|||
146811925|NCT02143713|529483076|FG003|Treatment Period (6 Months)|Other|2|||
146811926|NCT02143713|529483073|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
146811927|NCT02143713|529483074|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
146811928|NCT02143713|529483075|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
146811929|NCT02143713|529483076|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
146811930|NCT02143713|529483073|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
146811931|NCT02143713|529483074|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
146811932|NCT02143713|529483075|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
146811933|NCT02143713|529483076|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
146811934|NCT02143713|529483073|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
146811935|NCT02143713|529483074|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
146811936|NCT02143713|529483075|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
146811937|NCT02143713|529483076|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
146811938|NCT02143713|529483073|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
146811939|NCT02143713|529483074|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
146811940|NCT02143713|529483075|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
146811941|NCT02143713|529483076|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
146811942|NCT02143713|529483073|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
146811943|NCT02143713|529483074|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
146811944|NCT02143713|529483075|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
146811945|NCT02143713|529483076|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
146811946|NCT02143713|529483073|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
146811947|NCT02143713|529483074|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
146811948|NCT02143713|529483075|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
146811949|NCT02143713|529483076|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
146811950|NCT02143713|529483073|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
146811951|NCT02143713|529483074|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
146811952|NCT02143713|529483075|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
146811953|NCT02143713|529483076|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
146811954|NCT02143713|529483073|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
146811955|NCT02143713|529483074|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
146811956|NCT02143713|529483075|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
146811957|NCT02143713|529483076|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
146811958|NCT02143713|529483073|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
146811959|NCT02143713|529483074|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
146811960|NCT02143713|529483075|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
146811961|NCT02143713|529483076|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
146811962|NCT01768572|529483079|FG000|Overall Study|Adverse Event|7|||
146811963|NCT01768572|529483080|FG001|Overall Study|Adverse Event|8|||
146811964|NCT01768572|529483081|FG002|Overall Study|Adverse Event|4|||
146811965|NCT01768572|529483079|FG000|Overall Study|Lack of Efficacy|1|||
146811966|NCT01768572|529483080|FG001|Overall Study|Lack of Efficacy|3|||
146811967|NCT01768572|529483081|FG002|Overall Study|Lack of Efficacy|1|||
146811968|NCT01768572|529483079|FG000|Overall Study|Other, Not due to an adverse event|1|||
146811969|NCT01768572|529483080|FG001|Overall Study|Other, Not due to an adverse event|1|||
146811970|NCT01768572|529483081|FG002|Overall Study|Other, Not due to an adverse event|1|||
146811971|NCT00080119|529483082|FG000|Overall Study|Discontinued because of study closure|0|||
146811972|NCT00080119|529483083|FG001|Overall Study|Discontinued because of study closure|0|||
146811973|NCT00080119|529483084|FG002|Overall Study|Discontinued because of study closure|130|||
146811974|NCT00080119|529483085|FG003|Overall Study|Discontinued because of study closure|141|||
146811975|NCT00080119|529483082|FG000|Overall Study|Unable to get to clinic|24|||
146811976|NCT00080119|529483083|FG001|Overall Study|Unable to get to clinic|24|||
146811977|NCT00080119|529483084|FG002|Overall Study|Unable to get to clinic|7|||
146811978|NCT00080119|529483085|FG003|Overall Study|Unable to get to clinic|1|||
146811979|NCT00080119|529483082|FG000|Overall Study|Consent withdrawn|13|||
146811980|NCT00080119|529483083|FG001|Overall Study|Consent withdrawn|17|||
146811981|NCT00080119|529483084|FG002|Overall Study|Consent withdrawn|4|||
146811982|NCT00080119|529483085|FG003|Overall Study|Consent withdrawn|6|||
146811983|NCT00080119|529483082|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
146811984|NCT00080119|529483083|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
146811985|NCT00080119|529483084|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
146811986|NCT00080119|529483085|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
146811987|NCT00080119|529483082|FG000|Overall Study|Lost to Follow-up|16|||
146811988|NCT00080119|529483083|FG001|Overall Study|Lost to Follow-up|19|||
146811989|NCT00080119|529483084|FG002|Overall Study|Lost to Follow-up|19|||
146811990|NCT00080119|529483085|FG003|Overall Study|Lost to Follow-up|14|||
146811991|NCT01322386|529483086|FG000|Overall Study|Protocol Violation|0|||
146811992|NCT01322386|529483087|FG001|Overall Study|Protocol Violation|1|||
146811993|NCT01322386|529483086|FG000|Overall Study|Physician Decision|0|||
146811994|NCT01322386|529483087|FG001|Overall Study|Physician Decision|1|||
146811995|NCT02988713|529483094|FG000|Overall Study|Withdrawal by Subject|1|||
146811996|NCT02988713|529483094|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
146811997|NCT02404441|529483095|FG000|Phase 1 Part|Adverse Event|1|||
146811998|NCT02404441|529483096|FG001|Phase 1 Part|Adverse Event|0|||
146811999|NCT02404441|529483097|FG002|Phase 1 Part|Adverse Event|0|||
146812000|NCT02404441|529483098|FG003|Phase 1 Part|Adverse Event|0|||
146812001|NCT02404441|529483099|FG004|Phase 1 Part|Adverse Event|0|||
146812002|NCT02404441|529483100|FG005|Phase 1 Part|Adverse Event|0|||
146812003|NCT02404441|529483101|FG006|Phase 1 Part|Adverse Event|0|||
146812004|NCT02404441|529483102|FG007|Phase 1 Part|Adverse Event|0|||
146812005|NCT02404441|529483103|FG008|Phase 1 Part|Adverse Event|0|||
146812006|NCT02404441|529483104|FG009|Phase 1 Part|Adverse Event|0|||
146812007|NCT02404441|529483095|FG000|Phase 1 Part|Physician Decision|0|||
146812008|NCT02404441|529483096|FG001|Phase 1 Part|Physician Decision|1|||
146812009|NCT02404441|529483097|FG002|Phase 1 Part|Physician Decision|0|||
146812010|NCT02404441|529483098|FG003|Phase 1 Part|Physician Decision|0|||
146812011|NCT02404441|529483099|FG004|Phase 1 Part|Physician Decision|0|||
146812012|NCT02404441|529483100|FG005|Phase 1 Part|Physician Decision|0|||
146812013|NCT02404441|529483101|FG006|Phase 1 Part|Physician Decision|0|||
146812014|NCT02404441|529483102|FG007|Phase 1 Part|Physician Decision|0|||
146812015|NCT02404441|529483103|FG008|Phase 1 Part|Physician Decision|0|||
146812016|NCT02404441|529483104|FG009|Phase 1 Part|Physician Decision|0|||
146812017|NCT02404441|529483095|FG000|Phase 1 Part|Progressive Disease|14|||
146812018|NCT02404441|529483096|FG001|Phase 1 Part|Progressive Disease|11|||
146812019|NCT02404441|529483097|FG002|Phase 1 Part|Progressive Disease|7|||
146812020|NCT02404441|529483098|FG003|Phase 1 Part|Progressive Disease|6|||
146812021|NCT02404441|529483099|FG004|Phase 1 Part|Progressive Disease|9|||
146812022|NCT02404441|529483100|FG005|Phase 1 Part|Progressive Disease|0|||
146812023|NCT02404441|529483101|FG006|Phase 1 Part|Progressive Disease|0|||
146812024|NCT02404441|529483102|FG007|Phase 1 Part|Progressive Disease|0|||
146812025|NCT02404441|529483103|FG008|Phase 1 Part|Progressive Disease|0|||
146812026|NCT02404441|529483104|FG009|Phase 1 Part|Progressive Disease|0|||
146812027|NCT02404441|529483095|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
146812028|NCT02404441|529483096|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
146812029|NCT02404441|529483097|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
146812030|NCT02404441|529483098|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
146812031|NCT02404441|529483099|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
146812032|NCT02404441|529483100|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
146812033|NCT02404441|529483101|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
146812034|NCT02404441|529483102|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
146812035|NCT02404441|529483103|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
146812036|NCT02404441|529483104|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
146812037|NCT02404441|529483095|FG000|Phase 1 Part|Death|1|||
146812038|NCT02404441|529483096|FG001|Phase 1 Part|Death|1|||
146812039|NCT02404441|529483097|FG002|Phase 1 Part|Death|1|||
146812040|NCT02404441|529483098|FG003|Phase 1 Part|Death|0|||
146812041|NCT02404441|529483099|FG004|Phase 1 Part|Death|1|||
146812042|NCT02404441|529483100|FG005|Phase 1 Part|Death|0|||
146812043|NCT02404441|529483101|FG006|Phase 1 Part|Death|0|||
146812044|NCT02404441|529483102|FG007|Phase 1 Part|Death|0|||
146812045|NCT02404441|529483103|FG008|Phase 1 Part|Death|0|||
146812046|NCT02404441|529483104|FG009|Phase 1 Part|Death|0|||
146812047|NCT02404441|529483095|FG000|Phase 2 Part|Adverse Event|0|||
146812048|NCT02404441|529483096|FG001|Phase 2 Part|Adverse Event|0|||
146812049|NCT02404441|529483097|FG002|Phase 2 Part|Adverse Event|0|||
146812050|NCT02404441|529483098|FG003|Phase 2 Part|Adverse Event|0|||
146812051|NCT02404441|529483099|FG004|Phase 2 Part|Adverse Event|0|||
146812052|NCT02404441|529483100|FG005|Phase 2 Part|Adverse Event|2|||
146812053|NCT02404441|529483101|FG006|Phase 2 Part|Adverse Event|3|||
146812054|NCT02404441|529483102|FG007|Phase 2 Part|Adverse Event|3|||
146812055|NCT02404441|529483103|FG008|Phase 2 Part|Adverse Event|6|||
146812056|NCT02404441|529483104|FG009|Phase 2 Part|Adverse Event|1|||
146812057|NCT02404441|529483095|FG000|Phase 2 Part|Physician Decision|0|||
146812058|NCT02404441|529483096|FG001|Phase 2 Part|Physician Decision|0|||
146812059|NCT02404441|529483097|FG002|Phase 2 Part|Physician Decision|0|||
146812060|NCT02404441|529483098|FG003|Phase 2 Part|Physician Decision|0|||
146812061|NCT02404441|529483099|FG004|Phase 2 Part|Physician Decision|0|||
146812062|NCT02404441|529483100|FG005|Phase 2 Part|Physician Decision|7|||
146812063|NCT02404441|529483101|FG006|Phase 2 Part|Physician Decision|9|||
146812064|NCT02404441|529483102|FG007|Phase 2 Part|Physician Decision|2|||
146812065|NCT02404441|529483103|FG008|Phase 2 Part|Physician Decision|1|||
146812066|NCT02404441|529483104|FG009|Phase 2 Part|Physician Decision|3|||
146812067|NCT02404441|529483095|FG000|Phase 2 Part|Progressive disease|0|||
146812068|NCT02404441|529483096|FG001|Phase 2 Part|Progressive disease|0|||
146812069|NCT02404441|529483097|FG002|Phase 2 Part|Progressive disease|0|||
146812070|NCT02404441|529483098|FG003|Phase 2 Part|Progressive disease|0|||
146812071|NCT02404441|529483099|FG004|Phase 2 Part|Progressive disease|0|||
146812072|NCT02404441|529483100|FG005|Phase 2 Part|Progressive disease|43|||
146812073|NCT02404441|529483101|FG006|Phase 2 Part|Progressive disease|32|||
146812074|NCT02404441|529483102|FG007|Phase 2 Part|Progressive disease|31|||
146812075|NCT02404441|529483103|FG008|Phase 2 Part|Progressive disease|39|||
146812076|NCT02404441|529483104|FG009|Phase 2 Part|Progressive disease|27|||
146812077|NCT02404441|529483095|FG000|Phase 2 Part|Subject/guardian decision|0|||
146812078|NCT02404441|529483096|FG001|Phase 2 Part|Subject/guardian decision|0|||
146812079|NCT02404441|529483097|FG002|Phase 2 Part|Subject/guardian decision|0|||
146812080|NCT02404441|529483098|FG003|Phase 2 Part|Subject/guardian decision|0|||
146812081|NCT02404441|529483099|FG004|Phase 2 Part|Subject/guardian decision|0|||
146812082|NCT02404441|529483100|FG005|Phase 2 Part|Subject/guardian decision|3|||
146812083|NCT02404441|529483101|FG006|Phase 2 Part|Subject/guardian decision|9|||
146812084|NCT02404441|529483102|FG007|Phase 2 Part|Subject/guardian decision|0|||
146812085|NCT02404441|529483103|FG008|Phase 2 Part|Subject/guardian decision|3|||
146812086|NCT02404441|529483104|FG009|Phase 2 Part|Subject/guardian decision|2|||
146812087|NCT02404441|529483095|FG000|Phase 2 Part|Death|0|||
146812088|NCT02404441|529483096|FG001|Phase 2 Part|Death|0|||
146812089|NCT02404441|529483097|FG002|Phase 2 Part|Death|0|||
146812090|NCT02404441|529483098|FG003|Phase 2 Part|Death|0|||
146812091|NCT02404441|529483099|FG004|Phase 2 Part|Death|0|||
146812092|NCT02404441|529483100|FG005|Phase 2 Part|Death|4|||
146812093|NCT02404441|529483101|FG006|Phase 2 Part|Death|8|||
146812094|NCT02404441|529483102|FG007|Phase 2 Part|Death|4|||
146812095|NCT02404441|529483103|FG008|Phase 2 Part|Death|10|||
146812096|NCT02404441|529483104|FG009|Phase 2 Part|Death|9|||
146812097|NCT01918033|529483105|FG000|Overall Study|Adverse Event|1|||
146812098|NCT01918033|529483106|FG001|Overall Study|Adverse Event|0|||
146812099|NCT01918033|529483107|FG002|Overall Study|Adverse Event|2|||
146812100|NCT01918033|529483105|FG000|Overall Study|Lost to Follow-up|0|||
146812101|NCT01918033|529483106|FG001|Overall Study|Lost to Follow-up|1|||
146812102|NCT01918033|529483107|FG002|Overall Study|Lost to Follow-up|0|||
146812103|NCT01918033|529483105|FG000|Overall Study|Protocol Violation|2|||
146812104|NCT01918033|529483106|FG001|Overall Study|Protocol Violation|0|||
146812105|NCT01918033|529483107|FG002|Overall Study|Protocol Violation|1|||
146812106|NCT01918033|529483105|FG000|Overall Study|Withdrawal by Subject|2|||
146812107|NCT01918033|529483106|FG001|Overall Study|Withdrawal by Subject|1|||
146812108|NCT01918033|529483107|FG002|Overall Study|Withdrawal by Subject|0|||
146812109|NCT03265132|529483108|FG000|Overall Study|Adverse Event|0|||
146812110|NCT03265132|529483109|FG001|Overall Study|Adverse Event|1|||
146812111|NCT03265132|529483108|FG000|Overall Study|Lack of Efficacy|0|||
146812112|NCT03265132|529483109|FG001|Overall Study|Lack of Efficacy|2|||
146812113|NCT03265132|529483108|FG000|Overall Study|Progressive disease|0|||
146812114|NCT03265132|529483109|FG001|Overall Study|Progressive disease|2|||
146812115|NCT03265132|529483108|FG000|Overall Study|Withdrawal by Subject|0|||
146812116|NCT03265132|529483109|FG001|Overall Study|Withdrawal by Subject|1|||
146812117|NCT01976507|529483113|FG000|Overall Study|Adverse Event|6|||
146812118|NCT01976507|529483113|FG000|Overall Study|ablation not done, drug not given|1|||
146812119|NCT01794299|529483115|FG000|Overall Study|ATIR manufacturing not possible|1|||
146812120|NCT01794299|529483115|FG000|Overall Study|Death|14|||
146812121|NCT01794299|529483115|FG000|Overall Study|Graft failure|1|||
146944479|NCT00621244|529956353|FG000|Overall Study|Withdrawal by Subject|7|||
146944480|NCT00621244|529956354|FG001|Overall Study|Withdrawal by Subject|3|||
146944481|NCT00621244|529956355|FG002|Overall Study|Withdrawal by Subject|3|||
146812122|NCT01794299|529483115|FG000|Overall Study|ATIR batch rejected|2|||
146812123|NCT01794299|529483115|FG000|Overall Study|Relapse|2|||
146812124|NCT01794299|529483115|FG000|Overall Study|Discontinued from active follow-up|1|||
146812125|NCT01794299|529483115|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
146812126|NCT03006393|529483116|FG000|Overall Study|Withdrawal by Subject|1|||
146812127|NCT03006393|529483117|FG001|Overall Study|Withdrawal by Subject|1|||
146812128|NCT03006393|529483116|FG000|Overall Study|Pregnancy|0|||
146812129|NCT03006393|529483117|FG001|Overall Study|Pregnancy|1|||
146812130|NCT03006393|529483116|FG000|Overall Study|Lost to Follow-up|0|||
146812131|NCT03006393|529483117|FG001|Overall Study|Lost to Follow-up|1|||
146812132|NCT02161458|529483118|FG000|Overall Study|Withdrawal by Subject|0|||
146812133|NCT02161458|529483119|FG001|Overall Study|Withdrawal by Subject|4|||
146812134|NCT02161458|529483120|FG002|Overall Study|Withdrawal by Subject|4|||
146812135|NCT02161458|529483121|FG003|Overall Study|Withdrawal by Subject|0|||
146812136|NCT02161458|529483118|FG000|Overall Study|Lost to Follow-up|0|||
146812137|NCT02161458|529483119|FG001|Overall Study|Lost to Follow-up|2|||
146812138|NCT02161458|529483120|FG002|Overall Study|Lost to Follow-up|1|||
146812139|NCT02161458|529483121|FG003|Overall Study|Lost to Follow-up|0|||
146812140|NCT03136861|529483125|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
146812141|NCT03136861|529483126|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
146812142|NCT03136861|529483127|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
146812143|NCT03136861|529483128|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
146812144|NCT03136861|529483129|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
146812145|NCT03136861|529483130|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
146812146|NCT03136861|529483131|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
146812147|NCT03136861|529483125|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
146812148|NCT03136861|529483126|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
146812149|NCT03136861|529483127|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
146812150|NCT03136861|529483128|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
146812151|NCT03136861|529483129|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
146812152|NCT03136861|529483130|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
146812153|NCT03136861|529483131|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
146812154|NCT03136861|529483125|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
146812155|NCT03136861|529483126|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
146812156|NCT03136861|529483127|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
146812157|NCT03136861|529483128|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
146812158|NCT03136861|529483129|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
146812159|NCT03136861|529483130|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
146812160|NCT03136861|529483131|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
146812161|NCT03136861|529483125|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
146812162|NCT03136861|529483126|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
146812163|NCT03136861|529483127|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
146812164|NCT03136861|529483128|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
146812165|NCT03136861|529483129|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
146812166|NCT03136861|529483130|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
146812167|NCT03136861|529483131|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
146812168|NCT03136861|529483125|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
146812169|NCT03136861|529483126|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
146812170|NCT03136861|529483127|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
146812171|NCT03136861|529483128|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
146812172|NCT03136861|529483129|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
146812173|NCT03136861|529483130|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
146812174|NCT03136861|529483131|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
146812175|NCT03136861|529483125|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
146812176|NCT03136861|529483126|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
146812177|NCT03136861|529483127|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
146812178|NCT03136861|529483128|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
146812179|NCT03136861|529483129|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
146812180|NCT03136861|529483130|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
146812181|NCT03136861|529483131|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
146812182|NCT03136861|529483125|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
146812183|NCT03136861|529483126|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
146812184|NCT03136861|529483127|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
146812185|NCT03136861|529483128|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
146812186|NCT03136861|529483129|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
146812187|NCT03136861|529483130|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
146812188|NCT03136861|529483131|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
146812189|NCT03136861|529483125|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
146812190|NCT03136861|529483126|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
146812191|NCT03136861|529483127|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
146812192|NCT03136861|529483128|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
146812193|NCT03136861|529483129|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
146848466|NCT00548262|529615690|FG000|Overall Study|Withdrawal by Subject|1|||
146812194|NCT03136861|529483130|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
146812195|NCT03136861|529483131|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
146812196|NCT03390166|529483132|FG000|Overall Study|Death|0|||
146812197|NCT03390166|529483133|FG001|Overall Study|Death|1|||
146812198|NCT03390166|529483132|FG000|Overall Study|Lost to Follow-up|6|||
146812199|NCT03390166|529483133|FG001|Overall Study|Lost to Follow-up|4|||
146812200|NCT03390166|529483132|FG000|Overall Study|Physician Decision|2|||
146812201|NCT03390166|529483133|FG001|Overall Study|Physician Decision|1|||
146812202|NCT03390166|529483132|FG000|Overall Study|Move from study area|3|||
146812203|NCT03390166|529483133|FG001|Overall Study|Move from study area|2|||
146812204|NCT03390166|529483132|FG000|Overall Study|To militarycamp for conscript|1|||
146812205|NCT03390166|529483133|FG001|Overall Study|To militarycamp for conscript|0|||
146812206|NCT03390166|529483132|FG000|Overall Study|To drug therapy course|0|||
146812207|NCT03390166|529483133|FG001|Overall Study|To drug therapy course|1|||
146812208|NCT03390166|529483132|FG000|Overall Study|Move to work oversea|0|||
146812209|NCT03390166|529483133|FG001|Overall Study|Move to work oversea|1|||
146812210|NCT03692871|529483140|FG000|Overall Study|Death|1|||
146812211|NCT03692871|529483141|FG001|Overall Study|Death|1|||
146812212|NCT03692871|529483140|FG000|Overall Study|Lost to Follow-up|24|||
146812213|NCT03692871|529483141|FG001|Overall Study|Lost to Follow-up|9|||
146812214|NCT03692871|529483140|FG000|Overall Study|Physician Decision|22|||
146812215|NCT03692871|529483141|FG001|Overall Study|Physician Decision|7|||
146812216|NCT03692871|529483140|FG000|Overall Study|Protocol Deviation|1|||
146812217|NCT03692871|529483141|FG001|Overall Study|Protocol Deviation|0|||
146812218|NCT03692871|529483140|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
146812219|NCT03692871|529483141|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
146812220|NCT02852824|529483142|FG000|Overall Study|Withdrawal by Subject|1|||
146812221|NCT02852824|529483143|FG001|Overall Study|Withdrawal by Subject|0|||
146812222|NCT02852824|529483144|FG002|Overall Study|Withdrawal by Subject|0|||
146812223|NCT02852824|529483145|FG003|Overall Study|Withdrawal by Subject|0|||
146812224|NCT02852824|529483146|FG004|Overall Study|Withdrawal by Subject|0|||
146812225|NCT02852824|529483147|FG005|Overall Study|Withdrawal by Subject|0|||
146812226|NCT02852824|529483148|FG006|Overall Study|Withdrawal by Subject|0|||
146812227|NCT02852824|529483142|FG000|Overall Study|Adverse Event|0|||
146812228|NCT02852824|529483143|FG001|Overall Study|Adverse Event|0|||
146812229|NCT02852824|529483144|FG002|Overall Study|Adverse Event|0|||
146812230|NCT02852824|529483145|FG003|Overall Study|Adverse Event|0|||
146812231|NCT02852824|529483146|FG004|Overall Study|Adverse Event|2|||
146812232|NCT02852824|529483147|FG005|Overall Study|Adverse Event|0|||
146812233|NCT02852824|529483148|FG006|Overall Study|Adverse Event|0|||
146812234|NCT01316913|529483149|FG000|Overall Study|Adverse Event|17|||
146812235|NCT01316913|529483150|FG001|Overall Study|Adverse Event|20|||
146812236|NCT01316913|529483151|FG002|Overall Study|Adverse Event|15|||
146812237|NCT01316913|529483152|FG003|Overall Study|Adverse Event|11|||
146812238|NCT01316913|529483149|FG000|Overall Study|Lack of Efficacy|22|||
146812239|NCT01316913|529483150|FG001|Overall Study|Lack of Efficacy|12|||
146812240|NCT01316913|529483151|FG002|Overall Study|Lack of Efficacy|9|||
146812241|NCT01316913|529483152|FG003|Overall Study|Lack of Efficacy|13|||
146812242|NCT01316913|529483149|FG000|Overall Study|Protocol Violation|1|||
146812243|NCT01316913|529483150|FG001|Overall Study|Protocol Violation|4|||
146812244|NCT01316913|529483151|FG002|Overall Study|Protocol Violation|4|||
146812245|NCT01316913|529483152|FG003|Overall Study|Protocol Violation|1|||
146812246|NCT01316913|529483149|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
146812247|NCT01316913|529483150|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
146812248|NCT01316913|529483151|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
146812249|NCT01316913|529483152|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
146812250|NCT01316913|529483149|FG000|Overall Study|Lost to Follow-up|0|||
146812251|NCT01316913|529483150|FG001|Overall Study|Lost to Follow-up|1|||
146812252|NCT01316913|529483151|FG002|Overall Study|Lost to Follow-up|0|||
146812253|NCT01316913|529483152|FG003|Overall Study|Lost to Follow-up|2|||
146812254|NCT01316913|529483149|FG000|Overall Study|Withdrawal by Subject|10|||
146812255|NCT01316913|529483150|FG001|Overall Study|Withdrawal by Subject|9|||
146812256|NCT01316913|529483151|FG002|Overall Study|Withdrawal by Subject|10|||
146984296|NCT02826603|530103405|FG001|Overall Study|Physician Decision|7|||
146812257|NCT01316913|529483152|FG003|Overall Study|Withdrawal by Subject|6|||
146812258|NCT05445557|529483153|FG000|Double Blind Part|Lost to Follow-up|1|||
146812259|NCT02915783|529483154|FG000|Overall Study|Death|21|||
146812260|NCT02915783|529483154|FG000|Overall Study|Lost to Follow-up|1|||
146812261|NCT02915783|529483154|FG000|Overall Study|Withdrawal by Subject|2|||
146812262|NCT02950961|529483156|FG000|Overall Study|Study had to stop due to COVID.|7|||
146812263|NCT03055988|529483157|FG000|Period 1|Adverse Event|0|||
146812264|NCT03055988|529483158|FG001|Period 1|Adverse Event|1|||
146812265|NCT03055988|529483157|FG000|Period 1|Lost to Follow-up|1|||
146812266|NCT03055988|529483158|FG001|Period 1|Lost to Follow-up|0|||
146812267|NCT03055988|529483157|FG000|Period 1|Withdrawal by Subject|0|||
146812268|NCT03055988|529483158|FG001|Period 1|Withdrawal by Subject|4|||
146812269|NCT03055988|529483157|FG000|Period 2|Adverse Event|0|||
146812270|NCT03055988|529483158|FG001|Period 2|Adverse Event|1|||
146812271|NCT03055988|529483157|FG000|Period 2|Other than listed|1|||
146812272|NCT03055988|529483158|FG001|Period 2|Other than listed|1|||
146812273|NCT01915914|529483161|FG000|Acute Phase|Withdrawal by Subject|4|||
146812274|NCT01915914|529483162|FG001|Acute Phase|Withdrawal by Subject|0|||
146812275|NCT01915914|529483163|FG002|Acute Phase|Withdrawal by Subject|0|||
146812276|NCT01915914|529483164|FG003|Acute Phase|Withdrawal by Subject|0|||
146812277|NCT01915914|529483161|FG000|Acute Phase|Lost to Follow-up|4|||
146812278|NCT01915914|529483162|FG001|Acute Phase|Lost to Follow-up|0|||
146812279|NCT01915914|529483163|FG002|Acute Phase|Lost to Follow-up|0|||
146812280|NCT01915914|529483164|FG003|Acute Phase|Lost to Follow-up|0|||
146812281|NCT01915914|529483161|FG000|Acute Phase|Physician Decision|1|||
146812282|NCT01915914|529483162|FG001|Acute Phase|Physician Decision|0|||
146812283|NCT01915914|529483163|FG002|Acute Phase|Physician Decision|0|||
146812284|NCT01915914|529483164|FG003|Acute Phase|Physician Decision|0|||
146812285|NCT01915914|529483161|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
146812286|NCT01915914|529483162|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
146812287|NCT01915914|529483163|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
146812288|NCT01915914|529483164|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
146812289|NCT01915914|529483161|FG000|Acute Phase|"Not Achieved treatment success"|1|||
146812290|NCT01915914|529483162|FG001|Acute Phase|"Not Achieved treatment success"|0|||
146812291|NCT01915914|529483163|FG002|Acute Phase|"Not Achieved treatment success"|0|||
146812292|NCT01915914|529483164|FG003|Acute Phase|"Not Achieved treatment success"|0|||
146812293|NCT01915914|529483161|FG000|Acute Phase|Missing|1|||
146812294|NCT01915914|529483162|FG001|Acute Phase|Missing|0|||
146812295|NCT01915914|529483163|FG002|Acute Phase|Missing|0|||
146812296|NCT01915914|529483164|FG003|Acute Phase|Missing|0|||
146812297|NCT01915914|529483161|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146812298|NCT01915914|529483162|FG001|Maintenance Phase|Withdrawal by Subject|1|||
146812299|NCT01915914|529483163|FG002|Maintenance Phase|Withdrawal by Subject|1|||
146812300|NCT01915914|529483164|FG003|Maintenance Phase|Withdrawal by Subject|0|||
146812301|NCT01915914|529483161|FG000|Maintenance Phase|Lost to Follow-up|0|||
146812302|NCT01915914|529483162|FG001|Maintenance Phase|Lost to Follow-up|4|||
146812303|NCT01915914|529483163|FG002|Maintenance Phase|Lost to Follow-up|1|||
146812304|NCT01915914|529483164|FG003|Maintenance Phase|Lost to Follow-up|0|||
146812305|NCT01915914|529483161|FG000|Maintenance Phase|Missing|0|||
146812306|NCT01915914|529483162|FG001|Maintenance Phase|Missing|1|||
146812307|NCT01915914|529483163|FG002|Maintenance Phase|Missing|0|||
146812308|NCT01915914|529483164|FG003|Maintenance Phase|Missing|0|||
146812309|NCT01915914|529483161|FG000|Follow-up Phase|Withdrawal by Subject|0|||
146812310|NCT01915914|529483162|FG001|Follow-up Phase|Withdrawal by Subject|0|||
146812311|NCT01915914|529483163|FG002|Follow-up Phase|Withdrawal by Subject|0|||
146812312|NCT01915914|529483164|FG003|Follow-up Phase|Withdrawal by Subject|1|||
146812313|NCT01915914|529483161|FG000|Follow-up Phase|Physician Decision|0|||
146812314|NCT01915914|529483162|FG001|Follow-up Phase|Physician Decision|0|||
146812315|NCT01915914|529483163|FG002|Follow-up Phase|Physician Decision|0|||
146812316|NCT01915914|529483164|FG003|Follow-up Phase|Physician Decision|1|||
146812317|NCT00428714|529483166|FG000|Overall Study|Progressive Disease|28|||
146812318|NCT00428714|529483167|FG001|Overall Study|Progressive Disease|36|||
146812319|NCT00428714|529483166|FG000|Overall Study|Withdrawal by Subject|0|||
146812320|NCT00428714|529483167|FG001|Overall Study|Withdrawal by Subject|3|||
146812321|NCT00428714|529483166|FG000|Overall Study|Adverse Event|0|||
146812322|NCT00428714|529483167|FG001|Overall Study|Adverse Event|2|||
146812323|NCT00428714|529483166|FG000|Overall Study|Physician Decision|1|||
146812324|NCT00428714|529483167|FG001|Overall Study|Physician Decision|1|||
146812325|NCT00428714|529483166|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
146812326|NCT00428714|529483167|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
146812327|NCT00428714|529483166|FG000|Overall Study|Death due to other then PD|1|||
146812328|NCT00428714|529483167|FG001|Overall Study|Death due to other then PD|0|||
146812329|NCT01736475|529483170|FG000|Overall Study|Adverse Event|4|||
146812330|NCT01736475|529483171|FG001|Overall Study|Adverse Event|0|||
146812331|NCT01736475|529483170|FG000|Overall Study|Withdrawal by Subject|2|||
146812332|NCT01736475|529483171|FG001|Overall Study|Withdrawal by Subject|0|||
146812333|NCT01736475|529483170|FG000|Overall Study|Protocol Violation|4|||
146812334|NCT01736475|529483171|FG001|Overall Study|Protocol Violation|0|||
146812335|NCT01736475|529483170|FG000|Overall Study|Other - Screen failure|1|||
146812336|NCT01736475|529483171|FG001|Overall Study|Other - Screen failure|0|||
146812337|NCT01736475|529483170|FG000|Overall Study|Other - Surgical procedure|1|||
146812338|NCT01736475|529483171|FG001|Overall Study|Other - Surgical procedure|0|||
146812339|NCT00513071|529483172|FG000|Overall Study|Adverse Event|1|||
146812340|NCT00513071|529483172|FG000|Overall Study|Withdrawal by Subject|1|||
146812341|NCT00513071|529483172|FG000|Overall Study|Physician Decision|3|||
146812342|NCT02114515|529483176|FG000|Overall Study|Lost to Follow-up|52|||
146812343|NCT02114515|529483177|FG001|Overall Study|Lost to Follow-up|55|||
146812344|NCT02114515|529483176|FG000|Overall Study|Death|12|||
146812345|NCT02114515|529483177|FG001|Overall Study|Death|12|||
146812346|NCT02114515|529483176|FG000|Overall Study|Withdrawal by Subject|4|||
146812347|NCT02114515|529483177|FG001|Overall Study|Withdrawal by Subject|22|||
146812348|NCT02114515|529483176|FG000|Overall Study|Other|65|||
146812349|NCT02114515|529483177|FG001|Overall Study|Other|61|||
146812350|NCT00667732|529483178|FG000|Run -In (8 Weeks)|Adverse Event|4|||
146812351|NCT00667732|529483179|FG001|Run -In (8 Weeks)|Adverse Event|0|||
146812352|NCT00667732|529483180|FG002|Run -In (8 Weeks)|Adverse Event|0|||
146812353|NCT00667732|529483178|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
146812354|NCT00667732|529483179|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
146812355|NCT00667732|529483180|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
146812356|NCT00667732|529483178|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
146812357|NCT00667732|529483179|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
146812358|NCT00667732|529483180|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
146812359|NCT02106325|529483183|FG000|Phase 1|Lost to Follow-up|2|||
146812360|NCT02106325|529483184|FG001|Phase 1|Lost to Follow-up|2|||
146812361|NCT02106325|529483183|FG000|Phase 2|Lost to Follow-up|2|||
146812362|NCT02106325|529483184|FG001|Phase 2|Lost to Follow-up|3|||
146812363|NCT02106325|529483183|FG000|Phase 3|Lost to Follow-up|2|||
146812364|NCT02106325|529483184|FG001|Phase 3|Lost to Follow-up|1|||
146812365|NCT00824850|529483186|FG000|Overall Study|Withdrawal by Subject|0|||
146812366|NCT00824850|529483187|FG001|Overall Study|Withdrawal by Subject|1|||
146812367|NCT04820491|529483188|FG000|Overall Study|Withdrawal by Subject|1|||
146812368|NCT04820491|529483189|FG001|Overall Study|Withdrawal by Subject|0|||
146812369|NCT04369664|529484278|FG000|Overall Study|Physician Decision|1|||
146812370|NCT04369664|529484279|FG001|Overall Study|Physician Decision|0|||
146812371|NCT02489799|529484283|FG000|Overall Study|Lost to Follow-up|4|||
146812372|NCT02489799|529484284|FG001|Overall Study|Lost to Follow-up|1|||
146812373|NCT02489799|529484283|FG000|Overall Study|Failure to Maintain Eligibility|4|||
146812374|NCT02489799|529484284|FG001|Overall Study|Failure to Maintain Eligibility|6|||
146812375|NCT02489799|529484283|FG000|Overall Study|Withdrawal by Subject|1|||
146812376|NCT02489799|529484284|FG001|Overall Study|Withdrawal by Subject|1|||
146812377|NCT02489799|529484283|FG000|Overall Study|Death|0|||
146812378|NCT02489799|529484284|FG001|Overall Study|Death|1|||
146812379|NCT04909593|529484285|FG000|Overall Study|Withdrawal by Subject|1|||
146812380|NCT01018992|529484286|FG000|Overall Study|Adverse Event|8|||
146812381|NCT01018992|529484287|FG001|Overall Study|Adverse Event|3|||
146812382|NCT01018992|529484286|FG000|Overall Study|Withdrawal by Subject|3|||
146812383|NCT01018992|529484287|FG001|Overall Study|Withdrawal by Subject|8|||
146812384|NCT01018992|529484286|FG000|Overall Study|Protocol Violation|0|||
146812385|NCT01018992|529484287|FG001|Overall Study|Protocol Violation|4|||
146812386|NCT01018992|529484286|FG000|Overall Study|Lost to Follow-up|5|||
146812387|NCT01018992|529484287|FG001|Overall Study|Lost to Follow-up|1|||
146812388|NCT01825785|529484288|FG000|Overall Study|Adverse Event|0|||
146812389|NCT01825785|529484289|FG001|Overall Study|Adverse Event|0|||
146812390|NCT01825785|529484290|FG002|Overall Study|Adverse Event|0|||
146812391|NCT01825785|529484291|FG003|Overall Study|Adverse Event|0|||
146812392|NCT01825785|529484292|FG004|Overall Study|Adverse Event|1|||
146812393|NCT01825785|529484293|FG005|Overall Study|Adverse Event|0|||
146812394|NCT01825785|529484294|FG006|Overall Study|Adverse Event|0|||
146812395|NCT01825785|529484288|FG000|Overall Study|Withdrawal by Subject|0|||
146812396|NCT01825785|529484289|FG001|Overall Study|Withdrawal by Subject|0|||
146812397|NCT01825785|529484290|FG002|Overall Study|Withdrawal by Subject|0|||
146812398|NCT01825785|529484291|FG003|Overall Study|Withdrawal by Subject|0|||
146812399|NCT01825785|529484292|FG004|Overall Study|Withdrawal by Subject|1|||
146812400|NCT01825785|529484293|FG005|Overall Study|Withdrawal by Subject|1|||
146812401|NCT01825785|529484294|FG006|Overall Study|Withdrawal by Subject|0|||
146812402|NCT01304940|529484296|FG000|Overall Study|not meet symptom severity requirement|3|||
146812403|NCT01304940|529484297|FG001|Overall Study|not meet symptom severity requirement|0|||
146812404|NCT02065895|529484298|FG000|Overall Study|Protocol Violation|1|||
146812405|NCT02065895|529484299|FG001|Overall Study|Protocol Violation|0|||
146812406|NCT02065895|529484300|FG002|Overall Study|Protocol Violation|0|||
146812407|NCT02065895|529484301|FG003|Overall Study|Protocol Violation|1|||
146812408|NCT02065895|529484302|FG004|Overall Study|Protocol Violation|0|||
146812409|NCT02065895|529484303|FG005|Overall Study|Protocol Violation|0|||
146812410|NCT02065895|529484298|FG000|Overall Study|Scheduling conflicts|0|||
146812411|NCT02065895|529484299|FG001|Overall Study|Scheduling conflicts|1|||
146812412|NCT02065895|529484300|FG002|Overall Study|Scheduling conflicts|0|||
146812413|NCT02065895|529484301|FG003|Overall Study|Scheduling conflicts|0|||
146812414|NCT02065895|529484302|FG004|Overall Study|Scheduling conflicts|0|||
146812415|NCT02065895|529484303|FG005|Overall Study|Scheduling conflicts|0|||
146812416|NCT03137784|529484304|FG000|Overall Study|Adverse Event|1|||
146812417|NCT03137784|529484305|FG001|Overall Study|Adverse Event|1|||
146812418|NCT03137784|529484306|FG002|Overall Study|Adverse Event|0|||
146812419|NCT03137784|529484307|FG003|Overall Study|Adverse Event|0|||
146812420|NCT03137784|529484308|FG004|Overall Study|Adverse Event|0|||
146812421|NCT03137784|529484309|FG005|Overall Study|Adverse Event|0|||
146812422|NCT03137784|529484304|FG000|Overall Study|Subject/guardian decision|1|||
146812423|NCT03137784|529484305|FG001|Overall Study|Subject/guardian decision|0|||
146812424|NCT03137784|529484306|FG002|Overall Study|Subject/guardian decision|0|||
146812425|NCT03137784|529484307|FG003|Overall Study|Subject/guardian decision|0|||
146812426|NCT03137784|529484308|FG004|Overall Study|Subject/guardian decision|0|||
146812427|NCT03137784|529484309|FG005|Overall Study|Subject/guardian decision|0|||
146812428|NCT03137784|529484304|FG000|Overall Study|Non-compliance with study treatment|0|||
146812429|NCT03137784|529484305|FG001|Overall Study|Non-compliance with study treatment|0|||
146812430|NCT03137784|529484306|FG002|Overall Study|Non-compliance with study treatment|0|||
146812431|NCT03137784|529484307|FG003|Overall Study|Non-compliance with study treatment|0|||
146812432|NCT03137784|529484308|FG004|Overall Study|Non-compliance with study treatment|1|||
146812433|NCT03137784|529484309|FG005|Overall Study|Non-compliance with study treatment|0|||
146812434|NCT01205126|529484310|FG000|Titration Phase|Adverse Event|5|||
146812435|NCT01205126|529484311|FG001|Titration Phase|Adverse Event|3|||
146812436|NCT01205126|529484310|FG000|Titration Phase|Withdrawal by Subject|5|||
146812437|NCT01205126|529484311|FG001|Titration Phase|Withdrawal by Subject|5|||
146812438|NCT01205126|529484310|FG000|Titration Phase|Lost to Follow-up|2|||
146812439|NCT01205126|529484311|FG001|Titration Phase|Lost to Follow-up|2|||
146812440|NCT01205126|529484310|FG000|Titration Phase|No stable titration dose|1|||
146812441|NCT01205126|529484311|FG001|Titration Phase|No stable titration dose|0|||
146812442|NCT01205126|529484310|FG000|Titration Phase|More than maximum dosage required|2|||
146812443|NCT01205126|529484311|FG001|Titration Phase|More than maximum dosage required|3|||
146812444|NCT01205126|529484310|FG000|Titration Phase|Other|8|||
146812445|NCT01205126|529484311|FG001|Titration Phase|Other|6|||
146812446|NCT01205126|529484310|FG000|Between Titration & Maintenance Phase|Other|0|||
146812447|NCT01205126|529484311|FG001|Between Titration & Maintenance Phase|Other|4|||
146812448|NCT01205126|529484310|FG000|Maintenance Phase|Adverse Event|3|||
146812449|NCT01205126|529484311|FG001|Maintenance Phase|Adverse Event|7|||
146812450|NCT01205126|529484310|FG000|Maintenance Phase|Death|4|||
146812451|NCT01205126|529484311|FG001|Maintenance Phase|Death|4|||
146812452|NCT01205126|529484310|FG000|Maintenance Phase|More than the maximum dosage required|5|||
146812453|NCT01205126|529484311|FG001|Maintenance Phase|More than the maximum dosage required|5|||
146812454|NCT01205126|529484310|FG000|Maintenance Phase|Prohibited drugs used|1|||
146812455|NCT01205126|529484311|FG001|Maintenance Phase|Prohibited drugs used|0|||
146812456|NCT01205126|529484310|FG000|Maintenance Phase|Other|11|||
146812457|NCT01205126|529484311|FG001|Maintenance Phase|Other|8|||
146812458|NCT01205126|529484310|FG000|Maintenance Phase|Lost to Follow-up|5|||
146812459|NCT01205126|529484311|FG001|Maintenance Phase|Lost to Follow-up|5|||
146812460|NCT01205126|529484310|FG000|Maintenance Phase|Withdrawal by Subject|8|||
146812461|NCT01205126|529484311|FG001|Maintenance Phase|Withdrawal by Subject|11|||
146812462|NCT00805792|529484314|FG000|Overall Study|Death|3|||
146812463|NCT00805792|529484314|FG000|Overall Study|Lost to Follow-up|2|||
146812464|NCT04328467|529484317|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
146812465|NCT04328467|529484318|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
146812466|NCT04328467|529484319|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
146812467|NCT01655498|529484320|FG000|Overall Study|Unrelated health issue|2|||
146812468|NCT01655498|529484320|FG000|Overall Study|Protocol Violation|2|||
146812469|NCT01655498|529484320|FG000|Overall Study|Withdrawal by Subject|1|||
146812470|NCT01393600|529484323|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
146812471|NCT01393600|529484324|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
146812472|NCT01393600|529484325|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
146812473|NCT01393600|529484326|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
146812474|NCT01393600|529484323|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
146812475|NCT01393600|529484324|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
146812476|NCT01393600|529484325|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
146812477|NCT01393600|529484326|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
146812478|NCT01393600|529484323|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
146812479|NCT01393600|529484324|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
146812480|NCT01393600|529484325|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
146812481|NCT01393600|529484326|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
146812482|NCT01393600|529484323|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
146812483|NCT01393600|529484324|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
146812484|NCT01393600|529484325|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
146812485|NCT01393600|529484326|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
146812486|NCT01393600|529484323|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
146812487|NCT01393600|529484324|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
146812488|NCT01393600|529484325|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
146812489|NCT01393600|529484326|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
146812490|NCT01393600|529484323|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
146812491|NCT01393600|529484324|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
146812492|NCT01393600|529484325|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
146812493|NCT01393600|529484326|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
146812494|NCT01393600|529484323|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
146812495|NCT01393600|529484324|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
146984297|NCT02826603|530103404|FG000|Overall Study|Pregnancy|1|||
146812496|NCT01393600|529484325|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
146984298|NCT02826603|530103405|FG001|Overall Study|Pregnancy|2|||
146812497|NCT01393600|529484326|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
146812498|NCT01072149|529484327|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812499|NCT01072149|529484328|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812500|NCT01072149|529484329|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
146812501|NCT01072149|529484330|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812502|NCT01072149|529484331|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812503|NCT01072149|529484332|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812504|NCT01072149|529484333|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812505|NCT01072149|529484334|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812506|NCT01072149|529484335|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812507|NCT01072149|529484336|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812508|NCT01072149|529484337|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812509|NCT01072149|529484338|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812510|NCT01072149|529484339|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812511|NCT01072149|529484340|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812512|NCT01072149|529484341|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812513|NCT01072149|529484342|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812514|NCT01072149|529484343|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812515|NCT01072149|529484344|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146812516|NCT01072149|529484327|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812517|NCT01072149|529484328|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812518|NCT01072149|529484329|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812519|NCT01072149|529484330|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812520|NCT01072149|529484331|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812521|NCT01072149|529484332|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812522|NCT01072149|529484333|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812523|NCT01072149|529484334|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812524|NCT01072149|529484335|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812525|NCT01072149|529484336|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812526|NCT01072149|529484337|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812527|NCT01072149|529484338|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812528|NCT01072149|529484339|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812529|NCT01072149|529484340|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812530|NCT01072149|529484341|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812531|NCT01072149|529484342|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812532|NCT01072149|529484343|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146812533|NCT01072149|529484344|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
146812534|NCT01072149|529484327|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812535|NCT01072149|529484328|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812536|NCT01072149|529484329|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812537|NCT01072149|529484330|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812538|NCT01072149|529484331|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812539|NCT01072149|529484332|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812540|NCT01072149|529484333|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812541|NCT01072149|529484334|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812542|NCT01072149|529484335|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812543|NCT01072149|529484336|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812544|NCT01072149|529484337|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
146812545|NCT01072149|529484338|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812546|NCT01072149|529484339|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812547|NCT01072149|529484340|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812548|NCT01072149|529484341|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812549|NCT01072149|529484342|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812550|NCT01072149|529484343|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812551|NCT01072149|529484344|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146812552|NCT01072149|529484327|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812553|NCT01072149|529484328|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
146812554|NCT01072149|529484329|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812555|NCT01072149|529484330|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812556|NCT01072149|529484331|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812557|NCT01072149|529484332|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812558|NCT01072149|529484333|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812559|NCT01072149|529484334|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812560|NCT01072149|529484335|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812561|NCT01072149|529484336|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812562|NCT01072149|529484337|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812563|NCT01072149|529484338|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812564|NCT01072149|529484339|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812565|NCT01072149|529484340|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812566|NCT01072149|529484341|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812567|NCT01072149|529484342|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812568|NCT01072149|529484343|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812569|NCT01072149|529484344|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146812570|NCT01072149|529484327|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812571|NCT01072149|529484328|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812572|NCT01072149|529484329|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
146812573|NCT01072149|529484330|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812574|NCT01072149|529484331|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812575|NCT01072149|529484332|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812576|NCT01072149|529484333|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812577|NCT01072149|529484334|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812578|NCT01072149|529484335|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812579|NCT01072149|529484336|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812580|NCT01072149|529484337|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812581|NCT01072149|529484338|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812582|NCT01072149|529484339|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812583|NCT01072149|529484340|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812584|NCT01072149|529484341|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812585|NCT01072149|529484342|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812586|NCT01072149|529484343|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812587|NCT01072149|529484344|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146812588|NCT01072149|529484327|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812589|NCT01072149|529484328|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812590|NCT01072149|529484329|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812591|NCT01072149|529484330|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812592|NCT01072149|529484331|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812593|NCT01072149|529484332|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812594|NCT01072149|529484333|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812595|NCT01072149|529484334|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
146812596|NCT01072149|529484335|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812597|NCT01072149|529484336|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812598|NCT01072149|529484337|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812599|NCT01072149|529484338|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812600|NCT01072149|529484339|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812601|NCT01072149|529484340|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812602|NCT01072149|529484341|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812603|NCT01072149|529484342|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812604|NCT01072149|529484343|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812605|NCT01072149|529484344|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
146812606|NCT01072149|529484327|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
146812607|NCT01072149|529484328|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
146812608|NCT01072149|529484329|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
146812609|NCT01072149|529484330|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
146812610|NCT01072149|529484331|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
146812611|NCT01072149|529484332|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
146812612|NCT01072149|529484333|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
146812613|NCT01072149|529484334|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
146812614|NCT01072149|529484335|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
146812615|NCT01072149|529484336|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
146812616|NCT01072149|529484337|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
146812617|NCT01072149|529484338|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
146812618|NCT01072149|529484339|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
146812619|NCT01072149|529484340|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
146812620|NCT01072149|529484341|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
146812621|NCT01072149|529484342|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
146812622|NCT01072149|529484343|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
146812623|NCT01072149|529484344|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
146812624|NCT01072149|529484327|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146812625|NCT01072149|529484328|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146812626|NCT01072149|529484329|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146812627|NCT01072149|529484330|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146812628|NCT01072149|529484331|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146812629|NCT01072149|529484332|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146812630|NCT01072149|529484333|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146812631|NCT01072149|529484334|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146984299|NCT02826603|530103404|FG000|Overall Study|Protocol Violation|3|||
146984300|NCT02826603|530103405|FG001|Overall Study|Protocol Violation|3|||
146984301|NCT02826603|530103404|FG000|Overall Study|Withdrawal by Subject|20|||
146812632|NCT01072149|529484335|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146812633|NCT01072149|529484336|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146812634|NCT01072149|529484337|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146812635|NCT01072149|529484338|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146812636|NCT01072149|529484339|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146812637|NCT01072149|529484340|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146812638|NCT01072149|529484341|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146812639|NCT01072149|529484342|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
146812640|NCT01072149|529484343|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146812641|NCT01072149|529484344|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146812642|NCT01072149|529484327|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
146812643|NCT01072149|529484328|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
146812644|NCT01072149|529484329|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
146812645|NCT01072149|529484330|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
146812646|NCT01072149|529484331|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
146812647|NCT01072149|529484332|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
146812648|NCT01072149|529484333|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
146812649|NCT01072149|529484334|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
146812650|NCT01072149|529484335|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
146812651|NCT01072149|529484336|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
146812652|NCT01072149|529484337|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
146812653|NCT01072149|529484338|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
146812654|NCT01072149|529484339|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
146812655|NCT01072149|529484340|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
146812656|NCT01072149|529484341|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
146812657|NCT01072149|529484342|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
146812658|NCT01072149|529484343|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
146812659|NCT01072149|529484344|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
146812660|NCT01072149|529484327|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812661|NCT01072149|529484328|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812662|NCT01072149|529484329|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812663|NCT01072149|529484330|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812664|NCT01072149|529484331|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812665|NCT01072149|529484332|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812666|NCT01072149|529484333|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812667|NCT01072149|529484334|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812668|NCT01072149|529484335|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812669|NCT01072149|529484336|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812670|NCT01072149|529484337|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812671|NCT01072149|529484338|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812672|NCT01072149|529484339|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
146812673|NCT01072149|529484340|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812674|NCT01072149|529484341|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812675|NCT01072149|529484342|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812676|NCT01072149|529484343|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812677|NCT01072149|529484344|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146812678|NCT01072149|529484327|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146812679|NCT01072149|529484328|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146812680|NCT01072149|529484329|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
146812681|NCT01072149|529484330|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146812682|NCT01072149|529484331|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146812683|NCT01072149|529484332|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146944482|NCT00621244|529956356|FG003|Overall Study|Withdrawal by Subject|3|||
146944483|NCT00621244|529956353|FG000|Overall Study|Disease progression|44|||
146944484|NCT00621244|529956354|FG001|Overall Study|Disease progression|20|||
146944485|NCT00621244|529956355|FG002|Overall Study|Disease progression|20|||
146944486|NCT00621244|529956356|FG003|Overall Study|Disease progression|15|||
146944487|NCT00621244|529956353|FG000|Overall Study|Death|3|||
146944488|NCT00621244|529956354|FG001|Overall Study|Death|3|||
146944489|NCT00621244|529956355|FG002|Overall Study|Death|1|||
146944490|NCT00621244|529956356|FG003|Overall Study|Death|1|||
146944491|NCT00621244|529956353|FG000|Overall Study|Adverse Event|27|||
146944492|NCT00621244|529956354|FG001|Overall Study|Adverse Event|7|||
146944493|NCT00621244|529956355|FG002|Overall Study|Adverse Event|9|||
146944494|NCT00621244|529956356|FG003|Overall Study|Adverse Event|2|||
146944495|NCT00621244|529956353|FG000|Overall Study|Administrative problems|5|||
146944496|NCT00621244|529956354|FG001|Overall Study|Administrative problems|1|||
146944497|NCT00621244|529956355|FG002|Overall Study|Administrative problems|0|||
146944498|NCT00621244|529956356|FG003|Overall Study|Administrative problems|2|||
146944499|NCT01466062|529956357|FG000|Overall Study|Adverse Event|1|||
146944500|NCT01466062|529956357|FG000|Overall Study|Withdrawal by Subject|1|||
146944501|NCT02865928|529956358|FG000|Overall Study|Withdrawal by Subject|1|||
146944502|NCT02865928|529956359|FG001|Overall Study|Withdrawal by Subject|0|||
146812684|NCT01072149|529484333|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146812685|NCT01072149|529484334|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146812686|NCT01072149|529484335|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146812687|NCT01072149|529484336|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146812688|NCT01072149|529484337|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146812689|NCT01072149|529484338|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146812690|NCT01072149|529484339|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146812691|NCT01072149|529484340|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
146812692|NCT01072149|529484341|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146812693|NCT01072149|529484342|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146812694|NCT01072149|529484343|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146812695|NCT01072149|529484344|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146812696|NCT00871494|529484349|FG000|Overall Study|Protocol Violation|5|||
146812697|NCT00871494|529484349|FG000|Overall Study|Lack of Efficacy|4|||
146812698|NCT00871494|529484349|FG000|Overall Study|Adverse Event|4|||
146812699|NCT00871494|529484349|FG000|Overall Study|Lost to Follow-up|1|||
146812700|NCT00889863|529484353|FG000|Part I: Open Label|Death|1|||
146812701|NCT00889863|529484354|FG001|Part I: Open Label|Death|0|||
146812702|NCT00889863|529484353|FG000|Part I: Open Label|Adverse Event|4|||
146812703|NCT00889863|529484354|FG001|Part I: Open Label|Adverse Event|0|||
146812704|NCT00889863|529484353|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
146812705|NCT00889863|529484354|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
146812706|NCT00889863|529484353|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
146812707|NCT00889863|529484354|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
146812708|NCT00889863|529484353|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
146812709|NCT00889863|529484354|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
146812710|NCT00889863|529484353|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
146812711|NCT00889863|529484354|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
146812712|NCT00889863|529484353|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
146812713|NCT00889863|529484354|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
146812714|NCT01090739|529484355|FG000|Enrollment|Withdrawal by Subject|24|||
146812715|NCT01090739|529484355|FG000|Enrollment|Protocol Violation|14|||
146812716|NCT01090739|529484355|FG000|Enrollment|Lost to Follow-up|5|||
146812717|NCT01090739|529484355|FG000|Enrollment|Physician Decision|5|||
146812718|NCT01090739|529484355|FG000|Enrollment|Sponsor termination of site|4|||
146812719|NCT01090739|529484355|FG000|Enrollment|Study implant limit reached|2|||
146812720|NCT01090739|529484355|FG000|Enrollment|Adverse Event|1|||
146812721|NCT01090739|529484355|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
146812722|NCT01090739|529484355|FG000|12 Month Follow-up|Lost to Follow-up|1|||
146812723|NCT01090739|529484355|FG000|12 Month Follow-up|Physician Decision|1|||
146812724|NCT01090739|529484355|FG000|12 Month Follow-up|Death|1|||
146812725|NCT01090739|529484355|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
146812726|NCT01090739|529484355|FG000|24 Month Follow-up|Lost to Follow-up|1|||
146812727|NCT01090739|529484355|FG000|24 Month Follow-up|Death|1|||
146812728|NCT01090739|529484355|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
146812729|NCT01090739|529484355|FG000|36 Month Follow-up|Visit still pending|17|||
146812730|NCT00441168|529484356|FG000|Treatment Period|Death|3|||
146812731|NCT00441168|529484357|FG001|Treatment Period|Death|0|||
146812732|NCT00441168|529484356|FG000|Treatment Period|Adverse Event|1|||
146812733|NCT00441168|529484357|FG001|Treatment Period|Adverse Event|2|||
146812734|NCT00441168|529484356|FG000|Treatment Period|Progressive Disease|0|||
146812735|NCT00441168|529484357|FG001|Treatment Period|Progressive Disease|2|||
146812736|NCT00441168|529484356|FG000|Treatment Period|Protocol Violation|0|||
146812737|NCT00441168|529484357|FG001|Treatment Period|Protocol Violation|1|||
146812738|NCT00441168|529484356|FG000|Treatment Period|Lost to Follow-up|0|||
146812739|NCT00441168|529484357|FG001|Treatment Period|Lost to Follow-up|1|||
146812740|NCT00441168|529484356|FG000|Treatment Period|Withdrawal by Subject|3|||
146812741|NCT00441168|529484357|FG001|Treatment Period|Withdrawal by Subject|0|||
146812742|NCT00441168|529484356|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
146812743|NCT00441168|529484357|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
146812744|NCT00441168|529484356|FG000|Treatment Period|refractory disease|1|||
146944503|NCT02865928|529956358|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
146944504|NCT02865928|529956359|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
146812745|NCT00441168|529484357|FG001|Treatment Period|refractory disease|0|||
146812746|NCT00441168|529484356|FG000|Follow-up Period|Death|3|||
146812747|NCT00441168|529484357|FG001|Follow-up Period|Death|0|||
146812748|NCT00441168|529484356|FG000|Follow-up Period|Lost to Follow-up|5|||
146812749|NCT00441168|529484357|FG001|Follow-up Period|Lost to Follow-up|6|||
146812750|NCT00441168|529484356|FG000|Follow-up Period|Withdrawal by Subject|3|||
146812751|NCT00441168|529484357|FG001|Follow-up Period|Withdrawal by Subject|0|||
146812752|NCT00441168|529484356|FG000|Follow-up Period|Other|1|||
146812753|NCT00441168|529484357|FG001|Follow-up Period|Other|3|||
146812754|NCT00988429|529484358|FG000|Overall Study|Adverse Event|9|||
146812755|NCT00988429|529484359|FG001|Overall Study|Adverse Event|21|||
146812756|NCT00988429|529484360|FG002|Overall Study|Adverse Event|45|||
146812757|NCT00988429|529484358|FG000|Overall Study|Lack of Efficacy|0|||
146812758|NCT00988429|529484359|FG001|Overall Study|Lack of Efficacy|0|||
146812759|NCT00988429|529484360|FG002|Overall Study|Lack of Efficacy|1|||
146812760|NCT00988429|529484358|FG000|Overall Study|Non-Compliance with Study Drug|5|||
146812761|NCT00988429|529484359|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146812762|NCT00988429|529484360|FG002|Overall Study|Non-Compliance with Study Drug|3|||
146812763|NCT00988429|529484358|FG000|Overall Study|Physician Decision|1|||
146812764|NCT00988429|529484359|FG001|Overall Study|Physician Decision|0|||
146812765|NCT00988429|529484360|FG002|Overall Study|Physician Decision|3|||
146812766|NCT00988429|529484358|FG000|Overall Study|Pregnancy|2|||
146812767|NCT00988429|529484359|FG001|Overall Study|Pregnancy|1|||
146812768|NCT00988429|529484360|FG002|Overall Study|Pregnancy|0|||
146812769|NCT00988429|529484358|FG000|Overall Study|Protocol Violation|4|||
146812770|NCT00988429|529484359|FG001|Overall Study|Protocol Violation|3|||
146812771|NCT00988429|529484360|FG002|Overall Study|Protocol Violation|3|||
146812772|NCT00988429|529484358|FG000|Overall Study|Withdrawal by Subject|7|||
146812773|NCT00988429|529484359|FG001|Overall Study|Withdrawal by Subject|7|||
146812774|NCT00988429|529484360|FG002|Overall Study|Withdrawal by Subject|12|||
146812775|NCT00988429|529484358|FG000|Overall Study|Administrative Reasons|1|||
146812776|NCT00988429|529484359|FG001|Overall Study|Administrative Reasons|2|||
146812777|NCT00988429|529484360|FG002|Overall Study|Administrative Reasons|1|||
146812778|NCT00988429|529484358|FG000|Overall Study|other reasons|8|||
146812779|NCT00988429|529484359|FG001|Overall Study|other reasons|8|||
146812780|NCT00988429|529484360|FG002|Overall Study|other reasons|1|||
146812781|NCT02964234|529484361|FG000|Overall Study|Lost to Follow-up|22|||
146984302|NCT02826603|530103405|FG001|Overall Study|Withdrawal by Subject|19|||
146812782|NCT02964234|529484362|FG001|Overall Study|Lost to Follow-up|13|||
146812783|NCT01799993|529484364|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
146812784|NCT01799993|529484365|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
146812785|NCT01799993|529484364|FG000|Overall Study|Death|61|||
146812786|NCT01799993|529484365|FG001|Overall Study|Death|45|||
146812787|NCT01799993|529484364|FG000|Overall Study|Withdrawal by Subject|23|||
146812788|NCT01799993|529484365|FG001|Overall Study|Withdrawal by Subject|24|||
146812789|NCT01799993|529484364|FG000|Overall Study|Lost to Follow-up|5|||
146812790|NCT01799993|529484365|FG001|Overall Study|Lost to Follow-up|8|||
146812791|NCT01799993|529484364|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
146812792|NCT01799993|529484365|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
146812793|NCT01799993|529484364|FG000|Overall Study|Protocol driven decision point|0|||
146812794|NCT01799993|529484365|FG001|Overall Study|Protocol driven decision point|3|||
146812795|NCT01799993|529484364|FG000|Overall Study|Protocol Violation|1|||
146812796|NCT01799993|529484365|FG001|Overall Study|Protocol Violation|1|||
146812797|NCT01799993|529484364|FG000|Overall Study|Deterioration of general conditions|2|||
146812798|NCT01799993|529484365|FG001|Overall Study|Deterioration of general conditions|0|||
146812799|NCT01799993|529484364|FG000|Overall Study|Screen failure|0|||
146812800|NCT01799993|529484365|FG001|Overall Study|Screen failure|1|||
146812801|NCT01799993|529484364|FG000|Overall Study|Adverse Event|1|||
146812802|NCT01799993|529484365|FG001|Overall Study|Adverse Event|0|||
146812803|NCT01799993|529484364|FG000|Overall Study|Lack of Efficacy|1|||
146812804|NCT01799993|529484365|FG001|Overall Study|Lack of Efficacy|0|||
146812805|NCT01799993|529484364|FG000|Overall Study|Recovery|0|||
146812806|NCT01799993|529484365|FG001|Overall Study|Recovery|1|||
146812807|NCT01799993|529484364|FG000|Overall Study|Logistical difficulties|1|||
146812808|NCT01799993|529484365|FG001|Overall Study|Logistical difficulties|0|||
146812809|NCT01799993|529484364|FG000|Overall Study|Protocol deviation|1|||
146812810|NCT01799993|529484365|FG001|Overall Study|Protocol deviation|0|||
146812811|NCT01799993|529484364|FG000|Overall Study|Non-compliance with medical device|1|||
146812812|NCT01799993|529484365|FG001|Overall Study|Non-compliance with medical device|0|||
146812813|NCT01799993|529484364|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146812814|NCT01799993|529484365|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146812815|NCT01799993|529484364|FG000|Overall Study|Other|1|||
146812816|NCT01799993|529484365|FG001|Overall Study|Other|0|||
146812817|NCT01799993|529484364|FG000|Overall Study|Subject didn't return for follow-up|0|||
146812818|NCT01799993|529484365|FG001|Overall Study|Subject didn't return for follow-up|1|||
146812819|NCT04410445|529484366|FG000|Overall Study|Lost to Follow-up|3|||
146812820|NCT04410445|529484367|FG001|Overall Study|Lost to Follow-up|9|||
146812821|NCT04410445|529484366|FG000|Overall Study|Withdrawal by Subject|27|||
146812822|NCT04410445|529484367|FG001|Overall Study|Withdrawal by Subject|15|||
146812823|NCT01320683|529484368|FG000|Overall Study|Positive antibody response|1|||
146812824|NCT02291861|529484369|FG000|Overall Study|Adverse Event|2|||
146812825|NCT02291861|529484370|FG001|Overall Study|Adverse Event|4|||
146812826|NCT02291861|529484371|FG002|Overall Study|Adverse Event|1|||
146812827|NCT02291861|529484372|FG003|Overall Study|Adverse Event|2|||
146812828|NCT02291861|529484369|FG000|Overall Study|Death|0|||
146812829|NCT02291861|529484370|FG001|Overall Study|Death|0|||
146812830|NCT02291861|529484371|FG002|Overall Study|Death|1|||
146812831|NCT02291861|529484372|FG003|Overall Study|Death|1|||
146812832|NCT02291861|529484369|FG000|Overall Study|Protocol Violation|1|||
146812833|NCT02291861|529484370|FG001|Overall Study|Protocol Violation|0|||
146812834|NCT02291861|529484371|FG002|Overall Study|Protocol Violation|0|||
146812835|NCT02291861|529484372|FG003|Overall Study|Protocol Violation|1|||
146812836|NCT02291861|529484369|FG000|Overall Study|Withdrawal by Subject|1|||
146812837|NCT02291861|529484370|FG001|Overall Study|Withdrawal by Subject|2|||
146812838|NCT02291861|529484371|FG002|Overall Study|Withdrawal by Subject|1|||
146812839|NCT02291861|529484372|FG003|Overall Study|Withdrawal by Subject|4|||
146812840|NCT02291861|529484369|FG000|Overall Study|Noncompliance|1|||
146812841|NCT02291861|529484370|FG001|Overall Study|Noncompliance|1|||
146812842|NCT02291861|529484371|FG002|Overall Study|Noncompliance|2|||
146812843|NCT02291861|529484372|FG003|Overall Study|Noncompliance|1|||
146812844|NCT02291861|529484369|FG000|Overall Study|Lost to Follow-up|2|||
146812845|NCT02291861|529484370|FG001|Overall Study|Lost to Follow-up|1|||
146812846|NCT02291861|529484371|FG002|Overall Study|Lost to Follow-up|4|||
146812847|NCT02291861|529484372|FG003|Overall Study|Lost to Follow-up|0|||
146812848|NCT02291861|529484369|FG000|Overall Study|Other|0|||
146812849|NCT02291861|529484370|FG001|Overall Study|Other|0|||
146812850|NCT02291861|529484371|FG002|Overall Study|Other|0|||
146812851|NCT02291861|529484372|FG003|Overall Study|Other|1|||
146812852|NCT03547154|529484377|FG000|Overall Study|Disease Progression/Recurrence|6|||
146812853|NCT03547154|529484378|FG001|Overall Study|Disease Progression/Recurrence|14|||
146812854|NCT03547154|529484377|FG000|Overall Study|Adverse Event|26|||
146812855|NCT03547154|529484378|FG001|Overall Study|Adverse Event|31|||
146812856|NCT03547154|529484377|FG000|Overall Study|Protocol Violation|6|||
146812857|NCT03547154|529484378|FG001|Overall Study|Protocol Violation|1|||
146812858|NCT03547154|529484377|FG000|Overall Study|Physician Decision|4|||
146812859|NCT03547154|529484378|FG001|Overall Study|Physician Decision|3|||
146812860|NCT03547154|529484377|FG000|Overall Study|Insufficient Therapeutic Response|13|||
146812861|NCT03547154|529484378|FG001|Overall Study|Insufficient Therapeutic Response|10|||
146812862|NCT03547154|529484377|FG000|Overall Study|Withdrawal by Subject|10|||
146812863|NCT03547154|529484378|FG001|Overall Study|Withdrawal by Subject|6|||
146812864|NCT03547154|529484377|FG000|Overall Study|Not Selected|0|||
146812865|NCT03547154|529484378|FG001|Overall Study|Not Selected|1|||
146812866|NCT03547154|529484377|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
146812867|NCT03547154|529484378|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
146812868|NCT00088166|529484383|FG000|Overall Study|Adverse Event|11|||
146812869|NCT00088166|529484384|FG001|Overall Study|Adverse Event|9|||
146812870|NCT00088166|529484383|FG000|Overall Study|Death|3|||
146812871|NCT00088166|529484384|FG001|Overall Study|Death|1|||
146812872|NCT00088166|529484383|FG000|Overall Study|Lost to Follow-up|0|||
146812873|NCT00088166|529484384|FG001|Overall Study|Lost to Follow-up|1|||
146812874|NCT00088166|529484383|FG000|Overall Study|Physician Decision|4|||
146812875|NCT00088166|529484384|FG001|Overall Study|Physician Decision|1|||
146812876|NCT00088166|529484383|FG000|Overall Study|Protocol Violation|1|||
146812877|NCT00088166|529484384|FG001|Overall Study|Protocol Violation|5|||
146812878|NCT00088166|529484383|FG000|Overall Study|Patient deterioration|29|||
146812879|NCT00088166|529484384|FG001|Overall Study|Patient deterioration|39|||
146812880|NCT00088166|529484383|FG000|Overall Study|Withdrawal by Subject|5|||
146812881|NCT00088166|529484384|FG001|Overall Study|Withdrawal by Subject|5|||
146812882|NCT02671266|529484385|FG000|Overall Study|Withdrawal by Subject|1|||
146812883|NCT02671266|529484386|FG001|Overall Study|Withdrawal by Subject|1|||
146812884|NCT01328756|529484387|FG000|Overall Study|Protocol Violation|4|||
146812885|NCT01328756|529484387|FG000|Overall Study|Adverse Event|39|||
146812886|NCT01328756|529484387|FG000|Overall Study|Lack of Efficacy|5|||
146812887|NCT01328756|529484387|FG000|Overall Study|Withdrawal by Subject|41|||
146812888|NCT01328756|529484387|FG000|Overall Study|Lost to Follow-up|5|||
146812889|NCT01328756|529484387|FG000|Overall Study|Other|29|||
146812890|NCT01262456|529484388|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
146812891|NCT01262456|529484389|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
146984303|NCT02826603|530103404|FG000|Overall Study|Death|2|||
146984304|NCT02826603|530103405|FG001|Overall Study|Death|0|||
146812892|NCT01262456|529484390|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
146812893|NCT01262456|529484388|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
146812894|NCT01262456|529484389|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
146984305|NCT02826603|530103404|FG000|Overall Study|New therapy for study indication|0|||
146812895|NCT01262456|529484390|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
146812896|NCT01262456|529484388|FG000|3-Month Double-Blind Period|Adverse Event|6|||
146812897|NCT01262456|529484389|FG001|3-Month Double-Blind Period|Adverse Event|4|||
146812898|NCT01262456|529484390|FG002|3-Month Double-Blind Period|Adverse Event|8|||
146812899|NCT01262456|529484388|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
146812900|NCT01262456|529484389|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
146812901|NCT01262456|529484390|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
146812902|NCT01262456|529484388|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
146812903|NCT01262456|529484389|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
146812904|NCT01262456|529484390|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
146984306|NCT02826603|530103405|FG001|Overall Study|New therapy for study indication|1|||
146812905|NCT01262456|529484388|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
146812906|NCT01262456|529484389|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
146812907|NCT01262456|529484390|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
146812908|NCT01262456|529484388|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
146812909|NCT01262456|529484389|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
146812910|NCT01262456|529484390|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
146812911|NCT01262456|529484388|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
146812912|NCT01262456|529484389|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
146812913|NCT01262456|529484390|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
146812914|NCT01262456|529484388|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
146812915|NCT01262456|529484389|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
146812916|NCT01262456|529484390|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
146812917|NCT02326220|529484395|FG000|Double-blind Treatment Period|Adverse Event|1|||
146812918|NCT02326220|529484396|FG001|Double-blind Treatment Period|Adverse Event|2|||
146812919|NCT02326220|529484397|FG002|Double-blind Treatment Period|Adverse Event|0|||
146812920|NCT02326220|529484395|FG000|Double-blind Treatment Period|Protocol Violation|0|||
146812921|NCT02326220|529484396|FG001|Double-blind Treatment Period|Protocol Violation|1|||
146812922|NCT02326220|529484397|FG002|Double-blind Treatment Period|Protocol Violation|0|||
146812923|NCT02326220|529484395|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
146812924|NCT02326220|529484396|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
146812925|NCT02326220|529484397|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146812926|NCT02326220|529484395|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
146812927|NCT02326220|529484396|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
146812928|NCT02326220|529484397|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
146812929|NCT02326220|529484395|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
146812930|NCT02326220|529484396|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
146812931|NCT02326220|529484397|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
146812932|NCT02699099|529484398|FG000|Overall Study|Adverse Event|1|||
146812933|NCT02699099|529484399|FG001|Overall Study|Adverse Event|0|||
146812934|NCT02699099|529484400|FG002|Overall Study|Adverse Event|2|||
146812935|NCT02699099|529484398|FG000|Overall Study|Lost to Follow-up|0|||
146812936|NCT02699099|529484399|FG001|Overall Study|Lost to Follow-up|1|||
146812937|NCT02699099|529484400|FG002|Overall Study|Lost to Follow-up|0|||
146812938|NCT02699099|529484398|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
146812939|NCT02699099|529484399|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
146812940|NCT02699099|529484400|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
146812941|NCT02659540|529484401|FG000|Overall Study|Adverse Event|3|||
146812942|NCT02659540|529484402|FG001|Overall Study|Adverse Event|2|||
146812943|NCT02659540|529484401|FG000|Overall Study|Death|1|||
146812944|NCT02659540|529484402|FG001|Overall Study|Death|0|||
146812945|NCT02659540|529484401|FG000|Overall Study|Progressive disease|2|||
146812946|NCT02659540|529484402|FG001|Overall Study|Progressive disease|6|||
146812947|NCT05184062|529484405|FG000|Overall Study|Lost to Follow-up|5|||
146812948|NCT05184062|529484406|FG001|Overall Study|Lost to Follow-up|1|||
146812949|NCT05184062|529484405|FG000|Overall Study|Withdrawal by Subject|1|||
146812950|NCT05184062|529484406|FG001|Overall Study|Withdrawal by Subject|0|||
146812951|NCT00747149|529486170|FG000|Overall Study|Adverse Event|0|||
146812952|NCT00747149|529486171|FG001|Overall Study|Adverse Event|15|||
146812953|NCT00747149|529486170|FG000|Overall Study|Lost to Follow-up|0|||
146812954|NCT00747149|529486171|FG001|Overall Study|Lost to Follow-up|10|||
146812955|NCT00747149|529486170|FG000|Overall Study|Withdrawal by Subject|0|||
146812956|NCT00747149|529486171|FG001|Overall Study|Withdrawal by Subject|6|||
146812957|NCT00747149|529486170|FG000|Overall Study|Did not receive treatment|0|||
146812958|NCT00747149|529486171|FG001|Overall Study|Did not receive treatment|1|||
146812959|NCT00747149|529486170|FG000|Overall Study|Incorrect enrollment|0|||
146812960|NCT00747149|529486171|FG001|Overall Study|Incorrect enrollment|6|||
146812961|NCT00747149|529486170|FG000|Overall Study|Severe non-compliance to protocol|0|||
146812962|NCT00747149|529486171|FG001|Overall Study|Severe non-compliance to protocol|1|||
146812963|NCT00747149|529486170|FG000|Overall Study|Not reported|1|||
146812964|NCT00747149|529486171|FG001|Overall Study|Not reported|4|||
146812965|NCT05522777|529486176|FG000|Overall Study|Lack of Efficacy|1|||
146812966|NCT05522777|529486176|FG000|Overall Study|Withdrawal by Subject|1|||
146812967|NCT01241448|529486179|FG000|Overall Study|Adverse Event|1|||
146812968|NCT01241448|529486180|FG001|Overall Study|Adverse Event|0|||
146812969|NCT01241448|529486181|FG002|Overall Study|Adverse Event|2|||
146812970|NCT01241448|529486182|FG003|Overall Study|Adverse Event|2|||
146812971|NCT01241448|529486179|FG000|Overall Study|Lost to Follow-up|2|||
146812972|NCT01241448|529486180|FG001|Overall Study|Lost to Follow-up|1|||
146812973|NCT01241448|529486181|FG002|Overall Study|Lost to Follow-up|1|||
146812974|NCT01241448|529486182|FG003|Overall Study|Lost to Follow-up|1|||
146812975|NCT01241448|529486179|FG000|Overall Study|Physician Decision|0|||
146812976|NCT01241448|529486180|FG001|Overall Study|Physician Decision|2|||
146812977|NCT01241448|529486181|FG002|Overall Study|Physician Decision|0|||
146812978|NCT01241448|529486182|FG003|Overall Study|Physician Decision|0|||
146812979|NCT01241448|529486179|FG000|Overall Study|Protocol Violation|10|||
146812980|NCT01241448|529486180|FG001|Overall Study|Protocol Violation|5|||
146812981|NCT01241448|529486181|FG002|Overall Study|Protocol Violation|3|||
146812982|NCT01241448|529486182|FG003|Overall Study|Protocol Violation|6|||
146812983|NCT01241448|529486179|FG000|Overall Study|Sponsor Decision|17|||
146812984|NCT01241448|529486180|FG001|Overall Study|Sponsor Decision|14|||
146812985|NCT01241448|529486181|FG002|Overall Study|Sponsor Decision|12|||
146812986|NCT01241448|529486182|FG003|Overall Study|Sponsor Decision|6|||
146812987|NCT01241448|529486179|FG000|Overall Study|Withdrawal by Subject|4|||
146812988|NCT01241448|529486180|FG001|Overall Study|Withdrawal by Subject|5|||
146812989|NCT01241448|529486181|FG002|Overall Study|Withdrawal by Subject|3|||
146812990|NCT01241448|529486182|FG003|Overall Study|Withdrawal by Subject|6|||
146812991|NCT01241448|529486179|FG000|Overall Study|Excluded due to data integrity issues|3|||
146812992|NCT01241448|529486180|FG001|Overall Study|Excluded due to data integrity issues|2|||
146812993|NCT01241448|529486181|FG002|Overall Study|Excluded due to data integrity issues|2|||
146812994|NCT01241448|529486182|FG003|Overall Study|Excluded due to data integrity issues|2|||
146812995|NCT03340961|529486183|FG000|Overall Study|Adverse Event|1|||
146812996|NCT03340961|529486184|FG001|Overall Study|Adverse Event|3|||
146812997|NCT03340961|529486185|FG002|Overall Study|Adverse Event|2|||
146812998|NCT03340961|529486186|FG003|Overall Study|Adverse Event|4|||
146812999|NCT03340961|529486183|FG000|Overall Study|Lost to Follow-up|0|||
146813000|NCT03340961|529486184|FG001|Overall Study|Lost to Follow-up|1|||
146813001|NCT03340961|529486185|FG002|Overall Study|Lost to Follow-up|0|||
146813002|NCT03340961|529486186|FG003|Overall Study|Lost to Follow-up|1|||
146813003|NCT03340961|529486183|FG000|Overall Study|Withdrawal by Subject|3|||
146813004|NCT03340961|529486184|FG001|Overall Study|Withdrawal by Subject|2|||
146813005|NCT03340961|529486185|FG002|Overall Study|Withdrawal by Subject|4|||
146813006|NCT03340961|529486186|FG003|Overall Study|Withdrawal by Subject|7|||
146813007|NCT03340961|529486183|FG000|Overall Study|Use of prohibited treatment|0|||
146813008|NCT03340961|529486184|FG001|Overall Study|Use of prohibited treatment|3|||
146813009|NCT03340961|529486185|FG002|Overall Study|Use of prohibited treatment|2|||
146813010|NCT03340961|529486186|FG003|Overall Study|Use of prohibited treatment|4|||
146813011|NCT03340961|529486183|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
146813012|NCT03340961|529486184|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
146813013|NCT03340961|529486185|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
146813014|NCT03340961|529486186|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
146813015|NCT03340961|529486183|FG000|Overall Study|Subject developed an exclusion criterion|0|||
146813016|NCT03340961|529486184|FG001|Overall Study|Subject developed an exclusion criterion|1|||
146813017|NCT03340961|529486185|FG002|Overall Study|Subject developed an exclusion criterion|0|||
146813018|NCT03340961|529486186|FG003|Overall Study|Subject developed an exclusion criterion|0|||
146813019|NCT03340961|529486183|FG000|Overall Study|Protocol Violation|1|||
146813020|NCT03340961|529486184|FG001|Overall Study|Protocol Violation|0|||
146813021|NCT03340961|529486185|FG002|Overall Study|Protocol Violation|1|||
146813022|NCT03340961|529486186|FG003|Overall Study|Protocol Violation|0|||
146813023|NCT03340961|529486183|FG000|Overall Study|Adverse Event|1|||
146813024|NCT03340961|529486184|FG001|Overall Study|Adverse Event|1|||
146813025|NCT03340961|529486185|FG002|Overall Study|Adverse Event|0|||
146813026|NCT03340961|529486186|FG003|Overall Study|Adverse Event|0|||
146813027|NCT03340961|529486183|FG000|Overall Study|Lack of Efficacy|0|||
146813028|NCT03340961|529486184|FG001|Overall Study|Lack of Efficacy|0|||
146813029|NCT03340961|529486185|FG002|Overall Study|Lack of Efficacy|0|||
146813030|NCT03340961|529486186|FG003|Overall Study|Lack of Efficacy|1|||
146813031|NCT04311983|529486187|FG000|Overall Study|Lost to Follow-up|421|||
146813032|NCT04311983|529486188|FG001|Overall Study|Lost to Follow-up|456|||
146813033|NCT04311983|529486187|FG000|Overall Study|Incomplete survey|7|||
146813034|NCT04311983|529486188|FG001|Overall Study|Incomplete survey|9|||
146813035|NCT04311983|529486187|FG000|Overall Study|Death|1|||
146813036|NCT04311983|529486188|FG001|Overall Study|Death|0|||
146813037|NCT00990184|529486194|FG000|Overall Study|Physician Decision|1|||
146813038|NCT02446015|529486195|FG000|Overall Study|Adverse Event|0|||
146813039|NCT02446015|529486196|FG001|Overall Study|Adverse Event|1|||
146813040|NCT02446015|529486195|FG000|Overall Study|Withdrawal by Subject|1|||
146813041|NCT02446015|529486196|FG001|Overall Study|Withdrawal by Subject|0|||
146813042|NCT00666705|529486202|FG000|Overall Study|Withdrawal by Subject|1|||
146813043|NCT01029704|529486206|FG000|Overall Study|Adverse Event|0|||
146813044|NCT01029704|529486207|FG001|Overall Study|Adverse Event|0|||
146813045|NCT01029704|529486208|FG002|Overall Study|Adverse Event|0|||
146813046|NCT01029704|529486209|FG003|Overall Study|Adverse Event|0|||
146813047|NCT01029704|529486210|FG004|Overall Study|Adverse Event|0|||
146813048|NCT01029704|529486211|FG005|Overall Study|Adverse Event|0|||
146813049|NCT01029704|529486212|FG006|Overall Study|Adverse Event|1|||
146813050|NCT01029704|529486213|FG007|Overall Study|Adverse Event|1|||
146813051|NCT01029704|529486214|FG008|Overall Study|Adverse Event|0|||
146813052|NCT01029704|529486206|FG000|Overall Study|Withdrawal by Subject|0|||
146813053|NCT01029704|529486207|FG001|Overall Study|Withdrawal by Subject|0|||
146813054|NCT01029704|529486208|FG002|Overall Study|Withdrawal by Subject|0|||
146813055|NCT01029704|529486209|FG003|Overall Study|Withdrawal by Subject|0|||
146813056|NCT01029704|529486210|FG004|Overall Study|Withdrawal by Subject|2|||
146813057|NCT01029704|529486211|FG005|Overall Study|Withdrawal by Subject|1|||
146813058|NCT01029704|529486212|FG006|Overall Study|Withdrawal by Subject|1|||
146813059|NCT01029704|529486213|FG007|Overall Study|Withdrawal by Subject|1|||
146813060|NCT01029704|529486214|FG008|Overall Study|Withdrawal by Subject|0|||
146813061|NCT01029704|529486206|FG000|Overall Study|Lost to Follow-up|0|||
146813062|NCT01029704|529486207|FG001|Overall Study|Lost to Follow-up|0|||
146813063|NCT01029704|529486208|FG002|Overall Study|Lost to Follow-up|0|||
146813064|NCT01029704|529486209|FG003|Overall Study|Lost to Follow-up|0|||
146813065|NCT01029704|529486210|FG004|Overall Study|Lost to Follow-up|0|||
146813066|NCT01029704|529486211|FG005|Overall Study|Lost to Follow-up|0|||
146813067|NCT01029704|529486212|FG006|Overall Study|Lost to Follow-up|1|||
146813068|NCT01029704|529486213|FG007|Overall Study|Lost to Follow-up|1|||
146813069|NCT01029704|529486214|FG008|Overall Study|Lost to Follow-up|1|||
146813070|NCT01029704|529486206|FG000|Overall Study|Lack of Efficacy|0|||
146813071|NCT01029704|529486207|FG001|Overall Study|Lack of Efficacy|0|||
146813072|NCT01029704|529486208|FG002|Overall Study|Lack of Efficacy|0|||
146813073|NCT01029704|529486209|FG003|Overall Study|Lack of Efficacy|0|||
146813074|NCT01029704|529486210|FG004|Overall Study|Lack of Efficacy|2|||
146813075|NCT01029704|529486211|FG005|Overall Study|Lack of Efficacy|3|||
146813076|NCT01029704|529486212|FG006|Overall Study|Lack of Efficacy|1|||
146813077|NCT01029704|529486213|FG007|Overall Study|Lack of Efficacy|2|||
146813078|NCT01029704|529486214|FG008|Overall Study|Lack of Efficacy|0|||
146813079|NCT01029704|529486206|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
146813080|NCT01029704|529486207|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
146813081|NCT01029704|529486208|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
146813082|NCT01029704|529486209|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
146813083|NCT01029704|529486210|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
146813084|NCT01029704|529486211|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
146813085|NCT01029704|529486212|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
146813086|NCT01029704|529486213|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
146813087|NCT01029704|529486214|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
146813088|NCT00687297|529486215|FG000|Randomization|Withdrawal by Subject|2|||
146813089|NCT00687297|529486216|FG001|Randomization|Withdrawal by Subject|0|||
146813090|NCT00687297|529486215|FG000|Randomization|Withdrew before treatment, ineligible|1|||
146813091|NCT00687297|529486216|FG001|Randomization|Withdrew before treatment, ineligible|1|||
146813092|NCT00687297|529486215|FG000|Induction|Withdrawal by Subject|4|||
146813093|NCT00687297|529486216|FG001|Induction|Withdrawal by Subject|4|||
146813094|NCT00687297|529486215|FG000|Induction|Adverse Event|16|||
146813095|NCT00687297|529486216|FG001|Induction|Adverse Event|15|||
146813096|NCT00687297|529486215|FG000|Induction|Death|7|||
146813097|NCT00687297|529486216|FG001|Induction|Death|11|||
146813098|NCT00687297|529486215|FG000|Induction|Lack of Efficacy|17|||
146813099|NCT00687297|529486216|FG001|Induction|Lack of Efficacy|21|||
146813100|NCT00687297|529486215|FG000|Induction|Ineligible|0|||
146813101|NCT00687297|529486216|FG001|Induction|Ineligible|1|||
146813102|NCT00687297|529486215|FG000|Induction|Patient Noncompliance|1|||
146813103|NCT00687297|529486216|FG001|Induction|Patient Noncompliance|0|||
146813104|NCT00687297|529486215|FG000|Induction|Physician Decision|0|||
146813105|NCT00687297|529486216|FG001|Induction|Physician Decision|2|||
146813106|NCT00687297|529486215|FG000|Induction|Other|0|||
146813107|NCT00687297|529486216|FG001|Induction|Other|1|||
146813108|NCT03845517|529486217|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
146813109|NCT03845517|529486218|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
146813110|NCT03845517|529486219|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
146813111|NCT03845517|529486220|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
146813112|NCT03845517|529486217|FG000|Treatment Period (52 Weeks)|Death|0|||
146813113|NCT03845517|529486218|FG001|Treatment Period (52 Weeks)|Death|0|||
146813114|NCT03845517|529486219|FG002|Treatment Period (52 Weeks)|Death|1|||
146813115|NCT03845517|529486220|FG003|Treatment Period (52 Weeks)|Death|0|||
146813116|NCT03845517|529486217|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
146813117|NCT03845517|529486218|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
146813118|NCT03845517|529486219|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
146813119|NCT03845517|529486220|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
146813120|NCT03845517|529486217|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
146813121|NCT03845517|529486218|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
146813122|NCT03845517|529486219|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
146813123|NCT03845517|529486220|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
146813124|NCT03845517|529486217|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
146813125|NCT03845517|529486218|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
146813126|NCT03845517|529486219|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
146813127|NCT03845517|529486220|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
146813128|NCT03845517|529486217|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
146813129|NCT03845517|529486218|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
146813130|NCT03845517|529486219|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
146813131|NCT03845517|529486220|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
146813132|NCT03845517|529486217|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
146813133|NCT03845517|529486218|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
146813134|NCT03845517|529486219|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
146813135|NCT03845517|529486220|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
146813136|NCT03845517|529486217|FG000|Treatment Period (52 Weeks)|Other|2|||
146813137|NCT03845517|529486218|FG001|Treatment Period (52 Weeks)|Other|0|||
146813138|NCT03845517|529486219|FG002|Treatment Period (52 Weeks)|Other|0|||
146813139|NCT03845517|529486220|FG003|Treatment Period (52 Weeks)|Other|0|||
146813140|NCT03845517|529486217|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
146813141|NCT03845517|529486218|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
146813142|NCT03845517|529486219|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
146813143|NCT03845517|529486220|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
146813144|NCT03845517|529486217|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
146813145|NCT03845517|529486218|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
146813146|NCT03845517|529486219|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
146813147|NCT03845517|529486220|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
146813148|NCT03845517|529486217|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
146813149|NCT03845517|529486218|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
146813150|NCT03845517|529486219|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
146813151|NCT03845517|529486220|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
146813152|NCT03845517|529486217|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
146813153|NCT03845517|529486218|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
146813154|NCT03845517|529486219|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
146813155|NCT03845517|529486220|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
146813156|NCT03845517|529486217|FG000|Follow-up Period (4 Weeks)|Death|0|||
146813157|NCT03845517|529486218|FG001|Follow-up Period (4 Weeks)|Death|0|||
146813158|NCT03845517|529486219|FG002|Follow-up Period (4 Weeks)|Death|1|||
146813159|NCT03845517|529486220|FG003|Follow-up Period (4 Weeks)|Death|1|||
146813160|NCT03845517|529486217|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
146813161|NCT03845517|529486218|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
146813162|NCT03845517|529486219|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
146813163|NCT03845517|529486220|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
146813164|NCT03845517|529486217|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
146813165|NCT03845517|529486218|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
146813166|NCT03845517|529486219|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
146813167|NCT03845517|529486220|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
146813168|NCT03845517|529486217|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
146813169|NCT03845517|529486218|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
146813170|NCT03845517|529486219|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
146813171|NCT03845517|529486220|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
146813172|NCT03845517|529486217|FG000|Follow-up Period (4 Weeks)|Other|1|||
146813173|NCT03845517|529486218|FG001|Follow-up Period (4 Weeks)|Other|0|||
146813174|NCT03845517|529486219|FG002|Follow-up Period (4 Weeks)|Other|1|||
146813175|NCT03845517|529486220|FG003|Follow-up Period (4 Weeks)|Other|0|||
146813176|NCT03845517|529486217|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
146813177|NCT03845517|529486218|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
146813178|NCT03845517|529486219|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
146813179|NCT03845517|529486220|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
146813180|NCT03845517|529486217|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
146813181|NCT03845517|529486218|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
146813182|NCT03845517|529486219|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
146813183|NCT03845517|529486220|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
146813184|NCT03845517|529486217|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
146813185|NCT03845517|529486218|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
146813186|NCT03845517|529486219|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
146813187|NCT03845517|529486220|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
146813188|NCT01109979|529486221|FG000|Overall Study|Physician Decision|2|||
146813189|NCT01109979|529486222|FG001|Overall Study|Physician Decision|0|||
146813190|NCT01109979|529486221|FG000|Overall Study|Withdrawal by Subject|0|||
146813191|NCT01109979|529486222|FG001|Overall Study|Withdrawal by Subject|1|||
146813192|NCT00807599|529486226|FG000|Overall Study|Not treated on protocol study|0|||
146813193|NCT00807599|529486227|FG001|Overall Study|Not treated on protocol study|0|||
146813194|NCT00807599|529486228|FG002|Overall Study|Not treated on protocol study|2|||
146813195|NCT00807599|529486226|FG000|Overall Study|Adverse Event|0|||
146813196|NCT00807599|529486227|FG001|Overall Study|Adverse Event|0|||
146813197|NCT00807599|529486228|FG002|Overall Study|Adverse Event|5|||
146813198|NCT00807599|529486226|FG000|Overall Study|Inadequate response to induction|0|||
146813199|NCT00807599|529486227|FG001|Overall Study|Inadequate response to induction|0|||
146813200|NCT00807599|529486228|FG002|Overall Study|Inadequate response to induction|9|||
146813201|NCT00807599|529486226|FG000|Overall Study|Withdrawal by Subject|0|||
146813202|NCT00807599|529486227|FG001|Overall Study|Withdrawal by Subject|0|||
146984307|NCT00905489|530103406|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
146813203|NCT00807599|529486228|FG002|Overall Study|Withdrawal by Subject|1|||
146813204|NCT03695185|529486229|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
146813205|NCT03695185|529486229|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
146813206|NCT03695185|529486229|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
146813207|NCT03695185|529486229|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
146813208|NCT03695185|529486229|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
146813209|NCT03695185|529486229|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
146813210|NCT05376397|529486232|FG000|Overall Study|Lost to Follow-up|1|||
146813211|NCT01535261|529486235|FG000|Overall Study|Physician Decision|8|||
146813212|NCT01535261|529486235|FG000|Overall Study|Protocol Violation|3|||
146813213|NCT01535261|529486235|FG000|Overall Study|Death|5|||
146813214|NCT01535261|529486235|FG000|Overall Study|Lost to Follow-up|8|||
146813215|NCT01535261|529486235|FG000|Overall Study|Withdrawal by Subject|14|||
146813216|NCT01535261|529486235|FG000|Overall Study|Adverse Event|12|||
146813217|NCT01137682|529486236|FG000|Overall Study|Adverse Event-CORE|2|||
146813218|NCT01137682|529486237|FG001|Overall Study|Adverse Event-CORE|4|||
146813219|NCT01137682|529486238|FG002|Overall Study|Adverse Event-CORE|0|||
146813220|NCT01137682|529486236|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
146813221|NCT01137682|529486237|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
146813222|NCT01137682|529486238|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
146813223|NCT01137682|529486236|FG000|Overall Study|Administrative problems-CORE|2|||
146813224|NCT01137682|529486237|FG001|Overall Study|Administrative problems-CORE|1|||
146813225|NCT01137682|529486238|FG002|Overall Study|Administrative problems-CORE|0|||
146813226|NCT01137682|529486236|FG000|Overall Study|Protocol Violation-CORE|0|||
146813227|NCT01137682|529486237|FG001|Overall Study|Protocol Violation-CORE|1|||
146813228|NCT01137682|529486238|FG002|Overall Study|Protocol Violation-CORE|1|||
146813229|NCT01137682|529486236|FG000|Overall Study|Adverse Event-Extension|4|||
146813230|NCT01137682|529486237|FG001|Overall Study|Adverse Event-Extension|8|||
146813231|NCT01137682|529486238|FG002|Overall Study|Adverse Event-Extension|7|||
146813232|NCT01137682|529486236|FG000|Overall Study|Lack of Efficacy-Extension|15|||
146813233|NCT01137682|529486237|FG001|Overall Study|Lack of Efficacy-Extension|9|||
146813234|NCT01137682|529486238|FG002|Overall Study|Lack of Efficacy-Extension|13|||
146813235|NCT01137682|529486236|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
146813236|NCT01137682|529486237|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
146813237|NCT01137682|529486238|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
146813238|NCT01137682|529486236|FG000|Overall Study|Lost to Follow Up-Extension|0|||
146813239|NCT01137682|529486237|FG001|Overall Study|Lost to Follow Up-Extension|1|||
146813240|NCT01137682|529486238|FG002|Overall Study|Lost to Follow Up-Extension|0|||
146813241|NCT01137682|529486236|FG000|Overall Study|Administrative problems-Extension|0|||
146813242|NCT01137682|529486237|FG001|Overall Study|Administrative problems-Extension|2|||
146813243|NCT01137682|529486238|FG002|Overall Study|Administrative problems-Extension|0|||
146813244|NCT01137682|529486236|FG000|Overall Study|Death-Extension|2|||
146813245|NCT01137682|529486237|FG001|Overall Study|Death-Extension|0|||
146813246|NCT01137682|529486238|FG002|Overall Study|Death-Extension|0|||
146813247|NCT01137682|529486236|FG000|Overall Study|Protocol Violation-Extension|2|||
146813248|NCT01137682|529486237|FG001|Overall Study|Protocol Violation-Extension|1|||
146813249|NCT01137682|529486238|FG002|Overall Study|Protocol Violation-Extension|0|||
146813250|NCT01137682|529486236|FG000|Overall Study|Did not enter extension|2|||
146813251|NCT01137682|529486237|FG001|Overall Study|Did not enter extension|3|||
146813252|NCT01137682|529486238|FG002|Overall Study|Did not enter extension|2|||
146813253|NCT01137682|529486236|FG000|Overall Study|Did not receive treatment in extension|0|||
146813254|NCT01137682|529486237|FG001|Overall Study|Did not receive treatment in extension|0|||
146813255|NCT01137682|529486238|FG002|Overall Study|Did not receive treatment in extension|1|||
146813256|NCT02525744|529486242|FG000|Period 1|Physician Decision|0|||
146813257|NCT02525744|529486243|FG001|Period 1|Physician Decision|0|||
146813258|NCT02525744|529486244|FG002|Period 1|Physician Decision|1|||
146813259|NCT02525744|529486245|FG003|Period 1|Physician Decision|0|||
146813260|NCT02525744|529486242|FG000|Period 3|Adverse Event|0|||
146813261|NCT02525744|529486243|FG001|Period 3|Adverse Event|1|||
146813262|NCT02525744|529486244|FG002|Period 3|Adverse Event|0|||
146813263|NCT02525744|529486245|FG003|Period 3|Adverse Event|0|||
146813264|NCT02525744|529486242|FG000|Period 4|Withdrawal by Subject|1|||
146813265|NCT02525744|529486243|FG001|Period 4|Withdrawal by Subject|0|||
146813266|NCT02525744|529486244|FG002|Period 4|Withdrawal by Subject|0|||
146813267|NCT02525744|529486245|FG003|Period 4|Withdrawal by Subject|0|||
146813268|NCT02525744|529486242|FG000|Period 5|Physician Decision|1|||
146813269|NCT02525744|529486243|FG001|Period 5|Physician Decision|0|||
146813270|NCT02525744|529486244|FG002|Period 5|Physician Decision|0|||
146813271|NCT02525744|529486245|FG003|Period 5|Physician Decision|0|||
146813272|NCT00472082|529486246|FG000|Overall Study|Study prematurely terminated|5|||
146813273|NCT02069379|529486247|FG000|Baseline Measurements|Lost to Follow-up|1|||
146813274|NCT02069379|529486248|FG001|Baseline Measurements|Lost to Follow-up|0|||
146813275|NCT02069379|529486249|FG002|Baseline Measurements|Lost to Follow-up|0|||
146813276|NCT02069379|529486250|FG003|Baseline Measurements|Lost to Follow-up|0|||
146813277|NCT02069379|529486247|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
146813278|NCT02069379|529486248|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
146813279|NCT02069379|529486249|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
146813280|NCT02069379|529486250|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
146813281|NCT02069379|529486247|FG000|First Treatment Arm|Lost to Follow-up|0|||
146813282|NCT02069379|529486248|FG001|First Treatment Arm|Lost to Follow-up|1|||
146813283|NCT02069379|529486249|FG002|First Treatment Arm|Lost to Follow-up|1|||
146813284|NCT02069379|529486250|FG003|First Treatment Arm|Lost to Follow-up|0|||
146813285|NCT02069379|529486247|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
146813286|NCT02069379|529486248|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
146813287|NCT02069379|529486249|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
146813288|NCT02069379|529486250|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
146813289|NCT02069379|529486247|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
146813290|NCT02069379|529486248|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
146813291|NCT02069379|529486249|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
146813292|NCT02069379|529486250|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
146813293|NCT02069379|529486247|FG000|Second Treatment Arm|Lost to Follow-up|0|||
146813294|NCT02069379|529486248|FG001|Second Treatment Arm|Lost to Follow-up|0|||
146813295|NCT02069379|529486249|FG002|Second Treatment Arm|Lost to Follow-up|1|||
146813296|NCT02069379|529486250|FG003|Second Treatment Arm|Lost to Follow-up|0|||
146813297|NCT04421456|529486251|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
146813298|NCT04421456|529486252|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
146813299|NCT04421456|529486253|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
146813300|NCT04421456|529486251|FG000|Randomized Treatment Period|Adverse Event|0|||
146813301|NCT04421456|529486252|FG001|Randomized Treatment Period|Adverse Event|1|||
146813302|NCT04421456|529486253|FG002|Randomized Treatment Period|Adverse Event|0|||
146813303|NCT04421456|529486251|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
146813304|NCT04421456|529486252|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
146813305|NCT04421456|529486253|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
146813306|NCT04421456|529486251|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
146813307|NCT04421456|529486252|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
146813308|NCT04421456|529486253|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
146813309|NCT04421456|529486251|FG000|Randomized Treatment Period|Participant non-compliance|1|||
146813310|NCT04421456|529486252|FG001|Randomized Treatment Period|Participant non-compliance|1|||
146813311|NCT04421456|529486253|FG002|Randomized Treatment Period|Participant non-compliance|2|||
146813312|NCT04421456|529486251|FG000|Randomized Treatment Period|Other|0|||
146813313|NCT04421456|529486252|FG001|Randomized Treatment Period|Other|1|||
146813314|NCT04421456|529486253|FG002|Randomized Treatment Period|Other|3|||
146813315|NCT04617847|529486254|FG000|Overall Study|Withdrawal by Subject|1|||
146813316|NCT04617847|529486255|FG001|Overall Study|Withdrawal by Subject|0|||
146813317|NCT04617847|529486254|FG000|Overall Study|Adverse Event|0|||
146813318|NCT04617847|529486255|FG001|Overall Study|Adverse Event|2|||
146813319|NCT04617847|529486254|FG000|Overall Study|Death|0|||
146813320|NCT04617847|529486255|FG001|Overall Study|Death|1|||
146813321|NCT04617847|529486254|FG000|Overall Study|Termination of Study by Sponsor|2|||
146813322|NCT04617847|529486255|FG001|Overall Study|Termination of Study by Sponsor|21|||
146813323|NCT02206607|529486256|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
146813324|NCT02206607|529486257|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
146813325|NCT02206607|529486258|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
146813326|NCT02206607|529486259|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
146813327|NCT02206607|529486260|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
146813328|NCT02206607|529486256|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
146813329|NCT02206607|529486257|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
146813330|NCT02206607|529486258|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
146813331|NCT02206607|529486259|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
146813332|NCT02206607|529486260|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
146813333|NCT04183491|529486265|FG000|Overall Study|Withdrawal by Subject|0|||
146813334|NCT04183491|529486266|FG001|Overall Study|Withdrawal by Subject|0|||
146813335|NCT04183491|529486267|FG002|Overall Study|Withdrawal by Subject|1|||
146813336|NCT04183491|529486268|FG003|Overall Study|Withdrawal by Subject|0|||
146813337|NCT04183491|529486269|FG004|Overall Study|Withdrawal by Subject|0|||
146813338|NCT04183491|529486270|FG005|Overall Study|Withdrawal by Subject|1|||
146813339|NCT04183491|529486271|FG006|Overall Study|Withdrawal by Subject|0|||
146813340|NCT03989232|529486275|FG000|Overall Study|Lost to Follow-up|3|||
146944505|NCT02865928|529956358|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
146944506|NCT02865928|529956359|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
146944507|NCT01925014|529956366|FG000|Overall Study|Inappropriate enrollment|4|||
146813341|NCT03989232|529486276|FG001|Overall Study|Lost to Follow-up|10|||
146813342|NCT03989232|529486275|FG000|Overall Study|Withdrawal by Subject|6|||
146813343|NCT03989232|529486276|FG001|Overall Study|Withdrawal by Subject|6|||
146813344|NCT03989232|529486275|FG000|Overall Study|Death|1|||
146813345|NCT03989232|529486276|FG001|Overall Study|Death|2|||
146813346|NCT01930188|529486277|FG000|Overall Study|unclassified|4|||
146813347|NCT01930188|529486278|FG001|Overall Study|unclassified|5|||
146813348|NCT01930188|529486279|FG002|Overall Study|unclassified|3|||
146813349|NCT01930188|529486277|FG000|Overall Study|Missing follow-up information|2|||
146813350|NCT01930188|529486278|FG001|Overall Study|Missing follow-up information|2|||
146813351|NCT01930188|529486279|FG002|Overall Study|Missing follow-up information|3|||
146813352|NCT01930188|529486277|FG000|Overall Study|Lost to Follow-up|5|||
146813353|NCT01930188|529486278|FG001|Overall Study|Lost to Follow-up|2|||
146813354|NCT01930188|529486279|FG002|Overall Study|Lost to Follow-up|2|||
146813355|NCT01930188|529486277|FG000|Overall Study|Death|2|||
146813356|NCT01930188|529486278|FG001|Overall Study|Death|1|||
146813357|NCT01930188|529486279|FG002|Overall Study|Death|3|||
146813358|NCT01930188|529486277|FG000|Overall Study|Withdrawal by Subject|9|||
146813359|NCT01930188|529486278|FG001|Overall Study|Withdrawal by Subject|11|||
146813360|NCT01930188|529486279|FG002|Overall Study|Withdrawal by Subject|8|||
146813361|NCT00337610|529486282|FG000|Overall Study|Adverse Event|2|||
146813362|NCT00337610|529486283|FG001|Overall Study|Adverse Event|2|||
146813363|NCT00337610|529486282|FG000|Overall Study|Death|0|||
146813364|NCT00337610|529486283|FG001|Overall Study|Death|1|||
146813365|NCT00337610|529486282|FG000|Overall Study|Lack of Efficacy|6|||
146813366|NCT00337610|529486283|FG001|Overall Study|Lack of Efficacy|3|||
146813367|NCT00337610|529486282|FG000|Overall Study|Lost to Follow-up|3|||
146813368|NCT00337610|529486283|FG001|Overall Study|Lost to Follow-up|3|||
146813369|NCT00337610|529486282|FG000|Overall Study|Withdrawal by Subject|6|||
146813370|NCT00337610|529486283|FG001|Overall Study|Withdrawal by Subject|5|||
146813371|NCT04867382|529486286|FG000|Overall Study|Did not complete the survey|2|||
146813372|NCT04867382|529486287|FG001|Overall Study|Did not complete the survey|1|||
146813373|NCT02102724|529486292|FG000|Overall Study|Lost to Follow-up|1|||
146813374|NCT02102724|529486293|FG001|Overall Study|Lost to Follow-up|0|||
146813375|NCT02102724|529486292|FG000|Overall Study|surgery for brain aneurysm|1|||
146813376|NCT02102724|529486293|FG001|Overall Study|surgery for brain aneurysm|1|||
146813377|NCT02203513|529486297|FG000|Overall Study|Refused further treatment|2|||
146813378|NCT02203513|529486298|FG001|Overall Study|Refused further treatment|0|||
146813379|NCT02203513|529486299|FG002|Overall Study|Refused further treatment|1|||
146813380|NCT02203513|529486300|FG003|Overall Study|Refused further treatment|0|||
146813381|NCT02203513|529486301|FG004|Overall Study|Refused further treatment|0|||
146813382|NCT02203513|529486297|FG000|Overall Study|Switched to alternative treatment|3|||
146813383|NCT02203513|529486298|FG001|Overall Study|Switched to alternative treatment|4|||
146813384|NCT02203513|529486299|FG002|Overall Study|Switched to alternative treatment|0|||
146813385|NCT02203513|529486300|FG003|Overall Study|Switched to alternative treatment|0|||
146813386|NCT02203513|529486301|FG004|Overall Study|Switched to alternative treatment|4|||
146813387|NCT02203513|529486297|FG000|Overall Study|Did not receive investigational product (IP)|0|||
146813388|NCT02203513|529486298|FG001|Overall Study|Did not receive investigational product (IP)|1|||
146813389|NCT02203513|529486299|FG002|Overall Study|Did not receive investigational product (IP)|0|||
146813390|NCT02203513|529486300|FG003|Overall Study|Did not receive investigational product (IP)|0|||
146813391|NCT02203513|529486301|FG004|Overall Study|Did not receive investigational product (IP)|0|||
146813392|NCT02203513|529486297|FG000|Overall Study|Death (unrelated to study therapy)|1|||
146813393|NCT02203513|529486298|FG001|Overall Study|Death (unrelated to study therapy)|3|||
146813394|NCT02203513|529486299|FG002|Overall Study|Death (unrelated to study therapy)|1|||
146813395|NCT02203513|529486300|FG003|Overall Study|Death (unrelated to study therapy)|0|||
146813396|NCT02203513|529486301|FG004|Overall Study|Death (unrelated to study therapy)|2|||
146813397|NCT02203513|529486297|FG000|Overall Study|Lost to Follow-up|0|||
146813398|NCT02203513|529486298|FG001|Overall Study|Lost to Follow-up|0|||
146813399|NCT02203513|529486299|FG002|Overall Study|Lost to Follow-up|1|||
146813400|NCT02203513|529486300|FG003|Overall Study|Lost to Follow-up|1|||
146813401|NCT02203513|529486301|FG004|Overall Study|Lost to Follow-up|0|||
146813402|NCT01441596|529486302|FG000|Overall Study|Other reason not defined below|0|||
146813403|NCT01441596|529486303|FG001|Overall Study|Other reason not defined below|2|||
146813404|NCT01441596|529486304|FG002|Overall Study|Other reason not defined below|1|||
146813405|NCT01441596|529486302|FG000|Overall Study|Withdrawal by Subject|4|||
146984308|NCT00905489|530103406|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
146984309|NCT00905489|530103406|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
146984310|NCT00583596|530103407|FG000|Overall Study|Lost to Follow-up|110|||
146813406|NCT01441596|529486303|FG001|Overall Study|Withdrawal by Subject|0|||
146813407|NCT01441596|529486304|FG002|Overall Study|Withdrawal by Subject|2|||
146813408|NCT01441596|529486302|FG000|Overall Study|Not treated|0|||
146813409|NCT01441596|529486303|FG001|Overall Study|Not treated|1|||
146813410|NCT01441596|529486304|FG002|Overall Study|Not treated|1|||
146813411|NCT02008916|529486305|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
146813412|NCT02008916|529486306|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
146813413|NCT02008916|529486307|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
146813414|NCT02008916|529486305|FG000|Week 16 - 156|Adverse Event|4|||
146813415|NCT02008916|529486306|FG001|Week 16 - 156|Adverse Event|2|||
146813416|NCT02008916|529486307|FG002|Week 16 - 156|Adverse Event|3|||
146813417|NCT02008916|529486305|FG000|Week 16 - 156|Withdrawal by Subject|7|||
146813418|NCT02008916|529486306|FG001|Week 16 - 156|Withdrawal by Subject|3|||
146813419|NCT02008916|529486307|FG002|Week 16 - 156|Withdrawal by Subject|5|||
146813420|NCT02008916|529486305|FG000|Week 16 - 156|No longer requires treatment|0|||
146813421|NCT02008916|529486306|FG001|Week 16 - 156|No longer requires treatment|1|||
146813422|NCT02008916|529486307|FG002|Week 16 - 156|No longer requires treatment|0|||
146813423|NCT02008916|529486305|FG000|Week 16 - 156|Lost to Follow-up|5|||
146813424|NCT02008916|529486306|FG001|Week 16 - 156|Lost to Follow-up|0|||
146813425|NCT02008916|529486307|FG002|Week 16 - 156|Lost to Follow-up|0|||
146813426|NCT02008916|529486305|FG000|Week 16 - 156|Lack of Efficacy|3|||
146813427|NCT02008916|529486306|FG001|Week 16 - 156|Lack of Efficacy|5|||
146813428|NCT02008916|529486307|FG002|Week 16 - 156|Lack of Efficacy|2|||
146813429|NCT02008916|529486305|FG000|Week 16 - 156|Pregnancy|0|||
146813430|NCT02008916|529486306|FG001|Week 16 - 156|Pregnancy|1|||
146813431|NCT02008916|529486307|FG002|Week 16 - 156|Pregnancy|0|||
146813432|NCT02008916|529486305|FG000|Week 16 - 156|Physician Decision|0|||
146813433|NCT02008916|529486306|FG001|Week 16 - 156|Physician Decision|1|||
146813434|NCT02008916|529486307|FG002|Week 16 - 156|Physician Decision|0|||
146813435|NCT01528605|529486308|FG000|Overall Study|Lost to Follow-up|1|||
146813436|NCT01528605|529486309|FG001|Overall Study|Lost to Follow-up|0|||
146813437|NCT01528605|529486310|FG002|Overall Study|Lost to Follow-up|1|||
146813438|NCT01528605|529486311|FG003|Overall Study|Lost to Follow-up|1|||
146813439|NCT01528605|529486312|FG004|Overall Study|Lost to Follow-up|0|||
146813440|NCT01528605|529486313|FG005|Overall Study|Lost to Follow-up|0|||
146813441|NCT01528605|529486308|FG000|Overall Study|Death|1|||
146813442|NCT01528605|529486309|FG001|Overall Study|Death|0|||
146813443|NCT01528605|529486310|FG002|Overall Study|Death|0|||
146813444|NCT01528605|529486311|FG003|Overall Study|Death|0|||
146813445|NCT01528605|529486312|FG004|Overall Study|Death|0|||
146813446|NCT01528605|529486313|FG005|Overall Study|Death|0|||
146813447|NCT01681511|529486314|FG000|Overall Study|No Treatment Received|1|||
146813448|NCT01681511|529486315|FG001|Overall Study|No Treatment Received|3|||
146813449|NCT01681511|529486314|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
146813450|NCT01681511|529486315|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
146813451|NCT01681511|529486314|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
146813452|NCT01681511|529486315|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
146813453|NCT01681511|529486314|FG000|Overall Study|No Daily Urine Sample Collected|0|||
146813454|NCT01681511|529486315|FG001|Overall Study|No Daily Urine Sample Collected|1|||
146813455|NCT01681511|529486314|FG000|Overall Study|No post-catheter sample collected|11|||
146813456|NCT01681511|529486315|FG001|Overall Study|No post-catheter sample collected|4|||
146813457|NCT01156675|529486316|FG000|Overall Study|Death|5|||
146813458|NCT01156675|529486317|FG001|Overall Study|Death|3|||
146813459|NCT01156675|529486318|FG002|Overall Study|Death|0|||
146813460|NCT01156675|529486316|FG000|Overall Study|No data|29|||
146813461|NCT01156675|529486317|FG001|Overall Study|No data|22|||
146813462|NCT01156675|529486318|FG002|Overall Study|No data|2|||
146813463|NCT02432274|529486332|FG000|Overall Study|Death|2|||
146813464|NCT02432274|529486333|FG001|Overall Study|Death|6|||
146813465|NCT02432274|529486334|FG002|Overall Study|Death|7|||
146813466|NCT02432274|529486335|FG003|Overall Study|Death|0|||
146813467|NCT02432274|529486336|FG004|Overall Study|Death|27|||
146813468|NCT02432274|529486337|FG005|Overall Study|Death|7|||
146813469|NCT02432274|529486338|FG006|Overall Study|Death|9|||
146813470|NCT02432274|529486339|FG007|Overall Study|Death|14|||
146813471|NCT02432274|529486332|FG000|Overall Study|Withdrawal of Consent|0|||
146813472|NCT02432274|529486333|FG001|Overall Study|Withdrawal of Consent|0|||
146813473|NCT02432274|529486334|FG002|Overall Study|Withdrawal of Consent|0|||
146813474|NCT02432274|529486335|FG003|Overall Study|Withdrawal of Consent|0|||
146813475|NCT02432274|529486336|FG004|Overall Study|Withdrawal of Consent|2|||
146813476|NCT02432274|529486337|FG005|Overall Study|Withdrawal of Consent|0|||
146813477|NCT02432274|529486338|FG006|Overall Study|Withdrawal of Consent|1|||
146813478|NCT02432274|529486339|FG007|Overall Study|Withdrawal of Consent|2|||
146813479|NCT00090519|529486340|FG000|Overall Study|Adverse Event|5|||
146813480|NCT00090519|529486341|FG001|Overall Study|Adverse Event|4|||
146813481|NCT00090519|529486340|FG000|Overall Study|Death|9|||
146813482|NCT00090519|529486341|FG001|Overall Study|Death|9|||
146813483|NCT00090519|529486340|FG000|Overall Study|Lost to Follow-up|26|||
146813484|NCT00090519|529486341|FG001|Overall Study|Lost to Follow-up|29|||
146813485|NCT00090519|529486340|FG000|Overall Study|Withdrawal by Subject|28|||
146813486|NCT00090519|529486341|FG001|Overall Study|Withdrawal by Subject|29|||
146813487|NCT00090519|529486340|FG000|Overall Study|Physician Decision|2|||
146813488|NCT00090519|529486341|FG001|Overall Study|Physician Decision|3|||
146813489|NCT00090519|529486340|FG000|Overall Study|Sponsor Decision|3|||
146813490|NCT00090519|529486341|FG001|Overall Study|Sponsor Decision|1|||
146813491|NCT00116649|529486342|FG000|Overall Study|Adverse Event|20|||
146813492|NCT00116649|529486342|FG000|Overall Study|Lack of Efficacy|1|||
146813493|NCT00116649|529486342|FG000|Overall Study|Lost to Follow-up|32|||
146813494|NCT00116649|529486342|FG000|Overall Study|Withdrawal by Subject|68|||
146813495|NCT00116649|529486342|FG000|Overall Study|Local Skin Reaction|9|||
146813496|NCT00116649|529486342|FG000|Overall Study|Various Reasons|18|||
146813497|NCT00116649|529486342|FG000|Overall Study|Protocol Specified|7|||
146813498|NCT02161146|529486343|FG000|Overall Study|Adverse Event|1|||
146813499|NCT02161146|529486344|FG001|Overall Study|Adverse Event|1|||
146813500|NCT02161146|529486345|FG002|Overall Study|Adverse Event|0|||
146813501|NCT02161146|529486346|FG003|Overall Study|Adverse Event|1|||
146813502|NCT02161146|529486347|FG004|Overall Study|Adverse Event|0|||
146813503|NCT02161146|529486343|FG000|Overall Study|Lost to Follow-up|0|||
146813504|NCT02161146|529486344|FG001|Overall Study|Lost to Follow-up|1|||
146813505|NCT02161146|529486345|FG002|Overall Study|Lost to Follow-up|0|||
146813506|NCT02161146|529486346|FG003|Overall Study|Lost to Follow-up|0|||
146813507|NCT02161146|529486347|FG004|Overall Study|Lost to Follow-up|0|||
146813508|NCT02161146|529486343|FG000|Overall Study|Personal Reasons|0|||
146813509|NCT02161146|529486344|FG001|Overall Study|Personal Reasons|1|||
146813510|NCT02161146|529486345|FG002|Overall Study|Personal Reasons|0|||
146813511|NCT02161146|529486346|FG003|Overall Study|Personal Reasons|2|||
146813512|NCT02161146|529486347|FG004|Overall Study|Personal Reasons|1|||
146813513|NCT02161146|529486343|FG000|Overall Study|Other Miscellaneous Reasons|0|||
146813514|NCT02161146|529486344|FG001|Overall Study|Other Miscellaneous Reasons|1|||
146813515|NCT02161146|529486345|FG002|Overall Study|Other Miscellaneous Reasons|0|||
146813516|NCT02161146|529486346|FG003|Overall Study|Other Miscellaneous Reasons|0|||
146813517|NCT02161146|529486347|FG004|Overall Study|Other Miscellaneous Reasons|0|||
146813518|NCT00845520|529486348|FG000|Overall Study|Death|1|||
146813519|NCT00845520|529486349|FG001|Overall Study|Death|2|||
146813520|NCT00845520|529486350|FG002|Overall Study|Death|0|||
146813521|NCT00845520|529486348|FG000|Overall Study|Lost to Follow-up|1|||
146813522|NCT00845520|529486349|FG001|Overall Study|Lost to Follow-up|0|||
146813523|NCT00845520|529486350|FG002|Overall Study|Lost to Follow-up|0|||
146813524|NCT00845520|529486348|FG000|Overall Study|Adverse Event|0|||
146813525|NCT00845520|529486349|FG001|Overall Study|Adverse Event|0|||
146813526|NCT00845520|529486350|FG002|Overall Study|Adverse Event|1|||
146813527|NCT02613403|529486351|FG000|Overall Study|Lost to Follow-up|0|||
146813528|NCT02613403|529486352|FG001|Overall Study|Lost to Follow-up|1|||
146813529|NCT02613403|529486353|FG002|Overall Study|Lost to Follow-up|0|||
146813530|NCT02613403|529486354|FG003|Overall Study|Lost to Follow-up|0|||
146813531|NCT02613403|529486355|FG004|Overall Study|Lost to Follow-up|0|||
146813532|NCT02613403|529486351|FG000|Overall Study|Withdrawal by Subject|2|||
146813533|NCT02613403|529486352|FG001|Overall Study|Withdrawal by Subject|0|||
146813534|NCT02613403|529486353|FG002|Overall Study|Withdrawal by Subject|0|||
146813535|NCT02613403|529486354|FG003|Overall Study|Withdrawal by Subject|0|||
146813536|NCT02613403|529486355|FG004|Overall Study|Withdrawal by Subject|0|||
146813537|NCT02807857|529486356|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
146813538|NCT02807857|529486356|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
146813539|NCT02807857|529486356|FG000|Follow-Up Set|Withdrawal by Subject|8|||
146813540|NCT02807857|529486356|FG000|Follow-Up Set|Lost to Follow-up|7|||
146813541|NCT02807857|529486356|FG000|Follow-Up Set|Physician Decision|6|||
146813542|NCT02807857|529486356|FG000|Follow-Up Set|Adverse Event|3|||
146813543|NCT02807857|529486356|FG000|Follow-Up Set|Death|27|||
146813544|NCT02807857|529486356|FG000|Follow-Up Set|Relocation|2|||
146813545|NCT00800176|529486357|FG000|Overall Study|Adverse Event|2|||
146813546|NCT00800176|529486358|FG001|Overall Study|Adverse Event|1|||
146813547|NCT00800176|529486359|FG002|Overall Study|Adverse Event|0|||
146813548|NCT00800176|529486360|FG003|Overall Study|Adverse Event|2|||
146813549|NCT00800176|529486361|FG004|Overall Study|Adverse Event|1|||
146813550|NCT00800176|529486362|FG005|Overall Study|Adverse Event|1|||
146813551|NCT00800176|529486357|FG000|Overall Study|Refused treatment|3|||
146813552|NCT00800176|529486358|FG001|Overall Study|Refused treatment|2|||
146813553|NCT00800176|529486359|FG002|Overall Study|Refused treatment|0|||
146813554|NCT00800176|529486360|FG003|Overall Study|Refused treatment|0|||
146813555|NCT00800176|529486361|FG004|Overall Study|Refused treatment|1|||
146813556|NCT00800176|529486362|FG005|Overall Study|Refused treatment|4|||
146813557|NCT00800176|529486357|FG000|Overall Study|Failure to return|3|||
146813558|NCT00800176|529486358|FG001|Overall Study|Failure to return|3|||
146813559|NCT00800176|529486359|FG002|Overall Study|Failure to return|0|||
146813560|NCT00800176|529486360|FG003|Overall Study|Failure to return|2|||
146813561|NCT00800176|529486361|FG004|Overall Study|Failure to return|0|||
146813562|NCT00800176|529486362|FG005|Overall Study|Failure to return|0|||
146813563|NCT00800176|529486357|FG000|Overall Study|Other|1|||
146813564|NCT00800176|529486358|FG001|Overall Study|Other|0|||
146813565|NCT00800176|529486359|FG002|Overall Study|Other|0|||
146813566|NCT00800176|529486360|FG003|Overall Study|Other|0|||
146813567|NCT00800176|529486361|FG004|Overall Study|Other|2|||
146813568|NCT00800176|529486362|FG005|Overall Study|Other|0|||
146813569|NCT01240590|529486365|FG000|Phase I|Refused further treatment|0|||
146813570|NCT01240590|529486366|FG001|Phase I|Refused further treatment|0|||
146813571|NCT01240590|529486367|FG002|Phase I|Refused further treatment|3|||
146813572|NCT01240590|529486368|FG003|Phase I|Refused further treatment|0|||
146813573|NCT01240590|529486369|FG004|Phase I|Refused further treatment|0|||
146813574|NCT01240590|529486365|FG000|Phase II|Refused further treatment|0|||
146813575|NCT01240590|529486366|FG001|Phase II|Refused further treatment|0|||
146813576|NCT01240590|529486367|FG002|Phase II|Refused further treatment|0|||
146813577|NCT01240590|529486368|FG003|Phase II|Refused further treatment|2|||
146813578|NCT01240590|529486369|FG004|Phase II|Refused further treatment|1|||
146813579|NCT01075152|529486371|FG000|Overall Study|Withdrawal by Subject|1|||
146813580|NCT01075152|529486372|FG001|Overall Study|Withdrawal by Subject|0|||
146813581|NCT01079949|529486373|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
146813582|NCT01079949|529486374|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
146813583|NCT01079949|529486373|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
146813584|NCT01079949|529486374|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
146813585|NCT01079949|529486373|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
146813586|NCT01079949|529486374|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
146813587|NCT01079949|529486373|FG000|Overall Study|Randomized but not treated|1|||
146813588|NCT01079949|529486374|FG001|Overall Study|Randomized but not treated|0|||
146813589|NCT02144285|529486375|FG000|Overall Study|Withdrawal by Subject|0|||
146813590|NCT02144285|529486376|FG001|Overall Study|Withdrawal by Subject|0|||
146813591|NCT02144285|529486377|FG002|Overall Study|Withdrawal by Subject|0|||
146813592|NCT02144285|529486378|FG003|Overall Study|Withdrawal by Subject|0|||
146813593|NCT02144285|529486379|FG004|Overall Study|Withdrawal by Subject|1|||
146813594|NCT02144285|529486380|FG005|Overall Study|Withdrawal by Subject|0|||
146813595|NCT02144285|529486381|FG006|Overall Study|Withdrawal by Subject|0|||
146813596|NCT02144285|529486382|FG007|Overall Study|Withdrawal by Subject|0|||
146813597|NCT02144285|529486383|FG008|Overall Study|Withdrawal by Subject|0|||
146813598|NCT02144285|529486384|FG009|Overall Study|Withdrawal by Subject|0|||
146813599|NCT01529632|529486385|FG000|Overall Study|Administrative problem|2|||
146813600|NCT01529632|529486386|FG001|Overall Study|Administrative problem|1|||
146813601|NCT01529632|529486385|FG000|Overall Study|Protocol Violation|0|||
146813602|NCT01529632|529486386|FG001|Overall Study|Protocol Violation|1|||
146813603|NCT01529632|529486385|FG000|Overall Study|Adverse Event|1|||
146813604|NCT01529632|529486386|FG001|Overall Study|Adverse Event|1|||
146813605|NCT00452452|529486387|FG000|Overall Study|Protocol Violation|0|||
146813606|NCT00452452|529486388|FG001|Overall Study|Protocol Violation|0|||
146813607|NCT00452452|529486389|FG002|Overall Study|Protocol Violation|1|||
146813608|NCT00452452|529486387|FG000|Overall Study|Withdrawal by Subject|1|||
146813609|NCT00452452|529486388|FG001|Overall Study|Withdrawal by Subject|0|||
146813610|NCT00452452|529486389|FG002|Overall Study|Withdrawal by Subject|0|||
146813611|NCT00452452|529486387|FG000|Overall Study|Lost to Follow-up|1|||
146813612|NCT00452452|529486388|FG001|Overall Study|Lost to Follow-up|0|||
146813613|NCT00452452|529486389|FG002|Overall Study|Lost to Follow-up|0|||
146813614|NCT03840200|529487823|FG000|Overall Study|Death|6|||
146813615|NCT03840200|529487824|FG001|Overall Study|Death|3|||
146813616|NCT03840200|529487825|FG002|Overall Study|Death|6|||
146813617|NCT03840200|529487826|FG003|Overall Study|Death|10|||
146813618|NCT03840200|529487823|FG000|Overall Study|Reason Not Specified|2|||
146813619|NCT03840200|529487824|FG001|Overall Study|Reason Not Specified|2|||
146813620|NCT03840200|529487825|FG002|Overall Study|Reason Not Specified|1|||
146813621|NCT03840200|529487826|FG003|Overall Study|Reason Not Specified|15|||
146813622|NCT03840200|529487823|FG000|Overall Study|Physician Decision|0|||
146813623|NCT03840200|529487824|FG001|Overall Study|Physician Decision|0|||
146813624|NCT03840200|529487825|FG002|Overall Study|Physician Decision|0|||
146813625|NCT03840200|529487826|FG003|Overall Study|Physician Decision|2|||
146813626|NCT03840200|529487823|FG000|Overall Study|Progressive Disease|0|||
146813627|NCT03840200|529487824|FG001|Overall Study|Progressive Disease|0|||
146813628|NCT03840200|529487825|FG002|Overall Study|Progressive Disease|0|||
146813629|NCT03840200|529487826|FG003|Overall Study|Progressive Disease|1|||
146813630|NCT03840200|529487823|FG000|Overall Study|Withdrawal by Subject|0|||
146813631|NCT03840200|529487824|FG001|Overall Study|Withdrawal by Subject|1|||
146813632|NCT03840200|529487825|FG002|Overall Study|Withdrawal by Subject|0|||
146813633|NCT03840200|529487826|FG003|Overall Study|Withdrawal by Subject|2|||
146813634|NCT05487300|529487827|FG000|Overall Study|Withdrawal by Subject|1|||
146813635|NCT05487300|529487828|FG001|Overall Study|Withdrawal by Subject|0|||
146813636|NCT03141177|529487829|FG000|Overall Study|Death|62|||
146813637|NCT03141177|529487830|FG001|Overall Study|Death|13|||
146944508|NCT01925014|529956367|FG001|Overall Study|Inappropriate enrollment|6|||
146944509|NCT01925014|529956366|FG000|Overall Study|Withdrawal by Subject|5|||
146944510|NCT01925014|529956367|FG001|Overall Study|Withdrawal by Subject|13|||
146944511|NCT01690988|529956370|FG000|Overall Study|Withdrawal by Subject|2|||
146944512|NCT01690988|529956371|FG001|Overall Study|Withdrawal by Subject|2|||
146944513|NCT01690988|529956372|FG002|Overall Study|Withdrawal by Subject|3|||
146944514|NCT01690988|529956370|FG000|Overall Study|Physician Decision|0|||
146944515|NCT01690988|529956371|FG001|Overall Study|Physician Decision|0|||
146944516|NCT01690988|529956372|FG002|Overall Study|Physician Decision|1|||
146944517|NCT01690988|529956370|FG000|Overall Study|Operation Cancelled|1|||
146813638|NCT03141177|529487831|FG002|Overall Study|Death|84|||
146813639|NCT03141177|529487829|FG000|Overall Study|Participant withdrew consent|9|||
146813640|NCT03141177|529487830|FG001|Overall Study|Participant withdrew consent|2|||
146813641|NCT03141177|529487831|FG002|Overall Study|Participant withdrew consent|13|||
146813642|NCT03141177|529487829|FG000|Overall Study|Not reported|1|||
146813643|NCT03141177|529487830|FG001|Overall Study|Not reported|0|||
146813644|NCT03141177|529487831|FG002|Overall Study|Not reported|1|||
146813645|NCT03141177|529487829|FG000|Overall Study|Lost to Follow-up|2|||
146813646|NCT03141177|529487830|FG001|Overall Study|Lost to Follow-up|1|||
146813647|NCT03141177|529487831|FG002|Overall Study|Lost to Follow-up|1|||
146813648|NCT03141177|529487829|FG000|Overall Study|Other reasons|4|||
146813649|NCT03141177|529487830|FG001|Overall Study|Other reasons|0|||
146813650|NCT03141177|529487831|FG002|Overall Study|Other reasons|11|||
146813651|NCT03141177|529487829|FG000|Overall Study|Participants did not start treatment period|3|||
146813652|NCT03141177|529487830|FG001|Overall Study|Participants did not start treatment period|0|||
146813653|NCT03141177|529487831|FG002|Overall Study|Participants did not start treatment period|8|||
146813654|NCT05006703|529487832|FG000|Overall Study|Withdrawal by Subject|1|||
146813655|NCT05006703|529487833|FG001|Overall Study|Withdrawal by Subject|0|||
146813656|NCT05006703|529487832|FG000|Overall Study|Lost to Follow-up|13|||
146813657|NCT05006703|529487833|FG001|Overall Study|Lost to Follow-up|5|||
146813658|NCT04620733|529487836|FG000|Overall Study|Adverse Event|4|||
146813659|NCT04620733|529487837|FG001|Overall Study|Adverse Event|3|||
146813660|NCT04620733|529487836|FG000|Overall Study|Withdrawal by Subject|2|||
146813661|NCT04620733|529487837|FG001|Overall Study|Withdrawal by Subject|5|||
146813662|NCT04620733|529487836|FG000|Overall Study|Lost to Follow-up|1|||
146813663|NCT04620733|529487837|FG001|Overall Study|Lost to Follow-up|1|||
146813664|NCT04620733|529487836|FG000|Overall Study|Protocol Deviation|1|||
146813665|NCT04620733|529487837|FG001|Overall Study|Protocol Deviation|1|||
146813666|NCT04620733|529487836|FG000|Overall Study|Reason Not Specified|0|||
146813667|NCT04620733|529487837|FG001|Overall Study|Reason Not Specified|1|||
146813668|NCT02196259|529487845|FG000|Overall Study|Researcher choice|0|||
146813669|NCT02196259|529487846|FG001|Overall Study|Researcher choice|0|||
146813670|NCT02196259|529487847|FG002|Overall Study|Researcher choice|1|||
146813671|NCT02196259|529487845|FG000|Overall Study|Partial data analysis|0|||
146813672|NCT02196259|529487846|FG001|Overall Study|Partial data analysis|3|||
146813673|NCT02196259|529487847|FG002|Overall Study|Partial data analysis|0|||
146813674|NCT00264576|529487848|FG000|Overall Study|Lost to Follow-up|1|||
146813675|NCT00264576|529487849|FG001|Overall Study|Lost to Follow-up|1|||
146813676|NCT02659059|529487852|FG000|Overall Study|Other reasons|6|||
146813677|NCT02659059|529487853|FG001|Overall Study|Other reasons|1|||
146813678|NCT02659059|529487852|FG000|Overall Study|Disease Progression|143|||
146813679|NCT02659059|529487853|FG001|Overall Study|Disease Progression|16|||
146813680|NCT02659059|529487852|FG000|Overall Study|Study Drug toxicity|56|||
146813681|NCT02659059|529487853|FG001|Overall Study|Study Drug toxicity|9|||
146813682|NCT02659059|529487852|FG000|Overall Study|Death|3|||
146813683|NCT02659059|529487853|FG001|Overall Study|Death|1|||
146813684|NCT02659059|529487852|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
146813685|NCT02659059|529487853|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
146813686|NCT02659059|529487852|FG000|Overall Study|Participant request to discontinue study treatment|5|||
146813687|NCT02659059|529487853|FG001|Overall Study|Participant request to discontinue study treatment|0|||
146813688|NCT02659059|529487852|FG000|Overall Study|Participant withdrew consent|6|||
146813689|NCT02659059|529487853|FG001|Overall Study|Participant withdrew consent|1|||
146813690|NCT00092456|529487859|FG000|Overall Study|Adverse Event|0|||
146813691|NCT00092456|529487860|FG001|Overall Study|Adverse Event|0|||
146813692|NCT00092456|529487861|FG002|Overall Study|Adverse Event|1|||
146813693|NCT00092456|529487862|FG003|Overall Study|Adverse Event|1|||
146813694|NCT00092456|529487859|FG000|Overall Study|Lost to Follow-up|2|||
146813695|NCT00092456|529487860|FG001|Overall Study|Lost to Follow-up|2|||
146813696|NCT00092456|529487861|FG002|Overall Study|Lost to Follow-up|1|||
146813697|NCT00092456|529487862|FG003|Overall Study|Lost to Follow-up|2|||
146813698|NCT00092456|529487859|FG000|Overall Study|Protocol Violation|5|||
146813699|NCT00092456|529487860|FG001|Overall Study|Protocol Violation|7|||
146813700|NCT00092456|529487861|FG002|Overall Study|Protocol Violation|8|||
146813701|NCT00092456|529487862|FG003|Overall Study|Protocol Violation|6|||
146813702|NCT00092456|529487859|FG000|Overall Study|Withdrawal by Subject|13|||
146813703|NCT00092456|529487860|FG001|Overall Study|Withdrawal by Subject|5|||
146813704|NCT00092456|529487861|FG002|Overall Study|Withdrawal by Subject|16|||
146813705|NCT00092456|529487862|FG003|Overall Study|Withdrawal by Subject|6|||
146813706|NCT00092456|529487859|FG000|Overall Study|Moved|1|||
146813707|NCT00092456|529487860|FG001|Overall Study|Moved|1|||
146813708|NCT00092456|529487861|FG002|Overall Study|Moved|0|||
146813709|NCT00092456|529487862|FG003|Overall Study|Moved|1|||
146813710|NCT00092456|529487859|FG000|Overall Study|Other|4|||
146813711|NCT00092456|529487860|FG001|Overall Study|Other|2|||
146813712|NCT00092456|529487861|FG002|Overall Study|Other|3|||
146813713|NCT00092456|529487862|FG003|Overall Study|Other|0|||
146813714|NCT04783389|529487863|FG000|Overall Study|Withdrawal by Subject|2|||
146813715|NCT04783389|529487864|FG001|Overall Study|Withdrawal by Subject|0|||
146813716|NCT04783389|529487865|FG002|Overall Study|Withdrawal by Subject|0|||
146813717|NCT04783389|529487863|FG000|Overall Study|Termination of Study by Sponsor|10|||
146813718|NCT04783389|529487864|FG001|Overall Study|Termination of Study by Sponsor|12|||
146813719|NCT04783389|529487865|FG002|Overall Study|Termination of Study by Sponsor|14|||
146813720|NCT00451906|529487866|FG000|Overall Study|Adverse Event|515|||
146813721|NCT00451906|529487866|FG000|Overall Study|Lost to Follow-up|31|||
146813722|NCT00451906|529487866|FG000|Overall Study|Withdrawal by Subject|111|||
146813723|NCT00451906|529487866|FG000|Overall Study|Protocol Violation|21|||
146813724|NCT00451906|529487866|FG000|Overall Study|Progressive disease|1328|||
146813725|NCT00451906|529487866|FG000|Overall Study|Termination of the study|108|||
146813726|NCT00451906|529487866|FG000|Overall Study|Other Reasons|121|||
146813727|NCT00451906|529487866|FG000|Overall Study|Did not complete final visit|4|||
146813728|NCT02121808|529487872|FG000|Overall Study|Technical problem|3|||
146813729|NCT02164578|529487873|FG000|Treatment Period|Withdrawal by Subject|3|||
146813730|NCT02164578|529487874|FG001|Treatment Period|Withdrawal by Subject|3|||
146813731|NCT02164578|529487873|FG000|Treatment Period|Adverse Event|13|||
146813732|NCT02164578|529487874|FG001|Treatment Period|Adverse Event|6|||
146813733|NCT02164578|529487873|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
146813734|NCT02164578|529487874|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
146813735|NCT02164578|529487873|FG000|Treatment Period|Protocol Violation|0|||
146813736|NCT02164578|529487874|FG001|Treatment Period|Protocol Violation|2|||
146813737|NCT02164578|529487873|FG000|Extension Period|Withdrawal by Subject|2|||
146813738|NCT02164578|529487874|FG001|Extension Period|Withdrawal by Subject|0|||
146813739|NCT02164578|529487873|FG000|Extension Period|Adverse Event|4|||
146813740|NCT02164578|529487874|FG001|Extension Period|Adverse Event|0|||
146813741|NCT02164578|529487873|FG000|Extension Period|Expiry of study medication|1|||
146813742|NCT02164578|529487874|FG001|Extension Period|Expiry of study medication|0|||
146813743|NCT02164578|529487873|FG000|Extension Period|Protocol Violation|0|||
146813744|NCT02164578|529487874|FG001|Extension Period|Protocol Violation|1|||
146813745|NCT03924193|529487875|FG000|Overall Study|Adverse Event|10|||
146813746|NCT03924193|529487876|FG001|Overall Study|Adverse Event|0|||
146813747|NCT03924193|529487877|FG002|Overall Study|Adverse Event|10|||
146813748|NCT03924193|529487875|FG000|Overall Study|Withdrawal by Subject|5|||
146813749|NCT03924193|529487876|FG001|Overall Study|Withdrawal by Subject|10|||
146813750|NCT03924193|529487877|FG002|Overall Study|Withdrawal by Subject|2|||
146813751|NCT00647699|529487878|FG000|Overall Study|Lost to Follow-up|5|||
146813752|NCT00647699|529487879|FG001|Overall Study|Lost to Follow-up|4|||
146813753|NCT00647699|529487878|FG000|Overall Study|Withdrawal by Subject|3|||
146813754|NCT00647699|529487879|FG001|Overall Study|Withdrawal by Subject|8|||
146813755|NCT03029585|529487880|FG000|Overall Study|Death|1|||
146813756|NCT03029585|529487881|FG001|Overall Study|Death|1|||
146813757|NCT03029585|529487880|FG000|Overall Study|Withdrawal by Subject|1|||
146813758|NCT03029585|529487881|FG001|Overall Study|Withdrawal by Subject|0|||
146813759|NCT02165202|529487882|FG000|Oral Phase|Refused further participation|5|||
146813760|NCT02165202|529487883|FG001|Oral Phase|Refused further participation|1|||
146813761|NCT02165202|529487882|FG000|Oral Phase|Study product Related Toxicity|1|||
146813762|NCT02165202|529487883|FG001|Oral Phase|Study product Related Toxicity|0|||
146813763|NCT02165202|529487882|FG000|Oral Phase|Unable to contact Participant|1|||
146813764|NCT02165202|529487883|FG001|Oral Phase|Unable to contact Participant|1|||
146813765|NCT02165202|529487882|FG000|Oral Phase|Clinical reasons|1|||
146813766|NCT02165202|529487883|FG001|Oral Phase|Clinical reasons|0|||
146813767|NCT02165202|529487882|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
146813768|NCT02165202|529487883|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
146813769|NCT02165202|529487882|FG000|Oral Phase|CMC advised termination|1|||
146813770|NCT02165202|529487883|FG001|Oral Phase|CMC advised termination|0|||
146813771|NCT02165202|529487882|FG000|Oral Phase|Relocated, no follow-up planned|1|||
146813772|NCT02165202|529487883|FG001|Oral Phase|Relocated, no follow-up planned|0|||
146813773|NCT02165202|529487882|FG000|Oral Phase|Abnormal EKG|0|||
146813774|NCT02165202|529487883|FG001|Oral Phase|Abnormal EKG|1|||
146813775|NCT02165202|529487882|FG000|Injection Phase|Abnormal Lab Value|5|||
146813776|NCT02165202|529487883|FG001|Injection Phase|Abnormal Lab Value|1|||
146813777|NCT02165202|529487882|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
146813778|NCT02165202|529487883|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
146813779|NCT02165202|529487882|FG000|Injection Phase|Unable to attend within Visit Window|1|||
146813780|NCT02165202|529487883|FG001|Injection Phase|Unable to attend within Visit Window|0|||
146813781|NCT02165202|529487882|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
146813782|NCT02165202|529487883|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
146813783|NCT02165202|529487882|FG000|Injection Phase|End of Study|2|||
146813784|NCT02165202|529487883|FG001|Injection Phase|End of Study|1|||
146813785|NCT02165202|529487882|FG000|Injection Phase|Study Product related Toxicity|1|||
146813786|NCT02165202|529487883|FG001|Injection Phase|Study Product related Toxicity|0|||
146813787|NCT02165202|529487882|FG000|Injection Phase|No longer interested|0|||
146813788|NCT02165202|529487883|FG001|Injection Phase|No longer interested|1|||
146813789|NCT02165202|529487882|FG000|Injection Phase|Participant unwilling to comply|1|||
146813790|NCT02165202|529487883|FG001|Injection Phase|Participant unwilling to comply|0|||
146813791|NCT01975701|529487891|FG000|Overall Study|Lost to Follow-up|1|||
146813792|NCT01975701|529487891|FG000|Overall Study|Death|23|||
146813793|NCT01975701|529487891|FG000|Overall Study|Physician Decision|1|||
146813794|NCT02753075|529487892|FG000|Overall Study|Adverse Event|2|||
146813795|NCT02753075|529487893|FG001|Overall Study|Adverse Event|1|||
146813796|NCT02753075|529487894|FG002|Overall Study|Adverse Event|0|||
146813797|NCT02753075|529487892|FG000|Overall Study|Lost to Follow-up|2|||
146813798|NCT02753075|529487893|FG001|Overall Study|Lost to Follow-up|0|||
146813799|NCT02753075|529487894|FG002|Overall Study|Lost to Follow-up|0|||
146813800|NCT02753075|529487892|FG000|Overall Study|Withdrawal of Consent|1|||
146813801|NCT02753075|529487893|FG001|Overall Study|Withdrawal of Consent|1|||
146813802|NCT02753075|529487894|FG002|Overall Study|Withdrawal of Consent|3|||
146813803|NCT02753075|529487892|FG000|Overall Study|Physician Decision|3|||
146813804|NCT02753075|529487893|FG001|Overall Study|Physician Decision|1|||
146813805|NCT02753075|529487894|FG002|Overall Study|Physician Decision|0|||
146813806|NCT02152384|529487897|FG000|Period 1|Withdrawal by Subject|0|||
146813807|NCT02152384|529487898|FG001|Period 1|Withdrawal by Subject|1|||
146813808|NCT02152384|529487897|FG000|Period 1|Adverse Event|1|||
146813809|NCT02152384|529487898|FG001|Period 1|Adverse Event|1|||
146813810|NCT00603798|529487901|FG000|Overall Study|Adverse Event|4|||
146813811|NCT00603798|529487902|FG001|Overall Study|Adverse Event|2|||
146813812|NCT00603798|529487903|FG002|Overall Study|Adverse Event|1|||
146813813|NCT00603798|529487901|FG000|Overall Study|Withdrawal by Subject|4|||
146813814|NCT00603798|529487902|FG001|Overall Study|Withdrawal by Subject|3|||
146813815|NCT00603798|529487903|FG002|Overall Study|Withdrawal by Subject|4|||
146813816|NCT00603798|529487901|FG000|Overall Study|Lost to Follow-up|1|||
146813817|NCT00603798|529487902|FG001|Overall Study|Lost to Follow-up|0|||
146813818|NCT00603798|529487903|FG002|Overall Study|Lost to Follow-up|1|||
146813819|NCT00603798|529487901|FG000|Overall Study|Non-compliance with study procedures|0|||
146813820|NCT00603798|529487902|FG001|Overall Study|Non-compliance with study procedures|1|||
146813821|NCT00603798|529487903|FG002|Overall Study|Non-compliance with study procedures|0|||
146813822|NCT00603798|529487901|FG000|Overall Study|Not due to AE|1|||
146813823|NCT00603798|529487902|FG001|Overall Study|Not due to AE|1|||
146813824|NCT00603798|529487903|FG002|Overall Study|Not due to AE|4|||
146813825|NCT04361617|529487907|FG000|Overall Study|Withdrawal by Subject|0|||
146813826|NCT04361617|529487908|FG001|Overall Study|Withdrawal by Subject|1|||
146813827|NCT02005484|529487910|FG000|Overall Study|Death|1|||
146813828|NCT02005484|529487910|FG000|Overall Study|Disease progression|1|||
146813829|NCT02005484|529487910|FG000|Overall Study|Changed to a Different Study|1|||
146813830|NCT02005484|529487910|FG000|Overall Study|Sponsor decision|1|||
146813831|NCT02584257|529487916|FG000|Period 1|Withdrawal by Subject|0|||
146813832|NCT02584257|529487917|FG001|Period 1|Withdrawal by Subject|0|||
146813833|NCT02584257|529487918|FG002|Period 1|Withdrawal by Subject|0|||
146813834|NCT02584257|529487919|FG003|Period 1|Withdrawal by Subject|0|||
146813835|NCT02584257|529487920|FG004|Period 1|Withdrawal by Subject|0|||
146813836|NCT02584257|529487921|FG005|Period 1|Withdrawal by Subject|0|||
146813837|NCT02584257|529487922|FG006|Period 1|Withdrawal by Subject|1|||
146813838|NCT02584257|529487923|FG007|Period 1|Withdrawal by Subject|0|||
146813839|NCT02584257|529487924|FG008|Period 1|Withdrawal by Subject|0|||
146813840|NCT02584257|529487916|FG000|Period 2|Physician Decision|1|||
146813841|NCT02584257|529487917|FG001|Period 2|Physician Decision|0|||
146813842|NCT02584257|529487918|FG002|Period 2|Physician Decision|0|||
146813843|NCT02584257|529487919|FG003|Period 2|Physician Decision|0|||
146813844|NCT02584257|529487920|FG004|Period 2|Physician Decision|0|||
146813845|NCT02584257|529487921|FG005|Period 2|Physician Decision|0|||
146813846|NCT02584257|529487922|FG006|Period 2|Physician Decision|0|||
146813847|NCT02584257|529487923|FG007|Period 2|Physician Decision|0|||
146813848|NCT02584257|529487924|FG008|Period 2|Physician Decision|0|||
146813849|NCT02584257|529487916|FG000|Period 2|Adverse Event|0|||
146813850|NCT02584257|529487917|FG001|Period 2|Adverse Event|1|||
146813851|NCT02584257|529487918|FG002|Period 2|Adverse Event|0|||
146813852|NCT02584257|529487919|FG003|Period 2|Adverse Event|0|||
146813853|NCT02584257|529487920|FG004|Period 2|Adverse Event|0|||
146813854|NCT02584257|529487921|FG005|Period 2|Adverse Event|0|||
146813855|NCT02584257|529487922|FG006|Period 2|Adverse Event|0|||
146813856|NCT02584257|529487923|FG007|Period 2|Adverse Event|0|||
146813857|NCT02584257|529487924|FG008|Period 2|Adverse Event|0|||
146813858|NCT02137785|529487925|FG000|Overall Study|Lost to Follow-up|1|||
146813859|NCT02137785|529487926|FG001|Overall Study|Lost to Follow-up|0|||
146813860|NCT02137785|529487925|FG000|Overall Study|Withdrawal by Subject|1|||
146813861|NCT02137785|529487926|FG001|Overall Study|Withdrawal by Subject|4|||
146813862|NCT02137785|529487925|FG000|Overall Study|subject moved out of state|1|||
146813863|NCT02137785|529487926|FG001|Overall Study|subject moved out of state|0|||
146813864|NCT01670877|529487927|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
146944518|NCT01690988|529956371|FG001|Overall Study|Operation Cancelled|1|||
146944519|NCT01690988|529956372|FG002|Overall Study|Operation Cancelled|0|||
146813865|NCT01670877|529487928|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
146813866|NCT01670877|529487929|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
146813867|NCT01670877|529487930|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
146813868|NCT01670877|529487931|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
146813869|NCT01670877|529487932|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
146813870|NCT01670877|529487927|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
146813871|NCT01670877|529487928|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
146813872|NCT01670877|529487929|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
146813873|NCT01670877|529487930|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
146813874|NCT01670877|529487931|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
146813875|NCT01670877|529487932|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
146813876|NCT01670877|529487927|FG000|Part I and Part 2|Grade 2 vomiting|0|||
146813877|NCT01670877|529487928|FG001|Part I and Part 2|Grade 2 vomiting|0|||
146813878|NCT01670877|529487929|FG002|Part I and Part 2|Grade 2 vomiting|0|||
146813879|NCT01670877|529487930|FG003|Part I and Part 2|Grade 2 vomiting|1|||
146813880|NCT01670877|529487931|FG004|Part I and Part 2|Grade 2 vomiting|0|||
146813881|NCT01670877|529487932|FG005|Part I and Part 2|Grade 2 vomiting|0|||
146813882|NCT01670877|529487927|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
146813883|NCT01670877|529487928|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
146813884|NCT01670877|529487929|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
146813885|NCT01670877|529487930|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
146813886|NCT01670877|529487931|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
146813887|NCT01670877|529487932|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
146813888|NCT01670877|529487927|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
146813889|NCT01670877|529487928|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
146813890|NCT01670877|529487929|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
146813891|NCT01670877|529487930|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
146813892|NCT01670877|529487931|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
146813893|NCT01670877|529487932|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
146813894|NCT00417885|529487933|FG000|Overall Study|Adverse Event|1|||
146813895|NCT00417885|529487933|FG000|Overall Study|Objective Progression or Relapse|3|||
146813896|NCT00417885|529487933|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
146813897|NCT02309892|529487934|FG000|Overall Study|Physician Decision|1|||
146813898|NCT02309892|529487935|FG001|Overall Study|Physician Decision|0|||
146813899|NCT02309892|529487936|FG002|Overall Study|Physician Decision|0|||
146813900|NCT02309892|529487937|FG003|Overall Study|Physician Decision|0|||
146813901|NCT02309892|529487938|FG004|Overall Study|Physician Decision|0|||
146813902|NCT02309892|529487939|FG005|Overall Study|Physician Decision|0|||
146813903|NCT02309892|529487940|FG006|Overall Study|Physician Decision|0|||
146813904|NCT02309892|529487934|FG000|Overall Study|Adverse Event|1|||
146813905|NCT02309892|529487935|FG001|Overall Study|Adverse Event|0|||
146813906|NCT02309892|529487936|FG002|Overall Study|Adverse Event|1|||
146813907|NCT02309892|529487937|FG003|Overall Study|Adverse Event|0|||
146813908|NCT02309892|529487938|FG004|Overall Study|Adverse Event|0|||
146813909|NCT02309892|529487939|FG005|Overall Study|Adverse Event|0|||
146813910|NCT02309892|529487940|FG006|Overall Study|Adverse Event|0|||
146813911|NCT02309892|529487934|FG000|Overall Study|Progressive Disease|0|||
146813912|NCT02309892|529487935|FG001|Overall Study|Progressive Disease|1|||
146813913|NCT02309892|529487936|FG002|Overall Study|Progressive Disease|0|||
146813914|NCT02309892|529487937|FG003|Overall Study|Progressive Disease|0|||
146813915|NCT02309892|529487938|FG004|Overall Study|Progressive Disease|1|||
146813916|NCT02309892|529487939|FG005|Overall Study|Progressive Disease|0|||
146813917|NCT02309892|529487940|FG006|Overall Study|Progressive Disease|0|||
146813918|NCT02309892|529487934|FG000|Overall Study|Death|0|||
146813919|NCT02309892|529487935|FG001|Overall Study|Death|0|||
146813920|NCT02309892|529487936|FG002|Overall Study|Death|0|||
146813921|NCT02309892|529487937|FG003|Overall Study|Death|0|||
146813922|NCT02309892|529487938|FG004|Overall Study|Death|0|||
146813923|NCT02309892|529487939|FG005|Overall Study|Death|1|||
146813924|NCT02309892|529487940|FG006|Overall Study|Death|0|||
146813925|NCT01584648|529487941|FG000|Overall Study|Death|136|||
146813926|NCT01584648|529487942|FG001|Overall Study|Death|146|||
146813927|NCT01584648|529487941|FG000|Overall Study|Lost to Follow-up|9|||
146813928|NCT01584648|529487942|FG001|Overall Study|Lost to Follow-up|9|||
146813929|NCT01584648|529487941|FG000|Overall Study|Investigator discretion|3|||
146813930|NCT01584648|529487942|FG001|Overall Study|Investigator discretion|2|||
146813931|NCT01584648|529487941|FG000|Overall Study|Withdrew consent|13|||
146813932|NCT01584648|529487942|FG001|Overall Study|Withdrew consent|4|||
146813933|NCT01584648|529487941|FG000|Overall Study|Study closed/terminated|50|||
146813934|NCT01584648|529487942|FG001|Overall Study|Study closed/terminated|23|||
146813935|NCT01584648|529487941|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
146813936|NCT01584648|529487942|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
146813937|NCT02009332|529487945|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
146813938|NCT02009332|529487946|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
146813939|NCT02009332|529487947|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
146813940|NCT02009332|529487948|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
146813941|NCT02009332|529487949|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
146813942|NCT02009332|529487950|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
146984311|NCT00583596|530103407|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
146813943|NCT02009332|529487945|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
146813944|NCT02009332|529487946|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
146813945|NCT02009332|529487947|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
146813946|NCT02009332|529487948|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
146813947|NCT02009332|529487949|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
146813948|NCT02009332|529487950|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
146813949|NCT02009332|529487945|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
146813950|NCT02009332|529487946|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
146813951|NCT02009332|529487947|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
146813952|NCT02009332|529487948|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
146813953|NCT02009332|529487949|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
146813954|NCT02009332|529487950|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
146813955|NCT01912599|529487951|FG000|Overall Study|Withdrawal by Subject|0|||
146813956|NCT01912599|529487952|FG001|Overall Study|Withdrawal by Subject|1|||
146813957|NCT03449979|529487960|FG000|Overall Study|Technical difficulty|0|||
146813958|NCT03449979|529487961|FG001|Overall Study|Technical difficulty|0|||
146813959|NCT03449979|529487962|FG002|Overall Study|Technical difficulty|0|||
146813960|NCT03449979|529487963|FG003|Overall Study|Technical difficulty|1|||
146813961|NCT00068107|529487964|FG000|Overall Study|end-stage renal disease|6|||
146813962|NCT00068107|529487964|FG000|Overall Study|Death|2|||
146813963|NCT00068107|529487964|FG000|Overall Study|Withdrawal by Subject|1|||
146813964|NCT03288506|529487965|FG000|Overall Study|Withdrawal by Subject|52|||
146813965|NCT02644122|529487969|FG000|Overall Study|Withdrawal by Subject|1|||
146813966|NCT00805441|529487972|FG000|Overall Study|Adverse Event|5|||
146813967|NCT00805441|529487973|FG001|Overall Study|Adverse Event|2|||
146813968|NCT00805441|529487972|FG000|Overall Study|Lack of Efficacy|0|||
146813969|NCT00805441|529487973|FG001|Overall Study|Lack of Efficacy|2|||
146813970|NCT00805441|529487972|FG000|Overall Study|Protocol Violation|4|||
146813971|NCT00805441|529487973|FG001|Overall Study|Protocol Violation|8|||
146813972|NCT00805441|529487972|FG000|Overall Study|Lost to Follow-up|10|||
146813973|NCT00805441|529487973|FG001|Overall Study|Lost to Follow-up|13|||
146813974|NCT00805441|529487972|FG000|Overall Study|Withdrawal by Subject|15|||
146813975|NCT00805441|529487973|FG001|Overall Study|Withdrawal by Subject|9|||
146813976|NCT00805441|529487972|FG000|Overall Study|Physician Decision|0|||
146813977|NCT00805441|529487973|FG001|Overall Study|Physician Decision|1|||
146813978|NCT00805441|529487972|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
146813979|NCT00805441|529487973|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
146813980|NCT02935894|529487975|FG000|Overall Study|Subject dismissed|1|||
146813981|NCT03786471|529487978|FG000|Overall Study|Death|254|||
146813982|NCT03786471|529487979|FG001|Overall Study|Death|223|||
146813983|NCT03786471|529487980|FG002|Overall Study|Death|37|||
146813984|NCT03786471|529487978|FG000|Overall Study|Lost to Follow-up|63|||
146813985|NCT03786471|529487979|FG001|Overall Study|Lost to Follow-up|50|||
146813986|NCT03786471|529487980|FG002|Overall Study|Lost to Follow-up|15|||
146813987|NCT03786471|529487978|FG000|Overall Study|Withdrawal by Subject|99|||
146813988|NCT03786471|529487979|FG001|Overall Study|Withdrawal by Subject|81|||
146813989|NCT03786471|529487980|FG002|Overall Study|Withdrawal by Subject|11|||
146813990|NCT03976102|529489789|FG000|Overall Study|Withdrawal by Subject|4|||
146813991|NCT03976102|529489790|FG001|Overall Study|Withdrawal by Subject|4|||
146813992|NCT03976102|529489789|FG000|Overall Study|Adverse Event|2|||
146813993|NCT03976102|529489790|FG001|Overall Study|Adverse Event|4|||
146813994|NCT03976102|529489789|FG000|Overall Study|Not related to Covid-19|9|||
146813995|NCT03976102|529489790|FG001|Overall Study|Not related to Covid-19|13|||
146813996|NCT03976102|529489789|FG000|Overall Study|Lost to Follow-up|0|||
146813997|NCT03976102|529489790|FG001|Overall Study|Lost to Follow-up|2|||
146813998|NCT03976102|529489789|FG000|Overall Study|Death|3|||
146813999|NCT03976102|529489790|FG001|Overall Study|Death|2|||
146814000|NCT03976102|529489789|FG000|Overall Study|Physician Decision|1|||
146814001|NCT03976102|529489790|FG001|Overall Study|Physician Decision|1|||
146814002|NCT05066230|529489793|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
146814003|NCT05066230|529489794|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
146814004|NCT05066230|529489793|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
146814005|NCT05066230|529489794|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
146814006|NCT05066230|529489793|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
146814007|NCT05066230|529489794|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
146814008|NCT05066230|529489793|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
146814009|NCT05066230|529489794|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
146814010|NCT05066230|529489793|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
146814011|NCT05066230|529489794|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
146814012|NCT05066230|529489793|FG000|After Week 48|Adverse Event|1|||
146814013|NCT05066230|529489794|FG001|After Week 48|Adverse Event|0|||
146814014|NCT05066230|529489793|FG000|After Week 48|Non-compliance with study schedule|1|||
146814015|NCT05066230|529489794|FG001|After Week 48|Non-compliance with study schedule|0|||
146814016|NCT05066230|529489793|FG000|After Week 48|Withdrawal by Subject|0|||
146814017|NCT05066230|529489794|FG001|After Week 48|Withdrawal by Subject|1|||
146814018|NCT05066230|529489793|FG000|After Week 48|Lost to Follow-up|3|||
146814019|NCT05066230|529489794|FG001|After Week 48|Lost to Follow-up|3|||
146814020|NCT05066230|529489793|FG000|After Week 48|Sponsor Request|115|||
146814021|NCT05066230|529489794|FG001|After Week 48|Sponsor Request|111|||
146814022|NCT03072238|529489795|FG000|Overall Study|Withdrawal by Subject|44|||
146814023|NCT03072238|529489796|FG001|Overall Study|Withdrawal by Subject|64|||
146814024|NCT03072238|529489795|FG000|Overall Study|Lost to Follow-up|14|||
146814025|NCT03072238|529489796|FG001|Overall Study|Lost to Follow-up|5|||
146814026|NCT03072238|529489795|FG000|Overall Study|Physician Decision|4|||
146814027|NCT03072238|529489796|FG001|Overall Study|Physician Decision|6|||
146814028|NCT03072238|529489795|FG000|Overall Study|Death|351|||
146814029|NCT03072238|529489796|FG001|Overall Study|Death|318|||
146814030|NCT03072238|529489795|FG000|Overall Study|Progressive Disease|3|||
146814031|NCT03072238|529489796|FG001|Overall Study|Progressive Disease|4|||
146814032|NCT03072238|529489795|FG000|Overall Study|Reason Not Specified|138|||
146814033|NCT03072238|529489796|FG001|Overall Study|Reason Not Specified|150|||
146814034|NCT01562275|529489802|FG000|Stage 1|Adverse Event|0|||
146814035|NCT01562275|529489803|FG001|Stage 1|Adverse Event|0|||
146814036|NCT01562275|529489804|FG002|Stage 1|Adverse Event|0|||
146814037|NCT01562275|529489805|FG003|Stage 1|Adverse Event|1|||
146814038|NCT01562275|529489806|FG004|Stage 1|Adverse Event|1|||
146814039|NCT01562275|529489807|FG005|Stage 1|Adverse Event|0|||
146814040|NCT01562275|529489808|FG006|Stage 1|Adverse Event|0|||
146814041|NCT01562275|529489809|FG007|Stage 1|Adverse Event|0|||
146814042|NCT01562275|529489810|FG008|Stage 1|Adverse Event|0|||
146814043|NCT01562275|529489811|FG009|Stage 1|Adverse Event|1|||
146814044|NCT01562275|529489812|FG010|Stage 1|Adverse Event|0|||
146814045|NCT01562275|529489813|FG011|Stage 1|Adverse Event|0|||
146814046|NCT01562275|529489814|FG012|Stage 1|Adverse Event|0|||
146814047|NCT01562275|529489802|FG000|Stage 1|Death|1|||
146814048|NCT01562275|529489803|FG001|Stage 1|Death|0|||
146814049|NCT01562275|529489804|FG002|Stage 1|Death|0|||
146814050|NCT01562275|529489805|FG003|Stage 1|Death|0|||
146814051|NCT01562275|529489806|FG004|Stage 1|Death|0|||
146814052|NCT01562275|529489807|FG005|Stage 1|Death|0|||
146814053|NCT01562275|529489808|FG006|Stage 1|Death|0|||
146814054|NCT01562275|529489809|FG007|Stage 1|Death|0|||
146814055|NCT01562275|529489810|FG008|Stage 1|Death|0|||
146814056|NCT01562275|529489811|FG009|Stage 1|Death|0|||
146814057|NCT01562275|529489812|FG010|Stage 1|Death|0|||
146814058|NCT01562275|529489813|FG011|Stage 1|Death|0|||
146814059|NCT01562275|529489814|FG012|Stage 1|Death|0|||
146814060|NCT01562275|529489802|FG000|Stage 1|Non Compliance|0|||
146814061|NCT01562275|529489803|FG001|Stage 1|Non Compliance|0|||
146814062|NCT01562275|529489804|FG002|Stage 1|Non Compliance|1|||
146814063|NCT01562275|529489805|FG003|Stage 1|Non Compliance|0|||
146814064|NCT01562275|529489806|FG004|Stage 1|Non Compliance|0|||
146814065|NCT01562275|529489807|FG005|Stage 1|Non Compliance|0|||
146814066|NCT01562275|529489808|FG006|Stage 1|Non Compliance|0|||
146814067|NCT01562275|529489809|FG007|Stage 1|Non Compliance|0|||
146814068|NCT01562275|529489810|FG008|Stage 1|Non Compliance|0|||
146814069|NCT01562275|529489811|FG009|Stage 1|Non Compliance|0|||
146814070|NCT01562275|529489812|FG010|Stage 1|Non Compliance|0|||
146814071|NCT01562275|529489813|FG011|Stage 1|Non Compliance|0|||
146814072|NCT01562275|529489814|FG012|Stage 1|Non Compliance|0|||
146814073|NCT01562275|529489802|FG000|Stage 1|Physician Decision|0|||
146814074|NCT01562275|529489803|FG001|Stage 1|Physician Decision|0|||
146814075|NCT01562275|529489804|FG002|Stage 1|Physician Decision|0|||
146814076|NCT01562275|529489805|FG003|Stage 1|Physician Decision|0|||
146814077|NCT01562275|529489806|FG004|Stage 1|Physician Decision|1|||
146814078|NCT01562275|529489807|FG005|Stage 1|Physician Decision|0|||
146814079|NCT01562275|529489808|FG006|Stage 1|Physician Decision|1|||
146814080|NCT01562275|529489809|FG007|Stage 1|Physician Decision|0|||
146814081|NCT01562275|529489810|FG008|Stage 1|Physician Decision|1|||
146814082|NCT01562275|529489811|FG009|Stage 1|Physician Decision|0|||
146814083|NCT01562275|529489812|FG010|Stage 1|Physician Decision|0|||
146814084|NCT01562275|529489813|FG011|Stage 1|Physician Decision|0|||
146814085|NCT01562275|529489814|FG012|Stage 1|Physician Decision|0|||
146814086|NCT01562275|529489802|FG000|Stage 1|Progression of Disease|2|||
146814087|NCT01562275|529489803|FG001|Stage 1|Progression of Disease|6|||
146814088|NCT01562275|529489804|FG002|Stage 1|Progression of Disease|2|||
146814089|NCT01562275|529489805|FG003|Stage 1|Progression of Disease|1|||
146814090|NCT01562275|529489806|FG004|Stage 1|Progression of Disease|2|||
146814091|NCT01562275|529489807|FG005|Stage 1|Progression of Disease|4|||
146814092|NCT01562275|529489808|FG006|Stage 1|Progression of Disease|1|||
146814093|NCT01562275|529489809|FG007|Stage 1|Progression of Disease|7|||
146814094|NCT01562275|529489810|FG008|Stage 1|Progression of Disease|2|||
146814095|NCT01562275|529489811|FG009|Stage 1|Progression of Disease|5|||
146814096|NCT01562275|529489812|FG010|Stage 1|Progression of Disease|3|||
146814097|NCT01562275|529489813|FG011|Stage 1|Progression of Disease|0|||
146814098|NCT01562275|529489814|FG012|Stage 1|Progression of Disease|0|||
146814099|NCT01562275|529489802|FG000|Stage 1|Withdrawal by Subject|0|||
146814100|NCT01562275|529489803|FG001|Stage 1|Withdrawal by Subject|1|||
146814101|NCT01562275|529489804|FG002|Stage 1|Withdrawal by Subject|0|||
146814102|NCT01562275|529489805|FG003|Stage 1|Withdrawal by Subject|2|||
146814103|NCT01562275|529489806|FG004|Stage 1|Withdrawal by Subject|0|||
146814104|NCT01562275|529489807|FG005|Stage 1|Withdrawal by Subject|0|||
146814105|NCT01562275|529489808|FG006|Stage 1|Withdrawal by Subject|1|||
146814106|NCT01562275|529489809|FG007|Stage 1|Withdrawal by Subject|0|||
146814107|NCT01562275|529489810|FG008|Stage 1|Withdrawal by Subject|0|||
146814108|NCT01562275|529489811|FG009|Stage 1|Withdrawal by Subject|1|||
146814109|NCT01562275|529489812|FG010|Stage 1|Withdrawal by Subject|0|||
146814110|NCT01562275|529489813|FG011|Stage 1|Withdrawal by Subject|0|||
146814111|NCT01562275|529489814|FG012|Stage 1|Withdrawal by Subject|0|||
146814112|NCT01562275|529489802|FG000|Stage 2|Death|0|||
146814113|NCT01562275|529489803|FG001|Stage 2|Death|0|||
146814114|NCT01562275|529489804|FG002|Stage 2|Death|0|||
146814115|NCT01562275|529489805|FG003|Stage 2|Death|0|||
146814116|NCT01562275|529489806|FG004|Stage 2|Death|0|||
146814117|NCT01562275|529489807|FG005|Stage 2|Death|0|||
146814118|NCT01562275|529489808|FG006|Stage 2|Death|0|||
146814119|NCT01562275|529489809|FG007|Stage 2|Death|0|||
146814120|NCT01562275|529489810|FG008|Stage 2|Death|0|||
146814121|NCT01562275|529489811|FG009|Stage 2|Death|0|||
146814122|NCT01562275|529489812|FG010|Stage 2|Death|0|||
146814123|NCT01562275|529489813|FG011|Stage 2|Death|2|||
146814124|NCT01562275|529489814|FG012|Stage 2|Death|1|||
146814125|NCT01562275|529489802|FG000|Stage 2|Progression of Disease|0|||
146814126|NCT01562275|529489803|FG001|Stage 2|Progression of Disease|0|||
146814127|NCT01562275|529489804|FG002|Stage 2|Progression of Disease|0|||
146814128|NCT01562275|529489805|FG003|Stage 2|Progression of Disease|0|||
146814129|NCT01562275|529489806|FG004|Stage 2|Progression of Disease|0|||
146814130|NCT01562275|529489807|FG005|Stage 2|Progression of Disease|0|||
146814131|NCT01562275|529489808|FG006|Stage 2|Progression of Disease|0|||
146814132|NCT01562275|529489809|FG007|Stage 2|Progression of Disease|0|||
146814133|NCT01562275|529489810|FG008|Stage 2|Progression of Disease|0|||
146814134|NCT01562275|529489811|FG009|Stage 2|Progression of Disease|0|||
146814135|NCT01562275|529489812|FG010|Stage 2|Progression of Disease|0|||
146814136|NCT01562275|529489813|FG011|Stage 2|Progression of Disease|12|||
146814137|NCT01562275|529489814|FG012|Stage 2|Progression of Disease|4|||
146814138|NCT01863368|529489815|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
146814139|NCT01863368|529489816|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
146814140|NCT01863368|529489815|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
146814141|NCT01863368|529489816|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
146814142|NCT01863368|529489815|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
146814143|NCT01863368|529489816|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
146814144|NCT01863368|529489815|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
146814145|NCT01863368|529489816|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
146814146|NCT01863368|529489815|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
146814147|NCT01863368|529489816|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
146814148|NCT01863368|529489815|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
146814149|NCT01863368|529489816|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
146814150|NCT00515112|529489818|FG000|Overall Study|Death|0|||
146814151|NCT00515112|529489819|FG001|Overall Study|Death|1|||
146814152|NCT00515112|529489818|FG000|Overall Study|The study was terminated|3|||
146814153|NCT00515112|529489819|FG001|Overall Study|The study was terminated|2|||
146814154|NCT00307489|529489822|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
146814155|NCT00307489|529489823|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
146814156|NCT00307489|529489822|FG000|Baseline Through Week 48|Physician Decision|1|||
146814157|NCT00307489|529489823|FG001|Baseline Through Week 48|Physician Decision|0|||
146814158|NCT00307489|529489822|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
146814159|NCT00307489|529489823|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
146814160|NCT00307489|529489822|FG000|Week 48 Through Week 168|Adverse Event|1|||
146814161|NCT00307489|529489823|FG001|Week 48 Through Week 168|Adverse Event|0|||
146814162|NCT00307489|529489822|FG000|Week 48 Through Week 168|Physician Decision|1|||
146814163|NCT00307489|529489823|FG001|Week 48 Through Week 168|Physician Decision|0|||
146814164|NCT00307489|529489822|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
146814165|NCT00307489|529489823|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
146814166|NCT00307489|529489822|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
146814167|NCT00307489|529489823|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
146814168|NCT00307489|529489822|FG000|Week 48 Through Week 168|Death|0|||
146814169|NCT00307489|529489823|FG001|Week 48 Through Week 168|Death|1|||
146814170|NCT00307489|529489822|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
146814171|NCT00307489|529489823|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
146984312|NCT00583596|530103407|FG000|Overall Study|Death|2|||
146984313|NCT00583596|530103407|FG000|Overall Study|Withdrawal by Subject|6|||
146984314|NCT00583596|530103407|FG000|Overall Study|Lost to Follow-up|94|||
146814172|NCT00307489|529489822|FG000|Week 48 Through Week 168|Seroconversion|1|||
146814173|NCT00307489|529489823|FG001|Week 48 Through Week 168|Seroconversion|0|||
146814174|NCT00304278|529489825|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
146814175|NCT00304278|529489825|FG000|Overall Study|PT had medical condition preventing TX|1|||
146814176|NCT04025762|529489828|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
146814177|NCT04025762|529489829|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
146814178|NCT01286311|529489831|FG000|Overall Study|Physician did not want outreach sent|14|||
146814179|NCT01286311|529489832|FG001|Overall Study|Physician did not want outreach sent|0|||
146814180|NCT01381549|529489835|FG000|Overall Study|Ineligible: No organisms isolated|0|||
146814181|NCT01381549|529489836|FG001|Overall Study|Ineligible: No organisms isolated|0|||
146814182|NCT01381549|529489837|FG002|Overall Study|Ineligible: No organisms isolated|1|||
146814183|NCT02981953|529489838|FG000|Overall Study|Death|9|||
146814184|NCT02981953|529489838|FG000|Overall Study|Withdrawal by Subject|1|||
146814185|NCT02981953|529489838|FG000|Overall Study|Withdrawal to non-compliance|1|||
146814186|NCT02889900|529489839|FG000|Overall Study|Adverse Event|11|||
146814187|NCT02889900|529489839|FG000|Overall Study|Condition under investigation worsened|32|||
146814188|NCT02889900|529489839|FG000|Overall Study|Other|5|||
146814189|NCT02889900|529489839|FG000|Overall Study|Withdrawal by Subject|7|||
146814190|NCT02889900|529489839|FG000|Overall Study|Not treated|2|||
146814191|NCT00813709|529489850|FG000|Double Blind Period|Adverse Event|4|||
146814192|NCT00813709|529489851|FG001|Double Blind Period|Adverse Event|1|||
146814193|NCT00813709|529489852|FG002|Double Blind Period|Adverse Event|4|||
146814194|NCT00813709|529489853|FG003|Double Blind Period|Adverse Event|0|||
146814195|NCT00813709|529489854|FG004|Double Blind Period|Adverse Event|0|||
146814196|NCT00813709|529489855|FG005|Double Blind Period|Adverse Event|0|||
146814197|NCT00813709|529489850|FG000|Double Blind Period|Lost to Follow-up|3|||
146814198|NCT00813709|529489851|FG001|Double Blind Period|Lost to Follow-up|2|||
146814199|NCT00813709|529489852|FG002|Double Blind Period|Lost to Follow-up|2|||
146814200|NCT00813709|529489853|FG003|Double Blind Period|Lost to Follow-up|0|||
146814201|NCT00813709|529489854|FG004|Double Blind Period|Lost to Follow-up|0|||
146814202|NCT00813709|529489855|FG005|Double Blind Period|Lost to Follow-up|0|||
146814203|NCT00813709|529489850|FG000|Double Blind Period|Switched to open label phase|9|||
146814204|NCT00813709|529489851|FG001|Double Blind Period|Switched to open label phase|26|||
146814205|NCT00813709|529489852|FG002|Double Blind Period|Switched to open label phase|18|||
146814206|NCT00813709|529489853|FG003|Double Blind Period|Switched to open label phase|0|||
146814207|NCT00813709|529489854|FG004|Double Blind Period|Switched to open label phase|0|||
146814208|NCT00813709|529489855|FG005|Double Blind Period|Switched to open label phase|0|||
146814209|NCT00813709|529489850|FG000|Double Blind Period|Randomized but not treated|1|||
146814210|NCT00813709|529489851|FG001|Double Blind Period|Randomized but not treated|3|||
146814211|NCT00813709|529489852|FG002|Double Blind Period|Randomized but not treated|1|||
146814212|NCT00813709|529489853|FG003|Double Blind Period|Randomized but not treated|0|||
146814213|NCT00813709|529489854|FG004|Double Blind Period|Randomized but not treated|0|||
146814214|NCT00813709|529489855|FG005|Double Blind Period|Randomized but not treated|0|||
146814215|NCT00813709|529489850|FG000|Double Blind Period|Other|14|||
146814216|NCT00813709|529489851|FG001|Double Blind Period|Other|9|||
146814217|NCT00813709|529489852|FG002|Double Blind Period|Other|6|||
146814218|NCT00813709|529489853|FG003|Double Blind Period|Other|0|||
146814219|NCT00813709|529489854|FG004|Double Blind Period|Other|0|||
146814220|NCT00813709|529489855|FG005|Double Blind Period|Other|0|||
146814221|NCT00813709|529489850|FG000|Open Label Period|Adverse Event|0|||
146814222|NCT00813709|529489851|FG001|Open Label Period|Adverse Event|0|||
146814223|NCT00813709|529489852|FG002|Open Label Period|Adverse Event|0|||
146814224|NCT00813709|529489853|FG003|Open Label Period|Adverse Event|5|||
146814225|NCT00813709|529489854|FG004|Open Label Period|Adverse Event|4|||
146814226|NCT00813709|529489855|FG005|Open Label Period|Adverse Event|3|||
146814227|NCT00813709|529489850|FG000|Open Label Period|Lack of Efficacy|0|||
146814228|NCT00813709|529489851|FG001|Open Label Period|Lack of Efficacy|0|||
146814229|NCT00813709|529489852|FG002|Open Label Period|Lack of Efficacy|0|||
146814230|NCT00813709|529489853|FG003|Open Label Period|Lack of Efficacy|3|||
146814231|NCT00813709|529489854|FG004|Open Label Period|Lack of Efficacy|1|||
146814232|NCT00813709|529489855|FG005|Open Label Period|Lack of Efficacy|1|||
146814233|NCT00813709|529489850|FG000|Open Label Period|Randomized but not treated|0|||
146814234|NCT00813709|529489851|FG001|Open Label Period|Randomized but not treated|0|||
146814235|NCT00813709|529489852|FG002|Open Label Period|Randomized but not treated|0|||
146814236|NCT00813709|529489853|FG003|Open Label Period|Randomized but not treated|1|||
146814237|NCT00813709|529489854|FG004|Open Label Period|Randomized but not treated|0|||
146814238|NCT00813709|529489855|FG005|Open Label Period|Randomized but not treated|1|||
146814239|NCT00813709|529489850|FG000|Open Label Period|Other|0|||
146814240|NCT00813709|529489851|FG001|Open Label Period|Other|0|||
146814241|NCT00813709|529489852|FG002|Open Label Period|Other|0|||
146814242|NCT00813709|529489853|FG003|Open Label Period|Other|11|||
146814243|NCT00813709|529489854|FG004|Open Label Period|Other|5|||
146944520|NCT01690988|529956370|FG000|Overall Study|Determined ineligible|1|||
146944521|NCT01690988|529956371|FG001|Overall Study|Determined ineligible|0|||
146944522|NCT01690988|529956372|FG002|Overall Study|Determined ineligible|0|||
146944523|NCT01690988|529956370|FG000|Overall Study|Death|1|||
146944524|NCT01690988|529956371|FG001|Overall Study|Death|1|||
146944525|NCT01690988|529956372|FG002|Overall Study|Death|1|||
146814244|NCT00813709|529489855|FG005|Open Label Period|Other|6|||
146814245|NCT00759681|529489856|FG000|Overall Study|Death|2|||
146814246|NCT00759681|529489857|FG001|Overall Study|Death|5|||
146944526|NCT01690988|529956370|FG000|Overall Study|Sedated|1|||
146814247|NCT00759681|529489856|FG000|Overall Study|Lost to Follow-up|8|||
146814248|NCT00759681|529489857|FG001|Overall Study|Lost to Follow-up|5|||
146814249|NCT03146845|529489859|FG000|Overall Study|Reference ulcer healed|1|||
146814250|NCT03146845|529489860|FG001|Overall Study|Reference ulcer healed|0|||
146814251|NCT03146845|529489859|FG000|Overall Study|Physician Decision|1|||
146814252|NCT03146845|529489860|FG001|Overall Study|Physician Decision|0|||
146814253|NCT03146845|529489859|FG000|Overall Study|Adverse Event|1|||
146814254|NCT03146845|529489860|FG001|Overall Study|Adverse Event|0|||
146814255|NCT03146845|529489859|FG000|Overall Study|Withdrawal by Subject|2|||
146814256|NCT03146845|529489860|FG001|Overall Study|Withdrawal by Subject|0|||
146814257|NCT03146845|529489859|FG000|Overall Study|Noncompliance|0|||
146814258|NCT03146845|529489860|FG001|Overall Study|Noncompliance|1|||
146814259|NCT03146845|529489859|FG000|Overall Study|Protocol Violation|0|||
146814260|NCT03146845|529489860|FG001|Overall Study|Protocol Violation|2|||
146814261|NCT03146845|529489859|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
146814262|NCT03146845|529489860|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
146814263|NCT02721147|529489861|FG000|Overall Study|Lost to Follow-up|2|||
146814264|NCT02721147|529489862|FG001|Overall Study|Lost to Follow-up|0|||
146814265|NCT02721147|529489863|FG002|Overall Study|Lost to Follow-up|0|||
146814266|NCT01722097|529489867|FG000|Overall Study|Patient sheets not returned|6|||
146814267|NCT01722097|529489868|FG001|Overall Study|Patient sheets not returned|5|||
146814268|NCT01757288|529489871|FG000|Overall Study|Consent withdrawal|0|||
146814269|NCT01757288|529489872|FG001|Overall Study|Consent withdrawal|4|||
146814270|NCT01757288|529489873|FG002|Overall Study|Consent withdrawal|4|||
146814271|NCT01757288|529489871|FG000|Overall Study|Patient off study, IRB hold.|0|||
146814272|NCT01757288|529489872|FG001|Overall Study|Patient off study, IRB hold.|0|||
146814273|NCT01757288|529489873|FG002|Overall Study|Patient off study, IRB hold.|1|||
146814274|NCT01757288|529489871|FG000|Overall Study|Patient death prior to starting treatment|0|||
146814275|NCT01757288|529489872|FG001|Overall Study|Patient death prior to starting treatment|0|||
146814276|NCT01757288|529489873|FG002|Overall Study|Patient death prior to starting treatment|1|||
146814277|NCT01757288|529489871|FG000|Overall Study|Wrong medication administered|0|||
146814278|NCT01757288|529489872|FG001|Overall Study|Wrong medication administered|1|||
146814279|NCT01757288|529489873|FG002|Overall Study|Wrong medication administered|0|||
146814280|NCT01757288|529489871|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
146814281|NCT01757288|529489872|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
146814282|NCT01757288|529489873|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
146814283|NCT01757288|529489871|FG000|Overall Study|Not meeting protocol constraints|0|||
146814284|NCT01757288|529489872|FG001|Overall Study|Not meeting protocol constraints|1|||
146814285|NCT01757288|529489873|FG002|Overall Study|Not meeting protocol constraints|1|||
146814286|NCT01757288|529489871|FG000|Overall Study|Multiple missed appointments|0|||
146814287|NCT01757288|529489872|FG001|Overall Study|Multiple missed appointments|1|||
146814288|NCT01757288|529489873|FG002|Overall Study|Multiple missed appointments|0|||
146814289|NCT01757288|529489871|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
146814290|NCT01757288|529489872|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
146814291|NCT01757288|529489873|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
146814292|NCT01757288|529489871|FG000|Overall Study|>2 weeks treatment break|0|||
146814293|NCT01757288|529489872|FG001|Overall Study|>2 weeks treatment break|0|||
146814294|NCT01757288|529489873|FG002|Overall Study|>2 weeks treatment break|1|||
146814295|NCT02825550|529489874|FG000|Overall Study|Physician Decision|1|||
146814296|NCT00042939|529489875|FG000|Overall Study|Adverse Event|6|||
146814297|NCT00042939|529489876|FG001|Overall Study|Adverse Event|7|||
146814298|NCT00042939|529489875|FG000|Overall Study|Death|3|||
146814299|NCT00042939|529489876|FG001|Overall Study|Death|2|||
146814300|NCT00042939|529489875|FG000|Overall Study|Withdrawal by Subject|3|||
146814301|NCT00042939|529489876|FG001|Overall Study|Withdrawal by Subject|4|||
146814302|NCT00042939|529489875|FG000|Overall Study|Other disease|1|||
146814303|NCT00042939|529489876|FG001|Overall Study|Other disease|0|||
146814304|NCT00042939|529489875|FG000|Overall Study|Ineligible|2|||
146814305|NCT00042939|529489876|FG001|Overall Study|Ineligible|2|||
146814306|NCT00042939|529489875|FG000|Overall Study|Deterioration of health|3|||
146814307|NCT00042939|529489876|FG001|Overall Study|Deterioration of health|4|||
146814308|NCT00042939|529489875|FG000|Overall Study|QOL diminished|1|||
146814309|NCT00042939|529489876|FG001|Overall Study|QOL diminished|0|||
146814310|NCT00042939|529489875|FG000|Overall Study|Rising ca 19-9|1|||
146814311|NCT00042939|529489876|FG001|Overall Study|Rising ca 19-9|0|||
146814312|NCT00042939|529489875|FG000|Overall Study|Patient non-compliance|1|||
146944527|NCT01690988|529956371|FG001|Overall Study|Sedated|1|||
146944528|NCT01690988|529956372|FG002|Overall Study|Sedated|2|||
146944529|NCT00312728|529956373|FG000|Overall Study|Progressive disease|53|||
146944530|NCT00312728|529956373|FG000|Overall Study|Adverse Event|32|||
146944531|NCT00312728|529956373|FG000|Overall Study|Withdrawal by Subject|10|||
146944532|NCT00312728|529956373|FG000|Overall Study|Required non-protocol cancer treatment|2|||
146944533|NCT00312728|529956373|FG000|Overall Study|Protocol Violation|2|||
146944534|NCT00312728|529956373|FG000|Overall Study|Other|10|||
146944535|NCT00312728|529956373|FG000|Overall Study|Other|1|||
146944536|NCT03696576|529956374|FG000|Overall Study|Soreness of throat after therapy|1|||
146944537|NCT03696576|529956375|FG001|Overall Study|Soreness of throat after therapy|1|||
146814313|NCT00042939|529489876|FG001|Overall Study|Patient non-compliance|0|||
146814314|NCT00042939|529489875|FG000|Overall Study|Still on treatment|1|||
146814315|NCT00042939|529489876|FG001|Overall Study|Still on treatment|0|||
146944538|NCT03696576|529956374|FG000|Overall Study|Lost to Follow-up|2|||
146814316|NCT00042939|529489875|FG000|Overall Study|Treatment break > 4 weeks|0|||
146814317|NCT00042939|529489876|FG001|Overall Study|Treatment break > 4 weeks|1|||
146814318|NCT00042939|529489875|FG000|Overall Study|Did not start treatment|2|||
146814319|NCT00042939|529489876|FG001|Overall Study|Did not start treatment|1|||
146814320|NCT03349476|529489877|FG000|Overall Study|Physician Decision|3|||
146814321|NCT00795639|529489878|FG000|Overall Study|Death|1|||
146814322|NCT00795639|529489879|FG001|Overall Study|Death|6|||
146814323|NCT00795639|529489878|FG000|Overall Study|Withdrawal by Subject|1|||
146814324|NCT00795639|529489879|FG001|Overall Study|Withdrawal by Subject|3|||
146814325|NCT00795639|529489878|FG000|Overall Study|Pregnancy|1|||
146814326|NCT00795639|529489879|FG001|Overall Study|Pregnancy|0|||
146814327|NCT00795639|529489878|FG000|Overall Study|Adverse Event|5|||
146814328|NCT00795639|529489879|FG001|Overall Study|Adverse Event|2|||
146814329|NCT00795639|529489878|FG000|Overall Study|Other|0|||
146814330|NCT00795639|529489879|FG001|Overall Study|Other|2|||
146814331|NCT00795639|529489878|FG000|Overall Study|Terminated by sponsor|13|||
146814332|NCT00795639|529489879|FG001|Overall Study|Terminated by sponsor|12|||
146814333|NCT00795639|529489878|FG000|Overall Study|Randomized and not treated|0|||
146814334|NCT00795639|529489879|FG001|Overall Study|Randomized and not treated|1|||
146814335|NCT00248794|529489880|FG000|Overall Study|Lost to Follow-up|6|||
146814336|NCT00248794|529489881|FG001|Overall Study|Lost to Follow-up|8|||
146814337|NCT00248794|529489882|FG002|Overall Study|Lost to Follow-up|3|||
146814338|NCT01762345|529489885|FG000|Overall Study|Adverse Event|5|||
146814339|NCT01762345|529489885|FG000|Overall Study|Protocol Violation|2|||
146814340|NCT00244751|529489886|FG000|Overall Study|Adverse Event|7|||
146814341|NCT00244751|529489887|FG001|Overall Study|Adverse Event|7|||
146814342|NCT00244751|529489888|FG002|Overall Study|Adverse Event|5|||
146814343|NCT00244751|529489886|FG000|Overall Study|Lost to Follow-up|0|||
146814344|NCT00244751|529489887|FG001|Overall Study|Lost to Follow-up|1|||
146814345|NCT00244751|529489888|FG002|Overall Study|Lost to Follow-up|0|||
146814346|NCT00244751|529489886|FG000|Overall Study|Protocol Violation|1|||
146814347|NCT00244751|529489887|FG001|Overall Study|Protocol Violation|0|||
146814348|NCT00244751|529489888|FG002|Overall Study|Protocol Violation|1|||
146814349|NCT00244751|529489886|FG000|Overall Study|Withdrawal by Subject|7|||
146814350|NCT00244751|529489887|FG001|Overall Study|Withdrawal by Subject|5|||
146814351|NCT00244751|529489888|FG002|Overall Study|Withdrawal by Subject|3|||
146814352|NCT00244751|529489886|FG000|Overall Study|Elevated liver enzymes|1|||
146814353|NCT00244751|529489887|FG001|Overall Study|Elevated liver enzymes|0|||
146814354|NCT00244751|529489888|FG002|Overall Study|Elevated liver enzymes|0|||
146814355|NCT00244751|529489886|FG000|Overall Study|Lack of compliance with protocol|0|||
146814356|NCT00244751|529489887|FG001|Overall Study|Lack of compliance with protocol|1|||
146814357|NCT00244751|529489888|FG002|Overall Study|Lack of compliance with protocol|0|||
146814358|NCT00244751|529489886|FG000|Overall Study|Safety reasons|0|||
146814359|NCT00244751|529489887|FG001|Overall Study|Safety reasons|1|||
146814360|NCT00244751|529489888|FG002|Overall Study|Safety reasons|0|||
146814361|NCT00244751|529489886|FG000|Overall Study|Participant randomized by mistake|0|||
146814362|NCT00244751|529489887|FG001|Overall Study|Participant randomized by mistake|0|||
146814363|NCT00244751|529489888|FG002|Overall Study|Participant randomized by mistake|1|||
146984315|NCT00583596|530103407|FG000|Overall Study|Data not complete|1|||
146984316|NCT00583596|530103407|FG000|Overall Study|Not consented|15|||
146984317|NCT00583596|530103407|FG000|Overall Study|Outside f-up window|26|||
146984318|NCT01855126|530103408|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
146984319|NCT01855126|530103409|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
146984320|NCT01855126|530103408|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
146984321|NCT01855126|530103409|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
146984322|NCT04535583|530103421|FG000|Overall Study|Lost to Follow-up|1|||
146814364|NCT00761267|529489893|FG000|Overall Study|Death|1|||
146814365|NCT00761267|529489894|FG001|Overall Study|Death|2|||
146814366|NCT00761267|529489895|FG002|Overall Study|Death|5|||
146814367|NCT00761267|529489893|FG000|Overall Study|Lost to Follow-up|0|||
146814368|NCT00761267|529489894|FG001|Overall Study|Lost to Follow-up|0|||
146814369|NCT00761267|529489895|FG002|Overall Study|Lost to Follow-up|1|||
146814370|NCT00761267|529489893|FG000|Overall Study|Randomized but not treated|1|||
146814371|NCT00761267|529489894|FG001|Overall Study|Randomized but not treated|1|||
146814372|NCT00761267|529489895|FG002|Overall Study|Randomized but not treated|0|||
146814373|NCT00761267|529489893|FG000|Overall Study|Withdrawal by Subject|0|||
146984323|NCT04535583|530103421|FG000|Overall Study|Physician Decision|1|||
146814374|NCT00761267|529489894|FG001|Overall Study|Withdrawal by Subject|1|||
146814375|NCT00761267|529489895|FG002|Overall Study|Withdrawal by Subject|0|||
146814376|NCT01777932|529489896|FG000|Overall Study|Disease progression|136|||
146984324|NCT04535583|530103421|FG000|Overall Study|Withdrawal by Subject|1|||
146814377|NCT01777932|529489896|FG000|Overall Study|Death|3|||
146814378|NCT01777932|529489896|FG000|Overall Study|Adverse Event|34|||
146814379|NCT01777932|529489896|FG000|Overall Study|Lost to Follow-up|3|||
146814380|NCT01777932|529489896|FG000|Overall Study|Investigator decision|10|||
146814381|NCT01777932|529489896|FG000|Overall Study|Reimbursement limit|9|||
146814382|NCT01777932|529489896|FG000|Overall Study|Patient refused further treatment|10|||
146814383|NCT01419184|529489900|FG000|Overall Study|Site data not available|3|||
146814384|NCT01419184|529489901|FG001|Overall Study|Site data not available|2|||
146814385|NCT01419184|529489900|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
146814386|NCT01419184|529489901|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
146814387|NCT01419184|529489900|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
146814388|NCT01419184|529489901|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
146814389|NCT01419184|529489900|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
146814390|NCT01419184|529489901|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
146814391|NCT01419184|529489900|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
146814392|NCT01419184|529489901|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
146814393|NCT01419184|529489900|FG000|Overall Study|Participant randomized, not treated|1|||
146814394|NCT01419184|529489901|FG001|Overall Study|Participant randomized, not treated|0|||
146814395|NCT03031782|529489904|FG000|Treatment Period 1|Lack of Efficacy|3|||
146814396|NCT03031782|529489905|FG001|Treatment Period 1|Lack of Efficacy|0|||
146814397|NCT03031782|529489906|FG002|Treatment Period 1|Lack of Efficacy|0|||
146814398|NCT03031782|529489907|FG003|Treatment Period 1|Lack of Efficacy|0|||
146814399|NCT03031782|529489908|FG004|Treatment Period 1|Lack of Efficacy|0|||
146814400|NCT03031782|529489904|FG000|Treatment Period 2|Physician Decision|0|||
146814401|NCT03031782|529489905|FG001|Treatment Period 2|Physician Decision|1|||
146814402|NCT03031782|529489906|FG002|Treatment Period 2|Physician Decision|0|||
146814403|NCT03031782|529489907|FG003|Treatment Period 2|Physician Decision|0|||
146814404|NCT03031782|529489908|FG004|Treatment Period 2|Physician Decision|3|||
146814405|NCT03031782|529489904|FG000|Treatment Period 2|Lack of Efficacy|0|||
146814406|NCT03031782|529489905|FG001|Treatment Period 2|Lack of Efficacy|1|||
146814407|NCT03031782|529489906|FG002|Treatment Period 2|Lack of Efficacy|0|||
146814408|NCT03031782|529489907|FG003|Treatment Period 2|Lack of Efficacy|0|||
146814409|NCT03031782|529489908|FG004|Treatment Period 2|Lack of Efficacy|1|||
146814410|NCT03031782|529489904|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146814411|NCT03031782|529489905|FG001|Treatment Period 2|Withdrawal by Subject|3|||
146814412|NCT03031782|529489906|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146814413|NCT03031782|529489907|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146814414|NCT03031782|529489908|FG004|Treatment Period 2|Withdrawal by Subject|1|||
146814415|NCT03031782|529489904|FG000|Treatment Period 2|Adverse Event|0|||
146814416|NCT03031782|529489905|FG001|Treatment Period 2|Adverse Event|1|||
146814417|NCT03031782|529489906|FG002|Treatment Period 2|Adverse Event|2|||
146814418|NCT03031782|529489907|FG003|Treatment Period 2|Adverse Event|0|||
146814419|NCT03031782|529489908|FG004|Treatment Period 2|Adverse Event|0|||
146814420|NCT03031782|529489904|FG000|Treatment Period 3|Withdrawal by Subject|0|||
146814421|NCT03031782|529489905|FG001|Treatment Period 3|Withdrawal by Subject|0|||
146814422|NCT03031782|529489906|FG002|Treatment Period 3|Withdrawal by Subject|0|||
146814423|NCT03031782|529489907|FG003|Treatment Period 3|Withdrawal by Subject|1|||
146814424|NCT03031782|529489908|FG004|Treatment Period 3|Withdrawal by Subject|0|||
146814425|NCT00424476|529489911|FG000|Overall Study|Withdrawal by Subject|7|||
146814426|NCT00424476|529489912|FG001|Overall Study|Withdrawal by Subject|6|||
146814427|NCT00424476|529489913|FG002|Overall Study|Withdrawal by Subject|3|||
146814428|NCT00424476|529489911|FG000|Overall Study|Adverse Event|19|||
146814429|NCT00424476|529489912|FG001|Overall Study|Adverse Event|16|||
146814430|NCT00424476|529489913|FG002|Overall Study|Adverse Event|15|||
146814431|NCT00424476|529489911|FG000|Overall Study|Lack of Efficacy|16|||
146814432|NCT00424476|529489912|FG001|Overall Study|Lack of Efficacy|12|||
146814433|NCT00424476|529489913|FG002|Overall Study|Lack of Efficacy|12|||
146814434|NCT00424476|529489911|FG000|Overall Study|Lack of Compliance|1|||
146814435|NCT00424476|529489912|FG001|Overall Study|Lack of Compliance|1|||
146814436|NCT00424476|529489913|FG002|Overall Study|Lack of Compliance|1|||
146814437|NCT00424476|529489911|FG000|Overall Study|Lost to Follow-up|4|||
146814438|NCT00424476|529489912|FG001|Overall Study|Lost to Follow-up|6|||
146814439|NCT00424476|529489913|FG002|Overall Study|Lost to Follow-up|3|||
146814440|NCT00424476|529489911|FG000|Overall Study|Protocol Violation|7|||
146814441|NCT00424476|529489912|FG001|Overall Study|Protocol Violation|2|||
146814442|NCT00424476|529489913|FG002|Overall Study|Protocol Violation|3|||
146814443|NCT00424476|529489911|FG000|Overall Study|Physician Decision|3|||
146814444|NCT00424476|529489912|FG001|Overall Study|Physician Decision|2|||
146814445|NCT00424476|529489913|FG002|Overall Study|Physician Decision|3|||
146814446|NCT00424476|529489911|FG000|Overall Study|Other|4|||
146814447|NCT00424476|529489912|FG001|Overall Study|Other|3|||
146814448|NCT00424476|529489913|FG002|Overall Study|Other|9|||
146814449|NCT03979040|529489914|FG000|Overall Study|Withdrawal by Subject|24|||
146814450|NCT03979040|529489915|FG001|Overall Study|Withdrawal by Subject|32|||
146814451|NCT03979040|529489914|FG000|Overall Study|randomized but never started treatment|32|||
146814452|NCT03979040|529489915|FG001|Overall Study|randomized but never started treatment|39|||
146814453|NCT03979040|529489914|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
146814454|NCT03979040|529489915|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
146814455|NCT03541369|529489918|FG000|Overall Study|Death|0|||
146814456|NCT03541369|529489919|FG001|Overall Study|Death|0|||
146814457|NCT03541369|529489920|FG002|Overall Study|Death|0|||
146814458|NCT03541369|529489921|FG003|Overall Study|Death|0|||
146814459|NCT03541369|529489922|FG004|Overall Study|Death|1|||
146814460|NCT03541369|529489923|FG005|Overall Study|Death|1|||
146814461|NCT03541369|529489924|FG006|Overall Study|Death|0|||
146814462|NCT03541369|529489925|FG007|Overall Study|Death|2|||
146814463|NCT03541369|529489926|FG008|Overall Study|Death|1|||
146814464|NCT03541369|529489927|FG009|Overall Study|Death|2|||
146814465|NCT03541369|529489928|FG010|Overall Study|Death|1|||
146814466|NCT03541369|529489929|FG011|Overall Study|Death|0|||
146814467|NCT03541369|529489930|FG012|Overall Study|Death|2|||
146814468|NCT03541369|529489931|FG013|Overall Study|Death|1|||
146814469|NCT03541369|529489932|FG014|Overall Study|Death|1|||
146814470|NCT03541369|529489933|FG015|Overall Study|Death|1|||
146814471|NCT03541369|529489934|FG016|Overall Study|Death|0|||
146814472|NCT03541369|529489935|FG017|Overall Study|Death|1|||
146814473|NCT03541369|529489918|FG000|Overall Study|Decision by sponsor|0|||
146814474|NCT03541369|529489919|FG001|Overall Study|Decision by sponsor|0|||
146814475|NCT03541369|529489920|FG002|Overall Study|Decision by sponsor|0|||
146814476|NCT03541369|529489921|FG003|Overall Study|Decision by sponsor|1|||
146814477|NCT03541369|529489922|FG004|Overall Study|Decision by sponsor|0|||
146814478|NCT03541369|529489923|FG005|Overall Study|Decision by sponsor|2|||
146814479|NCT03541369|529489924|FG006|Overall Study|Decision by sponsor|0|||
146814480|NCT03541369|529489925|FG007|Overall Study|Decision by sponsor|1|||
146814481|NCT03541369|529489926|FG008|Overall Study|Decision by sponsor|2|||
146814482|NCT03541369|529489927|FG009|Overall Study|Decision by sponsor|0|||
146814483|NCT03541369|529489928|FG010|Overall Study|Decision by sponsor|0|||
146814484|NCT03541369|529489929|FG011|Overall Study|Decision by sponsor|0|||
146814485|NCT03541369|529489930|FG012|Overall Study|Decision by sponsor|2|||
146814486|NCT03541369|529489931|FG013|Overall Study|Decision by sponsor|2|||
146814487|NCT03541369|529489932|FG014|Overall Study|Decision by sponsor|0|||
146814488|NCT03541369|529489933|FG015|Overall Study|Decision by sponsor|1|||
146814489|NCT03541369|529489934|FG016|Overall Study|Decision by sponsor|1|||
146814490|NCT03541369|529489935|FG017|Overall Study|Decision by sponsor|1|||
146814491|NCT03541369|529489918|FG000|Overall Study|Withdrawal by Subject|0|||
146814492|NCT03541369|529489919|FG001|Overall Study|Withdrawal by Subject|0|||
146814493|NCT03541369|529489920|FG002|Overall Study|Withdrawal by Subject|0|||
146814494|NCT03541369|529489921|FG003|Overall Study|Withdrawal by Subject|0|||
146814495|NCT03541369|529489922|FG004|Overall Study|Withdrawal by Subject|0|||
146814496|NCT03541369|529489923|FG005|Overall Study|Withdrawal by Subject|0|||
146814497|NCT03541369|529489924|FG006|Overall Study|Withdrawal by Subject|1|||
146814498|NCT03541369|529489925|FG007|Overall Study|Withdrawal by Subject|0|||
146814499|NCT03541369|529489926|FG008|Overall Study|Withdrawal by Subject|0|||
146814500|NCT03541369|529489927|FG009|Overall Study|Withdrawal by Subject|0|||
146814501|NCT03541369|529489928|FG010|Overall Study|Withdrawal by Subject|0|||
146814502|NCT03541369|529489929|FG011|Overall Study|Withdrawal by Subject|1|||
146814503|NCT03541369|529489930|FG012|Overall Study|Withdrawal by Subject|0|||
146814504|NCT03541369|529489931|FG013|Overall Study|Withdrawal by Subject|0|||
146814505|NCT03541369|529489932|FG014|Overall Study|Withdrawal by Subject|3|||
146814506|NCT03541369|529489933|FG015|Overall Study|Withdrawal by Subject|0|||
146814507|NCT03541369|529489934|FG016|Overall Study|Withdrawal by Subject|4|||
146814508|NCT03541369|529489935|FG017|Overall Study|Withdrawal by Subject|2|||
146814509|NCT03541369|529489918|FG000|Overall Study|Lost to Follow-up|0|||
146814510|NCT03541369|529489919|FG001|Overall Study|Lost to Follow-up|0|||
146814511|NCT03541369|529489920|FG002|Overall Study|Lost to Follow-up|0|||
146814512|NCT03541369|529489921|FG003|Overall Study|Lost to Follow-up|0|||
146814513|NCT03541369|529489922|FG004|Overall Study|Lost to Follow-up|1|||
146814514|NCT03541369|529489923|FG005|Overall Study|Lost to Follow-up|0|||
146814515|NCT03541369|529489924|FG006|Overall Study|Lost to Follow-up|0|||
146984325|NCT01078090|530103422|FG000|Overall Study|Lost to Follow-up|2363|||
146984326|NCT01078090|530103422|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
146984327|NCT01078090|530103422|FG000|Overall Study|Lack of Efficacy|1193|||
146814516|NCT03541369|529489925|FG007|Overall Study|Lost to Follow-up|0|||
146814517|NCT03541369|529489926|FG008|Overall Study|Lost to Follow-up|1|||
146814518|NCT03541369|529489927|FG009|Overall Study|Lost to Follow-up|0|||
146814519|NCT03541369|529489928|FG010|Overall Study|Lost to Follow-up|0|||
146814520|NCT03541369|529489929|FG011|Overall Study|Lost to Follow-up|0|||
146814521|NCT03541369|529489930|FG012|Overall Study|Lost to Follow-up|1|||
146814522|NCT03541369|529489931|FG013|Overall Study|Lost to Follow-up|0|||
146984328|NCT01078090|530103422|FG000|Overall Study|ADR and lack of efficacy|61|||
146984329|NCT01078090|530103422|FG000|Overall Study|Other|523|||
146984330|NCT01748890|530103424|FG000|Overall Study|Insufficient recruitment for analysis|4|||
146984331|NCT00526890|530103425|FG000|Overall Study|Adverse Event|2|||
146814523|NCT03541369|529489932|FG014|Overall Study|Lost to Follow-up|0|||
146814524|NCT03541369|529489933|FG015|Overall Study|Lost to Follow-up|0|||
146814525|NCT03541369|529489934|FG016|Overall Study|Lost to Follow-up|0|||
146814526|NCT03541369|529489935|FG017|Overall Study|Lost to Follow-up|0|||
146814527|NCT02279732|529489938|FG000|Overall Study|Death|23|||
146814528|NCT02279732|529489939|FG001|Overall Study|Death|20|||
146814529|NCT02279732|529489938|FG000|Overall Study|Disease Progression|13|||
146814530|NCT02279732|529489939|FG001|Overall Study|Disease Progression|3|||
146814531|NCT02279732|529489938|FG000|Overall Study|Withdrawal by Subject|2|||
146984332|NCT03035227|530103426|FG000|Overall Study|study stopped due to PI leaving institut|1|||
146814532|NCT02279732|529489939|FG001|Overall Study|Withdrawal by Subject|7|||
146814533|NCT02279732|529489938|FG000|Overall Study|Adverse Event|1|||
146814534|NCT02279732|529489939|FG001|Overall Study|Adverse Event|2|||
146814535|NCT02279732|529489938|FG000|Overall Study|Administrative Reason By Sponsor|0|||
146814536|NCT02279732|529489939|FG001|Overall Study|Administrative Reason By Sponsor|2|||
146814537|NCT02279732|529489938|FG000|Overall Study|Study Drug Toxicity|2|||
146814538|NCT02279732|529489939|FG001|Overall Study|Study Drug Toxicity|0|||
146814539|NCT02279732|529489938|FG000|Overall Study|Lost to Follow-up|0|||
146814540|NCT02279732|529489939|FG001|Overall Study|Lost to Follow-up|1|||
146814541|NCT02279732|529489938|FG000|Overall Study|Maximum Clinical Benefit|1|||
146814542|NCT02279732|529489939|FG001|Overall Study|Maximum Clinical Benefit|0|||
146814543|NCT02279732|529489938|FG000|Overall Study|Subject Requested to Discontinue|0|||
146814544|NCT02279732|529489939|FG001|Overall Study|Subject Requested to Discontinue|1|||
146814545|NCT02279732|529489938|FG000|Overall Study|Other|53|||
146814546|NCT02279732|529489939|FG001|Overall Study|Other|67|||
146814547|NCT02279732|529489938|FG000|Overall Study|Other|3|||
146814548|NCT02279732|529489939|FG001|Overall Study|Other|3|||
146814549|NCT03072862|529489943|FG000|Overall Study|Withdrawal by Subject|4|||
146814550|NCT03072862|529489943|FG000|Overall Study|Lost to Follow-up|6|||
146814551|NCT03072862|529489943|FG000|Overall Study|Protocol Violation|4|||
146814552|NCT03072862|529489943|FG000|Overall Study|Physician Decision|2|||
146814553|NCT03072862|529489943|FG000|Overall Study|Death|1|||
146814554|NCT03072862|529489943|FG000|Overall Study|Adverse Event|1|||
146814555|NCT02513667|529489944|FG000|Overall Study|Withdrawal by Subject|0|||
146814556|NCT02513667|529489945|FG001|Overall Study|Withdrawal by Subject|1|||
146814557|NCT03347396|529489946|FG000|Part A (26 Weeks)|Adverse Event|1|||
146814558|NCT03347396|529489947|FG001|Part A (26 Weeks)|Adverse Event|0|||
146814559|NCT03347396|529489946|FG000|Part A (26 Weeks)|Death|0|||
146814560|NCT03347396|529489947|FG001|Part A (26 Weeks)|Death|1|||
146814561|NCT03347396|529489946|FG000|Part B (149 Weeks)|Adverse Event|1|||
146814562|NCT03347396|529489947|FG001|Part B (149 Weeks)|Adverse Event|1|||
146814563|NCT03347396|529489946|FG000|Part B (149 Weeks)|Death|1|||
146814564|NCT03347396|529489947|FG001|Part B (149 Weeks)|Death|0|||
146814565|NCT01670526|529489954|FG000|Overall Study|Withdrawal by Subject|3|||
146814566|NCT01670526|529489955|FG001|Overall Study|Withdrawal by Subject|1|||
146814567|NCT01670526|529489954|FG000|Overall Study|Lost to Follow-up|9|||
146814568|NCT01670526|529489955|FG001|Overall Study|Lost to Follow-up|5|||
146814569|NCT00392197|529489956|FG000|Overall Study|Adverse Event|4|||
146814570|NCT00392197|529489957|FG001|Overall Study|Adverse Event|12|||
146814571|NCT00392197|529489956|FG000|Overall Study|Lack of Efficacy|3|||
146814572|NCT00392197|529489957|FG001|Overall Study|Lack of Efficacy|4|||
146814573|NCT00392197|529489956|FG000|Overall Study|Lost to Follow-up|0|||
146814574|NCT00392197|529489957|FG001|Overall Study|Lost to Follow-up|1|||
146814575|NCT00392197|529489956|FG000|Overall Study|Physician Decision|3|||
146814576|NCT00392197|529489957|FG001|Overall Study|Physician Decision|2|||
146814577|NCT00392197|529489956|FG000|Overall Study|Protocol Violation|7|||
146814578|NCT00392197|529489957|FG001|Overall Study|Protocol Violation|5|||
146814579|NCT00392197|529489956|FG000|Overall Study|Withdrawal by Subject|4|||
146814580|NCT00392197|529489957|FG001|Overall Study|Withdrawal by Subject|6|||
146814581|NCT01970527|529489959|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
146814582|NCT01970527|529489960|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
146814583|NCT01970527|529489959|FG000|Treatment|Disease progression|0|||
146814584|NCT01970527|529489960|FG001|Treatment|Disease progression|1|||
146814585|NCT01970527|529489959|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
146814586|NCT01970527|529489960|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
146814587|NCT01970527|529489959|FG000|Treatment|Death|0|||
146814588|NCT01970527|529489960|FG001|Treatment|Death|1|||
146814589|NCT01970527|529489959|FG000|Follow-up Clinic Visit|Disease progression|1|||
146814590|NCT01970527|529489960|FG001|Follow-up Clinic Visit|Disease progression|1|||
146814591|NCT01970527|529489959|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
146814592|NCT01970527|529489960|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
146814593|NCT01970527|529489959|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
146814594|NCT01970527|529489960|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
146814595|NCT03659136|529489967|FG000|Overall Study|Not treated|2|||
146814596|NCT03659136|529489968|FG001|Overall Study|Not treated|0|||
146814597|NCT03659136|529489967|FG000|Overall Study|Covid-19 related|1|||
146814598|NCT03659136|529489968|FG001|Overall Study|Covid-19 related|1|||
146814599|NCT03659136|529489967|FG000|Overall Study|Withdrawal by Subject|1|||
146814600|NCT03659136|529489968|FG001|Overall Study|Withdrawal by Subject|6|||
146814601|NCT03659136|529489967|FG000|Overall Study|Adverse Event|4|||
146814602|NCT03659136|529489968|FG001|Overall Study|Adverse Event|6|||
146814603|NCT03659136|529489967|FG000|Overall Study|Progressive disease|37|||
146814604|NCT03659136|529489968|FG001|Overall Study|Progressive disease|31|||
146814605|NCT03659136|529489967|FG000|Overall Study|Study closure|2|||
146814606|NCT03659136|529489968|FG001|Overall Study|Study closure|2|||
146814607|NCT03659136|529489967|FG000|Overall Study|Sponsor decision/recommendation|3|||
146814608|NCT03659136|529489968|FG001|Overall Study|Sponsor decision/recommendation|2|||
146814609|NCT03659136|529489967|FG000|Overall Study|Switched to other drug/therapy|2|||
146944539|NCT03696576|529956375|FG001|Overall Study|Lost to Follow-up|4|||
146814610|NCT03659136|529489968|FG001|Overall Study|Switched to other drug/therapy|2|||
146814611|NCT03659136|529489967|FG000|Overall Study|Lack of clinical benefit|0|||
146814612|NCT03659136|529489968|FG001|Overall Study|Lack of clinical benefit|1|||
146814613|NCT04914897|529492017|FG000|Overall Study|Withdrawal by Subject|3|||
146814614|NCT04914897|529492018|FG001|Overall Study|Withdrawal by Subject|1|||
146814615|NCT04914897|529492019|FG002|Overall Study|Withdrawal by Subject|1|||
146814616|NCT04914897|529492020|FG003|Overall Study|Withdrawal by Subject|1|||
146814617|NCT04914897|529492017|FG000|Overall Study|Poor compliance to protocol|0|||
146814618|NCT04914897|529492018|FG001|Overall Study|Poor compliance to protocol|0|||
146814619|NCT04914897|529492019|FG002|Overall Study|Poor compliance to protocol|1|||
146814620|NCT04914897|529492020|FG003|Overall Study|Poor compliance to protocol|0|||
146814621|NCT04914897|529492017|FG000|Overall Study|Progressive disease|5|||
146814622|NCT04914897|529492018|FG001|Overall Study|Progressive disease|14|||
146814623|NCT04914897|529492019|FG002|Overall Study|Progressive disease|30|||
146814624|NCT04914897|529492020|FG003|Overall Study|Progressive disease|21|||
146814625|NCT04914897|529492017|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
146814626|NCT04914897|529492018|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
146814627|NCT04914897|529492019|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
146814628|NCT04914897|529492020|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
146814629|NCT04914897|529492017|FG000|Overall Study|Other|1|||
146814630|NCT04914897|529492018|FG001|Overall Study|Other|0|||
146814631|NCT04914897|529492019|FG002|Overall Study|Other|0|||
146814632|NCT04914897|529492020|FG003|Overall Study|Other|1|||
146814633|NCT03020914|529492021|FG000|Overall Study|Surgery Cancelled|1|||
146814634|NCT03020914|529492022|FG001|Overall Study|Surgery Cancelled|0|||
146814635|NCT04425252|529492024|FG000|Overall Study|Withdrawal by Subject|2|||
146814636|NCT04425252|529492025|FG001|Overall Study|Withdrawal by Subject|1|||
146814637|NCT04425252|529492024|FG000|Overall Study|Lost to Follow-up|1|||
146814638|NCT04425252|529492025|FG001|Overall Study|Lost to Follow-up|0|||
146814639|NCT04425252|529492024|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
146814640|NCT04425252|529492025|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
146814641|NCT01215253|529492027|FG000|Overall Study|Withdrawal by Subject|57|||
146814642|NCT01215253|529492028|FG001|Overall Study|Withdrawal by Subject|35|||
146814643|NCT01215253|529492027|FG000|Overall Study|Physician Decision|9|||
146814644|NCT01215253|529492028|FG001|Overall Study|Physician Decision|12|||
146814645|NCT01215253|529492027|FG000|Overall Study|Lost to Follow-up|6|||
146814646|NCT01215253|529492028|FG001|Overall Study|Lost to Follow-up|4|||
146814647|NCT01215253|529492027|FG000|Overall Study|Other|14|||
146814648|NCT01215253|529492028|FG001|Overall Study|Other|12|||
146814649|NCT01131325|529492029|FG000|Overall Study|Adverse Event|1|||
146814650|NCT01131325|529492029|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
146814651|NCT03761849|529492030|FG000|Overall Study|transferred to OpenLabelExtension|35|||
146814652|NCT03761849|529492031|FG001|Overall Study|transferred to OpenLabelExtension|34|||
146814653|NCT03761849|529492032|FG002|Overall Study|transferred to OpenLabelExtension|36|||
146814654|NCT03761849|529492033|FG003|Overall Study|transferred to OpenLabelExtension|0|||
146814655|NCT03761849|529492034|FG004|Overall Study|transferred to OpenLabelExtension|0|||
146814656|NCT03761849|529492035|FG005|Overall Study|transferred to OpenLabelExtension|0|||
146814657|NCT03761849|529492030|FG000|Overall Study|Adverse Event|1|||
146814658|NCT03761849|529492031|FG001|Overall Study|Adverse Event|0|||
146814659|NCT03761849|529492032|FG002|Overall Study|Adverse Event|0|||
146814660|NCT03761849|529492033|FG003|Overall Study|Adverse Event|0|||
146814661|NCT03761849|529492034|FG004|Overall Study|Adverse Event|2|||
146814662|NCT03761849|529492035|FG005|Overall Study|Adverse Event|3|||
146984333|NCT03035227|530103427|FG001|Overall Study|study stopped due to PI leaving institut|1|||
146984334|NCT00859469|530103428|FG000|Overall Study|Adverse Event|2|||
146984335|NCT00859469|530103428|FG000|Overall Study|Lack of Efficacy|9|||
146814663|NCT03761849|529492030|FG000|Overall Study|Withdrawal by Subject|0|||
146814664|NCT03761849|529492031|FG001|Overall Study|Withdrawal by Subject|0|||
146814665|NCT03761849|529492032|FG002|Overall Study|Withdrawal by Subject|0|||
146814666|NCT03761849|529492033|FG003|Overall Study|Withdrawal by Subject|41|||
146814667|NCT03761849|529492034|FG004|Overall Study|Withdrawal by Subject|43|||
146814668|NCT03761849|529492035|FG005|Overall Study|Withdrawal by Subject|35|||
146814669|NCT03761849|529492030|FG000|Overall Study|Lost to Follow-up|0|||
146814670|NCT03761849|529492031|FG001|Overall Study|Lost to Follow-up|1|||
146984336|NCT00859469|530103428|FG000|Overall Study|Withdrawal by Subject|1|||
146984337|NCT00859469|530103428|FG000|Overall Study|Death|16|||
146984338|NCT02220907|530103429|FG000|Overall Study|Adverse Event|7|||
146814671|NCT03761849|529492032|FG002|Overall Study|Lost to Follow-up|0|||
146984339|NCT02220907|530103429|FG000|Overall Study|Physician Decision|1|||
146814672|NCT03761849|529492033|FG003|Overall Study|Lost to Follow-up|2|||
146814673|NCT03761849|529492034|FG004|Overall Study|Lost to Follow-up|4|||
146814674|NCT03761849|529492035|FG005|Overall Study|Lost to Follow-up|5|||
146814675|NCT03761849|529492030|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
146814676|NCT03761849|529492031|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
146814677|NCT03761849|529492032|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
146814678|NCT03761849|529492033|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
146814679|NCT03761849|529492034|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
146814680|NCT03761849|529492035|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
146814681|NCT03761849|529492030|FG000|Overall Study|Physician Decision|0|||
146814682|NCT03761849|529492031|FG001|Overall Study|Physician Decision|0|||
146814683|NCT03761849|529492032|FG002|Overall Study|Physician Decision|0|||
146814684|NCT03761849|529492033|FG003|Overall Study|Physician Decision|1|||
146814685|NCT03761849|529492034|FG004|Overall Study|Physician Decision|4|||
146814686|NCT03761849|529492035|FG005|Overall Study|Physician Decision|4|||
146814687|NCT03761849|529492030|FG000|Overall Study|Death|0|||
146814688|NCT03761849|529492031|FG001|Overall Study|Death|0|||
146814689|NCT03761849|529492032|FG002|Overall Study|Death|0|||
146814690|NCT03761849|529492033|FG003|Overall Study|Death|1|||
146814691|NCT03761849|529492034|FG004|Overall Study|Death|1|||
146814692|NCT03761849|529492035|FG005|Overall Study|Death|3|||
146814693|NCT03761849|529492030|FG000|Overall Study|Protocol Violation|0|||
146814694|NCT03761849|529492031|FG001|Overall Study|Protocol Violation|0|||
146814695|NCT03761849|529492032|FG002|Overall Study|Protocol Violation|0|||
146814696|NCT03761849|529492033|FG003|Overall Study|Protocol Violation|2|||
146814697|NCT03761849|529492034|FG004|Overall Study|Protocol Violation|2|||
146814698|NCT03761849|529492035|FG005|Overall Study|Protocol Violation|1|||
146814699|NCT03761849|529492030|FG000|Overall Study|Participant could not come to site|0|||
146814700|NCT03761849|529492031|FG001|Overall Study|Participant could not come to site|0|||
146814701|NCT03761849|529492032|FG002|Overall Study|Participant could not come to site|0|||
146814702|NCT03761849|529492033|FG003|Overall Study|Participant could not come to site|0|||
146814703|NCT03761849|529492034|FG004|Overall Study|Participant could not come to site|1|||
146814704|NCT03761849|529492035|FG005|Overall Study|Participant could not come to site|0|||
146814705|NCT03761849|529492030|FG000|Overall Study|SF- safety Finding|0|||
146814706|NCT03761849|529492031|FG001|Overall Study|SF- safety Finding|0|||
146814707|NCT03761849|529492032|FG002|Overall Study|SF- safety Finding|0|||
146814708|NCT03761849|529492033|FG003|Overall Study|SF- safety Finding|0|||
146814709|NCT03761849|529492034|FG004|Overall Study|SF- safety Finding|0|||
146814710|NCT03761849|529492035|FG005|Overall Study|SF- safety Finding|1|||
146814711|NCT03761849|529492030|FG000|Overall Study|Patient did not attend visit|0|||
146814712|NCT03761849|529492031|FG001|Overall Study|Patient did not attend visit|0|||
146814713|NCT03761849|529492032|FG002|Overall Study|Patient did not attend visit|0|||
146814714|NCT03761849|529492033|FG003|Overall Study|Patient did not attend visit|0|||
146814715|NCT03761849|529492034|FG004|Overall Study|Patient did not attend visit|0|||
146814716|NCT03761849|529492035|FG005|Overall Study|Patient did not attend visit|1|||
146814717|NCT03840993|529492036|FG000|Overall Study|Adverse Event|1|||
146814718|NCT03840993|529492037|FG001|Overall Study|Adverse Event|0|||
146814719|NCT03840993|529492036|FG000|Overall Study|Lost to Follow-up|4|||
146814720|NCT03840993|529492037|FG001|Overall Study|Lost to Follow-up|0|||
146814721|NCT03840993|529492036|FG000|Overall Study|Physician Decision|0|||
146814722|NCT03840993|529492037|FG001|Overall Study|Physician Decision|1|||
146814723|NCT03840993|529492036|FG000|Overall Study|Pregnancy|0|||
146814724|NCT03840993|529492037|FG001|Overall Study|Pregnancy|1|||
146814725|NCT03840993|529492036|FG000|Overall Study|Withdrawal by Subject|1|||
146814726|NCT03840993|529492037|FG001|Overall Study|Withdrawal by Subject|3|||
146814727|NCT03840993|529492036|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
146814728|NCT03840993|529492037|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
146814729|NCT04271254|529492038|FG000|Overall Study|Withdrawal by Subject|3|||
146814730|NCT00473512|529492039|FG000|Period 1 (Phase 1)|Adverse Event|0|||
146814731|NCT00473512|529492040|FG001|Period 1 (Phase 1)|Adverse Event|0|||
146814732|NCT00473512|529492041|FG002|Period 1 (Phase 1)|Adverse Event|0|||
146814733|NCT00473512|529492042|FG003|Period 1 (Phase 1)|Adverse Event|5|||
146814734|NCT00473512|529492043|FG004|Period 1 (Phase 1)|Adverse Event|0|||
146814735|NCT00473512|529492039|FG000|Period 1 (Phase 1)|Death|0|||
146814736|NCT00473512|529492040|FG001|Period 1 (Phase 1)|Death|0|||
146814737|NCT00473512|529492041|FG002|Period 1 (Phase 1)|Death|0|||
146814738|NCT00473512|529492042|FG003|Period 1 (Phase 1)|Death|1|||
146814739|NCT00473512|529492043|FG004|Period 1 (Phase 1)|Death|0|||
146814740|NCT00473512|529492039|FG000|Period 1 (Phase 1)|Disease Progression|1|||
146814741|NCT00473512|529492040|FG001|Period 1 (Phase 1)|Disease Progression|1|||
146814742|NCT00473512|529492041|FG002|Period 1 (Phase 1)|Disease Progression|0|||
146814743|NCT00473512|529492042|FG003|Period 1 (Phase 1)|Disease Progression|10|||
146814744|NCT00473512|529492043|FG004|Period 1 (Phase 1)|Disease Progression|1|||
146814745|NCT00473512|529492039|FG000|Period 1 (Phase 1)|Other|0|||
146814746|NCT00473512|529492040|FG001|Period 1 (Phase 1)|Other|0|||
146814747|NCT00473512|529492041|FG002|Period 1 (Phase 1)|Other|0|||
146814748|NCT00473512|529492042|FG003|Period 1 (Phase 1)|Other|1|||
146814749|NCT00473512|529492043|FG004|Period 1 (Phase 1)|Other|0|||
146814750|NCT00473512|529492039|FG000|Period 2 (Phase 2)|Adverse Event|0|||
146814751|NCT00473512|529492040|FG001|Period 2 (Phase 2)|Adverse Event|0|||
146814752|NCT00473512|529492041|FG002|Period 2 (Phase 2)|Adverse Event|0|||
146814753|NCT00473512|529492042|FG003|Period 2 (Phase 2)|Adverse Event|1|||
146814754|NCT00473512|529492043|FG004|Period 2 (Phase 2)|Adverse Event|0|||
146814755|NCT00473512|529492039|FG000|Period 2 (Phase 2)|Death|0|||
146814756|NCT00473512|529492040|FG001|Period 2 (Phase 2)|Death|0|||
146814757|NCT00473512|529492041|FG002|Period 2 (Phase 2)|Death|0|||
146814758|NCT00473512|529492042|FG003|Period 2 (Phase 2)|Death|1|||
146814759|NCT00473512|529492043|FG004|Period 2 (Phase 2)|Death|1|||
146814760|NCT00473512|529492039|FG000|Period 2 (Phase 2)|Disease Progression|0|||
146814761|NCT00473512|529492040|FG001|Period 2 (Phase 2)|Disease Progression|2|||
146814762|NCT00473512|529492041|FG002|Period 2 (Phase 2)|Disease Progression|2|||
146814763|NCT00473512|529492042|FG003|Period 2 (Phase 2)|Disease Progression|17|||
146814764|NCT00473512|529492043|FG004|Period 2 (Phase 2)|Disease Progression|1|||
146814765|NCT00473512|529492039|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
146814766|NCT00473512|529492040|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
146814767|NCT00473512|529492041|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
146814768|NCT00473512|529492042|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
146814769|NCT00473512|529492043|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
146814770|NCT00473512|529492039|FG000|Period 2 (Phase 2)|Other|1|||
146814771|NCT00473512|529492040|FG001|Period 2 (Phase 2)|Other|0|||
146814772|NCT00473512|529492041|FG002|Period 2 (Phase 2)|Other|0|||
146814773|NCT00473512|529492042|FG003|Period 2 (Phase 2)|Other|3|||
146814774|NCT00473512|529492043|FG004|Period 2 (Phase 2)|Other|0|||
146814775|NCT00267956|529492048|FG000|Controlled Period|Adverse Event|4|||
146814776|NCT00267956|529492049|FG001|Controlled Period|Adverse Event|1|||
146814777|NCT00267956|529492050|FG002|Controlled Period|Adverse Event|0|||
146814778|NCT00267956|529492051|FG003|Controlled Period|Adverse Event|0|||
146814779|NCT00267956|529492048|FG000|Controlled Period|Lack of Efficacy|4|||
146814780|NCT00267956|529492049|FG001|Controlled Period|Lack of Efficacy|2|||
146814781|NCT00267956|529492050|FG002|Controlled Period|Lack of Efficacy|0|||
146814782|NCT00267956|529492051|FG003|Controlled Period|Lack of Efficacy|0|||
146814783|NCT00267956|529492048|FG000|Controlled Period|Lost to Follow-up|2|||
146814784|NCT00267956|529492049|FG001|Controlled Period|Lost to Follow-up|0|||
146814785|NCT00267956|529492050|FG002|Controlled Period|Lost to Follow-up|0|||
146814786|NCT00267956|529492051|FG003|Controlled Period|Lost to Follow-up|0|||
146814787|NCT00267956|529492048|FG000|Controlled Period|Withdrew consent|3|||
146814788|NCT00267956|529492049|FG001|Controlled Period|Withdrew consent|1|||
146814789|NCT00267956|529492050|FG002|Controlled Period|Withdrew consent|0|||
146814790|NCT00267956|529492051|FG003|Controlled Period|Withdrew consent|0|||
146814791|NCT00267956|529492048|FG000|After Controlled Period|Adverse Event|0|||
146814792|NCT00267956|529492049|FG001|After Controlled Period|Adverse Event|0|||
146814793|NCT00267956|529492050|FG002|After Controlled Period|Adverse Event|2|||
146814794|NCT00267956|529492051|FG003|After Controlled Period|Adverse Event|1|||
146814795|NCT00267956|529492048|FG000|After Controlled Period|Lack of Efficacy|0|||
146814796|NCT00267956|529492049|FG001|After Controlled Period|Lack of Efficacy|0|||
146814797|NCT00267956|529492050|FG002|After Controlled Period|Lack of Efficacy|1|||
146814798|NCT00267956|529492051|FG003|After Controlled Period|Lack of Efficacy|1|||
146814799|NCT00267956|529492048|FG000|After Controlled Period|Lost to Follow-up|0|||
146814800|NCT00267956|529492049|FG001|After Controlled Period|Lost to Follow-up|0|||
146814801|NCT00267956|529492050|FG002|After Controlled Period|Lost to Follow-up|1|||
146814802|NCT00267956|529492051|FG003|After Controlled Period|Lost to Follow-up|0|||
146814803|NCT00267956|529492048|FG000|After Controlled Period|Withdrew consent|0|||
146814804|NCT00267956|529492049|FG001|After Controlled Period|Withdrew consent|0|||
146814805|NCT00267956|529492050|FG002|After Controlled Period|Withdrew consent|1|||
146814806|NCT00267956|529492051|FG003|After Controlled Period|Withdrew consent|0|||
146814807|NCT01263223|529492052|FG000|Period 2|Withdrawal by Subject|0|||
146814808|NCT01263223|529492053|FG001|Period 2|Withdrawal by Subject|1|||
146814809|NCT01263223|529492052|FG000|7-day Follow-up|Withdrawal by Subject|0|||
146814810|NCT01263223|529492053|FG001|7-day Follow-up|Withdrawal by Subject|1|||
146814811|NCT01263223|529492052|FG000|7-day Follow-up|Lost to Follow-up|1|||
146814812|NCT01263223|529492053|FG001|7-day Follow-up|Lost to Follow-up|0|||
146814813|NCT02246647|529492054|FG000|Overall Study|Withdrawal by Subject|1|||
146814814|NCT02246647|529492055|FG001|Overall Study|Withdrawal by Subject|1|||
146814815|NCT01113541|529492059|FG000|Overall Study|Withdrawal by Subject|1|||
146814816|NCT01113541|529492059|FG000|Overall Study|Protocol Violation|1|||
146814817|NCT01113541|529492059|FG000|Overall Study|Study Terminated by Sponsor|7|||
146814818|NCT01113541|529492059|FG000|Overall Study|Adverse Event|4|||
146814819|NCT01494467|529492066|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
146814820|NCT01494467|529492067|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
146944540|NCT00552344|529956385|FG000|Overall Study|Lack of Efficacy|55|||
146814821|NCT01494467|529492066|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
146814822|NCT01494467|529492067|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
146814823|NCT01494467|529492066|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
146814824|NCT01494467|529492067|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
146814825|NCT01494467|529492066|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
146814826|NCT01494467|529492067|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
146814827|NCT01494467|529492066|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
146814828|NCT01494467|529492067|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
146814829|NCT01494467|529492066|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
146814830|NCT01494467|529492067|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
146814831|NCT01494467|529492066|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
146814832|NCT01494467|529492067|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
146814833|NCT01494467|529492066|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
146814834|NCT01494467|529492067|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
146814835|NCT01494467|529492066|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
146814836|NCT01494467|529492067|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
146814837|NCT01494467|529492066|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
146814838|NCT01494467|529492067|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
146814839|NCT01494467|529492066|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
146814840|NCT01494467|529492067|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
146814841|NCT01494467|529492066|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
146814842|NCT01494467|529492067|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
146814843|NCT01494467|529492066|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
146814844|NCT01494467|529492067|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
146814845|NCT01494467|529492066|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
146814846|NCT01494467|529492067|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
146814847|NCT03386344|529492070|FG000|Overall Study|Adverse Event|6|||
146814848|NCT03386344|529492071|FG001|Overall Study|Adverse Event|3|||
146814849|NCT03386344|529492072|FG002|Overall Study|Adverse Event|1|||
146814850|NCT03386344|529492070|FG000|Overall Study|Poor Compliance to Protocol|0|||
146814851|NCT03386344|529492071|FG001|Overall Study|Poor Compliance to Protocol|1|||
146814852|NCT03386344|529492072|FG002|Overall Study|Poor Compliance to Protocol|0|||
146814853|NCT03386344|529492070|FG000|Overall Study|Study Terminated by Sponsor|101|||
146814854|NCT03386344|529492071|FG001|Overall Study|Study Terminated by Sponsor|102|||
146814855|NCT03386344|529492072|FG002|Overall Study|Study Terminated by Sponsor|106|||
146814856|NCT03386344|529492070|FG000|Overall Study|Lost to Follow-up|3|||
146814857|NCT03386344|529492071|FG001|Overall Study|Lost to Follow-up|2|||
146814858|NCT03386344|529492072|FG002|Overall Study|Lost to Follow-up|1|||
146814859|NCT03386344|529492070|FG000|Overall Study|At the Participant's own Request|7|||
146814860|NCT03386344|529492071|FG001|Overall Study|At the Participant's own Request|7|||
146814861|NCT03386344|529492072|FG002|Overall Study|At the Participant's own Request|8|||
146814862|NCT03386344|529492070|FG000|Overall Study|Reason not Specified|0|||
146814863|NCT03386344|529492071|FG001|Overall Study|Reason not Specified|1|||
146814864|NCT03386344|529492072|FG002|Overall Study|Reason not Specified|0|||
146814865|NCT01280721|529492075|FG000|Overall Study|Adverse Event|4|||
146814866|NCT01280721|529492075|FG000|Overall Study|Physician Decision|3|||
146814867|NCT01280721|529492075|FG000|Overall Study|Withdrawal by Subject|6|||
146814868|NCT01280721|529492075|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
146814869|NCT01280721|529492075|FG000|Overall Study|No tolerability for the lowest dose|2|||
146814870|NCT01180400|529492076|FG000|Overall Study|Withdrawal by Subject|5|||
146814871|NCT01180400|529492077|FG001|Overall Study|Withdrawal by Subject|6|||
146814872|NCT01180400|529492076|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146814873|NCT01180400|529492077|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
146814874|NCT01180400|529492076|FG000|Overall Study|Adverse Event|12|||
146814875|NCT01180400|529492077|FG001|Overall Study|Adverse Event|10|||
146814876|NCT01180400|529492076|FG000|Overall Study|Severe non-compliance to protocol|1|||
146814877|NCT01180400|529492077|FG001|Overall Study|Severe non-compliance to protocol|2|||
146814878|NCT01180400|529492076|FG000|Overall Study|Condition under investigation worsened|2|||
146814879|NCT01180400|529492077|FG001|Overall Study|Condition under investigation worsened|1|||
146814880|NCT01180400|529492076|FG000|Overall Study|Lack of Efficacy|2|||
146814881|NCT01180400|529492077|FG001|Overall Study|Lack of Efficacy|0|||
146814882|NCT01180400|529492076|FG000|Overall Study|Study-specific withdrawal criteria|1|||
146814883|NCT01180400|529492077|FG001|Overall Study|Study-specific withdrawal criteria|2|||
146814884|NCT01180400|529492076|FG000|Overall Study|Lost to Follow-up|2|||
146814885|NCT01180400|529492077|FG001|Overall Study|Lost to Follow-up|3|||
146814886|NCT01180400|529492076|FG000|Overall Study|Other|0|||
146814887|NCT01180400|529492077|FG001|Overall Study|Other|1|||
146814888|NCT01182285|529492079|FG000|First Intervention Week 1-10|Disease progression|1|||
146814889|NCT01182285|529492080|FG001|First Intervention Week 1-10|Disease progression|0|||
146814890|NCT01182285|529492081|FG002|First Intervention Week 1-10|Disease progression|0|||
146814891|NCT01182285|529492079|FG000|First Intervention Week 1-10|Adverse Event|1|||
146814892|NCT01182285|529492080|FG001|First Intervention Week 1-10|Adverse Event|0|||
146814893|NCT01182285|529492081|FG002|First Intervention Week 1-10|Adverse Event|0|||
146814894|NCT01182285|529492079|FG000|First Intervention Week 1-10|Non-compliance|1|||
146814895|NCT01182285|529492080|FG001|First Intervention Week 1-10|Non-compliance|0|||
146814896|NCT01182285|529492081|FG002|First Intervention Week 1-10|Non-compliance|0|||
146814897|NCT01182285|529492079|FG000|Third Intervention Week 11-52|Disease Progression|0|||
146814898|NCT01182285|529492080|FG001|Third Intervention Week 11-52|Disease Progression|0|||
146814899|NCT01182285|529492081|FG002|Third Intervention Week 11-52|Disease Progression|6|||
146814900|NCT01182285|529492079|FG000|Third Intervention Week 11-52|Other|0|||
146814901|NCT01182285|529492080|FG001|Third Intervention Week 11-52|Other|0|||
146814902|NCT01182285|529492081|FG002|Third Intervention Week 11-52|Other|2|||
146814903|NCT03209492|529492082|FG000|Overall Study|Case Report Forms Uncollected|5|||
146814904|NCT01525875|529492083|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
146814905|NCT01525875|529492084|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
146814906|NCT01525875|529492083|FG000|Open-label Period|Lost to Follow-up|0|||
146814907|NCT01525875|529492084|FG001|Open-label Period|Lost to Follow-up|2|||
146814908|NCT00700999|529492085|FG000|Overall Study|Lost to Follow-up|7|||
146814909|NCT00700999|529492086|FG001|Overall Study|Lost to Follow-up|7|||
146814910|NCT00700999|529492085|FG000|Overall Study|Excluded - did not meet study criteria|0|||
146814911|NCT00700999|529492086|FG001|Overall Study|Excluded - did not meet study criteria|1|||
146814912|NCT00700999|529492085|FG000|Overall Study|Withdrawal by Subject|8|||
146814913|NCT00700999|529492086|FG001|Overall Study|Withdrawal by Subject|1|||
146814914|NCT02379078|529492087|FG000|Overall Study|Lost to Follow-up|33|||
146814915|NCT02379078|529492088|FG001|Overall Study|Lost to Follow-up|30|||
146814916|NCT02379078|529492087|FG000|Overall Study|Withdrawal by Subject|6|||
146814917|NCT02379078|529492088|FG001|Overall Study|Withdrawal by Subject|5|||
146814918|NCT03481725|529492089|FG000|Overall Study|Withdrawal by Subject|1|||
146814919|NCT03481725|529492090|FG001|Overall Study|Withdrawal by Subject|0|||
146814920|NCT01133678|529492091|FG000|Overall Study|Death|1|||
146814921|NCT01133678|529492092|FG001|Overall Study|Death|1|||
146814922|NCT00879710|529492099|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
146814923|NCT00879710|529492100|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
146814924|NCT00879710|529492101|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
146814925|NCT00879710|529492102|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
146814926|NCT00879710|529492099|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
146814927|NCT00879710|529492100|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
146814928|NCT00879710|529492101|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
146814929|NCT00879710|529492102|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
146814930|NCT01864200|529492103|FG000|Overall Study|Lost to Follow-up|1|||
146814931|NCT01864200|529492104|FG001|Overall Study|Lost to Follow-up|3|||
146814932|NCT01864200|529492103|FG000|Overall Study|Protocol Violation|1|||
146814933|NCT01864200|529492104|FG001|Overall Study|Protocol Violation|0|||
146814934|NCT02514824|529492112|FG000|Overall Study|Withdrawal by Subject|1|||
146814935|NCT02514824|529492113|FG001|Overall Study|Withdrawal by Subject|0|||
146814936|NCT02514824|529492114|FG002|Overall Study|Withdrawal by Subject|0|||
146814937|NCT02514824|529492115|FG003|Overall Study|Withdrawal by Subject|0|||
146814938|NCT02514824|529492112|FG000|Overall Study|Dose-Limiting Toxicity|0|||
146814939|NCT02514824|529492113|FG001|Overall Study|Dose-Limiting Toxicity|1|||
146814940|NCT02514824|529492114|FG002|Overall Study|Dose-Limiting Toxicity|0|||
146814941|NCT02514824|529492115|FG003|Overall Study|Dose-Limiting Toxicity|0|||
146814942|NCT02170207|529492118|FG000|Overall Study|Case report forms unavailable|5|||
146814943|NCT03122860|529492119|FG000|Overall Study|Discontinued Before Treatment|1|||
146814944|NCT03122860|529492120|FG001|Overall Study|Discontinued Before Treatment|1|||
146814945|NCT03122860|529492121|FG002|Overall Study|Discontinued Before Treatment|2|||
146814946|NCT03122860|529492122|FG003|Overall Study|Discontinued Before Treatment|0|||
146814947|NCT03122860|529492123|FG004|Overall Study|Discontinued Before Treatment|1|||
146814948|NCT03122860|529492124|FG005|Overall Study|Discontinued Before Treatment|0|||
146814949|NCT03122860|529492119|FG000|Overall Study|Adverse Event|1|||
146814950|NCT03122860|529492120|FG001|Overall Study|Adverse Event|0|||
146814951|NCT03122860|529492121|FG002|Overall Study|Adverse Event|1|||
146814952|NCT03122860|529492122|FG003|Overall Study|Adverse Event|1|||
146814953|NCT03122860|529492123|FG004|Overall Study|Adverse Event|0|||
146814954|NCT03122860|529492124|FG005|Overall Study|Adverse Event|0|||
146814955|NCT03122860|529492119|FG000|Overall Study|Lost to Follow-up|5|||
146814956|NCT03122860|529492120|FG001|Overall Study|Lost to Follow-up|2|||
146814957|NCT03122860|529492121|FG002|Overall Study|Lost to Follow-up|3|||
146814958|NCT03122860|529492122|FG003|Overall Study|Lost to Follow-up|3|||
146814959|NCT03122860|529492123|FG004|Overall Study|Lost to Follow-up|5|||
146814960|NCT03122860|529492124|FG005|Overall Study|Lost to Follow-up|4|||
146814961|NCT03122860|529492119|FG000|Overall Study|Subject Non-Compliance|0|||
146814962|NCT03122860|529492120|FG001|Overall Study|Subject Non-Compliance|0|||
146814963|NCT03122860|529492121|FG002|Overall Study|Subject Non-Compliance|1|||
146814964|NCT03122860|529492122|FG003|Overall Study|Subject Non-Compliance|0|||
146814965|NCT03122860|529492123|FG004|Overall Study|Subject Non-Compliance|0|||
146814966|NCT03122860|529492124|FG005|Overall Study|Subject Non-Compliance|0|||
146814967|NCT03122860|529492119|FG000|Overall Study|Withdrawal by Subject|3|||
146814968|NCT03122860|529492120|FG001|Overall Study|Withdrawal by Subject|2|||
146814969|NCT03122860|529492121|FG002|Overall Study|Withdrawal by Subject|5|||
146814970|NCT03122860|529492122|FG003|Overall Study|Withdrawal by Subject|7|||
146814971|NCT03122860|529492123|FG004|Overall Study|Withdrawal by Subject|9|||
146814972|NCT03122860|529492124|FG005|Overall Study|Withdrawal by Subject|8|||
146814973|NCT01138657|529492125|FG000|Overall Study|Adverse Event|3|||
146814974|NCT01138657|529492126|FG001|Overall Study|Adverse Event|10|||
146814975|NCT01138657|529492125|FG000|Overall Study|Lack of Efficacy|2|||
146814976|NCT01138657|529492126|FG001|Overall Study|Lack of Efficacy|1|||
146814977|NCT01138657|529492125|FG000|Overall Study|Lost to Follow-up|0|||
146814978|NCT01138657|529492126|FG001|Overall Study|Lost to Follow-up|3|||
146814979|NCT01138657|529492125|FG000|Overall Study|Miscellaneous Reasons|3|||
146814980|NCT01138657|529492126|FG001|Overall Study|Miscellaneous Reasons|4|||
146814981|NCT02159352|529492127|FG000|Overall Study|Adverse Event|3|||
146814982|NCT02159352|529492128|FG001|Overall Study|Adverse Event|1|||
146814983|NCT02159352|529492127|FG000|Overall Study|Withdrawal by Subject|0|||
146814984|NCT02159352|529492128|FG001|Overall Study|Withdrawal by Subject|1|||
146814985|NCT00529529|529492133|FG000|Overall Study|Adverse Event|12|||
146814986|NCT00529529|529492134|FG001|Overall Study|Adverse Event|17|||
146814987|NCT00529529|529492135|FG002|Overall Study|Adverse Event|8|||
146814988|NCT00529529|529492133|FG000|Overall Study|Subject withdrew consent|12|||
146814989|NCT00529529|529492134|FG001|Overall Study|Subject withdrew consent|9|||
146814990|NCT00529529|529492135|FG002|Overall Study|Subject withdrew consent|12|||
146814991|NCT00529529|529492133|FG000|Overall Study|Protocol deviation|8|||
146814992|NCT00529529|529492134|FG001|Overall Study|Protocol deviation|12|||
146814993|NCT00529529|529492135|FG002|Overall Study|Protocol deviation|5|||
146814994|NCT00529529|529492133|FG000|Overall Study|Lost to Follow-up|5|||
146814995|NCT00529529|529492134|FG001|Overall Study|Lost to Follow-up|3|||
146814996|NCT00529529|529492135|FG002|Overall Study|Lost to Follow-up|1|||
146814997|NCT00529529|529492133|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146814998|NCT00529529|529492134|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146814999|NCT00529529|529492135|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
146815000|NCT00529529|529492133|FG000|Overall Study|Death|2|||
146815001|NCT00529529|529492134|FG001|Overall Study|Death|0|||
146815002|NCT00529529|529492135|FG002|Overall Study|Death|0|||
146815003|NCT00529529|529492133|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146815004|NCT00529529|529492134|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146815005|NCT00529529|529492135|FG002|Overall Study|Abnormal test procedure result(s)|0|||
146815006|NCT00529529|529492133|FG000|Overall Study|Administrative problems|1|||
146815007|NCT00529529|529492134|FG001|Overall Study|Administrative problems|0|||
146815008|NCT00529529|529492135|FG002|Overall Study|Administrative problems|3|||
146815009|NCT01000649|529492138|FG000|Overall Study|Adverse Event|5|||
146815010|NCT01000649|529492139|FG001|Overall Study|Adverse Event|1|||
146815011|NCT01000649|529492140|FG002|Overall Study|Adverse Event|2|||
146815012|NCT01000649|529492141|FG003|Overall Study|Adverse Event|4|||
146815013|NCT01000649|529492138|FG000|Overall Study|Lost to Follow-up|0|||
146815014|NCT01000649|529492139|FG001|Overall Study|Lost to Follow-up|2|||
146815015|NCT01000649|529492140|FG002|Overall Study|Lost to Follow-up|0|||
146815016|NCT01000649|529492141|FG003|Overall Study|Lost to Follow-up|2|||
146815017|NCT01916109|529492142|FG000|Overall Study|Withdrawal by Subject|1|||
146815018|NCT00103857|529492145|FG000|54-Week Base Study|Adverse Event|12|||
146815019|NCT00103857|529492146|FG001|54-Week Base Study|Adverse Event|9|||
146815020|NCT00103857|529492147|FG002|54-Week Base Study|Adverse Event|11|||
146815021|NCT00103857|529492148|FG003|54-Week Base Study|Adverse Event|6|||
146815022|NCT00103857|529492149|FG004|54-Week Base Study|Adverse Event|5|||
146815023|NCT00103857|529492150|FG005|54-Week Base Study|Adverse Event|11|||
146815024|NCT00103857|529492151|FG006|54-Week Base Study|Adverse Event|3|||
146815025|NCT00103857|529492145|FG000|54-Week Base Study|Death|0|||
146815026|NCT00103857|529492146|FG001|54-Week Base Study|Death|0|||
146815027|NCT00103857|529492147|FG002|54-Week Base Study|Death|0|||
146815028|NCT00103857|529492148|FG003|54-Week Base Study|Death|0|||
146815029|NCT00103857|529492149|FG004|54-Week Base Study|Death|1|||
146815030|NCT00103857|529492150|FG005|54-Week Base Study|Death|1|||
146815031|NCT00103857|529492151|FG006|54-Week Base Study|Death|0|||
146815032|NCT00103857|529492145|FG000|54-Week Base Study|Lack of Efficacy|11|||
146815033|NCT00103857|529492146|FG001|54-Week Base Study|Lack of Efficacy|14|||
146815034|NCT00103857|529492147|FG002|54-Week Base Study|Lack of Efficacy|8|||
146815035|NCT00103857|529492148|FG003|54-Week Base Study|Lack of Efficacy|4|||
146815036|NCT00103857|529492149|FG004|54-Week Base Study|Lack of Efficacy|3|||
146815037|NCT00103857|529492150|FG005|54-Week Base Study|Lack of Efficacy|14|||
146815038|NCT00103857|529492151|FG006|54-Week Base Study|Lack of Efficacy|19|||
146815039|NCT00103857|529492145|FG000|54-Week Base Study|Lost to Follow-up|5|||
146815040|NCT00103857|529492146|FG001|54-Week Base Study|Lost to Follow-up|4|||
146815041|NCT00103857|529492147|FG002|54-Week Base Study|Lost to Follow-up|7|||
146815042|NCT00103857|529492148|FG003|54-Week Base Study|Lost to Follow-up|5|||
146815043|NCT00103857|529492149|FG004|54-Week Base Study|Lost to Follow-up|10|||
146815044|NCT00103857|529492150|FG005|54-Week Base Study|Lost to Follow-up|9|||
146815045|NCT00103857|529492151|FG006|54-Week Base Study|Lost to Follow-up|3|||
146815046|NCT00103857|529492145|FG000|54-Week Base Study|Physician Decision|1|||
146815047|NCT00103857|529492146|FG001|54-Week Base Study|Physician Decision|1|||
146944541|NCT00552344|529956385|FG000|Overall Study|Loss of efficacy|75|||
146815048|NCT00103857|529492147|FG002|54-Week Base Study|Physician Decision|0|||
146815049|NCT00103857|529492148|FG003|54-Week Base Study|Physician Decision|0|||
146815050|NCT00103857|529492149|FG004|54-Week Base Study|Physician Decision|1|||
146815051|NCT00103857|529492150|FG005|54-Week Base Study|Physician Decision|0|||
146815052|NCT00103857|529492151|FG006|54-Week Base Study|Physician Decision|0|||
146815053|NCT00103857|529492145|FG000|54-Week Base Study|Pregnancy|1|||
146815054|NCT00103857|529492146|FG001|54-Week Base Study|Pregnancy|0|||
146815055|NCT00103857|529492147|FG002|54-Week Base Study|Pregnancy|0|||
146815056|NCT00103857|529492148|FG003|54-Week Base Study|Pregnancy|0|||
146815057|NCT00103857|529492149|FG004|54-Week Base Study|Pregnancy|1|||
146815058|NCT00103857|529492150|FG005|54-Week Base Study|Pregnancy|0|||
146815059|NCT00103857|529492151|FG006|54-Week Base Study|Pregnancy|1|||
146815060|NCT00103857|529492145|FG000|54-Week Base Study|Protocol Violation|6|||
146815061|NCT00103857|529492146|FG001|54-Week Base Study|Protocol Violation|4|||
146815062|NCT00103857|529492147|FG002|54-Week Base Study|Protocol Violation|2|||
146815063|NCT00103857|529492148|FG003|54-Week Base Study|Protocol Violation|4|||
146815064|NCT00103857|529492149|FG004|54-Week Base Study|Protocol Violation|0|||
146815065|NCT00103857|529492150|FG005|54-Week Base Study|Protocol Violation|3|||
146815066|NCT00103857|529492151|FG006|54-Week Base Study|Protocol Violation|3|||
146815067|NCT00103857|529492145|FG000|54-Week Base Study|Withdrawal by Subject|17|||
146815068|NCT00103857|529492146|FG001|54-Week Base Study|Withdrawal by Subject|16|||
146815069|NCT00103857|529492147|FG002|54-Week Base Study|Withdrawal by Subject|16|||
146815070|NCT00103857|529492148|FG003|54-Week Base Study|Withdrawal by Subject|15|||
146815071|NCT00103857|529492149|FG004|54-Week Base Study|Withdrawal by Subject|10|||
146815072|NCT00103857|529492150|FG005|54-Week Base Study|Withdrawal by Subject|15|||
146815073|NCT00103857|529492151|FG006|54-Week Base Study|Withdrawal by Subject|4|||
146815074|NCT00103857|529492145|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
146815075|NCT00103857|529492146|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
146815076|NCT00103857|529492147|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
146815077|NCT00103857|529492148|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
146815078|NCT00103857|529492149|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
146815079|NCT00103857|529492150|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
146815080|NCT00103857|529492151|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
146815081|NCT00103857|529492145|FG000|54-Week Base Study|patient moved|0|||
146815082|NCT00103857|529492146|FG001|54-Week Base Study|patient moved|1|||
146815083|NCT00103857|529492147|FG002|54-Week Base Study|patient moved|1|||
146815084|NCT00103857|529492148|FG003|54-Week Base Study|patient moved|2|||
146815085|NCT00103857|529492149|FG004|54-Week Base Study|patient moved|3|||
146815086|NCT00103857|529492150|FG005|54-Week Base Study|patient moved|1|||
146815087|NCT00103857|529492151|FG006|54-Week Base Study|patient moved|0|||
146815088|NCT00103857|529492145|FG000|54-Week Base Study|non-compliance with study procedures|1|||
146815089|NCT00103857|529492146|FG001|54-Week Base Study|non-compliance with study procedures|2|||
146815090|NCT00103857|529492147|FG002|54-Week Base Study|non-compliance with study procedures|0|||
146815091|NCT00103857|529492148|FG003|54-Week Base Study|non-compliance with study procedures|0|||
146815092|NCT00103857|529492149|FG004|54-Week Base Study|non-compliance with study procedures|0|||
146815093|NCT00103857|529492150|FG005|54-Week Base Study|non-compliance with study procedures|2|||
146815094|NCT00103857|529492151|FG006|54-Week Base Study|non-compliance with study procedures|0|||
146815095|NCT00103857|529492145|FG000|54-Week Base Study|patient incarcerated|0|||
146815096|NCT00103857|529492146|FG001|54-Week Base Study|patient incarcerated|0|||
146815097|NCT00103857|529492147|FG002|54-Week Base Study|patient incarcerated|0|||
146815098|NCT00103857|529492148|FG003|54-Week Base Study|patient incarcerated|0|||
146815099|NCT00103857|529492149|FG004|54-Week Base Study|patient incarcerated|1|||
146815100|NCT00103857|529492150|FG005|54-Week Base Study|patient incarcerated|1|||
146815101|NCT00103857|529492151|FG006|54-Week Base Study|patient incarcerated|0|||
146815102|NCT00103857|529492145|FG000|54-Week Base Study|laboratory reporting error|0|||
146815103|NCT00103857|529492146|FG001|54-Week Base Study|laboratory reporting error|0|||
146815104|NCT00103857|529492147|FG002|54-Week Base Study|laboratory reporting error|0|||
146815105|NCT00103857|529492148|FG003|54-Week Base Study|laboratory reporting error|0|||
146815106|NCT00103857|529492149|FG004|54-Week Base Study|laboratory reporting error|1|||
146815107|NCT00103857|529492150|FG005|54-Week Base Study|laboratory reporting error|0|||
146815108|NCT00103857|529492151|FG006|54-Week Base Study|laboratory reporting error|0|||
146815109|NCT00103857|529492145|FG000|54-Week Base Study|site error|0|||
146815110|NCT00103857|529492146|FG001|54-Week Base Study|site error|0|||
146815111|NCT00103857|529492147|FG002|54-Week Base Study|site error|0|||
146815112|NCT00103857|529492148|FG003|54-Week Base Study|site error|0|||
146815113|NCT00103857|529492149|FG004|54-Week Base Study|site error|0|||
146815114|NCT00103857|529492150|FG005|54-Week Base Study|site error|1|||
146815115|NCT00103857|529492151|FG006|54-Week Base Study|site error|0|||
146815116|NCT00103857|529492145|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
146815117|NCT00103857|529492146|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
146815118|NCT00103857|529492147|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
146815119|NCT00103857|529492148|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
146815120|NCT00103857|529492149|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
146815121|NCT00103857|529492150|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
146815122|NCT00103857|529492151|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
146815123|NCT00103857|529492145|FG000|50-Week Extension Study|Adverse Event|2|||
146815124|NCT00103857|529492146|FG001|50-Week Extension Study|Adverse Event|3|||
146815125|NCT00103857|529492147|FG002|50-Week Extension Study|Adverse Event|2|||
146815126|NCT00103857|529492148|FG003|50-Week Extension Study|Adverse Event|0|||
146815127|NCT00103857|529492149|FG004|50-Week Extension Study|Adverse Event|1|||
146815128|NCT00103857|529492150|FG005|50-Week Extension Study|Adverse Event|1|||
146815129|NCT00103857|529492151|FG006|50-Week Extension Study|Adverse Event|0|||
146815130|NCT00103857|529492145|FG000|50-Week Extension Study|Death|0|||
146815131|NCT00103857|529492146|FG001|50-Week Extension Study|Death|0|||
146815132|NCT00103857|529492147|FG002|50-Week Extension Study|Death|0|||
146815133|NCT00103857|529492148|FG003|50-Week Extension Study|Death|1|||
146815134|NCT00103857|529492149|FG004|50-Week Extension Study|Death|0|||
146815135|NCT00103857|529492150|FG005|50-Week Extension Study|Death|1|||
146815136|NCT00103857|529492151|FG006|50-Week Extension Study|Death|0|||
146815137|NCT00103857|529492145|FG000|50-Week Extension Study|Lack of Efficacy|26|||
146815138|NCT00103857|529492146|FG001|50-Week Extension Study|Lack of Efficacy|15|||
146815139|NCT00103857|529492147|FG002|50-Week Extension Study|Lack of Efficacy|13|||
146815140|NCT00103857|529492148|FG003|50-Week Extension Study|Lack of Efficacy|16|||
146815141|NCT00103857|529492149|FG004|50-Week Extension Study|Lack of Efficacy|8|||
146815142|NCT00103857|529492150|FG005|50-Week Extension Study|Lack of Efficacy|8|||
146815143|NCT00103857|529492151|FG006|50-Week Extension Study|Lack of Efficacy|0|||
146815144|NCT00103857|529492145|FG000|50-Week Extension Study|Lost to Follow-up|4|||
146815145|NCT00103857|529492146|FG001|50-Week Extension Study|Lost to Follow-up|0|||
146815146|NCT00103857|529492147|FG002|50-Week Extension Study|Lost to Follow-up|1|||
146815147|NCT00103857|529492148|FG003|50-Week Extension Study|Lost to Follow-up|4|||
146815148|NCT00103857|529492149|FG004|50-Week Extension Study|Lost to Follow-up|3|||
146815149|NCT00103857|529492150|FG005|50-Week Extension Study|Lost to Follow-up|3|||
146815150|NCT00103857|529492151|FG006|50-Week Extension Study|Lost to Follow-up|0|||
146815151|NCT00103857|529492145|FG000|50-Week Extension Study|Physician Decision|0|||
146815152|NCT00103857|529492146|FG001|50-Week Extension Study|Physician Decision|1|||
146815153|NCT00103857|529492147|FG002|50-Week Extension Study|Physician Decision|1|||
146815154|NCT00103857|529492148|FG003|50-Week Extension Study|Physician Decision|0|||
146815155|NCT00103857|529492149|FG004|50-Week Extension Study|Physician Decision|0|||
146815156|NCT00103857|529492150|FG005|50-Week Extension Study|Physician Decision|0|||
146815157|NCT00103857|529492151|FG006|50-Week Extension Study|Physician Decision|0|||
146815158|NCT00103857|529492145|FG000|50-Week Extension Study|Pregnancy|0|||
146815159|NCT00103857|529492146|FG001|50-Week Extension Study|Pregnancy|0|||
146815160|NCT00103857|529492147|FG002|50-Week Extension Study|Pregnancy|1|||
146815161|NCT00103857|529492148|FG003|50-Week Extension Study|Pregnancy|0|||
146815162|NCT00103857|529492149|FG004|50-Week Extension Study|Pregnancy|1|||
146815163|NCT00103857|529492150|FG005|50-Week Extension Study|Pregnancy|0|||
146815164|NCT00103857|529492151|FG006|50-Week Extension Study|Pregnancy|0|||
146815165|NCT00103857|529492145|FG000|50-Week Extension Study|Protocol Violation|1|||
146815166|NCT00103857|529492146|FG001|50-Week Extension Study|Protocol Violation|1|||
146815167|NCT00103857|529492147|FG002|50-Week Extension Study|Protocol Violation|1|||
146815168|NCT00103857|529492148|FG003|50-Week Extension Study|Protocol Violation|2|||
146815169|NCT00103857|529492149|FG004|50-Week Extension Study|Protocol Violation|0|||
146815170|NCT00103857|529492150|FG005|50-Week Extension Study|Protocol Violation|1|||
146815171|NCT00103857|529492151|FG006|50-Week Extension Study|Protocol Violation|0|||
146815172|NCT00103857|529492145|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
146815173|NCT00103857|529492146|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
146815174|NCT00103857|529492147|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
146815175|NCT00103857|529492148|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
146815176|NCT00103857|529492149|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
146815177|NCT00103857|529492150|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
146815178|NCT00103857|529492151|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
146815179|NCT00103857|529492145|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
146815180|NCT00103857|529492146|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
146815181|NCT00103857|529492147|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
146815182|NCT00103857|529492148|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
146815183|NCT00103857|529492149|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
146944542|NCT00552344|529956385|FG000|Overall Study|Lost to Follow-up|8|||
146944543|NCT00552344|529956385|FG000|Overall Study|Withdrawal by Subject|48|||
146944544|NCT00552344|529956385|FG000|Overall Study|SAE, non-fatal|6|||
146944545|NCT00552344|529956385|FG000|Overall Study|AE, non-serious non-fatal|38|||
146944546|NCT00552344|529956385|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
146944547|NCT00552344|529956385|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
146944548|NCT00552344|529956385|FG000|Overall Study|Other Reason|22|||
146944549|NCT00338806|529956386|FG000|Acute Phase|Withdrawal by Subject|0|||
146944550|NCT00338806|529956387|FG001|Acute Phase|Withdrawal by Subject|1|||
146944551|NCT00338806|529956386|FG000|Follow-up|Lost to Follow-up|1|||
146944552|NCT00338806|529956387|FG001|Follow-up|Lost to Follow-up|3|||
146944553|NCT00744991|529956390|FG000|Overall Study|Progressive Disease|11|||
146944554|NCT00744991|529956390|FG000|Overall Study|Withdrawal by Subject|8|||
146815184|NCT00103857|529492150|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
146815185|NCT00103857|529492151|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
146815186|NCT00103857|529492145|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
146815187|NCT00103857|529492146|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
146815188|NCT00103857|529492147|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
146815189|NCT00103857|529492148|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
146944555|NCT00744991|529956390|FG000|Overall Study|Physician Decision|3|||
146984340|NCT02220907|530103429|FG000|Overall Study|Withdrawal by Subject|2|||
146984341|NCT02220907|530103429|FG000|Overall Study|Conflict with the stopping criteria|1|||
146984342|NCT01098240|530103434|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
146984343|NCT01098240|530103435|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
146984344|NCT01098240|530103436|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
146984345|NCT01098240|530103434|FG000|Open-Label Phase|Protocol Violation|4|||
146984346|NCT01098240|530103435|FG001|Open-Label Phase|Protocol Violation|0|||
146984347|NCT01098240|530103436|FG002|Open-Label Phase|Protocol Violation|0|||
146984348|NCT01098240|530103434|FG000|Open-Label Phase|Lost to Follow-up|13|||
146984349|NCT01098240|530103435|FG001|Open-Label Phase|Lost to Follow-up|0|||
146984350|NCT01098240|530103436|FG002|Open-Label Phase|Lost to Follow-up|0|||
146984351|NCT01098240|530103434|FG000|Open-Label Phase|Other|19|||
146984352|NCT01098240|530103435|FG001|Open-Label Phase|Other|0|||
146984353|NCT01098240|530103436|FG002|Open-Label Phase|Other|0|||
146984354|NCT01098240|530103434|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
146984355|NCT01098240|530103435|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
146944556|NCT00744991|529956390|FG000|Overall Study|Adverse Event|2|||
146944557|NCT00744991|529956390|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
146944558|NCT01662986|529956391|FG000|Overall Study|Adverse Event|5|||
146944559|NCT01662986|529956392|FG001|Overall Study|Adverse Event|4|||
146944560|NCT01662986|529956391|FG000|Overall Study|Protocol Violation|2|||
146944561|NCT01662986|529956392|FG001|Overall Study|Protocol Violation|3|||
146944562|NCT01662986|529956391|FG000|Overall Study|Lost to Follow-up|5|||
146944563|NCT01662986|529956392|FG001|Overall Study|Lost to Follow-up|4|||
146944564|NCT01662986|529956391|FG000|Overall Study|Withdrawal by Subject|2|||
146944565|NCT01662986|529956392|FG001|Overall Study|Withdrawal by Subject|2|||
146944566|NCT01662986|529956391|FG000|Overall Study|Not Treated|1|||
146944567|NCT01662986|529956392|FG001|Overall Study|Not Treated|0|||
146944568|NCT01662986|529956391|FG000|Overall Study|Other than stated above|3|||
146944569|NCT01662986|529956392|FG001|Overall Study|Other than stated above|0|||
146944570|NCT01487863|529956393|FG000|Overall Study|Death|19|||
146944571|NCT01487863|529956394|FG001|Overall Study|Death|19|||
146944572|NCT01975376|529956395|FG000|Overall Study|Adverse Event|5|||
146944573|NCT01975376|529956396|FG001|Overall Study|Adverse Event|5|||
146944574|NCT01975376|529956395|FG000|Overall Study|Death|65|||
146944575|NCT01975376|529956396|FG001|Overall Study|Death|72|||
146944576|NCT01975376|529956395|FG000|Overall Study|Lost to Follow-up|70|||
146944577|NCT01975376|529956396|FG001|Overall Study|Lost to Follow-up|66|||
146944578|NCT01975376|529956395|FG000|Overall Study|Withdrew consent|68|||
146944579|NCT01975376|529956396|FG001|Overall Study|Withdrew consent|62|||
146944580|NCT01975376|529956395|FG000|Overall Study|Other|2|||
146944581|NCT01975376|529956396|FG001|Overall Study|Other|4|||
146944582|NCT01975376|529956395|FG000|Overall Study|Randomized, Not Treated|16|||
146944583|NCT01975376|529956396|FG001|Overall Study|Randomized, Not Treated|8|||
146944584|NCT01819194|529956398|FG000|Overall Study|Loss of study articles|2|||
146944585|NCT00045630|529956399|FG000|Overall Study|Adverse Event|1|||
146944586|NCT00045630|529956399|FG000|Overall Study|Refusal unrelated to adverse event|1|||
146944587|NCT00045630|529956399|FG000|Overall Study|Progression/relapse|1|||
146944588|NCT00045630|529956399|FG000|Overall Study|Death|1|||
146944589|NCT00045630|529956399|FG000|Overall Study|Ineligible|2|||
146944590|NCT04449276|529956400|FG000|Overall Study|Adverse Event|1|||
146944591|NCT04449276|529956401|FG001|Overall Study|Adverse Event|2|||
146944592|NCT04449276|529956402|FG002|Overall Study|Adverse Event|0|||
146944593|NCT04449276|529956403|FG003|Overall Study|Adverse Event|0|||
146944594|NCT04449276|529956404|FG004|Overall Study|Adverse Event|2|||
146944595|NCT04449276|529956405|FG005|Overall Study|Adverse Event|0|||
146944596|NCT04449276|529956406|FG006|Overall Study|Adverse Event|0|||
146984356|NCT01098240|530103436|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
146944597|NCT04449276|529956407|FG007|Overall Study|Adverse Event|1|||
146944598|NCT04449276|529956400|FG000|Overall Study|Withdrawal by Subject|2|||
146944599|NCT04449276|529956401|FG001|Overall Study|Withdrawal by Subject|0|||
146944600|NCT04449276|529956402|FG002|Overall Study|Withdrawal by Subject|0|||
146944601|NCT04449276|529956403|FG003|Overall Study|Withdrawal by Subject|1|||
146944602|NCT04449276|529956404|FG004|Overall Study|Withdrawal by Subject|0|||
146944603|NCT04449276|529956405|FG005|Overall Study|Withdrawal by Subject|0|||
146944604|NCT04449276|529956406|FG006|Overall Study|Withdrawal by Subject|0|||
146944605|NCT04449276|529956407|FG007|Overall Study|Withdrawal by Subject|0|||
146944606|NCT04449276|529956400|FG000|Overall Study|Other|0|||
146984357|NCT01098240|530103434|FG000|Open-Label Phase|Pregnancy|1|||
146984358|NCT01098240|530103435|FG001|Open-Label Phase|Pregnancy|0|||
146984359|NCT01098240|530103436|FG002|Open-Label Phase|Pregnancy|0|||
146984360|NCT01098240|530103434|FG000|Open-Label Phase|Withdrawal by Subject|9|||
146944607|NCT04449276|529956401|FG001|Overall Study|Other|2|||
146944608|NCT04449276|529956402|FG002|Overall Study|Other|3|||
146944609|NCT04449276|529956403|FG003|Overall Study|Other|2|||
146944610|NCT04449276|529956404|FG004|Overall Study|Other|0|||
146944611|NCT04449276|529956405|FG005|Overall Study|Other|0|||
146944612|NCT04449276|529956406|FG006|Overall Study|Other|0|||
146944613|NCT04449276|529956407|FG007|Overall Study|Other|1|||
146944614|NCT01614795|529956408|FG000|Overall Study|Adverse Event|0|||
146944615|NCT01614795|529956409|FG001|Overall Study|Adverse Event|0|||
146944616|NCT01614795|529956410|FG002|Overall Study|Adverse Event|1|||
146944617|NCT01614795|529956411|FG003|Overall Study|Adverse Event|1|||
146944618|NCT01614795|529956408|FG000|Overall Study|Lack of Efficacy|10|||
146944619|NCT01614795|529956409|FG001|Overall Study|Lack of Efficacy|10|||
146944620|NCT01614795|529956410|FG002|Overall Study|Lack of Efficacy|9|||
146944621|NCT01614795|529956411|FG003|Overall Study|Lack of Efficacy|8|||
146944622|NCT01614795|529956408|FG000|Overall Study|Physician Decision|1|||
146944623|NCT01614795|529956409|FG001|Overall Study|Physician Decision|0|||
146944624|NCT01614795|529956410|FG002|Overall Study|Physician Decision|1|||
146944625|NCT01614795|529956411|FG003|Overall Study|Physician Decision|1|||
146944626|NCT01614795|529956408|FG000|Overall Study|Withdrawal by Subject|0|||
146944627|NCT01614795|529956409|FG001|Overall Study|Withdrawal by Subject|1|||
146944628|NCT01614795|529956410|FG002|Overall Study|Withdrawal by Subject|0|||
146944629|NCT01614795|529956411|FG003|Overall Study|Withdrawal by Subject|2|||
146944630|NCT01614795|529956408|FG000|Overall Study|Ineligible|0|||
146944631|NCT01614795|529956409|FG001|Overall Study|Ineligible|1|||
146944632|NCT01614795|529956410|FG002|Overall Study|Ineligible|0|||
146944633|NCT01614795|529956411|FG003|Overall Study|Ineligible|0|||
146944634|NCT00701103|529956417|FG000|Overall Study|Adverse Event|0|||
146944635|NCT00701103|529956418|FG001|Overall Study|Adverse Event|0|||
146944636|NCT00701103|529956419|FG002|Overall Study|Adverse Event|1|||
146944637|NCT00701103|529956420|FG003|Overall Study|Adverse Event|1|||
146944638|NCT00701103|529956421|FG004|Overall Study|Adverse Event|0|||
146944639|NCT00701103|529956422|FG005|Overall Study|Adverse Event|1|||
146944640|NCT00701103|529956423|FG006|Overall Study|Adverse Event|1|||
146944641|NCT00701103|529956424|FG007|Overall Study|Adverse Event|0|||
146944642|NCT00701103|529956425|FG008|Overall Study|Adverse Event|0|||
146944643|NCT00701103|529956426|FG009|Overall Study|Adverse Event|2|||
146944644|NCT00701103|529956427|FG010|Overall Study|Adverse Event|0|||
146944645|NCT00701103|529956417|FG000|Overall Study|Progressive Disease|5|||
146944646|NCT00701103|529956418|FG001|Overall Study|Progressive Disease|2|||
146944647|NCT00701103|529956419|FG002|Overall Study|Progressive Disease|6|||
146944648|NCT00701103|529956420|FG003|Overall Study|Progressive Disease|5|||
146944649|NCT00701103|529956421|FG004|Overall Study|Progressive Disease|6|||
146944650|NCT00701103|529956422|FG005|Overall Study|Progressive Disease|5|||
146944651|NCT00701103|529956423|FG006|Overall Study|Progressive Disease|7|||
146944652|NCT00701103|529956424|FG007|Overall Study|Progressive Disease|7|||
146944653|NCT00701103|529956425|FG008|Overall Study|Progressive Disease|8|||
146944654|NCT00701103|529956426|FG009|Overall Study|Progressive Disease|8|||
146944655|NCT00701103|529956427|FG010|Overall Study|Progressive Disease|11|||
146944656|NCT00701103|529956417|FG000|Overall Study|Withdrawal by Subject|0|||
146944657|NCT00701103|529956418|FG001|Overall Study|Withdrawal by Subject|1|||
146944658|NCT00701103|529956419|FG002|Overall Study|Withdrawal by Subject|1|||
146944659|NCT00701103|529956420|FG003|Overall Study|Withdrawal by Subject|0|||
146944660|NCT00701103|529956421|FG004|Overall Study|Withdrawal by Subject|0|||
146944661|NCT00701103|529956422|FG005|Overall Study|Withdrawal by Subject|0|||
146944662|NCT00701103|529956423|FG006|Overall Study|Withdrawal by Subject|0|||
146944663|NCT00701103|529956424|FG007|Overall Study|Withdrawal by Subject|0|||
146944664|NCT00701103|529956425|FG008|Overall Study|Withdrawal by Subject|0|||
146944665|NCT00701103|529956426|FG009|Overall Study|Withdrawal by Subject|0|||
146944666|NCT00701103|529956427|FG010|Overall Study|Withdrawal by Subject|0|||
146944667|NCT00701103|529956417|FG000|Overall Study|Other|0|||
146944668|NCT00701103|529956418|FG001|Overall Study|Other|0|||
146944669|NCT00701103|529956419|FG002|Overall Study|Other|0|||
146944670|NCT00701103|529956420|FG003|Overall Study|Other|0|||
146944671|NCT00701103|529956421|FG004|Overall Study|Other|0|||
146944672|NCT00701103|529956422|FG005|Overall Study|Other|0|||
146944673|NCT00701103|529956423|FG006|Overall Study|Other|0|||
146944674|NCT00701103|529956424|FG007|Overall Study|Other|0|||
146944675|NCT00701103|529956425|FG008|Overall Study|Other|1|||
146944676|NCT00701103|529956426|FG009|Overall Study|Other|1|||
146944677|NCT00701103|529956427|FG010|Overall Study|Other|0|||
146944678|NCT00614991|529956436|FG000|Overall Study|Adverse Event|3|||
146984361|NCT01098240|530103435|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146944679|NCT00614991|529956437|FG001|Overall Study|Adverse Event|3|||
146984362|NCT01098240|530103436|FG002|Open-Label Phase|Withdrawal by Subject|0|||
146944680|NCT00614991|529956438|FG002|Overall Study|Adverse Event|0|||
146944681|NCT00614991|529956439|FG003|Overall Study|Adverse Event|0|||
146944682|NCT00614991|529956440|FG004|Overall Study|Adverse Event|1|||
146944683|NCT00614991|529956441|FG005|Overall Study|Adverse Event|0|||
146944684|NCT02623699|529956442|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146944685|NCT02623699|529956443|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
146944686|NCT02623699|529956444|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146944687|NCT02623699|529956445|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146944688|NCT02623699|529956446|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146944689|NCT02623699|529956447|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146944690|NCT02623699|529956448|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146944691|NCT02623699|529956449|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146984363|NCT01098240|530103434|FG000|Open-Label Phase|Adverse Event|12|||
146984364|NCT01098240|530103435|FG001|Open-Label Phase|Adverse Event|0|||
146984365|NCT01098240|530103436|FG002|Open-Label Phase|Adverse Event|0|||
146984366|NCT01098240|530103434|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
146984367|NCT01098240|530103435|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
146984368|NCT01098240|530103436|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
146984369|NCT01098240|530103434|FG000|Double-Blind Phase|Protocol Violation|0|||
146984370|NCT01098240|530103435|FG001|Double-Blind Phase|Protocol Violation|2|||
146984371|NCT01098240|530103436|FG002|Double-Blind Phase|Protocol Violation|4|||
146984372|NCT01098240|530103434|FG000|Double-Blind Phase|Lost to Follow-up|0|||
146984373|NCT01098240|530103435|FG001|Double-Blind Phase|Lost to Follow-up|2|||
146984374|NCT01098240|530103436|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146984375|NCT01098240|530103434|FG000|Double-Blind Phase|Other|0|||
146984376|NCT01098240|530103435|FG001|Double-Blind Phase|Other|2|||
146984377|NCT01098240|530103436|FG002|Double-Blind Phase|Other|2|||
146984378|NCT01098240|530103434|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
146984379|NCT01098240|530103435|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
146984380|NCT01098240|530103436|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
146984381|NCT01098240|530103434|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
146984382|NCT01098240|530103435|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
146984383|NCT01098240|530103436|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
146984384|NCT01098240|530103434|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
146984385|NCT01098240|530103435|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
146984386|NCT01098240|530103436|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
146984387|NCT01098240|530103434|FG000|Double-Blind Phase|Adverse Event|0|||
146984388|NCT01098240|530103435|FG001|Double-Blind Phase|Adverse Event|3|||
146984389|NCT01098240|530103436|FG002|Double-Blind Phase|Adverse Event|3|||
146984390|NCT03280537|530103437|FG000|Overall Study|Withdrawal by Subject|2|||
146984391|NCT03280537|530103438|FG001|Overall Study|Withdrawal by Subject|4|||
146984392|NCT01588106|530103439|FG000|Overall Study|Withdrawal by Subject|5|||
146984393|NCT01588106|530103440|FG001|Overall Study|Withdrawal by Subject|4|||
146984394|NCT02995837|530103441|FG000|Overall Study|Lost to Follow-up|9|||
146984395|NCT02995837|530103442|FG001|Overall Study|Lost to Follow-up|8|||
146984396|NCT00458302|530105021|FG000|Overall Study|Adverse Event|4|||
146984397|NCT00458302|530105022|FG001|Overall Study|Adverse Event|14|||
146984398|NCT00458302|530105021|FG000|Overall Study|Pregnancy|2|||
146984399|NCT00458302|530105022|FG001|Overall Study|Pregnancy|1|||
146984400|NCT00458302|530105021|FG000|Overall Study|Protocol Violation|0|||
146984401|NCT00458302|530105022|FG001|Overall Study|Protocol Violation|2|||
146984402|NCT00458302|530105021|FG000|Overall Study|Withdrawal by Subject|6|||
146984403|NCT00458302|530105022|FG001|Overall Study|Withdrawal by Subject|4|||
146984404|NCT00458302|530105021|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
146984405|NCT00458302|530105022|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
146984406|NCT00458302|530105021|FG000|Overall Study|Study Termination By Sponsor|1|||
146815190|NCT00103857|529492149|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
146815191|NCT00103857|529492150|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
146815192|NCT00103857|529492151|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
146815193|NCT00103857|529492145|FG000|50-Week Extension Study|patient moved|0|||
146815194|NCT00103857|529492146|FG001|50-Week Extension Study|patient moved|0|||
146815195|NCT00103857|529492147|FG002|50-Week Extension Study|patient moved|1|||
146815196|NCT00103857|529492148|FG003|50-Week Extension Study|patient moved|2|||
146815197|NCT00103857|529492149|FG004|50-Week Extension Study|patient moved|0|||
146815198|NCT00103857|529492150|FG005|50-Week Extension Study|patient moved|0|||
146815199|NCT00103857|529492151|FG006|50-Week Extension Study|patient moved|0|||
146815200|NCT00103857|529492145|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
146815201|NCT00103857|529492146|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
146815202|NCT00103857|529492147|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
146815203|NCT00103857|529492148|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
146815204|NCT00103857|529492149|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
146815205|NCT00103857|529492150|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
146815206|NCT00103857|529492151|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
146815207|NCT00103857|529492145|FG000|50-Week Extension Study|reason unspecified|0|||
146815208|NCT00103857|529492146|FG001|50-Week Extension Study|reason unspecified|0|||
146815209|NCT00103857|529492147|FG002|50-Week Extension Study|reason unspecified|0|||
146815210|NCT00103857|529492148|FG003|50-Week Extension Study|reason unspecified|0|||
146815211|NCT00103857|529492149|FG004|50-Week Extension Study|reason unspecified|1|||
146984407|NCT00458302|530105022|FG001|Overall Study|Study Termination By Sponsor|0|||
146984408|NCT00458302|530105021|FG000|Overall Study|Lost to Follow-up|2|||
146984409|NCT00458302|530105022|FG001|Overall Study|Lost to Follow-up|0|||
146984410|NCT00458302|530105021|FG000|Overall Study|Other|4|||
146984411|NCT00458302|530105022|FG001|Overall Study|Other|2|||
146984412|NCT02224456|530105023|FG000|Overall Study|Lack of Efficacy|1|||
146984413|NCT02224456|530105023|FG000|Overall Study|Lost to Follow-up|15|||
146984414|NCT02224456|530105023|FG000|Overall Study|Withdrawal by Subject|9|||
146815212|NCT00103857|529492150|FG005|50-Week Extension Study|reason unspecified|0|||
146815213|NCT00103857|529492151|FG006|50-Week Extension Study|reason unspecified|0|||
146815214|NCT01856569|529492152|FG000|Overall Study|Other|1|||
146815215|NCT01856569|529492152|FG000|Overall Study|Changed Site/Structure|1|||
146815216|NCT01856569|529492152|FG000|Overall Study|Lost to Follow-up|3|||
146815217|NCT01856569|529492152|FG000|Overall Study|Did not met inclusion criteria|8|||
146815218|NCT00696241|529492153|FG000|Overall Study|Adverse Event|11|||
146815219|NCT00696241|529492154|FG001|Overall Study|Adverse Event|3|||
146815220|NCT00696241|529492155|FG002|Overall Study|Adverse Event|6|||
146815221|NCT00696241|529492156|FG003|Overall Study|Adverse Event|4|||
146815222|NCT00696241|529492157|FG004|Overall Study|Adverse Event|5|||
146815223|NCT00696241|529492153|FG000|Overall Study|Protocol Violation|1|||
146815224|NCT00696241|529492154|FG001|Overall Study|Protocol Violation|1|||
146815225|NCT00696241|529492155|FG002|Overall Study|Protocol Violation|2|||
146815226|NCT00696241|529492156|FG003|Overall Study|Protocol Violation|0|||
146815227|NCT00696241|529492157|FG004|Overall Study|Protocol Violation|3|||
146815228|NCT00696241|529492153|FG000|Overall Study|Lost to Follow-up|1|||
146815229|NCT00696241|529492154|FG001|Overall Study|Lost to Follow-up|4|||
146815230|NCT00696241|529492155|FG002|Overall Study|Lost to Follow-up|1|||
146815231|NCT00696241|529492156|FG003|Overall Study|Lost to Follow-up|2|||
146815232|NCT00696241|529492157|FG004|Overall Study|Lost to Follow-up|0|||
146815233|NCT00696241|529492153|FG000|Overall Study|Withdrawal by Subject|4|||
146815234|NCT00696241|529492154|FG001|Overall Study|Withdrawal by Subject|8|||
146815235|NCT00696241|529492155|FG002|Overall Study|Withdrawal by Subject|6|||
146815236|NCT00696241|529492156|FG003|Overall Study|Withdrawal by Subject|1|||
146815237|NCT00696241|529492157|FG004|Overall Study|Withdrawal by Subject|0|||
146815238|NCT00696241|529492153|FG000|Overall Study|Lack of Efficacy|1|||
146815239|NCT00696241|529492154|FG001|Overall Study|Lack of Efficacy|5|||
146815240|NCT00696241|529492155|FG002|Overall Study|Lack of Efficacy|4|||
146815241|NCT00696241|529492156|FG003|Overall Study|Lack of Efficacy|5|||
146815242|NCT00696241|529492157|FG004|Overall Study|Lack of Efficacy|3|||
146984415|NCT02224456|530105023|FG000|Overall Study|Physician Decision|3|||
146984416|NCT02224456|530105023|FG000|Overall Study|Death|2|||
146984417|NCT02224456|530105023|FG000|Overall Study|Pregnancy|4|||
146984418|NCT02224456|530105023|FG000|Overall Study|Protocol Violation|1|||
146984419|NCT02224456|530105023|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
146984420|NCT01241461|530105024|FG000|Overall Study|Progressive Disease|3|||
146984421|NCT01241461|530105025|FG001|Overall Study|Progressive Disease|6|||
146984422|NCT01379781|530105029|FG000|Overall Study|Lost to Follow-up|11|||
146984423|NCT01379781|530105030|FG001|Overall Study|Lost to Follow-up|8|||
146984424|NCT03273387|530105034|FG000|Overall Study|Death|2|||
146984425|NCT03273387|530105035|FG001|Overall Study|Death|2|||
146984426|NCT03273387|530105034|FG000|Overall Study|Withdrawal by Subject|1|||
146984427|NCT03273387|530105035|FG001|Overall Study|Withdrawal by Subject|1|||
146984428|NCT01162499|530105044|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
146984429|NCT01162499|530105045|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
146984430|NCT00832078|530105046|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
146984431|NCT00832078|530105047|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
146984432|NCT00832078|530105046|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
146984433|NCT00832078|530105047|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
146984434|NCT03551730|530105048|FG000|Overall Study|Adverse Event|1|||
146984435|NCT03551730|530105049|FG001|Overall Study|Adverse Event|0|||
146984436|NCT03551730|530105050|FG002|Overall Study|Adverse Event|0|||
146984437|NCT03551730|530105051|FG003|Overall Study|Adverse Event|0|||
146984438|NCT01628120|530105060|FG000|Overall Study|Withdrawal by Subject|7|||
146984439|NCT01628120|530105060|FG000|Overall Study|Adverse Event|12|||
146984440|NCT01628120|530105060|FG000|Overall Study|Lost to Follow-up|1|||
146984441|NCT01628120|530105060|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
146984442|NCT01628120|530105060|FG000|Overall Study|Non-compliant with Study Procedures|1|||
146984443|NCT01628120|530105060|FG000|Overall Study|Not Treated|3|||
146984444|NCT01628120|530105060|FG000|Overall Study|Sponsor Decision|5|||
146984445|NCT01628120|530105060|FG000|Overall Study|Switched Dialysis Method|2|||
146984446|NCT01628120|530105060|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
146984447|NCT01628120|530105060|FG000|Overall Study|Moved or Relocated|5|||
146984448|NCT01628120|530105060|FG000|Overall Study|Kidney Transplant|2|||
146984449|NCT01628120|530105060|FG000|Overall Study|Use of Standard of Care|1|||
146984450|NCT01165996|530105064|FG000|Overall Study|Death|1|||
146984451|NCT01165996|530105064|FG000|Overall Study|Physician Decision|1|||
146984452|NCT00096265|530105065|FG000|Overall Study|Ineligible|1|||
146815243|NCT00696241|529492153|FG000|Overall Study|Other|6|||
146815244|NCT00696241|529492154|FG001|Overall Study|Other|1|||
146815245|NCT00696241|529492155|FG002|Overall Study|Other|5|||
146984453|NCT00096265|530105066|FG001|Overall Study|Ineligible|0|||
146984454|NCT00096265|530105067|FG002|Overall Study|Ineligible|0|||
146984455|NCT01506323|530105068|FG000|Overall Study|Lost to Follow-up|5|||
146815246|NCT00696241|529492156|FG003|Overall Study|Other|2|||
146815247|NCT00696241|529492157|FG004|Overall Study|Other|1|||
146815248|NCT03065400|529492158|FG000|Overall Study|Adverse Event|1|||
146815249|NCT03065400|529492158|FG000|Overall Study|Physician Decision|3|||
146984456|NCT01506323|530105069|FG001|Overall Study|Lost to Follow-up|4|||
146815250|NCT03065400|529492158|FG000|Overall Study|Withdrawal by Subject|1|||
146815251|NCT03065400|529492158|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
146815252|NCT03060525|529492159|FG000|Overall Study|moved out of state|1|||
146815253|NCT03060525|529492160|FG001|Overall Study|moved out of state|1|||
146815254|NCT03060525|529492161|FG002|Overall Study|moved out of state|1|||
146815255|NCT03060525|529492162|FG003|Overall Study|moved out of state|1|||
146815256|NCT03060525|529492159|FG000|Overall Study|unable to meet time commitment required of study|2|||
146815257|NCT03060525|529492160|FG001|Overall Study|unable to meet time commitment required of study|3|||
146815258|NCT03060525|529492161|FG002|Overall Study|unable to meet time commitment required of study|3|||
146815259|NCT03060525|529492162|FG003|Overall Study|unable to meet time commitment required of study|1|||
146815260|NCT03060525|529492159|FG000|Overall Study|no longer interested in doing intervention|0|||
146815261|NCT03060525|529492160|FG001|Overall Study|no longer interested in doing intervention|0|||
146815262|NCT03060525|529492161|FG002|Overall Study|no longer interested in doing intervention|0|||
146815263|NCT03060525|529492162|FG003|Overall Study|no longer interested in doing intervention|1|||
146815264|NCT02147093|529492163|FG000|Period 1|Lost to Follow-up|0|||
146815265|NCT02147093|529492164|FG001|Period 1|Lost to Follow-up|1|||
146815266|NCT02147093|529492163|FG000|Period 2|Protocol Violation|2|||
146815267|NCT02147093|529492164|FG001|Period 2|Protocol Violation|0|||
146815268|NCT02189759|529492170|FG000|Overall Study|Lost to Follow-up|0|||
146815269|NCT02189759|529492171|FG001|Overall Study|Lost to Follow-up|0|||
146815270|NCT02189759|529492172|FG002|Overall Study|Lost to Follow-up|2|||
146815271|NCT02189759|529492173|FG003|Overall Study|Lost to Follow-up|5|||
146815272|NCT01147471|529492174|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
146815273|NCT01147471|529492175|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
146815274|NCT01147471|529492174|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
146815275|NCT01147471|529492175|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
146815276|NCT01147471|529492174|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
146815277|NCT01147471|529492175|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
146815278|NCT01147471|529492174|FG000|3 Month Follow Up|Lost to Follow-up|1|||
146815279|NCT01147471|529492175|FG001|3 Month Follow Up|Lost to Follow-up|1|||
146815280|NCT01147471|529492174|FG000|3 Month Follow Up|Physician Decision|0|||
146815281|NCT01147471|529492175|FG001|3 Month Follow Up|Physician Decision|1|||
146815282|NCT01147471|529492174|FG000|6 Month Follow Up|Lost to Follow-up|4|||
146815283|NCT01147471|529492175|FG001|6 Month Follow Up|Lost to Follow-up|2|||
146815284|NCT03890484|529492181|FG000|Overall Study|Lost to Follow-up|1|||
146815285|NCT03890484|529492182|FG001|Overall Study|Lost to Follow-up|1|||
146815286|NCT00518206|529492183|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
146815287|NCT00518206|529492184|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
146815288|NCT00518206|529492183|FG000|Overall Study|Withdrawal by Subject|2|||
146815289|NCT00518206|529492184|FG001|Overall Study|Withdrawal by Subject|0|||
146815290|NCT00518206|529492183|FG000|Overall Study|Drug Supply Issue|1|||
146815291|NCT00518206|529492184|FG001|Overall Study|Drug Supply Issue|0|||
146815292|NCT00518206|529492183|FG000|Overall Study|Reason Unknown|1|||
146815293|NCT00518206|529492184|FG001|Overall Study|Reason Unknown|0|||
146815294|NCT00518206|529492183|FG000|Overall Study|Completion Status Unknown|1|||
146815295|NCT00518206|529492184|FG001|Overall Study|Completion Status Unknown|0|||
146815296|NCT01294644|529492185|FG000|Overall Study|Adverse Event|2|||
146815297|NCT01294644|529492186|FG001|Overall Study|Adverse Event|0|||
146815298|NCT01294644|529492187|FG002|Overall Study|Adverse Event|1|||
146815299|NCT01294644|529492185|FG000|Overall Study|Withdrawal by Subject|3|||
146815300|NCT01294644|529492186|FG001|Overall Study|Withdrawal by Subject|7|||
146815301|NCT01294644|529492187|FG002|Overall Study|Withdrawal by Subject|4|||
146815302|NCT01294644|529492185|FG000|Overall Study|Lost to Follow-up|3|||
146815303|NCT01294644|529492186|FG001|Overall Study|Lost to Follow-up|2|||
146984457|NCT01506323|530105068|FG000|Overall Study|Withdrawal by Subject|4|||
146815304|NCT01294644|529492187|FG002|Overall Study|Lost to Follow-up|5|||
146815305|NCT01294644|529492185|FG000|Overall Study|Miscellaneous Reason|2|||
146815306|NCT01294644|529492186|FG001|Overall Study|Miscellaneous Reason|1|||
146815307|NCT01294644|529492187|FG002|Overall Study|Miscellaneous Reason|4|||
146815308|NCT02188459|529492188|FG000|Overall Study|Lost to Follow-up|3|||
146815309|NCT02188459|529492189|FG001|Overall Study|Lost to Follow-up|4|||
146815310|NCT02188459|529492188|FG000|Overall Study|Early Termination|0|||
146815311|NCT02188459|529492189|FG001|Overall Study|Early Termination|3|||
146815312|NCT02548585|529492190|FG000|Overall Study|Withdrawal by Subject|0|||
146815313|NCT02548585|529492191|FG001|Overall Study|Withdrawal by Subject|0|||
146815314|NCT02548585|529492192|FG002|Overall Study|Withdrawal by Subject|0|||
146815315|NCT02548585|529492193|FG003|Overall Study|Withdrawal by Subject|0|||
146815316|NCT02548585|529492194|FG004|Overall Study|Withdrawal by Subject|0|||
146815317|NCT02548585|529492195|FG005|Overall Study|Withdrawal by Subject|1|||
146815318|NCT02548585|529492196|FG006|Overall Study|Withdrawal by Subject|0|||
146815319|NCT02548585|529492190|FG000|Overall Study|Lost to Follow-up|1|||
146815320|NCT02548585|529492191|FG001|Overall Study|Lost to Follow-up|0|||
146815321|NCT02548585|529492192|FG002|Overall Study|Lost to Follow-up|0|||
146815322|NCT02548585|529492193|FG003|Overall Study|Lost to Follow-up|0|||
146815323|NCT02548585|529492194|FG004|Overall Study|Lost to Follow-up|0|||
146815324|NCT02548585|529492195|FG005|Overall Study|Lost to Follow-up|0|||
146815325|NCT02548585|529492196|FG006|Overall Study|Lost to Follow-up|0|||
146815326|NCT02548585|529492190|FG000|Overall Study|Other|1|||
146815327|NCT02548585|529492191|FG001|Overall Study|Other|0|||
146815328|NCT02548585|529492192|FG002|Overall Study|Other|0|||
146815329|NCT02548585|529492193|FG003|Overall Study|Other|2|||
146815330|NCT02548585|529492194|FG004|Overall Study|Other|3|||
146815331|NCT02548585|529492195|FG005|Overall Study|Other|0|||
146815332|NCT02548585|529492196|FG006|Overall Study|Other|1|||
146815333|NCT02548585|529492190|FG000|Overall Study|Randomized but not treated|0|||
146815334|NCT02548585|529492191|FG001|Overall Study|Randomized but not treated|0|||
146815335|NCT02548585|529492192|FG002|Overall Study|Randomized but not treated|0|||
146815336|NCT02548585|529492193|FG003|Overall Study|Randomized but not treated|0|||
146815337|NCT02548585|529492194|FG004|Overall Study|Randomized but not treated|0|||
146815338|NCT02548585|529492195|FG005|Overall Study|Randomized but not treated|1|||
146815339|NCT02548585|529492196|FG006|Overall Study|Randomized but not treated|0|||
146815340|NCT02612285|529492197|FG000|Overall Study|Withdrawal by Subject|1|||
146815341|NCT00853957|529492202|FG000|Overall Study|Adverse Event|9|||
146815342|NCT00853957|529492203|FG001|Overall Study|Adverse Event|3|||
146815343|NCT00853957|529492202|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146815344|NCT00853957|529492203|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146815345|NCT00853957|529492202|FG000|Overall Study|Subject withdrew consent|4|||
146815346|NCT00853957|529492203|FG001|Overall Study|Subject withdrew consent|5|||
146815347|NCT00853957|529492202|FG000|Overall Study|Lost to Follow-up|1|||
146815348|NCT00853957|529492203|FG001|Overall Study|Lost to Follow-up|6|||
146815349|NCT00853957|529492202|FG000|Overall Study|Protocol deviation|0|||
146815350|NCT00853957|529492203|FG001|Overall Study|Protocol deviation|3|||
146815351|NCT02942771|529492204|FG000|Overall Study|Adverse Event|1|||
146815352|NCT02942771|529492205|FG001|Overall Study|Adverse Event|0|||
146815353|NCT02942771|529492206|FG002|Overall Study|Adverse Event|0|||
146815354|NCT02942771|529492207|FG003|Overall Study|Adverse Event|0|||
146815355|NCT02942771|529492208|FG004|Overall Study|Adverse Event|2|||
146815356|NCT02942771|529492204|FG000|Overall Study|Lost to Follow-up|1|||
146815357|NCT02942771|529492205|FG001|Overall Study|Lost to Follow-up|0|||
146815358|NCT02942771|529492206|FG002|Overall Study|Lost to Follow-up|0|||
146815359|NCT02942771|529492207|FG003|Overall Study|Lost to Follow-up|0|||
146815360|NCT02942771|529492208|FG004|Overall Study|Lost to Follow-up|0|||
146815361|NCT02942771|529492204|FG000|Overall Study|Withdrawal by Subject|1|||
146815362|NCT02942771|529492205|FG001|Overall Study|Withdrawal by Subject|0|||
146815363|NCT02942771|529492206|FG002|Overall Study|Withdrawal by Subject|0|||
146815364|NCT02942771|529492207|FG003|Overall Study|Withdrawal by Subject|0|||
146815365|NCT02942771|529492208|FG004|Overall Study|Withdrawal by Subject|2|||
146815366|NCT04919499|529492209|FG000|Overall Study|Adverse Event|0|||
146815367|NCT04919499|529492210|FG001|Overall Study|Adverse Event|0|||
146815368|NCT04919499|529492211|FG002|Overall Study|Adverse Event|0|||
146815369|NCT04919499|529492212|FG003|Overall Study|Adverse Event|0|||
146815370|NCT04919499|529492213|FG004|Overall Study|Adverse Event|2|||
146815371|NCT04919499|529492209|FG000|Overall Study|Not treated|0|||
146815372|NCT04919499|529492210|FG001|Overall Study|Not treated|0|||
146815373|NCT04919499|529492211|FG002|Overall Study|Not treated|0|||
146815374|NCT04919499|529492212|FG003|Overall Study|Not treated|1|||
146815375|NCT04919499|529492213|FG004|Overall Study|Not treated|0|||
146815376|NCT01437540|529493788|FG000|Overall Study|Not listed below|7|||
146815377|NCT01437540|529493789|FG001|Overall Study|Not listed below|6|||
146815378|NCT01437540|529493788|FG000|Overall Study|COPD exacerbation|13|||
146815379|NCT01437540|529493789|FG001|Overall Study|COPD exacerbation|3|||
146815380|NCT01437540|529493788|FG000|Overall Study|Lost to Follow-up|3|||
146815381|NCT01437540|529493789|FG001|Overall Study|Lost to Follow-up|5|||
146815382|NCT01437540|529493788|FG000|Overall Study|Lack of Efficacy|23|||
146815383|NCT01437540|529493789|FG001|Overall Study|Lack of Efficacy|11|||
146815384|NCT01437540|529493788|FG000|Overall Study|Protocol Violation|24|||
146815385|NCT01437540|529493789|FG001|Overall Study|Protocol Violation|12|||
146815386|NCT01437540|529493788|FG000|Overall Study|Adverse Event|26|||
146815387|NCT01437540|529493789|FG001|Overall Study|Adverse Event|13|||
146815388|NCT01437540|529493788|FG000|Overall Study|Withdrawal by Subject|31|||
146815389|NCT01437540|529493789|FG001|Overall Study|Withdrawal by Subject|15|||
146815390|NCT00608959|529493790|FG000|Part 1|Did not meet eligibility criteria|1|||
146815391|NCT01416285|529493791|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
146815392|NCT01416285|529493792|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
146815393|NCT01005602|529493793|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
146815394|NCT01005602|529493794|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
146815395|NCT01248715|529493795|FG000|Overall Study|Not influenza positive|501|||
146815396|NCT01248715|529493796|FG001|Overall Study|Not influenza positive|510|||
146815397|NCT01919489|529493800|FG000|Overall Study|Rejected the need of injections|4|||
146815398|NCT01919489|529493801|FG001|Overall Study|Rejected the need of injections|7|||
146815399|NCT01919489|529493800|FG000|Overall Study|Adverse Event|10|||
146815400|NCT01919489|529493801|FG001|Overall Study|Adverse Event|0|||
146815401|NCT01919489|529493800|FG000|Overall Study|Hospital readmission|2|||
146815402|NCT01919489|529493801|FG001|Overall Study|Hospital readmission|9|||
146815403|NCT01919489|529493800|FG000|Overall Study|Death|2|||
146815404|NCT01919489|529493801|FG001|Overall Study|Death|1|||
146815405|NCT01919489|529493800|FG000|Overall Study|Lost to Follow-up|38|||
146815406|NCT01919489|529493801|FG001|Overall Study|Lost to Follow-up|27|||
146815407|NCT00828139|529493802|FG000|Overall Study|Adverse Event|8|||
146815408|NCT00828139|529493803|FG001|Overall Study|Adverse Event|1|||
146815409|NCT00828139|529493804|FG002|Overall Study|Adverse Event|10|||
146815410|NCT00828139|529493805|FG003|Overall Study|Adverse Event|5|||
146815411|NCT00828139|529493802|FG000|Overall Study|Death|2|||
146815412|NCT00828139|529493803|FG001|Overall Study|Death|1|||
146815413|NCT00828139|529493804|FG002|Overall Study|Death|0|||
146815414|NCT00828139|529493805|FG003|Overall Study|Death|2|||
146815415|NCT00828139|529493802|FG000|Overall Study|Refusal unrelated to toxicity|3|||
146815416|NCT00828139|529493803|FG001|Overall Study|Refusal unrelated to toxicity|4|||
146815417|NCT00828139|529493804|FG002|Overall Study|Refusal unrelated to toxicity|5|||
146815418|NCT00828139|529493805|FG003|Overall Study|Refusal unrelated to toxicity|3|||
146815419|NCT00828139|529493802|FG000|Overall Study|Disease Progression|24|||
146815420|NCT00828139|529493803|FG001|Overall Study|Disease Progression|33|||
146815421|NCT00828139|529493804|FG002|Overall Study|Disease Progression|35|||
146815422|NCT00828139|529493805|FG003|Overall Study|Disease Progression|39|||
146815423|NCT00828139|529493802|FG000|Overall Study|Other|4|||
146815424|NCT00828139|529493803|FG001|Overall Study|Other|2|||
146815425|NCT00828139|529493804|FG002|Overall Study|Other|5|||
146815426|NCT00828139|529493805|FG003|Overall Study|Other|2|||
146815427|NCT01714947|529493806|FG000|Part B|Progressive Disease|3|||
146815428|NCT04751929|529493807|FG000|Overall Study|Withdrawal by Subject|2|||
146815429|NCT04751929|529493808|FG001|Overall Study|Withdrawal by Subject|0|||
146815430|NCT04751929|529493809|FG002|Overall Study|Withdrawal by Subject|0|||
146815431|NCT04751929|529493810|FG003|Overall Study|Withdrawal by Subject|0|||
146815432|NCT04751929|529493807|FG000|Overall Study|Rising PSA|0|||
146815433|NCT04751929|529493808|FG001|Overall Study|Rising PSA|1|||
146815434|NCT04751929|529493809|FG002|Overall Study|Rising PSA|0|||
146815435|NCT04751929|529493810|FG003|Overall Study|Rising PSA|0|||
146815436|NCT04751929|529493807|FG000|Overall Study|Adverse Event|1|||
146815437|NCT04751929|529493808|FG001|Overall Study|Adverse Event|2|||
146815438|NCT04751929|529493809|FG002|Overall Study|Adverse Event|0|||
146815439|NCT04751929|529493810|FG003|Overall Study|Adverse Event|0|||
146815440|NCT04751929|529493807|FG000|Overall Study|Progressive Disease|3|||
146815441|NCT04751929|529493808|FG001|Overall Study|Progressive Disease|4|||
146815442|NCT04751929|529493809|FG002|Overall Study|Progressive Disease|4|||
146815443|NCT04751929|529493810|FG003|Overall Study|Progressive Disease|0|||
146815444|NCT04751929|529493807|FG000|Overall Study|Death|1|||
146815445|NCT04751929|529493808|FG001|Overall Study|Death|1|||
146815446|NCT04751929|529493809|FG002|Overall Study|Death|0|||
146815447|NCT04751929|529493810|FG003|Overall Study|Death|0|||
146815448|NCT01123356|529493811|FG000|Overall Study|Adverse Event|2|||
146815449|NCT01123356|529493811|FG000|Overall Study|Lack of Efficacy|4|||
146815450|NCT01123356|529493811|FG000|Overall Study|Withdrawal by Subject|1|||
146815451|NCT00376259|529493814|FG000|Overall Study|Sponsor request - study termination|21|||
146815452|NCT00376259|529493815|FG001|Overall Study|Sponsor request - study termination|21|||
146815453|NCT00376259|529493814|FG000|Overall Study|Patient request|1|||
146815454|NCT00376259|529493815|FG001|Overall Study|Patient request|0|||
146815455|NCT00930644|529493816|FG000|Overall Study|Withdrawal by Subject|4|||
146815456|NCT00930644|529493816|FG000|Overall Study|Physician Decision|2|||
146815457|NCT00930644|529493816|FG000|Overall Study|Death|1|||
146815458|NCT00930644|529493816|FG000|Overall Study|Adverse Event|16|||
146815459|NCT01877720|529493817|FG000|Overall Study|Adverse Event|1|||
146815460|NCT01877720|529493818|FG001|Overall Study|Adverse Event|0|||
146815461|NCT02068352|529493821|FG000|Overall Study|Lost to Follow-up|0|||
146984458|NCT01506323|530105069|FG001|Overall Study|Withdrawal by Subject|4|||
146984459|NCT01506323|530105068|FG000|Overall Study|Lack of Efficacy|1|||
146984460|NCT01506323|530105069|FG001|Overall Study|Lack of Efficacy|3|||
146815462|NCT02068352|529493822|FG001|Overall Study|Lost to Follow-up|2|||
146815463|NCT02068352|529493823|FG002|Overall Study|Lost to Follow-up|0|||
146815464|NCT02068352|529493821|FG000|Overall Study|Adverse Event|4|||
146815465|NCT02068352|529493822|FG001|Overall Study|Adverse Event|2|||
146815466|NCT02068352|529493823|FG002|Overall Study|Adverse Event|7|||
146815467|NCT02068352|529493821|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
146815468|NCT02068352|529493822|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
146815469|NCT02068352|529493823|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
146984461|NCT01506323|530105068|FG000|Overall Study|Moved out of area|5|||
146815470|NCT02068352|529493821|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
146984462|NCT01506323|530105069|FG001|Overall Study|Moved out of area|2|||
146984463|NCT01506323|530105068|FG000|Overall Study|Schedule or Transportation conflict|8|||
146815471|NCT02068352|529493822|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
146815472|NCT02068352|529493823|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
146815473|NCT02068352|529493821|FG000|Overall Study|Protocol Deviation|0|||
146815474|NCT02068352|529493822|FG001|Overall Study|Protocol Deviation|0|||
146815475|NCT02068352|529493823|FG002|Overall Study|Protocol Deviation|1|||
146815476|NCT01129011|529493829|FG000|Overall Study|Adverse Event|20|||
146815477|NCT01129011|529493830|FG001|Overall Study|Adverse Event|30|||
146815478|NCT01129011|529493829|FG000|Overall Study|Withdrawal by Subject|24|||
146815479|NCT01129011|529493830|FG001|Overall Study|Withdrawal by Subject|8|||
146815480|NCT01129011|529493829|FG000|Overall Study|Lost to Follow-up|6|||
146815481|NCT01129011|529493830|FG001|Overall Study|Lost to Follow-up|7|||
146815482|NCT01129011|529493829|FG000|Overall Study|Duodenal Ulcer|2|||
146815483|NCT01129011|529493830|FG001|Overall Study|Duodenal Ulcer|8|||
146815484|NCT01129011|529493829|FG000|Overall Study|misc|7|||
146815485|NCT01129011|529493830|FG001|Overall Study|misc|4|||
146815486|NCT03745651|529493831|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
146815487|NCT03745651|529493832|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
146815488|NCT03745651|529493833|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146815489|NCT03745651|529493834|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146815490|NCT03745651|529493835|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146815491|NCT03745651|529493836|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146815492|NCT03745651|529493837|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146815493|NCT03745651|529493831|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
146815494|NCT03745651|529493832|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
146984464|NCT01506323|530105069|FG001|Overall Study|Schedule or Transportation conflict|0|||
146984465|NCT01506323|530105068|FG000|Overall Study|Started another treatment|1|||
146984466|NCT01506323|530105069|FG001|Overall Study|Started another treatment|0|||
146984467|NCT00704418|530105072|FG000|Overall Study|Withdrawal by Subject|2|||
146984468|NCT00704418|530105073|FG001|Overall Study|Withdrawal by Subject|0|||
146984469|NCT00704418|530105072|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
146984470|NCT00704418|530105073|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
146984471|NCT01579474|530105074|FG000|Overall Study|Adverse Event|1|||
146984472|NCT01579474|530105075|FG001|Overall Study|Adverse Event|13|||
146984473|NCT01579474|530105076|FG002|Overall Study|Adverse Event|2|||
146984474|NCT01579474|530105077|FG003|Overall Study|Adverse Event|0|||
146984475|NCT01579474|530105078|FG004|Overall Study|Adverse Event|0|||
146984476|NCT01579474|530105079|FG005|Overall Study|Adverse Event|1|||
146984477|NCT01579474|530105074|FG000|Overall Study|Lack of Efficacy|1|||
146984478|NCT01579474|530105075|FG001|Overall Study|Lack of Efficacy|0|||
146984479|NCT01579474|530105076|FG002|Overall Study|Lack of Efficacy|0|||
146815495|NCT03745651|529493833|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
146815496|NCT03745651|529493834|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146815497|NCT03745651|529493835|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146944692|NCT02623699|529956450|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146944693|NCT02623699|529956451|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146944694|NCT02623699|529956452|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146944695|NCT02623699|529956453|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146944696|NCT02623699|529956442|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146944697|NCT02623699|529956443|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146944698|NCT02623699|529956444|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146944699|NCT02623699|529956445|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146944700|NCT02623699|529956446|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146944701|NCT02623699|529956447|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146944702|NCT02623699|529956448|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
146944703|NCT02623699|529956449|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146944704|NCT02623699|529956450|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146944705|NCT02623699|529956451|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146944706|NCT02623699|529956452|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146984480|NCT01579474|530105077|FG003|Overall Study|Lack of Efficacy|0|||
146984481|NCT01579474|530105078|FG004|Overall Study|Lack of Efficacy|1|||
146984482|NCT01579474|530105079|FG005|Overall Study|Lack of Efficacy|0|||
146984483|NCT01579474|530105074|FG000|Overall Study|Withdrawal by Subject|1|||
146984484|NCT01579474|530105075|FG001|Overall Study|Withdrawal by Subject|0|||
146984485|NCT01579474|530105076|FG002|Overall Study|Withdrawal by Subject|0|||
146984486|NCT01579474|530105077|FG003|Overall Study|Withdrawal by Subject|0|||
146984487|NCT01579474|530105078|FG004|Overall Study|Withdrawal by Subject|0|||
146984488|NCT01579474|530105079|FG005|Overall Study|Withdrawal by Subject|0|||
146944707|NCT02623699|529956453|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146984489|NCT01075763|530105080|FG000|Overall Study|Lost to Follow-up|2|||
146944708|NCT02623699|529956442|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146984490|NCT01075763|530105081|FG001|Overall Study|Lost to Follow-up|1|||
146944709|NCT02623699|529956443|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146944710|NCT02623699|529956444|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146984491|NCT01075763|530105080|FG000|Overall Study|Lack of Efficacy|0|||
146984492|NCT01075763|530105081|FG001|Overall Study|Lack of Efficacy|1|||
146984493|NCT01075763|530105080|FG000|Overall Study|Withdrawal by Subject|2|||
146984494|NCT01075763|530105081|FG001|Overall Study|Withdrawal by Subject|2|||
146944711|NCT02623699|529956445|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146944712|NCT02623699|529956446|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146944713|NCT02623699|529956447|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
146944714|NCT02623699|529956448|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146944715|NCT02623699|529956449|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146944716|NCT02623699|529956450|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146944717|NCT02623699|529956451|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146944718|NCT02623699|529956452|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146944719|NCT02623699|529956453|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146944720|NCT02623699|529956442|FG000|Part B (Up to 289 Days)|Death|0|||
146944721|NCT02623699|529956443|FG001|Part B (Up to 289 Days)|Death|0|||
146944722|NCT02623699|529956444|FG002|Part B (Up to 289 Days)|Death|0|||
146944723|NCT02623699|529956445|FG003|Part B (Up to 289 Days)|Death|0|||
146944724|NCT02623699|529956446|FG004|Part B (Up to 289 Days)|Death|0|||
146944725|NCT02623699|529956447|FG005|Part B (Up to 289 Days)|Death|1|||
146944726|NCT02623699|529956448|FG006|Part B (Up to 289 Days)|Death|1|||
146944727|NCT02623699|529956449|FG007|Part B (Up to 289 Days)|Death|0|||
146944728|NCT02623699|529956450|FG008|Part B (Up to 289 Days)|Death|1|||
146944729|NCT02623699|529956451|FG009|Part B (Up to 289 Days)|Death|0|||
146944730|NCT02623699|529956452|FG010|Part B (Up to 289 Days)|Death|0|||
146944731|NCT02623699|529956453|FG011|Part B (Up to 289 Days)|Death|0|||
146944732|NCT02623699|529956442|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
146944733|NCT02623699|529956443|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
146944734|NCT02623699|529956444|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
146984495|NCT00586521|530105082|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
146984496|NCT03734237|530105086|FG000|Overall Study|Lost to Follow-up|1|||
146984497|NCT03734237|530105087|FG001|Overall Study|Lost to Follow-up|3|||
146984498|NCT03734237|530105088|FG002|Overall Study|Lost to Follow-up|0|||
146984499|NCT03734237|530105086|FG000|Overall Study|Withdrawal by Subject|7|||
146984500|NCT03734237|530105087|FG001|Overall Study|Withdrawal by Subject|9|||
146984501|NCT03734237|530105088|FG002|Overall Study|Withdrawal by Subject|10|||
146984502|NCT00818623|530105093|FG000|Overall Study|Adverse Event|1|||
146984503|NCT00818623|530105094|FG001|Overall Study|Adverse Event|0|||
146984504|NCT00818623|530105095|FG002|Overall Study|Adverse Event|1|||
146984505|NCT00818623|530105096|FG003|Overall Study|Adverse Event|0|||
146984506|NCT00818623|530105097|FG004|Overall Study|Adverse Event|0|||
146984507|NCT00818623|530105098|FG005|Overall Study|Adverse Event|1|||
146984508|NCT00818623|530105099|FG006|Overall Study|Adverse Event|0|||
146984509|NCT00818623|530105100|FG007|Overall Study|Adverse Event|0|||
146984510|NCT00818623|530105093|FG000|Overall Study|Bad prostate specific antigen response|0|||
146984511|NCT00818623|530105094|FG001|Overall Study|Bad prostate specific antigen response|3|||
146984512|NCT00818623|530105095|FG002|Overall Study|Bad prostate specific antigen response|2|||
146984513|NCT00818623|530105096|FG003|Overall Study|Bad prostate specific antigen response|5|||
146984514|NCT00818623|530105097|FG004|Overall Study|Bad prostate specific antigen response|0|||
146984515|NCT00818623|530105098|FG005|Overall Study|Bad prostate specific antigen response|1|||
146984516|NCT00818623|530105099|FG006|Overall Study|Bad prostate specific antigen response|0|||
146984517|NCT00818623|530105100|FG007|Overall Study|Bad prostate specific antigen response|0|||
146984518|NCT00818623|530105093|FG000|Overall Study|Withdrawal by Subject|0|||
146984519|NCT00818623|530105094|FG001|Overall Study|Withdrawal by Subject|1|||
146984520|NCT00818623|530105095|FG002|Overall Study|Withdrawal by Subject|1|||
146984521|NCT00818623|530105096|FG003|Overall Study|Withdrawal by Subject|0|||
146984522|NCT00818623|530105097|FG004|Overall Study|Withdrawal by Subject|0|||
146984523|NCT00818623|530105098|FG005|Overall Study|Withdrawal by Subject|1|||
146984524|NCT00818623|530105099|FG006|Overall Study|Withdrawal by Subject|1|||
146984525|NCT00818623|530105100|FG007|Overall Study|Withdrawal by Subject|1|||
146984526|NCT00818623|530105093|FG000|Overall Study|Protocol Violation|1|||
146984527|NCT00818623|530105094|FG001|Overall Study|Protocol Violation|0|||
146984528|NCT00818623|530105095|FG002|Overall Study|Protocol Violation|0|||
146984529|NCT00818623|530105096|FG003|Overall Study|Protocol Violation|0|||
146984530|NCT00818623|530105097|FG004|Overall Study|Protocol Violation|1|||
146984531|NCT00818623|530105098|FG005|Overall Study|Protocol Violation|0|||
146984532|NCT00818623|530105099|FG006|Overall Study|Protocol Violation|1|||
146984533|NCT00818623|530105100|FG007|Overall Study|Protocol Violation|0|||
146984534|NCT00818623|530105093|FG000|Overall Study|Need of additional treatment|0|||
146984535|NCT00818623|530105094|FG001|Overall Study|Need of additional treatment|0|||
146984536|NCT00818623|530105095|FG002|Overall Study|Need of additional treatment|0|||
146815498|NCT03745651|529493836|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146944735|NCT02623699|529956445|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
146944736|NCT02623699|529956446|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
146944737|NCT02623699|529956447|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
146944738|NCT02623699|529956448|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
146944739|NCT02623699|529956449|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
146944740|NCT02623699|529956450|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
146944741|NCT02623699|529956451|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
146944742|NCT02623699|529956452|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
146984537|NCT00818623|530105096|FG003|Overall Study|Need of additional treatment|0|||
146944743|NCT02623699|529956453|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
146944744|NCT02623699|529956442|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146944745|NCT02623699|529956443|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146944746|NCT02623699|529956444|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146944747|NCT02623699|529956445|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146944748|NCT02623699|529956446|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146944749|NCT02623699|529956447|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146944750|NCT02623699|529956448|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146944751|NCT02623699|529956449|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146944752|NCT02623699|529956450|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146944753|NCT02623699|529956451|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146944754|NCT02623699|529956452|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
146944755|NCT02623699|529956453|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
146944756|NCT02623699|529956442|FG000|Part C (Up to 236 Days)|Death|0|||
146944757|NCT02623699|529956443|FG001|Part C (Up to 236 Days)|Death|0|||
146944758|NCT02623699|529956444|FG002|Part C (Up to 236 Days)|Death|0|||
146944759|NCT02623699|529956445|FG003|Part C (Up to 236 Days)|Death|0|||
146944760|NCT02623699|529956446|FG004|Part C (Up to 236 Days)|Death|0|||
146944761|NCT02623699|529956447|FG005|Part C (Up to 236 Days)|Death|0|||
146944762|NCT02623699|529956448|FG006|Part C (Up to 236 Days)|Death|0|||
146944763|NCT02623699|529956449|FG007|Part C (Up to 236 Days)|Death|0|||
146944764|NCT02623699|529956450|FG008|Part C (Up to 236 Days)|Death|0|||
146944765|NCT02623699|529956451|FG009|Part C (Up to 236 Days)|Death|0|||
146944766|NCT02623699|529956452|FG010|Part C (Up to 236 Days)|Death|0|||
146944767|NCT02623699|529956453|FG011|Part C (Up to 236 Days)|Death|1|||
146944768|NCT02623699|529956442|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
146944769|NCT02623699|529956443|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
146944770|NCT02623699|529956444|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
146944771|NCT02623699|529956445|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
146944772|NCT02623699|529956446|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
146944773|NCT02623699|529956447|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
146944774|NCT02623699|529956448|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
146944775|NCT02623699|529956449|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
146944776|NCT02623699|529956450|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
146944777|NCT02623699|529956451|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
146944778|NCT02623699|529956452|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
146944779|NCT02623699|529956453|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
146944780|NCT00033371|529956454|FG000|Overall Study|Adverse Event|1|||
146944781|NCT00033371|529956455|FG001|Overall Study|Adverse Event|5|||
146944782|NCT00033371|529956454|FG000|Overall Study|Lost to Follow-up|2|||
146944783|NCT00033371|529956455|FG001|Overall Study|Lost to Follow-up|1|||
146944784|NCT00033371|529956454|FG000|Overall Study|Withdrawal by Subject|3|||
146944785|NCT00033371|529956455|FG001|Overall Study|Withdrawal by Subject|3|||
146944786|NCT00033371|529956454|FG000|Overall Study|Disease Progression|0|||
146944787|NCT00033371|529956455|FG001|Overall Study|Disease Progression|1|||
146944788|NCT00251589|529956456|FG000|Overall Study|Adverse Event|5|||
146944789|NCT00251589|529956457|FG001|Overall Study|Adverse Event|1|||
146944790|NCT00251589|529956458|FG002|Overall Study|Adverse Event|2|||
146944791|NCT00251589|529956459|FG003|Overall Study|Adverse Event|1|||
146944792|NCT00251589|529956456|FG000|Overall Study|Withdrawal by Subject|1|||
146944793|NCT00251589|529956457|FG001|Overall Study|Withdrawal by Subject|1|||
146944794|NCT00251589|529956458|FG002|Overall Study|Withdrawal by Subject|0|||
146944795|NCT00251589|529956459|FG003|Overall Study|Withdrawal by Subject|0|||
146944796|NCT00251589|529956456|FG000|Overall Study|Discontinued due to progressive disease|9|||
146944797|NCT00251589|529956457|FG001|Overall Study|Discontinued due to progressive disease|1|||
146944798|NCT00251589|529956458|FG002|Overall Study|Discontinued due to progressive disease|0|||
146944799|NCT00251589|529956459|FG003|Overall Study|Discontinued due to progressive disease|1|||
146944800|NCT02493868|529956462|FG000|Induction Phase: DE Participants|Adverse Event|22|||
146944801|NCT02493868|529956463|FG001|Induction Phase: DE Participants|Adverse Event|0|||
146944802|NCT02493868|529956462|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
146944803|NCT02493868|529956463|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
146944804|NCT02493868|529956462|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
146944805|NCT02493868|529956463|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
146944806|NCT02493868|529956462|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
146944807|NCT02493868|529956463|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
146944808|NCT02493868|529956462|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
146944809|NCT02493868|529956463|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
146944810|NCT02493868|529956462|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
146944811|NCT02493868|529956463|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
146944812|NCT02493868|529956462|FG000|Induction Phase: DE Participants|Other|8|||
146944813|NCT02493868|529956463|FG001|Induction Phase: DE Participants|Other|0|||
146944814|NCT02493868|529956462|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
146944815|NCT02493868|529956463|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
146944816|NCT02493868|529956462|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
146944817|NCT02493868|529956463|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
146944818|NCT02493868|529956462|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
146944819|NCT02493868|529956463|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
146944820|NCT02493868|529956462|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
146944821|NCT02493868|529956463|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
146944822|NCT02493868|529956462|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
146944823|NCT02493868|529956463|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
146944824|NCT02493868|529956462|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
146944825|NCT02493868|529956463|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
146944826|NCT02493868|529956462|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
146944827|NCT02493868|529956463|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
146944828|NCT02493868|529956462|FG000|Optimization Phase: DE+TE Participants|Other|10|||
146944829|NCT02493868|529956463|FG001|Optimization Phase: DE+TE Participants|Other|2|||
146944830|NCT02493868|529956462|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
146944831|NCT02493868|529956463|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
146944832|NCT02493868|529956462|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
146944833|NCT02493868|529956463|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
146944834|NCT02493868|529956462|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
146944835|NCT02493868|529956463|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
146944836|NCT02493868|529956462|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
146944837|NCT02493868|529956463|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
146944838|NCT02493868|529956462|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
146944839|NCT02493868|529956463|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
146944840|NCT02493868|529956462|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
146944841|NCT02493868|529956463|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
146944842|NCT02493868|529956462|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
146944843|NCT02493868|529956463|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
146944844|NCT02493868|529956462|FG000|Follow-up Phase|Lost to Follow-up|1|||
146944845|NCT02493868|529956463|FG001|Follow-up Phase|Lost to Follow-up|0|||
146944846|NCT02493868|529956462|FG000|Follow-up Phase|Withdrawal by Subject|3|||
146944847|NCT02493868|529956463|FG001|Follow-up Phase|Withdrawal by Subject|0|||
146944848|NCT02493868|529956462|FG000|Follow-up Phase|Investigator Decision|5|||
146944849|NCT02493868|529956463|FG001|Follow-up Phase|Investigator Decision|1|||
146944850|NCT02493868|529956462|FG000|Follow-up Phase|Other|2|||
146944851|NCT02493868|529956463|FG001|Follow-up Phase|Other|1|||
146944852|NCT02407236|529956464|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
146944853|NCT02407236|529956465|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
146944854|NCT02407236|529956466|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
146944855|NCT02407236|529956467|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
146944856|NCT02407236|529956468|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
146944857|NCT02407236|529956469|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
146944858|NCT02407236|529956470|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
146944859|NCT02407236|529956471|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
146944860|NCT02407236|529956472|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
146944861|NCT02407236|529956473|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
146944862|NCT02407236|529956474|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
146944863|NCT02407236|529956475|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
146944864|NCT02407236|529956476|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
146944865|NCT02407236|529956464|FG000|Induction Study (8 Weeks)|Death|0|||
146944866|NCT02407236|529956465|FG001|Induction Study (8 Weeks)|Death|0|||
146944867|NCT02407236|529956466|FG002|Induction Study (8 Weeks)|Death|1|||
146944868|NCT02407236|529956467|FG003|Induction Study (8 Weeks)|Death|0|||
146944869|NCT02407236|529956468|FG004|Induction Study (8 Weeks)|Death|0|||
146944870|NCT02407236|529956469|FG005|Induction Study (8 Weeks)|Death|0|||
146944871|NCT02407236|529956470|FG006|Induction Study (8 Weeks)|Death|0|||
146944872|NCT02407236|529956471|FG007|Induction Study (8 Weeks)|Death|0|||
146944873|NCT02407236|529956472|FG008|Induction Study (8 Weeks)|Death|0|||
146944874|NCT02407236|529956473|FG009|Induction Study (8 Weeks)|Death|0|||
146944875|NCT02407236|529956474|FG010|Induction Study (8 Weeks)|Death|0|||
146944876|NCT02407236|529956475|FG011|Induction Study (8 Weeks)|Death|0|||
146944877|NCT02407236|529956476|FG012|Induction Study (8 Weeks)|Death|0|||
146944878|NCT02407236|529956464|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
146944879|NCT02407236|529956465|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
146944880|NCT02407236|529956466|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
146944881|NCT02407236|529956467|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146944882|NCT02407236|529956468|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146944883|NCT02407236|529956469|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146944884|NCT02407236|529956470|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146944885|NCT02407236|529956471|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146944886|NCT02407236|529956472|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146815499|NCT03745651|529493837|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146815500|NCT03745651|529493831|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
146815501|NCT03745651|529493832|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146815502|NCT03745651|529493833|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
146815503|NCT03745651|529493834|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146815504|NCT03745651|529493835|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146815505|NCT03745651|529493836|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146815506|NCT03745651|529493837|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146815507|NCT03745651|529493831|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146815508|NCT03745651|529493832|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
146815509|NCT03745651|529493833|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146815510|NCT03745651|529493834|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146815511|NCT03745651|529493835|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146815512|NCT03745651|529493836|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146815513|NCT03745651|529493837|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146815514|NCT03745651|529493831|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
146815515|NCT03745651|529493832|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
146815516|NCT03745651|529493833|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
146815517|NCT03745651|529493834|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146815518|NCT03745651|529493835|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146815519|NCT03745651|529493836|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146815520|NCT03745651|529493837|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146815521|NCT03745651|529493831|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
146815522|NCT03745651|529493832|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
146815523|NCT03745651|529493833|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
146815524|NCT03745651|529493834|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
146815525|NCT03745651|529493835|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
146815526|NCT03745651|529493836|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
146815527|NCT03745651|529493837|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
146815528|NCT03745651|529493831|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146815529|NCT03745651|529493832|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146815530|NCT03745651|529493833|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146815531|NCT03745651|529493834|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146815532|NCT03745651|529493835|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146815533|NCT03745651|529493836|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
146815534|NCT03745651|529493837|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146815535|NCT03745651|529493831|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146815536|NCT03745651|529493832|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146815537|NCT03745651|529493833|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146815538|NCT03745651|529493834|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
146815539|NCT03745651|529493835|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146815540|NCT03745651|529493836|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
146815541|NCT03745651|529493837|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
146815542|NCT03745651|529493831|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146815543|NCT03745651|529493832|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146815544|NCT03745651|529493833|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146815545|NCT03745651|529493834|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
146815546|NCT03745651|529493835|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
146815547|NCT03745651|529493836|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
146815548|NCT03745651|529493837|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
146815549|NCT03745651|529493831|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146815550|NCT03745651|529493832|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146815551|NCT03745651|529493833|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146815552|NCT03745651|529493834|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
146815553|NCT03745651|529493835|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146815554|NCT03745651|529493836|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
146815555|NCT03745651|529493837|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
146815556|NCT03745651|529493831|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
146815557|NCT03745651|529493832|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
146815558|NCT03745651|529493833|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
146944887|NCT02407236|529956473|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146944888|NCT02407236|529956474|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146944889|NCT02407236|529956475|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146944890|NCT02407236|529956476|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146944891|NCT02407236|529956464|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146944892|NCT02407236|529956465|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146944893|NCT02407236|529956466|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
146944894|NCT02407236|529956467|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146944895|NCT02407236|529956468|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146944896|NCT02407236|529956469|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146944897|NCT02407236|529956470|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146944898|NCT02407236|529956471|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146944899|NCT02407236|529956472|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146944900|NCT02407236|529956473|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146944901|NCT02407236|529956474|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146944902|NCT02407236|529956475|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146944903|NCT02407236|529956476|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146944904|NCT02407236|529956464|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
146944905|NCT02407236|529956465|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
146944906|NCT02407236|529956466|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
146944907|NCT02407236|529956467|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
146944908|NCT02407236|529956468|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
146944909|NCT02407236|529956469|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
146944910|NCT02407236|529956470|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
146944911|NCT02407236|529956471|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
146944912|NCT02407236|529956472|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
146944913|NCT02407236|529956473|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
146944914|NCT02407236|529956474|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
146944915|NCT02407236|529956475|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
146944916|NCT02407236|529956476|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
146944917|NCT02407236|529956464|FG000|Induction Study (8 Weeks)|Other|2|||
146944918|NCT02407236|529956465|FG001|Induction Study (8 Weeks)|Other|1|||
146944919|NCT02407236|529956466|FG002|Induction Study (8 Weeks)|Other|5|||
146944920|NCT02407236|529956467|FG003|Induction Study (8 Weeks)|Other|0|||
146944921|NCT02407236|529956468|FG004|Induction Study (8 Weeks)|Other|0|||
146944922|NCT02407236|529956469|FG005|Induction Study (8 Weeks)|Other|0|||
146944923|NCT02407236|529956470|FG006|Induction Study (8 Weeks)|Other|0|||
146944924|NCT02407236|529956471|FG007|Induction Study (8 Weeks)|Other|0|||
146944925|NCT02407236|529956472|FG008|Induction Study (8 Weeks)|Other|0|||
146944926|NCT02407236|529956473|FG009|Induction Study (8 Weeks)|Other|0|||
146944927|NCT02407236|529956474|FG010|Induction Study (8 Weeks)|Other|0|||
146944928|NCT02407236|529956475|FG011|Induction Study (8 Weeks)|Other|0|||
146944929|NCT02407236|529956476|FG012|Induction Study (8 Weeks)|Other|0|||
146944930|NCT02407236|529956464|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
146944931|NCT02407236|529956465|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
146944932|NCT02407236|529956466|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
146944933|NCT02407236|529956467|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
146944934|NCT02407236|529956468|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
146944935|NCT02407236|529956469|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
146944936|NCT02407236|529956470|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
146944937|NCT02407236|529956471|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
146944938|NCT02407236|529956472|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
146944939|NCT02407236|529956473|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
146944940|NCT02407236|529956474|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
146944941|NCT02407236|529956475|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
146944942|NCT02407236|529956476|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
146944943|NCT02407236|529956464|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
146944944|NCT02407236|529956465|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
146944945|NCT02407236|529956466|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
146944946|NCT02407236|529956467|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
146944947|NCT02407236|529956468|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
146944948|NCT02407236|529956469|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
146944949|NCT02407236|529956470|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
146944950|NCT02407236|529956471|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
146944951|NCT02407236|529956472|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
146944952|NCT02407236|529956473|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
146944953|NCT02407236|529956474|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
146944954|NCT02407236|529956475|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
146944955|NCT02407236|529956476|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
146944956|NCT02407236|529956464|FG000|Maintenance Study (44 Weeks)|Other|0|||
146944957|NCT02407236|529956465|FG001|Maintenance Study (44 Weeks)|Other|0|||
146944958|NCT02407236|529956466|FG002|Maintenance Study (44 Weeks)|Other|0|||
146944959|NCT02407236|529956467|FG003|Maintenance Study (44 Weeks)|Other|5|||
146944960|NCT02407236|529956468|FG004|Maintenance Study (44 Weeks)|Other|7|||
146944961|NCT02407236|529956469|FG005|Maintenance Study (44 Weeks)|Other|8|||
146735737|NCT02202434|529205145|FG002|Overall Study|Other|0|||
146815559|NCT03745651|529493834|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
146815560|NCT03745651|529493835|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
146815561|NCT03745651|529493836|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
146815562|NCT03745651|529493837|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
146815563|NCT03745651|529493831|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146815564|NCT03745651|529493832|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146815565|NCT03745651|529493833|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146815566|NCT03745651|529493834|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146815567|NCT03745651|529493835|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146815568|NCT03745651|529493836|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
146815569|NCT03745651|529493837|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146815570|NCT03745651|529493831|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146815571|NCT03745651|529493832|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146815572|NCT03745651|529493833|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146815573|NCT03745651|529493834|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
146815574|NCT03745651|529493835|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
146815575|NCT03745651|529493836|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
146815576|NCT03745651|529493837|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
146815577|NCT03745651|529493831|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
146815578|NCT03745651|529493832|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
146815579|NCT03745651|529493833|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
146815580|NCT03745651|529493834|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
146815581|NCT03745651|529493835|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
146815582|NCT03745651|529493836|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
146815583|NCT03745651|529493837|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
146815584|NCT04175834|529493838|FG000|Overall Study|Withdrawal by Subject|1|||
146815585|NCT04175834|529493839|FG001|Overall Study|Withdrawal by Subject|0|||
146815586|NCT02542696|529493844|FG000|Overall Study|Adverse Event|167|||
146815587|NCT02542696|529493844|FG000|Overall Study|Lack of Efficacy|26|||
146815588|NCT02542696|529493844|FG000|Overall Study|Lost to Follow-up|6|||
146815589|NCT02542696|529493844|FG000|Overall Study|Withdrawal by Subject|104|||
146815590|NCT02542696|529493844|FG000|Overall Study|Protocol Violation|5|||
146815591|NCT02542696|529493844|FG000|Overall Study|Death|8|||
146815592|NCT02542696|529493844|FG000|Overall Study|DECREASED OFF TIME|1|||
146815593|NCT02542696|529493844|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
146815594|NCT02542696|529493844|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
146815595|NCT02542696|529493844|FG000|Overall Study|MEDICAL HISTORY|1|||
146815596|NCT02542696|529493844|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
146815597|NCT02542696|529493844|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
146815598|NCT02542696|529493844|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
146815599|NCT02542696|529493844|FG000|Overall Study|SPONSOR DECISION|3|||
146815600|NCT02542696|529493844|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
146815601|NCT02542696|529493844|FG000|Overall Study|SUBJECT DECISION|2|||
146815602|NCT02410278|529493845|FG000|Run-in Period|Adverse Event|5|||
146815603|NCT02410278|529493846|FG001|Run-in Period|Adverse Event|0|||
146815604|NCT02410278|529493847|FG002|Run-in Period|Adverse Event|0|||
146815605|NCT02410278|529493845|FG000|Run-in Period|GSRS Threshold Not Met|30|||
146815606|NCT02410278|529493846|FG001|Run-in Period|GSRS Threshold Not Met|0|||
146815607|NCT02410278|529493847|FG002|Run-in Period|GSRS Threshold Not Met|0|||
146815608|NCT02410278|529493845|FG000|Run-in Period|Lost to Follow-up|1|||
146815609|NCT02410278|529493846|FG001|Run-in Period|Lost to Follow-up|0|||
146815610|NCT02410278|529493847|FG002|Run-in Period|Lost to Follow-up|0|||
146815611|NCT02410278|529493845|FG000|Run-in Period|Withdrawal by Subject|1|||
146815612|NCT02410278|529493846|FG001|Run-in Period|Withdrawal by Subject|0|||
146815613|NCT02410278|529493847|FG002|Run-in Period|Withdrawal by Subject|0|||
146815614|NCT02410278|529493845|FG000|Run-in Period|Pregnancy|1|||
146815615|NCT02410278|529493846|FG001|Run-in Period|Pregnancy|0|||
146815616|NCT02410278|529493847|FG002|Run-in Period|Pregnancy|0|||
146815617|NCT02410278|529493845|FG000|Study Treatment Period|Adverse Event|0|||
146815618|NCT02410278|529493846|FG001|Study Treatment Period|Adverse Event|6|||
146815619|NCT02410278|529493847|FG002|Study Treatment Period|Adverse Event|3|||
146815620|NCT02410278|529493845|FG000|Study Treatment Period|Physician Decision|0|||
146815621|NCT02410278|529493846|FG001|Study Treatment Period|Physician Decision|0|||
146815622|NCT02410278|529493847|FG002|Study Treatment Period|Physician Decision|1|||
146815623|NCT02410278|529493845|FG000|Study Treatment Period|Withdrawal by Subject|0|||
146815624|NCT02410278|529493846|FG001|Study Treatment Period|Withdrawal by Subject|1|||
146944962|NCT02407236|529956470|FG006|Maintenance Study (44 Weeks)|Other|4|||
146944963|NCT02407236|529956471|FG007|Maintenance Study (44 Weeks)|Other|6|||
146944964|NCT02407236|529956472|FG008|Maintenance Study (44 Weeks)|Other|0|||
146944965|NCT02407236|529956473|FG009|Maintenance Study (44 Weeks)|Other|0|||
146944966|NCT02407236|529956474|FG010|Maintenance Study (44 Weeks)|Other|0|||
146984538|NCT00818623|530105097|FG004|Overall Study|Need of additional treatment|1|||
146984539|NCT00818623|530105098|FG005|Overall Study|Need of additional treatment|0|||
146984540|NCT00818623|530105099|FG006|Overall Study|Need of additional treatment|0|||
146984541|NCT00818623|530105100|FG007|Overall Study|Need of additional treatment|0|||
146984542|NCT00818623|530105093|FG000|Overall Study|Lack of trial drug at site|0|||
146984543|NCT00818623|530105094|FG001|Overall Study|Lack of trial drug at site|0|||
146984544|NCT00818623|530105095|FG002|Overall Study|Lack of trial drug at site|0|||
146984545|NCT00818623|530105096|FG003|Overall Study|Lack of trial drug at site|0|||
146984546|NCT00818623|530105097|FG004|Overall Study|Lack of trial drug at site|2|||
146984547|NCT00818623|530105098|FG005|Overall Study|Lack of trial drug at site|0|||
146984548|NCT00818623|530105099|FG006|Overall Study|Lack of trial drug at site|1|||
146984549|NCT00818623|530105100|FG007|Overall Study|Lack of trial drug at site|0|||
146984550|NCT00818623|530105093|FG000|Overall Study|Disease progression|0|||
146984551|NCT00818623|530105094|FG001|Overall Study|Disease progression|0|||
146984552|NCT00818623|530105095|FG002|Overall Study|Disease progression|0|||
146984553|NCT00818623|530105096|FG003|Overall Study|Disease progression|0|||
146984554|NCT00818623|530105097|FG004|Overall Study|Disease progression|0|||
146984555|NCT00818623|530105098|FG005|Overall Study|Disease progression|0|||
146984556|NCT00818623|530105099|FG006|Overall Study|Disease progression|1|||
146984557|NCT00818623|530105100|FG007|Overall Study|Disease progression|0|||
146984558|NCT00617461|530105101|FG000|First Treatment Intervention Period|Adverse Event|2|||
146984559|NCT00617461|530105102|FG001|First Treatment Intervention Period|Adverse Event|0|||
146944967|NCT02407236|529956475|FG011|Maintenance Study (44 Weeks)|Other|0|||
146944968|NCT02407236|529956476|FG012|Maintenance Study (44 Weeks)|Other|0|||
146944969|NCT02407236|529956464|FG000|Maintenance Study (44 Weeks)|Death|0|||
146944970|NCT02407236|529956465|FG001|Maintenance Study (44 Weeks)|Death|0|||
146944971|NCT02407236|529956466|FG002|Maintenance Study (44 Weeks)|Death|0|||
146944972|NCT02407236|529956467|FG003|Maintenance Study (44 Weeks)|Death|0|||
146944973|NCT02407236|529956468|FG004|Maintenance Study (44 Weeks)|Death|0|||
146944974|NCT02407236|529956469|FG005|Maintenance Study (44 Weeks)|Death|0|||
146944975|NCT02407236|529956470|FG006|Maintenance Study (44 Weeks)|Death|0|||
146944976|NCT02407236|529956471|FG007|Maintenance Study (44 Weeks)|Death|1|||
146944977|NCT02407236|529956472|FG008|Maintenance Study (44 Weeks)|Death|0|||
146944978|NCT02407236|529956473|FG009|Maintenance Study (44 Weeks)|Death|0|||
146944979|NCT02407236|529956474|FG010|Maintenance Study (44 Weeks)|Death|0|||
146944980|NCT02407236|529956475|FG011|Maintenance Study (44 Weeks)|Death|0|||
146944981|NCT02407236|529956476|FG012|Maintenance Study (44 Weeks)|Death|0|||
146944982|NCT02407236|529956464|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
146944983|NCT02407236|529956465|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
146944984|NCT02407236|529956466|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
146944985|NCT02407236|529956467|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
146984560|NCT00617461|530105101|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
146984561|NCT00617461|530105102|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
146735738|NCT02202434|529205146|FG003|Overall Study|Other|1|||
146735739|NCT03237858|529205147|FG000|Overall Study|Death|19|||
146735740|NCT03237858|529205147|FG000|Overall Study|Withdrawal by Subject|37|||
146735741|NCT04858802|529205150|FG000|Overall Study|Lost to Follow-up|1|||
146735742|NCT04858802|529205151|FG001|Overall Study|Lost to Follow-up|1|||
146735743|NCT04858802|529205150|FG000|Overall Study|Withdrawal by Subject|1|||
146735744|NCT04858802|529205151|FG001|Overall Study|Withdrawal by Subject|1|||
146735745|NCT03610737|529205154|FG000|Overall Study|Withdrawal by Subject|1|||
146735746|NCT03610737|529205155|FG001|Overall Study|Withdrawal by Subject|5|||
146735747|NCT03610737|529205154|FG000|Overall Study|Death|1|||
146735748|NCT03610737|529205155|FG001|Overall Study|Death|0|||
146735749|NCT03610737|529205154|FG000|Overall Study|Not treated|5|||
146735750|NCT03610737|529205155|FG001|Overall Study|Not treated|2|||
146735751|NCT03610737|529205154|FG000|Overall Study|Missed Visit|1|||
146735752|NCT03610737|529205155|FG001|Overall Study|Missed Visit|2|||
146735753|NCT02013388|529205158|FG000|Overall Study|work emergency|1|||
146735754|NCT02013388|529205159|FG001|Overall Study|work emergency|0|||
146735755|NCT02013388|529205160|FG002|Overall Study|work emergency|0|||
146735756|NCT02013388|529205161|FG003|Overall Study|work emergency|0|||
146735757|NCT02013388|529205162|FG004|Overall Study|work emergency|1|||
146735758|NCT02013388|529205163|FG005|Overall Study|work emergency|0|||
146735759|NCT02013388|529205164|FG006|Overall Study|work emergency|0|||
146735760|NCT02013388|529205165|FG007|Overall Study|work emergency|0|||
146735761|NCT03243422|529205166|FG000|Overall Study|Death|20|||
146735762|NCT03243422|529205167|FG001|Overall Study|Death|21|||
146735763|NCT03243422|529205166|FG000|Overall Study|Lost to Follow-up|9|||
146735764|NCT03243422|529205167|FG001|Overall Study|Lost to Follow-up|21|||
146735765|NCT03243422|529205166|FG000|Overall Study|Withdrawal by Subject|22|||
146735766|NCT03243422|529205167|FG001|Overall Study|Withdrawal by Subject|8|||
146735767|NCT00215540|529205171|FG000|Overall Study|Withdrew from study medication|1|||
146735768|NCT00215540|529205172|FG001|Overall Study|Withdrew from study medication|0|||
146735769|NCT00215540|529205173|FG002|Overall Study|Withdrew from study medication|0|||
146944986|NCT02407236|529956468|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
146944987|NCT02407236|529956469|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
146944988|NCT02407236|529956470|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
146944989|NCT02407236|529956471|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
146944990|NCT02407236|529956472|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
146944991|NCT02407236|529956473|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
146944992|NCT02407236|529956474|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
146944993|NCT02407236|529956475|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
146944994|NCT02407236|529956476|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
146944995|NCT02407236|529956464|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146944996|NCT02407236|529956465|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146944997|NCT02407236|529956466|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146944998|NCT02407236|529956467|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146944999|NCT02407236|529956468|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146945000|NCT02407236|529956469|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146945001|NCT02407236|529956470|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146945002|NCT02407236|529956471|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146945003|NCT02407236|529956472|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146945004|NCT02407236|529956473|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146945005|NCT02407236|529956474|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
146945006|NCT02407236|529956475|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146945007|NCT02407236|529956476|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146945008|NCT02407236|529956464|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
146945009|NCT02407236|529956465|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
146945010|NCT02407236|529956466|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
146945011|NCT02407236|529956467|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
146945012|NCT02407236|529956468|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
146945013|NCT02407236|529956469|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
146945014|NCT02407236|529956470|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
146945015|NCT02407236|529956471|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
146945016|NCT02407236|529956472|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
146945017|NCT02407236|529956473|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
146945018|NCT02407236|529956474|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
146945019|NCT02407236|529956475|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
146945020|NCT02407236|529956476|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
146945021|NCT02407236|529956464|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
146945022|NCT02407236|529956465|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
146945023|NCT02407236|529956466|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
146945024|NCT02407236|529956467|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
146945025|NCT02407236|529956468|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
146945026|NCT02407236|529956469|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
146945027|NCT02407236|529956470|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
146945028|NCT02407236|529956471|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
146945029|NCT02407236|529956472|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
146945030|NCT02407236|529956473|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
146945031|NCT02407236|529956474|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
146945032|NCT02407236|529956475|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
146945033|NCT02407236|529956476|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
146945034|NCT01627782|529956481|FG000|Overall Study|Adverse Event|1|||
146945035|NCT01627782|529956482|FG001|Overall Study|Adverse Event|2|||
146945036|NCT01627782|529956483|FG002|Overall Study|Adverse Event|0|||
146945037|NCT01627782|529956484|FG003|Overall Study|Adverse Event|1|||
146945038|NCT01627782|529956481|FG000|Overall Study|Lack of Efficacy|11|||
146945039|NCT01627782|529956482|FG001|Overall Study|Lack of Efficacy|1|||
146945040|NCT01627782|529956483|FG002|Overall Study|Lack of Efficacy|15|||
146945041|NCT01627782|529956484|FG003|Overall Study|Lack of Efficacy|2|||
146945042|NCT01627782|529956481|FG000|Overall Study|Protocol Violation|1|||
146945043|NCT01627782|529956482|FG001|Overall Study|Protocol Violation|0|||
146945044|NCT01627782|529956483|FG002|Overall Study|Protocol Violation|0|||
146945045|NCT01627782|529956484|FG003|Overall Study|Protocol Violation|0|||
146815625|NCT02410278|529493847|FG002|Study Treatment Period|Withdrawal by Subject|0|||
146815626|NCT02410278|529493845|FG000|Study Treatment Period|Other|0|||
146815627|NCT02410278|529493846|FG001|Study Treatment Period|Other|3|||
146815628|NCT02410278|529493847|FG002|Study Treatment Period|Other|0|||
146815629|NCT02410278|529493845|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
146945046|NCT01627782|529956481|FG000|Overall Study|Withdrawal by Subject|2|||
146945047|NCT01627782|529956482|FG001|Overall Study|Withdrawal by Subject|1|||
146945048|NCT01627782|529956483|FG002|Overall Study|Withdrawal by Subject|0|||
146945049|NCT01627782|529956484|FG003|Overall Study|Withdrawal by Subject|0|||
146945050|NCT01627782|529956481|FG000|Overall Study|Other|0|||
146945051|NCT01627782|529956482|FG001|Overall Study|Other|2|||
146945052|NCT01627782|529956483|FG002|Overall Study|Other|0|||
146945053|NCT01627782|529956484|FG003|Overall Study|Other|3|||
146945054|NCT01627782|529956481|FG000|Overall Study|Randomized But Not Treated|1|||
146945055|NCT01627782|529956482|FG001|Overall Study|Randomized But Not Treated|0|||
146945056|NCT01627782|529956483|FG002|Overall Study|Randomized But Not Treated|0|||
146945057|NCT01627782|529956484|FG003|Overall Study|Randomized But Not Treated|0|||
146945058|NCT00643448|529956485|FG000|Overall Study|Lack of Efficacy|2|||
146945059|NCT00643448|529956486|FG001|Overall Study|Lack of Efficacy|0|||
146945060|NCT00643448|529956487|FG002|Overall Study|Lack of Efficacy|4|||
146945061|NCT00643448|529956485|FG000|Overall Study|Adverse Event|2|||
146945062|NCT00643448|529956486|FG001|Overall Study|Adverse Event|2|||
146945063|NCT00643448|529956487|FG002|Overall Study|Adverse Event|2|||
146945064|NCT00643448|529956485|FG000|Overall Study|QTcF>550 ms|0|||
146945065|NCT00643448|529956486|FG001|Overall Study|QTcF>550 ms|3|||
146945066|NCT00643448|529956487|FG002|Overall Study|QTcF>550 ms|0|||
146945067|NCT02177812|529956491|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
146945068|NCT02177812|529956492|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
146945069|NCT02177812|529956493|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
146945070|NCT02177812|529956494|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
146945071|NCT02177812|529956495|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
146945072|NCT02177812|529956496|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
146945073|NCT02177812|529956497|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
146945074|NCT02177812|529956498|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
146945075|NCT02177812|529956499|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
146945076|NCT02177812|529956491|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
146945077|NCT02177812|529956492|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
146945078|NCT02177812|529956493|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
146945079|NCT02177812|529956494|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
146945080|NCT02177812|529956495|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
146945081|NCT02177812|529956496|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
146945082|NCT02177812|529956497|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
146945083|NCT02177812|529956498|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
146945084|NCT02177812|529956499|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
146945085|NCT02177812|529956491|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
146945086|NCT02177812|529956492|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
146945087|NCT02177812|529956493|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
146945088|NCT02177812|529956494|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
146945089|NCT02177812|529956495|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
146945090|NCT02177812|529956496|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
146945091|NCT02177812|529956497|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
146945092|NCT02177812|529956498|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
146945093|NCT02177812|529956499|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
146945094|NCT00089999|529956500|FG000|Overall Study|Adverse Event|4|||
146945095|NCT00089999|529956501|FG001|Overall Study|Adverse Event|7|||
146945096|NCT00089999|529956500|FG000|Overall Study|Withdrawal by Subject|0|||
146945097|NCT00089999|529956501|FG001|Overall Study|Withdrawal by Subject|4|||
146945098|NCT00089999|529956500|FG000|Overall Study|Lost to Follow-up|2|||
146945099|NCT00089999|529956501|FG001|Overall Study|Lost to Follow-up|1|||
146945100|NCT00089999|529956500|FG000|Overall Study|Radiological Progression of Cancer|52|||
146945101|NCT00089999|529956501|FG001|Overall Study|Radiological Progression of Cancer|44|||
146945102|NCT00089999|529956500|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
146945103|NCT00089999|529956501|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
146945104|NCT00089999|529956500|FG000|Overall Study|Death|3|||
146945105|NCT00089999|529956501|FG001|Overall Study|Death|3|||
146945106|NCT00089999|529956500|FG000|Overall Study|Poor General Condition|1|||
146945107|NCT00089999|529956501|FG001|Overall Study|Poor General Condition|0|||
146945108|NCT00089999|529956500|FG000|Overall Study|Clinical Progression|1|||
146945109|NCT00089999|529956501|FG001|Overall Study|Clinical Progression|2|||
146945110|NCT00089999|529956500|FG000|Overall Study|Physician Decision|2|||
146945111|NCT00089999|529956501|FG001|Overall Study|Physician Decision|2|||
146945112|NCT00089999|529956500|FG000|Overall Study|Patient Underwent Surgery|2|||
146945113|NCT00089999|529956501|FG001|Overall Study|Patient Underwent Surgery|0|||
146945114|NCT00089999|529956500|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
146945115|NCT00089999|529956501|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
146945116|NCT03039569|529956503|FG000|Overall Study|Lost to Follow-up|5|||
146945117|NCT03039569|529956504|FG001|Overall Study|Lost to Follow-up|4|||
146945118|NCT03695471|529958218|FG000|Overall Study|Cancellation|1|||
146945119|NCT02859558|529958219|FG000|Step 1|Not Eligible|0|||
146945120|NCT02859558|529958220|FG001|Step 1|Not Eligible|0|||
146945121|NCT02859558|529958221|FG002|Step 1|Not Eligible|0|||
146945122|NCT02859558|529958222|FG003|Step 1|Not Eligible|0|||
146945123|NCT02859558|529958223|FG004|Step 1|Not Eligible|3|||
146945124|NCT02859558|529958219|FG000|Step 1|Lost to Follow-up|1|||
146945125|NCT02859558|529958220|FG001|Step 1|Lost to Follow-up|3|||
146945126|NCT02859558|529958221|FG002|Step 1|Lost to Follow-up|3|||
146945127|NCT02859558|529958222|FG003|Step 1|Lost to Follow-up|0|||
146945128|NCT02859558|529958223|FG004|Step 1|Lost to Follow-up|0|||
146945129|NCT02859558|529958219|FG000|Step 1|Did Not Return to Clinic|2|||
146945130|NCT02859558|529958220|FG001|Step 1|Did Not Return to Clinic|3|||
146945131|NCT02859558|529958221|FG002|Step 1|Did Not Return to Clinic|4|||
146945132|NCT02859558|529958222|FG003|Step 1|Did Not Return to Clinic|0|||
146945133|NCT02859558|529958223|FG004|Step 1|Did Not Return to Clinic|0|||
146945134|NCT02859558|529958219|FG000|Step 1|Moved|0|||
146945135|NCT02859558|529958220|FG001|Step 1|Moved|1|||
146945136|NCT02859558|529958221|FG002|Step 1|Moved|1|||
146945137|NCT02859558|529958222|FG003|Step 1|Moved|0|||
146945138|NCT02859558|529958223|FG004|Step 1|Moved|0|||
146945139|NCT02859558|529958219|FG000|Step 1|Withdrawal By Participant|1|||
146945140|NCT02859558|529958220|FG001|Step 1|Withdrawal By Participant|2|||
146945141|NCT02859558|529958221|FG002|Step 1|Withdrawal By Participant|1|||
146945142|NCT02859558|529958222|FG003|Step 1|Withdrawal By Participant|0|||
146945143|NCT02859558|529958223|FG004|Step 1|Withdrawal By Participant|0|||
146945144|NCT02859558|529958219|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
146945145|NCT02859558|529958220|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
146945146|NCT02859558|529958221|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
146945147|NCT02859558|529958222|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
146945148|NCT02859558|529958223|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
146945149|NCT02859558|529958219|FG000|Step 1|Incarceration|0|||
146945150|NCT02859558|529958220|FG001|Step 1|Incarceration|1|||
146945151|NCT02859558|529958221|FG002|Step 1|Incarceration|0|||
146945152|NCT02859558|529958222|FG003|Step 1|Incarceration|0|||
146945153|NCT02859558|529958223|FG004|Step 1|Incarceration|0|||
146945154|NCT02859558|529958219|FG000|Step 1|Non-Adherence to Study Drug|2|||
146945155|NCT02859558|529958220|FG001|Step 1|Non-Adherence to Study Drug|0|||
146945156|NCT02859558|529958221|FG002|Step 1|Non-Adherence to Study Drug|1|||
146945157|NCT02859558|529958222|FG003|Step 1|Non-Adherence to Study Drug|0|||
146945158|NCT02859558|529958223|FG004|Step 1|Non-Adherence to Study Drug|0|||
146945159|NCT02859558|529958219|FG000|Step 1|Non-Adherence to Study Requirements|3|||
146945160|NCT02859558|529958220|FG001|Step 1|Non-Adherence to Study Requirements|1|||
146815630|NCT02410278|529493846|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
146815631|NCT02410278|529493847|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
146815632|NCT03693989|529493848|FG000|Overall Study|Protocol Violation|3|||
146815633|NCT03693989|529493849|FG001|Overall Study|Protocol Violation|4|||
146815634|NCT01190436|529493850|FG000|Overall Study|Lost to Follow-up|35|||
146815635|NCT01190436|529493850|FG000|Overall Study|Other|4|||
146815636|NCT00113529|529493851|FG000|Overall Study|Adverse Event|4|||
146815637|NCT00113529|529493851|FG000|Overall Study|Lack of Efficacy|20|||
146815638|NCT00113529|529493851|FG000|Overall Study|Decision of sponsor|6|||
146815639|NCT00113529|529493851|FG000|Overall Study|Withdrawal by Subject|4|||
146815640|NCT00648895|529493852|FG000|Overall Study|Lack of Efficacy|0|||
146815641|NCT00648895|529493853|FG001|Overall Study|Lack of Efficacy|1|||
146815642|NCT01077284|529493854|FG000|Overall Study|Adverse Event|2|||
146815643|NCT01077284|529493855|FG001|Overall Study|Adverse Event|0|||
146815644|NCT01077284|529493856|FG002|Overall Study|Adverse Event|1|||
146815645|NCT01077284|529493854|FG000|Overall Study|Lost to Follow-up|1|||
146815646|NCT01077284|529493855|FG001|Overall Study|Lost to Follow-up|2|||
146815647|NCT01077284|529493856|FG002|Overall Study|Lost to Follow-up|0|||
146815648|NCT01077284|529493854|FG000|Overall Study|Withdrawal by Subject|2|||
146815649|NCT01077284|529493855|FG001|Overall Study|Withdrawal by Subject|3|||
146815650|NCT01077284|529493856|FG002|Overall Study|Withdrawal by Subject|1|||
146815651|NCT01077284|529493854|FG000|Overall Study|Other|0|||
146815652|NCT01077284|529493855|FG001|Overall Study|Other|0|||
146815653|NCT01077284|529493856|FG002|Overall Study|Other|1|||
146815654|NCT04626128|529493857|FG000|Overall Study|Withdrawal by Subject|0|||
146815655|NCT04626128|529493858|FG001|Overall Study|Withdrawal by Subject|1|||
146945161|NCT02859558|529958221|FG002|Step 1|Non-Adherence to Study Requirements|0|||
146945162|NCT02859558|529958222|FG003|Step 1|Non-Adherence to Study Requirements|0|||
146815656|NCT04626128|529493859|FG002|Overall Study|Withdrawal by Subject|0|||
146815657|NCT04626128|529493860|FG003|Overall Study|Withdrawal by Subject|0|||
146945163|NCT02859558|529958223|FG004|Step 1|Non-Adherence to Study Requirements|0|||
146945164|NCT02859558|529958219|FG000|Step 1|Virologic Failure|2|||
146945165|NCT02859558|529958220|FG001|Step 1|Virologic Failure|1|||
146945166|NCT02859558|529958221|FG002|Step 1|Virologic Failure|1|||
146945167|NCT02859558|529958222|FG003|Step 1|Virologic Failure|0|||
146945168|NCT02859558|529958223|FG004|Step 1|Virologic Failure|0|||
146815658|NCT00841321|529493861|FG000|Overall Study|Lost to Follow-up|1|||
146945169|NCT02859558|529958219|FG000|Step 2|Lost to Follow-up|3|||
146945170|NCT02859558|529958220|FG001|Step 2|Lost to Follow-up|3|||
146945171|NCT02859558|529958221|FG002|Step 2|Lost to Follow-up|1|||
146945172|NCT02859558|529958222|FG003|Step 2|Lost to Follow-up|0|||
146945173|NCT02859558|529958223|FG004|Step 2|Lost to Follow-up|0|||
146945174|NCT02859558|529958219|FG000|Step 2|Withdrawal by Subject|0|||
146945175|NCT02859558|529958220|FG001|Step 2|Withdrawal by Subject|1|||
146945176|NCT02859558|529958221|FG002|Step 2|Withdrawal by Subject|1|||
146945177|NCT02859558|529958222|FG003|Step 2|Withdrawal by Subject|0|||
146945178|NCT02859558|529958223|FG004|Step 2|Withdrawal by Subject|0|||
146945179|NCT02859558|529958219|FG000|Step 2|Unexpected Closure of Site|0|||
146815659|NCT00841321|529493862|FG001|Overall Study|Lost to Follow-up|1|||
146815660|NCT00841321|529493861|FG000|Overall Study|Adverse Event|0|||
146815661|NCT00841321|529493862|FG001|Overall Study|Adverse Event|2|||
146815662|NCT02632747|529493865|FG000|Wash-out Period|Adverse Event|1|||
146815663|NCT02632747|529493866|FG001|Wash-out Period|Adverse Event|0|||
146815664|NCT00379210|529493867|FG000|Overall Study|Withdrawal by Subject|10|||
146815665|NCT00379210|529493868|FG001|Overall Study|Withdrawal by Subject|7|||
146815666|NCT03444155|529493869|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
146815667|NCT03444155|529493870|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
146815668|NCT01894620|529493871|FG000|Overall Study|Withdrawal by Subject|0|||
146815669|NCT01894620|529493872|FG001|Overall Study|Withdrawal by Subject|1|||
146815670|NCT02877680|529493873|FG000|Overall Study|Lost to Follow-up|1|||
146815671|NCT02877680|529493874|FG001|Overall Study|Lost to Follow-up|1|||
146815672|NCT02077374|529493875|FG000|Overall Study|Withdrawal by Subject|0|||
146815673|NCT02077374|529493876|FG001|Overall Study|Withdrawal by Subject|1|||
146815674|NCT02077374|529493875|FG000|Overall Study|Protocol Violation|0|||
146815675|NCT02077374|529493876|FG001|Overall Study|Protocol Violation|1|||
146815676|NCT02574286|529493877|FG000|Overall Study|Adverse Event|3|||
146815677|NCT02574286|529493877|FG000|Overall Study|Withdrawal by Subject|2|||
146815678|NCT03875729|529493878|FG000|Overall Study|Adverse Event|0|||
146815679|NCT03875729|529493879|FG001|Overall Study|Adverse Event|5|||
146815680|NCT03875729|529493878|FG000|Overall Study|Withdrawal by Subject|8|||
146815681|NCT03875729|529493879|FG001|Overall Study|Withdrawal by Subject|11|||
146815682|NCT03875729|529493878|FG000|Overall Study|Pregnancy|0|||
146815683|NCT03875729|529493879|FG001|Overall Study|Pregnancy|1|||
146815684|NCT03875729|529493878|FG000|Overall Study|Lost to Follow-up|0|||
146815685|NCT03875729|529493879|FG001|Overall Study|Lost to Follow-up|5|||
146815686|NCT03875729|529493878|FG000|Overall Study|Personal reasons|2|||
146815687|NCT03875729|529493879|FG001|Overall Study|Personal reasons|0|||
146815688|NCT00952523|529493882|FG000|Overall Study|Withdrawal by Subject|7|||
146815689|NCT04085614|529493883|FG000|Overall Study|Protocol Violation|9|||
146815690|NCT04085614|529493884|FG001|Overall Study|Protocol Violation|6|||
146815691|NCT01029925|529493885|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
146815692|NCT01029925|529493885|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
146815693|NCT01029925|529493885|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
146815694|NCT05265247|529493886|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
146815695|NCT05265247|529493887|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
146815696|NCT05265247|529493886|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
146815697|NCT05265247|529493887|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
146815698|NCT05265247|529493886|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
146815699|NCT05265247|529493887|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
146815700|NCT02399449|529493888|FG000|Overall Study|Withdrawal by Subject|3|||
146815701|NCT02399449|529493889|FG001|Overall Study|Withdrawal by Subject|9|||
146815702|NCT02399449|529493888|FG000|Overall Study|Physician Decision|0|||
146815703|NCT02399449|529493889|FG001|Overall Study|Physician Decision|1|||
146815704|NCT02516202|529493890|FG000|Overall Study|Withdrawal by Subject|1|||
146815705|NCT02516202|529493891|FG001|Overall Study|Withdrawal by Subject|0|||
146815706|NCT02516202|529493892|FG002|Overall Study|Withdrawal by Subject|1|||
146815707|NCT02516202|529493890|FG000|Overall Study|Lost to Follow-up|1|||
146815708|NCT02516202|529493891|FG001|Overall Study|Lost to Follow-up|1|||
146815709|NCT02516202|529493892|FG002|Overall Study|Lost to Follow-up|1|||
146815710|NCT02516202|529493890|FG000|Overall Study|Stopped Follow-up|0|||
146815711|NCT02516202|529493891|FG001|Overall Study|Stopped Follow-up|0|||
146815712|NCT02516202|529493892|FG002|Overall Study|Stopped Follow-up|1|||
146815713|NCT01020435|529493895|FG000|Overall Study|Lost to Follow-up|0|||
146815714|NCT01020435|529493896|FG001|Overall Study|Lost to Follow-up|1|||
146815715|NCT00346398|529493897|FG000|Overall Study|Lost to Follow-up|3|||
146815716|NCT00346398|529493898|FG001|Overall Study|Lost to Follow-up|0|||
146815717|NCT00346398|529493897|FG000|Overall Study|Withdrawal by Subject|0|||
146815718|NCT00346398|529493898|FG001|Overall Study|Withdrawal by Subject|2|||
146815719|NCT02607956|529493899|FG000|Double-Blinded Phase|Withdrew Consent|17|||
146815720|NCT02607956|529493900|FG001|Double-Blinded Phase|Withdrew Consent|19|||
146815721|NCT02607956|529493901|FG002|Double-Blinded Phase|Withdrew Consent|0|||
146815722|NCT02607956|529493902|FG003|Double-Blinded Phase|Withdrew Consent|0|||
146815723|NCT02607956|529493899|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
146815724|NCT02607956|529493900|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
146815725|NCT02607956|529493901|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
146815726|NCT02607956|529493902|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
146815727|NCT02607956|529493899|FG000|Double-Blinded Phase|Randomized but never treated|7|||
146815728|NCT02607956|529493900|FG001|Double-Blinded Phase|Randomized but never treated|5|||
146815729|NCT02607956|529493901|FG002|Double-Blinded Phase|Randomized but never treated|0|||
146815730|NCT02607956|529493902|FG003|Double-Blinded Phase|Randomized but never treated|0|||
146815731|NCT02607956|529493899|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
146815732|NCT02607956|529493900|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
146945180|NCT02859558|529958220|FG001|Step 2|Unexpected Closure of Site|1|||
146945181|NCT02859558|529958221|FG002|Step 2|Unexpected Closure of Site|1|||
146815733|NCT02607956|529493901|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
146815734|NCT02607956|529493902|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
146815735|NCT02607956|529493899|FG000|Double-Blinded Phase|Death|4|||
146815736|NCT02607956|529493900|FG001|Double-Blinded Phase|Death|4|||
146815737|NCT02607956|529493901|FG002|Double-Blinded Phase|Death|0|||
146815738|NCT02607956|529493902|FG003|Double-Blinded Phase|Death|0|||
146815739|NCT02607956|529493899|FG000|Double-Blinded Phase|Adverse Event|4|||
146815740|NCT02607956|529493900|FG001|Double-Blinded Phase|Adverse Event|3|||
146815741|NCT02607956|529493901|FG002|Double-Blinded Phase|Adverse Event|0|||
146815742|NCT02607956|529493902|FG003|Double-Blinded Phase|Adverse Event|0|||
146815743|NCT02607956|529493899|FG000|Double-Blinded Phase|Protocol Violation|3|||
146815744|NCT02607956|529493900|FG001|Double-Blinded Phase|Protocol Violation|1|||
146815745|NCT02607956|529493901|FG002|Double-Blinded Phase|Protocol Violation|0|||
146815746|NCT02607956|529493902|FG003|Double-Blinded Phase|Protocol Violation|0|||
146815747|NCT02607956|529493899|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
146815748|NCT02607956|529493900|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
146815749|NCT02607956|529493901|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
146815750|NCT02607956|529493902|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
146815751|NCT02607956|529493899|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
146815752|NCT02607956|529493900|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
146815753|NCT02607956|529493901|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
146815754|NCT02607956|529493902|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
146815755|NCT02607956|529493899|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
146815756|NCT02607956|529493900|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
146815757|NCT02607956|529493901|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
146815758|NCT02607956|529493902|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
146815759|NCT02607956|529493899|FG000|Open-Label Extension Phase|Death|0|||
146815760|NCT02607956|529493900|FG001|Open-Label Extension Phase|Death|0|||
146815761|NCT02607956|529493901|FG002|Open-Label Extension Phase|Death|1|||
146815762|NCT02607956|529493902|FG003|Open-Label Extension Phase|Death|3|||
146815763|NCT02607956|529493899|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
146815764|NCT02607956|529493900|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
146815765|NCT02607956|529493901|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
146815766|NCT02607956|529493902|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
146815767|NCT02607956|529493899|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
146815768|NCT02607956|529493900|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
146815769|NCT02607956|529493901|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
146815770|NCT02607956|529493902|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
146815771|NCT02607956|529493899|FG000|Open-Label Extension Phase|Protocol Violation|0|||
146815772|NCT02607956|529493900|FG001|Open-Label Extension Phase|Protocol Violation|0|||
146815773|NCT02607956|529493901|FG002|Open-Label Extension Phase|Protocol Violation|0|||
146815774|NCT02607956|529493902|FG003|Open-Label Extension Phase|Protocol Violation|2|||
146815775|NCT02607956|529493899|FG000|Open-Label Extension Phase|Pregnancy|0|||
146815776|NCT02607956|529493900|FG001|Open-Label Extension Phase|Pregnancy|0|||
146815777|NCT02607956|529493901|FG002|Open-Label Extension Phase|Pregnancy|0|||
146815778|NCT02607956|529493902|FG003|Open-Label Extension Phase|Pregnancy|1|||
146815779|NCT02707952|529493903|FG000|Overall Study|Adverse Event|1|||
146815780|NCT02707952|529493904|FG001|Overall Study|Adverse Event|0|||
146815781|NCT02707952|529493905|FG002|Overall Study|Adverse Event|0|||
146815782|NCT02707952|529493906|FG003|Overall Study|Adverse Event|0|||
146945182|NCT02859558|529958222|FG003|Step 2|Unexpected Closure of Site|0|||
146945183|NCT02859558|529958223|FG004|Step 2|Unexpected Closure of Site|0|||
146945184|NCT02859558|529958219|FG000|Step 2|Death|1|||
146945185|NCT02859558|529958220|FG001|Step 2|Death|0|||
146945186|NCT02859558|529958221|FG002|Step 2|Death|0|||
146945187|NCT02859558|529958222|FG003|Step 2|Death|0|||
146945188|NCT02859558|529958223|FG004|Step 2|Death|0|||
146945189|NCT02859558|529958219|FG000|Step 2|Incarceration|0|||
146815783|NCT02707952|529493903|FG000|Overall Study|Lost to Follow-up|1|||
146815784|NCT02707952|529493904|FG001|Overall Study|Lost to Follow-up|0|||
146815785|NCT02707952|529493905|FG002|Overall Study|Lost to Follow-up|0|||
146815786|NCT02707952|529493906|FG003|Overall Study|Lost to Follow-up|0|||
146815787|NCT02707952|529493903|FG000|Overall Study|Withdrawal by Subject|0|||
146815788|NCT02707952|529493904|FG001|Overall Study|Withdrawal by Subject|1|||
146815789|NCT02707952|529493905|FG002|Overall Study|Withdrawal by Subject|2|||
146815790|NCT02707952|529493906|FG003|Overall Study|Withdrawal by Subject|0|||
146945190|NCT02859558|529958220|FG001|Step 2|Incarceration|0|||
146815791|NCT00871715|529493907|FG000|Overall Study|Withdrawal by Subject|6|||
146815792|NCT00871715|529493908|FG001|Overall Study|Withdrawal by Subject|10|||
146815793|NCT00871715|529493909|FG002|Overall Study|Withdrawal by Subject|15|||
146815794|NCT00871715|529493907|FG000|Overall Study|Physician Decision|6|||
146815795|NCT00871715|529493908|FG001|Overall Study|Physician Decision|0|||
146815796|NCT00871715|529493909|FG002|Overall Study|Physician Decision|2|||
146945191|NCT02859558|529958221|FG002|Step 2|Incarceration|1|||
146945192|NCT02859558|529958222|FG003|Step 2|Incarceration|0|||
146945193|NCT02859558|529958223|FG004|Step 2|Incarceration|0|||
146815797|NCT00871715|529493907|FG000|Overall Study|Lost to Follow-up|3|||
146815798|NCT00871715|529493908|FG001|Overall Study|Lost to Follow-up|6|||
146815799|NCT00871715|529493909|FG002|Overall Study|Lost to Follow-up|9|||
146815800|NCT01794689|529493910|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
146815801|NCT01794689|529493911|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
146815802|NCT01794689|529493912|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
146815803|NCT01794689|529493913|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
146815804|NCT01794689|529493910|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
146815805|NCT01794689|529493911|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
146815806|NCT01794689|529493912|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
146815807|NCT01794689|529493913|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
146815808|NCT01794689|529493910|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
146815809|NCT01794689|529493911|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
146815810|NCT01794689|529493912|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
146815811|NCT01794689|529493913|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
146815812|NCT01794689|529493910|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
146815813|NCT01794689|529493911|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
146815814|NCT01794689|529493912|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
146815815|NCT01794689|529493913|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
146815816|NCT01697956|529493914|FG000|Overall Study|Protocol Violation|1|||
146815817|NCT01697956|529493915|FG001|Overall Study|Protocol Violation|1|||
146815818|NCT01964547|529493916|FG000|Overall Study|Adverse Event|8|||
146815819|NCT01964547|529493917|FG001|Overall Study|Adverse Event|2|||
146815820|NCT01964547|529493916|FG000|Overall Study|Withdrawal by Subject|4|||
146815821|NCT01964547|529493917|FG001|Overall Study|Withdrawal by Subject|7|||
146815822|NCT01964547|529493916|FG000|Overall Study|Lost to Follow-up|0|||
146815823|NCT01964547|529493917|FG001|Overall Study|Lost to Follow-up|1|||
146815824|NCT01964547|529493916|FG000|Overall Study|Withdrawal by Investigator|0|||
146815825|NCT01964547|529493917|FG001|Overall Study|Withdrawal by Investigator|1|||
146815826|NCT01115309|529493918|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
146815827|NCT01115309|529493918|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
146815828|NCT01115309|529493918|FG000|Long-term Follow-up|Lost to Follow-up|6|||
146815829|NCT05700851|529493919|FG000|Overall Study|Received a kidney transplant|1|||
146815830|NCT05700851|529493919|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
146815831|NCT05700851|529493919|FG000|Overall Study|Withdrawal by Subject|1|||
146815832|NCT03246724|529493920|FG000|Overall Study|Withdrawal by Subject|5|||
146815833|NCT03246724|529493921|FG001|Overall Study|Withdrawal by Subject|2|||
146815834|NCT03246724|529493922|FG002|Overall Study|Withdrawal by Subject|4|||
146815835|NCT03246724|529493923|FG003|Overall Study|Withdrawal by Subject|2|||
146815836|NCT03246724|529493920|FG000|Overall Study|Ineligible on day of surgery|7|||
146815837|NCT03246724|529493921|FG001|Overall Study|Ineligible on day of surgery|2|||
146815838|NCT03246724|529493922|FG002|Overall Study|Ineligible on day of surgery|0|||
146815839|NCT03246724|529493923|FG003|Overall Study|Ineligible on day of surgery|3|||
146815840|NCT03246724|529493920|FG000|Overall Study|Study completed before surgical date|2|||
146815841|NCT03246724|529493921|FG001|Overall Study|Study completed before surgical date|1|||
146815842|NCT03246724|529493922|FG002|Overall Study|Study completed before surgical date|8|||
146815843|NCT03246724|529493923|FG003|Overall Study|Study completed before surgical date|1|||
146815844|NCT03246724|529493920|FG000|Overall Study|Transferred to other arm|0|||
146815845|NCT03246724|529493921|FG001|Overall Study|Transferred to other arm|0|||
146815846|NCT03246724|529493922|FG002|Overall Study|Transferred to other arm|1|||
146815847|NCT03246724|529493923|FG003|Overall Study|Transferred to other arm|0|||
146815848|NCT03246724|529493920|FG000|Overall Study|Unable to obtain medication timely|0|||
146815849|NCT03246724|529493921|FG001|Overall Study|Unable to obtain medication timely|2|||
146815850|NCT03246724|529493922|FG002|Overall Study|Unable to obtain medication timely|2|||
146815851|NCT03246724|529493923|FG003|Overall Study|Unable to obtain medication timely|1|||
146815852|NCT03246724|529493920|FG000|Overall Study|Re-consented to participate|0|||
146815853|NCT03246724|529493921|FG001|Overall Study|Re-consented to participate|0|||
146815854|NCT03246724|529493922|FG002|Overall Study|Re-consented to participate|0|||
146815855|NCT03246724|529493923|FG003|Overall Study|Re-consented to participate|1|||
146815856|NCT02978716|529493924|FG000|Overall Study|Death|25|||
146815857|NCT02978716|529493925|FG001|Overall Study|Death|13|||
146815858|NCT02978716|529493926|FG002|Overall Study|Death|20|||
146815859|NCT02978716|529493924|FG000|Overall Study|Lost to Follow-up|0|||
146815860|NCT02978716|529493925|FG001|Overall Study|Lost to Follow-up|0|||
146815861|NCT02978716|529493926|FG002|Overall Study|Lost to Follow-up|1|||
146815862|NCT02978716|529493924|FG000|Overall Study|Withdrawal by Subject|6|||
146815863|NCT02978716|529493925|FG001|Overall Study|Withdrawal by Subject|4|||
146815864|NCT02978716|529493926|FG002|Overall Study|Withdrawal by Subject|5|||
146815865|NCT02978716|529493924|FG000|Overall Study|Sponsor terminated|2|||
146815866|NCT02978716|529493925|FG001|Overall Study|Sponsor terminated|13|||
146815867|NCT02978716|529493926|FG002|Overall Study|Sponsor terminated|9|||
146815868|NCT02978716|529493924|FG000|Overall Study|Other|1|||
146815869|NCT02978716|529493925|FG001|Overall Study|Other|3|||
146815870|NCT02978716|529493926|FG002|Overall Study|Other|0|||
146815871|NCT00589628|529493927|FG000|Overall Study|Lost to Follow-up|0|||
146815872|NCT00589628|529493928|FG001|Overall Study|Lost to Follow-up|1|||
146815873|NCT00689351|529493932|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
146815874|NCT00689351|529493933|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
146815875|NCT00689351|529493932|FG000|Infant Series of Dosing|Adverse Event|1|||
146815876|NCT00689351|529493933|FG001|Infant Series of Dosing|Adverse Event|0|||
146815877|NCT00689351|529493932|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
146815878|NCT00689351|529493933|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
146945194|NCT04984876|529958224|FG000|Overall Study|Subject decision|2|||
146945195|NCT04984876|529958225|FG001|Overall Study|Subject decision|10|||
146945196|NCT04984876|529958226|FG002|Overall Study|Subject decision|3|||
146945197|NCT04984876|529958227|FG003|Overall Study|Subject decision|3|||
146945198|NCT04984876|529958228|FG004|Overall Study|Subject decision|3|||
146945199|NCT04984876|529958229|FG005|Overall Study|Subject decision|0|||
146945200|NCT04984876|529958224|FG000|Overall Study|Guardian decision|0|||
146945201|NCT04984876|529958225|FG001|Overall Study|Guardian decision|1|||
146945202|NCT04984876|529958226|FG002|Overall Study|Guardian decision|0|||
146945203|NCT04984876|529958227|FG003|Overall Study|Guardian decision|2|||
146945204|NCT04984876|529958228|FG004|Overall Study|Guardian decision|0|||
146945205|NCT04984876|529958229|FG005|Overall Study|Guardian decision|1|||
146945206|NCT04984876|529958224|FG000|Overall Study|Lost to Follow-up|0|||
146945207|NCT04984876|529958225|FG001|Overall Study|Lost to Follow-up|0|||
146945208|NCT04984876|529958226|FG002|Overall Study|Lost to Follow-up|1|||
146945209|NCT04984876|529958227|FG003|Overall Study|Lost to Follow-up|1|||
146945210|NCT04984876|529958228|FG004|Overall Study|Lost to Follow-up|0|||
146945211|NCT04984876|529958229|FG005|Overall Study|Lost to Follow-up|0|||
146945212|NCT04984876|529958224|FG000|Overall Study|Physician Decision|1|||
146945213|NCT04984876|529958225|FG001|Overall Study|Physician Decision|0|||
146945214|NCT04984876|529958226|FG002|Overall Study|Physician Decision|0|||
146945215|NCT04984876|529958227|FG003|Overall Study|Physician Decision|1|||
146945216|NCT04984876|529958228|FG004|Overall Study|Physician Decision|0|||
146945217|NCT04984876|529958229|FG005|Overall Study|Physician Decision|0|||
146945218|NCT04984876|529958224|FG000|Overall Study|Adverse Event|0|||
146945219|NCT04984876|529958225|FG001|Overall Study|Adverse Event|0|||
146945220|NCT04984876|529958226|FG002|Overall Study|Adverse Event|1|||
146945221|NCT04984876|529958227|FG003|Overall Study|Adverse Event|0|||
146945222|NCT04984876|529958228|FG004|Overall Study|Adverse Event|0|||
146945223|NCT04984876|529958229|FG005|Overall Study|Adverse Event|0|||
146945224|NCT02204410|529958230|FG000|Overall Study|Lost to Follow-up|5|||
146945225|NCT02204410|529958230|FG000|Overall Study|Physician Decision|2|||
146945226|NCT02204410|529958230|FG000|Overall Study|Protocol Violation|1|||
146945227|NCT02204410|529958230|FG000|Overall Study|Withdrawal by Subject|3|||
146945228|NCT01462045|529958233|FG000|Overall Study|Family matter|0|||
146945229|NCT01462045|529958234|FG001|Overall Study|Family matter|1|||
146945230|NCT01462045|529958235|FG002|Overall Study|Family matter|0|||
146945231|NCT01938391|529958240|FG000|6 Month Follow up|Withdrawal by Subject|1|||
146945232|NCT01938391|529958240|FG000|12 Month Follow up|Physician Decision|1|||
146945233|NCT01938391|529958240|FG000|12 Month Follow up|Withdrawal by Subject|1|||
146945234|NCT01077193|529958241|FG000|Overall Study|Lost to Follow-up|1|||
146945235|NCT01077193|529958241|FG000|Overall Study|Withdrawal by Subject|2|||
146945236|NCT01077193|529958241|FG000|Overall Study|Lack of Efficacy|1|||
146945237|NCT01077193|529958241|FG000|Overall Study|Study Terminated by Sponsor|40|||
146945238|NCT02234050|529958260|FG000|Overall Study|Lack of Efficacy|38|||
146945239|NCT02234050|529958261|FG001|Overall Study|Lack of Efficacy|22|||
146945240|NCT02234050|529958260|FG000|Overall Study|Adverse Event|13|||
146945241|NCT02234050|529958261|FG001|Overall Study|Adverse Event|1|||
146945242|NCT02234050|529958260|FG000|Overall Study|Withdrawal by Subject|4|||
146815879|NCT00689351|529493932|FG000|After Infant Series|Parent/legal guardian request|1|||
146815880|NCT00689351|529493933|FG001|After Infant Series|Parent/legal guardian request|0|||
146815881|NCT03075878|529493934|FG000|Overall Study|Physician Decision|1|||
146815882|NCT01986348|529493935|FG000|Overall Study|Death|8|||
146815883|NCT01986348|529493936|FG001|Overall Study|Death|22|||
146815884|NCT01986348|529493937|FG002|Overall Study|Death|10|||
146815885|NCT01986348|529493938|FG003|Overall Study|Death|21|||
146815886|NCT01986348|529493935|FG000|Overall Study|Lost to Follow-up|0|||
146815887|NCT01986348|529493936|FG001|Overall Study|Lost to Follow-up|0|||
146945243|NCT02234050|529958261|FG001|Overall Study|Withdrawal by Subject|2|||
146945244|NCT02234050|529958260|FG000|Overall Study|Sponsor's decision|6|||
146945245|NCT02234050|529958261|FG001|Overall Study|Sponsor's decision|0|||
146945246|NCT01680991|529958263|FG000|Overall Study|Adverse Event|1|||
146945247|NCT01680991|529958264|FG001|Overall Study|Adverse Event|0|||
146945248|NCT01680991|529958265|FG002|Overall Study|Adverse Event|0|||
146945249|NCT01680991|529958263|FG000|Overall Study|Death|1|||
146945250|NCT01680991|529958264|FG001|Overall Study|Death|0|||
146945251|NCT01680991|529958265|FG002|Overall Study|Death|1|||
146945252|NCT01680991|529958263|FG000|Overall Study|Protocol Violation|0|||
146945253|NCT01680991|529958264|FG001|Overall Study|Protocol Violation|1|||
146945254|NCT01680991|529958265|FG002|Overall Study|Protocol Violation|0|||
146945255|NCT01680991|529958263|FG000|Overall Study|Withdrawal by Subject|5|||
146945256|NCT01680991|529958264|FG001|Overall Study|Withdrawal by Subject|1|||
146945257|NCT01680991|529958265|FG002|Overall Study|Withdrawal by Subject|0|||
146815888|NCT01986348|529493937|FG002|Overall Study|Lost to Follow-up|0|||
146815889|NCT01986348|529493938|FG003|Overall Study|Lost to Follow-up|2|||
146815890|NCT01986348|529493935|FG000|Overall Study|Physician Decision|0|||
146815891|NCT01986348|529493936|FG001|Overall Study|Physician Decision|0|||
146815892|NCT01986348|529493937|FG002|Overall Study|Physician Decision|0|||
146815893|NCT01986348|529493938|FG003|Overall Study|Physician Decision|1|||
146815894|NCT01986348|529493935|FG000|Overall Study|Progressive Disease|0|||
146815895|NCT01986348|529493936|FG001|Overall Study|Progressive Disease|0|||
146815896|NCT01986348|529493937|FG002|Overall Study|Progressive Disease|2|||
146815897|NCT01986348|529493938|FG003|Overall Study|Progressive Disease|0|||
146815898|NCT01986348|529493935|FG000|Overall Study|Withdrawal by Participant|0|||
146815899|NCT01986348|529493936|FG001|Overall Study|Withdrawal by Participant|1|||
146815900|NCT01986348|529493937|FG002|Overall Study|Withdrawal by Participant|2|||
146815901|NCT01986348|529493938|FG003|Overall Study|Withdrawal by Participant|1|||
146815902|NCT01986348|529493935|FG000|Overall Study|Study Terminated by Sponsor|0|||
146815903|NCT01986348|529493936|FG001|Overall Study|Study Terminated by Sponsor|0|||
146815904|NCT01986348|529493937|FG002|Overall Study|Study Terminated by Sponsor|0|||
146815905|NCT01986348|529493938|FG003|Overall Study|Study Terminated by Sponsor|3|||
146815906|NCT01986348|529493935|FG000|Overall Study|Other-unspecified|0|||
146815907|NCT01986348|529493936|FG001|Overall Study|Other-unspecified|1|||
146815908|NCT01986348|529493937|FG002|Overall Study|Other-unspecified|0|||
146815909|NCT01986348|529493938|FG003|Overall Study|Other-unspecified|2|||
146815910|NCT02158806|529493939|FG000|Overall Study|Death|2|||
146815911|NCT02158806|529493940|FG001|Overall Study|Death|0|||
146815912|NCT02158806|529493939|FG000|Overall Study|Withdrawal by Subject|2|||
146815913|NCT02158806|529493940|FG001|Overall Study|Withdrawal by Subject|0|||
146815914|NCT02158806|529493939|FG000|Overall Study|Lost to Follow-up|0|||
146815915|NCT02158806|529493940|FG001|Overall Study|Lost to Follow-up|3|||
146815916|NCT02158806|529493939|FG000|Overall Study|Moved out of area|0|||
146815917|NCT02158806|529493940|FG001|Overall Study|Moved out of area|1|||
146815918|NCT02158806|529493939|FG000|Overall Study|Transferred to palliative care|0|||
146815919|NCT02158806|529493940|FG001|Overall Study|Transferred to palliative care|1|||
146815920|NCT01898299|529493941|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
146815921|NCT01898299|529493942|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
146815922|NCT00760877|529495722|FG000|Overall Study|Protocol Violation|1|||
146815923|NCT00760877|529495723|FG001|Overall Study|Protocol Violation|0|||
146815924|NCT00760877|529495722|FG000|Overall Study|Non-compliance with protocol treatment|2|||
146815925|NCT00760877|529495723|FG001|Overall Study|Non-compliance with protocol treatment|1|||
146815926|NCT00760877|529495722|FG000|Overall Study|Pregnancy|1|||
146815927|NCT00760877|529495723|FG001|Overall Study|Pregnancy|4|||
146815928|NCT00760877|529495722|FG000|Overall Study|Death|2|||
146815929|NCT00760877|529495723|FG001|Overall Study|Death|1|||
146815930|NCT00760877|529495722|FG000|Overall Study|Withdrawal by Subject|7|||
146815931|NCT00760877|529495723|FG001|Overall Study|Withdrawal by Subject|3|||
146815932|NCT00760877|529495722|FG000|Overall Study|Adverse Event|19|||
146815933|NCT00760877|529495723|FG001|Overall Study|Adverse Event|12|||
146815934|NCT00760877|529495722|FG000|Overall Study|Participant diagnosed with AML|0|||
146815935|NCT00760877|529495723|FG001|Overall Study|Participant diagnosed with AML|1|||
146815936|NCT00760877|529495722|FG000|Overall Study|Participant not eligible to cross-over|0|||
146815937|NCT00760877|529495723|FG001|Overall Study|Participant not eligible to cross-over|1|||
146815938|NCT00760877|529495722|FG000|Overall Study|Physician Decision|1|||
146815939|NCT00760877|529495723|FG001|Overall Study|Physician Decision|2|||
146815940|NCT00760877|529495722|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
146815941|NCT00760877|529495723|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
146815942|NCT00760877|529495722|FG000|Overall Study|Treatment failure|1|||
146815943|NCT00760877|529495723|FG001|Overall Study|Treatment failure|0|||
146815944|NCT00711555|529495726|FG000|Overall Study|Adverse Event|3|||
146815945|NCT04820023|529495733|FG000|Overall Study|Death|0|||
146815946|NCT04820023|529495734|FG001|Overall Study|Death|0|||
146815947|NCT04820023|529495735|FG002|Overall Study|Death|0|||
146815948|NCT04820023|529495736|FG003|Overall Study|Death|0|||
146815949|NCT04820023|529495737|FG004|Overall Study|Death|0|||
146815950|NCT04820023|529495738|FG005|Overall Study|Death|0|||
146815951|NCT04820023|529495739|FG006|Overall Study|Death|1|||
146815952|NCT04820023|529495740|FG007|Overall Study|Death|0|||
146815953|NCT04820023|529495741|FG008|Overall Study|Death|1|||
146815954|NCT04820023|529495733|FG000|Overall Study|Withdrawal by Subject|1|||
146815955|NCT04820023|529495734|FG001|Overall Study|Withdrawal by Subject|2|||
146815956|NCT04820023|529495735|FG002|Overall Study|Withdrawal by Subject|2|||
146815957|NCT04820023|529495736|FG003|Overall Study|Withdrawal by Subject|1|||
146815958|NCT04820023|529495737|FG004|Overall Study|Withdrawal by Subject|4|||
146815959|NCT04820023|529495738|FG005|Overall Study|Withdrawal by Subject|3|||
146815960|NCT04820023|529495739|FG006|Overall Study|Withdrawal by Subject|3|||
146815961|NCT04820023|529495740|FG007|Overall Study|Withdrawal by Subject|6|||
146815962|NCT04820023|529495741|FG008|Overall Study|Withdrawal by Subject|5|||
146815963|NCT04820023|529495733|FG000|Overall Study|Progressive Disease|3|||
146815964|NCT04820023|529495734|FG001|Overall Study|Progressive Disease|0|||
146815965|NCT04820023|529495735|FG002|Overall Study|Progressive Disease|2|||
146945258|NCT01680991|529958263|FG000|Overall Study|Progressive disease (PD)|0|||
146945259|NCT01680991|529958264|FG001|Overall Study|Progressive disease (PD)|10|||
146945260|NCT01680991|529958265|FG002|Overall Study|Progressive disease (PD)|0|||
146945261|NCT01680991|529958263|FG000|Overall Study|Physician Decision|0|||
146945262|NCT01680991|529958264|FG001|Overall Study|Physician Decision|7|||
146945263|NCT01680991|529958265|FG002|Overall Study|Physician Decision|2|||
146945264|NCT01680991|529958263|FG000|Overall Study|Bad physical condition|0|||
146945265|NCT01680991|529958264|FG001|Overall Study|Bad physical condition|0|||
146945266|NCT01680991|529958265|FG002|Overall Study|Bad physical condition|1|||
146945267|NCT01680991|529958263|FG000|Overall Study|PD confirmed in other hospital|1|||
146945268|NCT01680991|529958264|FG001|Overall Study|PD confirmed in other hospital|0|||
146945269|NCT01680991|529958265|FG002|Overall Study|PD confirmed in other hospital|0|||
146945270|NCT06073054|529958266|FG000|Overall Study|Withdrawal by Subject|2|||
146945271|NCT03149029|529958267|FG000|Overall Study|Adverse Event|2|||
146945272|NCT03149029|529958268|FG001|Overall Study|Adverse Event|0|||
146945273|NCT00068822|529958269|FG000|First Randomized Intervention|Lost to Follow-up|1|||
146945274|NCT00068822|529958270|FG001|First Randomized Intervention|Lost to Follow-up|2|||
146945275|NCT00981292|529958271|FG000|Day 1|Protocol Violation|1|||
146945276|NCT00981292|529958272|FG001|Day 1|Protocol Violation|0|||
146945277|NCT00981292|529958273|FG002|Day 1|Protocol Violation|0|||
146945278|NCT00981292|529958274|FG003|Day 1|Protocol Violation|0|||
146945279|NCT00981292|529958275|FG004|Day 1|Protocol Violation|0|||
146945280|NCT00981292|529958276|FG005|Day 1|Protocol Violation|2|||
146945281|NCT00981292|529958271|FG000|Day 2|Protocol Violation|2|||
146945282|NCT00981292|529958272|FG001|Day 2|Protocol Violation|0|||
146945283|NCT00981292|529958273|FG002|Day 2|Protocol Violation|0|||
146945284|NCT00981292|529958274|FG003|Day 2|Protocol Violation|0|||
146945285|NCT00981292|529958275|FG004|Day 2|Protocol Violation|0|||
146945286|NCT00981292|529958276|FG005|Day 2|Protocol Violation|0|||
146945287|NCT00981292|529958271|FG000|Day 3|Protocol Violation|0|||
146945288|NCT00981292|529958272|FG001|Day 3|Protocol Violation|0|||
146984562|NCT00617461|530105101|FG000|First Treatment Intervention Period|Protocol Violation|2|||
146984563|NCT00617461|530105102|FG001|First Treatment Intervention Period|Protocol Violation|1|||
146984564|NCT00617461|530105101|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
146984565|NCT00617461|530105102|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
146984566|NCT00617461|530105101|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
146984567|NCT00617461|530105102|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
146984568|NCT00617461|530105101|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
146984569|NCT00617461|530105102|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
146984570|NCT00617461|530105101|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
146984571|NCT00617461|530105102|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
146984572|NCT00617461|530105101|FG000|Second Treatment Intervention Period|Adverse Event|0|||
146984573|NCT00617461|530105102|FG001|Second Treatment Intervention Period|Adverse Event|1|||
146984574|NCT00617461|530105101|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
146984575|NCT00617461|530105102|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
146984576|NCT00617461|530105101|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
146984577|NCT00617461|530105102|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
146984578|NCT00617461|530105101|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
146984579|NCT00617461|530105102|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
146984580|NCT00358826|530105103|FG000|Core Study|Adverse Event|1|||
146984581|NCT00358826|530105104|FG001|Core Study|Adverse Event|3|||
146984582|NCT00358826|530105105|FG002|Core Study|Adverse Event|1|||
146984583|NCT00358826|530105106|FG003|Core Study|Adverse Event|1|||
146984584|NCT00358826|530105107|FG004|Core Study|Adverse Event|0|||
146984585|NCT00358826|530105108|FG005|Core Study|Adverse Event|0|||
146984586|NCT00358826|530105109|FG006|Core Study|Adverse Event|0|||
146984587|NCT00358826|530105110|FG007|Core Study|Adverse Event|0|||
146984588|NCT00358826|530105103|FG000|Core Study|Withdrawal by Subject|2|||
146984589|NCT00358826|530105104|FG001|Core Study|Withdrawal by Subject|2|||
146984590|NCT00358826|530105105|FG002|Core Study|Withdrawal by Subject|0|||
146984591|NCT00358826|530105106|FG003|Core Study|Withdrawal by Subject|0|||
146984592|NCT00358826|530105107|FG004|Core Study|Withdrawal by Subject|0|||
146984593|NCT00358826|530105108|FG005|Core Study|Withdrawal by Subject|0|||
146984594|NCT00358826|530105109|FG006|Core Study|Withdrawal by Subject|0|||
146945289|NCT00981292|529958273|FG002|Day 3|Protocol Violation|0|||
146945290|NCT00981292|529958274|FG003|Day 3|Protocol Violation|0|||
146945291|NCT00981292|529958275|FG004|Day 3|Protocol Violation|0|||
146984595|NCT00358826|530105110|FG007|Core Study|Withdrawal by Subject|0|||
146945292|NCT00981292|529958276|FG005|Day 3|Protocol Violation|1|||
146945293|NCT01408732|529958277|FG000|Overall Study|Withdrawal by Subject|2|||
146945294|NCT01408732|529958278|FG001|Overall Study|Withdrawal by Subject|2|||
146984596|NCT00358826|530105103|FG000|Core Study|Lost to Follow-up|0|||
146984597|NCT00358826|530105104|FG001|Core Study|Lost to Follow-up|0|||
146984598|NCT00358826|530105105|FG002|Core Study|Lost to Follow-up|0|||
146945295|NCT00424099|529958279|FG000|Overall Study|Adverse Event|0|||
146984599|NCT00358826|530105106|FG003|Core Study|Lost to Follow-up|1|||
146945296|NCT00424099|529958280|FG001|Overall Study|Adverse Event|1|||
146945297|NCT00424099|529958281|FG002|Overall Study|Adverse Event|1|||
146945298|NCT00424099|529958282|FG003|Overall Study|Adverse Event|0|||
146945299|NCT00424099|529958279|FG000|Overall Study|Death|0|||
146945300|NCT00424099|529958280|FG001|Overall Study|Death|1|||
146945301|NCT00424099|529958281|FG002|Overall Study|Death|0|||
146945302|NCT00424099|529958282|FG003|Overall Study|Death|0|||
146945303|NCT00424099|529958279|FG000|Overall Study|Illness|2|||
146945304|NCT00424099|529958280|FG001|Overall Study|Illness|0|||
146945305|NCT00424099|529958281|FG002|Overall Study|Illness|1|||
146945306|NCT00424099|529958282|FG003|Overall Study|Illness|4|||
146945307|NCT00424099|529958279|FG000|Overall Study|Lost to Follow-up|0|||
146945308|NCT00424099|529958280|FG001|Overall Study|Lost to Follow-up|0|||
146945309|NCT00424099|529958281|FG002|Overall Study|Lost to Follow-up|3|||
146945310|NCT00424099|529958282|FG003|Overall Study|Lost to Follow-up|0|||
146945311|NCT00424099|529958279|FG000|Overall Study|Hospitalized|1|||
146945312|NCT00424099|529958280|FG001|Overall Study|Hospitalized|2|||
146945313|NCT00424099|529958281|FG002|Overall Study|Hospitalized|1|||
146945314|NCT00424099|529958282|FG003|Overall Study|Hospitalized|3|||
146945315|NCT00424099|529958279|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
146945316|NCT00424099|529958280|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
146945317|NCT00424099|529958281|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
146945318|NCT00424099|529958282|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
146945319|NCT00424099|529958279|FG000|Overall Study|Withdrawal by Subject|1|||
146945320|NCT00424099|529958280|FG001|Overall Study|Withdrawal by Subject|9|||
146945321|NCT00424099|529958281|FG002|Overall Study|Withdrawal by Subject|4|||
146945322|NCT00424099|529958282|FG003|Overall Study|Withdrawal by Subject|6|||
146945323|NCT00424099|529958279|FG000|Overall Study|Physician Decision|0|||
146945324|NCT00424099|529958280|FG001|Overall Study|Physician Decision|0|||
146945325|NCT00424099|529958281|FG002|Overall Study|Physician Decision|1|||
146945326|NCT00424099|529958282|FG003|Overall Study|Physician Decision|0|||
146945327|NCT00424099|529958279|FG000|Overall Study|Missing|0|||
146945328|NCT00424099|529958280|FG001|Overall Study|Missing|0|||
146945329|NCT00424099|529958281|FG002|Overall Study|Missing|1|||
146945330|NCT00424099|529958282|FG003|Overall Study|Missing|0|||
146945331|NCT03377452|529958283|FG000|Overall Study|Refused assessment|0|||
146945332|NCT03377452|529958284|FG001|Overall Study|Refused assessment|2|||
146945333|NCT03377452|529958283|FG000|Overall Study|Lost to Follow-up|5|||
146945334|NCT03377452|529958284|FG001|Overall Study|Lost to Follow-up|4|||
146945335|NCT00764322|529958285|FG000|Overall Study|Withdrawal by Subject|11|||
146945336|NCT00764322|529958285|FG000|Overall Study|No CYP2D6 genotyping|9|||
146945337|NCT03345342|529958286|FG000|Open-Label Phase|Adverse Event|30|||
146945338|NCT03345342|529958287|FG001|Open-Label Phase|Adverse Event|0|||
146945339|NCT03345342|529958288|FG002|Open-Label Phase|Adverse Event|0|||
146945340|NCT03345342|529958289|FG003|Open-Label Phase|Adverse Event|0|||
146945341|NCT03345342|529958290|FG004|Open-Label Phase|Adverse Event|0|||
146815966|NCT04820023|529495736|FG003|Overall Study|Progressive Disease|2|||
146815967|NCT04820023|529495737|FG004|Overall Study|Progressive Disease|2|||
146815968|NCT04820023|529495738|FG005|Overall Study|Progressive Disease|0|||
146815969|NCT04820023|529495739|FG006|Overall Study|Progressive Disease|1|||
146815970|NCT04820023|529495740|FG007|Overall Study|Progressive Disease|1|||
146815971|NCT04820023|529495741|FG008|Overall Study|Progressive Disease|0|||
146815972|NCT04820023|529495733|FG000|Overall Study|New anti-cancer therapy|0|||
146815973|NCT04820023|529495734|FG001|Overall Study|New anti-cancer therapy|0|||
146815974|NCT04820023|529495735|FG002|Overall Study|New anti-cancer therapy|0|||
146815975|NCT04820023|529495736|FG003|Overall Study|New anti-cancer therapy|0|||
146815976|NCT04820023|529495737|FG004|Overall Study|New anti-cancer therapy|2|||
146815977|NCT04820023|529495738|FG005|Overall Study|New anti-cancer therapy|0|||
146815978|NCT04820023|529495739|FG006|Overall Study|New anti-cancer therapy|0|||
146815979|NCT04820023|529495740|FG007|Overall Study|New anti-cancer therapy|0|||
146815980|NCT04820023|529495741|FG008|Overall Study|New anti-cancer therapy|0|||
146815981|NCT04820023|529495733|FG000|Overall Study|Other|0|||
146815982|NCT04820023|529495734|FG001|Overall Study|Other|1|||
146945342|NCT03345342|529958286|FG000|Open-Label Phase|Death|1|||
146945343|NCT03345342|529958287|FG001|Open-Label Phase|Death|0|||
146945344|NCT03345342|529958288|FG002|Open-Label Phase|Death|0|||
146984600|NCT00358826|530105107|FG004|Core Study|Lost to Follow-up|0|||
146815983|NCT04820023|529495735|FG002|Overall Study|Other|0|||
146815984|NCT04820023|529495736|FG003|Overall Study|Other|0|||
146815985|NCT04820023|529495737|FG004|Overall Study|Other|0|||
146815986|NCT04820023|529495738|FG005|Overall Study|Other|0|||
146945345|NCT03345342|529958289|FG003|Open-Label Phase|Death|0|||
146945346|NCT03345342|529958290|FG004|Open-Label Phase|Death|0|||
146945347|NCT03345342|529958286|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
146945348|NCT03345342|529958287|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
146945349|NCT03345342|529958288|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
146945350|NCT03345342|529958289|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
146945351|NCT03345342|529958290|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
146945352|NCT03345342|529958286|FG000|Open-Label Phase|Lack of Efficacy|6|||
146815987|NCT04820023|529495739|FG006|Overall Study|Other|0|||
146945353|NCT03345342|529958287|FG001|Open-Label Phase|Lack of Efficacy|0|||
146945354|NCT03345342|529958288|FG002|Open-Label Phase|Lack of Efficacy|0|||
146945355|NCT03345342|529958289|FG003|Open-Label Phase|Lack of Efficacy|0|||
146945356|NCT03345342|529958290|FG004|Open-Label Phase|Lack of Efficacy|0|||
146945357|NCT03345342|529958286|FG000|Open-Label Phase|Lost to Follow-up|9|||
146945358|NCT03345342|529958287|FG001|Open-Label Phase|Lost to Follow-up|0|||
146945359|NCT03345342|529958288|FG002|Open-Label Phase|Lost to Follow-up|0|||
146945360|NCT03345342|529958289|FG003|Open-Label Phase|Lost to Follow-up|0|||
146945361|NCT03345342|529958290|FG004|Open-Label Phase|Lost to Follow-up|0|||
146945362|NCT03345342|529958286|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
146945363|NCT03345342|529958287|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
146945364|NCT03345342|529958288|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
146945365|NCT03345342|529958289|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
146945366|NCT03345342|529958290|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
146945367|NCT03345342|529958286|FG000|Open-Label Phase|Physician Decision|4|||
146945368|NCT03345342|529958287|FG001|Open-Label Phase|Physician Decision|0|||
146945369|NCT03345342|529958288|FG002|Open-Label Phase|Physician Decision|0|||
146945370|NCT03345342|529958289|FG003|Open-Label Phase|Physician Decision|0|||
146945371|NCT03345342|529958290|FG004|Open-Label Phase|Physician Decision|0|||
146945372|NCT03345342|529958286|FG000|Open-Label Phase|Protocol Violation|8|||
146945373|NCT03345342|529958287|FG001|Open-Label Phase|Protocol Violation|0|||
146945374|NCT03345342|529958288|FG002|Open-Label Phase|Protocol Violation|0|||
146945375|NCT03345342|529958289|FG003|Open-Label Phase|Protocol Violation|0|||
146945376|NCT03345342|529958290|FG004|Open-Label Phase|Protocol Violation|0|||
146945377|NCT03345342|529958286|FG000|Open-Label Phase|Withdrawal by Subject|57|||
146945378|NCT03345342|529958287|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146945379|NCT03345342|529958288|FG002|Open-Label Phase|Withdrawal by Subject|0|||
146945380|NCT03345342|529958289|FG003|Open-Label Phase|Withdrawal by Subject|0|||
146945381|NCT03345342|529958290|FG004|Open-Label Phase|Withdrawal by Subject|0|||
146945382|NCT03345342|529958286|FG000|Open-Label Phase|Other|15|||
146945383|NCT03345342|529958287|FG001|Open-Label Phase|Other|0|||
146945384|NCT03345342|529958288|FG002|Open-Label Phase|Other|0|||
146945385|NCT03345342|529958289|FG003|Open-Label Phase|Other|0|||
146945386|NCT03345342|529958290|FG004|Open-Label Phase|Other|0|||
146945387|NCT03345342|529958286|FG000|Double-Blind Phase|Adverse Event|0|||
146945388|NCT03345342|529958287|FG001|Double-Blind Phase|Adverse Event|1|||
146945389|NCT03345342|529958288|FG002|Double-Blind Phase|Adverse Event|6|||
146945390|NCT03345342|529958289|FG003|Double-Blind Phase|Adverse Event|0|||
146945391|NCT03345342|529958290|FG004|Double-Blind Phase|Adverse Event|0|||
146945392|NCT03345342|529958286|FG000|Double-Blind Phase|Death|0|||
146945393|NCT03345342|529958287|FG001|Double-Blind Phase|Death|2|||
146945394|NCT03345342|529958288|FG002|Double-Blind Phase|Death|1|||
146945395|NCT03345342|529958289|FG003|Double-Blind Phase|Death|0|||
146945396|NCT03345342|529958290|FG004|Double-Blind Phase|Death|0|||
146945397|NCT03345342|529958286|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
146945398|NCT03345342|529958287|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
146945399|NCT03345342|529958288|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
146945400|NCT03345342|529958289|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
146945401|NCT03345342|529958290|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
146945402|NCT03345342|529958286|FG000|Double-Blind Phase|Lost to Follow-up|0|||
146945403|NCT03345342|529958287|FG001|Double-Blind Phase|Lost to Follow-up|1|||
146945404|NCT03345342|529958288|FG002|Double-Blind Phase|Lost to Follow-up|7|||
146945405|NCT03345342|529958289|FG003|Double-Blind Phase|Lost to Follow-up|0|||
146945406|NCT03345342|529958290|FG004|Double-Blind Phase|Lost to Follow-up|0|||
146945407|NCT03345342|529958286|FG000|Double-Blind Phase|Physician Decision|0|||
146945408|NCT03345342|529958287|FG001|Double-Blind Phase|Physician Decision|1|||
146945409|NCT03345342|529958288|FG002|Double-Blind Phase|Physician Decision|4|||
146945410|NCT03345342|529958289|FG003|Double-Blind Phase|Physician Decision|0|||
146945411|NCT03345342|529958290|FG004|Double-Blind Phase|Physician Decision|0|||
146945412|NCT03345342|529958286|FG000|Double-Blind Phase|Protocol Violation|0|||
146945413|NCT03345342|529958287|FG001|Double-Blind Phase|Protocol Violation|0|||
146984601|NCT00358826|530105108|FG005|Core Study|Lost to Follow-up|0|||
146984602|NCT00358826|530105109|FG006|Core Study|Lost to Follow-up|0|||
146945414|NCT03345342|529958288|FG002|Double-Blind Phase|Protocol Violation|1|||
146945415|NCT03345342|529958289|FG003|Double-Blind Phase|Protocol Violation|0|||
146945416|NCT03345342|529958290|FG004|Double-Blind Phase|Protocol Violation|0|||
146945417|NCT03345342|529958286|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
146945418|NCT03345342|529958287|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
146945419|NCT03345342|529958288|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
146945420|NCT03345342|529958289|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
146945421|NCT03345342|529958290|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
146945422|NCT03345342|529958286|FG000|Double-Blind Phase|Other|0|||
146984603|NCT00358826|530105110|FG007|Core Study|Lost to Follow-up|0|||
146945423|NCT03345342|529958287|FG001|Double-Blind Phase|Other|1|||
146945424|NCT03345342|529958288|FG002|Double-Blind Phase|Other|3|||
146945425|NCT03345342|529958289|FG003|Double-Blind Phase|Other|0|||
146945426|NCT03345342|529958290|FG004|Double-Blind Phase|Other|0|||
146945427|NCT03345342|529958286|FG000|Follow-Up Phase|Adverse Event|0|||
146945428|NCT03345342|529958287|FG001|Follow-Up Phase|Adverse Event|0|||
146945429|NCT03345342|529958288|FG002|Follow-Up Phase|Adverse Event|0|||
146945430|NCT03345342|529958289|FG003|Follow-Up Phase|Adverse Event|0|||
146945431|NCT03345342|529958290|FG004|Follow-Up Phase|Adverse Event|4|||
146945432|NCT03345342|529958286|FG000|Follow-Up Phase|Lost to Follow-up|0|||
146945433|NCT03345342|529958287|FG001|Follow-Up Phase|Lost to Follow-up|0|||
146945434|NCT03345342|529958288|FG002|Follow-Up Phase|Lost to Follow-up|0|||
146945435|NCT03345342|529958289|FG003|Follow-Up Phase|Lost to Follow-up|0|||
146945436|NCT03345342|529958290|FG004|Follow-Up Phase|Lost to Follow-up|6|||
146945437|NCT03345342|529958286|FG000|Follow-Up Phase|Physician Decision|0|||
146945438|NCT03345342|529958287|FG001|Follow-Up Phase|Physician Decision|0|||
146945439|NCT03345342|529958288|FG002|Follow-Up Phase|Physician Decision|0|||
146945440|NCT03345342|529958289|FG003|Follow-Up Phase|Physician Decision|0|||
146945441|NCT03345342|529958290|FG004|Follow-Up Phase|Physician Decision|5|||
146945442|NCT03345342|529958286|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
146945443|NCT03345342|529958287|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
146945444|NCT03345342|529958288|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
146945445|NCT03345342|529958289|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
146945446|NCT03345342|529958290|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
146945447|NCT03345342|529958286|FG000|Follow-Up Phase|Other|0|||
146945448|NCT03345342|529958287|FG001|Follow-Up Phase|Other|0|||
146945449|NCT03345342|529958288|FG002|Follow-Up Phase|Other|0|||
146945450|NCT03345342|529958289|FG003|Follow-Up Phase|Other|3|||
146945451|NCT03345342|529958290|FG004|Follow-Up Phase|Other|1|||
146945452|NCT03277105|529958291|FG000|Overall Study|Death|129|||
146945453|NCT03277105|529958292|FG001|Overall Study|Death|124|||
146945454|NCT03277105|529958291|FG000|Overall Study|Lost to Follow-up|2|||
146945455|NCT03277105|529958292|FG001|Overall Study|Lost to Follow-up|4|||
146945456|NCT03277105|529958291|FG000|Overall Study|Withdrawal by Subject|10|||
146945457|NCT03277105|529958292|FG001|Overall Study|Withdrawal by Subject|10|||
146945458|NCT03277105|529958291|FG000|Overall Study|Other|118|||
146945459|NCT03277105|529958292|FG001|Overall Study|Other|125|||
146945460|NCT03321526|529958293|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
146945461|NCT03321526|529958294|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
146945462|NCT03321526|529958293|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
146945463|NCT03321526|529958294|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
146945464|NCT03321526|529958293|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
146945465|NCT03321526|529958294|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
146945466|NCT03321526|529958293|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
146945467|NCT03321526|529958294|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
146945468|NCT03321526|529958293|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
146945469|NCT03321526|529958294|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
146945470|NCT03321526|529958293|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
146945471|NCT03321526|529958294|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
146945472|NCT03321526|529958293|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
146945473|NCT03321526|529958294|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
146945474|NCT03321526|529958293|FG000|Follow-up Phase (2 Weeks)|Other|24|||
146945475|NCT03321526|529958294|FG001|Follow-up Phase (2 Weeks)|Other|24|||
146945476|NCT01989572|529958295|FG000|Overall Study|Lack of Efficacy|35|||
146945477|NCT01989572|529958296|FG001|Overall Study|Lack of Efficacy|48|||
146945478|NCT01989572|529958297|FG002|Overall Study|Lack of Efficacy|48|||
146984604|NCT00358826|530105103|FG000|Core Study|Physician Decision|0|||
146984605|NCT00358826|530105104|FG001|Core Study|Physician Decision|0|||
146984606|NCT00358826|530105105|FG002|Core Study|Physician Decision|1|||
146945479|NCT01989572|529958298|FG003|Overall Study|Lack of Efficacy|43|||
146945480|NCT01989572|529958299|FG004|Overall Study|Lack of Efficacy|71|||
146945481|NCT01989572|529958300|FG005|Overall Study|Lack of Efficacy|79|||
146945482|NCT01989572|529958295|FG000|Overall Study|Adverse Event|2|||
146945483|NCT01989572|529958296|FG001|Overall Study|Adverse Event|1|||
146945484|NCT01989572|529958297|FG002|Overall Study|Adverse Event|3|||
146945485|NCT01989572|529958298|FG003|Overall Study|Adverse Event|0|||
146945486|NCT01989572|529958299|FG004|Overall Study|Adverse Event|3|||
146945487|NCT01989572|529958300|FG005|Overall Study|Adverse Event|0|||
146945488|NCT01989572|529958295|FG000|Overall Study|Death|0|||
146945489|NCT01989572|529958296|FG001|Overall Study|Death|0|||
146984607|NCT00358826|530105106|FG003|Core Study|Physician Decision|0|||
146945490|NCT01989572|529958297|FG002|Overall Study|Death|0|||
146945491|NCT01989572|529958298|FG003|Overall Study|Death|0|||
146945492|NCT01989572|529958299|FG004|Overall Study|Death|1|||
146945493|NCT01989572|529958300|FG005|Overall Study|Death|0|||
146945494|NCT01989572|529958295|FG000|Overall Study|Withdrawal by Subject|4|||
146945495|NCT01989572|529958296|FG001|Overall Study|Withdrawal by Subject|1|||
146945496|NCT01989572|529958297|FG002|Overall Study|Withdrawal by Subject|5|||
146945497|NCT01989572|529958298|FG003|Overall Study|Withdrawal by Subject|1|||
146945498|NCT01989572|529958299|FG004|Overall Study|Withdrawal by Subject|12|||
146945499|NCT01989572|529958300|FG005|Overall Study|Withdrawal by Subject|4|||
146945500|NCT01989572|529958295|FG000|Overall Study|complicating disease|1|||
146945501|NCT01989572|529958296|FG001|Overall Study|complicating disease|1|||
146945502|NCT01989572|529958297|FG002|Overall Study|complicating disease|2|||
146945503|NCT01989572|529958298|FG003|Overall Study|complicating disease|0|||
146945504|NCT01989572|529958299|FG004|Overall Study|complicating disease|1|||
146945505|NCT01989572|529958300|FG005|Overall Study|complicating disease|0|||
146945506|NCT01989572|529958295|FG000|Overall Study|error|2|||
146945507|NCT01989572|529958296|FG001|Overall Study|error|1|||
146945508|NCT01989572|529958297|FG002|Overall Study|error|1|||
146945509|NCT01989572|529958298|FG003|Overall Study|error|1|||
146945510|NCT01989572|529958299|FG004|Overall Study|error|1|||
146945511|NCT01989572|529958300|FG005|Overall Study|error|1|||
146945512|NCT01989572|529958295|FG000|Overall Study|maximum dose reached|0|||
146945513|NCT01989572|529958296|FG001|Overall Study|maximum dose reached|1|||
146945514|NCT01989572|529958297|FG002|Overall Study|maximum dose reached|0|||
146945515|NCT01989572|529958298|FG003|Overall Study|maximum dose reached|0|||
146945516|NCT01989572|529958299|FG004|Overall Study|maximum dose reached|1|||
146945517|NCT01989572|529958300|FG005|Overall Study|maximum dose reached|0|||
146945518|NCT01989572|529958295|FG000|Overall Study|unknown/not specify|3|||
146945519|NCT01989572|529958296|FG001|Overall Study|unknown/not specify|4|||
146945520|NCT01989572|529958297|FG002|Overall Study|unknown/not specify|1|||
146945521|NCT01989572|529958298|FG003|Overall Study|unknown/not specify|3|||
146945522|NCT01989572|529958299|FG004|Overall Study|unknown/not specify|3|||
146945523|NCT01989572|529958300|FG005|Overall Study|unknown/not specify|5|||
146945524|NCT01989572|529958295|FG000|Overall Study|not start protocol therapy|5|||
146945525|NCT01989572|529958296|FG001|Overall Study|not start protocol therapy|1|||
146945526|NCT01989572|529958297|FG002|Overall Study|not start protocol therapy|2|||
146945527|NCT01989572|529958298|FG003|Overall Study|not start protocol therapy|3|||
146945528|NCT01989572|529958299|FG004|Overall Study|not start protocol therapy|4|||
146945529|NCT01989572|529958300|FG005|Overall Study|not start protocol therapy|18|||
146945530|NCT01989572|529958295|FG000|Overall Study|alternative therapy|3|||
146945531|NCT01989572|529958296|FG001|Overall Study|alternative therapy|0|||
146945532|NCT01989572|529958297|FG002|Overall Study|alternative therapy|0|||
146945533|NCT01989572|529958298|FG003|Overall Study|alternative therapy|0|||
146945534|NCT01989572|529958299|FG004|Overall Study|alternative therapy|1|||
146945535|NCT01989572|529958300|FG005|Overall Study|alternative therapy|3|||
146945536|NCT02280096|529958301|FG000|Overall Study|Pregnancy|1|||
146945537|NCT02280096|529958302|FG001|Overall Study|Pregnancy|0|||
146945538|NCT02280096|529958301|FG000|Overall Study|Functional neurological disorder|1|||
146945539|NCT02280096|529958302|FG001|Overall Study|Functional neurological disorder|0|||
146945540|NCT02280096|529958301|FG000|Overall Study|Lack of attachment|0|||
146945541|NCT02280096|529958302|FG001|Overall Study|Lack of attachment|1|||
146945542|NCT00285649|529958305|FG000|Overall Study|Lost to Follow-up|6|||
146945543|NCT00285649|529958306|FG001|Overall Study|Lost to Follow-up|4|||
146945544|NCT00285649|529958307|FG002|Overall Study|Lost to Follow-up|4|||
146945545|NCT00285649|529958305|FG000|Overall Study|Withdrawal by Subject|3|||
146945546|NCT00285649|529958306|FG001|Overall Study|Withdrawal by Subject|2|||
146945547|NCT00285649|529958307|FG002|Overall Study|Withdrawal by Subject|2|||
146945548|NCT02465489|529958308|FG000|Overall Study|Adverse Event|5|||
146945549|NCT02972593|529958309|FG000|Overall Study|Lost to Follow-up|19|||
146945550|NCT02972593|529958310|FG001|Overall Study|Lost to Follow-up|15|||
146945551|NCT02972593|529958309|FG000|Overall Study|Protocol Violation|1|||
146945552|NCT02972593|529958310|FG001|Overall Study|Protocol Violation|0|||
146945553|NCT00693693|529958311|FG000|Overall Study|Lost to Follow-up|1|||
146945554|NCT00693693|529958312|FG001|Overall Study|Lost to Follow-up|1|||
146945555|NCT00693693|529958313|FG002|Overall Study|Lost to Follow-up|2|||
146945556|NCT02203916|529958316|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
146945557|NCT02203916|529958317|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
146945558|NCT02203916|529958318|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
146945559|NCT02203916|529958316|FG000|Overall Study|Major Protocol Deviation|1|||
146945560|NCT02203916|529958317|FG001|Overall Study|Major Protocol Deviation|1|||
146945561|NCT02203916|529958318|FG002|Overall Study|Major Protocol Deviation|0|||
146945562|NCT02203916|529958316|FG000|Overall Study|Lost to Follow-up|0|||
146945563|NCT02203916|529958317|FG001|Overall Study|Lost to Follow-up|1|||
146945564|NCT02203916|529958318|FG002|Overall Study|Lost to Follow-up|0|||
146945565|NCT02203916|529958316|FG000|Overall Study|Voluntary Withdrawal|3|||
146945566|NCT02203916|529958317|FG001|Overall Study|Voluntary Withdrawal|3|||
146945567|NCT02203916|529958318|FG002|Overall Study|Voluntary Withdrawal|8|||
146945568|NCT02203916|529958316|FG000|Overall Study|Lack of Efficacy|3|||
146945569|NCT02203916|529958317|FG001|Overall Study|Lack of Efficacy|0|||
146945570|NCT02203916|529958318|FG002|Overall Study|Lack of Efficacy|0|||
146945571|NCT02203916|529958316|FG000|Overall Study|Reason Not Specified|0|||
146945572|NCT02203916|529958317|FG001|Overall Study|Reason Not Specified|2|||
146945573|NCT02203916|529958318|FG002|Overall Study|Reason Not Specified|1|||
146945574|NCT01448707|529958326|FG000|Overall Study|Adverse Event|3|||
146945575|NCT01448707|529958327|FG001|Overall Study|Adverse Event|1|||
146945576|NCT01448707|529958326|FG000|Overall Study|Lost to Follow-up|2|||
146945577|NCT01448707|529958327|FG001|Overall Study|Lost to Follow-up|6|||
146945578|NCT01448707|529958326|FG000|Overall Study|Withdrawal by Subject|6|||
146945579|NCT01448707|529958327|FG001|Overall Study|Withdrawal by Subject|7|||
146945580|NCT01448707|529958326|FG000|Overall Study|Other|7|||
146945581|NCT01448707|529958327|FG001|Overall Study|Other|4|||
146945582|NCT02033850|529958332|FG000|Overall Study|Death|1|||
146945583|NCT02033850|529958333|FG001|Overall Study|Death|0|||
146945584|NCT02033850|529958332|FG000|Overall Study|unrelated medical reason|1|||
146945585|NCT02033850|529958333|FG001|Overall Study|unrelated medical reason|1|||
146945586|NCT02820038|529958334|FG000|Overall Study|Lost to Follow-up|7|||
146945587|NCT02820038|529958335|FG001|Overall Study|Lost to Follow-up|11|||
146945588|NCT02820038|529958336|FG002|Overall Study|Lost to Follow-up|2|||
146945589|NCT02820038|529958337|FG003|Overall Study|Lost to Follow-up|9|||
146945590|NCT02820038|529958334|FG000|Overall Study|Withdrawal by Subject|3|||
146945591|NCT02820038|529958335|FG001|Overall Study|Withdrawal by Subject|14|||
146945592|NCT02820038|529958336|FG002|Overall Study|Withdrawal by Subject|3|||
146945593|NCT02820038|529958337|FG003|Overall Study|Withdrawal by Subject|13|||
146945594|NCT03215667|529958338|FG000|Overall Study|Physician Decision|4|||
146945595|NCT03934203|529958339|FG000|Overall Study|Adverse Event|0|||
146945596|NCT03934203|529958340|FG001|Overall Study|Adverse Event|0|||
146945597|NCT03934203|529958341|FG002|Overall Study|Adverse Event|1|||
146945598|NCT03934203|529958342|FG003|Overall Study|Adverse Event|0|||
146945599|NCT03934203|529958343|FG004|Overall Study|Adverse Event|1|||
146945600|NCT03934203|529958344|FG005|Overall Study|Adverse Event|0|||
146945601|NCT03934203|529958345|FG006|Overall Study|Adverse Event|2|||
146945602|NCT03934203|529958346|FG007|Overall Study|Adverse Event|0|||
146945603|NCT03934203|529958347|FG008|Overall Study|Adverse Event|0|||
146945604|NCT03934203|529958348|FG009|Overall Study|Adverse Event|0|||
146945605|NCT03934203|529958349|FG010|Overall Study|Adverse Event|0|||
146945606|NCT03934203|529958350|FG011|Overall Study|Adverse Event|0|||
146945607|NCT03934203|529958351|FG012|Overall Study|Adverse Event|0|||
146945608|NCT03934203|529958352|FG013|Overall Study|Adverse Event|1|||
146945609|NCT03934203|529958353|FG014|Overall Study|Adverse Event|0|||
146945610|NCT01810380|529958355|FG000|Overall Study|Randomised not treated|2|||
146945611|NCT01810380|529958356|FG001|Overall Study|Randomised not treated|1|||
146945612|NCT01810380|529958357|FG002|Overall Study|Randomised not treated|1|||
146945613|NCT01810380|529958355|FG000|Overall Study|Adverse Event|11|||
146945614|NCT01810380|529958356|FG001|Overall Study|Adverse Event|14|||
146945615|NCT01810380|529958357|FG002|Overall Study|Adverse Event|4|||
146945616|NCT01810380|529958355|FG000|Overall Study|Lack of Efficacy|24|||
146945617|NCT01810380|529958356|FG001|Overall Study|Lack of Efficacy|10|||
146945618|NCT01810380|529958357|FG002|Overall Study|Lack of Efficacy|11|||
146945619|NCT01810380|529958355|FG000|Overall Study|Protocol Violation|1|||
146945620|NCT01810380|529958356|FG001|Overall Study|Protocol Violation|0|||
146945621|NCT01810380|529958357|FG002|Overall Study|Protocol Violation|1|||
146945622|NCT01810380|529958355|FG000|Overall Study|Withdrawal by Subject|6|||
146945623|NCT01810380|529958356|FG001|Overall Study|Withdrawal by Subject|0|||
146945624|NCT01810380|529958357|FG002|Overall Study|Withdrawal by Subject|6|||
146945625|NCT01810380|529958355|FG000|Overall Study|Administrative or other reasons|11|||
146945626|NCT01810380|529958356|FG001|Overall Study|Administrative or other reasons|13|||
146945627|NCT01810380|529958357|FG002|Overall Study|Administrative or other reasons|9|||
146945628|NCT00441480|529958358|FG000|Overall Study|Protocol Violation|1|||
146945629|NCT00441480|529958359|FG001|Overall Study|Protocol Violation|1|||
146945630|NCT00441480|529958358|FG000|Overall Study|Withdrawal by Subject|2|||
146945631|NCT00441480|529958359|FG001|Overall Study|Withdrawal by Subject|3|||
146945632|NCT01390038|529958360|FG000|Overall Study|Death|1|||
146945633|NCT01390038|529958360|FG000|Overall Study|Lost to Follow-up|1|||
146945634|NCT01390038|529958360|FG000|Overall Study|Withdrawal by Subject|4|||
146945635|NCT01390038|529958360|FG000|Overall Study|Simpliciti System Removal|2|||
146945636|NCT01922739|529958361|FG000|Titration/Adjustment Period|Adverse Event|3|||
146945637|NCT01922739|529958361|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
146945638|NCT01922739|529958361|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
146945639|NCT01922739|529958361|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
146945640|NCT01922739|529958361|FG000|Open-label Treatment Period|Adverse Event|6|||
146945641|NCT01922739|529958361|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
146945642|NCT01922739|529958361|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
146945643|NCT01922739|529958361|FG000|Open-label Treatment Period|Protocol Violation|5|||
146945644|NCT01922739|529958361|FG000|Open-label Treatment Period|Pregnancy|1|||
146945645|NCT01922739|529958361|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
146945646|NCT01922739|529958361|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
146945647|NCT01922739|529958361|FG000|Open-label Treatment Period|Physician Decision|1|||
146945648|NCT01922739|529958361|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
146815988|NCT04820023|529495740|FG007|Overall Study|Other|2|||
146945649|NCT00422240|529958362|FG000|Overall Study|Lack of Efficacy|1|||
146945650|NCT00422240|529958363|FG001|Overall Study|Lack of Efficacy|2|||
146945651|NCT00422240|529958364|FG002|Overall Study|Lack of Efficacy|0|||
146945652|NCT00422240|529958365|FG003|Overall Study|Lack of Efficacy|1|||
146945653|NCT00422240|529958362|FG000|Overall Study|Adverse Event|11|||
146945654|NCT00422240|529958363|FG001|Overall Study|Adverse Event|4|||
146945655|NCT00422240|529958364|FG002|Overall Study|Adverse Event|5|||
146945656|NCT00422240|529958365|FG003|Overall Study|Adverse Event|2|||
146945657|NCT00422240|529958362|FG000|Overall Study|Subject request|21|||
146945658|NCT00422240|529958363|FG001|Overall Study|Subject request|17|||
146945659|NCT00422240|529958364|FG002|Overall Study|Subject request|18|||
146945660|NCT00422240|529958365|FG003|Overall Study|Subject request|30|||
146945661|NCT00422240|529958362|FG000|Overall Study|Protocol Violation|0|||
146945662|NCT00422240|529958363|FG001|Overall Study|Protocol Violation|1|||
146945663|NCT00422240|529958364|FG002|Overall Study|Protocol Violation|0|||
146945664|NCT00422240|529958365|FG003|Overall Study|Protocol Violation|1|||
146945665|NCT00422240|529958362|FG000|Overall Study|Lost to Follow-up|31|||
146945666|NCT00422240|529958363|FG001|Overall Study|Lost to Follow-up|32|||
146945667|NCT00422240|529958364|FG002|Overall Study|Lost to Follow-up|19|||
146945668|NCT00422240|529958365|FG003|Overall Study|Lost to Follow-up|34|||
146945669|NCT00422240|529958362|FG000|Overall Study|Other|1|||
146945670|NCT00422240|529958363|FG001|Overall Study|Other|0|||
146945671|NCT00422240|529958364|FG002|Overall Study|Other|0|||
146945672|NCT00422240|529958365|FG003|Overall Study|Other|1|||
146945673|NCT00422240|529958362|FG000|Overall Study|Pregnancy|3|||
146945674|NCT00422240|529958363|FG001|Overall Study|Pregnancy|1|||
146945675|NCT00422240|529958364|FG002|Overall Study|Pregnancy|1|||
146945676|NCT00422240|529958365|FG003|Overall Study|Pregnancy|2|||
146945677|NCT01927068|529958366|FG000|Overall Study|Death|37|||
146945678|NCT01927068|529958367|FG001|Overall Study|Death|3|||
146945679|NCT01927068|529958366|FG000|Overall Study|Withdrawal by Subject|50|||
146945680|NCT01927068|529958367|FG001|Overall Study|Withdrawal by Subject|3|||
146945681|NCT01927068|529958366|FG000|Overall Study|Lost to Follow-up|10|||
146945682|NCT01927068|529958367|FG001|Overall Study|Lost to Follow-up|2|||
146945683|NCT01927068|529958366|FG000|Overall Study|Physician Decision|9|||
146945684|NCT01927068|529958367|FG001|Overall Study|Physician Decision|0|||
146945685|NCT01927068|529958366|FG000|Overall Study|Missed last follow-up visit|2|||
146945686|NCT01927068|529958367|FG001|Overall Study|Missed last follow-up visit|0|||
146945687|NCT00441012|529958368|FG000|Overall Study|Adverse Event|0|||
146945688|NCT00441012|529958369|FG001|Overall Study|Adverse Event|1|||
146945689|NCT00441012|529958368|FG000|Overall Study|Lost to Follow-up|3|||
146945690|NCT00441012|529958369|FG001|Overall Study|Lost to Follow-up|3|||
146945691|NCT00441012|529958368|FG000|Overall Study|Protocol Violation|10|||
146945692|NCT00441012|529958369|FG001|Overall Study|Protocol Violation|9|||
146945693|NCT00441012|529958368|FG000|Overall Study|Withdrawal by Subject|4|||
146945694|NCT00441012|529958369|FG001|Overall Study|Withdrawal by Subject|0|||
146945695|NCT00441012|529958368|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
146945696|NCT00441012|529958369|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
146945697|NCT04489940|529958370|FG000|Overall Study|Other|2|||
146945698|NCT04489940|529958370|FG000|Overall Study|Withdrawal by Subject|2|||
146945699|NCT04489940|529958370|FG000|Overall Study|Death|5|||
146945700|NCT04489940|529958370|FG000|Overall Study|Lost to Follow-up|1|||
146945701|NCT02725268|529958371|FG000|Overall Study|Death|58|||
146945702|NCT02725268|529958372|FG001|Overall Study|Death|59|||
146945703|NCT02725268|529958373|FG002|Overall Study|Death|30|||
146945704|NCT02725268|529958374|FG003|Overall Study|Death|16|||
146945705|NCT02725268|529958371|FG000|Overall Study|Lost to Follow-up|4|||
146945706|NCT02725268|529958372|FG001|Overall Study|Lost to Follow-up|3|||
146945707|NCT02725268|529958373|FG002|Overall Study|Lost to Follow-up|0|||
146945708|NCT02725268|529958374|FG003|Overall Study|Lost to Follow-up|1|||
146945709|NCT02725268|529958371|FG000|Overall Study|Site Terminated by Sponsor|0|||
146945710|NCT02725268|529958372|FG001|Overall Study|Site Terminated by Sponsor|1|||
146945711|NCT02725268|529958373|FG002|Overall Study|Site Terminated by Sponsor|0|||
146945712|NCT02725268|529958374|FG003|Overall Study|Site Terminated by Sponsor|0|||
146945713|NCT02725268|529958371|FG000|Overall Study|Withdrawal by Subject|8|||
146945714|NCT02725268|529958372|FG001|Overall Study|Withdrawal by Subject|6|||
146945715|NCT02725268|529958373|FG002|Overall Study|Withdrawal by Subject|8|||
146945716|NCT02725268|529958374|FG003|Overall Study|Withdrawal by Subject|1|||
146945717|NCT02725268|529958371|FG000|Overall Study|Reason not Specified|2|||
146815989|NCT04820023|529495741|FG008|Overall Study|Other|0|||
146815990|NCT01020487|529495742|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
146815991|NCT01020487|529495743|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
146815992|NCT01020487|529495744|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
146815993|NCT01020487|529495742|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
146945718|NCT02725268|529958372|FG001|Overall Study|Reason not Specified|1|||
146945719|NCT02725268|529958373|FG002|Overall Study|Reason not Specified|0|||
146945720|NCT02725268|529958374|FG003|Overall Study|Reason not Specified|0|||
146945721|NCT01624467|529958375|FG000|Overall Study|Withdrawal by Subject|2|||
146945722|NCT01624467|529958375|FG000|Overall Study|Lost to Follow-up|1|||
146945723|NCT01624467|529958375|FG000|Overall Study|Adverse Event|7|||
146945724|NCT01624467|529958375|FG000|Overall Study|Progressive Disease|19|||
146945725|NCT01624467|529958375|FG000|Overall Study|Per Sponsor Requirement|1|||
146945726|NCT01624467|529958375|FG000|Overall Study|Subject Withdrew from Treatment|1|||
146945727|NCT04498468|529958376|FG000|Overall Study|Lost to Follow-up|3|||
146945728|NCT00262314|529958382|FG000|Overall Study|Changing physicians|38|||
146945729|NCT00262314|529958382|FG000|Overall Study|Death|12|||
146945730|NCT00262314|529958382|FG000|Overall Study|Patient's decision|92|||
146945731|NCT00262314|529958382|FG000|Overall Study|Other|95|||
146945732|NCT00262314|529958382|FG000|Overall Study|Lost to Follow-up|70|||
146945733|NCT00262314|529958382|FG000|Overall Study|Administrative withdrawal|30|||
146945734|NCT05104749|529958383|FG000|Overall Study|Lost to Follow-up|2|||
146945735|NCT05104749|529958384|FG001|Overall Study|Lost to Follow-up|3|||
146945736|NCT03964493|529958385|FG000|Overall Study|Withdrawal by Subject|4|||
146945737|NCT03964493|529958386|FG001|Overall Study|Withdrawal by Subject|1|||
146945738|NCT03964493|529958385|FG000|Overall Study|Lost to Follow-up|13|||
146945739|NCT03964493|529958386|FG001|Overall Study|Lost to Follow-up|4|||
146945740|NCT02963766|529958387|FG000|Double-Blind Period|Adverse Event|1|||
146945741|NCT02963766|529958388|FG001|Double-Blind Period|Adverse Event|0|||
146945742|NCT02963766|529958389|FG002|Double-Blind Period|Adverse Event|1|||
146945743|NCT02963766|529958387|FG000|Double-Blind Period|Physician Decision|1|||
146945744|NCT02963766|529958388|FG001|Double-Blind Period|Physician Decision|0|||
146945745|NCT02963766|529958389|FG002|Double-Blind Period|Physician Decision|0|||
146945746|NCT02963766|529958387|FG000|Double-Blind Period|Withdrawal by Subject|1|||
146945747|NCT02963766|529958388|FG001|Double-Blind Period|Withdrawal by Subject|1|||
146945748|NCT02963766|529958389|FG002|Double-Blind Period|Withdrawal by Subject|0|||
146945749|NCT02963766|529958387|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
146945750|NCT02963766|529958388|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
146945751|NCT02963766|529958389|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
146945752|NCT02963766|529958387|FG000|Double-Blind Period|Protocol Violation|1|||
146945753|NCT02963766|529958388|FG001|Double-Blind Period|Protocol Violation|0|||
146945754|NCT02963766|529958389|FG002|Double-Blind Period|Protocol Violation|0|||
146945755|NCT02963766|529958387|FG000|Double-Blind Period|Lost to Follow-up|0|||
146945756|NCT02963766|529958388|FG001|Double-Blind Period|Lost to Follow-up|1|||
146945757|NCT02963766|529958389|FG002|Double-Blind Period|Lost to Follow-up|0|||
146945758|NCT02963766|529958387|FG000|Open Label Extension (OLE)|Physician Decision|1|||
146945759|NCT02963766|529958388|FG001|Open Label Extension (OLE)|Physician Decision|2|||
146945760|NCT02963766|529958389|FG002|Open Label Extension (OLE)|Physician Decision|2|||
146945761|NCT02963766|529958387|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
146945762|NCT02963766|529958388|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
146945763|NCT02963766|529958389|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
146945764|NCT02224274|529958392|FG000|Overall Study|Death|1|||
146945765|NCT02224274|529958393|FG001|Overall Study|Death|0|||
146945766|NCT00499460|529958394|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
146945767|NCT00499460|529958395|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
146945768|NCT00499460|529958394|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
146945769|NCT00499460|529958395|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
146945770|NCT00499460|529958394|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
146945771|NCT00499460|529958395|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
146945772|NCT00887068|529958396|FG000|Overall Study|Withdrawal by Subject|2|||
146945773|NCT00887068|529958397|FG001|Overall Study|Withdrawal by Subject|0|||
146945774|NCT00887068|529958396|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
146945775|NCT00887068|529958397|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
146945776|NCT00901394|529958398|FG000|Overall Study|Physician Decision|1|||
146815994|NCT01020487|529495743|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
146815995|NCT01020487|529495744|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
146815996|NCT01020487|529495742|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
146815997|NCT01020487|529495743|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
146945777|NCT00901394|529958399|FG001|Overall Study|Physician Decision|1|||
146945778|NCT00901394|529958400|FG002|Overall Study|Physician Decision|2|||
146945779|NCT02290340|529958401|FG000|Overall Study|Lost to Follow-up|0|||
146945780|NCT02290340|529958402|FG001|Overall Study|Lost to Follow-up|0|||
146945781|NCT02290340|529958403|FG002|Overall Study|Lost to Follow-up|0|||
146945782|NCT02290340|529958404|FG003|Overall Study|Lost to Follow-up|1|||
146945783|NCT02290340|529958401|FG000|Overall Study|Withdrawal by Subject|1|||
146945784|NCT02290340|529958402|FG001|Overall Study|Withdrawal by Subject|0|||
146945785|NCT02290340|529958403|FG002|Overall Study|Withdrawal by Subject|0|||
146945786|NCT02290340|529958404|FG003|Overall Study|Withdrawal by Subject|0|||
146945787|NCT02290340|529958401|FG000|Overall Study|Other|1|||
146945788|NCT02290340|529958402|FG001|Overall Study|Other|0|||
146945789|NCT02290340|529958403|FG002|Overall Study|Other|0|||
146945790|NCT02290340|529958404|FG003|Overall Study|Other|1|||
146945791|NCT03209362|529958405|FG000|Overall Study|Adverse Event|0|||
146945792|NCT03209362|529958406|FG001|Overall Study|Adverse Event|1|||
146945793|NCT03209362|529958405|FG000|Overall Study|Lost to Follow-up|0|||
146945794|NCT03209362|529958406|FG001|Overall Study|Lost to Follow-up|1|||
146945795|NCT03209362|529958405|FG000|Overall Study|Withdrawal by Subject|2|||
146945796|NCT03209362|529958406|FG001|Overall Study|Withdrawal by Subject|0|||
146945797|NCT03209362|529958405|FG000|Overall Study|Other|0|||
146945798|NCT03209362|529958406|FG001|Overall Study|Other|1|||
146945799|NCT01432756|529960566|FG000|Overall Study|Lost to Follow-up|1|||
146945800|NCT01432756|529960567|FG001|Overall Study|Lost to Follow-up|0|||
146945801|NCT01432756|529960568|FG002|Overall Study|Lost to Follow-up|2|||
146945802|NCT01432756|529960569|FG003|Overall Study|Lost to Follow-up|1|||
146815998|NCT01020487|529495744|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
146815999|NCT01020487|529495742|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
146816000|NCT01020487|529495743|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
146816001|NCT01020487|529495744|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
146816002|NCT01020487|529495742|FG000|Part 2 Open-label Period|Adverse Event|0|||
146984608|NCT00358826|530105107|FG004|Core Study|Physician Decision|0|||
146816003|NCT01020487|529495743|FG001|Part 2 Open-label Period|Adverse Event|4|||
146816004|NCT01020487|529495744|FG002|Part 2 Open-label Period|Adverse Event|1|||
146816005|NCT04049578|529495745|FG000|Overall Study|Physician Decision|1|||
146816006|NCT02400749|529495746|FG000|Week 0 -16|Withdrawal by Subject|5|||
146816007|NCT02400749|529495747|FG001|Week 0 -16|Withdrawal by Subject|5|||
146816008|NCT02400749|529495746|FG000|Week 0 -16|Adverse Event|3|||
146816009|NCT02400749|529495747|FG001|Week 0 -16|Adverse Event|1|||
146816010|NCT02400749|529495746|FG000|Week 0 -16|Lost to Follow-up|2|||
146816011|NCT02400749|529495747|FG001|Week 0 -16|Lost to Follow-up|0|||
146816012|NCT02400749|529495746|FG000|Week 0 -16|Protocol Violation|1|||
146816013|NCT02400749|529495747|FG001|Week 0 -16|Protocol Violation|0|||
146816014|NCT02400749|529495746|FG000|Week 17 - 32|Withdrawal by Subject|3|||
146816015|NCT02400749|529495747|FG001|Week 17 - 32|Withdrawal by Subject|2|||
146816016|NCT02400749|529495746|FG000|Week 17 - 32|Adverse Event|2|||
146816017|NCT02400749|529495747|FG001|Week 17 - 32|Adverse Event|1|||
146816018|NCT01945593|529495750|FG000|Overall Study|Adverse Event|0|||
146816019|NCT01945593|529495751|FG001|Overall Study|Adverse Event|0|||
146816020|NCT01945593|529495752|FG002|Overall Study|Adverse Event|0|||
146816021|NCT01945593|529495753|FG003|Overall Study|Adverse Event|5|||
146816022|NCT01945593|529495750|FG000|Overall Study|Physician Decision|0|||
146816023|NCT01945593|529495751|FG001|Overall Study|Physician Decision|0|||
146816024|NCT01945593|529495752|FG002|Overall Study|Physician Decision|1|||
146816025|NCT01945593|529495753|FG003|Overall Study|Physician Decision|1|||
146816026|NCT01945593|529495750|FG000|Overall Study|Withdrawal by Subject|0|||
146816027|NCT01945593|529495751|FG001|Overall Study|Withdrawal by Subject|2|||
146816028|NCT01945593|529495752|FG002|Overall Study|Withdrawal by Subject|0|||
146816029|NCT01945593|529495753|FG003|Overall Study|Withdrawal by Subject|4|||
146816030|NCT01945593|529495750|FG000|Overall Study|Protocol Violation|0|||
146816031|NCT01945593|529495751|FG001|Overall Study|Protocol Violation|2|||
146816032|NCT01945593|529495752|FG002|Overall Study|Protocol Violation|1|||
146816033|NCT01945593|529495753|FG003|Overall Study|Protocol Violation|3|||
146816034|NCT01945593|529495750|FG000|Overall Study|Death|0|||
146816035|NCT01945593|529495751|FG001|Overall Study|Death|0|||
146816036|NCT01945593|529495752|FG002|Overall Study|Death|1|||
146816037|NCT01945593|529495753|FG003|Overall Study|Death|0|||
146816038|NCT01945593|529495750|FG000|Overall Study|Other: Terminated|0|||
146816039|NCT01945593|529495751|FG001|Overall Study|Other: Terminated|0|||
146816040|NCT01945593|529495752|FG002|Overall Study|Other: Terminated|0|||
146816041|NCT01945593|529495753|FG003|Overall Study|Other: Terminated|1|||
146816042|NCT01945593|529495750|FG000|Overall Study|Other: Surgical Procedure|0|||
146816043|NCT01945593|529495751|FG001|Overall Study|Other: Surgical Procedure|2|||
146816044|NCT01945593|529495752|FG002|Overall Study|Other: Surgical Procedure|0|||
146816045|NCT01945593|529495753|FG003|Overall Study|Other: Surgical Procedure|6|||
146816046|NCT01945593|529495750|FG000|Overall Study|Other: Screen Failure|0|||
146816047|NCT01945593|529495751|FG001|Overall Study|Other: Screen Failure|2|||
146816048|NCT01945593|529495752|FG002|Overall Study|Other: Screen Failure|0|||
146816049|NCT01945593|529495753|FG003|Overall Study|Other: Screen Failure|0|||
146816050|NCT00228813|529495754|FG000|Overall Study|Death|4|||
146816051|NCT00507429|529495755|FG000|Treatment Phase|Disease Progression|12|||
146816052|NCT00507429|529495756|FG001|Treatment Phase|Disease Progression|5|||
146816053|NCT00507429|529495755|FG000|Treatment Phase|Adverse Event|12|||
146816054|NCT00507429|529495756|FG001|Treatment Phase|Adverse Event|5|||
146816055|NCT00507429|529495755|FG000|Treatment Phase|Withdrawal by Subject|3|||
146816056|NCT00507429|529495756|FG001|Treatment Phase|Withdrawal by Subject|3|||
146816057|NCT00507429|529495755|FG000|Treatment Phase|Physician Decision|4|||
146816058|NCT00507429|529495756|FG001|Treatment Phase|Physician Decision|2|||
146816059|NCT00507429|529495755|FG000|Treatment Phase|Other|6|||
146816060|NCT00507429|529495756|FG001|Treatment Phase|Other|3|||
146816061|NCT00507429|529495755|FG000|Maintenance Phase|Progressive Disease|14|||
146816062|NCT00507429|529495756|FG001|Maintenance Phase|Progressive Disease|0|||
146816063|NCT03884478|529495763|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
146816064|NCT03884478|529495764|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
146816065|NCT03884478|529495765|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
146816066|NCT03884478|529495763|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
146816067|NCT03884478|529495764|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
146816068|NCT03884478|529495765|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
146816069|NCT03884478|529495763|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
146816070|NCT03884478|529495764|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
146816071|NCT03884478|529495765|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
146816072|NCT03884478|529495763|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
146816073|NCT03884478|529495764|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
146816074|NCT03884478|529495765|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
146816075|NCT02213094|529495766|FG000|Overall Study|Adverse Event|1|||
146816076|NCT02213094|529495767|FG001|Overall Study|Adverse Event|0|||
146816077|NCT01807234|529495768|FG000|Overall Study|Lost to Follow-up|2|||
146816078|NCT01807234|529495769|FG001|Overall Study|Lost to Follow-up|5|||
146816079|NCT01807234|529495770|FG002|Overall Study|Lost to Follow-up|1|||
146816080|NCT01807234|529495771|FG003|Overall Study|Lost to Follow-up|1|||
146816081|NCT01807234|529495772|FG004|Overall Study|Lost to Follow-up|1|||
146816082|NCT01807234|529495773|FG005|Overall Study|Lost to Follow-up|2|||
146816083|NCT01807234|529495768|FG000|Overall Study|Withdrawal by Subject|3|||
146816084|NCT01807234|529495769|FG001|Overall Study|Withdrawal by Subject|1|||
146816085|NCT01807234|529495770|FG002|Overall Study|Withdrawal by Subject|1|||
146816086|NCT01807234|529495771|FG003|Overall Study|Withdrawal by Subject|1|||
146816087|NCT01807234|529495772|FG004|Overall Study|Withdrawal by Subject|2|||
146816088|NCT01807234|529495773|FG005|Overall Study|Withdrawal by Subject|1|||
146816089|NCT01807234|529495768|FG000|Overall Study|Lack of Efficacy|0|||
146816090|NCT01807234|529495769|FG001|Overall Study|Lack of Efficacy|0|||
146816091|NCT01807234|529495770|FG002|Overall Study|Lack of Efficacy|0|||
146816092|NCT01807234|529495771|FG003|Overall Study|Lack of Efficacy|0|||
146816093|NCT01807234|529495772|FG004|Overall Study|Lack of Efficacy|1|||
146816094|NCT01807234|529495773|FG005|Overall Study|Lack of Efficacy|1|||
146816095|NCT01074229|529495774|FG000|Overall Study|Lost to Follow-up|1|||
146816096|NCT01074229|529495775|FG001|Overall Study|Lost to Follow-up|0|||
146816097|NCT01074229|529495776|FG002|Overall Study|Lost to Follow-up|0|||
146816098|NCT01074229|529495774|FG000|Overall Study|Change to open surgical procedure|1|||
146816099|NCT01074229|529495775|FG001|Overall Study|Change to open surgical procedure|3|||
146816100|NCT01074229|529495776|FG002|Overall Study|Change to open surgical procedure|4|||
146816101|NCT02163499|529495777|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
146816102|NCT02163499|529495777|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
146816103|NCT02163499|529495777|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
146816104|NCT02163499|529495777|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
146816105|NCT02163499|529495777|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
146816106|NCT02163499|529495777|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
146816107|NCT02163499|529495777|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
146816108|NCT02163499|529495777|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
146816109|NCT02163499|529495777|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
146816110|NCT02163499|529495777|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
146816111|NCT02163499|529495777|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
146816112|NCT02163499|529495777|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
146816113|NCT02163499|529495777|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
146816114|NCT02163499|529495777|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
146816115|NCT02163499|529495777|FG000|Extended Dosing Phase: ZS|Death|8|||
146816116|NCT02163499|529495777|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
146816117|NCT02163499|529495777|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
146816118|NCT02163499|529495777|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
146816119|NCT01540474|529495778|FG000|Vaccination Period|Lost to Follow-up|0|||
146816120|NCT01540474|529495779|FG001|Vaccination Period|Lost to Follow-up|1|||
146816121|NCT01540474|529495780|FG002|Vaccination Period|Lost to Follow-up|0|||
146816122|NCT01540474|529495781|FG003|Vaccination Period|Lost to Follow-up|0|||
146816123|NCT00857311|529495782|FG000|Overall Study|Lost to Follow-up|1|||
146816124|NCT00857311|529495783|FG001|Overall Study|Lost to Follow-up|0|||
146816125|NCT00857311|529495784|FG002|Overall Study|Lost to Follow-up|0|||
146816126|NCT00857311|529495785|FG003|Overall Study|Lost to Follow-up|0|||
146816127|NCT01587703|529495786|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
146816128|NCT01587703|529495787|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146816129|NCT01587703|529495788|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146816130|NCT01587703|529495789|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146816131|NCT01587703|529495790|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146816132|NCT01587703|529495791|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146816133|NCT01587703|529495792|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146816134|NCT01587703|529495793|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146816135|NCT01587703|529495794|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146816136|NCT01587703|529495795|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146816137|NCT01587703|529495796|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146816138|NCT01587703|529495797|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146816139|NCT01587703|529495798|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146816140|NCT01587703|529495799|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146816141|NCT01587703|529495800|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146945803|NCT00777257|529960577|FG000|Overall Study|Adverse Event|3|||
146816142|NCT01587703|529495801|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146945804|NCT00777257|529960578|FG001|Overall Study|Adverse Event|1|||
146945805|NCT00777257|529960579|FG002|Overall Study|Adverse Event|0|||
146945806|NCT00777257|529960577|FG000|Overall Study|Lost to Follow-up|3|||
146945807|NCT00777257|529960578|FG001|Overall Study|Lost to Follow-up|3|||
146945808|NCT00777257|529960579|FG002|Overall Study|Lost to Follow-up|2|||
146945809|NCT00777257|529960577|FG000|Overall Study|Protocol Violation|2|||
146945810|NCT00777257|529960578|FG001|Overall Study|Protocol Violation|2|||
146945811|NCT00777257|529960579|FG002|Overall Study|Protocol Violation|2|||
146945812|NCT00777257|529960577|FG000|Overall Study|Withdrawal by Subject|3|||
146945813|NCT00777257|529960578|FG001|Overall Study|Withdrawal by Subject|6|||
146945814|NCT00777257|529960579|FG002|Overall Study|Withdrawal by Subject|5|||
146945815|NCT02973997|529960584|FG000|Overall Study|Withdrawal by Subject|4|||
146945816|NCT02973997|529960585|FG001|Overall Study|Withdrawal by Subject|0|||
146945817|NCT02973997|529960584|FG000|Overall Study|Adverse Event|4|||
146945818|NCT02973997|529960585|FG001|Overall Study|Adverse Event|1|||
146945819|NCT02973997|529960584|FG000|Overall Study|Disease Progression|11|||
146945820|NCT02973997|529960585|FG001|Overall Study|Disease Progression|20|||
146945821|NCT02973997|529960584|FG000|Overall Study|Alternative Therapy|3|||
146945822|NCT02973997|529960585|FG001|Overall Study|Alternative Therapy|0|||
146945823|NCT02973997|529960584|FG000|Overall Study|Other complicating disease|0|||
146945824|NCT02973997|529960585|FG001|Overall Study|Other complicating disease|1|||
146945825|NCT02973997|529960584|FG000|Overall Study|Death|0|||
146945826|NCT02973997|529960585|FG001|Overall Study|Death|1|||
146945827|NCT01431521|529960586|FG000|Overall Study|Withdrawal by Subject|0|||
146945828|NCT01431521|529960587|FG001|Overall Study|Withdrawal by Subject|0|||
146945829|NCT01431521|529960588|FG002|Overall Study|Withdrawal by Subject|1|||
146945830|NCT01431521|529960589|FG003|Overall Study|Withdrawal by Subject|0|||
146945831|NCT00444951|529960590|FG000|Overall Study|Lost to Follow-up|1|||
146945832|NCT00444951|529960591|FG001|Overall Study|Lost to Follow-up|1|||
146945833|NCT00444951|529960592|FG002|Overall Study|Lost to Follow-up|0|||
146945834|NCT00444951|529960590|FG000|Overall Study|Withdrawal by Subject|4|||
146945835|NCT00444951|529960591|FG001|Overall Study|Withdrawal by Subject|5|||
146945836|NCT00444951|529960592|FG002|Overall Study|Withdrawal by Subject|3|||
146945837|NCT00366444|529960594|FG000|Overall Study|Withdrawal by Subject|1|||
146945838|NCT00366444|529960595|FG001|Overall Study|Withdrawal by Subject|1|||
146945839|NCT00366444|529960594|FG000|Overall Study|Lack of Efficacy|0|||
146945840|NCT00366444|529960595|FG001|Overall Study|Lack of Efficacy|1|||
146945841|NCT02000622|529960596|FG000|Overall Study|Withdrawal by Subject|5|||
146945842|NCT02000622|529960597|FG001|Overall Study|Withdrawal by Subject|7|||
146945843|NCT02000622|529960596|FG000|Overall Study|Lost to Follow-up|4|||
146945844|NCT02000622|529960597|FG001|Overall Study|Lost to Follow-up|0|||
146945845|NCT02000622|529960596|FG000|Overall Study|Death|159|||
146945846|NCT02000622|529960597|FG001|Overall Study|Death|73|||
146945847|NCT02000622|529960596|FG000|Overall Study|Withdrawn due to site closure|1|||
146945848|NCT02000622|529960597|FG001|Overall Study|Withdrawn due to site closure|0|||
146945849|NCT01405027|529960598|FG000|Overall Study|Withdrawn consent|3|||
146816143|NCT01587703|529495802|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146816144|NCT01587703|529495803|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146816145|NCT01587703|529495804|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146816146|NCT01587703|529495786|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146816147|NCT01587703|529495787|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146816148|NCT01587703|529495788|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146816149|NCT01587703|529495789|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146816150|NCT01587703|529495790|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146816151|NCT01587703|529495791|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
146816152|NCT01587703|529495792|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146816153|NCT01587703|529495793|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
146816154|NCT01587703|529495794|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146945850|NCT01405027|529960599|FG001|Overall Study|Withdrawn consent|0|||
146945851|NCT01405027|529960598|FG000|Overall Study|Lost to Follow-up|16|||
146945852|NCT01405027|529960599|FG001|Overall Study|Lost to Follow-up|24|||
146945853|NCT01405027|529960598|FG000|Overall Study|Investigator judgement|0|||
146945854|NCT01405027|529960599|FG001|Overall Study|Investigator judgement|2|||
146945855|NCT01405027|529960598|FG000|Overall Study|Death|1|||
146945856|NCT01405027|529960599|FG001|Overall Study|Death|0|||
146945857|NCT01405027|529960598|FG000|Overall Study|Other or Unknown|12|||
146945858|NCT01405027|529960599|FG001|Overall Study|Other or Unknown|25|||
146945859|NCT06048809|529960612|FG000|Overall Study|Adverse Event|2|||
146945860|NCT06048809|529960613|FG001|Overall Study|Adverse Event|0|||
146945861|NCT06048809|529960612|FG000|Overall Study|Withdrawal by Subject|1|||
146945862|NCT06048809|529960613|FG001|Overall Study|Withdrawal by Subject|1|||
146945863|NCT04960202|529960615|FG000|Overall Study|Other|5|||
146945864|NCT04960202|529960616|FG001|Overall Study|Other|0|||
146984609|NCT00358826|530105108|FG005|Core Study|Physician Decision|0|||
146945865|NCT04960202|529960615|FG000|Overall Study|Withdrawal by Subject|37|||
146945866|NCT04960202|529960616|FG001|Overall Study|Withdrawal by Subject|43|||
146945867|NCT04960202|529960615|FG000|Overall Study|Lost to Follow-up|20|||
146816155|NCT01587703|529495795|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146816156|NCT01587703|529495796|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146816157|NCT01587703|529495797|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146816158|NCT01587703|529495798|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146816159|NCT01587703|529495799|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146816160|NCT01587703|529495800|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146816161|NCT01587703|529495801|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146816162|NCT01587703|529495802|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146816163|NCT01587703|529495803|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146816164|NCT01587703|529495804|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146816165|NCT01587703|529495786|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146816166|NCT01587703|529495787|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146816167|NCT01587703|529495788|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146816168|NCT01587703|529495789|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146816169|NCT01587703|529495790|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146816170|NCT01587703|529495791|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146816171|NCT01587703|529495792|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
146816172|NCT01587703|529495793|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146816173|NCT01587703|529495794|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146816174|NCT01587703|529495795|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146945868|NCT04960202|529960616|FG001|Overall Study|Lost to Follow-up|16|||
146945869|NCT04960202|529960615|FG000|Overall Study|Death|0|||
146945870|NCT04960202|529960616|FG001|Overall Study|Death|15|||
146945871|NCT02158728|529960617|FG000|Overall Study|no procedure according to CIP done|3|||
146945872|NCT02158728|529960617|FG000|Overall Study|no qualified dataset|24|||
146945873|NCT03558828|529960618|FG000|Overall Study|Lost to Follow-up|4|||
146945874|NCT03558828|529960619|FG001|Overall Study|Lost to Follow-up|3|||
146945875|NCT03558828|529960620|FG002|Overall Study|Lost to Follow-up|3|||
146945876|NCT03558828|529960621|FG003|Overall Study|Lost to Follow-up|5|||
146945877|NCT03558828|529960622|FG004|Overall Study|Lost to Follow-up|2|||
146945878|NCT03558828|529960623|FG005|Overall Study|Lost to Follow-up|3|||
146945879|NCT03558828|529960618|FG000|Overall Study|dropped before the intervention|1|||
146945880|NCT03558828|529960619|FG001|Overall Study|dropped before the intervention|1|||
146945881|NCT03558828|529960620|FG002|Overall Study|dropped before the intervention|0|||
146945882|NCT03558828|529960621|FG003|Overall Study|dropped before the intervention|0|||
146945883|NCT03558828|529960622|FG004|Overall Study|dropped before the intervention|0|||
146945884|NCT03558828|529960623|FG005|Overall Study|dropped before the intervention|0|||
146945885|NCT00673816|529960628|FG000|Overall Study|Adverse Event|1|||
146945886|NCT00673816|529960628|FG000|Overall Study|Withdrawal by Subject|1|||
146945887|NCT00589602|529960629|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
146945888|NCT01804842|529960630|FG000|Overall Study|Adverse Event|1|||
146945889|NCT01804842|529960631|FG001|Overall Study|Adverse Event|1|||
146945890|NCT01804842|529960632|FG002|Overall Study|Adverse Event|0|||
146945891|NCT01804842|529960630|FG000|Overall Study|Lost to Follow-up|1|||
146945892|NCT01804842|529960631|FG001|Overall Study|Lost to Follow-up|0|||
146945893|NCT01804842|529960632|FG002|Overall Study|Lost to Follow-up|0|||
146945894|NCT01804842|529960630|FG000|Overall Study|Non-Compliance|1|||
146945895|NCT01804842|529960631|FG001|Overall Study|Non-Compliance|1|||
146945896|NCT01804842|529960632|FG002|Overall Study|Non-Compliance|0|||
146945897|NCT01804842|529960630|FG000|Overall Study|Personal Reason|0|||
146945898|NCT01804842|529960631|FG001|Overall Study|Personal Reason|0|||
146945899|NCT01804842|529960632|FG002|Overall Study|Personal Reason|1|||
146945900|NCT03774875|529960633|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
146945901|NCT03774875|529960634|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
146945902|NCT03774875|529960633|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
146945903|NCT03774875|529960634|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
146945904|NCT03774875|529960633|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
146945905|NCT03774875|529960634|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
146945906|NCT03774875|529960633|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
146945907|NCT03774875|529960634|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
146816175|NCT01587703|529495796|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146816176|NCT01587703|529495797|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146816177|NCT01587703|529495798|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146816178|NCT01587703|529495799|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146945908|NCT03774875|529960633|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
146945909|NCT03774875|529960634|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
146984610|NCT00358826|530105109|FG006|Core Study|Physician Decision|0|||
146945910|NCT03774875|529960633|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
146945911|NCT03774875|529960634|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
146945912|NCT03774875|529960633|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
146945913|NCT03774875|529960634|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
146945914|NCT03774875|529960633|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
146945915|NCT03774875|529960634|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
146945916|NCT03774875|529960633|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
146945917|NCT03774875|529960634|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
146945918|NCT03774875|529960633|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
146945919|NCT03774875|529960634|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
146945920|NCT03774875|529960633|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
146945921|NCT03774875|529960634|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
146945922|NCT03774875|529960633|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
146945923|NCT03774875|529960634|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
146945924|NCT03774875|529960633|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
146945925|NCT03774875|529960634|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
146945926|NCT02352090|529960635|FG000|Overall Study|general malaise|1|||
146945927|NCT02352090|529960636|FG001|Overall Study|general malaise|0|||
146945928|NCT02352090|529960637|FG002|Overall Study|general malaise|0|||
146945929|NCT02352090|529960635|FG000|Overall Study|non-specified mild side-effects|0|||
146945930|NCT02352090|529960636|FG001|Overall Study|non-specified mild side-effects|0|||
146945931|NCT02352090|529960637|FG002|Overall Study|non-specified mild side-effects|2|||
146816179|NCT01587703|529495800|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146816180|NCT01587703|529495801|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146816181|NCT01587703|529495802|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146816182|NCT01587703|529495803|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146816183|NCT01587703|529495804|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146816184|NCT01587703|529495786|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
146816185|NCT01587703|529495787|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
146816186|NCT01587703|529495788|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
146816187|NCT01587703|529495789|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
146816188|NCT01587703|529495790|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
146816189|NCT01587703|529495791|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
146816190|NCT01587703|529495792|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
146816191|NCT01587703|529495793|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
146816192|NCT01587703|529495794|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146816193|NCT01587703|529495795|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146816194|NCT01587703|529495796|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146816195|NCT01587703|529495797|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146816196|NCT01587703|529495798|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146816197|NCT01587703|529495799|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146816198|NCT01587703|529495800|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146816199|NCT01587703|529495801|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146816200|NCT01587703|529495802|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146816201|NCT01587703|529495803|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146816202|NCT01587703|529495804|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146816203|NCT01587703|529495786|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146816204|NCT01587703|529495787|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146816205|NCT01587703|529495788|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146816206|NCT01587703|529495789|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146816207|NCT01587703|529495790|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146816208|NCT01587703|529495791|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146816209|NCT01587703|529495792|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146816210|NCT01587703|529495793|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146816211|NCT01587703|529495794|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
146816212|NCT01587703|529495795|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
146816213|NCT01587703|529495796|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
146816214|NCT01587703|529495797|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146816215|NCT01587703|529495798|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146816216|NCT01587703|529495799|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146816217|NCT01587703|529495800|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146816218|NCT01587703|529495801|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146816219|NCT01587703|529495802|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146816220|NCT01587703|529495803|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146816221|NCT01587703|529495804|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146816222|NCT01587703|529495786|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146984611|NCT00358826|530105110|FG007|Core Study|Physician Decision|0|||
146816223|NCT01587703|529495787|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146816224|NCT01587703|529495788|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146816225|NCT01587703|529495789|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146945932|NCT00796003|529960640|FG000|Overall Study|Disease Progression|2|||
146945933|NCT00796003|529960641|FG001|Overall Study|Disease Progression|13|||
146984612|NCT00358826|530105103|FG000|MDCT Substudy|Adverse Event|0|||
146945934|NCT00796003|529960640|FG000|Overall Study|Adverse Event|1|||
146945935|NCT00796003|529960641|FG001|Overall Study|Adverse Event|7|||
146945936|NCT00796003|529960640|FG000|Overall Study|Specified organ function not met|0|||
146945937|NCT00796003|529960641|FG001|Overall Study|Specified organ function not met|1|||
146945938|NCT00796003|529960640|FG000|Overall Study|Physician Decision|0|||
146945939|NCT00796003|529960641|FG001|Overall Study|Physician Decision|4|||
146945940|NCT00796003|529960640|FG000|Overall Study|Withdrawal by Subject|0|||
146945941|NCT00796003|529960641|FG001|Overall Study|Withdrawal by Subject|1|||
146945942|NCT00796003|529960640|FG000|Overall Study|Other|0|||
146945943|NCT00796003|529960641|FG001|Overall Study|Other|1|||
146945944|NCT00796003|529960640|FG000|Overall Study|Participants Not treated|0|||
146945945|NCT00796003|529960641|FG001|Overall Study|Participants Not treated|2|||
146945946|NCT05179057|529960642|FG000|Overall Study|Adverse Event|3|||
146945947|NCT05179057|529960643|FG001|Overall Study|Adverse Event|2|||
146945948|NCT05179057|529960642|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
146945949|NCT05179057|529960643|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
146945950|NCT05179057|529960642|FG000|Overall Study|Study terminated|13|||
146945951|NCT05179057|529960643|FG001|Overall Study|Study terminated|7|||
146945952|NCT05179057|529960642|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
146945953|NCT05179057|529960643|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
146945954|NCT05179057|529960642|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
146945955|NCT05179057|529960643|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
146945956|NCT04288089|529960649|FG000|Overall Study|Ongoing Treatment|2|||
146945957|NCT04288089|529960650|FG001|Overall Study|Ongoing Treatment|1|||
146945958|NCT04288089|529960651|FG002|Overall Study|Ongoing Treatment|1|||
146945959|NCT04288089|529960652|FG003|Overall Study|Ongoing Treatment|4|||
146945960|NCT03146403|529960657|FG000|Overall Study|Withdrawal by Subject|0|||
146945961|NCT03146403|529960658|FG001|Overall Study|Withdrawal by Subject|3|||
146945962|NCT03146403|529960657|FG000|Overall Study|Lost to Follow-up|2|||
146945963|NCT03146403|529960658|FG001|Overall Study|Lost to Follow-up|0|||
146945964|NCT02182999|529960660|FG000|Overall Study|Adverse Event|4|||
146945965|NCT02182999|529960661|FG001|Overall Study|Adverse Event|3|||
146945966|NCT02182999|529960660|FG000|Overall Study|Physician Decision|1|||
146945967|NCT02182999|529960661|FG001|Overall Study|Physician Decision|0|||
146945968|NCT02252588|529960663|FG000|Overall Study|Withdrawal by Subject|4|||
146945969|NCT02252588|529960664|FG001|Overall Study|Withdrawal by Subject|0|||
146945970|NCT02736929|529960666|FG000|Main Study|Lost to Follow-up|7|||
146945971|NCT02736929|529960667|FG001|Main Study|Lost to Follow-up|1|||
146945972|NCT02736929|529960668|FG002|Main Study|Lost to Follow-up|0|||
146945973|NCT02736929|529960666|FG000|Main Study|Withdrawal by Subject|1|||
146945974|NCT02736929|529960667|FG001|Main Study|Withdrawal by Subject|1|||
146945975|NCT02736929|529960668|FG002|Main Study|Withdrawal by Subject|0|||
146945976|NCT02736929|529960666|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
146945977|NCT02736929|529960667|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
146945978|NCT02736929|529960668|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
146945979|NCT02148952|529960671|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
146945980|NCT02148952|529960672|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
146945981|NCT02148952|529960671|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
146945982|NCT02148952|529960672|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
146945983|NCT02148952|529960671|FG000|Follow-Up|Lost to Follow-up|219|||
146945984|NCT02148952|529960672|FG001|Follow-Up|Lost to Follow-up|231|||
146945985|NCT02148952|529960671|FG000|Follow-Up|Withdrawal by Subject|46|||
146945986|NCT02148952|529960672|FG001|Follow-Up|Withdrawal by Subject|48|||
146945987|NCT04007367|529960673|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
146945988|NCT04007367|529960674|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
146945989|NCT04007367|529960675|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
146945990|NCT04007367|529960673|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
146945991|NCT04007367|529960674|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
146945992|NCT04007367|529960675|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
146945993|NCT04007367|529960673|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
146945994|NCT04007367|529960674|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
146945995|NCT04007367|529960675|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
146945996|NCT04007367|529960673|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
146945997|NCT04007367|529960674|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
146816226|NCT01587703|529495790|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146945998|NCT04007367|529960675|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
146945999|NCT04007367|529960673|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
146946000|NCT04007367|529960674|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
146946001|NCT04007367|529960675|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
146946002|NCT01764022|529960676|FG000|Overall Study|Death|3|||
146946003|NCT01764022|529960677|FG001|Overall Study|Death|5|||
146946004|NCT01764022|529960676|FG000|Overall Study|Withdrawal by Subject|2|||
146946005|NCT01764022|529960677|FG001|Overall Study|Withdrawal by Subject|6|||
146946006|NCT01764022|529960676|FG000|Overall Study|Lack of Efficacy|0|||
146946007|NCT01764022|529960677|FG001|Overall Study|Lack of Efficacy|1|||
146946008|NCT01764022|529960676|FG000|Overall Study|Physician Decision|0|||
146946009|NCT01764022|529960677|FG001|Overall Study|Physician Decision|2|||
146946010|NCT01764022|529960676|FG000|Overall Study|Lost to Follow-up|2|||
146946011|NCT01764022|529960677|FG001|Overall Study|Lost to Follow-up|0|||
146946012|NCT01764022|529960676|FG000|Overall Study|Protocol Violation|1|||
146946013|NCT01764022|529960677|FG001|Overall Study|Protocol Violation|0|||
146946014|NCT00414973|529960678|FG000|Overall Study|Withdrawal by Subject|14|||
146946015|NCT00414973|529960679|FG001|Overall Study|Withdrawal by Subject|4|||
146946016|NCT00414973|529960680|FG002|Overall Study|Withdrawal by Subject|1|||
146946017|NCT00414973|529960681|FG003|Overall Study|Withdrawal by Subject|0|||
146946018|NCT00414973|529960678|FG000|Overall Study|Adverse Event|10|||
146946019|NCT00414973|529960679|FG001|Overall Study|Adverse Event|0|||
146946020|NCT00414973|529960680|FG002|Overall Study|Adverse Event|1|||
146946021|NCT00414973|529960681|FG003|Overall Study|Adverse Event|0|||
146946022|NCT00414973|529960678|FG000|Overall Study|Protocol Violation|3|||
146946023|NCT00414973|529960679|FG001|Overall Study|Protocol Violation|4|||
146946024|NCT00414973|529960680|FG002|Overall Study|Protocol Violation|0|||
146946025|NCT00414973|529960681|FG003|Overall Study|Protocol Violation|0|||
146946026|NCT00414973|529960678|FG000|Overall Study|Lost to Follow-up|0|||
146946027|NCT00414973|529960679|FG001|Overall Study|Lost to Follow-up|2|||
146946028|NCT00414973|529960680|FG002|Overall Study|Lost to Follow-up|0|||
146946029|NCT00414973|529960681|FG003|Overall Study|Lost to Follow-up|0|||
146946030|NCT00414973|529960678|FG000|Overall Study|Sponsor Decision|1|||
146946031|NCT00414973|529960679|FG001|Overall Study|Sponsor Decision|0|||
146946032|NCT00414973|529960680|FG002|Overall Study|Sponsor Decision|0|||
146946033|NCT00414973|529960681|FG003|Overall Study|Sponsor Decision|0|||
146946034|NCT00414973|529960678|FG000|Overall Study|Death|0|||
146946035|NCT00414973|529960679|FG001|Overall Study|Death|0|||
146946036|NCT00414973|529960680|FG002|Overall Study|Death|1|||
146946037|NCT00414973|529960681|FG003|Overall Study|Death|0|||
146946038|NCT01512693|529960693|FG000|Overall Study|Withdrawal by Subject|0|||
146946039|NCT01512693|529960694|FG001|Overall Study|Withdrawal by Subject|1|||
146946040|NCT04731922|529960704|FG000|Overall Study|Adverse Event|0|||
146946041|NCT04731922|529960705|FG001|Overall Study|Adverse Event|0|||
146946042|NCT04731922|529960706|FG002|Overall Study|Adverse Event|0|||
146946043|NCT04731922|529960707|FG003|Overall Study|Adverse Event|0|||
146946044|NCT04731922|529960708|FG004|Overall Study|Adverse Event|0|||
146946045|NCT04731922|529960709|FG005|Overall Study|Adverse Event|0|||
146946046|NCT04731922|529960710|FG006|Overall Study|Adverse Event|0|||
146946047|NCT04731922|529960711|FG007|Overall Study|Adverse Event|0|||
146946048|NCT04731922|529960712|FG008|Overall Study|Adverse Event|0|||
146946049|NCT04731922|529960713|FG009|Overall Study|Adverse Event|0|||
146946050|NCT04731922|529960714|FG010|Overall Study|Adverse Event|1|||
146946051|NCT04731922|529960715|FG011|Overall Study|Adverse Event|0|||
146946052|NCT04731922|529960716|FG012|Overall Study|Adverse Event|0|||
146946053|NCT04731922|529960717|FG013|Overall Study|Adverse Event|0|||
146946054|NCT04731922|529960718|FG014|Overall Study|Adverse Event|0|||
146946055|NCT04731922|529960719|FG015|Overall Study|Adverse Event|0|||
146946056|NCT04731922|529960720|FG016|Overall Study|Adverse Event|0|||
146946057|NCT04731922|529960704|FG000|Overall Study|Lost to Follow-up|0|||
146946058|NCT04731922|529960705|FG001|Overall Study|Lost to Follow-up|0|||
146946059|NCT04731922|529960706|FG002|Overall Study|Lost to Follow-up|0|||
146946060|NCT04731922|529960707|FG003|Overall Study|Lost to Follow-up|1|||
146946061|NCT04731922|529960708|FG004|Overall Study|Lost to Follow-up|0|||
146946062|NCT04731922|529960709|FG005|Overall Study|Lost to Follow-up|1|||
146946063|NCT04731922|529960710|FG006|Overall Study|Lost to Follow-up|0|||
146946064|NCT04731922|529960711|FG007|Overall Study|Lost to Follow-up|0|||
146946065|NCT04731922|529960712|FG008|Overall Study|Lost to Follow-up|0|||
146946066|NCT04731922|529960713|FG009|Overall Study|Lost to Follow-up|0|||
146946067|NCT04731922|529960714|FG010|Overall Study|Lost to Follow-up|0|||
146946068|NCT04731922|529960715|FG011|Overall Study|Lost to Follow-up|0|||
146946069|NCT04731922|529960716|FG012|Overall Study|Lost to Follow-up|0|||
146946070|NCT04731922|529960717|FG013|Overall Study|Lost to Follow-up|0|||
146946071|NCT04731922|529960718|FG014|Overall Study|Lost to Follow-up|0|||
146946072|NCT04731922|529960719|FG015|Overall Study|Lost to Follow-up|0|||
146946073|NCT04731922|529960720|FG016|Overall Study|Lost to Follow-up|0|||
146946074|NCT04731922|529960704|FG000|Overall Study|Withdrawal by Subject|1|||
146946075|NCT04731922|529960705|FG001|Overall Study|Withdrawal by Subject|0|||
146946076|NCT04731922|529960706|FG002|Overall Study|Withdrawal by Subject|0|||
146735770|NCT03145766|529205174|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
146946077|NCT04731922|529960707|FG003|Overall Study|Withdrawal by Subject|0|||
146946078|NCT04731922|529960708|FG004|Overall Study|Withdrawal by Subject|1|||
146946079|NCT04731922|529960709|FG005|Overall Study|Withdrawal by Subject|0|||
146946080|NCT04731922|529960710|FG006|Overall Study|Withdrawal by Subject|1|||
146946081|NCT04731922|529960711|FG007|Overall Study|Withdrawal by Subject|0|||
146946082|NCT04731922|529960712|FG008|Overall Study|Withdrawal by Subject|0|||
146946083|NCT04731922|529960713|FG009|Overall Study|Withdrawal by Subject|0|||
146946084|NCT04731922|529960714|FG010|Overall Study|Withdrawal by Subject|0|||
146946085|NCT04731922|529960715|FG011|Overall Study|Withdrawal by Subject|0|||
146946086|NCT04731922|529960716|FG012|Overall Study|Withdrawal by Subject|0|||
146946087|NCT04731922|529960717|FG013|Overall Study|Withdrawal by Subject|1|||
146946088|NCT04731922|529960718|FG014|Overall Study|Withdrawal by Subject|0|||
146946089|NCT04731922|529960719|FG015|Overall Study|Withdrawal by Subject|0|||
146816227|NCT01587703|529495791|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146816228|NCT01587703|529495792|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146816229|NCT01587703|529495793|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146816230|NCT01587703|529495794|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
146816231|NCT01587703|529495795|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146816232|NCT01587703|529495796|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
146816233|NCT01587703|529495797|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146816234|NCT01587703|529495798|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146816235|NCT01587703|529495799|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146816236|NCT01587703|529495800|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146816237|NCT01587703|529495801|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146816238|NCT01587703|529495802|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146816239|NCT01587703|529495803|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146816240|NCT01587703|529495804|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146816241|NCT01587703|529495786|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816242|NCT01587703|529495787|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816243|NCT01587703|529495788|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816244|NCT01587703|529495789|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816245|NCT01587703|529495790|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816246|NCT01587703|529495791|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816247|NCT01587703|529495792|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816248|NCT01587703|529495793|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816249|NCT01587703|529495794|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816250|NCT01587703|529495795|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
146816251|NCT01587703|529495796|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
146816252|NCT01587703|529495797|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816253|NCT01587703|529495798|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816254|NCT01587703|529495799|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816255|NCT01587703|529495800|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816256|NCT01587703|529495801|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816257|NCT01587703|529495802|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816258|NCT01587703|529495803|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816259|NCT01587703|529495804|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146816260|NCT01587703|529495786|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816261|NCT01587703|529495787|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816262|NCT01587703|529495788|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816263|NCT01587703|529495789|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816264|NCT01587703|529495790|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816265|NCT01587703|529495791|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816266|NCT01587703|529495792|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816267|NCT01587703|529495793|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816268|NCT01587703|529495794|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
146816269|NCT01587703|529495795|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816270|NCT01587703|529495796|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816271|NCT01587703|529495797|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816272|NCT01587703|529495798|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816273|NCT01587703|529495799|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816274|NCT01587703|529495800|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816275|NCT01587703|529495801|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816276|NCT01587703|529495802|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816277|NCT01587703|529495803|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816278|NCT01587703|529495804|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146816279|NCT01587703|529495786|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146816280|NCT01587703|529495787|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146816281|NCT01587703|529495788|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146946090|NCT04731922|529960720|FG016|Overall Study|Withdrawal by Subject|0|||
146946091|NCT04731922|529960704|FG000|Overall Study|Other|0|||
146946092|NCT04731922|529960705|FG001|Overall Study|Other|0|||
146946093|NCT04731922|529960706|FG002|Overall Study|Other|0|||
146946094|NCT04731922|529960707|FG003|Overall Study|Other|0|||
146946095|NCT04731922|529960708|FG004|Overall Study|Other|0|||
146946096|NCT04731922|529960709|FG005|Overall Study|Other|0|||
146946097|NCT04731922|529960710|FG006|Overall Study|Other|1|||
146946098|NCT04731922|529960711|FG007|Overall Study|Other|0|||
146946099|NCT04731922|529960712|FG008|Overall Study|Other|0|||
146946100|NCT04731922|529960713|FG009|Overall Study|Other|0|||
146946101|NCT04731922|529960714|FG010|Overall Study|Other|0|||
146946102|NCT04731922|529960715|FG011|Overall Study|Other|0|||
146946103|NCT04731922|529960716|FG012|Overall Study|Other|0|||
146946104|NCT04731922|529960717|FG013|Overall Study|Other|0|||
146946105|NCT04731922|529960718|FG014|Overall Study|Other|0|||
146946106|NCT04731922|529960719|FG015|Overall Study|Other|0|||
146946107|NCT04731922|529960720|FG016|Overall Study|Other|0|||
146946108|NCT00981747|529960726|FG000|Losartan|Withdrawal by Subject|1|||
146946109|NCT00981747|529960726|FG000|Losartan|Death|1|||
146946110|NCT00981747|529960726|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
146946111|NCT01437267|529960727|FG000|Overall Study|Withdrawal by Subject|0|||
146946112|NCT01437267|529960728|FG001|Overall Study|Withdrawal by Subject|0|||
146946113|NCT01437267|529960729|FG002|Overall Study|Withdrawal by Subject|0|||
146946114|NCT01437267|529960730|FG003|Overall Study|Withdrawal by Subject|1|||
146946115|NCT01437267|529960731|FG004|Overall Study|Withdrawal by Subject|0|||
146946116|NCT01437267|529960732|FG005|Overall Study|Withdrawal by Subject|0|||
146946117|NCT01437267|529960727|FG000|Overall Study|Protocol Violation|0|||
146946118|NCT01437267|529960728|FG001|Overall Study|Protocol Violation|1|||
146946119|NCT01437267|529960729|FG002|Overall Study|Protocol Violation|0|||
146946120|NCT01437267|529960730|FG003|Overall Study|Protocol Violation|0|||
146946121|NCT01437267|529960731|FG004|Overall Study|Protocol Violation|0|||
146946122|NCT01437267|529960732|FG005|Overall Study|Protocol Violation|0|||
146946123|NCT00608842|529960735|FG000|Overall Study|Participant's Request|0|||
146946124|NCT00608842|529960736|FG001|Overall Study|Participant's Request|1|||
146946125|NCT00608842|529960737|FG002|Overall Study|Participant's Request|2|||
146946126|NCT00608842|529960738|FG003|Overall Study|Participant's Request|1|||
146946127|NCT00608842|529960735|FG000|Overall Study|Lost to Follow-up|1|||
146946128|NCT00608842|529960736|FG001|Overall Study|Lost to Follow-up|0|||
146946129|NCT00608842|529960737|FG002|Overall Study|Lost to Follow-up|0|||
146946130|NCT00608842|529960738|FG003|Overall Study|Lost to Follow-up|0|||
146946131|NCT03799627|529960739|FG000|Overall Study|Adverse Event|1|||
146946132|NCT03799627|529960740|FG001|Overall Study|Adverse Event|2|||
146946133|NCT03799627|529960741|FG002|Overall Study|Adverse Event|0|||
146946134|NCT03799627|529960742|FG003|Overall Study|Adverse Event|0|||
146946135|NCT03799627|529960743|FG004|Overall Study|Adverse Event|2|||
146946136|NCT03799627|529960744|FG005|Overall Study|Adverse Event|5|||
146946137|NCT03799627|529960745|FG006|Overall Study|Adverse Event|0|||
146946138|NCT03799627|529960746|FG007|Overall Study|Adverse Event|2|||
146946139|NCT03799627|529960747|FG008|Overall Study|Adverse Event|0|||
146946140|NCT03799627|529960739|FG000|Overall Study|Physician Decision|2|||
146946141|NCT03799627|529960740|FG001|Overall Study|Physician Decision|2|||
146946142|NCT03799627|529960741|FG002|Overall Study|Physician Decision|0|||
146946143|NCT03799627|529960742|FG003|Overall Study|Physician Decision|0|||
146946144|NCT03799627|529960743|FG004|Overall Study|Physician Decision|2|||
146946145|NCT03799627|529960744|FG005|Overall Study|Physician Decision|2|||
146946146|NCT03799627|529960745|FG006|Overall Study|Physician Decision|0|||
146946147|NCT03799627|529960746|FG007|Overall Study|Physician Decision|0|||
146946148|NCT03799627|529960747|FG008|Overall Study|Physician Decision|0|||
146946149|NCT03799627|529960739|FG000|Overall Study|Withdrawal by Subject|1|||
146946150|NCT03799627|529960740|FG001|Overall Study|Withdrawal by Subject|1|||
146946151|NCT03799627|529960741|FG002|Overall Study|Withdrawal by Subject|0|||
146946152|NCT03799627|529960742|FG003|Overall Study|Withdrawal by Subject|2|||
146946153|NCT03799627|529960743|FG004|Overall Study|Withdrawal by Subject|0|||
146946154|NCT03799627|529960744|FG005|Overall Study|Withdrawal by Subject|3|||
146946155|NCT03799627|529960745|FG006|Overall Study|Withdrawal by Subject|0|||
146984613|NCT00358826|530105104|FG001|MDCT Substudy|Adverse Event|0|||
146946156|NCT03799627|529960746|FG007|Overall Study|Withdrawal by Subject|0|||
146946157|NCT03799627|529960747|FG008|Overall Study|Withdrawal by Subject|0|||
146946158|NCT03799627|529960739|FG000|Overall Study|Lack of Efficacy|0|||
146946159|NCT03799627|529960740|FG001|Overall Study|Lack of Efficacy|0|||
146946160|NCT03799627|529960741|FG002|Overall Study|Lack of Efficacy|0|||
146946161|NCT03799627|529960742|FG003|Overall Study|Lack of Efficacy|1|||
146946162|NCT03799627|529960743|FG004|Overall Study|Lack of Efficacy|0|||
146946163|NCT03799627|529960744|FG005|Overall Study|Lack of Efficacy|0|||
146946164|NCT03799627|529960745|FG006|Overall Study|Lack of Efficacy|0|||
146946165|NCT03799627|529960746|FG007|Overall Study|Lack of Efficacy|0|||
146946166|NCT03799627|529960747|FG008|Overall Study|Lack of Efficacy|0|||
146946167|NCT03799627|529960739|FG000|Overall Study|Lost to Follow-up|0|||
146946168|NCT03799627|529960740|FG001|Overall Study|Lost to Follow-up|0|||
146946169|NCT03799627|529960741|FG002|Overall Study|Lost to Follow-up|0|||
146946170|NCT03799627|529960742|FG003|Overall Study|Lost to Follow-up|0|||
146946171|NCT03799627|529960743|FG004|Overall Study|Lost to Follow-up|0|||
146946172|NCT03799627|529960744|FG005|Overall Study|Lost to Follow-up|0|||
146946173|NCT03799627|529960745|FG006|Overall Study|Lost to Follow-up|1|||
146946174|NCT03799627|529960746|FG007|Overall Study|Lost to Follow-up|0|||
146946175|NCT03799627|529960747|FG008|Overall Study|Lost to Follow-up|1|||
146946176|NCT03799627|529960739|FG000|Overall Study|Death|0|||
146946177|NCT03799627|529960740|FG001|Overall Study|Death|0|||
146946178|NCT03799627|529960741|FG002|Overall Study|Death|0|||
146946179|NCT03799627|529960742|FG003|Overall Study|Death|1|||
146946180|NCT03799627|529960743|FG004|Overall Study|Death|0|||
146946181|NCT03799627|529960744|FG005|Overall Study|Death|0|||
146946182|NCT03799627|529960745|FG006|Overall Study|Death|0|||
146946183|NCT03799627|529960746|FG007|Overall Study|Death|0|||
146946184|NCT03799627|529960747|FG008|Overall Study|Death|0|||
146946185|NCT03799627|529960739|FG000|Overall Study|Study Drug Put on Hold|1|||
146946186|NCT03799627|529960740|FG001|Overall Study|Study Drug Put on Hold|0|||
146946187|NCT03799627|529960741|FG002|Overall Study|Study Drug Put on Hold|0|||
146946188|NCT03799627|529960742|FG003|Overall Study|Study Drug Put on Hold|0|||
146946189|NCT03799627|529960743|FG004|Overall Study|Study Drug Put on Hold|0|||
146946190|NCT03799627|529960744|FG005|Overall Study|Study Drug Put on Hold|0|||
146946191|NCT03799627|529960745|FG006|Overall Study|Study Drug Put on Hold|0|||
146946192|NCT03799627|529960746|FG007|Overall Study|Study Drug Put on Hold|0|||
146946193|NCT03799627|529960747|FG008|Overall Study|Study Drug Put on Hold|0|||
146946194|NCT03799627|529960739|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
146946195|NCT03799627|529960740|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
146946196|NCT03799627|529960741|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
146946197|NCT03799627|529960742|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
146946198|NCT03799627|529960743|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
146946199|NCT03799627|529960744|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
146946200|NCT03799627|529960745|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
146946201|NCT03799627|529960746|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
146946202|NCT03799627|529960747|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
146946203|NCT03799627|529960739|FG000|Overall Study|Kidney Transplantation|1|||
146946204|NCT03799627|529960740|FG001|Overall Study|Kidney Transplantation|0|||
146946205|NCT03799627|529960741|FG002|Overall Study|Kidney Transplantation|0|||
146946206|NCT03799627|529960742|FG003|Overall Study|Kidney Transplantation|1|||
146946207|NCT03799627|529960743|FG004|Overall Study|Kidney Transplantation|1|||
146946208|NCT03799627|529960744|FG005|Overall Study|Kidney Transplantation|0|||
146946209|NCT03799627|529960745|FG006|Overall Study|Kidney Transplantation|0|||
146946210|NCT03799627|529960746|FG007|Overall Study|Kidney Transplantation|0|||
146946211|NCT03799627|529960747|FG008|Overall Study|Kidney Transplantation|0|||
146946212|NCT03799627|529960739|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
146946213|NCT03799627|529960740|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
146946214|NCT03799627|529960741|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
146946215|NCT03799627|529960742|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
146946216|NCT03799627|529960743|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
146946217|NCT03799627|529960744|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
146946218|NCT03799627|529960745|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
146946219|NCT03799627|529960746|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
146946220|NCT03799627|529960747|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
146946221|NCT03799627|529960739|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
146946222|NCT03799627|529960740|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
146946223|NCT03799627|529960741|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
146946224|NCT03799627|529960742|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
146946225|NCT03799627|529960743|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
146946226|NCT03799627|529960744|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
146946227|NCT03799627|529960745|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
146946228|NCT03799627|529960746|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
146946229|NCT03799627|529960747|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
146946230|NCT03799627|529960739|FG000|Overall Study|Met Exclusion Criteria|0|||
146946231|NCT03799627|529960740|FG001|Overall Study|Met Exclusion Criteria|0|||
146946232|NCT03799627|529960741|FG002|Overall Study|Met Exclusion Criteria|0|||
146946233|NCT03799627|529960742|FG003|Overall Study|Met Exclusion Criteria|1|||
146946234|NCT03799627|529960743|FG004|Overall Study|Met Exclusion Criteria|0|||
146946235|NCT03799627|529960744|FG005|Overall Study|Met Exclusion Criteria|0|||
146946236|NCT03799627|529960745|FG006|Overall Study|Met Exclusion Criteria|0|||
146946237|NCT03799627|529960746|FG007|Overall Study|Met Exclusion Criteria|0|||
146946238|NCT03799627|529960747|FG008|Overall Study|Met Exclusion Criteria|0|||
146946239|NCT03799627|529960739|FG000|Overall Study|Investigational Product Noncompliance|0|||
146946240|NCT03799627|529960740|FG001|Overall Study|Investigational Product Noncompliance|0|||
146946241|NCT03799627|529960741|FG002|Overall Study|Investigational Product Noncompliance|0|||
146946242|NCT03799627|529960742|FG003|Overall Study|Investigational Product Noncompliance|1|||
146946243|NCT03799627|529960743|FG004|Overall Study|Investigational Product Noncompliance|0|||
146946244|NCT03799627|529960744|FG005|Overall Study|Investigational Product Noncompliance|0|||
146946245|NCT03799627|529960745|FG006|Overall Study|Investigational Product Noncompliance|0|||
146946246|NCT03799627|529960746|FG007|Overall Study|Investigational Product Noncompliance|0|||
146946247|NCT03799627|529960747|FG008|Overall Study|Investigational Product Noncompliance|0|||
146946248|NCT03799627|529960739|FG000|Overall Study|Participant Relocation|0|||
146946249|NCT03799627|529960740|FG001|Overall Study|Participant Relocation|0|||
146946250|NCT03799627|529960741|FG002|Overall Study|Participant Relocation|0|||
146946251|NCT03799627|529960742|FG003|Overall Study|Participant Relocation|1|||
146946252|NCT03799627|529960743|FG004|Overall Study|Participant Relocation|0|||
146946253|NCT03799627|529960744|FG005|Overall Study|Participant Relocation|1|||
146946254|NCT03799627|529960745|FG006|Overall Study|Participant Relocation|0|||
146946255|NCT03799627|529960746|FG007|Overall Study|Participant Relocation|0|||
146946256|NCT03799627|529960747|FG008|Overall Study|Participant Relocation|0|||
146946257|NCT03799627|529960739|FG000|Overall Study|Eurofin Issue|0|||
146946258|NCT03799627|529960740|FG001|Overall Study|Eurofin Issue|0|||
146946259|NCT03799627|529960741|FG002|Overall Study|Eurofin Issue|0|||
146946260|NCT03799627|529960742|FG003|Overall Study|Eurofin Issue|0|||
146946261|NCT03799627|529960743|FG004|Overall Study|Eurofin Issue|1|||
146946262|NCT03799627|529960744|FG005|Overall Study|Eurofin Issue|0|||
146946263|NCT03799627|529960745|FG006|Overall Study|Eurofin Issue|0|||
146946264|NCT03799627|529960746|FG007|Overall Study|Eurofin Issue|0|||
146946265|NCT03799627|529960747|FG008|Overall Study|Eurofin Issue|0|||
146946266|NCT03799627|529960739|FG000|Overall Study|Noncompliance with Site Instructions|0|||
146946267|NCT03799627|529960740|FG001|Overall Study|Noncompliance with Site Instructions|0|||
146946268|NCT03799627|529960741|FG002|Overall Study|Noncompliance with Site Instructions|0|||
146946269|NCT03799627|529960742|FG003|Overall Study|Noncompliance with Site Instructions|0|||
146946270|NCT03799627|529960743|FG004|Overall Study|Noncompliance with Site Instructions|1|||
146946271|NCT03799627|529960744|FG005|Overall Study|Noncompliance with Site Instructions|0|||
146946272|NCT03799627|529960745|FG006|Overall Study|Noncompliance with Site Instructions|0|||
146946273|NCT03799627|529960746|FG007|Overall Study|Noncompliance with Site Instructions|0|||
146946274|NCT03799627|529960747|FG008|Overall Study|Noncompliance with Site Instructions|0|||
146946275|NCT03799627|529960739|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
146946276|NCT03799627|529960740|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
146946277|NCT03799627|529960741|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
146946278|NCT03799627|529960742|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
146946279|NCT03799627|529960743|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
146946280|NCT03799627|529960744|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
146946281|NCT03799627|529960745|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
146946282|NCT03799627|529960746|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
146946283|NCT03799627|529960747|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
146946284|NCT03799627|529960739|FG000|Overall Study|Changes In Hemoglobin Values|1|||
146946285|NCT03799627|529960740|FG001|Overall Study|Changes In Hemoglobin Values|2|||
146946286|NCT03799627|529960741|FG002|Overall Study|Changes In Hemoglobin Values|1|||
146946287|NCT03799627|529960742|FG003|Overall Study|Changes In Hemoglobin Values|0|||
146946288|NCT03799627|529960743|FG004|Overall Study|Changes In Hemoglobin Values|0|||
146946289|NCT03799627|529960744|FG005|Overall Study|Changes In Hemoglobin Values|2|||
146946290|NCT03799627|529960745|FG006|Overall Study|Changes In Hemoglobin Values|1|||
146946291|NCT03799627|529960746|FG007|Overall Study|Changes In Hemoglobin Values|0|||
146946292|NCT03799627|529960747|FG008|Overall Study|Changes In Hemoglobin Values|1|||
146946293|NCT00814307|529960752|FG000|Overall Study|Randomized but not treated|1|||
146946294|NCT00814307|529960753|FG001|Overall Study|Randomized but not treated|0|||
146946295|NCT00814307|529960754|FG002|Overall Study|Randomized but not treated|0|||
146946296|NCT00814307|529960755|FG003|Overall Study|Randomized but not treated|0|||
146946297|NCT00814307|529960752|FG000|Overall Study|Adverse Event|3|||
146946298|NCT00814307|529960753|FG001|Overall Study|Adverse Event|9|||
146946299|NCT00814307|529960754|FG002|Overall Study|Adverse Event|3|||
146946300|NCT00814307|529960755|FG003|Overall Study|Adverse Event|2|||
146946301|NCT00814307|529960752|FG000|Overall Study|Lack of Efficacy|1|||
146946302|NCT00814307|529960753|FG001|Overall Study|Lack of Efficacy|1|||
146946303|NCT00814307|529960754|FG002|Overall Study|Lack of Efficacy|3|||
146946304|NCT00814307|529960755|FG003|Overall Study|Lack of Efficacy|4|||
146946305|NCT00814307|529960752|FG000|Overall Study|Other|1|||
146946306|NCT00814307|529960753|FG001|Overall Study|Other|2|||
146946307|NCT00814307|529960754|FG002|Overall Study|Other|0|||
146946308|NCT00814307|529960755|FG003|Overall Study|Other|1|||
146946309|NCT00814307|529960752|FG000|Overall Study|Protocol Violation|2|||
146816282|NCT01587703|529495789|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146816283|NCT01587703|529495790|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146946310|NCT00814307|529960753|FG001|Overall Study|Protocol Violation|8|||
146946311|NCT00814307|529960754|FG002|Overall Study|Protocol Violation|1|||
146946312|NCT00814307|529960755|FG003|Overall Study|Protocol Violation|1|||
146946313|NCT00814307|529960752|FG000|Overall Study|Withdrawal by Subject|4|||
146946314|NCT00814307|529960753|FG001|Overall Study|Withdrawal by Subject|6|||
146946315|NCT00814307|529960754|FG002|Overall Study|Withdrawal by Subject|0|||
146946316|NCT00814307|529960755|FG003|Overall Study|Withdrawal by Subject|2|||
146946317|NCT00814307|529960752|FG000|Overall Study|Death|0|||
146816284|NCT01587703|529495791|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146816285|NCT01587703|529495792|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146946318|NCT00814307|529960753|FG001|Overall Study|Death|1|||
146946319|NCT00814307|529960754|FG002|Overall Study|Death|0|||
146946320|NCT00814307|529960755|FG003|Overall Study|Death|0|||
146946321|NCT03073200|529960764|FG000|Double Blind Treatment Period|Protocol Violation|1|||
146946322|NCT03073200|529960765|FG001|Double Blind Treatment Period|Protocol Violation|0|||
146946323|NCT03073200|529960766|FG002|Double Blind Treatment Period|Protocol Violation|0|||
146946324|NCT03073200|529960767|FG003|Double Blind Treatment Period|Protocol Violation|0|||
146946325|NCT03073200|529960768|FG004|Double Blind Treatment Period|Protocol Violation|0|||
146946326|NCT03073200|529960769|FG005|Double Blind Treatment Period|Protocol Violation|0|||
146946327|NCT03073200|529960770|FG006|Double Blind Treatment Period|Protocol Violation|0|||
146946328|NCT03073200|529960771|FG007|Double Blind Treatment Period|Protocol Violation|0|||
146946329|NCT03073200|529960772|FG008|Double Blind Treatment Period|Protocol Violation|0|||
146946330|NCT03073200|529960773|FG009|Double Blind Treatment Period|Protocol Violation|0|||
146946331|NCT03073200|529960774|FG010|Double Blind Treatment Period|Protocol Violation|0|||
146946332|NCT03073200|529960775|FG011|Double Blind Treatment Period|Protocol Violation|0|||
146946333|NCT03073200|529960776|FG012|Double Blind Treatment Period|Protocol Violation|0|||
146946334|NCT03073200|529960777|FG013|Double Blind Treatment Period|Protocol Violation|0|||
146946335|NCT03073200|529960778|FG014|Double Blind Treatment Period|Protocol Violation|0|||
146946336|NCT03073200|529960764|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146946337|NCT03073200|529960765|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
146946338|NCT03073200|529960766|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146946339|NCT03073200|529960767|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146946340|NCT03073200|529960768|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146946341|NCT03073200|529960769|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146946342|NCT03073200|529960770|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146946343|NCT03073200|529960771|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146946344|NCT03073200|529960772|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146946345|NCT03073200|529960773|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146946346|NCT03073200|529960774|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146946347|NCT03073200|529960775|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146946348|NCT03073200|529960776|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146946349|NCT03073200|529960777|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146816286|NCT01587703|529495793|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146816287|NCT01587703|529495794|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146946350|NCT03073200|529960778|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146946351|NCT03073200|529960764|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
146946352|NCT03073200|529960765|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
146946353|NCT03073200|529960766|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
146946354|NCT03073200|529960767|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
146946355|NCT03073200|529960768|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
146946356|NCT03073200|529960769|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
146946357|NCT03073200|529960770|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
146946358|NCT03073200|529960771|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
146946359|NCT03073200|529960772|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
146946360|NCT03073200|529960773|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
146946361|NCT03073200|529960774|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
146946362|NCT03073200|529960775|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
146946363|NCT03073200|529960776|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
146946364|NCT03073200|529960777|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
146946365|NCT03073200|529960778|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
146946366|NCT03073200|529960764|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
146946367|NCT03073200|529960765|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
146946368|NCT03073200|529960766|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
146946369|NCT03073200|529960767|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
146946370|NCT03073200|529960768|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
146816288|NCT01587703|529495795|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146816289|NCT01587703|529495796|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146816290|NCT01587703|529495797|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146946371|NCT03073200|529960769|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
146946372|NCT03073200|529960770|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
146946373|NCT03073200|529960771|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
146946374|NCT03073200|529960772|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
146946375|NCT03073200|529960773|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
146984614|NCT00358826|530105105|FG002|MDCT Substudy|Adverse Event|0|||
146984615|NCT00358826|530105106|FG003|MDCT Substudy|Adverse Event|0|||
146946376|NCT03073200|529960774|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
146946377|NCT03073200|529960775|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
146946378|NCT03073200|529960776|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
146946379|NCT03073200|529960777|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
146946380|NCT03073200|529960778|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
146946381|NCT03073200|529960764|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
146946382|NCT03073200|529960765|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
146946383|NCT03073200|529960766|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
146946384|NCT03073200|529960767|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
146946385|NCT03073200|529960768|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
146946386|NCT03073200|529960769|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
146946387|NCT03073200|529960770|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
146946388|NCT03073200|529960771|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
146946389|NCT03073200|529960772|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
146946390|NCT03073200|529960773|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
146946391|NCT03073200|529960774|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
146946392|NCT03073200|529960775|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
146946393|NCT03073200|529960776|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
146946394|NCT03073200|529960777|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
146946395|NCT03073200|529960778|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
146946396|NCT03073200|529960764|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
146946397|NCT03073200|529960765|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
146946398|NCT03073200|529960766|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
146946399|NCT03073200|529960767|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
146946400|NCT03073200|529960768|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
146946401|NCT03073200|529960769|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
146946402|NCT03073200|529960770|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
146946403|NCT03073200|529960771|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
146946404|NCT03073200|529960772|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
146946405|NCT03073200|529960773|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
146946406|NCT03073200|529960774|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
146946407|NCT03073200|529960775|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
146946408|NCT03073200|529960776|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
146946409|NCT03073200|529960777|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
146946410|NCT03073200|529960778|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
146946411|NCT03073200|529960764|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146946412|NCT03073200|529960765|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146946413|NCT03073200|529960766|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146946414|NCT03073200|529960767|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
146946415|NCT03073200|529960768|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
146946416|NCT03073200|529960769|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146946417|NCT03073200|529960770|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146946418|NCT03073200|529960771|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146946419|NCT03073200|529960772|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146946420|NCT03073200|529960773|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146946421|NCT03073200|529960774|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146946422|NCT03073200|529960775|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146946423|NCT03073200|529960776|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146946424|NCT03073200|529960777|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146946425|NCT03073200|529960778|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146946426|NCT03073200|529960764|FG000|Extension Period|Lost to Follow-up|0|||
146946427|NCT03073200|529960765|FG001|Extension Period|Lost to Follow-up|0|||
146946428|NCT03073200|529960766|FG002|Extension Period|Lost to Follow-up|0|||
146946429|NCT03073200|529960767|FG003|Extension Period|Lost to Follow-up|0|||
146946430|NCT03073200|529960768|FG004|Extension Period|Lost to Follow-up|0|||
146946431|NCT03073200|529960769|FG005|Extension Period|Lost to Follow-up|0|||
146946432|NCT03073200|529960770|FG006|Extension Period|Lost to Follow-up|1|||
146946433|NCT03073200|529960771|FG007|Extension Period|Lost to Follow-up|1|||
146946434|NCT03073200|529960772|FG008|Extension Period|Lost to Follow-up|0|||
146946435|NCT03073200|529960773|FG009|Extension Period|Lost to Follow-up|0|||
146946436|NCT03073200|529960774|FG010|Extension Period|Lost to Follow-up|0|||
146946437|NCT03073200|529960775|FG011|Extension Period|Lost to Follow-up|0|||
146946438|NCT03073200|529960776|FG012|Extension Period|Lost to Follow-up|0|||
146984616|NCT00358826|530105107|FG004|MDCT Substudy|Adverse Event|1|||
146946439|NCT03073200|529960777|FG013|Extension Period|Lost to Follow-up|0|||
146946440|NCT03073200|529960778|FG014|Extension Period|Lost to Follow-up|0|||
146946441|NCT03073200|529960764|FG000|Extension Period|Sponsor Decision|0|||
146946442|NCT03073200|529960765|FG001|Extension Period|Sponsor Decision|0|||
146946443|NCT03073200|529960766|FG002|Extension Period|Sponsor Decision|0|||
146946444|NCT03073200|529960767|FG003|Extension Period|Sponsor Decision|0|||
146946445|NCT03073200|529960768|FG004|Extension Period|Sponsor Decision|0|||
146946446|NCT03073200|529960769|FG005|Extension Period|Sponsor Decision|0|||
146946447|NCT03073200|529960770|FG006|Extension Period|Sponsor Decision|0|||
146946448|NCT03073200|529960771|FG007|Extension Period|Sponsor Decision|0|||
146946449|NCT03073200|529960772|FG008|Extension Period|Sponsor Decision|1|||
146946450|NCT03073200|529960773|FG009|Extension Period|Sponsor Decision|0|||
146946451|NCT03073200|529960774|FG010|Extension Period|Sponsor Decision|0|||
146946452|NCT03073200|529960775|FG011|Extension Period|Sponsor Decision|0|||
146946453|NCT03073200|529960776|FG012|Extension Period|Sponsor Decision|0|||
146946454|NCT03073200|529960777|FG013|Extension Period|Sponsor Decision|0|||
146946455|NCT03073200|529960778|FG014|Extension Period|Sponsor Decision|0|||
146946456|NCT03073200|529960764|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
146946457|NCT03073200|529960765|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
146946458|NCT03073200|529960766|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
146946459|NCT03073200|529960767|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
146946460|NCT03073200|529960768|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
146946461|NCT03073200|529960769|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
146946462|NCT03073200|529960770|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
146946463|NCT03073200|529960771|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
146946464|NCT03073200|529960772|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
146946465|NCT03073200|529960773|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
146946466|NCT03073200|529960774|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
146946467|NCT03073200|529960775|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
146946468|NCT03073200|529960776|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
146946469|NCT03073200|529960777|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
146946470|NCT03073200|529960778|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
146946471|NCT03073200|529960764|FG000|Extension Period|Withdrawal by Subject|0|||
146946472|NCT03073200|529960765|FG001|Extension Period|Withdrawal by Subject|0|||
146946473|NCT03073200|529960766|FG002|Extension Period|Withdrawal by Subject|0|||
146946474|NCT03073200|529960767|FG003|Extension Period|Withdrawal by Subject|0|||
146946475|NCT03073200|529960768|FG004|Extension Period|Withdrawal by Subject|0|||
146946476|NCT03073200|529960769|FG005|Extension Period|Withdrawal by Subject|0|||
146946477|NCT03073200|529960770|FG006|Extension Period|Withdrawal by Subject|1|||
146946478|NCT03073200|529960771|FG007|Extension Period|Withdrawal by Subject|2|||
146946479|NCT03073200|529960772|FG008|Extension Period|Withdrawal by Subject|0|||
146946480|NCT03073200|529960773|FG009|Extension Period|Withdrawal by Subject|0|||
146946481|NCT03073200|529960774|FG010|Extension Period|Withdrawal by Subject|0|||
146946482|NCT03073200|529960775|FG011|Extension Period|Withdrawal by Subject|0|||
146946483|NCT03073200|529960776|FG012|Extension Period|Withdrawal by Subject|0|||
146946484|NCT03073200|529960777|FG013|Extension Period|Withdrawal by Subject|0|||
146946485|NCT03073200|529960778|FG014|Extension Period|Withdrawal by Subject|0|||
146946486|NCT03073200|529960764|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
146946487|NCT03073200|529960765|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
146946488|NCT03073200|529960766|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
146946489|NCT03073200|529960767|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
146946490|NCT03073200|529960768|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
146946491|NCT03073200|529960769|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
146946492|NCT03073200|529960770|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
146946493|NCT03073200|529960771|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
146946494|NCT03073200|529960772|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
146946495|NCT03073200|529960773|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
146946496|NCT03073200|529960774|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
146946497|NCT03073200|529960775|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
146946498|NCT03073200|529960776|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
146946499|NCT03073200|529960777|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
146946500|NCT03073200|529960778|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
146946501|NCT03073200|529960764|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146946502|NCT03073200|529960765|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146946503|NCT03073200|529960766|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146946504|NCT03073200|529960767|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146946505|NCT03073200|529960768|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146946506|NCT03073200|529960769|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146946507|NCT03073200|529960770|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146946508|NCT03073200|529960771|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146946509|NCT03073200|529960772|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146946510|NCT03073200|529960773|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146946511|NCT03073200|529960774|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146946512|NCT03073200|529960775|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
146946513|NCT03073200|529960776|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146946514|NCT03073200|529960777|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146946515|NCT03073200|529960778|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146946516|NCT03073200|529960764|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146946517|NCT03073200|529960765|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146946518|NCT03073200|529960766|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146946519|NCT03073200|529960767|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146946520|NCT03073200|529960768|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146946521|NCT03073200|529960769|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146946522|NCT03073200|529960770|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146946523|NCT03073200|529960771|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146946524|NCT03073200|529960772|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146946525|NCT03073200|529960773|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146946526|NCT03073200|529960774|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
146946527|NCT03073200|529960775|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
146946528|NCT03073200|529960776|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146946529|NCT03073200|529960777|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146946530|NCT03073200|529960778|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146946531|NCT03073200|529960764|FG000|Randomized Withdrawal Period|Adverse Event|0|||
146946532|NCT03073200|529960765|FG001|Randomized Withdrawal Period|Adverse Event|0|||
146946533|NCT03073200|529960766|FG002|Randomized Withdrawal Period|Adverse Event|0|||
146946534|NCT03073200|529960767|FG003|Randomized Withdrawal Period|Adverse Event|0|||
146946535|NCT03073200|529960768|FG004|Randomized Withdrawal Period|Adverse Event|0|||
146946536|NCT03073200|529960769|FG005|Randomized Withdrawal Period|Adverse Event|0|||
146946537|NCT03073200|529960770|FG006|Randomized Withdrawal Period|Adverse Event|0|||
146946538|NCT03073200|529960771|FG007|Randomized Withdrawal Period|Adverse Event|0|||
146946539|NCT03073200|529960772|FG008|Randomized Withdrawal Period|Adverse Event|0|||
146946540|NCT03073200|529960773|FG009|Randomized Withdrawal Period|Adverse Event|0|||
146946541|NCT03073200|529960774|FG010|Randomized Withdrawal Period|Adverse Event|1|||
146946542|NCT03073200|529960775|FG011|Randomized Withdrawal Period|Adverse Event|0|||
146946543|NCT03073200|529960776|FG012|Randomized Withdrawal Period|Adverse Event|0|||
146946544|NCT03073200|529960777|FG013|Randomized Withdrawal Period|Adverse Event|0|||
146946545|NCT03073200|529960778|FG014|Randomized Withdrawal Period|Adverse Event|0|||
146946546|NCT03073200|529960764|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
146946547|NCT03073200|529960765|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
146946548|NCT03073200|529960766|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
146946549|NCT03073200|529960767|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
146946550|NCT03073200|529960768|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
146946551|NCT03073200|529960769|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
146946552|NCT03073200|529960770|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
146946553|NCT03073200|529960771|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
146946554|NCT03073200|529960772|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
146946555|NCT03073200|529960773|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
146946556|NCT03073200|529960774|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
146946557|NCT03073200|529960775|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
146946558|NCT03073200|529960776|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
146946559|NCT03073200|529960777|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
146946560|NCT03073200|529960778|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
146946561|NCT03073200|529960764|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146946562|NCT03073200|529960765|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146946563|NCT03073200|529960766|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146946564|NCT03073200|529960767|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146946565|NCT03073200|529960768|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146946566|NCT03073200|529960769|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146946567|NCT03073200|529960770|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146946568|NCT03073200|529960771|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146946569|NCT03073200|529960772|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146946570|NCT03073200|529960773|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146946571|NCT03073200|529960774|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146946572|NCT03073200|529960775|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146946573|NCT03073200|529960776|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146984617|NCT00358826|530105108|FG005|MDCT Substudy|Adverse Event|0|||
146984618|NCT00358826|530105109|FG006|MDCT Substudy|Adverse Event|0|||
146946574|NCT03073200|529960777|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
146946575|NCT03073200|529960778|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146946576|NCT03073200|529960764|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146984619|NCT00358826|530105110|FG007|MDCT Substudy|Adverse Event|0|||
146984620|NCT00358826|530105103|FG000|MDCT Substudy|Lost to Follow-up|0|||
146946577|NCT03073200|529960765|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146946578|NCT03073200|529960766|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146946579|NCT03073200|529960767|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146946580|NCT03073200|529960768|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146946581|NCT03073200|529960769|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146946582|NCT03073200|529960770|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146946583|NCT03073200|529960771|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146946584|NCT03073200|529960772|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146946585|NCT03073200|529960773|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146946586|NCT03073200|529960774|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146946587|NCT03073200|529960775|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146946588|NCT03073200|529960776|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146946589|NCT03073200|529960777|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
146946590|NCT03073200|529960778|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146946591|NCT03073200|529960764|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146946592|NCT03073200|529960765|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146946593|NCT03073200|529960766|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146946594|NCT03073200|529960767|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146946595|NCT03073200|529960768|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146946596|NCT03073200|529960769|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146946597|NCT03073200|529960770|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146946598|NCT03073200|529960771|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146946599|NCT03073200|529960772|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146946600|NCT03073200|529960773|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146946601|NCT03073200|529960774|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146946602|NCT03073200|529960775|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146946603|NCT03073200|529960776|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146946604|NCT03073200|529960777|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
146946605|NCT03073200|529960778|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146946606|NCT03073200|529960764|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146946607|NCT03073200|529960765|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146946608|NCT03073200|529960766|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146946609|NCT03073200|529960767|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146946610|NCT03073200|529960768|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146946611|NCT03073200|529960769|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146946612|NCT03073200|529960770|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146946613|NCT03073200|529960771|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146946614|NCT03073200|529960772|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146946615|NCT03073200|529960773|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146946616|NCT03073200|529960774|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146946617|NCT03073200|529960775|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146946618|NCT03073200|529960776|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146946619|NCT03073200|529960777|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146946620|NCT03073200|529960778|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
146946621|NCT03073200|529960764|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146946622|NCT03073200|529960765|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146946623|NCT03073200|529960766|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146946624|NCT03073200|529960767|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146946625|NCT03073200|529960768|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146946626|NCT03073200|529960769|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146946627|NCT03073200|529960770|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146946628|NCT03073200|529960771|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146946629|NCT03073200|529960772|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146946630|NCT03073200|529960773|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146946631|NCT03073200|529960774|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146946632|NCT03073200|529960775|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146946633|NCT03073200|529960776|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146946634|NCT03073200|529960777|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
146946635|NCT03073200|529960778|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146946636|NCT03073200|529960764|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146816291|NCT01587703|529495798|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146816292|NCT01587703|529495799|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146946637|NCT03073200|529960765|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146946638|NCT03073200|529960766|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146946639|NCT03073200|529960767|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146984621|NCT00358826|530105104|FG001|MDCT Substudy|Lost to Follow-up|0|||
146984622|NCT00358826|530105105|FG002|MDCT Substudy|Lost to Follow-up|0|||
146984623|NCT00358826|530105106|FG003|MDCT Substudy|Lost to Follow-up|0|||
146984624|NCT00358826|530105107|FG004|MDCT Substudy|Lost to Follow-up|0|||
146984625|NCT00358826|530105108|FG005|MDCT Substudy|Lost to Follow-up|1|||
146984626|NCT00358826|530105109|FG006|MDCT Substudy|Lost to Follow-up|0|||
146984627|NCT00358826|530105110|FG007|MDCT Substudy|Lost to Follow-up|0|||
146984628|NCT00358826|530105103|FG000|MDCT Substudy|Withdrawal by Subject|0|||
146984629|NCT00358826|530105104|FG001|MDCT Substudy|Withdrawal by Subject|0|||
146984630|NCT00358826|530105105|FG002|MDCT Substudy|Withdrawal by Subject|0|||
146984631|NCT00358826|530105106|FG003|MDCT Substudy|Withdrawal by Subject|0|||
146984632|NCT00358826|530105107|FG004|MDCT Substudy|Withdrawal by Subject|0|||
146984633|NCT00358826|530105108|FG005|MDCT Substudy|Withdrawal by Subject|1|||
146984634|NCT00358826|530105109|FG006|MDCT Substudy|Withdrawal by Subject|0|||
146984635|NCT00358826|530105110|FG007|MDCT Substudy|Withdrawal by Subject|0|||
146984636|NCT00457665|530105112|FG000|12 Months|Drug allergy|1|||
146816293|NCT01587703|529495800|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146816294|NCT01587703|529495801|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146816295|NCT01587703|529495802|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146816296|NCT01587703|529495803|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146816297|NCT01587703|529495804|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
146816298|NCT01587703|529495786|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816299|NCT01587703|529495787|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816300|NCT01587703|529495788|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816301|NCT01587703|529495789|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816302|NCT01587703|529495790|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816303|NCT01587703|529495791|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816304|NCT01587703|529495792|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816305|NCT01587703|529495793|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816306|NCT01587703|529495794|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816307|NCT01587703|529495795|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816308|NCT01587703|529495796|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816309|NCT01587703|529495797|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816310|NCT01587703|529495798|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816311|NCT01587703|529495799|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816312|NCT01587703|529495800|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816313|NCT01587703|529495801|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816314|NCT01587703|529495802|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146816315|NCT01587703|529495803|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
146816316|NCT01587703|529495804|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
146816317|NCT01587703|529495786|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816318|NCT01587703|529495787|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816319|NCT01587703|529495788|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816320|NCT01587703|529495789|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816321|NCT01587703|529495790|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816322|NCT01587703|529495791|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816323|NCT01587703|529495792|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816324|NCT01587703|529495793|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816325|NCT01587703|529495794|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816326|NCT01587703|529495795|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816327|NCT01587703|529495796|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816328|NCT01587703|529495797|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816329|NCT01587703|529495798|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816330|NCT01587703|529495799|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816331|NCT01587703|529495800|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816332|NCT01587703|529495801|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
146816333|NCT01587703|529495802|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816334|NCT01587703|529495803|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816335|NCT01587703|529495804|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146816336|NCT01587703|529495786|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146816337|NCT01587703|529495787|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146816338|NCT01587703|529495788|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146816339|NCT01587703|529495789|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146816340|NCT01587703|529495790|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146816341|NCT01587703|529495791|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146984637|NCT00457665|530105113|FG001|12 Months|Drug allergy|1|||
146984638|NCT00457665|530105112|FG000|12 Months|High HIV viral load|5|||
146984639|NCT00457665|530105113|FG001|12 Months|High HIV viral load|1|||
146984640|NCT00457665|530105112|FG000|12 Months|Lipodystrophy|2|||
146946640|NCT03073200|529960768|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146946641|NCT03073200|529960769|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146946642|NCT03073200|529960770|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146946643|NCT03073200|529960771|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146946644|NCT03073200|529960772|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146946645|NCT03073200|529960773|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146946646|NCT03073200|529960774|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146946647|NCT03073200|529960775|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146946648|NCT03073200|529960776|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146946649|NCT03073200|529960777|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
146946650|NCT03073200|529960778|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146946651|NCT03073200|529960764|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146946652|NCT03073200|529960765|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146946653|NCT03073200|529960766|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146946654|NCT03073200|529960767|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146946655|NCT03073200|529960768|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146946656|NCT03073200|529960769|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146946657|NCT03073200|529960770|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146946658|NCT03073200|529960771|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146946659|NCT03073200|529960772|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146946660|NCT03073200|529960773|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146946661|NCT03073200|529960774|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146946662|NCT03073200|529960775|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146946663|NCT03073200|529960776|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146946664|NCT03073200|529960777|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
146946665|NCT03073200|529960778|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146946666|NCT01474889|529960779|FG000|Overall Study|Physician Decision|1|||
146946667|NCT01474889|529960780|FG001|Overall Study|Physician Decision|0|||
146946668|NCT01474889|529960781|FG002|Overall Study|Physician Decision|0|||
146946669|NCT01474889|529960779|FG000|Overall Study|Did not meet inclusion|1|||
146946670|NCT01474889|529960780|FG001|Overall Study|Did not meet inclusion|0|||
146946671|NCT01474889|529960781|FG002|Overall Study|Did not meet inclusion|0|||
146946672|NCT01474889|529960779|FG000|Overall Study|Withdrawal by Subject|0|||
146946673|NCT01474889|529960780|FG001|Overall Study|Withdrawal by Subject|1|||
146946674|NCT01474889|529960781|FG002|Overall Study|Withdrawal by Subject|0|||
146946675|NCT02569398|529960788|FG000|Overall Study|Adverse Event|0|||
146946676|NCT02569398|529960789|FG001|Overall Study|Adverse Event|1|||
146946677|NCT02569398|529960790|FG002|Overall Study|Adverse Event|6|||
146946678|NCT02569398|529960788|FG000|Overall Study|Withdrawal by Subject|43|||
146946679|NCT02569398|529960789|FG001|Overall Study|Withdrawal by Subject|43|||
146946680|NCT02569398|529960790|FG002|Overall Study|Withdrawal by Subject|30|||
146946681|NCT02569398|529960788|FG000|Overall Study|Study terminated by sponsor|130|||
146946682|NCT02569398|529960789|FG001|Overall Study|Study terminated by sponsor|131|||
146946683|NCT02569398|529960790|FG002|Overall Study|Study terminated by sponsor|134|||
146946684|NCT02569398|529960788|FG000|Overall Study|Other|12|||
146946685|NCT02569398|529960789|FG001|Overall Study|Other|14|||
146946686|NCT02569398|529960790|FG002|Overall Study|Other|13|||
146946687|NCT02571972|529960791|FG000|Overall Study|Protocol Violation|2|||
146946688|NCT02571972|529960791|FG000|Overall Study|Withdrawal by Subject|2|||
146946689|NCT03039192|529960794|FG000|Overall Study|Lost to Follow-up|4|||
146946690|NCT03039192|529960795|FG001|Overall Study|Lost to Follow-up|4|||
146946691|NCT03039192|529960794|FG000|Overall Study|Adverse event, serious fatal|0|||
146946692|NCT03039192|529960795|FG001|Overall Study|Adverse event, serious fatal|1|||
146946693|NCT03039192|529960794|FG000|Overall Study|Adverse event, non-fatal|0|||
146946694|NCT03039192|529960795|FG001|Overall Study|Adverse event, non-fatal|2|||
146946695|NCT03039192|529960794|FG000|Overall Study|Withdrawal by Subject|6|||
146946696|NCT03039192|529960795|FG001|Overall Study|Withdrawal by Subject|9|||
146816342|NCT01587703|529495792|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146816343|NCT01587703|529495793|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146816344|NCT01587703|529495794|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146816345|NCT01587703|529495795|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146816346|NCT01587703|529495796|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146946697|NCT03039192|529960794|FG000|Overall Study|Discontinued from treatment phase|19|||
146946698|NCT03039192|529960795|FG001|Overall Study|Discontinued from treatment phase|12|||
146946699|NCT03039192|529960794|FG000|Overall Study|Other|3|||
146946700|NCT03039192|529960795|FG001|Overall Study|Other|2|||
146946701|NCT03559192|529960796|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
146946702|NCT03559192|529960797|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
146946703|NCT03559192|529960798|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
146946704|NCT03559192|529960796|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
146816347|NCT01587703|529495797|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
146816348|NCT01587703|529495798|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146816349|NCT01587703|529495799|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146816350|NCT01587703|529495800|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
146816351|NCT01587703|529495801|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146816352|NCT01587703|529495802|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146816353|NCT01587703|529495803|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146816354|NCT01587703|529495804|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146816355|NCT01587703|529495786|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146816356|NCT01587703|529495787|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146816357|NCT01587703|529495788|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146816358|NCT01587703|529495789|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146816359|NCT01587703|529495790|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146816360|NCT01587703|529495791|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146816361|NCT01587703|529495792|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146816362|NCT01587703|529495793|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146816363|NCT01587703|529495794|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146816364|NCT01587703|529495795|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146816365|NCT01587703|529495796|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146816366|NCT01587703|529495797|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
146816367|NCT01587703|529495798|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
146816368|NCT01587703|529495799|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
146816369|NCT01587703|529495800|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
146816370|NCT01587703|529495801|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
146816371|NCT01587703|529495802|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
146816372|NCT01587703|529495803|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146816373|NCT01587703|529495804|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146816374|NCT01587703|529495786|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
146816375|NCT01587703|529495787|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
146816376|NCT01587703|529495788|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
146816377|NCT01587703|529495789|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
146816378|NCT01587703|529495790|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
146816379|NCT01587703|529495791|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
146816380|NCT01587703|529495792|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
146816381|NCT01587703|529495793|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
146816382|NCT01587703|529495794|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
146816383|NCT01587703|529495795|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
146816384|NCT01587703|529495796|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
146816385|NCT01587703|529495797|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
146816386|NCT01587703|529495798|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
146816387|NCT01587703|529495799|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
146816388|NCT01587703|529495800|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
146816389|NCT01587703|529495801|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
146816390|NCT01587703|529495802|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
146816391|NCT01587703|529495803|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
146984641|NCT00457665|530105113|FG001|12 Months|Lipodystrophy|0|||
146984642|NCT00457665|530105112|FG000|12 Months|Withdrawal by Subject|0|||
146984643|NCT00457665|530105113|FG001|12 Months|Withdrawal by Subject|2|||
146984644|NCT00457665|530105112|FG000|12 Months|Abnormal Liver function tests|0|||
146984645|NCT00457665|530105113|FG001|12 Months|Abnormal Liver function tests|5|||
146984646|NCT00457665|530105112|FG000|24 Months|Withdrawal by Subject|3|||
146984647|NCT00457665|530105113|FG001|24 Months|Withdrawal by Subject|2|||
146984648|NCT00457665|530105112|FG000|24 Months|Lipodystrophy|1|||
146816392|NCT01587703|529495804|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
146816393|NCT01587703|529495786|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816394|NCT01587703|529495787|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816395|NCT01587703|529495788|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816396|NCT01587703|529495789|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816397|NCT01587703|529495790|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816398|NCT01587703|529495791|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816399|NCT01587703|529495792|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816400|NCT01587703|529495793|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816401|NCT01587703|529495794|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816402|NCT01587703|529495795|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816403|NCT01587703|529495796|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816404|NCT01587703|529495797|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
146984649|NCT00457665|530105113|FG001|24 Months|Lipodystrophy|1|||
146984650|NCT00457665|530105112|FG000|24 Months|Abnormal liver function tests|1|||
146984651|NCT00457665|530105113|FG001|24 Months|Abnormal liver function tests|5|||
146984652|NCT02535000|530105115|FG000|Overall Study|Cancellation of surgery.|1|||
146946705|NCT03559192|529960797|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
146946706|NCT03559192|529960798|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
146946707|NCT03559192|529960796|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
146946708|NCT03559192|529960797|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
146946709|NCT03559192|529960798|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
146946710|NCT03559192|529960796|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
146946711|NCT03559192|529960797|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
146946712|NCT03559192|529960798|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
146946713|NCT03559192|529960796|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
146946714|NCT03559192|529960797|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
146946715|NCT03559192|529960798|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
146946716|NCT03559192|529960796|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
146946717|NCT03559192|529960797|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
146946718|NCT03559192|529960798|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
146946719|NCT03559192|529960796|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
146946720|NCT03559192|529960797|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
146946721|NCT03559192|529960798|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
146946722|NCT03559192|529960796|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
146946723|NCT03559192|529960797|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
146946724|NCT03559192|529960798|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
146946725|NCT03559192|529960796|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
146946726|NCT03559192|529960797|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
146816405|NCT01587703|529495798|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816406|NCT01587703|529495799|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816407|NCT01587703|529495800|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816408|NCT01587703|529495801|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816409|NCT01587703|529495802|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816410|NCT01587703|529495803|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816411|NCT01587703|529495804|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146816412|NCT01012999|529495806|FG000|Overall Study|Protocol Violation|1|||
146816413|NCT01322347|529495807|FG000|Overall Study|Adverse Event|7|||
146816414|NCT01322347|529495808|FG001|Overall Study|Adverse Event|2|||
146816415|NCT01322347|529495807|FG000|Overall Study|Death|5|||
146816416|NCT01322347|529495808|FG001|Overall Study|Death|3|||
146816417|NCT01322347|529495807|FG000|Overall Study|Physician Decision|2|||
146816418|NCT01322347|529495808|FG001|Overall Study|Physician Decision|1|||
146816419|NCT01322347|529495807|FG000|Overall Study|Protocol Violation|5|||
146816420|NCT01322347|529495808|FG001|Overall Study|Protocol Violation|2|||
146816421|NCT01322347|529495807|FG000|Overall Study|Withdrawal by Subject|1|||
146816422|NCT01322347|529495808|FG001|Overall Study|Withdrawal by Subject|4|||
146946727|NCT03559192|529960798|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
146946728|NCT04888507|529962137|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
146946729|NCT00636155|529962138|FG000|Overall Study|Adverse Event|8|||
146946730|NCT00636155|529962138|FG000|Overall Study|Lack of Efficacy|1|||
146946731|NCT00636155|529962138|FG000|Overall Study|Withdrawal by Subject|3|||
146946732|NCT00636155|529962138|FG000|Overall Study|Stem cell transplant|1|||
146946733|NCT00636155|529962138|FG000|Overall Study|Physician Decision|5|||
146946734|NCT00766142|529962139|FG000|Overall Study|Protocol Violation|4|||
146946735|NCT00400946|529962140|FG000|Overall Study|Ineligible|0|||
146946736|NCT00400946|529962141|FG001|Overall Study|Ineligible|0|||
146946737|NCT00400946|529962142|FG002|Overall Study|Ineligible|0|||
146946738|NCT00400946|529962143|FG003|Overall Study|Ineligible|5|||
146946739|NCT00400946|529962144|FG004|Overall Study|Ineligible|1|||
146946740|NCT00400946|529962140|FG000|Overall Study|Induction Failure|0|||
146946741|NCT00400946|529962141|FG001|Overall Study|Induction Failure|0|||
146946742|NCT00400946|529962142|FG002|Overall Study|Induction Failure|0|||
146946743|NCT00400946|529962143|FG003|Overall Study|Induction Failure|11|||
146946744|NCT00400946|529962144|FG004|Overall Study|Induction Failure|8|||
146946745|NCT00400946|529962140|FG000|Overall Study|Induction Death|0|||
146946746|NCT00400946|529962141|FG001|Overall Study|Induction Death|0|||
146946747|NCT00400946|529962142|FG002|Overall Study|Induction Death|0|||
146946748|NCT00400946|529962143|FG003|Overall Study|Induction Death|13|||
146946749|NCT00400946|529962144|FG004|Overall Study|Induction Death|3|||
146946750|NCT00400946|529962140|FG000|Overall Study|Lost to Follow-up|1|||
146946751|NCT00400946|529962141|FG001|Overall Study|Lost to Follow-up|1|||
146816423|NCT01322347|529495807|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
146816424|NCT01322347|529495808|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
146816425|NCT01322347|529495807|FG000|Overall Study|blood transfusion|5|||
146816426|NCT01322347|529495808|FG001|Overall Study|blood transfusion|5|||
146946752|NCT00400946|529962142|FG002|Overall Study|Lost to Follow-up|0|||
146946753|NCT00400946|529962143|FG003|Overall Study|Lost to Follow-up|0|||
146946754|NCT00400946|529962144|FG004|Overall Study|Lost to Follow-up|1|||
146946755|NCT00400946|529962140|FG000|Overall Study|Remission Death|1|||
146816427|NCT01322347|529495807|FG000|Overall Study|sponsor decision|1|||
146816428|NCT01322347|529495808|FG001|Overall Study|sponsor decision|3|||
146816429|NCT01322347|529495807|FG000|Overall Study|ineligible|6|||
146816430|NCT01322347|529495808|FG001|Overall Study|ineligible|3|||
146816431|NCT01322347|529495807|FG000|Overall Study|kidney transplant|3|||
146816432|NCT01322347|529495808|FG001|Overall Study|kidney transplant|1|||
146816433|NCT01322347|529495807|FG000|Overall Study|study drug withheld > 12 wks|0|||
146816434|NCT01322347|529495808|FG001|Overall Study|study drug withheld > 12 wks|1|||
146984653|NCT02535000|530105116|FG001|Overall Study|Cancellation of surgery.|2|||
146984654|NCT01620489|530105121|FG000|Overall Study|Adverse Event|17|||
146984655|NCT01620489|530105122|FG001|Overall Study|Adverse Event|4|||
146984656|NCT01620489|530105121|FG000|Overall Study|Protocol Violation|0|||
146984657|NCT01620489|530105122|FG001|Overall Study|Protocol Violation|3|||
146984658|NCT01620489|530105121|FG000|Overall Study|Withdrawal Criteria|17|||
146984659|NCT01620489|530105122|FG001|Overall Study|Withdrawal Criteria|25|||
146816435|NCT01322347|529495807|FG000|Overall Study|moved/changed dialysis|2|||
146816436|NCT01322347|529495808|FG001|Overall Study|moved/changed dialysis|4|||
146816437|NCT04883541|529495809|FG000|Overall Study|Not attending regular yoga class|16|||
146816438|NCT04883541|529495810|FG001|Overall Study|Not attending regular yoga class|0|||
146816439|NCT04883541|529495809|FG000|Overall Study|Not attending the pregnancy school|0|||
146816440|NCT04883541|529495810|FG001|Overall Study|Not attending the pregnancy school|9|||
146816441|NCT01369147|529495811|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
146816442|NCT01369147|529495812|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
146816443|NCT01369147|529495813|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
146816444|NCT02823574|529495814|FG000|Randomization|Disease Progression|0|||
146816445|NCT02823574|529495815|FG001|Randomization|Disease Progression|0|||
146816446|NCT02823574|529495816|FG002|Randomization|Disease Progression|1|||
146816447|NCT02823574|529495817|FG003|Randomization|Disease Progression|0|||
146816448|NCT02823574|529495814|FG000|Randomization|AE unrelated to Study Drug|1|||
146816449|NCT02823574|529495815|FG001|Randomization|AE unrelated to Study Drug|0|||
146816450|NCT02823574|529495816|FG002|Randomization|AE unrelated to Study Drug|0|||
146816451|NCT02823574|529495817|FG003|Randomization|AE unrelated to Study Drug|0|||
146816452|NCT02823574|529495814|FG000|Treatment Period|Poor/Non Compliance|1|||
146816453|NCT02823574|529495815|FG001|Treatment Period|Poor/Non Compliance|0|||
146816454|NCT02823574|529495816|FG002|Treatment Period|Poor/Non Compliance|0|||
146816455|NCT02823574|529495817|FG003|Treatment Period|Poor/Non Compliance|1|||
146816456|NCT02823574|529495814|FG000|Treatment Period|Maximum Clinical Benefit|8|||
146816457|NCT02823574|529495815|FG001|Treatment Period|Maximum Clinical Benefit|4|||
146816458|NCT02823574|529495816|FG002|Treatment Period|Maximum Clinical Benefit|7|||
146816459|NCT02823574|529495817|FG003|Treatment Period|Maximum Clinical Benefit|1|||
146816460|NCT02823574|529495814|FG000|Treatment Period|Lost to Follow-up|1|||
146816461|NCT02823574|529495815|FG001|Treatment Period|Lost to Follow-up|1|||
146816462|NCT02823574|529495816|FG002|Treatment Period|Lost to Follow-up|0|||
146816463|NCT02823574|529495817|FG003|Treatment Period|Lost to Follow-up|0|||
146984660|NCT01620489|530105121|FG000|Overall Study|Unclassified|1|||
146984661|NCT01620489|530105122|FG001|Overall Study|Unclassified|2|||
146984662|NCT01851590|530105124|FG000|Overall Study|Withdrawal by Subject|0|||
146984663|NCT01851590|530105125|FG001|Overall Study|Withdrawal by Subject|0|||
146816464|NCT02823574|529495814|FG000|Treatment Period|Participant withdrew consent|4|||
146816465|NCT02823574|529495815|FG001|Treatment Period|Participant withdrew consent|0|||
146816466|NCT02823574|529495816|FG002|Treatment Period|Participant withdrew consent|0|||
146816467|NCT02823574|529495817|FG003|Treatment Period|Participant withdrew consent|1|||
146816468|NCT02823574|529495814|FG000|Treatment Period|Participant request to discontinue|5|||
146816469|NCT02823574|529495815|FG001|Treatment Period|Participant request to discontinue|0|||
146816470|NCT02823574|529495816|FG002|Treatment Period|Participant request to discontinue|3|||
146816471|NCT02823574|529495817|FG003|Treatment Period|Participant request to discontinue|2|||
146816472|NCT02823574|529495814|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
146816473|NCT02823574|529495815|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
146816474|NCT02823574|529495816|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
146816475|NCT02823574|529495817|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
146816476|NCT02823574|529495814|FG000|Treatment Period|Study Drug Toxicity|11|||
146816477|NCT02823574|529495815|FG001|Treatment Period|Study Drug Toxicity|2|||
146816478|NCT02823574|529495816|FG002|Treatment Period|Study Drug Toxicity|14|||
146816479|NCT02823574|529495817|FG003|Treatment Period|Study Drug Toxicity|4|||
146816480|NCT02823574|529495814|FG000|Treatment Period|Disease Progression|113|||
146816481|NCT02823574|529495815|FG001|Treatment Period|Disease Progression|64|||
146816482|NCT02823574|529495816|FG002|Treatment Period|Disease Progression|82|||
146816483|NCT02823574|529495817|FG003|Treatment Period|Disease Progression|43|||
146816484|NCT02823574|529495814|FG000|Treatment Period|Other reasons|5|||
146816485|NCT02823574|529495815|FG001|Treatment Period|Other reasons|9|||
146816486|NCT02823574|529495816|FG002|Treatment Period|Other reasons|3|||
146816487|NCT02823574|529495817|FG003|Treatment Period|Other reasons|6|||
146984664|NCT01851590|530105126|FG002|Overall Study|Withdrawal by Subject|1|||
146984665|NCT01851590|530105124|FG000|Overall Study|Adverse Event|0|||
146946756|NCT00400946|529962141|FG001|Overall Study|Remission Death|1|||
146946757|NCT00400946|529962142|FG002|Overall Study|Remission Death|0|||
146946758|NCT00400946|529962143|FG003|Overall Study|Remission Death|0|||
146946759|NCT00400946|529962144|FG004|Overall Study|Remission Death|1|||
146946760|NCT00400946|529962140|FG000|Overall Study|Relapse|9|||
146946761|NCT00400946|529962141|FG001|Overall Study|Relapse|2|||
146946762|NCT00400946|529962142|FG002|Overall Study|Relapse|1|||
146946763|NCT00400946|529962143|FG003|Overall Study|Relapse|1|||
146946764|NCT00400946|529962144|FG004|Overall Study|Relapse|5|||
146946765|NCT00400946|529962140|FG000|Overall Study|Transplant in CR1|0|||
146946766|NCT00400946|529962141|FG001|Overall Study|Transplant in CR1|0|||
146946767|NCT00400946|529962142|FG002|Overall Study|Transplant in CR1|0|||
146946768|NCT00400946|529962143|FG003|Overall Study|Transplant in CR1|10|||
146946769|NCT00400946|529962144|FG004|Overall Study|Transplant in CR1|1|||
146946770|NCT00400946|529962140|FG000|Overall Study|Withdrawal by Subject|2|||
146946771|NCT00400946|529962141|FG001|Overall Study|Withdrawal by Subject|5|||
146946772|NCT00400946|529962142|FG002|Overall Study|Withdrawal by Subject|1|||
146946773|NCT00400946|529962143|FG003|Overall Study|Withdrawal by Subject|5|||
146946774|NCT00400946|529962144|FG004|Overall Study|Withdrawal by Subject|8|||
146946775|NCT00400946|529962140|FG000|Overall Study|Clinical|1|||
146946776|NCT00400946|529962141|FG001|Overall Study|Clinical|2|||
146946777|NCT00400946|529962142|FG002|Overall Study|Clinical|0|||
146946778|NCT00400946|529962143|FG003|Overall Study|Clinical|2|||
146946779|NCT00400946|529962144|FG004|Overall Study|Clinical|9|||
146946780|NCT00400946|529962140|FG000|Overall Study|Other|0|||
146946781|NCT00400946|529962141|FG001|Overall Study|Other|0|||
146946782|NCT00400946|529962142|FG002|Overall Study|Other|0|||
146946783|NCT00400946|529962143|FG003|Overall Study|Other|0|||
146946784|NCT00400946|529962144|FG004|Overall Study|Other|1|||
146946785|NCT05643170|529962150|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
146946786|NCT05643170|529962150|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
146946787|NCT02358863|529962155|FG000|Overall Study|Physician Decision|3|||
146946788|NCT01673373|529962165|FG000|Overall Study|Death|2|||
146946789|NCT02632344|529962166|FG000|Overall Study|Adverse Event|3|||
146946790|NCT02632344|529962166|FG000|Overall Study|Lack of Efficacy|3|||
146946791|NCT02632344|529962166|FG000|Overall Study|Withdrawal by Subject|2|||
146946792|NCT05426460|529962167|FG000|Overall Study|Protocol Violation|1|||
146946793|NCT05426460|529962168|FG001|Overall Study|Protocol Violation|1|||
146946794|NCT05426460|529962169|FG002|Overall Study|Protocol Violation|1|||
146946795|NCT05426460|529962170|FG003|Overall Study|Protocol Violation|0|||
146946796|NCT00413777|529962172|FG000|Fixed-dose Period|Lost to Follow-up|1|||
146946797|NCT00413777|529962173|FG001|Fixed-dose Period|Lost to Follow-up|1|||
146946798|NCT00413777|529962172|FG000|Fixed-dose Period|Adverse Event|2|||
146946799|NCT00413777|529962173|FG001|Fixed-dose Period|Adverse Event|1|||
146946800|NCT00413777|529962172|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
146946801|NCT00413777|529962173|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
146946802|NCT00413777|529962172|FG000|Fixed-dose Period|Withdrew Consent|0|||
146946803|NCT00413777|529962173|FG001|Fixed-dose Period|Withdrew Consent|1|||
146946804|NCT03287830|529962174|FG000|Overall Study|Withdrawal by Subject|1|||
146946805|NCT03287830|529962175|FG001|Overall Study|Withdrawal by Subject|1|||
146946806|NCT03287830|529962174|FG000|Overall Study|not meeting inclusion criteria|5|||
146946807|NCT03287830|529962175|FG001|Overall Study|not meeting inclusion criteria|12|||
146946808|NCT00976963|529962178|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
146946809|NCT00976963|529962179|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
146946810|NCT00976963|529962178|FG000|Overall Study|administrative error|1|||
146946811|NCT00976963|529962179|FG001|Overall Study|administrative error|0|||
146946812|NCT00976963|529962178|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
146946813|NCT00976963|529962179|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
146946814|NCT03039790|529962181|FG000|Overall Study|Lost to Follow-up|2|||
146946815|NCT03039790|529962182|FG001|Overall Study|Lost to Follow-up|0|||
146946816|NCT03039790|529962183|FG002|Overall Study|Lost to Follow-up|1|||
146946817|NCT03039790|529962184|FG003|Overall Study|Lost to Follow-up|1|||
146946818|NCT03039790|529962185|FG004|Overall Study|Lost to Follow-up|0|||
146946819|NCT03039790|529962186|FG005|Overall Study|Lost to Follow-up|1|||
146946820|NCT03039790|529962187|FG006|Overall Study|Lost to Follow-up|1|||
146816488|NCT02823574|529495814|FG000|Treatment Period|Participant no longer meets study criteria|0|||
146946821|NCT03039790|529962188|FG007|Overall Study|Lost to Follow-up|1|||
146946822|NCT03039790|529962189|FG008|Overall Study|Lost to Follow-up|0|||
146946823|NCT03039790|529962190|FG009|Overall Study|Lost to Follow-up|1|||
146816489|NCT02823574|529495815|FG001|Treatment Period|Participant no longer meets study criteria|0|||
146946824|NCT03039790|529962191|FG010|Overall Study|Lost to Follow-up|1|||
146946825|NCT03039790|529962192|FG011|Overall Study|Lost to Follow-up|0|||
146946826|NCT03039790|529962193|FG012|Overall Study|Lost to Follow-up|1|||
146946827|NCT03039790|529962194|FG013|Overall Study|Lost to Follow-up|0|||
146946828|NCT03039790|529962195|FG014|Overall Study|Lost to Follow-up|3|||
146946829|NCT03039790|529962196|FG015|Overall Study|Lost to Follow-up|1|||
146946830|NCT03039790|529962197|FG016|Overall Study|Lost to Follow-up|2|||
146816490|NCT02823574|529495816|FG002|Treatment Period|Participant no longer meets study criteria|1|||
146816491|NCT02823574|529495817|FG003|Treatment Period|Participant no longer meets study criteria|0|||
146816492|NCT02823574|529495814|FG000|Treatment Period|Death|0|||
146816493|NCT02823574|529495815|FG001|Treatment Period|Death|0|||
146816494|NCT02823574|529495816|FG002|Treatment Period|Death|3|||
146816495|NCT02823574|529495817|FG003|Treatment Period|Death|1|||
146816496|NCT00590759|529495818|FG000|Overall Study|Death|52|||
146816497|NCT00590759|529495818|FG000|Overall Study|Lost to Follow-up|28|||
146816498|NCT02991118|529495819|FG000|Overall Study|Death|3|||
146816499|NCT02991118|529495820|FG001|Overall Study|Death|8|||
146816500|NCT02991118|529495819|FG000|Overall Study|Protocol Violation|0|||
146816501|NCT02991118|529495820|FG001|Overall Study|Protocol Violation|3|||
146816502|NCT02991118|529495819|FG000|Overall Study|Physician Decision|0|||
146816503|NCT02991118|529495820|FG001|Overall Study|Physician Decision|1|||
146816504|NCT02991118|529495819|FG000|Overall Study|Moved out of the country|0|||
146816505|NCT02991118|529495820|FG001|Overall Study|Moved out of the country|1|||
146816506|NCT02991118|529495819|FG000|Overall Study|Adverse Event|2|||
146816507|NCT02991118|529495820|FG001|Overall Study|Adverse Event|2|||
146816508|NCT02991118|529495819|FG000|Overall Study|Withdrawal by Subject|1|||
146816509|NCT02991118|529495820|FG001|Overall Study|Withdrawal by Subject|7|||
146816510|NCT02991118|529495819|FG000|Overall Study|Could not attend study visits|0|||
146816511|NCT02991118|529495820|FG001|Overall Study|Could not attend study visits|1|||
146816512|NCT02991118|529495819|FG000|Overall Study|Lost to Follow-up|1|||
146816513|NCT02991118|529495820|FG001|Overall Study|Lost to Follow-up|9|||
146816514|NCT00963924|529495825|FG000|Overall Study|Adverse Event|1|||
146816515|NCT00963924|529495826|FG001|Overall Study|Adverse Event|0|||
146816516|NCT00963924|529495825|FG000|Overall Study|Withdrawal by Subject|0|||
146816517|NCT00963924|529495826|FG001|Overall Study|Withdrawal by Subject|1|||
146816518|NCT00963924|529495825|FG000|Overall Study|Changed antipsychotic|0|||
146816519|NCT00963924|529495826|FG001|Overall Study|Changed antipsychotic|1|||
146816520|NCT00963924|529495825|FG000|Overall Study|Lost to Follow-up|0|||
146816521|NCT00963924|529495826|FG001|Overall Study|Lost to Follow-up|1|||
146816522|NCT00446095|529495827|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
146816523|NCT00446095|529495828|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
146816524|NCT00446095|529495829|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
146816525|NCT00446095|529495830|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
146816526|NCT00446095|529495831|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
146816527|NCT00446095|529495827|FG000|Phase II (8 Weeks)|Adverse Event|0|||
146816528|NCT00446095|529495828|FG001|Phase II (8 Weeks)|Adverse Event|1|||
146816529|NCT00446095|529495829|FG002|Phase II (8 Weeks)|Adverse Event|1|||
146816530|NCT00446095|529495830|FG003|Phase II (8 Weeks)|Adverse Event|0|||
146816531|NCT00446095|529495831|FG004|Phase II (8 Weeks)|Adverse Event|0|||
146816532|NCT00446095|529495827|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
146816533|NCT00446095|529495828|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
146816534|NCT00446095|529495829|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
146816535|NCT00446095|529495830|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
146816536|NCT00446095|529495831|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
146816537|NCT00446095|529495827|FG000|Phase II (8 Weeks)|Physician Decision|1|||
146816538|NCT00446095|529495828|FG001|Phase II (8 Weeks)|Physician Decision|0|||
146816539|NCT00446095|529495829|FG002|Phase II (8 Weeks)|Physician Decision|0|||
146816540|NCT00446095|529495830|FG003|Phase II (8 Weeks)|Physician Decision|0|||
146816541|NCT00446095|529495831|FG004|Phase II (8 Weeks)|Physician Decision|0|||
146816542|NCT00446095|529495827|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
146946831|NCT03039790|529962198|FG017|Overall Study|Lost to Follow-up|2|||
146946832|NCT03039790|529962199|FG018|Overall Study|Lost to Follow-up|1|||
146946833|NCT03039790|529962200|FG019|Overall Study|Lost to Follow-up|3|||
146946834|NCT03039790|529962181|FG000|Overall Study|Withdrawal of Consent|1|||
146946835|NCT03039790|529962182|FG001|Overall Study|Withdrawal of Consent|0|||
146946836|NCT03039790|529962183|FG002|Overall Study|Withdrawal of Consent|0|||
146946837|NCT03039790|529962184|FG003|Overall Study|Withdrawal of Consent|1|||
146946838|NCT03039790|529962185|FG004|Overall Study|Withdrawal of Consent|0|||
146946839|NCT03039790|529962186|FG005|Overall Study|Withdrawal of Consent|0|||
146946840|NCT03039790|529962187|FG006|Overall Study|Withdrawal of Consent|0|||
146946841|NCT03039790|529962188|FG007|Overall Study|Withdrawal of Consent|0|||
146816543|NCT00446095|529495828|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
146816544|NCT00446095|529495829|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
146816545|NCT00446095|529495830|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
146816546|NCT00446095|529495831|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
146816547|NCT00446095|529495827|FG000|Phase II (8 Weeks)|Ongoing|0|||
146816548|NCT00446095|529495828|FG001|Phase II (8 Weeks)|Ongoing|0|||
146946842|NCT03039790|529962189|FG008|Overall Study|Withdrawal of Consent|0|||
146946843|NCT03039790|529962190|FG009|Overall Study|Withdrawal of Consent|1|||
146946844|NCT03039790|529962191|FG010|Overall Study|Withdrawal of Consent|0|||
146946845|NCT03039790|529962192|FG011|Overall Study|Withdrawal of Consent|0|||
146816549|NCT00446095|529495829|FG002|Phase II (8 Weeks)|Ongoing|1|||
146816550|NCT00446095|529495830|FG003|Phase II (8 Weeks)|Ongoing|0|||
146816551|NCT00446095|529495831|FG004|Phase II (8 Weeks)|Ongoing|0|||
146816552|NCT00446095|529495827|FG000|Phase I (28 Days)|Adverse Event|0|||
146946846|NCT03039790|529962193|FG012|Overall Study|Withdrawal of Consent|2|||
146946847|NCT03039790|529962194|FG013|Overall Study|Withdrawal of Consent|0|||
146946848|NCT03039790|529962195|FG014|Overall Study|Withdrawal of Consent|1|||
146946849|NCT03039790|529962196|FG015|Overall Study|Withdrawal of Consent|5|||
146946850|NCT03039790|529962197|FG016|Overall Study|Withdrawal of Consent|3|||
146946851|NCT03039790|529962198|FG017|Overall Study|Withdrawal of Consent|0|||
146946852|NCT03039790|529962199|FG018|Overall Study|Withdrawal of Consent|2|||
146946853|NCT03039790|529962200|FG019|Overall Study|Withdrawal of Consent|5|||
146946854|NCT03039790|529962181|FG000|Overall Study|Death|0|||
146946855|NCT03039790|529962182|FG001|Overall Study|Death|0|||
146946856|NCT03039790|529962183|FG002|Overall Study|Death|0|||
146946857|NCT03039790|529962184|FG003|Overall Study|Death|0|||
146946858|NCT03039790|529962185|FG004|Overall Study|Death|0|||
146946859|NCT03039790|529962186|FG005|Overall Study|Death|0|||
146946860|NCT03039790|529962187|FG006|Overall Study|Death|0|||
146946861|NCT03039790|529962188|FG007|Overall Study|Death|0|||
146946862|NCT03039790|529962189|FG008|Overall Study|Death|0|||
146946863|NCT03039790|529962190|FG009|Overall Study|Death|0|||
146946864|NCT03039790|529962191|FG010|Overall Study|Death|0|||
146946865|NCT03039790|529962192|FG011|Overall Study|Death|0|||
146946866|NCT03039790|529962193|FG012|Overall Study|Death|0|||
146946867|NCT03039790|529962194|FG013|Overall Study|Death|0|||
146946868|NCT03039790|529962195|FG014|Overall Study|Death|0|||
146946869|NCT03039790|529962196|FG015|Overall Study|Death|1|||
146946870|NCT03039790|529962197|FG016|Overall Study|Death|3|||
146946871|NCT03039790|529962198|FG017|Overall Study|Death|0|||
146946872|NCT03039790|529962199|FG018|Overall Study|Death|2|||
146946873|NCT03039790|529962200|FG019|Overall Study|Death|0|||
146946874|NCT03039790|529962181|FG000|Overall Study|Reason, not Specified|1|||
146946875|NCT03039790|529962182|FG001|Overall Study|Reason, not Specified|0|||
146946876|NCT03039790|529962183|FG002|Overall Study|Reason, not Specified|0|||
146946877|NCT03039790|529962184|FG003|Overall Study|Reason, not Specified|0|||
146946878|NCT03039790|529962185|FG004|Overall Study|Reason, not Specified|0|||
146946879|NCT03039790|529962186|FG005|Overall Study|Reason, not Specified|0|||
146946880|NCT03039790|529962187|FG006|Overall Study|Reason, not Specified|0|||
146946881|NCT03039790|529962188|FG007|Overall Study|Reason, not Specified|0|||
146946882|NCT03039790|529962189|FG008|Overall Study|Reason, not Specified|0|||
146946883|NCT03039790|529962190|FG009|Overall Study|Reason, not Specified|0|||
146946884|NCT03039790|529962191|FG010|Overall Study|Reason, not Specified|0|||
146946885|NCT03039790|529962192|FG011|Overall Study|Reason, not Specified|0|||
146946886|NCT03039790|529962193|FG012|Overall Study|Reason, not Specified|0|||
146946887|NCT03039790|529962194|FG013|Overall Study|Reason, not Specified|0|||
146946888|NCT03039790|529962195|FG014|Overall Study|Reason, not Specified|0|||
146946889|NCT03039790|529962196|FG015|Overall Study|Reason, not Specified|0|||
146946890|NCT03039790|529962197|FG016|Overall Study|Reason, not Specified|2|||
146946891|NCT03039790|529962198|FG017|Overall Study|Reason, not Specified|0|||
146946892|NCT03039790|529962199|FG018|Overall Study|Reason, not Specified|1|||
146946893|NCT03039790|529962200|FG019|Overall Study|Reason, not Specified|0|||
146946894|NCT00557323|529962201|FG000|Overall Study|Death|3|||
146946895|NCT00557323|529962201|FG000|Overall Study|Withdrawal by Subject|2|||
146946896|NCT00557323|529962201|FG000|Overall Study|Administrative change|2|||
146946897|NCT00498368|529962211|FG000|Overall Study|Withdrawal by Subject|3|||
146946898|NCT00498368|529962212|FG001|Overall Study|Withdrawal by Subject|2|||
146946899|NCT02266004|529962213|FG000|Overall Study|unrelated adverse event|1|||
146946900|NCT02266004|529962213|FG000|Overall Study|Physician Decision|1|||
146946901|NCT00537771|529962218|FG000|Overall Study|Withdrawal by Subject|6|||
146946902|NCT00537771|529962219|FG001|Overall Study|Withdrawal by Subject|23|||
146946903|NCT00537771|529962218|FG000|Overall Study|Adverse Event|8|||
146946904|NCT00537771|529962219|FG001|Overall Study|Adverse Event|15|||
146946905|NCT00537771|529962218|FG000|Overall Study|Lost to Follow-up|9|||
146946906|NCT00537771|529962219|FG001|Overall Study|Lost to Follow-up|15|||
146946907|NCT00537771|529962218|FG000|Overall Study|Protocol Violation|2|||
146946908|NCT00537771|529962219|FG001|Overall Study|Protocol Violation|6|||
146946909|NCT00537771|529962218|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
146946910|NCT00537771|529962219|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
146946911|NCT03748420|529962229|FG000|Overall Study|No 12 month medication adherence data available|0|||
146946912|NCT03748420|529962230|FG001|Overall Study|No 12 month medication adherence data available|1|||
146946913|NCT03748420|529962229|FG000|Overall Study|Death|24|||
146946914|NCT03748420|529962230|FG001|Overall Study|Death|28|||
146946915|NCT03748420|529962229|FG000|Overall Study|Lost to Follow-up|231|||
146946916|NCT03748420|529962230|FG001|Overall Study|Lost to Follow-up|230|||
146946917|NCT00372489|529962234|FG000|Overall Study|Adverse Event|18|||
146946918|NCT00372489|529962234|FG000|Overall Study|Lack of Efficacy|1|||
146946919|NCT00372489|529962234|FG000|Overall Study|Lost to Follow-up|3|||
146946920|NCT00372489|529962234|FG000|Overall Study|Physician Decision|3|||
146946921|NCT00372489|529962234|FG000|Overall Study|Withdrawal by Subject|5|||
146946922|NCT00372489|529962234|FG000|Overall Study|Patient Relocation|2|||
146946923|NCT00372489|529962234|FG000|Overall Study|Renal transplant|6|||
146946924|NCT00372489|529962234|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
146816553|NCT00446095|529495828|FG001|Phase I (28 Days)|Adverse Event|0|||
146816554|NCT00446095|529495829|FG002|Phase I (28 Days)|Adverse Event|0|||
146816555|NCT00446095|529495830|FG003|Phase I (28 Days)|Adverse Event|1|||
146816556|NCT00446095|529495831|FG004|Phase I (28 Days)|Adverse Event|0|||
146816557|NCT00446095|529495827|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
146816558|NCT00446095|529495828|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
146816559|NCT00446095|529495829|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
146816560|NCT00446095|529495830|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
146816561|NCT00446095|529495831|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
146816562|NCT00886834|529495832|FG000|Overall Study|Protocol Violation|0|||
146816563|NCT00886834|529495833|FG001|Overall Study|Protocol Violation|3|||
146816564|NCT00657709|529495834|FG000|Overall Study|AE or Death|7|||
146816565|NCT00657709|529495835|FG001|Overall Study|AE or Death|7|||
146816566|NCT00657709|529495836|FG002|Overall Study|AE or Death|6|||
146816567|NCT00657709|529495837|FG003|Overall Study|AE or Death|7|||
146816568|NCT00657709|529495838|FG004|Overall Study|AE or Death|1|||
146816569|NCT00657709|529495834|FG000|Overall Study|Withdrawal by Subject|7|||
146816570|NCT00657709|529495835|FG001|Overall Study|Withdrawal by Subject|15|||
146816571|NCT00657709|529495836|FG002|Overall Study|Withdrawal by Subject|15|||
146816572|NCT00657709|529495837|FG003|Overall Study|Withdrawal by Subject|5|||
146816573|NCT00657709|529495838|FG004|Overall Study|Withdrawal by Subject|9|||
146816574|NCT00657709|529495834|FG000|Overall Study|Lost to Follow-up|9|||
146816575|NCT00657709|529495835|FG001|Overall Study|Lost to Follow-up|9|||
146816576|NCT00657709|529495836|FG002|Overall Study|Lost to Follow-up|7|||
146816577|NCT00657709|529495837|FG003|Overall Study|Lost to Follow-up|1|||
146816578|NCT00657709|529495838|FG004|Overall Study|Lost to Follow-up|21|||
146816579|NCT00657709|529495834|FG000|Overall Study|Protocol Violation|0|||
146816580|NCT00657709|529495835|FG001|Overall Study|Protocol Violation|2|||
146816581|NCT00657709|529495836|FG002|Overall Study|Protocol Violation|0|||
146816582|NCT00657709|529495837|FG003|Overall Study|Protocol Violation|1|||
146816583|NCT00657709|529495838|FG004|Overall Study|Protocol Violation|2|||
146816584|NCT02764320|529495839|FG000|Overall Study|Withdrawal by Subject|35|||
146816585|NCT02764320|529495840|FG001|Overall Study|Withdrawal by Subject|38|||
146816586|NCT02764320|529495839|FG000|Overall Study|Protocol Violation|11|||
146816587|NCT02764320|529495840|FG001|Overall Study|Protocol Violation|6|||
146816588|NCT02764320|529495839|FG000|Overall Study|Adverse Event|2|||
146816589|NCT02764320|529495840|FG001|Overall Study|Adverse Event|0|||
146816590|NCT02764320|529495839|FG000|Overall Study|Health Issues unable to continue|2|||
146816591|NCT02764320|529495840|FG001|Overall Study|Health Issues unable to continue|0|||
146816592|NCT02764320|529495839|FG000|Overall Study|Did not meet inclusion criteria|1|||
146816593|NCT02764320|529495840|FG001|Overall Study|Did not meet inclusion criteria|0|||
146816594|NCT02764320|529495839|FG000|Overall Study|Subject moved|0|||
146816595|NCT02764320|529495840|FG001|Overall Study|Subject moved|2|||
146816596|NCT02764320|529495839|FG000|Overall Study|Overused medication unavailable|0|||
146816597|NCT02764320|529495840|FG001|Overall Study|Overused medication unavailable|1|||
146816598|NCT02764320|529495839|FG000|Overall Study|Seeking care outside site|0|||
146816599|NCT02764320|529495840|FG001|Overall Study|Seeking care outside site|1|||
146816600|NCT02764320|529495839|FG000|Overall Study|Technology barriers|0|||
146816601|NCT02764320|529495840|FG001|Overall Study|Technology barriers|1|||
146816602|NCT00753896|529495841|FG000|Overall Study|Adverse Event|4|||
146816603|NCT00753896|529495841|FG000|Overall Study|Death|1|||
146816604|NCT00753896|529495841|FG000|Overall Study|Lost to Follow-up|2|||
146816605|NCT00753896|529495841|FG000|Overall Study|Protocol Violation|1|||
146816606|NCT00753896|529495841|FG000|Overall Study|Withdrawal by Subject|4|||
146816607|NCT00753896|529495841|FG000|Overall Study|Entry Criteria Not Met|4|||
146816608|NCT01280656|529495842|FG000|Overall Study|Adverse Event|1|||
146816609|NCT01280656|529495843|FG001|Overall Study|Adverse Event|14|||
146816610|NCT01280656|529495844|FG002|Overall Study|Adverse Event|13|||
146816611|NCT01280656|529495842|FG000|Overall Study|Lack of Efficacy|1|||
146816612|NCT01280656|529495843|FG001|Overall Study|Lack of Efficacy|22|||
146816613|NCT01280656|529495844|FG002|Overall Study|Lack of Efficacy|38|||
146816614|NCT01280656|529495842|FG000|Overall Study|Treatment shortening (RGT)|0|||
146816615|NCT01280656|529495843|FG001|Overall Study|Treatment shortening (RGT)|4|||
146816616|NCT01280656|529495844|FG002|Overall Study|Treatment shortening (RGT)|5|||
146816617|NCT01280656|529495842|FG000|Overall Study|Other|1|||
146946925|NCT00623766|529962235|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
146946926|NCT00623766|529962236|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
146946927|NCT00623766|529962235|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
146946928|NCT00623766|529962236|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
146946929|NCT00623766|529962235|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
146816618|NCT01280656|529495843|FG001|Overall Study|Other|7|||
146816619|NCT01280656|529495844|FG002|Overall Study|Other|7|||
146816620|NCT02959866|529495845|FG000|Overall Study|Withdrawal by Subject|1|||
146816621|NCT03150589|529495846|FG000|Overall Study|Withdrawal by Subject|16|||
146816622|NCT03150589|529495847|FG001|Overall Study|Withdrawal by Subject|9|||
146816623|NCT03150589|529495846|FG000|Overall Study|Adverse Event|7|||
146816624|NCT03150589|529495847|FG001|Overall Study|Adverse Event|6|||
146816625|NCT03150589|529495846|FG000|Overall Study|Protocol Violation|4|||
146946930|NCT00623766|529962236|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
146946931|NCT00623766|529962235|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
146946932|NCT00623766|529962236|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
146946933|NCT00623766|529962235|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
146946934|NCT00623766|529962236|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
146946935|NCT04247828|529962238|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
146946936|NCT00893763|529962239|FG000|Overall Study|extubated|110|||
146946937|NCT00893763|529962240|FG001|Overall Study|extubated|110|||
146946938|NCT02699125|529962243|FG000|Placebo|Lost to Follow-up|2|||
146946939|NCT02699125|529962244|FG001|Placebo|Lost to Follow-up|0|||
146946940|NCT02699125|529962243|FG000|Placebo|Protocol Violation|1|||
146946941|NCT02699125|529962244|FG001|Placebo|Protocol Violation|0|||
146946942|NCT02699125|529962243|FG000|Placebo|Withdrawal by Subject|0|||
146946943|NCT02699125|529962244|FG001|Placebo|Withdrawal by Subject|4|||
146946944|NCT02699125|529962243|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
146946945|NCT02699125|529962244|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
146946946|NCT04445051|529962245|FG000|Overall Study|Adverse Event|0|||
146946947|NCT04445051|529962246|FG001|Overall Study|Adverse Event|0|||
146946948|NCT04445051|529962247|FG002|Overall Study|Adverse Event|1|||
146946949|NCT04445051|529962248|FG003|Overall Study|Adverse Event|0|||
146946950|NCT04445051|529962249|FG004|Overall Study|Adverse Event|0|||
146946951|NCT04445051|529962250|FG005|Overall Study|Adverse Event|0|||
146946952|NCT02092324|529962258|FG000|Overall Study|Adverse Event|1|||
146946953|NCT02092324|529962258|FG000|Overall Study|Lack of Efficacy|6|||
146946954|NCT02092324|529962258|FG000|Overall Study|Proceed to Transplant|3|||
146946955|NCT02092324|529962258|FG000|Overall Study|Physician Decision|7|||
146946956|NCT02092324|529962258|FG000|Overall Study|Misdiagnosis|2|||
146946957|NCT00398138|529962261|FG000|Overall Study|Adverse Event|2|||
146946958|NCT04973085|529962266|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
146946959|NCT04973085|529962267|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
146946960|NCT03924427|529962273|FG000|Overall Study|Adverse Event|4|||
146946961|NCT03924427|529962273|FG000|Overall Study|Lack of Efficacy|1|||
146946962|NCT03924427|529962273|FG000|Overall Study|Withdrawal by Subject|1|||
146946963|NCT01316380|529962278|FG000|Overall Study|Adverse Event|0|||
146946964|NCT01316380|529962279|FG001|Overall Study|Adverse Event|2|||
146946965|NCT01316380|529962280|FG002|Overall Study|Adverse Event|1|||
146946966|NCT01316380|529962278|FG000|Overall Study|Protocol Violation|0|||
146946967|NCT01316380|529962279|FG001|Overall Study|Protocol Violation|0|||
146946968|NCT01316380|529962280|FG002|Overall Study|Protocol Violation|1|||
146946969|NCT01316380|529962278|FG000|Overall Study|Withdrawal by Subject|1|||
146946970|NCT01316380|529962279|FG001|Overall Study|Withdrawal by Subject|2|||
146946971|NCT01316380|529962280|FG002|Overall Study|Withdrawal by Subject|0|||
146946972|NCT01316380|529962278|FG000|Overall Study|Other|0|||
146946973|NCT01316380|529962279|FG001|Overall Study|Other|1|||
146946974|NCT01316380|529962280|FG002|Overall Study|Other|1|||
146946975|NCT01316380|529962278|FG000|Overall Study|Not treated|1|||
146946976|NCT01316380|529962279|FG001|Overall Study|Not treated|0|||
146946977|NCT01316380|529962280|FG002|Overall Study|Not treated|0|||
146946978|NCT00149890|529962284|FG000|Overall Study|Adverse Event|1|||
146946979|NCT00149890|529962285|FG001|Overall Study|Adverse Event|8|||
146946980|NCT00149890|529962284|FG000|Overall Study|Lack of Efficacy|8|||
146946981|NCT00149890|529962285|FG001|Overall Study|Lack of Efficacy|9|||
146946982|NCT00149890|529962284|FG000|Overall Study|Protocol Violation|1|||
146946983|NCT00149890|529962285|FG001|Overall Study|Protocol Violation|0|||
146946984|NCT00149890|529962284|FG000|Overall Study|Lost to Follow-up|1|||
146946985|NCT00149890|529962285|FG001|Overall Study|Lost to Follow-up|0|||
146946986|NCT00149890|529962284|FG000|Overall Study|Graft Loss|2|||
146946987|NCT00149890|529962285|FG001|Overall Study|Graft Loss|1|||
146946988|NCT01387594|529962286|FG000|Overall Study|Withdrawal by Subject|0|||
146946989|NCT01387594|529962287|FG001|Overall Study|Withdrawal by Subject|2|||
146946990|NCT01387594|529962286|FG000|Overall Study|Lost to Follow-up|0|||
146946991|NCT01387594|529962287|FG001|Overall Study|Lost to Follow-up|1|||
146946992|NCT01365091|529962288|FG000|Period 1|Adverse Event|1|||
146946993|NCT01365091|529962289|FG001|Period 1|Adverse Event|0|||
146946994|NCT01365091|529962290|FG002|Period 1|Adverse Event|2|||
146946995|NCT01365091|529962291|FG003|Period 1|Adverse Event|3|||
146946996|NCT01365091|529962288|FG000|Period 1|Positive test result for drugs of abuse|1|||
146946997|NCT01365091|529962289|FG001|Period 1|Positive test result for drugs of abuse|0|||
146946998|NCT01365091|529962290|FG002|Period 1|Positive test result for drugs of abuse|0|||
146946999|NCT01365091|529962291|FG003|Period 1|Positive test result for drugs of abuse|0|||
146947000|NCT01365091|529962288|FG000|Period 1|No longer met study criteria|0|||
146947001|NCT01365091|529962289|FG001|Period 1|No longer met study criteria|1|||
146947002|NCT01365091|529962290|FG002|Period 1|No longer met study criteria|0|||
146947003|NCT01365091|529962291|FG003|Period 1|No longer met study criteria|0|||
146947004|NCT01365091|529962288|FG000|Period 1|Withdrawal by Subject|0|||
146947005|NCT01365091|529962289|FG001|Period 1|Withdrawal by Subject|1|||
146947006|NCT01365091|529962290|FG002|Period 1|Withdrawal by Subject|0|||
146947007|NCT01365091|529962291|FG003|Period 1|Withdrawal by Subject|0|||
146816626|NCT03150589|529495847|FG001|Overall Study|Protocol Violation|3|||
146816627|NCT03150589|529495846|FG000|Overall Study|Lost to Follow-up|3|||
146816628|NCT03150589|529495847|FG001|Overall Study|Lost to Follow-up|3|||
146816629|NCT03150589|529495846|FG000|Overall Study|Death|2|||
146816630|NCT03150589|529495847|FG001|Overall Study|Death|3|||
146816631|NCT03150589|529495846|FG000|Overall Study|IP non-compliance and other reasons|12|||
146816632|NCT03150589|529495847|FG001|Overall Study|IP non-compliance and other reasons|3|||
146816633|NCT01405508|529495848|FG000|Overall Study|AE, non-serious non-fatal|1|||
146816634|NCT01405508|529495849|FG001|Overall Study|AE, non-serious non-fatal|1|||
146816635|NCT01405508|529495850|FG002|Overall Study|AE, non-serious non-fatal|0|||
146816636|NCT01405508|529495851|FG003|Overall Study|AE, non-serious non-fatal|0|||
146816637|NCT00476957|529495852|FG000|Overall Study|Lost to Follow-up|176|||
146816638|NCT00476957|529495853|FG001|Overall Study|Lost to Follow-up|193|||
146816639|NCT02006641|529495859|FG000|Overall Study|Withdrawal before treatment|2|||
146816640|NCT02006641|529495860|FG001|Overall Study|Withdrawal before treatment|5|||
146816641|NCT02006641|529495861|FG002|Overall Study|Withdrawal before treatment|3|||
146816642|NCT02006641|529495859|FG000|Overall Study|Adverse Event|15|||
146816643|NCT02006641|529495860|FG001|Overall Study|Adverse Event|11|||
146816644|NCT02006641|529495861|FG002|Overall Study|Adverse Event|15|||
146816645|NCT02006641|529495859|FG000|Overall Study|Protocol Violation|0|||
146816646|NCT02006641|529495860|FG001|Overall Study|Protocol Violation|2|||
146816647|NCT02006641|529495861|FG002|Overall Study|Protocol Violation|2|||
146816648|NCT02006641|529495859|FG000|Overall Study|Lost to Follow-up|0|||
146816649|NCT02006641|529495860|FG001|Overall Study|Lost to Follow-up|1|||
146816650|NCT02006641|529495861|FG002|Overall Study|Lost to Follow-up|0|||
146816651|NCT02006641|529495859|FG000|Overall Study|Withdrawal by Subject|7|||
146816652|NCT02006641|529495860|FG001|Overall Study|Withdrawal by Subject|12|||
146816653|NCT02006641|529495861|FG002|Overall Study|Withdrawal by Subject|11|||
146816654|NCT02006641|529495859|FG000|Overall Study|Other reason: patient didn't show up|1|||
146816655|NCT02006641|529495860|FG001|Overall Study|Other reason: patient didn't show up|0|||
146816656|NCT02006641|529495861|FG002|Overall Study|Other reason: patient didn't show up|0|||
146816657|NCT02006641|529495859|FG000|Overall Study|Other reason:patient didn't want to come|0|||
146816658|NCT02006641|529495860|FG001|Overall Study|Other reason:patient didn't want to come|0|||
146816659|NCT02006641|529495861|FG002|Overall Study|Other reason:patient didn't want to come|1|||
146816660|NCT02006641|529495859|FG000|Overall Study|Other reason: patient has moved|1|||
146816661|NCT02006641|529495860|FG001|Overall Study|Other reason: patient has moved|0|||
146816662|NCT02006641|529495861|FG002|Overall Study|Other reason: patient has moved|1|||
146816663|NCT02006641|529495859|FG000|Overall Study|Other reason: caregiver in hospital|0|||
146816664|NCT02006641|529495860|FG001|Overall Study|Other reason: caregiver in hospital|1|||
146816665|NCT02006641|529495861|FG002|Overall Study|Other reason: caregiver in hospital|0|||
146816666|NCT02006641|529495859|FG000|Overall Study|Other reason: patient's wife has died|0|||
146816667|NCT02006641|529495860|FG001|Overall Study|Other reason: patient's wife has died|0|||
146816668|NCT02006641|529495861|FG002|Overall Study|Other reason: patient's wife has died|1|||
146816669|NCT02006641|529495859|FG000|Overall Study|Other reason: hospitalisation|0|||
146816670|NCT02006641|529495860|FG001|Overall Study|Other reason: hospitalisation|1|||
146816671|NCT02006641|529495861|FG002|Overall Study|Other reason: hospitalisation|0|||
146816672|NCT02006641|529495859|FG000|Overall Study|Other reason: caregiver impossibility|0|||
146816673|NCT02006641|529495860|FG001|Overall Study|Other reason: caregiver impossibility|0|||
146816674|NCT02006641|529495861|FG002|Overall Study|Other reason: caregiver impossibility|1|||
146816675|NCT02006641|529495859|FG000|Overall Study|Other reason: protocol non-compliance|0|||
146816676|NCT02006641|529495860|FG001|Overall Study|Other reason: protocol non-compliance|0|||
146816677|NCT02006641|529495861|FG002|Overall Study|Other reason: protocol non-compliance|1|||
146816678|NCT02132195|529495862|FG000|Initial Assignment|Relapsed|14|||
146816679|NCT02132195|529495863|FG001|Initial Assignment|Relapsed|0|||
146816680|NCT02132195|529495864|FG002|Initial Assignment|Relapsed|0|||
146816681|NCT02132195|529495862|FG000|Rescue Therapy|Relapsed|0|||
146816682|NCT02132195|529495863|FG001|Rescue Therapy|Relapsed|0|||
146816683|NCT02132195|529495864|FG002|Rescue Therapy|Relapsed|7|||
146816684|NCT02132195|529495862|FG000|Rescue Therapy|Physician Decision|0|||
146816685|NCT02132195|529495863|FG001|Rescue Therapy|Physician Decision|0|||
146816686|NCT02132195|529495864|FG002|Rescue Therapy|Physician Decision|1|||
146947008|NCT01365091|529962288|FG000|Period 1|Personal reasons|0|||
146947009|NCT01365091|529962289|FG001|Period 1|Personal reasons|0|||
146947010|NCT01365091|529962290|FG002|Period 1|Personal reasons|1|||
146947011|NCT01365091|529962291|FG003|Period 1|Personal reasons|0|||
146947012|NCT01365091|529962288|FG000|Period 2|Withdrawal by Subject|1|||
146816687|NCT02132195|529495862|FG000|Rescue Therapy|Withdrawal by Subject|0|||
146816688|NCT02132195|529495863|FG001|Rescue Therapy|Withdrawal by Subject|0|||
146816689|NCT02132195|529495864|FG002|Rescue Therapy|Withdrawal by Subject|1|||
146816690|NCT02132195|529495862|FG000|Rescue Therapy|Adverse Event|0|||
146816691|NCT02132195|529495863|FG001|Rescue Therapy|Adverse Event|0|||
146816692|NCT02132195|529495864|FG002|Rescue Therapy|Adverse Event|2|||
146816693|NCT01287832|529495865|FG000|Overall Study|Adverse Event|1|||
146816694|NCT01287832|529495866|FG001|Overall Study|Adverse Event|0|||
146816695|NCT01287832|529495865|FG000|Overall Study|Death|0|||
146947013|NCT01365091|529962289|FG001|Period 2|Withdrawal by Subject|0|||
146947014|NCT01365091|529962290|FG002|Period 2|Withdrawal by Subject|0|||
146947015|NCT01365091|529962291|FG003|Period 2|Withdrawal by Subject|0|||
146947016|NCT01365091|529962288|FG000|Period 2|Adverse Event|0|||
146947017|NCT01365091|529962289|FG001|Period 2|Adverse Event|0|||
146947018|NCT01365091|529962290|FG002|Period 2|Adverse Event|1|||
146947019|NCT01365091|529962291|FG003|Period 2|Adverse Event|0|||
146947020|NCT05116683|529962293|FG000|Overall Study|Physician Decision|4|||
146947021|NCT04964557|529962294|FG000|Overall Study|Withdrawal by Subject|3|||
146947022|NCT04964557|529962295|FG001|Overall Study|Withdrawal by Subject|2|||
146947023|NCT04964557|529962294|FG000|Overall Study|Lost to Follow-up|1|||
146947024|NCT04964557|529962295|FG001|Overall Study|Lost to Follow-up|2|||
146947025|NCT04964557|529962294|FG000|Overall Study|Physician Decision|2|||
146947026|NCT04964557|529962295|FG001|Overall Study|Physician Decision|0|||
146947027|NCT04964557|529962294|FG000|Overall Study|Death|3|||
146947028|NCT04964557|529962295|FG001|Overall Study|Death|0|||
146947029|NCT04964557|529962294|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
146947030|NCT04964557|529962295|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
146947031|NCT04924114|529964173|FG000|Overall Study|Withdrawal by Subject|0|||
146947032|NCT04924114|529964174|FG001|Overall Study|Withdrawal by Subject|2|||
146947033|NCT04924114|529964175|FG002|Overall Study|Withdrawal by Subject|2|||
146947034|NCT04924114|529964176|FG003|Overall Study|Withdrawal by Subject|0|||
146947035|NCT04924114|529964177|FG004|Overall Study|Withdrawal by Subject|2|||
146947036|NCT03671148|529964179|FG000|Overall Study|Adverse Event|3|||
146947037|NCT03671148|529964180|FG001|Overall Study|Adverse Event|2|||
146947038|NCT03671148|529964179|FG000|Overall Study|Withdrawal by Subject|8|||
146947039|NCT03671148|529964180|FG001|Overall Study|Withdrawal by Subject|2|||
146947040|NCT03671148|529964179|FG000|Overall Study|Lost to Follow-up|1|||
146947041|NCT03671148|529964180|FG001|Overall Study|Lost to Follow-up|2|||
146947042|NCT03671148|529964179|FG000|Overall Study|Lack of Efficacy|7|||
146947043|NCT03671148|529964180|FG001|Overall Study|Lack of Efficacy|2|||
146947044|NCT03671148|529964179|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
146947045|NCT03671148|529964180|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
146947046|NCT03671148|529964179|FG000|Overall Study|Other|1|||
146947047|NCT03671148|529964180|FG001|Overall Study|Other|0|||
146947048|NCT03671148|529964179|FG000|Overall Study|Incomplete Randomization Visit|1|||
146947049|NCT03671148|529964180|FG001|Overall Study|Incomplete Randomization Visit|0|||
146947050|NCT03878160|529964184|FG000|Overall Study|Lost to Follow-up|1|||
146947051|NCT03878160|529964185|FG001|Overall Study|Lost to Follow-up|1|||
146947052|NCT03878160|529964186|FG002|Overall Study|Lost to Follow-up|1|||
146947053|NCT03878160|529964184|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
146947054|NCT03878160|529964185|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
146947055|NCT03878160|529964186|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
146947056|NCT03887052|529964188|FG000|Overall Study|Adverse Event|2|||
146947057|NCT03887052|529964188|FG000|Overall Study|Physician Decision|2|||
146947058|NCT03887052|529964188|FG000|Overall Study|Withdrawal by Subject|3|||
146947059|NCT03887052|529964188|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
146947060|NCT03887052|529964188|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
146947061|NCT02365506|529964189|FG000|Overall Study|Investigator's Discretion|0|||
146947062|NCT02365506|529964190|FG001|Overall Study|Investigator's Discretion|0|||
146947063|NCT02365506|529964191|FG002|Overall Study|Investigator's Discretion|1|||
146947064|NCT05505734|529964193|FG000|Overall Study|Withdrawal by Subject|51|||
146947065|NCT05505734|529964194|FG001|Overall Study|Withdrawal by Subject|64|||
146947066|NCT05505734|529964193|FG000|Overall Study|Adverse Event|6|||
146947067|NCT05505734|529964194|FG001|Overall Study|Adverse Event|20|||
146947068|NCT05505734|529964193|FG000|Overall Study|Protocol Violation|8|||
146947069|NCT05505734|529964194|FG001|Overall Study|Protocol Violation|15|||
146947070|NCT05505734|529964193|FG000|Overall Study|Lack of therapeutic response|0|||
146947071|NCT05505734|529964194|FG001|Overall Study|Lack of therapeutic response|1|||
146947072|NCT05505734|529964193|FG000|Overall Study|Lost to Follow-up|247|||
146947073|NCT05505734|529964194|FG001|Overall Study|Lost to Follow-up|237|||
146947074|NCT05505734|529964193|FG000|Overall Study|Physician Decision|22|||
146947075|NCT05505734|529964194|FG001|Overall Study|Physician Decision|13|||
146947076|NCT05505734|529964193|FG000|Overall Study|Death|2|||
146947077|NCT05505734|529964194|FG001|Overall Study|Death|1|||
146947078|NCT05505734|529964193|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146947079|NCT05505734|529964194|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146947080|NCT05505734|529964193|FG000|Overall Study|Pregnancy|1|||
146947081|NCT05505734|529964194|FG001|Overall Study|Pregnancy|0|||
146947082|NCT05505734|529964193|FG000|Overall Study|Other|17|||
146947083|NCT05505734|529964194|FG001|Overall Study|Other|13|||
146947084|NCT02155712|529964197|FG000|Overall Study|Death|12|||
146947085|NCT02155712|529964198|FG001|Overall Study|Death|0|||
146947086|NCT02155712|529964197|FG000|Overall Study|Lost to Follow-up|37|||
146947087|NCT02155712|529964198|FG001|Overall Study|Lost to Follow-up|22|||
146947088|NCT02155712|529964197|FG000|Overall Study|Revision of device|4|||
146947089|NCT02155712|529964198|FG001|Overall Study|Revision of device|3|||
146947090|NCT02155712|529964197|FG000|Overall Study|Withdrawal by Subject|39|||
146816696|NCT01287832|529495866|FG001|Overall Study|Death|1|||
146816697|NCT04749797|529495867|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
146816698|NCT04749797|529495868|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
146947091|NCT02155712|529964198|FG001|Overall Study|Withdrawal by Subject|21|||
146947092|NCT02155712|529964197|FG000|Overall Study|Site termination|77|||
146947093|NCT02155712|529964198|FG001|Overall Study|Site termination|19|||
146947094|NCT02155712|529964197|FG000|Overall Study|Sponsor terminated study early|150|||
146947095|NCT02155712|529964198|FG001|Overall Study|Sponsor terminated study early|0|||
146947096|NCT02155712|529964197|FG000|Overall Study|Missed final 5-year protocol visit|0|||
146947097|NCT02155712|529964198|FG001|Overall Study|Missed final 5-year protocol visit|32|||
146947098|NCT02155712|529964197|FG000|Overall Study|Censored because surgery cancelled|6|||
146947099|NCT02155712|529964198|FG001|Overall Study|Censored because surgery cancelled|10|||
146947100|NCT02155712|529964197|FG000|Overall Study|Censored because study device was not implanted|61|||
146947101|NCT02155712|529964198|FG001|Overall Study|Censored because study device was not implanted|66|||
146947102|NCT02155712|529964197|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
146947103|NCT02155712|529964198|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
146947104|NCT01058395|529964199|FG000|Overall Study|Death|2|||
146947105|NCT01058395|529964200|FG001|Overall Study|Death|1|||
146947106|NCT01058395|529964199|FG000|Overall Study|Lost to Follow-up|1|||
146947107|NCT01058395|529964200|FG001|Overall Study|Lost to Follow-up|0|||
146947108|NCT01266876|529964201|FG000|Overall Study|Adverse Event|0|||
146947109|NCT01266876|529964202|FG001|Overall Study|Adverse Event|0|||
146947110|NCT01266876|529964203|FG002|Overall Study|Adverse Event|0|||
146947111|NCT01266876|529964204|FG003|Overall Study|Adverse Event|1|||
146947112|NCT01266876|529964205|FG004|Overall Study|Adverse Event|0|||
146947113|NCT05180721|529964206|FG000|Overall Study|Lost to Follow-up|4|||
146947114|NCT05016037|529964207|FG000|Overall Study|Lost to Follow-up|2|||
146947115|NCT03575351|529964208|FG000|Overall Study|Adverse Event|1|||
146947116|NCT03575351|529964209|FG001|Overall Study|Adverse Event|0|||
146947117|NCT03575351|529964208|FG000|Overall Study|Death|2|||
146947118|NCT03575351|529964209|FG001|Overall Study|Death|2|||
146947119|NCT03575351|529964208|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
146947120|NCT03575351|529964209|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
146947121|NCT03575351|529964208|FG000|Overall Study|Lack of Efficacy|28|||
146947122|NCT03575351|529964209|FG001|Overall Study|Lack of Efficacy|0|||
146947123|NCT03575351|529964208|FG000|Overall Study|Withdrawal by Subject|1|||
146947124|NCT03575351|529964209|FG001|Overall Study|Withdrawal by Subject|1|||
146947125|NCT03575351|529964208|FG000|Overall Study|Physician Decision|3|||
146947126|NCT03575351|529964209|FG001|Overall Study|Physician Decision|0|||
146947127|NCT03575351|529964208|FG000|Overall Study|Disease relapse|15|||
146947128|NCT03575351|529964209|FG001|Overall Study|Disease relapse|6|||
146947129|NCT03575351|529964208|FG000|Overall Study|Study drug manufacturing failure|0|||
146947130|NCT03575351|529964209|FG001|Overall Study|Study drug manufacturing failure|1|||
146947131|NCT03575351|529964208|FG000|Overall Study|other reasons|5|||
146947132|NCT03575351|529964209|FG001|Overall Study|other reasons|0|||
146947133|NCT01688999|529964212|FG000|Overall Study|Withdrawal by Subject|5|||
146947134|NCT01688999|529964213|FG001|Overall Study|Withdrawal by Subject|1|||
146947135|NCT01688999|529964214|FG002|Overall Study|Withdrawal by Subject|1|||
146947136|NCT01688999|529964212|FG000|Overall Study|Adverse Event|2|||
146947137|NCT01688999|529964213|FG001|Overall Study|Adverse Event|0|||
146947138|NCT01688999|529964214|FG002|Overall Study|Adverse Event|2|||
146947139|NCT01688999|529964212|FG000|Overall Study|Ineligible/Not treated|1|||
146947140|NCT01688999|529964213|FG001|Overall Study|Ineligible/Not treated|0|||
146947141|NCT01688999|529964214|FG002|Overall Study|Ineligible/Not treated|0|||
146947142|NCT02768103|529964215|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
146947143|NCT01855425|529964234|FG000|Overall Study|Physician Decision|20|||
146816699|NCT04749797|529495869|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
146947144|NCT01025232|529964241|FG000|Overall Study|Study drug no longer available|3|||
146947145|NCT01025232|529964242|FG001|Overall Study|Study drug no longer available|6|||
146947146|NCT01600105|529964243|FG000|Total Participants|Withdrawal by Subject|1|||
146947147|NCT01600105|529964244|FG001|Total Participants|Withdrawal by Subject|0|||
146947148|NCT01600105|529964243|FG000|Total Participants|No images in PACS|10|||
146947149|NCT01600105|529964244|FG001|Total Participants|No images in PACS|0|||
146947150|NCT01600105|529964243|FG000|Total Participants|Insufficient image quality|30|||
146947151|NCT01600105|529964244|FG001|Total Participants|Insufficient image quality|10|||
146947152|NCT01600105|529964243|FG000|Sub Study I|Insufficient image quality|0|||
146816700|NCT00537914|529495870|FG000|Overall Study|Death|1|||
146947153|NCT01600105|529964244|FG001|Sub Study I|Insufficient image quality|10|||
146947154|NCT01600105|529964243|FG000|Sub Study II|Withdrawal by Subject|1|||
146947155|NCT01600105|529964244|FG001|Sub Study II|Withdrawal by Subject|0|||
146947156|NCT01600105|529964243|FG000|Sub Study II|No images in PACS|1|||
146947157|NCT01600105|529964244|FG001|Sub Study II|No images in PACS|0|||
146947158|NCT01600105|529964243|FG000|Sub Study II|Insufficient image quality|3|||
146947159|NCT01600105|529964244|FG001|Sub Study II|Insufficient image quality|0|||
146947160|NCT01600105|529964243|FG000|Sub Study III|Insufficient image quality|5|||
146816701|NCT00537914|529495870|FG000|Overall Study|Adverse Event|7|||
146816702|NCT00537914|529495870|FG000|Overall Study|Treatment failure|10|||
146816703|NCT00537914|529495870|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
146816704|NCT00537914|529495870|FG000|Overall Study|Lost to Follow-up|19|||
146816705|NCT00537914|529495870|FG000|Overall Study|Withdrawal of informed consent|59|||
146816706|NCT02312258|529495871|FG000|Overall Study|Lost to Follow-up|8|||
146816707|NCT02312258|529495872|FG001|Overall Study|Lost to Follow-up|8|||
146816708|NCT02312258|529495871|FG000|Overall Study|Withdrawal by Patient|49|||
146816709|NCT02312258|529495872|FG001|Overall Study|Withdrawal by Patient|76|||
146816710|NCT02312258|529495871|FG000|Overall Study|Reason not Specified|107|||
146816711|NCT02312258|529495872|FG001|Overall Study|Reason not Specified|159|||
146816712|NCT02312258|529495871|FG000|Overall Study|Missing|2|||
146816713|NCT02312258|529495872|FG001|Overall Study|Missing|1|||
146816714|NCT02312258|529495871|FG000|Overall Study|Death|115|||
146816715|NCT02312258|529495872|FG001|Overall Study|Death|181|||
146816716|NCT01766206|529495873|FG000|Overall Study|Withdrawal by Subject|22|||
146816717|NCT01766206|529495873|FG000|Overall Study|Lost to Follow-up|10|||
146816718|NCT01766206|529495873|FG000|Overall Study|Inappropriate enrollment|18|||
146816719|NCT01766206|529495873|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
146816720|NCT01662505|529495874|FG000|Overall Study|Progressive disease|6|||
146816721|NCT01662505|529495875|FG001|Overall Study|Progressive disease|1|||
146816722|NCT01662505|529495876|FG002|Overall Study|Progressive disease|5|||
146816723|NCT01662505|529495874|FG000|Overall Study|Refused cont. medication|0|||
146816724|NCT01662505|529495875|FG001|Overall Study|Refused cont. medication|0|||
146816725|NCT01662505|529495876|FG002|Overall Study|Refused cont. medication|1|||
146816726|NCT01662505|529495874|FG000|Overall Study|Not specified above|1|||
146816727|NCT01662505|529495875|FG001|Overall Study|Not specified above|3|||
146816728|NCT01662505|529495876|FG002|Overall Study|Not specified above|2|||
146816729|NCT01313663|529495877|FG000|Overall Study|Study Closed/Terminated|2|||
146816730|NCT01313663|529495878|FG001|Overall Study|Study Closed/Terminated|4|||
146816731|NCT01313663|529495877|FG000|Overall Study|Lost to Follow-up|0|||
146816732|NCT01313663|529495878|FG001|Overall Study|Lost to Follow-up|1|||
146816733|NCT01313663|529495877|FG000|Overall Study|Physician Decision|0|||
146816734|NCT01313663|529495878|FG001|Overall Study|Physician Decision|2|||
146816735|NCT01313663|529495877|FG000|Overall Study|Withdrawal by Subject|2|||
146816736|NCT01313663|529495878|FG001|Overall Study|Withdrawal by Subject|1|||
146816737|NCT02340806|529495882|FG000|Overall Study|Protocol Violation|2|||
146816738|NCT02340806|529495883|FG001|Overall Study|Protocol Violation|0|||
146816739|NCT02340806|529495882|FG000|Overall Study|epidural catheter replaced|2|||
146816740|NCT02340806|529495883|FG001|Overall Study|epidural catheter replaced|1|||
146816741|NCT02340806|529495882|FG000|Overall Study|history of chronic pain medication|1|||
146816742|NCT02340806|529495883|FG001|Overall Study|history of chronic pain medication|0|||
146816743|NCT02340806|529495882|FG000|Overall Study|re-dose < 90 min of CSE|1|||
146816744|NCT02340806|529495883|FG001|Overall Study|re-dose < 90 min of CSE|3|||
146816745|NCT01186809|529495884|FG000|Overall Study|Death|30|||
146816746|NCT04895085|529495885|FG000|Overall Study|Death|1|||
146816747|NCT04895085|529495885|FG000|Overall Study|Withdrawal by Subject|1|||
146816748|NCT04895085|529495885|FG000|Overall Study|No longer eligible: Moved from area|1|||
146816749|NCT05379400|529497458|FG000|Overall Study|Lost to Follow-up|1|||
146816750|NCT05379400|529497459|FG001|Overall Study|Lost to Follow-up|1|||
146816751|NCT01922102|529497460|FG000|Overall Study|Withdrawal by Subject|7|||
146816752|NCT01922102|529497461|FG001|Overall Study|Withdrawal by Subject|3|||
146816753|NCT01922102|529497462|FG002|Overall Study|Withdrawal by Subject|7|||
146816754|NCT01922102|529497460|FG000|Overall Study|Physician Decision|0|||
146816755|NCT01922102|529497461|FG001|Overall Study|Physician Decision|2|||
146816756|NCT01922102|529497462|FG002|Overall Study|Physician Decision|1|||
146816757|NCT01922102|529497460|FG000|Overall Study|Adverse Event|1|||
146816758|NCT01922102|529497461|FG001|Overall Study|Adverse Event|2|||
146816759|NCT01922102|529497462|FG002|Overall Study|Adverse Event|0|||
146816760|NCT01922102|529497460|FG000|Overall Study|Lost to Follow-up|1|||
146816761|NCT01922102|529497461|FG001|Overall Study|Lost to Follow-up|0|||
146816762|NCT01922102|529497462|FG002|Overall Study|Lost to Follow-up|0|||
146816763|NCT01922102|529497460|FG000|Overall Study|Administrative problems|0|||
146816764|NCT01922102|529497461|FG001|Overall Study|Administrative problems|2|||
146816765|NCT01922102|529497462|FG002|Overall Study|Administrative problems|0|||
146947161|NCT01600105|529964244|FG001|Sub Study III|Insufficient image quality|0|||
146947162|NCT01600105|529964243|FG000|Sub Study V|Poor Image Quality|2|||
146947163|NCT01600105|529964244|FG001|Sub Study V|Poor Image Quality|0|||
146947164|NCT01263444|529964245|FG000|Overall Study|Adverse Event|8|||
146947165|NCT01263444|529964245|FG000|Overall Study|Withdrawal by Subject|1|||
146947166|NCT01263444|529964245|FG000|Overall Study|Protocol Violation|1|||
146947167|NCT01899768|529964247|FG000|Part A|Adverse Event|2|||
146947168|NCT01899768|529964247|FG000|Part A|Withdrawal by Subject|1|||
146947169|NCT01899768|529964247|FG000|Part B|Adverse Event|1|||
146947170|NCT01899768|529964247|FG000|Part B|Withdrawal by Subject|1|||
146947171|NCT04043416|529964249|FG000|Washout|Change in health condition|0|||
146947172|NCT04043416|529964250|FG001|Washout|Change in health condition|1|||
146816766|NCT01345253|529497467|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
146816767|NCT01345253|529497468|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
146816768|NCT01345253|529497467|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
146816769|NCT01345253|529497468|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
146816770|NCT01345253|529497467|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
146816771|NCT01345253|529497468|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
146816772|NCT01345253|529497467|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
146816773|NCT01345253|529497468|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
146816774|NCT01345253|529497467|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
146816775|NCT01345253|529497468|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
146816776|NCT01345253|529497467|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
146816777|NCT01345253|529497468|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
146816778|NCT01345253|529497467|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
146816779|NCT01345253|529497468|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
146816780|NCT01345253|529497467|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
146816781|NCT01345253|529497468|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
146816782|NCT01345253|529497467|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
146816783|NCT01345253|529497468|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
146816784|NCT01345253|529497467|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
146816785|NCT01345253|529497468|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
146816786|NCT01345253|529497467|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
146816787|NCT01345253|529497468|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
146816788|NCT01345253|529497467|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
146816789|NCT01345253|529497468|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
146816790|NCT01345253|529497467|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
146816791|NCT01345253|529497468|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
146816792|NCT01345253|529497467|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
146816793|NCT01345253|529497468|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
146816794|NCT01345253|529497467|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
146816795|NCT01345253|529497468|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
146816796|NCT05361304|529497471|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
146816797|NCT05361304|529497472|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
146816798|NCT05361304|529497471|FG000|Overall Study|COVID-19 Related|1|||
146816799|NCT05361304|529497472|FG001|Overall Study|COVID-19 Related|2|||
146816800|NCT05361304|529497471|FG000|Overall Study|Withdrawal by Subject|1|||
146816801|NCT05361304|529497472|FG001|Overall Study|Withdrawal by Subject|0|||
146816802|NCT00476151|529497473|FG000|Overall Study|Adverse Event|0|||
146816803|NCT00476151|529497474|FG001|Overall Study|Adverse Event|2|||
146816804|NCT00476151|529497473|FG000|Overall Study|Protocol Violation|1|||
146816805|NCT00476151|529497474|FG001|Overall Study|Protocol Violation|3|||
146816806|NCT00476151|529497473|FG000|Overall Study|Withdrawal by Subject|2|||
146816807|NCT00476151|529497474|FG001|Overall Study|Withdrawal by Subject|0|||
146816808|NCT00476151|529497473|FG000|Overall Study|Physician Decision|0|||
146816809|NCT00476151|529497474|FG001|Overall Study|Physician Decision|2|||
146816810|NCT03557307|529497478|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
146816811|NCT03557307|529497478|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
146816812|NCT03557307|529497478|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
146816813|NCT03557307|529497478|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
146816814|NCT03557307|529497478|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
146816815|NCT03557307|529497478|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
146816816|NCT03557307|529497478|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
146816817|NCT03557307|529497478|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
146816818|NCT03557307|529497478|FG000|Period 2: Maintenance Phase|Death|3|||
146816819|NCT03557307|529497478|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
146816820|NCT03557307|529497478|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
146816821|NCT03557307|529497478|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
146816822|NCT03557307|529497478|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
146816823|NCT03557307|529497478|FG000|Period 2: Maintenance Phase|other|3|||
146816824|NCT04239911|529497481|FG000|Overall Study|Lost to Follow-up|2|||
146816825|NCT04239911|529497482|FG001|Overall Study|Lost to Follow-up|1|||
146816826|NCT03456856|529497483|FG000|Overall Study|Lost to Follow-up|2|||
146816827|NCT03456856|529497483|FG000|Overall Study|Withdrawal by Subject|1|||
146947173|NCT01196091|529964251|FG000|Overall Study|Adverse Event|22|||
146947174|NCT01196091|529964252|FG001|Overall Study|Adverse Event|27|||
146947175|NCT01196091|529964253|FG002|Overall Study|Adverse Event|26|||
146947176|NCT01196091|529964251|FG000|Overall Study|Death|3|||
146947177|NCT01196091|529964252|FG001|Overall Study|Death|2|||
146816828|NCT03262389|529497486|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
146816829|NCT03262389|529497486|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
146947178|NCT01196091|529964253|FG002|Overall Study|Death|2|||
146947179|NCT01196091|529964251|FG000|Overall Study|Entry Criteria Not Met|11|||
146947180|NCT01196091|529964252|FG001|Overall Study|Entry Criteria Not Met|11|||
146947181|NCT01196091|529964253|FG002|Overall Study|Entry Criteria Not Met|10|||
146947182|NCT01196091|529964251|FG000|Overall Study|Lack of Efficacy|15|||
146947183|NCT01196091|529964252|FG001|Overall Study|Lack of Efficacy|12|||
146947184|NCT01196091|529964253|FG002|Overall Study|Lack of Efficacy|17|||
146947185|NCT01196091|529964251|FG000|Overall Study|Lost to Follow-up|5|||
146947186|NCT01196091|529964252|FG001|Overall Study|Lost to Follow-up|5|||
146947187|NCT01196091|529964253|FG002|Overall Study|Lost to Follow-up|6|||
146947188|NCT01196091|529964251|FG000|Overall Study|Parent/Caregiver Decision|0|||
146947189|NCT01196091|529964252|FG001|Overall Study|Parent/Caregiver Decision|0|||
146947190|NCT01196091|529964253|FG002|Overall Study|Parent/Caregiver Decision|1|||
146947191|NCT01196091|529964251|FG000|Overall Study|Withdrawal by Subject|16|||
146947192|NCT01196091|529964252|FG001|Overall Study|Withdrawal by Subject|19|||
146947193|NCT01196091|529964253|FG002|Overall Study|Withdrawal by Subject|22|||
146947194|NCT01196091|529964251|FG000|Overall Study|Physician Decision|3|||
146947195|NCT01196091|529964252|FG001|Overall Study|Physician Decision|3|||
146947196|NCT01196091|529964253|FG002|Overall Study|Physician Decision|4|||
146947197|NCT01196091|529964251|FG000|Overall Study|Protocol Violation|1|||
146947198|NCT01196091|529964252|FG001|Overall Study|Protocol Violation|3|||
146947199|NCT01196091|529964253|FG002|Overall Study|Protocol Violation|3|||
146947200|NCT01196091|529964251|FG000|Overall Study|Sponsor Decision|6|||
146947201|NCT01196091|529964252|FG001|Overall Study|Sponsor Decision|5|||
146947202|NCT01196091|529964253|FG002|Overall Study|Sponsor Decision|4|||
146947203|NCT01196091|529964251|FG000|Overall Study|Excluded Site|5|||
146947204|NCT01196091|529964252|FG001|Overall Study|Excluded Site|11|||
146947205|NCT01196091|529964253|FG002|Overall Study|Excluded Site|8|||
146947206|NCT01196091|529964251|FG000|Overall Study|Randomized, No Study Drug Received|1|||
146947207|NCT01196091|529964252|FG001|Overall Study|Randomized, No Study Drug Received|0|||
146947208|NCT01196091|529964253|FG002|Overall Study|Randomized, No Study Drug Received|1|||
146947209|NCT04476108|529964254|FG000|Overall Study|Adverse Event|4|||
146947210|NCT04476108|529964255|FG001|Overall Study|Adverse Event|1|||
146947211|NCT04476108|529964254|FG000|Overall Study|Lost to Follow-up|1|||
146947212|NCT04476108|529964255|FG001|Overall Study|Lost to Follow-up|0|||
146947213|NCT04476108|529964254|FG000|Overall Study|Inadvertent Enrollment|1|||
146947214|NCT04476108|529964255|FG001|Overall Study|Inadvertent Enrollment|0|||
146947215|NCT04476108|529964254|FG000|Overall Study|Protocol Violation|1|||
146947216|NCT04476108|529964255|FG001|Overall Study|Protocol Violation|1|||
146947217|NCT04476108|529964254|FG000|Overall Study|Withdrawal by Subject|1|||
146947218|NCT04476108|529964255|FG001|Overall Study|Withdrawal by Subject|1|||
146947219|NCT00355615|529964257|FG000|Randomized Double Blind Period|Adverse Event|1|||
146947220|NCT00355615|529964258|FG001|Randomized Double Blind Period|Adverse Event|0|||
146947221|NCT00355615|529964259|FG002|Randomized Double Blind Period|Adverse Event|0|||
146947222|NCT00355615|529964260|FG003|Randomized Double Blind Period|Adverse Event|0|||
146947223|NCT00355615|529964261|FG004|Randomized Double Blind Period|Adverse Event|0|||
146947224|NCT00355615|529964257|FG000|Randomized Double Blind Period|Protocol Violation|0|||
146947225|NCT00355615|529964258|FG001|Randomized Double Blind Period|Protocol Violation|0|||
146947226|NCT00355615|529964259|FG002|Randomized Double Blind Period|Protocol Violation|1|||
146947227|NCT00355615|529964260|FG003|Randomized Double Blind Period|Protocol Violation|1|||
146947228|NCT00355615|529964261|FG004|Randomized Double Blind Period|Protocol Violation|0|||
146947229|NCT00355615|529964257|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
146947230|NCT00355615|529964258|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
146947231|NCT00355615|529964259|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
146947232|NCT00355615|529964260|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
146947233|NCT00355615|529964261|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
146947234|NCT00355615|529964257|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
146947235|NCT00355615|529964258|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
146947236|NCT00355615|529964259|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
146947237|NCT00355615|529964260|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
146947238|NCT00355615|529964261|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
146947239|NCT00355615|529964257|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
146947240|NCT00355615|529964258|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
146947241|NCT00355615|529964259|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
146984666|NCT01851590|530105125|FG001|Overall Study|Adverse Event|0|||
146984667|NCT01851590|530105126|FG002|Overall Study|Adverse Event|2|||
146947242|NCT00355615|529964260|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
146947243|NCT00355615|529964261|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
146947244|NCT00355615|529964257|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
146947245|NCT00355615|529964258|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
146947246|NCT00355615|529964259|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
146947247|NCT00355615|529964260|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
146947248|NCT00355615|529964261|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
146947249|NCT04259346|529964262|FG000|Overall Study|Lost to Follow-up|1|||
146816830|NCT03262389|529497486|FG000|Overall Study|opted out of PET/MR|1|||
146816831|NCT01052272|529497487|FG000|Overall Study|Death|0|||
146816832|NCT01052272|529497488|FG001|Overall Study|Death|0|||
146816833|NCT01052272|529497489|FG002|Overall Study|Death|1|||
146816834|NCT01052272|529497490|FG003|Overall Study|Death|1|||
146816835|NCT01052272|529497487|FG000|Overall Study|Physician Decision|0|||
146816836|NCT01052272|529497488|FG001|Overall Study|Physician Decision|1|||
146816837|NCT01052272|529497489|FG002|Overall Study|Physician Decision|0|||
146816838|NCT01052272|529497490|FG003|Overall Study|Physician Decision|0|||
146816839|NCT01052272|529497487|FG000|Overall Study|patient refuses follow-up|5|||
146816840|NCT01052272|529497488|FG001|Overall Study|patient refuses follow-up|4|||
146816841|NCT01052272|529497489|FG002|Overall Study|patient refuses follow-up|2|||
146816842|NCT01052272|529497490|FG003|Overall Study|patient refuses follow-up|4|||
146816843|NCT01052272|529497487|FG000|Overall Study|Withdrawal by Subject|0|||
146816844|NCT01052272|529497488|FG001|Overall Study|Withdrawal by Subject|2|||
146816845|NCT01052272|529497489|FG002|Overall Study|Withdrawal by Subject|3|||
146816846|NCT01052272|529497490|FG003|Overall Study|Withdrawal by Subject|2|||
146816847|NCT01052272|529497487|FG000|Overall Study|placed in long-term care|0|||
146816848|NCT01052272|529497488|FG001|Overall Study|placed in long-term care|0|||
146816849|NCT01052272|529497489|FG002|Overall Study|placed in long-term care|1|||
146816850|NCT01052272|529497490|FG003|Overall Study|placed in long-term care|0|||
146816851|NCT01052272|529497487|FG000|Overall Study|decline in health|0|||
146816852|NCT01052272|529497488|FG001|Overall Study|decline in health|0|||
146816853|NCT01052272|529497489|FG002|Overall Study|decline in health|1|||
146816854|NCT01052272|529497490|FG003|Overall Study|decline in health|0|||
146816855|NCT00096278|529497493|FG000|Overall Study|No follow-up data|15|||
146816856|NCT00096278|529497494|FG001|Overall Study|No follow-up data|18|||
146816857|NCT00096278|529497493|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
146816858|NCT00096278|529497494|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
146816859|NCT02105688|529497495|FG000|Part A: Double-Blind|Adverse Event|1|||
146816860|NCT02105688|529497496|FG001|Part A: Double-Blind|Adverse Event|0|||
146816861|NCT02105688|529497495|FG000|Part A: Double-Blind|Death|0|||
146816862|NCT02105688|529497496|FG001|Part A: Double-Blind|Death|1|||
146816863|NCT02105688|529497495|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
146816864|NCT02105688|529497496|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
146816865|NCT02105688|529497495|FG000|Part A: Double-Blind|Physician Decision|0|||
146816866|NCT02105688|529497496|FG001|Part A: Double-Blind|Physician Decision|1|||
146816867|NCT02105688|529497495|FG000|Part A: Double-Blind|Status Unknown|0|||
146816868|NCT02105688|529497496|FG001|Part A: Double-Blind|Status Unknown|2|||
146816869|NCT02105688|529497495|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
146816870|NCT02105688|529497496|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
146816871|NCT02105688|529497495|FG000|Part B: Observational Follow-up|Death|2|||
146816872|NCT02105688|529497496|FG001|Part B: Observational Follow-up|Death|1|||
146816873|NCT02105688|529497495|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
146816874|NCT02105688|529497496|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
146816875|NCT02105688|529497495|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
146816876|NCT02105688|529497496|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
146816877|NCT02105688|529497495|FG000|Part B: Observational Follow-up|Physician Decision|3|||
146816878|NCT02105688|529497496|FG001|Part B: Observational Follow-up|Physician Decision|1|||
146816879|NCT04908488|529497499|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
146816880|NCT04908488|529497500|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
146816881|NCT04908488|529497499|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
146947250|NCT04259346|529964263|FG001|Overall Study|Lost to Follow-up|3|||
146947251|NCT04259346|529964262|FG000|Overall Study|Protocol Violation|1|||
146947252|NCT04259346|529964263|FG001|Overall Study|Protocol Violation|0|||
146947253|NCT04259346|529964262|FG000|Overall Study|Withdrawal by Subject|1|||
146947254|NCT04259346|529964263|FG001|Overall Study|Withdrawal by Subject|0|||
146947255|NCT04259346|529964262|FG000|Overall Study|Adverse Event|1|||
146947256|NCT04259346|529964263|FG001|Overall Study|Adverse Event|1|||
146947257|NCT00085644|529964264|FG000|Double-Blind Period|Adverse Event|5|||
146947258|NCT00085644|529964265|FG001|Double-Blind Period|Adverse Event|2|||
146947259|NCT00085644|529964266|FG002|Double-Blind Period|Adverse Event|0|||
146947260|NCT00085644|529964264|FG000|Double-Blind Period|Withdrawal by Subject|3|||
146947261|NCT00085644|529964265|FG001|Double-Blind Period|Withdrawal by Subject|0|||
146947262|NCT00085644|529964266|FG002|Double-Blind Period|Withdrawal by Subject|0|||
146947263|NCT00085644|529964264|FG000|Double-Blind Period|Lost to Follow-up|2|||
146947264|NCT00085644|529964265|FG001|Double-Blind Period|Lost to Follow-up|1|||
146947265|NCT00085644|529964266|FG002|Double-Blind Period|Lost to Follow-up|0|||
146816882|NCT04908488|529497500|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
146816883|NCT01107912|529497502|FG000|Period 1|Adverse Event|0|||
146816884|NCT01107912|529497503|FG001|Period 1|Adverse Event|0|||
146816885|NCT01107912|529497504|FG002|Period 1|Adverse Event|0|||
146816886|NCT01107912|529497505|FG003|Period 1|Adverse Event|0|||
146947266|NCT00085644|529964264|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
146947267|NCT00085644|529964265|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
146947268|NCT00085644|529964266|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
146947269|NCT00085644|529964264|FG000|Double-Blind Period|Contemplating pregnancy|1|||
146947270|NCT00085644|529964265|FG001|Double-Blind Period|Contemplating pregnancy|0|||
146947271|NCT00085644|529964266|FG002|Double-Blind Period|Contemplating pregnancy|0|||
146947272|NCT00085644|529964264|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
146947273|NCT00085644|529964265|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
146947274|NCT00085644|529964266|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
146947275|NCT00085644|529964264|FG000|Open-Label Period|Adverse Event|0|||
146947276|NCT00085644|529964265|FG001|Open-Label Period|Adverse Event|0|||
146947277|NCT00085644|529964266|FG002|Open-Label Period|Adverse Event|38|||
146947278|NCT00085644|529964264|FG000|Open-Label Period|Withdrawal by Subject|0|||
146947279|NCT00085644|529964265|FG001|Open-Label Period|Withdrawal by Subject|0|||
146947280|NCT00085644|529964266|FG002|Open-Label Period|Withdrawal by Subject|29|||
146947281|NCT00085644|529964264|FG000|Open-Label Period|Lost to Follow-up|0|||
146947282|NCT00085644|529964265|FG001|Open-Label Period|Lost to Follow-up|0|||
146947283|NCT00085644|529964266|FG002|Open-Label Period|Lost to Follow-up|13|||
146947284|NCT00085644|529964264|FG000|Open-Label Period|Lack of Efficacy|0|||
146947285|NCT00085644|529964265|FG001|Open-Label Period|Lack of Efficacy|0|||
146947286|NCT00085644|529964266|FG002|Open-Label Period|Lack of Efficacy|15|||
146947287|NCT00085644|529964264|FG000|Open-Label Period|Pregnancy|0|||
146947288|NCT00085644|529964265|FG001|Open-Label Period|Pregnancy|0|||
146947289|NCT00085644|529964266|FG002|Open-Label Period|Pregnancy|3|||
146947290|NCT00085644|529964264|FG000|Open-Label Period|Contemplating pregnancy|0|||
146947291|NCT00085644|529964265|FG001|Open-Label Period|Contemplating pregnancy|0|||
146947292|NCT00085644|529964266|FG002|Open-Label Period|Contemplating pregnancy|3|||
146947293|NCT00085644|529964264|FG000|Open-Label Period|Protocol Violation|0|||
146947294|NCT00085644|529964265|FG001|Open-Label Period|Protocol Violation|0|||
146947295|NCT00085644|529964266|FG002|Open-Label Period|Protocol Violation|4|||
146947296|NCT00085644|529964264|FG000|Open-Label Period|Personal reason|0|||
146947297|NCT00085644|529964265|FG001|Open-Label Period|Personal reason|0|||
146947298|NCT00085644|529964266|FG002|Open-Label Period|Personal reason|4|||
146947299|NCT03330106|529964267|FG000|Part A|Withdrawal by Subject|1|||
146947300|NCT03330106|529964268|FG001|Part A|Withdrawal by Subject|1|||
146947301|NCT03330106|529964269|FG002|Part A|Withdrawal by Subject|0|||
146816887|NCT01107912|529497506|FG004|Period 1|Adverse Event|2|||
146816888|NCT01107912|529497507|FG005|Period 1|Adverse Event|0|||
146816889|NCT01107912|529497502|FG000|Period 1|Physician Decision|0|||
146816890|NCT01107912|529497503|FG001|Period 1|Physician Decision|0|||
146816891|NCT01107912|529497504|FG002|Period 1|Physician Decision|0|||
146816892|NCT01107912|529497505|FG003|Period 1|Physician Decision|0|||
146816893|NCT01107912|529497506|FG004|Period 1|Physician Decision|1|||
146816894|NCT01107912|529497507|FG005|Period 1|Physician Decision|0|||
146816895|NCT01107912|529497502|FG000|Period 1|Withdrawal by Subject|1|||
146816896|NCT01107912|529497503|FG001|Period 1|Withdrawal by Subject|0|||
146816897|NCT01107912|529497504|FG002|Period 1|Withdrawal by Subject|0|||
146816898|NCT01107912|529497505|FG003|Period 1|Withdrawal by Subject|0|||
146816899|NCT01107912|529497506|FG004|Period 1|Withdrawal by Subject|0|||
146816900|NCT01107912|529497507|FG005|Period 1|Withdrawal by Subject|0|||
146816901|NCT01107912|529497502|FG000|Period 2|Physician Decision|0|||
146816902|NCT01107912|529497503|FG001|Period 2|Physician Decision|0|||
146816903|NCT01107912|529497504|FG002|Period 2|Physician Decision|1|||
146816904|NCT01107912|529497505|FG003|Period 2|Physician Decision|0|||
146816905|NCT01107912|529497506|FG004|Period 2|Physician Decision|0|||
146816906|NCT01107912|529497507|FG005|Period 2|Physician Decision|0|||
146816907|NCT01107912|529497502|FG000|Period 3|Adverse Event|0|||
146816908|NCT01107912|529497503|FG001|Period 3|Adverse Event|1|||
146816909|NCT01107912|529497504|FG002|Period 3|Adverse Event|1|||
146816910|NCT01107912|529497505|FG003|Period 3|Adverse Event|0|||
146816911|NCT01107912|529497506|FG004|Period 3|Adverse Event|0|||
146816912|NCT01107912|529497507|FG005|Period 3|Adverse Event|0|||
146816913|NCT01107912|529497502|FG000|Period 3|Withdrawal by Subject|0|||
146816914|NCT01107912|529497503|FG001|Period 3|Withdrawal by Subject|0|||
146947302|NCT03330106|529964270|FG003|Part A|Withdrawal by Subject|0|||
146816915|NCT01107912|529497504|FG002|Period 3|Withdrawal by Subject|0|||
146816916|NCT01107912|529497505|FG003|Period 3|Withdrawal by Subject|1|||
146816917|NCT01107912|529497506|FG004|Period 3|Withdrawal by Subject|0|||
146816918|NCT01107912|529497507|FG005|Period 3|Withdrawal by Subject|0|||
146816919|NCT00595959|529497512|FG000|Overall Study|Withdrawal by Subject|1|||
146947303|NCT03330106|529964267|FG000|Part A|Death|2|||
146947304|NCT03330106|529964268|FG001|Part A|Death|1|||
146947305|NCT03330106|529964269|FG002|Part A|Death|0|||
146816920|NCT00595959|529497512|FG000|Overall Study|Lost to Follow-up|1|||
146947306|NCT03330106|529964270|FG003|Part A|Death|0|||
146816921|NCT03529942|529497515|FG000|Overall Study|Withdrawal by Subject|13|||
146816922|NCT03529942|529497515|FG000|Overall Study|Physician Decision|1|||
146816923|NCT03529942|529497515|FG000|Overall Study|Lost to Follow-up|7|||
146947307|NCT03330106|529964267|FG000|Part A|Adverse Event|0|||
146947308|NCT03330106|529964268|FG001|Part A|Adverse Event|1|||
146947309|NCT03330106|529964269|FG002|Part A|Adverse Event|0|||
146947310|NCT03330106|529964270|FG003|Part A|Adverse Event|0|||
146947311|NCT03330106|529964267|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
146816924|NCT03529942|529497515|FG000|Overall Study|Needle inserted but no drug administered|1|||
146816925|NCT03529942|529497515|FG000|Overall Study|Personal reasons|1|||
146816926|NCT00409747|529497518|FG000|Overall Study|Withdrawal by Subject|1|||
146816927|NCT00636168|529497519|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
146816928|NCT00636168|529497520|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
146816929|NCT00636168|529497519|FG000|Randomized to Study Drug|Adverse Event|1|||
146816930|NCT00636168|529497520|FG001|Randomized to Study Drug|Adverse Event|0|||
146816931|NCT00636168|529497519|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
146816932|NCT00636168|529497520|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
146816933|NCT00636168|529497519|FG000|Treated With Study Drug|Recurrence of disease|135|||
146816934|NCT00636168|529497520|FG001|Treated With Study Drug|Recurrence of disease|282|||
146816935|NCT00636168|529497519|FG000|Treated With Study Drug|Adverse Event|250|||
146816936|NCT00636168|529497520|FG001|Treated With Study Drug|Adverse Event|22|||
146816937|NCT00636168|529497519|FG000|Treated With Study Drug|Participant withdrew consent|16|||
146816938|NCT00636168|529497520|FG001|Treated With Study Drug|Participant withdrew consent|21|||
146816939|NCT00636168|529497519|FG000|Treated With Study Drug|Poor/non-compliance|1|||
146947312|NCT03330106|529964268|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
146947313|NCT03330106|529964269|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
146947314|NCT03330106|529964270|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
146947315|NCT03330106|529964267|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
146947316|NCT03330106|529964268|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
146947317|NCT03330106|529964269|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
146947318|NCT03330106|529964270|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
146947319|NCT03330106|529964267|FG000|Part A|Progressive Disease|0|||
146947320|NCT03330106|529964268|FG001|Part A|Progressive Disease|1|||
146947321|NCT03330106|529964269|FG002|Part A|Progressive Disease|0|||
146947322|NCT03330106|529964270|FG003|Part A|Progressive Disease|0|||
146947323|NCT03330106|529964267|FG000|Part B|Lost to Follow-up|0|||
146947324|NCT03330106|529964268|FG001|Part B|Lost to Follow-up|0|||
146947325|NCT03330106|529964269|FG002|Part B|Lost to Follow-up|0|||
146947326|NCT03330106|529964270|FG003|Part B|Lost to Follow-up|1|||
146947327|NCT03330106|529964267|FG000|Part B|Withdrawal by Subject|0|||
146947328|NCT03330106|529964268|FG001|Part B|Withdrawal by Subject|0|||
146947329|NCT03330106|529964269|FG002|Part B|Withdrawal by Subject|4|||
146947330|NCT03330106|529964270|FG003|Part B|Withdrawal by Subject|0|||
146947331|NCT03330106|529964267|FG000|Part B|Death|0|||
146947332|NCT03330106|529964268|FG001|Part B|Death|0|||
146947333|NCT03330106|529964269|FG002|Part B|Death|2|||
146947334|NCT03330106|529964270|FG003|Part B|Death|0|||
146947335|NCT03330106|529964267|FG000|Part B|Clinical Progression|0|||
146947336|NCT03330106|529964268|FG001|Part B|Clinical Progression|0|||
146947337|NCT03330106|529964269|FG002|Part B|Clinical Progression|1|||
146816940|NCT00636168|529497520|FG001|Treated With Study Drug|Poor/non-compliance|3|||
146816941|NCT00636168|529497519|FG000|Treated With Study Drug|Death|3|||
146816942|NCT00636168|529497520|FG001|Treated With Study Drug|Death|0|||
146816943|NCT00636168|529497519|FG000|Treated With Study Drug|Pregnancy|1|||
146816944|NCT00636168|529497520|FG001|Treated With Study Drug|Pregnancy|0|||
146816945|NCT00636168|529497519|FG000|Treated With Study Drug|No longer meets study criteria|1|||
146816946|NCT00636168|529497520|FG001|Treated With Study Drug|No longer meets study criteria|0|||
146816947|NCT00636168|529497519|FG000|Treated With Study Drug|Other reason|1|||
146816948|NCT00636168|529497520|FG001|Treated With Study Drug|Other reason|3|||
146816949|NCT00636168|529497519|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
146816950|NCT00636168|529497520|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
146816951|NCT00636168|529497519|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
146816952|NCT00636168|529497520|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
146816953|NCT00636168|529497519|FG000|Long Term Follow-Up|Death|8|||
146816954|NCT00636168|529497520|FG001|Long Term Follow-Up|Death|9|||
146816955|NCT00632736|529497521|FG000|Overall Study|Adverse Event|104|||
146816956|NCT00632736|529497521|FG000|Overall Study|Lost to Follow-up|15|||
146816957|NCT00632736|529497521|FG000|Overall Study|Protocol Violation|14|||
146984668|NCT01851590|530105124|FG000|Overall Study|Lack of Efficacy|0|||
146984669|NCT01851590|530105125|FG001|Overall Study|Lack of Efficacy|1|||
146816958|NCT00632736|529497521|FG000|Overall Study|Withdrawal by Subject|99|||
146816959|NCT00632736|529497521|FG000|Overall Study|Lack of Efficacy|5|||
146947338|NCT03330106|529964270|FG003|Part B|Clinical Progression|1|||
146947339|NCT03330106|529964267|FG000|Part B|Symptomatic Deterioration|0|||
146816960|NCT00632736|529497521|FG000|Overall Study|Sponsor terminated study|5|||
146816961|NCT00632736|529497521|FG000|Overall Study|Non-compliance|10|||
146816962|NCT00632736|529497521|FG000|Overall Study|Other|16|||
146816963|NCT03015220|529497522|FG000|Overall Study|Withdrawal by Subject|3|||
146816964|NCT03015220|529497523|FG001|Overall Study|Withdrawal by Subject|2|||
146947340|NCT03330106|529964268|FG001|Part B|Symptomatic Deterioration|0|||
146947341|NCT03330106|529964269|FG002|Part B|Symptomatic Deterioration|0|||
146947342|NCT03330106|529964270|FG003|Part B|Symptomatic Deterioration|1|||
146984670|NCT01851590|530105126|FG002|Overall Study|Lack of Efficacy|0|||
146947343|NCT03330106|529964267|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
146947344|NCT03330106|529964268|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
146947345|NCT03330106|529964269|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
146947346|NCT03330106|529964270|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
146947347|NCT03330106|529964267|FG000|Part B|Progressive Disease|0|||
146947348|NCT03330106|529964268|FG001|Part B|Progressive Disease|0|||
146947349|NCT03330106|529964269|FG002|Part B|Progressive Disease|11|||
146947350|NCT03330106|529964270|FG003|Part B|Progressive Disease|4|||
146947351|NCT00486889|529964272|FG000|Overall Study|Death|3|||
146947352|NCT00486889|529964272|FG000|Overall Study|Non-compliant|2|||
146947353|NCT00486889|529964272|FG000|Overall Study|Withdrawal by Subject|6|||
146947354|NCT02324049|529964273|FG000|Part C|Study terminated|11|||
146947355|NCT02159365|529964274|FG000|Overall Study|Disease Progression|23|||
146947356|NCT02159365|529964274|FG000|Overall Study|Other reasons|11|||
146947357|NCT02159365|529964274|FG000|Overall Study|Administrative reason by Sponsor|9|||
146947358|NCT02159365|529964274|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
146947359|NCT02159365|529964274|FG000|Overall Study|Study drug toxicity|7|||
146947360|NCT02159365|529964274|FG000|Overall Study|Maximum clinical benefit|3|||
146947361|NCT02159365|529964274|FG000|Overall Study|Subject request to discontinue treatment|3|||
146947362|NCT02159365|529964274|FG000|Overall Study|Subject withdrew consent|3|||
146947363|NCT02159365|529964274|FG000|Overall Study|Death|1|||
146947364|NCT02159365|529964274|FG000|Overall Study|Lost to Follow-up|1|||
146947365|NCT03198728|529964276|FG000|Overall Study|Adverse Event|10|||
146947366|NCT03198728|529964277|FG001|Overall Study|Adverse Event|5|||
146947367|NCT03198728|529964276|FG000|Overall Study|Lost to Follow-up|21|||
146947368|NCT03198728|529964277|FG001|Overall Study|Lost to Follow-up|7|||
146947369|NCT03198728|529964276|FG000|Overall Study|Physician Decision|7|||
146947370|NCT03198728|529964277|FG001|Overall Study|Physician Decision|2|||
146947371|NCT03198728|529964276|FG000|Overall Study|Withdrawal by Subject|14|||
146947372|NCT03198728|529964277|FG001|Overall Study|Withdrawal by Subject|10|||
146947373|NCT04051944|529964279|FG000|Overall Study|Study ending|1|||
146947374|NCT04051944|529964280|FG001|Overall Study|Study ending|1|||
146947375|NCT04051944|529964279|FG000|Overall Study|Early study termination by participant|1|||
146947376|NCT04051944|529964280|FG001|Overall Study|Early study termination by participant|0|||
146947377|NCT04051944|529964279|FG000|Overall Study|Withdrawal by Subject|2|||
146947378|NCT04051944|529964280|FG001|Overall Study|Withdrawal by Subject|2|||
146947379|NCT04051944|529964279|FG000|Overall Study|Lack of Efficacy|3|||
146947380|NCT04051944|529964280|FG001|Overall Study|Lack of Efficacy|0|||
146947381|NCT04051944|529964279|FG000|Overall Study|Adverse event, non- fatal|1|||
146947382|NCT04051944|529964280|FG001|Overall Study|Adverse event, non- fatal|1|||
146947383|NCT03083470|529964281|FG000|Overall Study|Lost to Follow-up|0|||
146947384|NCT03083470|529964282|FG001|Overall Study|Lost to Follow-up|0|||
146947385|NCT03083470|529964283|FG002|Overall Study|Lost to Follow-up|0|||
146947386|NCT03083470|529964284|FG003|Overall Study|Lost to Follow-up|0|||
146947387|NCT03083470|529964285|FG004|Overall Study|Lost to Follow-up|1|||
146947388|NCT03083470|529964281|FG000|Overall Study|Withdrawal by Subject|0|||
146947389|NCT03083470|529964282|FG001|Overall Study|Withdrawal by Subject|0|||
146947390|NCT03083470|529964283|FG002|Overall Study|Withdrawal by Subject|0|||
146947391|NCT03083470|529964284|FG003|Overall Study|Withdrawal by Subject|0|||
146947392|NCT03083470|529964285|FG004|Overall Study|Withdrawal by Subject|1|||
146947393|NCT03077711|529964286|FG000|Overall Study|Lost to Follow-up|2|||
146947394|NCT03077711|529964287|FG001|Overall Study|Lost to Follow-up|2|||
146947395|NCT03077711|529964286|FG000|Overall Study|noncompliant taking medication|2|||
146947396|NCT03077711|529964287|FG001|Overall Study|noncompliant taking medication|0|||
146947397|NCT01526928|529964288|FG000|Overall Study|Progressive Disease|35|||
146947398|NCT01526928|529964289|FG001|Overall Study|Progressive Disease|17|||
146947399|NCT01526928|529964290|FG002|Overall Study|Progressive Disease|150|||
146947400|NCT01526928|529964291|FG003|Overall Study|Progressive Disease|182|||
146947401|NCT01526928|529964292|FG004|Overall Study|Progressive Disease|76|||
146947402|NCT01526928|529964293|FG005|Overall Study|Progressive Disease|4|||
146947403|NCT01526928|529964288|FG000|Overall Study|Adverse Event|2|||
146947404|NCT01526928|529964289|FG001|Overall Study|Adverse Event|1|||
146947405|NCT01526928|529964290|FG002|Overall Study|Adverse Event|29|||
146947406|NCT01526928|529964291|FG003|Overall Study|Adverse Event|40|||
146947407|NCT01526928|529964292|FG004|Overall Study|Adverse Event|13|||
146947408|NCT01526928|529964293|FG005|Overall Study|Adverse Event|2|||
146984671|NCT00696709|530105127|FG000|Overall Study|Withdrawal by Subject|1|||
146984672|NCT00696709|530105128|FG001|Overall Study|Withdrawal by Subject|2|||
146984673|NCT00696709|530105129|FG002|Overall Study|Withdrawal by Subject|1|||
146984674|NCT00696709|530105130|FG003|Overall Study|Withdrawal by Subject|4|||
146984675|NCT00696709|530105131|FG004|Overall Study|Withdrawal by Subject|3|||
146984676|NCT00696709|530105127|FG000|Overall Study|Protocol Violation|1|||
146947409|NCT01526928|529964288|FG000|Overall Study|Death|0|||
146947410|NCT01526928|529964289|FG001|Overall Study|Death|0|||
146947411|NCT01526928|529964290|FG002|Overall Study|Death|3|||
146947412|NCT01526928|529964291|FG003|Overall Study|Death|0|||
146984677|NCT00696709|530105128|FG001|Overall Study|Protocol Violation|0|||
146984678|NCT00696709|530105129|FG002|Overall Study|Protocol Violation|0|||
146947413|NCT01526928|529964292|FG004|Overall Study|Death|0|||
146947414|NCT01526928|529964293|FG005|Overall Study|Death|0|||
146947415|NCT01526928|529964288|FG000|Overall Study|Withdrawal by Subject|1|||
146947416|NCT01526928|529964289|FG001|Overall Study|Withdrawal by Subject|0|||
146947417|NCT01526928|529964290|FG002|Overall Study|Withdrawal by Subject|13|||
146947418|NCT01526928|529964291|FG003|Overall Study|Withdrawal by Subject|11|||
146947419|NCT01526928|529964292|FG004|Overall Study|Withdrawal by Subject|3|||
146947420|NCT01526928|529964293|FG005|Overall Study|Withdrawal by Subject|0|||
146947421|NCT01526928|529964288|FG000|Overall Study|Physician Decision|0|||
146947422|NCT01526928|529964289|FG001|Overall Study|Physician Decision|0|||
146947423|NCT01526928|529964290|FG002|Overall Study|Physician Decision|2|||
146947424|NCT01526928|529964291|FG003|Overall Study|Physician Decision|5|||
146947425|NCT01526928|529964292|FG004|Overall Study|Physician Decision|0|||
146947426|NCT01526928|529964293|FG005|Overall Study|Physician Decision|0|||
146947427|NCT01526928|529964288|FG000|Overall Study|Other Reason|0|||
146947428|NCT01526928|529964289|FG001|Overall Study|Other Reason|1|||
146947429|NCT01526928|529964290|FG002|Overall Study|Other Reason|11|||
146947430|NCT01526928|529964291|FG003|Overall Study|Other Reason|4|||
146947431|NCT01526928|529964292|FG004|Overall Study|Other Reason|1|||
146947432|NCT01526928|529964293|FG005|Overall Study|Other Reason|0|||
146947433|NCT01526928|529964288|FG000|Overall Study|Lost to Follow-up|0|||
146947434|NCT01526928|529964289|FG001|Overall Study|Lost to Follow-up|0|||
146947435|NCT01526928|529964290|FG002|Overall Study|Lost to Follow-up|0|||
146947436|NCT01526928|529964291|FG003|Overall Study|Lost to Follow-up|1|||
146947437|NCT01526928|529964292|FG004|Overall Study|Lost to Follow-up|0|||
146947438|NCT01526928|529964293|FG005|Overall Study|Lost to Follow-up|0|||
146947439|NCT01526928|529964288|FG000|Overall Study|Protocol Deviation|0|||
146947440|NCT01526928|529964289|FG001|Overall Study|Protocol Deviation|0|||
146947441|NCT01526928|529964290|FG002|Overall Study|Protocol Deviation|0|||
146947442|NCT01526928|529964291|FG003|Overall Study|Protocol Deviation|2|||
146947443|NCT01526928|529964292|FG004|Overall Study|Protocol Deviation|0|||
146947444|NCT01526928|529964293|FG005|Overall Study|Protocol Deviation|0|||
146947445|NCT01526928|529964288|FG000|Overall Study|Missing|0|||
146947446|NCT01526928|529964289|FG001|Overall Study|Missing|0|||
146947447|NCT01526928|529964290|FG002|Overall Study|Missing|1|||
146947448|NCT01526928|529964291|FG003|Overall Study|Missing|0|||
146947449|NCT01526928|529964292|FG004|Overall Study|Missing|2|||
146947450|NCT01526928|529964293|FG005|Overall Study|Missing|0|||
146947451|NCT00736450|529964294|FG000|Overall Study|Not ABC gene eligible|19|||
146947452|NCT00736450|529964294|FG000|Overall Study|Withdrawal by Subject|5|||
146947453|NCT00736450|529964294|FG000|Overall Study|Physician Decision|1|||
146947454|NCT04157751|529964295|FG000|Overall Study|Withdrawal by Subject|12|||
146947455|NCT04157751|529964296|FG001|Overall Study|Withdrawal by Subject|17|||
146947456|NCT04157751|529964295|FG000|Overall Study|Lost to Follow-up|6|||
146947457|NCT04157751|529964296|FG001|Overall Study|Lost to Follow-up|2|||
146947458|NCT04157751|529964295|FG000|Overall Study|Adverse Event|34|||
146947459|NCT04157751|529964296|FG001|Overall Study|Adverse Event|23|||
146947460|NCT04157751|529964295|FG000|Overall Study|Not treated|1|||
146947461|NCT04157751|529964296|FG001|Overall Study|Not treated|5|||
146947462|NCT04157751|529964295|FG000|Overall Study|Other reason not stated above|10|||
146947463|NCT04157751|529964296|FG001|Overall Study|Other reason not stated above|10|||
146947464|NCT03446612|529964302|FG000|Overall Study|Protocol defined stopping criteria|0|||
146947465|NCT03446612|529964303|FG001|Overall Study|Protocol defined stopping criteria|1|||
146947466|NCT00333970|529964305|FG000|Overall Study|Withdrawal by Subject|13|||
146947467|NCT00333970|529964306|FG001|Overall Study|Withdrawal by Subject|7|||
146947468|NCT00899678|529964308|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
146947469|NCT00899678|529964309|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
146947470|NCT00899678|529964310|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
146947471|NCT00899678|529964308|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
146947472|NCT00899678|529964309|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
146947473|NCT00899678|529964310|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
146947474|NCT00899678|529964308|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
146947475|NCT00899678|529964309|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
146984679|NCT00696709|530105130|FG003|Overall Study|Protocol Violation|0|||
146984680|NCT00696709|530105131|FG004|Overall Study|Protocol Violation|0|||
146947476|NCT00899678|529964310|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
146947477|NCT00899678|529964308|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
146947478|NCT00899678|529964309|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
146947479|NCT00899678|529964310|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
146947480|NCT00899678|529964308|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
146947481|NCT00899678|529964309|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
146947482|NCT00899678|529964310|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
146947483|NCT00899678|529964308|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
146947484|NCT00899678|529964309|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
146947485|NCT00899678|529964310|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
146947486|NCT00899678|529964308|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
146984681|NCT00696709|530105127|FG000|Overall Study|Lost to Follow-up|1|||
146947487|NCT00899678|529964309|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
146947488|NCT00899678|529964310|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
146947489|NCT00899678|529964308|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
146947490|NCT00899678|529964309|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
146947491|NCT00899678|529964310|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
146947492|NCT00899678|529964308|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
146947493|NCT00899678|529964309|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
146947494|NCT00899678|529964310|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
146947495|NCT03148795|529964315|FG000|Overall Study|Progressive Disease|1|||
146947496|NCT01435122|529964326|FG000|Overall Study|Early withdrawal due to toxicity|8|||
146947497|NCT02406027|529964327|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
146947498|NCT02406027|529964328|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
146947499|NCT02406027|529964329|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
146947500|NCT02406027|529964330|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
146947501|NCT02406027|529964331|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
146947502|NCT02406027|529964332|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
146947503|NCT02406027|529964333|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
146947504|NCT02406027|529964327|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
146947505|NCT02406027|529964328|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
146947506|NCT02406027|529964329|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
146947507|NCT02406027|529964330|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
146947508|NCT02406027|529964331|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
146947509|NCT02406027|529964332|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
146947510|NCT02406027|529964333|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
146947511|NCT02406027|529964327|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
146947512|NCT02406027|529964328|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
146947513|NCT02406027|529964329|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
146947514|NCT02406027|529964330|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
146947515|NCT02406027|529964331|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
146947516|NCT02406027|529964332|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
146947517|NCT02406027|529964333|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
146947518|NCT02406027|529964327|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
146947519|NCT02406027|529964328|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
146947520|NCT02406027|529964329|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
146947521|NCT02406027|529964330|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
146947522|NCT02406027|529964331|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
146816965|NCT03015220|529497524|FG002|Overall Study|Withdrawal by Subject|2|||
146816966|NCT03015220|529497525|FG003|Overall Study|Withdrawal by Subject|2|||
146816967|NCT03015220|529497522|FG000|Overall Study|Lost to Follow-up|0|||
146816968|NCT03015220|529497523|FG001|Overall Study|Lost to Follow-up|0|||
146816969|NCT03015220|529497524|FG002|Overall Study|Lost to Follow-up|1|||
146816970|NCT03015220|529497525|FG003|Overall Study|Lost to Follow-up|0|||
146816971|NCT02291549|529497526|FG000|Overall Study|Lost to Follow-up|1|||
146816972|NCT02291549|529497527|FG001|Overall Study|Lost to Follow-up|0|||
146816973|NCT02291549|529497526|FG000|Overall Study|Withdrawal by Subject|0|||
146816974|NCT02291549|529497527|FG001|Overall Study|Withdrawal by Subject|1|||
146816975|NCT01468597|529497529|FG000|Overall Study|Found ineligible|17|||
146816976|NCT01468597|529497529|FG000|Overall Study|concomitant valves|12|||
146816977|NCT01468597|529497529|FG000|Overall Study|off-pump CABG|1|||
146816978|NCT01468597|529497529|FG000|Overall Study|no platelet function data|5|||
146816979|NCT04447287|529497530|FG000|Period 1: Run-in Period|Adverse Event|3|||
146816980|NCT04447287|529497531|FG001|Period 1: Run-in Period|Adverse Event|0|||
146816981|NCT04447287|529497532|FG002|Period 1: Run-in Period|Adverse Event|0|||
146816982|NCT04447287|529497530|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
146816983|NCT04447287|529497531|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
146816984|NCT04447287|529497532|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
146816985|NCT04447287|529497530|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
146816986|NCT04447287|529497531|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
146816987|NCT04447287|529497532|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
146816988|NCT00912964|529497533|FG000|Overall Study|Eligibility criterion not met|1|||
146816989|NCT00912964|529497534|FG001|Overall Study|Eligibility criterion not met|1|||
146816990|NCT00912964|529497535|FG002|Overall Study|Eligibility criterion not met|0|||
146816991|NCT00912964|529497533|FG000|Overall Study|Adverse Event|15|||
146816992|NCT00912964|529497534|FG001|Overall Study|Adverse Event|18|||
146816993|NCT00912964|529497535|FG002|Overall Study|Adverse Event|12|||
146816994|NCT00912964|529497533|FG000|Overall Study|Lack of Efficacy|11|||
146816995|NCT00912964|529497534|FG001|Overall Study|Lack of Efficacy|4|||
146947523|NCT02406027|529964332|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
146947524|NCT02406027|529964333|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
146947525|NCT02406027|529964327|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
146947526|NCT02406027|529964328|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
146947527|NCT02406027|529964329|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
146947528|NCT02406027|529964330|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
146947529|NCT02406027|529964331|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
146947530|NCT02406027|529964332|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
146947531|NCT02406027|529964333|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
146947532|NCT02406027|529964327|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
146947533|NCT02406027|529964328|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
146947534|NCT02406027|529964329|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
146947535|NCT02406027|529964330|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
146947536|NCT02406027|529964331|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
146947537|NCT02406027|529964332|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
146947538|NCT02406027|529964333|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
146947539|NCT02406027|529964327|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
146947540|NCT02406027|529964328|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
146947541|NCT02406027|529964329|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
146947542|NCT02406027|529964330|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
146947543|NCT02406027|529964331|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
146947544|NCT02406027|529964332|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
146947545|NCT02406027|529964333|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
146947546|NCT02406027|529964327|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
146947547|NCT02406027|529964328|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
146947548|NCT02406027|529964329|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
146947549|NCT02406027|529964330|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
146947550|NCT02406027|529964331|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
146947551|NCT02406027|529964332|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
146947552|NCT02406027|529964333|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
146947553|NCT02406027|529964327|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
146947554|NCT02406027|529964328|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
146947555|NCT02406027|529964329|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
146947556|NCT02406027|529964330|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
146947557|NCT02406027|529964331|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
146947558|NCT02406027|529964332|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
146947559|NCT02406027|529964333|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
146947560|NCT02406027|529964327|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
146947561|NCT02406027|529964328|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
146947562|NCT02406027|529964329|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
146947563|NCT02406027|529964330|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
146947564|NCT02406027|529964331|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
146947565|NCT02406027|529964332|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
146947566|NCT02406027|529964333|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
146947567|NCT03277794|529964336|FG000|Overall Study|Lost to Follow-up|2|||
146947568|NCT03277794|529964337|FG001|Overall Study|Lost to Follow-up|4|||
146947569|NCT03277794|529964336|FG000|Overall Study|Withdrew due to high acuity|1|||
146947570|NCT03277794|529964337|FG001|Overall Study|Withdrew due to high acuity|0|||
146947571|NCT02254304|529964339|FG000|Overall Study|Adverse Event|2|||
146947572|NCT02254304|529964340|FG001|Overall Study|Adverse Event|1|||
146947573|NCT02254304|529964339|FG000|Overall Study|Lost to Follow-up|2|||
146947574|NCT02254304|529964340|FG001|Overall Study|Lost to Follow-up|2|||
146947575|NCT02254304|529964339|FG000|Overall Study|Protocol Violation|1|||
146947576|NCT02254304|529964340|FG001|Overall Study|Protocol Violation|0|||
146947577|NCT02254304|529964339|FG000|Overall Study|Withdrawal by Subject|3|||
146947578|NCT02254304|529964340|FG001|Overall Study|Withdrawal by Subject|0|||
146947579|NCT02254304|529964339|FG000|Overall Study|Injection site pain and Injection fear|1|||
146947580|NCT02254304|529964340|FG001|Overall Study|Injection site pain and Injection fear|0|||
146947581|NCT02254304|529964339|FG000|Overall Study|Personal causes|4|||
146947582|NCT02254304|529964340|FG001|Overall Study|Personal causes|1|||
146947583|NCT02254304|529964339|FG000|Overall Study|Personal decision|1|||
146947584|NCT02254304|529964340|FG001|Overall Study|Personal decision|0|||
146816996|NCT00912964|529497535|FG002|Overall Study|Lack of Efficacy|3|||
146816997|NCT00912964|529497533|FG000|Overall Study|Withdrawal by Subject|20|||
146816998|NCT00912964|529497534|FG001|Overall Study|Withdrawal by Subject|12|||
146816999|NCT00912964|529497535|FG002|Overall Study|Withdrawal by Subject|18|||
146947585|NCT05166603|529964341|FG000|Overall Study|Withdrawal by Subject|68|||
146817000|NCT00912964|529497533|FG000|Overall Study|Lost to Follow-up|4|||
146984682|NCT00696709|530105128|FG001|Overall Study|Lost to Follow-up|1|||
146984683|NCT00696709|530105129|FG002|Overall Study|Lost to Follow-up|0|||
146984684|NCT00696709|530105130|FG003|Overall Study|Lost to Follow-up|0|||
146984685|NCT00696709|530105131|FG004|Overall Study|Lost to Follow-up|0|||
146984686|NCT00696709|530105127|FG000|Overall Study|Adverse Event|0|||
146984687|NCT00696709|530105128|FG001|Overall Study|Adverse Event|0|||
146984688|NCT00696709|530105129|FG002|Overall Study|Adverse Event|0|||
146984689|NCT00696709|530105130|FG003|Overall Study|Adverse Event|1|||
146984690|NCT00696709|530105131|FG004|Overall Study|Adverse Event|0|||
146984691|NCT00310856|530105132|FG000|Overall Study|Withdrawal by Subject|2|||
146984692|NCT00310856|530105133|FG001|Overall Study|Withdrawal by Subject|2|||
146984693|NCT00310856|530105134|FG002|Overall Study|Withdrawal by Subject|2|||
146984694|NCT00310856|530105132|FG000|Overall Study|Lost to Follow-up|1|||
146984695|NCT00310856|530105133|FG001|Overall Study|Lost to Follow-up|2|||
146984696|NCT00310856|530105134|FG002|Overall Study|Lost to Follow-up|6|||
146984697|NCT00310856|530105132|FG000|Overall Study|Inappropriate enrollment|1|||
146984698|NCT00310856|530105133|FG001|Overall Study|Inappropriate enrollment|1|||
146984699|NCT00310856|530105134|FG002|Overall Study|Inappropriate enrollment|0|||
146984700|NCT00310856|530105132|FG000|Overall Study|Unable to classify|1|||
146984701|NCT00310856|530105133|FG001|Overall Study|Unable to classify|0|||
146984702|NCT00310856|530105134|FG002|Overall Study|Unable to classify|0|||
146817001|NCT00912964|529497534|FG001|Overall Study|Lost to Follow-up|3|||
146817002|NCT00912964|529497535|FG002|Overall Study|Lost to Follow-up|3|||
146817003|NCT00912964|529497533|FG000|Overall Study|Protocol Violation|5|||
146817004|NCT00912964|529497534|FG001|Overall Study|Protocol Violation|3|||
146817005|NCT00912964|529497535|FG002|Overall Study|Protocol Violation|8|||
146817006|NCT00912964|529497533|FG000|Overall Study|Taking exclusionary medications|7|||
146817007|NCT00912964|529497534|FG001|Overall Study|Taking exclusionary medications|4|||
146947586|NCT05166603|529964342|FG001|Overall Study|Withdrawal by Subject|0|||
146947587|NCT02531633|529966731|FG000|Part A (52 Weeks)|Sponsor request|24|||
146947588|NCT02531633|529966732|FG001|Part A (52 Weeks)|Sponsor request|24|||
146947589|NCT02531633|529966733|FG002|Part A (52 Weeks)|Sponsor request|18|||
146947590|NCT02531633|529966734|FG003|Part A (52 Weeks)|Sponsor request|18|||
146947591|NCT02531633|529966735|FG004|Part A (52 Weeks)|Sponsor request|19|||
146947592|NCT02531633|529966736|FG005|Part A (52 Weeks)|Sponsor request|0|||
146947593|NCT02531633|529966737|FG006|Part A (52 Weeks)|Sponsor request|0|||
146947594|NCT02531633|529966738|FG007|Part A (52 Weeks)|Sponsor request|0|||
146947595|NCT02531633|529966739|FG008|Part A (52 Weeks)|Sponsor request|0|||
146947596|NCT02531633|529966740|FG009|Part A (52 Weeks)|Sponsor request|0|||
146947597|NCT02531633|529966731|FG000|Part A (52 Weeks)|Protocol Violation|1|||
146947598|NCT02531633|529966732|FG001|Part A (52 Weeks)|Protocol Violation|0|||
146947599|NCT02531633|529966733|FG002|Part A (52 Weeks)|Protocol Violation|0|||
146947600|NCT02531633|529966734|FG003|Part A (52 Weeks)|Protocol Violation|0|||
146947601|NCT02531633|529966735|FG004|Part A (52 Weeks)|Protocol Violation|0|||
146947602|NCT02531633|529966736|FG005|Part A (52 Weeks)|Protocol Violation|0|||
146947603|NCT02531633|529966737|FG006|Part A (52 Weeks)|Protocol Violation|0|||
146947604|NCT02531633|529966738|FG007|Part A (52 Weeks)|Protocol Violation|0|||
146947605|NCT02531633|529966739|FG008|Part A (52 Weeks)|Protocol Violation|0|||
146947606|NCT02531633|529966740|FG009|Part A (52 Weeks)|Protocol Violation|0|||
146947607|NCT02531633|529966731|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
146947608|NCT02531633|529966732|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
146947609|NCT02531633|529966733|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
146947610|NCT02531633|529966734|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
146947611|NCT02531633|529966735|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
146947612|NCT02531633|529966736|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
146947613|NCT02531633|529966737|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
146947614|NCT02531633|529966738|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
146947615|NCT02531633|529966739|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
146947616|NCT02531633|529966740|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
146947617|NCT02531633|529966731|FG000|Part A (52 Weeks)|Physician Decision|1|||
146947618|NCT02531633|529966732|FG001|Part A (52 Weeks)|Physician Decision|4|||
146947619|NCT02531633|529966733|FG002|Part A (52 Weeks)|Physician Decision|3|||
146984703|NCT01306253|530105141|FG000|Overall Study|Lost to Follow-up|1|||
146984704|NCT01306253|530105142|FG001|Overall Study|Lost to Follow-up|1|||
146984705|NCT00543439|530105143|FG000|Period 1|Adverse Event|0|||
146984706|NCT00543439|530105144|FG001|Period 1|Adverse Event|2|||
146984707|NCT00543439|530105145|FG002|Period 1|Adverse Event|1|||
146984708|NCT00543439|530105143|FG000|Period 1|Withdrawal by Subject|1|||
146817008|NCT00912964|529497535|FG002|Overall Study|Taking exclusionary medications|8|||
146947620|NCT02531633|529966734|FG003|Part A (52 Weeks)|Physician Decision|1|||
146947621|NCT02531633|529966735|FG004|Part A (52 Weeks)|Physician Decision|0|||
146947622|NCT02531633|529966736|FG005|Part A (52 Weeks)|Physician Decision|0|||
146947623|NCT02531633|529966737|FG006|Part A (52 Weeks)|Physician Decision|0|||
146984709|NCT00543439|530105144|FG001|Period 1|Withdrawal by Subject|1|||
146984710|NCT00543439|530105145|FG002|Period 1|Withdrawal by Subject|0|||
146984711|NCT00543439|530105143|FG000|Period 1|Physician Decision|0|||
146984712|NCT00543439|530105144|FG001|Period 1|Physician Decision|0|||
146984713|NCT00543439|530105145|FG002|Period 1|Physician Decision|1|||
146947624|NCT02531633|529966738|FG007|Part A (52 Weeks)|Physician Decision|0|||
146947625|NCT02531633|529966739|FG008|Part A (52 Weeks)|Physician Decision|0|||
146947626|NCT02531633|529966740|FG009|Part A (52 Weeks)|Physician Decision|0|||
146947627|NCT02531633|529966731|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
146947628|NCT02531633|529966732|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
146947629|NCT02531633|529966733|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
146947630|NCT02531633|529966734|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
146947631|NCT02531633|529966735|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
146947632|NCT02531633|529966736|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
146947633|NCT02531633|529966737|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
146947634|NCT02531633|529966738|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
146947635|NCT02531633|529966739|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
146947636|NCT02531633|529966740|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
146947637|NCT02531633|529966731|FG000|Part A (52 Weeks)|Other|2|||
146947638|NCT02531633|529966732|FG001|Part A (52 Weeks)|Other|0|||
146947639|NCT02531633|529966733|FG002|Part A (52 Weeks)|Other|0|||
146947640|NCT02531633|529966734|FG003|Part A (52 Weeks)|Other|0|||
146947641|NCT02531633|529966735|FG004|Part A (52 Weeks)|Other|0|||
146947642|NCT02531633|529966736|FG005|Part A (52 Weeks)|Other|0|||
146947643|NCT02531633|529966737|FG006|Part A (52 Weeks)|Other|0|||
146947644|NCT02531633|529966738|FG007|Part A (52 Weeks)|Other|0|||
146947645|NCT02531633|529966739|FG008|Part A (52 Weeks)|Other|0|||
146947646|NCT02531633|529966740|FG009|Part A (52 Weeks)|Other|0|||
146947647|NCT02531633|529966731|FG000|Part B (104 Weeks)|Sponsor request|0|||
146947648|NCT02531633|529966732|FG001|Part B (104 Weeks)|Sponsor request|0|||
146947649|NCT02531633|529966733|FG002|Part B (104 Weeks)|Sponsor request|0|||
146947650|NCT02531633|529966734|FG003|Part B (104 Weeks)|Sponsor request|0|||
146947651|NCT02531633|529966735|FG004|Part B (104 Weeks)|Sponsor request|0|||
146947652|NCT02531633|529966736|FG005|Part B (104 Weeks)|Sponsor request|8|||
146947653|NCT02531633|529966737|FG006|Part B (104 Weeks)|Sponsor request|5|||
146947654|NCT02531633|529966738|FG007|Part B (104 Weeks)|Sponsor request|3|||
146947655|NCT02531633|529966739|FG008|Part B (104 Weeks)|Sponsor request|5|||
146947656|NCT02531633|529966740|FG009|Part B (104 Weeks)|Sponsor request|4|||
146947657|NCT02531633|529966731|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
146947658|NCT02531633|529966732|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
146947659|NCT02531633|529966733|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
146947660|NCT02531633|529966734|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
146947661|NCT02531633|529966735|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
146947662|NCT02531633|529966736|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
146947663|NCT02531633|529966737|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
146947664|NCT02531633|529966738|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
146947665|NCT02531633|529966739|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
146947666|NCT02531633|529966740|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
146947667|NCT04517253|529966743|FG000|Primary Treatment Period|Adverse Event|1|||
146947668|NCT04517253|529966744|FG001|Primary Treatment Period|Adverse Event|0|||
146947669|NCT04517253|529966745|FG002|Primary Treatment Period|Adverse Event|0|||
146947670|NCT04517253|529966743|FG000|Primary Treatment Period|Death|0|||
146947671|NCT04517253|529966744|FG001|Primary Treatment Period|Death|1|||
146947672|NCT04517253|529966745|FG002|Primary Treatment Period|Death|0|||
146947673|NCT04517253|529966743|FG000|Maintenance Period|Withdrawal by Subject|1|||
146947674|NCT04517253|529966744|FG001|Maintenance Period|Withdrawal by Subject|0|||
146947675|NCT04517253|529966745|FG002|Maintenance Period|Withdrawal by Subject|0|||
146947676|NCT04517253|529966743|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
146947677|NCT04517253|529966744|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
146947678|NCT04517253|529966745|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
146947679|NCT02136134|529966751|FG000|Overall Study|Death|170|||
146947680|NCT02136134|529966752|FG001|Overall Study|Death|148|||
146947681|NCT02136134|529966751|FG000|Overall Study|Withdrawal by Subject|19|||
146947682|NCT02136134|529966752|FG001|Overall Study|Withdrawal by Subject|10|||
146947683|NCT02136134|529966751|FG000|Overall Study|Lost to Follow-up|3|||
146947684|NCT02136134|529966752|FG001|Overall Study|Lost to Follow-up|3|||
146947685|NCT02136134|529966751|FG000|Overall Study|Uspecified|55|||
146947686|NCT02136134|529966752|FG001|Overall Study|Uspecified|90|||
146947687|NCT03070119|529966755|FG000|Overall Study|Adverse Event|0|||
146947688|NCT03070119|529966756|FG001|Overall Study|Adverse Event|0|||
146947689|NCT03070119|529966757|FG002|Overall Study|Adverse Event|1|||
146984714|NCT00543439|530105143|FG000|Period 2|Protocol Violation|1|||
146817009|NCT00912964|529497533|FG000|Overall Study|Medical History|1|||
146947690|NCT03070119|529966755|FG000|Overall Study|Lost to Follow-up|0|||
146947691|NCT03070119|529966756|FG001|Overall Study|Lost to Follow-up|1|||
146947692|NCT03070119|529966757|FG002|Overall Study|Lost to Follow-up|0|||
146947693|NCT03070119|529966755|FG000|Overall Study|Consent Withdrawn|6|||
146947694|NCT03070119|529966756|FG001|Overall Study|Consent Withdrawn|5|||
146947695|NCT03070119|529966757|FG002|Overall Study|Consent Withdrawn|3|||
146947696|NCT03070119|529966755|FG000|Overall Study|Investigator Decision|0|||
146947697|NCT03070119|529966756|FG001|Overall Study|Investigator Decision|0|||
146947698|NCT03070119|529966757|FG002|Overall Study|Investigator Decision|1|||
146947699|NCT03070119|529966755|FG000|Overall Study|Death|7|||
146947700|NCT03070119|529966756|FG001|Overall Study|Death|14|||
146947701|NCT03070119|529966757|FG002|Overall Study|Death|5|||
146947702|NCT03070119|529966755|FG000|Overall Study|Disease Progression|5|||
146947703|NCT03070119|529966756|FG001|Overall Study|Disease Progression|7|||
146947704|NCT03070119|529966757|FG002|Overall Study|Disease Progression|7|||
146947705|NCT03070119|529966755|FG000|Overall Study|Reason not Specified|2|||
146817010|NCT00912964|529497534|FG001|Overall Study|Medical History|0|||
146817011|NCT00912964|529497535|FG002|Overall Study|Medical History|0|||
146947706|NCT03070119|529966756|FG001|Overall Study|Reason not Specified|2|||
146947707|NCT03070119|529966757|FG002|Overall Study|Reason not Specified|1|||
146947708|NCT02974621|529966759|FG000|Overall Study|Didn't receive study treatment|1|||
146947709|NCT02974621|529966760|FG001|Overall Study|Didn't receive study treatment|10|||
146947710|NCT00732472|529966761|FG000|Overall Study|Adverse Event|0|||
146947711|NCT00732472|529966762|FG001|Overall Study|Adverse Event|1|||
146947712|NCT00732472|529966763|FG002|Overall Study|Adverse Event|1|||
146947713|NCT00732472|529966764|FG003|Overall Study|Adverse Event|1|||
146947714|NCT00732472|529966761|FG000|Overall Study|Protocol Violation|0|||
146947715|NCT00732472|529966762|FG001|Overall Study|Protocol Violation|0|||
146947716|NCT00732472|529966763|FG002|Overall Study|Protocol Violation|0|||
146947717|NCT00732472|529966764|FG003|Overall Study|Protocol Violation|1|||
146947718|NCT00732472|529966761|FG000|Overall Study|Withdrawal by Subject|0|||
146947719|NCT00732472|529966762|FG001|Overall Study|Withdrawal by Subject|2|||
146947720|NCT00732472|529966763|FG002|Overall Study|Withdrawal by Subject|0|||
146947721|NCT00732472|529966764|FG003|Overall Study|Withdrawal by Subject|1|||
146947722|NCT03342404|529966766|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
146947723|NCT03342404|529966767|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
146947724|NCT03342404|529966766|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
146947725|NCT03342404|529966767|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
146947726|NCT03342404|529966766|FG000|Blinded Treatment Phase|Adverse Event|5|||
146947727|NCT03342404|529966767|FG001|Blinded Treatment Phase|Adverse Event|4|||
146947728|NCT03342404|529966766|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
146947729|NCT03342404|529966767|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
146947730|NCT03342404|529966766|FG000|Blinded Treatment Phase|Other reasons|1|||
146947731|NCT03342404|529966767|FG001|Blinded Treatment Phase|Other reasons|0|||
146947732|NCT03342404|529966766|FG000|Blinded Treatment Phase|Physician Decision|1|||
146947733|NCT03342404|529966767|FG001|Blinded Treatment Phase|Physician Decision|0|||
146947734|NCT03342404|529966766|FG000|Blinded Treatment Phase|Death|1|||
146947735|NCT03342404|529966767|FG001|Blinded Treatment Phase|Death|0|||
146947736|NCT03342404|529966766|FG000|Open-Label Phase|Lost to Follow-up|0|||
146947737|NCT03342404|529966767|FG001|Open-Label Phase|Lost to Follow-up|1|||
146947738|NCT03342404|529966766|FG000|Open-Label Phase|Other reasons|0|||
146947739|NCT03342404|529966767|FG001|Open-Label Phase|Other reasons|1|||
146947740|NCT03342404|529966766|FG000|Open-Label Phase|Adverse Event|0|||
146947741|NCT03342404|529966767|FG001|Open-Label Phase|Adverse Event|3|||
146947742|NCT03342404|529966766|FG000|Open-Label Phase|Withdrawal by Subject|0|||
146947743|NCT03342404|529966767|FG001|Open-Label Phase|Withdrawal by Subject|6|||
146947744|NCT00850135|529966768|FG000|Overall Study|Physician Decision|1|||
146947745|NCT02253992|529966769|FG000|Overall Study|Study drug toxicity|1|||
146947746|NCT02253992|529966770|FG001|Overall Study|Study drug toxicity|0|||
146947747|NCT02253992|529966771|FG002|Overall Study|Study drug toxicity|10|||
146947748|NCT02253992|529966769|FG000|Overall Study|Disease progression|4|||
146817012|NCT00912964|529497533|FG000|Overall Study|Non-compliance with study procedures|2|||
146817013|NCT00912964|529497534|FG001|Overall Study|Non-compliance with study procedures|0|||
146817014|NCT00912964|529497535|FG002|Overall Study|Non-compliance with study procedures|0|||
146817015|NCT00912964|529497533|FG000|Overall Study|Violation of exclusion criterion|0|||
146817016|NCT00912964|529497534|FG001|Overall Study|Violation of exclusion criterion|0|||
146817017|NCT00912964|529497535|FG002|Overall Study|Violation of exclusion criterion|2|||
146817018|NCT00912964|529497533|FG000|Overall Study|Randomized but never received study drug|0|||
146817019|NCT00912964|529497534|FG001|Overall Study|Randomized but never received study drug|1|||
146817020|NCT00912964|529497535|FG002|Overall Study|Randomized but never received study drug|0|||
146817021|NCT00655824|529497538|FG000|Overall Study|Adverse Event|3|||
146817022|NCT00655824|529497538|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
146947749|NCT02253992|529966770|FG001|Overall Study|Disease progression|3|||
146984715|NCT00543439|530105144|FG001|Period 2|Protocol Violation|0|||
146817023|NCT00655824|529497538|FG000|Overall Study|Protocol Violation|1|||
146817024|NCT00655824|529497538|FG000|Overall Study|Withdrawal by Subject|4|||
146947750|NCT02253992|529966771|FG002|Overall Study|Disease progression|98|||
146947751|NCT02253992|529966769|FG000|Overall Study|Withdrawal by Subject|0|||
146947752|NCT02253992|529966770|FG001|Overall Study|Withdrawal by Subject|0|||
146947753|NCT02253992|529966771|FG002|Overall Study|Withdrawal by Subject|3|||
146947754|NCT02253992|529966769|FG000|Overall Study|Adverse Event|0|||
146947755|NCT02253992|529966770|FG001|Overall Study|Adverse Event|0|||
146947756|NCT02253992|529966771|FG002|Overall Study|Adverse Event|8|||
146947757|NCT02253992|529966769|FG000|Overall Study|Death|0|||
146947758|NCT02253992|529966770|FG001|Overall Study|Death|0|||
146947759|NCT02253992|529966771|FG002|Overall Study|Death|1|||
146947760|NCT02253992|529966769|FG000|Overall Study|Subject discontinued study drug|1|||
146947761|NCT02253992|529966770|FG001|Overall Study|Subject discontinued study drug|0|||
146947762|NCT02253992|529966771|FG002|Overall Study|Subject discontinued study drug|1|||
146947763|NCT02253992|529966769|FG000|Overall Study|Completed treatment as per protocol|0|||
146947764|NCT02253992|529966770|FG001|Overall Study|Completed treatment as per protocol|1|||
146947765|NCT02253992|529966771|FG002|Overall Study|Completed treatment as per protocol|22|||
146947766|NCT02253992|529966769|FG000|Overall Study|Other|0|||
146947767|NCT02253992|529966770|FG001|Overall Study|Other|0|||
146947768|NCT02253992|529966771|FG002|Overall Study|Other|1|||
146947769|NCT00796549|529966779|FG000|Overall Study|Adverse Event|11|||
146947770|NCT00796549|529966779|FG000|Overall Study|not entered|149|||
146947771|NCT00796549|529966779|FG000|Overall Study|Other|2|||
146947772|NCT00796549|529966779|FG000|Overall Study|Progressive disease|56|||
146947773|NCT03523715|529966780|FG000|Overall Study|Lost to Follow-up|11|||
146947774|NCT03523715|529966781|FG001|Overall Study|Lost to Follow-up|14|||
146947775|NCT03523715|529966780|FG000|Overall Study|Did not meet inclusion criteria|1|||
146947776|NCT03523715|529966781|FG001|Overall Study|Did not meet inclusion criteria|0|||
146947777|NCT03523715|529966780|FG000|Overall Study|Internally inconsistent reporting|0|||
146947778|NCT03523715|529966781|FG001|Overall Study|Internally inconsistent reporting|2|||
146947779|NCT00606229|529966782|FG000|Overall Study|Adverse Event|11|||
146947780|NCT00606229|529966782|FG000|Overall Study|Lack of Efficacy|1|||
146947781|NCT00606229|529966782|FG000|Overall Study|Withdrawal by Subject|4|||
146947782|NCT00606229|529966782|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
146947783|NCT00606229|529966782|FG000|Overall Study|change of residence or other commitments|2|||
146947784|NCT01332851|529966783|FG000|Overall Study|Withdrawal by Subject|4|||
146947785|NCT01332851|529966784|FG001|Overall Study|Withdrawal by Subject|2|||
146947786|NCT01332851|529966783|FG000|Overall Study|Lost to Follow-up|7|||
146947787|NCT01332851|529966784|FG001|Overall Study|Lost to Follow-up|11|||
146947788|NCT03299166|529966785|FG000|Overall Study|Adverse Event|9|||
146947789|NCT03299166|529966786|FG001|Overall Study|Adverse Event|4|||
146947790|NCT03299166|529966785|FG000|Overall Study|Withdrawal by Subject|6|||
146947791|NCT03299166|529966786|FG001|Overall Study|Withdrawal by Subject|5|||
146947792|NCT03299166|529966785|FG000|Overall Study|Physician Decision|1|||
146947793|NCT03299166|529966786|FG001|Overall Study|Physician Decision|1|||
146947794|NCT03299166|529966785|FG000|Overall Study|Sponsor Decision|3|||
146947795|NCT03299166|529966786|FG001|Overall Study|Sponsor Decision|0|||
146947796|NCT03299166|529966785|FG000|Overall Study|Lost to Follow-up|2|||
146947797|NCT03299166|529966786|FG001|Overall Study|Lost to Follow-up|4|||
146947798|NCT03299166|529966785|FG000|Overall Study|Randomization Error|0|||
146947799|NCT03299166|529966786|FG001|Overall Study|Randomization Error|1|||
146947800|NCT03299166|529966785|FG000|Overall Study|Subject unable to return due to COVID|1|||
146947801|NCT03299166|529966786|FG001|Overall Study|Subject unable to return due to COVID|0|||
146947802|NCT03299166|529966785|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
146947803|NCT03299166|529966786|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
146947804|NCT01302691|529966789|FG000|Overall Study|Adverse Event|2|||
146947805|NCT01302691|529966790|FG001|Overall Study|Adverse Event|0|||
146947806|NCT01302691|529966789|FG000|Overall Study|Death|0|||
146947807|NCT01302691|529966790|FG001|Overall Study|Death|1|||
146947808|NCT01302691|529966789|FG000|Overall Study|Lost to Follow-up|1|||
146947809|NCT01302691|529966790|FG001|Overall Study|Lost to Follow-up|0|||
146947810|NCT01302691|529966789|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
146947811|NCT01302691|529966790|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
146947812|NCT01302691|529966789|FG000|Overall Study|Physician Decision|0|||
146947813|NCT01302691|529966790|FG001|Overall Study|Physician Decision|1|||
146947814|NCT01302691|529966789|FG000|Overall Study|Protocol Violation|1|||
146947815|NCT01302691|529966790|FG001|Overall Study|Protocol Violation|0|||
146947816|NCT02829775|529966791|FG000|Overall Study|Death|1|||
146947817|NCT02829775|529966791|FG000|Overall Study|Withdrawal by Subject|3|||
146947818|NCT02829775|529966791|FG000|Overall Study|Disease remission|1|||
146947819|NCT00062647|529966792|FG000|Overall Study|Death|2|||
146947820|NCT00062647|529966793|FG001|Overall Study|Death|2|||
146947821|NCT00062647|529966792|FG000|Overall Study|Adverse Event|1|||
146947822|NCT00062647|529966793|FG001|Overall Study|Adverse Event|1|||
146947823|NCT00062647|529966792|FG000|Overall Study|Withdrawal by Subject|2|||
146947824|NCT00062647|529966793|FG001|Overall Study|Withdrawal by Subject|1|||
146817025|NCT00655824|529497538|FG000|Overall Study|Deterioration of Trial Disease|2|||
146817026|NCT00960206|529497539|FG000|Overall Study|Death|7|||
146817027|NCT00960206|529497540|FG001|Overall Study|Death|4|||
146817028|NCT00960206|529497541|FG002|Overall Study|Death|1|||
146947825|NCT00062647|529966792|FG000|Overall Study|Protocol Violation|1|||
146947826|NCT00062647|529966793|FG001|Overall Study|Protocol Violation|0|||
146947827|NCT00062647|529966792|FG000|Overall Study|Lost to Follow-up|1|||
146947828|NCT00062647|529966793|FG001|Overall Study|Lost to Follow-up|2|||
146947829|NCT00062647|529966792|FG000|Overall Study|Failed continuation criteria|4|||
146947830|NCT00062647|529966793|FG001|Overall Study|Failed continuation criteria|2|||
146947831|NCT00062647|529966792|FG000|Overall Study|Other|4|||
146947832|NCT00062647|529966793|FG001|Overall Study|Other|4|||
146947833|NCT00062647|529966792|FG000|Overall Study|Never received study treatment|1|||
146947834|NCT00062647|529966793|FG001|Overall Study|Never received study treatment|1|||
146947835|NCT01039428|529966798|FG000|Overall Study|Protocol Violation|1|||
146947836|NCT01039428|529966799|FG001|Overall Study|Protocol Violation|0|||
146947837|NCT01039428|529966798|FG000|Overall Study|Withdrawal by Subject|1|||
146947838|NCT01039428|529966799|FG001|Overall Study|Withdrawal by Subject|0|||
146947839|NCT01313039|529966800|FG000|Overall Study|Physician Decision|1|||
146947840|NCT01313039|529966800|FG000|Overall Study|Adverse Event|1|||
146947841|NCT01678560|529966801|FG000|Overall Study|Physician Decision|4|||
146947842|NCT01678560|529966802|FG001|Overall Study|Physician Decision|4|||
146947843|NCT01678560|529966801|FG000|Overall Study|Death|0|||
146947844|NCT01678560|529966802|FG001|Overall Study|Death|1|||
146947845|NCT01678560|529966801|FG000|Overall Study|Withdrawal by Subject|0|||
146947846|NCT01678560|529966802|FG001|Overall Study|Withdrawal by Subject|1|||
146947847|NCT02201472|529966803|FG000|Overall Study|Lack of Efficacy|2|||
146947848|NCT01300767|529966804|FG000|Overall Study|Discomfort|2|||
146947849|NCT01300767|529966804|FG000|Overall Study|Biomicroscopy|1|||
146947850|NCT01300767|529966804|FG000|Overall Study|Unacceptable fit|1|||
146947851|NCT00117572|529966805|FG000|Overall Study|Site withdrew before starting treatment|2|||
146947852|NCT00117572|529966806|FG001|Overall Study|Site withdrew before starting treatment|3|||
146947853|NCT00117572|529966805|FG000|Overall Study|Withdrawal by Subject|3|||
146947854|NCT00117572|529966806|FG001|Overall Study|Withdrawal by Subject|3|||
146947855|NCT00117572|529966805|FG000|Overall Study|Protocol Violation|1|||
146947856|NCT00117572|529966806|FG001|Overall Study|Protocol Violation|0|||
146947857|NCT01188811|529966809|FG000|Overall Study|Withdrawal by Subject|0|||
146947858|NCT01188811|529966810|FG001|Overall Study|Withdrawal by Subject|2|||
146947859|NCT01188811|529966809|FG000|Overall Study|Adverse Event|6|||
146947860|NCT01188811|529966810|FG001|Overall Study|Adverse Event|0|||
146947861|NCT01602744|529966811|FG000|Overall Study|Death|17|||
146947862|NCT01602744|529966812|FG001|Overall Study|Death|15|||
146947863|NCT01602744|529966811|FG000|Overall Study|Lost to Follow-up|13|||
146947864|NCT01602744|529966812|FG001|Overall Study|Lost to Follow-up|8|||
146947865|NCT00654368|529966813|FG000|Overall Study|Ineligibility determined|6|||
146947866|NCT00654368|529966814|FG001|Overall Study|Ineligibility determined|0|||
146947867|NCT00654368|529966815|FG002|Overall Study|Ineligibility determined|0|||
146947868|NCT00654368|529966813|FG000|Overall Study|Protocol deviation|3|||
146947869|NCT00654368|529966814|FG001|Overall Study|Protocol deviation|2|||
146947870|NCT00654368|529966815|FG002|Overall Study|Protocol deviation|1|||
146947871|NCT00654368|529966813|FG000|Overall Study|Non-compliance|2|||
146947872|NCT00654368|529966814|FG001|Overall Study|Non-compliance|1|||
146947873|NCT00654368|529966815|FG002|Overall Study|Non-compliance|2|||
146947874|NCT00654368|529966813|FG000|Overall Study|Withdrawal by Subject|5|||
146947875|NCT00654368|529966814|FG001|Overall Study|Withdrawal by Subject|2|||
146947876|NCT00654368|529966815|FG002|Overall Study|Withdrawal by Subject|2|||
146947877|NCT00654368|529966813|FG000|Overall Study|Disease progression|21|||
146947878|NCT00654368|529966814|FG001|Overall Study|Disease progression|31|||
146947879|NCT00654368|529966815|FG002|Overall Study|Disease progression|13|||
146947880|NCT00654368|529966813|FG000|Overall Study|Requirement for alternative therapy|1|||
146947881|NCT00654368|529966814|FG001|Overall Study|Requirement for alternative therapy|1|||
146947882|NCT00654368|529966815|FG002|Overall Study|Requirement for alternative therapy|1|||
146947883|NCT00654368|529966813|FG000|Overall Study|Physician Decision|0|||
146947884|NCT00654368|529966814|FG001|Overall Study|Physician Decision|0|||
146947885|NCT00654368|529966815|FG002|Overall Study|Physician Decision|2|||
146947886|NCT00654368|529966813|FG000|Overall Study|Death|1|||
146947887|NCT00654368|529966814|FG001|Overall Study|Death|0|||
146947888|NCT00654368|529966815|FG002|Overall Study|Death|0|||
146947889|NCT00654368|529966813|FG000|Overall Study|Pregnancy|0|||
146947890|NCT00654368|529966814|FG001|Overall Study|Pregnancy|0|||
146947891|NCT00654368|529966815|FG002|Overall Study|Pregnancy|2|||
146947892|NCT00654368|529966813|FG000|Overall Study|Other|0|||
146947893|NCT00654368|529966814|FG001|Overall Study|Other|2|||
146947894|NCT00654368|529966815|FG002|Overall Study|Other|3|||
146984716|NCT00543439|530105145|FG002|Period 2|Protocol Violation|1|||
146817029|NCT00960206|529497539|FG000|Overall Study|Unwilling/Unable to return|1|||
146817030|NCT00960206|529497540|FG001|Overall Study|Unwilling/Unable to return|2|||
146817031|NCT00960206|529497541|FG002|Overall Study|Unwilling/Unable to return|0|||
146817032|NCT00960206|529497539|FG000|Overall Study|Lost to Follow-up|8|||
146947895|NCT00654368|529966813|FG000|Overall Study|Adverse Event|14|||
146947896|NCT00654368|529966814|FG001|Overall Study|Adverse Event|9|||
146947897|NCT00654368|529966815|FG002|Overall Study|Adverse Event|6|||
146947898|NCT04228445|529966819|FG000|Overall Study|Lost to Follow-up|1|||
146947899|NCT04228445|529966820|FG001|Overall Study|Lost to Follow-up|1|||
146947900|NCT04228445|529966819|FG000|Overall Study|Physician Decision|1|||
146947901|NCT04228445|529966820|FG001|Overall Study|Physician Decision|2|||
146947902|NCT04228445|529966819|FG000|Overall Study|Withdrawal by Subject|0|||
146947903|NCT04228445|529966820|FG001|Overall Study|Withdrawal by Subject|1|||
146947904|NCT04228445|529966819|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
146947905|NCT04228445|529966820|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
146947906|NCT00606294|529966821|FG000|Overall Study|Withdrawal by Subject|36|||
146947907|NCT00606294|529966822|FG001|Overall Study|Withdrawal by Subject|0|||
146947908|NCT03418376|529966823|FG000|Overall Study|Musculoskeletal injury|1|||
146947909|NCT03418376|529966824|FG001|Overall Study|Musculoskeletal injury|2|||
146947910|NCT03418376|529966825|FG002|Overall Study|Musculoskeletal injury|1|||
146947911|NCT03418376|529966826|FG003|Overall Study|Musculoskeletal injury|0|||
146947912|NCT03418376|529966823|FG000|Overall Study|Personal reasons|0|||
146947913|NCT03418376|529966824|FG001|Overall Study|Personal reasons|2|||
146947914|NCT03418376|529966825|FG002|Overall Study|Personal reasons|2|||
146947915|NCT03418376|529966826|FG003|Overall Study|Personal reasons|1|||
146947916|NCT03418376|529966823|FG000|Overall Study|Exacerbation|0|||
146947917|NCT03418376|529966824|FG001|Overall Study|Exacerbation|1|||
146947918|NCT03418376|529966825|FG002|Overall Study|Exacerbation|0|||
146947919|NCT03418376|529966826|FG003|Overall Study|Exacerbation|0|||
146947920|NCT01976624|529966827|FG000|Overall Study|Participants contraindicated|2|||
146947921|NCT01976624|529966827|FG000|Overall Study|Participants age less than 19 years|12|||
146947922|NCT02774291|529966828|FG000|Overall Study|Lost to Follow-up|1|||
146947923|NCT00471315|529966829|FG000|Overall Study|Adverse Event|7|||
146947924|NCT00471315|529966829|FG000|Overall Study|Withdrawal by Subject|1|||
146947925|NCT04757376|529966835|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
146947926|NCT04757376|529966836|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
146947927|NCT04757376|529966837|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
146947928|NCT04757376|529966838|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
146947929|NCT04757376|529966839|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
146947930|NCT04757376|529966835|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
146947931|NCT04757376|529966836|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
146947932|NCT04757376|529966837|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
146947933|NCT04757376|529966838|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
146947934|NCT04757376|529966839|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
146947935|NCT04757376|529966835|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
146947936|NCT04757376|529966836|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
146947937|NCT04757376|529966837|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
146947938|NCT04757376|529966838|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
146947939|NCT04757376|529966839|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
146947940|NCT04757376|529966835|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
146947941|NCT04757376|529966836|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
146947942|NCT04757376|529966837|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
146947943|NCT04757376|529966838|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
146947944|NCT04757376|529966839|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
146947945|NCT04757376|529966835|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
146947946|NCT04757376|529966836|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
146947947|NCT04757376|529966837|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
146947948|NCT04757376|529966838|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
146947949|NCT04757376|529966839|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
146947950|NCT04757376|529966835|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
146947951|NCT04757376|529966836|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
146947952|NCT04757376|529966837|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
146947953|NCT04757376|529966838|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
146947954|NCT04757376|529966839|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
146947955|NCT04757376|529966835|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
146947956|NCT04757376|529966836|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
146947957|NCT04757376|529966837|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
146947958|NCT04757376|529966838|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
146947959|NCT04757376|529966839|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
146947960|NCT04757376|529966835|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
146947961|NCT04757376|529966836|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
146947962|NCT04757376|529966837|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
146947963|NCT04757376|529966838|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
146947964|NCT04757376|529966839|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
146947965|NCT01307046|529966840|FG000|Overall Study|Adverse Event|3|||
146947966|NCT01307046|529966841|FG001|Overall Study|Adverse Event|3|||
146947967|NCT01307046|529966840|FG000|Overall Study|Lack of Efficacy|0|||
146984717|NCT00543439|530105143|FG000|Period 2|Adverse Event|0|||
146984718|NCT00543439|530105144|FG001|Period 2|Adverse Event|1|||
146947968|NCT01307046|529966841|FG001|Overall Study|Lack of Efficacy|2|||
146947969|NCT01307046|529966840|FG000|Overall Study|Physician Decision|2|||
146947970|NCT01307046|529966841|FG001|Overall Study|Physician Decision|0|||
146947971|NCT01307046|529966840|FG000|Overall Study|Withdrawal by Subject|1|||
146947972|NCT01307046|529966841|FG001|Overall Study|Withdrawal by Subject|1|||
146947973|NCT01307046|529966840|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
146947974|NCT01307046|529966841|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
146947975|NCT01307046|529966840|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
146947976|NCT01307046|529966841|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
146947977|NCT00609167|529966842|FG000|Overall Study|Withdrawal by Subject|1|||
146947978|NCT00609167|529966843|FG001|Overall Study|Withdrawal by Subject|0|||
146947979|NCT00609167|529966842|FG000|Overall Study|Lack of Efficacy|1|||
146947980|NCT00609167|529966843|FG001|Overall Study|Lack of Efficacy|0|||
146947981|NCT00609167|529966842|FG000|Overall Study|Adverse Event|5|||
146947982|NCT00609167|529966843|FG001|Overall Study|Adverse Event|1|||
146947983|NCT00609167|529966842|FG000|Overall Study|Disease Progression|1|||
146947984|NCT00609167|529966843|FG001|Overall Study|Disease Progression|0|||
146947985|NCT00609167|529966842|FG000|Overall Study|Stem Cell Transplant|0|||
146947986|NCT00609167|529966843|FG001|Overall Study|Stem Cell Transplant|6|||
146947987|NCT03898323|529966844|FG000|Overall Study|Physician Decision|1|||
146947988|NCT00712270|529966846|FG000|Overall Study|Withdrawal by Subject|11|||
146947989|NCT00712270|529966846|FG000|Overall Study|Screen Failure|3|||
146947990|NCT02574520|529966847|FG000|Overall Study|Not dosed|2|||
146984719|NCT00543439|530105145|FG002|Period 2|Adverse Event|1|||
146984720|NCT01709383|530105150|FG000|Overall Study|Lost to Follow-up|1|||
146817033|NCT00960206|529497540|FG001|Overall Study|Lost to Follow-up|14|||
146817034|NCT00960206|529497541|FG002|Overall Study|Lost to Follow-up|8|||
146817035|NCT00960206|529497539|FG000|Overall Study|Withdrawal by Subject|2|||
146817036|NCT00960206|529497540|FG001|Overall Study|Withdrawal by Subject|4|||
146817037|NCT00960206|529497541|FG002|Overall Study|Withdrawal by Subject|0|||
146817038|NCT00960206|529497539|FG000|Overall Study|Revision of study component|2|||
146817039|NCT00960206|529497540|FG001|Overall Study|Revision of study component|2|||
146817040|NCT00960206|529497541|FG002|Overall Study|Revision of study component|2|||
146817041|NCT00960206|529497539|FG000|Overall Study|Missing 10 year data|20|||
146817042|NCT00960206|529497540|FG001|Overall Study|Missing 10 year data|1|||
146817043|NCT00960206|529497541|FG002|Overall Study|Missing 10 year data|1|||
146817044|NCT03032198|529497548|FG000|Overall Study|Screen Fail|1|||
146817045|NCT02470806|529497549|FG000|Overall Study|Lost to Follow-up|1|||
146817046|NCT02470806|529497550|FG001|Overall Study|Lost to Follow-up|1|||
146817047|NCT02470806|529497549|FG000|Overall Study|Adverse Event|5|||
146817048|NCT02470806|529497550|FG001|Overall Study|Adverse Event|2|||
146817049|NCT02470806|529497549|FG000|Overall Study|Protocol Violation|4|||
146817050|NCT02470806|529497550|FG001|Overall Study|Protocol Violation|11|||
146817051|NCT02470806|529497549|FG000|Overall Study|Physician Decision|0|||
146817052|NCT02470806|529497550|FG001|Overall Study|Physician Decision|3|||
146817053|NCT02470806|529497549|FG000|Overall Study|Withdrawal by Subject|3|||
146817054|NCT02470806|529497550|FG001|Overall Study|Withdrawal by Subject|10|||
146817055|NCT02470806|529497549|FG000|Overall Study|Lack of Efficacy|5|||
146817056|NCT02470806|529497550|FG001|Overall Study|Lack of Efficacy|15|||
146817057|NCT00866619|529497551|FG000|Overall Study|Adverse Event|112|||
146817058|NCT00866619|529497552|FG001|Overall Study|Adverse Event|106|||
146817059|NCT00866619|529497553|FG002|Overall Study|Adverse Event|47|||
146817060|NCT00866619|529497554|FG003|Overall Study|Adverse Event|44|||
146817061|NCT00866619|529497551|FG000|Overall Study|Protocol Violation|2|||
146817062|NCT00866619|529497552|FG001|Overall Study|Protocol Violation|39|||
146817063|NCT00866619|529497553|FG002|Overall Study|Protocol Violation|2|||
146817064|NCT00866619|529497554|FG003|Overall Study|Protocol Violation|17|||
146817065|NCT00866619|529497551|FG000|Overall Study|Withdrawal by Subject|587|||
146817066|NCT00866619|529497552|FG001|Overall Study|Withdrawal by Subject|295|||
146817067|NCT00866619|529497553|FG002|Overall Study|Withdrawal by Subject|272|||
146817068|NCT00866619|529497554|FG003|Overall Study|Withdrawal by Subject|144|||
146817069|NCT00866619|529497551|FG000|Overall Study|Lost to Follow-up|1145|||
146947991|NCT02574520|529966848|FG001|Overall Study|Not dosed|0|||
146947992|NCT02574520|529966849|FG002|Overall Study|Not dosed|5|||
146947993|NCT02574520|529966850|FG003|Overall Study|Not dosed|4|||
146817070|NCT00866619|529497552|FG001|Overall Study|Lost to Follow-up|830|||
146947994|NCT02574520|529966847|FG000|Overall Study|Adverse Event|0|||
146947995|NCT02574520|529966848|FG001|Overall Study|Adverse Event|0|||
146947996|NCT02574520|529966849|FG002|Overall Study|Adverse Event|0|||
146947997|NCT02574520|529966850|FG003|Overall Study|Adverse Event|1|||
146817071|NCT00866619|529497553|FG002|Overall Study|Lost to Follow-up|568|||
146817072|NCT00866619|529497554|FG003|Overall Study|Lost to Follow-up|425|||
146817073|NCT02892019|529497556|FG000|Overall Study|randomized but not treated|0|||
146817074|NCT02892019|529497557|FG001|Overall Study|randomized but not treated|1|||
146817075|NCT02892019|529497556|FG000|Overall Study|Withdrawal by Subject|0|||
146817076|NCT02892019|529497557|FG001|Overall Study|Withdrawal by Subject|1|||
146817077|NCT02892019|529497556|FG000|Overall Study|Adverse Event|1|||
146817078|NCT02892019|529497557|FG001|Overall Study|Adverse Event|1|||
146984721|NCT01709383|530105151|FG001|Overall Study|Lost to Follow-up|0|||
146947998|NCT02574520|529966847|FG000|Overall Study|Withdrawal by Subject|0|||
146947999|NCT02574520|529966848|FG001|Overall Study|Withdrawal by Subject|0|||
146948000|NCT02574520|529966849|FG002|Overall Study|Withdrawal by Subject|0|||
146948001|NCT02574520|529966850|FG003|Overall Study|Withdrawal by Subject|1|||
146948002|NCT02574520|529966847|FG000|Overall Study|Other|0|||
146948003|NCT02574520|529966848|FG001|Overall Study|Other|0|||
146948004|NCT02574520|529966849|FG002|Overall Study|Other|0|||
146948005|NCT02574520|529966850|FG003|Overall Study|Other|2|||
146948006|NCT03935594|529966867|FG000|Overall Study|Physician Decision|3|||
146948007|NCT03954704|529966870|FG000|Overall Study|Death|1|||
146948008|NCT03954704|529966871|FG001|Overall Study|Death|1|||
146948009|NCT03954704|529966872|FG002|Overall Study|Death|1|||
146948010|NCT03954704|529966873|FG003|Overall Study|Death|3|||
146948011|NCT03954704|529966874|FG004|Overall Study|Death|2|||
146948012|NCT03954704|529966875|FG005|Overall Study|Death|2|||
146948013|NCT03954704|529966876|FG006|Overall Study|Death|0|||
146948014|NCT03954704|529966870|FG000|Overall Study|Withdrew Consent|0|||
146948015|NCT03954704|529966871|FG001|Overall Study|Withdrew Consent|0|||
146948016|NCT03954704|529966872|FG002|Overall Study|Withdrew Consent|1|||
146948017|NCT03954704|529966873|FG003|Overall Study|Withdrew Consent|0|||
146948018|NCT03954704|529966874|FG004|Overall Study|Withdrew Consent|0|||
146948019|NCT03954704|529966875|FG005|Overall Study|Withdrew Consent|1|||
146948020|NCT03954704|529966876|FG006|Overall Study|Withdrew Consent|0|||
146948021|NCT03954704|529966870|FG000|Overall Study|Lost to Follow-up|0|||
146948022|NCT03954704|529966871|FG001|Overall Study|Lost to Follow-up|0|||
146948023|NCT03954704|529966872|FG002|Overall Study|Lost to Follow-up|0|||
146948024|NCT03954704|529966873|FG003|Overall Study|Lost to Follow-up|0|||
146948025|NCT03954704|529966874|FG004|Overall Study|Lost to Follow-up|0|||
146948026|NCT03954704|529966875|FG005|Overall Study|Lost to Follow-up|0|||
146948027|NCT03954704|529966876|FG006|Overall Study|Lost to Follow-up|1|||
146948028|NCT03954704|529966870|FG000|Overall Study|Study Terminated by Sponsor|0|||
146948029|NCT03954704|529966871|FG001|Overall Study|Study Terminated by Sponsor|0|||
146948030|NCT03954704|529966872|FG002|Overall Study|Study Terminated by Sponsor|1|||
146948031|NCT03954704|529966873|FG003|Overall Study|Study Terminated by Sponsor|0|||
146948032|NCT03954704|529966874|FG004|Overall Study|Study Terminated by Sponsor|1|||
146948033|NCT03954704|529966875|FG005|Overall Study|Study Terminated by Sponsor|4|||
146948034|NCT03954704|529966876|FG006|Overall Study|Study Terminated by Sponsor|2|||
146948035|NCT03954704|529966870|FG000|Overall Study|Enrolled but not Treated|0|||
146948036|NCT03954704|529966871|FG001|Overall Study|Enrolled but not Treated|0|||
146948037|NCT03954704|529966872|FG002|Overall Study|Enrolled but not Treated|0|||
146948038|NCT03954704|529966873|FG003|Overall Study|Enrolled but not Treated|0|||
146948039|NCT03954704|529966874|FG004|Overall Study|Enrolled but not Treated|0|||
146948040|NCT03954704|529966875|FG005|Overall Study|Enrolled but not Treated|1|||
146948041|NCT03954704|529966876|FG006|Overall Study|Enrolled but not Treated|0|||
146948042|NCT01388491|529966878|FG000|Overall Study|Adverse Event|10|||
146948043|NCT01388491|529966879|FG001|Overall Study|Adverse Event|9|||
146948044|NCT01388491|529966878|FG000|Overall Study|Sponsor Request|9|||
146948045|NCT01388491|529966879|FG001|Overall Study|Sponsor Request|7|||
146948046|NCT01388491|529966878|FG000|Overall Study|Withdrawal by Subject|6|||
146948047|NCT01388491|529966879|FG001|Overall Study|Withdrawal by Subject|10|||
146948048|NCT01388491|529966878|FG000|Overall Study|Lost to Follow-up|4|||
146948049|NCT01388491|529966879|FG001|Overall Study|Lost to Follow-up|3|||
146948050|NCT01388491|529966878|FG000|Overall Study|Protocol Violation|2|||
146948051|NCT01388491|529966879|FG001|Overall Study|Protocol Violation|0|||
146948052|NCT01388491|529966878|FG000|Overall Study|Noncompliance|2|||
146948053|NCT01388491|529966879|FG001|Overall Study|Noncompliance|0|||
146948054|NCT01388491|529966878|FG000|Overall Study|Pregnancy|1|||
146948055|NCT01388491|529966879|FG001|Overall Study|Pregnancy|0|||
146948056|NCT04035473|529966880|FG000|Screening/Baseline|Death|0|||
146948057|NCT04035473|529966881|FG001|Screening/Baseline|Death|1|||
146948058|NCT04035473|529966880|FG000|Screening/Baseline|Adverse Event|0|||
146948059|NCT04035473|529966881|FG001|Screening/Baseline|Adverse Event|1|||
146948060|NCT04035473|529966880|FG000|Follow-up Period|Adverse Event|2|||
146948061|NCT04035473|529966881|FG001|Follow-up Period|Adverse Event|0|||
146948062|NCT02735044|529966883|FG000|Overall Study|Adverse Event|3|||
146948063|NCT02735044|529966884|FG001|Overall Study|Adverse Event|3|||
146948064|NCT02735044|529966883|FG000|Overall Study|Lack of Efficacy|1|||
146948065|NCT02735044|529966884|FG001|Overall Study|Lack of Efficacy|0|||
146948066|NCT02735044|529966883|FG000|Overall Study|Poor compliance to protocol|7|||
146948067|NCT02735044|529966884|FG001|Overall Study|Poor compliance to protocol|7|||
146948068|NCT02735044|529966883|FG000|Overall Study|Randomized and not treated|0|||
146817079|NCT01661972|529497558|FG000|Overall Study|Adverse Event|1|||
146948069|NCT02735044|529966884|FG001|Overall Study|Randomized and not treated|2|||
146948070|NCT02735044|529966883|FG000|Overall Study|Other, not specified above|5|||
146948071|NCT02735044|529966884|FG001|Overall Study|Other, not specified above|11|||
146948072|NCT01682759|529966886|FG000|Overall Study|Death|2|||
146948073|NCT01682759|529966887|FG001|Overall Study|Death|1|||
146948074|NCT01682759|529966886|FG000|Overall Study|Lost to Follow-up|10|||
146948075|NCT01682759|529966887|FG001|Overall Study|Lost to Follow-up|13|||
146948076|NCT01682759|529966886|FG000|Overall Study|Physician Decision|1|||
146948077|NCT01682759|529966887|FG001|Overall Study|Physician Decision|1|||
146948078|NCT01682759|529966886|FG000|Overall Study|Withdrawal by Subject|56|||
146948079|NCT01682759|529966887|FG001|Overall Study|Withdrawal by Subject|55|||
146948080|NCT00397891|529966888|FG000|Overall Study|Withdrawal by Subject|1|||
146948081|NCT00397891|529966889|FG001|Overall Study|Withdrawal by Subject|0|||
146948082|NCT00397891|529966890|FG002|Overall Study|Withdrawal by Subject|0|||
146948083|NCT00397891|529966891|FG003|Overall Study|Withdrawal by Subject|0|||
146948084|NCT00397891|529966892|FG004|Overall Study|Withdrawal by Subject|1|||
146948085|NCT00412113|529966893|FG000|Overall Study|Adverse Event|11|||
146948086|NCT00412113|529966894|FG001|Overall Study|Adverse Event|15|||
146948087|NCT00412113|529966893|FG000|Overall Study|did not receive treatment|1|||
146948088|NCT00412113|529966894|FG001|Overall Study|did not receive treatment|0|||
146948089|NCT01190020|529966899|FG000|Overall Study|Adverse Event|2|||
146948090|NCT01190020|529966900|FG001|Overall Study|Adverse Event|0|||
146948091|NCT01190020|529966899|FG000|Overall Study|Lost to Follow-up|2|||
146948092|NCT01190020|529966900|FG001|Overall Study|Lost to Follow-up|0|||
146948093|NCT01190020|529966899|FG000|Overall Study|Withdrawal by Subject|3|||
146948094|NCT01190020|529966900|FG001|Overall Study|Withdrawal by Subject|0|||
146948095|NCT00796224|529966901|FG000|Overall Study|Adverse Event|1|||
146948096|NCT00796224|529966902|FG001|Overall Study|Adverse Event|0|||
146948097|NCT00796224|529966901|FG000|Overall Study|Protocol Violation|0|||
146948098|NCT00796224|529966902|FG001|Overall Study|Protocol Violation|1|||
146948099|NCT03227224|529966905|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
146948100|NCT03227224|529966906|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
146948101|NCT03227224|529966907|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
146948102|NCT03227224|529966908|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
146948103|NCT03227224|529966905|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
146948104|NCT03227224|529966906|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
146948105|NCT03227224|529966907|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
146948106|NCT03227224|529966908|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
146948107|NCT03227224|529966905|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
146948108|NCT03227224|529966906|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
146948109|NCT03227224|529966907|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
146948110|NCT03227224|529966908|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
146948111|NCT03227224|529966905|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
146948112|NCT03227224|529966906|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
146948113|NCT03227224|529966907|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
146948114|NCT03227224|529966908|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
146948115|NCT03227224|529966905|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
146948116|NCT03227224|529966906|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
146948117|NCT03227224|529966907|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
146948118|NCT03227224|529966908|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
146948119|NCT03227224|529966905|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
146948120|NCT03227224|529966906|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
146948121|NCT03227224|529966907|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
146948122|NCT03227224|529966908|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
146948123|NCT03227224|529966905|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
146948124|NCT03227224|529966906|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
146948125|NCT03227224|529966907|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
146948126|NCT03227224|529966908|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
146948127|NCT03227224|529966905|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
146948128|NCT03227224|529966906|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
146948129|NCT03227224|529966907|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
146948130|NCT03227224|529966908|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
146948131|NCT03227224|529966905|FG000|Follow-up Phase (2 Weeks)|Other|4|||
146948132|NCT03227224|529966906|FG001|Follow-up Phase (2 Weeks)|Other|4|||
146948133|NCT03227224|529966907|FG002|Follow-up Phase (2 Weeks)|Other|6|||
146948134|NCT03227224|529966908|FG003|Follow-up Phase (2 Weeks)|Other|3|||
146948135|NCT04195750|529966909|FG000|Overall Study|Death|245|||
146948136|NCT04195750|529966910|FG001|Overall Study|Death|253|||
146948137|NCT04195750|529966911|FG002|Overall Study|Death|5|||
146948138|NCT04195750|529966909|FG000|Overall Study|Physician Decision|0|||
146948139|NCT04195750|529966910|FG001|Overall Study|Physician Decision|1|||
146948140|NCT04195750|529966911|FG002|Overall Study|Physician Decision|0|||
146948141|NCT04195750|529966909|FG000|Overall Study|Withdrawal by Subject|9|||
146948142|NCT04195750|529966910|FG001|Overall Study|Withdrawal by Subject|8|||
146948143|NCT04195750|529966911|FG002|Overall Study|Withdrawal by Subject|0|||
146948144|NCT04195750|529966909|FG000|Overall Study|Ongoing|120|||
146948145|NCT04195750|529966910|FG001|Overall Study|Ongoing|110|||
146948146|NCT04195750|529966911|FG002|Overall Study|Ongoing|4|||
146948147|NCT03782376|529966912|FG000|Overall Study|Lost to Follow-up|2|||
146817080|NCT01661972|529497559|FG001|Overall Study|Adverse Event|2|||
146817081|NCT01661972|529497558|FG000|Overall Study|Death during Treatment period|1|||
146817082|NCT01661972|529497559|FG001|Overall Study|Death during Treatment period|1|||
146817083|NCT01661972|529497558|FG000|Overall Study|Withdrawal by Subject|0|||
146817084|NCT01661972|529497559|FG001|Overall Study|Withdrawal by Subject|1|||
146817085|NCT01229176|529497560|FG000|Overall Study|Withdrawal by Subject|0|||
146817086|NCT01229176|529497561|FG001|Overall Study|Withdrawal by Subject|0|||
146817087|NCT01229176|529497562|FG002|Overall Study|Withdrawal by Subject|0|||
146817088|NCT01229176|529497563|FG003|Overall Study|Withdrawal by Subject|1|||
146817089|NCT01229176|529497564|FG004|Overall Study|Withdrawal by Subject|1|||
146817090|NCT01229176|529497565|FG005|Overall Study|Withdrawal by Subject|1|||
146817091|NCT01229176|529497566|FG006|Overall Study|Withdrawal by Subject|0|||
146817092|NCT01229176|529497567|FG007|Overall Study|Withdrawal by Subject|1|||
146817093|NCT01229176|529497560|FG000|Overall Study|Lost to Follow-up|0|||
146817094|NCT01229176|529497561|FG001|Overall Study|Lost to Follow-up|3|||
146817095|NCT01229176|529497562|FG002|Overall Study|Lost to Follow-up|0|||
146817096|NCT01229176|529497563|FG003|Overall Study|Lost to Follow-up|0|||
146817097|NCT01229176|529497564|FG004|Overall Study|Lost to Follow-up|1|||
146817098|NCT01229176|529497565|FG005|Overall Study|Lost to Follow-up|1|||
146817099|NCT01229176|529497566|FG006|Overall Study|Lost to Follow-up|0|||
146817100|NCT01229176|529497567|FG007|Overall Study|Lost to Follow-up|2|||
146817101|NCT02367794|529497572|FG000|Overall Study|Death|252|||
146817102|NCT02367794|529497573|FG001|Overall Study|Death|245|||
146817103|NCT02367794|529497574|FG002|Overall Study|Death|243|||
146817104|NCT02367794|529497572|FG000|Overall Study|Lost to Follow-up|1|||
146817105|NCT02367794|529497573|FG001|Overall Study|Lost to Follow-up|2|||
146817106|NCT02367794|529497574|FG002|Overall Study|Lost to Follow-up|2|||
146817107|NCT02367794|529497572|FG000|Overall Study|Physician Decision|0|||
146817108|NCT02367794|529497573|FG001|Overall Study|Physician Decision|5|||
146817109|NCT02367794|529497574|FG002|Overall Study|Physician Decision|3|||
146817110|NCT02367794|529497572|FG000|Overall Study|Protocol Violation|1|||
146817111|NCT02367794|529497573|FG001|Overall Study|Protocol Violation|0|||
146817112|NCT02367794|529497574|FG002|Overall Study|Protocol Violation|1|||
146817113|NCT02367794|529497572|FG000|Overall Study|Withdrawal by Subject|25|||
146817114|NCT02367794|529497573|FG001|Overall Study|Withdrawal by Subject|12|||
146817115|NCT02367794|529497574|FG002|Overall Study|Withdrawal by Subject|20|||
146817116|NCT02367794|529497572|FG000|Overall Study|Brain metastasis|1|||
146817117|NCT02367794|529497573|FG001|Overall Study|Brain metastasis|0|||
146817118|NCT02367794|529497574|FG002|Overall Study|Brain metastasis|0|||
146817119|NCT02367794|529497572|FG000|Overall Study|Randomized in error|0|||
146817120|NCT02367794|529497573|FG001|Overall Study|Randomized in error|0|||
146817121|NCT02367794|529497574|FG002|Overall Study|Randomized in error|1|||
146817122|NCT02367794|529497572|FG000|Overall Study|Patient unable to receive carboplatin|0|||
146817123|NCT02367794|529497573|FG001|Overall Study|Patient unable to receive carboplatin|0|||
146817124|NCT02367794|529497574|FG002|Overall Study|Patient unable to receive carboplatin|1|||
146817125|NCT02367794|529497572|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
146817126|NCT02367794|529497573|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
146817127|NCT02367794|529497574|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
146817128|NCT02367794|529497572|FG000|Overall Study|Adverse Event|0|||
146817129|NCT02367794|529497573|FG001|Overall Study|Adverse Event|0|||
146817130|NCT02367794|529497574|FG002|Overall Study|Adverse Event|2|||
146817131|NCT02367794|529497572|FG000|Overall Study|Study Terminated By Sponsor|0|||
146817132|NCT02367794|529497573|FG001|Overall Study|Study Terminated By Sponsor|1|||
146817133|NCT02367794|529497574|FG002|Overall Study|Study Terminated By Sponsor|1|||
146817134|NCT02367794|529497572|FG000|Overall Study|Moved to Roll-Over Study|0|||
146817135|NCT02367794|529497573|FG001|Overall Study|Moved to Roll-Over Study|15|||
146817136|NCT02367794|529497574|FG002|Overall Study|Moved to Roll-Over Study|13|||
146817137|NCT02367794|529497572|FG000|Overall Study|Sponsor Request|60|||
146817138|NCT02367794|529497573|FG001|Overall Study|Sponsor Request|57|||
146817139|NCT02367794|529497574|FG002|Overall Study|Sponsor Request|45|||
146817140|NCT02367794|529497572|FG000|Overall Study|Moved into PTAP Study|0|||
146948148|NCT03782376|529966913|FG001|Overall Study|Lost to Follow-up|2|||
146948149|NCT03782376|529966912|FG000|Overall Study|Withdrawal by Subject|7|||
146948150|NCT03782376|529966913|FG001|Overall Study|Withdrawal by Subject|11|||
146817141|NCT02367794|529497573|FG001|Overall Study|Moved into PTAP Study|2|||
146948151|NCT03782376|529966912|FG000|Overall Study|Death|1|||
146948152|NCT03782376|529966913|FG001|Overall Study|Death|0|||
146817142|NCT02367794|529497574|FG002|Overall Study|Moved into PTAP Study|3|||
146817143|NCT02367794|529497572|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
146817144|NCT02367794|529497573|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
146817145|NCT02367794|529497574|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
146817146|NCT02367794|529497572|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
146817147|NCT02367794|529497573|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
146817148|NCT02367794|529497574|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
146817149|NCT02367794|529497572|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
146817150|NCT02367794|529497573|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
146948153|NCT03782376|529966912|FG000|Overall Study|Other|16|||
146948154|NCT03782376|529966913|FG001|Overall Study|Other|17|||
146948155|NCT01226472|529966917|FG000|Overall Study|Progressive Disease|1|||
146948156|NCT02903966|529968779|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
146948157|NCT02903966|529968780|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
146948158|NCT02903966|529968779|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
146948159|NCT02903966|529968780|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
146948160|NCT02903966|529968779|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
146948161|NCT02903966|529968780|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
146948162|NCT00378534|529968787|FG000|Overall Study|Participants did not receive transplant|3|||
146948163|NCT00378534|529968788|FG001|Overall Study|Participants did not receive transplant|0|||
146948164|NCT04969900|529968789|FG000|Overall Study|Physician Decision|1|||
146948165|NCT04969900|529968790|FG001|Overall Study|Physician Decision|1|||
146948166|NCT04969900|529968789|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
146948167|NCT04969900|529968790|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
146948168|NCT04423718|529968796|FG000|Main Study|Adverse Event|9|||
146948169|NCT04423718|529968797|FG001|Main Study|Adverse Event|5|||
146948170|NCT04423718|529968798|FG002|Main Study|Adverse Event|8|||
146948171|NCT04423718|529968796|FG000|Main Study|Physician Decision|3|||
146948172|NCT04423718|529968797|FG001|Main Study|Physician Decision|3|||
146948173|NCT04423718|529968798|FG002|Main Study|Physician Decision|2|||
146948174|NCT04423718|529968796|FG000|Main Study|Protocol Violation|0|||
146948175|NCT04423718|529968797|FG001|Main Study|Protocol Violation|0|||
146948176|NCT04423718|529968798|FG002|Main Study|Protocol Violation|1|||
146948177|NCT04423718|529968796|FG000|Main Study|Lost to Follow-up|3|||
146948178|NCT04423718|529968797|FG001|Main Study|Lost to Follow-up|3|||
146948179|NCT04423718|529968798|FG002|Main Study|Lost to Follow-up|4|||
146948180|NCT04423718|529968796|FG000|Main Study|Lack of Efficacy|2|||
146948181|NCT04423718|529968797|FG001|Main Study|Lack of Efficacy|1|||
146948182|NCT04423718|529968798|FG002|Main Study|Lack of Efficacy|0|||
146948183|NCT04423718|529968796|FG000|Main Study|Withdrawal by Subject|14|||
146948184|NCT04423718|529968797|FG001|Main Study|Withdrawal by Subject|20|||
146948185|NCT04423718|529968798|FG002|Main Study|Withdrawal by Subject|20|||
146948186|NCT04423718|529968796|FG000|Main Study|Death|10|||
146948187|NCT04423718|529968797|FG001|Main Study|Death|7|||
146948188|NCT04423718|529968798|FG002|Main Study|Death|7|||
146948189|NCT04423718|529968796|FG000|Main Study|COVID-19 pandemic|2|||
146948190|NCT04423718|529968797|FG001|Main Study|COVID-19 pandemic|2|||
146948191|NCT04423718|529968798|FG002|Main Study|COVID-19 pandemic|2|||
146948192|NCT04423718|529968796|FG000|Main Study|Other|7|||
146948193|NCT04423718|529968797|FG001|Main Study|Other|3|||
146948194|NCT04423718|529968798|FG002|Main Study|Other|2|||
146948195|NCT04423718|529968796|FG000|Extension Phase|Other|1|||
146948196|NCT04423718|529968797|FG001|Extension Phase|Other|0|||
146948197|NCT04423718|529968798|FG002|Extension Phase|Other|0|||
146948198|NCT04423718|529968796|FG000|Extension Phase|Logistical problems|0|||
146948199|NCT04423718|529968797|FG001|Extension Phase|Logistical problems|1|||
146948200|NCT04423718|529968798|FG002|Extension Phase|Logistical problems|1|||
146948201|NCT04423718|529968796|FG000|Extension Phase|Physician Decision|1|||
146948202|NCT04423718|529968797|FG001|Extension Phase|Physician Decision|0|||
146948203|NCT04423718|529968798|FG002|Extension Phase|Physician Decision|1|||
146948204|NCT04423718|529968796|FG000|Extension Phase|Lack of Efficacy|2|||
146948205|NCT04423718|529968797|FG001|Extension Phase|Lack of Efficacy|0|||
146948206|NCT04423718|529968798|FG002|Extension Phase|Lack of Efficacy|1|||
146948207|NCT04423718|529968796|FG000|Extension Phase|Lost to Follow-up|0|||
146948208|NCT04423718|529968797|FG001|Extension Phase|Lost to Follow-up|2|||
146948209|NCT04423718|529968798|FG002|Extension Phase|Lost to Follow-up|3|||
146948210|NCT04423718|529968796|FG000|Extension Phase|Adverse Event|2|||
146948211|NCT04423718|529968797|FG001|Extension Phase|Adverse Event|3|||
146948212|NCT04423718|529968798|FG002|Extension Phase|Adverse Event|1|||
146948213|NCT04423718|529968796|FG000|Extension Phase|Death|4|||
146948214|NCT04423718|529968797|FG001|Extension Phase|Death|7|||
146948215|NCT04423718|529968798|FG002|Extension Phase|Death|2|||
146948216|NCT04423718|529968796|FG000|Extension Phase|Withdrawal by Subject|11|||
146948217|NCT04423718|529968797|FG001|Extension Phase|Withdrawal by Subject|11|||
146948218|NCT04423718|529968798|FG002|Extension Phase|Withdrawal by Subject|7|||
146984722|NCT03264066|530105152|FG000|Overall Study|Adverse Event|1|||
146948219|NCT00425945|529968799|FG000|Overall Study|Concern about Supplement|2|||
146948220|NCT00425945|529968800|FG001|Overall Study|Concern about Supplement|0|||
146948221|NCT00425945|529968799|FG000|Overall Study|Inconvenience|0|||
146948222|NCT00425945|529968800|FG001|Overall Study|Inconvenience|2|||
146948223|NCT00425945|529968799|FG000|Overall Study|Lost to Follow-up|0|||
146948224|NCT00425945|529968800|FG001|Overall Study|Lost to Follow-up|2|||
146948225|NCT00425945|529968799|FG000|Overall Study|Began hypertension medication|1|||
146948226|NCT00425945|529968800|FG001|Overall Study|Began hypertension medication|0|||
146948227|NCT00425945|529968799|FG000|Overall Study|Began cancer treatments|1|||
146948228|NCT00425945|529968800|FG001|Overall Study|Began cancer treatments|0|||
146948229|NCT00425945|529968799|FG000|Overall Study|Moved from area|0|||
146948230|NCT00425945|529968800|FG001|Overall Study|Moved from area|1|||
146817151|NCT02367794|529497574|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
146817152|NCT02367794|529497572|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
146817153|NCT02367794|529497573|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
146817154|NCT02367794|529497574|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
146817155|NCT00882050|529497575|FG000|Overall Study|Physician Decision|1|||
146817156|NCT00882050|529497576|FG001|Overall Study|Physician Decision|0|||
146817157|NCT00882050|529497577|FG002|Overall Study|Physician Decision|0|||
146817158|NCT01159600|529497579|FG000|Overall Study|Not treated|0|||
146817159|NCT01159600|529497580|FG001|Overall Study|Not treated|0|||
146817160|NCT01159600|529497581|FG002|Overall Study|Not treated|1|||
146817161|NCT01159600|529497582|FG003|Overall Study|Not treated|0|||
146817162|NCT01159600|529497583|FG004|Overall Study|Not treated|0|||
146817163|NCT01159600|529497584|FG005|Overall Study|Not treated|1|||
146817164|NCT01159600|529497585|FG006|Overall Study|Not treated|2|||
146817165|NCT01159600|529497586|FG007|Overall Study|Not treated|2|||
146817166|NCT01159600|529497579|FG000|Overall Study|Adverse Event|7|||
146817167|NCT01159600|529497580|FG001|Overall Study|Adverse Event|2|||
146817168|NCT01159600|529497581|FG002|Overall Study|Adverse Event|5|||
146817169|NCT01159600|529497582|FG003|Overall Study|Adverse Event|1|||
146817170|NCT01159600|529497583|FG004|Overall Study|Adverse Event|8|||
146817171|NCT01159600|529497584|FG005|Overall Study|Adverse Event|6|||
146817172|NCT01159600|529497585|FG006|Overall Study|Adverse Event|7|||
146817173|NCT01159600|529497586|FG007|Overall Study|Adverse Event|5|||
146817174|NCT01159600|529497579|FG000|Overall Study|Lack of Efficacy|0|||
146817175|NCT01159600|529497580|FG001|Overall Study|Lack of Efficacy|0|||
146817176|NCT01159600|529497581|FG002|Overall Study|Lack of Efficacy|0|||
146817177|NCT01159600|529497582|FG003|Overall Study|Lack of Efficacy|0|||
146817178|NCT01159600|529497583|FG004|Overall Study|Lack of Efficacy|2|||
146817179|NCT01159600|529497584|FG005|Overall Study|Lack of Efficacy|0|||
146817180|NCT01159600|529497585|FG006|Overall Study|Lack of Efficacy|0|||
146817181|NCT01159600|529497586|FG007|Overall Study|Lack of Efficacy|1|||
146817182|NCT01159600|529497579|FG000|Overall Study|Non compliant with protocol|2|||
146817183|NCT01159600|529497580|FG001|Overall Study|Non compliant with protocol|1|||
146817184|NCT01159600|529497581|FG002|Overall Study|Non compliant with protocol|0|||
146817185|NCT01159600|529497582|FG003|Overall Study|Non compliant with protocol|0|||
146817186|NCT01159600|529497583|FG004|Overall Study|Non compliant with protocol|2|||
146817187|NCT01159600|529497584|FG005|Overall Study|Non compliant with protocol|0|||
146817188|NCT01159600|529497585|FG006|Overall Study|Non compliant with protocol|2|||
146817189|NCT01159600|529497586|FG007|Overall Study|Non compliant with protocol|0|||
146817190|NCT01159600|529497579|FG000|Overall Study|Lost to Follow-up|2|||
146817191|NCT01159600|529497580|FG001|Overall Study|Lost to Follow-up|3|||
146817192|NCT01159600|529497581|FG002|Overall Study|Lost to Follow-up|4|||
146817193|NCT01159600|529497582|FG003|Overall Study|Lost to Follow-up|3|||
146817194|NCT01159600|529497583|FG004|Overall Study|Lost to Follow-up|3|||
146817195|NCT01159600|529497584|FG005|Overall Study|Lost to Follow-up|0|||
146817196|NCT01159600|529497585|FG006|Overall Study|Lost to Follow-up|3|||
146817197|NCT01159600|529497586|FG007|Overall Study|Lost to Follow-up|2|||
146817198|NCT01159600|529497579|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
146817199|NCT01159600|529497580|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
146817200|NCT01159600|529497581|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
146817201|NCT01159600|529497582|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
146817202|NCT01159600|529497583|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
146817203|NCT01159600|529497584|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
146817204|NCT01159600|529497585|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
146817205|NCT01159600|529497586|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
146817206|NCT01159600|529497579|FG000|Overall Study|Other reason not defined above|3|||
146817207|NCT01159600|529497580|FG001|Overall Study|Other reason not defined above|0|||
146817208|NCT01159600|529497581|FG002|Overall Study|Other reason not defined above|4|||
146817209|NCT01159600|529497582|FG003|Overall Study|Other reason not defined above|2|||
146817210|NCT01159600|529497583|FG004|Overall Study|Other reason not defined above|5|||
146948231|NCT01874353|529968801|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
146817211|NCT01159600|529497584|FG005|Overall Study|Other reason not defined above|7|||
146817212|NCT01159600|529497585|FG006|Overall Study|Other reason not defined above|3|||
146817213|NCT01159600|529497586|FG007|Overall Study|Other reason not defined above|3|||
146817214|NCT00946998|529498941|FG000|Overall Study|Exited prior to first outcome assessment|5|||
146817215|NCT00946998|529498942|FG001|Overall Study|Exited prior to first outcome assessment|3|||
146817216|NCT01279447|529498951|FG000|Overall Study|Lost to Follow-up|3|||
146817217|NCT01279447|529498952|FG001|Overall Study|Lost to Follow-up|1|||
146817218|NCT00538629|529498958|FG000|Overall Study|At subject's request|1|||
146817219|NCT00538629|529498958|FG000|Overall Study|Adverse Event|2|||
146948232|NCT01874353|529968802|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
146817220|NCT00538629|529498958|FG000|Overall Study|Lack of Efficacy|12|||
146817221|NCT00538629|529498958|FG000|Overall Study|Lost to Follow-up|6|||
146817222|NCT00538629|529498958|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
146817223|NCT00555620|529498964|FG000|Overall Study|Death|0|||
146948233|NCT01874353|529968803|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
146948234|NCT01874353|529968804|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
146948235|NCT01874353|529968801|FG000|Overall Study|Lost to Follow-up|2|||
146948236|NCT01874353|529968802|FG001|Overall Study|Lost to Follow-up|2|||
146948237|NCT01874353|529968803|FG002|Overall Study|Lost to Follow-up|2|||
146948238|NCT01874353|529968804|FG003|Overall Study|Lost to Follow-up|0|||
146948239|NCT01874353|529968801|FG000|Overall Study|Death|110|||
146948240|NCT01874353|529968802|FG001|Overall Study|Death|60|||
146948241|NCT01874353|529968803|FG002|Overall Study|Death|13|||
146948242|NCT01874353|529968804|FG003|Overall Study|Death|7|||
146948243|NCT01874353|529968801|FG000|Overall Study|Withdrawal by Subject|13|||
146948244|NCT01874353|529968802|FG001|Overall Study|Withdrawal by Subject|11|||
146948245|NCT01874353|529968803|FG002|Overall Study|Withdrawal by Subject|0|||
146948246|NCT01874353|529968804|FG003|Overall Study|Withdrawal by Subject|0|||
146948247|NCT04992507|529968809|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
146948248|NCT04992507|529968810|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
146948249|NCT04992507|529968809|FG000|Overall Study|Death|0|||
146948250|NCT04992507|529968810|FG001|Overall Study|Death|1|||
146948251|NCT01852591|529968811|FG000|Overall Study|Withdrawal by Subject|2|||
146948252|NCT01852591|529968811|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
146948253|NCT03728881|529968814|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
146948254|NCT03728881|529968815|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
146948255|NCT03728881|529968814|FG000|Enrolled and Received 1st Vaccination|Death|1|||
146948256|NCT03728881|529968815|FG001|Enrolled and Received 1st Vaccination|Death|1|||
146948257|NCT03728881|529968814|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
146948258|NCT03728881|529968815|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
146948259|NCT03728881|529968814|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
146948260|NCT03728881|529968815|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
146948261|NCT03728881|529968814|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
146948262|NCT03728881|529968815|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
146948263|NCT03728881|529968814|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
146948264|NCT03728881|529968815|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
146948265|NCT03728881|529968814|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
146948266|NCT03728881|529968815|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
146948267|NCT03728881|529968814|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
146948268|NCT03728881|529968815|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
146948269|NCT03728881|529968814|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
146948270|NCT03728881|529968815|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
146948271|NCT03728881|529968814|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
146948272|NCT03728881|529968815|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
146948273|NCT03728881|529968814|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
146948274|NCT03728881|529968815|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
146948275|NCT04651777|529968820|FG000|Overall Study|Adverse Event|1|||
146948276|NCT04651777|529968820|FG000|Overall Study|Withdrawal by Subject|2|||
146948277|NCT06048367|529968821|FG000|Overall Study|Withdrawal by Subject|0|||
146948278|NCT06048367|529968822|FG001|Overall Study|Withdrawal by Subject|1|||
146948279|NCT06048367|529968823|FG002|Overall Study|Withdrawal by Subject|0|||
146948280|NCT06048367|529968824|FG003|Overall Study|Withdrawal by Subject|0|||
146948281|NCT06048367|529968825|FG004|Overall Study|Withdrawal by Subject|0|||
146948282|NCT06048367|529968821|FG000|Overall Study|Withdrawal by Subject|0|||
146948283|NCT06048367|529968822|FG001|Overall Study|Withdrawal by Subject|0|||
146948284|NCT06048367|529968823|FG002|Overall Study|Withdrawal by Subject|1|||
146948285|NCT06048367|529968824|FG003|Overall Study|Withdrawal by Subject|0|||
146948286|NCT06048367|529968825|FG004|Overall Study|Withdrawal by Subject|0|||
146948287|NCT06048367|529968821|FG000|Overall Study|Withdrawal by Subject|0|||
146948288|NCT06048367|529968822|FG001|Overall Study|Withdrawal by Subject|0|||
146948289|NCT06048367|529968823|FG002|Overall Study|Withdrawal by Subject|0|||
146948290|NCT06048367|529968824|FG003|Overall Study|Withdrawal by Subject|1|||
146948291|NCT06048367|529968825|FG004|Overall Study|Withdrawal by Subject|0|||
146948292|NCT06048367|529968821|FG000|Overall Study|Withdrawal by Subject|0|||
146948293|NCT06048367|529968822|FG001|Overall Study|Withdrawal by Subject|0|||
146948294|NCT06048367|529968823|FG002|Overall Study|Withdrawal by Subject|0|||
146948295|NCT06048367|529968824|FG003|Overall Study|Withdrawal by Subject|1|||
146948296|NCT06048367|529968825|FG004|Overall Study|Withdrawal by Subject|0|||
146948297|NCT04088331|529968826|FG000|Overall Study|Lost to Follow-up|3|||
146948298|NCT04088331|529968826|FG000|Overall Study|Withdrawal by Subject|7|||
146948299|NCT04088331|529968826|FG000|Overall Study|Adverse Event|4|||
146948300|NCT03715205|529968828|FG000|Overall Study|Death|13|||
146948301|NCT03715205|529968828|FG000|Overall Study|Lost to Follow-up|2|||
146948302|NCT03715205|529968828|FG000|Overall Study|Physician Decision|93|||
146948303|NCT03715205|529968828|FG000|Overall Study|Withdrawal by Subject|26|||
146948304|NCT02756845|529968829|FG000|Overall Study|Death|12|||
146948305|NCT02756845|529968830|FG001|Overall Study|Death|2|||
146948306|NCT02756845|529968829|FG000|Overall Study|Withdrawal by Subject|1|||
146948307|NCT02756845|529968830|FG001|Overall Study|Withdrawal by Subject|0|||
146948308|NCT03733249|529968832|FG000|Overall Study|Death|7|||
146948309|NCT03733249|529968832|FG000|Overall Study|Disease relapse|16|||
146948310|NCT03733249|529968832|FG000|Overall Study|Lost to Follow-up|4|||
146948311|NCT03733249|529968832|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
146948312|NCT03733249|529968832|FG000|Overall Study|Withdrawal by Subject|1|||
146948313|NCT00772889|529968833|FG000|Overall Study|Adverse Event|7|||
146948314|NCT00772889|529968834|FG001|Overall Study|Adverse Event|4|||
146948315|NCT00772889|529968835|FG002|Overall Study|Adverse Event|0|||
146948316|NCT00772889|529968833|FG000|Overall Study|Withdrawal by Subject|9|||
146948317|NCT00772889|529968834|FG001|Overall Study|Withdrawal by Subject|8|||
146817224|NCT00555620|529498965|FG001|Overall Study|Death|1|||
146817225|NCT00555620|529498966|FG002|Overall Study|Death|0|||
146817226|NCT00555620|529498967|FG003|Overall Study|Death|0|||
146817227|NCT00555620|529498968|FG004|Overall Study|Death|0|||
146817228|NCT00555620|529498969|FG005|Overall Study|Death|1|||
146817229|NCT00555620|529498964|FG000|Overall Study|Study terminated by sponsor|0|||
146817230|NCT00555620|529498965|FG001|Overall Study|Study terminated by sponsor|0|||
146817231|NCT00555620|529498966|FG002|Overall Study|Study terminated by sponsor|1|||
146817232|NCT00555620|529498967|FG003|Overall Study|Study terminated by sponsor|0|||
146817233|NCT00555620|529498968|FG004|Overall Study|Study terminated by sponsor|0|||
146817234|NCT00555620|529498969|FG005|Overall Study|Study terminated by sponsor|0|||
146817235|NCT00555620|529498964|FG000|Overall Study|Adverse Event|0|||
146817236|NCT00555620|529498965|FG001|Overall Study|Adverse Event|0|||
146817237|NCT00555620|529498966|FG002|Overall Study|Adverse Event|1|||
146817238|NCT00555620|529498967|FG003|Overall Study|Adverse Event|5|||
146817239|NCT00555620|529498968|FG004|Overall Study|Adverse Event|0|||
146817240|NCT00555620|529498969|FG005|Overall Study|Adverse Event|1|||
146817241|NCT00555620|529498964|FG000|Overall Study|Objective progression or relapse|6|||
146817242|NCT00555620|529498965|FG001|Overall Study|Objective progression or relapse|5|||
146817243|NCT00555620|529498966|FG002|Overall Study|Objective progression or relapse|12|||
146817244|NCT00555620|529498967|FG003|Overall Study|Objective progression or relapse|17|||
146817245|NCT00555620|529498968|FG004|Overall Study|Objective progression or relapse|3|||
146817246|NCT00555620|529498969|FG005|Overall Study|Objective progression or relapse|16|||
146817247|NCT00555620|529498964|FG000|Overall Study|Participant refused treatment|0|||
146817248|NCT00555620|529498965|FG001|Overall Study|Participant refused treatment|1|||
146817249|NCT00555620|529498966|FG002|Overall Study|Participant refused treatment|1|||
146817250|NCT00555620|529498967|FG003|Overall Study|Participant refused treatment|0|||
146817251|NCT00555620|529498968|FG004|Overall Study|Participant refused treatment|0|||
146817252|NCT00555620|529498969|FG005|Overall Study|Participant refused treatment|1|||
146817253|NCT00555620|529498964|FG000|Overall Study|Other|0|||
146817254|NCT00555620|529498965|FG001|Overall Study|Other|0|||
146817255|NCT00555620|529498966|FG002|Overall Study|Other|0|||
146817256|NCT00555620|529498967|FG003|Overall Study|Other|1|||
146817257|NCT00555620|529498968|FG004|Overall Study|Other|0|||
146817258|NCT00555620|529498969|FG005|Overall Study|Other|3|||
146817259|NCT05203822|529498970|FG000|Overall Study|Adverse Event|1|||
146817260|NCT05203822|529498970|FG000|Overall Study|Withdrawal by Subject|1|||
146817261|NCT03320941|529498974|FG000|Overall Study|subject/guardian decision|0|||
146817262|NCT03320941|529498975|FG001|Overall Study|subject/guardian decision|0|||
146817263|NCT03320941|529498976|FG002|Overall Study|subject/guardian decision|0|||
146817264|NCT03320941|529498977|FG003|Overall Study|subject/guardian decision|1|||
146817265|NCT03320941|529498978|FG004|Overall Study|subject/guardian decision|0|||
146948318|NCT00772889|529968835|FG002|Overall Study|Withdrawal by Subject|9|||
146948319|NCT00772889|529968833|FG000|Overall Study|Lost to Follow-up|6|||
146948320|NCT00772889|529968834|FG001|Overall Study|Lost to Follow-up|6|||
146817266|NCT00447499|529498979|FG000|Overall Study|Adverse Event|1|||
146817267|NCT00447499|529498979|FG000|Overall Study|Patient Decision|4|||
146817268|NCT00447499|529498979|FG000|Overall Study|Sponsor Decision|1|||
146817269|NCT00447499|529498979|FG000|Overall Study|Physician Decision|1|||
146817270|NCT01767376|529498981|FG000|Overall Study|Lost to Follow-up|3|||
146817271|NCT01767376|529498982|FG001|Overall Study|Lost to Follow-up|2|||
146817272|NCT01767376|529498983|FG002|Overall Study|Lost to Follow-up|0|||
146817273|NCT01767376|529498981|FG000|Overall Study|Withdrawal by Subject|1|||
146817274|NCT01767376|529498982|FG001|Overall Study|Withdrawal by Subject|1|||
146948321|NCT00772889|529968835|FG002|Overall Study|Lost to Follow-up|7|||
146948322|NCT03323086|529968836|FG000|Overall Study|Lost to Follow-up|3|||
146948323|NCT03323086|529968837|FG001|Overall Study|Lost to Follow-up|2|||
146817275|NCT01767376|529498983|FG002|Overall Study|Withdrawal by Subject|0|||
146817276|NCT00946088|529498984|FG000|Overall Study|Withdrawal by Subject|0|||
146817277|NCT00946088|529498985|FG001|Overall Study|Withdrawal by Subject|1|||
146817278|NCT03184519|529498987|FG000|Overall Study|Lost to Follow-up|6|||
146817279|NCT03184519|529498987|FG000|Overall Study|Physician Decision|21|||
146948324|NCT02139280|529968844|FG000|Overall Study|No longer eligible|2|||
146948325|NCT02139280|529968845|FG001|Overall Study|No longer eligible|0|||
146948326|NCT05559203|529968846|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
146948327|NCT00422903|529968848|FG000|Overall Study|Disease Progression|3|||
146948328|NCT00422903|529968849|FG001|Overall Study|Disease Progression|1|||
146948329|NCT00422903|529968848|FG000|Overall Study|Adverse Event|0|||
146948330|NCT00422903|529968849|FG001|Overall Study|Adverse Event|2|||
146948331|NCT00422903|529968848|FG000|Overall Study|Informed Consent Withdrawn|1|||
146948332|NCT00422903|529968849|FG001|Overall Study|Informed Consent Withdrawn|2|||
146948333|NCT01947894|529968854|FG000|Overall Study|Other|3|||
146948334|NCT01947894|529968855|FG001|Overall Study|Other|4|||
146948335|NCT01947894|529968856|FG002|Overall Study|Other|3|||
146948336|NCT01947894|529968854|FG000|Overall Study|Withdrawal by Subject|12|||
146948337|NCT01947894|529968855|FG001|Overall Study|Withdrawal by Subject|4|||
146948338|NCT01947894|529968856|FG002|Overall Study|Withdrawal by Subject|1|||
146948339|NCT01947894|529968854|FG000|Overall Study|Death|12|||
146948340|NCT01947894|529968855|FG001|Overall Study|Death|1|||
146948341|NCT01947894|529968856|FG002|Overall Study|Death|0|||
146948342|NCT01947894|529968854|FG000|Overall Study|Physician Decision|2|||
146948343|NCT01947894|529968855|FG001|Overall Study|Physician Decision|0|||
146948344|NCT01947894|529968856|FG002|Overall Study|Physician Decision|0|||
146948345|NCT01947894|529968854|FG000|Overall Study|Adverse Event|5|||
146948346|NCT01947894|529968855|FG001|Overall Study|Adverse Event|1|||
146948347|NCT01947894|529968856|FG002|Overall Study|Adverse Event|0|||
146948348|NCT01947894|529968854|FG000|Overall Study|Switched to other growth hormone brand|53|||
146948349|NCT01947894|529968855|FG001|Overall Study|Switched to other growth hormone brand|8|||
146948350|NCT01947894|529968856|FG002|Overall Study|Switched to other growth hormone brand|23|||
146948351|NCT01249157|529968857|FG000|Overall Study|Withdrawal by Subject|1|||
146948352|NCT03796195|529968858|FG000|Overall Study|Study closed early|1|||
146948353|NCT02392468|529968860|FG000|Overall Study|Adverse Event|0|||
146948354|NCT02392468|529968861|FG001|Overall Study|Adverse Event|1|||
146948355|NCT02392468|529968862|FG002|Overall Study|Adverse Event|0|||
146948356|NCT02392468|529968863|FG003|Overall Study|Adverse Event|0|||
146948357|NCT02392468|529968864|FG004|Overall Study|Adverse Event|0|||
146948358|NCT02392468|529968865|FG005|Overall Study|Adverse Event|1|||
146948359|NCT03630016|529968866|FG000|Overall Study|Poor Sensor Placement|1|||
146948360|NCT02470429|529968869|FG000|Overall Study|Adverse Event|1|||
146948361|NCT02470429|529968870|FG001|Overall Study|Adverse Event|0|||
146948362|NCT02470429|529968869|FG000|Overall Study|Withdrawal by Subject|1|||
146948363|NCT02470429|529968870|FG001|Overall Study|Withdrawal by Subject|0|||
146948364|NCT00090766|529968871|FG000|Overall Study|Nephrectomy Planned|0|||
146948365|NCT00090766|529968872|FG001|Overall Study|Nephrectomy Planned|0|||
146948366|NCT00090766|529968873|FG002|Overall Study|Nephrectomy Planned|1|||
146948367|NCT00090766|529968871|FG000|Overall Study|Death|1|||
146948368|NCT00090766|529968872|FG001|Overall Study|Death|0|||
146948369|NCT00090766|529968873|FG002|Overall Study|Death|0|||
146948370|NCT00090766|529968871|FG000|Overall Study|Admin|0|||
146948371|NCT00090766|529968872|FG001|Overall Study|Admin|2|||
146948372|NCT00090766|529968873|FG002|Overall Study|Admin|0|||
146948373|NCT00090766|529968871|FG000|Overall Study|Lost to Follow-up|2|||
146948374|NCT00090766|529968872|FG001|Overall Study|Lost to Follow-up|0|||
146948375|NCT00090766|529968873|FG002|Overall Study|Lost to Follow-up|2|||
146948376|NCT00804986|529968874|FG000|Overall Study|Adverse Event|0|||
146948377|NCT00804986|529968875|FG001|Overall Study|Adverse Event|1|||
146948378|NCT00804986|529968876|FG002|Overall Study|Adverse Event|2|||
146948379|NCT00804986|529968877|FG003|Overall Study|Adverse Event|1|||
146948380|NCT00804986|529968878|FG004|Overall Study|Adverse Event|3|||
146948381|NCT00804986|529968879|FG005|Overall Study|Adverse Event|0|||
146948382|NCT00804986|529968874|FG000|Overall Study|Lack of Efficacy|0|||
146948383|NCT00804986|529968875|FG001|Overall Study|Lack of Efficacy|0|||
146948384|NCT00804986|529968876|FG002|Overall Study|Lack of Efficacy|0|||
146948385|NCT00804986|529968877|FG003|Overall Study|Lack of Efficacy|1|||
146948386|NCT00804986|529968878|FG004|Overall Study|Lack of Efficacy|0|||
146948387|NCT00804986|529968879|FG005|Overall Study|Lack of Efficacy|3|||
146948388|NCT00804986|529968874|FG000|Overall Study|Lost to Follow-up|0|||
146948389|NCT00804986|529968875|FG001|Overall Study|Lost to Follow-up|0|||
146948390|NCT00804986|529968876|FG002|Overall Study|Lost to Follow-up|0|||
146948391|NCT00804986|529968877|FG003|Overall Study|Lost to Follow-up|1|||
146948392|NCT00804986|529968878|FG004|Overall Study|Lost to Follow-up|1|||
146948393|NCT00804986|529968879|FG005|Overall Study|Lost to Follow-up|3|||
146948394|NCT00804986|529968874|FG000|Overall Study|Protocol Violation|0|||
146948395|NCT00804986|529968875|FG001|Overall Study|Protocol Violation|1|||
146948396|NCT00804986|529968876|FG002|Overall Study|Protocol Violation|0|||
146948397|NCT00804986|529968877|FG003|Overall Study|Protocol Violation|1|||
146948398|NCT00804986|529968878|FG004|Overall Study|Protocol Violation|0|||
146948399|NCT00804986|529968879|FG005|Overall Study|Protocol Violation|0|||
146948400|NCT00804986|529968874|FG000|Overall Study|Withdrawal by Subject|0|||
146948401|NCT00804986|529968875|FG001|Overall Study|Withdrawal by Subject|3|||
146948402|NCT00804986|529968876|FG002|Overall Study|Withdrawal by Subject|0|||
146948403|NCT00804986|529968877|FG003|Overall Study|Withdrawal by Subject|3|||
146948404|NCT00804986|529968878|FG004|Overall Study|Withdrawal by Subject|5|||
146948405|NCT00804986|529968879|FG005|Overall Study|Withdrawal by Subject|3|||
146948406|NCT00804986|529968874|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
146948407|NCT00804986|529968875|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
146948408|NCT00804986|529968876|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
146948409|NCT00804986|529968877|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
146948410|NCT00804986|529968878|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
146948411|NCT00804986|529968879|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
146948412|NCT00804986|529968874|FG000|Overall Study|Sponsor Decision|0|||
146948413|NCT00804986|529968875|FG001|Overall Study|Sponsor Decision|1|||
146948414|NCT00804986|529968876|FG002|Overall Study|Sponsor Decision|0|||
146948415|NCT00804986|529968877|FG003|Overall Study|Sponsor Decision|0|||
146948416|NCT00804986|529968878|FG004|Overall Study|Sponsor Decision|0|||
146948417|NCT00804986|529968879|FG005|Overall Study|Sponsor Decision|0|||
146948418|NCT00804986|529968874|FG000|Overall Study|Physician Decision|1|||
146948419|NCT00804986|529968875|FG001|Overall Study|Physician Decision|0|||
146948420|NCT00804986|529968876|FG002|Overall Study|Physician Decision|0|||
146948421|NCT00804986|529968877|FG003|Overall Study|Physician Decision|0|||
146948422|NCT00804986|529968878|FG004|Overall Study|Physician Decision|0|||
146948423|NCT00804986|529968879|FG005|Overall Study|Physician Decision|0|||
146948424|NCT00959699|529968880|FG000|Treatment Period|Adverse Event|3|||
146948425|NCT00959699|529968881|FG001|Treatment Period|Adverse Event|13|||
146948426|NCT00959699|529968880|FG000|Treatment Period|Lack of Efficacy|15|||
146948427|NCT00959699|529968881|FG001|Treatment Period|Lack of Efficacy|6|||
146948428|NCT00959699|529968880|FG000|Treatment Period|Lost to Follow-up|0|||
146948429|NCT00959699|529968881|FG001|Treatment Period|Lost to Follow-up|1|||
146948430|NCT00959699|529968880|FG000|Treatment Period|Withdrawal by Subject|1|||
146948431|NCT00959699|529968881|FG001|Treatment Period|Withdrawal by Subject|3|||
146948432|NCT00959699|529968880|FG000|Treatment Period|Non-Compliance with Protocol|0|||
146948433|NCT00959699|529968881|FG001|Treatment Period|Non-Compliance with Protocol|1|||
146948434|NCT00959699|529968880|FG000|Treatment Period|Did not receive treatment|0|||
146948435|NCT00959699|529968881|FG001|Treatment Period|Did not receive treatment|1|||
146948436|NCT00959699|529968880|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
146948437|NCT00959699|529968881|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
146948438|NCT00959699|529968880|FG000|Follow-up Period|Lost to Follow-up|3|||
146948439|NCT00959699|529968881|FG001|Follow-up Period|Lost to Follow-up|2|||
146948440|NCT00959699|529968880|FG000|Follow-up Period|Withdrawal by Subject|3|||
146948441|NCT00959699|529968881|FG001|Follow-up Period|Withdrawal by Subject|4|||
146948442|NCT01885104|529968883|FG000|Overall Study|Withdrawal of Consent|1|||
146948443|NCT01885104|529968884|FG001|Overall Study|Withdrawal of Consent|0|||
146948444|NCT01885104|529968883|FG000|Overall Study|Lost to Follow-up|0|||
146948445|NCT01885104|529968884|FG001|Overall Study|Lost to Follow-up|1|||
146948446|NCT01885104|529968883|FG000|Overall Study|Physician Decision|1|||
146948447|NCT01885104|529968884|FG001|Overall Study|Physician Decision|0|||
146948448|NCT00126425|529968887|FG000|Overall Study|Withdrawal by Subject|17|||
146948449|NCT00126425|529968888|FG001|Overall Study|Withdrawal by Subject|1|||
146948450|NCT00126425|529968887|FG000|Overall Study|Lost to Follow-up|8|||
146948451|NCT00126425|529968888|FG001|Overall Study|Lost to Follow-up|4|||
146948452|NCT00126425|529968887|FG000|Overall Study|Protocol Violation|9|||
146948453|NCT00126425|529968888|FG001|Overall Study|Protocol Violation|6|||
146948454|NCT00126425|529968887|FG000|Overall Study|Adverse Event|1|||
146948455|NCT00126425|529968888|FG001|Overall Study|Adverse Event|0|||
146948456|NCT00126425|529968887|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
146948457|NCT00126425|529968888|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
146948458|NCT00126425|529968887|FG000|Overall Study|Other|5|||
146948459|NCT00126425|529968888|FG001|Overall Study|Other|0|||
146948460|NCT03325010|529968890|FG000|Overall Study|Adverse Event|3|||
146948461|NCT03325010|529968891|FG001|Overall Study|Adverse Event|8|||
146948462|NCT03325010|529968890|FG000|Overall Study|Protocol Violation|1|||
146948463|NCT03325010|529968891|FG001|Overall Study|Protocol Violation|8|||
146948464|NCT03325010|529968890|FG000|Overall Study|Withdrawal by Subject|1|||
146948465|NCT03325010|529968891|FG001|Overall Study|Withdrawal by Subject|3|||
146948466|NCT03325010|529968890|FG000|Overall Study|Lost to Follow-up|1|||
146948467|NCT03325010|529968891|FG001|Overall Study|Lost to Follow-up|0|||
146948468|NCT03325010|529968890|FG000|Overall Study|Physician Decision|1|||
146948469|NCT03325010|529968891|FG001|Overall Study|Physician Decision|1|||
146948470|NCT03325010|529968890|FG000|Overall Study|Lack of Efficacy|2|||
146948471|NCT03325010|529968891|FG001|Overall Study|Lack of Efficacy|0|||
146948472|NCT04350372|529968896|FG000|Overall Study|Death|1|||
146948473|NCT00113555|529968898|FG000|Overall Study|Baseline Failure|59|||
146948474|NCT00113555|529968898|FG000|Overall Study|Permanently Explanted|7|||
146948475|NCT00113555|529968898|FG000|Overall Study|Death|1|||
146948476|NCT00113555|529968898|FG000|Overall Study|Missed Followup|4|||
146948477|NCT00113555|529968898|FG000|Overall Study|Lost to Follow-up|8|||
146948478|NCT03864627|529968899|FG000|Overall Study|Adverse Event|0|||
146948479|NCT03864627|529968900|FG001|Overall Study|Adverse Event|1|||
146948480|NCT03864627|529968899|FG000|Overall Study|Lack of Efficacy|0|||
146948481|NCT03864627|529968900|FG001|Overall Study|Lack of Efficacy|1|||
146948482|NCT03864627|529968899|FG000|Overall Study|Lost to Follow-up|0|||
146948483|NCT03864627|529968900|FG001|Overall Study|Lost to Follow-up|1|||
146948484|NCT03864627|529968899|FG000|Overall Study|Withdrawal by Subject|4|||
146948485|NCT03864627|529968900|FG001|Overall Study|Withdrawal by Subject|8|||
146948486|NCT03864627|529968899|FG000|Overall Study|Study terminated by sponsor|0|||
146948487|NCT03864627|529968900|FG001|Overall Study|Study terminated by sponsor|1|||
146948488|NCT00112840|529968901|FG000|Overall Study|Physician Decision|1|||
146948489|NCT00112840|529968902|FG001|Overall Study|Physician Decision|0|||
146948490|NCT00112840|529968903|FG002|Overall Study|Physician Decision|0|||
146948491|NCT00112840|529968901|FG000|Overall Study|Withdrawal by Subject|1|||
146948492|NCT00112840|529968902|FG001|Overall Study|Withdrawal by Subject|0|||
146948493|NCT00112840|529968903|FG002|Overall Study|Withdrawal by Subject|1|||
146948494|NCT00112840|529968901|FG000|Overall Study|Protocol Violation|0|||
146948495|NCT00112840|529968902|FG001|Overall Study|Protocol Violation|0|||
146948496|NCT00112840|529968903|FG002|Overall Study|Protocol Violation|5|||
146948497|NCT00683774|529968904|FG000|Overall Study|Withdrawal by Subject|0|||
146948498|NCT00683774|529968905|FG001|Overall Study|Withdrawal by Subject|1|||
146948499|NCT00683774|529968904|FG000|Overall Study|Physician Decision|3|||
146948500|NCT00683774|529968905|FG001|Overall Study|Physician Decision|0|||
146948501|NCT02875366|529968906|FG000|Overall Study|Adverse Event|0|||
146948502|NCT02875366|529968907|FG001|Overall Study|Adverse Event|2|||
146948503|NCT02875366|529968906|FG000|Overall Study|Noncompliance|0|||
146948504|NCT02875366|529968907|FG001|Overall Study|Noncompliance|1|||
146948505|NCT03595176|529968908|FG000|Overall Study|Death|0|||
146948506|NCT03595176|529968909|FG001|Overall Study|Death|2|||
146948507|NCT03595176|529968908|FG000|Overall Study|Lost to Follow-up|0|||
146948508|NCT03595176|529968909|FG001|Overall Study|Lost to Follow-up|1|||
146948509|NCT01201967|529968912|FG000|Overall Study|Lost to Follow-up|6|||
146948510|NCT01201967|529968913|FG001|Overall Study|Lost to Follow-up|5|||
146948511|NCT02497287|529968914|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
146948512|NCT02497287|529968914|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
146948513|NCT02497287|529968914|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
146948514|NCT02497287|529968914|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
146948515|NCT02497287|529968914|FG000|Induction Phase (4 Weeks)|Other|13|||
146948516|NCT02497287|529968914|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
146948517|NCT02497287|529968914|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
146948518|NCT02497287|529968914|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
146948519|NCT02497287|529968914|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
146948520|NCT02497287|529968914|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
146948521|NCT02497287|529968914|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
146948522|NCT02497287|529968914|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
146948523|NCT02497287|529968914|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
146948524|NCT02497287|529968914|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
146948525|NCT02497287|529968914|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
146948526|NCT02497287|529968914|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
146948527|NCT02497287|529968914|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
146948528|NCT02497287|529968914|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
146948529|NCT02497287|529968914|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
146948530|NCT02497287|529968914|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
146948531|NCT02497287|529968914|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
146948532|NCT02497287|529968914|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
146948533|NCT02497287|529968914|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
146948534|NCT02497287|529968914|FG000|Follow-up Phase (4 Week)|Other|1|||
146948535|NCT02422186|529968915|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
146948536|NCT02422186|529968916|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
146948537|NCT02422186|529968915|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
146948538|NCT02422186|529968916|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
146948539|NCT02422186|529968915|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
146948540|NCT02422186|529968916|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
146948541|NCT02422186|529968915|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
146948542|NCT02422186|529968916|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
146948543|NCT02422186|529968915|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
146948544|NCT02422186|529968916|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
146948545|NCT02422186|529968915|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
146948546|NCT02422186|529968916|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
146948547|NCT02422186|529968915|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
146948548|NCT02422186|529968916|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
146948549|NCT02422186|529968915|FG000|Follow-up Phase (2 Weeks)|Other|3|||
146948550|NCT02422186|529968916|FG001|Follow-up Phase (2 Weeks)|Other|0|||
146948551|NCT03074318|529968917|FG000|Overall Study|Adverse Event|0|||
146948552|NCT03074318|529968918|FG001|Overall Study|Adverse Event|1|||
146948553|NCT03074318|529968919|FG002|Overall Study|Adverse Event|1|||
146948554|NCT03074318|529968920|FG003|Overall Study|Adverse Event|1|||
146948555|NCT03074318|529968917|FG000|Overall Study|Death|1|||
146817280|NCT00584909|529498991|FG000|Overall Study|Adverse Event|4|||
146817281|NCT03345407|529498992|FG000|Overall Study|Withdrawal by Subject|11|||
146817282|NCT03345407|529498993|FG001|Overall Study|Withdrawal by Subject|1|||
146817283|NCT03345407|529498994|FG002|Overall Study|Withdrawal by Subject|5|||
146817284|NCT03345407|529498995|FG003|Overall Study|Withdrawal by Subject|6|||
146817285|NCT03345407|529498996|FG004|Overall Study|Withdrawal by Subject|3|||
146817286|NCT03345407|529498997|FG005|Overall Study|Withdrawal by Subject|6|||
146817287|NCT03345407|529498998|FG006|Overall Study|Withdrawal by Subject|16|||
146817288|NCT03345407|529498992|FG000|Overall Study|Physician Decision|3|||
146817289|NCT03345407|529498993|FG001|Overall Study|Physician Decision|1|||
146817290|NCT03345407|529498994|FG002|Overall Study|Physician Decision|0|||
146817291|NCT03345407|529498995|FG003|Overall Study|Physician Decision|0|||
146817292|NCT03345407|529498996|FG004|Overall Study|Physician Decision|1|||
146817293|NCT03345407|529498997|FG005|Overall Study|Physician Decision|2|||
146817294|NCT03345407|529498998|FG006|Overall Study|Physician Decision|3|||
146817295|NCT03345407|529498992|FG000|Overall Study|Lost to Follow-up|2|||
146817296|NCT03345407|529498993|FG001|Overall Study|Lost to Follow-up|0|||
146817297|NCT03345407|529498994|FG002|Overall Study|Lost to Follow-up|1|||
146817298|NCT03345407|529498995|FG003|Overall Study|Lost to Follow-up|0|||
146817299|NCT03345407|529498996|FG004|Overall Study|Lost to Follow-up|1|||
146817300|NCT03345407|529498997|FG005|Overall Study|Lost to Follow-up|2|||
146817301|NCT03345407|529498998|FG006|Overall Study|Lost to Follow-up|3|||
146817302|NCT03345407|529498992|FG000|Overall Study|Protocol-defined stopping criteria|9|||
146817303|NCT03345407|529498993|FG001|Overall Study|Protocol-defined stopping criteria|0|||
146817304|NCT03345407|529498994|FG002|Overall Study|Protocol-defined stopping criteria|0|||
146817305|NCT03345407|529498995|FG003|Overall Study|Protocol-defined stopping criteria|0|||
146817306|NCT03345407|529498996|FG004|Overall Study|Protocol-defined stopping criteria|2|||
146817307|NCT03345407|529498997|FG005|Overall Study|Protocol-defined stopping criteria|1|||
146817308|NCT03345407|529498998|FG006|Overall Study|Protocol-defined stopping criteria|1|||
146817309|NCT03345407|529498992|FG000|Overall Study|Protocol Violation|2|||
146817310|NCT03345407|529498993|FG001|Overall Study|Protocol Violation|0|||
146817311|NCT03345407|529498994|FG002|Overall Study|Protocol Violation|0|||
146817312|NCT03345407|529498995|FG003|Overall Study|Protocol Violation|0|||
146817313|NCT03345407|529498996|FG004|Overall Study|Protocol Violation|1|||
146817314|NCT03345407|529498997|FG005|Overall Study|Protocol Violation|0|||
146817315|NCT03345407|529498998|FG006|Overall Study|Protocol Violation|3|||
146817316|NCT03345407|529498992|FG000|Overall Study|Lack of Efficacy|1|||
146817317|NCT03345407|529498993|FG001|Overall Study|Lack of Efficacy|1|||
146817318|NCT03345407|529498994|FG002|Overall Study|Lack of Efficacy|1|||
146817319|NCT03345407|529498995|FG003|Overall Study|Lack of Efficacy|1|||
146817320|NCT03345407|529498996|FG004|Overall Study|Lack of Efficacy|1|||
146817321|NCT03345407|529498997|FG005|Overall Study|Lack of Efficacy|0|||
146817322|NCT03345407|529498998|FG006|Overall Study|Lack of Efficacy|3|||
146817323|NCT03345407|529498992|FG000|Overall Study|Adverse Event|4|||
146817324|NCT03345407|529498993|FG001|Overall Study|Adverse Event|0|||
146817325|NCT03345407|529498994|FG002|Overall Study|Adverse Event|5|||
146817326|NCT03345407|529498995|FG003|Overall Study|Adverse Event|4|||
146817327|NCT03345407|529498996|FG004|Overall Study|Adverse Event|6|||
146817328|NCT03345407|529498997|FG005|Overall Study|Adverse Event|5|||
146817329|NCT03345407|529498998|FG006|Overall Study|Adverse Event|16|||
146817330|NCT02092909|529499001|FG000|Overall Study|Adverse Event|0|||
146817331|NCT02092909|529499002|FG001|Overall Study|Adverse Event|0|||
146817332|NCT02092909|529499003|FG002|Overall Study|Adverse Event|4|||
146817333|NCT02092909|529499004|FG003|Overall Study|Adverse Event|2|||
146817334|NCT02092909|529499001|FG000|Overall Study|Lack of Efficacy|0|||
146817335|NCT02092909|529499002|FG001|Overall Study|Lack of Efficacy|2|||
146817336|NCT02092909|529499003|FG002|Overall Study|Lack of Efficacy|1|||
146817337|NCT02092909|529499004|FG003|Overall Study|Lack of Efficacy|0|||
146948556|NCT03074318|529968918|FG001|Overall Study|Death|0|||
146817338|NCT02092909|529499001|FG000|Overall Study|Withdrawal by Subject|0|||
146817339|NCT02092909|529499002|FG001|Overall Study|Withdrawal by Subject|0|||
146817340|NCT02092909|529499003|FG002|Overall Study|Withdrawal by Subject|2|||
146817341|NCT02092909|529499004|FG003|Overall Study|Withdrawal by Subject|1|||
146817342|NCT02092909|529499001|FG000|Overall Study|Study terminated by Sponsor|0|||
146817343|NCT02092909|529499002|FG001|Overall Study|Study terminated by Sponsor|0|||
146817344|NCT02092909|529499003|FG002|Overall Study|Study terminated by Sponsor|0|||
146817345|NCT02092909|529499004|FG003|Overall Study|Study terminated by Sponsor|2|||
146817346|NCT02092909|529499001|FG000|Overall Study|Miscellaneous|1|||
146817347|NCT02092909|529499002|FG001|Overall Study|Miscellaneous|1|||
146817348|NCT02092909|529499003|FG002|Overall Study|Miscellaneous|2|||
146817349|NCT02092909|529499004|FG003|Overall Study|Miscellaneous|1|||
146817350|NCT03436797|529499005|FG000|Main Study|Withdrawal by Subject|2|||
146817351|NCT03436797|529499005|FG000|Main Study|Adverse Event|4|||
146817352|NCT03436797|529499005|FG000|Main Study|Lost to Follow-up|1|||
146817353|NCT03436797|529499005|FG000|Main Study|Death|1|||
146817354|NCT03436797|529499005|FG000|Main Study|Non-Specific|2|||
146817355|NCT03436797|529499005|FG000|Extended Dosing|Patient decision|1|||
146817356|NCT02865083|529499006|FG000|Overall Study|Early Termination|3|||
146817357|NCT02865083|529499007|FG001|Overall Study|Early Termination|1|||
146817358|NCT01358175|529499010|FG000|Overall Study|Death|1|||
146817359|NCT01358175|529499011|FG001|Overall Study|Death|0|||
146817360|NCT01358175|529499012|FG002|Overall Study|Death|1|||
146817361|NCT01358175|529499010|FG000|Overall Study|Withdrawal by Subject|9|||
146817362|NCT01358175|529499011|FG001|Overall Study|Withdrawal by Subject|5|||
146817363|NCT01358175|529499012|FG002|Overall Study|Withdrawal by Subject|10|||
146817364|NCT01358175|529499010|FG000|Overall Study|Technical issues|0|||
146817365|NCT01358175|529499011|FG001|Overall Study|Technical issues|1|||
146817366|NCT01358175|529499012|FG002|Overall Study|Technical issues|0|||
146817367|NCT01358175|529499010|FG000|Overall Study|Pregnancy|0|||
146817368|NCT01358175|529499011|FG001|Overall Study|Pregnancy|1|||
146817369|NCT01358175|529499012|FG002|Overall Study|Pregnancy|0|||
146817370|NCT01358175|529499010|FG000|Overall Study|Physician Decision|1|||
146817371|NCT01358175|529499011|FG001|Overall Study|Physician Decision|0|||
146817372|NCT01358175|529499012|FG002|Overall Study|Physician Decision|0|||
146817373|NCT01358175|529499010|FG000|Overall Study|Non Compliance with Study Treatment|0|||
146817374|NCT01358175|529499011|FG001|Overall Study|Non Compliance with Study Treatment|1|||
146817375|NCT01358175|529499012|FG002|Overall Study|Non Compliance with Study Treatment|1|||
146817376|NCT01358175|529499010|FG000|Overall Study|Lost to Follow-up|1|||
146817377|NCT01358175|529499011|FG001|Overall Study|Lost to Follow-up|1|||
146817378|NCT01358175|529499012|FG002|Overall Study|Lost to Follow-up|3|||
146817379|NCT01358175|529499010|FG000|Overall Study|Lack of Efficacy|3|||
146817380|NCT01358175|529499011|FG001|Overall Study|Lack of Efficacy|8|||
146817381|NCT01358175|529499012|FG002|Overall Study|Lack of Efficacy|6|||
146817382|NCT01358175|529499010|FG000|Overall Study|Adverse Event|6|||
146817383|NCT01358175|529499011|FG001|Overall Study|Adverse Event|11|||
146817384|NCT01358175|529499012|FG002|Overall Study|Adverse Event|11|||
146817385|NCT01124916|529499013|FG000|Overall Study|Lost to Follow-up|3|||
146817386|NCT01124916|529499014|FG001|Overall Study|Lost to Follow-up|2|||
146817387|NCT05104242|529499017|FG000|Overall Study|Withdrawal by Subject|1|||
146817388|NCT05104242|529499018|FG001|Overall Study|Withdrawal by Subject|5|||
146817389|NCT05104242|529499017|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
146817390|NCT05104242|529499018|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
146817391|NCT02469155|529499023|FG000|Overall Study|Adverse Event|6|||
146817392|NCT02469155|529499024|FG001|Overall Study|Adverse Event|0|||
146817393|NCT02469155|529499025|FG002|Overall Study|Adverse Event|1|||
146817394|NCT02469155|529499026|FG003|Overall Study|Adverse Event|10|||
146817395|NCT02469155|529499023|FG000|Overall Study|Lack of Efficacy|13|||
146817396|NCT02469155|529499024|FG001|Overall Study|Lack of Efficacy|10|||
146817397|NCT02469155|529499025|FG002|Overall Study|Lack of Efficacy|10|||
146817398|NCT02469155|529499026|FG003|Overall Study|Lack of Efficacy|8|||
146817399|NCT02469155|529499023|FG000|Overall Study|Death|0|||
146817400|NCT02469155|529499024|FG001|Overall Study|Death|0|||
146817401|NCT02469155|529499025|FG002|Overall Study|Death|0|||
146817402|NCT02469155|529499026|FG003|Overall Study|Death|1|||
146817403|NCT02469155|529499023|FG000|Overall Study|Lost to Follow-up|5|||
146817404|NCT02469155|529499024|FG001|Overall Study|Lost to Follow-up|2|||
146817405|NCT02469155|529499025|FG002|Overall Study|Lost to Follow-up|7|||
146817406|NCT02469155|529499026|FG003|Overall Study|Lost to Follow-up|2|||
146817407|NCT02469155|529499023|FG000|Overall Study|Physician Decision|0|||
146817408|NCT02469155|529499024|FG001|Overall Study|Physician Decision|0|||
146817409|NCT02469155|529499025|FG002|Overall Study|Physician Decision|1|||
146817410|NCT02469155|529499026|FG003|Overall Study|Physician Decision|0|||
146817411|NCT02469155|529499023|FG000|Overall Study|Withdrawal by Subject|34|||
146817412|NCT02469155|529499024|FG001|Overall Study|Withdrawal by Subject|30|||
146817413|NCT02469155|529499025|FG002|Overall Study|Withdrawal by Subject|20|||
146817414|NCT02469155|529499026|FG003|Overall Study|Withdrawal by Subject|37|||
146817415|NCT02469155|529499023|FG000|Overall Study|Other|3|||
146817416|NCT02469155|529499024|FG001|Overall Study|Other|3|||
146817417|NCT02469155|529499025|FG002|Overall Study|Other|2|||
146817418|NCT02469155|529499026|FG003|Overall Study|Other|10|||
146817419|NCT02469155|529499023|FG000|Overall Study|Protocol Violation|0|||
146817420|NCT02469155|529499024|FG001|Overall Study|Protocol Violation|1|||
146817421|NCT02469155|529499025|FG002|Overall Study|Protocol Violation|0|||
146817422|NCT02469155|529499026|FG003|Overall Study|Protocol Violation|1|||
146817423|NCT00901459|529499028|FG000|Overall Study|Withdrawal by Subject|6|||
146817424|NCT04765046|529499029|FG000|Overall Study|Screen Failure|2|||
146817425|NCT04765046|529499029|FG000|Overall Study|Withdrawal by Subject|4|||
146817426|NCT04765046|529499029|FG000|Overall Study|Physician Decision|4|||
146817427|NCT04765046|529499029|FG000|Overall Study|Surgery Cancelled|8|||
146817428|NCT04930263|529499037|FG000|Overall Study|Withdrawal by Subject|3|||
146817429|NCT04930263|529499038|FG001|Overall Study|Withdrawal by Subject|5|||
146817430|NCT01989156|529499039|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
146817431|NCT01989156|529499040|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
146817432|NCT01989156|529499041|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
146817433|NCT01989156|529499039|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
146817434|NCT01989156|529499040|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
146817435|NCT01989156|529499041|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
146948557|NCT03074318|529968919|FG002|Overall Study|Death|0|||
146948558|NCT03074318|529968920|FG003|Overall Study|Death|0|||
146948559|NCT03074318|529968917|FG000|Overall Study|Withdrawal by Subject|1|||
146948560|NCT03074318|529968918|FG001|Overall Study|Withdrawal by Subject|2|||
146948561|NCT03074318|529968919|FG002|Overall Study|Withdrawal by Subject|2|||
146948562|NCT03074318|529968920|FG003|Overall Study|Withdrawal by Subject|4|||
146948563|NCT03074318|529968917|FG000|Overall Study|Trial Closure|2|||
146948564|NCT03074318|529968918|FG001|Overall Study|Trial Closure|2|||
146948565|NCT03074318|529968919|FG002|Overall Study|Trial Closure|3|||
146948566|NCT03074318|529968920|FG003|Overall Study|Trial Closure|11|||
146948567|NCT01952041|529970239|FG000|Overall Study|Lost to Follow-up|9|||
146948568|NCT01952041|529970240|FG001|Overall Study|Lost to Follow-up|16|||
146948569|NCT01952041|529970239|FG000|Overall Study|Withdrawal by Subject|7|||
146948570|NCT01952041|529970240|FG001|Overall Study|Withdrawal by Subject|5|||
146948571|NCT01952041|529970239|FG000|Overall Study|Death|1|||
146948572|NCT01952041|529970240|FG001|Overall Study|Death|0|||
146948573|NCT01736176|529970241|FG000|Overall Study|Adverse Event|3|||
146948574|NCT01736176|529970241|FG000|Overall Study|Withdrawal by Subject|4|||
146948575|NCT01736176|529970241|FG000|Overall Study|Lack of Efficacy|3|||
146948576|NCT01736176|529970241|FG000|Overall Study|Unable to Complete PEG Placement|1|||
146948577|NCT00186121|529970242|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
146948578|NCT00186121|529970242|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
146948579|NCT00186121|529970242|FG000|Overall Study|Not eligible (no treatment)|1|||
146948580|NCT03650387|529970243|FG000|Overall Study|Withdrawal by Subject|13|||
146948581|NCT03650387|529970243|FG000|Overall Study|Lost to Follow-up|12|||
146948582|NCT03650387|529970243|FG000|Overall Study|Adverse Event (Not related)|1|||
146948583|NCT03650387|529970243|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
146948584|NCT01370499|529970244|FG000|Overall Study|Adverse Event|38|||
146948585|NCT01370499|529970245|FG001|Overall Study|Adverse Event|12|||
146948586|NCT01370499|529970244|FG000|Overall Study|Lack of Efficacy|4|||
146948587|NCT01370499|529970245|FG001|Overall Study|Lack of Efficacy|2|||
146948588|NCT01370499|529970244|FG000|Overall Study|Lost to Follow-up|2|||
146948589|NCT01370499|529970245|FG001|Overall Study|Lost to Follow-up|1|||
146948590|NCT01370499|529970244|FG000|Overall Study|Physician Decision|3|||
146948591|NCT01370499|529970245|FG001|Overall Study|Physician Decision|3|||
146948592|NCT01370499|529970244|FG000|Overall Study|Protocol Violation|5|||
146948593|NCT01370499|529970245|FG001|Overall Study|Protocol Violation|4|||
146948594|NCT01370499|529970244|FG000|Overall Study|Withdrawal by Subject|18|||
146948595|NCT01370499|529970245|FG001|Overall Study|Withdrawal by Subject|7|||
146948596|NCT01370499|529970244|FG000|Overall Study|Sponsor Decision|41|||
146948597|NCT01370499|529970245|FG001|Overall Study|Sponsor Decision|15|||
146948598|NCT00887822|529970246|FG000|Overall Study|Insufficient therapeutic response|53|||
146948599|NCT00887822|529970247|FG001|Overall Study|Insufficient therapeutic response|55|||
146948600|NCT00887822|529970246|FG000|Overall Study|Adverse Event|14|||
146948601|NCT00887822|529970247|FG001|Overall Study|Adverse Event|17|||
146948602|NCT00887822|529970246|FG000|Overall Study|Failure to return|11|||
146948603|NCT00887822|529970247|FG001|Overall Study|Failure to return|11|||
146948604|NCT00887822|529970246|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
146948605|NCT00887822|529970247|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
146948606|NCT00887822|529970246|FG000|Overall Study|Administrative/Other than specified|5|||
146948607|NCT00887822|529970247|FG001|Overall Study|Administrative/Other than specified|4|||
146948608|NCT00887822|529970246|FG000|Overall Study|Death|2|||
146948609|NCT00887822|529970247|FG001|Overall Study|Death|3|||
146948610|NCT00887822|529970246|FG000|Overall Study|Protocol Violation|0|||
146948611|NCT00887822|529970247|FG001|Overall Study|Protocol Violation|1|||
146948612|NCT00887822|529970246|FG000|Overall Study|Randomized but not treated|0|||
146948613|NCT00887822|529970247|FG001|Overall Study|Randomized but not treated|1|||
146948614|NCT05815758|529970248|FG000|Overall Study|Adverse Event|6|||
146948615|NCT05815758|529970249|FG001|Overall Study|Adverse Event|2|||
146948616|NCT05815758|529970248|FG000|Overall Study|Lost to Follow-up|14|||
146948617|NCT05815758|529970249|FG001|Overall Study|Lost to Follow-up|1|||
146948618|NCT05815758|529970248|FG000|Overall Study|Withdrawal by Subject|6|||
146948619|NCT05815758|529970249|FG001|Overall Study|Withdrawal by Subject|6|||
146948620|NCT05815758|529970248|FG000|Overall Study|Protocol Violation|1|||
146948621|NCT05815758|529970249|FG001|Overall Study|Protocol Violation|1|||
146948622|NCT05815758|529970248|FG000|Overall Study|Discontinued|4|||
146948623|NCT05815758|529970249|FG001|Overall Study|Discontinued|4|||
146948624|NCT03661983|529970250|FG000|Open Label Stabilization Phase|Adverse Event|5|||
146948625|NCT03661983|529970251|FG001|Open Label Stabilization Phase|Adverse Event|0|||
146948626|NCT03661983|529970252|FG002|Open Label Stabilization Phase|Adverse Event|0|||
146948627|NCT03661983|529970253|FG003|Open Label Stabilization Phase|Adverse Event|0|||
146948628|NCT03661983|529970250|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
146948629|NCT03661983|529970251|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
146948630|NCT03661983|529970252|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
146948631|NCT03661983|529970253|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
146948632|NCT03661983|529970250|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
146948633|NCT03661983|529970251|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
146817436|NCT01989156|529499039|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
146817437|NCT01989156|529499040|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
146817438|NCT01989156|529499041|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
146817439|NCT01989156|529499039|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
146817440|NCT01989156|529499040|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
146817441|NCT01989156|529499041|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
146817442|NCT01989156|529499039|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
146817443|NCT01989156|529499040|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
146817444|NCT01989156|529499041|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
146817445|NCT01989156|529499039|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
146817446|NCT01989156|529499040|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
146817447|NCT01989156|529499041|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
146817448|NCT01989156|529499039|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
146817449|NCT01989156|529499040|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
146817450|NCT01989156|529499041|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
146817451|NCT01989156|529499039|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
146817452|NCT01989156|529499040|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
146817453|NCT01989156|529499041|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
146817454|NCT00850993|529499042|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
146817455|NCT00850993|529499043|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
146817456|NCT00850993|529499044|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
146817457|NCT00850993|529499045|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
146948634|NCT03661983|529970252|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
146984723|NCT03264066|530105153|FG001|Overall Study|Adverse Event|1|||
146984724|NCT03264066|530105154|FG002|Overall Study|Adverse Event|0|||
146984725|NCT03264066|530105155|FG003|Overall Study|Adverse Event|0|||
146984726|NCT03264066|530105156|FG004|Overall Study|Adverse Event|0|||
146984727|NCT03264066|530105157|FG005|Overall Study|Adverse Event|0|||
146948635|NCT03661983|529970253|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
146948636|NCT03661983|529970250|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
146948637|NCT03661983|529970251|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
146948638|NCT03661983|529970252|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
146948639|NCT03661983|529970253|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
146948640|NCT03661983|529970250|FG000|Double-blind Randomized Phase|Adverse Event|0|||
146948641|NCT03661983|529970251|FG001|Double-blind Randomized Phase|Adverse Event|1|||
146948642|NCT03661983|529970252|FG002|Double-blind Randomized Phase|Adverse Event|0|||
146948643|NCT03661983|529970253|FG003|Double-blind Randomized Phase|Adverse Event|0|||
146948644|NCT03661983|529970250|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
146948645|NCT03661983|529970251|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
146948646|NCT03661983|529970252|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
146948647|NCT03661983|529970253|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
146948648|NCT03661983|529970250|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
146948649|NCT03661983|529970251|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
146948650|NCT03661983|529970252|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
146948651|NCT03661983|529970253|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
146948652|NCT03661983|529970250|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
146948653|NCT03661983|529970251|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
146948654|NCT03661983|529970252|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
146948655|NCT03661983|529970253|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
146948656|NCT02045979|529970254|FG000|Overall Study|Informed Consent Withdrawn|2|||
146948657|NCT02045979|529970255|FG001|Overall Study|Informed Consent Withdrawn|0|||
146948658|NCT02045979|529970256|FG002|Overall Study|Informed Consent Withdrawn|1|||
146817458|NCT03839355|529499046|FG000|Overall Study|Withdrawal by Subject|1|||
146817459|NCT03839355|529499047|FG001|Overall Study|Withdrawal by Subject|0|||
146948659|NCT02045979|529970254|FG000|Overall Study|not specified above|0|||
146948660|NCT02045979|529970255|FG001|Overall Study|not specified above|1|||
146948661|NCT02045979|529970256|FG002|Overall Study|not specified above|0|||
146948662|NCT01320033|529970257|FG000|Overall Study|Lack of Efficacy|0|||
146948663|NCT01320033|529970258|FG001|Overall Study|Lack of Efficacy|0|||
146948664|NCT01320033|529970259|FG002|Overall Study|Lack of Efficacy|1|||
146817460|NCT04501614|529499054|FG000|Overall Study|Study Terminated by Sponsor|6|||
146817461|NCT04501614|529499055|FG001|Overall Study|Study Terminated by Sponsor|3|||
146817462|NCT04501614|529499054|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
146948665|NCT01320033|529970257|FG000|Overall Study|Adverse Event|9|||
146948666|NCT01320033|529970258|FG001|Overall Study|Adverse Event|7|||
146948667|NCT01320033|529970259|FG002|Overall Study|Adverse Event|8|||
146948668|NCT01320033|529970257|FG000|Overall Study|Withdrawal by Subject|22|||
146948669|NCT01320033|529970258|FG001|Overall Study|Withdrawal by Subject|23|||
146984728|NCT03264066|530105152|FG000|Overall Study|Death|12|||
146984729|NCT03264066|530105153|FG001|Overall Study|Death|12|||
146948670|NCT01320033|529970259|FG002|Overall Study|Withdrawal by Subject|23|||
146948671|NCT01320033|529970257|FG000|Overall Study|Protocol Violation|3|||
146948672|NCT01320033|529970258|FG001|Overall Study|Protocol Violation|5|||
146948673|NCT01320033|529970259|FG002|Overall Study|Protocol Violation|3|||
146948674|NCT01320033|529970257|FG000|Overall Study|Lost to Follow-up|22|||
146948675|NCT01320033|529970258|FG001|Overall Study|Lost to Follow-up|26|||
146948676|NCT01320033|529970259|FG002|Overall Study|Lost to Follow-up|17|||
146948677|NCT01320033|529970257|FG000|Overall Study|Other|2|||
146948678|NCT01320033|529970258|FG001|Overall Study|Other|3|||
146817463|NCT04501614|529499055|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
146817464|NCT02555397|529499056|FG000|Overall Study|Withdrawal by Subject|1|||
146948679|NCT01320033|529970259|FG002|Overall Study|Other|1|||
146948680|NCT00963469|529970260|FG000|Overall Study|Adverse Event|15|||
146948681|NCT00963469|529970261|FG001|Overall Study|Adverse Event|11|||
146948682|NCT00963469|529970262|FG002|Overall Study|Adverse Event|1|||
146948683|NCT00963469|529970260|FG000|Overall Study|Lack of Efficacy|10|||
146948684|NCT00963469|529970261|FG001|Overall Study|Lack of Efficacy|7|||
146948685|NCT00963469|529970262|FG002|Overall Study|Lack of Efficacy|2|||
146948686|NCT00963469|529970260|FG000|Overall Study|Lost to Follow-up|1|||
146948687|NCT00963469|529970261|FG001|Overall Study|Lost to Follow-up|1|||
146948688|NCT00963469|529970262|FG002|Overall Study|Lost to Follow-up|0|||
146817465|NCT02555397|529499057|FG001|Overall Study|Withdrawal by Subject|0|||
146817466|NCT02555397|529499058|FG002|Overall Study|Withdrawal by Subject|0|||
146817467|NCT02555397|529499059|FG003|Overall Study|Withdrawal by Subject|0|||
146817468|NCT02555397|529499060|FG004|Overall Study|Withdrawal by Subject|0|||
146817469|NCT00237809|529499061|FG000|Overall Study|Lost to Follow-up|11|||
146817470|NCT00237809|529499062|FG001|Overall Study|Lost to Follow-up|10|||
146817471|NCT00237809|529499063|FG002|Overall Study|Lost to Follow-up|9|||
146817472|NCT00237809|529499064|FG003|Overall Study|Lost to Follow-up|9|||
146817473|NCT02138838|529499070|FG000|Overall Study|Study Closure|7|||
146817474|NCT02138838|529499071|FG001|Overall Study|Study Closure|6|||
146817475|NCT02138838|529499070|FG000|Overall Study|Withdrawal by Subject|1|||
146817476|NCT02138838|529499071|FG001|Overall Study|Withdrawal by Subject|5|||
146817477|NCT02010684|529499074|FG000|Overall Study|Lost to Follow-up|8|||
146817478|NCT02010684|529499075|FG001|Overall Study|Lost to Follow-up|18|||
146817479|NCT02010684|529499074|FG000|Overall Study|Withdrawal by Subject|4|||
146817480|NCT02010684|529499075|FG001|Overall Study|Withdrawal by Subject|5|||
146817481|NCT01884571|529499080|FG000|Overall Study|Adverse Event|1|||
146817482|NCT01884571|529499080|FG000|Overall Study|Death|2|||
146817483|NCT01884571|529499080|FG000|Overall Study|Withdrawal by Subject|2|||
146817484|NCT01884571|529499080|FG000|Overall Study|Disease progression|3|||
146817485|NCT00091572|529499081|FG000|Overall Study|Lost to Follow-up|1|||
146817486|NCT00091572|529499082|FG001|Overall Study|Lost to Follow-up|1|||
146817487|NCT00091572|529499081|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
146817488|NCT00091572|529499082|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
146817489|NCT00091572|529499081|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
146817490|NCT00091572|529499082|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
146817491|NCT00091572|529499081|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
146817492|NCT00091572|529499082|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
146817493|NCT00091572|529499081|FG000|Overall Study|Other Reason|6|||
146817494|NCT00091572|529499082|FG001|Overall Study|Other Reason|13|||
146817495|NCT00091572|529499081|FG000|Overall Study|Ongoing (still on treatment)|8|||
146817496|NCT00091572|529499082|FG001|Overall Study|Ongoing (still on treatment)|12|||
146948689|NCT00963469|529970260|FG000|Overall Study|Protocol Violation|5|||
146948690|NCT00963469|529970261|FG001|Overall Study|Protocol Violation|5|||
146948691|NCT00963469|529970262|FG002|Overall Study|Protocol Violation|3|||
146948692|NCT00963469|529970260|FG000|Overall Study|Withdrawal by Subject|4|||
146948693|NCT00963469|529970261|FG001|Overall Study|Withdrawal by Subject|1|||
146948694|NCT00963469|529970262|FG002|Overall Study|Withdrawal by Subject|1|||
146948695|NCT00963469|529970260|FG000|Overall Study|Pre-randomization Adverse Event|1|||
146948696|NCT00963469|529970261|FG001|Overall Study|Pre-randomization Adverse Event|2|||
146948697|NCT00963469|529970262|FG002|Overall Study|Pre-randomization Adverse Event|0|||
146948698|NCT00963469|529970260|FG000|Overall Study|Moved|1|||
146817497|NCT00091572|529499081|FG000|Overall Study|Major Protocol Violation|2|||
146817498|NCT00091572|529499082|FG001|Overall Study|Major Protocol Violation|0|||
146817499|NCT00091572|529499081|FG000|Overall Study|Toxicity (Related AE)|53|||
146817500|NCT00091572|529499082|FG001|Overall Study|Toxicity (Related AE)|9|||
146817501|NCT01199302|529499084|FG000|Overall Study|Adverse Event|1|||
146817502|NCT01199302|529499085|FG001|Overall Study|Adverse Event|1|||
146817503|NCT01199302|529499086|FG002|Overall Study|Adverse Event|2|||
146817504|NCT01199302|529499087|FG003|Overall Study|Adverse Event|0|||
146817505|NCT01199302|529499084|FG000|Overall Study|Withdrawal by Subject|2|||
146817506|NCT01199302|529499085|FG001|Overall Study|Withdrawal by Subject|2|||
146948699|NCT00963469|529970261|FG001|Overall Study|Moved|0|||
146948700|NCT00963469|529970262|FG002|Overall Study|Moved|0|||
146948701|NCT00963469|529970260|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
146948702|NCT00963469|529970261|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
146948703|NCT00963469|529970262|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
146948704|NCT02881151|529970265|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
146948705|NCT03258593|529970267|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
146948706|NCT03258593|529970268|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
146948707|NCT03258593|529970269|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
146948708|NCT03258593|529970270|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
146948709|NCT03258593|529970267|FG000|Run-In Maintenance Phase|Disease progression|3|||
146948710|NCT03258593|529970268|FG001|Run-In Maintenance Phase|Disease progression|0|||
146948711|NCT03258593|529970269|FG002|Run-In Maintenance Phase|Disease progression|0|||
146948712|NCT03258593|529970270|FG003|Run-In Maintenance Phase|Disease progression|0|||
146948713|NCT03258593|529970267|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
146948714|NCT03258593|529970268|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
146948715|NCT03258593|529970269|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
146948716|NCT03258593|529970270|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
146948717|NCT03258593|529970267|FG000|Expansion Maintenance Phase|Physician Decision|0|||
146948718|NCT03258593|529970268|FG001|Expansion Maintenance Phase|Physician Decision|1|||
146948719|NCT03258593|529970269|FG002|Expansion Maintenance Phase|Physician Decision|0|||
146948720|NCT03258593|529970270|FG003|Expansion Maintenance Phase|Physician Decision|0|||
146948721|NCT05618808|529970274|FG000|Overall Study|Withdrawal by Subject|3|||
146948722|NCT05618808|529970275|FG001|Overall Study|Withdrawal by Subject|1|||
146948723|NCT05618808|529970276|FG002|Overall Study|Withdrawal by Subject|3|||
146948724|NCT03381274|529970277|FG000|Overall Study|Death|2|||
146948725|NCT03381274|529970278|FG001|Overall Study|Death|9|||
146948726|NCT03381274|529970279|FG002|Overall Study|Death|3|||
146948727|NCT03381274|529970280|FG003|Overall Study|Death|2|||
146948728|NCT03381274|529970281|FG004|Overall Study|Death|3|||
146948729|NCT03381274|529970277|FG000|Overall Study|Lost to Follow-up|0|||
146948730|NCT03381274|529970278|FG001|Overall Study|Lost to Follow-up|0|||
146948731|NCT03381274|529970279|FG002|Overall Study|Lost to Follow-up|0|||
146948732|NCT03381274|529970280|FG003|Overall Study|Lost to Follow-up|1|||
146948733|NCT03381274|529970281|FG004|Overall Study|Lost to Follow-up|0|||
146948734|NCT03381274|529970277|FG000|Overall Study|Withdrawal by Subject|2|||
146948735|NCT03381274|529970278|FG001|Overall Study|Withdrawal by Subject|1|||
146948736|NCT03381274|529970279|FG002|Overall Study|Withdrawal by Subject|3|||
146948737|NCT03381274|529970280|FG003|Overall Study|Withdrawal by Subject|1|||
146948738|NCT03381274|529970281|FG004|Overall Study|Withdrawal by Subject|0|||
146948739|NCT03381274|529970277|FG000|Overall Study|Other|1|||
146948740|NCT03381274|529970278|FG001|Overall Study|Other|11|||
146948741|NCT03381274|529970279|FG002|Overall Study|Other|0|||
146948742|NCT03381274|529970280|FG003|Overall Study|Other|2|||
146948743|NCT03381274|529970281|FG004|Overall Study|Other|2|||
146948744|NCT04284787|529970282|FG000|Overall Study|Disease Progression|9|||
146948745|NCT04284787|529970283|FG001|Overall Study|Disease Progression|12|||
146948746|NCT04284787|529970282|FG000|Overall Study|Physician Decision|12|||
146948747|NCT04284787|529970283|FG001|Overall Study|Physician Decision|7|||
146948748|NCT04284787|529970282|FG000|Overall Study|Transplant|5|||
146948749|NCT04284787|529970283|FG001|Overall Study|Transplant|4|||
146948750|NCT04284787|529970282|FG000|Overall Study|Death|1|||
146948751|NCT04284787|529970283|FG001|Overall Study|Death|2|||
146948752|NCT04284787|529970282|FG000|Overall Study|Adverse Event|0|||
146948753|NCT04284787|529970283|FG001|Overall Study|Adverse Event|4|||
146948754|NCT04284787|529970282|FG000|Overall Study|Non-adherence|2|||
146948755|NCT04284787|529970283|FG001|Overall Study|Non-adherence|0|||
146948756|NCT04284787|529970282|FG000|Overall Study|Lack of Efficacy|2|||
146948757|NCT04284787|529970283|FG001|Overall Study|Lack of Efficacy|0|||
146948758|NCT03233308|529970288|FG000|Overall Study|Adverse Event|1|||
146948759|NCT03233308|529970288|FG000|Overall Study|Protocol Violation|1|||
146948760|NCT02559115|529970289|FG000|Overall Study|Withdrawal by Subject|3|||
146948761|NCT01996865|529970290|FG000|Induction Period|Protocol Violation|1|||
146948762|NCT01996865|529970291|FG001|Induction Period|Protocol Violation|0|||
146948763|NCT01996865|529970292|FG002|Induction Period|Protocol Violation|0|||
146948764|NCT01996865|529970290|FG000|Induction Period|Progressive Disease|4|||
146948765|NCT01996865|529970291|FG001|Induction Period|Progressive Disease|0|||
146948766|NCT01996865|529970292|FG002|Induction Period|Progressive Disease|0|||
146948767|NCT01996865|529970290|FG000|Induction Period|Lost to Follow-up|10|||
146948768|NCT01996865|529970291|FG001|Induction Period|Lost to Follow-up|0|||
146948769|NCT01996865|529970292|FG002|Induction Period|Lost to Follow-up|0|||
146948770|NCT01996865|529970290|FG000|Induction Period|Other Reasons|13|||
146948771|NCT01996865|529970291|FG001|Induction Period|Other Reasons|0|||
146948772|NCT01996865|529970292|FG002|Induction Period|Other Reasons|0|||
146948773|NCT01996865|529970290|FG000|Induction Period|Adverse Event|20|||
146948774|NCT01996865|529970291|FG001|Induction Period|Adverse Event|0|||
146948775|NCT01996865|529970292|FG002|Induction Period|Adverse Event|0|||
146948776|NCT01996865|529970290|FG000|Induction Period|Withdrawal by Subject|60|||
146948777|NCT01996865|529970291|FG001|Induction Period|Withdrawal by Subject|0|||
146948778|NCT01996865|529970292|FG002|Induction Period|Withdrawal by Subject|0|||
146948779|NCT01996865|529970290|FG000|Induction Period|Death|111|||
146948780|NCT01996865|529970291|FG001|Induction Period|Death|0|||
146948781|NCT01996865|529970292|FG002|Induction Period|Death|0|||
146948782|NCT01996865|529970290|FG000|Maintenance Period|Protocol Violation|0|||
146948783|NCT01996865|529970291|FG001|Maintenance Period|Protocol Violation|1|||
146948784|NCT01996865|529970292|FG002|Maintenance Period|Protocol Violation|1|||
146948785|NCT01996865|529970290|FG000|Maintenance Period|Other reasons|0|||
146948786|NCT01996865|529970291|FG001|Maintenance Period|Other reasons|8|||
146948787|NCT01996865|529970292|FG002|Maintenance Period|Other reasons|5|||
146948788|NCT01996865|529970290|FG000|Maintenance Period|Progressive Disease|0|||
146948789|NCT01996865|529970291|FG001|Maintenance Period|Progressive Disease|6|||
146948790|NCT01996865|529970292|FG002|Maintenance Period|Progressive Disease|23|||
146948791|NCT01996865|529970290|FG000|Maintenance Period|Withdrawal by Subject|0|||
146948792|NCT01996865|529970291|FG001|Maintenance Period|Withdrawal by Subject|18|||
146948793|NCT01996865|529970292|FG002|Maintenance Period|Withdrawal by Subject|4|||
146948794|NCT01996865|529970290|FG000|Maintenance Period|Adverse Event|0|||
146948795|NCT01996865|529970291|FG001|Maintenance Period|Adverse Event|7|||
146948796|NCT01996865|529970292|FG002|Maintenance Period|Adverse Event|7|||
146948797|NCT01996865|529970290|FG000|Maintenance Period|Death|0|||
146948798|NCT01996865|529970291|FG001|Maintenance Period|Death|15|||
146948799|NCT01996865|529970292|FG002|Maintenance Period|Death|3|||
146948800|NCT01996865|529970290|FG000|Maintenance Period|Lost to Follow-up|0|||
146948801|NCT01996865|529970291|FG001|Maintenance Period|Lost to Follow-up|2|||
146948802|NCT01996865|529970292|FG002|Maintenance Period|Lost to Follow-up|0|||
146817507|NCT01199302|529499086|FG002|Overall Study|Withdrawal by Subject|3|||
146817508|NCT01199302|529499087|FG003|Overall Study|Withdrawal by Subject|0|||
146817509|NCT01199302|529499084|FG000|Overall Study|Disease Progression|3|||
146817510|NCT01199302|529499085|FG001|Overall Study|Disease Progression|4|||
146817511|NCT01199302|529499086|FG002|Overall Study|Disease Progression|4|||
146817512|NCT01199302|529499087|FG003|Overall Study|Disease Progression|2|||
146817513|NCT01199302|529499084|FG000|Overall Study|Study Termination|13|||
146817514|NCT01199302|529499085|FG001|Overall Study|Study Termination|8|||
146817515|NCT01199302|529499086|FG002|Overall Study|Study Termination|11|||
146817516|NCT01199302|529499087|FG003|Overall Study|Study Termination|9|||
146817517|NCT01199302|529499084|FG000|Overall Study|Lost to Follow-up|0|||
146817518|NCT01199302|529499085|FG001|Overall Study|Lost to Follow-up|1|||
146817519|NCT01199302|529499086|FG002|Overall Study|Lost to Follow-up|0|||
146817520|NCT01199302|529499087|FG003|Overall Study|Lost to Follow-up|0|||
146817521|NCT01199302|529499084|FG000|Overall Study|Other|1|||
146817522|NCT01199302|529499085|FG001|Overall Study|Other|0|||
146817523|NCT01199302|529499086|FG002|Overall Study|Other|0|||
146817524|NCT01199302|529499087|FG003|Overall Study|Other|0|||
146817525|NCT04433091|529499088|FG000|Overall Study|Lost to Follow-up|1|||
146817526|NCT04433091|529499089|FG001|Overall Study|Lost to Follow-up|0|||
146817527|NCT04433091|529499088|FG000|Overall Study|Withdrawn .|2|||
146817528|NCT04433091|529499089|FG001|Overall Study|Withdrawn .|4|||
146817529|NCT05356130|529500267|FG000|Overall Study|Withdrawal by Subject|0|||
146817530|NCT05356130|529500268|FG001|Overall Study|Withdrawal by Subject|0|||
146817531|NCT05356130|529500269|FG002|Overall Study|Withdrawal by Subject|3|||
146817532|NCT04851587|529500270|FG000|Overall Study|Lost to Follow-up|18|||
146817533|NCT02880293|529500271|FG000|Overall Study|Inevaluable|5|||
146817534|NCT02109172|529500275|FG000|Overall Study|Withdrawal by Subject|1|||
146817535|NCT02109172|529500276|FG001|Overall Study|Withdrawal by Subject|0|||
146817536|NCT02109172|529500277|FG002|Overall Study|Withdrawal by Subject|0|||
146817537|NCT02109172|529500278|FG003|Overall Study|Withdrawal by Subject|1|||
146817538|NCT02109172|529500279|FG004|Overall Study|Withdrawal by Subject|0|||
146817539|NCT02109172|529500280|FG005|Overall Study|Withdrawal by Subject|0|||
146817540|NCT02109172|529500275|FG000|Overall Study|Adverse Event|0|||
146817541|NCT02109172|529500276|FG001|Overall Study|Adverse Event|0|||
146817542|NCT02109172|529500277|FG002|Overall Study|Adverse Event|1|||
146817543|NCT02109172|529500278|FG003|Overall Study|Adverse Event|0|||
146817544|NCT02109172|529500279|FG004|Overall Study|Adverse Event|0|||
146948803|NCT00255008|529970304|FG000|Overall Study|Adverse Event|1|||
146817545|NCT02109172|529500280|FG005|Overall Study|Adverse Event|1|||
146817546|NCT02109172|529500275|FG000|Overall Study|Death|0|||
146817547|NCT02109172|529500276|FG001|Overall Study|Death|0|||
146817548|NCT02109172|529500277|FG002|Overall Study|Death|0|||
146817549|NCT02109172|529500278|FG003|Overall Study|Death|0|||
146817550|NCT02109172|529500279|FG004|Overall Study|Death|1|||
146817551|NCT02109172|529500280|FG005|Overall Study|Death|0|||
146817552|NCT03409276|529500281|FG000|Overall Study|Withdrawal by Subject|0|||
146817553|NCT03409276|529500282|FG001|Overall Study|Withdrawal by Subject|0|||
146948804|NCT00255008|529970305|FG001|Overall Study|Adverse Event|1|||
146948805|NCT00255008|529970306|FG002|Overall Study|Adverse Event|2|||
146948806|NCT00255008|529970307|FG003|Overall Study|Adverse Event|0|||
146817554|NCT03409276|529500283|FG002|Overall Study|Withdrawal by Subject|0|||
146817555|NCT03409276|529500284|FG003|Overall Study|Withdrawal by Subject|0|||
146817556|NCT03409276|529500285|FG004|Overall Study|Withdrawal by Subject|1|||
146817557|NCT03409276|529500281|FG000|Overall Study|Lost to Follow-up|0|||
146948807|NCT00255008|529970304|FG000|Overall Study|Lost to Follow-up|1|||
146948808|NCT00255008|529970305|FG001|Overall Study|Lost to Follow-up|0|||
146948809|NCT00255008|529970306|FG002|Overall Study|Lost to Follow-up|1|||
146948810|NCT00255008|529970307|FG003|Overall Study|Lost to Follow-up|2|||
146948811|NCT00255008|529970304|FG000|Overall Study|Did not meet viral reduction criteria|4|||
146948812|NCT00255008|529970305|FG001|Overall Study|Did not meet viral reduction criteria|5|||
146948813|NCT00255008|529970306|FG002|Overall Study|Did not meet viral reduction criteria|0|||
146948814|NCT00255008|529970307|FG003|Overall Study|Did not meet viral reduction criteria|1|||
146948815|NCT00255008|529970304|FG000|Overall Study|Withdrew consent|0|||
146948816|NCT00255008|529970305|FG001|Overall Study|Withdrew consent|0|||
146948817|NCT00255008|529970306|FG002|Overall Study|Withdrew consent|2|||
146948818|NCT00255008|529970307|FG003|Overall Study|Withdrew consent|0|||
146948819|NCT00255008|529970304|FG000|Overall Study|Sponsor request|18|||
146948820|NCT00255008|529970305|FG001|Overall Study|Sponsor request|3|||
146948821|NCT00255008|529970306|FG002|Overall Study|Sponsor request|8|||
146948822|NCT00255008|529970307|FG003|Overall Study|Sponsor request|17|||
146948823|NCT00255008|529970304|FG000|Overall Study|Adverse lab experience|1|||
146948824|NCT00255008|529970305|FG001|Overall Study|Adverse lab experience|0|||
146948825|NCT00255008|529970306|FG002|Overall Study|Adverse lab experience|0|||
146948826|NCT00255008|529970307|FG003|Overall Study|Adverse lab experience|0|||
146948827|NCT00255008|529970304|FG000|Overall Study|Other|7|||
146948828|NCT00255008|529970305|FG001|Overall Study|Other|0|||
146948829|NCT00255008|529970306|FG002|Overall Study|Other|3|||
146948830|NCT00255008|529970307|FG003|Overall Study|Other|2|||
146948831|NCT00707486|529970310|FG000|Overall Study|Withdrawal by Subject|1|||
146948832|NCT01894776|529970321|FG000|Overall Study|Withdrawal by Subject|1|||
146948833|NCT04474366|529970322|FG000|Overall Study|Lost to Follow-up|2|||
146948834|NCT04474366|529970323|FG001|Overall Study|Lost to Follow-up|5|||
146948835|NCT00320190|529970324|FG000|First 12 Months|Completed but did not enter extension|5|||
146948836|NCT00320190|529970325|FG001|First 12 Months|Completed but did not enter extension|3|||
146948837|NCT00320190|529970324|FG000|First 12 Months|Sponsor terminated study|2|||
146948838|NCT00320190|529970325|FG001|First 12 Months|Sponsor terminated study|2|||
146948839|NCT00320190|529970324|FG000|First 12 Months|Lost to Follow-up|0|||
146948840|NCT00320190|529970325|FG001|First 12 Months|Lost to Follow-up|1|||
146948841|NCT00320190|529970324|FG000|First 12 Months|Enrollment failure|0|||
146948842|NCT00320190|529970325|FG001|First 12 Months|Enrollment failure|1|||
146948843|NCT00320190|529970324|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
146948844|NCT00320190|529970325|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
146948845|NCT00320190|529970324|FG000|First 12 Months|Investigator request|0|||
146948846|NCT00320190|529970325|FG001|First 12 Months|Investigator request|1|||
146948847|NCT00320190|529970324|FG000|First 12 Months|Study drug toxicity|0|||
146948848|NCT00320190|529970325|FG001|First 12 Months|Study drug toxicity|1|||
146948849|NCT00320190|529970324|FG000|First 12 Months|Withdrawal by Subject|0|||
146948850|NCT00320190|529970325|FG001|First 12 Months|Withdrawal by Subject|1|||
146948851|NCT00320190|529970324|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
146948852|NCT00320190|529970325|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
146948853|NCT00320190|529970324|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
146948854|NCT00320190|529970325|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
146948855|NCT00320190|529970324|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
146948856|NCT00320190|529970325|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
146948857|NCT05307523|529970327|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
146948858|NCT05307523|529970328|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
146948859|NCT05307523|529970327|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
146948860|NCT05307523|529970328|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
146948861|NCT03858686|529970331|FG000|Period 1|Adverse Event|1|||
146948862|NCT03858686|529970332|FG001|Period 1|Adverse Event|1|||
146984730|NCT03264066|530105154|FG002|Overall Study|Death|8|||
146948863|NCT03858686|529970331|FG000|Period 1|Lack of compliance|0|||
146948864|NCT03858686|529970332|FG001|Period 1|Lack of compliance|1|||
146948865|NCT03858686|529970331|FG000|Period 1|Adverse Event|0|||
146948866|NCT03858686|529970332|FG001|Period 1|Adverse Event|1|||
146948867|NCT03858686|529970331|FG000|Period 2|Adverse Event|0|||
146984731|NCT03264066|530105155|FG003|Overall Study|Death|10|||
146984732|NCT03264066|530105156|FG004|Overall Study|Death|6|||
146948868|NCT03858686|529970332|FG001|Period 2|Adverse Event|1|||
146948869|NCT04412668|529970333|FG000|Overall Study|Death - multiple comorbidities|2|||
146948870|NCT04412668|529970334|FG001|Overall Study|Death - multiple comorbidities|0|||
146984733|NCT03264066|530105157|FG005|Overall Study|Death|1|||
146948871|NCT04412668|529970335|FG002|Overall Study|Death - multiple comorbidities|0|||
146948872|NCT04412668|529970333|FG000|Overall Study|Withdrawal by Subject|3|||
146948873|NCT04412668|529970334|FG001|Overall Study|Withdrawal by Subject|0|||
146948874|NCT04412668|529970335|FG002|Overall Study|Withdrawal by Subject|0|||
146948875|NCT04412668|529970333|FG000|Overall Study|Other than Specified|2|||
146948876|NCT04412668|529970334|FG001|Overall Study|Other than Specified|0|||
146948877|NCT04412668|529970335|FG002|Overall Study|Other than Specified|0|||
146948878|NCT00102804|529970336|FG000|Overall Study|Progressive Disease (PD)|307|||
146984734|NCT03264066|530105152|FG000|Overall Study|Lost to Follow-up|1|||
146984735|NCT03264066|530105153|FG001|Overall Study|Lost to Follow-up|0|||
146984736|NCT03264066|530105154|FG002|Overall Study|Lost to Follow-up|0|||
146948879|NCT00102804|529970337|FG001|Overall Study|Progressive Disease (PD)|196|||
146948880|NCT00102804|529970336|FG000|Overall Study|Withdrawal by Subject|46|||
146948881|NCT00102804|529970337|FG001|Overall Study|Withdrawal by Subject|7|||
146948882|NCT00102804|529970336|FG000|Overall Study|Adverse Event|37|||
146948883|NCT00102804|529970337|FG001|Overall Study|Adverse Event|3|||
146948884|NCT00102804|529970336|FG000|Overall Study|Physician Decision|24|||
146948885|NCT00102804|529970337|FG001|Overall Study|Physician Decision|6|||
146948886|NCT00102804|529970336|FG000|Overall Study|Death|5|||
146948887|NCT00102804|529970337|FG001|Overall Study|Death|6|||
146948888|NCT00102804|529970336|FG000|Overall Study|Enrollment Criteria Not Met|6|||
146948889|NCT00102804|529970337|FG001|Overall Study|Enrollment Criteria Not Met|0|||
146948890|NCT00102804|529970336|FG000|Overall Study|Lost to Follow-up|4|||
146948891|NCT00102804|529970337|FG001|Overall Study|Lost to Follow-up|1|||
146948892|NCT00102804|529970336|FG000|Overall Study|Protocol Violation|2|||
146948893|NCT00102804|529970337|FG001|Overall Study|Protocol Violation|1|||
146948894|NCT00102804|529970336|FG000|Overall Study|Satisfactory Response|2|||
146948895|NCT00102804|529970337|FG001|Overall Study|Satisfactory Response|0|||
146948896|NCT00102804|529970336|FG000|Overall Study|Sponsor Decision|1|||
146948897|NCT00102804|529970337|FG001|Overall Study|Sponsor Decision|0|||
146948898|NCT00102804|529970336|FG000|Overall Study|Alive, Receiving Treatment|7|||
146948899|NCT00102804|529970337|FG001|Overall Study|Alive, Receiving Treatment|2|||
146948900|NCT02299206|529970344|FG000|Overall Study|Lost to Follow-up|1|||
146948901|NCT02299206|529970344|FG000|Overall Study|Withdrawal by Subject|1|||
146948902|NCT00691054|529970345|FG000|Overall Study|Withdrawal by Subject|1|||
146948903|NCT02141854|529970347|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
146948904|NCT02141854|529970348|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146948905|NCT02141854|529970349|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146948906|NCT02141854|529970350|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146948907|NCT02141854|529970351|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146948908|NCT02141854|529970352|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146948909|NCT02141854|529970347|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
146948910|NCT02141854|529970348|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146948911|NCT02141854|529970349|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146948912|NCT02141854|529970350|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146948913|NCT02141854|529970351|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146948914|NCT02141854|529970352|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146948915|NCT02141854|529970347|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
146948916|NCT02141854|529970348|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146948917|NCT02141854|529970349|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146948918|NCT02141854|529970350|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146948919|NCT02141854|529970351|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146948920|NCT02141854|529970352|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146948921|NCT02141854|529970347|FG000|Run-In Period (Pre-assignment)|Other|14|||
146948922|NCT02141854|529970348|FG001|Run-In Period (Pre-assignment)|Other|0|||
146948923|NCT02141854|529970349|FG002|Run-In Period (Pre-assignment)|Other|0|||
146948924|NCT02141854|529970350|FG003|Run-In Period (Pre-assignment)|Other|0|||
146948925|NCT02141854|529970351|FG004|Run-In Period (Pre-assignment)|Other|0|||
146948926|NCT02141854|529970352|FG005|Run-In Period (Pre-assignment)|Other|0|||
146948927|NCT02141854|529970347|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
146948928|NCT02141854|529970348|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
146948929|NCT02141854|529970349|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
146948930|NCT02141854|529970350|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
146948931|NCT02141854|529970351|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
146948932|NCT02141854|529970352|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
146948933|NCT02141854|529970347|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
146948934|NCT02141854|529970348|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146948935|NCT02141854|529970349|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146948936|NCT02141854|529970350|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146948937|NCT02141854|529970351|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146948938|NCT02141854|529970352|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146817558|NCT03409276|529500282|FG001|Overall Study|Lost to Follow-up|0|||
146817559|NCT03409276|529500283|FG002|Overall Study|Lost to Follow-up|0|||
146948939|NCT02141854|529970347|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
146948940|NCT02141854|529970348|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146817560|NCT03409276|529500284|FG003|Overall Study|Lost to Follow-up|2|||
146948941|NCT02141854|529970349|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146948942|NCT02141854|529970350|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146948943|NCT02141854|529970351|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146817561|NCT03409276|529500285|FG004|Overall Study|Lost to Follow-up|2|||
146817562|NCT03605745|529500286|FG000|Overall Study|Study was terminated for business reasons|47|||
146948944|NCT02141854|529970352|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146948945|NCT02141854|529970347|FG000|Treatment Period|Protocol Violation|0|||
146817563|NCT04454125|529500291|FG000|Overall Study|Lost to Follow-up|0|||
146817564|NCT04454125|529500292|FG001|Overall Study|Lost to Follow-up|1|||
146817565|NCT03360071|529500296|FG000|Overall Study|Lost to Follow-up|1|||
146817566|NCT03360071|529500297|FG001|Overall Study|Lost to Follow-up|0|||
146817567|NCT01193283|529500301|FG000|Overall Study|Death|1|||
146817568|NCT02256553|529500304|FG000|Period I|Adverse Event|5|||
146817569|NCT02256553|529500304|FG000|Period I|Protocol Violation|1|||
146817570|NCT02256553|529500304|FG000|Period II|Adverse Event|1|||
146817571|NCT02256553|529500304|FG000|Period II|Subject Moved|1|||
146817572|NCT02256553|529500304|FG000|Period III|Adverse Event|3|||
146817573|NCT01951105|529500305|FG000|Overall Study|Adverse Event|0|||
146817574|NCT01951105|529500306|FG001|Overall Study|Adverse Event|5|||
146817575|NCT01951105|529500307|FG002|Overall Study|Adverse Event|0|||
146817576|NCT01951105|529500305|FG000|Overall Study|Lost to Follow-up|0|||
146817577|NCT01951105|529500306|FG001|Overall Study|Lost to Follow-up|1|||
146817578|NCT01951105|529500307|FG002|Overall Study|Lost to Follow-up|0|||
146817579|NCT01951105|529500305|FG000|Overall Study|Protocol Violation|1|||
146817580|NCT01951105|529500306|FG001|Overall Study|Protocol Violation|1|||
146817581|NCT01951105|529500307|FG002|Overall Study|Protocol Violation|1|||
146817582|NCT01951105|529500305|FG000|Overall Study|Withdrawal by Subject|0|||
146817583|NCT01951105|529500306|FG001|Overall Study|Withdrawal by Subject|3|||
146817584|NCT01951105|529500307|FG002|Overall Study|Withdrawal by Subject|1|||
146817585|NCT02727998|529500308|FG000|Overall Study|Lost to Follow-up|3|||
146817586|NCT02727998|529500309|FG001|Overall Study|Lost to Follow-up|3|||
146817587|NCT02727998|529500308|FG000|Overall Study|Withdrawal by Subject|0|||
146817588|NCT02727998|529500309|FG001|Overall Study|Withdrawal by Subject|1|||
146817589|NCT05072795|529500310|FG000|Overall Study|Lost to Follow-up|5|||
146817590|NCT03651271|529500311|FG000|Overall Study|Death|4|||
146817591|NCT03651271|529500312|FG001|Overall Study|Death|37|||
146817592|NCT03651271|529500313|FG002|Overall Study|Death|0|||
146817593|NCT03651271|529500314|FG003|Overall Study|Death|2|||
146817594|NCT03651271|529500315|FG004|Overall Study|Death|6|||
146817595|NCT03651271|529500311|FG000|Overall Study|Lost to Follow-up|1|||
146817596|NCT03651271|529500312|FG001|Overall Study|Lost to Follow-up|5|||
146817597|NCT03651271|529500313|FG002|Overall Study|Lost to Follow-up|0|||
146817598|NCT03651271|529500314|FG003|Overall Study|Lost to Follow-up|1|||
146817599|NCT03651271|529500315|FG004|Overall Study|Lost to Follow-up|0|||
146817600|NCT03651271|529500311|FG000|Overall Study|Physician Decision|0|||
146817601|NCT03651271|529500312|FG001|Overall Study|Physician Decision|2|||
146817602|NCT03651271|529500313|FG002|Overall Study|Physician Decision|0|||
146817603|NCT03651271|529500314|FG003|Overall Study|Physician Decision|0|||
146817604|NCT03651271|529500315|FG004|Overall Study|Physician Decision|0|||
146817605|NCT03651271|529500311|FG000|Overall Study|Withdrawal by Subject|1|||
146817606|NCT03651271|529500312|FG001|Overall Study|Withdrawal by Subject|15|||
146817607|NCT03651271|529500313|FG002|Overall Study|Withdrawal by Subject|0|||
146817608|NCT03651271|529500314|FG003|Overall Study|Withdrawal by Subject|0|||
146817609|NCT03651271|529500315|FG004|Overall Study|Withdrawal by Subject|1|||
146817610|NCT03651271|529500311|FG000|Overall Study|Patient medically unable to continue|0|||
146817611|NCT03651271|529500312|FG001|Overall Study|Patient medically unable to continue|0|||
146817612|NCT03651271|529500313|FG002|Overall Study|Patient medically unable to continue|0|||
146817613|NCT03651271|529500314|FG003|Overall Study|Patient medically unable to continue|1|||
146817614|NCT03651271|529500315|FG004|Overall Study|Patient medically unable to continue|0|||
146817615|NCT00821093|529500316|FG000|Overall Study|Adverse Event|20|||
146817616|NCT00821093|529500317|FG001|Overall Study|Adverse Event|12|||
146817617|NCT00821093|529500316|FG000|Overall Study|Withdrawal by Subject|9|||
146817618|NCT00821093|529500317|FG001|Overall Study|Withdrawal by Subject|13|||
146817619|NCT00821093|529500316|FG000|Overall Study|Lost to Follow-up|9|||
146817620|NCT00821093|529500317|FG001|Overall Study|Lost to Follow-up|3|||
146817621|NCT00821093|529500316|FG000|Overall Study|Protocol deviation|3|||
146817622|NCT00821093|529500317|FG001|Overall Study|Protocol deviation|6|||
146817623|NCT00821093|529500316|FG000|Overall Study|Abnormal laboratory value(s)|2|||
146817624|NCT00821093|529500317|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146817625|NCT00821093|529500316|FG000|Overall Study|Lack of Efficacy|2|||
146817626|NCT00821093|529500317|FG001|Overall Study|Lack of Efficacy|2|||
146817627|NCT00821093|529500316|FG000|Overall Study|Death|2|||
146817628|NCT00821093|529500317|FG001|Overall Study|Death|1|||
146817629|NCT00821093|529500316|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146817630|NCT00821093|529500317|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146817631|NCT00821093|529500316|FG000|Overall Study|Administrative problems|1|||
146817632|NCT00821093|529500317|FG001|Overall Study|Administrative problems|2|||
146817633|NCT01601821|529500320|FG000|Overall Study|Death|2|||
146817634|NCT01601821|529500321|FG001|Overall Study|Death|5|||
146817635|NCT01601821|529500320|FG000|Overall Study|Protocol Violation|2|||
146817636|NCT01601821|529500321|FG001|Overall Study|Protocol Violation|2|||
146817637|NCT01601821|529500320|FG000|Overall Study|Lost to Follow-up|6|||
146817638|NCT01601821|529500321|FG001|Overall Study|Lost to Follow-up|14|||
146817639|NCT01601821|529500320|FG000|Overall Study|Withdrawal by Subject|1|||
146817640|NCT01601821|529500321|FG001|Overall Study|Withdrawal by Subject|0|||
146817641|NCT01601821|529500320|FG000|Overall Study|Graft Loss|6|||
146948946|NCT02141854|529970348|FG001|Treatment Period|Protocol Violation|1|||
146948947|NCT02141854|529970349|FG002|Treatment Period|Protocol Violation|0|||
146948948|NCT02141854|529970350|FG003|Treatment Period|Protocol Violation|2|||
146948949|NCT02141854|529970351|FG004|Treatment Period|Protocol Violation|2|||
146948950|NCT02141854|529970352|FG005|Treatment Period|Protocol Violation|1|||
146948951|NCT02141854|529970347|FG000|Treatment Period|Noncompliance|0|||
146948952|NCT02141854|529970348|FG001|Treatment Period|Noncompliance|0|||
146948953|NCT02141854|529970349|FG002|Treatment Period|Noncompliance|0|||
146948954|NCT02141854|529970350|FG003|Treatment Period|Noncompliance|1|||
146948955|NCT02141854|529970351|FG004|Treatment Period|Noncompliance|0|||
146948956|NCT02141854|529970352|FG005|Treatment Period|Noncompliance|0|||
146948957|NCT02141854|529970347|FG000|Treatment Period|Lack of Efficacy|0|||
146948958|NCT02141854|529970348|FG001|Treatment Period|Lack of Efficacy|0|||
146948959|NCT02141854|529970349|FG002|Treatment Period|Lack of Efficacy|0|||
146948960|NCT02141854|529970350|FG003|Treatment Period|Lack of Efficacy|1|||
146948961|NCT02141854|529970351|FG004|Treatment Period|Lack of Efficacy|1|||
146948962|NCT02141854|529970352|FG005|Treatment Period|Lack of Efficacy|7|||
146948963|NCT02141854|529970347|FG000|Treatment Period|Pregnancy|0|||
146948964|NCT02141854|529970348|FG001|Treatment Period|Pregnancy|1|||
146948965|NCT02141854|529970349|FG002|Treatment Period|Pregnancy|0|||
146948966|NCT02141854|529970350|FG003|Treatment Period|Pregnancy|0|||
146948967|NCT02141854|529970351|FG004|Treatment Period|Pregnancy|0|||
146948968|NCT02141854|529970352|FG005|Treatment Period|Pregnancy|0|||
146948969|NCT02141854|529970347|FG000|Treatment Period|Other|0|||
146948970|NCT02141854|529970348|FG001|Treatment Period|Other|1|||
146948971|NCT02141854|529970349|FG002|Treatment Period|Other|2|||
146948972|NCT02141854|529970350|FG003|Treatment Period|Other|0|||
146948973|NCT02141854|529970351|FG004|Treatment Period|Other|1|||
146948974|NCT02141854|529970352|FG005|Treatment Period|Other|2|||
146948975|NCT02141854|529970347|FG000|Treatment Period|Adverse Event|0|||
146948976|NCT02141854|529970348|FG001|Treatment Period|Adverse Event|2|||
146948977|NCT02141854|529970349|FG002|Treatment Period|Adverse Event|2|||
146948978|NCT02141854|529970350|FG003|Treatment Period|Adverse Event|0|||
146948979|NCT02141854|529970351|FG004|Treatment Period|Adverse Event|2|||
146948980|NCT02141854|529970352|FG005|Treatment Period|Adverse Event|2|||
146948981|NCT02141854|529970347|FG000|Treatment Period|Withdrawal by Subject|0|||
146948982|NCT02141854|529970348|FG001|Treatment Period|Withdrawal by Subject|2|||
146948983|NCT02141854|529970349|FG002|Treatment Period|Withdrawal by Subject|3|||
146948984|NCT02141854|529970350|FG003|Treatment Period|Withdrawal by Subject|3|||
146948985|NCT02141854|529970351|FG004|Treatment Period|Withdrawal by Subject|4|||
146948986|NCT02141854|529970352|FG005|Treatment Period|Withdrawal by Subject|7|||
146948987|NCT02141854|529970347|FG000|Treatment Period|Disease progression|0|||
146948988|NCT02141854|529970348|FG001|Treatment Period|Disease progression|2|||
146948989|NCT02141854|529970349|FG002|Treatment Period|Disease progression|1|||
146948990|NCT02141854|529970350|FG003|Treatment Period|Disease progression|3|||
146948991|NCT02141854|529970351|FG004|Treatment Period|Disease progression|0|||
146948992|NCT02141854|529970352|FG005|Treatment Period|Disease progression|18|||
146948993|NCT02141854|529970347|FG000|Treatment Period|Lost to Follow-up|0|||
146948994|NCT02141854|529970348|FG001|Treatment Period|Lost to Follow-up|1|||
146948995|NCT02141854|529970349|FG002|Treatment Period|Lost to Follow-up|1|||
146948996|NCT02141854|529970350|FG003|Treatment Period|Lost to Follow-up|1|||
146948997|NCT02141854|529970351|FG004|Treatment Period|Lost to Follow-up|0|||
146948998|NCT02141854|529970352|FG005|Treatment Period|Lost to Follow-up|1|||
146948999|NCT01868594|529970353|FG000|Overall Study|Do not meet inclusion criteria|4|||
146949000|NCT01868594|529970354|FG001|Overall Study|Do not meet inclusion criteria|3|||
146949001|NCT02116361|529970359|FG000|Overall Study|Pregnancy|0|||
146949002|NCT02116361|529970360|FG001|Overall Study|Pregnancy|0|||
146949003|NCT02116361|529970361|FG002|Overall Study|Pregnancy|0|||
146949004|NCT02116361|529970362|FG003|Overall Study|Pregnancy|1|||
146949005|NCT02116361|529970359|FG000|Overall Study|Protocol Violation|1|||
146949006|NCT02116361|529970360|FG001|Overall Study|Protocol Violation|0|||
146949007|NCT02116361|529970361|FG002|Overall Study|Protocol Violation|0|||
146949008|NCT02116361|529970362|FG003|Overall Study|Protocol Violation|2|||
146949009|NCT02116361|529970359|FG000|Overall Study|Physician Decision|2|||
146949010|NCT02116361|529970360|FG001|Overall Study|Physician Decision|3|||
146949011|NCT02116361|529970361|FG002|Overall Study|Physician Decision|0|||
146949012|NCT02116361|529970362|FG003|Overall Study|Physician Decision|0|||
146949013|NCT02116361|529970359|FG000|Overall Study|Adverse Event|1|||
146949014|NCT02116361|529970360|FG001|Overall Study|Adverse Event|0|||
146949015|NCT02116361|529970361|FG002|Overall Study|Adverse Event|0|||
146949016|NCT02116361|529970362|FG003|Overall Study|Adverse Event|3|||
146949017|NCT02116361|529970359|FG000|Overall Study|Other Reasons|3|||
146949018|NCT02116361|529970360|FG001|Overall Study|Other Reasons|3|||
146949019|NCT02116361|529970361|FG002|Overall Study|Other Reasons|3|||
146949020|NCT02116361|529970362|FG003|Overall Study|Other Reasons|3|||
146949021|NCT02116361|529970359|FG000|Overall Study|Lack of Efficacy|5|||
146949022|NCT02116361|529970360|FG001|Overall Study|Lack of Efficacy|7|||
146949023|NCT02116361|529970361|FG002|Overall Study|Lack of Efficacy|4|||
146949024|NCT02116361|529970362|FG003|Overall Study|Lack of Efficacy|3|||
146949025|NCT02116361|529970359|FG000|Overall Study|Lost to Follow-up|4|||
146817642|NCT01601821|529500321|FG001|Overall Study|Graft Loss|6|||
146817643|NCT01601821|529500320|FG000|Overall Study|Study Events|7|||
146817644|NCT01601821|529500321|FG001|Overall Study|Study Events|1|||
146817645|NCT01601821|529500320|FG000|Overall Study|Other|5|||
146817646|NCT01601821|529500321|FG001|Overall Study|Other|1|||
146817647|NCT01901302|529500325|FG000|Overall Study|Adverse Event|2|||
146817648|NCT01901302|529500326|FG001|Overall Study|Adverse Event|1|||
146817649|NCT01901302|529500325|FG000|Overall Study|Lack of Efficacy|0|||
146817650|NCT01901302|529500326|FG001|Overall Study|Lack of Efficacy|2|||
146817651|NCT01901302|529500325|FG000|Overall Study|Study Terminated by Sponsor|23|||
146817652|NCT01901302|529500326|FG001|Overall Study|Study Terminated by Sponsor|20|||
146817653|NCT01901302|529500325|FG000|Overall Study|Withdrawal by Subject|2|||
146817654|NCT01901302|529500326|FG001|Overall Study|Withdrawal by Subject|0|||
146817655|NCT02812706|529500331|FG000|Phase 1|Adverse Event|0|||
146817656|NCT02812706|529500332|FG001|Phase 1|Adverse Event|2|||
146817657|NCT02812706|529500333|FG002|Phase 1|Adverse Event|0|||
146817658|NCT02812706|529500331|FG000|Phase 1|Progressive disease|3|||
146817659|NCT02812706|529500332|FG001|Phase 1|Progressive disease|3|||
146817660|NCT02812706|529500333|FG002|Phase 1|Progressive disease|0|||
146817661|NCT02812706|529500331|FG000|Phase 2|Adverse Event|0|||
146817662|NCT02812706|529500332|FG001|Phase 2|Adverse Event|0|||
146817663|NCT02812706|529500333|FG002|Phase 2|Adverse Event|2|||
146817664|NCT02812706|529500331|FG000|Phase 2|Progressive disease|0|||
146817665|NCT02812706|529500332|FG001|Phase 2|Progressive disease|0|||
146817666|NCT02812706|529500333|FG002|Phase 2|Progressive disease|22|||
146817667|NCT02812706|529500331|FG000|Phase 2|Other-Unspecified|0|||
146817668|NCT02812706|529500332|FG001|Phase 2|Other-Unspecified|0|||
146817669|NCT02812706|529500333|FG002|Phase 2|Other-Unspecified|4|||
146817670|NCT00910871|529500339|FG000|Overall Study|Adverse Event|5|||
146817671|NCT00910871|529500339|FG000|Overall Study|Death|12|||
146817672|NCT00910871|529500339|FG000|Overall Study|Lost to Follow-up|8|||
146817673|NCT00910871|529500339|FG000|Overall Study|Protocol Violation|11|||
146817674|NCT00910871|529500339|FG000|Overall Study|Withdrawal by Subject|12|||
146817675|NCT00910871|529500339|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
146817676|NCT00910871|529500339|FG000|Overall Study|Undefined|1|||
146817677|NCT04529941|529500343|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
146817678|NCT04529941|529500344|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
146817679|NCT01005914|529500345|FG000|Overall Study|Adverse Event|4|||
146817680|NCT01005914|529500345|FG000|Overall Study|Death|4|||
146817681|NCT01005914|529500345|FG000|Overall Study|Lack of Efficacy|1|||
146817682|NCT01005914|529500345|FG000|Overall Study|Withdrawal by Subject|1|||
146817683|NCT01240785|529500346|FG000|Overall Study|Lost to Follow-up|1|||
146817684|NCT01240785|529500347|FG001|Overall Study|Lost to Follow-up|0|||
146817685|NCT01240785|529500346|FG000|Overall Study|Protocol Violation|0|||
146817686|NCT01240785|529500347|FG001|Overall Study|Protocol Violation|3|||
146817687|NCT01755598|529500349|FG000|Overall Study|Other|109|||
146817688|NCT01755598|529500350|FG001|Overall Study|Other|109|||
146817689|NCT01755598|529500349|FG000|Overall Study|Lost to Follow-up|32|||
146817690|NCT01755598|529500350|FG001|Overall Study|Lost to Follow-up|43|||
146817691|NCT01755598|529500349|FG000|Overall Study|Migrated/moved from study area|76|||
146817692|NCT01755598|529500350|FG001|Overall Study|Migrated/moved from study area|65|||
146817693|NCT01755598|529500349|FG000|Overall Study|Withdrawal by Subject|22|||
146817694|NCT01755598|529500350|FG001|Overall Study|Withdrawal by Subject|31|||
146817695|NCT01755598|529500349|FG000|Overall Study|Protocol Violation|7|||
146817696|NCT01755598|529500350|FG001|Overall Study|Protocol Violation|7|||
146817697|NCT01755598|529500349|FG000|Overall Study|Adverse Event|19|||
146817698|NCT01755598|529500350|FG001|Overall Study|Adverse Event|28|||
146817699|NCT04016415|529500351|FG000|Overall Study|Adverse Event|2|||
146817700|NCT04016415|529500352|FG001|Overall Study|Adverse Event|1|||
146817701|NCT04016415|529500351|FG000|Overall Study|Lost to Follow-up|6|||
146817702|NCT04016415|529500352|FG001|Overall Study|Lost to Follow-up|2|||
146949026|NCT02116361|529970360|FG001|Overall Study|Lost to Follow-up|5|||
146949027|NCT02116361|529970361|FG002|Overall Study|Lost to Follow-up|7|||
146949028|NCT02116361|529970362|FG003|Overall Study|Lost to Follow-up|5|||
146817703|NCT04016415|529500351|FG000|Overall Study|Physician Decision|5|||
146817704|NCT04016415|529500352|FG001|Overall Study|Physician Decision|1|||
146949029|NCT02116361|529970359|FG000|Overall Study|Personal Reasons|6|||
146949030|NCT02116361|529970360|FG001|Overall Study|Personal Reasons|6|||
146949031|NCT02116361|529970361|FG002|Overall Study|Personal Reasons|4|||
146817705|NCT04016415|529500351|FG000|Overall Study|Pregnancy|0|||
146817706|NCT04016415|529500352|FG001|Overall Study|Pregnancy|1|||
146817707|NCT04016415|529500351|FG000|Overall Study|Withdrawal by Subject|24|||
146817708|NCT04016415|529500352|FG001|Overall Study|Withdrawal by Subject|27|||
146817709|NCT04016415|529500351|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
146817710|NCT04016415|529500352|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
146817711|NCT02260154|529500363|FG000|Overall Study|Screening failure|2|||
146817712|NCT03547167|529500364|FG000|Overall Study|Withdrawal by Subject|34|||
146817713|NCT03547167|529500365|FG001|Overall Study|Withdrawal by Subject|12|||
146817714|NCT03547167|529500364|FG000|Overall Study|Screen Failure|0|||
146817715|NCT03547167|529500365|FG001|Overall Study|Screen Failure|1|||
146817716|NCT03547167|529500364|FG000|Overall Study|Lost to Follow-up|59|||
146817717|NCT03547167|529500365|FG001|Overall Study|Lost to Follow-up|15|||
146817718|NCT03547167|529500364|FG000|Overall Study|Death|4|||
146817719|NCT03547167|529500365|FG001|Overall Study|Death|2|||
146817720|NCT00736502|529500366|FG000|Overall Study|Adverse Event|22|||
146817721|NCT00736502|529500366|FG000|Overall Study|Lack of Efficacy|16|||
146817722|NCT00736502|529500366|FG000|Overall Study|Lost to Follow-up|27|||
146817723|NCT00645411|529500367|FG000|Overall Study|Adverse Event|0|||
146817724|NCT00645411|529500368|FG001|Overall Study|Adverse Event|0|||
146817725|NCT00645411|529500369|FG002|Overall Study|Adverse Event|0|||
146817726|NCT00645411|529500370|FG003|Overall Study|Adverse Event|2|||
146817727|NCT00645411|529500367|FG000|Overall Study|Withdrawal by Subject|2|||
146817728|NCT00645411|529500368|FG001|Overall Study|Withdrawal by Subject|1|||
146817729|NCT00645411|529500369|FG002|Overall Study|Withdrawal by Subject|19|||
146817730|NCT00645411|529500370|FG003|Overall Study|Withdrawal by Subject|21|||
146817731|NCT00645411|529500367|FG000|Overall Study|Lost to Follow-up|10|||
146817732|NCT00645411|529500368|FG001|Overall Study|Lost to Follow-up|5|||
146817733|NCT00645411|529500369|FG002|Overall Study|Lost to Follow-up|124|||
146817734|NCT00645411|529500370|FG003|Overall Study|Lost to Follow-up|75|||
146817735|NCT00645411|529500367|FG000|Overall Study|Protocol Violation|1|||
146817736|NCT00645411|529500368|FG001|Overall Study|Protocol Violation|0|||
146817737|NCT00645411|529500369|FG002|Overall Study|Protocol Violation|1|||
146817738|NCT00645411|529500370|FG003|Overall Study|Protocol Violation|0|||
146817739|NCT00645411|529500367|FG000|Overall Study|Inappropriate enrollment|0|||
146817740|NCT00645411|529500368|FG001|Overall Study|Inappropriate enrollment|0|||
146817741|NCT00645411|529500369|FG002|Overall Study|Inappropriate enrollment|4|||
146817742|NCT00645411|529500370|FG003|Overall Study|Inappropriate enrollment|1|||
146817743|NCT00645411|529500367|FG000|Overall Study|Unable to classify|0|||
146817744|NCT00645411|529500368|FG001|Overall Study|Unable to classify|0|||
146817745|NCT00645411|529500369|FG002|Overall Study|Unable to classify|3|||
146817746|NCT00645411|529500370|FG003|Overall Study|Unable to classify|4|||
146817747|NCT01307800|529500371|FG000|Overall Study|Adverse Event|9|||
146817748|NCT01307800|529500372|FG001|Overall Study|Adverse Event|8|||
146817749|NCT01307800|529500373|FG002|Overall Study|Adverse Event|10|||
146817750|NCT01307800|529500374|FG003|Overall Study|Adverse Event|14|||
146817751|NCT01307800|529500371|FG000|Overall Study|Entry Criteria Not Met|0|||
146817752|NCT01307800|529500372|FG001|Overall Study|Entry Criteria Not Met|0|||
146817753|NCT01307800|529500373|FG002|Overall Study|Entry Criteria Not Met|0|||
146817754|NCT01307800|529500374|FG003|Overall Study|Entry Criteria Not Met|2|||
146817755|NCT01307800|529500371|FG000|Overall Study|Lost to Follow-up|5|||
146817756|NCT01307800|529500372|FG001|Overall Study|Lost to Follow-up|6|||
146817757|NCT01307800|529500373|FG002|Overall Study|Lost to Follow-up|2|||
146817758|NCT01307800|529500374|FG003|Overall Study|Lost to Follow-up|8|||
146817759|NCT01307800|529500371|FG000|Overall Study|Perceived Lack of Efficacy|24|||
146817760|NCT01307800|529500372|FG001|Overall Study|Perceived Lack of Efficacy|23|||
146817761|NCT01307800|529500373|FG002|Overall Study|Perceived Lack of Efficacy|20|||
146817762|NCT01307800|529500374|FG003|Overall Study|Perceived Lack of Efficacy|33|||
146817763|NCT01307800|529500371|FG000|Overall Study|Protocol Violation|0|||
146817764|NCT01307800|529500372|FG001|Overall Study|Protocol Violation|3|||
146817765|NCT01307800|529500373|FG002|Overall Study|Protocol Violation|4|||
146817766|NCT01307800|529500374|FG003|Overall Study|Protocol Violation|5|||
146817767|NCT01307800|529500371|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
146817768|NCT01307800|529500372|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
146817769|NCT01307800|529500373|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
146817770|NCT01307800|529500374|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
146817771|NCT01307800|529500371|FG000|Overall Study|Sponsor Decision|6|||
146817772|NCT01307800|529500372|FG001|Overall Study|Sponsor Decision|9|||
146817773|NCT01307800|529500373|FG002|Overall Study|Sponsor Decision|12|||
146817774|NCT01307800|529500374|FG003|Overall Study|Sponsor Decision|28|||
146817775|NCT01307800|529500371|FG000|Overall Study|Withdrawal by Subject|10|||
146817776|NCT01307800|529500372|FG001|Overall Study|Withdrawal by Subject|11|||
146817777|NCT01307800|529500373|FG002|Overall Study|Withdrawal by Subject|8|||
146817778|NCT01307800|529500374|FG003|Overall Study|Withdrawal by Subject|15|||
146817779|NCT01307800|529500371|FG000|Overall Study|Participant Moved|0|||
146817780|NCT01307800|529500372|FG001|Overall Study|Participant Moved|2|||
146817781|NCT01307800|529500373|FG002|Overall Study|Participant Moved|1|||
146817782|NCT01307800|529500374|FG003|Overall Study|Participant Moved|3|||
146817783|NCT02674399|529500375|FG000|Overall Study|Lost to Follow-up|2|||
146817784|NCT02674399|529500376|FG001|Overall Study|Lost to Follow-up|0|||
146817785|NCT02255474|529500377|FG000|Overall Study|Lost to Follow-up|1|||
146817786|NCT02255474|529500378|FG001|Overall Study|Lost to Follow-up|1|||
146817787|NCT02255474|529500379|FG002|Overall Study|Lost to Follow-up|3|||
146817788|NCT02255474|529500377|FG000|Overall Study|Withdrawal by Subject|1|||
146817789|NCT02255474|529500378|FG001|Overall Study|Withdrawal by Subject|1|||
146817790|NCT02255474|529500379|FG002|Overall Study|Withdrawal by Subject|0|||
146817791|NCT04520256|529500385|FG000|Overall Study|Lost to Follow-up|6|||
146817792|NCT04520256|529500386|FG001|Overall Study|Lost to Follow-up|4|||
146817793|NCT04520256|529500387|FG002|Overall Study|Lost to Follow-up|2|||
146817794|NCT04520256|529500388|FG003|Overall Study|Lost to Follow-up|3|||
146949032|NCT02116361|529970362|FG003|Overall Study|Personal Reasons|9|||
146949033|NCT02116361|529970359|FG000|Overall Study|Investigator Decision - Relapse|9|||
146949034|NCT02116361|529970360|FG001|Overall Study|Investigator Decision - Relapse|7|||
146949035|NCT02116361|529970361|FG002|Overall Study|Investigator Decision - Relapse|8|||
146949036|NCT02116361|529970362|FG003|Overall Study|Investigator Decision - Relapse|5|||
146949037|NCT02659098|529970363|FG000|Overall Study|Withdrawal by Subject|7|||
146949038|NCT04363944|529970364|FG000|Overall Study|Withdrawal by Subject|2|||
146949039|NCT04363944|529970365|FG001|Overall Study|Withdrawal by Subject|0|||
146949040|NCT03517722|529970366|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
146949041|NCT03517722|529970367|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
146949042|NCT03517722|529970366|FG000|Double Blind Period: Week 0-52|Death|0|||
146949043|NCT03517722|529970367|FG001|Double Blind Period: Week 0-52|Death|4|||
146949044|NCT03517722|529970366|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
146949045|NCT03517722|529970367|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
146949046|NCT03517722|529970366|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
146949047|NCT03517722|529970367|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
146949048|NCT03517722|529970366|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
146949049|NCT03517722|529970367|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
146949050|NCT03517722|529970366|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
146949051|NCT03517722|529970367|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
146949052|NCT03517722|529970366|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
146949053|NCT03517722|529970367|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
146949054|NCT03517722|529970366|FG000|Double Blind Period: Week 0-52|Other|4|||
146949055|NCT03517722|529970367|FG001|Double Blind Period: Week 0-52|Other|3|||
146949056|NCT03517722|529970366|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
146949057|NCT03517722|529970367|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
146949058|NCT03517722|529970366|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
146949059|NCT03517722|529970367|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
146949060|NCT03517722|529970366|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
146949061|NCT03517722|529970367|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
146949062|NCT03517722|529970366|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
146949063|NCT03517722|529970367|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
146949064|NCT03517722|529970366|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
146949065|NCT03517722|529970367|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
146949066|NCT00952419|529970368|FG000|Overall Study|Adverse Event|2|||
146949067|NCT00952419|529970369|FG001|Overall Study|Adverse Event|0|||
146949068|NCT00952419|529970370|FG002|Overall Study|Adverse Event|0|||
146949069|NCT00952419|529970368|FG000|Overall Study|Protocol Violation|3|||
146949070|NCT00952419|529970369|FG001|Overall Study|Protocol Violation|7|||
146949071|NCT00952419|529970370|FG002|Overall Study|Protocol Violation|0|||
146949072|NCT00952419|529970368|FG000|Overall Study|Withdrawal by Subject|1|||
146949073|NCT00952419|529970369|FG001|Overall Study|Withdrawal by Subject|3|||
146949074|NCT00952419|529970370|FG002|Overall Study|Withdrawal by Subject|0|||
146949075|NCT03573804|529970374|FG000|Overall Study|claustrophobia or MRI table problems|10|||
146949076|NCT03128307|529970375|FG000|Overall Study|Lost to Follow-up|29|||
146949077|NCT03128307|529970375|FG000|Overall Study|Withdrawal by Subject|5|||
146949078|NCT01592773|529971997|FG000|Overall Study|Study Terminated by Sponsor|582|||
146949079|NCT01592773|529971997|FG000|Overall Study|Withdrawal by Subject|35|||
146949080|NCT01592773|529971997|FG000|Overall Study|Lost to Follow-up|19|||
146949081|NCT01592773|529971997|FG000|Overall Study|Adverse Event|17|||
146949082|NCT01592773|529971997|FG000|Overall Study|Lack of Efficacy|9|||
146949083|NCT01592773|529971997|FG000|Overall Study|Protocol Violation|2|||
146949084|NCT01592773|529971997|FG000|Overall Study|Inclusion/exclusion not meet|1|||
146949085|NCT01592773|529971997|FG000|Overall Study|Other Reason|1|||
146949086|NCT04418427|529971998|FG000|Overall Study|Death|0|||
146949087|NCT04418427|529971999|FG001|Overall Study|Death|1|||
146949088|NCT04418427|529972000|FG002|Overall Study|Death|0|||
146949089|NCT04418427|529971998|FG000|Overall Study|Lost to Follow-up|0|||
146949090|NCT04418427|529971999|FG001|Overall Study|Lost to Follow-up|2|||
146949091|NCT04418427|529972000|FG002|Overall Study|Lost to Follow-up|2|||
146949092|NCT04418427|529971998|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
146949093|NCT04418427|529971999|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
146949094|NCT04418427|529972000|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
146817795|NCT04520256|529500389|FG004|Overall Study|Lost to Follow-up|6|||
146949095|NCT04418427|529971998|FG000|Overall Study|Pre-existing medical condition|0|||
146817796|NCT04520256|529500390|FG005|Overall Study|Lost to Follow-up|6|||
146817797|NCT04520256|529500391|FG006|Overall Study|Lost to Follow-up|4|||
146817798|NCT04520256|529500392|FG007|Overall Study|Lost to Follow-up|6|||
146949096|NCT04418427|529971999|FG001|Overall Study|Pre-existing medical condition|1|||
146949097|NCT04418427|529972000|FG002|Overall Study|Pre-existing medical condition|0|||
146949098|NCT01293123|529972001|FG000|Overall Study|Lost to Follow-up|0|||
146949099|NCT01293123|529972002|FG001|Overall Study|Lost to Follow-up|1|||
146984737|NCT03264066|530105155|FG003|Overall Study|Lost to Follow-up|0|||
146817799|NCT04520256|529500393|FG008|Overall Study|Lost to Follow-up|1|||
146817800|NCT04520256|529500394|FG009|Overall Study|Lost to Follow-up|3|||
146817801|NCT04520256|529500395|FG010|Overall Study|Lost to Follow-up|3|||
146817802|NCT04520256|529500396|FG011|Overall Study|Lost to Follow-up|2|||
146817803|NCT04520256|529500397|FG012|Overall Study|Lost to Follow-up|5|||
146817804|NCT04520256|529500398|FG013|Overall Study|Lost to Follow-up|3|||
146817805|NCT04520256|529500399|FG014|Overall Study|Lost to Follow-up|3|||
146817806|NCT04520256|529500400|FG015|Overall Study|Lost to Follow-up|6|||
146817807|NCT04520256|529500401|FG016|Overall Study|Lost to Follow-up|6|||
146817808|NCT04520256|529500402|FG017|Overall Study|Lost to Follow-up|4|||
146817809|NCT04520256|529500403|FG018|Overall Study|Lost to Follow-up|3|||
146817810|NCT04520256|529500404|FG019|Overall Study|Lost to Follow-up|3|||
146817811|NCT04520256|529500405|FG020|Overall Study|Lost to Follow-up|7|||
146817812|NCT04520256|529500406|FG021|Overall Study|Lost to Follow-up|3|||
146817813|NCT04520256|529500407|FG022|Overall Study|Lost to Follow-up|3|||
146817814|NCT04520256|529500408|FG023|Overall Study|Lost to Follow-up|8|||
146817815|NCT04520256|529500409|FG024|Overall Study|Lost to Follow-up|5|||
146817816|NCT04520256|529500410|FG025|Overall Study|Lost to Follow-up|4|||
146817817|NCT04520256|529500411|FG026|Overall Study|Lost to Follow-up|3|||
146817818|NCT04520256|529500412|FG027|Overall Study|Lost to Follow-up|4|||
146817819|NCT04520256|529500413|FG028|Overall Study|Lost to Follow-up|3|||
146817820|NCT04520256|529500414|FG029|Overall Study|Lost to Follow-up|4|||
146817821|NCT04520256|529500415|FG030|Overall Study|Lost to Follow-up|4|||
146817822|NCT04520256|529500416|FG031|Overall Study|Lost to Follow-up|4|||
146817823|NCT01730118|529501382|FG000|Dose Escalation|Death on study|5|||
146817824|NCT01730118|529501383|FG001|Dose Escalation|Death on study|7|||
146817825|NCT01730118|529501384|FG002|Dose Escalation|Death on study|2|||
146817826|NCT01730118|529501385|FG003|Dose Escalation|Death on study|6|||
146817827|NCT01730118|529501386|FG004|Dose Escalation|Death on study|0|||
146817828|NCT01730118|529501387|FG005|Dose Escalation|Death on study|0|||
146817829|NCT01730118|529501388|FG006|Dose Escalation|Death on study|0|||
146817830|NCT01730118|529501382|FG000|Dose Escalation|Died before treatment|0|||
146817831|NCT01730118|529501383|FG001|Dose Escalation|Died before treatment|0|||
146817832|NCT01730118|529501384|FG002|Dose Escalation|Died before treatment|0|||
146817833|NCT01730118|529501385|FG003|Dose Escalation|Died before treatment|0|||
146817834|NCT01730118|529501386|FG004|Dose Escalation|Died before treatment|0|||
146817835|NCT01730118|529501387|FG005|Dose Escalation|Died before treatment|0|||
146817836|NCT01730118|529501388|FG006|Dose Escalation|Died before treatment|1|||
146817837|NCT01730118|529501382|FG000|Dose Escalation|Chose to start a different treatment|1|||
146817838|NCT01730118|529501383|FG001|Dose Escalation|Chose to start a different treatment|0|||
146817839|NCT01730118|529501384|FG002|Dose Escalation|Chose to start a different treatment|0|||
146817840|NCT01730118|529501385|FG003|Dose Escalation|Chose to start a different treatment|0|||
146817841|NCT01730118|529501386|FG004|Dose Escalation|Chose to start a different treatment|0|||
146817842|NCT01730118|529501387|FG005|Dose Escalation|Chose to start a different treatment|0|||
146817843|NCT01730118|529501388|FG006|Dose Escalation|Chose to start a different treatment|0|||
146817844|NCT01730118|529501382|FG000|Dose Escalation|Withdrawal by Subject|0|||
146817845|NCT01730118|529501383|FG001|Dose Escalation|Withdrawal by Subject|0|||
146817846|NCT01730118|529501384|FG002|Dose Escalation|Withdrawal by Subject|1|||
146817847|NCT01730118|529501385|FG003|Dose Escalation|Withdrawal by Subject|0|||
146817848|NCT01730118|529501386|FG004|Dose Escalation|Withdrawal by Subject|0|||
146817849|NCT01730118|529501387|FG005|Dose Escalation|Withdrawal by Subject|0|||
146817850|NCT01730118|529501388|FG006|Dose Escalation|Withdrawal by Subject|0|||
146817851|NCT01730118|529501382|FG000|Dose Escalation|Disease progression prior to treatment|0|||
146817852|NCT01730118|529501383|FG001|Dose Escalation|Disease progression prior to treatment|0|||
146817853|NCT01730118|529501384|FG002|Dose Escalation|Disease progression prior to treatment|0|||
146817854|NCT01730118|529501385|FG003|Dose Escalation|Disease progression prior to treatment|0|||
146817855|NCT01730118|529501386|FG004|Dose Escalation|Disease progression prior to treatment|0|||
146817856|NCT01730118|529501387|FG005|Dose Escalation|Disease progression prior to treatment|0|||
146817857|NCT01730118|529501388|FG006|Dose Escalation|Disease progression prior to treatment|1|||
146817858|NCT01730118|529501382|FG000|Dose Expansion|Death|0|||
146817859|NCT01730118|529501383|FG001|Dose Expansion|Death|0|||
146817860|NCT01730118|529501384|FG002|Dose Expansion|Death|0|||
146984738|NCT03264066|530105156|FG004|Overall Study|Lost to Follow-up|0|||
146817861|NCT01730118|529501385|FG003|Dose Expansion|Death|0|||
146817862|NCT01730118|529501386|FG004|Dose Expansion|Death|1|||
146817863|NCT01730118|529501387|FG005|Dose Expansion|Death|0|||
146817864|NCT01730118|529501388|FG006|Dose Expansion|Death|0|||
146817865|NCT01730118|529501382|FG000|Dose Expansion|Other medical condition|0|||
146817866|NCT01730118|529501383|FG001|Dose Expansion|Other medical condition|0|||
146817867|NCT01730118|529501384|FG002|Dose Expansion|Other medical condition|0|||
146817868|NCT01730118|529501385|FG003|Dose Expansion|Other medical condition|0|||
146817869|NCT01730118|529501386|FG004|Dose Expansion|Other medical condition|1|||
146817870|NCT01730118|529501387|FG005|Dose Expansion|Other medical condition|0|||
146817871|NCT01730118|529501388|FG006|Dose Expansion|Other medical condition|0|||
146817872|NCT01730118|529501382|FG000|Dose Expansion|Withdrawal by Subject|0|||
146817873|NCT01730118|529501383|FG001|Dose Expansion|Withdrawal by Subject|0|||
146984739|NCT03264066|530105157|FG005|Overall Study|Lost to Follow-up|0|||
146949100|NCT01888965|529972007|FG000|Overall Study|Adverse Event|5|||
146949101|NCT01888965|529972007|FG000|Overall Study|Lack of Efficacy|4|||
146949102|NCT04076579|529972008|FG000|Overall Study|Adverse Event|2|||
146949103|NCT04076579|529972009|FG001|Overall Study|Adverse Event|0|||
146949104|NCT04076579|529972008|FG000|Overall Study|discontinued due to toxicity|1|||
146949105|NCT04076579|529972009|FG001|Overall Study|discontinued due to toxicity|0|||
146949106|NCT04076579|529972008|FG000|Overall Study|Physician Decision|1|||
146949107|NCT04076579|529972009|FG001|Overall Study|Physician Decision|0|||
146949108|NCT04076579|529972008|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
146949109|NCT04076579|529972009|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
146949110|NCT04076579|529972008|FG000|Overall Study|Noncompliance|0|||
146949111|NCT04076579|529972009|FG001|Overall Study|Noncompliance|1|||
146949112|NCT04076579|529972008|FG000|Overall Study|Withdrawal by Subject|0|||
146949113|NCT04076579|529972009|FG001|Overall Study|Withdrawal by Subject|2|||
146949114|NCT03793010|529972010|FG000|Overall Study|Withdrawal by Subject|5|||
146949115|NCT03793010|529972011|FG001|Overall Study|Withdrawal by Subject|7|||
146949116|NCT03793010|529972010|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
146949117|NCT03793010|529972011|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
146949118|NCT03793010|529972010|FG000|Overall Study|Lost to Follow-up|1|||
146949119|NCT03793010|529972011|FG001|Overall Study|Lost to Follow-up|2|||
146949120|NCT03793010|529972010|FG000|Overall Study|Patient couldn't sit still for injection|1|||
146949121|NCT03793010|529972011|FG001|Overall Study|Patient couldn't sit still for injection|0|||
146949122|NCT03793010|529972010|FG000|Overall Study|Withdrew to pursue other treatment|1|||
146949123|NCT03793010|529972011|FG001|Overall Study|Withdrew to pursue other treatment|0|||
146949124|NCT03793010|529972010|FG000|Overall Study|Did not meet eligibility criteria|1|||
146949125|NCT03793010|529972011|FG001|Overall Study|Did not meet eligibility criteria|0|||
146949126|NCT00417248|529972015|FG000|Overall Study|Study Terminated|6|||
146949127|NCT00417248|529972015|FG000|Overall Study|Death|1|||
146949128|NCT00417248|529972015|FG000|Overall Study|Lack of Efficacy|1|||
146949129|NCT01569568|529972016|FG000|Overall Study|Physician Decision|0|||
146949130|NCT01569568|529972017|FG001|Overall Study|Physician Decision|2|||
146949131|NCT00934791|529972018|FG000|Overall Study|Withdrawal by Subject|1|||
146949132|NCT00934791|529972019|FG001|Overall Study|Withdrawal by Subject|0|||
146949133|NCT02425891|529972021|FG000|Overall Study|Death|333|||
146949134|NCT02425891|529972022|FG001|Overall Study|Death|314|||
146949135|NCT02425891|529972021|FG000|Overall Study|Lost to Follow-up|4|||
146949136|NCT02425891|529972022|FG001|Overall Study|Lost to Follow-up|6|||
146949137|NCT02425891|529972021|FG000|Overall Study|Non-Compliance|1|||
146949138|NCT02425891|529972022|FG001|Overall Study|Non-Compliance|1|||
146949139|NCT02425891|529972021|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
146949140|NCT02425891|529972022|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
146949141|NCT02425891|529972021|FG000|Overall Study|Physician Decision|0|||
146949142|NCT02425891|529972022|FG001|Overall Study|Physician Decision|1|||
146949143|NCT02425891|529972021|FG000|Overall Study|Protocol Violation|1|||
146949144|NCT02425891|529972022|FG001|Overall Study|Protocol Violation|1|||
146949145|NCT02425891|529972021|FG000|Overall Study|Study Terminated By Sponsor|85|||
146949146|NCT02425891|529972022|FG001|Overall Study|Study Terminated By Sponsor|95|||
146949147|NCT02425891|529972021|FG000|Overall Study|Withdrawal by Subject|27|||
146949148|NCT02425891|529972022|FG001|Overall Study|Withdrawal by Subject|32|||
146949149|NCT04124952|529972023|FG000|Overall Study|Lost to Follow-up|1|||
146949150|NCT00166504|529972025|FG000|Overall Study|Adverse Event|3|||
146949151|NCT00166504|529972026|FG001|Overall Study|Adverse Event|3|||
146949152|NCT00166504|529972025|FG000|Overall Study|Lost to Follow-up|1|||
146949153|NCT00166504|529972026|FG001|Overall Study|Lost to Follow-up|1|||
146949154|NCT00166504|529972025|FG000|Overall Study|Withdrawal by Subject|1|||
146949155|NCT00166504|529972026|FG001|Overall Study|Withdrawal by Subject|0|||
146949156|NCT03261037|529972029|FG000|Overall Study|Withdrawal by Subject|2|||
146949157|NCT03261037|529972030|FG001|Overall Study|Withdrawal by Subject|13|||
146949158|NCT03261037|529972031|FG002|Overall Study|Withdrawal by Subject|0|||
146817874|NCT01730118|529501384|FG002|Dose Expansion|Withdrawal by Subject|0|||
146817875|NCT01730118|529501385|FG003|Dose Expansion|Withdrawal by Subject|0|||
146817876|NCT01730118|529501386|FG004|Dose Expansion|Withdrawal by Subject|1|||
146817877|NCT01730118|529501387|FG005|Dose Expansion|Withdrawal by Subject|0|||
146817878|NCT01730118|529501388|FG006|Dose Expansion|Withdrawal by Subject|0|||
146817879|NCT01730118|529501382|FG000|Dose Expansion|Disease progression|0|||
146817880|NCT01730118|529501383|FG001|Dose Expansion|Disease progression|0|||
146949159|NCT03261037|529972032|FG003|Overall Study|Withdrawal by Subject|18|||
146949160|NCT03261037|529972029|FG000|Overall Study|Non-compliance with study procedures|0|||
146949161|NCT03261037|529972030|FG001|Overall Study|Non-compliance with study procedures|2|||
146949162|NCT03261037|529972031|FG002|Overall Study|Non-compliance with study procedures|0|||
146949163|NCT03261037|529972032|FG003|Overall Study|Non-compliance with study procedures|6|||
146949164|NCT03261037|529972029|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
146949165|NCT03261037|529972030|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
146949166|NCT03261037|529972031|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
146949167|NCT03261037|529972032|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
146949168|NCT03261037|529972029|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
146949169|NCT03261037|529972030|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
146949170|NCT03261037|529972031|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
146949171|NCT03261037|529972032|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
146949172|NCT03261037|529972029|FG000|Overall Study|Diagnosed but protocol deviation|1|||
146949173|NCT03261037|529972030|FG001|Overall Study|Diagnosed but protocol deviation|0|||
146949174|NCT03261037|529972031|FG002|Overall Study|Diagnosed but protocol deviation|0|||
146949175|NCT03261037|529972032|FG003|Overall Study|Diagnosed but protocol deviation|0|||
146949176|NCT03261037|529972029|FG000|Overall Study|Participant did not want to continue the study|0|||
146949177|NCT03261037|529972030|FG001|Overall Study|Participant did not want to continue the study|1|||
146949178|NCT03261037|529972031|FG002|Overall Study|Participant did not want to continue the study|0|||
146949179|NCT03261037|529972032|FG003|Overall Study|Participant did not want to continue the study|0|||
146949180|NCT03261037|529972029|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
146949181|NCT03261037|529972030|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
146949182|NCT03261037|529972031|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
146949183|NCT03261037|529972032|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
146949184|NCT03261037|529972029|FG000|Overall Study|Participant presented clinical improvement|0|||
146949185|NCT03261037|529972030|FG001|Overall Study|Participant presented clinical improvement|2|||
146949186|NCT03261037|529972031|FG002|Overall Study|Participant presented clinical improvement|0|||
146949187|NCT03261037|529972032|FG003|Overall Study|Participant presented clinical improvement|0|||
146949188|NCT03261037|529972029|FG000|Overall Study|Technical difficulties|0|||
146949189|NCT03261037|529972030|FG001|Overall Study|Technical difficulties|0|||
146949190|NCT03261037|529972031|FG002|Overall Study|Technical difficulties|0|||
146949191|NCT03261037|529972032|FG003|Overall Study|Technical difficulties|1|||
146949192|NCT03261037|529972029|FG000|Overall Study|Equipment failed to work|0|||
146949193|NCT03261037|529972030|FG001|Overall Study|Equipment failed to work|0|||
146949194|NCT03261037|529972031|FG002|Overall Study|Equipment failed to work|0|||
146949195|NCT03261037|529972032|FG003|Overall Study|Equipment failed to work|1|||
146949196|NCT03261037|529972029|FG000|Overall Study|End of study for participant and no follow up|0|||
146949197|NCT03261037|529972030|FG001|Overall Study|End of study for participant and no follow up|0|||
146949198|NCT03261037|529972031|FG002|Overall Study|End of study for participant and no follow up|0|||
146949199|NCT03261037|529972032|FG003|Overall Study|End of study for participant and no follow up|1|||
146949200|NCT03261037|529972029|FG000|Overall Study|Participant was too weak to continue in study|1|||
146949201|NCT03261037|529972030|FG001|Overall Study|Participant was too weak to continue in study|0|||
146949202|NCT03261037|529972031|FG002|Overall Study|Participant was too weak to continue in study|0|||
146949203|NCT03261037|529972032|FG003|Overall Study|Participant was too weak to continue in study|0|||
146949204|NCT01944462|529972037|FG000|PPPP Educational Program|Lost to Follow-up|60|||
146949205|NCT01222767|529972038|FG000|Overall Study|Progressive disease|13|||
146949206|NCT01222767|529972038|FG000|Overall Study|Adverse Event|2|||
146817881|NCT01730118|529501384|FG002|Dose Expansion|Disease progression|0|||
146817882|NCT01730118|529501385|FG003|Dose Expansion|Disease progression|0|||
146817883|NCT01730118|529501386|FG004|Dose Expansion|Disease progression|0|||
146817884|NCT01730118|529501387|FG005|Dose Expansion|Disease progression|1|||
146817885|NCT01730118|529501388|FG006|Dose Expansion|Disease progression|0|||
146817886|NCT01730118|529501382|FG000|Dose Expansion|Inability to return|0|||
146817887|NCT01730118|529501383|FG001|Dose Expansion|Inability to return|0|||
146817888|NCT01730118|529501384|FG002|Dose Expansion|Inability to return|0|||
146817889|NCT01730118|529501385|FG003|Dose Expansion|Inability to return|0|||
146817890|NCT01730118|529501386|FG004|Dose Expansion|Inability to return|0|||
146817891|NCT01730118|529501387|FG005|Dose Expansion|Inability to return|1|||
146817892|NCT01730118|529501388|FG006|Dose Expansion|Inability to return|0|||
146817893|NCT01730118|529501382|FG000|Dose Expansion|Physician Decision|0|||
146817894|NCT01730118|529501383|FG001|Dose Expansion|Physician Decision|0|||
146817895|NCT01730118|529501384|FG002|Dose Expansion|Physician Decision|0|||
146817896|NCT01730118|529501385|FG003|Dose Expansion|Physician Decision|0|||
146817897|NCT01730118|529501386|FG004|Dose Expansion|Physician Decision|0|||
146817898|NCT01730118|529501387|FG005|Dose Expansion|Physician Decision|1|||
146817899|NCT01730118|529501388|FG006|Dose Expansion|Physician Decision|0|||
146817900|NCT00668746|529501391|FG000|Overall Study|Lost to Follow-up|2|||
146817901|NCT00668746|529501392|FG001|Overall Study|Lost to Follow-up|1|||
146817902|NCT02409732|529501395|FG000|Overall Study|Withdrawal by Subject|4|||
146817903|NCT02409732|529501395|FG000|Overall Study|Lost to Follow-up|2|||
146817904|NCT01183013|529501396|FG000|Overall Study|Adverse Event|6|||
146817905|NCT01183013|529501397|FG001|Overall Study|Adverse Event|8|||
146817906|NCT01183013|529501398|FG002|Overall Study|Adverse Event|5|||
146817907|NCT01183013|529501399|FG003|Overall Study|Adverse Event|5|||
146817908|NCT01183013|529501400|FG004|Overall Study|Adverse Event|10|||
146817909|NCT01183013|529501401|FG005|Overall Study|Adverse Event|10|||
146817910|NCT01183013|529501402|FG006|Overall Study|Adverse Event|6|||
146817911|NCT01183013|529501396|FG000|Overall Study|Lack of Efficacy|3|||
146817912|NCT01183013|529501397|FG001|Overall Study|Lack of Efficacy|2|||
146817913|NCT01183013|529501398|FG002|Overall Study|Lack of Efficacy|1|||
146817914|NCT01183013|529501399|FG003|Overall Study|Lack of Efficacy|2|||
146817915|NCT01183013|529501400|FG004|Overall Study|Lack of Efficacy|1|||
146817916|NCT01183013|529501401|FG005|Overall Study|Lack of Efficacy|2|||
146817917|NCT01183013|529501402|FG006|Overall Study|Lack of Efficacy|0|||
146817918|NCT01183013|529501396|FG000|Overall Study|Protocol Violation|5|||
146817919|NCT01183013|529501397|FG001|Overall Study|Protocol Violation|2|||
146817920|NCT01183013|529501398|FG002|Overall Study|Protocol Violation|4|||
146817921|NCT01183013|529501399|FG003|Overall Study|Protocol Violation|0|||
146817922|NCT01183013|529501400|FG004|Overall Study|Protocol Violation|4|||
146817923|NCT01183013|529501401|FG005|Overall Study|Protocol Violation|3|||
146817924|NCT01183013|529501402|FG006|Overall Study|Protocol Violation|3|||
146817925|NCT01183013|529501396|FG000|Overall Study|Lost to Follow-up|7|||
146817926|NCT01183013|529501397|FG001|Overall Study|Lost to Follow-up|3|||
146817927|NCT01183013|529501398|FG002|Overall Study|Lost to Follow-up|4|||
146817928|NCT01183013|529501399|FG003|Overall Study|Lost to Follow-up|3|||
146817929|NCT01183013|529501400|FG004|Overall Study|Lost to Follow-up|2|||
146817930|NCT01183013|529501401|FG005|Overall Study|Lost to Follow-up|6|||
146817931|NCT01183013|529501402|FG006|Overall Study|Lost to Follow-up|5|||
146817932|NCT01183013|529501396|FG000|Overall Study|Withdrawal by Subject|9|||
146817933|NCT01183013|529501397|FG001|Overall Study|Withdrawal by Subject|13|||
146817934|NCT01183013|529501398|FG002|Overall Study|Withdrawal by Subject|10|||
146817935|NCT01183013|529501399|FG003|Overall Study|Withdrawal by Subject|8|||
146817936|NCT01183013|529501400|FG004|Overall Study|Withdrawal by Subject|7|||
146817937|NCT01183013|529501401|FG005|Overall Study|Withdrawal by Subject|9|||
146817938|NCT01183013|529501402|FG006|Overall Study|Withdrawal by Subject|10|||
146817939|NCT01183013|529501396|FG000|Overall Study|Reasons other than stated above|15|||
146817940|NCT01183013|529501397|FG001|Overall Study|Reasons other than stated above|11|||
146817941|NCT01183013|529501398|FG002|Overall Study|Reasons other than stated above|17|||
146817942|NCT01183013|529501399|FG003|Overall Study|Reasons other than stated above|12|||
146817943|NCT01183013|529501400|FG004|Overall Study|Reasons other than stated above|12|||
146817944|NCT01183013|529501401|FG005|Overall Study|Reasons other than stated above|15|||
146817945|NCT01183013|529501402|FG006|Overall Study|Reasons other than stated above|13|||
146817946|NCT04739306|529501403|FG000|Main Study Period|Adverse Event|6|||
146817947|NCT04739306|529501404|FG001|Main Study Period|Adverse Event|7|||
146817948|NCT04739306|529501403|FG000|Main Study Period|Lost to Follow-up|4|||
146817949|NCT04739306|529501404|FG001|Main Study Period|Lost to Follow-up|6|||
146817950|NCT04739306|529501403|FG000|Main Study Period|Physician Decision|1|||
146817951|NCT04739306|529501404|FG001|Main Study Period|Physician Decision|1|||
146817952|NCT04739306|529501403|FG000|Main Study Period|Withdrawal by Subject|8|||
146817953|NCT04739306|529501404|FG001|Main Study Period|Withdrawal by Subject|6|||
146817954|NCT04739306|529501403|FG000|Main Study Period|Protocol Violation|0|||
146817955|NCT04739306|529501404|FG001|Main Study Period|Protocol Violation|1|||
146817956|NCT04739306|529501403|FG000|Main Study Period|War in Ukraine|1|||
146817957|NCT04739306|529501404|FG001|Main Study Period|War in Ukraine|1|||
146817958|NCT04175392|529501405|FG000|Overall Study|Withdrawal by Subject|3|||
146817959|NCT04175392|529501406|FG001|Overall Study|Withdrawal by Subject|2|||
146817960|NCT01613599|529501409|FG000|Overall Study|Death|9|||
146817961|NCT01613599|529501409|FG000|Overall Study|Lost to Follow-up|5|||
146817962|NCT01613599|529501409|FG000|Overall Study|Withdrawal by Subject|8|||
146817963|NCT01613599|529501409|FG000|Overall Study|Reason not specified|3|||
146817964|NCT02991456|529501410|FG000|Overall Study|Adverse Event|2|||
146817965|NCT02991456|529501411|FG001|Overall Study|Adverse Event|0|||
146817966|NCT02991456|529501410|FG000|Overall Study|Lost to Follow-up|0|||
146817967|NCT02991456|529501411|FG001|Overall Study|Lost to Follow-up|2|||
146817968|NCT02991456|529501410|FG000|Overall Study|Withdrawal by Subject|1|||
146817969|NCT02991456|529501411|FG001|Overall Study|Withdrawal by Subject|0|||
146817970|NCT03503188|529501412|FG000|Overall Study|Non eligible in the sub study|0|||
146817971|NCT03503188|529501413|FG001|Overall Study|Non eligible in the sub study|1|||
146817972|NCT01699178|529501414|FG000|Overall Study|Adverse Event|1|||
146817973|NCT01699178|529501415|FG001|Overall Study|Adverse Event|5|||
146817974|NCT01699178|529501414|FG000|Overall Study|Lost to Follow-up|1|||
146817975|NCT01699178|529501415|FG001|Overall Study|Lost to Follow-up|6|||
146817976|NCT01699178|529501414|FG000|Overall Study|Non-compliance with Study Drug|3|||
146817977|NCT01699178|529501415|FG001|Overall Study|Non-compliance with Study Drug|1|||
146817978|NCT01699178|529501414|FG000|Overall Study|Physician Decision|1|||
146817979|NCT01699178|529501415|FG001|Overall Study|Physician Decision|0|||
146817980|NCT01699178|529501414|FG000|Overall Study|Withdrawal by Subject|4|||
146817981|NCT01699178|529501415|FG001|Overall Study|Withdrawal by Subject|12|||
146817982|NCT01699178|529501414|FG000|Overall Study|Hematocrit >54%|1|||
146817983|NCT01699178|529501415|FG001|Overall Study|Hematocrit >54%|1|||
146817984|NCT01699178|529501414|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
146817985|NCT01699178|529501415|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
146817986|NCT01699178|529501414|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
146817987|NCT01699178|529501415|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
146949207|NCT01222767|529972038|FG000|Overall Study|Surgical resection|1|||
146949208|NCT01222767|529972038|FG000|Overall Study|Never treated|1|||
146949209|NCT00723489|529972039|FG000|Overall Study|Physician Decision|0|||
146949210|NCT00723489|529972040|FG001|Overall Study|Physician Decision|1|||
146949211|NCT00723489|529972041|FG002|Overall Study|Physician Decision|0|||
146949212|NCT00723489|529972042|FG003|Overall Study|Physician Decision|0|||
146949213|NCT00723489|529972039|FG000|Overall Study|Pregnancy|0|||
146949214|NCT00723489|529972040|FG001|Overall Study|Pregnancy|0|||
146949215|NCT00723489|529972041|FG002|Overall Study|Pregnancy|0|||
146949216|NCT00723489|529972042|FG003|Overall Study|Pregnancy|1|||
146949217|NCT00723489|529972039|FG000|Overall Study|Withdrawal by Subject|0|||
146949218|NCT00723489|529972040|FG001|Overall Study|Withdrawal by Subject|0|||
146949219|NCT00723489|529972041|FG002|Overall Study|Withdrawal by Subject|0|||
146949220|NCT00723489|529972042|FG003|Overall Study|Withdrawal by Subject|1|||
146949221|NCT00723489|529972039|FG000|Overall Study|Seropositive at baseline|1|||
146949222|NCT00723489|529972040|FG001|Overall Study|Seropositive at baseline|0|||
146949223|NCT00723489|529972041|FG002|Overall Study|Seropositive at baseline|0|||
146949224|NCT00723489|529972042|FG003|Overall Study|Seropositive at baseline|0|||
146949225|NCT00723489|529972039|FG000|Overall Study|Prohibited Medication|0|||
146949226|NCT00723489|529972040|FG001|Overall Study|Prohibited Medication|0|||
146949227|NCT00723489|529972041|FG002|Overall Study|Prohibited Medication|0|||
146949228|NCT00723489|529972042|FG003|Overall Study|Prohibited Medication|1|||
146949229|NCT00723489|529972039|FG000|Overall Study|Samples Collected Out of Window|0|||
146949230|NCT00723489|529972040|FG001|Overall Study|Samples Collected Out of Window|3|||
146949231|NCT00723489|529972041|FG002|Overall Study|Samples Collected Out of Window|0|||
146949232|NCT00723489|529972042|FG003|Overall Study|Samples Collected Out of Window|0|||
146949233|NCT03657576|529972043|FG000|Overall Study|Death|0|||
146949234|NCT03657576|529972044|FG001|Overall Study|Death|1|||
146949235|NCT03657576|529972045|FG002|Overall Study|Death|1|||
146949236|NCT03657576|529972046|FG003|Overall Study|Death|0|||
146949237|NCT03657576|529972047|FG004|Overall Study|Death|0|||
146949238|NCT03657576|529972048|FG005|Overall Study|Death|0|||
146949239|NCT03657576|529972043|FG000|Overall Study|Withdrawal by Subject|0|||
146949240|NCT03657576|529972044|FG001|Overall Study|Withdrawal by Subject|0|||
146949241|NCT03657576|529972045|FG002|Overall Study|Withdrawal by Subject|0|||
146949242|NCT03657576|529972046|FG003|Overall Study|Withdrawal by Subject|1|||
146949243|NCT03657576|529972047|FG004|Overall Study|Withdrawal by Subject|0|||
146949244|NCT03657576|529972048|FG005|Overall Study|Withdrawal by Subject|0|||
146949245|NCT03657576|529972043|FG000|Overall Study|Screen Fail|0|||
146949246|NCT03657576|529972044|FG001|Overall Study|Screen Fail|0|||
146949247|NCT03657576|529972045|FG002|Overall Study|Screen Fail|0|||
146949248|NCT03657576|529972046|FG003|Overall Study|Screen Fail|0|||
146949249|NCT03657576|529972047|FG004|Overall Study|Screen Fail|0|||
146949250|NCT03657576|529972048|FG005|Overall Study|Screen Fail|5|||
146949251|NCT03657576|529972043|FG000|Overall Study|Disease Progression|1|||
146949252|NCT03657576|529972044|FG001|Overall Study|Disease Progression|1|||
146949253|NCT03657576|529972045|FG002|Overall Study|Disease Progression|0|||
146949254|NCT03657576|529972046|FG003|Overall Study|Disease Progression|5|||
146949255|NCT03657576|529972047|FG004|Overall Study|Disease Progression|0|||
146949256|NCT03657576|529972048|FG005|Overall Study|Disease Progression|0|||
146949257|NCT03657576|529972043|FG000|Overall Study|Insurance Coverage|0|||
146949258|NCT03657576|529972044|FG001|Overall Study|Insurance Coverage|0|||
146949259|NCT03657576|529972045|FG002|Overall Study|Insurance Coverage|0|||
146949260|NCT03657576|529972046|FG003|Overall Study|Insurance Coverage|1|||
146949261|NCT03657576|529972047|FG004|Overall Study|Insurance Coverage|0|||
146949262|NCT03657576|529972048|FG005|Overall Study|Insurance Coverage|0|||
146949263|NCT04437511|529972049|FG000|Overall Study|Adverse Event|50|||
146949264|NCT04437511|529972050|FG001|Overall Study|Adverse Event|21|||
146949265|NCT04437511|529972049|FG000|Overall Study|Death|15|||
146949266|NCT04437511|529972050|FG001|Overall Study|Death|10|||
146949267|NCT04437511|529972049|FG000|Overall Study|Lost to Follow-up|11|||
146949268|NCT04437511|529972050|FG001|Overall Study|Lost to Follow-up|11|||
146949269|NCT04437511|529972049|FG000|Overall Study|Physician Decision|19|||
146949270|NCT04437511|529972050|FG001|Overall Study|Physician Decision|10|||
146949271|NCT04437511|529972049|FG000|Overall Study|Progressive Disease|4|||
146949272|NCT04437511|529972050|FG001|Overall Study|Progressive Disease|7|||
146949273|NCT04437511|529972049|FG000|Overall Study|Withdrawal by Subject|111|||
146949274|NCT04437511|529972050|FG001|Overall Study|Withdrawal by Subject|94|||
146949275|NCT04437511|529972049|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
146949276|NCT04437511|529972050|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
146949277|NCT04437511|529972049|FG000|Overall Study|Continuing Study|7|||
146949278|NCT04437511|529972050|FG001|Overall Study|Continuing Study|5|||
146949279|NCT05298774|529972055|FG000|Overall Study|Physician Decision|3|||
146949280|NCT05298774|529972055|FG000|Overall Study|Withdrawal by Subject|2|||
146949281|NCT05298774|529972055|FG000|Overall Study|Lost to Follow-up|3|||
146949282|NCT05298774|529972055|FG000|Overall Study|Screen failure|1|||
146949283|NCT00081263|529972057|FG000|Overall Study|clerical error|1|||
146949284|NCT00081263|529972058|FG001|Overall Study|clerical error|0|||
146949285|NCT00081263|529972057|FG000|Overall Study|wrong cell type|7|||
146949286|NCT00081263|529972058|FG001|Overall Study|wrong cell type|5|||
146949287|NCT00081263|529972057|FG000|Overall Study|improper pre-protocol therapy|0|||
146949288|NCT00081263|529972058|FG001|Overall Study|improper pre-protocol therapy|1|||
146949289|NCT00081263|529972057|FG000|Overall Study|Inadequate pathology|0|||
146949290|NCT00081263|529972058|FG001|Overall Study|Inadequate pathology|1|||
146949291|NCT00081263|529972057|FG000|Overall Study|Never treated|4|||
146949292|NCT00081263|529972058|FG001|Overall Study|Never treated|5|||
146949293|NCT00081263|529972057|FG000|Overall Study|Inadequate data|5|||
146949294|NCT00081263|529972058|FG001|Overall Study|Inadequate data|10|||
146949295|NCT01267955|529972059|FG000|Stage 1 (6 Months)|Death|3|||
146949296|NCT01267955|529972059|FG000|Stage 2 (6 Months)|Death|5|||
146949297|NCT01267955|529972059|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
146984740|NCT03264066|530105152|FG000|Overall Study|Progressive Disease|0|||
146984741|NCT03264066|530105153|FG001|Overall Study|Progressive Disease|2|||
146984742|NCT03264066|530105154|FG002|Overall Study|Progressive Disease|1|||
146984743|NCT03264066|530105155|FG003|Overall Study|Progressive Disease|0|||
146984744|NCT03264066|530105156|FG004|Overall Study|Progressive Disease|0|||
146984745|NCT03264066|530105157|FG005|Overall Study|Progressive Disease|0|||
146817988|NCT00321555|529501416|FG000|Overall Study|Developed antibodies|1|||
146817989|NCT00321555|529501416|FG000|Overall Study|Switched to alternative treatment|3|||
146817990|NCT00321555|529501416|FG000|Overall Study|Physician Decision|1|||
146817991|NCT00321555|529501416|FG000|Overall Study|Disease progression on study|1|||
146817992|NCT02066389|529501418|FG000|Overall Study|Adverse Event|1|||
146817993|NCT02066389|529501419|FG001|Overall Study|Adverse Event|1|||
146817994|NCT02066389|529501420|FG002|Overall Study|Adverse Event|1|||
146817995|NCT02066389|529501421|FG003|Overall Study|Adverse Event|1|||
146817996|NCT02066389|529501422|FG004|Overall Study|Adverse Event|5|||
146817997|NCT02066389|529501423|FG005|Overall Study|Adverse Event|1|||
146817998|NCT02066389|529501418|FG000|Overall Study|Withdrawal by Subject|4|||
146817999|NCT02066389|529501419|FG001|Overall Study|Withdrawal by Subject|0|||
146818000|NCT02066389|529501420|FG002|Overall Study|Withdrawal by Subject|5|||
146818001|NCT02066389|529501421|FG003|Overall Study|Withdrawal by Subject|1|||
146818002|NCT02066389|529501422|FG004|Overall Study|Withdrawal by Subject|1|||
146818003|NCT02066389|529501423|FG005|Overall Study|Withdrawal by Subject|2|||
146818004|NCT02066389|529501418|FG000|Overall Study|Lost to Follow-up|0|||
146818005|NCT02066389|529501419|FG001|Overall Study|Lost to Follow-up|0|||
146818006|NCT02066389|529501420|FG002|Overall Study|Lost to Follow-up|0|||
146818007|NCT02066389|529501421|FG003|Overall Study|Lost to Follow-up|1|||
146818008|NCT02066389|529501422|FG004|Overall Study|Lost to Follow-up|1|||
146818009|NCT02066389|529501423|FG005|Overall Study|Lost to Follow-up|1|||
146818010|NCT02066389|529501418|FG000|Overall Study|Randomized in Error|0|||
146818011|NCT02066389|529501419|FG001|Overall Study|Randomized in Error|0|||
146818012|NCT02066389|529501420|FG002|Overall Study|Randomized in Error|0|||
146818013|NCT02066389|529501421|FG003|Overall Study|Randomized in Error|0|||
146818014|NCT02066389|529501422|FG004|Overall Study|Randomized in Error|0|||
146818015|NCT02066389|529501423|FG005|Overall Study|Randomized in Error|1|||
146818016|NCT03905512|529501429|FG000|Overall Study|Withdrawal by Subject|9|||
146818017|NCT03905512|529501430|FG001|Overall Study|Withdrawal by Subject|8|||
146818018|NCT03905512|529501429|FG000|Overall Study|Adverse Event|1|||
146818019|NCT03905512|529501430|FG001|Overall Study|Adverse Event|2|||
146818020|NCT03905512|529501429|FG000|Overall Study|Lost to Follow-up|4|||
146818021|NCT03905512|529501430|FG001|Overall Study|Lost to Follow-up|3|||
146818022|NCT03905512|529501429|FG000|Overall Study|Other than Specified|7|||
146818023|NCT03905512|529501430|FG001|Overall Study|Other than Specified|4|||
146818024|NCT00070317|529501435|FG000|Overall Study|Inevaluable (Never Treated)|1|||
146818025|NCT00070317|529501435|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
146949298|NCT03662789|529972060|FG000|Overall Study|Lost to Follow-up|1|||
146984746|NCT03264066|530105152|FG000|Overall Study|Study Terminated by Sponsor|5|||
146818026|NCT00070317|529501435|FG000|Overall Study|Ineligible required test not done|1|||
146818027|NCT00070317|529501435|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
146818028|NCT00070317|529501435|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
146818029|NCT03560206|529501437|FG000|Overall Study|Lost to Follow-up|19|||
146818030|NCT03560206|529501438|FG001|Overall Study|Lost to Follow-up|11|||
146818031|NCT03560206|529501437|FG000|Overall Study|Withdrawal by Subject|2|||
146818032|NCT03560206|529501438|FG001|Overall Study|Withdrawal by Subject|4|||
146818033|NCT03560206|529501437|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
146949299|NCT03662789|529972061|FG001|Overall Study|Lost to Follow-up|2|||
146949300|NCT03662789|529972060|FG000|Overall Study|Could not perform treadmill test|4|||
146984747|NCT03264066|530105153|FG001|Overall Study|Study Terminated by Sponsor|5|||
146818034|NCT03560206|529501438|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
146818035|NCT03560206|529501437|FG000|Overall Study|Busy schedule|14|||
146818036|NCT03560206|529501438|FG001|Overall Study|Busy schedule|2|||
146818037|NCT03560206|529501437|FG000|Overall Study|patients' new health condition such as cancer|10|||
146818038|NCT03560206|529501438|FG001|Overall Study|patients' new health condition such as cancer|1|||
146818039|NCT03100370|529501439|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146818040|NCT03100370|529501440|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146984748|NCT03264066|530105154|FG002|Overall Study|Study Terminated by Sponsor|8|||
146949301|NCT03662789|529972061|FG001|Overall Study|Could not perform treadmill test|4|||
146949302|NCT03662789|529972060|FG000|Overall Study|Death|0|||
146949303|NCT03662789|529972061|FG001|Overall Study|Death|1|||
146949304|NCT03598140|529972062|FG000|Overall Study|enrolled but didn't start|1|||
146949305|NCT03598140|529972063|FG001|Overall Study|enrolled but didn't start|0|||
146949306|NCT05304611|529972064|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
146949307|NCT05304611|529972065|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
146949308|NCT05304611|529972066|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
146949309|NCT05304611|529972067|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
146949310|NCT05304611|529972068|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
146949311|NCT05304611|529972069|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
146949312|NCT05304611|529972070|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
146949313|NCT05304611|529972071|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
146949314|NCT05304611|529972072|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
146949315|NCT05304611|529972073|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
146949316|NCT05304611|529972074|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
146949317|NCT05304611|529972075|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
146949318|NCT05304611|529972064|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
146949319|NCT05304611|529972065|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
146949320|NCT05304611|529972066|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
146949321|NCT05304611|529972067|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
146949322|NCT05304611|529972068|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
146949323|NCT05304611|529972069|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
146949324|NCT05304611|529972070|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
146949325|NCT05304611|529972071|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
146949326|NCT05304611|529972072|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
146949327|NCT05304611|529972073|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
146949328|NCT05304611|529972074|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
146949329|NCT05304611|529972075|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
146949330|NCT05304611|529972064|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
146949331|NCT05304611|529972065|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
146949332|NCT05304611|529972066|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
146949333|NCT05304611|529972067|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
146949334|NCT05304611|529972068|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
146818041|NCT03100370|529501441|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146818042|NCT03100370|529501442|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
146818043|NCT03100370|529501443|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146818044|NCT03100370|529501444|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146818045|NCT03987074|529501445|FG000|Overall Study|Withdrew Consent|1|||
146818046|NCT03987074|529501446|FG001|Overall Study|Withdrew Consent|1|||
146818047|NCT03987074|529501447|FG002|Overall Study|Withdrew Consent|0|||
146818048|NCT03987074|529501448|FG003|Overall Study|Withdrew Consent|2|||
146818049|NCT03987074|529501449|FG004|Overall Study|Withdrew Consent|1|||
146818050|NCT03987074|529501445|FG000|Overall Study|Adverse Event|2|||
146818051|NCT03987074|529501446|FG001|Overall Study|Adverse Event|1|||
146818052|NCT03987074|529501447|FG002|Overall Study|Adverse Event|0|||
146818053|NCT03987074|529501448|FG003|Overall Study|Adverse Event|0|||
146818054|NCT03987074|529501449|FG004|Overall Study|Adverse Event|1|||
146818055|NCT03987074|529501445|FG000|Overall Study|Lost to Follow-up|0|||
146818056|NCT03987074|529501446|FG001|Overall Study|Lost to Follow-up|0|||
146949335|NCT05304611|529972069|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
146949336|NCT05304611|529972070|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
146949337|NCT05304611|529972071|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
146949338|NCT05304611|529972072|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
146949339|NCT05304611|529972073|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
146949340|NCT05304611|529972074|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
146949341|NCT05304611|529972075|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
146949342|NCT00963820|529972080|FG000|Dose Escalation Phase|Progressive Disease|3|||
146949343|NCT00963820|529972081|FG001|Dose Escalation Phase|Progressive Disease|3|||
146949344|NCT00963820|529972082|FG002|Dose Escalation Phase|Progressive Disease|3|||
146949345|NCT00963820|529972083|FG003|Dose Escalation Phase|Progressive Disease|3|||
146949346|NCT00963820|529972084|FG004|Dose Escalation Phase|Progressive Disease|4|||
146949347|NCT00963820|529972085|FG005|Dose Escalation Phase|Progressive Disease|3|||
146949348|NCT00963820|529972086|FG006|Dose Escalation Phase|Progressive Disease|3|||
146949349|NCT00963820|529972087|FG007|Dose Escalation Phase|Progressive Disease|2|||
146949350|NCT00963820|529972088|FG008|Dose Escalation Phase|Progressive Disease|0|||
146949351|NCT00963820|529972089|FG009|Dose Escalation Phase|Progressive Disease|0|||
146818057|NCT03987074|529501447|FG002|Overall Study|Lost to Follow-up|1|||
146949352|NCT00963820|529972090|FG010|Dose Escalation Phase|Progressive Disease|0|||
146949353|NCT00963820|529972091|FG011|Dose Escalation Phase|Progressive Disease|0|||
146818058|NCT03987074|529501448|FG003|Overall Study|Lost to Follow-up|1|||
146818059|NCT03987074|529501449|FG004|Overall Study|Lost to Follow-up|0|||
146818060|NCT03987074|529501445|FG000|Overall Study|Investigator's Discretion|0|||
146818061|NCT03987074|529501446|FG001|Overall Study|Investigator's Discretion|0|||
146949354|NCT00963820|529972080|FG000|Dose Escalation Phase|Adverse Event|0|||
146949355|NCT00963820|529972081|FG001|Dose Escalation Phase|Adverse Event|0|||
146949356|NCT00963820|529972082|FG002|Dose Escalation Phase|Adverse Event|0|||
146949357|NCT00963820|529972083|FG003|Dose Escalation Phase|Adverse Event|0|||
146949358|NCT00963820|529972084|FG004|Dose Escalation Phase|Adverse Event|0|||
146949359|NCT00963820|529972085|FG005|Dose Escalation Phase|Adverse Event|0|||
146949360|NCT00963820|529972086|FG006|Dose Escalation Phase|Adverse Event|3|||
146949361|NCT00963820|529972087|FG007|Dose Escalation Phase|Adverse Event|1|||
146949362|NCT00963820|529972088|FG008|Dose Escalation Phase|Adverse Event|0|||
146949363|NCT00963820|529972089|FG009|Dose Escalation Phase|Adverse Event|0|||
146949364|NCT00963820|529972090|FG010|Dose Escalation Phase|Adverse Event|0|||
146949365|NCT00963820|529972091|FG011|Dose Escalation Phase|Adverse Event|0|||
146949366|NCT00963820|529972080|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
146949367|NCT00963820|529972081|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
146949368|NCT00963820|529972082|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
146949369|NCT00963820|529972083|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
146949370|NCT00963820|529972084|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
146949371|NCT00963820|529972085|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
146949372|NCT00963820|529972086|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
146949373|NCT00963820|529972087|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
146949374|NCT00963820|529972088|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
146949375|NCT00963820|529972089|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
146949376|NCT00963820|529972090|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
146949377|NCT00963820|529972091|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
146949378|NCT00963820|529972080|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146949379|NCT00963820|529972081|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146949380|NCT00963820|529972082|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146949381|NCT00963820|529972083|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146949382|NCT00963820|529972084|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146949383|NCT00963820|529972085|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146949384|NCT00963820|529972086|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
146949385|NCT00963820|529972087|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146949386|NCT00963820|529972088|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146949387|NCT00963820|529972089|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146949388|NCT00963820|529972090|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146818062|NCT03987074|529501447|FG002|Overall Study|Investigator's Discretion|0|||
146818063|NCT03987074|529501448|FG003|Overall Study|Investigator's Discretion|1|||
146818064|NCT03987074|529501449|FG004|Overall Study|Investigator's Discretion|0|||
146818065|NCT00508144|529501452|FG000|Overall Study|Not eligible|6|||
146818066|NCT00508144|529501452|FG000|Overall Study|Death|5|||
146818067|NCT01084772|529501455|FG000|Baseline|Withdrawal by Subject|7|||
146818068|NCT01084772|529501456|FG001|Baseline|Withdrawal by Subject|6|||
146818069|NCT01084772|529501455|FG000|3 Months|Death|1|||
146949389|NCT00963820|529972091|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146949390|NCT00963820|529972080|FG000|Expansion Phase|Progressive Disease|0|||
146949391|NCT00963820|529972081|FG001|Expansion Phase|Progressive Disease|0|||
146949392|NCT00963820|529972082|FG002|Expansion Phase|Progressive Disease|0|||
146949393|NCT00963820|529972083|FG003|Expansion Phase|Progressive Disease|0|||
146949394|NCT00963820|529972084|FG004|Expansion Phase|Progressive Disease|0|||
146949395|NCT00963820|529972085|FG005|Expansion Phase|Progressive Disease|0|||
146949396|NCT00963820|529972086|FG006|Expansion Phase|Progressive Disease|0|||
146949397|NCT00963820|529972087|FG007|Expansion Phase|Progressive Disease|0|||
146949398|NCT00963820|529972088|FG008|Expansion Phase|Progressive Disease|8|||
146949399|NCT00963820|529972089|FG009|Expansion Phase|Progressive Disease|6|||
146949400|NCT00963820|529972090|FG010|Expansion Phase|Progressive Disease|4|||
146949401|NCT00963820|529972091|FG011|Expansion Phase|Progressive Disease|2|||
146818070|NCT01084772|529501456|FG001|3 Months|Death|0|||
146949402|NCT00963820|529972080|FG000|Expansion Phase|Adverse Event|0|||
146949403|NCT00963820|529972081|FG001|Expansion Phase|Adverse Event|0|||
146949404|NCT00963820|529972082|FG002|Expansion Phase|Adverse Event|0|||
146949405|NCT00963820|529972083|FG003|Expansion Phase|Adverse Event|0|||
146949406|NCT00963820|529972084|FG004|Expansion Phase|Adverse Event|0|||
146949407|NCT00963820|529972085|FG005|Expansion Phase|Adverse Event|0|||
146949408|NCT00963820|529972086|FG006|Expansion Phase|Adverse Event|0|||
146818071|NCT01084772|529501455|FG000|3 Months|Study Termination|2|||
146818072|NCT01084772|529501456|FG001|3 Months|Study Termination|2|||
146818073|NCT01084772|529501455|FG000|1 Year|Withdrawal by Subject|0|||
146818074|NCT01084772|529501456|FG001|1 Year|Withdrawal by Subject|1|||
146818075|NCT01084772|529501455|FG000|1 Year|Lost to Follow-up|3|||
146818076|NCT01084772|529501456|FG001|1 Year|Lost to Follow-up|0|||
146818077|NCT01084772|529501455|FG000|1 Year|Study Termination|0|||
146818078|NCT01084772|529501456|FG001|1 Year|Study Termination|7|||
146949409|NCT00963820|529972087|FG007|Expansion Phase|Adverse Event|0|||
146949410|NCT00963820|529972088|FG008|Expansion Phase|Adverse Event|1|||
146949411|NCT00963820|529972089|FG009|Expansion Phase|Adverse Event|3|||
146818079|NCT01084772|529501455|FG000|2 Years|Withdrawal by Subject|1|||
146818080|NCT01084772|529501456|FG001|2 Years|Withdrawal by Subject|0|||
146818081|NCT01084772|529501455|FG000|2 Years|Lost to Follow-up|5|||
146818082|NCT01084772|529501456|FG001|2 Years|Lost to Follow-up|2|||
146818083|NCT01084772|529501455|FG000|2 Years|Study Termination|3|||
146818084|NCT01084772|529501456|FG001|2 Years|Study Termination|2|||
146818085|NCT02009865|529501458|FG000|Overall Study|Adverse Event|0|||
146818086|NCT02009865|529501459|FG001|Overall Study|Adverse Event|2|||
146818087|NCT02009865|529501458|FG000|Overall Study|Protocol Violation|0|||
146818088|NCT02009865|529501459|FG001|Overall Study|Protocol Violation|2|||
146818089|NCT02009865|529501458|FG000|Overall Study|Withdrawal by Subject|1|||
146818090|NCT02009865|529501459|FG001|Overall Study|Withdrawal by Subject|1|||
146818091|NCT01517282|529501460|FG000|Overall Study|Consent withdrawn|0|||
146818092|NCT01517282|529501461|FG001|Overall Study|Consent withdrawn|1|||
146818093|NCT01517282|529501462|FG002|Overall Study|Consent withdrawn|1|||
146818094|NCT01517282|529501463|FG003|Overall Study|Consent withdrawn|1|||
146818095|NCT01517282|529501460|FG000|Overall Study|Physician Decision|1|||
146818096|NCT01517282|529501461|FG001|Overall Study|Physician Decision|0|||
146818097|NCT01517282|529501462|FG002|Overall Study|Physician Decision|0|||
146818098|NCT01517282|529501463|FG003|Overall Study|Physician Decision|0|||
146818099|NCT00525915|529501464|FG000|Overall Study|Non-Compliance|0|||
146818100|NCT00525915|529501465|FG001|Overall Study|Non-Compliance|1|||
146818101|NCT00525915|529501464|FG000|Overall Study|Disease Progression|5|||
146818102|NCT00525915|529501465|FG001|Overall Study|Disease Progression|6|||
146818103|NCT00525915|529501464|FG000|Overall Study|Withdrawal by Subject|1|||
146818104|NCT00525915|529501465|FG001|Overall Study|Withdrawal by Subject|0|||
146818105|NCT00525915|529501464|FG000|Overall Study|Refused Surgery|1|||
146818106|NCT00525915|529501465|FG001|Overall Study|Refused Surgery|2|||
146818107|NCT00525915|529501464|FG000|Overall Study|Unrelated illness|1|||
146818108|NCT00525915|529501465|FG001|Overall Study|Unrelated illness|0|||
146818109|NCT02332889|529501473|FG000|Overall Study|Physician Decision|1|||
146818110|NCT02135445|529501477|FG000|Overall Study|Lost to Follow-up|1|||
146818111|NCT02135445|529501478|FG001|Overall Study|Lost to Follow-up|0|||
146818112|NCT02135445|529501477|FG000|Overall Study|Withdrawal by Subject|1|||
146818113|NCT02135445|529501478|FG001|Overall Study|Withdrawal by Subject|0|||
146818114|NCT04097535|529501481|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
146818115|NCT03070301|529501482|FG000|Overall Study|Progression of disease|16|||
146818116|NCT03070301|529501482|FG000|Overall Study|Physician Decision|3|||
146818117|NCT03070301|529501482|FG000|Overall Study|Withdrawal by Subject|1|||
146818118|NCT03556891|529501483|FG000|Initial Pivotal Study|Adverse Event|4|||
146818119|NCT03556891|529501483|FG000|Initial Pivotal Study|MRI Need|3|||
146818120|NCT03556891|529501483|FG000|Initial Pivotal Study|Device Failure|1|||
146818121|NCT03556891|529501483|FG000|Initial Pivotal Study|Death|1|||
146818122|NCT03556891|529501483|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
146818123|NCT03556891|529501483|FG000|Initial Pivotal Study|Missing at random|1|||
146818124|NCT03556891|529501483|FG000|Initial Pivotal Study|Missing due to COVID|1|||
146818125|NCT03556891|529501483|FG000|Initial Pivotal Study|Protocol Violation|1|||
146818126|NCT00489489|529502713|FG000|Overall Study|Not treated due to protocol violation|0|||
146818127|NCT00489489|529502714|FG001|Overall Study|Not treated due to protocol violation|1|||
146818128|NCT00489489|529502715|FG002|Overall Study|Not treated due to protocol violation|1|||
146818129|NCT00489489|529502713|FG000|Overall Study|Adverse Event|1|||
146818130|NCT00489489|529502714|FG001|Overall Study|Adverse Event|1|||
146818131|NCT00489489|529502715|FG002|Overall Study|Adverse Event|1|||
146818132|NCT00489489|529502713|FG000|Overall Study|Protocol Violation|1|||
146818133|NCT00489489|529502714|FG001|Overall Study|Protocol Violation|0|||
146818134|NCT00489489|529502715|FG002|Overall Study|Protocol Violation|1|||
146818135|NCT00489489|529502713|FG000|Overall Study|Progressive disease|0|||
146818136|NCT00489489|529502714|FG001|Overall Study|Progressive disease|1|||
146818137|NCT00489489|529502715|FG002|Overall Study|Progressive disease|0|||
146818138|NCT00489489|529502713|FG000|Overall Study|Participant did not wish to continue|1|||
146818139|NCT00489489|529502714|FG001|Overall Study|Participant did not wish to continue|1|||
146818140|NCT00489489|529502715|FG002|Overall Study|Participant did not wish to continue|0|||
146818141|NCT00489489|529502713|FG000|Overall Study|Other than above|0|||
146818142|NCT00489489|529502714|FG001|Overall Study|Other than above|1|||
146818143|NCT00489489|529502715|FG002|Overall Study|Other than above|0|||
146818144|NCT03978130|529502718|FG000|Overall Study|Lost to Follow-up|13|||
146818145|NCT03978130|529502719|FG001|Overall Study|Lost to Follow-up|14|||
146818146|NCT03978130|529502718|FG000|Overall Study|Withdrawal by Subject|12|||
146818147|NCT03978130|529502719|FG001|Overall Study|Withdrawal by Subject|2|||
146818148|NCT03978130|529502718|FG000|Overall Study|Adverse Event|2|||
146818149|NCT03978130|529502719|FG001|Overall Study|Adverse Event|1|||
146818150|NCT02101554|529502724|FG000|Overall Study|Protocol Violation|0|||
146818151|NCT02101554|529502725|FG001|Overall Study|Protocol Violation|1|||
146818152|NCT02101554|529502726|FG002|Overall Study|Protocol Violation|0|||
146818153|NCT02101554|529502724|FG000|Overall Study|Insufficient Clinical Response|0|||
146818154|NCT02101554|529502725|FG001|Overall Study|Insufficient Clinical Response|2|||
146818155|NCT02101554|529502726|FG002|Overall Study|Insufficient Clinical Response|0|||
146818156|NCT02101554|529502724|FG000|Overall Study|Adverse Event|2|||
146818157|NCT02101554|529502725|FG001|Overall Study|Adverse Event|1|||
146949412|NCT00963820|529972090|FG010|Expansion Phase|Adverse Event|0|||
146949413|NCT00963820|529972091|FG011|Expansion Phase|Adverse Event|0|||
146949414|NCT00963820|529972080|FG000|Expansion Phase|Withdrawal by Subject|0|||
146949415|NCT00963820|529972081|FG001|Expansion Phase|Withdrawal by Subject|0|||
146949416|NCT00963820|529972082|FG002|Expansion Phase|Withdrawal by Subject|0|||
146949417|NCT00963820|529972083|FG003|Expansion Phase|Withdrawal by Subject|0|||
146949418|NCT00963820|529972084|FG004|Expansion Phase|Withdrawal by Subject|0|||
146949419|NCT00963820|529972085|FG005|Expansion Phase|Withdrawal by Subject|0|||
146949420|NCT00963820|529972086|FG006|Expansion Phase|Withdrawal by Subject|0|||
146949421|NCT00963820|529972087|FG007|Expansion Phase|Withdrawal by Subject|0|||
146949422|NCT00963820|529972088|FG008|Expansion Phase|Withdrawal by Subject|1|||
146949423|NCT00963820|529972089|FG009|Expansion Phase|Withdrawal by Subject|0|||
146949424|NCT00963820|529972090|FG010|Expansion Phase|Withdrawal by Subject|1|||
146949425|NCT00963820|529972091|FG011|Expansion Phase|Withdrawal by Subject|1|||
146949426|NCT00963820|529972080|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146949427|NCT00963820|529972081|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146949428|NCT00963820|529972082|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146949429|NCT00963820|529972083|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146949430|NCT00963820|529972084|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146949431|NCT00963820|529972085|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146949432|NCT00963820|529972086|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146949433|NCT00963820|529972087|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146949434|NCT00963820|529972088|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146949435|NCT00963820|529972089|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146949436|NCT00963820|529972090|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146949437|NCT00963820|529972091|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
146949438|NCT02354690|529972092|FG000|Overall Study|Physician Decision|1|||
146949439|NCT05549505|529972094|FG000|Overall Study|Lost to Follow-up|2|||
146949440|NCT05549505|529972095|FG001|Overall Study|Lost to Follow-up|0|||
146949441|NCT05549505|529972094|FG000|Overall Study|Withdrawal by Subject|3|||
146949442|NCT05549505|529972095|FG001|Overall Study|Withdrawal by Subject|3|||
146949443|NCT05549505|529972094|FG000|Overall Study|Other: Miscellaneous|3|||
146949444|NCT05549505|529972095|FG001|Overall Study|Other: Miscellaneous|6|||
146949445|NCT00515099|529972098|FG000|Overall Study|Lost to Follow-up|0|||
146949446|NCT00515099|529972099|FG001|Overall Study|Lost to Follow-up|4|||
146949447|NCT00515099|529972098|FG000|Overall Study|Withdrawal by Subject|2|||
146949448|NCT00515099|529972099|FG001|Overall Study|Withdrawal by Subject|0|||
146949449|NCT00515099|529972098|FG000|Overall Study|IRB Recommendation|1|||
146949450|NCT00515099|529972099|FG001|Overall Study|IRB Recommendation|0|||
146949451|NCT00592072|529972100|FG000|Wash Out Period|Lost to Follow-up|1|||
146949452|NCT00592072|529972101|FG001|Wash Out Period|Lost to Follow-up|1|||
146949453|NCT03369704|529972102|FG000|Treatment Epoch|technical problems|1|||
146949454|NCT03369704|529972103|FG001|Treatment Epoch|technical problems|0|||
146949455|NCT03369704|529972102|FG000|Treatment Epoch|Protocol Violation|1|||
146949456|NCT03369704|529972103|FG001|Treatment Epoch|Protocol Violation|0|||
146949457|NCT03369704|529972102|FG000|Treatment Epoch|Lost to Follow-up|0|||
146949458|NCT03369704|529972103|FG001|Treatment Epoch|Lost to Follow-up|1|||
146949459|NCT03369704|529972102|FG000|Treatment Epoch|Lack of Efficacy|0|||
146949460|NCT03369704|529972103|FG001|Treatment Epoch|Lack of Efficacy|2|||
146949461|NCT03369704|529972102|FG000|Treatment Epoch|Adverse Event|2|||
146949462|NCT03369704|529972103|FG001|Treatment Epoch|Adverse Event|0|||
146949463|NCT03369704|529972102|FG000|Follow-up Epoch|Lost to Follow-up|1|||
146949464|NCT03369704|529972103|FG001|Follow-up Epoch|Lost to Follow-up|0|||
146949465|NCT05333289|529972104|FG000|Overall Study|Other|1|||
146949466|NCT05333289|529972105|FG001|Overall Study|Other|0|||
146949467|NCT05333289|529972106|FG002|Overall Study|Other|0|||
146949468|NCT05333289|529972107|FG003|Overall Study|Other|1|||
146949469|NCT05333289|529972108|FG004|Overall Study|Other|1|||
146949470|NCT05333289|529972109|FG005|Overall Study|Other|2|||
146949471|NCT05333289|529972110|FG006|Overall Study|Other|2|||
146949472|NCT05333289|529972111|FG007|Overall Study|Other|0|||
146949473|NCT05333289|529972104|FG000|Overall Study|Withdrawal by Subject|1|||
146949474|NCT05333289|529972105|FG001|Overall Study|Withdrawal by Subject|2|||
146818158|NCT02101554|529502726|FG002|Overall Study|Adverse Event|1|||
146949475|NCT05333289|529972106|FG002|Overall Study|Withdrawal by Subject|2|||
146949476|NCT05333289|529972107|FG003|Overall Study|Withdrawal by Subject|1|||
146818159|NCT02101554|529502724|FG000|Overall Study|Lost to Follow-up|0|||
146984749|NCT03264066|530105155|FG003|Overall Study|Study Terminated by Sponsor|5|||
146949477|NCT05333289|529972108|FG004|Overall Study|Withdrawal by Subject|1|||
146949478|NCT05333289|529972109|FG005|Overall Study|Withdrawal by Subject|2|||
146949479|NCT05333289|529972110|FG006|Overall Study|Withdrawal by Subject|1|||
146949480|NCT05333289|529972111|FG007|Overall Study|Withdrawal by Subject|3|||
146818160|NCT02101554|529502725|FG001|Overall Study|Lost to Follow-up|1|||
146949481|NCT05333289|529972104|FG000|Overall Study|Protocol Violation|1|||
146949482|NCT05333289|529972105|FG001|Overall Study|Protocol Violation|0|||
146818161|NCT02101554|529502726|FG002|Overall Study|Lost to Follow-up|0|||
146818162|NCT02101554|529502724|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
146818163|NCT02101554|529502725|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
146818164|NCT02101554|529502726|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
146818165|NCT02136797|529502727|FG000|Overall Study|Not Treated|8|||
146818166|NCT04523571|529502728|FG000|Received 2 Doses|Withdrawal by Subject|0|||
146818167|NCT04523571|529502729|FG001|Received 2 Doses|Withdrawal by Subject|0|||
146818168|NCT04523571|529502730|FG002|Received 2 Doses|Withdrawal by Subject|0|||
146818169|NCT04523571|529502731|FG003|Received 2 Doses|Withdrawal by Subject|1|||
146818170|NCT04523571|529502732|FG004|Received 2 Doses|Withdrawal by Subject|1|||
146818171|NCT04523571|529502733|FG005|Received 2 Doses|Withdrawal by Subject|0|||
146818172|NCT04523571|529502728|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
146818173|NCT04523571|529502729|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
146818174|NCT04523571|529502730|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
146818175|NCT04523571|529502731|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
146818176|NCT04523571|529502732|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
146818177|NCT04523571|529502733|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
146818178|NCT04523571|529502728|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
146818179|NCT04523571|529502729|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
146818180|NCT04523571|529502730|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
146818181|NCT04523571|529502731|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
146818182|NCT04523571|529502732|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
146818183|NCT04523571|529502733|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
146818184|NCT04523571|529502728|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
146818185|NCT04523571|529502729|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
146818186|NCT04523571|529502730|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
146818187|NCT04523571|529502731|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
146818188|NCT04523571|529502732|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
146818189|NCT04523571|529502733|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
146818190|NCT04198428|529502734|FG000|Overall Study|Withdrawal by Subject|150|||
146818191|NCT04198428|529502735|FG001|Overall Study|Withdrawal by Subject|156|||
146818192|NCT03344458|529502738|FG000|Overall Study|Physician Decision|1|||
146818193|NCT03344458|529502738|FG000|Overall Study|Withdrawal by Subject|16|||
146818194|NCT03344458|529502738|FG000|Overall Study|Other reasons|10|||
146818195|NCT03344458|529502738|FG000|Overall Study|Lost to Follow-up|9|||
146818196|NCT03344458|529502738|FG000|Overall Study|Protocol Violation|3|||
146818197|NCT03696342|529502741|FG000|Overall Study|Lost to Follow-up|1|||
146818198|NCT03696342|529502742|FG001|Overall Study|Lost to Follow-up|0|||
146818199|NCT01816165|529502745|FG000|Overall Study|Adverse Event|1|||
146818200|NCT01816165|529502746|FG001|Overall Study|Adverse Event|0|||
146818201|NCT01816165|529502747|FG002|Overall Study|Adverse Event|0|||
146818202|NCT01816165|529502748|FG003|Overall Study|Adverse Event|0|||
146818203|NCT03960437|529502750|FG000|Overall Study|Removed by PI|4|||
146818204|NCT03960437|529502750|FG000|Overall Study|Lost to Follow-up|2|||
146818205|NCT03960437|529502750|FG000|Overall Study|Withdrawal by Subject|1|||
146818206|NCT03960437|529502750|FG000|Overall Study|Death|2|||
146818207|NCT01838499|529502751|FG000|Overall Study|Protocol Violation|0|||
146818208|NCT01838499|529502752|FG001|Overall Study|Protocol Violation|1|||
146818209|NCT01838499|529502751|FG000|Overall Study|Lost to Follow-up|2|||
146818210|NCT01838499|529502752|FG001|Overall Study|Lost to Follow-up|4|||
146818211|NCT01838499|529502751|FG000|Overall Study|Lack of Efficacy|1|||
146818212|NCT01838499|529502752|FG001|Overall Study|Lack of Efficacy|2|||
146818213|NCT01838499|529502751|FG000|Overall Study|Adverse Event|2|||
146818214|NCT01838499|529502752|FG001|Overall Study|Adverse Event|1|||
146984750|NCT03264066|530105156|FG004|Overall Study|Study Terminated by Sponsor|1|||
146818215|NCT01838499|529502751|FG000|Overall Study|Withdrawal by Subject|19|||
146818216|NCT01838499|529502752|FG001|Overall Study|Withdrawal by Subject|9|||
146818217|NCT03614923|529502753|FG000|Overall Study|Withdrawal by Subject|2|||
146818218|NCT03614923|529502754|FG001|Overall Study|Withdrawal by Subject|1|||
146818219|NCT03614923|529502755|FG002|Overall Study|Withdrawal by Subject|1|||
146818220|NCT03614923|529502753|FG000|Overall Study|Adverse Event|0|||
146818221|NCT03614923|529502754|FG001|Overall Study|Adverse Event|2|||
146818222|NCT03614923|529502755|FG002|Overall Study|Adverse Event|1|||
146818223|NCT03614923|529502753|FG000|Overall Study|Lost to Follow-up|1|||
146818224|NCT03614923|529502754|FG001|Overall Study|Lost to Follow-up|0|||
146818225|NCT03614923|529502755|FG002|Overall Study|Lost to Follow-up|1|||
146818226|NCT03614923|529502753|FG000|Overall Study|Lack of Efficacy|2|||
146818227|NCT03614923|529502754|FG001|Overall Study|Lack of Efficacy|0|||
146818228|NCT03614923|529502755|FG002|Overall Study|Lack of Efficacy|1|||
146818229|NCT03614923|529502753|FG000|Overall Study|Non-compliance|0|||
146818230|NCT03614923|529502754|FG001|Overall Study|Non-compliance|1|||
146818231|NCT03614923|529502755|FG002|Overall Study|Non-compliance|0|||
146818232|NCT03614923|529502753|FG000|Overall Study|Other|0|||
146949483|NCT05333289|529972106|FG002|Overall Study|Protocol Violation|0|||
146949484|NCT05333289|529972107|FG003|Overall Study|Protocol Violation|0|||
146949485|NCT05333289|529972108|FG004|Overall Study|Protocol Violation|0|||
146949486|NCT05333289|529972109|FG005|Overall Study|Protocol Violation|0|||
146949487|NCT05333289|529972110|FG006|Overall Study|Protocol Violation|0|||
146949488|NCT05333289|529972111|FG007|Overall Study|Protocol Violation|0|||
146949489|NCT05333289|529972104|FG000|Overall Study|Physician Decision|0|||
146949490|NCT05333289|529972105|FG001|Overall Study|Physician Decision|0|||
146949491|NCT05333289|529972106|FG002|Overall Study|Physician Decision|1|||
146949492|NCT05333289|529972107|FG003|Overall Study|Physician Decision|0|||
146949493|NCT05333289|529972108|FG004|Overall Study|Physician Decision|0|||
146949494|NCT05333289|529972109|FG005|Overall Study|Physician Decision|2|||
146818233|NCT03614923|529502754|FG001|Overall Study|Other|1|||
146818234|NCT03614923|529502755|FG002|Overall Study|Other|1|||
146818235|NCT01882088|529502756|FG000|Overall Study|Intolerance of esophageal manometry|1|||
146818236|NCT01882088|529502756|FG000|Overall Study|no possibility to place the catheter|1|||
146818237|NCT01882088|529502756|FG000|Overall Study|Protocol Violation|1|||
146818238|NCT01882088|529502756|FG000|Overall Study|inadequate pH-impedance tracings|2|||
146818239|NCT02030847|529502762|FG000|Overall Study|Death|10|||
146818240|NCT02030847|529502762|FG000|Overall Study|Disease Progression|15|||
146818241|NCT02030847|529502762|FG000|Overall Study|New Cancer Therapy|8|||
146818242|NCT02030847|529502762|FG000|Overall Study|Physician Decision|3|||
146818243|NCT02030847|529502762|FG000|Overall Study|Withdrawal by Subject|1|||
146818244|NCT00168805|529502763|FG000|Overall Study|Adverse Event|7|||
146818245|NCT00168805|529502764|FG001|Overall Study|Adverse Event|11|||
146818246|NCT00168805|529502765|FG002|Overall Study|Adverse Event|16|||
146818247|NCT00168805|529502763|FG000|Overall Study|Protocol Violation|12|||
146818248|NCT00168805|529502764|FG001|Overall Study|Protocol Violation|11|||
146818249|NCT00168805|529502765|FG002|Overall Study|Protocol Violation|8|||
146818250|NCT00168805|529502763|FG000|Overall Study|Lost to Follow-up|12|||
146818251|NCT00168805|529502764|FG001|Overall Study|Lost to Follow-up|17|||
146818252|NCT00168805|529502765|FG002|Overall Study|Lost to Follow-up|11|||
146818253|NCT00168805|529502763|FG000|Overall Study|Withdrawal by Subject|16|||
146818254|NCT00168805|529502764|FG001|Overall Study|Withdrawal by Subject|18|||
146818255|NCT00168805|529502765|FG002|Overall Study|Withdrawal by Subject|21|||
146818256|NCT00168805|529502763|FG000|Overall Study|Other|24|||
146818257|NCT00168805|529502764|FG001|Overall Study|Other|21|||
146818258|NCT00168805|529502765|FG002|Overall Study|Other|22|||
146818259|NCT00168805|529502763|FG000|Treatment|Adverse Event|25|||
146818260|NCT00168805|529502764|FG001|Treatment|Adverse Event|26|||
146818261|NCT00168805|529502765|FG002|Treatment|Adverse Event|32|||
146949495|NCT05333289|529972110|FG006|Overall Study|Physician Decision|0|||
146949496|NCT05333289|529972111|FG007|Overall Study|Physician Decision|0|||
146949497|NCT05333289|529972104|FG000|Overall Study|Lost to Follow-up|6|||
146949498|NCT05333289|529972105|FG001|Overall Study|Lost to Follow-up|0|||
146949499|NCT05333289|529972106|FG002|Overall Study|Lost to Follow-up|1|||
146949500|NCT05333289|529972107|FG003|Overall Study|Lost to Follow-up|6|||
146949501|NCT05333289|529972108|FG004|Overall Study|Lost to Follow-up|3|||
146818262|NCT00168805|529502763|FG000|Treatment|Protocol Violation|3|||
146818263|NCT00168805|529502764|FG001|Treatment|Protocol Violation|5|||
146818264|NCT00168805|529502765|FG002|Treatment|Protocol Violation|5|||
146818265|NCT00168805|529502763|FG000|Treatment|Withdrawal by Subject|3|||
146818266|NCT00168805|529502764|FG001|Treatment|Withdrawal by Subject|7|||
146818267|NCT00168805|529502765|FG002|Treatment|Withdrawal by Subject|8|||
146818268|NCT00168805|529502763|FG000|Treatment|Other|18|||
146818269|NCT00168805|529502764|FG001|Treatment|Other|18|||
146818270|NCT00168805|529502765|FG002|Treatment|Other|17|||
146818271|NCT02062827|529502773|FG000|Overall Study|Death|1|||
146818272|NCT02062827|529502774|FG001|Overall Study|Death|0|||
146818273|NCT02062827|529502775|FG002|Overall Study|Death|0|||
146949502|NCT05333289|529972109|FG005|Overall Study|Lost to Follow-up|3|||
146949503|NCT05333289|529972110|FG006|Overall Study|Lost to Follow-up|2|||
146949504|NCT05333289|529972111|FG007|Overall Study|Lost to Follow-up|1|||
146949505|NCT05333289|529972104|FG000|Overall Study|Death|1|||
146949506|NCT05333289|529972105|FG001|Overall Study|Death|0|||
146818274|NCT02062827|529502776|FG003|Overall Study|Death|0|||
146818275|NCT02062827|529502777|FG004|Overall Study|Death|0|||
146818276|NCT02062827|529502778|FG005|Overall Study|Death|0|||
146818277|NCT02062827|529502779|FG006|Overall Study|Death|0|||
146818278|NCT02062827|529502780|FG007|Overall Study|Death|0|||
146818279|NCT02062827|529502773|FG000|Overall Study|Withdrawal by Subject|3|||
146818280|NCT02062827|529502774|FG001|Overall Study|Withdrawal by Subject|1|||
146818281|NCT02062827|529502775|FG002|Overall Study|Withdrawal by Subject|1|||
146818282|NCT02062827|529502776|FG003|Overall Study|Withdrawal by Subject|2|||
146818283|NCT02062827|529502777|FG004|Overall Study|Withdrawal by Subject|6|||
146818284|NCT02062827|529502778|FG005|Overall Study|Withdrawal by Subject|0|||
146949507|NCT05333289|529972106|FG002|Overall Study|Death|0|||
146949508|NCT05333289|529972107|FG003|Overall Study|Death|0|||
146949509|NCT05333289|529972108|FG004|Overall Study|Death|0|||
146949510|NCT05333289|529972109|FG005|Overall Study|Death|0|||
146949511|NCT05333289|529972110|FG006|Overall Study|Death|0|||
146949512|NCT05333289|529972111|FG007|Overall Study|Death|0|||
146949513|NCT03685643|529972112|FG000|Overall Study|Lost to Follow-up|14|||
146949514|NCT03685643|529972113|FG001|Overall Study|Lost to Follow-up|22|||
146949515|NCT02750501|529972114|FG000|Overall Study|Adverse Event|4|||
146949516|NCT02750501|529972114|FG000|Overall Study|Physician Decision|1|||
146949517|NCT02750501|529972114|FG000|Overall Study|Protocol Violation|1|||
146949518|NCT02750501|529972114|FG000|Overall Study|G-tube came out|1|||
146949519|NCT02750501|529972114|FG000|Overall Study|Non-compliant use of PERT|1|||
146949520|NCT03797144|529972115|FG000|Enrollment|Protocol Violation|4|||
146949521|NCT03797144|529972116|FG001|Enrollment|Protocol Violation|1|||
146949522|NCT03797144|529972115|FG000|Surgery|Protocol Violation|1|||
146949523|NCT03797144|529972116|FG001|Surgery|Protocol Violation|0|||
146949524|NCT03797144|529972115|FG000|3 Month|Early termination cut-off date|2|||
146949525|NCT03797144|529972116|FG001|3 Month|Early termination cut-off date|0|||
146949526|NCT03797144|529972115|FG000|12 Month|Early termination cut-off date|8|||
146949527|NCT03797144|529972116|FG001|12 Month|Early termination cut-off date|9|||
146949528|NCT03797144|529972115|FG000|24 Month|Early termination cut-off date|1|||
146949529|NCT03797144|529972116|FG001|24 Month|Early termination cut-off date|1|||
146949530|NCT04430036|529972117|FG000|Safety Run in Phase|Progression of disease|2|||
146949531|NCT01842334|529972118|FG000|Overall Study|Withdrawal by Subject|3|||
146949532|NCT01842334|529972119|FG001|Overall Study|Withdrawal by Subject|3|||
146949533|NCT01842334|529972118|FG000|Overall Study|Moved away mid-study|0|||
146949534|NCT01842334|529972119|FG001|Overall Study|Moved away mid-study|1|||
146949535|NCT00376675|529972120|FG000|Overall Study|Withdrawal by Subject|9|||
146949536|NCT00376675|529972121|FG001|Overall Study|Withdrawal by Subject|2|||
146949537|NCT00376675|529972120|FG000|Overall Study|Adverse Event|10|||
146949538|NCT00376675|529972121|FG001|Overall Study|Adverse Event|5|||
146949539|NCT00376675|529972120|FG000|Overall Study|Other Reason|1|||
146949540|NCT00376675|529972121|FG001|Overall Study|Other Reason|7|||
146949541|NCT00942422|529972125|FG000|Overall Study|Withdrawal by Subject|1|||
146949542|NCT00942422|529972125|FG000|Overall Study|Death|1|||
146949543|NCT00942422|529972125|FG000|Overall Study|Progressive diease|1|||
146949544|NCT00423592|529972128|FG000|Overall Study|Adverse Event (through Week 12)|2|||
146949545|NCT00423592|529972128|FG000|Overall Study|Adverse Event (post Week 12)|5|||
146949546|NCT00002981|529972131|FG000|Overall Study|Inevaluable|6|||
146949547|NCT01833806|529972134|FG000|Overall Study|Alternative treatment|2|||
146949548|NCT01833806|529972134|FG000|Overall Study|Death|5|||
146949549|NCT01833806|529972134|FG000|Overall Study|Physician Decision|1|||
146949550|NCT01833806|529972134|FG000|Overall Study|Lost to Follow-up|1|||
146949551|NCT03457636|529972135|FG000|Overall Study|Lost to Follow-up|2|||
146949552|NCT05083949|529972136|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
146949553|NCT05083949|529972137|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
146949554|NCT05083949|529972136|FG000|Period 1|Adverse Event|1|||
146949555|NCT05083949|529972137|FG001|Period 1|Adverse Event|1|||
146949556|NCT05083949|529972136|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
146949557|NCT05083949|529972137|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
146949558|NCT05083949|529972136|FG000|Period 2|Adverse Event|0|||
146949559|NCT05083949|529972137|FG001|Period 2|Adverse Event|2|||
146949560|NCT00322387|529972144|FG000|Treatment Period|Adverse Event|0|||
146949561|NCT00322387|529972145|FG001|Treatment Period|Adverse Event|1|||
146949562|NCT00322387|529972144|FG000|Follow-up Period|Final assessment not done|1|||
146949563|NCT00322387|529972145|FG001|Follow-up Period|Final assessment not done|3|||
146949564|NCT00322387|529972144|FG000|Follow-up Period|Death|1|||
146949565|NCT00322387|529972145|FG001|Follow-up Period|Death|0|||
146949566|NCT01855919|529973631|FG000|Overall Study|Adverse Event|16|||
146949567|NCT01855919|529973632|FG001|Overall Study|Adverse Event|8|||
146949568|NCT01855919|529973631|FG000|Overall Study|Lack of Efficacy|1|||
146949569|NCT01855919|529973632|FG001|Overall Study|Lack of Efficacy|3|||
146949570|NCT01855919|529973631|FG000|Overall Study|Withdrawal by Subject|4|||
146949571|NCT01855919|529973632|FG001|Overall Study|Withdrawal by Subject|10|||
146949572|NCT01855919|529973631|FG000|Overall Study|Entry Criteria Not Met|1|||
146949573|NCT01855919|529973632|FG001|Overall Study|Entry Criteria Not Met|1|||
146949574|NCT01855919|529973631|FG000|Overall Study|Protocol Violation|1|||
146949575|NCT01855919|529973632|FG001|Overall Study|Protocol Violation|4|||
146949576|NCT03455530|529973633|FG000|Overall Study|Withdrawal by Subject|9|||
146949577|NCT03455530|529973634|FG001|Overall Study|Withdrawal by Subject|1|||
146949578|NCT03455530|529973635|FG002|Overall Study|Withdrawal by Subject|3|||
146949579|NCT03455530|529973636|FG003|Overall Study|Withdrawal by Subject|3|||
146949580|NCT00740116|529973642|FG000|Overall Study|Withdrawal by Subject|1|||
146949581|NCT00740116|529973643|FG001|Overall Study|Withdrawal by Subject|1|||
146949582|NCT00740116|529973642|FG000|Overall Study|Protocol Violation|1|||
146949583|NCT00740116|529973643|FG001|Overall Study|Protocol Violation|4|||
146949584|NCT00121485|529973644|FG000|Overall Study|Not implanted|1|||
146949585|NCT00121485|529973645|FG001|Overall Study|Not implanted|5|||
146949586|NCT00121485|529973644|FG000|Overall Study|Crossover|0|||
146949587|NCT00121485|529973645|FG001|Overall Study|Crossover|2|||
146949588|NCT00908895|529973648|FG000|Overall Study|Lost to Follow-up|1|||
146949589|NCT00908895|529973649|FG001|Overall Study|Lost to Follow-up|3|||
146949590|NCT00908895|529973648|FG000|Overall Study|algodystrophy|2|||
146949591|NCT00908895|529973649|FG001|Overall Study|algodystrophy|2|||
146949592|NCT00908895|529973648|FG000|Overall Study|Adverse Event|1|||
146949593|NCT00908895|529973649|FG001|Overall Study|Adverse Event|1|||
146949594|NCT01997892|529973652|FG000|Overall Study|Physician Decision|2|||
146949595|NCT01997892|529973652|FG000|Overall Study|Lost to Follow-up|6|||
146949596|NCT01997892|529973652|FG000|Overall Study|Death|14|||
146949597|NCT01997892|529973652|FG000|Overall Study|Renal transplant|8|||
146949598|NCT01997892|529973652|FG000|Overall Study|Other|3|||
146949599|NCT01997892|529973652|FG000|Overall Study|Study completion data not recorded|35|||
146949600|NCT02710422|529973653|FG000|Overall Study|Termination of study|9|||
146949601|NCT02710422|529973654|FG001|Overall Study|Termination of study|9|||
146949602|NCT02608099|529973671|FG000|Overall Study|Ablation procedure not initiated|3|||
146949603|NCT02608099|529973672|FG001|Overall Study|Ablation procedure not initiated|2|||
146949604|NCT01654224|529973676|FG000|Overall Study|Lost to Follow-up|2|||
146949605|NCT01654224|529973677|FG001|Overall Study|Lost to Follow-up|2|||
146949606|NCT01654224|529973676|FG000|Overall Study|Did not receive allocation|1|||
146949607|NCT01654224|529973677|FG001|Overall Study|Did not receive allocation|8|||
146949608|NCT01654224|529973676|FG000|Overall Study|Insufficient blood sample|3|||
146949609|NCT01654224|529973677|FG001|Overall Study|Insufficient blood sample|2|||
146949610|NCT03763942|529973678|FG000|Overall Study|Lost to Follow-up|114|||
146949611|NCT03763942|529973679|FG001|Overall Study|Lost to Follow-up|54|||
146949612|NCT03763942|529973678|FG000|Overall Study|Protocol Violation|1|||
146949613|NCT03763942|529973679|FG001|Overall Study|Protocol Violation|0|||
146949614|NCT03763942|529973678|FG000|Overall Study|Withdrawal by Subject|2|||
146949615|NCT03763942|529973679|FG001|Overall Study|Withdrawal by Subject|0|||
146949616|NCT03763942|529973678|FG000|Overall Study|Other|2|||
146949617|NCT03763942|529973679|FG001|Overall Study|Other|3|||
146949618|NCT02145429|529973680|FG000|Overall Study|Death|4|||
146949619|NCT02145429|529973681|FG001|Overall Study|Death|5|||
146949620|NCT02145429|529973680|FG000|Overall Study|Lost to Follow-up|4|||
146949621|NCT02145429|529973681|FG001|Overall Study|Lost to Follow-up|3|||
146949622|NCT02145429|529973680|FG000|Overall Study|Withdrawal by Subject|8|||
146949623|NCT02145429|529973681|FG001|Overall Study|Withdrawal by Subject|3|||
146949624|NCT02200510|529973682|FG000|Overall Study|Death|1|||
146949625|NCT02200510|529973683|FG001|Overall Study|Death|1|||
146949626|NCT02200510|529973682|FG000|Overall Study|Protocol Violation|0|||
146949627|NCT02200510|529973683|FG001|Overall Study|Protocol Violation|1|||
146949628|NCT02200510|529973682|FG000|Overall Study|Lost to Follow-up|7|||
146949629|NCT02200510|529973683|FG001|Overall Study|Lost to Follow-up|1|||
146949630|NCT02200510|529973682|FG000|Overall Study|potential COI - joined study team|1|||
146949631|NCT02200510|529973683|FG001|Overall Study|potential COI - joined study team|0|||
146949632|NCT04556175|529973687|FG000|Overall Study|Study terminated due to COVID-19|8|||
146949633|NCT04556175|529973688|FG001|Overall Study|Study terminated due to COVID-19|8|||
146949634|NCT05492877|529973690|FG000|Overall Study|Adverse Event|11|||
146949635|NCT05492877|529973691|FG001|Overall Study|Adverse Event|7|||
146949636|NCT05492877|529973690|FG000|Overall Study|Death|1|||
146949637|NCT05492877|529973691|FG001|Overall Study|Death|0|||
146949638|NCT05492877|529973690|FG000|Overall Study|Lost to Follow-up|1|||
146949639|NCT05492877|529973691|FG001|Overall Study|Lost to Follow-up|1|||
146949640|NCT05492877|529973690|FG000|Overall Study|Physician Decision|1|||
146949641|NCT05492877|529973691|FG001|Overall Study|Physician Decision|2|||
146949642|NCT05492877|529973690|FG000|Overall Study|Protocol Violation|1|||
146949643|NCT05492877|529973691|FG001|Overall Study|Protocol Violation|1|||
146949644|NCT05492877|529973690|FG000|Overall Study|Withdrawal by Subject|3|||
146949645|NCT05492877|529973691|FG001|Overall Study|Withdrawal by Subject|7|||
146949646|NCT05492877|529973690|FG000|Overall Study|Reason not specified|6|||
146949647|NCT05492877|529973691|FG001|Overall Study|Reason not specified|4|||
146949648|NCT02871791|529973692|FG000|Phase 1b|Death|0|||
146949649|NCT02871791|529973693|FG001|Phase 1b|Death|1|||
146949650|NCT02871791|529973692|FG000|Phase 1b|progressive disease|6|||
146949651|NCT02871791|529973693|FG001|Phase 1b|progressive disease|2|||
146949652|NCT02871791|529973692|FG000|Phase 2|Death|1|||
146949653|NCT02871791|529973693|FG001|Phase 2|Death|0|||
146949654|NCT02871791|529973692|FG000|Phase 2|Lost to Follow-up|2|||
146949655|NCT02871791|529973693|FG001|Phase 2|Lost to Follow-up|0|||
146949656|NCT02010567|529973707|FG000|Overall Study|Adverse Event|0|||
146949657|NCT02010567|529973708|FG001|Overall Study|Adverse Event|0|||
146949658|NCT02010567|529973709|FG002|Overall Study|Adverse Event|1|||
146949659|NCT02010567|529973710|FG003|Overall Study|Adverse Event|0|||
146949660|NCT02010567|529973711|FG004|Overall Study|Adverse Event|1|||
146949661|NCT00118040|529973716|FG000|Overall Study|Adverse Event|0|||
146949662|NCT00118040|529973717|FG001|Overall Study|Adverse Event|1|||
146949663|NCT00118040|529973718|FG002|Overall Study|Adverse Event|0|||
146949664|NCT00118040|529973716|FG000|Overall Study|Withdrawal by Subject|0|||
146949665|NCT00118040|529973717|FG001|Overall Study|Withdrawal by Subject|0|||
146949666|NCT00118040|529973718|FG002|Overall Study|Withdrawal by Subject|2|||
146949667|NCT00118040|529973716|FG000|Overall Study|Medical Contraindication|0|||
146949668|NCT00118040|529973717|FG001|Overall Study|Medical Contraindication|0|||
146949669|NCT00118040|529973718|FG002|Overall Study|Medical Contraindication|1|||
146949670|NCT00118040|529973716|FG000|Overall Study|Non-Compliant Participant|1|||
146818285|NCT02062827|529502779|FG006|Overall Study|Withdrawal by Subject|5|||
146818286|NCT02062827|529502780|FG007|Overall Study|Withdrawal by Subject|0|||
146818287|NCT02062827|529502773|FG000|Overall Study|Screen Fail|0|||
146818288|NCT02062827|529502774|FG001|Overall Study|Screen Fail|0|||
146818289|NCT02062827|529502775|FG002|Overall Study|Screen Fail|0|||
146818290|NCT02062827|529502776|FG003|Overall Study|Screen Fail|0|||
146818291|NCT02062827|529502777|FG004|Overall Study|Screen Fail|0|||
146818292|NCT02062827|529502778|FG005|Overall Study|Screen Fail|0|||
146818293|NCT02062827|529502779|FG006|Overall Study|Screen Fail|0|||
146818294|NCT02062827|529502780|FG007|Overall Study|Screen Fail|8|||
146818295|NCT02604199|529502783|FG000|Overall Study|Pregnancy|0|||
146818296|NCT02604199|529502784|FG001|Overall Study|Pregnancy|0|||
146818297|NCT02604199|529502785|FG002|Overall Study|Pregnancy|0|||
146818298|NCT02604199|529502786|FG003|Overall Study|Pregnancy|1|||
146818299|NCT02604199|529502783|FG000|Overall Study|Study terminated by sponsor|0|||
146818300|NCT02604199|529502784|FG001|Overall Study|Study terminated by sponsor|2|||
146818301|NCT02604199|529502785|FG002|Overall Study|Study terminated by sponsor|0|||
146818302|NCT02604199|529502786|FG003|Overall Study|Study terminated by sponsor|2|||
146818303|NCT02604199|529502783|FG000|Overall Study|Withdrawal by Subject|0|||
146818304|NCT02604199|529502784|FG001|Overall Study|Withdrawal by Subject|1|||
146818305|NCT02604199|529502785|FG002|Overall Study|Withdrawal by Subject|0|||
146818306|NCT02604199|529502786|FG003|Overall Study|Withdrawal by Subject|0|||
146818307|NCT02213458|529502791|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
146818308|NCT02213458|529502792|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
146818309|NCT02213458|529502791|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
146818310|NCT02213458|529502792|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
146818311|NCT02213458|529502791|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
146818312|NCT02213458|529502792|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
146818313|NCT02213458|529502791|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
146818314|NCT02213458|529502792|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
146818315|NCT02213458|529502791|FG000|Overall Study|Refused re-consent|6|||
146818316|NCT02213458|529502792|FG001|Overall Study|Refused re-consent|0|||
146818317|NCT02213458|529502791|FG000|Overall Study|Lost to Follow-up|2|||
146818318|NCT02213458|529502792|FG001|Overall Study|Lost to Follow-up|2|||
146818319|NCT02213458|529502791|FG000|Overall Study|Withdrawal by Subject|26|||
146818320|NCT02213458|529502792|FG001|Overall Study|Withdrawal by Subject|8|||
146818321|NCT01721109|529502794|FG000|Overall Study|Lack of Efficacy|1|||
146818322|NCT01721109|529502794|FG000|Overall Study|Non- Compliance with Study Drug|3|||
146818323|NCT01721109|529502794|FG000|Overall Study|Withdrew Consent|1|||
146818324|NCT01721109|529502794|FG000|Overall Study|Lost to Follow-up|2|||
146818325|NCT05740371|529502797|FG000|Overall Study|Death|1|||
146818326|NCT02561195|529502801|FG000|Vaccination 1 to 3|Adverse Event|4|||
146818327|NCT02561195|529502802|FG001|Vaccination 1 to 3|Adverse Event|5|||
146818328|NCT02561195|529502803|FG002|Vaccination 1 to 3|Adverse Event|0|||
146818329|NCT02561195|529502804|FG003|Vaccination 1 to 3|Adverse Event|3|||
146818330|NCT02561195|529502805|FG004|Vaccination 1 to 3|Adverse Event|4|||
146818331|NCT02561195|529502806|FG005|Vaccination 1 to 3|Adverse Event|0|||
146818332|NCT02561195|529502807|FG006|Vaccination 1 to 3|Adverse Event|0|||
146818333|NCT02561195|529502808|FG007|Vaccination 1 to 3|Adverse Event|0|||
146818334|NCT02561195|529502809|FG008|Vaccination 1 to 3|Adverse Event|0|||
146818335|NCT02561195|529502810|FG009|Vaccination 1 to 3|Adverse Event|0|||
146818336|NCT02561195|529502811|FG010|Vaccination 1 to 3|Adverse Event|0|||
146818337|NCT02561195|529502812|FG011|Vaccination 1 to 3|Adverse Event|0|||
146818338|NCT02561195|529502813|FG012|Vaccination 1 to 3|Adverse Event|0|||
146818339|NCT02561195|529502814|FG013|Vaccination 1 to 3|Adverse Event|0|||
146818340|NCT02561195|529502801|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
146818341|NCT02561195|529502802|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
146818342|NCT02561195|529502803|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
146818343|NCT02561195|529502804|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
146818344|NCT02561195|529502805|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
146949671|NCT00118040|529973717|FG001|Overall Study|Non-Compliant Participant|1|||
146949672|NCT00118040|529973718|FG002|Overall Study|Non-Compliant Participant|2|||
146818345|NCT02561195|529502806|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
146818346|NCT02561195|529502807|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
146818347|NCT02561195|529502808|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
146818348|NCT02561195|529502809|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
146818349|NCT02561195|529502810|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
146818350|NCT02561195|529502811|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
146818351|NCT02561195|529502812|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
146818352|NCT02561195|529502813|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
146818353|NCT02561195|529502814|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
146818354|NCT02561195|529502801|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146818355|NCT02561195|529502802|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
146818356|NCT02561195|529502803|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146818357|NCT02561195|529502804|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
146818358|NCT02561195|529502805|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
146818359|NCT02561195|529502806|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
146818360|NCT02561195|529502807|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146818361|NCT02561195|529502808|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146949673|NCT00118040|529973716|FG000|Overall Study|Other|0|||
146949674|NCT00118040|529973717|FG001|Overall Study|Other|0|||
146949675|NCT00118040|529973718|FG002|Overall Study|Other|1|||
146949676|NCT00397631|529973719|FG000|Overall Study|Adverse Event|5|||
146949677|NCT00397631|529973720|FG001|Overall Study|Adverse Event|6|||
146949678|NCT00397631|529973719|FG000|Overall Study|Lack of Efficacy|7|||
146949679|NCT00397631|529973720|FG001|Overall Study|Lack of Efficacy|10|||
146949680|NCT00397631|529973719|FG000|Overall Study|Lost to Follow-up|8|||
146949681|NCT00397631|529973720|FG001|Overall Study|Lost to Follow-up|9|||
146949682|NCT00397631|529973719|FG000|Overall Study|Physician Decision|2|||
146949683|NCT00397631|529973720|FG001|Overall Study|Physician Decision|0|||
146949684|NCT00397631|529973719|FG000|Overall Study|Protocol Violation|0|||
146949685|NCT00397631|529973720|FG001|Overall Study|Protocol Violation|1|||
146949686|NCT00397631|529973719|FG000|Overall Study|Withdrawal by Subject|7|||
146949687|NCT00397631|529973720|FG001|Overall Study|Withdrawal by Subject|14|||
146949688|NCT00397631|529973719|FG000|Overall Study|protocol discontinuation criteria|1|||
146949689|NCT00397631|529973720|FG001|Overall Study|protocol discontinuation criteria|4|||
146949690|NCT01738594|529973721|FG000|Registration and Treatment Start|Adverse Event|0|||
146949691|NCT01738594|529973722|FG001|Registration and Treatment Start|Adverse Event|1|||
146949692|NCT01738594|529973723|FG002|Registration and Treatment Start|Adverse Event|0|||
146949693|NCT01738594|529973724|FG003|Registration and Treatment Start|Adverse Event|0|||
146949694|NCT01738594|529973725|FG004|Registration and Treatment Start|Adverse Event|0|||
146949695|NCT01738594|529973726|FG005|Registration and Treatment Start|Adverse Event|0|||
146949696|NCT01738594|529973727|FG006|Registration and Treatment Start|Adverse Event|0|||
146949697|NCT01738594|529973728|FG007|Registration and Treatment Start|Adverse Event|0|||
146949698|NCT01738594|529973721|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
146949699|NCT01738594|529973722|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
146949700|NCT01738594|529973723|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
146949701|NCT01738594|529973724|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
146949702|NCT01738594|529973725|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
146949703|NCT01738594|529973726|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
146949704|NCT01738594|529973727|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
146949705|NCT01738594|529973728|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
146949706|NCT01738594|529973721|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
146949707|NCT01738594|529973722|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
146949708|NCT01738594|529973723|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
146949709|NCT01738594|529973724|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
146949710|NCT01738594|529973725|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
146949711|NCT01738594|529973726|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
146949712|NCT01738594|529973727|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
146949713|NCT01738594|529973728|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
146949714|NCT01738594|529973721|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
146949715|NCT01738594|529973722|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
146949716|NCT01738594|529973723|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
146949717|NCT01738594|529973724|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
146949718|NCT01738594|529973725|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
146949719|NCT01738594|529973726|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
146949720|NCT01738594|529973727|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
146949721|NCT01738594|529973728|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
146949722|NCT01738594|529973721|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
146949723|NCT01738594|529973722|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
146949724|NCT01738594|529973723|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
146949725|NCT01738594|529973724|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
146949726|NCT01738594|529973725|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
146949727|NCT01738594|529973726|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
146949728|NCT01738594|529973727|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
146949729|NCT01738594|529973728|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
146949730|NCT01738594|529973721|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
146949731|NCT01738594|529973722|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
146949732|NCT01738594|529973723|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
146949733|NCT01738594|529973724|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
146949734|NCT01738594|529973725|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
146818362|NCT02561195|529502809|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146818363|NCT02561195|529502810|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146949735|NCT01738594|529973726|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
146949736|NCT01738594|529973727|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
146949737|NCT01738594|529973728|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
146949738|NCT01738594|529973721|FG000|Follow up for 1 Year|Death|0|||
146949739|NCT01738594|529973722|FG001|Follow up for 1 Year|Death|0|||
146949740|NCT01738594|529973723|FG002|Follow up for 1 Year|Death|0|||
146949741|NCT01738594|529973724|FG003|Follow up for 1 Year|Death|0|||
146949742|NCT01738594|529973725|FG004|Follow up for 1 Year|Death|0|||
146949743|NCT01738594|529973726|FG005|Follow up for 1 Year|Death|1|||
146949744|NCT01738594|529973727|FG006|Follow up for 1 Year|Death|0|||
146949745|NCT01738594|529973728|FG007|Follow up for 1 Year|Death|0|||
146949746|NCT01738594|529973721|FG000|Follow up for 1 Year|Other|0|||
146949747|NCT01738594|529973722|FG001|Follow up for 1 Year|Other|0|||
146949748|NCT01738594|529973723|FG002|Follow up for 1 Year|Other|0|||
146949749|NCT01738594|529973724|FG003|Follow up for 1 Year|Other|0|||
146949750|NCT01738594|529973725|FG004|Follow up for 1 Year|Other|0|||
146949751|NCT01738594|529973726|FG005|Follow up for 1 Year|Other|2|||
146949752|NCT01738594|529973727|FG006|Follow up for 1 Year|Other|0|||
146949753|NCT01738594|529973728|FG007|Follow up for 1 Year|Other|0|||
146949754|NCT00403390|529973730|FG000|Overall Study|Withdrawal by Subject|1|||
146949755|NCT00403390|529973731|FG001|Overall Study|Withdrawal by Subject|0|||
146949756|NCT00403390|529973730|FG000|Overall Study|samples lost|1|||
146949757|NCT00403390|529973731|FG001|Overall Study|samples lost|0|||
146949758|NCT00403390|529973730|FG000|Overall Study|non-compliant|1|||
146949759|NCT00403390|529973731|FG001|Overall Study|non-compliant|0|||
146949760|NCT01878175|529973732|FG000|Overall Study|Developed contraindicated health problem|2|||
146949761|NCT01796106|529973733|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
146949762|NCT01796106|529973734|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
146949763|NCT02943668|529973735|FG000|Overall Study|Disease Progression|1|||
146949764|NCT02711553|529973736|FG000|Overall Study|Withdrawal by Subject|2|||
146949765|NCT02711553|529973737|FG001|Overall Study|Withdrawal by Subject|1|||
146949766|NCT02711553|529973738|FG002|Overall Study|Withdrawal by Subject|1|||
146949767|NCT02711553|529973739|FG003|Overall Study|Withdrawal by Subject|0|||
146949768|NCT02711553|529973736|FG000|Overall Study|Lost to Follow-up|3|||
146949769|NCT02711553|529973737|FG001|Overall Study|Lost to Follow-up|3|||
146949770|NCT02711553|529973738|FG002|Overall Study|Lost to Follow-up|6|||
146949771|NCT02711553|529973739|FG003|Overall Study|Lost to Follow-up|3|||
146949772|NCT02711553|529973736|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
146949773|NCT02711553|529973737|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
146949774|NCT02711553|529973738|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
146949775|NCT02711553|529973739|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
146949776|NCT00572728|529973742|FG000|Overall Study|Withdrawal by Subject|10|||
146949777|NCT00572728|529973742|FG000|Overall Study|Ineligible|3|||
146949778|NCT00572728|529973742|FG000|Overall Study|Enrolled under Amendment 4|5|||
146949779|NCT00572728|529973742|FG000|Overall Study|Offstudy due to complicating disease|1|||
146949780|NCT00572728|529973742|FG000|Overall Study|FLT1 not completed|4|||
146949781|NCT00572728|529973742|FG000|Overall Study|First Chemotherapy not initiated|2|||
146949782|NCT00572728|529973742|FG000|Overall Study|FLT2 not completed|5|||
146949783|NCT00572728|529973742|FG000|Overall Study|Second chemotherapy not initiated|1|||
146949784|NCT00572728|529973742|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
146949785|NCT00572728|529973742|FG000|Overall Study|Pathology missing|1|||
146949786|NCT02724111|529973745|FG000|Overall Study|Protocol Violation|2|||
146949787|NCT02724111|529973746|FG001|Overall Study|Protocol Violation|5|||
146949788|NCT02996500|529973747|FG000|Overall Study|Adverse Event|1|||
146949789|NCT02996500|529973748|FG001|Overall Study|Adverse Event|1|||
146949790|NCT02996500|529973749|FG002|Overall Study|Adverse Event|4|||
146949791|NCT02996500|529973750|FG003|Overall Study|Adverse Event|3|||
146949792|NCT02996500|529973751|FG004|Overall Study|Adverse Event|1|||
146818364|NCT02561195|529502811|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146949793|NCT02996500|529973752|FG005|Overall Study|Adverse Event|2|||
146949794|NCT02996500|529973747|FG000|Overall Study|Lack of Efficacy|0|||
146818365|NCT02561195|529502812|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146818366|NCT02561195|529502813|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146949795|NCT02996500|529973748|FG001|Overall Study|Lack of Efficacy|0|||
146818367|NCT02561195|529502814|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146949796|NCT02996500|529973749|FG002|Overall Study|Lack of Efficacy|0|||
146949797|NCT02996500|529973750|FG003|Overall Study|Lack of Efficacy|0|||
146949798|NCT02996500|529973751|FG004|Overall Study|Lack of Efficacy|2|||
146949799|NCT02996500|529973752|FG005|Overall Study|Lack of Efficacy|0|||
146949800|NCT02996500|529973747|FG000|Overall Study|Lost to Follow-up|1|||
146818368|NCT02561195|529502801|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
146949801|NCT02996500|529973748|FG001|Overall Study|Lost to Follow-up|0|||
146949802|NCT02996500|529973749|FG002|Overall Study|Lost to Follow-up|0|||
146949803|NCT02996500|529973750|FG003|Overall Study|Lost to Follow-up|0|||
146949804|NCT02996500|529973751|FG004|Overall Study|Lost to Follow-up|0|||
146818369|NCT02561195|529502802|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
146818370|NCT02561195|529502803|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
146818371|NCT02561195|529502804|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
146818372|NCT02561195|529502805|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
146818373|NCT02561195|529502806|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
146818374|NCT02561195|529502807|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
146818375|NCT02561195|529502808|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
146818376|NCT02561195|529502809|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
146818377|NCT02561195|529502810|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
146818378|NCT02561195|529502811|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
146818379|NCT02561195|529502812|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
146818380|NCT02561195|529502813|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
146818381|NCT02561195|529502814|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
146818382|NCT02561195|529502801|FG000|Vaccination 1 to 3|Other|7|||
146818383|NCT02561195|529502802|FG001|Vaccination 1 to 3|Other|3|||
146818384|NCT02561195|529502803|FG002|Vaccination 1 to 3|Other|1|||
146818385|NCT02561195|529502804|FG003|Vaccination 1 to 3|Other|7|||
146818386|NCT02561195|529502805|FG004|Vaccination 1 to 3|Other|5|||
146818387|NCT02561195|529502806|FG005|Vaccination 1 to 3|Other|1|||
146818388|NCT02561195|529502807|FG006|Vaccination 1 to 3|Other|0|||
146818389|NCT02561195|529502808|FG007|Vaccination 1 to 3|Other|0|||
146818390|NCT02561195|529502809|FG008|Vaccination 1 to 3|Other|0|||
146818391|NCT02561195|529502810|FG009|Vaccination 1 to 3|Other|0|||
146818392|NCT02561195|529502811|FG010|Vaccination 1 to 3|Other|0|||
146818393|NCT02561195|529502812|FG011|Vaccination 1 to 3|Other|0|||
146818394|NCT02561195|529502813|FG012|Vaccination 1 to 3|Other|0|||
146818395|NCT02561195|529502814|FG013|Vaccination 1 to 3|Other|0|||
146818396|NCT02561195|529502801|FG000|Vaccination 1 to 3|Protocol Violation|1|||
146818397|NCT02561195|529502802|FG001|Vaccination 1 to 3|Protocol Violation|0|||
146818398|NCT02561195|529502803|FG002|Vaccination 1 to 3|Protocol Violation|1|||
146818399|NCT02561195|529502804|FG003|Vaccination 1 to 3|Protocol Violation|2|||
146818400|NCT02561195|529502805|FG004|Vaccination 1 to 3|Protocol Violation|5|||
146818401|NCT02561195|529502806|FG005|Vaccination 1 to 3|Protocol Violation|2|||
146818402|NCT02561195|529502807|FG006|Vaccination 1 to 3|Protocol Violation|0|||
146818403|NCT02561195|529502808|FG007|Vaccination 1 to 3|Protocol Violation|0|||
146818404|NCT02561195|529502809|FG008|Vaccination 1 to 3|Protocol Violation|0|||
146818405|NCT02561195|529502810|FG009|Vaccination 1 to 3|Protocol Violation|0|||
146818406|NCT02561195|529502811|FG010|Vaccination 1 to 3|Protocol Violation|0|||
146818407|NCT02561195|529502812|FG011|Vaccination 1 to 3|Protocol Violation|0|||
146818408|NCT02561195|529502813|FG012|Vaccination 1 to 3|Protocol Violation|0|||
146818409|NCT02561195|529502814|FG013|Vaccination 1 to 3|Protocol Violation|0|||
146818410|NCT02561195|529502801|FG000|Vaccination 1 to 3|Death|2|||
146818411|NCT02561195|529502802|FG001|Vaccination 1 to 3|Death|1|||
146818412|NCT02561195|529502803|FG002|Vaccination 1 to 3|Death|0|||
146818413|NCT02561195|529502804|FG003|Vaccination 1 to 3|Death|2|||
146818414|NCT02561195|529502805|FG004|Vaccination 1 to 3|Death|0|||
146818415|NCT02561195|529502806|FG005|Vaccination 1 to 3|Death|0|||
146818416|NCT02561195|529502807|FG006|Vaccination 1 to 3|Death|0|||
146818417|NCT02561195|529502808|FG007|Vaccination 1 to 3|Death|0|||
146818418|NCT02561195|529502809|FG008|Vaccination 1 to 3|Death|0|||
146818419|NCT02561195|529502810|FG009|Vaccination 1 to 3|Death|0|||
146818420|NCT02561195|529502811|FG010|Vaccination 1 to 3|Death|0|||
146818421|NCT02561195|529502812|FG011|Vaccination 1 to 3|Death|0|||
146818422|NCT02561195|529502813|FG012|Vaccination 1 to 3|Death|0|||
146949805|NCT02996500|529973752|FG005|Overall Study|Lost to Follow-up|1|||
146949806|NCT02996500|529973747|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
146949807|NCT02996500|529973748|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146818423|NCT02561195|529502814|FG013|Vaccination 1 to 3|Death|0|||
146818424|NCT02561195|529502801|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
146818425|NCT02561195|529502802|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
146818426|NCT02561195|529502803|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
146818427|NCT02561195|529502804|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
146818428|NCT02561195|529502805|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
146818429|NCT02561195|529502806|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
146818430|NCT02561195|529502807|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
146818431|NCT02561195|529502808|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
146818432|NCT02561195|529502809|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
146818433|NCT02561195|529502810|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
146818434|NCT02561195|529502811|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
146818435|NCT02561195|529502812|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
146818436|NCT02561195|529502813|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
146818437|NCT02561195|529502814|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
146818438|NCT02561195|529502801|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
146818439|NCT02561195|529502802|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
146818440|NCT02561195|529502803|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
146818441|NCT02561195|529502804|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
146818442|NCT02561195|529502805|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
146949808|NCT02996500|529973749|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
146949809|NCT02996500|529973750|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
146949810|NCT02996500|529973751|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
146949811|NCT02996500|529973752|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
146949812|NCT02996500|529973747|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146949813|NCT02996500|529973748|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146949814|NCT02996500|529973749|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146949815|NCT02996500|529973750|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146949816|NCT02996500|529973751|FG004|Overall Study|Non-Compliance With Study Drug|0|||
146949817|NCT02996500|529973752|FG005|Overall Study|Non-Compliance With Study Drug|1|||
146949818|NCT02996500|529973747|FG000|Overall Study|Progressive Disease|1|||
146949819|NCT02996500|529973748|FG001|Overall Study|Progressive Disease|0|||
146949820|NCT02996500|529973749|FG002|Overall Study|Progressive Disease|0|||
146949821|NCT02996500|529973750|FG003|Overall Study|Progressive Disease|0|||
146949822|NCT02996500|529973751|FG004|Overall Study|Progressive Disease|0|||
146949823|NCT02996500|529973752|FG005|Overall Study|Progressive Disease|0|||
146949824|NCT02996500|529973747|FG000|Overall Study|Other|2|||
146949825|NCT02996500|529973748|FG001|Overall Study|Other|0|||
146949826|NCT02996500|529973749|FG002|Overall Study|Other|2|||
146949827|NCT02996500|529973750|FG003|Overall Study|Other|0|||
146949828|NCT02996500|529973751|FG004|Overall Study|Other|0|||
146949829|NCT02996500|529973752|FG005|Overall Study|Other|0|||
146949830|NCT02996500|529973747|FG000|Overall Study|Protocol Violation|0|||
146949831|NCT02996500|529973748|FG001|Overall Study|Protocol Violation|0|||
146949832|NCT02996500|529973749|FG002|Overall Study|Protocol Violation|0|||
146949833|NCT02996500|529973750|FG003|Overall Study|Protocol Violation|1|||
146949834|NCT02996500|529973751|FG004|Overall Study|Protocol Violation|0|||
146949835|NCT02996500|529973752|FG005|Overall Study|Protocol Violation|0|||
146949836|NCT02996500|529973747|FG000|Overall Study|Withdrawal by Subject|3|||
146949837|NCT02996500|529973748|FG001|Overall Study|Withdrawal by Subject|0|||
146949838|NCT02996500|529973749|FG002|Overall Study|Withdrawal by Subject|3|||
146949839|NCT02996500|529973750|FG003|Overall Study|Withdrawal by Subject|0|||
146949840|NCT02996500|529973751|FG004|Overall Study|Withdrawal by Subject|2|||
146949841|NCT02996500|529973752|FG005|Overall Study|Withdrawal by Subject|0|||
146949842|NCT01828567|529973753|FG000|Overall Study|Lost to Follow-up|27|||
146949843|NCT01828567|529973754|FG001|Overall Study|Lost to Follow-up|9|||
146949844|NCT01828567|529973753|FG000|Overall Study|Excluded - did not meet criteria|4|||
146949845|NCT01828567|529973754|FG001|Overall Study|Excluded - did not meet criteria|1|||
146949846|NCT02332876|529973755|FG000|Overall Study|Lost to Follow-up|1|||
146949847|NCT02332876|529973756|FG001|Overall Study|Lost to Follow-up|1|||
146949848|NCT02415595|529973757|FG000|Overall Study|Administrative reason by sponsor|39|||
146949849|NCT02415595|529973758|FG001|Overall Study|Administrative reason by sponsor|40|||
146949850|NCT02415595|529973759|FG002|Overall Study|Administrative reason by sponsor|41|||
146949851|NCT02415595|529973760|FG003|Overall Study|Administrative reason by sponsor|39|||
146949852|NCT02415595|529973757|FG000|Overall Study|Adverse Event|1|||
146949853|NCT02415595|529973758|FG001|Overall Study|Adverse Event|3|||
146949854|NCT02415595|529973759|FG002|Overall Study|Adverse Event|5|||
146949855|NCT02415595|529973760|FG003|Overall Study|Adverse Event|10|||
146949856|NCT02415595|529973757|FG000|Overall Study|Lack of Efficacy|4|||
146949857|NCT02415595|529973758|FG001|Overall Study|Lack of Efficacy|4|||
146949858|NCT02415595|529973759|FG002|Overall Study|Lack of Efficacy|0|||
146949859|NCT02415595|529973760|FG003|Overall Study|Lack of Efficacy|0|||
146949860|NCT02415595|529973757|FG000|Overall Study|Lost to Follow-up|1|||
146949861|NCT02415595|529973758|FG001|Overall Study|Lost to Follow-up|3|||
146949862|NCT02415595|529973759|FG002|Overall Study|Lost to Follow-up|1|||
146949863|NCT02415595|529973760|FG003|Overall Study|Lost to Follow-up|1|||
146949864|NCT02415595|529973757|FG000|Overall Study|Poor/Non-compliance|1|||
146949865|NCT02415595|529973758|FG001|Overall Study|Poor/Non-compliance|0|||
146949866|NCT02415595|529973759|FG002|Overall Study|Poor/Non-compliance|1|||
146949867|NCT02415595|529973760|FG003|Overall Study|Poor/Non-compliance|0|||
146949868|NCT02415595|529973757|FG000|Overall Study|Reached stopping criteria|0|||
146949869|NCT02415595|529973758|FG001|Overall Study|Reached stopping criteria|1|||
146949870|NCT02415595|529973759|FG002|Overall Study|Reached stopping criteria|1|||
146949871|NCT02415595|529973760|FG003|Overall Study|Reached stopping criteria|0|||
146949872|NCT02415595|529973757|FG000|Overall Study|Withdrawal by Subject|4|||
146949873|NCT02415595|529973758|FG001|Overall Study|Withdrawal by Subject|0|||
146949874|NCT02415595|529973759|FG002|Overall Study|Withdrawal by Subject|1|||
146949875|NCT02415595|529973760|FG003|Overall Study|Withdrawal by Subject|3|||
146949876|NCT02415595|529973757|FG000|Overall Study|Other|0|||
146949877|NCT02415595|529973758|FG001|Overall Study|Other|1|||
146949878|NCT02415595|529973759|FG002|Overall Study|Other|1|||
146949879|NCT02415595|529973760|FG003|Overall Study|Other|0|||
146949880|NCT02614261|529973761|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
146949881|NCT02614261|529973762|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
146949882|NCT02614261|529973763|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
146949883|NCT02614261|529973764|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
146949884|NCT02614261|529973761|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
146949885|NCT02614261|529973762|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
146949886|NCT02614261|529973763|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
146949887|NCT02614261|529973764|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
146949888|NCT02614261|529973761|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
146949889|NCT02614261|529973762|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
146949890|NCT02614261|529973763|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
146949891|NCT02614261|529973764|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146949892|NCT02614261|529973761|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
146949893|NCT02614261|529973762|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
146949894|NCT02614261|529973763|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
146949895|NCT02614261|529973764|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
146949896|NCT02614261|529973761|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
146949897|NCT02614261|529973762|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
146949898|NCT02614261|529973763|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
146949899|NCT02614261|529973764|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
146949900|NCT02614261|529973761|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
146949901|NCT02614261|529973762|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
146949902|NCT02614261|529973763|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
146949903|NCT02614261|529973764|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
146949904|NCT02614261|529973761|FG000|Double-Blind Treatment Phase|Screen failure|0|||
146949905|NCT02614261|529973762|FG001|Double-Blind Treatment Phase|Screen failure|1|||
146949906|NCT02614261|529973763|FG002|Double-Blind Treatment Phase|Screen failure|2|||
146949907|NCT02614261|529973764|FG003|Double-Blind Treatment Phase|Screen failure|0|||
146949908|NCT02614261|529973761|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
146949909|NCT02614261|529973762|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
146949910|NCT02614261|529973763|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
146949911|NCT02614261|529973764|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
146949912|NCT02614261|529973761|FG000|Open-Label Extension Phase|Adverse Event|23|||
146949913|NCT02614261|529973762|FG001|Open-Label Extension Phase|Adverse Event|12|||
146949914|NCT02614261|529973763|FG002|Open-Label Extension Phase|Adverse Event|11|||
146949915|NCT02614261|529973764|FG003|Open-Label Extension Phase|Adverse Event|0|||
146949916|NCT02614261|529973761|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
146949917|NCT02614261|529973762|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
146949918|NCT02614261|529973763|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
146949919|NCT02614261|529973764|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
146949920|NCT02614261|529973761|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
146949921|NCT02614261|529973762|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
146949922|NCT02614261|529973763|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
146949923|NCT02614261|529973764|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
146949924|NCT02614261|529973761|FG000|Open-Label Extension Phase|Physician Decision|2|||
146949925|NCT02614261|529973762|FG001|Open-Label Extension Phase|Physician Decision|0|||
146949926|NCT02614261|529973763|FG002|Open-Label Extension Phase|Physician Decision|0|||
146949927|NCT02614261|529973764|FG003|Open-Label Extension Phase|Physician Decision|0|||
146949928|NCT02614261|529973761|FG000|Open-Label Extension Phase|Pregnancy|1|||
146949929|NCT02614261|529973762|FG001|Open-Label Extension Phase|Pregnancy|2|||
146949930|NCT02614261|529973763|FG002|Open-Label Extension Phase|Pregnancy|1|||
146949931|NCT02614261|529973764|FG003|Open-Label Extension Phase|Pregnancy|0|||
146949932|NCT02614261|529973761|FG000|Open-Label Extension Phase|Protocol Violation|3|||
146949933|NCT02614261|529973762|FG001|Open-Label Extension Phase|Protocol Violation|4|||
146949934|NCT02614261|529973763|FG002|Open-Label Extension Phase|Protocol Violation|1|||
146949935|NCT02614261|529973764|FG003|Open-Label Extension Phase|Protocol Violation|0|||
146949936|NCT02614261|529973761|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
146949937|NCT02614261|529973762|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
146949938|NCT02614261|529973763|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
146949939|NCT02614261|529973764|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
146949940|NCT02614261|529973761|FG000|Follow-up Phase|Adverse Event|2|||
146949941|NCT02614261|529973762|FG001|Follow-up Phase|Adverse Event|0|||
146949942|NCT02614261|529973763|FG002|Follow-up Phase|Adverse Event|1|||
146949943|NCT02614261|529973764|FG003|Follow-up Phase|Adverse Event|0|||
146949944|NCT02614261|529973761|FG000|Follow-up Phase|Lost to Follow-up|12|||
146949945|NCT02614261|529973762|FG001|Follow-up Phase|Lost to Follow-up|5|||
146949946|NCT02614261|529973763|FG002|Follow-up Phase|Lost to Follow-up|2|||
146949947|NCT02614261|529973764|FG003|Follow-up Phase|Lost to Follow-up|0|||
146949948|NCT02614261|529973761|FG000|Follow-up Phase|Physician Decision|5|||
146949949|NCT02614261|529973762|FG001|Follow-up Phase|Physician Decision|1|||
146818443|NCT02561195|529502806|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
146949950|NCT02614261|529973763|FG002|Follow-up Phase|Physician Decision|0|||
146818444|NCT02561195|529502807|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
146949951|NCT02614261|529973764|FG003|Follow-up Phase|Physician Decision|0|||
146949952|NCT02614261|529973761|FG000|Follow-up Phase|Pregnancy|0|||
146949953|NCT02614261|529973762|FG001|Follow-up Phase|Pregnancy|1|||
146818445|NCT02561195|529502808|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
146949954|NCT02614261|529973763|FG002|Follow-up Phase|Pregnancy|0|||
146949955|NCT02614261|529973764|FG003|Follow-up Phase|Pregnancy|0|||
146949956|NCT02614261|529973761|FG000|Follow-up Phase|Protocol Violation|1|||
146949957|NCT02614261|529973762|FG001|Follow-up Phase|Protocol Violation|0|||
146949958|NCT02614261|529973763|FG002|Follow-up Phase|Protocol Violation|0|||
146949959|NCT02614261|529973764|FG003|Follow-up Phase|Protocol Violation|0|||
146949960|NCT02614261|529973761|FG000|Follow-up Phase|Withdrawal by Subject|12|||
146949961|NCT02614261|529973762|FG001|Follow-up Phase|Withdrawal by Subject|4|||
146949962|NCT02614261|529973763|FG002|Follow-up Phase|Withdrawal by Subject|11|||
146949963|NCT02614261|529973764|FG003|Follow-up Phase|Withdrawal by Subject|0|||
146949964|NCT02614261|529973761|FG000|Israel Addendum|Withdrawal by Subject|0|||
146949965|NCT02614261|529973762|FG001|Israel Addendum|Withdrawal by Subject|0|||
146949966|NCT02614261|529973763|FG002|Israel Addendum|Withdrawal by Subject|0|||
146949967|NCT02614261|529973764|FG003|Israel Addendum|Withdrawal by Subject|4|||
146949968|NCT03512275|529973767|FG000|Overall Study|Withdrawal by Subject|1|||
146949969|NCT03512275|529973768|FG001|Overall Study|Withdrawal by Subject|3|||
146949970|NCT03512275|529973767|FG000|Overall Study|Physician Decision|0|||
146949971|NCT03512275|529973768|FG001|Overall Study|Physician Decision|1|||
146949972|NCT03512275|529973767|FG000|Overall Study|Lost to Follow-up|0|||
146949973|NCT03512275|529973768|FG001|Overall Study|Lost to Follow-up|3|||
146949974|NCT03512275|529973767|FG000|Overall Study|Other|1|||
146949975|NCT03512275|529973768|FG001|Overall Study|Other|0|||
146949976|NCT04063865|529973769|FG000|Overall Study|Physician Decision|1|||
146949977|NCT04063865|529973770|FG001|Overall Study|Physician Decision|3|||
146949978|NCT04063865|529973769|FG000|Overall Study|Study Closed Prior to Completion|4|||
146949979|NCT04063865|529973770|FG001|Overall Study|Study Closed Prior to Completion|4|||
146949980|NCT04063865|529973769|FG000|Overall Study|Withdrawal by Subject|1|||
146949981|NCT04063865|529973770|FG001|Overall Study|Withdrawal by Subject|1|||
146949982|NCT03231228|529973772|FG000|Overall Study|Lost to Follow-up|2|||
146949983|NCT03231228|529973773|FG001|Overall Study|Lost to Follow-up|0|||
146949984|NCT03231228|529973772|FG000|Overall Study|Physician Decision|1|||
146949985|NCT03231228|529973773|FG001|Overall Study|Physician Decision|0|||
146949986|NCT03399786|529973779|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
146949987|NCT03399786|529973780|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
146949988|NCT03399786|529973781|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
146949989|NCT03399786|529973782|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
146949990|NCT03399786|529973779|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
146949991|NCT03399786|529973780|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
146949992|NCT03399786|529973781|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
146949993|NCT03399786|529973782|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
146949994|NCT03399786|529973779|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
146949995|NCT03399786|529973780|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
146949996|NCT03399786|529973781|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
146949997|NCT03399786|529973782|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
146949998|NCT03037489|529976075|FG000|Overall Study|Adverse Event|4|||
146949999|NCT03037489|529976076|FG001|Overall Study|Adverse Event|0|||
146950000|NCT03037489|529976075|FG000|Overall Study|Withdrawal by Subject|3|||
146950001|NCT03037489|529976076|FG001|Overall Study|Withdrawal by Subject|0|||
146950002|NCT02499172|529976077|FG000|Overall Study|Financial reason|0|||
146950003|NCT02499172|529976078|FG001|Overall Study|Financial reason|0|||
146950004|NCT02499172|529976079|FG002|Overall Study|Financial reason|523|||
146950005|NCT02499172|529976080|FG003|Overall Study|Financial reason|436|||
146950006|NCT02499172|529976077|FG000|Overall Study|Lost to Follow-up|65|||
146950007|NCT02499172|529976078|FG001|Overall Study|Lost to Follow-up|64|||
146818446|NCT02561195|529502809|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
146818447|NCT02561195|529502810|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
146818448|NCT02561195|529502811|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
146818449|NCT02561195|529502812|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
146818450|NCT02561195|529502813|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
146818451|NCT02561195|529502814|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
146818452|NCT02561195|529502801|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146818453|NCT02561195|529502802|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146818454|NCT02561195|529502803|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146950008|NCT02499172|529976079|FG002|Overall Study|Lost to Follow-up|0|||
146950009|NCT02499172|529976080|FG003|Overall Study|Lost to Follow-up|0|||
146818455|NCT02561195|529502804|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146818456|NCT02561195|529502805|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146950010|NCT00724243|529976083|FG000|Overall Study|Lack of Efficacy|10|||
146950011|NCT00724243|529976083|FG000|Overall Study|Adverse Event|5|||
146950012|NCT04610827|529976085|FG000|Overall Study|Withdrawal by Subject|1|||
146950013|NCT04610827|529976086|FG001|Overall Study|Withdrawal by Subject|1|||
146950014|NCT04610827|529976087|FG002|Overall Study|Withdrawal by Subject|0|||
146950015|NCT02059174|529976096|FG000|Period 1|Withdrawal by Subject|0|||
146950016|NCT02059174|529976097|FG001|Period 1|Withdrawal by Subject|2|||
146818457|NCT02561195|529502806|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146818458|NCT02561195|529502807|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146818459|NCT02561195|529502808|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146818460|NCT02561195|529502809|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
146818461|NCT02561195|529502810|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
146818462|NCT02561195|529502811|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
146818463|NCT02561195|529502812|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
146818464|NCT02561195|529502813|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
146818465|NCT02561195|529502814|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146818466|NCT02561195|529502801|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
146818467|NCT02561195|529502802|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
146818468|NCT02561195|529502803|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
146818469|NCT02561195|529502804|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
146818470|NCT02561195|529502805|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
146818471|NCT02561195|529502806|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
146818472|NCT02561195|529502807|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
146818473|NCT02561195|529502808|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
146818474|NCT02561195|529502809|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
146818475|NCT02561195|529502810|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
146818476|NCT02561195|529502811|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
146818477|NCT02561195|529502812|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
146818478|NCT02561195|529502813|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
146818479|NCT02561195|529502814|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
146818480|NCT02561195|529502801|FG000|Extension Stage (Vaccination 4)|Death|0|||
146818481|NCT02561195|529502802|FG001|Extension Stage (Vaccination 4)|Death|0|||
146818482|NCT02561195|529502803|FG002|Extension Stage (Vaccination 4)|Death|0|||
146818483|NCT02561195|529502804|FG003|Extension Stage (Vaccination 4)|Death|0|||
146818484|NCT02561195|529502805|FG004|Extension Stage (Vaccination 4)|Death|0|||
146818485|NCT02561195|529502806|FG005|Extension Stage (Vaccination 4)|Death|0|||
146818486|NCT02561195|529502807|FG006|Extension Stage (Vaccination 4)|Death|0|||
146818487|NCT02561195|529502808|FG007|Extension Stage (Vaccination 4)|Death|0|||
146818488|NCT02561195|529502809|FG008|Extension Stage (Vaccination 4)|Death|0|||
146818489|NCT02561195|529502810|FG009|Extension Stage (Vaccination 4)|Death|1|||
146818490|NCT02561195|529502811|FG010|Extension Stage (Vaccination 4)|Death|0|||
146818491|NCT02561195|529502812|FG011|Extension Stage (Vaccination 4)|Death|0|||
146818492|NCT02561195|529502813|FG012|Extension Stage (Vaccination 4)|Death|0|||
146818493|NCT02561195|529502814|FG013|Extension Stage (Vaccination 4)|Death|0|||
146818494|NCT02561195|529502801|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
146818495|NCT02561195|529502802|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
146818496|NCT02561195|529502803|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
146818497|NCT02561195|529502804|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
146818498|NCT02561195|529502805|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
146818499|NCT02561195|529502806|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
146818500|NCT02561195|529502807|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
146818501|NCT02561195|529502808|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
146818502|NCT02561195|529502809|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
146818503|NCT02561195|529502810|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
146818504|NCT02561195|529502811|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
146818505|NCT02561195|529502812|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
146818506|NCT02561195|529502813|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
146818507|NCT02561195|529502814|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
146818508|NCT02561195|529502801|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146818509|NCT02561195|529502802|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146818510|NCT02561195|529502803|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146818511|NCT02561195|529502804|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146818512|NCT02561195|529502805|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146984751|NCT03264066|530105157|FG005|Overall Study|Study Terminated by Sponsor|2|||
146984752|NCT03264066|530105152|FG000|Overall Study|Withdrawal by Subject|1|||
146818513|NCT02561195|529502806|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146818514|NCT02561195|529502807|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146818515|NCT02561195|529502808|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146818516|NCT02561195|529502809|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146818517|NCT02561195|529502810|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146818518|NCT02561195|529502811|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146818519|NCT02561195|529502812|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
146818520|NCT02561195|529502813|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
146818521|NCT02561195|529502814|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
146818522|NCT02561195|529502801|FG000|Extension Stage (Vaccination 4)|Other|0|||
146818523|NCT02561195|529502802|FG001|Extension Stage (Vaccination 4)|Other|0|||
146818524|NCT02561195|529502803|FG002|Extension Stage (Vaccination 4)|Other|0|||
146818525|NCT02561195|529502804|FG003|Extension Stage (Vaccination 4)|Other|0|||
146818526|NCT02561195|529502805|FG004|Extension Stage (Vaccination 4)|Other|0|||
146818527|NCT02561195|529502806|FG005|Extension Stage (Vaccination 4)|Other|0|||
146818528|NCT02561195|529502807|FG006|Extension Stage (Vaccination 4)|Other|0|||
146818529|NCT02561195|529502808|FG007|Extension Stage (Vaccination 4)|Other|0|||
146818530|NCT02561195|529502809|FG008|Extension Stage (Vaccination 4)|Other|0|||
146818531|NCT02561195|529502810|FG009|Extension Stage (Vaccination 4)|Other|0|||
146818532|NCT02561195|529502811|FG010|Extension Stage (Vaccination 4)|Other|2|||
146818533|NCT02561195|529502812|FG011|Extension Stage (Vaccination 4)|Other|2|||
146818534|NCT02561195|529502813|FG012|Extension Stage (Vaccination 4)|Other|1|||
146818535|NCT02561195|529502814|FG013|Extension Stage (Vaccination 4)|Other|0|||
146818536|NCT02561195|529502801|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146818537|NCT02561195|529502802|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146818538|NCT02561195|529502803|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146818539|NCT02561195|529502804|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146818540|NCT02561195|529502805|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146818541|NCT02561195|529502806|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146818542|NCT02561195|529502807|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
146818543|NCT02561195|529502808|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146818544|NCT02561195|529502809|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146818545|NCT02561195|529502810|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146818546|NCT02561195|529502811|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
146818547|NCT02561195|529502812|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
146818548|NCT02561195|529502813|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146818549|NCT02561195|529502814|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
146818550|NCT01885559|529502817|FG000|Overall Study|Lost to Follow-up|15|||
146818551|NCT01885559|529502818|FG001|Overall Study|Lost to Follow-up|16|||
146818552|NCT01885559|529502817|FG000|Overall Study|Less than full participation|9|||
146818553|NCT01885559|529502818|FG001|Overall Study|Less than full participation|19|||
146818554|NCT01885559|529502817|FG000|Overall Study|Protocol Violation|0|||
146818555|NCT01885559|529502818|FG001|Overall Study|Protocol Violation|1|||
146818556|NCT01867307|529502821|FG000|Overall Study|Protocol Violation|2|||
146818557|NCT01867307|529502822|FG001|Overall Study|Protocol Violation|0|||
146818558|NCT01867307|529502821|FG000|Overall Study|Other Adverse Event|1|||
146818559|NCT01867307|529502822|FG001|Overall Study|Other Adverse Event|3|||
146818560|NCT01634165|529502827|FG000|Period 2|Adverse Event|0|||
146818561|NCT01634165|529502828|FG001|Period 2|Adverse Event|1|||
146818562|NCT01634165|529502829|FG002|Period 2|Adverse Event|0|||
146818563|NCT01634165|529502830|FG003|Period 2|Adverse Event|0|||
146818564|NCT03820024|529502831|FG000|Overall Study|Physician Decision|1|||
146818565|NCT03820024|529502832|FG001|Overall Study|Physician Decision|2|||
146818566|NCT00676195|529503945|FG000|Overall Study|Lost to Follow-up|1|||
146818567|NCT00676195|529503945|FG000|Overall Study|Adverse Event|1|||
146818568|NCT00676195|529503945|FG000|Overall Study|Physician Decision|1|||
146818569|NCT05927753|529503948|FG000|Overall Study|Withdrawal by Subject|0|||
146818570|NCT05927753|529503949|FG001|Overall Study|Withdrawal by Subject|2|||
146818571|NCT05927753|529503948|FG000|Overall Study|Physician Decision|0|||
146818572|NCT05927753|529503949|FG001|Overall Study|Physician Decision|1|||
146818573|NCT02011568|529503955|FG000|Overall Study|Withdrawal by Subject|8|||
146818574|NCT02011568|529503956|FG001|Overall Study|Withdrawal by Subject|10|||
146818575|NCT02011568|529503955|FG000|Overall Study|Physician Decision|1|||
146818576|NCT02011568|529503956|FG001|Overall Study|Physician Decision|3|||
146818577|NCT00396409|529503957|FG000|Period 1 - 2007|Adverse Event|0|||
146818578|NCT00396409|529503958|FG001|Period 1 - 2007|Adverse Event|1|||
146818579|NCT00396409|529503957|FG000|Period 1 - 2007|Lack of Efficacy|0|||
146818580|NCT00396409|529503958|FG001|Period 1 - 2007|Lack of Efficacy|1|||
146818581|NCT00396409|529503957|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
146818582|NCT00396409|529503958|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
146818583|NCT00396409|529503957|FG000|Period 1 - 2007|Lost to Follow-up|2|||
146818584|NCT00396409|529503958|FG001|Period 1 - 2007|Lost to Follow-up|3|||
146818585|NCT00396409|529503957|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
146818586|NCT00396409|529503958|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
146818587|NCT00396409|529503957|FG000|Period 2 - 2008|Protocol Violation|1|||
146818588|NCT00396409|529503958|FG001|Period 2 - 2008|Protocol Violation|0|||
146818589|NCT00396409|529503957|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
146818590|NCT00396409|529503958|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
146818591|NCT00396409|529503957|FG000|Period 2 - 2008|Lost to Follow-up|3|||
146818592|NCT00396409|529503958|FG001|Period 2 - 2008|Lost to Follow-up|1|||
146818593|NCT02069366|529503959|FG000|Overall Study|Lost to Follow-up|0|||
146818594|NCT02069366|529503960|FG001|Overall Study|Lost to Follow-up|0|||
146818595|NCT02069366|529503961|FG002|Overall Study|Lost to Follow-up|1|||
146818596|NCT02069366|529503962|FG003|Overall Study|Lost to Follow-up|0|||
146818597|NCT02069366|529503963|FG004|Overall Study|Lost to Follow-up|0|||
146818598|NCT02069366|529503964|FG005|Overall Study|Lost to Follow-up|2|||
146950017|NCT02059174|529976096|FG000|Period 2|Withdrawal by Subject|0|||
146950018|NCT02059174|529976097|FG001|Period 2|Withdrawal by Subject|2|||
146950019|NCT02059174|529976096|FG000|Period 2|Protocol Violation|1|||
146950020|NCT02059174|529976097|FG001|Period 2|Protocol Violation|0|||
146950021|NCT02059174|529976096|FG000|Period 3|Physician Decision|1|||
146950022|NCT02059174|529976097|FG001|Period 3|Physician Decision|0|||
146950023|NCT02306148|529976098|FG000|Overall Study|Adverse Event|12|||
146950024|NCT02306148|529976099|FG001|Overall Study|Adverse Event|6|||
146950025|NCT02306148|529976098|FG000|Overall Study|Lost to Follow-up|1|||
146950026|NCT02306148|529976099|FG001|Overall Study|Lost to Follow-up|4|||
146950027|NCT04167514|529976106|FG000|Overall Study|Adverse event, not serious|0|||
146950028|NCT04167514|529976107|FG001|Overall Study|Adverse event, not serious|1|||
146950029|NCT04167514|529976106|FG000|Overall Study|Lost to Follow-up|1|||
146950030|NCT04167514|529976107|FG001|Overall Study|Lost to Follow-up|0|||
146950031|NCT04167514|529976106|FG000|Overall Study|Participant Decision|2|||
146950032|NCT04167514|529976107|FG001|Overall Study|Participant Decision|4|||
146950033|NCT04167514|529976106|FG000|Overall Study|Physician Decision|3|||
146950034|NCT04167514|529976107|FG001|Overall Study|Physician Decision|2|||
146950035|NCT04167514|529976106|FG000|Overall Study|Death|14|||
146950036|NCT04167514|529976107|FG001|Overall Study|Death|18|||
146950037|NCT04167514|529976106|FG000|Overall Study|Enrolled but treatment not administered|2|||
146950038|NCT04167514|529976107|FG001|Overall Study|Enrolled but treatment not administered|0|||
146950039|NCT04167514|529976106|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
146950040|NCT04167514|529976107|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
146950041|NCT04167514|529976106|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
146950042|NCT04167514|529976107|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
146950043|NCT00290355|529976108|FG000|Overall Study|Serious adverse event|7|||
146950044|NCT00290355|529976109|FG001|Overall Study|Serious adverse event|4|||
146950045|NCT00290355|529976108|FG000|Overall Study|Study product reactogenicity|1|||
146950046|NCT00290355|529976109|FG001|Overall Study|Study product reactogenicity|0|||
146950047|NCT00290355|529976108|FG000|Overall Study|Protocol Violation|1|||
146950048|NCT00290355|529976109|FG001|Overall Study|Protocol Violation|0|||
146950049|NCT00290355|529976108|FG000|Overall Study|Withdrawal by Subject|2|||
146950050|NCT00290355|529976109|FG001|Overall Study|Withdrawal by Subject|0|||
146950051|NCT00290355|529976108|FG000|Overall Study|Migrated / moved from the study area|1|||
146950052|NCT00290355|529976109|FG001|Overall Study|Migrated / moved from the study area|0|||
146950053|NCT00290355|529976108|FG000|Overall Study|Lost to Follow-up|3|||
146950054|NCT00290355|529976109|FG001|Overall Study|Lost to Follow-up|1|||
146950055|NCT00290355|529976108|FG000|Overall Study|Other|2|||
146950056|NCT00290355|529976109|FG001|Overall Study|Other|0|||
146950057|NCT03345849|529976110|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
146950058|NCT03345849|529976111|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
146950059|NCT03345849|529976112|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
146950060|NCT03345849|529976113|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
146950061|NCT03345849|529976110|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
146950062|NCT03345849|529976111|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
146950063|NCT03345849|529976112|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
146950064|NCT03345849|529976113|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
146950065|NCT03345849|529976110|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
146950066|NCT03345849|529976111|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
146950067|NCT03345849|529976112|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
146950068|NCT03345849|529976113|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
146950069|NCT03345849|529976110|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
146950070|NCT03345849|529976111|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
146818599|NCT02069366|529503959|FG000|Overall Study|Protocol Violation|0|||
146950071|NCT03345849|529976112|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
146950072|NCT03345849|529976113|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
146950073|NCT03345849|529976110|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
146950074|NCT03345849|529976111|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
146950075|NCT03345849|529976112|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
146950076|NCT03345849|529976113|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
146950077|NCT03345849|529976110|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
146950078|NCT03345849|529976111|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
146950079|NCT03345849|529976112|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
146950080|NCT03345849|529976113|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
146950081|NCT03345849|529976110|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
146950082|NCT03345849|529976111|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
146950083|NCT03345849|529976112|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
146818600|NCT02069366|529503960|FG001|Overall Study|Protocol Violation|0|||
146950084|NCT03345849|529976113|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
146950085|NCT03345849|529976110|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
146950086|NCT03345849|529976111|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
146950087|NCT03345849|529976112|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
146950088|NCT03345849|529976113|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
146950089|NCT03345849|529976110|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
146950090|NCT03345849|529976111|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
146950091|NCT03345849|529976112|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
146950092|NCT03345849|529976113|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
146950093|NCT03345849|529976110|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
146950094|NCT03345849|529976111|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
146950095|NCT03345849|529976112|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
146950096|NCT03345849|529976113|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
146950097|NCT03345849|529976110|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
146950098|NCT03345849|529976111|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
146950099|NCT03345849|529976112|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
146950100|NCT03345849|529976113|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
146950101|NCT02943577|529976114|FG000|Overall Study|Protocol Violation|0|||
146950102|NCT02943577|529976115|FG001|Overall Study|Protocol Violation|1|||
146950103|NCT02943577|529976114|FG000|Overall Study|Adverse Event|3|||
146950104|NCT02943577|529976115|FG001|Overall Study|Adverse Event|2|||
146950105|NCT02943577|529976114|FG000|Overall Study|Lost to Follow-up|0|||
146950106|NCT02943577|529976115|FG001|Overall Study|Lost to Follow-up|1|||
146950107|NCT02943577|529976114|FG000|Overall Study|Withdrawal by Subject|1|||
146950108|NCT02943577|529976115|FG001|Overall Study|Withdrawal by Subject|1|||
146950109|NCT02943577|529976114|FG000|Overall Study|Pregnancy|1|||
146950110|NCT02943577|529976115|FG001|Overall Study|Pregnancy|0|||
146950111|NCT00939055|529976120|FG000|Overall Study|Discontinuation prior to procedure|4|||
146950112|NCT00939055|529976121|FG001|Overall Study|Discontinuation prior to procedure|0|||
146950113|NCT00584987|529976122|FG000|Overall Study|Protocol Violation|1|||
146950114|NCT00584987|529976123|FG001|Overall Study|Protocol Violation|1|||
146950115|NCT00584987|529976124|FG002|Overall Study|Protocol Violation|1|||
146950116|NCT00584987|529976125|FG003|Overall Study|Protocol Violation|0|||
146950117|NCT00584987|529976122|FG000|Overall Study|Adverse Event|0|||
146950118|NCT00584987|529976123|FG001|Overall Study|Adverse Event|0|||
146950119|NCT00584987|529976124|FG002|Overall Study|Adverse Event|0|||
146950120|NCT00584987|529976125|FG003|Overall Study|Adverse Event|1|||
146950121|NCT03225833|529976129|FG000|Overall Study|Adverse Event|0|||
146950122|NCT03225833|529976130|FG001|Overall Study|Adverse Event|1|||
146950123|NCT03225833|529976131|FG002|Overall Study|Adverse Event|2|||
146950124|NCT03225833|529976132|FG003|Overall Study|Adverse Event|0|||
146950125|NCT03225833|529976133|FG004|Overall Study|Adverse Event|0|||
146950126|NCT03225833|529976134|FG005|Overall Study|Adverse Event|2|||
146950127|NCT03225833|529976129|FG000|Overall Study|Withdrawal by Subject|1|||
146818601|NCT02069366|529503961|FG002|Overall Study|Protocol Violation|1|||
146818602|NCT02069366|529503962|FG003|Overall Study|Protocol Violation|0|||
146818603|NCT02069366|529503963|FG004|Overall Study|Protocol Violation|0|||
146818604|NCT02069366|529503964|FG005|Overall Study|Protocol Violation|0|||
146818605|NCT02069366|529503959|FG000|Overall Study|Withdrawal by Subject|1|||
146818606|NCT02069366|529503960|FG001|Overall Study|Withdrawal by Subject|0|||
146818607|NCT02069366|529503961|FG002|Overall Study|Withdrawal by Subject|1|||
146818608|NCT02069366|529503962|FG003|Overall Study|Withdrawal by Subject|2|||
146818609|NCT02069366|529503963|FG004|Overall Study|Withdrawal by Subject|0|||
146818610|NCT02069366|529503964|FG005|Overall Study|Withdrawal by Subject|0|||
146818611|NCT03314233|529503966|FG000|Overall Study|No longer eligible at time of delivery|1|||
146818612|NCT01797705|529503967|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
146818613|NCT01797705|529503967|FG000|Overall Study|Withdrawal by Subject|1|||
146818614|NCT01838447|529503968|FG000|Overall Study|Change in surgical plan|1|||
146818615|NCT01838447|529503969|FG001|Overall Study|Change in surgical plan|2|||
146818616|NCT01838447|529503968|FG000|Overall Study|Withdrawal by Subject|1|||
146818617|NCT01838447|529503969|FG001|Overall Study|Withdrawal by Subject|1|||
146818618|NCT01114217|529503970|FG000|Overall Study|Adverse Event|5|||
146818619|NCT01114217|529503971|FG001|Overall Study|Adverse Event|3|||
146818620|NCT01114217|529503970|FG000|Overall Study|Lost to Follow-up|17|||
146818621|NCT01114217|529503971|FG001|Overall Study|Lost to Follow-up|33|||
146818622|NCT01114217|529503970|FG000|Overall Study|Withdrawal by Subject|21|||
146818623|NCT01114217|529503971|FG001|Overall Study|Withdrawal by Subject|28|||
146950128|NCT03225833|529976130|FG001|Overall Study|Withdrawal by Subject|0|||
146950129|NCT03225833|529976131|FG002|Overall Study|Withdrawal by Subject|0|||
146818624|NCT01114217|529503970|FG000|Overall Study|Other-Clerical Error|3|||
146818625|NCT01114217|529503971|FG001|Overall Study|Other-Clerical Error|0|||
146818626|NCT01114217|529503970|FG000|Overall Study|Other-Early termination|6|||
146818627|NCT01114217|529503971|FG001|Overall Study|Other-Early termination|10|||
146818628|NCT01114217|529503970|FG000|Overall Study|Other-Procedure|1|||
146818629|NCT01114217|529503971|FG001|Overall Study|Other-Procedure|1|||
146818630|NCT01114217|529503970|FG000|Overall Study|Other-Pregnancy|2|||
146818631|NCT01114217|529503971|FG001|Overall Study|Other-Pregnancy|4|||
146818632|NCT01114217|529503970|FG000|Overall Study|Other-Protocol Violation|1|||
146818633|NCT01114217|529503971|FG001|Overall Study|Other-Protocol Violation|3|||
146818634|NCT01114217|529503970|FG000|Overall Study|Other-Lack of Efficacy|1|||
146818635|NCT01114217|529503971|FG001|Overall Study|Other-Lack of Efficacy|0|||
146818636|NCT01114217|529503970|FG000|Overall Study|Other-Non Compliance|2|||
146818637|NCT01114217|529503971|FG001|Overall Study|Other-Non Compliance|0|||
146818638|NCT01114217|529503970|FG000|Overall Study|Other-Physician Decision|1|||
146818639|NCT01114217|529503971|FG001|Overall Study|Other-Physician Decision|1|||
146818640|NCT01114217|529503970|FG000|Overall Study|Other-Sponsor Decision|10|||
146818641|NCT01114217|529503971|FG001|Overall Study|Other-Sponsor Decision|12|||
146818642|NCT01114217|529503970|FG000|Overall Study|Other-Study Termination|0|||
146984753|NCT03264066|530105153|FG001|Overall Study|Withdrawal by Subject|0|||
146984754|NCT03264066|530105154|FG002|Overall Study|Withdrawal by Subject|0|||
146818643|NCT01114217|529503971|FG001|Overall Study|Other-Study Termination|1|||
146818644|NCT01114217|529503970|FG000|Overall Study|Other-Study Withdrawn|1|||
146818645|NCT01114217|529503971|FG001|Overall Study|Other-Study Withdrawn|1|||
146818646|NCT01114217|529503970|FG000|Overall Study|Other-Site Stopped Communicating|2|||
146818647|NCT01114217|529503971|FG001|Overall Study|Other-Site Stopped Communicating|0|||
146818648|NCT01114217|529503970|FG000|Overall Study|Other-Lost to Follow-up|1|||
146818649|NCT01114217|529503971|FG001|Overall Study|Other-Lost to Follow-up|0|||
146818650|NCT01114217|529503970|FG000|Overall Study|Other-Withdrawal by Subject|1|||
146818651|NCT01114217|529503971|FG001|Overall Study|Other-Withdrawal by Subject|1|||
146818652|NCT06247488|529503972|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
146818653|NCT06247488|529503973|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
146818654|NCT06247488|529503974|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
146818655|NCT06247488|529503975|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
146818656|NCT06247488|529503976|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
146818657|NCT06247488|529503977|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
146818658|NCT06247488|529503972|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
146818659|NCT06247488|529503973|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
146818660|NCT06247488|529503974|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
146818661|NCT06247488|529503975|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
146818662|NCT06247488|529503976|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
146818663|NCT06247488|529503977|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
146818664|NCT06247488|529503972|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
146818665|NCT06247488|529503973|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
146818666|NCT06247488|529503974|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
146818667|NCT06247488|529503975|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
146818668|NCT06247488|529503976|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
146818669|NCT06247488|529503977|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
146818670|NCT06247488|529503972|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
146818671|NCT06247488|529503973|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
146818672|NCT06247488|529503974|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
146818673|NCT06247488|529503975|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
146818674|NCT06247488|529503976|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
146818675|NCT06247488|529503977|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
146818676|NCT06247488|529503972|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
146818677|NCT06247488|529503973|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
146818678|NCT06247488|529503974|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
146818679|NCT06247488|529503975|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
146818680|NCT06247488|529503976|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
146818681|NCT06247488|529503977|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
146818682|NCT06247488|529503972|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
146818683|NCT06247488|529503973|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
146818684|NCT06247488|529503974|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
146818685|NCT06247488|529503975|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
146818686|NCT06247488|529503976|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
146818687|NCT06247488|529503977|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
146984755|NCT03264066|530105155|FG003|Overall Study|Withdrawal by Subject|5|||
146818688|NCT06247488|529503972|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
146818689|NCT06247488|529503973|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
146818690|NCT06247488|529503974|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
146818691|NCT06247488|529503975|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
146818692|NCT06247488|529503976|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
146818693|NCT06247488|529503977|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
146818694|NCT03785210|529503980|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
146984756|NCT03264066|530105156|FG004|Overall Study|Withdrawal by Subject|0|||
146818695|NCT03785210|529503981|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
146818696|NCT00460434|529503982|FG000|Overall Study|Lost to Follow-up|3|||
146818697|NCT00460434|529503983|FG001|Overall Study|Lost to Follow-up|7|||
146818698|NCT02722278|529503986|FG000|Overall Study|Withdrawal by Subject|5|||
146818699|NCT02722278|529503987|FG001|Overall Study|Withdrawal by Subject|3|||
146818700|NCT02722278|529503986|FG000|Overall Study|Adverse Event|4|||
146818701|NCT02722278|529503987|FG001|Overall Study|Adverse Event|1|||
146818702|NCT02722278|529503986|FG000|Overall Study|Lost to Follow-up|2|||
146818703|NCT02722278|529503987|FG001|Overall Study|Lost to Follow-up|0|||
146818704|NCT02722278|529503986|FG000|Overall Study|Protocol Violation|1|||
146818705|NCT02722278|529503987|FG001|Overall Study|Protocol Violation|0|||
146818706|NCT02722278|529503986|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
146818707|NCT02722278|529503987|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
146818708|NCT02722278|529503986|FG000|Overall Study|Subject declined after tx assignment|0|||
146818709|NCT02722278|529503987|FG001|Overall Study|Subject declined after tx assignment|1|||
146818710|NCT02722278|529503986|FG000|Overall Study|Site closure not study related|0|||
146818711|NCT02722278|529503987|FG001|Overall Study|Site closure not study related|1|||
146818712|NCT00561678|529503988|FG000|Overall Study|Withdrawal by Subject|4|||
146818713|NCT00561678|529503989|FG001|Overall Study|Withdrawal by Subject|3|||
146818714|NCT00561678|529503988|FG000|Overall Study|surgery cancelled|1|||
146818715|NCT00561678|529503989|FG001|Overall Study|surgery cancelled|1|||
146818716|NCT00561678|529503988|FG000|Overall Study|surgery rescheduled to different site|2|||
146818717|NCT00561678|529503989|FG001|Overall Study|surgery rescheduled to different site|2|||
146818718|NCT00561678|529503988|FG000|Overall Study|anesthesia provider refusal|1|||
146818719|NCT00561678|529503989|FG001|Overall Study|anesthesia provider refusal|0|||
146818720|NCT01103141|529503990|FG000|Overall Study|Death|0|||
146818721|NCT01103141|529503991|FG001|Overall Study|Death|1|||
146818722|NCT01103141|529503990|FG000|Overall Study|Lost to Follow-up|2|||
146818723|NCT01103141|529503991|FG001|Overall Study|Lost to Follow-up|1|||
146818724|NCT00422162|529503992|FG000|Overall Study|Adverse Event|11|||
146818725|NCT00422162|529503993|FG001|Overall Study|Adverse Event|9|||
146818726|NCT00422162|529503992|FG000|Overall Study|Lack of Efficacy|4|||
146818727|NCT00422162|529503993|FG001|Overall Study|Lack of Efficacy|10|||
146818728|NCT00422162|529503992|FG000|Overall Study|Withdrawal by Subject|7|||
146818729|NCT00422162|529503993|FG001|Overall Study|Withdrawal by Subject|6|||
146818730|NCT00422162|529503992|FG000|Overall Study|Lost to Follow-up|1|||
146818731|NCT00422162|529503993|FG001|Overall Study|Lost to Follow-up|2|||
146818732|NCT00422162|529503992|FG000|Overall Study|Non-Compliant with Protocol|1|||
146818733|NCT00422162|529503993|FG001|Overall Study|Non-Compliant with Protocol|1|||
146818734|NCT00422162|529503992|FG000|Overall Study|Other|0|||
146818735|NCT00422162|529503993|FG001|Overall Study|Other|1|||
146818736|NCT00422162|529503992|FG000|Overall Study|Didn't Receive Treatment|0|||
146818737|NCT00422162|529503993|FG001|Overall Study|Didn't Receive Treatment|1|||
146818738|NCT05274906|529503995|FG000|Overall Study|Withdrawal by Subject|2|||
146818739|NCT05274906|529503996|FG001|Overall Study|Withdrawal by Subject|1|||
146818740|NCT00848198|529503997|FG000|Overall Study|Incomplete Case Report Forms|15|||
146818741|NCT03708744|529503998|FG000|Overall Study|Withdrawal by Subject|0|||
146818742|NCT03708744|529503999|FG001|Overall Study|Withdrawal by Subject|0|||
146818743|NCT03708744|529504000|FG002|Overall Study|Withdrawal by Subject|1|||
146818744|NCT03708744|529504001|FG003|Overall Study|Withdrawal by Subject|0|||
146818745|NCT00460577|529504002|FG000|Overall Study|Protocol Violation|2|||
146818746|NCT00460577|529504003|FG001|Overall Study|Protocol Violation|6|||
146818747|NCT04043806|529504004|FG000|Overall Study|Commercial drug is available for participants|13|||
146818748|NCT04043806|529504004|FG000|Overall Study|Physician Decision|2|||
146818749|NCT04043806|529504004|FG000|Overall Study|Other|12|||
146818750|NCT04043806|529504004|FG000|Overall Study|Adverse Event|2|||
146818751|NCT04043806|529504004|FG000|Overall Study|Lost to Follow-up|6|||
146818752|NCT04043806|529504004|FG000|Overall Study|Other non-compliance|2|||
146818753|NCT04043806|529504004|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
146818754|NCT04043806|529504004|FG000|Overall Study|Never Dosed|1|||
146950130|NCT03225833|529976132|FG003|Overall Study|Withdrawal by Subject|0|||
146950131|NCT03225833|529976133|FG004|Overall Study|Withdrawal by Subject|1|||
146818755|NCT01622088|529504007|FG000|Overall Study|Adverse Event|20|||
146818756|NCT01622088|529504007|FG000|Overall Study|Lost to Follow-up|1|||
146818757|NCT01622088|529504007|FG000|Overall Study|Withdrawal by Subject|20|||
146818758|NCT01622088|529504007|FG000|Overall Study|Investigator Decision|1|||
146818759|NCT01622088|529504007|FG000|Overall Study|Death|53|||
146818760|NCT01622088|529504007|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
146818761|NCT03166215|529504012|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
146818762|NCT03166215|529504013|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
146818763|NCT03166215|529504014|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
146818764|NCT03166215|529504012|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
146818765|NCT03166215|529504013|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
146818766|NCT03166215|529504014|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
146818767|NCT04362176|529504017|FG000|Overall Study|Lost to Follow-up|5|||
146818768|NCT04362176|529504018|FG001|Overall Study|Lost to Follow-up|8|||
146818769|NCT04362176|529504017|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
146818770|NCT04362176|529504018|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
146818771|NCT00658632|529504020|FG000|Overall Study|Adverse Event|13|||
146818772|NCT00658632|529504021|FG001|Overall Study|Adverse Event|11|||
146818773|NCT00658632|529504020|FG000|Overall Study|Lost to Follow-up|25|||
146818774|NCT00658632|529504021|FG001|Overall Study|Lost to Follow-up|23|||
146818775|NCT00658632|529504020|FG000|Overall Study|Withdrawal by Subject|10|||
146818776|NCT00658632|529504021|FG001|Overall Study|Withdrawal by Subject|7|||
146818777|NCT00658632|529504020|FG000|Overall Study|Lack of Efficacy|0|||
146818778|NCT00658632|529504021|FG001|Overall Study|Lack of Efficacy|1|||
146818779|NCT00658632|529504020|FG000|Overall Study|Withdrawal of consent|8|||
146818780|NCT00658632|529504021|FG001|Overall Study|Withdrawal of consent|14|||
146950132|NCT03225833|529976134|FG005|Overall Study|Withdrawal by Subject|0|||
146950133|NCT03225833|529976129|FG000|Overall Study|Termination of Study by Sponsor|4|||
146950134|NCT03225833|529976130|FG001|Overall Study|Termination of Study by Sponsor|0|||
146950135|NCT03225833|529976131|FG002|Overall Study|Termination of Study by Sponsor|0|||
146950136|NCT03225833|529976132|FG003|Overall Study|Termination of Study by Sponsor|0|||
146950137|NCT03225833|529976133|FG004|Overall Study|Termination of Study by Sponsor|0|||
146950138|NCT03225833|529976134|FG005|Overall Study|Termination of Study by Sponsor|7|||
146950139|NCT03225833|529976129|FG000|Overall Study|Sponsor Decision|0|||
146950140|NCT03225833|529976130|FG001|Overall Study|Sponsor Decision|0|||
146950141|NCT03225833|529976131|FG002|Overall Study|Sponsor Decision|0|||
146950142|NCT03225833|529976132|FG003|Overall Study|Sponsor Decision|0|||
146950143|NCT03225833|529976133|FG004|Overall Study|Sponsor Decision|0|||
146950144|NCT03225833|529976134|FG005|Overall Study|Sponsor Decision|1|||
146950145|NCT00808028|529976135|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
146950146|NCT00808028|529976136|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
146950147|NCT00808028|529976137|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
146950148|NCT00808028|529976138|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
146950149|NCT00808028|529976135|FG000|Stage 1 (6 Months)|Other|1|||
146950150|NCT00808028|529976136|FG001|Stage 1 (6 Months)|Other|0|||
146950151|NCT00808028|529976137|FG002|Stage 1 (6 Months)|Other|2|||
146950152|NCT00808028|529976138|FG003|Stage 1 (6 Months)|Other|4|||
146950153|NCT00808028|529976135|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
146950154|NCT00808028|529976136|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
146950155|NCT00808028|529976137|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
146950156|NCT00808028|529976138|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
146950157|NCT00808028|529976135|FG000|Stage 1 (6 Months)|Adverse Event|0|||
146950158|NCT00808028|529976136|FG001|Stage 1 (6 Months)|Adverse Event|0|||
146950159|NCT00808028|529976137|FG002|Stage 1 (6 Months)|Adverse Event|1|||
146950160|NCT00808028|529976138|FG003|Stage 1 (6 Months)|Adverse Event|2|||
146950161|NCT00808028|529976135|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
146950162|NCT00808028|529976136|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
146950163|NCT00808028|529976137|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
146950164|NCT00808028|529976138|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
146950165|NCT00808028|529976135|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
146950166|NCT00808028|529976136|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
146950167|NCT00808028|529976137|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
146950168|NCT00808028|529976138|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
146950169|NCT00808028|529976135|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
146950170|NCT00808028|529976136|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
146950171|NCT00808028|529976137|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
146950172|NCT00808028|529976138|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
146950173|NCT00808028|529976135|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
146950174|NCT00808028|529976136|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
146950175|NCT00808028|529976137|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
146950176|NCT00808028|529976138|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
146950177|NCT00808028|529976135|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
146950178|NCT00808028|529976136|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
146950179|NCT00808028|529976137|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
146950180|NCT00808028|529976138|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
146950181|NCT00808028|529976135|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
146818781|NCT00658632|529504020|FG000|Overall Study|Pregnancy|1|||
146818782|NCT00658632|529504021|FG001|Overall Study|Pregnancy|1|||
146950182|NCT00808028|529976136|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
146950183|NCT00808028|529976137|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
146950184|NCT00808028|529976138|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
146818783|NCT00658632|529504020|FG000|Overall Study|Other|7|||
146818784|NCT00658632|529504021|FG001|Overall Study|Other|8|||
146818785|NCT02632045|529504025|FG000|Overall Study|Withdrawal by Subject|1|||
146950185|NCT00808028|529976135|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
146950186|NCT00808028|529976136|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
146950187|NCT00808028|529976137|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
146818786|NCT02632045|529504026|FG001|Overall Study|Withdrawal by Subject|2|||
146984757|NCT03264066|530105157|FG005|Overall Study|Withdrawal by Subject|0|||
146984758|NCT01484028|530105158|FG000|Period 1|Lost to Follow-up|0|||
146984759|NCT01484028|530105159|FG001|Period 1|Lost to Follow-up|1|||
146984760|NCT01484028|530105160|FG002|Period 1|Lost to Follow-up|0|||
146818787|NCT05878522|529504027|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146818788|NCT05878522|529504028|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146818789|NCT05878522|529504029|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146818790|NCT05878522|529504030|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146818791|NCT05878522|529504031|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146818792|NCT05878522|529504032|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146818793|NCT05878522|529504033|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146818794|NCT05878522|529504034|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146818795|NCT05878522|529504035|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
146818796|NCT05878522|529504036|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146818797|NCT05878522|529504037|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146818798|NCT05878522|529504038|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146818799|NCT05878522|529504027|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
146818800|NCT05878522|529504028|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146818801|NCT05878522|529504029|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146818802|NCT05878522|529504030|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146818803|NCT05878522|529504031|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146818804|NCT05878522|529504032|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146818805|NCT05878522|529504033|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146818806|NCT05878522|529504034|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146818807|NCT05878522|529504035|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146818808|NCT05878522|529504036|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
146818809|NCT05878522|529504037|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146818810|NCT05878522|529504038|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146818811|NCT05878522|529504027|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146818812|NCT05878522|529504028|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
146818813|NCT05878522|529504029|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146818814|NCT05878522|529504030|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
146818815|NCT05878522|529504031|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146818816|NCT05878522|529504032|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146818817|NCT05878522|529504033|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146818818|NCT05878522|529504034|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146818819|NCT05878522|529504035|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146818820|NCT05878522|529504036|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146818821|NCT05878522|529504037|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146818822|NCT05878522|529504038|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146818823|NCT05878522|529504027|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146818824|NCT05878522|529504028|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146818825|NCT05878522|529504029|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146818826|NCT05878522|529504030|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146818827|NCT05878522|529504031|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
146818828|NCT05878522|529504032|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146818829|NCT05878522|529504033|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146818830|NCT05878522|529504034|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146818831|NCT05878522|529504035|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146818832|NCT05878522|529504036|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146818833|NCT05878522|529504037|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146818834|NCT05878522|529504038|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146818835|NCT00617708|529504040|FG000|Overall Study|Adverse Event|0|||
146818836|NCT00617708|529504041|FG001|Overall Study|Adverse Event|6|||
146818837|NCT00617708|529504042|FG002|Overall Study|Adverse Event|9|||
146818838|NCT00617708|529504040|FG000|Overall Study|Withdrawal by Subject|1|||
146818839|NCT00617708|529504041|FG001|Overall Study|Withdrawal by Subject|1|||
146818840|NCT00617708|529504042|FG002|Overall Study|Withdrawal by Subject|7|||
146818841|NCT00617708|529504040|FG000|Overall Study|Death|0|||
146984761|NCT01484028|530105161|FG003|Period 1|Lost to Follow-up|0|||
146818842|NCT00617708|529504041|FG001|Overall Study|Death|6|||
146818843|NCT00617708|529504042|FG002|Overall Study|Death|5|||
146818844|NCT00617708|529504040|FG000|Overall Study|Progression/Relapse|7|||
146818845|NCT00617708|529504041|FG001|Overall Study|Progression/Relapse|40|||
146818846|NCT00617708|529504042|FG002|Overall Study|Progression/Relapse|36|||
146818847|NCT00617708|529504040|FG000|Overall Study|Not protocol specified|1|||
146818848|NCT00617708|529504041|FG001|Overall Study|Not protocol specified|4|||
146818849|NCT00617708|529504042|FG002|Overall Study|Not protocol specified|2|||
146984762|NCT01484028|530105158|FG000|Period 1|Non-Compliance to Protocol|0|||
146984763|NCT01484028|530105159|FG001|Period 1|Non-Compliance to Protocol|1|||
146950188|NCT00808028|529976138|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
146950189|NCT00808028|529976135|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
146950190|NCT00808028|529976136|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
146950191|NCT00808028|529976137|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
146950192|NCT00808028|529976138|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
146950193|NCT00808028|529976135|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
146950194|NCT00808028|529976136|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
146950195|NCT00808028|529976137|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
146950196|NCT00808028|529976138|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
146950197|NCT00808028|529976135|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
146950198|NCT00808028|529976136|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
146950199|NCT00808028|529976137|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
146950200|NCT00808028|529976138|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
146950201|NCT00808028|529976135|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
146950202|NCT00808028|529976136|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
146950203|NCT00808028|529976137|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
146950204|NCT00808028|529976138|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
146950205|NCT02274311|529976141|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
146950206|NCT00508001|529976142|FG000|Overall Study|Adverse Event|2|||
146950207|NCT00508001|529976143|FG001|Overall Study|Adverse Event|0|||
146950208|NCT00508001|529976144|FG002|Overall Study|Adverse Event|4|||
146950209|NCT00508001|529976142|FG000|Overall Study|condition under investigation worsened|13|||
146950210|NCT00508001|529976143|FG001|Overall Study|condition under investigation worsened|7|||
146950211|NCT00508001|529976144|FG002|Overall Study|condition under investigation worsened|1|||
146950212|NCT00508001|529976142|FG000|Overall Study|Death|0|||
146950213|NCT00508001|529976143|FG001|Overall Study|Death|1|||
146950214|NCT00508001|529976144|FG002|Overall Study|Death|1|||
146950215|NCT00508001|529976142|FG000|Overall Study|Withdrawal by Subject|4|||
146950216|NCT00508001|529976143|FG001|Overall Study|Withdrawal by Subject|4|||
146950217|NCT00508001|529976144|FG002|Overall Study|Withdrawal by Subject|1|||
146950218|NCT03093350|529976145|FG000|Overall Study|Death|1|||
146950219|NCT03093350|529976145|FG000|Overall Study|Signed consent, never began treartment|1|||
146950220|NCT04564027|529976152|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
146950221|NCT04564027|529976153|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
146950222|NCT04564027|529976154|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
146950223|NCT04564027|529976155|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
146950224|NCT00777036|529976156|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
146950225|NCT00777036|529976157|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
146950226|NCT00777036|529976158|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
146950227|NCT00777036|529976159|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
146950228|NCT00777036|529976156|FG000|On Treatment|Administrative Reason By Sponsor|1|||
146950229|NCT00777036|529976157|FG001|On Treatment|Administrative Reason By Sponsor|0|||
146950230|NCT00777036|529976158|FG002|On Treatment|Administrative Reason By Sponsor|9|||
146950231|NCT00777036|529976159|FG003|On Treatment|Administrative Reason By Sponsor|0|||
146950232|NCT00777036|529976156|FG000|On Treatment|Failure to Meet Study Criteria|0|||
146950233|NCT00777036|529976157|FG001|On Treatment|Failure to Meet Study Criteria|1|||
146950234|NCT00777036|529976158|FG002|On Treatment|Failure to Meet Study Criteria|4|||
146950235|NCT00777036|529976159|FG003|On Treatment|Failure to Meet Study Criteria|0|||
146950236|NCT00777036|529976156|FG000|On Treatment|Pregnancy|1|||
146950237|NCT00777036|529976157|FG001|On Treatment|Pregnancy|0|||
146950238|NCT00777036|529976158|FG002|On Treatment|Pregnancy|1|||
146950239|NCT00777036|529976159|FG003|On Treatment|Pregnancy|0|||
146950240|NCT00777036|529976156|FG000|On Treatment|Non-compliance with Study Drug|1|||
146950241|NCT00777036|529976157|FG001|On Treatment|Non-compliance with Study Drug|0|||
146950242|NCT00777036|529976158|FG002|On Treatment|Non-compliance with Study Drug|1|||
146950243|NCT00777036|529976159|FG003|On Treatment|Non-compliance with Study Drug|0|||
146950244|NCT00777036|529976156|FG000|On Treatment|Maximum Clinical Benefit|2|||
146950245|NCT00777036|529976157|FG001|On Treatment|Maximum Clinical Benefit|0|||
146950246|NCT00777036|529976158|FG002|On Treatment|Maximum Clinical Benefit|5|||
146950247|NCT00777036|529976159|FG003|On Treatment|Maximum Clinical Benefit|0|||
146950248|NCT00777036|529976156|FG000|On Treatment|Withdrawal by Subject|0|||
146950249|NCT00777036|529976157|FG001|On Treatment|Withdrawal by Subject|2|||
146950250|NCT00777036|529976158|FG002|On Treatment|Withdrawal by Subject|2|||
146950251|NCT00777036|529976159|FG003|On Treatment|Withdrawal by Subject|0|||
146984764|NCT01484028|530105160|FG002|Period 1|Non-Compliance to Protocol|0|||
146984765|NCT01484028|530105161|FG003|Period 1|Non-Compliance to Protocol|1|||
146950252|NCT00777036|529976156|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
146950253|NCT00777036|529976157|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
146950254|NCT00777036|529976158|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
146950255|NCT00777036|529976159|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
146950256|NCT00777036|529976156|FG000|On Treatment|Death|0|||
146950257|NCT00777036|529976157|FG001|On Treatment|Death|2|||
146950258|NCT00777036|529976158|FG002|On Treatment|Death|0|||
146950259|NCT00777036|529976159|FG003|On Treatment|Death|0|||
146950260|NCT00777036|529976156|FG000|On Treatment|Study Drug Toxicity|1|||
146950261|NCT00777036|529976157|FG001|On Treatment|Study Drug Toxicity|0|||
146950262|NCT00777036|529976158|FG002|On Treatment|Study Drug Toxicity|4|||
146950263|NCT00777036|529976159|FG003|On Treatment|Study Drug Toxicity|0|||
146950264|NCT00777036|529976156|FG000|On Treatment|Progressive Disease|6|||
146950265|NCT00777036|529976157|FG001|On Treatment|Progressive Disease|4|||
146950266|NCT00777036|529976158|FG002|On Treatment|Progressive Disease|7|||
146950267|NCT00777036|529976159|FG003|On Treatment|Progressive Disease|0|||
146950268|NCT00777036|529976156|FG000|On Treatment|Not Reported|0|||
146950269|NCT00777036|529976157|FG001|On Treatment|Not Reported|0|||
146950270|NCT00777036|529976158|FG002|On Treatment|Not Reported|2|||
146950271|NCT00777036|529976159|FG003|On Treatment|Not Reported|0|||
146950272|NCT00777036|529976156|FG000|On Treatment|Site Closed|0|||
146950273|NCT00777036|529976157|FG001|On Treatment|Site Closed|1|||
146950274|NCT00777036|529976158|FG002|On Treatment|Site Closed|1|||
146950275|NCT00777036|529976159|FG003|On Treatment|Site Closed|0|||
146950276|NCT00777036|529976156|FG000|Follow-Up|Withdrawal by Subject|0|||
146950277|NCT00777036|529976157|FG001|Follow-Up|Withdrawal by Subject|0|||
146950278|NCT00777036|529976158|FG002|Follow-Up|Withdrawal by Subject|5|||
146950279|NCT00777036|529976159|FG003|Follow-Up|Withdrawal by Subject|0|||
146950280|NCT00777036|529976156|FG000|Follow-Up|Death|1|||
146950281|NCT00777036|529976157|FG001|Follow-Up|Death|9|||
146950282|NCT00777036|529976158|FG002|Follow-Up|Death|0|||
146950283|NCT00777036|529976159|FG003|Follow-Up|Death|0|||
146950284|NCT00777036|529976156|FG000|Follow-Up|Lost to Follow-up|3|||
146950285|NCT00777036|529976157|FG001|Follow-Up|Lost to Follow-up|0|||
146950286|NCT00777036|529976158|FG002|Follow-Up|Lost to Follow-up|0|||
146950287|NCT00777036|529976159|FG003|Follow-Up|Lost to Follow-up|0|||
146950288|NCT00777036|529976156|FG000|Follow-Up|Reason Not Specified|4|||
146950289|NCT00777036|529976157|FG001|Follow-Up|Reason Not Specified|0|||
146950290|NCT00777036|529976158|FG002|Follow-Up|Reason Not Specified|13|||
146950291|NCT00777036|529976159|FG003|Follow-Up|Reason Not Specified|0|||
146950292|NCT00777036|529976156|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
146950293|NCT00777036|529976157|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
146950294|NCT00777036|529976158|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
146950295|NCT00777036|529976159|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
146950296|NCT05827978|529976162|FG000|Overall Study|Adverse Event|1|||
146950297|NCT05827978|529976163|FG001|Overall Study|Adverse Event|0|||
146950298|NCT05827978|529976164|FG002|Overall Study|Adverse Event|0|||
146950299|NCT05827978|529976165|FG003|Overall Study|Adverse Event|1|||
146950300|NCT05827978|529976166|FG004|Overall Study|Adverse Event|0|||
146950301|NCT05827978|529976167|FG005|Overall Study|Adverse Event|0|||
146950302|NCT05827978|529976162|FG000|Overall Study|Death|1|||
146950303|NCT05827978|529976163|FG001|Overall Study|Death|5|||
146950304|NCT05827978|529976164|FG002|Overall Study|Death|2|||
146950305|NCT05827978|529976165|FG003|Overall Study|Death|3|||
146950306|NCT05827978|529976166|FG004|Overall Study|Death|1|||
146950307|NCT05827978|529976167|FG005|Overall Study|Death|3|||
146950308|NCT05827978|529976162|FG000|Overall Study|Lost to Follow-up|57|||
146950309|NCT05827978|529976163|FG001|Overall Study|Lost to Follow-up|88|||
146950310|NCT05827978|529976164|FG002|Overall Study|Lost to Follow-up|54|||
146950311|NCT05827978|529976165|FG003|Overall Study|Lost to Follow-up|47|||
146950312|NCT05827978|529976166|FG004|Overall Study|Lost to Follow-up|25|||
146950313|NCT05827978|529976167|FG005|Overall Study|Lost to Follow-up|10|||
146950314|NCT05827978|529976162|FG000|Overall Study|Noncompliance with Study Procedures|0|||
146950315|NCT05827978|529976163|FG001|Overall Study|Noncompliance with Study Procedures|1|||
146950316|NCT05827978|529976164|FG002|Overall Study|Noncompliance with Study Procedures|1|||
146950317|NCT05827978|529976165|FG003|Overall Study|Noncompliance with Study Procedures|1|||
146950318|NCT05827978|529976166|FG004|Overall Study|Noncompliance with Study Procedures|1|||
146950319|NCT05827978|529976167|FG005|Overall Study|Noncompliance with Study Procedures|0|||
146950320|NCT05827978|529976162|FG000|Overall Study|Physician Decision|2|||
146950321|NCT05827978|529976163|FG001|Overall Study|Physician Decision|0|||
146950322|NCT05827978|529976164|FG002|Overall Study|Physician Decision|1|||
146950323|NCT05827978|529976165|FG003|Overall Study|Physician Decision|2|||
146950324|NCT05827978|529976166|FG004|Overall Study|Physician Decision|1|||
146950325|NCT05827978|529976167|FG005|Overall Study|Physician Decision|1|||
146950326|NCT05827978|529976162|FG000|Overall Study|Protocol Violation|5|||
146818850|NCT00617708|529504040|FG000|Overall Study|Not eligible|1|||
146950327|NCT05827978|529976163|FG001|Overall Study|Protocol Violation|2|||
146950328|NCT05827978|529976164|FG002|Overall Study|Protocol Violation|0|||
146950329|NCT05827978|529976165|FG003|Overall Study|Protocol Violation|0|||
146950330|NCT05827978|529976166|FG004|Overall Study|Protocol Violation|0|||
146950331|NCT05827978|529976167|FG005|Overall Study|Protocol Violation|0|||
146950332|NCT05827978|529976162|FG000|Overall Study|Withdrawal by Subject|17|||
146950333|NCT05827978|529976163|FG001|Overall Study|Withdrawal by Subject|16|||
146950334|NCT05827978|529976164|FG002|Overall Study|Withdrawal by Subject|10|||
146950335|NCT05827978|529976165|FG003|Overall Study|Withdrawal by Subject|12|||
146950336|NCT05827978|529976166|FG004|Overall Study|Withdrawal by Subject|10|||
146950337|NCT05827978|529976167|FG005|Overall Study|Withdrawal by Subject|9|||
146950338|NCT05827978|529976162|FG000|Overall Study|Other Than Specified|0|||
146950339|NCT05827978|529976163|FG001|Overall Study|Other Than Specified|0|||
146950340|NCT05827978|529976164|FG002|Overall Study|Other Than Specified|1|||
146950341|NCT05827978|529976165|FG003|Overall Study|Other Than Specified|0|||
146950342|NCT05827978|529976166|FG004|Overall Study|Other Than Specified|2|||
146950343|NCT05827978|529976167|FG005|Overall Study|Other Than Specified|0|||
146950344|NCT05564039|529976168|FG000|Overall Study|Adverse Event|1|||
146950345|NCT05564039|529976169|FG001|Overall Study|Adverse Event|0|||
146950346|NCT05564039|529976168|FG000|Overall Study|Death|1|||
146950347|NCT05564039|529976169|FG001|Overall Study|Death|1|||
146950348|NCT05564039|529976168|FG000|Overall Study|Lost to Follow-up|3|||
146950349|NCT05564039|529976169|FG001|Overall Study|Lost to Follow-up|2|||
146950350|NCT05564039|529976168|FG000|Overall Study|Withdrawal by Subject|2|||
146950351|NCT05564039|529976169|FG001|Overall Study|Withdrawal by Subject|0|||
146950352|NCT05564039|529976168|FG000|Overall Study|Inadvertent enrollment|3|||
146950353|NCT05564039|529976169|FG001|Overall Study|Inadvertent enrollment|6|||
146950354|NCT04566445|529976170|FG000|Overall Study|Death|4|||
146950355|NCT04566445|529976171|FG001|Overall Study|Death|1|||
146950356|NCT04566445|529976172|FG002|Overall Study|Death|1|||
146950357|NCT04566445|529976170|FG000|Overall Study|Lost to Follow-up|3|||
146950358|NCT04566445|529976171|FG001|Overall Study|Lost to Follow-up|1|||
146950359|NCT04566445|529976172|FG002|Overall Study|Lost to Follow-up|1|||
146950360|NCT04566445|529976170|FG000|Overall Study|Study terminated by sponsor|11|||
146950361|NCT04566445|529976171|FG001|Overall Study|Study terminated by sponsor|17|||
146950362|NCT04566445|529976172|FG002|Overall Study|Study terminated by sponsor|32|||
146950363|NCT04566445|529976170|FG000|Overall Study|Withdrawal by Subject|12|||
146950364|NCT04566445|529976171|FG001|Overall Study|Withdrawal by Subject|14|||
146950365|NCT04566445|529976172|FG002|Overall Study|Withdrawal by Subject|13|||
146950366|NCT04566445|529976170|FG000|Overall Study|Randomized but not treated due to AE|2|||
146950367|NCT04566445|529976171|FG001|Overall Study|Randomized but not treated due to AE|1|||
146950368|NCT04566445|529976172|FG002|Overall Study|Randomized but not treated due to AE|0|||
146950369|NCT04566445|529976170|FG000|Overall Study|Adverse Event|1|||
146950370|NCT04566445|529976171|FG001|Overall Study|Adverse Event|1|||
146950371|NCT04566445|529976172|FG002|Overall Study|Adverse Event|0|||
146950372|NCT04785144|529976173|FG000|Overall Study|Withdrawal by Subject|4|||
146950373|NCT04785144|529976174|FG001|Overall Study|Withdrawal by Subject|1|||
146950374|NCT04785144|529976175|FG002|Overall Study|Withdrawal by Subject|0|||
146950375|NCT04785144|529976176|FG003|Overall Study|Withdrawal by Subject|0|||
146950376|NCT04785144|529976177|FG004|Overall Study|Withdrawal by Subject|0|||
146950377|NCT04785144|529976178|FG005|Overall Study|Withdrawal by Subject|2|||
146950378|NCT04785144|529976179|FG006|Overall Study|Withdrawal by Subject|2|||
146950379|NCT04785144|529976180|FG007|Overall Study|Withdrawal by Subject|0|||
146950380|NCT04785144|529976181|FG008|Overall Study|Withdrawal by Subject|1|||
146950381|NCT04785144|529976182|FG009|Overall Study|Withdrawal by Subject|0|||
146950382|NCT04785144|529976173|FG000|Overall Study|Lost to Follow-up|1|||
146950383|NCT04785144|529976174|FG001|Overall Study|Lost to Follow-up|0|||
146950384|NCT04785144|529976175|FG002|Overall Study|Lost to Follow-up|0|||
146950385|NCT04785144|529976176|FG003|Overall Study|Lost to Follow-up|0|||
146950386|NCT04785144|529976177|FG004|Overall Study|Lost to Follow-up|1|||
146950387|NCT04785144|529976178|FG005|Overall Study|Lost to Follow-up|2|||
146950388|NCT04785144|529976179|FG006|Overall Study|Lost to Follow-up|1|||
146950389|NCT04785144|529976180|FG007|Overall Study|Lost to Follow-up|2|||
146950390|NCT04785144|529976181|FG008|Overall Study|Lost to Follow-up|4|||
146950391|NCT04785144|529976182|FG009|Overall Study|Lost to Follow-up|1|||
146950392|NCT04785144|529976173|FG000|Overall Study|Protocol Violation|0|||
146950393|NCT04785144|529976174|FG001|Overall Study|Protocol Violation|0|||
146950394|NCT04785144|529976175|FG002|Overall Study|Protocol Violation|0|||
146950395|NCT04785144|529976176|FG003|Overall Study|Protocol Violation|0|||
146950396|NCT04785144|529976177|FG004|Overall Study|Protocol Violation|0|||
146950397|NCT04785144|529976178|FG005|Overall Study|Protocol Violation|0|||
146950398|NCT04785144|529976179|FG006|Overall Study|Protocol Violation|1|||
146950399|NCT04785144|529976180|FG007|Overall Study|Protocol Violation|0|||
146950400|NCT04785144|529976181|FG008|Overall Study|Protocol Violation|0|||
146950401|NCT04785144|529976182|FG009|Overall Study|Protocol Violation|0|||
146950402|NCT04785144|529976173|FG000|Overall Study|Physician Decision|0|||
146950403|NCT04785144|529976174|FG001|Overall Study|Physician Decision|0|||
146950404|NCT04785144|529976175|FG002|Overall Study|Physician Decision|0|||
146950405|NCT04785144|529976176|FG003|Overall Study|Physician Decision|0|||
146950406|NCT04785144|529976177|FG004|Overall Study|Physician Decision|0|||
146950407|NCT04785144|529976178|FG005|Overall Study|Physician Decision|0|||
146950408|NCT04785144|529976179|FG006|Overall Study|Physician Decision|0|||
146950409|NCT04785144|529976180|FG007|Overall Study|Physician Decision|0|||
146984766|NCT01484028|530105158|FG000|Period 1|Lens Discomfort|0|||
146950410|NCT04785144|529976181|FG008|Overall Study|Physician Decision|0|||
146818851|NCT00617708|529504041|FG001|Overall Study|Not eligible|3|||
146950411|NCT04785144|529976182|FG009|Overall Study|Physician Decision|1|||
146950412|NCT04785144|529976173|FG000|Overall Study|Unable to continue due to work schedule|0|||
146984767|NCT01484028|530105159|FG001|Period 1|Lens Discomfort|1|||
146950413|NCT04785144|529976174|FG001|Overall Study|Unable to continue due to work schedule|0|||
146950414|NCT04785144|529976175|FG002|Overall Study|Unable to continue due to work schedule|0|||
146950415|NCT04785144|529976176|FG003|Overall Study|Unable to continue due to work schedule|0|||
146950416|NCT04785144|529976177|FG004|Overall Study|Unable to continue due to work schedule|0|||
146950417|NCT04785144|529976178|FG005|Overall Study|Unable to continue due to work schedule|0|||
146950418|NCT04785144|529976179|FG006|Overall Study|Unable to continue due to work schedule|0|||
146950419|NCT04785144|529976180|FG007|Overall Study|Unable to continue due to work schedule|0|||
146950420|NCT04785144|529976181|FG008|Overall Study|Unable to continue due to work schedule|0|||
146950421|NCT04785144|529976182|FG009|Overall Study|Unable to continue due to work schedule|1|||
146950422|NCT01263470|529976185|FG000|Overall Study|Adverse Event|2|||
146950423|NCT01263470|529976186|FG001|Overall Study|Adverse Event|2|||
146950424|NCT01263470|529976187|FG002|Overall Study|Adverse Event|1|||
146950425|NCT01263470|529976188|FG003|Overall Study|Adverse Event|1|||
146950426|NCT01263470|529976189|FG004|Overall Study|Adverse Event|2|||
146950427|NCT01263470|529976190|FG005|Overall Study|Adverse Event|2|||
146950428|NCT01263470|529976185|FG000|Overall Study|Protocol Violation|0|||
146950429|NCT01263470|529976186|FG001|Overall Study|Protocol Violation|1|||
146950430|NCT01263470|529976187|FG002|Overall Study|Protocol Violation|0|||
146950431|NCT01263470|529976188|FG003|Overall Study|Protocol Violation|0|||
146950432|NCT01263470|529976189|FG004|Overall Study|Protocol Violation|0|||
146950433|NCT01263470|529976190|FG005|Overall Study|Protocol Violation|1|||
146950434|NCT01263470|529976185|FG000|Overall Study|Withdrawal by Subject|0|||
146950435|NCT01263470|529976186|FG001|Overall Study|Withdrawal by Subject|1|||
146950436|NCT01263470|529976187|FG002|Overall Study|Withdrawal by Subject|1|||
146950437|NCT01263470|529976188|FG003|Overall Study|Withdrawal by Subject|2|||
146950438|NCT01263470|529976189|FG004|Overall Study|Withdrawal by Subject|0|||
146950439|NCT01263470|529976190|FG005|Overall Study|Withdrawal by Subject|2|||
146950440|NCT01263470|529976185|FG000|Overall Study|Lack of Efficacy|0|||
146950441|NCT01263470|529976186|FG001|Overall Study|Lack of Efficacy|0|||
146950442|NCT01263470|529976187|FG002|Overall Study|Lack of Efficacy|2|||
146950443|NCT01263470|529976188|FG003|Overall Study|Lack of Efficacy|0|||
146818852|NCT00617708|529504042|FG002|Overall Study|Not eligible|5|||
146818853|NCT05615870|529504043|FG000|Overall Study|Lost to Follow-up|10|||
146818854|NCT05615870|529504044|FG001|Overall Study|Lost to Follow-up|13|||
146818855|NCT05615870|529504043|FG000|Overall Study|Physician Decision|2|||
146818856|NCT05615870|529504044|FG001|Overall Study|Physician Decision|0|||
146818857|NCT05615870|529504043|FG000|Overall Study|Withdrawal by Subject|0|||
146818858|NCT05615870|529504044|FG001|Overall Study|Withdrawal by Subject|2|||
146818859|NCT05615870|529504043|FG000|Overall Study|Protocol Violation|0|||
146818860|NCT05615870|529504044|FG001|Overall Study|Protocol Violation|3|||
146818861|NCT05615870|529504043|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
146818862|NCT05615870|529504044|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
146818863|NCT05615870|529504043|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
146818864|NCT05615870|529504044|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
146818865|NCT05615870|529504043|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
146818866|NCT05615870|529504044|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
146818867|NCT02993926|529504050|FG000|Enantone Treatment Phase|Adverse Event|1|||
146818868|NCT02993926|529504051|FG001|Enantone Treatment Phase|Adverse Event|0|||
146818869|NCT02993926|529504052|FG002|Enantone Treatment Phase|Adverse Event|0|||
146818870|NCT02993926|529504050|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
146818871|NCT02993926|529504051|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
146818872|NCT02993926|529504052|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
146818873|NCT02993926|529504050|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
146818874|NCT02993926|529504051|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
146818875|NCT02993926|529504052|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
146818876|NCT02993926|529504050|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
146818877|NCT02993926|529504051|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
146818878|NCT02993926|529504052|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
146818879|NCT01760876|529504053|FG000|Overall Study|Non-cardiac death (head injury)|1|||
146818880|NCT01760876|529504053|FG000|Overall Study|Carcinoma of prostate|1|||
146818881|NCT01760876|529504053|FG000|Overall Study|Impaired renal function|1|||
146818882|NCT01760876|529504053|FG000|Overall Study|Major depression|1|||
146818883|NCT01760876|529504053|FG000|Overall Study|Very poor baseline OCT quality|2|||
146818884|NCT00732498|529504060|FG000|Overall Study|Ineligible|1|||
146950444|NCT01263470|529976189|FG004|Overall Study|Lack of Efficacy|0|||
146950445|NCT01263470|529976190|FG005|Overall Study|Lack of Efficacy|0|||
146818885|NCT00732498|529504060|FG000|Overall Study|Adverse Event|2|||
146950446|NCT01263470|529976185|FG000|Overall Study|Participant Unavailability|0|||
146950447|NCT01263470|529976186|FG001|Overall Study|Participant Unavailability|1|||
146950448|NCT01263470|529976187|FG002|Overall Study|Participant Unavailability|0|||
146950449|NCT01263470|529976188|FG003|Overall Study|Participant Unavailability|0|||
146818886|NCT00732498|529504060|FG000|Overall Study|Physician Decision|3|||
146818887|NCT03394508|529504061|FG000|Overall Study|Protocol Violation|0|||
146818888|NCT03394508|529504062|FG001|Overall Study|Protocol Violation|3|||
146818889|NCT03394508|529504061|FG000|Overall Study|Lost to Follow-up|1|||
146818890|NCT03394508|529504062|FG001|Overall Study|Lost to Follow-up|0|||
146818891|NCT00267865|529504063|FG000|Induction Treatment|Died before completing.|2|||
146818892|NCT00267865|529504063|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
146818893|NCT03122548|529504067|FG000|Overall Study|Death|2|||
146818894|NCT03122548|529504067|FG000|Overall Study|Progression - subject went into hospice|1|||
146818895|NCT03122548|529504067|FG000|Overall Study|Study Terminated by Sponsor|2|||
146818896|NCT02819141|529504068|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
146818897|NCT02819141|529504069|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
146818898|NCT00409006|529505564|FG000|Overall Study|Death|15|||
146818899|NCT00409006|529505565|FG001|Overall Study|Death|6|||
146818900|NCT00409006|529505564|FG000|Overall Study|Lost to Follow-up|1|||
146818901|NCT00409006|529505565|FG001|Overall Study|Lost to Follow-up|2|||
146818902|NCT00409006|529505564|FG000|Overall Study|Withdrawal by Subject|3|||
146818903|NCT00409006|529505565|FG001|Overall Study|Withdrawal by Subject|2|||
146818904|NCT00409006|529505564|FG000|Overall Study|Physician Decision|1|||
146818905|NCT00409006|529505565|FG001|Overall Study|Physician Decision|2|||
146818906|NCT03050372|529505568|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
146818907|NCT03050372|529505569|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
146818908|NCT03050372|529505568|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
146818909|NCT03050372|529505569|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
146818910|NCT02123797|529505570|FG000|Baseline Intervention|Death|9|||
146818911|NCT02123797|529505571|FG001|Baseline Intervention|Death|16|||
146818912|NCT02123797|529505572|FG002|Baseline Intervention|Death|0|||
146818913|NCT02123797|529505573|FG003|Baseline Intervention|Death|0|||
146818914|NCT02123797|529505574|FG004|Baseline Intervention|Death|0|||
146818915|NCT02123797|529505570|FG000|Baseline Intervention|Withdrawal by Subject|2|||
146818916|NCT02123797|529505571|FG001|Baseline Intervention|Withdrawal by Subject|8|||
146818917|NCT02123797|529505572|FG002|Baseline Intervention|Withdrawal by Subject|0|||
146818918|NCT02123797|529505573|FG003|Baseline Intervention|Withdrawal by Subject|0|||
146818919|NCT02123797|529505574|FG004|Baseline Intervention|Withdrawal by Subject|0|||
146818920|NCT02123797|529505570|FG000|Baseline Intervention|Relocation|2|||
146818921|NCT02123797|529505571|FG001|Baseline Intervention|Relocation|0|||
146818922|NCT02123797|529505572|FG002|Baseline Intervention|Relocation|0|||
146818923|NCT02123797|529505573|FG003|Baseline Intervention|Relocation|0|||
146818924|NCT02123797|529505574|FG004|Baseline Intervention|Relocation|0|||
146818925|NCT02123797|529505570|FG000|Baseline Intervention|Out of window for initial survey|6|||
146818926|NCT02123797|529505571|FG001|Baseline Intervention|Out of window for initial survey|13|||
146818927|NCT02123797|529505572|FG002|Baseline Intervention|Out of window for initial survey|0|||
146818928|NCT02123797|529505573|FG003|Baseline Intervention|Out of window for initial survey|0|||
146818929|NCT02123797|529505574|FG004|Baseline Intervention|Out of window for initial survey|0|||
146818930|NCT02123797|529505570|FG000|Baseline Intervention|Lost to Follow-up|0|||
146818931|NCT02123797|529505571|FG001|Baseline Intervention|Lost to Follow-up|5|||
146818932|NCT02123797|529505572|FG002|Baseline Intervention|Lost to Follow-up|0|||
146818933|NCT02123797|529505573|FG003|Baseline Intervention|Lost to Follow-up|0|||
146818934|NCT02123797|529505574|FG004|Baseline Intervention|Lost to Follow-up|0|||
146818935|NCT02123797|529505570|FG000|Baseline Intervention|Other Disease|3|||
146818936|NCT02123797|529505571|FG001|Baseline Intervention|Other Disease|0|||
146818937|NCT02123797|529505572|FG002|Baseline Intervention|Other Disease|0|||
146818938|NCT02123797|529505573|FG003|Baseline Intervention|Other Disease|0|||
146818939|NCT02123797|529505574|FG004|Baseline Intervention|Other Disease|0|||
146818940|NCT02123797|529505570|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
146818941|NCT02123797|529505571|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
146818942|NCT02123797|529505572|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
146818943|NCT02123797|529505573|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
146818944|NCT02123797|529505574|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
146818945|NCT02123797|529505570|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
146818946|NCT02123797|529505571|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
146818947|NCT02123797|529505572|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
146818948|NCT02123797|529505573|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
146818949|NCT02123797|529505574|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
146818950|NCT02123797|529505570|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
146818951|NCT02123797|529505571|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
146818952|NCT02123797|529505572|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
146818953|NCT02123797|529505573|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
146818954|NCT02123797|529505574|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
146818955|NCT02123797|529505570|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
146818956|NCT02123797|529505571|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
146818957|NCT02123797|529505572|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
146818958|NCT02123797|529505573|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
146950450|NCT01263470|529976189|FG004|Overall Study|Participant Unavailability|0|||
146950451|NCT01263470|529976190|FG005|Overall Study|Participant Unavailability|0|||
146950452|NCT01263470|529976185|FG000|Overall Study|Study Drug Non-compliance|0|||
146950453|NCT01263470|529976186|FG001|Overall Study|Study Drug Non-compliance|0|||
146950454|NCT01263470|529976187|FG002|Overall Study|Study Drug Non-compliance|0|||
146950455|NCT01263470|529976188|FG003|Overall Study|Study Drug Non-compliance|0|||
146950456|NCT01263470|529976189|FG004|Overall Study|Study Drug Non-compliance|1|||
146950457|NCT01263470|529976190|FG005|Overall Study|Study Drug Non-compliance|0|||
146950458|NCT00610714|529976191|FG000|Overall Study|Adverse Event|3|||
146950459|NCT00610714|529976192|FG001|Overall Study|Adverse Event|1|||
146950460|NCT00610714|529976191|FG000|Overall Study|Death|12|||
146950461|NCT00610714|529976192|FG001|Overall Study|Death|18|||
146950462|NCT00610714|529976191|FG000|Overall Study|Withdrawal by Subject|9|||
146950463|NCT00610714|529976192|FG001|Overall Study|Withdrawal by Subject|3|||
146950464|NCT00610714|529976191|FG000|Overall Study|Study completion at 120 PFS events|2|||
146950465|NCT00610714|529976192|FG001|Overall Study|Study completion at 120 PFS events|2|||
146950466|NCT01327573|529976193|FG000|Overall Study|Physician Decision|3|||
146950467|NCT01327573|529976194|FG001|Overall Study|Physician Decision|1|||
146950468|NCT01108263|529976195|FG000|Overall Study|Adverse Event|0|||
146950469|NCT01108263|529976196|FG001|Overall Study|Adverse Event|1|||
146950470|NCT00712712|529976197|FG000|Overall Study|Protocol Violation|11|||
146950471|NCT00712712|529976197|FG000|Overall Study|Radiofrequency not done|3|||
146950472|NCT00712712|529976197|FG000|Overall Study|Death|8|||
146950473|NCT00712712|529976197|FG000|Overall Study|Withdrawal by Subject|1|||
146950474|NCT00729560|529976198|FG000|Overall Study|Withdrawal by Subject|3|||
146950475|NCT00829010|529976201|FG000|Overall Study|Adverse Event|1|||
146950476|NCT00829010|529976202|FG001|Overall Study|Adverse Event|0|||
146950477|NCT00829010|529976203|FG002|Overall Study|Adverse Event|0|||
146950478|NCT00829010|529976204|FG003|Overall Study|Adverse Event|0|||
146950479|NCT00829010|529976205|FG004|Overall Study|Adverse Event|0|||
146950480|NCT00829010|529976201|FG000|Overall Study|Withdrawal by Subject|0|||
146950481|NCT00829010|529976202|FG001|Overall Study|Withdrawal by Subject|1|||
146950482|NCT00829010|529976203|FG002|Overall Study|Withdrawal by Subject|1|||
146950483|NCT00829010|529976204|FG003|Overall Study|Withdrawal by Subject|0|||
146950484|NCT00829010|529976205|FG004|Overall Study|Withdrawal by Subject|2|||
146950485|NCT00829010|529976201|FG000|Overall Study|Lost to Follow-up|1|||
146950486|NCT00829010|529976202|FG001|Overall Study|Lost to Follow-up|0|||
146950487|NCT00829010|529976203|FG002|Overall Study|Lost to Follow-up|2|||
146950488|NCT00829010|529976204|FG003|Overall Study|Lost to Follow-up|0|||
146950489|NCT00829010|529976205|FG004|Overall Study|Lost to Follow-up|0|||
146950490|NCT00829010|529976201|FG000|Overall Study|Fatality|5|||
146950491|NCT00829010|529976202|FG001|Overall Study|Fatality|4|||
146950492|NCT00829010|529976203|FG002|Overall Study|Fatality|0|||
146950493|NCT00829010|529976204|FG003|Overall Study|Fatality|3|||
146950494|NCT00829010|529976205|FG004|Overall Study|Fatality|0|||
146950495|NCT00829010|529976201|FG000|Overall Study|Migrated/Moved from study area|3|||
146950496|NCT00829010|529976202|FG001|Overall Study|Migrated/Moved from study area|4|||
146950497|NCT00829010|529976203|FG002|Overall Study|Migrated/Moved from study area|0|||
146950498|NCT00829010|529976204|FG003|Overall Study|Migrated/Moved from study area|5|||
146950499|NCT00829010|529976205|FG004|Overall Study|Migrated/Moved from study area|0|||
146950500|NCT01029691|529976206|FG000|Continued APAP to Delivery|Death|0|||
146950501|NCT01029691|529976207|FG001|Continued APAP to Delivery|Death|0|||
146950502|NCT01029691|529976208|FG002|Continued APAP to Delivery|Death|1|||
146950503|NCT01023516|529976209|FG000|Overall Study|Voluntary discontinuation|7|||
146950504|NCT01023516|529976210|FG001|Overall Study|Voluntary discontinuation|5|||
146950505|NCT01023516|529976209|FG000|Overall Study|Adverse Event|9|||
146950506|NCT01023516|529976210|FG001|Overall Study|Adverse Event|6|||
146950507|NCT01023516|529976209|FG000|Overall Study|Safety reason|0|||
146818959|NCT02123797|529505574|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
146818960|NCT02123797|529505570|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
146818961|NCT02123797|529505571|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
146818962|NCT02123797|529505572|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
146818963|NCT02123797|529505573|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
146950508|NCT01023516|529976210|FG001|Overall Study|Safety reason|3|||
146950509|NCT01023516|529976209|FG000|Overall Study|Study-specific criteria|4|||
146950510|NCT01023516|529976210|FG001|Overall Study|Study-specific criteria|2|||
146950511|NCT01023516|529976209|FG000|Overall Study|Incorrect enrolment|4|||
146950512|NCT01023516|529976210|FG001|Overall Study|Incorrect enrolment|2|||
146950513|NCT02060903|529976216|FG000|Overall Study|Lost to Follow-up|4|||
146950514|NCT02060903|529976217|FG001|Overall Study|Lost to Follow-up|0|||
146950515|NCT02060903|529976216|FG000|Overall Study|Withdrawal by Subject|0|||
146950516|NCT02060903|529976217|FG001|Overall Study|Withdrawal by Subject|7|||
146818964|NCT02123797|529505574|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
146950517|NCT00137267|529976218|FG000|Overall Study|Lost to Follow-up|15|||
146950518|NCT00137267|529976219|FG001|Overall Study|Lost to Follow-up|21|||
146950519|NCT00638989|529976221|FG000|Overall Study|Lost to Follow-up|0|||
146950520|NCT00638989|529976222|FG001|Overall Study|Lost to Follow-up|0|||
146818965|NCT02123797|529505570|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
146818966|NCT02123797|529505571|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
146818967|NCT02123797|529505572|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
146818968|NCT02123797|529505573|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
146818969|NCT02123797|529505574|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
146818970|NCT02123797|529505570|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
146818971|NCT02123797|529505571|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
146818972|NCT02123797|529505572|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
146818973|NCT02123797|529505573|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
146818974|NCT02123797|529505574|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
146818975|NCT02123797|529505570|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
146818976|NCT02123797|529505571|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
146818977|NCT02123797|529505572|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
146818978|NCT02123797|529505573|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
146818979|NCT02123797|529505574|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
146818980|NCT02123797|529505570|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
146818981|NCT02123797|529505571|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
146818982|NCT02123797|529505572|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
146818983|NCT02123797|529505573|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
146818984|NCT02123797|529505574|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
146818985|NCT05878990|529505577|FG000|Overall Study|Lost to Follow-up|7|||
146818986|NCT05878990|529505577|FG000|Overall Study|Withdrawal by Subject|1|||
146818987|NCT00331799|529505585|FG000|Overall Study|Withdrawal by Subject|2|||
146818988|NCT00331799|529505585|FG000|Overall Study|Sedation|1|||
146818989|NCT02889809|529505586|FG000|Overall Study|Withdrawal by Subject|30|||
146818990|NCT02889809|529505587|FG001|Overall Study|Withdrawal by Subject|21|||
146818991|NCT02889809|529505586|FG000|Overall Study|Lost to Follow-up|1|||
146818992|NCT02889809|529505587|FG001|Overall Study|Lost to Follow-up|1|||
146818993|NCT02889809|529505586|FG000|Overall Study|Site Closed|12|||
146818994|NCT02889809|529505587|FG001|Overall Study|Site Closed|11|||
146818995|NCT04203199|529505590|FG000|First Intervention Period|Lost to Follow-up|0|||
146818996|NCT04203199|529505591|FG001|First Intervention Period|Lost to Follow-up|1|||
146818997|NCT04203199|529505590|FG000|Second Intervention Period|Medication change|1|||
146818998|NCT04203199|529505591|FG001|Second Intervention Period|Medication change|0|||
146818999|NCT01107353|529505600|FG000|Overall Study|Positive Drug Screen|1|||
146819000|NCT01107353|529505601|FG001|Overall Study|Positive Drug Screen|0|||
146819001|NCT03034772|529505602|FG000|Overall Study|Adverse Event|0|||
146819002|NCT03034772|529505603|FG001|Overall Study|Adverse Event|1|||
146819003|NCT03034772|529505602|FG000|Overall Study|Withdrawal by Subject|0|||
146819004|NCT03034772|529505603|FG001|Overall Study|Withdrawal by Subject|1|||
146819005|NCT01136733|529505604|FG000|Phase 1b|Adverse Event|0|||
146819006|NCT01136733|529505605|FG001|Phase 1b|Adverse Event|3|||
146819007|NCT01136733|529505606|FG002|Phase 1b|Adverse Event|1|||
146819008|NCT01136733|529505607|FG003|Phase 1b|Adverse Event|0|||
146819009|NCT01136733|529505608|FG004|Phase 1b|Adverse Event|0|||
146819010|NCT01136733|529505609|FG005|Phase 1b|Adverse Event|0|||
146819011|NCT01136733|529505610|FG006|Phase 1b|Adverse Event|0|||
146819012|NCT01136733|529505604|FG000|Phase 1b|Participant Choice|0|||
146819013|NCT01136733|529505605|FG001|Phase 1b|Participant Choice|0|||
146819014|NCT01136733|529505606|FG002|Phase 1b|Participant Choice|1|||
146819015|NCT01136733|529505607|FG003|Phase 1b|Participant Choice|0|||
146819016|NCT01136733|529505608|FG004|Phase 1b|Participant Choice|0|||
146819017|NCT01136733|529505609|FG005|Phase 1b|Participant Choice|0|||
146819018|NCT01136733|529505610|FG006|Phase 1b|Participant Choice|0|||
146819019|NCT01136733|529505604|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
146819020|NCT01136733|529505605|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
146819021|NCT01136733|529505606|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
146819022|NCT01136733|529505607|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
146819023|NCT01136733|529505608|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
146819024|NCT01136733|529505609|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
146819025|NCT01136733|529505610|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
146819026|NCT01136733|529505604|FG000|Phase 1b|Clinical Progression|1|||
146819027|NCT01136733|529505605|FG001|Phase 1b|Clinical Progression|1|||
146819028|NCT01136733|529505606|FG002|Phase 1b|Clinical Progression|0|||
146819029|NCT01136733|529505607|FG003|Phase 1b|Clinical Progression|0|||
146819030|NCT01136733|529505608|FG004|Phase 1b|Clinical Progression|0|||
146819031|NCT01136733|529505609|FG005|Phase 1b|Clinical Progression|0|||
146819032|NCT01136733|529505610|FG006|Phase 1b|Clinical Progression|0|||
146819033|NCT01136733|529505604|FG000|Phase 2|Disease Progression|0|||
146819034|NCT01136733|529505605|FG001|Phase 2|Disease Progression|0|||
146819035|NCT01136733|529505606|FG002|Phase 2|Disease Progression|0|||
146819036|NCT01136733|529505607|FG003|Phase 2|Disease Progression|0|||
146819037|NCT01136733|529505608|FG004|Phase 2|Disease Progression|30|||
146819038|NCT01136733|529505609|FG005|Phase 2|Disease Progression|32|||
146819039|NCT01136733|529505610|FG006|Phase 2|Disease Progression|38|||
146819040|NCT01136733|529505604|FG000|Phase 2|Adverse Event|0|||
146819041|NCT01136733|529505605|FG001|Phase 2|Adverse Event|0|||
146819042|NCT01136733|529505606|FG002|Phase 2|Adverse Event|0|||
146819043|NCT01136733|529505607|FG003|Phase 2|Adverse Event|0|||
146819044|NCT01136733|529505608|FG004|Phase 2|Adverse Event|11|||
146819045|NCT01136733|529505609|FG005|Phase 2|Adverse Event|13|||
146819046|NCT01136733|529505610|FG006|Phase 2|Adverse Event|5|||
146819047|NCT01136733|529505604|FG000|Phase 2|Participant Choice|0|||
146950521|NCT00638989|529976223|FG002|Overall Study|Lost to Follow-up|1|||
146950522|NCT05245071|529976225|FG000|Overall Study|Progressive disease|18|||
146950523|NCT05245071|529976225|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
146950524|NCT05245071|529976225|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
146950525|NCT01602822|529976226|FG000|Overall Study|Adverse Event|11|||
146950526|NCT00853112|529976229|FG000|Overall Study|Randomized but not treated|0|||
146950527|NCT00853112|529976230|FG001|Overall Study|Randomized but not treated|1|||
146950528|NCT00853112|529976231|FG002|Overall Study|Randomized but not treated|0|||
146950529|NCT00853112|529976232|FG003|Overall Study|Randomized but not treated|2|||
146950530|NCT00853112|529976233|FG004|Overall Study|Randomized but not treated|0|||
146950531|NCT00853112|529976234|FG005|Overall Study|Randomized but not treated|0|||
146950532|NCT00853112|529976235|FG006|Overall Study|Randomized but not treated|1|||
146950533|NCT01553591|529976236|FG000|Overall Study|Voluntarily withdrew|94|||
146950534|NCT01553591|529976237|FG001|Overall Study|Voluntarily withdrew|79|||
146950535|NCT01553591|529976238|FG002|Overall Study|Voluntarily withdrew|96|||
146950536|NCT01553591|529976236|FG000|Overall Study|Adverse Event|36|||
146950537|NCT01553591|529976237|FG001|Overall Study|Adverse Event|45|||
146950538|NCT01553591|529976238|FG002|Overall Study|Adverse Event|16|||
146950539|NCT01553591|529976236|FG000|Overall Study|Lost to Follow-up|25|||
146950540|NCT01553591|529976237|FG001|Overall Study|Lost to Follow-up|23|||
146950541|NCT01553591|529976238|FG002|Overall Study|Lost to Follow-up|16|||
146950542|NCT01553591|529976236|FG000|Overall Study|Physician decision: other|11|||
146950543|NCT01553591|529976237|FG001|Overall Study|Physician decision: other|14|||
146950544|NCT01553591|529976238|FG002|Overall Study|Physician decision: other|16|||
146950545|NCT01553591|529976236|FG000|Overall Study|Physician decision: lack of efficacy|2|||
146950546|NCT01553591|529976237|FG001|Overall Study|Physician decision: lack of efficacy|3|||
146950547|NCT01553591|529976238|FG002|Overall Study|Physician decision: lack of efficacy|7|||
146950548|NCT01553591|529976236|FG000|Overall Study|Protocol Violation|3|||
146950549|NCT01553591|529976237|FG001|Overall Study|Protocol Violation|4|||
146950550|NCT01553591|529976238|FG002|Overall Study|Protocol Violation|4|||
146950551|NCT01553591|529976236|FG000|Overall Study|Sponsor decision|1|||
146984768|NCT01484028|530105160|FG002|Period 1|Lens Discomfort|0|||
146984769|NCT01484028|530105161|FG003|Period 1|Lens Discomfort|0|||
146819048|NCT01136733|529505605|FG001|Phase 2|Participant Choice|0|||
146819049|NCT01136733|529505606|FG002|Phase 2|Participant Choice|0|||
146819050|NCT01136733|529505607|FG003|Phase 2|Participant Choice|0|||
146819051|NCT01136733|529505608|FG004|Phase 2|Participant Choice|3|||
146819052|NCT01136733|529505609|FG005|Phase 2|Participant Choice|0|||
146819053|NCT01136733|529505610|FG006|Phase 2|Participant Choice|1|||
146819054|NCT01136733|529505604|FG000|Phase 2|Administrative-Withdrew Consent|0|||
146819055|NCT01136733|529505605|FG001|Phase 2|Administrative-Withdrew Consent|0|||
146819056|NCT01136733|529505606|FG002|Phase 2|Administrative-Withdrew Consent|0|||
146819057|NCT01136733|529505607|FG003|Phase 2|Administrative-Withdrew Consent|0|||
146819058|NCT01136733|529505608|FG004|Phase 2|Administrative-Withdrew Consent|1|||
146819059|NCT01136733|529505609|FG005|Phase 2|Administrative-Withdrew Consent|0|||
146819060|NCT01136733|529505610|FG006|Phase 2|Administrative-Withdrew Consent|0|||
146819061|NCT01136733|529505604|FG000|Phase 2|Other|0|||
146819062|NCT01136733|529505605|FG001|Phase 2|Other|0|||
146819063|NCT01136733|529505606|FG002|Phase 2|Other|0|||
146819064|NCT01136733|529505607|FG003|Phase 2|Other|0|||
146819065|NCT01136733|529505608|FG004|Phase 2|Other|6|||
146819066|NCT01136733|529505609|FG005|Phase 2|Other|7|||
146819067|NCT01136733|529505610|FG006|Phase 2|Other|6|||
146819068|NCT01745380|529505611|FG000|Overall Study|Lost to Follow-up|1|||
146819069|NCT01745380|529505612|FG001|Overall Study|Lost to Follow-up|0|||
146950552|NCT01553591|529976237|FG001|Overall Study|Sponsor decision|0|||
146950553|NCT01553591|529976238|FG002|Overall Study|Sponsor decision|3|||
146950554|NCT01553591|529976236|FG000|Overall Study|Randomized and never dispensed drug|0|||
146819070|NCT01745380|529505611|FG000|Overall Study|Lack of Efficacy|0|||
146819071|NCT01745380|529505612|FG001|Overall Study|Lack of Efficacy|1|||
146819072|NCT02368691|529505613|FG000|Overall Study|Death|13|||
146819073|NCT02368691|529505613|FG000|Overall Study|Lack of Efficacy|15|||
146819074|NCT02368691|529505613|FG000|Overall Study|Physician Decision|4|||
146950555|NCT01553591|529976237|FG001|Overall Study|Randomized and never dispensed drug|1|||
146950556|NCT01553591|529976238|FG002|Overall Study|Randomized and never dispensed drug|0|||
146950557|NCT01426009|529976239|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
146819075|NCT02660034|529505614|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
146819076|NCT02660034|529505615|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
146819077|NCT02660034|529505616|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
146819078|NCT02660034|529505617|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
146819079|NCT02660034|529505618|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
146984770|NCT01193517|530105162|FG000|Overall Study|Early Progression|1|||
146950558|NCT01426009|529976239|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
146950559|NCT01426009|529976239|FG000|Washout 1|Withdrawal by Subject|1|||
146950560|NCT01426009|529976239|FG000|Washout 1|Personal Reasons|1|||
146950561|NCT01426009|529976239|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
146950562|NCT01426009|529976239|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
146950563|NCT01426009|529976239|FG000|Washout 2|electrive surgery|1|||
146950564|NCT01426009|529976239|FG000|Washout 3|personal reasons|1|||
146950565|NCT01426009|529976239|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
146950566|NCT01426009|529976239|FG000|Washout 4|Lost to Follow-up|1|||
146950567|NCT04107935|529976241|FG000|Overall Study|Death|1|||
146950568|NCT04107935|529976242|FG001|Overall Study|Death|0|||
146950569|NCT01108068|529976243|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
146950570|NCT01108068|529976244|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
146950571|NCT00836953|529976245|FG000|Overall Study|Withdrawal by Subject|1|||
146950572|NCT00836953|529976245|FG000|Overall Study|Lost to Follow-up|1|||
146950573|NCT02201251|529976247|FG000|Overall Study|Adverse Event|1|||
146950574|NCT02201251|529976248|FG001|Overall Study|Adverse Event|1|||
146950575|NCT02201251|529976247|FG000|Overall Study|Protocol Violation|1|||
146950576|NCT02201251|529976248|FG001|Overall Study|Protocol Violation|0|||
146950577|NCT02201251|529976247|FG000|Overall Study|Noncompliance with Study Drug|0|||
146950578|NCT02201251|529976248|FG001|Overall Study|Noncompliance with Study Drug|1|||
146950579|NCT02201251|529976247|FG000|Overall Study|Withdrawal by Subject|2|||
146950580|NCT02201251|529976248|FG001|Overall Study|Withdrawal by Subject|1|||
146950581|NCT04048876|529976254|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
146950582|NCT04048876|529976255|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
146950583|NCT04048876|529976256|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
146950584|NCT04048876|529976257|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
146950585|NCT04048876|529976254|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
146950586|NCT04048876|529976255|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
146950587|NCT04048876|529976256|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
146950588|NCT04048876|529976257|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
146950589|NCT04048876|529976254|FG000|Placebo Controlled Phase|Adverse Event|0|||
146950590|NCT04048876|529976255|FG001|Placebo Controlled Phase|Adverse Event|1|||
146950591|NCT04048876|529976256|FG002|Placebo Controlled Phase|Adverse Event|0|||
146950592|NCT04048876|529976257|FG003|Placebo Controlled Phase|Adverse Event|0|||
146950593|NCT04048876|529976254|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
146950594|NCT04048876|529976255|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
146950595|NCT04048876|529976256|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
146950596|NCT04048876|529976257|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
146950597|NCT01700140|529976258|FG000|Overall Study|Use of rescue drugs|3|||
146950598|NCT01700140|529976259|FG001|Overall Study|Use of rescue drugs|3|||
146950599|NCT01700140|529976260|FG002|Overall Study|Use of rescue drugs|1|||
146950600|NCT01700140|529976258|FG000|Overall Study|Discontinuation of radiotherapy|1|||
146950601|NCT01700140|529976259|FG001|Overall Study|Discontinuation of radiotherapy|0|||
146950602|NCT01700140|529976260|FG002|Overall Study|Discontinuation of radiotherapy|0|||
146950603|NCT01700140|529976258|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
146950604|NCT01700140|529976259|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
146950605|NCT01700140|529976260|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
146950606|NCT01700140|529976258|FG000|Overall Study|Aggravation of symptoms|1|||
146950607|NCT01700140|529976259|FG001|Overall Study|Aggravation of symptoms|0|||
146950608|NCT01700140|529976260|FG002|Overall Study|Aggravation of symptoms|0|||
146950609|NCT01700140|529976258|FG000|Overall Study|Adverse Event|0|||
146950610|NCT01700140|529976259|FG001|Overall Study|Adverse Event|1|||
146950611|NCT01700140|529976260|FG002|Overall Study|Adverse Event|0|||
146950612|NCT01700140|529976258|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
146950613|NCT01700140|529976259|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
146950614|NCT01700140|529976260|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
146950615|NCT01060124|529976261|FG000|Overall Study|Other|16|||
146950616|NCT01060124|529976261|FG000|Overall Study|Adverse Event|14|||
146950617|NCT01060124|529976261|FG000|Overall Study|Withdrawal by Subject|7|||
146984771|NCT01193517|530105163|FG001|Overall Study|Early Progression|0|||
146984772|NCT01193517|530105164|FG002|Overall Study|Early Progression|0|||
146984773|NCT00146770|530105165|FG000|Overall Study|Adverse Event|2|||
146950618|NCT01708915|529976263|FG000|Overall Study|Adverse Event|1|||
146984774|NCT00146770|530105166|FG001|Overall Study|Adverse Event|0|||
146819080|NCT02660034|529505619|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
146950619|NCT01708915|529976264|FG001|Overall Study|Adverse Event|0|||
146950620|NCT01708915|529976265|FG002|Overall Study|Adverse Event|9|||
146950621|NCT01708915|529976266|FG003|Overall Study|Adverse Event|13|||
146950622|NCT01708915|529976263|FG000|Overall Study|Lack of Efficacy|84|||
146950623|NCT01708915|529976264|FG001|Overall Study|Lack of Efficacy|60|||
146950624|NCT01708915|529976265|FG002|Overall Study|Lack of Efficacy|35|||
146950625|NCT01708915|529976266|FG003|Overall Study|Lack of Efficacy|15|||
146950626|NCT01708915|529976263|FG000|Overall Study|Protocol Violation|0|||
146950627|NCT01708915|529976264|FG001|Overall Study|Protocol Violation|0|||
146950628|NCT01708915|529976265|FG002|Overall Study|Protocol Violation|0|||
146950629|NCT01708915|529976266|FG003|Overall Study|Protocol Violation|1|||
146950630|NCT01708915|529976263|FG000|Overall Study|Withdrawal by Subject|0|||
146950631|NCT01708915|529976264|FG001|Overall Study|Withdrawal by Subject|1|||
146950632|NCT01708915|529976265|FG002|Overall Study|Withdrawal by Subject|2|||
146950633|NCT01708915|529976266|FG003|Overall Study|Withdrawal by Subject|2|||
146950634|NCT01708915|529976263|FG000|Overall Study|Other reasons than stated above|1|||
146950635|NCT01708915|529976264|FG001|Overall Study|Other reasons than stated above|1|||
146950636|NCT01708915|529976265|FG002|Overall Study|Other reasons than stated above|0|||
146950637|NCT01708915|529976266|FG003|Overall Study|Other reasons than stated above|2|||
146950638|NCT01222416|529976267|FG000|Overall Study|ineligible;metastasis|3|||
146950639|NCT01222416|529976268|FG001|Overall Study|ineligible;metastasis|0|||
146950640|NCT01222416|529976267|FG000|Overall Study|Adverse Event|4|||
146950641|NCT01222416|529976268|FG001|Overall Study|Adverse Event|0|||
146950642|NCT01222416|529976267|FG000|Overall Study|Withdrawal by Subject|5|||
146950643|NCT01222416|529976268|FG001|Overall Study|Withdrawal by Subject|0|||
146950644|NCT01222416|529976267|FG000|Overall Study|scheduling|6|||
146950645|NCT01222416|529976268|FG001|Overall Study|scheduling|0|||
146950646|NCT01222416|529976267|FG000|Overall Study|missed view/scan|1|||
146950647|NCT01222416|529976268|FG001|Overall Study|missed view/scan|0|||
146950648|NCT01222416|529976267|FG000|Overall Study|Death|1|||
146950649|NCT01222416|529976268|FG001|Overall Study|Death|0|||
146950650|NCT00518336|529976269|FG000|Year 7|Lost to Follow-up|2|||
146950651|NCT00518336|529976270|FG001|Year 7|Lost to Follow-up|0|||
146950652|NCT00518336|529976269|FG000|Year 7|Could not attend in time|0|||
146950653|NCT00518336|529976270|FG001|Year 7|Could not attend in time|3|||
146950654|NCT00518336|529976269|FG000|Year 8|Lost to Follow-up|1|||
146950655|NCT00518336|529976270|FG001|Year 8|Lost to Follow-up|1|||
146950656|NCT00518336|529976269|FG000|Year 8|Could not attend in time|0|||
146950657|NCT00518336|529976270|FG001|Year 8|Could not attend in time|1|||
146950658|NCT00518336|529976269|FG000|Year 9|Migrated/moved from study area|1|||
146950659|NCT00518336|529976270|FG001|Year 9|Migrated/moved from study area|1|||
146950660|NCT00518336|529976269|FG000|Year 9|Lost to Follow-up|3|||
146950661|NCT00518336|529976270|FG001|Year 9|Lost to Follow-up|0|||
146950662|NCT00518336|529976269|FG000|Year 9|Personal reasons|1|||
146950663|NCT00518336|529976270|FG001|Year 9|Personal reasons|0|||
146950664|NCT02972658|529977956|FG000|Overall Study|Adverse Event|0|||
146950665|NCT02972658|529977957|FG001|Overall Study|Adverse Event|3|||
146950666|NCT02972658|529977958|FG002|Overall Study|Adverse Event|0|||
146950667|NCT02972658|529977959|FG003|Overall Study|Adverse Event|2|||
146950668|NCT02972658|529977956|FG000|Overall Study|Other-determined by Investigator|1|||
146950669|NCT02972658|529977957|FG001|Overall Study|Other-determined by Investigator|1|||
146950670|NCT02972658|529977958|FG002|Overall Study|Other-determined by Investigator|0|||
146950671|NCT02972658|529977959|FG003|Overall Study|Other-determined by Investigator|0|||
146950672|NCT02972658|529977956|FG000|Overall Study|Death|0|||
146950673|NCT02972658|529977957|FG001|Overall Study|Death|0|||
146950674|NCT02972658|529977958|FG002|Overall Study|Death|0|||
146950675|NCT02972658|529977959|FG003|Overall Study|Death|1|||
146950676|NCT02972658|529977956|FG000|Overall Study|Lost to Follow-up|0|||
146950677|NCT02972658|529977957|FG001|Overall Study|Lost to Follow-up|1|||
146950678|NCT02972658|529977958|FG002|Overall Study|Lost to Follow-up|1|||
146950679|NCT02972658|529977959|FG003|Overall Study|Lost to Follow-up|2|||
146950680|NCT02972658|529977956|FG000|Overall Study|Progressive Disease|0|||
146950681|NCT02972658|529977957|FG001|Overall Study|Progressive Disease|1|||
146950682|NCT02972658|529977958|FG002|Overall Study|Progressive Disease|0|||
146950683|NCT02972658|529977959|FG003|Overall Study|Progressive Disease|1|||
146950684|NCT02972658|529977956|FG000|Overall Study|Withdrawal by Subject|4|||
146950685|NCT02972658|529977957|FG001|Overall Study|Withdrawal by Subject|4|||
146950686|NCT02972658|529977958|FG002|Overall Study|Withdrawal by Subject|1|||
146950687|NCT02972658|529977959|FG003|Overall Study|Withdrawal by Subject|6|||
146950688|NCT02972658|529977956|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
146950689|NCT02972658|529977957|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
146950690|NCT02972658|529977958|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
146950691|NCT02972658|529977959|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
146950692|NCT02972658|529977956|FG000|Overall Study|Sponsor Decision|70|||
146950693|NCT02972658|529977957|FG001|Overall Study|Sponsor Decision|127|||
146950694|NCT02972658|529977958|FG002|Overall Study|Sponsor Decision|72|||
146950695|NCT02972658|529977959|FG003|Overall Study|Sponsor Decision|119|||
146984775|NCT00146770|530105165|FG000|Overall Study|Pregnancy|1|||
146950696|NCT03958149|529977960|FG000|Overall Study|Withdrawal by Subject|0|||
146950697|NCT03958149|529977961|FG001|Overall Study|Withdrawal by Subject|1|||
146950698|NCT00621764|529977963|FG000|Overall Study|Protocol Violation|0|||
146950699|NCT00621764|529977964|FG001|Overall Study|Protocol Violation|0|||
146950700|NCT00621764|529977965|FG002|Overall Study|Protocol Violation|0|||
146950701|NCT00621764|529977966|FG003|Overall Study|Protocol Violation|1|||
146950702|NCT03031327|529977971|FG000|Overall Study|Withdrawal by Subject|0|||
146950703|NCT03031327|529977972|FG001|Overall Study|Withdrawal by Subject|1|||
146950704|NCT03031327|529977973|FG002|Overall Study|Withdrawal by Subject|1|||
146950705|NCT00669240|529977974|FG000|Overall Study|Lack of Efficacy|33|||
146950706|NCT00669240|529977974|FG000|Overall Study|Withdrawal by Subject|42|||
146950707|NCT00669240|529977974|FG000|Overall Study|Lost to Follow-up|34|||
146950708|NCT00669240|529977974|FG000|Overall Study|Adverse Event|21|||
146950709|NCT00669240|529977974|FG000|Overall Study|Other|19|||
146950710|NCT00669240|529977974|FG000|Overall Study|Enrolled but not treated|15|||
146950711|NCT00669240|529977974|FG000|Overall Study|Enrolled but no dosing record|1|||
146950712|NCT00686699|529977975|FG000|Treatment Period 1|Adverse Event|0|||
146950713|NCT00686699|529977976|FG001|Treatment Period 1|Adverse Event|2|||
146950714|NCT00364611|529977978|FG000|Overall Study|Did not receive study medication|0|||
146950715|NCT00364611|529977979|FG001|Overall Study|Did not receive study medication|1|||
146950716|NCT00364611|529977978|FG000|Overall Study|Adverse Event|7|||
146950717|NCT00364611|529977979|FG001|Overall Study|Adverse Event|4|||
146950718|NCT00364611|529977978|FG000|Overall Study|Participant's Request|3|||
146950719|NCT00364611|529977979|FG001|Overall Study|Participant's Request|4|||
146950720|NCT00364611|529977978|FG000|Overall Study|Disease Progression|38|||
146950721|NCT00364611|529977979|FG001|Overall Study|Disease Progression|8|||
146950722|NCT00364611|529977978|FG000|Overall Study|Investigator decision|2|||
146950723|NCT00364611|529977979|FG001|Overall Study|Investigator decision|2|||
146950724|NCT00364611|529977978|FG000|Overall Study|Found Ineligible|1|||
146950725|NCT00364611|529977979|FG001|Overall Study|Found Ineligible|0|||
146950726|NCT00364611|529977978|FG000|Overall Study|Presumed CR on Study|0|||
146950727|NCT00364611|529977979|FG001|Overall Study|Presumed CR on Study|1|||
146950728|NCT00364611|529977978|FG000|Overall Study|Receiving Liver Ablation|0|||
146950729|NCT00364611|529977979|FG001|Overall Study|Receiving Liver Ablation|1|||
146950730|NCT04097925|529977984|FG000|Overall Study|Withdrawal by Subject|1|||
146950731|NCT04397757|529977987|FG000|Overall Study|Death|3|||
146950732|NCT04397757|529977988|FG001|Overall Study|Death|11|||
146950733|NCT04397757|529977987|FG000|Overall Study|Withdrawal by Subject|2|||
146950734|NCT04397757|529977988|FG001|Overall Study|Withdrawal by Subject|0|||
146950735|NCT04397757|529977987|FG000|Overall Study|Lost to Follow-up|4|||
146950736|NCT04397757|529977988|FG001|Overall Study|Lost to Follow-up|3|||
146950737|NCT00033514|529977989|FG000|Overall Study|Lost to Follow-up|1|||
146950738|NCT00033514|529977990|FG001|Overall Study|Lost to Follow-up|1|||
146950739|NCT00033514|529977989|FG000|Overall Study|Withdrawal by Subject|0|||
146950740|NCT00033514|529977990|FG001|Overall Study|Withdrawal by Subject|3|||
146950741|NCT01599585|529978000|FG000|Overall Study|Withdrawal by Subject|16|||
146950742|NCT01599585|529978001|FG001|Overall Study|Withdrawal by Subject|9|||
146950743|NCT01599585|529978000|FG000|Overall Study|Lost to Follow-up|3|||
146950744|NCT01599585|529978001|FG001|Overall Study|Lost to Follow-up|5|||
146950745|NCT01599585|529978000|FG000|Overall Study|randomized did not start treatment|3|||
146950746|NCT01599585|529978001|FG001|Overall Study|randomized did not start treatment|3|||
146950747|NCT04005755|529978012|FG000|Overall Study|Adverse Event|6|||
146950748|NCT04005755|529978012|FG000|Overall Study|Physician Decision|3|||
146950749|NCT04005755|529978012|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
146950750|NCT04005755|529978012|FG000|Overall Study|Withdrawal by Subject|3|||
146950751|NCT04005755|529978012|FG000|Overall Study|Lost to Follow-up|1|||
146950752|NCT02005211|529978015|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
146950753|NCT02005211|529978016|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
146950754|NCT02005211|529978017|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
146950755|NCT02005211|529978018|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
146950756|NCT02005211|529978019|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
146950757|NCT02005211|529978020|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
146950758|NCT02005211|529978021|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
146950759|NCT02202161|529978024|FG000|Overall Study|Adverse Event|1|||
146819081|NCT02660034|529505620|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
146819082|NCT02660034|529505621|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
146984776|NCT00146770|530105166|FG001|Overall Study|Pregnancy|0|||
146819083|NCT02660034|529505622|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
146950760|NCT02202161|529978025|FG001|Overall Study|Adverse Event|1|||
146950761|NCT02202161|529978026|FG002|Overall Study|Adverse Event|0|||
146950762|NCT02202161|529978027|FG003|Overall Study|Adverse Event|0|||
146950763|NCT02202161|529978028|FG004|Overall Study|Adverse Event|0|||
146950764|NCT02202161|529978029|FG005|Overall Study|Adverse Event|1|||
146950765|NCT02202161|529978030|FG006|Overall Study|Adverse Event|0|||
146950766|NCT02202161|529978031|FG007|Overall Study|Adverse Event|0|||
146950767|NCT02202161|529978024|FG000|Overall Study|Did not meet continuation criteria|0|||
146950768|NCT02202161|529978025|FG001|Overall Study|Did not meet continuation criteria|0|||
146984777|NCT00146770|530105165|FG000|Overall Study|Withdrawal by Subject|2|||
146950769|NCT02202161|529978026|FG002|Overall Study|Did not meet continuation criteria|0|||
146950770|NCT02202161|529978027|FG003|Overall Study|Did not meet continuation criteria|0|||
146950771|NCT02202161|529978028|FG004|Overall Study|Did not meet continuation criteria|0|||
146950772|NCT02202161|529978029|FG005|Overall Study|Did not meet continuation criteria|0|||
146950773|NCT02202161|529978030|FG006|Overall Study|Did not meet continuation criteria|0|||
146984778|NCT00146770|530105166|FG001|Overall Study|Withdrawal by Subject|0|||
146950774|NCT02202161|529978031|FG007|Overall Study|Did not meet continuation criteria|3|||
146950775|NCT02202161|529978024|FG000|Overall Study|Physician Decision|0|||
146950776|NCT02202161|529978025|FG001|Overall Study|Physician Decision|0|||
146950777|NCT02202161|529978026|FG002|Overall Study|Physician Decision|0|||
146950778|NCT02202161|529978027|FG003|Overall Study|Physician Decision|0|||
146950779|NCT02202161|529978028|FG004|Overall Study|Physician Decision|0|||
146950780|NCT02202161|529978029|FG005|Overall Study|Physician Decision|0|||
146950781|NCT02202161|529978030|FG006|Overall Study|Physician Decision|0|||
146950782|NCT02202161|529978031|FG007|Overall Study|Physician Decision|3|||
146950783|NCT02202161|529978024|FG000|Overall Study|Withdrawal by Subject|0|||
146950784|NCT02202161|529978025|FG001|Overall Study|Withdrawal by Subject|0|||
146950785|NCT02202161|529978026|FG002|Overall Study|Withdrawal by Subject|0|||
146950786|NCT02202161|529978027|FG003|Overall Study|Withdrawal by Subject|0|||
146950787|NCT02202161|529978028|FG004|Overall Study|Withdrawal by Subject|1|||
146950788|NCT02202161|529978029|FG005|Overall Study|Withdrawal by Subject|0|||
146950789|NCT02202161|529978030|FG006|Overall Study|Withdrawal by Subject|0|||
146950790|NCT02202161|529978031|FG007|Overall Study|Withdrawal by Subject|0|||
146950791|NCT00832091|529978032|FG000|Overall Study|Adverse Event|1|||
146950792|NCT00832091|529978033|FG001|Overall Study|Adverse Event|1|||
146950793|NCT00832091|529978032|FG000|Overall Study|Protocol Violation|1|||
146950794|NCT00832091|529978033|FG001|Overall Study|Protocol Violation|0|||
146950795|NCT00832091|529978032|FG000|Overall Study|Withdrawal by Subject|2|||
146950796|NCT00832091|529978033|FG001|Overall Study|Withdrawal by Subject|1|||
146950797|NCT00832091|529978032|FG000|Overall Study|Prohibited Medication|1|||
146950798|NCT00832091|529978033|FG001|Overall Study|Prohibited Medication|0|||
146950799|NCT00952588|529978034|FG000|Overall Study|Death|28|||
146950800|NCT00952588|529978035|FG001|Overall Study|Death|13|||
146950801|NCT00952588|529978034|FG000|Overall Study|Withdrawal by Subject|2|||
146950802|NCT00952588|529978035|FG001|Overall Study|Withdrawal by Subject|5|||
146950803|NCT00952588|529978034|FG000|Overall Study|Adverse Event|2|||
146950804|NCT00952588|529978035|FG001|Overall Study|Adverse Event|3|||
146950805|NCT00952588|529978034|FG000|Overall Study|Lost to Follow-up|2|||
146950806|NCT00952588|529978035|FG001|Overall Study|Lost to Follow-up|0|||
146950807|NCT00952588|529978034|FG000|Overall Study|Physician Decision|0|||
146950808|NCT00952588|529978035|FG001|Overall Study|Physician Decision|1|||
146950809|NCT00952588|529978034|FG000|Overall Study|Lack of Efficacy|2|||
146950810|NCT00952588|529978035|FG001|Overall Study|Lack of Efficacy|2|||
146950811|NCT04554394|529978036|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
146950812|NCT04554394|529978037|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
146950813|NCT04554394|529978036|FG000|Overall Study|Withdrawal by Subject|2|||
146950814|NCT04554394|529978037|FG001|Overall Study|Withdrawal by Subject|2|||
146950815|NCT04554394|529978036|FG000|Overall Study|Lost to Follow-up|2|||
146950816|NCT04554394|529978037|FG001|Overall Study|Lost to Follow-up|2|||
146950817|NCT04554394|529978036|FG000|Overall Study|Physician Decision|1|||
146950818|NCT04554394|529978037|FG001|Overall Study|Physician Decision|1|||
146950819|NCT01766401|529978038|FG000|Overall Study|Adverse Event|7|||
146950820|NCT01766401|529978039|FG001|Overall Study|Adverse Event|22|||
146950821|NCT01766401|529978038|FG000|Overall Study|Lack of Efficacy|1|||
146950822|NCT01766401|529978039|FG001|Overall Study|Lack of Efficacy|2|||
146950823|NCT01766401|529978038|FG000|Overall Study|Protocol Violation|3|||
146950824|NCT01766401|529978039|FG001|Overall Study|Protocol Violation|8|||
146950825|NCT01766401|529978038|FG000|Overall Study|Withdrawal by Subject|15|||
146950826|NCT01766401|529978039|FG001|Overall Study|Withdrawal by Subject|12|||
146950827|NCT01766401|529978038|FG000|Overall Study|Lost to Follow-up|10|||
146950828|NCT01766401|529978039|FG001|Overall Study|Lost to Follow-up|11|||
146950829|NCT01766401|529978038|FG000|Overall Study|Pregnancy|1|||
146950830|NCT01766401|529978039|FG001|Overall Study|Pregnancy|1|||
146950831|NCT01021553|529978040|FG000|Overall Study|Adverse Event|1|||
146950832|NCT01021553|529978041|FG001|Overall Study|Adverse Event|0|||
146950833|NCT01021553|529978042|FG002|Overall Study|Adverse Event|0|||
146950834|NCT01021553|529978040|FG000|Overall Study|Lack of Efficacy|2|||
146950835|NCT01021553|529978041|FG001|Overall Study|Lack of Efficacy|2|||
146950836|NCT01021553|529978042|FG002|Overall Study|Lack of Efficacy|0|||
146950837|NCT01021553|529978040|FG000|Overall Study|Protocol Violation|0|||
146950838|NCT01021553|529978041|FG001|Overall Study|Protocol Violation|2|||
146950839|NCT01021553|529978042|FG002|Overall Study|Protocol Violation|2|||
146950840|NCT01021553|529978040|FG000|Overall Study|Lost to Follow-up|0|||
146950841|NCT01021553|529978041|FG001|Overall Study|Lost to Follow-up|0|||
146950842|NCT01021553|529978042|FG002|Overall Study|Lost to Follow-up|1|||
146950843|NCT01021553|529978040|FG000|Overall Study|Withdrawal by Subject|1|||
146950844|NCT01021553|529978041|FG001|Overall Study|Withdrawal by Subject|1|||
146950845|NCT01021553|529978042|FG002|Overall Study|Withdrawal by Subject|0|||
146950846|NCT01950364|529978043|FG000|Overall Study|Adverse Event|3|||
146950847|NCT01950364|529978044|FG001|Overall Study|Adverse Event|0|||
146950848|NCT01950364|529978043|FG000|Overall Study|Stem Cell Transplant|2|||
146950849|NCT01950364|529978044|FG001|Overall Study|Stem Cell Transplant|6|||
146950850|NCT01950364|529978043|FG000|Overall Study|Disease Progression|5|||
146950851|NCT01950364|529978044|FG001|Overall Study|Disease Progression|2|||
146950852|NCT01950364|529978043|FG000|Overall Study|Withdrawal by Subject|0|||
146984779|NCT01626885|530105169|FG000|Overall Study|Adverse Event|8|||
146819084|NCT02660034|529505623|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
146819085|NCT02660034|529505624|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
146819086|NCT02660034|529505625|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
146819087|NCT02660034|529505626|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
146819088|NCT02660034|529505627|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
146819089|NCT02660034|529505614|FG000|Overall Study|Progressive Disease (Clinical)|7|||
146819090|NCT02660034|529505615|FG001|Overall Study|Progressive Disease (Clinical)|8|||
146819091|NCT02660034|529505616|FG002|Overall Study|Progressive Disease (Clinical)|3|||
146819092|NCT02660034|529505617|FG003|Overall Study|Progressive Disease (Clinical)|9|||
146819093|NCT02660034|529505618|FG004|Overall Study|Progressive Disease (Clinical)|3|||
146819094|NCT02660034|529505619|FG005|Overall Study|Progressive Disease (Clinical)|0|||
146819095|NCT02660034|529505620|FG006|Overall Study|Progressive Disease (Clinical)|0|||
146819096|NCT02660034|529505621|FG007|Overall Study|Progressive Disease (Clinical)|0|||
146819097|NCT02660034|529505622|FG008|Overall Study|Progressive Disease (Clinical)|0|||
146819098|NCT02660034|529505623|FG009|Overall Study|Progressive Disease (Clinical)|0|||
146819099|NCT02660034|529505624|FG010|Overall Study|Progressive Disease (Clinical)|0|||
146819100|NCT02660034|529505625|FG011|Overall Study|Progressive Disease (Clinical)|0|||
146819101|NCT02660034|529505626|FG012|Overall Study|Progressive Disease (Clinical)|0|||
146819102|NCT02660034|529505627|FG013|Overall Study|Progressive Disease (Clinical)|0|||
146819103|NCT02660034|529505614|FG000|Overall Study|Lost to Follow-up|0|||
146819104|NCT02660034|529505615|FG001|Overall Study|Lost to Follow-up|0|||
146819105|NCT02660034|529505616|FG002|Overall Study|Lost to Follow-up|1|||
146819106|NCT02660034|529505617|FG003|Overall Study|Lost to Follow-up|1|||
146819107|NCT02660034|529505618|FG004|Overall Study|Lost to Follow-up|0|||
146819108|NCT02660034|529505619|FG005|Overall Study|Lost to Follow-up|0|||
146819109|NCT02660034|529505620|FG006|Overall Study|Lost to Follow-up|0|||
146819110|NCT02660034|529505621|FG007|Overall Study|Lost to Follow-up|0|||
146819111|NCT02660034|529505622|FG008|Overall Study|Lost to Follow-up|0|||
146819112|NCT02660034|529505623|FG009|Overall Study|Lost to Follow-up|1|||
146819113|NCT02660034|529505624|FG010|Overall Study|Lost to Follow-up|1|||
146819114|NCT02660034|529505625|FG011|Overall Study|Lost to Follow-up|1|||
146819115|NCT02660034|529505626|FG012|Overall Study|Lost to Follow-up|0|||
146819116|NCT02660034|529505627|FG013|Overall Study|Lost to Follow-up|0|||
146819117|NCT02660034|529505614|FG000|Overall Study|Participant moved into special access scheme|1|||
146819118|NCT02660034|529505615|FG001|Overall Study|Participant moved into special access scheme|2|||
146819119|NCT02660034|529505616|FG002|Overall Study|Participant moved into special access scheme|0|||
146819120|NCT02660034|529505617|FG003|Overall Study|Participant moved into special access scheme|0|||
146819121|NCT02660034|529505618|FG004|Overall Study|Participant moved into special access scheme|0|||
146819122|NCT02660034|529505619|FG005|Overall Study|Participant moved into special access scheme|0|||
146819123|NCT02660034|529505620|FG006|Overall Study|Participant moved into special access scheme|0|||
146819124|NCT02660034|529505621|FG007|Overall Study|Participant moved into special access scheme|0|||
146819125|NCT02660034|529505622|FG008|Overall Study|Participant moved into special access scheme|0|||
146819126|NCT02660034|529505623|FG009|Overall Study|Participant moved into special access scheme|0|||
146819127|NCT02660034|529505624|FG010|Overall Study|Participant moved into special access scheme|0|||
146819128|NCT02660034|529505625|FG011|Overall Study|Participant moved into special access scheme|0|||
146819129|NCT02660034|529505626|FG012|Overall Study|Participant moved into special access scheme|0|||
146819130|NCT02660034|529505627|FG013|Overall Study|Participant moved into special access scheme|0|||
146819131|NCT02660034|529505614|FG000|Overall Study|Adverse Event|1|||
146819132|NCT02660034|529505615|FG001|Overall Study|Adverse Event|0|||
146819133|NCT02660034|529505616|FG002|Overall Study|Adverse Event|0|||
146819134|NCT02660034|529505617|FG003|Overall Study|Adverse Event|0|||
146819135|NCT02660034|529505618|FG004|Overall Study|Adverse Event|0|||
146819136|NCT02660034|529505619|FG005|Overall Study|Adverse Event|0|||
146819137|NCT02660034|529505620|FG006|Overall Study|Adverse Event|0|||
146819138|NCT02660034|529505621|FG007|Overall Study|Adverse Event|0|||
146819139|NCT02660034|529505622|FG008|Overall Study|Adverse Event|0|||
146819140|NCT02660034|529505623|FG009|Overall Study|Adverse Event|0|||
146819141|NCT02660034|529505624|FG010|Overall Study|Adverse Event|0|||
146819142|NCT02660034|529505625|FG011|Overall Study|Adverse Event|0|||
146819143|NCT02660034|529505626|FG012|Overall Study|Adverse Event|0|||
146819144|NCT02660034|529505627|FG013|Overall Study|Adverse Event|0|||
146819145|NCT02660034|529505614|FG000|Overall Study|Sponsor Decision|0|||
146819146|NCT02660034|529505615|FG001|Overall Study|Sponsor Decision|1|||
146819147|NCT02660034|529505616|FG002|Overall Study|Sponsor Decision|2|||
146819148|NCT02660034|529505617|FG003|Overall Study|Sponsor Decision|2|||
146819149|NCT02660034|529505618|FG004|Overall Study|Sponsor Decision|3|||
146819150|NCT02660034|529505619|FG005|Overall Study|Sponsor Decision|0|||
146819151|NCT02660034|529505620|FG006|Overall Study|Sponsor Decision|0|||
146819152|NCT02660034|529505621|FG007|Overall Study|Sponsor Decision|0|||
146819153|NCT02660034|529505622|FG008|Overall Study|Sponsor Decision|0|||
146819154|NCT02660034|529505623|FG009|Overall Study|Sponsor Decision|0|||
146819155|NCT02660034|529505624|FG010|Overall Study|Sponsor Decision|0|||
146984780|NCT01626885|530105169|FG000|Overall Study|Withdrawal by Subject|4|||
146950853|NCT01950364|529978044|FG001|Overall Study|Withdrawal by Subject|1|||
146950854|NCT01950364|529978043|FG000|Overall Study|Protocol Violation|0|||
146950855|NCT01950364|529978044|FG001|Overall Study|Protocol Violation|1|||
146950856|NCT00935701|529978045|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
146950857|NCT02877134|529978046|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
146950858|NCT02877134|529978047|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
146950859|NCT02877134|529978048|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
146950860|NCT02877134|529978049|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
146950861|NCT02877134|529978050|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
146950862|NCT02877134|529978051|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
146950863|NCT02877134|529978052|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
146950864|NCT02877134|529978053|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
146950865|NCT02877134|529978054|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
146950866|NCT02877134|529978055|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
146950867|NCT02877134|529978056|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
146950868|NCT02877134|529978057|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
146819156|NCT02660034|529505625|FG011|Overall Study|Sponsor Decision|0|||
146819157|NCT02660034|529505626|FG012|Overall Study|Sponsor Decision|0|||
146819158|NCT02660034|529505627|FG013|Overall Study|Sponsor Decision|1|||
146819159|NCT02660034|529505614|FG000|Overall Study|Withdrawal by Subject|0|||
146819160|NCT02660034|529505615|FG001|Overall Study|Withdrawal by Subject|0|||
146819161|NCT02660034|529505616|FG002|Overall Study|Withdrawal by Subject|0|||
146819162|NCT02660034|529505617|FG003|Overall Study|Withdrawal by Subject|0|||
146819163|NCT02660034|529505618|FG004|Overall Study|Withdrawal by Subject|0|||
146819164|NCT02660034|529505619|FG005|Overall Study|Withdrawal by Subject|0|||
146819165|NCT02660034|529505620|FG006|Overall Study|Withdrawal by Subject|1|||
146819166|NCT02660034|529505621|FG007|Overall Study|Withdrawal by Subject|1|||
146819167|NCT02660034|529505622|FG008|Overall Study|Withdrawal by Subject|1|||
146819168|NCT02660034|529505623|FG009|Overall Study|Withdrawal by Subject|0|||
146819169|NCT02660034|529505624|FG010|Overall Study|Withdrawal by Subject|0|||
146819170|NCT02660034|529505625|FG011|Overall Study|Withdrawal by Subject|1|||
146819171|NCT02660034|529505626|FG012|Overall Study|Withdrawal by Subject|2|||
146819172|NCT02660034|529505627|FG013|Overall Study|Withdrawal by Subject|0|||
146819173|NCT02660034|529505614|FG000|Overall Study|Death|0|||
146819174|NCT02660034|529505615|FG001|Overall Study|Death|0|||
146819175|NCT02660034|529505616|FG002|Overall Study|Death|0|||
146819176|NCT02660034|529505617|FG003|Overall Study|Death|0|||
146819177|NCT02660034|529505618|FG004|Overall Study|Death|0|||
146819178|NCT02660034|529505619|FG005|Overall Study|Death|13|||
146819179|NCT02660034|529505620|FG006|Overall Study|Death|14|||
146819180|NCT02660034|529505621|FG007|Overall Study|Death|10|||
146819181|NCT02660034|529505622|FG008|Overall Study|Death|9|||
146819182|NCT02660034|529505623|FG009|Overall Study|Death|21|||
146819183|NCT02660034|529505624|FG010|Overall Study|Death|17|||
146819184|NCT02660034|529505625|FG011|Overall Study|Death|15|||
146819185|NCT02660034|529505626|FG012|Overall Study|Death|18|||
146819186|NCT02660034|529505627|FG013|Overall Study|Death|7|||
146819187|NCT02660034|529505614|FG000|Overall Study|Physician Decision|0|||
146819188|NCT02660034|529505615|FG001|Overall Study|Physician Decision|0|||
146819189|NCT02660034|529505616|FG002|Overall Study|Physician Decision|0|||
146819190|NCT02660034|529505617|FG003|Overall Study|Physician Decision|0|||
146819191|NCT02660034|529505618|FG004|Overall Study|Physician Decision|0|||
146819192|NCT02660034|529505619|FG005|Overall Study|Physician Decision|0|||
146819193|NCT02660034|529505620|FG006|Overall Study|Physician Decision|0|||
146819194|NCT02660034|529505621|FG007|Overall Study|Physician Decision|0|||
146819195|NCT02660034|529505622|FG008|Overall Study|Physician Decision|0|||
146819196|NCT02660034|529505623|FG009|Overall Study|Physician Decision|0|||
146819197|NCT02660034|529505624|FG010|Overall Study|Physician Decision|0|||
146950869|NCT02877134|529978046|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146950870|NCT02877134|529978047|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
146950871|NCT02877134|529978048|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146950872|NCT02877134|529978049|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
146950873|NCT02877134|529978050|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146950874|NCT02877134|529978051|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146819198|NCT02660034|529505625|FG011|Overall Study|Physician Decision|0|||
146819199|NCT02660034|529505626|FG012|Overall Study|Physician Decision|0|||
146819200|NCT02660034|529505627|FG013|Overall Study|Physician Decision|1|||
146819201|NCT02660034|529505614|FG000|Overall Study|Participants transferred to LTE|0|||
146819202|NCT02660034|529505615|FG001|Overall Study|Participants transferred to LTE|0|||
146819203|NCT02660034|529505616|FG002|Overall Study|Participants transferred to LTE|0|||
146819204|NCT02660034|529505617|FG003|Overall Study|Participants transferred to LTE|0|||
146819205|NCT02660034|529505618|FG004|Overall Study|Participants transferred to LTE|0|||
146819206|NCT02660034|529505619|FG005|Overall Study|Participants transferred to LTE|10|||
146819207|NCT02660034|529505620|FG006|Overall Study|Participants transferred to LTE|8|||
146819208|NCT02660034|529505621|FG007|Overall Study|Participants transferred to LTE|8|||
146819209|NCT02660034|529505622|FG008|Overall Study|Participants transferred to LTE|10|||
146950875|NCT02877134|529978052|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
146950876|NCT02877134|529978053|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146950877|NCT02877134|529978054|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146950878|NCT02877134|529978055|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146950879|NCT02877134|529978056|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146950880|NCT02877134|529978057|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146950881|NCT02877134|529978046|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
146950882|NCT02877134|529978047|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
146950883|NCT02877134|529978048|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
146950884|NCT02877134|529978049|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
146950885|NCT02877134|529978050|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
146950886|NCT02877134|529978051|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
146950887|NCT02877134|529978052|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
146950888|NCT02877134|529978053|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
146950889|NCT02877134|529978054|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
146950890|NCT02877134|529978055|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
146950891|NCT02877134|529978056|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
146950892|NCT02877134|529978057|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
146950893|NCT02877134|529978046|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
146950894|NCT02877134|529978047|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
146950895|NCT02877134|529978048|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
146950896|NCT02877134|529978049|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
146950897|NCT02877134|529978050|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
146950898|NCT02877134|529978051|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
146950899|NCT02877134|529978052|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
146950900|NCT02877134|529978053|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
146950901|NCT02877134|529978054|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
146950902|NCT02877134|529978055|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
146950903|NCT02877134|529978056|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
146950904|NCT02877134|529978057|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
146950905|NCT02877134|529978046|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146950906|NCT02877134|529978047|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146950907|NCT02877134|529978048|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146950908|NCT02877134|529978049|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146950909|NCT02877134|529978050|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146950910|NCT02877134|529978051|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146950911|NCT02877134|529978052|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146950912|NCT02877134|529978053|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146950913|NCT02877134|529978054|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
146950914|NCT02877134|529978055|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146950915|NCT02877134|529978056|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146950916|NCT02877134|529978057|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146950917|NCT02877134|529978046|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
146950918|NCT02877134|529978047|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
146950919|NCT02877134|529978048|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
146950920|NCT02877134|529978049|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
146950921|NCT02877134|529978050|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
146950922|NCT02877134|529978051|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
146950923|NCT02877134|529978052|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
146950924|NCT02877134|529978053|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
146950925|NCT02877134|529978054|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
146950926|NCT02877134|529978055|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
146950927|NCT02877134|529978056|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
146950928|NCT02877134|529978057|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
146950929|NCT02877134|529978046|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146950930|NCT02877134|529978047|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146950931|NCT02877134|529978048|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146950932|NCT02877134|529978049|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146950933|NCT02877134|529978050|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146950934|NCT02877134|529978051|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146950935|NCT02877134|529978052|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146950936|NCT02877134|529978053|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
146950937|NCT02877134|529978054|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
146950938|NCT02877134|529978055|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
146950939|NCT02877134|529978056|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146950940|NCT02877134|529978057|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146950941|NCT02877134|529978046|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
146950942|NCT02877134|529978047|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
146950943|NCT02877134|529978048|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
146819210|NCT02660034|529505623|FG009|Overall Study|Participants transferred to LTE|1|||
146819211|NCT02660034|529505624|FG010|Overall Study|Participants transferred to LTE|2|||
146819212|NCT02660034|529505625|FG011|Overall Study|Participants transferred to LTE|4|||
146819213|NCT02660034|529505626|FG012|Overall Study|Participants transferred to LTE|1|||
146819214|NCT02660034|529505627|FG013|Overall Study|Participants transferred to LTE|1|||
146819215|NCT01403805|529505630|FG000|Overall Study|Withdrawal by Subject|0|||
146819216|NCT01403805|529505631|FG001|Overall Study|Withdrawal by Subject|4|||
146819217|NCT01403805|529505630|FG000|Overall Study|Lost to Follow-up|0|||
146819218|NCT01403805|529505631|FG001|Overall Study|Lost to Follow-up|2|||
146819219|NCT01403805|529505630|FG000|Overall Study|Death|0|||
146819220|NCT01403805|529505631|FG001|Overall Study|Death|1|||
146819221|NCT00147745|529505632|FG000|Overall Study|Withdrawal by Subject|1|||
146819222|NCT00147745|529505633|FG001|Overall Study|Withdrawal by Subject|0|||
146819223|NCT00147745|529505634|FG002|Overall Study|Withdrawal by Subject|0|||
146819224|NCT00316121|529505638|FG000|Overall Study|Death|1|||
146819225|NCT00316121|529505639|FG001|Overall Study|Death|0|||
146819226|NCT00316121|529505638|FG000|Overall Study|Lost to Follow-up|14|||
146819227|NCT00316121|529505639|FG001|Overall Study|Lost to Follow-up|8|||
146819228|NCT00316121|529505638|FG000|Overall Study|Withdrawal by Subject|2|||
146819229|NCT00316121|529505639|FG001|Overall Study|Withdrawal by Subject|0|||
146819230|NCT00316121|529505638|FG000|Overall Study|Reason is missing|1|||
146819231|NCT00316121|529505639|FG001|Overall Study|Reason is missing|0|||
146819232|NCT00316121|529505638|FG000|Overall Study|Subject relocated|1|||
146819233|NCT00316121|529505639|FG001|Overall Study|Subject relocated|1|||
146819234|NCT00316121|529505638|FG000|Overall Study|Subject refused to return|1|||
146819235|NCT00316121|529505639|FG001|Overall Study|Subject refused to return|0|||
146819236|NCT00316121|529505638|FG000|Overall Study|Subject no show for visit x 3|1|||
146819237|NCT00316121|529505639|FG001|Overall Study|Subject no show for visit x 3|0|||
146819238|NCT00316121|529505638|FG000|Overall Study|Subject did not have 24 month visit|1|||
146819239|NCT00316121|529505639|FG001|Overall Study|Subject did not have 24 month visit|0|||
146819240|NCT03045302|529505640|FG000|Overall Study|Pre-treatment adverse event|1|||
146819241|NCT00134056|529505641|FG000|Randomization|Not eligible for assigned treatment|22|||
146819242|NCT00134056|529505642|FG001|Randomization|Not eligible for assigned treatment|20|||
146819243|NCT00134056|529505641|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
146819244|NCT00134056|529505642|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
146819245|NCT00134056|529505641|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
146819246|NCT00134056|529505642|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
146819247|NCT00134056|529505641|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
146819248|NCT00134056|529505642|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
146819249|NCT00134056|529505641|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
146819250|NCT00134056|529505642|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
146819251|NCT00742560|529505644|FG000|Overall Study|Adverse Event|0|||
146819252|NCT00742560|529505645|FG001|Overall Study|Adverse Event|0|||
146819253|NCT00742560|529505646|FG002|Overall Study|Adverse Event|1|||
146819254|NCT00742560|529505647|FG003|Overall Study|Adverse Event|1|||
146819255|NCT00742560|529505648|FG004|Overall Study|Adverse Event|1|||
146819256|NCT00742560|529505644|FG000|Overall Study|Death|0|||
146819257|NCT00742560|529505645|FG001|Overall Study|Death|2|||
146819258|NCT00742560|529505646|FG002|Overall Study|Death|0|||
146819259|NCT00742560|529505647|FG003|Overall Study|Death|2|||
146819260|NCT00742560|529505648|FG004|Overall Study|Death|3|||
146819261|NCT00742560|529505644|FG000|Overall Study|Subject's Decision|1|||
146819262|NCT00742560|529505645|FG001|Overall Study|Subject's Decision|0|||
146950944|NCT02877134|529978049|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
146950945|NCT02877134|529978050|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
146950946|NCT02877134|529978051|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
146950947|NCT02877134|529978052|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
146950948|NCT02877134|529978053|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
146819263|NCT00742560|529505646|FG002|Overall Study|Subject's Decision|2|||
146819264|NCT00742560|529505647|FG003|Overall Study|Subject's Decision|3|||
146819265|NCT00742560|529505648|FG004|Overall Study|Subject's Decision|3|||
146819266|NCT00742560|529505644|FG000|Overall Study|Investigator's Decision|0|||
146819267|NCT00742560|529505645|FG001|Overall Study|Investigator's Decision|0|||
146819268|NCT00742560|529505646|FG002|Overall Study|Investigator's Decision|4|||
146819269|NCT00742560|529505647|FG003|Overall Study|Investigator's Decision|1|||
146819270|NCT00742560|529505648|FG004|Overall Study|Investigator's Decision|0|||
146819271|NCT00742560|529505644|FG000|Overall Study|Disease Progression|1|||
146819272|NCT00742560|529505645|FG001|Overall Study|Disease Progression|0|||
146819273|NCT00742560|529505646|FG002|Overall Study|Disease Progression|5|||
146819274|NCT00742560|529505647|FG003|Overall Study|Disease Progression|17|||
146819275|NCT00742560|529505648|FG004|Overall Study|Disease Progression|16|||
146950949|NCT02877134|529978054|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
146819276|NCT00742560|529505644|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
146819277|NCT00742560|529505645|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
146819278|NCT00742560|529505646|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
146819279|NCT00742560|529505647|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
146819280|NCT00742560|529505648|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
146819281|NCT00742560|529505644|FG000|Overall Study|Other|0|||
146819282|NCT00742560|529505645|FG001|Overall Study|Other|1|||
146819283|NCT00742560|529505646|FG002|Overall Study|Other|8|||
146819284|NCT00742560|529505647|FG003|Overall Study|Other|9|||
146819285|NCT00742560|529505648|FG004|Overall Study|Other|9|||
146819286|NCT00742560|529505644|FG000|Overall Study|MIssing|0|||
146819287|NCT00742560|529505645|FG001|Overall Study|MIssing|0|||
146819288|NCT00742560|529505646|FG002|Overall Study|MIssing|0|||
146819289|NCT00742560|529505647|FG003|Overall Study|MIssing|0|||
146819290|NCT00742560|529505648|FG004|Overall Study|MIssing|1|||
146819291|NCT01536795|529505649|FG000|Overall Study|Lost to Follow-up|0|||
146819292|NCT01536795|529505650|FG001|Overall Study|Lost to Follow-up|2|||
146819293|NCT01536795|529505649|FG000|Overall Study|Lack of Efficacy|1|||
146819294|NCT01536795|529505650|FG001|Overall Study|Lack of Efficacy|0|||
146819295|NCT04985604|529505651|FG000|Overall Study|Death|4|||
146819296|NCT04985604|529505652|FG001|Overall Study|Death|6|||
146819297|NCT04985604|529505651|FG000|Overall Study|Withdrawal by Subject|0|||
146819298|NCT04985604|529505652|FG001|Overall Study|Withdrawal by Subject|1|||
146819299|NCT04598776|529505653|FG000|Overall Study|Protocol Violation|5|||
146819300|NCT04598776|529505653|FG000|Overall Study|Physician Decision|4|||
146819301|NCT00348283|529505654|FG000|Induction|Adverse Event|0|||
146819302|NCT00348283|529505655|FG001|Induction|Adverse Event|2|||
146819303|NCT00348283|529505654|FG000|Induction|Protocol Violation|0|||
146819304|NCT00348283|529505655|FG001|Induction|Protocol Violation|4|||
146819305|NCT00348283|529505654|FG000|Double Blind|Adverse Event|2|||
146819306|NCT00348283|529505655|FG001|Double Blind|Adverse Event|5|||
146819307|NCT00348283|529505654|FG000|Double Blind|Withdrawal by Subject|1|||
146819308|NCT00348283|529505655|FG001|Double Blind|Withdrawal by Subject|1|||
146819309|NCT00348283|529505654|FG000|Double Blind|Protocol Violation|0|||
146819310|NCT00348283|529505655|FG001|Double Blind|Protocol Violation|1|||
146819311|NCT00348283|529505654|FG000|Double Blind|Lack of Efficacy|2|||
146819312|NCT00348283|529505655|FG001|Double Blind|Lack of Efficacy|2|||
146819313|NCT00348283|529505654|FG000|Double Blind|Pregnancy|0|||
146819314|NCT00348283|529505655|FG001|Double Blind|Pregnancy|1|||
146819315|NCT00348283|529505654|FG000|Open Label|Adverse Event|0|||
146819316|NCT00348283|529505655|FG001|Open Label|Adverse Event|8|||
146819317|NCT00348283|529505654|FG000|Open Label|Withdrawal by Subject|0|||
146819318|NCT00348283|529505655|FG001|Open Label|Withdrawal by Subject|4|||
146819319|NCT00348283|529505654|FG000|Open Label|Lost to Follow-up|0|||
146819320|NCT00348283|529505655|FG001|Open Label|Lost to Follow-up|1|||
146819321|NCT00348283|529505654|FG000|Open Label|Lack of Efficacy|0|||
146819322|NCT00348283|529505655|FG001|Open Label|Lack of Efficacy|13|||
146819323|NCT00348283|529505654|FG000|Open Label|Administrative reasons|0|||
146819324|NCT00348283|529505655|FG001|Open Label|Administrative reasons|5|||
146819325|NCT00348283|529505654|FG000|Open Label|Subject moved to the United States|0|||
146819326|NCT00348283|529505655|FG001|Open Label|Subject moved to the United States|1|||
146819327|NCT00348283|529505654|FG000|Open Label|Pregnancy|0|||
146819328|NCT00348283|529505655|FG001|Open Label|Pregnancy|1|||
146819329|NCT00348283|529505654|FG000|Open Label|Sponsor decision|0|||
146819330|NCT00348283|529505655|FG001|Open Label|Sponsor decision|1|||
146819331|NCT02282761|529505658|FG000|Overall Study|Death|0|||
146819332|NCT02282761|529505659|FG001|Overall Study|Death|0|||
146819333|NCT02282761|529505660|FG002|Overall Study|Death|1|||
146819334|NCT02282761|529505658|FG000|Overall Study|Adverse Event|6|||
146819335|NCT02282761|529505659|FG001|Overall Study|Adverse Event|2|||
146819336|NCT02282761|529505660|FG002|Overall Study|Adverse Event|0|||
146819337|NCT02282761|529505658|FG000|Overall Study|Lack of Efficacy|11|||
146819338|NCT02282761|529505659|FG001|Overall Study|Lack of Efficacy|6|||
146819339|NCT02282761|529505660|FG002|Overall Study|Lack of Efficacy|17|||
146819340|NCT02282761|529505658|FG000|Overall Study|Lost to Follow-up|2|||
146819341|NCT02282761|529505659|FG001|Overall Study|Lost to Follow-up|2|||
146819342|NCT02282761|529505660|FG002|Overall Study|Lost to Follow-up|1|||
146819343|NCT02282761|529505658|FG000|Overall Study|Physician Decision|0|||
146819344|NCT02282761|529505659|FG001|Overall Study|Physician Decision|0|||
146819345|NCT02282761|529505660|FG002|Overall Study|Physician Decision|2|||
146819346|NCT02282761|529505658|FG000|Overall Study|Withdrawal by Subject|8|||
146819347|NCT02282761|529505659|FG001|Overall Study|Withdrawal by Subject|10|||
146819348|NCT02282761|529505660|FG002|Overall Study|Withdrawal by Subject|16|||
146819349|NCT02282761|529505658|FG000|Overall Study|Other|3|||
146819350|NCT02282761|529505659|FG001|Overall Study|Other|2|||
146819351|NCT02282761|529505660|FG002|Overall Study|Other|1|||
146819352|NCT06312566|529505664|FG000|Overall Study|Protocol Violation|0|||
146819353|NCT06312566|529505665|FG001|Overall Study|Protocol Violation|1|||
146819354|NCT04551053|529505666|FG000|Overall Study|Death|10|||
146819355|NCT04551053|529505667|FG001|Overall Study|Death|9|||
146819356|NCT04551053|529505666|FG000|Overall Study|Lost to Follow-up|0|||
146819357|NCT04551053|529505667|FG001|Overall Study|Lost to Follow-up|2|||
146819358|NCT04551053|529505666|FG000|Overall Study|Study Terminated by Sponsor|57|||
146819359|NCT04551053|529505667|FG001|Overall Study|Study Terminated by Sponsor|65|||
146819360|NCT04551053|529505666|FG000|Overall Study|Withdrawal by Subject|12|||
146819361|NCT04551053|529505667|FG001|Overall Study|Withdrawal by Subject|5|||
146819362|NCT04551053|529505666|FG000|Overall Study|Adverse Event|2|||
146819363|NCT04551053|529505667|FG001|Overall Study|Adverse Event|0|||
146819364|NCT04551053|529505666|FG000|Overall Study|Lack of Efficacy|2|||
146819365|NCT04551053|529505667|FG001|Overall Study|Lack of Efficacy|1|||
146819366|NCT04551053|529505666|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
146819367|NCT04551053|529505667|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
146819368|NCT04551053|529505666|FG000|Overall Study|Splenapendectomi|1|||
146819369|NCT04551053|529505667|FG001|Overall Study|Splenapendectomi|0|||
146819370|NCT04551053|529505666|FG000|Overall Study|Medical Decision|1|||
146819371|NCT04551053|529505667|FG001|Overall Study|Medical Decision|1|||
146819372|NCT02971683|529505668|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
146819373|NCT02971683|529505669|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
146819374|NCT02971683|529505668|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
146819375|NCT02971683|529505669|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
146819376|NCT02971683|529505668|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
146819377|NCT02971683|529505669|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
146819378|NCT02971683|529505668|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
146819379|NCT02971683|529505669|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
146819380|NCT02971683|529505668|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
146819381|NCT02971683|529505669|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
146819382|NCT02971683|529505668|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
146819383|NCT02971683|529505669|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
146819384|NCT02971683|529505668|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
146819385|NCT02971683|529505669|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
146819386|NCT02971683|529505668|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
146819387|NCT02971683|529505669|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
146819388|NCT02971683|529505668|FG000|Open-Label|Lost to Follow-up|1|||
146819389|NCT02971683|529505669|FG001|Open-Label|Lost to Follow-up|0|||
146819390|NCT02971683|529505668|FG000|Open-Label|Participants withdrew consent|0|||
146819391|NCT02971683|529505669|FG001|Open-Label|Participants withdrew consent|2|||
146819392|NCT02971683|529505668|FG000|Open-Label|Participant request to discontinue study treatment|1|||
146819393|NCT02971683|529505669|FG001|Open-Label|Participant request to discontinue study treatment|0|||
146819394|NCT02971683|529505668|FG000|Open-Label|Lack of Efficacy|2|||
146819395|NCT02971683|529505669|FG001|Open-Label|Lack of Efficacy|0|||
146819396|NCT02971683|529505668|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
146819397|NCT02971683|529505669|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
146819398|NCT02971683|529505668|FG000|Long-Term Open Label|Participant withdrew consent|1|||
146819399|NCT02971683|529505669|FG001|Long-Term Open Label|Participant withdrew consent|0|||
146819400|NCT02971683|529505668|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
146819401|NCT02971683|529505669|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
146819402|NCT02971683|529505668|FG000|Long-Term Open Label|Adverse Event|1|||
146819403|NCT02971683|529505669|FG001|Long-Term Open Label|Adverse Event|2|||
146819404|NCT02971683|529505668|FG000|Long-Term Open Label|Lack of Efficacy|1|||
146819405|NCT02971683|529505669|FG001|Long-Term Open Label|Lack of Efficacy|1|||
146819406|NCT03747575|529505675|FG000|Overall Study|Withdrawal by Subject|6|||
146819407|NCT03747575|529505676|FG001|Overall Study|Withdrawal by Subject|3|||
146819408|NCT03747575|529505675|FG000|Overall Study|Lost to Follow-up|3|||
146819409|NCT03747575|529505676|FG001|Overall Study|Lost to Follow-up|3|||
146819410|NCT03747575|529505675|FG000|Overall Study|Adverse Event|0|||
146819411|NCT03747575|529505676|FG001|Overall Study|Adverse Event|1|||
146819412|NCT02924051|529505681|FG000|Overall Study|Withdrawal by Subject|1|||
146819413|NCT02924051|529505682|FG001|Overall Study|Withdrawal by Subject|9|||
146819414|NCT00914732|529505686|FG000|Overall Study|Lost to Follow-up|6|||
146819415|NCT00914732|529505687|FG001|Overall Study|Lost to Follow-up|7|||
146819416|NCT00914732|529505688|FG002|Overall Study|Lost to Follow-up|9|||
146819417|NCT00914732|529505686|FG000|Overall Study|Withdrawal by Subject|3|||
146819418|NCT00914732|529505687|FG001|Overall Study|Withdrawal by Subject|0|||
146819419|NCT00914732|529505688|FG002|Overall Study|Withdrawal by Subject|2|||
146819420|NCT00914732|529505686|FG000|Overall Study|Adverse Event|1|||
146819421|NCT00914732|529505687|FG001|Overall Study|Adverse Event|0|||
146819422|NCT00914732|529505688|FG002|Overall Study|Adverse Event|0|||
146819423|NCT02130401|529505689|FG000|Overall Study|Poor enrollment|6|||
146819424|NCT00321672|529505690|FG000|Overall Study|Withdrawal by Subject|5|||
146819425|NCT00321672|529505691|FG001|Overall Study|Withdrawal by Subject|1|||
146819426|NCT00321672|529505692|FG002|Overall Study|Withdrawal by Subject|2|||
146984781|NCT01533428|530105170|FG000|Overall Study|Adverse Event|0|||
146819427|NCT00321672|529505693|FG003|Overall Study|Withdrawal by Subject|0|||
146819428|NCT00321672|529505690|FG000|Overall Study|Noncompliance|1|||
146819429|NCT00321672|529505691|FG001|Overall Study|Noncompliance|2|||
146819430|NCT00321672|529505692|FG002|Overall Study|Noncompliance|1|||
146819431|NCT00321672|529505693|FG003|Overall Study|Noncompliance|0|||
146819432|NCT00321672|529505690|FG000|Overall Study|Adverse Event|1|||
146819433|NCT00321672|529505691|FG001|Overall Study|Adverse Event|1|||
146819434|NCT00321672|529505692|FG002|Overall Study|Adverse Event|0|||
146819435|NCT00321672|529505693|FG003|Overall Study|Adverse Event|0|||
146819436|NCT00321672|529505690|FG000|Overall Study|Lack of Efficacy|1|||
146819437|NCT00321672|529505691|FG001|Overall Study|Lack of Efficacy|1|||
146819438|NCT00321672|529505692|FG002|Overall Study|Lack of Efficacy|0|||
146819439|NCT00321672|529505693|FG003|Overall Study|Lack of Efficacy|0|||
146819440|NCT00321672|529505690|FG000|Overall Study|Lost to Follow-up|2|||
146819441|NCT00321672|529505691|FG001|Overall Study|Lost to Follow-up|0|||
146819442|NCT00321672|529505692|FG002|Overall Study|Lost to Follow-up|4|||
146819443|NCT00321672|529505693|FG003|Overall Study|Lost to Follow-up|2|||
146819444|NCT00321672|529505690|FG000|Overall Study|Death|1|||
146819445|NCT00321672|529505691|FG001|Overall Study|Death|0|||
146819446|NCT00321672|529505692|FG002|Overall Study|Death|0|||
146819447|NCT00321672|529505693|FG003|Overall Study|Death|0|||
146819448|NCT00321672|529505690|FG000|Overall Study|Too far to travel for visits|1|||
146819449|NCT00321672|529505691|FG001|Overall Study|Too far to travel for visits|0|||
146819450|NCT00321672|529505692|FG002|Overall Study|Too far to travel for visits|0|||
146819451|NCT00321672|529505693|FG003|Overall Study|Too far to travel for visits|0|||
146819452|NCT00321672|529505690|FG000|Overall Study|Incarcerated|0|||
146819453|NCT00321672|529505691|FG001|Overall Study|Incarcerated|0|||
146819454|NCT00321672|529505692|FG002|Overall Study|Incarcerated|2|||
146819455|NCT00321672|529505693|FG003|Overall Study|Incarcerated|0|||
146819456|NCT00321672|529505690|FG000|Overall Study|Moved out of state|0|||
146819457|NCT00321672|529505691|FG001|Overall Study|Moved out of state|1|||
146819458|NCT00321672|529505692|FG002|Overall Study|Moved out of state|1|||
146819459|NCT00321672|529505693|FG003|Overall Study|Moved out of state|0|||
146819460|NCT00321672|529505690|FG000|Overall Study|Protocol Violation|0|||
146819461|NCT00321672|529505691|FG001|Overall Study|Protocol Violation|0|||
146819462|NCT00321672|529505692|FG002|Overall Study|Protocol Violation|1|||
146819463|NCT00321672|529505693|FG003|Overall Study|Protocol Violation|0|||
146819464|NCT00321672|529505690|FG000|Overall Study|Diagnosis of testicular cancer|0|||
146819465|NCT00321672|529505691|FG001|Overall Study|Diagnosis of testicular cancer|1|||
146819466|NCT00321672|529505692|FG002|Overall Study|Diagnosis of testicular cancer|0|||
146819467|NCT00321672|529505693|FG003|Overall Study|Diagnosis of testicular cancer|0|||
146819468|NCT00321672|529505690|FG000|Overall Study|Extensive travel required for new job|0|||
146819469|NCT00321672|529505691|FG001|Overall Study|Extensive travel required for new job|1|||
146819470|NCT00321672|529505692|FG002|Overall Study|Extensive travel required for new job|0|||
146819471|NCT00321672|529505693|FG003|Overall Study|Extensive travel required for new job|0|||
146819472|NCT00512902|529505696|FG000|Overall Study|Adverse Event|7|||
146819473|NCT00512902|529505696|FG000|Overall Study|Lost to Follow-up|1|||
146819474|NCT03689452|529505697|FG000|Overall Study|Lost to Follow-up|1|||
146819475|NCT03689452|529505698|FG001|Overall Study|Lost to Follow-up|1|||
146819476|NCT02676778|529505699|FG000|Overall Study|Disease Progression|7|||
146819477|NCT02676778|529505700|FG001|Overall Study|Disease Progression|3|||
146819478|NCT02676778|529505701|FG002|Overall Study|Disease Progression|1|||
146819479|NCT02676778|529505699|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
146819480|NCT02676778|529505700|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
146819481|NCT02676778|529505701|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
146819482|NCT02676778|529505699|FG000|Overall Study|Withdrawal by Subject|3|||
146819483|NCT02676778|529505700|FG001|Overall Study|Withdrawal by Subject|2|||
146819484|NCT02676778|529505701|FG002|Overall Study|Withdrawal by Subject|0|||
146819485|NCT02676778|529505699|FG000|Overall Study|Other|4|||
146819486|NCT02676778|529505700|FG001|Overall Study|Other|3|||
146950950|NCT02877134|529978055|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
146950951|NCT02877134|529978056|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
146950952|NCT02877134|529978057|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
146950953|NCT01197794|529978058|FG000|Overall Study|Adverse Event|3|||
146950954|NCT01197794|529978059|FG001|Overall Study|Adverse Event|2|||
146950955|NCT01197794|529978060|FG002|Overall Study|Adverse Event|4|||
146950956|NCT01197794|529978061|FG003|Overall Study|Adverse Event|4|||
146819487|NCT02676778|529505701|FG002|Overall Study|Other|0|||
146819488|NCT02676778|529505699|FG000|Overall Study|Adverse Event|2|||
146819489|NCT02676778|529505700|FG001|Overall Study|Adverse Event|3|||
146819490|NCT02676778|529505701|FG002|Overall Study|Adverse Event|0|||
146819491|NCT03214198|529505708|FG000|Overall Study|Case Report Forms Uncollected|18|||
146819492|NCT03214198|529505708|FG000|Overall Study|Protocol Deviation|18|||
146819493|NCT03686176|529505709|FG000|Overall Study|Procedure cancelled|1|||
146819494|NCT03686176|529505710|FG001|Overall Study|Procedure cancelled|0|||
146819495|NCT03686176|529505711|FG002|Overall Study|Procedure cancelled|0|||
146819496|NCT03686176|529505709|FG000|Overall Study|VR Malfunction|1|||
146819497|NCT03686176|529505710|FG001|Overall Study|VR Malfunction|0|||
146819498|NCT03686176|529505711|FG002|Overall Study|VR Malfunction|0|||
146819499|NCT04295499|529505716|FG000|Overall Study|moving out of state|1|||
146819500|NCT04295499|529505717|FG001|Overall Study|moving out of state|0|||
146950957|NCT01197794|529978062|FG004|Overall Study|Adverse Event|4|||
146819501|NCT04295499|529505716|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
146819502|NCT04295499|529505717|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
146819503|NCT00308113|529505720|FG000|Overall Study|Protocol closure|0|||
146819504|NCT00308113|529505721|FG001|Overall Study|Protocol closure|0|||
146819505|NCT00308113|529505722|FG002|Overall Study|Protocol closure|0|||
146819506|NCT00308113|529505723|FG003|Overall Study|Protocol closure|1|||
146819507|NCT04448561|529505724|FG000|Overall Study|Noncompliance|1|||
146819508|NCT04448561|529505725|FG001|Overall Study|Noncompliance|0|||
146819509|NCT04413149|529507666|FG000|Overall Study|Death|10|||
146819510|NCT04413149|529507667|FG001|Overall Study|Death|5|||
146819511|NCT04413149|529507666|FG000|Overall Study|Lung transplantation|1|||
146819512|NCT04413149|529507667|FG001|Overall Study|Lung transplantation|0|||
146819513|NCT02661490|529507670|FG000|Overall Study|Lost to Follow-up|0|||
146819514|NCT02661490|529507671|FG001|Overall Study|Lost to Follow-up|1|||
146819515|NCT02661490|529507672|FG002|Overall Study|Lost to Follow-up|0|||
146819516|NCT02661490|529507673|FG003|Overall Study|Lost to Follow-up|0|||
146819517|NCT02661490|529507674|FG004|Overall Study|Lost to Follow-up|2|||
146819518|NCT02661490|529507670|FG000|Overall Study|Withdrawal by Subject|2|||
146819519|NCT02661490|529507671|FG001|Overall Study|Withdrawal by Subject|0|||
146819520|NCT02661490|529507672|FG002|Overall Study|Withdrawal by Subject|2|||
146819521|NCT02661490|529507673|FG003|Overall Study|Withdrawal by Subject|0|||
146819522|NCT02661490|529507674|FG004|Overall Study|Withdrawal by Subject|0|||
146819523|NCT02661490|529507670|FG000|Overall Study|Death|1|||
146819524|NCT02661490|529507671|FG001|Overall Study|Death|1|||
146819525|NCT02661490|529507672|FG002|Overall Study|Death|0|||
146819526|NCT02661490|529507673|FG003|Overall Study|Death|1|||
146819527|NCT02661490|529507674|FG004|Overall Study|Death|0|||
146819528|NCT02661490|529507670|FG000|Overall Study|Reason not Specified|0|||
146819529|NCT02661490|529507671|FG001|Overall Study|Reason not Specified|0|||
146819530|NCT02661490|529507672|FG002|Overall Study|Reason not Specified|0|||
146819531|NCT02661490|529507673|FG003|Overall Study|Reason not Specified|0|||
146819532|NCT02661490|529507674|FG004|Overall Study|Reason not Specified|1|||
146819533|NCT02878590|529507675|FG000|Overall Study|Withdrawal by Subject|2|||
146819534|NCT03322514|529507676|FG000|Overall Study|Withdrawal by Subject|1|||
146819535|NCT03322514|529507677|FG001|Overall Study|Withdrawal by Subject|1|||
146819536|NCT01184859|529507678|FG000|Period 1: Single Dose|Insufficient urine production|0|||
146819537|NCT01184859|529507679|FG001|Period 1: Single Dose|Insufficient urine production|1|||
146819538|NCT01184859|529507680|FG002|Period 1: Single Dose|Insufficient urine production|0|||
146819539|NCT01184859|529507681|FG003|Period 1: Single Dose|Insufficient urine production|0|||
146819540|NCT01184859|529507682|FG004|Period 1: Single Dose|Insufficient urine production|0|||
146819541|NCT01184859|529507678|FG000|Period 1: Single Dose|Protocol Violation|0|||
146819542|NCT01184859|529507679|FG001|Period 1: Single Dose|Protocol Violation|1|||
146819543|NCT01184859|529507680|FG002|Period 1: Single Dose|Protocol Violation|0|||
146819544|NCT01184859|529507681|FG003|Period 1: Single Dose|Protocol Violation|0|||
146819545|NCT01184859|529507682|FG004|Period 1: Single Dose|Protocol Violation|0|||
146819546|NCT01184859|529507678|FG000|Period 1: Single Dose|Adverse Event|0|||
146819547|NCT01184859|529507679|FG001|Period 1: Single Dose|Adverse Event|0|||
146819548|NCT01184859|529507680|FG002|Period 1: Single Dose|Adverse Event|0|||
146819549|NCT01184859|529507681|FG003|Period 1: Single Dose|Adverse Event|0|||
146819550|NCT01184859|529507682|FG004|Period 1: Single Dose|Adverse Event|1|||
146819551|NCT01184859|529507678|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
146819552|NCT01184859|529507679|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
146819553|NCT01184859|529507680|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
146819554|NCT01184859|529507681|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
146819555|NCT01184859|529507682|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
146819556|NCT01184859|529507678|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
146819557|NCT01184859|529507679|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
146819558|NCT01184859|529507680|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
146819559|NCT01184859|529507681|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
146819560|NCT01184859|529507682|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
146819561|NCT00961298|529507683|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
146819562|NCT00961298|529507683|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
146819563|NCT00961298|529507683|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
146819564|NCT00814632|529507684|FG000|Overall Study|Lack of Efficacy|2|||
146819565|NCT01038128|529507690|FG000|Overall Study|Lack of Efficacy|1|||
146819566|NCT01038128|529507690|FG000|Overall Study|Lost to Follow-up|1|||
146819567|NCT01038128|529507690|FG000|Overall Study|Withdrawal by Subject|2|||
146819568|NCT02186015|529507691|FG000|Overall Study|Physician Decision|1|||
146819569|NCT02186015|529507692|FG001|Overall Study|Physician Decision|0|||
146819570|NCT01837719|529507695|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
146819571|NCT01837719|529507695|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
146819572|NCT01703988|529507696|FG000|Overall Study|Investigator Judgment|0|||
146819573|NCT01703988|529507697|FG001|Overall Study|Investigator Judgment|0|||
146950958|NCT01197794|529978063|FG005|Overall Study|Adverse Event|2|||
146819574|NCT01703988|529507698|FG002|Overall Study|Investigator Judgment|0|||
146819575|NCT01703988|529507699|FG003|Overall Study|Investigator Judgment|1|||
146819576|NCT02995733|529507700|FG000|Overall Study|Study site closed|9|||
146819577|NCT02995733|529507701|FG001|Overall Study|Study site closed|10|||
146819578|NCT02995733|529507700|FG000|Overall Study|Death|3|||
146819579|NCT02995733|529507701|FG001|Overall Study|Death|4|||
146819580|NCT02995733|529507700|FG000|Overall Study|Withdrawal by Subject|6|||
146819581|NCT02995733|529507701|FG001|Overall Study|Withdrawal by Subject|2|||
146819582|NCT02995733|529507700|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
146819583|NCT02995733|529507701|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
146819584|NCT02995733|529507700|FG000|Overall Study|Lost to Follow-up|48|||
146819585|NCT02995733|529507701|FG001|Overall Study|Lost to Follow-up|37|||
146819586|NCT02995733|529507700|FG000|Overall Study|Other|0|||
146819587|NCT02995733|529507701|FG001|Overall Study|Other|1|||
146819588|NCT02720198|529507702|FG000|Overall Study|Withdrawal by Subject|0|||
146819589|NCT02720198|529507703|FG001|Overall Study|Withdrawal by Subject|1|||
146819590|NCT04468633|529507706|FG000|Overall Study|Withdrawal by Subject|4|||
146819591|NCT04468633|529507707|FG001|Overall Study|Withdrawal by Subject|0|||
146819592|NCT01498445|529507708|FG000|Overall Study|Lack of Efficacy|0|||
146819593|NCT01498445|529507709|FG001|Overall Study|Lack of Efficacy|0|||
146819594|NCT01498445|529507710|FG002|Overall Study|Lack of Efficacy|1|||
146819595|NCT01498445|529507711|FG003|Overall Study|Lack of Efficacy|2|||
146819596|NCT01498445|529507712|FG004|Overall Study|Lack of Efficacy|0|||
146819597|NCT01498445|529507713|FG005|Overall Study|Lack of Efficacy|0|||
146819598|NCT01498445|529507708|FG000|Overall Study|Screen Failure|0|||
146819599|NCT01498445|529507709|FG001|Overall Study|Screen Failure|0|||
146819600|NCT01498445|529507710|FG002|Overall Study|Screen Failure|0|||
146819601|NCT01498445|529507711|FG003|Overall Study|Screen Failure|0|||
146819602|NCT01498445|529507712|FG004|Overall Study|Screen Failure|1|||
146819603|NCT01498445|529507713|FG005|Overall Study|Screen Failure|1|||
146819604|NCT02592434|529507714|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
146819605|NCT02592434|529507715|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
146819606|NCT02592434|529507716|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
146819607|NCT02592434|529507714|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
146819608|NCT02592434|529507715|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
146819609|NCT02592434|529507716|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
146819610|NCT02592434|529507714|FG000|Open-Label Phase (18 Weeks)|Other|3|||
146819611|NCT02592434|529507715|FG001|Open-Label Phase (18 Weeks)|Other|0|||
146819612|NCT02592434|529507716|FG002|Open-Label Phase (18 Weeks)|Other|0|||
146819613|NCT02592434|529507714|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
146819614|NCT02592434|529507715|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
146819615|NCT02592434|529507716|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
146819616|NCT02592434|529507714|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
146819617|NCT02592434|529507715|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
146819618|NCT02592434|529507716|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
146819619|NCT02592434|529507714|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
146819620|NCT02592434|529507715|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
146819621|NCT02592434|529507716|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
146819622|NCT02592434|529507714|FG000|Double Blind Phase (26 Weeks)|Other|0|||
146819623|NCT02592434|529507715|FG001|Double Blind Phase (26 Weeks)|Other|1|||
146819624|NCT02592434|529507716|FG002|Double Blind Phase (26 Weeks)|Other|0|||
146819625|NCT02592434|529507714|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
146819626|NCT02592434|529507715|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
146819627|NCT02592434|529507716|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
146819628|NCT02592434|529507714|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
146819629|NCT02592434|529507715|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
146819630|NCT02592434|529507716|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
146819631|NCT02592434|529507714|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
146819632|NCT02592434|529507715|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
146819633|NCT02592434|529507716|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
146819634|NCT00105521|529507719|FG000|Overall Study|Other|1|||
146819635|NCT00105521|529507720|FG001|Overall Study|Other|1|||
146819636|NCT00105521|529507721|FG002|Overall Study|Other|2|||
146819637|NCT00105521|529507722|FG003|Overall Study|Other|0|||
146819638|NCT00105521|529507719|FG000|Overall Study|Adverse Event|10|||
146819639|NCT00105521|529507720|FG001|Overall Study|Adverse Event|4|||
146819640|NCT00105521|529507721|FG002|Overall Study|Adverse Event|10|||
146819641|NCT00105521|529507722|FG003|Overall Study|Adverse Event|8|||
146819642|NCT00105521|529507719|FG000|Overall Study|Withdrawal by Subject|1|||
146819643|NCT00105521|529507720|FG001|Overall Study|Withdrawal by Subject|0|||
146819644|NCT00105521|529507721|FG002|Overall Study|Withdrawal by Subject|1|||
146819645|NCT00105521|529507722|FG003|Overall Study|Withdrawal by Subject|4|||
146819646|NCT00105521|529507719|FG000|Overall Study|Lack of Efficacy|0|||
146819647|NCT00105521|529507720|FG001|Overall Study|Lack of Efficacy|0|||
146819648|NCT00105521|529507721|FG002|Overall Study|Lack of Efficacy|0|||
146819649|NCT00105521|529507722|FG003|Overall Study|Lack of Efficacy|1|||
146819650|NCT00105521|529507719|FG000|Overall Study|Protocol Violation|3|||
146819651|NCT00105521|529507720|FG001|Overall Study|Protocol Violation|5|||
146819652|NCT00105521|529507721|FG002|Overall Study|Protocol Violation|4|||
146819653|NCT00105521|529507722|FG003|Overall Study|Protocol Violation|4|||
146819654|NCT00105521|529507719|FG000|Overall Study|Lost to Follow-up|0|||
146819655|NCT00105521|529507720|FG001|Overall Study|Lost to Follow-up|1|||
146819656|NCT00105521|529507721|FG002|Overall Study|Lost to Follow-up|0|||
146819657|NCT00105521|529507722|FG003|Overall Study|Lost to Follow-up|0|||
146819658|NCT00385697|529507724|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
146819659|NCT00385697|529507725|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
146819660|NCT00385697|529507726|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
146819661|NCT00385697|529507727|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
146819662|NCT00385697|529507728|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
146819663|NCT00385697|529507724|FG000|Open-label Segment 1|Lost to Follow-up|1|||
146819664|NCT00385697|529507725|FG001|Open-label Segment 1|Lost to Follow-up|0|||
146819665|NCT00385697|529507726|FG002|Open-label Segment 1|Lost to Follow-up|0|||
146819666|NCT00385697|529507727|FG003|Open-label Segment 1|Lost to Follow-up|0|||
146819667|NCT00385697|529507728|FG004|Open-label Segment 1|Lost to Follow-up|0|||
146819668|NCT00385697|529507724|FG000|Double-blind Segment 2|Adverse Event|0|||
146819669|NCT00385697|529507725|FG001|Double-blind Segment 2|Adverse Event|3|||
146819670|NCT00385697|529507726|FG002|Double-blind Segment 2|Adverse Event|1|||
146819671|NCT00385697|529507727|FG003|Double-blind Segment 2|Adverse Event|0|||
146819672|NCT00385697|529507728|FG004|Double-blind Segment 2|Adverse Event|0|||
146819673|NCT00385697|529507724|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
146819674|NCT00385697|529507725|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
146819675|NCT00385697|529507726|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
146819676|NCT00385697|529507727|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
146819677|NCT00385697|529507728|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
146819678|NCT00385697|529507724|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
146819679|NCT00385697|529507725|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
146950959|NCT01197794|529978064|FG006|Overall Study|Adverse Event|3|||
146950960|NCT01197794|529978058|FG000|Overall Study|Protocol Violation|0|||
146950961|NCT01197794|529978059|FG001|Overall Study|Protocol Violation|0|||
146950962|NCT01197794|529978060|FG002|Overall Study|Protocol Violation|0|||
146950963|NCT01197794|529978061|FG003|Overall Study|Protocol Violation|0|||
146950964|NCT01197794|529978062|FG004|Overall Study|Protocol Violation|2|||
146950965|NCT01197794|529978063|FG005|Overall Study|Protocol Violation|0|||
146950966|NCT01197794|529978064|FG006|Overall Study|Protocol Violation|1|||
146950967|NCT01197794|529978058|FG000|Overall Study|Development of study withdrawal criteria|3|||
146950968|NCT01197794|529978059|FG001|Overall Study|Development of study withdrawal criteria|0|||
146950969|NCT01197794|529978060|FG002|Overall Study|Development of study withdrawal criteria|0|||
146950970|NCT01197794|529978061|FG003|Overall Study|Development of study withdrawal criteria|1|||
146950971|NCT01197794|529978062|FG004|Overall Study|Development of study withdrawal criteria|0|||
146950972|NCT01197794|529978063|FG005|Overall Study|Development of study withdrawal criteria|0|||
146950973|NCT01197794|529978064|FG006|Overall Study|Development of study withdrawal criteria|1|||
146950974|NCT01197794|529978058|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
146950975|NCT01197794|529978059|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
146950976|NCT01197794|529978060|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
146950977|NCT01197794|529978061|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
146950978|NCT01197794|529978062|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
146950979|NCT01197794|529978063|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
146950980|NCT01197794|529978064|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
146950981|NCT01197794|529978058|FG000|Overall Study|Withdrawal by Subject|3|||
146984782|NCT01533428|530105171|FG001|Overall Study|Adverse Event|1|||
146984783|NCT01533428|530105170|FG000|Overall Study|Lost to Follow-up|2|||
146819680|NCT00385697|529507726|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
146819681|NCT00385697|529507727|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
146819682|NCT00385697|529507728|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
146819683|NCT00385697|529507724|FG000|Double-blind Segment 2|Other|0|||
146819684|NCT00385697|529507725|FG001|Double-blind Segment 2|Other|2|||
146819685|NCT00385697|529507726|FG002|Double-blind Segment 2|Other|0|||
146950982|NCT01197794|529978059|FG001|Overall Study|Withdrawal by Subject|3|||
146950983|NCT01197794|529978060|FG002|Overall Study|Withdrawal by Subject|4|||
146950984|NCT01197794|529978061|FG003|Overall Study|Withdrawal by Subject|1|||
146950985|NCT01197794|529978062|FG004|Overall Study|Withdrawal by Subject|1|||
146950986|NCT01197794|529978063|FG005|Overall Study|Withdrawal by Subject|5|||
146984784|NCT01533428|530105171|FG001|Overall Study|Lost to Follow-up|1|||
146819686|NCT00385697|529507727|FG003|Double-blind Segment 2|Other|0|||
146819687|NCT00385697|529507728|FG004|Double-blind Segment 2|Other|0|||
146819688|NCT00510783|529507730|FG000|Overall Study|Lost to Follow-up|29|||
146819689|NCT00510783|529507731|FG001|Overall Study|Lost to Follow-up|25|||
146819690|NCT00510783|529507730|FG000|Overall Study|Withdrawal by Subject|2|||
146819691|NCT00510783|529507731|FG001|Overall Study|Withdrawal by Subject|3|||
146819692|NCT00510783|529507730|FG000|Overall Study|Protocol Violation|0|||
146819693|NCT00510783|529507731|FG001|Overall Study|Protocol Violation|1|||
146819694|NCT00442559|529507732|FG000|Overall Study|Lost to Follow-up|32|||
146819695|NCT00442559|529507733|FG001|Overall Study|Lost to Follow-up|34|||
146819696|NCT00442559|529507732|FG000|Overall Study|Protocol Violation|1|||
146819697|NCT00442559|529507733|FG001|Overall Study|Protocol Violation|1|||
146819698|NCT00442559|529507732|FG000|Overall Study|Withdrawal by Subject|1|||
146984785|NCT01533428|530105170|FG000|Overall Study|Withdrawal by Subject|7|||
146819699|NCT00442559|529507733|FG001|Overall Study|Withdrawal by Subject|0|||
146819700|NCT01426217|529507748|FG000|Overall Study|lost sample|8|||
146819701|NCT01426217|529507749|FG001|Overall Study|lost sample|14|||
146819702|NCT01648699|529507750|FG000|Overall Study|Death|1|||
146819703|NCT01648699|529507750|FG000|Overall Study|Lost to Follow-up|2|||
146819704|NCT01648699|529507750|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
146819705|NCT02267746|529507751|FG000|Overall Study|Adverse Event|0|||
146819706|NCT02267746|529507752|FG001|Overall Study|Adverse Event|2|||
146819707|NCT02267746|529507753|FG002|Overall Study|Adverse Event|1|||
146819708|NCT02267746|529507751|FG000|Overall Study|Protocol Violation|8|||
146819709|NCT02267746|529507752|FG001|Overall Study|Protocol Violation|7|||
146819710|NCT02267746|529507753|FG002|Overall Study|Protocol Violation|3|||
146819711|NCT02267746|529507751|FG000|Overall Study|Lack of Efficacy|11|||
146819712|NCT02267746|529507752|FG001|Overall Study|Lack of Efficacy|11|||
146819713|NCT02267746|529507753|FG002|Overall Study|Lack of Efficacy|15|||
146819714|NCT02267746|529507751|FG000|Overall Study|Protocol Violation|1|||
146819715|NCT02267746|529507752|FG001|Overall Study|Protocol Violation|2|||
146819716|NCT02267746|529507753|FG002|Overall Study|Protocol Violation|1|||
146819717|NCT02267746|529507751|FG000|Overall Study|Miscellaneous|1|||
146819718|NCT02267746|529507752|FG001|Overall Study|Miscellaneous|0|||
146819719|NCT02267746|529507753|FG002|Overall Study|Miscellaneous|1|||
146819720|NCT01812837|529507754|FG000|Overall Study|Lost to Follow-up|1|||
146819721|NCT01812837|529507755|FG001|Overall Study|Lost to Follow-up|1|||
146819722|NCT01812837|529507756|FG002|Overall Study|Lost to Follow-up|0|||
146819723|NCT01812837|529507754|FG000|Overall Study|Protocol Violation|1|||
146819724|NCT01812837|529507755|FG001|Overall Study|Protocol Violation|0|||
146819725|NCT01812837|529507756|FG002|Overall Study|Protocol Violation|0|||
146984786|NCT01533428|530105171|FG001|Overall Study|Withdrawal by Subject|6|||
146984787|NCT02669264|530105174|FG000|Overall Study|Death|5|||
146984788|NCT02669264|530105175|FG001|Overall Study|Death|5|||
146984789|NCT02669264|530105176|FG002|Overall Study|Death|3|||
146984790|NCT02669264|530105177|FG003|Overall Study|Death|3|||
146984791|NCT02669264|530105178|FG004|Overall Study|Death|3|||
146819726|NCT05008224|529507761|FG000|Overall Study|Death|3|||
146819727|NCT05008224|529507761|FG000|Overall Study|Lost to Follow-up|2|||
146819728|NCT05008224|529507761|FG000|Overall Study|Did Not Continue on Extension Study|39|||
146819729|NCT05008224|529507761|FG000|Overall Study|Transferred to Extension Study|100|||
146819730|NCT05008224|529507761|FG000|Overall Study|Withdrawal by Subject|2|||
146819731|NCT05234632|529507762|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
146819732|NCT05234632|529507763|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
146819733|NCT05234632|529507762|FG000|Overall Study|Withdrawal by Subject|2|||
146819734|NCT05234632|529507763|FG001|Overall Study|Withdrawal by Subject|0|||
146950987|NCT01197794|529978064|FG006|Overall Study|Withdrawal by Subject|6|||
146950988|NCT01197794|529978058|FG000|Overall Study|Lost to Follow-up|1|||
146950989|NCT01197794|529978059|FG001|Overall Study|Lost to Follow-up|1|||
146950990|NCT01197794|529978060|FG002|Overall Study|Lost to Follow-up|0|||
146950991|NCT01197794|529978061|FG003|Overall Study|Lost to Follow-up|1|||
146950992|NCT01197794|529978062|FG004|Overall Study|Lost to Follow-up|0|||
146950993|NCT01197794|529978063|FG005|Overall Study|Lost to Follow-up|1|||
146819735|NCT05234632|529507762|FG000|Overall Study|Adverse Event|0|||
146819736|NCT05234632|529507763|FG001|Overall Study|Adverse Event|4|||
146819737|NCT05234632|529507762|FG000|Overall Study|Physician Decision|1|||
146819738|NCT05234632|529507763|FG001|Overall Study|Physician Decision|1|||
146819739|NCT05234632|529507762|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
146819740|NCT05234632|529507763|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
146819741|NCT05234632|529507762|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
146819742|NCT05234632|529507763|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
146819743|NCT04799587|529507764|FG000|Overall Study|Withdrawal by Subject|0|||
146819744|NCT04799587|529507765|FG001|Overall Study|Withdrawal by Subject|1|||
146819745|NCT00728884|529507766|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
146819746|NCT00728884|529507766|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
146950994|NCT01197794|529978064|FG006|Overall Study|Lost to Follow-up|0|||
146950995|NCT01197794|529978058|FG000|Overall Study|Other|1|||
146950996|NCT01197794|529978059|FG001|Overall Study|Other|1|||
146950997|NCT01197794|529978060|FG002|Overall Study|Other|3|||
146950998|NCT01197794|529978061|FG003|Overall Study|Other|0|||
146950999|NCT01197794|529978062|FG004|Overall Study|Other|2|||
146951000|NCT01197794|529978063|FG005|Overall Study|Other|2|||
146984792|NCT02669264|530105179|FG005|Overall Study|Death|6|||
146984793|NCT02669264|530105180|FG006|Overall Study|Death|3|||
146819747|NCT05263492|529507767|FG000|Overall Study|Adverse Event|1|||
146819748|NCT05263492|529507767|FG000|Overall Study|Disease progression during active treatment|3|||
146819749|NCT03345420|529507770|FG000|Overall Study|Withdrawal by Subject|1|||
146819750|NCT05216835|529507771|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
146819751|NCT05216835|529507772|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
146819752|NCT05216835|529507773|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
146819753|NCT05216835|529507774|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
146819754|NCT05216835|529507775|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
146819755|NCT05216835|529507776|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
146819756|NCT05216835|529507777|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
146819757|NCT05216835|529507778|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
146819758|NCT05216835|529507771|FG000|Overall Study|Death|0|||
146819759|NCT05216835|529507772|FG001|Overall Study|Death|0|||
146819760|NCT05216835|529507773|FG002|Overall Study|Death|0|||
146819761|NCT05216835|529507774|FG003|Overall Study|Death|1|||
146819762|NCT05216835|529507775|FG004|Overall Study|Death|1|||
146819763|NCT05216835|529507776|FG005|Overall Study|Death|1|||
146819764|NCT05216835|529507777|FG006|Overall Study|Death|1|||
146819765|NCT05216835|529507778|FG007|Overall Study|Death|1|||
146819766|NCT05216835|529507771|FG000|Overall Study|Physician Decision|0|||
146819767|NCT05216835|529507772|FG001|Overall Study|Physician Decision|0|||
146819768|NCT05216835|529507773|FG002|Overall Study|Physician Decision|0|||
146819769|NCT05216835|529507774|FG003|Overall Study|Physician Decision|0|||
146819770|NCT05216835|529507775|FG004|Overall Study|Physician Decision|0|||
146819771|NCT05216835|529507776|FG005|Overall Study|Physician Decision|1|||
146819772|NCT05216835|529507777|FG006|Overall Study|Physician Decision|1|||
146819773|NCT05216835|529507778|FG007|Overall Study|Physician Decision|0|||
146819774|NCT05216835|529507771|FG000|Overall Study|Study terminated by Sponsor|0|||
146819775|NCT05216835|529507772|FG001|Overall Study|Study terminated by Sponsor|0|||
146819776|NCT05216835|529507773|FG002|Overall Study|Study terminated by Sponsor|0|||
146819777|NCT05216835|529507774|FG003|Overall Study|Study terminated by Sponsor|0|||
146819778|NCT05216835|529507775|FG004|Overall Study|Study terminated by Sponsor|0|||
146819779|NCT05216835|529507776|FG005|Overall Study|Study terminated by Sponsor|0|||
146819780|NCT05216835|529507777|FG006|Overall Study|Study terminated by Sponsor|0|||
146819781|NCT05216835|529507778|FG007|Overall Study|Study terminated by Sponsor|1|||
146819782|NCT05216835|529507771|FG000|Overall Study|Withdrawal by Subject|1|||
146819783|NCT05216835|529507772|FG001|Overall Study|Withdrawal by Subject|0|||
146819784|NCT05216835|529507773|FG002|Overall Study|Withdrawal by Subject|1|||
146819785|NCT05216835|529507774|FG003|Overall Study|Withdrawal by Subject|0|||
146819786|NCT05216835|529507775|FG004|Overall Study|Withdrawal by Subject|1|||
146819787|NCT05216835|529507776|FG005|Overall Study|Withdrawal by Subject|0|||
146819788|NCT05216835|529507777|FG006|Overall Study|Withdrawal by Subject|0|||
146819789|NCT05216835|529507778|FG007|Overall Study|Withdrawal by Subject|1|||
146819790|NCT05216835|529507771|FG000|Overall Study|Other|0|||
146819791|NCT05216835|529507772|FG001|Overall Study|Other|1|||
146819792|NCT05216835|529507773|FG002|Overall Study|Other|0|||
146819793|NCT05216835|529507774|FG003|Overall Study|Other|0|||
146819794|NCT05216835|529507775|FG004|Overall Study|Other|0|||
146819795|NCT05216835|529507776|FG005|Overall Study|Other|0|||
146819796|NCT05216835|529507777|FG006|Overall Study|Other|0|||
146819797|NCT05216835|529507778|FG007|Overall Study|Other|0|||
146819798|NCT05179603|529507779|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
146819799|NCT05179603|529507779|FG000|Overall Study|Withdrawal by Subject|1|||
146819800|NCT05179603|529507779|FG000|Overall Study|Progressive disease|4|||
146819801|NCT05179603|529507779|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
146819802|NCT03861078|529507780|FG000|Overall Study|COVID-19 shut down|4|||
146819803|NCT03861078|529507780|FG000|Overall Study|Lost to Follow-up|1|||
146819804|NCT03861078|529507780|FG000|Overall Study|Protocol Violation|2|||
146819805|NCT03861078|529507780|FG000|Overall Study|lack of venous access|1|||
146819806|NCT01075815|529507781|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
146819807|NCT01075815|529507782|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
146819808|NCT01075815|529507781|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
146819809|NCT01075815|529507782|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
146819810|NCT01075815|529507781|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
146819811|NCT01075815|529507782|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
146819812|NCT00596960|529507783|FG000|Overall Study|Death|1|||
146819813|NCT00596960|529507784|FG001|Overall Study|Death|2|||
146819814|NCT00596960|529507783|FG000|Overall Study|Lost to Follow-up|6|||
146819815|NCT00596960|529507784|FG001|Overall Study|Lost to Follow-up|5|||
146819816|NCT00596960|529507783|FG000|Overall Study|Withdrawal by Subject|1|||
146819817|NCT00596960|529507784|FG001|Overall Study|Withdrawal by Subject|0|||
146819818|NCT00596960|529507783|FG000|Overall Study|Incarcerated|2|||
146819819|NCT00596960|529507784|FG001|Overall Study|Incarcerated|0|||
146819820|NCT00596960|529507783|FG000|Overall Study|Physician Decision|1|||
146819821|NCT00596960|529507784|FG001|Overall Study|Physician Decision|0|||
146819822|NCT00596960|529507783|FG000|Overall Study|Protocol Violation|0|||
146819823|NCT00596960|529507784|FG001|Overall Study|Protocol Violation|1|||
146819824|NCT00596960|529507783|FG000|Overall Study|No alcohol use data|0|||
146819825|NCT00596960|529507784|FG001|Overall Study|No alcohol use data|1|||
146819826|NCT02058992|529507785|FG000|Overall Study|Lost to Follow-up|4|||
146819827|NCT02058992|529507785|FG000|Overall Study|Protocol Violation|92|||
146819828|NCT02058992|529507785|FG000|Overall Study|CRF Uncollected|20|||
146819829|NCT03005106|529507789|FG000|Overall Study|Lost to Follow-up|16|||
146819830|NCT03005106|529507789|FG000|Overall Study|Adverse Event|1|||
146819831|NCT03005106|529507789|FG000|Overall Study|Physician Decision|1|||
146819832|NCT03005106|529507789|FG000|Overall Study|Death|2|||
146819833|NCT01855399|529507790|FG000|6 Month|Lost to Follow-up|12|||
146819834|NCT01855399|529507791|FG001|6 Month|Lost to Follow-up|9|||
146819835|NCT01855399|529507790|FG000|6 Month|Withdrawal by Subject|8|||
146819836|NCT01855399|529507791|FG001|6 Month|Withdrawal by Subject|6|||
146819837|NCT01855399|529507790|FG000|12 Month|Lost to Follow-up|7|||
146819838|NCT01855399|529507791|FG001|12 Month|Lost to Follow-up|11|||
146819839|NCT03019289|529507792|FG000|Overall Study|Adverse Event|1|||
146819840|NCT03019289|529507793|FG001|Overall Study|Adverse Event|0|||
146819841|NCT03019289|529507794|FG002|Overall Study|Adverse Event|0|||
146819842|NCT03019289|529507795|FG003|Overall Study|Adverse Event|0|||
146819843|NCT03019289|529507796|FG004|Overall Study|Adverse Event|0|||
146819844|NCT03019289|529507797|FG005|Overall Study|Adverse Event|0|||
146819845|NCT03019289|529507798|FG006|Overall Study|Adverse Event|0|||
146819846|NCT03019289|529507799|FG007|Overall Study|Adverse Event|0|||
146819847|NCT03019289|529507800|FG008|Overall Study|Adverse Event|1|||
146819848|NCT03019289|529507792|FG000|Overall Study|Other|1|||
146819849|NCT03019289|529507793|FG001|Overall Study|Other|0|||
146819850|NCT03019289|529507794|FG002|Overall Study|Other|0|||
146819851|NCT03019289|529507795|FG003|Overall Study|Other|0|||
146819852|NCT03019289|529507796|FG004|Overall Study|Other|0|||
146819853|NCT03019289|529507797|FG005|Overall Study|Other|0|||
146819854|NCT03019289|529507798|FG006|Overall Study|Other|0|||
146819855|NCT03019289|529507799|FG007|Overall Study|Other|0|||
146819856|NCT03019289|529507800|FG008|Overall Study|Other|0|||
146819857|NCT00936065|529507801|FG000|Overall Study|Adverse Event|1|||
146819858|NCT00936065|529507802|FG001|Overall Study|Adverse Event|0|||
146819859|NCT00936065|529507803|FG002|Overall Study|Adverse Event|1|||
146819860|NCT00936065|529507801|FG000|Overall Study|Lack of Efficacy|1|||
146819861|NCT00936065|529507802|FG001|Overall Study|Lack of Efficacy|0|||
146819862|NCT00936065|529507803|FG002|Overall Study|Lack of Efficacy|1|||
146819863|NCT00936065|529507801|FG000|Overall Study|Lost to Follow-up|1|||
146819864|NCT00936065|529507802|FG001|Overall Study|Lost to Follow-up|0|||
146819865|NCT00936065|529507803|FG002|Overall Study|Lost to Follow-up|0|||
146819866|NCT00936065|529507801|FG000|Overall Study|Protocol Violation|1|||
146819867|NCT00936065|529507802|FG001|Overall Study|Protocol Violation|2|||
146819868|NCT00936065|529507803|FG002|Overall Study|Protocol Violation|1|||
146819869|NCT00936065|529507801|FG000|Overall Study|Withdrawal by Subject|0|||
146819870|NCT00936065|529507802|FG001|Overall Study|Withdrawal by Subject|2|||
146819871|NCT00936065|529507803|FG002|Overall Study|Withdrawal by Subject|4|||
146819872|NCT02389894|529507804|FG000|Overall Study|Death|4|||
146819873|NCT02389894|529507805|FG001|Overall Study|Death|5|||
146819874|NCT02389894|529507806|FG002|Overall Study|Death|3|||
146819875|NCT02389894|529507804|FG000|Overall Study|Withdrawal by Subject|2|||
146819876|NCT02389894|529507805|FG001|Overall Study|Withdrawal by Subject|4|||
146819877|NCT02389894|529507806|FG002|Overall Study|Withdrawal by Subject|5|||
146819878|NCT02389894|529507804|FG000|Overall Study|Lost to Follow-up|2|||
146819879|NCT02389894|529507805|FG001|Overall Study|Lost to Follow-up|1|||
146819880|NCT02389894|529507806|FG002|Overall Study|Lost to Follow-up|1|||
146819881|NCT01429285|529507809|FG000|Overall Study|Protocol Violation|9|||
146819882|NCT01429285|529507810|FG001|Overall Study|Protocol Violation|4|||
146819883|NCT01429285|529507809|FG000|Overall Study|Missing Data|5|||
146819884|NCT01429285|529507810|FG001|Overall Study|Missing Data|3|||
146819885|NCT01429285|529507809|FG000|Overall Study|Erroneously Enrolled Twice|8|||
146819886|NCT01429285|529507810|FG001|Overall Study|Erroneously Enrolled Twice|2|||
146819887|NCT01549951|529507811|FG000|Overall Study|Adverse Event|15|||
146819888|NCT01549951|529507811|FG000|Overall Study|Withdrawal by Subject|2|||
146819889|NCT01549951|529507811|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
146819890|NCT01549951|529507811|FG000|Overall Study|Progressive disease|29|||
146819891|NCT01549951|529507811|FG000|Overall Study|Symptomatic deterioration|1|||
146819892|NCT01549951|529507811|FG000|Overall Study|Other|2|||
146819893|NCT00738400|529507812|FG000|Overall Study|Adverse Event|3|||
146819894|NCT00738400|529507813|FG001|Overall Study|Adverse Event|1|||
146819895|NCT00738400|529507812|FG000|Overall Study|Withdrawal by Subject|0|||
146819896|NCT00738400|529507813|FG001|Overall Study|Withdrawal by Subject|1|||
146819897|NCT00738400|529507812|FG000|Overall Study|Lack of Efficacy|0|||
146819898|NCT00738400|529507813|FG001|Overall Study|Lack of Efficacy|1|||
146819899|NCT00738400|529507812|FG000|Overall Study|Lost to Follow-up|0|||
146819900|NCT00738400|529507813|FG001|Overall Study|Lost to Follow-up|3|||
146819901|NCT00738400|529507812|FG000|Overall Study|Protocol Violation|1|||
146819902|NCT00738400|529507813|FG001|Overall Study|Protocol Violation|0|||
146819903|NCT00738400|529507812|FG000|Overall Study|Non-compliant with study medication|0|||
146819904|NCT00738400|529507813|FG001|Overall Study|Non-compliant with study medication|1|||
146819905|NCT01052714|529507820|FG000|Overall Study|Adverse Event|6|||
146819906|NCT01052714|529507821|FG001|Overall Study|Adverse Event|3|||
146819907|NCT01052714|529507822|FG002|Overall Study|Adverse Event|0|||
146819908|NCT01052714|529507820|FG000|Overall Study|Death|1|||
146819909|NCT01052714|529507821|FG001|Overall Study|Death|2|||
146819910|NCT01052714|529507822|FG002|Overall Study|Death|0|||
146819911|NCT01052714|529507820|FG000|Overall Study|Lost to Follow-up|2|||
146819912|NCT01052714|529507821|FG001|Overall Study|Lost to Follow-up|3|||
146819913|NCT01052714|529507822|FG002|Overall Study|Lost to Follow-up|0|||
146819914|NCT01052714|529507820|FG000|Overall Study|Physician Decision|9|||
146819915|NCT01052714|529507821|FG001|Overall Study|Physician Decision|9|||
146819916|NCT01052714|529507822|FG002|Overall Study|Physician Decision|1|||
146819917|NCT01052714|529507820|FG000|Overall Study|Withdrawal by Subject|7|||
146819918|NCT01052714|529507821|FG001|Overall Study|Withdrawal by Subject|12|||
146819919|NCT01052714|529507822|FG002|Overall Study|Withdrawal by Subject|1|||
146819920|NCT00990314|529507823|FG000|Overall Study|Death|2|||
146819921|NCT00990314|529507823|FG000|Overall Study|Adverse Event|2|||
146819922|NCT00990314|529507823|FG000|Overall Study|Withdrawal by Subject|3|||
146819923|NCT00990314|529507823|FG000|Overall Study|Non-Compliance|1|||
146819924|NCT00990314|529507823|FG000|Overall Study|Physician Decision|3|||
146819925|NCT00990314|529507823|FG000|Overall Study|Lack of Efficacy|1|||
146819926|NCT01288729|529507833|FG000|Overall Study|Withdrawal by Subject|1|||
146819927|NCT01288729|529507834|FG001|Overall Study|Withdrawal by Subject|0|||
146819928|NCT02514577|529509252|FG000|Overall Study|Lost to Follow-up|6|||
146819929|NCT02514577|529509253|FG001|Overall Study|Lost to Follow-up|6|||
146819930|NCT02514577|529509252|FG000|Overall Study|Protocol Violation|1|||
146819931|NCT02514577|529509253|FG001|Overall Study|Protocol Violation|0|||
146819932|NCT02514577|529509252|FG000|Overall Study|Withdrawal by Subject|6|||
146819933|NCT02514577|529509253|FG001|Overall Study|Withdrawal by Subject|6|||
146819934|NCT02514577|529509252|FG000|Overall Study|Adverse Event|1|||
146819935|NCT02514577|529509253|FG001|Overall Study|Adverse Event|1|||
146819936|NCT02388932|529509254|FG000|Overall Study|Death|1|||
146819937|NCT00627523|529509256|FG000|Overall Study|Lack of Efficacy|1|||
146819938|NCT00627523|529509257|FG001|Overall Study|Lack of Efficacy|0|||
146819939|NCT00627523|529509256|FG000|Overall Study|Withdrawal by Subject|0|||
146819940|NCT00627523|529509257|FG001|Overall Study|Withdrawal by Subject|2|||
146819941|NCT00627523|529509256|FG000|Overall Study|Other|1|||
146819942|NCT00627523|529509257|FG001|Overall Study|Other|0|||
146819943|NCT03672188|529509273|FG000|Overall Study|Withdrawal by Subject|0|||
146819944|NCT03672188|529509274|FG001|Overall Study|Withdrawal by Subject|0|||
146819945|NCT03672188|529509275|FG002|Overall Study|Withdrawal by Subject|0|||
146819946|NCT03672188|529509276|FG003|Overall Study|Withdrawal by Subject|3|||
146819947|NCT03672188|529509277|FG004|Overall Study|Withdrawal by Subject|0|||
146819948|NCT03672188|529509278|FG005|Overall Study|Withdrawal by Subject|0|||
146819949|NCT03672188|529509279|FG006|Overall Study|Withdrawal by Subject|0|||
146819950|NCT03672188|529509280|FG007|Overall Study|Withdrawal by Subject|0|||
146819951|NCT03672188|529509281|FG008|Overall Study|Withdrawal by Subject|0|||
146819952|NCT03672188|529509282|FG009|Overall Study|Withdrawal by Subject|0|||
146819953|NCT03672188|529509283|FG010|Overall Study|Withdrawal by Subject|0|||
146819954|NCT03672188|529509284|FG011|Overall Study|Withdrawal by Subject|0|||
146819955|NCT03672188|529509285|FG012|Overall Study|Withdrawal by Subject|0|||
146819956|NCT03672188|529509286|FG013|Overall Study|Withdrawal by Subject|0|||
146819957|NCT03672188|529509287|FG014|Overall Study|Withdrawal by Subject|0|||
146819958|NCT03672188|529509273|FG000|Overall Study|Death|0|||
146819959|NCT03672188|529509274|FG001|Overall Study|Death|0|||
146819960|NCT03672188|529509275|FG002|Overall Study|Death|0|||
146819961|NCT03672188|529509276|FG003|Overall Study|Death|0|||
146819962|NCT03672188|529509277|FG004|Overall Study|Death|0|||
146819963|NCT03672188|529509278|FG005|Overall Study|Death|0|||
146735771|NCT03145766|529205175|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
146735772|NCT03145766|529205176|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
146735773|NCT03145766|529205177|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
146735774|NCT03145766|529205178|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
146735775|NCT03145766|529205174|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
146735776|NCT03145766|529205175|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
146819964|NCT03672188|529509279|FG006|Overall Study|Death|0|||
146819965|NCT03672188|529509280|FG007|Overall Study|Death|0|||
146819966|NCT03672188|529509281|FG008|Overall Study|Death|0|||
146819967|NCT03672188|529509282|FG009|Overall Study|Death|0|||
146819968|NCT03672188|529509283|FG010|Overall Study|Death|0|||
146819969|NCT03672188|529509284|FG011|Overall Study|Death|0|||
146819970|NCT03672188|529509285|FG012|Overall Study|Death|1|||
146819971|NCT03672188|529509286|FG013|Overall Study|Death|0|||
146819972|NCT03672188|529509287|FG014|Overall Study|Death|0|||
146819973|NCT03672188|529509273|FG000|Overall Study|Lost to Follow-up|0|||
146819974|NCT03672188|529509274|FG001|Overall Study|Lost to Follow-up|0|||
146819975|NCT03672188|529509275|FG002|Overall Study|Lost to Follow-up|1|||
146819976|NCT03672188|529509276|FG003|Overall Study|Lost to Follow-up|0|||
146819977|NCT03672188|529509277|FG004|Overall Study|Lost to Follow-up|0|||
146819978|NCT03672188|529509278|FG005|Overall Study|Lost to Follow-up|0|||
146819979|NCT03672188|529509279|FG006|Overall Study|Lost to Follow-up|0|||
146819980|NCT03672188|529509280|FG007|Overall Study|Lost to Follow-up|0|||
146819981|NCT03672188|529509281|FG008|Overall Study|Lost to Follow-up|0|||
146819982|NCT03672188|529509282|FG009|Overall Study|Lost to Follow-up|0|||
146819983|NCT03672188|529509283|FG010|Overall Study|Lost to Follow-up|0|||
146819984|NCT03672188|529509284|FG011|Overall Study|Lost to Follow-up|0|||
146819985|NCT03672188|529509285|FG012|Overall Study|Lost to Follow-up|0|||
146951001|NCT01197794|529978064|FG006|Overall Study|Other|4|||
146951002|NCT04055844|529978065|FG000|Overall Study|Adverse Event|12|||
146951003|NCT04055844|529978065|FG000|Overall Study|Poor Performance|1|||
146951004|NCT04055844|529978065|FG000|Overall Study|Death|1|||
146951005|NCT01347840|529978078|FG000|Overall Study|Withdrawal by Subject|1|||
146951006|NCT00374127|529978087|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
146951007|NCT00374127|529978087|FG000|Overall Study|Blood could not be drawn.|2|||
146951008|NCT00374127|529978087|FG000|Overall Study|Protocol Violation|5|||
146951009|NCT00374127|529978087|FG000|Overall Study|Pregnancy|1|||
146951010|NCT04223778|529978088|FG000|Overall Study|Death|1|||
146951011|NCT04223778|529978089|FG001|Overall Study|Death|1|||
146951012|NCT04223778|529978088|FG000|Overall Study|Lost to Follow-up|4|||
146951013|NCT04223778|529978089|FG001|Overall Study|Lost to Follow-up|5|||
146951014|NCT04223778|529978088|FG000|Overall Study|Physician Decision|10|||
146951015|NCT04223778|529978089|FG001|Overall Study|Physician Decision|6|||
146951016|NCT04223778|529978088|FG000|Overall Study|Withdrawal by Subject|35|||
146951017|NCT04223778|529978089|FG001|Overall Study|Withdrawal by Subject|17|||
146951018|NCT04223778|529978088|FG000|Overall Study|Not Reported|7|||
146951019|NCT04223778|529978089|FG001|Overall Study|Not Reported|8|||
146819986|NCT03672188|529509286|FG013|Overall Study|Lost to Follow-up|0|||
146819987|NCT03672188|529509287|FG014|Overall Study|Lost to Follow-up|0|||
146819988|NCT01234675|529509288|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
146819989|NCT01234675|529509289|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
146819990|NCT01234675|529509288|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
146819991|NCT01234675|529509289|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
146819992|NCT01753323|529509290|FG000|Overall Study|Lack of Efficacy|0|||
146819993|NCT01753323|529509291|FG001|Overall Study|Lack of Efficacy|0|||
146819994|NCT01753323|529509292|FG002|Overall Study|Lack of Efficacy|8|||
146819995|NCT01753323|529509290|FG000|Overall Study|Protocol deviation|1|||
146819996|NCT01753323|529509291|FG001|Overall Study|Protocol deviation|0|||
146819997|NCT01753323|529509292|FG002|Overall Study|Protocol deviation|0|||
146819998|NCT01753323|529509290|FG000|Overall Study|Adverse Event|0|||
146819999|NCT01753323|529509291|FG001|Overall Study|Adverse Event|0|||
146820000|NCT01753323|529509292|FG002|Overall Study|Adverse Event|1|||
146820001|NCT01870999|529509294|FG000|Overall Study|Adverse Event|0|||
146820002|NCT01870999|529509295|FG001|Overall Study|Adverse Event|4|||
146820003|NCT01870999|529509296|FG002|Overall Study|Adverse Event|1|||
146820004|NCT01870999|529509294|FG000|Overall Study|Subject met withdrawal criteria|3|||
146820005|NCT01870999|529509295|FG001|Overall Study|Subject met withdrawal criteria|2|||
146820006|NCT01870999|529509296|FG002|Overall Study|Subject met withdrawal criteria|0|||
146820007|NCT01870999|529509294|FG000|Overall Study|Subject withdrawn by Investigator|1|||
146820008|NCT01870999|529509295|FG001|Overall Study|Subject withdrawn by Investigator|0|||
146820009|NCT01870999|529509296|FG002|Overall Study|Subject withdrawn by Investigator|0|||
146820010|NCT01870999|529509294|FG000|Overall Study|Withdrawal by Subject|0|||
146820011|NCT01870999|529509295|FG001|Overall Study|Withdrawal by Subject|2|||
146820012|NCT01870999|529509296|FG002|Overall Study|Withdrawal by Subject|5|||
146820013|NCT01870999|529509294|FG000|Overall Study|Protocol Violation|0|||
146820014|NCT01870999|529509295|FG001|Overall Study|Protocol Violation|0|||
146820015|NCT01870999|529509296|FG002|Overall Study|Protocol Violation|1|||
146820016|NCT00116584|529509307|FG000|Overall Study|Withdrawal by Subject|1|||
146820017|NCT00116584|529509308|FG001|Overall Study|Withdrawal by Subject|0|||
146951020|NCT03893630|529978092|FG000|Overall Study|Lost to Follow-up|5|||
146951021|NCT03893630|529978093|FG001|Overall Study|Lost to Follow-up|4|||
146951022|NCT03893630|529978094|FG002|Overall Study|Lost to Follow-up|2|||
146951023|NCT03893630|529978092|FG000|Overall Study|Withdrawal by Subject|3|||
146951024|NCT03893630|529978093|FG001|Overall Study|Withdrawal by Subject|6|||
146820018|NCT00116584|529509307|FG000|Overall Study|Protocol Violation|1|||
146951025|NCT03893630|529978094|FG002|Overall Study|Withdrawal by Subject|3|||
146951026|NCT03893630|529978092|FG000|Overall Study|Discontinued Intervention|0|||
146951027|NCT03893630|529978093|FG001|Overall Study|Discontinued Intervention|4|||
146951028|NCT03893630|529978094|FG002|Overall Study|Discontinued Intervention|2|||
146951029|NCT03053180|529979887|FG000|Overall Study|Failure to Return|1|||
146820019|NCT00116584|529509308|FG001|Overall Study|Protocol Violation|1|||
146820020|NCT02798861|529509311|FG000|Overall Study|Lost to Follow-up|22|||
146820021|NCT02798861|529509311|FG000|Overall Study|Withdrawal by Subject|1|||
146820022|NCT00907517|529509312|FG000|Overall Study|Progressive Disease|3|||
146820023|NCT00907517|529509313|FG001|Overall Study|Progressive Disease|3|||
146820024|NCT00907517|529509314|FG002|Overall Study|Progressive Disease|4|||
146951030|NCT02785588|529979895|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
146951031|NCT02785588|529979895|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
146820025|NCT00907517|529509315|FG003|Overall Study|Progressive Disease|4|||
146820026|NCT00907517|529509316|FG004|Overall Study|Progressive Disease|4|||
146820027|NCT00907517|529509312|FG000|Overall Study|Symptomatic Deterioration|0|||
146820028|NCT00907517|529509313|FG001|Overall Study|Symptomatic Deterioration|0|||
146820029|NCT00907517|529509314|FG002|Overall Study|Symptomatic Deterioration|0|||
146820030|NCT00907517|529509315|FG003|Overall Study|Symptomatic Deterioration|0|||
146820031|NCT00907517|529509316|FG004|Overall Study|Symptomatic Deterioration|1|||
146820032|NCT01533181|529509317|FG000|Overall Study|Disease progression pre-active treatment|0|||
146820033|NCT01533181|529509318|FG001|Overall Study|Disease progression pre-active treatment|1|||
146820034|NCT01533181|529509317|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
146820035|NCT01533181|529509318|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
146820036|NCT04879823|529509326|FG000|Overall Study|Physician Decision|3|||
146820037|NCT04879823|529509327|FG001|Overall Study|Physician Decision|1|||
146820038|NCT04879823|529509326|FG000|Overall Study|Protocol Violation|2|||
146820039|NCT04879823|529509327|FG001|Overall Study|Protocol Violation|3|||
146820040|NCT04879823|529509326|FG000|Overall Study|Lost to Follow-up|43|||
146820041|NCT04879823|529509327|FG001|Overall Study|Lost to Follow-up|35|||
146820042|NCT02465866|529509330|FG000|Period 3|Withdrawal by Subject|0|||
146820043|NCT02465866|529509331|FG001|Period 3|Withdrawal by Subject|1|||
146820044|NCT02465866|529509332|FG002|Period 3|Withdrawal by Subject|0|||
146820045|NCT02465866|529509333|FG003|Period 3|Withdrawal by Subject|0|||
146820046|NCT00203502|529509334|FG000|Overall Study|Death|1|||
146820047|NCT02023099|529509335|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
146820048|NCT02023099|529509336|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
146820049|NCT02023099|529509337|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
146820050|NCT02023099|529509335|FG000|Overall Study|Withdrawn Consent|3|||
146820051|NCT02023099|529509336|FG001|Overall Study|Withdrawn Consent|0|||
146820052|NCT02023099|529509337|FG002|Overall Study|Withdrawn Consent|1|||
146820053|NCT02023099|529509335|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
146820054|NCT02023099|529509336|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
146820055|NCT02023099|529509337|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
146820056|NCT01469819|529509338|FG000|Overall Study|Withdrawal by Subject|1|||
146820057|NCT01469819|529509338|FG000|Overall Study|Did not meet inclusionary criteria|2|||
146820058|NCT01469819|529509338|FG000|Overall Study|Could not swallow SmartPill|2|||
146820059|NCT01469819|529509338|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
146820060|NCT01695993|529509339|FG000|Overall Study|Lost to Follow-up|2|||
146820061|NCT01695993|529509340|FG001|Overall Study|Lost to Follow-up|1|||
146820062|NCT01695993|529509341|FG002|Overall Study|Lost to Follow-up|3|||
146820063|NCT01695993|529509339|FG000|Overall Study|Withdrawal by Subject|2|||
146820064|NCT01695993|529509340|FG001|Overall Study|Withdrawal by Subject|2|||
146820065|NCT01695993|529509341|FG002|Overall Study|Withdrawal by Subject|2|||
146820066|NCT01695993|529509339|FG000|Overall Study|To ill to continue|1|||
146820067|NCT01695993|529509340|FG001|Overall Study|To ill to continue|2|||
146820068|NCT01695993|529509341|FG002|Overall Study|To ill to continue|0|||
146820069|NCT01695993|529509339|FG000|Overall Study|Changed Medical Facility|0|||
146820070|NCT01695993|529509340|FG001|Overall Study|Changed Medical Facility|0|||
146820071|NCT01695993|529509341|FG002|Overall Study|Changed Medical Facility|1|||
146820072|NCT04057937|529509364|FG000|Placebo-controlled Phase|Adverse Event|3|||
146820073|NCT04057937|529509365|FG001|Placebo-controlled Phase|Adverse Event|0|||
146820074|NCT04057937|529509364|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
146820075|NCT04057937|529509365|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
146820076|NCT04057937|529509364|FG000|Active-treatment Phase|Pregnancy|0|||
146820077|NCT04057937|529509365|FG001|Active-treatment Phase|Pregnancy|1|||
146820078|NCT04057937|529509364|FG000|Active-treatment Phase|Physician Decision|0|||
146820079|NCT04057937|529509365|FG001|Active-treatment Phase|Physician Decision|1|||
146820080|NCT01072396|529509366|FG000|Period One|Adverse Event|1|||
146820081|NCT01072396|529509367|FG001|Period One|Adverse Event|1|||
146820082|NCT01072396|529509366|FG000|Period One|Protocol Violation|2|||
146820083|NCT01072396|529509367|FG001|Period One|Protocol Violation|1|||
146820084|NCT01072396|529509366|FG000|Period One|Withdrawal by Subject|2|||
146820085|NCT01072396|529509367|FG001|Period One|Withdrawal by Subject|0|||
146820086|NCT01072396|529509366|FG000|Washout Period|Missing termination information|0|||
146820087|NCT01072396|529509367|FG001|Washout Period|Missing termination information|1|||
146820088|NCT01072396|529509366|FG000|Period Two|Adverse Event|0|||
146820089|NCT01072396|529509367|FG001|Period Two|Adverse Event|3|||
146820090|NCT01072396|529509366|FG000|Period Two|Lost to Follow-up|1|||
146820091|NCT01072396|529509367|FG001|Period Two|Lost to Follow-up|0|||
146820092|NCT00472199|529509368|FG000|Overall Study|Adverse Event|19|||
146820093|NCT00472199|529509369|FG001|Overall Study|Adverse Event|23|||
146820094|NCT00472199|529509368|FG000|Overall Study|Lack of Efficacy|4|||
146820095|NCT00472199|529509369|FG001|Overall Study|Lack of Efficacy|25|||
146820096|NCT00472199|529509368|FG000|Overall Study|Lost to Follow-up|2|||
146820097|NCT00472199|529509369|FG001|Overall Study|Lost to Follow-up|4|||
146820098|NCT00472199|529509368|FG000|Overall Study|Protocol Violation|3|||
146820099|NCT00472199|529509369|FG001|Overall Study|Protocol Violation|2|||
146820100|NCT00472199|529509368|FG000|Overall Study|Withdrawal by Subject|6|||
146820101|NCT00472199|529509369|FG001|Overall Study|Withdrawal by Subject|5|||
146820102|NCT00472199|529509368|FG000|Overall Study|personal reason|0|||
146820103|NCT00472199|529509369|FG001|Overall Study|personal reason|1|||
146820104|NCT00472199|529509368|FG000|Overall Study|patient was asymptomatic|1|||
146820105|NCT00472199|529509369|FG001|Overall Study|patient was asymptomatic|0|||
146820106|NCT01268488|529509371|FG000|Overall Study|Adverse Event|3|||
146820107|NCT01268488|529509371|FG000|Overall Study|Physician Decision|2|||
146820108|NCT01014013|529509377|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
146820109|NCT01014013|529509378|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
146820110|NCT01014013|529509377|FG000|Overall Study|Clinical adverse experience|4|||
146820111|NCT01014013|529509378|FG001|Overall Study|Clinical adverse experience|2|||
146820112|NCT01014013|529509377|FG000|Overall Study|Laboratory adverse experience|1|||
146820113|NCT01014013|529509378|FG001|Overall Study|Laboratory adverse experience|1|||
146820114|NCT01014013|529509377|FG000|Overall Study|Protocol Violation|1|||
146820115|NCT01014013|529509378|FG001|Overall Study|Protocol Violation|3|||
146820116|NCT01014013|529509377|FG000|Overall Study|Withdrawal by Subject|7|||
146820117|NCT01014013|529509378|FG001|Overall Study|Withdrawal by Subject|4|||
146820118|NCT01014013|529509377|FG000|Overall Study|Clinical/microbiologic failure|1|||
146820119|NCT01014013|529509378|FG001|Overall Study|Clinical/microbiologic failure|2|||
146820120|NCT01014013|529509377|FG000|Overall Study|Pathogen culture = no growth|26|||
146820121|NCT01014013|529509378|FG001|Overall Study|Pathogen culture = no growth|34|||
146820122|NCT01014013|529509377|FG000|Overall Study|Negative urine culture|2|||
146820123|NCT01014013|529509378|FG001|Overall Study|Negative urine culture|0|||
146820124|NCT01014013|529509377|FG000|Overall Study|Pathogen resistant|7|||
146820125|NCT01014013|529509378|FG001|Overall Study|Pathogen resistant|4|||
146820126|NCT01014013|529509377|FG000|Overall Study|Physician Decision|0|||
146820127|NCT01014013|529509378|FG001|Overall Study|Physician Decision|1|||
146820128|NCT01014013|529509377|FG000|Overall Study|Another antibiotic therapy required|0|||
146820129|NCT01014013|529509378|FG001|Overall Study|Another antibiotic therapy required|1|||
146820130|NCT01014013|529509377|FG000|Overall Study|Appendectomy|1|||
146820131|NCT01014013|529509378|FG001|Overall Study|Appendectomy|0|||
146820132|NCT01014013|529509377|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
146820133|NCT01014013|529509378|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
146820134|NCT02305797|529509379|FG000|Overall Study|Adverse Event|11|||
146820135|NCT02305797|529509380|FG001|Overall Study|Adverse Event|2|||
146820136|NCT02305797|529509379|FG000|Overall Study|Withdrawal by Subject|9|||
146820137|NCT02305797|529509380|FG001|Overall Study|Withdrawal by Subject|10|||
146820138|NCT02305797|529509379|FG000|Overall Study|Lack of Efficacy|6|||
146820139|NCT02305797|529509380|FG001|Overall Study|Lack of Efficacy|0|||
146820140|NCT02305797|529509379|FG000|Overall Study|Lost to Follow-up|5|||
146820141|NCT02305797|529509380|FG001|Overall Study|Lost to Follow-up|11|||
146820142|NCT02305797|529509379|FG000|Overall Study|Pregnancy|0|||
146820143|NCT02305797|529509380|FG001|Overall Study|Pregnancy|2|||
146820144|NCT02305797|529509379|FG000|Overall Study|Noncompliance|14|||
146820145|NCT02305797|529509380|FG001|Overall Study|Noncompliance|12|||
146820146|NCT02305797|529509379|FG000|Overall Study|Reason not collected|0|||
146820147|NCT02305797|529509380|FG001|Overall Study|Reason not collected|1|||
146820148|NCT03508830|529509381|FG000|Overall Study|Withdrawal by Subject|3|||
146820149|NCT03508830|529509382|FG001|Overall Study|Withdrawal by Subject|4|||
146820150|NCT03508830|529509381|FG000|Overall Study|Physician Decision|2|||
146820151|NCT03508830|529509382|FG001|Overall Study|Physician Decision|2|||
146820152|NCT02097056|529509385|FG000|Overall Study|Protocol Violation|2|||
146820153|NCT02097056|529509385|FG000|Overall Study|Withdrawal by Subject|15|||
146820154|NCT02097056|529509385|FG000|Overall Study|Lost to Follow-up|2|||
146820155|NCT02097056|529509385|FG000|Overall Study|Adverse Event|37|||
146820156|NCT02097056|529509385|FG000|Overall Study|Other|2|||
146820157|NCT03906240|529509386|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
146820158|NCT03906240|529509387|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
146820159|NCT03906240|529509386|FG000|Overall Study|Lost to Follow-up|1|||
146820160|NCT03906240|529509387|FG001|Overall Study|Lost to Follow-up|0|||
146820161|NCT03906240|529509386|FG000|Overall Study|Withdrawal by Subject|0|||
146820162|NCT03906240|529509387|FG001|Overall Study|Withdrawal by Subject|1|||
146820163|NCT01446042|529509388|FG000|Overall Study|Withdrawal by Subject|12|||
146820164|NCT01446042|529509389|FG001|Overall Study|Withdrawal by Subject|2|||
146820165|NCT01446042|529509390|FG002|Overall Study|Withdrawal by Subject|4|||
146820166|NCT01446042|529509388|FG000|Overall Study|Adverse Event|1|||
146820167|NCT01446042|529509389|FG001|Overall Study|Adverse Event|0|||
146820168|NCT01446042|529509390|FG002|Overall Study|Adverse Event|4|||
146820169|NCT01446042|529509388|FG000|Overall Study|Lost to Follow-up|5|||
146820170|NCT01446042|529509389|FG001|Overall Study|Lost to Follow-up|0|||
146820171|NCT01446042|529509390|FG002|Overall Study|Lost to Follow-up|0|||
146820172|NCT01446042|529509388|FG000|Overall Study|Other reasons|2|||
146820173|NCT01446042|529509389|FG001|Overall Study|Other reasons|1|||
146820174|NCT01446042|529509390|FG002|Overall Study|Other reasons|1|||
146820175|NCT05287178|529509401|FG000|Overall Study|Lost to Follow-up|2|||
146820176|NCT00288353|529509402|FG000|Overall Study|Lack of Efficacy|2|||
146820177|NCT00288353|529509403|FG001|Overall Study|Lack of Efficacy|2|||
146820178|NCT00288353|529509402|FG000|Overall Study|Withdrawal by Subject|5|||
146820179|NCT00288353|529509403|FG001|Overall Study|Withdrawal by Subject|5|||
146820180|NCT00145496|529509413|FG000|Overall Study|Adverse Event|42|||
146820181|NCT00145496|529509414|FG001|Overall Study|Adverse Event|30|||
146820182|NCT00145496|529509413|FG000|Overall Study|Lack of Efficacy|12|||
146820183|NCT00145496|529509414|FG001|Overall Study|Lack of Efficacy|7|||
146820184|NCT00145496|529509413|FG000|Overall Study|Withdrawal by Subject|32|||
146820185|NCT00145496|529509414|FG001|Overall Study|Withdrawal by Subject|26|||
146820186|NCT00145496|529509413|FG000|Overall Study|Lost to Follow-up|12|||
146820187|NCT00145496|529509414|FG001|Overall Study|Lost to Follow-up|5|||
146820188|NCT00145496|529509413|FG000|Overall Study|Other|25|||
146820189|NCT00145496|529509414|FG001|Overall Study|Other|13|||
146820190|NCT03138499|529509416|FG000|Overall Study|Lost to Follow-up|1|||
146820191|NCT03138499|529509417|FG001|Overall Study|Lost to Follow-up|0|||
146820192|NCT03138499|529509416|FG000|Overall Study|Participants withdrew consent|1|||
146820193|NCT03138499|529509417|FG001|Overall Study|Participants withdrew consent|0|||
146820194|NCT03138499|529509416|FG000|Overall Study|Participant discontinued study before treatment|0|||
146820195|NCT03138499|529509417|FG001|Overall Study|Participant discontinued study before treatment|1|||
146820196|NCT03138499|529509416|FG000|Overall Study|Disease Progression|2|||
146820197|NCT03138499|529509417|FG001|Overall Study|Disease Progression|6|||
146820198|NCT03138499|529509416|FG000|Overall Study|Study drug toxicity|2|||
146820199|NCT03138499|529509417|FG001|Overall Study|Study drug toxicity|2|||
146820200|NCT03138499|529509416|FG000|Overall Study|Participant request to discontinue study treatment|1|||
146820201|NCT03138499|529509417|FG001|Overall Study|Participant request to discontinue study treatment|1|||
146820202|NCT03138499|529509416|FG000|Overall Study|Other reasons|2|||
146820203|NCT03138499|529509417|FG001|Overall Study|Other reasons|0|||
146820204|NCT01334606|529509418|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
146820205|NCT02312245|529509419|FG000|Overall Study|Death|0|||
146820206|NCT02312245|529509420|FG001|Overall Study|Death|0|||
146820207|NCT02312245|529509421|FG002|Overall Study|Death|0|||
146820208|NCT02312245|529509422|FG003|Overall Study|Death|1|||
146820209|NCT02312245|529509419|FG000|Overall Study|Withdrawal by Subject|1|||
146820210|NCT02312245|529509420|FG001|Overall Study|Withdrawal by Subject|1|||
146820211|NCT02312245|529509421|FG002|Overall Study|Withdrawal by Subject|0|||
146820212|NCT02312245|529509422|FG003|Overall Study|Withdrawal by Subject|2|||
146820213|NCT02312245|529509419|FG000|Overall Study|Alternative Therapy|1|||
146820214|NCT02312245|529509420|FG001|Overall Study|Alternative Therapy|0|||
146820215|NCT02312245|529509421|FG002|Overall Study|Alternative Therapy|0|||
146820216|NCT02312245|529509422|FG003|Overall Study|Alternative Therapy|0|||
146820217|NCT02312245|529509419|FG000|Overall Study|Progression|0|||
146820218|NCT02312245|529509420|FG001|Overall Study|Progression|0|||
146820219|NCT02312245|529509421|FG002|Overall Study|Progression|0|||
146820220|NCT02312245|529509422|FG003|Overall Study|Progression|5|||
146820221|NCT02312245|529509419|FG000|Overall Study|Patient went to hospice|0|||
146820222|NCT02312245|529509420|FG001|Overall Study|Patient went to hospice|0|||
146820223|NCT02312245|529509421|FG002|Overall Study|Patient went to hospice|0|||
146820224|NCT02312245|529509422|FG003|Overall Study|Patient went to hospice|1|||
146820225|NCT02312245|529509419|FG000|Overall Study|Ineligible|1|||
146820226|NCT02312245|529509420|FG001|Overall Study|Ineligible|0|||
146820227|NCT02312245|529509421|FG002|Overall Study|Ineligible|0|||
146820228|NCT02312245|529509422|FG003|Overall Study|Ineligible|0|||
146820229|NCT00448344|529509423|FG000|Overall Study|Lost to Follow-up|20|||
146820230|NCT00448344|529509424|FG001|Overall Study|Lost to Follow-up|22|||
146820231|NCT00448344|529509423|FG000|Overall Study|Withdrawal by Subject|6|||
146820232|NCT00448344|529509424|FG001|Overall Study|Withdrawal by Subject|8|||
146820233|NCT00448344|529509423|FG000|Overall Study|Death|3|||
146820234|NCT00448344|529509424|FG001|Overall Study|Death|4|||
146820235|NCT00448344|529509423|FG000|Overall Study|Physician Decision|1|||
146820236|NCT00448344|529509424|FG001|Overall Study|Physician Decision|2|||
146820237|NCT01123200|529509428|FG000|Overall Study|Withdrawal by Subject|1|||
146820238|NCT01232569|529511176|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
146820239|NCT01232569|529511177|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
146820240|NCT01232569|529511178|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146820241|NCT01232569|529511179|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
146820242|NCT01232569|529511176|FG000|Double-blind Treatment Period|Escape|2|||
146820243|NCT01232569|529511177|FG001|Double-blind Treatment Period|Escape|2|||
146820244|NCT01232569|529511178|FG002|Double-blind Treatment Period|Escape|0|||
146820245|NCT01232569|529511179|FG003|Double-blind Treatment Period|Escape|0|||
146820246|NCT01232569|529511176|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
146820247|NCT01232569|529511177|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
146820248|NCT01232569|529511178|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
146820249|NCT01232569|529511179|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
146820250|NCT01232569|529511176|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
146820251|NCT01232569|529511177|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
146820252|NCT01232569|529511178|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
146820253|NCT01232569|529511179|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
146820254|NCT01232569|529511176|FG000|Double-blind Treatment Period|Physician Decision|1|||
146820255|NCT01232569|529511177|FG001|Double-blind Treatment Period|Physician Decision|0|||
146820256|NCT01232569|529511178|FG002|Double-blind Treatment Period|Physician Decision|0|||
146820257|NCT01232569|529511179|FG003|Double-blind Treatment Period|Physician Decision|0|||
146820258|NCT01232569|529511176|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
146820259|NCT01232569|529511177|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
146820260|NCT01232569|529511178|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
146820261|NCT01232569|529511179|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
146820262|NCT01232569|529511176|FG000|Double-blind Treatment Period|Death|2|||
146820263|NCT01232569|529511177|FG001|Double-blind Treatment Period|Death|0|||
146820264|NCT01232569|529511178|FG002|Double-blind Treatment Period|Death|0|||
146820265|NCT01232569|529511179|FG003|Double-blind Treatment Period|Death|0|||
146820266|NCT01537120|529511187|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
146820267|NCT01537120|529511187|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
146820268|NCT05335005|529511189|FG000|Overall Study|Lost to Follow-up|1|||
146820269|NCT00644332|529511191|FG000|Overall Study|Adverse Event|11|||
146820270|NCT00644332|529511191|FG000|Overall Study|Withdrawal by Subject|6|||
146820271|NCT00644332|529511191|FG000|Overall Study|Completion Status Unknown|2|||
146820272|NCT00644332|529511191|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
146820273|NCT00644332|529511191|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
146820274|NCT03694210|529511192|FG000|Overall Study|Death|1|||
146820275|NCT03694210|529511192|FG000|Overall Study|Screen Failure|7|||
146820276|NCT00443755|529511193|FG000|Overall Study|Withdrawal by Subject|2|||
146820277|NCT00443755|529511194|FG001|Overall Study|Withdrawal by Subject|1|||
146820278|NCT00678899|529511201|FG000|Overall Study|Adverse Event|1|||
146820279|NCT03451292|529511202|FG000|Overall Study|Death|44|||
146820280|NCT03451292|529511203|FG001|Overall Study|Death|59|||
146820281|NCT03451292|529511202|FG000|Overall Study|Withdrawal by Subject|18|||
146820282|NCT03451292|529511203|FG001|Overall Study|Withdrawal by Subject|13|||
146820283|NCT03451292|529511202|FG000|Overall Study|Transplantation|18|||
146820284|NCT03451292|529511203|FG001|Overall Study|Transplantation|12|||
146820285|NCT03451292|529511202|FG000|Overall Study|Lost to Follow-up|4|||
146820286|NCT03451292|529511203|FG001|Overall Study|Lost to Follow-up|12|||
146820287|NCT03451292|529511202|FG000|Overall Study|Physician Decision|4|||
146820288|NCT03451292|529511203|FG001|Overall Study|Physician Decision|3|||
146820289|NCT03451292|529511202|FG000|Overall Study|Adverse Event|3|||
146820290|NCT03451292|529511203|FG001|Overall Study|Adverse Event|3|||
146820291|NCT03451292|529511202|FG000|Overall Study|Non-compliance with Study Drug|2|||
146820292|NCT03451292|529511203|FG001|Overall Study|Non-compliance with Study Drug|0|||
146820293|NCT04385849|529511204|FG000|Overall Study|Lost to Follow-up|1|||
146820294|NCT04385849|529511205|FG001|Overall Study|Lost to Follow-up|0|||
146820295|NCT01375777|529511206|FG000|Overall Study|Withdrawal by Subject|0|||
146820296|NCT01375777|529511207|FG001|Overall Study|Withdrawal by Subject|2|||
146820297|NCT01375777|529511208|FG002|Overall Study|Withdrawal by Subject|1|||
146820298|NCT01375777|529511209|FG003|Overall Study|Withdrawal by Subject|0|||
146820299|NCT01375777|529511210|FG004|Overall Study|Withdrawal by Subject|1|||
146820300|NCT01375777|529511211|FG005|Overall Study|Withdrawal by Subject|1|||
146820301|NCT01375777|529511212|FG006|Overall Study|Withdrawal by Subject|1|||
146820302|NCT01375777|529511213|FG007|Overall Study|Withdrawal by Subject|2|||
146820303|NCT01375777|529511214|FG008|Overall Study|Withdrawal by Subject|1|||
146820304|NCT01375777|529511206|FG000|Overall Study|Lost to Follow-up|1|||
146820305|NCT01375777|529511207|FG001|Overall Study|Lost to Follow-up|0|||
146820306|NCT01375777|529511208|FG002|Overall Study|Lost to Follow-up|0|||
146820307|NCT01375777|529511209|FG003|Overall Study|Lost to Follow-up|0|||
146820308|NCT01375777|529511210|FG004|Overall Study|Lost to Follow-up|0|||
146820309|NCT01375777|529511211|FG005|Overall Study|Lost to Follow-up|0|||
146820310|NCT01375777|529511212|FG006|Overall Study|Lost to Follow-up|1|||
146820311|NCT01375777|529511213|FG007|Overall Study|Lost to Follow-up|0|||
146820312|NCT01375777|529511214|FG008|Overall Study|Lost to Follow-up|0|||
146820313|NCT01375777|529511206|FG000|Overall Study|Other|1|||
146820314|NCT01375777|529511207|FG001|Overall Study|Other|1|||
146820315|NCT01375777|529511208|FG002|Overall Study|Other|0|||
146820316|NCT01375777|529511209|FG003|Overall Study|Other|0|||
146820317|NCT01375777|529511210|FG004|Overall Study|Other|0|||
146820318|NCT01375777|529511211|FG005|Overall Study|Other|0|||
146820319|NCT01375777|529511212|FG006|Overall Study|Other|0|||
146820320|NCT01375777|529511213|FG007|Overall Study|Other|0|||
146820321|NCT01375777|529511214|FG008|Overall Study|Other|1|||
146820322|NCT00355784|529511215|FG000|Overall Study|Withdrawal by Subject|0|||
146820323|NCT00355784|529511216|FG001|Overall Study|Withdrawal by Subject|0|||
146820324|NCT00355784|529511217|FG002|Overall Study|Withdrawal by Subject|2|||
146820325|NCT02543294|529511218|FG000|Overall Study|Lost to Follow-up|3|||
146820326|NCT02543294|529511218|FG000|Overall Study|Physician Decision|2|||
146820327|NCT02543294|529511218|FG000|Overall Study|Withdrawal by Subject|7|||
146820328|NCT03602053|529511219|FG000|Overall Study|Withdrawal by Subject|7|||
146820329|NCT03602053|529511220|FG001|Overall Study|Withdrawal by Subject|9|||
146820330|NCT03602053|529511221|FG002|Overall Study|Withdrawal by Subject|7|||
146820331|NCT03602053|529511219|FG000|Overall Study|Lost to Follow-up|5|||
146820332|NCT03602053|529511220|FG001|Overall Study|Lost to Follow-up|6|||
146820333|NCT03602053|529511221|FG002|Overall Study|Lost to Follow-up|0|||
146820334|NCT03602053|529511219|FG000|Overall Study|Protocol Violation|3|||
146820335|NCT03602053|529511220|FG001|Overall Study|Protocol Violation|0|||
146820336|NCT03602053|529511221|FG002|Overall Study|Protocol Violation|4|||
146820337|NCT03602053|529511219|FG000|Overall Study|Physician Decision|1|||
146820338|NCT03602053|529511220|FG001|Overall Study|Physician Decision|0|||
146820339|NCT03602053|529511221|FG002|Overall Study|Physician Decision|0|||
146820340|NCT03602053|529511219|FG000|Overall Study|migration|2|||
146820341|NCT03602053|529511220|FG001|Overall Study|migration|3|||
146820342|NCT03602053|529511221|FG002|Overall Study|migration|0|||
146820343|NCT03602053|529511219|FG000|Overall Study|Other|1|||
146820344|NCT03602053|529511220|FG001|Overall Study|Other|0|||
146820345|NCT03602053|529511221|FG002|Overall Study|Other|0|||
146820346|NCT03997409|529511222|FG000|Overall Study|Protocol Violation|1|||
146820347|NCT03997409|529511223|FG001|Overall Study|Protocol Violation|1|||
146820348|NCT03997409|529511224|FG002|Overall Study|Protocol Violation|0|||
146820349|NCT03997409|529511222|FG000|Overall Study|Withdrawal by Subject|3|||
146820350|NCT03997409|529511223|FG001|Overall Study|Withdrawal by Subject|0|||
146820351|NCT03997409|529511224|FG002|Overall Study|Withdrawal by Subject|0|||
146820352|NCT03997409|529511222|FG000|Overall Study|Lost to Follow-up|0|||
146820353|NCT03997409|529511223|FG001|Overall Study|Lost to Follow-up|0|||
146820354|NCT03997409|529511224|FG002|Overall Study|Lost to Follow-up|1|||
146820355|NCT01636258|529511225|FG000|Overall Study|Lost to Follow-up|1|||
146820356|NCT01636258|529511226|FG001|Overall Study|Lost to Follow-up|0|||
146820357|NCT02029521|529511228|FG000|Overall Study|Protocol Violation|1|||
146820358|NCT02029521|529511229|FG001|Overall Study|Protocol Violation|0|||
146820359|NCT02029521|529511228|FG000|Overall Study|Withdrawal by Subject|1|||
146820360|NCT02029521|529511229|FG001|Overall Study|Withdrawal by Subject|1|||
146820361|NCT02446912|529511230|FG000|Overall Study|Adverse Event|3|||
146820362|NCT02446912|529511231|FG001|Overall Study|Adverse Event|13|||
146820363|NCT02446912|529511232|FG002|Overall Study|Adverse Event|5|||
146951032|NCT00211536|529979898|FG000|Overall Study|Withdrawal by Subject|2|||
146951033|NCT00211536|529979899|FG001|Overall Study|Withdrawal by Subject|2|||
146951034|NCT00211536|529979898|FG000|Overall Study|Physician Decision|0|||
146951035|NCT00211536|529979899|FG001|Overall Study|Physician Decision|5|||
146951036|NCT00211536|529979898|FG000|Overall Study|Adverse Event|2|||
146951037|NCT00211536|529979899|FG001|Overall Study|Adverse Event|0|||
146951038|NCT02583399|529979900|FG000|Overall Study|Able to be discharged|3|||
146951039|NCT02583399|529979900|FG000|Overall Study|Wanted to use a restricted medication|3|||
146951040|NCT01004861|529979901|FG000|Overall Study|Disease progression|3|||
146951041|NCT01004861|529979902|FG001|Overall Study|Disease progression|4|||
146951042|NCT01004861|529979903|FG002|Overall Study|Disease progression|5|||
146820364|NCT02446912|529511230|FG000|Overall Study|Condition under investigation worsened|0|||
146820365|NCT02446912|529511231|FG001|Overall Study|Condition under investigation worsened|1|||
146820366|NCT02446912|529511232|FG002|Overall Study|Condition under investigation worsened|1|||
146820367|NCT02446912|529511230|FG000|Overall Study|Study-specific withdrawal criteria|1|||
146820368|NCT02446912|529511231|FG001|Overall Study|Study-specific withdrawal criteria|0|||
146820369|NCT02446912|529511232|FG002|Overall Study|Study-specific withdrawal criteria|0|||
146820370|NCT02446912|529511230|FG000|Overall Study|Lack of Efficacy|1|||
146820371|NCT02446912|529511231|FG001|Overall Study|Lack of Efficacy|4|||
146820372|NCT02446912|529511232|FG002|Overall Study|Lack of Efficacy|7|||
146820373|NCT02446912|529511230|FG000|Overall Study|Lost to Follow-up|0|||
146820374|NCT02446912|529511231|FG001|Overall Study|Lost to Follow-up|0|||
146820375|NCT02446912|529511232|FG002|Overall Study|Lost to Follow-up|2|||
146820376|NCT02446912|529511230|FG000|Overall Study|Severe non-compliance to protocol|1|||
146820377|NCT02446912|529511231|FG001|Overall Study|Severe non-compliance to protocol|0|||
146820378|NCT02446912|529511232|FG002|Overall Study|Severe non-compliance to protocol|1|||
146820379|NCT02446912|529511230|FG000|Overall Study|Withdrawal by Subject|10|||
146820380|NCT02446912|529511231|FG001|Overall Study|Withdrawal by Subject|15|||
146820381|NCT02446912|529511232|FG002|Overall Study|Withdrawal by Subject|15|||
146820382|NCT02446912|529511230|FG000|Overall Study|Miscellaneous|2|||
146820383|NCT02446912|529511231|FG001|Overall Study|Miscellaneous|2|||
146820384|NCT02446912|529511232|FG002|Overall Study|Miscellaneous|4|||
146820385|NCT01106586|529511235|FG000|Overall Study|Adverse Event|9|||
146820386|NCT01106586|529511236|FG001|Overall Study|Adverse Event|15|||
146820387|NCT01106586|529511235|FG000|Overall Study|Death|1|||
146820388|NCT01106586|529511236|FG001|Overall Study|Death|3|||
146820389|NCT01106586|529511235|FG000|Overall Study|Pregnancy|2|||
146951043|NCT01004861|529979904|FG003|Overall Study|Disease progression|4|||
146951044|NCT01004861|529979905|FG004|Overall Study|Disease progression|4|||
146951045|NCT01004861|529979906|FG005|Overall Study|Disease progression|4|||
146820390|NCT01106586|529511236|FG001|Overall Study|Pregnancy|2|||
146820391|NCT01106586|529511235|FG000|Overall Study|Lack of Efficacy|1|||
146820392|NCT01106586|529511236|FG001|Overall Study|Lack of Efficacy|0|||
146820393|NCT01106586|529511235|FG000|Overall Study|Investigator's Discretion|5|||
146820394|NCT01106586|529511236|FG001|Overall Study|Investigator's Discretion|8|||
146820395|NCT01106586|529511235|FG000|Overall Study|Withdrew Consent|18|||
146820396|NCT01106586|529511236|FG001|Overall Study|Withdrew Consent|30|||
146820397|NCT01106586|529511235|FG000|Overall Study|Lost to Follow-up|24|||
146820398|NCT01106586|529511236|FG001|Overall Study|Lost to Follow-up|20|||
146820399|NCT01106586|529511235|FG000|Overall Study|Participant Noncompliance|12|||
146820400|NCT01106586|529511236|FG001|Overall Study|Participant Noncompliance|10|||
146820401|NCT01106586|529511235|FG000|Overall Study|Protocol Violation|1|||
146820402|NCT01106586|529511236|FG001|Overall Study|Protocol Violation|0|||
146820403|NCT01106586|529511235|FG000|Overall Study|Participant Transferred to Another Study|212|||
146820404|NCT01106586|529511236|FG001|Overall Study|Participant Transferred to Another Study|197|||
146820405|NCT01757171|529511237|FG000|Overall Study|Adverse Event|5|||
146820406|NCT01757171|529511238|FG001|Overall Study|Adverse Event|1|||
146820407|NCT01757171|529511237|FG000|Overall Study|Disease Progression|1|||
146820408|NCT01757171|529511238|FG001|Overall Study|Disease Progression|0|||
146820409|NCT01757171|529511237|FG000|Overall Study|Hospitalization|1|||
146820410|NCT01757171|529511238|FG001|Overall Study|Hospitalization|0|||
146820411|NCT01757171|529511237|FG000|Overall Study|ECOG decline|1|||
146820412|NCT01757171|529511238|FG001|Overall Study|ECOG decline|0|||
146820413|NCT02504502|529511239|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
146820414|NCT02504502|529511240|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
146820415|NCT02504502|529511239|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
146820416|NCT02504502|529511240|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
146820417|NCT00428441|529511241|FG000|Overall Study|Lost to Follow-up|1|||
146820418|NCT02475733|529511242|FG000|Overall Study|Withdrawal by Subject|1|||
146820419|NCT02475733|529511243|FG001|Overall Study|Withdrawal by Subject|0|||
146820420|NCT02475733|529511242|FG000|Overall Study|Physician Decision|1|||
146820421|NCT02475733|529511243|FG001|Overall Study|Physician Decision|0|||
146820422|NCT00475735|529511244|FG000|Treatment Period 1|Adverse Event|2|||
146820423|NCT00475735|529511245|FG001|Treatment Period 1|Adverse Event|0|||
146820424|NCT00475735|529511246|FG002|Treatment Period 1|Adverse Event|0|||
146820425|NCT00475735|529511247|FG003|Treatment Period 1|Adverse Event|0|||
146820426|NCT00475735|529511248|FG004|Treatment Period 1|Adverse Event|0|||
146820427|NCT00475735|529511249|FG005|Treatment Period 1|Adverse Event|0|||
146820428|NCT00475735|529511244|FG000|Treatment Period 1|Lack of Efficacy|1|||
146820429|NCT00475735|529511245|FG001|Treatment Period 1|Lack of Efficacy|0|||
146820430|NCT00475735|529511246|FG002|Treatment Period 1|Lack of Efficacy|0|||
146820431|NCT00475735|529511247|FG003|Treatment Period 1|Lack of Efficacy|0|||
146820432|NCT00475735|529511248|FG004|Treatment Period 1|Lack of Efficacy|0|||
146820433|NCT00475735|529511249|FG005|Treatment Period 1|Lack of Efficacy|0|||
146820434|NCT00475735|529511244|FG000|Treatment Period 1|Lost to Follow-up|0|||
146820435|NCT00475735|529511245|FG001|Treatment Period 1|Lost to Follow-up|0|||
146820436|NCT00475735|529511246|FG002|Treatment Period 1|Lost to Follow-up|0|||
146820437|NCT00475735|529511247|FG003|Treatment Period 1|Lost to Follow-up|0|||
146820438|NCT00475735|529511248|FG004|Treatment Period 1|Lost to Follow-up|0|||
146820439|NCT00475735|529511249|FG005|Treatment Period 1|Lost to Follow-up|1|||
146820440|NCT00475735|529511244|FG000|Treatment Period 1|Protocol Violation|0|||
146820441|NCT00475735|529511245|FG001|Treatment Period 1|Protocol Violation|0|||
146820442|NCT00475735|529511246|FG002|Treatment Period 1|Protocol Violation|0|||
146820443|NCT00475735|529511247|FG003|Treatment Period 1|Protocol Violation|1|||
146820444|NCT00475735|529511248|FG004|Treatment Period 1|Protocol Violation|0|||
146820445|NCT00475735|529511249|FG005|Treatment Period 1|Protocol Violation|0|||
146820446|NCT00475735|529511244|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146820447|NCT00475735|529511245|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146820448|NCT00475735|529511246|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146820449|NCT00475735|529511247|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146820450|NCT00475735|529511248|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146820451|NCT00475735|529511249|FG005|Treatment Period 1|Withdrawal by Subject|0|||
146820452|NCT00475735|529511244|FG000|Treatment Period 1|DC due to AE but continuing|0|||
146820453|NCT00475735|529511245|FG001|Treatment Period 1|DC due to AE but continuing|0|||
146820454|NCT00475735|529511246|FG002|Treatment Period 1|DC due to AE but continuing|0|||
146820455|NCT00475735|529511247|FG003|Treatment Period 1|DC due to AE but continuing|1|||
146820456|NCT00475735|529511248|FG004|Treatment Period 1|DC due to AE but continuing|2|||
146820457|NCT00475735|529511249|FG005|Treatment Period 1|DC due to AE but continuing|2|||
146820458|NCT00475735|529511244|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
146820459|NCT00475735|529511245|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
146820460|NCT00475735|529511246|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
146820461|NCT00475735|529511247|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
146820462|NCT00475735|529511248|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
146820463|NCT00475735|529511249|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
146820464|NCT00475735|529511244|FG000|Treatment Washout|Lost to Follow-up|0|||
146820465|NCT00475735|529511245|FG001|Treatment Washout|Lost to Follow-up|1|||
146820466|NCT00475735|529511246|FG002|Treatment Washout|Lost to Follow-up|0|||
146820467|NCT00475735|529511247|FG003|Treatment Washout|Lost to Follow-up|0|||
146820468|NCT00475735|529511248|FG004|Treatment Washout|Lost to Follow-up|0|||
146820469|NCT00475735|529511249|FG005|Treatment Washout|Lost to Follow-up|0|||
146820470|NCT00475735|529511244|FG000|Treatment Washout|Protocol Violation|0|||
146820471|NCT00475735|529511245|FG001|Treatment Washout|Protocol Violation|1|||
146820472|NCT00475735|529511246|FG002|Treatment Washout|Protocol Violation|0|||
146820473|NCT00475735|529511247|FG003|Treatment Washout|Protocol Violation|0|||
146820474|NCT00475735|529511248|FG004|Treatment Washout|Protocol Violation|0|||
146820475|NCT00475735|529511249|FG005|Treatment Washout|Protocol Violation|0|||
146820476|NCT00475735|529511244|FG000|Treatment Period 2|Adverse Event|0|||
146820477|NCT00475735|529511245|FG001|Treatment Period 2|Adverse Event|1|||
146820478|NCT00475735|529511246|FG002|Treatment Period 2|Adverse Event|0|||
146820479|NCT00475735|529511247|FG003|Treatment Period 2|Adverse Event|2|||
146820480|NCT00475735|529511248|FG004|Treatment Period 2|Adverse Event|0|||
146820481|NCT00475735|529511249|FG005|Treatment Period 2|Adverse Event|0|||
146820482|NCT00475735|529511244|FG000|Treatment Period 2|Lack of Efficacy|0|||
146820483|NCT00475735|529511245|FG001|Treatment Period 2|Lack of Efficacy|0|||
146820484|NCT00475735|529511246|FG002|Treatment Period 2|Lack of Efficacy|0|||
146820485|NCT00475735|529511247|FG003|Treatment Period 2|Lack of Efficacy|0|||
146820486|NCT00475735|529511248|FG004|Treatment Period 2|Lack of Efficacy|0|||
146820487|NCT00475735|529511249|FG005|Treatment Period 2|Lack of Efficacy|1|||
146820488|NCT00475735|529511244|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146820489|NCT00475735|529511245|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146820490|NCT00475735|529511246|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146820491|NCT00475735|529511247|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146820492|NCT00475735|529511248|FG004|Treatment Period 2|Withdrawal by Subject|1|||
146820493|NCT00475735|529511249|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146820494|NCT00296504|529511256|FG000|Interim Analysis|Withdrawal by Subject|8|||
146820495|NCT00296504|529511257|FG001|Interim Analysis|Withdrawal by Subject|0|||
146820496|NCT00296504|529511258|FG002|Interim Analysis|Withdrawal by Subject|12|||
146820497|NCT00296504|529511259|FG003|Interim Analysis|Withdrawal by Subject|0|||
146820498|NCT00296504|529511260|FG004|Interim Analysis|Withdrawal by Subject|5|||
146820499|NCT00296504|529511261|FG005|Interim Analysis|Withdrawal by Subject|5|||
146820500|NCT00296504|529511262|FG006|Interim Analysis|Withdrawal by Subject|9|||
146820501|NCT00296504|529511263|FG007|Interim Analysis|Withdrawal by Subject|3|||
146820502|NCT00296504|529511264|FG008|Interim Analysis|Withdrawal by Subject|0|||
146820503|NCT00296504|529511256|FG000|Interim Analysis|Lost to Follow-up|13|||
146820504|NCT00296504|529511257|FG001|Interim Analysis|Lost to Follow-up|3|||
146820505|NCT00296504|529511258|FG002|Interim Analysis|Lost to Follow-up|26|||
146820506|NCT00296504|529511259|FG003|Interim Analysis|Lost to Follow-up|8|||
146820507|NCT00296504|529511260|FG004|Interim Analysis|Lost to Follow-up|14|||
146820508|NCT00296504|529511261|FG005|Interim Analysis|Lost to Follow-up|4|||
146820509|NCT00296504|529511262|FG006|Interim Analysis|Lost to Follow-up|11|||
146820510|NCT00296504|529511263|FG007|Interim Analysis|Lost to Follow-up|4|||
146820511|NCT00296504|529511264|FG008|Interim Analysis|Lost to Follow-up|0|||
146820512|NCT00296504|529511256|FG000|Interim Analysis|Clinical Progression|1|||
146820513|NCT00296504|529511257|FG001|Interim Analysis|Clinical Progression|0|||
146820514|NCT00296504|529511258|FG002|Interim Analysis|Clinical Progression|1|||
146820515|NCT00296504|529511259|FG003|Interim Analysis|Clinical Progression|1|||
146820516|NCT00296504|529511260|FG004|Interim Analysis|Clinical Progression|0|||
146820517|NCT00296504|529511261|FG005|Interim Analysis|Clinical Progression|2|||
146820518|NCT00296504|529511262|FG006|Interim Analysis|Clinical Progression|1|||
146820519|NCT00296504|529511263|FG007|Interim Analysis|Clinical Progression|2|||
146820520|NCT00296504|529511264|FG008|Interim Analysis|Clinical Progression|0|||
146820521|NCT00296504|529511256|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
146820522|NCT00296504|529511257|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
146820523|NCT00296504|529511258|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
146820524|NCT00296504|529511259|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
146820525|NCT00296504|529511260|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
146820526|NCT00296504|529511261|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
146820527|NCT00296504|529511262|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
146820528|NCT00296504|529511263|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
146820529|NCT00296504|529511264|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
146820530|NCT00296504|529511256|FG000|Interim Analysis|Adverse Event|0|||
146820531|NCT00296504|529511257|FG001|Interim Analysis|Adverse Event|0|||
146820532|NCT00296504|529511258|FG002|Interim Analysis|Adverse Event|13|||
146820533|NCT00296504|529511259|FG003|Interim Analysis|Adverse Event|4|||
146820534|NCT00296504|529511260|FG004|Interim Analysis|Adverse Event|6|||
146820535|NCT00296504|529511261|FG005|Interim Analysis|Adverse Event|3|||
146820536|NCT00296504|529511262|FG006|Interim Analysis|Adverse Event|4|||
146820537|NCT00296504|529511263|FG007|Interim Analysis|Adverse Event|5|||
146820538|NCT00296504|529511264|FG008|Interim Analysis|Adverse Event|0|||
146820539|NCT00296504|529511256|FG000|Interim Analysis|Protocol Violation|0|||
146820540|NCT00296504|529511257|FG001|Interim Analysis|Protocol Violation|0|||
146820541|NCT00296504|529511258|FG002|Interim Analysis|Protocol Violation|2|||
146820542|NCT00296504|529511259|FG003|Interim Analysis|Protocol Violation|0|||
146820543|NCT00296504|529511260|FG004|Interim Analysis|Protocol Violation|1|||
146820544|NCT00296504|529511261|FG005|Interim Analysis|Protocol Violation|0|||
146820545|NCT00296504|529511262|FG006|Interim Analysis|Protocol Violation|0|||
146820546|NCT00296504|529511263|FG007|Interim Analysis|Protocol Violation|1|||
146820547|NCT00296504|529511264|FG008|Interim Analysis|Protocol Violation|0|||
146820548|NCT00296504|529511256|FG000|Interim Analysis|Insufficient CD4 Response|0|||
146820549|NCT00296504|529511257|FG001|Interim Analysis|Insufficient CD4 Response|0|||
146820550|NCT00296504|529511258|FG002|Interim Analysis|Insufficient CD4 Response|0|||
146820551|NCT00296504|529511259|FG003|Interim Analysis|Insufficient CD4 Response|0|||
146820552|NCT00296504|529511260|FG004|Interim Analysis|Insufficient CD4 Response|1|||
146820553|NCT00296504|529511261|FG005|Interim Analysis|Insufficient CD4 Response|1|||
146820554|NCT00296504|529511262|FG006|Interim Analysis|Insufficient CD4 Response|0|||
146820555|NCT00296504|529511263|FG007|Interim Analysis|Insufficient CD4 Response|0|||
146820556|NCT00296504|529511264|FG008|Interim Analysis|Insufficient CD4 Response|0|||
146820557|NCT00296504|529511256|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
146820558|NCT00296504|529511257|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
146820559|NCT00296504|529511258|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
146820560|NCT00296504|529511259|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
146820561|NCT00296504|529511260|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
146820562|NCT00296504|529511261|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
146820563|NCT00296504|529511262|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
146820564|NCT00296504|529511263|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
146820565|NCT00296504|529511264|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
146820566|NCT00296504|529511256|FG000|Interim Analysis|Pregnancy|4|||
146820567|NCT00296504|529511257|FG001|Interim Analysis|Pregnancy|1|||
146820568|NCT00296504|529511258|FG002|Interim Analysis|Pregnancy|4|||
146820569|NCT00296504|529511259|FG003|Interim Analysis|Pregnancy|2|||
146820570|NCT00296504|529511260|FG004|Interim Analysis|Pregnancy|0|||
146820571|NCT00296504|529511261|FG005|Interim Analysis|Pregnancy|1|||
146820572|NCT00296504|529511262|FG006|Interim Analysis|Pregnancy|1|||
146820573|NCT00296504|529511263|FG007|Interim Analysis|Pregnancy|1|||
146820574|NCT00296504|529511264|FG008|Interim Analysis|Pregnancy|0|||
146820575|NCT00296504|529511256|FG000|Interim Analysis|Death|1|||
146820576|NCT00296504|529511257|FG001|Interim Analysis|Death|0|||
146820577|NCT00296504|529511258|FG002|Interim Analysis|Death|3|||
146820578|NCT00296504|529511259|FG003|Interim Analysis|Death|0|||
146820579|NCT00296504|529511260|FG004|Interim Analysis|Death|0|||
146820580|NCT00296504|529511261|FG005|Interim Analysis|Death|0|||
146820581|NCT00296504|529511262|FG006|Interim Analysis|Death|0|||
146820582|NCT00296504|529511263|FG007|Interim Analysis|Death|0|||
146820583|NCT00296504|529511264|FG008|Interim Analysis|Death|0|||
146820584|NCT00296504|529511256|FG000|Interim Analysis|Participant Non-compliant|0|||
146820585|NCT00296504|529511257|FG001|Interim Analysis|Participant Non-compliant|1|||
146820586|NCT00296504|529511258|FG002|Interim Analysis|Participant Non-compliant|2|||
146820587|NCT00296504|529511259|FG003|Interim Analysis|Participant Non-compliant|1|||
146820588|NCT00296504|529511260|FG004|Interim Analysis|Participant Non-compliant|1|||
146820589|NCT00296504|529511261|FG005|Interim Analysis|Participant Non-compliant|3|||
146820590|NCT00296504|529511262|FG006|Interim Analysis|Participant Non-compliant|6|||
146820591|NCT00296504|529511263|FG007|Interim Analysis|Participant Non-compliant|2|||
146820592|NCT00296504|529511264|FG008|Interim Analysis|Participant Non-compliant|0|||
146820593|NCT00296504|529511256|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
146820594|NCT00296504|529511257|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
146820595|NCT00296504|529511258|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
146820596|NCT00296504|529511259|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
146820597|NCT00296504|529511260|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
146820598|NCT00296504|529511261|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
146820599|NCT00296504|529511262|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
146820600|NCT00296504|529511263|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
146820601|NCT00296504|529511264|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
146820602|NCT00296504|529511256|FG000|Interim Analysis|To Simplify Treatment|0|||
146820603|NCT00296504|529511257|FG001|Interim Analysis|To Simplify Treatment|0|||
146820604|NCT00296504|529511258|FG002|Interim Analysis|To Simplify Treatment|1|||
146820605|NCT00296504|529511259|FG003|Interim Analysis|To Simplify Treatment|0|||
146820606|NCT00296504|529511260|FG004|Interim Analysis|To Simplify Treatment|0|||
146820607|NCT00296504|529511261|FG005|Interim Analysis|To Simplify Treatment|0|||
146820608|NCT00296504|529511262|FG006|Interim Analysis|To Simplify Treatment|2|||
146820609|NCT00296504|529511263|FG007|Interim Analysis|To Simplify Treatment|0|||
146820610|NCT00296504|529511264|FG008|Interim Analysis|To Simplify Treatment|0|||
146820611|NCT00296504|529511256|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
146820612|NCT00296504|529511257|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
146820613|NCT00296504|529511258|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
146820614|NCT00296504|529511259|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
146820615|NCT00296504|529511260|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
146820616|NCT00296504|529511261|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
146820617|NCT00296504|529511262|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
146820618|NCT00296504|529511263|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
146820619|NCT00296504|529511264|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
146820620|NCT00296504|529511256|FG000|Interim Analysis|Participant Moved|1|||
146820621|NCT00296504|529511257|FG001|Interim Analysis|Participant Moved|0|||
146820622|NCT00296504|529511258|FG002|Interim Analysis|Participant Moved|1|||
146820623|NCT00296504|529511259|FG003|Interim Analysis|Participant Moved|0|||
146820624|NCT00296504|529511260|FG004|Interim Analysis|Participant Moved|0|||
146820625|NCT00296504|529511261|FG005|Interim Analysis|Participant Moved|1|||
146820626|NCT00296504|529511262|FG006|Interim Analysis|Participant Moved|1|||
146820627|NCT00296504|529511263|FG007|Interim Analysis|Participant Moved|0|||
146820628|NCT00296504|529511264|FG008|Interim Analysis|Participant Moved|0|||
146820629|NCT00296504|529511256|FG000|Interim Analysis|Participant Was Incarcerated|2|||
146820630|NCT00296504|529511257|FG001|Interim Analysis|Participant Was Incarcerated|0|||
146820631|NCT00296504|529511258|FG002|Interim Analysis|Participant Was Incarcerated|1|||
146820632|NCT00296504|529511259|FG003|Interim Analysis|Participant Was Incarcerated|0|||
146820633|NCT00296504|529511260|FG004|Interim Analysis|Participant Was Incarcerated|0|||
146820634|NCT00296504|529511261|FG005|Interim Analysis|Participant Was Incarcerated|0|||
146820635|NCT00296504|529511262|FG006|Interim Analysis|Participant Was Incarcerated|0|||
146820636|NCT00296504|529511263|FG007|Interim Analysis|Participant Was Incarcerated|0|||
146820637|NCT00296504|529511264|FG008|Interim Analysis|Participant Was Incarcerated|0|||
146820638|NCT00296504|529511256|FG000|Interim Analysis|Resistance to FPV|0|||
146820639|NCT00296504|529511257|FG001|Interim Analysis|Resistance to FPV|0|||
146820640|NCT00296504|529511258|FG002|Interim Analysis|Resistance to FPV|1|||
146820641|NCT00296504|529511259|FG003|Interim Analysis|Resistance to FPV|0|||
146820642|NCT00296504|529511260|FG004|Interim Analysis|Resistance to FPV|0|||
146820643|NCT00296504|529511261|FG005|Interim Analysis|Resistance to FPV|0|||
146820644|NCT00296504|529511262|FG006|Interim Analysis|Resistance to FPV|0|||
146820645|NCT00296504|529511263|FG007|Interim Analysis|Resistance to FPV|0|||
146820646|NCT00296504|529511264|FG008|Interim Analysis|Resistance to FPV|0|||
146820647|NCT00296504|529511256|FG000|Interim Analysis|Physician Decision|0|||
146820648|NCT00296504|529511257|FG001|Interim Analysis|Physician Decision|0|||
146820649|NCT00296504|529511258|FG002|Interim Analysis|Physician Decision|1|||
146820650|NCT00296504|529511259|FG003|Interim Analysis|Physician Decision|0|||
146820651|NCT00296504|529511260|FG004|Interim Analysis|Physician Decision|0|||
146820652|NCT00296504|529511261|FG005|Interim Analysis|Physician Decision|0|||
146820653|NCT00296504|529511262|FG006|Interim Analysis|Physician Decision|0|||
146820654|NCT00296504|529511263|FG007|Interim Analysis|Physician Decision|0|||
146820655|NCT00296504|529511264|FG008|Interim Analysis|Physician Decision|0|||
146820656|NCT00296504|529511256|FG000|Interim Analysis|Principle Investigator Discretion|2|||
146820657|NCT00296504|529511257|FG001|Interim Analysis|Principle Investigator Discretion|0|||
146820658|NCT00296504|529511258|FG002|Interim Analysis|Principle Investigator Discretion|1|||
146820659|NCT00296504|529511259|FG003|Interim Analysis|Principle Investigator Discretion|1|||
146820660|NCT00296504|529511260|FG004|Interim Analysis|Principle Investigator Discretion|0|||
146820661|NCT00296504|529511261|FG005|Interim Analysis|Principle Investigator Discretion|0|||
146820662|NCT00296504|529511262|FG006|Interim Analysis|Principle Investigator Discretion|0|||
146820663|NCT00296504|529511263|FG007|Interim Analysis|Principle Investigator Discretion|0|||
146820664|NCT00296504|529511264|FG008|Interim Analysis|Principle Investigator Discretion|0|||
146820665|NCT00296504|529511256|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
146820666|NCT00296504|529511257|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
146820667|NCT00296504|529511258|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
146820668|NCT00296504|529511259|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
146820669|NCT00296504|529511260|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
146820670|NCT00296504|529511261|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
146820671|NCT00296504|529511262|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
146820672|NCT00296504|529511263|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
146820673|NCT00296504|529511264|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
146820674|NCT00296504|529511256|FG000|Interim Analysis|Non-adherence|2|||
146951046|NCT01004861|529979907|FG006|Overall Study|Disease progression|5|||
146820675|NCT00296504|529511257|FG001|Interim Analysis|Non-adherence|0|||
146820676|NCT00296504|529511258|FG002|Interim Analysis|Non-adherence|0|||
146820677|NCT00296504|529511259|FG003|Interim Analysis|Non-adherence|0|||
146820678|NCT00296504|529511260|FG004|Interim Analysis|Non-adherence|1|||
146820679|NCT00296504|529511261|FG005|Interim Analysis|Non-adherence|0|||
146820680|NCT00296504|529511262|FG006|Interim Analysis|Non-adherence|0|||
146820681|NCT00296504|529511263|FG007|Interim Analysis|Non-adherence|1|||
146820682|NCT00296504|529511264|FG008|Interim Analysis|Non-adherence|0|||
146820683|NCT00296504|529511256|FG000|Interim Analysis|Site Closing|1|||
146820684|NCT00296504|529511257|FG001|Interim Analysis|Site Closing|0|||
146820685|NCT00296504|529511258|FG002|Interim Analysis|Site Closing|0|||
146820686|NCT00296504|529511259|FG003|Interim Analysis|Site Closing|0|||
146820687|NCT00296504|529511260|FG004|Interim Analysis|Site Closing|0|||
146820688|NCT00296504|529511261|FG005|Interim Analysis|Site Closing|1|||
146820689|NCT00296504|529511262|FG006|Interim Analysis|Site Closing|2|||
146820690|NCT00296504|529511263|FG007|Interim Analysis|Site Closing|0|||
146820691|NCT00296504|529511264|FG008|Interim Analysis|Site Closing|0|||
146820692|NCT00296504|529511256|FG000|Interim Analysis|Lack of Personnel at Site|1|||
146820693|NCT00296504|529511257|FG001|Interim Analysis|Lack of Personnel at Site|0|||
146820694|NCT00296504|529511258|FG002|Interim Analysis|Lack of Personnel at Site|0|||
146820695|NCT00296504|529511259|FG003|Interim Analysis|Lack of Personnel at Site|0|||
146820696|NCT00296504|529511260|FG004|Interim Analysis|Lack of Personnel at Site|0|||
146820697|NCT00296504|529511261|FG005|Interim Analysis|Lack of Personnel at Site|0|||
146820698|NCT00296504|529511262|FG006|Interim Analysis|Lack of Personnel at Site|0|||
146820699|NCT00296504|529511263|FG007|Interim Analysis|Lack of Personnel at Site|0|||
146820700|NCT00296504|529511264|FG008|Interim Analysis|Lack of Personnel at Site|0|||
146820701|NCT00296504|529511256|FG000|Interim Analysis|Missed Schedule Date|1|||
146820702|NCT00296504|529511257|FG001|Interim Analysis|Missed Schedule Date|0|||
146820703|NCT00296504|529511258|FG002|Interim Analysis|Missed Schedule Date|0|||
146820704|NCT00296504|529511259|FG003|Interim Analysis|Missed Schedule Date|0|||
146820705|NCT00296504|529511260|FG004|Interim Analysis|Missed Schedule Date|0|||
146820706|NCT00296504|529511261|FG005|Interim Analysis|Missed Schedule Date|0|||
146820707|NCT00296504|529511262|FG006|Interim Analysis|Missed Schedule Date|0|||
146820708|NCT00296504|529511263|FG007|Interim Analysis|Missed Schedule Date|0|||
146820709|NCT00296504|529511264|FG008|Interim Analysis|Missed Schedule Date|0|||
146820710|NCT00296504|529511256|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
146820711|NCT00296504|529511257|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
146820712|NCT00296504|529511258|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
146820713|NCT00296504|529511259|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
146820714|NCT00296504|529511260|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
146820715|NCT00296504|529511261|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
146820716|NCT00296504|529511262|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
146820717|NCT00296504|529511263|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
146820718|NCT00296504|529511264|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
146820719|NCT00296504|529511256|FG000|Interim Analysis|Participant Stopped|0|||
146820720|NCT00296504|529511257|FG001|Interim Analysis|Participant Stopped|0|||
146820721|NCT00296504|529511258|FG002|Interim Analysis|Participant Stopped|0|||
146820722|NCT00296504|529511259|FG003|Interim Analysis|Participant Stopped|0|||
146820723|NCT00296504|529511260|FG004|Interim Analysis|Participant Stopped|1|||
146820724|NCT00296504|529511261|FG005|Interim Analysis|Participant Stopped|0|||
146820725|NCT00296504|529511262|FG006|Interim Analysis|Participant Stopped|0|||
146820726|NCT00296504|529511263|FG007|Interim Analysis|Participant Stopped|0|||
146820727|NCT00296504|529511264|FG008|Interim Analysis|Participant Stopped|0|||
146820728|NCT00296504|529511256|FG000|Interim Analysis|Physician and Participant Decision|0|||
146820729|NCT00296504|529511257|FG001|Interim Analysis|Physician and Participant Decision|0|||
146820730|NCT00296504|529511258|FG002|Interim Analysis|Physician and Participant Decision|0|||
146820731|NCT00296504|529511259|FG003|Interim Analysis|Physician and Participant Decision|0|||
146820732|NCT00296504|529511260|FG004|Interim Analysis|Physician and Participant Decision|0|||
146820733|NCT00296504|529511261|FG005|Interim Analysis|Physician and Participant Decision|1|||
146820734|NCT00296504|529511262|FG006|Interim Analysis|Physician and Participant Decision|0|||
146820735|NCT00296504|529511263|FG007|Interim Analysis|Physician and Participant Decision|0|||
146820736|NCT00296504|529511264|FG008|Interim Analysis|Physician and Participant Decision|0|||
146820737|NCT00296504|529511256|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
146820738|NCT00296504|529511257|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
146820739|NCT00296504|529511258|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
146820740|NCT00296504|529511259|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
146820741|NCT00296504|529511260|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
146820742|NCT00296504|529511261|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
146820743|NCT00296504|529511262|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
146820744|NCT00296504|529511263|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
146820745|NCT00296504|529511264|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
146820746|NCT00296504|529511256|FG000|Interim Analysis|Study Ended|0|||
146820747|NCT00296504|529511257|FG001|Interim Analysis|Study Ended|0|||
146820748|NCT00296504|529511258|FG002|Interim Analysis|Study Ended|0|||
146820749|NCT00296504|529511259|FG003|Interim Analysis|Study Ended|0|||
146820750|NCT00296504|529511260|FG004|Interim Analysis|Study Ended|0|||
146820751|NCT00296504|529511261|FG005|Interim Analysis|Study Ended|0|||
146820752|NCT00296504|529511262|FG006|Interim Analysis|Study Ended|1|||
146820753|NCT00296504|529511263|FG007|Interim Analysis|Study Ended|0|||
146820754|NCT00296504|529511264|FG008|Interim Analysis|Study Ended|0|||
146820755|NCT00296504|529511256|FG000|Interim Analysis|Participant Needed Interferon|0|||
146820756|NCT00296504|529511257|FG001|Interim Analysis|Participant Needed Interferon|0|||
146820757|NCT00296504|529511258|FG002|Interim Analysis|Participant Needed Interferon|0|||
146820758|NCT00296504|529511259|FG003|Interim Analysis|Participant Needed Interferon|0|||
146820759|NCT00296504|529511260|FG004|Interim Analysis|Participant Needed Interferon|0|||
146820760|NCT00296504|529511261|FG005|Interim Analysis|Participant Needed Interferon|0|||
146820761|NCT00296504|529511262|FG006|Interim Analysis|Participant Needed Interferon|0|||
146820762|NCT00296504|529511263|FG007|Interim Analysis|Participant Needed Interferon|1|||
146820763|NCT00296504|529511264|FG008|Interim Analysis|Participant Needed Interferon|0|||
146820764|NCT00296504|529511256|FG000|Interim Analysis|Ongoing|32|||
146820765|NCT00296504|529511257|FG001|Interim Analysis|Ongoing|12|||
146820766|NCT00296504|529511258|FG002|Interim Analysis|Ongoing|16|||
146820767|NCT00296504|529511259|FG003|Interim Analysis|Ongoing|22|||
146820768|NCT00296504|529511260|FG004|Interim Analysis|Ongoing|0|||
146820769|NCT00296504|529511261|FG005|Interim Analysis|Ongoing|0|||
146820770|NCT00296504|529511262|FG006|Interim Analysis|Ongoing|30|||
146820771|NCT00296504|529511263|FG007|Interim Analysis|Ongoing|1|||
146820772|NCT00296504|529511264|FG008|Interim Analysis|Ongoing|0|||
146820773|NCT00296504|529511256|FG000|Final Analysis|Withdrawal by Subject|0|||
146820774|NCT00296504|529511257|FG001|Final Analysis|Withdrawal by Subject|0|||
146820775|NCT00296504|529511258|FG002|Final Analysis|Withdrawal by Subject|0|||
146820776|NCT00296504|529511259|FG003|Final Analysis|Withdrawal by Subject|0|||
146820777|NCT00296504|529511260|FG004|Final Analysis|Withdrawal by Subject|0|||
146820778|NCT00296504|529511261|FG005|Final Analysis|Withdrawal by Subject|0|||
146820779|NCT00296504|529511262|FG006|Final Analysis|Withdrawal by Subject|0|||
146820780|NCT00296504|529511263|FG007|Final Analysis|Withdrawal by Subject|0|||
146820781|NCT00296504|529511264|FG008|Final Analysis|Withdrawal by Subject|1|||
146820782|NCT00296504|529511256|FG000|Final Analysis|Lost to Follow-up|0|||
146820783|NCT00296504|529511257|FG001|Final Analysis|Lost to Follow-up|0|||
146820784|NCT00296504|529511258|FG002|Final Analysis|Lost to Follow-up|0|||
146820785|NCT00296504|529511259|FG003|Final Analysis|Lost to Follow-up|0|||
146820786|NCT00296504|529511260|FG004|Final Analysis|Lost to Follow-up|0|||
146820787|NCT00296504|529511261|FG005|Final Analysis|Lost to Follow-up|0|||
146820788|NCT00296504|529511262|FG006|Final Analysis|Lost to Follow-up|0|||
146820789|NCT00296504|529511263|FG007|Final Analysis|Lost to Follow-up|0|||
146820790|NCT00296504|529511264|FG008|Final Analysis|Lost to Follow-up|5|||
146820791|NCT00296504|529511256|FG000|Final Analysis|Insufficient Viral Load Response|0|||
146820792|NCT00296504|529511257|FG001|Final Analysis|Insufficient Viral Load Response|0|||
146820793|NCT00296504|529511258|FG002|Final Analysis|Insufficient Viral Load Response|0|||
146820794|NCT00296504|529511259|FG003|Final Analysis|Insufficient Viral Load Response|0|||
146820795|NCT00296504|529511260|FG004|Final Analysis|Insufficient Viral Load Response|0|||
146820796|NCT00296504|529511261|FG005|Final Analysis|Insufficient Viral Load Response|0|||
146820797|NCT00296504|529511262|FG006|Final Analysis|Insufficient Viral Load Response|0|||
146820798|NCT00296504|529511263|FG007|Final Analysis|Insufficient Viral Load Response|0|||
146820799|NCT00296504|529511264|FG008|Final Analysis|Insufficient Viral Load Response|6|||
146820800|NCT00296504|529511256|FG000|Final Analysis|Adverse Event|0|||
146820801|NCT00296504|529511257|FG001|Final Analysis|Adverse Event|0|||
146820802|NCT00296504|529511258|FG002|Final Analysis|Adverse Event|0|||
146820803|NCT00296504|529511259|FG003|Final Analysis|Adverse Event|0|||
146820804|NCT00296504|529511260|FG004|Final Analysis|Adverse Event|0|||
146820805|NCT00296504|529511261|FG005|Final Analysis|Adverse Event|0|||
146820806|NCT00296504|529511262|FG006|Final Analysis|Adverse Event|0|||
146820807|NCT00296504|529511263|FG007|Final Analysis|Adverse Event|0|||
146820808|NCT00296504|529511264|FG008|Final Analysis|Adverse Event|2|||
146820809|NCT00296504|529511256|FG000|Final Analysis|Pregnancy|0|||
146820810|NCT00296504|529511257|FG001|Final Analysis|Pregnancy|0|||
146820811|NCT00296504|529511258|FG002|Final Analysis|Pregnancy|0|||
146820812|NCT00296504|529511259|FG003|Final Analysis|Pregnancy|0|||
146820813|NCT00296504|529511260|FG004|Final Analysis|Pregnancy|0|||
146820814|NCT00296504|529511261|FG005|Final Analysis|Pregnancy|0|||
146820815|NCT00296504|529511262|FG006|Final Analysis|Pregnancy|0|||
146820816|NCT00296504|529511263|FG007|Final Analysis|Pregnancy|0|||
146820817|NCT00296504|529511264|FG008|Final Analysis|Pregnancy|4|||
146820818|NCT00296504|529511256|FG000|Final Analysis|Tuberculosis|0|||
146820819|NCT00296504|529511257|FG001|Final Analysis|Tuberculosis|0|||
146820820|NCT00296504|529511258|FG002|Final Analysis|Tuberculosis|0|||
146820821|NCT00296504|529511259|FG003|Final Analysis|Tuberculosis|0|||
146820822|NCT00296504|529511260|FG004|Final Analysis|Tuberculosis|0|||
146820823|NCT00296504|529511261|FG005|Final Analysis|Tuberculosis|0|||
146820824|NCT00296504|529511262|FG006|Final Analysis|Tuberculosis|0|||
146820825|NCT00296504|529511263|FG007|Final Analysis|Tuberculosis|0|||
146820826|NCT00296504|529511264|FG008|Final Analysis|Tuberculosis|1|||
146820827|NCT00296504|529511256|FG000|Final Analysis|Participant Moved to Another Country|0|||
146820828|NCT00296504|529511257|FG001|Final Analysis|Participant Moved to Another Country|0|||
146820829|NCT00296504|529511258|FG002|Final Analysis|Participant Moved to Another Country|0|||
146820830|NCT00296504|529511259|FG003|Final Analysis|Participant Moved to Another Country|0|||
146820831|NCT00296504|529511260|FG004|Final Analysis|Participant Moved to Another Country|0|||
146820832|NCT00296504|529511261|FG005|Final Analysis|Participant Moved to Another Country|0|||
146820833|NCT00296504|529511262|FG006|Final Analysis|Participant Moved to Another Country|0|||
146820834|NCT00296504|529511263|FG007|Final Analysis|Participant Moved to Another Country|0|||
146820835|NCT00296504|529511264|FG008|Final Analysis|Participant Moved to Another Country|1|||
146820836|NCT00296504|529511256|FG000|Final Analysis|Poor Adherence|0|||
146820837|NCT00296504|529511257|FG001|Final Analysis|Poor Adherence|0|||
146820838|NCT00296504|529511258|FG002|Final Analysis|Poor Adherence|0|||
146820839|NCT00296504|529511259|FG003|Final Analysis|Poor Adherence|0|||
146820840|NCT00296504|529511260|FG004|Final Analysis|Poor Adherence|0|||
146820841|NCT00296504|529511261|FG005|Final Analysis|Poor Adherence|0|||
146820842|NCT00296504|529511262|FG006|Final Analysis|Poor Adherence|0|||
146820843|NCT00296504|529511263|FG007|Final Analysis|Poor Adherence|0|||
146820844|NCT00296504|529511264|FG008|Final Analysis|Poor Adherence|1|||
146820845|NCT01078571|529511265|FG000|Overall Study|Adverse Event|36|||
146820846|NCT01078571|529511265|FG000|Overall Study|Lack of effectiveness|36|||
146820847|NCT01078571|529511265|FG000|Overall Study|Reason not reported|21|||
146820848|NCT01078571|529511265|FG000|Overall Study|Withdrawal by Subject|12|||
146820849|NCT01078571|529511265|FG000|Overall Study|Lost to Follow-up|8|||
146820850|NCT01078571|529511265|FG000|Overall Study|Protocol Violation|2|||
146820851|NCT01047306|529511268|FG000|Overall Study|Withdrawal by Subject|2|||
146820852|NCT01047306|529511269|FG001|Overall Study|Withdrawal by Subject|0|||
146820853|NCT01047306|529511268|FG000|Overall Study|Lost to Follow-up|1|||
146820854|NCT01047306|529511269|FG001|Overall Study|Lost to Follow-up|0|||
146820855|NCT01878253|529511270|FG000|Overall Study|Death|1|||
146820856|NCT01878253|529511270|FG000|Overall Study|SIdus System Removal|3|||
146820857|NCT01878253|529511270|FG000|Overall Study|Withdrawal by Subject|1|||
146820858|NCT01878253|529511270|FG000|Overall Study|Lost to Follow-up|2|||
146820859|NCT01878253|529511270|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
146820860|NCT03647709|529511275|FG000|Overall Study|Lost to Follow-up|5|||
146820861|NCT03647709|529511275|FG000|Overall Study|Physician Decision|6|||
146820862|NCT03647709|529511275|FG000|Overall Study|Withdrawal by Subject|3|||
146820863|NCT04393779|529511278|FG000|Overall Study|Death|1|||
146820864|NCT04393779|529511278|FG000|Overall Study|Device reintervention or explant|4|||
146820865|NCT00274846|529511279|FG000|Overall Study|Did not receive adequate NK cells|1|||
146820866|NCT01395914|529511282|FG000|Overall Study|Unrelated to study drug AE|6|||
146820867|NCT01395914|529511283|FG001|Overall Study|Unrelated to study drug AE|1|||
146820868|NCT01395914|529511282|FG000|Overall Study|Death|23|||
146820869|NCT01395914|529511283|FG001|Overall Study|Death|17|||
146820870|NCT01395914|529511282|FG000|Overall Study|Other|9|||
146820871|NCT01395914|529511283|FG001|Overall Study|Other|3|||
146820872|NCT01395914|529511282|FG000|Overall Study|Withdrawal by patient|27|||
146820873|NCT01395914|529511283|FG001|Overall Study|Withdrawal by patient|14|||
146820874|NCT01395914|529511282|FG000|Overall Study|Study drug-related AE|1|||
146820875|NCT01395914|529511283|FG001|Overall Study|Study drug-related AE|0|||
146820876|NCT01395914|529511282|FG000|Overall Study|Lost to Follow-up|6|||
146820877|NCT01395914|529511283|FG001|Overall Study|Lost to Follow-up|2|||
146820878|NCT01920178|529511284|FG000|Overall Study|Lost to Follow-up|2|||
146820879|NCT01920178|529511285|FG001|Overall Study|Lost to Follow-up|1|||
146820880|NCT03023878|529511286|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
146820881|NCT03023878|529511286|FG000|Pre-Study Run-In Period|Death|1|||
146820882|NCT03023878|529511286|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
146820883|NCT03023878|529511286|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
146820884|NCT03023878|529511286|FG000|Treatment Period|Disease Progression|1|||
146820885|NCT03023878|529511286|FG000|Treatment Period|Withdrawal by Subject|1|||
146820886|NCT03023878|529511286|FG000|Treatment Period|Adverse Event|1|||
146820887|NCT03023878|529511286|FG000|Long Term Follow-Up Period|Death|2|||
146820888|NCT02849509|529511287|FG000|Overall Study|Worsening of disease under study|1|||
146820889|NCT02849509|529511288|FG001|Overall Study|Worsening of disease under study|1|||
146820890|NCT02849509|529511289|FG002|Overall Study|Worsening of disease under study|1|||
146820891|NCT02849509|529511287|FG000|Overall Study|Worsening of other pre-existing disease|0|||
146820892|NCT02849509|529511288|FG001|Overall Study|Worsening of other pre-existing disease|1|||
146820893|NCT02849509|529511289|FG002|Overall Study|Worsening of other pre-existing disease|2|||
146820894|NCT02849509|529511287|FG000|Overall Study|Other adverse event|36|||
146820895|NCT02849509|529511288|FG001|Overall Study|Other adverse event|41|||
146820896|NCT02849509|529511289|FG002|Overall Study|Other adverse event|8|||
146820897|NCT02849509|529511287|FG000|Overall Study|Withdrawal by Subject|6|||
146820898|NCT02849509|529511288|FG001|Overall Study|Withdrawal by Subject|17|||
146820899|NCT02849509|529511289|FG002|Overall Study|Withdrawal by Subject|12|||
146820900|NCT02849509|529511287|FG000|Overall Study|Lost to Follow-up|27|||
146820901|NCT02849509|529511288|FG001|Overall Study|Lost to Follow-up|67|||
146820902|NCT02849509|529511289|FG002|Overall Study|Lost to Follow-up|36|||
146820903|NCT02849509|529511287|FG000|Overall Study|Other, reason not specified|14|||
146820904|NCT02849509|529511288|FG001|Overall Study|Other, reason not specified|29|||
146820905|NCT02849509|529511289|FG002|Overall Study|Other, reason not specified|25|||
146820906|NCT02849509|529511287|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
146820907|NCT02849509|529511288|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
146820908|NCT02849509|529511289|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
146820909|NCT02374476|529511291|FG000|VT Induced Ablation|Screening Failures|36|||
146820910|NCT02374476|529511292|FG001|VT Induced Ablation|Screening Failures|0|||
146820911|NCT02374476|529511293|FG002|VT Induced Ablation|Screening Failures|0|||
146820912|NCT02374476|529511291|FG000|Arm Assignment|Withdrawal by Subject|0|||
146820913|NCT02374476|529511292|FG001|Arm Assignment|Withdrawal by Subject|0|||
146820914|NCT02374476|529511293|FG002|Arm Assignment|Withdrawal by Subject|1|||
146820915|NCT05431543|529511294|FG000|Overall Study|Medical History|1|||
146820916|NCT05431543|529511295|FG001|Overall Study|Medical History|0|||
146820917|NCT05431543|529511296|FG002|Overall Study|Medical History|0|||
146820918|NCT01945086|529511299|FG000|Overall Study|Withdrawal by Subject|1|||
146820919|NCT01945086|529511300|FG001|Overall Study|Withdrawal by Subject|0|||
146820920|NCT01945086|529511301|FG002|Overall Study|Withdrawal by Subject|1|||
146820921|NCT01945086|529511299|FG000|Overall Study|Adverse Event|0|||
146820922|NCT01945086|529511300|FG001|Overall Study|Adverse Event|0|||
146820923|NCT01945086|529511301|FG002|Overall Study|Adverse Event|1|||
146820924|NCT04853394|529511305|FG000|Follow-up Interviews|Lost to Follow-up|22|||
146820925|NCT04853394|529511306|FG001|Follow-up Interviews|Lost to Follow-up|15|||
146820926|NCT00748098|529511307|FG000|First Treatment Intervention Period|Adverse Event|1|||
146820927|NCT00748098|529511308|FG001|First Treatment Intervention Period|Adverse Event|1|||
146820928|NCT00748098|529511307|FG000|First Treatment Intervention Period|Protocol Violation|1|||
146820929|NCT00748098|529511308|FG001|First Treatment Intervention Period|Protocol Violation|0|||
146820930|NCT00748098|529511307|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
146820931|NCT00748098|529511308|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
146820932|NCT00748098|529511307|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
146820933|NCT00748098|529511308|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
146820934|NCT00748098|529511307|FG000|First Taper Period|Protocol Violation|1|||
146820935|NCT00748098|529511308|FG001|First Taper Period|Protocol Violation|0|||
146820936|NCT00748098|529511307|FG000|First Taper Period|Withdrawal by Subject|2|||
146820937|NCT00748098|529511308|FG001|First Taper Period|Withdrawal by Subject|0|||
146820938|NCT00748098|529511307|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
146820939|NCT00748098|529511308|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
146820940|NCT00748098|529511307|FG000|1-Week Washout Period|Adverse Event|0|||
146820941|NCT00748098|529511308|FG001|1-Week Washout Period|Adverse Event|1|||
146820942|NCT00748098|529511307|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
146820943|NCT00748098|529511308|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
146820944|NCT00748098|529511307|FG000|Second Treatment Intervention Period|Adverse Event|4|||
146820945|NCT00748098|529511308|FG001|Second Treatment Intervention Period|Adverse Event|1|||
146820946|NCT00748098|529511307|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
146820947|NCT00748098|529511308|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
146820948|NCT00748098|529511307|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
146820949|NCT00748098|529511308|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
146820950|NCT04212299|529511309|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
146820951|NCT00088452|529513018|FG000|Overall Study|Did not receive intervention|1|||
146820952|NCT00088452|529513019|FG001|Overall Study|Did not receive intervention|0|||
146820953|NCT00088452|529513020|FG002|Overall Study|Did not receive intervention|1|||
146820954|NCT04044352|529513026|FG000|Overall Study|Lost to Follow-up|9|||
146820955|NCT04044352|529513026|FG000|Overall Study|Withdrawal by Subject|2|||
146820956|NCT02176356|529513028|FG000|Overall Study|Screen Failure|14|||
146820957|NCT02176356|529513028|FG000|Overall Study|Lost to Follow-up|4|||
146820958|NCT02176356|529513028|FG000|Overall Study|Personal Reasons|3|||
146820959|NCT02176356|529513028|FG000|Overall Study|Other Miscellaneous Reasons|2|||
146820960|NCT02706834|529513029|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
146820961|NCT02706834|529513030|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
146820962|NCT02706834|529513031|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
146820963|NCT02706834|529513032|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
146820964|NCT02706834|529513033|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
146820965|NCT02706834|529513034|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
146820966|NCT02706834|529513035|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
146820967|NCT02706834|529513036|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
146820968|NCT02706834|529513037|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
146820969|NCT02706834|529513038|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
146820970|NCT02706834|529513039|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
146820971|NCT02706834|529513029|FG000|Overall Study|Lost to Follow-up|0|||
146820972|NCT02706834|529513030|FG001|Overall Study|Lost to Follow-up|0|||
146820973|NCT02706834|529513031|FG002|Overall Study|Lost to Follow-up|1|||
146820974|NCT02706834|529513032|FG003|Overall Study|Lost to Follow-up|0|||
146820975|NCT02706834|529513033|FG004|Overall Study|Lost to Follow-up|0|||
146820976|NCT02706834|529513034|FG005|Overall Study|Lost to Follow-up|0|||
146820977|NCT02706834|529513035|FG006|Overall Study|Lost to Follow-up|0|||
146820978|NCT02706834|529513036|FG007|Overall Study|Lost to Follow-up|0|||
146820979|NCT02706834|529513037|FG008|Overall Study|Lost to Follow-up|0|||
146951047|NCT01004861|529979908|FG007|Overall Study|Disease progression|1|||
146951048|NCT01004861|529979909|FG008|Overall Study|Disease progression|4|||
146951049|NCT01004861|529979910|FG009|Overall Study|Disease progression|7|||
146820980|NCT02706834|529513038|FG009|Overall Study|Lost to Follow-up|0|||
146820981|NCT02706834|529513039|FG010|Overall Study|Lost to Follow-up|0|||
146820982|NCT02706834|529513029|FG000|Overall Study|Voluntary Withdrawal|1|||
146820983|NCT02706834|529513030|FG001|Overall Study|Voluntary Withdrawal|0|||
146820984|NCT02706834|529513031|FG002|Overall Study|Voluntary Withdrawal|0|||
146820985|NCT02706834|529513032|FG003|Overall Study|Voluntary Withdrawal|0|||
146820986|NCT02706834|529513033|FG004|Overall Study|Voluntary Withdrawal|0|||
146984794|NCT02669264|530105174|FG000|Overall Study|Withdrawal by Subject|0|||
146984795|NCT02669264|530105175|FG001|Overall Study|Withdrawal by Subject|1|||
146984796|NCT02669264|530105176|FG002|Overall Study|Withdrawal by Subject|0|||
146984797|NCT02669264|530105177|FG003|Overall Study|Withdrawal by Subject|0|||
146984798|NCT02669264|530105178|FG004|Overall Study|Withdrawal by Subject|1|||
146984799|NCT02669264|530105179|FG005|Overall Study|Withdrawal by Subject|0|||
146984800|NCT02669264|530105180|FG006|Overall Study|Withdrawal by Subject|0|||
146984801|NCT02669264|530105174|FG000|Overall Study|Lost to Follow-up|0|||
146984802|NCT02669264|530105175|FG001|Overall Study|Lost to Follow-up|0|||
146984803|NCT02669264|530105176|FG002|Overall Study|Lost to Follow-up|0|||
146984804|NCT02669264|530105177|FG003|Overall Study|Lost to Follow-up|0|||
146984805|NCT02669264|530105178|FG004|Overall Study|Lost to Follow-up|1|||
146820987|NCT02706834|529513034|FG005|Overall Study|Voluntary Withdrawal|0|||
146820988|NCT02706834|529513035|FG006|Overall Study|Voluntary Withdrawal|0|||
146820989|NCT02706834|529513036|FG007|Overall Study|Voluntary Withdrawal|0|||
146820990|NCT02706834|529513037|FG008|Overall Study|Voluntary Withdrawal|0|||
146820991|NCT02706834|529513038|FG009|Overall Study|Voluntary Withdrawal|1|||
146820992|NCT02706834|529513039|FG010|Overall Study|Voluntary Withdrawal|0|||
146820993|NCT02706834|529513029|FG000|Overall Study|Other Reason Not Specified|1|||
146820994|NCT02706834|529513030|FG001|Overall Study|Other Reason Not Specified|0|||
146820995|NCT02706834|529513031|FG002|Overall Study|Other Reason Not Specified|0|||
146820996|NCT02706834|529513032|FG003|Overall Study|Other Reason Not Specified|0|||
146820997|NCT02706834|529513033|FG004|Overall Study|Other Reason Not Specified|1|||
146820998|NCT02706834|529513034|FG005|Overall Study|Other Reason Not Specified|0|||
146820999|NCT02706834|529513035|FG006|Overall Study|Other Reason Not Specified|0|||
146821000|NCT02706834|529513036|FG007|Overall Study|Other Reason Not Specified|0|||
146821001|NCT02706834|529513037|FG008|Overall Study|Other Reason Not Specified|0|||
146821002|NCT02706834|529513038|FG009|Overall Study|Other Reason Not Specified|0|||
146821003|NCT02706834|529513039|FG010|Overall Study|Other Reason Not Specified|0|||
146821004|NCT00730925|529513043|FG000|Overall Study|Progressive Disease|21|||
146821005|NCT00730925|529513043|FG000|Overall Study|Dose reducing Event|2|||
146821006|NCT00730925|529513043|FG000|Overall Study|Other Averse Event|7|||
146821007|NCT00730925|529513043|FG000|Overall Study|Protocol Violation|1|||
146821008|NCT00730925|529513043|FG000|Overall Study|Withdrawal by Subject|1|||
146821009|NCT00730925|529513043|FG000|Overall Study|Switch to combination therapy|8|||
146821010|NCT00730925|529513043|FG000|Overall Study|Other|1|||
146821011|NCT02131155|529513049|FG000|Overall Study|Adverse Event|1|||
146951050|NCT01004861|529979911|FG010|Overall Study|Disease progression|6|||
146951051|NCT01004861|529979912|FG011|Overall Study|Disease progression|3|||
146951052|NCT01004861|529979913|FG012|Overall Study|Disease progression|8|||
146951053|NCT01004861|529979901|FG000|Overall Study|Physician Decision|0|||
146951054|NCT01004861|529979902|FG001|Overall Study|Physician Decision|2|||
146951055|NCT01004861|529979903|FG002|Overall Study|Physician Decision|1|||
146951056|NCT01004861|529979904|FG003|Overall Study|Physician Decision|1|||
146951057|NCT01004861|529979905|FG004|Overall Study|Physician Decision|1|||
146951058|NCT01004861|529979906|FG005|Overall Study|Physician Decision|0|||
146951059|NCT01004861|529979907|FG006|Overall Study|Physician Decision|0|||
146951060|NCT01004861|529979908|FG007|Overall Study|Physician Decision|1|||
146951061|NCT01004861|529979909|FG008|Overall Study|Physician Decision|0|||
146951062|NCT01004861|529979910|FG009|Overall Study|Physician Decision|0|||
146951063|NCT01004861|529979911|FG010|Overall Study|Physician Decision|0|||
146951064|NCT01004861|529979912|FG011|Overall Study|Physician Decision|0|||
146951065|NCT01004861|529979913|FG012|Overall Study|Physician Decision|3|||
146951066|NCT01004861|529979901|FG000|Overall Study|Adverse Event|0|||
146951067|NCT01004861|529979902|FG001|Overall Study|Adverse Event|0|||
146951068|NCT01004861|529979903|FG002|Overall Study|Adverse Event|0|||
146951069|NCT01004861|529979904|FG003|Overall Study|Adverse Event|1|||
146951070|NCT01004861|529979905|FG004|Overall Study|Adverse Event|0|||
146951071|NCT01004861|529979906|FG005|Overall Study|Adverse Event|2|||
146951072|NCT01004861|529979907|FG006|Overall Study|Adverse Event|1|||
146951073|NCT01004861|529979908|FG007|Overall Study|Adverse Event|1|||
146951074|NCT01004861|529979909|FG008|Overall Study|Adverse Event|13|||
146951075|NCT01004861|529979910|FG009|Overall Study|Adverse Event|1|||
146951076|NCT01004861|529979911|FG010|Overall Study|Adverse Event|1|||
146821012|NCT02131155|529513050|FG001|Overall Study|Adverse Event|0|||
146821013|NCT02131155|529513049|FG000|Overall Study|Treatment completed|1|||
146821014|NCT02131155|529513050|FG001|Overall Study|Treatment completed|0|||
146821015|NCT02131155|529513049|FG000|Overall Study|Primary tumour recurrence|2|||
146951077|NCT01004861|529979912|FG011|Overall Study|Adverse Event|0|||
146951078|NCT01004861|529979913|FG012|Overall Study|Adverse Event|2|||
146951079|NCT01004861|529979901|FG000|Overall Study|Protocol Violation|0|||
146821016|NCT02131155|529513050|FG001|Overall Study|Primary tumour recurrence|1|||
146951080|NCT01004861|529979902|FG001|Overall Study|Protocol Violation|0|||
146951081|NCT01004861|529979903|FG002|Overall Study|Protocol Violation|0|||
146951082|NCT01004861|529979904|FG003|Overall Study|Protocol Violation|0|||
146951083|NCT01004861|529979905|FG004|Overall Study|Protocol Violation|1|||
146951084|NCT01004861|529979906|FG005|Overall Study|Protocol Violation|0|||
146984806|NCT02669264|530105179|FG005|Overall Study|Lost to Follow-up|0|||
146984807|NCT02669264|530105180|FG006|Overall Study|Lost to Follow-up|0|||
146821017|NCT02131155|529513049|FG000|Overall Study|Refused to continue study medication|1|||
146821018|NCT02131155|529513050|FG001|Overall Study|Refused to continue study medication|0|||
146821019|NCT02131155|529513049|FG000|Overall Study|Study early termination|20|||
146821020|NCT02131155|529513050|FG001|Overall Study|Study early termination|10|||
146821021|NCT01887418|529513053|FG000|Overall Study|Travelling difficulties|0|||
146821022|NCT01887418|529513054|FG001|Overall Study|Travelling difficulties|0|||
146821023|NCT01887418|529513055|FG002|Overall Study|Travelling difficulties|1|||
146821024|NCT03132753|529513056|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
146821025|NCT03132753|529513057|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
146821026|NCT03132753|529513056|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
146821027|NCT03132753|529513057|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
146821028|NCT00084747|529513058|FG000|Overall Study|Relapsed|8|||
146821029|NCT00084747|529513058|FG000|Overall Study|Death|3|||
146821030|NCT00084747|529513058|FG000|Overall Study|Withdrawal by Subject|2|||
146821031|NCT02744898|529513060|FG000|Overall Study|Progressive Disease|2|||
146821032|NCT02744898|529513060|FG000|Overall Study|Physician Decision|1|||
146821033|NCT02744898|529513060|FG000|Overall Study|Toxicity|1|||
146821034|NCT03751280|529513062|FG000|Overall Study|Adverse Event|0|||
146821035|NCT03751280|529513063|FG001|Overall Study|Adverse Event|1|||
146821036|NCT03751280|529513062|FG000|Overall Study|Lost to Follow-up|3|||
146821037|NCT03751280|529513063|FG001|Overall Study|Lost to Follow-up|5|||
146821038|NCT03751280|529513062|FG000|Overall Study|Physician Decision|0|||
146821039|NCT03751280|529513063|FG001|Overall Study|Physician Decision|2|||
146821040|NCT03751280|529513062|FG000|Overall Study|Protocol Violation|0|||
146821041|NCT03751280|529513063|FG001|Overall Study|Protocol Violation|2|||
146821042|NCT03751280|529513062|FG000|Overall Study|Withdrawal by Subject|5|||
146821043|NCT03751280|529513063|FG001|Overall Study|Withdrawal by Subject|2|||
146821044|NCT01348763|529513064|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
146821045|NCT01348763|529513064|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
146821046|NCT02162771|529513065|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
146821047|NCT02162771|529513066|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
146821048|NCT02162771|529513065|FG000|Core Study Period (Part 2)|Adverse Event|4|||
146821049|NCT02162771|529513066|FG001|Core Study Period (Part 2)|Adverse Event|1|||
146821050|NCT02162771|529513065|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
146821051|NCT02162771|529513066|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
146821052|NCT02162771|529513065|FG000|Core Study Period (Part 2)|Physician Decision|0|||
146821053|NCT02162771|529513066|FG001|Core Study Period (Part 2)|Physician Decision|2|||
146821054|NCT02162771|529513065|FG000|Core Study Period (Part 2)|Death|1|||
146821055|NCT02162771|529513066|FG001|Core Study Period (Part 2)|Death|0|||
146821056|NCT02162771|529513065|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
146821057|NCT02162771|529513066|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
146821058|NCT02162771|529513065|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
146821059|NCT02162771|529513066|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
146821060|NCT02162771|529513065|FG000|Maintenance Study Period (Part 2)|Death|2|||
146821061|NCT02162771|529513066|FG001|Maintenance Study Period (Part 2)|Death|1|||
146821062|NCT02162771|529513065|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
146821063|NCT02162771|529513066|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
146821064|NCT02162771|529513065|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
146821065|NCT02162771|529513066|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
146821066|NCT02162771|529513065|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
146821067|NCT02162771|529513066|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
146821068|NCT03802513|529513070|FG000|Overall Study|Lost to Follow-up|1|||
146821069|NCT01190228|529513075|FG000|Overall Study|Protocol Violation|4|||
146821070|NCT01190228|529513076|FG001|Overall Study|Protocol Violation|0|||
146821071|NCT01190228|529513077|FG002|Overall Study|Protocol Violation|0|||
146821072|NCT01190228|529513075|FG000|Overall Study|Withdrawal by Subject|1|||
146821073|NCT01190228|529513076|FG001|Overall Study|Withdrawal by Subject|0|||
146821074|NCT01190228|529513077|FG002|Overall Study|Withdrawal by Subject|0|||
146821075|NCT00832650|529513081|FG000|Overall Study|Randomized but not treated|0|||
146821076|NCT00832650|529513082|FG001|Overall Study|Randomized but not treated|0|||
146821077|NCT00832650|529513083|FG002|Overall Study|Randomized but not treated|1|||
146821078|NCT03219216|529513084|FG000|Overall Study|Lost to Follow-up|0|||
146821079|NCT03219216|529513085|FG001|Overall Study|Lost to Follow-up|1|||
146821080|NCT02332824|529513086|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
146821081|NCT02332824|529513087|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
146821082|NCT02332824|529513088|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
146821083|NCT02332824|529513089|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
146821084|NCT02332824|529513090|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
146821085|NCT02332824|529513091|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
146821086|NCT02332824|529513086|FG000|Overall Study|Voluntary Withdrawal|1|||
146821087|NCT02332824|529513087|FG001|Overall Study|Voluntary Withdrawal|0|||
146821088|NCT02332824|529513088|FG002|Overall Study|Voluntary Withdrawal|0|||
146821089|NCT02332824|529513089|FG003|Overall Study|Voluntary Withdrawal|0|||
146821090|NCT02332824|529513090|FG004|Overall Study|Voluntary Withdrawal|0|||
146821091|NCT02332824|529513091|FG005|Overall Study|Voluntary Withdrawal|0|||
146821092|NCT02332824|529513086|FG000|Overall Study|Inconvenient schedule|1|||
146821093|NCT02332824|529513087|FG001|Overall Study|Inconvenient schedule|1|||
146821094|NCT02332824|529513088|FG002|Overall Study|Inconvenient schedule|0|||
146821095|NCT02332824|529513089|FG003|Overall Study|Inconvenient schedule|0|||
146821096|NCT02332824|529513090|FG004|Overall Study|Inconvenient schedule|0|||
146821097|NCT02332824|529513091|FG005|Overall Study|Inconvenient schedule|0|||
146821098|NCT02332824|529513086|FG000|Overall Study|Transfer|0|||
146821099|NCT02332824|529513087|FG001|Overall Study|Transfer|0|||
146821100|NCT02332824|529513088|FG002|Overall Study|Transfer|1|||
146821101|NCT02332824|529513089|FG003|Overall Study|Transfer|1|||
146821102|NCT02332824|529513090|FG004|Overall Study|Transfer|0|||
146821103|NCT02332824|529513091|FG005|Overall Study|Transfer|0|||
146821104|NCT00440037|529513092|FG000|Overall Study|Withdrawal by Subject|6|||
146821105|NCT00440037|529513092|FG000|Overall Study|Administrative decision|3|||
146821106|NCT00498797|529513093|FG000|Overall Study|Withdrawal by Subject|4|||
146821107|NCT00498797|529513094|FG001|Overall Study|Withdrawal by Subject|2|||
146821108|NCT00498797|529513093|FG000|Overall Study|Adverse Event|12|||
146821109|NCT00498797|529513094|FG001|Overall Study|Adverse Event|5|||
146821110|NCT00498797|529513093|FG000|Overall Study|Condition under investigation worsened|19|||
146821111|NCT00498797|529513094|FG001|Overall Study|Condition under investigation worsened|21|||
146821112|NCT00498797|529513093|FG000|Overall Study|Other|3|||
146821113|NCT00498797|529513094|FG001|Overall Study|Other|1|||
146821114|NCT03928821|529513095|FG000|Overall Study|Death|0|||
146821115|NCT03928821|529513096|FG001|Overall Study|Death|1|||
146821116|NCT03928821|529513097|FG002|Overall Study|Death|0|||
146821117|NCT03928821|529513098|FG003|Overall Study|Death|0|||
146821118|NCT03928821|529513095|FG000|Overall Study|Lost to Follow-up|0|||
146821119|NCT03928821|529513096|FG001|Overall Study|Lost to Follow-up|2|||
146821120|NCT03928821|529513097|FG002|Overall Study|Lost to Follow-up|3|||
146821121|NCT03928821|529513098|FG003|Overall Study|Lost to Follow-up|0|||
146821122|NCT03928821|529513095|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
146821123|NCT03928821|529513096|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
146821124|NCT03928821|529513097|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
146821125|NCT03928821|529513098|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
146821126|NCT02784535|529513099|FG000|Overall Study|Adverse Event|1|||
146821127|NCT02784535|529513100|FG001|Overall Study|Adverse Event|0|||
146821128|NCT02784535|529513099|FG000|Overall Study|Withdrawal by Subject|0|||
146821129|NCT02784535|529513100|FG001|Overall Study|Withdrawal by Subject|1|||
146821130|NCT02784535|529513099|FG000|Overall Study|Physician Decision|0|||
146821131|NCT02784535|529513100|FG001|Overall Study|Physician Decision|1|||
146821132|NCT03740919|529513101|FG000|Lead-in Period|Lost to Follow-up|1|||
146821133|NCT03740919|529513102|FG001|Lead-in Period|Lost to Follow-up|0|||
146821134|NCT03740919|529513103|FG002|Lead-in Period|Lost to Follow-up|0|||
146821135|NCT03740919|529513104|FG003|Lead-in Period|Lost to Follow-up|0|||
146821136|NCT03740919|529513101|FG000|Lead-in Period|Physician Decision|2|||
146821137|NCT03740919|529513102|FG001|Lead-in Period|Physician Decision|0|||
146821138|NCT03740919|529513103|FG002|Lead-in Period|Physician Decision|0|||
146821139|NCT03740919|529513104|FG003|Lead-in Period|Physician Decision|0|||
146821140|NCT03740919|529513101|FG000|Lead-in Period|Protocol Violation|1|||
146821141|NCT03740919|529513102|FG001|Lead-in Period|Protocol Violation|0|||
146821142|NCT03740919|529513103|FG002|Lead-in Period|Protocol Violation|0|||
146821143|NCT03740919|529513104|FG003|Lead-in Period|Protocol Violation|0|||
146821144|NCT03740919|529513101|FG000|Lead-in Period|Withdrawal by Subject|10|||
146821145|NCT03740919|529513102|FG001|Lead-in Period|Withdrawal by Subject|0|||
146821146|NCT03740919|529513103|FG002|Lead-in Period|Withdrawal by Subject|0|||
146951085|NCT01004861|529979907|FG006|Overall Study|Protocol Violation|0|||
146951086|NCT01004861|529979908|FG007|Overall Study|Protocol Violation|0|||
146951087|NCT01004861|529979909|FG008|Overall Study|Protocol Violation|0|||
146821147|NCT03740919|529513104|FG003|Lead-in Period|Withdrawal by Subject|0|||
146821148|NCT03740919|529513101|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
146821149|NCT03740919|529513102|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
146821150|NCT03740919|529513103|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
146821151|NCT03740919|529513104|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
146821152|NCT03740919|529513101|FG000|Lead-in Period|Study Task Too Burdensome|1|||
146821153|NCT03740919|529513102|FG001|Lead-in Period|Study Task Too Burdensome|0|||
146821154|NCT03740919|529513103|FG002|Lead-in Period|Study Task Too Burdensome|0|||
146821155|NCT03740919|529513104|FG003|Lead-in Period|Study Task Too Burdensome|0|||
146821156|NCT03740919|529513101|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
146821157|NCT03740919|529513102|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
146821158|NCT03740919|529513103|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
146821159|NCT03740919|529513104|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
146821160|NCT03740919|529513101|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
146821161|NCT03740919|529513102|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
146821162|NCT03740919|529513103|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
146951088|NCT01004861|529979910|FG009|Overall Study|Protocol Violation|0|||
146821163|NCT03740919|529513104|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
146821164|NCT03740919|529513101|FG000|Treatment Period|Adverse Event|0|||
146821165|NCT03740919|529513102|FG001|Treatment Period|Adverse Event|0|||
146821166|NCT03740919|529513103|FG002|Treatment Period|Adverse Event|2|||
146821167|NCT03740919|529513104|FG003|Treatment Period|Adverse Event|0|||
146821168|NCT03740919|529513101|FG000|Treatment Period|Protocol Violation|0|||
146821169|NCT03740919|529513102|FG001|Treatment Period|Protocol Violation|1|||
146821170|NCT03740919|529513103|FG002|Treatment Period|Protocol Violation|0|||
146821171|NCT03740919|529513104|FG003|Treatment Period|Protocol Violation|0|||
146821172|NCT03740919|529513101|FG000|Treatment Period|Withdrawal by Subject|0|||
146821173|NCT03740919|529513102|FG001|Treatment Period|Withdrawal by Subject|7|||
146821174|NCT03740919|529513103|FG002|Treatment Period|Withdrawal by Subject|6|||
146821175|NCT03740919|529513104|FG003|Treatment Period|Withdrawal by Subject|2|||
146821176|NCT03740919|529513101|FG000|Treatment Period|Terminated by Sponsor|0|||
146821177|NCT03740919|529513102|FG001|Treatment Period|Terminated by Sponsor|1|||
146821178|NCT03740919|529513103|FG002|Treatment Period|Terminated by Sponsor|0|||
146821179|NCT03740919|529513104|FG003|Treatment Period|Terminated by Sponsor|0|||
146821180|NCT03740919|529513101|FG000|Treatment Period|Issue with Insulin Pump|0|||
146821181|NCT03740919|529513102|FG001|Treatment Period|Issue with Insulin Pump|1|||
146821182|NCT03740919|529513103|FG002|Treatment Period|Issue with Insulin Pump|0|||
146821183|NCT03740919|529513104|FG003|Treatment Period|Issue with Insulin Pump|0|||
146821184|NCT03740919|529513101|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
146821185|NCT03740919|529513102|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
146821186|NCT03740919|529513103|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
146951089|NCT01004861|529979911|FG010|Overall Study|Protocol Violation|0|||
146951090|NCT01004861|529979912|FG011|Overall Study|Protocol Violation|0|||
146951091|NCT01004861|529979913|FG012|Overall Study|Protocol Violation|0|||
146951092|NCT01004861|529979901|FG000|Overall Study|Lost to Follow-up|0|||
146951093|NCT01004861|529979902|FG001|Overall Study|Lost to Follow-up|0|||
146951094|NCT01004861|529979903|FG002|Overall Study|Lost to Follow-up|0|||
146951095|NCT01004861|529979904|FG003|Overall Study|Lost to Follow-up|0|||
146951096|NCT01004861|529979905|FG004|Overall Study|Lost to Follow-up|0|||
146951097|NCT01004861|529979906|FG005|Overall Study|Lost to Follow-up|0|||
146951098|NCT01004861|529979907|FG006|Overall Study|Lost to Follow-up|0|||
146951099|NCT01004861|529979908|FG007|Overall Study|Lost to Follow-up|1|||
146951100|NCT01004861|529979909|FG008|Overall Study|Lost to Follow-up|3|||
146951101|NCT01004861|529979910|FG009|Overall Study|Lost to Follow-up|0|||
146951102|NCT01004861|529979911|FG010|Overall Study|Lost to Follow-up|0|||
146951103|NCT01004861|529979912|FG011|Overall Study|Lost to Follow-up|1|||
146951104|NCT01004861|529979913|FG012|Overall Study|Lost to Follow-up|0|||
146951105|NCT01004861|529979901|FG000|Overall Study|Non-compliance|0|||
146951106|NCT01004861|529979902|FG001|Overall Study|Non-compliance|0|||
146951107|NCT01004861|529979903|FG002|Overall Study|Non-compliance|0|||
146951108|NCT01004861|529979904|FG003|Overall Study|Non-compliance|0|||
146951109|NCT01004861|529979905|FG004|Overall Study|Non-compliance|0|||
146951110|NCT01004861|529979906|FG005|Overall Study|Non-compliance|0|||
146951111|NCT01004861|529979907|FG006|Overall Study|Non-compliance|0|||
146951112|NCT01004861|529979908|FG007|Overall Study|Non-compliance|0|||
146951113|NCT01004861|529979909|FG008|Overall Study|Non-compliance|5|||
146951114|NCT01004861|529979910|FG009|Overall Study|Non-compliance|0|||
146951115|NCT01004861|529979911|FG010|Overall Study|Non-compliance|0|||
146951116|NCT01004861|529979912|FG011|Overall Study|Non-compliance|0|||
146951117|NCT01004861|529979913|FG012|Overall Study|Non-compliance|1|||
146951118|NCT01004861|529979901|FG000|Overall Study|Other|0|||
146951119|NCT01004861|529979902|FG001|Overall Study|Other|0|||
146951120|NCT01004861|529979903|FG002|Overall Study|Other|0|||
146951121|NCT01004861|529979904|FG003|Overall Study|Other|0|||
146951122|NCT01004861|529979905|FG004|Overall Study|Other|0|||
146951123|NCT01004861|529979906|FG005|Overall Study|Other|0|||
146951124|NCT01004861|529979907|FG006|Overall Study|Other|0|||
146951125|NCT01004861|529979908|FG007|Overall Study|Other|0|||
146951126|NCT01004861|529979909|FG008|Overall Study|Other|0|||
146951127|NCT01004861|529979910|FG009|Overall Study|Other|2|||
146951128|NCT01004861|529979911|FG010|Overall Study|Other|1|||
146821187|NCT03740919|529513104|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
146821188|NCT03740919|529513101|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
146821189|NCT03740919|529513102|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
146821190|NCT03740919|529513103|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
146821191|NCT03740919|529513104|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
146951129|NCT01004861|529979912|FG011|Overall Study|Other|2|||
146951130|NCT01004861|529979913|FG012|Overall Study|Other|3|||
146951131|NCT01004861|529979901|FG000|Overall Study|Patient decision|0|||
146951132|NCT01004861|529979902|FG001|Overall Study|Patient decision|0|||
146951133|NCT01004861|529979903|FG002|Overall Study|Patient decision|0|||
146951134|NCT01004861|529979904|FG003|Overall Study|Patient decision|0|||
146951135|NCT01004861|529979905|FG004|Overall Study|Patient decision|1|||
146951136|NCT01004861|529979906|FG005|Overall Study|Patient decision|0|||
146951137|NCT01004861|529979907|FG006|Overall Study|Patient decision|1|||
146951138|NCT01004861|529979908|FG007|Overall Study|Patient decision|0|||
146951139|NCT01004861|529979909|FG008|Overall Study|Patient decision|7|||
146984808|NCT02669264|530105174|FG000|Overall Study|Miscellaneous|0|||
146984809|NCT02669264|530105175|FG001|Overall Study|Miscellaneous|0|||
146984810|NCT02669264|530105176|FG002|Overall Study|Miscellaneous|0|||
146984811|NCT02669264|530105177|FG003|Overall Study|Miscellaneous|0|||
146821192|NCT03740919|529513101|FG000|Treatment Period|Not Completing Diary|0|||
146821193|NCT03740919|529513102|FG001|Treatment Period|Not Completing Diary|0|||
146821194|NCT03740919|529513103|FG002|Treatment Period|Not Completing Diary|1|||
146821195|NCT03740919|529513104|FG003|Treatment Period|Not Completing Diary|0|||
146821196|NCT03740919|529513101|FG000|Treatment Period|Insulin Painful to Participant|0|||
146821197|NCT03740919|529513102|FG001|Treatment Period|Insulin Painful to Participant|0|||
146821198|NCT03740919|529513103|FG002|Treatment Period|Insulin Painful to Participant|1|||
146821199|NCT03740919|529513104|FG003|Treatment Period|Insulin Painful to Participant|0|||
146821200|NCT00985621|529513107|FG000|Overall Study|Adverse Event|2|||
146821201|NCT00985621|529513108|FG001|Overall Study|Adverse Event|3|||
146821202|NCT00985621|529513109|FG002|Overall Study|Adverse Event|4|||
146821203|NCT00985621|529513110|FG003|Overall Study|Adverse Event|16|||
146821204|NCT00985621|529513107|FG000|Overall Study|Lack of Efficacy|10|||
146821205|NCT00985621|529513108|FG001|Overall Study|Lack of Efficacy|6|||
146821206|NCT00985621|529513109|FG002|Overall Study|Lack of Efficacy|5|||
146821207|NCT00985621|529513110|FG003|Overall Study|Lack of Efficacy|12|||
146821208|NCT00985621|529513107|FG000|Overall Study|Lost to Follow-up|2|||
146821209|NCT00985621|529513108|FG001|Overall Study|Lost to Follow-up|3|||
146821210|NCT00985621|529513109|FG002|Overall Study|Lost to Follow-up|4|||
146821211|NCT00985621|529513110|FG003|Overall Study|Lost to Follow-up|4|||
146821212|NCT00985621|529513107|FG000|Overall Study|Study Terminated by Sponsor|89|||
146821213|NCT00985621|529513108|FG001|Overall Study|Study Terminated by Sponsor|108|||
146821214|NCT00985621|529513109|FG002|Overall Study|Study Terminated by Sponsor|99|||
146821215|NCT00985621|529513110|FG003|Overall Study|Study Terminated by Sponsor|92|||
146821216|NCT00985621|529513107|FG000|Overall Study|Protocol Violation|1|||
146821217|NCT00985621|529513108|FG001|Overall Study|Protocol Violation|1|||
146821218|NCT00985621|529513109|FG002|Overall Study|Protocol Violation|1|||
146821219|NCT00985621|529513110|FG003|Overall Study|Protocol Violation|0|||
146821220|NCT00985621|529513107|FG000|Overall Study|Withdrawal by Subject|8|||
146821221|NCT00985621|529513108|FG001|Overall Study|Withdrawal by Subject|10|||
146821222|NCT00985621|529513109|FG002|Overall Study|Withdrawal by Subject|8|||
146821223|NCT00985621|529513110|FG003|Overall Study|Withdrawal by Subject|12|||
146821224|NCT00985621|529513107|FG000|Overall Study|Other|1|||
146821225|NCT00985621|529513108|FG001|Overall Study|Other|0|||
146821226|NCT00985621|529513109|FG002|Overall Study|Other|0|||
146821227|NCT00985621|529513110|FG003|Overall Study|Other|0|||
146821228|NCT00985621|529513107|FG000|Overall Study|Randomized but not Treated|1|||
146821229|NCT00985621|529513108|FG001|Overall Study|Randomized but not Treated|0|||
146821230|NCT00985621|529513109|FG002|Overall Study|Randomized but not Treated|2|||
146821231|NCT00985621|529513110|FG003|Overall Study|Randomized but not Treated|1|||
146821232|NCT01911819|529513111|FG000|Overall Study|Adverse Event|0|||
146821233|NCT01911819|529513112|FG001|Overall Study|Adverse Event|1|||
146821234|NCT01911819|529513113|FG002|Overall Study|Adverse Event|0|||
146821235|NCT01911819|529513111|FG000|Overall Study|Withdrawal by Subject|1|||
146821236|NCT01911819|529513112|FG001|Overall Study|Withdrawal by Subject|1|||
146821237|NCT01911819|529513113|FG002|Overall Study|Withdrawal by Subject|0|||
146984812|NCT02669264|530105178|FG004|Overall Study|Miscellaneous|0|||
146821238|NCT03953079|529513114|FG000|Core Study|Withdrawal by Subject|1|||
146821239|NCT03953079|529513115|FG001|Core Study|Withdrawal by Subject|2|||
146821240|NCT03953079|529513116|FG002|Core Study|Withdrawal by Subject|1|||
146821241|NCT03953079|529513114|FG000|Core Study|COVID-19|0|||
146821242|NCT03953079|529513115|FG001|Core Study|COVID-19|1|||
146821243|NCT03953079|529513116|FG002|Core Study|COVID-19|0|||
146821244|NCT03953079|529513114|FG000|Core Study|Difficulties leaving the house|0|||
146821245|NCT03953079|529513115|FG001|Core Study|Difficulties leaving the house|1|||
146821246|NCT03953079|529513116|FG002|Core Study|Difficulties leaving the house|0|||
146821247|NCT03953079|529513114|FG000|Extension Study|Withdrawal by Subject|1|||
146821248|NCT03953079|529513115|FG001|Extension Study|Withdrawal by Subject|0|||
146821249|NCT03953079|529513116|FG002|Extension Study|Withdrawal by Subject|0|||
146821250|NCT03953079|529513114|FG000|Extension Study|Received Rescue Treatment|5|||
146821251|NCT03953079|529513115|FG001|Extension Study|Received Rescue Treatment|6|||
146821252|NCT03953079|529513116|FG002|Extension Study|Received Rescue Treatment|5|||
146821253|NCT04394624|529513120|FG000|Overall Study|Adverse Event|6|||
146821254|NCT04394624|529513121|FG001|Overall Study|Adverse Event|0|||
146821255|NCT04394624|529513120|FG000|Overall Study|Progressive disease|24|||
146821256|NCT04394624|529513121|FG001|Overall Study|Progressive disease|0|||
146821257|NCT04394624|529513120|FG000|Overall Study|Not related to COVID-19|1|||
146821258|NCT04394624|529513121|FG001|Overall Study|Not related to COVID-19|0|||
146821259|NCT00603278|529513123|FG000|Overall Study|Lack of Efficacy|35|||
146821260|NCT00603278|529513124|FG001|Overall Study|Lack of Efficacy|10|||
146821261|NCT00603278|529513125|FG002|Overall Study|Lack of Efficacy|11|||
146821262|NCT00603278|529513126|FG003|Overall Study|Lack of Efficacy|8|||
146821263|NCT00603278|529513127|FG004|Overall Study|Lack of Efficacy|7|||
146984813|NCT02669264|530105179|FG005|Overall Study|Miscellaneous|0|||
146984814|NCT02669264|530105180|FG006|Overall Study|Miscellaneous|2|||
146821264|NCT00603278|529513128|FG005|Overall Study|Lack of Efficacy|14|||
146821265|NCT00603278|529513123|FG000|Overall Study|Adverse Event|0|||
146821266|NCT00603278|529513124|FG001|Overall Study|Adverse Event|3|||
146821267|NCT00603278|529513125|FG002|Overall Study|Adverse Event|1|||
146821268|NCT00603278|529513126|FG003|Overall Study|Adverse Event|0|||
146821269|NCT00603278|529513127|FG004|Overall Study|Adverse Event|2|||
146821270|NCT00603278|529513128|FG005|Overall Study|Adverse Event|1|||
146821271|NCT00603278|529513123|FG000|Overall Study|Withdrawal by Subject|2|||
146821272|NCT00603278|529513124|FG001|Overall Study|Withdrawal by Subject|3|||
146821273|NCT00603278|529513125|FG002|Overall Study|Withdrawal by Subject|1|||
146821274|NCT00603278|529513126|FG003|Overall Study|Withdrawal by Subject|2|||
146821275|NCT00603278|529513127|FG004|Overall Study|Withdrawal by Subject|1|||
146821276|NCT00603278|529513128|FG005|Overall Study|Withdrawal by Subject|2|||
146821277|NCT00603278|529513123|FG000|Overall Study|Protocol Violation|3|||
146821278|NCT00603278|529513124|FG001|Overall Study|Protocol Violation|0|||
146821279|NCT00603278|529513125|FG002|Overall Study|Protocol Violation|1|||
146821280|NCT00603278|529513126|FG003|Overall Study|Protocol Violation|1|||
146821281|NCT00603278|529513127|FG004|Overall Study|Protocol Violation|0|||
146821282|NCT00603278|529513128|FG005|Overall Study|Protocol Violation|1|||
146821283|NCT00603278|529513123|FG000|Overall Study|Physician Decision|0|||
146821284|NCT00603278|529513124|FG001|Overall Study|Physician Decision|1|||
146821285|NCT00603278|529513125|FG002|Overall Study|Physician Decision|0|||
146821286|NCT00603278|529513126|FG003|Overall Study|Physician Decision|0|||
146821287|NCT00603278|529513127|FG004|Overall Study|Physician Decision|2|||
146821288|NCT00603278|529513128|FG005|Overall Study|Physician Decision|1|||
146821289|NCT00603278|529513123|FG000|Overall Study|Lost to Follow-up|1|||
146821290|NCT00603278|529513124|FG001|Overall Study|Lost to Follow-up|0|||
146821291|NCT00603278|529513125|FG002|Overall Study|Lost to Follow-up|0|||
146821292|NCT00603278|529513126|FG003|Overall Study|Lost to Follow-up|0|||
146821293|NCT00603278|529513127|FG004|Overall Study|Lost to Follow-up|1|||
146821294|NCT00603278|529513128|FG005|Overall Study|Lost to Follow-up|0|||
146821295|NCT04743999|529513130|FG000|3-month Questionnaire|Death|1|||
146821296|NCT04743999|529513130|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
146821297|NCT04743999|529513130|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
146821298|NCT04743999|529513130|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
146821299|NCT01721759|529513131|FG000|Treatment Period|Disease Progression|85|||
146821300|NCT01721759|529513131|FG000|Treatment Period|Study drug toxicity|14|||
146821301|NCT01721759|529513131|FG000|Treatment Period|Death|1|||
146821302|NCT01721759|529513131|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
146821303|NCT01721759|529513131|FG000|Treatment Period|Participant request to withdraw|3|||
146821304|NCT01721759|529513131|FG000|Treatment Period|Other Reasons|3|||
146821305|NCT01721759|529513131|FG000|End of Study Period|Participant Withdrew Consent|5|||
146821306|NCT01721759|529513131|FG000|End of Study Period|Death|101|||
146821307|NCT01721759|529513131|FG000|End of Study Period|Lost to Follow-up|1|||
146821308|NCT01721759|529513131|FG000|End of Study Period|Other Reasons|10|||
146821309|NCT02577315|529513138|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
146821310|NCT02577315|529513139|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
146821311|NCT00417989|529513140|FG000|Overall Study|Withdrawal by Subject|13|||
146951140|NCT01004861|529979910|FG009|Overall Study|Patient decision|1|||
146951141|NCT01004861|529979911|FG010|Overall Study|Patient decision|1|||
146951142|NCT01004861|529979912|FG011|Overall Study|Patient decision|2|||
146951143|NCT01004861|529979913|FG012|Overall Study|Patient decision|3|||
146951144|NCT01004861|529979901|FG000|Overall Study|Transitioned to Phase 4 study|0|||
146821312|NCT00417989|529513141|FG001|Overall Study|Withdrawal by Subject|13|||
146821313|NCT00417989|529513140|FG000|Overall Study|Lost to Follow-up|1|||
146821314|NCT00417989|529513141|FG001|Overall Study|Lost to Follow-up|6|||
146821315|NCT00417989|529513140|FG000|Overall Study|Protocol Violation|1|||
146821316|NCT00417989|529513141|FG001|Overall Study|Protocol Violation|0|||
146821317|NCT00417989|529513140|FG000|Overall Study|Death|0|||
146821318|NCT00417989|529513141|FG001|Overall Study|Death|1|||
146821319|NCT00417989|529513140|FG000|Overall Study|Physician Decision|5|||
146821320|NCT00417989|529513141|FG001|Overall Study|Physician Decision|2|||
146821321|NCT01636778|529513144|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
146821322|NCT01636778|529513145|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
146821323|NCT01636778|529513146|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
146821324|NCT01636778|529513144|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
146821325|NCT01636778|529513145|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
146821326|NCT01636778|529513146|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
146951145|NCT01004861|529979902|FG001|Overall Study|Transitioned to Phase 4 study|0|||
146951146|NCT01004861|529979903|FG002|Overall Study|Transitioned to Phase 4 study|0|||
146951147|NCT01004861|529979904|FG003|Overall Study|Transitioned to Phase 4 study|0|||
146951148|NCT01004861|529979905|FG004|Overall Study|Transitioned to Phase 4 study|0|||
146821327|NCT01636778|529513144|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
146821328|NCT01636778|529513145|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
146951149|NCT01004861|529979906|FG005|Overall Study|Transitioned to Phase 4 study|0|||
146821329|NCT01636778|529513146|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
146821330|NCT01636778|529513144|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
146821331|NCT01636778|529513145|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
146821332|NCT01636778|529513146|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
146984815|NCT04345471|530105182|FG000|Overall Study|Adverse Event|8|||
146984816|NCT04345471|530105183|FG001|Overall Study|Adverse Event|5|||
146984817|NCT04345471|530105184|FG002|Overall Study|Adverse Event|6|||
146984818|NCT04345471|530105182|FG000|Overall Study|Lack of Efficacy|1|||
146984819|NCT04345471|530105183|FG001|Overall Study|Lack of Efficacy|1|||
146984820|NCT04345471|530105184|FG002|Overall Study|Lack of Efficacy|0|||
146984821|NCT04345471|530105182|FG000|Overall Study|Protocol Violation|0|||
146984822|NCT04345471|530105183|FG001|Overall Study|Protocol Violation|1|||
146984823|NCT04345471|530105184|FG002|Overall Study|Protocol Violation|2|||
146984824|NCT04345471|530105182|FG000|Overall Study|Withdrawal by Subject|10|||
146821333|NCT01636778|529513144|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
146821334|NCT01636778|529513145|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
146821335|NCT01636778|529513146|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
146821336|NCT01636778|529513144|FG000|Follow-up Period After Part 2|Other|0|||
146821337|NCT01636778|529513145|FG001|Follow-up Period After Part 2|Other|0|||
146821338|NCT01636778|529513146|FG002|Follow-up Period After Part 2|Other|1|||
146821339|NCT01636778|529513144|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
146821340|NCT01636778|529513145|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
146821341|NCT01636778|529513146|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
146821342|NCT01636778|529513144|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
146821343|NCT01636778|529513145|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
146821344|NCT01636778|529513146|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
146821345|NCT00990821|529513150|FG000|Overall Study|Withdrawal by Subject|0|||
146821346|NCT00990821|529513151|FG001|Overall Study|Withdrawal by Subject|2|||
146821347|NCT00990821|529513152|FG002|Overall Study|Withdrawal by Subject|0|||
146821348|NCT00990821|529513153|FG003|Overall Study|Withdrawal by Subject|0|||
146821349|NCT00990821|529513154|FG004|Overall Study|Withdrawal by Subject|3|||
146821350|NCT00990821|529513155|FG005|Overall Study|Withdrawal by Subject|3|||
146821351|NCT00990821|529513156|FG006|Overall Study|Withdrawal by Subject|1|||
146821352|NCT00990821|529513157|FG007|Overall Study|Withdrawal by Subject|0|||
146821353|NCT00990821|529513158|FG008|Overall Study|Withdrawal by Subject|0|||
146821354|NCT00990821|529513159|FG009|Overall Study|Withdrawal by Subject|1|||
146821355|NCT00990821|529513160|FG010|Overall Study|Withdrawal by Subject|3|||
146821356|NCT00990821|529513161|FG011|Overall Study|Withdrawal by Subject|5|||
146821357|NCT00990821|529513162|FG012|Overall Study|Withdrawal by Subject|2|||
146821358|NCT00990821|529513163|FG013|Overall Study|Withdrawal by Subject|1|||
146821359|NCT03530345|529513164|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
146821360|NCT03530345|529513165|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
146821361|NCT03530345|529513164|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
146821362|NCT03530345|529513165|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
146821363|NCT03530345|529513164|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
146821364|NCT03530345|529513165|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
146821365|NCT03530345|529513164|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
146821366|NCT03530345|529513165|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
146821367|NCT04150250|529513166|FG000|Overall Study|Lost to Follow-up|0|||
146821368|NCT04150250|529513167|FG001|Overall Study|Lost to Follow-up|2|||
146951150|NCT01004861|529979907|FG006|Overall Study|Transitioned to Phase 4 study|0|||
146951151|NCT01004861|529979908|FG007|Overall Study|Transitioned to Phase 4 study|0|||
146951152|NCT01004861|529979909|FG008|Overall Study|Transitioned to Phase 4 study|2|||
146951153|NCT01004861|529979910|FG009|Overall Study|Transitioned to Phase 4 study|0|||
146951154|NCT01004861|529979911|FG010|Overall Study|Transitioned to Phase 4 study|0|||
146951155|NCT01004861|529979912|FG011|Overall Study|Transitioned to Phase 4 study|0|||
146951156|NCT01004861|529979913|FG012|Overall Study|Transitioned to Phase 4 study|0|||
146951157|NCT01004861|529979901|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146951158|NCT01004861|529979902|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146951159|NCT01004861|529979903|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146951160|NCT01004861|529979904|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146951161|NCT01004861|529979905|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146951162|NCT01004861|529979906|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146951163|NCT01004861|529979907|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146951164|NCT01004861|529979908|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146984825|NCT04345471|530105183|FG001|Overall Study|Withdrawal by Subject|5|||
146984826|NCT04345471|530105184|FG002|Overall Study|Withdrawal by Subject|10|||
146821369|NCT02442622|529513173|FG000|Overall Study|Withdrawal by Subject|3|||
146821370|NCT02442622|529513174|FG001|Overall Study|Withdrawal by Subject|1|||
146821371|NCT00383500|529513175|FG000|Overall Study|Withdrawal by Subject|8|||
146821372|NCT00383500|529513176|FG001|Overall Study|Withdrawal by Subject|3|||
146821373|NCT00383500|529513177|FG002|Overall Study|Withdrawal by Subject|0|||
146821374|NCT00383500|529513175|FG000|Overall Study|Lost to Follow-up|0|||
146821375|NCT00383500|529513176|FG001|Overall Study|Lost to Follow-up|0|||
146821376|NCT00383500|529513177|FG002|Overall Study|Lost to Follow-up|2|||
146821377|NCT01002547|529515220|FG000|Overall Study|Withdrawal by Subject|4|||
146821378|NCT01002547|529515221|FG001|Overall Study|Withdrawal by Subject|0|||
146821379|NCT01002547|529515222|FG002|Overall Study|Withdrawal by Subject|5|||
146821380|NCT01002547|529515220|FG000|Overall Study|Lost to Follow-up|2|||
146821381|NCT01002547|529515221|FG001|Overall Study|Lost to Follow-up|1|||
146821382|NCT01002547|529515222|FG002|Overall Study|Lost to Follow-up|1|||
146821383|NCT01002547|529515220|FG000|Overall Study|Physician Decision|1|||
146821384|NCT01002547|529515221|FG001|Overall Study|Physician Decision|0|||
146821385|NCT01002547|529515222|FG002|Overall Study|Physician Decision|0|||
146821386|NCT01002547|529515220|FG000|Overall Study|Death|0|||
146821387|NCT01002547|529515221|FG001|Overall Study|Death|2|||
146821388|NCT01002547|529515222|FG002|Overall Study|Death|2|||
146821389|NCT01002547|529515220|FG000|Overall Study|Adverse Event|1|||
146821390|NCT01002547|529515221|FG001|Overall Study|Adverse Event|0|||
146821391|NCT01002547|529515222|FG002|Overall Study|Adverse Event|0|||
146821392|NCT00705614|529515227|FG000|Initial Intervention|Adverse Event|40|||
146821393|NCT00705614|529515228|FG001|Initial Intervention|Adverse Event|21|||
146821394|NCT00705614|529515227|FG000|Initial Intervention|Lost to Follow-up|310|||
146821395|NCT00705614|529515228|FG001|Initial Intervention|Lost to Follow-up|191|||
146821396|NCT00705614|529515227|FG000|Initial Intervention|Withdrawal by Subject|114|||
146821397|NCT00705614|529515228|FG001|Initial Intervention|Withdrawal by Subject|71|||
146821398|NCT00705614|529515227|FG000|Initial Intervention|Administrative Reason|51|||
146821399|NCT00705614|529515228|FG001|Initial Intervention|Administrative Reason|38|||
146821400|NCT00705614|529515227|FG000|Initial Intervention|Status completion unknown|3|||
146821401|NCT00705614|529515228|FG001|Initial Intervention|Status completion unknown|0|||
146821402|NCT00705614|529515227|FG000|Switch to Remicade|Adverse Event|0|||
146821403|NCT00705614|529515228|FG001|Switch to Remicade|Adverse Event|5|||
146821404|NCT00705614|529515227|FG000|Switch to Remicade|Lost to Follow-up|0|||
146821405|NCT00705614|529515228|FG001|Switch to Remicade|Lost to Follow-up|23|||
146821406|NCT00705614|529515227|FG000|Switch to Remicade|Withdrawal by Subject|0|||
146821407|NCT00705614|529515228|FG001|Switch to Remicade|Withdrawal by Subject|12|||
146821408|NCT00705614|529515227|FG000|Switch to Remicade|Administrative Reason|0|||
146821409|NCT00705614|529515228|FG001|Switch to Remicade|Administrative Reason|9|||
146821410|NCT00925288|529515229|FG000|Overall Study|Lost to Follow-up|9|||
146821411|NCT00925288|529515230|FG001|Overall Study|Lost to Follow-up|7|||
146821412|NCT02081196|529515231|FG000|Overall Study|Lost to Follow-up|1|||
146821413|NCT00434577|529515232|FG000|Months 0-3|Serious Adverse Event|0|||
146821414|NCT00434577|529515233|FG001|Months 0-3|Serious Adverse Event|0|||
146821415|NCT00434577|529515234|FG002|Months 0-3|Serious Adverse Event|1|||
146821416|NCT00434577|529515235|FG003|Months 0-3|Serious Adverse Event|0|||
146821417|NCT00434577|529515236|FG004|Months 0-3|Serious Adverse Event|0|||
146821418|NCT00434577|529515232|FG000|Months 0-3|Adverse Event|0|||
146821419|NCT00434577|529515233|FG001|Months 0-3|Adverse Event|1|||
146821420|NCT00434577|529515234|FG002|Months 0-3|Adverse Event|1|||
146821421|NCT00434577|529515235|FG003|Months 0-3|Adverse Event|0|||
146821422|NCT00434577|529515236|FG004|Months 0-3|Adverse Event|0|||
146821423|NCT00434577|529515232|FG000|Months 0-3|Lost to Follow-up|0|||
146821424|NCT00434577|529515233|FG001|Months 0-3|Lost to Follow-up|0|||
146821425|NCT00434577|529515234|FG002|Months 0-3|Lost to Follow-up|0|||
146821426|NCT00434577|529515235|FG003|Months 0-3|Lost to Follow-up|0|||
146821427|NCT00434577|529515236|FG004|Months 0-3|Lost to Follow-up|2|||
146821428|NCT00434577|529515232|FG000|Months 0-3|Protocol Violation|1|||
146821429|NCT00434577|529515233|FG001|Months 0-3|Protocol Violation|0|||
146821430|NCT00434577|529515234|FG002|Months 0-3|Protocol Violation|1|||
146821431|NCT00434577|529515235|FG003|Months 0-3|Protocol Violation|0|||
146821432|NCT00434577|529515236|FG004|Months 0-3|Protocol Violation|0|||
146821433|NCT00434577|529515232|FG000|Months 0-3|Withdrawal by Subject|2|||
146821434|NCT00434577|529515233|FG001|Months 0-3|Withdrawal by Subject|1|||
146821435|NCT00434577|529515234|FG002|Months 0-3|Withdrawal by Subject|1|||
146821436|NCT00434577|529515235|FG003|Months 0-3|Withdrawal by Subject|1|||
146821437|NCT00434577|529515236|FG004|Months 0-3|Withdrawal by Subject|1|||
146821438|NCT00635570|529515237|FG000|Overall Study|Lost to Follow-up|8|||
146821439|NCT00635570|529515238|FG001|Overall Study|Lost to Follow-up|8|||
146821440|NCT00635570|529515237|FG000|Overall Study|Withdrawal by Subject|1|||
146821441|NCT00635570|529515238|FG001|Overall Study|Withdrawal by Subject|1|||
146821442|NCT00635570|529515237|FG000|Overall Study|Adverse Event|2|||
146821443|NCT00635570|529515238|FG001|Overall Study|Adverse Event|0|||
146821444|NCT00635570|529515237|FG000|Overall Study|Physician Decision|1|||
146821445|NCT00635570|529515238|FG001|Overall Study|Physician Decision|0|||
146821446|NCT00635570|529515237|FG000|Overall Study|Did not complete survey|2|||
146821447|NCT00635570|529515238|FG001|Overall Study|Did not complete survey|1|||
146821448|NCT00635570|529515237|FG000|Overall Study|Early termination(No sexual activity)|1|||
146821449|NCT00635570|529515238|FG001|Overall Study|Early termination(No sexual activity)|1|||
146821450|NCT00332488|529515242|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
146821451|NCT00332488|529515243|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
146821452|NCT00332488|529515244|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
146821453|NCT00332488|529515242|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
146821454|NCT00332488|529515243|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
146821455|NCT00332488|529515244|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
146821456|NCT00332488|529515242|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
146821457|NCT00332488|529515243|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
146821458|NCT00332488|529515244|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
146821459|NCT00332488|529515242|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
146821460|NCT00332488|529515243|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
146821461|NCT00332488|529515244|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
146821462|NCT00332488|529515242|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
146821463|NCT00332488|529515243|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
146821464|NCT00332488|529515244|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
146821465|NCT00332488|529515242|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
146821466|NCT00332488|529515243|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
146821467|NCT00332488|529515244|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
146821468|NCT00332488|529515242|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
146821469|NCT00332488|529515243|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
146821470|NCT00332488|529515244|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
146821471|NCT00332488|529515242|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
146821472|NCT00332488|529515243|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
146821473|NCT00332488|529515244|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
146821474|NCT00332488|529515242|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
146821475|NCT00332488|529515243|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
146821476|NCT00332488|529515244|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
146821477|NCT00332488|529515242|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
146821478|NCT00332488|529515243|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
146821479|NCT00332488|529515244|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
146821480|NCT00332488|529515242|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
146821481|NCT00332488|529515243|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
146821482|NCT00332488|529515244|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
146821483|NCT00332488|529515242|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
146821484|NCT00332488|529515243|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
146821485|NCT00332488|529515244|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
146821486|NCT04816708|529515247|FG000|Overall Study|Lost to Follow-up|10|||
146821487|NCT04816708|529515248|FG001|Overall Study|Lost to Follow-up|4|||
146821488|NCT01503515|529515252|FG000|Overall Study|Adverse Event|4|||
146821489|NCT01503515|529515253|FG001|Overall Study|Adverse Event|5|||
146821490|NCT01503515|529515252|FG000|Overall Study|Death|0|||
146821491|NCT01503515|529515253|FG001|Overall Study|Death|1|||
146821492|NCT01503515|529515252|FG000|Overall Study|Physician Decision|14|||
146821493|NCT01503515|529515253|FG001|Overall Study|Physician Decision|23|||
146821494|NCT01503515|529515252|FG000|Overall Study|Withdrawal by Subject|0|||
146821495|NCT01503515|529515253|FG001|Overall Study|Withdrawal by Subject|1|||
146821496|NCT01503515|529515252|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
146821497|NCT01503515|529515253|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
146821498|NCT01503515|529515252|FG000|Overall Study|Ineligible|1|||
146821499|NCT01503515|529515253|FG001|Overall Study|Ineligible|1|||
146821500|NCT04050722|529515254|FG000|Overall Study|Withdrawal by Subject|1|||
146821501|NCT04050722|529515255|FG001|Overall Study|Withdrawal by Subject|0|||
146821502|NCT01350102|529515256|FG000|Overall Study|Adverse Event|0|||
146821503|NCT01350102|529515257|FG001|Overall Study|Adverse Event|0|||
146821504|NCT01350102|529515258|FG002|Overall Study|Adverse Event|1|||
146821505|NCT01350102|529515259|FG003|Overall Study|Adverse Event|0|||
146821506|NCT03087851|529515263|FG000|Overall Study|Withdraw on medical grounds|0|||
146821507|NCT03087851|529515264|FG001|Overall Study|Withdraw on medical grounds|1|||
146821508|NCT03087851|529515265|FG002|Overall Study|Withdraw on medical grounds|2|||
146821509|NCT00377312|529515268|FG000|Overall Study|Adverse Event|1|||
146951165|NCT01004861|529979909|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
146951166|NCT01004861|529979910|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146821510|NCT00377312|529515269|FG001|Overall Study|Adverse Event|1|||
146821511|NCT02775214|529515270|FG000|Overall Study|Withdrawal by Subject|2|||
146821512|NCT02775214|529515271|FG001|Overall Study|Withdrawal by Subject|0|||
146821513|NCT00762723|529515272|FG000|Overall Study|Study Terminated slow enrollement|5|||
146962311|NCT01049360|530021583|FG009|Period 1|Did not meet inc/exc criteria|0|||
146821514|NCT00762723|529515273|FG001|Overall Study|Study Terminated slow enrollement|5|||
146821515|NCT00762723|529515274|FG002|Overall Study|Study Terminated slow enrollement|3|||
146821516|NCT01572493|529515279|FG000|Overall Study|Physician Decision|1|||
146821517|NCT01572493|529515280|FG001|Overall Study|Physician Decision|0|||
146821518|NCT01572493|529515281|FG002|Overall Study|Physician Decision|0|||
146821519|NCT01572493|529515282|FG003|Overall Study|Physician Decision|0|||
146821520|NCT01572493|529515283|FG004|Overall Study|Physician Decision|0|||
146821521|NCT01572493|529515284|FG005|Overall Study|Physician Decision|0|||
146821522|NCT01572493|529515285|FG006|Overall Study|Physician Decision|0|||
146821523|NCT01572493|529515286|FG007|Overall Study|Physician Decision|0|||
146821524|NCT01572493|529515287|FG008|Overall Study|Physician Decision|0|||
146821525|NCT01572493|529515279|FG000|Overall Study|Switched to alternative treatment|0|||
146821526|NCT01572493|529515280|FG001|Overall Study|Switched to alternative treatment|1|||
146821527|NCT01572493|529515281|FG002|Overall Study|Switched to alternative treatment|2|||
146821528|NCT01572493|529515282|FG003|Overall Study|Switched to alternative treatment|1|||
146821529|NCT01572493|529515283|FG004|Overall Study|Switched to alternative treatment|2|||
146821530|NCT01572493|529515284|FG005|Overall Study|Switched to alternative treatment|0|||
146821531|NCT01572493|529515285|FG006|Overall Study|Switched to alternative treatment|2|||
146821532|NCT01572493|529515286|FG007|Overall Study|Switched to alternative treatment|0|||
146821533|NCT01572493|529515287|FG008|Overall Study|Switched to alternative treatment|2|||
146821534|NCT01572493|529515279|FG000|Overall Study|Death|0|||
146821535|NCT01572493|529515280|FG001|Overall Study|Death|0|||
146821536|NCT01572493|529515281|FG002|Overall Study|Death|0|||
146821537|NCT01572493|529515282|FG003|Overall Study|Death|1|||
146821538|NCT01572493|529515283|FG004|Overall Study|Death|0|||
146821539|NCT01572493|529515284|FG005|Overall Study|Death|1|||
146821540|NCT01572493|529515285|FG006|Overall Study|Death|0|||
146821541|NCT01572493|529515286|FG007|Overall Study|Death|0|||
146821542|NCT01572493|529515287|FG008|Overall Study|Death|0|||
146821543|NCT01572493|529515279|FG000|Overall Study|Adverse Event|0|||
146821544|NCT01572493|529515280|FG001|Overall Study|Adverse Event|0|||
146821545|NCT01572493|529515281|FG002|Overall Study|Adverse Event|0|||
146821546|NCT01572493|529515282|FG003|Overall Study|Adverse Event|0|||
146821547|NCT01572493|529515283|FG004|Overall Study|Adverse Event|0|||
146821548|NCT01572493|529515284|FG005|Overall Study|Adverse Event|0|||
146821549|NCT01572493|529515285|FG006|Overall Study|Adverse Event|1|||
146821550|NCT01572493|529515286|FG007|Overall Study|Adverse Event|0|||
146821551|NCT01572493|529515287|FG008|Overall Study|Adverse Event|0|||
146821552|NCT00609245|529515288|FG000|Overall Study|Adverse Event|1|||
146821553|NCT01090076|529515289|FG000|Overall Study|Death|1|||
146821554|NCT01090076|529515290|FG001|Overall Study|Death|1|||
146821555|NCT01090076|529515289|FG000|Overall Study|Withdrawal by Subject|0|||
146821556|NCT01090076|529515290|FG001|Overall Study|Withdrawal by Subject|1|||
146821557|NCT01116440|529515291|FG000|Treatment|Withdrawal by Subject|2|||
146821558|NCT01116440|529515292|FG001|Treatment|Withdrawal by Subject|2|||
146821559|NCT01116440|529515291|FG000|Treatment|Lost to Follow-up|1|||
146821560|NCT01116440|529515292|FG001|Treatment|Lost to Follow-up|1|||
146821561|NCT01116440|529515291|FG000|Treatment|Protocol Violation|0|||
146821562|NCT01116440|529515292|FG001|Treatment|Protocol Violation|2|||
146821563|NCT01116440|529515291|FG000|Treatment|Lack of Efficacy|0|||
146821564|NCT01116440|529515292|FG001|Treatment|Lack of Efficacy|1|||
146821565|NCT01116440|529515291|FG000|Treatment|Adverse Event|0|||
146821566|NCT01116440|529515292|FG001|Treatment|Adverse Event|1|||
146821567|NCT01116440|529515291|FG000|Withdrawal|Withdrawal by Subject|0|||
146821568|NCT01116440|529515292|FG001|Withdrawal|Withdrawal by Subject|1|||
146821569|NCT01116440|529515291|FG000|Withdrawal|Lost to Follow-up|0|||
146821570|NCT01116440|529515292|FG001|Withdrawal|Lost to Follow-up|1|||
146821571|NCT01116440|529515291|FG000|Follow-up|Lost to Follow-up|0|||
146821572|NCT01116440|529515292|FG001|Follow-up|Lost to Follow-up|1|||
146821573|NCT01116440|529515291|FG000|Follow-up|Withdrawal by Subject|0|||
146821574|NCT01116440|529515292|FG001|Follow-up|Withdrawal by Subject|1|||
146821575|NCT02402465|529515304|FG000|Overall Study|Withdrawal by Subject|0|||
146821576|NCT02402465|529515305|FG001|Overall Study|Withdrawal by Subject|0|||
146821577|NCT02402465|529515306|FG002|Overall Study|Withdrawal by Subject|0|||
146821578|NCT02402465|529515307|FG003|Overall Study|Withdrawal by Subject|0|||
146821579|NCT02402465|529515308|FG004|Overall Study|Withdrawal by Subject|0|||
146821580|NCT02402465|529515309|FG005|Overall Study|Withdrawal by Subject|1|||
146821581|NCT02402465|529515304|FG000|Overall Study|Lost to Follow-up|0|||
146821582|NCT02402465|529515305|FG001|Overall Study|Lost to Follow-up|1|||
146821583|NCT02402465|529515306|FG002|Overall Study|Lost to Follow-up|0|||
146821584|NCT02402465|529515307|FG003|Overall Study|Lost to Follow-up|0|||
146821585|NCT02402465|529515308|FG004|Overall Study|Lost to Follow-up|1|||
146821586|NCT02402465|529515309|FG005|Overall Study|Lost to Follow-up|0|||
146821587|NCT01284634|529515310|FG000|Overall Study|Adverse Event|1|||
146821588|NCT01284634|529515311|FG001|Overall Study|Adverse Event|0|||
146821589|NCT01284634|529515312|FG002|Overall Study|Adverse Event|2|||
146821590|NCT01284634|529515313|FG003|Overall Study|Adverse Event|1|||
146821591|NCT02236598|529515314|FG000|Overall Study|Adverse Event|0|||
146821592|NCT02236598|529515315|FG001|Overall Study|Adverse Event|1|||
146821593|NCT02236598|529515314|FG000|Overall Study|Withdrawal by Subject|0|||
146821594|NCT02236598|529515315|FG001|Overall Study|Withdrawal by Subject|1|||
146821595|NCT03334747|529515325|FG000|Treatment Phase|Technical problems|0|||
146821596|NCT03334747|529515326|FG001|Treatment Phase|Technical problems|0|||
146821597|NCT03334747|529515327|FG002|Treatment Phase|Technical problems|0|||
146821598|NCT03334747|529515328|FG003|Treatment Phase|Technical problems|0|||
146821599|NCT03334747|529515329|FG004|Treatment Phase|Technical problems|1|||
146821600|NCT03334747|529515330|FG005|Treatment Phase|Technical problems|0|||
146821601|NCT03334747|529515331|FG006|Treatment Phase|Technical problems|0|||
146821602|NCT03334747|529515332|FG007|Treatment Phase|Technical problems|0|||
146821603|NCT03334747|529515333|FG008|Treatment Phase|Technical problems|0|||
146821604|NCT03334747|529515325|FG000|Treatment Phase|Subject/guardian decision|1|||
146821605|NCT03334747|529515326|FG001|Treatment Phase|Subject/guardian decision|0|||
146821606|NCT03334747|529515327|FG002|Treatment Phase|Subject/guardian decision|0|||
146821607|NCT03334747|529515328|FG003|Treatment Phase|Subject/guardian decision|0|||
146821608|NCT03334747|529515329|FG004|Treatment Phase|Subject/guardian decision|0|||
146821609|NCT03334747|529515330|FG005|Treatment Phase|Subject/guardian decision|1|||
146821610|NCT03334747|529515331|FG006|Treatment Phase|Subject/guardian decision|0|||
146821611|NCT03334747|529515332|FG007|Treatment Phase|Subject/guardian decision|0|||
146821612|NCT03334747|529515333|FG008|Treatment Phase|Subject/guardian decision|0|||
146821613|NCT03334747|529515325|FG000|Follow-Up Phase|Subject/guardian decision|0|||
146821614|NCT03334747|529515326|FG001|Follow-Up Phase|Subject/guardian decision|0|||
146821615|NCT03334747|529515327|FG002|Follow-Up Phase|Subject/guardian decision|0|||
146821616|NCT03334747|529515328|FG003|Follow-Up Phase|Subject/guardian decision|0|||
146821617|NCT03334747|529515329|FG004|Follow-Up Phase|Subject/guardian decision|0|||
146821618|NCT03334747|529515330|FG005|Follow-Up Phase|Subject/guardian decision|0|||
146821619|NCT03334747|529515331|FG006|Follow-Up Phase|Subject/guardian decision|1|||
146821620|NCT03334747|529515332|FG007|Follow-Up Phase|Subject/guardian decision|0|||
146821621|NCT03334747|529515333|FG008|Follow-Up Phase|Subject/guardian decision|1|||
146821622|NCT00191984|529515334|FG000|Overall Study|Disease Progression|21|||
146821623|NCT00191984|529515334|FG000|Overall Study|Adverse Event|4|||
146821624|NCT00191984|529515334|FG000|Overall Study|Death|2|||
146821625|NCT00191984|529515334|FG000|Overall Study|Entry Criteria Exclusion|1|||
146821626|NCT00191984|529515334|FG000|Overall Study|Withdrawal by Subject|7|||
146821627|NCT00191984|529515334|FG000|Overall Study|Physician Decision|4|||
146821628|NCT03303521|529515335|FG000|Overall Study|Withdrawal by Subject|2|||
146821629|NCT03303521|529515336|FG001|Overall Study|Withdrawal by Subject|0|||
146821630|NCT03303521|529515335|FG000|Overall Study|Death|1|||
146821631|NCT03303521|529515336|FG001|Overall Study|Death|0|||
146821632|NCT03303521|529515335|FG000|Overall Study|Kidney transplantation|0|||
146821633|NCT03303521|529515336|FG001|Overall Study|Kidney transplantation|1|||
146821634|NCT03303521|529515335|FG000|Overall Study|Investigational product discontinuation|0|||
146821635|NCT03303521|529515336|FG001|Overall Study|Investigational product discontinuation|1|||
146821636|NCT03303521|529515335|FG000|Overall Study|Transferred to non-study dialysis center|1|||
146821637|NCT03303521|529515336|FG001|Overall Study|Transferred to non-study dialysis center|0|||
146821638|NCT03303521|529515335|FG000|Overall Study|Non-comliance to study protocol|0|||
146821639|NCT03303521|529515336|FG001|Overall Study|Non-comliance to study protocol|1|||
146821640|NCT03303521|529515335|FG000|Overall Study|Adverse Event|1|||
146821641|NCT03303521|529515336|FG001|Overall Study|Adverse Event|0|||
146821642|NCT01654289|529515337|FG000|Overall Study|Withdrawal by Subject|10|||
146821643|NCT01654289|529515338|FG001|Overall Study|Withdrawal by Subject|8|||
146821644|NCT01654289|529515339|FG002|Overall Study|Withdrawal by Subject|5|||
146821645|NCT01654289|529515337|FG000|Overall Study|Withdrew from intervention only|17|||
146821646|NCT01654289|529515338|FG001|Overall Study|Withdrew from intervention only|20|||
146821647|NCT01654289|529515339|FG002|Overall Study|Withdrew from intervention only|0|||
146821648|NCT01732627|529515340|FG000|Overall Study|Withdrawal by Subject|1|||
146821649|NCT01732627|529515341|FG001|Overall Study|Withdrawal by Subject|0|||
146821650|NCT02137239|529515342|FG000|Overall Study|Discontinued Study Treatment|0|||
146951167|NCT01004861|529979911|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146951168|NCT01004861|529979912|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146951169|NCT01004861|529979913|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146951170|NCT01004861|529979901|FG000|Overall Study|Patient withdrew|0|||
146951171|NCT01004861|529979902|FG001|Overall Study|Patient withdrew|0|||
146951172|NCT01004861|529979903|FG002|Overall Study|Patient withdrew|0|||
146951173|NCT01004861|529979904|FG003|Overall Study|Patient withdrew|0|||
146951174|NCT01004861|529979905|FG004|Overall Study|Patient withdrew|0|||
146821651|NCT02137239|529515343|FG001|Overall Study|Discontinued Study Treatment|3|||
146821652|NCT02137239|529515342|FG000|Overall Study|Withdrew Consent|1|||
146821653|NCT02137239|529515343|FG001|Overall Study|Withdrew Consent|1|||
146821654|NCT02137239|529515342|FG000|Overall Study|Adverse Event|2|||
146821655|NCT02137239|529515343|FG001|Overall Study|Adverse Event|2|||
146821656|NCT00005908|529515346|FG000|Overall Study|Withdrawal by Subject|1|||
146821657|NCT00005908|529515347|FG001|Overall Study|Withdrawal by Subject|0|||
146821658|NCT04736602|529515348|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
146821659|NCT04736602|529515348|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
146821660|NCT01379521|529515353|FG000|Overall Study -Treatment Period|Adverse Event|3|||
146821661|NCT01379521|529515354|FG001|Overall Study -Treatment Period|Adverse Event|0|||
146821662|NCT01379521|529515353|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
146821663|NCT01379521|529515354|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
146821664|NCT01379521|529515353|FG000|Overall Study -Treatment Period|Disease Progression|23|||
146821665|NCT01379521|529515354|FG001|Overall Study -Treatment Period|Disease Progression|22|||
146821666|NCT01379521|529515353|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
146821667|NCT01379521|529515354|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
146821668|NCT01379521|529515353|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
146821669|NCT01379521|529515354|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
146821670|NCT01379521|529515353|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
146821671|NCT01379521|529515354|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
146821672|NCT01379521|529515353|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
146821673|NCT01379521|529515354|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
146821674|NCT01379521|529515353|FG000|Overall Study -Treatment Period|Death|2|||
146821675|NCT01379521|529515354|FG001|Overall Study -Treatment Period|Death|1|||
146821676|NCT01379521|529515353|FG000|Post-Treatment Evaluations|Disease Progression|22|||
146821677|NCT01379521|529515354|FG001|Post-Treatment Evaluations|Disease Progression|20|||
146821678|NCT01379521|529515353|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
146821679|NCT01379521|529515354|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
146821680|NCT01379521|529515353|FG000|Post-Treatment Evaluations|Death|1|||
146821681|NCT01379521|529515354|FG001|Post-Treatment Evaluations|Death|0|||
146821682|NCT00938041|529515355|FG000|Overall Study|Lost to Follow-up|6|||
146821683|NCT00938041|529515355|FG000|Overall Study|Received Alternative Therapy|1|||
146821684|NCT00938041|529515355|FG000|Overall Study|Progressive Disease|5|||
146821685|NCT00938041|529515355|FG000|Overall Study|Death|12|||
146821686|NCT00938041|529515355|FG000|Overall Study|Adrenal Insufficiency|3|||
146821687|NCT03042559|529515356|FG000|Overall Study|drop out|1|||
146821688|NCT03042559|529515357|FG001|Overall Study|drop out|1|||
146821689|NCT01536535|529515359|FG000|Overall Study|Withdrawal by Subject|10|||
146821690|NCT01536535|529515360|FG001|Overall Study|Withdrawal by Subject|5|||
146821691|NCT01536535|529515359|FG000|Overall Study|Lost to Follow-up|4|||
146821692|NCT01536535|529515360|FG001|Overall Study|Lost to Follow-up|6|||
146821693|NCT01536535|529515359|FG000|Overall Study|Physician Decision|1|||
146821694|NCT01536535|529515360|FG001|Overall Study|Physician Decision|1|||
146821695|NCT01536535|529515359|FG000|Overall Study|Participant moved|0|||
146821696|NCT01536535|529515360|FG001|Overall Study|Participant moved|1|||
146821697|NCT01485991|529515364|FG000|Overall Study|Adverse Event|0|||
146821698|NCT01485991|529515365|FG001|Overall Study|Adverse Event|4|||
146821699|NCT01485991|529515364|FG000|Overall Study|Lost to Follow-up|13|||
146821700|NCT01485991|529515365|FG001|Overall Study|Lost to Follow-up|10|||
146821701|NCT01485991|529515364|FG000|Overall Study|Withdrawal by Subject|13|||
146821702|NCT01485991|529515365|FG001|Overall Study|Withdrawal by Subject|20|||
146821703|NCT01485991|529515364|FG000|Overall Study|randomized but not treated|6|||
146821704|NCT01485991|529515365|FG001|Overall Study|randomized but not treated|2|||
146821705|NCT02538471|529515366|FG000|Overall Study|Progression of disease|2|||
146821706|NCT01475370|529515367|FG000|Overall Study|Exacerbation of primary disease|2|||
146821707|NCT01475370|529515368|FG001|Overall Study|Exacerbation of primary disease|2|||
146821708|NCT01475370|529515369|FG002|Overall Study|Exacerbation of primary disease|2|||
146821709|NCT01475370|529515367|FG000|Overall Study|Study drug administration difficult|0|||
146821710|NCT01475370|529515368|FG001|Overall Study|Study drug administration difficult|1|||
146821711|NCT01475370|529515369|FG002|Overall Study|Study drug administration difficult|1|||
146821712|NCT01475370|529515367|FG000|Overall Study|Other than specified|1|||
146821713|NCT01475370|529515368|FG001|Overall Study|Other than specified|0|||
146821714|NCT01475370|529515369|FG002|Overall Study|Other than specified|0|||
146821715|NCT00125853|529515370|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
146821716|NCT00125853|529515371|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
146821717|NCT02522299|529515372|FG000|Overall Study|Adverse Event|2|||
146821718|NCT02522299|529515373|FG001|Overall Study|Adverse Event|0|||
146821719|NCT02522299|529515372|FG000|Overall Study|Physician Decision|0|||
146821720|NCT02522299|529515373|FG001|Overall Study|Physician Decision|1|||
146821721|NCT02522299|529515372|FG000|Overall Study|Withdrawal by Subject|2|||
146821722|NCT02522299|529515373|FG001|Overall Study|Withdrawal by Subject|0|||
146821723|NCT04908800|529515374|FG000|Overall Study|Adverse Event|0|||
146821724|NCT04908800|529515375|FG001|Overall Study|Adverse Event|0|||
146821725|NCT04908800|529515376|FG002|Overall Study|Adverse Event|0|||
146821726|NCT04908800|529515377|FG003|Overall Study|Adverse Event|0|||
146821727|NCT04908800|529515378|FG004|Overall Study|Adverse Event|0|||
146821728|NCT04908800|529515379|FG005|Overall Study|Adverse Event|0|||
146821729|NCT04908800|529515380|FG006|Overall Study|Adverse Event|0|||
146821730|NCT04908800|529515381|FG007|Overall Study|Adverse Event|0|||
146821731|NCT04908800|529515382|FG008|Overall Study|Adverse Event|0|||
146821732|NCT04908800|529515383|FG009|Overall Study|Adverse Event|0|||
146821733|NCT04908800|529515384|FG010|Overall Study|Adverse Event|1|||
146821734|NCT04908800|529515385|FG011|Overall Study|Adverse Event|0|||
146821735|NCT04908800|529515386|FG012|Overall Study|Adverse Event|0|||
146821736|NCT00157209|529515387|FG000|Overall Study|Ongoing at data cut-off|10|||
146821737|NCT00157209|529515388|FG001|Overall Study|Ongoing at data cut-off|0|||
146821738|NCT04474691|529515389|FG000|Overall Study|Withdrawal by Subject|9|||
146821739|NCT01323309|529515390|FG000|Overall Study|Death|9|||
146821740|NCT01323309|529515391|FG001|Overall Study|Death|15|||
146821741|NCT01323309|529515392|FG002|Overall Study|Death|5|||
146821742|NCT01323309|529515390|FG000|Overall Study|Lost to Follow-up|11|||
146821743|NCT01323309|529515391|FG001|Overall Study|Lost to Follow-up|14|||
146821744|NCT01323309|529515392|FG002|Overall Study|Lost to Follow-up|24|||
146821745|NCT01323309|529515390|FG000|Overall Study|Withdrawal by Subject|14|||
146821746|NCT01323309|529515391|FG001|Overall Study|Withdrawal by Subject|14|||
146821747|NCT01323309|529515392|FG002|Overall Study|Withdrawal by Subject|18|||
146821748|NCT01323309|529515390|FG000|Overall Study|Disease progression|5|||
146821749|NCT01323309|529515391|FG001|Overall Study|Disease progression|11|||
146821750|NCT01323309|529515392|FG002|Overall Study|Disease progression|4|||
146821751|NCT00449033|529515405|FG000|Treatment Period|Adverse Event|117|||
146821752|NCT00449033|529515406|FG001|Treatment Period|Adverse Event|83|||
146821753|NCT00449033|529515405|FG000|Treatment Period|Death|21|||
146821754|NCT00449033|529515406|FG001|Treatment Period|Death|12|||
146821755|NCT00449033|529515405|FG000|Treatment Period|Lost to Follow-up|0|||
146821756|NCT00449033|529515406|FG001|Treatment Period|Lost to Follow-up|2|||
146821757|NCT00449033|529515405|FG000|Treatment Period|Physician Decision|4|||
146821758|NCT00449033|529515406|FG001|Treatment Period|Physician Decision|5|||
146821759|NCT00449033|529515405|FG000|Treatment Period|Protocol Violation|8|||
146821760|NCT00449033|529515406|FG001|Treatment Period|Protocol Violation|7|||
146821761|NCT00449033|529515405|FG000|Treatment Period|Disease Progression|231|||
146821762|NCT00449033|529515406|FG001|Treatment Period|Disease Progression|288|||
146821763|NCT00449033|529515405|FG000|Treatment Period|Consent Withdrawn|36|||
146821764|NCT00449033|529515406|FG001|Treatment Period|Consent Withdrawn|20|||
146821765|NCT00449033|529515405|FG000|Treatment Period|Amended Protocol Criteria|22|||
146821766|NCT00449033|529515406|FG001|Treatment Period|Amended Protocol Criteria|18|||
146821767|NCT00449033|529515405|FG000|Treatment Period|Non-compliance|7|||
146821768|NCT00449033|529515406|FG001|Treatment Period|Non-compliance|8|||
146821769|NCT00449033|529515405|FG000|Treatment Period|Second Malignancy|0|||
146821770|NCT00449033|529515406|FG001|Treatment Period|Second Malignancy|1|||
146821771|NCT00449033|529515405|FG000|Treatment Period|Reason Missing|0|||
146821772|NCT00449033|529515406|FG001|Treatment Period|Reason Missing|4|||
146821773|NCT00449033|529515405|FG000|Treatment Period|Treatment Ongoing|6|||
146821774|NCT00449033|529515406|FG001|Treatment Period|Treatment Ongoing|4|||
146821775|NCT00449033|529515405|FG000|Follow-up Period|Death|299|||
146821776|NCT00449033|529515406|FG001|Follow-up Period|Death|311|||
146821777|NCT00449033|529515405|FG000|Follow-up Period|Lost to Follow-up|6|||
146821778|NCT00449033|529515406|FG001|Follow-up Period|Lost to Follow-up|10|||
146821779|NCT00449033|529515405|FG000|Follow-up Period|Reason Missing|120|||
146821780|NCT00449033|529515406|FG001|Follow-up Period|Reason Missing|113|||
146821781|NCT01261793|529515412|FG000|Overall Study|Lack of Efficacy|44|||
146821782|NCT01261793|529515413|FG001|Overall Study|Lack of Efficacy|37|||
146821783|NCT01261793|529515414|FG002|Overall Study|Lack of Efficacy|32|||
146821784|NCT01261793|529515412|FG000|Overall Study|Protocol Violation|3|||
146821785|NCT01261793|529515413|FG001|Overall Study|Protocol Violation|5|||
146821786|NCT01261793|529515414|FG002|Overall Study|Protocol Violation|6|||
146821787|NCT01261793|529515412|FG000|Overall Study|Lost to Follow-up|10|||
146821788|NCT01261793|529515413|FG001|Overall Study|Lost to Follow-up|3|||
146821789|NCT01261793|529515414|FG002|Overall Study|Lost to Follow-up|7|||
146821790|NCT01261793|529515412|FG000|Overall Study|Withdrawal by Subject|12|||
146821791|NCT01261793|529515413|FG001|Overall Study|Withdrawal by Subject|14|||
146821792|NCT01261793|529515414|FG002|Overall Study|Withdrawal by Subject|14|||
146821793|NCT01261793|529515412|FG000|Overall Study|Death|3|||
146821794|NCT01261793|529515413|FG001|Overall Study|Death|1|||
146821795|NCT01261793|529515414|FG002|Overall Study|Death|0|||
146821796|NCT01261793|529515412|FG000|Overall Study|Adverse Event|9|||
146821797|NCT01261793|529515413|FG001|Overall Study|Adverse Event|24|||
146821798|NCT01261793|529515414|FG002|Overall Study|Adverse Event|19|||
146821799|NCT01261793|529515412|FG000|Overall Study|Patient non-availability|1|||
146821800|NCT01261793|529515413|FG001|Overall Study|Patient non-availability|1|||
146821801|NCT01261793|529515414|FG002|Overall Study|Patient non-availability|1|||
146821802|NCT01261793|529515412|FG000|Overall Study|Suspected pregnancy|1|||
146821803|NCT01261793|529515413|FG001|Overall Study|Suspected pregnancy|1|||
146821804|NCT01261793|529515414|FG002|Overall Study|Suspected pregnancy|0|||
146821805|NCT01261793|529515412|FG000|Overall Study|Patient non-compliance|1|||
146821806|NCT01261793|529515413|FG001|Overall Study|Patient non-compliance|0|||
146821807|NCT01261793|529515414|FG002|Overall Study|Patient non-compliance|1|||
146821808|NCT01261793|529515412|FG000|Overall Study|Patient pregnant|1|||
146821809|NCT01261793|529515413|FG001|Overall Study|Patient pregnant|0|||
146821810|NCT01261793|529515414|FG002|Overall Study|Patient pregnant|0|||
146821811|NCT01261793|529515412|FG000|Overall Study|Outside the study area|0|||
146821812|NCT01261793|529515413|FG001|Overall Study|Outside the study area|2|||
146951175|NCT01004861|529979906|FG005|Overall Study|Patient withdrew|0|||
146821813|NCT01261793|529515414|FG002|Overall Study|Outside the study area|1|||
146821814|NCT01261793|529515412|FG000|Overall Study|Lack of efficacy & patient not available|0|||
146821815|NCT01261793|529515413|FG001|Overall Study|Lack of efficacy & patient not available|1|||
146821816|NCT01261793|529515414|FG002|Overall Study|Lack of efficacy & patient not available|0|||
146821817|NCT01261793|529515412|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
146821818|NCT01261793|529515413|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
146821819|NCT01261793|529515414|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
146821820|NCT01261793|529515412|FG000|Overall Study|Randomization error|0|||
146821821|NCT01261793|529515413|FG001|Overall Study|Randomization error|1|||
146821822|NCT01261793|529515414|FG002|Overall Study|Randomization error|0|||
146821823|NCT01261793|529515412|FG000|Overall Study|Patient unable to start IV line|0|||
146821824|NCT01261793|529515413|FG001|Overall Study|Patient unable to start IV line|0|||
146821825|NCT01261793|529515414|FG002|Overall Study|Patient unable to start IV line|1|||
146821826|NCT03305458|529515415|FG000|Overall Study|Withdrawal by Subject|50|||
146821827|NCT03305458|529515416|FG001|Overall Study|Withdrawal by Subject|46|||
146821828|NCT03305458|529515417|FG002|Overall Study|Withdrawal by Subject|93|||
146821829|NCT03305458|529515415|FG000|Overall Study|Lost to Follow-up|85|||
146821830|NCT03305458|529515416|FG001|Overall Study|Lost to Follow-up|85|||
146821831|NCT03305458|529515417|FG002|Overall Study|Lost to Follow-up|35|||
146821832|NCT01786551|529515418|FG000|Overall Study|Participant withdrew consent|2|||
146821833|NCT01904019|529516829|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
146821834|NCT01904019|529516829|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
146821835|NCT01904019|529516829|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
146821836|NCT01904019|529516829|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
146821837|NCT01904019|529516829|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
146821838|NCT01904019|529516829|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
146821839|NCT04357964|529516830|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
146821840|NCT04357964|529516831|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
146821841|NCT04357964|529516830|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
146821842|NCT04357964|529516831|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
146821843|NCT04357964|529516830|FG000|Overall Study|Adipose sample was insufficient quality|0|||
146821844|NCT04357964|529516831|FG001|Overall Study|Adipose sample was insufficient quality|1|||
146821845|NCT00733226|529516832|FG000|Overall Study|Withdrawal by Subject|1|||
146821846|NCT00733226|529516833|FG001|Overall Study|Withdrawal by Subject|0|||
146821847|NCT00733226|529516832|FG000|Overall Study|Lost to Follow-up|2|||
146821848|NCT00733226|529516833|FG001|Overall Study|Lost to Follow-up|0|||
146821849|NCT00733226|529516832|FG000|Overall Study|moved to another place|2|||
146821850|NCT00733226|529516833|FG001|Overall Study|moved to another place|0|||
146821851|NCT02561078|529516834|FG000|Overall Study|Adverse Event|5|||
146821852|NCT02561078|529516835|FG001|Overall Study|Adverse Event|2|||
146821853|NCT02561078|529516834|FG000|Overall Study|Death|2|||
146821854|NCT02561078|529516835|FG001|Overall Study|Death|1|||
146821855|NCT02561078|529516834|FG000|Overall Study|Lost to Follow-up|2|||
146821856|NCT02561078|529516835|FG001|Overall Study|Lost to Follow-up|6|||
146821857|NCT02561078|529516834|FG000|Overall Study|Non-Compliance with Study Drug|6|||
146821858|NCT02561078|529516835|FG001|Overall Study|Non-Compliance with Study Drug|3|||
146821859|NCT02561078|529516834|FG000|Overall Study|Physician Decision|2|||
146821860|NCT02561078|529516835|FG001|Overall Study|Physician Decision|3|||
146821861|NCT02561078|529516834|FG000|Overall Study|Withdrawal by Subject|13|||
146821862|NCT02561078|529516835|FG001|Overall Study|Withdrawal by Subject|10|||
146821863|NCT03722485|529516836|FG000|Overall Study|Withdrawal by Subject|1|||
146821864|NCT03722485|529516837|FG001|Overall Study|Withdrawal by Subject|0|||
146821865|NCT03722485|529516836|FG000|Overall Study|Adverse Event|0|||
146821866|NCT03722485|529516837|FG001|Overall Study|Adverse Event|2|||
146821867|NCT03722485|529516836|FG000|Overall Study|subject discharged prior to study completion|1|||
146821868|NCT03722485|529516837|FG001|Overall Study|subject discharged prior to study completion|5|||
146821869|NCT03722485|529516836|FG000|Overall Study|eligibility criteria not met|2|||
146821870|NCT03722485|529516837|FG001|Overall Study|eligibility criteria not met|0|||
146821871|NCT02151643|529516838|FG000|Overall Study|Adverse Event|2|||
146821872|NCT02151643|529516839|FG001|Overall Study|Adverse Event|0|||
146821873|NCT02151643|529516840|FG002|Overall Study|Adverse Event|1|||
146821874|NCT02151643|529516841|FG003|Overall Study|Adverse Event|4|||
146821875|NCT02151643|529516842|FG004|Overall Study|Adverse Event|0|||
146821876|NCT02151643|529516838|FG000|Overall Study|Withdrawal by Subject|0|||
146821877|NCT02151643|529516839|FG001|Overall Study|Withdrawal by Subject|1|||
146821878|NCT02151643|529516840|FG002|Overall Study|Withdrawal by Subject|1|||
146821879|NCT02151643|529516841|FG003|Overall Study|Withdrawal by Subject|1|||
146821880|NCT02151643|529516842|FG004|Overall Study|Withdrawal by Subject|1|||
146821881|NCT02151643|529516838|FG000|Overall Study|Hyperphosphataemia|1|||
146821882|NCT02151643|529516839|FG001|Overall Study|Hyperphosphataemia|0|||
146821883|NCT02151643|529516840|FG002|Overall Study|Hyperphosphataemia|0|||
146821884|NCT02151643|529516841|FG003|Overall Study|Hyperphosphataemia|0|||
146821885|NCT02151643|529516842|FG004|Overall Study|Hyperphosphataemia|1|||
146984827|NCT00982410|530107076|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
146984828|NCT00982410|530107077|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
146821886|NCT02151643|529516838|FG000|Overall Study|High Ferritin levels|3|||
146821887|NCT02151643|529516839|FG001|Overall Study|High Ferritin levels|3|||
146821888|NCT02151643|529516840|FG002|Overall Study|High Ferritin levels|2|||
146984829|NCT00982410|530107076|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
146984830|NCT00982410|530107077|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
146984831|NCT00982410|530107076|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
146984832|NCT00982410|530107077|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
146984833|NCT00982410|530107076|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
146984834|NCT00982410|530107077|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
146984835|NCT00982410|530107076|FG000|6-month Follow-up Assessment|participant no transportation|1|||
146821889|NCT02151643|529516841|FG003|Overall Study|High Ferritin levels|2|||
146821890|NCT02151643|529516842|FG004|Overall Study|High Ferritin levels|1|||
146821891|NCT00197106|529516843|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
146821892|NCT00197106|529516844|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
146821893|NCT00197106|529516845|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
146821894|NCT00197106|529516843|FG000|Overall Treatment Period|Lack of Efficacy|0|||
146821895|NCT00197106|529516844|FG001|Overall Treatment Period|Lack of Efficacy|1|||
146821896|NCT00197106|529516845|FG002|Overall Treatment Period|Lack of Efficacy|0|||
146821897|NCT00197106|529516843|FG000|Overall Treatment Period|Lost to Follow-up|0|||
146821898|NCT00197106|529516844|FG001|Overall Treatment Period|Lost to Follow-up|0|||
146821899|NCT00197106|529516845|FG002|Overall Treatment Period|Lost to Follow-up|2|||
146821900|NCT00197106|529516843|FG000|Overall Treatment Period|Protocol Violation|0|||
146821901|NCT00197106|529516844|FG001|Overall Treatment Period|Protocol Violation|0|||
146821902|NCT00197106|529516845|FG002|Overall Treatment Period|Protocol Violation|2|||
146821903|NCT00197106|529516843|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
146821904|NCT00197106|529516844|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
146821905|NCT00197106|529516845|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
146821906|NCT01797562|529516851|FG000|Overall Study|Protocol Violation|5|||
146821907|NCT00404547|529516854|FG000|Overall Study|Adverse Event|39|||
146821908|NCT00404547|529516855|FG001|Overall Study|Adverse Event|6|||
146821909|NCT00404547|529516854|FG000|Overall Study|Withdrawal by Subject|19|||
146821910|NCT00404547|529516855|FG001|Overall Study|Withdrawal by Subject|2|||
146821911|NCT00404547|529516854|FG000|Overall Study|Protocol Violation|0|||
146821912|NCT00404547|529516855|FG001|Overall Study|Protocol Violation|1|||
146821913|NCT00404547|529516854|FG000|Overall Study|Lost to Follow-up|20|||
146821914|NCT00404547|529516855|FG001|Overall Study|Lost to Follow-up|9|||
146821915|NCT00404547|529516854|FG000|Overall Study|Lack of compliance|5|||
146821916|NCT00404547|529516855|FG001|Overall Study|Lack of compliance|1|||
146821917|NCT00404547|529516854|FG000|Overall Study|Other|4|||
146821918|NCT00404547|529516855|FG001|Overall Study|Other|0|||
146821919|NCT00404547|529516854|FG000|Overall Study|Reason not stated|3|||
146821920|NCT00404547|529516855|FG001|Overall Study|Reason not stated|6|||
146821921|NCT02350127|529516861|FG000|4-Month Assessment|Withdrawal by Subject|10|||
146821922|NCT02350127|529516862|FG001|4-Month Assessment|Withdrawal by Subject|9|||
146821923|NCT02350127|529516861|FG000|4-Month Assessment|Death|1|||
146821924|NCT02350127|529516862|FG001|4-Month Assessment|Death|0|||
146821925|NCT02350127|529516861|FG000|8-Month Assessment|Death|1|||
146951176|NCT01004861|529979907|FG006|Overall Study|Patient withdrew|0|||
146951177|NCT01004861|529979908|FG007|Overall Study|Patient withdrew|0|||
146951178|NCT01004861|529979909|FG008|Overall Study|Patient withdrew|1|||
146951179|NCT01004861|529979910|FG009|Overall Study|Patient withdrew|0|||
146951180|NCT01004861|529979911|FG010|Overall Study|Patient withdrew|0|||
146951181|NCT01004861|529979912|FG011|Overall Study|Patient withdrew|0|||
146951182|NCT01004861|529979913|FG012|Overall Study|Patient withdrew|0|||
146951183|NCT01004861|529979901|FG000|Overall Study|Surgical resection|0|||
146951184|NCT01004861|529979902|FG001|Overall Study|Surgical resection|0|||
146951185|NCT01004861|529979903|FG002|Overall Study|Surgical resection|0|||
146951186|NCT01004861|529979904|FG003|Overall Study|Surgical resection|0|||
146951187|NCT01004861|529979905|FG004|Overall Study|Surgical resection|0|||
146984836|NCT00982410|530107077|FG001|6-month Follow-up Assessment|participant no transportation|0|||
146984837|NCT00982410|530107076|FG000|6-month Follow-up Assessment|incarceration|0|||
146821926|NCT02350127|529516862|FG001|8-Month Assessment|Death|1|||
146821927|NCT02350127|529516861|FG000|8-Month Assessment|Withdrawal by Subject|5|||
146951188|NCT01004861|529979906|FG005|Overall Study|Surgical resection|0|||
146951189|NCT01004861|529979907|FG006|Overall Study|Surgical resection|0|||
146821928|NCT02350127|529516862|FG001|8-Month Assessment|Withdrawal by Subject|8|||
146951190|NCT01004861|529979908|FG007|Overall Study|Surgical resection|0|||
146821929|NCT03575572|529516865|FG000|Overall Study|Withdrawal by Subject|2|||
146821930|NCT03575572|529516865|FG000|Overall Study|Physician Decision|2|||
146821931|NCT03048058|529516868|FG000|Overall Study|Lost to Follow-up|4|||
146821932|NCT03048058|529516869|FG001|Overall Study|Lost to Follow-up|0|||
146821933|NCT03048058|529516868|FG000|Overall Study|Withdrawal by Subject|0|||
146821934|NCT03048058|529516869|FG001|Overall Study|Withdrawal by Subject|4|||
146951191|NCT01004861|529979909|FG008|Overall Study|Surgical resection|1|||
146821935|NCT01257698|529516870|FG000|Overall Study|Protocol Violation|4|||
146821936|NCT01257698|529516871|FG001|Overall Study|Protocol Violation|0|||
146821937|NCT00050167|529516873|FG000|Overall Study|not eligible not invasive|1|||
146821938|NCT00050167|529516874|FG001|Overall Study|not eligible not invasive|1|||
146821939|NCT02038803|529516878|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
146821940|NCT02038803|529516878|FG000|Overall Study|Lost to Follow-up|1|||
146821941|NCT04754594|529516879|FG000|Blinded Period|Withdrawal by Subject|4|||
146821942|NCT04754594|529516880|FG001|Blinded Period|Withdrawal by Subject|9|||
146821943|NCT04754594|529516881|FG002|Blinded Period|Withdrawal by Subject|0|||
146821944|NCT04754594|529516882|FG003|Blinded Period|Withdrawal by Subject|0|||
146821945|NCT04754594|529516879|FG000|Blinded Period|Protocol Violation|2|||
146821946|NCT04754594|529516880|FG001|Blinded Period|Protocol Violation|2|||
146821947|NCT04754594|529516881|FG002|Blinded Period|Protocol Violation|0|||
146821948|NCT04754594|529516882|FG003|Blinded Period|Protocol Violation|0|||
146821949|NCT04754594|529516879|FG000|Blinded Period|Lost to Follow-up|1|||
146821950|NCT04754594|529516880|FG001|Blinded Period|Lost to Follow-up|1|||
146821951|NCT04754594|529516881|FG002|Blinded Period|Lost to Follow-up|0|||
146821952|NCT04754594|529516882|FG003|Blinded Period|Lost to Follow-up|0|||
146821953|NCT04754594|529516879|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
146821954|NCT04754594|529516880|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
146821955|NCT04754594|529516881|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
146821956|NCT04754594|529516882|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
146821957|NCT04754594|529516879|FG000|Unblinded Period|Withdrawal by Subject|6|||
146821958|NCT04754594|529516880|FG001|Unblinded Period|Withdrawal by Subject|8|||
146821959|NCT04754594|529516881|FG002|Unblinded Period|Withdrawal by Subject|0|||
146821960|NCT04754594|529516882|FG003|Unblinded Period|Withdrawal by Subject|0|||
146821961|NCT04754594|529516879|FG000|Unblinded Period|Lost to Follow-up|5|||
146821962|NCT04754594|529516880|FG001|Unblinded Period|Lost to Follow-up|3|||
146821963|NCT04754594|529516881|FG002|Unblinded Period|Lost to Follow-up|0|||
146821964|NCT04754594|529516882|FG003|Unblinded Period|Lost to Follow-up|0|||
146821965|NCT04754594|529516879|FG000|Unblinded Period|Protocol Violation|2|||
146821966|NCT04754594|529516880|FG001|Unblinded Period|Protocol Violation|4|||
146821967|NCT04754594|529516881|FG002|Unblinded Period|Protocol Violation|0|||
146821968|NCT04754594|529516882|FG003|Unblinded Period|Protocol Violation|0|||
146821969|NCT04754594|529516879|FG000|Unblinded Period|Other|3|||
146821970|NCT04754594|529516880|FG001|Unblinded Period|Other|0|||
146821971|NCT04754594|529516881|FG002|Unblinded Period|Other|0|||
146821972|NCT04754594|529516882|FG003|Unblinded Period|Other|0|||
146821973|NCT04754594|529516879|FG000|Infant Participants|Withdrawal by Subject|0|||
146821974|NCT04754594|529516880|FG001|Infant Participants|Withdrawal by Subject|0|||
146821975|NCT04754594|529516881|FG002|Infant Participants|Withdrawal by Subject|9|||
146821976|NCT04754594|529516882|FG003|Infant Participants|Withdrawal by Subject|17|||
146821977|NCT04754594|529516879|FG000|Infant Participants|Lost to Follow-up|0|||
146821978|NCT04754594|529516880|FG001|Infant Participants|Lost to Follow-up|0|||
146821979|NCT04754594|529516881|FG002|Infant Participants|Lost to Follow-up|4|||
146821980|NCT04754594|529516882|FG003|Infant Participants|Lost to Follow-up|10|||
146821981|NCT04754594|529516879|FG000|Infant Participants|Death|0|||
146821982|NCT04754594|529516880|FG001|Infant Participants|Death|0|||
146821983|NCT04754594|529516881|FG002|Infant Participants|Death|1|||
146821984|NCT04754594|529516882|FG003|Infant Participants|Death|1|||
146821985|NCT04754594|529516879|FG000|Infant Participants|Other|0|||
146821986|NCT04754594|529516880|FG001|Infant Participants|Other|0|||
146821987|NCT04754594|529516881|FG002|Infant Participants|Other|1|||
146821988|NCT04754594|529516882|FG003|Infant Participants|Other|1|||
146821989|NCT01247922|529516883|FG000|Overall Study|Disease progression|4|||
146821990|NCT02588027|529516884|FG000|Overall Study|Withdrawal by Subject|1|||
146821991|NCT02588027|529516885|FG001|Overall Study|Withdrawal by Subject|3|||
146821992|NCT02588027|529516884|FG000|Overall Study|Protocol Violation|4|||
146821993|NCT02588027|529516885|FG001|Overall Study|Protocol Violation|1|||
146821994|NCT04372186|529516886|FG000|Overall Study|Death|24|||
146821995|NCT04372186|529516887|FG001|Overall Study|Death|11|||
146821996|NCT04372186|529516886|FG000|Overall Study|Transferred to a different facility for care|0|||
146821997|NCT04372186|529516887|FG001|Overall Study|Transferred to a different facility for care|2|||
146821998|NCT04736472|529516888|FG000|Overall Study|Lost to Follow-up|1|||
146821999|NCT04736472|529516889|FG001|Overall Study|Lost to Follow-up|0|||
146822000|NCT04736472|529516890|FG002|Overall Study|Lost to Follow-up|0|||
146822001|NCT04736472|529516888|FG000|Overall Study|Withdrawal by Subject|2|||
146822002|NCT04736472|529516889|FG001|Overall Study|Withdrawal by Subject|0|||
146822003|NCT04736472|529516890|FG002|Overall Study|Withdrawal by Subject|0|||
146822004|NCT04736472|529516888|FG000|Overall Study|Protocol Violation|48|||
146822005|NCT04736472|529516889|FG001|Overall Study|Protocol Violation|0|||
146822006|NCT04736472|529516890|FG002|Overall Study|Protocol Violation|6|||
146822007|NCT02116582|529516891|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
146822008|NCT02116582|529516891|FG000|Overall Study|Adverse Event|22|||
146822009|NCT02116582|529516891|FG000|Overall Study|Death|9|||
146822010|NCT02116582|529516891|FG000|Overall Study|Progressive Disease|148|||
146822011|NCT02116582|529516891|FG000|Overall Study|Protocol Violation|3|||
146822012|NCT02116582|529516891|FG000|Overall Study|Withdrawal by Subject|8|||
146822013|NCT02116582|529516891|FG000|Overall Study|Other: Miscellaneous|11|||
146822014|NCT02116582|529516891|FG000|Overall Study|Lost to Follow-up|1|||
146822015|NCT02116582|529516891|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
146822016|NCT01876823|529516892|FG000|Overall Study|Withdrawal by Subject|5|||
146822017|NCT01876823|529516892|FG000|Overall Study|Physician Decision|2|||
146822018|NCT01876823|529516892|FG000|Overall Study|Patients moved|2|||
146822019|NCT02256488|529516893|FG000|Overall Study|Lost to Follow-up|6|||
146822020|NCT02256488|529516894|FG001|Overall Study|Lost to Follow-up|6|||
146822021|NCT02256488|529516895|FG002|Overall Study|Lost to Follow-up|9|||
146822022|NCT02256488|529516896|FG003|Overall Study|Lost to Follow-up|3|||
146822023|NCT02256488|529516893|FG000|Overall Study|OTHER|1|||
146822024|NCT02256488|529516894|FG001|Overall Study|OTHER|0|||
146822025|NCT02256488|529516895|FG002|Overall Study|OTHER|1|||
146822026|NCT02256488|529516896|FG003|Overall Study|OTHER|1|||
146822027|NCT02256488|529516893|FG000|Overall Study|Withdrawal by Subject|1|||
146822028|NCT02256488|529516894|FG001|Overall Study|Withdrawal by Subject|0|||
146822029|NCT02256488|529516895|FG002|Overall Study|Withdrawal by Subject|0|||
146822030|NCT02256488|529516896|FG003|Overall Study|Withdrawal by Subject|2|||
146822031|NCT02268526|529516897|FG000|Overall Study|Adverse Event|0|||
146822032|NCT02268526|529516898|FG001|Overall Study|Adverse Event|2|||
146822033|NCT02268526|529516899|FG002|Overall Study|Adverse Event|1|||
146822034|NCT02268526|529516897|FG000|Overall Study|Death|1|||
146822035|NCT02268526|529516898|FG001|Overall Study|Death|11|||
146822036|NCT02268526|529516899|FG002|Overall Study|Death|0|||
146822037|NCT02268526|529516897|FG000|Overall Study|protocol deviation|0|||
146822038|NCT02268526|529516898|FG001|Overall Study|protocol deviation|1|||
146822039|NCT02268526|529516899|FG002|Overall Study|protocol deviation|0|||
146822040|NCT02268526|529516897|FG000|Overall Study|Physician Decision|0|||
146822041|NCT02268526|529516898|FG001|Overall Study|Physician Decision|0|||
146822042|NCT02268526|529516899|FG002|Overall Study|Physician Decision|1|||
146822043|NCT02268526|529516897|FG000|Overall Study|Subject/guardian decision|0|||
146822044|NCT02268526|529516898|FG001|Overall Study|Subject/guardian decision|7|||
146822045|NCT02268526|529516899|FG002|Overall Study|Subject/guardian decision|3|||
146822046|NCT00975130|529516900|FG000|Study Part 1|Adverse Event|150|||
146822047|NCT00975130|529516901|FG001|Study Part 1|Adverse Event|0|||
146822048|NCT00975130|529516902|FG002|Study Part 1|Adverse Event|0|||
146822049|NCT00975130|529516900|FG000|Study Part 1|Lost to Follow-up|19|||
146822050|NCT00975130|529516901|FG001|Study Part 1|Lost to Follow-up|0|||
146822051|NCT00975130|529516902|FG002|Study Part 1|Lost to Follow-up|0|||
146822052|NCT00975130|529516900|FG000|Study Part 1|Withdrawal by Subject|61|||
146822053|NCT00975130|529516901|FG001|Study Part 1|Withdrawal by Subject|0|||
146822054|NCT00975130|529516902|FG002|Study Part 1|Withdrawal by Subject|0|||
146822055|NCT00975130|529516900|FG000|Study Part 1|Protocol Violation|13|||
146822056|NCT00975130|529516901|FG001|Study Part 1|Protocol Violation|0|||
146822057|NCT00975130|529516902|FG002|Study Part 1|Protocol Violation|0|||
146822058|NCT00975130|529516900|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
146822059|NCT00975130|529516901|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
146822060|NCT00975130|529516902|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
146822061|NCT00975130|529516900|FG000|Study Part 1|Administrative|4|||
146822062|NCT00975130|529516901|FG001|Study Part 1|Administrative|0|||
146822063|NCT00975130|529516902|FG002|Study Part 1|Administrative|0|||
146822064|NCT00975130|529516900|FG000|Study Part 1|Withdrew Consent|24|||
146822065|NCT00975130|529516901|FG001|Study Part 1|Withdrew Consent|0|||
146822066|NCT00975130|529516902|FG002|Study Part 1|Withdrew Consent|0|||
146822067|NCT00975130|529516900|FG000|Study Part 2|Adverse Event|0|||
146822068|NCT00975130|529516901|FG001|Study Part 2|Adverse Event|14|||
146951192|NCT01004861|529979910|FG009|Overall Study|Surgical resection|0|||
146822069|NCT00975130|529516902|FG002|Study Part 2|Adverse Event|7|||
146822070|NCT00975130|529516900|FG000|Study Part 2|Lost to Follow-up|0|||
146822071|NCT00975130|529516901|FG001|Study Part 2|Lost to Follow-up|0|||
146822072|NCT00975130|529516902|FG002|Study Part 2|Lost to Follow-up|1|||
146822073|NCT00975130|529516900|FG000|Study Part 2|Withdrawal by Subject|0|||
146822074|NCT00975130|529516901|FG001|Study Part 2|Withdrawal by Subject|13|||
146822075|NCT00975130|529516902|FG002|Study Part 2|Withdrawal by Subject|5|||
146822076|NCT00975130|529516900|FG000|Study Part 2|Withdrew Consent|0|||
146822077|NCT00975130|529516901|FG001|Study Part 2|Withdrew Consent|6|||
146822078|NCT00975130|529516902|FG002|Study Part 2|Withdrew Consent|2|||
146822079|NCT00975130|529516900|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
146822080|NCT00975130|529516901|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
146822081|NCT00975130|529516902|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
146951193|NCT01004861|529979911|FG010|Overall Study|Surgical resection|0|||
146951194|NCT01004861|529979912|FG011|Overall Study|Surgical resection|0|||
146822082|NCT00975130|529516900|FG000|Study Part 2|Administrative|0|||
146822083|NCT00975130|529516901|FG001|Study Part 2|Administrative|1|||
146822084|NCT00975130|529516902|FG002|Study Part 2|Administrative|0|||
146822085|NCT00975130|529516900|FG000|Study Part 2|Protocol Violation|0|||
146822086|NCT00975130|529516901|FG001|Study Part 2|Protocol Violation|0|||
146822087|NCT00975130|529516902|FG002|Study Part 2|Protocol Violation|1|||
146822088|NCT00577096|529516903|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
146822089|NCT00577096|529516904|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
146822090|NCT00577096|529516903|FG000|Short Term Participation|Withdrawal by Subject|3|||
146822091|NCT00577096|529516904|FG001|Short Term Participation|Withdrawal by Subject|5|||
146822092|NCT00577096|529516903|FG000|Short Term Participation|Death|1|||
146822093|NCT00577096|529516904|FG001|Short Term Participation|Death|1|||
146822094|NCT03562117|529516906|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
146822095|NCT03562117|529516907|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
146822096|NCT03562117|529516908|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
146822097|NCT02418819|529516917|FG000|Overall Study|Adverse Event|0|||
146822098|NCT02418819|529516918|FG001|Overall Study|Adverse Event|0|||
146822099|NCT02418819|529516919|FG002|Overall Study|Adverse Event|1|||
146822100|NCT02418819|529516920|FG003|Overall Study|Adverse Event|0|||
146822101|NCT02418819|529516917|FG000|Overall Study|Lost to Follow-up|1|||
146822102|NCT02418819|529516918|FG001|Overall Study|Lost to Follow-up|0|||
146822103|NCT02418819|529516919|FG002|Overall Study|Lost to Follow-up|0|||
146822104|NCT02418819|529516920|FG003|Overall Study|Lost to Follow-up|0|||
146822105|NCT02418819|529516917|FG000|Overall Study|No longer meets eligibility criteria|0|||
146822106|NCT02418819|529516918|FG001|Overall Study|No longer meets eligibility criteria|0|||
146822107|NCT02418819|529516919|FG002|Overall Study|No longer meets eligibility criteria|1|||
146822108|NCT02418819|529516920|FG003|Overall Study|No longer meets eligibility criteria|0|||
146822109|NCT02418819|529516917|FG000|Overall Study|No longer willing to participate|0|||
146822110|NCT02418819|529516918|FG001|Overall Study|No longer willing to participate|0|||
146822111|NCT02418819|529516919|FG002|Overall Study|No longer willing to participate|2|||
146822112|NCT02418819|529516920|FG003|Overall Study|No longer willing to participate|1|||
146822113|NCT04374253|529516924|FG000|Overall Study|Adverse Event|0|||
146822114|NCT04374253|529516925|FG001|Overall Study|Adverse Event|26|||
146822115|NCT04374253|529516926|FG002|Overall Study|Adverse Event|2|||
146822116|NCT04374253|529516927|FG003|Overall Study|Adverse Event|12|||
146822117|NCT04374253|529516924|FG000|Overall Study|Study terminated by sponsor|13|||
146822118|NCT04374253|529516925|FG001|Overall Study|Study terminated by sponsor|593|||
146822119|NCT04374253|529516926|FG002|Overall Study|Study terminated by sponsor|21|||
146822120|NCT04374253|529516927|FG003|Overall Study|Study terminated by sponsor|567|||
146822121|NCT04374253|529516924|FG000|Overall Study|Withdrawal by Subject|0|||
146822122|NCT04374253|529516925|FG001|Overall Study|Withdrawal by Subject|55|||
146822123|NCT04374253|529516926|FG002|Overall Study|Withdrawal by Subject|3|||
146822124|NCT04374253|529516927|FG003|Overall Study|Withdrawal by Subject|40|||
146822125|NCT04374253|529516924|FG000|Overall Study|Physician Decision|1|||
146822126|NCT04374253|529516925|FG001|Overall Study|Physician Decision|10|||
146822127|NCT04374253|529516926|FG002|Overall Study|Physician Decision|1|||
146822128|NCT04374253|529516927|FG003|Overall Study|Physician Decision|10|||
146822129|NCT04374253|529516924|FG000|Overall Study|Protocol Violation|0|||
146822130|NCT04374253|529516925|FG001|Overall Study|Protocol Violation|0|||
146822131|NCT04374253|529516926|FG002|Overall Study|Protocol Violation|0|||
146822132|NCT04374253|529516927|FG003|Overall Study|Protocol Violation|2|||
146822133|NCT04374253|529516924|FG000|Overall Study|Death|0|||
146822134|NCT04374253|529516925|FG001|Overall Study|Death|3|||
146822135|NCT04374253|529516926|FG002|Overall Study|Death|1|||
146822136|NCT04374253|529516927|FG003|Overall Study|Death|1|||
146822137|NCT04374253|529516924|FG000|Overall Study|Lack of Efficacy|0|||
146822138|NCT04374253|529516925|FG001|Overall Study|Lack of Efficacy|0|||
146822139|NCT04374253|529516926|FG002|Overall Study|Lack of Efficacy|0|||
146822140|NCT04374253|529516927|FG003|Overall Study|Lack of Efficacy|1|||
146822141|NCT04374253|529516924|FG000|Overall Study|Lost to Follow-up|1|||
146822142|NCT04374253|529516925|FG001|Overall Study|Lost to Follow-up|1|||
146822143|NCT04374253|529516926|FG002|Overall Study|Lost to Follow-up|0|||
146822144|NCT04374253|529516927|FG003|Overall Study|Lost to Follow-up|2|||
146822145|NCT04374253|529516924|FG000|Overall Study|Reason Not Specified|0|||
146822146|NCT04374253|529516925|FG001|Overall Study|Reason Not Specified|8|||
146822147|NCT04374253|529516926|FG002|Overall Study|Reason Not Specified|0|||
146822148|NCT04374253|529516927|FG003|Overall Study|Reason Not Specified|8|||
146822149|NCT01207453|529516930|FG000|First Intervention|Adverse Event|2|||
146822150|NCT01207453|529516931|FG001|First Intervention|Adverse Event|1|||
146822151|NCT01207453|529516930|FG000|Washout|Adverse Event|1|||
146822152|NCT01207453|529516931|FG001|Washout|Adverse Event|0|||
146822153|NCT01207453|529516930|FG000|Washout|Lost to Follow-up|1|||
146822154|NCT01207453|529516931|FG001|Washout|Lost to Follow-up|0|||
146984838|NCT00982410|530107077|FG001|6-month Follow-up Assessment|incarceration|2|||
146822155|NCT01207453|529516930|FG000|2nd Intervention|Adverse Event|1|||
146822156|NCT01207453|529516931|FG001|2nd Intervention|Adverse Event|2|||
146822157|NCT01207453|529516930|FG000|2nd Intervention|Lost to Follow-up|1|||
146822158|NCT01207453|529516931|FG001|2nd Intervention|Lost to Follow-up|0|||
146822159|NCT00676663|529516932|FG000|Overall Study|Death|43|||
146822160|NCT00676663|529516933|FG001|Overall Study|Death|27|||
146822161|NCT00676663|529516932|FG000|Overall Study|Withdrew Consent|1|||
146822162|NCT00676663|529516933|FG001|Overall Study|Withdrew Consent|8|||
146822163|NCT00676663|529516932|FG000|Overall Study|Lost to Follow-up|1|||
146822164|NCT00676663|529516933|FG001|Overall Study|Lost to Follow-up|3|||
146984839|NCT00982410|530107076|FG000|6-month Follow-up Assessment|patent surgery|0|||
146984840|NCT00982410|530107077|FG001|6-month Follow-up Assessment|patent surgery|1|||
146984841|NCT00982410|530107076|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
146984842|NCT00982410|530107077|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
146984843|NCT00982410|530107076|FG000|12-month Follow-up Assessment|Death|0|||
146984844|NCT00982410|530107077|FG001|12-month Follow-up Assessment|Death|2|||
146984845|NCT00982410|530107076|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
146984846|NCT00982410|530107077|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
146984847|NCT00982410|530107076|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
146984848|NCT00982410|530107077|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
146984849|NCT00982410|530107076|FG000|12-month Follow-up Assessment|incarceration|2|||
146984850|NCT00982410|530107077|FG001|12-month Follow-up Assessment|incarceration|1|||
146984851|NCT00982410|530107076|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
146984852|NCT00982410|530107077|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
146984853|NCT04014959|530107078|FG000|Baseline MRI and Assessments|Physician Decision|2|||
146984854|NCT04014959|530107078|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
146984855|NCT04014959|530107078|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
146984856|NCT02004847|530107079|FG000|Overall Study|Protocol Violation|1|||
146984857|NCT02004847|530107080|FG001|Overall Study|Protocol Violation|1|||
146984858|NCT00759148|530107084|FG000|Overall Study|Adverse Event|1|||
146984859|NCT00759148|530107085|FG001|Overall Study|Adverse Event|6|||
146984860|NCT00759148|530107084|FG000|Overall Study|Withdrawal by Subject|3|||
146984861|NCT00759148|530107085|FG001|Overall Study|Withdrawal by Subject|7|||
146984862|NCT00759148|530107084|FG000|Overall Study|Lost to Follow-up|3|||
146984863|NCT00759148|530107085|FG001|Overall Study|Lost to Follow-up|9|||
146984864|NCT00759148|530107084|FG000|Overall Study|Treatment Failure|6|||
146984865|NCT00759148|530107085|FG001|Overall Study|Treatment Failure|10|||
146984866|NCT00759148|530107084|FG000|Overall Study|Reason not given|1|||
146984867|NCT00759148|530107085|FG001|Overall Study|Reason not given|0|||
146984868|NCT03381248|530107086|FG000|0-6 Months|Withdrawal by Subject|4|||
146984869|NCT03381248|530107087|FG001|0-6 Months|Withdrawal by Subject|1|||
146984870|NCT03381248|530107086|FG000|0-6 Months|Lost to Follow-up|3|||
146984871|NCT03381248|530107087|FG001|0-6 Months|Lost to Follow-up|2|||
146984872|NCT03381248|530107086|FG000|0-6 Months|Lack of Efficacy|1|||
146984873|NCT03381248|530107087|FG001|0-6 Months|Lack of Efficacy|0|||
146984874|NCT03381248|530107086|FG000|0-6 Months|Adverse Event|1|||
146984875|NCT03381248|530107087|FG001|0-6 Months|Adverse Event|0|||
146984876|NCT03381248|530107086|FG000|0-6 Months|Protocol Violation|2|||
146984877|NCT03381248|530107087|FG001|0-6 Months|Protocol Violation|1|||
146984878|NCT03381248|530107086|FG000|0-6 Months|Physician Decision|1|||
146984879|NCT03381248|530107087|FG001|0-6 Months|Physician Decision|0|||
146984880|NCT03381248|530107086|FG000|0-6 Months|Planning another procedure|1|||
146984881|NCT03381248|530107087|FG001|0-6 Months|Planning another procedure|2|||
146984882|NCT03381248|530107086|FG000|6-12 Months|Withdrawal by Subject|1|||
146984883|NCT03381248|530107087|FG001|6-12 Months|Withdrawal by Subject|3|||
146984884|NCT03381248|530107086|FG000|6-12 Months|Lost to Follow-up|0|||
146984885|NCT03381248|530107087|FG001|6-12 Months|Lost to Follow-up|2|||
146984886|NCT03381248|530107086|FG000|6-12 Months|Protocol Violation|3|||
146984887|NCT03381248|530107087|FG001|6-12 Months|Protocol Violation|2|||
146984888|NCT03381248|530107086|FG000|6-12 Months|Planning another procedure|6|||
146984889|NCT03381248|530107087|FG001|6-12 Months|Planning another procedure|2|||
146984890|NCT03381248|530107086|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
146984891|NCT03381248|530107087|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
146984892|NCT03381248|530107086|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
146984893|NCT03381248|530107087|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
146984894|NCT03381248|530107086|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
146984895|NCT03381248|530107087|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
146984896|NCT05188521|530107088|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
146984897|NCT05188521|530107089|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
146984898|NCT04582266|530107090|FG000|Overall Study|Lost to Follow-up|7|||
146984899|NCT04582266|530107091|FG001|Overall Study|Lost to Follow-up|5|||
146984900|NCT04582266|530107090|FG000|Overall Study|Withdrawal by Subject|1|||
146984901|NCT04582266|530107091|FG001|Overall Study|Withdrawal by Subject|0|||
146984902|NCT04582266|530107090|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
146984903|NCT04582266|530107091|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
146822165|NCT04382053|529516939|FG000|Overall Study|Death|6|||
146822166|NCT04382053|529516940|FG001|Overall Study|Death|8|||
146984904|NCT01341639|530107092|FG000|Infant Series|Protocol Violation|1|||
146984905|NCT01341639|530107093|FG001|Infant Series|Protocol Violation|0|||
146984906|NCT01341639|530107092|FG000|Infant Series|Not Vaccinated|0|||
146984907|NCT01341639|530107093|FG001|Infant Series|Not Vaccinated|1|||
146984908|NCT01341639|530107092|FG000|Infant Series|Adverse Event|0|||
146984909|NCT01341639|530107093|FG001|Infant Series|Adverse Event|5|||
146984910|NCT01341639|530107092|FG000|Infant Series|Withdrawal by Subject|11|||
146822167|NCT04382053|529516939|FG000|Overall Study|Lost to Follow-up|0|||
146822168|NCT04382053|529516940|FG001|Overall Study|Lost to Follow-up|2|||
146822169|NCT04382053|529516939|FG000|Overall Study|Protocol Deviation|1|||
146822170|NCT04382053|529516940|FG001|Overall Study|Protocol Deviation|2|||
146822171|NCT04382053|529516939|FG000|Overall Study|Withdrawal by Subject|2|||
146822172|NCT04382053|529516940|FG001|Overall Study|Withdrawal by Subject|1|||
146822173|NCT01399905|529516943|FG000|Overall Study|Withdrawal by Subject|1|||
146822174|NCT01399905|529516944|FG001|Overall Study|Withdrawal by Subject|1|||
146822175|NCT00714688|529516952|FG000|Overall Study|Lack of Efficacy|14|||
146822176|NCT00714688|529516953|FG001|Overall Study|Lack of Efficacy|1|||
146822177|NCT00714688|529516954|FG002|Overall Study|Lack of Efficacy|4|||
146822178|NCT00714688|529516952|FG000|Overall Study|Withdrawal by Subject|4|||
146822179|NCT00714688|529516953|FG001|Overall Study|Withdrawal by Subject|3|||
146822180|NCT00714688|529516954|FG002|Overall Study|Withdrawal by Subject|3|||
146822181|NCT00714688|529516952|FG000|Overall Study|Lost to Follow-up|5|||
146822182|NCT00714688|529516953|FG001|Overall Study|Lost to Follow-up|2|||
146822183|NCT00714688|529516954|FG002|Overall Study|Lost to Follow-up|0|||
146822184|NCT00714688|529516952|FG000|Overall Study|Adverse Event|2|||
146822185|NCT00714688|529516953|FG001|Overall Study|Adverse Event|15|||
146822186|NCT00714688|529516954|FG002|Overall Study|Adverse Event|19|||
146822187|NCT00714688|529516952|FG000|Overall Study|Subject Non-compliant|3|||
146822188|NCT00714688|529516953|FG001|Overall Study|Subject Non-compliant|5|||
146822189|NCT00714688|529516954|FG002|Overall Study|Subject Non-compliant|5|||
146822190|NCT00714688|529516952|FG000|Overall Study|Ineligible to Continue the Study|0|||
146822191|NCT00714688|529516953|FG001|Overall Study|Ineligible to Continue the Study|1|||
146822192|NCT00714688|529516954|FG002|Overall Study|Ineligible to Continue the Study|1|||
146822193|NCT00714688|529516952|FG000|Overall Study|Sponsor's Decision|0|||
146822194|NCT00714688|529516953|FG001|Overall Study|Sponsor's Decision|2|||
146822195|NCT00714688|529516954|FG002|Overall Study|Sponsor's Decision|0|||
146822196|NCT00714688|529516952|FG000|Overall Study|Other|1|||
146822197|NCT00714688|529516953|FG001|Overall Study|Other|6|||
146984911|NCT01341639|530107093|FG001|Infant Series|Withdrawal by Subject|8|||
146984912|NCT01341639|530107092|FG000|Infant Series|Lost to Follow-up|0|||
146822198|NCT00714688|529516954|FG002|Overall Study|Other|5|||
146822199|NCT01123642|529516955|FG000|Overall Study|Lost to Follow-up|23|||
146822200|NCT01123642|529516955|FG000|Overall Study|Withdrawal by Subject|9|||
146822201|NCT01123642|529516955|FG000|Overall Study|ineligible at baseline assessment|36|||
146848467|NCT01712659|529615691|FG000|Dose Escalation|Physician Decision|0|||
146848468|NCT01712659|529615692|FG001|Dose Escalation|Physician Decision|1|||
146848469|NCT01712659|529615693|FG002|Dose Escalation|Physician Decision|0|||
146848470|NCT01712659|529615694|FG003|Dose Escalation|Physician Decision|0|||
146848471|NCT01712659|529615695|FG004|Dose Escalation|Physician Decision|0|||
146848472|NCT01712659|529615691|FG000|Dose Escalation|Unable to take study drug|0|||
146848473|NCT01712659|529615692|FG001|Dose Escalation|Unable to take study drug|1|||
146848474|NCT01712659|529615693|FG002|Dose Escalation|Unable to take study drug|0|||
146848475|NCT01712659|529615694|FG003|Dose Escalation|Unable to take study drug|0|||
146848476|NCT01712659|529615695|FG004|Dose Escalation|Unable to take study drug|0|||
146848477|NCT01712659|529615691|FG000|Dose Expansion|Early disease progression|1|||
146848478|NCT01712659|529615692|FG001|Dose Expansion|Early disease progression|0|||
146848479|NCT01712659|529615693|FG002|Dose Expansion|Early disease progression|0|||
146848480|NCT01712659|529615694|FG003|Dose Expansion|Early disease progression|0|||
146848481|NCT01712659|529615695|FG004|Dose Expansion|Early disease progression|0|||
146848482|NCT01712659|529615691|FG000|Dose Expansion|Physician Decision|1|||
146848483|NCT01712659|529615692|FG001|Dose Expansion|Physician Decision|0|||
146848484|NCT01712659|529615693|FG002|Dose Expansion|Physician Decision|0|||
146848485|NCT01712659|529615694|FG003|Dose Expansion|Physician Decision|0|||
146848486|NCT01712659|529615695|FG004|Dose Expansion|Physician Decision|0|||
146848487|NCT03189745|529615703|FG000|Overall Study|Conflict in work schedule of participant|1|||
146848488|NCT03189745|529615704|FG001|Overall Study|Conflict in work schedule of participant|1|||
146848489|NCT05017103|529615705|FG000|Overall Study|Death|2|||
146848490|NCT01373151|529615716|FG000|Period 1|Lack of Efficacy|3|||
146848491|NCT01373151|529615717|FG001|Period 1|Lack of Efficacy|0|||
146848492|NCT01373151|529615718|FG002|Period 1|Lack of Efficacy|0|||
146848493|NCT01373151|529615719|FG003|Period 1|Lack of Efficacy|0|||
146848494|NCT01373151|529615720|FG004|Period 1|Lack of Efficacy|1|||
146848495|NCT01373151|529615721|FG005|Period 1|Lack of Efficacy|0|||
146848496|NCT01373151|529615722|FG006|Period 1|Lack of Efficacy|0|||
146848497|NCT01373151|529615716|FG000|Period 1|Adverse Event|0|||
146848498|NCT01373151|529615717|FG001|Period 1|Adverse Event|0|||
146848499|NCT01373151|529615718|FG002|Period 1|Adverse Event|1|||
146848500|NCT01373151|529615719|FG003|Period 1|Adverse Event|0|||
146848501|NCT01373151|529615720|FG004|Period 1|Adverse Event|4|||
146848502|NCT01373151|529615721|FG005|Period 1|Adverse Event|3|||
146848503|NCT01373151|529615722|FG006|Period 1|Adverse Event|0|||
146848504|NCT01373151|529615716|FG000|Period 1|Withdrawal by Subject|2|||
146848505|NCT01373151|529615717|FG001|Period 1|Withdrawal by Subject|0|||
146848506|NCT01373151|529615718|FG002|Period 1|Withdrawal by Subject|3|||
146848507|NCT01373151|529615719|FG003|Period 1|Withdrawal by Subject|1|||
146848508|NCT01373151|529615720|FG004|Period 1|Withdrawal by Subject|0|||
146822202|NCT00651937|529518927|FG000|Overall Study|Withdrawal by Subject|4|||
146822203|NCT00651937|529518928|FG001|Overall Study|Withdrawal by Subject|1|||
146822204|NCT00848393|529518935|FG000|Overall Study|Protocol Violation|0|||
146822205|NCT00848393|529518936|FG001|Overall Study|Protocol Violation|0|||
146822206|NCT00848393|529518937|FG002|Overall Study|Protocol Violation|1|||
146822207|NCT00848393|529518935|FG000|Overall Study|surgical complications unrelated to stud|0|||
146822208|NCT00848393|529518936|FG001|Overall Study|surgical complications unrelated to stud|0|||
146822209|NCT00848393|529518937|FG002|Overall Study|surgical complications unrelated to stud|2|||
146822210|NCT00443898|529518942|FG000|Overall Study|Adverse Event|0|||
146822211|NCT00443898|529518943|FG001|Overall Study|Adverse Event|0|||
146822212|NCT00443898|529518944|FG002|Overall Study|Adverse Event|1|||
146822213|NCT00443898|529518945|FG003|Overall Study|Adverse Event|1|||
146822214|NCT00443898|529518942|FG000|Overall Study|Lack of Efficacy|2|||
146822215|NCT00443898|529518943|FG001|Overall Study|Lack of Efficacy|3|||
146822216|NCT00443898|529518944|FG002|Overall Study|Lack of Efficacy|3|||
146822217|NCT00443898|529518945|FG003|Overall Study|Lack of Efficacy|1|||
146822218|NCT00443898|529518942|FG000|Overall Study|Protocol Violation|1|||
146822219|NCT00443898|529518943|FG001|Overall Study|Protocol Violation|1|||
146822220|NCT00443898|529518944|FG002|Overall Study|Protocol Violation|1|||
146822221|NCT00443898|529518945|FG003|Overall Study|Protocol Violation|0|||
146822222|NCT00443898|529518942|FG000|Overall Study|Withdrawal by Subject|11|||
146822223|NCT00443898|529518943|FG001|Overall Study|Withdrawal by Subject|10|||
146822224|NCT00443898|529518944|FG002|Overall Study|Withdrawal by Subject|10|||
146822225|NCT00443898|529518945|FG003|Overall Study|Withdrawal by Subject|6|||
146822226|NCT00443898|529518942|FG000|Overall Study|Lost to Follow-up|10|||
146822227|NCT00443898|529518943|FG001|Overall Study|Lost to Follow-up|10|||
146822228|NCT00443898|529518944|FG002|Overall Study|Lost to Follow-up|14|||
146822229|NCT00443898|529518945|FG003|Overall Study|Lost to Follow-up|10|||
146822230|NCT00443898|529518942|FG000|Overall Study|Death|0|||
146822231|NCT00443898|529518943|FG001|Overall Study|Death|1|||
146822232|NCT00443898|529518944|FG002|Overall Study|Death|0|||
146822233|NCT00443898|529518945|FG003|Overall Study|Death|0|||
146822234|NCT00043186|529518946|FG000|Overall Study|Physician Decision|0|||
146822235|NCT00043186|529518947|FG001|Overall Study|Physician Decision|0|||
146822236|NCT00043186|529518948|FG002|Overall Study|Physician Decision|3|||
146822237|NCT00043186|529518949|FG003|Overall Study|Physician Decision|0|||
146822238|NCT00043186|529518950|FG004|Overall Study|Physician Decision|1|||
146822239|NCT00043186|529518951|FG005|Overall Study|Physician Decision|0|||
146822240|NCT00043186|529518952|FG006|Overall Study|Physician Decision|0|||
146822241|NCT00043186|529518953|FG007|Overall Study|Physician Decision|1|||
146822242|NCT00043186|529518954|FG008|Overall Study|Physician Decision|1|||
146822243|NCT00043186|529518946|FG000|Overall Study|Adverse Event|2|||
146822244|NCT00043186|529518947|FG001|Overall Study|Adverse Event|2|||
146822245|NCT00043186|529518948|FG002|Overall Study|Adverse Event|2|||
146822246|NCT00043186|529518949|FG003|Overall Study|Adverse Event|3|||
146822247|NCT00043186|529518950|FG004|Overall Study|Adverse Event|2|||
146822248|NCT00043186|529518951|FG005|Overall Study|Adverse Event|1|||
146822249|NCT00043186|529518952|FG006|Overall Study|Adverse Event|2|||
146822250|NCT00043186|529518953|FG007|Overall Study|Adverse Event|1|||
146822251|NCT00043186|529518954|FG008|Overall Study|Adverse Event|3|||
146822252|NCT00043186|529518946|FG000|Overall Study|Withdrawal by Subject|11|||
146822253|NCT00043186|529518947|FG001|Overall Study|Withdrawal by Subject|8|||
146951195|NCT01004861|529979913|FG012|Overall Study|Surgical resection|0|||
146951196|NCT01004861|529979901|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146951197|NCT01004861|529979902|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146951198|NCT01004861|529979903|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146951199|NCT01004861|529979904|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146951200|NCT01004861|529979905|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146951201|NCT01004861|529979906|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146951202|NCT01004861|529979907|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146951203|NCT01004861|529979908|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146951204|NCT01004861|529979909|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
146951205|NCT01004861|529979910|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146951206|NCT01004861|529979911|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146951207|NCT01004861|529979912|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146951208|NCT01004861|529979913|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146951209|NCT01004861|529979901|FG000|Overall Study|Study termination by Sponsor|0|||
146951210|NCT01004861|529979902|FG001|Overall Study|Study termination by Sponsor|0|||
146951211|NCT01004861|529979903|FG002|Overall Study|Study termination by Sponsor|0|||
146822254|NCT00043186|529518948|FG002|Overall Study|Withdrawal by Subject|11|||
146822255|NCT00043186|529518949|FG003|Overall Study|Withdrawal by Subject|13|||
146822256|NCT00043186|529518950|FG004|Overall Study|Withdrawal by Subject|14|||
146822257|NCT00043186|529518951|FG005|Overall Study|Withdrawal by Subject|6|||
146822258|NCT00043186|529518952|FG006|Overall Study|Withdrawal by Subject|12|||
146822259|NCT00043186|529518953|FG007|Overall Study|Withdrawal by Subject|9|||
146822260|NCT00043186|529518954|FG008|Overall Study|Withdrawal by Subject|10|||
146822261|NCT00043186|529518946|FG000|Overall Study|Death|0|||
146822262|NCT00043186|529518947|FG001|Overall Study|Death|0|||
146822263|NCT00043186|529518948|FG002|Overall Study|Death|1|||
146822264|NCT00043186|529518949|FG003|Overall Study|Death|0|||
146822265|NCT00043186|529518950|FG004|Overall Study|Death|0|||
146822266|NCT00043186|529518951|FG005|Overall Study|Death|0|||
146822267|NCT00043186|529518952|FG006|Overall Study|Death|2|||
146822268|NCT00043186|529518953|FG007|Overall Study|Death|0|||
146822269|NCT00043186|529518954|FG008|Overall Study|Death|0|||
146822270|NCT00043186|529518946|FG000|Overall Study|Disease progression|1|||
146822271|NCT00043186|529518947|FG001|Overall Study|Disease progression|0|||
146822272|NCT00043186|529518948|FG002|Overall Study|Disease progression|0|||
146822273|NCT00043186|529518949|FG003|Overall Study|Disease progression|3|||
146822274|NCT00043186|529518950|FG004|Overall Study|Disease progression|0|||
146822275|NCT00043186|529518951|FG005|Overall Study|Disease progression|0|||
146822276|NCT00043186|529518952|FG006|Overall Study|Disease progression|0|||
146822277|NCT00043186|529518953|FG007|Overall Study|Disease progression|4|||
146951212|NCT01004861|529979904|FG003|Overall Study|Study termination by Sponsor|0|||
146951213|NCT01004861|529979905|FG004|Overall Study|Study termination by Sponsor|0|||
146951214|NCT01004861|529979906|FG005|Overall Study|Study termination by Sponsor|0|||
146951215|NCT01004861|529979907|FG006|Overall Study|Study termination by Sponsor|0|||
146951216|NCT01004861|529979908|FG007|Overall Study|Study termination by Sponsor|0|||
146951217|NCT01004861|529979909|FG008|Overall Study|Study termination by Sponsor|1|||
146951218|NCT01004861|529979910|FG009|Overall Study|Study termination by Sponsor|0|||
146951219|NCT01004861|529979911|FG010|Overall Study|Study termination by Sponsor|0|||
146951220|NCT01004861|529979912|FG011|Overall Study|Study termination by Sponsor|0|||
146951221|NCT01004861|529979913|FG012|Overall Study|Study termination by Sponsor|0|||
146951222|NCT00003389|529979914|FG000|Overall Study|Disease progression|6|||
146951223|NCT00003389|529979915|FG001|Overall Study|Disease progression|1|||
146951224|NCT00003389|529979914|FG000|Overall Study|Adverse Event|13|||
146951225|NCT00003389|529979915|FG001|Overall Study|Adverse Event|2|||
146951226|NCT00003389|529979914|FG000|Overall Study|Death|0|||
146951227|NCT00003389|529979915|FG001|Overall Study|Death|3|||
146951228|NCT00003389|529979914|FG000|Overall Study|Withdrawal by Subject|12|||
146951229|NCT00003389|529979915|FG001|Overall Study|Withdrawal by Subject|5|||
146951230|NCT00003389|529979914|FG000|Overall Study|Alternative therapy|2|||
146951231|NCT00003389|529979915|FG001|Overall Study|Alternative therapy|1|||
146951232|NCT00003389|529979914|FG000|Overall Study|Complicating disease|1|||
146951233|NCT00003389|529979915|FG001|Overall Study|Complicating disease|0|||
146951234|NCT00003389|529979914|FG000|Overall Study|Off-treatment reason missing|31|||
146951235|NCT00003389|529979915|FG001|Overall Study|Off-treatment reason missing|21|||
146951236|NCT00003389|529979914|FG000|Overall Study|Ineligible|33|||
146951237|NCT00003389|529979915|FG001|Overall Study|Ineligible|27|||
146951238|NCT02554721|529979916|FG000|Overall Study|Adverse Event|1|||
146951239|NCT02554721|529979917|FG001|Overall Study|Adverse Event|0|||
146951240|NCT02554721|529979918|FG002|Overall Study|Adverse Event|0|||
146951241|NCT02554721|529979919|FG003|Overall Study|Adverse Event|0|||
146951242|NCT02554721|529979920|FG004|Overall Study|Adverse Event|1|||
146951243|NCT02554721|529979916|FG000|Overall Study|Noncompliance|0|||
146951244|NCT02554721|529979917|FG001|Overall Study|Noncompliance|0|||
146951245|NCT02554721|529979918|FG002|Overall Study|Noncompliance|0|||
146951246|NCT02554721|529979919|FG003|Overall Study|Noncompliance|0|||
146951247|NCT02554721|529979920|FG004|Overall Study|Noncompliance|1|||
146951248|NCT01693562|529979922|FG000|Escalation Phase|Withdrawal by Subject|0|||
146951249|NCT01693562|529979923|FG001|Escalation Phase|Withdrawal by Subject|1|||
146951250|NCT01693562|529979924|FG002|Escalation Phase|Withdrawal by Subject|0|||
146951251|NCT01693562|529979925|FG003|Escalation Phase|Withdrawal by Subject|0|||
146951252|NCT01693562|529979926|FG004|Escalation Phase|Withdrawal by Subject|0|||
146951253|NCT01693562|529979927|FG005|Escalation Phase|Withdrawal by Subject|2|||
146822278|NCT00043186|529518954|FG008|Overall Study|Disease progression|0|||
146822279|NCT00043186|529518946|FG000|Overall Study|Ineligibility determined|0|||
146822280|NCT00043186|529518947|FG001|Overall Study|Ineligibility determined|0|||
146822281|NCT00043186|529518948|FG002|Overall Study|Ineligibility determined|0|||
146822282|NCT00043186|529518949|FG003|Overall Study|Ineligibility determined|0|||
146951254|NCT01693562|529979928|FG006|Escalation Phase|Withdrawal by Subject|0|||
146951255|NCT01693562|529979929|FG007|Escalation Phase|Withdrawal by Subject|0|||
146951256|NCT01693562|529979930|FG008|Escalation Phase|Withdrawal by Subject|0|||
146951257|NCT01693562|529979931|FG009|Escalation Phase|Withdrawal by Subject|0|||
146951258|NCT01693562|529979932|FG010|Escalation Phase|Withdrawal by Subject|0|||
146951259|NCT01693562|529979933|FG011|Escalation Phase|Withdrawal by Subject|0|||
146951260|NCT01693562|529979934|FG012|Escalation Phase|Withdrawal by Subject|0|||
146951261|NCT01693562|529979935|FG013|Escalation Phase|Withdrawal by Subject|0|||
146951262|NCT01693562|529979936|FG014|Escalation Phase|Withdrawal by Subject|0|||
146951263|NCT01693562|529979937|FG015|Escalation Phase|Withdrawal by Subject|0|||
146822283|NCT00043186|529518950|FG004|Overall Study|Ineligibility determined|0|||
146822284|NCT00043186|529518951|FG005|Overall Study|Ineligibility determined|0|||
146822285|NCT00043186|529518952|FG006|Overall Study|Ineligibility determined|0|||
146822286|NCT00043186|529518953|FG007|Overall Study|Ineligibility determined|0|||
146951264|NCT01693562|529979938|FG016|Escalation Phase|Withdrawal by Subject|0|||
146951265|NCT01693562|529979939|FG017|Escalation Phase|Withdrawal by Subject|0|||
146951266|NCT01693562|529979940|FG018|Escalation Phase|Withdrawal by Subject|0|||
146951267|NCT01693562|529979941|FG019|Escalation Phase|Withdrawal by Subject|0|||
146822287|NCT00043186|529518954|FG008|Overall Study|Ineligibility determined|1|||
146822288|NCT00043186|529518946|FG000|Overall Study|Lost to Follow-up|3|||
146822289|NCT00043186|529518947|FG001|Overall Study|Lost to Follow-up|5|||
146822290|NCT00043186|529518948|FG002|Overall Study|Lost to Follow-up|1|||
146822291|NCT00043186|529518949|FG003|Overall Study|Lost to Follow-up|1|||
146822292|NCT00043186|529518950|FG004|Overall Study|Lost to Follow-up|1|||
146822293|NCT00043186|529518951|FG005|Overall Study|Lost to Follow-up|1|||
146822294|NCT00043186|529518952|FG006|Overall Study|Lost to Follow-up|1|||
146822295|NCT00043186|529518953|FG007|Overall Study|Lost to Follow-up|1|||
146822296|NCT00043186|529518954|FG008|Overall Study|Lost to Follow-up|2|||
146822297|NCT00043186|529518946|FG000|Overall Study|Noncompliance|0|||
146822298|NCT00043186|529518947|FG001|Overall Study|Noncompliance|0|||
146822299|NCT00043186|529518948|FG002|Overall Study|Noncompliance|1|||
146822300|NCT00043186|529518949|FG003|Overall Study|Noncompliance|1|||
146822301|NCT00043186|529518950|FG004|Overall Study|Noncompliance|0|||
146822302|NCT00043186|529518951|FG005|Overall Study|Noncompliance|0|||
146822303|NCT00043186|529518952|FG006|Overall Study|Noncompliance|0|||
146822304|NCT00043186|529518953|FG007|Overall Study|Noncompliance|0|||
146822305|NCT00043186|529518954|FG008|Overall Study|Noncompliance|0|||
146822306|NCT00043186|529518946|FG000|Overall Study|Other|0|||
146822307|NCT00043186|529518947|FG001|Overall Study|Other|0|||
146822308|NCT00043186|529518948|FG002|Overall Study|Other|1|||
146822309|NCT00043186|529518949|FG003|Overall Study|Other|1|||
146822310|NCT00043186|529518950|FG004|Overall Study|Other|0|||
146822311|NCT00043186|529518951|FG005|Overall Study|Other|0|||
146822312|NCT00043186|529518952|FG006|Overall Study|Other|0|||
146822313|NCT00043186|529518953|FG007|Overall Study|Other|0|||
146822314|NCT00043186|529518954|FG008|Overall Study|Other|0|||
146822315|NCT00958711|529518955|FG000|Overall Study|Withdrawal by Subject|0|||
146822316|NCT00958711|529518956|FG001|Overall Study|Withdrawal by Subject|4|||
146822317|NCT00958711|529518955|FG000|Overall Study|Physician Decision|5|||
146822318|NCT00958711|529518956|FG001|Overall Study|Physician Decision|7|||
146822319|NCT00958711|529518955|FG000|Overall Study|Lost to Follow-up|4|||
146822320|NCT00958711|529518956|FG001|Overall Study|Lost to Follow-up|1|||
146822321|NCT00958711|529518955|FG000|Overall Study|Other|2|||
146822322|NCT00958711|529518956|FG001|Overall Study|Other|5|||
146822323|NCT00958711|529518955|FG000|Overall Study|Death|1|||
146822324|NCT00958711|529518956|FG001|Overall Study|Death|2|||
146822325|NCT00958711|529518955|FG000|Overall Study|Adverse Event|1|||
146822326|NCT00958711|529518956|FG001|Overall Study|Adverse Event|2|||
146822327|NCT00755716|529518959|FG000|Overall Study|Adverse Event|1|||
146822328|NCT00755716|529518960|FG001|Overall Study|Adverse Event|4|||
146822329|NCT00755716|529518961|FG002|Overall Study|Adverse Event|1|||
146822330|NCT00755716|529518959|FG000|Overall Study|Lack of Efficacy|2|||
146822331|NCT00755716|529518960|FG001|Overall Study|Lack of Efficacy|0|||
146822332|NCT00755716|529518961|FG002|Overall Study|Lack of Efficacy|0|||
146822333|NCT00755716|529518959|FG000|Overall Study|Lost to Follow-up|5|||
146822334|NCT00755716|529518960|FG001|Overall Study|Lost to Follow-up|3|||
146822335|NCT00755716|529518961|FG002|Overall Study|Lost to Follow-up|1|||
146822336|NCT00755716|529518959|FG000|Overall Study|work schedule issues|0|||
146822337|NCT00755716|529518960|FG001|Overall Study|work schedule issues|1|||
146951268|NCT01693562|529979942|FG020|Escalation Phase|Withdrawal by Subject|0|||
146951269|NCT01693562|529979943|FG021|Escalation Phase|Withdrawal by Subject|0|||
146951270|NCT01693562|529979944|FG022|Escalation Phase|Withdrawal by Subject|0|||
146822338|NCT00755716|529518961|FG002|Overall Study|work schedule issues|1|||
146822339|NCT00726388|529518962|FG000|Overall Study|Withdrawal by Subject|5|||
146822340|NCT00726388|529518962|FG000|Overall Study|Adverse Event|3|||
146822341|NCT00726388|529518962|FG000|Overall Study|Lost to Follow-up|10|||
146951271|NCT01693562|529979922|FG000|Escalation Phase|Death|4|||
146822342|NCT00726388|529518962|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
146822343|NCT00726388|529518962|FG000|Overall Study|Other|5|||
146951272|NCT01693562|529979923|FG001|Escalation Phase|Death|2|||
146951273|NCT01693562|529979924|FG002|Escalation Phase|Death|0|||
146822344|NCT00726388|529518962|FG000|Overall Study|Enrolled, Not Treated|79|||
146822345|NCT00520403|529518963|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
146822346|NCT00520403|529518963|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
146822347|NCT00520403|529518963|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
146822348|NCT00520403|529518963|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
146822349|NCT00520403|529518963|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
146822350|NCT00520403|529518963|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
146822351|NCT00520403|529518963|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
146822352|NCT00520403|529518963|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
146822353|NCT01145417|529518964|FG000|Overall Study|Death|1|||
146822354|NCT01145417|529518965|FG001|Overall Study|Death|0|||
146822355|NCT01145417|529518964|FG000|Overall Study|Lost to Follow-up|2|||
146822356|NCT01145417|529518965|FG001|Overall Study|Lost to Follow-up|1|||
146822357|NCT01145417|529518964|FG000|Overall Study|Withdrawal by Subject|1|||
146822358|NCT01145417|529518965|FG001|Overall Study|Withdrawal by Subject|2|||
146822359|NCT01145417|529518964|FG000|Overall Study|Pregnancy|1|||
146822360|NCT01145417|529518965|FG001|Overall Study|Pregnancy|0|||
146822361|NCT01145417|529518964|FG000|Overall Study|Adverse Event|0|||
146822362|NCT01145417|529518965|FG001|Overall Study|Adverse Event|1|||
146822363|NCT01145417|529518964|FG000|Overall Study|Study terminated by sponsor|35|||
146822364|NCT01145417|529518965|FG001|Overall Study|Study terminated by sponsor|43|||
146822365|NCT01145417|529518964|FG000|Overall Study|Other|1|||
146822366|NCT01145417|529518965|FG001|Overall Study|Other|0|||
146822367|NCT00917462|529518966|FG000|Overall Study|Clinical Deterioration|1|||
146822368|NCT03341312|529518973|FG000|Period 1|Withdrawal by Subject|0|||
146822369|NCT03341312|529518974|FG001|Period 1|Withdrawal by Subject|1|||
146822370|NCT03341312|529518975|FG002|Period 1|Withdrawal by Subject|0|||
146822371|NCT03341312|529518976|FG003|Period 1|Withdrawal by Subject|0|||
146822372|NCT01631825|529518977|FG000|Overall Study|Adverse Event|42|||
146822373|NCT01631825|529518977|FG000|Overall Study|Lack of Efficacy|7|||
146822374|NCT01631825|529518977|FG000|Overall Study|Withdrawal by Subject|9|||
146822375|NCT01631825|529518977|FG000|Overall Study|Protocol Violation|4|||
146822376|NCT01631825|529518977|FG000|Overall Study|Discontinuation criteria|1|||
146822377|NCT01631825|529518977|FG000|Overall Study|Physician Decision|2|||
146822378|NCT03568708|529518979|FG000|Overall Study|Withdrawal by Subject|1|||
146822379|NCT03568708|529518980|FG001|Overall Study|Withdrawal by Subject|1|||
146822380|NCT03568708|529518979|FG000|Overall Study|Lost to Follow-up|0|||
146822381|NCT03568708|529518980|FG001|Overall Study|Lost to Follow-up|1|||
146822382|NCT00511147|529518981|FG000|Overall Study|Withdrawal by Subject|1|||
146822383|NCT00511147|529518981|FG000|Overall Study|Disease progression|5|||
146822384|NCT00511147|529518981|FG000|Overall Study|Required platelet transfusion|1|||
146822385|NCT05372913|529518988|FG000|Overall Study|Withdrawal by Subject|0|||
146822386|NCT05372913|529518989|FG001|Overall Study|Withdrawal by Subject|2|||
146822387|NCT05372913|529518988|FG000|Overall Study|Protocol Violation|2|||
146822388|NCT05372913|529518989|FG001|Overall Study|Protocol Violation|2|||
146822389|NCT05372913|529518988|FG000|Overall Study|Adverse Event|0|||
146822390|NCT05372913|529518989|FG001|Overall Study|Adverse Event|1|||
146822391|NCT03193216|529518990|FG000|Overall Study|Lost to Follow-up|1|||
146822392|NCT03193216|529518991|FG001|Overall Study|Lost to Follow-up|0|||
146822393|NCT03193216|529518990|FG000|Overall Study|Withdrawal by Subject|5|||
146822394|NCT03193216|529518991|FG001|Overall Study|Withdrawal by Subject|0|||
146822395|NCT03193216|529518990|FG000|Overall Study|Physician Decision|4|||
146822396|NCT03193216|529518991|FG001|Overall Study|Physician Decision|0|||
146822397|NCT03275402|529518992|FG000|Overall Study|Death|17|||
146822398|NCT03275402|529518992|FG000|Overall Study|Study terminated by sponsor|21|||
146822399|NCT03275402|529518992|FG000|Overall Study|Withdrawal by Subject|1|||
146822400|NCT01514864|529518993|FG000|Overall Study|Disease progression|7|||
146822401|NCT01514864|529518994|FG001|Overall Study|Disease progression|5|||
146822402|NCT01514864|529518993|FG000|Overall Study|Study drug toxicity|2|||
146822403|NCT01514864|529518994|FG001|Overall Study|Study drug toxicity|0|||
146822404|NCT05135156|529518995|FG000|Overall Study|Lost to Follow-up|0|||
146822405|NCT05135156|529518996|FG001|Overall Study|Lost to Follow-up|0|||
146822406|NCT05135156|529518997|FG002|Overall Study|Lost to Follow-up|2|||
146822407|NCT02986659|529518998|FG000|First Intervention Period|Adverse Event|3|||
146822408|NCT02986659|529518999|FG001|First Intervention Period|Adverse Event|1|||
146822409|NCT02986659|529518998|FG000|First Intervention Period|Lost to Follow-up|1|||
146822410|NCT02986659|529518999|FG001|First Intervention Period|Lost to Follow-up|0|||
146822411|NCT02986659|529518998|FG000|First Intervention Period|Withdrawal by Subject|0|||
146822412|NCT02986659|529518999|FG001|First Intervention Period|Withdrawal by Subject|1|||
146822413|NCT02986659|529518998|FG000|Second Intervention Period|Adverse Event|0|||
146822414|NCT02986659|529518999|FG001|Second Intervention Period|Adverse Event|6|||
146822415|NCT02254681|529519005|FG000|Overall Study|Lack of Efficacy|6|||
146822416|NCT02469077|529519006|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
146822417|NCT02469077|529519007|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
146822418|NCT02469077|529519006|FG000|Post Randomization/Intervention Period|Relocated|1|||
146822419|NCT02469077|529519007|FG001|Post Randomization/Intervention Period|Relocated|1|||
146822420|NCT02469077|529519006|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
146822421|NCT02469077|529519007|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
146822422|NCT02469077|529519006|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
146822423|NCT02469077|529519007|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
146822424|NCT01059526|529519008|FG000|Overall Study|Patient enrolled but not treated|20|||
146822425|NCT01059526|529519009|FG001|Overall Study|Patient enrolled but not treated|17|||
146822426|NCT01059526|529519008|FG000|Overall Study|Adverse Event|2|||
146822427|NCT01059526|529519009|FG001|Overall Study|Adverse Event|2|||
146822428|NCT01059526|529519008|FG000|Overall Study|Protocol Violation|0|||
146822429|NCT01059526|529519009|FG001|Overall Study|Protocol Violation|1|||
146822430|NCT01059526|529519008|FG000|Overall Study|Withdrawal by Subject|3|||
146822431|NCT01059526|529519009|FG001|Overall Study|Withdrawal by Subject|1|||
146822432|NCT01059526|529519008|FG000|Overall Study|Lost to Follow-up|4|||
146822433|NCT01059526|529519009|FG001|Overall Study|Lost to Follow-up|1|||
146822434|NCT01059526|529519008|FG000|Overall Study|Patient found to be dermatographic|1|||
146822435|NCT01059526|529519009|FG001|Overall Study|Patient found to be dermatographic|0|||
146822436|NCT01732588|529519010|FG000|First Intervention (7 Days)|Adverse Event|0|||
146822437|NCT01732588|529519011|FG001|First Intervention (7 Days)|Adverse Event|1|||
146822438|NCT01732588|529519012|FG002|First Intervention (7 Days)|Adverse Event|0|||
146822439|NCT02005029|529519013|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
146822440|NCT02005029|529519014|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
146822441|NCT02621047|529519015|FG000|Overall Study|Adverse Event|0|||
146822442|NCT02621047|529519016|FG001|Overall Study|Adverse Event|0|||
146822443|NCT02621047|529519017|FG002|Overall Study|Adverse Event|1|||
146822444|NCT01370018|529519018|FG000|Overall Study|Did not meet criteria for analysis|1|||
146822445|NCT03772041|529519021|FG000|Overall Study|Adverse Event|8|||
146822446|NCT03772041|529519022|FG001|Overall Study|Adverse Event|3|||
146822447|NCT03772041|529519021|FG000|Overall Study|Withdrawal by Subject|0|||
146822448|NCT03772041|529519022|FG001|Overall Study|Withdrawal by Subject|2|||
146822449|NCT03772041|529519021|FG000|Overall Study|Protocol Violation|4|||
146822450|NCT03772041|529519022|FG001|Overall Study|Protocol Violation|2|||
146822451|NCT03772041|529519021|FG000|Overall Study|Physician Decision|2|||
146822452|NCT03772041|529519022|FG001|Overall Study|Physician Decision|3|||
146822453|NCT01525641|529519023|FG000|Overall Study|Case report form not collected|25|||
146822454|NCT01525641|529519023|FG000|Overall Study|No visit since the first visit|16|||
146822455|NCT01525641|529519023|FG000|Overall Study|Adverse Event|73|||
146822456|NCT01525641|529519023|FG000|Overall Study|Lack of Efficacy|24|||
146822457|NCT01525641|529519023|FG000|Overall Study|Improvement|5|||
146822458|NCT01525641|529519023|FG000|Overall Study|Lost to follow-up (relocation)|1|||
146822459|NCT01525641|529519023|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
146822460|NCT01525641|529519023|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
146822461|NCT01525641|529519023|FG000|Overall Study|Other than stated above|7|||
146822462|NCT02204319|529519024|FG000|Overall Study|Pregnancy|1|||
146822463|NCT02204319|529519024|FG000|Overall Study|Withdrawal by Subject|2|||
146822464|NCT03544229|529519029|FG000|Overall Study|Adverse Event|1|||
146822465|NCT03544229|529519030|FG001|Overall Study|Adverse Event|0|||
146822466|NCT03544229|529519031|FG002|Overall Study|Adverse Event|1|||
146822467|NCT03544229|529519032|FG003|Overall Study|Adverse Event|0|||
146822468|NCT03544229|529519029|FG000|Overall Study|Protocol Deviation|0|||
146822469|NCT03544229|529519030|FG001|Overall Study|Protocol Deviation|0|||
146822470|NCT03544229|529519031|FG002|Overall Study|Protocol Deviation|1|||
146822471|NCT03544229|529519032|FG003|Overall Study|Protocol Deviation|0|||
146822472|NCT03544229|529519029|FG000|Overall Study|Lost to Follow-up|3|||
146822473|NCT03544229|529519030|FG001|Overall Study|Lost to Follow-up|0|||
146822474|NCT03544229|529519031|FG002|Overall Study|Lost to Follow-up|0|||
146822475|NCT03544229|529519032|FG003|Overall Study|Lost to Follow-up|2|||
146822476|NCT03544229|529519029|FG000|Overall Study|Voluntary Withdrawal|2|||
146822477|NCT03544229|529519030|FG001|Overall Study|Voluntary Withdrawal|1|||
146822478|NCT03544229|529519031|FG002|Overall Study|Voluntary Withdrawal|3|||
146822479|NCT03544229|529519032|FG003|Overall Study|Voluntary Withdrawal|0|||
146822480|NCT03544229|529519029|FG000|Overall Study|Lack of Efficacy|0|||
146822481|NCT03544229|529519030|FG001|Overall Study|Lack of Efficacy|1|||
146822482|NCT03544229|529519031|FG002|Overall Study|Lack of Efficacy|0|||
146822483|NCT03544229|529519032|FG003|Overall Study|Lack of Efficacy|0|||
146822484|NCT05012397|529519034|FG000|Overall Study|Death|10|||
146822485|NCT05012397|529519034|FG000|Overall Study|Physician Decision|9|||
146822486|NCT05012397|529519034|FG000|Overall Study|Withdrawal by Subject|5|||
146822487|NCT05012397|529519034|FG000|Overall Study|Lost to Follow-up|2|||
146822488|NCT04748445|529519037|FG000|Overall Study|No longer met eligibility criteria|12|||
146822489|NCT04748445|529519037|FG000|Overall Study|Other|36|||
146822490|NCT04748445|529519037|FG000|Overall Study|Withdrawal by Subject|553|||
146822491|NCT04748445|529519037|FG000|Overall Study|Lost to Follow-up|30|||
146822492|NCT00679549|529519040|FG000|Overall Study|dropout|2|||
146822493|NCT00679549|529519041|FG001|Overall Study|dropout|4|||
146822494|NCT00679549|529519040|FG000|Overall Study|missing outcome echocardiograms|4|||
146822495|NCT00679549|529519041|FG001|Overall Study|missing outcome echocardiograms|5|||
146822496|NCT00139659|529519044|FG000|Overall Study|Adverse Event|12|||
146822497|NCT00139659|529519045|FG001|Overall Study|Adverse Event|1|||
146822498|NCT00139659|529519044|FG000|Overall Study|Lack of Efficacy|1|||
146822499|NCT00139659|529519045|FG001|Overall Study|Lack of Efficacy|1|||
146822500|NCT00139659|529519044|FG000|Overall Study|Lost to Follow-up|7|||
146822501|NCT00139659|529519045|FG001|Overall Study|Lost to Follow-up|3|||
146822502|NCT00139659|529519044|FG000|Overall Study|Reason not Specified|6|||
146822503|NCT00139659|529519045|FG001|Overall Study|Reason not Specified|3|||
146822504|NCT00139659|529519044|FG000|Overall Study|Withdrawal by Subject|14|||
146822505|NCT00139659|529519045|FG001|Overall Study|Withdrawal by Subject|10|||
146822506|NCT04089332|529519075|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
146822507|NCT04089332|529519075|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
146822508|NCT04089332|529519075|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
146822509|NCT06016127|529519080|FG000|Overall Study|Withdrawal by Subject|4|||
146822510|NCT06016127|529519081|FG001|Overall Study|Withdrawal by Subject|3|||
146822511|NCT00734851|529519084|FG000|Overall Study|Withdrawal by Subject|2|||
146822512|NCT00734851|529519084|FG000|Overall Study|Lost to Follow-up|1|||
146822513|NCT00734851|529519084|FG000|Overall Study|Physician Decision|18|||
146822514|NCT01524887|529519085|FG000|Overall Study|Withdrawal by Subject|6|||
146822515|NCT01524887|529519086|FG001|Overall Study|Withdrawal by Subject|2|||
146822516|NCT01524887|529519087|FG002|Overall Study|Withdrawal by Subject|3|||
146822517|NCT01524887|529519085|FG000|Overall Study|Adverse Event|5|||
146822518|NCT01524887|529519086|FG001|Overall Study|Adverse Event|1|||
146822519|NCT01524887|529519087|FG002|Overall Study|Adverse Event|1|||
146822520|NCT01524887|529519085|FG000|Overall Study|Protocol Violation|0|||
146822521|NCT01524887|529519086|FG001|Overall Study|Protocol Violation|0|||
146822522|NCT01524887|529519087|FG002|Overall Study|Protocol Violation|1|||
146822523|NCT01524887|529519085|FG000|Overall Study|Study termination|73|||
146822524|NCT01524887|529519086|FG001|Overall Study|Study termination|87|||
146822525|NCT01524887|529519087|FG002|Overall Study|Study termination|79|||
146822526|NCT01524887|529519085|FG000|Overall Study|Withdrawal by Caregiver|0|||
146822527|NCT01524887|529519086|FG001|Overall Study|Withdrawal by Caregiver|0|||
146822528|NCT01524887|529519087|FG002|Overall Study|Withdrawal by Caregiver|2|||
146822529|NCT01524887|529519085|FG000|Overall Study|Use of prohibited medication|1|||
146822530|NCT01524887|529519086|FG001|Overall Study|Use of prohibited medication|0|||
146822531|NCT01524887|529519087|FG002|Overall Study|Use of prohibited medication|0|||
146822532|NCT00170950|529519088|FG000|Overall Study|Death|236|||
146822533|NCT00170950|529519089|FG001|Overall Study|Death|274|||
146822534|NCT00170950|529519088|FG000|Overall Study|Withdrawal by Subject|496|||
146822535|NCT00170950|529519089|FG001|Overall Study|Withdrawal by Subject|498|||
146822536|NCT00170950|529519088|FG000|Overall Study|Lost to Follow-up|134|||
146822537|NCT00170950|529519089|FG001|Overall Study|Lost to Follow-up|115|||
146822538|NCT00170950|529519088|FG000|Overall Study|Missing|2|||
146822539|NCT00170950|529519089|FG001|Overall Study|Missing|1|||
146822540|NCT00170950|529519088|FG000|Overall Study|Termination Data Not Recorded|17|||
146822541|NCT00170950|529519089|FG001|Overall Study|Termination Data Not Recorded|22|||
146822542|NCT00497198|529519094|FG000|Overall Study|Adverse Event|4|||
146822543|NCT00497198|529519095|FG001|Overall Study|Adverse Event|2|||
146822544|NCT00497198|529519094|FG000|Overall Study|Physician Decision|1|||
146822545|NCT00497198|529519095|FG001|Overall Study|Physician Decision|2|||
146822546|NCT00497198|529519094|FG000|Overall Study|Withdrawal by Subject|0|||
146822547|NCT00497198|529519095|FG001|Overall Study|Withdrawal by Subject|1|||
146822548|NCT00381888|529520929|FG000|Overall Study|Death|1|||
146822549|NCT00381888|529520929|FG000|Overall Study|Withdrawal by Subject|1|||
146822550|NCT00381888|529520929|FG000|Overall Study|Physician Decision|1|||
146822551|NCT00381888|529520929|FG000|Overall Study|Protocol Violation|9|||
146822552|NCT00381888|529520929|FG000|Overall Study|Had laparoscopic surgery|2|||
146822553|NCT00381888|529520929|FG000|Overall Study|Surgery was cancelled|2|||
146822554|NCT00381888|529520929|FG000|Overall Study|Adverse Event|1|||
146822555|NCT01589523|529520932|FG000|Overall Study|Withdrawal by Subject|1|||
146822556|NCT00961896|529520933|FG000|Overall Study|Abnormal laboratory value|0|||
146984913|NCT01341639|530107093|FG001|Infant Series|Lost to Follow-up|2|||
146822557|NCT00961896|529520934|FG001|Overall Study|Abnormal laboratory value|0|||
146822558|NCT00961896|529520935|FG002|Overall Study|Abnormal laboratory value|1|||
146822559|NCT00506922|529520936|FG000|Overall Study|Physician Decision|0|||
146822560|NCT00506922|529520937|FG001|Overall Study|Physician Decision|0|||
146822561|NCT00506922|529520938|FG002|Overall Study|Physician Decision|0|||
146822562|NCT00506922|529520939|FG003|Overall Study|Physician Decision|2|||
146951274|NCT01693562|529979925|FG003|Escalation Phase|Death|3|||
146951275|NCT01693562|529979926|FG004|Escalation Phase|Death|6|||
146951276|NCT01693562|529979927|FG005|Escalation Phase|Death|4|||
146951277|NCT01693562|529979928|FG006|Escalation Phase|Death|0|||
146951278|NCT01693562|529979929|FG007|Escalation Phase|Death|0|||
146951279|NCT01693562|529979930|FG008|Escalation Phase|Death|0|||
146822563|NCT00506922|529520940|FG004|Overall Study|Physician Decision|0|||
146822564|NCT00506922|529520936|FG000|Overall Study|Withdrawal by Subject|0|||
146822565|NCT00506922|529520937|FG001|Overall Study|Withdrawal by Subject|0|||
146822566|NCT00506922|529520938|FG002|Overall Study|Withdrawal by Subject|0|||
146822567|NCT00506922|529520939|FG003|Overall Study|Withdrawal by Subject|0|||
146822568|NCT00506922|529520940|FG004|Overall Study|Withdrawal by Subject|1|||
146822569|NCT00792259|529520941|FG000|Overall Study|Poor Quality Scans|1|||
146951280|NCT01693562|529979931|FG009|Escalation Phase|Death|0|||
146951281|NCT01693562|529979932|FG010|Escalation Phase|Death|0|||
146951282|NCT01693562|529979933|FG011|Escalation Phase|Death|0|||
146951283|NCT01693562|529979934|FG012|Escalation Phase|Death|0|||
146951284|NCT01693562|529979935|FG013|Escalation Phase|Death|0|||
146951285|NCT01693562|529979936|FG014|Escalation Phase|Death|0|||
146951286|NCT01693562|529979937|FG015|Escalation Phase|Death|0|||
146951287|NCT01693562|529979938|FG016|Escalation Phase|Death|0|||
146951288|NCT01693562|529979939|FG017|Escalation Phase|Death|0|||
146822570|NCT00792259|529520942|FG001|Overall Study|Poor Quality Scans|0|||
146822571|NCT00792259|529520943|FG002|Overall Study|Poor Quality Scans|0|||
146822572|NCT03721978|529520944|FG000|Overall Study|Withdrawal by Subject|6|||
146822573|NCT03721978|529520945|FG001|Overall Study|Withdrawal by Subject|1|||
146822574|NCT03721978|529520944|FG000|Overall Study|Adverse Event|1|||
146822575|NCT03721978|529520945|FG001|Overall Study|Adverse Event|1|||
146822576|NCT03721978|529520944|FG000|Overall Study|Progressive Disease|1|||
146822577|NCT03721978|529520945|FG001|Overall Study|Progressive Disease|0|||
146822578|NCT03721978|529520944|FG000|Overall Study|Lost to Follow-up|5|||
146822579|NCT03721978|529520945|FG001|Overall Study|Lost to Follow-up|1|||
146822580|NCT03721978|529520944|FG000|Overall Study|Reason not Specified|0|||
146822581|NCT03721978|529520945|FG001|Overall Study|Reason not Specified|2|||
146822582|NCT05244226|529520946|FG000|Overall Study|Adverse Event|1|||
146822583|NCT05244226|529520947|FG001|Overall Study|Adverse Event|0|||
146822584|NCT05244226|529520948|FG002|Overall Study|Adverse Event|0|||
146822585|NCT05244226|529520946|FG000|Overall Study|Lost to Follow-up|0|||
146822586|NCT05244226|529520947|FG001|Overall Study|Lost to Follow-up|0|||
146822587|NCT05244226|529520948|FG002|Overall Study|Lost to Follow-up|1|||
146822588|NCT05244226|529520946|FG000|Overall Study|Protocol Violation|0|||
146822589|NCT05244226|529520947|FG001|Overall Study|Protocol Violation|2|||
146822590|NCT05244226|529520948|FG002|Overall Study|Protocol Violation|2|||
146822591|NCT02507687|529520955|FG000|Overall Study|Adverse Event|3|||
146822592|NCT02507687|529520956|FG001|Overall Study|Adverse Event|2|||
146822593|NCT02507687|529520957|FG002|Overall Study|Adverse Event|2|||
146822594|NCT02507687|529520958|FG003|Overall Study|Adverse Event|2|||
146822595|NCT02507687|529520955|FG000|Overall Study|Withdrawal by Subject|1|||
146822596|NCT02507687|529520956|FG001|Overall Study|Withdrawal by Subject|4|||
146822597|NCT02507687|529520957|FG002|Overall Study|Withdrawal by Subject|6|||
146822598|NCT02507687|529520958|FG003|Overall Study|Withdrawal by Subject|6|||
146822599|NCT02507687|529520955|FG000|Overall Study|Protocol Violation|1|||
146822600|NCT02507687|529520956|FG001|Overall Study|Protocol Violation|0|||
146822601|NCT02507687|529520957|FG002|Overall Study|Protocol Violation|2|||
146822602|NCT02507687|529520958|FG003|Overall Study|Protocol Violation|0|||
146822603|NCT02507687|529520955|FG000|Overall Study|Lost to Follow-up|0|||
146822604|NCT02507687|529520956|FG001|Overall Study|Lost to Follow-up|0|||
146822605|NCT02507687|529520957|FG002|Overall Study|Lost to Follow-up|2|||
146822606|NCT02507687|529520958|FG003|Overall Study|Lost to Follow-up|1|||
146822607|NCT02507687|529520955|FG000|Overall Study|Screen Failure|0|||
146822608|NCT02507687|529520956|FG001|Overall Study|Screen Failure|0|||
146822609|NCT02507687|529520957|FG002|Overall Study|Screen Failure|1|||
146822610|NCT02507687|529520958|FG003|Overall Study|Screen Failure|0|||
146822611|NCT02507687|529520955|FG000|Overall Study|Other, Not Specified|0|||
146822612|NCT02507687|529520956|FG001|Overall Study|Other, Not Specified|0|||
146822613|NCT02507687|529520957|FG002|Overall Study|Other, Not Specified|2|||
146822614|NCT02507687|529520958|FG003|Overall Study|Other, Not Specified|4|||
146822615|NCT02675998|529520959|FG000|8-Week Treatment Period|Adverse Event|6|||
146822616|NCT02675998|529520960|FG001|8-Week Treatment Period|Adverse Event|5|||
146822617|NCT02675998|529520961|FG002|8-Week Treatment Period|Adverse Event|6|||
146822618|NCT02675998|529520962|FG003|8-Week Treatment Period|Adverse Event|0|||
146822619|NCT02675998|529520959|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
146822620|NCT02675998|529520960|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
146822621|NCT02675998|529520961|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
146822622|NCT02675998|529520962|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
146822623|NCT02675998|529520959|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
146822624|NCT02675998|529520960|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
146822625|NCT02675998|529520961|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
146822626|NCT02675998|529520962|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
146822627|NCT02675998|529520959|FG000|8-Week Treatment Period|Physician Decision|1|||
146822628|NCT02675998|529520960|FG001|8-Week Treatment Period|Physician Decision|0|||
146822629|NCT02675998|529520961|FG002|8-Week Treatment Period|Physician Decision|2|||
146822630|NCT02675998|529520962|FG003|8-Week Treatment Period|Physician Decision|0|||
146822631|NCT02675998|529520959|FG000|8-Week Treatment Period|GI side Effects|1|||
146822632|NCT02675998|529520960|FG001|8-Week Treatment Period|GI side Effects|4|||
146822633|NCT02675998|529520961|FG002|8-Week Treatment Period|GI side Effects|2|||
146822634|NCT02675998|529520962|FG003|8-Week Treatment Period|GI side Effects|0|||
146822635|NCT02675998|529520959|FG000|8-Week Treatment Period|Protocol Violation|1|||
146822636|NCT02675998|529520960|FG001|8-Week Treatment Period|Protocol Violation|1|||
146822637|NCT02675998|529520961|FG002|8-Week Treatment Period|Protocol Violation|1|||
146822638|NCT02675998|529520962|FG003|8-Week Treatment Period|Protocol Violation|0|||
146822639|NCT02675998|529520959|FG000|8-Week Treatment Period|Other|3|||
146822640|NCT02675998|529520960|FG001|8-Week Treatment Period|Other|1|||
146822641|NCT02675998|529520961|FG002|8-Week Treatment Period|Other|2|||
146822642|NCT02675998|529520962|FG003|8-Week Treatment Period|Other|0|||
146822643|NCT02675998|529520959|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
146822644|NCT02675998|529520960|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
146984914|NCT01341639|530107092|FG000|Infant Series|Site 0048 Participants|17|||
146848509|NCT01373151|529615721|FG005|Period 1|Withdrawal by Subject|1|||
146822645|NCT02675998|529520961|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
146822646|NCT02675998|529520962|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
146822647|NCT02675998|529520959|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
146822648|NCT02675998|529520960|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
146822649|NCT02675998|529520961|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
146822650|NCT02675998|529520962|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
146822651|NCT02675998|529520959|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
146822652|NCT02675998|529520960|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
146822653|NCT02675998|529520961|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
146822654|NCT02675998|529520962|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
146822655|NCT02675998|529520959|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
146822656|NCT02675998|529520960|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
146822657|NCT02675998|529520961|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
146822658|NCT02675998|529520962|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
146822659|NCT02675998|529520959|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
146822660|NCT02675998|529520960|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
146822661|NCT02675998|529520961|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
146822662|NCT02675998|529520962|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
146822663|NCT00275301|529520963|FG000|Overall Study|Adverse Event|5|||
146822664|NCT00598871|529520964|FG000|Overall Study|Adverse Event|0|||
146822665|NCT00598871|529520965|FG001|Overall Study|Adverse Event|1|||
146822666|NCT01194271|529520966|FG000|Overall Study|Withdrawal by Subject|1|||
146822667|NCT01194271|529520966|FG000|Overall Study|Ineligible, Screen Failure|1|||
146822668|NCT01194271|529520966|FG000|Overall Study|Death|1|||
146822669|NCT01983462|529520969|FG000|Overall Study|Adverse Event|1|||
146822670|NCT01983462|529520970|FG001|Overall Study|Adverse Event|0|||
146822671|NCT01983462|529520971|FG002|Overall Study|Adverse Event|0|||
146822672|NCT00550771|529520975|FG000|Overall Study|Adverse Event|11|||
146822673|NCT00550771|529520976|FG001|Overall Study|Adverse Event|3|||
146822674|NCT00550771|529520975|FG000|Overall Study|Discontinued for study-related reasons|0|||
146822675|NCT00550771|529520976|FG001|Overall Study|Discontinued for study-related reasons|1|||
146822676|NCT00550771|529520975|FG000|Overall Study|Physician Decision|2|||
146822677|NCT00550771|529520976|FG001|Overall Study|Physician Decision|0|||
146822678|NCT00550771|529520975|FG000|Overall Study|Withdrawal by Subject|0|||
146822679|NCT00550771|529520976|FG001|Overall Study|Withdrawal by Subject|1|||
146822680|NCT00550771|529520975|FG000|Overall Study|Protocol Violation|4|||
146822681|NCT00550771|529520976|FG001|Overall Study|Protocol Violation|5|||
146822682|NCT03022578|529520977|FG000|Overall Study|Adverse Event|1|||
146822683|NCT03022578|529520977|FG000|Overall Study|Lack of Efficacy|2|||
146822684|NCT03022578|529520977|FG000|Overall Study|Withdrawal by Subject|1|||
146822685|NCT03681353|529520978|FG000|Overall Study|Lost to Follow-up|2|||
146822686|NCT03681353|529520978|FG000|Overall Study|Withdrawal by Subject|3|||
146822687|NCT03681353|529520978|FG000|Overall Study|withdrawn by PI|2|||
146822688|NCT00382408|529520982|FG000|Overall Study|Did not meet protocol requirement|3|||
146822689|NCT00382408|529520983|FG001|Overall Study|Did not meet protocol requirement|3|||
146822690|NCT00382408|529520982|FG000|Overall Study|Protocol Violation|2|||
146822691|NCT00382408|529520983|FG001|Overall Study|Protocol Violation|2|||
146822692|NCT00382408|529520982|FG000|Overall Study|Physician Decision|1|||
146822693|NCT00382408|529520983|FG001|Overall Study|Physician Decision|0|||
146822694|NCT00382408|529520982|FG000|Overall Study|Withdrawal by Subject|17|||
146822695|NCT00382408|529520983|FG001|Overall Study|Withdrawal by Subject|6|||
146822696|NCT00382408|529520982|FG000|Overall Study|Pregnancy|2|||
146822697|NCT00382408|529520983|FG001|Overall Study|Pregnancy|0|||
146822698|NCT00382408|529520982|FG000|Overall Study|Lost to Follow-up|19|||
146822699|NCT00382408|529520983|FG001|Overall Study|Lost to Follow-up|8|||
146822700|NCT00382408|529520982|FG000|Overall Study|Other|100|||
146822701|NCT00382408|529520983|FG001|Overall Study|Other|35|||
146822702|NCT01812707|529520984|FG000|Overall Study|Adverse Event|0|||
146822703|NCT01812707|529520985|FG001|Overall Study|Adverse Event|0|||
146822704|NCT01812707|529520986|FG002|Overall Study|Adverse Event|0|||
146822705|NCT01812707|529520987|FG003|Overall Study|Adverse Event|2|||
146822706|NCT01812707|529520984|FG000|Overall Study|Poor compliance to protocol|1|||
146822707|NCT01812707|529520985|FG001|Overall Study|Poor compliance to protocol|0|||
146822708|NCT01812707|529520986|FG002|Overall Study|Poor compliance to protocol|0|||
146822709|NCT01812707|529520987|FG003|Overall Study|Poor compliance to protocol|0|||
146951289|NCT01693562|529979940|FG018|Escalation Phase|Death|0|||
146822710|NCT01812707|529520984|FG000|Overall Study|Consent withdrawn by participant|1|||
146822711|NCT01812707|529520985|FG001|Overall Study|Consent withdrawn by participant|0|||
146822712|NCT01812707|529520986|FG002|Overall Study|Consent withdrawn by participant|0|||
146822713|NCT01812707|529520987|FG003|Overall Study|Consent withdrawn by participant|0|||
146822714|NCT02110225|529520988|FG000|Overall Study|Lost to Follow-up|0|||
146822715|NCT02110225|529520989|FG001|Overall Study|Lost to Follow-up|1|||
146822716|NCT02110225|529520990|FG002|Overall Study|Lost to Follow-up|0|||
146822717|NCT02176018|529520991|FG000|Overall Study|Adverse Event|0|||
146951290|NCT01693562|529979941|FG019|Escalation Phase|Death|0|||
146822718|NCT02176018|529520992|FG001|Overall Study|Adverse Event|2|||
146822719|NCT02176018|529520991|FG000|Overall Study|Lost to Follow-up|3|||
146822720|NCT02176018|529520992|FG001|Overall Study|Lost to Follow-up|1|||
146822721|NCT02176018|529520991|FG000|Overall Study|Protocol Violation|1|||
146822722|NCT02176018|529520992|FG001|Overall Study|Protocol Violation|1|||
146822723|NCT02176018|529520991|FG000|Overall Study|Withdrawal by Subject|1|||
146822724|NCT02176018|529520992|FG001|Overall Study|Withdrawal by Subject|2|||
146822725|NCT00265096|529520993|FG000|Overall Study|Adverse Event|14|||
146822726|NCT00265096|529520994|FG001|Overall Study|Adverse Event|18|||
146822727|NCT00265096|529520995|FG002|Overall Study|Adverse Event|18|||
146822728|NCT00265096|529520993|FG000|Overall Study|Lost to Follow-up|2|||
146822729|NCT00265096|529520994|FG001|Overall Study|Lost to Follow-up|5|||
146822730|NCT00265096|529520995|FG002|Overall Study|Lost to Follow-up|3|||
146822731|NCT00265096|529520993|FG000|Overall Study|Death|0|||
146822732|NCT00265096|529520994|FG001|Overall Study|Death|1|||
146822733|NCT00265096|529520995|FG002|Overall Study|Death|2|||
146822734|NCT00265096|529520993|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
146822735|NCT00265096|529520994|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
146822736|NCT00265096|529520995|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
146822737|NCT00265096|529520993|FG000|Overall Study|Other|11|||
146822738|NCT00265096|529520994|FG001|Overall Study|Other|19|||
146822739|NCT00265096|529520995|FG002|Overall Study|Other|10|||
146822740|NCT00774306|529520996|FG000|Overall Study|Adverse Event|3|||
146822741|NCT00774306|529520997|FG001|Overall Study|Adverse Event|0|||
146822742|NCT00774306|529520998|FG002|Overall Study|Adverse Event|0|||
146822743|NCT00774306|529520999|FG003|Overall Study|Adverse Event|0|||
146822744|NCT00774306|529520996|FG000|Overall Study|Protocol Violation|2|||
146822745|NCT00774306|529520997|FG001|Overall Study|Protocol Violation|0|||
146822746|NCT00774306|529520998|FG002|Overall Study|Protocol Violation|3|||
146822747|NCT00774306|529520999|FG003|Overall Study|Protocol Violation|0|||
146822748|NCT00774306|529520996|FG000|Overall Study|Withdrawal by Subject|6|||
146822749|NCT00774306|529520997|FG001|Overall Study|Withdrawal by Subject|1|||
146822750|NCT00774306|529520998|FG002|Overall Study|Withdrawal by Subject|1|||
146822751|NCT00774306|529520999|FG003|Overall Study|Withdrawal by Subject|0|||
146822752|NCT00774306|529520996|FG000|Overall Study|Lost to Follow-up|6|||
146822753|NCT00774306|529520997|FG001|Overall Study|Lost to Follow-up|0|||
146822754|NCT00774306|529520998|FG002|Overall Study|Lost to Follow-up|4|||
146822755|NCT00774306|529520999|FG003|Overall Study|Lost to Follow-up|5|||
146822756|NCT00774306|529520996|FG000|Overall Study|Death|1|||
146822757|NCT00774306|529520997|FG001|Overall Study|Death|1|||
146822758|NCT00774306|529520998|FG002|Overall Study|Death|0|||
146822759|NCT00774306|529520999|FG003|Overall Study|Death|0|||
146822760|NCT00809783|529521005|FG000|Overall Study|Death|1|||
146822761|NCT00809783|529521006|FG001|Overall Study|Death|0|||
146822762|NCT00809783|529521007|FG002|Overall Study|Death|0|||
146822763|NCT00809783|529521005|FG000|Overall Study|Adverse Event|34|||
146822764|NCT00809783|529521006|FG001|Overall Study|Adverse Event|52|||
146822765|NCT00809783|529521007|FG002|Overall Study|Adverse Event|71|||
146822766|NCT00809783|529521005|FG000|Overall Study|Lack of Efficacy|39|||
146822767|NCT00809783|529521006|FG001|Overall Study|Lack of Efficacy|52|||
146822768|NCT00809783|529521007|FG002|Overall Study|Lack of Efficacy|63|||
146822769|NCT00809783|529521005|FG000|Overall Study|Lost to Follow-up|0|||
146822770|NCT00809783|529521006|FG001|Overall Study|Lost to Follow-up|3|||
146822771|NCT00809783|529521007|FG002|Overall Study|Lost to Follow-up|4|||
146822772|NCT00809783|529521005|FG000|Overall Study|Withdrawal by Subject|47|||
146822773|NCT00809783|529521006|FG001|Overall Study|Withdrawal by Subject|72|||
146822774|NCT00809783|529521007|FG002|Overall Study|Withdrawal by Subject|64|||
146822775|NCT00809783|529521005|FG000|Overall Study|Protocol Violation|2|||
146822776|NCT00809783|529521006|FG001|Overall Study|Protocol Violation|6|||
146822777|NCT00809783|529521007|FG002|Overall Study|Protocol Violation|5|||
146822778|NCT00809783|529521005|FG000|Overall Study|Randomized, but not treated|3|||
146822779|NCT00809783|529521006|FG001|Overall Study|Randomized, but not treated|0|||
146822780|NCT00809783|529521007|FG002|Overall Study|Randomized, but not treated|2|||
146822781|NCT00809783|529521005|FG000|Overall Study|Study Terminated by Sponsor|378|||
146984915|NCT01341639|530107093|FG001|Infant Series|Site 0048 Participants|16|||
146822782|NCT00809783|529521006|FG001|Overall Study|Study Terminated by Sponsor|626|||
146984916|NCT01341639|530107092|FG000|Interim Period|Withdrawal by Subject|6|||
146822783|NCT00809783|529521007|FG002|Overall Study|Study Terminated by Sponsor|565|||
146822784|NCT00809783|529521005|FG000|Overall Study|Other|21|||
146822785|NCT00809783|529521006|FG001|Overall Study|Other|21|||
146984917|NCT01341639|530107093|FG001|Interim Period|Withdrawal by Subject|7|||
146822786|NCT00809783|529521007|FG002|Overall Study|Other|16|||
146822787|NCT00126555|529521008|FG000|Overall Study|Withdrawal by Subject|1|||
146822788|NCT00126555|529521008|FG000|Overall Study|Adverse Event|2|||
146984918|NCT01341639|530107092|FG000|Interim Period|Lost to Follow-up|2|||
146822789|NCT00126555|529521008|FG000|Overall Study|Progressive Disease|3|||
146822790|NCT01780545|529521012|FG000|Overall Study|Withdrawal by Subject|3|||
146822791|NCT01780545|529521013|FG001|Overall Study|Withdrawal by Subject|1|||
146822792|NCT01780545|529521012|FG000|Overall Study|Lost to Follow-up|1|||
146822793|NCT01780545|529521013|FG001|Overall Study|Lost to Follow-up|1|||
146822794|NCT00498433|529521014|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
146822795|NCT00498433|529521015|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
146822796|NCT00498433|529521016|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
146822797|NCT00498433|529521014|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
146822798|NCT00498433|529521015|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
146822799|NCT00498433|529521016|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
146822800|NCT00498433|529521014|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
146822801|NCT00498433|529521015|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
146822802|NCT00498433|529521016|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
146822803|NCT00498433|529521014|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
146822804|NCT00498433|529521015|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
146822805|NCT00498433|529521016|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
146822806|NCT01264887|529521026|FG000|Overall Study|Adverse Event|5|||
146822807|NCT01264887|529521026|FG000|Overall Study|Death|7|||
146822808|NCT01264887|529521026|FG000|Overall Study|Lack of Efficacy|5|||
146822809|NCT01264887|529521026|FG000|Overall Study|Physician Decision|4|||
146822810|NCT01264887|529521026|FG000|Overall Study|Withdrawal by Subject|6|||
146822811|NCT01264887|529521026|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
146822812|NCT01264887|529521026|FG000|Overall Study|Other|2|||
146822813|NCT02171130|529521027|FG000|Overall Study|Death|1|||
146822814|NCT02171130|529521027|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
146822815|NCT02171130|529521027|FG000|Overall Study|Discontinued; Site Termination|5|||
146822816|NCT02171130|529521027|FG000|Overall Study|Withdrawal by Subject|3|||
146822817|NCT02171130|529521027|FG000|Overall Study|Physician Decision|1|||
146822818|NCT02171130|529521027|FG000|Overall Study|Lost to Follow-up|1|||
146822819|NCT02171130|529521027|FG000|Overall Study|Met Exclusion Criteria|1|||
146822820|NCT00591409|529521028|FG000|Overall Study|Not Treated|0|||
146822821|NCT00591409|529521029|FG001|Overall Study|Not Treated|0|||
146822822|NCT00591409|529521030|FG002|Overall Study|Not Treated|0|||
146822823|NCT00591409|529521031|FG003|Overall Study|Not Treated|0|||
146822824|NCT00591409|529521032|FG004|Overall Study|Not Treated|1|||
146822825|NCT00591409|529521033|FG005|Overall Study|Not Treated|0|||
146822826|NCT00591409|529521034|FG006|Overall Study|Not Treated|0|||
146822827|NCT00591409|529521035|FG007|Overall Study|Not Treated|0|||
146822828|NCT00591409|529521036|FG008|Overall Study|Not Treated|0|||
146822829|NCT00591409|529521037|FG009|Overall Study|Not Treated|1|||
146822830|NCT04531813|529521038|FG000|Overall Study|Protocol Violation|1|||
146822831|NCT04531813|529521038|FG000|Overall Study|Withdrawal by Subject|1|||
146822832|NCT02853305|529521039|FG000|Overall Study|Death|287|||
146822833|NCT02853305|529521040|FG001|Overall Study|Death|249|||
146822834|NCT02853305|529521041|FG002|Overall Study|Death|300|||
146822835|NCT02853305|529521039|FG000|Overall Study|Withdrawal by Subject|2|||
146822836|NCT02853305|529521040|FG001|Overall Study|Withdrawal by Subject|8|||
146822837|NCT02853305|529521041|FG002|Overall Study|Withdrawal by Subject|3|||
146822838|NCT02853305|529521039|FG000|Overall Study|Transferred to Extension Study|46|||
146822839|NCT02853305|529521040|FG001|Overall Study|Transferred to Extension Study|30|||
146822840|NCT02853305|529521041|FG002|Overall Study|Transferred to Extension Study|25|||
146822841|NCT02853305|529521039|FG000|Overall Study|Did Not Continue on Extension Study|16|||
146822842|NCT02853305|529521040|FG001|Overall Study|Did Not Continue on Extension Study|20|||
146822843|NCT02853305|529521041|FG002|Overall Study|Did Not Continue on Extension Study|24|||
146822844|NCT04772313|529521044|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
146822845|NCT04772313|529521044|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
146822846|NCT01836198|529521045|FG000|Part A, Period 2|Protocol Violation|0|||
146822847|NCT01836198|529521046|FG001|Part A, Period 2|Protocol Violation|1|||
146822848|NCT01836198|529521047|FG002|Part A, Period 2|Protocol Violation|0|||
146822849|NCT03187353|529521048|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
146822850|NCT03187353|529521049|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
146822851|NCT03187353|529521048|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
146822852|NCT03187353|529521049|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
146822853|NCT03187353|529521048|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
146822854|NCT03187353|529521049|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
146822855|NCT03187353|529521048|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
146822856|NCT03187353|529521049|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
146984919|NCT01341639|530107093|FG001|Interim Period|Lost to Follow-up|0|||
146822857|NCT03187353|529521048|FG000|Washout (2 Weeks)|Adverse Event|2|||
146822858|NCT03187353|529521049|FG001|Washout (2 Weeks)|Adverse Event|0|||
146822859|NCT03187353|529521048|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
146822860|NCT03187353|529521049|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
146822861|NCT03794609|529521053|FG000|Overall Study|Other|10|||
146822862|NCT03794609|529521053|FG000|Overall Study|Withdrawal by Subject|66|||
146822863|NCT03794609|529521053|FG000|Overall Study|The child is enrolled in an interventional study|70|||
146822864|NCT03794609|529521053|FG000|Overall Study|Inclusion/exclusion criteria|8|||
146984920|NCT01341639|530107092|FG000|Interim Period|Physician Decision|0|||
146984921|NCT01341639|530107093|FG001|Interim Period|Physician Decision|1|||
146984922|NCT01341639|530107092|FG000|Interim Period|Protocol Violation|0|||
146822865|NCT03794609|529521053|FG000|Overall Study|At sponsor's request|151|||
146822866|NCT03794609|529521053|FG000|Overall Study|Physician Decision|1|||
146822867|NCT03794609|529521053|FG000|Overall Study|Lost to Follow-up|5|||
146822868|NCT02205476|529521054|FG000|Overall Study|Study termination by Sponsor|7|||
146822869|NCT02205476|529521055|FG001|Overall Study|Study termination by Sponsor|3|||
146822870|NCT02359552|529521060|FG000|Overall Study|Lost to Follow-up|3|||
146822871|NCT02359552|529521061|FG001|Overall Study|Lost to Follow-up|4|||
146822872|NCT02391116|529521062|FG000|Treatment|Withdrawal by Subject|1|||
146822873|NCT02391116|529521062|FG000|Treatment|Protocol Violation|1|||
146822874|NCT02391116|529521062|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
146822875|NCT02391116|529521062|FG000|Treatment|AE with Clinical PD|3|||
146822876|NCT02391116|529521062|FG000|Safety Follow-up|Adverse Event|1|||
146822877|NCT02391116|529521062|FG000|Safety Follow-up|Withdrawal by Subject|4|||
146822878|NCT02391116|529521062|FG000|Safety Follow-up|Switching to Other Therapy|4|||
146822879|NCT02391116|529521062|FG000|Safety Follow-up|No Follow Up|1|||
146822880|NCT02391116|529521062|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
146822881|NCT02391116|529521062|FG000|Active Follow-up|Withdrawal by Subject|1|||
146822882|NCT02391116|529521062|FG000|Active Follow-up|Switching to Other Therapy|2|||
146822883|NCT02391116|529521062|FG000|Survival Follow-up|Withdrawal by Subject|3|||
146822884|NCT02391116|529521062|FG000|Survival Follow-up|Switching to Other Therapy|1|||
146822885|NCT02282917|529521063|FG000|Overall Study|Withdrawal by Subject|1|||
146822886|NCT02282917|529521063|FG000|Overall Study|Screen Failure/Not Eligible|1|||
146822887|NCT01747629|529521064|FG000|Overall Study|Adverse Event|1|||
146822888|NCT01747629|529521065|FG001|Overall Study|Adverse Event|2|||
146822889|NCT01747629|529521064|FG000|Overall Study|Withdrawal by Subject|2|||
146822890|NCT01747629|529521065|FG001|Overall Study|Withdrawal by Subject|2|||
146822891|NCT01747629|529521064|FG000|Overall Study|Noncompliance|1|||
146822892|NCT01747629|529521065|FG001|Overall Study|Noncompliance|1|||
146822893|NCT01747629|529521064|FG000|Overall Study|Inclusion criteria not met|1|||
146822894|NCT01747629|529521065|FG001|Overall Study|Inclusion criteria not met|0|||
146822895|NCT01747629|529521064|FG000|Overall Study|Not treated|1|||
146822896|NCT01747629|529521065|FG001|Overall Study|Not treated|0|||
146822897|NCT01747629|529521064|FG000|Overall Study|Other|2|||
146822898|NCT01747629|529521065|FG001|Overall Study|Other|1|||
146822899|NCT01770509|529521066|FG000|Overall Study|Injury|0|||
146822900|NCT01770509|529521067|FG001|Overall Study|Injury|1|||
146822901|NCT01770509|529521066|FG000|Overall Study|Lost to Follow-up|1|||
146822902|NCT01770509|529521067|FG001|Overall Study|Lost to Follow-up|2|||
146822903|NCT00794573|529521077|FG000|Overall Study|Death|3|||
146822904|NCT00794573|529521078|FG001|Overall Study|Death|0|||
146822905|NCT00794573|529521077|FG000|Overall Study|Withdrawal by Subject|9|||
146822906|NCT00794573|529521078|FG001|Overall Study|Withdrawal by Subject|12|||
146822907|NCT00794573|529521077|FG000|Overall Study|Lost to Follow-up|26|||
146822908|NCT00794573|529521078|FG001|Overall Study|Lost to Follow-up|33|||
146822909|NCT01294358|529521079|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
146822910|NCT01294358|529521080|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
146822911|NCT01294358|529521081|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
146822912|NCT01294358|529521082|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
146822913|NCT01294358|529521083|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
146822914|NCT01294358|529521079|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
146822915|NCT01294358|529521080|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
146822916|NCT01294358|529521081|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
146822917|NCT01294358|529521082|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
146822918|NCT01294358|529521083|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
146822919|NCT01294358|529521079|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
146822920|NCT01294358|529521080|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
146822921|NCT01294358|529521081|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
146951291|NCT01693562|529979942|FG020|Escalation Phase|Death|0|||
146951292|NCT01693562|529979943|FG021|Escalation Phase|Death|0|||
146951293|NCT01693562|529979944|FG022|Escalation Phase|Death|0|||
146951294|NCT01693562|529979922|FG000|Escalation Phase|Lost to Follow-up|0|||
146951295|NCT01693562|529979923|FG001|Escalation Phase|Lost to Follow-up|1|||
146951296|NCT01693562|529979924|FG002|Escalation Phase|Lost to Follow-up|1|||
146822922|NCT01294358|529521082|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
146822923|NCT01294358|529521083|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
146822924|NCT01294358|529521079|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
146951297|NCT01693562|529979925|FG003|Escalation Phase|Lost to Follow-up|0|||
146951298|NCT01693562|529979926|FG004|Escalation Phase|Lost to Follow-up|0|||
146951299|NCT01693562|529979927|FG005|Escalation Phase|Lost to Follow-up|0|||
146951300|NCT01693562|529979928|FG006|Escalation Phase|Lost to Follow-up|0|||
146951301|NCT01693562|529979929|FG007|Escalation Phase|Lost to Follow-up|0|||
146951302|NCT01693562|529979930|FG008|Escalation Phase|Lost to Follow-up|0|||
146951303|NCT01693562|529979931|FG009|Escalation Phase|Lost to Follow-up|0|||
146822925|NCT01294358|529521080|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
146822926|NCT01294358|529521081|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
146822927|NCT01294358|529521082|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
146822928|NCT01294358|529521083|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
146822929|NCT03356145|529521084|FG000|Overall Study|Withdrawal by Subject|2|||
146822930|NCT03356145|529521085|FG001|Overall Study|Withdrawal by Subject|1|||
146822931|NCT03356145|529521084|FG000|Overall Study|Did not meet inclusion criteria|1|||
146822932|NCT03356145|529521085|FG001|Overall Study|Did not meet inclusion criteria|0|||
146822933|NCT02963922|529521086|FG000|Overall Study|Adverse Event|15|||
146822934|NCT02963922|529521087|FG001|Overall Study|Adverse Event|6|||
146822935|NCT02963922|529521086|FG000|Overall Study|Protocol deviation|6|||
146822936|NCT02963922|529521087|FG001|Overall Study|Protocol deviation|6|||
146822937|NCT02963922|529521086|FG000|Overall Study|Lack of Efficacy|1|||
146822938|NCT02963922|529521087|FG001|Overall Study|Lack of Efficacy|1|||
146822939|NCT02963922|529521086|FG000|Overall Study|Lost to Follow-up|2|||
146822940|NCT02963922|529521087|FG001|Overall Study|Lost to Follow-up|3|||
146822941|NCT02963922|529521086|FG000|Overall Study|Other|8|||
146822942|NCT02963922|529521087|FG001|Overall Study|Other|14|||
146822943|NCT00905255|529521096|FG000|Overall Study|Adverse Event|7|||
146822944|NCT00905255|529521097|FG001|Overall Study|Adverse Event|5|||
146822945|NCT00905255|529521096|FG000|Overall Study|Withdrawal by Subject|5|||
146822946|NCT00905255|529521097|FG001|Overall Study|Withdrawal by Subject|4|||
146822947|NCT00905255|529521096|FG000|Overall Study|Familial and Personal Reasons|1|||
146822948|NCT00905255|529521097|FG001|Overall Study|Familial and Personal Reasons|0|||
146822949|NCT01332318|529521100|FG000|Overall Study|Adverse Event|0|||
146822950|NCT01332318|529521101|FG001|Overall Study|Adverse Event|3|||
146822951|NCT01332318|529521102|FG002|Overall Study|Adverse Event|0|||
146822952|NCT01332318|529521103|FG003|Overall Study|Adverse Event|0|||
146822953|NCT01332318|529521100|FG000|Overall Study|Withdrawal by Subject|1|||
146822954|NCT01332318|529521101|FG001|Overall Study|Withdrawal by Subject|1|||
146822955|NCT01332318|529521102|FG002|Overall Study|Withdrawal by Subject|0|||
146822956|NCT01332318|529521103|FG003|Overall Study|Withdrawal by Subject|1|||
146822957|NCT01332318|529521100|FG000|Overall Study|Protocol Violation|1|||
146822958|NCT01332318|529521101|FG001|Overall Study|Protocol Violation|0|||
146822959|NCT01332318|529521102|FG002|Overall Study|Protocol Violation|1|||
146822960|NCT01332318|529521103|FG003|Overall Study|Protocol Violation|1|||
146822961|NCT02040532|529521104|FG000|Overall Study|Lost to Follow-up|1|||
146822962|NCT02040532|529521104|FG000|Overall Study|Physician Decision|4|||
146822963|NCT02040532|529521104|FG000|Overall Study|Adverse Event|4|||
146822964|NCT02040532|529521104|FG000|Overall Study|Withdrawal by Subject|3|||
146822965|NCT00500539|529521106|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
146822966|NCT00500539|529521106|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
146822967|NCT00500539|529521106|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
146822968|NCT00500539|529521106|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
146822969|NCT00500539|529521106|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
146822970|NCT00500539|529521106|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
146822971|NCT00500539|529521106|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
146822972|NCT00500539|529521106|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
146822973|NCT00500539|529521106|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
146822974|NCT00500539|529521106|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
146822975|NCT00500539|529521106|FG000|Follow-up Period (16 Weeks)|Death|1|||
146822976|NCT00500539|529521106|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
146822977|NCT00500539|529521106|FG000|Follow-up Period (16 Weeks)|Missing|3|||
146822978|NCT01808144|529521107|FG000|Overall Study|Death|1|||
146822979|NCT01808144|529521108|FG001|Overall Study|Death|0|||
146822980|NCT01808144|529521107|FG000|Overall Study|Withdrawal by Subject|16|||
146822981|NCT01808144|529521108|FG001|Overall Study|Withdrawal by Subject|23|||
146822982|NCT01808144|529521107|FG000|Overall Study|Lost to Follow-up|6|||
146822983|NCT01808144|529521108|FG001|Overall Study|Lost to Follow-up|3|||
146822984|NCT01808144|529521107|FG000|Overall Study|Protocol Violation|6|||
146822985|NCT01808144|529521108|FG001|Overall Study|Protocol Violation|6|||
146822986|NCT01808144|529521107|FG000|Overall Study|Gout flare|0|||
146822987|NCT01808144|529521108|FG001|Overall Study|Gout flare|1|||
146822988|NCT01808144|529521107|FG000|Overall Study|Adverse Event|11|||
146822989|NCT01808144|529521108|FG001|Overall Study|Adverse Event|15|||
146822990|NCT03993054|529521109|FG000|Overall Study|PI Decision|1|||
146822991|NCT04341584|529521110|FG000|Overall Study|Withdrew consent|0|||
146822992|NCT04341584|529521111|FG001|Overall Study|Withdrew consent|2|||
146822993|NCT04341584|529521112|FG002|Overall Study|Withdrew consent|2|||
146822994|NCT04341584|529521113|FG003|Overall Study|Withdrew consent|1|||
146822995|NCT04853238|529521114|FG000|Overall Study|Death|4|||
146822996|NCT04853238|529521115|FG001|Overall Study|Death|0|||
146822997|NCT04853238|529521116|FG002|Overall Study|Death|2|||
146822998|NCT04853238|529521114|FG000|Overall Study|Lost to Follow-up|16|||
146822999|NCT04853238|529521115|FG001|Overall Study|Lost to Follow-up|2|||
146823000|NCT04853238|529521116|FG002|Overall Study|Lost to Follow-up|37|||
146823001|NCT04853238|529521114|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
146823002|NCT04853238|529521115|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
146848510|NCT01373151|529615722|FG006|Period 1|Withdrawal by Subject|0|||
146823003|NCT04853238|529521116|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
146823004|NCT04853238|529521114|FG000|Overall Study|Withdrawal by Subject|6|||
146823005|NCT04853238|529521115|FG001|Overall Study|Withdrawal by Subject|0|||
146823006|NCT04853238|529521116|FG002|Overall Study|Withdrawal by Subject|21|||
146823007|NCT04853238|529521114|FG000|Overall Study|Physician Decision|0|||
146823008|NCT04853238|529521115|FG001|Overall Study|Physician Decision|0|||
146823009|NCT04853238|529521116|FG002|Overall Study|Physician Decision|2|||
146823010|NCT04853238|529521114|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
146823011|NCT04853238|529521115|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
146823012|NCT04853238|529521116|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
146823013|NCT03098797|529522779|FG000|Part 2 Open Label Extension|Adverse Event|2|||
146823014|NCT03098797|529522780|FG001|Part 2 Open Label Extension|Adverse Event|0|||
146823015|NCT00509821|529522781|FG000|Study Period 1 (Induction)|Death|0|||
146823016|NCT00509821|529522782|FG001|Study Period 1 (Induction)|Death|1|||
146823017|NCT00509821|529522781|FG000|Study Period 1 (Induction)|Adverse Event|0|||
146823018|NCT00509821|529522782|FG001|Study Period 1 (Induction)|Adverse Event|2|||
146823019|NCT00509821|529522781|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
146823020|NCT00509821|529522782|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
146823021|NCT00552513|529522785|FG000|Overall Study|Lost to Follow-up|5|||
146823022|NCT00552513|529522786|FG001|Overall Study|Lost to Follow-up|1|||
146823023|NCT01816685|529522787|FG000|Overall Study|Lost to Follow-up|7|||
146823024|NCT01816685|529522788|FG001|Overall Study|Lost to Follow-up|9|||
146823025|NCT01816685|529522787|FG000|Overall Study|Surgery Cancelled|3|||
146823026|NCT01816685|529522788|FG001|Overall Study|Surgery Cancelled|2|||
146823027|NCT02720185|529522789|FG000|Overall Study|Lost to Follow-up|1|||
146823028|NCT00371462|529522790|FG000|Overall Study|Withdrawal by Subject|1|||
146823029|NCT00371462|529522791|FG001|Overall Study|Withdrawal by Subject|0|||
146823030|NCT00371462|529522790|FG000|Overall Study|Other|7|||
146823031|NCT00371462|529522791|FG001|Overall Study|Other|8|||
146823032|NCT00349622|529522797|FG000|Overall Study|Death|168|||
146823033|NCT00349622|529522798|FG001|Overall Study|Death|86|||
146823034|NCT00349622|529522797|FG000|Overall Study|Lost to Follow-up|5|||
146823035|NCT00349622|529522798|FG001|Overall Study|Lost to Follow-up|1|||
146823036|NCT00349622|529522797|FG000|Overall Study|Withdrawal by Subject|5|||
146823037|NCT00349622|529522798|FG001|Overall Study|Withdrawal by Subject|9|||
146823038|NCT00508274|529522799|FG000|Overall Study|Adverse Event|5|||
146823039|NCT00508274|529522799|FG000|Overall Study|Death|7|||
146823040|NCT00508274|529522799|FG000|Overall Study|Disease progression|32|||
146823041|NCT00508274|529522799|FG000|Overall Study|Withdrawal by Subject|1|||
146823042|NCT00508274|529522799|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
146823043|NCT00508274|529522799|FG000|Overall Study|Missing|3|||
146823044|NCT03296566|529522800|FG000|Overall Study|Lost to Follow-up|19|||
146823045|NCT03296566|529522801|FG001|Overall Study|Lost to Follow-up|46|||
146823046|NCT03296566|529522800|FG000|Overall Study|Withdrawal by Subject|0|||
146823047|NCT03296566|529522801|FG001|Overall Study|Withdrawal by Subject|3|||
146823048|NCT02229396|529522806|FG000|Overall Study|Adverse Event|6|||
146823049|NCT02229396|529522807|FG001|Overall Study|Adverse Event|12|||
146823050|NCT02229396|529522808|FG002|Overall Study|Adverse Event|12|||
146823051|NCT02229396|529522806|FG000|Overall Study|Death|2|||
146823052|NCT02229396|529522807|FG001|Overall Study|Death|3|||
146823053|NCT02229396|529522808|FG002|Overall Study|Death|1|||
146823054|NCT02229396|529522806|FG000|Overall Study|Lost to Follow-up|14|||
146823055|NCT02229396|529522807|FG001|Overall Study|Lost to Follow-up|14|||
146823056|NCT02229396|529522808|FG002|Overall Study|Lost to Follow-up|21|||
146823057|NCT02229396|529522806|FG000|Overall Study|Protocol Violation|2|||
146823058|NCT02229396|529522807|FG001|Overall Study|Protocol Violation|1|||
146823059|NCT02229396|529522808|FG002|Overall Study|Protocol Violation|0|||
146823060|NCT02229396|529522806|FG000|Overall Study|Patient Incorrectly Randomized|0|||
146823061|NCT02229396|529522807|FG001|Overall Study|Patient Incorrectly Randomized|0|||
146823062|NCT02229396|529522808|FG002|Overall Study|Patient Incorrectly Randomized|1|||
146823063|NCT02229396|529522806|FG000|Overall Study|Other|10|||
146823064|NCT02229396|529522807|FG001|Overall Study|Other|18|||
146823065|NCT02229396|529522808|FG002|Overall Study|Other|15|||
146823066|NCT02229396|529522806|FG000|Overall Study|Withdrawal by Subject|42|||
146823067|NCT02229396|529522807|FG001|Overall Study|Withdrawal by Subject|28|||
146823068|NCT02229396|529522808|FG002|Overall Study|Withdrawal by Subject|41|||
146823069|NCT02229396|529522806|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
146823070|NCT02229396|529522807|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
146823071|NCT02229396|529522808|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
146823072|NCT02229396|529522806|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
146984923|NCT01341639|530107093|FG001|Interim Period|Protocol Violation|1|||
146823073|NCT02229396|529522807|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
146823074|NCT02229396|529522808|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
146823075|NCT01243411|529522809|FG000|Overall Study|Withdrawal by Subject|18|||
146823076|NCT01243411|529522809|FG000|Overall Study|Lost to Follow-up|10|||
146823077|NCT01243411|529522809|FG000|Overall Study|Adverse Event|5|||
146823078|NCT01243411|529522809|FG000|Overall Study|Other|8|||
146823079|NCT00805285|529522812|FG000|Overall Study|Lack of Efficacy|1|||
146823080|NCT00839306|529522813|FG000|Overall Study|Adverse Event|3|||
146823081|NCT00839306|529522814|FG001|Overall Study|Adverse Event|5|||
146823082|NCT00839306|529522813|FG000|Overall Study|Lost to Follow-up|6|||
146823083|NCT00839306|529522814|FG001|Overall Study|Lost to Follow-up|9|||
146823084|NCT00839306|529522813|FG000|Overall Study|Withdrawal by Subject|5|||
146823085|NCT00839306|529522814|FG001|Overall Study|Withdrawal by Subject|7|||
146823086|NCT00839306|529522813|FG000|Overall Study|Lack of Efficacy|5|||
146823087|NCT00839306|529522814|FG001|Overall Study|Lack of Efficacy|4|||
146823088|NCT00839306|529522813|FG000|Overall Study|Other|6|||
146823089|NCT00839306|529522814|FG001|Overall Study|Other|18|||
146823090|NCT01066897|529522815|FG000|Overall Study|Withdrawal by Subject|1|||
146823091|NCT01066897|529522816|FG001|Overall Study|Withdrawal by Subject|0|||
146823092|NCT01066897|529522815|FG000|Overall Study|stopped study after developing the flu.|1|||
146823093|NCT01066897|529522816|FG001|Overall Study|stopped study after developing the flu.|0|||
146823094|NCT02396758|529522819|FG000|Overall Study|Withdrawal by Subject|2|||
146823095|NCT02396758|529522820|FG001|Overall Study|Withdrawal by Subject|0|||
146823096|NCT02396758|529522821|FG002|Overall Study|Withdrawal by Subject|0|||
146823097|NCT02396758|529522822|FG003|Overall Study|Withdrawal by Subject|1|||
146823098|NCT02396758|529522819|FG000|Overall Study|Lost to Follow-up|8|||
146823099|NCT02396758|529522820|FG001|Overall Study|Lost to Follow-up|5|||
146823100|NCT02396758|529522821|FG002|Overall Study|Lost to Follow-up|3|||
146823101|NCT02396758|529522822|FG003|Overall Study|Lost to Follow-up|3|||
146823102|NCT02396758|529522819|FG000|Overall Study|Death|1|||
146823103|NCT02396758|529522820|FG001|Overall Study|Death|1|||
146823104|NCT02396758|529522821|FG002|Overall Study|Death|0|||
146823105|NCT02396758|529522822|FG003|Overall Study|Death|1|||
146823106|NCT02396758|529522819|FG000|Overall Study|Randomized but not treated|1|||
146823107|NCT02396758|529522820|FG001|Overall Study|Randomized but not treated|0|||
146823108|NCT02396758|529522821|FG002|Overall Study|Randomized but not treated|1|||
146823109|NCT02396758|529522822|FG003|Overall Study|Randomized but not treated|0|||
146823110|NCT03022045|529522823|FG000|Overall Study|Adverse Event|0|||
146823111|NCT03022045|529522824|FG001|Overall Study|Adverse Event|1|||
146823112|NCT03022045|529522823|FG000|Overall Study|Withdrawal by Subject|1|||
146823113|NCT03022045|529522824|FG001|Overall Study|Withdrawal by Subject|1|||
146823114|NCT01126879|529522825|FG000|Overall Study|Progressive Disease|3|||
146823115|NCT01126879|529522826|FG001|Overall Study|Progressive Disease|1|||
146823116|NCT01126879|529522825|FG000|Overall Study|Withdrawal by Subject|1|||
146823117|NCT01126879|529522826|FG001|Overall Study|Withdrawal by Subject|0|||
146823118|NCT01126879|529522825|FG000|Overall Study|Adverse Event|0|||
146823119|NCT01126879|529522826|FG001|Overall Study|Adverse Event|1|||
146823120|NCT01126879|529522825|FG000|Overall Study|Physician Decision|1|||
146823121|NCT01126879|529522826|FG001|Overall Study|Physician Decision|0|||
146823122|NCT00666835|529522827|FG000|Overall Study|Withdrawal by Subject|5|||
146823123|NCT00666835|529522828|FG001|Overall Study|Withdrawal by Subject|2|||
146823124|NCT00666835|529522827|FG000|Overall Study|Lack of Efficacy|0|||
146823125|NCT00666835|529522828|FG001|Overall Study|Lack of Efficacy|1|||
146823126|NCT00666835|529522827|FG000|Overall Study|Incl./excl. not fulfilled|7|||
146823127|NCT00666835|529522828|FG001|Overall Study|Incl./excl. not fulfilled|2|||
146823128|NCT00666835|529522827|FG000|Overall Study|Adverse Event|7|||
146823129|NCT00666835|529522828|FG001|Overall Study|Adverse Event|6|||
146823130|NCT00666835|529522827|FG000|Overall Study|Protocol Violation|2|||
146823131|NCT00666835|529522828|FG001|Overall Study|Protocol Violation|0|||
146823132|NCT00666835|529522827|FG000|Overall Study|Death|15|||
146823133|NCT00666835|529522828|FG001|Overall Study|Death|4|||
146823134|NCT00666835|529522827|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
146823135|NCT00666835|529522828|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
146823136|NCT00666835|529522827|FG000|Overall Study|Hemoglobulin concentration|4|||
146823137|NCT00666835|529522828|FG001|Overall Study|Hemoglobulin concentration|3|||
146823138|NCT00666835|529522827|FG000|Overall Study|Planned operation|2|||
146823139|NCT00666835|529522828|FG001|Overall Study|Planned operation|0|||
146823140|NCT00666835|529522827|FG000|Overall Study|Physician Decision|1|||
146823141|NCT00666835|529522828|FG001|Overall Study|Physician Decision|2|||
146823142|NCT00899379|529522829|FG000|Overall Study|Adverse Event|2|||
146823143|NCT00899379|529522830|FG001|Overall Study|Adverse Event|2|||
146951304|NCT01693562|529979932|FG010|Escalation Phase|Lost to Follow-up|0|||
146823144|NCT00899379|529522831|FG002|Overall Study|Adverse Event|1|||
146951305|NCT01693562|529979933|FG011|Escalation Phase|Lost to Follow-up|0|||
146951306|NCT01693562|529979934|FG012|Escalation Phase|Lost to Follow-up|0|||
146823145|NCT00899379|529522832|FG003|Overall Study|Adverse Event|1|||
146951307|NCT01693562|529979935|FG013|Escalation Phase|Lost to Follow-up|0|||
146823146|NCT00899379|529522833|FG004|Overall Study|Adverse Event|2|||
146823147|NCT00899379|529522829|FG000|Overall Study|Lack of Efficacy|0|||
146823148|NCT00899379|529522830|FG001|Overall Study|Lack of Efficacy|4|||
146823149|NCT00899379|529522831|FG002|Overall Study|Lack of Efficacy|3|||
146823150|NCT00899379|529522832|FG003|Overall Study|Lack of Efficacy|0|||
146951308|NCT01693562|529979936|FG014|Escalation Phase|Lost to Follow-up|0|||
146823151|NCT00899379|529522833|FG004|Overall Study|Lack of Efficacy|1|||
146823152|NCT00899379|529522829|FG000|Overall Study|Lost to Follow-up|9|||
146823153|NCT00899379|529522830|FG001|Overall Study|Lost to Follow-up|3|||
146823154|NCT00899379|529522831|FG002|Overall Study|Lost to Follow-up|0|||
146823155|NCT00899379|529522832|FG003|Overall Study|Lost to Follow-up|6|||
146823156|NCT00899379|529522833|FG004|Overall Study|Lost to Follow-up|2|||
146823157|NCT00899379|529522829|FG000|Overall Study|Protocol Violation|0|||
146823158|NCT00899379|529522830|FG001|Overall Study|Protocol Violation|0|||
146823159|NCT00899379|529522831|FG002|Overall Study|Protocol Violation|1|||
146823160|NCT00899379|529522832|FG003|Overall Study|Protocol Violation|1|||
146823161|NCT00899379|529522833|FG004|Overall Study|Protocol Violation|0|||
146823162|NCT00899379|529522829|FG000|Overall Study|Withdrawal by Subject|2|||
146823163|NCT00899379|529522830|FG001|Overall Study|Withdrawal by Subject|4|||
146823164|NCT00899379|529522831|FG002|Overall Study|Withdrawal by Subject|2|||
146823165|NCT00899379|529522832|FG003|Overall Study|Withdrawal by Subject|3|||
146823166|NCT00899379|529522833|FG004|Overall Study|Withdrawal by Subject|6|||
146823167|NCT00899379|529522829|FG000|Overall Study|Pregnancy|0|||
146823168|NCT00899379|529522830|FG001|Overall Study|Pregnancy|0|||
146823169|NCT00899379|529522831|FG002|Overall Study|Pregnancy|1|||
146823170|NCT00899379|529522832|FG003|Overall Study|Pregnancy|0|||
146823171|NCT00899379|529522833|FG004|Overall Study|Pregnancy|1|||
146823172|NCT00899379|529522829|FG000|Overall Study|Patient Uncooperative|0|||
146823173|NCT00899379|529522830|FG001|Overall Study|Patient Uncooperative|1|||
146823174|NCT00899379|529522831|FG002|Overall Study|Patient Uncooperative|0|||
146823175|NCT00899379|529522832|FG003|Overall Study|Patient Uncooperative|1|||
146823176|NCT00899379|529522833|FG004|Overall Study|Patient Uncooperative|2|||
146823177|NCT00899379|529522829|FG000|Overall Study|Abnormal Baseline ECG|0|||
146823178|NCT00899379|529522830|FG001|Overall Study|Abnormal Baseline ECG|0|||
146823179|NCT00899379|529522831|FG002|Overall Study|Abnormal Baseline ECG|0|||
146823180|NCT00899379|529522832|FG003|Overall Study|Abnormal Baseline ECG|1|||
146823181|NCT00899379|529522833|FG004|Overall Study|Abnormal Baseline ECG|0|||
146823182|NCT00899379|529522829|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
146823183|NCT00899379|529522830|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
146823184|NCT00899379|529522831|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
146823185|NCT00899379|529522832|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
146823186|NCT00899379|529522833|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
146823187|NCT00899379|529522829|FG000|Overall Study|Not Completed/Entered Extn|5|||
146823188|NCT00899379|529522830|FG001|Overall Study|Not Completed/Entered Extn|1|||
146823189|NCT00899379|529522831|FG002|Overall Study|Not Completed/Entered Extn|6|||
146823190|NCT00899379|529522832|FG003|Overall Study|Not Completed/Entered Extn|4|||
146823191|NCT00899379|529522833|FG004|Overall Study|Not Completed/Entered Extn|3|||
146823192|NCT00899379|529522829|FG000|Overall Study|Study Terminated|3|||
146823193|NCT00899379|529522830|FG001|Overall Study|Study Terminated|0|||
146823194|NCT00899379|529522831|FG002|Overall Study|Study Terminated|3|||
146823195|NCT00899379|529522832|FG003|Overall Study|Study Terminated|3|||
146823196|NCT00899379|529522833|FG004|Overall Study|Study Terminated|1|||
146823197|NCT00899379|529522829|FG000|Overall Study|Lost to Follow-up|3|||
146823198|NCT00899379|529522830|FG001|Overall Study|Lost to Follow-up|1|||
146823199|NCT00899379|529522831|FG002|Overall Study|Lost to Follow-up|0|||
146823200|NCT00899379|529522832|FG003|Overall Study|Lost to Follow-up|2|||
146823201|NCT00899379|529522833|FG004|Overall Study|Lost to Follow-up|5|||
146823202|NCT00899379|529522829|FG000|Overall Study|Withdrawal by Subject|4|||
146823203|NCT00899379|529522830|FG001|Overall Study|Withdrawal by Subject|7|||
146823204|NCT00899379|529522831|FG002|Overall Study|Withdrawal by Subject|4|||
146823205|NCT00899379|529522832|FG003|Overall Study|Withdrawal by Subject|7|||
146823206|NCT00899379|529522833|FG004|Overall Study|Withdrawal by Subject|2|||
146823207|NCT00899379|529522829|FG000|Overall Study|Pregnancy|1|||
146823208|NCT00899379|529522830|FG001|Overall Study|Pregnancy|0|||
146823209|NCT00899379|529522831|FG002|Overall Study|Pregnancy|0|||
146823210|NCT00899379|529522832|FG003|Overall Study|Pregnancy|0|||
146823211|NCT00899379|529522833|FG004|Overall Study|Pregnancy|0|||
146823212|NCT00899379|529522829|FG000|Overall Study|Patient Uncooperative|0|||
146823213|NCT00899379|529522830|FG001|Overall Study|Patient Uncooperative|0|||
146823214|NCT00899379|529522831|FG002|Overall Study|Patient Uncooperative|0|||
146823215|NCT00899379|529522832|FG003|Overall Study|Patient Uncooperative|1|||
146984924|NCT01341639|530107092|FG000|Post-Treatment|Withdrawal by Subject|0|||
146984925|NCT01341639|530107093|FG001|Post-Treatment|Withdrawal by Subject|1|||
146984926|NCT01341639|530107092|FG000|Post-Treatment|Adverse Event|0|||
146984927|NCT01341639|530107093|FG001|Post-Treatment|Adverse Event|2|||
146984928|NCT02247479|530107094|FG000|Overall Study|Adverse Event|8|||
146823216|NCT00899379|529522833|FG004|Overall Study|Patient Uncooperative|0|||
146823217|NCT00899379|529522829|FG000|Overall Study|Abnormal Prestudy Labs|0|||
146823218|NCT00899379|529522830|FG001|Overall Study|Abnormal Prestudy Labs|0|||
146823219|NCT00899379|529522831|FG002|Overall Study|Abnormal Prestudy Labs|0|||
146823220|NCT00899379|529522832|FG003|Overall Study|Abnormal Prestudy Labs|0|||
146823221|NCT00899379|529522833|FG004|Overall Study|Abnormal Prestudy Labs|2|||
146823222|NCT00899379|529522829|FG000|Overall Study|Abnormal Baseline ECG|0|||
146823223|NCT00899379|529522830|FG001|Overall Study|Abnormal Baseline ECG|0|||
146823224|NCT00899379|529522831|FG002|Overall Study|Abnormal Baseline ECG|1|||
146823225|NCT00899379|529522832|FG003|Overall Study|Abnormal Baseline ECG|1|||
146984929|NCT02247479|530107095|FG001|Overall Study|Adverse Event|9|||
146984930|NCT02247479|530107096|FG002|Overall Study|Adverse Event|8|||
146984931|NCT02247479|530107094|FG000|Overall Study|Death|5|||
146984932|NCT02247479|530107095|FG001|Overall Study|Death|4|||
146984933|NCT02247479|530107096|FG002|Overall Study|Death|6|||
146984934|NCT02247479|530107094|FG000|Overall Study|Lost to Follow-up|3|||
146984935|NCT02247479|530107095|FG001|Overall Study|Lost to Follow-up|3|||
146984936|NCT02247479|530107096|FG002|Overall Study|Lost to Follow-up|1|||
146984937|NCT02247479|530107094|FG000|Overall Study|Non-compliance|0|||
146984938|NCT02247479|530107095|FG001|Overall Study|Non-compliance|0|||
146984939|NCT02247479|530107096|FG002|Overall Study|Non-compliance|1|||
146984940|NCT02247479|530107094|FG000|Overall Study|Withdrawal by Subject|25|||
146984941|NCT02247479|530107095|FG001|Overall Study|Withdrawal by Subject|29|||
146984942|NCT02247479|530107096|FG002|Overall Study|Withdrawal by Subject|24|||
146984943|NCT02247479|530107094|FG000|Overall Study|Study Terminated by Sponsor|98|||
146984944|NCT02247479|530107095|FG001|Overall Study|Study Terminated by Sponsor|88|||
146984945|NCT02247479|530107096|FG002|Overall Study|Study Terminated by Sponsor|94|||
146984946|NCT02247479|530107094|FG000|Overall Study|Physician Decision|1|||
146984947|NCT02247479|530107095|FG001|Overall Study|Physician Decision|0|||
146984948|NCT02247479|530107096|FG002|Overall Study|Physician Decision|2|||
146984949|NCT02247479|530107094|FG000|Overall Study|Unspecified Reason|2|||
146984950|NCT02247479|530107095|FG001|Overall Study|Unspecified Reason|5|||
146984951|NCT02247479|530107096|FG002|Overall Study|Unspecified Reason|2|||
146984952|NCT01132118|530107097|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
146984953|NCT01132118|530107098|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
146984954|NCT01132118|530107097|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
146823226|NCT00899379|529522833|FG004|Overall Study|Abnormal Baseline ECG|0|||
146823227|NCT00899379|529522829|FG000|Overall Study|No Attack Pretreatment|3|||
146951309|NCT01693562|529979937|FG015|Escalation Phase|Lost to Follow-up|0|||
146951310|NCT01693562|529979938|FG016|Escalation Phase|Lost to Follow-up|0|||
146951311|NCT01693562|529979939|FG017|Escalation Phase|Lost to Follow-up|0|||
146951312|NCT01693562|529979940|FG018|Escalation Phase|Lost to Follow-up|0|||
146951313|NCT01693562|529979941|FG019|Escalation Phase|Lost to Follow-up|0|||
146951314|NCT01693562|529979942|FG020|Escalation Phase|Lost to Follow-up|0|||
146951315|NCT01693562|529979943|FG021|Escalation Phase|Lost to Follow-up|0|||
146951316|NCT01693562|529979944|FG022|Escalation Phase|Lost to Follow-up|0|||
146951317|NCT01693562|529979922|FG000|Escalation Phase|Other|0|||
146951318|NCT01693562|529979923|FG001|Escalation Phase|Other|0|||
146951319|NCT01693562|529979924|FG002|Escalation Phase|Other|2|||
146951320|NCT01693562|529979925|FG003|Escalation Phase|Other|0|||
146951321|NCT01693562|529979926|FG004|Escalation Phase|Other|0|||
146951322|NCT01693562|529979927|FG005|Escalation Phase|Other|1|||
146951323|NCT01693562|529979928|FG006|Escalation Phase|Other|0|||
146951324|NCT01693562|529979929|FG007|Escalation Phase|Other|0|||
146951325|NCT01693562|529979930|FG008|Escalation Phase|Other|0|||
146951326|NCT01693562|529979931|FG009|Escalation Phase|Other|0|||
146951327|NCT01693562|529979932|FG010|Escalation Phase|Other|0|||
146951328|NCT01693562|529979933|FG011|Escalation Phase|Other|0|||
146951329|NCT01693562|529979934|FG012|Escalation Phase|Other|0|||
146951330|NCT01693562|529979935|FG013|Escalation Phase|Other|0|||
146951331|NCT01693562|529979936|FG014|Escalation Phase|Other|0|||
146951332|NCT01693562|529979937|FG015|Escalation Phase|Other|0|||
146951333|NCT01693562|529979938|FG016|Escalation Phase|Other|0|||
146951334|NCT01693562|529979939|FG017|Escalation Phase|Other|0|||
146951335|NCT01693562|529979940|FG018|Escalation Phase|Other|0|||
146951336|NCT01693562|529979941|FG019|Escalation Phase|Other|0|||
146951337|NCT01693562|529979942|FG020|Escalation Phase|Other|0|||
146951338|NCT01693562|529979943|FG021|Escalation Phase|Other|0|||
146951339|NCT01693562|529979944|FG022|Escalation Phase|Other|0|||
146951340|NCT01693562|529979922|FG000|Exploration Phase|Withdrawal by Subject|0|||
146951341|NCT01693562|529979923|FG001|Exploration Phase|Withdrawal by Subject|0|||
146951342|NCT01693562|529979924|FG002|Exploration Phase|Withdrawal by Subject|0|||
146984955|NCT01132118|530107098|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
146984956|NCT01132118|530107097|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
146984957|NCT01132118|530107098|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
146984958|NCT01299038|530107101|FG000|Overall Study|Withdrawal by Subject|1|||
146951343|NCT01693562|529979925|FG003|Exploration Phase|Withdrawal by Subject|0|||
146984959|NCT01299038|530107102|FG001|Overall Study|Withdrawal by Subject|0|||
146951344|NCT01693562|529979926|FG004|Exploration Phase|Withdrawal by Subject|0|||
146951345|NCT01693562|529979927|FG005|Exploration Phase|Withdrawal by Subject|0|||
146951346|NCT01693562|529979928|FG006|Exploration Phase|Withdrawal by Subject|2|||
146951347|NCT01693562|529979929|FG007|Exploration Phase|Withdrawal by Subject|0|||
146951348|NCT01693562|529979930|FG008|Exploration Phase|Withdrawal by Subject|0|||
146951349|NCT01693562|529979931|FG009|Exploration Phase|Withdrawal by Subject|0|||
146951350|NCT01693562|529979932|FG010|Exploration Phase|Withdrawal by Subject|0|||
146984960|NCT00322556|530107103|FG000|Overall Study|Adverse Event|1|||
146951351|NCT01693562|529979933|FG011|Exploration Phase|Withdrawal by Subject|0|||
146951352|NCT01693562|529979934|FG012|Exploration Phase|Withdrawal by Subject|0|||
146951353|NCT01693562|529979935|FG013|Exploration Phase|Withdrawal by Subject|0|||
146984961|NCT00322556|530107103|FG000|Overall Study|Withdrawal by Subject|1|||
146984962|NCT00322556|530107103|FG000|Overall Study|Lost to Follow-up|3|||
146984963|NCT00322556|530107103|FG000|Overall Study|Other Reason|7|||
146984964|NCT01590433|530107104|FG000|Overall Study|Lost to Follow-up|20|||
146984965|NCT01590433|530107105|FG001|Overall Study|Lost to Follow-up|8|||
146823228|NCT00899379|529522830|FG001|Overall Study|No Attack Pretreatment|5|||
146823229|NCT00899379|529522831|FG002|Overall Study|No Attack Pretreatment|5|||
146823230|NCT00899379|529522832|FG003|Overall Study|No Attack Pretreatment|6|||
146823231|NCT00899379|529522833|FG004|Overall Study|No Attack Pretreatment|4|||
146823232|NCT00899379|529522829|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
146823233|NCT00899379|529522830|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
146823234|NCT00899379|529522831|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
146823235|NCT00899379|529522832|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
146823236|NCT00899379|529522833|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
146823237|NCT00899379|529522829|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
146823238|NCT00899379|529522830|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
146823239|NCT00899379|529522831|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
146823240|NCT00899379|529522832|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
146823241|NCT00899379|529522833|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
146823242|NCT03319719|529522839|FG000|Overall Study|Lost to Follow-up|1|||
146823243|NCT00744796|529522840|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
146823244|NCT02581189|529522841|FG000|Overall Study|Failure to return|36|||
146823245|NCT02581189|529522841|FG000|Overall Study|Withdrew consent|5|||
146823246|NCT02581189|529522841|FG000|Overall Study|Death|3|||
146823247|NCT02581189|529522841|FG000|Overall Study|Insufficient virological response|2|||
146823248|NCT02581189|529522841|FG000|Overall Study|Other, not specified|7|||
146823249|NCT02253147|529522842|FG000|Overall Study|Protocol Violation|30|||
146823250|NCT02253147|529522842|FG000|Overall Study|Did not consent to study extension|9|||
146823251|NCT02253147|529522842|FG000|Overall Study|Conditional re-treatment at W52|5|||
146823252|NCT02253147|529522842|FG000|Overall Study|Lost to Follow-up|2|||
146823253|NCT02253147|529522842|FG000|Overall Study|Withdrawal by Subject|1|||
146823254|NCT00396097|529522846|FG000|Overall Study|Withdrawal by Subject|17|||
146823255|NCT00396097|529522847|FG001|Overall Study|Withdrawal by Subject|17|||
146823256|NCT00396097|529522846|FG000|Overall Study|Lost to Follow-up|4|||
146823257|NCT00396097|529522847|FG001|Overall Study|Lost to Follow-up|9|||
146823258|NCT00396097|529522846|FG000|Overall Study|Other|3|||
146823259|NCT00396097|529522847|FG001|Overall Study|Other|5|||
146823260|NCT00396097|529522846|FG000|Overall Study|Protocol Violation|0|||
146823261|NCT00396097|529522847|FG001|Overall Study|Protocol Violation|6|||
146823262|NCT00396097|529522846|FG000|Overall Study|Adverse Event|1|||
146823263|NCT00396097|529522847|FG001|Overall Study|Adverse Event|5|||
146823264|NCT00396097|529522846|FG000|Overall Study|Insufficient Clinical Response|1|||
146823265|NCT00396097|529522847|FG001|Overall Study|Insufficient Clinical Response|4|||
146823266|NCT03461211|529522848|FG000|Overall Study|Adverse Event|1|||
146823267|NCT03461211|529522849|FG001|Overall Study|Adverse Event|1|||
146823268|NCT03461211|529522848|FG000|Overall Study|Lack of Efficacy|0|||
146823269|NCT03461211|529522849|FG001|Overall Study|Lack of Efficacy|1|||
146823270|NCT03807700|529522850|FG000|Overall Study|Withdrawal by Subject|2|||
146823271|NCT03807700|529522851|FG001|Overall Study|Withdrawal by Subject|1|||
146823272|NCT02720081|529522852|FG000|Overall Study|Adverse Event|0|||
146823273|NCT02720081|529522853|FG001|Overall Study|Adverse Event|3|||
146823274|NCT02720081|529522852|FG000|Overall Study|Protocol Violation|4|||
146823275|NCT02720081|529522853|FG001|Overall Study|Protocol Violation|1|||
146823276|NCT02316847|529522855|FG000|Overall Study|Adverse Event|0|||
146823277|NCT02316847|529522856|FG001|Overall Study|Adverse Event|3|||
146823278|NCT02316847|529522855|FG000|Overall Study|Lost to Follow-up|0|||
146823279|NCT02316847|529522856|FG001|Overall Study|Lost to Follow-up|2|||
146823280|NCT02316847|529522855|FG000|Overall Study|Physician Decision|0|||
146823281|NCT02316847|529522856|FG001|Overall Study|Physician Decision|1|||
146823282|NCT02316847|529522855|FG000|Overall Study|Pregnancy|0|||
146823283|NCT02316847|529522856|FG001|Overall Study|Pregnancy|1|||
146823284|NCT02316847|529522855|FG000|Overall Study|Withdrawal by Subject|2|||
146823285|NCT02316847|529522856|FG001|Overall Study|Withdrawal by Subject|9|||
146823286|NCT02316847|529522855|FG000|Overall Study|Noncompliance with study drug|0|||
146823287|NCT02316847|529522856|FG001|Overall Study|Noncompliance with study drug|3|||
146823288|NCT02316847|529522855|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
146823289|NCT02316847|529522856|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
146823290|NCT03371485|529522859|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
146823291|NCT03371485|529522859|FG000|2-year Follow-up|Death|5|||
146823292|NCT01061775|529522862|FG000|Overall Study|Physician Decision|2|||
146823293|NCT01061775|529522862|FG000|Overall Study|Lost to Follow-up|1|||
146823294|NCT02567227|529522863|FG000|9 Weeks|Adverse Event|5|||
146823295|NCT02567227|529522864|FG001|9 Weeks|Adverse Event|5|||
146823296|NCT02567227|529522863|FG000|9 Weeks|Withdrawal by Subject|18|||
146823297|NCT02567227|529522864|FG001|9 Weeks|Withdrawal by Subject|8|||
146984966|NCT01590433|530107104|FG000|Overall Study|Withdrawal by Subject|21|||
146823298|NCT02567227|529522863|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
146823299|NCT02567227|529522864|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
146951354|NCT01693562|529979936|FG014|Exploration Phase|Withdrawal by Subject|0|||
146951355|NCT01693562|529979937|FG015|Exploration Phase|Withdrawal by Subject|0|||
146951356|NCT01693562|529979938|FG016|Exploration Phase|Withdrawal by Subject|0|||
146951357|NCT01693562|529979939|FG017|Exploration Phase|Withdrawal by Subject|0|||
146951358|NCT01693562|529979940|FG018|Exploration Phase|Withdrawal by Subject|0|||
146951359|NCT01693562|529979941|FG019|Exploration Phase|Withdrawal by Subject|0|||
146951360|NCT01693562|529979942|FG020|Exploration Phase|Withdrawal by Subject|0|||
146951361|NCT01693562|529979943|FG021|Exploration Phase|Withdrawal by Subject|0|||
146951362|NCT01693562|529979944|FG022|Exploration Phase|Withdrawal by Subject|0|||
146951363|NCT01693562|529979922|FG000|Exploration Phase|Death|0|||
146951364|NCT01693562|529979923|FG001|Exploration Phase|Death|0|||
146951365|NCT01693562|529979924|FG002|Exploration Phase|Death|0|||
146951366|NCT01693562|529979925|FG003|Exploration Phase|Death|0|||
146951367|NCT01693562|529979926|FG004|Exploration Phase|Death|0|||
146951368|NCT01693562|529979927|FG005|Exploration Phase|Death|0|||
146951369|NCT01693562|529979928|FG006|Exploration Phase|Death|17|||
146823300|NCT02567227|529522863|FG000|6 Month|Death|2|||
146823301|NCT02567227|529522864|FG001|6 Month|Death|0|||
146823302|NCT02567227|529522863|FG000|6 Month|Lost to Follow-up|43|||
146823303|NCT02567227|529522864|FG001|6 Month|Lost to Follow-up|40|||
146823304|NCT02567227|529522863|FG000|12 Months|Lost to Follow-up|31|||
146823305|NCT02567227|529522864|FG001|12 Months|Lost to Follow-up|32|||
146823306|NCT02567227|529522863|FG000|12 Months|Death|0|||
146823307|NCT02567227|529522864|FG001|12 Months|Death|2|||
146823308|NCT03746483|529522865|FG000|Overall Study|Adverse Event|0|||
146823309|NCT03746483|529522866|FG001|Overall Study|Adverse Event|1|||
146823310|NCT03746483|529522865|FG000|Overall Study|Lack of Efficacy|3|||
146823311|NCT03746483|529522866|FG001|Overall Study|Lack of Efficacy|2|||
146823312|NCT03746483|529522865|FG000|Overall Study|Lost to Follow-up|1|||
146823313|NCT03746483|529522866|FG001|Overall Study|Lost to Follow-up|0|||
146823314|NCT03746483|529522865|FG000|Overall Study|Protocol Violation|2|||
146823315|NCT03746483|529522866|FG001|Overall Study|Protocol Violation|0|||
146823316|NCT02498418|529522869|FG000|Overall Study|Lack of Efficacy|0|||
146823317|NCT02498418|529522870|FG001|Overall Study|Lack of Efficacy|0|||
146823318|NCT02498418|529522871|FG002|Overall Study|Lack of Efficacy|1|||
146823319|NCT02498418|529522869|FG000|Overall Study|Withdrawal by Subject|2|||
146823320|NCT02498418|529522870|FG001|Overall Study|Withdrawal by Subject|0|||
146823321|NCT02498418|529522871|FG002|Overall Study|Withdrawal by Subject|3|||
146823322|NCT02498418|529522869|FG000|Overall Study|Lost to Follow-up|0|||
146823323|NCT02498418|529522870|FG001|Overall Study|Lost to Follow-up|1|||
146823324|NCT02498418|529522871|FG002|Overall Study|Lost to Follow-up|1|||
146823325|NCT02498418|529522869|FG000|Overall Study|Participant taken prohibited medication|0|||
146823326|NCT02498418|529522870|FG001|Overall Study|Participant taken prohibited medication|1|||
146823327|NCT02498418|529522871|FG002|Overall Study|Participant taken prohibited medication|1|||
146823328|NCT01026103|529522873|FG000|Overall Study|Physician Decision|1|||
146823329|NCT01026103|529522873|FG000|Overall Study|did not receive study device bc of error|1|||
146823330|NCT00762502|529522874|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
146823331|NCT00762502|529522875|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
146823332|NCT00762502|529522876|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
146823333|NCT00762502|529522874|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
146823334|NCT00762502|529522875|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
146823335|NCT00762502|529522876|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
146823336|NCT00762502|529522874|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
146823337|NCT00762502|529522875|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
146823338|NCT00762502|529522876|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
146823339|NCT02625922|529522878|FG000|Overall Study|Non-availability of IMP|1|||
146823340|NCT02625922|529522879|FG001|Overall Study|Non-availability of IMP|1|||
146823341|NCT02625922|529522878|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
146823342|NCT02625922|529522879|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
146823343|NCT03840148|529522884|FG000|Study Drug Disposition|Adverse Event|13|||
146951370|NCT01693562|529979929|FG007|Exploration Phase|Death|0|||
146823344|NCT03840148|529522885|FG001|Study Drug Disposition|Adverse Event|2|||
146951371|NCT01693562|529979930|FG008|Exploration Phase|Death|0|||
146951372|NCT01693562|529979931|FG009|Exploration Phase|Death|0|||
146951373|NCT01693562|529979932|FG010|Exploration Phase|Death|0|||
146951374|NCT01693562|529979933|FG011|Exploration Phase|Death|0|||
146823345|NCT03840148|529522884|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
146823346|NCT03840148|529522885|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
146823347|NCT03840148|529522884|FG000|Study Drug Disposition|Lack of Efficacy|3|||
146823348|NCT03840148|529522885|FG001|Study Drug Disposition|Lack of Efficacy|0|||
146823349|NCT03840148|529522884|FG000|Study Drug Disposition|Physician Decision|2|||
146823350|NCT03840148|529522885|FG001|Study Drug Disposition|Physician Decision|0|||
146823351|NCT03840148|529522884|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
146823352|NCT03840148|529522885|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
146823353|NCT03840148|529522884|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
146951375|NCT01693562|529979934|FG012|Exploration Phase|Death|0|||
146951376|NCT01693562|529979935|FG013|Exploration Phase|Death|0|||
146823354|NCT03840148|529522885|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
146823355|NCT03840148|529522884|FG000|Study Completion Disposition|Physician Decision|2|||
146823356|NCT03840148|529522885|FG001|Study Completion Disposition|Physician Decision|0|||
146823357|NCT03840148|529522884|FG000|Study Completion Disposition|Covid-19 related|2|||
146823358|NCT03840148|529522885|FG001|Study Completion Disposition|Covid-19 related|0|||
146823359|NCT03840148|529522884|FG000|Study Completion Disposition|Lost to Follow-up|1|||
146823360|NCT03840148|529522885|FG001|Study Completion Disposition|Lost to Follow-up|1|||
146823361|NCT03840148|529522884|FG000|Study Completion Disposition|Death|1|||
146823362|NCT03840148|529522885|FG001|Study Completion Disposition|Death|0|||
146823363|NCT03840148|529522884|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
146823364|NCT03840148|529522885|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
146823365|NCT03615404|529522886|FG000|Overall Study|Death|1|||
146823366|NCT03615404|529522886|FG000|Overall Study|vaccine did not pass quality assurance|1|||
146823367|NCT00257556|529522887|FG000|Overall Study|Adverse Event|1|||
146823368|NCT00257556|529522888|FG001|Overall Study|Adverse Event|4|||
146823369|NCT00257556|529522887|FG000|Overall Study|Physician Decision|6|||
146823370|NCT00257556|529522888|FG001|Overall Study|Physician Decision|0|||
146823371|NCT00257556|529522887|FG000|Overall Study|Did not meet hCG criterion|3|||
146823372|NCT00257556|529522888|FG001|Overall Study|Did not meet hCG criterion|0|||
146823373|NCT00257556|529522887|FG000|Overall Study|other reason|4|||
146823374|NCT00257556|529522888|FG001|Overall Study|other reason|6|||
146823375|NCT03849300|529522890|FG000|Overall Study|move out to different area|1|||
146823376|NCT03849300|529522891|FG001|Overall Study|move out to different area|3|||
146823377|NCT03849300|529522892|FG002|Overall Study|move out to different area|1|||
146823378|NCT03849300|529522893|FG003|Overall Study|move out to different area|4|||
146823379|NCT03849300|529522890|FG000|Overall Study|scheduling/transportation conflict|4|||
146823380|NCT03849300|529522891|FG001|Overall Study|scheduling/transportation conflict|4|||
146823381|NCT03849300|529522892|FG002|Overall Study|scheduling/transportation conflict|3|||
146823382|NCT03849300|529522893|FG003|Overall Study|scheduling/transportation conflict|2|||
146823383|NCT01774929|529522894|FG000|Overall Study|Adverse Event|3|||
146823384|NCT04839289|529522895|FG000|Overall Study|Withdrawal by Subject|1|||
146823385|NCT04839289|529522896|FG001|Overall Study|Withdrawal by Subject|0|||
146823386|NCT01544153|529522897|FG000|Overall Study|Under 18|0|||
146823387|NCT01544153|529522898|FG001|Overall Study|Under 18|1|||
146823388|NCT01544153|529522899|FG002|Overall Study|Under 18|0|||
146823389|NCT01544153|529522900|FG003|Overall Study|Under 18|0|||
146823390|NCT01544153|529522897|FG000|Overall Study|Non-smoker|0|||
146823391|NCT01544153|529522898|FG001|Overall Study|Non-smoker|0|||
146823392|NCT01544153|529522899|FG002|Overall Study|Non-smoker|1|||
146823393|NCT01544153|529522900|FG003|Overall Study|Non-smoker|0|||
146823394|NCT00390806|529522905|FG000|Overall Study|Lost to Follow-up|7|||
146823395|NCT00390806|529522906|FG001|Overall Study|Lost to Follow-up|6|||
146823396|NCT00390806|529522905|FG000|Overall Study|Protocol Violation|2|||
146823397|NCT00390806|529522906|FG001|Overall Study|Protocol Violation|2|||
146823398|NCT00390806|529522905|FG000|Overall Study|Withdrawal by Subject|12|||
146823399|NCT00390806|529522906|FG001|Overall Study|Withdrawal by Subject|15|||
146823400|NCT00390806|529522905|FG000|Overall Study|Investigator Decision|4|||
146823401|NCT00390806|529522906|FG001|Overall Study|Investigator Decision|6|||
146823402|NCT00390806|529522905|FG000|Overall Study|Death|1|||
146823403|NCT00390806|529522906|FG001|Overall Study|Death|0|||
146823404|NCT00390806|529522905|FG000|Overall Study|Physician Decision|0|||
146823405|NCT00390806|529522906|FG001|Overall Study|Physician Decision|1|||
146823406|NCT00390806|529522905|FG000|Overall Study|Ongoing|4|||
146823407|NCT00390806|529522906|FG001|Overall Study|Ongoing|2|||
146823408|NCT03169530|529522909|FG000|Overall Study|Study ended by NIH|15|||
146823409|NCT03169530|529522910|FG001|Overall Study|Study ended by NIH|17|||
146823410|NCT00884793|529522911|FG000|Overall Study|Withdrawal by Subject|1|||
146823411|NCT01032200|529522912|FG000|Overall Study|Death|1|||
146823412|NCT01032200|529522913|FG001|Overall Study|Death|1|||
146823413|NCT01032200|529522912|FG000|Overall Study|Withdrawal by Subject|1|||
146823414|NCT01032200|529522913|FG001|Overall Study|Withdrawal by Subject|3|||
146823415|NCT01032200|529522912|FG000|Overall Study|Toxicity|0|||
146823416|NCT01032200|529522913|FG001|Overall Study|Toxicity|2|||
146823417|NCT01032200|529522912|FG000|Overall Study|Progression|1|||
146823418|NCT01032200|529522913|FG001|Overall Study|Progression|0|||
146823419|NCT01032200|529522912|FG000|Overall Study|Multiple|1|||
146823420|NCT01032200|529522913|FG001|Overall Study|Multiple|1|||
146823421|NCT00727259|529522917|FG000|Overall Study|Not all questionnaires completed|1055|||
146823422|NCT01021683|529522918|FG000|Overall Study|Lack of Efficacy|12|||
146823423|NCT01021683|529522918|FG000|Overall Study|Recovery of neutrophil count|51|||
146823424|NCT01021683|529522918|FG000|Overall Study|Other|8|||
146823425|NCT00663923|529522919|FG000|Overall Study|Lost to Follow-up|2|||
146823426|NCT01804140|529522921|FG000|Overall Study|No sampling or biopsy procedures done|114|||
146823427|NCT02785900|529522924|FG000|Overall Study|Study Termination by Sponsor|64|||
146823428|NCT02785900|529522925|FG001|Overall Study|Study Termination by Sponsor|81|||
146823429|NCT02785900|529522924|FG000|Overall Study|Death|46|||
146823430|NCT02785900|529522925|FG001|Overall Study|Death|32|||
146951377|NCT01693562|529979936|FG014|Exploration Phase|Death|0|||
146951378|NCT01693562|529979937|FG015|Exploration Phase|Death|0|||
146951379|NCT01693562|529979938|FG016|Exploration Phase|Death|0|||
146951380|NCT01693562|529979939|FG017|Exploration Phase|Death|0|||
146951381|NCT01693562|529979940|FG018|Exploration Phase|Death|0|||
146951382|NCT01693562|529979941|FG019|Exploration Phase|Death|0|||
146951383|NCT01693562|529979942|FG020|Exploration Phase|Death|0|||
146951384|NCT01693562|529979943|FG021|Exploration Phase|Death|0|||
146951385|NCT01693562|529979944|FG022|Exploration Phase|Death|0|||
146951386|NCT01693562|529979922|FG000|Exploration Phase|Other|0|||
146951387|NCT01693562|529979923|FG001|Exploration Phase|Other|0|||
146951388|NCT01693562|529979924|FG002|Exploration Phase|Other|0|||
146951389|NCT01693562|529979925|FG003|Exploration Phase|Other|0|||
146951390|NCT01693562|529979926|FG004|Exploration Phase|Other|0|||
146951391|NCT01693562|529979927|FG005|Exploration Phase|Other|0|||
146951392|NCT01693562|529979928|FG006|Exploration Phase|Other|2|||
146951393|NCT01693562|529979929|FG007|Exploration Phase|Other|0|||
146951394|NCT01693562|529979930|FG008|Exploration Phase|Other|0|||
146951395|NCT01693562|529979931|FG009|Exploration Phase|Other|0|||
146951396|NCT01693562|529979932|FG010|Exploration Phase|Other|0|||
146951397|NCT01693562|529979933|FG011|Exploration Phase|Other|0|||
146951398|NCT01693562|529979934|FG012|Exploration Phase|Other|0|||
146951399|NCT01693562|529979935|FG013|Exploration Phase|Other|0|||
146951400|NCT01693562|529979936|FG014|Exploration Phase|Other|0|||
146951401|NCT01693562|529979937|FG015|Exploration Phase|Other|0|||
146951402|NCT01693562|529979938|FG016|Exploration Phase|Other|0|||
146951403|NCT01693562|529979939|FG017|Exploration Phase|Other|0|||
146951404|NCT01693562|529979940|FG018|Exploration Phase|Other|0|||
146951405|NCT01693562|529979941|FG019|Exploration Phase|Other|0|||
146951406|NCT01693562|529979942|FG020|Exploration Phase|Other|0|||
146951407|NCT01693562|529979943|FG021|Exploration Phase|Other|0|||
146951408|NCT01693562|529979944|FG022|Exploration Phase|Other|0|||
146951409|NCT01693562|529979922|FG000|Expansion Phase|Withdrawal by Subject|0|||
146951410|NCT01693562|529979923|FG001|Expansion Phase|Withdrawal by Subject|0|||
146951411|NCT01693562|529979924|FG002|Expansion Phase|Withdrawal by Subject|0|||
146951412|NCT01693562|529979925|FG003|Expansion Phase|Withdrawal by Subject|0|||
146951413|NCT01693562|529979926|FG004|Expansion Phase|Withdrawal by Subject|0|||
146951414|NCT01693562|529979927|FG005|Expansion Phase|Withdrawal by Subject|0|||
146951415|NCT01693562|529979928|FG006|Expansion Phase|Withdrawal by Subject|0|||
146951416|NCT01693562|529979929|FG007|Expansion Phase|Withdrawal by Subject|16|||
146951417|NCT01693562|529979930|FG008|Expansion Phase|Withdrawal by Subject|2|||
146951418|NCT01693562|529979931|FG009|Expansion Phase|Withdrawal by Subject|54|||
146951419|NCT01693562|529979932|FG010|Expansion Phase|Withdrawal by Subject|2|||
146951420|NCT01693562|529979933|FG011|Expansion Phase|Withdrawal by Subject|2|||
146951421|NCT01693562|529979934|FG012|Expansion Phase|Withdrawal by Subject|3|||
146951422|NCT01693562|529979935|FG013|Expansion Phase|Withdrawal by Subject|5|||
146951423|NCT01693562|529979936|FG014|Expansion Phase|Withdrawal by Subject|16|||
146951424|NCT01693562|529979937|FG015|Expansion Phase|Withdrawal by Subject|7|||
146951425|NCT01693562|529979938|FG016|Expansion Phase|Withdrawal by Subject|40|||
146951426|NCT01693562|529979939|FG017|Expansion Phase|Withdrawal by Subject|4|||
146951427|NCT01693562|529979940|FG018|Expansion Phase|Withdrawal by Subject|8|||
146951428|NCT01693562|529979941|FG019|Expansion Phase|Withdrawal by Subject|3|||
146951429|NCT01693562|529979942|FG020|Expansion Phase|Withdrawal by Subject|1|||
146951430|NCT01693562|529979943|FG021|Expansion Phase|Withdrawal by Subject|8|||
146951431|NCT01693562|529979944|FG022|Expansion Phase|Withdrawal by Subject|1|||
146951432|NCT01693562|529979922|FG000|Expansion Phase|Death|0|||
146951433|NCT01693562|529979923|FG001|Expansion Phase|Death|0|||
146951434|NCT01693562|529979924|FG002|Expansion Phase|Death|0|||
146951435|NCT01693562|529979925|FG003|Expansion Phase|Death|0|||
146951436|NCT01693562|529979926|FG004|Expansion Phase|Death|0|||
146951437|NCT01693562|529979927|FG005|Expansion Phase|Death|0|||
146951438|NCT01693562|529979928|FG006|Expansion Phase|Death|0|||
146951439|NCT01693562|529979929|FG007|Expansion Phase|Death|42|||
146951440|NCT01693562|529979930|FG008|Expansion Phase|Death|17|||
146951441|NCT01693562|529979931|FG009|Expansion Phase|Death|208|||
146951442|NCT01693562|529979932|FG010|Expansion Phase|Death|30|||
146951443|NCT01693562|529979933|FG011|Expansion Phase|Death|8|||
146951444|NCT01693562|529979934|FG012|Expansion Phase|Death|19|||
146951445|NCT01693562|529979935|FG013|Expansion Phase|Death|42|||
146951446|NCT01693562|529979936|FG014|Expansion Phase|Death|23|||
146951447|NCT01693562|529979937|FG015|Expansion Phase|Death|23|||
146951448|NCT01693562|529979938|FG016|Expansion Phase|Death|128|||
146951449|NCT01693562|529979939|FG017|Expansion Phase|Death|16|||
146951450|NCT01693562|529979940|FG018|Expansion Phase|Death|36|||
146951451|NCT01693562|529979941|FG019|Expansion Phase|Death|16|||
146951452|NCT01693562|529979942|FG020|Expansion Phase|Death|17|||
146951453|NCT01693562|529979943|FG021|Expansion Phase|Death|35|||
146951454|NCT01693562|529979944|FG022|Expansion Phase|Death|7|||
146951455|NCT01693562|529979922|FG000|Expansion Phase|Lost to Follow-up|0|||
146951456|NCT01693562|529979923|FG001|Expansion Phase|Lost to Follow-up|0|||
146951457|NCT01693562|529979924|FG002|Expansion Phase|Lost to Follow-up|0|||
146951458|NCT01693562|529979925|FG003|Expansion Phase|Lost to Follow-up|0|||
146951459|NCT01693562|529979926|FG004|Expansion Phase|Lost to Follow-up|0|||
146951460|NCT01693562|529979927|FG005|Expansion Phase|Lost to Follow-up|0|||
146823431|NCT02785900|529522924|FG000|Overall Study|Withdrawal by Subject|4|||
146823432|NCT02785900|529522925|FG001|Overall Study|Withdrawal by Subject|8|||
146823433|NCT02785900|529522924|FG000|Overall Study|Physician Decision|3|||
146823434|NCT02785900|529522925|FG001|Overall Study|Physician Decision|2|||
146823435|NCT00547300|529522926|FG000|Overall Study|Study was Administratively Terminated|25|||
146823436|NCT00547300|529522927|FG001|Overall Study|Study was Administratively Terminated|24|||
146823437|NCT00547300|529522926|FG000|Overall Study|Did not Meet Entry Criteria|0|||
146823438|NCT00547300|529522927|FG001|Overall Study|Did not Meet Entry Criteria|2|||
146823439|NCT04130061|529522928|FG000|Overall Study|OR team forgot to request membrane|1|||
146823440|NCT04130061|529522929|FG001|Overall Study|OR team forgot to request membrane|0|||
146823441|NCT02972242|529524832|FG000|Overall Study|Withdrawal by Subject|1|||
146823442|NCT02972242|529524833|FG001|Overall Study|Withdrawal by Subject|0|||
146823443|NCT02679079|529524840|FG000|Overall Study|Adverse Event|2|||
146823444|NCT02679079|529524841|FG001|Overall Study|Adverse Event|0|||
146823445|NCT02679079|529524842|FG002|Overall Study|Adverse Event|2|||
146823446|NCT02679079|529524840|FG000|Overall Study|Protocol Violation|0|||
146823447|NCT02679079|529524841|FG001|Overall Study|Protocol Violation|1|||
146823448|NCT02679079|529524842|FG002|Overall Study|Protocol Violation|0|||
146823449|NCT02679079|529524840|FG000|Overall Study|Withdrawal by Subject|2|||
146823450|NCT02679079|529524841|FG001|Overall Study|Withdrawal by Subject|1|||
146823451|NCT02679079|529524842|FG002|Overall Study|Withdrawal by Subject|0|||
146823452|NCT03924947|529524843|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
146823453|NCT03924947|529524844|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
146823454|NCT03924947|529524845|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
146823455|NCT03924947|529524846|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
146823456|NCT03924947|529524847|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
146823457|NCT03924947|529524848|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
146823458|NCT01441583|529524851|FG000|Overall Study|Withdrawal by Subject|1|||
146823459|NCT01441583|529524852|FG001|Overall Study|Withdrawal by Subject|1|||
146823460|NCT01441583|529524853|FG002|Overall Study|Withdrawal by Subject|1|||
146823461|NCT01441583|529524851|FG000|Overall Study|Death|1|||
146823462|NCT01441583|529524852|FG001|Overall Study|Death|0|||
146823463|NCT01441583|529524853|FG002|Overall Study|Death|4|||
146848511|NCT01373151|529615716|FG000|Period 2|Lack of Efficacy|9|||
146848512|NCT01373151|529615717|FG001|Period 2|Lack of Efficacy|0|||
146848513|NCT01373151|529615718|FG002|Period 2|Lack of Efficacy|0|||
146848514|NCT01373151|529615719|FG003|Period 2|Lack of Efficacy|1|||
146848515|NCT01373151|529615720|FG004|Period 2|Lack of Efficacy|2|||
146848516|NCT01373151|529615721|FG005|Period 2|Lack of Efficacy|0|||
146848517|NCT01373151|529615722|FG006|Period 2|Lack of Efficacy|3|||
146848518|NCT01373151|529615716|FG000|Period 2|Adverse Event|0|||
146848519|NCT01373151|529615717|FG001|Period 2|Adverse Event|0|||
146848520|NCT01373151|529615718|FG002|Period 2|Adverse Event|3|||
146848521|NCT01373151|529615719|FG003|Period 2|Adverse Event|3|||
146848522|NCT01373151|529615720|FG004|Period 2|Adverse Event|0|||
146848523|NCT01373151|529615721|FG005|Period 2|Adverse Event|0|||
146848524|NCT01373151|529615722|FG006|Period 2|Adverse Event|1|||
146848525|NCT01373151|529615716|FG000|Period 2|subject request to discontinue|0|||
146848526|NCT01373151|529615717|FG001|Period 2|subject request to discontinue|1|||
146848527|NCT01373151|529615718|FG002|Period 2|subject request to discontinue|0|||
146848528|NCT01373151|529615719|FG003|Period 2|subject request to discontinue|0|||
146848529|NCT01373151|529615720|FG004|Period 2|subject request to discontinue|0|||
146848530|NCT01373151|529615721|FG005|Period 2|subject request to discontinue|0|||
146848531|NCT01373151|529615722|FG006|Period 2|subject request to discontinue|0|||
146848532|NCT01373151|529615716|FG000|Period 2|Withdrawal by Subject|0|||
146848533|NCT01373151|529615717|FG001|Period 2|Withdrawal by Subject|0|||
146848534|NCT01373151|529615718|FG002|Period 2|Withdrawal by Subject|0|||
146848535|NCT01373151|529615719|FG003|Period 2|Withdrawal by Subject|1|||
146848536|NCT01373151|529615720|FG004|Period 2|Withdrawal by Subject|0|||
146848537|NCT01373151|529615721|FG005|Period 2|Withdrawal by Subject|0|||
146848538|NCT01373151|529615722|FG006|Period 2|Withdrawal by Subject|0|||
146848539|NCT01373151|529615716|FG000|Period 2|Other|0|||
146848540|NCT01373151|529615717|FG001|Period 2|Other|0|||
146848541|NCT01373151|529615718|FG002|Period 2|Other|1|||
146848542|NCT01373151|529615719|FG003|Period 2|Other|0|||
146848543|NCT01373151|529615720|FG004|Period 2|Other|0|||
146848544|NCT01373151|529615721|FG005|Period 2|Other|0|||
146848545|NCT01373151|529615722|FG006|Period 2|Other|1|||
146848546|NCT03026075|529615727|FG000|Overall Study|Physician Decision|1|||
146848547|NCT03381339|529615730|FG000|Overall Study|Protocol Violation|4|||
146848548|NCT03381339|529615731|FG001|Overall Study|Protocol Violation|3|||
146848549|NCT03381339|529615730|FG000|Overall Study|Lost to Follow-up|0|||
146848550|NCT03381339|529615731|FG001|Overall Study|Lost to Follow-up|1|||
146848551|NCT04927247|529615733|FG000|Overall Study|Other|2|||
146848552|NCT04927247|529615734|FG001|Overall Study|Other|1|||
146848553|NCT04927247|529615733|FG000|Overall Study|Physician Decision|0|||
146848554|NCT04927247|529615734|FG001|Overall Study|Physician Decision|1|||
146848555|NCT04927247|529615733|FG000|Overall Study|Adverse Event|1|||
146823464|NCT01441583|529524851|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
146823465|NCT01441583|529524852|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
146823466|NCT01441583|529524853|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
146823467|NCT05060237|529524855|FG000|Overall Study|Withdrawal by Subject|4|||
146823468|NCT05060237|529524855|FG000|Overall Study|Screening failure|8|||
146823469|NCT01697592|529524859|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
146823470|NCT01697592|529524860|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146823471|NCT01697592|529524861|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146823472|NCT01697592|529524862|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146823473|NCT01697592|529524863|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146823474|NCT01697592|529524864|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146823475|NCT01697592|529524865|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146823476|NCT01697592|529524866|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146823477|NCT01697592|529524867|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146823478|NCT01697592|529524868|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146823479|NCT01697592|529524859|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146823480|NCT01697592|529524860|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146823481|NCT01697592|529524861|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146823482|NCT01697592|529524862|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146823483|NCT01697592|529524863|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146823484|NCT01697592|529524864|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
146823485|NCT01697592|529524865|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146823486|NCT01697592|529524866|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146823487|NCT01697592|529524867|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146823488|NCT01697592|529524868|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146823489|NCT01697592|529524859|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
146823490|NCT01697592|529524860|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146823491|NCT01697592|529524861|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146823492|NCT01697592|529524862|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146823493|NCT01697592|529524863|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146823494|NCT01697592|529524864|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146823495|NCT01697592|529524865|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146823496|NCT01697592|529524866|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146823497|NCT01697592|529524867|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146823498|NCT01697592|529524868|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146823499|NCT01697592|529524859|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
146823500|NCT01697592|529524860|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
146823501|NCT01697592|529524861|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
146823502|NCT01697592|529524862|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
146823503|NCT01697592|529524863|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
146823504|NCT01697592|529524864|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
146823505|NCT01697592|529524865|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
146823506|NCT01697592|529524866|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
146823507|NCT01697592|529524867|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
146823508|NCT01697592|529524868|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
146823509|NCT01697592|529524859|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
146823510|NCT01697592|529524860|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
146823511|NCT01697592|529524861|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
146823512|NCT01697592|529524862|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
146823513|NCT01697592|529524863|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
146823514|NCT01697592|529524864|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
146823515|NCT01697592|529524865|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
146823516|NCT01697592|529524866|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
146823517|NCT01697592|529524867|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
146823518|NCT01697592|529524868|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
146823519|NCT01697592|529524859|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
146823520|NCT01697592|529524860|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
146823521|NCT01697592|529524861|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
146823522|NCT01697592|529524862|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
146823523|NCT01697592|529524863|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
146823524|NCT01697592|529524864|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
146823525|NCT01697592|529524865|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
146823526|NCT01697592|529524866|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
146823527|NCT01697592|529524867|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
146823528|NCT01697592|529524868|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
146823529|NCT01697592|529524859|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
146823530|NCT01697592|529524860|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
146823531|NCT01697592|529524861|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
146823532|NCT01697592|529524862|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
146951461|NCT01693562|529979928|FG006|Expansion Phase|Lost to Follow-up|0|||
146823533|NCT01697592|529524863|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
146823534|NCT01697592|529524864|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
146823535|NCT01697592|529524865|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
146823536|NCT01697592|529524866|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
146823537|NCT01697592|529524867|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
146823538|NCT01697592|529524868|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
146823539|NCT01697592|529524859|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
146823540|NCT01697592|529524860|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
146823541|NCT01697592|529524861|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
146823542|NCT01697592|529524862|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
146823543|NCT01697592|529524863|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
146823544|NCT01697592|529524864|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
146823545|NCT01697592|529524865|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
146823546|NCT01697592|529524866|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
146823547|NCT01697592|529524867|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
146823548|NCT01697592|529524868|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
146823549|NCT05109117|529524869|FG000|Overall Study|Lost to Follow-up|1|||
146823550|NCT05109117|529524869|FG000|Overall Study|Discontinued for non-compliance|1|||
146823551|NCT02499835|529524870|FG000|Overall Study|Withdrawal by Subject|1|||
146823552|NCT02499835|529524871|FG001|Overall Study|Withdrawal by Subject|0|||
146823553|NCT02499835|529524872|FG002|Overall Study|Withdrawal by Subject|0|||
146823554|NCT02499835|529524873|FG003|Overall Study|Withdrawal by Subject|1|||
146823555|NCT02499835|529524870|FG000|Overall Study|Physician Decision|0|||
146823556|NCT02499835|529524871|FG001|Overall Study|Physician Decision|3|||
146823557|NCT02499835|529524872|FG002|Overall Study|Physician Decision|18|||
146823558|NCT02499835|529524873|FG003|Overall Study|Physician Decision|7|||
146823559|NCT02499835|529524870|FG000|Overall Study|Adverse Event|0|||
146823560|NCT02499835|529524871|FG001|Overall Study|Adverse Event|0|||
146823561|NCT02499835|529524872|FG002|Overall Study|Adverse Event|0|||
146823562|NCT02499835|529524873|FG003|Overall Study|Adverse Event|1|||
146823563|NCT02499835|529524870|FG000|Overall Study|Disease progression|2|||
146823564|NCT02499835|529524871|FG001|Overall Study|Disease progression|1|||
146823565|NCT02499835|529524872|FG002|Overall Study|Disease progression|0|||
146823566|NCT02499835|529524873|FG003|Overall Study|Disease progression|7|||
146823567|NCT03972137|529524877|FG000|Overall Study|Lost to Follow-up|2|||
146823568|NCT03972137|529524877|FG000|Overall Study|Withdrawal by Subject|4|||
146823569|NCT02973477|529524878|FG000|First Intervention|Lost to Follow-up|0|||
146823570|NCT02973477|529524879|FG001|First Intervention|Lost to Follow-up|2|||
146823571|NCT02973477|529524878|FG000|Washout|Withdrawal by Subject|1|||
146823572|NCT02973477|529524879|FG001|Washout|Withdrawal by Subject|0|||
146823573|NCT02973477|529524878|FG000|Second Intervention|Lost to Follow-up|1|||
146823574|NCT02973477|529524879|FG001|Second Intervention|Lost to Follow-up|0|||
146823575|NCT02381652|529524886|FG000|Overall Study|Withdrawal by Subject|0|||
146823576|NCT02381652|529524887|FG001|Overall Study|Withdrawal by Subject|0|||
146823577|NCT02381652|529524888|FG002|Overall Study|Withdrawal by Subject|1|||
146823578|NCT01340300|529524889|FG000|Overall Study|Lost to Follow-up|3|||
146823579|NCT01340300|529524890|FG001|Overall Study|Lost to Follow-up|0|||
146823580|NCT01340300|529524891|FG002|Overall Study|Lost to Follow-up|5|||
146823581|NCT01340300|529524892|FG003|Overall Study|Lost to Follow-up|10|||
146823582|NCT01340300|529524889|FG000|Overall Study|Withdrawal by Subject|5|||
146823583|NCT01340300|529524890|FG001|Overall Study|Withdrawal by Subject|6|||
146823584|NCT01340300|529524891|FG002|Overall Study|Withdrawal by Subject|6|||
146823585|NCT01340300|529524892|FG003|Overall Study|Withdrawal by Subject|3|||
146823586|NCT01340300|529524889|FG000|Overall Study|Adverse Event|1|||
146823587|NCT01340300|529524890|FG001|Overall Study|Adverse Event|0|||
146823588|NCT01340300|529524891|FG002|Overall Study|Adverse Event|4|||
146823589|NCT01340300|529524892|FG003|Overall Study|Adverse Event|0|||
146823590|NCT01340300|529524889|FG000|Overall Study|Physician Decision|0|||
146823591|NCT01340300|529524890|FG001|Overall Study|Physician Decision|1|||
146823592|NCT01340300|529524891|FG002|Overall Study|Physician Decision|0|||
146823593|NCT01340300|529524892|FG003|Overall Study|Physician Decision|0|||
146823594|NCT01340300|529524889|FG000|Overall Study|Unrelated sickness|0|||
146951462|NCT01693562|529979929|FG007|Expansion Phase|Lost to Follow-up|1|||
146823595|NCT01340300|529524890|FG001|Overall Study|Unrelated sickness|2|||
146823596|NCT01340300|529524891|FG002|Overall Study|Unrelated sickness|0|||
146951463|NCT01693562|529979930|FG008|Expansion Phase|Lost to Follow-up|2|||
146823597|NCT01340300|529524892|FG003|Overall Study|Unrelated sickness|1|||
146823598|NCT02642159|529524894|FG000|Overall Study|Randomized but not treated|1|||
146823599|NCT02642159|529524895|FG001|Overall Study|Randomized but not treated|0|||
146823600|NCT02642159|529524894|FG000|Overall Study|Adverse Event|10|||
146823601|NCT02642159|529524895|FG001|Overall Study|Adverse Event|4|||
146823602|NCT02642159|529524894|FG000|Overall Study|Withdrawal by Subject|9|||
146951464|NCT01693562|529979931|FG009|Expansion Phase|Lost to Follow-up|10|||
146823603|NCT02642159|529524895|FG001|Overall Study|Withdrawal by Subject|1|||
146823604|NCT02642159|529524894|FG000|Overall Study|Poor compliance to study protocol|1|||
146823605|NCT02642159|529524895|FG001|Overall Study|Poor compliance to study protocol|0|||
146951465|NCT01693562|529979932|FG010|Expansion Phase|Lost to Follow-up|4|||
146951466|NCT01693562|529979933|FG011|Expansion Phase|Lost to Follow-up|4|||
146951467|NCT01693562|529979934|FG012|Expansion Phase|Lost to Follow-up|1|||
146951468|NCT01693562|529979935|FG013|Expansion Phase|Lost to Follow-up|3|||
146951469|NCT01693562|529979936|FG014|Expansion Phase|Lost to Follow-up|0|||
146951470|NCT01693562|529979937|FG015|Expansion Phase|Lost to Follow-up|1|||
146951471|NCT01693562|529979938|FG016|Expansion Phase|Lost to Follow-up|1|||
146951472|NCT01693562|529979939|FG017|Expansion Phase|Lost to Follow-up|0|||
146951473|NCT01693562|529979940|FG018|Expansion Phase|Lost to Follow-up|2|||
146951474|NCT01693562|529979941|FG019|Expansion Phase|Lost to Follow-up|1|||
146951475|NCT01693562|529979942|FG020|Expansion Phase|Lost to Follow-up|2|||
146951476|NCT01693562|529979943|FG021|Expansion Phase|Lost to Follow-up|2|||
146951477|NCT01693562|529979944|FG022|Expansion Phase|Lost to Follow-up|1|||
146951478|NCT01693562|529979922|FG000|Expansion Phase|Other|0|||
146951479|NCT01693562|529979923|FG001|Expansion Phase|Other|0|||
146951480|NCT01693562|529979924|FG002|Expansion Phase|Other|0|||
146951481|NCT01693562|529979925|FG003|Expansion Phase|Other|0|||
146951482|NCT01693562|529979926|FG004|Expansion Phase|Other|0|||
146951483|NCT01693562|529979927|FG005|Expansion Phase|Other|0|||
146951484|NCT01693562|529979928|FG006|Expansion Phase|Other|0|||
146951485|NCT01693562|529979929|FG007|Expansion Phase|Other|3|||
146951486|NCT01693562|529979930|FG008|Expansion Phase|Other|1|||
146951487|NCT01693562|529979931|FG009|Expansion Phase|Other|28|||
146951488|NCT01693562|529979932|FG010|Expansion Phase|Other|4|||
146951489|NCT01693562|529979933|FG011|Expansion Phase|Other|7|||
146951490|NCT01693562|529979934|FG012|Expansion Phase|Other|0|||
146951491|NCT01693562|529979935|FG013|Expansion Phase|Other|1|||
146951492|NCT01693562|529979936|FG014|Expansion Phase|Other|1|||
146951493|NCT01693562|529979937|FG015|Expansion Phase|Other|0|||
146951494|NCT01693562|529979938|FG016|Expansion Phase|Other|28|||
146951495|NCT01693562|529979939|FG017|Expansion Phase|Other|0|||
146951496|NCT01693562|529979940|FG018|Expansion Phase|Other|1|||
146951497|NCT01693562|529979941|FG019|Expansion Phase|Other|0|||
146951498|NCT01693562|529979942|FG020|Expansion Phase|Other|1|||
146951499|NCT01693562|529979943|FG021|Expansion Phase|Other|17|||
146951500|NCT01693562|529979944|FG022|Expansion Phase|Other|1|||
146951501|NCT02759939|529979945|FG000|Overall Study|Missing data on first outcome assessed|11|||
146951502|NCT02759939|529979946|FG001|Overall Study|Missing data on first outcome assessed|2|||
146951503|NCT02759939|529979947|FG002|Overall Study|Missing data on first outcome assessed|5|||
146951504|NCT02759939|529979948|FG003|Overall Study|Missing data on first outcome assessed|2|||
146951505|NCT02759939|529979945|FG000|Overall Study|Ineligible for T2 and T3|310|||
146951506|NCT02759939|529979946|FG001|Overall Study|Ineligible for T2 and T3|179|||
146951507|NCT02759939|529979947|FG002|Overall Study|Ineligible for T2 and T3|366|||
146951508|NCT02759939|529979948|FG003|Overall Study|Ineligible for T2 and T3|391|||
146951509|NCT02759939|529979945|FG000|Overall Study|Lost to Follow-up|735|||
146951510|NCT02759939|529979946|FG001|Overall Study|Lost to Follow-up|791|||
146951511|NCT02759939|529979947|FG002|Overall Study|Lost to Follow-up|783|||
146951512|NCT02759939|529979948|FG003|Overall Study|Lost to Follow-up|650|||
146951513|NCT00087594|529979949|FG000|Overall Study|Adverse Event|2|||
146951514|NCT00087594|529979950|FG001|Overall Study|Adverse Event|3|||
146951515|NCT00087594|529979949|FG000|Overall Study|Lost to Follow-up|0|||
146951516|NCT00087594|529979950|FG001|Overall Study|Lost to Follow-up|2|||
146951517|NCT00087594|529979949|FG000|Overall Study|Withdrawal by Subject|4|||
146951518|NCT00087594|529979950|FG001|Overall Study|Withdrawal by Subject|2|||
146951519|NCT00087594|529979949|FG000|Overall Study|Lack of Efficacy|2|||
146951520|NCT00087594|529979950|FG001|Overall Study|Lack of Efficacy|5|||
146951521|NCT04657003|529979951|FG000|Overall Study|Adverse Event|5|||
146951522|NCT04657003|529979952|FG001|Overall Study|Adverse Event|1|||
146951523|NCT04657003|529979953|FG002|Overall Study|Adverse Event|5|||
146951524|NCT04657003|529979951|FG000|Overall Study|Death|0|||
146951525|NCT04657003|529979952|FG001|Overall Study|Death|2|||
146951526|NCT04657003|529979953|FG002|Overall Study|Death|0|||
146951527|NCT04657003|529979951|FG000|Overall Study|Lost to Follow-up|8|||
146951528|NCT04657003|529979952|FG001|Overall Study|Lost to Follow-up|4|||
146951529|NCT04657003|529979953|FG002|Overall Study|Lost to Follow-up|10|||
146951530|NCT04657003|529979951|FG000|Overall Study|Other - As Reported by Investigator|3|||
146951531|NCT04657003|529979952|FG001|Overall Study|Other - As Reported by Investigator|2|||
146951532|NCT04657003|529979953|FG002|Overall Study|Other - As Reported by Investigator|2|||
146951533|NCT04657003|529979951|FG000|Overall Study|Pregnancy|2|||
146951534|NCT04657003|529979952|FG001|Overall Study|Pregnancy|0|||
146951535|NCT04657003|529979953|FG002|Overall Study|Pregnancy|2|||
146951536|NCT04657003|529979951|FG000|Overall Study|Withdrawal by Subject|16|||
146951537|NCT04657003|529979952|FG001|Overall Study|Withdrawal by Subject|7|||
146951538|NCT04657003|529979953|FG002|Overall Study|Withdrawal by Subject|10|||
146951539|NCT01823991|529979956|FG000|Overall Study|Withdrawal by Subject|8|||
146951540|NCT01823991|529979957|FG001|Overall Study|Withdrawal by Subject|5|||
146951541|NCT00768040|529979958|FG000|Overall Study|Adverse Event|3|||
146951542|NCT00768040|529979959|FG001|Overall Study|Adverse Event|2|||
146951543|NCT00768040|529979958|FG000|Overall Study|Abnormal laboratory value|1|||
146951544|NCT00768040|529979959|FG001|Overall Study|Abnormal laboratory value|1|||
146951545|NCT02185040|529979964|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
146984967|NCT01590433|530107105|FG001|Overall Study|Withdrawal by Subject|11|||
146984968|NCT01590433|530107104|FG000|Overall Study|Adverse Event|11|||
146984969|NCT01590433|530107105|FG001|Overall Study|Adverse Event|3|||
146984970|NCT00555009|530107106|FG000|Overall Study|Withdrawal by Subject|0|||
146984971|NCT00555009|530107107|FG001|Overall Study|Withdrawal by Subject|1|||
146823606|NCT02642159|529524894|FG000|Overall Study|Other than specified above|10|||
146823607|NCT02642159|529524895|FG001|Overall Study|Other than specified above|3|||
146823608|NCT04194541|529524896|FG000|Day 1 Through 13|Lost to Follow-up|3|||
146823609|NCT04194541|529524896|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
146823610|NCT04194541|529524896|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
146823611|NCT01954771|529524897|FG000|Overall Study|Missing HbA1c of end-point|1|||
146823612|NCT01954771|529524898|FG001|Overall Study|Missing HbA1c of end-point|1|||
146823613|NCT01954771|529524899|FG002|Overall Study|Missing HbA1c of end-point|0|||
146823614|NCT01954771|529524897|FG000|Overall Study|Missing CGMS of end-point|1|||
146823615|NCT01954771|529524898|FG001|Overall Study|Missing CGMS of end-point|1|||
146823616|NCT01954771|529524899|FG002|Overall Study|Missing CGMS of end-point|0|||
146823617|NCT01954771|529524897|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
146823618|NCT01954771|529524898|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
146823619|NCT01954771|529524899|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
146823620|NCT03635775|529524902|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
146823621|NCT03635775|529524903|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
146823622|NCT03635775|529524904|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
146823623|NCT03635775|529524905|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
146823624|NCT01675050|529524907|FG000|Period One Treatment|Withdrawal by Subject|1|||
146823625|NCT01675050|529524908|FG001|Period One Treatment|Withdrawal by Subject|0|||
146823626|NCT01820637|529524910|FG000|Overall Study|Death|2|||
146823627|NCT01820637|529524910|FG000|Overall Study|Withdrawal by Subject|1|||
146823628|NCT00583115|529524911|FG000|Overall Study|Death|1|||
146823629|NCT00264498|529524912|FG000|Randomized Treatment|Death|0|||
146823630|NCT00264498|529524913|FG001|Randomized Treatment|Death|3|||
146823631|NCT00264498|529524912|FG000|Randomized Treatment|Withdrawal by Subject|0|||
146823632|NCT00264498|529524913|FG001|Randomized Treatment|Withdrawal by Subject|1|||
146823633|NCT00264498|529524912|FG000|Randomized Treatment|Objective disease Progression|13|||
146823634|NCT00264498|529524913|FG001|Randomized Treatment|Objective disease Progression|14|||
146823635|NCT00264498|529524912|FG000|Randomized Treatment|Physician Decision|1|||
146823636|NCT00264498|529524913|FG001|Randomized Treatment|Physician Decision|0|||
146823637|NCT00264498|529524912|FG000|Randomized Treatment|Incorrectly randomized|1|||
146823638|NCT00264498|529524913|FG001|Randomized Treatment|Incorrectly randomized|0|||
146823639|NCT00264498|529524912|FG000|Randomized Treatment|Study Closure|1|||
146823640|NCT00264498|529524913|FG001|Randomized Treatment|Study Closure|0|||
146823641|NCT00264498|529524912|FG000|Randomized Treatment|Protocol Violation|1|||
146823642|NCT00264498|529524913|FG001|Randomized Treatment|Protocol Violation|0|||
146823643|NCT00264498|529524912|FG000|Crossover Treatment|Death|1|||
146823644|NCT00264498|529524913|FG001|Crossover Treatment|Death|3|||
146823645|NCT00264498|529524912|FG000|Crossover Treatment|Objective disease progression|4|||
146823646|NCT00264498|529524913|FG001|Crossover Treatment|Objective disease progression|5|||
146823647|NCT00264498|529524912|FG000|Crossover Treatment|Study closure|0|||
146823648|NCT00264498|529524913|FG001|Crossover Treatment|Study closure|1|||
146823649|NCT00264498|529524912|FG000|Crossover Treatment|Withdrawal by Subject|1|||
146823650|NCT00264498|529524913|FG001|Crossover Treatment|Withdrawal by Subject|0|||
146823651|NCT02382406|529524914|FG000|Study Treatment|Disease Progression|8|||
146823652|NCT02382406|529524915|FG001|Study Treatment|Disease Progression|0|||
146823653|NCT02382406|529524916|FG002|Study Treatment|Disease Progression|20|||
146823654|NCT02382406|529524914|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
146823655|NCT02382406|529524915|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
146823656|NCT02382406|529524916|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
146823657|NCT02382406|529524914|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
146823658|NCT02382406|529524915|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
146823659|NCT02382406|529524916|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
146823660|NCT02382406|529524914|FG000|Study Treatment|symptomatic deterioration|1|||
146823661|NCT02382406|529524915|FG001|Study Treatment|symptomatic deterioration|0|||
146823662|NCT02382406|529524916|FG002|Study Treatment|symptomatic deterioration|1|||
146823663|NCT02382406|529524914|FG000|Study Treatment|Death|0|||
146823664|NCT02382406|529524915|FG001|Study Treatment|Death|0|||
146823665|NCT02382406|529524916|FG002|Study Treatment|Death|2|||
146823666|NCT02382406|529524914|FG000|Follow up|Death|11|||
146823667|NCT02382406|529524915|FG001|Follow up|Death|0|||
146823668|NCT02382406|529524916|FG002|Follow up|Death|19|||
146823669|NCT02382406|529524914|FG000|Follow up|Symptomatic deterioration|1|||
146823670|NCT02382406|529524915|FG001|Follow up|Symptomatic deterioration|0|||
146823671|NCT02382406|529524916|FG002|Follow up|Symptomatic deterioration|1|||
146823672|NCT02382406|529524914|FG000|Follow up|Patient Refused Follow-up|1|||
146823673|NCT02382406|529524915|FG001|Follow up|Patient Refused Follow-up|0|||
146984972|NCT00555009|530107106|FG000|Overall Study|Terminated by Sponsor|2|||
146823674|NCT02382406|529524916|FG002|Follow up|Patient Refused Follow-up|0|||
146823675|NCT02382406|529524914|FG000|Follow up|Study Terminated|1|||
146823676|NCT02382406|529524915|FG001|Follow up|Study Terminated|0|||
146823677|NCT02382406|529524916|FG002|Follow up|Study Terminated|8|||
146823678|NCT02382406|529524914|FG000|Follow up|Withdrawal by Subject|0|||
146823679|NCT02382406|529524915|FG001|Follow up|Withdrawal by Subject|0|||
146823680|NCT02382406|529524916|FG002|Follow up|Withdrawal by Subject|2|||
146823681|NCT04543942|529524917|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
146823682|NCT04543942|529524918|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
146823683|NCT04543942|529524917|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
146823684|NCT04543942|529524918|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
146823685|NCT02506881|529524924|FG000|First Intervention (Day 1)|Protocol Violation|0|||
146823686|NCT02506881|529524925|FG001|First Intervention (Day 1)|Protocol Violation|0|||
146823687|NCT02506881|529524926|FG002|First Intervention (Day 1)|Protocol Violation|1|||
146823688|NCT02506881|529524927|FG003|First Intervention (Day 1)|Protocol Violation|0|||
146823689|NCT02506881|529524924|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
146823690|NCT02506881|529524925|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
146823691|NCT02506881|529524926|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
146823692|NCT02506881|529524927|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
146823693|NCT02506881|529524924|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
146823694|NCT02506881|529524925|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
146823695|NCT02506881|529524926|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
146823696|NCT02506881|529524927|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
146823697|NCT02391545|529524928|FG000|Overall Study|Death|0|||
146823698|NCT02391545|529524929|FG001|Overall Study|Death|2|||
146823699|NCT02391545|529524928|FG000|Overall Study|Lost to Follow-up|0|||
146823700|NCT02391545|529524929|FG001|Overall Study|Lost to Follow-up|1|||
146823701|NCT02391545|529524928|FG000|Overall Study|Termination of study by sponsor|20|||
146823702|NCT02391545|529524929|FG001|Overall Study|Termination of study by sponsor|20|||
146823703|NCT02391545|529524928|FG000|Overall Study|Withdrawal by Subject|0|||
146823704|NCT02391545|529524929|FG001|Overall Study|Withdrawal by Subject|1|||
146823705|NCT02391545|529524928|FG000|Overall Study|Other Reasons|6|||
146823706|NCT02391545|529524929|FG001|Overall Study|Other Reasons|4|||
146823707|NCT02016690|529524930|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
146823708|NCT02016690|529524930|FG000|Overall Study|Excluded from SAS: Duplication|2|||
146823709|NCT02016690|529524930|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
146823710|NCT02016690|529524930|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
146823711|NCT02016690|529524930|FG000|Overall Study|Did not meet inclusion criteria|13|||
146823712|NCT02016690|529524930|FG000|Overall Study|Hospitalized for RSV at study start|3|||
146823713|NCT01222078|529524931|FG000|Overall Study|Early termination of the study|1|||
146823714|NCT01363297|529524933|FG000|Overall Study|Other|0|||
146823715|NCT01363297|529524934|FG001|Overall Study|Other|0|||
146823716|NCT01363297|529524935|FG002|Overall Study|Other|0|||
146823717|NCT01363297|529524936|FG003|Overall Study|Other|0|||
146823718|NCT01363297|529524937|FG004|Overall Study|Other|1|||
146823719|NCT01363297|529524933|FG000|Overall Study|Death|3|||
146823720|NCT01363297|529524934|FG001|Overall Study|Death|6|||
146823721|NCT01363297|529524935|FG002|Overall Study|Death|6|||
146823722|NCT01363297|529524936|FG003|Overall Study|Death|10|||
146823723|NCT01363297|529524937|FG004|Overall Study|Death|30|||
146823724|NCT00495612|529524938|FG000|Overall Study|Lost to Follow-up|1|||
146823725|NCT00495612|529524939|FG001|Overall Study|Lost to Follow-up|0|||
146823726|NCT00495612|529524938|FG000|Overall Study|Subject's Decision to Withdraw|3|||
146823727|NCT00495612|529524939|FG001|Overall Study|Subject's Decision to Withdraw|0|||
146823728|NCT03340766|529524947|FG000|Overall Study|Withdrawal by Subject|2|||
146823729|NCT03340766|529524948|FG001|Overall Study|Withdrawal by Subject|1|||
146823730|NCT03340766|529524949|FG002|Overall Study|Withdrawal by Subject|3|||
146823731|NCT03340766|529524947|FG000|Overall Study|Lost to Follow-up|0|||
146823732|NCT03340766|529524948|FG001|Overall Study|Lost to Follow-up|0|||
146823733|NCT03340766|529524949|FG002|Overall Study|Lost to Follow-up|1|||
146823734|NCT03340766|529524947|FG000|Overall Study|Death|6|||
146823735|NCT03340766|529524948|FG001|Overall Study|Death|7|||
146823736|NCT03340766|529524949|FG002|Overall Study|Death|4|||
146823737|NCT02864147|529524953|FG000|Overall Study|Withdrawal by Subject|3|||
146823738|NCT02864147|529524954|FG001|Overall Study|Withdrawal by Subject|2|||
146823739|NCT02864147|529524955|FG002|Overall Study|Withdrawal by Subject|1|||
146823740|NCT02864147|529524953|FG000|Overall Study|Lost to Follow-up|0|||
146823741|NCT02864147|529524954|FG001|Overall Study|Lost to Follow-up|4|||
146823742|NCT02864147|529524955|FG002|Overall Study|Lost to Follow-up|0|||
146823743|NCT02864147|529524953|FG000|Overall Study|Adverse Event|0|||
146823744|NCT02864147|529524954|FG001|Overall Study|Adverse Event|1|||
146823745|NCT02864147|529524955|FG002|Overall Study|Adverse Event|0|||
146823746|NCT02864147|529524953|FG000|Overall Study|Pregnancy|4|||
146823747|NCT02864147|529524954|FG001|Overall Study|Pregnancy|0|||
146823748|NCT02864147|529524955|FG002|Overall Study|Pregnancy|0|||
146823749|NCT02864147|529524953|FG000|Overall Study|Physician Decision|0|||
146823750|NCT02864147|529524954|FG001|Overall Study|Physician Decision|0|||
146951546|NCT02185040|529979965|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
146951547|NCT02185040|529979966|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
146951548|NCT02185040|529979967|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
146951549|NCT02185040|529979968|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
146951550|NCT02185040|529979969|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
146951551|NCT02185040|529979970|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
146951552|NCT02185040|529979964|FG000|Part 1 Treatment Phase|Adverse Event|1|||
146951553|NCT02185040|529979965|FG001|Part 1 Treatment Phase|Adverse Event|0|||
146951554|NCT02185040|529979966|FG002|Part 1 Treatment Phase|Adverse Event|0|||
146951555|NCT02185040|529979967|FG003|Part 1 Treatment Phase|Adverse Event|2|||
146951556|NCT02185040|529979968|FG004|Part 1 Treatment Phase|Adverse Event|3|||
146951557|NCT02185040|529979969|FG005|Part 1 Treatment Phase|Adverse Event|0|||
146951558|NCT02185040|529979970|FG006|Part 1 Treatment Phase|Adverse Event|0|||
146951559|NCT02185040|529979964|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
146951560|NCT02185040|529979965|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
146951561|NCT02185040|529979966|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
146951562|NCT02185040|529979967|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
146951563|NCT02185040|529979968|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
146951564|NCT02185040|529979969|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
146951565|NCT02185040|529979970|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
146951566|NCT02185040|529979964|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
146951567|NCT02185040|529979965|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
146951568|NCT02185040|529979966|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
146951569|NCT02185040|529979967|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
146951570|NCT02185040|529979968|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
146951571|NCT02185040|529979969|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
146951572|NCT02185040|529979970|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
146951573|NCT02185040|529979964|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
146951574|NCT02185040|529979965|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
146951575|NCT02185040|529979966|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
146951576|NCT02185040|529979967|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
146951577|NCT02185040|529979968|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
146951578|NCT02185040|529979969|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
146951579|NCT02185040|529979970|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
146951580|NCT02185040|529979964|FG000|Active Treatment Extension Phase|Adverse Event|0|||
146951581|NCT02185040|529979965|FG001|Active Treatment Extension Phase|Adverse Event|0|||
146951582|NCT02185040|529979966|FG002|Active Treatment Extension Phase|Adverse Event|0|||
146951583|NCT02185040|529979967|FG003|Active Treatment Extension Phase|Adverse Event|0|||
146951584|NCT02185040|529979968|FG004|Active Treatment Extension Phase|Adverse Event|0|||
146951585|NCT02185040|529979969|FG005|Active Treatment Extension Phase|Adverse Event|1|||
146951586|NCT02185040|529979970|FG006|Active Treatment Extension Phase|Adverse Event|4|||
146951587|NCT02185040|529979964|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
146951588|NCT02185040|529979965|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
146951589|NCT02185040|529979966|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
146951590|NCT02185040|529979967|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
146951591|NCT02185040|529979968|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
146951592|NCT02185040|529979969|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
146951593|NCT02185040|529979970|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
146951594|NCT02185040|529979964|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
146951595|NCT02185040|529979965|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
146951596|NCT02185040|529979966|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
146951597|NCT02185040|529979967|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
146951598|NCT02185040|529979968|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
146951599|NCT02185040|529979969|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
146951600|NCT02185040|529979970|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
146951601|NCT03347279|529979971|FG000|Overall Study|Withdrawal by Subject|8|||
146951602|NCT03347279|529979972|FG001|Overall Study|Withdrawal by Subject|15|||
146951603|NCT03347279|529979971|FG000|Overall Study|Death|0|||
146951604|NCT03347279|529979972|FG001|Overall Study|Death|2|||
146951605|NCT03347279|529979971|FG000|Overall Study|Lost to Follow-up|5|||
146951606|NCT03347279|529979972|FG001|Overall Study|Lost to Follow-up|2|||
146951607|NCT03347279|529979971|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
146951608|NCT03347279|529979972|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
146823751|NCT02864147|529524955|FG002|Overall Study|Physician Decision|1|||
146823752|NCT02864147|529524953|FG000|Overall Study|Opted for excisional procedures|0|||
146951609|NCT03558503|529979976|FG000|Overall Study|Adverse Event|1|||
146951610|NCT03558503|529979976|FG000|Overall Study|Death|1|||
146951611|NCT03558503|529979976|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
146951612|NCT02094612|529979977|FG000|Overall Study|Lost to Follow-up|47|||
146823753|NCT02864147|529524954|FG001|Overall Study|Opted for excisional procedures|0|||
146951613|NCT02094612|529979978|FG001|Overall Study|Lost to Follow-up|47|||
146951614|NCT02094612|529979977|FG000|Overall Study|Never started ADHD medication|32|||
146951615|NCT02094612|529979978|FG001|Overall Study|Never started ADHD medication|23|||
146951616|NCT01542632|529979979|FG000|Overall Study|Withdrawal of Consent|0|||
146951617|NCT01542632|529979980|FG001|Overall Study|Withdrawal of Consent|0|||
146951618|NCT01542632|529979981|FG002|Overall Study|Withdrawal of Consent|0|||
146951619|NCT01542632|529979982|FG003|Overall Study|Withdrawal of Consent|2|||
146951620|NCT01542632|529979983|FG004|Overall Study|Withdrawal of Consent|3|||
146951621|NCT01542632|529979984|FG005|Overall Study|Withdrawal of Consent|0|||
146951622|NCT01542632|529979979|FG000|Overall Study|Adverse Event|0|||
146951623|NCT01542632|529979980|FG001|Overall Study|Adverse Event|0|||
146951624|NCT01542632|529979981|FG002|Overall Study|Adverse Event|1|||
146951625|NCT01542632|529979982|FG003|Overall Study|Adverse Event|0|||
146951626|NCT01542632|529979983|FG004|Overall Study|Adverse Event|0|||
146951627|NCT01542632|529979984|FG005|Overall Study|Adverse Event|0|||
146951628|NCT01542632|529979979|FG000|Overall Study|Lost to Follow-up|0|||
146951629|NCT01542632|529979980|FG001|Overall Study|Lost to Follow-up|1|||
146951630|NCT01542632|529979981|FG002|Overall Study|Lost to Follow-up|0|||
146951631|NCT01542632|529979982|FG003|Overall Study|Lost to Follow-up|0|||
146951632|NCT01542632|529979983|FG004|Overall Study|Lost to Follow-up|0|||
146951633|NCT01542632|529979984|FG005|Overall Study|Lost to Follow-up|0|||
146951634|NCT01542632|529979979|FG000|Overall Study|Sponsor/Investigator Decision|0|||
146951635|NCT01542632|529979980|FG001|Overall Study|Sponsor/Investigator Decision|0|||
146951636|NCT01542632|529979981|FG002|Overall Study|Sponsor/Investigator Decision|0|||
146951637|NCT01542632|529979982|FG003|Overall Study|Sponsor/Investigator Decision|0|||
146951638|NCT01542632|529979983|FG004|Overall Study|Sponsor/Investigator Decision|1|||
146951639|NCT01542632|529979984|FG005|Overall Study|Sponsor/Investigator Decision|0|||
146951640|NCT03991936|529979985|FG000|Overall Study|Lost to Follow-up|1|||
146951641|NCT03991936|529979986|FG001|Overall Study|Lost to Follow-up|1|||
146951642|NCT03991936|529979987|FG002|Overall Study|Lost to Follow-up|1|||
146951643|NCT03991936|529979988|FG003|Overall Study|Lost to Follow-up|1|||
146951644|NCT03991936|529979989|FG004|Overall Study|Lost to Follow-up|1|||
146951645|NCT02773849|529979991|FG000|Overall Study|Lost to Follow-up|11|||
146951646|NCT02773849|529979991|FG000|Overall Study|Death|26|||
146951647|NCT02773849|529979991|FG000|Overall Study|Withdrawal by Subject|5|||
146951648|NCT02773849|529979991|FG000|Overall Study|Withdrawal of Consent|9|||
146951649|NCT02773849|529979991|FG000|Overall Study|Other: not due to lack of tolerability|11|||
146823754|NCT02864147|529524955|FG002|Overall Study|Opted for excisional procedures|3|||
146823755|NCT02269917|529524956|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
146823756|NCT02269917|529524957|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
146823757|NCT02269917|529524958|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
146823758|NCT02269917|529524956|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
146823759|NCT02269917|529524957|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
146823760|NCT02269917|529524958|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
146823761|NCT02269917|529524956|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
146823762|NCT02269917|529524957|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
146823763|NCT02269917|529524958|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
146951676|NCT01685372|529980004|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
146951677|NCT01685372|529980005|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
146951678|NCT02477800|529980006|FG000|Placebo-Controlled Period|Adverse Event|16|||
146951679|NCT02477800|529980007|FG001|Placebo-Controlled Period|Adverse Event|25|||
146951680|NCT02477800|529980008|FG002|Placebo-Controlled Period|Adverse Event|28|||
146951681|NCT02477800|529980009|FG003|Placebo-Controlled Period|Adverse Event|0|||
146951682|NCT02477800|529980010|FG004|Placebo-Controlled Period|Adverse Event|0|||
146951683|NCT02477800|529980011|FG005|Placebo-Controlled Period|Adverse Event|0|||
146951684|NCT02477800|529980012|FG006|Placebo-Controlled Period|Adverse Event|0|||
146951685|NCT02477800|529980006|FG000|Placebo-Controlled Period|Change of Treatment|1|||
146951686|NCT02477800|529980007|FG001|Placebo-Controlled Period|Change of Treatment|2|||
146951687|NCT02477800|529980008|FG002|Placebo-Controlled Period|Change of Treatment|1|||
146951688|NCT02477800|529980009|FG003|Placebo-Controlled Period|Change of Treatment|0|||
146951689|NCT02477800|529980010|FG004|Placebo-Controlled Period|Change of Treatment|0|||
146951690|NCT02477800|529980011|FG005|Placebo-Controlled Period|Change of Treatment|0|||
146951691|NCT02477800|529980012|FG006|Placebo-Controlled Period|Change of Treatment|0|||
146951692|NCT02477800|529980006|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
146951693|NCT02477800|529980007|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
146951694|NCT02477800|529980008|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
146951695|NCT02477800|529980009|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
146951696|NCT02477800|529980010|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
146951697|NCT02477800|529980011|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
146951698|NCT02477800|529980012|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
146951699|NCT02477800|529980006|FG000|Placebo-Controlled Period|Death|0|||
146951700|NCT02477800|529980007|FG001|Placebo-Controlled Period|Death|3|||
146951701|NCT02477800|529980008|FG002|Placebo-Controlled Period|Death|2|||
146951702|NCT02477800|529980009|FG003|Placebo-Controlled Period|Death|0|||
146951703|NCT02477800|529980010|FG004|Placebo-Controlled Period|Death|0|||
146951704|NCT02477800|529980011|FG005|Placebo-Controlled Period|Death|0|||
146951705|NCT02477800|529980012|FG006|Placebo-Controlled Period|Death|0|||
146951706|NCT02477800|529980006|FG000|Placebo-Controlled Period|Disease Progression|1|||
146951707|NCT02477800|529980007|FG001|Placebo-Controlled Period|Disease Progression|0|||
146951708|NCT02477800|529980008|FG002|Placebo-Controlled Period|Disease Progression|1|||
146951709|NCT02477800|529980009|FG003|Placebo-Controlled Period|Disease Progression|0|||
146951710|NCT02477800|529980010|FG004|Placebo-Controlled Period|Disease Progression|0|||
146951711|NCT02477800|529980011|FG005|Placebo-Controlled Period|Disease Progression|0|||
146951712|NCT02477800|529980012|FG006|Placebo-Controlled Period|Disease Progression|0|||
146951713|NCT02477800|529980006|FG000|Placebo-Controlled Period|Investigator Decision|3|||
146951714|NCT02477800|529980007|FG001|Placebo-Controlled Period|Investigator Decision|2|||
146951715|NCT02477800|529980008|FG002|Placebo-Controlled Period|Investigator Decision|1|||
146951716|NCT02477800|529980009|FG003|Placebo-Controlled Period|Investigator Decision|0|||
146951717|NCT02477800|529980010|FG004|Placebo-Controlled Period|Investigator Decision|0|||
146951718|NCT02477800|529980011|FG005|Placebo-Controlled Period|Investigator Decision|0|||
146951719|NCT02477800|529980012|FG006|Placebo-Controlled Period|Investigator Decision|0|||
146951720|NCT02477800|529980006|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
146951721|NCT02477800|529980007|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
146951722|NCT02477800|529980008|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
146951723|NCT02477800|529980009|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
146951724|NCT02477800|529980010|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
146951725|NCT02477800|529980011|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
146951726|NCT02477800|529980012|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
146951727|NCT02477800|529980006|FG000|Placebo-Controlled Period|Relocation|2|||
146951728|NCT02477800|529980007|FG001|Placebo-Controlled Period|Relocation|0|||
146951729|NCT02477800|529980008|FG002|Placebo-Controlled Period|Relocation|0|||
146951730|NCT02477800|529980009|FG003|Placebo-Controlled Period|Relocation|0|||
146951731|NCT02477800|529980010|FG004|Placebo-Controlled Period|Relocation|0|||
146951732|NCT02477800|529980011|FG005|Placebo-Controlled Period|Relocation|0|||
146951733|NCT02477800|529980012|FG006|Placebo-Controlled Period|Relocation|0|||
146951734|NCT02477800|529980006|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
146951735|NCT02477800|529980007|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
146823764|NCT02269917|529524956|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
146823765|NCT02269917|529524957|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
146951736|NCT02477800|529980008|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
146951737|NCT02477800|529980009|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
146951738|NCT02477800|529980010|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
146951739|NCT02477800|529980011|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
146951740|NCT02477800|529980012|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
146951741|NCT02477800|529980006|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
146951742|NCT02477800|529980007|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
146951743|NCT02477800|529980008|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
146951744|NCT02477800|529980009|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
146951745|NCT02477800|529980010|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
146951746|NCT02477800|529980011|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
146951747|NCT02477800|529980012|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
146951748|NCT02477800|529980006|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
146951749|NCT02477800|529980007|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
146951750|NCT02477800|529980008|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
146951751|NCT02477800|529980009|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
146951752|NCT02477800|529980010|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
146951753|NCT02477800|529980011|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
146951754|NCT02477800|529980012|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
146951755|NCT02477800|529980006|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
146951756|NCT02477800|529980007|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
146951757|NCT02477800|529980008|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
146951758|NCT02477800|529980009|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146951759|NCT02477800|529980010|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146951760|NCT02477800|529980011|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146951761|NCT02477800|529980012|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146951762|NCT02477800|529980006|FG000|Placebo-Controlled Period|Reason not Specified|161|||
146951763|NCT02477800|529980007|FG001|Placebo-Controlled Period|Reason not Specified|161|||
146951764|NCT02477800|529980008|FG002|Placebo-Controlled Period|Reason not Specified|189|||
146951765|NCT02477800|529980009|FG003|Placebo-Controlled Period|Reason not Specified|0|||
146951766|NCT02477800|529980010|FG004|Placebo-Controlled Period|Reason not Specified|0|||
146951767|NCT02477800|529980011|FG005|Placebo-Controlled Period|Reason not Specified|0|||
146951768|NCT02477800|529980012|FG006|Placebo-Controlled Period|Reason not Specified|0|||
146951769|NCT02477800|529980006|FG000|Long Term Extension Period|Adverse Event|0|||
146951770|NCT02477800|529980007|FG001|Long Term Extension Period|Adverse Event|0|||
146951771|NCT02477800|529980008|FG002|Long Term Extension Period|Adverse Event|0|||
146951772|NCT02477800|529980009|FG003|Long Term Extension Period|Adverse Event|6|||
146951773|NCT02477800|529980010|FG004|Long Term Extension Period|Adverse Event|2|||
146951774|NCT02477800|529980011|FG005|Long Term Extension Period|Adverse Event|4|||
146951775|NCT02477800|529980012|FG006|Long Term Extension Period|Adverse Event|3|||
146951776|NCT02477800|529980006|FG000|Long Term Extension Period|Death|0|||
146951777|NCT02477800|529980007|FG001|Long Term Extension Period|Death|0|||
146951778|NCT02477800|529980008|FG002|Long Term Extension Period|Death|0|||
146951779|NCT02477800|529980009|FG003|Long Term Extension Period|Death|1|||
146951780|NCT02477800|529980010|FG004|Long Term Extension Period|Death|1|||
146951781|NCT02477800|529980011|FG005|Long Term Extension Period|Death|1|||
146951782|NCT02477800|529980012|FG006|Long Term Extension Period|Death|2|||
146951783|NCT02477800|529980006|FG000|Long Term Extension Period|Consent Withdrawn|0|||
146951784|NCT02477800|529980007|FG001|Long Term Extension Period|Consent Withdrawn|0|||
146951785|NCT02477800|529980008|FG002|Long Term Extension Period|Consent Withdrawn|0|||
146951786|NCT02477800|529980009|FG003|Long Term Extension Period|Consent Withdrawn|10|||
146951787|NCT02477800|529980010|FG004|Long Term Extension Period|Consent Withdrawn|4|||
146951788|NCT02477800|529980011|FG005|Long Term Extension Period|Consent Withdrawn|13|||
146951789|NCT02477800|529980012|FG006|Long Term Extension Period|Consent Withdrawn|16|||
146951790|NCT02477800|529980006|FG000|Long Term Extension Period|Disease Progression|0|||
146951791|NCT02477800|529980007|FG001|Long Term Extension Period|Disease Progression|0|||
146951792|NCT02477800|529980008|FG002|Long Term Extension Period|Disease Progression|0|||
146951793|NCT02477800|529980009|FG003|Long Term Extension Period|Disease Progression|3|||
146951794|NCT02477800|529980010|FG004|Long Term Extension Period|Disease Progression|1|||
146951795|NCT02477800|529980011|FG005|Long Term Extension Period|Disease Progression|1|||
146951796|NCT02477800|529980012|FG006|Long Term Extension Period|Disease Progression|0|||
146951797|NCT02477800|529980006|FG000|Long Term Extension Period|Investigator Decision|0|||
146951798|NCT02477800|529980007|FG001|Long Term Extension Period|Investigator Decision|0|||
146951799|NCT02477800|529980008|FG002|Long Term Extension Period|Investigator Decision|0|||
146951800|NCT02477800|529980009|FG003|Long Term Extension Period|Investigator Decision|0|||
146951801|NCT02477800|529980010|FG004|Long Term Extension Period|Investigator Decision|0|||
146951802|NCT02477800|529980011|FG005|Long Term Extension Period|Investigator Decision|0|||
146951803|NCT02477800|529980012|FG006|Long Term Extension Period|Investigator Decision|2|||
146951804|NCT02477800|529980006|FG000|Long Term Extension Period|Lost to Follow-up|0|||
146951805|NCT02477800|529980007|FG001|Long Term Extension Period|Lost to Follow-up|0|||
146951806|NCT02477800|529980008|FG002|Long Term Extension Period|Lost to Follow-up|0|||
146951807|NCT02477800|529980009|FG003|Long Term Extension Period|Lost to Follow-up|0|||
146951808|NCT02477800|529980010|FG004|Long Term Extension Period|Lost to Follow-up|1|||
146951809|NCT02477800|529980011|FG005|Long Term Extension Period|Lost to Follow-up|3|||
146951810|NCT02477800|529980012|FG006|Long Term Extension Period|Lost to Follow-up|0|||
146951811|NCT02477800|529980006|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
146951812|NCT02477800|529980007|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
146951813|NCT02477800|529980008|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
146823766|NCT02269917|529524958|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
146823767|NCT02269917|529524956|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
146823768|NCT02269917|529524957|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
146823769|NCT02269917|529524958|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
146823770|NCT02269917|529524956|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
146823771|NCT02269917|529524957|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
146823772|NCT02269917|529524958|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
146823773|NCT02269917|529524956|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
146823774|NCT02269917|529524957|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
146823775|NCT02269917|529524958|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
146823776|NCT02269917|529524956|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
146823777|NCT02269917|529524957|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
146823778|NCT02269917|529524958|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
146823779|NCT02269917|529524956|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
146823780|NCT02269917|529524957|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
146823781|NCT02269917|529524958|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
146823782|NCT02269917|529524956|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
146823783|NCT02269917|529524957|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
146823784|NCT02269917|529524958|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
146823785|NCT02269917|529524956|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
146823786|NCT02269917|529524957|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
146823787|NCT02269917|529524958|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
146823788|NCT02269917|529524956|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
146823789|NCT02269917|529524957|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
146823790|NCT02269917|529524958|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
146823791|NCT02269917|529524956|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
146823792|NCT02269917|529524957|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
146823793|NCT02269917|529524958|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
146823794|NCT02269917|529524956|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
146823795|NCT02269917|529524957|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
146823796|NCT02269917|529524958|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
146823797|NCT02269917|529524956|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
146823798|NCT02269917|529524957|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
146823799|NCT02269917|529524958|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
146823800|NCT02269917|529524956|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
146823801|NCT02269917|529524957|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
146823802|NCT02269917|529524958|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
146823803|NCT00240097|529524959|FG000|Part I|Adverse Event|1|||
146823804|NCT00240097|529524959|FG000|Part I|Death|1|||
146823805|NCT00240097|529524959|FG000|Part I|histology|1|||
146823806|NCT00240097|529524959|FG000|Part I|unevaluable|1|||
146823807|NCT00240097|529524959|FG000|Part II|did not continue from Part I|23|||
146823808|NCT02383927|529524960|FG000|Overall Study|Disease Progression|8|||
146823809|NCT02383927|529524961|FG001|Overall Study|Disease Progression|8|||
146823810|NCT02383927|529524962|FG002|Overall Study|Disease Progression|15|||
146823811|NCT02383927|529524963|FG003|Overall Study|Disease Progression|4|||
146823812|NCT02383927|529524960|FG000|Overall Study|Physician Decision|0|||
146823813|NCT02383927|529524961|FG001|Overall Study|Physician Decision|0|||
146823814|NCT02383927|529524962|FG002|Overall Study|Physician Decision|2|||
146823815|NCT02383927|529524963|FG003|Overall Study|Physician Decision|0|||
146823816|NCT02383927|529524960|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
146823817|NCT02383927|529524961|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
146823818|NCT02383927|529524962|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
146823819|NCT02383927|529524963|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
146823820|NCT02383927|529524960|FG000|Overall Study|Adverse Event|4|||
146823821|NCT02383927|529524961|FG001|Overall Study|Adverse Event|1|||
146823822|NCT02383927|529524962|FG002|Overall Study|Adverse Event|3|||
146823823|NCT02383927|529524963|FG003|Overall Study|Adverse Event|5|||
146823824|NCT02383927|529524960|FG000|Overall Study|Miscellaneous|1|||
146823825|NCT02383927|529524961|FG001|Overall Study|Miscellaneous|0|||
146823826|NCT02383927|529524962|FG002|Overall Study|Miscellaneous|0|||
146823827|NCT02383927|529524963|FG003|Overall Study|Miscellaneous|1|||
146823828|NCT02383927|529524960|FG000|Overall Study|Withdrawal by Subject|0|||
146823829|NCT02383927|529524961|FG001|Overall Study|Withdrawal by Subject|1|||
146823830|NCT02383927|529524962|FG002|Overall Study|Withdrawal by Subject|4|||
146823831|NCT02383927|529524963|FG003|Overall Study|Withdrawal by Subject|0|||
146823832|NCT00818519|529524964|FG000|Overall Study|Adverse Event|2|||
146823833|NCT00818519|529524965|FG001|Overall Study|Adverse Event|2|||
146823834|NCT00818519|529524964|FG000|Overall Study|Lost to Follow-up|4|||
146823835|NCT00818519|529524965|FG001|Overall Study|Lost to Follow-up|6|||
146823836|NCT00818519|529524964|FG000|Overall Study|Protocol Violation|2|||
146823837|NCT00818519|529524965|FG001|Overall Study|Protocol Violation|1|||
146951814|NCT02477800|529980009|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
146951815|NCT02477800|529980010|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
146951816|NCT02477800|529980011|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
146951817|NCT02477800|529980012|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
146951818|NCT02477800|529980006|FG000|Long Term Extension Period|Study Visit Burden|0|||
146951819|NCT02477800|529980007|FG001|Long Term Extension Period|Study Visit Burden|0|||
146951820|NCT02477800|529980008|FG002|Long Term Extension Period|Study Visit Burden|0|||
146951821|NCT02477800|529980009|FG003|Long Term Extension Period|Study Visit Burden|3|||
146951822|NCT02477800|529980010|FG004|Long Term Extension Period|Study Visit Burden|0|||
146951823|NCT02477800|529980011|FG005|Long Term Extension Period|Study Visit Burden|2|||
146951824|NCT02477800|529980012|FG006|Long Term Extension Period|Study Visit Burden|2|||
146951825|NCT02477800|529980006|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
146951826|NCT02477800|529980007|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
146951827|NCT02477800|529980008|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
146951828|NCT02477800|529980009|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
146951829|NCT02477800|529980010|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
146951830|NCT02477800|529980011|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
146951831|NCT02477800|529980012|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
146951832|NCT02477800|529980006|FG000|Long Term Extension Period|Reason not Specified|0|||
146951833|NCT02477800|529980007|FG001|Long Term Extension Period|Reason not Specified|0|||
146951834|NCT02477800|529980008|FG002|Long Term Extension Period|Reason not Specified|0|||
146951835|NCT02477800|529980009|FG003|Long Term Extension Period|Reason not Specified|126|||
146951836|NCT02477800|529980010|FG004|Long Term Extension Period|Reason not Specified|140|||
146951837|NCT02477800|529980011|FG005|Long Term Extension Period|Reason not Specified|270|||
146951838|NCT02477800|529980012|FG006|Long Term Extension Period|Reason not Specified|224|||
146951839|NCT00129376|529980013|FG000|Overall Study|Adverse Event|1|||
146951840|NCT00129376|529980013|FG000|Overall Study|Lack of Efficacy|1|||
146951841|NCT02061540|529980014|FG000|Overall Study|Adverse Event|2|||
146951842|NCT02061540|529980014|FG000|Overall Study|Withdrawal by Subject|2|||
146951843|NCT02289833|529980016|FG000|Overall Study|Study discontinuation|0|||
146951844|NCT02289833|529980017|FG001|Overall Study|Study discontinuation|1|||
146951845|NCT02289833|529980016|FG000|Overall Study|Lost to Follow-up|4|||
146951846|NCT02289833|529980017|FG001|Overall Study|Lost to Follow-up|0|||
146951847|NCT02289833|529980016|FG000|Overall Study|Death|23|||
146951848|NCT02289833|529980017|FG001|Overall Study|Death|16|||
146951849|NCT02561273|529980024|FG000|Overall Study|Protocol Violation|1|||
146951850|NCT02561273|529980025|FG001|Overall Study|Protocol Violation|0|||
146951851|NCT02723019|529980026|FG000|Overall Study|Death|17|||
146951852|NCT02723019|529980027|FG001|Overall Study|Death|13|||
146951853|NCT02723019|529980026|FG000|Overall Study|Withdrawal by Subject|11|||
146951854|NCT02723019|529980027|FG001|Overall Study|Withdrawal by Subject|7|||
146951855|NCT02723019|529980026|FG000|Overall Study|Lost to Follow-up|57|||
146951856|NCT02723019|529980027|FG001|Overall Study|Lost to Follow-up|70|||
146951857|NCT00958191|529980029|FG000|Overall Study|Death|4|||
146951858|NCT00958191|529980029|FG000|Overall Study|Lost to Follow-up|5|||
146951859|NCT00958191|529980029|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
146951860|NCT00958191|529980029|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
146951861|NCT00958191|529980029|FG000|Overall Study|Revision of study device|4|||
146951862|NCT00958191|529980029|FG000|Overall Study|Site termination|11|||
146951863|NCT00958191|529980029|FG000|Overall Study|No 5 yr x-rays|56|||
146951864|NCT00611767|529980030|FG000|Overall Study|Withdrawal by Subject|4|||
146951865|NCT00611767|529980031|FG001|Overall Study|Withdrawal by Subject|1|||
146951866|NCT00611767|529980030|FG000|Overall Study|Thiopental not available|3|||
146951867|NCT00611767|529980031|FG001|Overall Study|Thiopental not available|0|||
146951868|NCT00611767|529980030|FG000|Overall Study|didn't like the medication|1|||
146951869|NCT00611767|529980031|FG001|Overall Study|didn't like the medication|1|||
146951870|NCT00611767|529980030|FG000|Overall Study|Physician Decision|1|||
146951871|NCT00611767|529980031|FG001|Overall Study|Physician Decision|0|||
146951872|NCT01642004|529980032|FG000|Randomization|Adverse Event unrelated to study drug|1|||
146951873|NCT01642004|529980033|FG001|Randomization|Adverse Event unrelated to study drug|0|||
146951874|NCT01642004|529980032|FG000|Randomization|Participant withdrew consent|1|||
146823838|NCT00818519|529524964|FG000|Overall Study|Pregnancy|0|||
146823839|NCT00818519|529524965|FG001|Overall Study|Pregnancy|1|||
146823840|NCT00818519|529524964|FG000|Overall Study|Withdrawal by Subject|4|||
146951875|NCT01642004|529980033|FG001|Randomization|Participant withdrew consent|6|||
146951876|NCT01642004|529980032|FG000|Randomization|No longer meets study criteria|2|||
146951877|NCT01642004|529980033|FG001|Randomization|No longer meets study criteria|2|||
146951878|NCT01642004|529980032|FG000|Treatment|Disease progression|95|||
146951879|NCT01642004|529980033|FG001|Treatment|Disease progression|79|||
146823841|NCT00818519|529524965|FG001|Overall Study|Withdrawal by Subject|9|||
146823842|NCT00818519|529524964|FG000|Overall Study|participant recovered completely|1|||
146951880|NCT01642004|529980032|FG000|Treatment|Study drug toxicity|10|||
146951881|NCT01642004|529980033|FG001|Treatment|Study drug toxicity|13|||
146951882|NCT01642004|529980032|FG000|Treatment|Death|1|||
146823843|NCT00818519|529524965|FG001|Overall Study|participant recovered completely|0|||
146823844|NCT00818519|529524964|FG000|Overall Study|participant will leave for long tme|1|||
146823845|NCT00818519|529524965|FG001|Overall Study|participant will leave for long tme|0|||
146823846|NCT00981578|529524966|FG000|Overall Study|Death|1|||
146823847|NCT00981578|529524966|FG000|Overall Study|Withdrawal by Subject|2|||
146823848|NCT02865135|529524967|FG000|Overall Study|Death|0|||
146823849|NCT02865135|529524968|FG001|Overall Study|Death|1|||
146823850|NCT02865135|529524969|FG002|Overall Study|Death|0|||
146823851|NCT02865135|529524967|FG000|Overall Study|Progression|6|||
146823852|NCT02865135|529524968|FG001|Overall Study|Progression|2|||
146823853|NCT02865135|529524969|FG002|Overall Study|Progression|2|||
146823854|NCT01180790|529524976|FG000|Overall Study|Adverse Event|1|||
146823855|NCT01180790|529524977|FG001|Overall Study|Adverse Event|1|||
146823856|NCT01180790|529524978|FG002|Overall Study|Adverse Event|2|||
146823857|NCT01180790|529524979|FG003|Overall Study|Adverse Event|0|||
146823858|NCT01180790|529524980|FG004|Overall Study|Adverse Event|1|||
146823859|NCT01180790|529524981|FG005|Overall Study|Adverse Event|3|||
146823860|NCT01180790|529524982|FG006|Overall Study|Adverse Event|0|||
146823861|NCT01180790|529524976|FG000|Overall Study|Withdrawal by Subject|3|||
146823862|NCT01180790|529524977|FG001|Overall Study|Withdrawal by Subject|0|||
146823863|NCT01180790|529524978|FG002|Overall Study|Withdrawal by Subject|5|||
146823864|NCT01180790|529524979|FG003|Overall Study|Withdrawal by Subject|0|||
146823865|NCT01180790|529524980|FG004|Overall Study|Withdrawal by Subject|2|||
146823866|NCT01180790|529524981|FG005|Overall Study|Withdrawal by Subject|1|||
146823867|NCT01180790|529524982|FG006|Overall Study|Withdrawal by Subject|0|||
146823868|NCT01180790|529524976|FG000|Overall Study|Lost to Follow-up|3|||
146823869|NCT01180790|529524977|FG001|Overall Study|Lost to Follow-up|1|||
146823870|NCT01180790|529524978|FG002|Overall Study|Lost to Follow-up|0|||
146823871|NCT01180790|529524979|FG003|Overall Study|Lost to Follow-up|2|||
146823872|NCT01180790|529524980|FG004|Overall Study|Lost to Follow-up|1|||
146823873|NCT01180790|529524981|FG005|Overall Study|Lost to Follow-up|0|||
146823874|NCT01180790|529524982|FG006|Overall Study|Lost to Follow-up|1|||
146823875|NCT01180790|529524976|FG000|Overall Study|Physician Decision|1|||
146823876|NCT01180790|529524977|FG001|Overall Study|Physician Decision|0|||
146823877|NCT01180790|529524978|FG002|Overall Study|Physician Decision|0|||
146823878|NCT01180790|529524979|FG003|Overall Study|Physician Decision|1|||
146823879|NCT01180790|529524980|FG004|Overall Study|Physician Decision|0|||
146823880|NCT01180790|529524981|FG005|Overall Study|Physician Decision|0|||
146823881|NCT01180790|529524982|FG006|Overall Study|Physician Decision|0|||
146823882|NCT01180790|529524976|FG000|Overall Study|Lack of Efficacy|1|||
146823883|NCT01180790|529524977|FG001|Overall Study|Lack of Efficacy|2|||
146823884|NCT01180790|529524978|FG002|Overall Study|Lack of Efficacy|5|||
146823885|NCT01180790|529524979|FG003|Overall Study|Lack of Efficacy|6|||
146823886|NCT01180790|529524980|FG004|Overall Study|Lack of Efficacy|1|||
146823887|NCT01180790|529524981|FG005|Overall Study|Lack of Efficacy|3|||
146823888|NCT01180790|529524982|FG006|Overall Study|Lack of Efficacy|0|||
146823889|NCT01180790|529524976|FG000|Overall Study|compliance|0|||
146823890|NCT01180790|529524977|FG001|Overall Study|compliance|1|||
146823891|NCT01180790|529524978|FG002|Overall Study|compliance|0|||
146823892|NCT01180790|529524979|FG003|Overall Study|compliance|0|||
146823893|NCT01180790|529524980|FG004|Overall Study|compliance|0|||
146823894|NCT01180790|529524981|FG005|Overall Study|compliance|0|||
146823895|NCT01180790|529524982|FG006|Overall Study|compliance|0|||
146823896|NCT01180790|529524976|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
146823897|NCT01180790|529524977|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
146823898|NCT01180790|529524978|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
146823899|NCT01180790|529524979|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
146823900|NCT01180790|529524980|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
146823901|NCT01180790|529524981|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
146823902|NCT01180790|529524982|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
146823903|NCT00655668|529524983|FG000|Overall Study|Adverse Event|6|||
146951883|NCT01642004|529980033|FG001|Treatment|Death|1|||
146823904|NCT00655668|529524983|FG000|Overall Study|Death|5|||
146823905|NCT00655668|529524983|FG000|Overall Study|Disease Progression|27|||
146823906|NCT00655668|529524983|FG000|Overall Study|Study Terminated|9|||
146823907|NCT00655668|529524983|FG000|Overall Study|Other|1|||
146823908|NCT00655668|529524983|FG000|Overall Study|New Lymphoma Treatment Started|4|||
146823909|NCT00655668|529524983|FG000|Overall Study|Withdrawal by Subject|2|||
146823910|NCT02335242|529524984|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
146823911|NCT02335242|529524985|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
146823912|NCT02335242|529524984|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
146823913|NCT02335242|529524985|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
146823914|NCT02335242|529524984|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
146823915|NCT02335242|529524985|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
146823916|NCT03873038|529524986|FG000|Part 2|Withdrawal by Subject|0|||
146823917|NCT03873038|529524987|FG001|Part 2|Withdrawal by Subject|0|||
146823918|NCT03873038|529524988|FG002|Part 2|Withdrawal by Subject|0|||
146951884|NCT01642004|529980032|FG000|Treatment|Adverse event unrelated to study drug|9|||
146823919|NCT03873038|529524989|FG003|Part 2|Withdrawal by Subject|0|||
146823920|NCT03873038|529524990|FG004|Part 2|Withdrawal by Subject|0|||
146823921|NCT03873038|529524991|FG005|Part 2|Withdrawal by Subject|1|||
146823922|NCT03873038|529524986|FG000|Part 2|Unknon|0|||
146823923|NCT03873038|529524987|FG001|Part 2|Unknon|0|||
146823924|NCT03873038|529524988|FG002|Part 2|Unknon|0|||
146823925|NCT03873038|529524989|FG003|Part 2|Unknon|0|||
146823926|NCT03873038|529524990|FG004|Part 2|Unknon|1|||
146823927|NCT03873038|529524991|FG005|Part 2|Unknon|0|||
146823928|NCT04222088|529524992|FG000|Overall Study|Lost to Follow-up|5|||
146823929|NCT04222088|529524993|FG001|Overall Study|Lost to Follow-up|1|||
146823930|NCT04222088|529524992|FG000|Overall Study|Withdrawal by Subject|4|||
146823931|NCT04222088|529524993|FG001|Overall Study|Withdrawal by Subject|0|||
146823932|NCT00595764|529524994|FG000|Overall Study|Protocol Violation|24|||
146823933|NCT00595764|529524995|FG001|Overall Study|Protocol Violation|19|||
146823934|NCT00595764|529524994|FG000|Overall Study|Missed Medication >1 week|10|||
146823935|NCT00595764|529524995|FG001|Overall Study|Missed Medication >1 week|17|||
146823936|NCT00595764|529524994|FG000|Overall Study|Missed 3 PM visits|1|||
146823937|NCT00595764|529524995|FG001|Overall Study|Missed 3 PM visits|7|||
146823938|NCT00595764|529524994|FG000|Overall Study|Withdrawal by Subject|4|||
146823939|NCT00595764|529524995|FG001|Overall Study|Withdrawal by Subject|0|||
146823940|NCT00464737|529524996|FG000|Overall Study|Adverse Event|12|||
146823941|NCT00464737|529524997|FG001|Overall Study|Adverse Event|17|||
146823942|NCT00464737|529524998|FG002|Overall Study|Adverse Event|33|||
146823943|NCT00464737|529524996|FG000|Overall Study|Lack of Efficacy|7|||
146823944|NCT00464737|529524997|FG001|Overall Study|Lack of Efficacy|7|||
146823945|NCT00464737|529524998|FG002|Overall Study|Lack of Efficacy|4|||
146823946|NCT00464737|529524996|FG000|Overall Study|Withdrawal by Subject|5|||
146823947|NCT00464737|529524997|FG001|Overall Study|Withdrawal by Subject|3|||
146823948|NCT00464737|529524998|FG002|Overall Study|Withdrawal by Subject|5|||
146823949|NCT00464737|529524996|FG000|Overall Study|Protocol Violation|1|||
146823950|NCT00464737|529524997|FG001|Overall Study|Protocol Violation|1|||
146823951|NCT00464737|529524998|FG002|Overall Study|Protocol Violation|5|||
146823952|NCT00464737|529524996|FG000|Overall Study|Non-compliance|0|||
146823953|NCT00464737|529524997|FG001|Overall Study|Non-compliance|1|||
146823954|NCT00464737|529524998|FG002|Overall Study|Non-compliance|1|||
146823955|NCT00464737|529524996|FG000|Overall Study|Lost to Follow-up|5|||
146823956|NCT00464737|529524997|FG001|Overall Study|Lost to Follow-up|2|||
146823957|NCT00464737|529524998|FG002|Overall Study|Lost to Follow-up|5|||
146823958|NCT00464737|529524996|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
146823959|NCT00464737|529524997|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
146823960|NCT00464737|529524998|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
146823961|NCT00464737|529524996|FG000|Overall Study|Other: Subject left town; family illness|1|||
146823962|NCT00464737|529524997|FG001|Overall Study|Other: Subject left town; family illness|0|||
146823963|NCT00464737|529524998|FG002|Overall Study|Other: Subject left town; family illness|0|||
146823964|NCT00464737|529524996|FG000|Overall Study|Other: Study demands too great|0|||
146823965|NCT00464737|529524997|FG001|Overall Study|Other: Study demands too great|1|||
146823966|NCT00464737|529524998|FG002|Overall Study|Other: Study demands too great|0|||
146823967|NCT00464737|529524996|FG000|Overall Study|Other: Personal family reasons|0|||
146823968|NCT00464737|529524997|FG001|Overall Study|Other: Personal family reasons|0|||
146823969|NCT00464737|529524998|FG002|Overall Study|Other: Personal family reasons|1|||
146823970|NCT00464737|529524996|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
146823971|NCT00464737|529524997|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
146823972|NCT00464737|529524998|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
146823973|NCT02820298|529524999|FG000|Overall Study|Withdrawal by Subject|0|||
146823974|NCT02820298|529525000|FG001|Overall Study|Withdrawal by Subject|1|||
146823975|NCT02820298|529524999|FG000|Overall Study|Physician Decision|1|||
146823976|NCT02820298|529525000|FG001|Overall Study|Physician Decision|0|||
146823977|NCT02820298|529524999|FG000|Overall Study|Protocol Violation|0|||
146823978|NCT02820298|529525000|FG001|Overall Study|Protocol Violation|1|||
146823979|NCT01894256|529525001|FG000|Part A|Adverse Event|0|||
146823980|NCT01894256|529525002|FG001|Part A|Adverse Event|1|||
146823981|NCT01894256|529525003|FG002|Part A|Adverse Event|0|||
146823982|NCT01894256|529525001|FG000|Part B|Death|0|||
146823983|NCT01894256|529525002|FG001|Part B|Death|1|||
146823984|NCT01894256|529525003|FG002|Part B|Death|1|||
146823985|NCT01894256|529525001|FG000|Part B|Withdrawal by Subject|0|||
146823986|NCT01894256|529525002|FG001|Part B|Withdrawal by Subject|1|||
146823987|NCT01894256|529525003|FG002|Part B|Withdrawal by Subject|0|||
146823988|NCT01894256|529525001|FG000|Part B|Lack of Efficacy|15|||
146823989|NCT01894256|529525002|FG001|Part B|Lack of Efficacy|12|||
146823990|NCT01894256|529525003|FG002|Part B|Lack of Efficacy|13|||
146823991|NCT00141271|529525006|FG000|Overall Study|Adverse Event|31|||
146823992|NCT00141271|529525007|FG001|Overall Study|Adverse Event|19|||
146823993|NCT00141271|529525008|FG002|Overall Study|Adverse Event|17|||
146823994|NCT00141271|529525006|FG000|Overall Study|Laboratory Abnormality|2|||
146848556|NCT04927247|529615734|FG001|Overall Study|Adverse Event|0|||
146848557|NCT04828837|529615736|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
146951885|NCT01642004|529980033|FG001|Treatment|Adverse event unrelated to study drug|13|||
146951886|NCT01642004|529980032|FG000|Treatment|Maximum clinical benefit|1|||
146951887|NCT01642004|529980033|FG001|Treatment|Maximum clinical benefit|9|||
146951888|NCT01642004|529980032|FG000|Treatment|Poor/non-compliance|1|||
146951889|NCT01642004|529980033|FG001|Treatment|Poor/non-compliance|0|||
146951890|NCT01642004|529980032|FG000|Treatment|No longer meets study criteria|1|||
146951891|NCT01642004|529980033|FG001|Treatment|No longer meets study criteria|2|||
146951892|NCT01642004|529980032|FG000|Treatment|Other reasons|2|||
146951893|NCT01642004|529980033|FG001|Treatment|Other reasons|0|||
146951894|NCT01642004|529980032|FG000|Treatment|Not reported|0|||
146951895|NCT01642004|529980033|FG001|Treatment|Not reported|3|||
146951896|NCT01642004|529980032|FG000|Treatment|Participant request to discontinue study treatment|6|||
146951897|NCT01642004|529980033|FG001|Treatment|Participant request to discontinue study treatment|4|||
146951898|NCT01642004|529980032|FG000|Treatment|Participant withdrew consent|5|||
146951899|NCT01642004|529980033|FG001|Treatment|Participant withdrew consent|5|||
146951900|NCT02718625|529980034|FG000|Overall Study|Adverse Event|0|||
146951901|NCT02718625|529980035|FG001|Overall Study|Adverse Event|1|||
146951902|NCT02718625|529980034|FG000|Overall Study|Termination of Study by Sponsor|0|||
146951903|NCT02718625|529980035|FG001|Overall Study|Termination of Study by Sponsor|1|||
146951904|NCT01818765|529980038|FG000|Overall Study|Death|2|||
146951905|NCT01603628|529980043|FG000|Overall Study|Personal Reasons|1|||
146951906|NCT01603628|529980044|FG001|Overall Study|Personal Reasons|1|||
146951907|NCT01603628|529980045|FG002|Overall Study|Personal Reasons|2|||
146951908|NCT01603628|529980043|FG000|Overall Study|Protocol Violation|1|||
146951909|NCT01603628|529980044|FG001|Overall Study|Protocol Violation|1|||
146951910|NCT01603628|529980045|FG002|Overall Study|Protocol Violation|0|||
146951911|NCT01603628|529980043|FG000|Overall Study|Lost to Follow-up|0|||
146951912|NCT01603628|529980044|FG001|Overall Study|Lost to Follow-up|1|||
146951913|NCT01603628|529980045|FG002|Overall Study|Lost to Follow-up|0|||
146951914|NCT01603628|529980043|FG000|Overall Study|Other Miscellaneous Reason|1|||
146951915|NCT01603628|529980044|FG001|Overall Study|Other Miscellaneous Reason|0|||
146951916|NCT01603628|529980045|FG002|Overall Study|Other Miscellaneous Reason|0|||
146951917|NCT01969565|529980046|FG000|Overall Study|Withdrawal by Subject|1|||
146951918|NCT01055457|529980051|FG000|Overall Study|Lost to Follow-up|0|||
146951919|NCT01055457|529980052|FG001|Overall Study|Lost to Follow-up|1|||
146951920|NCT01055457|529980053|FG002|Overall Study|Lost to Follow-up|0|||
146951921|NCT01055457|529980054|FG003|Overall Study|Lost to Follow-up|0|||
146951922|NCT01055457|529980055|FG004|Overall Study|Lost to Follow-up|0|||
146951923|NCT01055457|529980056|FG005|Overall Study|Lost to Follow-up|1|||
146951924|NCT01055457|529980057|FG006|Overall Study|Lost to Follow-up|0|||
146951925|NCT01055457|529980058|FG007|Overall Study|Lost to Follow-up|0|||
146951926|NCT01055457|529980059|FG008|Overall Study|Lost to Follow-up|0|||
146951927|NCT01055457|529980060|FG009|Overall Study|Lost to Follow-up|0|||
146951928|NCT01055457|529980051|FG000|Overall Study|Protocol Violation|0|||
146951929|NCT01055457|529980052|FG001|Overall Study|Protocol Violation|0|||
146951930|NCT01055457|529980053|FG002|Overall Study|Protocol Violation|1|||
146951931|NCT01055457|529980054|FG003|Overall Study|Protocol Violation|1|||
146951932|NCT01055457|529980055|FG004|Overall Study|Protocol Violation|1|||
146951933|NCT01055457|529980056|FG005|Overall Study|Protocol Violation|2|||
146951934|NCT01055457|529980057|FG006|Overall Study|Protocol Violation|1|||
146951935|NCT01055457|529980058|FG007|Overall Study|Protocol Violation|0|||
146951936|NCT01055457|529980059|FG008|Overall Study|Protocol Violation|0|||
146951937|NCT01055457|529980060|FG009|Overall Study|Protocol Violation|1|||
146951938|NCT01055457|529980051|FG000|Overall Study|Subject Disinterest|0|||
146951939|NCT01055457|529980052|FG001|Overall Study|Subject Disinterest|0|||
146951940|NCT01055457|529980053|FG002|Overall Study|Subject Disinterest|0|||
146951941|NCT01055457|529980054|FG003|Overall Study|Subject Disinterest|0|||
146951942|NCT01055457|529980055|FG004|Overall Study|Subject Disinterest|0|||
146951943|NCT01055457|529980056|FG005|Overall Study|Subject Disinterest|0|||
146951944|NCT01055457|529980057|FG006|Overall Study|Subject Disinterest|0|||
146951945|NCT01055457|529980058|FG007|Overall Study|Subject Disinterest|1|||
146951946|NCT01055457|529980059|FG008|Overall Study|Subject Disinterest|0|||
146951947|NCT01055457|529980060|FG009|Overall Study|Subject Disinterest|0|||
146951948|NCT01055457|529980051|FG000|Overall Study|Subject Ineligible|1|||
146951949|NCT01055457|529980052|FG001|Overall Study|Subject Ineligible|0|||
146951950|NCT01055457|529980053|FG002|Overall Study|Subject Ineligible|1|||
146951951|NCT01055457|529980054|FG003|Overall Study|Subject Ineligible|0|||
146951952|NCT01055457|529980055|FG004|Overall Study|Subject Ineligible|1|||
146951953|NCT01055457|529980056|FG005|Overall Study|Subject Ineligible|0|||
146951954|NCT01055457|529980057|FG006|Overall Study|Subject Ineligible|0|||
146951955|NCT01055457|529980058|FG007|Overall Study|Subject Ineligible|0|||
146951956|NCT01055457|529980059|FG008|Overall Study|Subject Ineligible|0|||
146984973|NCT00555009|530107107|FG001|Overall Study|Terminated by Sponsor|5|||
146951957|NCT01055457|529980060|FG009|Overall Study|Subject Ineligible|0|||
146951958|NCT01055457|529980051|FG000|Overall Study|Discomfort|0|||
146951959|NCT01055457|529980052|FG001|Overall Study|Discomfort|0|||
146951960|NCT01055457|529980053|FG002|Overall Study|Discomfort|0|||
146951961|NCT01055457|529980054|FG003|Overall Study|Discomfort|0|||
146951962|NCT01055457|529980055|FG004|Overall Study|Discomfort|1|||
146951963|NCT01055457|529980056|FG005|Overall Study|Discomfort|0|||
146951964|NCT01055457|529980057|FG006|Overall Study|Discomfort|0|||
146951965|NCT01055457|529980058|FG007|Overall Study|Discomfort|0|||
146951966|NCT01055457|529980059|FG008|Overall Study|Discomfort|0|||
146951967|NCT01055457|529980060|FG009|Overall Study|Discomfort|0|||
146951968|NCT01055457|529980051|FG000|Overall Study|Pregnancy|0|||
146951969|NCT01055457|529980052|FG001|Overall Study|Pregnancy|0|||
146951970|NCT01055457|529980053|FG002|Overall Study|Pregnancy|0|||
146951971|NCT01055457|529980054|FG003|Overall Study|Pregnancy|1|||
146951972|NCT01055457|529980055|FG004|Overall Study|Pregnancy|0|||
146951973|NCT01055457|529980056|FG005|Overall Study|Pregnancy|0|||
146951974|NCT01055457|529980057|FG006|Overall Study|Pregnancy|0|||
146951975|NCT01055457|529980058|FG007|Overall Study|Pregnancy|0|||
146951976|NCT01055457|529980059|FG008|Overall Study|Pregnancy|0|||
146951977|NCT01055457|529980060|FG009|Overall Study|Pregnancy|0|||
146951978|NCT01055457|529980051|FG000|Overall Study|Adverse Event|0|||
146951979|NCT01055457|529980052|FG001|Overall Study|Adverse Event|0|||
146951980|NCT01055457|529980053|FG002|Overall Study|Adverse Event|0|||
146951981|NCT01055457|529980054|FG003|Overall Study|Adverse Event|1|||
146951982|NCT01055457|529980055|FG004|Overall Study|Adverse Event|0|||
146951983|NCT01055457|529980056|FG005|Overall Study|Adverse Event|0|||
146951984|NCT01055457|529980057|FG006|Overall Study|Adverse Event|0|||
146951985|NCT01055457|529980058|FG007|Overall Study|Adverse Event|0|||
146951986|NCT01055457|529980059|FG008|Overall Study|Adverse Event|0|||
146951987|NCT01055457|529980060|FG009|Overall Study|Adverse Event|0|||
146951988|NCT02187224|529980061|FG000|Overall Study|Did not show up for test day|1|||
146951989|NCT02187224|529980062|FG001|Overall Study|Did not show up for test day|0|||
146951990|NCT01010776|529980066|FG000|Main Phase|Withdrawal by Subject|14|||
146951991|NCT01010776|529980066|FG000|Main Phase|Lack of Efficacy|8|||
146951992|NCT01010776|529980066|FG000|Main Phase|Adverse Event|7|||
146951993|NCT01010776|529980066|FG000|Main Phase|Lost to Follow-up|6|||
146951994|NCT01010776|529980066|FG000|Main Phase|Non-compliance to study medication|5|||
146951995|NCT01010776|529980066|FG000|Main Phase|Selection failure|2|||
146951996|NCT01010776|529980066|FG000|Main Phase|Inform consent withdrawal|1|||
146951997|NCT01010776|529980066|FG000|Main Phase|Other|1|||
146951998|NCT01010776|529980066|FG000|Main Phase|Did not received study medication|5|||
146951999|NCT01010776|529980066|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
146952000|NCT01010776|529980066|FG000|Extension Phase|Other|3|||
146952001|NCT00703781|529980070|FG000|Overall Study|Withdrawal by Subject|1|||
146952002|NCT00703781|529980071|FG001|Overall Study|Withdrawal by Subject|2|||
146952003|NCT00703781|529980070|FG000|Overall Study|Cancelled surgery|1|||
146952004|NCT00703781|529980071|FG001|Overall Study|Cancelled surgery|0|||
146952005|NCT04191096|529980072|FG000|Overall Study|Death|102|||
146952006|NCT04191096|529980073|FG001|Overall Study|Death|89|||
146952007|NCT04191096|529980072|FG000|Overall Study|Lost to Follow-up|1|||
146952008|NCT04191096|529980073|FG001|Overall Study|Lost to Follow-up|1|||
146952009|NCT04191096|529980072|FG000|Overall Study|Withdrawal by Subject|5|||
146952010|NCT04191096|529980073|FG001|Overall Study|Withdrawal by Subject|5|||
146952011|NCT04191096|529980072|FG000|Overall Study|Participants Ongoing|518|||
146952012|NCT04191096|529980073|FG001|Overall Study|Participants Ongoing|530|||
146952013|NCT02683668|529980077|FG000|Period 2|Withdrawal by Subject|0|||
146952014|NCT02683668|529980078|FG001|Period 2|Withdrawal by Subject|1|||
146952015|NCT02683668|529980079|FG002|Period 2|Withdrawal by Subject|0|||
146952016|NCT01465958|529981859|FG000|Run-in Phase|Protocol Violation|1|||
146952017|NCT01465958|529981860|FG001|Run-in Phase|Protocol Violation|0|||
146952018|NCT01465958|529981859|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
146952019|NCT01465958|529981860|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
146952020|NCT02442765|529981861|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
146952021|NCT02442765|529981862|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
146952022|NCT02442765|529981863|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
146952023|NCT02442765|529981864|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
146952024|NCT02442765|529981865|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
146984974|NCT02232074|530107108|FG000|Overall Study|Withdrawal by Subject|5|||
146984975|NCT02232074|530107109|FG001|Overall Study|Withdrawal by Subject|3|||
146984976|NCT02232074|530107108|FG000|Overall Study|No legal concerns at baseline|36|||
146984977|NCT02232074|530107109|FG001|Overall Study|No legal concerns at baseline|41|||
146952025|NCT02442765|529981866|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
146952026|NCT02442765|529981867|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
146952027|NCT02442765|529981868|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
146952028|NCT02442765|529981861|FG000|Stage 2- (Days 43 to 85)|Death|0|||
146952029|NCT02442765|529981862|FG001|Stage 2- (Days 43 to 85)|Death|0|||
146952030|NCT02442765|529981863|FG002|Stage 2- (Days 43 to 85)|Death|0|||
146952031|NCT02442765|529981864|FG003|Stage 2- (Days 43 to 85)|Death|1|||
146952032|NCT02442765|529981865|FG004|Stage 2- (Days 43 to 85)|Death|1|||
146984978|NCT02232074|530107108|FG000|Overall Study|deemed ineligible|0|||
146952033|NCT02442765|529981866|FG005|Stage 2- (Days 43 to 85)|Death|0|||
146952034|NCT02442765|529981867|FG006|Stage 2- (Days 43 to 85)|Death|2|||
146952035|NCT02442765|529981868|FG007|Stage 2- (Days 43 to 85)|Death|0|||
146952036|NCT02442765|529981861|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
146952037|NCT02442765|529981862|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
146952038|NCT02442765|529981863|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
146952039|NCT02442765|529981864|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
146952040|NCT02442765|529981865|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
146952041|NCT02442765|529981866|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
146952042|NCT02442765|529981867|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
146952043|NCT02442765|529981868|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
146952044|NCT02442765|529981861|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
146952045|NCT02442765|529981862|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
146952046|NCT02442765|529981863|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
146952047|NCT02442765|529981864|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
146952048|NCT02442765|529981865|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
146952049|NCT02442765|529981866|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
146952050|NCT02442765|529981867|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
146952051|NCT02442765|529981868|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
146952052|NCT02442765|529981861|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
146952053|NCT02442765|529981862|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
146952054|NCT02442765|529981863|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
146952055|NCT02442765|529981864|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
146952056|NCT02442765|529981865|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
146952057|NCT02442765|529981866|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
146952058|NCT02442765|529981867|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
146952059|NCT02442765|529981868|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
146952060|NCT02442765|529981861|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
146952061|NCT02442765|529981862|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
146952062|NCT02442765|529981863|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
146952063|NCT02442765|529981864|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
146952064|NCT02442765|529981865|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
146952065|NCT02442765|529981866|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
146952066|NCT02442765|529981867|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
146952067|NCT02442765|529981868|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
146952068|NCT02442765|529981861|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
146952069|NCT02442765|529981862|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
146952070|NCT02442765|529981863|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
146952071|NCT02442765|529981864|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
146952072|NCT02442765|529981865|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
146952073|NCT02442765|529981866|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
146952074|NCT02442765|529981867|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
146952075|NCT02442765|529981868|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
146952076|NCT02442765|529981861|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
146952077|NCT02442765|529981862|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
146952078|NCT02442765|529981863|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
146952079|NCT02442765|529981864|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
146952080|NCT02442765|529981865|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
146952081|NCT02442765|529981866|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
146952082|NCT02442765|529981867|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
146952083|NCT02442765|529981868|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
146952084|NCT05158244|529981869|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
146952085|NCT05158244|529981870|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
146952086|NCT05158244|529981871|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
146952087|NCT05158244|529981872|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
146952088|NCT05158244|529981873|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
146952089|NCT05158244|529981869|FG000|Overall Study|Withdrawal by Subject|0|||
146952090|NCT05158244|529981870|FG001|Overall Study|Withdrawal by Subject|0|||
146952091|NCT05158244|529981871|FG002|Overall Study|Withdrawal by Subject|1|||
146952092|NCT05158244|529981872|FG003|Overall Study|Withdrawal by Subject|0|||
146952093|NCT05158244|529981873|FG004|Overall Study|Withdrawal by Subject|0|||
146952094|NCT03818399|529981877|FG000|Overall Study|Lost to Follow-up|11|||
146952095|NCT03818399|529981877|FG000|Overall Study|Withdrawal by Subject|1|||
146952096|NCT03818399|529981877|FG000|Overall Study|Protocol Violation|2|||
146952097|NCT00141297|529981878|FG000|Overall Study|Adverse Event|0|||
146952098|NCT00141297|529981879|FG001|Overall Study|Adverse Event|0|||
146952099|NCT00141297|529981880|FG002|Overall Study|Adverse Event|1|||
146823995|NCT00141271|529525007|FG001|Overall Study|Laboratory Abnormality|1|||
146823996|NCT00141271|529525008|FG002|Overall Study|Laboratory Abnormality|1|||
146823997|NCT00141271|529525006|FG000|Overall Study|Lack of Efficacy|7|||
146823998|NCT00141271|529525007|FG001|Overall Study|Lack of Efficacy|7|||
146823999|NCT00141271|529525008|FG002|Overall Study|Lack of Efficacy|3|||
146824000|NCT00141271|529525006|FG000|Overall Study|Lost to Follow-up|15|||
146824001|NCT00141271|529525007|FG001|Overall Study|Lost to Follow-up|15|||
146952100|NCT00141297|529981881|FG003|Overall Study|Adverse Event|0|||
146952101|NCT00141297|529981882|FG004|Overall Study|Adverse Event|1|||
146952102|NCT00141297|529981883|FG005|Overall Study|Adverse Event|1|||
146952103|NCT00141297|529981884|FG006|Overall Study|Adverse Event|0|||
146952104|NCT00141297|529981885|FG007|Overall Study|Adverse Event|1|||
146952105|NCT00141297|529981886|FG008|Overall Study|Adverse Event|1|||
146952106|NCT00141297|529981887|FG009|Overall Study|Adverse Event|0|||
146952107|NCT00141297|529981878|FG000|Overall Study|Death|1|||
146952108|NCT00141297|529981879|FG001|Overall Study|Death|0|||
146952109|NCT00141297|529981880|FG002|Overall Study|Death|0|||
146952110|NCT00141297|529981881|FG003|Overall Study|Death|0|||
146952111|NCT00141297|529981882|FG004|Overall Study|Death|0|||
146952112|NCT00141297|529981883|FG005|Overall Study|Death|0|||
146952113|NCT00141297|529981884|FG006|Overall Study|Death|0|||
146952114|NCT00141297|529981885|FG007|Overall Study|Death|0|||
146952115|NCT00141297|529981886|FG008|Overall Study|Death|1|||
146952116|NCT00141297|529981887|FG009|Overall Study|Death|0|||
146952117|NCT00141297|529981878|FG000|Overall Study|Withdrawal by Subject|0|||
146952118|NCT00141297|529981879|FG001|Overall Study|Withdrawal by Subject|0|||
146952119|NCT00141297|529981880|FG002|Overall Study|Withdrawal by Subject|0|||
146824002|NCT00141271|529525008|FG002|Overall Study|Lost to Follow-up|21|||
146824003|NCT00141271|529525006|FG000|Overall Study|Withdrawal by Subject|14|||
146824004|NCT00141271|529525007|FG001|Overall Study|Withdrawal by Subject|9|||
146824005|NCT00141271|529525008|FG002|Overall Study|Withdrawal by Subject|10|||
146824006|NCT00141271|529525006|FG000|Overall Study|Other|11|||
146824007|NCT00141271|529525007|FG001|Overall Study|Other|12|||
146824008|NCT00141271|529525008|FG002|Overall Study|Other|5|||
146824009|NCT02133131|529525009|FG000|Overall Study|Adverse Event|0|||
146824010|NCT02133131|529525010|FG001|Overall Study|Adverse Event|0|||
146824011|NCT02133131|529525011|FG002|Overall Study|Adverse Event|0|||
146824012|NCT02133131|529525012|FG003|Overall Study|Adverse Event|1|||
146824013|NCT02133131|529525013|FG004|Overall Study|Adverse Event|0|||
146824014|NCT02133131|529525014|FG005|Overall Study|Adverse Event|0|||
146824015|NCT02133131|529525015|FG006|Overall Study|Adverse Event|0|||
146824016|NCT02133131|529525009|FG000|Overall Study|Lost to Follow-up|1|||
146824017|NCT02133131|529525010|FG001|Overall Study|Lost to Follow-up|0|||
146824018|NCT02133131|529525011|FG002|Overall Study|Lost to Follow-up|0|||
146824019|NCT02133131|529525012|FG003|Overall Study|Lost to Follow-up|1|||
146824020|NCT02133131|529525013|FG004|Overall Study|Lost to Follow-up|0|||
146824021|NCT02133131|529525014|FG005|Overall Study|Lost to Follow-up|0|||
146824022|NCT02133131|529525015|FG006|Overall Study|Lost to Follow-up|0|||
146824023|NCT02133131|529525009|FG000|Overall Study|Status not recorded|4|||
146824024|NCT02133131|529525010|FG001|Overall Study|Status not recorded|5|||
146824025|NCT02133131|529525011|FG002|Overall Study|Status not recorded|1|||
146824026|NCT02133131|529525012|FG003|Overall Study|Status not recorded|4|||
146824027|NCT02133131|529525013|FG004|Overall Study|Status not recorded|0|||
146824028|NCT02133131|529525014|FG005|Overall Study|Status not recorded|0|||
146824029|NCT02133131|529525015|FG006|Overall Study|Status not recorded|0|||
146824030|NCT02133131|529525009|FG000|Overall Study|Ongoing in study|0|||
146824031|NCT02133131|529525010|FG001|Overall Study|Ongoing in study|0|||
146824032|NCT02133131|529525011|FG002|Overall Study|Ongoing in study|0|||
146824033|NCT02133131|529525012|FG003|Overall Study|Ongoing in study|0|||
146824034|NCT02133131|529525013|FG004|Overall Study|Ongoing in study|15|||
146824035|NCT02133131|529525014|FG005|Overall Study|Ongoing in study|14|||
146824036|NCT02133131|529525015|FG006|Overall Study|Ongoing in study|11|||
146824037|NCT02133131|529525009|FG000|Overall Study|Protocol Violation|0|||
146824038|NCT02133131|529525010|FG001|Overall Study|Protocol Violation|0|||
146824039|NCT02133131|529525011|FG002|Overall Study|Protocol Violation|0|||
146824040|NCT02133131|529525012|FG003|Overall Study|Protocol Violation|0|||
146824041|NCT02133131|529525013|FG004|Overall Study|Protocol Violation|0|||
146952120|NCT00141297|529981881|FG003|Overall Study|Withdrawal by Subject|0|||
146952121|NCT00141297|529981882|FG004|Overall Study|Withdrawal by Subject|0|||
146952122|NCT00141297|529981883|FG005|Overall Study|Withdrawal by Subject|0|||
146952123|NCT00141297|529981884|FG006|Overall Study|Withdrawal by Subject|0|||
146952124|NCT00141297|529981885|FG007|Overall Study|Withdrawal by Subject|0|||
146952125|NCT00141297|529981886|FG008|Overall Study|Withdrawal by Subject|1|||
146824042|NCT02133131|529525014|FG005|Overall Study|Protocol Violation|0|||
146824043|NCT02133131|529525015|FG006|Overall Study|Protocol Violation|1|||
146824044|NCT02316171|529525016|FG000|Overall Study|difficulties with urinary catheter|1|||
146824045|NCT02316171|529525017|FG001|Overall Study|difficulties with urinary catheter|0|||
146824046|NCT02316171|529525018|FG002|Overall Study|difficulties with urinary catheter|0|||
146824047|NCT02316171|529525019|FG003|Overall Study|difficulties with urinary catheter|0|||
146824048|NCT01772147|529526533|FG000|Overall Study|Adverse Event|13|||
146824049|NCT01772147|529526534|FG001|Overall Study|Adverse Event|10|||
146824050|NCT01772147|529526535|FG002|Overall Study|Adverse Event|6|||
146824051|NCT01772147|529526533|FG000|Overall Study|Withdrew Consent|7|||
146952126|NCT00141297|529981887|FG009|Overall Study|Withdrawal by Subject|0|||
146952127|NCT00141297|529981878|FG000|Overall Study|Other|0|||
146952128|NCT00141297|529981879|FG001|Overall Study|Other|0|||
146952129|NCT00141297|529981880|FG002|Overall Study|Other|0|||
146952130|NCT00141297|529981881|FG003|Overall Study|Other|1|||
146824052|NCT01772147|529526534|FG001|Overall Study|Withdrew Consent|8|||
146824053|NCT01772147|529526535|FG002|Overall Study|Withdrew Consent|4|||
146824054|NCT01772147|529526533|FG000|Overall Study|Lost to Follow-up|1|||
146824055|NCT01772147|529526534|FG001|Overall Study|Lost to Follow-up|0|||
146824056|NCT01772147|529526535|FG002|Overall Study|Lost to Follow-up|1|||
146824057|NCT01772147|529526533|FG000|Overall Study|Protocol Deviation|2|||
146824058|NCT01772147|529526534|FG001|Overall Study|Protocol Deviation|1|||
146824059|NCT01772147|529526535|FG002|Overall Study|Protocol Deviation|1|||
146824060|NCT01772147|529526533|FG000|Overall Study|Lack of Efficacy|8|||
146824061|NCT01772147|529526534|FG001|Overall Study|Lack of Efficacy|6|||
146824062|NCT01772147|529526535|FG002|Overall Study|Lack of Efficacy|6|||
146824063|NCT02093897|529526537|FG000|Overall Study|Physician Decision|1|||
146824064|NCT02093897|529526537|FG000|Overall Study|Planned age group closure - no's reached|17|||
146824065|NCT02093897|529526537|FG000|Overall Study|Adverse event, non-fatal|1|||
146824066|NCT04572997|529526541|FG000|Overall Study|Adverse Event|1|||
146824067|NCT02956278|529526542|FG000|Overall Study|Withdrawal by Subject|6|||
146824068|NCT02956278|529526543|FG001|Overall Study|Withdrawal by Subject|2|||
146824069|NCT02956278|529526544|FG002|Overall Study|Withdrawal by Subject|0|||
146824070|NCT01967719|529526545|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
146824071|NCT01967719|529526546|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
146824072|NCT01967719|529526547|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
146824073|NCT01967719|529526548|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
146824074|NCT01967719|529526545|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
146824075|NCT01967719|529526546|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
146824076|NCT01967719|529526547|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
146824077|NCT01967719|529526548|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
146824078|NCT02329223|529526549|FG000|Overall Study|Withdrawal by Subject|1|||
146824079|NCT02329223|529526550|FG001|Overall Study|Withdrawal by Subject|2|||
146824080|NCT02329223|529526551|FG002|Overall Study|Withdrawal by Subject|5|||
146824081|NCT02329223|529526549|FG000|Overall Study|Physician Decision|0|||
146824082|NCT02329223|529526550|FG001|Overall Study|Physician Decision|0|||
146824083|NCT02329223|529526551|FG002|Overall Study|Physician Decision|1|||
146824084|NCT02329223|529526549|FG000|Overall Study|Adverse Event|0|||
146824085|NCT02329223|529526550|FG001|Overall Study|Adverse Event|1|||
146824086|NCT02329223|529526551|FG002|Overall Study|Adverse Event|0|||
146824087|NCT00796614|529526561|FG000|Overall Study|Adverse Event|1|||
146824088|NCT00796614|529526562|FG001|Overall Study|Adverse Event|2|||
146824089|NCT00796614|529526563|FG002|Overall Study|Adverse Event|0|||
146824090|NCT00796614|529526564|FG003|Overall Study|Adverse Event|0|||
146824091|NCT00796614|529526561|FG000|Overall Study|Protocol Violation|0|||
146824092|NCT00796614|529526562|FG001|Overall Study|Protocol Violation|0|||
146824093|NCT00796614|529526563|FG002|Overall Study|Protocol Violation|2|||
146824094|NCT00796614|529526564|FG003|Overall Study|Protocol Violation|0|||
146824095|NCT00796614|529526561|FG000|Overall Study|Lost to Follow-up|2|||
146824096|NCT00796614|529526562|FG001|Overall Study|Lost to Follow-up|2|||
146824097|NCT00796614|529526563|FG002|Overall Study|Lost to Follow-up|1|||
146824098|NCT00796614|529526564|FG003|Overall Study|Lost to Follow-up|0|||
146824099|NCT00796614|529526561|FG000|Overall Study|Withdrawal by Subject|1|||
146824100|NCT00796614|529526562|FG001|Overall Study|Withdrawal by Subject|0|||
146824101|NCT00796614|529526563|FG002|Overall Study|Withdrawal by Subject|0|||
146824102|NCT00796614|529526564|FG003|Overall Study|Withdrawal by Subject|1|||
146824103|NCT00796614|529526561|FG000|Overall Study|Other than stated|1|||
146824104|NCT00796614|529526562|FG001|Overall Study|Other than stated|0|||
146824105|NCT00796614|529526563|FG002|Overall Study|Other than stated|0|||
146824106|NCT00796614|529526564|FG003|Overall Study|Other than stated|0|||
146824107|NCT00740597|529526565|FG000|Overall Study|insurance would not cover treatment|1|||
146824108|NCT01157351|529526567|FG000|Overall Study|Adverse Event|5|||
146824109|NCT01157351|529526568|FG001|Overall Study|Adverse Event|4|||
146824110|NCT01157351|529526567|FG000|Overall Study|Death|1|||
146824111|NCT01157351|529526568|FG001|Overall Study|Death|0|||
146824112|NCT01157351|529526567|FG000|Overall Study|Lost to Follow-up|53|||
146824113|NCT01157351|529526568|FG001|Overall Study|Lost to Follow-up|55|||
146824114|NCT01157351|529526567|FG000|Overall Study|Withdrawal by Subject|37|||
146824115|NCT01157351|529526568|FG001|Overall Study|Withdrawal by Subject|27|||
146824116|NCT01157351|529526567|FG000|Overall Study|Physician Decision|5|||
146824117|NCT01157351|529526568|FG001|Overall Study|Physician Decision|4|||
146824118|NCT01157351|529526567|FG000|Overall Study|Protocol Violation|0|||
146824119|NCT01157351|529526568|FG001|Overall Study|Protocol Violation|1|||
146824120|NCT01157351|529526567|FG000|Overall Study|Other|32|||
146824121|NCT01157351|529526568|FG001|Overall Study|Other|36|||
146824122|NCT01157351|529526567|FG000|Overall Study|Noncompliance with Study Drug|0|||
146824123|NCT01157351|529526568|FG001|Overall Study|Noncompliance with Study Drug|3|||
146824124|NCT01157351|529526567|FG000|Overall Study|Randomized but not Treated|4|||
146824125|NCT01157351|529526568|FG001|Overall Study|Randomized but not Treated|2|||
146824126|NCT00746785|529526569|FG000|Overall Study|Lost to Follow-up|29|||
146824127|NCT00746785|529526570|FG001|Overall Study|Lost to Follow-up|25|||
146824128|NCT00746785|529526571|FG002|Overall Study|Lost to Follow-up|27|||
146824129|NCT01231464|529526572|FG000|Overall Study|Adverse Event|0|||
146952131|NCT00141297|529981882|FG004|Overall Study|Other|5|||
146952132|NCT00141297|529981883|FG005|Overall Study|Other|0|||
146952133|NCT00141297|529981884|FG006|Overall Study|Other|0|||
146952134|NCT00141297|529981885|FG007|Overall Study|Other|0|||
146952135|NCT00141297|529981886|FG008|Overall Study|Other|2|||
146952136|NCT00141297|529981887|FG009|Overall Study|Other|0|||
146952137|NCT00141297|529981878|FG000|Overall Study|Progressive Disease|2|||
146952138|NCT00141297|529981879|FG001|Overall Study|Progressive Disease|3|||
146952139|NCT00141297|529981880|FG002|Overall Study|Progressive Disease|6|||
146952140|NCT00141297|529981881|FG003|Overall Study|Progressive Disease|2|||
146952141|NCT00141297|529981882|FG004|Overall Study|Progressive Disease|15|||
146952142|NCT00141297|529981883|FG005|Overall Study|Progressive Disease|2|||
146952143|NCT00141297|529981884|FG006|Overall Study|Progressive Disease|3|||
146952144|NCT00141297|529981885|FG007|Overall Study|Progressive Disease|3|||
146952145|NCT00141297|529981886|FG008|Overall Study|Progressive Disease|15|||
146952146|NCT00141297|529981887|FG009|Overall Study|Progressive Disease|6|||
146952147|NCT00141297|529981878|FG000|Overall Study|Transitioned|0|||
146952148|NCT00141297|529981879|FG001|Overall Study|Transitioned|0|||
146952149|NCT00141297|529981880|FG002|Overall Study|Transitioned|0|||
146952150|NCT00141297|529981881|FG003|Overall Study|Transitioned|0|||
146952151|NCT00141297|529981882|FG004|Overall Study|Transitioned|1|||
146952152|NCT00141297|529981883|FG005|Overall Study|Transitioned|0|||
146952153|NCT00141297|529981884|FG006|Overall Study|Transitioned|0|||
146952154|NCT00141297|529981885|FG007|Overall Study|Transitioned|0|||
146952155|NCT00141297|529981886|FG008|Overall Study|Transitioned|0|||
146952156|NCT00141297|529981887|FG009|Overall Study|Transitioned|0|||
146952157|NCT02987205|529981888|FG000|Overall Study|Adverse Event|1|||
146952158|NCT02987205|529981888|FG000|Overall Study|Withdrawal by Subject|3|||
146952159|NCT02646891|529981889|FG000|Overall Study|Adverse Event|0|||
146952160|NCT02646891|529981890|FG001|Overall Study|Adverse Event|1|||
146952161|NCT02646891|529981891|FG002|Overall Study|Adverse Event|0|||
146952162|NCT02646891|529981892|FG003|Overall Study|Adverse Event|0|||
146952163|NCT02646891|529981893|FG004|Overall Study|Adverse Event|0|||
146952164|NCT02646891|529981894|FG005|Overall Study|Adverse Event|0|||
146824130|NCT01231464|529526573|FG001|Overall Study|Adverse Event|1|||
146824131|NCT01231464|529526572|FG000|Overall Study|Protocol Violation|1|||
146824132|NCT01231464|529526573|FG001|Overall Study|Protocol Violation|2|||
146824133|NCT01231464|529526572|FG000|Overall Study|Lost to Follow-up|1|||
146824134|NCT01231464|529526573|FG001|Overall Study|Lost to Follow-up|2|||
146824135|NCT01231464|529526572|FG000|Overall Study|Withdrawal by Subject|3|||
146824136|NCT01231464|529526573|FG001|Overall Study|Withdrawal by Subject|2|||
146824137|NCT03449134|529526574|FG000|52-Week Treatment Period|Death|2|||
146824138|NCT03449134|529526575|FG001|52-Week Treatment Period|Death|1|||
146824139|NCT03449134|529526576|FG002|52-Week Treatment Period|Death|0|||
146824140|NCT03449134|529526574|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
146824141|NCT03449134|529526575|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
146824142|NCT03449134|529526576|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
146824143|NCT03449134|529526574|FG000|52-Week Treatment Period|Physician Decision|2|||
146824144|NCT03449134|529526575|FG001|52-Week Treatment Period|Physician Decision|3|||
146824145|NCT03449134|529526576|FG002|52-Week Treatment Period|Physician Decision|3|||
146824146|NCT03449134|529526574|FG000|52-Week Treatment Period|Screen Failure|1|||
146824147|NCT03449134|529526575|FG001|52-Week Treatment Period|Screen Failure|0|||
146824148|NCT03449134|529526576|FG002|52-Week Treatment Period|Screen Failure|1|||
146824149|NCT03449134|529526574|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
146824150|NCT03449134|529526575|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
146824151|NCT03449134|529526576|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
146824152|NCT03449134|529526574|FG000|52-Week Treatment Period|Site Closure|1|||
146824153|NCT03449134|529526575|FG001|52-Week Treatment Period|Site Closure|0|||
146824154|NCT03449134|529526576|FG002|52-Week Treatment Period|Site Closure|0|||
146824155|NCT00957996|529526577|FG000|Overall Study|Death|4|||
146824156|NCT00957996|529526578|FG001|Overall Study|Death|10|||
146824157|NCT00957996|529526577|FG000|Overall Study|Lost to Follow-up|4|||
146824158|NCT00957996|529526578|FG001|Overall Study|Lost to Follow-up|7|||
146824159|NCT00957996|529526577|FG000|Overall Study|Withdrawal by Subject|9|||
146952165|NCT02646891|529981895|FG006|Overall Study|Adverse Event|0|||
146952166|NCT02646891|529981896|FG007|Overall Study|Adverse Event|0|||
146952167|NCT02646891|529981897|FG008|Overall Study|Adverse Event|0|||
146984979|NCT02232074|530107109|FG001|Overall Study|deemed ineligible|1|||
146824160|NCT00957996|529526578|FG001|Overall Study|Withdrawal by Subject|2|||
146952168|NCT02646891|529981898|FG009|Overall Study|Adverse Event|0|||
146952169|NCT02646891|529981889|FG000|Overall Study|Lost to Follow-up|0|||
146952170|NCT02646891|529981890|FG001|Overall Study|Lost to Follow-up|0|||
146952171|NCT02646891|529981891|FG002|Overall Study|Lost to Follow-up|0|||
146952172|NCT02646891|529981892|FG003|Overall Study|Lost to Follow-up|0|||
146952173|NCT02646891|529981893|FG004|Overall Study|Lost to Follow-up|0|||
146824161|NCT00957996|529526577|FG000|Overall Study|Adverse Event|2|||
146824162|NCT00957996|529526578|FG001|Overall Study|Adverse Event|1|||
146952174|NCT02646891|529981894|FG005|Overall Study|Lost to Follow-up|0|||
146952175|NCT02646891|529981895|FG006|Overall Study|Lost to Follow-up|2|||
146824163|NCT00957996|529526577|FG000|Overall Study|Physician Decision|1|||
146824164|NCT00957996|529526578|FG001|Overall Study|Physician Decision|1|||
146824165|NCT00957996|529526577|FG000|Overall Study|Influenza-related complication|0|||
146824166|NCT00957996|529526578|FG001|Overall Study|Influenza-related complication|1|||
146824167|NCT00957996|529526577|FG000|Overall Study|Missing|1|||
146824168|NCT00957996|529526578|FG001|Overall Study|Missing|0|||
146824169|NCT00957996|529526577|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
146824170|NCT00957996|529526578|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
146824171|NCT01960348|529526583|FG000|Overall Study|Adverse event, not serious|2|||
146824172|NCT01960348|529526584|FG001|Overall Study|Adverse event, not serious|2|||
146824173|NCT01960348|529526583|FG000|Overall Study|Adverse event, serious fatal|6|||
146824174|NCT01960348|529526584|FG001|Overall Study|Adverse event, serious fatal|5|||
146824175|NCT01960348|529526583|FG000|Overall Study|Adverse event, serious non-fatal|0|||
146824176|NCT01960348|529526584|FG001|Overall Study|Adverse event, serious non-fatal|3|||
146824177|NCT01960348|529526583|FG000|Overall Study|Withdrawal by Subject|1|||
146824178|NCT01960348|529526584|FG001|Overall Study|Withdrawal by Subject|11|||
146824179|NCT01960348|529526583|FG000|Overall Study|Physician Decision|0|||
146824180|NCT01960348|529526584|FG001|Overall Study|Physician Decision|1|||
146824181|NCT01960348|529526583|FG000|Overall Study|Protocol Violation|1|||
146824182|NCT01960348|529526584|FG001|Overall Study|Protocol Violation|0|||
146824183|NCT01580995|529526585|FG000|Overall Study|Lost to Follow-up|2|||
146824184|NCT01580995|529526586|FG001|Overall Study|Lost to Follow-up|2|||
146824185|NCT02916706|529526587|FG000|Overall Study|Adverse Event|0|||
146824186|NCT02916706|529526588|FG001|Overall Study|Adverse Event|1|||
146824187|NCT02916706|529526587|FG000|Overall Study|Lost to Follow-up|0|||
146824188|NCT02916706|529526588|FG001|Overall Study|Lost to Follow-up|1|||
146824189|NCT02916706|529526587|FG000|Overall Study|Physician Decision|1|||
146824190|NCT02916706|529526588|FG001|Overall Study|Physician Decision|0|||
146824191|NCT02916706|529526587|FG000|Overall Study|Protocol Violation|3|||
146824192|NCT02916706|529526588|FG001|Overall Study|Protocol Violation|1|||
146824193|NCT02916706|529526587|FG000|Overall Study|Withdrawal by Subject|6|||
146824194|NCT02916706|529526588|FG001|Overall Study|Withdrawal by Subject|9|||
146824195|NCT02916706|529526587|FG000|Overall Study|Other|5|||
146824196|NCT02916706|529526588|FG001|Overall Study|Other|19|||
146824197|NCT01902381|529526591|FG000|Overall Study|Withdrawal by Subject|1|||
146824198|NCT04140266|529526592|FG000|Overall Study|Physician Decision|2|||
146824199|NCT04140266|529526593|FG001|Overall Study|Physician Decision|0|||
146824200|NCT04140266|529526592|FG000|Overall Study|Withdrawal by Subject|4|||
146824201|NCT04140266|529526593|FG001|Overall Study|Withdrawal by Subject|2|||
146824202|NCT03511378|529526596|FG000|Overall Study|Withdrawal by Subject|2|||
146824203|NCT03511378|529526597|FG001|Overall Study|Withdrawal by Subject|2|||
146824204|NCT03511378|529526596|FG000|Overall Study|Patient not coming or schedule visit|1|||
146824205|NCT03511378|529526597|FG001|Overall Study|Patient not coming or schedule visit|0|||
146824206|NCT02762500|529526598|FG000|Overall Study|Lack of Efficacy|1|||
146824207|NCT02762500|529526599|FG001|Overall Study|Lack of Efficacy|0|||
146824208|NCT02762500|529526598|FG000|Overall Study|Withdrawal by Subject|1|||
146824209|NCT02762500|529526599|FG001|Overall Study|Withdrawal by Subject|1|||
146824210|NCT02762500|529526598|FG000|Overall Study|Adverse Event|0|||
146824211|NCT02762500|529526599|FG001|Overall Study|Adverse Event|2|||
146824212|NCT00730847|529526601|FG000|Overall Study|Adverse Event|1|||
146824213|NCT00730847|529526601|FG000|Overall Study|Protocol Violation|2|||
146824214|NCT00730847|529526601|FG000|Overall Study|Withdrawal by Subject|16|||
146824215|NCT00730847|529526601|FG000|Overall Study|Lost to Follow-up|67|||
146824216|NCT00730847|529526601|FG000|Overall Study|Unknown completion status|21|||
146824217|NCT00730847|529526601|FG000|Overall Study|Other|24|||
146824218|NCT00280683|529526602|FG000|Overall Study|Withdrawal by Subject|1|||
146824219|NCT00280683|529526603|FG001|Overall Study|Withdrawal by Subject|2|||
146824220|NCT00280683|529526602|FG000|Overall Study|Adverse Event|1|||
146824221|NCT00280683|529526603|FG001|Overall Study|Adverse Event|1|||
146824222|NCT00329550|529526607|FG000|Overall Study|Adverse Event|3|||
146824223|NCT00329550|529526608|FG001|Overall Study|Adverse Event|4|||
146824224|NCT00329550|529526609|FG002|Overall Study|Adverse Event|2|||
146952176|NCT02646891|529981896|FG007|Overall Study|Lost to Follow-up|2|||
146952177|NCT02646891|529981897|FG008|Overall Study|Lost to Follow-up|2|||
146952178|NCT02646891|529981898|FG009|Overall Study|Lost to Follow-up|2|||
146952179|NCT02646891|529981889|FG000|Overall Study|Protocol Violation|0|||
146824225|NCT00329550|529526607|FG000|Overall Study|Withdrawal of Consent|1|||
146824226|NCT00329550|529526608|FG001|Overall Study|Withdrawal of Consent|0|||
146824227|NCT00329550|529526609|FG002|Overall Study|Withdrawal of Consent|1|||
146824228|NCT00329550|529526607|FG000|Overall Study|Due to Relocation|0|||
146824229|NCT00329550|529526608|FG001|Overall Study|Due to Relocation|0|||
146824230|NCT00329550|529526609|FG002|Overall Study|Due to Relocation|1|||
146824231|NCT00111839|529526613|FG000|Overall Study|Disease Progression|30|||
146824232|NCT00111839|529526614|FG001|Overall Study|Disease Progression|33|||
146824233|NCT00111839|529526615|FG002|Overall Study|Disease Progression|33|||
146952180|NCT02646891|529981890|FG001|Overall Study|Protocol Violation|0|||
146824234|NCT00111839|529526613|FG000|Overall Study|Adverse Event|5|||
146824235|NCT00111839|529526614|FG001|Overall Study|Adverse Event|3|||
146952181|NCT02646891|529981891|FG002|Overall Study|Protocol Violation|0|||
146952182|NCT02646891|529981892|FG003|Overall Study|Protocol Violation|0|||
146952183|NCT02646891|529981893|FG004|Overall Study|Protocol Violation|0|||
146952184|NCT02646891|529981894|FG005|Overall Study|Protocol Violation|0|||
146952185|NCT02646891|529981895|FG006|Overall Study|Protocol Violation|1|||
146952186|NCT02646891|529981896|FG007|Overall Study|Protocol Violation|1|||
146952187|NCT02646891|529981897|FG008|Overall Study|Protocol Violation|0|||
146952188|NCT02646891|529981898|FG009|Overall Study|Protocol Violation|0|||
146952189|NCT02646891|529981889|FG000|Overall Study|Withdrawal by Subject|2|||
146952190|NCT02646891|529981890|FG001|Overall Study|Withdrawal by Subject|0|||
146952191|NCT02646891|529981891|FG002|Overall Study|Withdrawal by Subject|1|||
146952192|NCT02646891|529981892|FG003|Overall Study|Withdrawal by Subject|0|||
146952193|NCT02646891|529981893|FG004|Overall Study|Withdrawal by Subject|0|||
146952194|NCT02646891|529981894|FG005|Overall Study|Withdrawal by Subject|0|||
146952195|NCT02646891|529981895|FG006|Overall Study|Withdrawal by Subject|5|||
146952196|NCT02646891|529981896|FG007|Overall Study|Withdrawal by Subject|9|||
146952197|NCT02646891|529981897|FG008|Overall Study|Withdrawal by Subject|7|||
146952198|NCT02646891|529981898|FG009|Overall Study|Withdrawal by Subject|3|||
146952199|NCT02646891|529981889|FG000|Overall Study|Death|0|||
146952200|NCT02646891|529981890|FG001|Overall Study|Death|0|||
146952201|NCT02646891|529981891|FG002|Overall Study|Death|0|||
146952202|NCT02646891|529981892|FG003|Overall Study|Death|0|||
146952203|NCT02646891|529981893|FG004|Overall Study|Death|0|||
146952204|NCT02646891|529981894|FG005|Overall Study|Death|0|||
146952205|NCT02646891|529981895|FG006|Overall Study|Death|1|||
146952206|NCT02646891|529981896|FG007|Overall Study|Death|1|||
146952207|NCT02646891|529981897|FG008|Overall Study|Death|1|||
146952208|NCT02646891|529981898|FG009|Overall Study|Death|0|||
146952209|NCT00103207|529981901|FG000|Overall Study|Adverse Event|3|||
146952210|NCT00103207|529981901|FG000|Overall Study|Death|1|||
146952211|NCT00103207|529981901|FG000|Overall Study|Withdrawal by Subject|2|||
146952212|NCT00103207|529981901|FG000|Overall Study|Other complicating disease|1|||
146952213|NCT00103207|529981901|FG000|Overall Study|Ineligible|4|||
146952214|NCT00103207|529981901|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
146952215|NCT03442595|529981902|FG000|Overall Study|Lost to Follow-up|94|||
146952216|NCT03442595|529981903|FG001|Overall Study|Lost to Follow-up|0|||
146952217|NCT00811395|529981904|FG000|Extension Treatment|Adverse Event|1|||
146952218|NCT00811395|529981905|FG001|Extension Treatment|Adverse Event|2|||
146952219|NCT00811395|529981906|FG002|Extension Treatment|Adverse Event|2|||
146952220|NCT00811395|529981907|FG003|Extension Treatment|Adverse Event|2|||
146952221|NCT00811395|529981908|FG004|Extension Treatment|Adverse Event|0|||
146952222|NCT00811395|529981909|FG005|Extension Treatment|Adverse Event|1|||
146952223|NCT00811395|529981904|FG000|Extension Treatment|Progressive disease|1|||
146952224|NCT00811395|529981905|FG001|Extension Treatment|Progressive disease|1|||
146952225|NCT00811395|529981906|FG002|Extension Treatment|Progressive disease|0|||
146952226|NCT00811395|529981907|FG003|Extension Treatment|Progressive disease|0|||
146952227|NCT00811395|529981908|FG004|Extension Treatment|Progressive disease|0|||
146952228|NCT00811395|529981909|FG005|Extension Treatment|Progressive disease|0|||
146952229|NCT00811395|529981904|FG000|Extension Treatment|Participant did not wish to continue|0|||
146952230|NCT00811395|529981905|FG001|Extension Treatment|Participant did not wish to continue|3|||
146952231|NCT00811395|529981906|FG002|Extension Treatment|Participant did not wish to continue|0|||
146952232|NCT00811395|529981907|FG003|Extension Treatment|Participant did not wish to continue|1|||
146952233|NCT00811395|529981908|FG004|Extension Treatment|Participant did not wish to continue|0|||
146952234|NCT00811395|529981909|FG005|Extension Treatment|Participant did not wish to continue|1|||
146952235|NCT00811395|529981904|FG000|Extension Treatment|Other than above|0|||
146952236|NCT00811395|529981905|FG001|Extension Treatment|Other than above|0|||
146952237|NCT00811395|529981906|FG002|Extension Treatment|Other than above|1|||
146952238|NCT00811395|529981907|FG003|Extension Treatment|Other than above|0|||
146952239|NCT00811395|529981908|FG004|Extension Treatment|Other than above|0|||
146952240|NCT00811395|529981909|FG005|Extension Treatment|Other than above|0|||
146952241|NCT01562327|529981912|FG000|Overall Study|Adverse Event|2|||
146952242|NCT01562327|529981912|FG000|Overall Study|Lack of Efficacy|1|||
146952243|NCT01562327|529981912|FG000|Overall Study|Participant drop-out|1|||
146952244|NCT01562327|529981912|FG000|Overall Study|Infusion not received at 6 month window|4|||
146952245|NCT01947127|529981913|FG000|Overall Study|Protocol Violation|18|||
146952246|NCT01947127|529981914|FG001|Overall Study|Protocol Violation|38|||
146952247|NCT01947127|529981913|FG000|Overall Study|Withdrawal by Subject|1|||
146952248|NCT01947127|529981914|FG001|Overall Study|Withdrawal by Subject|1|||
146952249|NCT01947127|529981913|FG000|Overall Study|Data loss|4|||
146952250|NCT01947127|529981914|FG001|Overall Study|Data loss|4|||
146952251|NCT00170846|529981915|FG000|Overall Study|Subject withdrew Informed Consent|5|||
146952252|NCT00170846|529981916|FG001|Overall Study|Subject withdrew Informed Consent|12|||
146952253|NCT00170846|529981917|FG002|Overall Study|Subject withdrew Informed Consent|8|||
146952254|NCT00170846|529981915|FG000|Overall Study|Lost to Follow-up|6|||
146952255|NCT00170846|529981916|FG001|Overall Study|Lost to Follow-up|3|||
146952256|NCT00170846|529981917|FG002|Overall Study|Lost to Follow-up|2|||
146952257|NCT00170846|529981915|FG000|Overall Study|Death|0|||
146952258|NCT00170846|529981916|FG001|Overall Study|Death|3|||
146824236|NCT00111839|529526615|FG002|Overall Study|Adverse Event|1|||
146824237|NCT00111839|529526613|FG000|Overall Study|Protocol Violation|2|||
146824238|NCT00111839|529526614|FG001|Overall Study|Protocol Violation|4|||
146824239|NCT00111839|529526615|FG002|Overall Study|Protocol Violation|2|||
146824240|NCT00111839|529526613|FG000|Overall Study|Death|1|||
146824241|NCT00111839|529526614|FG001|Overall Study|Death|1|||
146824242|NCT00111839|529526615|FG002|Overall Study|Death|6|||
146824243|NCT00111839|529526613|FG000|Overall Study|Withdrawal by Subject|2|||
146824244|NCT00111839|529526614|FG001|Overall Study|Withdrawal by Subject|2|||
146824245|NCT00111839|529526615|FG002|Overall Study|Withdrawal by Subject|2|||
146824246|NCT00111839|529526613|FG000|Overall Study|Lost to Follow-up|1|||
146824247|NCT00111839|529526614|FG001|Overall Study|Lost to Follow-up|0|||
146824248|NCT00111839|529526615|FG002|Overall Study|Lost to Follow-up|0|||
146824249|NCT00111839|529526613|FG000|Overall Study|Logistical Constraint|1|||
146824250|NCT00111839|529526614|FG001|Overall Study|Logistical Constraint|0|||
146824251|NCT00111839|529526615|FG002|Overall Study|Logistical Constraint|0|||
146824252|NCT00111839|529526613|FG000|Overall Study|Other|6|||
146824253|NCT00111839|529526614|FG001|Overall Study|Other|3|||
146824254|NCT00111839|529526615|FG002|Overall Study|Other|3|||
146824255|NCT00111839|529526613|FG000|Overall Study|Randomized but Not Treated|0|||
146824256|NCT00111839|529526614|FG001|Overall Study|Randomized but Not Treated|0|||
146824257|NCT00111839|529526615|FG002|Overall Study|Randomized but Not Treated|2|||
146824258|NCT00588341|529526621|FG000|Overall Study|Withdrawal by Subject|3|||
146824259|NCT00588341|529526621|FG000|Overall Study|Not treated due to metastatic disease|1|||
146824260|NCT00588341|529526621|FG000|Overall Study|Patient ineligible|1|||
146824261|NCT03280108|529526622|FG000|Overall Study|Lost to Follow-up|2|||
146824262|NCT03280108|529526623|FG001|Overall Study|Lost to Follow-up|0|||
146824263|NCT01187407|529526624|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
146824264|NCT01187407|529526625|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146824265|NCT01187407|529526626|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146824266|NCT01187407|529526627|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146824267|NCT01187407|529526628|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146824268|NCT01187407|529526624|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
146824269|NCT01187407|529526625|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146824270|NCT01187407|529526626|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146824271|NCT01187407|529526627|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146824272|NCT01187407|529526628|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146824273|NCT01187407|529526624|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
146824274|NCT01187407|529526625|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146824275|NCT01187407|529526626|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146824276|NCT01187407|529526627|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146824277|NCT01187407|529526628|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146824278|NCT01187407|529526624|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
146824279|NCT01187407|529526625|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146824280|NCT01187407|529526626|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146824281|NCT01187407|529526627|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146824282|NCT01187407|529526628|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146824283|NCT01187407|529526624|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
146824284|NCT01187407|529526625|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146824285|NCT01187407|529526626|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146824286|NCT01187407|529526627|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146824287|NCT01187407|529526628|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146824288|NCT01187407|529526624|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
146824289|NCT01187407|529526625|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146824290|NCT01187407|529526626|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146824291|NCT01187407|529526627|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146824292|NCT01187407|529526628|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146824293|NCT01187407|529526624|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
146824294|NCT01187407|529526625|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146824295|NCT01187407|529526626|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146824296|NCT01187407|529526627|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146824297|NCT01187407|529526628|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146824298|NCT01187407|529526624|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
146824299|NCT01187407|529526625|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
146824300|NCT01187407|529526626|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
146824301|NCT01187407|529526627|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
146824302|NCT01187407|529526628|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
146824303|NCT01187407|529526624|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
146824304|NCT01187407|529526625|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
146824305|NCT01187407|529526626|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
146824306|NCT01187407|529526627|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
146952259|NCT00170846|529981917|FG002|Overall Study|Death|3|||
146952260|NCT00170846|529981915|FG000|Overall Study|Reason Missing|0|||
146952261|NCT00170846|529981916|FG001|Overall Study|Reason Missing|1|||
146952262|NCT00170846|529981917|FG002|Overall Study|Reason Missing|0|||
146952263|NCT00528840|529981920|FG000|Overall Study|Lost to Follow-up|10|||
146952264|NCT00528840|529981920|FG000|Overall Study|Adverse Event|1|||
146952265|NCT00528840|529981920|FG000|Overall Study|Withdrawal by Subject|17|||
146952266|NCT00528840|529981920|FG000|Overall Study|Death|2|||
146952267|NCT00528840|529981920|FG000|Overall Study|Administrative Reasons|1|||
146952268|NCT00528840|529981920|FG000|Overall Study|Other|2|||
146952269|NCT02447952|529981921|FG000|Overall Study|Adverse Event|2|||
146952270|NCT02447952|529981921|FG000|Overall Study|Physician Decision|1|||
146952271|NCT02447952|529981921|FG000|Overall Study|Withdrawal by Subject|4|||
146952272|NCT01756833|529981927|FG000|Overall Study|Withdrawal by Subject|4|||
146952273|NCT01756833|529981928|FG001|Overall Study|Withdrawal by Subject|3|||
146952274|NCT00808132|529981932|FG000|Overall Study|Adverse Event|34|||
146952275|NCT00808132|529981933|FG001|Overall Study|Adverse Event|33|||
146952276|NCT00808132|529981934|FG002|Overall Study|Adverse Event|16|||
146952277|NCT00808132|529981935|FG003|Overall Study|Adverse Event|31|||
146952278|NCT00808132|529981936|FG004|Overall Study|Adverse Event|33|||
146952279|NCT00808132|529981932|FG000|Overall Study|Death|0|||
146952280|NCT00808132|529981933|FG001|Overall Study|Death|0|||
146952281|NCT00808132|529981934|FG002|Overall Study|Death|0|||
146952282|NCT00808132|529981935|FG003|Overall Study|Death|0|||
146952283|NCT00808132|529981936|FG004|Overall Study|Death|1|||
146952284|NCT00808132|529981932|FG000|Overall Study|Physician Decision|0|||
146952285|NCT00808132|529981933|FG001|Overall Study|Physician Decision|1|||
146952286|NCT00808132|529981934|FG002|Overall Study|Physician Decision|0|||
146952287|NCT00808132|529981935|FG003|Overall Study|Physician Decision|0|||
146952288|NCT00808132|529981936|FG004|Overall Study|Physician Decision|0|||
146952289|NCT00808132|529981932|FG000|Overall Study|Lost to Follow-up|8|||
146952290|NCT00808132|529981933|FG001|Overall Study|Lost to Follow-up|10|||
146952291|NCT00808132|529981934|FG002|Overall Study|Lost to Follow-up|11|||
146952292|NCT00808132|529981935|FG003|Overall Study|Lost to Follow-up|8|||
146952293|NCT00808132|529981936|FG004|Overall Study|Lost to Follow-up|9|||
146952294|NCT00808132|529981932|FG000|Overall Study|Protocol Violation|8|||
146952295|NCT00808132|529981933|FG001|Overall Study|Protocol Violation|9|||
146952296|NCT00808132|529981934|FG002|Overall Study|Protocol Violation|4|||
146952297|NCT00808132|529981935|FG003|Overall Study|Protocol Violation|9|||
146952298|NCT00808132|529981936|FG004|Overall Study|Protocol Violation|5|||
146952299|NCT00808132|529981932|FG000|Overall Study|Withdrawal by Subject|27|||
146952300|NCT00808132|529981933|FG001|Overall Study|Withdrawal by Subject|18|||
146952301|NCT00808132|529981934|FG002|Overall Study|Withdrawal by Subject|2|||
146824307|NCT01187407|529526628|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
146824308|NCT01187407|529526624|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
146824309|NCT01187407|529526625|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
146824310|NCT01187407|529526626|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
146824311|NCT01187407|529526627|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
146824312|NCT01187407|529526628|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
146824313|NCT01187407|529526624|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
146824314|NCT01187407|529526625|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
146824315|NCT01187407|529526626|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
146824316|NCT01187407|529526627|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
146824317|NCT01187407|529526628|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
146824318|NCT01187407|529526624|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
146824319|NCT01187407|529526625|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
146824320|NCT01187407|529526626|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
146824321|NCT01187407|529526627|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
146824322|NCT01187407|529526628|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
146824323|NCT01187407|529526624|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
146824324|NCT01187407|529526625|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
146824325|NCT01187407|529526626|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
146824326|NCT01187407|529526627|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
146952302|NCT00808132|529981935|FG003|Overall Study|Withdrawal by Subject|7|||
146952303|NCT00808132|529981936|FG004|Overall Study|Withdrawal by Subject|16|||
146952304|NCT00808132|529981932|FG000|Overall Study|Other|6|||
146952305|NCT00808132|529981933|FG001|Overall Study|Other|4|||
146952306|NCT00808132|529981934|FG002|Overall Study|Other|6|||
146952307|NCT00808132|529981935|FG003|Overall Study|Other|2|||
146952308|NCT00808132|529981936|FG004|Overall Study|Other|15|||
146952309|NCT00808132|529981932|FG000|Overall Study|Randomized, but not treated|10|||
146952310|NCT00808132|529981933|FG001|Overall Study|Randomized, but not treated|7|||
146952311|NCT00808132|529981934|FG002|Overall Study|Randomized, but not treated|9|||
146952312|NCT00808132|529981935|FG003|Overall Study|Randomized, but not treated|8|||
146952313|NCT00808132|529981936|FG004|Overall Study|Randomized, but not treated|9|||
146952314|NCT00808132|529981932|FG000|Overall Study|Unsatisfactory response|5|||
146952315|NCT00808132|529981933|FG001|Overall Study|Unsatisfactory response|6|||
146952316|NCT00808132|529981934|FG002|Overall Study|Unsatisfactory response|6|||
146952317|NCT00808132|529981935|FG003|Overall Study|Unsatisfactory response|4|||
146952318|NCT00808132|529981936|FG004|Overall Study|Unsatisfactory response|12|||
146952319|NCT02795182|529981937|FG000|Overall Study|Death|5|||
146952320|NCT02795182|529981938|FG001|Overall Study|Death|4|||
146952321|NCT02795182|529981939|FG002|Overall Study|Death|4|||
146952322|NCT02795182|529981940|FG003|Overall Study|Death|18|||
146952323|NCT02795182|529981937|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
146952324|NCT02795182|529981938|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
146952325|NCT02795182|529981939|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
146952326|NCT02795182|529981940|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
146952327|NCT02795182|529981937|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
146952328|NCT02795182|529981938|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
146952329|NCT02795182|529981939|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
146952330|NCT02795182|529981940|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
146952331|NCT02795182|529981937|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
146952332|NCT02795182|529981938|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
146952333|NCT02795182|529981939|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
146952334|NCT02795182|529981940|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
146952335|NCT02795182|529981937|FG000|Overall Study|Withdrawal by Subject|4|||
146952336|NCT02795182|529981938|FG001|Overall Study|Withdrawal by Subject|0|||
146952337|NCT02795182|529981939|FG002|Overall Study|Withdrawal by Subject|0|||
146952338|NCT02795182|529981940|FG003|Overall Study|Withdrawal by Subject|3|||
146952339|NCT02795182|529981937|FG000|Overall Study|Lost to Follow-up|0|||
146952340|NCT02795182|529981938|FG001|Overall Study|Lost to Follow-up|0|||
146952341|NCT02795182|529981939|FG002|Overall Study|Lost to Follow-up|1|||
146952342|NCT02795182|529981940|FG003|Overall Study|Lost to Follow-up|1|||
146952343|NCT02795182|529981937|FG000|Overall Study|Roll Over to Long Term Extension|3|||
146952344|NCT02795182|529981938|FG001|Overall Study|Roll Over to Long Term Extension|3|||
146952345|NCT02795182|529981939|FG002|Overall Study|Roll Over to Long Term Extension|2|||
146952346|NCT02795182|529981940|FG003|Overall Study|Roll Over to Long Term Extension|5|||
146952347|NCT02795182|529981937|FG000|Overall Study|Progressive Disease|0|||
146952348|NCT02795182|529981938|FG001|Overall Study|Progressive Disease|1|||
146952349|NCT02795182|529981939|FG002|Overall Study|Progressive Disease|0|||
146952350|NCT02795182|529981940|FG003|Overall Study|Progressive Disease|4|||
146952351|NCT02795182|529981937|FG000|Overall Study|Physician Decision|0|||
146952352|NCT02795182|529981938|FG001|Overall Study|Physician Decision|0|||
146952353|NCT02795182|529981939|FG002|Overall Study|Physician Decision|0|||
146952354|NCT02795182|529981940|FG003|Overall Study|Physician Decision|1|||
146952355|NCT00398086|529981943|FG000|Overall Study|Unacceptable Toxicity|2|||
146952356|NCT00398086|529981944|FG001|Overall Study|Unacceptable Toxicity|8|||
146952357|NCT00398086|529981945|FG002|Overall Study|Unacceptable Toxicity|2|||
146824327|NCT01187407|529526628|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
146824328|NCT01187407|529526624|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
146824329|NCT01187407|529526625|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
146824330|NCT01187407|529526626|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
146824331|NCT01187407|529526627|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
146824332|NCT01187407|529526628|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
146824333|NCT01713998|529526629|FG000|Overall Study|Lost to Follow-up|2|||
146824334|NCT01713998|529526630|FG001|Overall Study|Lost to Follow-up|0|||
146824335|NCT01713998|529526631|FG002|Overall Study|Lost to Follow-up|2|||
146824336|NCT01713998|529526629|FG000|Overall Study|Withdrawal by Subject|1|||
146824337|NCT01713998|529526630|FG001|Overall Study|Withdrawal by Subject|0|||
146824338|NCT01713998|529526631|FG002|Overall Study|Withdrawal by Subject|0|||
146952358|NCT00398086|529981943|FG000|Overall Study|Adverse Event|1|||
146952359|NCT00398086|529981944|FG001|Overall Study|Adverse Event|4|||
146952360|NCT00398086|529981945|FG002|Overall Study|Adverse Event|0|||
146952361|NCT00398086|529981943|FG000|Overall Study|Physician Decision|1|||
146952362|NCT00398086|529981944|FG001|Overall Study|Physician Decision|4|||
146952363|NCT00398086|529981945|FG002|Overall Study|Physician Decision|0|||
146824339|NCT03638258|529526632|FG000|Overall Study|Adverse Event|1|||
146952364|NCT00398086|529981943|FG000|Overall Study|Withdrawal by Subject|5|||
146952365|NCT00398086|529981944|FG001|Overall Study|Withdrawal by Subject|7|||
146952366|NCT00398086|529981945|FG002|Overall Study|Withdrawal by Subject|0|||
146952367|NCT00696774|529981946|FG000|Period II|Adverse Event|0|||
146952368|NCT00696774|529981947|FG001|Period II|Adverse Event|0|||
146952369|NCT00696774|529981948|FG002|Period II|Adverse Event|15|||
146952370|NCT00696774|529981946|FG000|Period II|Lost to Follow-up|0|||
146952371|NCT00696774|529981947|FG001|Period II|Lost to Follow-up|0|||
146824340|NCT03638258|529526633|FG001|Overall Study|Adverse Event|0|||
146824341|NCT03638258|529526634|FG002|Overall Study|Adverse Event|2|||
146824342|NCT03638258|529526632|FG000|Overall Study|Lost to Follow-up|2|||
146824343|NCT03638258|529526633|FG001|Overall Study|Lost to Follow-up|4|||
146824344|NCT03638258|529526634|FG002|Overall Study|Lost to Follow-up|5|||
146824345|NCT03638258|529526632|FG000|Overall Study|Pregnancy|0|||
146824346|NCT03638258|529526633|FG001|Overall Study|Pregnancy|0|||
146824347|NCT03638258|529526634|FG002|Overall Study|Pregnancy|1|||
146824348|NCT03638258|529526632|FG000|Overall Study|Protocol Violation|0|||
146824349|NCT03638258|529526633|FG001|Overall Study|Protocol Violation|0|||
146824350|NCT03638258|529526634|FG002|Overall Study|Protocol Violation|1|||
146824351|NCT03638258|529526632|FG000|Overall Study|Withdrawal by Subject|4|||
146824352|NCT03638258|529526633|FG001|Overall Study|Withdrawal by Subject|5|||
146824353|NCT03638258|529526634|FG002|Overall Study|Withdrawal by Subject|12|||
146824354|NCT03638258|529526632|FG000|Overall Study|Lack of Efficacy|0|||
146824355|NCT03638258|529526633|FG001|Overall Study|Lack of Efficacy|0|||
146824356|NCT03638258|529526634|FG002|Overall Study|Lack of Efficacy|2|||
146824357|NCT01287416|529526635|FG000|Pre-post Training|Withdrawal by Subject|17|||
146824358|NCT01287416|529526636|FG001|Pre-post Training|Withdrawal by Subject|24|||
146824359|NCT01287416|529526635|FG000|Pre-post Training|Lost to Follow-up|5|||
146824360|NCT01287416|529526636|FG001|Pre-post Training|Lost to Follow-up|1|||
146824361|NCT01287416|529526635|FG000|6 Month Follow-up|Lost to Follow-up|3|||
146824362|NCT01287416|529526636|FG001|6 Month Follow-up|Lost to Follow-up|2|||
146824363|NCT00607789|529526638|FG000|Overall Study|Adverse Event|3|||
146824364|NCT00607789|529526639|FG001|Overall Study|Adverse Event|0|||
146824365|NCT00607789|529526638|FG000|Overall Study|Lack of Efficacy|0|||
146824366|NCT00607789|529526639|FG001|Overall Study|Lack of Efficacy|1|||
146824367|NCT00607789|529526638|FG000|Overall Study|Inadequate adherence|3|||
146824368|NCT00607789|529526639|FG001|Overall Study|Inadequate adherence|0|||
146824369|NCT00607789|529526638|FG000|Overall Study|Lost to Follow-up|0|||
146824370|NCT00607789|529526639|FG001|Overall Study|Lost to Follow-up|5|||
146824371|NCT00607789|529526638|FG000|Overall Study|Withdrawal by Subject|1|||
146824372|NCT00607789|529526639|FG001|Overall Study|Withdrawal by Subject|0|||
146824373|NCT01313299|529526640|FG000|Overall Study|Adverse Event|3|||
146824374|NCT01313299|529526641|FG001|Overall Study|Adverse Event|1|||
146824375|NCT01313299|529526642|FG002|Overall Study|Adverse Event|1|||
146824376|NCT01313299|529526640|FG000|Overall Study|Lost to Follow-up|1|||
146824377|NCT01313299|529526641|FG001|Overall Study|Lost to Follow-up|0|||
146824378|NCT01313299|529526642|FG002|Overall Study|Lost to Follow-up|0|||
146824379|NCT01313299|529526640|FG000|Overall Study|Protocol Violation|2|||
146824380|NCT01313299|529526641|FG001|Overall Study|Protocol Violation|0|||
146824381|NCT01313299|529526642|FG002|Overall Study|Protocol Violation|0|||
146824382|NCT01313299|529526640|FG000|Overall Study|Withdrawal by Subject|1|||
146824383|NCT01313299|529526641|FG001|Overall Study|Withdrawal by Subject|0|||
146824384|NCT01313299|529526642|FG002|Overall Study|Withdrawal by Subject|2|||
146824385|NCT01313299|529526640|FG000|Overall Study|Family reason and moved out of state|0|||
146824386|NCT01313299|529526641|FG001|Overall Study|Family reason and moved out of state|2|||
146824387|NCT01313299|529526642|FG002|Overall Study|Family reason and moved out of state|0|||
146824388|NCT01313299|529526640|FG000|Overall Study|Lack of subject compliance|0|||
146824389|NCT01313299|529526641|FG001|Overall Study|Lack of subject compliance|0|||
146824390|NCT01313299|529526642|FG002|Overall Study|Lack of subject compliance|1|||
146824391|NCT01919398|529526643|FG000|Overall Study|Progressive Disease|0|||
146824392|NCT01919398|529526644|FG001|Overall Study|Progressive Disease|0|||
146824393|NCT01919398|529526645|FG002|Overall Study|Progressive Disease|4|||
146824394|NCT00580047|529526655|FG000|Overall Study|Lost to Follow-up|1|||
146824395|NCT00580047|529526656|FG001|Overall Study|Lost to Follow-up|1|||
146824396|NCT00580047|529526657|FG002|Overall Study|Lost to Follow-up|0|||
146824397|NCT00580047|529526655|FG000|Overall Study|Withdrawal by Subject|1|||
146824398|NCT00580047|529526656|FG001|Overall Study|Withdrawal by Subject|1|||
146824399|NCT00580047|529526657|FG002|Overall Study|Withdrawal by Subject|2|||
146824400|NCT00580047|529526655|FG000|Overall Study|Withdrawal by Subject|1|||
146824401|NCT00580047|529526656|FG001|Overall Study|Withdrawal by Subject|0|||
146824402|NCT00580047|529526657|FG002|Overall Study|Withdrawal by Subject|0|||
146824403|NCT01064856|529526660|FG000|Double-blind (DB) Period|Adverse Event|1|||
146824404|NCT01064856|529526661|FG001|Double-blind (DB) Period|Adverse Event|0|||
146824405|NCT01064856|529526662|FG002|Double-blind (DB) Period|Adverse Event|0|||
146824406|NCT01064856|529526663|FG003|Double-blind (DB) Period|Adverse Event|0|||
146824407|NCT01064856|529526660|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
146824408|NCT01064856|529526661|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
146824409|NCT01064856|529526662|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
146824410|NCT01064856|529526663|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
146824411|NCT01064856|529526660|FG000|Open-label (OL) Period|Adverse Event|0|||
146824412|NCT01064856|529526661|FG001|Open-label (OL) Period|Adverse Event|0|||
146824413|NCT01064856|529526662|FG002|Open-label (OL) Period|Adverse Event|12|||
146824414|NCT01064856|529526663|FG003|Open-label (OL) Period|Adverse Event|6|||
146824415|NCT01064856|529526660|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
146824416|NCT01064856|529526661|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
146952372|NCT00696774|529981948|FG002|Period II|Lost to Follow-up|4|||
146952373|NCT00696774|529981946|FG000|Period II|Protocol Violation|0|||
146952374|NCT00696774|529981947|FG001|Period II|Protocol Violation|0|||
146952375|NCT00696774|529981948|FG002|Period II|Protocol Violation|11|||
146952376|NCT00696774|529981946|FG000|Period II|Withdrawal by Subject|0|||
146952377|NCT00696774|529981947|FG001|Period II|Withdrawal by Subject|0|||
146952378|NCT00696774|529981948|FG002|Period II|Withdrawal by Subject|4|||
146952379|NCT00696774|529981946|FG000|Period II|Sponsor Decision|0|||
146952380|NCT00696774|529981947|FG001|Period II|Sponsor Decision|0|||
146952381|NCT00696774|529981948|FG002|Period II|Sponsor Decision|0|||
146952382|NCT00696774|529981946|FG000|Period II|Lack of Efficacy|0|||
146952383|NCT00696774|529981947|FG001|Period II|Lack of Efficacy|0|||
146952384|NCT00696774|529981948|FG002|Period II|Lack of Efficacy|2|||
146952385|NCT00696774|529981946|FG000|Period III|Adverse Event|1|||
146952386|NCT00696774|529981947|FG001|Period III|Adverse Event|1|||
146952387|NCT00696774|529981948|FG002|Period III|Adverse Event|0|||
146952388|NCT00696774|529981946|FG000|Period III|Lost to Follow-up|2|||
146952389|NCT00696774|529981947|FG001|Period III|Lost to Follow-up|1|||
146952390|NCT00696774|529981948|FG002|Period III|Lost to Follow-up|0|||
146952391|NCT00696774|529981946|FG000|Period III|Protocol Violation|1|||
146952392|NCT00696774|529981947|FG001|Period III|Protocol Violation|1|||
146952393|NCT00696774|529981948|FG002|Period III|Protocol Violation|0|||
146952394|NCT00696774|529981946|FG000|Period III|Withdrawal by Subject|1|||
146952395|NCT00696774|529981947|FG001|Period III|Withdrawal by Subject|2|||
146952396|NCT00696774|529981948|FG002|Period III|Withdrawal by Subject|0|||
146952397|NCT00696774|529981946|FG000|Period III|Sponsor Decision|2|||
146952398|NCT00696774|529981947|FG001|Period III|Sponsor Decision|0|||
146952399|NCT00696774|529981948|FG002|Period III|Sponsor Decision|0|||
146952400|NCT00696774|529981946|FG000|Period III|Lack of Efficacy|0|||
146952401|NCT00696774|529981947|FG001|Period III|Lack of Efficacy|2|||
146952402|NCT00696774|529981948|FG002|Period III|Lack of Efficacy|0|||
146952403|NCT00890201|529981949|FG000|Overall Study|Protocol Violation|5|||
146952404|NCT00890201|529981950|FG001|Overall Study|Protocol Violation|56|||
146952405|NCT00033293|529981951|FG000|Overall Study|Death|0|||
146952406|NCT00033293|529981952|FG001|Overall Study|Death|1|||
146952407|NCT00033293|529981951|FG000|Overall Study|Lack of Efficacy|5|||
146952408|NCT00033293|529981952|FG001|Overall Study|Lack of Efficacy|8|||
146952409|NCT00033293|529981951|FG000|Overall Study|Lost to Follow-up|0|||
146952410|NCT00033293|529981952|FG001|Overall Study|Lost to Follow-up|1|||
146952411|NCT00033293|529981951|FG000|Overall Study|Physician Decision|3|||
146952412|NCT00033293|529981952|FG001|Overall Study|Physician Decision|1|||
146952413|NCT00033293|529981951|FG000|Overall Study|Withdrawal by Subject|1|||
146952414|NCT00033293|529981952|FG001|Overall Study|Withdrawal by Subject|0|||
146952415|NCT00033293|529981951|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
146952416|NCT00033293|529981952|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
146952417|NCT00033293|529981951|FG000|Overall Study|Treatment refused|0|||
146952418|NCT00033293|529981952|FG001|Overall Study|Treatment refused|6|||
146952419|NCT02087241|529981953|FG000|Overall Study|Death|2|||
146952420|NCT02087241|529981954|FG001|Overall Study|Death|1|||
146952421|NCT02087241|529981955|FG002|Overall Study|Death|1|||
146952422|NCT02087241|529981956|FG003|Overall Study|Death|1|||
146952423|NCT02087241|529981953|FG000|Overall Study|Withdrawal by Subject|1|||
146952424|NCT02087241|529981954|FG001|Overall Study|Withdrawal by Subject|0|||
146952425|NCT02087241|529981955|FG002|Overall Study|Withdrawal by Subject|0|||
146952426|NCT02087241|529981956|FG003|Overall Study|Withdrawal by Subject|1|||
146952427|NCT02087241|529981953|FG000|Overall Study|Progressive Disease|0|||
146952428|NCT02087241|529981954|FG001|Overall Study|Progressive Disease|0|||
146952429|NCT02087241|529981955|FG002|Overall Study|Progressive Disease|0|||
146952430|NCT02087241|529981956|FG003|Overall Study|Progressive Disease|1|||
146952431|NCT02087241|529981953|FG000|Overall Study|Study Terminated by Sponsor|0|||
146952432|NCT02087241|529981954|FG001|Overall Study|Study Terminated by Sponsor|2|||
146952433|NCT02087241|529981955|FG002|Overall Study|Study Terminated by Sponsor|0|||
146952434|NCT02087241|529981956|FG003|Overall Study|Study Terminated by Sponsor|4|||
146952435|NCT02181504|529981957|FG000|Overall Study|Adverse Event|1|||
146952436|NCT02181504|529981958|FG001|Overall Study|Adverse Event|1|||
146952437|NCT02181504|529981959|FG002|Overall Study|Adverse Event|1|||
146952438|NCT00887913|529981960|FG000|Overall Study|Withdrawal by Subject|6|||
146952439|NCT00598585|529981963|FG000|Overall Study|Lost to Follow-up|1|||
146952440|NCT00598585|529981964|FG001|Overall Study|Lost to Follow-up|0|||
146952441|NCT01200758|529981965|FG000|Stage I|Death|0|||
146952442|NCT01200758|529981966|FG001|Stage I|Death|1|||
146952443|NCT01200758|529981967|FG002|Stage I|Death|0|||
146952444|NCT01200758|529981968|FG003|Stage I|Death|0|||
146952445|NCT01200758|529981965|FG000|Stage I|Physician Decision|1|||
146952446|NCT01200758|529981966|FG001|Stage I|Physician Decision|1|||
146952447|NCT01200758|529981967|FG002|Stage I|Physician Decision|0|||
146952448|NCT01200758|529981968|FG003|Stage I|Physician Decision|0|||
146952449|NCT01200758|529981965|FG000|Stage I|Lack of Efficacy|2|||
146952450|NCT01200758|529981966|FG001|Stage I|Lack of Efficacy|1|||
146952451|NCT01200758|529981967|FG002|Stage I|Lack of Efficacy|0|||
146952452|NCT01200758|529981968|FG003|Stage I|Lack of Efficacy|0|||
146952453|NCT01200758|529981965|FG000|Stage I|Adverse Event|5|||
146952454|NCT01200758|529981966|FG001|Stage I|Adverse Event|5|||
146952455|NCT01200758|529981967|FG002|Stage I|Adverse Event|0|||
146952456|NCT01200758|529981968|FG003|Stage I|Adverse Event|0|||
146952457|NCT01200758|529981965|FG000|Stage I|Withdrawal by Subject|1|||
146952458|NCT01200758|529981966|FG001|Stage I|Withdrawal by Subject|2|||
146952459|NCT01200758|529981967|FG002|Stage I|Withdrawal by Subject|0|||
146952460|NCT01200758|529981968|FG003|Stage I|Withdrawal by Subject|0|||
146952461|NCT01200758|529981965|FG000|Stage I|Disease Progression|9|||
146952462|NCT01200758|529981966|FG001|Stage I|Disease Progression|7|||
146952463|NCT01200758|529981967|FG002|Stage I|Disease Progression|0|||
146952464|NCT01200758|529981968|FG003|Stage I|Disease Progression|0|||
146952465|NCT01200758|529981965|FG000|Stage 2|Disease Progression|0|||
146952466|NCT01200758|529981966|FG001|Stage 2|Disease Progression|0|||
146952467|NCT01200758|529981967|FG002|Stage 2|Disease Progression|16|||
146952468|NCT01200758|529981968|FG003|Stage 2|Disease Progression|21|||
146952469|NCT01200758|529981965|FG000|Stage 2|Lack of Efficacy|0|||
146952470|NCT01200758|529981966|FG001|Stage 2|Lack of Efficacy|0|||
146952471|NCT01200758|529981967|FG002|Stage 2|Lack of Efficacy|4|||
146952472|NCT01200758|529981968|FG003|Stage 2|Lack of Efficacy|2|||
146952473|NCT01200758|529981965|FG000|Stage 2|Physician Decision|0|||
146952474|NCT01200758|529981966|FG001|Stage 2|Physician Decision|0|||
146952475|NCT01200758|529981967|FG002|Stage 2|Physician Decision|5|||
146952476|NCT01200758|529981968|FG003|Stage 2|Physician Decision|7|||
146952477|NCT01200758|529981965|FG000|Stage 2|Adverse Event|0|||
146952478|NCT01200758|529981966|FG001|Stage 2|Adverse Event|0|||
146952479|NCT01200758|529981967|FG002|Stage 2|Adverse Event|5|||
146952480|NCT01200758|529981968|FG003|Stage 2|Adverse Event|9|||
146952481|NCT01200758|529981965|FG000|Stage 2|Withdrawal by Subject|0|||
146952482|NCT01200758|529981966|FG001|Stage 2|Withdrawal by Subject|0|||
146952483|NCT01200758|529981967|FG002|Stage 2|Withdrawal by Subject|4|||
146952484|NCT01200758|529981968|FG003|Stage 2|Withdrawal by Subject|1|||
146952485|NCT01200758|529981965|FG000|Stage 2|Lost to Follow-up|0|||
146952486|NCT01200758|529981966|FG001|Stage 2|Lost to Follow-up|0|||
146952487|NCT01200758|529981967|FG002|Stage 2|Lost to Follow-up|3|||
146952488|NCT01200758|529981968|FG003|Stage 2|Lost to Follow-up|1|||
146952489|NCT01200758|529981965|FG000|Stage 2|Protocol Violation|0|||
146952490|NCT01200758|529981966|FG001|Stage 2|Protocol Violation|0|||
146952491|NCT01200758|529981967|FG002|Stage 2|Protocol Violation|1|||
146952492|NCT01200758|529981968|FG003|Stage 2|Protocol Violation|4|||
146952493|NCT01200758|529981965|FG000|Stage 2|Death|0|||
146952494|NCT01200758|529981966|FG001|Stage 2|Death|0|||
146952495|NCT01200758|529981967|FG002|Stage 2|Death|3|||
146952496|NCT01200758|529981968|FG003|Stage 2|Death|5|||
146952497|NCT00461552|529981971|FG000|Overall Study|Drug Dispensing error|0|||
146952498|NCT00461552|529981972|FG001|Overall Study|Drug Dispensing error|2|||
146952499|NCT01289028|529981973|FG000|Overall Study|Progressive Disease|49|||
146952500|NCT01289028|529981973|FG000|Overall Study|Adverse Event|14|||
146952501|NCT01289028|529981973|FG000|Overall Study|Withdrawal by Subject|6|||
146952502|NCT01289028|529981973|FG000|Overall Study|Death|4|||
146952503|NCT01289028|529981973|FG000|Overall Study|Lack of Efficacy|2|||
146952504|NCT01289028|529981973|FG000|Overall Study|No longer required|2|||
146952505|NCT01289028|529981973|FG000|Overall Study|Lost to Follow-up|2|||
146952506|NCT01289028|529981973|FG000|Overall Study|New Cancer Therapy|2|||
146952507|NCT01289028|529981973|FG000|Overall Study|Abnormal Lab Value|1|||
146952508|NCT01289028|529981973|FG000|Overall Study|Missing reason for discon|1|||
146952509|NCT03267576|529981984|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
146952510|NCT03267576|529981985|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
146952511|NCT03267576|529981984|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
146952512|NCT03267576|529981985|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
146952513|NCT01846208|529981986|FG000|Overall Study|Withdrew prior to treatment|1|||
146952514|NCT01846208|529981987|FG001|Overall Study|Withdrew prior to treatment|1|||
146952515|NCT01846208|529981988|FG002|Overall Study|Withdrew prior to treatment|1|||
146952516|NCT01846208|529981986|FG000|Overall Study|Dosing Symptoms|1|||
146952517|NCT01846208|529981987|FG001|Overall Study|Dosing Symptoms|2|||
146984980|NCT02710071|530107113|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
146952518|NCT01846208|529981988|FG002|Overall Study|Dosing Symptoms|6|||
146952519|NCT01846208|529981986|FG000|Overall Study|Withdrawal by Subject|5|||
146952520|NCT01846208|529981987|FG001|Overall Study|Withdrawal by Subject|0|||
146952521|NCT01846208|529981988|FG002|Overall Study|Withdrawal by Subject|0|||
146952522|NCT01846208|529981986|FG000|Overall Study|Non-compliance|1|||
146952523|NCT01846208|529981987|FG001|Overall Study|Non-compliance|1|||
146952524|NCT01846208|529981988|FG002|Overall Study|Non-compliance|0|||
146952525|NCT01846208|529981986|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
146952526|NCT01846208|529981987|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
146952527|NCT01846208|529981988|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
146952528|NCT01846208|529981986|FG000|Overall Study|Refused SU OFC|0|||
146952529|NCT01846208|529981987|FG001|Overall Study|Refused SU OFC|0|||
146952530|NCT01846208|529981988|FG002|Overall Study|Refused SU OFC|1|||
146952531|NCT01268514|529981989|FG000|Overall Study|Adverse Event|20|||
146952532|NCT01268514|529981989|FG000|Overall Study|Death|8|||
146952533|NCT01268514|529981989|FG000|Overall Study|Lost to Follow-up|5|||
146824417|NCT01064856|529526662|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
146824418|NCT01064856|529526663|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
146824419|NCT01064856|529526660|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
146824420|NCT01064856|529526661|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
146824421|NCT01064856|529526662|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
146824422|NCT01064856|529526663|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
146824423|NCT01064856|529526660|FG000|Open-label (OL) Period|Other|0|||
146824424|NCT01064856|529526661|FG001|Open-label (OL) Period|Other|0|||
146824425|NCT01064856|529526662|FG002|Open-label (OL) Period|Other|7|||
146824426|NCT01064856|529526663|FG003|Open-label (OL) Period|Other|7|||
146824427|NCT01780584|529526664|FG000|Overall Study|Death|1|||
146824428|NCT01780584|529526665|FG001|Overall Study|Death|0|||
146824429|NCT01780584|529526666|FG002|Overall Study|Death|1|||
146824430|NCT01780584|529526664|FG000|Overall Study|Adverse Event|0|||
146824431|NCT01780584|529526665|FG001|Overall Study|Adverse Event|1|||
146824432|NCT01780584|529526666|FG002|Overall Study|Adverse Event|0|||
146824433|NCT01780584|529526664|FG000|Overall Study|Protocol Violation|0|||
146824434|NCT01780584|529526665|FG001|Overall Study|Protocol Violation|0|||
146824435|NCT01780584|529526666|FG002|Overall Study|Protocol Violation|1|||
146824436|NCT04783519|529526667|FG000|Overall Study|Withdrawal by Subject|2|||
146824437|NCT04783519|529526668|FG001|Overall Study|Withdrawal by Subject|7|||
146824438|NCT04783519|529526669|FG002|Overall Study|Withdrawal by Subject|3|||
146824439|NCT04783519|529526667|FG000|Overall Study|Lost to Follow-up|9|||
146824440|NCT04783519|529526668|FG001|Overall Study|Lost to Follow-up|7|||
146824441|NCT04783519|529526669|FG002|Overall Study|Lost to Follow-up|6|||
146824442|NCT00645099|529526670|FG000|Overall Study|Lack of Efficacy|15|||
146824443|NCT00645099|529526671|FG001|Overall Study|Lack of Efficacy|6|||
146824444|NCT00645099|529526670|FG000|Overall Study|Withdrawal by Subject|30|||
146824445|NCT00645099|529526671|FG001|Overall Study|Withdrawal by Subject|22|||
146824446|NCT00645099|529526670|FG000|Overall Study|Lost to Follow-up|6|||
146824447|NCT00645099|529526671|FG001|Overall Study|Lost to Follow-up|4|||
146824448|NCT00645099|529526670|FG000|Overall Study|Adverse Event|11|||
146824449|NCT00645099|529526671|FG001|Overall Study|Adverse Event|5|||
146824450|NCT00645099|529526670|FG000|Overall Study|Other|9|||
146824451|NCT00645099|529526671|FG001|Overall Study|Other|5|||
146824452|NCT01201915|529526672|FG000|Overall Study|Adverse Event|2|||
146824453|NCT01201915|529526673|FG001|Overall Study|Adverse Event|1|||
146824454|NCT01201915|529526674|FG002|Overall Study|Adverse Event|1|||
146824455|NCT01201915|529526672|FG000|Overall Study|Lost to Follow-up|0|||
146824456|NCT01201915|529526673|FG001|Overall Study|Lost to Follow-up|4|||
146824457|NCT01201915|529526674|FG002|Overall Study|Lost to Follow-up|0|||
146824458|NCT01201915|529526672|FG000|Overall Study|Physician Decision|3|||
146824459|NCT01201915|529526673|FG001|Overall Study|Physician Decision|0|||
146824460|NCT01201915|529526674|FG002|Overall Study|Physician Decision|0|||
146824461|NCT01201915|529526672|FG000|Overall Study|Subject Decision|3|||
146824462|NCT01201915|529526673|FG001|Overall Study|Subject Decision|3|||
146824463|NCT01201915|529526674|FG002|Overall Study|Subject Decision|5|||
146824464|NCT01201915|529526672|FG000|Overall Study|Target Lesion Progression|0|||
146824465|NCT01201915|529526673|FG001|Overall Study|Target Lesion Progression|3|||
146824466|NCT01201915|529526674|FG002|Overall Study|Target Lesion Progression|0|||
146824467|NCT03406507|529526675|FG000|Extension Period|Lack of Efficacy|0|||
146824468|NCT03406507|529526676|FG001|Extension Period|Lack of Efficacy|1|||
146824469|NCT01821729|529528318|FG000|Overall Study|Withdrawal by Subject|1|||
146824470|NCT00381797|529528324|FG000|Overall Study|Withdrawal by Subject|1|||
146824471|NCT00381797|529528325|FG001|Overall Study|Withdrawal by Subject|1|||
146824472|NCT00381797|529528326|FG002|Overall Study|Withdrawal by Subject|0|||
146824473|NCT00381797|529528327|FG003|Overall Study|Withdrawal by Subject|0|||
146824474|NCT00381797|529528328|FG004|Overall Study|Withdrawal by Subject|2|||
146824475|NCT00381797|529528324|FG000|Overall Study|Ineligible|0|||
146824476|NCT00381797|529528325|FG001|Overall Study|Ineligible|0|||
146824477|NCT00381797|529528326|FG002|Overall Study|Ineligible|0|||
146824478|NCT00381797|529528327|FG003|Overall Study|Ineligible|1|||
146824479|NCT00381797|529528328|FG004|Overall Study|Ineligible|0|||
146824480|NCT00684203|529528329|FG000|Overall Study|Adverse Event|6|||
146824481|NCT00684203|529528330|FG001|Overall Study|Adverse Event|4|||
146824482|NCT00684203|529528331|FG002|Overall Study|Adverse Event|8|||
146824483|NCT00684203|529528332|FG003|Overall Study|Adverse Event|0|||
146824484|NCT00684203|529528333|FG004|Overall Study|Adverse Event|0|||
146824485|NCT00684203|529528334|FG005|Overall Study|Adverse Event|0|||
146952534|NCT01268514|529981989|FG000|Overall Study|Withdrawal by Subject|3|||
146824486|NCT00684203|529528329|FG000|Overall Study|Protocol-defined clinical event|3|||
146824487|NCT00684203|529528330|FG001|Overall Study|Protocol-defined clinical event|1|||
146824488|NCT00684203|529528331|FG002|Overall Study|Protocol-defined clinical event|0|||
146824489|NCT00684203|529528332|FG003|Overall Study|Protocol-defined clinical event|0|||
146824490|NCT00684203|529528333|FG004|Overall Study|Protocol-defined clinical event|0|||
146824491|NCT00684203|529528334|FG005|Overall Study|Protocol-defined clinical event|0|||
146824492|NCT00684203|529528329|FG000|Overall Study|Withdrawal by Subject|0|||
146824493|NCT00684203|529528330|FG001|Overall Study|Withdrawal by Subject|2|||
146824494|NCT00684203|529528331|FG002|Overall Study|Withdrawal by Subject|1|||
146952535|NCT01268514|529981989|FG000|Overall Study|Withdrawal by Surgeon|5|||
146952536|NCT01432938|529981990|FG000|First Intervention|Protocol Violation|1|||
146952537|NCT01432938|529981991|FG001|First Intervention|Protocol Violation|0|||
146952538|NCT01432938|529981990|FG000|First Intervention|Physician Decision|1|||
146952539|NCT01432938|529981991|FG001|First Intervention|Physician Decision|0|||
146952540|NCT01432938|529981990|FG000|Second Intervention|Adverse Event|1|||
146952541|NCT01432938|529981991|FG001|Second Intervention|Adverse Event|0|||
146952542|NCT01424306|529981992|FG000|Overall Study|Protocol Violation|0|||
146952543|NCT01424306|529981993|FG001|Overall Study|Protocol Violation|0|||
146952544|NCT01424306|529981994|FG002|Overall Study|Protocol Violation|0|||
146952545|NCT01424306|529981995|FG003|Overall Study|Protocol Violation|0|||
146952546|NCT01424306|529981996|FG004|Overall Study|Protocol Violation|1|||
146952547|NCT01424306|529981997|FG005|Overall Study|Protocol Violation|0|||
146952548|NCT01875874|529982001|FG000|Overall Study|Death|3|||
146952549|NCT03344562|529982004|FG000|Overall Study|Withdrawal by Subject|2|||
146952550|NCT03344562|529982005|FG001|Overall Study|Withdrawal by Subject|0|||
146952551|NCT02736474|529982006|FG000|Overall Study|Lost to Follow-up|0|||
146952552|NCT02736474|529982007|FG001|Overall Study|Lost to Follow-up|1|||
146952553|NCT02463331|529982008|FG000|Overall Study|Adverse Event|4|||
146952554|NCT02463331|529982009|FG001|Overall Study|Adverse Event|2|||
146952555|NCT02463331|529982008|FG000|Overall Study|Lost to Follow-up|1|||
146952556|NCT02463331|529982009|FG001|Overall Study|Lost to Follow-up|1|||
146952557|NCT02463331|529982008|FG000|Overall Study|Pregnancy|2|||
146952558|NCT02463331|529982009|FG001|Overall Study|Pregnancy|3|||
146952559|NCT02463331|529982008|FG000|Overall Study|Lack of Efficacy|6|||
146952560|NCT02463331|529982009|FG001|Overall Study|Lack of Efficacy|0|||
146952561|NCT02463331|529982008|FG000|Overall Study|Physician Decision|3|||
146952562|NCT02463331|529982009|FG001|Overall Study|Physician Decision|0|||
146952563|NCT02382276|529982010|FG000|Overall Study|Withdrawal by Subject|4|||
146952564|NCT02382276|529982011|FG001|Overall Study|Withdrawal by Subject|8|||
146952565|NCT02382276|529982012|FG002|Overall Study|Withdrawal by Subject|5|||
146952566|NCT02382276|529982010|FG000|Overall Study|Adverse Event|7|||
146952567|NCT02382276|529982011|FG001|Overall Study|Adverse Event|2|||
146952568|NCT02382276|529982012|FG002|Overall Study|Adverse Event|32|||
146952569|NCT02382276|529982010|FG000|Overall Study|Physician Decision|0|||
146952570|NCT02382276|529982011|FG001|Overall Study|Physician Decision|0|||
146952571|NCT02382276|529982012|FG002|Overall Study|Physician Decision|2|||
146952572|NCT04652102|529983219|FG000|Overall Study|Adverse Event|14|||
146952573|NCT04652102|529983220|FG001|Overall Study|Adverse Event|13|||
146952574|NCT04652102|529983219|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
146952575|NCT04652102|529983220|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
146952576|NCT04652102|529983219|FG000|Overall Study|Physician Decision|78|||
146952577|NCT04652102|529983220|FG001|Overall Study|Physician Decision|40|||
146952578|NCT04652102|529983219|FG000|Overall Study|Study Ended by Sponsor|64|||
146952579|NCT04652102|529983220|FG001|Overall Study|Study Ended by Sponsor|17|||
146952580|NCT04652102|529983219|FG000|Overall Study|Withdrawal by Subject|4625|||
146952581|NCT04652102|529983220|FG001|Overall Study|Withdrawal by Subject|5594|||
146952582|NCT04652102|529983219|FG000|Overall Study|Lost to Follow-up|2019|||
146952583|NCT04652102|529983220|FG001|Overall Study|Lost to Follow-up|1082|||
146952584|NCT04652102|529983219|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
146952585|NCT04652102|529983220|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
146952586|NCT04652102|529983219|FG000|Overall Study|Miscellaneous|80|||
146952587|NCT04652102|529983220|FG001|Overall Study|Miscellaneous|64|||
146952588|NCT02405091|529983223|FG000|Overall Study|Adverse Event|16|||
146952589|NCT02405091|529983224|FG001|Overall Study|Adverse Event|10|||
146952590|NCT02405091|529983225|FG002|Overall Study|Adverse Event|0|||
146952591|NCT02405091|529983223|FG000|Overall Study|Protocol Violation|1|||
146952592|NCT02405091|529983224|FG001|Overall Study|Protocol Violation|0|||
146952593|NCT02405091|529983225|FG002|Overall Study|Protocol Violation|0|||
146952594|NCT02405091|529983223|FG000|Overall Study|Noncompliance|1|||
146952595|NCT02405091|529983224|FG001|Overall Study|Noncompliance|6|||
146952596|NCT02405091|529983225|FG002|Overall Study|Noncompliance|2|||
146952597|NCT02405091|529983223|FG000|Overall Study|Withdrawal by Subject|4|||
146952598|NCT02405091|529983224|FG001|Overall Study|Withdrawal by Subject|8|||
146952599|NCT02405091|529983225|FG002|Overall Study|Withdrawal by Subject|0|||
146952600|NCT02405091|529983223|FG000|Overall Study|Death|0|||
146952601|NCT02405091|529983224|FG001|Overall Study|Death|1|||
146952602|NCT02405091|529983225|FG002|Overall Study|Death|0|||
146952603|NCT02405091|529983223|FG000|Overall Study|Lost to Follow-up|5|||
146952604|NCT02405091|529983224|FG001|Overall Study|Lost to Follow-up|6|||
146952605|NCT02405091|529983225|FG002|Overall Study|Lost to Follow-up|0|||
146952606|NCT02405091|529983223|FG000|Overall Study|Physician Decision|2|||
146952607|NCT02405091|529983224|FG001|Overall Study|Physician Decision|2|||
146952608|NCT02405091|529983225|FG002|Overall Study|Physician Decision|0|||
146952609|NCT00247962|529983234|FG000|Overall Study|Adverse Event|15|||
146952610|NCT00247962|529983235|FG001|Overall Study|Adverse Event|12|||
146952611|NCT00247962|529983234|FG000|Overall Study|Lost to Follow-up|3|||
146952612|NCT00247962|529983235|FG001|Overall Study|Lost to Follow-up|1|||
146952613|NCT00247962|529983234|FG000|Overall Study|Physician Decision|0|||
146952614|NCT00247962|529983235|FG001|Overall Study|Physician Decision|1|||
146952615|NCT00247962|529983234|FG000|Overall Study|Protocol Violation|1|||
146952616|NCT00247962|529983235|FG001|Overall Study|Protocol Violation|1|||
146952617|NCT00247962|529983234|FG000|Overall Study|Withdrawal by Subject|3|||
146952618|NCT00247962|529983235|FG001|Overall Study|Withdrawal by Subject|2|||
146952619|NCT00247962|529983234|FG000|Overall Study|Lack of Efficacy|4|||
146952620|NCT00247962|529983235|FG001|Overall Study|Lack of Efficacy|2|||
146952621|NCT01469637|529983240|FG000|First Intervention|Unacceptable behavior|0|||
146952622|NCT01469637|529983241|FG001|First Intervention|Unacceptable behavior|1|||
146952623|NCT01469637|529983240|FG000|Second Intervention|Incarcerated|1|||
146952624|NCT01469637|529983241|FG001|Second Intervention|Incarcerated|0|||
146952625|NCT01371721|529983242|FG000|Overall Study|Adverse Event|5|||
146952626|NCT01371721|529983243|FG001|Overall Study|Adverse Event|4|||
146952627|NCT01371721|529983244|FG002|Overall Study|Adverse Event|5|||
146952628|NCT01371721|529983242|FG000|Overall Study|Protocol Violation|6|||
146952629|NCT01371721|529983243|FG001|Overall Study|Protocol Violation|4|||
146952630|NCT01371721|529983244|FG002|Overall Study|Protocol Violation|5|||
146952631|NCT01371721|529983242|FG000|Overall Study|Lost to Follow-up|8|||
146952632|NCT01371721|529983243|FG001|Overall Study|Lost to Follow-up|2|||
146952633|NCT01371721|529983244|FG002|Overall Study|Lost to Follow-up|6|||
146952634|NCT01371721|529983242|FG000|Overall Study|Withdrawal by Subject|5|||
146952635|NCT01371721|529983243|FG001|Overall Study|Withdrawal by Subject|7|||
146952636|NCT01371721|529983244|FG002|Overall Study|Withdrawal by Subject|11|||
146952637|NCT01371721|529983242|FG000|Overall Study|Other|2|||
146952638|NCT01371721|529983243|FG001|Overall Study|Other|3|||
146952639|NCT01371721|529983244|FG002|Overall Study|Other|0|||
146952640|NCT01371721|529983242|FG000|Overall Study|Lack of Efficacy|2|||
146952641|NCT01371721|529983243|FG001|Overall Study|Lack of Efficacy|4|||
146952642|NCT01371721|529983244|FG002|Overall Study|Lack of Efficacy|3|||
146952643|NCT01371721|529983242|FG000|Overall Study|Randomized but not treated|1|||
146952644|NCT01371721|529983243|FG001|Overall Study|Randomized but not treated|0|||
146952645|NCT01371721|529983244|FG002|Overall Study|Randomized but not treated|0|||
146952646|NCT02584660|529983247|FG000|Overall Study|Adverse Event|4|||
146952647|NCT02584660|529983248|FG001|Overall Study|Adverse Event|0|||
146952648|NCT02584660|529983247|FG000|Overall Study|Lost to Follow-up|3|||
146952649|NCT02584660|529983248|FG001|Overall Study|Lost to Follow-up|4|||
146952650|NCT02584660|529983247|FG000|Overall Study|Protocol Violation|0|||
146952651|NCT02584660|529983248|FG001|Overall Study|Protocol Violation|1|||
146952652|NCT02584660|529983247|FG000|Overall Study|Withdrawal by Subject|0|||
146952653|NCT02584660|529983248|FG001|Overall Study|Withdrawal by Subject|2|||
146952654|NCT02584660|529983247|FG000|Overall Study|Other|0|||
146952655|NCT02584660|529983248|FG001|Overall Study|Other|1|||
146952656|NCT02120469|529983249|FG000|Overall Study|HER-2/neu-amplified|1|||
146952657|NCT02120469|529983250|FG001|Overall Study|HER-2/neu-amplified|0|||
146952658|NCT02120469|529983251|FG002|Overall Study|HER-2/neu-amplified|1|||
146952659|NCT00998985|529983252|FG000|Overall Study|Withdrawal by Subject|0|||
146952660|NCT00998985|529983253|FG001|Overall Study|Withdrawal by Subject|0|||
146984981|NCT02710071|530107114|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
146824495|NCT00684203|529528332|FG003|Overall Study|Withdrawal by Subject|0|||
146824496|NCT00684203|529528333|FG004|Overall Study|Withdrawal by Subject|0|||
146824497|NCT00684203|529528334|FG005|Overall Study|Withdrawal by Subject|0|||
146824498|NCT00684203|529528329|FG000|Overall Study|Did not meet protocol eligibility|0|||
146824499|NCT00684203|529528330|FG001|Overall Study|Did not meet protocol eligibility|1|||
146824500|NCT00684203|529528331|FG002|Overall Study|Did not meet protocol eligibility|0|||
146824501|NCT00684203|529528332|FG003|Overall Study|Did not meet protocol eligibility|0|||
146824502|NCT00684203|529528333|FG004|Overall Study|Did not meet protocol eligibility|0|||
146824503|NCT00684203|529528334|FG005|Overall Study|Did not meet protocol eligibility|0|||
146824504|NCT00719212|529528337|FG000|Overall Study|Death|41|||
146824505|NCT00719212|529528337|FG000|Overall Study|Lost to Follow-up|2|||
146824506|NCT00719212|529528337|FG000|Overall Study|Withdrawal by Subject|1|||
146824507|NCT00837096|529528338|FG000|Overall Study|Physician Decision|1|||
146824508|NCT00837096|529528339|FG001|Overall Study|Physician Decision|1|||
146824509|NCT00837096|529528338|FG000|Overall Study|Not reported|9|||
146824510|NCT00837096|529528339|FG001|Overall Study|Not reported|8|||
146824511|NCT01011049|529528340|FG000|Overall Study|Protocol Violation|0|||
146824512|NCT01011049|529528341|FG001|Overall Study|Protocol Violation|0|||
146952661|NCT00998985|529983254|FG002|Overall Study|Withdrawal by Subject|0|||
146952662|NCT00998985|529983255|FG003|Overall Study|Withdrawal by Subject|0|||
146952663|NCT00998985|529983256|FG004|Overall Study|Withdrawal by Subject|0|||
146952664|NCT00998985|529983257|FG005|Overall Study|Withdrawal by Subject|0|||
146952665|NCT00998985|529983258|FG006|Overall Study|Withdrawal by Subject|0|||
146952666|NCT00998985|529983259|FG007|Overall Study|Withdrawal by Subject|0|||
146952667|NCT00998985|529983260|FG008|Overall Study|Withdrawal by Subject|1|||
146952668|NCT00998985|529983261|FG009|Overall Study|Withdrawal by Subject|0|||
146952669|NCT00998985|529983262|FG010|Overall Study|Withdrawal by Subject|0|||
146952670|NCT00998985|529983263|FG011|Overall Study|Withdrawal by Subject|0|||
146952671|NCT00998985|529983264|FG012|Overall Study|Withdrawal by Subject|0|||
146952672|NCT00998985|529983265|FG013|Overall Study|Withdrawal by Subject|0|||
146824513|NCT01011049|529528342|FG002|Overall Study|Protocol Violation|2|||
146824514|NCT01011049|529528343|FG003|Overall Study|Protocol Violation|0|||
146952673|NCT00998985|529983252|FG000|Overall Study|Protocol Violation|0|||
146952674|NCT00998985|529983253|FG001|Overall Study|Protocol Violation|0|||
146952675|NCT00998985|529983254|FG002|Overall Study|Protocol Violation|0|||
146952676|NCT00998985|529983255|FG003|Overall Study|Protocol Violation|0|||
146952677|NCT00998985|529983256|FG004|Overall Study|Protocol Violation|0|||
146952678|NCT00998985|529983257|FG005|Overall Study|Protocol Violation|1|||
146952679|NCT00998985|529983258|FG006|Overall Study|Protocol Violation|0|||
146952680|NCT00998985|529983259|FG007|Overall Study|Protocol Violation|0|||
146952681|NCT00998985|529983260|FG008|Overall Study|Protocol Violation|0|||
146952682|NCT00998985|529983261|FG009|Overall Study|Protocol Violation|0|||
146952683|NCT00998985|529983262|FG010|Overall Study|Protocol Violation|0|||
146952684|NCT00998985|529983263|FG011|Overall Study|Protocol Violation|0|||
146952685|NCT00998985|529983264|FG012|Overall Study|Protocol Violation|0|||
146952686|NCT00998985|529983265|FG013|Overall Study|Protocol Violation|0|||
146952687|NCT01040728|529983267|FG000|Overall Study|Adverse Event|4|||
146952688|NCT01040728|529983268|FG001|Overall Study|Adverse Event|8|||
146952689|NCT01040728|529983269|FG002|Overall Study|Adverse Event|0|||
146952690|NCT01040728|529983270|FG003|Overall Study|Adverse Event|4|||
146952691|NCT01040728|529983267|FG000|Overall Study|Withdrawal by Subject|0|||
146952692|NCT01040728|529983268|FG001|Overall Study|Withdrawal by Subject|1|||
146952693|NCT01040728|529983269|FG002|Overall Study|Withdrawal by Subject|1|||
146952694|NCT01040728|529983270|FG003|Overall Study|Withdrawal by Subject|0|||
146952695|NCT01040728|529983267|FG000|Overall Study|Protocol Violation|0|||
146952696|NCT01040728|529983268|FG001|Overall Study|Protocol Violation|0|||
146952697|NCT01040728|529983269|FG002|Overall Study|Protocol Violation|0|||
146952698|NCT01040728|529983270|FG003|Overall Study|Protocol Violation|1|||
146952699|NCT01040728|529983267|FG000|Overall Study|Lack of Efficacy|0|||
146952700|NCT01040728|529983268|FG001|Overall Study|Lack of Efficacy|1|||
146952701|NCT01040728|529983269|FG002|Overall Study|Lack of Efficacy|0|||
146952702|NCT01040728|529983270|FG003|Overall Study|Lack of Efficacy|1|||
146952703|NCT01040728|529983267|FG000|Overall Study|Other reasons not listed above|0|||
146952704|NCT01040728|529983268|FG001|Overall Study|Other reasons not listed above|1|||
146952705|NCT01040728|529983269|FG002|Overall Study|Other reasons not listed above|0|||
146952706|NCT01040728|529983270|FG003|Overall Study|Other reasons not listed above|0|||
146952707|NCT01012037|529983273|FG000|Overall Study|Adverse Event|0|||
146952708|NCT01012037|529983274|FG001|Overall Study|Adverse Event|8|||
146952709|NCT01012037|529983275|FG002|Overall Study|Adverse Event|3|||
146952710|NCT01012037|529983273|FG000|Overall Study|Protocol Violation|0|||
146952711|NCT01012037|529983274|FG001|Overall Study|Protocol Violation|3|||
146952712|NCT01012037|529983275|FG002|Overall Study|Protocol Violation|5|||
146952713|NCT01012037|529983273|FG000|Overall Study|Withdrawal by Subject|0|||
146952714|NCT01012037|529983274|FG001|Overall Study|Withdrawal by Subject|4|||
146952715|NCT01012037|529983275|FG002|Overall Study|Withdrawal by Subject|1|||
146952716|NCT01012037|529983273|FG000|Overall Study|Other reason (not specified)|1|||
146952717|NCT01012037|529983274|FG001|Overall Study|Other reason (not specified)|1|||
146952718|NCT01012037|529983275|FG002|Overall Study|Other reason (not specified)|1|||
146952719|NCT02583711|529983276|FG000|Overall Study|Withdrawal by Subject|0|||
146952720|NCT02583711|529983277|FG001|Overall Study|Withdrawal by Subject|10|||
146952721|NCT02583711|529983278|FG002|Overall Study|Withdrawal by Subject|0|||
146952722|NCT00415623|529983282|FG000|Overall Study|Adverse Event|3|||
146952723|NCT00415623|529983283|FG001|Overall Study|Adverse Event|4|||
146952724|NCT00415623|529983282|FG000|Overall Study|Death|1|||
146952725|NCT00415623|529983283|FG001|Overall Study|Death|0|||
146952726|NCT00415623|529983282|FG000|Overall Study|Withdrawal by Subject|1|||
146952727|NCT00415623|529983283|FG001|Overall Study|Withdrawal by Subject|1|||
146952728|NCT01369069|529983284|FG000|Overall Study|Lost to Follow-up|8|||
146952729|NCT01369069|529983285|FG001|Overall Study|Lost to Follow-up|9|||
146952730|NCT01369069|529983284|FG000|Overall Study|Withdrawal by Subject|9|||
146952731|NCT01369069|529983285|FG001|Overall Study|Withdrawal by Subject|7|||
146952732|NCT02573012|529983286|FG000|Overall Study|Adverse Event|5|||
146952733|NCT02573012|529983287|FG001|Overall Study|Adverse Event|5|||
146824515|NCT01011049|529528340|FG000|Overall Study|Lost to Follow-up|1|||
146824516|NCT01011049|529528341|FG001|Overall Study|Lost to Follow-up|2|||
146952734|NCT02573012|529983286|FG000|Overall Study|Lack of Efficacy|5|||
146952735|NCT02573012|529983287|FG001|Overall Study|Lack of Efficacy|4|||
146952736|NCT02573012|529983286|FG000|Overall Study|Non-compliance|1|||
146952737|NCT02573012|529983287|FG001|Overall Study|Non-compliance|2|||
146952738|NCT02573012|529983286|FG000|Overall Study|Withdrawal by Subject|2|||
146952739|NCT02573012|529983287|FG001|Overall Study|Withdrawal by Subject|2|||
146952740|NCT02573012|529983286|FG000|Overall Study|Study Ended per Protocol|1|||
146952741|NCT02573012|529983287|FG001|Overall Study|Study Ended per Protocol|0|||
146952742|NCT02573012|529983286|FG000|Overall Study|Physician Decision|1|||
146952743|NCT02573012|529983287|FG001|Overall Study|Physician Decision|2|||
146952744|NCT00882362|529983288|FG000|Overall Study|Adverse Event|13|||
146952745|NCT00882362|529983289|FG001|Overall Study|Adverse Event|10|||
146952746|NCT00882362|529983288|FG000|Overall Study|Withdrawal by Subject|13|||
146952747|NCT00882362|529983289|FG001|Overall Study|Withdrawal by Subject|10|||
146824517|NCT01011049|529528342|FG002|Overall Study|Lost to Follow-up|1|||
146824518|NCT01011049|529528343|FG003|Overall Study|Lost to Follow-up|0|||
146824519|NCT01011049|529528340|FG000|Overall Study|Withdrawal by Subject|0|||
146824520|NCT01011049|529528341|FG001|Overall Study|Withdrawal by Subject|0|||
146824521|NCT01011049|529528342|FG002|Overall Study|Withdrawal by Subject|1|||
146824522|NCT01011049|529528343|FG003|Overall Study|Withdrawal by Subject|0|||
146824523|NCT00352053|529528344|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
146824524|NCT00352053|529528345|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
146824525|NCT00352053|529528344|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
146824526|NCT00352053|529528345|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
146824527|NCT00352053|529528344|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
146824528|NCT00352053|529528345|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
146824529|NCT00352053|529528344|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
146824530|NCT00352053|529528345|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
146824531|NCT00352053|529528344|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
146824532|NCT00352053|529528345|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
146824533|NCT00352053|529528344|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
146824534|NCT00352053|529528345|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
146824535|NCT00352053|529528344|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
146824536|NCT00352053|529528345|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
146824537|NCT00352053|529528344|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
146824538|NCT00352053|529528345|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
146824539|NCT00352053|529528344|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
146824540|NCT00352053|529528345|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
146824541|NCT00352053|529528344|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
146824542|NCT00352053|529528345|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
146824543|NCT00352053|529528344|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
146824544|NCT00352053|529528345|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
146824545|NCT00352053|529528344|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
146824546|NCT00352053|529528345|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
146824547|NCT00352053|529528344|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
146824548|NCT00352053|529528345|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
146824549|NCT02435381|529528346|FG000|Overall Study|Lost to Follow-up|2|||
146824550|NCT02435381|529528347|FG001|Overall Study|Lost to Follow-up|1|||
146824551|NCT04150341|529528350|FG000|Overall Study|Physician Decision|0|||
146824552|NCT04150341|529528351|FG001|Overall Study|Physician Decision|0|||
146824553|NCT04150341|529528352|FG002|Overall Study|Physician Decision|1|||
146824554|NCT04150341|529528353|FG003|Overall Study|Physician Decision|0|||
146824555|NCT04150341|529528354|FG004|Overall Study|Physician Decision|0|||
146824556|NCT04150341|529528355|FG005|Overall Study|Physician Decision|0|||
146824557|NCT04150341|529528350|FG000|Overall Study|Adverse Event|0|||
146824558|NCT04150341|529528351|FG001|Overall Study|Adverse Event|0|||
146824559|NCT04150341|529528352|FG002|Overall Study|Adverse Event|0|||
146824560|NCT04150341|529528353|FG003|Overall Study|Adverse Event|0|||
146824561|NCT04150341|529528354|FG004|Overall Study|Adverse Event|1|||
146824562|NCT04150341|529528355|FG005|Overall Study|Adverse Event|0|||
146824563|NCT00875615|529528356|FG000|Overall Study|Withdrawal by Subject|1|||
146824564|NCT00833898|529528362|FG000|Overall Study|Withdrawal by Subject|33|||
146824565|NCT00833898|529528363|FG001|Overall Study|Withdrawal by Subject|27|||
146824566|NCT00833898|529528362|FG000|Overall Study|Lost to Follow-up|7|||
146824567|NCT00833898|529528363|FG001|Overall Study|Lost to Follow-up|7|||
146824568|NCT00833898|529528362|FG000|Overall Study|Patient did not receive transplant|0|||
146824569|NCT00833898|529528363|FG001|Overall Study|Patient did not receive transplant|2|||
146824570|NCT00666198|529528367|FG000|Overall Study|Protocol Violation|10|||
146824571|NCT00666198|529528367|FG000|Overall Study|No Visit After First Day of Treatment|13|||
146824572|NCT00666198|529528367|FG000|Overall Study|Safety Not Assessable|6|||
146824573|NCT00666198|529528367|FG000|Overall Study|No Drug Administration|4|||
146824574|NCT05153499|529528368|FG000|Overall Study|Withdrawal by Subject|1|||
146824575|NCT05153499|529528369|FG001|Overall Study|Withdrawal by Subject|0|||
146824576|NCT05153499|529528368|FG000|Overall Study|Clinical Hold|1|||
146824577|NCT05153499|529528369|FG001|Overall Study|Clinical Hold|0|||
146824578|NCT05153499|529528368|FG000|Overall Study|Study Termination|6|||
146824579|NCT05153499|529528369|FG001|Overall Study|Study Termination|5|||
146824580|NCT03220776|529528375|FG000|Overall Study|Claustrophobia|0|||
146824581|NCT03220776|529528376|FG001|Overall Study|Claustrophobia|1|||
146824582|NCT03220776|529528377|FG002|Overall Study|Claustrophobia|1|||
146824583|NCT03220776|529528378|FG003|Overall Study|Claustrophobia|0|||
146824584|NCT03220776|529528379|FG004|Overall Study|Claustrophobia|1|||
146824585|NCT03220776|529528380|FG005|Overall Study|Claustrophobia|0|||
146824586|NCT03220776|529528375|FG000|Overall Study|MRI Equipment Failure|1|||
146824587|NCT03220776|529528376|FG001|Overall Study|MRI Equipment Failure|0|||
146824588|NCT03220776|529528377|FG002|Overall Study|MRI Equipment Failure|0|||
146952748|NCT00882362|529983288|FG000|Overall Study|Lack of Efficacy|3|||
146952749|NCT00882362|529983289|FG001|Overall Study|Lack of Efficacy|0|||
146952750|NCT00882362|529983288|FG000|Overall Study|Protocol Violation|7|||
146952751|NCT00882362|529983289|FG001|Overall Study|Protocol Violation|2|||
146952752|NCT00882362|529983288|FG000|Overall Study|Pregnancy|1|||
146952753|NCT00882362|529983289|FG001|Overall Study|Pregnancy|0|||
146952754|NCT00882362|529983288|FG000|Overall Study|Physician Decision|5|||
146952755|NCT00882362|529983289|FG001|Overall Study|Physician Decision|1|||
146952756|NCT00882362|529983288|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
146952757|NCT00882362|529983289|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
146952758|NCT00882362|529983288|FG000|Overall Study|change of residence or other commitments|5|||
146952759|NCT00882362|529983289|FG001|Overall Study|change of residence or other commitments|0|||
146952760|NCT01601873|529983290|FG000|Overall Study|Lost to Follow-up|2|||
146952761|NCT01601873|529983291|FG001|Overall Study|Lost to Follow-up|3|||
146952762|NCT02096471|529983292|FG000|Overall Study|Adverse Event|1|||
146952763|NCT02096471|529983292|FG000|Overall Study|Lack of Efficacy|7|||
146952764|NCT02096471|529983292|FG000|Overall Study|Withdrawal by Subject|3|||
146952765|NCT02096471|529983292|FG000|Overall Study|Non-Compliant|2|||
146952766|NCT01809327|529983293|FG000|Overall Study|Lost to Follow-up|5|||
146952767|NCT01809327|529983294|FG001|Overall Study|Lost to Follow-up|2|||
146952768|NCT01809327|529983295|FG002|Overall Study|Lost to Follow-up|4|||
146952769|NCT01809327|529983296|FG003|Overall Study|Lost to Follow-up|2|||
146952770|NCT01809327|529983297|FG004|Overall Study|Lost to Follow-up|3|||
146952771|NCT01809327|529983293|FG000|Overall Study|Withdrawal by Subject|6|||
146952772|NCT01809327|529983294|FG001|Overall Study|Withdrawal by Subject|4|||
146952773|NCT01809327|529983295|FG002|Overall Study|Withdrawal by Subject|4|||
146952774|NCT01809327|529983296|FG003|Overall Study|Withdrawal by Subject|2|||
146952775|NCT01809327|529983297|FG004|Overall Study|Withdrawal by Subject|5|||
146952776|NCT01809327|529983293|FG000|Overall Study|Adverse Event|4|||
146952777|NCT01809327|529983294|FG001|Overall Study|Adverse Event|3|||
146952778|NCT01809327|529983295|FG002|Overall Study|Adverse Event|7|||
146952779|NCT01809327|529983296|FG003|Overall Study|Adverse Event|4|||
146952780|NCT01809327|529983297|FG004|Overall Study|Adverse Event|8|||
146952781|NCT01809327|529983293|FG000|Overall Study|Death|1|||
146952782|NCT01809327|529983294|FG001|Overall Study|Death|0|||
146952783|NCT01809327|529983295|FG002|Overall Study|Death|0|||
146952784|NCT01809327|529983296|FG003|Overall Study|Death|0|||
146952785|NCT01809327|529983297|FG004|Overall Study|Death|0|||
146952786|NCT01809327|529983293|FG000|Overall Study|Protocol Violation|0|||
146952787|NCT01809327|529983294|FG001|Overall Study|Protocol Violation|1|||
146952788|NCT01809327|529983295|FG002|Overall Study|Protocol Violation|0|||
146952789|NCT01809327|529983296|FG003|Overall Study|Protocol Violation|0|||
146952790|NCT01809327|529983297|FG004|Overall Study|Protocol Violation|0|||
146952791|NCT01809327|529983293|FG000|Overall Study|Physician Decision|1|||
146952792|NCT01809327|529983294|FG001|Overall Study|Physician Decision|1|||
146952793|NCT01809327|529983295|FG002|Overall Study|Physician Decision|0|||
146952794|NCT01809327|529983296|FG003|Overall Study|Physician Decision|0|||
146952795|NCT01809327|529983297|FG004|Overall Study|Physician Decision|0|||
146952796|NCT01809327|529983293|FG000|Overall Study|Pregnancy|1|||
146952797|NCT01809327|529983294|FG001|Overall Study|Pregnancy|0|||
146952798|NCT01809327|529983295|FG002|Overall Study|Pregnancy|0|||
146952799|NCT01809327|529983296|FG003|Overall Study|Pregnancy|0|||
146952800|NCT01809327|529983297|FG004|Overall Study|Pregnancy|0|||
146952801|NCT01809327|529983293|FG000|Overall Study|Other|14|||
146824589|NCT03220776|529528378|FG003|Overall Study|MRI Equipment Failure|0|||
146952802|NCT01809327|529983294|FG001|Overall Study|Other|15|||
146952803|NCT01809327|529983295|FG002|Overall Study|Other|7|||
146952804|NCT01809327|529983296|FG003|Overall Study|Other|4|||
146952805|NCT01809327|529983297|FG004|Overall Study|Other|9|||
146952806|NCT03196973|529983298|FG000|Overall Study|Adverse Event|1|||
146952807|NCT03196973|529983299|FG001|Overall Study|Adverse Event|1|||
146952808|NCT03196973|529983300|FG002|Overall Study|Adverse Event|2|||
146824590|NCT03220776|529528379|FG004|Overall Study|MRI Equipment Failure|0|||
146824591|NCT03220776|529528380|FG005|Overall Study|MRI Equipment Failure|0|||
146824592|NCT03220776|529528375|FG000|Overall Study|Inclimate Weather|0|||
146952809|NCT03196973|529983298|FG000|Overall Study|Lack of Efficacy|2|||
146952810|NCT03196973|529983299|FG001|Overall Study|Lack of Efficacy|6|||
146952811|NCT03196973|529983300|FG002|Overall Study|Lack of Efficacy|1|||
146952812|NCT03196973|529983298|FG000|Overall Study|Lost to Follow-up|4|||
146952813|NCT03196973|529983299|FG001|Overall Study|Lost to Follow-up|3|||
146952814|NCT03196973|529983300|FG002|Overall Study|Lost to Follow-up|2|||
146952815|NCT03196973|529983298|FG000|Overall Study|Consent withdrawn|2|||
146952816|NCT03196973|529983299|FG001|Overall Study|Consent withdrawn|1|||
146952817|NCT03196973|529983300|FG002|Overall Study|Consent withdrawn|0|||
146952818|NCT03196973|529983298|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
146952819|NCT03196973|529983299|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
146952820|NCT03196973|529983300|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
146952821|NCT02520141|529983313|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
146952822|NCT02168816|529983318|FG000|Overall Study|Lost to Follow-up|2|||
146952823|NCT02168816|529983319|FG001|Overall Study|Lost to Follow-up|2|||
146952824|NCT01066546|529983324|FG000|Overall Study|Study terminated by sponsor|5|||
146952825|NCT03258762|529983329|FG000|Overall Study|Lost to Follow-up|0|||
146952826|NCT03258762|529983330|FG001|Overall Study|Lost to Follow-up|1|||
146952827|NCT02545049|529983332|FG000|Overall Study|Withdrawal by Subject|1|||
146952828|NCT02545049|529983333|FG001|Overall Study|Withdrawal by Subject|7|||
146952829|NCT02545049|529983332|FG000|Overall Study|Lost to Follow-up|4|||
146952830|NCT02545049|529983333|FG001|Overall Study|Lost to Follow-up|6|||
146952831|NCT02545049|529983332|FG000|Overall Study|GCP violations|37|||
146952832|NCT02545049|529983333|FG001|Overall Study|GCP violations|48|||
146952833|NCT02985684|529983334|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
146952834|NCT02985684|529983334|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
146952835|NCT02985684|529983334|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
146952836|NCT04144140|529984878|FG000|Overall Study|Other|0|||
146952837|NCT04144140|529984879|FG001|Overall Study|Other|0|||
146952838|NCT04144140|529984880|FG002|Overall Study|Other|0|||
146952839|NCT04144140|529984881|FG003|Overall Study|Other|0|||
146952840|NCT04144140|529984882|FG004|Overall Study|Other|0|||
146952841|NCT04144140|529984883|FG005|Overall Study|Other|1|||
146952842|NCT04144140|529984884|FG006|Overall Study|Other|0|||
146952843|NCT04735432|529984887|FG000|Overall Study|Other - due to personal reason|1|||
146952844|NCT04735432|529984888|FG001|Overall Study|Other - due to personal reason|0|||
146952845|NCT04735432|529984887|FG000|Overall Study|Adverse Event|2|||
146952846|NCT04735432|529984888|FG001|Overall Study|Adverse Event|0|||
146952847|NCT01066819|529984889|FG000|Overall Study|Adverse Event|18|||
146952848|NCT01066819|529984890|FG001|Overall Study|Adverse Event|1|||
146952849|NCT01066819|529984891|FG002|Overall Study|Adverse Event|6|||
146952850|NCT01066819|529984892|FG003|Overall Study|Adverse Event|0|||
146952851|NCT01066819|529984893|FG004|Overall Study|Adverse Event|0|||
146952852|NCT01066819|529984894|FG005|Overall Study|Adverse Event|0|||
146952853|NCT01066819|529984889|FG000|Overall Study|Death|5|||
146952854|NCT01066819|529984890|FG001|Overall Study|Death|0|||
146952855|NCT01066819|529984891|FG002|Overall Study|Death|1|||
146952856|NCT01066819|529984892|FG003|Overall Study|Death|0|||
146952857|NCT01066819|529984893|FG004|Overall Study|Death|0|||
146952858|NCT01066819|529984894|FG005|Overall Study|Death|0|||
146952859|NCT01066819|529984889|FG000|Overall Study|Lack of Efficacy|22|||
146952860|NCT01066819|529984890|FG001|Overall Study|Lack of Efficacy|1|||
146952861|NCT01066819|529984891|FG002|Overall Study|Lack of Efficacy|2|||
146952862|NCT01066819|529984892|FG003|Overall Study|Lack of Efficacy|1|||
146952863|NCT01066819|529984893|FG004|Overall Study|Lack of Efficacy|0|||
146952864|NCT01066819|529984894|FG005|Overall Study|Lack of Efficacy|0|||
146952865|NCT01066819|529984889|FG000|Overall Study|Physician Decision|6|||
146952866|NCT01066819|529984890|FG001|Overall Study|Physician Decision|2|||
146952867|NCT01066819|529984891|FG002|Overall Study|Physician Decision|3|||
146952868|NCT01066819|529984892|FG003|Overall Study|Physician Decision|0|||
146952869|NCT01066819|529984893|FG004|Overall Study|Physician Decision|0|||
146952870|NCT01066819|529984894|FG005|Overall Study|Physician Decision|0|||
146952871|NCT01066819|529984889|FG000|Overall Study|Protocol Violation|12|||
146952872|NCT01066819|529984890|FG001|Overall Study|Protocol Violation|6|||
146952873|NCT01066819|529984891|FG002|Overall Study|Protocol Violation|0|||
146952874|NCT01066819|529984892|FG003|Overall Study|Protocol Violation|0|||
146952875|NCT01066819|529984893|FG004|Overall Study|Protocol Violation|0|||
146952876|NCT01066819|529984894|FG005|Overall Study|Protocol Violation|0|||
146952877|NCT01066819|529984889|FG000|Overall Study|Withdrawal by Subject|29|||
146952878|NCT01066819|529984890|FG001|Overall Study|Withdrawal by Subject|11|||
146952879|NCT01066819|529984891|FG002|Overall Study|Withdrawal by Subject|6|||
146952880|NCT01066819|529984892|FG003|Overall Study|Withdrawal by Subject|0|||
146952881|NCT01066819|529984893|FG004|Overall Study|Withdrawal by Subject|0|||
146952882|NCT01066819|529984894|FG005|Overall Study|Withdrawal by Subject|0|||
146952883|NCT01066819|529984889|FG000|Overall Study|Administrative|6|||
146952884|NCT01066819|529984890|FG001|Overall Study|Administrative|4|||
146952885|NCT01066819|529984891|FG002|Overall Study|Administrative|2|||
146952886|NCT01066819|529984892|FG003|Overall Study|Administrative|0|||
146952887|NCT01066819|529984893|FG004|Overall Study|Administrative|0|||
146824593|NCT03220776|529528376|FG001|Overall Study|Inclimate Weather|0|||
146824594|NCT03220776|529528377|FG002|Overall Study|Inclimate Weather|0|||
146952888|NCT01066819|529984894|FG005|Overall Study|Administrative|0|||
146952889|NCT01066819|529984889|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
146952890|NCT01066819|529984890|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
146952891|NCT01066819|529984891|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
146952892|NCT01066819|529984892|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
146952893|NCT01066819|529984893|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
146952894|NCT01066819|529984894|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
146952895|NCT01066819|529984889|FG000|Overall Study|Early termination|2|||
146952896|NCT01066819|529984890|FG001|Overall Study|Early termination|0|||
146952897|NCT01066819|529984891|FG002|Overall Study|Early termination|0|||
146952898|NCT01066819|529984892|FG003|Overall Study|Early termination|0|||
146952899|NCT01066819|529984893|FG004|Overall Study|Early termination|0|||
146952900|NCT01066819|529984894|FG005|Overall Study|Early termination|0|||
146952901|NCT01066819|529984889|FG000|Overall Study|Failed to return|298|||
146952902|NCT01066819|529984890|FG001|Overall Study|Failed to return|107|||
146952903|NCT01066819|529984891|FG002|Overall Study|Failed to return|68|||
146952904|NCT01066819|529984892|FG003|Overall Study|Failed to return|7|||
146952905|NCT01066819|529984893|FG004|Overall Study|Failed to return|2|||
146952906|NCT01066819|529984894|FG005|Overall Study|Failed to return|3|||
146824595|NCT03220776|529528378|FG003|Overall Study|Inclimate Weather|0|||
146824596|NCT03220776|529528379|FG004|Overall Study|Inclimate Weather|0|||
146824597|NCT03220776|529528380|FG005|Overall Study|Inclimate Weather|1|||
146824598|NCT03220776|529528375|FG000|Overall Study|Physician Decision|0|||
146824599|NCT03220776|529528376|FG001|Overall Study|Physician Decision|0|||
146824600|NCT03220776|529528377|FG002|Overall Study|Physician Decision|0|||
146824601|NCT03220776|529528378|FG003|Overall Study|Physician Decision|1|||
146824602|NCT03220776|529528379|FG004|Overall Study|Physician Decision|0|||
146824603|NCT03220776|529528380|FG005|Overall Study|Physician Decision|0|||
146824604|NCT03220776|529528375|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
146824605|NCT03220776|529528376|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
146824606|NCT03220776|529528377|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
146824607|NCT03220776|529528378|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
146824608|NCT03220776|529528379|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
146824609|NCT03220776|529528380|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
146824610|NCT03220776|529528375|FG000|Overall Study|Protocol Violation|0|||
146824611|NCT03220776|529528376|FG001|Overall Study|Protocol Violation|0|||
146824612|NCT03220776|529528377|FG002|Overall Study|Protocol Violation|0|||
146824613|NCT03220776|529528378|FG003|Overall Study|Protocol Violation|2|||
146824614|NCT03220776|529528379|FG004|Overall Study|Protocol Violation|0|||
146824615|NCT03220776|529528380|FG005|Overall Study|Protocol Violation|1|||
146824616|NCT03220776|529528375|FG000|Overall Study|Withdrawal by Subject|1|||
146824617|NCT03220776|529528376|FG001|Overall Study|Withdrawal by Subject|0|||
146824618|NCT03220776|529528377|FG002|Overall Study|Withdrawal by Subject|0|||
146824619|NCT03220776|529528378|FG003|Overall Study|Withdrawal by Subject|0|||
146824620|NCT03220776|529528379|FG004|Overall Study|Withdrawal by Subject|0|||
146824621|NCT03220776|529528380|FG005|Overall Study|Withdrawal by Subject|0|||
146824622|NCT03226353|529528381|FG000|Overall Study|Withdrawal by Subject|1|||
146824623|NCT03226353|529528381|FG000|Overall Study|Screen Failure|5|||
146824624|NCT03441789|529528382|FG000|Overall Study|Withdrawal by Subject|1|||
146824625|NCT03441789|529528383|FG001|Overall Study|Withdrawal by Subject|1|||
146824626|NCT03441789|529528382|FG000|Overall Study|Adverse Event|0|||
146824627|NCT03441789|529528383|FG001|Overall Study|Adverse Event|1|||
146824628|NCT03441789|529528382|FG000|Overall Study|Protocol Violation|0|||
146824629|NCT03441789|529528383|FG001|Overall Study|Protocol Violation|1|||
146824630|NCT03441789|529528382|FG000|Overall Study|Lost to Follow-up|0|||
146824631|NCT03441789|529528383|FG001|Overall Study|Lost to Follow-up|1|||
146824632|NCT03168425|529528386|FG000|Overall Study|Lost to Follow-up|5|||
146824633|NCT03168425|529528387|FG001|Overall Study|Lost to Follow-up|8|||
146824634|NCT03168425|529528386|FG000|Overall Study|unable to confirm post op opioids|2|||
146824635|NCT03168425|529528387|FG001|Overall Study|unable to confirm post op opioids|3|||
146824636|NCT02166047|529528388|FG000|Overall Study|Withdrawal by Participant|0|||
146824637|NCT02166047|529528389|FG001|Overall Study|Withdrawal by Participant|1|||
146824638|NCT02166047|529528390|FG002|Overall Study|Withdrawal by Participant|2|||
146824639|NCT02166047|529528391|FG003|Overall Study|Withdrawal by Participant|0|||
146824640|NCT02166047|529528392|FG004|Overall Study|Withdrawal by Participant|0|||
146824641|NCT02166047|529528393|FG005|Overall Study|Withdrawal by Participant|0|||
146824642|NCT02166047|529528394|FG006|Overall Study|Withdrawal by Participant|1|||
146824643|NCT02166047|529528395|FG007|Overall Study|Withdrawal by Participant|0|||
146824644|NCT02166047|529528396|FG008|Overall Study|Withdrawal by Participant|0|||
146824645|NCT02166047|529528397|FG009|Overall Study|Withdrawal by Participant|0|||
146824646|NCT02166047|529528398|FG010|Overall Study|Withdrawal by Participant|0|||
146824647|NCT02166047|529528399|FG011|Overall Study|Withdrawal by Participant|0|||
146824648|NCT02166047|529528388|FG000|Overall Study|Adverse Event|0|||
146824649|NCT02166047|529528389|FG001|Overall Study|Adverse Event|0|||
146824650|NCT02166047|529528390|FG002|Overall Study|Adverse Event|0|||
146824651|NCT02166047|529528391|FG003|Overall Study|Adverse Event|0|||
146824652|NCT02166047|529528392|FG004|Overall Study|Adverse Event|1|||
146824653|NCT02166047|529528393|FG005|Overall Study|Adverse Event|0|||
146824654|NCT02166047|529528394|FG006|Overall Study|Adverse Event|1|||
146824655|NCT02166047|529528395|FG007|Overall Study|Adverse Event|0|||
146824656|NCT02166047|529528396|FG008|Overall Study|Adverse Event|0|||
146824657|NCT02166047|529528397|FG009|Overall Study|Adverse Event|0|||
146824658|NCT02166047|529528398|FG010|Overall Study|Adverse Event|2|||
146824659|NCT02166047|529528399|FG011|Overall Study|Adverse Event|0|||
146824660|NCT01960114|529528401|FG000|Overall Study|Adverse Event|1|||
146824661|NCT01960114|529528402|FG001|Overall Study|Adverse Event|0|||
146824662|NCT01960114|529528401|FG000|Overall Study|Could not swallow study medication|0|||
146952907|NCT01066819|529984889|FG000|Overall Study|Lab test not done|9|||
146952908|NCT01066819|529984890|FG001|Overall Study|Lab test not done|0|||
146952909|NCT01066819|529984891|FG002|Overall Study|Lab test not done|2|||
146952910|NCT01066819|529984892|FG003|Overall Study|Lab test not done|1|||
146952911|NCT01066819|529984893|FG004|Overall Study|Lab test not done|0|||
146952912|NCT01066819|529984894|FG005|Overall Study|Lab test not done|0|||
146952913|NCT01066819|529984889|FG000|Overall Study|Miscellaneous|28|||
146952914|NCT01066819|529984890|FG001|Overall Study|Miscellaneous|10|||
146952915|NCT01066819|529984891|FG002|Overall Study|Miscellaneous|18|||
146952916|NCT01066819|529984892|FG003|Overall Study|Miscellaneous|1|||
146952917|NCT01066819|529984893|FG004|Overall Study|Miscellaneous|0|||
146952918|NCT01066819|529984894|FG005|Overall Study|Miscellaneous|0|||
146952919|NCT01066819|529984889|FG000|Overall Study|Non responders|123|||
146952920|NCT01066819|529984890|FG001|Overall Study|Non responders|2|||
146952921|NCT01066819|529984891|FG002|Overall Study|Non responders|7|||
146952922|NCT01066819|529984892|FG003|Overall Study|Non responders|2|||
146952923|NCT01066819|529984893|FG004|Overall Study|Non responders|0|||
146952924|NCT01066819|529984894|FG005|Overall Study|Non responders|1|||
146952925|NCT01066819|529984889|FG000|Overall Study|Not categorised|9|||
146952926|NCT01066819|529984890|FG001|Overall Study|Not categorised|2|||
146952927|NCT01066819|529984891|FG002|Overall Study|Not categorised|6|||
146952928|NCT01066819|529984892|FG003|Overall Study|Not categorised|1|||
146952929|NCT01066819|529984893|FG004|Overall Study|Not categorised|0|||
146952930|NCT01066819|529984894|FG005|Overall Study|Not categorised|0|||
146952931|NCT01066819|529984889|FG000|Overall Study|Relapse|16|||
146952932|NCT01066819|529984890|FG001|Overall Study|Relapse|4|||
146952933|NCT01066819|529984891|FG002|Overall Study|Relapse|3|||
146952934|NCT01066819|529984892|FG003|Overall Study|Relapse|0|||
146952935|NCT01066819|529984893|FG004|Overall Study|Relapse|0|||
146952936|NCT01066819|529984894|FG005|Overall Study|Relapse|0|||
146952937|NCT01066819|529984889|FG000|Overall Study|Results not available|1|||
146952938|NCT01066819|529984890|FG001|Overall Study|Results not available|0|||
146952939|NCT01066819|529984891|FG002|Overall Study|Results not available|0|||
146952940|NCT01066819|529984892|FG003|Overall Study|Results not available|0|||
146952941|NCT01066819|529984893|FG004|Overall Study|Results not available|0|||
146952942|NCT01066819|529984894|FG005|Overall Study|Results not available|0|||
146952943|NCT01066819|529984889|FG000|Overall Study|Screen failure|1|||
146952944|NCT01066819|529984890|FG001|Overall Study|Screen failure|0|||
146952945|NCT01066819|529984891|FG002|Overall Study|Screen failure|0|||
146952946|NCT01066819|529984892|FG003|Overall Study|Screen failure|0|||
146952947|NCT01066819|529984893|FG004|Overall Study|Screen failure|0|||
146952948|NCT01066819|529984894|FG005|Overall Study|Screen failure|0|||
146952949|NCT01066819|529984889|FG000|Overall Study|Spontaneous cure|1|||
146952950|NCT01066819|529984890|FG001|Overall Study|Spontaneous cure|0|||
146952951|NCT01066819|529984891|FG002|Overall Study|Spontaneous cure|0|||
146952952|NCT01066819|529984892|FG003|Overall Study|Spontaneous cure|0|||
146952953|NCT01066819|529984893|FG004|Overall Study|Spontaneous cure|0|||
146952954|NCT01066819|529984894|FG005|Overall Study|Spontaneous cure|0|||
146952955|NCT01066819|529984889|FG000|Overall Study|Treatment never started|85|||
146952956|NCT01066819|529984890|FG001|Overall Study|Treatment never started|19|||
146952957|NCT01066819|529984891|FG002|Overall Study|Treatment never started|19|||
146952958|NCT01066819|529984892|FG003|Overall Study|Treatment never started|3|||
146952959|NCT01066819|529984893|FG004|Overall Study|Treatment never started|2|||
146952960|NCT01066819|529984894|FG005|Overall Study|Treatment never started|2|||
146952961|NCT01066819|529984889|FG000|Overall Study|Treatment stopped|12|||
146952962|NCT01066819|529984890|FG001|Overall Study|Treatment stopped|1|||
146952963|NCT01066819|529984891|FG002|Overall Study|Treatment stopped|2|||
146952964|NCT01066819|529984892|FG003|Overall Study|Treatment stopped|1|||
146952965|NCT01066819|529984893|FG004|Overall Study|Treatment stopped|0|||
146952966|NCT01066819|529984894|FG005|Overall Study|Treatment stopped|0|||
146952967|NCT01066819|529984889|FG000|Overall Study|Other|5|||
146952968|NCT01066819|529984890|FG001|Overall Study|Other|1|||
146952969|NCT01066819|529984891|FG002|Overall Study|Other|1|||
146952970|NCT01066819|529984892|FG003|Overall Study|Other|0|||
146952971|NCT01066819|529984893|FG004|Overall Study|Other|0|||
146952972|NCT01066819|529984894|FG005|Overall Study|Other|0|||
146952973|NCT02408016|529984895|FG000|Overall Study|Death|6|||
146952974|NCT02408016|529984896|FG001|Overall Study|Death|1|||
146824663|NCT01960114|529528402|FG001|Overall Study|Could not swallow study medication|1|||
146952975|NCT02408016|529984897|FG002|Overall Study|Death|0|||
146952976|NCT02408016|529984895|FG000|Overall Study|Physician Decision|0|||
146952977|NCT02408016|529984896|FG001|Overall Study|Physician Decision|2|||
146952978|NCT02408016|529984897|FG002|Overall Study|Physician Decision|0|||
146952979|NCT00718887|529984899|FG000|Overall Study|Withdrawal by Subject|3|||
146952980|NCT00718887|529984900|FG001|Overall Study|Withdrawal by Subject|2|||
146952981|NCT00718887|529984899|FG000|Overall Study|Not identified|2|||
146952982|NCT00718887|529984900|FG001|Overall Study|Not identified|7|||
146952983|NCT00775138|529984901|FG000|Overall Study|Withdrawal by Subject|0|||
146952984|NCT00775138|529984902|FG001|Overall Study|Withdrawal by Subject|0|||
146952985|NCT00775138|529984903|FG002|Overall Study|Withdrawal by Subject|2|||
146952986|NCT00775138|529984904|FG003|Overall Study|Withdrawal by Subject|2|||
146952987|NCT00775138|529984901|FG000|Overall Study|Adverse Event|0|||
146952988|NCT00775138|529984902|FG001|Overall Study|Adverse Event|0|||
146952989|NCT00775138|529984903|FG002|Overall Study|Adverse Event|1|||
146824664|NCT02490878|529528406|FG000|Overall Study|deemed ineligible|0|||
146824665|NCT02490878|529528407|FG001|Overall Study|deemed ineligible|1|||
146824666|NCT02490878|529528406|FG000|Overall Study|progression prior to treatment|0|||
146824667|NCT02490878|529528407|FG001|Overall Study|progression prior to treatment|1|||
146824668|NCT02490878|529528406|FG000|Overall Study|only submitted baseline QOL|0|||
146824669|NCT02490878|529528407|FG001|Overall Study|only submitted baseline QOL|1|||
146824670|NCT02845375|529528408|FG000|Overall Study|upper airway obstruction|1|||
146824671|NCT02845375|529528409|FG001|Overall Study|upper airway obstruction|2|||
146824672|NCT02845375|529528410|FG002|Overall Study|upper airway obstruction|1|||
146824673|NCT01177137|529528411|FG000|Overall Study|Withdrawal by Subject|10|||
146824674|NCT01177137|529528412|FG001|Overall Study|Withdrawal by Subject|10|||
146824675|NCT01177137|529528413|FG002|Overall Study|Withdrawal by Subject|2|||
146824676|NCT02215954|529528415|FG000|Overall Study|Adverse Event|0|||
146824677|NCT02215954|529528416|FG001|Overall Study|Adverse Event|0|||
146824678|NCT02215954|529528417|FG002|Overall Study|Adverse Event|1|||
146824679|NCT02215954|529528415|FG000|Overall Study|Withdrawal by Subject|0|||
146824680|NCT02215954|529528416|FG001|Overall Study|Withdrawal by Subject|0|||
146824681|NCT02215954|529528417|FG002|Overall Study|Withdrawal by Subject|2|||
146824682|NCT02215954|529528415|FG000|Overall Study|Not exposed|1|||
146824683|NCT02215954|529528416|FG001|Overall Study|Not exposed|1|||
146824684|NCT02215954|529528417|FG002|Overall Study|Not exposed|3|||
146824685|NCT02460562|529528418|FG000|Overall Study|Lost to Follow-up|15|||
146824686|NCT02460562|529528419|FG001|Overall Study|Lost to Follow-up|16|||
146824687|NCT01951261|529528420|FG000|Overall Study|Death|1|||
146824688|NCT01951261|529528421|FG001|Overall Study|Death|0|||
146824689|NCT01951261|529528420|FG000|Overall Study|Lost to Follow-up|4|||
146824690|NCT01951261|529528421|FG001|Overall Study|Lost to Follow-up|3|||
146824691|NCT01951261|529528420|FG000|Overall Study|Protocol Violation|4|||
146824692|NCT01951261|529528421|FG001|Overall Study|Protocol Violation|3|||
146824693|NCT01924806|529528422|FG000|Overall Study|Physician Decision|2|||
146824694|NCT01924806|529528423|FG001|Overall Study|Physician Decision|1|||
146824695|NCT00297778|529528431|FG000|Overall Study|Adverse Event|16|||
146824696|NCT00297778|529528432|FG001|Overall Study|Adverse Event|10|||
146824697|NCT00297778|529528431|FG000|Overall Study|Withdrawal by Subject|1|||
146824698|NCT00297778|529528432|FG001|Overall Study|Withdrawal by Subject|5|||
146824699|NCT00297778|529528431|FG000|Overall Study|Lack of Efficacy|2|||
146824700|NCT00297778|529528432|FG001|Overall Study|Lack of Efficacy|1|||
146824701|NCT00297778|529528431|FG000|Overall Study|Non-compliant with trial protocol|0|||
146824702|NCT00297778|529528432|FG001|Overall Study|Non-compliant with trial protocol|3|||
146824703|NCT00297778|529528431|FG000|Overall Study|Other|0|||
146824704|NCT00297778|529528432|FG001|Overall Study|Other|1|||
146824705|NCT02996097|529528433|FG000|Overall Study|Lost to Follow-up|11|||
146824706|NCT02996097|529528434|FG001|Overall Study|Lost to Follow-up|11|||
146824707|NCT02201771|529528435|FG000|Overall Study|Death|3|||
146824708|NCT02201771|529528436|FG001|Overall Study|Death|2|||
146824709|NCT02201771|529528437|FG002|Overall Study|Death|0|||
146824710|NCT02201771|529528435|FG000|Overall Study|Protocol Violation|10|||
146824711|NCT02201771|529528436|FG001|Overall Study|Protocol Violation|8|||
146824712|NCT02201771|529528437|FG002|Overall Study|Protocol Violation|10|||
146824713|NCT03569475|529528438|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
146824714|NCT03569475|529528439|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
146824715|NCT03569475|529528440|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
146824716|NCT03569475|529528438|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
146824717|NCT03569475|529528439|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
146824718|NCT03569475|529528440|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
146824719|NCT03569475|529528438|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
146824720|NCT03569475|529528439|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
146824721|NCT03569475|529528440|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
146824722|NCT03569475|529528438|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
146824723|NCT03569475|529528439|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
146824724|NCT03569475|529528440|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
146824725|NCT03569475|529528438|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
146824726|NCT03569475|529528439|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
146824727|NCT03569475|529528440|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
146824728|NCT03569475|529528438|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
146824729|NCT03569475|529528439|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
146824730|NCT03569475|529528440|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
146824731|NCT03569475|529528438|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
146824732|NCT03569475|529528439|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
146824733|NCT03569475|529528440|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
146824734|NCT03569475|529528438|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
146952990|NCT00775138|529984904|FG003|Overall Study|Adverse Event|0|||
146952991|NCT03557801|529984905|FG000|Overall Study|Protocol Violation|1|||
146952992|NCT03557801|529984906|FG001|Overall Study|Protocol Violation|0|||
146952993|NCT03557801|529984907|FG002|Overall Study|Protocol Violation|0|||
146952994|NCT03557801|529984905|FG000|Overall Study|Withdrawal by Subject|1|||
146952995|NCT03557801|529984906|FG001|Overall Study|Withdrawal by Subject|0|||
146952996|NCT03557801|529984907|FG002|Overall Study|Withdrawal by Subject|3|||
146952997|NCT03557801|529984905|FG000|Overall Study|Lost to Follow-up|0|||
146952998|NCT03557801|529984906|FG001|Overall Study|Lost to Follow-up|1|||
146952999|NCT03557801|529984907|FG002|Overall Study|Lost to Follow-up|0|||
146953000|NCT00535236|529984908|FG000|Overall Study|Adverse Event|1|||
146953001|NCT00535236|529984909|FG001|Overall Study|Adverse Event|0|||
146953002|NCT00535236|529984910|FG002|Overall Study|Adverse Event|9|||
146953003|NCT00535236|529984911|FG003|Overall Study|Adverse Event|3|||
146953004|NCT00535236|529984912|FG004|Overall Study|Adverse Event|3|||
146953005|NCT00535236|529984913|FG005|Overall Study|Adverse Event|0|||
146953006|NCT00535236|529984914|FG006|Overall Study|Adverse Event|5|||
146953007|NCT00535236|529984915|FG007|Overall Study|Adverse Event|1|||
146953008|NCT00535236|529984916|FG008|Overall Study|Adverse Event|2|||
146953009|NCT00535236|529984917|FG009|Overall Study|Adverse Event|1|||
146953010|NCT00535236|529984908|FG000|Overall Study|Lost to Follow-up|1|||
146953011|NCT00535236|529984909|FG001|Overall Study|Lost to Follow-up|2|||
146953012|NCT00535236|529984910|FG002|Overall Study|Lost to Follow-up|0|||
146953013|NCT00535236|529984911|FG003|Overall Study|Lost to Follow-up|0|||
146953014|NCT00535236|529984912|FG004|Overall Study|Lost to Follow-up|2|||
146953015|NCT00535236|529984913|FG005|Overall Study|Lost to Follow-up|0|||
146953016|NCT00535236|529984914|FG006|Overall Study|Lost to Follow-up|0|||
146953017|NCT00535236|529984915|FG007|Overall Study|Lost to Follow-up|0|||
146953018|NCT00535236|529984916|FG008|Overall Study|Lost to Follow-up|6|||
146953019|NCT00535236|529984917|FG009|Overall Study|Lost to Follow-up|1|||
146953020|NCT00535236|529984908|FG000|Overall Study|Physician Decision|0|||
146953021|NCT00535236|529984909|FG001|Overall Study|Physician Decision|0|||
146953022|NCT00535236|529984910|FG002|Overall Study|Physician Decision|0|||
146953023|NCT00535236|529984911|FG003|Overall Study|Physician Decision|0|||
146953024|NCT00535236|529984912|FG004|Overall Study|Physician Decision|1|||
146953025|NCT00535236|529984913|FG005|Overall Study|Physician Decision|0|||
146953026|NCT00535236|529984914|FG006|Overall Study|Physician Decision|1|||
146953027|NCT00535236|529984915|FG007|Overall Study|Physician Decision|0|||
146953028|NCT00535236|529984916|FG008|Overall Study|Physician Decision|0|||
146953029|NCT00535236|529984917|FG009|Overall Study|Physician Decision|0|||
146953030|NCT00535236|529984908|FG000|Overall Study|Protocol Violation|2|||
146953031|NCT00535236|529984909|FG001|Overall Study|Protocol Violation|0|||
146953032|NCT00535236|529984910|FG002|Overall Study|Protocol Violation|1|||
146953033|NCT00535236|529984911|FG003|Overall Study|Protocol Violation|0|||
146953034|NCT00535236|529984912|FG004|Overall Study|Protocol Violation|0|||
146953035|NCT00535236|529984913|FG005|Overall Study|Protocol Violation|0|||
146953036|NCT00535236|529984914|FG006|Overall Study|Protocol Violation|0|||
146953037|NCT00535236|529984915|FG007|Overall Study|Protocol Violation|0|||
146953038|NCT00535236|529984916|FG008|Overall Study|Protocol Violation|1|||
146953039|NCT00535236|529984917|FG009|Overall Study|Protocol Violation|0|||
146953040|NCT00535236|529984908|FG000|Overall Study|Withdrawal by Subject|3|||
146953041|NCT00535236|529984909|FG001|Overall Study|Withdrawal by Subject|0|||
146953042|NCT00535236|529984910|FG002|Overall Study|Withdrawal by Subject|2|||
146953043|NCT00535236|529984911|FG003|Overall Study|Withdrawal by Subject|1|||
146953044|NCT00535236|529984912|FG004|Overall Study|Withdrawal by Subject|6|||
146953045|NCT00535236|529984913|FG005|Overall Study|Withdrawal by Subject|1|||
146953046|NCT00535236|529984914|FG006|Overall Study|Withdrawal by Subject|5|||
146953047|NCT00535236|529984915|FG007|Overall Study|Withdrawal by Subject|0|||
146953048|NCT00535236|529984916|FG008|Overall Study|Withdrawal by Subject|4|||
146953049|NCT00535236|529984917|FG009|Overall Study|Withdrawal by Subject|2|||
146953050|NCT04880642|529984918|FG000|Randomization|Withdrawal by Subject|2|||
146953051|NCT04880642|529984919|FG001|Randomization|Withdrawal by Subject|3|||
146953052|NCT04880642|529984918|FG000|Treatment Period|Adverse Event|0|||
146953053|NCT04880642|529984919|FG001|Treatment Period|Adverse Event|1|||
146953054|NCT04880642|529984918|FG000|Treatment Period|Death|6|||
146953055|NCT04880642|529984919|FG001|Treatment Period|Death|6|||
146953056|NCT04880642|529984918|FG000|Treatment Period|Lost to Follow-up|1|||
146953057|NCT04880642|529984919|FG001|Treatment Period|Lost to Follow-up|0|||
146953058|NCT04880642|529984918|FG000|Treatment Period|Protocol Violation|0|||
146953059|NCT04880642|529984919|FG001|Treatment Period|Protocol Violation|1|||
146953060|NCT04880642|529984918|FG000|Treatment Period|Withdrawal by Subject|5|||
146953061|NCT04880642|529984919|FG001|Treatment Period|Withdrawal by Subject|3|||
146953062|NCT04880642|529984918|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
146984982|NCT02710071|530107113|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
146984983|NCT02710071|530107114|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
146953063|NCT04880642|529984919|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
146953064|NCT04880642|529984918|FG000|Follow-up|Death|4|||
146953065|NCT04880642|529984919|FG001|Follow-up|Death|3|||
146953066|NCT04880642|529984918|FG000|Follow-up|Withdrawal by Subject|1|||
146953067|NCT04880642|529984919|FG001|Follow-up|Withdrawal by Subject|0|||
146953068|NCT02275052|529984922|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146953069|NCT02275052|529984923|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
146953070|NCT02275052|529984924|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146953071|NCT02275052|529984925|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146953072|NCT02275052|529984922|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
146953073|NCT02275052|529984923|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
146953074|NCT02275052|529984924|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
146953075|NCT02275052|529984925|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
146953076|NCT02275052|529984922|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
146953077|NCT02275052|529984923|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
146953078|NCT02275052|529984924|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146953079|NCT02275052|529984925|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146953080|NCT02275052|529984922|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
146953081|NCT02275052|529984923|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
146953082|NCT02275052|529984924|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
146953083|NCT02275052|529984925|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
146953084|NCT02275052|529984922|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
146953085|NCT02275052|529984923|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
146953086|NCT02275052|529984924|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
146953087|NCT02275052|529984925|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
146953088|NCT02275052|529984922|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
146953089|NCT02275052|529984923|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
146953090|NCT02275052|529984924|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
146953091|NCT02275052|529984925|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
146953092|NCT02275052|529984922|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
146953093|NCT02275052|529984923|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
146953094|NCT02275052|529984924|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
146953095|NCT02275052|529984925|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
146953096|NCT02275052|529984922|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
146953097|NCT02275052|529984923|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
146953098|NCT02275052|529984924|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
146953099|NCT02275052|529984925|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
146953100|NCT02275052|529984922|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146953101|NCT02275052|529984923|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146953102|NCT02275052|529984924|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146953103|NCT02275052|529984925|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
146953104|NCT02275052|529984922|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
146953105|NCT02275052|529984923|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
146953106|NCT02275052|529984924|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
146953107|NCT02275052|529984925|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
146953108|NCT02275052|529984922|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
146953109|NCT02275052|529984923|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
146953110|NCT02275052|529984924|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
146953111|NCT02275052|529984925|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
146953112|NCT00561795|529984926|FG000|Overall Study|Adverse Event|3|||
146953113|NCT00561795|529984927|FG001|Overall Study|Adverse Event|3|||
146953114|NCT00561795|529984928|FG002|Overall Study|Adverse Event|0|||
146953115|NCT00561795|529984929|FG003|Overall Study|Adverse Event|0|||
146953116|NCT00561795|529984926|FG000|Overall Study|Study Closed/Terminated|0|||
146953117|NCT00561795|529984927|FG001|Overall Study|Study Closed/Terminated|3|||
146953118|NCT00561795|529984928|FG002|Overall Study|Study Closed/Terminated|0|||
146953119|NCT00561795|529984929|FG003|Overall Study|Study Closed/Terminated|0|||
146953120|NCT00561795|529984926|FG000|Overall Study|Physician Decision|1|||
146953121|NCT00561795|529984927|FG001|Overall Study|Physician Decision|0|||
146953122|NCT00561795|529984928|FG002|Overall Study|Physician Decision|0|||
146953123|NCT00561795|529984929|FG003|Overall Study|Physician Decision|0|||
146953124|NCT02807376|529984930|FG000|Overall Study|Intra-operative exclusion criteria|3|||
146953125|NCT02807376|529984931|FG001|Overall Study|Intra-operative exclusion criteria|0|||
146953126|NCT02807376|529984930|FG000|Overall Study|Lost to Follow-up|0|||
146953127|NCT02807376|529984931|FG001|Overall Study|Lost to Follow-up|1|||
146953128|NCT00846027|529984932|FG000|Overall Study|Death|3|||
146953129|NCT00846027|529984932|FG000|Overall Study|Disease Progression|30|||
146953130|NCT00846027|529984932|FG000|Overall Study|Toxicity|12|||
146953131|NCT00846027|529984932|FG000|Overall Study|Patient Decision|7|||
146953132|NCT00846027|529984932|FG000|Overall Study|Investigator Discretion|29|||
146953133|NCT00846027|529984932|FG000|Overall Study|Protocol Violation|2|||
146953134|NCT00846027|529984932|FG000|Overall Study|Subject Not Treated|7|||
146953135|NCT03228836|529984937|FG000|Overall Study|Adverse Event|3|||
146953136|NCT03228836|529984937|FG000|Overall Study|Withdrawal by Subject|1|||
146953137|NCT03228836|529984937|FG000|Overall Study|Death|1|||
146953138|NCT03228836|529984937|FG000|Overall Study|Physician Decision|1|||
146953139|NCT03228836|529984937|FG000|Overall Study|Disease Progression|7|||
146953140|NCT03228836|529984937|FG000|Overall Study|Other|4|||
146953141|NCT00948389|529984938|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
146953142|NCT00948389|529984939|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
146953143|NCT00948389|529984940|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
146953144|NCT00948389|529984941|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
146953145|NCT00948389|529984942|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
146953146|NCT00948389|529984938|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
146953147|NCT00948389|529984939|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
146953148|NCT00948389|529984940|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
146953149|NCT00948389|529984941|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
146953150|NCT00948389|529984942|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
146953151|NCT00948389|529984938|FG000|Overall Study|Both Progression and Toxicity|1|||
146953152|NCT00948389|529984939|FG001|Overall Study|Both Progression and Toxicity|0|||
146953153|NCT00948389|529984940|FG002|Overall Study|Both Progression and Toxicity|0|||
146953154|NCT00948389|529984941|FG003|Overall Study|Both Progression and Toxicity|0|||
146953155|NCT00948389|529984942|FG004|Overall Study|Both Progression and Toxicity|0|||
146953156|NCT02967562|529984945|FG000|Overall Study|Consent not obtained|1|||
146953157|NCT02967562|529984946|FG001|Overall Study|Consent not obtained|0|||
146953158|NCT02967562|529984945|FG000|Overall Study|High leak precluding analysis|1|||
146953159|NCT02967562|529984946|FG001|Overall Study|High leak precluding analysis|1|||
146953160|NCT02908841|529984947|FG000|Overall Study|Physician Decision|4|||
146953161|NCT02908841|529984948|FG001|Overall Study|Physician Decision|0|||
146953162|NCT03798366|529984949|FG000|Overall Study|Lost to Follow-up|0|||
146953163|NCT03798366|529984950|FG001|Overall Study|Lost to Follow-up|1|||
146953164|NCT02192190|529984953|FG000|Overall Study|Adverse Event|1|||
146953165|NCT02192190|529984954|FG001|Overall Study|Adverse Event|1|||
146953166|NCT02192190|529984955|FG002|Overall Study|Adverse Event|0|||
146953167|NCT02192190|529984956|FG003|Overall Study|Adverse Event|0|||
146953168|NCT02192190|529984957|FG004|Overall Study|Adverse Event|0|||
146953169|NCT02192190|529984958|FG005|Overall Study|Adverse Event|0|||
146953170|NCT02192190|529984953|FG000|Overall Study|Lost to Follow-up|3|||
146953171|NCT02192190|529984954|FG001|Overall Study|Lost to Follow-up|3|||
146953172|NCT02192190|529984955|FG002|Overall Study|Lost to Follow-up|2|||
146953173|NCT02192190|529984956|FG003|Overall Study|Lost to Follow-up|1|||
146953174|NCT02192190|529984957|FG004|Overall Study|Lost to Follow-up|4|||
146953175|NCT02192190|529984958|FG005|Overall Study|Lost to Follow-up|3|||
146953176|NCT02192190|529984953|FG000|Overall Study|Physician Decision|2|||
146953177|NCT02192190|529984954|FG001|Overall Study|Physician Decision|0|||
146953178|NCT02192190|529984955|FG002|Overall Study|Physician Decision|0|||
146953179|NCT02192190|529984956|FG003|Overall Study|Physician Decision|0|||
146953180|NCT02192190|529984957|FG004|Overall Study|Physician Decision|0|||
146953181|NCT02192190|529984958|FG005|Overall Study|Physician Decision|0|||
146953182|NCT02192190|529984953|FG000|Overall Study|Terminated by Sponsor|43|||
146953183|NCT02192190|529984954|FG001|Overall Study|Terminated by Sponsor|23|||
146953184|NCT02192190|529984955|FG002|Overall Study|Terminated by Sponsor|20|||
146953185|NCT02192190|529984956|FG003|Overall Study|Terminated by Sponsor|23|||
146953186|NCT02192190|529984957|FG004|Overall Study|Terminated by Sponsor|21|||
146953187|NCT02192190|529984958|FG005|Overall Study|Terminated by Sponsor|23|||
146953188|NCT02192190|529984953|FG000|Overall Study|Withdrawal by Subject|4|||
146953189|NCT02192190|529984954|FG001|Overall Study|Withdrawal by Subject|1|||
146953190|NCT02192190|529984955|FG002|Overall Study|Withdrawal by Subject|2|||
146953191|NCT02192190|529984956|FG003|Overall Study|Withdrawal by Subject|1|||
146953192|NCT02192190|529984957|FG004|Overall Study|Withdrawal by Subject|5|||
146953193|NCT02192190|529984958|FG005|Overall Study|Withdrawal by Subject|3|||
146953194|NCT02192190|529984953|FG000|Overall Study|Could not Keep Visit Schedule|1|||
146953195|NCT02192190|529984954|FG001|Overall Study|Could not Keep Visit Schedule|0|||
146953196|NCT02192190|529984955|FG002|Overall Study|Could not Keep Visit Schedule|0|||
146953197|NCT02192190|529984956|FG003|Overall Study|Could not Keep Visit Schedule|0|||
146953198|NCT02192190|529984957|FG004|Overall Study|Could not Keep Visit Schedule|0|||
146953199|NCT02192190|529984958|FG005|Overall Study|Could not Keep Visit Schedule|0|||
146953200|NCT02192190|529984953|FG000|Overall Study|Positive Drug Screen|0|||
146953201|NCT02192190|529984954|FG001|Overall Study|Positive Drug Screen|0|||
146953202|NCT02192190|529984955|FG002|Overall Study|Positive Drug Screen|0|||
146953203|NCT02192190|529984956|FG003|Overall Study|Positive Drug Screen|1|||
146953204|NCT02192190|529984957|FG004|Overall Study|Positive Drug Screen|0|||
146953205|NCT02192190|529984958|FG005|Overall Study|Positive Drug Screen|0|||
146953206|NCT02192190|529984953|FG000|Overall Study|Inadequate Pain Relief|0|||
146953207|NCT02192190|529984954|FG001|Overall Study|Inadequate Pain Relief|1|||
146953208|NCT02192190|529984955|FG002|Overall Study|Inadequate Pain Relief|1|||
146953209|NCT02192190|529984956|FG003|Overall Study|Inadequate Pain Relief|0|||
146953210|NCT02192190|529984957|FG004|Overall Study|Inadequate Pain Relief|0|||
146953211|NCT02192190|529984958|FG005|Overall Study|Inadequate Pain Relief|0|||
146953212|NCT02607865|529984959|FG000|Overall Study|Lost to Follow-up|9|||
146953213|NCT02607865|529984960|FG001|Overall Study|Lost to Follow-up|7|||
146953214|NCT02607865|529984961|FG002|Overall Study|Lost to Follow-up|7|||
146953215|NCT02607865|529984962|FG003|Overall Study|Lost to Follow-up|5|||
146953216|NCT02607865|529984959|FG000|Overall Study|Withdrawal by Subject|18|||
146953217|NCT02607865|529984960|FG001|Overall Study|Withdrawal by Subject|18|||
146953218|NCT02607865|529984961|FG002|Overall Study|Withdrawal by Subject|17|||
146953219|NCT02607865|529984962|FG003|Overall Study|Withdrawal by Subject|8|||
146824735|NCT03569475|529528439|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
146824736|NCT03569475|529528440|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
146824737|NCT03569475|529528438|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
146824738|NCT03569475|529528439|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
146824739|NCT03569475|529528440|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
146824740|NCT02109107|529528441|FG000|Overall Study|Lost to Follow-up|2|||
146824741|NCT03078751|529528442|FG000|Overall Study|Adverse Event|4|||
146824742|NCT03078751|529528443|FG001|Overall Study|Adverse Event|0|||
146824743|NCT03078751|529528442|FG000|Overall Study|Physician Decision|1|||
146824744|NCT03078751|529528443|FG001|Overall Study|Physician Decision|0|||
146824745|NCT03078751|529528442|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
146824746|NCT03078751|529528443|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
146824747|NCT03078751|529528442|FG000|Overall Study|Subject/guardian decision|8|||
146824748|NCT03078751|529528443|FG001|Overall Study|Subject/guardian decision|1|||
146824749|NCT03078751|529528442|FG000|Overall Study|Untreated|0|||
146824750|NCT03078751|529528443|FG001|Overall Study|Untreated|4|||
146824751|NCT02515097|529528444|FG000|Overall Study|Lost to Follow-up|4|||
146824752|NCT02515097|529528445|FG001|Overall Study|Lost to Follow-up|2|||
146824753|NCT02515097|529528444|FG000|Overall Study|Withdrawal by Subject|1|||
146824754|NCT02515097|529528445|FG001|Overall Study|Withdrawal by Subject|3|||
146824755|NCT02515097|529528444|FG000|Overall Study|Adverse Event|2|||
146824756|NCT02515097|529528445|FG001|Overall Study|Adverse Event|1|||
146824757|NCT00853021|529528446|FG000|Overall Study|Adverse Event|2|||
146824758|NCT00853021|529528446|FG000|Overall Study|Withdrawal by Subject|2|||
146824759|NCT00853021|529528446|FG000|Overall Study|Death|1|||
146824760|NCT03613454|529528447|FG000|Overall Study|Protocol Violation|1|||
146824761|NCT03613454|529528448|FG001|Overall Study|Protocol Violation|0|||
146824762|NCT03613454|529528447|FG000|Overall Study|Protocol Violation|0|||
146824763|NCT03613454|529528448|FG001|Overall Study|Protocol Violation|1|||
146824764|NCT04167085|529528449|FG000|Baseline|Withdrawal by Subject|2|||
146824765|NCT04167085|529528450|FG001|Baseline|Withdrawal by Subject|1|||
146824766|NCT04167085|529528449|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
146824767|NCT04167085|529528450|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
146824768|NCT02273180|529528454|FG000|Overall Study|Adverse Event|2|||
146824769|NCT02273180|529528455|FG001|Overall Study|Adverse Event|2|||
146824770|NCT02273180|529528454|FG000|Overall Study|Lack of Efficacy|1|||
146824771|NCT02273180|529528455|FG001|Overall Study|Lack of Efficacy|0|||
146824772|NCT02273180|529528454|FG000|Overall Study|Protocol Violation|1|||
146824773|NCT02273180|529528455|FG001|Overall Study|Protocol Violation|7|||
146824774|NCT02273180|529528454|FG000|Overall Study|Randomized but not treated|1|||
146824775|NCT02273180|529528455|FG001|Overall Study|Randomized but not treated|0|||
146824776|NCT02273180|529528454|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
146824777|NCT02273180|529528455|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
146824778|NCT02273180|529528454|FG000|Overall Study|Other than specified above|21|||
146824779|NCT02273180|529528455|FG001|Overall Study|Other than specified above|10|||
146824780|NCT02154516|529528456|FG000|Overall Study|Withdrawal by Subject|0|||
146824781|NCT02154516|529528457|FG001|Overall Study|Withdrawal by Subject|1|||
146824782|NCT02154516|529528456|FG000|Overall Study|Lost to Follow-up|1|||
146824783|NCT02154516|529528457|FG001|Overall Study|Lost to Follow-up|0|||
146824784|NCT02154516|529528456|FG000|Overall Study|Removal/revision of device|1|||
146824785|NCT02154516|529528457|FG001|Overall Study|Removal/revision of device|0|||
146824786|NCT02154516|529528456|FG000|Overall Study|Death|2|||
146824787|NCT02154516|529528457|FG001|Overall Study|Death|1|||
146824788|NCT02965599|529528461|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
146824789|NCT02965599|529528462|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
146824790|NCT04435522|529528466|FG000|Overall Study|Withdrawal by Subject|2|||
146953220|NCT02607865|529984959|FG000|Overall Study|Death|5|||
146953221|NCT02607865|529984960|FG001|Overall Study|Death|4|||
146953222|NCT02607865|529984961|FG002|Overall Study|Death|1|||
146953223|NCT02607865|529984962|FG003|Overall Study|Death|3|||
146824791|NCT02799745|529528469|FG000|Overall Study|Participant moved out of state|1|||
146824792|NCT02799745|529528470|FG001|Overall Study|Participant moved out of state|0|||
146824793|NCT02799745|529528469|FG000|Overall Study|Discontinued due to planned surgery|1|||
146824794|NCT02799745|529528470|FG001|Overall Study|Discontinued due to planned surgery|0|||
146824795|NCT02799745|529528469|FG000|Overall Study|Withdrawal by Subject|16|||
146824796|NCT02799745|529528470|FG001|Overall Study|Withdrawal by Subject|25|||
146953224|NCT02607865|529984959|FG000|Overall Study|Unclassified|1|||
146953225|NCT02607865|529984960|FG001|Overall Study|Unclassified|1|||
146953226|NCT02607865|529984961|FG002|Overall Study|Unclassified|2|||
146824797|NCT02799745|529528469|FG000|Overall Study|Protocol Deviation|4|||
146953227|NCT02607865|529984962|FG003|Overall Study|Unclassified|0|||
146953228|NCT03227692|529984963|FG000|Overall Study|Protocol Violation|1|||
146953229|NCT03227692|529984964|FG001|Overall Study|Protocol Violation|1|||
146953230|NCT03227692|529984963|FG000|Overall Study|Lost to Follow-up|4|||
146953231|NCT03227692|529984964|FG001|Overall Study|Lost to Follow-up|2|||
146953232|NCT03227692|529984963|FG000|Overall Study|Adverse Event|0|||
146953233|NCT03227692|529984964|FG001|Overall Study|Adverse Event|2|||
146953234|NCT00381706|529984965|FG000|Overall Study|Never treated|7|||
146953235|NCT00381706|529984966|FG001|Overall Study|Never treated|2|||
146953236|NCT00381706|529984967|FG002|Overall Study|Never treated|1|||
146953237|NCT00203294|529984968|FG000|Overall Study|Withdrawal by Subject|8|||
146953238|NCT00203294|529984969|FG001|Overall Study|Withdrawal by Subject|13|||
146953239|NCT00886587|529984970|FG000|Overall Study|Adverse Event|2|||
146953240|NCT00886587|529984971|FG001|Overall Study|Adverse Event|1|||
146953241|NCT00886587|529984970|FG000|Overall Study|Protocol Violation|2|||
146953242|NCT00886587|529984971|FG001|Overall Study|Protocol Violation|0|||
146953243|NCT00886587|529984970|FG000|Overall Study|Withdrawal by Subject|0|||
146953244|NCT00886587|529984971|FG001|Overall Study|Withdrawal by Subject|1|||
146953245|NCT00550615|529984973|FG000|Overall Study|Withdrawal by Subject|0|||
146953246|NCT00550615|529984974|FG001|Overall Study|Withdrawal by Subject|0|||
146953247|NCT00550615|529984975|FG002|Overall Study|Withdrawal by Subject|2|||
146953248|NCT00550615|529984976|FG003|Overall Study|Withdrawal by Subject|3|||
146953249|NCT00550615|529984973|FG000|Overall Study|Not evaluable|0|||
146953250|NCT00550615|529984974|FG001|Overall Study|Not evaluable|0|||
146953251|NCT00550615|529984975|FG002|Overall Study|Not evaluable|2|||
146953252|NCT00550615|529984976|FG003|Overall Study|Not evaluable|7|||
146953253|NCT01948791|529984983|FG000|Overall Study|Adverse Event|12|||
146953254|NCT01948791|529984983|FG000|Overall Study|Lack of Efficacy|3|||
146953255|NCT01948791|529984983|FG000|Overall Study|Protocol Violation|2|||
146953256|NCT01948791|529984983|FG000|Overall Study|Withdrawal by Subject|5|||
146953257|NCT01948791|529984983|FG000|Overall Study|Lost to Follow-up|6|||
146953258|NCT01948791|529984983|FG000|Overall Study|Management issues|1|||
146953259|NCT01948791|529984983|FG000|Overall Study|Others|7|||
146953260|NCT01948791|529984983|FG000|Overall Study|Screening failure|35|||
146953261|NCT01955005|529984987|FG000|Overall Study|Withdrawal by Subject|3|||
146953262|NCT01955005|529984988|FG001|Overall Study|Withdrawal by Subject|5|||
146953263|NCT00545584|529984989|FG000|Overall Study|Only one reason for discontinuation|62|||
146953264|NCT00545584|529984990|FG001|Overall Study|Only one reason for discontinuation|61|||
146953265|NCT00545584|529984991|FG002|Overall Study|Only one reason for discontinuation|48|||
146953266|NCT00545584|529984989|FG000|Overall Study|Two or more reasons for discontinuation|17|||
146953267|NCT00545584|529984990|FG001|Overall Study|Two or more reasons for discontinuation|19|||
146953268|NCT00545584|529984991|FG002|Overall Study|Two or more reasons for discontinuation|8|||
146953269|NCT03525613|529984992|FG000|Overall Study|Adverse Event|11|||
146953270|NCT03525613|529984993|FG001|Overall Study|Adverse Event|8|||
146953271|NCT03525613|529984994|FG002|Overall Study|Adverse Event|3|||
146953272|NCT03525613|529984995|FG003|Overall Study|Adverse Event|3|||
146953273|NCT03525613|529984992|FG000|Overall Study|Lost to Follow-up|4|||
146953274|NCT03525613|529984993|FG001|Overall Study|Lost to Follow-up|5|||
146953275|NCT03525613|529984994|FG002|Overall Study|Lost to Follow-up|3|||
146953276|NCT03525613|529984995|FG003|Overall Study|Lost to Follow-up|2|||
146953277|NCT03525613|529984992|FG000|Overall Study|Physician Decision|0|||
146953278|NCT03525613|529984993|FG001|Overall Study|Physician Decision|1|||
146953279|NCT03525613|529984994|FG002|Overall Study|Physician Decision|0|||
146953280|NCT03525613|529984995|FG003|Overall Study|Physician Decision|1|||
146953281|NCT03525613|529984992|FG000|Overall Study|Consent Withdrawal|25|||
146953282|NCT03525613|529984993|FG001|Overall Study|Consent Withdrawal|16|||
146953283|NCT03525613|529984994|FG002|Overall Study|Consent Withdrawal|12|||
146953284|NCT03525613|529984995|FG003|Overall Study|Consent Withdrawal|9|||
146953285|NCT03525613|529984992|FG000|Overall Study|Death|20|||
146824798|NCT02799745|529528470|FG001|Overall Study|Protocol Deviation|5|||
146824799|NCT02799745|529528469|FG000|Overall Study|Progressive Disease|28|||
146824800|NCT02799745|529528470|FG001|Overall Study|Progressive Disease|38|||
146824801|NCT02799745|529528469|FG000|Overall Study|Lost to Follow-up|3|||
146824802|NCT02799745|529528470|FG001|Overall Study|Lost to Follow-up|2|||
146824803|NCT02799745|529528469|FG000|Overall Study|Death|3|||
146824804|NCT02799745|529528470|FG001|Overall Study|Death|0|||
146953286|NCT03525613|529984993|FG001|Overall Study|Death|9|||
146953287|NCT03525613|529984994|FG002|Overall Study|Death|7|||
146953288|NCT03525613|529984995|FG003|Overall Study|Death|1|||
146953289|NCT03525613|529984992|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
146953290|NCT03525613|529984993|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
146953291|NCT03525613|529984994|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
146953292|NCT03525613|529984995|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
146953293|NCT00135694|529984999|FG000|Overall Study|Adverse Event|17|||
146953294|NCT00135694|529985000|FG001|Overall Study|Adverse Event|4|||
146953295|NCT00135694|529985001|FG002|Overall Study|Adverse Event|0|||
146953296|NCT00135694|529984999|FG000|Overall Study|Death|14|||
146953297|NCT00135694|529985000|FG001|Overall Study|Death|1|||
146953298|NCT00135694|529985001|FG002|Overall Study|Death|2|||
146824805|NCT02799745|529528469|FG000|Overall Study|Adverse Event|0|||
146824806|NCT02799745|529528470|FG001|Overall Study|Adverse Event|1|||
146824807|NCT02517528|529529900|FG000|Overall Study|Withdrawal by Subject|1|||
146824808|NCT01093599|529529901|FG000|Overall Study|Lost to Follow-up|32|||
146824809|NCT01093599|529529902|FG001|Overall Study|Lost to Follow-up|46|||
146824810|NCT00630552|529529906|FG000|Overall Study|Adverse Event|0|||
146824811|NCT00630552|529529907|FG001|Overall Study|Adverse Event|1|||
146824812|NCT00630552|529529908|FG002|Overall Study|Adverse Event|5|||
146824813|NCT00630552|529529909|FG003|Overall Study|Adverse Event|4|||
146824814|NCT00630552|529529910|FG004|Overall Study|Adverse Event|2|||
146824815|NCT00630552|529529906|FG000|Overall Study|Disease progression|5|||
146824816|NCT00630552|529529907|FG001|Overall Study|Disease progression|6|||
146824817|NCT00630552|529529908|FG002|Overall Study|Disease progression|27|||
146824818|NCT00630552|529529909|FG003|Overall Study|Disease progression|22|||
146824819|NCT00630552|529529910|FG004|Overall Study|Disease progression|31|||
146824820|NCT00630552|529529906|FG000|Overall Study|Never received IP|0|||
146824821|NCT00630552|529529907|FG001|Overall Study|Never received IP|0|||
146824822|NCT00630552|529529908|FG002|Overall Study|Never received IP|0|||
146824823|NCT00630552|529529909|FG003|Overall Study|Never received IP|2|||
146824824|NCT00630552|529529910|FG004|Overall Study|Never received IP|2|||
146824825|NCT00630552|529529906|FG000|Overall Study|Ineligibility determined|0|||
146824826|NCT00630552|529529907|FG001|Overall Study|Ineligibility determined|0|||
146824827|NCT00630552|529529908|FG002|Overall Study|Ineligibility determined|0|||
146824828|NCT00630552|529529909|FG003|Overall Study|Ineligibility determined|0|||
146824829|NCT00630552|529529910|FG004|Overall Study|Ineligibility determined|1|||
146824830|NCT00630552|529529906|FG000|Overall Study|Protocol Violation|0|||
146824831|NCT00630552|529529907|FG001|Overall Study|Protocol Violation|0|||
146824832|NCT00630552|529529908|FG002|Overall Study|Protocol Violation|0|||
146824833|NCT00630552|529529909|FG003|Overall Study|Protocol Violation|1|||
146824834|NCT00630552|529529910|FG004|Overall Study|Protocol Violation|0|||
146824835|NCT00630552|529529906|FG000|Overall Study|Physician Decision|0|||
146824836|NCT00630552|529529907|FG001|Overall Study|Physician Decision|0|||
146824837|NCT00630552|529529908|FG002|Overall Study|Physician Decision|0|||
146824838|NCT00630552|529529909|FG003|Overall Study|Physician Decision|0|||
146824839|NCT00630552|529529910|FG004|Overall Study|Physician Decision|1|||
146824840|NCT00630552|529529906|FG000|Overall Study|Death|0|||
146824841|NCT00630552|529529907|FG001|Overall Study|Death|0|||
146824842|NCT00630552|529529908|FG002|Overall Study|Death|1|||
146824843|NCT00630552|529529909|FG003|Overall Study|Death|2|||
146824844|NCT00630552|529529910|FG004|Overall Study|Death|2|||
146824845|NCT00630552|529529906|FG000|Overall Study|Withdrawal by Subject|0|||
146824846|NCT00630552|529529907|FG001|Overall Study|Withdrawal by Subject|0|||
146824847|NCT00630552|529529908|FG002|Overall Study|Withdrawal by Subject|0|||
146824848|NCT00630552|529529909|FG003|Overall Study|Withdrawal by Subject|1|||
146824849|NCT00630552|529529910|FG004|Overall Study|Withdrawal by Subject|0|||
146824850|NCT00630552|529529906|FG000|Overall Study|Other|0|||
146824851|NCT00630552|529529907|FG001|Overall Study|Other|0|||
146824852|NCT00630552|529529908|FG002|Overall Study|Other|4|||
146824853|NCT00630552|529529909|FG003|Overall Study|Other|2|||
146824854|NCT00630552|529529910|FG004|Overall Study|Other|0|||
146824855|NCT03226106|529529911|FG000|Overall Study|Withdrawal by Subject|2|||
146824856|NCT03226106|529529912|FG001|Overall Study|Withdrawal by Subject|0|||
146824857|NCT03226106|529529911|FG000|Overall Study|Adverse Event|1|||
146824858|NCT03226106|529529912|FG001|Overall Study|Adverse Event|0|||
146824859|NCT03226106|529529911|FG000|Overall Study|Lost to Follow-up|2|||
146824860|NCT03226106|529529912|FG001|Overall Study|Lost to Follow-up|0|||
146824861|NCT01084239|529529913|FG000|28-Day Follow-up|Lost to Follow-up|4|||
146824862|NCT01084239|529529914|FG001|28-Day Follow-up|Lost to Follow-up|9|||
146824863|NCT00721214|529529915|FG000|Overall Study|Chose another center for transplant|1|||
146824864|NCT00721214|529529915|FG000|Overall Study|Death|3|||
146824865|NCT00983905|529529916|FG000|Theophylline Alone|Adverse Event|1|||
146824866|NCT00983905|529529916|FG000|Colchicine Alone|Adverse Event|2|||
146824867|NCT00494026|529529917|FG000|Overall Study|Sponsor Decision|4|||
146824868|NCT02466243|529529918|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
146824869|NCT02466243|529529919|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
146824870|NCT02466243|529529918|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
146824871|NCT02466243|529529919|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
146824872|NCT02466243|529529918|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
146824873|NCT02466243|529529919|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
146824874|NCT02466243|529529918|FG000|Part B Open-label Treatment Period|Missing|2|||
146824875|NCT02466243|529529919|FG001|Part B Open-label Treatment Period|Missing|2|||
146824876|NCT00488319|529529920|FG000|Overall Study|Adverse Event|1|||
146824877|NCT00488319|529529921|FG001|Overall Study|Adverse Event|2|||
146824878|NCT00488319|529529922|FG002|Overall Study|Adverse Event|23|||
146824879|NCT00488319|529529920|FG000|Overall Study|Lack of Efficacy|6|||
146824880|NCT00488319|529529921|FG001|Overall Study|Lack of Efficacy|12|||
146824881|NCT00488319|529529922|FG002|Overall Study|Lack of Efficacy|27|||
146824882|NCT00488319|529529920|FG000|Overall Study|Lost to Follow-up|3|||
146824883|NCT00488319|529529921|FG001|Overall Study|Lost to Follow-up|5|||
146953299|NCT00135694|529984999|FG000|Overall Study|Lost to Follow-up|8|||
146953300|NCT00135694|529985000|FG001|Overall Study|Lost to Follow-up|7|||
146953301|NCT00135694|529985001|FG002|Overall Study|Lost to Follow-up|1|||
146953302|NCT00135694|529984999|FG000|Overall Study|Withdrawal by Subject|41|||
146953303|NCT00135694|529985000|FG001|Overall Study|Withdrawal by Subject|7|||
146953304|NCT00135694|529985001|FG002|Overall Study|Withdrawal by Subject|4|||
146953305|NCT00135694|529984999|FG000|Overall Study|Protocol Violation|19|||
146953306|NCT00135694|529985000|FG001|Overall Study|Protocol Violation|1|||
146953307|NCT00135694|529985001|FG002|Overall Study|Protocol Violation|0|||
146953308|NCT00135694|529984999|FG000|Overall Study|Hepatitis C related reasons|39|||
146953309|NCT00135694|529985000|FG001|Overall Study|Hepatitis C related reasons|1|||
146953310|NCT00135694|529985001|FG002|Overall Study|Hepatitis C related reasons|0|||
146953311|NCT00135694|529984999|FG000|Overall Study|Ineligible for Random assignment|42|||
146953312|NCT00135694|529985000|FG001|Overall Study|Ineligible for Random assignment|0|||
146953313|NCT00135694|529985001|FG002|Overall Study|Ineligible for Random assignment|0|||
146953314|NCT00374452|529985002|FG000|Overall Study|Left clinic before intervention started|4|||
146953315|NCT00374452|529985003|FG001|Overall Study|Left clinic before intervention started|1|||
146953316|NCT00374452|529985002|FG000|Overall Study|Change in job role before intervention|0|||
146953317|NCT00374452|529985003|FG001|Overall Study|Change in job role before intervention|1|||
146953318|NCT00374452|529985002|FG000|Overall Study|Left clinic after intervention started|1|||
146953319|NCT00374452|529985003|FG001|Overall Study|Left clinic after intervention started|1|||
146953320|NCT00374452|529985002|FG000|Overall Study|Withdrawal by Subject|0|||
146953321|NCT00374452|529985003|FG001|Overall Study|Withdrawal by Subject|2|||
146953322|NCT03117309|529985007|FG000|Overall Study|Not meeting inclusion criteria|0|||
146953323|NCT03117309|529985008|FG001|Overall Study|Not meeting inclusion criteria|1|||
146953324|NCT03452397|529985019|FG000|Overall Study|Adverse Event|1|||
146953325|NCT03452397|529985020|FG001|Overall Study|Adverse Event|0|||
146953326|NCT03452397|529985021|FG002|Overall Study|Adverse Event|0|||
146953327|NCT03452397|529985022|FG003|Overall Study|Adverse Event|0|||
146953328|NCT03452397|529985019|FG000|Overall Study|Administrative reason|0|||
146953329|NCT03452397|529985020|FG001|Overall Study|Administrative reason|0|||
146953330|NCT03452397|529985021|FG002|Overall Study|Administrative reason|1|||
146953331|NCT03452397|529985022|FG003|Overall Study|Administrative reason|1|||
146953332|NCT03452397|529985019|FG000|Overall Study|Withdrawal by Subject|0|||
146953333|NCT03452397|529985020|FG001|Overall Study|Withdrawal by Subject|0|||
146953334|NCT03452397|529985021|FG002|Overall Study|Withdrawal by Subject|1|||
146953335|NCT03452397|529985022|FG003|Overall Study|Withdrawal by Subject|0|||
146953336|NCT00125268|529985023|FG000|Overall Study|Withdrawal by Subject|1|||
146953337|NCT00125268|529985024|FG001|Overall Study|Withdrawal by Subject|1|||
146953338|NCT00925522|529985025|FG000|Overall Study|study closed -- business decision|20|||
146953339|NCT00805142|529985026|FG000|Titration Period|Adverse Event|3|||
146953340|NCT00805142|529985027|FG001|Titration Period|Adverse Event|3|||
146953341|NCT00805142|529985026|FG000|Titration Period|Lack of Efficacy|1|||
146953342|NCT00805142|529985027|FG001|Titration Period|Lack of Efficacy|1|||
146953343|NCT00805142|529985026|FG000|Titration Period|Lost to Follow-up|0|||
146953344|NCT00805142|529985027|FG001|Titration Period|Lost to Follow-up|1|||
146953345|NCT00805142|529985026|FG000|Titration Period|Disease Progression|2|||
146953346|NCT00805142|529985027|FG001|Titration Period|Disease Progression|1|||
146953347|NCT00805142|529985026|FG000|Titration Period|Withdrawal of consent|0|||
146953348|NCT00805142|529985027|FG001|Titration Period|Withdrawal of consent|1|||
146953349|NCT00805142|529985026|FG000|Titration Period|Other|0|||
146953350|NCT00805142|529985027|FG001|Titration Period|Other|3|||
146953351|NCT00805142|529985026|FG000|Maintenance Period|Adverse Event|0|||
146953352|NCT00805142|529985027|FG001|Maintenance Period|Adverse Event|1|||
146953353|NCT00805142|529985026|FG000|Maintenance Period|Other|0|||
146953354|NCT00805142|529985027|FG001|Maintenance Period|Other|1|||
146953355|NCT00424463|529985029|FG000|Overall Study|Adverse Event|2|||
146953356|NCT00424463|529985030|FG001|Overall Study|Adverse Event|3|||
146953357|NCT00424463|529985031|FG002|Overall Study|Adverse Event|2|||
146953358|NCT00424463|529985029|FG000|Overall Study|Physician Decision|0|||
146953359|NCT00424463|529985030|FG001|Overall Study|Physician Decision|2|||
146953360|NCT00424463|529985031|FG002|Overall Study|Physician Decision|2|||
146953361|NCT00424463|529985029|FG000|Overall Study|Withdrawal by Subject|4|||
146953362|NCT00424463|529985030|FG001|Overall Study|Withdrawal by Subject|2|||
146953363|NCT00424463|529985031|FG002|Overall Study|Withdrawal by Subject|5|||
146953364|NCT00424463|529985029|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
146953365|NCT00424463|529985030|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
146953366|NCT00424463|529985031|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
146953367|NCT00424463|529985029|FG000|Overall Study|Patient's convenience|0|||
146953368|NCT00424463|529985030|FG001|Overall Study|Patient's convenience|0|||
146953369|NCT00424463|529985031|FG002|Overall Study|Patient's convenience|1|||
146953370|NCT02449915|529985032|FG000|Overall Study|Exclusion criteria - drug use|1|||
146953371|NCT02449915|529985033|FG001|Overall Study|Exclusion criteria - drug use|0|||
146953372|NCT02449915|529985032|FG000|Overall Study|Withdrawal by Subject|0|||
146953373|NCT02449915|529985033|FG001|Overall Study|Withdrawal by Subject|2|||
146953374|NCT02449915|529985032|FG000|Overall Study|Intraoperative surgical findings|1|||
146953375|NCT02449915|529985033|FG001|Overall Study|Intraoperative surgical findings|1|||
146824884|NCT00488319|529529922|FG002|Overall Study|Lost to Follow-up|16|||
146824885|NCT00488319|529529920|FG000|Overall Study|Withdrawal by Subject|5|||
146824886|NCT00488319|529529921|FG001|Overall Study|Withdrawal by Subject|20|||
146824887|NCT00488319|529529922|FG002|Overall Study|Withdrawal by Subject|44|||
146824888|NCT00488319|529529920|FG000|Overall Study|Other reasons for withdrawal|0|||
146824889|NCT00488319|529529921|FG001|Overall Study|Other reasons for withdrawal|4|||
146824890|NCT00488319|529529922|FG002|Overall Study|Other reasons for withdrawal|12|||
146824891|NCT00405912|529529926|FG000|Overall Study|Withdrawal by Subject|12|||
146824892|NCT00405912|529529927|FG001|Overall Study|Withdrawal by Subject|11|||
146824893|NCT00405912|529529928|FG002|Overall Study|Withdrawal by Subject|12|||
146824894|NCT00405912|529529926|FG000|Overall Study|Lost to Follow-up|4|||
146824895|NCT00405912|529529927|FG001|Overall Study|Lost to Follow-up|8|||
146824896|NCT00405912|529529928|FG002|Overall Study|Lost to Follow-up|4|||
146824897|NCT03730662|529529929|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
146824898|NCT03730662|529529930|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
146824899|NCT03730662|529529931|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
146824900|NCT03730662|529529932|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
146824901|NCT03730662|529529929|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
146824902|NCT03730662|529529930|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
146824903|NCT03730662|529529931|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
146824904|NCT03730662|529529932|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
146824905|NCT03730662|529529929|FG000|Treatment Period (52 Weeks)|Death|6|||
146824906|NCT03730662|529529930|FG001|Treatment Period (52 Weeks)|Death|2|||
146824907|NCT03730662|529529931|FG002|Treatment Period (52 Weeks)|Death|2|||
146824908|NCT03730662|529529932|FG003|Treatment Period (52 Weeks)|Death|9|||
146824909|NCT03730662|529529929|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
146824910|NCT03730662|529529930|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
146824911|NCT03730662|529529931|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
146824912|NCT03730662|529529932|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
146824913|NCT03730662|529529929|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
146824914|NCT03730662|529529930|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
146824915|NCT03730662|529529931|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
146824916|NCT03730662|529529932|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
146824917|NCT03730662|529529929|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
146824918|NCT03730662|529529930|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
146824919|NCT03730662|529529931|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
146824920|NCT03730662|529529932|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
146824921|NCT03730662|529529929|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
146824922|NCT03730662|529529930|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
146824923|NCT03730662|529529931|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
146824924|NCT03730662|529529932|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
146824925|NCT03730662|529529929|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
146824926|NCT03730662|529529930|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
146824927|NCT03730662|529529931|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
146824928|NCT03730662|529529932|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
146824929|NCT03730662|529529929|FG000|Variable Treatment Period|Adverse Event|1|||
146824930|NCT03730662|529529930|FG001|Variable Treatment Period|Adverse Event|2|||
146824931|NCT03730662|529529931|FG002|Variable Treatment Period|Adverse Event|0|||
146824932|NCT03730662|529529932|FG003|Variable Treatment Period|Adverse Event|7|||
146824933|NCT03730662|529529929|FG000|Variable Treatment Period|Death|9|||
146824934|NCT03730662|529529930|FG001|Variable Treatment Period|Death|0|||
146824935|NCT03730662|529529931|FG002|Variable Treatment Period|Death|6|||
146824936|NCT03730662|529529932|FG003|Variable Treatment Period|Death|26|||
146824937|NCT03730662|529529929|FG000|Variable Treatment Period|Lost to Follow-up|2|||
146824938|NCT03730662|529529930|FG001|Variable Treatment Period|Lost to Follow-up|1|||
146824939|NCT03730662|529529931|FG002|Variable Treatment Period|Lost to Follow-up|4|||
146824940|NCT03730662|529529932|FG003|Variable Treatment Period|Lost to Follow-up|11|||
146824941|NCT03730662|529529929|FG000|Variable Treatment Period|Personal Reason|0|||
146824942|NCT03730662|529529930|FG001|Variable Treatment Period|Personal Reason|2|||
146824943|NCT03730662|529529931|FG002|Variable Treatment Period|Personal Reason|1|||
146824944|NCT03730662|529529932|FG003|Variable Treatment Period|Personal Reason|6|||
146824945|NCT03730662|529529929|FG000|Variable Treatment Period|Physician Decision|0|||
146824946|NCT03730662|529529930|FG001|Variable Treatment Period|Physician Decision|0|||
146824947|NCT03730662|529529931|FG002|Variable Treatment Period|Physician Decision|0|||
146824948|NCT03730662|529529932|FG003|Variable Treatment Period|Physician Decision|3|||
146824949|NCT03730662|529529929|FG000|Variable Treatment Period|Protocol Violation|0|||
146824950|NCT03730662|529529930|FG001|Variable Treatment Period|Protocol Violation|1|||
146824951|NCT03730662|529529931|FG002|Variable Treatment Period|Protocol Violation|1|||
146824952|NCT03730662|529529932|FG003|Variable Treatment Period|Protocol Violation|1|||
146824953|NCT03730662|529529929|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
146953376|NCT02449915|529985032|FG000|Overall Study|Abnormal preop lab|0|||
146824954|NCT03730662|529529930|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
146953377|NCT02449915|529985033|FG001|Overall Study|Abnormal preop lab|1|||
146953378|NCT01436357|529985034|FG000|Overall Study|Death|5|||
146953379|NCT01436357|529985035|FG001|Overall Study|Death|1|||
146953380|NCT01436357|529985034|FG000|Overall Study|Enrolled but not vaccinated|1|||
146953381|NCT01436357|529985035|FG001|Overall Study|Enrolled but not vaccinated|1|||
146953382|NCT01436357|529985034|FG000|Overall Study|Incarceration|18|||
146953383|NCT01436357|529985035|FG001|Overall Study|Incarceration|20|||
146953384|NCT01436357|529985034|FG000|Overall Study|Lost to Follow-up|67|||
146953385|NCT01436357|529985035|FG001|Overall Study|Lost to Follow-up|61|||
146953386|NCT01436357|529985034|FG000|Overall Study|Protocol Violation|1|||
146953387|NCT01436357|529985035|FG001|Overall Study|Protocol Violation|0|||
146953388|NCT01436357|529985034|FG000|Overall Study|Withdrawal by Subject|26|||
146953389|NCT01436357|529985035|FG001|Overall Study|Withdrawal by Subject|38|||
146953390|NCT01436357|529985034|FG000|Overall Study|Physician Decision|3|||
146953391|NCT01436357|529985035|FG001|Overall Study|Physician Decision|4|||
146953392|NCT01436357|529985034|FG000|Overall Study|Moved out of area|1|||
146953393|NCT01436357|529985035|FG001|Overall Study|Moved out of area|2|||
146953394|NCT01436357|529985034|FG000|Overall Study|Subject in rehab|0|||
146953395|NCT01436357|529985035|FG001|Overall Study|Subject in rehab|1|||
146953396|NCT00656799|529985036|FG000|Overall Study|Death|2|||
146953397|NCT05281094|529985037|FG000|Overall Study|Adverse Event|1|||
146953398|NCT05281094|529985038|FG001|Overall Study|Adverse Event|0|||
146953399|NCT05281094|529985037|FG000|Overall Study|Lost to Follow-up|29|||
146953400|NCT05281094|529985038|FG001|Overall Study|Lost to Follow-up|22|||
146953401|NCT05281094|529985037|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
146953402|NCT05281094|529985038|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
146953403|NCT05281094|529985037|FG000|Overall Study|Death|1|||
146953404|NCT05281094|529985038|FG001|Overall Study|Death|2|||
146953405|NCT05281094|529985037|FG000|Overall Study|Not pre-specified reason|8|||
146953406|NCT05281094|529985038|FG001|Overall Study|Not pre-specified reason|5|||
146953407|NCT00631969|529985039|FG000|Overall Study|Adverse Event|3|||
146953408|NCT00631969|529985040|FG001|Overall Study|Adverse Event|1|||
146953409|NCT00631969|529985039|FG000|Overall Study|Lack of Efficacy|2|||
146953410|NCT00631969|529985040|FG001|Overall Study|Lack of Efficacy|8|||
146953411|NCT00631969|529985039|FG000|Overall Study|Lost to Follow-up|2|||
146953412|NCT00631969|529985040|FG001|Overall Study|Lost to Follow-up|1|||
146953413|NCT00631969|529985039|FG000|Overall Study|Protocol Violation|1|||
146953414|NCT00631969|529985040|FG001|Overall Study|Protocol Violation|1|||
146953415|NCT00631969|529985039|FG000|Overall Study|Consent Withdrawn|5|||
146953416|NCT00631969|529985040|FG001|Overall Study|Consent Withdrawn|7|||
146953417|NCT00631969|529985039|FG000|Overall Study|Noncompliant With Study Medication|0|||
146953418|NCT00631969|529985040|FG001|Overall Study|Noncompliant With Study Medication|1|||
146953419|NCT00631969|529985039|FG000|Overall Study|No Drug Exposure|2|||
146953420|NCT00631969|529985040|FG001|Overall Study|No Drug Exposure|2|||
146953421|NCT00957034|529985041|FG000|Overall Study|Adverse Event|0|||
146953422|NCT00957034|529985042|FG001|Overall Study|Adverse Event|1|||
146953423|NCT00957034|529985043|FG002|Overall Study|Adverse Event|1|||
146953424|NCT00957034|529985041|FG000|Overall Study|Sponsor Terminated Study|6|||
146953425|NCT00957034|529985042|FG001|Overall Study|Sponsor Terminated Study|1|||
146953426|NCT00957034|529985043|FG002|Overall Study|Sponsor Terminated Study|5|||
146953427|NCT00957034|529985041|FG000|Overall Study|Withdrawal by Subject|0|||
146953428|NCT00957034|529985042|FG001|Overall Study|Withdrawal by Subject|2|||
146953429|NCT00957034|529985043|FG002|Overall Study|Withdrawal by Subject|0|||
146953430|NCT02390167|529987467|FG000|Overall Study|Lost to Follow-up|1|||
146953431|NCT00805194|529987468|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
146953432|NCT00805194|529987469|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
146953433|NCT00805194|529987468|FG000|Overall Study|Worsening or AE of underlying disease|64|||
146953434|NCT00805194|529987469|FG001|Overall Study|Worsening or AE of underlying disease|70|||
146953435|NCT00805194|529987468|FG000|Overall Study|Other AE|84|||
146953436|NCT00805194|529987469|FG001|Overall Study|Other AE|73|||
146953437|NCT00805194|529987468|FG000|Overall Study|Protocol Violation|9|||
146953438|NCT00805194|529987469|FG001|Overall Study|Protocol Violation|9|||
146953439|NCT00805194|529987468|FG000|Overall Study|Lost to Follow-up|5|||
146953440|NCT00805194|529987469|FG001|Overall Study|Lost to Follow-up|5|||
146953441|NCT00805194|529987468|FG000|Overall Study|Withdrawal by Subject|60|||
146953442|NCT00805194|529987469|FG001|Overall Study|Withdrawal by Subject|42|||
146953443|NCT00805194|529987468|FG000|Overall Study|Not treated|3|||
146953444|NCT00805194|529987469|FG001|Overall Study|Not treated|4|||
146824955|NCT03730662|529529931|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
146953445|NCT00805194|529987468|FG000|Overall Study|Reasons other than stated above|20|||
146953446|NCT00805194|529987469|FG001|Overall Study|Reasons other than stated above|16|||
146953447|NCT01488994|529987473|FG000|Overall Study|Withdrawal by Subject|0|||
146953448|NCT01488994|529987474|FG001|Overall Study|Withdrawal by Subject|1|||
146953449|NCT01072500|529987475|FG000|Overall Study|Death|2|||
146953450|NCT01072500|529987476|FG001|Overall Study|Death|2|||
146953451|NCT01072500|529987475|FG000|Overall Study|Lost to Follow-up|5|||
146953452|NCT01072500|529987476|FG001|Overall Study|Lost to Follow-up|2|||
146953453|NCT01072500|529987475|FG000|Overall Study|Withdrawal by Subject|17|||
146953454|NCT01072500|529987476|FG001|Overall Study|Withdrawal by Subject|10|||
146953455|NCT01611558|529987477|FG000|Induction Phase|Study drug toxicity|15|||
146953456|NCT01611558|529987477|FG000|Induction Phase|Disease progression|18|||
146953457|NCT01611558|529987477|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
146953458|NCT01611558|529987477|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
146953459|NCT01611558|529987477|FG000|Induction Phase|Death|1|||
146953460|NCT01611558|529987477|FG000|Maintenance Phase|Withdrawal by Subject|1|||
146953461|NCT01611558|529987477|FG000|Maintenance Phase|Elevated Uric acid|1|||
146953462|NCT04005885|529987492|FG000|First Intervention|Withdrawal by Subject|1|||
146953463|NCT04005885|529987493|FG001|First Intervention|Withdrawal by Subject|1|||
146953464|NCT04005885|529987492|FG000|Second Intervention|Withdrawal by Subject|0|||
146953465|NCT04005885|529987493|FG001|Second Intervention|Withdrawal by Subject|2|||
146953466|NCT01412333|529987495|FG000|Overall Study|Adverse Event|40|||
146953467|NCT01412333|529987496|FG001|Overall Study|Adverse Event|42|||
146953468|NCT01412333|529987495|FG000|Overall Study|Death|5|||
146953469|NCT01412333|529987496|FG001|Overall Study|Death|6|||
146953470|NCT01412333|529987495|FG000|Overall Study|Lack of Efficacy|22|||
146953471|NCT01412333|529987496|FG001|Overall Study|Lack of Efficacy|10|||
146953472|NCT01412333|529987495|FG000|Overall Study|Lost to Follow-up|15|||
146953473|NCT01412333|529987496|FG001|Overall Study|Lost to Follow-up|12|||
146953474|NCT01412333|529987495|FG000|Overall Study|Non-Compliance|3|||
146953475|NCT01412333|529987496|FG001|Overall Study|Non-Compliance|7|||
146953476|NCT01412333|529987495|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146953477|NCT01412333|529987496|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146953478|NCT01412333|529987495|FG000|Overall Study|Other|30|||
146953479|NCT01412333|529987496|FG001|Overall Study|Other|33|||
146953480|NCT01412333|529987495|FG000|Overall Study|Physician Decision|11|||
146953481|NCT01412333|529987496|FG001|Overall Study|Physician Decision|16|||
146953482|NCT01412333|529987495|FG000|Overall Study|Pregnancy|6|||
146953483|NCT01412333|529987496|FG001|Overall Study|Pregnancy|4|||
146953484|NCT01412333|529987495|FG000|Overall Study|Protocol Violation|1|||
146953485|NCT01412333|529987496|FG001|Overall Study|Protocol Violation|2|||
146953486|NCT01412333|529987495|FG000|Overall Study|Study Terminated By Sponsor|3|||
146953487|NCT01412333|529987496|FG001|Overall Study|Study Terminated By Sponsor|2|||
146953488|NCT01412333|529987495|FG000|Overall Study|Withdrawal by Subject|51|||
146953489|NCT01412333|529987496|FG001|Overall Study|Withdrawal by Subject|54|||
146953490|NCT01412333|529987495|FG000|Overall Study|Missing|1|||
146953491|NCT01412333|529987496|FG001|Overall Study|Missing|3|||
146953492|NCT00750867|529987497|FG000|Overall Study|Adverse Event|2|||
146953493|NCT00474539|529987498|FG000|Infant Series|Withdrawal by Subject|3|||
146953494|NCT00474539|529987499|FG001|Infant Series|Withdrawal by Subject|4|||
146953495|NCT00474539|529987498|FG000|Infant Series|Randomization error|5|||
146953496|NCT00474539|529987499|FG001|Infant Series|Randomization error|0|||
146953497|NCT00474539|529987498|FG000|Infant Series|Lost to Follow-up|2|||
146953498|NCT00474539|529987499|FG001|Infant Series|Lost to Follow-up|1|||
146953499|NCT00474539|529987498|FG000|Infant Series|Protocol Violation|0|||
146953500|NCT00474539|529987499|FG001|Infant Series|Protocol Violation|1|||
146953501|NCT00474539|529987498|FG000|After Infant Series|Lost to Follow-up|3|||
146953502|NCT00474539|529987499|FG001|After Infant Series|Lost to Follow-up|0|||
146953503|NCT00474539|529987498|FG000|After Infant Series|Withdrawal by Subject|1|||
146953504|NCT00474539|529987499|FG001|After Infant Series|Withdrawal by Subject|0|||
146953505|NCT00474539|529987498|FG000|Toddler Dose|Protocol Violation|1|||
146953506|NCT00474539|529987499|FG001|Toddler Dose|Protocol Violation|0|||
146953507|NCT03018340|529987500|FG000|Overall Study|Adverse Event|1|||
146953508|NCT03018340|529987501|FG001|Overall Study|Adverse Event|2|||
146953509|NCT03018340|529987500|FG000|Overall Study|Withdrawal by Subject|0|||
146953510|NCT03018340|529987501|FG001|Overall Study|Withdrawal by Subject|8|||
146953511|NCT03018340|529987500|FG000|Overall Study|Lack of Efficacy|0|||
146953512|NCT03018340|529987501|FG001|Overall Study|Lack of Efficacy|1|||
146953513|NCT03018340|529987500|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
146953514|NCT03018340|529987501|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
146953515|NCT03018340|529987500|FG000|Overall Study|Lost to Follow-up|1|||
146953516|NCT03018340|529987501|FG001|Overall Study|Lost to Follow-up|7|||
146953517|NCT03018340|529987500|FG000|Overall Study|Protocol Violation|3|||
146824956|NCT03730662|529529932|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
146824957|NCT01309243|529529933|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
146953518|NCT03018340|529987501|FG001|Overall Study|Protocol Violation|7|||
146953519|NCT03018340|529987500|FG000|Overall Study|Not further specified|0|||
146953520|NCT03018340|529987501|FG001|Overall Study|Not further specified|1|||
146953521|NCT01836549|529987502|FG000|Overall Study|Did not receive study drug|0|||
146953522|NCT01836549|529987503|FG001|Overall Study|Did not receive study drug|0|||
146953523|NCT01836549|529987504|FG002|Overall Study|Did not receive study drug|1|||
146953524|NCT01836549|529987505|FG003|Overall Study|Did not receive study drug|0|||
146953525|NCT01836549|529987506|FG004|Overall Study|Did not receive study drug|0|||
146953526|NCT01836549|529987507|FG005|Overall Study|Did not receive study drug|0|||
146953527|NCT01836549|529987508|FG006|Overall Study|Did not receive study drug|0|||
146953528|NCT01836549|529987502|FG000|Overall Study|Patient declared ineligible|0|||
146953529|NCT01836549|529987503|FG001|Overall Study|Patient declared ineligible|0|||
146953530|NCT01836549|529987504|FG002|Overall Study|Patient declared ineligible|0|||
146953531|NCT01836549|529987505|FG003|Overall Study|Patient declared ineligible|1|||
146953532|NCT01836549|529987506|FG004|Overall Study|Patient declared ineligible|0|||
146953533|NCT01836549|529987507|FG005|Overall Study|Patient declared ineligible|0|||
146953534|NCT01836549|529987508|FG006|Overall Study|Patient declared ineligible|0|||
146953535|NCT01836549|529987502|FG000|Overall Study|Patient inevaluable to start therapy|0|||
146953536|NCT01836549|529987503|FG001|Overall Study|Patient inevaluable to start therapy|0|||
146953537|NCT01836549|529987504|FG002|Overall Study|Patient inevaluable to start therapy|0|||
146953538|NCT01836549|529987505|FG003|Overall Study|Patient inevaluable to start therapy|0|||
146953539|NCT01836549|529987506|FG004|Overall Study|Patient inevaluable to start therapy|0|||
146953540|NCT01836549|529987507|FG005|Overall Study|Patient inevaluable to start therapy|0|||
146953541|NCT01836549|529987508|FG006|Overall Study|Patient inevaluable to start therapy|1|||
146953542|NCT01657253|529987511|FG000|Overall Study|Lost to Follow-up|6|||
146953543|NCT01657253|529987512|FG001|Overall Study|Lost to Follow-up|5|||
146953544|NCT01657253|529987511|FG000|Overall Study|Withdrawal by Subject|11|||
146953545|NCT01657253|529987512|FG001|Overall Study|Withdrawal by Subject|12|||
146953546|NCT01657253|529987511|FG000|Overall Study|Adverse Event|0|||
146953547|NCT01657253|529987512|FG001|Overall Study|Adverse Event|1|||
146953548|NCT01970540|529987513|FG000|Overall Study|Non-treatment-related AE|0|||
146953549|NCT01970540|529987514|FG001|Overall Study|Non-treatment-related AE|0|||
146953550|NCT01970540|529987515|FG002|Overall Study|Non-treatment-related AE|1|||
146953551|NCT01970540|529987513|FG000|Overall Study|Progressive disease|55|||
146953552|NCT01970540|529987514|FG001|Overall Study|Progressive disease|23|||
146953553|NCT01970540|529987515|FG002|Overall Study|Progressive disease|10|||
146953554|NCT01970540|529987513|FG000|Overall Study|Treatment delay over protocol|0|||
146953555|NCT01970540|529987514|FG001|Overall Study|Treatment delay over protocol|0|||
146953556|NCT01970540|529987515|FG002|Overall Study|Treatment delay over protocol|1|||
146953557|NCT01970540|529987513|FG000|Overall Study|Physician Decision|7|||
146953558|NCT01970540|529987514|FG001|Overall Study|Physician Decision|2|||
146953559|NCT01970540|529987515|FG002|Overall Study|Physician Decision|0|||
146953560|NCT01970540|529987513|FG000|Overall Study|Clinical progression|0|||
146953561|NCT01970540|529987514|FG001|Overall Study|Clinical progression|1|||
146953562|NCT01970540|529987515|FG002|Overall Study|Clinical progression|1|||
146953563|NCT01970540|529987513|FG000|Overall Study|End of study|2|||
146953564|NCT01970540|529987514|FG001|Overall Study|End of study|0|||
146953565|NCT01970540|529987515|FG002|Overall Study|End of study|2|||
146953566|NCT01970540|529987513|FG000|Overall Study|Adverse Event|0|||
146953567|NCT01970540|529987514|FG001|Overall Study|Adverse Event|2|||
146953568|NCT01970540|529987515|FG002|Overall Study|Adverse Event|1|||
146953569|NCT01970540|529987513|FG000|Overall Study|Treatment-related AE|4|||
146953570|NCT01970540|529987514|FG001|Overall Study|Treatment-related AE|0|||
146953571|NCT01970540|529987515|FG002|Overall Study|Treatment-related AE|2|||
146953572|NCT01970540|529987513|FG000|Overall Study|Withdrawal by Subject|4|||
146953573|NCT01970540|529987514|FG001|Overall Study|Withdrawal by Subject|0|||
146953574|NCT01970540|529987515|FG002|Overall Study|Withdrawal by Subject|1|||
146953575|NCT01970540|529987513|FG000|Overall Study|Clinical deterioration|1|||
146953576|NCT01970540|529987514|FG001|Overall Study|Clinical deterioration|0|||
146953577|NCT01970540|529987515|FG002|Overall Study|Clinical deterioration|0|||
146953578|NCT00242710|529987516|FG000|Core Study (up to Year 1)|Adverse Event|30|||
146953579|NCT00242710|529987517|FG001|Core Study (up to Year 1)|Adverse Event|25|||
146953580|NCT00242710|529987518|FG002|Core Study (up to Year 1)|Adverse Event|23|||
146953581|NCT00242710|529987519|FG003|Core Study (up to Year 1)|Adverse Event|14|||
146953582|NCT00242710|529987516|FG000|Core Study (up to Year 1)|Death|0|||
146953583|NCT00242710|529987517|FG001|Core Study (up to Year 1)|Death|0|||
146953584|NCT00242710|529987518|FG002|Core Study (up to Year 1)|Death|1|||
146953585|NCT00242710|529987519|FG003|Core Study (up to Year 1)|Death|0|||
146953586|NCT00242710|529987516|FG000|Core Study (up to Year 1)|Physician Decision|0|||
146953587|NCT00242710|529987517|FG001|Core Study (up to Year 1)|Physician Decision|1|||
146953588|NCT00242710|529987518|FG002|Core Study (up to Year 1)|Physician Decision|0|||
146953589|NCT00242710|529987519|FG003|Core Study (up to Year 1)|Physician Decision|1|||
146953590|NCT00242710|529987516|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
146953591|NCT00242710|529987517|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
146953592|NCT00242710|529987518|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
146953593|NCT00242710|529987519|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
146953594|NCT00242710|529987516|FG000|Core Study (up to Year 1)|Other|6|||
146953595|NCT00242710|529987517|FG001|Core Study (up to Year 1)|Other|1|||
146953596|NCT00242710|529987518|FG002|Core Study (up to Year 1)|Other|0|||
146953597|NCT00242710|529987519|FG003|Core Study (up to Year 1)|Other|2|||
146953598|NCT00242710|529987516|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
146953599|NCT00242710|529987517|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
146953600|NCT00242710|529987518|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
146953601|NCT00242710|529987519|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
146953602|NCT00242710|529987516|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
146953603|NCT00242710|529987517|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
146953604|NCT00242710|529987518|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
146953605|NCT00242710|529987519|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
146953606|NCT00242710|529987516|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
146953607|NCT00242710|529987517|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
146953608|NCT00242710|529987518|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
146953609|NCT00242710|529987519|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
146953610|NCT00242710|529987516|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
146953611|NCT00242710|529987517|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
146953612|NCT00242710|529987518|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
146953613|NCT00242710|529987519|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
146953614|NCT00242710|529987516|FG000|Period Between Core Study and Extension|Adverse Event|2|||
146953615|NCT00242710|529987517|FG001|Period Between Core Study and Extension|Adverse Event|3|||
146953616|NCT00242710|529987518|FG002|Period Between Core Study and Extension|Adverse Event|5|||
146953617|NCT00242710|529987519|FG003|Period Between Core Study and Extension|Adverse Event|2|||
146953618|NCT00242710|529987516|FG000|Period Between Core Study and Extension|Physician Decision|1|||
146953619|NCT00242710|529987517|FG001|Period Between Core Study and Extension|Physician Decision|1|||
146953620|NCT00242710|529987518|FG002|Period Between Core Study and Extension|Physician Decision|0|||
146953621|NCT00242710|529987519|FG003|Period Between Core Study and Extension|Physician Decision|0|||
146953622|NCT00242710|529987516|FG000|Period Between Core Study and Extension|Other|24|||
146953623|NCT00242710|529987517|FG001|Period Between Core Study and Extension|Other|24|||
146953624|NCT00242710|529987518|FG002|Period Between Core Study and Extension|Other|9|||
146953625|NCT00242710|529987519|FG003|Period Between Core Study and Extension|Other|11|||
146953626|NCT00242710|529987516|FG000|Period Between Core Study and Extension|Extension not Available|17|||
146953627|NCT00242710|529987517|FG001|Period Between Core Study and Extension|Extension not Available|21|||
146953628|NCT00242710|529987518|FG002|Period Between Core Study and Extension|Extension not Available|8|||
146953629|NCT00242710|529987519|FG003|Period Between Core Study and Extension|Extension not Available|7|||
146953630|NCT00242710|529987516|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
146953631|NCT00242710|529987517|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
146953632|NCT00242710|529987518|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
146953633|NCT00242710|529987519|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
146953634|NCT00242710|529987516|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
146953635|NCT00242710|529987517|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
146953636|NCT00242710|529987518|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
146953637|NCT00242710|529987519|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
146953638|NCT00242710|529987516|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
146953639|NCT00242710|529987517|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
146953640|NCT00242710|529987518|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
146953641|NCT00242710|529987519|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
146953642|NCT00242710|529987516|FG000|Study Extension (up to Year 2)|Death|0|||
146953643|NCT00242710|529987517|FG001|Study Extension (up to Year 2)|Death|0|||
146953644|NCT00242710|529987518|FG002|Study Extension (up to Year 2)|Death|0|||
146953645|NCT00242710|529987519|FG003|Study Extension (up to Year 2)|Death|1|||
146953646|NCT00242710|529987516|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
146953647|NCT00242710|529987517|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
146953648|NCT00242710|529987518|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
146953649|NCT00242710|529987519|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
146953650|NCT00242710|529987516|FG000|Study Extension (up to Year 2)|Other|3|||
146953651|NCT00242710|529987517|FG001|Study Extension (up to Year 2)|Other|5|||
146953652|NCT00242710|529987518|FG002|Study Extension (up to Year 2)|Other|4|||
146953653|NCT00242710|529987519|FG003|Study Extension (up to Year 2)|Other|3|||
146953654|NCT00242710|529987516|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
146953655|NCT00242710|529987517|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
146953656|NCT00242710|529987518|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
146953657|NCT00242710|529987519|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
146953658|NCT00242710|529987516|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
146953659|NCT00242710|529987517|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
146953660|NCT00242710|529987518|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
146953661|NCT00242710|529987519|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
146953662|NCT00579527|529987520|FG000|Overall Study|Death|4|||
146953663|NCT02364999|529987521|FG000|Overall Study|Death|136|||
146953664|NCT02364999|529987522|FG001|Overall Study|Death|138|||
146953665|NCT02364999|529987521|FG000|Overall Study|Lost to Follow-up|10|||
146953666|NCT02364999|529987522|FG001|Overall Study|Lost to Follow-up|15|||
146953667|NCT02364999|529987521|FG000|Overall Study|Protocol Violation|3|||
146953668|NCT02364999|529987522|FG001|Overall Study|Protocol Violation|2|||
146953669|NCT02364999|529987521|FG000|Overall Study|Withdrawal by Subject|14|||
146953670|NCT02364999|529987522|FG001|Overall Study|Withdrawal by Subject|14|||
146953671|NCT02364999|529987521|FG000|Overall Study|Other|0|||
146953672|NCT02364999|529987522|FG001|Overall Study|Other|1|||
146953673|NCT02364999|529987521|FG000|Overall Study|Randomized but did not receive treatment|2|||
146953674|NCT02364999|529987522|FG001|Overall Study|Randomized but did not receive treatment|3|||
146953675|NCT02555722|529987526|FG000|Week 2|Adverse Event|0|||
146953676|NCT02555722|529987527|FG001|Week 2|Adverse Event|1|||
146953677|NCT02555722|529987526|FG000|Week 2|Withdrawal by Subject|1|||
146953678|NCT02555722|529987527|FG001|Week 2|Withdrawal by Subject|0|||
146953679|NCT02555722|529987526|FG000|Month 1|Lens Discomfort|1|||
146953680|NCT02555722|529987527|FG001|Month 1|Lens Discomfort|0|||
146953681|NCT02555722|529987526|FG000|Month 2|Withdrawal by Subject|3|||
146953682|NCT02555722|529987527|FG001|Month 2|Withdrawal by Subject|0|||
146953683|NCT02555722|529987526|FG000|Month 2|Lost to Follow-up|1|||
146953684|NCT02555722|529987527|FG001|Month 2|Lost to Follow-up|0|||
146953685|NCT00702949|529987528|FG000|Overall Study|Refusal|3|||
146953686|NCT00702949|529987529|FG001|Overall Study|Refusal|2|||
146953687|NCT00702949|529987530|FG002|Overall Study|Refusal|2|||
146953688|NCT00702949|529987528|FG000|Overall Study|Adverse Event|1|||
146953689|NCT00702949|529987529|FG001|Overall Study|Adverse Event|6|||
146953690|NCT00702949|529987530|FG002|Overall Study|Adverse Event|3|||
146953691|NCT00702949|529987528|FG000|Overall Study|Other Medical Reason/unknown|1|||
146953692|NCT00702949|529987529|FG001|Overall Study|Other Medical Reason/unknown|1|||
146953693|NCT00702949|529987530|FG002|Overall Study|Other Medical Reason/unknown|3|||
146953694|NCT00523744|529987532|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
146953695|NCT00523744|529987532|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
146953696|NCT00523744|529987532|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
146953697|NCT00523744|529987532|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
146953698|NCT00523744|529987532|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
146953699|NCT00523744|529987532|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
146953700|NCT00542425|529987536|FG000|Initial 24 Weeks|Administrative reasons|0|||
146953701|NCT00542425|529987537|FG001|Initial 24 Weeks|Administrative reasons|0|||
146953702|NCT00542425|529987538|FG002|Initial 24 Weeks|Administrative reasons|1|||
146953703|NCT00542425|529987539|FG003|Initial 24 Weeks|Administrative reasons|1|||
146953704|NCT00542425|529987540|FG004|Initial 24 Weeks|Administrative reasons|0|||
146953705|NCT00542425|529987536|FG000|Initial 24 Weeks|Adverse Event|0|||
146953706|NCT00542425|529987537|FG001|Initial 24 Weeks|Adverse Event|1|||
146953707|NCT00542425|529987538|FG002|Initial 24 Weeks|Adverse Event|1|||
146953708|NCT00542425|529987539|FG003|Initial 24 Weeks|Adverse Event|3|||
146984984|NCT01844583|530107121|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
146984985|NCT01844583|530107122|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
146984986|NCT00449072|530107125|FG000|Overall Study|Adverse Event|3|||
146824958|NCT01309243|529529934|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
146824959|NCT01309243|529529933|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
146824960|NCT01309243|529529934|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
146824961|NCT01309243|529529933|FG000|Randomized Phase Through Week 96|Death|0|||
146824962|NCT01309243|529529934|FG001|Randomized Phase Through Week 96|Death|1|||
146824963|NCT01309243|529529933|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
146824964|NCT01309243|529529934|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
146824965|NCT01309243|529529933|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
146824966|NCT01309243|529529934|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
146824967|NCT01309243|529529933|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
146824968|NCT01309243|529529934|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
146824969|NCT01309243|529529933|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
146824970|NCT01309243|529529934|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
146824971|NCT01309243|529529933|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
146824972|NCT01309243|529529934|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
146824973|NCT01309243|529529933|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
146824974|NCT01309243|529529934|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
146824975|NCT01309243|529529933|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
146824976|NCT01309243|529529934|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
146824977|NCT01309243|529529933|FG000|Extension Phase|Lost to Follow-up|6|||
146824978|NCT01309243|529529934|FG001|Extension Phase|Lost to Follow-up|0|||
146824979|NCT00632931|529529935|FG000|Part 1, Period 1|Protocol Violation|1|||
146824980|NCT00632931|529529936|FG001|Part 1, Period 1|Protocol Violation|0|||
146824981|NCT00632931|529529937|FG002|Part 1, Period 1|Protocol Violation|0|||
146824982|NCT00632931|529529935|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
146824983|NCT00632931|529529936|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
146953709|NCT00542425|529987540|FG004|Initial 24 Weeks|Adverse Event|2|||
146953710|NCT00542425|529987536|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
146953711|NCT00542425|529987537|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
146953712|NCT00542425|529987538|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
146953713|NCT00542425|529987539|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
146824984|NCT00632931|529529937|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
146824985|NCT00632931|529529935|FG000|Part 2|Adverse Event|0|||
146953714|NCT00542425|529987540|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
146824986|NCT00632931|529529936|FG001|Part 2|Adverse Event|0|||
146824987|NCT00632931|529529937|FG002|Part 2|Adverse Event|3|||
146824988|NCT00632931|529529935|FG000|Part 2|Death|0|||
146953715|NCT00542425|529987536|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
146953716|NCT00542425|529987537|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
146953717|NCT00542425|529987538|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
146953718|NCT00542425|529987539|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
146953719|NCT00542425|529987540|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
146953720|NCT00542425|529987536|FG000|Initial 24 Weeks|Non-compliance|0|||
146953721|NCT00542425|529987537|FG001|Initial 24 Weeks|Non-compliance|0|||
146953722|NCT00542425|529987538|FG002|Initial 24 Weeks|Non-compliance|0|||
146953723|NCT00542425|529987539|FG003|Initial 24 Weeks|Non-compliance|1|||
146953724|NCT00542425|529987540|FG004|Initial 24 Weeks|Non-compliance|1|||
146953725|NCT00542425|529987536|FG000|Initial 24 Weeks|Protocol Violation|0|||
146953726|NCT00542425|529987537|FG001|Initial 24 Weeks|Protocol Violation|0|||
146953727|NCT00542425|529987538|FG002|Initial 24 Weeks|Protocol Violation|0|||
146953728|NCT00542425|529987539|FG003|Initial 24 Weeks|Protocol Violation|1|||
146953729|NCT00542425|529987540|FG004|Initial 24 Weeks|Protocol Violation|0|||
146953730|NCT00542425|529987536|FG000|Initial 24 Weeks|Refusal of treatment|2|||
146953731|NCT00542425|529987537|FG001|Initial 24 Weeks|Refusal of treatment|2|||
146953732|NCT00542425|529987538|FG002|Initial 24 Weeks|Refusal of treatment|1|||
146953733|NCT00542425|529987539|FG003|Initial 24 Weeks|Refusal of treatment|4|||
146953734|NCT00542425|529987540|FG004|Initial 24 Weeks|Refusal of treatment|1|||
146953735|NCT00542425|529987536|FG000|Initial 24 Weeks|Other|0|||
146953736|NCT00542425|529987537|FG001|Initial 24 Weeks|Other|2|||
146953737|NCT00542425|529987538|FG002|Initial 24 Weeks|Other|1|||
146953738|NCT00542425|529987539|FG003|Initial 24 Weeks|Other|0|||
146953739|NCT00542425|529987540|FG004|Initial 24 Weeks|Other|0|||
146953740|NCT00542425|529987536|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
146824989|NCT00632931|529529936|FG001|Part 2|Death|0|||
146824990|NCT00632931|529529937|FG002|Part 2|Death|1|||
146824991|NCT00632931|529529935|FG000|Part 2|Lack of Efficacy|0|||
146824992|NCT00632931|529529936|FG001|Part 2|Lack of Efficacy|0|||
146824993|NCT00632931|529529937|FG002|Part 2|Lack of Efficacy|17|||
146953741|NCT00542425|529987537|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
146953742|NCT00542425|529987538|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
146953743|NCT00542425|529987539|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
146953744|NCT00542425|529987540|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
146953745|NCT00542425|529987536|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
146953746|NCT00542425|529987537|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
146953747|NCT00542425|529987538|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
146953748|NCT00542425|529987539|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
146953749|NCT00542425|529987540|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
146953750|NCT00542425|529987536|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
146953751|NCT00542425|529987537|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
146953752|NCT00542425|529987538|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
146824994|NCT00632931|529529935|FG000|Part 2|Withdrawal by Subject|0|||
146824995|NCT00632931|529529936|FG001|Part 2|Withdrawal by Subject|0|||
146824996|NCT00632931|529529937|FG002|Part 2|Withdrawal by Subject|3|||
146824997|NCT01402063|529529938|FG000|Overall Study|Withdrawal by Subject|3|||
146824998|NCT01402063|529529939|FG001|Overall Study|Withdrawal by Subject|3|||
146824999|NCT03712449|529529942|FG000|Overall Study|Withdraw Consent|0|||
146825000|NCT03712449|529529943|FG001|Overall Study|Withdraw Consent|1|||
146953753|NCT00542425|529987539|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
146953754|NCT00542425|529987540|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
146953755|NCT00542425|529987536|FG000|Extended 24 Weeks of Treatment|Other|1|||
146953756|NCT00542425|529987537|FG001|Extended 24 Weeks of Treatment|Other|1|||
146953757|NCT00542425|529987538|FG002|Extended 24 Weeks of Treatment|Other|0|||
146953758|NCT00542425|529987539|FG003|Extended 24 Weeks of Treatment|Other|0|||
146953759|NCT00542425|529987540|FG004|Extended 24 Weeks of Treatment|Other|1|||
146953760|NCT00590031|529987543|FG000|Overall Study|Adverse Event|3|||
146953761|NCT00590031|529987543|FG000|Overall Study|Withdrawal by Subject|1|||
146953762|NCT00590031|529987543|FG000|Overall Study|Metastatic Disease|1|||
146953763|NCT00590031|529987543|FG000|Overall Study|Admin Hold|1|||
146953764|NCT01610414|529987544|FG000|Study Start - Month 13|Serious Adverse Event|65|||
146953765|NCT01610414|529987545|FG001|Study Start - Month 13|Serious Adverse Event|67|||
146953766|NCT01610414|529987544|FG000|Study Start - Month 13|Adverse Event|14|||
146984987|NCT00449072|530107126|FG001|Overall Study|Adverse Event|1|||
146984988|NCT00449072|530107125|FG000|Overall Study|Protocol Violation|14|||
146953767|NCT01610414|529987545|FG001|Study Start - Month 13|Adverse Event|14|||
146953768|NCT01610414|529987544|FG000|Study Start - Month 13|Protocol Violation|3|||
146953769|NCT01610414|529987545|FG001|Study Start - Month 13|Protocol Violation|1|||
146953770|NCT01610414|529987544|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
146953771|NCT01610414|529987545|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
146984989|NCT00449072|530107126|FG001|Overall Study|Protocol Violation|12|||
146825001|NCT04491006|529529946|FG000|Overall Study|Adverse Event|0|||
146825002|NCT04491006|529529947|FG001|Overall Study|Adverse Event|3|||
146825003|NCT04491006|529529948|FG002|Overall Study|Adverse Event|5|||
146825004|NCT04491006|529529946|FG000|Overall Study|Withdrawal by Subject|1|||
146825005|NCT04491006|529529947|FG001|Overall Study|Withdrawal by Subject|0|||
146825006|NCT04491006|529529948|FG002|Overall Study|Withdrawal by Subject|2|||
146825007|NCT00451555|529529956|FG000|Overall Study|Protocol Violation|2|||
146825008|NCT00451555|529529957|FG001|Overall Study|Protocol Violation|2|||
146825009|NCT00451555|529529956|FG000|Overall Study|Adverse Event|3|||
146825010|NCT00451555|529529957|FG001|Overall Study|Adverse Event|1|||
146825011|NCT00451555|529529956|FG000|Overall Study|Withdrawal by Subject|6|||
146825012|NCT00451555|529529957|FG001|Overall Study|Withdrawal by Subject|0|||
146825013|NCT00451555|529529956|FG000|Overall Study|Physician Decision|2|||
146825014|NCT00451555|529529957|FG001|Overall Study|Physician Decision|1|||
146825015|NCT00922441|529529958|FG000|Overall Study|Protocol Violation|0|||
146825016|NCT00922441|529529959|FG001|Overall Study|Protocol Violation|0|||
146825017|NCT00922441|529529960|FG002|Overall Study|Protocol Violation|2|||
146825018|NCT00922441|529529958|FG000|Overall Study|Withdrawal by Subject|0|||
146825019|NCT00922441|529529959|FG001|Overall Study|Withdrawal by Subject|0|||
146825020|NCT00922441|529529960|FG002|Overall Study|Withdrawal by Subject|1|||
146825021|NCT00468858|529529965|FG000|Overall Study|Adverse Event|0|||
146825022|NCT00468858|529529966|FG001|Overall Study|Adverse Event|1|||
146825023|NCT00468858|529529967|FG002|Overall Study|Adverse Event|0|||
146825024|NCT00468858|529529965|FG000|Overall Study|Withdrawal by Subject|7|||
146825025|NCT00468858|529529966|FG001|Overall Study|Withdrawal by Subject|4|||
146825026|NCT00468858|529529967|FG002|Overall Study|Withdrawal by Subject|5|||
146825027|NCT00468858|529529965|FG000|Overall Study|Relocation|1|||
146825028|NCT00468858|529529966|FG001|Overall Study|Relocation|3|||
146825029|NCT00468858|529529967|FG002|Overall Study|Relocation|3|||
146825030|NCT00468858|529529965|FG000|Overall Study|Lost to Follow-up|1|||
146825031|NCT00468858|529529966|FG001|Overall Study|Lost to Follow-up|2|||
146825032|NCT00468858|529529967|FG002|Overall Study|Lost to Follow-up|5|||
146825033|NCT00468858|529529965|FG000|Overall Study|Other|0|||
146825034|NCT00468858|529529966|FG001|Overall Study|Other|0|||
146825035|NCT00468858|529529967|FG002|Overall Study|Other|1|||
146825036|NCT01885936|529529970|FG000|Overall Study|Withdrawal by Subject|1|||
146825037|NCT01885936|529529971|FG001|Overall Study|Withdrawal by Subject|0|||
146825038|NCT00317603|529529972|FG000|Overall Study|Progressive Disease|3|||
146825039|NCT00523549|529529975|FG000|Overall Study|Adverse Event|6|||
146825040|NCT00523549|529529976|FG001|Overall Study|Adverse Event|3|||
146825041|NCT00523549|529529975|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146825042|NCT00523549|529529976|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146825043|NCT00523549|529529975|FG000|Overall Study|Protocol Deviation|3|||
146825044|NCT00523549|529529976|FG001|Overall Study|Protocol Deviation|1|||
146825045|NCT00523549|529529975|FG000|Overall Study|Patient withdrew consent|7|||
146825046|NCT00523549|529529976|FG001|Overall Study|Patient withdrew consent|6|||
146825047|NCT00523549|529529975|FG000|Overall Study|Lost to Follow-up|3|||
146825048|NCT00523549|529529976|FG001|Overall Study|Lost to Follow-up|5|||
146825049|NCT00427778|529529981|FG000|First Intervention (4 Weeks)|no longer interested|1|||
146825050|NCT00427778|529529982|FG001|First Intervention (4 Weeks)|no longer interested|0|||
146825051|NCT00427778|529529981|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
146825052|NCT00427778|529529982|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
146825053|NCT00427778|529529981|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
146825054|NCT00427778|529529982|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
146825055|NCT00427778|529529981|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
146825056|NCT00427778|529529982|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
146825057|NCT00439647|529529984|FG000|Overall Study|Withdrawal by Subject|25|||
146825058|NCT00439647|529529985|FG001|Overall Study|Withdrawal by Subject|22|||
146825059|NCT00439647|529529984|FG000|Overall Study|Death|15|||
146825060|NCT00439647|529529985|FG001|Overall Study|Death|18|||
146825061|NCT00439647|529529984|FG000|Overall Study|Adverse Event|11|||
146825062|NCT00439647|529529985|FG001|Overall Study|Adverse Event|11|||
146825063|NCT00439647|529529984|FG000|Overall Study|Lost to Follow-up|4|||
146825064|NCT00439647|529529985|FG001|Overall Study|Lost to Follow-up|12|||
146825065|NCT00439647|529529984|FG000|Overall Study|Protocol Violation|3|||
146825066|NCT00439647|529529985|FG001|Overall Study|Protocol Violation|4|||
146825067|NCT00439647|529529984|FG000|Overall Study|Lack of Efficacy|0|||
146825068|NCT00439647|529529985|FG001|Overall Study|Lack of Efficacy|4|||
146825069|NCT00843115|529529986|FG000|Overall Study|Death|4|||
146825070|NCT00843115|529529986|FG000|Overall Study|Adverse Event|30|||
146825071|NCT00843115|529529986|FG000|Overall Study|Lost to Follow-up|4|||
146825072|NCT00843115|529529986|FG000|Overall Study|Withdrawal by Subject|17|||
146825073|NCT00843115|529529986|FG000|Overall Study|Family wanted meds stopped|1|||
146825074|NCT00843115|529529986|FG000|Overall Study|Family does not want continuation|1|||
146825075|NCT00843115|529529986|FG000|Overall Study|Patient forgot to take meds|1|||
146825076|NCT00843115|529529986|FG000|Overall Study|Does not meet entrance criteria|1|||
146825077|NCT00843115|529529986|FG000|Overall Study|Physician Decision|1|||
146825078|NCT00843115|529529986|FG000|Overall Study|Family discontinued meds|1|||
146825079|NCT00843115|529529986|FG000|Overall Study|patient took for 2 days then stopped|1|||
146825080|NCT00843115|529529986|FG000|Overall Study|patient never took the medication|1|||
146825081|NCT00843115|529529986|FG000|Overall Study|hospitalized due to deterioration|1|||
146953772|NCT01610414|529987544|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
146953773|NCT01610414|529987545|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
146953774|NCT01610414|529987544|FG000|Study Start - Month 13|Lost to Follow-up|4|||
146953775|NCT01610414|529987545|FG001|Study Start - Month 13|Lost to Follow-up|6|||
146953776|NCT01610414|529987544|FG000|Study Start - Month 13|Suspected HZ episode|1|||
146953777|NCT01610414|529987545|FG001|Study Start - Month 13|Suspected HZ episode|3|||
146953778|NCT01610414|529987544|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
146953779|NCT01610414|529987545|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
146825082|NCT00843115|529529986|FG000|Overall Study|week 12 not done|1|||
146953780|NCT01610414|529987544|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
146953781|NCT01610414|529987545|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
146953782|NCT01610414|529987544|FG000|Month 13 - Month 25|Adverse Event|8|||
146953783|NCT01610414|529987545|FG001|Month 13 - Month 25|Adverse Event|4|||
146953784|NCT01610414|529987544|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
146953785|NCT01610414|529987545|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
146953786|NCT01610414|529987544|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
146953787|NCT01610414|529987545|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
146953788|NCT01610414|529987544|FG000|Month 13 - Month 25|Protocol Violation|0|||
146953789|NCT01610414|529987545|FG001|Month 13 - Month 25|Protocol Violation|2|||
146953790|NCT01610414|529987544|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
146953791|NCT01610414|529987545|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
146953792|NCT01610414|529987544|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
146953793|NCT01610414|529987545|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
146953794|NCT01610414|529987544|FG000|After Month 25|Study end not reached|48|||
146953795|NCT01610414|529987545|FG001|After Month 25|Study end not reached|53|||
146953796|NCT00826540|529987552|FG000|Overall Study|ineligible|3|||
146953797|NCT00826540|529987552|FG000|Overall Study|Withdrawal by Subject|1|||
146953798|NCT02802735|529987553|FG000|Overall Study|Withdrawal by Subject|0|||
146953799|NCT02802735|529987554|FG001|Overall Study|Withdrawal by Subject|1|||
146953800|NCT02802735|529987555|FG002|Overall Study|Withdrawal by Subject|0|||
146953801|NCT02802735|529987556|FG003|Overall Study|Withdrawal by Subject|0|||
146953802|NCT02802735|529987557|FG004|Overall Study|Withdrawal by Subject|0|||
146953803|NCT01166386|529987558|FG000|Overall Study|Withdrawal by Subject|3|||
146953804|NCT01166386|529987559|FG001|Overall Study|Withdrawal by Subject|5|||
146953805|NCT03922711|529987564|FG000|Overall Study|Adverse Event|3|||
146953806|NCT03922711|529987565|FG001|Overall Study|Adverse Event|2|||
146953807|NCT03922711|529987566|FG002|Overall Study|Adverse Event|2|||
146953808|NCT03922711|529987564|FG000|Overall Study|Protocol Violation|1|||
146953809|NCT03922711|529987565|FG001|Overall Study|Protocol Violation|0|||
146953810|NCT03922711|529987566|FG002|Overall Study|Protocol Violation|0|||
146953811|NCT03922711|529987564|FG000|Overall Study|Withdrawal by Subject|0|||
146953812|NCT03922711|529987565|FG001|Overall Study|Withdrawal by Subject|3|||
146953813|NCT03922711|529987566|FG002|Overall Study|Withdrawal by Subject|1|||
146953814|NCT03922711|529987564|FG000|Overall Study|Not further specified|0|||
146953815|NCT03922711|529987565|FG001|Overall Study|Not further specified|0|||
146953816|NCT03922711|529987566|FG002|Overall Study|Not further specified|1|||
146953817|NCT02390362|529987567|FG000|Overall Study|Withdrawal by Subject|0|||
146953818|NCT02390362|529987568|FG001|Overall Study|Withdrawal by Subject|1|||
146953819|NCT04009824|529987569|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
146953820|NCT04009824|529987570|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
146953821|NCT04009824|529987571|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
146953822|NCT04009824|529987572|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
146953823|NCT04009824|529987573|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
146825083|NCT00843115|529529986|FG000|Overall Study|Syndrome De Glissement|1|||
146953824|NCT03147495|529987574|FG000|Overall Study|Physician Decision|0|||
146953825|NCT03147495|529987575|FG001|Overall Study|Physician Decision|6|||
146953826|NCT01024946|529987576|FG000|Overall Study|Screen Failure|3|||
146953827|NCT01024946|529987576|FG000|Overall Study|Withdrawal by Subject|1|||
146953828|NCT01024946|529987576|FG000|Overall Study|Adverse Event|1|||
146953829|NCT02483611|529987577|FG000|Overall Study|Protocol Violation|0|||
146953830|NCT02483611|529987578|FG001|Overall Study|Protocol Violation|0|||
146953831|NCT02483611|529987579|FG002|Overall Study|Protocol Violation|1|||
146953832|NCT02608892|529987580|FG000|Overall Study|Lost to Follow-up|1|||
146953833|NCT02608892|529987581|FG001|Overall Study|Lost to Follow-up|0|||
146953834|NCT03032523|529987582|FG000|Overall Study|Withdrawal by Subject|2|||
146953835|NCT03032523|529987583|FG001|Overall Study|Withdrawal by Subject|2|||
146953836|NCT03032523|529987582|FG000|Overall Study|Physician Decision|1|||
146953837|NCT03032523|529987583|FG001|Overall Study|Physician Decision|0|||
146953838|NCT02590406|529987584|FG000|Overall Study|Adverse Event|1|||
146953839|NCT02590406|529987585|FG001|Overall Study|Adverse Event|0|||
146953840|NCT02590406|529987584|FG000|Overall Study|Saturometer malfunction|0|||
146953841|NCT02590406|529987585|FG001|Overall Study|Saturometer malfunction|1|||
146953842|NCT00957723|529987588|FG000|Overall Study|Death|3|||
146953843|NCT00957723|529987588|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
146953844|NCT00957723|529987588|FG000|Overall Study|Lost to Follow-up|8|||
146825084|NCT00225277|529529987|FG000|Overall Study|Adverse Event|30|||
146825085|NCT00225277|529529988|FG001|Overall Study|Adverse Event|34|||
146825086|NCT00225277|529529987|FG000|Overall Study|Lack of Efficacy|4|||
146825087|NCT00225277|529529988|FG001|Overall Study|Lack of Efficacy|1|||
146825088|NCT00225277|529529987|FG000|Overall Study|Lost to Follow-up|4|||
146825089|NCT00225277|529529988|FG001|Overall Study|Lost to Follow-up|6|||
146825090|NCT00225277|529529987|FG000|Overall Study|Physician Decision|6|||
146825091|NCT00225277|529529988|FG001|Overall Study|Physician Decision|8|||
146825092|NCT00225277|529529987|FG000|Overall Study|Protocol Violation|6|||
146825093|NCT00225277|529529988|FG001|Overall Study|Protocol Violation|3|||
146825094|NCT00225277|529529987|FG000|Overall Study|Withdrawal by Subject|40|||
146825095|NCT00225277|529529988|FG001|Overall Study|Withdrawal by Subject|34|||
146825096|NCT00225277|529529987|FG000|Overall Study|Other|7|||
146825097|NCT00225277|529529988|FG001|Overall Study|Other|9|||
146825098|NCT02959177|529529991|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
146825099|NCT02959177|529529992|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
146825100|NCT02959177|529529993|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
146825101|NCT02959177|529529991|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
146825102|NCT02959177|529529992|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
146825103|NCT02959177|529529993|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
146825104|NCT02959177|529529991|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
146825105|NCT02959177|529529992|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
146825106|NCT02959177|529529993|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
146825107|NCT02959177|529529991|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
146825108|NCT02959177|529529992|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
146825109|NCT02959177|529529993|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
146825110|NCT02959177|529529991|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
146825111|NCT02959177|529529992|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
146825112|NCT02959177|529529993|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
146825113|NCT02959177|529529991|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
146825114|NCT02959177|529529992|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
146825115|NCT02959177|529529993|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
146825116|NCT02959177|529529991|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
146825117|NCT02959177|529529992|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
146825118|NCT02959177|529529993|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
146825119|NCT00677092|529529995|FG000|Overall Study|Adverse Event|1|||
146825120|NCT00677092|529529995|FG000|Overall Study|Lost to Follow-up|1|||
146825121|NCT00677092|529529995|FG000|Overall Study|Withdrawal by Subject|3|||
146825122|NCT00677092|529529995|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
146825123|NCT00784277|529529996|FG000|IR Treatment|Adverse Event|4|||
146825124|NCT00784277|529529997|FG001|IR Treatment|Adverse Event|8|||
146825125|NCT00784277|529529998|FG002|IR Treatment|Adverse Event|19|||
146825126|NCT00784277|529529999|FG003|IR Treatment|Adverse Event|35|||
146825127|NCT00784277|529530000|FG004|IR Treatment|Adverse Event|0|||
146825128|NCT00784277|529530001|FG005|IR Treatment|Adverse Event|0|||
146825129|NCT00784277|529530002|FG006|IR Treatment|Adverse Event|0|||
146825130|NCT00784277|529529996|FG000|IR Treatment|Lack of Efficacy|4|||
146825131|NCT00784277|529529997|FG001|IR Treatment|Lack of Efficacy|4|||
146825132|NCT00784277|529529998|FG002|IR Treatment|Lack of Efficacy|1|||
146825133|NCT00784277|529529999|FG003|IR Treatment|Lack of Efficacy|0|||
146825134|NCT00784277|529530000|FG004|IR Treatment|Lack of Efficacy|0|||
146825135|NCT00784277|529530001|FG005|IR Treatment|Lack of Efficacy|0|||
146825136|NCT00784277|529530002|FG006|IR Treatment|Lack of Efficacy|0|||
146825137|NCT00784277|529529996|FG000|IR Treatment|Lost to Follow-up|1|||
146825138|NCT00784277|529529997|FG001|IR Treatment|Lost to Follow-up|0|||
146825139|NCT00784277|529529998|FG002|IR Treatment|Lost to Follow-up|1|||
146825140|NCT00784277|529529999|FG003|IR Treatment|Lost to Follow-up|0|||
146825141|NCT00784277|529530000|FG004|IR Treatment|Lost to Follow-up|0|||
146825142|NCT00784277|529530001|FG005|IR Treatment|Lost to Follow-up|0|||
146825143|NCT00784277|529530002|FG006|IR Treatment|Lost to Follow-up|0|||
146825144|NCT00784277|529529996|FG000|IR Treatment|Withdrawal by Subject|5|||
146825145|NCT00784277|529529997|FG001|IR Treatment|Withdrawal by Subject|1|||
146825146|NCT00784277|529529998|FG002|IR Treatment|Withdrawal by Subject|4|||
146825147|NCT00784277|529529999|FG003|IR Treatment|Withdrawal by Subject|6|||
146825148|NCT00784277|529530000|FG004|IR Treatment|Withdrawal by Subject|0|||
146825149|NCT00784277|529530001|FG005|IR Treatment|Withdrawal by Subject|0|||
146825150|NCT00784277|529530002|FG006|IR Treatment|Withdrawal by Subject|0|||
146825151|NCT00784277|529529996|FG000|IR Treatment|Resolution Of Pain|0|||
146825152|NCT00784277|529529997|FG001|IR Treatment|Resolution Of Pain|1|||
146825153|NCT00784277|529529998|FG002|IR Treatment|Resolution Of Pain|0|||
146825154|NCT00784277|529529999|FG003|IR Treatment|Resolution Of Pain|0|||
146825155|NCT00784277|529530000|FG004|IR Treatment|Resolution Of Pain|0|||
146825156|NCT00784277|529530001|FG005|IR Treatment|Resolution Of Pain|0|||
146825157|NCT00784277|529530002|FG006|IR Treatment|Resolution Of Pain|0|||
146825158|NCT00784277|529529996|FG000|IR Treatment|Other|2|||
146825159|NCT00784277|529529997|FG001|IR Treatment|Other|3|||
146825160|NCT00784277|529529998|FG002|IR Treatment|Other|3|||
146953845|NCT00957723|529987588|FG000|Overall Study|Withdrawal by Subject|24|||
146953846|NCT00957723|529987588|FG000|Overall Study|Investigative Site Terminated|61|||
146953847|NCT00957723|529987588|FG000|Overall Study|Intercurrent Illness|2|||
146953848|NCT00957723|529987588|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
146953849|NCT00877890|529987589|FG000|Overall Study|Adverse Event|6|||
146953850|NCT00877890|529987590|FG001|Overall Study|Adverse Event|6|||
146953851|NCT00877890|529987589|FG000|Overall Study|Lost to Follow-up|5|||
146953852|NCT00877890|529987590|FG001|Overall Study|Lost to Follow-up|5|||
146953853|NCT00877890|529987589|FG000|Overall Study|Protocol Violation|0|||
146953854|NCT00877890|529987590|FG001|Overall Study|Protocol Violation|1|||
146953855|NCT00877890|529987589|FG000|Overall Study|Withdrawal of Consent|6|||
146953856|NCT00877890|529987590|FG001|Overall Study|Withdrawal of Consent|12|||
146953857|NCT00877890|529987589|FG000|Overall Study|Investigator Decision|0|||
146953858|NCT00877890|529987590|FG001|Overall Study|Investigator Decision|2|||
146953859|NCT00877890|529987589|FG000|Overall Study|Loss of Glucose Control|3|||
146953860|NCT00877890|529987590|FG001|Overall Study|Loss of Glucose Control|4|||
146953861|NCT00984009|529987591|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
146953862|NCT00281528|529987592|FG000|Overall Study|Progressive Disease|28|||
146953863|NCT00281528|529987593|FG001|Overall Study|Progressive Disease|18|||
146953864|NCT00281528|529987594|FG002|Overall Study|Progressive Disease|27|||
146953865|NCT00281528|529987592|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
146953866|NCT00281528|529987593|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
146953867|NCT00281528|529987594|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
146953868|NCT00281528|529987592|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
146953869|NCT00281528|529987593|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
146953870|NCT00281528|529987594|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
146953871|NCT00281528|529987592|FG000|Overall Study|Physician Decision|11|||
146953872|NCT00281528|529987593|FG001|Overall Study|Physician Decision|4|||
146953873|NCT00281528|529987594|FG002|Overall Study|Physician Decision|5|||
146953874|NCT00281528|529987592|FG000|Overall Study|Protocol Violation|1|||
146953875|NCT00281528|529987593|FG001|Overall Study|Protocol Violation|0|||
146953876|NCT00281528|529987594|FG002|Overall Study|Protocol Violation|1|||
146953877|NCT00281528|529987592|FG000|Overall Study|Withdrawal by Subject|5|||
146953878|NCT00281528|529987593|FG001|Overall Study|Withdrawal by Subject|5|||
146953879|NCT00281528|529987594|FG002|Overall Study|Withdrawal by Subject|7|||
146953880|NCT00281528|529987592|FG000|Overall Study|Other|6|||
146953881|NCT00281528|529987593|FG001|Overall Study|Other|3|||
146953882|NCT00281528|529987594|FG002|Overall Study|Other|5|||
146953883|NCT02178592|529987595|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
146953884|NCT02178592|529987596|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
146953885|NCT02178592|529987595|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
146953886|NCT02178592|529987596|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
146953887|NCT02178592|529987595|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
146953888|NCT02178592|529987596|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
146953889|NCT02178592|529987595|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
146953890|NCT02178592|529987596|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
146953891|NCT02178592|529987595|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
146953892|NCT02178592|529987596|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
146953893|NCT02178592|529987595|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
146953894|NCT02178592|529987596|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
146953895|NCT02178592|529987595|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
146953896|NCT02178592|529987596|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
146953897|NCT02178592|529987595|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
146953898|NCT02178592|529987596|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
146953899|NCT02178592|529987595|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
146953900|NCT02178592|529987596|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
146953901|NCT02178592|529987595|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
146953902|NCT02178592|529987596|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
146953903|NCT02178592|529987595|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
146953904|NCT02178592|529987596|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
146953905|NCT02178592|529987595|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
146953906|NCT02178592|529987596|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
146953907|NCT02036476|529987598|FG000|Overall Study|Withdrawal by Subject|2|||
146953908|NCT02036476|529987598|FG000|Overall Study|Progressive Disease|4|||
146953909|NCT02036476|529987598|FG000|Overall Study|Unacceptable Toxicity|2|||
146825161|NCT00784277|529529999|FG003|IR Treatment|Other|2|||
146825162|NCT00784277|529530000|FG004|IR Treatment|Other|0|||
146953910|NCT01984294|529987601|FG000|Overall Study|Randomized but Never Treated|0|||
146953911|NCT01984294|529987602|FG001|Overall Study|Randomized but Never Treated|0|||
146953912|NCT01984294|529987603|FG002|Overall Study|Randomized but Never Treated|1|||
146953913|NCT01984294|529987601|FG000|Overall Study|Lack of Efficacy|4|||
146953914|NCT01984294|529987602|FG001|Overall Study|Lack of Efficacy|2|||
146953915|NCT01984294|529987603|FG002|Overall Study|Lack of Efficacy|6|||
146984990|NCT00449072|530107125|FG000|Overall Study|Lost to Follow-up|5|||
146984991|NCT00449072|530107126|FG001|Overall Study|Lost to Follow-up|7|||
146984992|NCT00449072|530107125|FG000|Overall Study|Withdrawal by Subject|11|||
146984993|NCT00449072|530107126|FG001|Overall Study|Withdrawal by Subject|8|||
146984994|NCT00449072|530107125|FG000|Overall Study|Lack of Efficacy|1|||
146984995|NCT00449072|530107126|FG001|Overall Study|Lack of Efficacy|1|||
146984996|NCT00449072|530107125|FG000|Overall Study|Physician Decision|1|||
146984997|NCT00449072|530107126|FG001|Overall Study|Physician Decision|0|||
146984998|NCT00449072|530107125|FG000|Overall Study|Not treated|0|||
146984999|NCT00449072|530107126|FG001|Overall Study|Not treated|1|||
146985000|NCT00449072|530107125|FG000|Overall Study|Excluded medication|0|||
146985001|NCT00449072|530107126|FG001|Overall Study|Excluded medication|2|||
146985002|NCT00449072|530107125|FG000|Overall Study|Non-compliance|2|||
146985003|NCT00449072|530107126|FG001|Overall Study|Non-compliance|5|||
146985004|NCT00449072|530107125|FG000|Overall Study|Sponsor decision|1|||
146985005|NCT00449072|530107126|FG001|Overall Study|Sponsor decision|3|||
146985006|NCT00449072|530107125|FG000|Overall Study|Relocation|3|||
146985007|NCT00449072|530107126|FG001|Overall Study|Relocation|2|||
146985008|NCT01787825|530107127|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
146985009|NCT01787825|530107128|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
146985010|NCT01787825|530107127|FG000|Overall Study|Data Not Analyzable|5|||
146985011|NCT01787825|530107128|FG001|Overall Study|Data Not Analyzable|1|||
146985012|NCT00989261|530107134|FG000|Overall Study|Still in follow up|12|||
146985013|NCT00989261|530107135|FG001|Overall Study|Still in follow up|21|||
146985014|NCT00989261|530107134|FG000|Overall Study|Withdrawal by Subject|0|||
146985015|NCT00989261|530107135|FG001|Overall Study|Withdrawal by Subject|1|||
146985016|NCT00989261|530107134|FG000|Overall Study|Lost to Follow-up|3|||
146985017|NCT00989261|530107135|FG001|Overall Study|Lost to Follow-up|0|||
146985018|NCT01238848|530107136|FG000|Overall Study|Physician Decision|13|||
146985019|NCT01238848|530107137|FG001|Overall Study|Physician Decision|5|||
146985020|NCT00576901|530107138|FG000|Overall Study|Withdrawal by Subject|1|||
146985021|NCT00576901|530107138|FG000|Overall Study|Disease course|1|||
146985022|NCT00576901|530107138|FG000|Overall Study|Protocol Violation|1|||
146985023|NCT02398188|530107139|FG000|Overall Study|Adverse Event|2|||
146985024|NCT02398188|530107140|FG001|Overall Study|Adverse Event|3|||
146985025|NCT02398188|530107139|FG000|Overall Study|Lost to Follow-up|5|||
146985026|NCT02398188|530107140|FG001|Overall Study|Lost to Follow-up|0|||
146985027|NCT02398188|530107139|FG000|Overall Study|Non-compliance|4|||
146985028|NCT02398188|530107140|FG001|Overall Study|Non-compliance|4|||
146985029|NCT02398188|530107139|FG000|Overall Study|Protocol Violation|6|||
146985030|NCT02398188|530107140|FG001|Overall Study|Protocol Violation|10|||
146985031|NCT02398188|530107139|FG000|Overall Study|Sponsor Decision|2|||
146985032|NCT02398188|530107140|FG001|Overall Study|Sponsor Decision|1|||
146985033|NCT02398188|530107139|FG000|Overall Study|Pregnancy|1|||
146985034|NCT02398188|530107140|FG001|Overall Study|Pregnancy|0|||
146985035|NCT02398188|530107139|FG000|Overall Study|Withdrawal by Subject|7|||
146985036|NCT02398188|530107140|FG001|Overall Study|Withdrawal by Subject|16|||
146985037|NCT01259869|530107141|FG000|Overall Study|Duplicated registration|1|||
146985038|NCT03209570|530107146|FG000|Overall Study|Death|1|||
146985039|NCT03209570|530107147|FG001|Overall Study|Death|0|||
146985040|NCT03209570|530107146|FG000|Overall Study|Incomplete Data|8|||
146953916|NCT01984294|529987601|FG000|Overall Study|Adverse Event|0|||
146953917|NCT01984294|529987602|FG001|Overall Study|Adverse Event|1|||
146953918|NCT01984294|529987603|FG002|Overall Study|Adverse Event|0|||
146953919|NCT03049852|529987611|FG000|Overall Study|Lost to Follow-up|0|||
146953920|NCT03049852|529987612|FG001|Overall Study|Lost to Follow-up|1|||
146953921|NCT03049852|529987613|FG002|Overall Study|Lost to Follow-up|0|||
146953922|NCT02610231|529987614|FG000|Overall Study|Withdrawal by Subject|27|||
146953923|NCT02610231|529987614|FG000|Overall Study|Adverse Event|20|||
146953924|NCT02610231|529987614|FG000|Overall Study|Death|5|||
146953925|NCT02610231|529987614|FG000|Overall Study|Surgery|2|||
146953926|NCT02610231|529987614|FG000|Overall Study|Physician Decision|1|||
146985041|NCT03209570|530107147|FG001|Overall Study|Incomplete Data|10|||
146985042|NCT03209570|530107146|FG000|Overall Study|Protocol Violation|1|||
146985043|NCT03209570|530107147|FG001|Overall Study|Protocol Violation|0|||
146985044|NCT03209570|530107146|FG000|Overall Study|Withdrawal by Subject|0|||
146953927|NCT02610231|529987614|FG000|Overall Study|Non Compliance|2|||
146985045|NCT03209570|530107147|FG001|Overall Study|Withdrawal by Subject|3|||
146985046|NCT00220701|530107148|FG000|Overall Study|Lost to Follow-up|5|||
146953928|NCT02610231|529987614|FG000|Overall Study|Other|3|||
146953929|NCT02140762|529987624|FG000|Overall Study|Adverse Event|1|||
146985047|NCT00220701|530107149|FG001|Overall Study|Lost to Follow-up|4|||
146985048|NCT00755326|530107151|FG000|Overall Study|Lost to Follow-up|2|||
146985049|NCT00755326|530107152|FG001|Overall Study|Lost to Follow-up|3|||
146985050|NCT00368966|530107159|FG000|Infant Series|Withdrawal by Subject|11|||
146985051|NCT00368966|530107160|FG001|Infant Series|Withdrawal by Subject|6|||
146953930|NCT02140762|529987625|FG001|Overall Study|Adverse Event|1|||
146985052|NCT00368966|530107159|FG000|Infant Series|Protocol Violation|2|||
146985053|NCT00368966|530107160|FG001|Infant Series|Protocol Violation|1|||
146985054|NCT00368966|530107159|FG000|Infant Series|Lost to Follow-up|2|||
146985055|NCT00368966|530107160|FG001|Infant Series|Lost to Follow-up|0|||
146953931|NCT02140762|529987624|FG000|Overall Study|Lost to Follow-up|9|||
146953932|NCT02140762|529987625|FG001|Overall Study|Lost to Follow-up|5|||
146953933|NCT02140762|529987624|FG000|Overall Study|Protocol Violation|1|||
146953934|NCT02140762|529987625|FG001|Overall Study|Protocol Violation|1|||
146953935|NCT02140762|529987624|FG000|Overall Study|Withdrawal by Subject|6|||
146953936|NCT02140762|529987625|FG001|Overall Study|Withdrawal by Subject|4|||
146953937|NCT02140762|529987624|FG000|Overall Study|Other|0|||
146953938|NCT02140762|529987625|FG001|Overall Study|Other|1|||
146953939|NCT02709889|529987626|FG000|Overall Study|Withdrawal by Subject|11|||
146953940|NCT02709889|529987627|FG001|Overall Study|Withdrawal by Subject|10|||
146953941|NCT02709889|529987628|FG002|Overall Study|Withdrawal by Subject|2|||
146953942|NCT02709889|529987629|FG003|Overall Study|Withdrawal by Subject|12|||
146953943|NCT02709889|529987626|FG000|Overall Study|Death|25|||
146953944|NCT02709889|529987627|FG001|Overall Study|Death|38|||
146953945|NCT02709889|529987628|FG002|Overall Study|Death|4|||
146953946|NCT02709889|529987629|FG003|Overall Study|Death|44|||
146953947|NCT02709889|529987626|FG000|Overall Study|Physician Decision|1|||
146953948|NCT02709889|529987627|FG001|Overall Study|Physician Decision|2|||
146953949|NCT02709889|529987628|FG002|Overall Study|Physician Decision|3|||
146953950|NCT02709889|529987629|FG003|Overall Study|Physician Decision|5|||
146953951|NCT02709889|529987626|FG000|Overall Study|Lost to Follow-up|2|||
146953952|NCT02709889|529987627|FG001|Overall Study|Lost to Follow-up|0|||
146953953|NCT02709889|529987628|FG002|Overall Study|Lost to Follow-up|0|||
146953954|NCT02709889|529987629|FG003|Overall Study|Lost to Follow-up|4|||
146953955|NCT02709889|529987626|FG000|Overall Study|Study Terminated by Sponsor|4|||
146953956|NCT02709889|529987627|FG001|Overall Study|Study Terminated by Sponsor|6|||
146953957|NCT02709889|529987628|FG002|Overall Study|Study Terminated by Sponsor|2|||
146953958|NCT02709889|529987629|FG003|Overall Study|Study Terminated by Sponsor|17|||
146953959|NCT02709889|529987626|FG000|Overall Study|Other, Not Specified|0|||
146953960|NCT02709889|529987627|FG001|Overall Study|Other, Not Specified|1|||
146953961|NCT02709889|529987628|FG002|Overall Study|Other, Not Specified|1|||
146953962|NCT02709889|529987629|FG003|Overall Study|Other, Not Specified|6|||
146953963|NCT00537810|529987630|FG000|Overall Study|Withdrawal by Subject|4|||
146953964|NCT00537810|529987631|FG001|Overall Study|Withdrawal by Subject|11|||
146953965|NCT00537810|529987632|FG002|Overall Study|Withdrawal by Subject|4|||
146953966|NCT00537810|529987633|FG003|Overall Study|Withdrawal by Subject|3|||
146953967|NCT00537810|529987630|FG000|Overall Study|Medically withdrawn|2|||
146953968|NCT00537810|529987631|FG001|Overall Study|Medically withdrawn|2|||
146953969|NCT00537810|529987632|FG002|Overall Study|Medically withdrawn|0|||
146953970|NCT00537810|529987633|FG003|Overall Study|Medically withdrawn|1|||
146953971|NCT01711359|529987634|FG000|Treatment Period|Withdrawal by Subject|18|||
146953972|NCT01711359|529987635|FG001|Treatment Period|Withdrawal by Subject|7|||
146953973|NCT01711359|529987636|FG002|Treatment Period|Withdrawal by Subject|13|||
146953974|NCT01711359|529987634|FG000|Treatment Period|Lack of Efficacy|13|||
146953975|NCT01711359|529987635|FG001|Treatment Period|Lack of Efficacy|2|||
146953976|NCT01711359|529987636|FG002|Treatment Period|Lack of Efficacy|2|||
146953977|NCT01711359|529987634|FG000|Treatment Period|Adverse Event|8|||
146953978|NCT01711359|529987635|FG001|Treatment Period|Adverse Event|10|||
146953979|NCT01711359|529987636|FG002|Treatment Period|Adverse Event|24|||
146953980|NCT01711359|529987634|FG000|Treatment Period|Physician Decision|4|||
146953981|NCT01711359|529987635|FG001|Treatment Period|Physician Decision|3|||
146953982|NCT01711359|529987636|FG002|Treatment Period|Physician Decision|2|||
146953983|NCT01711359|529987634|FG000|Treatment Period|Death|3|||
146953984|NCT01711359|529987635|FG001|Treatment Period|Death|0|||
146953985|NCT01711359|529987636|FG002|Treatment Period|Death|0|||
146953986|NCT01711359|529987634|FG000|Treatment Period|Entry Criteria Not Met|1|||
146953987|NCT01711359|529987635|FG001|Treatment Period|Entry Criteria Not Met|0|||
146953988|NCT01711359|529987636|FG002|Treatment Period|Entry Criteria Not Met|0|||
146985056|NCT00368966|530107159|FG000|Infant Series|Randomization error|0|||
146985057|NCT00368966|530107160|FG001|Infant Series|Randomization error|1|||
146985058|NCT00368966|530107159|FG000|Infant Series|Failed to meet eligibility criteria|0|||
146985059|NCT00368966|530107160|FG001|Infant Series|Failed to meet eligibility criteria|1|||
146985060|NCT00368966|530107159|FG000|Infant Series|Adverse Event|0|||
146985061|NCT00368966|530107160|FG001|Infant Series|Adverse Event|1|||
146985062|NCT00368966|530107159|FG000|Infant Series|Failed to return|1|||
146953989|NCT01711359|529987634|FG000|Treatment Period|Sponsor Decision|1|||
146953990|NCT01711359|529987635|FG001|Treatment Period|Sponsor Decision|0|||
146953991|NCT01711359|529987636|FG002|Treatment Period|Sponsor Decision|0|||
146953992|NCT01711359|529987634|FG000|Treatment Period|Lost to Follow-up|1|||
146953993|NCT01711359|529987635|FG001|Treatment Period|Lost to Follow-up|1|||
146825163|NCT00784277|529530001|FG005|IR Treatment|Other|0|||
146953994|NCT01711359|529987636|FG002|Treatment Period|Lost to Follow-up|1|||
146953995|NCT01711359|529987634|FG000|Treatment Period|Randomized, Not Treated|3|||
146953996|NCT01711359|529987635|FG001|Treatment Period|Randomized, Not Treated|1|||
146953997|NCT01711359|529987636|FG002|Treatment Period|Randomized, Not Treated|0|||
146953998|NCT02698176|529987637|FG000|Overall Study|Progressive disease|4|||
146953999|NCT02698176|529987638|FG001|Overall Study|Progressive disease|3|||
146954000|NCT02698176|529987639|FG002|Overall Study|Progressive disease|1|||
146954001|NCT02698176|529987640|FG003|Overall Study|Progressive disease|0|||
146954002|NCT02698176|529987637|FG000|Overall Study|Adverse Event|2|||
146954003|NCT02698176|529987638|FG001|Overall Study|Adverse Event|0|||
146954004|NCT02698176|529987639|FG002|Overall Study|Adverse Event|0|||
146954005|NCT02698176|529987640|FG003|Overall Study|Adverse Event|0|||
146954006|NCT02698176|529987637|FG000|Overall Study|Clinical progression|3|||
146954007|NCT02698176|529987638|FG001|Overall Study|Clinical progression|0|||
146954008|NCT02698176|529987639|FG002|Overall Study|Clinical progression|0|||
146954009|NCT02698176|529987640|FG003|Overall Study|Clinical progression|0|||
146954010|NCT02561572|529987645|FG000|Overall Study|Inadequate time before surgery|2|||
146954011|NCT02561572|529987646|FG001|Overall Study|Inadequate time before surgery|1|||
146954012|NCT02561572|529987645|FG000|Overall Study|Protocol Violation|0|||
146954013|NCT02561572|529987646|FG001|Overall Study|Protocol Violation|1|||
146954014|NCT00795717|529987647|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
146954015|NCT00795717|529987648|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
146954016|NCT00795717|529987647|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
146954017|NCT00795717|529987648|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
146954018|NCT00795717|529987647|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
146954019|NCT00795717|529987648|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
146954020|NCT00795717|529987647|FG000|Phase II|too busy|0|||
146954021|NCT00795717|529987648|FG001|Phase II|too busy|1|||
146954022|NCT00410514|529987651|FG000|Overall Study|Adverse Event|2|||
146954023|NCT00410514|529987652|FG001|Overall Study|Adverse Event|2|||
146954024|NCT00410514|529987653|FG002|Overall Study|Adverse Event|2|||
146954025|NCT00410514|529987651|FG000|Overall Study|Protocol Violation|0|||
146954026|NCT00410514|529987652|FG001|Overall Study|Protocol Violation|1|||
146954027|NCT00410514|529987653|FG002|Overall Study|Protocol Violation|1|||
146954028|NCT00410514|529987651|FG000|Overall Study|Lost to Follow-up|0|||
146954029|NCT00410514|529987652|FG001|Overall Study|Lost to Follow-up|0|||
146954030|NCT00410514|529987653|FG002|Overall Study|Lost to Follow-up|2|||
146954031|NCT00410514|529987651|FG000|Overall Study|Non-compliant with study procedures|0|||
146954032|NCT00410514|529987652|FG001|Overall Study|Non-compliant with study procedures|0|||
146954033|NCT00410514|529987653|FG002|Overall Study|Non-compliant with study procedures|2|||
146954034|NCT02691468|529987655|FG000|Overall Study|Bronchial blocker use|2|||
146954035|NCT02691468|529987656|FG001|Overall Study|Bronchial blocker use|1|||
146954036|NCT02691468|529987655|FG000|Overall Study|Lost to Follow-up|2|||
146954037|NCT02691468|529987656|FG001|Overall Study|Lost to Follow-up|1|||
146954038|NCT02691468|529987655|FG000|Overall Study|Failure to advance FOB|2|||
146954039|NCT02691468|529987656|FG001|Overall Study|Failure to advance FOB|0|||
146954040|NCT01021423|529987657|FG000|Overall Study|Study terminated|4|||
146954041|NCT01021423|529987658|FG001|Overall Study|Study terminated|5|||
146954042|NCT02886338|529987659|FG000|Overall Study|Withdrawal by Subject|1|||
146954043|NCT00394654|529987660|FG000|Overall Study|Lost to Follow-up|1|||
146954044|NCT00394654|529987661|FG001|Overall Study|Lost to Follow-up|0|||
146954045|NCT00394654|529987660|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
146954046|NCT00394654|529987661|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
146954047|NCT03756285|529987662|FG000|Overall Study|Lost to Follow-up|0|||
146954048|NCT03756285|529987663|FG001|Overall Study|Lost to Follow-up|1|||
146954049|NCT03756285|529987662|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
146954050|NCT03756285|529987663|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
146985063|NCT00368966|530107160|FG001|Infant Series|Failed to return|0|||
146985064|NCT00368966|530107159|FG000|After Infant|Failed to return|3|||
146825164|NCT00784277|529530002|FG006|IR Treatment|Other|0|||
146825165|NCT00784277|529529996|FG000|ER Treatment|Adverse Event|0|||
146825166|NCT00784277|529529997|FG001|ER Treatment|Adverse Event|0|||
146825167|NCT00784277|529529998|FG002|ER Treatment|Adverse Event|0|||
146825168|NCT00784277|529529999|FG003|ER Treatment|Adverse Event|0|||
146825169|NCT00784277|529530000|FG004|ER Treatment|Adverse Event|1|||
146825170|NCT00784277|529530001|FG005|ER Treatment|Adverse Event|7|||
146825171|NCT00784277|529530002|FG006|ER Treatment|Adverse Event|7|||
146825172|NCT00784277|529529996|FG000|ER Treatment|Lack of Efficacy|0|||
146825173|NCT00784277|529529997|FG001|ER Treatment|Lack of Efficacy|0|||
146825174|NCT00784277|529529998|FG002|ER Treatment|Lack of Efficacy|0|||
146825175|NCT00784277|529529999|FG003|ER Treatment|Lack of Efficacy|0|||
146825176|NCT00784277|529530000|FG004|ER Treatment|Lack of Efficacy|3|||
146954051|NCT03756285|529987662|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
146954052|NCT03756285|529987663|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
146954053|NCT00286156|529987665|FG000|Overall Study|Missed 12 month visit|0|||
146954054|NCT00286156|529987666|FG001|Overall Study|Missed 12 month visit|0|||
146954055|NCT00286156|529987667|FG002|Overall Study|Missed 12 month visit|1|||
146954056|NCT00286156|529987665|FG000|Overall Study|AE: pulmonary embolus|0|||
146954057|NCT00286156|529987666|FG001|Overall Study|AE: pulmonary embolus|1|||
146954058|NCT00286156|529987667|FG002|Overall Study|AE: pulmonary embolus|0|||
146985065|NCT00368966|530107160|FG001|After Infant|Failed to return|1|||
146825177|NCT00784277|529530001|FG005|ER Treatment|Lack of Efficacy|4|||
146825178|NCT00784277|529530002|FG006|ER Treatment|Lack of Efficacy|0|||
146825179|NCT00784277|529529996|FG000|ER Treatment|Lost to Follow-up|0|||
146825180|NCT00784277|529529997|FG001|ER Treatment|Lost to Follow-up|0|||
146825181|NCT00784277|529529998|FG002|ER Treatment|Lost to Follow-up|0|||
146954059|NCT00286156|529987665|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
146954060|NCT00286156|529987666|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
146954061|NCT00286156|529987667|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
146954062|NCT00286156|529987665|FG000|Overall Study|AE: pneumonia|1|||
146954063|NCT00286156|529987666|FG001|Overall Study|AE: pneumonia|0|||
146954064|NCT00286156|529987667|FG002|Overall Study|AE: pneumonia|0|||
146954065|NCT06334055|529987671|FG000|Overall Study|Adverse Event|4|||
146954066|NCT06334055|529987671|FG000|Overall Study|Disqualified|72|||
146954067|NCT04728815|529987674|FG000|Overall Study|Lost to Follow-up|3|||
146954068|NCT04728815|529987675|FG001|Overall Study|Lost to Follow-up|0|||
146954069|NCT04728815|529987676|FG002|Overall Study|Lost to Follow-up|0|||
146954070|NCT04728815|529987677|FG003|Overall Study|Lost to Follow-up|1|||
146954071|NCT04728815|529987678|FG004|Overall Study|Lost to Follow-up|1|||
146954072|NCT04728815|529987679|FG005|Overall Study|Lost to Follow-up|0|||
146954073|NCT04728815|529987680|FG006|Overall Study|Lost to Follow-up|2|||
146954074|NCT04728815|529987681|FG007|Overall Study|Lost to Follow-up|0|||
146954075|NCT04728815|529987674|FG000|Overall Study|Physician Decision|0|||
146954076|NCT04728815|529987675|FG001|Overall Study|Physician Decision|0|||
146954077|NCT04728815|529987676|FG002|Overall Study|Physician Decision|1|||
146954078|NCT04728815|529987677|FG003|Overall Study|Physician Decision|0|||
146954079|NCT04728815|529987678|FG004|Overall Study|Physician Decision|0|||
146954080|NCT04728815|529987679|FG005|Overall Study|Physician Decision|0|||
146954081|NCT04728815|529987680|FG006|Overall Study|Physician Decision|0|||
146954082|NCT04728815|529987681|FG007|Overall Study|Physician Decision|0|||
146954083|NCT04728815|529987674|FG000|Overall Study|Treatment drop|0|||
146954084|NCT04728815|529987675|FG001|Overall Study|Treatment drop|2|||
146954085|NCT04728815|529987676|FG002|Overall Study|Treatment drop|1|||
146954086|NCT04728815|529987677|FG003|Overall Study|Treatment drop|0|||
146954087|NCT04728815|529987678|FG004|Overall Study|Treatment drop|3|||
146954088|NCT04728815|529987679|FG005|Overall Study|Treatment drop|1|||
146954089|NCT04728815|529987680|FG006|Overall Study|Treatment drop|3|||
146954090|NCT04728815|529987681|FG007|Overall Study|Treatment drop|0|||
146954091|NCT04728815|529987674|FG000|Overall Study|Study drop|0|||
146954092|NCT04728815|529987675|FG001|Overall Study|Study drop|3|||
146954093|NCT04728815|529987676|FG002|Overall Study|Study drop|3|||
146954094|NCT04728815|529987677|FG003|Overall Study|Study drop|0|||
146954095|NCT04728815|529987678|FG004|Overall Study|Study drop|0|||
146954096|NCT04728815|529987679|FG005|Overall Study|Study drop|0|||
146954097|NCT04728815|529987680|FG006|Overall Study|Study drop|7|||
146954098|NCT04728815|529987681|FG007|Overall Study|Study drop|0|||
146954099|NCT01265719|529989115|FG000|Overall Study|Does not meet entrance criteria|0|||
146954100|NCT01265719|529989116|FG001|Overall Study|Does not meet entrance criteria|3|||
146954101|NCT01265719|529989115|FG000|Overall Study|Other reasons|2|||
146954102|NCT01265719|529989116|FG001|Overall Study|Other reasons|0|||
146954103|NCT01265719|529989115|FG000|Overall Study|Withdrawal by Subject|8|||
146825182|NCT00784277|529529999|FG003|ER Treatment|Lost to Follow-up|0|||
146825183|NCT00784277|529530000|FG004|ER Treatment|Lost to Follow-up|0|||
146825184|NCT00784277|529530001|FG005|ER Treatment|Lost to Follow-up|2|||
146825185|NCT00784277|529530002|FG006|ER Treatment|Lost to Follow-up|0|||
146825186|NCT00784277|529529996|FG000|ER Treatment|Withdrawal by Subject|0|||
146825187|NCT00784277|529529997|FG001|ER Treatment|Withdrawal by Subject|0|||
146825188|NCT00784277|529529998|FG002|ER Treatment|Withdrawal by Subject|0|||
146825189|NCT00784277|529529999|FG003|ER Treatment|Withdrawal by Subject|0|||
146825190|NCT00784277|529530000|FG004|ER Treatment|Withdrawal by Subject|2|||
146825191|NCT00784277|529530001|FG005|ER Treatment|Withdrawal by Subject|5|||
146825192|NCT00784277|529530002|FG006|ER Treatment|Withdrawal by Subject|3|||
146825193|NCT00784277|529529996|FG000|ER Treatment|Study Medication Non-Compliant|0|||
146825194|NCT00784277|529529997|FG001|ER Treatment|Study Medication Non-Compliant|0|||
146825195|NCT00784277|529529998|FG002|ER Treatment|Study Medication Non-Compliant|0|||
146825196|NCT00784277|529529999|FG003|ER Treatment|Study Medication Non-Compliant|0|||
146825197|NCT00784277|529530000|FG004|ER Treatment|Study Medication Non-Compliant|2|||
146825198|NCT00784277|529530001|FG005|ER Treatment|Study Medication Non-Compliant|3|||
146825199|NCT00784277|529530002|FG006|ER Treatment|Study Medication Non-Compliant|3|||
146825200|NCT00784277|529529996|FG000|ER Treatment|Other|0|||
146825201|NCT00784277|529529997|FG001|ER Treatment|Other|0|||
146954104|NCT01265719|529989116|FG001|Overall Study|Withdrawal by Subject|3|||
146985066|NCT00368966|530107159|FG000|After Infant|Adverse Event|1|||
146954105|NCT01265719|529989115|FG000|Overall Study|Lost to Follow-up|2|||
146825202|NCT00784277|529529998|FG002|ER Treatment|Other|0|||
146825203|NCT00784277|529529999|FG003|ER Treatment|Other|0|||
146954106|NCT01265719|529989116|FG001|Overall Study|Lost to Follow-up|7|||
146954107|NCT01265719|529989115|FG000|Overall Study|Adverse Event|2|||
146954108|NCT01265719|529989116|FG001|Overall Study|Adverse Event|0|||
146954109|NCT00027027|529989117|FG000|Overall Study|Adverse Event|0|||
146954110|NCT00027027|529989118|FG001|Overall Study|Adverse Event|0|||
146954111|NCT00027027|529989119|FG002|Overall Study|Adverse Event|1|||
146985067|NCT00368966|530107160|FG001|After Infant|Adverse Event|2|||
146825204|NCT00784277|529530000|FG004|ER Treatment|Other|1|||
146825205|NCT00784277|529530001|FG005|ER Treatment|Other|3|||
146825206|NCT00784277|529530002|FG006|ER Treatment|Other|2|||
146825207|NCT01093222|529530003|FG000|Overall Study|Ineligible|6|||
146825208|NCT01093222|529530003|FG000|Overall Study|Adverse Event|7|||
146825209|NCT01093222|529530003|FG000|Overall Study|Progression/relapse|24|||
146825210|NCT01093222|529530003|FG000|Overall Study|Death|2|||
146825211|NCT01093222|529530003|FG000|Overall Study|Not protocol specified|1|||
146825212|NCT00187135|529530006|FG000|Visit One|Withdrawal by Subject|1|||
146825213|NCT00187135|529530007|FG001|Visit One|Withdrawal by Subject|0|||
146825214|NCT00187135|529530008|FG002|Visit One|Withdrawal by Subject|0|||
146825215|NCT00187135|529530009|FG003|Visit One|Withdrawal by Subject|0|||
146825216|NCT00187135|529530010|FG004|Visit One|Withdrawal by Subject|0|||
146825217|NCT00187135|529530011|FG005|Visit One|Withdrawal by Subject|1|||
146825218|NCT00187135|529530006|FG000|Visit One|Physician Decision|3|||
146825219|NCT00187135|529530007|FG001|Visit One|Physician Decision|1|||
146825220|NCT00187135|529530008|FG002|Visit One|Physician Decision|0|||
146825221|NCT00187135|529530009|FG003|Visit One|Physician Decision|0|||
146825222|NCT00187135|529530010|FG004|Visit One|Physician Decision|0|||
146825223|NCT00187135|529530011|FG005|Visit One|Physician Decision|1|||
146825224|NCT00187135|529530006|FG000|Visit Two|Death|0|||
146825225|NCT00187135|529530007|FG001|Visit Two|Death|0|||
146825226|NCT00187135|529530008|FG002|Visit Two|Death|0|||
146825227|NCT00187135|529530009|FG003|Visit Two|Death|1|||
146825228|NCT00187135|529530010|FG004|Visit Two|Death|0|||
146825229|NCT00187135|529530011|FG005|Visit Two|Death|1|||
146825230|NCT00187135|529530006|FG000|Visit Two|Physician Decision|1|||
146825231|NCT00187135|529530007|FG001|Visit Two|Physician Decision|0|||
146825232|NCT00187135|529530008|FG002|Visit Two|Physician Decision|0|||
146825233|NCT00187135|529530009|FG003|Visit Two|Physician Decision|0|||
146825234|NCT00187135|529530010|FG004|Visit Two|Physician Decision|0|||
146825235|NCT00187135|529530011|FG005|Visit Two|Physician Decision|0|||
146825236|NCT00187135|529530006|FG000|Visit Two|Withdrawal by Subject|1|||
146825237|NCT00187135|529530007|FG001|Visit Two|Withdrawal by Subject|1|||
146825238|NCT00187135|529530008|FG002|Visit Two|Withdrawal by Subject|1|||
146825239|NCT00187135|529530009|FG003|Visit Two|Withdrawal by Subject|0|||
146825240|NCT00187135|529530010|FG004|Visit Two|Withdrawal by Subject|1|||
146825241|NCT00187135|529530011|FG005|Visit Two|Withdrawal by Subject|1|||
146825242|NCT00187135|529530006|FG000|Visit Two|Study Discontinued|3|||
146825243|NCT00187135|529530007|FG001|Visit Two|Study Discontinued|2|||
146825244|NCT00187135|529530008|FG002|Visit Two|Study Discontinued|1|||
146825245|NCT00187135|529530009|FG003|Visit Two|Study Discontinued|7|||
146825246|NCT00187135|529530010|FG004|Visit Two|Study Discontinued|5|||
146985068|NCT00368966|530107159|FG000|After Infant|Withdrawal by Subject|1|||
146985069|NCT00368966|530107160|FG001|After Infant|Withdrawal by Subject|1|||
146985070|NCT00368966|530107159|FG000|After Infant|Death|1|||
146985071|NCT00368966|530107160|FG001|After Infant|Death|0|||
146985072|NCT00368966|530107159|FG000|After Infant|Lost to Follow-up|0|||
146985073|NCT00368966|530107160|FG001|After Infant|Lost to Follow-up|1|||
146985074|NCT00368966|530107159|FG000|Toddler Dose|Withdrawal by Subject|1|||
146985075|NCT00368966|530107160|FG001|Toddler Dose|Withdrawal by Subject|1|||
146985076|NCT00368966|530107159|FG000|Toddler Dose|Lost to Follow-up|0|||
146985077|NCT00368966|530107160|FG001|Toddler Dose|Lost to Follow-up|2|||
146985078|NCT01689974|530107161|FG000|Overall Study|Termination of Study|5|||
146985079|NCT01689974|530107162|FG001|Overall Study|Termination of Study|5|||
146985080|NCT01333033|530107163|FG000|Overall Study|Ineligible|0|||
146985081|NCT01333033|530107164|FG001|Overall Study|Ineligible|0|||
146985082|NCT01333033|530107165|FG002|Overall Study|Ineligible|0|||
146985083|NCT01333033|530107166|FG003|Overall Study|Ineligible|0|||
146985084|NCT01333033|530107167|FG004|Overall Study|Ineligible|6|||
146985085|NCT01333033|530107168|FG005|Overall Study|Ineligible|8|||
146985086|NCT01333033|530107163|FG000|Overall Study|Withdrawal by Subject|0|||
146985087|NCT01333033|530107164|FG001|Overall Study|Withdrawal by Subject|0|||
146985088|NCT01333033|530107165|FG002|Overall Study|Withdrawal by Subject|0|||
146825247|NCT00187135|529530011|FG005|Visit Two|Study Discontinued|6|||
146825248|NCT00187135|529530006|FG000|Visit Three|Death|0|||
146825249|NCT00187135|529530007|FG001|Visit Three|Death|0|||
146825250|NCT00187135|529530008|FG002|Visit Three|Death|1|||
146825251|NCT00187135|529530009|FG003|Visit Three|Death|0|||
146985089|NCT01333033|530107166|FG003|Overall Study|Withdrawal by Subject|0|||
146985090|NCT01333033|530107167|FG004|Overall Study|Withdrawal by Subject|4|||
146985091|NCT01333033|530107168|FG005|Overall Study|Withdrawal by Subject|2|||
146825252|NCT00187135|529530010|FG004|Visit Three|Death|1|||
146825253|NCT00187135|529530011|FG005|Visit Three|Death|0|||
146825254|NCT00187135|529530006|FG000|Visit Three|Withdrawal by Subject|0|||
146825255|NCT00187135|529530007|FG001|Visit Three|Withdrawal by Subject|1|||
146825256|NCT00187135|529530008|FG002|Visit Three|Withdrawal by Subject|1|||
146825257|NCT00187135|529530009|FG003|Visit Three|Withdrawal by Subject|2|||
146825258|NCT00187135|529530010|FG004|Visit Three|Withdrawal by Subject|0|||
146825259|NCT00187135|529530011|FG005|Visit Three|Withdrawal by Subject|0|||
146825260|NCT00187135|529530006|FG000|Visit Three|Study Discontinued|7|||
146825261|NCT00187135|529530007|FG001|Visit Three|Study Discontinued|6|||
146985092|NCT01333033|530107163|FG000|Overall Study|PET inevaluable|0|||
146825262|NCT00187135|529530008|FG002|Visit Three|Study Discontinued|7|||
146825263|NCT00187135|529530009|FG003|Visit Three|Study Discontinued|7|||
146825264|NCT00187135|529530010|FG004|Visit Three|Study Discontinued|7|||
146825265|NCT00187135|529530011|FG005|Visit Three|Study Discontinued|6|||
146825266|NCT03927222|529530012|FG000|Overall Study|Progression|3|||
146825267|NCT03927222|529530012|FG000|Overall Study|CMV testing results inconclusive|1|||
146825268|NCT03927222|529530012|FG000|Overall Study|Unable to generate enough vaccines|1|||
146825269|NCT03927222|529530012|FG000|Overall Study|Early study termination|1|||
146825270|NCT03723915|529530013|FG000|Screening|Failed to meet screening requirements.|2|||
146825271|NCT03723915|529530013|FG000|On Treatment|Failed to meet treatment requirements|2|||
146825272|NCT00640042|529530014|FG000|Enrollment|Did not receive study drug|83|||
146825273|NCT01592383|529530035|FG000|Overall Study|Adverse Event|1|||
146825274|NCT00560313|529531592|FG000|Overall Study|Adverse Events or Death|2|||
146825275|NCT00560313|529531592|FG000|Overall Study|Withdrawal by Subject|2|||
146825276|NCT00560313|529531592|FG000|Overall Study|Lost to Follow-up|1|||
146825277|NCT00560313|529531592|FG000|Overall Study|Protocol Violation|1|||
146825278|NCT00853372|529531597|FG000|Overall Study|Death|30|||
146825279|NCT00853372|529531598|FG001|Overall Study|Death|26|||
146825280|NCT00853372|529531597|FG000|Overall Study|Lost to Follow-up|1|||
146825281|NCT00853372|529531598|FG001|Overall Study|Lost to Follow-up|2|||
146825282|NCT00853372|529531597|FG000|Overall Study|Full Consent Withdrawn|1|||
146825283|NCT00853372|529531598|FG001|Overall Study|Full Consent Withdrawn|1|||
146825284|NCT01268098|529531603|FG000|Overall Study|Adverse Event|1|||
146825285|NCT01268098|529531604|FG001|Overall Study|Adverse Event|0|||
146825286|NCT01703845|529531606|FG000|Overall Study|Adverse Event|1|||
146825287|NCT01703845|529531607|FG001|Overall Study|Adverse Event|0|||
146825288|NCT01703845|529531606|FG000|Overall Study|Protocol Violation|1|||
146825289|NCT01703845|529531607|FG001|Overall Study|Protocol Violation|0|||
146825290|NCT01703845|529531606|FG000|Overall Study|other than stated above|1|||
146825291|NCT01703845|529531607|FG001|Overall Study|other than stated above|0|||
146825292|NCT01644188|529531608|FG000|Overall Study|Adverse Event|44|||
146825293|NCT01644188|529531609|FG001|Overall Study|Adverse Event|20|||
146825294|NCT01644188|529531608|FG000|Overall Study|Poor compliance to protocol|26|||
146825295|NCT01644188|529531609|FG001|Overall Study|Poor compliance to protocol|14|||
146825296|NCT01644188|529531608|FG000|Overall Study|Physician Decision|1|||
146825297|NCT01644188|529531609|FG001|Overall Study|Physician Decision|3|||
146825298|NCT01644188|529531608|FG000|Overall Study|Participant moved|7|||
146825299|NCT01644188|529531609|FG001|Overall Study|Participant moved|2|||
146825300|NCT01644188|529531608|FG000|Overall Study|Related to auto-injector administration|2|||
146825301|NCT01644188|529531609|FG001|Overall Study|Related to auto-injector administration|2|||
146825302|NCT01644188|529531608|FG000|Overall Study|Consent withdrawn by participant|14|||
146825303|NCT01644188|529531609|FG001|Overall Study|Consent withdrawn by participant|7|||
146825304|NCT01644188|529531608|FG000|Overall Study|Selection criteria finally not met|2|||
146825305|NCT01644188|529531609|FG001|Overall Study|Selection criteria finally not met|0|||
146825306|NCT01644188|529531608|FG000|Overall Study|Lost to Follow-up|1|||
146825307|NCT01644188|529531609|FG001|Overall Study|Lost to Follow-up|0|||
146825308|NCT01644188|529531608|FG000|Overall Study|Death|4|||
146825309|NCT01644188|529531609|FG001|Overall Study|Death|3|||
146825310|NCT01644188|529531608|FG000|Overall Study|Last visit outside protocol visit window|14|||
146825311|NCT01644188|529531609|FG001|Overall Study|Last visit outside protocol visit window|16|||
146825312|NCT01644188|529531608|FG000|Overall Study|Site closure|1|||
146825313|NCT01644188|529531609|FG001|Overall Study|Site closure|1|||
146825314|NCT01644188|529531608|FG000|Overall Study|Other than specified above|6|||
146825315|NCT01644188|529531609|FG001|Overall Study|Other than specified above|7|||
146825316|NCT01929876|529531611|FG000|Period 2|Non-Compliance|1|||
146825317|NCT01845649|529531616|FG000|Overall Study|Adverse Event|7|||
146825318|NCT01845649|529531617|FG001|Overall Study|Adverse Event|10|||
146825319|NCT01845649|529531616|FG000|Overall Study|Lack of Efficacy|1|||
146825320|NCT01845649|529531617|FG001|Overall Study|Lack of Efficacy|1|||
146954112|NCT00027027|529989120|FG003|Overall Study|Adverse Event|0|||
146954113|NCT00027027|529989121|FG004|Overall Study|Adverse Event|1|||
146954114|NCT00027027|529989117|FG000|Overall Study|Admitted for Signs of PD|0|||
146954115|NCT00027027|529989118|FG001|Overall Study|Admitted for Signs of PD|0|||
146954116|NCT00027027|529989119|FG002|Overall Study|Admitted for Signs of PD|0|||
146954117|NCT00027027|529989120|FG003|Overall Study|Admitted for Signs of PD|0|||
146954118|NCT00027027|529989121|FG004|Overall Study|Admitted for Signs of PD|1|||
146954119|NCT00027027|529989117|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
146954120|NCT00027027|529989118|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
146954121|NCT00027027|529989119|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
146954122|NCT00027027|529989120|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
146985093|NCT01333033|530107164|FG001|Overall Study|PET inevaluable|0|||
146825321|NCT01845649|529531616|FG000|Overall Study|Lost to Follow-up|2|||
146825322|NCT01845649|529531617|FG001|Overall Study|Lost to Follow-up|2|||
146825323|NCT01845649|529531616|FG000|Overall Study|Withdrew Consent|12|||
146825324|NCT01845649|529531617|FG001|Overall Study|Withdrew Consent|4|||
146825325|NCT01845649|529531616|FG000|Overall Study|Protocol Deviation|7|||
146825326|NCT01845649|529531617|FG001|Overall Study|Protocol Deviation|4|||
146954123|NCT00027027|529989121|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
146825327|NCT01845649|529531616|FG000|Overall Study|Reason not Specified|2|||
146825328|NCT01845649|529531617|FG001|Overall Study|Reason not Specified|1|||
146954124|NCT00027027|529989117|FG000|Overall Study|PD Requiring Surgery|0|||
146954125|NCT00027027|529989118|FG001|Overall Study|PD Requiring Surgery|0|||
146954126|NCT00027027|529989119|FG002|Overall Study|PD Requiring Surgery|1|||
146954127|NCT00027027|529989120|FG003|Overall Study|PD Requiring Surgery|0|||
146954128|NCT00027027|529989121|FG004|Overall Study|PD Requiring Surgery|0|||
146954129|NCT00027027|529989117|FG000|Overall Study|Physician Decision Due To PD|2|||
146954130|NCT00027027|529989118|FG001|Overall Study|Physician Decision Due To PD|3|||
146954131|NCT00027027|529989119|FG002|Overall Study|Physician Decision Due To PD|2|||
146954132|NCT00027027|529989120|FG003|Overall Study|Physician Decision Due To PD|3|||
146954133|NCT00027027|529989121|FG004|Overall Study|Physician Decision Due To PD|5|||
146954134|NCT00027027|529989117|FG000|Overall Study|Withdrawal by Subject|0|||
146954135|NCT00027027|529989118|FG001|Overall Study|Withdrawal by Subject|0|||
146954136|NCT00027027|529989119|FG002|Overall Study|Withdrawal by Subject|0|||
146954137|NCT00027027|529989120|FG003|Overall Study|Withdrawal by Subject|0|||
146954138|NCT00027027|529989121|FG004|Overall Study|Withdrawal by Subject|1|||
146954139|NCT00959192|529989127|FG000|Overall Study|Adverse Event|1|||
146954140|NCT00959192|529989128|FG001|Overall Study|Adverse Event|1|||
146954141|NCT00959192|529989129|FG002|Overall Study|Adverse Event|1|||
146954142|NCT00959192|529989130|FG003|Overall Study|Adverse Event|0|||
146954143|NCT00959192|529989127|FG000|Overall Study|Investigator Request|1|||
146954144|NCT00959192|529989128|FG001|Overall Study|Investigator Request|0|||
146954145|NCT00959192|529989129|FG002|Overall Study|Investigator Request|0|||
146954146|NCT00959192|529989130|FG003|Overall Study|Investigator Request|0|||
146954147|NCT00959192|529989127|FG000|Overall Study|Caregiver Request|0|||
146954148|NCT00959192|529989128|FG001|Overall Study|Caregiver Request|0|||
146954149|NCT00959192|529989129|FG002|Overall Study|Caregiver Request|2|||
146954150|NCT00959192|529989130|FG003|Overall Study|Caregiver Request|1|||
146954151|NCT01967134|529989131|FG000|Overall Study|Lost to Follow-up|0|||
146954152|NCT01967134|529989132|FG001|Overall Study|Lost to Follow-up|1|||
146954153|NCT01967134|529989133|FG002|Overall Study|Lost to Follow-up|0|||
146954154|NCT00305773|529989135|FG000|Overall Study|Death|3|||
146954155|NCT00305773|529989136|FG001|Overall Study|Death|2|||
146954156|NCT00305773|529989135|FG000|Overall Study|Adverse Event|1|||
146954157|NCT00305773|529989136|FG001|Overall Study|Adverse Event|2|||
146954158|NCT00305773|529989135|FG000|Overall Study|Alternative Treatment|4|||
146954159|NCT00305773|529989136|FG001|Overall Study|Alternative Treatment|4|||
146954160|NCT00305773|529989135|FG000|Overall Study|Physician Decision|1|||
146954161|NCT00305773|529989136|FG001|Overall Study|Physician Decision|1|||
146954162|NCT00305773|529989135|FG000|Overall Study|Withdrawal by Subject|1|||
146954163|NCT00305773|529989136|FG001|Overall Study|Withdrawal by Subject|4|||
146954164|NCT00305773|529989135|FG000|Overall Study|Disease Progression|1|||
146954165|NCT00305773|529989136|FG001|Overall Study|Disease Progression|3|||
146954166|NCT00305773|529989135|FG000|Overall Study|All other reasons|3|||
146954167|NCT00305773|529989136|FG001|Overall Study|All other reasons|2|||
146954168|NCT02679222|529989137|FG000|Overall Study|No time for project|1|||
146954169|NCT00945945|529989140|FG000|Overall Study|Adverse Event|15|||
146954170|NCT00945945|529989141|FG001|Overall Study|Adverse Event|35|||
146954171|NCT00945945|529989140|FG000|Overall Study|Withdrawal by Subject|7|||
146954172|NCT00945945|529989141|FG001|Overall Study|Withdrawal by Subject|10|||
146954173|NCT00945945|529989140|FG000|Overall Study|Lost to Follow-up|4|||
146954174|NCT00945945|529989141|FG001|Overall Study|Lost to Follow-up|5|||
146954175|NCT00945945|529989140|FG000|Overall Study|Lack of Efficacy|6|||
146954176|NCT00945945|529989141|FG001|Overall Study|Lack of Efficacy|2|||
146954177|NCT00945945|529989140|FG000|Overall Study|Protocol Violation|4|||
146954178|NCT00945945|529989141|FG001|Overall Study|Protocol Violation|2|||
146954179|NCT00945945|529989140|FG000|Overall Study|Entry Criteria Not Met|0|||
146954180|NCT00945945|529989141|FG001|Overall Study|Entry Criteria Not Met|1|||
146954181|NCT01716585|529989143|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
146954182|NCT01716585|529989144|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
146825329|NCT03991988|529531618|FG000|Overall Study|Withdrawal by Subject|2|||
146825330|NCT03991988|529531619|FG001|Overall Study|Withdrawal by Subject|2|||
146954183|NCT01716585|529989143|FG000|Double-blind Treatment|Adverse Event|2|||
146954184|NCT01716585|529989144|FG001|Double-blind Treatment|Adverse Event|1|||
146954185|NCT01716585|529989143|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
146954186|NCT01716585|529989144|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
146825331|NCT01222533|529531621|FG000|Overall Study|Adverse Event|5|||
146954187|NCT01716585|529989143|FG000|Double-blind Treatment|Lost to Follow-up|2|||
146825332|NCT01222533|529531621|FG000|Overall Study|Withdrawal by Subject|5|||
146954188|NCT01716585|529989144|FG001|Double-blind Treatment|Lost to Follow-up|0|||
146954189|NCT01716585|529989143|FG000|Double-blind Treatment|Subject Noncompliant|1|||
146954190|NCT01716585|529989144|FG001|Double-blind Treatment|Subject Noncompliant|0|||
146954191|NCT01716585|529989143|FG000|Double-blind Treatment|Other|1|||
146954192|NCT01716585|529989144|FG001|Double-blind Treatment|Other|0|||
146954193|NCT01716585|529989143|FG000|Open-label Treatment|Adverse Event|0|||
146825333|NCT01222533|529531621|FG000|Overall Study|Other|4|||
146825334|NCT03418493|529531622|FG000|Overall Study|Adverse Event|1|||
146825335|NCT03418493|529531623|FG001|Overall Study|Adverse Event|0|||
146825336|NCT03418493|529531624|FG002|Overall Study|Adverse Event|0|||
146825337|NCT03418493|529531625|FG003|Overall Study|Adverse Event|0|||
146825338|NCT03418493|529531626|FG004|Overall Study|Adverse Event|0|||
146825339|NCT03418493|529531627|FG005|Overall Study|Adverse Event|0|||
146825340|NCT03418493|529531628|FG006|Overall Study|Adverse Event|0|||
146825341|NCT03418493|529531629|FG007|Overall Study|Adverse Event|0|||
146825342|NCT03418493|529531630|FG008|Overall Study|Adverse Event|0|||
146825343|NCT03418493|529531631|FG009|Overall Study|Adverse Event|0|||
146825344|NCT03418493|529531632|FG010|Overall Study|Adverse Event|0|||
146825345|NCT03418493|529531622|FG000|Overall Study|Protocol Violation|0|||
146825346|NCT03418493|529531623|FG001|Overall Study|Protocol Violation|0|||
146825347|NCT03418493|529531624|FG002|Overall Study|Protocol Violation|0|||
146825348|NCT03418493|529531625|FG003|Overall Study|Protocol Violation|0|||
146825349|NCT03418493|529531626|FG004|Overall Study|Protocol Violation|0|||
146825350|NCT03418493|529531627|FG005|Overall Study|Protocol Violation|0|||
146825351|NCT03418493|529531628|FG006|Overall Study|Protocol Violation|0|||
146825352|NCT03418493|529531629|FG007|Overall Study|Protocol Violation|0|||
146825353|NCT03418493|529531630|FG008|Overall Study|Protocol Violation|0|||
146825354|NCT03418493|529531631|FG009|Overall Study|Protocol Violation|1|||
146825355|NCT03418493|529531632|FG010|Overall Study|Protocol Violation|0|||
146825356|NCT00526097|529531636|FG000|Overall Study|Adverse Event|6|||
146825357|NCT00526097|529531637|FG001|Overall Study|Adverse Event|44|||
146825358|NCT00526097|529531636|FG000|Overall Study|Protocol Violation|4|||
146825359|NCT00526097|529531637|FG001|Overall Study|Protocol Violation|10|||
146825360|NCT00526097|529531636|FG000|Overall Study|Withdrawal by Subject|3|||
146825361|NCT00526097|529531637|FG001|Overall Study|Withdrawal by Subject|1|||
146825362|NCT00526097|529531636|FG000|Overall Study|Other|2|||
146825363|NCT00526097|529531637|FG001|Overall Study|Other|1|||
146825364|NCT00966979|529531638|FG000|Overall Study|Death|1|||
146825365|NCT00966979|529531638|FG000|Overall Study|Lost to Follow-up|6|||
146825366|NCT00966979|529531638|FG000|Overall Study|Withdrawal by Subject|14|||
146825367|NCT00966979|529531638|FG000|Overall Study|Adverse Event|5|||
146825368|NCT00966979|529531638|FG000|Overall Study|Sponsor terminated early|49|||
146825369|NCT00966979|529531638|FG000|Overall Study|Censored because surgery not done|2|||
146825370|NCT00966979|529531638|FG000|Overall Study|Censored because study device was not implanted|14|||
146825371|NCT00966979|529531638|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
146825372|NCT03713281|529531639|FG000|Overall Study|Lens handling difficuluties|2|||
146825373|NCT03713281|529531639|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
146825374|NCT04349644|529531642|FG000|Allocation/Pretest|Lost to pretest|0|||
146825375|NCT04349644|529531643|FG001|Allocation/Pretest|Lost to pretest|3|||
146825376|NCT04349644|529531642|FG000|Posttest|Lost to posttest|0|||
146825377|NCT04349644|529531643|FG001|Posttest|Lost to posttest|8|||
146825378|NCT04349644|529531642|FG000|Posttest|Discontinued intervention|6|||
146825379|NCT04349644|529531643|FG001|Posttest|Discontinued intervention|0|||
146825380|NCT04349644|529531642|FG000|Follow-up|Lost to Follow-up|0|||
146825381|NCT04349644|529531643|FG001|Follow-up|Lost to Follow-up|2|||
146825382|NCT05006417|529531644|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
146825383|NCT01169636|529531645|FG000|Overall Study|Adverse Event|0|||
146825384|NCT01169636|529531646|FG001|Overall Study|Adverse Event|0|||
146825385|NCT01169636|529531647|FG002|Overall Study|Adverse Event|1|||
146825386|NCT01169636|529531648|FG003|Overall Study|Adverse Event|1|||
146825387|NCT01169636|529531649|FG004|Overall Study|Adverse Event|0|||
146825388|NCT01169636|529531645|FG000|Overall Study|Screen failure|0|||
146825389|NCT01169636|529531646|FG001|Overall Study|Screen failure|0|||
146825390|NCT01169636|529531647|FG002|Overall Study|Screen failure|2|||
146825391|NCT01169636|529531648|FG003|Overall Study|Screen failure|0|||
146985094|NCT01333033|530107165|FG002|Overall Study|PET inevaluable|0|||
146985095|NCT01333033|530107166|FG003|Overall Study|PET inevaluable|0|||
146985096|NCT01333033|530107167|FG004|Overall Study|PET inevaluable|2|||
146825392|NCT01169636|529531649|FG004|Overall Study|Screen failure|0|||
146825393|NCT01169636|529531645|FG000|Overall Study|Withdrawal by Subject|0|||
146825394|NCT01169636|529531646|FG001|Overall Study|Withdrawal by Subject|0|||
146825395|NCT01169636|529531647|FG002|Overall Study|Withdrawal by Subject|0|||
146825396|NCT01169636|529531648|FG003|Overall Study|Withdrawal by Subject|0|||
146825397|NCT01169636|529531649|FG004|Overall Study|Withdrawal by Subject|3|||
146825398|NCT02396953|529531650|FG000|Overall Study|Withdrawal by Subject|0|||
146825399|NCT02396953|529531651|FG001|Overall Study|Withdrawal by Subject|0|||
146825400|NCT02396953|529531652|FG002|Overall Study|Withdrawal by Subject|1|||
146825401|NCT02396953|529531650|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
146825402|NCT02396953|529531651|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
146825403|NCT02396953|529531652|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
146825404|NCT02396953|529531650|FG000|Overall Study|Personal Reasons|1|||
146825405|NCT02396953|529531651|FG001|Overall Study|Personal Reasons|1|||
146825406|NCT02396953|529531652|FG002|Overall Study|Personal Reasons|0|||
146825407|NCT00510198|529531653|FG000|Overall Study|Withdrawal by Subject|5|||
146954194|NCT01716585|529989144|FG001|Open-label Treatment|Adverse Event|2|||
146954195|NCT01716585|529989143|FG000|Open-label Treatment|Virologic Failure|0|||
146954196|NCT01716585|529989144|FG001|Open-label Treatment|Virologic Failure|2|||
146954197|NCT01716585|529989143|FG000|Open-label Treatment|Withdrawal by Subject|0|||
146954198|NCT01716585|529989144|FG001|Open-label Treatment|Withdrawal by Subject|3|||
146954199|NCT03288987|529989146|FG000|Overall Study|Protocol Violation|10|||
146954200|NCT03288987|529989147|FG001|Overall Study|Protocol Violation|4|||
146954201|NCT04235959|529989148|FG000|Overall Study|Protocol Violation|0|||
146954202|NCT04235959|529989149|FG001|Overall Study|Protocol Violation|1|||
146954203|NCT04235959|529989150|FG002|Overall Study|Protocol Violation|0|||
146954204|NCT04235959|529989148|FG000|Overall Study|Adverse Event|1|||
146954205|NCT04235959|529989149|FG001|Overall Study|Adverse Event|0|||
146954206|NCT04235959|529989150|FG002|Overall Study|Adverse Event|0|||
146954207|NCT03055806|529989153|FG000|Overall Study|Adverse Event|0|||
146954208|NCT03055806|529989154|FG001|Overall Study|Adverse Event|0|||
146954209|NCT03055806|529989155|FG002|Overall Study|Adverse Event|1|||
146954210|NCT03055806|529989156|FG003|Overall Study|Adverse Event|1|||
146954211|NCT03055806|529989153|FG000|Overall Study|Lost to Follow-up|0|||
146954212|NCT03055806|529989154|FG001|Overall Study|Lost to Follow-up|3|||
146954213|NCT03055806|529989155|FG002|Overall Study|Lost to Follow-up|6|||
146954214|NCT03055806|529989156|FG003|Overall Study|Lost to Follow-up|7|||
146954215|NCT03055806|529989153|FG000|Overall Study|Physician Decision|1|||
146954216|NCT03055806|529989154|FG001|Overall Study|Physician Decision|0|||
146954217|NCT03055806|529989155|FG002|Overall Study|Physician Decision|0|||
146954218|NCT03055806|529989156|FG003|Overall Study|Physician Decision|1|||
146954219|NCT03055806|529989153|FG000|Overall Study|Protocol Violation|1|||
146954220|NCT03055806|529989154|FG001|Overall Study|Protocol Violation|0|||
146954221|NCT03055806|529989155|FG002|Overall Study|Protocol Violation|0|||
146954222|NCT03055806|529989156|FG003|Overall Study|Protocol Violation|0|||
146954223|NCT03055806|529989153|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
146954224|NCT03055806|529989154|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
146954225|NCT03055806|529989155|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
146954226|NCT03055806|529989156|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
146954227|NCT03055806|529989153|FG000|Overall Study|Withdrawal of consent to continue study|2|||
146954228|NCT03055806|529989154|FG001|Overall Study|Withdrawal of consent to continue study|3|||
146954229|NCT03055806|529989155|FG002|Overall Study|Withdrawal of consent to continue study|4|||
146954230|NCT03055806|529989156|FG003|Overall Study|Withdrawal of consent to continue study|6|||
146954231|NCT03055806|529989153|FG000|Overall Study|Partner not willing to try intercourse|1|||
146954232|NCT03055806|529989154|FG001|Overall Study|Partner not willing to try intercourse|0|||
146954233|NCT03055806|529989155|FG002|Overall Study|Partner not willing to try intercourse|0|||
146954234|NCT03055806|529989156|FG003|Overall Study|Partner not willing to try intercourse|0|||
146954235|NCT04601194|529989157|FG000|Overall Study|Lost to Follow-up|7|||
146954236|NCT04905563|529989158|FG000|Overall Study|Withdrawal by Subject|1|||
146954237|NCT04905563|529989159|FG001|Overall Study|Withdrawal by Subject|0|||
146954238|NCT04905563|529989158|FG000|Overall Study|Standard of care orders entered by resident|1|||
146954239|NCT04905563|529989159|FG001|Overall Study|Standard of care orders entered by resident|0|||
146954240|NCT04905563|529989158|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
146954241|NCT04905563|529989159|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
146954242|NCT04905563|529989158|FG000|Overall Study|Withdrawal by Subject|0|||
146954243|NCT04905563|529989159|FG001|Overall Study|Withdrawal by Subject|1|||
146954244|NCT01797302|529989160|FG000|Overall Study|Lost to Follow-up|16|||
146954245|NCT01797302|529989161|FG001|Overall Study|Lost to Follow-up|23|||
146954246|NCT01797302|529989162|FG002|Overall Study|Lost to Follow-up|22|||
146954247|NCT01797302|529989160|FG000|Overall Study|Withdrawal by Subject|1|||
146954248|NCT01797302|529989161|FG001|Overall Study|Withdrawal by Subject|3|||
146954249|NCT01797302|529989162|FG002|Overall Study|Withdrawal by Subject|4|||
146954250|NCT00568399|529989163|FG000|Overall Study|Death|2|||
146954251|NCT00568399|529989163|FG000|Overall Study|Adverse Event|5|||
146825408|NCT00510198|529531654|FG001|Overall Study|Withdrawal by Subject|4|||
146954252|NCT00568399|529989163|FG000|Overall Study|Withdrawal by Subject|8|||
146954253|NCT02381795|529989168|FG000|Overall Study|Withdrawal by Subject|1|||
146954254|NCT02381795|529989168|FG000|Overall Study|Study Terminated|2|||
146954255|NCT02176226|529989169|FG000|Overall Study|Lost to Follow-up|3|||
146954256|NCT02176226|529989169|FG000|Overall Study|Withdrew prior to treatment|6|||
146954257|NCT01038635|529989178|FG000|Overall Study|Disease Progression|2|||
146954258|NCT01038635|529989179|FG001|Overall Study|Disease Progression|0|||
146954259|NCT01038635|529989180|FG002|Overall Study|Disease Progression|0|||
146954260|NCT01038635|529989181|FG003|Overall Study|Disease Progression|0|||
146954261|NCT01038635|529989182|FG004|Overall Study|Disease Progression|0|||
146954262|NCT01038635|529989183|FG005|Overall Study|Disease Progression|0|||
146954263|NCT01038635|529989184|FG006|Overall Study|Disease Progression|1|||
146954264|NCT01038635|529989185|FG007|Overall Study|Disease Progression|4|||
146954265|NCT01038635|529989186|FG008|Overall Study|Disease Progression|0|||
146954266|NCT01038635|529989178|FG000|Overall Study|Death|0|||
146954267|NCT01038635|529989179|FG001|Overall Study|Death|0|||
146954268|NCT01038635|529989180|FG002|Overall Study|Death|0|||
146825409|NCT02994784|529531655|FG000|6 Months Follow-up|Lost to Follow-up|3|||
146825410|NCT01649557|529531659|FG000|Overall Study|Lost to Follow-up|5|||
146825411|NCT01649557|529531660|FG001|Overall Study|Lost to Follow-up|0|||
146825412|NCT01649557|529531661|FG002|Overall Study|Lost to Follow-up|3|||
146825413|NCT01649557|529531659|FG000|Overall Study|Adverse Event|7|||
146825414|NCT01649557|529531660|FG001|Overall Study|Adverse Event|5|||
146825415|NCT01649557|529531661|FG002|Overall Study|Adverse Event|1|||
146825416|NCT01649557|529531659|FG000|Overall Study|Met withdrawal criteria|4|||
146825417|NCT01649557|529531660|FG001|Overall Study|Met withdrawal criteria|0|||
146825418|NCT01649557|529531661|FG002|Overall Study|Met withdrawal criteria|0|||
146825419|NCT01649557|529531659|FG000|Overall Study|Physician Decision|8|||
146825420|NCT01649557|529531660|FG001|Overall Study|Physician Decision|2|||
146825421|NCT01649557|529531661|FG002|Overall Study|Physician Decision|1|||
146825422|NCT01649557|529531659|FG000|Overall Study|Withdrawal by Subject|15|||
146825423|NCT01649557|529531660|FG001|Overall Study|Withdrawal by Subject|5|||
146825424|NCT01649557|529531661|FG002|Overall Study|Withdrawal by Subject|4|||
146954269|NCT01038635|529989181|FG003|Overall Study|Death|0|||
146954270|NCT01038635|529989182|FG004|Overall Study|Death|1|||
146954271|NCT01038635|529989183|FG005|Overall Study|Death|0|||
146954272|NCT01038635|529989184|FG006|Overall Study|Death|1|||
146954273|NCT01038635|529989185|FG007|Overall Study|Death|1|||
146954274|NCT01038635|529989186|FG008|Overall Study|Death|2|||
146954275|NCT01227252|529989187|FG000|Overall Study|Sponsor Decision|0|||
146954276|NCT01227252|529989188|FG001|Overall Study|Sponsor Decision|1|||
146954277|NCT01227252|529989189|FG002|Overall Study|Sponsor Decision|0|||
146954278|NCT01227252|529989190|FG003|Overall Study|Sponsor Decision|0|||
146954279|NCT01227252|529989187|FG000|Overall Study|Lost to Follow-up|0|||
146954280|NCT01227252|529989188|FG001|Overall Study|Lost to Follow-up|1|||
146954281|NCT01227252|529989189|FG002|Overall Study|Lost to Follow-up|0|||
146954282|NCT01227252|529989190|FG003|Overall Study|Lost to Follow-up|0|||
146954283|NCT01227252|529989187|FG000|Overall Study|Withdrawal by Subject|0|||
146954284|NCT01227252|529989188|FG001|Overall Study|Withdrawal by Subject|1|||
146954285|NCT01227252|529989189|FG002|Overall Study|Withdrawal by Subject|0|||
146954286|NCT01227252|529989190|FG003|Overall Study|Withdrawal by Subject|0|||
146954287|NCT01034709|529989192|FG000|Overall Study|Protocol Violation|9|||
146954288|NCT01034709|529989193|FG001|Overall Study|Protocol Violation|16|||
146954289|NCT01060150|529989196|FG000|Overall Study|Adverse Event|6|||
146954290|NCT01060150|529989196|FG000|Overall Study|Lost to Follow-up|1|||
146954291|NCT01060150|529989196|FG000|Overall Study|Protocol Violation|6|||
146954292|NCT01060150|529989196|FG000|Overall Study|Withdrawal by Subject|8|||
146954293|NCT01060150|529989196|FG000|Overall Study|Enrolled, but not treated|2|||
146954294|NCT02516306|529989197|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
146954295|NCT02516306|529989198|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
146954296|NCT01566981|529989200|FG000|Overall Study|Lost to Follow-up|5|||
146954297|NCT01566981|529989201|FG001|Overall Study|Lost to Follow-up|8|||
146954298|NCT01351415|529989202|FG000|Overall Study|Withdrawal by Subject|15|||
146954299|NCT01351415|529989203|FG001|Overall Study|Withdrawal by Subject|17|||
146954300|NCT01351415|529989202|FG000|Overall Study|Trial termination by the Sponsor|28|||
146954301|NCT01351415|529989203|FG001|Overall Study|Trial termination by the Sponsor|19|||
146954302|NCT01351415|529989202|FG000|Overall Study|Lost to Follow-up|5|||
146954303|NCT01351415|529989203|FG001|Overall Study|Lost to Follow-up|7|||
146954304|NCT01351415|529989202|FG000|Overall Study|Death|190|||
146954305|NCT01351415|529989203|FG001|Overall Study|Death|187|||
146954306|NCT01351415|529989202|FG000|Overall Study|Physician Decision|2|||
146954307|NCT01351415|529989203|FG001|Overall Study|Physician Decision|3|||
146954308|NCT01351415|529989202|FG000|Overall Study|Reason unknown|0|||
146954309|NCT01351415|529989203|FG001|Overall Study|Reason unknown|2|||
146954310|NCT01351415|529989202|FG000|Overall Study|Never Started|5|||
146954311|NCT01351415|529989203|FG001|Overall Study|Never Started|5|||
146954312|NCT03480360|529989208|FG000|Overall Study|Death|2|||
146954313|NCT00472043|529989211|FG000|Overall Study|Withdrawal by Subject|1|||
146954314|NCT00472043|529989212|FG001|Overall Study|Withdrawal by Subject|0|||
146954315|NCT00472043|529989211|FG000|Overall Study|Death|1|||
146954316|NCT00472043|529989212|FG001|Overall Study|Death|0|||
146954317|NCT01142791|529989223|FG000|Overall Study|Alternative Treatment|1|||
146954318|NCT01142791|529989224|FG001|Overall Study|Alternative Treatment|0|||
146954319|NCT01142791|529989223|FG000|Overall Study|Lost to Follow-up|1|||
146825425|NCT01649557|529531659|FG000|Overall Study|Protocol deviation|0|||
146825426|NCT01649557|529531660|FG001|Overall Study|Protocol deviation|2|||
146825427|NCT01649557|529531661|FG002|Overall Study|Protocol deviation|0|||
146954320|NCT01142791|529989224|FG001|Overall Study|Lost to Follow-up|0|||
146954321|NCT01142791|529989223|FG000|Overall Study|Withdrawal by Subject|5|||
146954322|NCT01142791|529989224|FG001|Overall Study|Withdrawal by Subject|0|||
146954323|NCT01142791|529989223|FG000|Overall Study|Received only 1 sonication|0|||
146954324|NCT01142791|529989224|FG001|Overall Study|Received only 1 sonication|6|||
146954325|NCT05375838|529989225|FG000|Overall Study|Other|0|||
146954326|NCT05375838|529989226|FG001|Overall Study|Other|0|||
146954327|NCT05375838|529989227|FG002|Overall Study|Other|0|||
146954328|NCT05375838|529989228|FG003|Overall Study|Other|1|||
146954329|NCT05375838|529989229|FG004|Overall Study|Other|1|||
146825428|NCT01649557|529531659|FG000|Overall Study|Lack of Efficacy|5|||
146825429|NCT01649557|529531660|FG001|Overall Study|Lack of Efficacy|0|||
146825430|NCT01649557|529531661|FG002|Overall Study|Lack of Efficacy|0|||
146825431|NCT03029234|529531662|FG000|Overall Study|Sponsor Decision|1|||
146825432|NCT03029234|529531662|FG000|Overall Study|Withdrawal by Subject|5|||
146825433|NCT03029234|529531662|FG000|Overall Study|Death|91|||
146825434|NCT03029234|529531662|FG000|Overall Study|Lost to Follow-up|2|||
146825435|NCT00797511|529531665|FG000|Overall Study|Withdrawal by Subject|1|||
146825436|NCT03036150|529531666|FG000|Overall Study|Withdrawal by Subject|8|||
146825437|NCT03036150|529531667|FG001|Overall Study|Withdrawal by Subject|3|||
146825438|NCT03036150|529531666|FG000|Overall Study|Lost to Follow-up|2|||
146825439|NCT03036150|529531667|FG001|Overall Study|Lost to Follow-up|2|||
146825440|NCT00809341|529531668|FG000|Overall Study|Physician Decision|0|||
146825441|NCT00809341|529531669|FG001|Overall Study|Physician Decision|1|||
146825442|NCT03891641|529531681|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
146825443|NCT03891641|529531682|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
146825444|NCT00745121|529531687|FG000|Overall Study|Death|3|||
146825445|NCT00745121|529531688|FG001|Overall Study|Death|0|||
146825446|NCT00745121|529531687|FG000|Overall Study|Adverse Event|1|||
146825447|NCT00745121|529531688|FG001|Overall Study|Adverse Event|0|||
146825448|NCT00745121|529531687|FG000|Overall Study|Lost to Follow-up|1|||
146825449|NCT00745121|529531688|FG001|Overall Study|Lost to Follow-up|0|||
146825450|NCT00745121|529531687|FG000|Overall Study|Withdrawal by Subject|4|||
146825451|NCT00745121|529531688|FG001|Overall Study|Withdrawal by Subject|2|||
146825452|NCT01281917|529531700|FG000|Overall Study|Withdrawal by Subject|1|||
146825453|NCT04016805|529531701|FG000|Overall Study|Sponsor's Discretion|30|||
146825454|NCT04016805|529531702|FG001|Overall Study|Sponsor's Discretion|6|||
146825455|NCT04016805|529531703|FG002|Overall Study|Sponsor's Discretion|5|||
146825456|NCT00740870|529531706|FG000|Overall Study|Not Catheterized|4|||
146825457|NCT00740870|529531706|FG000|Overall Study|Further testing contraindicated implant|17|||
146825458|NCT00607997|529531707|FG000|Overall Study|Lack of Efficacy|6|||
146825459|NCT00607997|529531708|FG001|Overall Study|Lack of Efficacy|20|||
146825460|NCT00607997|529531709|FG002|Overall Study|Lack of Efficacy|14|||
146825461|NCT00607997|529531710|FG003|Overall Study|Lack of Efficacy|10|||
146825462|NCT00607997|529531707|FG000|Overall Study|Death|8|||
146825463|NCT00607997|529531708|FG001|Overall Study|Death|5|||
146825464|NCT00607997|529531709|FG002|Overall Study|Death|2|||
146825465|NCT00607997|529531710|FG003|Overall Study|Death|5|||
146825466|NCT00607997|529531707|FG000|Overall Study|Adverse Event|3|||
146825467|NCT00607997|529531708|FG001|Overall Study|Adverse Event|1|||
146825468|NCT00607997|529531709|FG002|Overall Study|Adverse Event|2|||
146825469|NCT00607997|529531710|FG003|Overall Study|Adverse Event|0|||
146825470|NCT00607997|529531707|FG000|Overall Study|Physician Decision|4|||
146825471|NCT00607997|529531708|FG001|Overall Study|Physician Decision|1|||
146825472|NCT00607997|529531709|FG002|Overall Study|Physician Decision|0|||
146825473|NCT00607997|529531710|FG003|Overall Study|Physician Decision|0|||
146825474|NCT00607997|529531707|FG000|Overall Study|Relapse, recurrent illness|4|||
146825475|NCT00607997|529531708|FG001|Overall Study|Relapse, recurrent illness|0|||
146825476|NCT00607997|529531709|FG002|Overall Study|Relapse, recurrent illness|2|||
146825477|NCT00607997|529531710|FG003|Overall Study|Relapse, recurrent illness|0|||
146825478|NCT00607997|529531707|FG000|Overall Study|Other without explanation|2|||
146825479|NCT00607997|529531708|FG001|Overall Study|Other without explanation|0|||
146825480|NCT00607997|529531709|FG002|Overall Study|Other without explanation|4|||
146825481|NCT00607997|529531710|FG003|Overall Study|Other without explanation|1|||
146825482|NCT04414397|529531714|FG000|Control Period|Withdrawal by Subject|2|||
146825483|NCT04414397|529531715|FG001|Control Period|Withdrawal by Subject|2|||
146825484|NCT04414397|529531714|FG000|Control Period|Lost to Follow-up|0|||
146825485|NCT04414397|529531715|FG001|Control Period|Lost to Follow-up|4|||
146825486|NCT04414397|529531714|FG000|Control Period|Protocol deviation|0|||
146825487|NCT04414397|529531715|FG001|Control Period|Protocol deviation|1|||
146825488|NCT04414397|529531714|FG000|Post-Control Period|Withdrawal by Subject|3|||
146825489|NCT04414397|529531715|FG001|Post-Control Period|Withdrawal by Subject|6|||
146825490|NCT04414397|529531714|FG000|Post-Control Period|Lost to Follow-up|4|||
146825491|NCT04414397|529531715|FG001|Post-Control Period|Lost to Follow-up|9|||
146825492|NCT04414397|529531714|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
146825493|NCT04414397|529531715|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
146825494|NCT04414397|529531714|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
146825495|NCT04414397|529531715|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
146825496|NCT03640754|529531716|FG000|Overall Study|Withdrawal by Subject|1|||
146825497|NCT03640754|529531717|FG001|Overall Study|Withdrawal by Subject|0|||
146825498|NCT03640754|529531716|FG000|Overall Study|Lost to Follow-up|0|||
146825499|NCT03640754|529531717|FG001|Overall Study|Lost to Follow-up|1|||
146825500|NCT01204775|529531722|FG000|Overall Study|Poor/non-compliance|0|||
146825501|NCT01204775|529531723|FG001|Overall Study|Poor/non-compliance|1|||
146825502|NCT01204775|529531722|FG000|Overall Study|Withdrawal by Subject|1|||
146825503|NCT01204775|529531723|FG001|Overall Study|Withdrawal by Subject|0|||
146825504|NCT00276016|529531724|FG000|Intervention 1|Withdrawal by Subject|0|||
146825505|NCT00276016|529531725|FG001|Intervention 1|Withdrawal by Subject|1|||
146954330|NCT05375838|529989230|FG005|Overall Study|Other|0|||
146954331|NCT05375838|529989225|FG000|Overall Study|Withdrawal by Subject|2|||
146954332|NCT05375838|529989226|FG001|Overall Study|Withdrawal by Subject|1|||
146954333|NCT05375838|529989227|FG002|Overall Study|Withdrawal by Subject|3|||
146954334|NCT05375838|529989228|FG003|Overall Study|Withdrawal by Subject|2|||
146954335|NCT05375838|529989229|FG004|Overall Study|Withdrawal by Subject|2|||
146954336|NCT05375838|529989230|FG005|Overall Study|Withdrawal by Subject|0|||
146954337|NCT05375838|529989225|FG000|Overall Study|Protocol Violation|0|||
146954338|NCT05375838|529989226|FG001|Overall Study|Protocol Violation|0|||
146954339|NCT05375838|529989227|FG002|Overall Study|Protocol Violation|0|||
146954340|NCT05375838|529989228|FG003|Overall Study|Protocol Violation|0|||
146954341|NCT05375838|529989229|FG004|Overall Study|Protocol Violation|1|||
146954342|NCT05375838|529989230|FG005|Overall Study|Protocol Violation|0|||
146954343|NCT05375838|529989225|FG000|Overall Study|Physician Decision|0|||
146954344|NCT05375838|529989226|FG001|Overall Study|Physician Decision|1|||
146954345|NCT05375838|529989227|FG002|Overall Study|Physician Decision|0|||
146954346|NCT05375838|529989228|FG003|Overall Study|Physician Decision|0|||
146954347|NCT05375838|529989229|FG004|Overall Study|Physician Decision|0|||
146954348|NCT05375838|529989230|FG005|Overall Study|Physician Decision|1|||
146954349|NCT05375838|529989225|FG000|Overall Study|Lost to Follow-up|2|||
146954350|NCT05375838|529989226|FG001|Overall Study|Lost to Follow-up|7|||
146954351|NCT05375838|529989227|FG002|Overall Study|Lost to Follow-up|0|||
146954352|NCT05375838|529989228|FG003|Overall Study|Lost to Follow-up|4|||
146954353|NCT05375838|529989229|FG004|Overall Study|Lost to Follow-up|2|||
146954354|NCT05375838|529989230|FG005|Overall Study|Lost to Follow-up|3|||
146954355|NCT02975206|529989231|FG000|Overall Study|Withdrawal by Subject|14|||
146954356|NCT02975206|529989232|FG001|Overall Study|Withdrawal by Subject|11|||
146954357|NCT02975206|529989233|FG002|Overall Study|Withdrawal by Subject|11|||
146954358|NCT02975206|529989231|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
146954359|NCT02975206|529989232|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
146954360|NCT02975206|529989233|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
146954361|NCT01981096|529989234|FG000|Overall Study|Parent illness|1|||
146954362|NCT01981096|529989235|FG001|Overall Study|Parent illness|0|||
146954363|NCT01981096|529989234|FG000|Overall Study|Withdrawal by Subject|0|||
146954364|NCT01981096|529989235|FG001|Overall Study|Withdrawal by Subject|1|||
146954365|NCT01981096|529989234|FG000|Overall Study|Lost to Follow-up|2|||
146954366|NCT01981096|529989235|FG001|Overall Study|Lost to Follow-up|0|||
146954367|NCT00866606|529989236|FG000|Overall Study|Lost to Follow-up|3|||
146954368|NCT00866606|529989236|FG000|Overall Study|Adverse Event|1|||
146954369|NCT01225211|529989237|FG000|Overall Study|Adverse Event|0|||
146954370|NCT01225211|529989238|FG001|Overall Study|Adverse Event|0|||
146954371|NCT01225211|529989239|FG002|Overall Study|Adverse Event|1|||
146954372|NCT01225211|529989240|FG003|Overall Study|Adverse Event|0|||
146954373|NCT01225211|529989241|FG004|Overall Study|Adverse Event|0|||
146954374|NCT01225211|529989242|FG005|Overall Study|Adverse Event|0|||
146954375|NCT01225211|529989243|FG006|Overall Study|Adverse Event|0|||
146954376|NCT01225211|529989244|FG007|Overall Study|Adverse Event|0|||
146954377|NCT01225211|529989245|FG008|Overall Study|Adverse Event|0|||
146954378|NCT01225211|529989246|FG009|Overall Study|Adverse Event|1|||
146954379|NCT01225211|529989237|FG000|Overall Study|Withdrawal by Subject|0|||
146954380|NCT01225211|529989238|FG001|Overall Study|Withdrawal by Subject|0|||
146954381|NCT01225211|529989239|FG002|Overall Study|Withdrawal by Subject|0|||
146954382|NCT01225211|529989240|FG003|Overall Study|Withdrawal by Subject|0|||
146954383|NCT01225211|529989241|FG004|Overall Study|Withdrawal by Subject|0|||
146954384|NCT01225211|529989242|FG005|Overall Study|Withdrawal by Subject|0|||
146954385|NCT01225211|529989243|FG006|Overall Study|Withdrawal by Subject|1|||
146954386|NCT01225211|529989244|FG007|Overall Study|Withdrawal by Subject|0|||
146954387|NCT01225211|529989245|FG008|Overall Study|Withdrawal by Subject|1|||
146954388|NCT01225211|529989246|FG009|Overall Study|Withdrawal by Subject|3|||
146954389|NCT01225211|529989237|FG000|Overall Study|Other|0|||
146954390|NCT01225211|529989238|FG001|Overall Study|Other|0|||
146954391|NCT01225211|529989239|FG002|Overall Study|Other|0|||
146954392|NCT01225211|529989240|FG003|Overall Study|Other|0|||
146954393|NCT01225211|529989241|FG004|Overall Study|Other|0|||
146954394|NCT01225211|529989242|FG005|Overall Study|Other|0|||
146954395|NCT01225211|529989243|FG006|Overall Study|Other|0|||
146954396|NCT01225211|529989244|FG007|Overall Study|Other|0|||
146954397|NCT01225211|529989245|FG008|Overall Study|Other|0|||
146954398|NCT01225211|529989246|FG009|Overall Study|Other|1|||
146954399|NCT02067104|529989247|FG000|Overall Study|Study termination due to low accrual|4|||
146954400|NCT02067104|529989248|FG001|Overall Study|Study termination due to low accrual|5|||
146954401|NCT01987609|529989249|FG000|Overall Study|Adverse Event|1|||
146954402|NCT00806494|529989250|FG000|Overall Study|Adverse Event|29|||
146954403|NCT00806494|529989250|FG000|Overall Study|Lack of Efficacy|6|||
146954404|NCT00806494|529989250|FG000|Overall Study|Lost to Follow-up|10|||
146954405|NCT00806494|529989250|FG000|Overall Study|Other|30|||
146954406|NCT00806494|529989250|FG000|Overall Study|Withdrawal by Subject|5|||
146954407|NCT01279954|529989253|FG000|Overall Study|Lack of Efficacy|3|||
146954408|NCT01279954|529989254|FG001|Overall Study|Lack of Efficacy|4|||
146954409|NCT00554840|529989262|FG000|Overall Study|Physician Decision|0|||
146954410|NCT00554840|529989263|FG001|Overall Study|Physician Decision|1|||
146954411|NCT00122317|529989266|FG000|Overall Study|Death|3|||
146954412|NCT00122317|529989266|FG000|Overall Study|Adverse Event|4|||
146954413|NCT00122317|529989266|FG000|Overall Study|Physician Decision|2|||
146954414|NCT00122317|529989266|FG000|Overall Study|patient non-compliance|1|||
146954415|NCT00122317|529989266|FG000|Overall Study|Withdrawal by Subject|1|||
146954416|NCT03458234|529989267|FG000|Overall Study|Withdrawal by Subject|1|||
146954417|NCT01021293|529989272|FG000|Overall Study|Serious Adverse Event|2|||
146954418|NCT01021293|529989273|FG001|Overall Study|Serious Adverse Event|1|||
146954419|NCT01021293|529989272|FG000|Overall Study|Adverse Event|2|||
146954420|NCT01021293|529989273|FG001|Overall Study|Adverse Event|1|||
146954421|NCT01021293|529989272|FG000|Overall Study|Withdrawal by Subject|1|||
146954422|NCT01021293|529989273|FG001|Overall Study|Withdrawal by Subject|3|||
146954423|NCT01021293|529989272|FG000|Overall Study|Migrated/moved from study area|6|||
146954424|NCT01021293|529989273|FG001|Overall Study|Migrated/moved from study area|18|||
146954425|NCT01021293|529989272|FG000|Overall Study|Lost to Follow-up|1|||
146954426|NCT01021293|529989273|FG001|Overall Study|Lost to Follow-up|1|||
146954427|NCT05315297|529989274|FG000|Overall Study|Lost to Follow-up|6|||
146954428|NCT05315297|529989275|FG001|Overall Study|Lost to Follow-up|4|||
146954429|NCT05315297|529989274|FG000|Overall Study|Withdrawal by Subject|0|||
146954430|NCT05315297|529989275|FG001|Overall Study|Withdrawal by Subject|1|||
146954431|NCT02033369|529990567|FG000|Overall Study|Physician Decision|1|||
146954432|NCT02033369|529990568|FG001|Overall Study|Physician Decision|2|||
146954433|NCT02033369|529990567|FG000|Overall Study|Not a good demographic match|0|||
146954434|NCT02033369|529990568|FG001|Overall Study|Not a good demographic match|2|||
146954435|NCT02033369|529990567|FG000|Overall Study|Withdrawal by Subject|1|||
146954436|NCT02033369|529990568|FG001|Overall Study|Withdrawal by Subject|1|||
146954437|NCT02033369|529990567|FG000|Overall Study|Lost to Follow-up|1|||
146954438|NCT02033369|529990568|FG001|Overall Study|Lost to Follow-up|0|||
146954439|NCT02033369|529990567|FG000|Overall Study|Protocol Violation|2|||
146954440|NCT02033369|529990568|FG001|Overall Study|Protocol Violation|0|||
146954441|NCT01503229|529990569|FG000|Overall Study|Withdrew consent|1|||
146954442|NCT04335929|529990570|FG000|Overall Study|Lost to Follow-up|10|||
146954443|NCT02534324|529990576|FG000|Overall Study|Protocol Violation|4|||
146954444|NCT02534324|529990577|FG001|Overall Study|Protocol Violation|1|||
146954445|NCT02534324|529990576|FG000|Overall Study|Lost to Follow-up|20|||
146954446|NCT02534324|529990577|FG001|Overall Study|Lost to Follow-up|7|||
146954447|NCT02534324|529990576|FG000|Overall Study|Adverse Event|1|||
146954448|NCT02534324|529990577|FG001|Overall Study|Adverse Event|0|||
146954449|NCT02889861|529990580|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
146954450|NCT01041027|529990583|FG000|Overall Study|Withdrawal by Subject|2|||
146954451|NCT01041027|529990583|FG000|Overall Study|Protocol Violation|1|||
146954452|NCT01041027|529990583|FG000|Overall Study|Delayed Radiation Therapy|1|||
146954453|NCT01041027|529990583|FG000|Overall Study|Adverse Event|4|||
146954454|NCT02146274|529990585|FG000|Overall Study|Protocol Violation|73|||
146954455|NCT02039687|529990588|FG000|Overall Study|Adverse Event|0|||
146954456|NCT02039687|529990589|FG001|Overall Study|Adverse Event|0|||
146954457|NCT02039687|529990590|FG002|Overall Study|Adverse Event|1|||
146954458|NCT02039687|529990591|FG003|Overall Study|Adverse Event|0|||
146954459|NCT02039687|529990588|FG000|Overall Study|Withdrawal by Subject|0|||
146954460|NCT02039687|529990589|FG001|Overall Study|Withdrawal by Subject|1|||
146954461|NCT02039687|529990590|FG002|Overall Study|Withdrawal by Subject|0|||
146954462|NCT02039687|529990591|FG003|Overall Study|Withdrawal by Subject|0|||
146954463|NCT02039687|529990588|FG000|Overall Study|treatment assignment could not be confir|0|||
146954464|NCT02039687|529990589|FG001|Overall Study|treatment assignment could not be confir|0|||
146954465|NCT02039687|529990590|FG002|Overall Study|treatment assignment could not be confir|2|||
146954466|NCT02039687|529990591|FG003|Overall Study|treatment assignment could not be confir|0|||
146954467|NCT00532441|529990600|FG000|Overall Study|Death|1|||
146954468|NCT00532441|529990601|FG001|Overall Study|Death|0|||
146954469|NCT00443534|529990602|FG000|Overall Study|Lack of Efficacy|67|||
146954470|NCT00443534|529990602|FG000|Overall Study|Adverse Event|16|||
146954471|NCT00443534|529990602|FG000|Overall Study|Death|9|||
146954472|NCT00443534|529990602|FG000|Overall Study|Withdrawal by Subject|8|||
146954473|NCT00443534|529990602|FG000|Overall Study|Study Terminated by Sponsor|12|||
146954474|NCT00443534|529990602|FG000|Overall Study|Other|10|||
146954475|NCT00443534|529990602|FG000|Overall Study|Enrolled, Not Treated|1|||
146954476|NCT05466240|529990603|FG000|Overall Study|Adverse Event|1|||
146954477|NCT05466240|529990604|FG001|Overall Study|Adverse Event|0|||
146954478|NCT05466240|529990603|FG000|Overall Study|Withdrawal by Subject|1|||
146954479|NCT05466240|529990604|FG001|Overall Study|Withdrawal by Subject|0|||
146954480|NCT00303329|529990605|FG000|Overall Study|Adverse Event|7|||
146954481|NCT00303329|529990606|FG001|Overall Study|Adverse Event|14|||
146954482|NCT00303329|529990605|FG000|Overall Study|Abnormal Laboratory Values|0|||
146954483|NCT00303329|529990606|FG001|Overall Study|Abnormal Laboratory Values|1|||
146954484|NCT00303329|529990605|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
146954485|NCT00303329|529990606|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146985097|NCT01333033|530107168|FG005|Overall Study|PET inevaluable|4|||
146954486|NCT00303329|529990605|FG000|Overall Study|Condition no longer requires study drug|0|||
146954487|NCT00303329|529990606|FG001|Overall Study|Condition no longer requires study drug|8|||
146954488|NCT00303329|529990605|FG000|Overall Study|Protocol Violation|3|||
146954489|NCT00303329|529990606|FG001|Overall Study|Protocol Violation|0|||
146954490|NCT00303329|529990605|FG000|Overall Study|Withdrawal by Subject|9|||
146954491|NCT00303329|529990606|FG001|Overall Study|Withdrawal by Subject|15|||
146954492|NCT00303329|529990605|FG000|Overall Study|Lost to Follow-up|0|||
146954493|NCT00303329|529990606|FG001|Overall Study|Lost to Follow-up|1|||
146954494|NCT00303329|529990605|FG000|Overall Study|Administrative problems|1|||
146954495|NCT00303329|529990606|FG001|Overall Study|Administrative problems|0|||
146954496|NCT00303329|529990605|FG000|Overall Study|Death|2|||
146954497|NCT00303329|529990606|FG001|Overall Study|Death|12|||
146954498|NCT00303329|529990605|FG000|Overall Study|Stopped at end of core|3|||
146954499|NCT00303329|529990606|FG001|Overall Study|Stopped at end of core|9|||
146954500|NCT00303329|529990605|FG000|Overall Study|Stopped at end of extension 1|1|||
146954501|NCT00303329|529990606|FG001|Overall Study|Stopped at end of extension 1|0|||
146954502|NCT00413231|529990607|FG000|0 to 30-day Post Treatment|Death|5|||
146954503|NCT00413231|529990607|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
146954504|NCT00413231|529990607|FG000|30-day to 365-day Post Treatment|Death|13|||
146954505|NCT00413231|529990607|FG000|365-day to 60-month Post Treatment|Death|36|||
146954506|NCT00413231|529990607|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
146954507|NCT00413231|529990607|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
146954508|NCT00413231|529990607|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
146954509|NCT00626327|529990612|FG000|Overall Study|Withdrawal by Subject|21|||
146954510|NCT00626327|529990613|FG001|Overall Study|Withdrawal by Subject|29|||
146954511|NCT00626327|529990614|FG002|Overall Study|Withdrawal by Subject|30|||
146954512|NCT00626327|529990612|FG000|Overall Study|Adverse Event|1|||
146954513|NCT00626327|529990613|FG001|Overall Study|Adverse Event|0|||
146954514|NCT00626327|529990614|FG002|Overall Study|Adverse Event|0|||
146825506|NCT00276016|529531726|FG002|Intervention 1|Withdrawal by Subject|0|||
146825507|NCT00276016|529531727|FG003|Intervention 1|Withdrawal by Subject|0|||
146825508|NCT00276016|529531728|FG004|Intervention 1|Withdrawal by Subject|0|||
146825509|NCT00276016|529531729|FG005|Intervention 1|Withdrawal by Subject|0|||
146825510|NCT01679613|529531730|FG000|Overall Study|other than stated above|0|||
146825511|NCT01679613|529531731|FG001|Overall Study|other than stated above|1|||
146825512|NCT01679613|529531732|FG002|Overall Study|other than stated above|2|||
146825513|NCT01679613|529531733|FG003|Overall Study|other than stated above|2|||
146825514|NCT01374971|529531734|FG000|Overall Study|Withdrawal by Subject|1|||
146825515|NCT00509925|529531736|FG000|Overall Study|Personal reasons|0|||
146825516|NCT00509925|529531737|FG001|Overall Study|Personal reasons|1|||
146825517|NCT00951171|529531738|FG000|Overall Study|Adverse Event|2|||
146825518|NCT00951171|529531739|FG001|Overall Study|Adverse Event|0|||
146825519|NCT00919061|529531740|FG000|Overall Study|Adverse Event|1|||
146825520|NCT00919061|529531740|FG000|Overall Study|Withdrawal by Subject|1|||
146825521|NCT00113269|529533835|FG000|Overall Study|Not transplanted, donor issues|4|||
146825522|NCT00113269|529533836|FG001|Overall Study|Not transplanted, donor issues|0|||
146825523|NCT00113269|529533837|FG002|Overall Study|Not transplanted, donor issues|2|||
146825524|NCT00113269|529533838|FG003|Overall Study|Not transplanted, donor issues|2|||
146825525|NCT00113269|529533835|FG000|Overall Study|Not transplanted, recipient issues|2|||
146825526|NCT00113269|529533836|FG001|Overall Study|Not transplanted, recipient issues|1|||
146825527|NCT00113269|529533837|FG002|Overall Study|Not transplanted, recipient issues|7|||
146825528|NCT00113269|529533838|FG003|Overall Study|Not transplanted, recipient issues|4|||
146825529|NCT00113269|529533835|FG000|Overall Study|Early graft loss, technical|0|||
146825530|NCT00113269|529533836|FG001|Overall Study|Early graft loss, technical|0|||
146825531|NCT00113269|529533837|FG002|Overall Study|Early graft loss, technical|2|||
146825532|NCT00113269|529533838|FG003|Overall Study|Early graft loss, technical|0|||
146825533|NCT00113269|529533835|FG000|Overall Study|Death in operating room|0|||
146825534|NCT00113269|529533836|FG001|Overall Study|Death in operating room|0|||
146825535|NCT00113269|529533837|FG002|Overall Study|Death in operating room|0|||
146825536|NCT00113269|529533838|FG003|Overall Study|Death in operating room|1|||
146825537|NCT00113269|529533835|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
146825538|NCT00113269|529533836|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
146954515|NCT00626327|529990612|FG000|Overall Study|Lost to Follow-up|24|||
146954516|NCT00626327|529990613|FG001|Overall Study|Lost to Follow-up|21|||
146825539|NCT00113269|529533837|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
146825540|NCT00113269|529533838|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
146825541|NCT00113269|529533835|FG000|Overall Study|Adverse Event|2|||
146954517|NCT00626327|529990614|FG002|Overall Study|Lost to Follow-up|23|||
146954518|NCT00626327|529990612|FG000|Overall Study|Inappropriate enrollment|4|||
146954519|NCT00626327|529990613|FG001|Overall Study|Inappropriate enrollment|5|||
146954520|NCT00626327|529990614|FG002|Overall Study|Inappropriate enrollment|3|||
146985098|NCT01333033|530107163|FG000|Overall Study|Adverse Event|0|||
146825542|NCT00113269|529533836|FG001|Overall Study|Adverse Event|7|||
146825543|NCT00113269|529533837|FG002|Overall Study|Adverse Event|11|||
146825544|NCT00113269|529533838|FG003|Overall Study|Adverse Event|7|||
146825545|NCT00113269|529533835|FG000|Overall Study|Withdrawal by Subject|4|||
146825546|NCT00113269|529533836|FG001|Overall Study|Withdrawal by Subject|3|||
146825547|NCT00113269|529533837|FG002|Overall Study|Withdrawal by Subject|4|||
146825548|NCT00113269|529533838|FG003|Overall Study|Withdrawal by Subject|2|||
146825549|NCT00113269|529533835|FG000|Overall Study|Graft loss|6|||
146825550|NCT00113269|529533836|FG001|Overall Study|Graft loss|6|||
146825551|NCT00113269|529533837|FG002|Overall Study|Graft loss|4|||
146825552|NCT00113269|529533838|FG003|Overall Study|Graft loss|9|||
146825553|NCT00113269|529533835|FG000|Overall Study|Protocol Violation|1|||
146825554|NCT00113269|529533836|FG001|Overall Study|Protocol Violation|0|||
146825555|NCT00113269|529533837|FG002|Overall Study|Protocol Violation|4|||
146825556|NCT00113269|529533838|FG003|Overall Study|Protocol Violation|2|||
146825557|NCT00113269|529533835|FG000|Overall Study|Lost to Follow-up|2|||
146825558|NCT00113269|529533836|FG001|Overall Study|Lost to Follow-up|3|||
146825559|NCT00113269|529533837|FG002|Overall Study|Lost to Follow-up|6|||
146825560|NCT00113269|529533838|FG003|Overall Study|Lost to Follow-up|3|||
146825561|NCT00113269|529533835|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
146825562|NCT00113269|529533836|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
146825563|NCT00113269|529533837|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
146825564|NCT00113269|529533838|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
146825565|NCT00113269|529533835|FG000|Overall Study|Discontinued due to rejection|0|||
146825566|NCT00113269|529533836|FG001|Overall Study|Discontinued due to rejection|0|||
146825567|NCT00113269|529533837|FG002|Overall Study|Discontinued due to rejection|1|||
146825568|NCT00113269|529533838|FG003|Overall Study|Discontinued due to rejection|0|||
146825569|NCT00113269|529533835|FG000|Overall Study|Moved|0|||
146825570|NCT00113269|529533836|FG001|Overall Study|Moved|1|||
146825571|NCT00113269|529533837|FG002|Overall Study|Moved|0|||
146825572|NCT00113269|529533838|FG003|Overall Study|Moved|3|||
146825573|NCT00113269|529533835|FG000|Overall Study|Received pancreas transplant|0|||
146825574|NCT00113269|529533836|FG001|Overall Study|Received pancreas transplant|0|||
146825575|NCT00113269|529533837|FG002|Overall Study|Received pancreas transplant|0|||
146825576|NCT00113269|529533838|FG003|Overall Study|Received pancreas transplant|2|||
146825577|NCT00113269|529533835|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
146825578|NCT00113269|529533836|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
146825579|NCT00113269|529533837|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
146825580|NCT00113269|529533838|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
146825581|NCT00113269|529533835|FG000|Overall Study|Did not meet eligibility criteria|1|||
146825582|NCT00113269|529533836|FG001|Overall Study|Did not meet eligibility criteria|0|||
146825583|NCT00113269|529533837|FG002|Overall Study|Did not meet eligibility criteria|0|||
146825584|NCT00113269|529533838|FG003|Overall Study|Did not meet eligibility criteria|1|||
146825585|NCT00113269|529533835|FG000|Overall Study|Unable to return for follow up|2|||
146825586|NCT00113269|529533836|FG001|Overall Study|Unable to return for follow up|1|||
146825587|NCT00113269|529533837|FG002|Overall Study|Unable to return for follow up|0|||
146825588|NCT00113269|529533838|FG003|Overall Study|Unable to return for follow up|0|||
146825589|NCT01947517|529533839|FG000|Overall Study|Withdrawal by Subject|1|||
146825590|NCT01947517|529533840|FG001|Overall Study|Withdrawal by Subject|1|||
146825591|NCT05446714|529533841|FG000|Overall Study|Lost to Follow-up|1|||
146825592|NCT05446714|529533842|FG001|Overall Study|Lost to Follow-up|3|||
146825593|NCT05446714|529533843|FG002|Overall Study|Lost to Follow-up|2|||
146825594|NCT05446714|529533841|FG000|Overall Study|Protocol Violation|2|||
146825595|NCT05446714|529533842|FG001|Overall Study|Protocol Violation|0|||
146825596|NCT05446714|529533843|FG002|Overall Study|Protocol Violation|0|||
146825597|NCT00460564|529533849|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
146825598|NCT00460564|529533850|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
146825599|NCT00460564|529533851|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146825600|NCT00460564|529533852|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146825601|NCT00460564|529533853|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146825602|NCT00460564|529533854|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146825603|NCT00460564|529533855|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146825604|NCT00460564|529533856|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146825605|NCT00460564|529533849|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
146825606|NCT00460564|529533850|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146825607|NCT00460564|529533851|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146825608|NCT00460564|529533852|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146825609|NCT00460564|529533853|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146825610|NCT00460564|529533854|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146825611|NCT00460564|529533855|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146825612|NCT00460564|529533856|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146825613|NCT00460564|529533849|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
146825614|NCT00460564|529533850|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
146825615|NCT00460564|529533851|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
146825616|NCT00460564|529533852|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
146825617|NCT00460564|529533853|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
146825618|NCT00460564|529533854|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
146825619|NCT00460564|529533855|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
146825620|NCT00460564|529533856|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
146825621|NCT00460564|529533849|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
146825622|NCT00460564|529533850|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
146825623|NCT00460564|529533851|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
146825624|NCT00460564|529533852|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
146954521|NCT00626327|529990612|FG000|Overall Study|Administrative Reason|2|||
146954522|NCT00626327|529990613|FG001|Overall Study|Administrative Reason|0|||
146954523|NCT00626327|529990614|FG002|Overall Study|Administrative Reason|6|||
146954524|NCT00626327|529990612|FG000|Overall Study|Protocol Violation|26|||
146954525|NCT00626327|529990613|FG001|Overall Study|Protocol Violation|4|||
146954526|NCT00626327|529990614|FG002|Overall Study|Protocol Violation|26|||
146954527|NCT04450394|529990615|FG000|Overall Study|Adverse Event|2|||
146954528|NCT04450394|529990616|FG001|Overall Study|Adverse Event|0|||
146954529|NCT04450394|529990617|FG002|Overall Study|Adverse Event|0|||
146954530|NCT04450394|529990615|FG000|Overall Study|Death|0|||
146954531|NCT04450394|529990616|FG001|Overall Study|Death|1|||
146954532|NCT04450394|529990617|FG002|Overall Study|Death|0|||
146954533|NCT04450394|529990615|FG000|Overall Study|Lost to Follow-up|0|||
146954534|NCT04450394|529990616|FG001|Overall Study|Lost to Follow-up|3|||
146954535|NCT04450394|529990617|FG002|Overall Study|Lost to Follow-up|0|||
146954536|NCT04450394|529990615|FG000|Overall Study|Physician Decision|0|||
146954537|NCT04450394|529990616|FG001|Overall Study|Physician Decision|1|||
146954538|NCT04450394|529990617|FG002|Overall Study|Physician Decision|0|||
146954539|NCT04450394|529990615|FG000|Overall Study|Protocol Violation|2|||
146954540|NCT04450394|529990616|FG001|Overall Study|Protocol Violation|0|||
146954541|NCT04450394|529990617|FG002|Overall Study|Protocol Violation|0|||
146954542|NCT04450394|529990615|FG000|Overall Study|Withdrawal by Subject|6|||
146954543|NCT04450394|529990616|FG001|Overall Study|Withdrawal by Subject|9|||
146954544|NCT04450394|529990617|FG002|Overall Study|Withdrawal by Subject|0|||
146954545|NCT01710709|529990620|FG000|Overall Study|Lost to Follow-up|29|||
146954546|NCT01710709|529990620|FG000|Overall Study|Adverse Event|48|||
146954547|NCT01710709|529990620|FG000|Overall Study|Participant met withdrawal criteria|33|||
146954548|NCT01710709|529990620|FG000|Overall Study|Participant withdrawn by investigator|2|||
146954549|NCT01710709|529990620|FG000|Overall Study|Withdrawal by Subject|53|||
146954550|NCT01710709|529990620|FG000|Overall Study|Protocol Violation|5|||
146954551|NCT01710709|529990620|FG000|Overall Study|Lack of Efficacy|3|||
146954552|NCT00542321|529990622|FG000|Overall Study|Death|0|||
146954553|NCT00542321|529990623|FG001|Overall Study|Death|1|||
146954554|NCT02988115|529990630|FG000|Overall Study|Adverse Event|6|||
146954555|NCT02988115|529990631|FG001|Overall Study|Adverse Event|1|||
146954556|NCT02988115|529990630|FG000|Overall Study|Sponsor Decision|5|||
146954557|NCT02988115|529990631|FG001|Overall Study|Sponsor Decision|2|||
146954558|NCT02988115|529990630|FG000|Overall Study|Withdrawal by Subject|1|||
146954559|NCT02988115|529990631|FG001|Overall Study|Withdrawal by Subject|1|||
146954560|NCT02988115|529990630|FG000|Overall Study|Withdrawn by Mistake|1|||
146954561|NCT02988115|529990631|FG001|Overall Study|Withdrawn by Mistake|0|||
146954562|NCT02988115|529990630|FG000|Overall Study|Lost to Follow-up|1|||
146954563|NCT02988115|529990631|FG001|Overall Study|Lost to Follow-up|0|||
146954564|NCT01731951|529990632|FG000|Overall Study|Documented Disease Progression|1|||
146954565|NCT01731951|529990633|FG001|Overall Study|Documented Disease Progression|0|||
146954566|NCT01731951|529990634|FG002|Overall Study|Documented Disease Progression|0|||
146954567|NCT01731951|529990635|FG003|Overall Study|Documented Disease Progression|0|||
146954568|NCT01731951|529990636|FG004|Overall Study|Documented Disease Progression|0|||
146954569|NCT01731951|529990637|FG005|Overall Study|Documented Disease Progression|0|||
146954570|NCT01731951|529990632|FG000|Overall Study|Lost to Follow-up|2|||
146954571|NCT01731951|529990633|FG001|Overall Study|Lost to Follow-up|0|||
146954572|NCT01731951|529990634|FG002|Overall Study|Lost to Follow-up|0|||
146954573|NCT01731951|529990635|FG003|Overall Study|Lost to Follow-up|1|||
146954574|NCT01731951|529990636|FG004|Overall Study|Lost to Follow-up|3|||
146954575|NCT01731951|529990637|FG005|Overall Study|Lost to Follow-up|1|||
146954576|NCT01731951|529990632|FG000|Overall Study|Withdrawal of Consent|1|||
146954577|NCT01731951|529990633|FG001|Overall Study|Withdrawal of Consent|0|||
146954578|NCT01731951|529990634|FG002|Overall Study|Withdrawal of Consent|0|||
146954579|NCT01731951|529990635|FG003|Overall Study|Withdrawal of Consent|0|||
146954580|NCT01731951|529990636|FG004|Overall Study|Withdrawal of Consent|0|||
146954581|NCT01731951|529990637|FG005|Overall Study|Withdrawal of Consent|2|||
146954582|NCT01731951|529990632|FG000|Overall Study|Death|13|||
146954583|NCT01731951|529990633|FG001|Overall Study|Death|15|||
146954584|NCT01731951|529990634|FG002|Overall Study|Death|9|||
146954585|NCT01731951|529990635|FG003|Overall Study|Death|8|||
146954586|NCT01731951|529990636|FG004|Overall Study|Death|9|||
146954587|NCT01731951|529990637|FG005|Overall Study|Death|6|||
146954588|NCT00253747|529990638|FG000|Overall Study|Lost to Follow-up|13|||
146954589|NCT00253747|529990639|FG001|Overall Study|Lost to Follow-up|14|||
146954590|NCT00253747|529990638|FG000|Overall Study|Withdrawal by Subject|10|||
146954591|NCT00253747|529990639|FG001|Overall Study|Withdrawal by Subject|11|||
146954592|NCT00253747|529990638|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
146954593|NCT00253747|529990639|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
146954594|NCT00104299|529990640|FG000|Overall Study|Adverse Event|3|||
146954595|NCT00104299|529990641|FG001|Overall Study|Adverse Event|1|||
146954596|NCT00104299|529990640|FG000|Overall Study|Death|2|||
146954597|NCT00104299|529990641|FG001|Overall Study|Death|2|||
146954598|NCT00104299|529990640|FG000|Overall Study|Withdrawal by Subject|2|||
146954599|NCT00104299|529990641|FG001|Overall Study|Withdrawal by Subject|6|||
146954600|NCT00104299|529990640|FG000|Overall Study|Physician Decision|1|||
146954601|NCT00104299|529990641|FG001|Overall Study|Physician Decision|1|||
146954602|NCT00104299|529990640|FG000|Overall Study|To have renal transplant|1|||
146954603|NCT00104299|529990641|FG001|Overall Study|To have renal transplant|0|||
146954604|NCT02452034|529990642|FG000|Overall Study|Adverse Event|0|||
146954605|NCT02452034|529990643|FG001|Overall Study|Adverse Event|0|||
146954606|NCT02452034|529990644|FG002|Overall Study|Adverse Event|0|||
146954607|NCT02452034|529990645|FG003|Overall Study|Adverse Event|0|||
146954608|NCT02452034|529990646|FG004|Overall Study|Adverse Event|0|||
146954609|NCT02452034|529990647|FG005|Overall Study|Adverse Event|1|||
146954610|NCT02452034|529990642|FG000|Overall Study|Death|0|||
146954611|NCT02452034|529990643|FG001|Overall Study|Death|0|||
146954612|NCT02452034|529990644|FG002|Overall Study|Death|0|||
146954613|NCT02452034|529990645|FG003|Overall Study|Death|0|||
146954614|NCT02452034|529990646|FG004|Overall Study|Death|1|||
146954615|NCT02452034|529990647|FG005|Overall Study|Death|1|||
146954616|NCT02452034|529990642|FG000|Overall Study|Physician Decision|0|||
146954617|NCT02452034|529990643|FG001|Overall Study|Physician Decision|1|||
146954618|NCT02452034|529990644|FG002|Overall Study|Physician Decision|1|||
146954619|NCT02452034|529990645|FG003|Overall Study|Physician Decision|0|||
146954620|NCT02452034|529990646|FG004|Overall Study|Physician Decision|0|||
146954621|NCT02452034|529990647|FG005|Overall Study|Physician Decision|0|||
146954622|NCT02452034|529990642|FG000|Overall Study|Protocol Violation|0|||
146954623|NCT02452034|529990643|FG001|Overall Study|Protocol Violation|0|||
146954624|NCT02452034|529990644|FG002|Overall Study|Protocol Violation|0|||
146954625|NCT02452034|529990645|FG003|Overall Study|Protocol Violation|0|||
146954626|NCT02452034|529990646|FG004|Overall Study|Protocol Violation|0|||
146954627|NCT02452034|529990647|FG005|Overall Study|Protocol Violation|1|||
146954628|NCT02452034|529990642|FG000|Overall Study|Screen Failure|1|||
146954629|NCT02452034|529990643|FG001|Overall Study|Screen Failure|0|||
146954630|NCT02452034|529990644|FG002|Overall Study|Screen Failure|0|||
146954631|NCT02452034|529990645|FG003|Overall Study|Screen Failure|1|||
146954632|NCT02452034|529990646|FG004|Overall Study|Screen Failure|0|||
146954633|NCT02452034|529990647|FG005|Overall Study|Screen Failure|0|||
146954634|NCT02452034|529990642|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
146954635|NCT02452034|529990643|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
146954636|NCT02452034|529990644|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
146954637|NCT02452034|529990645|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
146954638|NCT02452034|529990646|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
146954639|NCT02452034|529990647|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
146954640|NCT05102734|529990649|FG000|Overall Study|Did not require vasopressors|1|||
146954641|NCT05102734|529990650|FG001|Overall Study|Did not require vasopressors|0|||
146954642|NCT05102734|529990649|FG000|Overall Study|Did not have functioning PA catheter|1|||
146954643|NCT05102734|529990650|FG001|Overall Study|Did not have functioning PA catheter|0|||
146954644|NCT05102734|529990649|FG000|Overall Study|Inadequate video quality|2|||
146954645|NCT05102734|529990650|FG001|Overall Study|Inadequate video quality|0|||
146954646|NCT00125138|529990654|FG000|Overall Study|Adverse Event|1|||
146954647|NCT00125138|529990655|FG001|Overall Study|Adverse Event|0|||
146954648|NCT00125138|529990656|FG002|Overall Study|Adverse Event|3|||
146954649|NCT00125138|529990657|FG003|Overall Study|Adverse Event|2|||
146954650|NCT00125138|529990654|FG000|Overall Study|Withdrawal by Subject|2|||
146954651|NCT00125138|529990655|FG001|Overall Study|Withdrawal by Subject|3|||
146954652|NCT00125138|529990656|FG002|Overall Study|Withdrawal by Subject|1|||
146954653|NCT00125138|529990657|FG003|Overall Study|Withdrawal by Subject|1|||
146954654|NCT00125138|529990654|FG000|Overall Study|Lack of Efficacy|0|||
146954655|NCT00125138|529990655|FG001|Overall Study|Lack of Efficacy|0|||
146954656|NCT00125138|529990656|FG002|Overall Study|Lack of Efficacy|0|||
146954657|NCT00125138|529990657|FG003|Overall Study|Lack of Efficacy|1|||
146954658|NCT00125138|529990654|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
146954659|NCT00125138|529990655|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
146954660|NCT00125138|529990656|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
146954661|NCT00125138|529990657|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
146954662|NCT02870348|529990660|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
146954663|NCT00672139|529990661|FG000|Overall Study|Death|14|||
146954664|NCT00672139|529990662|FG001|Overall Study|Death|23|||
146954665|NCT00672139|529990661|FG000|Overall Study|Withdrawal by Subject|2|||
146954666|NCT00672139|529990662|FG001|Overall Study|Withdrawal by Subject|11|||
146954667|NCT00672139|529990661|FG000|Overall Study|Adverse Event|4|||
146954668|NCT00672139|529990662|FG001|Overall Study|Adverse Event|7|||
146954669|NCT00672139|529990661|FG000|Overall Study|Physician Decision|2|||
146954670|NCT00672139|529990662|FG001|Overall Study|Physician Decision|0|||
146954671|NCT00672139|529990661|FG000|Overall Study|Lack of Efficacy|4|||
146954672|NCT00672139|529990662|FG001|Overall Study|Lack of Efficacy|1|||
146954673|NCT00672139|529990661|FG000|Overall Study|Protocol Violation|1|||
146954674|NCT00672139|529990662|FG001|Overall Study|Protocol Violation|1|||
146954675|NCT00672139|529990661|FG000|Overall Study|hospice discharge, caregiver requests|3|||
146954676|NCT00672139|529990662|FG001|Overall Study|hospice discharge, caregiver requests|2|||
146954677|NCT01051856|529990663|FG000|Overall Study|Withdrawal by Subject|1|||
146954678|NCT01051856|529990664|FG001|Overall Study|Withdrawal by Subject|0|||
146954679|NCT00256204|529990674|FG000|Overall Study|Adverse Event|10|||
146954680|NCT00256204|529990675|FG001|Overall Study|Adverse Event|14|||
146954681|NCT00256204|529990676|FG002|Overall Study|Adverse Event|16|||
146954682|NCT00256204|529990677|FG003|Overall Study|Adverse Event|14|||
146954683|NCT00256204|529990674|FG000|Overall Study|Death|0|||
146954684|NCT00256204|529990675|FG001|Overall Study|Death|1|||
146954685|NCT00256204|529990676|FG002|Overall Study|Death|0|||
146954686|NCT00256204|529990677|FG003|Overall Study|Death|0|||
146954687|NCT00256204|529990674|FG000|Overall Study|Lost to Follow-up|1|||
146954688|NCT00256204|529990675|FG001|Overall Study|Lost to Follow-up|1|||
146954689|NCT00256204|529990676|FG002|Overall Study|Lost to Follow-up|1|||
146954690|NCT00256204|529990677|FG003|Overall Study|Lost to Follow-up|2|||
146954691|NCT00256204|529990674|FG000|Overall Study|Protocol Violation|1|||
146954692|NCT00256204|529990675|FG001|Overall Study|Protocol Violation|0|||
146954693|NCT00256204|529990676|FG002|Overall Study|Protocol Violation|2|||
146954694|NCT00256204|529990677|FG003|Overall Study|Protocol Violation|1|||
146954695|NCT00256204|529990674|FG000|Overall Study|Physician Decision|0|||
146954696|NCT00256204|529990675|FG001|Overall Study|Physician Decision|0|||
146954697|NCT00256204|529990676|FG002|Overall Study|Physician Decision|1|||
146954698|NCT00256204|529990677|FG003|Overall Study|Physician Decision|2|||
146954699|NCT00256204|529990674|FG000|Overall Study|Withdrawal by Subject|17|||
146954700|NCT00256204|529990675|FG001|Overall Study|Withdrawal by Subject|6|||
146954701|NCT00256204|529990676|FG002|Overall Study|Withdrawal by Subject|7|||
146954702|NCT00256204|529990677|FG003|Overall Study|Withdrawal by Subject|5|||
146954703|NCT00256204|529990674|FG000|Overall Study|Need for additional prohibited treatment|38|||
146954704|NCT00256204|529990675|FG001|Overall Study|Need for additional prohibited treatment|28|||
146954705|NCT00256204|529990676|FG002|Overall Study|Need for additional prohibited treatment|27|||
146954706|NCT00256204|529990677|FG003|Overall Study|Need for additional prohibited treatment|25|||
146954707|NCT02177942|529990682|FG000|Overall Study|Adverse Event|1|||
146954708|NCT02177942|529990683|FG001|Overall Study|Adverse Event|0|||
146954709|NCT02177942|529990682|FG000|Overall Study|Lost to Follow-up|1|||
146954710|NCT02177942|529990683|FG001|Overall Study|Lost to Follow-up|1|||
146954711|NCT02177942|529990682|FG000|Overall Study|Protocol Violation|4|||
146954712|NCT02177942|529990683|FG001|Overall Study|Protocol Violation|6|||
146954713|NCT02177942|529990682|FG000|Overall Study|Withdrawal by Subject|71|||
146954714|NCT02177942|529990683|FG001|Overall Study|Withdrawal by Subject|81|||
146954715|NCT01234337|529990684|FG000|Overall Study|Adverse Event|58|||
146954716|NCT01234337|529990685|FG001|Overall Study|Adverse Event|21|||
146954717|NCT01234337|529990684|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
146954718|NCT01234337|529990685|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
146954719|NCT01234337|529990684|FG000|Overall Study|Investi. decision not protocol driven|5|||
146954720|NCT01234337|529990685|FG001|Overall Study|Investi. decision not protocol driven|6|||
146954721|NCT01234337|529990684|FG000|Overall Study|Non-compliant with study medication|3|||
146954722|NCT01234337|529990685|FG001|Overall Study|Non-compliant with study medication|2|||
146954723|NCT01234337|529990684|FG000|Overall Study|Randomized but not treated|6|||
146954724|NCT01234337|529990685|FG001|Overall Study|Randomized but not treated|4|||
146954725|NCT01234337|529990684|FG000|Overall Study|Lost to Follow-up|0|||
146954726|NCT01234337|529990685|FG001|Overall Study|Lost to Follow-up|1|||
146954727|NCT01234337|529990684|FG000|Overall Study|Protocol Violation|2|||
146954728|NCT01234337|529990685|FG001|Overall Study|Protocol Violation|3|||
146985099|NCT01333033|530107164|FG001|Overall Study|Adverse Event|0|||
146985100|NCT01333033|530107165|FG002|Overall Study|Adverse Event|0|||
146985101|NCT01333033|530107166|FG003|Overall Study|Adverse Event|0|||
146825625|NCT00460564|529533853|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
146954729|NCT01234337|529990684|FG000|Overall Study|Withdrawal by Subject|11|||
146954730|NCT01234337|529990685|FG001|Overall Study|Withdrawal by Subject|9|||
146954731|NCT01234337|529990684|FG000|Overall Study|Death|0|||
146954732|NCT01234337|529990685|FG001|Overall Study|Death|1|||
146954733|NCT01234337|529990684|FG000|Overall Study|Switch to commercial drug|0|||
146954734|NCT01234337|529990685|FG001|Overall Study|Switch to commercial drug|1|||
146954735|NCT03490734|529990688|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
146954736|NCT03490734|529990689|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
146954737|NCT03490734|529990690|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
146985102|NCT01333033|530107167|FG004|Overall Study|Adverse Event|2|||
146985103|NCT01333033|530107168|FG005|Overall Study|Adverse Event|1|||
146954738|NCT03490734|529990691|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
146954739|NCT03490734|529990688|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
146825626|NCT00460564|529533854|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
146825627|NCT00460564|529533855|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
146825628|NCT00460564|529533856|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
146825629|NCT00460564|529533849|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
146825630|NCT00460564|529533850|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
146825631|NCT00460564|529533851|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
146825632|NCT00460564|529533852|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
146825633|NCT00460564|529533853|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
146825634|NCT00460564|529533854|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
146825635|NCT00460564|529533855|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
146825636|NCT00460564|529533856|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
146825637|NCT00943618|529533859|FG000|Overall Study|Lost to Follow-up|38|||
146825638|NCT00943618|529533860|FG001|Overall Study|Lost to Follow-up|48|||
146825639|NCT00943618|529533861|FG002|Overall Study|Lost to Follow-up|20|||
146825640|NCT00943618|529533859|FG000|Overall Study|Discontinued Medication|17|||
146825641|NCT00943618|529533860|FG001|Overall Study|Discontinued Medication|29|||
146825642|NCT00943618|529533861|FG002|Overall Study|Discontinued Medication|11|||
146825643|NCT00487552|529533866|FG000|Overall Study|Unsuccessful magnet placements|3|||
146825644|NCT00487552|529533866|FG000|Overall Study|Death due to progressive malignancy|2|||
146825645|NCT00487552|529533866|FG000|Overall Study|Stent not placed|1|||
146825646|NCT02412111|529533867|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
146825647|NCT02412111|529533868|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
146825648|NCT02412111|529533869|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
146825649|NCT02412111|529533867|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
146825650|NCT02412111|529533868|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
146825651|NCT02412111|529533869|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
146825652|NCT02412111|529533867|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
146825653|NCT02412111|529533868|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
146825654|NCT02412111|529533869|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
146825655|NCT02412111|529533867|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
146825656|NCT02412111|529533868|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
146825657|NCT02412111|529533869|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
146825658|NCT02412111|529533867|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
146825659|NCT02412111|529533868|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
146825660|NCT02412111|529533869|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
146825661|NCT02412111|529533867|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
146825662|NCT02412111|529533868|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
146825663|NCT02412111|529533869|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
146825664|NCT02412111|529533867|FG000|Active Comparator Period (8 Weeks)|Other|0|||
146825665|NCT02412111|529533868|FG001|Active Comparator Period (8 Weeks)|Other|0|||
146825666|NCT02412111|529533869|FG002|Active Comparator Period (8 Weeks)|Other|2|||
146825667|NCT01917006|529533870|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
146825668|NCT01917006|529533871|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
146825669|NCT01917006|529533872|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
146825670|NCT01917006|529533873|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
146825671|NCT01917006|529533874|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
146825672|NCT01917006|529533875|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
146825673|NCT01917006|529533876|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
146825674|NCT01917006|529533877|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
146825675|NCT01917006|529533870|FG000|Randomized-treatment Period|Personal Reasons|0|||
146825676|NCT01917006|529533871|FG001|Randomized-treatment Period|Personal Reasons|0|||
146825677|NCT01917006|529533872|FG002|Randomized-treatment Period|Personal Reasons|0|||
146825678|NCT01917006|529533873|FG003|Randomized-treatment Period|Personal Reasons|0|||
146825679|NCT01917006|529533874|FG004|Randomized-treatment Period|Personal Reasons|0|||
146825680|NCT01917006|529533875|FG005|Randomized-treatment Period|Personal Reasons|1|||
146825681|NCT01917006|529533876|FG006|Randomized-treatment Period|Personal Reasons|0|||
146825682|NCT01917006|529533877|FG007|Randomized-treatment Period|Personal Reasons|0|||
146825683|NCT01917006|529533870|FG000|Randomized-treatment Period|Protocol Violation|1|||
146825684|NCT01917006|529533871|FG001|Randomized-treatment Period|Protocol Violation|0|||
146825685|NCT01917006|529533872|FG002|Randomized-treatment Period|Protocol Violation|0|||
146825686|NCT01917006|529533873|FG003|Randomized-treatment Period|Protocol Violation|0|||
146825687|NCT01917006|529533874|FG004|Randomized-treatment Period|Protocol Violation|0|||
146825688|NCT01917006|529533875|FG005|Randomized-treatment Period|Protocol Violation|0|||
146825689|NCT01917006|529533876|FG006|Randomized-treatment Period|Protocol Violation|0|||
146825690|NCT01917006|529533877|FG007|Randomized-treatment Period|Protocol Violation|0|||
146825691|NCT01917006|529533870|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
146825692|NCT01917006|529533871|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
146985104|NCT01333033|530107163|FG000|Overall Study|Progression|0|||
146954740|NCT03490734|529990689|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
146954741|NCT03490734|529990690|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
146954742|NCT03490734|529990691|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
146954743|NCT03490734|529990688|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
146954744|NCT03490734|529990689|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
146954745|NCT03490734|529990690|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
146954746|NCT03490734|529990691|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
146954747|NCT03490734|529990688|FG000|Post-intervention Scan Visit|Adverse Event|2|||
146954748|NCT03490734|529990689|FG001|Post-intervention Scan Visit|Adverse Event|0|||
146954749|NCT03490734|529990690|FG002|Post-intervention Scan Visit|Adverse Event|0|||
146954750|NCT03490734|529990691|FG003|Post-intervention Scan Visit|Adverse Event|0|||
146954751|NCT03490734|529990688|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
146954752|NCT03490734|529990689|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
146954753|NCT03490734|529990690|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
146954754|NCT03490734|529990691|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
146954755|NCT03490734|529990688|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
146954756|NCT03490734|529990689|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
146954757|NCT03490734|529990690|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
146954758|NCT03490734|529990691|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
146954759|NCT00392210|529990711|FG000|First Voiding Trial|Physician Decision|2|||
146954760|NCT00392210|529990712|FG001|First Voiding Trial|Physician Decision|2|||
146954761|NCT01277666|529990713|FG000|Overall Study|Adverse Event|26|||
146954762|NCT01277666|529990714|FG001|Overall Study|Adverse Event|25|||
146954763|NCT01277666|529990715|FG002|Overall Study|Adverse Event|20|||
146954764|NCT01277666|529990713|FG000|Overall Study|Lack of Efficacy|8|||
146954765|NCT01277666|529990714|FG001|Overall Study|Lack of Efficacy|20|||
146954766|NCT01277666|529990715|FG002|Overall Study|Lack of Efficacy|12|||
146954767|NCT01277666|529990713|FG000|Overall Study|Protocol Violation|2|||
146954768|NCT01277666|529990714|FG001|Overall Study|Protocol Violation|3|||
146954769|NCT01277666|529990715|FG002|Overall Study|Protocol Violation|2|||
146954770|NCT01277666|529990713|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
146954771|NCT01277666|529990714|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
146954772|NCT01277666|529990715|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
146954773|NCT01277666|529990713|FG000|Overall Study|Lost to Follow-up|1|||
146954774|NCT01277666|529990714|FG001|Overall Study|Lost to Follow-up|1|||
146954775|NCT01277666|529990715|FG002|Overall Study|Lost to Follow-up|2|||
146954776|NCT01277666|529990713|FG000|Overall Study|Withdrawal by Subject|7|||
146954777|NCT01277666|529990714|FG001|Overall Study|Withdrawal by Subject|8|||
146954778|NCT01277666|529990715|FG002|Overall Study|Withdrawal by Subject|6|||
146954779|NCT01277666|529990713|FG000|Overall Study|Death|0|||
146954780|NCT01277666|529990714|FG001|Overall Study|Death|0|||
146954781|NCT01277666|529990715|FG002|Overall Study|Death|1|||
146954782|NCT01385098|529990716|FG000|Overall Study|Adverse Event|10|||
146954783|NCT01385098|529990716|FG000|Overall Study|Lost to Follow-up|4|||
146954784|NCT01084096|529993577|FG000|Overall Study|Lost to Follow-up|1501|||
146954785|NCT01084096|529993578|FG001|Overall Study|Lost to Follow-up|1833|||
146954786|NCT01084096|529993577|FG000|Overall Study|Withdrawal by Subject|3|||
146954787|NCT01084096|529993578|FG001|Overall Study|Withdrawal by Subject|0|||
146954788|NCT01084096|529993577|FG000|Overall Study|Woman had a miscarriage|21|||
146954789|NCT01084096|529993578|FG001|Overall Study|Woman had a miscarriage|17|||
146954790|NCT05604781|529993579|FG000|Overall Study|Lost to Follow-up|3|||
146954791|NCT05604781|529993579|FG000|Overall Study|Adverse Event|1|||
146954792|NCT01864746|529993590|FG000|Overall Study|Disease recurrence|25|||
146954793|NCT01864746|529993591|FG001|Overall Study|Disease recurrence|40|||
146954794|NCT01864746|529993590|FG000|Overall Study|Second primary invasive nonbreast|2|||
146954795|NCT01864746|529993591|FG001|Overall Study|Second primary invasive nonbreast|3|||
146954796|NCT01864746|529993590|FG000|Overall Study|Death|2|||
146954797|NCT01864746|529993591|FG001|Overall Study|Death|1|||
146954798|NCT01864746|529993590|FG000|Overall Study|Adverse Event|33|||
146954799|NCT01864746|529993591|FG001|Overall Study|Adverse Event|5|||
146954800|NCT01864746|529993590|FG000|Overall Study|Withdrawal by Subject|56|||
146954801|NCT01864746|529993591|FG001|Overall Study|Withdrawal by Subject|41|||
146954802|NCT01864746|529993590|FG000|Overall Study|Physician Decision|5|||
146954803|NCT01864746|529993591|FG001|Overall Study|Physician Decision|6|||
146954804|NCT01005966|529993592|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
146954805|NCT01005966|529993593|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
146954806|NCT01005966|529993594|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
146954807|NCT01005966|529993595|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
146954808|NCT01005966|529993596|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
146954809|NCT01005966|529993592|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
146954810|NCT01005966|529993593|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
146954811|NCT01005966|529993594|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
146954812|NCT01005966|529993595|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
146954813|NCT01005966|529993596|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
146954814|NCT01005966|529993592|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
146954815|NCT01005966|529993593|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
146954816|NCT01005966|529993594|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
146954817|NCT01005966|529993595|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
146954818|NCT01005966|529993596|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
146954819|NCT01005966|529993592|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
146954820|NCT01005966|529993593|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
146954821|NCT01005966|529993594|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
146954822|NCT01005966|529993595|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
146954823|NCT01005966|529993596|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
146954824|NCT01005966|529993592|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146954825|NCT01005966|529993593|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146954826|NCT01005966|529993594|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146954827|NCT01005966|529993595|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
146954828|NCT01005966|529993596|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146954829|NCT01005966|529993592|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
146954830|NCT01005966|529993593|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
146954831|NCT01005966|529993594|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
146954832|NCT01005966|529993595|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
146954833|NCT01005966|529993596|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
146954834|NCT01005966|529993592|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
146954835|NCT01005966|529993593|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
146954836|NCT01005966|529993594|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
146954837|NCT01005966|529993595|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
146954838|NCT01005966|529993596|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
146954839|NCT01005966|529993592|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
146954840|NCT01005966|529993593|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
146954841|NCT01005966|529993594|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
146825693|NCT01917006|529533872|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
146825694|NCT01917006|529533873|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
146825695|NCT01917006|529533874|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
146825696|NCT01917006|529533875|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
146825697|NCT01917006|529533876|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
146825698|NCT01917006|529533877|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
146825699|NCT01917006|529533870|FG000|Open-label Period|Adverse Event|0|||
146825700|NCT01917006|529533871|FG001|Open-label Period|Adverse Event|0|||
146825701|NCT01917006|529533872|FG002|Open-label Period|Adverse Event|0|||
146825702|NCT01917006|529533873|FG003|Open-label Period|Adverse Event|0|||
146825703|NCT01917006|529533874|FG004|Open-label Period|Adverse Event|0|||
146954842|NCT01005966|529993595|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
146954843|NCT01005966|529993596|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
146954844|NCT01005966|529993592|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
146954845|NCT01005966|529993593|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
146954846|NCT01005966|529993594|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
146954847|NCT01005966|529993595|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
146954848|NCT01005966|529993596|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
146954849|NCT01451203|529993597|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
146954850|NCT01451203|529993598|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
146954851|NCT01451203|529993597|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
146954852|NCT01451203|529993598|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
146954853|NCT01451203|529993597|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
146954854|NCT01451203|529993598|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
146954855|NCT01451203|529993597|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
146954856|NCT01451203|529993598|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
146954857|NCT01451203|529993597|FG000|Double-blind Treatment Period|Adverse Event|6|||
146954858|NCT01451203|529993598|FG001|Double-blind Treatment Period|Adverse Event|9|||
146954859|NCT01451203|529993597|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
146954860|NCT01451203|529993598|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
146954861|NCT01451203|529993597|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
146954862|NCT01451203|529993598|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
146954863|NCT01451203|529993597|FG000|Double-blind Treatment Period|Investigator decision|2|||
146954864|NCT01451203|529993598|FG001|Double-blind Treatment Period|Investigator decision|0|||
146954865|NCT01451203|529993597|FG000|Post-treatment Period|Consent withdrawn|2|||
146954866|NCT01451203|529993598|FG001|Post-treatment Period|Consent withdrawn|4|||
146954867|NCT01451203|529993597|FG000|Post-treatment Period|Lack of Efficacy|12|||
146954868|NCT01451203|529993598|FG001|Post-treatment Period|Lack of Efficacy|28|||
146985105|NCT01333033|530107164|FG001|Overall Study|Progression|0|||
146825704|NCT01917006|529533875|FG005|Open-label Period|Adverse Event|0|||
146825705|NCT01917006|529533876|FG006|Open-label Period|Adverse Event|0|||
146954869|NCT01451203|529993597|FG000|Post-treatment Period|Adverse Event|0|||
146954870|NCT01451203|529993598|FG001|Post-treatment Period|Adverse Event|1|||
146954871|NCT01451203|529993597|FG000|Post-treatment Period|Investigator decision|0|||
146954872|NCT01451203|529993598|FG001|Post-treatment Period|Investigator decision|1|||
146954873|NCT02493712|529993599|FG000|Overall Study|Withdrawal by Subject|1|||
146954874|NCT02493712|529993600|FG001|Overall Study|Withdrawal by Subject|0|||
146954875|NCT02493712|529993601|FG002|Overall Study|Withdrawal by Subject|2|||
146954876|NCT02493712|529993599|FG000|Overall Study|Protocol Violation|0|||
146954877|NCT02493712|529993600|FG001|Overall Study|Protocol Violation|0|||
146954878|NCT02493712|529993601|FG002|Overall Study|Protocol Violation|1|||
146954879|NCT02493712|529993599|FG000|Overall Study|Lost to Follow-up|1|||
146954880|NCT02493712|529993600|FG001|Overall Study|Lost to Follow-up|0|||
146954881|NCT02493712|529993601|FG002|Overall Study|Lost to Follow-up|0|||
146954882|NCT02493712|529993599|FG000|Overall Study|Physician Decision|0|||
146954883|NCT02493712|529993600|FG001|Overall Study|Physician Decision|1|||
146954884|NCT02493712|529993601|FG002|Overall Study|Physician Decision|0|||
146954885|NCT02493712|529993599|FG000|Overall Study|Lack of Efficacy|0|||
146954886|NCT02493712|529993600|FG001|Overall Study|Lack of Efficacy|5|||
146954887|NCT02493712|529993601|FG002|Overall Study|Lack of Efficacy|3|||
146954888|NCT02528643|529993602|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
146954889|NCT02528643|529993603|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
146954890|NCT02528643|529993602|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
146954891|NCT02528643|529993603|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
146954892|NCT02528643|529993602|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
146954893|NCT02528643|529993603|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
146954894|NCT02528643|529993602|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
146954895|NCT02528643|529993603|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
146954896|NCT02528643|529993602|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
146954897|NCT02528643|529993603|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
146954898|NCT02528643|529993602|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
146954899|NCT02528643|529993603|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
146954900|NCT02528643|529993602|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
146954901|NCT02528643|529993603|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
146954902|NCT01640353|529993606|FG000|Overall Study|Withdrew prior to treatment|10|||
146954903|NCT01640353|529993606|FG000|Overall Study|Withdrawn from analysis at term site|12|||
146954904|NCT01640353|529993606|FG000|Overall Study|Withdrawal by Subject|5|||
146954905|NCT01640353|529993606|FG000|Overall Study|Death|2|||
146954906|NCT01640353|529993606|FG000|Overall Study|Early site termination|3|||
146954907|NCT01640353|529993606|FG000|Overall Study|Lost to Follow-up|12|||
146954908|NCT01640353|529993606|FG000|Overall Study|Physician Decision|1|||
146954909|NCT01524900|529993607|FG000|Overall Study|Lost to Follow-up|3|||
146954910|NCT01524900|529993608|FG001|Overall Study|Lost to Follow-up|12|||
146954911|NCT01524900|529993609|FG002|Overall Study|Lost to Follow-up|1|||
146954912|NCT01524900|529993610|FG003|Overall Study|Lost to Follow-up|0|||
146954913|NCT01524900|529993611|FG004|Overall Study|Lost to Follow-up|0|||
146954914|NCT01524900|529993607|FG000|Overall Study|Other reason than stated above|1|||
146954915|NCT01524900|529993608|FG001|Overall Study|Other reason than stated above|1|||
146954916|NCT01524900|529993609|FG002|Overall Study|Other reason than stated above|0|||
146954917|NCT01524900|529993610|FG003|Overall Study|Other reason than stated above|0|||
146954918|NCT01524900|529993611|FG004|Overall Study|Other reason than stated above|0|||
146954919|NCT01524900|529993607|FG000|Overall Study|No reason documented|2|||
146954920|NCT01524900|529993608|FG001|Overall Study|No reason documented|1|||
146954921|NCT01524900|529993609|FG002|Overall Study|No reason documented|0|||
146954922|NCT01524900|529993610|FG003|Overall Study|No reason documented|1|||
146954923|NCT01524900|529993611|FG004|Overall Study|No reason documented|0|||
146954924|NCT03758612|529993612|FG000|Washout Period|Withdrawal by Subject|0|||
146954925|NCT03758612|529993613|FG001|Washout Period|Withdrawal by Subject|0|||
146954926|NCT03758612|529993614|FG002|Washout Period|Withdrawal by Subject|2|||
146954927|NCT03758612|529993615|FG003|Washout Period|Withdrawal by Subject|0|||
146954928|NCT03758612|529993616|FG004|Washout Period|Withdrawal by Subject|0|||
146954929|NCT03758612|529993617|FG005|Washout Period|Withdrawal by Subject|0|||
146954930|NCT03758612|529993618|FG006|Washout Period|Withdrawal by Subject|0|||
146954931|NCT03758612|529993619|FG007|Washout Period|Withdrawal by Subject|0|||
146954932|NCT03758612|529993620|FG008|Washout Period|Withdrawal by Subject|0|||
146954933|NCT03758612|529993621|FG009|Washout Period|Withdrawal by Subject|0|||
146954934|NCT03758612|529993622|FG010|Washout Period|Withdrawal by Subject|0|||
146985106|NCT01333033|530107165|FG002|Overall Study|Progression|0|||
146954935|NCT03758612|529993623|FG011|Washout Period|Withdrawal by Subject|0|||
146954936|NCT03758612|529993612|FG000|Period 2|Protocol Violation|0|||
146954937|NCT03758612|529993613|FG001|Period 2|Protocol Violation|0|||
146954938|NCT03758612|529993614|FG002|Period 2|Protocol Violation|0|||
146954939|NCT03758612|529993615|FG003|Period 2|Protocol Violation|0|||
146954940|NCT03758612|529993616|FG004|Period 2|Protocol Violation|1|||
146954941|NCT03758612|529993617|FG005|Period 2|Protocol Violation|0|||
146954942|NCT03758612|529993618|FG006|Period 2|Protocol Violation|0|||
146954943|NCT03758612|529993619|FG007|Period 2|Protocol Violation|0|||
146985107|NCT01333033|530107166|FG003|Overall Study|Progression|0|||
146954944|NCT03758612|529993620|FG008|Period 2|Protocol Violation|0|||
146954945|NCT03758612|529993621|FG009|Period 2|Protocol Violation|0|||
146954946|NCT03758612|529993622|FG010|Period 2|Protocol Violation|0|||
146954947|NCT03758612|529993623|FG011|Period 2|Protocol Violation|0|||
146954948|NCT03812224|529993631|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
146954949|NCT03812224|529993632|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
146954950|NCT03812224|529993631|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
146954951|NCT03812224|529993632|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
146954952|NCT03812224|529993631|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
146954953|NCT03812224|529993632|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
146954954|NCT03812224|529993631|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
146954955|NCT03812224|529993632|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
146954956|NCT00303719|529993633|FG000|Overall Study|Not evaluable, prior therapies|0|||
146954957|NCT00303719|529993634|FG001|Overall Study|Not evaluable, prior therapies|30|||
146954958|NCT00303719|529993633|FG000|Overall Study|Lost to Follow-up|0|||
146954959|NCT00303719|529993634|FG001|Overall Study|Lost to Follow-up|7|||
146954960|NCT01641952|529993635|FG000|Overall Study|Lost to Follow-up|28|||
146954961|NCT01641952|529993635|FG000|Overall Study|Adverse Event|6|||
146954962|NCT03633461|529993649|FG000|Overall Study|Lost to Follow-up|0|||
146954963|NCT03633461|529993650|FG001|Overall Study|Lost to Follow-up|1|||
146954964|NCT03938857|529993657|FG000|Overall Study|Physician Decision|1|||
146954965|NCT03938857|529993658|FG001|Overall Study|Physician Decision|0|||
146954966|NCT03938857|529993659|FG002|Overall Study|Physician Decision|0|||
146954967|NCT03938857|529993660|FG003|Overall Study|Physician Decision|0|||
146954968|NCT02516605|529993661|FG000|Overall Study|Protocol Violation|0|||
146954969|NCT02516605|529993662|FG001|Overall Study|Protocol Violation|0|||
146954970|NCT02516605|529993663|FG002|Overall Study|Protocol Violation|0|||
146954971|NCT02516605|529993664|FG003|Overall Study|Protocol Violation|0|||
146954972|NCT02516605|529993665|FG004|Overall Study|Protocol Violation|1|||
146954973|NCT02516605|529993661|FG000|Overall Study|Withdrawal by Subject|0|||
146954974|NCT02516605|529993662|FG001|Overall Study|Withdrawal by Subject|0|||
146954975|NCT02516605|529993663|FG002|Overall Study|Withdrawal by Subject|0|||
146954976|NCT02516605|529993664|FG003|Overall Study|Withdrawal by Subject|1|||
146954977|NCT02516605|529993665|FG004|Overall Study|Withdrawal by Subject|0|||
146954978|NCT02643420|529993666|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
146954979|NCT02643420|529993667|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
146954980|NCT02643420|529993666|FG000|Overall Study|Withdrawal by Subject|25|||
146954981|NCT02643420|529993667|FG001|Overall Study|Withdrawal by Subject|19|||
146954982|NCT02643420|529993666|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
146954983|NCT02643420|529993667|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
146954984|NCT02643420|529993666|FG000|Overall Study|Lost to Follow-up|6|||
146954985|NCT02643420|529993667|FG001|Overall Study|Lost to Follow-up|10|||
146954986|NCT02643420|529993666|FG000|Overall Study|Investigator Decision|2|||
146954987|NCT02643420|529993667|FG001|Overall Study|Investigator Decision|4|||
146954988|NCT02643420|529993666|FG000|Overall Study|Sponsor decision|1|||
146954989|NCT02643420|529993667|FG001|Overall Study|Sponsor decision|1|||
146954990|NCT02643420|529993666|FG000|Overall Study|Death|0|||
146954991|NCT02643420|529993667|FG001|Overall Study|Death|2|||
146954992|NCT02643420|529993666|FG000|Overall Study|Reason not Specified|8|||
146954993|NCT02643420|529993667|FG001|Overall Study|Reason not Specified|7|||
146954994|NCT02127970|529993668|FG000|Overall Study|Adverse Event|2|||
146954995|NCT02127970|529993669|FG001|Overall Study|Adverse Event|1|||
146954996|NCT02127970|529993668|FG000|Overall Study|Death|1|||
146954997|NCT02127970|529993669|FG001|Overall Study|Death|1|||
146954998|NCT02127970|529993668|FG000|Overall Study|Lost to Follow-up|14|||
146954999|NCT02127970|529993669|FG001|Overall Study|Lost to Follow-up|14|||
146955000|NCT02127970|529993668|FG000|Overall Study|Reason not Specified|4|||
146955001|NCT02127970|529993669|FG001|Overall Study|Reason not Specified|7|||
146985108|NCT01333033|530107167|FG004|Overall Study|Progression|0|||
146985109|NCT01333033|530107168|FG005|Overall Study|Progression|1|||
146985110|NCT01333033|530107163|FG000|Overall Study|MD Decision|0|||
146985111|NCT01333033|530107164|FG001|Overall Study|MD Decision|0|||
146955002|NCT02127970|529993668|FG000|Overall Study|Pregnancy|0|||
146985112|NCT01333033|530107165|FG002|Overall Study|MD Decision|0|||
146985113|NCT01333033|530107166|FG003|Overall Study|MD Decision|0|||
146985114|NCT01333033|530107167|FG004|Overall Study|MD Decision|0|||
146825706|NCT01917006|529533877|FG007|Open-label Period|Adverse Event|1|||
146955003|NCT02127970|529993669|FG001|Overall Study|Pregnancy|1|||
146955004|NCT02127970|529993668|FG000|Overall Study|Subject Withdrew Consent|5|||
146955005|NCT02127970|529993669|FG001|Overall Study|Subject Withdrew Consent|3|||
146955006|NCT02630459|529993670|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
146955007|NCT02630459|529993671|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
146955008|NCT02630459|529993672|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
146955009|NCT02630459|529993673|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
146955010|NCT02630459|529993674|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
146985115|NCT01333033|530107168|FG005|Overall Study|MD Decision|2|||
146985116|NCT01388647|530107171|FG000|Overall Study|Adverse Event|1|||
146985117|NCT01388647|530107172|FG001|Overall Study|Adverse Event|2|||
146985118|NCT01336894|530107174|FG000|Follow-up|Study terminated prematurely|2|||
146985119|NCT01336894|530107175|FG001|Follow-up|Study terminated prematurely|7|||
146985120|NCT00903383|530107181|FG000|Overall Study|Adverse Event|1|||
146985121|NCT00903383|530107182|FG001|Overall Study|Adverse Event|2|||
146985122|NCT00903383|530107183|FG002|Overall Study|Adverse Event|3|||
146985123|NCT00903383|530107184|FG003|Overall Study|Adverse Event|1|||
146985124|NCT00903383|530107181|FG000|Overall Study|Physician Decision|1|||
146985125|NCT00903383|530107182|FG001|Overall Study|Physician Decision|2|||
146985126|NCT00903383|530107183|FG002|Overall Study|Physician Decision|0|||
146985127|NCT00903383|530107184|FG003|Overall Study|Physician Decision|0|||
146985128|NCT00903383|530107181|FG000|Overall Study|Lost to Follow-up|0|||
146985129|NCT00903383|530107182|FG001|Overall Study|Lost to Follow-up|0|||
146985130|NCT00903383|530107183|FG002|Overall Study|Lost to Follow-up|0|||
146985131|NCT00903383|530107184|FG003|Overall Study|Lost to Follow-up|1|||
146985132|NCT00903383|530107181|FG000|Overall Study|Decision of Sponsor|1|||
146985133|NCT00903383|530107182|FG001|Overall Study|Decision of Sponsor|0|||
146985134|NCT00903383|530107183|FG002|Overall Study|Decision of Sponsor|0|||
146985135|NCT00903383|530107184|FG003|Overall Study|Decision of Sponsor|0|||
146985136|NCT00903383|530107181|FG000|Overall Study|Withdrawal by Subject|4|||
146985137|NCT00903383|530107182|FG001|Overall Study|Withdrawal by Subject|1|||
146985138|NCT00903383|530107183|FG002|Overall Study|Withdrawal by Subject|0|||
146985139|NCT00903383|530107184|FG003|Overall Study|Withdrawal by Subject|2|||
146985140|NCT00903383|530107181|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
146985141|NCT00903383|530107182|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
146985142|NCT00903383|530107183|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
146985143|NCT00903383|530107184|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
146985144|NCT00903383|530107181|FG000|Overall Study|Patient Decision|0|||
146985145|NCT00903383|530107182|FG001|Overall Study|Patient Decision|0|||
146985146|NCT00903383|530107183|FG002|Overall Study|Patient Decision|0|||
146985147|NCT00903383|530107184|FG003|Overall Study|Patient Decision|1|||
146985148|NCT01076166|530107188|FG000|Overall Study|Adverse Event|3|||
146985149|NCT01076166|530107188|FG000|Overall Study|Symptoms improved/resolved|6|||
146985150|NCT00638157|530107191|FG000|Overall Study|Adverse Event|0|||
146985151|NCT00638157|530107192|FG001|Overall Study|Adverse Event|1|||
146985152|NCT00638157|530107191|FG000|Overall Study|Clinical (symptomatic) failure|1|||
146985153|NCT00638157|530107192|FG001|Overall Study|Clinical (symptomatic) failure|1|||
146985154|NCT00638157|530107191|FG000|Overall Study|Microbiological failure|1|||
146985155|NCT00638157|530107192|FG001|Overall Study|Microbiological failure|0|||
146985156|NCT00638157|530107191|FG000|Overall Study|Lost to Follow-up|1|||
146985157|NCT00638157|530107192|FG001|Overall Study|Lost to Follow-up|0|||
146985158|NCT00638157|530107191|FG000|Overall Study|Physician Decision|1|||
146985159|NCT00638157|530107192|FG001|Overall Study|Physician Decision|0|||
146985160|NCT00638157|530107191|FG000|Overall Study|Other|1|||
146985161|NCT00638157|530107192|FG001|Overall Study|Other|2|||
146985162|NCT00638157|530107191|FG000|Overall Study|Randomized, not treated|2|||
146985163|NCT00638157|530107192|FG001|Overall Study|Randomized, not treated|0|||
146985164|NCT02110706|530107193|FG000|Overall Study|Adverse Event|2|||
146985165|NCT02110706|530107194|FG001|Overall Study|Adverse Event|3|||
146985166|NCT02110706|530107193|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
146985167|NCT02110706|530107194|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
146985168|NCT02970669|530107197|FG000|Double-blind Period|Adverse Event|4|||
146985169|NCT02970669|530107198|FG001|Double-blind Period|Adverse Event|0|||
146985170|NCT02970669|530107197|FG000|Double-blind Period|Death|1|||
146985171|NCT02970669|530107198|FG001|Double-blind Period|Death|0|||
146985172|NCT02970669|530107197|FG000|Double-blind Period|Study terminated by sponsor|1|||
146985173|NCT02970669|530107198|FG001|Double-blind Period|Study terminated by sponsor|2|||
146985174|NCT02970669|530107197|FG000|Double-blind Period|Physician Decision|0|||
146825707|NCT01917006|529533870|FG000|Open-label Period|Lost to Follow-up|0|||
146955011|NCT02630459|529993675|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
146955012|NCT02630459|529993676|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
146955013|NCT02630459|529993677|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
146955014|NCT02630459|529993670|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
146955015|NCT02630459|529993671|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
146955016|NCT02630459|529993672|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
146955017|NCT02630459|529993673|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
146955018|NCT02630459|529993674|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
146955019|NCT02630459|529993675|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
146955020|NCT02630459|529993676|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
146985175|NCT02970669|530107198|FG001|Double-blind Period|Physician Decision|2|||
146985176|NCT02970669|530107197|FG000|Double-blind Period|Withdrawal by Subject|2|||
146985177|NCT02970669|530107198|FG001|Double-blind Period|Withdrawal by Subject|2|||
146985178|NCT02970669|530107197|FG000|Open-label Period|Withdrawal by Subject|2|||
146985179|NCT02970669|530107198|FG001|Open-label Period|Withdrawal by Subject|2|||
146985180|NCT02970669|530107197|FG000|Open-label Period|Adverse Event|1|||
146955021|NCT02630459|529993677|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
146955022|NCT02630459|529993670|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
146955023|NCT02630459|529993671|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
146955024|NCT02630459|529993672|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
146955025|NCT02630459|529993673|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
146955026|NCT02630459|529993674|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
146955027|NCT02630459|529993675|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
146955028|NCT02630459|529993676|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
146955029|NCT02630459|529993677|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
146955030|NCT02630459|529993670|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
146955031|NCT02630459|529993671|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
146955032|NCT02630459|529993672|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
146955033|NCT02630459|529993673|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
146955034|NCT02630459|529993674|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
146955035|NCT02630459|529993675|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
146955036|NCT02630459|529993676|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
146955037|NCT02630459|529993677|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
146955038|NCT02630459|529993670|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
146955039|NCT02630459|529993671|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
146955040|NCT02630459|529993672|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
146955041|NCT02630459|529993673|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
146955042|NCT02630459|529993674|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
146955043|NCT02630459|529993675|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
146955044|NCT02630459|529993676|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
146955045|NCT02630459|529993677|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
146955046|NCT02630459|529993670|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
146955047|NCT02630459|529993671|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
146955048|NCT02630459|529993672|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
146955049|NCT02630459|529993673|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
146955050|NCT02630459|529993674|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
146955051|NCT02630459|529993675|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
146955052|NCT02630459|529993676|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
146955053|NCT02630459|529993677|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
146955054|NCT02630459|529993670|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
146955055|NCT02630459|529993671|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
146955056|NCT02630459|529993672|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
146955057|NCT02630459|529993673|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
146955058|NCT02630459|529993674|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
146955059|NCT02630459|529993675|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
146955060|NCT02630459|529993676|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
146955061|NCT02630459|529993677|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
146955062|NCT00348686|529993678|FG000|Overall Study|Withdrawal by Subject|45|||
146955063|NCT00348686|529993678|FG000|Overall Study|Adverse Event|5|||
146955064|NCT00348686|529993678|FG000|Overall Study|Protocol Violation|6|||
146955065|NCT00348686|529993678|FG000|Overall Study|Lost to Follow-up|2|||
146955066|NCT00348686|529993678|FG000|Overall Study|Multiple Reasons|8|||
146955067|NCT01258738|529993681|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
146955068|NCT01258738|529993682|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
146955069|NCT01258738|529993681|FG000|Double-blind Period|Withdrawal by Subject|2|||
146955070|NCT01258738|529993682|FG001|Double-blind Period|Withdrawal by Subject|2|||
146955071|NCT01258738|529993681|FG000|Double-blind Period|Protocol Violation|1|||
146955072|NCT01258738|529993682|FG001|Double-blind Period|Protocol Violation|1|||
146955073|NCT01258738|529993681|FG000|Double-blind Period|Adverse Event|3|||
146955074|NCT01258738|529993682|FG001|Double-blind Period|Adverse Event|1|||
146955075|NCT01258738|529993681|FG000|Open-label Period|Did not meet inclusion criteria|0|||
146955076|NCT01258738|529993682|FG001|Open-label Period|Did not meet inclusion criteria|1|||
146955077|NCT01258738|529993681|FG000|Open-label Period|Insufficient clinical response|5|||
146955078|NCT01258738|529993682|FG001|Open-label Period|Insufficient clinical response|3|||
146955079|NCT01258738|529993681|FG000|Open-label Period|Lost to Follow-up|0|||
146955080|NCT01258738|529993682|FG001|Open-label Period|Lost to Follow-up|2|||
146955081|NCT01258738|529993681|FG000|Open-label Period|Withdrawal by Subject|5|||
146955082|NCT01258738|529993682|FG001|Open-label Period|Withdrawal by Subject|6|||
146955083|NCT01258738|529993681|FG000|Open-label Period|Protocol Violation|2|||
146955084|NCT01258738|529993682|FG001|Open-label Period|Protocol Violation|2|||
146955085|NCT01258738|529993681|FG000|Open-label Period|Adverse Event|4|||
146955086|NCT01258738|529993682|FG001|Open-label Period|Adverse Event|5|||
146955087|NCT01258738|529993681|FG000|Open-label Period|Other Reasons|0|||
146955088|NCT01258738|529993682|FG001|Open-label Period|Other Reasons|1|||
146955089|NCT01258738|529993681|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
146955090|NCT01258738|529993682|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
146955091|NCT02418000|529993683|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
146955092|NCT02418000|529993684|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
146955093|NCT02418000|529993685|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
146955094|NCT02418000|529993686|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
146955095|NCT02418000|529993687|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
146955096|NCT02418000|529993683|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
146955097|NCT02418000|529993684|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
146955098|NCT02418000|529993685|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
146955099|NCT02418000|529993686|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
146955100|NCT02418000|529993687|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
146955101|NCT02418000|529993683|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
146955102|NCT02418000|529993684|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
146955103|NCT02418000|529993685|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
146955104|NCT02418000|529993686|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
146955105|NCT02418000|529993687|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
146955106|NCT02418000|529993683|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
146955107|NCT02418000|529993684|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
146955108|NCT02418000|529993685|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
146955109|NCT02418000|529993686|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
146955110|NCT02418000|529993687|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
146955111|NCT02418000|529993683|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
146955112|NCT02418000|529993684|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
146955113|NCT02418000|529993685|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
146955114|NCT02418000|529993686|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
146955115|NCT02418000|529993687|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
146955116|NCT02418000|529993683|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146955117|NCT02418000|529993684|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146955118|NCT02418000|529993685|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
146955119|NCT02418000|529993686|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146955120|NCT02418000|529993687|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146955121|NCT02418000|529993683|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146955122|NCT02418000|529993684|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146955123|NCT02418000|529993685|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146955124|NCT02418000|529993686|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
146955125|NCT02418000|529993687|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146955126|NCT02418000|529993683|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
146955127|NCT02418000|529993684|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
146955128|NCT02418000|529993685|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
146955129|NCT02418000|529993686|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
146955130|NCT02418000|529993687|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
146955131|NCT02418000|529993683|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146955132|NCT02418000|529993684|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146955133|NCT02418000|529993685|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146955134|NCT02418000|529993686|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146955135|NCT02418000|529993687|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
146955136|NCT00689611|529993688|FG000|Overall Study|Death|6|||
146955137|NCT00689611|529993689|FG001|Overall Study|Death|9|||
146955138|NCT00689611|529993688|FG000|Overall Study|Withdrawal by Subject|8|||
146955139|NCT00689611|529993689|FG001|Overall Study|Withdrawal by Subject|9|||
146955140|NCT00689611|529993688|FG000|Overall Study|Lost to Follow-up|27|||
146955141|NCT00689611|529993689|FG001|Overall Study|Lost to Follow-up|28|||
146955142|NCT00490815|529993694|FG000|Overall Study|Adverse Event|2|||
146955143|NCT00490815|529993695|FG001|Overall Study|Adverse Event|3|||
146955144|NCT00490815|529993694|FG000|Overall Study|Withdrawal by Subject|4|||
146955145|NCT00490815|529993695|FG001|Overall Study|Withdrawal by Subject|0|||
146955146|NCT00490815|529993694|FG000|Overall Study|Lost to Follow-up|1|||
146955147|NCT00490815|529993695|FG001|Overall Study|Lost to Follow-up|3|||
146955148|NCT00490815|529993694|FG000|Overall Study|Death|1|||
146955149|NCT00490815|529993695|FG001|Overall Study|Death|3|||
146955150|NCT01904760|529993703|FG000|Overall Study|Protocol Violation|1|||
146955151|NCT01904760|529993704|FG001|Overall Study|Protocol Violation|0|||
146955152|NCT04249076|529993715|FG000|Overall Study|Adverse Event|1|||
146825708|NCT01917006|529533871|FG001|Open-label Period|Lost to Follow-up|0|||
146825709|NCT01917006|529533872|FG002|Open-label Period|Lost to Follow-up|0|||
146825710|NCT01917006|529533873|FG003|Open-label Period|Lost to Follow-up|0|||
146825711|NCT01917006|529533874|FG004|Open-label Period|Lost to Follow-up|0|||
146825712|NCT01917006|529533875|FG005|Open-label Period|Lost to Follow-up|0|||
146955153|NCT04249076|529993716|FG001|Overall Study|Adverse Event|1|||
146955154|NCT04249076|529993715|FG000|Overall Study|Protocol Violation|1|||
146955155|NCT04249076|529993716|FG001|Overall Study|Protocol Violation|2|||
146955156|NCT04249076|529993715|FG000|Overall Study|Lack of Efficacy|0|||
146955157|NCT04249076|529993716|FG001|Overall Study|Lack of Efficacy|1|||
146955158|NCT04249076|529993715|FG000|Overall Study|Withdrawal by Subject|0|||
146955159|NCT04249076|529993716|FG001|Overall Study|Withdrawal by Subject|1|||
146955160|NCT00783263|529993717|FG000|Overall Study|Adverse Event|3|||
146955161|NCT00783263|529993718|FG001|Overall Study|Adverse Event|0|||
146955162|NCT00783263|529993719|FG002|Overall Study|Adverse Event|2|||
146955163|NCT00783263|529993720|FG003|Overall Study|Adverse Event|1|||
146955164|NCT00783263|529993717|FG000|Overall Study|Lost to Follow-up|1|||
146955165|NCT00783263|529993718|FG001|Overall Study|Lost to Follow-up|1|||
146955166|NCT00783263|529993719|FG002|Overall Study|Lost to Follow-up|0|||
146955167|NCT00783263|529993720|FG003|Overall Study|Lost to Follow-up|0|||
146955168|NCT00783263|529993717|FG000|Overall Study|Withdrawal by Subject|0|||
146955169|NCT00783263|529993718|FG001|Overall Study|Withdrawal by Subject|1|||
146955170|NCT00783263|529993719|FG002|Overall Study|Withdrawal by Subject|1|||
146955171|NCT00783263|529993720|FG003|Overall Study|Withdrawal by Subject|2|||
146955172|NCT00106626|529993721|FG000|Overall Study|Adverse Event|5|||
146955173|NCT00106626|529993722|FG001|Overall Study|Adverse Event|4|||
146955174|NCT00106626|529993723|FG002|Overall Study|Adverse Event|3|||
146955175|NCT00106626|529993724|FG003|Overall Study|Adverse Event|3|||
146955176|NCT00106626|529993721|FG000|Overall Study|Progressive Disease|4|||
146955177|NCT00106626|529993722|FG001|Overall Study|Progressive Disease|1|||
146955178|NCT00106626|529993723|FG002|Overall Study|Progressive Disease|9|||
146955179|NCT00106626|529993724|FG003|Overall Study|Progressive Disease|10|||
146955180|NCT00106626|529993721|FG000|Overall Study|Received radiation on new therapy|1|||
146955181|NCT00106626|529993722|FG001|Overall Study|Received radiation on new therapy|0|||
146955182|NCT00106626|529993723|FG002|Overall Study|Received radiation on new therapy|0|||
146955183|NCT00106626|529993724|FG003|Overall Study|Received radiation on new therapy|0|||
146955184|NCT00106626|529993721|FG000|Overall Study|> 14 day delay in therapy start|0|||
146955185|NCT00106626|529993722|FG001|Overall Study|> 14 day delay in therapy start|1|||
146955186|NCT00106626|529993723|FG002|Overall Study|> 14 day delay in therapy start|0|||
146955187|NCT00106626|529993724|FG003|Overall Study|> 14 day delay in therapy start|0|||
146955188|NCT00732199|529993729|FG000|Overall Study|Withdrawal by Subject|25|||
146955189|NCT00732199|529993730|FG001|Overall Study|Withdrawal by Subject|18|||
146955190|NCT00732199|529993729|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
146955191|NCT00732199|529993730|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
146955192|NCT00405756|529993743|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
146955193|NCT00405756|529993744|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
146955194|NCT00405756|529993745|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
146955195|NCT00405756|529993743|FG000|Double-blind Treatment|Adverse Event|31|||
146955196|NCT00405756|529993744|FG001|Double-blind Treatment|Adverse Event|27|||
146955197|NCT00405756|529993745|FG002|Double-blind Treatment|Adverse Event|12|||
146955198|NCT00405756|529993743|FG000|Double-blind Treatment|Disease Progression|47|||
146955199|NCT00405756|529993744|FG001|Double-blind Treatment|Disease Progression|81|||
146955200|NCT00405756|529993745|FG002|Double-blind Treatment|Disease Progression|102|||
146955201|NCT00405756|529993743|FG000|Double-blind Treatment|Lack of Efficacy|1|||
146955202|NCT00405756|529993744|FG001|Double-blind Treatment|Lack of Efficacy|4|||
146955203|NCT00405756|529993745|FG002|Double-blind Treatment|Lack of Efficacy|2|||
146955204|NCT00405756|529993743|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
146955205|NCT00405756|529993744|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
146955206|NCT00405756|529993745|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
146955207|NCT00405756|529993743|FG000|Double-blind Treatment|Lost to Follow-up|1|||
146955208|NCT00405756|529993744|FG001|Double-blind Treatment|Lost to Follow-up|0|||
146955209|NCT00405756|529993745|FG002|Double-blind Treatment|Lost to Follow-up|0|||
146955210|NCT00405756|529993743|FG000|Double-blind Treatment|Death|4|||
146955211|NCT00405756|529993744|FG001|Double-blind Treatment|Death|4|||
146955212|NCT00405756|529993745|FG002|Double-blind Treatment|Death|4|||
146955213|NCT00405756|529993743|FG000|Double-blind Treatment|Protocol Violation|1|||
146955214|NCT00405756|529993744|FG001|Double-blind Treatment|Protocol Violation|0|||
146955215|NCT00405756|529993745|FG002|Double-blind Treatment|Protocol Violation|2|||
146955216|NCT00405756|529993743|FG000|Double-blind Treatment|Other|7|||
146955217|NCT00405756|529993744|FG001|Double-blind Treatment|Other|4|||
146955218|NCT00405756|529993745|FG002|Double-blind Treatment|Other|4|||
146955219|NCT00405756|529993743|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
146955220|NCT00405756|529993744|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
146955221|NCT00405756|529993745|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
146955222|NCT00405756|529993743|FG000|Open-label Extension|Adverse Event|1|||
146955223|NCT00405756|529993744|FG001|Open-label Extension|Adverse Event|3|||
146955224|NCT00405756|529993745|FG002|Open-label Extension|Adverse Event|7|||
146955225|NCT00405756|529993743|FG000|Open-label Extension|Disease Progression|8|||
146955226|NCT00405756|529993744|FG001|Open-label Extension|Disease Progression|23|||
146955227|NCT00405756|529993745|FG002|Open-label Extension|Disease Progression|26|||
146825713|NCT01917006|529533876|FG006|Open-label Period|Lost to Follow-up|0|||
146825714|NCT01917006|529533877|FG007|Open-label Period|Lost to Follow-up|1|||
146825715|NCT02158247|529533878|FG000|Overall Study|Invisible vocal cords|5|||
146825716|NCT02544113|529533882|FG000|Overall Study|Death|3|||
146825717|NCT02544113|529533883|FG001|Overall Study|Death|4|||
146825718|NCT02847637|529533885|FG000|Overall Study|Withdrawal by Subject|0|||
146825719|NCT02847637|529533886|FG001|Overall Study|Withdrawal by Subject|1|||
146825720|NCT02847637|529533887|FG002|Overall Study|Withdrawal by Subject|1|||
146825721|NCT02847637|529533888|FG003|Overall Study|Withdrawal by Subject|0|||
146825722|NCT02847637|529533885|FG000|Overall Study|Lost to Follow-up|1|||
146825723|NCT02847637|529533886|FG001|Overall Study|Lost to Follow-up|1|||
146825724|NCT02847637|529533887|FG002|Overall Study|Lost to Follow-up|0|||
146825725|NCT02847637|529533888|FG003|Overall Study|Lost to Follow-up|0|||
146825726|NCT01746108|529533891|FG000|Overall Study|Migrated /moved from study area|0|||
146825727|NCT01746108|529533892|FG001|Overall Study|Migrated /moved from study area|1|||
146825728|NCT01746108|529533893|FG002|Overall Study|Migrated /moved from study area|0|||
146825729|NCT01746108|529533891|FG000|Overall Study|Adverse event, non-fatal|0|||
146825730|NCT01746108|529533892|FG001|Overall Study|Adverse event, non-fatal|1|||
146825731|NCT01746108|529533893|FG002|Overall Study|Adverse event, non-fatal|0|||
146825732|NCT01746108|529533891|FG000|Overall Study|Withdrawal by Subject|0|||
146825733|NCT01746108|529533892|FG001|Overall Study|Withdrawal by Subject|1|||
146825734|NCT01746108|529533893|FG002|Overall Study|Withdrawal by Subject|0|||
146825735|NCT01746108|529533891|FG000|Overall Study|Lost to Follow-up|0|||
146825736|NCT01746108|529533892|FG001|Overall Study|Lost to Follow-up|1|||
146825737|NCT01746108|529533893|FG002|Overall Study|Lost to Follow-up|0|||
146825738|NCT00053352|529533899|FG000|Overall Study|Lost to Follow-up|0|||
146825739|NCT00053352|529533900|FG001|Overall Study|Lost to Follow-up|1|||
146825740|NCT00053352|529533899|FG000|Overall Study|Physician Decision|11|||
146825741|NCT00053352|529533900|FG001|Overall Study|Physician Decision|1|||
146825742|NCT00053352|529533899|FG000|Overall Study|Withdrawal by Subject|1|||
146825743|NCT00053352|529533900|FG001|Overall Study|Withdrawal by Subject|0|||
146825744|NCT00053352|529533899|FG000|Overall Study|Ineligible|8|||
146825745|NCT00053352|529533900|FG001|Overall Study|Ineligible|8|||
146825746|NCT00053352|529533899|FG000|Overall Study|Disease at new site|1|||
146825747|NCT00053352|529533900|FG001|Overall Study|Disease at new site|0|||
146825748|NCT02741713|529533903|FG000|Overall Study|Surgery type changed intra-operatively|2|||
146825749|NCT02741713|529533904|FG001|Overall Study|Surgery type changed intra-operatively|1|||
146825750|NCT01388478|529533905|FG000|Overall Study|Adverse Event|4|||
146825751|NCT01388478|529533905|FG000|Overall Study|Withdrawal by Subject|1|||
146825752|NCT01037413|529533908|FG000|Part A: Skin Testing|Adverse Event|1|||
146825753|NCT01037413|529533909|FG001|Part A: Skin Testing|Adverse Event|0|||
146825754|NCT01037413|529533908|FG000|Part A: Skin Testing|Protocol Violation|1|||
146825755|NCT01037413|529533909|FG001|Part A: Skin Testing|Protocol Violation|0|||
146825756|NCT01037413|529533908|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
146825757|NCT01037413|529533909|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
146825758|NCT01037413|529533908|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
146825759|NCT01037413|529533909|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
146825760|NCT01990664|529533910|FG000|Overall Study|Lost to Follow-up|2|||
146825761|NCT01990664|529533911|FG001|Overall Study|Lost to Follow-up|6|||
146825762|NCT01990664|529533910|FG000|Overall Study|Withdrawal by Subject|2|||
146825763|NCT01990664|529533911|FG001|Overall Study|Withdrawal by Subject|3|||
146825764|NCT01990664|529533910|FG000|Overall Study|Protocol Violation|1|||
146825765|NCT01990664|529533911|FG001|Overall Study|Protocol Violation|0|||
146825766|NCT01990664|529533910|FG000|Overall Study|Lens Discomfort|1|||
146825767|NCT01990664|529533911|FG001|Overall Study|Lens Discomfort|1|||
146825768|NCT01990664|529533910|FG000|Overall Study|Lens Handling Difficulties|1|||
146825769|NCT01990664|529533911|FG001|Overall Study|Lens Handling Difficulties|0|||
146825770|NCT01990664|529533910|FG000|Overall Study|Unsatisfactory Visual Response|0|||
146825771|NCT01990664|529533911|FG001|Overall Study|Unsatisfactory Visual Response|1|||
146825772|NCT00619983|529533915|FG000|Test Drug Alone|Withdrawal by Subject|1|||
146825773|NCT00619983|529533916|FG001|Test Drug Alone|Withdrawal by Subject|0|||
146825774|NCT00619983|529533917|FG002|Test Drug Alone|Withdrawal by Subject|0|||
146825775|NCT00619983|529533918|FG003|Test Drug Alone|Withdrawal by Subject|1|||
146825776|NCT00619983|529533915|FG000|Test Drug Alone|Failure of daily diary device|1|||
146825777|NCT00619983|529533916|FG001|Test Drug Alone|Failure of daily diary device|1|||
146825778|NCT00619983|529533917|FG002|Test Drug Alone|Failure of daily diary device|2|||
146825779|NCT00619983|529533918|FG003|Test Drug Alone|Failure of daily diary device|2|||
146825780|NCT00931918|529533919|FG000|Overall Study|Adverse Event|4|||
146825781|NCT00931918|529533920|FG001|Overall Study|Adverse Event|6|||
146825782|NCT00931918|529533919|FG000|Overall Study|Progressive Disease|2|||
146825783|NCT00931918|529533920|FG001|Overall Study|Progressive Disease|1|||
146825784|NCT00931918|529533919|FG000|Overall Study|Symptomatic Deterioration|1|||
146825785|NCT00931918|529533920|FG001|Overall Study|Symptomatic Deterioration|0|||
146825786|NCT00931918|529533919|FG000|Overall Study|Withdrawal by Patient|3|||
146825787|NCT00931918|529533920|FG001|Overall Study|Withdrawal by Patient|4|||
146825788|NCT00931918|529533919|FG000|Overall Study|Other Reason not Specified|4|||
146825789|NCT00931918|529533920|FG001|Overall Study|Other Reason not Specified|4|||
146825790|NCT00931918|529533919|FG000|Overall Study|Did not receive study drug|3|||
146825791|NCT00931918|529533920|FG001|Overall Study|Did not receive study drug|2|||
146825792|NCT00570921|529533922|FG000|Overall Study|Protocol Violation|1|||
146955228|NCT00405756|529993743|FG000|Open-label Extension|Withdrawal by Subject|2|||
146955229|NCT00405756|529993744|FG001|Open-label Extension|Withdrawal by Subject|3|||
146955230|NCT00405756|529993745|FG002|Open-label Extension|Withdrawal by Subject|3|||
146955231|NCT00405756|529993743|FG000|Open-label Extension|Death|1|||
146955232|NCT00405756|529993744|FG001|Open-label Extension|Death|2|||
146955233|NCT00405756|529993745|FG002|Open-label Extension|Death|4|||
146955234|NCT00405756|529993743|FG000|Open-label Extension|Other|0|||
146955235|NCT00405756|529993744|FG001|Open-label Extension|Other|1|||
146955236|NCT00405756|529993745|FG002|Open-label Extension|Other|7|||
146955237|NCT00405756|529993743|FG000|Follow-up|Ongoing in Follow-up Period|52|||
146955238|NCT00405756|529993744|FG001|Follow-up|Ongoing in Follow-up Period|51|||
146955239|NCT00405756|529993745|FG002|Follow-up|Ongoing in Follow-up Period|60|||
146955240|NCT00405756|529993743|FG000|Follow-up|Death|21|||
146955241|NCT00405756|529993744|FG001|Follow-up|Death|31|||
146955242|NCT00405756|529993745|FG002|Follow-up|Death|24|||
146955243|NCT00405756|529993743|FG000|Follow-up|Lost to Follow-up|2|||
146955244|NCT00405756|529993744|FG001|Follow-up|Lost to Follow-up|8|||
146955245|NCT00405756|529993745|FG002|Follow-up|Lost to Follow-up|4|||
146955246|NCT01117428|529993749|FG000|Overall Study|Lack of Efficacy|1|||
146955247|NCT01117428|529993750|FG001|Overall Study|Lack of Efficacy|0|||
146955248|NCT01117428|529993751|FG002|Overall Study|Lack of Efficacy|0|||
146955249|NCT01117428|529993752|FG003|Overall Study|Lack of Efficacy|0|||
146955250|NCT01117428|529993753|FG004|Overall Study|Lack of Efficacy|0|||
146955251|NCT01117428|529993754|FG005|Overall Study|Lack of Efficacy|0|||
146955252|NCT01117428|529993749|FG000|Overall Study|Adverse Event|4|||
146955253|NCT01117428|529993750|FG001|Overall Study|Adverse Event|0|||
146955254|NCT01117428|529993751|FG002|Overall Study|Adverse Event|0|||
146955255|NCT01117428|529993752|FG003|Overall Study|Adverse Event|0|||
146955256|NCT01117428|529993753|FG004|Overall Study|Adverse Event|1|||
146955257|NCT01117428|529993754|FG005|Overall Study|Adverse Event|2|||
146955258|NCT01117428|529993749|FG000|Overall Study|Death|0|||
146955259|NCT01117428|529993750|FG001|Overall Study|Death|1|||
146955260|NCT01117428|529993751|FG002|Overall Study|Death|2|||
146955261|NCT01117428|529993752|FG003|Overall Study|Death|0|||
146955262|NCT01117428|529993753|FG004|Overall Study|Death|0|||
146955263|NCT01117428|529993754|FG005|Overall Study|Death|1|||
146955264|NCT01117428|529993749|FG000|Overall Study|Physician Decision|0|||
146955265|NCT01117428|529993750|FG001|Overall Study|Physician Decision|1|||
146955266|NCT01117428|529993751|FG002|Overall Study|Physician Decision|0|||
146955267|NCT01117428|529993752|FG003|Overall Study|Physician Decision|0|||
146955268|NCT01117428|529993753|FG004|Overall Study|Physician Decision|0|||
146955269|NCT01117428|529993754|FG005|Overall Study|Physician Decision|0|||
146955270|NCT01117428|529993749|FG000|Overall Study|Withdrawal by Subject|0|||
146955271|NCT01117428|529993750|FG001|Overall Study|Withdrawal by Subject|0|||
146955272|NCT01117428|529993751|FG002|Overall Study|Withdrawal by Subject|1|||
146955273|NCT01117428|529993752|FG003|Overall Study|Withdrawal by Subject|0|||
146955274|NCT01117428|529993753|FG004|Overall Study|Withdrawal by Subject|0|||
146955275|NCT01117428|529993754|FG005|Overall Study|Withdrawal by Subject|0|||
146955276|NCT01117428|529993749|FG000|Overall Study|Progressive disease|15|||
146955277|NCT01117428|529993750|FG001|Overall Study|Progressive disease|27|||
146955278|NCT01117428|529993751|FG002|Overall Study|Progressive disease|10|||
146955279|NCT01117428|529993752|FG003|Overall Study|Progressive disease|12|||
146955280|NCT01117428|529993753|FG004|Overall Study|Progressive disease|16|||
146955281|NCT01117428|529993754|FG005|Overall Study|Progressive disease|17|||
146955282|NCT02519777|529993755|FG000|Overall Study|Death|1|||
146825793|NCT00570921|529533922|FG000|Overall Study|Physician Decision|1|||
146825794|NCT03201900|529533925|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
146955283|NCT02519777|529993756|FG001|Overall Study|Death|0|||
146955284|NCT02519777|529993757|FG002|Overall Study|Death|0|||
146955285|NCT02519777|529993755|FG000|Overall Study|Lost to Follow-up|0|||
146955286|NCT02519777|529993756|FG001|Overall Study|Lost to Follow-up|4|||
146955287|NCT02519777|529993757|FG002|Overall Study|Lost to Follow-up|2|||
146825795|NCT03201900|529533925|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
146825796|NCT03201900|529533925|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
146825797|NCT03201900|529533925|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
146825798|NCT03201900|529533925|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
146955288|NCT02519777|529993755|FG000|Overall Study|Withdrawal by Subject|3|||
146955289|NCT02519777|529993756|FG001|Overall Study|Withdrawal by Subject|1|||
146955290|NCT02519777|529993757|FG002|Overall Study|Withdrawal by Subject|0|||
146955291|NCT02519777|529993755|FG000|Overall Study|Severe Debilitation|1|||
146955292|NCT02519777|529993756|FG001|Overall Study|Severe Debilitation|1|||
146955293|NCT02519777|529993757|FG002|Overall Study|Severe Debilitation|1|||
146955294|NCT02519777|529993755|FG000|Overall Study|Not able to get to clinic|1|||
146955295|NCT02519777|529993756|FG001|Overall Study|Not able to get to clinic|2|||
146955296|NCT02519777|529993757|FG002|Overall Study|Not able to get to clinic|1|||
146955297|NCT02195531|529993758|FG000|Overall Study|Withdrawal by Subject|1|||
146955298|NCT02195531|529993759|FG001|Overall Study|Withdrawal by Subject|1|||
146955299|NCT02195531|529993760|FG002|Overall Study|Withdrawal by Subject|1|||
146955300|NCT01284127|529993764|FG000|Overall Study|Adverse Event|2|||
146955301|NCT01284127|529993764|FG000|Overall Study|Withdrawal by Subject|4|||
146955302|NCT01284127|529993764|FG000|Overall Study|Physician Decision|1|||
146955303|NCT01683058|529993771|FG000|Overall Study|Lost to Follow-up|9|||
146955304|NCT01683058|529993771|FG000|Overall Study|Adverse Event|6|||
146955305|NCT01683058|529993771|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
146955306|NCT01683058|529993771|FG000|Overall Study|Withdrawal by Subject|7|||
146955307|NCT01683058|529993771|FG000|Overall Study|Lack of Efficacy|2|||
146955308|NCT04062240|529993772|FG000|Overall Study|equipment malfunction|1|||
146955309|NCT01957111|529993773|FG000|Overall Study|Withdrawal by Subject|1|||
146955310|NCT01957111|529993774|FG001|Overall Study|Withdrawal by Subject|1|||
146955311|NCT01057394|529993775|FG000|Overall Study|Not eligible|0|||
146955312|NCT01057394|529993776|FG001|Overall Study|Not eligible|2|||
146955313|NCT01195636|529993777|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
146955314|NCT01195636|529993778|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
146955315|NCT01195636|529993777|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
146955316|NCT01195636|529993778|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
146955317|NCT01195636|529993777|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
146955318|NCT01195636|529993778|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
146955319|NCT01195636|529993777|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
146955320|NCT01195636|529993778|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
146955321|NCT01195636|529993777|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
146955322|NCT01195636|529993778|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
146955323|NCT01195636|529993777|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
146955324|NCT01195636|529993778|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
146955325|NCT01195636|529993777|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
146955326|NCT01195636|529993778|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
146955327|NCT01195636|529993777|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
146955328|NCT01195636|529993778|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
146955329|NCT03961529|529993779|FG000|Overall Study|Adverse Event|13|||
146955330|NCT03961529|529993780|FG001|Overall Study|Adverse Event|5|||
146955331|NCT03961529|529993781|FG002|Overall Study|Adverse Event|2|||
146955332|NCT03961529|529993779|FG000|Overall Study|Withdrawal by Subject|17|||
146955333|NCT03961529|529993780|FG001|Overall Study|Withdrawal by Subject|2|||
146955334|NCT03961529|529993781|FG002|Overall Study|Withdrawal by Subject|1|||
146955335|NCT03961529|529993779|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146955336|NCT03961529|529993780|FG001|Overall Study|Withdrawal by parent/guardian|7|||
146955337|NCT03961529|529993781|FG002|Overall Study|Withdrawal by parent/guardian|0|||
146955338|NCT03961529|529993779|FG000|Overall Study|Physician Decision|2|||
146955339|NCT03961529|529993780|FG001|Overall Study|Physician Decision|1|||
146955340|NCT03961529|529993781|FG002|Overall Study|Physician Decision|1|||
146955341|NCT03961529|529993779|FG000|Overall Study|Lost to Follow-up|2|||
146955342|NCT03961529|529993780|FG001|Overall Study|Lost to Follow-up|1|||
146955343|NCT03961529|529993781|FG002|Overall Study|Lost to Follow-up|0|||
146955344|NCT03961529|529993779|FG000|Overall Study|Lack of Efficacy|2|||
146955345|NCT03961529|529993780|FG001|Overall Study|Lack of Efficacy|0|||
146955346|NCT03961529|529993781|FG002|Overall Study|Lack of Efficacy|1|||
146955347|NCT03961529|529993779|FG000|Overall Study|Other|6|||
146955348|NCT03961529|529993780|FG001|Overall Study|Other|1|||
146955349|NCT03961529|529993781|FG002|Overall Study|Other|0|||
146955350|NCT03644173|529993784|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
146955351|NCT03644173|529993784|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
146955352|NCT03644173|529993784|FG000|Participants at the 1-month Follow up|Death|2|||
146955353|NCT03644173|529993784|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
146955354|NCT03500419|529993785|FG000|Overall Study|Withdrawal by Subject|2|||
146955355|NCT03500419|529993786|FG001|Overall Study|Withdrawal by Subject|25|||
146955356|NCT00082628|529993791|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
146955357|NCT00082628|529993792|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
146955358|NCT00082628|529993793|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
146955359|NCT00082628|529993794|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
146955360|NCT00082628|529993795|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
146955361|NCT00082628|529993791|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
146955362|NCT00082628|529993792|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
146955363|NCT00082628|529993793|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
146955364|NCT00082628|529993794|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
146955365|NCT00082628|529993795|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
146955366|NCT00082628|529993791|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
146962312|NCT01049360|530021584|FG010|Period 1|Did not meet inc/exc criteria|0|||
146955367|NCT00082628|529993792|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
146955368|NCT00082628|529993793|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
146955369|NCT00082628|529993794|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
146955370|NCT00082628|529993795|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
146955371|NCT00082628|529993791|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
146955372|NCT00082628|529993792|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
146955373|NCT00082628|529993793|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
146955374|NCT00082628|529993794|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
146955375|NCT00082628|529993795|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
146955376|NCT00082628|529993791|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
146955377|NCT00082628|529993792|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
146955378|NCT00082628|529993793|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
146955379|NCT00082628|529993794|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
146955380|NCT00082628|529993795|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
146955381|NCT00082628|529993791|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
146955382|NCT00082628|529993792|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
146955383|NCT00082628|529993793|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
146955384|NCT00082628|529993794|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
146955385|NCT00082628|529993795|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
146955386|NCT00082628|529993791|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
146955387|NCT00082628|529993792|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
146955388|NCT00082628|529993793|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
146955389|NCT00082628|529993794|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
146955390|NCT00082628|529993795|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
146955391|NCT03481634|529993803|FG000|Overall Study|Withdrawal by Subject|16|||
146955392|NCT03481634|529993804|FG001|Overall Study|Withdrawal by Subject|19|||
146955393|NCT03481634|529993805|FG002|Overall Study|Withdrawal by Subject|14|||
146955394|NCT03481634|529993803|FG000|Overall Study|Protocol Violation|1|||
146955395|NCT03481634|529993804|FG001|Overall Study|Protocol Violation|0|||
146955396|NCT03481634|529993805|FG002|Overall Study|Protocol Violation|1|||
146955397|NCT03481634|529993803|FG000|Overall Study|Progressive disease|0|||
146955398|NCT03481634|529993804|FG001|Overall Study|Progressive disease|1|||
146955399|NCT03481634|529993805|FG002|Overall Study|Progressive disease|0|||
146955400|NCT03481634|529993803|FG000|Overall Study|Physician Decision|3|||
146955401|NCT03481634|529993804|FG001|Overall Study|Physician Decision|0|||
146955402|NCT03481634|529993805|FG002|Overall Study|Physician Decision|1|||
146955403|NCT03481634|529993803|FG000|Overall Study|Lost to Follow-up|3|||
146955404|NCT03481634|529993804|FG001|Overall Study|Lost to Follow-up|4|||
146955405|NCT03481634|529993805|FG002|Overall Study|Lost to Follow-up|4|||
146955406|NCT03481634|529993803|FG000|Overall Study|Death|4|||
146955407|NCT03481634|529993804|FG001|Overall Study|Death|8|||
146955408|NCT03481634|529993805|FG002|Overall Study|Death|7|||
146955409|NCT03481634|529993803|FG000|Overall Study|Adverse Event|6|||
146955410|NCT03481634|529993804|FG001|Overall Study|Adverse Event|3|||
146955411|NCT03481634|529993805|FG002|Overall Study|Adverse Event|7|||
146955412|NCT00994890|529993809|FG000|Overall Study|Adverse Event|13|||
146955413|NCT00994890|529993810|FG001|Overall Study|Adverse Event|9|||
146955414|NCT00994890|529993811|FG002|Overall Study|Adverse Event|11|||
146955415|NCT00994890|529993809|FG000|Overall Study|Lack of Efficacy|0|||
146955416|NCT00994890|529993810|FG001|Overall Study|Lack of Efficacy|0|||
146955417|NCT00994890|529993811|FG002|Overall Study|Lack of Efficacy|1|||
146955418|NCT00994890|529993809|FG000|Overall Study|Lost to Follow-up|6|||
146955419|NCT00994890|529993810|FG001|Overall Study|Lost to Follow-up|1|||
146955420|NCT00994890|529993811|FG002|Overall Study|Lost to Follow-up|3|||
146955421|NCT00994890|529993809|FG000|Overall Study|No longer willing to participate|8|||
146955422|NCT00994890|529993810|FG001|Overall Study|No longer willing to participate|5|||
146955423|NCT00994890|529993811|FG002|Overall Study|No longer willing to participate|13|||
146955424|NCT00994890|529993809|FG000|Overall Study|Protocol Violation|2|||
146955425|NCT00994890|529993810|FG001|Overall Study|Protocol Violation|4|||
146955426|NCT00994890|529993811|FG002|Overall Study|Protocol Violation|0|||
146955427|NCT00994890|529993809|FG000|Overall Study|Study terminated by sponsor|199|||
146955428|NCT00994890|529993810|FG001|Overall Study|Study terminated by sponsor|201|||
146955429|NCT00994890|529993811|FG002|Overall Study|Study terminated by sponsor|197|||
146955430|NCT00994890|529993809|FG000|Overall Study|Randomized, but not treated|1|||
146955431|NCT00994890|529993810|FG001|Overall Study|Randomized, but not treated|0|||
146955432|NCT00994890|529993811|FG002|Overall Study|Randomized, but not treated|0|||
146955433|NCT00994890|529993809|FG000|Overall Study|Other|2|||
146955434|NCT00994890|529993810|FG001|Overall Study|Other|2|||
146955435|NCT00994890|529993811|FG002|Overall Study|Other|1|||
146955436|NCT01849289|529993814|FG000|Overall Study|Adverse Event|3|||
146955437|NCT01849289|529993815|FG001|Overall Study|Adverse Event|3|||
146985181|NCT02970669|530107198|FG001|Open-label Period|Adverse Event|0|||
146825799|NCT03201900|529533925|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
146825800|NCT03201900|529533925|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
146825801|NCT03201900|529533925|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
146825802|NCT03201900|529533925|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
146825803|NCT03201900|529533925|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
146825804|NCT03201900|529533925|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
146825805|NCT03201900|529533925|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
146825806|NCT03201900|529533925|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
146825807|NCT02971228|529533926|FG000|Overall Study|Withdrawal by Subject|1|||
146825808|NCT02971228|529533927|FG001|Overall Study|Withdrawal by Subject|1|||
146825809|NCT02971228|529533928|FG002|Overall Study|Withdrawal by Subject|0|||
146825810|NCT02971228|529533929|FG003|Overall Study|Withdrawal by Subject|0|||
146825811|NCT02971228|529533930|FG004|Overall Study|Withdrawal by Subject|0|||
146825812|NCT02971228|529533926|FG000|Overall Study|Logistical challenges|0|||
146825813|NCT02971228|529533927|FG001|Overall Study|Logistical challenges|1|||
146825814|NCT02971228|529533928|FG002|Overall Study|Logistical challenges|0|||
146825815|NCT02971228|529533929|FG003|Overall Study|Logistical challenges|0|||
146825816|NCT02971228|529533930|FG004|Overall Study|Logistical challenges|0|||
146825817|NCT01233999|529533931|FG000|Overall Study|Withdrawal by Subject|1|||
146825818|NCT01233999|529533931|FG000|Overall Study|Lost to Follow-up|1|||
146825819|NCT02560389|529533934|FG000|Overall Study|Lost to Follow-up|1|||
146825820|NCT02560389|529533935|FG001|Overall Study|Lost to Follow-up|2|||
146825821|NCT02560389|529533936|FG002|Overall Study|Lost to Follow-up|2|||
146825822|NCT02560389|529533934|FG000|Overall Study|Tested positive for illicit substance|0|||
146825823|NCT02560389|529533935|FG001|Overall Study|Tested positive for illicit substance|1|||
146825824|NCT02560389|529533936|FG002|Overall Study|Tested positive for illicit substance|0|||
146825825|NCT02716298|529533937|FG000|First Intervention (1 Month)|Lens discomfort|1|||
146825826|NCT02716298|529533938|FG001|First Intervention (1 Month)|Lens discomfort|1|||
146825827|NCT00550446|529533939|FG000|Up To Week 12|Adverse Event|2|||
146825828|NCT00550446|529533940|FG001|Up To Week 12|Adverse Event|2|||
146825829|NCT00550446|529533941|FG002|Up To Week 12|Adverse Event|0|||
146825830|NCT00550446|529533942|FG003|Up To Week 12|Adverse Event|0|||
146825831|NCT00550446|529533943|FG004|Up To Week 12|Adverse Event|2|||
146825832|NCT00550446|529533944|FG005|Up To Week 12|Adverse Event|2|||
146825833|NCT00550446|529533945|FG006|Up To Week 12|Adverse Event|1|||
146825834|NCT00550446|529533946|FG007|Up To Week 12|Adverse Event|0|||
146825835|NCT00550446|529533947|FG008|Up To Week 12|Adverse Event|0|||
146825836|NCT00550446|529533948|FG009|Up To Week 12|Adverse Event|0|||
146825837|NCT00550446|529533949|FG010|Up To Week 12|Adverse Event|0|||
146825838|NCT00550446|529533939|FG000|Up To Week 12|Lack of Efficacy|3|||
146825839|NCT00550446|529533940|FG001|Up To Week 12|Lack of Efficacy|1|||
146825840|NCT00550446|529533941|FG002|Up To Week 12|Lack of Efficacy|0|||
146825841|NCT00550446|529533942|FG003|Up To Week 12|Lack of Efficacy|1|||
146825842|NCT00550446|529533943|FG004|Up To Week 12|Lack of Efficacy|0|||
146825843|NCT00550446|529533944|FG005|Up To Week 12|Lack of Efficacy|3|||
146825844|NCT00550446|529533945|FG006|Up To Week 12|Lack of Efficacy|3|||
146825845|NCT00550446|529533946|FG007|Up To Week 12|Lack of Efficacy|0|||
146825846|NCT00550446|529533947|FG008|Up To Week 12|Lack of Efficacy|0|||
146825847|NCT00550446|529533948|FG009|Up To Week 12|Lack of Efficacy|0|||
146825848|NCT00550446|529533949|FG010|Up To Week 12|Lack of Efficacy|0|||
146825849|NCT00550446|529533939|FG000|Up To Week 12|Lost to Follow-up|0|||
146825850|NCT00550446|529533940|FG001|Up To Week 12|Lost to Follow-up|1|||
146825851|NCT00550446|529533941|FG002|Up To Week 12|Lost to Follow-up|0|||
146825852|NCT00550446|529533942|FG003|Up To Week 12|Lost to Follow-up|0|||
146825853|NCT00550446|529533943|FG004|Up To Week 12|Lost to Follow-up|1|||
146825854|NCT00550446|529533944|FG005|Up To Week 12|Lost to Follow-up|1|||
146825855|NCT00550446|529533945|FG006|Up To Week 12|Lost to Follow-up|2|||
146825856|NCT00550446|529533946|FG007|Up To Week 12|Lost to Follow-up|0|||
146825857|NCT00550446|529533947|FG008|Up To Week 12|Lost to Follow-up|0|||
146825858|NCT00550446|529533948|FG009|Up To Week 12|Lost to Follow-up|0|||
146825859|NCT00550446|529533949|FG010|Up To Week 12|Lost to Follow-up|0|||
146825860|NCT00550446|529533939|FG000|Up To Week 12|Withdrawal by Subject|2|||
146825861|NCT00550446|529533940|FG001|Up To Week 12|Withdrawal by Subject|0|||
146825862|NCT00550446|529533941|FG002|Up To Week 12|Withdrawal by Subject|3|||
146825863|NCT00550446|529533942|FG003|Up To Week 12|Withdrawal by Subject|2|||
146825864|NCT00550446|529533943|FG004|Up To Week 12|Withdrawal by Subject|0|||
146825865|NCT00550446|529533944|FG005|Up To Week 12|Withdrawal by Subject|1|||
146825866|NCT00550446|529533945|FG006|Up To Week 12|Withdrawal by Subject|3|||
146825867|NCT00550446|529533946|FG007|Up To Week 12|Withdrawal by Subject|0|||
146825868|NCT00550446|529533947|FG008|Up To Week 12|Withdrawal by Subject|0|||
146825869|NCT00550446|529533948|FG009|Up To Week 12|Withdrawal by Subject|0|||
146825870|NCT00550446|529533949|FG010|Up To Week 12|Withdrawal by Subject|0|||
146825871|NCT00550446|529533939|FG000|Up To Week 12|Other|3|||
146825872|NCT00550446|529533940|FG001|Up To Week 12|Other|0|||
146825873|NCT00550446|529533941|FG002|Up To Week 12|Other|0|||
146825874|NCT00550446|529533942|FG003|Up To Week 12|Other|0|||
146955438|NCT01849289|529993814|FG000|Overall Study|Protocol Violation|3|||
146955439|NCT01849289|529993815|FG001|Overall Study|Protocol Violation|3|||
146955440|NCT01849289|529993814|FG000|Overall Study|Withdrawal criteria|1|||
146955441|NCT01849289|529993815|FG001|Overall Study|Withdrawal criteria|0|||
146955442|NCT01849289|529993814|FG000|Overall Study|Unclassified|25|||
146955443|NCT01849289|529993815|FG001|Overall Study|Unclassified|18|||
146955444|NCT00352027|529993816|FG000|Overall Study|Progressive disease|3|||
146955445|NCT04491591|529993817|FG000|Overall Study|Accidently randomized|3|||
146955446|NCT04491591|529993818|FG001|Overall Study|Accidently randomized|1|||
146955447|NCT04491591|529993819|FG002|Overall Study|Accidently randomized|0|||
146955448|NCT04491591|529993817|FG000|Overall Study|Did not complete survey|28|||
146955449|NCT04491591|529993818|FG001|Overall Study|Did not complete survey|20|||
146955450|NCT04491591|529993819|FG002|Overall Study|Did not complete survey|3|||
146955451|NCT00660816|529993820|FG000|Overall Study|Adverse Event|1|||
146955452|NCT00660816|529993821|FG001|Overall Study|Adverse Event|2|||
146955453|NCT00660816|529993820|FG000|Overall Study|Withdrawal by Subject|1|||
146955454|NCT00660816|529993821|FG001|Overall Study|Withdrawal by Subject|0|||
146955455|NCT00660816|529993820|FG000|Overall Study|Death|0|||
146955456|NCT00660816|529993821|FG001|Overall Study|Death|2|||
146955457|NCT00660816|529993820|FG000|Overall Study|Lack of Efficacy|1|||
146955458|NCT00660816|529993821|FG001|Overall Study|Lack of Efficacy|0|||
146955459|NCT00660816|529993820|FG000|Overall Study|Physician Decision|0|||
146955460|NCT00660816|529993821|FG001|Overall Study|Physician Decision|2|||
146955461|NCT00660816|529993820|FG000|Overall Study|Protocol Violation|1|||
146955462|NCT00660816|529993821|FG001|Overall Study|Protocol Violation|0|||
146955463|NCT00660816|529993820|FG000|Overall Study|Disease Progression|16|||
146955464|NCT00660816|529993821|FG001|Overall Study|Disease Progression|12|||
146955465|NCT00660816|529993820|FG000|Overall Study|Complicating Disease|0|||
146955466|NCT00660816|529993821|FG001|Overall Study|Complicating Disease|1|||
146955467|NCT02607735|529993824|FG000|Primary Study|Randomized but Never Treated|1|||
146955468|NCT02607735|529993825|FG001|Primary Study|Randomized but Never Treated|0|||
146955469|NCT02607735|529993826|FG002|Primary Study|Randomized but Never Treated|0|||
146955470|NCT02607735|529993824|FG000|Primary Study|Lost to Follow-up|4|||
146955471|NCT02607735|529993825|FG001|Primary Study|Lost to Follow-up|0|||
146955472|NCT02607735|529993826|FG002|Primary Study|Lost to Follow-up|0|||
146955473|NCT02607735|529993824|FG000|Primary Study|Withdrew Consent|2|||
146955474|NCT02607735|529993825|FG001|Primary Study|Withdrew Consent|0|||
146955475|NCT02607735|529993826|FG002|Primary Study|Withdrew Consent|0|||
146955476|NCT02607735|529993824|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
146955477|NCT02607735|529993825|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
146955478|NCT02607735|529993826|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
146955479|NCT02607735|529993824|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
146955480|NCT02607735|529993825|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
146955481|NCT02607735|529993826|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
146955482|NCT01058356|529993829|FG000|Overall Study|Adverse Event|5|||
146955483|NCT01058356|529993829|FG000|Overall Study|Administration of contraindicated drugs|12|||
146955484|NCT01058356|529993829|FG000|Overall Study|Withdrawal by Subject|21|||
146955485|NCT01058356|529993829|FG000|Overall Study|Lost to Follow-up|4|||
146955486|NCT02993783|529993830|FG000|Overall Study|Reason not Specified|6|||
146955487|NCT02993783|529993831|FG001|Overall Study|Reason not Specified|9|||
146955488|NCT00606021|529993834|FG000|Induction Phase|Death|73|||
146955489|NCT00606021|529993835|FG001|Induction Phase|Death|0|||
146955490|NCT00606021|529993836|FG002|Induction Phase|Death|0|||
146955491|NCT00606021|529993834|FG000|Induction Phase|Physician Decision|2|||
146955492|NCT00606021|529993835|FG001|Induction Phase|Physician Decision|0|||
146955493|NCT00606021|529993836|FG002|Induction Phase|Physician Decision|0|||
146955494|NCT00606021|529993834|FG000|Induction Phase|Withdrawal by Subject|2|||
146955495|NCT00606021|529993835|FG001|Induction Phase|Withdrawal by Subject|0|||
146955496|NCT00606021|529993836|FG002|Induction Phase|Withdrawal by Subject|0|||
146955497|NCT00606021|529993834|FG000|Induction Phase|Lost to Follow-up|10|||
146955498|NCT00606021|529993835|FG001|Induction Phase|Lost to Follow-up|0|||
146955499|NCT00606021|529993836|FG002|Induction Phase|Lost to Follow-up|0|||
146955500|NCT00606021|529993834|FG000|Maintenance Phase|Death|0|||
146955501|NCT00606021|529993835|FG001|Maintenance Phase|Death|17|||
146955502|NCT00606021|529993836|FG002|Maintenance Phase|Death|15|||
146955503|NCT00606021|529993834|FG000|Maintenance Phase|Physician Decision|0|||
146955504|NCT00606021|529993835|FG001|Maintenance Phase|Physician Decision|1|||
146955505|NCT00606021|529993836|FG002|Maintenance Phase|Physician Decision|0|||
146955506|NCT00606021|529993834|FG000|Maintenance Phase|Lost to Follow-up|0|||
146955507|NCT00606021|529993835|FG001|Maintenance Phase|Lost to Follow-up|5|||
146955508|NCT00606021|529993836|FG002|Maintenance Phase|Lost to Follow-up|2|||
146955509|NCT01899729|529993839|FG000|Overall Study|Adverse Event|1|||
146955510|NCT01899729|529993840|FG001|Overall Study|Adverse Event|0|||
146955511|NCT01899729|529993841|FG002|Overall Study|Adverse Event|0|||
146955512|NCT01899729|529993842|FG003|Overall Study|Adverse Event|0|||
146955513|NCT01899729|529993843|FG004|Overall Study|Adverse Event|1|||
146955514|NCT01899729|529993839|FG000|Overall Study|Withdrawal by Subject|1|||
146955515|NCT01899729|529993840|FG001|Overall Study|Withdrawal by Subject|2|||
146825875|NCT00550446|529533943|FG004|Up To Week 12|Other|0|||
146825876|NCT00550446|529533944|FG005|Up To Week 12|Other|1|||
146825877|NCT00550446|529533945|FG006|Up To Week 12|Other|4|||
146825878|NCT00550446|529533946|FG007|Up To Week 12|Other|0|||
146825879|NCT00550446|529533947|FG008|Up To Week 12|Other|0|||
146825880|NCT00550446|529533948|FG009|Up To Week 12|Other|0|||
146825881|NCT00550446|529533949|FG010|Up To Week 12|Other|0|||
146825882|NCT00550446|529533939|FG000|Up To Week 12|Randomized not treated|0|||
146825883|NCT00550446|529533940|FG001|Up To Week 12|Randomized not treated|1|||
146825884|NCT00550446|529533941|FG002|Up To Week 12|Randomized not treated|1|||
146825885|NCT00550446|529533942|FG003|Up To Week 12|Randomized not treated|0|||
146825886|NCT00550446|529533943|FG004|Up To Week 12|Randomized not treated|0|||
146825887|NCT00550446|529533944|FG005|Up To Week 12|Randomized not treated|0|||
146825888|NCT00550446|529533945|FG006|Up To Week 12|Randomized not treated|0|||
146825889|NCT00550446|529533946|FG007|Up To Week 12|Randomized not treated|0|||
146985182|NCT02970669|530107197|FG000|Open-label Period|Physician Decision|1|||
146985183|NCT02970669|530107198|FG001|Open-label Period|Physician Decision|0|||
146985184|NCT00876733|530107205|FG000|Overall Study|Adverse Event|34|||
146985185|NCT00876733|530107206|FG001|Overall Study|Adverse Event|20|||
146985186|NCT00876733|530107207|FG002|Overall Study|Adverse Event|10|||
146985187|NCT00876733|530107208|FG003|Overall Study|Adverse Event|3|||
146985188|NCT00876733|530107205|FG000|Overall Study|Lack of Efficacy|17|||
146985189|NCT00876733|530107206|FG001|Overall Study|Lack of Efficacy|9|||
146985190|NCT00876733|530107207|FG002|Overall Study|Lack of Efficacy|10|||
146985191|NCT00876733|530107208|FG003|Overall Study|Lack of Efficacy|1|||
146985192|NCT00876733|530107205|FG000|Overall Study|Lost to Follow-up|26|||
146985193|NCT00876733|530107206|FG001|Overall Study|Lost to Follow-up|10|||
146985194|NCT00876733|530107207|FG002|Overall Study|Lost to Follow-up|3|||
146985195|NCT00876733|530107208|FG003|Overall Study|Lost to Follow-up|2|||
146985196|NCT00876733|530107205|FG000|Overall Study|Data not available|14|||
146985197|NCT00876733|530107206|FG001|Overall Study|Data not available|3|||
146985198|NCT00876733|530107207|FG002|Overall Study|Data not available|7|||
146825890|NCT00550446|529533947|FG008|Up To Week 12|Randomized not treated|0|||
146955516|NCT01899729|529993841|FG002|Overall Study|Withdrawal by Subject|0|||
146955517|NCT01899729|529993842|FG003|Overall Study|Withdrawal by Subject|0|||
146955518|NCT01899729|529993843|FG004|Overall Study|Withdrawal by Subject|0|||
146955519|NCT01899729|529993839|FG000|Overall Study|Lack of Efficacy|0|||
146955520|NCT01899729|529993840|FG001|Overall Study|Lack of Efficacy|0|||
146955521|NCT01899729|529993841|FG002|Overall Study|Lack of Efficacy|2|||
146955522|NCT01899729|529993842|FG003|Overall Study|Lack of Efficacy|0|||
146955523|NCT01899729|529993843|FG004|Overall Study|Lack of Efficacy|1|||
146955524|NCT01454531|529993844|FG000|Overall Study|Adverse Event|14|||
146955525|NCT01454531|529993844|FG000|Overall Study|Withdrawal by Subject|5|||
146955526|NCT01454531|529993844|FG000|Overall Study|Lost to Follow-up|1|||
146955527|NCT01454531|529993844|FG000|Overall Study|Physician Decision|1|||
146955528|NCT01454531|529993844|FG000|Overall Study|Delay in IMP administration|1|||
146955529|NCT01454531|529993844|FG000|Overall Study|Other|1|||
146955530|NCT00027846|529996380|FG000|Overall Study|Lost to Follow-up|0|||
146955531|NCT00027846|529996381|FG001|Overall Study|Lost to Follow-up|41|||
146955532|NCT00027846|529996382|FG002|Overall Study|Lost to Follow-up|9|||
146955533|NCT00027846|529996380|FG000|Overall Study|Withdrawal by Subject|0|||
146955534|NCT00027846|529996381|FG001|Overall Study|Withdrawal by Subject|14|||
146955535|NCT00027846|529996382|FG002|Overall Study|Withdrawal by Subject|7|||
146955536|NCT00027846|529996380|FG000|Overall Study|Ineligible for study|2|||
146955537|NCT00027846|529996381|FG001|Overall Study|Ineligible for study|6|||
146955538|NCT00027846|529996382|FG002|Overall Study|Ineligible for study|14|||
146955539|NCT00027846|529996380|FG000|Overall Study|Entry into another COG therapeutic study|0|||
146955540|NCT00027846|529996381|FG001|Overall Study|Entry into another COG therapeutic study|5|||
146955541|NCT00027846|529996382|FG002|Overall Study|Entry into another COG therapeutic study|2|||
146955542|NCT00027846|529996380|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
146955543|NCT00027846|529996381|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
146955544|NCT00027846|529996382|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
146955545|NCT01354964|529996383|FG000|Overall Study|Lost to Follow-up|2|||
146955546|NCT01354964|529996384|FG001|Overall Study|Lost to Follow-up|0|||
146825891|NCT00550446|529533948|FG009|Up To Week 12|Randomized not treated|0|||
146955547|NCT01354964|529996383|FG000|Overall Study|IV access issues|1|||
146955548|NCT01354964|529996384|FG001|Overall Study|IV access issues|1|||
146955549|NCT01354964|529996383|FG000|Overall Study|Physician Decision|1|||
146955550|NCT01354964|529996384|FG001|Overall Study|Physician Decision|0|||
146985199|NCT00876733|530107208|FG003|Overall Study|Data not available|1|||
146985200|NCT02611752|530107209|FG000|Overall Study|Adverse Event|0|||
146825892|NCT00550446|529533949|FG010|Up To Week 12|Randomized not treated|0|||
146985201|NCT02611752|530107210|FG001|Overall Study|Adverse Event|1|||
146985202|NCT02843074|530107211|FG000|Overall Study|Withdrawal by Subject|5|||
146825893|NCT00550446|529533939|FG000|Post Week 12|Adverse Event|2|||
146825894|NCT00550446|529533940|FG001|Post Week 12|Adverse Event|1|||
146825895|NCT00550446|529533941|FG002|Post Week 12|Adverse Event|1|||
146825896|NCT00550446|529533942|FG003|Post Week 12|Adverse Event|1|||
146955551|NCT00711009|529996385|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
146955552|NCT00711009|529996386|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
146955553|NCT00711009|529996385|FG000|Overall Study|Withdrawal by Subject|4|||
146955554|NCT00711009|529996386|FG001|Overall Study|Withdrawal by Subject|2|||
146955555|NCT00711009|529996385|FG000|Overall Study|Lost to Follow-up|3|||
146955556|NCT00711009|529996386|FG001|Overall Study|Lost to Follow-up|9|||
146955557|NCT00711009|529996385|FG000|Overall Study|Participant Noncompliant|0|||
146955558|NCT00711009|529996386|FG001|Overall Study|Participant Noncompliant|1|||
146955559|NCT00711009|529996385|FG000|Overall Study|Virologic Failure|2|||
146955560|NCT00711009|529996386|FG001|Overall Study|Virologic Failure|1|||
146955561|NCT00711009|529996385|FG000|Overall Study|Pregnancy|1|||
146955562|NCT00711009|529996386|FG001|Overall Study|Pregnancy|0|||
146955563|NCT00711009|529996385|FG000|Overall Study|Site closing|0|||
146955564|NCT00711009|529996386|FG001|Overall Study|Site closing|1|||
146955565|NCT00711009|529996385|FG000|Overall Study|Dose adjustment|1|||
146955566|NCT00711009|529996386|FG001|Overall Study|Dose adjustment|0|||
146955567|NCT01459016|529996388|FG000|Overall Study|Withdrawal by Subject|11|||
146955568|NCT01459016|529996388|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
146955569|NCT00303602|529996392|FG000|Overall Study|Adverse Event|2|||
146955570|NCT00303602|529996393|FG001|Overall Study|Adverse Event|2|||
146955571|NCT00303602|529996392|FG000|Overall Study|Withdrawal by Subject|5|||
146955572|NCT00303602|529996393|FG001|Overall Study|Withdrawal by Subject|6|||
146955573|NCT00303602|529996392|FG000|Overall Study|Lost to Follow-up|5|||
146955574|NCT00303602|529996393|FG001|Overall Study|Lost to Follow-up|2|||
146955575|NCT00303602|529996392|FG000|Overall Study|Protocol entry criteria not met|2|||
146955576|NCT00303602|529996393|FG001|Overall Study|Protocol entry criteria not met|2|||
146955577|NCT00303602|529996392|FG000|Overall Study|Physician Decision|2|||
146955578|NCT00303602|529996393|FG001|Overall Study|Physician Decision|1|||
146955579|NCT00303602|529996392|FG000|Overall Study|Noncompliance|2|||
146955580|NCT00303602|529996393|FG001|Overall Study|Noncompliance|2|||
146955581|NCT00303602|529996392|FG000|Overall Study|Protocol Violation|1|||
146955582|NCT00303602|529996393|FG001|Overall Study|Protocol Violation|0|||
146955583|NCT02551874|529996400|FG000|Overall Study|Lost to Follow-up|0|||
146955584|NCT02551874|529996401|FG001|Overall Study|Lost to Follow-up|2|||
146955585|NCT02551874|529996400|FG000|Overall Study|Pregnancy|0|||
146955586|NCT02551874|529996401|FG001|Overall Study|Pregnancy|1|||
146955587|NCT02551874|529996400|FG000|Overall Study|Reason not reported|10|||
146955588|NCT02551874|529996401|FG001|Overall Study|Reason not reported|4|||
146955589|NCT02551874|529996400|FG000|Overall Study|Did not receive randomized treatment|0|||
146955590|NCT02551874|529996401|FG001|Overall Study|Did not receive randomized treatment|7|||
146955591|NCT02551874|529996400|FG000|Overall Study|Did not enter long-term study|18|||
146955592|NCT02551874|529996401|FG001|Overall Study|Did not enter long-term study|25|||
146955593|NCT00313716|529996402|FG000|Overall Study|Death|3|||
146955594|NCT00313716|529996403|FG001|Overall Study|Death|2|||
146955595|NCT00313716|529996404|FG002|Overall Study|Death|9|||
146955596|NCT00313716|529996405|FG003|Overall Study|Death|3|||
146955597|NCT00313716|529996406|FG004|Overall Study|Death|5|||
146955598|NCT00313716|529996407|FG005|Overall Study|Death|9|||
146955599|NCT00313716|529996402|FG000|Overall Study|Lost to Follow-up|2|||
146955600|NCT00313716|529996403|FG001|Overall Study|Lost to Follow-up|5|||
146955601|NCT00313716|529996404|FG002|Overall Study|Lost to Follow-up|2|||
146955602|NCT00313716|529996405|FG003|Overall Study|Lost to Follow-up|1|||
146955603|NCT00313716|529996406|FG004|Overall Study|Lost to Follow-up|0|||
146955604|NCT00313716|529996407|FG005|Overall Study|Lost to Follow-up|4|||
146955605|NCT00313716|529996402|FG000|Overall Study|Withdrawal by Subject|0|||
146955606|NCT00313716|529996403|FG001|Overall Study|Withdrawal by Subject|1|||
146955607|NCT00313716|529996404|FG002|Overall Study|Withdrawal by Subject|1|||
146955608|NCT00313716|529996405|FG003|Overall Study|Withdrawal by Subject|0|||
146955609|NCT00313716|529996406|FG004|Overall Study|Withdrawal by Subject|1|||
146955610|NCT00313716|529996407|FG005|Overall Study|Withdrawal by Subject|0|||
146955611|NCT02491463|529996408|FG000|Overall Study|Withdrawal by Subject|1|||
146955612|NCT02491463|529996409|FG001|Overall Study|Withdrawal by Subject|2|||
146955613|NCT02491463|529996410|FG002|Overall Study|Withdrawal by Subject|0|||
146955614|NCT02491463|529996411|FG003|Overall Study|Withdrawal by Subject|0|||
146955615|NCT02491463|529996408|FG000|Overall Study|Migrated/moved from study area|1|||
146955616|NCT02491463|529996409|FG001|Overall Study|Migrated/moved from study area|5|||
146955617|NCT02491463|529996410|FG002|Overall Study|Migrated/moved from study area|1|||
146955618|NCT02491463|529996411|FG003|Overall Study|Migrated/moved from study area|1|||
146955619|NCT02491463|529996408|FG000|Overall Study|Lost to Follow-up|0|||
146955620|NCT02491463|529996409|FG001|Overall Study|Lost to Follow-up|3|||
146955621|NCT02491463|529996410|FG002|Overall Study|Lost to Follow-up|3|||
146955622|NCT02491463|529996411|FG003|Overall Study|Lost to Follow-up|0|||
146955623|NCT01491802|529996412|FG000|Overall Study|Adverse Event|1|||
146955624|NCT01491802|529996413|FG001|Overall Study|Adverse Event|1|||
146955625|NCT01491802|529996412|FG000|Overall Study|Withdrawal by Subject|0|||
146955626|NCT01491802|529996413|FG001|Overall Study|Withdrawal by Subject|1|||
146955627|NCT00663208|529996414|FG000|Treatment Period|Lost to Follow-up|0|||
146955628|NCT00663208|529996415|FG001|Treatment Period|Lost to Follow-up|1|||
146955629|NCT00663208|529996416|FG002|Treatment Period|Lost to Follow-up|0|||
146955630|NCT00663208|529996417|FG003|Treatment Period|Lost to Follow-up|0|||
146955631|NCT00663208|529996418|FG004|Treatment Period|Lost to Follow-up|0|||
146955632|NCT00663208|529996419|FG005|Treatment Period|Lost to Follow-up|0|||
146955633|NCT00663208|529996420|FG006|Treatment Period|Lost to Follow-up|0|||
146955634|NCT00663208|529996414|FG000|Follow-up Period|Lost to Follow-up|2|||
146955635|NCT00663208|529996415|FG001|Follow-up Period|Lost to Follow-up|0|||
146955636|NCT00663208|529996416|FG002|Follow-up Period|Lost to Follow-up|3|||
146955637|NCT00663208|529996417|FG003|Follow-up Period|Lost to Follow-up|2|||
146955638|NCT00663208|529996418|FG004|Follow-up Period|Lost to Follow-up|0|||
146955639|NCT00663208|529996419|FG005|Follow-up Period|Lost to Follow-up|0|||
146955640|NCT00663208|529996420|FG006|Follow-up Period|Lost to Follow-up|0|||
146955641|NCT00663208|529996414|FG000|Follow-up Period|Other reason|1|||
146955642|NCT00663208|529996415|FG001|Follow-up Period|Other reason|0|||
146955643|NCT00663208|529996416|FG002|Follow-up Period|Other reason|0|||
146955644|NCT00663208|529996417|FG003|Follow-up Period|Other reason|0|||
146955645|NCT00663208|529996418|FG004|Follow-up Period|Other reason|0|||
146955646|NCT00663208|529996419|FG005|Follow-up Period|Other reason|0|||
146955647|NCT00663208|529996420|FG006|Follow-up Period|Other reason|1|||
146955648|NCT00039377|529996423|FG000|Initial Registration|Adverse Event|2|||
146955649|NCT00039377|529996424|FG001|Initial Registration|Adverse Event|0|||
146955650|NCT00039377|529996425|FG002|Initial Registration|Adverse Event|0|||
146955651|NCT00039377|529996426|FG003|Initial Registration|Adverse Event|0|||
146955652|NCT00039377|529996423|FG000|Initial Registration|Relapsed|6|||
146955653|NCT00039377|529996424|FG001|Initial Registration|Relapsed|0|||
146955654|NCT00039377|529996425|FG002|Initial Registration|Relapsed|0|||
146955655|NCT00039377|529996426|FG003|Initial Registration|Relapsed|0|||
146955656|NCT00039377|529996423|FG000|Initial Registration|Received non-protocol therapy|11|||
146955657|NCT00039377|529996424|FG001|Initial Registration|Received non-protocol therapy|0|||
146955658|NCT00039377|529996425|FG002|Initial Registration|Received non-protocol therapy|0|||
146955659|NCT00039377|529996426|FG003|Initial Registration|Received non-protocol therapy|0|||
146955660|NCT00039377|529996423|FG000|Initial Registration|Withdrawal by Subject|3|||
146955661|NCT00039377|529996424|FG001|Initial Registration|Withdrawal by Subject|0|||
146955662|NCT00039377|529996425|FG002|Initial Registration|Withdrawal by Subject|0|||
146955663|NCT00039377|529996426|FG003|Initial Registration|Withdrawal by Subject|0|||
146955664|NCT04067310|529996430|FG000|Overall Study|Physician Decision|2|||
146955665|NCT04067310|529996431|FG001|Overall Study|Physician Decision|6|||
146955666|NCT04067310|529996430|FG000|Overall Study|Lost to Follow-up|0|||
146955667|NCT04067310|529996431|FG001|Overall Study|Lost to Follow-up|1|||
146955668|NCT04067310|529996430|FG000|Overall Study|Withdrawal by Subject|3|||
146955669|NCT04067310|529996431|FG001|Overall Study|Withdrawal by Subject|0|||
146955670|NCT01249404|529996432|FG000|Overall Study|Study treatment not received|0|||
146955671|NCT01249404|529996433|FG001|Overall Study|Study treatment not received|1|||
146955672|NCT01249404|529996434|FG002|Overall Study|Study treatment not received|2|||
146955673|NCT01249404|529996432|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
146955674|NCT01249404|529996433|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
146955675|NCT01249404|529996434|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
146955676|NCT01249404|529996432|FG000|Overall Study|Adverse Event|2|||
146955677|NCT01249404|529996433|FG001|Overall Study|Adverse Event|2|||
146955678|NCT01249404|529996434|FG002|Overall Study|Adverse Event|2|||
146955679|NCT01249404|529996432|FG000|Overall Study|Withdrawal by Subject|2|||
146955680|NCT01249404|529996433|FG001|Overall Study|Withdrawal by Subject|2|||
146955681|NCT01249404|529996434|FG002|Overall Study|Withdrawal by Subject|0|||
146955682|NCT01249404|529996432|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
146955683|NCT01249404|529996433|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
146955684|NCT01249404|529996434|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
146955685|NCT01249404|529996432|FG000|Overall Study|Non compliance to visit schedule|0|||
146955686|NCT01249404|529996433|FG001|Overall Study|Non compliance to visit schedule|1|||
146955687|NCT01249404|529996434|FG002|Overall Study|Non compliance to visit schedule|0|||
146955688|NCT03890731|529996435|FG000|Overall Study|Progressive disease|1|||
146955689|NCT03890731|529996435|FG000|Overall Study|Patient's decision|1|||
146955690|NCT03890731|529996435|FG000|Overall Study|Adverse Event|4|||
146955691|NCT02058940|529996436|FG000|Overall Study|Discharged from Critical Care Unit|1|||
146955692|NCT01539720|529996447|FG000|Overall Study|Screen Fail|15|||
146955693|NCT01539720|529996448|FG001|Overall Study|Screen Fail|3|||
146955694|NCT01539720|529996447|FG000|Overall Study|Lost to Follow-up|14|||
146955695|NCT01539720|529996448|FG001|Overall Study|Lost to Follow-up|7|||
146955696|NCT00298766|529996449|FG000|Overall Study|Adverse Event|18|||
146955697|NCT00298766|529996449|FG000|Overall Study|Death|2|||
146955698|NCT00298766|529996449|FG000|Overall Study|Withdrawal by Subject|9|||
146955699|NCT00298766|529996449|FG000|Overall Study|Treatment ongoing|4|||
146955700|NCT00298766|529996449|FG000|Overall Study|Progression of amyloid markers|4|||
146955701|NCT00298766|529996449|FG000|Overall Study|Deterioration in KPS and organ function|1|||
146955702|NCT00298766|529996449|FG000|Overall Study|Subjects overall condition deterioration|4|||
146955703|NCT00298766|529996449|FG000|Overall Study|Other|4|||
146825897|NCT00550446|529533943|FG004|Post Week 12|Adverse Event|1|||
146825898|NCT00550446|529533944|FG005|Post Week 12|Adverse Event|1|||
146825899|NCT00550446|529533945|FG006|Post Week 12|Adverse Event|0|||
146825900|NCT00550446|529533946|FG007|Post Week 12|Adverse Event|0|||
146825901|NCT00550446|529533947|FG008|Post Week 12|Adverse Event|0|||
146825902|NCT00550446|529533948|FG009|Post Week 12|Adverse Event|4|||
146825903|NCT00550446|529533949|FG010|Post Week 12|Adverse Event|0|||
146825904|NCT00550446|529533939|FG000|Post Week 12|Lack of Efficacy|0|||
146825905|NCT00550446|529533940|FG001|Post Week 12|Lack of Efficacy|0|||
146825906|NCT00550446|529533941|FG002|Post Week 12|Lack of Efficacy|1|||
146825907|NCT00550446|529533942|FG003|Post Week 12|Lack of Efficacy|0|||
146825908|NCT00550446|529533943|FG004|Post Week 12|Lack of Efficacy|0|||
146825909|NCT00550446|529533944|FG005|Post Week 12|Lack of Efficacy|0|||
146825910|NCT00550446|529533945|FG006|Post Week 12|Lack of Efficacy|0|||
146825911|NCT00550446|529533946|FG007|Post Week 12|Lack of Efficacy|1|||
146825912|NCT00550446|529533947|FG008|Post Week 12|Lack of Efficacy|1|||
146825913|NCT00550446|529533948|FG009|Post Week 12|Lack of Efficacy|2|||
146825914|NCT00550446|529533949|FG010|Post Week 12|Lack of Efficacy|1|||
146825915|NCT00550446|529533939|FG000|Post Week 12|Lost to Follow-up|0|||
146825916|NCT00550446|529533940|FG001|Post Week 12|Lost to Follow-up|0|||
146825917|NCT00550446|529533941|FG002|Post Week 12|Lost to Follow-up|1|||
146825918|NCT00550446|529533942|FG003|Post Week 12|Lost to Follow-up|1|||
146825919|NCT00550446|529533943|FG004|Post Week 12|Lost to Follow-up|0|||
146825920|NCT00550446|529533944|FG005|Post Week 12|Lost to Follow-up|0|||
146825921|NCT00550446|529533945|FG006|Post Week 12|Lost to Follow-up|1|||
146825922|NCT00550446|529533946|FG007|Post Week 12|Lost to Follow-up|0|||
146825923|NCT00550446|529533947|FG008|Post Week 12|Lost to Follow-up|0|||
146825924|NCT00550446|529533948|FG009|Post Week 12|Lost to Follow-up|0|||
146825925|NCT00550446|529533949|FG010|Post Week 12|Lost to Follow-up|0|||
146825926|NCT00550446|529533939|FG000|Post Week 12|Withdrawal by Subject|0|||
146825927|NCT00550446|529533940|FG001|Post Week 12|Withdrawal by Subject|0|||
146825928|NCT00550446|529533941|FG002|Post Week 12|Withdrawal by Subject|0|||
146825929|NCT00550446|529533942|FG003|Post Week 12|Withdrawal by Subject|0|||
146825930|NCT00550446|529533943|FG004|Post Week 12|Withdrawal by Subject|1|||
146825931|NCT00550446|529533944|FG005|Post Week 12|Withdrawal by Subject|0|||
146825932|NCT00550446|529533945|FG006|Post Week 12|Withdrawal by Subject|0|||
146825933|NCT00550446|529533946|FG007|Post Week 12|Withdrawal by Subject|0|||
146825934|NCT00550446|529533947|FG008|Post Week 12|Withdrawal by Subject|0|||
146825935|NCT00550446|529533948|FG009|Post Week 12|Withdrawal by Subject|0|||
146825936|NCT00550446|529533949|FG010|Post Week 12|Withdrawal by Subject|0|||
146825937|NCT00550446|529533939|FG000|Post Week 12|Other|1|||
146825938|NCT00550446|529533940|FG001|Post Week 12|Other|1|||
146825939|NCT00550446|529533941|FG002|Post Week 12|Other|0|||
146825940|NCT00550446|529533942|FG003|Post Week 12|Other|1|||
146825941|NCT00550446|529533943|FG004|Post Week 12|Other|0|||
146825942|NCT00550446|529533944|FG005|Post Week 12|Other|0|||
146825943|NCT00550446|529533945|FG006|Post Week 12|Other|1|||
146825944|NCT00550446|529533946|FG007|Post Week 12|Other|0|||
146825945|NCT00550446|529533947|FG008|Post Week 12|Other|1|||
146825946|NCT00550446|529533948|FG009|Post Week 12|Other|1|||
146825947|NCT00550446|529533949|FG010|Post Week 12|Other|0|||
146825948|NCT02246218|529533950|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146825949|NCT02246218|529533951|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146825950|NCT02246218|529533950|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
146825951|NCT02246218|529533951|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
146825952|NCT02246218|529533950|FG000|Overall Study|Adverse Event|1|||
146825953|NCT02246218|529533951|FG001|Overall Study|Adverse Event|1|||
146825954|NCT02246218|529533950|FG000|Overall Study|Lost to Follow-up|1|||
146825955|NCT02246218|529533951|FG001|Overall Study|Lost to Follow-up|0|||
146955704|NCT02500901|529996452|FG000|Overall Study|Disease ProgressionDD|2|||
146955705|NCT00656136|529996453|FG000|Overall Study|Progressive disease|177|||
146955706|NCT00656136|529996454|FG001|Overall Study|Progressive disease|322|||
146955707|NCT00656136|529996453|FG000|Overall Study|Other Adverse Event|5|||
146955708|NCT00656136|529996454|FG001|Overall Study|Other Adverse Event|51|||
146825956|NCT01321723|529533952|FG000|Overall Study|Adverse Event|3|||
146825957|NCT01321723|529533953|FG001|Overall Study|Adverse Event|5|||
146825958|NCT01321723|529533954|FG002|Overall Study|Adverse Event|2|||
146825959|NCT01321723|529533952|FG000|Overall Study|Withdrawal by Subject|2|||
146825960|NCT01321723|529533953|FG001|Overall Study|Withdrawal by Subject|0|||
146825961|NCT01321723|529533954|FG002|Overall Study|Withdrawal by Subject|2|||
146825962|NCT04081389|529533956|FG000|Overall Study|Withdrawal by Subject|0|||
146825963|NCT04081389|529533957|FG001|Overall Study|Withdrawal by Subject|0|||
146825964|NCT04081389|529533958|FG002|Overall Study|Withdrawal by Subject|1|||
146825965|NCT04081389|529533959|FG003|Overall Study|Withdrawal by Subject|0|||
146825966|NCT00827775|529533965|FG000|Overall Study|Withdrawal by Subject|0|||
146955709|NCT00656136|529996453|FG000|Overall Study|Protocol Violation|2|||
146825967|NCT00827775|529533966|FG001|Overall Study|Withdrawal by Subject|5|||
146825968|NCT01670188|529533970|FG000|Overall Study|Death|0|||
146825969|NCT01670188|529533971|FG001|Overall Study|Death|1|||
146825970|NCT00866918|529533972|FG000|Overall Study|Death|1|||
146825971|NCT00866918|529533973|FG001|Overall Study|Death|5|||
146825972|NCT00866918|529533972|FG000|Overall Study|Lack of Efficacy|1|||
146825973|NCT00866918|529533973|FG001|Overall Study|Lack of Efficacy|1|||
146825974|NCT00866918|529533972|FG000|Overall Study|Physician Decision|10|||
146825975|NCT00866918|529533973|FG001|Overall Study|Physician Decision|2|||
146825976|NCT00866918|529533972|FG000|Overall Study|Ineligible|2|||
146825977|NCT00866918|529533973|FG001|Overall Study|Ineligible|4|||
146825978|NCT00866918|529533972|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
146825979|NCT00866918|529533973|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
146825980|NCT00866918|529533972|FG000|Overall Study|Secondary malignancy|1|||
146825981|NCT00866918|529533973|FG001|Overall Study|Secondary malignancy|0|||
146825982|NCT00802438|529533974|FG000|Overall Study|Screen Failure|20|||
146825983|NCT00802438|529533974|FG000|Overall Study|Withdrawal by Subject|7|||
146825984|NCT00802438|529533974|FG000|Overall Study|Physician Decision|1|||
146825985|NCT02101268|529533977|FG000|Randomized Treatment Phase|Subject Decision|8|||
146825986|NCT02101268|529533978|FG001|Randomized Treatment Phase|Subject Decision|4|||
146825987|NCT02101268|529533979|FG002|Randomized Treatment Phase|Subject Decision|0|||
146825988|NCT02101268|529533980|FG003|Randomized Treatment Phase|Subject Decision|0|||
146825989|NCT02101268|529533977|FG000|Randomized Treatment Phase|Physician Decision|4|||
146825990|NCT02101268|529533978|FG001|Randomized Treatment Phase|Physician Decision|1|||
146825991|NCT02101268|529533979|FG002|Randomized Treatment Phase|Physician Decision|0|||
146825992|NCT02101268|529533980|FG003|Randomized Treatment Phase|Physician Decision|0|||
146825993|NCT02101268|529533977|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
146825994|NCT02101268|529533978|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
146825995|NCT02101268|529533979|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
146825996|NCT02101268|529533980|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
146825997|NCT02101268|529533977|FG000|Randomized Treatment Phase|Adverse Event|6|||
146825998|NCT02101268|529533978|FG001|Randomized Treatment Phase|Adverse Event|0|||
146825999|NCT02101268|529533979|FG002|Randomized Treatment Phase|Adverse Event|0|||
146826000|NCT02101268|529533980|FG003|Randomized Treatment Phase|Adverse Event|0|||
146826001|NCT02101268|529533977|FG000|Randomized Treatment Phase|Death|5|||
146826002|NCT02101268|529533978|FG001|Randomized Treatment Phase|Death|4|||
146826003|NCT02101268|529533979|FG002|Randomized Treatment Phase|Death|0|||
146826004|NCT02101268|529533980|FG003|Randomized Treatment Phase|Death|0|||
146826005|NCT02101268|529533977|FG000|Randomized Treatment Phase|Disease Progression|4|||
146826006|NCT02101268|529533978|FG001|Randomized Treatment Phase|Disease Progression|1|||
146826007|NCT02101268|529533979|FG002|Randomized Treatment Phase|Disease Progression|0|||
146826008|NCT02101268|529533980|FG003|Randomized Treatment Phase|Disease Progression|0|||
146826009|NCT02101268|529533977|FG000|Extended Treatment Phase|Subject Decision|0|||
146826010|NCT02101268|529533978|FG001|Extended Treatment Phase|Subject Decision|0|||
146826011|NCT02101268|529533979|FG002|Extended Treatment Phase|Subject Decision|3|||
146826012|NCT02101268|529533980|FG003|Extended Treatment Phase|Subject Decision|2|||
146826013|NCT02101268|529533977|FG000|Extended Treatment Phase|Physician Decision|0|||
146826014|NCT02101268|529533978|FG001|Extended Treatment Phase|Physician Decision|0|||
146826015|NCT02101268|529533979|FG002|Extended Treatment Phase|Physician Decision|5|||
146826016|NCT02101268|529533980|FG003|Extended Treatment Phase|Physician Decision|2|||
146826017|NCT02101268|529533977|FG000|Extended Treatment Phase|Adverse Event|0|||
146826018|NCT02101268|529533978|FG001|Extended Treatment Phase|Adverse Event|0|||
146826019|NCT02101268|529533979|FG002|Extended Treatment Phase|Adverse Event|14|||
146826020|NCT02101268|529533980|FG003|Extended Treatment Phase|Adverse Event|18|||
146826021|NCT02101268|529533977|FG000|Extended Treatment Phase|Death|0|||
146826022|NCT02101268|529533978|FG001|Extended Treatment Phase|Death|0|||
146826023|NCT02101268|529533979|FG002|Extended Treatment Phase|Death|5|||
146826024|NCT02101268|529533980|FG003|Extended Treatment Phase|Death|1|||
146826025|NCT02101268|529533977|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
146826026|NCT02101268|529533978|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
146826027|NCT02101268|529533979|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
146826028|NCT02101268|529533980|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
146826029|NCT02101268|529533977|FG000|Extended Treatment Phase|Disease Progression|0|||
146826030|NCT02101268|529533978|FG001|Extended Treatment Phase|Disease Progression|0|||
146955710|NCT00656136|529996454|FG001|Overall Study|Protocol Violation|3|||
146955711|NCT00656136|529996453|FG000|Overall Study|Patient refused to take study medication|7|||
146955712|NCT00656136|529996454|FG001|Overall Study|Patient refused to take study medication|10|||
146826031|NCT02101268|529533979|FG002|Extended Treatment Phase|Disease Progression|13|||
146826032|NCT02101268|529533980|FG003|Extended Treatment Phase|Disease Progression|6|||
146826033|NCT02101268|529533977|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
146955713|NCT00656136|529996453|FG000|Overall Study|Unknown and others|4|||
146955714|NCT00656136|529996454|FG001|Overall Study|Unknown and others|4|||
146955715|NCT01345162|529996460|FG000|Overall Study|Protocol Violation|2|||
146826034|NCT02101268|529533978|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
146955716|NCT01345162|529996461|FG001|Overall Study|Protocol Violation|4|||
146955717|NCT02242305|529996462|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
146826035|NCT02101268|529533979|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
146955718|NCT02242305|529996463|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
146955719|NCT02242305|529996462|FG000|Overall Study|Adverse Event|1|||
146955720|NCT02242305|529996463|FG001|Overall Study|Adverse Event|0|||
146955721|NCT02242305|529996462|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
146955722|NCT02242305|529996463|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
146955723|NCT02242305|529996462|FG000|Overall Study|Subject withdraws inform consent|0|||
146955724|NCT02242305|529996463|FG001|Overall Study|Subject withdraws inform consent|4|||
146955725|NCT02242305|529996462|FG000|Overall Study|Lost to Follow-up|2|||
146955726|NCT02242305|529996463|FG001|Overall Study|Lost to Follow-up|0|||
146955727|NCT03018028|529996467|FG000|Overall Study|Withdrawal by Subject|3|||
146955728|NCT03018028|529996468|FG001|Overall Study|Withdrawal by Subject|0|||
146955729|NCT03018028|529996469|FG002|Overall Study|Withdrawal by Subject|1|||
146955730|NCT03018028|529996470|FG003|Overall Study|Withdrawal by Subject|2|||
146955731|NCT03018028|529996471|FG004|Overall Study|Withdrawal by Subject|0|||
146955732|NCT03323385|529996485|FG000|Overall Study|Withdrawal by Subject|1|||
146955733|NCT03323385|529996486|FG001|Overall Study|Withdrawal by Subject|2|||
146955734|NCT03323385|529996485|FG000|Overall Study|Noncompliance|0|||
146955735|NCT03323385|529996486|FG001|Overall Study|Noncompliance|1|||
146955736|NCT00699582|529996487|FG000|Overall Study|Adverse Event|4|||
146955737|NCT00699582|529996488|FG001|Overall Study|Adverse Event|11|||
146955738|NCT00699582|529996489|FG002|Overall Study|Adverse Event|23|||
146955739|NCT00699582|529996487|FG000|Overall Study|Withdrawal by Subject|6|||
146955740|NCT00699582|529996488|FG001|Overall Study|Withdrawal by Subject|7|||
146955741|NCT00699582|529996489|FG002|Overall Study|Withdrawal by Subject|4|||
146955742|NCT00699582|529996487|FG000|Overall Study|Lack of Efficacy|1|||
146955743|NCT00699582|529996488|FG001|Overall Study|Lack of Efficacy|0|||
146955744|NCT00699582|529996489|FG002|Overall Study|Lack of Efficacy|1|||
146955745|NCT00699582|529996487|FG000|Overall Study|Progressive Disease|1|||
146955746|NCT00699582|529996488|FG001|Overall Study|Progressive Disease|0|||
146955747|NCT00699582|529996489|FG002|Overall Study|Progressive Disease|0|||
146955748|NCT00699582|529996487|FG000|Overall Study|Administrative/Other|4|||
146955749|NCT00699582|529996488|FG001|Overall Study|Administrative/Other|3|||
146955750|NCT00699582|529996489|FG002|Overall Study|Administrative/Other|0|||
146955751|NCT00699582|529996487|FG000|Overall Study|Randomized, Not Treated|2|||
146955752|NCT00699582|529996488|FG001|Overall Study|Randomized, Not Treated|1|||
146955753|NCT00699582|529996489|FG002|Overall Study|Randomized, Not Treated|0|||
146955754|NCT03099304|529996495|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
146955755|NCT03099304|529996496|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
146955756|NCT03099304|529996497|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
146955757|NCT03099304|529996498|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
146955758|NCT03099304|529996499|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
146955759|NCT03099304|529996500|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
146955760|NCT03099304|529996495|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
146955761|NCT03099304|529996496|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
146955762|NCT03099304|529996497|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
146955763|NCT03099304|529996498|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
146955764|NCT03099304|529996499|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
146955765|NCT03099304|529996500|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
146955766|NCT03099304|529996495|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
146955767|NCT03099304|529996496|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
146955768|NCT03099304|529996497|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
146955769|NCT03099304|529996498|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
146955770|NCT03099304|529996499|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
146955771|NCT03099304|529996500|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
146955772|NCT03099304|529996495|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
146955773|NCT03099304|529996496|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
146955774|NCT03099304|529996497|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
146955775|NCT03099304|529996498|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
146955776|NCT03099304|529996499|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
146955777|NCT03099304|529996500|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
146955778|NCT03099304|529996495|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
146955779|NCT03099304|529996496|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
146955780|NCT03099304|529996497|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
146955781|NCT03099304|529996498|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
146955782|NCT03099304|529996499|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
146955783|NCT03099304|529996500|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
146955784|NCT03099304|529996495|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
146955785|NCT03099304|529996496|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
146955786|NCT03099304|529996497|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
146955787|NCT03099304|529996498|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
146955788|NCT03099304|529996499|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
146955789|NCT03099304|529996500|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
146955790|NCT03099304|529996495|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
146955791|NCT03099304|529996496|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
146955792|NCT03099304|529996497|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
146955793|NCT03099304|529996498|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
146955794|NCT03099304|529996499|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
146955795|NCT03099304|529996500|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
146955796|NCT03099304|529996495|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
146955797|NCT03099304|529996496|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
146955798|NCT03099304|529996497|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
146955799|NCT03099304|529996498|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
146955800|NCT03099304|529996499|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
146955801|NCT03099304|529996500|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
146955802|NCT03099304|529996495|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
146955803|NCT03099304|529996496|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
146955804|NCT03099304|529996497|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
146955805|NCT03099304|529996498|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
146955806|NCT03099304|529996499|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
146955807|NCT03099304|529996500|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
146955808|NCT03099304|529996495|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
146955809|NCT03099304|529996496|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
146955810|NCT03099304|529996497|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
146955811|NCT03099304|529996498|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
146955812|NCT03099304|529996499|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
146955813|NCT03099304|529996500|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
146955814|NCT03099304|529996495|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
146955815|NCT03099304|529996496|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
146955816|NCT03099304|529996497|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
146955817|NCT03099304|529996498|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
146955818|NCT03099304|529996499|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
146955819|NCT03099304|529996500|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
146955820|NCT03099304|529996495|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
146955821|NCT03099304|529996496|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
146955822|NCT03099304|529996497|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
146955823|NCT03099304|529996498|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
146955824|NCT03099304|529996499|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
146955825|NCT03099304|529996500|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
146955826|NCT03099304|529996495|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
146955827|NCT03099304|529996496|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
146955828|NCT03099304|529996497|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
146955829|NCT03099304|529996498|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
146955830|NCT03099304|529996499|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
146955831|NCT03099304|529996500|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
146955832|NCT03099304|529996495|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
146955833|NCT03099304|529996496|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
146955834|NCT03099304|529996497|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
146955835|NCT03099304|529996498|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
146955836|NCT03099304|529996499|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
146955837|NCT03099304|529996500|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
146955838|NCT03099304|529996495|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
146955839|NCT03099304|529996496|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
146955840|NCT03099304|529996497|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
146955841|NCT03099304|529996498|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
146955842|NCT03099304|529996499|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
146955843|NCT03099304|529996500|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
146955844|NCT03099304|529996495|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
146955845|NCT03099304|529996496|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
146985203|NCT02843074|530107211|FG000|Overall Study|Progressive disease|1|||
146826036|NCT02101268|529533980|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
146826037|NCT00819013|529533981|FG000|Overall Study|Not meeting continuing study eligibility|2|||
146955846|NCT03099304|529996497|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
146955847|NCT03099304|529996498|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
146955848|NCT03099304|529996499|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
146955849|NCT03099304|529996500|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
146955850|NCT03099304|529996495|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
146955851|NCT03099304|529996496|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
146955852|NCT03099304|529996497|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
146826038|NCT00819013|529533982|FG001|Overall Study|Not meeting continuing study eligibility|1|||
146826039|NCT00819013|529533983|FG002|Overall Study|Not meeting continuing study eligibility|2|||
146826040|NCT00819013|529533984|FG003|Overall Study|Not meeting continuing study eligibility|1|||
146826041|NCT00819013|529533981|FG000|Overall Study|Adverse Event|0|||
146826042|NCT00819013|529533982|FG001|Overall Study|Adverse Event|0|||
146826043|NCT00819013|529533983|FG002|Overall Study|Adverse Event|1|||
146826044|NCT00819013|529533984|FG003|Overall Study|Adverse Event|0|||
146826045|NCT00819013|529533981|FG000|Overall Study|Withdrawal by Subject|1|||
146826046|NCT00819013|529533982|FG001|Overall Study|Withdrawal by Subject|0|||
146826047|NCT00819013|529533983|FG002|Overall Study|Withdrawal by Subject|1|||
146826048|NCT00819013|529533984|FG003|Overall Study|Withdrawal by Subject|0|||
146826049|NCT00819013|529533981|FG000|Overall Study|Lost to Follow-up|0|||
146826050|NCT00819013|529533982|FG001|Overall Study|Lost to Follow-up|0|||
146826051|NCT00819013|529533983|FG002|Overall Study|Lost to Follow-up|1|||
146826052|NCT00819013|529533984|FG003|Overall Study|Lost to Follow-up|2|||
146826053|NCT00819013|529533981|FG000|Overall Study|Death|0|||
146826054|NCT00819013|529533982|FG001|Overall Study|Death|0|||
146826055|NCT00819013|529533983|FG002|Overall Study|Death|0|||
146826056|NCT00819013|529533984|FG003|Overall Study|Death|1|||
146826057|NCT00839332|529533989|FG000|Phase 1|Disease Progression|38|||
146826058|NCT00839332|529533990|FG001|Phase 1|Disease Progression|0|||
146826059|NCT00839332|529533991|FG002|Phase 1|Disease Progression|0|||
146826060|NCT00839332|529533989|FG000|Phase 1|Adverse Event|6|||
146826061|NCT00839332|529533990|FG001|Phase 1|Adverse Event|0|||
146826062|NCT00839332|529533991|FG002|Phase 1|Adverse Event|0|||
146826063|NCT00839332|529533989|FG000|Phase 1|Withdrawal by Subject|4|||
146826064|NCT00839332|529533990|FG001|Phase 1|Withdrawal by Subject|0|||
146826065|NCT00839332|529533991|FG002|Phase 1|Withdrawal by Subject|0|||
146826066|NCT00839332|529533989|FG000|Phase 1|Physician Decision|2|||
146826067|NCT00839332|529533990|FG001|Phase 1|Physician Decision|0|||
146826068|NCT00839332|529533991|FG002|Phase 1|Physician Decision|0|||
146826069|NCT00839332|529533989|FG000|Phase 2|Protocol Violation|0|||
146826070|NCT00839332|529533990|FG001|Phase 2|Protocol Violation|1|||
146826071|NCT00839332|529533991|FG002|Phase 2|Protocol Violation|0|||
146826072|NCT00839332|529533989|FG000|Phase 2|Disease Progression|0|||
146826073|NCT00839332|529533990|FG001|Phase 2|Disease Progression|46|||
146826074|NCT00839332|529533991|FG002|Phase 2|Disease Progression|21|||
146826075|NCT00839332|529533989|FG000|Phase 2|Adverse Event|0|||
146826076|NCT00839332|529533990|FG001|Phase 2|Adverse Event|8|||
146826077|NCT00839332|529533991|FG002|Phase 2|Adverse Event|6|||
146826078|NCT00839332|529533989|FG000|Phase 2|Death|0|||
146826079|NCT00839332|529533990|FG001|Phase 2|Death|4|||
146826080|NCT00839332|529533991|FG002|Phase 2|Death|2|||
146826081|NCT00839332|529533989|FG000|Phase 2|Withdrawal by Subject|0|||
146826082|NCT00839332|529533990|FG001|Phase 2|Withdrawal by Subject|5|||
146826083|NCT00839332|529533991|FG002|Phase 2|Withdrawal by Subject|8|||
146826084|NCT00839332|529533989|FG000|Phase 2|Physician Decision|0|||
146826085|NCT00839332|529533990|FG001|Phase 2|Physician Decision|4|||
146826086|NCT00839332|529533991|FG002|Phase 2|Physician Decision|1|||
146826087|NCT00839332|529533989|FG000|Phase 2|Lost to Follow-up|0|||
146826088|NCT00839332|529533990|FG001|Phase 2|Lost to Follow-up|0|||
146826089|NCT00839332|529533991|FG002|Phase 2|Lost to Follow-up|1|||
146826090|NCT01200485|529533992|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
146826091|NCT01200485|529533993|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
146826092|NCT01200485|529533994|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
146826093|NCT01200485|529533992|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
146826094|NCT01200485|529533993|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
146826095|NCT01200485|529533994|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
146826096|NCT06080438|529533995|FG000|Overall Study|Lost to Follow-up|2|||
146955853|NCT03099304|529996498|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
146955854|NCT03099304|529996499|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
146955855|NCT03099304|529996500|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
146955856|NCT02692560|529996501|FG000|Overall Study|Withdrawal by Subject|0|||
146955857|NCT02692560|529996502|FG001|Overall Study|Withdrawal by Subject|6|||
146955858|NCT00715949|529996505|FG000|Overall Study|could not finish first test|4|||
146826097|NCT03589300|529533997|FG000|Overall Study|Adverse Event|2|||
146826098|NCT03589300|529533997|FG000|Overall Study|Death|4|||
146826099|NCT03589300|529533997|FG000|Overall Study|Lost to Follow-up|12|||
146826100|NCT03589300|529533997|FG000|Overall Study|Withdrawal by Subject|5|||
146826101|NCT01678898|529534000|FG000|PB-102-F01|Adverse Event|0|||
146826102|NCT01678898|529534001|FG001|PB-102-F01|Adverse Event|1|||
146826103|NCT01678898|529534002|FG002|PB-102-F01|Adverse Event|0|||
146826104|NCT01678898|529534000|FG000|PB-102-F01|Physician Decision|0|||
146826105|NCT01678898|529534001|FG001|PB-102-F01|Physician Decision|1|||
146826106|NCT01678898|529534002|FG002|PB-102-F01|Physician Decision|0|||
146826107|NCT00776984|529534003|FG000|Overall Study|Adverse Event|8|||
146826108|NCT00776984|529534004|FG001|Overall Study|Adverse Event|2|||
146826109|NCT00776984|529534003|FG000|Overall Study|Protocol Violation|4|||
146826110|NCT00776984|529534004|FG001|Overall Study|Protocol Violation|2|||
146826111|NCT00776984|529534003|FG000|Overall Study|Lost to Follow-up|2|||
146826112|NCT00776984|529534004|FG001|Overall Study|Lost to Follow-up|0|||
146826113|NCT00776984|529534003|FG000|Overall Study|Withdrawal by Subject|12|||
146826114|NCT00776984|529534004|FG001|Overall Study|Withdrawal by Subject|7|||
146826115|NCT00776984|529534003|FG000|Overall Study|Lack of Efficacy|0|||
146826116|NCT00776984|529534004|FG001|Overall Study|Lack of Efficacy|1|||
146826117|NCT00776984|529534003|FG000|Overall Study|Other|5|||
146826118|NCT00776984|529534004|FG001|Overall Study|Other|9|||
146826119|NCT03030599|529534005|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
146826120|NCT03030599|529534006|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
146826121|NCT03030599|529534007|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
146826122|NCT03030599|529534005|FG000|Open Label Treatment and Titration|Other|1|||
146826123|NCT03030599|529534006|FG001|Open Label Treatment and Titration|Other|0|||
146826124|NCT03030599|529534007|FG002|Open Label Treatment and Titration|Other|0|||
146826125|NCT03030599|529534005|FG000|Open Label Treatment and Titration|Physician Decision|3|||
146826126|NCT03030599|529534006|FG001|Open Label Treatment and Titration|Physician Decision|0|||
146826127|NCT03030599|529534007|FG002|Open Label Treatment and Titration|Physician Decision|0|||
146826128|NCT03030599|529534005|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
146826129|NCT03030599|529534006|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
146826130|NCT03030599|529534007|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
146826131|NCT03030599|529534005|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
146826132|NCT03030599|529534006|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
146826133|NCT03030599|529534007|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
146826134|NCT03030599|529534005|FG000|Open Label Treatment and Titration|Adverse Event|18|||
146826135|NCT03030599|529534006|FG001|Open Label Treatment and Titration|Adverse Event|0|||
146826136|NCT03030599|529534007|FG002|Open Label Treatment and Titration|Adverse Event|0|||
146826137|NCT03030599|529534005|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
146826138|NCT03030599|529534006|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
146826139|NCT03030599|529534007|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
146826140|NCT03030599|529534005|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
146826141|NCT03030599|529534006|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
146826142|NCT03030599|529534007|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
146826143|NCT03030599|529534005|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
146826144|NCT03030599|529534006|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
146826145|NCT03030599|529534007|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
146826146|NCT03030599|529534005|FG000|Stable Dose|Protocol deviation|3|||
146826147|NCT03030599|529534006|FG001|Stable Dose|Protocol deviation|0|||
146826148|NCT03030599|529534007|FG002|Stable Dose|Protocol deviation|0|||
146826149|NCT03030599|529534005|FG000|Stable Dose|Adverse Event|1|||
146826150|NCT03030599|529534006|FG001|Stable Dose|Adverse Event|0|||
146826151|NCT03030599|529534007|FG002|Stable Dose|Adverse Event|0|||
146826152|NCT03030599|529534005|FG000|Stable Dose|Lost to Follow-up|1|||
146826153|NCT03030599|529534006|FG001|Stable Dose|Lost to Follow-up|0|||
146826154|NCT03030599|529534007|FG002|Stable Dose|Lost to Follow-up|0|||
146826155|NCT03030599|529534005|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
146826156|NCT03030599|529534006|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
146826157|NCT03030599|529534007|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
146826158|NCT03030599|529534005|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
146826159|NCT03030599|529534006|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
146826160|NCT03030599|529534007|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
146826161|NCT03030599|529534005|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
146826162|NCT03030599|529534006|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
146826163|NCT03030599|529534007|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
146826164|NCT03030599|529534005|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
146826165|NCT03030599|529534006|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
146826166|NCT03030599|529534007|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
146826167|NCT03030599|529534005|FG000|Open-label Extension|Adverse Event|3|||
146826168|NCT03030599|529534006|FG001|Open-label Extension|Adverse Event|0|||
146826169|NCT03030599|529534007|FG002|Open-label Extension|Adverse Event|0|||
146826170|NCT03030599|529534005|FG000|Open-label Extension|Lost to Follow-up|2|||
146826171|NCT03030599|529534006|FG001|Open-label Extension|Lost to Follow-up|0|||
146955859|NCT00420212|529996506|FG000|Overall Study|Adverse Event|22|||
146955860|NCT00420212|529996507|FG001|Overall Study|Adverse Event|40|||
146955861|NCT00420212|529996508|FG002|Overall Study|Adverse Event|36|||
146955862|NCT00420212|529996506|FG000|Overall Study|Lost to Follow-up|9|||
146826172|NCT03030599|529534007|FG002|Open-label Extension|Lost to Follow-up|0|||
146826173|NCT03030599|529534005|FG000|Open-label Extension|Lack of Efficacy|1|||
146955863|NCT00420212|529996507|FG001|Overall Study|Lost to Follow-up|11|||
146826174|NCT03030599|529534006|FG001|Open-label Extension|Lack of Efficacy|0|||
146826175|NCT03030599|529534007|FG002|Open-label Extension|Lack of Efficacy|0|||
146826176|NCT03030599|529534005|FG000|Open-label Extension|Other Reason|1|||
146826177|NCT03030599|529534006|FG001|Open-label Extension|Other Reason|0|||
146826178|NCT03030599|529534007|FG002|Open-label Extension|Other Reason|0|||
146826179|NCT00230971|529534009|FG000|Randomization|No study drug administered|3|||
146955864|NCT00420212|529996508|FG002|Overall Study|Lost to Follow-up|11|||
146955865|NCT00420212|529996506|FG000|Overall Study|Withdrawal by Subject|31|||
146826180|NCT00230971|529534010|FG001|Randomization|No study drug administered|3|||
146826181|NCT00230971|529534009|FG000|Baseline Participants|Lost to Follow-up|5|||
146826182|NCT00230971|529534010|FG001|Baseline Participants|Lost to Follow-up|12|||
146826183|NCT00230971|529534009|FG000|Baseline Participants|Death|6|||
146826184|NCT00230971|529534010|FG001|Baseline Participants|Death|5|||
146826185|NCT00230971|529534009|FG000|Baseline Participants|Withdrawal by Subject|7|||
146826186|NCT00230971|529534010|FG001|Baseline Participants|Withdrawal by Subject|1|||
146826187|NCT00230971|529534009|FG000|Baseline Participants|Adverse Event|1|||
146826188|NCT00230971|529534010|FG001|Baseline Participants|Adverse Event|0|||
146826189|NCT00230971|529534009|FG000|Baseline Participants|No bacteria observed|1|||
146826190|NCT00230971|529534010|FG001|Baseline Participants|No bacteria observed|0|||
146826191|NCT00230971|529534009|FG000|Baseline Participants|Failure to return|1|||
146826192|NCT00230971|529534010|FG001|Baseline Participants|Failure to return|1|||
146826193|NCT00230971|529534009|FG000|Baseline Participants|Reintervention|1|||
146826194|NCT00230971|529534010|FG001|Baseline Participants|Reintervention|0|||
146826195|NCT04380688|529534011|FG000|Overall Study|Death|2|||
146826196|NCT04380688|529534012|FG001|Overall Study|Death|2|||
146826197|NCT04380688|529534011|FG000|Overall Study|Lost to Follow-up|2|||
146826198|NCT04380688|529534012|FG001|Overall Study|Lost to Follow-up|4|||
146826199|NCT04380688|529534011|FG000|Overall Study|Withdrawal by Subject|3|||
146826200|NCT04380688|529534012|FG001|Overall Study|Withdrawal by Subject|3|||
146826201|NCT05294328|529534018|FG000|Overall Study|Adverse Event|1|||
146826202|NCT05294328|529534019|FG001|Overall Study|Adverse Event|0|||
146826203|NCT05294328|529534020|FG002|Overall Study|Adverse Event|0|||
146826204|NCT05294328|529534018|FG000|Overall Study|Physician Decision|1|||
146826205|NCT05294328|529534019|FG001|Overall Study|Physician Decision|1|||
146826206|NCT05294328|529534020|FG002|Overall Study|Physician Decision|0|||
146826207|NCT05294328|529534018|FG000|Overall Study|Withdrawal by Subject|0|||
146826208|NCT05294328|529534019|FG001|Overall Study|Withdrawal by Subject|2|||
146826209|NCT05294328|529534020|FG002|Overall Study|Withdrawal by Subject|1|||
146826210|NCT05294328|529534018|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
146826211|NCT05294328|529534019|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
146826212|NCT05294328|529534020|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
146826213|NCT04267393|529534021|FG000|Randomization|Adverse Event|1|||
146826214|NCT04267393|529534022|FG001|Randomization|Adverse Event|0|||
146826215|NCT04267393|529534023|FG002|Randomization|Adverse Event|0|||
146826216|NCT04267393|529534021|FG000|Randomization|Administrative Reasons by Sponsor|0|||
146826217|NCT04267393|529534022|FG001|Randomization|Administrative Reasons by Sponsor|1|||
146826218|NCT04267393|529534023|FG002|Randomization|Administrative Reasons by Sponsor|0|||
146826219|NCT04267393|529534021|FG000|Treatment Period|Adverse Event|0|||
146826220|NCT04267393|529534022|FG001|Treatment Period|Adverse Event|2|||
146826221|NCT04267393|529534023|FG002|Treatment Period|Adverse Event|3|||
146826222|NCT04267393|529534021|FG000|Treatment Period|Participant Withdrew Consent|0|||
146826223|NCT04267393|529534022|FG001|Treatment Period|Participant Withdrew Consent|0|||
146826224|NCT04267393|529534023|FG002|Treatment Period|Participant Withdrew Consent|1|||
146826225|NCT04267393|529534021|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
146826226|NCT04267393|529534022|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
146826227|NCT04267393|529534023|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
146826228|NCT02056873|529534024|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
146826229|NCT00092521|529535584|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
146826230|NCT00092521|529535585|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
146826231|NCT00092521|529535586|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
146826232|NCT00092521|529535587|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
146826233|NCT00092521|529535584|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
146826234|NCT00092521|529535585|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
146826235|NCT00092521|529535586|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
146826236|NCT00092521|529535587|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
146826237|NCT00092521|529535584|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
146955866|NCT00420212|529996507|FG001|Overall Study|Withdrawal by Subject|22|||
146955867|NCT00420212|529996508|FG002|Overall Study|Withdrawal by Subject|19|||
146955868|NCT00420212|529996506|FG000|Overall Study|Physician Decision|4|||
146955869|NCT00420212|529996507|FG001|Overall Study|Physician Decision|4|||
146955870|NCT00420212|529996508|FG002|Overall Study|Physician Decision|3|||
146955871|NCT00420212|529996506|FG000|Overall Study|Protocol Violation|4|||
146826238|NCT00092521|529535585|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
146826239|NCT00092521|529535586|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
146826240|NCT00092521|529535587|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
146826241|NCT00092521|529535584|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
146826242|NCT00092521|529535585|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
146826243|NCT00092521|529535586|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
146826244|NCT00092521|529535587|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
146826245|NCT00092521|529535584|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
146826246|NCT00092521|529535585|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
146826247|NCT00092521|529535586|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
146826248|NCT00092521|529535587|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
146826249|NCT00092521|529535584|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
146826250|NCT00092521|529535585|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
146826251|NCT00092521|529535586|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
146826252|NCT00092521|529535587|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
146826253|NCT00092521|529535584|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
146826254|NCT00092521|529535585|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
146826255|NCT00092521|529535586|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
146826256|NCT00092521|529535587|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
146826257|NCT00092521|529535584|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
146826258|NCT00092521|529535585|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
146826259|NCT00092521|529535586|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
146826260|NCT00092521|529535587|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
146826261|NCT00092521|529535584|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
146826262|NCT00092521|529535585|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
146826263|NCT00092521|529535586|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
146826264|NCT00092521|529535587|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
146826265|NCT00092521|529535584|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
146826266|NCT00092521|529535585|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
146826267|NCT00092521|529535586|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
146826268|NCT00092521|529535587|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
146826269|NCT00092521|529535584|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
146826270|NCT00092521|529535585|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
146826271|NCT00092521|529535586|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
146826272|NCT00092521|529535587|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
146826273|NCT00092521|529535584|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
146826274|NCT00092521|529535585|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
146826275|NCT00092521|529535586|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
146826276|NCT00092521|529535587|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
146955872|NCT00420212|529996507|FG001|Overall Study|Protocol Violation|4|||
146955873|NCT00420212|529996508|FG002|Overall Study|Protocol Violation|8|||
146955874|NCT00420212|529996506|FG000|Overall Study|Death|0|||
146955875|NCT00420212|529996507|FG001|Overall Study|Death|0|||
146955876|NCT00420212|529996508|FG002|Overall Study|Death|1|||
146955877|NCT00420212|529996506|FG000|Overall Study|Other-Unspecified|21|||
146955878|NCT00420212|529996507|FG001|Overall Study|Other-Unspecified|14|||
146955879|NCT00420212|529996508|FG002|Overall Study|Other-Unspecified|18|||
146955880|NCT01326910|529996509|FG000|Overall Study|Withdrawal by Subject|3|||
146955881|NCT01326910|529996510|FG001|Overall Study|Withdrawal by Subject|2|||
146955882|NCT01326910|529996509|FG000|Overall Study|Protocol Violation|1|||
146955883|NCT01326910|529996510|FG001|Overall Study|Protocol Violation|1|||
146955884|NCT02274766|529996513|FG000|Overall Study|Withdrawal by Subject|3|||
146955885|NCT02274766|529996514|FG001|Overall Study|Withdrawal by Subject|6|||
146955886|NCT02274766|529996513|FG000|Overall Study|Did Not Receive Study Drug|1|||
146955887|NCT02274766|529996514|FG001|Overall Study|Did Not Receive Study Drug|1|||
146955888|NCT02274766|529996513|FG000|Overall Study|Subject Unwilling to Proceed|0|||
146955889|NCT02274766|529996514|FG001|Overall Study|Subject Unwilling to Proceed|1|||
146955890|NCT02274766|529996513|FG000|Overall Study|Adverse Event|0|||
146955891|NCT02274766|529996514|FG001|Overall Study|Adverse Event|1|||
146955892|NCT01681836|529996519|FG000|Second Intervention|Withdrawal by Subject|0|||
146955893|NCT01681836|529996520|FG001|Second Intervention|Withdrawal by Subject|1|||
146955894|NCT02394028|529996521|FG000|Induction Phase|Adverse Event|2|||
146955895|NCT02394028|529996522|FG001|Induction Phase|Adverse Event|4|||
146955896|NCT02394028|529996523|FG002|Induction Phase|Adverse Event|1|||
146955897|NCT02394028|529996524|FG003|Induction Phase|Adverse Event|2|||
146955898|NCT02394028|529996525|FG004|Induction Phase|Adverse Event|5|||
146955899|NCT02394028|529996526|FG005|Induction Phase|Adverse Event|2|||
146955900|NCT02394028|529996527|FG006|Induction Phase|Adverse Event|0|||
146955901|NCT02394028|529996528|FG007|Induction Phase|Adverse Event|0|||
146955902|NCT02394028|529996529|FG008|Induction Phase|Adverse Event|0|||
146955903|NCT02394028|529996530|FG009|Induction Phase|Adverse Event|0|||
146955904|NCT02394028|529996531|FG010|Induction Phase|Adverse Event|0|||
146955905|NCT02394028|529996521|FG000|Induction Phase|Lack of Efficacy|3|||
146955906|NCT02394028|529996522|FG001|Induction Phase|Lack of Efficacy|6|||
146955907|NCT02394028|529996523|FG002|Induction Phase|Lack of Efficacy|2|||
146955908|NCT02394028|529996524|FG003|Induction Phase|Lack of Efficacy|17|||
146955909|NCT02394028|529996525|FG004|Induction Phase|Lack of Efficacy|14|||
146955910|NCT02394028|529996526|FG005|Induction Phase|Lack of Efficacy|8|||
146826277|NCT00092521|529535584|FG000|Follow-Up (After Month 7)|Death|2|||
146826278|NCT00092521|529535585|FG001|Follow-Up (After Month 7)|Death|0|||
146826279|NCT00092521|529535586|FG002|Follow-Up (After Month 7)|Death|1|||
146955911|NCT02394028|529996527|FG006|Induction Phase|Lack of Efficacy|17|||
146955912|NCT02394028|529996528|FG007|Induction Phase|Lack of Efficacy|23|||
146955913|NCT02394028|529996529|FG008|Induction Phase|Lack of Efficacy|0|||
146955914|NCT02394028|529996530|FG009|Induction Phase|Lack of Efficacy|0|||
146955915|NCT02394028|529996531|FG010|Induction Phase|Lack of Efficacy|0|||
146955916|NCT02394028|529996521|FG000|Induction Phase|Lost to Follow-up|1|||
146955917|NCT02394028|529996522|FG001|Induction Phase|Lost to Follow-up|0|||
146955918|NCT02394028|529996523|FG002|Induction Phase|Lost to Follow-up|0|||
146955919|NCT02394028|529996524|FG003|Induction Phase|Lost to Follow-up|1|||
146955920|NCT02394028|529996525|FG004|Induction Phase|Lost to Follow-up|0|||
146955921|NCT02394028|529996526|FG005|Induction Phase|Lost to Follow-up|0|||
146955922|NCT02394028|529996527|FG006|Induction Phase|Lost to Follow-up|1|||
146955923|NCT02394028|529996528|FG007|Induction Phase|Lost to Follow-up|0|||
146955924|NCT02394028|529996529|FG008|Induction Phase|Lost to Follow-up|0|||
146955925|NCT02394028|529996530|FG009|Induction Phase|Lost to Follow-up|0|||
146955926|NCT02394028|529996531|FG010|Induction Phase|Lost to Follow-up|0|||
146955927|NCT02394028|529996521|FG000|Induction Phase|Non-compliance|0|||
146955928|NCT02394028|529996522|FG001|Induction Phase|Non-compliance|1|||
146955929|NCT02394028|529996523|FG002|Induction Phase|Non-compliance|3|||
146955930|NCT02394028|529996524|FG003|Induction Phase|Non-compliance|1|||
146955931|NCT02394028|529996525|FG004|Induction Phase|Non-compliance|3|||
146955932|NCT02394028|529996526|FG005|Induction Phase|Non-compliance|0|||
146955933|NCT02394028|529996527|FG006|Induction Phase|Non-compliance|1|||
146955934|NCT02394028|529996528|FG007|Induction Phase|Non-compliance|1|||
146955935|NCT02394028|529996529|FG008|Induction Phase|Non-compliance|0|||
146955936|NCT02394028|529996530|FG009|Induction Phase|Non-compliance|0|||
146955937|NCT02394028|529996531|FG010|Induction Phase|Non-compliance|0|||
146955938|NCT02394028|529996521|FG000|Induction Phase|Physician Decision|0|||
146955939|NCT02394028|529996522|FG001|Induction Phase|Physician Decision|0|||
146955940|NCT02394028|529996523|FG002|Induction Phase|Physician Decision|1|||
146955941|NCT02394028|529996524|FG003|Induction Phase|Physician Decision|4|||
146955942|NCT02394028|529996525|FG004|Induction Phase|Physician Decision|0|||
146955943|NCT02394028|529996526|FG005|Induction Phase|Physician Decision|2|||
146955944|NCT02394028|529996527|FG006|Induction Phase|Physician Decision|1|||
146955945|NCT02394028|529996528|FG007|Induction Phase|Physician Decision|0|||
146955946|NCT02394028|529996529|FG008|Induction Phase|Physician Decision|0|||
146955947|NCT02394028|529996530|FG009|Induction Phase|Physician Decision|0|||
146955948|NCT02394028|529996531|FG010|Induction Phase|Physician Decision|0|||
146955949|NCT02394028|529996521|FG000|Induction Phase|Protocol Violation|0|||
146955950|NCT02394028|529996522|FG001|Induction Phase|Protocol Violation|2|||
146955951|NCT02394028|529996523|FG002|Induction Phase|Protocol Violation|0|||
146955952|NCT02394028|529996524|FG003|Induction Phase|Protocol Violation|3|||
146955953|NCT02394028|529996525|FG004|Induction Phase|Protocol Violation|0|||
146955954|NCT02394028|529996526|FG005|Induction Phase|Protocol Violation|1|||
146955955|NCT02394028|529996527|FG006|Induction Phase|Protocol Violation|1|||
146955956|NCT02394028|529996528|FG007|Induction Phase|Protocol Violation|0|||
146955957|NCT02394028|529996529|FG008|Induction Phase|Protocol Violation|0|||
146955958|NCT02394028|529996530|FG009|Induction Phase|Protocol Violation|0|||
146955959|NCT02394028|529996531|FG010|Induction Phase|Protocol Violation|0|||
146955960|NCT02394028|529996521|FG000|Induction Phase|Withdrawal by Subject|1|||
146955961|NCT02394028|529996522|FG001|Induction Phase|Withdrawal by Subject|2|||
146955962|NCT02394028|529996523|FG002|Induction Phase|Withdrawal by Subject|4|||
146955963|NCT02394028|529996524|FG003|Induction Phase|Withdrawal by Subject|6|||
146955964|NCT02394028|529996525|FG004|Induction Phase|Withdrawal by Subject|7|||
146955965|NCT02394028|529996526|FG005|Induction Phase|Withdrawal by Subject|4|||
146955966|NCT02394028|529996527|FG006|Induction Phase|Withdrawal by Subject|3|||
146955967|NCT02394028|529996528|FG007|Induction Phase|Withdrawal by Subject|6|||
146955968|NCT02394028|529996529|FG008|Induction Phase|Withdrawal by Subject|0|||
146955969|NCT02394028|529996530|FG009|Induction Phase|Withdrawal by Subject|0|||
146955970|NCT02394028|529996531|FG010|Induction Phase|Withdrawal by Subject|0|||
146955971|NCT02394028|529996521|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
146955972|NCT02394028|529996522|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
146955973|NCT02394028|529996523|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
146955974|NCT02394028|529996524|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
146955975|NCT02394028|529996525|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
146955976|NCT02394028|529996526|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
146955977|NCT02394028|529996527|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
146955978|NCT02394028|529996528|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
146955979|NCT02394028|529996529|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
146955980|NCT02394028|529996530|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
146955981|NCT02394028|529996531|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
146955982|NCT02394028|529996521|FG000|Induction Phase|Sponsor decision|0|||
146955983|NCT02394028|529996522|FG001|Induction Phase|Sponsor decision|1|||
146955984|NCT02394028|529996523|FG002|Induction Phase|Sponsor decision|2|||
146955985|NCT02394028|529996524|FG003|Induction Phase|Sponsor decision|0|||
146955986|NCT02394028|529996525|FG004|Induction Phase|Sponsor decision|0|||
146955987|NCT02394028|529996526|FG005|Induction Phase|Sponsor decision|0|||
146955988|NCT02394028|529996527|FG006|Induction Phase|Sponsor decision|0|||
146955989|NCT02394028|529996528|FG007|Induction Phase|Sponsor decision|0|||
146955990|NCT02394028|529996529|FG008|Induction Phase|Sponsor decision|0|||
146955991|NCT02394028|529996530|FG009|Induction Phase|Sponsor decision|0|||
146955992|NCT02394028|529996531|FG010|Induction Phase|Sponsor decision|0|||
146955993|NCT02394028|529996521|FG000|Induction Phase|Technical reason|0|||
146955994|NCT02394028|529996522|FG001|Induction Phase|Technical reason|0|||
146955995|NCT02394028|529996523|FG002|Induction Phase|Technical reason|0|||
146955996|NCT02394028|529996524|FG003|Induction Phase|Technical reason|1|||
146955997|NCT02394028|529996525|FG004|Induction Phase|Technical reason|0|||
146955998|NCT02394028|529996526|FG005|Induction Phase|Technical reason|0|||
146955999|NCT02394028|529996527|FG006|Induction Phase|Technical reason|0|||
146956000|NCT02394028|529996528|FG007|Induction Phase|Technical reason|0|||
146956001|NCT02394028|529996529|FG008|Induction Phase|Technical reason|0|||
146956002|NCT02394028|529996530|FG009|Induction Phase|Technical reason|0|||
146956003|NCT02394028|529996531|FG010|Induction Phase|Technical reason|0|||
146956004|NCT02394028|529996521|FG000|Induction Phase|:ack of calculation|0|||
146956005|NCT02394028|529996522|FG001|Induction Phase|:ack of calculation|0|||
146956006|NCT02394028|529996523|FG002|Induction Phase|:ack of calculation|0|||
146956007|NCT02394028|529996524|FG003|Induction Phase|:ack of calculation|0|||
146956008|NCT02394028|529996525|FG004|Induction Phase|:ack of calculation|0|||
146956009|NCT02394028|529996526|FG005|Induction Phase|:ack of calculation|0|||
146956010|NCT02394028|529996527|FG006|Induction Phase|:ack of calculation|0|||
146956011|NCT02394028|529996528|FG007|Induction Phase|:ack of calculation|1|||
146956012|NCT02394028|529996529|FG008|Induction Phase|:ack of calculation|0|||
146956013|NCT02394028|529996530|FG009|Induction Phase|:ack of calculation|0|||
146956014|NCT02394028|529996531|FG010|Induction Phase|:ack of calculation|0|||
146956015|NCT02394028|529996521|FG000|Maintenance Phase|Protocol Violation|0|||
146956016|NCT02394028|529996522|FG001|Maintenance Phase|Protocol Violation|0|||
146956017|NCT02394028|529996523|FG002|Maintenance Phase|Protocol Violation|0|||
146956018|NCT02394028|529996524|FG003|Maintenance Phase|Protocol Violation|0|||
146956019|NCT02394028|529996525|FG004|Maintenance Phase|Protocol Violation|0|||
146956020|NCT02394028|529996526|FG005|Maintenance Phase|Protocol Violation|0|||
146956021|NCT02394028|529996527|FG006|Maintenance Phase|Protocol Violation|0|||
146956022|NCT02394028|529996528|FG007|Maintenance Phase|Protocol Violation|0|||
146956023|NCT02394028|529996529|FG008|Maintenance Phase|Protocol Violation|0|||
146956024|NCT02394028|529996530|FG009|Maintenance Phase|Protocol Violation|0|||
146956025|NCT02394028|529996531|FG010|Maintenance Phase|Protocol Violation|1|||
146956026|NCT02394028|529996521|FG000|Maintenance Phase|Physician Decision|0|||
146956027|NCT02394028|529996522|FG001|Maintenance Phase|Physician Decision|0|||
146956028|NCT02394028|529996523|FG002|Maintenance Phase|Physician Decision|0|||
146956029|NCT02394028|529996524|FG003|Maintenance Phase|Physician Decision|0|||
146956030|NCT02394028|529996525|FG004|Maintenance Phase|Physician Decision|0|||
146956031|NCT02394028|529996526|FG005|Maintenance Phase|Physician Decision|0|||
146956032|NCT02394028|529996527|FG006|Maintenance Phase|Physician Decision|0|||
146956033|NCT02394028|529996528|FG007|Maintenance Phase|Physician Decision|0|||
146956034|NCT02394028|529996529|FG008|Maintenance Phase|Physician Decision|1|||
146956035|NCT02394028|529996530|FG009|Maintenance Phase|Physician Decision|3|||
146956036|NCT02394028|529996531|FG010|Maintenance Phase|Physician Decision|2|||
146956037|NCT02394028|529996521|FG000|Maintenance Phase|Lack of Efficacy|0|||
146956038|NCT02394028|529996522|FG001|Maintenance Phase|Lack of Efficacy|0|||
146956039|NCT02394028|529996523|FG002|Maintenance Phase|Lack of Efficacy|0|||
146956040|NCT02394028|529996524|FG003|Maintenance Phase|Lack of Efficacy|0|||
146956041|NCT02394028|529996525|FG004|Maintenance Phase|Lack of Efficacy|0|||
146956042|NCT02394028|529996526|FG005|Maintenance Phase|Lack of Efficacy|0|||
146956043|NCT02394028|529996527|FG006|Maintenance Phase|Lack of Efficacy|0|||
146956044|NCT02394028|529996528|FG007|Maintenance Phase|Lack of Efficacy|0|||
146956045|NCT02394028|529996529|FG008|Maintenance Phase|Lack of Efficacy|7|||
146956046|NCT02394028|529996530|FG009|Maintenance Phase|Lack of Efficacy|25|||
146956047|NCT02394028|529996531|FG010|Maintenance Phase|Lack of Efficacy|33|||
146956048|NCT02394028|529996521|FG000|Maintenance Phase|Death|0|||
146956049|NCT02394028|529996522|FG001|Maintenance Phase|Death|0|||
146956050|NCT02394028|529996523|FG002|Maintenance Phase|Death|0|||
146956051|NCT02394028|529996524|FG003|Maintenance Phase|Death|0|||
146956052|NCT02394028|529996525|FG004|Maintenance Phase|Death|0|||
146956053|NCT02394028|529996526|FG005|Maintenance Phase|Death|0|||
146956054|NCT02394028|529996527|FG006|Maintenance Phase|Death|0|||
146956055|NCT02394028|529996528|FG007|Maintenance Phase|Death|0|||
146956056|NCT02394028|529996529|FG008|Maintenance Phase|Death|0|||
146956057|NCT02394028|529996530|FG009|Maintenance Phase|Death|0|||
146956058|NCT02394028|529996531|FG010|Maintenance Phase|Death|1|||
146956059|NCT02394028|529996521|FG000|Maintenance Phase|Adverse Event|0|||
146956060|NCT02394028|529996522|FG001|Maintenance Phase|Adverse Event|0|||
146956061|NCT02394028|529996523|FG002|Maintenance Phase|Adverse Event|0|||
146956062|NCT02394028|529996524|FG003|Maintenance Phase|Adverse Event|0|||
146956063|NCT02394028|529996525|FG004|Maintenance Phase|Adverse Event|0|||
146956064|NCT02394028|529996526|FG005|Maintenance Phase|Adverse Event|0|||
146956065|NCT02394028|529996527|FG006|Maintenance Phase|Adverse Event|0|||
146956066|NCT02394028|529996528|FG007|Maintenance Phase|Adverse Event|0|||
146956067|NCT02394028|529996529|FG008|Maintenance Phase|Adverse Event|1|||
146956068|NCT02394028|529996530|FG009|Maintenance Phase|Adverse Event|1|||
146956069|NCT02394028|529996531|FG010|Maintenance Phase|Adverse Event|3|||
146956070|NCT02394028|529996521|FG000|Maintenance Phase|Site closure|0|||
146956071|NCT02394028|529996522|FG001|Maintenance Phase|Site closure|0|||
146956072|NCT02394028|529996523|FG002|Maintenance Phase|Site closure|0|||
146956073|NCT02394028|529996524|FG003|Maintenance Phase|Site closure|0|||
146956074|NCT02394028|529996525|FG004|Maintenance Phase|Site closure|0|||
146956075|NCT02394028|529996526|FG005|Maintenance Phase|Site closure|0|||
146956076|NCT02394028|529996527|FG006|Maintenance Phase|Site closure|0|||
146956077|NCT02394028|529996528|FG007|Maintenance Phase|Site closure|0|||
146956078|NCT02394028|529996529|FG008|Maintenance Phase|Site closure|0|||
146956079|NCT02394028|529996530|FG009|Maintenance Phase|Site closure|1|||
146956080|NCT02394028|529996531|FG010|Maintenance Phase|Site closure|0|||
146956081|NCT02394028|529996521|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146956082|NCT02394028|529996522|FG001|Maintenance Phase|Withdrawal by Subject|0|||
146956083|NCT02394028|529996523|FG002|Maintenance Phase|Withdrawal by Subject|0|||
146956084|NCT02394028|529996524|FG003|Maintenance Phase|Withdrawal by Subject|0|||
146956085|NCT02394028|529996525|FG004|Maintenance Phase|Withdrawal by Subject|0|||
146956086|NCT02394028|529996526|FG005|Maintenance Phase|Withdrawal by Subject|0|||
146956087|NCT02394028|529996527|FG006|Maintenance Phase|Withdrawal by Subject|0|||
146956088|NCT02394028|529996528|FG007|Maintenance Phase|Withdrawal by Subject|0|||
146956089|NCT02394028|529996529|FG008|Maintenance Phase|Withdrawal by Subject|3|||
146956090|NCT02394028|529996530|FG009|Maintenance Phase|Withdrawal by Subject|12|||
146956091|NCT02394028|529996531|FG010|Maintenance Phase|Withdrawal by Subject|12|||
146956092|NCT00742391|529996532|FG000|Overall Study|Adverse Event|2|||
146956093|NCT00742391|529996533|FG001|Overall Study|Adverse Event|1|||
146956094|NCT00742391|529996532|FG000|Overall Study|Lost to Follow-up|1|||
146956095|NCT00742391|529996533|FG001|Overall Study|Lost to Follow-up|0|||
146956096|NCT00742391|529996532|FG000|Overall Study|Protocol Violation|1|||
146956097|NCT00742391|529996533|FG001|Overall Study|Protocol Violation|0|||
146956098|NCT04815291|529996548|FG000|Overall Study|Lost to Follow-up|1|||
146956099|NCT04815291|529996548|FG000|Overall Study|Physician Decision|4|||
146956100|NCT04815291|529996548|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
146956101|NCT00989664|529996551|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
146956102|NCT00989664|529996551|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
146956103|NCT00989664|529996551|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
146956104|NCT00989664|529996551|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
146956105|NCT00989664|529996551|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
146956106|NCT00989664|529996551|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
146956107|NCT00989664|529996551|FG000|Long-Term Follow-Up|Death|3|||
146956108|NCT01230827|529996553|FG000|Overall Study|Lost to Follow-up|0|||
146956109|NCT01230827|529996554|FG001|Overall Study|Lost to Follow-up|0|||
146956110|NCT01230827|529996555|FG002|Overall Study|Lost to Follow-up|1|||
146956111|NCT01230827|529996556|FG003|Overall Study|Lost to Follow-up|3|||
146956112|NCT01230827|529996553|FG000|Overall Study|Withdrawal by Subject|1|||
146956113|NCT01230827|529996554|FG001|Overall Study|Withdrawal by Subject|0|||
146956114|NCT01230827|529996555|FG002|Overall Study|Withdrawal by Subject|3|||
146956115|NCT01230827|529996556|FG003|Overall Study|Withdrawal by Subject|2|||
146956116|NCT01230827|529996553|FG000|Overall Study|Lack of Efficacy|14|||
146956117|NCT01230827|529996554|FG001|Overall Study|Lack of Efficacy|1|||
146956118|NCT01230827|529996555|FG002|Overall Study|Lack of Efficacy|2|||
146956119|NCT01230827|529996556|FG003|Overall Study|Lack of Efficacy|3|||
146956120|NCT01230827|529996553|FG000|Overall Study|Adverse Event|4|||
146956121|NCT01230827|529996554|FG001|Overall Study|Adverse Event|2|||
146956122|NCT01230827|529996555|FG002|Overall Study|Adverse Event|3|||
146956123|NCT01230827|529996556|FG003|Overall Study|Adverse Event|7|||
146956124|NCT01230827|529996553|FG000|Overall Study|Recovery|0|||
146956125|NCT01230827|529996554|FG001|Overall Study|Recovery|6|||
146956126|NCT01230827|529996555|FG002|Overall Study|Recovery|0|||
146956127|NCT01230827|529996556|FG003|Overall Study|Recovery|0|||
146956128|NCT01230827|529996553|FG000|Overall Study|Study terminated by Sponsor|0|||
146956129|NCT01230827|529996554|FG001|Overall Study|Study terminated by Sponsor|2|||
146956130|NCT01230827|529996555|FG002|Overall Study|Study terminated by Sponsor|56|||
146956131|NCT01230827|529996556|FG003|Overall Study|Study terminated by Sponsor|63|||
146956132|NCT01854918|529996557|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
146956133|NCT01854918|529996558|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
146956134|NCT01854918|529996557|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
146956135|NCT01854918|529996558|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
146956136|NCT01854918|529996557|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
146956137|NCT01854918|529996558|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
146956138|NCT01854918|529996557|FG000|SOC-controlled Period (Year 1)|Death|5|||
146956139|NCT01854918|529996558|FG001|SOC-controlled Period (Year 1)|Death|5|||
146956140|NCT01854918|529996557|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
146826280|NCT00092521|529535587|FG003|Follow-Up (After Month 7)|Death|0|||
146826281|NCT00092521|529535584|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
146826282|NCT00092521|529535585|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
146826283|NCT00092521|529535586|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
146826284|NCT00092521|529535587|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
146826285|NCT00092521|529535584|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
146826286|NCT00092521|529535585|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
146826287|NCT00092521|529535586|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
146826288|NCT00092521|529535587|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
146826289|NCT00092521|529535584|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
146956141|NCT01854918|529996558|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
146956142|NCT01854918|529996557|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
146956143|NCT01854918|529996558|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
146956144|NCT01854918|529996557|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
146826290|NCT00092521|529535585|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
146826291|NCT00092521|529535586|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
146826292|NCT00092521|529535587|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
146826293|NCT00092521|529535584|FG000|Follow-Up (After Month 7)|Moved|32|||
146826294|NCT00092521|529535585|FG001|Follow-Up (After Month 7)|Moved|2|||
146826295|NCT00092521|529535586|FG002|Follow-Up (After Month 7)|Moved|28|||
146826296|NCT00092521|529535587|FG003|Follow-Up (After Month 7)|Moved|0|||
146826297|NCT00092521|529535584|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
146826298|NCT00092521|529535585|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
146826299|NCT00092521|529535586|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
146826300|NCT00092521|529535587|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
146826301|NCT00092521|529535584|FG000|Follow-Up (After Month 7)|Travel|2|||
146826302|NCT00092521|529535585|FG001|Follow-Up (After Month 7)|Travel|0|||
146826303|NCT00092521|529535586|FG002|Follow-Up (After Month 7)|Travel|0|||
146826304|NCT00092521|529535587|FG003|Follow-Up (After Month 7)|Travel|0|||
146826305|NCT00092521|529535584|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
146826306|NCT00092521|529535585|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
146826307|NCT00092521|529535586|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
146826308|NCT00092521|529535587|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
146826309|NCT00092521|529535584|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
146826310|NCT00092521|529535585|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
146826311|NCT00092521|529535586|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
146826312|NCT00092521|529535587|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
146826313|NCT00092521|529535584|FG000|Extension Study (Group 4)|Adverse Event|0|||
146826314|NCT00092521|529535585|FG001|Extension Study (Group 4)|Adverse Event|0|||
146826315|NCT00092521|529535586|FG002|Extension Study (Group 4)|Adverse Event|0|||
146826316|NCT00092521|529535587|FG003|Extension Study (Group 4)|Adverse Event|2|||
146826317|NCT00092521|529535584|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
146826318|NCT00092521|529535585|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
146826319|NCT00092521|529535586|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
146826320|NCT00092521|529535587|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
146826321|NCT00092521|529535584|FG000|Extension Study (Group 4)|Pregnancy|0|||
146826322|NCT00092521|529535585|FG001|Extension Study (Group 4)|Pregnancy|0|||
146826323|NCT00092521|529535586|FG002|Extension Study (Group 4)|Pregnancy|0|||
146826324|NCT00092521|529535587|FG003|Extension Study (Group 4)|Pregnancy|4|||
146826325|NCT00092521|529535584|FG000|Extension Study (Group 4)|Protocol Violation|0|||
146826326|NCT00092521|529535585|FG001|Extension Study (Group 4)|Protocol Violation|0|||
146826327|NCT00092521|529535586|FG002|Extension Study (Group 4)|Protocol Violation|0|||
146826328|NCT00092521|529535587|FG003|Extension Study (Group 4)|Protocol Violation|2|||
146826329|NCT00092521|529535584|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
146826330|NCT00092521|529535585|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
146826331|NCT00092521|529535586|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
146826332|NCT00092521|529535587|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
146826333|NCT00092521|529535584|FG000|Extension Study (Group 4)|Moved|0|||
146826334|NCT00092521|529535585|FG001|Extension Study (Group 4)|Moved|0|||
146826335|NCT00092521|529535586|FG002|Extension Study (Group 4)|Moved|0|||
146826336|NCT00092521|529535587|FG003|Extension Study (Group 4)|Moved|16|||
146826337|NCT00092521|529535584|FG000|Extension Study (Group 4)|Site Terminated|0|||
146826338|NCT00092521|529535585|FG001|Extension Study (Group 4)|Site Terminated|0|||
146826339|NCT00092521|529535586|FG002|Extension Study (Group 4)|Site Terminated|0|||
146956145|NCT01854918|529996558|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
146956146|NCT01854918|529996557|FG000|All-IP Period (Years 2 and 3)|Death|5|||
146956147|NCT01854918|529996558|FG001|All-IP Period (Years 2 and 3)|Death|16|||
146826340|NCT00092521|529535587|FG003|Extension Study (Group 4)|Site Terminated|4|||
146826341|NCT00092521|529535584|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
146826342|NCT00092521|529535585|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
146826343|NCT00092521|529535586|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
146826344|NCT00092521|529535587|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
146956148|NCT01347931|529998495|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
146956149|NCT01603615|529998500|FG000|Overall Study|Did not Receive Treatment|7|||
146956150|NCT01603615|529998500|FG000|Overall Study|Lost to Follow-up|9|||
146956151|NCT01603615|529998500|FG000|Overall Study|Personal Reasons|17|||
146956152|NCT01603615|529998500|FG000|Overall Study|Other Miscellaneous|1|||
146956153|NCT03287960|529998504|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
146956154|NCT03287960|529998504|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
146956155|NCT01398176|529998507|FG000|Overall Study|Lost to Follow-up|1|||
146956156|NCT01398176|529998508|FG001|Overall Study|Lost to Follow-up|3|||
146956157|NCT01398176|529998507|FG000|Overall Study|Physician Decision|2|||
146956158|NCT01398176|529998508|FG001|Overall Study|Physician Decision|3|||
146956159|NCT01871870|529998509|FG000|Overall Study|Hardware issues|7|||
146956160|NCT01871870|529998509|FG000|Overall Study|hyperglycemia|2|||
146956161|NCT01977651|529998512|FG000|4 Month Treatment Period|Adverse Event|34|||
146956162|NCT01977651|529998512|FG000|4 Month Treatment Period|Death|3|||
146956163|NCT01977651|529998512|FG000|4 Month Treatment Period|Progressive Disease|43|||
146956164|NCT01977651|529998512|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
146956165|NCT01977651|529998512|FG000|4 Month Treatment Period|Physician Decision|4|||
146956166|NCT01977651|529998512|FG000|1 Year Extension Period|Adverse Event|14|||
146956167|NCT01977651|529998512|FG000|1 Year Extension Period|Death|10|||
146956168|NCT01977651|529998512|FG000|1 Year Extension Period|Lost to Follow-up|2|||
146956169|NCT01977651|529998512|FG000|1 Year Extension Period|Progressive Disease|86|||
146956170|NCT01977651|529998512|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
146956171|NCT01977651|529998512|FG000|1 Year Extension Period|Physician Decision|6|||
146956172|NCT01977651|529998512|FG000|1 Year Extension Period|Miscellaneous|1|||
146956173|NCT01977651|529998512|FG000|Post 1 Year Extension Period|Adverse Event|5|||
146956174|NCT01977651|529998512|FG000|Post 1 Year Extension Period|Death|13|||
146956175|NCT01977651|529998512|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
146956176|NCT01977651|529998512|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
146956177|NCT01977651|529998512|FG000|Post 1 Year Extension Period|Physician Decision|4|||
146956178|NCT01977651|529998512|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
146956179|NCT03287089|529998513|FG000|Overall Study|Lost to Follow-up|0|||
146956180|NCT03287089|529998514|FG001|Overall Study|Lost to Follow-up|2|||
146956181|NCT03287089|529998513|FG000|Overall Study|Physician Decision|0|||
146956182|NCT03287089|529998514|FG001|Overall Study|Physician Decision|2|||
146956183|NCT03287089|529998513|FG000|Overall Study|Withdrawal by Subject|0|||
146956184|NCT03287089|529998514|FG001|Overall Study|Withdrawal by Subject|2|||
146956185|NCT04118127|529998517|FG000|Overall Study|Trial terminated by sponsor|0|||
146956186|NCT04118127|529998518|FG001|Overall Study|Trial terminated by sponsor|12|||
146956187|NCT04118127|529998517|FG000|Overall Study|Adverse Event|1|||
146956188|NCT04118127|529998518|FG001|Overall Study|Adverse Event|2|||
146956189|NCT04118127|529998517|FG000|Overall Study|Physician Decision|0|||
146956190|NCT04118127|529998518|FG001|Overall Study|Physician Decision|1|||
146956191|NCT04118127|529998517|FG000|Overall Study|Withdrawal by Subject|2|||
146956192|NCT04118127|529998518|FG001|Overall Study|Withdrawal by Subject|1|||
146956193|NCT01376908|529998519|FG000|Overall Study|Protocol Violation|1|||
146956194|NCT01376908|529998520|FG001|Overall Study|Protocol Violation|1|||
146956195|NCT01376908|529998519|FG000|Overall Study|Withdrawal by Subject|1|||
146956196|NCT01376908|529998520|FG001|Overall Study|Withdrawal by Subject|2|||
146956197|NCT01646255|529998521|FG000|Overall Study|Adverse Event|7|||
146956198|NCT01646255|529998522|FG001|Overall Study|Adverse Event|8|||
146956199|NCT01646255|529998521|FG000|Overall Study|Lack of Efficacy|2|||
146956200|NCT01646255|529998522|FG001|Overall Study|Lack of Efficacy|0|||
146956201|NCT01646255|529998521|FG000|Overall Study|Withdrawal by Subject|10|||
146956202|NCT01646255|529998522|FG001|Overall Study|Withdrawal by Subject|6|||
146956203|NCT01646255|529998521|FG000|Overall Study|Compliance is not well|1|||
146956204|NCT01646255|529998522|FG001|Overall Study|Compliance is not well|0|||
146956205|NCT01646255|529998521|FG000|Overall Study|Inclusion Criteria Deviation|1|||
146956206|NCT01646255|529998522|FG001|Overall Study|Inclusion Criteria Deviation|0|||
146956207|NCT01241318|529998523|FG000|Overall Study|Woman: false pregnancies|27|||
146956208|NCT01241318|529998524|FG001|Overall Study|Woman: false pregnancies|15|||
146956209|NCT01241318|529998523|FG000|Overall Study|Woman: miscarriage/abortion|46|||
146956210|NCT01241318|529998524|FG001|Overall Study|Woman: miscarriage/abortion|38|||
146956211|NCT01241318|529998523|FG000|Overall Study|Withdrawal by Subject|175|||
146956212|NCT01241318|529998524|FG001|Overall Study|Withdrawal by Subject|46|||
146956213|NCT01241318|529998523|FG000|Overall Study|Lost to Follow-up|740|||
146956214|NCT01241318|529998524|FG001|Overall Study|Lost to Follow-up|455|||
146956215|NCT01241318|529998523|FG000|Overall Study|Death|2|||
146956216|NCT01241318|529998524|FG001|Overall Study|Death|4|||
146956217|NCT01241318|529998523|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
146956218|NCT01241318|529998524|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
146956219|NCT01241318|529998523|FG000|Overall Study|Woman: Stillborn infant|129|||
146956220|NCT01241318|529998524|FG001|Overall Study|Woman: Stillborn infant|146|||
146956221|NCT02355665|529998525|FG000|Overall Study|Adverse Event|16|||
146956222|NCT02355665|529998526|FG001|Overall Study|Adverse Event|24|||
146956223|NCT02355665|529998525|FG000|Overall Study|Protocol Violation|2|||
146956224|NCT02355665|529998526|FG001|Overall Study|Protocol Violation|0|||
146956225|NCT02355665|529998525|FG000|Overall Study|Withdrawal by Subject|90|||
146956226|NCT02355665|529998526|FG001|Overall Study|Withdrawal by Subject|100|||
146956227|NCT02355665|529998525|FG000|Overall Study|Lost to Follow-up|131|||
146956228|NCT02355665|529998526|FG001|Overall Study|Lost to Follow-up|103|||
146956229|NCT02355665|529998525|FG000|Overall Study|Death|4|||
146956230|NCT02355665|529998526|FG001|Overall Study|Death|2|||
146956231|NCT02355665|529998525|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
146956232|NCT02355665|529998526|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
146956233|NCT04129242|529998527|FG000|Overall Study|Physician Decision|1|||
146956234|NCT04129242|529998528|FG001|Overall Study|Physician Decision|1|||
146956235|NCT04129242|529998527|FG000|Overall Study|Protocol Violation|0|||
146956236|NCT04129242|529998528|FG001|Overall Study|Protocol Violation|1|||
146956237|NCT03480841|529998529|FG000|Overall Study|Lost to Follow-up|2|||
146956238|NCT01362049|529998530|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
146956239|NCT01362049|529998531|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
146956240|NCT01362049|529998532|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
146956241|NCT01362049|529998533|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
146956242|NCT01362049|529998530|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
146956243|NCT01362049|529998531|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
146956244|NCT01362049|529998532|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
146956245|NCT01362049|529998533|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
146956246|NCT02417935|529998536|FG000|Treatment Period|Adverse Event|12|||
146956247|NCT02417935|529998537|FG001|Treatment Period|Adverse Event|10|||
146956248|NCT02417935|529998536|FG000|Treatment Period|Lost to Follow-up|1|||
146956249|NCT02417935|529998537|FG001|Treatment Period|Lost to Follow-up|0|||
146956250|NCT02417935|529998536|FG000|Treatment Period|Entry Criteria not met|0|||
146956251|NCT02417935|529998537|FG001|Treatment Period|Entry Criteria not met|1|||
146956252|NCT02417935|529998536|FG000|Treatment Period|Protocol Violation|2|||
146956253|NCT02417935|529998537|FG001|Treatment Period|Protocol Violation|1|||
146956254|NCT02417935|529998536|FG000|Treatment Period|Withdrawal by Subject|3|||
146956255|NCT02417935|529998537|FG001|Treatment Period|Withdrawal by Subject|3|||
146956256|NCT02417935|529998536|FG000|Treatment Period|Physician Decision|3|||
146956257|NCT02417935|529998537|FG001|Treatment Period|Physician Decision|1|||
146956258|NCT02850276|529998538|FG000|Overall Study|screen failure|43|||
146956259|NCT02850276|529998538|FG000|Overall Study|Withdrawal by Subject|14|||
146956260|NCT02850276|529998538|FG000|Overall Study|Physician Decision|2|||
146956261|NCT02850276|529998538|FG000|Overall Study|Lost to Follow-up|2|||
146956262|NCT00095836|529998540|FG000|Overall Study|Lost to Follow-up|1|||
146956263|NCT00095836|529998540|FG000|Overall Study|Adverse Event|1|||
146956264|NCT00095836|529998540|FG000|Overall Study|Death|2|||
146956265|NCT00962780|529998543|FG000|Overall Study|Death|0|||
146956266|NCT00962780|529998544|FG001|Overall Study|Death|1|||
146956267|NCT00962780|529998543|FG000|Overall Study|Protocol Violation|9|||
146956268|NCT00962780|529998544|FG001|Overall Study|Protocol Violation|4|||
146956269|NCT00962780|529998543|FG000|Overall Study|Withdrawal by Subject|1|||
146956270|NCT00962780|529998544|FG001|Overall Study|Withdrawal by Subject|8|||
146956271|NCT00962780|529998543|FG000|Overall Study|Other|0|||
146956272|NCT00962780|529998544|FG001|Overall Study|Other|1|||
146956273|NCT02853318|529998547|FG000|Overall Study|Withdrawal by Subject|1|||
146956274|NCT02363322|529998548|FG000|Overall Study|Lost to Follow-up|1|||
146956275|NCT02363322|529998549|FG001|Overall Study|Lost to Follow-up|0|||
146956276|NCT02269709|529998550|FG000|Time of Enrollment|Withdrawal by Subject|3|||
146956277|NCT02269709|529998550|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
146956278|NCT02269709|529998550|FG000|Six Month Follow-up|Lost to Follow-up|12|||
146956279|NCT02909504|529998551|FG000|Overall Study|Adverse Event|2|||
146956280|NCT02909504|529998551|FG000|Overall Study|Lack of Efficacy|3|||
146956281|NCT02909504|529998551|FG000|Overall Study|Withdrawal by Subject|4|||
146956282|NCT02909504|529998551|FG000|Overall Study|Pregnancy|1|||
146956283|NCT02909504|529998551|FG000|Overall Study|Subject moved|1|||
146956284|NCT02909504|529998551|FG000|Overall Study|Lost to Follow-up|1|||
146956285|NCT02055976|529998552|FG000|Overall Study|Other|0|||
146956286|NCT02055976|529998553|FG001|Overall Study|Other|0|||
146956287|NCT02055976|529998554|FG002|Overall Study|Other|1|||
146956288|NCT02055976|529998555|FG003|Overall Study|Other|0|||
146956289|NCT02055976|529998556|FG004|Overall Study|Other|0|||
146956290|NCT02055976|529998557|FG005|Overall Study|Other|0|||
146956291|NCT02055976|529998558|FG006|Overall Study|Other|0|||
146956292|NCT02055976|529998559|FG007|Overall Study|Other|0|||
146956293|NCT02055976|529998560|FG008|Overall Study|Other|0|||
146956294|NCT02055976|529998552|FG000|Overall Study|Adverse Event|0|||
146956295|NCT02055976|529998553|FG001|Overall Study|Adverse Event|0|||
146956296|NCT02055976|529998554|FG002|Overall Study|Adverse Event|0|||
146956297|NCT02055976|529998555|FG003|Overall Study|Adverse Event|0|||
146956298|NCT02055976|529998556|FG004|Overall Study|Adverse Event|0|||
146956299|NCT02055976|529998557|FG005|Overall Study|Adverse Event|1|||
146956300|NCT02055976|529998558|FG006|Overall Study|Adverse Event|1|||
146956301|NCT02055976|529998559|FG007|Overall Study|Adverse Event|0|||
146956302|NCT02055976|529998560|FG008|Overall Study|Adverse Event|0|||
146956303|NCT02055976|529998552|FG000|Overall Study|Does not meet entrance criteria|0|||
146956304|NCT02055976|529998553|FG001|Overall Study|Does not meet entrance criteria|0|||
146956305|NCT02055976|529998554|FG002|Overall Study|Does not meet entrance criteria|0|||
146956306|NCT02055976|529998555|FG003|Overall Study|Does not meet entrance criteria|0|||
146956307|NCT02055976|529998556|FG004|Overall Study|Does not meet entrance criteria|0|||
146956308|NCT02055976|529998557|FG005|Overall Study|Does not meet entrance criteria|0|||
146956309|NCT02055976|529998558|FG006|Overall Study|Does not meet entrance criteria|1|||
146956310|NCT02055976|529998559|FG007|Overall Study|Does not meet entrance criteria|0|||
146956311|NCT02055976|529998560|FG008|Overall Study|Does not meet entrance criteria|0|||
146956312|NCT02055976|529998552|FG000|Overall Study|Lost to Follow-up|0|||
146956313|NCT02055976|529998553|FG001|Overall Study|Lost to Follow-up|0|||
146956314|NCT02055976|529998554|FG002|Overall Study|Lost to Follow-up|0|||
146956315|NCT02055976|529998555|FG003|Overall Study|Lost to Follow-up|1|||
146956316|NCT02055976|529998556|FG004|Overall Study|Lost to Follow-up|0|||
146956317|NCT02055976|529998557|FG005|Overall Study|Lost to Follow-up|0|||
146956318|NCT02055976|529998558|FG006|Overall Study|Lost to Follow-up|0|||
146956319|NCT02055976|529998559|FG007|Overall Study|Lost to Follow-up|0|||
146956320|NCT02055976|529998560|FG008|Overall Study|Lost to Follow-up|0|||
146956321|NCT02504424|529998561|FG000|Overall Study|Withdrawal by Subject|2|||
146956322|NCT00426842|529998565|FG000|Overall Study|Lost to Follow-up|1|||
146956323|NCT00362297|529998566|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
146956324|NCT00362297|529998567|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
146956325|NCT00982111|529998570|FG000|Overall Study|Adverse Event|1|||
146956326|NCT00982111|529998571|FG001|Overall Study|Adverse Event|1|||
146956327|NCT00982111|529998570|FG000|Overall Study|Progressive Disease|46|||
146956328|NCT00982111|529998571|FG001|Overall Study|Progressive Disease|39|||
146956329|NCT00982111|529998570|FG000|Overall Study|Lost to Follow-up|9|||
146956330|NCT00982111|529998571|FG001|Overall Study|Lost to Follow-up|6|||
146956331|NCT00982111|529998570|FG000|Overall Study|New Anti-Cancer Therapy|5|||
146956332|NCT00982111|529998571|FG001|Overall Study|New Anti-Cancer Therapy|5|||
146956333|NCT00982111|529998570|FG000|Overall Study|Medical Decision|1|||
146956334|NCT00982111|529998571|FG001|Overall Study|Medical Decision|0|||
146956335|NCT00982111|529998570|FG000|Overall Study|Withdrawal by Subject|17|||
146956336|NCT00982111|529998571|FG001|Overall Study|Withdrawal by Subject|19|||
146956337|NCT00982111|529998570|FG000|Overall Study|Global Study End|0|||
146956338|NCT00982111|529998571|FG001|Overall Study|Global Study End|1|||
146956339|NCT00982111|529998570|FG000|Overall Study|Sponsor's Decision|0|||
146956340|NCT00982111|529998571|FG001|Overall Study|Sponsor's Decision|1|||
146956341|NCT01070381|529998572|FG000|Period 2, 1 Week of Wear|Handling|0|||
146956342|NCT01070381|529998573|FG001|Period 2, 1 Week of Wear|Handling|1|||
146956343|NCT01070381|529998572|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
146956344|NCT01070381|529998573|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
146956345|NCT00684073|529998574|FG000|Selection|Selection/non-selection criteria|3|||
146956346|NCT00684073|529998574|FG000|Selection|Death|1|||
146956347|NCT00684073|529998574|FG000|Selection|noncompliance|1|||
146956348|NCT00684073|529998574|FG000|Selection|Lost to Follow-up|1|||
146956349|NCT00684073|529998574|FG000|Selection|request of the sponsor|1|||
146956350|NCT00684073|529998574|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
146956351|NCT03512028|529998576|FG000|Overall Study|Withdrawal by Subject|2|||
146956352|NCT03512028|529998577|FG001|Overall Study|Withdrawal by Subject|0|||
146956353|NCT03512028|529998576|FG000|Overall Study|Protocol Violation|2|||
146956354|NCT03512028|529998577|FG001|Overall Study|Protocol Violation|0|||
146956355|NCT00983827|529998578|FG000|Overall Study|Withdrawal by Subject|1|||
146956356|NCT02728804|529998584|FG000|Overall Study|Ineligible|3|||
146956357|NCT02728804|529998584|FG000|Overall Study|Did not complete baseline questionnaire|9|||
146956358|NCT02728804|529998584|FG000|Overall Study|Death|99|||
146956359|NCT02146352|529998587|FG000|Overall Study|Death|1|||
146956360|NCT02146352|529998587|FG000|Overall Study|Patient entered hospice care|1|||
146956361|NCT02918006|529998589|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
146956362|NCT02918006|529998590|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
146956363|NCT02918006|529998591|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
146956364|NCT02918006|529998589|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
146956365|NCT02918006|529998590|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
146956366|NCT02918006|529998591|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
146956367|NCT02918006|529998589|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
146956368|NCT02918006|529998590|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
146956369|NCT02918006|529998591|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
146956370|NCT02918006|529998589|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
146956371|NCT02918006|529998590|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
146956372|NCT02918006|529998591|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
146956373|NCT02918006|529998589|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
146956374|NCT02918006|529998590|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
146956375|NCT02918006|529998591|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
146956376|NCT02918006|529998589|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
146956377|NCT02918006|529998590|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
146826345|NCT01878383|529535588|FG000|Overall Study|Lost to Follow-up|0|||
146826346|NCT01878383|529535589|FG001|Overall Study|Lost to Follow-up|1499|||
146826347|NCT03464383|529535590|FG000|Overall Study|Lost to Follow-up|1|||
146826348|NCT03464383|529535591|FG001|Overall Study|Lost to Follow-up|0|||
146826349|NCT03464383|529535592|FG002|Overall Study|Lost to Follow-up|0|||
146826350|NCT03464383|529535590|FG000|Overall Study|Withdrawal by Subject|0|||
146826351|NCT03464383|529535591|FG001|Overall Study|Withdrawal by Subject|1|||
146826352|NCT03464383|529535592|FG002|Overall Study|Withdrawal by Subject|0|||
146826353|NCT03475056|529535593|FG000|Overall Study|Lost to Follow-up|0|||
146826354|NCT03475056|529535594|FG001|Overall Study|Lost to Follow-up|1|||
146826355|NCT03475056|529535593|FG000|Overall Study|Moved from Area|0|||
146826356|NCT03475056|529535594|FG001|Overall Study|Moved from Area|2|||
146826357|NCT01904136|529535598|FG000|Overall Study|Physician Decision|0|||
146826358|NCT01904136|529535599|FG001|Overall Study|Physician Decision|0|||
146826359|NCT01904136|529535600|FG002|Overall Study|Physician Decision|0|||
146826360|NCT01904136|529535601|FG003|Overall Study|Physician Decision|0|||
146826361|NCT01904136|529535602|FG004|Overall Study|Physician Decision|0|||
146826362|NCT01904136|529535603|FG005|Overall Study|Physician Decision|1|||
146826363|NCT01904136|529535604|FG006|Overall Study|Physician Decision|0|||
146826364|NCT01904136|529535605|FG007|Overall Study|Physician Decision|0|||
146826365|NCT01904136|529535606|FG008|Overall Study|Physician Decision|0|||
146826366|NCT02418845|529535609|FG000|Overall Study|Lost to Follow-up|7|||
146826367|NCT02418845|529535610|FG001|Overall Study|Lost to Follow-up|2|||
146826368|NCT02418845|529535609|FG000|Overall Study|Lack of Efficacy|0|||
146826369|NCT02418845|529535610|FG001|Overall Study|Lack of Efficacy|3|||
146826370|NCT02418845|529535609|FG000|Overall Study|Physician Decision|5|||
146826371|NCT02418845|529535610|FG001|Overall Study|Physician Decision|5|||
146826372|NCT02418845|529535609|FG000|Overall Study|Protocol Violation|1|||
146826373|NCT02418845|529535610|FG001|Overall Study|Protocol Violation|0|||
146826374|NCT02418845|529535609|FG000|Overall Study|Withdrawal by Subject|3|||
146826375|NCT02418845|529535610|FG001|Overall Study|Withdrawal by Subject|2|||
146826376|NCT01990313|529535614|FG000|Overall Study|Lost to Follow-up|1|||
146826377|NCT03119688|529535615|FG000|Overall Study|Adverse Event|4|||
146826378|NCT02624869|529535616|FG000|Overall Study|Lost to Follow-up|0|||
146826379|NCT02624869|529535617|FG001|Overall Study|Lost to Follow-up|0|||
146826380|NCT02624869|529535618|FG002|Overall Study|Lost to Follow-up|1|||
146826381|NCT02624869|529535616|FG000|Overall Study|Withdrawal by Subject|1|||
146826382|NCT02624869|529535617|FG001|Overall Study|Withdrawal by Subject|3|||
146826383|NCT02624869|529535618|FG002|Overall Study|Withdrawal by Subject|1|||
146826384|NCT02705625|529535619|FG000|Overall Study|Protocol Violation|1|||
146826385|NCT02705625|529535620|FG001|Overall Study|Protocol Violation|0|||
146826386|NCT02705625|529535621|FG002|Overall Study|Protocol Violation|0|||
146826387|NCT02705625|529535619|FG000|Overall Study|Adverse Event|6|||
146826388|NCT02705625|529535620|FG001|Overall Study|Adverse Event|5|||
146826389|NCT02705625|529535621|FG002|Overall Study|Adverse Event|2|||
146826390|NCT02705625|529535619|FG000|Overall Study|Death|0|||
146826391|NCT02705625|529535620|FG001|Overall Study|Death|0|||
146826392|NCT02705625|529535621|FG002|Overall Study|Death|1|||
146826393|NCT02705625|529535619|FG000|Overall Study|Withdrawal by Subject|1|||
146826394|NCT02705625|529535620|FG001|Overall Study|Withdrawal by Subject|4|||
146826395|NCT02705625|529535621|FG002|Overall Study|Withdrawal by Subject|5|||
146826396|NCT02705625|529535619|FG000|Overall Study|Lost to Follow-up|0|||
146826397|NCT02705625|529535620|FG001|Overall Study|Lost to Follow-up|0|||
146826398|NCT02705625|529535621|FG002|Overall Study|Lost to Follow-up|1|||
146826399|NCT02705625|529535619|FG000|Overall Study|Non-compliance|0|||
146826400|NCT02705625|529535620|FG001|Overall Study|Non-compliance|1|||
146826401|NCT02705625|529535621|FG002|Overall Study|Non-compliance|1|||
146826402|NCT02705625|529535619|FG000|Overall Study|Overdosing|0|||
146826403|NCT02705625|529535620|FG001|Overall Study|Overdosing|0|||
146826404|NCT02705625|529535621|FG002|Overall Study|Overdosing|1|||
146826405|NCT00863798|529535622|FG000|Overall Study|Adverse Event|5|||
146826406|NCT00863798|529535623|FG001|Overall Study|Adverse Event|2|||
146956378|NCT02918006|529998591|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
146956379|NCT02918006|529998589|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
146956380|NCT02918006|529998590|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
146826407|NCT00863798|529535624|FG002|Overall Study|Adverse Event|4|||
146826408|NCT00863798|529535622|FG000|Overall Study|Participant failed to return|2|||
146826409|NCT00863798|529535623|FG001|Overall Study|Participant failed to return|1|||
146826410|NCT00863798|529535624|FG002|Overall Study|Participant failed to return|0|||
146826411|NCT00863798|529535622|FG000|Overall Study|Investigator request|1|||
146826412|NCT00863798|529535623|FG001|Overall Study|Investigator request|2|||
146826413|NCT00863798|529535624|FG002|Overall Study|Investigator request|1|||
146826414|NCT00863798|529535622|FG000|Overall Study|Lack of Efficacy|4|||
146826415|NCT00863798|529535623|FG001|Overall Study|Lack of Efficacy|3|||
146826416|NCT00863798|529535624|FG002|Overall Study|Lack of Efficacy|6|||
146826417|NCT00863798|529535622|FG000|Overall Study|Lost to Follow-up|6|||
146826418|NCT00863798|529535623|FG001|Overall Study|Lost to Follow-up|9|||
146826419|NCT00863798|529535624|FG002|Overall Study|Lost to Follow-up|5|||
146826420|NCT00863798|529535622|FG000|Overall Study|Other|2|||
146956381|NCT02918006|529998591|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
146956382|NCT02918006|529998589|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
146956383|NCT02918006|529998590|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
146956384|NCT02918006|529998591|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
146956385|NCT02918006|529998589|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
146956386|NCT02918006|529998590|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
146956387|NCT02918006|529998591|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
146956388|NCT03091920|529998595|FG000|Overall Study|Adverse Event|0|||
146956389|NCT03091920|529998596|FG001|Overall Study|Adverse Event|1|||
146956390|NCT03091920|529998597|FG002|Overall Study|Adverse Event|0|||
146956391|NCT00453349|529998599|FG000|Randomized|Adverse Event|12|||
146956392|NCT00453349|529998600|FG001|Randomized|Adverse Event|11|||
146956393|NCT00453349|529998599|FG000|Randomized|Lack of Efficacy|2|||
146956394|NCT00453349|529998600|FG001|Randomized|Lack of Efficacy|1|||
146956395|NCT00453349|529998599|FG000|Randomized|Lost to Follow-up|7|||
146956396|NCT00453349|529998600|FG001|Randomized|Lost to Follow-up|5|||
146956397|NCT00453349|529998599|FG000|Randomized|Protocol Violation|1|||
146956398|NCT00453349|529998600|FG001|Randomized|Protocol Violation|1|||
146956399|NCT00453349|529998599|FG000|Randomized|Withdrawal by Subject|3|||
146956400|NCT00453349|529998600|FG001|Randomized|Withdrawal by Subject|5|||
146956401|NCT00453349|529998599|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
146956402|NCT00453349|529998600|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
146956403|NCT00453349|529998599|FG000|Completed Study|Adverse Event|12|||
146956404|NCT00453349|529998600|FG001|Completed Study|Adverse Event|11|||
146956405|NCT00453349|529998599|FG000|Completed Study|Lack of Efficacy|2|||
146956406|NCT00453349|529998600|FG001|Completed Study|Lack of Efficacy|1|||
146956407|NCT00453349|529998599|FG000|Completed Study|Lost to Follow-up|7|||
146956408|NCT00453349|529998600|FG001|Completed Study|Lost to Follow-up|5|||
146956409|NCT00453349|529998599|FG000|Completed Study|Protocol Violation|1|||
146956410|NCT00453349|529998600|FG001|Completed Study|Protocol Violation|1|||
146956411|NCT00453349|529998599|FG000|Completed Study|Withdrawal by Subject|3|||
146956412|NCT00453349|529998600|FG001|Completed Study|Withdrawal by Subject|5|||
146956413|NCT00453349|529998599|FG000|Completed Study|Lost to follow up after study treatment|2|||
146956414|NCT00453349|529998600|FG001|Completed Study|Lost to follow up after study treatment|11|||
146956415|NCT01513460|529998602|FG000|Overall Study|Death|0|||
146956416|NCT01513460|529998603|FG001|Overall Study|Death|0|||
146956417|NCT01513460|529998604|FG002|Overall Study|Death|1|||
146985204|NCT02843074|530107211|FG000|Overall Study|Physician Decision|1|||
146985205|NCT02843074|530107211|FG000|Overall Study|Lost to Follow-up|1|||
146985206|NCT02843074|530107211|FG000|Overall Study|Death|9|||
146985207|NCT03521999|530107212|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
146985208|NCT03521999|530107213|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
146985209|NCT03521999|530107212|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
146985210|NCT03521999|530107213|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
146956418|NCT01513460|529998602|FG000|Overall Study|Lost to Follow-up|0|||
146956419|NCT01513460|529998603|FG001|Overall Study|Lost to Follow-up|0|||
146956420|NCT01513460|529998604|FG002|Overall Study|Lost to Follow-up|2|||
146956421|NCT01513460|529998602|FG000|Overall Study|Abnormal laboratory value|1|||
146956422|NCT01513460|529998603|FG001|Overall Study|Abnormal laboratory value|0|||
146956423|NCT01513460|529998604|FG002|Overall Study|Abnormal laboratory value|1|||
146956424|NCT01513460|529998602|FG000|Overall Study|Lack of Efficacy|1|||
146956425|NCT01513460|529998603|FG001|Overall Study|Lack of Efficacy|2|||
146956426|NCT01513460|529998604|FG002|Overall Study|Lack of Efficacy|5|||
146985211|NCT03521999|530107212|FG000|Completed 3 Month Follow up|Death|0|||
146985212|NCT03521999|530107213|FG001|Completed 3 Month Follow up|Death|1|||
146985213|NCT03521999|530107212|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
146985214|NCT03521999|530107213|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
146826421|NCT00863798|529535623|FG001|Overall Study|Other|3|||
146826422|NCT00863798|529535624|FG002|Overall Study|Other|1|||
146826423|NCT00863798|529535622|FG000|Overall Study|Protocol Violation|0|||
146826424|NCT00863798|529535623|FG001|Overall Study|Protocol Violation|1|||
146826425|NCT00863798|529535624|FG002|Overall Study|Protocol Violation|1|||
146956427|NCT01513460|529998602|FG000|Overall Study|Protocol deviations|3|||
146956428|NCT01513460|529998603|FG001|Overall Study|Protocol deviations|4|||
146956429|NCT01513460|529998604|FG002|Overall Study|Protocol deviations|3|||
146956430|NCT01513460|529998602|FG000|Overall Study|Withdrawal by Subject|7|||
146956431|NCT01513460|529998603|FG001|Overall Study|Withdrawal by Subject|8|||
146956432|NCT01513460|529998604|FG002|Overall Study|Withdrawal by Subject|21|||
146956433|NCT01513460|529998602|FG000|Overall Study|Adverse Event|16|||
146956434|NCT01513460|529998603|FG001|Overall Study|Adverse Event|18|||
146956435|NCT01513460|529998604|FG002|Overall Study|Adverse Event|23|||
146956436|NCT01513460|529998602|FG000|Overall Study|Abnormal test procedure|1|||
146956437|NCT01513460|529998603|FG001|Overall Study|Abnormal test procedure|0|||
146956438|NCT01513460|529998604|FG002|Overall Study|Abnormal test procedure|0|||
146956439|NCT00489216|529998608|FG000|Overall Study|Adverse Event|1|||
146956440|NCT02828982|529998611|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
146956441|NCT02828982|529998612|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
146956442|NCT02312934|529998613|FG000|Overall Study|Lost to Follow-up|1|||
146956443|NCT02312934|529998614|FG001|Overall Study|Lost to Follow-up|0|||
146956444|NCT02312934|529998613|FG000|Overall Study|Physician Decision|1|||
146956445|NCT02312934|529998614|FG001|Overall Study|Physician Decision|0|||
146956446|NCT00701064|529998615|FG000|Overall Study|Protocol Violation|1|||
146956447|NCT00701064|529998616|FG001|Overall Study|Protocol Violation|1|||
146956448|NCT00701064|529998615|FG000|Overall Study|Withdrawal by Subject|1|||
146956449|NCT00701064|529998616|FG001|Overall Study|Withdrawal by Subject|1|||
146956450|NCT00701064|529998615|FG000|Overall Study|initiated other PTSD treatment|2|||
146956451|NCT00701064|529998616|FG001|Overall Study|initiated other PTSD treatment|2|||
146956452|NCT02098733|529998617|FG000|Overall Study|Data Not Available|5|||
146956453|NCT02098733|529998617|FG000|Overall Study|Lost to Follow-up|5|||
146956454|NCT03395704|529998618|FG000|Overall Study|Adverse Event|2|||
146956455|NCT03395704|529998619|FG001|Overall Study|Adverse Event|1|||
146956456|NCT03395704|529998618|FG000|Overall Study|Withdrawal by Subject|2|||
146956457|NCT03395704|529998619|FG001|Overall Study|Withdrawal by Subject|1|||
146956458|NCT03395704|529998618|FG000|Overall Study|Physician Decision|0|||
146956459|NCT03395704|529998619|FG001|Overall Study|Physician Decision|1|||
146956460|NCT01156012|529998620|FG000|Overall Study|Adverse Event|3|||
146956461|NCT01156012|529998621|FG001|Overall Study|Adverse Event|1|||
146956462|NCT01156012|529998620|FG000|Overall Study|Lost to Follow-up|1|||
146956463|NCT01156012|529998621|FG001|Overall Study|Lost to Follow-up|0|||
146956464|NCT01156012|529998620|FG000|Overall Study|Withdrawal by Subject|1|||
146956465|NCT01156012|529998621|FG001|Overall Study|Withdrawal by Subject|0|||
146956466|NCT01156012|529998620|FG000|Overall Study|use of commercial drug instead of study|0|||
146956467|NCT01156012|529998621|FG001|Overall Study|use of commercial drug instead of study|1|||
146956468|NCT01156012|529998620|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
146956469|NCT01156012|529998621|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
146956470|NCT02475564|529998622|FG000|Overall Study|Withdrawal by Subject|1|||
146956471|NCT02475564|529998623|FG001|Overall Study|Withdrawal by Subject|0|||
146956472|NCT02475564|529998622|FG000|Overall Study|Lost to Follow-up|2|||
146956473|NCT02475564|529998623|FG001|Overall Study|Lost to Follow-up|1|||
146956474|NCT02475564|529998622|FG000|Overall Study|Intense Menstrual bleeding|1|||
146956475|NCT02475564|529998623|FG001|Overall Study|Intense Menstrual bleeding|0|||
146956476|NCT03922945|530000336|FG000|Overall Study|Adverse Event|1|||
146956477|NCT03922945|530000337|FG001|Overall Study|Adverse Event|1|||
146956478|NCT03922945|530000338|FG002|Overall Study|Adverse Event|2|||
146956479|NCT03922945|530000336|FG000|Overall Study|Lost to Follow-up|13|||
146956480|NCT03922945|530000337|FG001|Overall Study|Lost to Follow-up|9|||
146956481|NCT03922945|530000338|FG002|Overall Study|Lost to Follow-up|20|||
146956482|NCT03922945|530000336|FG000|Overall Study|Lack of Efficacy|2|||
146956483|NCT03922945|530000337|FG001|Overall Study|Lack of Efficacy|0|||
146956484|NCT03922945|530000338|FG002|Overall Study|Lack of Efficacy|1|||
146956485|NCT03922945|530000336|FG000|Overall Study|Protocol Non-Compliance|0|||
146956486|NCT03922945|530000337|FG001|Overall Study|Protocol Non-Compliance|0|||
146956487|NCT03922945|530000338|FG002|Overall Study|Protocol Non-Compliance|1|||
146956488|NCT03922945|530000336|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
146956489|NCT03922945|530000337|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
146956490|NCT03922945|530000338|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
146956491|NCT03922945|530000336|FG000|Overall Study|All Other Personal Reasons|1|||
146956492|NCT03922945|530000337|FG001|Overall Study|All Other Personal Reasons|1|||
146956493|NCT03922945|530000338|FG002|Overall Study|All Other Personal Reasons|2|||
146956494|NCT00772031|530000345|FG000|Overall Study|Early termination of trial|12|||
146956495|NCT00772031|530000346|FG001|Overall Study|Early termination of trial|10|||
146956496|NCT00772031|530000345|FG000|Overall Study|Lost to Follow-up|20|||
146956497|NCT00772031|530000346|FG001|Overall Study|Lost to Follow-up|33|||
146956498|NCT03419741|530000347|FG000|Overall Study|Adverse Event|1|||
146956499|NCT03419741|530000348|FG001|Overall Study|Adverse Event|0|||
146956500|NCT03419741|530000347|FG000|Overall Study|Withdrawal by Subject|1|||
146956501|NCT03419741|530000348|FG001|Overall Study|Withdrawal by Subject|2|||
146956502|NCT04354870|530000349|FG000|Overall Study|Lost to Follow-up|32|||
146956503|NCT04354870|530000350|FG001|Overall Study|Lost to Follow-up|12|||
146985215|NCT01564758|530107214|FG000|Overall Study|Death|8|||
146985216|NCT01564758|530107214|FG000|Overall Study|Adverse Event|3|||
146956504|NCT04354870|530000349|FG000|Overall Study|Withdrawal by Subject|10|||
146956505|NCT04354870|530000350|FG001|Overall Study|Withdrawal by Subject|16|||
146956506|NCT04354870|530000349|FG000|Overall Study|Did not complete all study visits|6|||
146956507|NCT04354870|530000350|FG001|Overall Study|Did not complete all study visits|5|||
146956508|NCT03384316|530000351|FG000|Overall Study|Screen failure|0|||
146956509|NCT03384316|530000352|FG001|Overall Study|Screen failure|1|||
146956510|NCT02194699|530000357|FG000|Randomised|Did not receive treatment|1|||
146956511|NCT02194699|530000358|FG001|Randomised|Did not receive treatment|5|||
146956512|NCT02194699|530000357|FG000|Randomised|Without potential for 52 weeks of IP|5|||
146956513|NCT02194699|530000358|FG001|Randomised|Without potential for 52 weeks of IP|5|||
146956514|NCT02194699|530000357|FG000|Randomised|Duplicate patient|2|||
146956515|NCT02194699|530000358|FG001|Randomised|Duplicate patient|1|||
146985217|NCT01564758|530107214|FG000|Overall Study|Other|3|||
146956516|NCT02194699|530000357|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
146956517|NCT02194699|530000358|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
146956518|NCT02194699|530000357|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
146956519|NCT02194699|530000358|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
146956520|NCT02194699|530000357|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
146956521|NCT02194699|530000358|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
146956522|NCT02194699|530000357|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
146956523|NCT02194699|530000358|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
146985218|NCT01185288|530107218|FG000|Overall Study|Adverse Event|7|||
146956524|NCT02194699|530000357|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
146956525|NCT02194699|530000358|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
146956526|NCT02194699|530000357|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
146956527|NCT02194699|530000358|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
146956528|NCT02719028|530000359|FG000|Overall Study|Adverse Event|2|||
146956529|NCT02719028|530000360|FG001|Overall Study|Adverse Event|1|||
146956530|NCT02719028|530000361|FG002|Overall Study|Adverse Event|4|||
146956531|NCT02719028|530000362|FG003|Overall Study|Adverse Event|8|||
146956532|NCT02719028|530000359|FG000|Overall Study|Physician Decision|0|||
146956533|NCT02719028|530000360|FG001|Overall Study|Physician Decision|1|||
146956534|NCT02719028|530000361|FG002|Overall Study|Physician Decision|1|||
146956535|NCT02719028|530000362|FG003|Overall Study|Physician Decision|1|||
146956536|NCT02719028|530000359|FG000|Overall Study|Use of prohibited medication|0|||
146956537|NCT02719028|530000360|FG001|Overall Study|Use of prohibited medication|0|||
146956538|NCT02719028|530000361|FG002|Overall Study|Use of prohibited medication|1|||
146956539|NCT02719028|530000362|FG003|Overall Study|Use of prohibited medication|0|||
146956540|NCT02719028|530000359|FG000|Overall Study|Protocol Violation|0|||
146956541|NCT02719028|530000360|FG001|Overall Study|Protocol Violation|0|||
146956542|NCT02719028|530000361|FG002|Overall Study|Protocol Violation|0|||
146956543|NCT02719028|530000362|FG003|Overall Study|Protocol Violation|1|||
146956544|NCT01191190|530000363|FG000|Overall Study|Withdrawal by Subject|1|||
146956545|NCT01667731|530000365|FG000|Overall Study|Enrolled but not treated|0|||
146956546|NCT01667731|530000366|FG001|Overall Study|Enrolled but not treated|0|||
146956547|NCT01667731|530000367|FG002|Overall Study|Enrolled but not treated|0|||
146956548|NCT01667731|530000368|FG003|Overall Study|Enrolled but not treated|0|||
146956549|NCT01667731|530000369|FG004|Overall Study|Enrolled but not treated|1|||
146956550|NCT01667731|530000365|FG000|Overall Study|Efficacy Failure|1|||
146956551|NCT01667731|530000366|FG001|Overall Study|Efficacy Failure|12|||
146956552|NCT01667731|530000367|FG002|Overall Study|Efficacy Failure|0|||
146956553|NCT01667731|530000368|FG003|Overall Study|Efficacy Failure|1|||
146956554|NCT01667731|530000369|FG004|Overall Study|Efficacy Failure|24|||
146956555|NCT01667731|530000365|FG000|Overall Study|Lost to Follow-up|2|||
146956556|NCT01667731|530000366|FG001|Overall Study|Lost to Follow-up|3|||
146956557|NCT01667731|530000367|FG002|Overall Study|Lost to Follow-up|1|||
146956558|NCT01667731|530000368|FG003|Overall Study|Lost to Follow-up|1|||
146956559|NCT01667731|530000369|FG004|Overall Study|Lost to Follow-up|2|||
146956560|NCT01667731|530000365|FG000|Overall Study|Subject Withdrew Consent|2|||
146956561|NCT01667731|530000366|FG001|Overall Study|Subject Withdrew Consent|0|||
146956562|NCT01667731|530000367|FG002|Overall Study|Subject Withdrew Consent|1|||
146956563|NCT01667731|530000368|FG003|Overall Study|Subject Withdrew Consent|0|||
146956564|NCT01667731|530000369|FG004|Overall Study|Subject Withdrew Consent|1|||
146956565|NCT01667731|530000365|FG000|Overall Study|Death|0|||
146956566|NCT01667731|530000366|FG001|Overall Study|Death|1|||
146956567|NCT01667731|530000367|FG002|Overall Study|Death|0|||
146956568|NCT01667731|530000368|FG003|Overall Study|Death|0|||
146956569|NCT01667731|530000369|FG004|Overall Study|Death|0|||
146956570|NCT00561912|530000370|FG000|Overall Study|ineligible|1|||
146956571|NCT00577382|530000371|FG000|Overall Study|Adverse Event|0|||
146956572|NCT00577382|530000372|FG001|Overall Study|Adverse Event|6|||
146956573|NCT00577382|530000371|FG000|Overall Study|Withdrawal by Subject|0|||
146956574|NCT00577382|530000372|FG001|Overall Study|Withdrawal by Subject|1|||
146956575|NCT00577382|530000371|FG000|Overall Study|Progressive Disease|17|||
146956576|NCT00577382|530000372|FG001|Overall Study|Progressive Disease|19|||
146956577|NCT00577382|530000371|FG000|Overall Study|Intercurrent Illness|1|||
146956578|NCT00577382|530000372|FG001|Overall Study|Intercurrent Illness|2|||
146985219|NCT01185288|530107219|FG001|Overall Study|Adverse Event|6|||
146985220|NCT01185288|530107218|FG000|Overall Study|Withdrawal by Subject|6|||
146956579|NCT00577382|530000371|FG000|Overall Study|Death|1|||
146956580|NCT00577382|530000372|FG001|Overall Study|Death|1|||
146956581|NCT00577382|530000371|FG000|Overall Study|Lost to Follow-up|2|||
146956582|NCT00577382|530000372|FG001|Overall Study|Lost to Follow-up|2|||
146956583|NCT03007472|530000374|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
146956584|NCT03007472|530000374|FG000|Overall Study|Death|2|||
146956585|NCT03007472|530000374|FG000|Overall Study|Loss to Follow Up|1|||
146956586|NCT00649220|530000375|FG000|Overall Study|Adverse Event|2|||
146956587|NCT00649220|530000375|FG000|Overall Study|Withdrawal by Subject|1|||
146956588|NCT00525499|530000376|FG000|Overall Study|Lost to Follow-up|2|||
146956589|NCT00525499|530000377|FG001|Overall Study|Lost to Follow-up|4|||
146956590|NCT00525499|530000378|FG002|Overall Study|Lost to Follow-up|1|||
146956591|NCT00525499|530000379|FG003|Overall Study|Lost to Follow-up|4|||
146956592|NCT00525499|530000376|FG000|Overall Study|Adverse Event|0|||
146956593|NCT00525499|530000377|FG001|Overall Study|Adverse Event|1|||
146956594|NCT00525499|530000378|FG002|Overall Study|Adverse Event|0|||
146956595|NCT00525499|530000379|FG003|Overall Study|Adverse Event|1|||
146956596|NCT00525499|530000376|FG000|Overall Study|Withdrawal by Subject|5|||
146956597|NCT00525499|530000377|FG001|Overall Study|Withdrawal by Subject|1|||
146956598|NCT00525499|530000378|FG002|Overall Study|Withdrawal by Subject|5|||
146956599|NCT00525499|530000379|FG003|Overall Study|Withdrawal by Subject|2|||
146956600|NCT00525499|530000376|FG000|Overall Study|Protocol Violation|0|||
146956601|NCT00525499|530000377|FG001|Overall Study|Protocol Violation|1|||
146956602|NCT00525499|530000378|FG002|Overall Study|Protocol Violation|1|||
146956603|NCT00525499|530000379|FG003|Overall Study|Protocol Violation|0|||
146956604|NCT01729559|530000384|FG000|Overall Study|Protocol Violation|31|||
146956605|NCT01729559|530000385|FG001|Overall Study|Protocol Violation|28|||
146956606|NCT02906644|530000390|FG000|First 2 Weeks|Withdrawal by Subject|0|||
146956607|NCT02906644|530000391|FG001|First 2 Weeks|Withdrawal by Subject|2|||
146956608|NCT02906644|530000390|FG000|First 2 Weeks|Physician Decision|1|||
146956609|NCT02906644|530000391|FG001|First 2 Weeks|Physician Decision|1|||
146956610|NCT02906644|530000390|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
146956611|NCT02906644|530000391|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
146956612|NCT02906644|530000390|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
146956613|NCT02906644|530000391|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
146956614|NCT03672006|530000394|FG000|Overall Study|exclusion criteria met|0|||
146956615|NCT03672006|530000395|FG001|Overall Study|exclusion criteria met|1|||
146956616|NCT00608426|530000396|FG000|Overall Study|Death|32|||
146956617|NCT00608426|530000397|FG001|Overall Study|Death|36|||
146956618|NCT00608426|530000396|FG000|Overall Study|Lost to Follow-up|485|||
146956619|NCT00608426|530000397|FG001|Overall Study|Lost to Follow-up|521|||
146956620|NCT00608426|530000396|FG000|Overall Study|refused, health issues, wrong address|319|||
146956621|NCT00608426|530000397|FG001|Overall Study|refused, health issues, wrong address|348|||
146956622|NCT00761891|530000398|FG000|Overall Study|Withdrawal by Subject|10|||
146956623|NCT01453439|530000402|FG000|Treatment Phase|Withdrawal by Subject|13|||
146956624|NCT01453439|530000403|FG001|Treatment Phase|Withdrawal by Subject|10|||
146956625|NCT01453439|530000402|FG000|Treatment Phase|Suicidal Ideation|2|||
146956626|NCT01453439|530000403|FG001|Treatment Phase|Suicidal Ideation|0|||
146956627|NCT01453439|530000402|FG000|Treatment Phase|Need for higher level of care|1|||
146956628|NCT01453439|530000403|FG001|Treatment Phase|Need for higher level of care|1|||
146956629|NCT01453439|530000402|FG000|Treatment Phase|Therapist conflict of interest|1|||
146956630|NCT01453439|530000403|FG001|Treatment Phase|Therapist conflict of interest|0|||
146956631|NCT01453439|530000402|FG000|Follow-up|Withdrawal by Subject|0|||
146956632|NCT01453439|530000403|FG001|Follow-up|Withdrawal by Subject|1|||
146956633|NCT01453439|530000402|FG000|Follow-up|Lost to Follow-up|5|||
146956634|NCT01453439|530000403|FG001|Follow-up|Lost to Follow-up|10|||
146956635|NCT01014442|530000404|FG000|Overall Study|Adverse Event|0|||
146956636|NCT01014442|530000405|FG001|Overall Study|Adverse Event|8|||
146956637|NCT01014442|530000404|FG000|Overall Study|Withdrawal by Subject|4|||
146956638|NCT01014442|530000405|FG001|Overall Study|Withdrawal by Subject|4|||
146956639|NCT01014442|530000404|FG000|Overall Study|Protocol Violation|2|||
146956640|NCT01014442|530000405|FG001|Overall Study|Protocol Violation|5|||
146956641|NCT01014442|530000404|FG000|Overall Study|Lack of Compliance|0|||
146956642|NCT01014442|530000405|FG001|Overall Study|Lack of Compliance|1|||
146956643|NCT01014442|530000404|FG000|Overall Study|Unspecified Reason|1|||
146956644|NCT01014442|530000405|FG001|Overall Study|Unspecified Reason|1|||
146956645|NCT02074059|530000406|FG000|Overall Study|Death|0|||
146956646|NCT02074059|530000407|FG001|Overall Study|Death|0|||
146956647|NCT02074059|530000408|FG002|Overall Study|Death|0|||
146956648|NCT02074059|530000409|FG003|Overall Study|Death|0|||
146956649|NCT02074059|530000410|FG004|Overall Study|Death|1|||
146956650|NCT02074059|530000411|FG005|Overall Study|Death|1|||
146956651|NCT02764229|530000414|FG000|Overall Study|Withdrawal by Subject|15|||
146956652|NCT02764229|530000414|FG000|Overall Study|Adverse Event|9|||
146956653|NCT02764229|530000414|FG000|Overall Study|Physician Decision|5|||
146956654|NCT02764229|530000414|FG000|Overall Study|Lost to Follow-up|3|||
146956655|NCT02764229|530000414|FG000|Overall Study|Lack of Efficacy|1|||
146956656|NCT02764229|530000414|FG000|Overall Study|Study Stopped by Sponsor|69|||
146956657|NCT02135848|530000418|FG000|Overall Study|Adverse Event|2|||
146956658|NCT02135848|530000419|FG001|Overall Study|Adverse Event|0|||
146956659|NCT02135848|530000418|FG000|Overall Study|Withdrawal by Subject|1|||
146956660|NCT02135848|530000419|FG001|Overall Study|Withdrawal by Subject|1|||
146956661|NCT02030067|530000423|FG000|Overall Study|Disease Progression|1|||
146956662|NCT02030067|530000424|FG001|Overall Study|Disease Progression|1|||
146956663|NCT02030067|530000425|FG002|Overall Study|Disease Progression|2|||
146956664|NCT02030067|530000426|FG003|Overall Study|Disease Progression|2|||
146956665|NCT02030067|530000427|FG004|Overall Study|Disease Progression|3|||
146956666|NCT02030067|530000428|FG005|Overall Study|Disease Progression|2|||
146956667|NCT02030067|530000429|FG006|Overall Study|Disease Progression|3|||
146956668|NCT02030067|530000430|FG007|Overall Study|Disease Progression|3|||
146956669|NCT02030067|530000431|FG008|Overall Study|Disease Progression|4|||
146956670|NCT02030067|530000432|FG009|Overall Study|Disease Progression|3|||
146956671|NCT02030067|530000433|FG010|Overall Study|Disease Progression|7|||
146956672|NCT02030067|530000434|FG011|Overall Study|Disease Progression|2|||
146956673|NCT02030067|530000435|FG012|Overall Study|Disease Progression|59|||
146956674|NCT02030067|530000423|FG000|Overall Study|Withdrawal by Subject|0|||
146956675|NCT02030067|530000424|FG001|Overall Study|Withdrawal by Subject|0|||
146956676|NCT02030067|530000425|FG002|Overall Study|Withdrawal by Subject|0|||
146956677|NCT02030067|530000426|FG003|Overall Study|Withdrawal by Subject|1|||
146956678|NCT02030067|530000427|FG004|Overall Study|Withdrawal by Subject|0|||
146956679|NCT02030067|530000428|FG005|Overall Study|Withdrawal by Subject|0|||
146956680|NCT02030067|530000429|FG006|Overall Study|Withdrawal by Subject|0|||
146956681|NCT02030067|530000430|FG007|Overall Study|Withdrawal by Subject|1|||
146956682|NCT02030067|530000431|FG008|Overall Study|Withdrawal by Subject|0|||
146956683|NCT02030067|530000432|FG009|Overall Study|Withdrawal by Subject|0|||
146956684|NCT02030067|530000433|FG010|Overall Study|Withdrawal by Subject|3|||
146956685|NCT02030067|530000434|FG011|Overall Study|Withdrawal by Subject|0|||
146956686|NCT02030067|530000435|FG012|Overall Study|Withdrawal by Subject|6|||
146956687|NCT02030067|530000423|FG000|Overall Study|Physician Decision|0|||
146956688|NCT02030067|530000424|FG001|Overall Study|Physician Decision|0|||
146956689|NCT02030067|530000425|FG002|Overall Study|Physician Decision|0|||
146956690|NCT02030067|530000426|FG003|Overall Study|Physician Decision|0|||
146956691|NCT02030067|530000427|FG004|Overall Study|Physician Decision|0|||
146956692|NCT02030067|530000428|FG005|Overall Study|Physician Decision|0|||
146956693|NCT02030067|530000429|FG006|Overall Study|Physician Decision|0|||
146956694|NCT02030067|530000430|FG007|Overall Study|Physician Decision|0|||
146956695|NCT02030067|530000431|FG008|Overall Study|Physician Decision|0|||
146956696|NCT02030067|530000432|FG009|Overall Study|Physician Decision|0|||
146956697|NCT02030067|530000433|FG010|Overall Study|Physician Decision|1|||
146956698|NCT02030067|530000434|FG011|Overall Study|Physician Decision|0|||
146956699|NCT02030067|530000435|FG012|Overall Study|Physician Decision|3|||
146956700|NCT02030067|530000423|FG000|Overall Study|other reasons|0|||
146956701|NCT02030067|530000424|FG001|Overall Study|other reasons|0|||
146956702|NCT02030067|530000425|FG002|Overall Study|other reasons|0|||
146956703|NCT02030067|530000426|FG003|Overall Study|other reasons|0|||
146956704|NCT02030067|530000427|FG004|Overall Study|other reasons|0|||
146956705|NCT02030067|530000428|FG005|Overall Study|other reasons|1|||
146956706|NCT02030067|530000429|FG006|Overall Study|other reasons|0|||
146956707|NCT02030067|530000430|FG007|Overall Study|other reasons|0|||
146956708|NCT02030067|530000431|FG008|Overall Study|other reasons|2|||
146956709|NCT02030067|530000432|FG009|Overall Study|other reasons|0|||
146956710|NCT02030067|530000433|FG010|Overall Study|other reasons|0|||
146956711|NCT02030067|530000434|FG011|Overall Study|other reasons|0|||
146956712|NCT02030067|530000435|FG012|Overall Study|other reasons|4|||
146956713|NCT02030067|530000423|FG000|Overall Study|Adverse Event|0|||
146956714|NCT02030067|530000424|FG001|Overall Study|Adverse Event|0|||
146956715|NCT02030067|530000425|FG002|Overall Study|Adverse Event|0|||
146956716|NCT02030067|530000426|FG003|Overall Study|Adverse Event|0|||
146956717|NCT02030067|530000427|FG004|Overall Study|Adverse Event|0|||
146956718|NCT02030067|530000428|FG005|Overall Study|Adverse Event|0|||
146956719|NCT02030067|530000429|FG006|Overall Study|Adverse Event|0|||
146956720|NCT02030067|530000430|FG007|Overall Study|Adverse Event|0|||
146956721|NCT02030067|530000431|FG008|Overall Study|Adverse Event|0|||
146956722|NCT02030067|530000432|FG009|Overall Study|Adverse Event|0|||
146956723|NCT02030067|530000433|FG010|Overall Study|Adverse Event|0|||
146956724|NCT02030067|530000434|FG011|Overall Study|Adverse Event|1|||
146956725|NCT02030067|530000435|FG012|Overall Study|Adverse Event|8|||
146956726|NCT00265382|530000436|FG000|Overall Study|Adverse Event|21|||
146956727|NCT00265382|530000436|FG000|Overall Study|Laboratory Abnormality|1|||
146956728|NCT00265382|530000436|FG000|Overall Study|Lost to Follow-up|3|||
146956729|NCT00265382|530000436|FG000|Overall Study|Lack of Efficacy|6|||
146956730|NCT00265382|530000436|FG000|Overall Study|Miscellaneous|6|||
146956731|NCT00265382|530000436|FG000|Overall Study|Withdrawal by Subject|13|||
146956732|NCT00265382|530000436|FG000|Overall Study|Study terminated by sponsor|94|||
146956733|NCT00265382|530000436|FG000|Overall Study|Death|1|||
146956734|NCT02543801|530000437|FG000|Overall Study|Protocol Violation|1|||
146956735|NCT02543801|530000438|FG001|Overall Study|Protocol Violation|2|||
146956736|NCT02543801|530000439|FG002|Overall Study|Protocol Violation|0|||
146956737|NCT02543801|530000440|FG003|Overall Study|Protocol Violation|0|||
146956738|NCT02142712|530000446|FG000|Overall Study|Lost to Follow-up|1|||
146956739|NCT02142712|530000447|FG001|Overall Study|Lost to Follow-up|1|||
146956740|NCT02142712|530000448|FG002|Overall Study|Lost to Follow-up|1|||
146956741|NCT02142712|530000449|FG003|Overall Study|Lost to Follow-up|0|||
146956742|NCT02646332|530000455|FG000|Overall Study|Lost to Follow-up|0|||
146956743|NCT02646332|530000456|FG001|Overall Study|Lost to Follow-up|3|||
146956744|NCT01882439|530000457|FG000|Overall Study|Adverse event related to study drug|3|||
146956745|NCT01882439|530000458|FG001|Overall Study|Adverse event related to study drug|8|||
146956746|NCT01882439|530000459|FG002|Overall Study|Adverse event related to study drug|1|||
146826426|NCT00863798|529535622|FG000|Overall Study|Withdrawal by Subject|8|||
146826427|NCT00863798|529535623|FG001|Overall Study|Withdrawal by Subject|7|||
146826428|NCT00863798|529535624|FG002|Overall Study|Withdrawal by Subject|4|||
146826429|NCT00863798|529535622|FG000|Overall Study|Randomized not treated|4|||
146826430|NCT00863798|529535623|FG001|Overall Study|Randomized not treated|2|||
146826431|NCT00863798|529535624|FG002|Overall Study|Randomized not treated|3|||
146826432|NCT04238520|529535626|FG000|Overall Study|Withdrawal by Subject|1|||
146826433|NCT04238520|529535627|FG001|Overall Study|Withdrawal by Subject|1|||
146826434|NCT04238520|529535626|FG000|Overall Study|Lost to Follow-up|1|||
146826435|NCT04238520|529535627|FG001|Overall Study|Lost to Follow-up|2|||
146826436|NCT04238520|529535626|FG000|Overall Study|Death|0|||
146826437|NCT04238520|529535627|FG001|Overall Study|Death|2|||
146826438|NCT04238520|529535626|FG000|Overall Study|Unsafe home environment for research staff|0|||
146826439|NCT04238520|529535627|FG001|Overall Study|Unsafe home environment for research staff|1|||
146826440|NCT01470599|529535628|FG000|Overall Study|Did not meet entrance criteria|1|||
146826441|NCT01470599|529535629|FG001|Overall Study|Did not meet entrance criteria|0|||
146826442|NCT01470599|529535628|FG000|Overall Study|Lost to Follow-up|2|||
146826443|NCT01470599|529535629|FG001|Overall Study|Lost to Follow-up|1|||
146826444|NCT01470599|529535628|FG000|Overall Study|Withdrawal by Subject|3|||
146826445|NCT01470599|529535629|FG001|Overall Study|Withdrawal by Subject|4|||
146826446|NCT01470599|529535628|FG000|Overall Study|Other|1|||
146826447|NCT01470599|529535629|FG001|Overall Study|Other|0|||
146826448|NCT01470599|529535628|FG000|Overall Study|Protocol Violation|3|||
146826449|NCT01470599|529535629|FG001|Overall Study|Protocol Violation|1|||
146826450|NCT01470599|529535628|FG000|Overall Study|Adverse event related to study drug|2|||
146826451|NCT01470599|529535629|FG001|Overall Study|Adverse event related to study drug|5|||
146826452|NCT01470599|529535628|FG000|Overall Study|Insufficient clinical response|6|||
146826453|NCT01470599|529535629|FG001|Overall Study|Insufficient clinical response|27|||
146826454|NCT01470599|529535628|FG000|Overall Study|Adverse event not related to study drug|1|||
146826455|NCT01470599|529535629|FG001|Overall Study|Adverse event not related to study drug|5|||
146826456|NCT00195442|529535630|FG000|Overall Study|Less than expected therapeutic effect|38|||
146826457|NCT00195442|529535630|FG000|Overall Study|Lost to Follow-up|27|||
146826458|NCT00195442|529535630|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
146826459|NCT00195442|529535630|FG000|Overall Study|Intermittent product shortage|21|||
146826460|NCT00195442|529535630|FG000|Overall Study|Death|7|||
146826461|NCT00195442|529535630|FG000|Overall Study|No reason specified|4|||
146826462|NCT00195442|529535630|FG000|Overall Study|Poor cooperation|2|||
146826463|NCT00195442|529535630|FG000|Overall Study|Other|14|||
146826464|NCT02637856|529535638|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
146826465|NCT02637856|529535639|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
146826466|NCT02637856|529535638|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
146826467|NCT02637856|529535639|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
146826468|NCT02637856|529535638|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
146826469|NCT02637856|529535639|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
146826470|NCT02637856|529535638|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
146826471|NCT02637856|529535639|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
146826472|NCT02637856|529535638|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
146826473|NCT02637856|529535639|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
146826474|NCT02637856|529535638|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
146826475|NCT02637856|529535639|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
146826476|NCT02637856|529535638|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
146826477|NCT02637856|529535639|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
146826478|NCT02637856|529535638|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
146826479|NCT02637856|529535639|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
146826480|NCT02637856|529535638|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
146826481|NCT02637856|529535639|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
146826482|NCT02637856|529535638|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
146826483|NCT02637856|529535639|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
146826484|NCT02637856|529535638|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
146826485|NCT02637856|529535639|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
146826486|NCT02637856|529535638|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
146826487|NCT02637856|529535639|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
146826488|NCT02637856|529535638|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
146826489|NCT02637856|529535639|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
146826490|NCT02509312|529535640|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
146826491|NCT02509312|529535641|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
146826492|NCT02509312|529535640|FG000|Overall Study|Obstetrician refusal|0|||
146826493|NCT02509312|529535641|FG001|Overall Study|Obstetrician refusal|1|||
146826494|NCT02509312|529535640|FG000|Overall Study|Patient elected for TOLAC|1|||
146826495|NCT02509312|529535641|FG001|Overall Study|Patient elected for TOLAC|0|||
146826496|NCT02509312|529535640|FG000|Overall Study|Cesarean deemed stat|1|||
146956747|NCT01882439|530000460|FG003|Overall Study|Adverse event related to study drug|2|||
146956748|NCT01882439|530000457|FG000|Overall Study|Pregnancy|0|||
146956749|NCT01882439|530000458|FG001|Overall Study|Pregnancy|1|||
146956750|NCT01882439|530000459|FG002|Overall Study|Pregnancy|0|||
146956751|NCT01882439|530000460|FG003|Overall Study|Pregnancy|0|||
146956752|NCT01882439|530000457|FG000|Overall Study|Protocol Violation|2|||
146956753|NCT01882439|530000458|FG001|Overall Study|Protocol Violation|2|||
146956754|NCT01882439|530000459|FG002|Overall Study|Protocol Violation|0|||
146956755|NCT01882439|530000460|FG003|Overall Study|Protocol Violation|1|||
146956756|NCT01882439|530000457|FG000|Overall Study|No longer willing to participate|1|||
146956757|NCT01882439|530000458|FG001|Overall Study|No longer willing to participate|4|||
146956758|NCT01882439|530000459|FG002|Overall Study|No longer willing to participate|2|||
146956759|NCT01882439|530000460|FG003|Overall Study|No longer willing to participate|3|||
146956760|NCT01882439|530000457|FG000|Overall Study|Medication error with no associated AE|0|||
146956761|NCT01882439|530000458|FG001|Overall Study|Medication error with no associated AE|0|||
146956762|NCT01882439|530000459|FG002|Overall Study|Medication error with no associated AE|2|||
146956763|NCT01882439|530000460|FG003|Overall Study|Medication error with no associated AE|0|||
146956764|NCT01882439|530000457|FG000|Overall Study|Insufficient clinical response|1|||
146956765|NCT01882439|530000458|FG001|Overall Study|Insufficient clinical response|4|||
146956766|NCT01882439|530000459|FG002|Overall Study|Insufficient clinical response|4|||
146956767|NCT01882439|530000460|FG003|Overall Study|Insufficient clinical response|2|||
146956768|NCT01882439|530000457|FG000|Overall Study|Adverse event unrelated to study drug|2|||
146956769|NCT01882439|530000458|FG001|Overall Study|Adverse event unrelated to study drug|2|||
146956770|NCT01882439|530000459|FG002|Overall Study|Adverse event unrelated to study drug|1|||
146956771|NCT01882439|530000460|FG003|Overall Study|Adverse event unrelated to study drug|1|||
146956772|NCT01775995|530000463|FG000|Overall Study|Lost to Follow-up|1|||
146956773|NCT01775995|530000464|FG001|Overall Study|Lost to Follow-up|1|||
146956774|NCT03125902|530000465|FG000|Overall Study|Adverse Event|0|||
146956775|NCT03125902|530000466|FG001|Overall Study|Adverse Event|1|||
146956776|NCT03125902|530000465|FG000|Overall Study|Death|119|||
146956777|NCT03125902|530000466|FG001|Overall Study|Death|229|||
146956778|NCT03125902|530000465|FG000|Overall Study|Lost to Follow-up|4|||
146956779|NCT03125902|530000466|FG001|Overall Study|Lost to Follow-up|13|||
146956780|NCT03125902|530000465|FG000|Overall Study|Other|0|||
146956781|NCT03125902|530000466|FG001|Overall Study|Other|4|||
146956782|NCT03125902|530000465|FG000|Overall Study|Physician Decision|2|||
146956783|NCT03125902|530000466|FG001|Overall Study|Physician Decision|1|||
146956784|NCT03125902|530000465|FG000|Overall Study|Progressive Disease|0|||
146956785|NCT03125902|530000466|FG001|Overall Study|Progressive Disease|3|||
146956786|NCT03125902|530000465|FG000|Overall Study|Study Terminated By Sponsor|74|||
146956787|NCT03125902|530000466|FG001|Overall Study|Study Terminated By Sponsor|143|||
146956788|NCT03125902|530000465|FG000|Overall Study|Withdrawal by Subject|21|||
146956789|NCT03125902|530000466|FG001|Overall Study|Withdrawal by Subject|37|||
146956790|NCT01997333|530000467|FG000|Randomization and Treatment|Disease Progression|70|||
146956791|NCT01997333|530000468|FG001|Randomization and Treatment|Disease Progression|159|||
146956792|NCT01997333|530000467|FG000|Randomization and Treatment|Adverse Event|10|||
146956793|NCT01997333|530000468|FG001|Randomization and Treatment|Adverse Event|32|||
146956794|NCT01997333|530000467|FG000|Randomization and Treatment|Physician Decision|0|||
146956795|NCT01997333|530000468|FG001|Randomization and Treatment|Physician Decision|4|||
146956796|NCT01997333|530000467|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
146956797|NCT01997333|530000468|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
146956798|NCT01997333|530000467|FG000|Randomization and Treatment|Did not receive treatment|17|||
146956799|NCT01997333|530000468|FG001|Randomization and Treatment|Did not receive treatment|5|||
146956800|NCT01997333|530000467|FG000|Survival Follow up|Withdrawal by Subject|15|||
146956801|NCT01997333|530000468|FG001|Survival Follow up|Withdrawal by Subject|6|||
146956802|NCT01997333|530000467|FG000|Survival Follow up|Lost to Follow-up|0|||
146956803|NCT01997333|530000468|FG001|Survival Follow up|Lost to Follow-up|6|||
146956804|NCT01997333|530000467|FG000|Survival Follow up|Various|1|||
146956805|NCT01997333|530000468|FG001|Survival Follow up|Various|2|||
146956806|NCT04411472|530000471|FG000|Overall Study|Adverse Event|5|||
146956807|NCT04411472|530000472|FG001|Overall Study|Adverse Event|10|||
146956808|NCT04411472|530000473|FG002|Overall Study|Adverse Event|1|||
146956809|NCT04411472|530000474|FG003|Overall Study|Adverse Event|0|||
146956810|NCT04411472|530000475|FG004|Overall Study|Adverse Event|0|||
146956811|NCT04411472|530000476|FG005|Overall Study|Adverse Event|0|||
146956812|NCT04411472|530000471|FG000|Overall Study|Protocol Violation|1|||
146956813|NCT04411472|530000472|FG001|Overall Study|Protocol Violation|0|||
146956814|NCT04411472|530000473|FG002|Overall Study|Protocol Violation|0|||
146956815|NCT04411472|530000474|FG003|Overall Study|Protocol Violation|0|||
146956816|NCT04411472|530000475|FG004|Overall Study|Protocol Violation|0|||
146956817|NCT04411472|530000476|FG005|Overall Study|Protocol Violation|0|||
146956818|NCT04411472|530000471|FG000|Overall Study|Withdrawal by Subject|0|||
146956819|NCT04411472|530000472|FG001|Overall Study|Withdrawal by Subject|1|||
146956820|NCT04411472|530000473|FG002|Overall Study|Withdrawal by Subject|0|||
146956821|NCT04411472|530000474|FG003|Overall Study|Withdrawal by Subject|1|||
146956822|NCT04411472|530000475|FG004|Overall Study|Withdrawal by Subject|0|||
146985221|NCT01185288|530107219|FG001|Overall Study|Withdrawal by Subject|4|||
146985222|NCT01185288|530107218|FG000|Overall Study|Lost to Follow-up|2|||
146985223|NCT01185288|530107219|FG001|Overall Study|Lost to Follow-up|5|||
146985224|NCT01185288|530107218|FG000|Overall Study|Lack of Efficacy|2|||
146985225|NCT01185288|530107219|FG001|Overall Study|Lack of Efficacy|0|||
146985226|NCT01185288|530107218|FG000|Overall Study|Investigator discretion|1|||
146985227|NCT01185288|530107219|FG001|Overall Study|Investigator discretion|0|||
146985228|NCT01185288|530107218|FG000|Overall Study|Did not meet inclusion criteria|1|||
146985229|NCT01185288|530107219|FG001|Overall Study|Did not meet inclusion criteria|0|||
146985230|NCT01185288|530107218|FG000|Overall Study|Noncompliance|0|||
146985231|NCT01185288|530107219|FG001|Overall Study|Noncompliance|1|||
146985232|NCT02427607|530107220|FG000|Overall Study|Withdrawal by Subject|1|||
146985233|NCT02277769|530107221|FG000|Overall Study|Protocol Violation|3|||
146985234|NCT02277769|530107222|FG001|Overall Study|Protocol Violation|3|||
146985235|NCT02277769|530107223|FG002|Overall Study|Protocol Violation|5|||
146985236|NCT02277769|530107221|FG000|Overall Study|Lack of Efficacy|17|||
146985237|NCT02277769|530107222|FG001|Overall Study|Lack of Efficacy|0|||
146985238|NCT02277769|530107223|FG002|Overall Study|Lack of Efficacy|4|||
146985239|NCT02277769|530107221|FG000|Overall Study|Adverse Event|14|||
146985240|NCT02277769|530107222|FG001|Overall Study|Adverse Event|2|||
146985241|NCT02277769|530107223|FG002|Overall Study|Adverse Event|4|||
146985242|NCT02277769|530107221|FG000|Overall Study|Other than specified above|12|||
146985243|NCT02277769|530107222|FG001|Overall Study|Other than specified above|8|||
146985244|NCT02277769|530107223|FG002|Overall Study|Other than specified above|5|||
146985245|NCT00656019|530107224|FG000|Overall Study|Not Eligible|10|||
146985246|NCT00656019|530107225|FG001|Overall Study|Not Eligible|0|||
146985247|NCT00656019|530107226|FG002|Overall Study|Not Eligible|0|||
146985248|NCT00656019|530107227|FG003|Overall Study|Not Eligible|0|||
146985249|NCT00656019|530107224|FG000|Overall Study|Withdrawal by Subject|2|||
146985250|NCT00656019|530107225|FG001|Overall Study|Withdrawal by Subject|0|||
146985251|NCT00656019|530107226|FG002|Overall Study|Withdrawal by Subject|0|||
146985252|NCT00656019|530107227|FG003|Overall Study|Withdrawal by Subject|0|||
146985253|NCT00656019|530107224|FG000|Overall Study|Lost to Follow-up|2|||
146985254|NCT00656019|530107225|FG001|Overall Study|Lost to Follow-up|1|||
146985255|NCT00656019|530107226|FG002|Overall Study|Lost to Follow-up|0|||
146985256|NCT00656019|530107227|FG003|Overall Study|Lost to Follow-up|0|||
146985257|NCT03083132|530107232|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
146985258|NCT03083132|530107233|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
146985259|NCT03083132|530107232|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
146985260|NCT03083132|530107233|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
146985261|NCT03083132|530107232|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
146985262|NCT03083132|530107233|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
146985263|NCT03118739|530107234|FG000|Overall Study|Physician Decision|0|||
146985264|NCT03118739|530107235|FG001|Overall Study|Physician Decision|1|||
146985265|NCT03118739|530107234|FG000|Overall Study|Withdrawal by Subject|5|||
146985266|NCT03118739|530107235|FG001|Overall Study|Withdrawal by Subject|3|||
146985267|NCT03118739|530107234|FG000|Overall Study|Lost to Follow-up|2|||
146985268|NCT03118739|530107235|FG001|Overall Study|Lost to Follow-up|0|||
146985269|NCT00669955|530107236|FG000|Overall Study|Adverse Event|3|||
146985270|NCT00669955|530107237|FG001|Overall Study|Adverse Event|5|||
146985271|NCT00669955|530107236|FG000|Overall Study|Death|0|||
146985272|NCT00669955|530107237|FG001|Overall Study|Death|1|||
146985273|NCT00669955|530107236|FG000|Overall Study|Withdrawal by Subject|2|||
146985274|NCT00669955|530107237|FG001|Overall Study|Withdrawal by Subject|3|||
146826497|NCT02509312|529535641|FG001|Overall Study|Cesarean deemed stat|0|||
146985275|NCT00669955|530107236|FG000|Overall Study|Lost to Follow-up|5|||
146985276|NCT00669955|530107237|FG001|Overall Study|Lost to Follow-up|7|||
146985277|NCT00669955|530107236|FG000|Overall Study|Protocol Violation|2|||
146985278|NCT00669955|530107237|FG001|Overall Study|Protocol Violation|7|||
146985279|NCT00669955|530107236|FG000|Overall Study|Investigator Sponsor Judgement|0|||
146985280|NCT00669955|530107237|FG001|Overall Study|Investigator Sponsor Judgement|1|||
146826498|NCT02509312|529535640|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
146826499|NCT02509312|529535641|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
146826500|NCT02815735|529535644|FG000|First Intervention (4 Weeks)|Discomfort|1|||
146985281|NCT00669955|530107236|FG000|Overall Study|not compliant with study drug/visit|2|||
146985282|NCT00669955|530107237|FG001|Overall Study|not compliant with study drug/visit|3|||
146985283|NCT01326026|530107245|FG000|Overall Study|Adverse Event|4|||
146985284|NCT01326026|530107246|FG001|Overall Study|Adverse Event|3|||
146985285|NCT01326026|530107245|FG000|Overall Study|Withdrawal Criteria|5|||
146985286|NCT01326026|530107246|FG001|Overall Study|Withdrawal Criteria|7|||
146985287|NCT01326026|530107245|FG000|Overall Study|Other|3|||
146985288|NCT01326026|530107246|FG001|Overall Study|Other|3|||
146826501|NCT02815735|529535645|FG001|First Intervention (4 Weeks)|Discomfort|0|||
146985289|NCT04317053|530107250|FG000|Overall Study|Withdrawn (screen failure)|4|||
146985290|NCT04317053|530107251|FG001|Overall Study|Withdrawn (screen failure)|2|||
146826502|NCT02815735|529535644|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
146826503|NCT02815735|529535645|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
146826504|NCT02815735|529535644|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
146826505|NCT02815735|529535645|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
146826506|NCT02815735|529535644|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
146826507|NCT02815735|529535645|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
146826508|NCT00702650|529535647|FG000|Overall Study|Withdrawal by Subject|9|||
146826509|NCT00702650|529535647|FG000|Overall Study|Non-Compliance of Study Drug|3|||
146826510|NCT00702650|529535647|FG000|Overall Study|Lost to Follow-up|2|||
146826511|NCT00702650|529535647|FG000|Overall Study|Non-Compliance with Site Directives|1|||
146826512|NCT00702650|529535647|FG000|Overall Study|Sponsor Request|1|||
146826513|NCT00702650|529535647|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
146826514|NCT00702650|529535647|FG000|Overall Study|Adverse Event|3|||
146826515|NCT00988533|529535648|FG000|Overall Study|Lost to Follow-up|3|||
146826516|NCT00943722|529535650|FG000|Base Study|Adverse Event|0|||
146826517|NCT00943722|529535651|FG001|Base Study|Adverse Event|0|||
146826518|NCT00943722|529535652|FG002|Base Study|Adverse Event|0|||
146826519|NCT00943722|529535653|FG003|Base Study|Adverse Event|1|||
146826520|NCT00943722|529535654|FG004|Base Study|Adverse Event|0|||
146826521|NCT00943722|529535655|FG005|Base Study|Adverse Event|0|||
146826522|NCT00943722|529535656|FG006|Base Study|Adverse Event|0|||
146826523|NCT00943722|529535650|FG000|Base Study|Lost to Follow-up|12|||
146826524|NCT00943722|529535651|FG001|Base Study|Lost to Follow-up|8|||
146826525|NCT00943722|529535652|FG002|Base Study|Lost to Follow-up|10|||
146826526|NCT00943722|529535653|FG003|Base Study|Lost to Follow-up|8|||
146826527|NCT00943722|529535654|FG004|Base Study|Lost to Follow-up|11|||
146826528|NCT00943722|529535655|FG005|Base Study|Lost to Follow-up|0|||
146826529|NCT00943722|529535656|FG006|Base Study|Lost to Follow-up|0|||
146826530|NCT00943722|529535650|FG000|Base Study|Physician Decision|1|||
146826531|NCT00943722|529535651|FG001|Base Study|Physician Decision|0|||
146826532|NCT00943722|529535652|FG002|Base Study|Physician Decision|0|||
146826533|NCT00943722|529535653|FG003|Base Study|Physician Decision|0|||
146826534|NCT00943722|529535654|FG004|Base Study|Physician Decision|1|||
146826535|NCT00943722|529535655|FG005|Base Study|Physician Decision|0|||
146826536|NCT00943722|529535656|FG006|Base Study|Physician Decision|0|||
146826537|NCT00943722|529535650|FG000|Base Study|Pregnancy|0|||
146826538|NCT00943722|529535651|FG001|Base Study|Pregnancy|0|||
146826539|NCT00943722|529535652|FG002|Base Study|Pregnancy|1|||
146826540|NCT00943722|529535653|FG003|Base Study|Pregnancy|0|||
146826541|NCT00943722|529535654|FG004|Base Study|Pregnancy|2|||
146826542|NCT00943722|529535655|FG005|Base Study|Pregnancy|0|||
146826543|NCT00943722|529535656|FG006|Base Study|Pregnancy|0|||
146826544|NCT00943722|529535650|FG000|Base Study|Protocol Violation|0|||
146826545|NCT00943722|529535651|FG001|Base Study|Protocol Violation|1|||
146826546|NCT00943722|529535652|FG002|Base Study|Protocol Violation|0|||
146826547|NCT00943722|529535653|FG003|Base Study|Protocol Violation|0|||
146826548|NCT00943722|529535654|FG004|Base Study|Protocol Violation|2|||
146826549|NCT00943722|529535655|FG005|Base Study|Protocol Violation|0|||
146826550|NCT00943722|529535656|FG006|Base Study|Protocol Violation|0|||
146826551|NCT00943722|529535650|FG000|Base Study|Withdrawal by Subject|12|||
146826552|NCT00943722|529535651|FG001|Base Study|Withdrawal by Subject|13|||
146826553|NCT00943722|529535652|FG002|Base Study|Withdrawal by Subject|2|||
146826554|NCT00943722|529535653|FG003|Base Study|Withdrawal by Subject|13|||
146826555|NCT00943722|529535654|FG004|Base Study|Withdrawal by Subject|8|||
146956823|NCT04411472|530000476|FG005|Overall Study|Withdrawal by Subject|0|||
146956824|NCT04411472|530000471|FG000|Overall Study|Physician Decision|1|||
146956825|NCT04411472|530000472|FG001|Overall Study|Physician Decision|0|||
146956826|NCT04411472|530000473|FG002|Overall Study|Physician Decision|0|||
146956827|NCT04411472|530000474|FG003|Overall Study|Physician Decision|0|||
146956828|NCT04411472|530000475|FG004|Overall Study|Physician Decision|0|||
146956829|NCT04411472|530000476|FG005|Overall Study|Physician Decision|0|||
146956830|NCT04411472|530000471|FG000|Overall Study|Study terminated by sponsor|17|||
146956831|NCT04411472|530000472|FG001|Overall Study|Study terminated by sponsor|20|||
146956832|NCT04411472|530000473|FG002|Overall Study|Study terminated by sponsor|3|||
146956833|NCT04411472|530000474|FG003|Overall Study|Study terminated by sponsor|0|||
146956834|NCT04411472|530000475|FG004|Overall Study|Study terminated by sponsor|0|||
146956835|NCT04411472|530000476|FG005|Overall Study|Study terminated by sponsor|0|||
146956836|NCT05060003|530000477|FG000|Overall Study|ctDNA negative|7|||
146956837|NCT00440232|530000478|FG000|Overall Study|Lost to Follow-up|1|||
146956838|NCT00440232|530000479|FG001|Overall Study|Lost to Follow-up|1|||
146985291|NCT00289458|530107252|FG000|Overall Study|Death|1|||
146826556|NCT00943722|529535655|FG005|Base Study|Withdrawal by Subject|0|||
146826557|NCT00943722|529535656|FG006|Base Study|Withdrawal by Subject|0|||
146826558|NCT00943722|529535650|FG000|Base Study|Month 12 visit not completed|0|||
146826559|NCT00943722|529535651|FG001|Base Study|Month 12 visit not completed|0|||
146826560|NCT00943722|529535652|FG002|Base Study|Month 12 visit not completed|0|||
146826561|NCT00943722|529535653|FG003|Base Study|Month 12 visit not completed|0|||
146985292|NCT00289458|530107253|FG001|Overall Study|Death|0|||
146826562|NCT00943722|529535654|FG004|Base Study|Month 12 visit not completed|2|||
146826563|NCT00943722|529535655|FG005|Base Study|Month 12 visit not completed|0|||
146826564|NCT00943722|529535656|FG006|Base Study|Month 12 visit not completed|0|||
146985293|NCT00289458|530107254|FG002|Overall Study|Death|0|||
146985294|NCT00289458|530107252|FG000|Overall Study|Physician Decision|3|||
146985295|NCT00289458|530107253|FG001|Overall Study|Physician Decision|4|||
146985296|NCT00289458|530107254|FG002|Overall Study|Physician Decision|2|||
146985297|NCT00289458|530107252|FG000|Overall Study|Withdrawal by Subject|2|||
146985298|NCT00289458|530107253|FG001|Overall Study|Withdrawal by Subject|2|||
146985299|NCT00289458|530107254|FG002|Overall Study|Withdrawal by Subject|4|||
146985300|NCT04274192|530107255|FG000|Overall Study|Protocol Violation|1|||
146985301|NCT04274192|530107256|FG001|Overall Study|Protocol Violation|0|||
146985302|NCT03507439|530107257|FG000|Overall Study|Other|2|||
146985303|NCT03507439|530107258|FG001|Overall Study|Other|1|||
146985304|NCT03507439|530107257|FG000|Overall Study|Withdrawal by Subject|1|||
146985305|NCT03507439|530107258|FG001|Overall Study|Withdrawal by Subject|0|||
146985306|NCT03507439|530107257|FG000|Overall Study|Death|1|||
146985307|NCT03507439|530107258|FG001|Overall Study|Death|1|||
146985308|NCT00874757|530107259|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
146985309|NCT01073020|530108805|FG000|Overall Study|Withdrawal by Subject|6|||
146985310|NCT01073020|530108806|FG001|Overall Study|Withdrawal by Subject|4|||
146985311|NCT01073020|530108807|FG002|Overall Study|Withdrawal by Subject|1|||
146985312|NCT01073020|530108808|FG003|Overall Study|Withdrawal by Subject|2|||
146985313|NCT01073020|530108805|FG000|Overall Study|Physician Decision|1|||
146985314|NCT01073020|530108806|FG001|Overall Study|Physician Decision|0|||
146985315|NCT01073020|530108807|FG002|Overall Study|Physician Decision|2|||
146985316|NCT01073020|530108808|FG003|Overall Study|Physician Decision|0|||
146985317|NCT01073020|530108805|FG000|Overall Study|Death|0|||
146985318|NCT01073020|530108806|FG001|Overall Study|Death|1|||
146985319|NCT01073020|530108807|FG002|Overall Study|Death|0|||
146985320|NCT01073020|530108808|FG003|Overall Study|Death|0|||
146985321|NCT01644890|530108809|FG000|Overall Study|Adverse Event|7|||
146985322|NCT01644890|530108810|FG001|Overall Study|Adverse Event|20|||
146985323|NCT01644890|530108809|FG000|Overall Study|Death|1|||
146985324|NCT01644890|530108810|FG001|Overall Study|Death|3|||
146985325|NCT01644890|530108809|FG000|Overall Study|Physician Decision|3|||
146985326|NCT01644890|530108810|FG001|Overall Study|Physician Decision|9|||
146985327|NCT01644890|530108809|FG000|Overall Study|Protocol Violation|6|||
146985328|NCT01644890|530108810|FG001|Overall Study|Protocol Violation|7|||
146985329|NCT01644890|530108809|FG000|Overall Study|Withdrawal by Subject|19|||
146985330|NCT01644890|530108810|FG001|Overall Study|Withdrawal by Subject|27|||
146985331|NCT01644890|530108809|FG000|Overall Study|Progression Disease|160|||
146985332|NCT01644890|530108810|FG001|Overall Study|Progression Disease|131|||
146985333|NCT01644890|530108809|FG000|Overall Study|Clinical Progression|6|||
146985334|NCT01644890|530108810|FG001|Overall Study|Clinical Progression|6|||
146985335|NCT01644890|530108809|FG000|Overall Study|> 28 days since last dose of study drug|6|||
146985336|NCT01644890|530108810|FG001|Overall Study|> 28 days since last dose of study drug|3|||
146985337|NCT01644890|530108809|FG000|Overall Study|Other|8|||
146985338|NCT01644890|530108810|FG001|Overall Study|Other|9|||
146985339|NCT03031899|530108815|FG000|Overall Study|Protocol Violation|1|||
146985340|NCT03031899|530108815|FG000|Overall Study|lesion disappeared after stopping habit|1|||
146985341|NCT01060670|530108816|FG000|Run In|screen failure|0|||
146985342|NCT01060670|530108817|FG001|Run In|screen failure|238|||
146985343|NCT00094302|530108818|FG000|Overall Study|Lost to Follow-up|43|||
146985344|NCT00094302|530108819|FG001|Overall Study|Lost to Follow-up|41|||
146985345|NCT00094302|530108818|FG000|Overall Study|Physician Decision|5|||
146985346|NCT00094302|530108819|FG001|Overall Study|Physician Decision|8|||
146985347|NCT00094302|530108818|FG000|Overall Study|Withdrawal by Subject|103|||
146985348|NCT00094302|530108819|FG001|Overall Study|Withdrawal by Subject|111|||
146985349|NCT00094302|530108818|FG000|Overall Study|Death|266|||
146985350|NCT00094302|530108819|FG001|Overall Study|Death|246|||
146985351|NCT03705351|530108825|FG000|Overall Study|Study termination|3|||
146985352|NCT03705351|530108825|FG000|Overall Study|Death|1|||
146985353|NCT03705351|530108825|FG000|Overall Study|Lack of Efficacy|2|||
146985354|NCT03705351|530108825|FG000|Overall Study|Withdrawal by Subject|1|||
146985355|NCT01907087|530108830|FG000|Overall Study|Withdrawal by Subject|1|||
146985356|NCT02180061|530108831|FG000|Overall Study|Adverse Event|4|||
146985357|NCT02180061|530108832|FG001|Overall Study|Adverse Event|2|||
146985358|NCT02180061|530108831|FG000|Overall Study|Clinical Progression|5|||
146985359|NCT02180061|530108832|FG001|Overall Study|Clinical Progression|1|||
146985360|NCT02180061|530108831|FG000|Overall Study|Progressive Disease|15|||
146985361|NCT02180061|530108832|FG001|Overall Study|Progressive Disease|5|||
146985362|NCT02180061|530108831|FG000|Overall Study|Physician Decision|1|||
146985363|NCT02180061|530108832|FG001|Overall Study|Physician Decision|0|||
146985364|NCT00056160|530108835|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
146985365|NCT00056160|530108836|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
146985366|NCT00056160|530108835|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
146985367|NCT00056160|530108836|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
146985368|NCT00056160|530108835|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
146985369|NCT00056160|530108836|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
146985370|NCT00056160|530108835|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
146985371|NCT00056160|530108836|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
146985372|NCT00056160|530108835|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
146985373|NCT00056160|530108836|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
146985374|NCT00056160|530108835|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
146985375|NCT00056160|530108836|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
146985376|NCT00056160|530108835|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
146985377|NCT00056160|530108836|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
146985378|NCT00056160|530108835|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
146985379|NCT00056160|530108836|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
146985380|NCT00056160|530108835|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
146985381|NCT00056160|530108836|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
146985382|NCT00056160|530108835|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
146985383|NCT00056160|530108836|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
146985384|NCT00056160|530108835|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
146985385|NCT00056160|530108836|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
146985386|NCT00056160|530108835|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
146985387|NCT00056160|530108836|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
146985388|NCT00056160|530108835|FG000|Final Follow-up|Transferred into expanded access study.|3|||
146985389|NCT00056160|530108836|FG001|Final Follow-up|Transferred into expanded access study.|0|||
146985390|NCT00056160|530108835|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
146985391|NCT00056160|530108836|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
146985392|NCT00056160|530108835|FG000|Final Follow-up|Adverse Event|1|||
146985393|NCT00056160|530108836|FG001|Final Follow-up|Adverse Event|0|||
146985394|NCT01469364|530108838|FG000|Overall Study|Adverse Event|1|||
146985395|NCT01469364|530108838|FG000|Overall Study|Withdrawal by Subject|1|||
146985396|NCT02742090|530108839|FG000|Overall Study|Adverse Event|10|||
146985397|NCT02742090|530108839|FG000|Overall Study|Death|3|||
146985398|NCT02742090|530108839|FG000|Overall Study|Disease Progression|25|||
146985399|NCT02742090|530108839|FG000|Overall Study|Investigator's Decision|1|||
146985400|NCT02742090|530108839|FG000|Overall Study|Lost to Follow-up|1|||
146985401|NCT02742090|530108839|FG000|Overall Study|Non-compliance with Study|1|||
146985402|NCT02742090|530108839|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
146985403|NCT02742090|530108839|FG000|Overall Study|Withdrawal by Subject|4|||
146985404|NCT02742090|530108839|FG000|Overall Study|Reason Not Specified|1|||
146985405|NCT01767597|530108840|FG000|Overall Study|Incomplete intervention|3|||
146985406|NCT01767597|530108841|FG001|Overall Study|Incomplete intervention|1|||
146985407|NCT01767597|530108840|FG000|Overall Study|Withdrawal by Subject|1|||
146826565|NCT00943722|529535650|FG000|First Extension Study: EXT 1|Adverse Event|0|||
146826566|NCT00943722|529535651|FG001|First Extension Study: EXT 1|Adverse Event|0|||
146826567|NCT00943722|529535652|FG002|First Extension Study: EXT 1|Adverse Event|0|||
146826568|NCT00943722|529535653|FG003|First Extension Study: EXT 1|Adverse Event|0|||
146826569|NCT00943722|529535654|FG004|First Extension Study: EXT 1|Adverse Event|0|||
146826570|NCT00943722|529535655|FG005|First Extension Study: EXT 1|Adverse Event|1|||
146826571|NCT00943722|529535656|FG006|First Extension Study: EXT 1|Adverse Event|0|||
146826572|NCT00943722|529535650|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
146826573|NCT00943722|529535651|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
146826574|NCT00943722|529535652|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
146826575|NCT00943722|529535653|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
146826576|NCT00943722|529535654|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
146826577|NCT00943722|529535655|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
146826578|NCT00943722|529535656|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
146826579|NCT00943722|529535650|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
146826580|NCT00943722|529535651|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
146826581|NCT00943722|529535652|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
146826582|NCT00943722|529535653|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
146826583|NCT00943722|529535654|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
146826584|NCT00943722|529535655|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
146826585|NCT00943722|529535656|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
146826586|NCT00943722|529535650|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
146826587|NCT00943722|529535651|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
146826588|NCT00943722|529535652|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
146826589|NCT00943722|529535653|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
146826590|NCT00943722|529535654|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
146985408|NCT01767597|530108841|FG001|Overall Study|Withdrawal by Subject|0|||
146985409|NCT03355742|530108842|FG000|Overall Study|Lost to Follow-up|4|||
146985410|NCT03355742|530108842|FG000|Overall Study|Withdrawal by Subject|29|||
146985411|NCT03355742|530108842|FG000|Overall Study|Physician Decision|6|||
146985412|NCT03355742|530108842|FG000|Overall Study|Death|55|||
146826591|NCT00943722|529535655|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
146826592|NCT00943722|529535656|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
146826593|NCT00943722|529535650|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
146956839|NCT00440232|530000478|FG000|Overall Study|Unable to treat within allowed time|0|||
146956840|NCT00440232|530000479|FG001|Overall Study|Unable to treat within allowed time|1|||
146956841|NCT00440232|530000478|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
146956842|NCT00440232|530000479|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
146956843|NCT01747655|530000482|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
146956844|NCT01747655|530000483|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
146956845|NCT01747655|530000482|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
146956846|NCT01747655|530000483|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
146956847|NCT01747655|530000482|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
146956848|NCT01747655|530000483|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
146956849|NCT03769753|530000486|FG000|Overall Study|Not Treated|6|||
146956850|NCT03769753|530000486|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
146956851|NCT01657903|530000488|FG000|Overall Study|Lost to Follow-up|1|||
146956852|NCT01657903|530000488|FG000|Overall Study|Withdrawal by Subject|1|||
146956853|NCT01259388|530000489|FG000|Overall Study|Adverse Event|3|||
146956854|NCT01259388|530000490|FG001|Overall Study|Adverse Event|0|||
146956855|NCT01259388|530000489|FG000|Overall Study|Withdrawal by Subject|1|||
146956856|NCT01259388|530000490|FG001|Overall Study|Withdrawal by Subject|1|||
146956857|NCT01259388|530000489|FG000|Overall Study|Physician Decision|1|||
146956858|NCT01259388|530000490|FG001|Overall Study|Physician Decision|0|||
146956859|NCT03529162|530000491|FG000|Overall Study|Lost to Follow-up|2|||
146956860|NCT03529162|530000492|FG001|Overall Study|Lost to Follow-up|2|||
146956861|NCT01906489|530000496|FG000|Overall Study|Adverse Event|10|||
146956862|NCT01906489|530000497|FG001|Overall Study|Adverse Event|3|||
146956863|NCT01906489|530000496|FG000|Overall Study|Worsening of CKD|6|||
146956864|NCT01906489|530000497|FG001|Overall Study|Worsening of CKD|4|||
146956865|NCT01906489|530000496|FG000|Overall Study|Withdrawal by Subject|5|||
146956866|NCT01906489|530000497|FG001|Overall Study|Withdrawal by Subject|0|||
146956867|NCT01906489|530000496|FG000|Overall Study|Worsening of Anemia|1|||
146956868|NCT01906489|530000497|FG001|Overall Study|Worsening of Anemia|0|||
146956869|NCT01906489|530000496|FG000|Overall Study|Protocol Violation|0|||
146956870|NCT01906489|530000497|FG001|Overall Study|Protocol Violation|1|||
146956871|NCT01906489|530000496|FG000|Overall Study|Non- Compliance|1|||
146956872|NCT01906489|530000497|FG001|Overall Study|Non- Compliance|0|||
146956873|NCT01906489|530000496|FG000|Overall Study|Sponsor Decision|1|||
146956874|NCT01906489|530000497|FG001|Overall Study|Sponsor Decision|0|||
146956875|NCT01906489|530000496|FG000|Overall Study|Lost to Follow-up|1|||
146956876|NCT01906489|530000497|FG001|Overall Study|Lost to Follow-up|1|||
146956877|NCT01906489|530000496|FG000|Overall Study|Other|1|||
146956878|NCT01906489|530000497|FG001|Overall Study|Other|0|||
146956879|NCT01078389|530002339|FG000|Overall Study|Adverse Event|10|||
146956880|NCT01078389|530002340|FG001|Overall Study|Adverse Event|6|||
146956881|NCT01078389|530002339|FG000|Overall Study|Major Protocol Deviation|2|||
146956882|NCT01078389|530002340|FG001|Overall Study|Major Protocol Deviation|0|||
146956883|NCT01078389|530002339|FG000|Overall Study|Lost to Follow-up|23|||
146956884|NCT01078389|530002340|FG001|Overall Study|Lost to Follow-up|23|||
146956885|NCT01078389|530002339|FG000|Overall Study|Voluntary Withdrawal|20|||
146956886|NCT01078389|530002340|FG001|Overall Study|Voluntary Withdrawal|36|||
146956887|NCT01078389|530002339|FG000|Overall Study|Other|9|||
146956888|NCT01078389|530002340|FG001|Overall Study|Other|2|||
146956889|NCT04563845|530002341|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146956890|NCT04563845|530002342|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146956891|NCT04563845|530002343|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146956892|NCT04563845|530002344|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146956893|NCT04563845|530002345|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146956894|NCT04563845|530002346|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146956895|NCT04563845|530002347|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146956896|NCT04563845|530002348|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
146956897|NCT04563845|530002349|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146956898|NCT04563845|530002350|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146956899|NCT04563845|530002351|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146956900|NCT04563845|530002352|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146956901|NCT04563845|530002353|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146956902|NCT04563845|530002354|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146956903|NCT04563845|530002341|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146956904|NCT04563845|530002342|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146956905|NCT04563845|530002343|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146956906|NCT04563845|530002344|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146956907|NCT04563845|530002345|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
146956908|NCT04563845|530002346|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146956909|NCT04563845|530002347|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146985413|NCT03355742|530108842|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
146985414|NCT00836927|530108843|FG000|Overall Study|Progressive disease|2|||
146985415|NCT00836927|530108844|FG001|Overall Study|Progressive disease|0|||
146985416|NCT00836927|530108845|FG002|Overall Study|Progressive disease|0|||
146985417|NCT00836927|530108846|FG003|Overall Study|Progressive disease|1|||
146985418|NCT00836927|530108847|FG004|Overall Study|Progressive disease|1|||
146985419|NCT00836927|530108843|FG000|Overall Study|Withdrawal by Subject|1|||
146985420|NCT00836927|530108844|FG001|Overall Study|Withdrawal by Subject|0|||
146985421|NCT00836927|530108845|FG002|Overall Study|Withdrawal by Subject|0|||
146985422|NCT00836927|530108846|FG003|Overall Study|Withdrawal by Subject|0|||
146985423|NCT00836927|530108847|FG004|Overall Study|Withdrawal by Subject|0|||
146985424|NCT00614055|530108853|FG000|Overall Study|Adverse Event|1|||
146985425|NCT00614055|530108854|FG001|Overall Study|Adverse Event|0|||
146985426|NCT00614055|530108855|FG002|Overall Study|Adverse Event|0|||
146985427|NCT00614055|530108853|FG000|Overall Study|Protocol Violation|2|||
146985428|NCT00614055|530108854|FG001|Overall Study|Protocol Violation|2|||
146985429|NCT00614055|530108855|FG002|Overall Study|Protocol Violation|1|||
146985430|NCT00614055|530108853|FG000|Overall Study|Lack of Efficacy|0|||
146985431|NCT00614055|530108854|FG001|Overall Study|Lack of Efficacy|0|||
146985432|NCT00614055|530108855|FG002|Overall Study|Lack of Efficacy|2|||
146985433|NCT00614055|530108853|FG000|Overall Study|Unclassified|1|||
146985434|NCT00614055|530108854|FG001|Overall Study|Unclassified|4|||
146985435|NCT00614055|530108855|FG002|Overall Study|Unclassified|2|||
146985436|NCT02637557|530108856|FG000|Overall Study|Adverse Event|3|||
146985437|NCT02637557|530108857|FG001|Overall Study|Adverse Event|1|||
146985438|NCT02637557|530108858|FG002|Overall Study|Adverse Event|3|||
146985439|NCT02637557|530108859|FG003|Overall Study|Adverse Event|3|||
146985440|NCT02637557|530108856|FG000|Overall Study|Lost to Follow-up|1|||
146985441|NCT02637557|530108857|FG001|Overall Study|Lost to Follow-up|1|||
146985442|NCT02637557|530108858|FG002|Overall Study|Lost to Follow-up|0|||
146985443|NCT02637557|530108859|FG003|Overall Study|Lost to Follow-up|1|||
146985444|NCT02637557|530108856|FG000|Overall Study|Physician Decision|1|||
146985445|NCT02637557|530108857|FG001|Overall Study|Physician Decision|0|||
146985446|NCT02637557|530108858|FG002|Overall Study|Physician Decision|0|||
146985447|NCT02637557|530108859|FG003|Overall Study|Physician Decision|0|||
146985448|NCT02637557|530108856|FG000|Overall Study|Protocol Violation|2|||
146985449|NCT02637557|530108857|FG001|Overall Study|Protocol Violation|0|||
146985450|NCT02637557|530108858|FG002|Overall Study|Protocol Violation|2|||
146985451|NCT02637557|530108859|FG003|Overall Study|Protocol Violation|1|||
146985452|NCT02637557|530108856|FG000|Overall Study|Withdrawal by Subject|1|||
146985453|NCT02637557|530108857|FG001|Overall Study|Withdrawal by Subject|3|||
146985454|NCT02637557|530108858|FG002|Overall Study|Withdrawal by Subject|4|||
146985455|NCT02637557|530108859|FG003|Overall Study|Withdrawal by Subject|2|||
146985456|NCT01673009|530108860|FG000|Overall Study|Physician Decision|5|||
146985457|NCT01673009|530108860|FG000|Overall Study|Withdrawal by Subject|8|||
146985458|NCT00952484|530108864|FG000|Overall Study|Withdrawal by Subject|0|||
146985459|NCT00952484|530108865|FG001|Overall Study|Withdrawal by Subject|1|||
146985460|NCT00952484|530108866|FG002|Overall Study|Withdrawal by Subject|0|||
146985461|NCT02750306|530108867|FG000|Overall Study|Withdrawal by Subject|5|||
146985462|NCT02750306|530108868|FG001|Overall Study|Withdrawal by Subject|2|||
146985463|NCT02750306|530108867|FG000|Overall Study|Protocol Violation|1|||
146985464|NCT02750306|530108868|FG001|Overall Study|Protocol Violation|0|||
146985465|NCT01829477|530108870|FG000|Overall Study|Study Terminated by Sponsor|15|||
146985466|NCT01829477|530108871|FG001|Overall Study|Study Terminated by Sponsor|15|||
146985467|NCT01829477|530108870|FG000|Overall Study|Withdrawal by Subject|1|||
146985468|NCT01829477|530108871|FG001|Overall Study|Withdrawal by Subject|0|||
146985469|NCT03361423|530108872|FG000|Overall Study|Withdrawal by Subject|4|||
146985470|NCT03361423|530108873|FG001|Overall Study|Withdrawal by Subject|3|||
146985471|NCT03361423|530108872|FG000|Overall Study|Did not treat|19|||
146826594|NCT00943722|529535651|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
146826595|NCT00943722|529535652|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
146985472|NCT03361423|530108873|FG001|Overall Study|Did not treat|18|||
146985473|NCT03361423|530108872|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
146985474|NCT03361423|530108873|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
146985475|NCT03361423|530108872|FG000|Overall Study|Missing data|4|||
146985476|NCT03361423|530108873|FG001|Overall Study|Missing data|1|||
146985477|NCT00299156|530108874|FG000|Period 2 (Randomized)|Screen Failure|0|||
146985478|NCT00299156|530108875|FG001|Period 2 (Randomized)|Screen Failure|1|||
146985479|NCT00299156|530108876|FG002|Period 2 (Randomized)|Screen Failure|0|||
146985480|NCT01725451|530108877|FG000|Period 1|Withdrawal by Subject|1|||
146985481|NCT01725451|530108878|FG001|Period 1|Withdrawal by Subject|0|||
146985482|NCT01725451|530108879|FG002|Period 1|Withdrawal by Subject|0|||
146985483|NCT01725451|530108880|FG003|Period 1|Withdrawal by Subject|0|||
146985484|NCT01725451|530108877|FG000|Washout From Period 3|Protocol Violation|0|||
146985485|NCT01725451|530108878|FG001|Washout From Period 3|Protocol Violation|0|||
146985486|NCT01725451|530108879|FG002|Washout From Period 3|Protocol Violation|1|||
146985487|NCT01725451|530108880|FG003|Washout From Period 3|Protocol Violation|0|||
146956910|NCT04563845|530002348|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146956911|NCT04563845|530002349|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146956912|NCT04563845|530002350|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146956913|NCT04563845|530002351|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146956914|NCT04563845|530002352|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146956915|NCT04563845|530002353|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146956916|NCT04563845|530002354|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146956917|NCT01020812|530002355|FG000|Overall Study|Physician Decision|1|||
146956918|NCT01020812|530002355|FG000|Overall Study|Withdrawal by Subject|1|||
146956919|NCT01020812|530002355|FG000|Overall Study|Protocol Violation|1|||
146956920|NCT01519700|530002356|FG000|Overall Study|Death|1|||
146956921|NCT01519700|530002357|FG001|Overall Study|Death|0|||
146956922|NCT01519700|530002358|FG002|Overall Study|Death|0|||
146956923|NCT01519700|530002359|FG003|Overall Study|Death|0|||
146956924|NCT01519700|530002356|FG000|Overall Study|Lost to Follow-up|0|||
146956925|NCT01519700|530002357|FG001|Overall Study|Lost to Follow-up|0|||
146956926|NCT01519700|530002358|FG002|Overall Study|Lost to Follow-up|1|||
146956927|NCT01519700|530002359|FG003|Overall Study|Lost to Follow-up|1|||
146956928|NCT01519700|530002356|FG000|Overall Study|Physician Decision|1|||
146956929|NCT01519700|530002357|FG001|Overall Study|Physician Decision|1|||
146956930|NCT01519700|530002358|FG002|Overall Study|Physician Decision|3|||
146956931|NCT01519700|530002359|FG003|Overall Study|Physician Decision|0|||
146956932|NCT01519700|530002356|FG000|Overall Study|Withdrawal by Subject|5|||
146956933|NCT01519700|530002357|FG001|Overall Study|Withdrawal by Subject|3|||
146956934|NCT01519700|530002358|FG002|Overall Study|Withdrawal by Subject|3|||
146956935|NCT01519700|530002359|FG003|Overall Study|Withdrawal by Subject|2|||
146956936|NCT01519700|530002356|FG000|Overall Study|Other Reason|2|||
146956937|NCT01519700|530002357|FG001|Overall Study|Other Reason|2|||
146956938|NCT01519700|530002358|FG002|Overall Study|Other Reason|0|||
146956939|NCT01519700|530002359|FG003|Overall Study|Other Reason|4|||
146956940|NCT02927990|530002363|FG000|Overall Study|Protocol Violation|4|||
146956941|NCT02927990|530002363|FG000|Overall Study|Physician Decision|9|||
146956942|NCT02927990|530002363|FG000|Overall Study|Room switched and therefore no study device available|15|||
146956943|NCT02927990|530002363|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
146956944|NCT00960323|530002364|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
146956945|NCT03824704|530002369|FG000|Overall Study|Study Terminated by Sponsor|1|||
146956946|NCT02155660|530002377|FG000|Overall Study|Other Reason|8|||
146956947|NCT02155660|530002378|FG001|Overall Study|Other Reason|6|||
146956948|NCT02155660|530002379|FG002|Overall Study|Other Reason|10|||
146956949|NCT02155660|530002380|FG003|Overall Study|Other Reason|10|||
146956950|NCT02155660|530002377|FG000|Overall Study|Study-specific withdrawal criteria|0|||
146956951|NCT02155660|530002378|FG001|Overall Study|Study-specific withdrawal criteria|1|||
146956952|NCT02155660|530002379|FG002|Overall Study|Study-specific withdrawal criteria|1|||
146956953|NCT02155660|530002380|FG003|Overall Study|Study-specific withdrawal criteria|1|||
146956954|NCT02155660|530002377|FG000|Overall Study|Severe non-compliance|0|||
146956955|NCT02155660|530002378|FG001|Overall Study|Severe non-compliance|4|||
146956956|NCT02155660|530002379|FG002|Overall Study|Severe non-compliance|0|||
146956957|NCT02155660|530002380|FG003|Overall Study|Severe non-compliance|1|||
146956958|NCT02155660|530002377|FG000|Overall Study|Adverse Event|2|||
146956959|NCT02155660|530002378|FG001|Overall Study|Adverse Event|6|||
146956960|NCT02155660|530002379|FG002|Overall Study|Adverse Event|3|||
146956961|NCT02155660|530002380|FG003|Overall Study|Adverse Event|1|||
146956962|NCT02155660|530002377|FG000|Overall Study|Lost to Follow-up|3|||
146956963|NCT02155660|530002378|FG001|Overall Study|Lost to Follow-up|6|||
146956964|NCT02155660|530002379|FG002|Overall Study|Lost to Follow-up|5|||
146956965|NCT02155660|530002380|FG003|Overall Study|Lost to Follow-up|8|||
146956966|NCT02155660|530002377|FG000|Overall Study|Death|17|||
146956967|NCT02155660|530002378|FG001|Overall Study|Death|19|||
146956968|NCT02155660|530002379|FG002|Overall Study|Death|17|||
146956969|NCT02155660|530002380|FG003|Overall Study|Death|19|||
146956970|NCT02155660|530002377|FG000|Overall Study|Withdrawal by Subject|28|||
146956971|NCT02155660|530002378|FG001|Overall Study|Withdrawal by Subject|31|||
146956972|NCT02155660|530002379|FG002|Overall Study|Withdrawal by Subject|24|||
146956973|NCT02155660|530002380|FG003|Overall Study|Withdrawal by Subject|21|||
146956974|NCT03730987|530002381|FG000|Overall Study|Lost to Follow-up|2|||
146956975|NCT03730987|530002382|FG001|Overall Study|Lost to Follow-up|0|||
146956976|NCT03730987|530002383|FG002|Overall Study|Lost to Follow-up|2|||
146956977|NCT03730987|530002384|FG003|Overall Study|Lost to Follow-up|0|||
146956978|NCT02505945|530002385|FG000|Overall Study|Withdrawal by Subject|13|||
146956979|NCT02505945|530002386|FG001|Overall Study|Withdrawal by Subject|2|||
146956980|NCT02505945|530002385|FG000|Overall Study|Adverse Event|1|||
146956981|NCT02505945|530002386|FG001|Overall Study|Adverse Event|0|||
146956982|NCT02505945|530002385|FG000|Overall Study|Physician Decision|2|||
146956983|NCT02505945|530002386|FG001|Overall Study|Physician Decision|1|||
146956984|NCT02505945|530002385|FG000|Overall Study|Lost to Follow-up|6|||
146956985|NCT02505945|530002386|FG001|Overall Study|Lost to Follow-up|1|||
146956986|NCT00386152|530002387|FG000|Overall Study|Adverse Event|6|||
146956987|NCT00386152|530002388|FG001|Overall Study|Adverse Event|5|||
146956988|NCT00386152|530002389|FG002|Overall Study|Adverse Event|4|||
146956989|NCT00386152|530002387|FG000|Overall Study|Chang from original chemo stratification|4|||
146956990|NCT00386152|530002388|FG001|Overall Study|Chang from original chemo stratification|5|||
146956991|NCT00386152|530002389|FG002|Overall Study|Chang from original chemo stratification|6|||
146956992|NCT00386152|530002387|FG000|Overall Study|Death|3|||
146956993|NCT00386152|530002388|FG001|Overall Study|Death|0|||
146956994|NCT00386152|530002389|FG002|Overall Study|Death|1|||
146956995|NCT00386152|530002387|FG000|Overall Study|Disease progression|7|||
146956996|NCT00386152|530002388|FG001|Overall Study|Disease progression|4|||
146956997|NCT00386152|530002389|FG002|Overall Study|Disease progression|5|||
146956998|NCT00386152|530002387|FG000|Overall Study|Physician Decision|13|||
146956999|NCT00386152|530002388|FG001|Overall Study|Physician Decision|10|||
146957000|NCT00386152|530002389|FG002|Overall Study|Physician Decision|4|||
146957001|NCT00386152|530002387|FG000|Overall Study|Lost to Follow-up|1|||
146957002|NCT00386152|530002388|FG001|Overall Study|Lost to Follow-up|0|||
146957003|NCT00386152|530002389|FG002|Overall Study|Lost to Follow-up|0|||
146957004|NCT00386152|530002387|FG000|Overall Study|Completed chemotherapy|4|||
146957005|NCT00386152|530002388|FG001|Overall Study|Completed chemotherapy|5|||
146957006|NCT00386152|530002389|FG002|Overall Study|Completed chemotherapy|1|||
146957007|NCT00386152|530002387|FG000|Overall Study|Protocol Violation|3|||
146957008|NCT00386152|530002388|FG001|Overall Study|Protocol Violation|5|||
146957009|NCT00386152|530002389|FG002|Overall Study|Protocol Violation|2|||
146957010|NCT00386152|530002387|FG000|Overall Study|Withdrawal by Subject|3|||
146957011|NCT00386152|530002388|FG001|Overall Study|Withdrawal by Subject|6|||
146957012|NCT00386152|530002389|FG002|Overall Study|Withdrawal by Subject|10|||
146957013|NCT02577107|530002393|FG000|Overall Study|Protocol deviation|0|||
146957014|NCT02577107|530002394|FG001|Overall Study|Protocol deviation|1|||
146957015|NCT01707667|530002395|FG000|Period 1|expulsion of colonic sensor catheter|1|||
146957016|NCT01707667|530002396|FG001|Period 1|expulsion of colonic sensor catheter|0|||
146957017|NCT03258710|530002402|FG000|Overall Study|Adverse Event|1|||
146957018|NCT03258710|530002402|FG000|Overall Study|Protocol-defined stopping criteria|1|||
146957019|NCT03258710|530002402|FG000|Overall Study|Physician Decision|1|||
146957020|NCT03451630|530002403|FG000|Overall Study|Death|15|||
146957021|NCT03451630|530002404|FG001|Overall Study|Death|16|||
146957022|NCT03451630|530002405|FG002|Overall Study|Death|11|||
146957023|NCT03451630|530002403|FG000|Overall Study|Lost to Follow-up|9|||
146957024|NCT03451630|530002404|FG001|Overall Study|Lost to Follow-up|0|||
146957025|NCT03451630|530002405|FG002|Overall Study|Lost to Follow-up|4|||
146957026|NCT03451630|530002403|FG000|Overall Study|Withdrawal by Subject|0|||
146957027|NCT03451630|530002404|FG001|Overall Study|Withdrawal by Subject|3|||
146957028|NCT03451630|530002405|FG002|Overall Study|Withdrawal by Subject|0|||
146957029|NCT03451630|530002403|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
146957030|NCT03451630|530002404|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
146957031|NCT03451630|530002405|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
146957032|NCT00089505|530002406|FG000|Overall Study|Death|4|||
146957033|NCT00089505|530002407|FG001|Overall Study|Death|1|||
146957034|NCT00089505|530002408|FG002|Overall Study|Death|5|||
146957035|NCT00089505|530002409|FG003|Overall Study|Death|8|||
146957036|NCT00089505|530002406|FG000|Overall Study|Withdrawal by Subject|3|||
146957037|NCT00089505|530002407|FG001|Overall Study|Withdrawal by Subject|0|||
146957038|NCT00089505|530002408|FG002|Overall Study|Withdrawal by Subject|6|||
146957039|NCT00089505|530002409|FG003|Overall Study|Withdrawal by Subject|6|||
146957040|NCT00089505|530002406|FG000|Overall Study|Lost to Follow-up|1|||
146957041|NCT00089505|530002407|FG001|Overall Study|Lost to Follow-up|1|||
146957042|NCT00089505|530002408|FG002|Overall Study|Lost to Follow-up|9|||
146957043|NCT00089505|530002409|FG003|Overall Study|Lost to Follow-up|7|||
146957044|NCT00089505|530002406|FG000|Overall Study|Physician Decision|1|||
146957045|NCT00089505|530002407|FG001|Overall Study|Physician Decision|0|||
146957046|NCT00089505|530002408|FG002|Overall Study|Physician Decision|0|||
146957047|NCT00089505|530002409|FG003|Overall Study|Physician Decision|0|||
146957048|NCT00089505|530002406|FG000|Overall Study|Protocol Violation|0|||
146957049|NCT00089505|530002407|FG001|Overall Study|Protocol Violation|0|||
146957050|NCT00089505|530002408|FG002|Overall Study|Protocol Violation|1|||
146957051|NCT00089505|530002409|FG003|Overall Study|Protocol Violation|0|||
146957052|NCT01724021|530002410|FG000|Overall Study|Adverse Event|11|||
146957053|NCT01724021|530002411|FG001|Overall Study|Adverse Event|6|||
146957054|NCT01724021|530002410|FG000|Overall Study|Death|46|||
146957055|NCT01724021|530002411|FG001|Overall Study|Death|58|||
146957056|NCT01724021|530002410|FG000|Overall Study|Participant request/ Withdrew consent|18|||
146957057|NCT01724021|530002411|FG001|Overall Study|Participant request/ Withdrew consent|14|||
146957058|NCT01724021|530002410|FG000|Overall Study|Lost to Follow-up|15|||
146957059|NCT01724021|530002411|FG001|Overall Study|Lost to Follow-up|15|||
146957060|NCT01724021|530002410|FG000|Overall Study|Reason Not Specified|36|||
146957061|NCT01724021|530002411|FG001|Overall Study|Reason Not Specified|39|||
146957062|NCT01724021|530002410|FG000|Overall Study|Missing|1|||
146826596|NCT00943722|529535653|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
146826597|NCT00943722|529535654|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
146826598|NCT00943722|529535655|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
146826599|NCT00943722|529535656|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
146826600|NCT00943722|529535650|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
146826601|NCT00943722|529535651|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
146826602|NCT00943722|529535652|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
146826603|NCT00943722|529535653|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
146826604|NCT00943722|529535654|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
146826605|NCT00943722|529535655|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
146826606|NCT00943722|529535656|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
146826607|NCT00943722|529535650|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
146826608|NCT00943722|529535651|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
146826609|NCT00943722|529535652|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
146826610|NCT00943722|529535653|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
146826611|NCT00943722|529535654|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
146826612|NCT00943722|529535655|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
146826613|NCT00943722|529535656|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
146826614|NCT00943722|529535650|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
146826615|NCT00943722|529535651|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
146826616|NCT00943722|529535652|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
146826617|NCT00943722|529535653|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
146826618|NCT00943722|529535654|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
146826619|NCT00943722|529535655|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
146826620|NCT00943722|529535656|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
146826621|NCT00943722|529535650|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
146826622|NCT00943722|529535651|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
146826623|NCT00943722|529535652|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
146826624|NCT00943722|529535653|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
146826625|NCT00943722|529535654|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
146826626|NCT00943722|529535655|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
146826627|NCT00943722|529535656|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
146826628|NCT01036165|529535657|FG000|Overall Study|Adverse Event|6|||
146826629|NCT01036165|529535657|FG000|Overall Study|Lost to Follow-up|2|||
146826630|NCT01036165|529535657|FG000|Overall Study|Withdrawal by Subject|3|||
146826631|NCT01036165|529535657|FG000|Overall Study|Device Related Issues|3|||
146826632|NCT01036165|529535657|FG000|Overall Study|Problems finding proper area to inject|1|||
146826633|NCT00307164|529535660|FG000|Overall Study|Death|1|||
146826634|NCT00307164|529535661|FG001|Overall Study|Death|0|||
146826635|NCT00307164|529535660|FG000|Overall Study|Severe debilitation, unable to continue|1|||
146826636|NCT00307164|529535661|FG001|Overall Study|Severe debilitation, unable to continue|0|||
146826637|NCT00307164|529535660|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
146826638|NCT00307164|529535661|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
146826639|NCT00307164|529535660|FG000|Overall Study|Withdrawal by Subject|1|||
146826640|NCT00307164|529535661|FG001|Overall Study|Withdrawal by Subject|8|||
146826641|NCT00307164|529535660|FG000|Overall Study|Not compliant with requirements|4|||
146826642|NCT00307164|529535661|FG001|Overall Study|Not compliant with requirements|4|||
146826643|NCT00307164|529535660|FG000|Overall Study|Lost to Follow-up|6|||
146826644|NCT00307164|529535661|FG001|Overall Study|Lost to Follow-up|1|||
146826645|NCT01649297|529535662|FG000|Overall Study|Adverse Event|5|||
146826646|NCT01649297|529535663|FG001|Overall Study|Adverse Event|5|||
146826647|NCT01649297|529535664|FG002|Overall Study|Adverse Event|4|||
146826648|NCT01649297|529535665|FG003|Overall Study|Adverse Event|13|||
146826649|NCT01649297|529535666|FG004|Overall Study|Adverse Event|1|||
146826650|NCT01649297|529535662|FG000|Overall Study|Lack of Efficacy|0|||
146826651|NCT01649297|529535663|FG001|Overall Study|Lack of Efficacy|0|||
146826652|NCT01649297|529535664|FG002|Overall Study|Lack of Efficacy|0|||
146826653|NCT01649297|529535665|FG003|Overall Study|Lack of Efficacy|0|||
146826654|NCT01649297|529535666|FG004|Overall Study|Lack of Efficacy|1|||
146826655|NCT01649297|529535662|FG000|Overall Study|Non compliant with Protocol|1|||
146826656|NCT01649297|529535663|FG001|Overall Study|Non compliant with Protocol|0|||
146826657|NCT01649297|529535664|FG002|Overall Study|Non compliant with Protocol|3|||
146826658|NCT01649297|529535665|FG003|Overall Study|Non compliant with Protocol|2|||
146957063|NCT01724021|530002411|FG001|Overall Study|Missing|1|||
146957064|NCT02041533|530002415|FG000|Pre-Treatment Period|Disease Progression|1|||
146957065|NCT02041533|530002416|FG001|Pre-Treatment Period|Disease Progression|1|||
146957066|NCT02041533|530002415|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
146957067|NCT02041533|530002416|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
146826659|NCT01649297|529535666|FG004|Overall Study|Non compliant with Protocol|1|||
146826660|NCT01649297|529535662|FG000|Overall Study|Lost to Follow-up|1|||
146826661|NCT01649297|529535663|FG001|Overall Study|Lost to Follow-up|1|||
146826662|NCT01649297|529535664|FG002|Overall Study|Lost to Follow-up|4|||
146826663|NCT01649297|529535665|FG003|Overall Study|Lost to Follow-up|3|||
146826664|NCT01649297|529535666|FG004|Overall Study|Lost to Follow-up|0|||
146957068|NCT02041533|530002415|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
146957069|NCT02041533|530002416|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
146957070|NCT02041533|530002415|FG000|Treatment Period|Disease progression|189|||
146957071|NCT02041533|530002416|FG001|Treatment Period|Disease progression|146|||
146957072|NCT02041533|530002415|FG000|Treatment Period|Study drug toxicity|30|||
146957073|NCT02041533|530002416|FG001|Treatment Period|Study drug toxicity|34|||
146957074|NCT02041533|530002415|FG000|Treatment Period|Death|1|||
146957075|NCT02041533|530002416|FG001|Treatment Period|Death|0|||
146957076|NCT02041533|530002415|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
146957077|NCT02041533|530002416|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
146957078|NCT02041533|530002415|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
146957079|NCT02041533|530002416|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
146957080|NCT02041533|530002415|FG000|Treatment Period|Participant withdrew consent|2|||
146957081|NCT02041533|530002416|FG001|Treatment Period|Participant withdrew consent|2|||
146957082|NCT02041533|530002415|FG000|Treatment Period|Maximum clinical benefit|0|||
146957083|NCT02041533|530002416|FG001|Treatment Period|Maximum clinical benefit|18|||
146957084|NCT02041533|530002415|FG000|Treatment Period|Poor/Non-compliance|1|||
146957085|NCT02041533|530002416|FG001|Treatment Period|Poor/Non-compliance|0|||
146957086|NCT02041533|530002415|FG000|Treatment Period|Administrative reason by sponsor|1|||
146957087|NCT02041533|530002416|FG001|Treatment Period|Administrative reason by sponsor|0|||
146957088|NCT02041533|530002415|FG000|Treatment Period|Other reasons|9|||
146957089|NCT02041533|530002416|FG001|Treatment Period|Other reasons|2|||
146957090|NCT02041533|530002415|FG000|Treatment Period|Not Reported|0|||
146957091|NCT02041533|530002416|FG001|Treatment Period|Not Reported|1|||
146957092|NCT01756846|530002417|FG000|Overall Study|Lost to Follow-up|5|||
146957093|NCT01756846|530002418|FG001|Overall Study|Lost to Follow-up|10|||
146957094|NCT01756846|530002417|FG000|Overall Study|Withdrawal by Subject|1|||
146957095|NCT01756846|530002418|FG001|Overall Study|Withdrawal by Subject|2|||
146957096|NCT02117024|530002421|FG000|Overall Study|Progressive Disease|26|||
146957097|NCT02117024|530002422|FG001|Overall Study|Progressive Disease|9|||
146957098|NCT02117024|530002421|FG000|Overall Study|Significant Clinical Progression|7|||
146957099|NCT02117024|530002422|FG001|Overall Study|Significant Clinical Progression|4|||
146957100|NCT02117024|530002421|FG000|Overall Study|Death|5|||
146957101|NCT02117024|530002422|FG001|Overall Study|Death|0|||
146957102|NCT02117024|530002421|FG000|Overall Study|Withdrawal by Subject|3|||
146957103|NCT02117024|530002422|FG001|Overall Study|Withdrawal by Subject|1|||
146957104|NCT02117024|530002421|FG000|Overall Study|Protocol Violation|1|||
146957105|NCT02117024|530002422|FG001|Overall Study|Protocol Violation|0|||
146957106|NCT02117024|530002421|FG000|Overall Study|Adverse Event|1|||
146957107|NCT02117024|530002422|FG001|Overall Study|Adverse Event|2|||
146957108|NCT02117024|530002421|FG000|Overall Study|Randomized in Error|1|||
146957109|NCT02117024|530002422|FG001|Overall Study|Randomized in Error|0|||
146957110|NCT02117024|530002421|FG000|Overall Study|Patient returned to primary oncologist|0|||
146957111|NCT02117024|530002422|FG001|Overall Study|Patient returned to primary oncologist|1|||
146957112|NCT02117024|530002421|FG000|Overall Study|Patient took treatment break|0|||
146957113|NCT02117024|530002422|FG001|Overall Study|Patient took treatment break|1|||
146957114|NCT02117024|530002421|FG000|Overall Study|Physician Decision|0|||
146957115|NCT02117024|530002422|FG001|Overall Study|Physician Decision|2|||
146957116|NCT00565721|530002425|FG000|Overall Study|Screen Failure|2|||
146957117|NCT00565721|530002425|FG000|Overall Study|Lost to Follow-up|6|||
146957118|NCT00565721|530002425|FG000|Overall Study|Technical Problems|1|||
146957119|NCT00565721|530002425|FG000|Overall Study|Physician Decision|2|||
146957120|NCT00565721|530002425|FG000|Overall Study|Other reasons|6|||
146957121|NCT02813681|530002426|FG000|Overall Study|Physician Decision|5|||
146957122|NCT02813681|530002427|FG001|Overall Study|Physician Decision|5|||
146957123|NCT02813681|530002428|FG002|Overall Study|Physician Decision|0|||
146957124|NCT02813681|530002426|FG000|Overall Study|Lost to Follow-up|0|||
146957125|NCT02813681|530002427|FG001|Overall Study|Lost to Follow-up|1|||
146957126|NCT02813681|530002428|FG002|Overall Study|Lost to Follow-up|0|||
146957127|NCT00529152|530002429|FG000|Overall Study|Adverse Event|2|||
146957128|NCT00529152|530002429|FG000|Overall Study|Withdrawal by Subject|2|||
146957129|NCT00529152|530002429|FG000|Overall Study|Lost to Follow-up|1|||
146957130|NCT02500706|530002430|FG000|Overall Study|Adverse Event|0|||
146957131|NCT02500706|530002431|FG001|Overall Study|Adverse Event|0|||
146957132|NCT02500706|530002432|FG002|Overall Study|Adverse Event|1|||
146957133|NCT02500706|530002430|FG000|Overall Study|Lost to Follow-up|0|||
146957134|NCT02500706|530002431|FG001|Overall Study|Lost to Follow-up|1|||
146957135|NCT02500706|530002432|FG002|Overall Study|Lost to Follow-up|1|||
146957136|NCT02500706|530002430|FG000|Overall Study|Withdrawal by Subject|4|||
146957137|NCT02500706|530002431|FG001|Overall Study|Withdrawal by Subject|6|||
146957138|NCT02500706|530002432|FG002|Overall Study|Withdrawal by Subject|4|||
146957139|NCT02500706|530002430|FG000|Overall Study|Unclassified|0|||
146957140|NCT02500706|530002431|FG001|Overall Study|Unclassified|0|||
146957141|NCT02500706|530002432|FG002|Overall Study|Unclassified|1|||
146957142|NCT01497899|530002433|FG000|Double-Blind Phase|Randomized but not Treated|1|||
146957143|NCT01497899|530002434|FG001|Double-Blind Phase|Randomized but not Treated|0|||
146985488|NCT01725451|530108877|FG000|Washout From Period 3|Adverse Event|0|||
146985489|NCT01725451|530108878|FG001|Washout From Period 3|Adverse Event|1|||
146985490|NCT01725451|530108879|FG002|Washout From Period 3|Adverse Event|0|||
146985491|NCT01725451|530108880|FG003|Washout From Period 3|Adverse Event|0|||
146985492|NCT01725451|530108877|FG000|Period 4|Adverse Event|0|||
146985493|NCT01725451|530108878|FG001|Period 4|Adverse Event|0|||
146985494|NCT01725451|530108879|FG002|Period 4|Adverse Event|1|||
146985495|NCT01725451|530108880|FG003|Period 4|Adverse Event|0|||
146985496|NCT02015793|530108885|FG000|Overall Study|Adverse Event|3|||
146985497|NCT02015793|530108886|FG001|Overall Study|Adverse Event|3|||
146985498|NCT02015793|530108885|FG000|Overall Study|Withdrawal by Subject|1|||
146985499|NCT02015793|530108886|FG001|Overall Study|Withdrawal by Subject|1|||
146985500|NCT00320593|530108887|FG000|Overall Study|Lost to Follow-up|3|||
146985501|NCT00320593|530108888|FG001|Overall Study|Lost to Follow-up|0|||
146985502|NCT00320593|530108887|FG000|Overall Study|Moved to another state|1|||
146985503|NCT00320593|530108888|FG001|Overall Study|Moved to another state|0|||
146985504|NCT00320593|530108887|FG000|Overall Study|Withdrawal by Subject|2|||
146985505|NCT00320593|530108888|FG001|Overall Study|Withdrawal by Subject|1|||
146985506|NCT00320593|530108887|FG000|Overall Study|Withdrawal by clinical center|1|||
146985507|NCT00320593|530108888|FG001|Overall Study|Withdrawal by clinical center|0|||
146985508|NCT00283686|530108889|FG000|Overall Study|Death|1|||
146985509|NCT00283686|530108890|FG001|Overall Study|Death|1|||
146985510|NCT00283686|530108891|FG002|Overall Study|Death|1|||
146985511|NCT00283686|530108892|FG003|Overall Study|Death|0|||
146985512|NCT00283686|530108889|FG000|Overall Study|Lost to Follow-up|21|||
146985513|NCT00283686|530108890|FG001|Overall Study|Lost to Follow-up|31|||
146985514|NCT00283686|530108891|FG002|Overall Study|Lost to Follow-up|26|||
146985515|NCT00283686|530108892|FG003|Overall Study|Lost to Follow-up|20|||
146985516|NCT00283686|530108889|FG000|Overall Study|Less than full participation|7|||
146985517|NCT00283686|530108890|FG001|Overall Study|Less than full participation|9|||
146985518|NCT00283686|530108891|FG002|Overall Study|Less than full participation|6|||
146985519|NCT00283686|530108892|FG003|Overall Study|Less than full participation|12|||
146985520|NCT00481247|530108893|FG000|Overall Study|Death|0|||
146985521|NCT00481247|530108894|FG001|Overall Study|Death|1|||
146985522|NCT00481247|530108893|FG000|Overall Study|Disease progression|18|||
146985523|NCT00481247|530108894|FG001|Overall Study|Disease progression|22|||
146985524|NCT00481247|530108893|FG000|Overall Study|Intolerance|42|||
146985525|NCT00481247|530108894|FG001|Overall Study|Intolerance|17|||
146985526|NCT00481247|530108893|FG000|Overall Study|Treatment failure|10|||
146985527|NCT00481247|530108894|FG001|Overall Study|Treatment failure|14|||
146985528|NCT00481247|530108893|FG000|Overall Study|AE unrelated to study drug|13|||
146985529|NCT00481247|530108894|FG001|Overall Study|AE unrelated to study drug|4|||
146985530|NCT00481247|530108893|FG000|Overall Study|Withdrawal by Subject|8|||
146985531|NCT00481247|530108894|FG001|Overall Study|Withdrawal by Subject|13|||
146985532|NCT00481247|530108893|FG000|Overall Study|Pregnancy|2|||
146985533|NCT00481247|530108894|FG001|Overall Study|Pregnancy|1|||
146985534|NCT00481247|530108893|FG000|Overall Study|Lost to Follow-up|1|||
146985535|NCT00481247|530108894|FG001|Overall Study|Lost to Follow-up|2|||
146985536|NCT00481247|530108893|FG000|Overall Study|Poor compliance/noncompliance|1|||
146985537|NCT00481247|530108894|FG001|Overall Study|Poor compliance/noncompliance|7|||
146985538|NCT00481247|530108893|FG000|Overall Study|Administrative reason by sponsor|157|||
146985539|NCT00481247|530108894|FG001|Overall Study|Administrative reason by sponsor|162|||
146985540|NCT00481247|530108893|FG000|Overall Study|Varied|6|||
146985541|NCT00481247|530108894|FG001|Overall Study|Varied|15|||
146985542|NCT00481247|530108893|FG000|Overall Study|Did not receive treatment|1|||
146985543|NCT00481247|530108894|FG001|Overall Study|Did not receive treatment|2|||
146985544|NCT01716754|530108895|FG000|Overall Study|Death|0|||
146985545|NCT01716754|530108896|FG001|Overall Study|Death|0|||
146985546|NCT01716754|530108897|FG002|Overall Study|Death|0|||
146826665|NCT01649297|529535662|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
146826666|NCT01649297|529535663|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
146826667|NCT01649297|529535664|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
146826668|NCT01649297|529535665|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
146826669|NCT01649297|529535666|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
146826670|NCT01649297|529535662|FG000|Overall Study|For other reason|4|||
146985547|NCT01716754|530108898|FG003|Overall Study|Death|1|||
146985548|NCT01716754|530108895|FG000|Overall Study|Protocol deviation|0|||
146985549|NCT01716754|530108896|FG001|Overall Study|Protocol deviation|2|||
146985550|NCT01716754|530108897|FG002|Overall Study|Protocol deviation|7|||
146985551|NCT01716754|530108898|FG003|Overall Study|Protocol deviation|2|||
146985552|NCT01716754|530108895|FG000|Overall Study|Non-compliance with study treatment|0|||
146985553|NCT01716754|530108896|FG001|Overall Study|Non-compliance with study treatment|0|||
146985554|NCT01716754|530108897|FG002|Overall Study|Non-compliance with study treatment|1|||
146985555|NCT01716754|530108898|FG003|Overall Study|Non-compliance with study treatment|0|||
146985556|NCT01716754|530108895|FG000|Overall Study|Physician Decision|1|||
146826671|NCT01649297|529535663|FG001|Overall Study|For other reason|1|||
146985557|NCT01716754|530108896|FG001|Overall Study|Physician Decision|0|||
146985558|NCT01716754|530108897|FG002|Overall Study|Physician Decision|0|||
146957144|NCT01497899|530002435|FG002|Double-Blind Phase|Randomized but not Treated|0|||
146957145|NCT01497899|530002436|FG003|Double-Blind Phase|Randomized but not Treated|0|||
146957146|NCT01497899|530002433|FG000|Double-Blind Phase|Adverse Event|1|||
146957147|NCT01497899|530002434|FG001|Double-Blind Phase|Adverse Event|0|||
146957148|NCT01497899|530002435|FG002|Double-Blind Phase|Adverse Event|0|||
146957149|NCT01497899|530002436|FG003|Double-Blind Phase|Adverse Event|0|||
146957150|NCT01497899|530002433|FG000|Double-Blind Phase|Lack of Efficacy|0|||
146957151|NCT01497899|530002434|FG001|Double-Blind Phase|Lack of Efficacy|1|||
146957152|NCT01497899|530002435|FG002|Double-Blind Phase|Lack of Efficacy|0|||
146957153|NCT01497899|530002436|FG003|Double-Blind Phase|Lack of Efficacy|0|||
146957154|NCT01497899|530002433|FG000|Double-Blind Phase|Investigator's Discretion|1|||
146957155|NCT01497899|530002434|FG001|Double-Blind Phase|Investigator's Discretion|0|||
146957156|NCT01497899|530002435|FG002|Double-Blind Phase|Investigator's Discretion|0|||
146957157|NCT01497899|530002436|FG003|Double-Blind Phase|Investigator's Discretion|0|||
146957158|NCT01497899|530002433|FG000|Double-Blind Phase|Withdrew Consent|0|||
146957159|NCT01497899|530002434|FG001|Double-Blind Phase|Withdrew Consent|1|||
146957160|NCT01497899|530002435|FG002|Double-Blind Phase|Withdrew Consent|0|||
146957161|NCT01497899|530002436|FG003|Double-Blind Phase|Withdrew Consent|0|||
146957162|NCT01497899|530002433|FG000|Double-Blind Phase|Lost to Follow-up|3|||
146957163|NCT01497899|530002434|FG001|Double-Blind Phase|Lost to Follow-up|2|||
146957164|NCT01497899|530002435|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146957165|NCT01497899|530002436|FG003|Double-Blind Phase|Lost to Follow-up|0|||
146957166|NCT01497899|530002433|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
146957167|NCT01497899|530002434|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
146957168|NCT01497899|530002435|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
146957169|NCT01497899|530002436|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
146957170|NCT01497899|530002433|FG000|Open-Label Extension Phase|Adverse Event|1|||
146957171|NCT01497899|530002434|FG001|Open-Label Extension Phase|Adverse Event|0|||
146957172|NCT01497899|530002435|FG002|Open-Label Extension Phase|Adverse Event|0|||
146957173|NCT01497899|530002436|FG003|Open-Label Extension Phase|Adverse Event|0|||
146957174|NCT01497899|530002433|FG000|Open-Label Extension Phase|Death|1|||
146957175|NCT01497899|530002434|FG001|Open-Label Extension Phase|Death|0|||
146957176|NCT01497899|530002435|FG002|Open-Label Extension Phase|Death|0|||
146957177|NCT01497899|530002436|FG003|Open-Label Extension Phase|Death|0|||
146957178|NCT01497899|530002433|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
146957179|NCT01497899|530002434|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
146957180|NCT01497899|530002435|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
146957181|NCT01497899|530002436|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
146957182|NCT01497899|530002433|FG000|Open-Label Extension Phase|Pregnancy|0|||
146957183|NCT01497899|530002434|FG001|Open-Label Extension Phase|Pregnancy|1|||
146957184|NCT01497899|530002435|FG002|Open-Label Extension Phase|Pregnancy|1|||
146957185|NCT01497899|530002436|FG003|Open-Label Extension Phase|Pregnancy|0|||
146957186|NCT01497899|530002433|FG000|Open-Label Extension Phase|Protocol Violation|0|||
146957187|NCT01497899|530002434|FG001|Open-Label Extension Phase|Protocol Violation|0|||
146957188|NCT01497899|530002435|FG002|Open-Label Extension Phase|Protocol Violation|1|||
146957189|NCT01497899|530002436|FG003|Open-Label Extension Phase|Protocol Violation|0|||
146957190|NCT01497899|530002433|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
146957191|NCT01497899|530002434|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
146957192|NCT01497899|530002435|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
146957193|NCT01497899|530002436|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
146957194|NCT01874288|530002440|FG000|Overall Study|Withdrawal by Subject|1|||
146957195|NCT01874288|530002441|FG001|Overall Study|Withdrawal by Subject|0|||
146957196|NCT01874288|530002442|FG002|Overall Study|Withdrawal by Subject|2|||
146957197|NCT01874288|530002443|FG003|Overall Study|Withdrawal by Subject|1|||
146957198|NCT01874288|530002444|FG004|Overall Study|Withdrawal by Subject|1|||
146957199|NCT01874288|530002440|FG000|Overall Study|Physician Decision|0|||
146957200|NCT01874288|530002441|FG001|Overall Study|Physician Decision|0|||
146957201|NCT01874288|530002442|FG002|Overall Study|Physician Decision|0|||
146957202|NCT01874288|530002443|FG003|Overall Study|Physician Decision|1|||
146957203|NCT01874288|530002444|FG004|Overall Study|Physician Decision|0|||
146957204|NCT01874288|530002440|FG000|Overall Study|Progressive disease|2|||
146957205|NCT01874288|530002441|FG001|Overall Study|Progressive disease|0|||
146957206|NCT01874288|530002442|FG002|Overall Study|Progressive disease|3|||
146957207|NCT01874288|530002443|FG003|Overall Study|Progressive disease|5|||
146957208|NCT01874288|530002444|FG004|Overall Study|Progressive disease|1|||
146957209|NCT04212221|530002445|FG000|Overall Study|Remained on Treatment|0|||
146957210|NCT04212221|530002446|FG001|Overall Study|Remained on Treatment|0|||
146957211|NCT04212221|530002447|FG002|Overall Study|Remained on Treatment|0|||
146957212|NCT04212221|530002448|FG003|Overall Study|Remained on Treatment|1|||
146985559|NCT01716754|530108898|FG003|Overall Study|Physician Decision|0|||
146957213|NCT04212221|530002449|FG004|Overall Study|Remained on Treatment|0|||
146957214|NCT04212221|530002450|FG005|Overall Study|Remained on Treatment|0|||
146957215|NCT04212221|530002451|FG006|Overall Study|Remained on Treatment|3|||
146957216|NCT04212221|530002452|FG007|Overall Study|Remained on Treatment|9|||
146957217|NCT04212221|530002445|FG000|Overall Study|Adverse Event|0|||
146957218|NCT04212221|530002446|FG001|Overall Study|Adverse Event|0|||
146957219|NCT04212221|530002447|FG002|Overall Study|Adverse Event|0|||
146957220|NCT04212221|530002448|FG003|Overall Study|Adverse Event|0|||
146957221|NCT04212221|530002449|FG004|Overall Study|Adverse Event|0|||
146957222|NCT04212221|530002450|FG005|Overall Study|Adverse Event|0|||
146957223|NCT04212221|530002451|FG006|Overall Study|Adverse Event|2|||
146957224|NCT04212221|530002452|FG007|Overall Study|Adverse Event|3|||
146957225|NCT04212221|530002445|FG000|Overall Study|Death|0|||
146957226|NCT04212221|530002446|FG001|Overall Study|Death|0|||
146957227|NCT04212221|530002447|FG002|Overall Study|Death|0|||
146957228|NCT04212221|530002448|FG003|Overall Study|Death|0|||
146957229|NCT04212221|530002449|FG004|Overall Study|Death|0|||
146957230|NCT04212221|530002450|FG005|Overall Study|Death|0|||
146957231|NCT04212221|530002451|FG006|Overall Study|Death|0|||
146957232|NCT04212221|530002452|FG007|Overall Study|Death|2|||
146957233|NCT04212221|530002445|FG000|Overall Study|Disease progression according to irRECIST|1|||
146957234|NCT04212221|530002446|FG001|Overall Study|Disease progression according to irRECIST|2|||
146957235|NCT04212221|530002447|FG002|Overall Study|Disease progression according to irRECIST|3|||
146957236|NCT04212221|530002448|FG003|Overall Study|Disease progression according to irRECIST|3|||
146957237|NCT04212221|530002449|FG004|Overall Study|Disease progression according to irRECIST|2|||
146957238|NCT04212221|530002450|FG005|Overall Study|Disease progression according to irRECIST|2|||
146957239|NCT04212221|530002451|FG006|Overall Study|Disease progression according to irRECIST|21|||
146957240|NCT04212221|530002452|FG007|Overall Study|Disease progression according to irRECIST|17|||
146957241|NCT04212221|530002445|FG000|Overall Study|Global Deterioration of Health Status|0|||
146957242|NCT04212221|530002446|FG001|Overall Study|Global Deterioration of Health Status|0|||
146957243|NCT04212221|530002447|FG002|Overall Study|Global Deterioration of Health Status|0|||
146957244|NCT04212221|530002448|FG003|Overall Study|Global Deterioration of Health Status|0|||
146957245|NCT04212221|530002449|FG004|Overall Study|Global Deterioration of Health Status|0|||
146957246|NCT04212221|530002450|FG005|Overall Study|Global Deterioration of Health Status|0|||
146957247|NCT04212221|530002451|FG006|Overall Study|Global Deterioration of Health Status|0|||
146957248|NCT04212221|530002452|FG007|Overall Study|Global Deterioration of Health Status|2|||
146957249|NCT04212221|530002445|FG000|Overall Study|Investigator's Decision|0|||
146957250|NCT04212221|530002446|FG001|Overall Study|Investigator's Decision|0|||
146957251|NCT04212221|530002447|FG002|Overall Study|Investigator's Decision|0|||
146957252|NCT04212221|530002448|FG003|Overall Study|Investigator's Decision|1|||
146957253|NCT04212221|530002449|FG004|Overall Study|Investigator's Decision|0|||
146957254|NCT04212221|530002450|FG005|Overall Study|Investigator's Decision|0|||
146957255|NCT04212221|530002451|FG006|Overall Study|Investigator's Decision|3|||
146957256|NCT04212221|530002452|FG007|Overall Study|Investigator's Decision|0|||
146957257|NCT04212221|530002445|FG000|Overall Study|Participant refused to continue treatment|0|||
146957258|NCT04212221|530002446|FG001|Overall Study|Participant refused to continue treatment|1|||
146957259|NCT04212221|530002447|FG002|Overall Study|Participant refused to continue treatment|0|||
146957260|NCT04212221|530002448|FG003|Overall Study|Participant refused to continue treatment|1|||
146957261|NCT04212221|530002449|FG004|Overall Study|Participant refused to continue treatment|1|||
146957262|NCT04212221|530002450|FG005|Overall Study|Participant refused to continue treatment|2|||
146957263|NCT04212221|530002451|FG006|Overall Study|Participant refused to continue treatment|4|||
146957264|NCT04212221|530002452|FG007|Overall Study|Participant refused to continue treatment|2|||
146957265|NCT04212221|530002445|FG000|Overall Study|Protocol Violation|0|||
146957266|NCT04212221|530002446|FG001|Overall Study|Protocol Violation|0|||
146957267|NCT04212221|530002447|FG002|Overall Study|Protocol Violation|0|||
146957268|NCT04212221|530002448|FG003|Overall Study|Protocol Violation|0|||
146957269|NCT04212221|530002449|FG004|Overall Study|Protocol Violation|0|||
146957270|NCT04212221|530002450|FG005|Overall Study|Protocol Violation|0|||
146957271|NCT04212221|530002451|FG006|Overall Study|Protocol Violation|0|||
146957272|NCT04212221|530002452|FG007|Overall Study|Protocol Violation|1|||
146957273|NCT03370133|530002460|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
146957274|NCT03370133|530002461|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
146957275|NCT03370133|530002462|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
146957276|NCT03370133|530002463|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
146957277|NCT03370133|530002464|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
146957278|NCT03370133|530002465|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
146957279|NCT03370133|530002460|FG000|Initial Treatment Period (WK 16)|Death|1|||
146957280|NCT03370133|530002461|FG001|Initial Treatment Period (WK 16)|Death|1|||
146957281|NCT03370133|530002462|FG002|Initial Treatment Period (WK 16)|Death|1|||
146957282|NCT03370133|530002463|FG003|Initial Treatment Period (WK 16)|Death|0|||
146957283|NCT03370133|530002464|FG004|Initial Treatment Period (WK 16)|Death|0|||
146957284|NCT03370133|530002465|FG005|Initial Treatment Period (WK 16)|Death|0|||
146957285|NCT03370133|530002460|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
146957286|NCT03370133|530002461|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
146957287|NCT03370133|530002462|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
146957288|NCT03370133|530002463|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
146957289|NCT03370133|530002464|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
146957290|NCT03370133|530002465|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
146957291|NCT03370133|530002460|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
146957292|NCT03370133|530002461|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
146957293|NCT03370133|530002462|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
146957294|NCT03370133|530002463|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
146957295|NCT03370133|530002464|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
146957296|NCT03370133|530002465|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
146957297|NCT03370133|530002460|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
146957298|NCT03370133|530002461|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
146957299|NCT03370133|530002462|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
146957300|NCT03370133|530002463|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
146957301|NCT03370133|530002464|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
146957302|NCT03370133|530002465|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
146957303|NCT03370133|530002460|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
146957304|NCT03370133|530002461|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
146957305|NCT03370133|530002462|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
146957306|NCT03370133|530002463|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
146957307|NCT03370133|530002464|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
146957308|NCT03370133|530002465|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
146957309|NCT03370133|530002460|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
146957310|NCT03370133|530002461|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
146957311|NCT03370133|530002462|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
146957312|NCT03370133|530002463|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
146957313|NCT03370133|530002464|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
146957314|NCT03370133|530002465|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
146957315|NCT03370133|530002460|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
146957316|NCT03370133|530002461|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
146957317|NCT03370133|530002462|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
146957318|NCT03370133|530002463|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
146957319|NCT03370133|530002464|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
146957320|NCT03370133|530002465|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
146957321|NCT03370133|530002460|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
146957322|NCT03370133|530002461|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
146957323|NCT03370133|530002462|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
146957324|NCT03370133|530002463|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
146957325|NCT03370133|530002464|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
146957326|NCT03370133|530002465|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
146957327|NCT03370133|530002460|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
146957328|NCT03370133|530002461|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
146957329|NCT03370133|530002462|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
146957330|NCT03370133|530002463|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
146957331|NCT03370133|530002464|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
146957332|NCT03370133|530002465|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
146957333|NCT03370133|530002460|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
146957334|NCT03370133|530002461|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
146957335|NCT03370133|530002462|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
146957336|NCT03370133|530002463|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
146957337|NCT03370133|530002464|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
146957338|NCT03370133|530002465|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
146957339|NCT03370133|530002460|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
146957340|NCT03370133|530002461|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
146957341|NCT03370133|530002462|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
146957342|NCT03370133|530002463|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
146957343|NCT03370133|530002464|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
146957344|NCT03370133|530002465|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
146957345|NCT03370133|530002460|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
146957346|NCT03370133|530002461|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
146957347|NCT03370133|530002462|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
146957348|NCT03370133|530002463|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
146957349|NCT03370133|530002464|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
146957350|NCT03370133|530002465|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
146957351|NCT03370133|530002460|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
146957352|NCT03370133|530002461|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
146957353|NCT03370133|530002462|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
146957354|NCT03370133|530002463|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
146957355|NCT03370133|530002464|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
146957356|NCT03370133|530002465|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
146826672|NCT01649297|529535664|FG002|Overall Study|For other reason|2|||
146826673|NCT01649297|529535665|FG003|Overall Study|For other reason|0|||
146957357|NCT03370133|530002460|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
146957358|NCT03370133|530002461|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
146957359|NCT03370133|530002462|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
146957360|NCT03370133|530002463|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
146957361|NCT03370133|530002464|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
146957362|NCT03370133|530002465|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
146957363|NCT00636506|530002466|FG000|Overall Study|Lost to Follow-up|8|||
146957364|NCT00636506|530002466|FG000|Overall Study|Explanted|1|||
146957365|NCT00636506|530002466|FG000|Overall Study|Withdrawal by Subject|6|||
146957366|NCT00636506|530002466|FG000|Overall Study|Procedure aborted|1|||
146957367|NCT03742271|530002467|FG000|Overall Study|Unsatisfactory Visual Response|1|||
146957368|NCT03742271|530002467|FG000|Overall Study|Withdrawal by Subject|3|||
146957369|NCT03742271|530002467|FG000|Overall Study|Lost to Follow-up|4|||
146957370|NCT03742271|530002467|FG000|Overall Study|Failed Insertion & removal|3|||
146957371|NCT03742271|530002467|FG000|Overall Study|Protocol Violation|1|||
146957372|NCT01624974|530002468|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
146957373|NCT01624974|530002469|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
146957374|NCT01624974|530002468|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
146957375|NCT01624974|530002469|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
146957376|NCT01624974|530002468|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
146957377|NCT01624974|530002469|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
146957378|NCT01624974|530002468|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
146957379|NCT01624974|530002469|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
146957380|NCT01624974|530002468|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
146957381|NCT01624974|530002469|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
146957382|NCT01624974|530002468|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
146957383|NCT01624974|530002469|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
146957384|NCT01624974|530002468|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
146957385|NCT01624974|530002469|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
146957386|NCT01624974|530002468|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
146957387|NCT01624974|530002469|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
146957388|NCT01624974|530002468|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
146957389|NCT01624974|530002469|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
146957390|NCT01624974|530002468|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
146957391|NCT01624974|530002469|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
146957392|NCT01624974|530002468|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
146957393|NCT01624974|530002469|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
146957394|NCT01624974|530002468|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
146957395|NCT01624974|530002469|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
146957396|NCT03607994|530002470|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
146957397|NCT03607994|530002471|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
146957398|NCT00620815|530002474|FG000|Overall Study|Adverse Event|1|||
146957399|NCT00620815|530002475|FG001|Overall Study|Adverse Event|1|||
146957400|NCT00620815|530002476|FG002|Overall Study|Adverse Event|2|||
146957401|NCT00620815|530002474|FG000|Overall Study|Withdrawal by Subject|1|||
146957402|NCT00620815|530002475|FG001|Overall Study|Withdrawal by Subject|2|||
146957403|NCT00620815|530002476|FG002|Overall Study|Withdrawal by Subject|0|||
146957404|NCT00620815|530002474|FG000|Overall Study|Lost to Follow-up|1|||
146957405|NCT00620815|530002475|FG001|Overall Study|Lost to Follow-up|6|||
146957406|NCT00620815|530002476|FG002|Overall Study|Lost to Follow-up|3|||
146957407|NCT00620815|530002474|FG000|Overall Study|Inappropriate enrolment|0|||
146957408|NCT00620815|530002475|FG001|Overall Study|Inappropriate enrolment|0|||
146957409|NCT00620815|530002476|FG002|Overall Study|Inappropriate enrolment|1|||
146957410|NCT00620815|530002474|FG000|Overall Study|Protocol Violation|1|||
146957411|NCT00620815|530002475|FG001|Overall Study|Protocol Violation|2|||
146957412|NCT00620815|530002476|FG002|Overall Study|Protocol Violation|1|||
146957413|NCT01888367|530002477|FG000|Overall Study|Physician Decision|3|||
146957414|NCT01888367|530002478|FG001|Overall Study|Physician Decision|4|||
146957415|NCT01888367|530002479|FG002|Overall Study|Physician Decision|2|||
146957416|NCT01888367|530002477|FG000|Overall Study|Death|2|||
146957417|NCT01888367|530002478|FG001|Overall Study|Death|0|||
146957418|NCT01888367|530002479|FG002|Overall Study|Death|1|||
146957419|NCT01888367|530002477|FG000|Overall Study|Withdrawal by Subject|1|||
146957420|NCT01888367|530002478|FG001|Overall Study|Withdrawal by Subject|0|||
146957421|NCT01888367|530002479|FG002|Overall Study|Withdrawal by Subject|1|||
146957422|NCT01888367|530002477|FG000|Overall Study|Lost to Follow-up|1|||
146957423|NCT01888367|530002478|FG001|Overall Study|Lost to Follow-up|1|||
146957424|NCT01888367|530002479|FG002|Overall Study|Lost to Follow-up|0|||
146957425|NCT01888367|530002477|FG000|Overall Study|Protocol Violation|0|||
146957426|NCT01888367|530002478|FG001|Overall Study|Protocol Violation|0|||
146957427|NCT01888367|530002479|FG002|Overall Study|Protocol Violation|1|||
146957428|NCT01888367|530002477|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
146957429|NCT01888367|530002478|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
146957430|NCT01888367|530002479|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
146957431|NCT00591786|530002480|FG000|Overall Study|Withdrawal of Informed Consent|0|||
146957432|NCT00591786|530002481|FG001|Overall Study|Withdrawal of Informed Consent|0|||
146957433|NCT00591786|530002482|FG002|Overall Study|Withdrawal of Informed Consent|1|||
146957434|NCT00591786|530002483|FG003|Overall Study|Withdrawal of Informed Consent|0|||
146957435|NCT00591786|530002484|FG004|Overall Study|Withdrawal of Informed Consent|0|||
146957436|NCT00591786|530002485|FG005|Overall Study|Withdrawal of Informed Consent|0|||
146957437|NCT00591786|530002486|FG006|Overall Study|Withdrawal of Informed Consent|0|||
146957438|NCT00591786|530002487|FG007|Overall Study|Withdrawal of Informed Consent|0|||
146957439|NCT00591786|530002488|FG008|Overall Study|Withdrawal of Informed Consent|0|||
146957440|NCT00591786|530002489|FG009|Overall Study|Withdrawal of Informed Consent|0|||
146957441|NCT03969589|530002490|FG000|Overall Study|Lost to Follow-up|3|||
146957442|NCT03969589|530002491|FG001|Overall Study|Lost to Follow-up|2|||
146957443|NCT03969589|530002490|FG000|Overall Study|Declined Follow-Up|0|||
146957444|NCT03969589|530002491|FG001|Overall Study|Declined Follow-Up|1|||
146957445|NCT00517634|530002492|FG000|Second Treatment Period|Withdrawal by Subject|0|||
146957446|NCT00517634|530002493|FG001|Second Treatment Period|Withdrawal by Subject|0|||
146957447|NCT00517634|530002494|FG002|Second Treatment Period|Withdrawal by Subject|0|||
146957448|NCT00517634|530002495|FG003|Second Treatment Period|Withdrawal by Subject|0|||
146957449|NCT00517634|530002496|FG004|Second Treatment Period|Withdrawal by Subject|1|||
146957450|NCT00517634|530002497|FG005|Second Treatment Period|Withdrawal by Subject|0|||
146957451|NCT03143855|530002498|FG000|Overall Study|Withdrawal by Subject|4|||
146957452|NCT03143855|530002499|FG001|Overall Study|Withdrawal by Subject|3|||
146957453|NCT03143855|530002498|FG000|Overall Study|Protocol Violation|1|||
146957454|NCT03143855|530002499|FG001|Overall Study|Protocol Violation|0|||
146957455|NCT03143855|530002498|FG000|Overall Study|Participant experienced withdrawal|0|||
146957456|NCT03143855|530002499|FG001|Overall Study|Participant experienced withdrawal|1|||
146957457|NCT03417999|530002500|FG000|Overall Study|Withdrawal by Subject|1|||
146957458|NCT03417999|530002501|FG001|Overall Study|Withdrawal by Subject|0|||
146957459|NCT03417999|530002502|FG002|Overall Study|Withdrawal by Subject|0|||
146957460|NCT03417999|530002500|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
146957461|NCT03417999|530002501|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
146957462|NCT03417999|530002502|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
146957463|NCT03417999|530002500|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
146957464|NCT03417999|530002501|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
146957465|NCT03417999|530002502|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
146957466|NCT03417999|530002500|FG000|Overall Study|Inadequate study staff available to process samples|0|||
146957467|NCT03417999|530002501|FG001|Overall Study|Inadequate study staff available to process samples|0|||
146957468|NCT03417999|530002502|FG002|Overall Study|Inadequate study staff available to process samples|1|||
146957469|NCT00422942|530002507|FG000|Overall Study|Study terminated by Sponsor|3|||
146957470|NCT00695318|530002509|FG000|Overall Study|Lost to Follow-up|1|||
146957471|NCT00695318|530002510|FG001|Overall Study|Lost to Follow-up|0|||
146957472|NCT00695318|530002509|FG000|Overall Study|Withdrawal by Subject|2|||
146957473|NCT00695318|530002510|FG001|Overall Study|Withdrawal by Subject|0|||
146957474|NCT00695318|530002509|FG000|Overall Study|Death|1|||
146957475|NCT00695318|530002510|FG001|Overall Study|Death|1|||
146957476|NCT00695318|530002509|FG000|Overall Study|Study Terminated|1|||
146957477|NCT00695318|530002510|FG001|Overall Study|Study Terminated|0|||
146957478|NCT00939094|530002511|FG000|Overall Study|Adverse Event|9|||
146957479|NCT00939094|530002512|FG001|Overall Study|Adverse Event|0|||
146957480|NCT00939094|530002511|FG000|Overall Study|Withdrawal by Subject|1|||
146957481|NCT00939094|530002512|FG001|Overall Study|Withdrawal by Subject|6|||
146957482|NCT00939094|530002511|FG000|Overall Study|Lost to Follow-up|1|||
146957483|NCT00939094|530002512|FG001|Overall Study|Lost to Follow-up|1|||
146957484|NCT00939094|530002511|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
146957485|NCT00939094|530002512|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146957486|NCT00939094|530002511|FG000|Overall Study|Severe non-compliance to protocol|0|||
146957487|NCT00939094|530002512|FG001|Overall Study|Severe non-compliance to protocol|1|||
146957488|NCT00939094|530002511|FG000|Overall Study|Study stopped by sponsor|0|||
146957489|NCT00939094|530002512|FG001|Overall Study|Study stopped by sponsor|2|||
146957490|NCT00939094|530002511|FG000|Overall Study|Abnormal ECG findings|1|||
146957491|NCT00939094|530002512|FG001|Overall Study|Abnormal ECG findings|0|||
146985560|NCT01716754|530108895|FG000|Overall Study|Lost to Follow-up|1|||
146957492|NCT02705755|530002513|FG000|Part A (6 Days)|Adverse Event|1|||
146957493|NCT02705755|530002514|FG001|Part A (6 Days)|Adverse Event|0|||
146957494|NCT02705755|530002515|FG002|Part A (6 Days)|Adverse Event|0|||
146957495|NCT02705755|530002516|FG003|Part A (6 Days)|Adverse Event|0|||
146957496|NCT02705755|530002513|FG000|Part A (6 Days)|Physician Decision|3|||
146957497|NCT02705755|530002514|FG001|Part A (6 Days)|Physician Decision|0|||
146985561|NCT01716754|530108896|FG001|Overall Study|Lost to Follow-up|0|||
146985562|NCT01716754|530108897|FG002|Overall Study|Lost to Follow-up|0|||
146985563|NCT01716754|530108898|FG003|Overall Study|Lost to Follow-up|1|||
146985564|NCT01716754|530108895|FG000|Overall Study|Adverse Event|4|||
146985565|NCT01716754|530108896|FG001|Overall Study|Adverse Event|2|||
146985566|NCT01716754|530108897|FG002|Overall Study|Adverse Event|2|||
146985567|NCT01716754|530108898|FG003|Overall Study|Adverse Event|1|||
146985568|NCT01716754|530108895|FG000|Overall Study|Withdrawal by Subject|5|||
146985569|NCT01716754|530108896|FG001|Overall Study|Withdrawal by Subject|0|||
146985570|NCT01716754|530108897|FG002|Overall Study|Withdrawal by Subject|4|||
146985571|NCT01716754|530108898|FG003|Overall Study|Withdrawal by Subject|3|||
146985572|NCT04317781|530108899|FG000|Overall Study|Adverse Event|1|||
146985573|NCT04317781|530108899|FG000|Overall Study|Disease relapse|1|||
146985574|NCT04317781|530108899|FG000|Overall Study|Withdrawal by Subject|1|||
146985575|NCT02649231|530108919|FG000|Overall Study|Adverse Event|0|||
146985576|NCT02649231|530108920|FG001|Overall Study|Adverse Event|0|||
146985577|NCT02649231|530108921|FG002|Overall Study|Adverse Event|0|||
146985578|NCT02649231|530108922|FG003|Overall Study|Adverse Event|1|||
146985579|NCT02649231|530108919|FG000|Overall Study|Lost to Follow-up|2|||
146985580|NCT02649231|530108920|FG001|Overall Study|Lost to Follow-up|1|||
146985581|NCT02649231|530108921|FG002|Overall Study|Lost to Follow-up|1|||
146985582|NCT02649231|530108922|FG003|Overall Study|Lost to Follow-up|0|||
146985583|NCT02649231|530108919|FG000|Overall Study|Withdrawal by Subject|0|||
146985584|NCT02649231|530108920|FG001|Overall Study|Withdrawal by Subject|1|||
146985585|NCT02649231|530108921|FG002|Overall Study|Withdrawal by Subject|0|||
146957498|NCT02705755|530002515|FG002|Part A (6 Days)|Physician Decision|0|||
146957499|NCT02705755|530002516|FG003|Part A (6 Days)|Physician Decision|0|||
146957500|NCT02705755|530002513|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
146957501|NCT02705755|530002514|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
146957502|NCT02705755|530002515|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
146957503|NCT02705755|530002516|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
146957504|NCT02705755|530002513|FG000|Part C (20 Weeks)|Physician Decision|0|||
146957505|NCT02705755|530002514|FG001|Part C (20 Weeks)|Physician Decision|0|||
146957506|NCT02705755|530002515|FG002|Part C (20 Weeks)|Physician Decision|0|||
146957507|NCT02705755|530002516|FG003|Part C (20 Weeks)|Physician Decision|2|||
146957508|NCT02705755|530002513|FG000|Part C (20 Weeks)|Adverse Event|0|||
146957509|NCT02705755|530002514|FG001|Part C (20 Weeks)|Adverse Event|0|||
146957510|NCT02705755|530002515|FG002|Part C (20 Weeks)|Adverse Event|0|||
146957511|NCT02705755|530002516|FG003|Part C (20 Weeks)|Adverse Event|6|||
146957512|NCT02705755|530002513|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
146957513|NCT02705755|530002514|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
146957514|NCT02705755|530002515|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
146957515|NCT02705755|530002516|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
146957516|NCT04823494|530004658|FG000|Overall Study|Programming software malfunction.|1|||
146957517|NCT04823494|530004659|FG001|Overall Study|Programming software malfunction.|0|||
146957518|NCT04823494|530004658|FG000|Overall Study|Withdrawal by Subject|1|||
146957519|NCT04823494|530004659|FG001|Overall Study|Withdrawal by Subject|0|||
146957520|NCT04823494|530004658|FG000|Overall Study|Devices lost|0|||
146957521|NCT04823494|530004659|FG001|Overall Study|Devices lost|1|||
146957522|NCT03691831|530004660|FG000|Overall Study|Lost to Follow-up|16|||
146957523|NCT03691831|530004661|FG001|Overall Study|Lost to Follow-up|12|||
146957524|NCT03691831|530004660|FG000|Overall Study|Withdrawal by Subject|9|||
146957525|NCT03691831|530004661|FG001|Overall Study|Withdrawal by Subject|17|||
146957526|NCT03691831|530004660|FG000|Overall Study|Investigator Decision|2|||
146957527|NCT03691831|530004661|FG001|Overall Study|Investigator Decision|2|||
146957528|NCT02198040|530004662|FG000|Overall Study|Work reasons|0|||
146957529|NCT02198040|530004663|FG001|Overall Study|Work reasons|1|||
146985586|NCT02649231|530108922|FG003|Overall Study|Withdrawal by Subject|1|||
146985587|NCT02649231|530108919|FG000|Overall Study|Protocol Violation|2|||
146985588|NCT02649231|530108920|FG001|Overall Study|Protocol Violation|1|||
146957530|NCT02198040|530004664|FG002|Overall Study|Work reasons|0|||
146957531|NCT02198040|530004662|FG000|Overall Study|Withdrawal by Subject|0|||
146957532|NCT02198040|530004663|FG001|Overall Study|Withdrawal by Subject|0|||
146985589|NCT02649231|530108921|FG002|Overall Study|Protocol Violation|1|||
146985590|NCT02649231|530108922|FG003|Overall Study|Protocol Violation|0|||
146985591|NCT01211769|530108923|FG000|Overall Study|Lost to Follow-up|7|||
146985592|NCT01211769|530108924|FG001|Overall Study|Lost to Follow-up|9|||
146985593|NCT01211769|530108925|FG002|Overall Study|Lost to Follow-up|5|||
146985594|NCT01211769|530108926|FG003|Overall Study|Lost to Follow-up|9|||
146985595|NCT01211769|530108923|FG000|Overall Study|Physician Decision|2|||
146985596|NCT01211769|530108924|FG001|Overall Study|Physician Decision|0|||
146957533|NCT02198040|530004664|FG002|Overall Study|Withdrawal by Subject|1|||
146957534|NCT04524663|530004665|FG000|Overall Study|Withdrawal by Subject|0|||
146957535|NCT04524663|530004666|FG001|Overall Study|Withdrawal by Subject|2|||
146985597|NCT01211769|530108925|FG002|Overall Study|Physician Decision|2|||
146985598|NCT01211769|530108926|FG003|Overall Study|Physician Decision|1|||
146957536|NCT01884675|530004667|FG000|Overall Study|Study closed/terminated|3|||
146957537|NCT01884675|530004668|FG001|Overall Study|Study closed/terminated|2|||
146957538|NCT02361307|530004669|FG000|Overall Study|Unstable medical condition.|0|||
146957539|NCT02361307|530004670|FG001|Overall Study|Unstable medical condition.|1|||
146957540|NCT03359811|530004671|FG000|Overall Study|Protocol Violation|2|||
146957541|NCT03359811|530004672|FG001|Overall Study|Protocol Violation|0|||
146957542|NCT01189201|530004677|FG000|Overall Study|Adverse Event|1|||
146957543|NCT01682876|530004678|FG000|Overall Study|Administrative reason|4|||
146957544|NCT01682876|530004679|FG001|Overall Study|Administrative reason|4|||
146957545|NCT01682876|530004680|FG002|Overall Study|Administrative reason|0|||
146957546|NCT01682876|530004681|FG003|Overall Study|Administrative reason|3|||
146957547|NCT01682876|530004678|FG000|Overall Study|Adverse Event|0|||
146957548|NCT01682876|530004679|FG001|Overall Study|Adverse Event|0|||
146957549|NCT01682876|530004680|FG002|Overall Study|Adverse Event|0|||
146957550|NCT01682876|530004681|FG003|Overall Study|Adverse Event|1|||
146957551|NCT01682876|530004678|FG000|Overall Study|Lost to Follow-up|11|||
146957552|NCT01682876|530004679|FG001|Overall Study|Lost to Follow-up|15|||
146957553|NCT01682876|530004680|FG002|Overall Study|Lost to Follow-up|9|||
146957554|NCT01682876|530004681|FG003|Overall Study|Lost to Follow-up|11|||
146957555|NCT01682876|530004678|FG000|Overall Study|Protocol Violation|1|||
146957556|NCT01682876|530004679|FG001|Overall Study|Protocol Violation|1|||
146957557|NCT01682876|530004680|FG002|Overall Study|Protocol Violation|1|||
146957558|NCT01682876|530004681|FG003|Overall Study|Protocol Violation|1|||
146957559|NCT01682876|530004678|FG000|Overall Study|Withdrawal by Subject|4|||
146957560|NCT01682876|530004679|FG001|Overall Study|Withdrawal by Subject|0|||
146957561|NCT01682876|530004680|FG002|Overall Study|Withdrawal by Subject|0|||
146957562|NCT01682876|530004681|FG003|Overall Study|Withdrawal by Subject|2|||
146957563|NCT01682876|530004678|FG000|Overall Study|Other|1|||
146957564|NCT01682876|530004679|FG001|Overall Study|Other|0|||
146957565|NCT01682876|530004680|FG002|Overall Study|Other|1|||
146957566|NCT01682876|530004681|FG003|Overall Study|Other|1|||
146957567|NCT00911508|530004685|FG000|Overall Study|Lost to Follow-up|27|||
146957568|NCT00911508|530004686|FG001|Overall Study|Lost to Follow-up|18|||
146957569|NCT00911508|530004685|FG000|Overall Study|Withdrawal by Subject|79|||
146957570|NCT00911508|530004686|FG001|Overall Study|Withdrawal by Subject|112|||
146957571|NCT00240331|530004689|FG000|Overall Study|Withdrawal by Subject|125|||
146957572|NCT00240331|530004690|FG001|Overall Study|Withdrawal by Subject|132|||
146957573|NCT00240331|530004689|FG000|Overall Study|Option selected by investigator|1|||
146957574|NCT00240331|530004690|FG001|Overall Study|Option selected by investigator|2|||
146957575|NCT01409382|530004691|FG000|Overall Study|Lost to Follow-up|1|||
146957576|NCT01409382|530004692|FG001|Overall Study|Lost to Follow-up|1|||
146957577|NCT01409382|530004691|FG000|Overall Study|Protocol Violation|0|||
146957578|NCT01409382|530004692|FG001|Overall Study|Protocol Violation|3|||
146957579|NCT01409382|530004691|FG000|Overall Study|Multiple pregnancy|2|||
146957580|NCT01409382|530004692|FG001|Overall Study|Multiple pregnancy|4|||
146957581|NCT01409382|530004691|FG000|Overall Study|Still pregnant when study ended|13|||
146957582|NCT01409382|530004692|FG001|Overall Study|Still pregnant when study ended|2|||
146957583|NCT01409382|530004691|FG000|Overall Study|Did not manage to get pregnant|64|||
146957584|NCT01409382|530004692|FG001|Overall Study|Did not manage to get pregnant|70|||
146957585|NCT01409382|530004691|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
146957586|NCT01409382|530004692|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
146957587|NCT01233076|530004693|FG000|Period 2, One Week|Lost to Follow-up|1|||
146957588|NCT01233076|530004694|FG001|Period 2, One Week|Lost to Follow-up|0|||
146957589|NCT04308668|530004695|FG000|Overall Study|Lost to Follow-up|32|||
146957590|NCT04308668|530004696|FG001|Overall Study|Lost to Follow-up|38|||
146957591|NCT04308668|530004695|FG000|Overall Study|Withdrawal by Subject|4|||
146957592|NCT04308668|530004696|FG001|Overall Study|Withdrawal by Subject|4|||
146957593|NCT01266967|530004697|FG000|Overall Study|Death|69|||
146957594|NCT01266967|530004698|FG001|Overall Study|Death|61|||
146957595|NCT01266967|530004697|FG000|Overall Study|Study Closed/Terminated|15|||
146957596|NCT01266967|530004698|FG001|Overall Study|Study Closed/Terminated|17|||
146957597|NCT01266967|530004697|FG000|Overall Study|Lost to Follow-up|2|||
146957598|NCT01266967|530004698|FG001|Overall Study|Lost to Follow-up|1|||
146957599|NCT01266967|530004697|FG000|Overall Study|Physician Decision|0|||
146957600|NCT01266967|530004698|FG001|Overall Study|Physician Decision|1|||
146957601|NCT01266967|530004697|FG000|Overall Study|Withdrawal by Subject|3|||
146957602|NCT01266967|530004698|FG001|Overall Study|Withdrawal by Subject|3|||
146957603|NCT00883896|530004701|FG000|Overall Study|Lost to Follow-up|0|||
146957604|NCT00883896|530004702|FG001|Overall Study|Lost to Follow-up|0|||
146957605|NCT00883896|530004703|FG002|Overall Study|Lost to Follow-up|0|||
146957606|NCT00883896|530004704|FG003|Overall Study|Lost to Follow-up|2|||
146957607|NCT00883896|530004701|FG000|Overall Study|Withdrawal by Subject|5|||
146957608|NCT00883896|530004702|FG001|Overall Study|Withdrawal by Subject|0|||
146957609|NCT00883896|530004703|FG002|Overall Study|Withdrawal by Subject|1|||
146985599|NCT01211769|530108923|FG000|Overall Study|Adverse Event|0|||
146957610|NCT00883896|530004704|FG003|Overall Study|Withdrawal by Subject|3|||
146957611|NCT00883896|530004701|FG000|Overall Study|Lack of Efficacy|0|||
146957612|NCT00883896|530004702|FG001|Overall Study|Lack of Efficacy|0|||
146957613|NCT00883896|530004703|FG002|Overall Study|Lack of Efficacy|0|||
146957614|NCT00883896|530004704|FG003|Overall Study|Lack of Efficacy|2|||
146826674|NCT01649297|529535666|FG004|Overall Study|For other reason|0|||
146826675|NCT01685047|529535667|FG000|Overall Study|Withdrawal by Subject|20|||
146826676|NCT01685047|529535667|FG000|Overall Study|Death|26|||
146826677|NCT01685047|529535667|FG000|Overall Study|Lost to Follow-up|8|||
146826678|NCT01685047|529535667|FG000|Overall Study|Physician Decision|25|||
146826679|NCT01685047|529535667|FG000|Overall Study|Adverse Event|5|||
146826680|NCT01685047|529535667|FG000|Overall Study|patient withdrawn by sponsor|1|||
146826681|NCT01049984|529535669|FG000|Overall Study|Withdrawal by Subject|1|||
146826682|NCT01049984|529535670|FG001|Overall Study|Withdrawal by Subject|5|||
146957615|NCT00883896|530004701|FG000|Overall Study|Other|1|||
146957616|NCT00883896|530004702|FG001|Overall Study|Other|0|||
146957617|NCT00883896|530004703|FG002|Overall Study|Other|0|||
146957618|NCT00883896|530004704|FG003|Overall Study|Other|0|||
146957619|NCT03380091|530004716|FG000|Overall Study|Withdrawal by Subject|2|||
146957620|NCT03380091|530004717|FG001|Overall Study|Withdrawal by Subject|1|||
146957621|NCT01980056|530004719|FG000|Overall Study|Death|1|||
146957622|NCT01980056|530004720|FG001|Overall Study|Death|1|||
146957623|NCT01980056|530004721|FG002|Overall Study|Death|0|||
146957624|NCT00535262|530004722|FG000|Overall Study|No funding|3|||
146957625|NCT03802331|530004723|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
146957626|NCT03802331|530004724|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
146957627|NCT00368069|530004726|FG000|Overall Study|Adverse Event|5|||
146957628|NCT00368069|530004727|FG001|Overall Study|Adverse Event|2|||
146957629|NCT00368069|530004726|FG000|Overall Study|Lack of Efficacy|0|||
146957630|NCT00368069|530004727|FG001|Overall Study|Lack of Efficacy|1|||
146957631|NCT00368069|530004726|FG000|Overall Study|Lost to Follow-up|1|||
146957632|NCT00368069|530004727|FG001|Overall Study|Lost to Follow-up|0|||
146957633|NCT00368069|530004726|FG000|Overall Study|Protocol Violation|0|||
146957634|NCT00368069|530004727|FG001|Overall Study|Protocol Violation|2|||
146957635|NCT00368069|530004726|FG000|Overall Study|Withdrawal of Consent|2|||
146957636|NCT00368069|530004727|FG001|Overall Study|Withdrawal of Consent|1|||
146957637|NCT00368069|530004726|FG000|Overall Study|no blood sampling possible|0|||
146957638|NCT00368069|530004727|FG001|Overall Study|no blood sampling possible|1|||
146957639|NCT01220024|530004733|FG000|Overall Study|Lost to Follow-up|1|||
146957640|NCT01220024|530004734|FG001|Overall Study|Lost to Follow-up|1|||
146957641|NCT00174460|530004737|FG000|Overall Study|Withdrawal by Subject|0|||
146957642|NCT00174460|530004738|FG001|Overall Study|Withdrawal by Subject|1|||
146957643|NCT00083616|530004739|FG000|Overall Study|Disease Progression|16|||
146957644|NCT00083616|530004739|FG000|Overall Study|Lost to Follow-up|1|||
146957645|NCT00083616|530004739|FG000|Overall Study|Physician Decision|2|||
146957646|NCT00083616|530004739|FG000|Overall Study|Withdrawal by Subject|3|||
146957647|NCT00083616|530004739|FG000|Overall Study|Ineligibility determined|2|||
146957648|NCT00083616|530004739|FG000|Overall Study|Non-compliance|1|||
146957649|NCT00083616|530004739|FG000|Overall Study|Other|6|||
146957650|NCT01474993|530004742|FG000|Overall Study|Lost to Follow-up|1|||
146957651|NCT01474993|530004743|FG001|Overall Study|Lost to Follow-up|2|||
146957652|NCT01474993|530004742|FG000|Overall Study|Adverse Event|0|||
146957653|NCT01474993|530004743|FG001|Overall Study|Adverse Event|1|||
146957654|NCT01853397|530004744|FG000|Overall Study|Withdrawal by Subject|0|||
146957655|NCT01853397|530004745|FG001|Overall Study|Withdrawal by Subject|0|||
146957656|NCT01853397|530004746|FG002|Overall Study|Withdrawal by Subject|0|||
146957657|NCT01853397|530004747|FG003|Overall Study|Withdrawal by Subject|1|||
146957658|NCT01853397|530004744|FG000|Overall Study|Subject Noncompliance|0|||
146957659|NCT01853397|530004745|FG001|Overall Study|Subject Noncompliance|0|||
146957660|NCT01853397|530004746|FG002|Overall Study|Subject Noncompliance|0|||
146957661|NCT01853397|530004747|FG003|Overall Study|Subject Noncompliance|1|||
146957662|NCT02132312|530004748|FG000|Overall Study|Adverse Event|2|||
146957663|NCT02132312|530004749|FG001|Overall Study|Adverse Event|0|||
146957664|NCT02132312|530004748|FG000|Overall Study|Physician Decision|1|||
146957665|NCT02132312|530004749|FG001|Overall Study|Physician Decision|1|||
146957666|NCT02132312|530004748|FG000|Overall Study|Protocol Violation|0|||
146957667|NCT02132312|530004749|FG001|Overall Study|Protocol Violation|1|||
146957668|NCT02132312|530004748|FG000|Overall Study|Withdrawal by Subject|1|||
146957669|NCT02132312|530004749|FG001|Overall Study|Withdrawal by Subject|0|||
146957670|NCT02132312|530004748|FG000|Overall Study|Lost to Follow-up|2|||
146957671|NCT02132312|530004749|FG001|Overall Study|Lost to Follow-up|1|||
146957672|NCT01632345|530004750|FG000|Treatment: Part I|Adverse Event|1|||
146957673|NCT01632345|530004751|FG001|Treatment: Part I|Adverse Event|4|||
146957674|NCT01632345|530004752|FG002|Treatment: Part I|Adverse Event|2|||
146957675|NCT01632345|530004753|FG003|Treatment: Part I|Adverse Event|1|||
146957676|NCT01632345|530004754|FG004|Treatment: Part I|Adverse Event|3|||
146957677|NCT01632345|530004755|FG005|Treatment: Part I|Adverse Event|0|||
146985600|NCT01211769|530108924|FG001|Overall Study|Adverse Event|1|||
146985601|NCT01211769|530108925|FG002|Overall Study|Adverse Event|1|||
146826683|NCT01049984|529535669|FG000|Overall Study|Protocol Violation|3|||
146957678|NCT01632345|530004756|FG006|Treatment: Part I|Adverse Event|0|||
146957679|NCT01632345|530004750|FG000|Treatment: Part I|Lack of Efficacy|0|||
146957680|NCT01632345|530004751|FG001|Treatment: Part I|Lack of Efficacy|1|||
146957681|NCT01632345|530004752|FG002|Treatment: Part I|Lack of Efficacy|0|||
146957682|NCT01632345|530004753|FG003|Treatment: Part I|Lack of Efficacy|1|||
146957683|NCT01632345|530004754|FG004|Treatment: Part I|Lack of Efficacy|1|||
146957684|NCT01632345|530004755|FG005|Treatment: Part I|Lack of Efficacy|0|||
146957685|NCT01632345|530004756|FG006|Treatment: Part I|Lack of Efficacy|0|||
146957686|NCT01632345|530004750|FG000|Treatment: Part I|Lost to Follow-up|3|||
146957687|NCT01632345|530004751|FG001|Treatment: Part I|Lost to Follow-up|2|||
146957688|NCT01632345|530004752|FG002|Treatment: Part I|Lost to Follow-up|1|||
146957689|NCT01632345|530004753|FG003|Treatment: Part I|Lost to Follow-up|3|||
146957690|NCT01632345|530004754|FG004|Treatment: Part I|Lost to Follow-up|4|||
146957691|NCT01632345|530004755|FG005|Treatment: Part I|Lost to Follow-up|0|||
146957692|NCT01632345|530004756|FG006|Treatment: Part I|Lost to Follow-up|0|||
146957693|NCT01632345|530004750|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
146957694|NCT01632345|530004751|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
146957695|NCT01632345|530004752|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
146957696|NCT01632345|530004753|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
146957697|NCT01632345|530004754|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
146957698|NCT01632345|530004755|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
146957699|NCT01632345|530004756|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
146957700|NCT01632345|530004750|FG000|Treatment: Part I|Physician Decision|2|||
146957701|NCT01632345|530004751|FG001|Treatment: Part I|Physician Decision|1|||
146957702|NCT01632345|530004752|FG002|Treatment: Part I|Physician Decision|0|||
146957703|NCT01632345|530004753|FG003|Treatment: Part I|Physician Decision|0|||
146957704|NCT01632345|530004754|FG004|Treatment: Part I|Physician Decision|1|||
146957705|NCT01632345|530004755|FG005|Treatment: Part I|Physician Decision|0|||
146957706|NCT01632345|530004756|FG006|Treatment: Part I|Physician Decision|0|||
146957707|NCT01632345|530004750|FG000|Treatment: Part I|Pregnancy|0|||
146957708|NCT01632345|530004751|FG001|Treatment: Part I|Pregnancy|1|||
146957709|NCT01632345|530004752|FG002|Treatment: Part I|Pregnancy|0|||
146957710|NCT01632345|530004753|FG003|Treatment: Part I|Pregnancy|0|||
146957711|NCT01632345|530004754|FG004|Treatment: Part I|Pregnancy|0|||
146957712|NCT01632345|530004755|FG005|Treatment: Part I|Pregnancy|0|||
146957713|NCT01632345|530004756|FG006|Treatment: Part I|Pregnancy|0|||
146957714|NCT01632345|530004750|FG000|Treatment: Part I|Protocol Deviation|0|||
146957715|NCT01632345|530004751|FG001|Treatment: Part I|Protocol Deviation|0|||
146957716|NCT01632345|530004752|FG002|Treatment: Part I|Protocol Deviation|1|||
146957717|NCT01632345|530004753|FG003|Treatment: Part I|Protocol Deviation|1|||
146957718|NCT01632345|530004754|FG004|Treatment: Part I|Protocol Deviation|0|||
146957719|NCT01632345|530004755|FG005|Treatment: Part I|Protocol Deviation|0|||
146957720|NCT01632345|530004756|FG006|Treatment: Part I|Protocol Deviation|0|||
146957721|NCT01632345|530004750|FG000|Treatment: Part I|Withdrawal by Subject|3|||
146957722|NCT01632345|530004751|FG001|Treatment: Part I|Withdrawal by Subject|4|||
146957723|NCT01632345|530004752|FG002|Treatment: Part I|Withdrawal by Subject|4|||
146957724|NCT01632345|530004753|FG003|Treatment: Part I|Withdrawal by Subject|1|||
146957725|NCT01632345|530004754|FG004|Treatment: Part I|Withdrawal by Subject|4|||
146957726|NCT01632345|530004755|FG005|Treatment: Part I|Withdrawal by Subject|0|||
146957727|NCT01632345|530004756|FG006|Treatment: Part I|Withdrawal by Subject|0|||
146957728|NCT01632345|530004750|FG000|Treatment: Part II|Adverse Event|0|||
146957729|NCT01632345|530004751|FG001|Treatment: Part II|Adverse Event|0|||
146957730|NCT01632345|530004752|FG002|Treatment: Part II|Adverse Event|0|||
146957731|NCT01632345|530004753|FG003|Treatment: Part II|Adverse Event|0|||
146957732|NCT01632345|530004754|FG004|Treatment: Part II|Adverse Event|0|||
146957733|NCT01632345|530004755|FG005|Treatment: Part II|Adverse Event|3|||
146957734|NCT01632345|530004756|FG006|Treatment: Part II|Adverse Event|8|||
146957735|NCT01632345|530004750|FG000|Treatment: Part II|Lost to Follow-up|0|||
146957736|NCT01632345|530004751|FG001|Treatment: Part II|Lost to Follow-up|0|||
146957737|NCT01632345|530004752|FG002|Treatment: Part II|Lost to Follow-up|0|||
146957738|NCT01632345|530004753|FG003|Treatment: Part II|Lost to Follow-up|0|||
146957739|NCT01632345|530004754|FG004|Treatment: Part II|Lost to Follow-up|0|||
146957740|NCT01632345|530004755|FG005|Treatment: Part II|Lost to Follow-up|3|||
146957741|NCT01632345|530004756|FG006|Treatment: Part II|Lost to Follow-up|1|||
146957742|NCT01632345|530004750|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
146957743|NCT01632345|530004751|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
146957744|NCT01632345|530004752|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
146957745|NCT01632345|530004753|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
146957746|NCT01632345|530004754|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
146826684|NCT01049984|529535670|FG001|Overall Study|Protocol Violation|4|||
146957747|NCT01632345|530004755|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
146957748|NCT01632345|530004756|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
146957749|NCT01632345|530004750|FG000|Treatment: Part II|Withdrawal by Subject|0|||
146957750|NCT01632345|530004751|FG001|Treatment: Part II|Withdrawal by Subject|0|||
146957751|NCT01632345|530004752|FG002|Treatment: Part II|Withdrawal by Subject|0|||
146957752|NCT01632345|530004753|FG003|Treatment: Part II|Withdrawal by Subject|0|||
146957753|NCT01632345|530004754|FG004|Treatment: Part II|Withdrawal by Subject|0|||
146957754|NCT01632345|530004755|FG005|Treatment: Part II|Withdrawal by Subject|2|||
146957755|NCT01632345|530004756|FG006|Treatment: Part II|Withdrawal by Subject|2|||
146957756|NCT02543918|530004757|FG000|Overall Study|Never treated|0|||
146957757|NCT02543918|530004758|FG001|Overall Study|Never treated|1|||
146957758|NCT02543918|530004757|FG000|Overall Study|Lost to Follow-up|1|||
146957759|NCT02543918|530004758|FG001|Overall Study|Lost to Follow-up|1|||
146957760|NCT02543918|530004757|FG000|Overall Study|Withdrawal by Subject|1|||
146957761|NCT02543918|530004758|FG001|Overall Study|Withdrawal by Subject|1|||
146957762|NCT02543918|530004757|FG000|Overall Study|Adverse Event|1|||
146957763|NCT02543918|530004758|FG001|Overall Study|Adverse Event|1|||
146957764|NCT02452892|530004759|FG000|Week 1 Initial Randommization|Adverse Event|1|||
146957765|NCT02452892|530004760|FG001|Week 1 Initial Randommization|Adverse Event|0|||
146957766|NCT02452892|530004761|FG002|Week 1 Initial Randommization|Adverse Event|0|||
146957767|NCT02452892|530004762|FG003|Week 1 Initial Randommization|Adverse Event|0|||
146957768|NCT02452892|530004759|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
146957769|NCT02452892|530004760|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
146957770|NCT02452892|530004761|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
146957771|NCT02452892|530004762|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
146957772|NCT02452892|530004759|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
146957773|NCT02452892|530004760|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
146957774|NCT02452892|530004761|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
146957775|NCT02452892|530004762|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
146957776|NCT02452892|530004759|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
146957777|NCT02452892|530004760|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
146957778|NCT02452892|530004761|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
146957779|NCT02452892|530004762|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
146957780|NCT02452892|530004759|FG000|Follow-up|Withdrawal by Subject|0|||
146957781|NCT02452892|530004760|FG001|Follow-up|Withdrawal by Subject|0|||
146957782|NCT02452892|530004761|FG002|Follow-up|Withdrawal by Subject|0|||
146957783|NCT02452892|530004762|FG003|Follow-up|Withdrawal by Subject|1|||
146957784|NCT02452892|530004759|FG000|Follow-up|Subject left town on Day 42|1|||
146957785|NCT02452892|530004760|FG001|Follow-up|Subject left town on Day 42|0|||
146957786|NCT02452892|530004761|FG002|Follow-up|Subject left town on Day 42|0|||
146957787|NCT02452892|530004762|FG003|Follow-up|Subject left town on Day 42|0|||
146957788|NCT00545740|530004763|FG000|Overall Study|Lack of Efficacy|34|||
146957789|NCT00545740|530004764|FG001|Overall Study|Lack of Efficacy|35|||
146957790|NCT00545740|530004765|FG002|Overall Study|Lack of Efficacy|47|||
146957791|NCT00545740|530004766|FG003|Overall Study|Lack of Efficacy|36|||
146957792|NCT00545740|530004763|FG000|Overall Study|Withdrawal by Subject|17|||
146957793|NCT00545740|530004764|FG001|Overall Study|Withdrawal by Subject|15|||
146957794|NCT00545740|530004765|FG002|Overall Study|Withdrawal by Subject|16|||
146957795|NCT00545740|530004766|FG003|Overall Study|Withdrawal by Subject|18|||
146957796|NCT00545740|530004763|FG000|Overall Study|Adverse Event|10|||
146957797|NCT00545740|530004764|FG001|Overall Study|Adverse Event|18|||
146957798|NCT00545740|530004765|FG002|Overall Study|Adverse Event|19|||
146957799|NCT00545740|530004766|FG003|Overall Study|Adverse Event|9|||
146957800|NCT00545740|530004763|FG000|Overall Study|Lost to Follow-up|7|||
146957801|NCT00545740|530004764|FG001|Overall Study|Lost to Follow-up|5|||
146957802|NCT00545740|530004765|FG002|Overall Study|Lost to Follow-up|5|||
146957803|NCT00545740|530004766|FG003|Overall Study|Lost to Follow-up|6|||
146957804|NCT00545740|530004763|FG000|Overall Study|Protocol Violation|1|||
146957805|NCT00545740|530004764|FG001|Overall Study|Protocol Violation|3|||
146957806|NCT00545740|530004765|FG002|Overall Study|Protocol Violation|1|||
146957807|NCT00545740|530004766|FG003|Overall Study|Protocol Violation|0|||
146957808|NCT00545740|530004763|FG000|Overall Study|Non-compliance|0|||
146957809|NCT00545740|530004764|FG001|Overall Study|Non-compliance|2|||
146957810|NCT00545740|530004765|FG002|Overall Study|Non-compliance|1|||
146957811|NCT00545740|530004766|FG003|Overall Study|Non-compliance|0|||
146957812|NCT00545740|530004763|FG000|Overall Study|Moved|2|||
146957813|NCT00545740|530004764|FG001|Overall Study|Moved|0|||
146957814|NCT00545740|530004765|FG002|Overall Study|Moved|1|||
146957815|NCT00545740|530004766|FG003|Overall Study|Moved|0|||
146957816|NCT00545740|530004763|FG000|Overall Study|Diverticulitis attack|0|||
146957817|NCT00545740|530004764|FG001|Overall Study|Diverticulitis attack|0|||
146957818|NCT00545740|530004765|FG002|Overall Study|Diverticulitis attack|1|||
146957819|NCT00545740|530004766|FG003|Overall Study|Diverticulitis attack|1|||
146957820|NCT00545740|530004763|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
146957821|NCT00545740|530004764|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
146957822|NCT00545740|530004765|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
146957823|NCT00545740|530004766|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
146957824|NCT00545740|530004763|FG000|Overall Study|Site closure|1|||
146957825|NCT00545740|530004764|FG001|Overall Study|Site closure|0|||
146957826|NCT00545740|530004765|FG002|Overall Study|Site closure|0|||
146957827|NCT00545740|530004766|FG003|Overall Study|Site closure|0|||
146957828|NCT00545740|530004763|FG000|Overall Study|Missed visit|1|||
146957829|NCT00545740|530004764|FG001|Overall Study|Missed visit|0|||
146985602|NCT01211769|530108926|FG003|Overall Study|Adverse Event|1|||
146957830|NCT00545740|530004765|FG002|Overall Study|Missed visit|0|||
146826685|NCT01049984|529535669|FG000|Overall Study|Lost to Follow-up|2|||
146826686|NCT01049984|529535670|FG001|Overall Study|Lost to Follow-up|1|||
146826687|NCT01049984|529535669|FG000|Overall Study|Adverse Event|13|||
146826688|NCT01049984|529535670|FG001|Overall Study|Adverse Event|7|||
146826689|NCT01049984|529535669|FG000|Overall Study|Treatment failure|0|||
146826690|NCT01049984|529535670|FG001|Overall Study|Treatment failure|2|||
146826691|NCT01040403|529535671|FG000|Overall Study|Adverse Event|10|||
146826692|NCT01040403|529535671|FG000|Overall Study|Protocol Violation|2|||
146826693|NCT01040403|529535671|FG000|Overall Study|Lost to Follow-up|1|||
146826694|NCT01040403|529535671|FG000|Overall Study|Not treated|1|||
146826695|NCT01040403|529535671|FG000|Overall Study|Other reason not defined above|6|||
146826696|NCT00292981|529535672|FG000|Overall Study|Adverse Event|1|||
146826697|NCT00292981|529535672|FG000|Overall Study|Lost to Follow-up|13|||
146826698|NCT00292981|529535672|FG000|Overall Study|Withdrawal by Subject|22|||
146826699|NCT00292981|529535672|FG000|Overall Study|Other|3|||
146826700|NCT00594178|529535675|FG000|Overall Study|Physician Decision|5|||
146826701|NCT04191148|529535681|FG000|Overall Study|Withdrawal by Subject|1|||
146826702|NCT04191148|529535682|FG001|Overall Study|Withdrawal by Subject|0|||
146826703|NCT04191148|529535681|FG000|Overall Study|Adverse Event|1|||
146826704|NCT04191148|529535682|FG001|Overall Study|Adverse Event|0|||
146826705|NCT04952701|529535683|FG000|Control Lens|Physician Decision|4|||
146826706|NCT04952701|529535683|FG000|Test Lens|Physician Decision|1|||
146826707|NCT02212301|529535684|FG000|Period 1|Lost to Follow-up|0|||
146826708|NCT02212301|529535685|FG001|Period 1|Lost to Follow-up|1|||
146826709|NCT00578318|529535690|FG000|Overall Study|Lost to Follow-up|2|||
146826710|NCT00578318|529535691|FG001|Overall Study|Lost to Follow-up|0|||
146826711|NCT00578318|529535690|FG000|Overall Study|Physician Decision|1|||
146826712|NCT00578318|529535691|FG001|Overall Study|Physician Decision|0|||
146826713|NCT02025985|529535692|FG000|Overall Study|Consent withdrawn|0|||
146826714|NCT02025985|529535693|FG001|Overall Study|Consent withdrawn|0|||
146826715|NCT02025985|529535694|FG002|Overall Study|Consent withdrawn|1|||
146826716|NCT02025985|529535695|FG003|Overall Study|Consent withdrawn|0|||
146826717|NCT02025985|529535696|FG004|Overall Study|Consent withdrawn|0|||
146826718|NCT02025985|529535692|FG000|Overall Study|Termination of study by Sponsor|4|||
146826719|NCT02025985|529535693|FG001|Overall Study|Termination of study by Sponsor|3|||
146826720|NCT02025985|529535694|FG002|Overall Study|Termination of study by Sponsor|1|||
146826721|NCT02025985|529535695|FG003|Overall Study|Termination of study by Sponsor|1|||
146826722|NCT02025985|529535696|FG004|Overall Study|Termination of study by Sponsor|3|||
146826723|NCT02025985|529535692|FG000|Overall Study|Death|21|||
146826724|NCT02025985|529535693|FG001|Overall Study|Death|20|||
146826725|NCT02025985|529535694|FG002|Overall Study|Death|23|||
146826726|NCT02025985|529535695|FG003|Overall Study|Death|20|||
146826727|NCT02025985|529535696|FG004|Overall Study|Death|17|||
146826728|NCT03041701|529535697|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
146826729|NCT03041701|529535698|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
146826730|NCT03041701|529535699|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
146826731|NCT03041701|529535697|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
146826732|NCT03041701|529535698|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
146826733|NCT03041701|529535699|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
146826734|NCT00527514|529535700|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
146826735|NCT00527514|529535700|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
146826736|NCT00527514|529535700|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
146826737|NCT00527514|529535700|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
146826738|NCT00527514|529535700|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
146826739|NCT00527514|529535700|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
146826740|NCT00527514|529535700|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
146826741|NCT03175198|529535701|FG000|Overall Study|Adverse Event|480|||
146826742|NCT03175198|529535701|FG000|Overall Study|No actual visit|120|||
146826743|NCT03175198|529535701|FG000|Overall Study|Registration rule not followed|4|||
146826744|NCT03175198|529535701|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
146826745|NCT03175198|529535701|FG000|Overall Study|Other personal reason|509|||
146826746|NCT03175198|529535701|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
146826747|NCT03175198|529535701|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
146826748|NCT03175198|529535701|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
146826749|NCT03175198|529535701|FG000|Overall Study|To conduct invasive treatment of operation|53|||
146826750|NCT03175198|529535701|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
146826751|NCT02630706|529535702|FG000|Overall Study|Adverse Event|2|||
146826752|NCT02630706|529535703|FG001|Overall Study|Adverse Event|1|||
146826753|NCT02630706|529535704|FG002|Overall Study|Adverse Event|1|||
146826754|NCT02630706|529535702|FG000|Overall Study|Lost to Follow-up|0|||
146826755|NCT02630706|529535703|FG001|Overall Study|Lost to Follow-up|1|||
146826756|NCT02630706|529535704|FG002|Overall Study|Lost to Follow-up|2|||
146826757|NCT02630706|529535702|FG000|Overall Study|Physician Decision|1|||
146985603|NCT01214330|530108927|FG000|Overall Study|Withdrawal by Subject|2|||
146826758|NCT02630706|529535703|FG001|Overall Study|Physician Decision|1|||
146826759|NCT02630706|529535704|FG002|Overall Study|Physician Decision|0|||
146826760|NCT02630706|529535702|FG000|Overall Study|Pregnancy|0|||
146826761|NCT02630706|529535703|FG001|Overall Study|Pregnancy|1|||
146826762|NCT02630706|529535704|FG002|Overall Study|Pregnancy|0|||
146826763|NCT02630706|529535702|FG000|Overall Study|Withdrawal by Subject|4|||
146826764|NCT02630706|529535703|FG001|Overall Study|Withdrawal by Subject|5|||
146826765|NCT02630706|529535704|FG002|Overall Study|Withdrawal by Subject|7|||
146826766|NCT01544309|529535709|FG000|Overall Study|Withdrawal by Subject|12|||
146826767|NCT01544309|529535710|FG001|Overall Study|Withdrawal by Subject|7|||
146826768|NCT01544309|529535709|FG000|Overall Study|Protocol Violation|2|||
146826769|NCT01544309|529535710|FG001|Overall Study|Protocol Violation|1|||
146826770|NCT01544309|529535709|FG000|Overall Study|Physician Decision|4|||
146957831|NCT00545740|530004766|FG003|Overall Study|Missed visit|0|||
146957832|NCT00545740|530004763|FG000|Overall Study|Physician Decision|0|||
146957833|NCT00545740|530004764|FG001|Overall Study|Physician Decision|0|||
146957834|NCT00545740|530004765|FG002|Overall Study|Physician Decision|3|||
146957835|NCT00545740|530004766|FG003|Overall Study|Physician Decision|0|||
146957836|NCT00545740|530004763|FG000|Overall Study|Accepted only monthly telephone calls|1|||
146957837|NCT00545740|530004764|FG001|Overall Study|Accepted only monthly telephone calls|0|||
146957838|NCT00545740|530004765|FG002|Overall Study|Accepted only monthly telephone calls|0|||
146957839|NCT00545740|530004766|FG003|Overall Study|Accepted only monthly telephone calls|0|||
146957840|NCT00545740|530004763|FG000|Overall Study|Sponsor decision|0|||
146957841|NCT00545740|530004764|FG001|Overall Study|Sponsor decision|1|||
146957842|NCT00545740|530004765|FG002|Overall Study|Sponsor decision|0|||
146957843|NCT00545740|530004766|FG003|Overall Study|Sponsor decision|0|||
146957844|NCT00545740|530004763|FG000|Overall Study|Lack of time|0|||
146957845|NCT00545740|530004764|FG001|Overall Study|Lack of time|1|||
146957846|NCT00545740|530004765|FG002|Overall Study|Lack of time|0|||
146957847|NCT00545740|530004766|FG003|Overall Study|Lack of time|0|||
146957848|NCT00545740|530004763|FG000|Overall Study|Non-adherence to visits|0|||
146957849|NCT00545740|530004764|FG001|Overall Study|Non-adherence to visits|1|||
146957850|NCT00545740|530004765|FG002|Overall Study|Non-adherence to visits|0|||
146957851|NCT00545740|530004766|FG003|Overall Study|Non-adherence to visits|0|||
146957852|NCT00545740|530004763|FG000|Overall Study|Patient difficulties|0|||
146957853|NCT00545740|530004764|FG001|Overall Study|Patient difficulties|1|||
146957854|NCT00545740|530004765|FG002|Overall Study|Patient difficulties|0|||
146957855|NCT00545740|530004766|FG003|Overall Study|Patient difficulties|0|||
146957856|NCT00545740|530004763|FG000|Overall Study|Husband against study|0|||
146957857|NCT00545740|530004764|FG001|Overall Study|Husband against study|0|||
146957858|NCT00545740|530004765|FG002|Overall Study|Husband against study|1|||
146957859|NCT00545740|530004766|FG003|Overall Study|Husband against study|0|||
146957860|NCT00266695|530004769|FG000|Overall Study|Adverse Event|1|||
146957861|NCT00266695|530004769|FG000|Overall Study|Death|9|||
146957862|NCT00266695|530004769|FG000|Overall Study|Physician Decision|1|||
146957863|NCT00266695|530004769|FG000|Overall Study|Lost to Follow-up|3|||
146957864|NCT00266695|530004769|FG000|Overall Study|Withdrawal by Subject|15|||
146957865|NCT02380703|530004770|FG000|Overall Study|Withdrawal by Subject|12|||
146957866|NCT02380703|530004771|FG001|Overall Study|Withdrawal by Subject|9|||
146957867|NCT02380703|530004770|FG000|Overall Study|Lost to Follow-up|12|||
146957868|NCT02380703|530004771|FG001|Overall Study|Lost to Follow-up|12|||
146957869|NCT02380703|530004770|FG000|Overall Study|Caregiver death|1|||
146957870|NCT02380703|530004771|FG001|Overall Study|Caregiver death|0|||
146957871|NCT02380703|530004770|FG000|Overall Study|Person with dementia (PWD) death|7|||
146957872|NCT02380703|530004771|FG001|Overall Study|Person with dementia (PWD) death|8|||
146957873|NCT02380703|530004770|FG000|Overall Study|Entered Long-term Care|4|||
146957874|NCT02380703|530004771|FG001|Overall Study|Entered Long-term Care|7|||
146957875|NCT04490499|530004772|FG000|Overall Study|Withdrawal by Subject|2|||
146957876|NCT01373294|530004775|FG000|Overall Study|Adverse Event|1|||
146957877|NCT01373294|530004776|FG001|Overall Study|Adverse Event|0|||
146957878|NCT01920061|530004781|FG000|Overall Study|Death|1|||
146957879|NCT01920061|530004782|FG001|Overall Study|Death|1|||
146957880|NCT01920061|530004783|FG002|Overall Study|Death|0|||
146957881|NCT01920061|530004784|FG003|Overall Study|Death|1|||
146957882|NCT01920061|530004785|FG004|Overall Study|Death|1|||
146957883|NCT01920061|530004786|FG005|Overall Study|Death|0|||
146957884|NCT01920061|530004787|FG006|Overall Study|Death|0|||
146957885|NCT01920061|530004788|FG007|Overall Study|Death|1|||
146957886|NCT01920061|530004789|FG008|Overall Study|Death|0|||
146826771|NCT01544309|529535710|FG001|Overall Study|Physician Decision|1|||
146826772|NCT01544309|529535709|FG000|Overall Study|Not performed pre-dose examination|1|||
146826773|NCT01544309|529535710|FG001|Overall Study|Not performed pre-dose examination|2|||
146957887|NCT01920061|530004790|FG009|Overall Study|Death|1|||
146957888|NCT01920061|530004791|FG010|Overall Study|Death|0|||
146957889|NCT01920061|530004792|FG011|Overall Study|Death|1|||
146957890|NCT01920061|530004793|FG012|Overall Study|Death|0|||
146957891|NCT01920061|530004794|FG013|Overall Study|Death|2|||
146957892|NCT01920061|530004795|FG014|Overall Study|Death|0|||
146957893|NCT01920061|530004796|FG015|Overall Study|Death|0|||
146985604|NCT01214330|530108927|FG000|Overall Study|Withdrawal by Subject|2|||
146985605|NCT00947427|530108928|FG000|Overall Study|Withdrawal by Subject|1|||
146985606|NCT00947427|530108929|FG001|Overall Study|Withdrawal by Subject|3|||
146985607|NCT00947427|530108928|FG000|Overall Study|Protocol Violation|0|||
146985608|NCT00947427|530108929|FG001|Overall Study|Protocol Violation|1|||
146985609|NCT03402893|530108930|FG000|Overall Study|Withdrawal by Subject|1|||
146985610|NCT00686036|530108935|FG000|Overall Study|Adverse Event|3|||
146985611|NCT00686036|530108936|FG001|Overall Study|Adverse Event|0|||
146985612|NCT00686036|530108935|FG000|Overall Study|Withdrawal by Subject|3|||
146985613|NCT00686036|530108936|FG001|Overall Study|Withdrawal by Subject|1|||
146985614|NCT00686036|530108935|FG000|Overall Study|Study terminated by AstraZeneca|2|||
146985615|NCT00686036|530108936|FG001|Overall Study|Study terminated by AstraZeneca|1|||
146985616|NCT00686036|530108935|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
146985617|NCT00686036|530108936|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
146985618|NCT00686036|530108935|FG000|Overall Study|Other reasons not identified|0|||
146985619|NCT00686036|530108936|FG001|Overall Study|Other reasons not identified|4|||
146985620|NCT01411995|530108937|FG000|Overall Study|Failed IUD insertion|0|||
146985621|NCT01411995|530108938|FG001|Overall Study|Failed IUD insertion|1|||
146985622|NCT01754259|530108947|FG000|Overall Study|Withdrawal by Subject|2|||
146985623|NCT01754259|530108948|FG001|Overall Study|Withdrawal by Subject|4|||
146985624|NCT01754259|530108947|FG000|Overall Study|Adverse Event|3|||
146985625|NCT01754259|530108948|FG001|Overall Study|Adverse Event|1|||
146985626|NCT01754259|530108947|FG000|Overall Study|Lost to Follow-up|0|||
146985627|NCT01754259|530108948|FG001|Overall Study|Lost to Follow-up|1|||
146985628|NCT01364870|530108953|FG000|Overall Study|Withdrawal by Subject|13|||
146985629|NCT01364870|530108954|FG001|Overall Study|Withdrawal by Subject|24|||
146985630|NCT01364870|530108955|FG002|Overall Study|Withdrawal by Subject|10|||
146985631|NCT01364870|530108953|FG000|Overall Study|Adverse Event|8|||
146985632|NCT01364870|530108954|FG001|Overall Study|Adverse Event|6|||
146985633|NCT01364870|530108955|FG002|Overall Study|Adverse Event|4|||
146985634|NCT01364870|530108953|FG000|Overall Study|Protocol Violation|1|||
146985635|NCT01364870|530108954|FG001|Overall Study|Protocol Violation|0|||
146985636|NCT01364870|530108955|FG002|Overall Study|Protocol Violation|0|||
146985637|NCT02102490|530108958|FG000|Overall Study|Death|6|||
146985638|NCT02102490|530108958|FG000|Overall Study|Lost to Follow-up|1|||
146985639|NCT00095199|530108961|FG000|Overall Study|Adverse Event|40|||
146985640|NCT00095199|530108962|FG001|Overall Study|Adverse Event|22|||
146985641|NCT00095199|530108963|FG002|Overall Study|Adverse Event|26|||
146985642|NCT00095199|530108964|FG003|Overall Study|Adverse Event|11|||
146985643|NCT00095199|530108961|FG000|Overall Study|Progressive disease|213|||
146985644|NCT00095199|530108962|FG001|Overall Study|Progressive disease|179|||
146985645|NCT00095199|530108963|FG002|Overall Study|Progressive disease|105|||
146985646|NCT00095199|530108964|FG003|Overall Study|Progressive disease|98|||
146985647|NCT00095199|530108961|FG000|Overall Study|Death|10|||
146985648|NCT00095199|530108962|FG001|Overall Study|Death|6|||
146985649|NCT00095199|530108963|FG002|Overall Study|Death|11|||
146985650|NCT00095199|530108964|FG003|Overall Study|Death|9|||
146985651|NCT00095199|530108961|FG000|Overall Study|Withdrawal by Subject|21|||
146985652|NCT00095199|530108962|FG001|Overall Study|Withdrawal by Subject|16|||
146985653|NCT00095199|530108963|FG002|Overall Study|Withdrawal by Subject|13|||
146985654|NCT00095199|530108964|FG003|Overall Study|Withdrawal by Subject|22|||
146985655|NCT00095199|530108961|FG000|Overall Study|Protocol Violation|4|||
146985656|NCT00095199|530108962|FG001|Overall Study|Protocol Violation|4|||
146985657|NCT00095199|530108963|FG002|Overall Study|Protocol Violation|2|||
146985658|NCT00095199|530108964|FG003|Overall Study|Protocol Violation|0|||
146985659|NCT00095199|530108961|FG000|Overall Study|Liver function test results elevated|0|||
146985660|NCT00095199|530108962|FG001|Overall Study|Liver function test results elevated|0|||
146985661|NCT00095199|530108963|FG002|Overall Study|Liver function test results elevated|1|||
146985662|NCT00095199|530108964|FG003|Overall Study|Liver function test results elevated|1|||
146985663|NCT00095199|530108961|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
146985664|NCT00095199|530108962|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
146985665|NCT00095199|530108963|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
146985666|NCT00095199|530108964|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
146985667|NCT00095199|530108961|FG000|Overall Study|Physician Decision|5|||
146985668|NCT00095199|530108962|FG001|Overall Study|Physician Decision|6|||
146985669|NCT00095199|530108963|FG002|Overall Study|Physician Decision|1|||
146985670|NCT00095199|530108964|FG003|Overall Study|Physician Decision|1|||
146985671|NCT00095199|530108961|FG000|Overall Study|Not eligible|1|||
146985672|NCT00095199|530108962|FG001|Overall Study|Not eligible|7|||
146985673|NCT00095199|530108963|FG002|Overall Study|Not eligible|0|||
146985674|NCT00095199|530108964|FG003|Overall Study|Not eligible|1|||
146985675|NCT00095199|530108961|FG000|Overall Study|Started Palliative Radiotherapy|1|||
146985676|NCT00095199|530108962|FG001|Overall Study|Started Palliative Radiotherapy|0|||
146985677|NCT00095199|530108963|FG002|Overall Study|Started Palliative Radiotherapy|0|||
146985678|NCT00095199|530108964|FG003|Overall Study|Started Palliative Radiotherapy|0|||
146985679|NCT00095199|530108961|FG000|Overall Study|Started radiotherapy regimen|0|||
146985680|NCT00095199|530108962|FG001|Overall Study|Started radiotherapy regimen|1|||
146985681|NCT00095199|530108963|FG002|Overall Study|Started radiotherapy regimen|0|||
146985682|NCT00095199|530108964|FG003|Overall Study|Started radiotherapy regimen|0|||
146985683|NCT00095199|530108961|FG000|Overall Study|Primary tumor removed in other surgery|0|||
146985684|NCT00095199|530108962|FG001|Overall Study|Primary tumor removed in other surgery|1|||
146985685|NCT00095199|530108963|FG002|Overall Study|Primary tumor removed in other surgery|0|||
146985686|NCT00095199|530108964|FG003|Overall Study|Primary tumor removed in other surgery|0|||
146985687|NCT00095199|530108961|FG000|Overall Study|Data inadvertently lost by site|1|||
146985688|NCT00095199|530108962|FG001|Overall Study|Data inadvertently lost by site|0|||
146985689|NCT00095199|530108963|FG002|Overall Study|Data inadvertently lost by site|0|||
146985690|NCT00095199|530108964|FG003|Overall Study|Data inadvertently lost by site|0|||
146985691|NCT03896490|530108999|FG000|Overall Study|Withdrawal by Subject|1|||
146985692|NCT03896490|530109000|FG001|Overall Study|Withdrawal by Subject|1|||
146985693|NCT01736553|530109005|FG000|Overall Study|Death|12|||
146985694|NCT01736553|530109006|FG001|Overall Study|Death|0|||
146985695|NCT01736553|530109005|FG000|Overall Study|Withdrawal by Subject|5|||
146985696|NCT01736553|530109006|FG001|Overall Study|Withdrawal by Subject|2|||
146985697|NCT01736553|530109005|FG000|Overall Study|Lost to Follow-up|2|||
146985698|NCT01736553|530109006|FG001|Overall Study|Lost to Follow-up|2|||
146985699|NCT01896297|530109007|FG000|Overall Study|Died in post treatment phase|1|||
146985700|NCT00003782|530109008|FG000|Overall Study|No follow up data|30|||
146985701|NCT00003782|530109009|FG001|Overall Study|No follow up data|31|||
146985702|NCT00003782|530109010|FG002|Overall Study|No follow up data|26|||
146985703|NCT01890707|530109011|FG000|Overall Study|Lost to Follow-up|1|||
146985704|NCT01890707|530109012|FG001|Overall Study|Lost to Follow-up|1|||
146985705|NCT00385541|530109014|FG000|Overall Study|severe pain, clinician requested unblind|0|||
146985706|NCT00385541|530109015|FG001|Overall Study|severe pain, clinician requested unblind|1|||
146985707|NCT00929708|530109016|FG000|Overall Study|Protocol Violation|2|||
146985708|NCT00929708|530109017|FG001|Overall Study|Protocol Violation|1|||
146985709|NCT00929708|530109018|FG002|Overall Study|Protocol Violation|1|||
146985710|NCT00929708|530109019|FG003|Overall Study|Protocol Violation|1|||
146985711|NCT00929708|530109020|FG004|Overall Study|Protocol Violation|1|||
146985712|NCT00929708|530109016|FG000|Overall Study|Withdrawal by Subject|2|||
146985713|NCT00929708|530109017|FG001|Overall Study|Withdrawal by Subject|0|||
146985714|NCT00929708|530109018|FG002|Overall Study|Withdrawal by Subject|0|||
146985715|NCT00929708|530109019|FG003|Overall Study|Withdrawal by Subject|2|||
146985716|NCT00929708|530109020|FG004|Overall Study|Withdrawal by Subject|1|||
146985717|NCT00929708|530109016|FG000|Overall Study|Adverse Event|0|||
146985718|NCT00929708|530109017|FG001|Overall Study|Adverse Event|0|||
146985719|NCT00929708|530109018|FG002|Overall Study|Adverse Event|0|||
146985720|NCT00929708|530109019|FG003|Overall Study|Adverse Event|0|||
146985721|NCT00929708|530109020|FG004|Overall Study|Adverse Event|3|||
146985722|NCT00929708|530109016|FG000|Overall Study|Physician Decision|0|||
146985723|NCT00929708|530109017|FG001|Overall Study|Physician Decision|2|||
146985724|NCT00929708|530109018|FG002|Overall Study|Physician Decision|2|||
146985725|NCT00929708|530109019|FG003|Overall Study|Physician Decision|2|||
146985726|NCT00929708|530109020|FG004|Overall Study|Physician Decision|1|||
146985727|NCT00929708|530109016|FG000|Overall Study|Lost to Follow-up|0|||
146985728|NCT00929708|530109017|FG001|Overall Study|Lost to Follow-up|0|||
146985729|NCT00929708|530109018|FG002|Overall Study|Lost to Follow-up|0|||
146985730|NCT00929708|530109019|FG003|Overall Study|Lost to Follow-up|1|||
146985731|NCT00929708|530109020|FG004|Overall Study|Lost to Follow-up|0|||
146985732|NCT01893138|530109021|FG000|Double-Blind Period|Withdrawal by Subject|1|||
146985733|NCT01893138|530109022|FG001|Double-Blind Period|Withdrawal by Subject|1|||
146985734|NCT01893138|530109021|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
146985735|NCT01893138|530109022|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
146985736|NCT01893138|530109021|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
146985737|NCT01893138|530109022|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
146985738|NCT01893138|530109021|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
146985739|NCT01893138|530109022|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
146985740|NCT01893138|530109021|FG000|Open Label - Unblinded Period|Adverse Event|1|||
146985741|NCT01893138|530109022|FG001|Open Label - Unblinded Period|Adverse Event|0|||
146985742|NCT02154529|530109023|FG000|Overall Study|Death|1|||
146985743|NCT02154529|530109024|FG001|Overall Study|Death|1|||
146985744|NCT02154529|530109025|FG002|Overall Study|Death|5|||
146985745|NCT02154529|530109026|FG003|Overall Study|Death|1|||
146985746|NCT02154529|530109023|FG000|Overall Study|Termination of study by sponsor|2|||
146985747|NCT02154529|530109024|FG001|Overall Study|Termination of study by sponsor|2|||
146985748|NCT02154529|530109025|FG002|Overall Study|Termination of study by sponsor|3|||
146985749|NCT02154529|530109026|FG003|Overall Study|Termination of study by sponsor|1|||
146985750|NCT02154529|530109023|FG000|Overall Study|Lost to Follow-up|1|||
146985751|NCT02154529|530109024|FG001|Overall Study|Lost to Follow-up|0|||
146985752|NCT02154529|530109025|FG002|Overall Study|Lost to Follow-up|0|||
146985753|NCT02154529|530109026|FG003|Overall Study|Lost to Follow-up|0|||
146985754|NCT02761980|530111054|FG000|Overall Study|Adverse Event|4|||
146985755|NCT02761980|530111055|FG001|Overall Study|Adverse Event|6|||
146985756|NCT02761980|530111056|FG002|Overall Study|Adverse Event|5|||
146985757|NCT02761980|530111057|FG003|Overall Study|Adverse Event|6|||
146985758|NCT02761980|530111054|FG000|Overall Study|Withdrawal by Subject|0|||
146985759|NCT02761980|530111055|FG001|Overall Study|Withdrawal by Subject|1|||
146985760|NCT02761980|530111056|FG002|Overall Study|Withdrawal by Subject|0|||
146985761|NCT02761980|530111057|FG003|Overall Study|Withdrawal by Subject|0|||
146985762|NCT02761980|530111054|FG000|Overall Study|Other|0|||
146985763|NCT02761980|530111055|FG001|Overall Study|Other|0|||
146985764|NCT02761980|530111056|FG002|Overall Study|Other|1|||
146985765|NCT02761980|530111057|FG003|Overall Study|Other|0|||
146985766|NCT02192905|530111058|FG000|Overall Study|Lost to Follow-up|1|||
146985767|NCT04820842|530111059|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
146985768|NCT04820842|530111060|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
146985769|NCT04820842|530111061|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
146985770|NCT04820842|530111062|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
146985771|NCT04820842|530111063|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
146985772|NCT04820842|530111064|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
146985773|NCT04820842|530111065|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
146985774|NCT04820842|530111059|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
146985775|NCT04820842|530111060|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
146985776|NCT04820842|530111061|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
146985777|NCT04820842|530111062|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146985778|NCT04820842|530111063|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146985779|NCT04820842|530111064|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146985780|NCT04820842|530111065|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146985781|NCT04820842|530111059|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
146985782|NCT04820842|530111060|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
146985783|NCT04820842|530111061|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
146826774|NCT01544309|529535709|FG000|Overall Study|Administered prohibit prior medication|1|||
146957894|NCT01920061|530004797|FG016|Overall Study|Death|0|||
146957895|NCT01920061|530004798|FG017|Overall Study|Death|0|||
146957896|NCT01920061|530004799|FG018|Overall Study|Death|1|||
146957897|NCT01920061|530004800|FG019|Overall Study|Death|0|||
146957898|NCT01920061|530004781|FG000|Overall Study|Lost to Follow-up|0|||
146957899|NCT01920061|530004782|FG001|Overall Study|Lost to Follow-up|2|||
146957900|NCT01920061|530004783|FG002|Overall Study|Lost to Follow-up|0|||
146957901|NCT01920061|530004784|FG003|Overall Study|Lost to Follow-up|0|||
146957902|NCT01920061|530004785|FG004|Overall Study|Lost to Follow-up|0|||
146957903|NCT01920061|530004786|FG005|Overall Study|Lost to Follow-up|0|||
146957904|NCT01920061|530004787|FG006|Overall Study|Lost to Follow-up|1|||
146957905|NCT01920061|530004788|FG007|Overall Study|Lost to Follow-up|0|||
146957906|NCT01920061|530004789|FG008|Overall Study|Lost to Follow-up|0|||
146957907|NCT01920061|530004790|FG009|Overall Study|Lost to Follow-up|0|||
146957908|NCT01920061|530004791|FG010|Overall Study|Lost to Follow-up|3|||
146957909|NCT01920061|530004792|FG011|Overall Study|Lost to Follow-up|0|||
146957910|NCT01920061|530004793|FG012|Overall Study|Lost to Follow-up|0|||
146957911|NCT01920061|530004794|FG013|Overall Study|Lost to Follow-up|0|||
146957912|NCT01920061|530004795|FG014|Overall Study|Lost to Follow-up|0|||
146957913|NCT01920061|530004796|FG015|Overall Study|Lost to Follow-up|0|||
146957914|NCT01920061|530004797|FG016|Overall Study|Lost to Follow-up|0|||
146957915|NCT01920061|530004798|FG017|Overall Study|Lost to Follow-up|1|||
146957916|NCT01920061|530004799|FG018|Overall Study|Lost to Follow-up|4|||
146957917|NCT01920061|530004800|FG019|Overall Study|Lost to Follow-up|3|||
146957918|NCT01920061|530004781|FG000|Overall Study|Other|1|||
146957919|NCT01920061|530004782|FG001|Overall Study|Other|1|||
146957920|NCT01920061|530004783|FG002|Overall Study|Other|2|||
146957921|NCT01920061|530004784|FG003|Overall Study|Other|1|||
146957922|NCT01920061|530004785|FG004|Overall Study|Other|0|||
146957923|NCT01920061|530004786|FG005|Overall Study|Other|1|||
146957924|NCT01920061|530004787|FG006|Overall Study|Other|0|||
146957925|NCT01920061|530004788|FG007|Overall Study|Other|0|||
146957926|NCT01920061|530004789|FG008|Overall Study|Other|0|||
146957927|NCT01920061|530004790|FG009|Overall Study|Other|1|||
146957928|NCT01920061|530004791|FG010|Overall Study|Other|1|||
146957929|NCT01920061|530004792|FG011|Overall Study|Other|2|||
146957930|NCT01920061|530004793|FG012|Overall Study|Other|1|||
146957931|NCT01920061|530004794|FG013|Overall Study|Other|4|||
146957932|NCT01920061|530004795|FG014|Overall Study|Other|0|||
146957933|NCT01920061|530004796|FG015|Overall Study|Other|1|||
146957934|NCT01920061|530004797|FG016|Overall Study|Other|1|||
146957935|NCT01920061|530004798|FG017|Overall Study|Other|0|||
146957936|NCT01920061|530004799|FG018|Overall Study|Other|1|||
146957937|NCT01920061|530004800|FG019|Overall Study|Other|1|||
146957938|NCT01920061|530004781|FG000|Overall Study|Participant refused further follow-up|0|||
146826775|NCT01544309|529535710|FG001|Overall Study|Administered prohibit prior medication|0|||
146826776|NCT02551692|529535715|FG000|Overall Study|Lost to Follow-up|0|||
146826777|NCT02551692|529535716|FG001|Overall Study|Lost to Follow-up|1|||
146826778|NCT02551692|529535717|FG002|Overall Study|Lost to Follow-up|4|||
146826779|NCT02551692|529535715|FG000|Overall Study|Withdrawal by Subject|1|||
146826780|NCT02551692|529535716|FG001|Overall Study|Withdrawal by Subject|0|||
146826781|NCT02551692|529535717|FG002|Overall Study|Withdrawal by Subject|1|||
146826782|NCT01091519|529535718|FG000|Overall Study|Adverse Event|12|||
146826783|NCT01091519|529535719|FG001|Overall Study|Adverse Event|16|||
146826784|NCT01091519|529535718|FG000|Overall Study|Death|1|||
146826785|NCT01091519|529535719|FG001|Overall Study|Death|0|||
146826786|NCT01091519|529535718|FG000|Overall Study|Lack of Efficacy|16|||
146826787|NCT01091519|529535719|FG001|Overall Study|Lack of Efficacy|19|||
146826788|NCT01091519|529535718|FG000|Overall Study|Lost to Follow-up|14|||
146826789|NCT01091519|529535719|FG001|Overall Study|Lost to Follow-up|24|||
146826790|NCT01091519|529535718|FG000|Overall Study|Withdrawal by Subject|2|||
146957939|NCT01920061|530004782|FG001|Overall Study|Participant refused further follow-up|0|||
146957940|NCT01920061|530004783|FG002|Overall Study|Participant refused further follow-up|0|||
146957941|NCT01920061|530004784|FG003|Overall Study|Participant refused further follow-up|0|||
146957942|NCT01920061|530004785|FG004|Overall Study|Participant refused further follow-up|1|||
146957943|NCT01920061|530004786|FG005|Overall Study|Participant refused further follow-up|1|||
146957944|NCT01920061|530004787|FG006|Overall Study|Participant refused further follow-up|0|||
146957945|NCT01920061|530004788|FG007|Overall Study|Participant refused further follow-up|0|||
146957946|NCT01920061|530004789|FG008|Overall Study|Participant refused further follow-up|1|||
146957947|NCT01920061|530004790|FG009|Overall Study|Participant refused further follow-up|0|||
146957948|NCT01920061|530004791|FG010|Overall Study|Participant refused further follow-up|1|||
146957949|NCT01920061|530004792|FG011|Overall Study|Participant refused further follow-up|0|||
146957950|NCT01920061|530004793|FG012|Overall Study|Participant refused further follow-up|1|||
146957951|NCT01920061|530004794|FG013|Overall Study|Participant refused further follow-up|0|||
146957952|NCT01920061|530004795|FG014|Overall Study|Participant refused further follow-up|1|||
146957953|NCT01920061|530004796|FG015|Overall Study|Participant refused further follow-up|2|||
146957954|NCT01920061|530004797|FG016|Overall Study|Participant refused further follow-up|1|||
146957955|NCT01920061|530004798|FG017|Overall Study|Participant refused further follow-up|1|||
146957956|NCT01920061|530004799|FG018|Overall Study|Participant refused further follow-up|0|||
146957957|NCT01920061|530004800|FG019|Overall Study|Participant refused further follow-up|0|||
146957958|NCT00877929|530004801|FG000|Overall Study|Adverse Event|11|||
146957959|NCT00877929|530004802|FG001|Overall Study|Adverse Event|20|||
146957960|NCT00877929|530004801|FG000|Overall Study|Protocol Violation|3|||
146957961|NCT00877929|530004802|FG001|Overall Study|Protocol Violation|3|||
146957962|NCT00877929|530004801|FG000|Overall Study|Lost to Follow-up|0|||
146957963|NCT00877929|530004802|FG001|Overall Study|Lost to Follow-up|1|||
146957964|NCT00877929|530004801|FG000|Overall Study|Withdrawal by Subject|4|||
146957965|NCT00877929|530004802|FG001|Overall Study|Withdrawal by Subject|4|||
146957966|NCT00877929|530004801|FG000|Overall Study|Lack of Efficacy|0|||
146957967|NCT00877929|530004802|FG001|Overall Study|Lack of Efficacy|1|||
146957968|NCT00877929|530004801|FG000|Overall Study|Other reason (not specified)|2|||
146957969|NCT00877929|530004802|FG001|Overall Study|Other reason (not specified)|6|||
146957970|NCT01140646|530004803|FG000|Overall Study|Adverse Event|4|||
146957971|NCT01140646|530004803|FG000|Overall Study|Refused Further Treatment|5|||
146957972|NCT02612194|530004814|FG000|Overall Study|Death|5|||
146957973|NCT02612194|530004815|FG001|Overall Study|Death|0|||
146957974|NCT02612194|530004816|FG002|Overall Study|Death|2|||
146957975|NCT02612194|530004814|FG000|Overall Study|Early Study Termination|1|||
146957976|NCT02612194|530004815|FG001|Overall Study|Early Study Termination|0|||
146957977|NCT02612194|530004816|FG002|Overall Study|Early Study Termination|0|||
146957978|NCT01681004|530004817|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
146957979|NCT01681004|530004818|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
146957980|NCT01681004|530004817|FG000|Study Completion|Lost to Follow-up|8|||
146957981|NCT01681004|530004818|FG001|Study Completion|Lost to Follow-up|3|||
146957982|NCT01681004|530004817|FG000|Study Completion|Physician Decision|1|||
146957983|NCT01681004|530004818|FG001|Study Completion|Physician Decision|3|||
146957984|NCT01681004|530004817|FG000|Study Completion|Site Termination|2|||
146957985|NCT01681004|530004818|FG001|Study Completion|Site Termination|1|||
146957986|NCT01681004|530004817|FG000|Study Completion|Death|1|||
146957987|NCT01681004|530004818|FG001|Study Completion|Death|1|||
146957988|NCT00337935|530006232|FG000|Overall Study|Adverse Event|2|||
146957989|NCT00337935|530006233|FG001|Overall Study|Adverse Event|5|||
146957990|NCT00337935|530006232|FG000|Overall Study|Death|2|||
146957991|NCT00337935|530006233|FG001|Overall Study|Death|8|||
146957992|NCT00337935|530006232|FG000|Overall Study|Physician Decision|1|||
146957993|NCT00337935|530006233|FG001|Overall Study|Physician Decision|1|||
146957994|NCT00337935|530006232|FG000|Overall Study|Lost to Follow-up|0|||
146957995|NCT00337935|530006233|FG001|Overall Study|Lost to Follow-up|1|||
146826791|NCT01091519|529535719|FG001|Overall Study|Withdrawal by Subject|2|||
146957996|NCT00337935|530006232|FG000|Overall Study|Protocol Violation|4|||
146985784|NCT04820842|530111062|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
146985785|NCT04820842|530111063|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
146985786|NCT04820842|530111064|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
146985787|NCT04820842|530111065|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
146985788|NCT04820842|530111059|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146985789|NCT04820842|530111060|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146985790|NCT04820842|530111061|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146985791|NCT04820842|530111062|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
146985792|NCT04820842|530111063|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146985793|NCT04820842|530111064|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146985794|NCT04820842|530111065|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
146985795|NCT01296932|530111066|FG000|Overall Study|Dose limiting toxicity|0|||
146985796|NCT01296932|530111067|FG001|Overall Study|Dose limiting toxicity|0|||
146985797|NCT01296932|530111068|FG002|Overall Study|Dose limiting toxicity|0|||
146985798|NCT01296932|530111069|FG003|Overall Study|Dose limiting toxicity|0|||
146985799|NCT01296932|530111070|FG004|Overall Study|Dose limiting toxicity|0|||
146985800|NCT01296932|530111071|FG005|Overall Study|Dose limiting toxicity|0|||
146985801|NCT01296932|530111072|FG006|Overall Study|Dose limiting toxicity|1|||
146985802|NCT01296932|530111073|FG007|Overall Study|Dose limiting toxicity|0|||
146985803|NCT01296932|530111074|FG008|Overall Study|Dose limiting toxicity|1|||
146985804|NCT01296932|530111066|FG000|Overall Study|Progressive disease|2|||
146985805|NCT01296932|530111067|FG001|Overall Study|Progressive disease|0|||
146985806|NCT01296932|530111068|FG002|Overall Study|Progressive disease|1|||
146985807|NCT01296932|530111069|FG003|Overall Study|Progressive disease|1|||
146985808|NCT01296932|530111070|FG004|Overall Study|Progressive disease|2|||
146985809|NCT01296932|530111071|FG005|Overall Study|Progressive disease|3|||
146985810|NCT01296932|530111072|FG006|Overall Study|Progressive disease|1|||
146985811|NCT01296932|530111073|FG007|Overall Study|Progressive disease|0|||
146985812|NCT01296932|530111074|FG008|Overall Study|Progressive disease|0|||
146985813|NCT01296932|530111066|FG000|Overall Study|Withdrawal by Subject|0|||
146985814|NCT01296932|530111067|FG001|Overall Study|Withdrawal by Subject|0|||
146985815|NCT01296932|530111068|FG002|Overall Study|Withdrawal by Subject|1|||
146985816|NCT01296932|530111069|FG003|Overall Study|Withdrawal by Subject|1|||
146985817|NCT01296932|530111070|FG004|Overall Study|Withdrawal by Subject|0|||
146985818|NCT01296932|530111071|FG005|Overall Study|Withdrawal by Subject|0|||
146985819|NCT01296932|530111072|FG006|Overall Study|Withdrawal by Subject|3|||
146985820|NCT01296932|530111073|FG007|Overall Study|Withdrawal by Subject|0|||
146985821|NCT01296932|530111074|FG008|Overall Study|Withdrawal by Subject|0|||
146985822|NCT01296932|530111066|FG000|Overall Study|Adverse Event|1|||
146985823|NCT01296932|530111067|FG001|Overall Study|Adverse Event|1|||
146985824|NCT01296932|530111068|FG002|Overall Study|Adverse Event|1|||
146985825|NCT01296932|530111069|FG003|Overall Study|Adverse Event|2|||
146985826|NCT01296932|530111070|FG004|Overall Study|Adverse Event|1|||
146985827|NCT01296932|530111071|FG005|Overall Study|Adverse Event|0|||
146985828|NCT01296932|530111072|FG006|Overall Study|Adverse Event|0|||
146985829|NCT01296932|530111073|FG007|Overall Study|Adverse Event|0|||
146985830|NCT01296932|530111074|FG008|Overall Study|Adverse Event|1|||
146985831|NCT01296932|530111066|FG000|Overall Study|Investigator decision|0|||
146985832|NCT01296932|530111067|FG001|Overall Study|Investigator decision|1|||
146985833|NCT01296932|530111068|FG002|Overall Study|Investigator decision|0|||
146985834|NCT01296932|530111069|FG003|Overall Study|Investigator decision|1|||
146985835|NCT01296932|530111070|FG004|Overall Study|Investigator decision|0|||
146985836|NCT01296932|530111071|FG005|Overall Study|Investigator decision|0|||
146985837|NCT01296932|530111072|FG006|Overall Study|Investigator decision|1|||
146985838|NCT01296932|530111073|FG007|Overall Study|Investigator decision|0|||
146985839|NCT01296932|530111074|FG008|Overall Study|Investigator decision|1|||
146985840|NCT01296932|530111066|FG000|Overall Study|No clinical benefit anymore|0|||
146985841|NCT01296932|530111067|FG001|Overall Study|No clinical benefit anymore|1|||
146985842|NCT01296932|530111068|FG002|Overall Study|No clinical benefit anymore|0|||
146985843|NCT01296932|530111069|FG003|Overall Study|No clinical benefit anymore|0|||
146985844|NCT01296932|530111070|FG004|Overall Study|No clinical benefit anymore|0|||
146985845|NCT01296932|530111071|FG005|Overall Study|No clinical benefit anymore|0|||
146985846|NCT01296932|530111072|FG006|Overall Study|No clinical benefit anymore|0|||
146985847|NCT01296932|530111073|FG007|Overall Study|No clinical benefit anymore|0|||
146985848|NCT01296932|530111074|FG008|Overall Study|No clinical benefit anymore|0|||
146985849|NCT01296932|530111066|FG000|Overall Study|Physician Decision|0|||
146985850|NCT01296932|530111067|FG001|Overall Study|Physician Decision|0|||
146985851|NCT01296932|530111068|FG002|Overall Study|Physician Decision|1|||
146985852|NCT01296932|530111069|FG003|Overall Study|Physician Decision|0|||
146985853|NCT01296932|530111070|FG004|Overall Study|Physician Decision|0|||
146826792|NCT01091519|529535718|FG000|Overall Study|Other|6|||
146826793|NCT01091519|529535719|FG001|Overall Study|Other|8|||
146826794|NCT01091519|529535718|FG000|Overall Study|Randomized not treated|4|||
146826795|NCT01091519|529535719|FG001|Overall Study|Randomized not treated|4|||
146826796|NCT01196741|529535722|FG000|Overall Study|Disease progression|34|||
146826797|NCT01196741|529535723|FG001|Overall Study|Disease progression|14|||
146826798|NCT01196741|529535722|FG000|Overall Study|Adverse Event|10|||
146826799|NCT01196741|529535723|FG001|Overall Study|Adverse Event|6|||
146826800|NCT01196741|529535722|FG000|Overall Study|Serious Adverse Event|3|||
146826801|NCT01196741|529535723|FG001|Overall Study|Serious Adverse Event|1|||
146826802|NCT01196741|529535722|FG000|Overall Study|Dose limiting Adverse Event|2|||
146826803|NCT01196741|529535723|FG001|Overall Study|Dose limiting Adverse Event|1|||
146826804|NCT01196741|529535722|FG000|Overall Study|Withdrawal by Subject|3|||
146826805|NCT01196741|529535723|FG001|Overall Study|Withdrawal by Subject|0|||
146826806|NCT01196741|529535722|FG000|Overall Study|Other reason|3|||
146826807|NCT01196741|529535723|FG001|Overall Study|Other reason|3|||
146826808|NCT01196741|529535722|FG000|Overall Study|Other|3|||
146826809|NCT01196741|529535723|FG001|Overall Study|Other|2|||
146826810|NCT01196741|529535722|FG000|Overall Study|Protocol Violation|2|||
146826811|NCT01196741|529535723|FG001|Overall Study|Protocol Violation|1|||
146826812|NCT01227928|529535724|FG000|Overall Study|Lost to Follow-up|4|||
146826813|NCT01227928|529535725|FG001|Overall Study|Lost to Follow-up|2|||
146826814|NCT01227928|529535724|FG000|Overall Study|Withdrawal by Subject|4|||
146826815|NCT01227928|529535725|FG001|Overall Study|Withdrawal by Subject|3|||
146826816|NCT01227928|529535724|FG000|Overall Study|Death|14|||
146826817|NCT01227928|529535725|FG001|Overall Study|Death|12|||
146826818|NCT04582864|529535726|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
146826819|NCT04582864|529535726|FG000|Overall Study|Death|1|||
146826820|NCT01772823|529537460|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
146826821|NCT01772823|529537461|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
146826822|NCT01772823|529537460|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
146826823|NCT01772823|529537461|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
146826824|NCT01772823|529537460|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
146826825|NCT01772823|529537461|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
146826826|NCT01772823|529537460|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
146826827|NCT01772823|529537461|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
146826828|NCT01772823|529537460|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
146826829|NCT01772823|529537461|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
146826830|NCT01772823|529537460|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
146826831|NCT01772823|529537461|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
146826832|NCT01772823|529537460|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
146826833|NCT01772823|529537461|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
146826834|NCT01772823|529537460|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
146826835|NCT01772823|529537461|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
146826836|NCT01772823|529537460|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
146826837|NCT01772823|529537461|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
146826838|NCT01772823|529537460|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
146826839|NCT01772823|529537461|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
146826840|NCT01772823|529537460|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
146826841|NCT01772823|529537461|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
146826842|NCT01772823|529537460|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
146826843|NCT01772823|529537461|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
146826844|NCT01772823|529537460|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
146826845|NCT01772823|529537461|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
146826846|NCT01772823|529537460|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
146826847|NCT01772823|529537461|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
146985854|NCT01296932|530111071|FG005|Overall Study|Physician Decision|0|||
146985855|NCT01296932|530111072|FG006|Overall Study|Physician Decision|0|||
146985856|NCT01296932|530111073|FG007|Overall Study|Physician Decision|0|||
146985857|NCT01296932|530111074|FG008|Overall Study|Physician Decision|0|||
146985858|NCT01296932|530111066|FG000|Overall Study|IV problems, administration not possible|0|||
146826848|NCT01772823|529537460|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
146826849|NCT01772823|529537461|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
146826850|NCT01772823|529537460|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
146826851|NCT01772823|529537461|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
146826852|NCT02895360|529537462|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
146985859|NCT01296932|530111067|FG001|Overall Study|IV problems, administration not possible|0|||
146826853|NCT02895360|529537463|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
146985860|NCT01296932|530111068|FG002|Overall Study|IV problems, administration not possible|1|||
146826854|NCT02895360|529537464|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
146826855|NCT02895360|529537465|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
146826856|NCT02895360|529537466|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
146826857|NCT02895360|529537467|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
146826858|NCT02895360|529537462|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
146826859|NCT02895360|529537463|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
146826860|NCT02895360|529537464|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
146826861|NCT02895360|529537465|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
146826862|NCT02895360|529537466|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
146826863|NCT02895360|529537467|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
146826864|NCT02895360|529537462|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
146826865|NCT02895360|529537463|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
146826866|NCT02895360|529537464|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
146826867|NCT02895360|529537465|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
146826868|NCT02895360|529537466|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
146826869|NCT02895360|529537467|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
146826870|NCT02895360|529537462|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
146826871|NCT02895360|529537463|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
146826872|NCT02895360|529537464|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
146826873|NCT02895360|529537465|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
146826874|NCT02895360|529537466|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
146826875|NCT02895360|529537467|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
146826876|NCT02895360|529537462|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
146826877|NCT02895360|529537463|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
146826878|NCT02895360|529537464|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
146826879|NCT02895360|529537465|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
146826880|NCT02895360|529537466|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
146826881|NCT02895360|529537467|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
146826882|NCT02895360|529537462|FG000|Phase 2a|Adverse Event|0|||
146826883|NCT02895360|529537463|FG001|Phase 2a|Adverse Event|0|||
146826884|NCT02895360|529537464|FG002|Phase 2a|Adverse Event|0|||
146826885|NCT02895360|529537465|FG003|Phase 2a|Adverse Event|0|||
146826886|NCT02895360|529537466|FG004|Phase 2a|Adverse Event|0|||
146826887|NCT02895360|529537467|FG005|Phase 2a|Adverse Event|1|||
146826888|NCT02895360|529537462|FG000|Phase 2a|Progressive disease|0|||
146826889|NCT02895360|529537463|FG001|Phase 2a|Progressive disease|0|||
146826890|NCT02895360|529537464|FG002|Phase 2a|Progressive disease|0|||
146826891|NCT02895360|529537465|FG003|Phase 2a|Progressive disease|0|||
146826892|NCT02895360|529537466|FG004|Phase 2a|Progressive disease|11|||
146826893|NCT02895360|529537467|FG005|Phase 2a|Progressive disease|11|||
146826894|NCT01732926|529537469|FG000|Overall Study|Study Terminated by Sponsor|168|||
146826895|NCT01732926|529537470|FG001|Overall Study|Study Terminated by Sponsor|80|||
146826896|NCT01732926|529537469|FG000|Overall Study|Withdrawal by Subject|46|||
146826897|NCT01732926|529537470|FG001|Overall Study|Withdrawal by Subject|8|||
146826898|NCT01732926|529537469|FG000|Overall Study|Physician Decision|24|||
146826899|NCT01732926|529537470|FG001|Overall Study|Physician Decision|11|||
146826900|NCT01732926|529537469|FG000|Overall Study|Other Reason|21|||
146826901|NCT01732926|529537470|FG001|Overall Study|Other Reason|4|||
146826902|NCT01732926|529537469|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
146826903|NCT01732926|529537470|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
146826904|NCT01732926|529537469|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
146826905|NCT01732926|529537470|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
146826906|NCT02262364|529537475|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
146826907|NCT00337285|529537478|FG000|Overall Study|Withdrawal by Subject|42|||
146826908|NCT00337285|529537478|FG000|Overall Study|Lost to Follow-up|41|||
146826909|NCT00337285|529537478|FG000|Overall Study|Adverse Event|28|||
146826910|NCT00337285|529537478|FG000|Overall Study|Protocol Violation|27|||
146826911|NCT00337285|529537478|FG000|Overall Study|Lack of Efficacy|11|||
146826912|NCT00337285|529537478|FG000|Overall Study|Death|1|||
146826913|NCT00337285|529537478|FG000|Overall Study|Physician Decision|1|||
146826914|NCT00337285|529537478|FG000|Overall Study|Lack of protocol compliance|7|||
146826915|NCT01004185|529537480|FG000|Overall Study|Adverse Event|1|||
146826916|NCT01004185|529537481|FG001|Overall Study|Adverse Event|1|||
146826917|NCT01004185|529537480|FG000|Overall Study|Lost to Follow-up|0|||
146826918|NCT01004185|529537481|FG001|Overall Study|Lost to Follow-up|1|||
146826919|NCT01004185|529537480|FG000|Overall Study|Lack of Efficacy|2|||
146826920|NCT01004185|529537481|FG001|Overall Study|Lack of Efficacy|1|||
146826921|NCT01004185|529537480|FG000|Overall Study|Sponsor Terminated Study|4|||
146826922|NCT01004185|529537481|FG001|Overall Study|Sponsor Terminated Study|5|||
146826923|NCT01004185|529537480|FG000|Overall Study|Withdrawal by Subject|2|||
146826924|NCT01004185|529537481|FG001|Overall Study|Withdrawal by Subject|1|||
146826925|NCT03214250|529537482|FG000|Overall Study|Death|5|||
146826926|NCT03214250|529537483|FG001|Overall Study|Death|5|||
146826927|NCT03214250|529537484|FG002|Overall Study|Death|7|||
146826928|NCT03214250|529537485|FG003|Overall Study|Death|4|||
146826929|NCT03214250|529537486|FG004|Overall Study|Death|23|||
146826930|NCT03214250|529537487|FG005|Overall Study|Death|23|||
146826931|NCT03214250|529537488|FG006|Overall Study|Death|24|||
146826932|NCT03214250|529537482|FG000|Overall Study|Lost to Follow-up|0|||
146826933|NCT03214250|529537483|FG001|Overall Study|Lost to Follow-up|0|||
146826934|NCT03214250|529537484|FG002|Overall Study|Lost to Follow-up|0|||
146826935|NCT03214250|529537485|FG003|Overall Study|Lost to Follow-up|1|||
146826936|NCT03214250|529537486|FG004|Overall Study|Lost to Follow-up|1|||
146826937|NCT03214250|529537487|FG005|Overall Study|Lost to Follow-up|2|||
146826938|NCT03214250|529537488|FG006|Overall Study|Lost to Follow-up|0|||
146826939|NCT03214250|529537482|FG000|Overall Study|Other|0|||
146826940|NCT03214250|529537483|FG001|Overall Study|Other|0|||
146826941|NCT03214250|529537484|FG002|Overall Study|Other|0|||
146826942|NCT03214250|529537485|FG003|Overall Study|Other|0|||
146826943|NCT03214250|529537486|FG004|Overall Study|Other|1|||
146826944|NCT03214250|529537487|FG005|Overall Study|Other|1|||
146826945|NCT03214250|529537488|FG006|Overall Study|Other|2|||
146826946|NCT03214250|529537482|FG000|Overall Study|Remains on Study|2|||
146826947|NCT03214250|529537483|FG001|Overall Study|Remains on Study|2|||
146826948|NCT03214250|529537484|FG002|Overall Study|Remains on Study|0|||
146826949|NCT03214250|529537485|FG003|Overall Study|Remains on Study|1|||
146826950|NCT03214250|529537486|FG004|Overall Study|Remains on Study|7|||
146826951|NCT03214250|529537487|FG005|Overall Study|Remains on Study|5|||
146826952|NCT03214250|529537488|FG006|Overall Study|Remains on Study|3|||
146826953|NCT03214250|529537482|FG000|Overall Study|Withdrawal by Subject|0|||
146826954|NCT03214250|529537483|FG001|Overall Study|Withdrawal by Subject|0|||
146826955|NCT03214250|529537484|FG002|Overall Study|Withdrawal by Subject|1|||
146826956|NCT03214250|529537485|FG003|Overall Study|Withdrawal by Subject|2|||
146826957|NCT03214250|529537486|FG004|Overall Study|Withdrawal by Subject|5|||
146985861|NCT01296932|530111069|FG003|Overall Study|IV problems, administration not possible|0|||
146985862|NCT01296932|530111070|FG004|Overall Study|IV problems, administration not possible|0|||
146985863|NCT01296932|530111071|FG005|Overall Study|IV problems, administration not possible|0|||
146985864|NCT01296932|530111072|FG006|Overall Study|IV problems, administration not possible|0|||
146985865|NCT01296932|530111073|FG007|Overall Study|IV problems, administration not possible|0|||
146985866|NCT01296932|530111074|FG008|Overall Study|IV problems, administration not possible|0|||
146985867|NCT01296932|530111066|FG000|Overall Study|per protocol|0|||
146985868|NCT01296932|530111067|FG001|Overall Study|per protocol|0|||
146985869|NCT01296932|530111068|FG002|Overall Study|per protocol|1|||
146985870|NCT01296932|530111069|FG003|Overall Study|per protocol|1|||
146985871|NCT01296932|530111070|FG004|Overall Study|per protocol|0|||
146985872|NCT01296932|530111071|FG005|Overall Study|per protocol|0|||
146985873|NCT01296932|530111072|FG006|Overall Study|per protocol|0|||
146985874|NCT01296932|530111073|FG007|Overall Study|per protocol|0|||
146985875|NCT01296932|530111074|FG008|Overall Study|per protocol|0|||
146985876|NCT01296932|530111066|FG000|Overall Study|Low benefit and too many side effects|0|||
146985877|NCT01296932|530111067|FG001|Overall Study|Low benefit and too many side effects|0|||
146985878|NCT01296932|530111068|FG002|Overall Study|Low benefit and too many side effects|0|||
146985879|NCT01296932|530111069|FG003|Overall Study|Low benefit and too many side effects|0|||
146985880|NCT01296932|530111070|FG004|Overall Study|Low benefit and too many side effects|0|||
146985881|NCT01296932|530111071|FG005|Overall Study|Low benefit and too many side effects|0|||
146985882|NCT01296932|530111072|FG006|Overall Study|Low benefit and too many side effects|0|||
146985883|NCT01296932|530111073|FG007|Overall Study|Low benefit and too many side effects|1|||
146985884|NCT01296932|530111074|FG008|Overall Study|Low benefit and too many side effects|0|||
146985885|NCT01296932|530111066|FG000|Overall Study|No adequate treatment response|0|||
146985886|NCT01296932|530111067|FG001|Overall Study|No adequate treatment response|0|||
146985887|NCT01296932|530111068|FG002|Overall Study|No adequate treatment response|0|||
146985888|NCT01296932|530111069|FG003|Overall Study|No adequate treatment response|0|||
146985889|NCT01296932|530111070|FG004|Overall Study|No adequate treatment response|0|||
146985890|NCT01296932|530111071|FG005|Overall Study|No adequate treatment response|0|||
146985891|NCT01296932|530111072|FG006|Overall Study|No adequate treatment response|0|||
146985892|NCT01296932|530111073|FG007|Overall Study|No adequate treatment response|1|||
146985893|NCT01296932|530111074|FG008|Overall Study|No adequate treatment response|0|||
146985894|NCT01296932|530111066|FG000|Overall Study|Dosage already reduced, AE still present|0|||
146985895|NCT01296932|530111067|FG001|Overall Study|Dosage already reduced, AE still present|0|||
146826958|NCT03214250|529537487|FG005|Overall Study|Withdrawal by Subject|0|||
146826959|NCT03214250|529537488|FG006|Overall Study|Withdrawal by Subject|2|||
146826960|NCT00496626|529537497|FG000|Overall Study|Lost to Follow-up|0|||
146826961|NCT00496626|529537498|FG001|Overall Study|Lost to Follow-up|1|||
146985896|NCT01296932|530111068|FG002|Overall Study|Dosage already reduced, AE still present|0|||
146985897|NCT01296932|530111069|FG003|Overall Study|Dosage already reduced, AE still present|0|||
146985898|NCT01296932|530111070|FG004|Overall Study|Dosage already reduced, AE still present|0|||
146826962|NCT00496626|529537497|FG000|Overall Study|Protocol Violation|1|||
146826963|NCT00496626|529537498|FG001|Overall Study|Protocol Violation|0|||
146826964|NCT00496626|529537497|FG000|Overall Study|Withdrawal by Subject|5|||
146826965|NCT00496626|529537498|FG001|Overall Study|Withdrawal by Subject|4|||
146826966|NCT00496626|529537497|FG000|Overall Study|Relocated|0|||
146826967|NCT00496626|529537498|FG001|Overall Study|Relocated|1|||
146826968|NCT04582669|529537499|FG000|Overall Study|Subject missed appointment(s).|1|||
146826969|NCT04582669|529537500|FG001|Overall Study|Subject missed appointment(s).|0|||
146826970|NCT04582669|529537501|FG002|Overall Study|Subject missed appointment(s).|1|||
146826971|NCT04582669|529537502|FG003|Overall Study|Subject missed appointment(s).|2|||
146826972|NCT04582669|529537499|FG000|Overall Study|Protocol Violation|0|||
146826973|NCT04582669|529537500|FG001|Overall Study|Protocol Violation|1|||
146826974|NCT04582669|529537501|FG002|Overall Study|Protocol Violation|1|||
146826975|NCT04582669|529537502|FG003|Overall Study|Protocol Violation|0|||
146826976|NCT01874665|529537503|FG000|Overall Study|Adverse Event|6|||
146826977|NCT01874665|529537504|FG001|Overall Study|Adverse Event|2|||
146826978|NCT01874665|529537503|FG000|Overall Study|Withdrawal by Subject|4|||
146826979|NCT01874665|529537504|FG001|Overall Study|Withdrawal by Subject|1|||
146826980|NCT01874665|529537503|FG000|Overall Study|Physician Decision|3|||
146826981|NCT01874665|529537504|FG001|Overall Study|Physician Decision|0|||
146826982|NCT01874665|529537503|FG000|Overall Study|Clinical Progressive Disease|4|||
146826983|NCT01874665|529537504|FG001|Overall Study|Clinical Progressive Disease|3|||
146826984|NCT01874665|529537503|FG000|Overall Study|Study Terminated by Sponsor|0|||
146826985|NCT01874665|529537504|FG001|Overall Study|Study Terminated by Sponsor|2|||
146826986|NCT01874665|529537503|FG000|Overall Study|Documented Progressive Disease|11|||
146826987|NCT01874665|529537504|FG001|Overall Study|Documented Progressive Disease|7|||
146826988|NCT01874665|529537503|FG000|Overall Study|Other|2|||
146826989|NCT01874665|529537504|FG001|Overall Study|Other|0|||
146826990|NCT02647788|529537507|FG000|Overall Study|Lost to Follow-up|13|||
146826991|NCT02647788|529537508|FG001|Overall Study|Lost to Follow-up|11|||
146826992|NCT02647788|529537507|FG000|Overall Study|Did not want opiate|0|||
146826993|NCT02647788|529537508|FG001|Overall Study|Did not want opiate|1|||
146826994|NCT02647788|529537507|FG000|Overall Study|Withdrawal by Subject|1|||
146826995|NCT02647788|529537508|FG001|Overall Study|Withdrawal by Subject|0|||
146826996|NCT02647788|529537507|FG000|Overall Study|Felt itchy with assigned medication|1|||
146826997|NCT02647788|529537508|FG001|Overall Study|Felt itchy with assigned medication|0|||
146826998|NCT02647788|529537507|FG000|Overall Study|Felt nauseous with assigned medication|1|||
146826999|NCT02647788|529537508|FG001|Overall Study|Felt nauseous with assigned medication|1|||
146827000|NCT01274559|529537509|FG000|Overall Study|Adverse Event|57|||
146827001|NCT01274559|529537510|FG001|Overall Study|Adverse Event|13|||
146827002|NCT01274559|529537509|FG000|Overall Study|Death|1|||
146827003|NCT01274559|529537510|FG001|Overall Study|Death|1|||
146827004|NCT01274559|529537509|FG000|Overall Study|Lost to Follow-up|3|||
146827005|NCT01274559|529537510|FG001|Overall Study|Lost to Follow-up|3|||
146827006|NCT01274559|529537509|FG000|Overall Study|Non-compliance with Study Drug|2|||
146827007|NCT01274559|529537510|FG001|Overall Study|Non-compliance with Study Drug|4|||
146827008|NCT01274559|529537509|FG000|Overall Study|Physician Decision|2|||
146827009|NCT01274559|529537510|FG001|Overall Study|Physician Decision|1|||
146827010|NCT01274559|529537509|FG000|Overall Study|Protocol Violation|28|||
146827011|NCT01274559|529537510|FG001|Overall Study|Protocol Violation|23|||
146827012|NCT01274559|529537509|FG000|Overall Study|Study Terminated by Sponsor|79|||
146827013|NCT01274559|529537510|FG001|Overall Study|Study Terminated by Sponsor|87|||
146827014|NCT01274559|529537509|FG000|Overall Study|Withdrawal by Subject|25|||
146827015|NCT01274559|529537510|FG001|Overall Study|Withdrawal by Subject|13|||
146827016|NCT03245619|529537511|FG000|Part A (Up to Day 22)|Physician Decision|4|||
146827017|NCT03245619|529537512|FG001|Part A (Up to Day 22)|Physician Decision|6|||
146827018|NCT03245619|529537513|FG002|Part A (Up to Day 22)|Physician Decision|6|||
146827019|NCT03245619|529537514|FG003|Part A (Up to Day 22)|Physician Decision|0|||
146827020|NCT03245619|529537515|FG004|Part A (Up to Day 22)|Physician Decision|0|||
146827021|NCT03245619|529537516|FG005|Part A (Up to Day 22)|Physician Decision|0|||
146827022|NCT03245619|529537517|FG006|Part A (Up to Day 22)|Physician Decision|0|||
146827023|NCT03245619|529537518|FG007|Part A (Up to Day 22)|Physician Decision|0|||
146827024|NCT03245619|529537519|FG008|Part A (Up to Day 22)|Physician Decision|0|||
146827025|NCT03245619|529537520|FG009|Part A (Up to Day 22)|Physician Decision|0|||
146827026|NCT03245619|529537521|FG010|Part A (Up to Day 22)|Physician Decision|0|||
146827027|NCT03245619|529537522|FG011|Part A (Up to Day 22)|Physician Decision|0|||
146827028|NCT03245619|529537523|FG012|Part A (Up to Day 22)|Physician Decision|0|||
146827029|NCT03245619|529537524|FG013|Part A (Up to Day 22)|Physician Decision|0|||
146827030|NCT03245619|529537525|FG014|Part A (Up to Day 22)|Physician Decision|0|||
146827031|NCT03245619|529537526|FG015|Part A (Up to Day 22)|Physician Decision|0|||
146827032|NCT03245619|529537527|FG016|Part A (Up to Day 22)|Physician Decision|0|||
146827033|NCT00776659|529537544|FG000|Overall Study|Lost to Follow-up|15|||
146827034|NCT00776659|529537544|FG000|Overall Study|Withdrawal by Subject|10|||
146827035|NCT00776659|529537544|FG000|Overall Study|Study Terminated by Sponsor|1|||
146957997|NCT00337935|530006233|FG001|Overall Study|Protocol Violation|3|||
146957998|NCT00337935|530006232|FG000|Overall Study|Withdrawal by Subject|1|||
146957999|NCT00337935|530006233|FG001|Overall Study|Withdrawal by Subject|7|||
146827036|NCT01167192|529537547|FG000|Overall Study|Adverse Event|1|||
146958000|NCT00337935|530006232|FG000|Overall Study|Other|0|||
146827037|NCT01167192|529537547|FG000|Overall Study|Death|1|||
146827038|NCT01167192|529537547|FG000|Overall Study|Withdrawal by Subject|1|||
146827039|NCT01167192|529537547|FG000|Overall Study|Insurance denial|1|||
146827040|NCT01336205|529537548|FG000|Overall Study|Other|22|||
146827041|NCT01336205|529537549|FG001|Overall Study|Other|9|||
146985899|NCT01296932|530111071|FG005|Overall Study|Dosage already reduced, AE still present|0|||
146985900|NCT01296932|530111072|FG006|Overall Study|Dosage already reduced, AE still present|0|||
146985901|NCT01296932|530111073|FG007|Overall Study|Dosage already reduced, AE still present|0|||
146985902|NCT01296932|530111074|FG008|Overall Study|Dosage already reduced, AE still present|1|||
146985903|NCT04161144|530111080|FG000|Overall Study|Withdrawal by Subject|0|||
146985904|NCT04161144|530111081|FG001|Overall Study|Withdrawal by Subject|1|||
146985905|NCT04161144|530111080|FG000|Overall Study|Protocol Violation|1|||
146985906|NCT04161144|530111081|FG001|Overall Study|Protocol Violation|0|||
146985907|NCT00634907|530111083|FG000|Overall Study|Withdrawal by Subject|3|||
146985908|NCT00634907|530111084|FG001|Overall Study|Withdrawal by Subject|0|||
146985909|NCT00634907|530111083|FG000|Overall Study|Physician Decision|3|||
146985910|NCT00634907|530111084|FG001|Overall Study|Physician Decision|9|||
146985911|NCT00634907|530111083|FG000|Overall Study|Withdrawal by Subject|11|||
146985912|NCT00634907|530111084|FG001|Overall Study|Withdrawal by Subject|8|||
146985913|NCT04041570|530111085|FG000|Overall Study|Moved from Area|0|||
146985914|NCT04041570|530111086|FG001|Overall Study|Moved from Area|2|||
146985915|NCT01338636|530111087|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
146985916|NCT02385526|530111088|FG000|Overall Study|Withdrawal by Subject|0|||
146985917|NCT02385526|530111089|FG001|Overall Study|Withdrawal by Subject|2|||
146827042|NCT01336205|529537548|FG000|Overall Study|Lost to Follow-up|40|||
146827043|NCT01336205|529537549|FG001|Overall Study|Lost to Follow-up|20|||
146827044|NCT01336205|529537548|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
146827045|NCT01336205|529537549|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
146827046|NCT01336205|529537548|FG000|Overall Study|Lack of Efficacy|4|||
146827047|NCT01336205|529537549|FG001|Overall Study|Lack of Efficacy|0|||
146827048|NCT01336205|529537548|FG000|Overall Study|Severe noncompliance with protocol|9|||
146827049|NCT01336205|529537549|FG001|Overall Study|Severe noncompliance with protocol|2|||
146827050|NCT01336205|529537548|FG000|Overall Study|Adverse Event|56|||
146827051|NCT01336205|529537549|FG001|Overall Study|Adverse Event|6|||
146827052|NCT01336205|529537548|FG000|Overall Study|Death|1|||
146827053|NCT01336205|529537549|FG001|Overall Study|Death|1|||
146827054|NCT01336205|529537548|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
146827055|NCT01336205|529537549|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
146827056|NCT01336205|529537548|FG000|Overall Study|Withdrawal by Subject|72|||
146827057|NCT01336205|529537549|FG001|Overall Study|Withdrawal by Subject|38|||
146827058|NCT01336205|529537548|FG000|Overall Study|Did not receive treatment|4|||
146827059|NCT01336205|529537549|FG001|Overall Study|Did not receive treatment|0|||
146827060|NCT00129649|529537565|FG000|Overall Study|Withdrawal by Subject|76|||
146827061|NCT00129649|529537566|FG001|Overall Study|Withdrawal by Subject|65|||
146827062|NCT02482935|529537567|FG000|Period 1|Withdrawal by Subject|1|||
146827063|NCT02482935|529537568|FG001|Period 1|Withdrawal by Subject|0|||
146827064|NCT03503162|529537569|FG000|Overall Study|did not meet eligibility|1|||
146827065|NCT02835092|529537570|FG000|Overall Study|Withdrawal by Subject|3|||
146827066|NCT02835092|529537571|FG001|Overall Study|Withdrawal by Subject|6|||
146827067|NCT02835092|529537572|FG002|Overall Study|Withdrawal by Subject|3|||
146827068|NCT02835092|529537570|FG000|Overall Study|Lost to Follow-up|0|||
146827069|NCT02835092|529537571|FG001|Overall Study|Lost to Follow-up|2|||
146827070|NCT02835092|529537572|FG002|Overall Study|Lost to Follow-up|0|||
146827071|NCT00025506|529537573|FG000|Overall Study|Ineligible: clerical error|1|||
146827072|NCT00025506|529537573|FG000|Overall Study|Ineligible: wrong cell type|5|||
146985918|NCT02385526|530111090|FG002|Overall Study|Withdrawal by Subject|0|||
146985919|NCT02385526|530111088|FG000|Overall Study|Lost to Follow-up|0|||
146985920|NCT02385526|530111089|FG001|Overall Study|Lost to Follow-up|1|||
146985921|NCT02385526|530111090|FG002|Overall Study|Lost to Follow-up|0|||
146985922|NCT02385526|530111088|FG000|Overall Study|Physician Decision|1|||
146985923|NCT02385526|530111089|FG001|Overall Study|Physician Decision|0|||
146985924|NCT02385526|530111090|FG002|Overall Study|Physician Decision|0|||
146985925|NCT02385526|530111088|FG000|Overall Study|Protocol Violation|1|||
146985926|NCT02385526|530111089|FG001|Overall Study|Protocol Violation|0|||
146985927|NCT02385526|530111090|FG002|Overall Study|Protocol Violation|0|||
146985928|NCT03532009|530111093|FG000|Overall Study|Other|1|||
146985929|NCT03532009|530111094|FG001|Overall Study|Other|1|||
146827073|NCT00025506|529537573|FG000|Overall Study|Ineligible: inadequate pathology|2|||
146827074|NCT00025506|529537573|FG000|Overall Study|Never Treated|2|||
146827075|NCT00713206|529537574|FG000|Overall Study|Lost to Follow-up|4|||
146827076|NCT00713206|529537575|FG001|Overall Study|Lost to Follow-up|4|||
146827077|NCT00713206|529537574|FG000|Overall Study|Death|1|||
146985930|NCT03532009|530111093|FG000|Overall Study|Death|1|||
146985931|NCT03532009|530111094|FG001|Overall Study|Death|1|||
146985932|NCT03532009|530111093|FG000|Overall Study|Withdrawal by Patient|0|||
146985933|NCT03532009|530111094|FG001|Overall Study|Withdrawal by Patient|2|||
146827078|NCT00713206|529537575|FG001|Overall Study|Death|0|||
146827079|NCT01657877|529537576|FG000|Overall Study|Withdrawal by Subject|4|||
146985934|NCT02866175|530111099|FG000|Overall Study|Adverse Event|56|||
146985935|NCT02866175|530111100|FG001|Overall Study|Adverse Event|54|||
146985936|NCT02866175|530111099|FG000|Overall Study|Withdrawal by Subject|31|||
146827080|NCT01657877|529537576|FG000|Overall Study|Protocol Violation|6|||
146827081|NCT01657877|529537576|FG000|Overall Study|Adverse Event|2|||
146827082|NCT01657877|529537576|FG000|Overall Study|Other Reason|2|||
146827083|NCT00905034|529537578|FG000|Overall Study|Withdrawal by Subject|1|||
146827084|NCT00920699|529537581|FG000|Overall Study|Withdrawal by Subject|2|||
146827085|NCT00920699|529537582|FG001|Overall Study|Withdrawal by Subject|0|||
146827086|NCT00920699|529537583|FG002|Overall Study|Withdrawal by Subject|2|||
146827087|NCT00920699|529537581|FG000|Overall Study|no longer met eligibility|0|||
146827088|NCT00920699|529537582|FG001|Overall Study|no longer met eligibility|1|||
146827089|NCT00920699|529537583|FG002|Overall Study|no longer met eligibility|0|||
146827090|NCT00920699|529537581|FG000|Overall Study|Lost to Follow-up|0|||
146827091|NCT00920699|529537582|FG001|Overall Study|Lost to Follow-up|0|||
146827092|NCT00920699|529537583|FG002|Overall Study|Lost to Follow-up|2|||
146827093|NCT00001941|529537584|FG000|Overall Study|not treated- rapidly progressing disease|0|||
146827094|NCT00001941|529537585|FG001|Overall Study|not treated- rapidly progressing disease|0|||
146827095|NCT00001941|529537586|FG002|Overall Study|not treated- rapidly progressing disease|0|||
146827096|NCT00001941|529537587|FG003|Overall Study|not treated- rapidly progressing disease|0|||
146827097|NCT00001941|529537588|FG004|Overall Study|not treated- rapidly progressing disease|1|||
146827098|NCT00634920|529537589|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
146827099|NCT00634920|529537590|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
146827100|NCT00634920|529537591|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
146827101|NCT00634920|529537589|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
146827102|NCT00634920|529537590|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
146827103|NCT00634920|529537591|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
146827104|NCT00634920|529537589|FG000|Period 1 - Pre-Randomization|Rejections|0|||
146827105|NCT00634920|529537590|FG001|Period 1 - Pre-Randomization|Rejections|0|||
146827106|NCT00634920|529537591|FG002|Period 1 - Pre-Randomization|Rejections|55|||
146827107|NCT00634920|529537589|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
146827108|NCT00634920|529537590|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
146827109|NCT00634920|529537591|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
146827110|NCT00634920|529537589|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
146827111|NCT00634920|529537590|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
146827112|NCT00634920|529537591|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
146827113|NCT00634920|529537589|FG000|Period 1 - Pre-Randomization|Other issues|0|||
146827114|NCT00634920|529537590|FG001|Period 1 - Pre-Randomization|Other issues|0|||
146827115|NCT00634920|529537591|FG002|Period 1 - Pre-Randomization|Other issues|6|||
146827116|NCT00634920|529537589|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
146827117|NCT00634920|529537590|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
146827118|NCT00634920|529537591|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
146827119|NCT00634920|529537589|FG000|Period 2 - Post-Randomization|Rejection|11|||
146827120|NCT00634920|529537590|FG001|Period 2 - Post-Randomization|Rejection|5|||
146827121|NCT00634920|529537591|FG002|Period 2 - Post-Randomization|Rejection|0|||
146827122|NCT00634920|529537589|FG000|Period 2 - Post-Randomization|Death|2|||
146827123|NCT00634920|529537590|FG001|Period 2 - Post-Randomization|Death|5|||
146827124|NCT00634920|529537591|FG002|Period 2 - Post-Randomization|Death|0|||
146827125|NCT00634920|529537589|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
146827126|NCT00634920|529537590|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
146827127|NCT00634920|529537591|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
146827128|NCT00634920|529537589|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
146827129|NCT00634920|529537590|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
146827130|NCT00634920|529537591|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
146827131|NCT01527500|529537593|FG000|Part A|Administrative|11|||
146827132|NCT01527500|529537594|FG001|Part A|Administrative|7|||
146827133|NCT01527500|529537593|FG000|Part A|Adverse Event|4|||
146827134|NCT01527500|529537594|FG001|Part A|Adverse Event|2|||
146827135|NCT01527500|529537593|FG000|Part A|Death|4|||
146827136|NCT01527500|529537594|FG001|Part A|Death|1|||
146827137|NCT01527500|529537593|FG000|Part A|Lost to Follow-up|0|||
146827138|NCT01527500|529537594|FG001|Part A|Lost to Follow-up|1|||
146827139|NCT01527500|529537593|FG000|Part A|Protocol Deviation|9|||
146827140|NCT01527500|529537594|FG001|Part A|Protocol Deviation|2|||
146827141|NCT01527500|529537593|FG000|Part A|Withdrawal by Subject|2|||
146827142|NCT01527500|529537594|FG001|Part A|Withdrawal by Subject|0|||
146827143|NCT01527500|529537593|FG000|Part B|Adverse Event|1|||
146827144|NCT01527500|529537594|FG001|Part B|Adverse Event|0|||
146827145|NCT00372255|529537595|FG000|Overall Study|Withdrawn for other reasons|2|||
146827146|NCT00372255|529537596|FG001|Overall Study|Withdrawn for other reasons|1|||
146827147|NCT02864342|529537597|FG000|Overall Study|Eligibility Criteria Deviation|2|||
146827148|NCT02864342|529537598|FG001|Overall Study|Eligibility Criteria Deviation|3|||
146827149|NCT02864342|529537597|FG000|Overall Study|Withdrawal by Subject|4|||
146827150|NCT02864342|529537598|FG001|Overall Study|Withdrawal by Subject|2|||
146827151|NCT02864342|529537597|FG000|Overall Study|Device Technology Issue|6|||
146827152|NCT02864342|529537598|FG001|Overall Study|Device Technology Issue|7|||
146827153|NCT02864342|529537597|FG000|Overall Study|Death|0|||
146985937|NCT02866175|530111100|FG001|Overall Study|Withdrawal by Subject|52|||
146985938|NCT02866175|530111099|FG000|Overall Study|Death|30|||
146985939|NCT02866175|530111100|FG001|Overall Study|Death|23|||
146985940|NCT02866175|530111099|FG000|Overall Study|Other|7|||
146827154|NCT02864342|529537598|FG001|Overall Study|Death|1|||
146827155|NCT02864342|529537597|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
146827156|NCT02864342|529537598|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
146827157|NCT02864342|529537597|FG000|Overall Study|Lost to Follow-up|1|||
146827158|NCT02864342|529537598|FG001|Overall Study|Lost to Follow-up|5|||
146827159|NCT02864342|529537597|FG000|Overall Study|Lost Device|1|||
146827160|NCT02864342|529537598|FG001|Overall Study|Lost Device|0|||
146827161|NCT02864342|529537597|FG000|Overall Study|Adverse Event|1|||
146827162|NCT02864342|529537598|FG001|Overall Study|Adverse Event|0|||
146827163|NCT02573883|529537599|FG000|Six Month Follow Up|Lost to Follow-up|1|||
146827164|NCT02573883|529537600|FG001|Six Month Follow Up|Lost to Follow-up|0|||
146827165|NCT02573883|529537601|FG002|Six Month Follow Up|Lost to Follow-up|0|||
146827166|NCT02573883|529537602|FG003|Six Month Follow Up|Lost to Follow-up|0|||
146827167|NCT02573883|529537599|FG000|One Year Follow Up|Lost to Follow-up|2|||
146827168|NCT02573883|529537600|FG001|One Year Follow Up|Lost to Follow-up|1|||
146827169|NCT02573883|529537601|FG002|One Year Follow Up|Lost to Follow-up|0|||
146827170|NCT02573883|529537602|FG003|One Year Follow Up|Lost to Follow-up|0|||
146827171|NCT01125566|529537608|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
146827172|NCT01125566|529537609|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
146827173|NCT01125566|529537610|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
146827174|NCT01125566|529537608|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
146827175|NCT01125566|529537609|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
146827176|NCT01125566|529537610|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
146827177|NCT01125566|529537608|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
146827178|NCT01125566|529537609|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
146827179|NCT01125566|529537610|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
146827180|NCT01125566|529537608|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
146827181|NCT01125566|529537609|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
146827182|NCT01125566|529537610|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
146827183|NCT01125566|529537608|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
146827184|NCT01125566|529537609|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
146827185|NCT01125566|529537610|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
146827186|NCT01125566|529537608|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
146827187|NCT01125566|529537609|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
146827188|NCT01125566|529537610|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
146827189|NCT01125566|529537608|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
146827190|NCT01125566|529537609|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
146827191|NCT01125566|529537610|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
146827192|NCT01125566|529537608|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
146827193|NCT01125566|529537609|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
146827194|NCT01125566|529537610|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
146827195|NCT01125566|529537608|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
146827196|NCT01125566|529537609|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
146827197|NCT01125566|529537610|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
146827198|NCT01125566|529537608|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
146827199|NCT01125566|529537609|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
146827200|NCT01125566|529537610|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
146827201|NCT01125566|529537608|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
146827202|NCT01125566|529537609|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
146827203|NCT01125566|529537610|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
146827204|NCT01125566|529537608|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
146827205|NCT01125566|529537609|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
146827206|NCT01125566|529537610|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
146827207|NCT01560585|529537611|FG000|Overall Study|Physician Decision|3|||
146827208|NCT00519285|529537612|FG000|Overall Study|Adverse Event|127|||
146827209|NCT00519285|529537613|FG001|Overall Study|Adverse Event|266|||
146827210|NCT00519285|529537612|FG000|Overall Study|Disease progression|334|||
146827211|NCT00519285|529537613|FG001|Overall Study|Disease progression|186|||
146827212|NCT00519285|529537612|FG000|Overall Study|Physician Decision|75|||
146827213|NCT00519285|529537613|FG001|Overall Study|Physician Decision|47|||
146827214|NCT00519285|529537612|FG000|Overall Study|Participant's request|53|||
146985941|NCT02866175|530111100|FG001|Overall Study|Other|14|||
146985942|NCT02866175|530111099|FG000|Overall Study|Progressive disease|1|||
146827215|NCT00519285|529537613|FG001|Overall Study|Participant's request|84|||
146827216|NCT00519285|529537612|FG000|Overall Study|Consent withdrawn|4|||
146827217|NCT00519285|529537613|FG001|Overall Study|Consent withdrawn|5|||
146827218|NCT00519285|529537612|FG000|Overall Study|Poor compliance to protocol|5|||
146827219|NCT00519285|529537613|FG001|Overall Study|Poor compliance to protocol|7|||
146827220|NCT00519285|529537612|FG000|Overall Study|Reason unspecified|5|||
146827221|NCT00519285|529537613|FG001|Overall Study|Reason unspecified|8|||
146827222|NCT00519285|529537612|FG000|Overall Study|Not treated|8|||
146827223|NCT00519285|529537613|FG001|Overall Study|Not treated|7|||
146827224|NCT00519285|529537612|FG000|Overall Study|Treatment ongoing|1|||
146827225|NCT00519285|529537613|FG001|Overall Study|Treatment ongoing|2|||
146827226|NCT02970305|529537614|FG000|Overall Study|Adverse Event|10|||
146827227|NCT02970305|529537615|FG001|Overall Study|Adverse Event|6|||
146827228|NCT02970305|529537614|FG000|Overall Study|Lack of Efficacy|1|||
146827229|NCT02970305|529537615|FG001|Overall Study|Lack of Efficacy|1|||
146827230|NCT02970305|529537614|FG000|Overall Study|Noncompliance with study drug|2|||
146827231|NCT02970305|529537615|FG001|Overall Study|Noncompliance with study drug|4|||
146827232|NCT02970305|529537614|FG000|Overall Study|Protocol Violation|2|||
146827233|NCT02970305|529537615|FG001|Overall Study|Protocol Violation|2|||
146827234|NCT02970305|529537614|FG000|Overall Study|Withdrawal by Subject|12|||
146827235|NCT02970305|529537615|FG001|Overall Study|Withdrawal by Subject|11|||
146827236|NCT02970305|529537614|FG000|Overall Study|Not further specified|1|||
146827237|NCT02970305|529537615|FG001|Overall Study|Not further specified|2|||
146827238|NCT02970305|529537614|FG000|Overall Study|Lost to Follow-up|1|||
146827239|NCT02970305|529537615|FG001|Overall Study|Lost to Follow-up|2|||
146827240|NCT01813305|529537617|FG000|Overall Study|Withdrawal by Subject|12|||
146827241|NCT01813305|529537618|FG001|Overall Study|Withdrawal by Subject|5|||
146827242|NCT01813305|529537617|FG000|Overall Study|Safety Concern|4|||
146827243|NCT01813305|529537618|FG001|Overall Study|Safety Concern|0|||
146827244|NCT01813305|529537617|FG000|Overall Study|Ulcer became worse|4|||
146827245|NCT01813305|529537618|FG001|Overall Study|Ulcer became worse|0|||
146827246|NCT01813305|529537617|FG000|Overall Study|Physician Decision|4|||
146827247|NCT01813305|529537618|FG001|Overall Study|Physician Decision|0|||
146827248|NCT01813305|529537617|FG000|Overall Study|Lost to Follow-up|3|||
146827249|NCT01813305|529537618|FG001|Overall Study|Lost to Follow-up|1|||
146827250|NCT01813305|529537617|FG000|Overall Study|Protocol Violation|1|||
146827251|NCT01813305|529537618|FG001|Overall Study|Protocol Violation|0|||
146827252|NCT01813305|529537617|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
146827253|NCT01813305|529537618|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
146827254|NCT00988117|529537619|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
146827255|NCT00988117|529537619|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
146827256|NCT04088500|529537620|FG000|Overall Study|Reason unknown|1|||
146827257|NCT04088500|529537620|FG000|Overall Study|Participant withdrew consent|1|||
146827258|NCT04088500|529537620|FG000|Overall Study|Disease progression|3|||
146827259|NCT02930837|529537624|FG000|Overall Study|Adverse Event|6|||
146827260|NCT02930837|529537624|FG000|Overall Study|Lost to Follow-up|5|||
146827261|NCT02930837|529537624|FG000|Overall Study|Withdrawal by Subject|1|||
146827262|NCT00006436|529537625|FG000|Overall Study|Refused further treatment|2|||
146827263|NCT00006436|529537625|FG000|Overall Study|Declined to participate (before treatment started)|1|||
146827264|NCT01071317|529537626|FG000|Overall Study|Lost to Follow-up|2|||
146827265|NCT01071317|529537627|FG001|Overall Study|Lost to Follow-up|2|||
146827266|NCT01502371|529537634|FG000|Overall Study|Withdrawal by Subject|1|||
146827267|NCT01502371|529537635|FG001|Overall Study|Withdrawal by Subject|2|||
146827268|NCT01502371|529537636|FG002|Overall Study|Withdrawal by Subject|1|||
146827269|NCT01502371|529537637|FG003|Overall Study|Withdrawal by Subject|1|||
146827270|NCT01502371|529537638|FG004|Overall Study|Withdrawal by Subject|1|||
146827271|NCT01502371|529537634|FG000|Overall Study|Adverse Event|2|||
146827272|NCT01502371|529537635|FG001|Overall Study|Adverse Event|1|||
146827273|NCT01502371|529537636|FG002|Overall Study|Adverse Event|0|||
146827274|NCT01502371|529537637|FG003|Overall Study|Adverse Event|4|||
146958001|NCT00337935|530006233|FG001|Overall Study|Other|1|||
146958002|NCT00337935|530006232|FG000|Overall Study|Lack of Efficacy|0|||
146958003|NCT00337935|530006233|FG001|Overall Study|Lack of Efficacy|1|||
146827275|NCT01502371|529537638|FG004|Overall Study|Adverse Event|3|||
146827276|NCT01502371|529537634|FG000|Overall Study|Treatment Failure|22|||
146827277|NCT01502371|529537635|FG001|Overall Study|Treatment Failure|20|||
146958004|NCT01336647|530006236|FG000|Overall Study|Lost to Follow-up|4|||
146827278|NCT01502371|529537636|FG002|Overall Study|Treatment Failure|12|||
146827279|NCT01502371|529537637|FG003|Overall Study|Treatment Failure|19|||
146827280|NCT01502371|529537638|FG004|Overall Study|Treatment Failure|30|||
146827281|NCT01502371|529537634|FG000|Overall Study|Lack of Efficacy|3|||
146827282|NCT01502371|529537635|FG001|Overall Study|Lack of Efficacy|3|||
146827283|NCT01502371|529537636|FG002|Overall Study|Lack of Efficacy|2|||
146827284|NCT01502371|529537637|FG003|Overall Study|Lack of Efficacy|2|||
146827285|NCT01502371|529537638|FG004|Overall Study|Lack of Efficacy|4|||
146827286|NCT01502371|529537634|FG000|Overall Study|Physician Decision|3|||
146827287|NCT01502371|529537635|FG001|Overall Study|Physician Decision|0|||
146827288|NCT01502371|529537636|FG002|Overall Study|Physician Decision|0|||
146827289|NCT01502371|529537637|FG003|Overall Study|Physician Decision|0|||
146827290|NCT01502371|529537638|FG004|Overall Study|Physician Decision|1|||
146827291|NCT01502371|529537634|FG000|Overall Study|Noncompliance with Study Drug|0|||
146827292|NCT01502371|529537635|FG001|Overall Study|Noncompliance with Study Drug|0|||
146827293|NCT01502371|529537636|FG002|Overall Study|Noncompliance with Study Drug|1|||
146827294|NCT01502371|529537637|FG003|Overall Study|Noncompliance with Study Drug|2|||
146827295|NCT01502371|529537638|FG004|Overall Study|Noncompliance with Study Drug|1|||
146827296|NCT01502371|529537634|FG000|Overall Study|Technical Problems|1|||
146827297|NCT01502371|529537635|FG001|Overall Study|Technical Problems|0|||
146827298|NCT01502371|529537636|FG002|Overall Study|Technical Problems|2|||
146827299|NCT01502371|529537637|FG003|Overall Study|Technical Problems|4|||
146827300|NCT01502371|529537638|FG004|Overall Study|Technical Problems|1|||
146827301|NCT01502371|529537634|FG000|Overall Study|Protocol Violation|9|||
146827302|NCT01502371|529537635|FG001|Overall Study|Protocol Violation|5|||
146827303|NCT01502371|529537636|FG002|Overall Study|Protocol Violation|6|||
146827304|NCT01502371|529537637|FG003|Overall Study|Protocol Violation|5|||
146827305|NCT01502371|529537638|FG004|Overall Study|Protocol Violation|10|||
146827306|NCT01502371|529537634|FG000|Overall Study|Excluded Medication|0|||
146827307|NCT01502371|529537635|FG001|Overall Study|Excluded Medication|1|||
146827308|NCT01502371|529537636|FG002|Overall Study|Excluded Medication|1|||
146827309|NCT01502371|529537637|FG003|Overall Study|Excluded Medication|0|||
146827310|NCT01502371|529537638|FG004|Overall Study|Excluded Medication|1|||
146827311|NCT02598934|529537643|FG000|Overall Study|Adverse Event|11|||
146827312|NCT02598934|529537644|FG001|Overall Study|Adverse Event|13|||
146827313|NCT02598934|529537643|FG000|Overall Study|Failure to Return|3|||
146827314|NCT02598934|529537644|FG001|Overall Study|Failure to Return|3|||
146827315|NCT02598934|529537643|FG000|Overall Study|Withdrawal by Subject|2|||
146827316|NCT02598934|529537644|FG001|Overall Study|Withdrawal by Subject|3|||
146827317|NCT02598934|529537643|FG000|Overall Study|Administrative|2|||
146827318|NCT02598934|529537644|FG001|Overall Study|Administrative|1|||
146827319|NCT02598934|529537643|FG000|Overall Study|Protocol Violation|1|||
146827320|NCT02598934|529537644|FG001|Overall Study|Protocol Violation|2|||
146827321|NCT02481934|529537646|FG000|Overall Study|Death|2|||
146827322|NCT03749616|529537650|FG000|Overall Study|Lost to Follow-up|4|||
146827323|NCT03749616|529537651|FG001|Overall Study|Lost to Follow-up|7|||
146827324|NCT03749616|529537650|FG000|Overall Study|Screen Failure|1|||
146827325|NCT03749616|529537651|FG001|Overall Study|Screen Failure|1|||
146827326|NCT03749616|529537650|FG000|Overall Study|Withdrawal by Subject|2|||
146827327|NCT03749616|529537651|FG001|Overall Study|Withdrawal by Subject|0|||
146827328|NCT03302559|529537654|FG000|Overall Study|Adverse Event|2|||
146827329|NCT03302559|529537654|FG000|Overall Study|Lost to Follow-up|1|||
146827330|NCT03302559|529537654|FG000|Overall Study|Withdrew Consent|3|||
146827331|NCT00605566|529539455|FG000|Overall Study|Adverse Event|1|||
146827332|NCT00605566|529539455|FG000|Overall Study|Clinical deterioration|1|||
146827333|NCT00605566|529539455|FG000|Overall Study|Poor compliance in run-in period|1|||
146827334|NCT01932762|529539456|FG000|Overall Study|Withdrawal by Subject|1|||
146827335|NCT01932762|529539457|FG001|Overall Study|Withdrawal by Subject|2|||
146827336|NCT01932762|529539458|FG002|Overall Study|Withdrawal by Subject|0|||
146827337|NCT01932762|529539459|FG003|Overall Study|Withdrawal by Subject|0|||
146827338|NCT01932762|529539456|FG000|Overall Study|Lost to Follow-up|4|||
146827339|NCT01932762|529539457|FG001|Overall Study|Lost to Follow-up|0|||
146827340|NCT01932762|529539458|FG002|Overall Study|Lost to Follow-up|0|||
146827341|NCT01932762|529539459|FG003|Overall Study|Lost to Follow-up|1|||
146827342|NCT01932762|529539456|FG000|Overall Study|Physician Decision|1|||
146827343|NCT01932762|529539457|FG001|Overall Study|Physician Decision|0|||
146827344|NCT01932762|529539458|FG002|Overall Study|Physician Decision|0|||
146827345|NCT01932762|529539459|FG003|Overall Study|Physician Decision|0|||
146827346|NCT03864341|529539460|FG000|Overall Study|Withdrawal by Subject|1|||
146827347|NCT01066936|529539461|FG000|Overall Study|Death|2|||
146958005|NCT01336647|530006237|FG001|Overall Study|Lost to Follow-up|1|||
146958006|NCT01336647|530006238|FG002|Overall Study|Lost to Follow-up|3|||
146958007|NCT00965458|530006247|FG000|Overall Study|Adverse Event|1|||
146827348|NCT01066936|529539461|FG000|Overall Study|Device revised/removed|1|||
146827349|NCT01066936|529539461|FG000|Overall Study|Lost to Follow-up|3|||
146827350|NCT01066936|529539461|FG000|Overall Study|Withdrawal by Subject|4|||
146827351|NCT00695136|529539462|FG000|Overall Study|Withdrawal by Subject|1|||
146827352|NCT00695136|529539462|FG000|Overall Study|unrelated adverse event|1|||
146827353|NCT01726049|529539464|FG000|Overall Study|Death|1|||
146827354|NCT01726049|529539465|FG001|Overall Study|Death|1|||
146958008|NCT00965458|530006248|FG001|Overall Study|Adverse Event|0|||
146958009|NCT00965458|530006247|FG000|Overall Study|Lost to Follow-up|1|||
146827355|NCT01726049|529539464|FG000|Overall Study|Adverse Event|4|||
146827356|NCT01726049|529539465|FG001|Overall Study|Adverse Event|1|||
146827357|NCT01726049|529539464|FG000|Overall Study|refused second HC|0|||
146827358|NCT01726049|529539465|FG001|Overall Study|refused second HC|2|||
146827359|NCT02202109|529539468|FG000|Overall Study|Lost to Follow-up|88|||
146827360|NCT02202109|529539469|FG001|Overall Study|Lost to Follow-up|87|||
146827361|NCT02202109|529539468|FG000|Overall Study|Withdrawal by Subject|2|||
146827362|NCT02202109|529539469|FG001|Overall Study|Withdrawal by Subject|0|||
146827363|NCT04156399|529539476|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
146827364|NCT04156399|529539476|FG000|Overall Study|study suspension due to COVID pandemic|3|||
146827365|NCT01333111|529539479|FG000|Overall Study|patient undergoing major surgery|0|||
146827366|NCT01333111|529539480|FG001|Overall Study|patient undergoing major surgery|2|||
146827367|NCT01333111|529539481|FG002|Overall Study|patient undergoing major surgery|0|||
146827368|NCT01333111|529539479|FG000|Overall Study|personal reasons|0|||
146827369|NCT01333111|529539480|FG001|Overall Study|personal reasons|0|||
146827370|NCT01333111|529539481|FG002|Overall Study|personal reasons|1|||
146827371|NCT01333111|529539479|FG000|Overall Study|unclassified|1|||
146827372|NCT01333111|529539480|FG001|Overall Study|unclassified|0|||
146827373|NCT01333111|529539481|FG002|Overall Study|unclassified|0|||
146827374|NCT01333111|529539479|FG000|Overall Study|withdrawal criteria|0|||
146827375|NCT01333111|529539480|FG001|Overall Study|withdrawal criteria|1|||
146827376|NCT01333111|529539481|FG002|Overall Study|withdrawal criteria|0|||
146827377|NCT01333111|529539479|FG000|Overall Study|Non-compliance|1|||
146827378|NCT01333111|529539480|FG001|Overall Study|Non-compliance|0|||
146827379|NCT01333111|529539481|FG002|Overall Study|Non-compliance|0|||
146827380|NCT01333111|529539479|FG000|Overall Study|Ineffective therapy|0|||
146827381|NCT01333111|529539480|FG001|Overall Study|Ineffective therapy|0|||
146827382|NCT01333111|529539481|FG002|Overall Study|Ineffective therapy|1|||
146985943|NCT02866175|530111100|FG001|Overall Study|Progressive disease|1|||
146985944|NCT02866175|530111099|FG000|Overall Study|Lost to Follow-up|2|||
146985945|NCT02866175|530111100|FG001|Overall Study|Lost to Follow-up|0|||
146985946|NCT02866175|530111099|FG000|Overall Study|Lack of Efficacy|0|||
146985947|NCT02866175|530111100|FG001|Overall Study|Lack of Efficacy|1|||
146985948|NCT02866175|530111099|FG000|Overall Study|Physician Decision|3|||
146985949|NCT02866175|530111100|FG001|Overall Study|Physician Decision|15|||
146985950|NCT02866175|530111099|FG000|Overall Study|Did not receive treatment|5|||
146985951|NCT02866175|530111100|FG001|Overall Study|Did not receive treatment|15|||
146985952|NCT01694485|530111101|FG000|Overall Study|Withdrawal by Subject|20|||
146985953|NCT01694485|530111102|FG001|Overall Study|Withdrawal by Subject|6|||
146985954|NCT01694485|530111103|FG002|Overall Study|Withdrawal by Subject|7|||
146985955|NCT01694485|530111104|FG003|Overall Study|Withdrawal by Subject|25|||
146985956|NCT01694485|530111105|FG004|Overall Study|Withdrawal by Subject|18|||
146985957|NCT01694485|530111101|FG000|Overall Study|Sponsor Decision|3|||
146985958|NCT01694485|530111102|FG001|Overall Study|Sponsor Decision|0|||
146985959|NCT01694485|530111103|FG002|Overall Study|Sponsor Decision|0|||
146985960|NCT01694485|530111104|FG003|Overall Study|Sponsor Decision|2|||
146985961|NCT01694485|530111105|FG004|Overall Study|Sponsor Decision|0|||
146985962|NCT01694485|530111101|FG000|Overall Study|Lost to Follow-up|9|||
146985963|NCT01694485|530111102|FG001|Overall Study|Lost to Follow-up|1|||
146985964|NCT01694485|530111103|FG002|Overall Study|Lost to Follow-up|6|||
146985965|NCT01694485|530111104|FG003|Overall Study|Lost to Follow-up|10|||
146985966|NCT01694485|530111105|FG004|Overall Study|Lost to Follow-up|7|||
146985967|NCT01694485|530111101|FG000|Overall Study|Death|1|||
146985968|NCT01694485|530111102|FG001|Overall Study|Death|0|||
146985969|NCT01694485|530111103|FG002|Overall Study|Death|0|||
146985970|NCT01694485|530111104|FG003|Overall Study|Death|1|||
146985971|NCT01694485|530111105|FG004|Overall Study|Death|0|||
146985972|NCT02907203|530111106|FG000|Overall Study|Death|1|||
146985973|NCT02907203|530111106|FG000|Overall Study|Lost to Follow-up|3|||
146985974|NCT02907203|530111106|FG000|Overall Study|Withdrawal by Subject|3|||
146985975|NCT02907203|530111106|FG000|Overall Study|Surgical bypass|1|||
146985976|NCT00681863|530111108|FG000|Overall Study|Adverse Event|1|||
146985977|NCT00681863|530111108|FG000|Overall Study|Lost to Follow-up|2|||
146985978|NCT00681863|530111108|FG000|Overall Study|Lack of Efficacy|2|||
146985979|NCT00681863|530111108|FG000|Overall Study|Other|18|||
146985980|NCT00384033|530111118|FG000|Overall Study|Adverse Event|10|||
146985981|NCT00384033|530111119|FG001|Overall Study|Adverse Event|8|||
146985982|NCT00384033|530111120|FG002|Overall Study|Adverse Event|11|||
146985983|NCT00384033|530111121|FG003|Overall Study|Adverse Event|20|||
146985984|NCT00384033|530111118|FG000|Overall Study|Failed to return|1|||
146985985|NCT00384033|530111119|FG001|Overall Study|Failed to return|3|||
146985986|NCT00384033|530111120|FG002|Overall Study|Failed to return|2|||
146985987|NCT00384033|530111121|FG003|Overall Study|Failed to return|2|||
146827383|NCT00320398|529539491|FG000|Overall Study|Adverse Event|1|||
146985988|NCT00384033|530111118|FG000|Overall Study|Physician Decision|1|||
146985989|NCT00384033|530111119|FG001|Overall Study|Physician Decision|0|||
146985990|NCT00384033|530111120|FG002|Overall Study|Physician Decision|0|||
146985991|NCT00384033|530111121|FG003|Overall Study|Physician Decision|0|||
146827384|NCT00320398|529539492|FG001|Overall Study|Adverse Event|4|||
146827385|NCT00320398|529539491|FG000|Overall Study|Other|1|||
146827386|NCT00320398|529539492|FG001|Overall Study|Other|0|||
146985992|NCT00384033|530111118|FG000|Overall Study|Lost to Follow-up|6|||
146985993|NCT00384033|530111119|FG001|Overall Study|Lost to Follow-up|12|||
146985994|NCT00384033|530111120|FG002|Overall Study|Lost to Follow-up|7|||
146985995|NCT00384033|530111121|FG003|Overall Study|Lost to Follow-up|7|||
146985996|NCT00384033|530111118|FG000|Overall Study|Other|2|||
146985997|NCT00384033|530111119|FG001|Overall Study|Other|0|||
146985998|NCT00384033|530111120|FG002|Overall Study|Other|0|||
146985999|NCT00384033|530111121|FG003|Overall Study|Other|0|||
146827387|NCT04190225|529539493|FG000|Overall Study|Lost to Follow-up|2|||
146827388|NCT04190225|529539494|FG001|Overall Study|Lost to Follow-up|3|||
146827389|NCT04190225|529539493|FG000|Overall Study|Withdrawal by Subject|3|||
146827390|NCT04190225|529539494|FG001|Overall Study|Withdrawal by Subject|2|||
146827391|NCT04190225|529539493|FG000|Overall Study|Unrelated health condition|2|||
146827392|NCT04190225|529539494|FG001|Overall Study|Unrelated health condition|0|||
146827393|NCT00847132|529539497|FG000|Overall Study|Death|1|||
146827394|NCT00847132|529539498|FG001|Overall Study|Death|1|||
146827395|NCT01057251|529539499|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
146827396|NCT01057251|529539500|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
146827397|NCT01057251|529539499|FG000|Overall Study|Adverse Event|4|||
146827398|NCT01057251|529539500|FG001|Overall Study|Adverse Event|2|||
146827399|NCT01057251|529539499|FG000|Overall Study|Lack of Efficacy|2|||
146827400|NCT01057251|529539500|FG001|Overall Study|Lack of Efficacy|11|||
146827401|NCT01057251|529539499|FG000|Overall Study|Protocol Violation|6|||
146827402|NCT01057251|529539500|FG001|Overall Study|Protocol Violation|2|||
146827403|NCT01057251|529539499|FG000|Overall Study|Withdrawal by Subject|4|||
146827404|NCT01057251|529539500|FG001|Overall Study|Withdrawal by Subject|5|||
146827405|NCT01057251|529539499|FG000|Overall Study|Lost to Follow-up|7|||
146827406|NCT01057251|529539500|FG001|Overall Study|Lost to Follow-up|6|||
146827407|NCT01057251|529539499|FG000|Overall Study|Other Reason|1|||
146827408|NCT01057251|529539500|FG001|Overall Study|Other Reason|1|||
146827409|NCT04544865|529539501|FG000|Overall Study|Death|0|||
146827410|NCT04544865|529539502|FG001|Overall Study|Death|2|||
146827411|NCT04544865|529539501|FG000|Overall Study|Lost to Follow-up|11|||
146827412|NCT04544865|529539502|FG001|Overall Study|Lost to Follow-up|7|||
146827413|NCT04544865|529539501|FG000|Overall Study|Withdrawal by Subject|0|||
146827414|NCT04544865|529539502|FG001|Overall Study|Withdrawal by Subject|1|||
146827415|NCT04544865|529539501|FG000|Overall Study|Other|0|||
146827416|NCT04544865|529539502|FG001|Overall Study|Other|1|||
146827417|NCT02973802|529539503|FG000|Overall Study|Lost to Follow-up|1|||
146827418|NCT02973802|529539503|FG000|Overall Study|Withdrawal by Subject|1|||
146827419|NCT01850823|529539504|FG000|Overall Study|Early Visit Window|0|||
146827420|NCT01850823|529539505|FG001|Overall Study|Early Visit Window|1|||
146827421|NCT01850823|529539506|FG002|Overall Study|Early Visit Window|4|||
146827422|NCT01850823|529539504|FG000|Overall Study|Enrolled in Error|0|||
146827423|NCT01850823|529539505|FG001|Overall Study|Enrolled in Error|1|||
146827424|NCT01850823|529539506|FG002|Overall Study|Enrolled in Error|2|||
146827425|NCT01850823|529539504|FG000|Overall Study|Lack of Efficacy|1|||
146827426|NCT01850823|529539505|FG001|Overall Study|Lack of Efficacy|0|||
146827427|NCT01850823|529539506|FG002|Overall Study|Lack of Efficacy|0|||
146827428|NCT01850823|529539504|FG000|Overall Study|Lost to Follow-up|0|||
146827429|NCT01850823|529539505|FG001|Overall Study|Lost to Follow-up|0|||
146827430|NCT01850823|529539506|FG002|Overall Study|Lost to Follow-up|1|||
146827431|NCT01850823|529539504|FG000|Overall Study|Restricted Medication|0|||
146827432|NCT01850823|529539505|FG001|Overall Study|Restricted Medication|0|||
146827433|NCT01850823|529539506|FG002|Overall Study|Restricted Medication|2|||
146827434|NCT01850823|529539504|FG000|Overall Study|Significant worstening of SAR|0|||
146827435|NCT01850823|529539505|FG001|Overall Study|Significant worstening of SAR|1|||
146827436|NCT01850823|529539506|FG002|Overall Study|Significant worstening of SAR|0|||
146827437|NCT01850823|529539504|FG000|Overall Study|Withdrawal by Subject|2|||
146827438|NCT01850823|529539505|FG001|Overall Study|Withdrawal by Subject|0|||
146827439|NCT01850823|529539506|FG002|Overall Study|Withdrawal by Subject|1|||
146827440|NCT01751165|529539507|FG000|Overall Study|Adverse event, serious fatal|1|||
146827441|NCT01751165|529539508|FG001|Overall Study|Adverse event, serious fatal|0|||
146827442|NCT01751165|529539509|FG002|Overall Study|Adverse event, serious fatal|1|||
146827443|NCT01751165|529539507|FG000|Overall Study|Withdrawal by Subject|0|||
146827444|NCT01751165|529539508|FG001|Overall Study|Withdrawal by Subject|0|||
146827445|NCT01751165|529539509|FG002|Overall Study|Withdrawal by Subject|1|||
146827446|NCT01751165|529539507|FG000|Overall Study|Serious adverse event|0|||
146827447|NCT01751165|529539508|FG001|Overall Study|Serious adverse event|2|||
146827448|NCT01751165|529539509|FG002|Overall Study|Serious adverse event|0|||
146827449|NCT01751165|529539507|FG000|Overall Study|Lost to Follow-up|1|||
146827450|NCT01751165|529539508|FG001|Overall Study|Lost to Follow-up|1|||
146827451|NCT01751165|529539509|FG002|Overall Study|Lost to Follow-up|1|||
146827452|NCT00913523|529539513|FG000|Overall Study|Withdrawal by Subject|3|||
146827453|NCT00913523|529539514|FG001|Overall Study|Withdrawal by Subject|2|||
146827454|NCT00913523|529539515|FG002|Overall Study|Withdrawal by Subject|2|||
146827455|NCT00913523|529539513|FG000|Overall Study|Lost to Follow-up|1|||
146827456|NCT00913523|529539514|FG001|Overall Study|Lost to Follow-up|1|||
146827457|NCT00913523|529539515|FG002|Overall Study|Lost to Follow-up|1|||
146827458|NCT00913523|529539513|FG000|Overall Study|Adverse Event|1|||
146827459|NCT00913523|529539514|FG001|Overall Study|Adverse Event|0|||
146827460|NCT00913523|529539515|FG002|Overall Study|Adverse Event|0|||
146827461|NCT00913523|529539513|FG000|Overall Study|Protocol Violation|5|||
146827462|NCT00913523|529539514|FG001|Overall Study|Protocol Violation|8|||
146827463|NCT00913523|529539515|FG002|Overall Study|Protocol Violation|8|||
146827464|NCT00913523|529539513|FG000|Overall Study|Pregnancy|1|||
146827465|NCT00913523|529539514|FG001|Overall Study|Pregnancy|3|||
146827466|NCT00913523|529539515|FG002|Overall Study|Pregnancy|0|||
146827467|NCT00913523|529539513|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
146827468|NCT00913523|529539514|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
146827469|NCT00913523|529539515|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
146827470|NCT01202409|529539516|FG000|Overall Study|Adverse Event|1|||
146827471|NCT01202409|529539516|FG000|Overall Study|Ineligible - KRAS mutants|7|||
146827472|NCT01774019|529539517|FG000|Overall Study|No longer meets protocol criteria|2|||
146827473|NCT01774019|529539518|FG001|Overall Study|No longer meets protocol criteria|0|||
146827474|NCT01774019|529539517|FG000|Overall Study|Withdrawal by Subject|1|||
146827475|NCT01774019|529539518|FG001|Overall Study|Withdrawal by Subject|0|||
146827476|NCT01774019|529539517|FG000|Overall Study|Surgery delayed > 120 days|1|||
146827477|NCT01774019|529539518|FG001|Overall Study|Surgery delayed > 120 days|0|||
146827478|NCT01774019|529539517|FG000|Overall Study|Patient refused surgery|1|||
146827479|NCT01774019|529539518|FG001|Overall Study|Patient refused surgery|1|||
146827480|NCT01774019|529539517|FG000|Overall Study|Unable to implant study device|1|||
146827481|NCT01774019|529539518|FG001|Overall Study|Unable to implant study device|0|||
146827482|NCT01774019|529539517|FG000|Overall Study|Lost to Follow-up|0|||
146827483|NCT01774019|529539518|FG001|Overall Study|Lost to Follow-up|3|||
146827484|NCT00553605|529539519|FG000|Overall Study|Did not meet entrance criteria|1|||
146827485|NCT00553605|529539520|FG001|Overall Study|Did not meet entrance criteria|3|||
146827486|NCT00553605|529539519|FG000|Overall Study|Did not receive full dose|1|||
146827487|NCT00553605|529539520|FG001|Overall Study|Did not receive full dose|0|||
146827488|NCT00553605|529539519|FG000|Overall Study|Randomized but not treated|2|||
146827489|NCT00553605|529539520|FG001|Overall Study|Randomized but not treated|0|||
146827490|NCT01085812|529539523|FG000|Open-Label Period|Adverse Event|0|||
146827491|NCT01085812|529539524|FG001|Open-Label Period|Adverse Event|80|||
146827492|NCT01085812|529539523|FG000|Open-Label Period|Lack of Efficacy|0|||
146827493|NCT01085812|529539524|FG001|Open-Label Period|Lack of Efficacy|26|||
146827494|NCT01085812|529539523|FG000|Open-Label Period|Protocol Violation|0|||
146827495|NCT01085812|529539524|FG001|Open-Label Period|Protocol Violation|39|||
146827496|NCT01085812|529539523|FG000|Open-Label Period|Withdrawal by Subject|0|||
146958010|NCT00965458|530006248|FG001|Overall Study|Lost to Follow-up|3|||
146958011|NCT00965458|530006247|FG000|Overall Study|Withdrawal by Subject|0|||
146958012|NCT00965458|530006248|FG001|Overall Study|Withdrawal by Subject|1|||
146958013|NCT00594958|530006251|FG000|Overall Study|Withdrawal by Subject|1|||
146958014|NCT00594958|530006252|FG001|Overall Study|Withdrawal by Subject|0|||
146958015|NCT00594958|530006253|FG002|Overall Study|Withdrawal by Subject|1|||
146958016|NCT00594958|530006251|FG000|Overall Study|Adverse Event|4|||
146958017|NCT00594958|530006252|FG001|Overall Study|Adverse Event|1|||
146958018|NCT00594958|530006253|FG002|Overall Study|Adverse Event|2|||
146958019|NCT00594958|530006251|FG000|Overall Study|Pregnancy|0|||
146958020|NCT00594958|530006252|FG001|Overall Study|Pregnancy|2|||
146958021|NCT00594958|530006253|FG002|Overall Study|Pregnancy|0|||
146958022|NCT00594958|530006251|FG000|Overall Study|Protocol Violation|1|||
146958023|NCT00594958|530006252|FG001|Overall Study|Protocol Violation|0|||
146958024|NCT00594958|530006253|FG002|Overall Study|Protocol Violation|2|||
146958025|NCT00594958|530006251|FG000|Overall Study|Lost to Follow-up|5|||
146958026|NCT00594958|530006252|FG001|Overall Study|Lost to Follow-up|0|||
146958027|NCT00594958|530006253|FG002|Overall Study|Lost to Follow-up|3|||
146958028|NCT00594958|530006251|FG000|Overall Study|administrative|3|||
146958029|NCT00594958|530006252|FG001|Overall Study|administrative|0|||
146958030|NCT00594958|530006253|FG002|Overall Study|administrative|2|||
146958031|NCT03233009|530006254|FG000|Overall Study|Lost to Follow-up|1|||
146958032|NCT02079077|530006255|FG000|Overall Study|Lost to Follow-up|5|||
146958033|NCT02079077|530006256|FG001|Overall Study|Lost to Follow-up|7|||
146958034|NCT02079077|530006255|FG000|Overall Study|Became STIs Positive|1|||
146958035|NCT02079077|530006256|FG001|Overall Study|Became STIs Positive|2|||
146958036|NCT01425268|530006257|FG000|Overall Study|Withdrawal by Subject|2|||
146958037|NCT01425268|530006258|FG001|Overall Study|Withdrawal by Subject|0|||
146958038|NCT01425268|530006257|FG000|Overall Study|Sponsor Decision|5|||
146958039|NCT01425268|530006258|FG001|Overall Study|Sponsor Decision|0|||
146958040|NCT01425268|530006257|FG000|Overall Study|Physician Decision|1|||
146958041|NCT01425268|530006258|FG001|Overall Study|Physician Decision|0|||
146958042|NCT01101321|530006259|FG000|Period 1|Withdrawal by Subject|1|||
146958043|NCT01101321|530006260|FG001|Period 1|Withdrawal by Subject|1|||
146958044|NCT01101321|530006259|FG000|Period 1|Adverse Event|3|||
146958045|NCT01101321|530006260|FG001|Period 1|Adverse Event|3|||
146958046|NCT00719706|530006261|FG000|Overall Study|Adverse Event|5|||
146958047|NCT00719706|530006262|FG001|Overall Study|Adverse Event|4|||
146958048|NCT00719706|530006261|FG000|Overall Study|Withdrawal by Subject|1|||
146958049|NCT00719706|530006262|FG001|Overall Study|Withdrawal by Subject|2|||
146958050|NCT00719706|530006261|FG000|Overall Study|Protocol Violation|3|||
146958051|NCT00719706|530006262|FG001|Overall Study|Protocol Violation|0|||
146958052|NCT00134563|530006263|FG000|Overall Study|Not treated due to protocol violation|0|||
146958053|NCT00134563|530006264|FG001|Overall Study|Not treated due to protocol violation|1|||
146958054|NCT00134563|530006265|FG002|Overall Study|Not treated due to protocol violation|1|||
146827497|NCT01085812|529539524|FG001|Open-Label Period|Withdrawal by Subject|53|||
146827498|NCT01085812|529539523|FG000|Open-Label Period|Lost to Follow-up|0|||
146827499|NCT01085812|529539524|FG001|Open-Label Period|Lost to Follow-up|42|||
146827500|NCT01085812|529539523|FG000|Double-Blind Period|Adverse Event|3|||
146827501|NCT01085812|529539524|FG001|Double-Blind Period|Adverse Event|8|||
146827502|NCT01085812|529539523|FG000|Double-Blind Period|Protocol Violation|2|||
146827503|NCT01085812|529539524|FG001|Double-Blind Period|Protocol Violation|7|||
146827504|NCT01085812|529539523|FG000|Double-Blind Period|Withdrawal by Subject|11|||
146827505|NCT01085812|529539524|FG001|Double-Blind Period|Withdrawal by Subject|24|||
146827506|NCT01085812|529539523|FG000|Double-Blind Period|Lost to Follow-up|5|||
146827507|NCT01085812|529539524|FG001|Double-Blind Period|Lost to Follow-up|17|||
146827508|NCT01085812|529539523|FG000|Double-Blind Period|Other Reasons|0|||
146827509|NCT01085812|529539524|FG001|Double-Blind Period|Other Reasons|2|||
146827510|NCT01085812|529539523|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
146827511|NCT01085812|529539524|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
146827512|NCT01085812|529539523|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
146827513|NCT01085812|529539524|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
146827514|NCT01085812|529539523|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
146827515|NCT01085812|529539524|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
146827516|NCT01085812|529539523|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
146827517|NCT01085812|529539524|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
146827518|NCT01085812|529539523|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
146827519|NCT01085812|529539524|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
146827520|NCT02561806|529539525|FG000|Induction Period|Adverse Event|0|||
146827521|NCT02561806|529539526|FG001|Induction Period|Adverse Event|2|||
146827522|NCT02561806|529539525|FG000|Induction Period|Lack of Efficacy|1|||
146827523|NCT02561806|529539526|FG001|Induction Period|Lack of Efficacy|0|||
146827524|NCT02561806|529539525|FG000|Induction Period|Withdrawal by Subject|0|||
146827525|NCT02561806|529539526|FG001|Induction Period|Withdrawal by Subject|2|||
146827526|NCT02561806|529539525|FG000|Induction Period|Site staff became unblinded|1|||
146827527|NCT02561806|529539526|FG001|Induction Period|Site staff became unblinded|0|||
146827528|NCT02561806|529539525|FG000|Induction Period|Randomized but not treated|0|||
146827529|NCT02561806|529539526|FG001|Induction Period|Randomized but not treated|1|||
146827530|NCT02561806|529539525|FG000|Maintenance Period|Adverse Event|2|||
146827531|NCT02561806|529539526|FG001|Maintenance Period|Adverse Event|1|||
146827532|NCT02561806|529539525|FG000|Maintenance Period|Lack of Efficacy|3|||
146827533|NCT02561806|529539526|FG001|Maintenance Period|Lack of Efficacy|1|||
146827534|NCT02561806|529539525|FG000|Maintenance Period|Lost to Follow-up|2|||
146827535|NCT02561806|529539526|FG001|Maintenance Period|Lost to Follow-up|2|||
146827536|NCT02561806|529539525|FG000|Maintenance Period|Protocol Violation|1|||
146827537|NCT02561806|529539526|FG001|Maintenance Period|Protocol Violation|0|||
146827538|NCT02561806|529539525|FG000|Maintenance Period|Withdrawal by Subject|5|||
146827539|NCT02561806|529539526|FG001|Maintenance Period|Withdrawal by Subject|3|||
146827540|NCT02561806|529539525|FG000|Maintenance Period|Site staff became unblinded|0|||
146827541|NCT02561806|529539526|FG001|Maintenance Period|Site staff became unblinded|1|||
146827542|NCT02561806|529539525|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
146827543|NCT02561806|529539526|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
146827544|NCT02561806|529539525|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
146827545|NCT02561806|529539526|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
146827546|NCT02547441|529539527|FG000|Double-Blind Study Period|Adverse Event|4|||
146827547|NCT02547441|529539528|FG001|Double-Blind Study Period|Adverse Event|9|||
146827548|NCT02547441|529539527|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
146827549|NCT02547441|529539528|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
146827550|NCT02547441|529539527|FG000|Double-Blind Study Period|Physician Decision|1|||
146827551|NCT02547441|529539528|FG001|Double-Blind Study Period|Physician Decision|0|||
146827552|NCT02547441|529539527|FG000|Double-Blind Study Period|Protocol Violation|1|||
146827553|NCT02547441|529539528|FG001|Double-Blind Study Period|Protocol Violation|2|||
146827554|NCT02547441|529539527|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
146827555|NCT02547441|529539528|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
146827556|NCT02547441|529539527|FG000|Double-Blind Study Period|Sponsor Decision|1|||
146827557|NCT02547441|529539528|FG001|Double-Blind Study Period|Sponsor Decision|0|||
146827558|NCT02547441|529539527|FG000|Open-Label Study Period|Adverse Event|10|||
146827559|NCT02547441|529539528|FG001|Open-Label Study Period|Adverse Event|11|||
146827560|NCT02547441|529539527|FG000|Open-Label Study Period|Lack of Efficacy|3|||
146827561|NCT02547441|529539528|FG001|Open-Label Study Period|Lack of Efficacy|2|||
146827562|NCT02547441|529539527|FG000|Open-Label Study Period|Lost to Follow-up|7|||
146827563|NCT02547441|529539528|FG001|Open-Label Study Period|Lost to Follow-up|8|||
146827564|NCT02547441|529539527|FG000|Open-Label Study Period|Physician Decision|1|||
146827565|NCT02547441|529539528|FG001|Open-Label Study Period|Physician Decision|0|||
146827566|NCT02547441|529539527|FG000|Open-Label Study Period|Protocol Violation|2|||
146827567|NCT02547441|529539528|FG001|Open-Label Study Period|Protocol Violation|0|||
146827568|NCT02547441|529539527|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
146827569|NCT02547441|529539528|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
146827570|NCT02547441|529539527|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
146827571|NCT02547441|529539528|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
146827572|NCT01322009|529539529|FG000|Overall Study|Death|0|||
146827573|NCT01322009|529539530|FG001|Overall Study|Death|1|||
146827574|NCT01322009|529539529|FG000|Overall Study|Adverse Event|0|||
146827575|NCT01322009|529539530|FG001|Overall Study|Adverse Event|1|||
146827576|NCT01322009|529539529|FG000|Overall Study|ng tube discontinued|0|||
146827577|NCT01322009|529539530|FG001|Overall Study|ng tube discontinued|1|||
146827578|NCT00394589|529539531|FG000|Overall Study|Adverse Event|2|||
146827579|NCT00394589|529539532|FG001|Overall Study|Adverse Event|1|||
146827580|NCT00394589|529539533|FG002|Overall Study|Adverse Event|2|||
146827581|NCT00394589|529539531|FG000|Overall Study|Lack of Efficacy|2|||
146827582|NCT00394589|529539532|FG001|Overall Study|Lack of Efficacy|2|||
146958055|NCT00134563|530006263|FG000|Overall Study|Adverse Event|29|||
146958056|NCT00134563|530006264|FG001|Overall Study|Adverse Event|37|||
146958057|NCT00134563|530006265|FG002|Overall Study|Adverse Event|38|||
146958058|NCT00134563|530006263|FG000|Overall Study|Lack of Efficacy|24|||
146958059|NCT00134563|530006264|FG001|Overall Study|Lack of Efficacy|14|||
146958060|NCT00134563|530006265|FG002|Overall Study|Lack of Efficacy|17|||
146958061|NCT00134563|530006263|FG000|Overall Study|Protocol Violation|3|||
146958062|NCT00134563|530006264|FG001|Overall Study|Protocol Violation|2|||
146958063|NCT00134563|530006265|FG002|Overall Study|Protocol Violation|5|||
146958064|NCT00134563|530006263|FG000|Overall Study|Lost to Follow-up|4|||
146958065|NCT00134563|530006264|FG001|Overall Study|Lost to Follow-up|0|||
146958066|NCT00134563|530006265|FG002|Overall Study|Lost to Follow-up|2|||
146958067|NCT00134563|530006263|FG000|Overall Study|progressive disease|11|||
146958068|NCT00134563|530006264|FG001|Overall Study|progressive disease|4|||
146958069|NCT00134563|530006265|FG002|Overall Study|progressive disease|2|||
146958070|NCT00134563|530006263|FG000|Overall Study|did not wish to continue|33|||
146958071|NCT00134563|530006264|FG001|Overall Study|did not wish to continue|32|||
146958072|NCT00134563|530006265|FG002|Overall Study|did not wish to continue|26|||
146958073|NCT00134563|530006263|FG000|Overall Study|Reason other than above|0|||
146958074|NCT00134563|530006264|FG001|Overall Study|Reason other than above|2|||
146958075|NCT00134563|530006265|FG002|Overall Study|Reason other than above|5|||
146958076|NCT02406586|530006266|FG000|Overall Study|Lost to Follow-up|0|||
146958077|NCT02406586|530006267|FG001|Overall Study|Lost to Follow-up|4|||
146958078|NCT02406586|530006268|FG002|Overall Study|Lost to Follow-up|2|||
146958079|NCT02406586|530006266|FG000|Overall Study|Withdrawal by Subject|1|||
146958080|NCT02406586|530006267|FG001|Overall Study|Withdrawal by Subject|0|||
146958081|NCT02406586|530006268|FG002|Overall Study|Withdrawal by Subject|0|||
146958082|NCT02839330|530006269|FG000|Overall Study|Adverse Event|0|||
146958083|NCT02839330|530006270|FG001|Overall Study|Adverse Event|1|||
146958084|NCT02839330|530006271|FG002|Overall Study|Adverse Event|2|||
146958085|NCT02839330|530006272|FG003|Overall Study|Adverse Event|2|||
146958086|NCT02839330|530006269|FG000|Overall Study|Death|4|||
146958087|NCT02839330|530006270|FG001|Overall Study|Death|6|||
146958088|NCT02839330|530006271|FG002|Overall Study|Death|1|||
146958089|NCT02839330|530006272|FG003|Overall Study|Death|1|||
146958090|NCT02839330|530006269|FG000|Overall Study|Withdrawal by Subject|27|||
146958091|NCT02839330|530006270|FG001|Overall Study|Withdrawal by Subject|19|||
146958092|NCT02839330|530006271|FG002|Overall Study|Withdrawal by Subject|11|||
146958093|NCT02839330|530006272|FG003|Overall Study|Withdrawal by Subject|13|||
146958094|NCT02839330|530006269|FG000|Overall Study|Lost to Follow-up|22|||
146958095|NCT02839330|530006270|FG001|Overall Study|Lost to Follow-up|27|||
146958096|NCT02839330|530006271|FG002|Overall Study|Lost to Follow-up|29|||
146958097|NCT02839330|530006272|FG003|Overall Study|Lost to Follow-up|25|||
146958098|NCT02839330|530006269|FG000|Overall Study|Administrative Reason|0|||
146958099|NCT02839330|530006270|FG001|Overall Study|Administrative Reason|0|||
146958100|NCT02839330|530006271|FG002|Overall Study|Administrative Reason|0|||
146958101|NCT02839330|530006272|FG003|Overall Study|Administrative Reason|1|||
146958102|NCT02839330|530006269|FG000|Overall Study|Protocol Violation|1|||
146958103|NCT02839330|530006270|FG001|Overall Study|Protocol Violation|2|||
146958104|NCT02839330|530006271|FG002|Overall Study|Protocol Violation|2|||
146827583|NCT00394589|529539533|FG002|Overall Study|Lack of Efficacy|3|||
146827584|NCT00394589|529539531|FG000|Overall Study|Protocol Violation|4|||
146958105|NCT02839330|530006272|FG003|Overall Study|Protocol Violation|3|||
146958106|NCT02839330|530006269|FG000|Overall Study|Other reason, not specified|4|||
146827585|NCT00394589|529539532|FG001|Overall Study|Protocol Violation|0|||
146827586|NCT00394589|529539533|FG002|Overall Study|Protocol Violation|2|||
146827587|NCT03409731|529539535|FG000|Overall Study|Withdrawal by Subject|17|||
146827588|NCT03409731|529539535|FG000|Overall Study|Death|4|||
146958107|NCT02839330|530006270|FG001|Overall Study|Other reason, not specified|3|||
146958108|NCT02839330|530006271|FG002|Overall Study|Other reason, not specified|3|||
146958109|NCT02839330|530006272|FG003|Overall Study|Other reason, not specified|6|||
146958110|NCT00682539|530006273|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
146958111|NCT00682539|530006274|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
146958112|NCT00682539|530006275|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
146958113|NCT00682539|530006273|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
146827589|NCT01114672|529539536|FG000|Overall Study|Death|0|||
146986000|NCT00384033|530111118|FG000|Overall Study|Protocol Violation|5|||
146986001|NCT00384033|530111119|FG001|Overall Study|Protocol Violation|0|||
146827590|NCT01114672|529539537|FG001|Overall Study|Death|1|||
146827591|NCT01114672|529539536|FG000|Overall Study|Withdrawal by Subject|2|||
146827592|NCT01114672|529539537|FG001|Overall Study|Withdrawal by Subject|1|||
146827593|NCT01114672|529539536|FG000|Overall Study|Lost to Follow-up|1|||
146827594|NCT01114672|529539537|FG001|Overall Study|Lost to Follow-up|0|||
146827595|NCT01114672|529539536|FG000|Overall Study|transplanted|1|||
146827596|NCT01114672|529539537|FG001|Overall Study|transplanted|0|||
146827597|NCT01710800|529539540|FG000|Overall Study|Withdrawal by Subject|21|||
146827598|NCT01710800|529539540|FG000|Overall Study|Protocol Violation|1|||
146827599|NCT02427958|529539541|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
146827600|NCT02427958|529539541|FG000|Overall Study|Lost to Follow-up|6|||
146827601|NCT02427958|529539541|FG000|Overall Study|Withdrawal by Subject|14|||
146827602|NCT02427958|529539541|FG000|Overall Study|Lack of Efficacy|1|||
146827603|NCT02287883|529539547|FG000|Overall Study|Death|8|||
146827604|NCT02287883|529539548|FG001|Overall Study|Death|7|||
146827605|NCT02287883|529539547|FG000|Overall Study|No longer eligible|222|||
146827606|NCT02287883|529539548|FG001|Overall Study|No longer eligible|182|||
146827607|NCT02287883|529539547|FG000|Overall Study|Non-response to survey|229|||
146827608|NCT02287883|529539548|FG001|Overall Study|Non-response to survey|237|||
146827609|NCT00545571|529539552|FG000|Overall Study|Administrative Reasons|1|||
146827610|NCT00545571|529539552|FG000|Overall Study|Adverse Event|2|||
146827611|NCT00545571|529539552|FG000|Overall Study|Death|5|||
146827612|NCT00545571|529539552|FG000|Overall Study|Lack of Efficacy|1|||
146827613|NCT00545571|529539552|FG000|Overall Study|Protocol Violation|2|||
146827614|NCT00545571|529539552|FG000|Overall Study|Refused Treatment|1|||
146827615|NCT00545571|529539552|FG000|Overall Study|Screen Failure|16|||
146827616|NCT00545571|529539552|FG000|Overall Study|Transfusion|12|||
146827617|NCT00545571|529539552|FG000|Overall Study|Early Termination of Study|24|||
146827618|NCT00545571|529539552|FG000|Overall Study|Kidney Transplantation|3|||
146827619|NCT01978236|529539553|FG000|Overall Study|Discontinued due to study close|2|||
146827620|NCT01193218|529539555|FG000|0-12 Weeks|Adverse Event|6|||
146827621|NCT01193218|529539556|FG001|0-12 Weeks|Adverse Event|0|||
146827622|NCT01193218|529539557|FG002|0-12 Weeks|Adverse Event|1|||
146827623|NCT01193218|529539558|FG003|0-12 Weeks|Adverse Event|0|||
146827624|NCT01193218|529539559|FG004|0-12 Weeks|Adverse Event|0|||
146827625|NCT01193218|529539560|FG005|0-12 Weeks|Adverse Event|2|||
146827626|NCT01193218|529539561|FG006|0-12 Weeks|Adverse Event|2|||
146827627|NCT01193218|529539562|FG007|0-12 Weeks|Adverse Event|0|||
146827628|NCT01193218|529539555|FG000|0-12 Weeks|Protocol Violation|0|||
146827629|NCT01193218|529539556|FG001|0-12 Weeks|Protocol Violation|0|||
146827630|NCT01193218|529539557|FG002|0-12 Weeks|Protocol Violation|0|||
146827631|NCT01193218|529539558|FG003|0-12 Weeks|Protocol Violation|0|||
146986002|NCT00384033|530111120|FG002|Overall Study|Protocol Violation|5|||
146986003|NCT00384033|530111121|FG003|Overall Study|Protocol Violation|6|||
146986004|NCT00384033|530111118|FG000|Overall Study|Withdrawal by Subject|6|||
146986005|NCT00384033|530111119|FG001|Overall Study|Withdrawal by Subject|2|||
146986006|NCT00384033|530111120|FG002|Overall Study|Withdrawal by Subject|5|||
146986007|NCT00384033|530111121|FG003|Overall Study|Withdrawal by Subject|2|||
146986008|NCT00384033|530111118|FG000|Overall Study|Lack of Efficacy|7|||
146986009|NCT00384033|530111119|FG001|Overall Study|Lack of Efficacy|3|||
146986010|NCT00384033|530111120|FG002|Overall Study|Lack of Efficacy|3|||
146986011|NCT00384033|530111121|FG003|Overall Study|Lack of Efficacy|1|||
146986012|NCT00384033|530111118|FG000|Overall Study|Randomized but not treated|3|||
146827632|NCT01193218|529539559|FG004|0-12 Weeks|Protocol Violation|1|||
146827633|NCT01193218|529539560|FG005|0-12 Weeks|Protocol Violation|1|||
146827634|NCT01193218|529539561|FG006|0-12 Weeks|Protocol Violation|0|||
146827635|NCT01193218|529539562|FG007|0-12 Weeks|Protocol Violation|0|||
146827636|NCT01193218|529539555|FG000|0-12 Weeks|Withdrawal by Subject|3|||
146986013|NCT00384033|530111119|FG001|Overall Study|Randomized but not treated|7|||
146986014|NCT00384033|530111120|FG002|Overall Study|Randomized but not treated|10|||
146986015|NCT00384033|530111121|FG003|Overall Study|Randomized but not treated|2|||
146986016|NCT01006707|530111122|FG000|Study Session 1|Lost to Follow-up|2|||
146986017|NCT01006707|530111123|FG001|Study Session 1|Lost to Follow-up|0|||
146986018|NCT01006707|530111124|FG002|Study Session 1|Lost to Follow-up|0|||
146986019|NCT01006707|530111122|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
146986020|NCT01006707|530111123|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
146827637|NCT01193218|529539556|FG001|0-12 Weeks|Withdrawal by Subject|0|||
146827638|NCT01193218|529539557|FG002|0-12 Weeks|Withdrawal by Subject|2|||
146827639|NCT01193218|529539558|FG003|0-12 Weeks|Withdrawal by Subject|0|||
146827640|NCT01193218|529539559|FG004|0-12 Weeks|Withdrawal by Subject|0|||
146827641|NCT01193218|529539560|FG005|0-12 Weeks|Withdrawal by Subject|0|||
146827642|NCT01193218|529539561|FG006|0-12 Weeks|Withdrawal by Subject|1|||
146827643|NCT01193218|529539562|FG007|0-12 Weeks|Withdrawal by Subject|0|||
146827644|NCT01193218|529539555|FG000|12-52 Weeks|Adverse Event|1|||
146827645|NCT01193218|529539556|FG001|12-52 Weeks|Adverse Event|0|||
146827646|NCT01193218|529539557|FG002|12-52 Weeks|Adverse Event|1|||
146827647|NCT01193218|529539558|FG003|12-52 Weeks|Adverse Event|2|||
146827648|NCT01193218|529539559|FG004|12-52 Weeks|Adverse Event|3|||
146827649|NCT01193218|529539560|FG005|12-52 Weeks|Adverse Event|3|||
146827650|NCT01193218|529539561|FG006|12-52 Weeks|Adverse Event|1|||
146827651|NCT01193218|529539562|FG007|12-52 Weeks|Adverse Event|2|||
146827652|NCT01193218|529539555|FG000|12-52 Weeks|Lack of Efficacy|0|||
146827653|NCT01193218|529539556|FG001|12-52 Weeks|Lack of Efficacy|0|||
146827654|NCT01193218|529539557|FG002|12-52 Weeks|Lack of Efficacy|0|||
146827655|NCT01193218|529539558|FG003|12-52 Weeks|Lack of Efficacy|0|||
146827656|NCT01193218|529539559|FG004|12-52 Weeks|Lack of Efficacy|0|||
146827657|NCT01193218|529539560|FG005|12-52 Weeks|Lack of Efficacy|0|||
146827658|NCT01193218|529539561|FG006|12-52 Weeks|Lack of Efficacy|1|||
146827659|NCT01193218|529539562|FG007|12-52 Weeks|Lack of Efficacy|0|||
146827660|NCT01193218|529539555|FG000|12-52 Weeks|Withdrawal by Subject|3|||
146827661|NCT01193218|529539556|FG001|12-52 Weeks|Withdrawal by Subject|0|||
146827662|NCT01193218|529539557|FG002|12-52 Weeks|Withdrawal by Subject|3|||
146827663|NCT01193218|529539558|FG003|12-52 Weeks|Withdrawal by Subject|0|||
146827664|NCT01193218|529539559|FG004|12-52 Weeks|Withdrawal by Subject|0|||
146827665|NCT01193218|529539560|FG005|12-52 Weeks|Withdrawal by Subject|2|||
146827666|NCT01193218|529539561|FG006|12-52 Weeks|Withdrawal by Subject|1|||
146827667|NCT01193218|529539562|FG007|12-52 Weeks|Withdrawal by Subject|2|||
146827668|NCT01193218|529539555|FG000|12-52 Weeks|Other reason than above|1|||
146827669|NCT01193218|529539556|FG001|12-52 Weeks|Other reason than above|0|||
146827670|NCT01193218|529539557|FG002|12-52 Weeks|Other reason than above|0|||
146827671|NCT01193218|529539558|FG003|12-52 Weeks|Other reason than above|1|||
146827672|NCT01193218|529539559|FG004|12-52 Weeks|Other reason than above|1|||
146827673|NCT01193218|529539560|FG005|12-52 Weeks|Other reason than above|0|||
146827674|NCT01193218|529539561|FG006|12-52 Weeks|Other reason than above|0|||
146827675|NCT01193218|529539562|FG007|12-52 Weeks|Other reason than above|0|||
146827676|NCT00363649|529539563|FG000|Overall Study|Withdrawal by Subject|1|||
146827677|NCT00363649|529539564|FG001|Overall Study|Withdrawal by Subject|1|||
146827678|NCT00363649|529539563|FG000|Overall Study|Adverse Event|6|||
146827679|NCT00363649|529539564|FG001|Overall Study|Adverse Event|0|||
146827680|NCT01013740|529539565|FG000|Overall Study|Lost to Follow-up|3|||
146827681|NCT01013740|529539566|FG001|Overall Study|Lost to Follow-up|5|||
146827682|NCT01013740|529539565|FG000|Overall Study|Physician Decision|2|||
146827683|NCT01013740|529539566|FG001|Overall Study|Physician Decision|0|||
146827684|NCT01013740|529539565|FG000|Overall Study|Withdrawal by Subject|2|||
146827685|NCT01013740|529539566|FG001|Overall Study|Withdrawal by Subject|10|||
146827686|NCT01013740|529539565|FG000|Overall Study|study close / terminated : done in error|2|||
146827687|NCT01013740|529539566|FG001|Overall Study|study close / terminated : done in error|1|||
146827688|NCT01013740|529539565|FG000|Overall Study|Missing|2|||
146827689|NCT01013740|529539566|FG001|Overall Study|Missing|1|||
146827690|NCT01013740|529539565|FG000|Overall Study|Ongoing: Study records not completed|0|||
146827691|NCT01013740|529539566|FG001|Overall Study|Ongoing: Study records not completed|2|||
146827692|NCT03811834|529539569|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
146827693|NCT00576823|529539570|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
146827694|NCT00576823|529539571|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
146827695|NCT00576823|529539572|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
146827696|NCT00576823|529539570|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
146827697|NCT00576823|529539571|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
146827698|NCT00576823|529539572|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
146827699|NCT01242371|529539573|FG000|Overall Study|Withdrawal by Subject|2|||
146827700|NCT01242371|529539574|FG001|Overall Study|Withdrawal by Subject|2|||
146827701|NCT01242371|529539573|FG000|Overall Study|Protocol Violation|0|||
146827702|NCT01242371|529539574|FG001|Overall Study|Protocol Violation|3|||
146827703|NCT00510146|529539577|FG000|Double-Blind Treatment|Adverse Event|30|||
146827704|NCT00510146|529539578|FG001|Double-Blind Treatment|Adverse Event|13|||
146827705|NCT00510146|529539577|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
146827706|NCT00510146|529539578|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
146827707|NCT00510146|529539577|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
146827708|NCT00510146|529539578|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
146827709|NCT00510146|529539577|FG000|Double-Blind Treatment|Physician Decision|6|||
146827710|NCT00510146|529539578|FG001|Double-Blind Treatment|Physician Decision|0|||
146827711|NCT00510146|529539577|FG000|Double-Blind Treatment|Protocol Violation|1|||
146958114|NCT00682539|530006274|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
146958115|NCT00682539|530006275|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
146958116|NCT00508872|530006283|FG000|Overall Study|Lost to Follow-up|1|||
146958117|NCT00508872|530006283|FG000|Overall Study|Physician Decision|1|||
146958118|NCT03339999|530006293|FG000|Overall Study|Adverse Event|1|||
146827712|NCT00510146|529539578|FG001|Double-Blind Treatment|Protocol Violation|2|||
146827713|NCT00510146|529539577|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
146827714|NCT00510146|529539578|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
146827715|NCT00510146|529539577|FG000|Double-Blind Treatment|Clinical Relapse|0|||
146827716|NCT00510146|529539578|FG001|Double-Blind Treatment|Clinical Relapse|1|||
146827717|NCT00510146|529539577|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
146827718|NCT00510146|529539578|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
146958119|NCT03339999|530006294|FG001|Overall Study|Adverse Event|2|||
146827719|NCT00510146|529539577|FG000|Open-Label Treatment|Adverse Event|22|||
146827720|NCT00510146|529539578|FG001|Open-Label Treatment|Adverse Event|8|||
146827721|NCT00510146|529539577|FG000|Open-Label Treatment|Death|1|||
146827722|NCT00510146|529539578|FG001|Open-Label Treatment|Death|1|||
146827723|NCT00510146|529539577|FG000|Open-Label Treatment|Lack of Efficacy|4|||
146827724|NCT00510146|529539578|FG001|Open-Label Treatment|Lack of Efficacy|0|||
146827725|NCT00510146|529539577|FG000|Open-Label Treatment|Lost to Follow-up|10|||
146827726|NCT00510146|529539578|FG001|Open-Label Treatment|Lost to Follow-up|1|||
146827727|NCT00510146|529539577|FG000|Open-Label Treatment|Physician Decision|3|||
146827728|NCT00510146|529539578|FG001|Open-Label Treatment|Physician Decision|1|||
146827729|NCT00510146|529539577|FG000|Open-Label Treatment|Protocol Violation|4|||
146827730|NCT00510146|529539578|FG001|Open-Label Treatment|Protocol Violation|2|||
146827731|NCT00510146|529539577|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
146827732|NCT00510146|529539578|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
146827733|NCT00510146|529539577|FG000|Open-Label Treatment|Clinical Relapse|1|||
146827734|NCT00510146|529539578|FG001|Open-Label Treatment|Clinical Relapse|1|||
146827735|NCT00510146|529539577|FG000|Open-Label Treatment|Sponsor Decision|2|||
146827736|NCT00510146|529539578|FG001|Open-Label Treatment|Sponsor Decision|0|||
146827737|NCT03188536|529539579|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
146827738|NCT03188536|529539579|FG000|Overall Study|Not participated/met inclusion criteria|1|||
146827739|NCT01930214|529539580|FG000|Overall Study|Death|4|||
146827740|NCT01930214|529539581|FG001|Overall Study|Death|4|||
146827741|NCT01930214|529539582|FG002|Overall Study|Death|11|||
146827742|NCT01930214|529539580|FG000|Overall Study|Lost to Follow-up|12|||
146827743|NCT01930214|529539581|FG001|Overall Study|Lost to Follow-up|13|||
146827744|NCT01930214|529539582|FG002|Overall Study|Lost to Follow-up|12|||
146827745|NCT01930214|529539580|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
146827746|NCT01930214|529539581|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
146827747|NCT01930214|529539582|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
146827748|NCT01930214|529539580|FG000|Overall Study|Physician Decision|2|||
146827749|NCT01930214|529539581|FG001|Overall Study|Physician Decision|0|||
146827750|NCT01930214|529539582|FG002|Overall Study|Physician Decision|0|||
146827751|NCT00025662|529539583|FG000|Overall Study|Withdrawal by Subject|2|||
146827752|NCT00025662|529539583|FG000|Overall Study|Technical failure of manipulation|1|||
146827753|NCT02132117|529539586|FG000|Overall Study|Adverse Event|6|||
146827754|NCT02132117|529539587|FG001|Overall Study|Adverse Event|1|||
146827755|NCT02132117|529539586|FG000|Overall Study|Lost to Follow-up|2|||
146827756|NCT02132117|529539587|FG001|Overall Study|Lost to Follow-up|2|||
146827757|NCT02132117|529539586|FG000|Overall Study|Personal Reasons|1|||
146827758|NCT02132117|529539587|FG001|Overall Study|Personal Reasons|2|||
146827759|NCT02132117|529539586|FG000|Overall Study|Other Miscellaneous Reasons|2|||
146827760|NCT02132117|529539587|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146827761|NCT04947436|529539588|FG000|Overall Study|Lost to Follow-up|3|||
146827762|NCT04947436|529539589|FG001|Overall Study|Lost to Follow-up|7|||
146827763|NCT04947436|529539590|FG002|Overall Study|Lost to Follow-up|5|||
146827764|NCT04947436|529539588|FG000|Overall Study|Death|1|||
146827765|NCT04947436|529539589|FG001|Overall Study|Death|1|||
146827766|NCT04947436|529539590|FG002|Overall Study|Death|1|||
146827767|NCT02161185|529539594|FG000|Treatment Phase|Administrative/Other|7|||
146827768|NCT00582114|529539598|FG000|Overall Study|Death|4|||
146827769|NCT00582114|529539599|FG001|Overall Study|Death|4|||
146827770|NCT00582114|529539598|FG000|Overall Study|Kidney Transplant|3|||
146827771|NCT00582114|529539599|FG001|Overall Study|Kidney Transplant|1|||
146827772|NCT00582114|529539598|FG000|Overall Study|Lost to Follow-up|7|||
146827773|NCT00582114|529539599|FG001|Overall Study|Lost to Follow-up|6|||
146827774|NCT00582114|529539598|FG000|Overall Study|Withdrawal by Subject|8|||
146827775|NCT00582114|529539599|FG001|Overall Study|Withdrawal by Subject|16|||
146827776|NCT00582114|529539598|FG000|Overall Study|Adverse Event|1|||
146827777|NCT00582114|529539599|FG001|Overall Study|Adverse Event|1|||
146827778|NCT00582114|529539598|FG000|Overall Study|Physician Decision|0|||
146827779|NCT00582114|529539599|FG001|Overall Study|Physician Decision|6|||
146827780|NCT00582114|529539598|FG000|Overall Study|Stopped by data safety monitoring board|19|||
146827781|NCT00582114|529539599|FG001|Overall Study|Stopped by data safety monitoring board|20|||
146827782|NCT00118703|529539600|FG000|Overall Study|Protocol Violation|1|||
146827783|NCT00118703|529539601|FG001|Overall Study|Protocol Violation|0|||
146827784|NCT00118703|529539600|FG000|Overall Study|Adverse Event|1|||
146827785|NCT00118703|529539601|FG001|Overall Study|Adverse Event|1|||
146827786|NCT00118703|529539600|FG000|Overall Study|Participant took two different treatment|0|||
146827787|NCT00118703|529539601|FG001|Overall Study|Participant took two different treatment|1|||
146827788|NCT00118703|529539600|FG000|Overall Study|Withdrawal by Subject|2|||
146827789|NCT00118703|529539601|FG001|Overall Study|Withdrawal by Subject|5|||
146827790|NCT00118703|529539600|FG000|Overall Study|Lost to Follow-up|1|||
146827791|NCT00118703|529539601|FG001|Overall Study|Lost to Follow-up|2|||
146827792|NCT01215032|529539606|FG000|Overall Study|Adverse Event|3|||
146827793|NCT01215032|529539606|FG000|Overall Study|Lack of Efficacy|17|||
146827794|NCT01283971|529539609|FG000|Overall Study|Adverse Event|3|||
146827795|NCT01283971|529539610|FG001|Overall Study|Adverse Event|5|||
146827796|NCT01283971|529539609|FG000|Overall Study|Insufficient therapeutic responses|3|||
146827797|NCT01283971|529539610|FG001|Overall Study|Insufficient therapeutic responses|3|||
146827798|NCT01283971|529539609|FG000|Overall Study|Protocol Violation|5|||
146827799|NCT01283971|529539610|FG001|Overall Study|Protocol Violation|1|||
146827800|NCT01283971|529539609|FG000|Overall Study|Refused treatment|3|||
146827801|NCT01283971|529539610|FG001|Overall Study|Refused treatment|1|||
146827802|NCT01283971|529539609|FG000|Overall Study|Failure to return|0|||
146827803|NCT01283971|529539610|FG001|Overall Study|Failure to return|1|||
146827804|NCT01283971|529539609|FG000|Overall Study|Administrative reasons|1|||
146827805|NCT01283971|529539610|FG001|Overall Study|Administrative reasons|1|||
146827806|NCT02154347|529539611|FG000|Double-blind Period|Adverse Event|1|||
146827807|NCT02154347|529539612|FG001|Double-blind Period|Adverse Event|2|||
146827808|NCT02154347|529539611|FG000|Double-blind Period|Lack of Efficacy|1|||
146827809|NCT02154347|529539612|FG001|Double-blind Period|Lack of Efficacy|0|||
146827810|NCT02154347|529539611|FG000|Double-blind Period|Physician Decision|0|||
146827811|NCT02154347|529539612|FG001|Double-blind Period|Physician Decision|1|||
146827812|NCT02154347|529539611|FG000|Double-blind Period|Withdrawal by Subject|1|||
146827813|NCT02154347|529539612|FG001|Double-blind Period|Withdrawal by Subject|1|||
146827814|NCT02154347|529539611|FG000|Open-label Period|Adverse Event|3|||
146827815|NCT02154347|529539612|FG001|Open-label Period|Adverse Event|4|||
146827816|NCT02154347|529539611|FG000|Open-label Period|Lack of Efficacy|4|||
146827817|NCT02154347|529539612|FG001|Open-label Period|Lack of Efficacy|19|||
146827818|NCT02154347|529539611|FG000|Open-label Period|Protocol Violation|0|||
146827819|NCT02154347|529539612|FG001|Open-label Period|Protocol Violation|1|||
146827820|NCT02154347|529539611|FG000|Open-label Period|Withdrawal by Subject|0|||
146827821|NCT02154347|529539612|FG001|Open-label Period|Withdrawal by Subject|1|||
146827822|NCT02188784|529539613|FG000|Overall Study|Death|3|||
146827823|NCT02188784|529539614|FG001|Overall Study|Death|1|||
146827824|NCT02188784|529539613|FG000|Overall Study|Lost to Follow-up|1|||
146827825|NCT02188784|529539614|FG001|Overall Study|Lost to Follow-up|0|||
146827826|NCT02188784|529539613|FG000|Overall Study|Withdrawal by Subject|3|||
146827827|NCT02188784|529539614|FG001|Overall Study|Withdrawal by Subject|9|||
146827828|NCT02188784|529539613|FG000|Overall Study|Physician Decision|2|||
146827829|NCT02188784|529539614|FG001|Overall Study|Physician Decision|3|||
146827830|NCT05041439|529539615|FG000|Overall Study|Withdrawal by Subject|1|||
146827831|NCT05041439|529539616|FG001|Overall Study|Withdrawal by Subject|1|||
146827832|NCT05041439|529539615|FG000|Overall Study|Death|1|||
146827833|NCT05041439|529539616|FG001|Overall Study|Death|0|||
146827834|NCT00664105|529540927|FG000|Overall Study|Death|3|||
146827835|NCT00664105|529540927|FG000|Overall Study|Withdrawal by Subject|5|||
146827836|NCT00664105|529540927|FG000|Overall Study|Adverse Event|9|||
146827837|NCT00664105|529540927|FG000|Overall Study|Disease progression|7|||
146827838|NCT01468077|529540934|FG000|Overall Study|Adverse Event|2|||
146827839|NCT01468077|529540935|FG001|Overall Study|Adverse Event|2|||
146827840|NCT01468077|529540934|FG000|Overall Study|Lack of Efficacy|1|||
146827841|NCT01468077|529540935|FG001|Overall Study|Lack of Efficacy|1|||
146827842|NCT01468077|529540934|FG000|Overall Study|Physician Decision|1|||
146827843|NCT01468077|529540935|FG001|Overall Study|Physician Decision|0|||
146827844|NCT04843579|529540936|FG000|Overall Study|Adverse Event|1|||
146827845|NCT04843579|529540936|FG000|Overall Study|Disease Progression|1|||
146827846|NCT03834623|529540937|FG000|Overall Study|Progression|0|||
146827847|NCT03834623|529540938|FG001|Overall Study|Progression|1|||
146827848|NCT03024996|529540940|FG000|Overall Study|Death|57|||
146827849|NCT03024996|529540941|FG001|Overall Study|Death|55|||
146958120|NCT03339999|530006295|FG002|Overall Study|Adverse Event|2|||
146958121|NCT03339999|530006296|FG003|Overall Study|Adverse Event|1|||
146958122|NCT03339999|530006293|FG000|Overall Study|Lack of Efficacy|0|||
146958123|NCT03339999|530006294|FG001|Overall Study|Lack of Efficacy|1|||
146958124|NCT03339999|530006295|FG002|Overall Study|Lack of Efficacy|0|||
146958125|NCT03339999|530006296|FG003|Overall Study|Lack of Efficacy|0|||
146958126|NCT03339999|530006293|FG000|Overall Study|Lost to Follow-up|0|||
146958127|NCT03339999|530006294|FG001|Overall Study|Lost to Follow-up|0|||
146958128|NCT03339999|530006295|FG002|Overall Study|Lost to Follow-up|0|||
146958129|NCT03339999|530006296|FG003|Overall Study|Lost to Follow-up|1|||
146958130|NCT03339999|530006293|FG000|Overall Study|Study Terminated by Sponsor|6|||
146958131|NCT03339999|530006294|FG001|Overall Study|Study Terminated by Sponsor|3|||
146958132|NCT03339999|530006295|FG002|Overall Study|Study Terminated by Sponsor|4|||
146958133|NCT03339999|530006296|FG003|Overall Study|Study Terminated by Sponsor|3|||
146958134|NCT01856920|530006297|FG000|Overall Study|Disease Progression On Study|3|||
146958135|NCT01856920|530006298|FG001|Overall Study|Disease Progression On Study|4|||
146958136|NCT01856920|530006297|FG000|Overall Study|Disease Progression before Treatment|1|||
146958137|NCT01856920|530006298|FG001|Overall Study|Disease Progression before Treatment|0|||
146958138|NCT01856920|530006297|FG000|Overall Study|Ineligible|0|||
146958139|NCT01856920|530006298|FG001|Overall Study|Ineligible|1|||
146958140|NCT01856920|530006297|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
146827850|NCT03024996|529540940|FG000|Overall Study|Disease relapse|1|||
146958141|NCT01856920|530006298|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
146958142|NCT01856920|530006297|FG000|Overall Study|Refused further Treatment|5|||
146827851|NCT03024996|529540941|FG001|Overall Study|Disease relapse|0|||
146827852|NCT03024996|529540940|FG000|Overall Study|Lost to Follow-up|5|||
146827853|NCT03024996|529540941|FG001|Overall Study|Lost to Follow-up|10|||
146827854|NCT03024996|529540940|FG000|Overall Study|Other|3|||
146827855|NCT03024996|529540941|FG001|Overall Study|Other|3|||
146827856|NCT03024996|529540940|FG000|Overall Study|Physician Decision|0|||
146827857|NCT03024996|529540941|FG001|Overall Study|Physician Decision|1|||
146827858|NCT03024996|529540940|FG000|Overall Study|Study terminated by sponsor|303|||
146827859|NCT03024996|529540941|FG001|Overall Study|Study terminated by sponsor|283|||
146827860|NCT03024996|529540940|FG000|Overall Study|Withdrawal by Subject|21|||
146827861|NCT03024996|529540941|FG001|Overall Study|Withdrawal by Subject|36|||
146827862|NCT00478647|529540942|FG000|Overall Study|Adverse Event|1|||
146827863|NCT00478647|529540942|FG000|Overall Study|Withdrawal by Subject|1|||
146827864|NCT00477464|529540946|FG000|Overall Study|Lost to Follow-up|1|||
146827865|NCT00477464|529540946|FG000|Overall Study|Death|36|||
146827866|NCT00477464|529540946|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
146827867|NCT00639769|529540947|FG000|Overall Study|Death|2|||
146827868|NCT00639769|529540947|FG000|Overall Study|Adverse Event|7|||
146827869|NCT00639769|529540947|FG000|Overall Study|Lack of Efficacy|1|||
146827870|NCT00639769|529540947|FG000|Overall Study|Disease progression|26|||
146827871|NCT00639769|529540947|FG000|Overall Study|Withdrawal by Subject|4|||
146827872|NCT00784147|529540948|FG000|Overall Study|Lost to Follow-up|2|||
146827873|NCT00784147|529540949|FG001|Overall Study|Lost to Follow-up|4|||
146827874|NCT00784147|529540948|FG000|Overall Study|Withdrawal by Subject|1|||
146827875|NCT00784147|529540949|FG001|Overall Study|Withdrawal by Subject|3|||
146827876|NCT00784147|529540948|FG000|Overall Study|Physician Decision|2|||
146827877|NCT00784147|529540949|FG001|Overall Study|Physician Decision|1|||
146827878|NCT00784147|529540948|FG000|Overall Study|Protocol Violation|1|||
146827879|NCT00784147|529540949|FG001|Overall Study|Protocol Violation|1|||
146827880|NCT00784147|529540948|FG000|Overall Study|Death|2|||
146827881|NCT00784147|529540949|FG001|Overall Study|Death|0|||
146827882|NCT03357471|529540954|FG000|Overall Study|Adverse Event|1|||
146827883|NCT03357471|529540955|FG001|Overall Study|Adverse Event|0|||
146827884|NCT03357471|529540954|FG000|Overall Study|Lost to Follow-up|1|||
146827885|NCT03357471|529540955|FG001|Overall Study|Lost to Follow-up|0|||
146827886|NCT03294941|529540956|FG000|Overall Study|Withdrawal by Subject|0|||
146827887|NCT03294941|529540957|FG001|Overall Study|Withdrawal by Subject|2|||
146827888|NCT04051242|529540958|FG000|Overall Study|Withdrawal by Subject|1|||
146827889|NCT04051242|529540958|FG000|Overall Study|Physician Decision|1|||
146827890|NCT00130728|529540961|FG000|Overall Study|Death|258|||
146827891|NCT00130728|529540962|FG001|Overall Study|Death|258|||
146827892|NCT00130728|529540961|FG000|Overall Study|Lost to Follow-up|4|||
146827893|NCT00130728|529540962|FG001|Overall Study|Lost to Follow-up|0|||
146827894|NCT00130728|529540961|FG000|Overall Study|Withdrawal by Subject|0|||
146827895|NCT00130728|529540962|FG001|Overall Study|Withdrawal by Subject|2|||
146827896|NCT01209286|529540964|FG000|Overall Study|Adverse Event|4|||
146827897|NCT01209286|529540965|FG001|Overall Study|Adverse Event|3|||
146827898|NCT01209286|529540966|FG002|Overall Study|Adverse Event|1|||
146827899|NCT01209286|529540964|FG000|Overall Study|Hematological Relapse After Remission|0|||
146827900|NCT01209286|529540965|FG001|Overall Study|Hematological Relapse After Remission|1|||
146827901|NCT01209286|529540966|FG002|Overall Study|Hematological Relapse After Remission|1|||
146827902|NCT01209286|529540964|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
146827903|NCT01209286|529540965|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
146827904|NCT01209286|529540966|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
146827905|NCT01209286|529540964|FG000|Overall Study|Physician Decision|0|||
146827906|NCT01209286|529540965|FG001|Overall Study|Physician Decision|2|||
146827907|NCT01209286|529540966|FG002|Overall Study|Physician Decision|0|||
146827908|NCT01209286|529540964|FG000|Overall Study|Other|0|||
146827909|NCT01209286|529540965|FG001|Overall Study|Other|1|||
146827910|NCT01209286|529540966|FG002|Overall Study|Other|0|||
146827911|NCT01349036|529540967|FG000|Overall Study|Disease progression|13|||
146827912|NCT01349036|529540968|FG001|Overall Study|Disease progression|22|||
146827913|NCT01349036|529540967|FG000|Overall Study|Other|1|||
146827914|NCT01349036|529540968|FG001|Overall Study|Other|0|||
146986021|NCT01006707|530111124|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
146827915|NCT01349036|529540967|FG000|Overall Study|Withdrawal by Subject|0|||
146827916|NCT01349036|529540968|FG001|Overall Study|Withdrawal by Subject|2|||
146827917|NCT03796208|529540969|FG000|Overall Study|Withdrawal by Subject|3|||
146827918|NCT03796208|529540970|FG001|Overall Study|Withdrawal by Subject|0|||
146827919|NCT03796208|529540969|FG000|Overall Study|Loss of pregnancy|1|||
146827920|NCT03796208|529540970|FG001|Overall Study|Loss of pregnancy|1|||
146827921|NCT03796208|529540969|FG000|Overall Study|Changed prenatal clinics|0|||
146827922|NCT03796208|529540970|FG001|Overall Study|Changed prenatal clinics|5|||
146827923|NCT03796208|529540969|FG000|Overall Study|Lost to Follow-up|20|||
146827924|NCT03796208|529540970|FG001|Overall Study|Lost to Follow-up|16|||
146827925|NCT02725008|529540974|FG000|Overall Study|Lost to Follow-up|7|||
146827926|NCT02725008|529540975|FG001|Overall Study|Lost to Follow-up|9|||
146827927|NCT02725008|529540974|FG000|Overall Study|Withdrawal by Subject|2|||
146827928|NCT02725008|529540975|FG001|Overall Study|Withdrawal by Subject|2|||
146827929|NCT02725008|529540974|FG000|Overall Study|Admitted to hospital|0|||
146827930|NCT02725008|529540975|FG001|Overall Study|Admitted to hospital|1|||
146827931|NCT01020747|529540976|FG000|Overall Study|Withdrawal by Subject|1|||
146827932|NCT02175745|529540977|FG000|Overall Study|Not Eligible|1|||
146827933|NCT00983892|529540978|FG000|Overall Study|Withdrawal by Subject|10|||
146827934|NCT00983892|529540979|FG001|Overall Study|Withdrawal by Subject|12|||
146827935|NCT03028012|529540980|FG000|Overall Study|Lost to Follow-up|2|||
146827936|NCT03028012|529540981|FG001|Overall Study|Lost to Follow-up|3|||
146827937|NCT03028012|529540982|FG002|Overall Study|Lost to Follow-up|3|||
146827938|NCT01424189|529540994|FG000|Overall Study|Adverse Event|1|||
146827939|NCT01424189|529540995|FG001|Overall Study|Adverse Event|0|||
146827940|NCT01424189|529540994|FG000|Overall Study|Lost to Follow-up|4|||
146827941|NCT01424189|529540995|FG001|Overall Study|Lost to Follow-up|1|||
146827942|NCT01424189|529540994|FG000|Overall Study|Withdrawal by Subject|4|||
146827943|NCT01424189|529540995|FG001|Overall Study|Withdrawal by Subject|4|||
146827944|NCT01424189|529540994|FG000|Overall Study|Subject moved|1|||
146827945|NCT01424189|529540995|FG001|Overall Study|Subject moved|0|||
146827946|NCT01424189|529540994|FG000|Overall Study|Death|3|||
146827947|NCT01424189|529540995|FG001|Overall Study|Death|1|||
146827948|NCT04688086|529540996|FG000|Overall Study|Lost to Follow-up|164|||
146827949|NCT04688086|529540996|FG000|Overall Study|Imaging error;|64|||
146827950|NCT03120949|529540997|FG000|Overall Study|randomized in error|1|||
146827951|NCT03120949|529540998|FG001|Overall Study|randomized in error|0|||
146827952|NCT03120949|529540997|FG000|Overall Study|Death|13|||
146827953|NCT03120949|529540998|FG001|Overall Study|Death|13|||
146827954|NCT03120949|529540997|FG000|Overall Study|Lost to Follow-up|23|||
146827955|NCT03120949|529540998|FG001|Overall Study|Lost to Follow-up|13|||
146827956|NCT03120949|529540997|FG000|Overall Study|Withdrawal by Subject|139|||
146827957|NCT03120949|529540998|FG001|Overall Study|Withdrawal by Subject|124|||
146827958|NCT03120949|529540997|FG000|Overall Study|Covid-19|43|||
146827959|NCT03120949|529540998|FG001|Overall Study|Covid-19|34|||
146827960|NCT03120949|529540997|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
146827961|NCT03120949|529540998|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
146827962|NCT03120949|529540997|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
146827963|NCT03120949|529540998|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
146827964|NCT03120949|529540997|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
146827965|NCT03120949|529540998|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
146827966|NCT03120949|529540997|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
146827967|NCT03120949|529540998|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
146827968|NCT03120949|529540997|FG000|Overall Study|Site was closed|2|||
146827969|NCT03120949|529540998|FG001|Overall Study|Site was closed|3|||
146827970|NCT03120949|529540997|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
146827971|NCT03120949|529540998|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
146827972|NCT03120949|529540997|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
146827973|NCT03120949|529540998|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
146827974|NCT03120949|529540997|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
146827975|NCT03120949|529540998|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
146827976|NCT03120949|529540997|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
146827977|NCT03120949|529540998|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
146827978|NCT03120949|529540997|FG000|Overall Study|Other: Adverse Event|0|||
146827979|NCT03120949|529540998|FG001|Overall Study|Other: Adverse Event|1|||
146827980|NCT03120949|529540997|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
146827981|NCT03120949|529540998|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
146827982|NCT03120949|529540997|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
146827983|NCT03120949|529540998|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
146827984|NCT03120949|529540997|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
146827985|NCT03120949|529540998|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
146827986|NCT03120949|529540997|FG000|Overall Study|Personal Reasons|0|||
146827987|NCT03120949|529540998|FG001|Overall Study|Personal Reasons|1|||
146827988|NCT03120949|529540997|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
146827989|NCT03120949|529540998|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
146827990|NCT03120949|529540997|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
146827991|NCT03120949|529540998|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
146958143|NCT01856920|530006298|FG001|Overall Study|Refused further Treatment|1|||
146958144|NCT01856920|530006297|FG000|Overall Study|Other Reasons|0|||
146827992|NCT03120949|529540997|FG000|Overall Study|Compliance With Medication|0|||
146827993|NCT03120949|529540998|FG001|Overall Study|Compliance With Medication|1|||
146827994|NCT03120949|529540997|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
146827995|NCT03120949|529540998|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
146827996|NCT03120949|529540997|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
146827997|NCT03120949|529540998|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
146827998|NCT03120949|529540997|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
146827999|NCT03120949|529540998|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
146828000|NCT01705145|529540999|FG000|Part B|Adverse Event|1|||
146828001|NCT01203956|529541000|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
146828002|NCT01203956|529541001|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
146828003|NCT01329419|529541004|FG000|Overall Study|Protocol Violation|235|||
146828004|NCT04522778|529541005|FG000|Overall Study|Patient did not want to wear the device|1|||
146828005|NCT04522778|529541006|FG001|Overall Study|Patient did not want to wear the device|0|||
146828006|NCT04522778|529541005|FG000|Overall Study|Lost to Follow-up|0|||
146828007|NCT04522778|529541006|FG001|Overall Study|Lost to Follow-up|1|||
146828008|NCT00069277|529541009|FG000|Overall Study|Adverse Event|3|||
146828009|NCT00069277|529541009|FG000|Overall Study|Withdrawal by Subject|1|||
146828010|NCT00069277|529541009|FG000|Overall Study|Progressive Disease|15|||
146828011|NCT00069277|529541009|FG000|Overall Study|Physician Decision|2|||
146828012|NCT02230306|529541010|FG000|Overall Study|Did not receive study treatment|1|||
146828013|NCT01225159|529541011|FG000|Overall Study|Change operation|1|||
146828014|NCT01225159|529541012|FG001|Overall Study|Change operation|0|||
146828015|NCT00312845|529541016|FG000|Overall Study|Adverse Event|19|||
146828016|NCT00312845|529541017|FG001|Overall Study|Adverse Event|5|||
146828017|NCT00312845|529541016|FG000|Overall Study|Death|2|||
146828018|NCT00312845|529541017|FG001|Overall Study|Death|2|||
146828019|NCT00312845|529541016|FG000|Overall Study|Withdrawal by Subject|14|||
146828020|NCT00312845|529541017|FG001|Overall Study|Withdrawal by Subject|6|||
146828021|NCT00312845|529541016|FG000|Overall Study|Disease Progression|56|||
146828022|NCT00312845|529541017|FG001|Overall Study|Disease Progression|77|||
146828023|NCT00312845|529541016|FG000|Overall Study|Lost to Follow-up|2|||
146828024|NCT00312845|529541017|FG001|Overall Study|Lost to Follow-up|0|||
146828025|NCT00312845|529541016|FG000|Overall Study|Other|6|||
146828026|NCT00312845|529541017|FG001|Overall Study|Other|5|||
146828027|NCT03512288|529541020|FG000|Overall Study|Adverse Event|1|||
146828028|NCT03512288|529541021|FG001|Overall Study|Adverse Event|0|||
146828029|NCT03512288|529541020|FG000|Overall Study|Lost to Follow-up|12|||
146828030|NCT03512288|529541021|FG001|Overall Study|Lost to Follow-up|15|||
146828031|NCT03512288|529541020|FG000|Overall Study|Physician Decision|0|||
146828032|NCT03512288|529541021|FG001|Overall Study|Physician Decision|2|||
146828033|NCT03512288|529541020|FG000|Overall Study|Protocol Violation|6|||
146828034|NCT03512288|529541021|FG001|Overall Study|Protocol Violation|4|||
146828035|NCT03512288|529541020|FG000|Overall Study|Medication error without associated adverse event|1|||
146828036|NCT03512288|529541021|FG001|Overall Study|Medication error without associated adverse event|0|||
146828037|NCT03512288|529541020|FG000|Overall Study|No longer met eligibility criteria|5|||
146828038|NCT03512288|529541021|FG001|Overall Study|No longer met eligibility criteria|2|||
146828039|NCT03512288|529541020|FG000|Overall Study|Withdrawal by parent/guardian|14|||
146828040|NCT03512288|529541021|FG001|Overall Study|Withdrawal by parent/guardian|18|||
146828041|NCT03512288|529541020|FG000|Overall Study|Other|1|||
146828042|NCT03512288|529541021|FG001|Overall Study|Other|1|||
146828043|NCT03512288|529541020|FG000|Overall Study|Randomized but not treated|1|||
146828044|NCT03512288|529541021|FG001|Overall Study|Randomized but not treated|1|||
146828045|NCT01078584|529541022|FG000|Overall Study|Final Status Unknown|1073|||
146828046|NCT01078584|529541022|FG000|Overall Study|Lost to Follow-up|670|||
146828047|NCT01078584|529541022|FG000|Overall Study|Non-serious Adverse Event|577|||
146828048|NCT01078584|529541022|FG000|Overall Study|Withdrawal of Consent|244|||
146828049|NCT01078584|529541022|FG000|Overall Study|Physician Withdrew from Study|90|||
146828050|NCT01078584|529541022|FG000|Overall Study|Non-compliance|67|||
146828051|NCT01078584|529541022|FG000|Overall Study|Blood Pressure Controlled|49|||
146828052|NCT01078584|529541022|FG000|Overall Study|Physician Switched Medication|26|||
146828053|NCT01078584|529541022|FG000|Overall Study|Physician Discontinued Patient|12|||
146828054|NCT01078584|529541022|FG000|Overall Study|Lack of Efficacy|98|||
146828055|NCT01078584|529541022|FG000|Overall Study|Protocol Violation|75|||
146828056|NCT01078584|529541022|FG000|Overall Study|Serious Adverse Event|27|||
146828057|NCT01078584|529541022|FG000|Overall Study|Multiple Reasons|2|||
146828058|NCT01208870|529541023|FG000|Overall Study|Lost to Follow-up|2|||
146828059|NCT01208870|529541024|FG001|Overall Study|Lost to Follow-up|8|||
146828060|NCT01121185|529541025|FG000|Overall Study|Not infused|0|||
146828061|NCT01121185|529541026|FG001|Overall Study|Not infused|1|||
146828062|NCT01121185|529541025|FG000|Overall Study|Not transplanted|1|||
146828063|NCT01121185|529541026|FG001|Overall Study|Not transplanted|0|||
146828064|NCT00424177|529541027|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
146828065|NCT00424177|529541027|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
146958145|NCT01856920|530006298|FG001|Overall Study|Other Reasons|1|||
146828066|NCT00424177|529541027|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
146828067|NCT00424177|529541027|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
146828068|NCT00424177|529541027|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
146828069|NCT00424177|529541027|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
146828070|NCT00424177|529541027|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
146828071|NCT00424177|529541027|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
146828072|NCT00424177|529541027|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
146828073|NCT00424177|529541027|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
146828074|NCT00316589|529541030|FG000|Overall Study|Withdrawal by Subject|0|||
146828075|NCT00316589|529541031|FG001|Overall Study|Withdrawal by Subject|5|||
146828076|NCT00316589|529541032|FG002|Overall Study|Withdrawal by Subject|0|||
146828077|NCT00316589|529541033|FG003|Overall Study|Withdrawal by Subject|1|||
146828078|NCT00316589|529541030|FG000|Overall Study|Subject unwilling/unable to comply|0|||
146828079|NCT00316589|529541031|FG001|Overall Study|Subject unwilling/unable to comply|6|||
146828080|NCT00316589|529541032|FG002|Overall Study|Subject unwilling/unable to comply|0|||
146828081|NCT00316589|529541033|FG003|Overall Study|Subject unwilling/unable to comply|2|||
146828082|NCT00316589|529541030|FG000|Overall Study|Adverse Event|1|||
146828083|NCT00316589|529541031|FG001|Overall Study|Adverse Event|0|||
146828084|NCT00316589|529541032|FG002|Overall Study|Adverse Event|0|||
146828085|NCT00316589|529541033|FG003|Overall Study|Adverse Event|1|||
146828086|NCT00316589|529541030|FG000|Overall Study|Physician Decision|0|||
146828087|NCT00316589|529541031|FG001|Overall Study|Physician Decision|1|||
146828088|NCT00316589|529541032|FG002|Overall Study|Physician Decision|0|||
146828089|NCT00316589|529541033|FG003|Overall Study|Physician Decision|0|||
146828090|NCT00316589|529541030|FG000|Overall Study|Other reason|0|||
146828091|NCT00316589|529541031|FG001|Overall Study|Other reason|12|||
146828092|NCT00316589|529541032|FG002|Overall Study|Other reason|1|||
146828093|NCT00316589|529541033|FG003|Overall Study|Other reason|1|||
146828094|NCT03325608|529541034|FG000|Overall Study|Lost to Follow-up|23|||
146828095|NCT03325608|529541035|FG001|Overall Study|Lost to Follow-up|23|||
146828096|NCT03325608|529541036|FG002|Overall Study|Lost to Follow-up|30|||
146828097|NCT03325608|529541037|FG003|Overall Study|Lost to Follow-up|30|||
146828098|NCT03325608|529541034|FG000|Overall Study|Death of Caregiver|0|||
146828099|NCT03325608|529541035|FG001|Overall Study|Death of Caregiver|0|||
146828100|NCT03325608|529541036|FG002|Overall Study|Death of Caregiver|2|||
146828101|NCT03325608|529541037|FG003|Overall Study|Death of Caregiver|2|||
146828102|NCT03325608|529541034|FG000|Overall Study|Death of Care Recipient|34|||
146828103|NCT03325608|529541035|FG001|Overall Study|Death of Care Recipient|34|||
146828104|NCT03325608|529541036|FG002|Overall Study|Death of Care Recipient|28|||
146828105|NCT03325608|529541037|FG003|Overall Study|Death of Care Recipient|28|||
146828106|NCT03325608|529541034|FG000|Overall Study|Withdrawal by Subject|49|||
146828107|NCT03325608|529541035|FG001|Overall Study|Withdrawal by Subject|49|||
146828108|NCT03325608|529541036|FG002|Overall Study|Withdrawal by Subject|35|||
146828109|NCT03325608|529541037|FG003|Overall Study|Withdrawal by Subject|35|||
146828110|NCT03325608|529541034|FG000|Overall Study|Ineligible|7|||
146828111|NCT03325608|529541035|FG001|Overall Study|Ineligible|7|||
146828112|NCT03325608|529541036|FG002|Overall Study|Ineligible|5|||
146828113|NCT03325608|529541037|FG003|Overall Study|Ineligible|5|||
146828114|NCT02250183|529541038|FG000|Overall Study|Withdrawal by Subject|2|||
146828115|NCT02250183|529541038|FG000|Overall Study|Adverse Event|5|||
146828116|NCT02250183|529541038|FG000|Overall Study|Lost to Follow-up|1|||
146828117|NCT03282799|529541039|FG000|Overall Study|Pregnancy|1|||
146828118|NCT03282799|529541040|FG001|Overall Study|Pregnancy|0|||
146828119|NCT03282799|529541039|FG000|Overall Study|Physician Decision|1|||
146828120|NCT03282799|529541040|FG001|Overall Study|Physician Decision|0|||
146828121|NCT03614676|529543153|FG000|Overall Study|Delivery before planned visit|2|||
146828122|NCT03614676|529543154|FG001|Overall Study|Delivery before planned visit|0|||
146828123|NCT03614676|529543153|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
146828124|NCT03614676|529543154|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
146828125|NCT03614676|529543153|FG000|Overall Study|Migrated / moved from the study area|30|||
146828126|NCT03614676|529543154|FG001|Overall Study|Migrated / moved from the study area|22|||
146958146|NCT01856920|530006297|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
146958147|NCT01856920|530006298|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
146958148|NCT02545270|530006300|FG000|Overall Study|technical difficulties|0|||
146958149|NCT02545270|530006301|FG001|Overall Study|technical difficulties|1|||
146828127|NCT03614676|529543153|FG000|Overall Study|Lost to Follow-up|17|||
146828128|NCT03614676|529543154|FG001|Overall Study|Lost to Follow-up|42|||
146958150|NCT02545270|530006302|FG002|Overall Study|technical difficulties|0|||
146828129|NCT03614676|529543153|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
146828130|NCT03614676|529543154|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
146828131|NCT03614676|529543153|FG000|Overall Study|Other|16|||
146828132|NCT03614676|529543154|FG001|Overall Study|Other|47|||
146828133|NCT03614676|529543153|FG000|Overall Study|Protocol Violation|0|||
146828134|NCT03614676|529543154|FG001|Overall Study|Protocol Violation|2|||
146828135|NCT03614676|529543153|FG000|Overall Study|Neonatal event of interest|0|||
146828136|NCT03614676|529543154|FG001|Overall Study|Neonatal event of interest|6|||
146828137|NCT03614676|529543153|FG000|Overall Study|Death in infant greater than 28 days old|0|||
146828138|NCT03614676|529543154|FG001|Overall Study|Death in infant greater than 28 days old|12|||
146828139|NCT03614676|529543153|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
146828140|NCT03614676|529543154|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
146828141|NCT02080403|529543155|FG000|Overall Study|Adverse Event|5|||
146828142|NCT02080403|529543156|FG001|Overall Study|Adverse Event|1|||
146828143|NCT02080403|529543155|FG000|Overall Study|Death|0|||
146828144|NCT02080403|529543156|FG001|Overall Study|Death|2|||
146828145|NCT02080403|529543155|FG000|Overall Study|Lost to Follow-up|2|||
146828146|NCT02080403|529543156|FG001|Overall Study|Lost to Follow-up|0|||
146828147|NCT02080403|529543155|FG000|Overall Study|Pregnancy|0|||
146828148|NCT02080403|529543156|FG001|Overall Study|Pregnancy|1|||
146828149|NCT02080403|529543155|FG000|Overall Study|Protocol Violation|3|||
146828150|NCT02080403|529543156|FG001|Overall Study|Protocol Violation|7|||
146828151|NCT02080403|529543155|FG000|Overall Study|Withdrawal by Subject|5|||
146828152|NCT02080403|529543156|FG001|Overall Study|Withdrawal by Subject|1|||
146828153|NCT01999972|529543157|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
146828154|NCT01999972|529543158|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
146828155|NCT01999972|529543159|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
146828156|NCT01999972|529543160|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
146828157|NCT01999972|529543161|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
146828158|NCT01999972|529543162|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
146828159|NCT01999972|529543157|FG000|Dose Escalation Part|Death|0|||
146828160|NCT01999972|529543158|FG001|Dose Escalation Part|Death|1|||
146828161|NCT01999972|529543159|FG002|Dose Escalation Part|Death|0|||
146828162|NCT01999972|529543160|FG003|Dose Escalation Part|Death|0|||
146828163|NCT01999972|529543161|FG004|Dose Escalation Part|Death|0|||
146828164|NCT01999972|529543162|FG005|Dose Escalation Part|Death|0|||
146828165|NCT01999972|529543157|FG000|Dose Escalation Part|Enrolled but not treated|0|||
146828166|NCT01999972|529543158|FG001|Dose Escalation Part|Enrolled but not treated|0|||
146828167|NCT01999972|529543159|FG002|Dose Escalation Part|Enrolled but not treated|1|||
146828168|NCT01999972|529543160|FG003|Dose Escalation Part|Enrolled but not treated|1|||
146828169|NCT01999972|529543161|FG004|Dose Escalation Part|Enrolled but not treated|0|||
146828170|NCT01999972|529543162|FG005|Dose Escalation Part|Enrolled but not treated|0|||
146828171|NCT01999972|529543157|FG000|Dose Escalation Part|Disease progression|3|||
146828172|NCT01999972|529543158|FG001|Dose Escalation Part|Disease progression|2|||
146828173|NCT01999972|529543159|FG002|Dose Escalation Part|Disease progression|3|||
146828174|NCT01999972|529543160|FG003|Dose Escalation Part|Disease progression|6|||
146828175|NCT01999972|529543161|FG004|Dose Escalation Part|Disease progression|0|||
146828176|NCT01999972|529543162|FG005|Dose Escalation Part|Disease progression|0|||
146828177|NCT01999972|529543157|FG000|Dose Escalation Part|Adverse Event|0|||
146828178|NCT01999972|529543158|FG001|Dose Escalation Part|Adverse Event|0|||
146828179|NCT01999972|529543159|FG002|Dose Escalation Part|Adverse Event|0|||
146828180|NCT01999972|529543160|FG003|Dose Escalation Part|Adverse Event|2|||
146828181|NCT01999972|529543161|FG004|Dose Escalation Part|Adverse Event|0|||
146828182|NCT01999972|529543162|FG005|Dose Escalation Part|Adverse Event|0|||
146828183|NCT01999972|529543157|FG000|Dose Escalation Part|Global deterioration of health status|1|||
146828184|NCT01999972|529543158|FG001|Dose Escalation Part|Global deterioration of health status|0|||
146828185|NCT01999972|529543159|FG002|Dose Escalation Part|Global deterioration of health status|0|||
146828186|NCT01999972|529543160|FG003|Dose Escalation Part|Global deterioration of health status|1|||
146828187|NCT01999972|529543161|FG004|Dose Escalation Part|Global deterioration of health status|0|||
146828188|NCT01999972|529543162|FG005|Dose Escalation Part|Global deterioration of health status|0|||
146828189|NCT01999972|529543157|FG000|Dose Expansion Part|Death|0|||
146828190|NCT01999972|529543158|FG001|Dose Expansion Part|Death|0|||
146828191|NCT01999972|529543159|FG002|Dose Expansion Part|Death|0|||
146828192|NCT01999972|529543160|FG003|Dose Expansion Part|Death|0|||
146828193|NCT01999972|529543161|FG004|Dose Expansion Part|Death|2|||
146828194|NCT01999972|529543162|FG005|Dose Expansion Part|Death|1|||
146828195|NCT01999972|529543157|FG000|Dose Expansion Part|Disease progression|0|||
146828196|NCT01999972|529543158|FG001|Dose Expansion Part|Disease progression|0|||
146828197|NCT01999972|529543159|FG002|Dose Expansion Part|Disease progression|0|||
146828198|NCT01999972|529543160|FG003|Dose Expansion Part|Disease progression|0|||
146828199|NCT01999972|529543161|FG004|Dose Expansion Part|Disease progression|9|||
146828200|NCT01999972|529543162|FG005|Dose Expansion Part|Disease progression|3|||
146828201|NCT01999972|529543157|FG000|Dose Expansion Part|Sponsor decision|0|||
146828202|NCT01999972|529543158|FG001|Dose Expansion Part|Sponsor decision|0|||
146828203|NCT01999972|529543159|FG002|Dose Expansion Part|Sponsor decision|0|||
146828204|NCT01999972|529543160|FG003|Dose Expansion Part|Sponsor decision|0|||
146828205|NCT01999972|529543161|FG004|Dose Expansion Part|Sponsor decision|1|||
146828206|NCT01999972|529543162|FG005|Dose Expansion Part|Sponsor decision|0|||
146828207|NCT01999972|529543157|FG000|Dose Expansion Part|Adverse Event|0|||
146828208|NCT01999972|529543158|FG001|Dose Expansion Part|Adverse Event|0|||
146828209|NCT01999972|529543159|FG002|Dose Expansion Part|Adverse Event|0|||
146828210|NCT01999972|529543160|FG003|Dose Expansion Part|Adverse Event|0|||
146828211|NCT01999972|529543161|FG004|Dose Expansion Part|Adverse Event|4|||
146828212|NCT01999972|529543162|FG005|Dose Expansion Part|Adverse Event|2|||
146828213|NCT01999972|529543157|FG000|Dose Expansion Part|Participant's non-compliance|0|||
146828214|NCT01999972|529543158|FG001|Dose Expansion Part|Participant's non-compliance|0|||
146828215|NCT01999972|529543159|FG002|Dose Expansion Part|Participant's non-compliance|0|||
146828216|NCT01999972|529543160|FG003|Dose Expansion Part|Participant's non-compliance|0|||
146828217|NCT01999972|529543161|FG004|Dose Expansion Part|Participant's non-compliance|0|||
146828218|NCT01999972|529543162|FG005|Dose Expansion Part|Participant's non-compliance|1|||
146828219|NCT01999972|529543157|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
146828220|NCT01999972|529543158|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
146828221|NCT01999972|529543159|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
146828222|NCT01999972|529543160|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
146828223|NCT01999972|529543161|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
146828224|NCT01999972|529543162|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
146828225|NCT01999972|529543157|FG000|Dose Expansion Part|Changed to standard of care|0|||
146828226|NCT01999972|529543158|FG001|Dose Expansion Part|Changed to standard of care|0|||
146828227|NCT01999972|529543159|FG002|Dose Expansion Part|Changed to standard of care|0|||
146828228|NCT01999972|529543160|FG003|Dose Expansion Part|Changed to standard of care|0|||
146828229|NCT01999972|529543161|FG004|Dose Expansion Part|Changed to standard of care|1|||
146828230|NCT01999972|529543162|FG005|Dose Expansion Part|Changed to standard of care|0|||
146828231|NCT02210208|529543163|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
146828232|NCT02210208|529543163|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
146828233|NCT02210208|529543163|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
146828234|NCT01171183|529543164|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
146828235|NCT01171183|529543165|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
146828236|NCT01171183|529543164|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
146828237|NCT01171183|529543165|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
146828238|NCT01171183|529543164|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
146828239|NCT01171183|529543165|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
146828240|NCT01171183|529543164|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
146828241|NCT01171183|529543165|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
146828242|NCT01171183|529543164|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
146828243|NCT01171183|529543165|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
146828244|NCT01171183|529543164|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
146828245|NCT01171183|529543165|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
146828246|NCT01101334|529543166|FG000|Overall Study|Adverse Event|9|||
146828247|NCT01101334|529543167|FG001|Overall Study|Adverse Event|4|||
146828248|NCT01101334|529543166|FG000|Overall Study|Death|7|||
146828249|NCT01101334|529543167|FG001|Overall Study|Death|1|||
146828250|NCT01101334|529543166|FG000|Overall Study|Withdrawal by Subject|4|||
146828251|NCT01101334|529543167|FG001|Overall Study|Withdrawal by Subject|3|||
146828252|NCT01101334|529543166|FG000|Overall Study|Withdrawal by Sponsor|1|||
146958151|NCT02545270|530006300|FG000|Overall Study|Videos being too similar to other|0|||
146958152|NCT02545270|530006301|FG001|Overall Study|Videos being too similar to other|0|||
146958153|NCT02545270|530006302|FG002|Overall Study|Videos being too similar to other|2|||
146958154|NCT04594213|530006308|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
146958155|NCT04594213|530006309|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
146958156|NCT04594213|530006310|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
146958157|NCT04594213|530006311|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
146958158|NCT04594213|530006312|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
146958159|NCT04594213|530006313|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
146958160|NCT04594213|530006308|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
146958161|NCT04594213|530006309|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
146958162|NCT04594213|530006310|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
146958163|NCT04594213|530006311|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
146958164|NCT04594213|530006312|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
146958165|NCT04594213|530006313|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
146958166|NCT04594213|530006308|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
146958167|NCT04594213|530006309|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
146958168|NCT04594213|530006310|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
146958169|NCT04594213|530006311|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
146958170|NCT04594213|530006312|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
146958171|NCT04594213|530006313|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
146958172|NCT04594213|530006308|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146958173|NCT04594213|530006309|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146828253|NCT01101334|529543167|FG001|Overall Study|Withdrawal by Sponsor|1|||
146828254|NCT01101334|529543166|FG000|Overall Study|Progressive Disease|22|||
146828255|NCT01101334|529543167|FG001|Overall Study|Progressive Disease|35|||
146828256|NCT01101334|529543166|FG000|Overall Study|Other|2|||
146828257|NCT01101334|529543167|FG001|Overall Study|Other|1|||
146828258|NCT03440047|529543168|FG000|Overall Study|Withdrawal by Subject|2|||
146828259|NCT01181609|529543169|FG000|Overall Study|Adverse Event|1|||
146828260|NCT01181609|529543169|FG000|Overall Study|Withdrawal by Subject|1|||
146828261|NCT01181609|529543169|FG000|Overall Study|Lost to Follow-up|1|||
146828262|NCT01181609|529543169|FG000|Overall Study|Death|50|||
146828263|NCT01722045|529543170|FG000|Overall Study|Adverse Event|8|||
146828264|NCT01722045|529543170|FG000|Overall Study|Death|3|||
146828265|NCT01722045|529543170|FG000|Overall Study|Withdrawal by Subject|8|||
146828266|NCT01722045|529543170|FG000|Overall Study|Lost to Follow-up|4|||
146828267|NCT01722045|529543170|FG000|Overall Study|Protocol Deviation|1|||
146828268|NCT01722045|529543170|FG000|Overall Study|Physician Decision|3|||
146828269|NCT01722045|529543170|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
146828270|NCT00612352|529543171|FG000|Overall Study|Adverse Event|1|||
146828271|NCT00612352|529543172|FG001|Overall Study|Adverse Event|0|||
146828272|NCT00612352|529543171|FG000|Overall Study|Withdrawal by Subject|3|||
146828273|NCT00612352|529543172|FG001|Overall Study|Withdrawal by Subject|5|||
146828274|NCT00612352|529543171|FG000|Overall Study|moved out of state|1|||
146828275|NCT00612352|529543172|FG001|Overall Study|moved out of state|0|||
146828276|NCT00612352|529543171|FG000|Overall Study|didn't return calls/show up on test date|4|||
146828277|NCT00612352|529543172|FG001|Overall Study|didn't return calls/show up on test date|1|||
146828278|NCT02161406|529543173|FG000|Overall Study|Death|2|||
146828279|NCT02161406|529543174|FG001|Overall Study|Death|1|||
146828280|NCT02161406|529543173|FG000|Overall Study|Lost to Follow-up|2|||
146828281|NCT02161406|529543174|FG001|Overall Study|Lost to Follow-up|1|||
146828282|NCT02161406|529543173|FG000|Overall Study|Withdrawal by Subject|2|||
146828283|NCT02161406|529543174|FG001|Overall Study|Withdrawal by Subject|4|||
146828284|NCT02161406|529543173|FG000|Overall Study|investigator withdrew subject|3|||
146828285|NCT02161406|529543174|FG001|Overall Study|investigator withdrew subject|1|||
146828286|NCT02161406|529543173|FG000|Overall Study|Lack of Efficacy|1|||
146828287|NCT02161406|529543174|FG001|Overall Study|Lack of Efficacy|1|||
146828288|NCT02161406|529543173|FG000|Overall Study|relocation|0|||
146828289|NCT02161406|529543174|FG001|Overall Study|relocation|1|||
146828290|NCT00263211|529543177|FG000|Overall Study|Death|1|||
146828291|NCT00263211|529543178|FG001|Overall Study|Death|0|||
146828292|NCT00263211|529543177|FG000|Overall Study|Withdrawal by Subject|3|||
146828293|NCT00263211|529543178|FG001|Overall Study|Withdrawal by Subject|0|||
146828294|NCT00263211|529543177|FG000|Overall Study|Protocol Violation|1|||
146828295|NCT00263211|529543178|FG001|Overall Study|Protocol Violation|0|||
146828296|NCT00263211|529543177|FG000|Overall Study|Disease Progression|0|||
146828297|NCT00263211|529543178|FG001|Overall Study|Disease Progression|1|||
146828298|NCT02034162|529543179|FG000|Double-blind|Lost to Follow-up|3|||
146828299|NCT02034162|529543180|FG001|Double-blind|Lost to Follow-up|0|||
146828300|NCT02034162|529543181|FG002|Double-blind|Lost to Follow-up|0|||
146828301|NCT02034162|529543179|FG000|Double-blind|Physician Decision|1|||
146828302|NCT02034162|529543180|FG001|Double-blind|Physician Decision|0|||
146828303|NCT02034162|529543181|FG002|Double-blind|Physician Decision|0|||
146828304|NCT02034162|529543179|FG000|Double-blind|Protocol Violation|0|||
146828305|NCT02034162|529543180|FG001|Double-blind|Protocol Violation|1|||
146828306|NCT02034162|529543181|FG002|Double-blind|Protocol Violation|0|||
146828307|NCT02034162|529543179|FG000|Double-blind|Withdrawal by Subject|5|||
146828308|NCT02034162|529543180|FG001|Double-blind|Withdrawal by Subject|7|||
146828309|NCT02034162|529543181|FG002|Double-blind|Withdrawal by Subject|0|||
146828310|NCT00760513|529543182|FG000|Overall Study|Withdrawal by Subject|5|||
146828311|NCT00760513|529543183|FG001|Overall Study|Withdrawal by Subject|7|||
146828312|NCT04333147|529543189|FG000|Overall Study|Adverse Event|43|||
146828313|NCT04333147|529543190|FG001|Overall Study|Adverse Event|40|||
146828314|NCT04333147|529543189|FG000|Overall Study|Lack of Efficacy|49|||
146828315|NCT04333147|529543190|FG001|Overall Study|Lack of Efficacy|48|||
146828316|NCT04333147|529543189|FG000|Overall Study|Lost to Follow-up|19|||
146828317|NCT04333147|529543190|FG001|Overall Study|Lost to Follow-up|16|||
146828318|NCT04333147|529543189|FG000|Overall Study|Physician Decision|17|||
146828319|NCT04333147|529543190|FG001|Overall Study|Physician Decision|20|||
146828320|NCT04333147|529543189|FG000|Overall Study|Withdrawal by Subject|65|||
146828321|NCT04333147|529543190|FG001|Overall Study|Withdrawal by Subject|68|||
146828322|NCT04333147|529543189|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
146828323|NCT04333147|529543190|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
146828324|NCT04333147|529543189|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
146828325|NCT04333147|529543190|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
146828326|NCT04333147|529543189|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
146828327|NCT04333147|529543190|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
146828328|NCT04606199|529543191|FG000|Overall Study|Withdrawal by Subject|2|||
146828329|NCT03596242|529543192|FG000|Overall Study|Lost to Follow-up|2|||
146828330|NCT03596242|529543193|FG001|Overall Study|Lost to Follow-up|2|||
146828331|NCT00706914|529543194|FG000|Overall Study|Lack of Efficacy|0|||
146828332|NCT00706914|529543195|FG001|Overall Study|Lack of Efficacy|1|||
146828333|NCT00706914|529543196|FG002|Overall Study|Lack of Efficacy|0|||
146828334|NCT00706914|529543194|FG000|Overall Study|Lost to Follow-up|1|||
146828335|NCT00706914|529543195|FG001|Overall Study|Lost to Follow-up|0|||
146828336|NCT00706914|529543196|FG002|Overall Study|Lost to Follow-up|0|||
146828337|NCT00706914|529543194|FG000|Overall Study|Adverse Event|2|||
146828338|NCT00706914|529543195|FG001|Overall Study|Adverse Event|2|||
146828339|NCT00706914|529543196|FG002|Overall Study|Adverse Event|0|||
146828340|NCT00706914|529543194|FG000|Overall Study|Protocol Violation|3|||
146828341|NCT00706914|529543195|FG001|Overall Study|Protocol Violation|1|||
146828342|NCT00706914|529543196|FG002|Overall Study|Protocol Violation|1|||
146828343|NCT00916305|529543197|FG000|Overall Study|Lost to Follow-up|21|||
146828344|NCT00916305|529543198|FG001|Overall Study|Lost to Follow-up|27|||
146828345|NCT00916305|529543197|FG000|Overall Study|Withdrawal by Subject|0|||
146828346|NCT00916305|529543198|FG001|Overall Study|Withdrawal by Subject|1|||
146828347|NCT01475461|529543201|FG000|Run-in Period|Not meet eligibility criteria|16|||
146828348|NCT01475461|529543202|FG001|Run-in Period|Not meet eligibility criteria|0|||
146828349|NCT01475461|529543203|FG002|Run-in Period|Not meet eligibility criteria|0|||
146828350|NCT01475461|529543204|FG003|Run-in Period|Not meet eligibility criteria|0|||
146828351|NCT01475461|529543205|FG004|Run-in Period|Not meet eligibility criteria|0|||
146828352|NCT01475461|529543206|FG005|Run-in Period|Not meet eligibility criteria|0|||
146828353|NCT01475461|529543207|FG006|Run-in Period|Not meet eligibility criteria|0|||
146828354|NCT01475461|529543201|FG000|Run-in Period|Lost to Follow-up|7|||
146828355|NCT01475461|529543202|FG001|Run-in Period|Lost to Follow-up|0|||
146828356|NCT01475461|529543203|FG002|Run-in Period|Lost to Follow-up|0|||
146828357|NCT01475461|529543204|FG003|Run-in Period|Lost to Follow-up|0|||
146828358|NCT01475461|529543205|FG004|Run-in Period|Lost to Follow-up|0|||
146828359|NCT01475461|529543206|FG005|Run-in Period|Lost to Follow-up|0|||
146828360|NCT01475461|529543207|FG006|Run-in Period|Lost to Follow-up|0|||
146828361|NCT01475461|529543201|FG000|Run-in Period|Withdrawal by Subject|11|||
146828362|NCT01475461|529543202|FG001|Run-in Period|Withdrawal by Subject|0|||
146828363|NCT01475461|529543203|FG002|Run-in Period|Withdrawal by Subject|0|||
146828364|NCT01475461|529543204|FG003|Run-in Period|Withdrawal by Subject|0|||
146828365|NCT01475461|529543205|FG004|Run-in Period|Withdrawal by Subject|0|||
146828366|NCT01475461|529543206|FG005|Run-in Period|Withdrawal by Subject|0|||
146828367|NCT01475461|529543207|FG006|Run-in Period|Withdrawal by Subject|0|||
146828368|NCT01475461|529543201|FG000|Run-in Period|Other|3|||
146828369|NCT01475461|529543202|FG001|Run-in Period|Other|0|||
146828370|NCT01475461|529543203|FG002|Run-in Period|Other|0|||
146828371|NCT01475461|529543204|FG003|Run-in Period|Other|0|||
146828372|NCT01475461|529543205|FG004|Run-in Period|Other|0|||
146828373|NCT01475461|529543206|FG005|Run-in Period|Other|0|||
146828374|NCT01475461|529543207|FG006|Run-in Period|Other|0|||
146828375|NCT01475461|529543201|FG000|Run-in Period|Protocol Violation|4|||
146828376|NCT01475461|529543202|FG001|Run-in Period|Protocol Violation|0|||
146828377|NCT01475461|529543203|FG002|Run-in Period|Protocol Violation|0|||
146828378|NCT01475461|529543204|FG003|Run-in Period|Protocol Violation|0|||
146828379|NCT01475461|529543205|FG004|Run-in Period|Protocol Violation|0|||
146828380|NCT01475461|529543206|FG005|Run-in Period|Protocol Violation|0|||
146828381|NCT01475461|529543207|FG006|Run-in Period|Protocol Violation|0|||
146828382|NCT01475461|529543201|FG000|Treatment Period|Death|0|||
146828383|NCT01475461|529543202|FG001|Treatment Period|Death|0|||
146828384|NCT01475461|529543203|FG002|Treatment Period|Death|0|||
146828385|NCT01475461|529543204|FG003|Treatment Period|Death|1|||
146828386|NCT01475461|529543205|FG004|Treatment Period|Death|0|||
146828387|NCT01475461|529543206|FG005|Treatment Period|Death|0|||
146828388|NCT01475461|529543207|FG006|Treatment Period|Death|0|||
146828389|NCT01475461|529543201|FG000|Treatment Period|Lost to Follow-up|0|||
146958174|NCT04594213|530006310|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146958175|NCT04594213|530006311|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146958176|NCT04594213|530006312|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
146958177|NCT04594213|530006313|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146958178|NCT04594213|530006308|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
146958179|NCT04594213|530006309|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
146828390|NCT01475461|529543202|FG001|Treatment Period|Lost to Follow-up|3|||
146828391|NCT01475461|529543203|FG002|Treatment Period|Lost to Follow-up|2|||
146828392|NCT01475461|529543204|FG003|Treatment Period|Lost to Follow-up|3|||
146828393|NCT01475461|529543205|FG004|Treatment Period|Lost to Follow-up|1|||
146828394|NCT01475461|529543206|FG005|Treatment Period|Lost to Follow-up|2|||
146828395|NCT01475461|529543207|FG006|Treatment Period|Lost to Follow-up|1|||
146828396|NCT01475461|529543201|FG000|Treatment Period|Withdrawal by Subject|0|||
146828397|NCT01475461|529543202|FG001|Treatment Period|Withdrawal by Subject|2|||
146828398|NCT01475461|529543203|FG002|Treatment Period|Withdrawal by Subject|2|||
146828399|NCT01475461|529543204|FG003|Treatment Period|Withdrawal by Subject|0|||
146828400|NCT01475461|529543205|FG004|Treatment Period|Withdrawal by Subject|2|||
146828401|NCT01475461|529543206|FG005|Treatment Period|Withdrawal by Subject|2|||
146828402|NCT01475461|529543207|FG006|Treatment Period|Withdrawal by Subject|0|||
146828403|NCT01475461|529543201|FG000|Treatment Period|Other|0|||
146828404|NCT01475461|529543202|FG001|Treatment Period|Other|1|||
146828405|NCT01475461|529543203|FG002|Treatment Period|Other|0|||
146828406|NCT01475461|529543204|FG003|Treatment Period|Other|0|||
146828407|NCT01475461|529543205|FG004|Treatment Period|Other|0|||
146828408|NCT01475461|529543206|FG005|Treatment Period|Other|0|||
146828409|NCT01475461|529543207|FG006|Treatment Period|Other|0|||
146828410|NCT01475461|529543201|FG000|Treatment Period|Protocol Violation|0|||
146828411|NCT01475461|529543202|FG001|Treatment Period|Protocol Violation|1|||
146828412|NCT01475461|529543203|FG002|Treatment Period|Protocol Violation|0|||
146828413|NCT01475461|529543204|FG003|Treatment Period|Protocol Violation|0|||
146828414|NCT01475461|529543205|FG004|Treatment Period|Protocol Violation|0|||
146828415|NCT01475461|529543206|FG005|Treatment Period|Protocol Violation|0|||
146828416|NCT01475461|529543207|FG006|Treatment Period|Protocol Violation|1|||
146828417|NCT01475461|529543201|FG000|Treatment Period|Lack of Efficacy|0|||
146828418|NCT01475461|529543202|FG001|Treatment Period|Lack of Efficacy|2|||
146828419|NCT01475461|529543203|FG002|Treatment Period|Lack of Efficacy|0|||
146828420|NCT01475461|529543204|FG003|Treatment Period|Lack of Efficacy|2|||
146828421|NCT01475461|529543205|FG004|Treatment Period|Lack of Efficacy|1|||
146828422|NCT01475461|529543206|FG005|Treatment Period|Lack of Efficacy|1|||
146828423|NCT01475461|529543207|FG006|Treatment Period|Lack of Efficacy|0|||
146828424|NCT01475461|529543201|FG000|Treatment Period|Medication Error|0|||
146828425|NCT01475461|529543202|FG001|Treatment Period|Medication Error|0|||
146828426|NCT01475461|529543203|FG002|Treatment Period|Medication Error|0|||
146828427|NCT01475461|529543204|FG003|Treatment Period|Medication Error|1|||
146828428|NCT01475461|529543205|FG004|Treatment Period|Medication Error|0|||
146828429|NCT01475461|529543206|FG005|Treatment Period|Medication Error|0|||
146828430|NCT01475461|529543207|FG006|Treatment Period|Medication Error|0|||
146828431|NCT01475461|529543201|FG000|Treatment Period|Adverse Event|0|||
146828432|NCT01475461|529543202|FG001|Treatment Period|Adverse Event|0|||
146828433|NCT01475461|529543203|FG002|Treatment Period|Adverse Event|0|||
146828434|NCT01475461|529543204|FG003|Treatment Period|Adverse Event|1|||
146828435|NCT01475461|529543205|FG004|Treatment Period|Adverse Event|0|||
146828436|NCT01475461|529543206|FG005|Treatment Period|Adverse Event|0|||
146828437|NCT01475461|529543207|FG006|Treatment Period|Adverse Event|0|||
146828438|NCT04545476|529543212|FG000|Overall Study|Lost to Follow-up|1|||
146828439|NCT04545476|529543213|FG001|Overall Study|Lost to Follow-up|1|||
146828440|NCT04545476|529543214|FG002|Overall Study|Lost to Follow-up|0|||
146828441|NCT04545476|529543215|FG003|Overall Study|Lost to Follow-up|0|||
146828442|NCT04035577|529543220|FG000|Overall Study|Lost to Follow-up|1|||
146828443|NCT04035577|529543220|FG000|Overall Study|Withdrawal by Subject|1|||
146828444|NCT00505414|529543222|FG000|Titration Phase|Adverse Event|0|||
146828445|NCT00505414|529543223|FG001|Titration Phase|Adverse Event|0|||
146828446|NCT00505414|529543224|FG002|Titration Phase|Adverse Event|0|||
146828447|NCT00505414|529543225|FG003|Titration Phase|Adverse Event|8|||
146828448|NCT00505414|529543226|FG004|Titration Phase|Adverse Event|3|||
146828449|NCT00505414|529543222|FG000|Titration Phase|Death|0|||
146828450|NCT00505414|529543223|FG001|Titration Phase|Death|0|||
146958180|NCT04594213|530006310|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
146958181|NCT04594213|530006311|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
146958182|NCT04594213|530006312|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
146958183|NCT04594213|530006313|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
146958184|NCT04594213|530006308|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146958185|NCT04594213|530006309|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146958186|NCT04594213|530006310|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146958187|NCT04594213|530006311|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146958188|NCT04594213|530006312|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146958189|NCT04594213|530006313|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
146958190|NCT04594213|530006308|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146958191|NCT04594213|530006309|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146958192|NCT04594213|530006310|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146958193|NCT04594213|530006311|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
146958194|NCT04594213|530006312|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146958195|NCT04594213|530006313|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146958196|NCT04594213|530006308|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
146958197|NCT04594213|530006309|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
146958198|NCT04594213|530006310|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
146958199|NCT04594213|530006311|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
146958200|NCT04594213|530006312|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
146828451|NCT00505414|529543224|FG002|Titration Phase|Death|0|||
146828452|NCT00505414|529543225|FG003|Titration Phase|Death|2|||
146828453|NCT00505414|529543226|FG004|Titration Phase|Death|0|||
146828454|NCT00505414|529543222|FG000|Titration Phase|Lack of Efficacy|0|||
146828455|NCT00505414|529543223|FG001|Titration Phase|Lack of Efficacy|0|||
146828456|NCT00505414|529543224|FG002|Titration Phase|Lack of Efficacy|0|||
146828457|NCT00505414|529543225|FG003|Titration Phase|Lack of Efficacy|10|||
146828458|NCT00505414|529543226|FG004|Titration Phase|Lack of Efficacy|1|||
146828459|NCT00505414|529543222|FG000|Titration Phase|Protocol Violation|0|||
146828460|NCT00505414|529543223|FG001|Titration Phase|Protocol Violation|0|||
146828461|NCT00505414|529543224|FG002|Titration Phase|Protocol Violation|0|||
146828462|NCT00505414|529543225|FG003|Titration Phase|Protocol Violation|0|||
146828463|NCT00505414|529543226|FG004|Titration Phase|Protocol Violation|1|||
146828464|NCT00505414|529543222|FG000|Titration Phase|Withdrawal by Subject|0|||
146828465|NCT00505414|529543223|FG001|Titration Phase|Withdrawal by Subject|0|||
146828466|NCT00505414|529543224|FG002|Titration Phase|Withdrawal by Subject|0|||
146828467|NCT00505414|529543225|FG003|Titration Phase|Withdrawal by Subject|3|||
146828468|NCT00505414|529543226|FG004|Titration Phase|Withdrawal by Subject|4|||
146828469|NCT00505414|529543222|FG000|Titration Phase|Underlying disease and therapy required|0|||
146828470|NCT00505414|529543223|FG001|Titration Phase|Underlying disease and therapy required|0|||
146828471|NCT00505414|529543224|FG002|Titration Phase|Underlying disease and therapy required|0|||
146828472|NCT00505414|529543225|FG003|Titration Phase|Underlying disease and therapy required|7|||
146828473|NCT00505414|529543226|FG004|Titration Phase|Underlying disease and therapy required|3|||
146828474|NCT00505414|529543222|FG000|Maintenance Phase|Adverse Event|2|||
146828475|NCT00505414|529543223|FG001|Maintenance Phase|Adverse Event|2|||
146828476|NCT00505414|529543224|FG002|Maintenance Phase|Adverse Event|3|||
146828477|NCT00505414|529543225|FG003|Maintenance Phase|Adverse Event|0|||
146828478|NCT00505414|529543226|FG004|Maintenance Phase|Adverse Event|0|||
146828479|NCT00505414|529543222|FG000|Maintenance Phase|Death|2|||
146828480|NCT00505414|529543223|FG001|Maintenance Phase|Death|0|||
146828481|NCT00505414|529543224|FG002|Maintenance Phase|Death|1|||
146828482|NCT00505414|529543225|FG003|Maintenance Phase|Death|0|||
146828483|NCT00505414|529543226|FG004|Maintenance Phase|Death|0|||
146828484|NCT00505414|529543222|FG000|Maintenance Phase|Lack of Efficacy|2|||
146828485|NCT00505414|529543223|FG001|Maintenance Phase|Lack of Efficacy|1|||
146828486|NCT00505414|529543224|FG002|Maintenance Phase|Lack of Efficacy|1|||
146828487|NCT00505414|529543225|FG003|Maintenance Phase|Lack of Efficacy|0|||
146828488|NCT00505414|529543226|FG004|Maintenance Phase|Lack of Efficacy|0|||
146828489|NCT00505414|529543222|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146828490|NCT00505414|529543223|FG001|Maintenance Phase|Withdrawal by Subject|0|||
146828491|NCT00505414|529543224|FG002|Maintenance Phase|Withdrawal by Subject|1|||
146828492|NCT00505414|529543225|FG003|Maintenance Phase|Withdrawal by Subject|0|||
146828493|NCT00505414|529543226|FG004|Maintenance Phase|Withdrawal by Subject|0|||
146828494|NCT00505414|529543222|FG000|Maintenance Phase|underlying disease and therapy required|0|||
146828495|NCT00505414|529543223|FG001|Maintenance Phase|underlying disease and therapy required|2|||
146828496|NCT00505414|529543224|FG002|Maintenance Phase|underlying disease and therapy required|2|||
146828497|NCT00505414|529543225|FG003|Maintenance Phase|underlying disease and therapy required|0|||
146828498|NCT00505414|529543226|FG004|Maintenance Phase|underlying disease and therapy required|0|||
146828499|NCT00846768|529543227|FG000|Overall Study|Adverse Event|0|||
146828500|NCT00846768|529543228|FG001|Overall Study|Adverse Event|1|||
146828501|NCT00846768|529543229|FG002|Overall Study|Adverse Event|0|||
146828502|NCT00846768|529543230|FG003|Overall Study|Adverse Event|0|||
146828503|NCT04353817|529543231|FG000|Overall Study|Adverse Event|0|||
146828504|NCT04353817|529543232|FG001|Overall Study|Adverse Event|1|||
146828505|NCT04358068|529543233|FG000|Overall Study|Did not initiate study treatment|2|||
146828506|NCT04358068|529543234|FG001|Overall Study|Did not initiate study treatment|2|||
146828507|NCT00338949|529543235|FG000|Subject Screening|Screen failures|11|||
146828508|NCT00338949|529543236|FG001|Subject Screening|Screen failures|11|||
146828509|NCT00338949|529543235|FG000|Randomization|Withdrawal by Subject|1|||
146828510|NCT00338949|529543236|FG001|Randomization|Withdrawal by Subject|0|||
146828511|NCT00338949|529543235|FG000|Randomization|Adverse Event|0|||
146828512|NCT00338949|529543236|FG001|Randomization|Adverse Event|5|||
146828513|NCT01841112|529543238|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
146828514|NCT01841112|529543239|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
146828515|NCT01841112|529543240|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
146828516|NCT01841112|529543241|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
146828517|NCT01841112|529543242|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
146828518|NCT02143063|529543243|FG000|Overall Study|Lost to Follow-up|16|||
146828519|NCT02143063|529543244|FG001|Overall Study|Lost to Follow-up|28|||
146828520|NCT02143063|529543245|FG002|Overall Study|Lost to Follow-up|29|||
146828521|NCT02143063|529543243|FG000|Overall Study|Withdrawal by Subject|0|||
146828522|NCT02143063|529543244|FG001|Overall Study|Withdrawal by Subject|1|||
146986022|NCT00760383|530111126|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
146828523|NCT02143063|529543245|FG002|Overall Study|Withdrawal by Subject|0|||
146828524|NCT02143063|529543243|FG000|Overall Study|Death|0|||
146828525|NCT02143063|529543244|FG001|Overall Study|Death|1|||
146828526|NCT02143063|529543245|FG002|Overall Study|Death|1|||
146828527|NCT00878553|529543246|FG000|Sleep Study|Withdrawal by Subject|2|||
146828528|NCT00878553|529543247|FG001|Sleep Study|Withdrawal by Subject|0|||
146828529|NCT00878553|529543248|FG002|Sleep Study|Withdrawal by Subject|0|||
146828530|NCT00878553|529543249|FG003|Sleep Study|Withdrawal by Subject|0|||
146828531|NCT00878553|529543250|FG004|Sleep Study|Withdrawal by Subject|0|||
146828532|NCT00878553|529543246|FG000|Sleep Study|Lost to Follow-up|1|||
146828533|NCT00878553|529543247|FG001|Sleep Study|Lost to Follow-up|0|||
146828534|NCT00878553|529543248|FG002|Sleep Study|Lost to Follow-up|0|||
146828535|NCT00878553|529543249|FG003|Sleep Study|Lost to Follow-up|0|||
146828536|NCT00878553|529543250|FG004|Sleep Study|Lost to Follow-up|0|||
146828537|NCT00878553|529543246|FG000|Sleep Study|car accident|1|||
146828538|NCT00878553|529543247|FG001|Sleep Study|car accident|0|||
146828539|NCT00878553|529543248|FG002|Sleep Study|car accident|0|||
146828540|NCT00878553|529543249|FG003|Sleep Study|car accident|0|||
146828541|NCT00878553|529543250|FG004|Sleep Study|car accident|0|||
146828542|NCT00878553|529543246|FG000|Sleep Study|family emergency|1|||
146828543|NCT00878553|529543247|FG001|Sleep Study|family emergency|0|||
146828544|NCT00878553|529543248|FG002|Sleep Study|family emergency|0|||
146828545|NCT00878553|529543249|FG003|Sleep Study|family emergency|0|||
146828546|NCT00878553|529543250|FG004|Sleep Study|family emergency|0|||
146828547|NCT00878553|529543246|FG000|PK Study|Withdrawal by Subject|0|||
146828548|NCT00878553|529543247|FG001|PK Study|Withdrawal by Subject|0|||
146828549|NCT00878553|529543248|FG002|PK Study|Withdrawal by Subject|0|||
146828550|NCT00878553|529543249|FG003|PK Study|Withdrawal by Subject|1|||
146828551|NCT00878553|529543250|FG004|PK Study|Withdrawal by Subject|0|||
146828552|NCT00461123|529543251|FG000|Overall Study|Adverse Event|1|||
146828553|NCT00461123|529543252|FG001|Overall Study|Adverse Event|0|||
146828554|NCT00461123|529543251|FG000|Overall Study|Lost to Follow-up|1|||
146828555|NCT00461123|529543252|FG001|Overall Study|Lost to Follow-up|1|||
146828556|NCT00461123|529543251|FG000|Overall Study|Protocol Violation|3|||
146828557|NCT00461123|529543252|FG001|Overall Study|Protocol Violation|2|||
146828558|NCT00461123|529543251|FG000|Overall Study|Withdrawal by Subject|1|||
146828559|NCT00461123|529543252|FG001|Overall Study|Withdrawal by Subject|3|||
146828560|NCT03029819|529543254|FG000|Overall Study|Lost to Follow-up|3|||
146828561|NCT03029819|529543255|FG001|Overall Study|Lost to Follow-up|5|||
146828562|NCT03029819|529543254|FG000|Overall Study|Removed due to disruptive behavior|0|||
146828563|NCT03029819|529543255|FG001|Overall Study|Removed due to disruptive behavior|1|||
146828564|NCT00808899|529543262|FG000|Overall Study|Death|1|||
146828565|NCT00808899|529543262|FG000|Overall Study|Physician Decision|3|||
146828566|NCT03448536|529543263|FG000|Overall Study|Protocol Violation|2|||
146828567|NCT03448536|529543264|FG001|Overall Study|Protocol Violation|0|||
146828568|NCT03448536|529543263|FG000|Overall Study|Pregnancy|1|||
146828569|NCT03448536|529543264|FG001|Overall Study|Pregnancy|0|||
146828570|NCT03448536|529543263|FG000|Overall Study|Withdrawal by Subject|1|||
146828571|NCT03448536|529543264|FG001|Overall Study|Withdrawal by Subject|2|||
146828572|NCT03448536|529543263|FG000|Overall Study|Lost to Follow-up|3|||
146828573|NCT03448536|529543264|FG001|Overall Study|Lost to Follow-up|2|||
146828574|NCT03448536|529543263|FG000|Overall Study|Inadequate pain reporter|1|||
146828575|NCT03448536|529543264|FG001|Overall Study|Inadequate pain reporter|0|||
146828576|NCT03448536|529543263|FG000|Overall Study|Other|3|||
146828577|NCT03448536|529543264|FG001|Overall Study|Other|0|||
146828578|NCT03448536|529543263|FG000|Overall Study|Physician Decision|1|||
146828579|NCT03448536|529543264|FG001|Overall Study|Physician Decision|0|||
146828580|NCT01220856|529543267|FG000|Overall Study|graft loss|3|||
146828581|NCT01220856|529543268|FG001|Overall Study|graft loss|3|||
146828582|NCT01220856|529543267|FG000|Overall Study|Lost to Follow-up|1|||
146828583|NCT01220856|529543268|FG001|Overall Study|Lost to Follow-up|0|||
146828584|NCT00361842|529543269|FG000|Overall Study|Withdrawal by Subject|2|||
146828585|NCT00361842|529543270|FG001|Overall Study|Withdrawal by Subject|3|||
146828586|NCT00361842|529543269|FG000|Overall Study|Death|2|||
146828587|NCT00361842|529543270|FG001|Overall Study|Death|1|||
146828588|NCT00361842|529543269|FG000|Overall Study|Disease progression|19|||
146828589|NCT00361842|529543270|FG001|Overall Study|Disease progression|20|||
146828590|NCT00361842|529543269|FG000|Overall Study|Adverse Event|2|||
146828591|NCT00361842|529543270|FG001|Overall Study|Adverse Event|3|||
146828592|NCT00361842|529543269|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
146828593|NCT00361842|529543270|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
146828594|NCT00361842|529543269|FG000|Overall Study|Other|1|||
146828595|NCT00361842|529543270|FG001|Overall Study|Other|0|||
146828596|NCT00361842|529543269|FG000|Overall Study|Other|0|||
146828597|NCT00361842|529543270|FG001|Overall Study|Other|2|||
146828598|NCT04206384|529543271|FG000|Overall Study|Withdrawal by Subject|8|||
146828599|NCT04206384|529543271|FG000|Overall Study|Adverse Event|2|||
146828600|NCT02212197|529543272|FG000|Overall Study|Need for radiotherapy|1|||
146828601|NCT02212197|529543273|FG001|Overall Study|Need for radiotherapy|0|||
146828602|NCT02212197|529543274|FG002|Overall Study|Need for radiotherapy|0|||
146828603|NCT03015181|529543275|FG000|Overall Study|Enrolled, but product never administered|1|||
146828604|NCT03015181|529543276|FG001|Overall Study|Enrolled, but product never administered|0|||
146828605|NCT03015181|529543277|FG002|Overall Study|Enrolled, but product never administered|0|||
146828606|NCT03015181|529543278|FG003|Overall Study|Enrolled, but product never administered|0|||
146828607|NCT03015181|529543279|FG004|Overall Study|Enrolled, but product never administered|0|||
146828608|NCT03015181|529543280|FG005|Overall Study|Enrolled, but product never administered|0|||
146828609|NCT03015181|529543281|FG006|Overall Study|Enrolled, but product never administered|0|||
146828610|NCT03015181|529543275|FG000|Overall Study|Withdrawal by Subject|0|||
146828611|NCT03015181|529543276|FG001|Overall Study|Withdrawal by Subject|0|||
146828612|NCT03015181|529543277|FG002|Overall Study|Withdrawal by Subject|0|||
146828613|NCT03015181|529543278|FG003|Overall Study|Withdrawal by Subject|0|||
146828614|NCT03015181|529543279|FG004|Overall Study|Withdrawal by Subject|0|||
146828615|NCT03015181|529543280|FG005|Overall Study|Withdrawal by Subject|1|||
146828616|NCT03015181|529543281|FG006|Overall Study|Withdrawal by Subject|0|||
146828617|NCT03015181|529543275|FG000|Overall Study|Physician Decision|0|||
146828618|NCT03015181|529543276|FG001|Overall Study|Physician Decision|0|||
146828619|NCT03015181|529543277|FG002|Overall Study|Physician Decision|0|||
146828620|NCT03015181|529543278|FG003|Overall Study|Physician Decision|0|||
146828621|NCT03015181|529543279|FG004|Overall Study|Physician Decision|0|||
146828622|NCT03015181|529543280|FG005|Overall Study|Physician Decision|0|||
146828623|NCT03015181|529543281|FG006|Overall Study|Physician Decision|1|||
146828624|NCT01077622|529543283|FG000|Overall Study|Physician Decision|2|||
146828625|NCT01077622|529543283|FG000|Overall Study|Withdrawal by Subject|1|||
146828626|NCT01260142|529543284|FG000|Treatment Period 1|Study on hold|1|||
146828627|NCT01260142|529543285|FG001|Treatment Period 1|Study on hold|1|||
146828628|NCT01260142|529543286|FG002|Treatment Period 1|Study on hold|0|||
146828629|NCT01260142|529543287|FG003|Treatment Period 1|Study on hold|0|||
146828630|NCT01260142|529543288|FG004|Treatment Period 1|Study on hold|1|||
146828631|NCT01260142|529543289|FG005|Treatment Period 1|Study on hold|2|||
146828632|NCT01260142|529543284|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
146828633|NCT01260142|529543285|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
146828634|NCT01260142|529543286|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
146828635|NCT01260142|529543287|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
146828636|NCT01260142|529543288|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
146828637|NCT01260142|529543289|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
146828638|NCT01260142|529543284|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146828639|NCT01260142|529543285|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146828640|NCT01260142|529543286|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146828641|NCT01260142|529543287|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146828642|NCT01260142|529543288|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146828643|NCT01260142|529543289|FG005|Treatment Period 1|Withdrawal by Subject|1|||
146828644|NCT00496834|529543298|FG000|Overall Study|Withdrawal by Subject|4|||
146828645|NCT00496834|529543299|FG001|Overall Study|Withdrawal by Subject|6|||
146828646|NCT00496834|529543298|FG000|Overall Study|Contraindicated medication administered|0|||
146828647|NCT00496834|529543299|FG001|Overall Study|Contraindicated medication administered|1|||
146828648|NCT00496834|529543298|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
146828649|NCT00496834|529543299|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
146828650|NCT00496834|529543298|FG000|Overall Study|Adverse Event|5|||
146828651|NCT00496834|529543299|FG001|Overall Study|Adverse Event|3|||
146828652|NCT00496834|529543298|FG000|Overall Study|IP administration violation|2|||
146828653|NCT00496834|529543299|FG001|Overall Study|IP administration violation|0|||
146828654|NCT00496834|529543298|FG000|Overall Study|Lost to Follow-up|2|||
146828655|NCT00496834|529543299|FG001|Overall Study|Lost to Follow-up|0|||
146828656|NCT00496834|529543298|FG000|Overall Study|Blood Pressure control failure|2|||
146828657|NCT00496834|529543299|FG001|Overall Study|Blood Pressure control failure|1|||
146828658|NCT01503164|529543300|FG000|Overall Study|Withdrawal by Subject|2|||
146828659|NCT01503164|529543301|FG001|Overall Study|Withdrawal by Subject|1|||
146828660|NCT04088136|529543304|FG000|Overall Study|Withdrawal by Subject|5|||
146828661|NCT04088136|529543305|FG001|Overall Study|Withdrawal by Subject|0|||
146828662|NCT04088136|529543304|FG000|Overall Study|Lack of Efficacy|0|||
146828663|NCT04088136|529543305|FG001|Overall Study|Lack of Efficacy|1|||
146828664|NCT01177228|529543306|FG000|Overall Study|Positive tuberculosis test|0|||
146828665|NCT01177228|529543307|FG001|Overall Study|Positive tuberculosis test|1|||
146828666|NCT01177228|529543308|FG002|Overall Study|Positive tuberculosis test|0|||
146828667|NCT01177228|529543309|FG003|Overall Study|Positive tuberculosis test|0|||
146828668|NCT01177228|529543306|FG000|Overall Study|Worsening disease activity|1|||
146828669|NCT01177228|529543307|FG001|Overall Study|Worsening disease activity|0|||
146828670|NCT01177228|529543308|FG002|Overall Study|Worsening disease activity|0|||
146828671|NCT01177228|529543309|FG003|Overall Study|Worsening disease activity|0|||
146828672|NCT01177228|529543306|FG000|Overall Study|Withdrawal by Subject|0|||
146828673|NCT01177228|529543307|FG001|Overall Study|Withdrawal by Subject|1|||
146828674|NCT01177228|529543308|FG002|Overall Study|Withdrawal by Subject|0|||
146828675|NCT01177228|529543309|FG003|Overall Study|Withdrawal by Subject|0|||
146828676|NCT00356759|529543310|FG000|Overall Study|Death|5|||
146828677|NCT00356759|529543311|FG001|Overall Study|Death|2|||
146828678|NCT00356759|529543310|FG000|Overall Study|Withdrawal by Subject|2|||
146828679|NCT00356759|529543311|FG001|Overall Study|Withdrawal by Subject|2|||
146828680|NCT00356759|529543310|FG000|Overall Study|Adverse Event|1|||
146828681|NCT00356759|529543311|FG001|Overall Study|Adverse Event|3|||
146828682|NCT00356759|529543310|FG000|Overall Study|Lost to Follow-up|1|||
146828683|NCT00356759|529543311|FG001|Overall Study|Lost to Follow-up|1|||
146958201|NCT04594213|530006313|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
146958202|NCT04594213|530006308|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
146958203|NCT04594213|530006309|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
146958204|NCT04594213|530006310|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
146828684|NCT00356759|529543310|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
146828685|NCT00356759|529543311|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
146828686|NCT04159805|529543312|FG000|Overall Study|Withdrawal by Subject|0|||
146828687|NCT04159805|529543313|FG001|Overall Study|Withdrawal by Subject|2|||
146828688|NCT04159805|529543314|FG002|Overall Study|Withdrawal by Subject|2|||
146828689|NCT01393613|529543315|FG000|Overall Study|Adverse Event|11|||
146828690|NCT01393613|529543316|FG001|Overall Study|Adverse Event|11|||
146828691|NCT01393613|529543317|FG002|Overall Study|Adverse Event|13|||
146828692|NCT01393613|529543318|FG003|Overall Study|Adverse Event|22|||
146828693|NCT01393613|529543315|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
146828694|NCT01393613|529543316|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
146828695|NCT01393613|529543317|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
146828696|NCT01393613|529543318|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
146828697|NCT01393613|529543315|FG000|Overall Study|Physician Decision|2|||
146828698|NCT01393613|529543316|FG001|Overall Study|Physician Decision|0|||
146828699|NCT01393613|529543317|FG002|Overall Study|Physician Decision|0|||
146828700|NCT01393613|529543318|FG003|Overall Study|Physician Decision|1|||
146828701|NCT01393613|529543315|FG000|Overall Study|Withdrawal by Subject|15|||
146828702|NCT01393613|529543316|FG001|Overall Study|Withdrawal by Subject|25|||
146828703|NCT01393613|529543317|FG002|Overall Study|Withdrawal by Subject|23|||
146828704|NCT01393613|529543318|FG003|Overall Study|Withdrawal by Subject|21|||
146828705|NCT01393613|529543315|FG000|Overall Study|Protocol Deviation|2|||
146828706|NCT01393613|529543316|FG001|Overall Study|Protocol Deviation|1|||
146828707|NCT01393613|529543317|FG002|Overall Study|Protocol Deviation|0|||
146828708|NCT01393613|529543318|FG003|Overall Study|Protocol Deviation|0|||
146828709|NCT01393613|529543315|FG000|Overall Study|Lack of Efficacy|9|||
146828710|NCT01393613|529543316|FG001|Overall Study|Lack of Efficacy|20|||
146828711|NCT01393613|529543317|FG002|Overall Study|Lack of Efficacy|16|||
146828712|NCT01393613|529543318|FG003|Overall Study|Lack of Efficacy|21|||
146828713|NCT03821064|529543319|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
146828714|NCT00474383|529543323|FG000|Main Study|Adverse Event|11|||
146828715|NCT00474383|529543324|FG001|Main Study|Adverse Event|0|||
146828716|NCT00474383|529543323|FG000|Main Study|Symptomatic Deterioration|1|||
146828717|NCT00474383|529543324|FG001|Main Study|Symptomatic Deterioration|0|||
146828718|NCT00474383|529543323|FG000|Main Study|Progressive Disease|23|||
146828719|NCT00474383|529543324|FG001|Main Study|Progressive Disease|0|||
146828720|NCT00474383|529543323|FG000|Main Study|Other|1|||
146828721|NCT00474383|529543324|FG001|Main Study|Other|0|||
146828722|NCT00474383|529543323|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
146828723|NCT00474383|529543324|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
146828724|NCT00474383|529543323|FG000|Extension|Progressive Disease|0|||
146828725|NCT00474383|529543324|FG001|Extension|Progressive Disease|5|||
146828726|NCT02998918|529543326|FG000|Overall Study|Withdrawal by Subject|1|||
146828727|NCT02998918|529543327|FG001|Overall Study|Withdrawal by Subject|0|||
146828728|NCT01482819|529543328|FG000|Overall Study|Lost to Follow-up|2|||
146828729|NCT00562484|529543331|FG000|Overall Study|Adverse Event|6|||
146828730|NCT00562484|529543332|FG001|Overall Study|Adverse Event|1|||
146828731|NCT00562484|529543331|FG000|Overall Study|Protocol Violation|11|||
146828732|NCT00562484|529543332|FG001|Overall Study|Protocol Violation|2|||
146828733|NCT00562484|529543331|FG000|Overall Study|Withdrawal by Subject|12|||
146828734|NCT00562484|529543332|FG001|Overall Study|Withdrawal by Subject|9|||
146828735|NCT00562484|529543331|FG000|Overall Study|Moved away from the study area|20|||
146828736|NCT00562484|529543332|FG001|Overall Study|Moved away from the study area|9|||
146828737|NCT00562484|529543331|FG000|Overall Study|Lost to Follow-up|132|||
146828738|NCT00562484|529543332|FG001|Overall Study|Lost to Follow-up|71|||
146828739|NCT00562484|529543331|FG000|Overall Study|Reason not provided or not specified|25|||
146828740|NCT00562484|529543332|FG001|Overall Study|Reason not provided or not specified|12|||
146828741|NCT00702520|529543335|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
146828742|NCT00702520|529543336|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
146828743|NCT00702520|529543337|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
146828744|NCT00702520|529543338|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
146828745|NCT00702520|529543335|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
146828746|NCT00702520|529543336|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
146828747|NCT00702520|529543337|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
146828748|NCT00702520|529543338|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
146828749|NCT00702520|529543335|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
146828750|NCT00702520|529543336|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
146828751|NCT00702520|529543337|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
146828752|NCT00702520|529543338|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
146828753|NCT00942188|529543339|FG000|Overall Study|Adverse Event|0|||
146828754|NCT00942188|529543340|FG001|Overall Study|Adverse Event|3|||
146828755|NCT00942188|529543341|FG002|Overall Study|Adverse Event|2|||
146828756|NCT00942188|529543342|FG003|Overall Study|Adverse Event|0|||
146828757|NCT00942188|529543339|FG000|Overall Study|Lack of Efficacy|0|||
146828758|NCT00942188|529543340|FG001|Overall Study|Lack of Efficacy|0|||
146828759|NCT00942188|529543341|FG002|Overall Study|Lack of Efficacy|0|||
146828760|NCT00942188|529543342|FG003|Overall Study|Lack of Efficacy|1|||
146828761|NCT00942188|529543339|FG000|Overall Study|Protocol Violation|1|||
146828762|NCT00942188|529543340|FG001|Overall Study|Protocol Violation|1|||
146828763|NCT00942188|529543341|FG002|Overall Study|Protocol Violation|0|||
146828764|NCT00942188|529543342|FG003|Overall Study|Protocol Violation|0|||
146828765|NCT00942188|529543339|FG000|Overall Study|Lost to Follow-up|2|||
146828766|NCT00942188|529543340|FG001|Overall Study|Lost to Follow-up|1|||
146828767|NCT00942188|529543341|FG002|Overall Study|Lost to Follow-up|2|||
146828768|NCT00942188|529543342|FG003|Overall Study|Lost to Follow-up|0|||
146828769|NCT00942188|529543339|FG000|Overall Study|Withdrawal by Subject|1|||
146828770|NCT00942188|529543340|FG001|Overall Study|Withdrawal by Subject|3|||
146828771|NCT00942188|529543341|FG002|Overall Study|Withdrawal by Subject|4|||
146828772|NCT00942188|529543342|FG003|Overall Study|Withdrawal by Subject|2|||
146828773|NCT00942188|529543339|FG000|Overall Study|Physician Decision|0|||
146828774|NCT00942188|529543340|FG001|Overall Study|Physician Decision|0|||
146828775|NCT00942188|529543341|FG002|Overall Study|Physician Decision|1|||
146828776|NCT00942188|529543342|FG003|Overall Study|Physician Decision|0|||
146828777|NCT00942188|529543339|FG000|Overall Study|Sponsor Decision|0|||
146828778|NCT00942188|529543340|FG001|Overall Study|Sponsor Decision|2|||
146828779|NCT00942188|529543341|FG002|Overall Study|Sponsor Decision|0|||
146828780|NCT00942188|529543342|FG003|Overall Study|Sponsor Decision|1|||
146828781|NCT02473913|529543344|FG000|Overall Study|Lost to Follow-up|3|||
146828782|NCT02473913|529543345|FG001|Overall Study|Lost to Follow-up|3|||
146828783|NCT02826798|529544913|FG000|Overall Study|Withdrawal by Subject|0|||
146828784|NCT02826798|529544914|FG001|Overall Study|Withdrawal by Subject|1|||
146828785|NCT02826798|529544915|FG002|Overall Study|Withdrawal by Subject|0|||
146828786|NCT02826798|529544916|FG003|Overall Study|Withdrawal by Subject|1|||
146828787|NCT02826798|529544917|FG004|Overall Study|Withdrawal by Subject|0|||
146828788|NCT02806505|529544918|FG000|Overall Study|Adverse event/intercurrent illness|1|||
146828789|NCT02806505|529544919|FG001|Overall Study|Adverse event/intercurrent illness|3|||
146828790|NCT02806505|529544918|FG000|Overall Study|Death|4|||
146828791|NCT02806505|529544919|FG001|Overall Study|Death|0|||
146828792|NCT02806505|529544918|FG000|Overall Study|Did not cooperate/refused treatment|3|||
146828793|NCT02806505|529544919|FG001|Overall Study|Did not cooperate/refused treatment|3|||
146828794|NCT02806505|529544918|FG000|Overall Study|Failure to return|0|||
146828795|NCT02806505|529544919|FG001|Overall Study|Failure to return|1|||
146828796|NCT02806505|529544918|FG000|Overall Study|Insufficient therapeutic response|2|||
146828797|NCT02806505|529544919|FG001|Overall Study|Insufficient therapeutic response|4|||
146828798|NCT03458728|529544925|FG000|Overall Study|Adverse Event|1|||
146828799|NCT03458728|529544926|FG001|Overall Study|Adverse Event|0|||
146828800|NCT03458728|529544925|FG000|Overall Study|Physician Decision|1|||
146828801|NCT03458728|529544926|FG001|Overall Study|Physician Decision|0|||
146828802|NCT03458728|529544925|FG000|Overall Study|Progressive disease - clinical assessment|1|||
146828803|NCT03458728|529544926|FG001|Overall Study|Progressive disease - clinical assessment|0|||
146828804|NCT03458728|529544925|FG000|Overall Study|Progressive disease - radiological progression|21|||
146828805|NCT03458728|529544926|FG001|Overall Study|Progressive disease - radiological progression|6|||
146828806|NCT03458728|529544925|FG000|Overall Study|Withdrawal by Subject|0|||
146828807|NCT03458728|529544926|FG001|Overall Study|Withdrawal by Subject|1|||
146828808|NCT00908349|529544930|FG000|Overall Study|Adverse Event|10|||
146828809|NCT00908349|529544930|FG000|Overall Study|Withdrawal by Subject|9|||
146828810|NCT00908349|529544930|FG000|Overall Study|Physician Decision|5|||
146828811|NCT00908349|529544930|FG000|Overall Study|Lost to Follow-up|5|||
146828812|NCT00908349|529544930|FG000|Overall Study|Various|6|||
146828813|NCT01755546|529544934|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
146828814|NCT01755546|529544934|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
146828815|NCT01755546|529544934|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
146828816|NCT01755546|529544934|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
146828817|NCT01755546|529544934|FG000|Titration Phase|Adverse Event|11|||
146828818|NCT01755546|529544934|FG000|Titration Phase|Lack of Efficacy|18|||
146828819|NCT01755546|529544934|FG000|Titration Phase|Protocol Violation|9|||
146828820|NCT01755546|529544934|FG000|Titration Phase|Lost to Follow-up|2|||
146828821|NCT01755546|529544934|FG000|Titration Phase|Other and Continuing|22|||
146828822|NCT01755546|529544934|FG000|Titration Phase|Withdrawal by Subject|8|||
146828823|NCT01755546|529544934|FG000|Long Term Treatment|Adverse Event|12|||
146828824|NCT01755546|529544934|FG000|Long Term Treatment|Lack of Efficacy|6|||
146828825|NCT01755546|529544934|FG000|Long Term Treatment|Protocol Violation|10|||
146828826|NCT01755546|529544934|FG000|Long Term Treatment|Withdrawal by Subject|35|||
146828827|NCT01755546|529544934|FG000|Long Term Treatment|Lost to Follow-up|17|||
146828828|NCT01755546|529544934|FG000|Long Term Treatment|other and ongoing|41|||
146828829|NCT01114139|529544935|FG000|Overall Study|Adverse Event|3|||
146828830|NCT01114139|529544936|FG001|Overall Study|Adverse Event|2|||
146828831|NCT01114139|529544935|FG000|Overall Study|Lost to Follow-up|15|||
146828832|NCT01114139|529544936|FG001|Overall Study|Lost to Follow-up|3|||
146828833|NCT01114139|529544935|FG000|Overall Study|Withdrawal by Subject|17|||
146828834|NCT01114139|529544936|FG001|Overall Study|Withdrawal by Subject|6|||
146828835|NCT01114139|529544935|FG000|Overall Study|Other-Missed 1 visit|1|||
146828836|NCT01114139|529544936|FG001|Overall Study|Other-Missed 1 visit|0|||
146828837|NCT01114139|529544935|FG000|Overall Study|Other-Protocol Violation|1|||
146828838|NCT01114139|529544936|FG001|Overall Study|Other-Protocol Violation|0|||
146828839|NCT01114139|529544935|FG000|Overall Study|Other-Out of window for study drug dose|1|||
146828840|NCT01114139|529544936|FG001|Overall Study|Other-Out of window for study drug dose|0|||
146828841|NCT01114139|529544935|FG000|Overall Study|Other-Participant falsified records|0|||
146828842|NCT01114139|529544936|FG001|Overall Study|Other-Participant falsified records|1|||
146828843|NCT01114139|529544935|FG000|Overall Study|Other-Participant went on hospice|0|||
146828844|NCT01114139|529544936|FG001|Overall Study|Other-Participant went on hospice|1|||
146828845|NCT01114139|529544935|FG000|Overall Study|Other-Physician changed treatment|1|||
146828846|NCT01114139|529544936|FG001|Overall Study|Other-Physician changed treatment|0|||
146828847|NCT01114139|529544935|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
146828848|NCT01114139|529544936|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
146828849|NCT02536742|529544938|FG000|Overall Study|Did not start protocol therapy|1|||
146828850|NCT02536742|529544938|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
146828851|NCT04629443|529544939|FG000|Overall Study|Adverse Event|2|||
146828852|NCT04629443|529544940|FG001|Overall Study|Adverse Event|1|||
146828853|NCT04629443|529544941|FG002|Overall Study|Adverse Event|2|||
146828854|NCT04629443|529544939|FG000|Overall Study|Progressive Disease|2|||
146828855|NCT04629443|529544940|FG001|Overall Study|Progressive Disease|3|||
146828856|NCT04629443|529544941|FG002|Overall Study|Progressive Disease|3|||
146828857|NCT04629443|529544939|FG000|Overall Study|Physician Decision|1|||
146828858|NCT04629443|529544940|FG001|Overall Study|Physician Decision|3|||
146828859|NCT04629443|529544941|FG002|Overall Study|Physician Decision|0|||
146828860|NCT00858247|529544948|FG000|Baseline Assessment|Withdrawal by Subject|1|||
146828861|NCT00858247|529544949|FG001|Baseline Assessment|Withdrawal by Subject|1|||
146828862|NCT00858247|529544948|FG000|Baseline Assessment|Poor IV access|1|||
146828863|NCT00858247|529544949|FG001|Baseline Assessment|Poor IV access|0|||
146828864|NCT00858247|529544948|FG000|Baseline Assessment|Protocol Violation|0|||
146828865|NCT00858247|529544949|FG001|Baseline Assessment|Protocol Violation|1|||
146828866|NCT00858247|529544948|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
146828867|NCT00858247|529544949|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
146828868|NCT02512861|529544950|FG000|Overall Study|Protocol Violation|3|||
146828869|NCT02512861|529544951|FG001|Overall Study|Protocol Violation|7|||
146828870|NCT02512861|529544950|FG000|Overall Study|Physician Decision|3|||
146828871|NCT02512861|529544951|FG001|Overall Study|Physician Decision|1|||
146828872|NCT02512861|529544950|FG000|Overall Study|Withdrawal by Subject|0|||
146828873|NCT02512861|529544951|FG001|Overall Study|Withdrawal by Subject|1|||
146828874|NCT01172639|529544952|FG000|Overall Study|Death|1|||
146828875|NCT01172639|529544953|FG001|Overall Study|Death|1|||
146828876|NCT01172639|529544954|FG002|Overall Study|Death|0|||
146828877|NCT01172639|529544955|FG003|Overall Study|Death|0|||
146828878|NCT01172639|529544956|FG004|Overall Study|Death|0|||
146828879|NCT01172639|529544952|FG000|Overall Study|Lost to Follow-up|9|||
146828880|NCT01172639|529544953|FG001|Overall Study|Lost to Follow-up|7|||
146828881|NCT01172639|529544954|FG002|Overall Study|Lost to Follow-up|11|||
146828882|NCT01172639|529544955|FG003|Overall Study|Lost to Follow-up|6|||
146828883|NCT01172639|529544956|FG004|Overall Study|Lost to Follow-up|6|||
146828884|NCT01172639|529544952|FG000|Overall Study|Withdrawal by Subject|3|||
146828885|NCT01172639|529544953|FG001|Overall Study|Withdrawal by Subject|3|||
146828886|NCT01172639|529544954|FG002|Overall Study|Withdrawal by Subject|5|||
146828887|NCT01172639|529544955|FG003|Overall Study|Withdrawal by Subject|5|||
146828888|NCT01172639|529544956|FG004|Overall Study|Withdrawal by Subject|0|||
146828889|NCT02447432|529544957|FG000|Epoch 001|Adverse Event|1|||
146828890|NCT02447432|529544958|FG001|Epoch 001|Adverse Event|1|||
146828891|NCT02447432|529544957|FG000|Epoch 001|Withdrawal by Subject|0|||
146828892|NCT02447432|529544958|FG001|Epoch 001|Withdrawal by Subject|4|||
146828893|NCT02447432|529544957|FG000|Epoch 001|Migrated/moved from study area|3|||
146828894|NCT02447432|529544958|FG001|Epoch 001|Migrated/moved from study area|5|||
146828895|NCT02447432|529544957|FG000|Epoch 001|Lost to Follow-up|1|||
146958205|NCT04594213|530006311|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
146958206|NCT04594213|530006312|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
146958207|NCT04594213|530006313|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
146958208|NCT04594213|530006308|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
146828896|NCT02447432|529544958|FG001|Epoch 001|Lost to Follow-up|3|||
146828897|NCT01585298|529544959|FG000|Overall Study|Study completion was not documented.|1|||
146828898|NCT01585298|529544959|FG000|Overall Study|Protocol deviation|1|||
146828899|NCT01585298|529544959|FG000|Overall Study|Administrative problems|4|||
146828900|NCT01585298|529544959|FG000|Overall Study|Lost to Follow-up|2|||
146828901|NCT01585298|529544959|FG000|Overall Study|Withdrawal by Subject|4|||
146828902|NCT01585298|529544959|FG000|Overall Study|Abnormal test procedure results|1|||
146828903|NCT01585298|529544959|FG000|Overall Study|Adverse Event|24|||
146828904|NCT00874497|529544969|FG000|Overall Study|Lost to Follow-up|2|||
146828905|NCT00874497|529544970|FG001|Overall Study|Lost to Follow-up|4|||
146828906|NCT00874497|529544969|FG000|Overall Study|Adverse Event|9|||
146986023|NCT00760383|530111127|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
146986024|NCT00192296|530111128|FG000|Overall Study|Withdrawal by Subject|0|||
146986025|NCT00192296|530111129|FG001|Overall Study|Withdrawal by Subject|1|||
146986026|NCT00192296|530111130|FG002|Overall Study|Withdrawal by Subject|0|||
146986027|NCT00192296|530111131|FG003|Overall Study|Withdrawal by Subject|0|||
146986028|NCT01842958|530111132|FG000|Overall Study|Lost to Follow-up|1|||
146986029|NCT01842958|530111133|FG001|Overall Study|Lost to Follow-up|1|||
146986030|NCT03465891|530111135|FG000|Overall Study|Withdrawal by Subject|0|||
146986031|NCT03465891|530111136|FG001|Overall Study|Withdrawal by Subject|1|||
146986032|NCT03465891|530111135|FG000|Overall Study|Disease progression|1|||
146986033|NCT03465891|530111136|FG001|Overall Study|Disease progression|0|||
146986034|NCT02737306|530111138|FG000|Overall Study|Adverse Event|3|||
146986035|NCT02737306|530111139|FG001|Overall Study|Adverse Event|0|||
146986036|NCT02737306|530111138|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
146986037|NCT02737306|530111139|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
146986038|NCT05034731|530111140|FG000|Overall Study|Screen fail|1|||
146986039|NCT05034731|530111141|FG001|Overall Study|Screen fail|1|||
146986040|NCT00622908|530111142|FG000|Overall Study|Protocol Violation|1|||
146986041|NCT00622908|530111143|FG001|Overall Study|Protocol Violation|0|||
146986042|NCT00622908|530111142|FG000|Overall Study|Adverse Event|0|||
146986043|NCT00622908|530111143|FG001|Overall Study|Adverse Event|1|||
146986044|NCT00622908|530111142|FG000|Overall Study|Lack of Efficacy|1|||
146986045|NCT00622908|530111143|FG001|Overall Study|Lack of Efficacy|7|||
146986046|NCT00622908|530111142|FG000|Overall Study|Lost to Follow-up|1|||
146986047|NCT00622908|530111143|FG001|Overall Study|Lost to Follow-up|0|||
146986048|NCT00622908|530111142|FG000|Overall Study|Refusal|0|||
146986049|NCT00622908|530111143|FG001|Overall Study|Refusal|1|||
146986050|NCT00622908|530111142|FG000|Overall Study|Termination by study sponser|0|||
146986051|NCT00622908|530111143|FG001|Overall Study|Termination by study sponser|1|||
146986052|NCT03937466|530111144|FG000|Overall Study|not eligbile after the 2-week diary|9|||
146986053|NCT03937466|530111144|FG000|Overall Study|never returned their diary|6|||
146986054|NCT03937466|530111144|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
146986055|NCT03937466|530111144|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
146986056|NCT03305055|530111145|FG000|Overall Study|Withdrawal by Subject|0|||
146986057|NCT03305055|530111146|FG001|Overall Study|Withdrawal by Subject|1|||
146986058|NCT03305055|530111145|FG000|Overall Study|Adverse Event|1|||
146986059|NCT03305055|530111146|FG001|Overall Study|Adverse Event|1|||
146986060|NCT03213210|530111147|FG000|Overall Study|Lost to Follow-up|2|||
146986061|NCT03213210|530111147|FG000|Overall Study|Study termination|3|||
146986062|NCT02540356|530111148|FG000|Overall Study|Terminated due to disease progression|1|||
146986063|NCT02540356|530111149|FG001|Overall Study|Terminated due to disease progression|0|||
146986064|NCT01166568|530111155|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
146986065|NCT01166568|530111156|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
146986066|NCT01166568|530111157|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
146986067|NCT01166568|530111155|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
146986068|NCT01166568|530111156|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
146986069|NCT01166568|530111157|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
146986070|NCT01166568|530111155|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
146986071|NCT01166568|530111156|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
146986072|NCT01166568|530111157|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
146986073|NCT03335371|530111158|FG000|Overall Study|Lost to Follow-up|0|||
146986074|NCT03335371|530111159|FG001|Overall Study|Lost to Follow-up|0|||
146986075|NCT03335371|530111160|FG002|Overall Study|Lost to Follow-up|0|||
146986076|NCT03335371|530111161|FG003|Overall Study|Lost to Follow-up|0|||
146986077|NCT03335371|530111162|FG004|Overall Study|Lost to Follow-up|1|||
146986078|NCT03335371|530111158|FG000|Overall Study|Withdrawal by Subject|0|||
146986079|NCT03335371|530111159|FG001|Overall Study|Withdrawal by Subject|0|||
146986080|NCT03335371|530111160|FG002|Overall Study|Withdrawal by Subject|0|||
146986081|NCT03335371|530111161|FG003|Overall Study|Withdrawal by Subject|0|||
146986082|NCT03335371|530111162|FG004|Overall Study|Withdrawal by Subject|1|||
146986083|NCT03335371|530111158|FG000|Overall Study|Randomization Error|0|||
146986084|NCT03335371|530111159|FG001|Overall Study|Randomization Error|0|||
146986085|NCT03335371|530111160|FG002|Overall Study|Randomization Error|1|||
146986086|NCT03335371|530111161|FG003|Overall Study|Randomization Error|0|||
146986087|NCT03335371|530111162|FG004|Overall Study|Randomization Error|0|||
146986088|NCT00684671|530111163|FG000|Overall Study|Adverse Event|1|||
146986089|NCT00684671|530111164|FG001|Overall Study|Adverse Event|0|||
146986090|NCT00684671|530111165|FG002|Overall Study|Adverse Event|0|||
146986091|NCT00684671|530111163|FG000|Overall Study|Lost to Follow-up|1|||
146986092|NCT00684671|530111164|FG001|Overall Study|Lost to Follow-up|0|||
146986093|NCT00684671|530111165|FG002|Overall Study|Lost to Follow-up|0|||
146828907|NCT00874497|529544970|FG001|Overall Study|Adverse Event|4|||
146986094|NCT00684671|530111163|FG000|Overall Study|Alcoholic dependance|1|||
146986095|NCT00684671|530111164|FG001|Overall Study|Alcoholic dependance|0|||
146986096|NCT00684671|530111165|FG002|Overall Study|Alcoholic dependance|0|||
146828908|NCT00874497|529544969|FG000|Overall Study|Sponsor Discontinued Trial|7|||
146828909|NCT00874497|529544970|FG001|Overall Study|Sponsor Discontinued Trial|3|||
146828910|NCT00874497|529544969|FG000|Overall Study|Met Withdrawal Criteria|4|||
146828911|NCT00874497|529544970|FG001|Overall Study|Met Withdrawal Criteria|2|||
146828912|NCT00874497|529544969|FG000|Overall Study|Physician Decision|1|||
146828913|NCT00874497|529544970|FG001|Overall Study|Physician Decision|1|||
146828914|NCT00874497|529544969|FG000|Overall Study|Withdrawal by Subject|5|||
146828915|NCT00874497|529544970|FG001|Overall Study|Withdrawal by Subject|4|||
146828916|NCT00644878|529544971|FG000|Overall Study|Adverse Event|2|||
146828917|NCT00644878|529544971|FG000|Overall Study|Abnormal laboratory value|3|||
146828918|NCT00644878|529544971|FG000|Overall Study|Protocol deviation|2|||
146828919|NCT00644878|529544971|FG000|Overall Study|Treatment duration completed as per protocol|11|||
146828920|NCT00770588|529544972|FG000|Overall Study|Adverse Event|9|||
146828921|NCT00770588|529544973|FG001|Overall Study|Adverse Event|2|||
146828922|NCT00770588|529544972|FG000|Overall Study|Death caused by progression of disease|70|||
146828923|NCT00770588|529544973|FG001|Overall Study|Death caused by progression of disease|91|||
146828924|NCT00770588|529544972|FG000|Overall Study|Lost to Follow-up|1|||
146828925|NCT00770588|529544973|FG001|Overall Study|Lost to Follow-up|1|||
146828926|NCT00770588|529544972|FG000|Overall Study|Withdrawal by Subject|1|||
146828927|NCT00770588|529544973|FG001|Overall Study|Withdrawal by Subject|1|||
146828928|NCT00665223|529544976|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
146828929|NCT00665223|529544977|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
146828930|NCT00665223|529544978|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
146828931|NCT00665223|529544976|FG000|Randomized Phase (26 Weeks)|Death|0|||
146828932|NCT00665223|529544977|FG001|Randomized Phase (26 Weeks)|Death|0|||
146828933|NCT00665223|529544978|FG002|Randomized Phase (26 Weeks)|Death|1|||
146828934|NCT00665223|529544976|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
146828935|NCT00665223|529544977|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
146828936|NCT00665223|529544978|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
146828937|NCT00665223|529544976|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
146828938|NCT00665223|529544977|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
146828939|NCT00665223|529544978|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
146828940|NCT00665223|529544976|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
146828941|NCT00665223|529544977|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
146828942|NCT00665223|529544978|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
146828943|NCT00665223|529544976|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
146828944|NCT00665223|529544977|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
146828945|NCT00665223|529544978|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
146828946|NCT00665223|529544976|FG000|Open-Label Period (26 Weeks)|Death|0|||
146828947|NCT00665223|529544977|FG001|Open-Label Period (26 Weeks)|Death|1|||
146828948|NCT00665223|529544978|FG002|Open-Label Period (26 Weeks)|Death|0|||
146828949|NCT00665223|529544976|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
146828950|NCT00665223|529544977|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
146828951|NCT00665223|529544978|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
146828952|NCT00665223|529544976|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
146828953|NCT00665223|529544977|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
146828954|NCT00665223|529544978|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
146828955|NCT00665223|529544976|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
146828956|NCT00665223|529544977|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
146828957|NCT00665223|529544978|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
146828958|NCT00665223|529544976|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
146828959|NCT00665223|529544977|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
146828960|NCT00665223|529544978|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
146828961|NCT00591591|529544979|FG000|Overall Study|Withdrawal by Subject|1|||
146828962|NCT00591591|529544980|FG001|Overall Study|Withdrawal by Subject|37|||
146828963|NCT00591591|529544979|FG000|Overall Study|Lack of Efficacy|10|||
146828964|NCT00591591|529544980|FG001|Overall Study|Lack of Efficacy|2|||
146828965|NCT00002597|529544981|FG000|Overall Study|Protocol Violation|19|||
146828966|NCT00002597|529544982|FG001|Overall Study|Protocol Violation|17|||
146828967|NCT00002597|529544981|FG000|Overall Study|Withdrawal by Subject|7|||
146828968|NCT00002597|529544982|FG001|Overall Study|Withdrawal by Subject|6|||
146828969|NCT01426113|529544985|FG000|Overall Study|Study Discontinued|1|||
146828970|NCT01426113|529544986|FG001|Overall Study|Study Discontinued|1|||
146828971|NCT01426113|529544985|FG000|Overall Study|Adverse Event|0|||
146828972|NCT01426113|529544986|FG001|Overall Study|Adverse Event|1|||
146828973|NCT00468130|529544989|FG000|Overall Study|Adverse Event|2|||
146828974|NCT00468130|529544990|FG001|Overall Study|Adverse Event|1|||
146828975|NCT00468130|529544989|FG000|Overall Study|Withdrawal by Subject|0|||
146828976|NCT00468130|529544990|FG001|Overall Study|Withdrawal by Subject|1|||
146828977|NCT02485899|529544991|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
146828978|NCT02485899|529544992|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146828979|NCT02485899|529544991|FG000|Overall Study|Withdrawal by Subject|1|||
146828980|NCT02485899|529544992|FG001|Overall Study|Withdrawal by Subject|0|||
146828981|NCT02485899|529544991|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
146986097|NCT00437281|530111168|FG000|Overall Study|Adverse Event|0|||
146986098|NCT00437281|530111169|FG001|Overall Study|Adverse Event|0|||
146986099|NCT00437281|530111170|FG002|Overall Study|Adverse Event|0|||
146986100|NCT00437281|530111171|FG003|Overall Study|Adverse Event|1|||
146986101|NCT00437281|530111172|FG004|Overall Study|Adverse Event|0|||
146986102|NCT00437281|530111173|FG005|Overall Study|Adverse Event|1|||
146986103|NCT00437281|530111174|FG006|Overall Study|Adverse Event|0|||
146986104|NCT00437281|530111175|FG007|Overall Study|Adverse Event|0|||
146986105|NCT00437281|530111176|FG008|Overall Study|Adverse Event|0|||
146986106|NCT00437281|530111177|FG009|Overall Study|Adverse Event|1|||
146986107|NCT00437281|530111178|FG010|Overall Study|Adverse Event|0|||
146986108|NCT00437281|530111179|FG011|Overall Study|Adverse Event|0|||
146986109|NCT00437281|530111180|FG012|Overall Study|Adverse Event|0|||
146986110|NCT00437281|530111181|FG013|Overall Study|Adverse Event|1|||
146986111|NCT00437281|530111182|FG014|Overall Study|Adverse Event|1|||
146986112|NCT00437281|530111183|FG015|Overall Study|Adverse Event|0|||
146986113|NCT00437281|530111184|FG016|Overall Study|Adverse Event|0|||
146986114|NCT00437281|530111185|FG017|Overall Study|Adverse Event|0|||
146986115|NCT00437281|530111186|FG018|Overall Study|Adverse Event|1|||
146986116|NCT00437281|530111187|FG019|Overall Study|Adverse Event|0|||
146986117|NCT00437281|530111168|FG000|Overall Study|Lost to Follow-up|0|||
146986118|NCT00437281|530111169|FG001|Overall Study|Lost to Follow-up|0|||
146986119|NCT00437281|530111170|FG002|Overall Study|Lost to Follow-up|0|||
146986120|NCT00437281|530111171|FG003|Overall Study|Lost to Follow-up|0|||
146986121|NCT00437281|530111172|FG004|Overall Study|Lost to Follow-up|0|||
146986122|NCT00437281|530111173|FG005|Overall Study|Lost to Follow-up|0|||
146986123|NCT00437281|530111174|FG006|Overall Study|Lost to Follow-up|0|||
146986124|NCT00437281|530111175|FG007|Overall Study|Lost to Follow-up|0|||
146986125|NCT00437281|530111176|FG008|Overall Study|Lost to Follow-up|0|||
146986126|NCT00437281|530111177|FG009|Overall Study|Lost to Follow-up|0|||
146986127|NCT00437281|530111178|FG010|Overall Study|Lost to Follow-up|0|||
146986128|NCT00437281|530111179|FG011|Overall Study|Lost to Follow-up|0|||
146986129|NCT00437281|530111180|FG012|Overall Study|Lost to Follow-up|0|||
146986130|NCT00437281|530111181|FG013|Overall Study|Lost to Follow-up|0|||
146986131|NCT00437281|530111182|FG014|Overall Study|Lost to Follow-up|0|||
146986132|NCT00437281|530111183|FG015|Overall Study|Lost to Follow-up|0|||
146986133|NCT00437281|530111184|FG016|Overall Study|Lost to Follow-up|0|||
146828982|NCT02485899|529544992|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
146828983|NCT00436956|529544993|FG000|Overall Study|Not evaluable|1|||
146828984|NCT00436956|529544994|FG001|Overall Study|Not evaluable|0|||
146828985|NCT03517111|529544997|FG000|Enrolled|Withdrawal by Subject|0|||
146828986|NCT03517111|529544998|FG001|Enrolled|Withdrawal by Subject|1|||
146828987|NCT03517111|529544999|FG002|Enrolled|Withdrawal by Subject|0|||
146828988|NCT03517111|529544997|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
146828989|NCT03517111|529544998|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
146828990|NCT03517111|529544999|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
146828991|NCT03517111|529544997|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
146828992|NCT03517111|529544998|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
146828993|NCT03517111|529544999|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
146828994|NCT03517111|529544997|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
146828995|NCT03517111|529544998|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
146828996|NCT03517111|529544999|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
146828997|NCT03517111|529544997|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
146828998|NCT03517111|529544998|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
146828999|NCT03517111|529544999|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
146829000|NCT00912223|529545000|FG000|Overall Study|Withdrawal by Subject|1|||
146829001|NCT00912223|529545000|FG000|Overall Study|Not transplanted|1|||
146829002|NCT00912223|529545000|FG000|Overall Study|Transformed disease|1|||
146829003|NCT02062645|529545003|FG000|Overall Study|Adverse Event|2|||
146829004|NCT02062645|529545003|FG000|Overall Study|Protocol Violation|8|||
146829005|NCT02062645|529545003|FG000|Overall Study|Lost to Follow-up|5|||
146829006|NCT02604342|529545004|FG000|Overall Study|Death|32|||
146829007|NCT02604342|529545005|FG001|Overall Study|Death|16|||
146829008|NCT02604342|529545004|FG000|Overall Study|Progression of disease|1|||
146986134|NCT00437281|530111185|FG017|Overall Study|Lost to Follow-up|0|||
146829009|NCT02604342|529545005|FG001|Overall Study|Progression of disease|0|||
146829010|NCT02604342|529545004|FG000|Overall Study|Withdrawal by Subject|5|||
146829011|NCT02604342|529545005|FG001|Overall Study|Withdrawal by Subject|6|||
146829012|NCT02604342|529545004|FG000|Overall Study|Other|1|||
146829013|NCT02604342|529545005|FG001|Overall Study|Other|0|||
146986135|NCT00437281|530111186|FG018|Overall Study|Lost to Follow-up|0|||
146986136|NCT00437281|530111187|FG019|Overall Study|Lost to Follow-up|1|||
146986137|NCT00249821|530111190|FG000|Overall Study|Technical problem|0|||
146986138|NCT00249821|530111191|FG001|Overall Study|Technical problem|1|||
146986139|NCT01348542|530111195|FG000|Overall Study|Withdrawal by Subject|3|||
146986140|NCT01348542|530111196|FG001|Overall Study|Withdrawal by Subject|0|||
146986141|NCT00467584|530111197|FG000|Overall Study|Withdrawal by Subject|4|||
146986142|NCT00467584|530111198|FG001|Overall Study|Withdrawal by Subject|5|||
146829014|NCT02604342|529545004|FG000|Overall Study|Study Termination by Sponsor|1|||
146829015|NCT02604342|529545005|FG001|Overall Study|Study Termination by Sponsor|0|||
146829016|NCT02604342|529545004|FG000|Overall Study|Lost to Follow-up|1|||
146829017|NCT02604342|529545005|FG001|Overall Study|Lost to Follow-up|1|||
146829018|NCT02604342|529545004|FG000|Overall Study|Physician Decision|2|||
146829019|NCT02604342|529545005|FG001|Overall Study|Physician Decision|0|||
146829020|NCT02024750|529545006|FG000|Overall Study|Withdrawal by Subject|2|||
146829021|NCT02024750|529545007|FG001|Overall Study|Withdrawal by Subject|1|||
146829022|NCT02261285|529545008|FG000|Overall Study|Disease progression|0|||
146829023|NCT02261285|529545009|FG001|Overall Study|Disease progression|0|||
146829024|NCT02261285|529545010|FG002|Overall Study|Disease progression|1|||
146829025|NCT01702519|529545011|FG000|Washout Period|Lost to Follow-up|1|||
146829026|NCT01702519|529545012|FG001|Washout Period|Lost to Follow-up|0|||
146829027|NCT01702519|529545011|FG000|Washout Period|Withdrawal by Subject|0|||
146829028|NCT01702519|529545012|FG001|Washout Period|Withdrawal by Subject|2|||
146829029|NCT01891890|529545013|FG000|Overall Study|Lost to Follow-up|0|||
146829030|NCT01891890|529545014|FG001|Overall Study|Lost to Follow-up|0|||
146829031|NCT01891890|529545015|FG002|Overall Study|Lost to Follow-up|1|||
146829032|NCT01891890|529545013|FG000|Overall Study|Study ended before endpoint reached|7|||
146829033|NCT01891890|529545014|FG001|Overall Study|Study ended before endpoint reached|3|||
146829034|NCT01891890|529545015|FG002|Overall Study|Study ended before endpoint reached|6|||
146829035|NCT01161628|529545016|FG000|Overall Study|Death|6|||
146829036|NCT01161628|529545016|FG000|Overall Study|Lack of Efficacy|2|||
146829037|NCT00746356|529545023|FG000|Overall Study|Withdrawal by Subject|2|||
146829038|NCT00746356|529545024|FG001|Overall Study|Withdrawal by Subject|3|||
146829039|NCT00746356|529545023|FG000|Overall Study|Death|7|||
146829040|NCT00746356|529545024|FG001|Overall Study|Death|3|||
146829041|NCT00746356|529545023|FG000|Overall Study|Lost to Follow-up|1|||
146829042|NCT00746356|529545024|FG001|Overall Study|Lost to Follow-up|0|||
146829043|NCT00746356|529545023|FG000|Overall Study|Removal of Device|0|||
146829044|NCT00746356|529545024|FG001|Overall Study|Removal of Device|1|||
146829045|NCT00746356|529545023|FG000|Overall Study|Patient relocated|1|||
146829046|NCT00746356|529545024|FG001|Overall Study|Patient relocated|0|||
146829047|NCT01263925|529545025|FG000|Overall Study|Protocol Violation|1|||
146829048|NCT01263925|529545026|FG001|Overall Study|Protocol Violation|0|||
146829049|NCT01263925|529545025|FG000|Overall Study|Lack of Efficacy|0|||
146829050|NCT01263925|529545026|FG001|Overall Study|Lack of Efficacy|1|||
146829051|NCT01263925|529545025|FG000|Overall Study|Adverse Event|23|||
146829052|NCT01263925|529545026|FG001|Overall Study|Adverse Event|22|||
146829053|NCT01263925|529545025|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
146829054|NCT01263925|529545026|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
146829055|NCT01263925|529545025|FG000|Overall Study|Withdrawal by Subject|6|||
146829056|NCT01263925|529545026|FG001|Overall Study|Withdrawal by Subject|8|||
146829057|NCT01263925|529545025|FG000|Overall Study|Other|4|||
146829058|NCT01263925|529545026|FG001|Overall Study|Other|4|||
146829059|NCT01263925|529545025|FG000|Overall Study|Lost to Follow-up|3|||
146829060|NCT01263925|529545026|FG001|Overall Study|Lost to Follow-up|1|||
146829061|NCT01263925|529545025|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
146829062|NCT01263925|529545026|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
146829063|NCT01263925|529545025|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
146829064|NCT01263925|529545026|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
146958209|NCT04594213|530006309|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
146958210|NCT04594213|530006310|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
146958211|NCT04594213|530006311|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
146958212|NCT04594213|530006312|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
146829065|NCT01263925|529545025|FG000|Overall Study|AE/ Withdrawal|1|||
146829066|NCT01263925|529545026|FG001|Overall Study|AE/ Withdrawal|4|||
146829067|NCT01263925|529545025|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
146829068|NCT01263925|529545026|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
146829069|NCT01263925|529545025|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
146829070|NCT01263925|529545026|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
146829071|NCT01263925|529545025|FG000|Overall Study|Withdrawal/ Not specified|0|||
146829072|NCT01263925|529545026|FG001|Overall Study|Withdrawal/ Not specified|1|||
146829073|NCT03605368|529545032|FG000|Overall Study|Lost to Follow-up|2|||
146829074|NCT03605368|529545033|FG001|Overall Study|Lost to Follow-up|1|||
146829075|NCT03605368|529545034|FG002|Overall Study|Lost to Follow-up|3|||
146829076|NCT03605368|529545035|FG003|Overall Study|Lost to Follow-up|2|||
146829077|NCT03605368|529545032|FG000|Overall Study|Withdrawal by Subject|0|||
146829078|NCT03605368|529545033|FG001|Overall Study|Withdrawal by Subject|0|||
146829079|NCT03605368|529545034|FG002|Overall Study|Withdrawal by Subject|4|||
146829080|NCT03605368|529545035|FG003|Overall Study|Withdrawal by Subject|3|||
146829081|NCT01726517|529545036|FG000|Overall Study|Withdrawal by Subject|0|||
146829082|NCT01726517|529545037|FG001|Overall Study|Withdrawal by Subject|0|||
146829083|NCT01726517|529545038|FG002|Overall Study|Withdrawal by Subject|1|||
146829084|NCT01726517|529545039|FG003|Overall Study|Withdrawal by Subject|0|||
146829085|NCT01726517|529545040|FG004|Overall Study|Withdrawal by Subject|0|||
146829086|NCT02484547|529545041|FG000|Placebo-Controlled Period|Adverse Event|10|||
146829087|NCT02484547|529545042|FG001|Placebo-Controlled Period|Adverse Event|13|||
146829088|NCT02484547|529545043|FG002|Placebo-Controlled Period|Adverse Event|20|||
146829089|NCT02484547|529545044|FG003|Placebo-Controlled Period|Adverse Event|0|||
146829090|NCT02484547|529545045|FG004|Placebo-Controlled Period|Adverse Event|0|||
146829091|NCT02484547|529545046|FG005|Placebo-Controlled Period|Adverse Event|0|||
146829092|NCT02484547|529545047|FG006|Placebo-Controlled Period|Adverse Event|0|||
146829093|NCT02484547|529545041|FG000|Placebo-Controlled Period|Change of Treatment|0|||
146829094|NCT02484547|529545042|FG001|Placebo-Controlled Period|Change of Treatment|0|||
146829095|NCT02484547|529545043|FG002|Placebo-Controlled Period|Change of Treatment|1|||
146829096|NCT02484547|529545044|FG003|Placebo-Controlled Period|Change of Treatment|0|||
146829097|NCT02484547|529545045|FG004|Placebo-Controlled Period|Change of Treatment|0|||
146829098|NCT02484547|529545046|FG005|Placebo-Controlled Period|Change of Treatment|0|||
146829099|NCT02484547|529545047|FG006|Placebo-Controlled Period|Change of Treatment|0|||
146829100|NCT02484547|529545041|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
146829101|NCT02484547|529545042|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
146829102|NCT02484547|529545043|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
146829103|NCT02484547|529545044|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
146829104|NCT02484547|529545045|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
146829105|NCT02484547|529545046|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
146829106|NCT02484547|529545047|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
146829107|NCT02484547|529545041|FG000|Placebo-Controlled Period|Death|5|||
146829108|NCT02484547|529545042|FG001|Placebo-Controlled Period|Death|0|||
146829109|NCT02484547|529545043|FG002|Placebo-Controlled Period|Death|6|||
146829110|NCT02484547|529545044|FG003|Placebo-Controlled Period|Death|0|||
146829111|NCT02484547|529545045|FG004|Placebo-Controlled Period|Death|0|||
146829112|NCT02484547|529545046|FG005|Placebo-Controlled Period|Death|0|||
146829113|NCT02484547|529545047|FG006|Placebo-Controlled Period|Death|0|||
146829114|NCT02484547|529545041|FG000|Placebo-Controlled Period|Disease Progression|2|||
146829115|NCT02484547|529545042|FG001|Placebo-Controlled Period|Disease Progression|0|||
146829116|NCT02484547|529545043|FG002|Placebo-Controlled Period|Disease Progression|1|||
146829117|NCT02484547|529545044|FG003|Placebo-Controlled Period|Disease Progression|0|||
146829118|NCT02484547|529545045|FG004|Placebo-Controlled Period|Disease Progression|0|||
146829119|NCT02484547|529545046|FG005|Placebo-Controlled Period|Disease Progression|0|||
146829120|NCT02484547|529545047|FG006|Placebo-Controlled Period|Disease Progression|0|||
146829121|NCT02484547|529545041|FG000|Placebo-Controlled Period|Investigator Decision|2|||
146829122|NCT02484547|529545042|FG001|Placebo-Controlled Period|Investigator Decision|2|||
146829123|NCT02484547|529545043|FG002|Placebo-Controlled Period|Investigator Decision|5|||
146829124|NCT02484547|529545044|FG003|Placebo-Controlled Period|Investigator Decision|0|||
146829125|NCT02484547|529545045|FG004|Placebo-Controlled Period|Investigator Decision|0|||
146829126|NCT02484547|529545046|FG005|Placebo-Controlled Period|Investigator Decision|0|||
146829127|NCT02484547|529545047|FG006|Placebo-Controlled Period|Investigator Decision|0|||
146829128|NCT02484547|529545041|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
146829129|NCT02484547|529545042|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
146829130|NCT02484547|529545043|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
146829131|NCT02484547|529545044|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
146829132|NCT02484547|529545045|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
146829133|NCT02484547|529545046|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
146829134|NCT02484547|529545047|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
146829135|NCT02484547|529545041|FG000|Placebo-Controlled Period|Relocation|1|||
146829136|NCT02484547|529545042|FG001|Placebo-Controlled Period|Relocation|1|||
146829137|NCT02484547|529545043|FG002|Placebo-Controlled Period|Relocation|1|||
146829138|NCT02484547|529545044|FG003|Placebo-Controlled Period|Relocation|0|||
146829139|NCT02484547|529545045|FG004|Placebo-Controlled Period|Relocation|0|||
146829140|NCT02484547|529545046|FG005|Placebo-Controlled Period|Relocation|0|||
146829141|NCT02484547|529545047|FG006|Placebo-Controlled Period|Relocation|0|||
146829142|NCT02484547|529545041|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
146829143|NCT02484547|529545042|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
146829144|NCT02484547|529545043|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
146829145|NCT02484547|529545044|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
146829146|NCT02484547|529545045|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
146986143|NCT00467584|530111199|FG002|Overall Study|Withdrawal by Subject|1|||
146829147|NCT02484547|529545046|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
146829148|NCT02484547|529545047|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
146829149|NCT02484547|529545041|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
146829150|NCT02484547|529545042|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
146829151|NCT02484547|529545043|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
146829152|NCT02484547|529545044|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146829153|NCT02484547|529545045|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146829154|NCT02484547|529545046|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146829155|NCT02484547|529545047|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146986144|NCT00926289|530111200|FG000|Overall Study|Adverse Event|9|||
146829156|NCT02484547|529545041|FG000|Placebo-Controlled Period|Reason not Specified|216|||
146829157|NCT02484547|529545042|FG001|Placebo-Controlled Period|Reason not Specified|194|||
146829158|NCT02484547|529545043|FG002|Placebo-Controlled Period|Reason not Specified|183|||
146829159|NCT02484547|529545044|FG003|Placebo-Controlled Period|Reason not Specified|0|||
146829160|NCT02484547|529545045|FG004|Placebo-Controlled Period|Reason not Specified|0|||
146829161|NCT02484547|529545046|FG005|Placebo-Controlled Period|Reason not Specified|0|||
146829162|NCT02484547|529545047|FG006|Placebo-Controlled Period|Reason not Specified|0|||
146829163|NCT02484547|529545041|FG000|Long-Term Extension Period|Adverse Event|0|||
146829164|NCT02484547|529545042|FG001|Long-Term Extension Period|Adverse Event|0|||
146829165|NCT02484547|529545043|FG002|Long-Term Extension Period|Adverse Event|0|||
146829166|NCT02484547|529545044|FG003|Long-Term Extension Period|Adverse Event|0|||
146829167|NCT02484547|529545045|FG004|Long-Term Extension Period|Adverse Event|1|||
146829168|NCT02484547|529545046|FG005|Long-Term Extension Period|Adverse Event|3|||
146829169|NCT02484547|529545047|FG006|Long-Term Extension Period|Adverse Event|2|||
146829170|NCT02484547|529545041|FG000|Long-Term Extension Period|Death|0|||
146829171|NCT02484547|529545042|FG001|Long-Term Extension Period|Death|0|||
146829172|NCT02484547|529545043|FG002|Long-Term Extension Period|Death|0|||
146829173|NCT02484547|529545044|FG003|Long-Term Extension Period|Death|0|||
146829174|NCT02484547|529545045|FG004|Long-Term Extension Period|Death|0|||
146829175|NCT02484547|529545046|FG005|Long-Term Extension Period|Death|3|||
146829176|NCT02484547|529545047|FG006|Long-Term Extension Period|Death|0|||
146829177|NCT02484547|529545041|FG000|Long-Term Extension Period|Disease Progression|0|||
146829178|NCT02484547|529545042|FG001|Long-Term Extension Period|Disease Progression|0|||
146829179|NCT02484547|529545043|FG002|Long-Term Extension Period|Disease Progression|0|||
146829180|NCT02484547|529545044|FG003|Long-Term Extension Period|Disease Progression|0|||
146829181|NCT02484547|529545045|FG004|Long-Term Extension Period|Disease Progression|2|||
146829182|NCT02484547|529545046|FG005|Long-Term Extension Period|Disease Progression|4|||
146829183|NCT02484547|529545047|FG006|Long-Term Extension Period|Disease Progression|0|||
146829184|NCT02484547|529545041|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
146829185|NCT02484547|529545042|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
146829186|NCT02484547|529545043|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
146829187|NCT02484547|529545044|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
146829188|NCT02484547|529545045|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
146829189|NCT02484547|529545046|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
146829190|NCT02484547|529545047|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
146829191|NCT02484547|529545041|FG000|Long-Term Extension Period|Loss of Capacity|0|||
146829192|NCT02484547|529545042|FG001|Long-Term Extension Period|Loss of Capacity|0|||
146829193|NCT02484547|529545043|FG002|Long-Term Extension Period|Loss of Capacity|0|||
146829194|NCT02484547|529545044|FG003|Long-Term Extension Period|Loss of Capacity|0|||
146829195|NCT02484547|529545045|FG004|Long-Term Extension Period|Loss of Capacity|1|||
146829196|NCT02484547|529545046|FG005|Long-Term Extension Period|Loss of Capacity|0|||
146829197|NCT02484547|529545047|FG006|Long-Term Extension Period|Loss of Capacity|0|||
146829198|NCT02484547|529545041|FG000|Long-Term Extension Period|Change of Treatment|0|||
146829199|NCT02484547|529545042|FG001|Long-Term Extension Period|Change of Treatment|0|||
146829200|NCT02484547|529545043|FG002|Long-Term Extension Period|Change of Treatment|0|||
146829201|NCT02484547|529545044|FG003|Long-Term Extension Period|Change of Treatment|0|||
146829202|NCT02484547|529545045|FG004|Long-Term Extension Period|Change of Treatment|0|||
146829203|NCT02484547|529545046|FG005|Long-Term Extension Period|Change of Treatment|0|||
146829204|NCT02484547|529545047|FG006|Long-Term Extension Period|Change of Treatment|1|||
146829205|NCT02484547|529545041|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
146829206|NCT02484547|529545042|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
146829207|NCT02484547|529545043|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
146829208|NCT02484547|529545044|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
146829209|NCT02484547|529545045|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
146829210|NCT02484547|529545046|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
146829211|NCT02484547|529545047|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
146829212|NCT02484547|529545041|FG000|Long-Term Extension Period|Investigator Decision|0|||
146829213|NCT02484547|529545042|FG001|Long-Term Extension Period|Investigator Decision|0|||
146829214|NCT02484547|529545043|FG002|Long-Term Extension Period|Investigator Decision|0|||
146829215|NCT02484547|529545044|FG003|Long-Term Extension Period|Investigator Decision|2|||
146829216|NCT02484547|529545045|FG004|Long-Term Extension Period|Investigator Decision|1|||
146829217|NCT02484547|529545046|FG005|Long-Term Extension Period|Investigator Decision|0|||
146829218|NCT02484547|529545047|FG006|Long-Term Extension Period|Investigator Decision|1|||
146829219|NCT02484547|529545041|FG000|Long-Term Extension Period|Relocation|0|||
146829220|NCT02484547|529545042|FG001|Long-Term Extension Period|Relocation|0|||
146829221|NCT02484547|529545043|FG002|Long-Term Extension Period|Relocation|0|||
146829222|NCT02484547|529545044|FG003|Long-Term Extension Period|Relocation|1|||
146829223|NCT02484547|529545045|FG004|Long-Term Extension Period|Relocation|1|||
146829224|NCT02484547|529545046|FG005|Long-Term Extension Period|Relocation|0|||
146829225|NCT02484547|529545047|FG006|Long-Term Extension Period|Relocation|0|||
146829226|NCT02484547|529545041|FG000|Long-Term Extension Period|Study Visit Burden|0|||
146829227|NCT02484547|529545042|FG001|Long-Term Extension Period|Study Visit Burden|0|||
146829228|NCT02484547|529545043|FG002|Long-Term Extension Period|Study Visit Burden|0|||
146829229|NCT02484547|529545044|FG003|Long-Term Extension Period|Study Visit Burden|2|||
146829230|NCT02484547|529545045|FG004|Long-Term Extension Period|Study Visit Burden|0|||
146829231|NCT02484547|529545046|FG005|Long-Term Extension Period|Study Visit Burden|0|||
146829232|NCT02484547|529545047|FG006|Long-Term Extension Period|Study Visit Burden|3|||
146829233|NCT02484547|529545041|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
146829234|NCT02484547|529545042|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
146829235|NCT02484547|529545043|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
146829236|NCT02484547|529545044|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
146829237|NCT02484547|529545045|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
146829238|NCT02484547|529545046|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
146829239|NCT02484547|529545047|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
146829240|NCT02484547|529545041|FG000|Long-Term Extension Period|Reason not Specified|0|||
146829241|NCT02484547|529545042|FG001|Long-Term Extension Period|Reason not Specified|0|||
146829242|NCT02484547|529545043|FG002|Long-Term Extension Period|Reason not Specified|0|||
146829243|NCT02484547|529545044|FG003|Long-Term Extension Period|Reason not Specified|119|||
146829244|NCT02484547|529545045|FG004|Long-Term Extension Period|Reason not Specified|117|||
146829245|NCT02484547|529545046|FG005|Long-Term Extension Period|Reason not Specified|223|||
146829246|NCT02484547|529545047|FG006|Long-Term Extension Period|Reason not Specified|231|||
146829247|NCT03765164|529545048|FG000|Pre-intervention|Withdrawal by Subject|5|||
146829248|NCT03765164|529545049|FG001|Pre-intervention|Withdrawal by Subject|6|||
146829249|NCT01665599|529545050|FG000|Overall Study|Adverse Event|1|||
146829250|NCT01665599|529545050|FG000|Overall Study|Consent Withdrawn|1|||
146829251|NCT01665599|529545050|FG000|Overall Study|Investigator/Sponsor decision|1|||
146829252|NCT01665599|529545050|FG000|Overall Study|Death|1|||
146829253|NCT01665599|529545050|FG000|Overall Study|Lost to Follow-up|2|||
146829254|NCT01665599|529545050|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
146829255|NCT01665599|529545050|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
146829256|NCT01494298|529545051|FG000|Overall Study|Protocol Violation|2|||
146829257|NCT01494298|529545052|FG001|Overall Study|Protocol Violation|8|||
146829258|NCT04944784|529545055|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
146829259|NCT04944784|529545056|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
146829260|NCT04944784|529545057|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
146829261|NCT04944784|529545058|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
146829262|NCT04944784|529545055|FG000|Double-blind Period|Adverse Event|20|||
146829263|NCT04944784|529545056|FG001|Double-blind Period|Adverse Event|4|||
146829264|NCT04944784|529545057|FG002|Double-blind Period|Adverse Event|0|||
146829265|NCT04944784|529545058|FG003|Double-blind Period|Adverse Event|0|||
146829266|NCT04944784|529545055|FG000|Double-blind Period|Withdrawal by Subject|15|||
146829267|NCT04944784|529545056|FG001|Double-blind Period|Withdrawal by Subject|4|||
146829268|NCT04944784|529545057|FG002|Double-blind Period|Withdrawal by Subject|0|||
146829269|NCT04944784|529545058|FG003|Double-blind Period|Withdrawal by Subject|0|||
146829270|NCT04944784|529545055|FG000|Double-blind Period|Death|7|||
146829271|NCT04944784|529545056|FG001|Double-blind Period|Death|2|||
146829272|NCT04944784|529545057|FG002|Double-blind Period|Death|0|||
146829273|NCT04944784|529545058|FG003|Double-blind Period|Death|0|||
146829274|NCT04944784|529545055|FG000|Double-blind Period|Physician Decision|2|||
146829275|NCT04944784|529545056|FG001|Double-blind Period|Physician Decision|1|||
146829276|NCT04944784|529545057|FG002|Double-blind Period|Physician Decision|0|||
146829277|NCT04944784|529545058|FG003|Double-blind Period|Physician Decision|0|||
146829278|NCT04944784|529545055|FG000|Double-blind Period|Lack of Efficacy|0|||
146829279|NCT04944784|529545056|FG001|Double-blind Period|Lack of Efficacy|1|||
146829280|NCT04944784|529545057|FG002|Double-blind Period|Lack of Efficacy|0|||
146829281|NCT04944784|529545058|FG003|Double-blind Period|Lack of Efficacy|0|||
146829282|NCT04944784|529545055|FG000|Double-blind Period|Sponsor Request|2|||
146829283|NCT04944784|529545056|FG001|Double-blind Period|Sponsor Request|1|||
146829284|NCT04944784|529545057|FG002|Double-blind Period|Sponsor Request|0|||
146829285|NCT04944784|529545058|FG003|Double-blind Period|Sponsor Request|0|||
146829286|NCT04944784|529545055|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
146829287|NCT04944784|529545056|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
146829288|NCT04944784|529545057|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
146829289|NCT04944784|529545058|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
146829290|NCT04944784|529545055|FG000|Double-blind Period|Participant Choice|1|||
146829291|NCT04944784|529545056|FG001|Double-blind Period|Participant Choice|1|||
146829292|NCT04944784|529545057|FG002|Double-blind Period|Participant Choice|0|||
146986145|NCT00926289|530111201|FG001|Overall Study|Adverse Event|11|||
146829293|NCT04944784|529545058|FG003|Double-blind Period|Participant Choice|0|||
146829294|NCT04944784|529545055|FG000|Double-blind Period|Progressive Disease|2|||
146829295|NCT04944784|529545056|FG001|Double-blind Period|Progressive Disease|2|||
146829296|NCT04944784|529545057|FG002|Double-blind Period|Progressive Disease|0|||
146829297|NCT04944784|529545058|FG003|Double-blind Period|Progressive Disease|0|||
146829298|NCT04944784|529545055|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
146829299|NCT04944784|529545056|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
146829300|NCT04944784|529545057|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
146829301|NCT04944784|529545058|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
146829302|NCT04944784|529545055|FG000|Active Drug Period|Adverse Event|0|||
146829303|NCT04944784|529545056|FG001|Active Drug Period|Adverse Event|0|||
146829304|NCT04944784|529545057|FG002|Active Drug Period|Adverse Event|3|||
146829305|NCT04944784|529545058|FG003|Active Drug Period|Adverse Event|6|||
146829306|NCT04944784|529545055|FG000|Active Drug Period|Withdrawal by Subject|0|||
146829307|NCT04944784|529545056|FG001|Active Drug Period|Withdrawal by Subject|0|||
146829308|NCT04944784|529545057|FG002|Active Drug Period|Withdrawal by Subject|4|||
146829309|NCT04944784|529545058|FG003|Active Drug Period|Withdrawal by Subject|7|||
146829310|NCT04944784|529545055|FG000|Active Drug Period|Death|0|||
146829311|NCT04944784|529545056|FG001|Active Drug Period|Death|0|||
146829312|NCT04944784|529545057|FG002|Active Drug Period|Death|3|||
146829313|NCT04944784|529545058|FG003|Active Drug Period|Death|4|||
146829314|NCT04944784|529545055|FG000|Active Drug Period|Lack of Efficacy|0|||
146829315|NCT04944784|529545056|FG001|Active Drug Period|Lack of Efficacy|0|||
146829316|NCT04944784|529545057|FG002|Active Drug Period|Lack of Efficacy|2|||
146829317|NCT04944784|529545058|FG003|Active Drug Period|Lack of Efficacy|2|||
146829318|NCT04944784|529545055|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
146829319|NCT04944784|529545056|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
146829320|NCT04944784|529545057|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
146829321|NCT04944784|529545058|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
146829322|NCT04944784|529545055|FG000|Active Drug Period|Participant Choice|0|||
146829323|NCT04944784|529545056|FG001|Active Drug Period|Participant Choice|0|||
146829324|NCT04944784|529545057|FG002|Active Drug Period|Participant Choice|0|||
146829325|NCT04944784|529545058|FG003|Active Drug Period|Participant Choice|1|||
146829326|NCT04944784|529545055|FG000|Active Drug Period|Progressive Disease|0|||
146829327|NCT04944784|529545056|FG001|Active Drug Period|Progressive Disease|0|||
146829328|NCT04944784|529545057|FG002|Active Drug Period|Progressive Disease|4|||
146829329|NCT04944784|529545058|FG003|Active Drug Period|Progressive Disease|4|||
146829330|NCT04944784|529545055|FG000|Active Drug Period|Lost to Follow-up|0|||
146829331|NCT04944784|529545056|FG001|Active Drug Period|Lost to Follow-up|0|||
146829332|NCT04944784|529545057|FG002|Active Drug Period|Lost to Follow-up|0|||
146829333|NCT04944784|529545058|FG003|Active Drug Period|Lost to Follow-up|1|||
146829334|NCT00497874|529546611|FG000|Overall Study|Withdrawal by Subject|48|||
146829335|NCT00497874|529546612|FG001|Overall Study|Withdrawal by Subject|17|||
146829336|NCT00497874|529546611|FG000|Overall Study|Illness|8|||
146829337|NCT00497874|529546612|FG001|Overall Study|Illness|4|||
146829338|NCT00497874|529546611|FG000|Overall Study|Death|2|||
146829339|NCT00497874|529546612|FG001|Overall Study|Death|4|||
146829340|NCT00497874|529546611|FG000|Overall Study|Unable to contact|52|||
146829341|NCT00497874|529546612|FG001|Overall Study|Unable to contact|67|||
146829342|NCT00497874|529546611|FG000|Overall Study|Unable to schedule|37|||
146829343|NCT00497874|529546612|FG001|Overall Study|Unable to schedule|24|||
146829344|NCT02820597|529546613|FG000|Overall Study|Lost to Follow-up|12|||
146829345|NCT01053247|529546614|FG000|Overall Study|Withdrawal by Subject|9|||
146829346|NCT01053247|529546615|FG001|Overall Study|Withdrawal by Subject|4|||
146829347|NCT01053247|529546616|FG002|Overall Study|Withdrawal by Subject|15|||
146829348|NCT01053247|529546614|FG000|Overall Study|Lack of Efficacy|1|||
146829349|NCT01053247|529546615|FG001|Overall Study|Lack of Efficacy|0|||
146829350|NCT01053247|529546616|FG002|Overall Study|Lack of Efficacy|1|||
146829351|NCT01053247|529546614|FG000|Overall Study|Protocol Violation|2|||
146829352|NCT01053247|529546615|FG001|Overall Study|Protocol Violation|1|||
146829353|NCT01053247|529546616|FG002|Overall Study|Protocol Violation|2|||
146829354|NCT01053247|529546614|FG000|Overall Study|Lost to Follow-up|8|||
146829355|NCT01053247|529546615|FG001|Overall Study|Lost to Follow-up|5|||
146829356|NCT01053247|529546616|FG002|Overall Study|Lost to Follow-up|7|||
146829357|NCT01053247|529546614|FG000|Overall Study|Adverse Event|0|||
146829358|NCT01053247|529546615|FG001|Overall Study|Adverse Event|9|||
146829359|NCT01053247|529546616|FG002|Overall Study|Adverse Event|3|||
146986146|NCT00926289|530111200|FG000|Overall Study|Protocol Violation|8|||
146986147|NCT00926289|530111201|FG001|Overall Study|Protocol Violation|12|||
146986148|NCT00926289|530111200|FG000|Overall Study|Lost to Follow-up|3|||
146986149|NCT00926289|530111201|FG001|Overall Study|Lost to Follow-up|6|||
146986150|NCT00926289|530111200|FG000|Overall Study|Withdrawal by Subject|4|||
146829360|NCT00511836|529546623|FG000|Double-blind Period|Lost to Follow-up|1|||
146829361|NCT00511836|529546624|FG001|Double-blind Period|Lost to Follow-up|0|||
146829362|NCT00030823|529546625|FG000|Overall Study|Withdrawal by Subject|1|||
146829363|NCT00891046|529546626|FG000|Overall Study|Protocol Violation|1|||
146829364|NCT00891046|529546627|FG001|Overall Study|Protocol Violation|1|||
146829365|NCT00891046|529546628|FG002|Overall Study|Protocol Violation|0|||
146829366|NCT00891046|529546629|FG003|Overall Study|Protocol Violation|0|||
146829367|NCT00891046|529546630|FG004|Overall Study|Protocol Violation|1|||
146829368|NCT00891046|529546626|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
146829369|NCT00891046|529546627|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146829370|NCT00891046|529546628|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
146829371|NCT00891046|529546629|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
146986151|NCT00926289|530111201|FG001|Overall Study|Withdrawal by Subject|4|||
146829372|NCT00891046|529546630|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
146829373|NCT00891046|529546626|FG000|Overall Study|Administrative problems|0|||
146829374|NCT00891046|529546627|FG001|Overall Study|Administrative problems|0|||
146829375|NCT00891046|529546628|FG002|Overall Study|Administrative problems|0|||
146829376|NCT00891046|529546629|FG003|Overall Study|Administrative problems|0|||
146829377|NCT00891046|529546630|FG004|Overall Study|Administrative problems|1|||
146829378|NCT00891046|529546626|FG000|Overall Study|Participant no longer required drug|0|||
146829379|NCT00891046|529546627|FG001|Overall Study|Participant no longer required drug|2|||
146829380|NCT00891046|529546628|FG002|Overall Study|Participant no longer required drug|0|||
146829381|NCT00891046|529546629|FG003|Overall Study|Participant no longer required drug|0|||
146829382|NCT00891046|529546630|FG004|Overall Study|Participant no longer required drug|1|||
146829383|NCT00891046|529546626|FG000|Overall Study|Adverse Event|4|||
146829384|NCT00891046|529546627|FG001|Overall Study|Adverse Event|3|||
146829385|NCT00891046|529546628|FG002|Overall Study|Adverse Event|2|||
146829386|NCT00891046|529546629|FG003|Overall Study|Adverse Event|0|||
146829387|NCT00891046|529546630|FG004|Overall Study|Adverse Event|14|||
146829388|NCT00891046|529546626|FG000|Overall Study|Withdrawal by Subject|2|||
146829389|NCT00891046|529546627|FG001|Overall Study|Withdrawal by Subject|1|||
146829390|NCT00891046|529546628|FG002|Overall Study|Withdrawal by Subject|2|||
146829391|NCT00891046|529546629|FG003|Overall Study|Withdrawal by Subject|1|||
146829392|NCT00891046|529546630|FG004|Overall Study|Withdrawal by Subject|1|||
146829393|NCT00891046|529546626|FG000|Overall Study|Lost to Follow-up|0|||
146829394|NCT00891046|529546627|FG001|Overall Study|Lost to Follow-up|0|||
146829395|NCT00891046|529546628|FG002|Overall Study|Lost to Follow-up|0|||
146829396|NCT00891046|529546629|FG003|Overall Study|Lost to Follow-up|0|||
146829397|NCT00891046|529546630|FG004|Overall Study|Lost to Follow-up|1|||
146829398|NCT00362375|529546631|FG000|Overall Study|Lost to Follow-up|40|||
146829399|NCT00362375|529546632|FG001|Overall Study|Lost to Follow-up|35|||
146829400|NCT04984239|529546633|FG000|Overall Study|Lost to Follow-up|1|||
146829401|NCT04523207|529546636|FG000|Overall Study|Adverse Event|5|||
146829402|NCT04523207|529546637|FG001|Overall Study|Adverse Event|1|||
146829403|NCT04523207|529546636|FG000|Overall Study|Lost to Follow-up|2|||
146829404|NCT04523207|529546637|FG001|Overall Study|Lost to Follow-up|0|||
146829405|NCT04523207|529546636|FG000|Overall Study|Withdrawal by Subject|2|||
146829406|NCT04523207|529546637|FG001|Overall Study|Withdrawal by Subject|0|||
146829407|NCT04523207|529546636|FG000|Overall Study|Progressive Disease|2|||
146829408|NCT04523207|529546637|FG001|Overall Study|Progressive Disease|1|||
146829409|NCT04523207|529546636|FG000|Overall Study|Other|7|||
146829410|NCT04523207|529546637|FG001|Overall Study|Other|1|||
146829411|NCT03113383|529546638|FG000|Overall Study|Death|4|||
146829412|NCT03113383|529546639|FG001|Overall Study|Death|0|||
146829413|NCT03062449|529546641|FG000|Overall Study|Withdrawal by Subject|7|||
146829414|NCT03062449|529546642|FG001|Overall Study|Withdrawal by Subject|1|||
146829415|NCT04702893|529546644|FG000|Overall Study|Other reasons than listed|11|||
146829416|NCT04702893|529546644|FG000|Overall Study|Withdrawal by Subject|3|||
146829417|NCT04702893|529546644|FG000|Overall Study|Lost to Follow-up|7|||
146829418|NCT04702893|529546644|FG000|Overall Study|Death|10|||
146829419|NCT04702893|529546644|FG000|Overall Study|Not treated|6|||
146829420|NCT00408928|529546645|FG000|Overall Study|Withdrawal by Subject|1|||
146829421|NCT00408928|529546645|FG000|Overall Study|Death|1|||
146829422|NCT00408928|529546645|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
146829423|NCT01951378|529546648|FG000|Overall Study|Study Terminated-Not completed|23|||
146829424|NCT01951378|529546649|FG001|Overall Study|Study Terminated-Not completed|17|||
146829425|NCT00543062|529546650|FG000|Overall Study|Withdrawal by Subject|1|||
146829426|NCT00543062|529546651|FG001|Overall Study|Withdrawal by Subject|0|||
146829427|NCT00543062|529546652|FG002|Overall Study|Withdrawal by Subject|2|||
146829428|NCT00543062|529546653|FG003|Overall Study|Withdrawal by Subject|0|||
146829429|NCT00543062|529546650|FG000|Overall Study|Adverse Event|0|||
146829430|NCT00543062|529546651|FG001|Overall Study|Adverse Event|1|||
146958213|NCT04594213|530006313|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
146958214|NCT04594213|530006308|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
146958215|NCT04594213|530006309|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
146958216|NCT04594213|530006310|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
146958217|NCT04594213|530006311|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
146829431|NCT00543062|529546652|FG002|Overall Study|Adverse Event|1|||
146829432|NCT00543062|529546653|FG003|Overall Study|Adverse Event|1|||
146829433|NCT00543062|529546650|FG000|Overall Study|Protocol Violation|1|||
146829434|NCT00543062|529546651|FG001|Overall Study|Protocol Violation|0|||
146829435|NCT00543062|529546652|FG002|Overall Study|Protocol Violation|0|||
146829436|NCT00543062|529546653|FG003|Overall Study|Protocol Violation|0|||
146829437|NCT03927690|529546656|FG000|Overall Study|Withdrawal by Subject|3|||
146829438|NCT03927690|529546657|FG001|Overall Study|Withdrawal by Subject|1|||
146829439|NCT03927690|529546658|FG002|Overall Study|Withdrawal by Subject|1|||
146829440|NCT03927690|529546656|FG000|Overall Study|Adverse Event|1|||
146829441|NCT03927690|529546657|FG001|Overall Study|Adverse Event|0|||
146829442|NCT03927690|529546658|FG002|Overall Study|Adverse Event|0|||
146829443|NCT03927690|529546656|FG000|Overall Study|Death|1|||
146958218|NCT04594213|530006312|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
146829444|NCT03927690|529546657|FG001|Overall Study|Death|0|||
146829445|NCT03927690|529546658|FG002|Overall Study|Death|0|||
146829446|NCT03927690|529546656|FG000|Overall Study|Lost to Follow-up|2|||
146829447|NCT03927690|529546657|FG001|Overall Study|Lost to Follow-up|2|||
146829448|NCT03927690|529546658|FG002|Overall Study|Lost to Follow-up|1|||
146829449|NCT01844726|529546665|FG000|Overall Study|Withdrawal by Subject|0|||
146829450|NCT01844726|529546666|FG001|Overall Study|Withdrawal by Subject|1|||
146829451|NCT01844726|529546665|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
146829452|NCT01844726|529546666|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
146829453|NCT03898960|529546669|FG000|Overall Study|Death|10|||
146829454|NCT00548847|529546670|FG000|Overall Study|Disease progression|7|||
146829455|NCT01772563|529546679|FG000|Cycle 1|Dose limiting toxicity|2|||
146829456|NCT01772563|529546679|FG000|Cycle 1|Progressive disease|2|||
146829457|NCT01772563|529546679|FG000|Cycle 2 and Beyond|Progressive disease|17|||
146829458|NCT01772563|529546679|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
146829459|NCT01772563|529546679|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
146829460|NCT00832000|529546681|FG000|Overall Study|Adverse Event|2|||
146829461|NCT00832000|529546682|FG001|Overall Study|Adverse Event|0|||
146829462|NCT00832000|529546681|FG000|Overall Study|Withdrawal by Subject|1|||
146829463|NCT00832000|529546682|FG001|Overall Study|Withdrawal by Subject|0|||
146829464|NCT00832000|529546681|FG000|Overall Study|No calls to IVR in either period|1|||
146829465|NCT00832000|529546682|FG001|Overall Study|No calls to IVR in either period|1|||
146829466|NCT00832000|529546681|FG000|Overall Study|No calls to IVR in period 2|2|||
146829467|NCT00832000|529546682|FG001|Overall Study|No calls to IVR in period 2|0|||
146829468|NCT01898442|529546683|FG000|Overall Study|Hemolysis/technical problems|1|||
146829469|NCT01898442|529546684|FG001|Overall Study|Hemolysis/technical problems|2|||
146829470|NCT01898442|529546685|FG002|Overall Study|Hemolysis/technical problems|2|||
146829471|NCT01898442|529546683|FG000|Overall Study|Patient vomited pills|0|||
146829472|NCT01898442|529546684|FG001|Overall Study|Patient vomited pills|0|||
146829473|NCT01898442|529546685|FG002|Overall Study|Patient vomited pills|1|||
146829474|NCT01435798|529546686|FG000|Overall Study|Withdrawal by Subject|1|||
146829475|NCT03974100|529546687|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
146829476|NCT03974100|529546688|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
146829477|NCT03974100|529546689|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
146829478|NCT03974100|529546690|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
146829479|NCT03974100|529546691|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
146829480|NCT03974100|529546687|FG000|TP1 - Day 1 to Week 52|Death|1|||
146829481|NCT03974100|529546688|FG001|TP1 - Day 1 to Week 52|Death|0|||
146829482|NCT03974100|529546689|FG002|TP1 - Day 1 to Week 52|Death|0|||
146829483|NCT03974100|529546690|FG003|TP1 - Day 1 to Week 52|Death|0|||
146829484|NCT03974100|529546691|FG004|TP1 - Day 1 to Week 52|Death|0|||
146829485|NCT03974100|529546687|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
146829486|NCT03974100|529546688|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
146829487|NCT03974100|529546689|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
146829488|NCT03974100|529546690|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
146829489|NCT03974100|529546691|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
146829490|NCT03974100|529546687|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
146829491|NCT03974100|529546688|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
146829492|NCT03974100|529546689|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
146829493|NCT03974100|529546690|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
146829494|NCT03974100|529546691|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
146829495|NCT03974100|529546687|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
146829496|NCT03974100|529546688|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
146829497|NCT03974100|529546689|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
146829498|NCT03974100|529546690|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
146829499|NCT03974100|529546691|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
146829500|NCT03974100|529546687|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
146829501|NCT03974100|529546688|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
146829502|NCT03974100|529546689|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
146829503|NCT03974100|529546690|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
146829504|NCT03974100|529546691|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
146829505|NCT03974100|529546687|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
146829506|NCT03974100|529546688|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
146829507|NCT03974100|529546689|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
146829508|NCT03974100|529546690|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
146829509|NCT03974100|529546691|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
146829510|NCT00690378|529546692|FG000|Overall Study|Adverse Event|1|||
146829511|NCT00690378|529546693|FG001|Overall Study|Adverse Event|0|||
146829512|NCT00690378|529546692|FG000|Overall Study|Withdrawal by Subject|2|||
146829513|NCT00690378|529546693|FG001|Overall Study|Withdrawal by Subject|0|||
146829514|NCT00690378|529546692|FG000|Overall Study|Protocol Violation|1|||
146829515|NCT00690378|529546693|FG001|Overall Study|Protocol Violation|0|||
146829516|NCT00690378|529546692|FG000|Overall Study|Lost to Follow-up|2|||
146829517|NCT00690378|529546693|FG001|Overall Study|Lost to Follow-up|3|||
146829518|NCT00690378|529546692|FG000|Overall Study|Did not meet inc/exc criteria|13|||
146958219|NCT04594213|530006313|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
146829519|NCT00690378|529546693|FG001|Overall Study|Did not meet inc/exc criteria|11|||
146829520|NCT00690378|529546692|FG000|Overall Study|Social problem|1|||
146829521|NCT00690378|529546693|FG001|Overall Study|Social problem|0|||
146829522|NCT00935259|529546694|FG000|Period 1|Administrative (scheduling conflict)|1|||
146829523|NCT00935259|529546695|FG001|Period 1|Administrative (scheduling conflict)|1|||
146829524|NCT03318783|529546696|FG000|Overall Study|Withdrawal by Subject|0|||
146829525|NCT03318783|529546697|FG001|Overall Study|Withdrawal by Subject|1|||
146829526|NCT03318783|529546696|FG000|Overall Study|Death|0|||
146829527|NCT03318783|529546697|FG001|Overall Study|Death|1|||
146829528|NCT00623363|529546698|FG000|Overall Study|Adverse Event|2|||
146829529|NCT00623363|529546699|FG001|Overall Study|Adverse Event|2|||
146829530|NCT02719743|529546700|FG000|Overall Study|Consent withdrawal|0|||
146829531|NCT02719743|529546701|FG001|Overall Study|Consent withdrawal|2|||
146829532|NCT02719743|529546702|FG002|Overall Study|Consent withdrawal|0|||
146829533|NCT02719743|529546703|FG003|Overall Study|Consent withdrawal|1|||
146829534|NCT02719743|529546704|FG004|Overall Study|Consent withdrawal|0|||
146829535|NCT02719743|529546700|FG000|Overall Study|Migrated/moved from study area|0|||
146829536|NCT02719743|529546701|FG001|Overall Study|Migrated/moved from study area|0|||
146829537|NCT02719743|529546702|FG002|Overall Study|Migrated/moved from study area|0|||
146829538|NCT02719743|529546703|FG003|Overall Study|Migrated/moved from study area|0|||
146829539|NCT02719743|529546704|FG004|Overall Study|Migrated/moved from study area|2|||
146829540|NCT02719743|529546700|FG000|Overall Study|Lost to Follow-up|1|||
146829541|NCT02719743|529546701|FG001|Overall Study|Lost to Follow-up|1|||
146829542|NCT02719743|529546702|FG002|Overall Study|Lost to Follow-up|0|||
146829543|NCT02719743|529546703|FG003|Overall Study|Lost to Follow-up|0|||
146829544|NCT02719743|529546704|FG004|Overall Study|Lost to Follow-up|0|||
146829545|NCT01438840|529546706|FG000|Core Study|Adverse Event|0|||
146829546|NCT01438840|529546707|FG001|Core Study|Adverse Event|3|||
146829547|NCT01438840|529546708|FG002|Core Study|Adverse Event|0|||
146829548|NCT01438840|529546706|FG000|Core Study|Lack of Efficacy|15|||
146829549|NCT01438840|529546707|FG001|Core Study|Lack of Efficacy|7|||
146829550|NCT01438840|529546708|FG002|Core Study|Lack of Efficacy|0|||
146829551|NCT01438840|529546706|FG000|Core Study|Withdrawal of consent|1|||
146829552|NCT01438840|529546707|FG001|Core Study|Withdrawal of consent|0|||
146829553|NCT01438840|529546708|FG002|Core Study|Withdrawal of consent|0|||
146829554|NCT01438840|529546706|FG000|Extension Phase|Adverse Event|0|||
146829555|NCT01438840|529546707|FG001|Extension Phase|Adverse Event|0|||
146829556|NCT01438840|529546708|FG002|Extension Phase|Adverse Event|3|||
146829557|NCT01438840|529546706|FG000|Extension Phase|Lost to Follow-up|0|||
146829558|NCT01438840|529546707|FG001|Extension Phase|Lost to Follow-up|0|||
146829559|NCT01438840|529546708|FG002|Extension Phase|Lost to Follow-up|1|||
146829560|NCT01438840|529546706|FG000|Extension Phase|Withdrawal by Subject|0|||
146829561|NCT01438840|529546707|FG001|Extension Phase|Withdrawal by Subject|0|||
146829562|NCT01438840|529546708|FG002|Extension Phase|Withdrawal by Subject|3|||
146829563|NCT01438840|529546706|FG000|Extension Phase|Lack of Efficacy|0|||
146829564|NCT01438840|529546707|FG001|Extension Phase|Lack of Efficacy|0|||
146829565|NCT01438840|529546708|FG002|Extension Phase|Lack of Efficacy|2|||
146829566|NCT01438840|529546706|FG000|Extension Phase|Other|0|||
146829567|NCT01438840|529546707|FG001|Extension Phase|Other|0|||
146829568|NCT01438840|529546708|FG002|Extension Phase|Other|1|||
146829569|NCT02601209|529546709|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
146829570|NCT02601209|529546710|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
146829571|NCT02601209|529546711|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
146958220|NCT00661362|530006314|FG000|Overall Study|Adverse Event|5|||
146958221|NCT00661362|530006315|FG001|Overall Study|Adverse Event|4|||
146958222|NCT00661362|530006314|FG000|Overall Study|Incorrect enrollment|2|||
146958223|NCT00661362|530006315|FG001|Overall Study|Incorrect enrollment|0|||
146958224|NCT00661362|530006314|FG000|Overall Study|Study specific discontinuation criteria|4|||
146958225|NCT00661362|530006315|FG001|Overall Study|Study specific discontinuation criteria|11|||
146829572|NCT02601209|529546712|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
146829573|NCT02601209|529546713|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
146829574|NCT02601209|529546714|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
146829575|NCT02601209|529546715|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
146829576|NCT02601209|529546716|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
146829577|NCT02601209|529546717|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
146829578|NCT02601209|529546709|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
146958226|NCT00661362|530006314|FG000|Overall Study|Withdrawal by Subject|13|||
146829579|NCT02601209|529546710|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
146829580|NCT02601209|529546711|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
146829581|NCT02601209|529546712|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
146829582|NCT02601209|529546713|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
146829583|NCT02601209|529546714|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
146829584|NCT02601209|529546715|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
146829585|NCT02601209|529546716|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
146829586|NCT02601209|529546717|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
146829587|NCT00927901|529546720|FG000|Treatment Period 1|Subject withdrew consent|0|||
146829588|NCT00927901|529546721|FG001|Treatment Period 1|Subject withdrew consent|0|||
146829589|NCT00927901|529546722|FG002|Treatment Period 1|Subject withdrew consent|1|||
146829590|NCT00927901|529546723|FG003|Treatment Period 1|Subject withdrew consent|0|||
146829591|NCT00927901|529546720|FG000|Treatment Period 4|Adverse Event|0|||
146829592|NCT00927901|529546721|FG001|Treatment Period 4|Adverse Event|0|||
146829593|NCT00927901|529546722|FG002|Treatment Period 4|Adverse Event|0|||
146829594|NCT00927901|529546723|FG003|Treatment Period 4|Adverse Event|1|||
146829595|NCT00927901|529546720|FG000|Treatment Period 4|Subject withdrew consent|0|||
146829596|NCT00927901|529546721|FG001|Treatment Period 4|Subject withdrew consent|0|||
146829597|NCT00927901|529546722|FG002|Treatment Period 4|Subject withdrew consent|1|||
146829598|NCT00927901|529546723|FG003|Treatment Period 4|Subject withdrew consent|0|||
146829599|NCT02344173|529546724|FG000|Procedure|Ablation Procedure Not Performed|7|||
146829600|NCT02344173|529546724|FG000|12-month Visit|Death|8|||
146829601|NCT02344173|529546724|FG000|12-month Visit|Withdrawal by Subject|30|||
146829602|NCT02344173|529546724|FG000|12-month Visit|Lost to Follow-up|58|||
146829603|NCT03738397|529546725|FG000|Overall Study|Adverse Event|3|||
146829604|NCT03738397|529546726|FG001|Overall Study|Adverse Event|7|||
146829605|NCT03738397|529546725|FG000|Overall Study|Withdrawal by Subject|8|||
146829606|NCT03738397|529546726|FG001|Overall Study|Withdrawal by Subject|11|||
146829607|NCT03738397|529546725|FG000|Overall Study|Lost to Follow-up|7|||
146829608|NCT03738397|529546726|FG001|Overall Study|Lost to Follow-up|5|||
146829609|NCT03738397|529546725|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
146829610|NCT03738397|529546726|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
146829611|NCT03738397|529546725|FG000|Overall Study|Other|4|||
146829612|NCT03738397|529546726|FG001|Overall Study|Other|6|||
146829613|NCT02881047|529546727|FG000|Overall Study|Adverse Event|1|||
146829614|NCT02881047|529546727|FG000|Overall Study|Withdrawal by Subject|1|||
146829615|NCT04814992|529546737|FG000|Overall Study|Withdrawal by Subject|6|||
146829616|NCT04814992|529546738|FG001|Overall Study|Withdrawal by Subject|3|||
146829617|NCT04814992|529546737|FG000|Overall Study|Lost to Follow-up|1|||
146829618|NCT04814992|529546738|FG001|Overall Study|Lost to Follow-up|4|||
146829619|NCT01831726|529546743|FG000|Overall Study|Adverse Event|16|||
146829620|NCT01831726|529546743|FG000|Overall Study|Death|7|||
146829621|NCT01831726|529546743|FG000|Overall Study|Disease Progression|49|||
146829622|NCT01831726|529546743|FG000|Overall Study|Physician Decision|1|||
146829623|NCT01831726|529546743|FG000|Overall Study|Subject/guardian decision|7|||
146829624|NCT00514813|529546746|FG000|Overall Study|Study terminated|14|||
146829625|NCT00514813|529546747|FG001|Overall Study|Study terminated|74|||
146829626|NCT00514813|529546748|FG002|Overall Study|Study terminated|40|||
146829627|NCT00514813|529546749|FG003|Overall Study|Study terminated|2|||
146829628|NCT00514813|529546746|FG000|Overall Study|Adverse Event|0|||
146829629|NCT00514813|529546747|FG001|Overall Study|Adverse Event|2|||
146829630|NCT00514813|529546748|FG002|Overall Study|Adverse Event|2|||
146829631|NCT00514813|529546749|FG003|Overall Study|Adverse Event|0|||
146829632|NCT00514813|529546746|FG000|Overall Study|Protocol Violation|1|||
146829633|NCT00514813|529546747|FG001|Overall Study|Protocol Violation|0|||
146829634|NCT00514813|529546748|FG002|Overall Study|Protocol Violation|0|||
146829635|NCT00514813|529546749|FG003|Overall Study|Protocol Violation|0|||
146829636|NCT00514813|529546746|FG000|Overall Study|Withdrawal by Subject|0|||
146829637|NCT00514813|529546747|FG001|Overall Study|Withdrawal by Subject|1|||
146829638|NCT00514813|529546748|FG002|Overall Study|Withdrawal by Subject|0|||
146829639|NCT00514813|529546749|FG003|Overall Study|Withdrawal by Subject|0|||
146829640|NCT00514813|529546746|FG000|Overall Study|Lack of Efficacy|0|||
146829641|NCT00514813|529546747|FG001|Overall Study|Lack of Efficacy|1|||
146829642|NCT00514813|529546748|FG002|Overall Study|Lack of Efficacy|0|||
146829643|NCT00514813|529546749|FG003|Overall Study|Lack of Efficacy|0|||
146829644|NCT00514813|529546746|FG000|Overall Study|Kidney transplant|0|||
146986152|NCT00926289|530111200|FG000|Overall Study|Other|1|||
146986153|NCT00926289|530111201|FG001|Overall Study|Other|3|||
146986154|NCT00319956|530111202|FG000|Overall Study|Death|20|||
146829645|NCT00514813|529546747|FG001|Overall Study|Kidney transplant|6|||
146829646|NCT00514813|529546748|FG002|Overall Study|Kidney transplant|2|||
146829647|NCT00514813|529546749|FG003|Overall Study|Kidney transplant|0|||
146829648|NCT00514813|529546746|FG000|Overall Study|Death|0|||
146829649|NCT00514813|529546747|FG001|Overall Study|Death|2|||
146829650|NCT00514813|529546748|FG002|Overall Study|Death|3|||
146829651|NCT00514813|529546749|FG003|Overall Study|Death|2|||
146829652|NCT02979613|529546750|FG000|Double-Blind Phase|Withdrew Consent|2|||
146829653|NCT02979613|529546751|FG001|Double-Blind Phase|Withdrew Consent|4|||
146986155|NCT00319956|530111203|FG001|Overall Study|Death|24|||
146829654|NCT02979613|529546750|FG000|Double-Blind Phase|Pregnancy|2|||
146829655|NCT02979613|529546751|FG001|Double-Blind Phase|Pregnancy|2|||
146829656|NCT02979613|529546750|FG000|Double-Blind Phase|Adverse Event|2|||
146829657|NCT02979613|529546751|FG001|Double-Blind Phase|Adverse Event|0|||
146829658|NCT02979613|529546750|FG000|Double-Blind Phase|Lost to Follow-up|1|||
146829659|NCT02979613|529546751|FG001|Double-Blind Phase|Lost to Follow-up|1|||
146829660|NCT02979613|529546750|FG000|Double-Blind Phase|Protocol Violation|1|||
146829661|NCT02979613|529546751|FG001|Double-Blind Phase|Protocol Violation|1|||
146829662|NCT02979613|529546750|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
146829663|NCT02979613|529546751|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
146829664|NCT02979613|529546750|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
146829665|NCT02979613|529546751|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
146829666|NCT02979613|529546750|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
146829667|NCT02979613|529546751|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
146829668|NCT02979613|529546750|FG000|Open-Label Extension (OLE) Phase|Death|0|||
146829669|NCT02979613|529546751|FG001|Open-Label Extension (OLE) Phase|Death|1|||
146829670|NCT02979613|529546750|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
146829671|NCT02979613|529546751|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
146829672|NCT01075100|529546754|FG000|Overall Study|Adverse Event|15|||
146829673|NCT01075100|529546755|FG001|Overall Study|Adverse Event|18|||
146829674|NCT01075100|529546754|FG000|Overall Study|Patient Request|4|||
146829675|NCT01075100|529546755|FG001|Overall Study|Patient Request|4|||
146829676|NCT01075100|529546754|FG000|Overall Study|Investigator Request|2|||
146829677|NCT01075100|529546755|FG001|Overall Study|Investigator Request|1|||
146829678|NCT01075100|529546754|FG000|Overall Study|Disease Progression|25|||
146829679|NCT01075100|529546755|FG001|Overall Study|Disease Progression|29|||
146829680|NCT01075100|529546754|FG000|Overall Study|Other|3|||
146829681|NCT01075100|529546755|FG001|Overall Study|Other|1|||
146829682|NCT01568112|529546760|FG000|Overall Study|Randomized But Not Treated|0|||
146829683|NCT01568112|529546761|FG001|Overall Study|Randomized But Not Treated|1|||
146829684|NCT01568112|529546762|FG002|Overall Study|Randomized But Not Treated|0|||
146829685|NCT01568112|529546763|FG003|Overall Study|Randomized But Not Treated|0|||
146829686|NCT01568112|529546760|FG000|Overall Study|Withdrew due to Adverse Event|2|||
146829687|NCT01568112|529546761|FG001|Overall Study|Withdrew due to Adverse Event|4|||
146829688|NCT01568112|529546762|FG002|Overall Study|Withdrew due to Adverse Event|6|||
146829689|NCT01568112|529546763|FG003|Overall Study|Withdrew due to Adverse Event|3|||
146829690|NCT01568112|529546760|FG000|Overall Study|Lost to Follow-up|0|||
146829691|NCT01568112|529546761|FG001|Overall Study|Lost to Follow-up|0|||
146829692|NCT01568112|529546762|FG002|Overall Study|Lost to Follow-up|0|||
146829693|NCT01568112|529546763|FG003|Overall Study|Lost to Follow-up|1|||
146829694|NCT01568112|529546760|FG000|Overall Study|Withdrawal by Subject|2|||
146829695|NCT01568112|529546761|FG001|Overall Study|Withdrawal by Subject|3|||
146829696|NCT01568112|529546762|FG002|Overall Study|Withdrawal by Subject|0|||
146829697|NCT01568112|529546763|FG003|Overall Study|Withdrawal by Subject|7|||
146829698|NCT01568112|529546760|FG000|Overall Study|Withdrawal by Physician|1|||
146829699|NCT01568112|529546761|FG001|Overall Study|Withdrawal by Physician|0|||
146829700|NCT01568112|529546762|FG002|Overall Study|Withdrawal by Physician|1|||
146829701|NCT01568112|529546763|FG003|Overall Study|Withdrawal by Physician|1|||
146829702|NCT02388347|529548723|FG000|Overall Study|Withdrawal by Subject|0|||
146829703|NCT02388347|529548724|FG001|Overall Study|Withdrawal by Subject|0|||
146829704|NCT02388347|529548725|FG002|Overall Study|Withdrawal by Subject|1|||
146829705|NCT02388347|529548726|FG003|Overall Study|Withdrawal by Subject|0|||
146829706|NCT02388347|529548727|FG004|Overall Study|Withdrawal by Subject|0|||
146829707|NCT03898700|529548728|FG000|Overall Study|Withdrawal by Subject|2|||
146829708|NCT00701909|529548729|FG000|Overall Study|Withdrawal by Subject|0|||
146829709|NCT00701909|529548730|FG001|Overall Study|Withdrawal by Subject|1|||
146829710|NCT00971997|529548731|FG000|Overall Study|Adverse Event|2|||
146829711|NCT00971997|529548731|FG000|Overall Study|Death|1|||
146829712|NCT00971997|529548731|FG000|Overall Study|Protocol Violation|4|||
146829713|NCT00971997|529548731|FG000|Overall Study|Withdrawal by Subject|5|||
146986156|NCT00753714|530111204|FG000|Overall Study|Lack of Efficacy|21|||
146986157|NCT00753714|530111205|FG001|Overall Study|Lack of Efficacy|34|||
146986158|NCT00753714|530111204|FG000|Overall Study|Adverse Event|26|||
146986159|NCT00753714|530111205|FG001|Overall Study|Adverse Event|18|||
146986160|NCT00753714|530111204|FG000|Overall Study|Protocol Violation|1|||
146829714|NCT00971997|529548731|FG000|Overall Study|Physician Decision|7|||
146986161|NCT00753714|530111205|FG001|Overall Study|Protocol Violation|0|||
146829715|NCT04009629|529548732|FG000|Overall Study|Withdrawal by Subject|2|||
146829716|NCT04009629|529548733|FG001|Overall Study|Withdrawal by Subject|0|||
146829717|NCT00761956|529548737|FG000|Overall Study|Lost to Follow-up|6|||
146829718|NCT00761956|529548738|FG001|Overall Study|Lost to Follow-up|11|||
146829719|NCT00761956|529548737|FG000|Overall Study|Withdrawal by Subject|3|||
146829720|NCT00761956|529548738|FG001|Overall Study|Withdrawal by Subject|8|||
146829721|NCT00761956|529548737|FG000|Overall Study|Death|0|||
146829722|NCT00761956|529548738|FG001|Overall Study|Death|1|||
146986162|NCT00753714|530111204|FG000|Overall Study|Lost to Follow-up|0|||
146986163|NCT00753714|530111205|FG001|Overall Study|Lost to Follow-up|1|||
146829723|NCT00761956|529548737|FG000|Overall Study|Adverse Event|26|||
146829724|NCT00761956|529548738|FG001|Overall Study|Adverse Event|34|||
146829725|NCT04398368|529548741|FG000|Overall Study|Withdrawal by Subject|2|||
146829726|NCT02808975|529548742|FG000|Overall Study|Adverse Event|3|||
146829727|NCT02808975|529548743|FG001|Overall Study|Adverse Event|4|||
146829728|NCT02808975|529548742|FG000|Overall Study|Withdrew consent|9|||
146829729|NCT02808975|529548743|FG001|Overall Study|Withdrew consent|8|||
146829730|NCT02808975|529548742|FG000|Overall Study|Lost to Follow-up|4|||
146829731|NCT02808975|529548743|FG001|Overall Study|Lost to Follow-up|6|||
146829732|NCT02808975|529548742|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
146829733|NCT02808975|529548743|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
146829734|NCT02808975|529548742|FG000|Overall Study|Other, not specified|5|||
146829735|NCT02808975|529548743|FG001|Overall Study|Other, not specified|1|||
146829736|NCT03602586|529548744|FG000|Overall Study|Withdrawal by Subject|3|||
146829737|NCT02106195|529548746|FG000|Overall Study|Adverse Event|2|||
146829738|NCT02106195|529548746|FG000|Overall Study|Protocol Violation|1|||
146829739|NCT03568812|529548747|FG000|Overall Study|Physician Decision|0|||
146829740|NCT03568812|529548748|FG001|Overall Study|Physician Decision|1|||
146829741|NCT03194867|529548752|FG000|Overall Study|Incorrect completion of end of study form|0|||
146829742|NCT03194867|529548753|FG001|Overall Study|Incorrect completion of end of study form|0|||
146829743|NCT03194867|529548754|FG002|Overall Study|Incorrect completion of end of study form|1|||
146829744|NCT03194867|529548755|FG003|Overall Study|Incorrect completion of end of study form|0|||
146829745|NCT00634842|529548756|FG000|Overall Study|Adverse Event|2|||
146829746|NCT00634842|529548757|FG001|Overall Study|Adverse Event|3|||
146829747|NCT00634842|529548756|FG000|Overall Study|Protocol Violation|8|||
146829748|NCT00634842|529548757|FG001|Overall Study|Protocol Violation|4|||
146829749|NCT00634842|529548756|FG000|Overall Study|Move to another state|1|||
146829750|NCT00634842|529548757|FG001|Overall Study|Move to another state|0|||
146829751|NCT00634842|529548756|FG000|Overall Study|Inclusion criteria were not met|1|||
146829752|NCT00634842|529548757|FG001|Overall Study|Inclusion criteria were not met|0|||
146829753|NCT00634842|529548756|FG000|Overall Study|Lost to Follow-up|1|||
146829754|NCT00634842|529548757|FG001|Overall Study|Lost to Follow-up|2|||
146829755|NCT00634842|529548756|FG000|Overall Study|Physician Decision|1|||
146829756|NCT00634842|529548757|FG001|Overall Study|Physician Decision|0|||
146829757|NCT00634842|529548756|FG000|Overall Study|Withdrawal by Subject|1|||
146829758|NCT00634842|529548757|FG001|Overall Study|Withdrawal by Subject|3|||
146829759|NCT00634842|529548756|FG000|Overall Study|Lack of time and intolerance to drug|0|||
146829760|NCT00634842|529548757|FG001|Overall Study|Lack of time and intolerance to drug|1|||
146829761|NCT00634842|529548756|FG000|Overall Study|Discontinued due to injection|0|||
146829762|NCT00634842|529548757|FG001|Overall Study|Discontinued due to injection|2|||
146829763|NCT00634842|529548756|FG000|Overall Study|No need of study drug to treat diabetes|0|||
146829764|NCT00634842|529548757|FG001|Overall Study|No need of study drug to treat diabetes|1|||
146829765|NCT00634842|529548756|FG000|Overall Study|No wish to keep taking Avandia|0|||
146829766|NCT00634842|529548757|FG001|Overall Study|No wish to keep taking Avandia|1|||
146829767|NCT00634842|529548756|FG000|Overall Study|Subject off study drug for too long|0|||
146829768|NCT00634842|529548757|FG001|Overall Study|Subject off study drug for too long|1|||
146829769|NCT00464945|529548758|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
146829770|NCT00464945|529548759|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
146829771|NCT00464945|529548758|FG000|Infant Series|Protocol Violation|1|||
146829772|NCT00464945|529548759|FG001|Infant Series|Protocol Violation|0|||
146829773|NCT00464945|529548758|FG000|Infant Series|Lost to Follow-up|1|||
146829774|NCT00464945|529548759|FG001|Infant Series|Lost to Follow-up|0|||
146829775|NCT00464945|529548758|FG000|After Infant Series|Withdrawal by Subject|0|||
146829776|NCT00464945|529548759|FG001|After Infant Series|Withdrawal by Subject|2|||
146829777|NCT00464945|529548758|FG000|Toddler Dose|Lost to Follow-up|0|||
146829778|NCT00464945|529548759|FG001|Toddler Dose|Lost to Follow-up|1|||
146829779|NCT03021551|529548761|FG000|Overall Study|Equipment Issues|2|||
146829780|NCT03021551|529548761|FG000|Overall Study|Protocol Violation|1|||
146986164|NCT00753714|530111204|FG000|Overall Study|Withdrawal by Subject|2|||
146829781|NCT00551135|529548768|FG000|Overall Study|Adverse Event|1|||
146829782|NCT00551135|529548769|FG001|Overall Study|Adverse Event|0|||
146829783|NCT00551135|529548770|FG002|Overall Study|Adverse Event|1|||
146829784|NCT00551135|529548771|FG003|Overall Study|Adverse Event|1|||
146829785|NCT00551135|529548768|FG000|Overall Study|Lost to Follow-up|0|||
146829786|NCT00551135|529548769|FG001|Overall Study|Lost to Follow-up|0|||
146829787|NCT00551135|529548770|FG002|Overall Study|Lost to Follow-up|0|||
146829788|NCT00551135|529548771|FG003|Overall Study|Lost to Follow-up|1|||
146829789|NCT00551135|529548768|FG000|Overall Study|Other|3|||
146829790|NCT00551135|529548769|FG001|Overall Study|Other|2|||
146829791|NCT00551135|529548770|FG002|Overall Study|Other|1|||
146829792|NCT00551135|529548771|FG003|Overall Study|Other|2|||
146829793|NCT00551135|529548768|FG000|Overall Study|Withdrawal by Subject|1|||
146829794|NCT00551135|529548769|FG001|Overall Study|Withdrawal by Subject|0|||
146986165|NCT00753714|530111205|FG001|Overall Study|Withdrawal by Subject|1|||
146829795|NCT00551135|529548770|FG002|Overall Study|Withdrawal by Subject|3|||
146829796|NCT00551135|529548771|FG003|Overall Study|Withdrawal by Subject|1|||
146829797|NCT04799418|529548772|FG000|Overall Study|Death|1|||
146829798|NCT04799418|529548773|FG001|Overall Study|Death|1|||
146829799|NCT04799418|529548772|FG000|Overall Study|Lack of Efficacy|14|||
146829800|NCT04799418|529548773|FG001|Overall Study|Lack of Efficacy|14|||
146829801|NCT04799418|529548772|FG000|Overall Study|Withdrawal by Subject|10|||
146829802|NCT04799418|529548773|FG001|Overall Study|Withdrawal by Subject|7|||
146829803|NCT04799418|529548772|FG000|Overall Study|Adverse Event|3|||
146829804|NCT04799418|529548773|FG001|Overall Study|Adverse Event|2|||
146829805|NCT01379703|529548774|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
146829806|NCT01379703|529548775|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
146829807|NCT01379703|529548776|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
146829808|NCT01379703|529548774|FG000|Study Start Through 9 Months|Adverse Event|0|||
146829809|NCT01379703|529548775|FG001|Study Start Through 9 Months|Adverse Event|14|||
146829810|NCT01379703|529548776|FG002|Study Start Through 9 Months|Adverse Event|10|||
146829811|NCT01379703|529548774|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
146829812|NCT01379703|529548775|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
146829813|NCT01379703|529548776|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
146829814|NCT01379703|529548774|FG000|Study Start Through 9 Months|Treatment Failure|0|||
146829815|NCT01379703|529548775|FG001|Study Start Through 9 Months|Treatment Failure|2|||
146829816|NCT01379703|529548776|FG002|Study Start Through 9 Months|Treatment Failure|2|||
146829817|NCT01379703|529548774|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
146829818|NCT01379703|529548775|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
146829819|NCT01379703|529548776|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
146829820|NCT01379703|529548774|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
146829821|NCT01379703|529548775|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
146829822|NCT01379703|529548776|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
146829823|NCT01379703|529548774|FG000|Study Start Through 9 Months|Medication not available|0|||
146829824|NCT01379703|529548775|FG001|Study Start Through 9 Months|Medication not available|2|||
146829825|NCT01379703|529548776|FG002|Study Start Through 9 Months|Medication not available|1|||
146829826|NCT01379703|529548774|FG000|Study Start Through 9 Months|Poor general condition|0|||
146829827|NCT01379703|529548775|FG001|Study Start Through 9 Months|Poor general condition|1|||
146829828|NCT01379703|529548776|FG002|Study Start Through 9 Months|Poor general condition|0|||
146829829|NCT01379703|529548774|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
146829830|NCT01379703|529548775|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
146829831|NCT01379703|529548776|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
146829832|NCT01379703|529548774|FG000|Study Start Through 9 Months|Reason unknown|2|||
146829833|NCT01379703|529548775|FG001|Study Start Through 9 Months|Reason unknown|31|||
146829834|NCT01379703|529548776|FG002|Study Start Through 9 Months|Reason unknown|24|||
146829835|NCT01379703|529548774|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
146829836|NCT01379703|529548775|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
146829837|NCT01379703|529548776|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
146829838|NCT01379703|529548774|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
146829839|NCT01379703|529548775|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
146829840|NCT01379703|529548776|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
146829841|NCT01379703|529548774|FG000|9 Months Through 18 Months|Adverse Event|0|||
146829842|NCT01379703|529548775|FG001|9 Months Through 18 Months|Adverse Event|6|||
146829843|NCT01379703|529548776|FG002|9 Months Through 18 Months|Adverse Event|0|||
146829844|NCT01379703|529548774|FG000|9 Months Through 18 Months|Treatment failure|0|||
146829845|NCT01379703|529548775|FG001|9 Months Through 18 Months|Treatment failure|5|||
146986166|NCT00753714|530111204|FG000|Overall Study|Death|3|||
146986167|NCT00753714|530111205|FG001|Overall Study|Death|3|||
146986168|NCT00753714|530111204|FG000|Overall Study|Other|7|||
146986169|NCT00753714|530111205|FG001|Overall Study|Other|5|||
146986170|NCT01202747|530111206|FG000|Overall Study|Withdrawal by Subject|1|||
146986171|NCT01446913|530111207|FG000|Overall Study|Significant illness|1|||
146986172|NCT01446913|530111208|FG001|Overall Study|Significant illness|1|||
146986173|NCT01446913|530111209|FG002|Overall Study|Significant illness|1|||
146986174|NCT01446913|530111207|FG000|Overall Study|Withdrawal by Subject|5|||
146986175|NCT01446913|530111208|FG001|Overall Study|Withdrawal by Subject|3|||
146986176|NCT01446913|530111209|FG002|Overall Study|Withdrawal by Subject|5|||
146986177|NCT01446913|530111207|FG000|Overall Study|Physician Decision|0|||
146986178|NCT01446913|530111208|FG001|Overall Study|Physician Decision|0|||
146986179|NCT01446913|530111209|FG002|Overall Study|Physician Decision|2|||
146986180|NCT01446913|530111207|FG000|Overall Study|Lost to Follow-up|3|||
146986181|NCT01446913|530111208|FG001|Overall Study|Lost to Follow-up|5|||
146986182|NCT01446913|530111209|FG002|Overall Study|Lost to Follow-up|3|||
146986183|NCT02292238|530111210|FG000|Overall Study|Protocol Violation|1|||
146986184|NCT02292238|530111211|FG001|Overall Study|Protocol Violation|2|||
146829846|NCT01379703|529548776|FG002|9 Months Through 18 Months|Treatment failure|0|||
146829847|NCT01379703|529548774|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
146829848|NCT01379703|529548775|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
146829849|NCT01379703|529548776|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
146829850|NCT01379703|529548774|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
146986185|NCT02292238|530111210|FG000|Overall Study|Withdrawal by Subject|2|||
146986186|NCT02292238|530111211|FG001|Overall Study|Withdrawal by Subject|1|||
146986187|NCT02292238|530111210|FG000|Overall Study|Lost to Follow-up|1|||
146986188|NCT02292238|530111211|FG001|Overall Study|Lost to Follow-up|0|||
146829851|NCT01379703|529548775|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
146829852|NCT01379703|529548776|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
146829853|NCT01379703|529548774|FG000|9 Months Through 18 Months|Fatigue|0|||
146829854|NCT01379703|529548775|FG001|9 Months Through 18 Months|Fatigue|1|||
146829855|NCT01379703|529548776|FG002|9 Months Through 18 Months|Fatigue|0|||
146829856|NCT01379703|529548774|FG000|9 Months Through 18 Months|Reason Unknown|0|||
146829857|NCT01379703|529548775|FG001|9 Months Through 18 Months|Reason Unknown|23|||
146829858|NCT01379703|529548776|FG002|9 Months Through 18 Months|Reason Unknown|0|||
146829859|NCT03463577|529548777|FG000|Overall Study|Lost to Follow-up|238|||
146829860|NCT03463577|529548778|FG001|Overall Study|Lost to Follow-up|435|||
146829861|NCT03463577|529548779|FG002|Overall Study|Lost to Follow-up|0|||
146829862|NCT03463577|529548780|FG003|Overall Study|Lost to Follow-up|0|||
146829863|NCT03463577|529548781|FG004|Overall Study|Lost to Follow-up|0|||
146829864|NCT03463577|529548782|FG005|Overall Study|Lost to Follow-up|0|||
146829865|NCT03463577|529548777|FG000|Overall Study|With unknown pregnancy outcome|0|||
146829866|NCT03463577|529548778|FG001|Overall Study|With unknown pregnancy outcome|5|||
146829867|NCT03463577|529548779|FG002|Overall Study|With unknown pregnancy outcome|0|||
146829868|NCT03463577|529548780|FG003|Overall Study|With unknown pregnancy outcome|0|||
146829869|NCT03463577|529548781|FG004|Overall Study|With unknown pregnancy outcome|0|||
146829870|NCT03463577|529548782|FG005|Overall Study|With unknown pregnancy outcome|0|||
146829871|NCT03463577|529548777|FG000|Overall Study|Maternal death|2|||
146829872|NCT03463577|529548778|FG001|Overall Study|Maternal death|0|||
146829873|NCT03463577|529548779|FG002|Overall Study|Maternal death|0|||
146829874|NCT03463577|529548780|FG003|Overall Study|Maternal death|0|||
146829875|NCT03463577|529548781|FG004|Overall Study|Maternal death|0|||
146829876|NCT03463577|529548782|FG005|Overall Study|Maternal death|0|||
146829877|NCT03463577|529548777|FG000|Overall Study|Neonatal death|0|||
146829878|NCT03463577|529548778|FG001|Overall Study|Neonatal death|0|||
146829879|NCT03463577|529548779|FG002|Overall Study|Neonatal death|0|||
146829880|NCT03463577|529548780|FG003|Overall Study|Neonatal death|15|||
146829881|NCT03463577|529548781|FG004|Overall Study|Neonatal death|17|||
146829882|NCT03463577|529548782|FG005|Overall Study|Neonatal death|0|||
146829883|NCT00236184|529548783|FG000|Overall Study|Adverse Event|5|||
146829884|NCT00236184|529548784|FG001|Overall Study|Adverse Event|2|||
146829885|NCT00236184|529548783|FG000|Overall Study|Lack of Efficacy|0|||
146829886|NCT00236184|529548784|FG001|Overall Study|Lack of Efficacy|1|||
146829887|NCT00236184|529548783|FG000|Overall Study|Lost to Follow-up|3|||
146829888|NCT00236184|529548784|FG001|Overall Study|Lost to Follow-up|4|||
146829889|NCT00236184|529548783|FG000|Overall Study|Physician Decision|1|||
146829890|NCT00236184|529548784|FG001|Overall Study|Physician Decision|1|||
146829891|NCT00236184|529548783|FG000|Overall Study|Withdrawal by Subject|3|||
146829892|NCT00236184|529548784|FG001|Overall Study|Withdrawal by Subject|0|||
146829893|NCT00236184|529548783|FG000|Overall Study|Protocol Violation|3|||
146829894|NCT00236184|529548784|FG001|Overall Study|Protocol Violation|0|||
146829895|NCT00236184|529548783|FG000|Overall Study|non-compliance with study drug|2|||
146829896|NCT00236184|529548784|FG001|Overall Study|non-compliance with study drug|1|||
146829897|NCT00236184|529548783|FG000|Overall Study|other|1|||
146829898|NCT00236184|529548784|FG001|Overall Study|other|2|||
146829899|NCT01101997|529548785|FG000|Overall Study|Withdrawal by Subject|2|||
146829900|NCT00469456|529548786|FG000|Overall Study|Adverse Event|4|||
146829901|NCT00469456|529548787|FG001|Overall Study|Adverse Event|3|||
146829902|NCT00469456|529548786|FG000|Overall Study|Protocol Violation|1|||
146829903|NCT00469456|529548787|FG001|Overall Study|Protocol Violation|0|||
146829904|NCT00469456|529548786|FG000|Overall Study|Withdrawal by Subject|4|||
146829905|NCT00469456|529548787|FG001|Overall Study|Withdrawal by Subject|1|||
146829906|NCT02669407|529548790|FG000|Overall Study|Physician Decision|3|||
146829907|NCT00704171|529548791|FG000|Overall Study|Withdrawal by Subject|1|||
146829908|NCT00704171|529548792|FG001|Overall Study|Withdrawal by Subject|0|||
146829909|NCT03634839|529548793|FG000|First Intervention (2 Hours)|Adverse Event|0|||
146829910|NCT03634839|529548794|FG001|First Intervention (2 Hours)|Adverse Event|2|||
146829911|NCT00719043|529548802|FG000|Overall Study|Adverse Event|5|||
146958227|NCT00661362|530006315|FG001|Overall Study|Withdrawal by Subject|23|||
146829912|NCT00719043|529548803|FG001|Overall Study|Adverse Event|1|||
146829913|NCT00719043|529548804|FG002|Overall Study|Adverse Event|2|||
146829914|NCT00719043|529548805|FG003|Overall Study|Adverse Event|2|||
146829915|NCT00719043|529548806|FG004|Overall Study|Adverse Event|1|||
146829916|NCT00719043|529548807|FG005|Overall Study|Adverse Event|4|||
146829917|NCT00719043|529548808|FG006|Overall Study|Adverse Event|4|||
146829918|NCT00719043|529548802|FG000|Overall Study|Lost to Follow-up|14|||
146958228|NCT00661362|530006314|FG000|Overall Study|Lost to Follow-up|3|||
146829919|NCT00719043|529548803|FG001|Overall Study|Lost to Follow-up|10|||
146829920|NCT00719043|529548804|FG002|Overall Study|Lost to Follow-up|8|||
146829921|NCT00719043|529548805|FG003|Overall Study|Lost to Follow-up|9|||
146829922|NCT00719043|529548806|FG004|Overall Study|Lost to Follow-up|10|||
146829923|NCT00719043|529548807|FG005|Overall Study|Lost to Follow-up|9|||
146829924|NCT00719043|529548808|FG006|Overall Study|Lost to Follow-up|9|||
146829925|NCT00719043|529548802|FG000|Overall Study|Protocol Violation|0|||
146829926|NCT00719043|529548803|FG001|Overall Study|Protocol Violation|0|||
146829927|NCT00719043|529548804|FG002|Overall Study|Protocol Violation|0|||
146829928|NCT00719043|529548805|FG003|Overall Study|Protocol Violation|0|||
146829929|NCT00719043|529548806|FG004|Overall Study|Protocol Violation|0|||
146829930|NCT00719043|529548807|FG005|Overall Study|Protocol Violation|1|||
146829931|NCT00719043|529548808|FG006|Overall Study|Protocol Violation|0|||
146829932|NCT00719043|529548802|FG000|Overall Study|Other|1|||
146829933|NCT00719043|529548803|FG001|Overall Study|Other|0|||
146829934|NCT00719043|529548804|FG002|Overall Study|Other|1|||
146829935|NCT00719043|529548805|FG003|Overall Study|Other|2|||
146829936|NCT00719043|529548806|FG004|Overall Study|Other|0|||
146829937|NCT00719043|529548807|FG005|Overall Study|Other|2|||
146829938|NCT00719043|529548808|FG006|Overall Study|Other|1|||
146829939|NCT00719043|529548802|FG000|Overall Study|Withdrawal by Subject|12|||
146829940|NCT00719043|529548803|FG001|Overall Study|Withdrawal by Subject|14|||
146829941|NCT00719043|529548804|FG002|Overall Study|Withdrawal by Subject|9|||
146829942|NCT00719043|529548805|FG003|Overall Study|Withdrawal by Subject|10|||
146829943|NCT00719043|529548806|FG004|Overall Study|Withdrawal by Subject|16|||
146829944|NCT00719043|529548807|FG005|Overall Study|Withdrawal by Subject|18|||
146829945|NCT00719043|529548808|FG006|Overall Study|Withdrawal by Subject|14|||
146829946|NCT01588366|529548809|FG000|Overall Study|Adverse Event|0|||
146829947|NCT01588366|529548810|FG001|Overall Study|Adverse Event|1|||
146829948|NCT01588366|529548811|FG002|Overall Study|Adverse Event|0|||
146829949|NCT01588366|529548812|FG003|Overall Study|Adverse Event|1|||
146829950|NCT01588366|529548813|FG004|Overall Study|Adverse Event|0|||
146829951|NCT01588366|529548814|FG005|Overall Study|Adverse Event|2|||
146829952|NCT00302159|529548815|FG000|Overall Study|pt declined before treatment started|1|||
146829953|NCT00302159|529548815|FG000|Overall Study|pt started Avastin|1|||
146829954|NCT00813098|529548816|FG000|Overall Study|Adverse Event|2|||
146829955|NCT00813098|529548817|FG001|Overall Study|Adverse Event|4|||
146829956|NCT00813098|529548818|FG002|Overall Study|Adverse Event|1|||
146829957|NCT00813098|529548816|FG000|Overall Study|Withdrawal by Subject|0|||
146829958|NCT00813098|529548817|FG001|Overall Study|Withdrawal by Subject|1|||
146829959|NCT00813098|529548818|FG002|Overall Study|Withdrawal by Subject|0|||
146829960|NCT00813098|529548816|FG000|Overall Study|Inability to complete study procedures|1|||
146829961|NCT00813098|529548817|FG001|Overall Study|Inability to complete study procedures|0|||
146829962|NCT00813098|529548818|FG002|Overall Study|Inability to complete study procedures|0|||
146829963|NCT00813098|529548816|FG000|Overall Study|Lost to Follow-up|0|||
146829964|NCT00813098|529548817|FG001|Overall Study|Lost to Follow-up|1|||
146829965|NCT00813098|529548818|FG002|Overall Study|Lost to Follow-up|0|||
146829966|NCT00813098|529548816|FG000|Overall Study|Protocol Violation|0|||
146829967|NCT00813098|529548817|FG001|Overall Study|Protocol Violation|0|||
146829968|NCT00813098|529548818|FG002|Overall Study|Protocol Violation|1|||
146829969|NCT00813098|529548816|FG000|Overall Study|Principal Investigator decision|0|||
146829970|NCT00813098|529548817|FG001|Overall Study|Principal Investigator decision|1|||
146829971|NCT00813098|529548818|FG002|Overall Study|Principal Investigator decision|0|||
146829972|NCT00813098|529548816|FG000|Overall Study|Withdrew Consent|0|||
146829973|NCT00813098|529548817|FG001|Overall Study|Withdrew Consent|1|||
146829974|NCT00813098|529548818|FG002|Overall Study|Withdrew Consent|0|||
146829975|NCT03470545|529548819|FG000|Overall Study|Death|0|||
146829976|NCT03470545|529548820|FG001|Overall Study|Death|1|||
146829977|NCT03470545|529548819|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
146829978|NCT03470545|529548820|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
146829979|NCT03470545|529548819|FG000|Overall Study|Adverse Event|2|||
146829980|NCT03470545|529548820|FG001|Overall Study|Adverse Event|0|||
146829981|NCT03470545|529548819|FG000|Overall Study|Withdrawal by Subject|1|||
146829982|NCT03470545|529548820|FG001|Overall Study|Withdrawal by Subject|1|||
146829983|NCT03470545|529548819|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
146829984|NCT03470545|529548820|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
146829985|NCT01664923|529548821|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
146829986|NCT01664923|529548822|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
146829987|NCT01664923|529548821|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
146829988|NCT01664923|529548822|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
146829989|NCT01664923|529548821|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
146829990|NCT01664923|529548822|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
146829991|NCT01664923|529548821|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
146829992|NCT01664923|529548822|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
146829993|NCT01664923|529548821|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
146829994|NCT01664923|529548822|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
146829995|NCT01664923|529548821|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
146829996|NCT01664923|529548822|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
146829997|NCT01664923|529548821|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
146829998|NCT01664923|529548822|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
146829999|NCT01664923|529548821|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
146958229|NCT00661362|530006315|FG001|Overall Study|Lost to Follow-up|1|||
146830000|NCT01664923|529548822|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
146830001|NCT01664923|529548821|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
146830002|NCT01664923|529548822|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
146830003|NCT01664923|529548821|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
146830004|NCT01664923|529548822|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
146830005|NCT01664923|529548821|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
146830006|NCT01664923|529548822|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
146830007|NCT01664923|529548821|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
146830008|NCT01664923|529548822|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
146830009|NCT01664923|529548821|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
146830010|NCT01664923|529548822|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
146830011|NCT01664923|529548821|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
146830012|NCT01664923|529548822|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
146830013|NCT01086384|529548825|FG000|2-week Run-in Period|Adverse Event|1|||
146830014|NCT01086384|529548826|FG001|2-week Run-in Period|Adverse Event|0|||
146830015|NCT01086384|529548827|FG002|2-week Run-in Period|Adverse Event|0|||
146830016|NCT01086384|529548825|FG000|2-week Run-in Period|Protocol Violation|1|||
146830017|NCT01086384|529548826|FG001|2-week Run-in Period|Protocol Violation|0|||
146830018|NCT01086384|529548827|FG002|2-week Run-in Period|Protocol Violation|0|||
146830019|NCT01086384|529548825|FG000|2-week Run-in Period|Lost to Follow-up|1|||
146830020|NCT01086384|529548826|FG001|2-week Run-in Period|Lost to Follow-up|0|||
146830021|NCT01086384|529548827|FG002|2-week Run-in Period|Lost to Follow-up|0|||
146830022|NCT01086384|529548825|FG000|2-week Run-in Period|Physician Decision|6|||
146830023|NCT01086384|529548826|FG001|2-week Run-in Period|Physician Decision|0|||
146830024|NCT01086384|529548827|FG002|2-week Run-in Period|Physician Decision|0|||
146830025|NCT01086384|529548825|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
146830026|NCT01086384|529548826|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
146830027|NCT01086384|529548827|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
146830028|NCT01086384|529548825|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
146830029|NCT01086384|529548826|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
146830030|NCT01086384|529548827|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
146830031|NCT01086384|529548825|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
146830032|NCT01086384|529548826|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
146830033|NCT01086384|529548827|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
146830034|NCT01086384|529548825|FG000|2-week Run-in Period|Randomized in Error|1|||
146830035|NCT01086384|529548826|FG001|2-week Run-in Period|Randomized in Error|0|||
146830036|NCT01086384|529548827|FG002|2-week Run-in Period|Randomized in Error|0|||
146830037|NCT01086384|529548825|FG000|Treatment Period|Withdrawal by Subject|0|||
146830038|NCT01086384|529548826|FG001|Treatment Period|Withdrawal by Subject|53|||
146830039|NCT01086384|529548827|FG002|Treatment Period|Withdrawal by Subject|55|||
146830040|NCT01086384|529548825|FG000|Treatment Period|Protocol Violation|0|||
146830041|NCT01086384|529548826|FG001|Treatment Period|Protocol Violation|26|||
146830042|NCT01086384|529548827|FG002|Treatment Period|Protocol Violation|17|||
146830043|NCT01086384|529548825|FG000|Treatment Period|Lack of Efficacy|0|||
146830044|NCT01086384|529548826|FG001|Treatment Period|Lack of Efficacy|22|||
146830045|NCT01086384|529548827|FG002|Treatment Period|Lack of Efficacy|13|||
146830046|NCT01086384|529548825|FG000|Treatment Period|Adverse Event|0|||
146830047|NCT01086384|529548826|FG001|Treatment Period|Adverse Event|19|||
146830048|NCT01086384|529548827|FG002|Treatment Period|Adverse Event|15|||
146830049|NCT01086384|529548825|FG000|Treatment Period|Lost to Follow-up|0|||
146830050|NCT01086384|529548826|FG001|Treatment Period|Lost to Follow-up|11|||
146830051|NCT01086384|529548827|FG002|Treatment Period|Lost to Follow-up|9|||
146830052|NCT01086384|529548825|FG000|Treatment Period|Physician Decision|0|||
146830053|NCT01086384|529548826|FG001|Treatment Period|Physician Decision|9|||
146830054|NCT01086384|529548827|FG002|Treatment Period|Physician Decision|6|||
146986189|NCT02292238|530111210|FG000|Overall Study|Physician Decision|0|||
146986190|NCT02292238|530111211|FG001|Overall Study|Physician Decision|1|||
146986191|NCT04000009|530111212|FG000|Overall Study|Adverse Event|13|||
146830055|NCT01086384|529548825|FG000|Treatment Period|Study Closed/Terminated|0|||
146830056|NCT01086384|529548826|FG001|Treatment Period|Study Closed/Terminated|7|||
146830057|NCT01086384|529548827|FG002|Treatment Period|Study Closed/Terminated|8|||
146830058|NCT01086384|529548825|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
146830059|NCT01086384|529548826|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
146830060|NCT01086384|529548827|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
146830061|NCT01086384|529548825|FG000|Treatment Period|Received Treatment in Error|0|||
146830062|NCT01086384|529548826|FG001|Treatment Period|Received Treatment in Error|1|||
146830063|NCT01086384|529548827|FG002|Treatment Period|Received Treatment in Error|0|||
146830064|NCT02872311|529548832|FG000|Overall Study|Death|2|||
146830065|NCT02872311|529548833|FG001|Overall Study|Death|0|||
146830066|NCT02872311|529548834|FG002|Overall Study|Death|0|||
146830067|NCT02872311|529548835|FG003|Overall Study|Death|0|||
146830068|NCT02872311|529548836|FG004|Overall Study|Death|0|||
146986192|NCT04000009|530111212|FG000|Overall Study|Lack of Efficacy|7|||
146830069|NCT02872311|529548832|FG000|Overall Study|Lost to Follow-up|2|||
146830070|NCT02872311|529548833|FG001|Overall Study|Lost to Follow-up|0|||
146830071|NCT02872311|529548834|FG002|Overall Study|Lost to Follow-up|0|||
146830072|NCT02872311|529548835|FG003|Overall Study|Lost to Follow-up|0|||
146830073|NCT02872311|529548836|FG004|Overall Study|Lost to Follow-up|0|||
146830074|NCT02872311|529548832|FG000|Overall Study|Protocol Violation|0|||
146830075|NCT02872311|529548833|FG001|Overall Study|Protocol Violation|2|||
146830076|NCT02872311|529548834|FG002|Overall Study|Protocol Violation|1|||
146830077|NCT02872311|529548835|FG003|Overall Study|Protocol Violation|0|||
146830078|NCT02872311|529548836|FG004|Overall Study|Protocol Violation|0|||
146830079|NCT02725567|529548838|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
146830080|NCT02725567|529548839|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
146830081|NCT02725567|529548838|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
146830082|NCT02725567|529548839|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
146830083|NCT02725567|529548838|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
146830084|NCT02725567|529548839|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
146830085|NCT01129115|529548840|FG000|Overall Study|Adverse Event|1|||
146830086|NCT01129115|529548841|FG001|Overall Study|Adverse Event|2|||
146830087|NCT01129115|529548842|FG002|Overall Study|Adverse Event|3|||
146830088|NCT01129115|529548843|FG003|Overall Study|Adverse Event|3|||
146830089|NCT01129115|529548840|FG000|Overall Study|Withdrawal by Subject|1|||
146830090|NCT01129115|529548841|FG001|Overall Study|Withdrawal by Subject|3|||
146830091|NCT01129115|529548842|FG002|Overall Study|Withdrawal by Subject|1|||
146830092|NCT01129115|529548843|FG003|Overall Study|Withdrawal by Subject|4|||
146830093|NCT01129115|529548840|FG000|Overall Study|Protocol Violation|0|||
146830094|NCT01129115|529548841|FG001|Overall Study|Protocol Violation|2|||
146830095|NCT01129115|529548842|FG002|Overall Study|Protocol Violation|2|||
146830096|NCT01129115|529548843|FG003|Overall Study|Protocol Violation|2|||
146986193|NCT04000009|530111212|FG000|Overall Study|Lost to Follow-up|8|||
146986194|NCT04000009|530111212|FG000|Overall Study|Noncompliance with study drug|4|||
146986195|NCT04000009|530111212|FG000|Overall Study|Physician Decision|1|||
146986196|NCT04000009|530111212|FG000|Overall Study|Use of prohibited medication|3|||
146986197|NCT04000009|530111212|FG000|Overall Study|Pregnancy|1|||
146986198|NCT04000009|530111212|FG000|Overall Study|Withdrawal by Subject|22|||
146986199|NCT04000009|530111212|FG000|Overall Study|Study terminated by sponsor|98|||
146986200|NCT04000009|530111212|FG000|Overall Study|Not further specified|8|||
146986201|NCT02041702|530111217|FG000|Overall Study|Lost to Follow-up|1|||
146986202|NCT02041702|530111218|FG001|Overall Study|Lost to Follow-up|6|||
146986203|NCT02041702|530111217|FG000|Overall Study|Death|4|||
146986204|NCT02041702|530111218|FG001|Overall Study|Death|0|||
146986205|NCT02041702|530111217|FG000|Overall Study|Withdrawal by Subject|4|||
146986206|NCT02041702|530111218|FG001|Overall Study|Withdrawal by Subject|3|||
146986207|NCT02041702|530111217|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
146986208|NCT02041702|530111218|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
146986209|NCT02041702|530111217|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
146986210|NCT02041702|530111218|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
146986211|NCT00203307|530111219|FG000|First Intervention|Adverse Event|2|||
146986212|NCT00203307|530111220|FG001|First Intervention|Adverse Event|0|||
146986213|NCT01618305|530111221|FG000|Overall Study|Death|0|||
146986214|NCT01618305|530111222|FG001|Overall Study|Death|1|||
146986215|NCT01618305|530111221|FG000|Overall Study|Lost to Follow-up|11|||
146986216|NCT01618305|530111222|FG001|Overall Study|Lost to Follow-up|7|||
146986217|NCT01618305|530111221|FG000|Overall Study|Protocol Violation|1|||
146986218|NCT01618305|530111222|FG001|Overall Study|Protocol Violation|0|||
146986219|NCT01618305|530111221|FG000|Overall Study|Withdrawal by Subject|3|||
146986220|NCT01618305|530111222|FG001|Overall Study|Withdrawal by Subject|2|||
146986221|NCT01960816|530111223|FG000|Overall Study|Lost to Follow-up|1|||
146986222|NCT01309919|530111239|FG000|Overall Study|Did not receive a postpartum IUD|17|||
146986223|NCT01309919|530111240|FG001|Overall Study|Did not receive a postpartum IUD|48|||
146986224|NCT04583579|530112835|FG000|Overall Study|Lost to Follow-up|4|||
146986225|NCT01691508|530112836|FG000|Overall Study|Adverse Event|3|||
146986226|NCT01691508|530112837|FG001|Overall Study|Adverse Event|3|||
146986227|NCT01691508|530112836|FG000|Overall Study|Withdrawal by Subject|1|||
146986228|NCT01691508|530112837|FG001|Overall Study|Withdrawal by Subject|0|||
146986229|NCT03731182|530112840|FG000|Overall Study|Lost to Follow-up|2|||
146986230|NCT03731182|530112841|FG001|Overall Study|Lost to Follow-up|0|||
146830097|NCT01747837|529548845|FG000|Overall Study|Lost to Follow-up|5|||
146830098|NCT01747837|529548846|FG001|Overall Study|Lost to Follow-up|2|||
146830099|NCT01747837|529548845|FG000|Overall Study|Death|4|||
146986231|NCT03731182|530112840|FG000|Overall Study|Physician Decision|1|||
146830100|NCT01747837|529548846|FG001|Overall Study|Death|4|||
146830101|NCT00817336|529548848|FG000|Overall Study|Withdrawal by Subject|1|||
146986232|NCT03731182|530112841|FG001|Overall Study|Physician Decision|0|||
146986233|NCT03731182|530112840|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
146986234|NCT03731182|530112841|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
146986235|NCT02006706|530112842|FG000|Overall Study|Lost to Follow-up|1|||
146830102|NCT00817336|529548849|FG001|Overall Study|Withdrawal by Subject|1|||
146830103|NCT02019641|529548856|FG000|10-Week Follow up|Withdrawal by investigator|2|||
146830104|NCT02019641|529548857|FG001|10-Week Follow up|Withdrawal by investigator|0|||
146830105|NCT02019641|529548858|FG002|10-Week Follow up|Withdrawal by investigator|0|||
146830106|NCT02019641|529548856|FG000|10-Week Follow up|Withdrawal by Subject|1|||
146830107|NCT02019641|529548857|FG001|10-Week Follow up|Withdrawal by Subject|1|||
146830108|NCT02019641|529548858|FG002|10-Week Follow up|Withdrawal by Subject|0|||
146830109|NCT02019641|529548856|FG000|20-Week Follow up|Withdrawal by investigator|0|||
146830110|NCT02019641|529548857|FG001|20-Week Follow up|Withdrawal by investigator|0|||
146830111|NCT02019641|529548858|FG002|20-Week Follow up|Withdrawal by investigator|1|||
146830112|NCT03856047|529548861|FG000|Overall Study|Withdrawal by Subject|0|||
146830113|NCT03856047|529548862|FG001|Overall Study|Withdrawal by Subject|1|||
146830114|NCT03856047|529548863|FG002|Overall Study|Withdrawal by Subject|1|||
146830115|NCT03856047|529548864|FG003|Overall Study|Withdrawal by Subject|0|||
146830116|NCT03856047|529548865|FG004|Overall Study|Withdrawal by Subject|3|||
146830117|NCT03856047|529548866|FG005|Overall Study|Withdrawal by Subject|0|||
146830118|NCT03856047|529548867|FG006|Overall Study|Withdrawal by Subject|2|||
146830119|NCT03856047|529548861|FG000|Overall Study|Lost to Follow-up|4|||
146830120|NCT03856047|529548862|FG001|Overall Study|Lost to Follow-up|2|||
146830121|NCT03856047|529548863|FG002|Overall Study|Lost to Follow-up|3|||
146830122|NCT03856047|529548864|FG003|Overall Study|Lost to Follow-up|1|||
146830123|NCT03856047|529548865|FG004|Overall Study|Lost to Follow-up|4|||
146830124|NCT03856047|529548866|FG005|Overall Study|Lost to Follow-up|4|||
146830125|NCT03856047|529548867|FG006|Overall Study|Lost to Follow-up|4|||
146830126|NCT03410108|529548868|FG000|Overall Study|Ongoing|41|||
146830127|NCT03410108|529548868|FG000|Overall Study|Adverse Event|4|||
146830128|NCT03410108|529548868|FG000|Overall Study|Progressive Disease|58|||
146830129|NCT03410108|529548868|FG000|Overall Study|Withdrawal by Subject|1|||
146830130|NCT00937521|529548870|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
146830131|NCT00937521|529548871|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
146830132|NCT00937521|529548872|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
146830133|NCT00937521|529548873|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
146830134|NCT00937521|529548874|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
146830135|NCT00937521|529548875|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
146830136|NCT00937521|529548876|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
146830137|NCT00937521|529548877|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
146830138|NCT00937521|529548870|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
146830139|NCT00937521|529548871|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
146830140|NCT00937521|529548872|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
146830141|NCT00937521|529548873|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
146830142|NCT00937521|529548874|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
146830143|NCT00937521|529548875|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
146830144|NCT00937521|529548876|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
146830145|NCT00937521|529548877|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
146830146|NCT00937521|529548870|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
146830147|NCT00937521|529548871|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
146830148|NCT00937521|529548872|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
146830149|NCT00937521|529548873|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
146830150|NCT00937521|529548874|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
146830151|NCT00937521|529548875|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
146830152|NCT00937521|529548876|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
146830153|NCT00937521|529548877|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
146830154|NCT00937521|529548870|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
146830155|NCT00937521|529548871|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
146830156|NCT00937521|529548872|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
146830157|NCT00937521|529548873|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
146830158|NCT00937521|529548874|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
146830159|NCT00937521|529548875|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
146830160|NCT00937521|529548876|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
146830161|NCT00937521|529548877|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
146958230|NCT00661362|530006314|FG000|Overall Study|Severe non-compliance to protocol|0|||
146958231|NCT00661362|530006315|FG001|Overall Study|Severe non-compliance to protocol|1|||
146958232|NCT00661362|530006314|FG000|Overall Study|Safety reasons|1|||
146958233|NCT00661362|530006315|FG001|Overall Study|Safety reasons|0|||
146958234|NCT00661362|530006314|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
146958235|NCT00661362|530006315|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
146958236|NCT03764813|530006316|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
146958237|NCT03764813|530006317|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
146958238|NCT03764813|530006318|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
146830162|NCT00937521|529548870|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
146830163|NCT00937521|529548871|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
146830164|NCT00937521|529548872|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
146830165|NCT00937521|529548873|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
146830166|NCT00937521|529548874|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
146830167|NCT00937521|529548875|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
146830168|NCT00937521|529548876|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
146830169|NCT00937521|529548877|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
146830170|NCT00937521|529548870|FG000|Booster Phase|Adverse Event|0|||
146830171|NCT00937521|529548871|FG001|Booster Phase|Adverse Event|0|||
146830172|NCT00937521|529548872|FG002|Booster Phase|Adverse Event|0|||
146830173|NCT00937521|529548873|FG003|Booster Phase|Adverse Event|0|||
146830174|NCT00937521|529548874|FG004|Booster Phase|Adverse Event|0|||
146830175|NCT00937521|529548875|FG005|Booster Phase|Adverse Event|0|||
146830176|NCT00937521|529548876|FG006|Booster Phase|Adverse Event|1|||
146830177|NCT00937521|529548877|FG007|Booster Phase|Adverse Event|0|||
146830178|NCT00937521|529548870|FG000|Booster Phase|Withdrawal by Subject|1|||
146830179|NCT00937521|529548871|FG001|Booster Phase|Withdrawal by Subject|0|||
146830180|NCT00937521|529548872|FG002|Booster Phase|Withdrawal by Subject|0|||
146830181|NCT00937521|529548873|FG003|Booster Phase|Withdrawal by Subject|1|||
146830182|NCT00937521|529548874|FG004|Booster Phase|Withdrawal by Subject|0|||
146830183|NCT00937521|529548875|FG005|Booster Phase|Withdrawal by Subject|0|||
146830184|NCT00937521|529548876|FG006|Booster Phase|Withdrawal by Subject|0|||
146830185|NCT00937521|529548877|FG007|Booster Phase|Withdrawal by Subject|2|||
146830186|NCT00937521|529548870|FG000|Booster Phase|Lost to Follow-up|2|||
146830187|NCT00937521|529548871|FG001|Booster Phase|Lost to Follow-up|2|||
146830188|NCT00937521|529548872|FG002|Booster Phase|Lost to Follow-up|4|||
146830189|NCT00937521|529548873|FG003|Booster Phase|Lost to Follow-up|2|||
146830190|NCT00937521|529548874|FG004|Booster Phase|Lost to Follow-up|4|||
146830191|NCT00937521|529548875|FG005|Booster Phase|Lost to Follow-up|4|||
146830192|NCT00937521|529548876|FG006|Booster Phase|Lost to Follow-up|3|||
146830193|NCT00937521|529548877|FG007|Booster Phase|Lost to Follow-up|0|||
146830194|NCT00937521|529548870|FG000|Booster Phase|Administrative Reason|0|||
146830195|NCT00937521|529548871|FG001|Booster Phase|Administrative Reason|0|||
146830196|NCT00937521|529548872|FG002|Booster Phase|Administrative Reason|1|||
146830197|NCT00937521|529548873|FG003|Booster Phase|Administrative Reason|0|||
146830198|NCT00937521|529548874|FG004|Booster Phase|Administrative Reason|1|||
146830199|NCT00937521|529548875|FG005|Booster Phase|Administrative Reason|1|||
146830200|NCT00937521|529548876|FG006|Booster Phase|Administrative Reason|0|||
146830201|NCT00937521|529548877|FG007|Booster Phase|Administrative Reason|0|||
146830202|NCT00937521|529548870|FG000|Booster Phase|Protocol Deviation|0|||
146830203|NCT00937521|529548871|FG001|Booster Phase|Protocol Deviation|0|||
146830204|NCT00937521|529548872|FG002|Booster Phase|Protocol Deviation|0|||
146830205|NCT00937521|529548873|FG003|Booster Phase|Protocol Deviation|0|||
146830206|NCT00937521|529548874|FG004|Booster Phase|Protocol Deviation|0|||
146830207|NCT00937521|529548875|FG005|Booster Phase|Protocol Deviation|0|||
146830208|NCT00937521|529548876|FG006|Booster Phase|Protocol Deviation|1|||
146830209|NCT00937521|529548877|FG007|Booster Phase|Protocol Deviation|0|||
146830210|NCT01721746|529548883|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
146830211|NCT01721746|529548884|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
146830212|NCT01721746|529548883|FG000|Pre-Treatment|Withdrawal by Subject|1|||
146830213|NCT01721746|529548884|FG001|Pre-Treatment|Withdrawal by Subject|16|||
146830214|NCT01721746|529548883|FG000|Pre-Treatment|Poor/Non-compliance|1|||
146830215|NCT01721746|529548884|FG001|Pre-Treatment|Poor/Non-compliance|0|||
146830216|NCT01721746|529548883|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
146962313|NCT01049360|530021585|FG011|Period 1|Did not meet inc/exc criteria|0|||
146830217|NCT01721746|529548884|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
146830218|NCT01721746|529548883|FG000|Treatment|Disease Progression|192|||
146830219|NCT01721746|529548884|FG001|Treatment|Disease Progression|74|||
146830220|NCT01721746|529548883|FG000|Treatment|Study Drug Toxicity|19|||
146830221|NCT01721746|529548884|FG001|Treatment|Study Drug Toxicity|11|||
146830222|NCT01721746|529548883|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
146830223|NCT01721746|529548884|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
146830224|NCT01721746|529548883|FG000|Treatment|Participant request to discontinue Study treatment|26|||
146830225|NCT01721746|529548884|FG001|Treatment|Participant request to discontinue Study treatment|7|||
146830226|NCT01721746|529548883|FG000|Treatment|Participant withdrew consent|4|||
146830227|NCT01721746|529548884|FG001|Treatment|Participant withdrew consent|2|||
146830228|NCT01721746|529548883|FG000|Treatment|Maximum Clinical Benefit|9|||
146830229|NCT01721746|529548884|FG001|Treatment|Maximum Clinical Benefit|3|||
146830230|NCT01721746|529548883|FG000|Treatment|Poor/Non-compliance|2|||
146830231|NCT01721746|529548884|FG001|Treatment|Poor/Non-compliance|0|||
146830232|NCT01721746|529548883|FG000|Treatment|Participant no longer met Study criteria|4|||
146830233|NCT01721746|529548884|FG001|Treatment|Participant no longer met Study criteria|0|||
146830234|NCT01721746|529548883|FG000|Treatment|Other reasons|6|||
146830235|NCT01721746|529548884|FG001|Treatment|Other reasons|2|||
146830236|NCT01185171|529548889|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
146830237|NCT01185171|529548889|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
146830238|NCT01185171|529548889|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
146830239|NCT01185171|529548889|FG000|Maintenance|Elevated liver transaminases|3|||
146830240|NCT01185171|529548889|FG000|Maintenance|Rush|2|||
146830241|NCT01185171|529548889|FG000|Maintenance|Diarrhea|1|||
146830242|NCT01185171|529548889|FG000|Maintenance|Xerostomia|1|||
146830243|NCT01185171|529548889|FG000|Maintenance|Nausea|1|||
146830244|NCT01185171|529548889|FG000|Maintenance|Comorbid Illness|2|||
146830245|NCT01185171|529548889|FG000|Maintenance|Withdrawal by Subject|1|||
146830246|NCT01185171|529548889|FG000|Maintenance|Disease Recurrence|1|||
146830247|NCT00573651|529548894|FG000|Overall Study|Lost to Follow-up|3|||
146830248|NCT00573651|529548894|FG000|Overall Study|Withdrawal by Subject|1|||
146830249|NCT01837797|529548895|FG000|Period 1|Adverse Event|9|||
146830250|NCT01837797|529548896|FG001|Period 1|Adverse Event|0|||
146830251|NCT01837797|529548897|FG002|Period 1|Adverse Event|0|||
146830252|NCT01837797|529548898|FG003|Period 1|Adverse Event|0|||
146830253|NCT01837797|529548899|FG004|Period 1|Adverse Event|0|||
146830254|NCT01837797|529548895|FG000|Period 1|Withdrawal by Subject|6|||
146830255|NCT01837797|529548896|FG001|Period 1|Withdrawal by Subject|0|||
146830256|NCT01837797|529548897|FG002|Period 1|Withdrawal by Subject|0|||
146830257|NCT01837797|529548898|FG003|Period 1|Withdrawal by Subject|0|||
146830258|NCT01837797|529548899|FG004|Period 1|Withdrawal by Subject|0|||
146830259|NCT01837797|529548895|FG000|Period 1|Administrative reasons|76|||
146830260|NCT01837797|529548896|FG001|Period 1|Administrative reasons|0|||
146830261|NCT01837797|529548897|FG002|Period 1|Administrative reasons|0|||
146830262|NCT01837797|529548898|FG003|Period 1|Administrative reasons|0|||
146830263|NCT01837797|529548899|FG004|Period 1|Administrative reasons|0|||
146830264|NCT01837797|529548895|FG000|Period 1|Withdrawal of consent before treatment|1|||
146830265|NCT01837797|529548896|FG001|Period 1|Withdrawal of consent before treatment|0|||
146830266|NCT01837797|529548897|FG002|Period 1|Withdrawal of consent before treatment|0|||
146830267|NCT01837797|529548898|FG003|Period 1|Withdrawal of consent before treatment|0|||
146830268|NCT01837797|529548899|FG004|Period 1|Withdrawal of consent before treatment|0|||
146830269|NCT01837797|529548895|FG000|Period 1|Other|10|||
146830270|NCT01837797|529548896|FG001|Period 1|Other|0|||
146830271|NCT01837797|529548897|FG002|Period 1|Other|0|||
146830272|NCT01837797|529548898|FG003|Period 1|Other|0|||
146830273|NCT01837797|529548899|FG004|Period 1|Other|0|||
146830274|NCT01837797|529548895|FG000|Period 2|Administrative or other reasons|0|||
146958239|NCT03764813|530006319|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
146958240|NCT01654666|530006322|FG000|Overall Study|Protocol Violation|7|||
146958241|NCT01654666|530006323|FG001|Overall Study|Protocol Violation|4|||
146958242|NCT01654666|530006324|FG002|Overall Study|Protocol Violation|8|||
146958243|NCT01654666|530006322|FG000|Overall Study|Lost to Follow-up|4|||
146958244|NCT01654666|530006323|FG001|Overall Study|Lost to Follow-up|5|||
146958245|NCT01654666|530006324|FG002|Overall Study|Lost to Follow-up|5|||
146958246|NCT01654666|530006322|FG000|Overall Study|Withdrawal by Subject|4|||
146958247|NCT01654666|530006323|FG001|Overall Study|Withdrawal by Subject|4|||
146958248|NCT01654666|530006324|FG002|Overall Study|Withdrawal by Subject|1|||
146958249|NCT02898662|530006326|FG000|Overall Study|Adverse Event|1|||
146958250|NCT02898662|530006327|FG001|Overall Study|Adverse Event|0|||
146958251|NCT02898662|530006326|FG000|Overall Study|Loss of asthma control|23|||
146958252|NCT02898662|530006327|FG001|Overall Study|Loss of asthma control|24|||
146958253|NCT02898662|530006326|FG000|Overall Study|Withdrawal by Subject|4|||
146958254|NCT02898662|530006327|FG001|Overall Study|Withdrawal by Subject|1|||
146958255|NCT02898662|530006326|FG000|Overall Study|Technical issue|0|||
146958256|NCT02898662|530006327|FG001|Overall Study|Technical issue|1|||
146958257|NCT02898662|530006326|FG000|Overall Study|Randomized in error|0|||
146958258|NCT02898662|530006327|FG001|Overall Study|Randomized in error|1|||
146958259|NCT02898662|530006326|FG000|Overall Study|Subject decision|1|||
146958260|NCT02898662|530006327|FG001|Overall Study|Subject decision|0|||
146958261|NCT02898662|530006326|FG000|Overall Study|Other|0|||
146958262|NCT02898662|530006327|FG001|Overall Study|Other|1|||
146958263|NCT03432819|530006330|FG000|Overall Study|Lost to Follow-up|2|||
146958264|NCT03432819|530006331|FG001|Overall Study|Lost to Follow-up|2|||
146958265|NCT03432819|530006330|FG000|Overall Study|Withdrawal by Subject|5|||
146986236|NCT02207621|530112844|FG000|Overall Study|Adverse Event|71|||
146958266|NCT03432819|530006331|FG001|Overall Study|Withdrawal by Subject|3|||
146830275|NCT01837797|529548896|FG001|Period 2|Administrative or other reasons|5|||
146830276|NCT01837797|529548897|FG002|Period 2|Administrative or other reasons|2|||
146830277|NCT01837797|529548898|FG003|Period 2|Administrative or other reasons|4|||
146830278|NCT01837797|529548899|FG004|Period 2|Administrative or other reasons|0|||
146830279|NCT01837797|529548895|FG000|Period 2|Adverse Event|0|||
146830280|NCT01837797|529548896|FG001|Period 2|Adverse Event|0|||
146830281|NCT01837797|529548897|FG002|Period 2|Adverse Event|0|||
146830282|NCT01837797|529548898|FG003|Period 2|Adverse Event|1|||
146830283|NCT01837797|529548899|FG004|Period 2|Adverse Event|0|||
146830284|NCT01837797|529548895|FG000|Period 3|Adverse Event|0|||
146830285|NCT01837797|529548896|FG001|Period 3|Adverse Event|0|||
146830286|NCT01837797|529548897|FG002|Period 3|Adverse Event|0|||
146958267|NCT04382066|530006332|FG000|Overall Study|Adverse Event|1|||
146830287|NCT01837797|529548898|FG003|Period 3|Adverse Event|0|||
146830288|NCT01837797|529548899|FG004|Period 3|Adverse Event|1|||
146830289|NCT01837797|529548895|FG000|Period 3|Administrative reasons|0|||
146986237|NCT02207621|530112845|FG001|Overall Study|Adverse Event|15|||
146986238|NCT02207621|530112846|FG002|Overall Study|Adverse Event|132|||
146986239|NCT02207621|530112844|FG000|Overall Study|Withdrawal by Subject|9|||
146986240|NCT02207621|530112845|FG001|Overall Study|Withdrawal by Subject|9|||
146986241|NCT02207621|530112846|FG002|Overall Study|Withdrawal by Subject|13|||
146986242|NCT02207621|530112844|FG000|Overall Study|Non-Compliant|3|||
146986243|NCT02207621|530112845|FG001|Overall Study|Non-Compliant|3|||
146986244|NCT02207621|530112846|FG002|Overall Study|Non-Compliant|1|||
146986245|NCT02207621|530112844|FG000|Overall Study|Lost to Follow-up|1|||
146986246|NCT02207621|530112845|FG001|Overall Study|Lost to Follow-up|0|||
146986247|NCT02207621|530112846|FG002|Overall Study|Lost to Follow-up|3|||
146986248|NCT02207621|530112844|FG000|Overall Study|Lack of Efficacy|10|||
146986249|NCT02207621|530112845|FG001|Overall Study|Lack of Efficacy|2|||
146986250|NCT02207621|530112846|FG002|Overall Study|Lack of Efficacy|4|||
146986251|NCT02207621|530112844|FG000|Overall Study|Disallowed Concurrent Medication|2|||
146986252|NCT02207621|530112845|FG001|Overall Study|Disallowed Concurrent Medication|5|||
146986253|NCT02207621|530112846|FG002|Overall Study|Disallowed Concurrent Medication|2|||
146986254|NCT02207621|530112844|FG000|Overall Study|Physician Decision|1|||
146986255|NCT02207621|530112845|FG001|Overall Study|Physician Decision|2|||
146986256|NCT02207621|530112846|FG002|Overall Study|Physician Decision|2|||
146986257|NCT02207621|530112844|FG000|Overall Study|Protocol Violation|4|||
146986258|NCT02207621|530112845|FG001|Overall Study|Protocol Violation|10|||
146986259|NCT02207621|530112846|FG002|Overall Study|Protocol Violation|6|||
146986260|NCT02207621|530112844|FG000|Overall Study|Death|2|||
146986261|NCT02207621|530112845|FG001|Overall Study|Death|0|||
146986262|NCT02207621|530112846|FG002|Overall Study|Death|0|||
146986263|NCT02207621|530112844|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
146986264|NCT02207621|530112845|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
146986265|NCT02207621|530112846|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
146986266|NCT00958256|530112847|FG000|Overall Study|Adverse Event|3|||
146986267|NCT03036579|530112851|FG000|2 Years|Lost to Follow-up|1|||
146986268|NCT03036579|530112852|FG001|2 Years|Lost to Follow-up|0|||
146986269|NCT03036579|530112851|FG000|3 Years|Lost to Follow-up|0|||
146986270|NCT03036579|530112852|FG001|3 Years|Lost to Follow-up|1|||
146986271|NCT02848599|530112853|FG000|Overall Study|Protocol Violation|7|||
146986272|NCT02848599|530112854|FG001|Overall Study|Protocol Violation|9|||
146986273|NCT05431153|530112855|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146986274|NCT05431153|530112856|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146986275|NCT05431153|530112857|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146986276|NCT05431153|530112858|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146986277|NCT05431153|530112859|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
146986278|NCT05431153|530112860|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146986279|NCT04828161|530112861|FG000|Overall Study|Withdrawal by Subject|0|||
146986280|NCT04828161|530112862|FG001|Overall Study|Withdrawal by Subject|3|||
146986281|NCT04828161|530112863|FG002|Overall Study|Withdrawal by Subject|3|||
146986282|NCT04828161|530112864|FG003|Overall Study|Withdrawal by Subject|4|||
146986283|NCT04828161|530112861|FG000|Overall Study|Lost to Follow-up|1|||
146986284|NCT04828161|530112862|FG001|Overall Study|Lost to Follow-up|4|||
146986285|NCT04828161|530112863|FG002|Overall Study|Lost to Follow-up|2|||
146986286|NCT04828161|530112864|FG003|Overall Study|Lost to Follow-up|2|||
146986287|NCT04828161|530112861|FG000|Overall Study|Other|2|||
146986288|NCT04828161|530112862|FG001|Overall Study|Other|0|||
146986289|NCT04828161|530112863|FG002|Overall Study|Other|2|||
146986290|NCT04828161|530112864|FG003|Overall Study|Other|0|||
146986291|NCT04828161|530112861|FG000|Overall Study|Death|0|||
146986292|NCT04828161|530112862|FG001|Overall Study|Death|0|||
146986293|NCT04828161|530112863|FG002|Overall Study|Death|0|||
146986294|NCT04828161|530112864|FG003|Overall Study|Death|2|||
146986295|NCT02352337|530112865|FG000|Overall Study|Patients never treated|4|||
146986296|NCT02352337|530112866|FG001|Overall Study|Patients never treated|1|||
146986297|NCT02352337|530112867|FG002|Overall Study|Patients never treated|2|||
146986298|NCT02458638|530112868|FG000|Overall Study|Death|309|||
146986299|NCT02458638|530112868|FG000|Overall Study|End of Cohort/End of Study|67|||
146986300|NCT02458638|530112868|FG000|Overall Study|Lost to Follow-up|31|||
146986301|NCT02458638|530112868|FG000|Overall Study|Other Reasons|4|||
146986302|NCT02458638|530112868|FG000|Overall Study|Physician Decision|1|||
146986303|NCT02458638|530112868|FG000|Overall Study|Withdrawal by Subject|47|||
146986304|NCT00135707|530112879|FG000|Overall Study|Lost to Follow-up|94|||
146986305|NCT00135707|530112880|FG001|Overall Study|Lost to Follow-up|89|||
146986306|NCT00135707|530112879|FG000|Overall Study|Withdrawal by Subject|0|||
146986307|NCT00135707|530112880|FG001|Overall Study|Withdrawal by Subject|1|||
146986308|NCT00135707|530112879|FG000|Overall Study|Institutional review board request|1|||
146986309|NCT00135707|530112880|FG001|Overall Study|Institutional review board request|0|||
146986310|NCT03093454|530112883|FG000|Overall Study|Withdrawal by Subject|1|||
146986311|NCT03093454|530112884|FG001|Overall Study|Withdrawal by Subject|1|||
146830290|NCT01837797|529548896|FG001|Period 3|Administrative reasons|0|||
146830291|NCT01837797|529548897|FG002|Period 3|Administrative reasons|0|||
146830292|NCT01837797|529548898|FG003|Period 3|Administrative reasons|0|||
146830293|NCT01837797|529548899|FG004|Period 3|Administrative reasons|20|||
146830294|NCT01837797|529548895|FG000|Period 3|Other|0|||
146830295|NCT01837797|529548896|FG001|Period 3|Other|0|||
146830296|NCT01837797|529548897|FG002|Period 3|Other|0|||
146830297|NCT01837797|529548898|FG003|Period 3|Other|0|||
146830298|NCT01837797|529548899|FG004|Period 3|Other|2|||
146830299|NCT03797989|529548900|FG000|VAC069A|Withdrawal by Subject|0|||
146830300|NCT03797989|529548901|FG001|VAC069A|Withdrawal by Subject|0|||
146830301|NCT03797989|529548902|FG002|VAC069A|Withdrawal by Subject|1|||
146830302|NCT03797989|529548903|FG003|VAC069A|Withdrawal by Subject|0|||
146830303|NCT03797989|529548904|FG004|VAC069A|Withdrawal by Subject|0|||
146830304|NCT03797989|529548905|FG005|VAC069A|Withdrawal by Subject|0|||
146830305|NCT03797989|529548906|FG006|VAC069A|Withdrawal by Subject|0|||
146830306|NCT03797989|529548907|FG007|VAC069A|Withdrawal by Subject|0|||
146830307|NCT03797989|529548908|FG008|VAC069A|Withdrawal by Subject|0|||
146830308|NCT03797989|529548909|FG009|VAC069A|Withdrawal by Subject|0|||
146830309|NCT03797989|529548910|FG010|VAC069A|Withdrawal by Subject|0|||
146830310|NCT03797989|529548911|FG011|VAC069A|Withdrawal by Subject|0|||
146830311|NCT04052997|529548912|FG000|Overall Study|Withdrawal by Subject|17|||
146830312|NCT04052997|529548912|FG000|Overall Study|Physician Decision|50|||
146830313|NCT04052997|529548912|FG000|Overall Study|Death|43|||
146830314|NCT04052997|529548912|FG000|Overall Study|Lost to Follow-up|5|||
146830315|NCT04052997|529548912|FG000|Overall Study|Progression of Disease|1|||
146830316|NCT00934700|529548919|FG000|Overall Study|missing scan|5|||
146830317|NCT00934700|529548920|FG001|Overall Study|missing scan|9|||
146830318|NCT00934700|529548919|FG000|Overall Study|Death|8|||
146830319|NCT00934700|529548920|FG001|Overall Study|Death|3|||
146830320|NCT03049306|529548923|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
146830321|NCT03049306|529548924|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
146830322|NCT03151551|529548925|FG000|Open-Label Treatment Period|Adverse Event|0|||
146830323|NCT03151551|529548926|FG001|Open-Label Treatment Period|Adverse Event|2|||
146830324|NCT03151551|529548925|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
146830325|NCT03151551|529548926|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
146830326|NCT03151551|529548925|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
146830327|NCT03151551|529548926|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
146830328|NCT03151551|529548925|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
146830329|NCT03151551|529548926|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
146830330|NCT03151551|529548925|FG000|Open-Label Treatment Period|Physician Decision|3|||
146830331|NCT03151551|529548926|FG001|Open-Label Treatment Period|Physician Decision|0|||
146830332|NCT03151551|529548925|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
146830333|NCT03151551|529548926|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
146830334|NCT03151551|529548925|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
146830335|NCT03151551|529548926|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
146830336|NCT03151551|529548925|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
146830337|NCT03151551|529548926|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
146830338|NCT03151551|529548925|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
146830339|NCT03151551|529548926|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
146830340|NCT03151551|529548925|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
146830341|NCT03151551|529548926|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
146830342|NCT05896696|529548927|FG000|Overall Study|Screening Failure|7|||
146830343|NCT05896696|529548927|FG000|Overall Study|Withdrawal by Subject|2|||
146830344|NCT00143598|529548928|FG000|Overall Study|Lost to Follow-up|23|||
146830345|NCT00143598|529548929|FG001|Overall Study|Lost to Follow-up|21|||
146830346|NCT00143598|529548928|FG000|Overall Study|Withdrawal by Subject|33|||
146830347|NCT00143598|529548929|FG001|Overall Study|Withdrawal by Subject|37|||
146830348|NCT00143598|529548928|FG000|Overall Study|Death|36|||
146830349|NCT00143598|529548929|FG001|Overall Study|Death|36|||
146830350|NCT03900715|529548930|FG000|Overall Study|Protocol Deviation|1|||
146830351|NCT03900715|529548930|FG000|Overall Study|Lack of Efficacy|1|||
146830352|NCT03900715|529548930|FG000|Overall Study|Progressive Disease|6|||
146830353|NCT03900715|529548930|FG000|Overall Study|Adverse Event|2|||
146830354|NCT03900715|529548930|FG000|Overall Study|Other reasons|11|||
146830355|NCT01639742|529550887|FG000|Overall Study|Study Ongoing|17|||
146830356|NCT01639742|529550887|FG000|Overall Study|Lost to Follow-up|1|||
146830357|NCT04120376|529550888|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
146830358|NCT04120376|529550889|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
146830359|NCT00781937|529550894|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
146830360|NCT00781937|529550895|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
146830361|NCT00781937|529550894|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
146830362|NCT00781937|529550895|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
146830363|NCT00781937|529550894|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
146830364|NCT00781937|529550895|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
146830365|NCT00781937|529550894|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
146958268|NCT04382066|530006333|FG001|Overall Study|Adverse Event|0|||
146830366|NCT00781937|529550895|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
146830367|NCT00781937|529550894|FG000|Main Trial Period Through Week 56|Unclassified|10|||
146830368|NCT00781937|529550895|FG001|Main Trial Period Through Week 56|Unclassified|15|||
146830369|NCT00781937|529550894|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
146830370|NCT00781937|529550895|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
146830371|NCT00781937|529550894|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
146830372|NCT00781937|529550895|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
146830373|NCT01663506|529550897|FG000|Overall Study|Lack of Efficacy|3|||
146830374|NCT01663506|529550897|FG000|Overall Study|Consent Withdrawal by Subject|1|||
146830375|NCT01663506|529550897|FG000|Overall Study|Lost to Follow-up|1|||
146830376|NCT01663506|529550897|FG000|Overall Study|Adverse Event|1|||
146830377|NCT01663506|529550897|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
146830378|NCT02094898|529550903|FG000|Overall Study|Clinical Worsening|2|||
146830379|NCT02094898|529550903|FG000|Overall Study|Adverse Event|2|||
146830380|NCT02094898|529550903|FG000|Overall Study|Lack of Efficacy|1|||
146830381|NCT03520075|529550904|FG000|Phase 1 (Dose Escalation)|Death|2|||
146830382|NCT03520075|529550905|FG001|Phase 1 (Dose Escalation)|Death|2|||
146830383|NCT03520075|529550906|FG002|Phase 1 (Dose Escalation)|Death|3|||
146830384|NCT03520075|529550907|FG003|Phase 1 (Dose Escalation)|Death|2|||
146830385|NCT03520075|529550908|FG004|Phase 1 (Dose Escalation)|Death|6|||
146830386|NCT03520075|529550909|FG005|Phase 1 (Dose Escalation)|Death|5|||
146830387|NCT03520075|529550910|FG006|Phase 1 (Dose Escalation)|Death|3|||
146830388|NCT03520075|529550911|FG007|Phase 1 (Dose Escalation)|Death|2|||
146830389|NCT03520075|529550912|FG008|Phase 1 (Dose Escalation)|Death|3|||
146830390|NCT03520075|529550913|FG009|Phase 1 (Dose Escalation)|Death|1|||
146830391|NCT03520075|529550914|FG010|Phase 1 (Dose Escalation)|Death|5|||
146830392|NCT03520075|529550915|FG011|Phase 1 (Dose Escalation)|Death|7|||
146830393|NCT03520075|529550916|FG012|Phase 1 (Dose Escalation)|Death|11|||
146830394|NCT03520075|529550917|FG013|Phase 1 (Dose Escalation)|Death|0|||
146830395|NCT03520075|529550918|FG014|Phase 1 (Dose Escalation)|Death|0|||
146830396|NCT03520075|529550919|FG015|Phase 1 (Dose Escalation)|Death|0|||
146830397|NCT03520075|529550920|FG016|Phase 1 (Dose Escalation)|Death|0|||
146830398|NCT03520075|529550921|FG017|Phase 1 (Dose Escalation)|Death|0|||
146830399|NCT03520075|529550922|FG018|Phase 1 (Dose Escalation)|Death|0|||
146830400|NCT03520075|529550904|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
146830401|NCT03520075|529550905|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146830402|NCT03520075|529550906|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146830403|NCT03520075|529550907|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
146830404|NCT03520075|529550908|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
146830405|NCT03520075|529550909|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
146830406|NCT03520075|529550910|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146830407|NCT03520075|529550911|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
146830408|NCT03520075|529550912|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146830409|NCT03520075|529550913|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
146830410|NCT03520075|529550914|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146830411|NCT03520075|529550915|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146830412|NCT03520075|529550916|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
146830413|NCT03520075|529550917|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146830414|NCT03520075|529550918|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146830415|NCT03520075|529550919|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146830416|NCT03520075|529550920|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146830417|NCT03520075|529550921|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146986312|NCT03093454|530112883|FG000|Overall Study|Scheduling conflict|3|||
146986313|NCT03093454|530112884|FG001|Overall Study|Scheduling conflict|1|||
146986314|NCT03093454|530112883|FG000|Overall Study|Physician Decision|2|||
146986315|NCT03093454|530112884|FG001|Overall Study|Physician Decision|1|||
146986316|NCT04540497|530112885|FG000|Overall Study|Adverse Event|0|||
146830418|NCT03520075|529550922|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146830419|NCT03520075|529550904|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146830420|NCT03520075|529550905|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
146830421|NCT03520075|529550906|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146830422|NCT03520075|529550907|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
146830423|NCT03520075|529550908|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
146986317|NCT04540497|530112886|FG001|Overall Study|Adverse Event|2|||
146986318|NCT04540497|530112885|FG000|Overall Study|Lost to Follow-up|1|||
146830424|NCT03520075|529550909|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146830425|NCT03520075|529550910|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146830426|NCT03520075|529550911|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146830427|NCT03520075|529550912|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146830428|NCT03520075|529550913|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146986319|NCT04540497|530112886|FG001|Overall Study|Lost to Follow-up|0|||
146986320|NCT04540497|530112885|FG000|Overall Study|Withdrawal by Subject|1|||
146986321|NCT04540497|530112886|FG001|Overall Study|Withdrawal by Subject|1|||
146830429|NCT03520075|529550914|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
146830430|NCT03520075|529550915|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146830431|NCT03520075|529550916|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
146830432|NCT03520075|529550917|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146830433|NCT03520075|529550918|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146830434|NCT03520075|529550919|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146830435|NCT03520075|529550920|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146830436|NCT03520075|529550921|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146830437|NCT03520075|529550922|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146830438|NCT03520075|529550904|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830439|NCT03520075|529550905|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830440|NCT03520075|529550906|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830441|NCT03520075|529550907|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830442|NCT03520075|529550908|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830443|NCT03520075|529550909|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830444|NCT03520075|529550910|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830445|NCT03520075|529550911|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830446|NCT03520075|529550912|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830447|NCT03520075|529550913|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
146830448|NCT03520075|529550914|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830449|NCT03520075|529550915|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830450|NCT03520075|529550916|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
146830451|NCT03520075|529550917|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830452|NCT03520075|529550918|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830453|NCT03520075|529550919|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830454|NCT03520075|529550920|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830455|NCT03520075|529550921|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830456|NCT03520075|529550922|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146830457|NCT03520075|529550904|FG000|Phase 2 (Dose Expansion)|Death|0|||
146830458|NCT03520075|529550905|FG001|Phase 2 (Dose Expansion)|Death|0|||
146830459|NCT03520075|529550906|FG002|Phase 2 (Dose Expansion)|Death|0|||
146830460|NCT03520075|529550907|FG003|Phase 2 (Dose Expansion)|Death|0|||
146830461|NCT03520075|529550908|FG004|Phase 2 (Dose Expansion)|Death|0|||
146830462|NCT03520075|529550909|FG005|Phase 2 (Dose Expansion)|Death|0|||
146830463|NCT03520075|529550910|FG006|Phase 2 (Dose Expansion)|Death|0|||
146830464|NCT03520075|529550911|FG007|Phase 2 (Dose Expansion)|Death|0|||
146830465|NCT03520075|529550912|FG008|Phase 2 (Dose Expansion)|Death|0|||
146830466|NCT03520075|529550913|FG009|Phase 2 (Dose Expansion)|Death|0|||
146830467|NCT03520075|529550914|FG010|Phase 2 (Dose Expansion)|Death|0|||
146830468|NCT03520075|529550915|FG011|Phase 2 (Dose Expansion)|Death|0|||
146830469|NCT03520075|529550916|FG012|Phase 2 (Dose Expansion)|Death|0|||
146830470|NCT03520075|529550917|FG013|Phase 2 (Dose Expansion)|Death|20|||
146830471|NCT03520075|529550918|FG014|Phase 2 (Dose Expansion)|Death|13|||
146830472|NCT03520075|529550919|FG015|Phase 2 (Dose Expansion)|Death|9|||
146830473|NCT03520075|529550920|FG016|Phase 2 (Dose Expansion)|Death|5|||
146830474|NCT03520075|529550921|FG017|Phase 2 (Dose Expansion)|Death|14|||
146830475|NCT03520075|529550922|FG018|Phase 2 (Dose Expansion)|Death|12|||
146830476|NCT03520075|529550904|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146830477|NCT03520075|529550905|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146830478|NCT03520075|529550906|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146830479|NCT03520075|529550907|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146830480|NCT03520075|529550908|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146830481|NCT03520075|529550909|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146830482|NCT03520075|529550910|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146830483|NCT03520075|529550911|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146830484|NCT03520075|529550912|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146830485|NCT03520075|529550913|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146830486|NCT03520075|529550914|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146830487|NCT03520075|529550915|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146830488|NCT03520075|529550916|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146830489|NCT03520075|529550917|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146830490|NCT03520075|529550918|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
146830491|NCT03520075|529550919|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
146830492|NCT03520075|529550920|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
146830493|NCT03520075|529550921|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
146830494|NCT03520075|529550922|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
146830495|NCT03520075|529550904|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146830496|NCT03520075|529550905|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146830497|NCT03520075|529550906|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146958269|NCT04382066|530006334|FG002|Overall Study|Adverse Event|0|||
146830498|NCT03520075|529550907|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146830499|NCT03520075|529550908|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146830500|NCT03520075|529550909|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146830501|NCT03520075|529550910|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146830502|NCT03520075|529550911|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146830503|NCT03520075|529550912|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146830504|NCT03520075|529550913|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146830505|NCT03520075|529550914|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146830506|NCT03520075|529550915|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146830507|NCT03520075|529550916|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146830508|NCT03520075|529550917|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146830509|NCT03520075|529550918|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
146830510|NCT03520075|529550919|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
146830511|NCT03520075|529550920|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146830512|NCT03520075|529550921|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146830513|NCT03520075|529550922|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
146958270|NCT04382066|530006332|FG000|Overall Study|Death|1|||
146958271|NCT04382066|530006333|FG001|Overall Study|Death|0|||
146958272|NCT04382066|530006334|FG002|Overall Study|Death|1|||
146958273|NCT01430559|530006335|FG000|Overall Study|Adverse Event|7|||
146958274|NCT01430559|530006336|FG001|Overall Study|Adverse Event|3|||
146958275|NCT01430559|530006335|FG000|Overall Study|Entry criteria not met|1|||
146958276|NCT01430559|530006336|FG001|Overall Study|Entry criteria not met|1|||
146958277|NCT01430559|530006335|FG000|Overall Study|Lost to Follow-up|1|||
146958278|NCT01430559|530006336|FG001|Overall Study|Lost to Follow-up|0|||
146958279|NCT01430559|530006335|FG000|Overall Study|Medication error|1|||
146958280|NCT01430559|530006336|FG001|Overall Study|Medication error|0|||
146958281|NCT01430559|530006335|FG000|Overall Study|Withdrawal by Subject|3|||
146958282|NCT01430559|530006336|FG001|Overall Study|Withdrawal by Subject|2|||
146958283|NCT01430559|530006335|FG000|Overall Study|Protocol Violation|1|||
146958284|NCT01430559|530006336|FG001|Overall Study|Protocol Violation|0|||
146958285|NCT01430559|530006335|FG000|Overall Study|Other|3|||
146958286|NCT01430559|530006336|FG001|Overall Study|Other|3|||
146958287|NCT01430559|530006335|FG000|Overall Study|Randomized, Not Treated|3|||
146958288|NCT01430559|530006336|FG001|Overall Study|Randomized, Not Treated|3|||
146958289|NCT04225026|530006337|FG000|Overall Study|Withdrawal by Subject|4|||
146958290|NCT04225026|530006337|FG000|Overall Study|Adverse Event|1|||
146958291|NCT04225026|530006337|FG000|Overall Study|Other|1|||
146958292|NCT04225026|530006337|FG000|Overall Study|Death|11|||
146958293|NCT04225026|530006337|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
146958294|NCT00579059|530006338|FG000|Overall Study|Study Canceled at 1 Year|21|||
146958295|NCT00579059|530006339|FG001|Overall Study|Study Canceled at 1 Year|10|||
146958296|NCT00779506|530006340|FG000|Overall Study|Screening Failed|2|||
146958297|NCT00779506|530006340|FG000|Overall Study|Adverse Event|4|||
146958298|NCT00779506|530006340|FG000|Overall Study|Lack of Efficacy|11|||
146958299|NCT00779506|530006340|FG000|Overall Study|Protocol Violation|5|||
146958300|NCT00779506|530006340|FG000|Overall Study|Withdrawal by Subject|6|||
146958301|NCT00779506|530006340|FG000|Overall Study|Lost to Follow-up|1|||
146958302|NCT03982069|530006341|FG000|Overall Study|Lost to Follow-up|5|||
146958303|NCT03982069|530006342|FG001|Overall Study|Lost to Follow-up|5|||
146958304|NCT03982069|530006343|FG002|Overall Study|Lost to Follow-up|3|||
146958305|NCT03982069|530006344|FG003|Overall Study|Lost to Follow-up|5|||
146958306|NCT03982069|530006341|FG000|Overall Study|Physician Decision|0|||
146958307|NCT03982069|530006342|FG001|Overall Study|Physician Decision|1|||
146958308|NCT03982069|530006343|FG002|Overall Study|Physician Decision|0|||
146958309|NCT03982069|530006344|FG003|Overall Study|Physician Decision|0|||
146958310|NCT03982069|530006341|FG000|Overall Study|Withdrawal by Subject|2|||
146958311|NCT03982069|530006342|FG001|Overall Study|Withdrawal by Subject|1|||
146958312|NCT03982069|530006343|FG002|Overall Study|Withdrawal by Subject|5|||
146958313|NCT03982069|530006344|FG003|Overall Study|Withdrawal by Subject|2|||
146958314|NCT03982069|530006341|FG000|Overall Study|Specimen loss|3|||
146958315|NCT03982069|530006342|FG001|Overall Study|Specimen loss|3|||
146958316|NCT03982069|530006343|FG002|Overall Study|Specimen loss|1|||
146958317|NCT03982069|530006344|FG003|Overall Study|Specimen loss|1|||
146958318|NCT01218477|530006345|FG000|Overall Study|Disease progression|2|||
146958319|NCT01218477|530006346|FG001|Overall Study|Disease progression|3|||
146958320|NCT01218477|530006347|FG002|Overall Study|Disease progression|6|||
146958321|NCT01218477|530006348|FG003|Overall Study|Disease progression|2|||
146958322|NCT01218477|530006345|FG000|Overall Study|Study drug toxicity|0|||
146958323|NCT01218477|530006346|FG001|Overall Study|Study drug toxicity|2|||
146958324|NCT01218477|530006347|FG002|Overall Study|Study drug toxicity|5|||
146958325|NCT01218477|530006348|FG003|Overall Study|Study drug toxicity|0|||
146830514|NCT03520075|529550904|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146830515|NCT03520075|529550905|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146830516|NCT03520075|529550906|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146958326|NCT01218477|530006345|FG000|Overall Study|No longer meets study criteria|1|||
146958327|NCT01218477|530006346|FG001|Overall Study|No longer meets study criteria|0|||
146986322|NCT04540497|530112885|FG000|Overall Study|Miscellaneous|2|||
146986323|NCT04540497|530112886|FG001|Overall Study|Miscellaneous|1|||
146986324|NCT00421174|530112888|FG000|Overall Study|Withdrawal by Subject|0|||
146986325|NCT00421174|530112889|FG001|Overall Study|Withdrawal by Subject|1|||
146986326|NCT00421174|530112888|FG000|Overall Study|Ineligible due to infection|2|||
146986327|NCT00421174|530112889|FG001|Overall Study|Ineligible due to infection|0|||
146986328|NCT01829464|530112893|FG000|Overall Study|Adverse Event|1|||
146986329|NCT01829464|530112894|FG001|Overall Study|Adverse Event|0|||
146986330|NCT01829464|530112895|FG002|Overall Study|Adverse Event|0|||
146986331|NCT01829464|530112893|FG000|Overall Study|Lost to Follow-up|0|||
146986332|NCT01829464|530112894|FG001|Overall Study|Lost to Follow-up|0|||
146986333|NCT01829464|530112895|FG002|Overall Study|Lost to Follow-up|1|||
146986334|NCT01829464|530112893|FG000|Overall Study|Withdrawal by Subject|2|||
146986335|NCT01829464|530112894|FG001|Overall Study|Withdrawal by Subject|0|||
146986336|NCT01829464|530112895|FG002|Overall Study|Withdrawal by Subject|0|||
146986337|NCT01829464|530112893|FG000|Overall Study|Study terminated by sponsor|25|||
146986338|NCT01829464|530112894|FG001|Overall Study|Study terminated by sponsor|28|||
146986339|NCT01829464|530112895|FG002|Overall Study|Study terminated by sponsor|25|||
146986340|NCT01829464|530112893|FG000|Overall Study|Lack of Efficacy|0|||
146986341|NCT01829464|530112894|FG001|Overall Study|Lack of Efficacy|1|||
146986342|NCT01829464|530112895|FG002|Overall Study|Lack of Efficacy|0|||
146986343|NCT00992407|530112900|FG000|Overall Study|Protocol Violation|2|||
146986344|NCT00992407|530112901|FG001|Overall Study|Protocol Violation|1|||
146986345|NCT00992407|530112900|FG000|Overall Study|Lost to Follow-up|3|||
146986346|NCT00992407|530112901|FG001|Overall Study|Lost to Follow-up|3|||
146986347|NCT00992407|530112900|FG000|Overall Study|Adverse Event|3|||
146986348|NCT00992407|530112901|FG001|Overall Study|Adverse Event|2|||
146830517|NCT03520075|529550907|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146830518|NCT03520075|529550908|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146830519|NCT03520075|529550909|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146830520|NCT03520075|529550910|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146830521|NCT03520075|529550911|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146830522|NCT03520075|529550912|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146830523|NCT03520075|529550913|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146830524|NCT03520075|529550914|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146830525|NCT03520075|529550915|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146830526|NCT03520075|529550916|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146830527|NCT03520075|529550917|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
146830528|NCT03520075|529550918|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146830529|NCT03520075|529550919|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146830530|NCT03520075|529550920|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
146830531|NCT03520075|529550921|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
146830532|NCT03520075|529550922|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146830533|NCT00328562|529550925|FG000|Overall Study|Disease progression|1|||
146830534|NCT03305809|529550926|FG000|Overall Study|Adverse Event|2|||
146830535|NCT03305809|529550927|FG001|Overall Study|Adverse Event|2|||
146830536|NCT03305809|529550928|FG002|Overall Study|Adverse Event|6|||
146830537|NCT03305809|529550929|FG003|Overall Study|Adverse Event|6|||
146830538|NCT03305809|529550926|FG000|Overall Study|Death|0|||
146830539|NCT03305809|529550927|FG001|Overall Study|Death|0|||
146830540|NCT03305809|529550928|FG002|Overall Study|Death|1|||
146830541|NCT03305809|529550929|FG003|Overall Study|Death|1|||
146830542|NCT03305809|529550926|FG000|Overall Study|Lost to Follow-up|1|||
146830543|NCT03305809|529550927|FG001|Overall Study|Lost to Follow-up|2|||
146830544|NCT03305809|529550928|FG002|Overall Study|Lost to Follow-up|0|||
146830545|NCT03305809|529550929|FG003|Overall Study|Lost to Follow-up|0|||
146830546|NCT03305809|529550926|FG000|Overall Study|Sponsor Decision|1|||
146830547|NCT03305809|529550927|FG001|Overall Study|Sponsor Decision|0|||
146830548|NCT03305809|529550928|FG002|Overall Study|Sponsor Decision|1|||
146986349|NCT00992407|530112900|FG000|Overall Study|protocol Violation & Adverse events|2|||
146830549|NCT03305809|529550929|FG003|Overall Study|Sponsor Decision|8|||
146986350|NCT00992407|530112901|FG001|Overall Study|protocol Violation & Adverse events|4|||
146986351|NCT00992407|530112900|FG000|Overall Study|Other|2|||
146830550|NCT03305809|529550926|FG000|Overall Study|Physician Decision|0|||
146986352|NCT00992407|530112901|FG001|Overall Study|Other|0|||
146986353|NCT00992407|530112900|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
146986354|NCT00992407|530112901|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
146986355|NCT00992407|530112900|FG000|Overall Study|Study medication not administered|17|||
146986356|NCT00992407|530112901|FG001|Overall Study|Study medication not administered|13|||
146986357|NCT04700449|530112906|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
146830551|NCT03305809|529550927|FG001|Overall Study|Physician Decision|0|||
146830552|NCT03305809|529550928|FG002|Overall Study|Physician Decision|2|||
146830553|NCT03305809|529550929|FG003|Overall Study|Physician Decision|4|||
146830554|NCT03305809|529550926|FG000|Overall Study|Progressive Disease|0|||
146830555|NCT03305809|529550927|FG001|Overall Study|Progressive Disease|0|||
146830556|NCT03305809|529550928|FG002|Overall Study|Progressive Disease|1|||
146830557|NCT03305809|529550929|FG003|Overall Study|Progressive Disease|0|||
146830558|NCT03305809|529550926|FG000|Overall Study|Protocol Violation|1|||
146830559|NCT03305809|529550927|FG001|Overall Study|Protocol Violation|0|||
146830560|NCT03305809|529550928|FG002|Overall Study|Protocol Violation|2|||
146830561|NCT03305809|529550929|FG003|Overall Study|Protocol Violation|3|||
146830562|NCT03305809|529550926|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
146830563|NCT03305809|529550927|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
146830564|NCT03305809|529550928|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
146830565|NCT03305809|529550929|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
146830566|NCT03305809|529550926|FG000|Overall Study|Withdrawal by Subject|2|||
146830567|NCT03305809|529550927|FG001|Overall Study|Withdrawal by Subject|4|||
146830568|NCT03305809|529550928|FG002|Overall Study|Withdrawal by Subject|5|||
146830569|NCT03305809|529550929|FG003|Overall Study|Withdrawal by Subject|2|||
146830570|NCT03305809|529550926|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
146830571|NCT03305809|529550927|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
146830572|NCT03305809|529550928|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
146830573|NCT03305809|529550929|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
146830574|NCT04014790|529550930|FG000|Overall Study|Death|4|||
146830575|NCT04014790|529550930|FG000|Overall Study|Adverse Event|1|||
146830576|NCT04014790|529550930|FG000|Overall Study|Withdrawal by Subject|1|||
146830577|NCT00816556|529550931|FG000|Overall Study|Adverse Event|1|||
146830578|NCT00816556|529550932|FG001|Overall Study|Adverse Event|1|||
146830579|NCT00816556|529550933|FG002|Overall Study|Adverse Event|1|||
146830580|NCT00816556|529550931|FG000|Overall Study|Withdrawal by Subject|1|||
146830581|NCT00816556|529550932|FG001|Overall Study|Withdrawal by Subject|1|||
146830582|NCT00816556|529550933|FG002|Overall Study|Withdrawal by Subject|1|||
146830583|NCT00816556|529550931|FG000|Overall Study|Lost to Follow-up|0|||
146830584|NCT00816556|529550932|FG001|Overall Study|Lost to Follow-up|0|||
146830585|NCT00816556|529550933|FG002|Overall Study|Lost to Follow-up|1|||
146830586|NCT03546816|529550934|FG000|Overall Study|Adverse Event|5|||
146830587|NCT03546816|529550935|FG001|Overall Study|Adverse Event|3|||
146830588|NCT03546816|529550934|FG000|Overall Study|Lack of Efficacy|2|||
146830589|NCT03546816|529550935|FG001|Overall Study|Lack of Efficacy|4|||
146830590|NCT03546816|529550934|FG000|Overall Study|Pregnancy|1|||
146830591|NCT03546816|529550935|FG001|Overall Study|Pregnancy|0|||
146830592|NCT03546816|529550934|FG000|Overall Study|Physician Decision|2|||
146830593|NCT03546816|529550935|FG001|Overall Study|Physician Decision|0|||
146830594|NCT03546816|529550934|FG000|Overall Study|Withdrawal by Subject|8|||
146830595|NCT03546816|529550935|FG001|Overall Study|Withdrawal by Subject|10|||
146830596|NCT03546816|529550934|FG000|Overall Study|Lost to Follow-up|3|||
146830597|NCT03546816|529550935|FG001|Overall Study|Lost to Follow-up|2|||
146830598|NCT02438371|529550936|FG000|Overall Study|Lost to Follow-up|3|||
146830599|NCT02438371|529550937|FG001|Overall Study|Lost to Follow-up|2|||
146830600|NCT02438371|529550936|FG000|Overall Study|Withdrawal by Subject|1|||
146830601|NCT02438371|529550937|FG001|Overall Study|Withdrawal by Subject|1|||
146830602|NCT01161446|529550938|FG000|Overall Study|Lost to Follow-up|18|||
146830603|NCT01161446|529550939|FG001|Overall Study|Lost to Follow-up|14|||
146830604|NCT01161446|529550938|FG000|Overall Study|Withdrawal by Subject|0|||
146830605|NCT01161446|529550939|FG001|Overall Study|Withdrawal by Subject|1|||
146830606|NCT00810342|529550940|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
146830607|NCT00810342|529550941|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
146830608|NCT00810342|529550940|FG000|Month 1 Follow-up|Pregnancy|1|||
146830609|NCT00810342|529550941|FG001|Month 1 Follow-up|Pregnancy|0|||
146830610|NCT00810342|529550940|FG000|6-month Follow-up|Lost to Follow-up|18|||
146830611|NCT00810342|529550941|FG001|6-month Follow-up|Lost to Follow-up|6|||
146830612|NCT00810342|529550940|FG000|6-month Follow-up|Pregnancy|6|||
146830613|NCT00810342|529550941|FG001|6-month Follow-up|Pregnancy|2|||
146830614|NCT00810342|529550940|FG000|12-month Followup|Pregnancy|9|||
146830615|NCT00810342|529550941|FG001|12-month Followup|Pregnancy|10|||
146830616|NCT00810342|529550940|FG000|12-month Followup|Lost to Follow-up|3|||
146830617|NCT00810342|529550941|FG001|12-month Followup|Lost to Follow-up|1|||
146830618|NCT03065933|529550942|FG000|Overall Study|study terminated|5|||
146830619|NCT04504630|529550943|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
146830620|NCT04504630|529550944|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
146830621|NCT04504630|529550943|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
146830622|NCT04504630|529550944|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
146830623|NCT01010204|529550945|FG000|Overall Study|Lost to Follow-up|2|||
146830624|NCT01010204|529550946|FG001|Overall Study|Lost to Follow-up|2|||
146958328|NCT01218477|530006347|FG002|Overall Study|No longer meets study criteria|0|||
146958329|NCT01218477|530006348|FG003|Overall Study|No longer meets study criteria|0|||
146830625|NCT01010204|529550945|FG000|Overall Study|Adverse Event|1|||
146830626|NCT01010204|529550946|FG001|Overall Study|Adverse Event|3|||
146830627|NCT01010204|529550945|FG000|Overall Study|Withdrawal by Subject|2|||
146830628|NCT01010204|529550946|FG001|Overall Study|Withdrawal by Subject|3|||
146830629|NCT01010204|529550945|FG000|Overall Study|psychiatric hospitalization|2|||
146830630|NCT01010204|529550946|FG001|Overall Study|psychiatric hospitalization|1|||
146830631|NCT01513330|529550947|FG000|SenSura Mio First,|Adverse Event|2|||
146830632|NCT01513330|529550948|FG001|SenSura Mio First,|Adverse Event|0|||
146830633|NCT01513330|529550947|FG000|SenSura Mio First,|Lack of Efficacy|0|||
146830634|NCT01513330|529550948|FG001|SenSura Mio First,|Lack of Efficacy|1|||
146830635|NCT01513330|529550947|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
146830636|NCT01513330|529550948|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
146830637|NCT01513330|529550947|FG000|SenSura Mio First,|Other|1|||
146830638|NCT01513330|529550948|FG001|SenSura Mio First,|Other|0|||
146830639|NCT01513330|529550947|FG000|Standard Care First,|Lack of Efficacy|2|||
146830640|NCT01513330|529550948|FG001|Standard Care First,|Lack of Efficacy|2|||
146830641|NCT01513330|529550947|FG000|Standard Care First,|Withdrawal by Subject|1|||
146830642|NCT01513330|529550948|FG001|Standard Care First,|Withdrawal by Subject|2|||
146830643|NCT01513330|529550947|FG000|Standard Care First,|Other|1|||
146830644|NCT01513330|529550948|FG001|Standard Care First,|Other|0|||
146830645|NCT01519778|529550949|FG000|Overall Study|Withdrawal by Subject|3|||
146830646|NCT01519778|529550949|FG000|Overall Study|Lost to Follow-up|10|||
146830647|NCT01519778|529550949|FG000|Overall Study|Physician Decision|1|||
146830648|NCT02330562|529550954|FG000|Overall Study|Adverse Event|0|||
146830649|NCT02330562|529550955|FG001|Overall Study|Adverse Event|0|||
146830650|NCT02330562|529550956|FG002|Overall Study|Adverse Event|3|||
146830651|NCT02330562|529550957|FG003|Overall Study|Adverse Event|0|||
146830652|NCT02330562|529550958|FG004|Overall Study|Adverse Event|3|||
146830653|NCT02330562|529550959|FG005|Overall Study|Adverse Event|1|||
146830654|NCT02330562|529550960|FG006|Overall Study|Adverse Event|0|||
146830655|NCT02330562|529550961|FG007|Overall Study|Adverse Event|0|||
146830656|NCT02330562|529550962|FG008|Overall Study|Adverse Event|0|||
146830657|NCT02330562|529550963|FG009|Overall Study|Adverse Event|1|||
146830658|NCT02330562|529550964|FG010|Overall Study|Adverse Event|1|||
146830659|NCT02330562|529550954|FG000|Overall Study|Participant decision|1|||
146830660|NCT02330562|529550955|FG001|Overall Study|Participant decision|0|||
146830661|NCT02330562|529550956|FG002|Overall Study|Participant decision|4|||
146830662|NCT02330562|529550957|FG003|Overall Study|Participant decision|1|||
146830663|NCT02330562|529550958|FG004|Overall Study|Participant decision|5|||
146830664|NCT02330562|529550959|FG005|Overall Study|Participant decision|2|||
146830665|NCT02330562|529550960|FG006|Overall Study|Participant decision|0|||
146830666|NCT02330562|529550961|FG007|Overall Study|Participant decision|0|||
146830667|NCT02330562|529550962|FG008|Overall Study|Participant decision|0|||
146830668|NCT02330562|529550963|FG009|Overall Study|Participant decision|3|||
146830669|NCT02330562|529550964|FG010|Overall Study|Participant decision|0|||
146830670|NCT02330562|529550954|FG000|Overall Study|Disease progression|5|||
146830671|NCT02330562|529550955|FG001|Overall Study|Disease progression|3|||
146830672|NCT02330562|529550956|FG002|Overall Study|Disease progression|20|||
146830673|NCT02330562|529550957|FG003|Overall Study|Disease progression|28|||
146830674|NCT02330562|529550958|FG004|Overall Study|Disease progression|23|||
146830675|NCT02330562|529550959|FG005|Overall Study|Disease progression|7|||
146830676|NCT02330562|529550960|FG006|Overall Study|Disease progression|1|||
146830677|NCT02330562|529550961|FG007|Overall Study|Disease progression|1|||
146830678|NCT02330562|529550962|FG008|Overall Study|Disease progression|1|||
146830679|NCT02330562|529550963|FG009|Overall Study|Disease progression|0|||
146830680|NCT02330562|529550964|FG010|Overall Study|Disease progression|5|||
146830681|NCT02330562|529550954|FG000|Overall Study|Other reasons|0|||
146830682|NCT02330562|529550955|FG001|Overall Study|Other reasons|0|||
146830683|NCT02330562|529550956|FG002|Overall Study|Other reasons|0|||
146830684|NCT02330562|529550957|FG003|Overall Study|Other reasons|1|||
146830685|NCT02330562|529550958|FG004|Overall Study|Other reasons|0|||
146830686|NCT02330562|529550959|FG005|Overall Study|Other reasons|0|||
146830687|NCT02330562|529550960|FG006|Overall Study|Other reasons|0|||
146830688|NCT02330562|529550961|FG007|Overall Study|Other reasons|0|||
146830689|NCT02330562|529550962|FG008|Overall Study|Other reasons|0|||
146830690|NCT02330562|529550963|FG009|Overall Study|Other reasons|0|||
146830691|NCT02330562|529550964|FG010|Overall Study|Other reasons|0|||
146830692|NCT02330562|529550954|FG000|Overall Study|Withdrawal by Subject|0|||
146830693|NCT02330562|529550955|FG001|Overall Study|Withdrawal by Subject|0|||
146830694|NCT02330562|529550956|FG002|Overall Study|Withdrawal by Subject|0|||
146830695|NCT02330562|529550957|FG003|Overall Study|Withdrawal by Subject|0|||
146830696|NCT02330562|529550958|FG004|Overall Study|Withdrawal by Subject|0|||
146830697|NCT02330562|529550959|FG005|Overall Study|Withdrawal by Subject|0|||
146830698|NCT02330562|529550960|FG006|Overall Study|Withdrawal by Subject|0|||
146830699|NCT02330562|529550961|FG007|Overall Study|Withdrawal by Subject|0|||
146830700|NCT02330562|529550962|FG008|Overall Study|Withdrawal by Subject|0|||
146830701|NCT02330562|529550963|FG009|Overall Study|Withdrawal by Subject|1|||
146830702|NCT02330562|529550964|FG010|Overall Study|Withdrawal by Subject|0|||
146830703|NCT01547117|529550965|FG000|Overall Study|Physician Decision|0|||
146830704|NCT01547117|529550966|FG001|Overall Study|Physician Decision|1|||
146830705|NCT01547117|529550967|FG002|Overall Study|Physician Decision|1|||
146830706|NCT01547117|529550968|FG003|Overall Study|Physician Decision|3|||
146830707|NCT01547117|529550965|FG000|Overall Study|Withdrawal by Subject|1|||
146830708|NCT01547117|529550966|FG001|Overall Study|Withdrawal by Subject|2|||
146830709|NCT01547117|529550967|FG002|Overall Study|Withdrawal by Subject|1|||
146830710|NCT01547117|529550968|FG003|Overall Study|Withdrawal by Subject|2|||
146830711|NCT00412880|529550973|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
146830712|NCT00412880|529550973|FG000|Overall Study|Consent withdrawn|1|||
146830713|NCT00412880|529550973|FG000|Overall Study|Adverse Event|1|||
146830714|NCT00412880|529550973|FG000|Overall Study|Progressive disease|20|||
146830715|NCT01288209|529550974|FG000|Overall Study|Withdrawal by Subject|1|||
146830716|NCT01288209|529550975|FG001|Overall Study|Withdrawal by Subject|3|||
146830717|NCT01288209|529550974|FG000|Overall Study|Other|1|||
146830718|NCT01288209|529550975|FG001|Overall Study|Other|0|||
146830719|NCT01015677|529550977|FG000|Overall Study|Adverse Event|0|||
146830720|NCT01015677|529550978|FG001|Overall Study|Adverse Event|1|||
146830721|NCT01015677|529550979|FG002|Overall Study|Adverse Event|0|||
146830722|NCT01015677|529550977|FG000|Overall Study|Lack of Efficacy|0|||
146830723|NCT01015677|529550978|FG001|Overall Study|Lack of Efficacy|1|||
146830724|NCT01015677|529550979|FG002|Overall Study|Lack of Efficacy|0|||
146830725|NCT01015677|529550977|FG000|Overall Study|Protocol Violation|0|||
146830726|NCT01015677|529550978|FG001|Overall Study|Protocol Violation|1|||
146830727|NCT01015677|529550979|FG002|Overall Study|Protocol Violation|0|||
146830728|NCT01015677|529550977|FG000|Overall Study|Withdrawal by Subject|1|||
146830729|NCT01015677|529550978|FG001|Overall Study|Withdrawal by Subject|1|||
146830730|NCT01015677|529550979|FG002|Overall Study|Withdrawal by Subject|0|||
146830731|NCT02706951|529550980|FG000|Period 1|Adverse Event|1|||
146830732|NCT02706951|529550981|FG001|Period 1|Adverse Event|5|||
146830733|NCT02706951|529550982|FG002|Period 1|Adverse Event|3|||
146830734|NCT02706951|529550983|FG003|Period 1|Adverse Event|0|||
146830735|NCT02706951|529550984|FG004|Period 1|Adverse Event|0|||
146830736|NCT02706951|529550980|FG000|Period 1|Withdrawal by Subject|10|||
146830737|NCT02706951|529550981|FG001|Period 1|Withdrawal by Subject|6|||
146830738|NCT02706951|529550982|FG002|Period 1|Withdrawal by Subject|6|||
146830739|NCT02706951|529550983|FG003|Period 1|Withdrawal by Subject|0|||
146830740|NCT02706951|529550984|FG004|Period 1|Withdrawal by Subject|0|||
146830741|NCT02706951|529550980|FG000|Period 1|Lost to Follow-up|0|||
146830742|NCT02706951|529550981|FG001|Period 1|Lost to Follow-up|4|||
146830743|NCT02706951|529550982|FG002|Period 1|Lost to Follow-up|1|||
146830744|NCT02706951|529550983|FG003|Period 1|Lost to Follow-up|0|||
146830745|NCT02706951|529550984|FG004|Period 1|Lost to Follow-up|0|||
146830746|NCT02706951|529550980|FG000|Period 1|Other|2|||
146830747|NCT02706951|529550981|FG001|Period 1|Other|1|||
146830748|NCT02706951|529550982|FG002|Period 1|Other|0|||
146830749|NCT02706951|529550983|FG003|Period 1|Other|0|||
146830750|NCT02706951|529550984|FG004|Period 1|Other|0|||
146830751|NCT02706951|529550980|FG000|Period 2|Adverse Event|0|||
146830752|NCT02706951|529550981|FG001|Period 2|Adverse Event|0|||
146830753|NCT02706951|529550982|FG002|Period 2|Adverse Event|0|||
146830754|NCT02706951|529550983|FG003|Period 2|Adverse Event|25|||
146830755|NCT02706951|529550984|FG004|Period 2|Adverse Event|34|||
146830756|NCT02706951|529550980|FG000|Period 2|Withdrawal by Subject|0|||
146830757|NCT02706951|529550981|FG001|Period 2|Withdrawal by Subject|0|||
146830758|NCT02706951|529550982|FG002|Period 2|Withdrawal by Subject|0|||
146830759|NCT02706951|529550983|FG003|Period 2|Withdrawal by Subject|38|||
146830760|NCT02706951|529550984|FG004|Period 2|Withdrawal by Subject|44|||
146830761|NCT02706951|529550980|FG000|Period 2|Lost to Follow-up|0|||
146830762|NCT02706951|529550981|FG001|Period 2|Lost to Follow-up|0|||
146830763|NCT02706951|529550982|FG002|Period 2|Lost to Follow-up|0|||
146830764|NCT02706951|529550983|FG003|Period 2|Lost to Follow-up|17|||
146830765|NCT02706951|529550984|FG004|Period 2|Lost to Follow-up|9|||
146830766|NCT02706951|529550980|FG000|Period 2|COVID-19 Related|0|||
146830767|NCT02706951|529550981|FG001|Period 2|COVID-19 Related|0|||
146830768|NCT02706951|529550982|FG002|Period 2|COVID-19 Related|0|||
146830769|NCT02706951|529550983|FG003|Period 2|COVID-19 Related|1|||
146830770|NCT02706951|529550984|FG004|Period 2|COVID-19 Related|2|||
146986358|NCT04700449|530112907|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
146986359|NCT04700449|530112908|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
146830771|NCT02706951|529550980|FG000|Period 2|Other|0|||
146830772|NCT02706951|529550981|FG001|Period 2|Other|0|||
146830773|NCT02706951|529550982|FG002|Period 2|Other|0|||
146830774|NCT02706951|529550983|FG003|Period 2|Other|37|||
146830775|NCT02706951|529550984|FG004|Period 2|Other|31|||
146830776|NCT03491215|529550985|FG000|Overall Study|Death|6|||
146830777|NCT03491215|529550986|FG001|Overall Study|Death|2|||
146830778|NCT03491215|529550987|FG002|Overall Study|Death|1|||
146830779|NCT03491215|529550988|FG003|Overall Study|Death|0|||
146830780|NCT03491215|529550985|FG000|Overall Study|Physician Decision|1|||
146830781|NCT03491215|529550986|FG001|Overall Study|Physician Decision|0|||
146830782|NCT03491215|529550987|FG002|Overall Study|Physician Decision|0|||
146830783|NCT03491215|529550988|FG003|Overall Study|Physician Decision|0|||
146830784|NCT02172950|529550995|FG000|Overall Study|Physician Decision|3|||
146830785|NCT02172950|529550996|FG001|Overall Study|Physician Decision|3|||
146830786|NCT02172950|529550995|FG000|Overall Study|Lack of Efficacy|1|||
146830787|NCT02172950|529550996|FG001|Overall Study|Lack of Efficacy|0|||
146830788|NCT02172950|529550995|FG000|Overall Study|Adverse Event|4|||
146830789|NCT02172950|529550996|FG001|Overall Study|Adverse Event|1|||
146830790|NCT02172950|529550995|FG000|Overall Study|Withdrawal by Subject|10|||
146830791|NCT02172950|529550996|FG001|Overall Study|Withdrawal by Subject|0|||
146830792|NCT02172950|529550995|FG000|Overall Study|Protocol Violation|1|||
146830793|NCT02172950|529550996|FG001|Overall Study|Protocol Violation|0|||
146830794|NCT02172950|529550995|FG000|Overall Study|Lost to Follow-up|1|||
146830795|NCT02172950|529550996|FG001|Overall Study|Lost to Follow-up|0|||
146830796|NCT02172950|529550995|FG000|Overall Study|Death|1|||
146830797|NCT02172950|529550996|FG001|Overall Study|Death|0|||
146830798|NCT02172950|529550995|FG000|Overall Study|Patient traveling|1|||
146830799|NCT02172950|529550996|FG001|Overall Study|Patient traveling|0|||
146830800|NCT02172950|529550995|FG000|Overall Study|Patient went to other country|1|||
146830801|NCT02172950|529550996|FG001|Overall Study|Patient went to other country|0|||
146830802|NCT02172950|529550995|FG000|Overall Study|Patient relocated overseas|1|||
146830803|NCT02172950|529550996|FG001|Overall Study|Patient relocated overseas|1|||
146830804|NCT02172950|529550995|FG000|Overall Study|Patient moving|1|||
146830805|NCT02172950|529550996|FG001|Overall Study|Patient moving|0|||
146830806|NCT04962698|529550997|FG000|Motor Imagery|Technical difficulty|1|||
146830807|NCT04962698|529550998|FG001|Motor Imagery|Technical difficulty|0|||
146830808|NCT04962698|529550997|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
146830809|NCT04962698|529550998|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
146830810|NCT04962698|529550997|FG000|Kinesthetic MI|Technical difficulty|1|||
146830811|NCT04962698|529550998|FG001|Kinesthetic MI|Technical difficulty|0|||
146830812|NCT04962698|529550997|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
146830813|NCT04962698|529550998|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
146830814|NCT04962698|529550997|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
146830815|NCT04962698|529550998|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
146830816|NCT04962698|529550997|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
146830817|NCT04962698|529550998|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
146830818|NCT04962698|529550997|FG000|Virtual-hand Interaction|Technical difficulty|1|||
146830819|NCT04962698|529550998|FG001|Virtual-hand Interaction|Technical difficulty|0|||
146830820|NCT04962698|529550997|FG000|Robotic Action Observation|Technical difficulty|1|||
146830821|NCT04962698|529550998|FG001|Robotic Action Observation|Technical difficulty|0|||
146830822|NCT04962698|529550997|FG000|Rest|Technical difficulty|1|||
146830823|NCT04962698|529550998|FG001|Rest|Technical difficulty|0|||
146830824|NCT04962698|529550997|FG000|Rest|Exclusion criteria met after enrollment|0|||
146830825|NCT04962698|529550998|FG001|Rest|Exclusion criteria met after enrollment|2|||
146830826|NCT00853229|529550999|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
146830827|NCT00853229|529551000|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
146830828|NCT03672175|529551003|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
146830829|NCT03672175|529551004|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
146830830|NCT03672175|529551005|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
146830831|NCT03672175|529551003|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
146830832|NCT03672175|529551004|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
146830833|NCT03672175|529551005|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
146830834|NCT03672175|529551003|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
146830835|NCT03672175|529551004|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
146830836|NCT03672175|529551005|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
146830837|NCT03672175|529551003|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
146830838|NCT03672175|529551004|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
146830839|NCT03672175|529551005|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
146830840|NCT03672175|529551003|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
146830841|NCT03672175|529551004|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
146830842|NCT03672175|529551005|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
146830843|NCT03672175|529551003|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
146830844|NCT03672175|529551004|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
146830845|NCT03672175|529551005|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
146830846|NCT03672175|529551003|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
146830847|NCT03672175|529551004|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
146830848|NCT03672175|529551005|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
146830849|NCT03672175|529551003|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
146830850|NCT03672175|529551004|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
146830851|NCT03672175|529551005|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
146958330|NCT01218477|530006345|FG000|Overall Study|Withdrawal by Subject|0|||
146958331|NCT01218477|530006346|FG001|Overall Study|Withdrawal by Subject|0|||
146958332|NCT01218477|530006347|FG002|Overall Study|Withdrawal by Subject|1|||
146830852|NCT03672175|529551003|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
146830853|NCT03672175|529551004|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
146830854|NCT03672175|529551005|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
146830855|NCT03672175|529551003|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
146830856|NCT03672175|529551004|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
146830857|NCT03672175|529551005|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
146830858|NCT03672175|529551003|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
146830859|NCT03672175|529551004|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
146830860|NCT03672175|529551005|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
146830861|NCT03672175|529551003|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
146830862|NCT03672175|529551004|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
146830863|NCT03672175|529551005|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
146830864|NCT02586415|529551009|FG000|Overall Study|Death|13|||
146830865|NCT02586415|529551010|FG001|Overall Study|Death|23|||
146830866|NCT02586415|529551009|FG000|Overall Study|Lost to Follow-up|1|||
146830867|NCT02586415|529551010|FG001|Overall Study|Lost to Follow-up|2|||
146830868|NCT02777242|529551011|FG000|Overall Study|Other|2|||
146830869|NCT02777242|529551011|FG000|Overall Study|Lost to Follow-up|1|||
146830870|NCT02777242|529551011|FG000|Overall Study|Multiple|1|||
146830871|NCT02777242|529551011|FG000|Overall Study|Sponsor's request|1|||
146830872|NCT02777242|529551011|FG000|Overall Study|Withdrawal by Subject|1|||
146830873|NCT05178979|529551012|FG000|Overall Study|Death|0|||
146830874|NCT05178979|529551013|FG001|Overall Study|Death|5|||
146830875|NCT05178979|529551014|FG002|Overall Study|Death|0|||
146830876|NCT05178979|529551015|FG003|Overall Study|Death|3|||
146830877|NCT05178979|529551012|FG000|Overall Study|Adverse Event|0|||
146830878|NCT05178979|529551013|FG001|Overall Study|Adverse Event|1|||
146830879|NCT05178979|529551014|FG002|Overall Study|Adverse Event|0|||
146830880|NCT05178979|529551015|FG003|Overall Study|Adverse Event|0|||
146830881|NCT05178979|529551012|FG000|Overall Study|Lost to Follow-up|1|||
146830882|NCT05178979|529551013|FG001|Overall Study|Lost to Follow-up|8|||
146830883|NCT05178979|529551014|FG002|Overall Study|Lost to Follow-up|3|||
146830884|NCT05178979|529551015|FG003|Overall Study|Lost to Follow-up|8|||
146830885|NCT00255944|529551016|FG000|Overall Study|Lost to Follow-up|797|||
146830886|NCT00255944|529551017|FG001|Overall Study|Lost to Follow-up|834|||
146830887|NCT02299427|529551019|FG000|Overall Study|Withdrawal by Subject|1|||
146830888|NCT02299427|529551020|FG001|Overall Study|Withdrawal by Subject|0|||
146830889|NCT02299427|529551019|FG000|Overall Study|Lost to Follow-up|1|||
146830890|NCT02299427|529551020|FG001|Overall Study|Lost to Follow-up|3|||
146830891|NCT02299427|529551019|FG000|Overall Study|not adherent to dog website use|21|||
146830892|NCT02299427|529551020|FG001|Overall Study|not adherent to dog website use|0|||
146830893|NCT03269695|529551021|FG000|Overall Study|Adverse Event|2|||
146830894|NCT03269695|529551022|FG001|Overall Study|Adverse Event|1|||
146830895|NCT03269695|529551021|FG000|Overall Study|Lack of Efficacy|0|||
146830896|NCT03269695|529551022|FG001|Overall Study|Lack of Efficacy|1|||
146830897|NCT03269695|529551021|FG000|Overall Study|Withdrawal by Subject|0|||
146830898|NCT03269695|529551022|FG001|Overall Study|Withdrawal by Subject|1|||
146830899|NCT00104637|529551023|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
146830900|NCT00104637|529551024|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
146830901|NCT01313624|529551025|FG000|Double-Blind Phase|Adverse Event|27|||
146830902|NCT01313624|529551026|FG001|Double-Blind Phase|Adverse Event|4|||
146830903|NCT01313624|529551025|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
146830904|NCT01313624|529551026|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
146830905|NCT01313624|529551025|FG000|Double-Blind Phase|Lost to Follow-up|0|||
146830906|NCT01313624|529551026|FG001|Double-Blind Phase|Lost to Follow-up|2|||
146830907|NCT01313624|529551025|FG000|Double-Blind Phase|Physician Decision|1|||
146830908|NCT01313624|529551026|FG001|Double-Blind Phase|Physician Decision|0|||
146830909|NCT01313624|529551025|FG000|Double-Blind Phase|Lack of Efficacy|1|||
146830910|NCT01313624|529551026|FG001|Double-Blind Phase|Lack of Efficacy|0|||
146830911|NCT01313624|529551025|FG000|Open-Label Phase|Adverse Event|1|||
146830912|NCT01313624|529551026|FG001|Open-Label Phase|Adverse Event|10|||
146830913|NCT01313624|529551025|FG000|Open-Label Phase|Withdrawal by Subject|2|||
146830914|NCT01313624|529551026|FG001|Open-Label Phase|Withdrawal by Subject|2|||
146830915|NCT01313624|529551025|FG000|Open-Label Phase|Lost to Follow-up|1|||
146830916|NCT01313624|529551026|FG001|Open-Label Phase|Lost to Follow-up|1|||
146830917|NCT00239681|529551029|FG000|Overall Study|Adverse Event|100|||
146830918|NCT00239681|529551030|FG001|Overall Study|Adverse Event|99|||
146830919|NCT00239681|529551029|FG000|Overall Study|Withdrawal by Subject|458|||
146830920|NCT00239681|529551030|FG001|Overall Study|Withdrawal by Subject|489|||
146830921|NCT00239681|529551029|FG000|Overall Study|Lost to Follow-up|28|||
146958333|NCT01218477|530006348|FG003|Overall Study|Withdrawal by Subject|0|||
146830922|NCT00239681|529551030|FG001|Overall Study|Lost to Follow-up|22|||
146830923|NCT00239681|529551029|FG000|Overall Study|Protocol Violation|4|||
146830924|NCT00239681|529551030|FG001|Overall Study|Protocol Violation|4|||
146830925|NCT00239681|529551029|FG000|Overall Study|Physician Decision|13|||
146830926|NCT00239681|529551030|FG001|Overall Study|Physician Decision|17|||
146830927|NCT00239681|529551029|FG000|Overall Study|No information chacked on CaseReportForm|90|||
146830928|NCT00239681|529551030|FG001|Overall Study|No information chacked on CaseReportForm|84|||
146830929|NCT02447718|529551031|FG000|Overall Study|Lost to Follow-up|8|||
146830930|NCT02447718|529551032|FG001|Overall Study|Lost to Follow-up|0|||
146830931|NCT02447718|529551031|FG000|Overall Study|Withdrawal by Subject|3|||
146830932|NCT02447718|529551032|FG001|Overall Study|Withdrawal by Subject|0|||
146830933|NCT02447718|529551031|FG000|Overall Study|Screen Failure|1|||
146830934|NCT02447718|529551032|FG001|Overall Study|Screen Failure|0|||
146830935|NCT02654132|529551035|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
146830936|NCT02654132|529551036|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
146830937|NCT02654132|529551035|FG000|Treatment Period|Disease progression|43|||
146830938|NCT02654132|529551036|FG001|Treatment Period|Disease progression|38|||
146830939|NCT02654132|529551035|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
146830940|NCT02654132|529551036|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
146830941|NCT02654132|529551035|FG000|Treatment Period|Other reasons|4|||
146830942|NCT02654132|529551036|FG001|Treatment Period|Other reasons|2|||
146830943|NCT02654132|529551035|FG000|Treatment Period|Study drug toxicity|2|||
146830944|NCT02654132|529551036|FG001|Treatment Period|Study drug toxicity|2|||
146830945|NCT02654132|529551035|FG000|Treatment Period|Withdrawal by Subject|2|||
146830946|NCT02654132|529551036|FG001|Treatment Period|Withdrawal by Subject|1|||
146830947|NCT02654132|529551035|FG000|Treatment Period|Maximum Clinical Benefit|0|||
146830948|NCT02654132|529551036|FG001|Treatment Period|Maximum Clinical Benefit|2|||
146830949|NCT02654132|529551035|FG000|Treatment Period|Participant request to discontinue|2|||
146830950|NCT02654132|529551036|FG001|Treatment Period|Participant request to discontinue|0|||
146830951|NCT02654132|529551035|FG000|Treatment Period|Administrative reasons by sponsor|0|||
146830952|NCT02654132|529551036|FG001|Treatment Period|Administrative reasons by sponsor|1|||
146830953|NCT02654132|529551035|FG000|Treatment Period|Death|1|||
146830954|NCT02654132|529551036|FG001|Treatment Period|Death|0|||
146830955|NCT01880437|529551037|FG000|Overall Study|Death|12|||
146830956|NCT01880437|529551038|FG001|Overall Study|Death|4|||
146830957|NCT01880437|529551039|FG002|Overall Study|Death|17|||
146830958|NCT01880437|529551037|FG000|Overall Study|Study terminated by Sponsor|3|||
146830959|NCT01880437|529551038|FG001|Overall Study|Study terminated by Sponsor|0|||
146830960|NCT01880437|529551039|FG002|Overall Study|Study terminated by Sponsor|2|||
146830961|NCT03713320|529551040|FG000|Randomized Period|Adverse Event|1|||
146830962|NCT03713320|529551041|FG001|Randomized Period|Adverse Event|5|||
146830963|NCT03713320|529551042|FG002|Randomized Period|Adverse Event|0|||
146830964|NCT03713320|529551040|FG000|Randomized Period|Physician Decision|1|||
146830965|NCT03713320|529551041|FG001|Randomized Period|Physician Decision|1|||
146830966|NCT03713320|529551042|FG002|Randomized Period|Physician Decision|0|||
146830967|NCT03713320|529551040|FG000|Randomized Period|Withdrawal by Subject|4|||
146830968|NCT03713320|529551041|FG001|Randomized Period|Withdrawal by Subject|0|||
146830969|NCT03713320|529551042|FG002|Randomized Period|Withdrawal by Subject|0|||
146830970|NCT03713320|529551040|FG000|Randomized Period|Participant decision|3|||
146830971|NCT03713320|529551041|FG001|Randomized Period|Participant decision|1|||
146830972|NCT03713320|529551042|FG002|Randomized Period|Participant decision|0|||
146830973|NCT03713320|529551040|FG000|Randomized Period|Study terminated by sponsor|6|||
146830974|NCT03713320|529551041|FG001|Randomized Period|Study terminated by sponsor|3|||
146830975|NCT03713320|529551042|FG002|Randomized Period|Study terminated by sponsor|0|||
146830976|NCT03713320|529551040|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
146830977|NCT03713320|529551041|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
146830978|NCT03713320|529551042|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
146830979|NCT03713320|529551040|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
146830980|NCT03713320|529551041|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
146830981|NCT03713320|529551042|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
146830982|NCT00909532|529551043|FG000|Overall Study|Adverse Event|4|||
146830983|NCT00909532|529551044|FG001|Overall Study|Adverse Event|1|||
146830984|NCT00909532|529551043|FG000|Overall Study|Pregnancy|0|||
146830985|NCT00909532|529551044|FG001|Overall Study|Pregnancy|1|||
146830986|NCT00909532|529551043|FG000|Overall Study|Prohibited Medication|2|||
146830987|NCT00909532|529551044|FG001|Overall Study|Prohibited Medication|1|||
146830988|NCT00909532|529551043|FG000|Overall Study|Withdrawal of Consent|1|||
146830989|NCT00909532|529551044|FG001|Overall Study|Withdrawal of Consent|1|||
146830990|NCT00909532|529551043|FG000|Overall Study|Noncompliance with Study Requirements|0|||
146830991|NCT00909532|529551044|FG001|Overall Study|Noncompliance with Study Requirements|2|||
146830992|NCT00909532|529551043|FG000|Overall Study|Physician Decision|1|||
146830993|NCT00909532|529551044|FG001|Overall Study|Physician Decision|0|||
146830994|NCT00909532|529551043|FG000|Overall Study|Wrong Genotype|1|||
146830995|NCT00909532|529551044|FG001|Overall Study|Wrong Genotype|0|||
146830996|NCT00909532|529551043|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
146830997|NCT00909532|529551044|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
146958334|NCT01218477|530006345|FG000|Overall Study|Prepared for cell transplantation|0|||
146958335|NCT01218477|530006346|FG001|Overall Study|Prepared for cell transplantation|1|||
146830998|NCT01209598|529551045|FG000|Overall Study|Withdrawal by Subject|1|||
146830999|NCT01209598|529551046|FG001|Overall Study|Withdrawal by Subject|0|||
146831000|NCT01174264|529551047|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
146831001|NCT01174264|529551048|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
146831002|NCT01174264|529551049|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
146831003|NCT01174264|529551047|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
146958336|NCT01218477|530006347|FG002|Overall Study|Prepared for cell transplantation|1|||
146831004|NCT01174264|529551048|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
146831005|NCT01174264|529551049|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
146831006|NCT01174264|529551047|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
146831007|NCT01174264|529551048|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
146831008|NCT01174264|529551049|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
146831009|NCT02370251|529553388|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
146831010|NCT02370251|529553388|FG000|Overall Study|Death|4|||
146831011|NCT04469465|529553389|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
146831012|NCT04469465|529553390|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
146831013|NCT04469465|529553389|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
146831014|NCT04469465|529553390|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
146831015|NCT04469465|529553389|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
146831016|NCT04469465|529553390|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
146831017|NCT04469465|529553389|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
146831018|NCT04469465|529553390|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
146831019|NCT04469465|529553389|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
146831020|NCT04469465|529553390|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
146831021|NCT04469465|529553389|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
146831022|NCT04469465|529553390|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
146831023|NCT04469465|529553389|FG000|Long-Term Extension (LTE)|Death|0|||
146831024|NCT04469465|529553390|FG001|Long-Term Extension (LTE)|Death|1|||
146831025|NCT04469465|529553389|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
146831026|NCT04469465|529553390|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
146831027|NCT02053610|529553391|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
146831028|NCT02053610|529553392|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
146831029|NCT02053610|529553391|FG000|Overall Study|Withdrew Consent|2|||
146831030|NCT02053610|529553392|FG001|Overall Study|Withdrew Consent|9|||
146831031|NCT02053610|529553391|FG000|Overall Study|Death|5|||
146831032|NCT02053610|529553392|FG001|Overall Study|Death|5|||
146831033|NCT02053610|529553391|FG000|Overall Study|Administrative/Other|1|||
146831034|NCT02053610|529553392|FG001|Overall Study|Administrative/Other|1|||
146831035|NCT02053610|529553391|FG000|Overall Study|Disease Progression|2|||
146831036|NCT02053610|529553392|FG001|Overall Study|Disease Progression|3|||
146831037|NCT02053610|529553391|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
146831038|NCT02053610|529553392|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
146831039|NCT02053610|529553391|FG000|Overall Study|Did not Receive Treatment|4|||
146831040|NCT02053610|529553392|FG001|Overall Study|Did not Receive Treatment|2|||
146831041|NCT02053610|529553391|FG000|Overall Study|Insufficient Therapeutic Response|1|||
146831042|NCT02053610|529553392|FG001|Overall Study|Insufficient Therapeutic Response|1|||
146831043|NCT02053610|529553391|FG000|Overall Study|Violation of Selection Criteria|1|||
146831044|NCT02053610|529553392|FG001|Overall Study|Violation of Selection Criteria|0|||
146831045|NCT01150045|529553394|FG000|Overall Study|Protocol Violation|0|||
146831046|NCT01150045|529553395|FG001|Overall Study|Protocol Violation|1|||
146831047|NCT01150045|529553396|FG002|Overall Study|Protocol Violation|0|||
146831048|NCT01150045|529553397|FG003|Overall Study|Protocol Violation|1|||
146831049|NCT01496365|529553401|FG000|Overall Study|Adverse Event|2|||
146831050|NCT01496365|529553402|FG001|Overall Study|Adverse Event|3|||
146831051|NCT01496365|529553403|FG002|Overall Study|Adverse Event|3|||
146831052|NCT01496365|529553404|FG003|Overall Study|Adverse Event|2|||
146831053|NCT01496365|529553405|FG004|Overall Study|Adverse Event|5|||
146831054|NCT01496365|529553406|FG005|Overall Study|Adverse Event|6|||
146831055|NCT01496365|529553407|FG006|Overall Study|Adverse Event|4|||
146831056|NCT01496365|529553401|FG000|Overall Study|Withdrawal by Subject|6|||
146831057|NCT01496365|529553402|FG001|Overall Study|Withdrawal by Subject|6|||
146831058|NCT01496365|529553403|FG002|Overall Study|Withdrawal by Subject|0|||
146831059|NCT01496365|529553404|FG003|Overall Study|Withdrawal by Subject|1|||
146831060|NCT01496365|529553405|FG004|Overall Study|Withdrawal by Subject|3|||
146831061|NCT01496365|529553406|FG005|Overall Study|Withdrawal by Subject|2|||
146831062|NCT01496365|529553407|FG006|Overall Study|Withdrawal by Subject|1|||
146831063|NCT01496365|529553401|FG000|Overall Study|Protocol Violation|2|||
146831064|NCT01496365|529553402|FG001|Overall Study|Protocol Violation|1|||
146831065|NCT01496365|529553403|FG002|Overall Study|Protocol Violation|1|||
146831066|NCT01496365|529553404|FG003|Overall Study|Protocol Violation|0|||
146831067|NCT01496365|529553405|FG004|Overall Study|Protocol Violation|0|||
146831068|NCT01496365|529553406|FG005|Overall Study|Protocol Violation|1|||
146831069|NCT01496365|529553407|FG006|Overall Study|Protocol Violation|0|||
146831070|NCT01496365|529553401|FG000|Overall Study|Lack of Efficacy|1|||
146831071|NCT01496365|529553402|FG001|Overall Study|Lack of Efficacy|0|||
146831072|NCT01496365|529553403|FG002|Overall Study|Lack of Efficacy|0|||
146831073|NCT01496365|529553404|FG003|Overall Study|Lack of Efficacy|0|||
146831074|NCT01496365|529553405|FG004|Overall Study|Lack of Efficacy|0|||
146831075|NCT01496365|529553406|FG005|Overall Study|Lack of Efficacy|1|||
146831076|NCT01496365|529553407|FG006|Overall Study|Lack of Efficacy|0|||
146831077|NCT01496365|529553401|FG000|Overall Study|Lost to Follow-up|0|||
146831078|NCT01496365|529553402|FG001|Overall Study|Lost to Follow-up|1|||
146831079|NCT01496365|529553403|FG002|Overall Study|Lost to Follow-up|0|||
146831080|NCT01496365|529553404|FG003|Overall Study|Lost to Follow-up|0|||
146831081|NCT01496365|529553405|FG004|Overall Study|Lost to Follow-up|2|||
146831082|NCT01496365|529553406|FG005|Overall Study|Lost to Follow-up|0|||
146831083|NCT01496365|529553407|FG006|Overall Study|Lost to Follow-up|0|||
146831084|NCT01496365|529553401|FG000|Overall Study|Other|4|||
146831085|NCT01496365|529553402|FG001|Overall Study|Other|4|||
146831086|NCT01496365|529553403|FG002|Overall Study|Other|2|||
146831087|NCT01496365|529553404|FG003|Overall Study|Other|1|||
146831088|NCT01496365|529553405|FG004|Overall Study|Other|3|||
146831089|NCT01496365|529553406|FG005|Overall Study|Other|0|||
146831090|NCT01496365|529553407|FG006|Overall Study|Other|1|||
146831091|NCT02232399|529553408|FG000|Overall Study|Adverse Event|1|||
146831092|NCT02232399|529553409|FG001|Overall Study|Adverse Event|0|||
146831093|NCT02232399|529553408|FG000|Overall Study|Withdrawal by Subject|0|||
146831094|NCT02232399|529553409|FG001|Overall Study|Withdrawal by Subject|1|||
146831095|NCT01660256|529553410|FG000|Overall Study|Adverse Event|4|||
146831096|NCT01660256|529553411|FG001|Overall Study|Adverse Event|0|||
146831097|NCT01660256|529553412|FG002|Overall Study|Adverse Event|2|||
146831098|NCT01660256|529553410|FG000|Overall Study|Withdrawal by Subject|1|||
146831099|NCT01660256|529553411|FG001|Overall Study|Withdrawal by Subject|0|||
146831100|NCT01660256|529553412|FG002|Overall Study|Withdrawal by Subject|2|||
146831101|NCT04599855|529553416|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
146831102|NCT04599855|529553417|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
146831103|NCT04599855|529553418|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
146831104|NCT04599855|529553416|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
146831105|NCT04599855|529553417|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
146831106|NCT04599855|529553418|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
146831107|NCT04599855|529553416|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
146831108|NCT04599855|529553417|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
146831109|NCT04599855|529553418|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
146831110|NCT04599855|529553416|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
146831111|NCT04599855|529553417|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
146831112|NCT04599855|529553418|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
146831113|NCT04599855|529553416|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
146831114|NCT04599855|529553417|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
146831115|NCT04599855|529553418|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
146831116|NCT04599855|529553416|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
146831117|NCT04599855|529553417|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
146831118|NCT04599855|529553418|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
146831119|NCT04599855|529553416|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
146831120|NCT04599855|529553417|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
146831121|NCT04599855|529553418|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
146831122|NCT04599855|529553416|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
146831123|NCT04599855|529553417|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
146831124|NCT04599855|529553418|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
146831125|NCT04599855|529553416|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
146831126|NCT04599855|529553417|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
146831127|NCT04599855|529553418|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
146831128|NCT04599855|529553416|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
146831129|NCT04599855|529553417|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
146831130|NCT04599855|529553418|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
146831131|NCT04599855|529553416|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
146831132|NCT04599855|529553417|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
146831133|NCT04599855|529553418|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
146831134|NCT04599855|529553416|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
146831135|NCT04599855|529553417|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
146831136|NCT04599855|529553418|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
146831137|NCT04599855|529553416|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
146831138|NCT04599855|529553417|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
146831139|NCT04599855|529553418|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
146831140|NCT04599855|529553416|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
146831141|NCT04599855|529553417|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
146831142|NCT04599855|529553418|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
146831143|NCT04294667|529553419|FG000|Overall Study|Lack of Efficacy|4|||
146831144|NCT04294667|529553420|FG001|Overall Study|Lack of Efficacy|4|||
146831145|NCT04294667|529553419|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
146958337|NCT01218477|530006348|FG003|Overall Study|Prepared for cell transplantation|0|||
146958338|NCT01218477|530006345|FG000|Overall Study|Administrative reason by sponsor|0|||
146958339|NCT01218477|530006346|FG001|Overall Study|Administrative reason by sponsor|0|||
146958340|NCT01218477|530006347|FG002|Overall Study|Administrative reason by sponsor|1|||
146831146|NCT04294667|529553420|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
146831147|NCT04294667|529553419|FG000|Overall Study|Patient has a Renal Flare|1|||
146831148|NCT04294667|529553420|FG001|Overall Study|Patient has a Renal Flare|0|||
146831149|NCT04294667|529553419|FG000|Overall Study|SLE Worsening|0|||
146831150|NCT04294667|529553420|FG001|Overall Study|SLE Worsening|1|||
146831151|NCT04294667|529553419|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
146831152|NCT04294667|529553420|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
146831153|NCT04294667|529553419|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
146831154|NCT04294667|529553420|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
146831155|NCT04294667|529553419|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
146831156|NCT04294667|529553420|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
146831157|NCT04294667|529553419|FG000|Overall Study|Subject Moved to Another State|0|||
146831158|NCT04294667|529553420|FG001|Overall Study|Subject Moved to Another State|1|||
146831159|NCT04294667|529553419|FG000|Overall Study|Adverse event, serious fatal|0|||
146831160|NCT04294667|529553420|FG001|Overall Study|Adverse event, serious fatal|1|||
146831161|NCT04294667|529553419|FG000|Overall Study|Adverse event, non-fatal|3|||
146831162|NCT04294667|529553420|FG001|Overall Study|Adverse event, non-fatal|4|||
146831163|NCT02165397|529553421|FG000|Overall Study|Death|7|||
146831164|NCT02165397|529553422|FG001|Overall Study|Death|10|||
146831165|NCT02165397|529553423|FG002|Overall Study|Death|8|||
146831166|NCT02165397|529553421|FG000|Overall Study|Lost to Follow-up|1|||
146831167|NCT02165397|529553422|FG001|Overall Study|Lost to Follow-up|3|||
146831168|NCT02165397|529553423|FG002|Overall Study|Lost to Follow-up|0|||
146831169|NCT02165397|529553421|FG000|Overall Study|Withdrawal by Subject|6|||
146831170|NCT02165397|529553422|FG001|Overall Study|Withdrawal by Subject|6|||
146831171|NCT02165397|529553423|FG002|Overall Study|Withdrawal by Subject|1|||
146831172|NCT02165397|529553421|FG000|Overall Study|Other, Not Specified|0|||
146831173|NCT02165397|529553422|FG001|Overall Study|Other, Not Specified|0|||
146831174|NCT02165397|529553423|FG002|Overall Study|Other, Not Specified|1|||
146831175|NCT03297398|529553424|FG000|Overall Study|Sponsor's decision|6|||
146831176|NCT03297398|529553425|FG001|Overall Study|Sponsor's decision|9|||
146831177|NCT03297398|529553426|FG002|Overall Study|Sponsor's decision|7|||
146958341|NCT01218477|530006348|FG003|Overall Study|Administrative reason by sponsor|0|||
146958342|NCT01218477|530006345|FG000|Overall Study|Maximum clinical benefit|0|||
146958343|NCT01218477|530006346|FG001|Overall Study|Maximum clinical benefit|2|||
146958344|NCT01218477|530006347|FG002|Overall Study|Maximum clinical benefit|0|||
146958345|NCT01218477|530006348|FG003|Overall Study|Maximum clinical benefit|0|||
146958346|NCT00787527|530006349|FG000|Overall Study|Toxicity|3|||
146958347|NCT03137433|530006352|FG000|Overall Study|Withdrawal by Subject|11|||
146958348|NCT03137433|530006353|FG001|Overall Study|Withdrawal by Subject|11|||
146958349|NCT03137433|530006352|FG000|Overall Study|Lost to Follow-up|5|||
146958350|NCT03137433|530006353|FG001|Overall Study|Lost to Follow-up|6|||
146958351|NCT03137433|530006352|FG000|Overall Study|Physician Decision|2|||
146958352|NCT03137433|530006353|FG001|Overall Study|Physician Decision|0|||
146958353|NCT03137433|530006352|FG000|Overall Study|Moved out of study area|1|||
146958354|NCT03137433|530006353|FG001|Overall Study|Moved out of study area|0|||
146958355|NCT03137433|530006352|FG000|Overall Study|Too far out of window due to COVID|0|||
146958356|NCT03137433|530006353|FG001|Overall Study|Too far out of window due to COVID|1|||
146958357|NCT01005875|530006357|FG000|Overall Study|Death|3|||
146958358|NCT00606931|530006360|FG000|Overall Study|Withdrawal by Subject|3|||
146958359|NCT00286234|530006361|FG000|Overall Study|Protocol Violation|1|||
146958360|NCT00286234|530006362|FG001|Overall Study|Protocol Violation|2|||
146958361|NCT00286234|530006363|FG002|Overall Study|Protocol Violation|0|||
146958362|NCT00286234|530006364|FG003|Overall Study|Protocol Violation|1|||
146958363|NCT00286234|530006361|FG000|Overall Study|Physician Decision|1|||
146958364|NCT00286234|530006362|FG001|Overall Study|Physician Decision|0|||
146958365|NCT00286234|530006363|FG002|Overall Study|Physician Decision|0|||
146958366|NCT00286234|530006364|FG003|Overall Study|Physician Decision|1|||
146958367|NCT00286234|530006361|FG000|Overall Study|Adverse Event|0|||
146958368|NCT00286234|530006362|FG001|Overall Study|Adverse Event|0|||
146958369|NCT00286234|530006363|FG002|Overall Study|Adverse Event|0|||
146958370|NCT00286234|530006364|FG003|Overall Study|Adverse Event|1|||
146958371|NCT00286234|530006361|FG000|Overall Study|Adverse Event|0|||
146958372|NCT00286234|530006362|FG001|Overall Study|Adverse Event|0|||
146958373|NCT00286234|530006363|FG002|Overall Study|Adverse Event|0|||
146958374|NCT00286234|530006364|FG003|Overall Study|Adverse Event|1|||
146958375|NCT01468844|530006369|FG000|Overall Study|Adverse Event|1|||
146958376|NCT01468844|530006370|FG001|Overall Study|Adverse Event|0|||
146831178|NCT03297398|529553424|FG000|Overall Study|Adverse Event|1|||
146831179|NCT03297398|529553425|FG001|Overall Study|Adverse Event|4|||
146831180|NCT03297398|529553426|FG002|Overall Study|Adverse Event|4|||
146831181|NCT03297398|529553424|FG000|Overall Study|Withdrawal by Subject|1|||
146831182|NCT03297398|529553425|FG001|Overall Study|Withdrawal by Subject|2|||
146831183|NCT03297398|529553426|FG002|Overall Study|Withdrawal by Subject|2|||
146831184|NCT03297398|529553424|FG000|Overall Study|Protocol Violation|0|||
146958377|NCT01468844|530006369|FG000|Overall Study|Withdrawal by Subject|1|||
146958378|NCT01468844|530006370|FG001|Overall Study|Withdrawal by Subject|0|||
146831185|NCT03297398|529553425|FG001|Overall Study|Protocol Violation|2|||
146831186|NCT03297398|529553426|FG002|Overall Study|Protocol Violation|0|||
146831187|NCT03297398|529553424|FG000|Overall Study|Physician Decision|0|||
146831188|NCT03297398|529553425|FG001|Overall Study|Physician Decision|0|||
146831189|NCT03297398|529553426|FG002|Overall Study|Physician Decision|1|||
146831190|NCT03297398|529553424|FG000|Overall Study|Lost to Follow-up|0|||
146831191|NCT03297398|529553425|FG001|Overall Study|Lost to Follow-up|0|||
146831192|NCT03297398|529553426|FG002|Overall Study|Lost to Follow-up|1|||
146831193|NCT03481556|529553427|FG000|Overall Study|Adverse Event|1|||
146831194|NCT03481556|529553428|FG001|Overall Study|Adverse Event|0|||
146831195|NCT03481556|529553429|FG002|Overall Study|Adverse Event|0|||
146831196|NCT03481556|529553430|FG003|Overall Study|Adverse Event|0|||
146831197|NCT03481556|529553427|FG000|Overall Study|Death|4|||
146831198|NCT03481556|529553428|FG001|Overall Study|Death|2|||
146831199|NCT03481556|529553429|FG002|Overall Study|Death|3|||
146831200|NCT03481556|529553430|FG003|Overall Study|Death|16|||
146831201|NCT03481556|529553427|FG000|Overall Study|Study Terminated by Sponsor|10|||
146831202|NCT03481556|529553428|FG001|Overall Study|Study Terminated by Sponsor|5|||
146831203|NCT03481556|529553429|FG002|Overall Study|Study Terminated by Sponsor|2|||
146831204|NCT03481556|529553430|FG003|Overall Study|Study Terminated by Sponsor|9|||
146831205|NCT01316887|529553431|FG000|Overall Study|Adverse Event|13|||
146831206|NCT01316887|529553432|FG001|Overall Study|Adverse Event|21|||
146831207|NCT01316887|529553433|FG002|Overall Study|Adverse Event|17|||
146831208|NCT01316887|529553431|FG000|Overall Study|Lack of Efficacy|9|||
146831209|NCT01316887|529553432|FG001|Overall Study|Lack of Efficacy|3|||
146958379|NCT01843933|530006371|FG000|Overall Study|Data lost|6|||
146958380|NCT01843933|530006372|FG001|Overall Study|Data lost|4|||
146958381|NCT00819052|530006373|FG000|Overall Study|Adverse Event|0|||
146958382|NCT00819052|530006374|FG001|Overall Study|Adverse Event|5|||
146958383|NCT00819052|530006373|FG000|Overall Study|Protocol Violation|1|||
146958384|NCT00819052|530006374|FG001|Overall Study|Protocol Violation|2|||
146958385|NCT00819052|530006373|FG000|Overall Study|Lost to Follow-up|1|||
146958386|NCT00819052|530006374|FG001|Overall Study|Lost to Follow-up|2|||
146958387|NCT00819052|530006373|FG000|Overall Study|Withdrawal by Subject|1|||
146958388|NCT00819052|530006374|FG001|Overall Study|Withdrawal by Subject|2|||
146958389|NCT00819052|530006373|FG000|Overall Study|Lack of Efficacy|1|||
146958390|NCT00819052|530006374|FG001|Overall Study|Lack of Efficacy|1|||
146958391|NCT00819052|530006373|FG000|Overall Study|Pregnancy|1|||
146958392|NCT00819052|530006374|FG001|Overall Study|Pregnancy|2|||
146958393|NCT00819052|530006373|FG000|Overall Study|Death or events leading to death|1|||
146958394|NCT00819052|530006374|FG001|Overall Study|Death or events leading to death|0|||
146958395|NCT03524664|530006375|FG000|Overall Study|Withdrawal by Subject|1|||
146958396|NCT03524664|530006376|FG001|Overall Study|Withdrawal by Subject|2|||
146958397|NCT03524664|530006375|FG000|Overall Study|Lost to Follow-up|4|||
146958398|NCT03524664|530006376|FG001|Overall Study|Lost to Follow-up|13|||
146958399|NCT02694562|530006377|FG000|Overall Study|Death|8|||
146958400|NCT02694562|530006377|FG000|Overall Study|Protocol Violation|4|||
146958401|NCT02694562|530006377|FG000|Overall Study|Lost to Follow-up|3|||
146958402|NCT02694562|530006377|FG000|Overall Study|Screen Failure|2|||
146958403|NCT02694562|530006377|FG000|Overall Study|Physician Decision|1|||
146958404|NCT02539160|530006381|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
146958405|NCT02539160|530006382|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
146958406|NCT02539160|530006383|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
146958407|NCT02539160|530006384|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
146958408|NCT02539160|530006381|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
146958409|NCT02539160|530006382|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
146958410|NCT02539160|530006383|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
146958411|NCT02539160|530006384|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
146958412|NCT02539160|530006381|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
146958413|NCT02539160|530006382|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
146958414|NCT02539160|530006383|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
146958415|NCT02539160|530006384|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
146958416|NCT00372905|530006385|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
146958417|NCT00372905|530006386|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
146958418|NCT00372905|530006387|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
146958419|NCT00372905|530006388|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
146958420|NCT00372905|530006385|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
146958421|NCT00372905|530006386|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
146958422|NCT00372905|530006387|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
146831210|NCT01316887|529553433|FG002|Overall Study|Lack of Efficacy|1|||
146831211|NCT01316887|529553431|FG000|Overall Study|Protocol Violation|2|||
146831212|NCT01316887|529553432|FG001|Overall Study|Protocol Violation|6|||
146831213|NCT01316887|529553433|FG002|Overall Study|Protocol Violation|6|||
146958423|NCT00372905|530006388|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
146831214|NCT01316887|529553431|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
146958424|NCT00372905|530006385|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
146831215|NCT01316887|529553432|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
146831216|NCT01316887|529553433|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
146831217|NCT01316887|529553431|FG000|Overall Study|Study Closed/Terminated|2|||
146831218|NCT01316887|529553432|FG001|Overall Study|Study Closed/Terminated|4|||
146831219|NCT01316887|529553433|FG002|Overall Study|Study Closed/Terminated|3|||
146831220|NCT01316887|529553431|FG000|Overall Study|Lost to Follow-up|1|||
146831221|NCT01316887|529553432|FG001|Overall Study|Lost to Follow-up|7|||
146831222|NCT01316887|529553433|FG002|Overall Study|Lost to Follow-up|5|||
146831223|NCT01316887|529553431|FG000|Overall Study|Withdrawal by Subject|8|||
146831224|NCT01316887|529553432|FG001|Overall Study|Withdrawal by Subject|16|||
146831225|NCT01316887|529553433|FG002|Overall Study|Withdrawal by Subject|15|||
146831226|NCT00611715|529553434|FG000|Overall Study|Disease Progression|24|||
146831227|NCT00611715|529553435|FG001|Overall Study|Disease Progression|4|||
146831228|NCT00611715|529553434|FG000|Overall Study|Withdrawal by Subject|5|||
146831229|NCT00611715|529553435|FG001|Overall Study|Withdrawal by Subject|1|||
146831230|NCT00611715|529553434|FG000|Overall Study|Adverse Event|9|||
146831231|NCT00611715|529553435|FG001|Overall Study|Adverse Event|1|||
146831232|NCT00611715|529553434|FG000|Overall Study|Death|1|||
146831233|NCT00611715|529553435|FG001|Overall Study|Death|0|||
146831234|NCT00611715|529553434|FG000|Overall Study|two patients are still on treatment|2|||
146831235|NCT00611715|529553435|FG001|Overall Study|two patients are still on treatment|0|||
146831236|NCT00107978|529553436|FG000|Overall Study|Adverse Event|1|||
146831237|NCT00107978|529553437|FG001|Overall Study|Adverse Event|5|||
146831238|NCT00107978|529553436|FG000|Overall Study|Death|3|||
146831239|NCT00107978|529553437|FG001|Overall Study|Death|3|||
146831240|NCT00107978|529553436|FG000|Overall Study|Lost to Follow-up|20|||
146831241|NCT00107978|529553437|FG001|Overall Study|Lost to Follow-up|28|||
146831242|NCT00107978|529553436|FG000|Overall Study|Withdrawal by Subject|4|||
146831243|NCT00107978|529553437|FG001|Overall Study|Withdrawal by Subject|9|||
146831244|NCT00107978|529553436|FG000|Overall Study|Protocol Violation|0|||
146831245|NCT00107978|529553437|FG001|Overall Study|Protocol Violation|1|||
146831246|NCT00107978|529553436|FG000|Overall Study|Other|5|||
146831247|NCT00107978|529553437|FG001|Overall Study|Other|4|||
146831248|NCT01841697|529553438|FG000|Overall Study|Death|0|||
146831249|NCT01841697|529553439|FG001|Overall Study|Death|1|||
146831250|NCT01841697|529553438|FG000|Overall Study|Lost to Follow-up|4|||
146831251|NCT01841697|529553439|FG001|Overall Study|Lost to Follow-up|1|||
146831252|NCT01841697|529553438|FG000|Overall Study|Withdrawal by Subject|16|||
146831253|NCT01841697|529553439|FG001|Overall Study|Withdrawal by Subject|16|||
146831254|NCT00350298|529553442|FG000|Overall Study|Death|7|||
146831255|NCT00350298|529553443|FG001|Overall Study|Death|8|||
146831256|NCT00350298|529553442|FG000|Overall Study|Lost to Follow-up|1|||
146831257|NCT00350298|529553443|FG001|Overall Study|Lost to Follow-up|2|||
146831258|NCT00350298|529553442|FG000|Overall Study|Withdrawal by Subject|1|||
146831259|NCT00350298|529553443|FG001|Overall Study|Withdrawal by Subject|3|||
146831260|NCT00233389|529553446|FG000|Overall Study|Adverse Event|5|||
146831261|NCT00233389|529553447|FG001|Overall Study|Adverse Event|5|||
146831262|NCT00233389|529553446|FG000|Overall Study|Lack of Efficacy|11|||
146831263|NCT00233389|529553447|FG001|Overall Study|Lack of Efficacy|8|||
146831264|NCT00233389|529553446|FG000|Overall Study|Lost to Follow-up|1|||
146831265|NCT00233389|529553447|FG001|Overall Study|Lost to Follow-up|1|||
146831266|NCT00233389|529553446|FG000|Overall Study|Physician Decision|1|||
146831267|NCT00233389|529553447|FG001|Overall Study|Physician Decision|0|||
146831268|NCT00233389|529553446|FG000|Overall Study|Protocol Violation|0|||
146831269|NCT00233389|529553447|FG001|Overall Study|Protocol Violation|1|||
146831270|NCT00233389|529553446|FG000|Overall Study|Withdrawal by Subject|0|||
146831271|NCT00233389|529553447|FG001|Overall Study|Withdrawal by Subject|1|||
146831272|NCT01777490|529553453|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
146831273|NCT01777490|529553454|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
146831274|NCT01777490|529553455|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
146831275|NCT01777490|529553456|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
146831276|NCT02312206|529553460|FG000|Overall Study|Adverse Event|3|||
146831277|NCT02312206|529553461|FG001|Overall Study|Adverse Event|6|||
146831278|NCT02312206|529553460|FG000|Overall Study|Withdrawal by Subject|6|||
146831279|NCT02312206|529553461|FG001|Overall Study|Withdrawal by Subject|6|||
146831280|NCT02312206|529553460|FG000|Overall Study|Physician Decision|7|||
146831281|NCT02312206|529553461|FG001|Overall Study|Physician Decision|6|||
146831282|NCT02312206|529553460|FG000|Overall Study|Death|31|||
146831283|NCT02312206|529553461|FG001|Overall Study|Death|36|||
146831284|NCT02312206|529553460|FG000|Overall Study|Study Terminated by Sponsor|81|||
146831285|NCT02312206|529553461|FG001|Overall Study|Study Terminated by Sponsor|74|||
146958425|NCT00372905|530006386|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
146958426|NCT00372905|530006387|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
146831286|NCT02312206|529553460|FG000|Overall Study|Patient transferred to hospice|0|||
146831287|NCT02312206|529553461|FG001|Overall Study|Patient transferred to hospice|1|||
146831288|NCT02312206|529553460|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
146831289|NCT02312206|529553461|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
146831290|NCT02312206|529553460|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
146831291|NCT02312206|529553461|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
146831292|NCT02312206|529553460|FG000|Overall Study|Disease Progression|1|||
146831293|NCT02312206|529553461|FG001|Overall Study|Disease Progression|0|||
146831294|NCT00585975|529553462|FG000|Overall Study|Withdrawal by Subject|3|||
146831295|NCT00585975|529553463|FG001|Overall Study|Withdrawal by Subject|3|||
146831296|NCT00585975|529553462|FG000|Overall Study|Lost to Follow-up|2|||
146831297|NCT00585975|529553463|FG001|Overall Study|Lost to Follow-up|1|||
146831298|NCT00585975|529553462|FG000|Overall Study|Enrollment met/over-enrolled|10|||
146831299|NCT00585975|529553463|FG001|Overall Study|Enrollment met/over-enrolled|9|||
146831300|NCT03082612|529553466|FG000|Overall Study|Lost to Follow-up|2|||
146831301|NCT03082612|529553467|FG001|Overall Study|Lost to Follow-up|0|||
146831302|NCT01006616|529553468|FG000|Period 1 (6 Months)|Adverse Event|10|||
146831303|NCT01006616|529553469|FG001|Period 1 (6 Months)|Adverse Event|31|||
146831304|NCT01006616|529553470|FG002|Period 1 (6 Months)|Adverse Event|37|||
146831305|NCT01006616|529553471|FG003|Period 1 (6 Months)|Adverse Event|9|||
146831306|NCT01006616|529553468|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
146831307|NCT01006616|529553469|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
146831308|NCT01006616|529553470|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
146831309|NCT01006616|529553471|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
146831310|NCT01006616|529553468|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
146831311|NCT01006616|529553469|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
146831312|NCT01006616|529553470|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
146831313|NCT01006616|529553471|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
146831314|NCT01006616|529553468|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
146831315|NCT01006616|529553469|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
146831316|NCT01006616|529553470|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
146831317|NCT01006616|529553471|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
146831318|NCT01006616|529553468|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
146831319|NCT01006616|529553469|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
146831320|NCT01006616|529553470|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
146831321|NCT01006616|529553471|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
146831322|NCT01006616|529553468|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
146831323|NCT01006616|529553469|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
146831324|NCT01006616|529553470|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
146831325|NCT01006616|529553471|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
146831326|NCT01006616|529553468|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
146831327|NCT01006616|529553469|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
146831328|NCT01006616|529553470|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
146831329|NCT01006616|529553471|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
146831330|NCT01006616|529553468|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
146831331|NCT01006616|529553469|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
146831332|NCT01006616|529553470|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
146831333|NCT01006616|529553471|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
146831334|NCT01006616|529553468|FG000|Period 1 (6 Months)|Not Treated|0|||
146831335|NCT01006616|529553469|FG001|Period 1 (6 Months)|Not Treated|0|||
146831336|NCT01006616|529553470|FG002|Period 1 (6 Months)|Not Treated|1|||
146831337|NCT01006616|529553471|FG003|Period 1 (6 Months)|Not Treated|1|||
146831338|NCT01006616|529553468|FG000|Period 2 (18 Months)|Adverse Event|6|||
146831339|NCT01006616|529553469|FG001|Period 2 (18 Months)|Adverse Event|6|||
146831340|NCT01006616|529553470|FG002|Period 2 (18 Months)|Adverse Event|6|||
146831341|NCT01006616|529553471|FG003|Period 2 (18 Months)|Adverse Event|4|||
146831342|NCT01006616|529553468|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
146831343|NCT01006616|529553469|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
146831344|NCT01006616|529553470|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
146831345|NCT01006616|529553471|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
146831346|NCT01006616|529553468|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
146831347|NCT01006616|529553469|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
146831348|NCT01006616|529553470|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
146831349|NCT01006616|529553471|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
146831350|NCT01006616|529553468|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
146831351|NCT01006616|529553469|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
146831352|NCT01006616|529553470|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
146831353|NCT01006616|529553471|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
146831354|NCT01006616|529553468|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
146831355|NCT01006616|529553469|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
146831356|NCT01006616|529553470|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
146831357|NCT01006616|529553471|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
146831358|NCT01006616|529553468|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
146958427|NCT00372905|530006388|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
146958428|NCT00372905|530006385|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
146958429|NCT00372905|530006386|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
146831359|NCT01006616|529553469|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
146831360|NCT01006616|529553470|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
146831361|NCT01006616|529553471|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
146831362|NCT01006616|529553468|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
146831363|NCT01006616|529553469|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
146831364|NCT01006616|529553470|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
146831365|NCT01006616|529553471|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
146831366|NCT01006616|529553468|FG000|Period 2 (18 Months)|Study Terminated|63|||
146831367|NCT01006616|529553469|FG001|Period 2 (18 Months)|Study Terminated|46|||
146831368|NCT01006616|529553470|FG002|Period 2 (18 Months)|Study Terminated|44|||
146831369|NCT01006616|529553471|FG003|Period 2 (18 Months)|Study Terminated|70|||
146831370|NCT00992992|529553478|FG000|Overall Study|Lost to Follow-up|3|||
146831371|NCT00992992|529553478|FG000|Overall Study|Death|16|||
146831372|NCT00992992|529553478|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
146831373|NCT00992992|529553478|FG000|Overall Study|Sponsor Closed the Study|4|||
146831374|NCT00952848|529553479|FG000|Overall Study|Withdrawal by Subject|4|||
146831375|NCT02250534|529553480|FG000|Overall Study|Lost to Follow-up|18|||
146831376|NCT02250534|529553481|FG001|Overall Study|Lost to Follow-up|28|||
146831377|NCT02250534|529553482|FG002|Overall Study|Lost to Follow-up|33|||
146831378|NCT02250534|529553480|FG000|Overall Study|Personal reasons|7|||
146831379|NCT02250534|529553481|FG001|Overall Study|Personal reasons|8|||
146831380|NCT02250534|529553482|FG002|Overall Study|Personal reasons|14|||
146831381|NCT02250534|529553480|FG000|Overall Study|Adverse Event|6|||
146831382|NCT02250534|529553481|FG001|Overall Study|Adverse Event|3|||
146831383|NCT02250534|529553482|FG002|Overall Study|Adverse Event|8|||
146831384|NCT02250534|529553480|FG000|Overall Study|incarcerated|2|||
146831385|NCT02250534|529553481|FG001|Overall Study|incarcerated|1|||
146831386|NCT02250534|529553482|FG002|Overall Study|incarcerated|2|||
146831387|NCT02250534|529553480|FG000|Overall Study|Withdrawal by Subject|0|||
146831388|NCT02250534|529553481|FG001|Overall Study|Withdrawal by Subject|1|||
146831389|NCT02250534|529553482|FG002|Overall Study|Withdrawal by Subject|2|||
146831390|NCT02250534|529553480|FG000|Overall Study|Death|0|||
146831391|NCT02250534|529553481|FG001|Overall Study|Death|1|||
146831392|NCT02250534|529553482|FG002|Overall Study|Death|1|||
146831393|NCT02250534|529553480|FG000|Overall Study|Physician Decision|1|||
146831394|NCT02250534|529553481|FG001|Overall Study|Physician Decision|3|||
146831395|NCT02250534|529553482|FG002|Overall Study|Physician Decision|1|||
146831396|NCT02250534|529553480|FG000|Overall Study|Protocol Violation|1|||
146831397|NCT02250534|529553481|FG001|Overall Study|Protocol Violation|0|||
146831398|NCT02250534|529553482|FG002|Overall Study|Protocol Violation|1|||
146831399|NCT02250534|529553480|FG000|Overall Study|Reason unknown|1|||
146831400|NCT02250534|529553481|FG001|Overall Study|Reason unknown|0|||
146831401|NCT02250534|529553482|FG002|Overall Study|Reason unknown|0|||
146831402|NCT00217022|529553484|FG000|Overall Study|Withdrawal by Subject|1|||
146831403|NCT00217022|529553485|FG001|Overall Study|Withdrawal by Subject|1|||
146831404|NCT00458393|529553486|FG000|Overall Study|Withdrawal by Subject|67|||
146831405|NCT00458393|529553487|FG001|Overall Study|Withdrawal by Subject|80|||
146831406|NCT00458393|529553486|FG000|Overall Study|Physician Decision|31|||
146986360|NCT04700449|530112909|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
146986361|NCT04700449|530112906|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
146986362|NCT04700449|530112907|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
146986363|NCT04700449|530112908|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
146986364|NCT04700449|530112909|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
146986365|NCT04700449|530112906|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
146986366|NCT04700449|530112907|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
146986367|NCT04700449|530112908|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
146831407|NCT00458393|529553487|FG001|Overall Study|Physician Decision|22|||
146831408|NCT00458393|529553486|FG000|Overall Study|Relocated|77|||
146831409|NCT00458393|529553487|FG001|Overall Study|Relocated|81|||
146831410|NCT00458393|529553486|FG000|Overall Study|Lost to Follow-up|115|||
146831411|NCT00458393|529553487|FG001|Overall Study|Lost to Follow-up|92|||
146831412|NCT00458393|529553486|FG000|Overall Study|Sites marked other on the form.|19|||
146831413|NCT00458393|529553487|FG001|Overall Study|Sites marked other on the form.|20|||
146831414|NCT01253447|529553489|FG000|Overall Study|Adverse Event|2|||
146831415|NCT02108652|529553490|FG000|Overall Study|Death|253|||
146831416|NCT02108652|529553490|FG000|Overall Study|Lost to Follow-up|2|||
146831417|NCT02108652|529553490|FG000|Overall Study|Withdrawal by Subject|16|||
146831418|NCT02108652|529553490|FG000|Overall Study|Study Terminated By Sponsor|31|||
146831419|NCT02108652|529553490|FG000|Overall Study|Non-Compliance|1|||
146831420|NCT02108652|529553490|FG000|Overall Study|Physician Decision|6|||
146986368|NCT04700449|530112909|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
146831421|NCT02108652|529553490|FG000|Overall Study|Progression Of Disease|1|||
146831422|NCT00511797|529553498|FG000|Overall Study|Adverse Event|1|||
146831423|NCT00511797|529553499|FG001|Overall Study|Adverse Event|2|||
146831424|NCT00511797|529553500|FG002|Overall Study|Adverse Event|2|||
146831425|NCT00511797|529553501|FG003|Overall Study|Adverse Event|2|||
146831426|NCT00511797|529553498|FG000|Overall Study|Lost to Follow-up|1|||
146831427|NCT00511797|529553499|FG001|Overall Study|Lost to Follow-up|0|||
146831428|NCT00511797|529553500|FG002|Overall Study|Lost to Follow-up|0|||
146831429|NCT00511797|529553501|FG003|Overall Study|Lost to Follow-up|1|||
146831430|NCT00511797|529553498|FG000|Overall Study|Pregnancy|0|||
146831431|NCT00511797|529553499|FG001|Overall Study|Pregnancy|0|||
146831432|NCT00511797|529553500|FG002|Overall Study|Pregnancy|0|||
146831433|NCT00511797|529553501|FG003|Overall Study|Pregnancy|1|||
146831434|NCT00511797|529553498|FG000|Overall Study|Protocol Violation|0|||
146831435|NCT00511797|529553499|FG001|Overall Study|Protocol Violation|2|||
146831436|NCT00511797|529553500|FG002|Overall Study|Protocol Violation|2|||
146831437|NCT00511797|529553501|FG003|Overall Study|Protocol Violation|3|||
146831438|NCT00511797|529553498|FG000|Overall Study|Withdrawal by Subject|3|||
146831439|NCT00511797|529553499|FG001|Overall Study|Withdrawal by Subject|3|||
146831440|NCT00511797|529553500|FG002|Overall Study|Withdrawal by Subject|4|||
146831441|NCT00511797|529553501|FG003|Overall Study|Withdrawal by Subject|2|||
146831442|NCT00511797|529553498|FG000|Overall Study|Never dispensed|1|||
146831443|NCT00511797|529553499|FG001|Overall Study|Never dispensed|0|||
146958430|NCT00372905|530006387|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
146958431|NCT00372905|530006388|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
146958432|NCT00372905|530006385|FG000|Follow up Until Relapse or Progression|Study closed|0|||
146958433|NCT00372905|530006386|FG001|Follow up Until Relapse or Progression|Study closed|0|||
146958434|NCT00372905|530006387|FG002|Follow up Until Relapse or Progression|Study closed|0|||
146958435|NCT00372905|530006388|FG003|Follow up Until Relapse or Progression|Study closed|3|||
146958436|NCT00372905|530006385|FG000|Follow up Until Relapse or Progression|Other|0|||
146958437|NCT00372905|530006386|FG001|Follow up Until Relapse or Progression|Other|1|||
146958438|NCT00372905|530006387|FG002|Follow up Until Relapse or Progression|Other|0|||
146958439|NCT00372905|530006388|FG003|Follow up Until Relapse or Progression|Other|0|||
146958440|NCT03726320|530007808|FG000|Overall Study|Lost to Follow-up|2|||
146958441|NCT03726320|530007809|FG001|Overall Study|Lost to Follow-up|4|||
146958442|NCT03726320|530007810|FG002|Overall Study|Lost to Follow-up|0|||
146958443|NCT03726320|530007808|FG000|Overall Study|Time Constraints|4|||
146958444|NCT03726320|530007809|FG001|Overall Study|Time Constraints|1|||
146958445|NCT03726320|530007810|FG002|Overall Study|Time Constraints|0|||
146958446|NCT03726320|530007808|FG000|Overall Study|Ineligible after enrollment|3|||
146958447|NCT03726320|530007809|FG001|Overall Study|Ineligible after enrollment|3|||
146958448|NCT03726320|530007810|FG002|Overall Study|Ineligible after enrollment|0|||
146958449|NCT03726320|530007808|FG000|Overall Study|Clinic / insurance issue|2|||
146958450|NCT03726320|530007809|FG001|Overall Study|Clinic / insurance issue|0|||
146958451|NCT03726320|530007810|FG002|Overall Study|Clinic / insurance issue|0|||
146958452|NCT03726320|530007808|FG000|Overall Study|Language barrier|1|||
146958453|NCT03726320|530007809|FG001|Overall Study|Language barrier|0|||
146958454|NCT03726320|530007810|FG002|Overall Study|Language barrier|0|||
146958455|NCT03726320|530007808|FG000|Overall Study|Provider left the clinic|0|||
146958456|NCT03726320|530007809|FG001|Overall Study|Provider left the clinic|0|||
146958457|NCT03726320|530007810|FG002|Overall Study|Provider left the clinic|1|||
146958458|NCT02028182|530007813|FG000|Overall Study|Protocol Violation|2|||
146958459|NCT01684930|530007816|FG000|Overall Study|Withdrawal by Subject|3|||
146958460|NCT01684930|530007817|FG001|Overall Study|Withdrawal by Subject|1|||
146958461|NCT01277757|530007818|FG000|Overall Study|Disease Progression|1|||
146958462|NCT01277757|530007818|FG000|Overall Study|Withdrawal by Subject|1|||
146958463|NCT03808298|530007819|FG000|Overall Study|Adverse Event|3|||
146958464|NCT03808298|530007819|FG000|Overall Study|Physician Decision|1|||
146958465|NCT03808298|530007819|FG000|Overall Study|Withdrawal by Subject|1|||
146958466|NCT03808298|530007819|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
146958467|NCT01004822|530007820|FG000|Overall Study|Objective progression or relapse|3|||
146958468|NCT01004822|530007821|FG001|Overall Study|Objective progression or relapse|3|||
146958469|NCT01004822|530007822|FG002|Overall Study|Objective progression or relapse|0|||
146958470|NCT01004822|530007823|FG003|Overall Study|Objective progression or relapse|1|||
146958471|NCT01004822|530007824|FG004|Overall Study|Objective progression or relapse|2|||
146958472|NCT01004822|530007825|FG005|Overall Study|Objective progression or relapse|2|||
146958473|NCT01004822|530007826|FG006|Overall Study|Objective progression or relapse|1|||
146958474|NCT01004822|530007827|FG007|Overall Study|Objective progression or relapse|4|||
146958475|NCT01004822|530007820|FG000|Overall Study|Global deterioration of health status|0|||
146958476|NCT01004822|530007821|FG001|Overall Study|Global deterioration of health status|0|||
146958477|NCT01004822|530007822|FG002|Overall Study|Global deterioration of health status|0|||
146958478|NCT01004822|530007823|FG003|Overall Study|Global deterioration of health status|1|||
146958479|NCT01004822|530007824|FG004|Overall Study|Global deterioration of health status|0|||
146831444|NCT00511797|529553500|FG002|Overall Study|Never dispensed|1|||
146831445|NCT00511797|529553501|FG003|Overall Study|Never dispensed|3|||
146831446|NCT00511797|529553498|FG000|Overall Study|Study drug not taken|0|||
146831447|NCT00511797|529553499|FG001|Overall Study|Study drug not taken|1|||
146831448|NCT00511797|529553500|FG002|Overall Study|Study drug not taken|0|||
146958480|NCT01004822|530007825|FG005|Overall Study|Global deterioration of health status|0|||
146831449|NCT00511797|529553501|FG003|Overall Study|Study drug not taken|1|||
146831450|NCT00511797|529553498|FG000|Overall Study|Partially missing diary|0|||
146831451|NCT00511797|529553499|FG001|Overall Study|Partially missing diary|0|||
146831452|NCT00511797|529553500|FG002|Overall Study|Partially missing diary|1|||
146831453|NCT00511797|529553501|FG003|Overall Study|Partially missing diary|0|||
146831454|NCT00511797|529553498|FG000|Overall Study|Other (moving etc)|1|||
146831455|NCT00511797|529553499|FG001|Overall Study|Other (moving etc)|0|||
146831456|NCT00511797|529553500|FG002|Overall Study|Other (moving etc)|1|||
146831457|NCT00511797|529553501|FG003|Overall Study|Other (moving etc)|2|||
146831458|NCT01121913|529553502|FG000|First Intervention Period|Adverse Event|0|||
146831459|NCT01121913|529553503|FG001|First Intervention Period|Adverse Event|0|||
146831460|NCT01121913|529553504|FG002|First Intervention Period|Adverse Event|1|||
146831461|NCT01121913|529553505|FG003|First Intervention Period|Adverse Event|0|||
146831462|NCT01121913|529553502|FG000|First Washout Period|Withdrawal by Subject|1|||
146831463|NCT01121913|529553503|FG001|First Washout Period|Withdrawal by Subject|0|||
146831464|NCT01121913|529553504|FG002|First Washout Period|Withdrawal by Subject|0|||
146831465|NCT01121913|529553505|FG003|First Washout Period|Withdrawal by Subject|0|||
146831466|NCT01121913|529553502|FG000|Second Intervention Period|Adverse Event|0|||
146831467|NCT01121913|529553503|FG001|Second Intervention Period|Adverse Event|0|||
146831468|NCT01121913|529553504|FG002|Second Intervention Period|Adverse Event|1|||
146831469|NCT01121913|529553505|FG003|Second Intervention Period|Adverse Event|0|||
146831470|NCT01121913|529553502|FG000|Second Washout Period|Withdrawal by Subject|0|||
146831471|NCT01121913|529553503|FG001|Second Washout Period|Withdrawal by Subject|0|||
146831472|NCT01121913|529553504|FG002|Second Washout Period|Withdrawal by Subject|1|||
146831473|NCT01121913|529553505|FG003|Second Washout Period|Withdrawal by Subject|0|||
146831474|NCT01121913|529553502|FG000|Third Washout Period|Adverse Event|1|||
146831475|NCT01121913|529553503|FG001|Third Washout Period|Adverse Event|0|||
146831476|NCT01121913|529553504|FG002|Third Washout Period|Adverse Event|0|||
146831477|NCT01121913|529553505|FG003|Third Washout Period|Adverse Event|0|||
146831478|NCT03845075|529553506|FG000|Part 1 - DB|Withdrawal by Subject|1|||
146831479|NCT03845075|529553507|FG001|Part 1 - DB|Withdrawal by Subject|1|||
146831480|NCT03845075|529553508|FG002|Part 1 - DB|Withdrawal by Subject|0|||
146831481|NCT03845075|529553509|FG003|Part 1 - DB|Withdrawal by Subject|0|||
146831482|NCT03845075|529553506|FG000|Part 1 - DB|Adverse Event|0|||
146831483|NCT03845075|529553507|FG001|Part 1 - DB|Adverse Event|1|||
146831484|NCT03845075|529553508|FG002|Part 1 - DB|Adverse Event|0|||
146831485|NCT03845075|529553509|FG003|Part 1 - DB|Adverse Event|0|||
146831486|NCT03845075|529553506|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
146831487|NCT03845075|529553507|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
146831488|NCT03845075|529553508|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
146831489|NCT03845075|529553509|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
146831490|NCT01017263|529553510|FG000|Overall Study|not eligible|12|||
146831491|NCT01560871|529553511|FG000|Overall Study|transportation issues|2|||
146831492|NCT01560871|529553512|FG001|Overall Study|transportation issues|1|||
146831493|NCT01560871|529553511|FG000|Overall Study|relocation|1|||
146831494|NCT01560871|529553512|FG001|Overall Study|relocation|0|||
146831495|NCT01560871|529553511|FG000|Overall Study|readmission to a hospital|2|||
146831496|NCT01560871|529553512|FG001|Overall Study|readmission to a hospital|1|||
146831497|NCT01560871|529553511|FG000|Overall Study|Lost to Follow-up|1|||
146831498|NCT01560871|529553512|FG001|Overall Study|Lost to Follow-up|0|||
146831499|NCT02287233|529553513|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
146831500|NCT02287233|529553514|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
146831501|NCT02287233|529553515|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
146831502|NCT02287233|529553513|FG000|Overall Study|Adverse Event Related to Progression|0|||
146831503|NCT02287233|529553514|FG001|Overall Study|Adverse Event Related to Progression|2|||
146831504|NCT02287233|529553515|FG002|Overall Study|Adverse Event Related to Progression|8|||
146831505|NCT02287233|529553513|FG000|Overall Study|Physician Decision|1|||
146831506|NCT02287233|529553514|FG001|Overall Study|Physician Decision|2|||
146831507|NCT02287233|529553515|FG002|Overall Study|Physician Decision|4|||
146831508|NCT02287233|529553513|FG000|Overall Study|Progressive Disease with Death|0|||
146831509|NCT02287233|529553514|FG001|Overall Study|Progressive Disease with Death|0|||
146831510|NCT02287233|529553515|FG002|Overall Study|Progressive Disease with Death|10|||
146831511|NCT02287233|529553513|FG000|Overall Study|Progressive Disease Without Death|2|||
146831512|NCT02287233|529553514|FG001|Overall Study|Progressive Disease Without Death|3|||
146958481|NCT01004822|530007826|FG006|Overall Study|Global deterioration of health status|1|||
146958482|NCT01004822|530007827|FG007|Overall Study|Global deterioration of health status|0|||
146831513|NCT02287233|529553515|FG002|Overall Study|Progressive Disease Without Death|20|||
146831514|NCT02287233|529553513|FG000|Overall Study|Withdrawal by Subject|1|||
146831515|NCT02287233|529553514|FG001|Overall Study|Withdrawal by Subject|1|||
146831516|NCT02287233|529553515|FG002|Overall Study|Withdrawal by Subject|7|||
146831517|NCT02287233|529553513|FG000|Overall Study|Other|3|||
146831518|NCT02287233|529553514|FG001|Overall Study|Other|0|||
146831519|NCT02287233|529553515|FG002|Overall Study|Other|15|||
146831520|NCT02287233|529553513|FG000|Overall Study|Did Not Receive Treatment|0|||
146831521|NCT02287233|529553514|FG001|Overall Study|Did Not Receive Treatment|0|||
146831522|NCT02287233|529553515|FG002|Overall Study|Did Not Receive Treatment|2|||
146831523|NCT00085566|529553516|FG000|Overall Study|Adverse Event|0|||
146831524|NCT00085566|529553517|FG001|Overall Study|Adverse Event|0|||
146831525|NCT00085566|529553518|FG002|Overall Study|Adverse Event|10|||
146831526|NCT00085566|529553516|FG000|Overall Study|Patient Not treated|0|||
146831527|NCT00085566|529553517|FG001|Overall Study|Patient Not treated|0|||
146831528|NCT00085566|529553518|FG002|Overall Study|Patient Not treated|3|||
146831529|NCT00085566|529553516|FG000|Overall Study|Clinical progression|0|||
146831530|NCT00085566|529553517|FG001|Overall Study|Clinical progression|0|||
146831531|NCT00085566|529553518|FG002|Overall Study|Clinical progression|1|||
146831532|NCT02804399|529553519|FG000|Period 2|Adverse Event|0|||
146831533|NCT02804399|529553520|FG001|Period 2|Adverse Event|1|||
146831534|NCT01774305|529553521|FG000|Overall Study|Physician Decision|1|||
146831535|NCT01774305|529553522|FG001|Overall Study|Physician Decision|0|||
146831536|NCT01157377|529553524|FG000|Overall Study|Lost to Follow-up|0|||
146831537|NCT01157377|529553525|FG001|Overall Study|Lost to Follow-up|0|||
146831538|NCT01157377|529553526|FG002|Overall Study|Lost to Follow-up|1|||
146831539|NCT01157377|529553527|FG003|Overall Study|Lost to Follow-up|0|||
146831540|NCT01157377|529553528|FG004|Overall Study|Lost to Follow-up|1|||
146831541|NCT01157377|529553529|FG005|Overall Study|Lost to Follow-up|1|||
146831542|NCT01157377|529553530|FG006|Overall Study|Lost to Follow-up|0|||
146831543|NCT01157377|529553524|FG000|Overall Study|Personal Reasons|2|||
146831544|NCT01157377|529553525|FG001|Overall Study|Personal Reasons|1|||
146831545|NCT01157377|529553526|FG002|Overall Study|Personal Reasons|0|||
146831546|NCT01157377|529553527|FG003|Overall Study|Personal Reasons|1|||
146831547|NCT01157377|529553528|FG004|Overall Study|Personal Reasons|0|||
146831548|NCT01157377|529553529|FG005|Overall Study|Personal Reasons|0|||
146831549|NCT01157377|529553530|FG006|Overall Study|Personal Reasons|0|||
146831550|NCT01157377|529553524|FG000|Overall Study|Protocol Violation|0|||
146831551|NCT01157377|529553525|FG001|Overall Study|Protocol Violation|0|||
146831552|NCT01157377|529553526|FG002|Overall Study|Protocol Violation|0|||
146831553|NCT01157377|529553527|FG003|Overall Study|Protocol Violation|0|||
146831554|NCT01157377|529553528|FG004|Overall Study|Protocol Violation|0|||
146831555|NCT01157377|529553529|FG005|Overall Study|Protocol Violation|1|||
146831556|NCT01157377|529553530|FG006|Overall Study|Protocol Violation|0|||
146831557|NCT01157377|529553524|FG000|Overall Study|Lack of Efficacy|0|||
146831558|NCT01157377|529553525|FG001|Overall Study|Lack of Efficacy|0|||
146831559|NCT01157377|529553526|FG002|Overall Study|Lack of Efficacy|0|||
146831560|NCT01157377|529553527|FG003|Overall Study|Lack of Efficacy|0|||
146831561|NCT01157377|529553528|FG004|Overall Study|Lack of Efficacy|0|||
146831562|NCT01157377|529553529|FG005|Overall Study|Lack of Efficacy|0|||
146831563|NCT01157377|529553530|FG006|Overall Study|Lack of Efficacy|1|||
146831564|NCT01157377|529553524|FG000|Overall Study|Other Miscellaneous Reasons|0|||
146831565|NCT01157377|529553525|FG001|Overall Study|Other Miscellaneous Reasons|2|||
146831566|NCT01157377|529553526|FG002|Overall Study|Other Miscellaneous Reasons|0|||
146831567|NCT01157377|529553527|FG003|Overall Study|Other Miscellaneous Reasons|0|||
146831568|NCT01157377|529553528|FG004|Overall Study|Other Miscellaneous Reasons|1|||
146831569|NCT01157377|529553529|FG005|Overall Study|Other Miscellaneous Reasons|1|||
146831570|NCT01157377|529553530|FG006|Overall Study|Other Miscellaneous Reasons|1|||
146831571|NCT00087555|529553531|FG000|Overall Study|Adverse Event|3|||
146831572|NCT00087555|529553532|FG001|Overall Study|Adverse Event|6|||
146831573|NCT00087555|529553533|FG002|Overall Study|Adverse Event|14|||
146831574|NCT00087555|529553531|FG000|Overall Study|Lost to Follow-up|0|||
146831575|NCT00087555|529553532|FG001|Overall Study|Lost to Follow-up|1|||
146831576|NCT00087555|529553533|FG002|Overall Study|Lost to Follow-up|1|||
146831577|NCT00087555|529553531|FG000|Overall Study|Non - Compliance|1|||
146831578|NCT00087555|529553532|FG001|Overall Study|Non - Compliance|0|||
146831579|NCT00087555|529553533|FG002|Overall Study|Non - Compliance|0|||
146831580|NCT00087555|529553531|FG000|Overall Study|Protocol Violation|0|||
146831581|NCT00087555|529553532|FG001|Overall Study|Protocol Violation|0|||
146831582|NCT00087555|529553533|FG002|Overall Study|Protocol Violation|2|||
146831583|NCT00087555|529553531|FG000|Overall Study|Screen Failure|1|||
146831584|NCT00087555|529553532|FG001|Overall Study|Screen Failure|1|||
146831585|NCT00087555|529553533|FG002|Overall Study|Screen Failure|0|||
146831586|NCT00087555|529553531|FG000|Overall Study|Pregnancy|0|||
146831587|NCT00087555|529553532|FG001|Overall Study|Pregnancy|1|||
146831588|NCT00087555|529553533|FG002|Overall Study|Pregnancy|1|||
146831589|NCT00087555|529553531|FG000|Overall Study|Withdrawal by Subject|3|||
146831590|NCT00087555|529553532|FG001|Overall Study|Withdrawal by Subject|2|||
146958483|NCT01004822|530007820|FG000|Overall Study|No longer willing to continue|0|||
146958484|NCT01004822|530007821|FG001|Overall Study|No longer willing to continue|0|||
146831591|NCT00087555|529553533|FG002|Overall Study|Withdrawal by Subject|1|||
146831592|NCT00087555|529553531|FG000|Overall Study|Lack of Efficacy|2|||
146831593|NCT00087555|529553532|FG001|Overall Study|Lack of Efficacy|0|||
146831594|NCT00087555|529553533|FG002|Overall Study|Lack of Efficacy|1|||
146831595|NCT00087555|529553531|FG000|Overall Study|Non Compliance|0|||
146831596|NCT00087555|529553532|FG001|Overall Study|Non Compliance|0|||
146831597|NCT00087555|529553533|FG002|Overall Study|Non Compliance|1|||
146831598|NCT00087555|529553531|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
146831599|NCT00087555|529553532|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
146986369|NCT04700449|530112906|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
146986370|NCT04700449|530112907|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
146986371|NCT04700449|530112908|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
146986372|NCT04700449|530112909|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
146986373|NCT04700449|530112906|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
146986374|NCT04700449|530112907|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
146986375|NCT04700449|530112908|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
146986376|NCT04700449|530112909|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
146986377|NCT04700449|530112906|FG000|Stage 1: Double-Blind Period|Other|0|||
146986378|NCT04700449|530112907|FG001|Stage 1: Double-Blind Period|Other|0|||
146986379|NCT04700449|530112908|FG002|Stage 1: Double-Blind Period|Other|1|||
146986380|NCT04700449|530112909|FG003|Stage 1: Double-Blind Period|Other|0|||
146986381|NCT04700449|530112906|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
146986382|NCT04700449|530112907|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
146986383|NCT04700449|530112908|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
146986384|NCT04700449|530112909|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
146986385|NCT04700449|530112906|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
146986386|NCT04700449|530112907|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
146986387|NCT04700449|530112908|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
146986388|NCT04700449|530112909|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
146986389|NCT04700449|530112906|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
146986390|NCT04700449|530112907|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
146986391|NCT04700449|530112908|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
146986392|NCT04700449|530112909|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
146986393|NCT04700449|530112906|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
146986394|NCT04700449|530112907|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
146986395|NCT04700449|530112908|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
146986396|NCT04700449|530112909|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
146986397|NCT04700449|530112906|FG000|Stage 2 Sub-study 1|Other|1|||
146986398|NCT04700449|530112907|FG001|Stage 2 Sub-study 1|Other|2|||
146986399|NCT04700449|530112908|FG002|Stage 2 Sub-study 1|Other|0|||
146986400|NCT04700449|530112909|FG003|Stage 2 Sub-study 1|Other|0|||
146986401|NCT04700449|530112906|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
146986402|NCT04700449|530112907|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
146986403|NCT04700449|530112908|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
146986404|NCT04700449|530112909|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
146986405|NCT04700449|530112906|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
146986406|NCT04700449|530112907|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
146986407|NCT04700449|530112908|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
146986408|NCT04700449|530112909|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
146986409|NCT04700449|530112906|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
146986410|NCT04700449|530112907|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
146986411|NCT04700449|530112908|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
146986412|NCT04700449|530112909|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
146986413|NCT04700449|530112906|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
146986414|NCT04700449|530112907|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
146986415|NCT04700449|530112908|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
146986416|NCT04700449|530112909|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
146986417|NCT04700449|530112906|FG000|Stage 2 Sub-study 2|Other|0|||
146986418|NCT04700449|530112907|FG001|Stage 2 Sub-study 2|Other|0|||
146986419|NCT04700449|530112908|FG002|Stage 2 Sub-study 2|Other|0|||
146986420|NCT04700449|530112909|FG003|Stage 2 Sub-study 2|Other|5|||
146986421|NCT03738332|530112910|FG000|Overall Study|Withdrawal by Subject|1|||
146986422|NCT02336737|530112911|FG000|Overall Study|Withdrawal by Subject|5|||
146986423|NCT02336737|530112911|FG000|Overall Study|Physician Decision|8|||
146986424|NCT02396381|530112912|FG000|Overall Study|Adverse Event|3|||
146986425|NCT02396381|530112913|FG001|Overall Study|Adverse Event|2|||
146986426|NCT02396381|530112912|FG000|Overall Study|Withdrawal by Subject|33|||
146986427|NCT02396381|530112913|FG001|Overall Study|Withdrawal by Subject|24|||
146986428|NCT02396381|530112912|FG000|Overall Study|Lost to Follow-up|49|||
146986429|NCT02396381|530112913|FG001|Overall Study|Lost to Follow-up|31|||
146986430|NCT02396381|530112912|FG000|Overall Study|Protocol Violation|1|||
146986431|NCT02396381|530112913|FG001|Overall Study|Protocol Violation|0|||
146986432|NCT02396381|530112912|FG000|Overall Study|Site terminated by sponsor|7|||
146986433|NCT02396381|530112913|FG001|Overall Study|Site terminated by sponsor|8|||
146986434|NCT02396381|530112912|FG000|Overall Study|Physician Decision|5|||
146986435|NCT02396381|530112913|FG001|Overall Study|Physician Decision|5|||
146986436|NCT02396381|530112912|FG000|Overall Study|Pregnancy|2|||
146986437|NCT02396381|530112913|FG001|Overall Study|Pregnancy|0|||
146986438|NCT02396381|530112912|FG000|Overall Study|Non-compliance with study procedures|1|||
146986439|NCT02396381|530112913|FG001|Overall Study|Non-compliance with study procedures|0|||
146986440|NCT02396381|530112912|FG000|Overall Study|Moved out of town/state|1|||
146986441|NCT02396381|530112913|FG001|Overall Study|Moved out of town/state|3|||
146986442|NCT02396381|530112912|FG000|Overall Study|Could not complete visit|1|||
146986443|NCT02396381|530112913|FG001|Overall Study|Could not complete visit|0|||
146986444|NCT02396381|530112912|FG000|Overall Study|Possible conflict of interest|1|||
146986445|NCT02396381|530112913|FG001|Overall Study|Possible conflict of interest|0|||
146831600|NCT00087555|529553533|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
146831601|NCT00087555|529553531|FG000|Overall Study|Patient wanted to go back on Med|1|||
146831602|NCT00087555|529553532|FG001|Overall Study|Patient wanted to go back on Med|0|||
146831603|NCT00087555|529553533|FG002|Overall Study|Patient wanted to go back on Med|0|||
146831604|NCT05523219|529553534|FG000|Overall Study|Wrong inclusion|1|||
146831605|NCT05523219|529553534|FG000|Overall Study|Lost to Follow-up|7|||
146831606|NCT03772613|529553537|FG000|Overall Study|Lost to Follow-up|0|||
146831607|NCT03772613|529553538|FG001|Overall Study|Lost to Follow-up|1|||
146831608|NCT03772613|529553539|FG002|Overall Study|Lost to Follow-up|1|||
146831609|NCT00904722|529553540|FG000|Overall Study|Physician Decision|1|||
146831610|NCT00661713|529553541|FG000|Overall Study|Death|1|||
146831611|NCT00661713|529553542|FG001|Overall Study|Death|0|||
146831612|NCT00661713|529553543|FG002|Overall Study|Death|0|||
146831613|NCT00661713|529553544|FG003|Overall Study|Death|0|||
146831614|NCT00661713|529553545|FG004|Overall Study|Death|1|||
146831615|NCT00661713|529553546|FG005|Overall Study|Death|0|||
146831616|NCT00661713|529553547|FG006|Overall Study|Death|0|||
146831617|NCT00661713|529553548|FG007|Overall Study|Death|0|||
146831618|NCT00661713|529553541|FG000|Overall Study|Unable to Classify|1|||
146831619|NCT00661713|529553542|FG001|Overall Study|Unable to Classify|0|||
146831620|NCT00661713|529553543|FG002|Overall Study|Unable to Classify|0|||
146831621|NCT00661713|529553544|FG003|Overall Study|Unable to Classify|0|||
146831622|NCT00661713|529553545|FG004|Overall Study|Unable to Classify|0|||
146831623|NCT00661713|529553546|FG005|Overall Study|Unable to Classify|0|||
146831624|NCT00661713|529553547|FG006|Overall Study|Unable to Classify|0|||
146831625|NCT00661713|529553548|FG007|Overall Study|Unable to Classify|0|||
146831626|NCT00661713|529553541|FG000|Overall Study|Protocol Violation|1|||
146831627|NCT00661713|529553542|FG001|Overall Study|Protocol Violation|6|||
146831628|NCT00661713|529553543|FG002|Overall Study|Protocol Violation|3|||
146831629|NCT00661713|529553544|FG003|Overall Study|Protocol Violation|3|||
146831630|NCT00661713|529553545|FG004|Overall Study|Protocol Violation|0|||
146831631|NCT00661713|529553546|FG005|Overall Study|Protocol Violation|2|||
146831632|NCT00661713|529553547|FG006|Overall Study|Protocol Violation|2|||
146831633|NCT00661713|529553548|FG007|Overall Study|Protocol Violation|1|||
146831634|NCT00661713|529553541|FG000|Overall Study|Withdrawal by Subject|11|||
146831635|NCT00661713|529553542|FG001|Overall Study|Withdrawal by Subject|25|||
146831636|NCT00661713|529553543|FG002|Overall Study|Withdrawal by Subject|12|||
146831637|NCT00661713|529553544|FG003|Overall Study|Withdrawal by Subject|21|||
146831638|NCT00661713|529553545|FG004|Overall Study|Withdrawal by Subject|12|||
146831639|NCT00661713|529553546|FG005|Overall Study|Withdrawal by Subject|26|||
146831640|NCT00661713|529553547|FG006|Overall Study|Withdrawal by Subject|45|||
146831641|NCT00661713|529553548|FG007|Overall Study|Withdrawal by Subject|9|||
146831642|NCT00661713|529553541|FG000|Overall Study|Lost to Follow-up|2|||
146831643|NCT00661713|529553542|FG001|Overall Study|Lost to Follow-up|7|||
146831644|NCT00661713|529553543|FG002|Overall Study|Lost to Follow-up|2|||
146831645|NCT00661713|529553544|FG003|Overall Study|Lost to Follow-up|2|||
146831646|NCT00661713|529553545|FG004|Overall Study|Lost to Follow-up|5|||
146831647|NCT00661713|529553546|FG005|Overall Study|Lost to Follow-up|7|||
146831648|NCT00661713|529553547|FG006|Overall Study|Lost to Follow-up|14|||
146831649|NCT00661713|529553548|FG007|Overall Study|Lost to Follow-up|1|||
146831650|NCT00661713|529553541|FG000|Overall Study|Administrative Reason|0|||
146831651|NCT00661713|529553542|FG001|Overall Study|Administrative Reason|1|||
146831652|NCT00661713|529553543|FG002|Overall Study|Administrative Reason|0|||
146831653|NCT00661713|529553544|FG003|Overall Study|Administrative Reason|2|||
146831654|NCT00661713|529553545|FG004|Overall Study|Administrative Reason|2|||
146831655|NCT00661713|529553546|FG005|Overall Study|Administrative Reason|2|||
146831656|NCT00661713|529553547|FG006|Overall Study|Administrative Reason|1|||
146831657|NCT00661713|529553548|FG007|Overall Study|Administrative Reason|0|||
146831658|NCT00661713|529553541|FG000|Overall Study|Adverse Event|0|||
146831659|NCT00661713|529553542|FG001|Overall Study|Adverse Event|0|||
146831660|NCT00661713|529553543|FG002|Overall Study|Adverse Event|0|||
146831661|NCT00661713|529553544|FG003|Overall Study|Adverse Event|0|||
146831662|NCT00661713|529553545|FG004|Overall Study|Adverse Event|0|||
146831663|NCT00661713|529553546|FG005|Overall Study|Adverse Event|0|||
146831664|NCT00661713|529553547|FG006|Overall Study|Adverse Event|1|||
146831665|NCT00661713|529553548|FG007|Overall Study|Adverse Event|0|||
146831666|NCT00661713|529553541|FG000|Overall Study|Inappropriate Enrollment|0|||
146831667|NCT00661713|529553542|FG001|Overall Study|Inappropriate Enrollment|0|||
146831668|NCT00661713|529553543|FG002|Overall Study|Inappropriate Enrollment|0|||
146831669|NCT00661713|529553544|FG003|Overall Study|Inappropriate Enrollment|0|||
146831670|NCT00661713|529553545|FG004|Overall Study|Inappropriate Enrollment|0|||
146831671|NCT00661713|529553546|FG005|Overall Study|Inappropriate Enrollment|0|||
146958485|NCT01004822|530007822|FG002|Overall Study|No longer willing to continue|0|||
146958486|NCT01004822|530007823|FG003|Overall Study|No longer willing to continue|1|||
146958487|NCT01004822|530007824|FG004|Overall Study|No longer willing to continue|2|||
146958488|NCT01004822|530007825|FG005|Overall Study|No longer willing to continue|1|||
146831672|NCT00661713|529553547|FG006|Overall Study|Inappropriate Enrollment|1|||
146831673|NCT00661713|529553548|FG007|Overall Study|Inappropriate Enrollment|0|||
146831674|NCT01801982|529553552|FG000|Overall Study|Lost to Follow-up|1|||
146831675|NCT00727506|529553553|FG000|Overall Study|Adverse Event|0|||
146831676|NCT00727506|529553554|FG001|Overall Study|Adverse Event|0|||
146831677|NCT00727506|529553555|FG002|Overall Study|Adverse Event|4|||
146831678|NCT00727506|529553556|FG003|Overall Study|Adverse Event|4|||
146831679|NCT00727506|529553557|FG004|Overall Study|Adverse Event|1|||
146831680|NCT00727506|529553558|FG005|Overall Study|Adverse Event|8|||
146831681|NCT00727506|529553553|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
146831682|NCT00727506|529553554|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146986446|NCT02396381|530112912|FG000|Overall Study|Randomization/Screening Error|3|||
146986447|NCT02396381|530112913|FG001|Overall Study|Randomization/Screening Error|1|||
146986448|NCT00356200|530112915|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
146986449|NCT00356200|530112916|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
146986450|NCT00356200|530112915|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
146986451|NCT00356200|530112916|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
146986452|NCT00635778|530112917|FG000|Overall Study|Adverse Event|1|||
146986453|NCT00635778|530112918|FG001|Overall Study|Adverse Event|0|||
146986454|NCT00635778|530112919|FG002|Overall Study|Adverse Event|0|||
146986455|NCT00635778|530112920|FG003|Overall Study|Adverse Event|3|||
146986456|NCT00635778|530112921|FG004|Overall Study|Adverse Event|3|||
146986457|NCT00635778|530112922|FG005|Overall Study|Adverse Event|6|||
146986458|NCT00635778|530112923|FG006|Overall Study|Adverse Event|1|||
146986459|NCT00635778|530112917|FG000|Overall Study|Withdrawal by Subject|0|||
146986460|NCT00635778|530112918|FG001|Overall Study|Withdrawal by Subject|0|||
146986461|NCT00635778|530112919|FG002|Overall Study|Withdrawal by Subject|0|||
146986462|NCT00635778|530112920|FG003|Overall Study|Withdrawal by Subject|1|||
146986463|NCT00635778|530112921|FG004|Overall Study|Withdrawal by Subject|0|||
146986464|NCT00635778|530112922|FG005|Overall Study|Withdrawal by Subject|1|||
146986465|NCT00635778|530112923|FG006|Overall Study|Withdrawal by Subject|1|||
146986466|NCT00635778|530112917|FG000|Overall Study|Progressive disease|0|||
146986467|NCT00635778|530112918|FG001|Overall Study|Progressive disease|3|||
146986468|NCT00635778|530112919|FG002|Overall Study|Progressive disease|3|||
146986469|NCT00635778|530112920|FG003|Overall Study|Progressive disease|4|||
146986470|NCT00635778|530112921|FG004|Overall Study|Progressive disease|5|||
146986471|NCT00635778|530112922|FG005|Overall Study|Progressive disease|14|||
146986472|NCT00635778|530112923|FG006|Overall Study|Progressive disease|4|||
146986473|NCT01000337|530112929|FG000|Overall Study|Lost to Follow-up|4|||
146986474|NCT01000337|530112930|FG001|Overall Study|Lost to Follow-up|3|||
146986475|NCT02227862|530112931|FG000|Overall Study|Protocol Violation|7|||
146986476|NCT02227862|530112932|FG001|Overall Study|Protocol Violation|9|||
146986477|NCT02227862|530112931|FG000|Overall Study|Other|0|||
146986478|NCT02227862|530112932|FG001|Overall Study|Other|2|||
146986479|NCT02227862|530112931|FG000|Overall Study|Adverse Event|4|||
146986480|NCT02227862|530112932|FG001|Overall Study|Adverse Event|3|||
146986481|NCT02227862|530112931|FG000|Overall Study|Withdrawal by Subject|7|||
146986482|NCT02227862|530112932|FG001|Overall Study|Withdrawal by Subject|6|||
146986483|NCT02227862|530112931|FG000|Overall Study|Lost to Follow-up|1|||
146986484|NCT02227862|530112932|FG001|Overall Study|Lost to Follow-up|2|||
146986485|NCT01612000|530112934|FG000|Overall Study|Lost to Follow-up|6|||
146986486|NCT01612000|530112935|FG001|Overall Study|Lost to Follow-up|4|||
146986487|NCT01612000|530112936|FG002|Overall Study|Lost to Follow-up|4|||
146986488|NCT01612000|530112937|FG003|Overall Study|Lost to Follow-up|8|||
146986489|NCT01612000|530112934|FG000|Overall Study|Physician Decision|0|||
146986490|NCT01612000|530112935|FG001|Overall Study|Physician Decision|0|||
146986491|NCT01612000|530112936|FG002|Overall Study|Physician Decision|1|||
146986492|NCT01612000|530112937|FG003|Overall Study|Physician Decision|0|||
146986493|NCT01612000|530112934|FG000|Overall Study|Withdrawal by Subject|3|||
146986494|NCT01612000|530112935|FG001|Overall Study|Withdrawal by Subject|1|||
146986495|NCT01612000|530112936|FG002|Overall Study|Withdrawal by Subject|2|||
146986496|NCT01612000|530112937|FG003|Overall Study|Withdrawal by Subject|2|||
146986497|NCT02173704|530112938|FG000|Overall Study|Adverse Event|1|||
146986498|NCT02173704|530112939|FG001|Overall Study|Adverse Event|0|||
146831683|NCT00727506|529553555|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
146831684|NCT00727506|529553556|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146986499|NCT02173704|530112938|FG000|Overall Study|Lost to Follow-up|1|||
146986500|NCT02173704|530112939|FG001|Overall Study|Lost to Follow-up|0|||
146986501|NCT02173704|530112938|FG000|Overall Study|Other|1|||
146986502|NCT02173704|530112939|FG001|Overall Study|Other|0|||
146986503|NCT02173704|530112938|FG000|Overall Study|Protocol Violation|1|||
146986504|NCT02173704|530112939|FG001|Overall Study|Protocol Violation|0|||
146986505|NCT02173704|530112938|FG000|Overall Study|Withdrawal by Subject|9|||
146986506|NCT02173704|530112939|FG001|Overall Study|Withdrawal by Subject|4|||
146986507|NCT00419926|530112940|FG000|Overall Study|Withdrawal by Subject|7|||
146986508|NCT00419926|530112941|FG001|Overall Study|Withdrawal by Subject|3|||
146986509|NCT00419926|530112940|FG000|Overall Study|Administrative Problem|4|||
146986510|NCT00419926|530112941|FG001|Overall Study|Administrative Problem|4|||
146986511|NCT00419926|530112940|FG000|Overall Study|Lost to Follow-up|1|||
146986512|NCT00419926|530112941|FG001|Overall Study|Lost to Follow-up|2|||
146831685|NCT00727506|529553557|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146831686|NCT00727506|529553558|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146831687|NCT00727506|529553553|FG000|Overall Study|Progressive disease|4|||
146831688|NCT00727506|529553554|FG001|Overall Study|Progressive disease|7|||
146831689|NCT00727506|529553555|FG002|Overall Study|Progressive disease|9|||
146831690|NCT00727506|529553556|FG003|Overall Study|Progressive disease|28|||
146831691|NCT00727506|529553557|FG004|Overall Study|Progressive disease|38|||
146831692|NCT00727506|529553558|FG005|Overall Study|Progressive disease|28|||
146831693|NCT00727506|529553553|FG000|Overall Study|Refused to continue medication|0|||
146831694|NCT00727506|529553554|FG001|Overall Study|Refused to continue medication|1|||
146831695|NCT00727506|529553555|FG002|Overall Study|Refused to continue medication|2|||
146831696|NCT00727506|529553556|FG003|Overall Study|Refused to continue medication|3|||
146831697|NCT00727506|529553557|FG004|Overall Study|Refused to continue medication|1|||
146831698|NCT00727506|529553558|FG005|Overall Study|Refused to continue medication|2|||
146831699|NCT00727506|529553553|FG000|Overall Study|Other reason not described above|0|||
146831700|NCT00727506|529553554|FG001|Overall Study|Other reason not described above|0|||
146831701|NCT00727506|529553555|FG002|Overall Study|Other reason not described above|1|||
146831702|NCT00727506|529553556|FG003|Overall Study|Other reason not described above|4|||
146831703|NCT00727506|529553557|FG004|Overall Study|Other reason not described above|1|||
146831704|NCT00727506|529553558|FG005|Overall Study|Other reason not described above|1|||
146831705|NCT01482429|529553559|FG000|Care Usual|Protocol Violation|0|||
146831706|NCT01482429|529553560|FG001|Care Usual|Protocol Violation|172|||
146831707|NCT01482429|529553559|FG000|Care Usual|Lost to Follow-up|0|||
146831708|NCT01482429|529553560|FG001|Care Usual|Lost to Follow-up|1|||
146831709|NCT01482429|529553559|FG000|Protocol|Protocol Violation|275|||
146831710|NCT01482429|529553560|FG001|Protocol|Protocol Violation|0|||
146831711|NCT03561597|529553561|FG000|Overall Study|Lost to Follow-up|20|||
146831712|NCT04887506|529553562|FG000|Overall Study|Death|1|||
146831713|NCT04887506|529553563|FG001|Overall Study|Death|1|||
146831714|NCT04887506|529553562|FG000|Overall Study|Withdrawal by Subject|0|||
146831715|NCT04887506|529553563|FG001|Overall Study|Withdrawal by Subject|3|||
146831716|NCT04887506|529553562|FG000|Overall Study|Adverse Event|4|||
146831717|NCT04887506|529553563|FG001|Overall Study|Adverse Event|3|||
146831718|NCT04887506|529553562|FG000|Overall Study|Other - Not Reported|1|||
146831719|NCT04887506|529553563|FG001|Overall Study|Other - Not Reported|1|||
146831720|NCT02636608|529553564|FG000|Overall Study|Failure to Return|4|||
146831721|NCT02636608|529553564|FG000|Overall Study|Insufficient Virological Response|1|||
146831722|NCT02636608|529553564|FG000|Overall Study|Death|3|||
146831723|NCT02636608|529553564|FG000|Overall Study|Other|2|||
146831724|NCT02636608|529553564|FG000|Overall Study|Did Not Receive Treatment|1|||
146831725|NCT04594733|529553588|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
146831726|NCT04594733|529553589|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
146831727|NCT04594733|529553588|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
146831728|NCT04594733|529553589|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
146831729|NCT04594733|529553588|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
146831730|NCT04594733|529553589|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
146831731|NCT01024036|529553590|FG000|Blinded Treatment|Adverse Event|1|||
146831732|NCT01024036|529553591|FG001|Blinded Treatment|Adverse Event|1|||
146831733|NCT01024036|529553590|FG000|Blinded Treatment|Lack of Efficacy|16|||
146831734|NCT01024036|529553591|FG001|Blinded Treatment|Lack of Efficacy|14|||
146831735|NCT01024036|529553590|FG000|Blinded Treatment|Physician Decision|1|||
146831736|NCT01024036|529553591|FG001|Blinded Treatment|Physician Decision|0|||
146831737|NCT01024036|529553590|FG000|Blinded Treatment|Death|0|||
146831738|NCT01024036|529553591|FG001|Blinded Treatment|Death|2|||
146831739|NCT01024036|529553590|FG000|Blinded Treatment|Withdrawal by Subject|4|||
146831740|NCT01024036|529553591|FG001|Blinded Treatment|Withdrawal by Subject|3|||
146831741|NCT01024036|529553590|FG000|Unblinded Treatment|Adverse Event|0|||
146831742|NCT01024036|529553591|FG001|Unblinded Treatment|Adverse Event|1|||
146831743|NCT01024036|529553590|FG000|Unblinded Treatment|Lack of Efficacy|0|||
146831744|NCT01024036|529553591|FG001|Unblinded Treatment|Lack of Efficacy|2|||
146831745|NCT01024036|529553590|FG000|Follow-Up Period|Lost to Follow-up|1|||
146831746|NCT01024036|529553591|FG001|Follow-Up Period|Lost to Follow-up|1|||
146831747|NCT01024036|529553590|FG000|Follow-Up Period|Withdrawal by Subject|0|||
146831748|NCT01024036|529553591|FG001|Follow-Up Period|Withdrawal by Subject|1|||
146831749|NCT01024036|529553590|FG000|Follow-Up Period|Adverse Event|4|||
146986513|NCT00419926|530112940|FG000|Overall Study|Death|2|||
146986514|NCT00419926|530112941|FG001|Overall Study|Death|1|||
146986515|NCT01180244|530112952|FG000|Overall Study|Lack of Efficacy|0|||
146986516|NCT01180244|530112953|FG001|Overall Study|Lack of Efficacy|7|||
146986517|NCT01180244|530112952|FG000|Overall Study|Physician Decision|3|||
146986518|NCT01180244|530112953|FG001|Overall Study|Physician Decision|0|||
146831750|NCT01024036|529553591|FG001|Follow-Up Period|Adverse Event|1|||
146831751|NCT01190449|529553597|FG000|Overall Study|Ineligible|0|||
146831752|NCT01190449|529553598|FG001|Overall Study|Ineligible|4|||
146831753|NCT04811339|529553599|FG000|Overall Study|lack of transportation not wanting to return|4|||
146986519|NCT01180244|530112952|FG000|Overall Study|Adverse Event|1|||
146986520|NCT01180244|530112953|FG001|Overall Study|Adverse Event|0|||
146831754|NCT04811339|529553600|FG001|Overall Study|lack of transportation not wanting to return|8|||
146831755|NCT04811339|529553601|FG002|Overall Study|lack of transportation not wanting to return|0|||
146831756|NCT04811339|529553599|FG000|Overall Study|Adverse Event|3|||
146831757|NCT04811339|529553600|FG001|Overall Study|Adverse Event|0|||
146831758|NCT04811339|529553601|FG002|Overall Study|Adverse Event|0|||
146831759|NCT04811339|529553599|FG000|Overall Study|Lost to Follow-up|1|||
146831760|NCT04811339|529553600|FG001|Overall Study|Lost to Follow-up|0|||
146831761|NCT04811339|529553601|FG002|Overall Study|Lost to Follow-up|0|||
146831762|NCT04811339|529553599|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
146831763|NCT04811339|529553600|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
146831764|NCT04811339|529553601|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
146831765|NCT04811339|529553599|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
146831766|NCT04811339|529553600|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
146831767|NCT04811339|529553601|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
146831768|NCT04811339|529553599|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
146831769|NCT04811339|529553600|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
146831770|NCT04811339|529553601|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
146831771|NCT04811339|529553599|FG000|Overall Study|Withdrawal by Subject|0|||
146831772|NCT04811339|529553600|FG001|Overall Study|Withdrawal by Subject|3|||
146831773|NCT04811339|529553601|FG002|Overall Study|Withdrawal by Subject|0|||
146831774|NCT04811339|529553599|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
146831775|NCT04811339|529553600|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
146831776|NCT04811339|529553601|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
146831777|NCT04811339|529553599|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
146831778|NCT04811339|529553600|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
146831779|NCT04811339|529553601|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
146831780|NCT00903760|529555281|FG000|Overall Study|Disease Progression/Death|8|||
146831781|NCT00903760|529555282|FG001|Overall Study|Disease Progression/Death|6|||
146831782|NCT00903760|529555281|FG000|Overall Study|Stem Cell Transplant|8|||
146831783|NCT00903760|529555282|FG001|Overall Study|Stem Cell Transplant|4|||
146831784|NCT00903760|529555281|FG000|Overall Study|Physician Decision|1|||
146831785|NCT00903760|529555282|FG001|Overall Study|Physician Decision|2|||
146831786|NCT00903760|529555281|FG000|Overall Study|Death|0|||
146831787|NCT00903760|529555282|FG001|Overall Study|Death|1|||
146831788|NCT00903760|529555281|FG000|Overall Study|Lost to Follow-up|1|||
146831789|NCT00903760|529555282|FG001|Overall Study|Lost to Follow-up|0|||
146831790|NCT00903760|529555281|FG000|Overall Study|Withdrawal by Subject|1|||
146831791|NCT00903760|529555282|FG001|Overall Study|Withdrawal by Subject|2|||
146831792|NCT00903760|529555281|FG000|Overall Study|Off treatment for long period|0|||
146831793|NCT00903760|529555282|FG001|Overall Study|Off treatment for long period|1|||
146831794|NCT01256671|529555288|FG000|Overall Study|Adverse Event|29|||
146958489|NCT01004822|530007826|FG006|Overall Study|No longer willing to continue|1|||
146958490|NCT01004822|530007827|FG007|Overall Study|No longer willing to continue|0|||
146958491|NCT01004822|530007820|FG000|Overall Study|Adverse Event|0|||
146958492|NCT01004822|530007821|FG001|Overall Study|Adverse Event|0|||
146958493|NCT01004822|530007822|FG002|Overall Study|Adverse Event|0|||
146958494|NCT01004822|530007823|FG003|Overall Study|Adverse Event|0|||
146958495|NCT01004822|530007824|FG004|Overall Study|Adverse Event|0|||
146958496|NCT01004822|530007825|FG005|Overall Study|Adverse Event|0|||
146958497|NCT01004822|530007826|FG006|Overall Study|Adverse Event|1|||
146958498|NCT01004822|530007827|FG007|Overall Study|Adverse Event|1|||
146958499|NCT01004822|530007820|FG000|Overall Study|Other|0|||
146958500|NCT01004822|530007821|FG001|Overall Study|Other|0|||
146958501|NCT01004822|530007822|FG002|Overall Study|Other|4|||
146958502|NCT01004822|530007823|FG003|Overall Study|Other|1|||
146958503|NCT01004822|530007824|FG004|Overall Study|Other|0|||
146958504|NCT01004822|530007825|FG005|Overall Study|Other|1|||
146958505|NCT01004822|530007826|FG006|Overall Study|Other|0|||
146958506|NCT01004822|530007827|FG007|Overall Study|Other|0|||
146958507|NCT01858701|530007828|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
146958508|NCT01858701|530007829|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
146958509|NCT01858701|530007828|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
146958510|NCT01858701|530007829|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
146958511|NCT01858701|530007828|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
146958512|NCT01858701|530007829|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
146958513|NCT01858701|530007828|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
146958514|NCT01858701|530007829|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
146958515|NCT01801475|530007832|FG000|Overall Study|Withdrawal by Subject|0|||
146958516|NCT01801475|530007833|FG001|Overall Study|Withdrawal by Subject|0|||
146958517|NCT01801475|530007834|FG002|Overall Study|Withdrawal by Subject|0|||
146958518|NCT01801475|530007835|FG003|Overall Study|Withdrawal by Subject|0|||
146958519|NCT01801475|530007836|FG004|Overall Study|Withdrawal by Subject|1|||
146831795|NCT01256671|529555288|FG000|Overall Study|Lost to Follow-up|16|||
146831796|NCT01256671|529555288|FG000|Overall Study|Withdrawal by Subject|31|||
146831797|NCT01256671|529555288|FG000|Overall Study|Physician Decision|3|||
146831798|NCT01256671|529555288|FG000|Overall Study|Lack of Efficacy|4|||
146831799|NCT01256671|529555288|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
146831800|NCT04411186|529555289|FG000|Overall Study|Withdrawn due to protocol violation|0|||
146831801|NCT04411186|529555290|FG001|Overall Study|Withdrawn due to protocol violation|1|||
146831802|NCT01266018|529555291|FG000|Overall Study|Physician Decision|1|||
146831803|NCT01266018|529555292|FG001|Overall Study|Physician Decision|0|||
146831804|NCT01266018|529555291|FG000|Overall Study|Progressive disease|0|||
146831805|NCT01266018|529555292|FG001|Overall Study|Progressive disease|1|||
146831806|NCT02641587|529555294|FG000|Confinement Period|Adverse Event|1|||
146831807|NCT02641587|529555295|FG001|Confinement Period|Adverse Event|0|||
146831808|NCT02641587|529555294|FG000|Confinement Period|Withdrawal by Subject|2|||
146831809|NCT02641587|529555295|FG001|Confinement Period|Withdrawal by Subject|1|||
146831810|NCT02641587|529555294|FG000|Ambulatory Period|Withdrawal by Subject|1|||
146831811|NCT02641587|529555295|FG001|Ambulatory Period|Withdrawal by Subject|0|||
146831812|NCT01165177|529555296|FG000|Overall Study|Serious Adverse Event|227|||
146831813|NCT01165177|529555297|FG001|Overall Study|Serious Adverse Event|235|||
146831814|NCT01165177|529555296|FG000|Overall Study|Withdrawal by Subject|368|||
146831815|NCT01165177|529555297|FG001|Overall Study|Withdrawal by Subject|354|||
146831816|NCT01165177|529555296|FG000|Overall Study|Protocol Violation|19|||
146831817|NCT01165177|529555297|FG001|Overall Study|Protocol Violation|21|||
146831818|NCT01165177|529555296|FG000|Overall Study|Non-serious adverse event|30|||
146831819|NCT01165177|529555297|FG001|Overall Study|Non-serious adverse event|18|||
146831820|NCT01165177|529555296|FG000|Overall Study|Other unspecified reasons|47|||
146831821|NCT01165177|529555297|FG001|Overall Study|Other unspecified reasons|35|||
146831822|NCT01165177|529555296|FG000|Overall Study|Suspected HZ episode|0|||
146831823|NCT01165177|529555297|FG001|Overall Study|Suspected HZ episode|2|||
146831824|NCT01165177|529555296|FG000|Overall Study|Lost to Follow-up|183|||
146831825|NCT01165177|529555297|FG001|Overall Study|Lost to Follow-up|194|||
146831826|NCT01165177|529555296|FG000|Overall Study|Migrated/ moved from study area|48|||
146831827|NCT01165177|529555297|FG001|Overall Study|Migrated/ moved from study area|43|||
146831828|NCT01657799|529555301|FG000|Overall Study|Adverse Event Related to progression|6|||
146831829|NCT01657799|529555302|FG001|Overall Study|Adverse Event Related to progression|8|||
146831830|NCT01657799|529555303|FG002|Overall Study|Adverse Event Related to progression|12|||
146831831|NCT01657799|529555301|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
146831832|NCT01657799|529555302|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
146831833|NCT01657799|529555303|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
146831834|NCT01657799|529555301|FG000|Overall Study|Withdrawal by Subject|13|||
146831835|NCT01657799|529555302|FG001|Overall Study|Withdrawal by Subject|10|||
146831836|NCT01657799|529555303|FG002|Overall Study|Withdrawal by Subject|10|||
146831837|NCT01657799|529555301|FG000|Overall Study|Lost to Follow-up|1|||
146831838|NCT01657799|529555302|FG001|Overall Study|Lost to Follow-up|0|||
146831839|NCT01657799|529555303|FG002|Overall Study|Lost to Follow-up|1|||
146831840|NCT01657799|529555301|FG000|Overall Study|Disease Progression|2|||
146831841|NCT01657799|529555302|FG001|Overall Study|Disease Progression|4|||
146831842|NCT01657799|529555303|FG002|Overall Study|Disease Progression|4|||
146831843|NCT01657799|529555301|FG000|Overall Study|Progressive Disease Clinical|7|||
146831844|NCT01657799|529555302|FG001|Overall Study|Progressive Disease Clinical|4|||
146831845|NCT01657799|529555303|FG002|Overall Study|Progressive Disease Clinical|7|||
146831846|NCT01657799|529555301|FG000|Overall Study|Radiographic & Clinical Progression|16|||
146831847|NCT01657799|529555302|FG001|Overall Study|Radiographic & Clinical Progression|11|||
146831848|NCT01657799|529555303|FG002|Overall Study|Radiographic & Clinical Progression|15|||
146831849|NCT01657799|529555301|FG000|Overall Study|Other|52|||
146831850|NCT01657799|529555302|FG001|Overall Study|Other|62|||
146831851|NCT01657799|529555303|FG002|Overall Study|Other|49|||
146831852|NCT01646385|529555310|FG000|Overall Study|Death|202|||
146831853|NCT01646385|529555311|FG001|Overall Study|Death|222|||
146831854|NCT01646385|529555310|FG000|Overall Study|Switched to alternate biologic|636|||
146958520|NCT01786707|530007837|FG000|Overall Study|Lost to Follow-up|1|||
146958521|NCT01786707|530007838|FG001|Overall Study|Lost to Follow-up|1|||
146831855|NCT01646385|529555311|FG001|Overall Study|Switched to alternate biologic|649|||
146831856|NCT01777334|529555312|FG000|Overall Study|Adverse Event|18|||
146831857|NCT01777334|529555313|FG001|Overall Study|Adverse Event|14|||
146831858|NCT01777334|529555312|FG000|Overall Study|Lack of Efficacy|15|||
146831859|NCT01777334|529555313|FG001|Overall Study|Lack of Efficacy|29|||
146831860|NCT01777334|529555312|FG000|Overall Study|Protocol Violation|3|||
146831861|NCT01777334|529555313|FG001|Overall Study|Protocol Violation|7|||
146831862|NCT01777334|529555312|FG000|Overall Study|Lost to Follow-up|3|||
146831863|NCT01777334|529555313|FG001|Overall Study|Lost to Follow-up|2|||
146831864|NCT01777334|529555312|FG000|Overall Study|Withdrawal by Subject|14|||
146831865|NCT01777334|529555313|FG001|Overall Study|Withdrawal by Subject|11|||
146831866|NCT00727415|529555317|FG000|Phase I|Dose Limiting Toxicity|2|||
146831867|NCT00756457|529555319|FG000|Overall Study|Lost to Follow-up|1|||
146831868|NCT00756457|529555320|FG001|Overall Study|Lost to Follow-up|2|||
146831869|NCT04593823|529555324|FG000|Overall Study|Withdrawal by Subject|1|||
146831870|NCT04593823|529555325|FG001|Overall Study|Withdrawal by Subject|1|||
146831871|NCT04593823|529555324|FG000|Overall Study|Lost to Follow-up|0|||
146831872|NCT04593823|529555325|FG001|Overall Study|Lost to Follow-up|1|||
146831873|NCT02564718|529555326|FG000|Overall Study|Withdrew from treatment|0|||
146831874|NCT02564718|529555327|FG001|Overall Study|Withdrew from treatment|1|||
146831875|NCT05043883|529555328|FG000|Overall Study|Minimum required measurements could not be taken|4|||
146831876|NCT02980705|529555329|FG000|Overall Study|Adverse Event|0|||
146831877|NCT02980705|529555330|FG001|Overall Study|Adverse Event|1|||
146831878|NCT02980705|529555329|FG000|Overall Study|Withdrawal by Subject|6|||
146831879|NCT02980705|529555330|FG001|Overall Study|Withdrawal by Subject|9|||
146831880|NCT02980705|529555329|FG000|Overall Study|withdrew participation|0|||
146831881|NCT02980705|529555330|FG001|Overall Study|withdrew participation|1|||
146831882|NCT02980705|529555329|FG000|Overall Study|Lost to Follow-up|2|||
146831883|NCT02980705|529555330|FG001|Overall Study|Lost to Follow-up|0|||
146831884|NCT00263575|529555331|FG000|Titration Period|Adverse Event|14|||
146831885|NCT00263575|529555331|FG000|Titration Period|Withdrawal by Subject|10|||
146831886|NCT00263575|529555331|FG000|Titration Period|Protocol Violation|9|||
146831887|NCT00263575|529555331|FG000|Titration Period|Sponsor Decision|2|||
146831888|NCT00263575|529555331|FG000|Titration Period|Other|2|||
146831889|NCT00263575|529555331|FG000|Titration Period|Lack of Efficacy|6|||
146831890|NCT00263575|529555331|FG000|Maintence Period|Adverse Event|23|||
146831891|NCT00263575|529555331|FG000|Maintence Period|Withdrawal by Subject|8|||
146831892|NCT00263575|529555331|FG000|Maintence Period|Protocol Violation|4|||
146831893|NCT00263575|529555331|FG000|Maintence Period|Lack of Efficacy|4|||
146831894|NCT00263575|529555331|FG000|Maintence Period|Physician Decision|6|||
146831895|NCT00263575|529555331|FG000|Maintence Period|Lost to Follow-up|1|||
146831896|NCT00263575|529555331|FG000|Maintence Period|Sponsor Decision|24|||
146831897|NCT00263575|529555331|FG000|Maintence Period|Other|7|||
146831898|NCT00537329|529555332|FG000|Overall Study|Death|10|||
146831899|NCT00537329|529555332|FG000|Overall Study|Adverse Event|3|||
146831900|NCT00537329|529555332|FG000|Overall Study|Lack of Efficacy|2|||
146831901|NCT00537329|529555332|FG000|Overall Study|Lost to Follow-up|6|||
146831902|NCT00537329|529555332|FG000|Overall Study|Withdrawal by Subject|4|||
146831903|NCT00537329|529555332|FG000|Overall Study|Other|1|||
146831904|NCT03599622|529555333|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
146831905|NCT03599622|529555334|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
146831906|NCT03599622|529555335|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
146831907|NCT03599622|529555336|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
146831908|NCT03599622|529555333|FG000|Pre-Treatment Period|Other reasons|1|||
146831909|NCT03599622|529555334|FG001|Pre-Treatment Period|Other reasons|1|||
146831910|NCT03599622|529555335|FG002|Pre-Treatment Period|Other reasons|1|||
146831911|NCT03599622|529555336|FG003|Pre-Treatment Period|Other reasons|0|||
146831912|NCT03599622|529555333|FG000|Treatment Period|Adverse Event|11|||
146831913|NCT03599622|529555334|FG001|Treatment Period|Adverse Event|20|||
146831914|NCT03599622|529555335|FG002|Treatment Period|Adverse Event|18|||
146831915|NCT03599622|529555336|FG003|Treatment Period|Adverse Event|2|||
146831916|NCT03599622|529555333|FG000|Treatment Period|Lack of Efficacy|18|||
146831917|NCT03599622|529555334|FG001|Treatment Period|Lack of Efficacy|12|||
146831918|NCT03599622|529555335|FG002|Treatment Period|Lack of Efficacy|13|||
146831919|NCT03599622|529555336|FG003|Treatment Period|Lack of Efficacy|2|||
146831920|NCT03599622|529555333|FG000|Treatment Period|Withdrawal by Subject|5|||
146831921|NCT03599622|529555334|FG001|Treatment Period|Withdrawal by Subject|11|||
146831922|NCT03599622|529555335|FG002|Treatment Period|Withdrawal by Subject|16|||
146831923|NCT03599622|529555336|FG003|Treatment Period|Withdrawal by Subject|1|||
146831924|NCT03599622|529555333|FG000|Treatment Period|Other reasons|4|||
146831925|NCT03599622|529555334|FG001|Treatment Period|Other reasons|6|||
146831926|NCT03599622|529555335|FG002|Treatment Period|Other reasons|7|||
146831927|NCT03599622|529555336|FG003|Treatment Period|Other reasons|0|||
146831928|NCT03599622|529555333|FG000|Treatment Period|Lost to Follow-up|1|||
146831929|NCT03599622|529555334|FG001|Treatment Period|Lost to Follow-up|0|||
146831930|NCT03599622|529555335|FG002|Treatment Period|Lost to Follow-up|0|||
146831931|NCT03599622|529555336|FG003|Treatment Period|Lost to Follow-up|0|||
146831932|NCT03599622|529555333|FG000|Treatment Period|Study terminated by sponsor|7|||
146831933|NCT03599622|529555334|FG001|Treatment Period|Study terminated by sponsor|20|||
146831934|NCT03599622|529555335|FG002|Treatment Period|Study terminated by sponsor|15|||
146831935|NCT03599622|529555336|FG003|Treatment Period|Study terminated by sponsor|0|||
146831936|NCT03599622|529555333|FG000|Treatment Period|Site terminated by sponsor|0|||
146831937|NCT03599622|529555334|FG001|Treatment Period|Site terminated by sponsor|1|||
146831938|NCT03599622|529555335|FG002|Treatment Period|Site terminated by sponsor|0|||
146831939|NCT03599622|529555336|FG003|Treatment Period|Site terminated by sponsor|0|||
146831940|NCT01278615|529555341|FG000|Overall Study|Withdrawal by Subject|2|||
146831941|NCT00905359|529555342|FG000|Overall Study|Lost to Follow-up|17|||
146831942|NCT00905359|529555343|FG001|Overall Study|Lost to Follow-up|10|||
146831943|NCT00905359|529555342|FG000|Overall Study|Death|2|||
146831944|NCT00905359|529555343|FG001|Overall Study|Death|0|||
146831945|NCT00905359|529555342|FG000|Overall Study|Withdrawal consent|5|||
146831946|NCT00905359|529555343|FG001|Overall Study|Withdrawal consent|6|||
146831947|NCT02138253|529555344|FG000|Overall Study|Adverse Event|3|||
146831948|NCT02138253|529555345|FG001|Overall Study|Adverse Event|3|||
146831949|NCT02138253|529555344|FG000|Overall Study|Lost to Follow-up|2|||
146831950|NCT02138253|529555345|FG001|Overall Study|Lost to Follow-up|1|||
146831951|NCT02138253|529555344|FG000|Overall Study|Physician Decision|2|||
146831952|NCT02138253|529555345|FG001|Overall Study|Physician Decision|0|||
146831953|NCT02138253|529555344|FG000|Overall Study|Non compliance|1|||
146831954|NCT02138253|529555345|FG001|Overall Study|Non compliance|0|||
146831955|NCT02138253|529555344|FG000|Overall Study|Withdrawal by Subject|1|||
146831956|NCT02138253|529555345|FG001|Overall Study|Withdrawal by Subject|0|||
146831957|NCT01918371|529555346|FG000|Overall Study|Missing Data|1|||
146831958|NCT01918371|529555347|FG001|Overall Study|Missing Data|1|||
146831959|NCT01006889|529555348|FG000|Overall Study|Withdrawal by Subject|3|||
146831960|NCT00243022|529555349|FG000|Overall Study|Withdrawal by Subject|1|||
146831961|NCT00243022|529555350|FG001|Overall Study|Withdrawal by Subject|0|||
146831962|NCT00243022|529555349|FG000|Overall Study|Death|1|||
146831963|NCT00243022|529555350|FG001|Overall Study|Death|0|||
146831964|NCT00243022|529555349|FG000|Overall Study|Difficult Travel Distance|0|||
146831965|NCT00243022|529555350|FG001|Overall Study|Difficult Travel Distance|1|||
146831966|NCT01390441|529555355|FG000|Treatment Period|Protocol Violation|0|||
146831967|NCT01390441|529555356|FG001|Treatment Period|Protocol Violation|1|||
146831968|NCT01390441|529555357|FG002|Treatment Period|Protocol Violation|0|||
146831969|NCT01390441|529555358|FG003|Treatment Period|Protocol Violation|0|||
146831970|NCT01390441|529555359|FG004|Treatment Period|Protocol Violation|0|||
146831971|NCT01390441|529555355|FG000|Treatment Period|Physician Decision|0|||
146831972|NCT01390441|529555356|FG001|Treatment Period|Physician Decision|0|||
146831973|NCT01390441|529555357|FG002|Treatment Period|Physician Decision|0|||
146831974|NCT01390441|529555358|FG003|Treatment Period|Physician Decision|1|||
146831975|NCT01390441|529555359|FG004|Treatment Period|Physician Decision|0|||
146831976|NCT01390441|529555355|FG000|Treatment Period|Lack of Efficacy|0|||
146831977|NCT01390441|529555356|FG001|Treatment Period|Lack of Efficacy|0|||
146831978|NCT01390441|529555357|FG002|Treatment Period|Lack of Efficacy|0|||
146831979|NCT01390441|529555358|FG003|Treatment Period|Lack of Efficacy|0|||
146831980|NCT01390441|529555359|FG004|Treatment Period|Lack of Efficacy|1|||
146831981|NCT01390441|529555355|FG000|Treatment Period|Unknown due to early stopping of study|0|||
146831982|NCT01390441|529555356|FG001|Treatment Period|Unknown due to early stopping of study|0|||
146831983|NCT01390441|529555357|FG002|Treatment Period|Unknown due to early stopping of study|8|||
146831984|NCT01390441|529555358|FG003|Treatment Period|Unknown due to early stopping of study|11|||
146831985|NCT01390441|529555359|FG004|Treatment Period|Unknown due to early stopping of study|7|||
146831986|NCT01390441|529555355|FG000|Treatment Period|Adverse Event|0|||
146831987|NCT01390441|529555356|FG001|Treatment Period|Adverse Event|0|||
146831988|NCT01390441|529555357|FG002|Treatment Period|Adverse Event|1|||
146831989|NCT01390441|529555358|FG003|Treatment Period|Adverse Event|1|||
146831990|NCT01390441|529555359|FG004|Treatment Period|Adverse Event|2|||
146831991|NCT01390441|529555355|FG000|Treatment Period|Withdrawal by Subject|0|||
146831992|NCT01390441|529555356|FG001|Treatment Period|Withdrawal by Subject|0|||
146831993|NCT01390441|529555357|FG002|Treatment Period|Withdrawal by Subject|1|||
146831994|NCT01390441|529555358|FG003|Treatment Period|Withdrawal by Subject|0|||
146831995|NCT01390441|529555359|FG004|Treatment Period|Withdrawal by Subject|1|||
146831996|NCT01390441|529555355|FG000|Treatment Period|Lost to Follow-up|1|||
146831997|NCT01390441|529555356|FG001|Treatment Period|Lost to Follow-up|0|||
146831998|NCT01390441|529555357|FG002|Treatment Period|Lost to Follow-up|0|||
146831999|NCT01390441|529555358|FG003|Treatment Period|Lost to Follow-up|0|||
146832000|NCT01390441|529555359|FG004|Treatment Period|Lost to Follow-up|0|||
146832001|NCT01390441|529555355|FG000|Extension Period|Protocol Violation|3|||
146832002|NCT01390441|529555356|FG001|Extension Period|Protocol Violation|1|||
146832003|NCT01390441|529555357|FG002|Extension Period|Protocol Violation|0|||
146958522|NCT00421928|530007839|FG000|Overall Study|Adverse Event|61|||
146958523|NCT00421928|530007840|FG001|Overall Study|Adverse Event|140|||
146958524|NCT00421928|530007841|FG002|Overall Study|Adverse Event|22|||
146958525|NCT00421928|530007839|FG000|Overall Study|Lost to Follow-up|5|||
146958526|NCT00421928|530007840|FG001|Overall Study|Lost to Follow-up|0|||
146958527|NCT00421928|530007841|FG002|Overall Study|Lost to Follow-up|3|||
146958528|NCT00421928|530007839|FG000|Overall Study|Withdrawal by Subject|50|||
146958529|NCT00421928|530007840|FG001|Overall Study|Withdrawal by Subject|48|||
146832004|NCT01390441|529555358|FG003|Extension Period|Protocol Violation|1|||
146832005|NCT01390441|529555359|FG004|Extension Period|Protocol Violation|0|||
146832006|NCT00621192|529555360|FG000|Overall Study|Withdrawal by Subject|0|||
146832007|NCT00621192|529555361|FG001|Overall Study|Withdrawal by Subject|0|||
146832008|NCT00621192|529555362|FG002|Overall Study|Withdrawal by Subject|2|||
146832009|NCT00621192|529555363|FG003|Overall Study|Withdrawal by Subject|0|||
146832010|NCT00621192|529555360|FG000|Overall Study|Physician Decision|1|||
146832011|NCT00621192|529555361|FG001|Overall Study|Physician Decision|3|||
146832012|NCT00621192|529555362|FG002|Overall Study|Physician Decision|0|||
146832013|NCT00621192|529555363|FG003|Overall Study|Physician Decision|0|||
146832014|NCT00621192|529555360|FG000|Overall Study|Protocol Violation|1|||
146832015|NCT00621192|529555361|FG001|Overall Study|Protocol Violation|0|||
146832016|NCT00621192|529555362|FG002|Overall Study|Protocol Violation|0|||
146832017|NCT00621192|529555363|FG003|Overall Study|Protocol Violation|1|||
146832018|NCT00621192|529555360|FG000|Overall Study|Adverse Event|0|||
146832019|NCT00621192|529555361|FG001|Overall Study|Adverse Event|1|||
146832020|NCT00621192|529555362|FG002|Overall Study|Adverse Event|0|||
146832021|NCT00621192|529555363|FG003|Overall Study|Adverse Event|1|||
146832022|NCT00621192|529555360|FG000|Overall Study|Death|2|||
146832023|NCT00621192|529555361|FG001|Overall Study|Death|5|||
146832024|NCT00621192|529555362|FG002|Overall Study|Death|0|||
146832025|NCT00621192|529555363|FG003|Overall Study|Death|0|||
146832026|NCT00621192|529555360|FG000|Overall Study|Final Assessments not Completed|0|||
146832027|NCT00621192|529555361|FG001|Overall Study|Final Assessments not Completed|0|||
146832028|NCT00621192|529555362|FG002|Overall Study|Final Assessments not Completed|3|||
146832029|NCT00621192|529555363|FG003|Overall Study|Final Assessments not Completed|1|||
146832030|NCT04706793|529555364|FG000|Treatment|Disease worsening|10|||
146832031|NCT04706793|529555365|FG001|Treatment|Disease worsening|10|||
146832032|NCT04706793|529555364|FG000|Follow-up|Lack of Efficacy|1|||
146832033|NCT04706793|529555365|FG001|Follow-up|Lack of Efficacy|0|||
146832034|NCT04706793|529555364|FG000|Follow-up|Disease worsening|8|||
146832035|NCT04706793|529555365|FG001|Follow-up|Disease worsening|10|||
146832036|NCT04706793|529555364|FG000|Follow-up|Adverse Event|1|||
146832037|NCT04706793|529555365|FG001|Follow-up|Adverse Event|0|||
146832038|NCT00823836|529555369|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
146832039|NCT00823836|529555370|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
146832040|NCT00823836|529555369|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
146832041|NCT00823836|529555370|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
146832042|NCT00823836|529555369|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
146832043|NCT00823836|529555370|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
146832044|NCT00823836|529555369|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
146832045|NCT00823836|529555370|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
146832046|NCT00823836|529555369|FG000|Long-term Phase|Adverse Event|3|||
146832047|NCT00823836|529555370|FG001|Long-term Phase|Adverse Event|2|||
146832048|NCT00823836|529555369|FG000|Long-term Phase|Physician Decision|1|||
146832049|NCT00823836|529555370|FG001|Long-term Phase|Physician Decision|2|||
146832050|NCT00823836|529555369|FG000|Long-term Phase|Withdrawal by Subject|1|||
146832051|NCT00823836|529555370|FG001|Long-term Phase|Withdrawal by Subject|1|||
146832052|NCT01099579|529555375|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
146832053|NCT01099579|529555376|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
146832054|NCT01099579|529555377|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
146832055|NCT01099579|529555375|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
146832056|NCT01099579|529555376|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
146832057|NCT01099579|529555377|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
146832058|NCT01099579|529555375|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
146832059|NCT01099579|529555376|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
146832060|NCT01099579|529555377|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
146832061|NCT01099579|529555375|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
146832062|NCT01099579|529555376|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
146832063|NCT01099579|529555377|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
146832064|NCT01099579|529555375|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
146832065|NCT01099579|529555376|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
146832066|NCT01099579|529555377|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
146832067|NCT01099579|529555375|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
146832068|NCT01099579|529555376|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
146832069|NCT01099579|529555377|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
146986521|NCT01180244|530112952|FG000|Overall Study|Withdrawal by Subject|0|||
146986522|NCT01180244|530112953|FG001|Overall Study|Withdrawal by Subject|1|||
146986523|NCT01180244|530112952|FG000|Overall Study|Protocol Violation|1|||
146832070|NCT01099579|529555375|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
146986524|NCT01180244|530112953|FG001|Overall Study|Protocol Violation|0|||
146986525|NCT01180244|530112952|FG000|Overall Study|Lost to Follow-up|1|||
146832071|NCT01099579|529555376|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
146832072|NCT01099579|529555377|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
146832073|NCT01099579|529555375|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
146832074|NCT01099579|529555376|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
146832075|NCT01099579|529555377|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
146832076|NCT01099579|529555375|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
146832077|NCT01099579|529555376|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
146832078|NCT01099579|529555377|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
146832079|NCT01099579|529555375|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
146832080|NCT01099579|529555376|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
146832081|NCT01099579|529555377|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
146832082|NCT01130168|529555378|FG000|Period 1|Withdrawal by Subject|0|||
146986526|NCT01180244|530112953|FG001|Overall Study|Lost to Follow-up|0|||
146832083|NCT01130168|529555379|FG001|Period 1|Withdrawal by Subject|1|||
146832084|NCT01130168|529555380|FG002|Period 1|Withdrawal by Subject|0|||
146832085|NCT01130168|529555381|FG003|Period 1|Withdrawal by Subject|1|||
146832086|NCT01130168|529555382|FG004|Period 1|Withdrawal by Subject|0|||
146832087|NCT01130168|529555383|FG005|Period 1|Withdrawal by Subject|0|||
146832088|NCT01130168|529555378|FG000|Period 1|Discontinued For Other Reason|0|||
146832089|NCT01130168|529555379|FG001|Period 1|Discontinued For Other Reason|0|||
146832090|NCT01130168|529555380|FG002|Period 1|Discontinued For Other Reason|1|||
146832091|NCT01130168|529555381|FG003|Period 1|Discontinued For Other Reason|1|||
146832092|NCT01130168|529555382|FG004|Period 1|Discontinued For Other Reason|0|||
146832093|NCT01130168|529555383|FG005|Period 1|Discontinued For Other Reason|0|||
146832094|NCT01130168|529555378|FG000|Period 1|Adverse Event|0|||
146832095|NCT01130168|529555379|FG001|Period 1|Adverse Event|0|||
146832096|NCT01130168|529555380|FG002|Period 1|Adverse Event|0|||
146832097|NCT01130168|529555381|FG003|Period 1|Adverse Event|1|||
146832098|NCT01130168|529555382|FG004|Period 1|Adverse Event|0|||
146832099|NCT01130168|529555383|FG005|Period 1|Adverse Event|0|||
146832100|NCT02725528|529555384|FG000|Overall Study|Lost to Follow-up|1|||
146832101|NCT02725528|529555385|FG001|Overall Study|Lost to Follow-up|4|||
146832102|NCT02725528|529555384|FG000|Overall Study|Withdrawal by Subject|0|||
146832103|NCT02725528|529555385|FG001|Overall Study|Withdrawal by Subject|1|||
146832104|NCT04354168|529555388|FG000|Overall Study|Lost to Follow-up|22|||
146832105|NCT01781832|529555389|FG000|Overall Study|Withdrawal by Subject|1|||
146832106|NCT03432390|529555392|FG000|Apnea Period|Protocol Violation|2|||
146832107|NCT03432390|529555393|FG001|Apnea Period|Protocol Violation|2|||
146832108|NCT03783689|529555397|FG000|Overall Study|Adverse Event|2|||
146832109|NCT03783689|529555398|FG001|Overall Study|Adverse Event|0|||
146832110|NCT03783689|529555397|FG000|Overall Study|Lost to Follow-up|2|||
146832111|NCT03783689|529555398|FG001|Overall Study|Lost to Follow-up|1|||
146986527|NCT00620763|530112956|FG000|Period: First Intervention|Withdrawal by Subject|0|||
146986528|NCT00620763|530112957|FG001|Period: First Intervention|Withdrawal by Subject|2|||
146986529|NCT00620763|530112956|FG000|Period: First Intervention|Protocol Violation|0|||
146986530|NCT00620763|530112957|FG001|Period: First Intervention|Protocol Violation|3|||
146986531|NCT00620763|530112956|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
146986532|NCT00620763|530112957|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
146986533|NCT01595009|530112958|FG000|Core|Patients completed per protocol|85|||
146986534|NCT01595009|530112959|FG001|Core|Patients completed per protocol|44|||
146986535|NCT01595009|530112960|FG002|Core|Patients completed per protocol|0|||
146986536|NCT01595009|530112961|FG003|Core|Patients completed per protocol|0|||
146986537|NCT01595009|530112958|FG000|Core|Adverse Event|19|||
146986538|NCT01595009|530112959|FG001|Core|Adverse Event|23|||
146986539|NCT01595009|530112960|FG002|Core|Adverse Event|0|||
146986540|NCT01595009|530112961|FG003|Core|Adverse Event|0|||
146986541|NCT01595009|530112958|FG000|Core|Disease progression|14|||
146986542|NCT01595009|530112959|FG001|Core|Disease progression|26|||
146986543|NCT01595009|530112960|FG002|Core|Disease progression|0|||
146986544|NCT01595009|530112961|FG003|Core|Disease progression|0|||
146986545|NCT01595009|530112958|FG000|Core|Withdrawal by Subject|4|||
146986546|NCT01595009|530112959|FG001|Core|Withdrawal by Subject|17|||
146986547|NCT01595009|530112960|FG002|Core|Withdrawal by Subject|0|||
146986548|NCT01595009|530112961|FG003|Core|Withdrawal by Subject|0|||
146986549|NCT01595009|530112958|FG000|Core|Death|3|||
146986550|NCT01595009|530112959|FG001|Core|Death|6|||
146986551|NCT01595009|530112960|FG002|Core|Death|0|||
146986552|NCT01595009|530112961|FG003|Core|Death|0|||
146986553|NCT01595009|530112958|FG000|Core|Lost to Follow-up|1|||
146986554|NCT01595009|530112959|FG001|Core|Lost to Follow-up|2|||
146986555|NCT01595009|530112960|FG002|Core|Lost to Follow-up|0|||
146986556|NCT01595009|530112961|FG003|Core|Lost to Follow-up|0|||
146986557|NCT01595009|530112958|FG000|Core|Protocol deviation|0|||
146832112|NCT03783689|529555397|FG000|Overall Study|Physician Decision|2|||
146832113|NCT03783689|529555398|FG001|Overall Study|Physician Decision|1|||
146832114|NCT03783689|529555397|FG000|Overall Study|Withdrawal by Subject|3|||
146832115|NCT03783689|529555398|FG001|Overall Study|Withdrawal by Subject|3|||
146832116|NCT04680637|529555400|FG000|Overall Study|Lost to Follow-up|0|||
146832117|NCT04680637|529555401|FG001|Overall Study|Lost to Follow-up|1|||
146832118|NCT04680637|529555402|FG002|Overall Study|Lost to Follow-up|0|||
146832119|NCT04680637|529555403|FG003|Overall Study|Lost to Follow-up|1|||
146832120|NCT04680637|529555400|FG000|Overall Study|Death|1|||
146832121|NCT04680637|529555401|FG001|Overall Study|Death|0|||
146832122|NCT04680637|529555402|FG002|Overall Study|Death|0|||
146986558|NCT01595009|530112959|FG001|Core|Protocol deviation|1|||
146986559|NCT01595009|530112960|FG002|Core|Protocol deviation|0|||
146986560|NCT01595009|530112961|FG003|Core|Protocol deviation|0|||
146986561|NCT01595009|530112958|FG000|Core|Administrative problems|0|||
146986562|NCT01595009|530112959|FG001|Core|Administrative problems|1|||
146986563|NCT01595009|530112960|FG002|Core|Administrative problems|0|||
146986564|NCT01595009|530112961|FG003|Core|Administrative problems|0|||
146986565|NCT01595009|530112958|FG000|Extension|Administrative problems|0|||
146986566|NCT01595009|530112959|FG001|Extension|Administrative problems|0|||
146986567|NCT01595009|530112960|FG002|Extension|Administrative problems|0|||
146986568|NCT01595009|530112961|FG003|Extension|Administrative problems|1|||
146832123|NCT04680637|529555403|FG003|Overall Study|Death|0|||
146832124|NCT04680637|529555400|FG000|Overall Study|Withdrawal by Subject|7|||
146832125|NCT04680637|529555401|FG001|Overall Study|Withdrawal by Subject|10|||
146832126|NCT04680637|529555402|FG002|Overall Study|Withdrawal by Subject|17|||
146832127|NCT04680637|529555403|FG003|Overall Study|Withdrawal by Subject|15|||
146832128|NCT04680637|529555400|FG000|Overall Study|Decision by Sponsor|21|||
146832129|NCT04680637|529555401|FG001|Overall Study|Decision by Sponsor|15|||
146832130|NCT04680637|529555402|FG002|Overall Study|Decision by Sponsor|7|||
146832131|NCT04680637|529555403|FG003|Overall Study|Decision by Sponsor|32|||
146832132|NCT00691678|529555404|FG000|Overall Study|Adverse Event|5|||
146832133|NCT00691678|529555404|FG000|Overall Study|life events, pain|11|||
146832134|NCT01251887|529555405|FG000|Overall Study|Scheduling conflict|1|||
146832135|NCT01251887|529555406|FG001|Overall Study|Scheduling conflict|2|||
146832136|NCT01251887|529555407|FG002|Overall Study|Scheduling conflict|2|||
146832137|NCT01251887|529555405|FG000|Overall Study|Physician Decision|0|||
146832138|NCT01251887|529555406|FG001|Overall Study|Physician Decision|1|||
146832139|NCT01251887|529555407|FG002|Overall Study|Physician Decision|0|||
146832140|NCT03167151|529556822|FG000|Overall Study|Withdrawal by Subject|1|||
146832141|NCT03167151|529556823|FG001|Overall Study|Withdrawal by Subject|0|||
146832142|NCT03167151|529556824|FG002|Overall Study|Withdrawal by Subject|0|||
146832143|NCT03167151|529556822|FG000|Overall Study|No evidence of tumour at surgery|0|||
146832144|NCT03167151|529556823|FG001|Overall Study|No evidence of tumour at surgery|1|||
146832145|NCT03167151|529556824|FG002|Overall Study|No evidence of tumour at surgery|1|||
146832146|NCT01458522|529556825|FG000|Overall Study|Withdrawal by Subject|2|||
146832147|NCT01458522|529556826|FG001|Overall Study|Withdrawal by Subject|2|||
146832148|NCT01458522|529556825|FG000|Overall Study|Physician Decision|1|||
146832149|NCT01458522|529556826|FG001|Overall Study|Physician Decision|9|||
146832150|NCT00516139|529556827|FG000|Overall Study|Adverse Event|27|||
146832151|NCT00516139|529556827|FG000|Overall Study|Lost to Follow-up|1|||
146832152|NCT00516139|529556827|FG000|Overall Study|Protocol Violation|1|||
146832153|NCT00516139|529556827|FG000|Overall Study|Withdrawal by Subject|8|||
146832154|NCT00516139|529556827|FG000|Overall Study|Lack of Efficacy|1|||
146832155|NCT00416598|529556828|FG000|Induction & Intensification|Adverse Event|38|||
146832156|NCT00416598|529556828|FG000|Induction & Intensification|Death|32|||
146832157|NCT00416598|529556828|FG000|Induction & Intensification|Withdrawal by Subject|46|||
146832158|NCT00416598|529556828|FG000|Induction & Intensification|Alternative Treatment|135|||
146832159|NCT00416598|529556828|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
146832160|NCT00416598|529556828|FG000|Induction & Intensification|Relapse/progression|29|||
146832161|NCT00416598|529556828|FG000|Induction & Intensification|Failed induction|87|||
146832162|NCT00416598|529556828|FG000|Decitabine Maintenance|Adverse Event|5|||
146832163|NCT00416598|529556828|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
146832164|NCT00416598|529556828|FG000|Decitabine Maintenance|Progression/relapse|38|||
146832165|NCT00416598|529556828|FG000|Decitabine Maintenance|Alternative treatment|2|||
146832166|NCT00416598|529556828|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
146832167|NCT02166476|529556835|FG000|Overall Study|Withdrawal by Subject|5|||
146832168|NCT02166476|529556836|FG001|Overall Study|Withdrawal by Subject|7|||
146832169|NCT02166476|529556835|FG000|Overall Study|Adverse Event|3|||
146832170|NCT02166476|529556836|FG001|Overall Study|Adverse Event|3|||
146832171|NCT02166476|529556835|FG000|Overall Study|Lost to Follow-up|5|||
146832172|NCT02166476|529556836|FG001|Overall Study|Lost to Follow-up|10|||
146832173|NCT02166476|529556835|FG000|Overall Study|Physician Decision|1|||
146832174|NCT02166476|529556836|FG001|Overall Study|Physician Decision|0|||
146832175|NCT02166476|529556835|FG000|Overall Study|Unable to Come for Visit|0|||
146832176|NCT02166476|529556836|FG001|Overall Study|Unable to Come for Visit|3|||
146832177|NCT04367480|529556843|FG000|Overall Study|Adverse Event|1|||
146986569|NCT01595009|530112958|FG000|Extension|Patients completed per protocol|0|||
146986570|NCT01595009|530112959|FG001|Extension|Patients completed per protocol|0|||
146986571|NCT01595009|530112960|FG002|Extension|Patients completed per protocol|0|||
146986572|NCT01595009|530112961|FG003|Extension|Patients completed per protocol|2|||
146986573|NCT01595009|530112958|FG000|Extension|Disease progression|0|||
146986574|NCT01595009|530112959|FG001|Extension|Disease progression|0|||
146986575|NCT01595009|530112960|FG002|Extension|Disease progression|4|||
146832178|NCT04367480|529556844|FG001|Overall Study|Adverse Event|1|||
146832179|NCT04367480|529556843|FG000|Overall Study|Death|1|||
146832180|NCT04367480|529556844|FG001|Overall Study|Death|0|||
146832181|NCT04367480|529556843|FG000|Overall Study|Lost to Follow-up|1|||
146832182|NCT04367480|529556844|FG001|Overall Study|Lost to Follow-up|1|||
146832183|NCT04367480|529556843|FG000|Overall Study|Withdrawal by Subject|0|||
146832184|NCT04367480|529556844|FG001|Overall Study|Withdrawal by Subject|3|||
146832185|NCT04367480|529556843|FG000|Overall Study|App glitch during the study|1|||
146832186|NCT04367480|529556844|FG001|Overall Study|App glitch during the study|0|||
146832187|NCT04367480|529556843|FG000|Overall Study|Device Distribution Error|0|||
146832188|NCT04367480|529556844|FG001|Overall Study|Device Distribution Error|2|||
146832189|NCT04367480|529556843|FG000|Overall Study|Ineligible after Randomization|0|||
146832190|NCT04367480|529556844|FG001|Overall Study|Ineligible after Randomization|1|||
146986576|NCT01595009|530112961|FG003|Extension|Disease progression|7|||
146986577|NCT01595009|530112958|FG000|Extension|Adverse Event|0|||
146986578|NCT01595009|530112959|FG001|Extension|Adverse Event|0|||
146986579|NCT01595009|530112960|FG002|Extension|Adverse Event|0|||
146986580|NCT01595009|530112961|FG003|Extension|Adverse Event|1|||
146986581|NCT04956666|530112963|FG000|Overall Study|Adverse Event|18|||
146986582|NCT04956666|530112963|FG000|Overall Study|Physician Decision|5|||
146986583|NCT00783796|530112964|FG000|Overall Study|Did not receive any stent|4|||
146986584|NCT00783796|530112964|FG000|Overall Study|Received non-XIENCE V stent|1|||
146986585|NCT00783796|530112964|FG000|Overall Study|Received commercial XIENCE V stent|1|||
146986586|NCT00626925|530112969|FG000|Overall Study|Lost to Follow-up|1|||
146986587|NCT00626925|530112970|FG001|Overall Study|Lost to Follow-up|2|||
146986588|NCT00626925|530112969|FG000|Overall Study|relapse|1|||
146986589|NCT00626925|530112970|FG001|Overall Study|relapse|0|||
146986590|NCT00626925|530112969|FG000|Overall Study|Adverse effect|6|||
146986591|NCT00626925|530112970|FG001|Overall Study|Adverse effect|2|||
146986592|NCT00626925|530112969|FG000|Overall Study|Lack of Efficacy|1|||
146986593|NCT00626925|530112970|FG001|Overall Study|Lack of Efficacy|4|||
146986594|NCT00626925|530112969|FG000|Overall Study|Time constraints|3|||
146986595|NCT00626925|530112970|FG001|Overall Study|Time constraints|1|||
146986596|NCT01215942|530112973|FG000|Treatment Period|Adverse Event|15|||
146986597|NCT01215942|530112974|FG001|Treatment Period|Adverse Event|26|||
146986598|NCT01215942|530112973|FG000|Treatment Period|Death|2|||
146986599|NCT01215942|530112974|FG001|Treatment Period|Death|4|||
146986600|NCT01215942|530112973|FG000|Treatment Period|Lack of Efficacy|23|||
146986601|NCT01215942|530112974|FG001|Treatment Period|Lack of Efficacy|62|||
146986602|NCT01215942|530112973|FG000|Treatment Period|Lost to Follow-up|3|||
146986603|NCT01215942|530112974|FG001|Treatment Period|Lost to Follow-up|4|||
146986604|NCT01215942|530112973|FG000|Treatment Period|Withdrawal by Subject|17|||
146986605|NCT01215942|530112974|FG001|Treatment Period|Withdrawal by Subject|40|||
146986606|NCT01215942|530112973|FG000|Treatment Period|Physician Decision|5|||
146986607|NCT01215942|530112974|FG001|Treatment Period|Physician Decision|5|||
146986608|NCT01215942|530112973|FG000|Treatment Period|Protocol Violation|0|||
146986609|NCT01215942|530112974|FG001|Treatment Period|Protocol Violation|1|||
146986610|NCT01215942|530112973|FG000|Treatment Period|Sponsor Decision|349|||
146986611|NCT01215942|530112974|FG001|Treatment Period|Sponsor Decision|530|||
146986612|NCT01215942|530112973|FG000|Post-Treatment Follow-Up Period|Death|0|||
146986613|NCT01215942|530112974|FG001|Post-Treatment Follow-Up Period|Death|1|||
146986614|NCT01215942|530112973|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
146986615|NCT01215942|530112974|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
146986616|NCT01215942|530112973|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
146986617|NCT01215942|530112974|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
146986618|NCT01215942|530112973|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
146986619|NCT01215942|530112974|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
146986620|NCT01215942|530112973|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
146986621|NCT01215942|530112974|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
146986622|NCT02162758|530112975|FG000|Overall Study|Study termination|0|||
146986623|NCT02162758|530112976|FG001|Overall Study|Study termination|1|||
146986624|NCT00313703|530114757|FG000|Overall Study|Lost to Follow-up|11|||
146986625|NCT00313703|530114758|FG001|Overall Study|Lost to Follow-up|2|||
146986626|NCT00313703|530114759|FG002|Overall Study|Lost to Follow-up|5|||
146986627|NCT00313703|530114760|FG003|Overall Study|Lost to Follow-up|12|||
146986628|NCT03329027|530114763|FG000|Overall Study|Lost to Follow-up|1|||
146986629|NCT03329027|530114764|FG001|Overall Study|Lost to Follow-up|0|||
146986630|NCT03329027|530114765|FG002|Overall Study|Lost to Follow-up|1|||
146986631|NCT03329027|530114763|FG000|Overall Study|Protocol Violation|9|||
146986632|NCT03329027|530114764|FG001|Overall Study|Protocol Violation|5|||
146986633|NCT03329027|530114765|FG002|Overall Study|Protocol Violation|7|||
146986634|NCT04849988|530114766|FG000|Overall Study|Lack of Efficacy|3|||
146986635|NCT04849988|530114767|FG001|Overall Study|Lack of Efficacy|4|||
146986636|NCT04849988|530114768|FG002|Overall Study|Lack of Efficacy|1|||
146986637|NCT04849988|530114769|FG003|Overall Study|Lack of Efficacy|4|||
146986638|NCT04849988|530114766|FG000|Overall Study|Other reasons|1|||
146986639|NCT04849988|530114767|FG001|Overall Study|Other reasons|2|||
146986640|NCT04849988|530114768|FG002|Overall Study|Other reasons|2|||
146986641|NCT04849988|530114769|FG003|Overall Study|Other reasons|1|||
146986642|NCT02146430|530114774|FG000|Overall Study|Protocol Violation|5|||
146832191|NCT04367480|529556843|FG000|Overall Study|Other Medical Reasons|0|||
146986643|NCT02146430|530114775|FG001|Overall Study|Protocol Violation|4|||
146986644|NCT02146430|530114776|FG002|Overall Study|Protocol Violation|8|||
146986645|NCT02146430|530114777|FG003|Overall Study|Protocol Violation|6|||
146986646|NCT02146430|530114774|FG000|Overall Study|Lack of Efficacy|13|||
146986647|NCT02146430|530114775|FG001|Overall Study|Lack of Efficacy|11|||
146986648|NCT02146430|530114776|FG002|Overall Study|Lack of Efficacy|8|||
146986649|NCT02146430|530114777|FG003|Overall Study|Lack of Efficacy|5|||
146986650|NCT02146430|530114774|FG000|Overall Study|Adverse Event|20|||
146986651|NCT02146430|530114775|FG001|Overall Study|Adverse Event|40|||
146986652|NCT02146430|530114776|FG002|Overall Study|Adverse Event|32|||
146986653|NCT02146430|530114777|FG003|Overall Study|Adverse Event|49|||
146986654|NCT02146430|530114774|FG000|Overall Study|Reason missing or not reported|2|||
146986655|NCT02146430|530114775|FG001|Overall Study|Reason missing or not reported|3|||
146832192|NCT04367480|529556844|FG001|Overall Study|Other Medical Reasons|2|||
146832193|NCT03382561|529556845|FG000|Overall Study|Disease progression|47|||
146832194|NCT03382561|529556846|FG001|Overall Study|Disease progression|6|||
146832195|NCT03382561|529556845|FG000|Overall Study|Adverse Event|10|||
146832196|NCT03382561|529556846|FG001|Overall Study|Adverse Event|2|||
146832197|NCT03382561|529556845|FG000|Overall Study|Death|8|||
146832198|NCT03382561|529556846|FG001|Overall Study|Death|3|||
146832199|NCT03382561|529556845|FG000|Overall Study|Withdrawal by Subject|6|||
146832200|NCT03382561|529556846|FG001|Overall Study|Withdrawal by Subject|5|||
146832201|NCT03382561|529556845|FG000|Overall Study|Alternative therapy|2|||
146832202|NCT03382561|529556846|FG001|Overall Study|Alternative therapy|8|||
146832203|NCT03382561|529556845|FG000|Overall Study|Never started treatment|3|||
146832204|NCT03382561|529556846|FG001|Overall Study|Never started treatment|6|||
146832205|NCT03382561|529556845|FG000|Overall Study|Lack of Efficacy|0|||
146832206|NCT03382561|529556846|FG001|Overall Study|Lack of Efficacy|1|||
146832207|NCT03382561|529556845|FG000|Overall Study|Physician Decision|0|||
146832208|NCT03382561|529556846|FG001|Overall Study|Physician Decision|1|||
146832209|NCT03382561|529556845|FG000|Overall Study|Other complicating disease|0|||
146832210|NCT03382561|529556846|FG001|Overall Study|Other complicating disease|1|||
146832211|NCT01131104|529556847|FG000|Overall Study|Withdrawal by Subject|3|||
146832212|NCT01131104|529556847|FG000|Overall Study|Physician Decision|4|||
146832213|NCT01131104|529556847|FG000|Overall Study|Information Not Available|5|||
146832214|NCT01131104|529556847|FG000|Overall Study|No Information on Index Date of Onset|1|||
146986656|NCT02146430|530114776|FG002|Overall Study|Reason missing or not reported|4|||
146986657|NCT02146430|530114777|FG003|Overall Study|Reason missing or not reported|5|||
146986658|NCT02146430|530114774|FG000|Overall Study|Withdrawal by Subject|27|||
146986659|NCT02146430|530114775|FG001|Overall Study|Withdrawal by Subject|29|||
146986660|NCT02146430|530114776|FG002|Overall Study|Withdrawal by Subject|30|||
146986661|NCT02146430|530114777|FG003|Overall Study|Withdrawal by Subject|34|||
146986662|NCT03312530|530114778|FG000|Overall Study|Death|5|||
146986663|NCT03312530|530114779|FG001|Overall Study|Death|5|||
146986664|NCT03312530|530114780|FG002|Overall Study|Death|4|||
146986665|NCT03312530|530114781|FG003|Overall Study|Death|10|||
146986666|NCT03312530|530114782|FG004|Overall Study|Death|8|||
146986667|NCT03312530|530114778|FG000|Overall Study|Lost to Follow-up|0|||
146986668|NCT03312530|530114779|FG001|Overall Study|Lost to Follow-up|0|||
146986669|NCT03312530|530114780|FG002|Overall Study|Lost to Follow-up|0|||
146986670|NCT03312530|530114781|FG003|Overall Study|Lost to Follow-up|1|||
146986671|NCT03312530|530114782|FG004|Overall Study|Lost to Follow-up|0|||
146986672|NCT03312530|530114778|FG000|Overall Study|Participant in another sponsor study.|0|||
146986673|NCT03312530|530114779|FG001|Overall Study|Participant in another sponsor study.|0|||
146986674|NCT03312530|530114780|FG002|Overall Study|Participant in another sponsor study.|0|||
146986675|NCT03312530|530114781|FG003|Overall Study|Participant in another sponsor study.|1|||
146986676|NCT03312530|530114782|FG004|Overall Study|Participant in another sponsor study.|0|||
146986677|NCT03312530|530114778|FG000|Overall Study|Study terminated by sponsor|1|||
146986678|NCT03312530|530114779|FG001|Overall Study|Study terminated by sponsor|0|||
146986679|NCT03312530|530114780|FG002|Overall Study|Study terminated by sponsor|2|||
146986680|NCT03312530|530114781|FG003|Overall Study|Study terminated by sponsor|3|||
146986681|NCT03312530|530114782|FG004|Overall Study|Study terminated by sponsor|7|||
146986682|NCT03312530|530114778|FG000|Overall Study|Withdrawal by Subject|0|||
146986683|NCT03312530|530114779|FG001|Overall Study|Withdrawal by Subject|1|||
146986684|NCT03312530|530114780|FG002|Overall Study|Withdrawal by Subject|0|||
146986685|NCT03312530|530114781|FG003|Overall Study|Withdrawal by Subject|0|||
146986686|NCT03312530|530114782|FG004|Overall Study|Withdrawal by Subject|0|||
146986687|NCT03312530|530114778|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
146986688|NCT03312530|530114779|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
146986689|NCT03312530|530114780|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
146986690|NCT03312530|530114781|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
146986691|NCT03312530|530114782|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
146986692|NCT01691859|530114787|FG000|Overall Study|Adverse Event|19|||
146986693|NCT01691859|530114787|FG000|Overall Study|Lack of Efficacy|11|||
146986694|NCT01691859|530114787|FG000|Overall Study|Protocol Violation|4|||
146986695|NCT01691859|530114787|FG000|Overall Study|Product commercially available|221|||
146986696|NCT01691859|530114787|FG000|Overall Study|Study closed/terminated|50|||
146986697|NCT01691859|530114787|FG000|Overall Study|Lost to Follow-up|5|||
146986698|NCT01691859|530114787|FG000|Overall Study|Physician Decision|6|||
146832215|NCT04836559|529556849|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
146832216|NCT04836559|529556850|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
146832217|NCT04836559|529556851|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
146832218|NCT04836559|529556852|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
146832219|NCT04836559|529556853|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
146832220|NCT04836559|529556854|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
146986699|NCT01691859|530114787|FG000|Overall Study|Withdrawal by Subject|31|||
146986700|NCT03519256|530114791|FG000|Overall Study|Disease recurrence|4|||
146986701|NCT03519256|530114792|FG001|Overall Study|Disease recurrence|4|||
146986702|NCT03519256|530114793|FG002|Overall Study|Disease recurrence|5|||
146986703|NCT03519256|530114794|FG003|Overall Study|Disease recurrence|2|||
146986704|NCT03519256|530114791|FG000|Overall Study|Study drug toxicity|0|||
146986705|NCT03519256|530114792|FG001|Overall Study|Study drug toxicity|2|||
146986706|NCT03519256|530114793|FG002|Overall Study|Study drug toxicity|5|||
146986707|NCT03519256|530114794|FG003|Overall Study|Study drug toxicity|2|||
146986708|NCT03519256|530114791|FG000|Overall Study|Adverse event unrelated to study drug|0|||
146986709|NCT03519256|530114792|FG001|Overall Study|Adverse event unrelated to study drug|1|||
146986710|NCT03519256|530114793|FG002|Overall Study|Adverse event unrelated to study drug|1|||
146986711|NCT03519256|530114794|FG003|Overall Study|Adverse event unrelated to study drug|0|||
146986712|NCT03519256|530114791|FG000|Overall Study|Participant request to discontinue study treatment|0|||
146986713|NCT03519256|530114792|FG001|Overall Study|Participant request to discontinue study treatment|0|||
146986714|NCT03519256|530114793|FG002|Overall Study|Participant request to discontinue study treatment|0|||
146986715|NCT03519256|530114794|FG003|Overall Study|Participant request to discontinue study treatment|2|||
146986716|NCT03519256|530114791|FG000|Overall Study|Other reasons|0|||
146986717|NCT03519256|530114792|FG001|Overall Study|Other reasons|0|||
146986718|NCT03519256|530114793|FG002|Overall Study|Other reasons|2|||
146986719|NCT03519256|530114794|FG003|Overall Study|Other reasons|0|||
146986720|NCT03519256|530114791|FG000|Overall Study|Disease progression|6|||
146986721|NCT03519256|530114792|FG001|Overall Study|Disease progression|3|||
146986722|NCT03519256|530114793|FG002|Overall Study|Disease progression|2|||
146986723|NCT03519256|530114794|FG003|Overall Study|Disease progression|1|||
146986724|NCT03519256|530114791|FG000|Overall Study|Lost to Follow-up|0|||
146986725|NCT03519256|530114792|FG001|Overall Study|Lost to Follow-up|1|||
146986726|NCT03519256|530114793|FG002|Overall Study|Lost to Follow-up|0|||
146986727|NCT03519256|530114794|FG003|Overall Study|Lost to Follow-up|0|||
146986728|NCT02524379|530114803|FG000|Overall Study|Death|1|||
146986729|NCT00812253|530114804|FG000|Overall Study|Withdrawal by Subject|3|||
146986730|NCT00812253|530114805|FG001|Overall Study|Withdrawal by Subject|2|||
146986731|NCT00812253|530114804|FG000|Overall Study|Protocol Violation|1|||
146986732|NCT00812253|530114805|FG001|Overall Study|Protocol Violation|1|||
146986733|NCT00812253|530114804|FG000|Overall Study|Lost to Follow-up|2|||
146986734|NCT00812253|530114805|FG001|Overall Study|Lost to Follow-up|0|||
146986735|NCT01884025|530114806|FG000|Overall Study|Lost to Follow-up|3|||
146986736|NCT01884025|530114807|FG001|Overall Study|Lost to Follow-up|4|||
146986737|NCT02655237|530114808|FG000|Overall Study|Adverse Event|10|||
146986738|NCT02655237|530114809|FG001|Overall Study|Adverse Event|7|||
146986739|NCT02655237|530114808|FG000|Overall Study|Protocol Deviation|2|||
146986740|NCT02655237|530114809|FG001|Overall Study|Protocol Deviation|0|||
146986741|NCT02655237|530114808|FG000|Overall Study|Withdrawal by Participant|1|||
146986742|NCT02655237|530114809|FG001|Overall Study|Withdrawal by Participant|2|||
146986743|NCT02655237|530114808|FG000|Overall Study|Lack of Efficacy|0|||
146986744|NCT02655237|530114809|FG001|Overall Study|Lack of Efficacy|1|||
146986745|NCT02655237|530114808|FG000|Overall Study|Recovery Leading to Surgery|2|||
146986746|NCT02655237|530114809|FG001|Overall Study|Recovery Leading to Surgery|1|||
146986747|NCT02655237|530114808|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
146986748|NCT02655237|530114809|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
146986749|NCT02655237|530114808|FG000|Overall Study|Randomized but Not Treated|1|||
146986750|NCT02655237|530114809|FG001|Overall Study|Randomized but Not Treated|0|||
146986751|NCT03679741|530114810|FG000|Period 1|No longer meet eligibility criteria|1|||
146986752|NCT03679741|530114811|FG001|Period 1|No longer meet eligibility criteria|0|||
146986753|NCT03679741|530114810|FG000|Period 1|Lost to Follow-up|0|||
146986754|NCT03679741|530114811|FG001|Period 1|Lost to Follow-up|1|||
146986755|NCT03679741|530114810|FG000|Period 1|Adverse Event|1|||
146986756|NCT03679741|530114811|FG001|Period 1|Adverse Event|1|||
146986757|NCT03679741|530114810|FG000|Period 1|Withdrawal by Subject|0|||
146986758|NCT03679741|530114811|FG001|Period 1|Withdrawal by Subject|1|||
146986759|NCT03679741|530114810|FG000|Period 2|Adverse Event|2|||
146986760|NCT03679741|530114811|FG001|Period 2|Adverse Event|1|||
146986761|NCT03679741|530114810|FG000|Period 2|Withdrawal by Subject|1|||
146986762|NCT03679741|530114811|FG001|Period 2|Withdrawal by Subject|1|||
146986763|NCT02750761|530114816|FG000|Overall Study|Lost to Follow-up|0|||
146986764|NCT02750761|530114817|FG001|Overall Study|Lost to Follow-up|0|||
146986765|NCT02750761|530114818|FG002|Overall Study|Lost to Follow-up|1|||
146986766|NCT02750761|530114819|FG003|Overall Study|Lost to Follow-up|0|||
146986767|NCT02750761|530114820|FG004|Overall Study|Lost to Follow-up|0|||
146986768|NCT02750761|530114821|FG005|Overall Study|Lost to Follow-up|0|||
146986769|NCT00729859|530114822|FG000|Overall Study|Adverse Event|0|||
146986770|NCT00729859|530114823|FG001|Overall Study|Adverse Event|1|||
146986771|NCT00729859|530114824|FG002|Overall Study|Adverse Event|0|||
146986772|NCT00729859|530114822|FG000|Overall Study|Withdrawal by Subject|0|||
146986773|NCT00729859|530114823|FG001|Overall Study|Withdrawal by Subject|1|||
146986774|NCT00729859|530114824|FG002|Overall Study|Withdrawal by Subject|0|||
146986775|NCT02623829|530114831|FG000|Overall Study|Lost to Follow-up|1|||
146986776|NCT02623829|530114832|FG001|Overall Study|Lost to Follow-up|1|||
146958530|NCT00421928|530007841|FG002|Overall Study|Withdrawal by Subject|43|||
146958531|NCT00421928|530007839|FG000|Overall Study|Lack of Efficacy|15|||
146958532|NCT00421928|530007840|FG001|Overall Study|Lack of Efficacy|7|||
146958533|NCT00421928|530007841|FG002|Overall Study|Lack of Efficacy|35|||
146958534|NCT00421928|530007839|FG000|Overall Study|Study drug non-compliant|6|||
146958535|NCT00421928|530007840|FG001|Overall Study|Study drug non-compliant|7|||
146958536|NCT00421928|530007841|FG002|Overall Study|Study drug non-compliant|4|||
146958537|NCT00421928|530007839|FG000|Overall Study|All other|26|||
146958538|NCT00421928|530007840|FG001|Overall Study|All other|21|||
146958539|NCT00421928|530007841|FG002|Overall Study|All other|27|||
146958540|NCT00421928|530007839|FG000|Overall Study|Death|0|||
146958541|NCT00421928|530007840|FG001|Overall Study|Death|1|||
146958542|NCT00421928|530007841|FG002|Overall Study|Death|0|||
146958543|NCT04120116|530007855|FG000|Overall Study|Lost to Follow-up|0|||
146958544|NCT04120116|530007856|FG001|Overall Study|Lost to Follow-up|1|||
146958545|NCT04120116|530007857|FG002|Overall Study|Lost to Follow-up|0|||
146958546|NCT04120116|530007858|FG003|Overall Study|Lost to Follow-up|2|||
146958547|NCT04120116|530007855|FG000|Overall Study|Withdrawal by Subject|1|||
146958548|NCT04120116|530007856|FG001|Overall Study|Withdrawal by Subject|0|||
146958549|NCT04120116|530007857|FG002|Overall Study|Withdrawal by Subject|1|||
146958550|NCT04120116|530007858|FG003|Overall Study|Withdrawal by Subject|1|||
146958551|NCT04120116|530007855|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
146958552|NCT04120116|530007856|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
146958553|NCT04120116|530007857|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
146958554|NCT04120116|530007858|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
146958555|NCT05111548|530007860|FG000|Overall Study|Withdrawal by Subject|2|||
146958556|NCT05111548|530007861|FG001|Overall Study|Withdrawal by Subject|1|||
146958557|NCT05111548|530007860|FG000|Overall Study|Adverse Event|1|||
146958558|NCT05111548|530007861|FG001|Overall Study|Adverse Event|0|||
146958559|NCT01846039|530007862|FG000|Overall Study|Protocol Violation|1|||
146958560|NCT01846039|530007862|FG000|Overall Study|Subject Withdrew Consent|1|||
146958561|NCT01855607|530007873|FG000|Overall Study|Withdrawal by Subject|1|||
146958562|NCT01855607|530007873|FG000|Overall Study|Study was terminated|11|||
146958563|NCT02181634|530007874|FG000|Overall Study|Lack of Efficacy|33|||
146958564|NCT02181634|530007874|FG000|Overall Study|Adverse Event|17|||
146958565|NCT02181634|530007874|FG000|Overall Study|Physician Decision|8|||
146958566|NCT02181634|530007874|FG000|Overall Study|Withdrawal by Subject|5|||
146958567|NCT02181634|530007874|FG000|Overall Study|Death|2|||
146958568|NCT02181634|530007874|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
146958569|NCT02181634|530007874|FG000|Overall Study|Ineligible|1|||
146958570|NCT02181634|530007874|FG000|Overall Study|Max number of dose reduction|1|||
146958571|NCT02181634|530007874|FG000|Overall Study|Symptomatic progression|1|||
146958572|NCT02181634|530007874|FG000|Overall Study|Patient opted to proceed to surgery|1|||
146958573|NCT02528331|530007875|FG000|Overall Study|Withdrawal by Subject|2|||
146958574|NCT02392078|530007876|FG000|Overall Study|Did not have procedure|32|||
146958575|NCT02392078|530007877|FG001|Overall Study|Did not have procedure|43|||
146958576|NCT02392078|530007878|FG002|Overall Study|Did not have procedure|20|||
146958577|NCT02392078|530007879|FG003|Overall Study|Did not have procedure|1|||
146958578|NCT00779142|530007883|FG000|Overall Study|Screen Failures|3|||
146958579|NCT00672490|530007884|FG000|Overall Study|Withdrawal by Subject|8|||
146958580|NCT00672490|530007885|FG001|Overall Study|Withdrawal by Subject|8|||
146958581|NCT00672490|530007884|FG000|Overall Study|Lack of Compliance|2|||
146958582|NCT00672490|530007885|FG001|Overall Study|Lack of Compliance|7|||
146958583|NCT00672490|530007884|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
146958584|NCT00672490|530007885|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
146958585|NCT00672490|530007884|FG000|Overall Study|Adverse Event|5|||
146958586|NCT00672490|530007885|FG001|Overall Study|Adverse Event|8|||
146958587|NCT00672490|530007884|FG000|Overall Study|Violation of Concomitant Medicine|1|||
146958588|NCT00672490|530007885|FG001|Overall Study|Violation of Concomitant Medicine|0|||
146958589|NCT00672490|530007884|FG000|Overall Study|Intolerance|0|||
146958590|NCT00672490|530007885|FG001|Overall Study|Intolerance|2|||
146958591|NCT00672490|530007884|FG000|Overall Study|Lost to Follow-up|1|||
146958592|NCT00672490|530007885|FG001|Overall Study|Lost to Follow-up|5|||
146958593|NCT00672490|530007884|FG000|Overall Study|No reason was provided|6|||
146958594|NCT00672490|530007885|FG001|Overall Study|No reason was provided|2|||
146958595|NCT04738123|530007889|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
146958596|NCT04738123|530007890|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
146958597|NCT04738123|530007889|FG000|Overall Study|Progressive Disease|0|||
146958598|NCT04738123|530007890|FG001|Overall Study|Progressive Disease|4|||
146958599|NCT04738123|530007889|FG000|Overall Study|Adverse Event|8|||
146958600|NCT04738123|530007890|FG001|Overall Study|Adverse Event|7|||
146958601|NCT04738123|530007889|FG000|Overall Study|Other Reasons|0|||
146958602|NCT04738123|530007890|FG001|Overall Study|Other Reasons|1|||
146958603|NCT04738123|530007889|FG000|Overall Study|Suicidal or assaultive behavior|0|||
146958604|NCT04738123|530007890|FG001|Overall Study|Suicidal or assaultive behavior|2|||
146832221|NCT04836559|529556855|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
146832222|NCT04836559|529556856|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
146832223|NCT04836559|529556849|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
146832224|NCT04836559|529556850|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
146832225|NCT04836559|529556851|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
146832226|NCT04836559|529556852|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
146832227|NCT04836559|529556853|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
146832228|NCT04836559|529556854|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
146832229|NCT04836559|529556855|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
146832230|NCT04836559|529556856|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
146832231|NCT04836559|529556849|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
146832232|NCT04836559|529556850|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
146832233|NCT04836559|529556851|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
146832234|NCT04836559|529556852|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
146832235|NCT04836559|529556853|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
146832236|NCT04836559|529556854|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
146832237|NCT04836559|529556855|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
146832238|NCT04836559|529556856|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
146832239|NCT04836559|529556849|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
146832240|NCT04836559|529556850|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
146832241|NCT04836559|529556851|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
146832242|NCT04836559|529556852|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
146832243|NCT04836559|529556853|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
146832244|NCT04836559|529556854|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
146832245|NCT04836559|529556855|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
146832246|NCT04836559|529556856|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
146832247|NCT04836559|529556849|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
146958605|NCT04738123|530007889|FG000|Overall Study|Protocol Violation|2|||
146958606|NCT04738123|530007890|FG001|Overall Study|Protocol Violation|2|||
146958607|NCT04738123|530007889|FG000|Overall Study|Consent Withdrawn|35|||
146958608|NCT04738123|530007890|FG001|Overall Study|Consent Withdrawn|22|||
146958609|NCT04047472|530007891|FG000|Overall Study|Adverse Event|3|||
146958610|NCT04047472|530007892|FG001|Overall Study|Adverse Event|3|||
146958611|NCT04047472|530007891|FG000|Overall Study|Death|0|||
146958612|NCT04047472|530007892|FG001|Overall Study|Death|1|||
146958613|NCT04047472|530007891|FG000|Overall Study|Lost to Follow-up|1|||
146958614|NCT04047472|530007892|FG001|Overall Study|Lost to Follow-up|0|||
146958615|NCT04047472|530007891|FG000|Overall Study|Physician Decision|1|||
146958616|NCT04047472|530007892|FG001|Overall Study|Physician Decision|2|||
146958617|NCT04047472|530007891|FG000|Overall Study|Protocol Violation|1|||
146958618|NCT04047472|530007892|FG001|Overall Study|Protocol Violation|0|||
146958619|NCT04047472|530007891|FG000|Overall Study|Withdrawal by Subject|10|||
146958620|NCT04047472|530007892|FG001|Overall Study|Withdrawal by Subject|10|||
146958621|NCT01288911|530007893|FG000|Double-blind Period|Death|11|||
146958622|NCT01288911|530007894|FG001|Double-blind Period|Death|7|||
146958623|NCT01288911|530007893|FG000|Double-blind Period|Lost to Follow-up|0|||
146958624|NCT01288911|530007894|FG001|Double-blind Period|Lost to Follow-up|2|||
146958625|NCT01288911|530007893|FG000|Double-blind Period|Progressive Disease|75|||
146958626|NCT01288911|530007894|FG001|Double-blind Period|Progressive Disease|103|||
146958627|NCT01288911|530007893|FG000|Double-blind Period|Protocol Violation|1|||
146958628|NCT01288911|530007894|FG001|Double-blind Period|Protocol Violation|0|||
146958629|NCT01288911|530007893|FG000|Double-blind Period|Withdrawal by Subject|25|||
146958630|NCT01288911|530007894|FG001|Double-blind Period|Withdrawal by Subject|26|||
146958631|NCT01288911|530007893|FG000|Double-blind Period|Miscellaneous Reason|29|||
146958632|NCT01288911|530007894|FG001|Double-blind Period|Miscellaneous Reason|42|||
146958633|NCT01288911|530007893|FG000|Double-blind Period|Randomized but never received study drug|1|||
146958634|NCT01288911|530007894|FG001|Double-blind Period|Randomized but never received study drug|2|||
146958635|NCT01288911|530007893|FG000|Open-label Period (All Enzalutamide)|Death|0|||
146958636|NCT01288911|530007894|FG001|Open-label Period (All Enzalutamide)|Death|1|||
146958637|NCT01288911|530007893|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
146958638|NCT01288911|530007894|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
146958639|NCT01288911|530007893|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
146958640|NCT01288911|530007894|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
146958641|NCT01288911|530007893|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
146958642|NCT01288911|530007894|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
146958643|NCT01288911|530007893|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
146958644|NCT01288911|530007894|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
146958645|NCT01288911|530007893|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
146958646|NCT01288911|530007894|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
146958647|NCT00486720|530007895|FG000|Overall Study|Adverse Event|1|||
146986777|NCT00662025|530114833|FG000|Overall Study|Objective progression or relapse|51|||
146986778|NCT00662025|530114833|FG000|Overall Study|Adverse Event|7|||
146986779|NCT00662025|530114833|FG000|Overall Study|Withdrawal by Subject|1|||
146986780|NCT00662025|530114833|FG000|Overall Study|Results of other clinical study|2|||
146986781|NCT00662025|530114833|FG000|Overall Study|Target lesion cannot be evaluated|1|||
146986782|NCT00662025|530114833|FG000|Overall Study|Domestic circumstances|1|||
146986783|NCT01700621|530114834|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
146986784|NCT01700621|530114835|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
146986785|NCT01700621|530114834|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
146986786|NCT01700621|530114835|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
146986787|NCT01700621|530114834|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
146986788|NCT01700621|530114835|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
146986789|NCT02035137|530114838|FG000|Overall Study|Physician Decision|0|||
146986790|NCT02035137|530114839|FG001|Overall Study|Physician Decision|0|||
146986791|NCT02035137|530114840|FG002|Overall Study|Physician Decision|1|||
146986792|NCT02035137|530114838|FG000|Overall Study|Withdrawal by Subject|0|||
146986793|NCT02035137|530114839|FG001|Overall Study|Withdrawal by Subject|1|||
146986794|NCT02035137|530114840|FG002|Overall Study|Withdrawal by Subject|2|||
146986795|NCT02035137|530114838|FG000|Overall Study|Ineligible|0|||
146986796|NCT02035137|530114839|FG001|Overall Study|Ineligible|1|||
146986797|NCT02035137|530114840|FG002|Overall Study|Ineligible|2|||
146986798|NCT02035137|530114838|FG000|Overall Study|Disease progression prior to treatment start|2|||
146986799|NCT02035137|530114839|FG001|Overall Study|Disease progression prior to treatment start|0|||
146986800|NCT02035137|530114840|FG002|Overall Study|Disease progression prior to treatment start|0|||
146986801|NCT03349333|530114847|FG000|Overall Study|Progression of Disease|36|||
146986802|NCT03349333|530114847|FG000|Overall Study|Adverse Event|11|||
146986803|NCT03349333|530114847|FG000|Overall Study|Other|6|||
146986804|NCT03349333|530114847|FG000|Overall Study|Withdrawal by Subject|5|||
146986805|NCT03349333|530114847|FG000|Overall Study|Conditions interfere with participation|2|||
146986806|NCT03349333|530114847|FG000|Overall Study|Physician Decision|2|||
146986807|NCT03349333|530114847|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
146986808|NCT03349333|530114847|FG000|Overall Study|Patients in treatment less than 24 month|8|||
146986809|NCT02985151|530114848|FG000|Original Randomization|Withdrawal by Subject|0|||
146986810|NCT02985151|530114849|FG001|Original Randomization|Withdrawal by Subject|1|||
146986811|NCT00290745|530114850|FG000|Overall Study|Withdrawal by Subject|4|||
146986812|NCT00290745|530114850|FG000|Overall Study|Physician Decision|2|||
146986813|NCT00290745|530114850|FG000|Overall Study|Surgery after 3 months for progression|3|||
146986814|NCT00290745|530114850|FG000|Overall Study|Baseline MRI not available|3|||
146986815|NCT00113490|530114854|FG000|Overall Study|Withdrawal by Subject|1|||
146986816|NCT00113490|530114855|FG001|Overall Study|Withdrawal by Subject|3|||
146986817|NCT00113490|530114854|FG000|Overall Study|Lost to Follow-up|1|||
146986818|NCT00113490|530114855|FG001|Overall Study|Lost to Follow-up|0|||
146986819|NCT00819247|530114856|FG000|Overall Study|Adverse Event|0|||
146986820|NCT00819247|530114857|FG001|Overall Study|Adverse Event|5|||
146986821|NCT00819247|530114858|FG002|Overall Study|Adverse Event|3|||
146986822|NCT00819247|530114856|FG000|Overall Study|Insufficient testosterone response|5|||
146986823|NCT00819247|530114857|FG001|Overall Study|Insufficient testosterone response|8|||
146986824|NCT00819247|530114858|FG002|Overall Study|Insufficient testosterone response|10|||
146986825|NCT00819247|530114856|FG000|Overall Study|Withdrawal by Subject|1|||
146986826|NCT00819247|530114857|FG001|Overall Study|Withdrawal by Subject|0|||
146986827|NCT00819247|530114858|FG002|Overall Study|Withdrawal by Subject|0|||
146986828|NCT00819247|530114856|FG000|Overall Study|Protocol Violation|1|||
146986829|NCT00819247|530114857|FG001|Overall Study|Protocol Violation|0|||
146986830|NCT00819247|530114858|FG002|Overall Study|Protocol Violation|1|||
146986831|NCT00819247|530114856|FG000|Overall Study|Mistakenly withdrawn|0|||
146986832|NCT00819247|530114857|FG001|Overall Study|Mistakenly withdrawn|1|||
146986833|NCT00819247|530114858|FG002|Overall Study|Mistakenly withdrawn|0|||
146986834|NCT00819247|530114856|FG000|Overall Study|Bad prostate-specific antigen response|3|||
146986835|NCT00819247|530114857|FG001|Overall Study|Bad prostate-specific antigen response|2|||
146986836|NCT00819247|530114858|FG002|Overall Study|Bad prostate-specific antigen response|0|||
146986837|NCT00819247|530114856|FG000|Overall Study|Other|1|||
146986838|NCT00819247|530114857|FG001|Overall Study|Other|0|||
146986839|NCT00819247|530114858|FG002|Overall Study|Other|0|||
146986840|NCT04471935|530114859|FG000|Overall Study|Withdrawal by Subject|1|||
146986841|NCT04471935|530114859|FG000|Overall Study|Deemed ineligible to participate|1|||
146986842|NCT01766921|530114864|FG000|Overall Study|Administrative Reason|5|||
146986843|NCT01766921|530114865|FG001|Overall Study|Administrative Reason|5|||
146986844|NCT01766921|530114864|FG000|Overall Study|Death|1|||
146986845|NCT01766921|530114865|FG001|Overall Study|Death|1|||
146986846|NCT01766921|530114864|FG000|Overall Study|Lost to Follow-up|1|||
146986847|NCT01766921|530114865|FG001|Overall Study|Lost to Follow-up|3|||
146986848|NCT01766921|530114864|FG000|Overall Study|Unclassified|2|||
146986849|NCT01766921|530114865|FG001|Overall Study|Unclassified|2|||
146986850|NCT01766921|530114864|FG000|Overall Study|Protocol Violation|1|||
146986851|NCT01766921|530114865|FG001|Overall Study|Protocol Violation|1|||
146986852|NCT01766921|530114864|FG000|Overall Study|Withdrawal by Subject|14|||
146986853|NCT01766921|530114865|FG001|Overall Study|Withdrawal by Subject|5|||
146986854|NCT00708422|530114866|FG000|Overall Study|Adverse Event|3|||
146986855|NCT00708422|530114867|FG001|Overall Study|Adverse Event|1|||
146986856|NCT00708422|530114866|FG000|Overall Study|Withdrawal by Subject|1|||
146986857|NCT00708422|530114867|FG001|Overall Study|Withdrawal by Subject|0|||
146986858|NCT05476679|530114871|FG000|Overall Study|Withdrawal by Subject|0|||
146986859|NCT05476679|530114872|FG001|Overall Study|Withdrawal by Subject|0|||
146986860|NCT05476679|530114873|FG002|Overall Study|Withdrawal by Subject|0|||
146986861|NCT05476679|530114874|FG003|Overall Study|Withdrawal by Subject|1|||
146986862|NCT05476679|530114875|FG004|Overall Study|Withdrawal by Subject|0|||
146986863|NCT05476679|530114871|FG000|Overall Study|Lost to Follow-up|0|||
146986864|NCT05476679|530114872|FG001|Overall Study|Lost to Follow-up|0|||
146986865|NCT05476679|530114873|FG002|Overall Study|Lost to Follow-up|0|||
146986866|NCT05476679|530114874|FG003|Overall Study|Lost to Follow-up|1|||
146986867|NCT05476679|530114875|FG004|Overall Study|Lost to Follow-up|0|||
146986868|NCT00601354|530114876|FG000|Overall Study|Lost to Follow-up|4|||
146986869|NCT00601354|530114877|FG001|Overall Study|Lost to Follow-up|5|||
146986870|NCT00278512|530114879|FG000|Overall Study|Death|1|||
146986871|NCT00278512|530114880|FG001|Overall Study|Death|0|||
146986872|NCT01620177|530114881|FG000|Overall Study|Failure at Screening Visit|43|||
146986873|NCT01620177|530114881|FG000|Overall Study|Withdrawal by Subject|26|||
146986874|NCT01620177|530114881|FG000|Overall Study|Lost to Follow-up|7|||
146986875|NCT01620177|530114881|FG000|Overall Study|Physician Decision|2|||
146986876|NCT01620177|530114881|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
146986877|NCT01789320|530114885|FG000|Overall Study|Re-enrolled into study|1|||
146986878|NCT01789320|530114885|FG000|Overall Study|Lost to Follow-up|1|||
146986879|NCT00619385|530114890|FG000|Overall Study|Adverse Event|0|||
146986880|NCT00619385|530114891|FG001|Overall Study|Adverse Event|0|||
146986881|NCT00619385|530114892|FG002|Overall Study|Adverse Event|3|||
146986882|NCT00619385|530114890|FG000|Overall Study|Other|1|||
146986883|NCT00619385|530114891|FG001|Overall Study|Other|2|||
146986884|NCT00619385|530114892|FG002|Overall Study|Other|1|||
146986885|NCT03730103|530114893|FG000|Overall Study|Did not meet inclusion criteria|0|||
146986886|NCT03730103|530114894|FG001|Overall Study|Did not meet inclusion criteria|5|||
146986887|NCT02626949|530114895|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
146986888|NCT02626949|530114896|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
146986889|NCT02626949|530114895|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
146986890|NCT02626949|530114896|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
146986891|NCT02626949|530114895|FG000|Enrolled|Lost to Follow-up|7|||
146986892|NCT02626949|530114896|FG001|Enrolled|Lost to Follow-up|6|||
146986893|NCT02626949|530114895|FG000|Enrolled|Withdrawal by Subject|3|||
146986894|NCT02626949|530114896|FG001|Enrolled|Withdrawal by Subject|2|||
146986895|NCT02789111|530114897|FG000|Overall Study|Withdrawal by Subject|1|||
146986896|NCT02789111|530114898|FG001|Overall Study|Withdrawal by Subject|4|||
146986897|NCT01488578|530114899|FG000|Overall Study|Protocol Violation|1836|||
146986898|NCT02308111|530114900|FG000|Overall Study|Adverse Event|31|||
146986899|NCT02308111|530114901|FG001|Overall Study|Adverse Event|19|||
146986900|NCT02308111|530114900|FG000|Overall Study|Death|9|||
146986901|NCT02308111|530114901|FG001|Overall Study|Death|6|||
146986902|NCT02308111|530114900|FG000|Overall Study|Lost to Follow-up|2|||
146986903|NCT02308111|530114901|FG001|Overall Study|Lost to Follow-up|7|||
146986904|NCT02308111|530114900|FG000|Overall Study|Physician Decision|6|||
146986905|NCT02308111|530114901|FG001|Overall Study|Physician Decision|17|||
146986906|NCT02308111|530114900|FG000|Overall Study|Protocol Violation|0|||
146986907|NCT02308111|530114901|FG001|Overall Study|Protocol Violation|1|||
146986908|NCT02308111|530114900|FG000|Overall Study|Withdrawal by Subject|28|||
146986909|NCT02308111|530114901|FG001|Overall Study|Withdrawal by Subject|38|||
146832248|NCT04836559|529556850|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
146832249|NCT04836559|529556851|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
146986910|NCT02308111|530114900|FG000|Overall Study|Study Terminated by Sponsor|72|||
146986911|NCT02308111|530114901|FG001|Overall Study|Study Terminated by Sponsor|61|||
146832250|NCT04836559|529556852|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
146832251|NCT04836559|529556853|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
146986912|NCT02308111|530114900|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
146986913|NCT02308111|530114901|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
146986914|NCT02308111|530114900|FG000|Overall Study|Site Closure|3|||
146986915|NCT02308111|530114901|FG001|Overall Study|Site Closure|3|||
146986916|NCT02308111|530114900|FG000|Overall Study|Non-compliance with Study Drug|3|||
146986917|NCT02308111|530114901|FG001|Overall Study|Non-compliance with Study Drug|1|||
146986918|NCT02308111|530114900|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
146986919|NCT02308111|530114901|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
146986920|NCT02308111|530114900|FG000|Overall Study|Liver Transplant|3|||
146986921|NCT02308111|530114901|FG001|Overall Study|Liver Transplant|3|||
146986922|NCT02308111|530114900|FG000|Overall Study|Liver Transplant Waitlist|2|||
146832252|NCT04836559|529556854|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
146832253|NCT04836559|529556855|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
146832254|NCT04836559|529556856|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
146832255|NCT04836559|529556849|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
146832256|NCT04836559|529556850|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
146832257|NCT04836559|529556851|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
146832258|NCT04836559|529556852|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
146832259|NCT04836559|529556853|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
146832260|NCT04836559|529556854|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
146832261|NCT04836559|529556855|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
146832262|NCT04836559|529556856|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
146832263|NCT04836559|529556849|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
146832264|NCT04836559|529556850|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
146832265|NCT04836559|529556851|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
146832266|NCT04836559|529556852|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
146832267|NCT04836559|529556853|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
146832268|NCT04836559|529556854|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
146832269|NCT04836559|529556855|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
146832270|NCT04836559|529556856|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
146832271|NCT04836559|529556849|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
146832272|NCT04836559|529556850|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
146832273|NCT04836559|529556851|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
146832274|NCT04836559|529556852|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
146832275|NCT04836559|529556853|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
146832276|NCT04836559|529556854|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
146832277|NCT04836559|529556855|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
146832278|NCT04836559|529556856|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
146832279|NCT04836559|529556849|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
146832280|NCT04836559|529556850|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
146832281|NCT04836559|529556851|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
146832282|NCT04836559|529556852|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
146832283|NCT04836559|529556853|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
146832284|NCT04836559|529556854|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
146832285|NCT04836559|529556855|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
146832286|NCT04836559|529556856|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
146832287|NCT00730015|529556857|FG000|Overall Study|Adverse Event|11|||
146832288|NCT00730015|529556858|FG001|Overall Study|Adverse Event|10|||
146832289|NCT00730015|529556859|FG002|Overall Study|Adverse Event|8|||
146832290|NCT00730015|529556857|FG000|Overall Study|Protocol Violation|2|||
146832291|NCT00730015|529556858|FG001|Overall Study|Protocol Violation|6|||
146832292|NCT00730015|529556859|FG002|Overall Study|Protocol Violation|4|||
146832293|NCT00730015|529556857|FG000|Overall Study|Withdrawal by Subject|12|||
146832294|NCT00730015|529556858|FG001|Overall Study|Withdrawal by Subject|12|||
146832295|NCT00730015|529556859|FG002|Overall Study|Withdrawal by Subject|8|||
146832296|NCT00730015|529556857|FG000|Overall Study|Lost to Follow-up|4|||
146832297|NCT00730015|529556858|FG001|Overall Study|Lost to Follow-up|10|||
146832298|NCT00730015|529556859|FG002|Overall Study|Lost to Follow-up|3|||
146832299|NCT00730015|529556857|FG000|Overall Study|Lack of Efficacy|1|||
146832300|NCT00730015|529556858|FG001|Overall Study|Lack of Efficacy|2|||
146832301|NCT00730015|529556859|FG002|Overall Study|Lack of Efficacy|8|||
146832302|NCT00730015|529556857|FG000|Overall Study|Other Reason|1|||
146832303|NCT00730015|529556858|FG001|Overall Study|Other Reason|0|||
146832304|NCT00730015|529556859|FG002|Overall Study|Other Reason|1|||
146832305|NCT01432626|529556860|FG000|Overall Study|LV function recovered|2|||
146832306|NCT01432626|529556860|FG000|Overall Study|Withdrawal by Subject|2|||
146832307|NCT01432626|529556860|FG000|Overall Study|Only 1 image competed|2|||
146832308|NCT01432626|529556860|FG000|Overall Study|Imaging agent not available|1|||
146832309|NCT05382039|529556861|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
146832310|NCT05382039|529556862|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
146832311|NCT05382039|529556863|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
146832312|NCT05382039|529556861|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
146832313|NCT05382039|529556862|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
146832314|NCT05382039|529556863|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
146832315|NCT05382039|529556861|FG000|Overall Study|waiting for confirmation|0|||
146832316|NCT05382039|529556862|FG001|Overall Study|waiting for confirmation|0|||
146832317|NCT05382039|529556863|FG002|Overall Study|waiting for confirmation|1|||
146832318|NCT03210519|529556866|FG000|Overall Study|Adverse Event|2|||
146832319|NCT03210519|529556867|FG001|Overall Study|Adverse Event|0|||
146958648|NCT00486720|530007896|FG001|Overall Study|Adverse Event|2|||
146958649|NCT00486720|530007895|FG000|Overall Study|Lack of Efficacy|4|||
146958650|NCT00486720|530007896|FG001|Overall Study|Lack of Efficacy|6|||
146958651|NCT00486720|530007895|FG000|Overall Study|Physician Decision|1|||
146958652|NCT00486720|530007896|FG001|Overall Study|Physician Decision|2|||
146958653|NCT00486720|530007895|FG000|Overall Study|Protocol Violation|1|||
146958654|NCT00486720|530007896|FG001|Overall Study|Protocol Violation|0|||
146958655|NCT00486720|530007895|FG000|Overall Study|Withdrawal by Subject|3|||
146958656|NCT00486720|530007896|FG001|Overall Study|Withdrawal by Subject|1|||
146958657|NCT00486720|530007895|FG000|Overall Study|Progressive Disease|0|||
146958658|NCT00486720|530007896|FG001|Overall Study|Progressive Disease|1|||
146958659|NCT05047601|530007898|FG000|Overall Study|Lost to Follow-up|9|||
146958660|NCT05047601|530007899|FG001|Overall Study|Lost to Follow-up|11|||
146958661|NCT05047601|530007900|FG002|Overall Study|Lost to Follow-up|7|||
146958662|NCT05047601|530007898|FG000|Overall Study|Withdrawal by Subject|25|||
146958663|NCT05047601|530007899|FG001|Overall Study|Withdrawal by Subject|36|||
146958664|NCT05047601|530007900|FG002|Overall Study|Withdrawal by Subject|23|||
146958665|NCT05047601|530007898|FG000|Overall Study|Other|10|||
146958666|NCT05047601|530007899|FG001|Overall Study|Other|6|||
146958667|NCT05047601|530007900|FG002|Overall Study|Other|5|||
146958668|NCT00302731|530007914|FG000|Overall Study|Lost to Follow-up|1|||
146958669|NCT00302731|530007915|FG001|Overall Study|Lost to Follow-up|2|||
146958670|NCT00302731|530007916|FG002|Overall Study|Lost to Follow-up|0|||
146958671|NCT00302731|530007917|FG003|Overall Study|Lost to Follow-up|0|||
146958672|NCT00302731|530007914|FG000|Overall Study|Adverse Event|0|||
146958673|NCT00302731|530007915|FG001|Overall Study|Adverse Event|2|||
146958674|NCT00302731|530007916|FG002|Overall Study|Adverse Event|2|||
146958675|NCT00302731|530007917|FG003|Overall Study|Adverse Event|0|||
146958676|NCT00302731|530007914|FG000|Overall Study|Withdrawal by Subject|1|||
146958677|NCT00302731|530007915|FG001|Overall Study|Withdrawal by Subject|1|||
146958678|NCT00302731|530007916|FG002|Overall Study|Withdrawal by Subject|0|||
146958679|NCT00302731|530007917|FG003|Overall Study|Withdrawal by Subject|0|||
146958680|NCT00302731|530007914|FG000|Overall Study|Protocol Violation|1|||
146958681|NCT00302731|530007915|FG001|Overall Study|Protocol Violation|0|||
146958682|NCT00302731|530007916|FG002|Overall Study|Protocol Violation|0|||
146958683|NCT00302731|530007917|FG003|Overall Study|Protocol Violation|0|||
146958684|NCT00302731|530007914|FG000|Overall Study|cancer unrelated to study discovered|1|||
146958685|NCT00302731|530007915|FG001|Overall Study|cancer unrelated to study discovered|0|||
146958686|NCT00302731|530007916|FG002|Overall Study|cancer unrelated to study discovered|1|||
146958687|NCT00302731|530007917|FG003|Overall Study|cancer unrelated to study discovered|0|||
146958688|NCT01000311|530007918|FG000|Overall Study|Adverse Event|2|||
146958689|NCT01000311|530007919|FG001|Overall Study|Adverse Event|5|||
146958690|NCT01000311|530007918|FG000|Overall Study|Withdrawal by Subject|16|||
146958691|NCT01000311|530007919|FG001|Overall Study|Withdrawal by Subject|24|||
146958692|NCT01000311|530007918|FG000|Overall Study|Lost to Follow-up|15|||
146958693|NCT01000311|530007919|FG001|Overall Study|Lost to Follow-up|24|||
146958694|NCT01000311|530007918|FG000|Overall Study|Protocol Violation|1|||
146958695|NCT01000311|530007919|FG001|Overall Study|Protocol Violation|2|||
146958696|NCT01000311|530007918|FG000|Overall Study|Inappropriate enrollment|2|||
146958697|NCT01000311|530007919|FG001|Overall Study|Inappropriate enrollment|0|||
146958698|NCT01000311|530007918|FG000|Overall Study|Administrative reason|9|||
146958699|NCT01000311|530007919|FG001|Overall Study|Administrative reason|15|||
146958700|NCT01610752|530007922|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
146958701|NCT01610752|530007923|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
146958702|NCT01610752|530007924|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
146958703|NCT00283062|530007928|FG000|Overall Study|Did not receive any study medication|5|||
146958704|NCT00283062|530007929|FG001|Overall Study|Did not receive any study medication|4|||
146958705|NCT00283062|530007930|FG002|Overall Study|Did not receive any study medication|36|||
146958706|NCT00283062|530007931|FG003|Overall Study|Did not receive any study medication|45|||
146958707|NCT00283062|530007928|FG000|Overall Study|Adverse Event|2|||
146958708|NCT00283062|530007929|FG001|Overall Study|Adverse Event|0|||
146958709|NCT00283062|530007930|FG002|Overall Study|Adverse Event|1|||
146958710|NCT00283062|530007931|FG003|Overall Study|Adverse Event|0|||
146958711|NCT00283062|530007928|FG000|Overall Study|Lost to Follow-up|1|||
146958712|NCT00283062|530007929|FG001|Overall Study|Lost to Follow-up|0|||
146958713|NCT00283062|530007930|FG002|Overall Study|Lost to Follow-up|1|||
146958714|NCT00283062|530007931|FG003|Overall Study|Lost to Follow-up|0|||
146958715|NCT00283062|530007928|FG000|Overall Study|Progressive disease|0|||
146958716|NCT00283062|530007929|FG001|Overall Study|Progressive disease|0|||
146958717|NCT00283062|530007930|FG002|Overall Study|Progressive disease|1|||
146958718|NCT00283062|530007931|FG003|Overall Study|Progressive disease|0|||
146958719|NCT00283062|530007928|FG000|Overall Study|Participant did not wish to continue|3|||
146986923|NCT02308111|530114901|FG001|Overall Study|Liver Transplant Waitlist|2|||
146986924|NCT02308111|530114900|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
146986925|NCT02308111|530114901|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
146986926|NCT03271528|530114903|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
146986927|NCT03271528|530114904|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
146986928|NCT03271528|530114903|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
146986929|NCT03271528|530114904|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
146986930|NCT03271528|530114903|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
146986931|NCT03271528|530114904|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
146986932|NCT03271528|530114903|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
146986933|NCT03271528|530114904|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
146986934|NCT03271528|530114903|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
146986935|NCT03271528|530114904|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
146986936|NCT03271528|530114903|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
146986937|NCT03271528|530114904|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
146986938|NCT03271528|530114903|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
146986939|NCT03271528|530114904|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
146986940|NCT00673790|530114905|FG000|Overall Study|Adverse Event|23|||
146986941|NCT00673790|530114906|FG001|Overall Study|Adverse Event|14|||
146986942|NCT00673790|530114907|FG002|Overall Study|Adverse Event|2|||
146986943|NCT00673790|530114905|FG000|Overall Study|Lack of Efficacy|2|||
146986944|NCT00673790|530114906|FG001|Overall Study|Lack of Efficacy|2|||
146986945|NCT00673790|530114907|FG002|Overall Study|Lack of Efficacy|2|||
146986946|NCT00673790|530114905|FG000|Overall Study|Protocol Violation|6|||
146986947|NCT00673790|530114906|FG001|Overall Study|Protocol Violation|9|||
146986948|NCT00673790|530114907|FG002|Overall Study|Protocol Violation|1|||
146986949|NCT00673790|530114905|FG000|Overall Study|Withdrawal by Subject|7|||
146986950|NCT00673790|530114906|FG001|Overall Study|Withdrawal by Subject|4|||
146986951|NCT00673790|530114907|FG002|Overall Study|Withdrawal by Subject|1|||
146986952|NCT00673790|530114905|FG000|Overall Study|Lost to Follow-up|6|||
146986953|NCT00673790|530114906|FG001|Overall Study|Lost to Follow-up|6|||
146986954|NCT00673790|530114907|FG002|Overall Study|Lost to Follow-up|5|||
146986955|NCT00673790|530114905|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
146986956|NCT00673790|530114906|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
146986957|NCT00673790|530114907|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
146986958|NCT00673790|530114905|FG000|Overall Study|Poor compliance|1|||
146986959|NCT00673790|530114906|FG001|Overall Study|Poor compliance|0|||
146986960|NCT00673790|530114907|FG002|Overall Study|Poor compliance|0|||
146986961|NCT00673790|530114905|FG000|Overall Study|Participated in two Nebivolol studies|0|||
146986962|NCT00673790|530114906|FG001|Overall Study|Participated in two Nebivolol studies|0|||
146986963|NCT00673790|530114907|FG002|Overall Study|Participated in two Nebivolol studies|1|||
146986964|NCT00673790|530114905|FG000|Overall Study|Unconfirmed pregnancy|0|||
146986965|NCT00673790|530114906|FG001|Overall Study|Unconfirmed pregnancy|1|||
146986966|NCT00673790|530114907|FG002|Overall Study|Unconfirmed pregnancy|0|||
146986967|NCT00673790|530114905|FG000|Overall Study|Randomization criteria not met|0|||
146986968|NCT00673790|530114906|FG001|Overall Study|Randomization criteria not met|1|||
146986969|NCT00673790|530114907|FG002|Overall Study|Randomization criteria not met|0|||
146986970|NCT00306384|530114908|FG000|Overall Study|Adverse Event|103|||
146986971|NCT00306384|530114909|FG001|Overall Study|Adverse Event|87|||
146986972|NCT00306384|530114910|FG002|Overall Study|Adverse Event|40|||
146986973|NCT00306384|530114908|FG000|Overall Study|Major protocol deviation|43|||
146986974|NCT00306384|530114909|FG001|Overall Study|Major protocol deviation|51|||
146986975|NCT00306384|530114910|FG002|Overall Study|Major protocol deviation|18|||
146986976|NCT00306384|530114908|FG000|Overall Study|Lost to Follow-up|57|||
146832320|NCT02270671|529556868|FG000|Overall Study|Withdrawal by Subject|1|||
146832321|NCT02270671|529556869|FG001|Overall Study|Withdrawal by Subject|1|||
146832322|NCT02270671|529556868|FG000|Overall Study|Protocol Violation|0|||
146832323|NCT02270671|529556869|FG001|Overall Study|Protocol Violation|1|||
146832324|NCT02270671|529556868|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
146832325|NCT02270671|529556869|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
146832326|NCT02270671|529556868|FG000|Overall Study|Lost to Follow-up|2|||
146832327|NCT02270671|529556869|FG001|Overall Study|Lost to Follow-up|1|||
146832328|NCT00174447|529556870|FG000|Overall Study|Adverse Event|19|||
146832329|NCT00174447|529556870|FG000|Overall Study|Withdrawal by Subject|15|||
146986977|NCT00306384|530114909|FG001|Overall Study|Lost to Follow-up|41|||
146986978|NCT00306384|530114910|FG002|Overall Study|Lost to Follow-up|35|||
146986979|NCT00306384|530114908|FG000|Overall Study|Voluntary withdrawal|199|||
146986980|NCT00306384|530114909|FG001|Overall Study|Voluntary withdrawal|187|||
146986981|NCT00306384|530114910|FG002|Overall Study|Voluntary withdrawal|91|||
146832330|NCT00174447|529556870|FG000|Overall Study|Protocol Violation|1|||
146986982|NCT00306384|530114908|FG000|Overall Study|Study termination|1|||
146832331|NCT00174447|529556870|FG000|Overall Study|Lack of Efficacy|1|||
146832332|NCT00174447|529556870|FG000|Overall Study|Administrative reason/Other|2|||
146832333|NCT00940875|529556873|FG000|Treatment Phase|Adverse Event|9|||
146832334|NCT00940875|529556874|FG001|Treatment Phase|Adverse Event|3|||
146832335|NCT00940875|529556873|FG000|Treatment Phase|Death|3|||
146832336|NCT00940875|529556874|FG001|Treatment Phase|Death|5|||
146832337|NCT00940875|529556873|FG000|Treatment Phase|Lack of Efficacy|1|||
146832338|NCT00940875|529556874|FG001|Treatment Phase|Lack of Efficacy|0|||
146832339|NCT00940875|529556873|FG000|Treatment Phase|Withdrawal by Subject|3|||
146832340|NCT00940875|529556874|FG001|Treatment Phase|Withdrawal by Subject|0|||
146986983|NCT00306384|530114909|FG001|Overall Study|Study termination|0|||
146986984|NCT00306384|530114910|FG002|Overall Study|Study termination|1|||
146986985|NCT00306384|530114908|FG000|Overall Study|Pregnancy|3|||
146986986|NCT00306384|530114909|FG001|Overall Study|Pregnancy|1|||
146986987|NCT00306384|530114910|FG002|Overall Study|Pregnancy|1|||
146986988|NCT00306384|530114908|FG000|Overall Study|Lack of Efficacy|26|||
146986989|NCT00306384|530114909|FG001|Overall Study|Lack of Efficacy|40|||
146986990|NCT00306384|530114910|FG002|Overall Study|Lack of Efficacy|38|||
146986991|NCT00306384|530114908|FG000|Overall Study|Investigator discretion|28|||
146986992|NCT00306384|530114909|FG001|Overall Study|Investigator discretion|31|||
146986993|NCT00306384|530114910|FG002|Overall Study|Investigator discretion|21|||
146986994|NCT00306384|530114908|FG000|Overall Study|Other|80|||
146986995|NCT00306384|530114909|FG001|Overall Study|Other|70|||
146986996|NCT00306384|530114910|FG002|Overall Study|Other|32|||
146986997|NCT00306384|530114908|FG000|Overall Study|Site closure|2|||
146986998|NCT00306384|530114909|FG001|Overall Study|Site closure|0|||
146986999|NCT00306384|530114910|FG002|Overall Study|Site closure|0|||
146987000|NCT00717756|530114911|FG000|Overall Study|Withdrawal by Subject|1|||
146987001|NCT01873859|530114916|FG000|Overall Study|Withdrawal by Subject|0|||
146987002|NCT01873859|530114917|FG001|Overall Study|Withdrawal by Subject|4|||
146987003|NCT00601484|530114919|FG000|Overall Study|Adverse Event|0|||
146987004|NCT00601484|530114920|FG001|Overall Study|Adverse Event|1|||
146987005|NCT00601484|530114919|FG000|Overall Study|Lost to Follow-up|4|||
146987006|NCT00601484|530114920|FG001|Overall Study|Lost to Follow-up|3|||
146987007|NCT00601484|530114919|FG000|Overall Study|Lack of Efficacy|0|||
146987008|NCT00601484|530114920|FG001|Overall Study|Lack of Efficacy|2|||
146987009|NCT00601484|530114919|FG000|Overall Study|Withdrawal by Subject|1|||
146987010|NCT00601484|530114920|FG001|Overall Study|Withdrawal by Subject|1|||
146987011|NCT00601484|530114919|FG000|Overall Study|Randomized, but not treated|0|||
146987012|NCT00601484|530114920|FG001|Overall Study|Randomized, but not treated|1|||
146987013|NCT03977584|530114921|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
146987014|NCT03977584|530114922|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
146987015|NCT03977584|530114923|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
146987016|NCT03504852|530114927|FG000|Overall Study|Withdrawal of informed consent|2|||
146987017|NCT03504852|530114928|FG001|Overall Study|Withdrawal of informed consent|1|||
146987018|NCT03504852|530114929|FG002|Overall Study|Withdrawal of informed consent|0|||
146987019|NCT03504852|530114927|FG000|Overall Study|Withdrawal by Subject|5|||
146987020|NCT03504852|530114928|FG001|Overall Study|Withdrawal by Subject|5|||
146987021|NCT03504852|530114929|FG002|Overall Study|Withdrawal by Subject|1|||
146987022|NCT03504852|530114927|FG000|Overall Study|Lost to Follow-up|4|||
146987023|NCT03504852|530114928|FG001|Overall Study|Lost to Follow-up|1|||
146987024|NCT03504852|530114929|FG002|Overall Study|Lost to Follow-up|0|||
146987025|NCT03504852|530114927|FG000|Overall Study|New therapy for study indication|1|||
146987026|NCT03504852|530114928|FG001|Overall Study|New therapy for study indication|0|||
146987027|NCT03504852|530114929|FG002|Overall Study|New therapy for study indication|0|||
146987028|NCT03504852|530114927|FG000|Overall Study|Lack of Efficacy|1|||
146987029|NCT03504852|530114928|FG001|Overall Study|Lack of Efficacy|2|||
146987030|NCT03504852|530114929|FG002|Overall Study|Lack of Efficacy|0|||
146987031|NCT03504852|530114927|FG000|Overall Study|Death|0|||
146987032|NCT03504852|530114928|FG001|Overall Study|Death|1|||
146832341|NCT00940875|529556873|FG000|Treatment Phase|Disease progression|9|||
146832342|NCT00940875|529556874|FG001|Treatment Phase|Disease progression|11|||
146832343|NCT00940875|529556873|FG000|Treatment Phase|Physician Decision|1|||
146832344|NCT00940875|529556874|FG001|Treatment Phase|Physician Decision|0|||
146987033|NCT03504852|530114929|FG002|Overall Study|Death|0|||
146987034|NCT03504852|530114927|FG000|Overall Study|Adverse Event|4|||
146987035|NCT03504852|530114928|FG001|Overall Study|Adverse Event|8|||
146987036|NCT03504852|530114929|FG002|Overall Study|Adverse Event|2|||
146987037|NCT00745251|530114930|FG000|Overall Study|Adverse Event|1|||
146987038|NCT00745251|530114931|FG001|Overall Study|Adverse Event|2|||
146987039|NCT00745251|530114930|FG000|Overall Study|Withdrawal by Subject|1|||
146987040|NCT00745251|530114931|FG001|Overall Study|Withdrawal by Subject|1|||
146987041|NCT02928848|530114932|FG000|Arm 2|Withdrawal by Subject|1|||
146987042|NCT02928848|530114933|FG001|Arm 2|Withdrawal by Subject|0|||
146987043|NCT03850509|530114934|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
146832345|NCT00940875|529556873|FG000|Post-Study Treatment|Death|0|||
146832346|NCT00940875|529556874|FG001|Post-Study Treatment|Death|1|||
146832347|NCT00940875|529556873|FG000|Post-Study Treatment|Disease Progression|0|||
146987044|NCT03850509|530114935|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
146987045|NCT00969332|530114936|FG000|Overall Study|Physician Decision|8|||
146987046|NCT00969332|530114936|FG000|Overall Study|Withdrawal by Subject|3|||
146987047|NCT02666430|530114937|FG000|Period 1|Lost to Follow-up|1|||
146987048|NCT02666430|530114938|FG001|Period 1|Lost to Follow-up|0|||
146987049|NCT02666430|530114937|FG000|Period 1|Adverse Event|0|||
146987050|NCT02666430|530114938|FG001|Period 1|Adverse Event|1|||
146987051|NCT02666430|530114937|FG000|Period 2|Withdrawal by Subject|1|||
146987052|NCT02666430|530114938|FG001|Period 2|Withdrawal by Subject|4|||
146987053|NCT02666430|530114937|FG000|Period 3|Lost to Follow-up|1|||
146987054|NCT02666430|530114938|FG001|Period 3|Lost to Follow-up|0|||
146987055|NCT03828461|530114939|FG000|Overall Study|Lost to Follow-up|1|||
146987056|NCT03828461|530114939|FG000|Overall Study|Withdrawal by Subject|3|||
146987057|NCT00576199|530114940|FG000|Overall Study|Adverse Event|12|||
146987058|NCT00576199|530114940|FG000|Overall Study|Insufficient Therapeutic Response|14|||
146987059|NCT00576199|530114940|FG000|Overall Study|Refused Treatment|2|||
146987060|NCT00576199|530114940|FG000|Overall Study|Reason Unspecified|2|||
146987061|NCT05328375|530116714|FG000|Overall Study|Withdrawal by Subject|0|||
146987062|NCT05328375|530116715|FG001|Overall Study|Withdrawal by Subject|1|||
146987063|NCT02178709|530116717|FG000|Overall Study|Adverse Event|5|||
146987064|NCT02178709|530116717|FG000|Overall Study|Death|2|||
146987065|NCT02178709|530116717|FG000|Overall Study|Withdrawal by Subject|2|||
146987066|NCT02178709|530116717|FG000|Overall Study|Physician Decision|2|||
146987067|NCT02178709|530116717|FG000|Overall Study|Disease Progression|5|||
146987068|NCT02946385|530116718|FG000|Overall Study|Lost to Follow-up|0|||
146987069|NCT02946385|530116719|FG001|Overall Study|Lost to Follow-up|0|||
146987070|NCT02946385|530116720|FG002|Overall Study|Lost to Follow-up|3|||
146987071|NCT02946385|530116721|FG003|Overall Study|Lost to Follow-up|0|||
146987072|NCT02946385|530116722|FG004|Overall Study|Lost to Follow-up|2|||
146987073|NCT02946385|530116723|FG005|Overall Study|Lost to Follow-up|1|||
146987074|NCT00101582|530116728|FG000|Overall Study|Ineligibility determined|0|||
146987075|NCT00101582|530116729|FG001|Overall Study|Ineligibility determined|1|||
146987076|NCT00101582|530116728|FG000|Overall Study|Adverse Event|1|||
146987077|NCT00101582|530116729|FG001|Overall Study|Adverse Event|4|||
146987078|NCT00101582|530116728|FG000|Overall Study|Withdrawal by Subject|6|||
146987079|NCT00101582|530116729|FG001|Overall Study|Withdrawal by Subject|4|||
146987080|NCT00101582|530116728|FG000|Overall Study|Physician Decision|1|||
146987081|NCT00101582|530116729|FG001|Overall Study|Physician Decision|0|||
146987082|NCT00101582|530116728|FG000|Overall Study|Death|3|||
146987083|NCT00101582|530116729|FG001|Overall Study|Death|5|||
146987084|NCT00101582|530116728|FG000|Overall Study|Other|0|||
146987085|NCT00101582|530116729|FG001|Overall Study|Other|1|||
146987086|NCT01919190|530116730|FG000|Overall Study|Intra-op findings, etc.|3|||
146987087|NCT01919190|530116731|FG001|Overall Study|Intra-op findings, etc.|0|||
146987088|NCT01893905|530116732|FG000|Overall Study|Withdrawal by Subject|1|||
146987089|NCT01893905|530116733|FG001|Overall Study|Withdrawal by Subject|0|||
146987090|NCT01893905|530116732|FG000|Overall Study|Adverse Event|9|||
146987091|NCT01893905|530116733|FG001|Overall Study|Adverse Event|3|||
146987092|NCT01893905|530116732|FG000|Overall Study|Lack of Efficacy|5|||
146987093|NCT01893905|530116733|FG001|Overall Study|Lack of Efficacy|7|||
146987094|NCT01893905|530116732|FG000|Overall Study|Lost to Follow-up|1|||
146987095|NCT01893905|530116733|FG001|Overall Study|Lost to Follow-up|0|||
146987096|NCT01893905|530116732|FG000|Overall Study|Protocol Violation|6|||
146987097|NCT01893905|530116733|FG001|Overall Study|Protocol Violation|1|||
146987098|NCT01893905|530116732|FG000|Overall Study|Lack of adherence to treatment|2|||
146987099|NCT01893905|530116733|FG001|Overall Study|Lack of adherence to treatment|0|||
146987100|NCT01893905|530116732|FG000|Overall Study|Other reason|1|||
146987101|NCT01893905|530116733|FG001|Overall Study|Other reason|3|||
146987102|NCT01768858|530116734|FG000|Overall Study|Lost to Follow-up|9|||
146987103|NCT01768858|530116734|FG000|Overall Study|Lack of Efficacy|8|||
146987104|NCT01768858|530116734|FG000|Overall Study|Serious Adverse Event|1|||
146987105|NCT01768858|530116734|FG000|Overall Study|Participant moved to Germany|1|||
146987106|NCT01768858|530116734|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
146987107|NCT01768858|530116734|FG000|Overall Study|Exanthema|1|||
146987108|NCT01768858|530116734|FG000|Overall Study|Withdrawal by Subject|1|||
146987109|NCT03093324|530116736|FG000|Overall Study|Adverse Event|4|||
146987110|NCT03093324|530116737|FG001|Overall Study|Adverse Event|15|||
146987111|NCT03093324|530116736|FG000|Overall Study|Lost to Follow-up|1|||
146987112|NCT03093324|530116737|FG001|Overall Study|Lost to Follow-up|0|||
146987113|NCT03093324|530116736|FG000|Overall Study|Protocol Deviation|2|||
146987114|NCT03093324|530116737|FG001|Overall Study|Protocol Deviation|2|||
146987115|NCT03093324|530116736|FG000|Overall Study|Withdrawal by Subject|2|||
146987116|NCT03093324|530116737|FG001|Overall Study|Withdrawal by Subject|2|||
146987117|NCT02688400|530116743|FG000|Overall Study|Protocol Violation|2|||
146987118|NCT02688400|530116744|FG001|Overall Study|Protocol Violation|5|||
146987119|NCT02688400|530116743|FG000|Overall Study|Lack of Efficacy|7|||
146987120|NCT02688400|530116744|FG001|Overall Study|Lack of Efficacy|7|||
146987121|NCT02688400|530116743|FG000|Overall Study|Adverse Event|21|||
146987122|NCT02688400|530116744|FG001|Overall Study|Adverse Event|12|||
146987123|NCT02688400|530116743|FG000|Overall Study|Withdrawal by Subject|15|||
146987124|NCT02688400|530116744|FG001|Overall Study|Withdrawal by Subject|13|||
146987125|NCT02688400|530116743|FG000|Overall Study|No study medication intake|1|||
146987126|NCT02688400|530116744|FG001|Overall Study|No study medication intake|4|||
146987127|NCT02688400|530116743|FG000|Overall Study|Lost to Follow-up|0|||
146987128|NCT02688400|530116744|FG001|Overall Study|Lost to Follow-up|3|||
146987129|NCT00275002|530116750|FG000|Overall Study|Death|1|||
146987130|NCT00275002|530116751|FG001|Overall Study|Death|0|||
146987131|NCT00275002|530116750|FG000|Overall Study|Disease progression|21|||
146987132|NCT00275002|530116751|FG001|Overall Study|Disease progression|15|||
146987133|NCT00275002|530116750|FG000|Overall Study|Adverse Event|0|||
146987134|NCT00275002|530116751|FG001|Overall Study|Adverse Event|1|||
146987135|NCT05456529|530116752|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
146987136|NCT05456529|530116752|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
146987137|NCT05456529|530116752|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
146987138|NCT05456529|530116752|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
146987139|NCT05456529|530116752|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
146987140|NCT05456529|530116752|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
146987141|NCT05456529|530116752|FG000|44-week Long-term Safety Period|Physician Decision|2|||
146987142|NCT05456529|530116752|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
146987143|NCT05456529|530116752|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
146987144|NCT05456529|530116752|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
146987145|NCT05456529|530116752|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
146987146|NCT02374918|530116753|FG000|Overall Study|Protocol Violation|2|||
146987147|NCT02374918|530116754|FG001|Overall Study|Protocol Violation|0|||
146987148|NCT02374918|530116755|FG002|Overall Study|Protocol Violation|2|||
146987149|NCT02374918|530116756|FG003|Overall Study|Protocol Violation|1|||
146987150|NCT02374918|530116753|FG000|Overall Study|Withdrawal by Subject|1|||
146987151|NCT02374918|530116754|FG001|Overall Study|Withdrawal by Subject|1|||
146987152|NCT02374918|530116755|FG002|Overall Study|Withdrawal by Subject|1|||
146987153|NCT02374918|530116756|FG003|Overall Study|Withdrawal by Subject|0|||
146987154|NCT02374918|530116753|FG000|Overall Study|Lack of Efficacy|0|||
146987155|NCT02374918|530116754|FG001|Overall Study|Lack of Efficacy|0|||
146987156|NCT02374918|530116755|FG002|Overall Study|Lack of Efficacy|1|||
146987157|NCT02374918|530116756|FG003|Overall Study|Lack of Efficacy|1|||
146987158|NCT01506947|530116757|FG000|Overall Study|Lost to Follow-up|7|||
146987159|NCT01506947|530116757|FG000|Overall Study|Adverse Event|5|||
146987160|NCT01506947|530116757|FG000|Overall Study|Death|1|||
146987161|NCT01506947|530116757|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
146987162|NCT02752776|530116760|FG000|Overall Study|Adverse Event|15|||
146987163|NCT02752776|530116761|FG001|Overall Study|Adverse Event|23|||
146987164|NCT02752776|530116762|FG002|Overall Study|Adverse Event|11|||
146987165|NCT02752776|530116760|FG000|Overall Study|Lack of Efficacy|2|||
146987166|NCT02752776|530116761|FG001|Overall Study|Lack of Efficacy|6|||
146987167|NCT02752776|530116762|FG002|Overall Study|Lack of Efficacy|14|||
146987168|NCT02752776|530116760|FG000|Overall Study|Lost to Follow-up|11|||
146987169|NCT02752776|530116761|FG001|Overall Study|Lost to Follow-up|12|||
146987170|NCT02752776|530116762|FG002|Overall Study|Lost to Follow-up|4|||
146987171|NCT02752776|530116760|FG000|Overall Study|Non-compliance with study treatment|0|||
146987172|NCT02752776|530116761|FG001|Overall Study|Non-compliance with study treatment|0|||
146987173|NCT02752776|530116762|FG002|Overall Study|Non-compliance with study treatment|1|||
146987174|NCT02752776|530116760|FG000|Overall Study|Physician Decision|2|||
146987175|NCT02752776|530116761|FG001|Overall Study|Physician Decision|6|||
146987176|NCT02752776|530116762|FG002|Overall Study|Physician Decision|2|||
146987177|NCT02752776|530116760|FG000|Overall Study|Pregnancy|1|||
146987178|NCT02752776|530116761|FG001|Overall Study|Pregnancy|6|||
146987179|NCT02752776|530116762|FG002|Overall Study|Pregnancy|3|||
146987180|NCT02752776|530116760|FG000|Overall Study|Protocol Violation|10|||
146987181|NCT02752776|530116761|FG001|Overall Study|Protocol Violation|13|||
146987182|NCT02752776|530116762|FG002|Overall Study|Protocol Violation|6|||
146987183|NCT02752776|530116760|FG000|Overall Study|Subject/guardian decision|8|||
146987184|NCT02752776|530116761|FG001|Overall Study|Subject/guardian decision|6|||
146987185|NCT02752776|530116762|FG002|Overall Study|Subject/guardian decision|4|||
146987186|NCT02752776|530116760|FG000|Overall Study|Death|0|||
146987187|NCT02752776|530116761|FG001|Overall Study|Death|0|||
146987188|NCT02752776|530116762|FG002|Overall Study|Death|1|||
146987189|NCT02752776|530116760|FG000|Overall Study|Withdrawal by Subject|3|||
146987190|NCT02752776|530116761|FG001|Overall Study|Withdrawal by Subject|4|||
146987191|NCT02752776|530116762|FG002|Overall Study|Withdrawal by Subject|2|||
146987192|NCT01816477|530116763|FG000|Overall Study|Withdrawal by Subject|13|||
146987193|NCT01816477|530116764|FG001|Overall Study|Withdrawal by Subject|1|||
146987194|NCT01816477|530116763|FG000|Overall Study|Unable to tolerate catheter placement|3|||
146987195|NCT01816477|530116764|FG001|Overall Study|Unable to tolerate catheter placement|0|||
146987196|NCT00108732|530116765|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
146987197|NCT00108732|530116765|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
146987198|NCT00108732|530116765|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
146987199|NCT00108732|530116765|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
146987200|NCT00108732|530116765|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
146987201|NCT00108732|530116765|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
146987202|NCT00108732|530116765|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
146987203|NCT02116803|530116767|FG000|Overall Study|Adverse Event|2|||
146987204|NCT02116803|530116768|FG001|Overall Study|Adverse Event|1|||
146987205|NCT02116803|530116767|FG000|Overall Study|Physician Decision|1|||
146987206|NCT02116803|530116768|FG001|Overall Study|Physician Decision|0|||
146987207|NCT02116803|530116767|FG000|Overall Study|Progressive disease|4|||
146987208|NCT02116803|530116768|FG001|Overall Study|Progressive disease|0|||
146987209|NCT02116803|530116767|FG000|Overall Study|Study terminated by sponsor|2|||
146987210|NCT02116803|530116768|FG001|Overall Study|Study terminated by sponsor|1|||
146987211|NCT02116803|530116767|FG000|Overall Study|Death|1|||
146987212|NCT02116803|530116768|FG001|Overall Study|Death|0|||
146987213|NCT01946165|530116769|FG000|Overall Study|Physician Decision|2|||
146987214|NCT01946165|530116770|FG001|Overall Study|Physician Decision|0|||
146987215|NCT01946165|530116769|FG000|Overall Study|Withdrawal by Subject|0|||
146987216|NCT01946165|530116770|FG001|Overall Study|Withdrawal by Subject|2|||
146987217|NCT01901055|530116771|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
146987218|NCT01901055|530116772|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
146987219|NCT01901055|530116771|FG000|Randomization But Not Titrated|Physician Decision|0|||
146987220|NCT01901055|530116772|FG001|Randomization But Not Titrated|Physician Decision|1|||
146987221|NCT01901055|530116771|FG000|Started Protocol to Week 6|Physician Decision|2|||
146987222|NCT01901055|530116772|FG001|Started Protocol to Week 6|Physician Decision|1|||
146987223|NCT01901055|530116771|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
146987224|NCT01901055|530116772|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
146987225|NCT01901055|530116771|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
146987226|NCT01901055|530116772|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
146987227|NCT01901055|530116771|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
146987228|NCT01901055|530116772|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
146987229|NCT01901055|530116771|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
146987230|NCT01901055|530116772|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
146987231|NCT01901055|530116771|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
146987232|NCT01901055|530116772|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
146987233|NCT01901055|530116771|FG000|Week 24|Withdrawal by Subject|13|||
146987234|NCT01901055|530116772|FG001|Week 24|Withdrawal by Subject|19|||
146987235|NCT01901055|530116771|FG000|Week 24|Physician Decision|1|||
146987236|NCT01901055|530116772|FG001|Week 24|Physician Decision|0|||
146987237|NCT01901055|530116771|FG000|Week 36|Withdrawal by Subject|0|||
146987238|NCT01901055|530116772|FG001|Week 36|Withdrawal by Subject|5|||
146987239|NCT03019965|530116775|FG000|Overall Study|Withdrawal by Subject|1|||
146987240|NCT03019965|530116776|FG001|Overall Study|Withdrawal by Subject|0|||
146987241|NCT03019965|530116775|FG000|Overall Study|Protocol Violation|1|||
146987242|NCT03019965|530116776|FG001|Overall Study|Protocol Violation|3|||
146987243|NCT03019965|530116775|FG000|Overall Study|viral or fungal infection|3|||
146987244|NCT03019965|530116776|FG001|Overall Study|viral or fungal infection|4|||
146987245|NCT03019965|530116775|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
146987246|NCT03019965|530116776|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
146987247|NCT03019965|530116775|FG000|Overall Study|Physician Decision|1|||
146987248|NCT03019965|530116776|FG001|Overall Study|Physician Decision|1|||
146987249|NCT01659567|530116777|FG000|Overall Study|Lack of Efficacy|22|||
146987250|NCT01659567|530116777|FG000|Overall Study|Switched to Pegferon|6|||
146987251|NCT01659567|530116777|FG000|Overall Study|Adverse Event|12|||
146987252|NCT01659567|530116777|FG000|Overall Study|Good result at early stage of treatment|5|||
146987253|NCT01659567|530116777|FG000|Overall Study|Withdrawal by Subject|64|||
146987254|NCT01659567|530116777|FG000|Overall Study|Progression of the main disease|1|||
146987255|NCT01659567|530116777|FG000|Overall Study|Other|13|||
146987256|NCT01915732|530116785|FG000|Overall Study|Withdrawal by Subject|18|||
146987257|NCT01915732|530116786|FG001|Overall Study|Withdrawal by Subject|18|||
146987258|NCT01915732|530116785|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
146987259|NCT01915732|530116786|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
146987260|NCT01915732|530116785|FG000|Overall Study|Adverse Event|12|||
146987261|NCT01915732|530116786|FG001|Overall Study|Adverse Event|4|||
146832348|NCT00940875|529556874|FG001|Post-Study Treatment|Disease Progression|2|||
146832349|NCT03603639|529556879|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
146987262|NCT01915732|530116785|FG000|Overall Study|Protocol Violation|5|||
146987263|NCT01915732|530116786|FG001|Overall Study|Protocol Violation|5|||
146987264|NCT01915732|530116785|FG000|Overall Study|Lack of Efficacy|6|||
146987265|NCT01915732|530116786|FG001|Overall Study|Lack of Efficacy|11|||
146832350|NCT03603639|529556880|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
146832351|NCT03603639|529556881|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
146832352|NCT03603639|529556882|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
146987266|NCT01915732|530116785|FG000|Overall Study|Lost to Follow-up|22|||
146987267|NCT01915732|530116786|FG001|Overall Study|Lost to Follow-up|26|||
146987268|NCT01915732|530116785|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
146987269|NCT01915732|530116786|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
146987270|NCT01915732|530116785|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
146987271|NCT01915732|530116786|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
146987272|NCT01915732|530116785|FG000|Overall Study|Drug Release Error|1|||
146987273|NCT01915732|530116786|FG001|Overall Study|Drug Release Error|0|||
146987274|NCT01915732|530116785|FG000|Overall Study|Recovered|1|||
146987275|NCT01915732|530116786|FG001|Overall Study|Recovered|0|||
146987276|NCT01915732|530116785|FG000|Overall Study|Pregnancy|1|||
146987277|NCT01915732|530116786|FG001|Overall Study|Pregnancy|0|||
146987278|NCT01915732|530116785|FG000|Overall Study|Poor Perceived Efficacy|1|||
146987279|NCT01915732|530116786|FG001|Overall Study|Poor Perceived Efficacy|0|||
146987280|NCT01915732|530116785|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
146987281|NCT01915732|530116786|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
146987282|NCT01915732|530116785|FG000|Overall Study|Got Well|0|||
146987283|NCT01915732|530116786|FG001|Overall Study|Got Well|1|||
146987284|NCT01915732|530116785|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
146987285|NCT01915732|530116786|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
146987286|NCT01915732|530116785|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
146987287|NCT01915732|530116786|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
146987288|NCT01915732|530116785|FG000|Overall Study|Job Transfer|0|||
146987289|NCT01915732|530116786|FG001|Overall Study|Job Transfer|1|||
146987290|NCT01915732|530116785|FG000|Overall Study|Improper Facial Procedure|0|||
146987291|NCT01915732|530116786|FG001|Overall Study|Improper Facial Procedure|1|||
146987292|NCT01915732|530116785|FG000|Overall Study|Poor Conscious Effect|0|||
146987293|NCT01915732|530116786|FG001|Overall Study|Poor Conscious Effect|1|||
146987294|NCT01325207|530116787|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
146987295|NCT01325207|530116788|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
146987296|NCT01325207|530116789|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
146987297|NCT01325207|530116790|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
146987298|NCT01325207|530116791|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
146987299|NCT01325207|530116792|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
146987300|NCT01325207|530116787|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
146987301|NCT01325207|530116788|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
146987302|NCT01325207|530116789|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
146987303|NCT01325207|530116790|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
146987304|NCT01325207|530116791|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
146987305|NCT01325207|530116792|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
146987306|NCT01325207|530116787|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
146987307|NCT01325207|530116788|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
146987308|NCT01325207|530116789|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
146987309|NCT01325207|530116790|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
146987310|NCT01325207|530116791|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
146987311|NCT01325207|530116792|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
146987312|NCT01325207|530116787|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
146987313|NCT01325207|530116788|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
146987314|NCT01325207|530116789|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
146987315|NCT01325207|530116790|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
146987316|NCT01325207|530116791|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
146987317|NCT01325207|530116792|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
146987318|NCT01325207|530116787|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
146987319|NCT01325207|530116788|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
146987320|NCT01325207|530116789|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
146987321|NCT01325207|530116790|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
146987322|NCT01325207|530116791|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
146987323|NCT01325207|530116792|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
146987324|NCT01325207|530116787|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
146987325|NCT01325207|530116788|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
146987326|NCT01325207|530116789|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
146832353|NCT03603639|529556883|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
146987327|NCT01325207|530116790|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
146987328|NCT01325207|530116791|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
146987329|NCT01325207|530116792|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
146987330|NCT01325207|530116787|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
146832354|NCT03603639|529556884|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
146832355|NCT03603639|529556879|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
146958720|NCT00283062|530007929|FG001|Overall Study|Participant did not wish to continue|2|||
146958721|NCT00283062|530007930|FG002|Overall Study|Participant did not wish to continue|1|||
146958722|NCT00283062|530007931|FG003|Overall Study|Participant did not wish to continue|0|||
146958723|NCT00283062|530007928|FG000|Overall Study|Undefined|0|||
146958724|NCT00283062|530007929|FG001|Overall Study|Undefined|1|||
146958725|NCT00283062|530007930|FG002|Overall Study|Undefined|1|||
146958726|NCT00283062|530007931|FG003|Overall Study|Undefined|4|||
146958727|NCT00283062|530007928|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
146958728|NCT00283062|530007929|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
146958729|NCT00283062|530007930|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
146958730|NCT00283062|530007931|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
146958731|NCT00252499|530007932|FG000|Overall Study|Lost to Follow-up|1|||
146958732|NCT00252499|530007933|FG001|Overall Study|Lost to Follow-up|0|||
146958733|NCT00252499|530007934|FG002|Overall Study|Lost to Follow-up|0|||
146958734|NCT01535638|530007935|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
146958735|NCT01535638|530007936|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
146958736|NCT01535638|530007937|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
146958737|NCT01535638|530007938|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
146958738|NCT01535638|530007939|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
146958739|NCT01535638|530007940|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
146958740|NCT01535638|530007935|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
146958741|NCT01535638|530007936|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
146958742|NCT01535638|530007937|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
146958743|NCT01535638|530007938|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
146958744|NCT01535638|530007939|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
146958745|NCT01535638|530007940|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
146958746|NCT03702166|530007941|FG000|Overall Study|Lost to Follow-up|1|||
146958747|NCT03702166|530007941|FG000|Overall Study|Withdrawal by Subject|1|||
146958748|NCT01333865|530007942|FG000|Overall Study|Adverse Event|2|||
146958749|NCT01521494|530007945|FG000|Overall Study|Adverse Event|1|||
146958750|NCT01521494|530007946|FG001|Overall Study|Adverse Event|2|||
146958751|NCT01521494|530007947|FG002|Overall Study|Adverse Event|9|||
146958752|NCT01521494|530007948|FG003|Overall Study|Adverse Event|6|||
146958753|NCT01521494|530007949|FG004|Overall Study|Adverse Event|2|||
146958754|NCT01521494|530007945|FG000|Overall Study|Lack of Efficacy|0|||
146958755|NCT01521494|530007946|FG001|Overall Study|Lack of Efficacy|0|||
146958756|NCT01521494|530007947|FG002|Overall Study|Lack of Efficacy|0|||
146958757|NCT01521494|530007948|FG003|Overall Study|Lack of Efficacy|0|||
146958758|NCT01521494|530007949|FG004|Overall Study|Lack of Efficacy|2|||
146958759|NCT01521494|530007945|FG000|Overall Study|Withdrawal by Subject|1|||
146958760|NCT01521494|530007946|FG001|Overall Study|Withdrawal by Subject|1|||
146958761|NCT01521494|530007947|FG002|Overall Study|Withdrawal by Subject|0|||
146958762|NCT01521494|530007948|FG003|Overall Study|Withdrawal by Subject|2|||
146958763|NCT01521494|530007949|FG004|Overall Study|Withdrawal by Subject|0|||
146958764|NCT01521494|530007945|FG000|Overall Study|Decrease in serum phosphate|0|||
146958765|NCT01521494|530007946|FG001|Overall Study|Decrease in serum phosphate|2|||
146958766|NCT01521494|530007947|FG002|Overall Study|Decrease in serum phosphate|3|||
146958767|NCT01521494|530007948|FG003|Overall Study|Decrease in serum phosphate|12|||
146958768|NCT01521494|530007949|FG004|Overall Study|Decrease in serum phosphate|0|||
146958769|NCT01521494|530007945|FG000|Overall Study|Decrease in serum calcium|0|||
146958770|NCT01521494|530007946|FG001|Overall Study|Decrease in serum calcium|0|||
146958771|NCT01521494|530007947|FG002|Overall Study|Decrease in serum calcium|0|||
146958772|NCT01521494|530007948|FG003|Overall Study|Decrease in serum calcium|1|||
146958773|NCT01521494|530007949|FG004|Overall Study|Decrease in serum calcium|1|||
146958774|NCT01521494|530007945|FG000|Overall Study|Physician Decision|0|||
146958775|NCT01521494|530007946|FG001|Overall Study|Physician Decision|0|||
146958776|NCT01521494|530007947|FG002|Overall Study|Physician Decision|0|||
146958777|NCT01521494|530007948|FG003|Overall Study|Physician Decision|0|||
146958778|NCT01521494|530007949|FG004|Overall Study|Physician Decision|2|||
146958779|NCT00554229|530007950|FG000|Overall Study|Lost to Follow-up|3|||
146958780|NCT00554229|530007951|FG001|Overall Study|Lost to Follow-up|6|||
146958781|NCT00554229|530007950|FG000|Overall Study|Withdrawal by Subject|29|||
146958782|NCT00554229|530007951|FG001|Overall Study|Withdrawal by Subject|37|||
146958783|NCT00554229|530007950|FG000|Overall Study|Adverse Event|71|||
146958784|NCT00554229|530007951|FG001|Overall Study|Adverse Event|39|||
146958785|NCT00554229|530007950|FG000|Overall Study|Protocol Violation|3|||
146958786|NCT00554229|530007951|FG001|Overall Study|Protocol Violation|3|||
146958787|NCT00554229|530007950|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
146958788|NCT00554229|530007951|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
146958789|NCT00554229|530007950|FG000|Overall Study|Randomised but no treatment received|1|||
146958790|NCT00554229|530007951|FG001|Overall Study|Randomised but no treatment received|0|||
146958791|NCT00784836|530007952|FG000|Overall Study|Early Study Termination|3|||
146958792|NCT00689299|530007953|FG000|Overall Study|Adverse Event|2|||
146958793|NCT00689299|530007954|FG001|Overall Study|Adverse Event|1|||
146958794|NCT00689299|530007955|FG002|Overall Study|Adverse Event|1|||
146987331|NCT01325207|530116788|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
146987332|NCT01325207|530116789|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
146987333|NCT01325207|530116790|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
146987334|NCT01325207|530116791|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
146987335|NCT01325207|530116792|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
146987336|NCT01254409|530116793|FG000|Overall Study|Adverse Event|0|||
146987337|NCT01254409|530116794|FG001|Overall Study|Adverse Event|1|||
146987338|NCT01254409|530116795|FG002|Overall Study|Adverse Event|0|||
146987339|NCT01254409|530116796|FG003|Overall Study|Adverse Event|0|||
146987340|NCT01974895|530116804|FG000|Overall Study|Protocol Violation|1|||
146987341|NCT01974895|530116805|FG001|Overall Study|Protocol Violation|0|||
146987342|NCT01974895|530116804|FG000|Overall Study|Lost to Follow-up|4|||
146987343|NCT01974895|530116805|FG001|Overall Study|Lost to Follow-up|6|||
146987344|NCT01974895|530116804|FG000|Overall Study|Withdrawal by Subject|0|||
146987345|NCT01974895|530116805|FG001|Overall Study|Withdrawal by Subject|1|||
146987346|NCT01974895|530116804|FG000|Overall Study|Other (Missed Visit)|1|||
146987347|NCT01974895|530116805|FG001|Overall Study|Other (Missed Visit)|0|||
146987348|NCT01974895|530116804|FG000|Overall Study|Other (Reason unknown)|9|||
146987349|NCT01974895|530116805|FG001|Overall Study|Other (Reason unknown)|8|||
146987350|NCT00635154|530116806|FG000|Overall Study|Alternative Treatment|8|||
146987351|NCT00635154|530116806|FG000|Overall Study|Other|4|||
146987352|NCT00635154|530116806|FG000|Overall Study|Still on treatment|21|||
146987353|NCT01399736|530116807|FG000|Overall Study|Withdrawal by Subject|4|||
146987354|NCT01399736|530116808|FG001|Overall Study|Withdrawal by Subject|2|||
146987355|NCT01399736|530116807|FG000|Overall Study|Lost to Follow-up|0|||
146987356|NCT01399736|530116808|FG001|Overall Study|Lost to Follow-up|2|||
146987357|NCT03500484|530116809|FG000|Overall Study|Adverse Event|2|||
146987358|NCT03500484|530116810|FG001|Overall Study|Adverse Event|0|||
146987359|NCT03500484|530116809|FG000|Overall Study|Physician Decision|1|||
146987360|NCT03500484|530116810|FG001|Overall Study|Physician Decision|0|||
146987361|NCT03500484|530116809|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
146987362|NCT03500484|530116810|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
146987363|NCT04652453|530116814|FG000|Overall Study|Death|8|||
146987364|NCT04652453|530116815|FG001|Overall Study|Death|2|||
146987365|NCT04652453|530116816|FG002|Overall Study|Death|0|||
146987366|NCT04652453|530116814|FG000|Overall Study|Hospice|5|||
146987367|NCT04652453|530116815|FG001|Overall Study|Hospice|5|||
146987368|NCT04652453|530116816|FG002|Overall Study|Hospice|0|||
146987369|NCT04652453|530116814|FG000|Overall Study|Withdrawal by Subject|2|||
146987370|NCT04652453|530116815|FG001|Overall Study|Withdrawal by Subject|0|||
146987371|NCT04652453|530116816|FG002|Overall Study|Withdrawal by Subject|0|||
146987372|NCT04543136|530116817|FG000|Overall Study|Withdrawal by Subject|0|||
146987373|NCT04543136|530116818|FG001|Overall Study|Withdrawal by Subject|1|||
146987374|NCT04543136|530116819|FG002|Overall Study|Withdrawal by Subject|0|||
146987375|NCT04543136|530116820|FG003|Overall Study|Withdrawal by Subject|1|||
146987376|NCT04543136|530116821|FG004|Overall Study|Withdrawal by Subject|0|||
146987377|NCT04543136|530116822|FG005|Overall Study|Withdrawal by Subject|0|||
146987378|NCT02192099|530116823|FG000|Overall Study|Adverse Event|1|||
146987379|NCT02192099|530116823|FG000|Overall Study|Lost to Follow-up|2|||
146987380|NCT02192099|530116823|FG000|Overall Study|Physician Decision|1|||
146987381|NCT02192099|530116823|FG000|Overall Study|Pregnancy|1|||
146987382|NCT02192099|530116823|FG000|Overall Study|Protocol Violation|8|||
146987383|NCT02192099|530116823|FG000|Overall Study|Study Terminated by Sponsor|32|||
146987384|NCT02192099|530116823|FG000|Overall Study|Withdrawal by Subject|11|||
146987385|NCT02192099|530116823|FG000|Overall Study|Miscellaneous Reasons|5|||
146987386|NCT00386009|530116824|FG000|Overall Study|Adverse Event|0|||
146987387|NCT00386009|530116825|FG001|Overall Study|Adverse Event|2|||
146987388|NCT00386009|530116824|FG000|Overall Study|Death|1|||
146987389|NCT00386009|530116825|FG001|Overall Study|Death|0|||
146832356|NCT03603639|529556880|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
146832357|NCT03603639|529556881|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
146832358|NCT03603639|529556882|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
146832359|NCT03603639|529556883|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
146832360|NCT03603639|529556884|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
146832361|NCT02402322|529556890|FG000|Pretreatment|Withdrawal by Subject|3|||
146987390|NCT00386009|530116824|FG000|Overall Study|Entry Criteria Not Met|0|||
146987391|NCT00386009|530116825|FG001|Overall Study|Entry Criteria Not Met|2|||
146987392|NCT00386009|530116824|FG000|Overall Study|Lost to Follow-up|1|||
146987393|NCT00386009|530116825|FG001|Overall Study|Lost to Follow-up|1|||
146987394|NCT00386009|530116824|FG000|Overall Study|Protocol Violation|1|||
146987395|NCT00386009|530116825|FG001|Overall Study|Protocol Violation|0|||
146987396|NCT00386009|530116824|FG000|Overall Study|Sponsor Decision|1|||
146987397|NCT00386009|530116825|FG001|Overall Study|Sponsor Decision|1|||
146987398|NCT00386009|530116824|FG000|Overall Study|Withdrawal by Subject|5|||
146987399|NCT00386009|530116825|FG001|Overall Study|Withdrawal by Subject|4|||
146987400|NCT01862328|530116836|FG000|Overall Study|Progressive Disease|3|||
146987401|NCT01862328|530116837|FG001|Overall Study|Progressive Disease|11|||
146987402|NCT01862328|530116838|FG002|Overall Study|Progressive Disease|5|||
146987403|NCT01862328|530116839|FG003|Overall Study|Progressive Disease|6|||
146987404|NCT01862328|530116840|FG004|Overall Study|Progressive Disease|7|||
146987405|NCT01862328|530116841|FG005|Overall Study|Progressive Disease|4|||
146987406|NCT01862328|530116842|FG006|Overall Study|Progressive Disease|3|||
146987407|NCT01862328|530116836|FG000|Overall Study|Adverse Event|0|||
146987408|NCT01862328|530116837|FG001|Overall Study|Adverse Event|4|||
146987409|NCT01862328|530116838|FG002|Overall Study|Adverse Event|0|||
146987410|NCT01862328|530116839|FG003|Overall Study|Adverse Event|1|||
146987411|NCT01862328|530116840|FG004|Overall Study|Adverse Event|0|||
146987412|NCT01862328|530116841|FG005|Overall Study|Adverse Event|2|||
146987413|NCT01862328|530116842|FG006|Overall Study|Adverse Event|4|||
146987414|NCT01862328|530116836|FG000|Overall Study|Other|0|||
146987415|NCT01862328|530116837|FG001|Overall Study|Other|2|||
146987416|NCT01862328|530116838|FG002|Overall Study|Other|1|||
146987417|NCT01862328|530116839|FG003|Overall Study|Other|0|||
146987418|NCT01862328|530116840|FG004|Overall Study|Other|4|||
146987419|NCT01862328|530116841|FG005|Overall Study|Other|0|||
146987420|NCT01862328|530116842|FG006|Overall Study|Other|1|||
146987421|NCT01862328|530116836|FG000|Overall Study|Withdrawal by Subject|1|||
146987422|NCT01862328|530116837|FG001|Overall Study|Withdrawal by Subject|1|||
146987423|NCT01862328|530116838|FG002|Overall Study|Withdrawal by Subject|0|||
146987424|NCT01862328|530116839|FG003|Overall Study|Withdrawal by Subject|0|||
146987425|NCT01862328|530116840|FG004|Overall Study|Withdrawal by Subject|1|||
146987426|NCT01862328|530116841|FG005|Overall Study|Withdrawal by Subject|1|||
146987427|NCT01862328|530116842|FG006|Overall Study|Withdrawal by Subject|1|||
146987428|NCT01862328|530116836|FG000|Overall Study|Symptomatic Deterioration|0|||
146987429|NCT01862328|530116837|FG001|Overall Study|Symptomatic Deterioration|0|||
146987430|NCT01862328|530116838|FG002|Overall Study|Symptomatic Deterioration|0|||
146987431|NCT01862328|530116839|FG003|Overall Study|Symptomatic Deterioration|0|||
146987432|NCT01862328|530116840|FG004|Overall Study|Symptomatic Deterioration|0|||
146987433|NCT01862328|530116841|FG005|Overall Study|Symptomatic Deterioration|0|||
146987434|NCT01862328|530116842|FG006|Overall Study|Symptomatic Deterioration|1|||
146987435|NCT00936975|530116843|FG000|Overall Study|Withdrawal by Subject|1|||
146987436|NCT00936975|530116843|FG000|Overall Study|Disease progression|3|||
146832362|NCT02402322|529556891|FG001|Pretreatment|Withdrawal by Subject|1|||
146832363|NCT02402322|529556892|FG002|Pretreatment|Withdrawal by Subject|1|||
146832364|NCT02402322|529556890|FG000|Follow-up|Withdrawal by Subject|6|||
146832365|NCT02402322|529556891|FG001|Follow-up|Withdrawal by Subject|3|||
146832366|NCT02402322|529556892|FG002|Follow-up|Withdrawal by Subject|24|||
146832367|NCT02818998|529556893|FG000|Overall Study|Adverse Event|3|||
146832368|NCT02818998|529556894|FG001|Overall Study|Adverse Event|2|||
146832369|NCT02818998|529556895|FG002|Overall Study|Adverse Event|1|||
146832370|NCT02818998|529556893|FG000|Overall Study|Lost to Follow-up|4|||
146832371|NCT02818998|529556894|FG001|Overall Study|Lost to Follow-up|1|||
146832372|NCT02818998|529556895|FG002|Overall Study|Lost to Follow-up|2|||
146832373|NCT02818998|529556893|FG000|Overall Study|Withdrawal by sponsor|0|||
146832374|NCT02818998|529556894|FG001|Overall Study|Withdrawal by sponsor|1|||
146832375|NCT02818998|529556895|FG002|Overall Study|Withdrawal by sponsor|1|||
146832376|NCT02818998|529556893|FG000|Overall Study|Death|3|||
146832377|NCT02818998|529556894|FG001|Overall Study|Death|6|||
146832378|NCT02818998|529556895|FG002|Overall Study|Death|8|||
146832379|NCT02818998|529556893|FG000|Overall Study|Withdrawal by Subject|7|||
146832380|NCT02818998|529556894|FG001|Overall Study|Withdrawal by Subject|6|||
146832381|NCT02818998|529556895|FG002|Overall Study|Withdrawal by Subject|6|||
146832382|NCT02818998|529556893|FG000|Overall Study|Physician Decision|1|||
146832383|NCT02818998|529556894|FG001|Overall Study|Physician Decision|0|||
146832384|NCT02818998|529556895|FG002|Overall Study|Physician Decision|0|||
146832385|NCT03414047|529556896|FG000|Overall Study|Adverse Event|0|||
146832386|NCT03414047|529556897|FG001|Overall Study|Adverse Event|0|||
146832387|NCT03414047|529556898|FG002|Overall Study|Adverse Event|1|||
146832388|NCT03414047|529556899|FG003|Overall Study|Adverse Event|1|||
146832389|NCT03414047|529556896|FG000|Overall Study|Physician Decision|1|||
146832390|NCT03414047|529556897|FG001|Overall Study|Physician Decision|0|||
146832391|NCT03414047|529556898|FG002|Overall Study|Physician Decision|0|||
146987437|NCT00936975|530116843|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
146987438|NCT02482571|530116844|FG000|Overall Study|Adverse Event|1|||
146832392|NCT03414047|529556899|FG003|Overall Study|Physician Decision|1|||
146832393|NCT03414047|529556896|FG000|Overall Study|Withdrawal by Subject|1|||
146832394|NCT03414047|529556897|FG001|Overall Study|Withdrawal by Subject|0|||
146832395|NCT03414047|529556898|FG002|Overall Study|Withdrawal by Subject|2|||
146832396|NCT03414047|529556899|FG003|Overall Study|Withdrawal by Subject|0|||
146832397|NCT01704547|529556901|FG000|Overall Study|Physician Decision|4|||
146832398|NCT01704547|529556901|FG000|Overall Study|Withdrawal by Subject|1|||
146832399|NCT02413593|529556904|FG000|Overall Study|Lost to Follow-up|3|||
146832400|NCT02413593|529556904|FG000|Overall Study|Adverse Event|1|||
146832401|NCT02569957|529556905|FG000|Overall Study|Withdrawal by Subject|0|||
146987439|NCT02482571|530116844|FG000|Overall Study|Scanner or Respiract failure|3|||
146832402|NCT02569957|529556906|FG001|Overall Study|Withdrawal by Subject|1|||
146832403|NCT02635386|529556907|FG000|Overall Study|Pregnancy|2|||
146832404|NCT02635386|529556908|FG001|Overall Study|Pregnancy|0|||
146832405|NCT02635386|529556909|FG002|Overall Study|Pregnancy|0|||
146832406|NCT02635386|529556910|FG003|Overall Study|Pregnancy|0|||
146832407|NCT02635386|529556911|FG004|Overall Study|Pregnancy|2|||
146832408|NCT02635386|529556907|FG000|Overall Study|Withdrawal by Subject|1|||
146832409|NCT02635386|529556908|FG001|Overall Study|Withdrawal by Subject|1|||
146832410|NCT02635386|529556909|FG002|Overall Study|Withdrawal by Subject|0|||
146832411|NCT02635386|529556910|FG003|Overall Study|Withdrawal by Subject|1|||
146832412|NCT02635386|529556911|FG004|Overall Study|Withdrawal by Subject|0|||
146832413|NCT02635386|529556907|FG000|Overall Study|Physician Decision|0|||
146832414|NCT02635386|529556908|FG001|Overall Study|Physician Decision|1|||
146832415|NCT02635386|529556909|FG002|Overall Study|Physician Decision|0|||
146832416|NCT02635386|529556910|FG003|Overall Study|Physician Decision|0|||
146832417|NCT02635386|529556911|FG004|Overall Study|Physician Decision|0|||
146832418|NCT02635386|529556907|FG000|Overall Study|Moved Out of State|0|||
146832419|NCT02635386|529556908|FG001|Overall Study|Moved Out of State|1|||
146832420|NCT02635386|529556909|FG002|Overall Study|Moved Out of State|0|||
146832421|NCT02635386|529556910|FG003|Overall Study|Moved Out of State|0|||
146832422|NCT02635386|529556911|FG004|Overall Study|Moved Out of State|0|||
146832423|NCT02635386|529556907|FG000|Overall Study|Noncompliant|0|||
146832424|NCT02635386|529556908|FG001|Overall Study|Noncompliant|2|||
146832425|NCT02635386|529556909|FG002|Overall Study|Noncompliant|1|||
146832426|NCT02635386|529556910|FG003|Overall Study|Noncompliant|1|||
146832427|NCT02635386|529556911|FG004|Overall Study|Noncompliant|1|||
146832428|NCT02635386|529556907|FG000|Overall Study|side effects|0|||
146832429|NCT02635386|529556908|FG001|Overall Study|side effects|0|||
146832430|NCT02635386|529556909|FG002|Overall Study|side effects|1|||
146832431|NCT02635386|529556910|FG003|Overall Study|side effects|4|||
146832432|NCT02635386|529556911|FG004|Overall Study|side effects|6|||
146832433|NCT02635386|529556907|FG000|Overall Study|needed other major surgery|0|||
146832434|NCT02635386|529556908|FG001|Overall Study|needed other major surgery|1|||
146832435|NCT02635386|529556909|FG002|Overall Study|needed other major surgery|0|||
146832436|NCT02635386|529556910|FG003|Overall Study|needed other major surgery|0|||
146987440|NCT02482571|530116844|FG000|Overall Study|Withdrawal by Subject|4|||
146987441|NCT03922477|530116845|FG000|Overall Study|Death|9|||
146987442|NCT03922477|530116845|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
146987443|NCT03922477|530116845|FG000|Overall Study|Physician Decision|1|||
146987444|NCT03922477|530116845|FG000|Overall Study|Withdrawal by Subject|2|||
146987445|NCT01498484|530116846|FG000|Overall Study|Death|6|||
146987446|NCT01498484|530116847|FG001|Overall Study|Death|3|||
146987447|NCT01498484|530116848|FG002|Overall Study|Death|1|||
146987448|NCT01498484|530116849|FG003|Overall Study|Death|1|||
146987449|NCT01498484|530116850|FG004|Overall Study|Death|0|||
146987450|NCT01498484|530116851|FG005|Overall Study|Death|0|||
146987451|NCT01498484|530116852|FG006|Overall Study|Death|10|||
146987452|NCT01498484|530116853|FG007|Overall Study|Death|1|||
146987453|NCT01498484|530116854|FG008|Overall Study|Death|0|||
146987454|NCT01498484|530116846|FG000|Overall Study|Physician Decision|3|||
146987455|NCT01498484|530116847|FG001|Overall Study|Physician Decision|2|||
146987456|NCT01498484|530116848|FG002|Overall Study|Physician Decision|1|||
146987457|NCT01498484|530116849|FG003|Overall Study|Physician Decision|1|||
146987458|NCT01498484|530116850|FG004|Overall Study|Physician Decision|0|||
146987459|NCT01498484|530116851|FG005|Overall Study|Physician Decision|0|||
146987460|NCT01498484|530116852|FG006|Overall Study|Physician Decision|8|||
146987461|NCT01498484|530116853|FG007|Overall Study|Physician Decision|13|||
146987462|NCT01498484|530116854|FG008|Overall Study|Physician Decision|1|||
146987463|NCT01498484|530116846|FG000|Overall Study|Adverse Event|0|||
146987464|NCT01498484|530116847|FG001|Overall Study|Adverse Event|0|||
146987465|NCT01498484|530116848|FG002|Overall Study|Adverse Event|0|||
146832437|NCT02635386|529556911|FG004|Overall Study|needed other major surgery|0|||
146832438|NCT02635386|529556907|FG000|Overall Study|Other medical problems not drug related|0|||
146832439|NCT02635386|529556908|FG001|Overall Study|Other medical problems not drug related|0|||
146832440|NCT02635386|529556909|FG002|Overall Study|Other medical problems not drug related|0|||
146987466|NCT01498484|530116849|FG003|Overall Study|Adverse Event|0|||
146987467|NCT01498484|530116850|FG004|Overall Study|Adverse Event|0|||
146987468|NCT01498484|530116851|FG005|Overall Study|Adverse Event|1|||
146987469|NCT01498484|530116852|FG006|Overall Study|Adverse Event|0|||
146832441|NCT02635386|529556910|FG003|Overall Study|Other medical problems not drug related|1|||
146832442|NCT02635386|529556911|FG004|Overall Study|Other medical problems not drug related|0|||
146832443|NCT02706847|529556914|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
146832444|NCT02706847|529556915|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
146832445|NCT02706847|529556916|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
146832446|NCT02706847|529556917|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
146832447|NCT02706847|529556914|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
146832448|NCT02706847|529556915|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
146987470|NCT01498484|530116853|FG007|Overall Study|Adverse Event|0|||
146987471|NCT01498484|530116854|FG008|Overall Study|Adverse Event|0|||
146832449|NCT02706847|529556916|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
146832450|NCT02706847|529556917|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
146832451|NCT02706847|529556914|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
146832452|NCT02706847|529556915|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
146832453|NCT02706847|529556916|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
146832454|NCT02706847|529556917|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
146832455|NCT02706847|529556914|FG000|Period 1: Day 1 to Week 12|Other|4|||
146832456|NCT02706847|529556915|FG001|Period 1: Day 1 to Week 12|Other|4|||
146832457|NCT02706847|529556916|FG002|Period 1: Day 1 to Week 12|Other|2|||
146832458|NCT02706847|529556917|FG003|Period 1: Day 1 to Week 12|Other|2|||
146832459|NCT02706847|529556914|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
146832460|NCT02706847|529556915|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
146832461|NCT02706847|529556916|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
146832462|NCT02706847|529556917|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
146832463|NCT02706847|529556914|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
146832464|NCT02706847|529556915|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
146832465|NCT02706847|529556916|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
146832466|NCT02706847|529556917|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
146832467|NCT02706847|529556914|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
146832468|NCT02706847|529556915|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
146832469|NCT02706847|529556916|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
146832470|NCT02706847|529556917|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
146832471|NCT02706847|529556914|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
146832472|NCT02706847|529556915|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
146832473|NCT02706847|529556916|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
146832474|NCT02706847|529556917|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
146832475|NCT02706847|529556914|FG000|Period 1: Week 12 to Week 24|Other|1|||
146832476|NCT02706847|529556915|FG001|Period 1: Week 12 to Week 24|Other|0|||
146832477|NCT02706847|529556916|FG002|Period 1: Week 12 to Week 24|Other|1|||
146832478|NCT02706847|529556917|FG003|Period 1: Week 12 to Week 24|Other|4|||
146832479|NCT02706847|529556914|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
146832480|NCT02706847|529556915|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
146832481|NCT02706847|529556916|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
146832482|NCT02706847|529556917|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
146832483|NCT02706847|529556914|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
146832484|NCT02706847|529556915|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
146832485|NCT02706847|529556916|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
146832486|NCT02706847|529556917|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
146832487|NCT02706847|529556914|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
146832488|NCT02706847|529556915|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
146832489|NCT02706847|529556916|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
146832490|NCT02706847|529556917|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
146832491|NCT02706847|529556914|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
146832492|NCT02706847|529556915|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
146832493|NCT02706847|529556916|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
146832494|NCT02706847|529556917|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
146832495|NCT02706847|529556914|FG000|Period 2: Week 24 to Week 260|Other|8|||
146832496|NCT02706847|529556915|FG001|Period 2: Week 24 to Week 260|Other|5|||
146832497|NCT02706847|529556916|FG002|Period 2: Week 24 to Week 260|Other|15|||
146832498|NCT02706847|529556917|FG003|Period 2: Week 24 to Week 260|Other|15|||
146832499|NCT02058836|529556918|FG000|Overall Study|Withdrawal by Subject|1|||
146832500|NCT02058836|529556919|FG001|Overall Study|Withdrawal by Subject|1|||
146832501|NCT02168478|529556921|FG000|Overall Study|Withdrawal by Subject|1|||
146832502|NCT02168478|529556921|FG000|Overall Study|Did Not Consent to Participation|2|||
146832503|NCT02168478|529556921|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
146832504|NCT01530087|529556922|FG000|Overall Study|Physician Decision|2|||
146832505|NCT01087814|529556931|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
146832506|NCT01087814|529556932|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
146832507|NCT01087814|529556931|FG000|Second Intervention (5 Days)|Physician Decision|1|||
146832508|NCT01087814|529556932|FG001|Second Intervention (5 Days)|Physician Decision|0|||
146832509|NCT01427738|529556933|FG000|Overall Study|Death|12|||
146832510|NCT01427738|529556934|FG001|Overall Study|Death|9|||
146832511|NCT01427738|529556933|FG000|Overall Study|Severe debilitation, unable to continue|0|||
146832512|NCT01427738|529556934|FG001|Overall Study|Severe debilitation, unable to continue|1|||
146832513|NCT01427738|529556933|FG000|Overall Study|Subject unable to get to clinic|5|||
146832514|NCT01427738|529556934|FG001|Overall Study|Subject unable to get to clinic|2|||
146832515|NCT01427738|529556933|FG000|Overall Study|Withdrawal by Subject|0|||
146832516|NCT01427738|529556934|FG001|Overall Study|Withdrawal by Subject|2|||
146832517|NCT01427738|529556933|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
146832518|NCT01427738|529556934|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
146832519|NCT01427738|529556933|FG000|Overall Study|Lost to Follow-up|1|||
146832520|NCT01427738|529556934|FG001|Overall Study|Lost to Follow-up|5|||
146832521|NCT05314374|529556935|FG000|Overall Study|Adverse Event|2|||
146832522|NCT05314374|529556936|FG001|Overall Study|Adverse Event|2|||
146832523|NCT02658175|529556937|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
146832524|NCT02658175|529556938|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
146832525|NCT02658175|529556939|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
146832526|NCT02658175|529556937|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
146832527|NCT02658175|529556938|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
146832528|NCT02658175|529556939|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
146832529|NCT02658175|529556937|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
146832530|NCT02658175|529556938|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
146832531|NCT02658175|529556939|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
146832532|NCT02658175|529556937|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
146832533|NCT02658175|529556938|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
146832534|NCT02658175|529556939|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
146832535|NCT02658175|529556937|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
146832536|NCT02658175|529556938|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
146832537|NCT02658175|529556939|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
146832538|NCT02658175|529556937|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
146832539|NCT02658175|529556938|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
146832540|NCT02658175|529556939|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
146832541|NCT02658175|529556937|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
146832542|NCT02658175|529556938|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
146832543|NCT02658175|529556939|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
146832544|NCT02658175|529556937|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
146832545|NCT02658175|529556938|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
146832546|NCT02658175|529556939|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
146832547|NCT02658175|529556937|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
146832548|NCT02658175|529556938|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
146832549|NCT02658175|529556939|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
146832550|NCT02658175|529556937|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
146832551|NCT02658175|529556938|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
146832552|NCT02658175|529556939|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
146832553|NCT02918292|529556944|FG000|Study Enrollment Prior to Transplant|Death|1|||
146832554|NCT02918292|529556944|FG000|Study Follow up After Transplant|Death|6|||
146832555|NCT02650466|529556945|FG000|Overall Study|Physician Decision|1|||
146832556|NCT02650466|529556945|FG000|Overall Study|Withdrawal by Subject|5|||
146832557|NCT02650466|529556945|FG000|Overall Study|Lost to Follow-up|1|||
146832558|NCT01214421|529556946|FG000|Overall Study|Lost to Follow-up|7|||
146832559|NCT01214421|529556947|FG001|Overall Study|Lost to Follow-up|3|||
146832560|NCT01214421|529556948|FG002|Overall Study|Lost to Follow-up|7|||
146832561|NCT01214421|529556949|FG003|Overall Study|Lost to Follow-up|3|||
146832562|NCT01214421|529556946|FG000|Overall Study|Adverse Event|16|||
146832563|NCT01214421|529556947|FG001|Overall Study|Adverse Event|35|||
146832564|NCT01214421|529556948|FG002|Overall Study|Adverse Event|14|||
146832565|NCT01214421|529556949|FG003|Overall Study|Adverse Event|3|||
146832566|NCT01214421|529556946|FG000|Overall Study|Sponsor Discontinued Site|1|||
146832567|NCT01214421|529556947|FG001|Overall Study|Sponsor Discontinued Site|2|||
146832568|NCT01214421|529556948|FG002|Overall Study|Sponsor Discontinued Site|0|||
146832569|NCT01214421|529556949|FG003|Overall Study|Sponsor Discontinued Site|0|||
146832570|NCT01214421|529556946|FG000|Overall Study|Withdrawal Criteria Met|3|||
146832571|NCT01214421|529556947|FG001|Overall Study|Withdrawal Criteria Met|0|||
146832572|NCT01214421|529556948|FG002|Overall Study|Withdrawal Criteria Met|2|||
146832573|NCT01214421|529556949|FG003|Overall Study|Withdrawal Criteria Met|1|||
146832574|NCT01214421|529556946|FG000|Overall Study|Physician Decision|2|||
146832575|NCT01214421|529556947|FG001|Overall Study|Physician Decision|0|||
146832576|NCT01214421|529556948|FG002|Overall Study|Physician Decision|4|||
146832577|NCT01214421|529556949|FG003|Overall Study|Physician Decision|0|||
146987472|NCT01498484|530116846|FG000|Overall Study|Withdrawal by Subject|0|||
146987473|NCT01498484|530116847|FG001|Overall Study|Withdrawal by Subject|0|||
146987474|NCT01498484|530116848|FG002|Overall Study|Withdrawal by Subject|0|||
146832578|NCT01214421|529556946|FG000|Overall Study|Withdrawal by Subject|21|||
146987475|NCT01498484|530116849|FG003|Overall Study|Withdrawal by Subject|1|||
146832579|NCT01214421|529556947|FG001|Overall Study|Withdrawal by Subject|18|||
146832580|NCT01214421|529556948|FG002|Overall Study|Withdrawal by Subject|11|||
146832581|NCT01214421|529556949|FG003|Overall Study|Withdrawal by Subject|2|||
146832582|NCT02392104|529556950|FG000|Overall Study|discontinuation of warfarin|3|||
146832583|NCT02392104|529556950|FG000|Overall Study|bleeding event|1|||
146832584|NCT02392104|529556950|FG000|Overall Study|transferred care to another doctor|2|||
146832585|NCT02392104|529556950|FG000|Overall Study|INR goal range changed|1|||
146832586|NCT02392104|529556950|FG000|Overall Study|admitted to skilled nursing facility|3|||
146832587|NCT02392104|529556950|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
146832588|NCT03912532|529556954|FG000|Overall Study|Adverse Event|3|||
146832589|NCT03912532|529556955|FG001|Overall Study|Adverse Event|3|||
146832590|NCT03912532|529556956|FG002|Overall Study|Adverse Event|2|||
146832591|NCT03912532|529556957|FG003|Overall Study|Adverse Event|2|||
146832592|NCT03912532|529556954|FG000|Overall Study|Lost to Follow-up|3|||
146832593|NCT03912532|529556955|FG001|Overall Study|Lost to Follow-up|2|||
146832594|NCT03912532|529556956|FG002|Overall Study|Lost to Follow-up|1|||
146832595|NCT03912532|529556957|FG003|Overall Study|Lost to Follow-up|2|||
146832596|NCT03912532|529556954|FG000|Overall Study|Withdrawal by Subject|1|||
146832597|NCT03912532|529556955|FG001|Overall Study|Withdrawal by Subject|1|||
146832598|NCT03912532|529556956|FG002|Overall Study|Withdrawal by Subject|2|||
146832599|NCT03912532|529556957|FG003|Overall Study|Withdrawal by Subject|0|||
146832600|NCT03912532|529556954|FG000|Overall Study|Physician Decision|1|||
146832601|NCT03912532|529556955|FG001|Overall Study|Physician Decision|0|||
146832602|NCT03912532|529556956|FG002|Overall Study|Physician Decision|0|||
146987476|NCT01498484|530116850|FG004|Overall Study|Withdrawal by Subject|0|||
146987477|NCT01498484|530116851|FG005|Overall Study|Withdrawal by Subject|0|||
146832603|NCT03912532|529556957|FG003|Overall Study|Physician Decision|3|||
146832604|NCT03912532|529556954|FG000|Overall Study|Other|0|||
146832605|NCT03912532|529556955|FG001|Overall Study|Other|1|||
146832606|NCT03912532|529556956|FG002|Overall Study|Other|1|||
146832607|NCT03912532|529556957|FG003|Overall Study|Other|0|||
146832608|NCT04913948|529556958|FG000|Overall Study|Withdrawal by Subject|2|||
146832609|NCT04913948|529556958|FG000|Overall Study|Sample processing issues|1|||
146832610|NCT04913948|529556958|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
146832611|NCT03783871|529556961|FG000|Overall Study|Withdrawal by Subject|15|||
146832612|NCT03783871|529556961|FG000|Overall Study|Death|13|||
146832613|NCT03783871|529556961|FG000|Overall Study|Lost to Follow-up|2|||
146832614|NCT05990387|529556962|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
146832615|NCT05990387|529556963|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
146832616|NCT00815919|529556964|FG000|Overall Study|Unrelated Fungal Infection|1|||
146832617|NCT00815919|529556964|FG000|Overall Study|AML Relapse|1|||
146832618|NCT00815919|529556964|FG000|Overall Study|Lack of Efficacy|2|||
146832619|NCT03522389|529556965|FG000|Overall Study|Lost to Follow-up|1|||
146832620|NCT03522389|529556966|FG001|Overall Study|Lost to Follow-up|1|||
146832621|NCT03522389|529556967|FG002|Overall Study|Lost to Follow-up|2|||
146832622|NCT03522389|529556965|FG000|Overall Study|had herniated nucleus pulposus|0|||
146832623|NCT03522389|529556966|FG001|Overall Study|had herniated nucleus pulposus|1|||
146832624|NCT03522389|529556967|FG002|Overall Study|had herniated nucleus pulposus|0|||
146832625|NCT03522389|529556965|FG000|Overall Study|go to work in other province|1|||
146832626|NCT03522389|529556966|FG001|Overall Study|go to work in other province|0|||
146832627|NCT03522389|529556967|FG002|Overall Study|go to work in other province|0|||
146832628|NCT00604188|529556968|FG000|Overall Study|Adverse Event|1|||
146832629|NCT00604188|529556969|FG001|Overall Study|Adverse Event|4|||
146832630|NCT00604188|529556968|FG000|Overall Study|Lost to Follow-up|17|||
146832631|NCT00604188|529556969|FG001|Overall Study|Lost to Follow-up|15|||
146832632|NCT00604188|529556968|FG000|Overall Study|Withdrawal by Subject|5|||
146832633|NCT00604188|529556969|FG001|Overall Study|Withdrawal by Subject|1|||
146832634|NCT00604188|529556968|FG000|Overall Study|Non-compliance with protocol|4|||
146832635|NCT00604188|529556969|FG001|Overall Study|Non-compliance with protocol|4|||
146832636|NCT00604188|529556968|FG000|Overall Study|Did not receive study drug|0|||
146832637|NCT00604188|529556969|FG001|Overall Study|Did not receive study drug|1|||
146832638|NCT04599907|529556971|FG000|Overall Study|Withdrawal by Subject|1|||
146832639|NCT04599907|529556972|FG001|Overall Study|Withdrawal by Subject|7|||
146832640|NCT04599907|529556973|FG002|Overall Study|Withdrawal by Subject|6|||
146832641|NCT04599907|529556971|FG000|Overall Study|Lost to Follow-up|0|||
146832642|NCT04599907|529556972|FG001|Overall Study|Lost to Follow-up|1|||
146832643|NCT04599907|529556973|FG002|Overall Study|Lost to Follow-up|0|||
146832644|NCT03668223|529556976|FG000|Overall Study|Death|10|||
146832645|NCT03668223|529556977|FG001|Overall Study|Death|5|||
146832646|NCT03668223|529556976|FG000|Overall Study|Lost to Follow-up|12|||
146832647|NCT03668223|529556977|FG001|Overall Study|Lost to Follow-up|12|||
146832648|NCT03668223|529556976|FG000|Overall Study|Withdrawal by Subject|8|||
146832649|NCT03668223|529556977|FG001|Overall Study|Withdrawal by Subject|3|||
146832650|NCT00443599|529556981|FG000|Overall Study|Physician Decision|2|||
146832651|NCT00443599|529556982|FG001|Overall Study|Physician Decision|1|||
146832652|NCT00443599|529556981|FG000|Overall Study|Death|1|||
146987478|NCT01498484|530116852|FG006|Overall Study|Withdrawal by Subject|1|||
146832653|NCT00443599|529556982|FG001|Overall Study|Death|1|||
146832654|NCT00443599|529556981|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
146832655|NCT00443599|529556982|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
146832656|NCT00966264|529559043|FG000|Overall Study|Lost to Follow-up|4|||
146832657|NCT00966264|529559044|FG001|Overall Study|Lost to Follow-up|3|||
146832658|NCT00487825|529559045|FG000|Overall Study|Adverse Event|2|||
146832659|NCT00487825|529559046|FG001|Overall Study|Adverse Event|2|||
146832660|NCT00487825|529559045|FG000|Overall Study|Lack of Efficacy|1|||
146832661|NCT00487825|529559046|FG001|Overall Study|Lack of Efficacy|1|||
146832662|NCT00487825|529559045|FG000|Overall Study|Other|3|||
146832663|NCT00487825|529559046|FG001|Overall Study|Other|2|||
146832664|NCT01986114|529559049|FG000|Overall Study|Adverse Event|59|||
146832665|NCT01986114|529559049|FG000|Overall Study|Lack of Efficacy|23|||
146832666|NCT01986114|529559049|FG000|Overall Study|Withdrawal by Subject|58|||
146832667|NCT01986114|529559049|FG000|Overall Study|Noncompliance|3|||
146832668|NCT01986114|529559049|FG000|Overall Study|Protocol Violation|1|||
146832669|NCT01986114|529559049|FG000|Overall Study|Lost to Follow-up|5|||
146832670|NCT01986114|529559049|FG000|Overall Study|Other reason|7|||
146832671|NCT01190644|529559050|FG000|Overall Study|Death|2|||
146832672|NCT01190644|529559050|FG000|Overall Study|Disease progression|1|||
146832673|NCT00575042|529559053|FG000|Overall Study|Adverse Event|2|||
146832674|NCT00575042|529559053|FG000|Overall Study|Lost to Follow-up|1|||
146832675|NCT01638390|529559054|FG000|Overall Study|screening failures|21|||
146832676|NCT01536587|529559061|FG000|Overall Study|Adverse Event|2|||
146832677|NCT02666664|529559062|FG000|Overall Study|Physician Decision|0|||
146832678|NCT02666664|529559063|FG001|Overall Study|Physician Decision|1|||
146832679|NCT02666664|529559062|FG000|Overall Study|Protocol Violation|0|||
146832680|NCT02666664|529559063|FG001|Overall Study|Protocol Violation|2|||
146832681|NCT02666664|529559062|FG000|Overall Study|Other|0|||
146832682|NCT02666664|529559063|FG001|Overall Study|Other|1|||
146832683|NCT02666664|529559062|FG000|Overall Study|Adverse Event|12|||
146832684|NCT02666664|529559063|FG001|Overall Study|Adverse Event|37|||
146832685|NCT02666664|529559062|FG000|Overall Study|Withdrawal by participant|23|||
146832686|NCT02666664|529559063|FG001|Overall Study|Withdrawal by participant|40|||
146832687|NCT02666664|529559062|FG000|Overall Study|Sponsor decision|0|||
146832688|NCT02666664|529559063|FG001|Overall Study|Sponsor decision|1|||
146832689|NCT02666664|529559062|FG000|Overall Study|Lost to Follow-up|1|||
146832690|NCT02666664|529559063|FG001|Overall Study|Lost to Follow-up|2|||
146832691|NCT04596995|529559064|FG000|Overall Study|Lack of Efficacy|8|||
146832692|NCT04596995|529559064|FG000|Overall Study|Lost to Follow-up|3|||
146832693|NCT04596995|529559064|FG000|Overall Study|Withdrawal by Subject|12|||
146832694|NCT04596995|529559064|FG000|Overall Study|Sponsor decision|3|||
146832695|NCT04596995|529559064|FG000|Overall Study|Enrolled in managed access program|3|||
146832696|NCT00129935|529559065|FG000|Overall Study|Adverse Event|18|||
146832697|NCT00129935|529559066|FG001|Overall Study|Adverse Event|56|||
146832698|NCT00129935|529559065|FG000|Overall Study|Death|1|||
146832699|NCT00129935|529559066|FG001|Overall Study|Death|1|||
146832700|NCT00129935|529559065|FG000|Overall Study|Withdrawal by Subject|7|||
146832701|NCT00129935|529559066|FG001|Overall Study|Withdrawal by Subject|20|||
146832702|NCT00129935|529559065|FG000|Overall Study|Protocol Violation|0|||
146832703|NCT00129935|529559066|FG001|Overall Study|Protocol Violation|4|||
146832704|NCT00129935|529559065|FG000|Overall Study|Physician Decision|3|||
146832705|NCT00129935|529559066|FG001|Overall Study|Physician Decision|4|||
146832706|NCT00129935|529559065|FG000|Overall Study|Recurrence|1|||
146832707|NCT00129935|529559066|FG001|Overall Study|Recurrence|3|||
146832708|NCT00129935|529559065|FG000|Overall Study|Second primary|0|||
146832709|NCT00129935|529559066|FG001|Overall Study|Second primary|1|||
146832710|NCT00129935|529559065|FG000|Overall Study|Other|3|||
146832711|NCT00129935|529559066|FG001|Overall Study|Other|2|||
146832712|NCT00129935|529559065|FG000|Overall Study|Crossed to the other arm|2|||
146832713|NCT00129935|529559066|FG001|Overall Study|Crossed to the other arm|1|||
146832714|NCT00129935|529559065|FG000|Overall Study|Incorrect study treatment|1|||
146832715|NCT00129935|529559066|FG001|Overall Study|Incorrect study treatment|0|||
146832716|NCT02783573|529559068|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
146832717|NCT02783573|529559069|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
146832718|NCT02783573|529559070|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
146832719|NCT02783573|529559068|FG000|Placebo-Controlled Treatment Period|Death|4|||
146832720|NCT02783573|529559069|FG001|Placebo-Controlled Treatment Period|Death|2|||
146832721|NCT02783573|529559070|FG002|Placebo-Controlled Treatment Period|Death|3|||
146832722|NCT02783573|529559068|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
146832723|NCT02783573|529559069|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
146832724|NCT02783573|529559070|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
146832725|NCT02783573|529559068|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
146832726|NCT02783573|529559069|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
146832727|NCT02783573|529559070|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
146832728|NCT02783573|529559068|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
146832729|NCT02783573|529559069|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
146832730|NCT02783573|529559070|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
146832731|NCT02783573|529559068|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
146832732|NCT02783573|529559069|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
146832733|NCT02783573|529559070|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
146832734|NCT02783573|529559068|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
146832735|NCT02783573|529559069|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
146832736|NCT02783573|529559070|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
146832737|NCT02783573|529559068|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
146832738|NCT02783573|529559069|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
146832739|NCT02783573|529559070|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
146832740|NCT02783573|529559068|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
146832741|NCT02783573|529559069|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
146832742|NCT02783573|529559070|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
146832743|NCT02783573|529559068|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
146832744|NCT02783573|529559069|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
146832745|NCT02783573|529559070|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
146832746|NCT02783573|529559068|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
146832747|NCT02783573|529559069|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
146832748|NCT02783573|529559070|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
146832749|NCT02783573|529559068|FG000|Delayed-Start Period|Sponsor Decision|0|||
146832750|NCT02783573|529559069|FG001|Delayed-Start Period|Sponsor Decision|17|||
146832751|NCT02783573|529559070|FG002|Delayed-Start Period|Sponsor Decision|12|||
146832752|NCT03020069|529559071|FG000|Overall Study|Lost to Follow-up|0|||
146832753|NCT03020069|529559072|FG001|Overall Study|Lost to Follow-up|1|||
146832754|NCT00589303|529559073|FG000|Overall Study|Withdrawal by Subject|2|||
146832755|NCT00589303|529559074|FG001|Overall Study|Withdrawal by Subject|1|||
146832756|NCT02056626|529559075|FG000|Overall Study|patient did not follow directions|3|||
146832757|NCT02056626|529559076|FG001|Overall Study|patient did not follow directions|1|||
146832758|NCT02056626|529559077|FG002|Overall Study|patient did not follow directions|0|||
146832759|NCT02056626|529559078|FG003|Overall Study|patient did not follow directions|0|||
146832760|NCT04978350|529559081|FG000|Overall Study|Lost to Follow-up|6|||
146832761|NCT00013611|529559082|FG000|Overall Study|Lost to Follow-up|91|||
146832762|NCT00013611|529559083|FG001|Overall Study|Lost to Follow-up|100|||
146832763|NCT02577003|529559084|FG000|Overall Study|Adverse Event|2|||
146832764|NCT02577003|529559085|FG001|Overall Study|Adverse Event|4|||
146832765|NCT02577003|529559084|FG000|Overall Study|Withdrawal by Subject|0|||
146832766|NCT02577003|529559085|FG001|Overall Study|Withdrawal by Subject|1|||
146832767|NCT02786004|529559086|FG000|Overall Study|Withdrawal by Subject|0|||
146832768|NCT02786004|529559087|FG001|Overall Study|Withdrawal by Subject|1|||
146832769|NCT04351269|529559088|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
146832770|NCT04351269|529559089|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
146832771|NCT04351269|529559090|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
146832772|NCT04351269|529559088|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
146832773|NCT04351269|529559089|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
146832774|NCT04351269|529559090|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
146832775|NCT04351269|529559088|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
146832776|NCT04351269|529559089|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
146832777|NCT04351269|529559090|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
146832778|NCT04351269|529559088|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
146832779|NCT04351269|529559089|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
146832780|NCT04351269|529559090|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
146832781|NCT04351269|529559088|FG000|Overall Study|Lost to Follow-up|1|||
146832782|NCT04351269|529559089|FG001|Overall Study|Lost to Follow-up|3|||
146832783|NCT04351269|529559090|FG002|Overall Study|Lost to Follow-up|0|||
146832784|NCT04486313|529559093|FG000|Overall Study|Lost to Follow-up|7|||
146832785|NCT04486313|529559094|FG001|Overall Study|Lost to Follow-up|9|||
146832786|NCT04486313|529559093|FG000|Overall Study|Withdrawal by Subject|8|||
146832787|NCT04486313|529559094|FG001|Overall Study|Withdrawal by Subject|6|||
146832788|NCT04486313|529559093|FG000|Overall Study|Physician Decision|1|||
146832789|NCT04486313|529559094|FG001|Overall Study|Physician Decision|1|||
146832790|NCT04486313|529559093|FG000|Overall Study|Death|2|||
146832791|NCT04486313|529559094|FG001|Overall Study|Death|0|||
146832792|NCT04486313|529559093|FG000|Overall Study|Protocol Violation|1|||
146832793|NCT04486313|529559094|FG001|Overall Study|Protocol Violation|1|||
146832794|NCT00126659|529559095|FG000|Overall Study|Adverse Event|0|||
146832795|NCT00126659|529559096|FG001|Overall Study|Adverse Event|0|||
146832796|NCT00126659|529559097|FG002|Overall Study|Adverse Event|2|||
146832797|NCT00882115|529559098|FG000|Overall Study|Withdrawal by Subject|3|||
146832798|NCT00882115|529559098|FG000|Overall Study|did not respond to DEP challe|6|||
146832799|NCT01271504|529559099|FG000|Overall Study|Death|7|||
146832800|NCT01271504|529559100|FG001|Overall Study|Death|6|||
146832801|NCT01271504|529559101|FG002|Overall Study|Death|32|||
146832802|NCT01271504|529559102|FG003|Overall Study|Death|32|||
146832803|NCT01271504|529559099|FG000|Overall Study|Lost to Follow-up|0|||
146832804|NCT01271504|529559100|FG001|Overall Study|Lost to Follow-up|1|||
146832805|NCT01271504|529559101|FG002|Overall Study|Lost to Follow-up|3|||
146832806|NCT01271504|529559102|FG003|Overall Study|Lost to Follow-up|1|||
146832807|NCT01271504|529559099|FG000|Overall Study|Protocol Violation|0|||
146832808|NCT01271504|529559100|FG001|Overall Study|Protocol Violation|0|||
146832809|NCT01271504|529559101|FG002|Overall Study|Protocol Violation|0|||
146832810|NCT01271504|529559102|FG003|Overall Study|Protocol Violation|2|||
146832811|NCT01271504|529559099|FG000|Overall Study|Administrative Reasons|0|||
146832812|NCT01271504|529559100|FG001|Overall Study|Administrative Reasons|0|||
146832813|NCT01271504|529559101|FG002|Overall Study|Administrative Reasons|6|||
146832814|NCT01271504|529559102|FG003|Overall Study|Administrative Reasons|5|||
146832815|NCT01271504|529559099|FG000|Overall Study|Withdrawal by Subject|0|||
146832816|NCT01271504|529559100|FG001|Overall Study|Withdrawal by Subject|0|||
146832817|NCT01271504|529559101|FG002|Overall Study|Withdrawal by Subject|1|||
146832818|NCT01271504|529559102|FG003|Overall Study|Withdrawal by Subject|3|||
146832819|NCT01271504|529559099|FG000|Overall Study|Other|0|||
146832820|NCT01271504|529559100|FG001|Overall Study|Other|1|||
146832821|NCT01271504|529559101|FG002|Overall Study|Other|2|||
146832822|NCT01271504|529559102|FG003|Overall Study|Other|0|||
146832823|NCT03865953|529559103|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
146832824|NCT03865953|529559104|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
146832825|NCT03865953|529559103|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
146832826|NCT03865953|529559104|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
146832827|NCT03865953|529559103|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
146832828|NCT03865953|529559104|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
146832829|NCT02229578|529559119|FG000|Overall Study|Withdrawal by Subject|1|||
146832830|NCT02229578|529559120|FG001|Overall Study|Withdrawal by Subject|3|||
146832831|NCT02229578|529559119|FG000|Overall Study|Protocol Violation|2|||
146832832|NCT02229578|529559120|FG001|Overall Study|Protocol Violation|0|||
146832833|NCT00943787|529559121|FG000|Overall Study|Physician Decision|4|||
146832834|NCT00943787|529559121|FG000|Overall Study|Withdrawal by Subject|3|||
146832835|NCT00490945|529559122|FG000|Overall Study|Adverse Event|0|||
146832836|NCT00490945|529559123|FG001|Overall Study|Adverse Event|1|||
146832837|NCT00490945|529559124|FG002|Overall Study|Adverse Event|0|||
146832838|NCT00490945|529559125|FG003|Overall Study|Adverse Event|0|||
146832839|NCT00490945|529559126|FG004|Overall Study|Adverse Event|0|||
146832840|NCT01216072|529559129|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
146832841|NCT01216072|529559130|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
146832842|NCT01216072|529559129|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
146832843|NCT01216072|529559130|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
146832844|NCT01216072|529559129|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
146832845|NCT01216072|529559130|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
146832846|NCT01216072|529559129|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
146958795|NCT00689299|530007953|FG000|Overall Study|Lost to Follow-up|0|||
146958796|NCT00689299|530007954|FG001|Overall Study|Lost to Follow-up|1|||
146958797|NCT00689299|530007955|FG002|Overall Study|Lost to Follow-up|1|||
146958798|NCT00689299|530007953|FG000|Overall Study|Withdrawal by Subject|4|||
146958799|NCT00689299|530007954|FG001|Overall Study|Withdrawal by Subject|1|||
146958800|NCT00689299|530007955|FG002|Overall Study|Withdrawal by Subject|3|||
146958801|NCT00689299|530007953|FG000|Overall Study|Protocol Violation|1|||
146958802|NCT00689299|530007954|FG001|Overall Study|Protocol Violation|0|||
146958803|NCT00689299|530007955|FG002|Overall Study|Protocol Violation|0|||
146958804|NCT02613910|530007956|FG000|Overall Study|Termination of study|1|||
146958805|NCT00434876|530007957|FG000|Overall Study|Lost to Follow-up|1|||
146958806|NCT00434876|530007958|FG001|Overall Study|Lost to Follow-up|1|||
146958807|NCT00758394|530007959|FG000|2nd Intervention Order|Lost to Follow-up|0|||
146958808|NCT00758394|530007960|FG001|2nd Intervention Order|Lost to Follow-up|1|||
146958809|NCT00758394|530007961|FG002|2nd Intervention Order|Lost to Follow-up|0|||
146958810|NCT00758394|530007962|FG003|2nd Intervention Order|Lost to Follow-up|0|||
146958811|NCT00758394|530007959|FG000|3rd Intervention|Lost to Follow-up|1|||
146958812|NCT00758394|530007960|FG001|3rd Intervention|Lost to Follow-up|0|||
146958813|NCT00758394|530007961|FG002|3rd Intervention|Lost to Follow-up|0|||
146958814|NCT00758394|530007962|FG003|3rd Intervention|Lost to Follow-up|1|||
146958815|NCT02087085|530009851|FG000|Overall Study|Adverse Event|10|||
146958816|NCT02087085|530009852|FG001|Overall Study|Adverse Event|14|||
146958817|NCT02087085|530009851|FG000|Overall Study|Lack of Efficacy|4|||
146958818|NCT02087085|530009852|FG001|Overall Study|Lack of Efficacy|3|||
146958819|NCT02087085|530009851|FG000|Overall Study|Lost to Follow-up|6|||
146958820|NCT02087085|530009852|FG001|Overall Study|Lost to Follow-up|4|||
146958821|NCT02087085|530009851|FG000|Overall Study|Withdrawal by Subject|9|||
146958822|NCT02087085|530009852|FG001|Overall Study|Withdrawal by Subject|11|||
146958823|NCT02087085|530009851|FG000|Overall Study|Protocol Violation|1|||
146958824|NCT02087085|530009852|FG001|Overall Study|Protocol Violation|0|||
146958825|NCT02087085|530009851|FG000|Overall Study|Study Terminated by Sponsor|87|||
146958826|NCT02087085|530009852|FG001|Overall Study|Study Terminated by Sponsor|80|||
146958827|NCT02087085|530009851|FG000|Overall Study|Other Miscellaneous Reasons|3|||
146958828|NCT02087085|530009852|FG001|Overall Study|Other Miscellaneous Reasons|4|||
146832847|NCT01216072|529559130|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
146832848|NCT01216072|529559129|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
146832849|NCT01216072|529559130|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
146832850|NCT01216072|529559129|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
146832851|NCT01216072|529559130|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
146832852|NCT01216072|529559129|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
146832853|NCT01216072|529559130|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
146832854|NCT01216072|529559129|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
146832855|NCT01216072|529559130|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
146832856|NCT01216072|529559129|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
146832857|NCT01216072|529559130|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
146832858|NCT01216072|529559129|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
146832859|NCT01216072|529559130|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
146832860|NCT02947100|529559131|FG000|Overall Study|study terminated early|3|||
146832861|NCT02947100|529559131|FG000|Overall Study|did not meet inclusion criteria|1|||
146832862|NCT00822770|529559132|FG000|Overall Study|Not treated|1|||
146832863|NCT00822770|529559133|FG001|Overall Study|Not treated|0|||
146832864|NCT00822770|529559132|FG000|Overall Study|Complication/Incomplete treatment|1|||
146832865|NCT00822770|529559133|FG001|Overall Study|Complication/Incomplete treatment|0|||
146832866|NCT00822770|529559132|FG000|Overall Study|Death|1|||
146832867|NCT00822770|529559133|FG001|Overall Study|Death|1|||
146832868|NCT02472145|529559137|FG000|Overall Study|Death|10|||
146832869|NCT02472145|529559138|FG001|Overall Study|Death|101|||
146832870|NCT02472145|529559139|FG002|Overall Study|Death|99|||
146832871|NCT02472145|529559137|FG000|Overall Study|Lost to Follow-up|0|||
146832872|NCT02472145|529559138|FG001|Overall Study|Lost to Follow-up|1|||
146832873|NCT02472145|529559139|FG002|Overall Study|Lost to Follow-up|0|||
146832874|NCT02472145|529559137|FG000|Overall Study|Withdrawal by Subject|0|||
146832875|NCT02472145|529559138|FG001|Overall Study|Withdrawal by Subject|9|||
146832876|NCT02472145|529559139|FG002|Overall Study|Withdrawal by Subject|13|||
146832877|NCT02472145|529559137|FG000|Overall Study|Sponsor decision|0|||
146832878|NCT02472145|529559138|FG001|Overall Study|Sponsor decision|3|||
146832879|NCT02472145|529559139|FG002|Overall Study|Sponsor decision|2|||
146832880|NCT02472145|529559137|FG000|Overall Study|Other|0|||
146832881|NCT02472145|529559138|FG001|Overall Study|Other|45|||
146832882|NCT02472145|529559139|FG002|Overall Study|Other|43|||
146832883|NCT01080326|529559140|FG000|Overall Study|Patient deterioration prior to procedure|3|||
146832884|NCT01080326|529559140|FG000|Overall Study|Surgeon decision|1|||
146832885|NCT01296555|529559141|FG000|Overall Study|Adverse Event|0|||
146832886|NCT01296555|529559142|FG001|Overall Study|Adverse Event|0|||
146832887|NCT01296555|529559143|FG002|Overall Study|Adverse Event|1|||
146832888|NCT01296555|529559144|FG003|Overall Study|Adverse Event|1|||
146832889|NCT01296555|529559145|FG004|Overall Study|Adverse Event|2|||
146832890|NCT01296555|529559146|FG005|Overall Study|Adverse Event|4|||
146832891|NCT01296555|529559147|FG006|Overall Study|Adverse Event|1|||
146832892|NCT01296555|529559148|FG007|Overall Study|Adverse Event|4|||
146832893|NCT01296555|529559149|FG008|Overall Study|Adverse Event|3|||
146832894|NCT01296555|529559150|FG009|Overall Study|Adverse Event|1|||
146832895|NCT01296555|529559151|FG010|Overall Study|Adverse Event|0|||
146832896|NCT01296555|529559152|FG011|Overall Study|Adverse Event|4|||
146832897|NCT01296555|529559153|FG012|Overall Study|Adverse Event|1|||
146832898|NCT01296555|529559154|FG013|Overall Study|Adverse Event|4|||
146832899|NCT01296555|529559155|FG014|Overall Study|Adverse Event|0|||
146832900|NCT01296555|529559156|FG015|Overall Study|Adverse Event|0|||
146832901|NCT01296555|529559157|FG016|Overall Study|Adverse Event|0|||
146832902|NCT01296555|529559158|FG017|Overall Study|Adverse Event|0|||
146832903|NCT01296555|529559159|FG018|Overall Study|Adverse Event|0|||
146832904|NCT01296555|529559160|FG019|Overall Study|Adverse Event|1|||
146958829|NCT02681094|530009853|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
146958830|NCT02681094|530009854|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
146958831|NCT02681094|530009855|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
146958832|NCT02681094|530009853|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
146958833|NCT02681094|530009854|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
146958834|NCT02681094|530009855|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
146958835|NCT02681094|530009853|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
146987479|NCT01498484|530116853|FG007|Overall Study|Withdrawal by Subject|0|||
146832905|NCT01296555|529559161|FG020|Overall Study|Adverse Event|0|||
146832906|NCT01296555|529559162|FG021|Overall Study|Adverse Event|0|||
146832907|NCT01296555|529559163|FG022|Overall Study|Adverse Event|0|||
146832908|NCT01296555|529559164|FG023|Overall Study|Adverse Event|0|||
146832909|NCT01296555|529559165|FG024|Overall Study|Adverse Event|0|||
146832910|NCT01296555|529559166|FG025|Overall Study|Adverse Event|0|||
146832911|NCT01296555|529559167|FG026|Overall Study|Adverse Event|0|||
146832912|NCT01296555|529559168|FG027|Overall Study|Adverse Event|0|||
146832913|NCT01296555|529559169|FG028|Overall Study|Adverse Event|0|||
146832914|NCT01296555|529559141|FG000|Overall Study|Reason Not Specified|0|||
146832915|NCT01296555|529559142|FG001|Overall Study|Reason Not Specified|0|||
146832916|NCT01296555|529559143|FG002|Overall Study|Reason Not Specified|0|||
146832917|NCT01296555|529559144|FG003|Overall Study|Reason Not Specified|0|||
146832918|NCT01296555|529559145|FG004|Overall Study|Reason Not Specified|0|||
146832919|NCT01296555|529559146|FG005|Overall Study|Reason Not Specified|0|||
146832920|NCT01296555|529559147|FG006|Overall Study|Reason Not Specified|0|||
146832921|NCT01296555|529559148|FG007|Overall Study|Reason Not Specified|0|||
146832922|NCT01296555|529559149|FG008|Overall Study|Reason Not Specified|0|||
146832923|NCT01296555|529559150|FG009|Overall Study|Reason Not Specified|0|||
146832924|NCT01296555|529559151|FG010|Overall Study|Reason Not Specified|0|||
146832925|NCT01296555|529559152|FG011|Overall Study|Reason Not Specified|0|||
146832926|NCT01296555|529559153|FG012|Overall Study|Reason Not Specified|0|||
146832927|NCT01296555|529559154|FG013|Overall Study|Reason Not Specified|1|||
146832928|NCT01296555|529559155|FG014|Overall Study|Reason Not Specified|2|||
146832929|NCT01296555|529559156|FG015|Overall Study|Reason Not Specified|3|||
146832930|NCT01296555|529559157|FG016|Overall Study|Reason Not Specified|7|||
146832931|NCT01296555|529559158|FG017|Overall Study|Reason Not Specified|4|||
146832932|NCT01296555|529559159|FG018|Overall Study|Reason Not Specified|3|||
146832933|NCT01296555|529559160|FG019|Overall Study|Reason Not Specified|7|||
146832934|NCT01296555|529559161|FG020|Overall Study|Reason Not Specified|11|||
146832935|NCT01296555|529559162|FG021|Overall Study|Reason Not Specified|5|||
146832936|NCT01296555|529559163|FG022|Overall Study|Reason Not Specified|5|||
146832937|NCT01296555|529559164|FG023|Overall Study|Reason Not Specified|7|||
146832938|NCT01296555|529559165|FG024|Overall Study|Reason Not Specified|2|||
146832939|NCT01296555|529559166|FG025|Overall Study|Reason Not Specified|2|||
146832940|NCT01296555|529559167|FG026|Overall Study|Reason Not Specified|19|||
146832941|NCT01296555|529559168|FG027|Overall Study|Reason Not Specified|11|||
146832942|NCT01296555|529559169|FG028|Overall Study|Reason Not Specified|9|||
146832943|NCT01296555|529559141|FG000|Overall Study|Physician Decision|0|||
146832944|NCT01296555|529559142|FG001|Overall Study|Physician Decision|0|||
146832945|NCT01296555|529559143|FG002|Overall Study|Physician Decision|0|||
146832946|NCT01296555|529559144|FG003|Overall Study|Physician Decision|0|||
146832947|NCT01296555|529559145|FG004|Overall Study|Physician Decision|1|||
146832948|NCT01296555|529559146|FG005|Overall Study|Physician Decision|0|||
146832949|NCT01296555|529559147|FG006|Overall Study|Physician Decision|0|||
146832950|NCT01296555|529559148|FG007|Overall Study|Physician Decision|0|||
146832951|NCT01296555|529559149|FG008|Overall Study|Physician Decision|0|||
146832952|NCT01296555|529559150|FG009|Overall Study|Physician Decision|0|||
146832953|NCT01296555|529559151|FG010|Overall Study|Physician Decision|0|||
146832954|NCT01296555|529559152|FG011|Overall Study|Physician Decision|0|||
146832955|NCT01296555|529559153|FG012|Overall Study|Physician Decision|0|||
146832956|NCT01296555|529559154|FG013|Overall Study|Physician Decision|1|||
146832957|NCT01296555|529559155|FG014|Overall Study|Physician Decision|0|||
146832958|NCT01296555|529559156|FG015|Overall Study|Physician Decision|0|||
146832959|NCT01296555|529559157|FG016|Overall Study|Physician Decision|0|||
146832960|NCT01296555|529559158|FG017|Overall Study|Physician Decision|0|||
146832961|NCT01296555|529559159|FG018|Overall Study|Physician Decision|0|||
146832962|NCT01296555|529559160|FG019|Overall Study|Physician Decision|1|||
146832963|NCT01296555|529559161|FG020|Overall Study|Physician Decision|0|||
146832964|NCT01296555|529559162|FG021|Overall Study|Physician Decision|0|||
146832965|NCT01296555|529559163|FG022|Overall Study|Physician Decision|0|||
146832966|NCT01296555|529559164|FG023|Overall Study|Physician Decision|0|||
146832967|NCT01296555|529559165|FG024|Overall Study|Physician Decision|0|||
146832968|NCT01296555|529559166|FG025|Overall Study|Physician Decision|0|||
146832969|NCT01296555|529559167|FG026|Overall Study|Physician Decision|0|||
146832970|NCT01296555|529559168|FG027|Overall Study|Physician Decision|0|||
146832971|NCT01296555|529559169|FG028|Overall Study|Physician Decision|0|||
146958836|NCT02681094|530009854|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
146958837|NCT02681094|530009855|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
146958838|NCT02681094|530009853|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
146958839|NCT02681094|530009854|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
146958840|NCT02681094|530009855|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
146958841|NCT02681094|530009853|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
146958842|NCT02681094|530009854|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
146958843|NCT02681094|530009855|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
146958844|NCT02681094|530009853|FG000|1 -Modified Enrolled Participants Set|Other|6|||
146958845|NCT02681094|530009854|FG001|1 -Modified Enrolled Participants Set|Other|6|||
146958846|NCT02681094|530009855|FG002|1 -Modified Enrolled Participants Set|Other|7|||
146958847|NCT02681094|530009853|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
146832972|NCT01296555|529559141|FG000|Overall Study|Progressive Disease|6|||
146832973|NCT01296555|529559142|FG001|Overall Study|Progressive Disease|3|||
146832974|NCT01296555|529559143|FG002|Overall Study|Progressive Disease|3|||
146832975|NCT01296555|529559144|FG003|Overall Study|Progressive Disease|7|||
146832976|NCT01296555|529559145|FG004|Overall Study|Progressive Disease|6|||
146832977|NCT01296555|529559146|FG005|Overall Study|Progressive Disease|16|||
146832978|NCT01296555|529559147|FG006|Overall Study|Progressive Disease|16|||
146832979|NCT01296555|529559148|FG007|Overall Study|Progressive Disease|8|||
146832980|NCT01296555|529559149|FG008|Overall Study|Progressive Disease|7|||
146832981|NCT01296555|529559150|FG009|Overall Study|Progressive Disease|18|||
146832982|NCT01296555|529559151|FG010|Overall Study|Progressive Disease|7|||
146832983|NCT01296555|529559152|FG011|Overall Study|Progressive Disease|14|||
146832984|NCT01296555|529559153|FG012|Overall Study|Progressive Disease|5|||
146832985|NCT01296555|529559154|FG013|Overall Study|Progressive Disease|12|||
146832986|NCT01296555|529559155|FG014|Overall Study|Progressive Disease|1|||
146832987|NCT01296555|529559156|FG015|Overall Study|Progressive Disease|1|||
146832988|NCT01296555|529559157|FG016|Overall Study|Progressive Disease|0|||
146832989|NCT01296555|529559158|FG017|Overall Study|Progressive Disease|0|||
146832990|NCT01296555|529559159|FG018|Overall Study|Progressive Disease|0|||
146832991|NCT01296555|529559160|FG019|Overall Study|Progressive Disease|1|||
146832992|NCT01296555|529559161|FG020|Overall Study|Progressive Disease|0|||
146832993|NCT01296555|529559162|FG021|Overall Study|Progressive Disease|0|||
146832994|NCT01296555|529559163|FG022|Overall Study|Progressive Disease|0|||
146832995|NCT01296555|529559164|FG023|Overall Study|Progressive Disease|0|||
146832996|NCT01296555|529559165|FG024|Overall Study|Progressive Disease|1|||
146832997|NCT01296555|529559166|FG025|Overall Study|Progressive Disease|0|||
146832998|NCT01296555|529559167|FG026|Overall Study|Progressive Disease|5|||
146832999|NCT01296555|529559168|FG027|Overall Study|Progressive Disease|1|||
146833000|NCT01296555|529559169|FG028|Overall Study|Progressive Disease|0|||
146833001|NCT01296555|529559141|FG000|Overall Study|Protocol Violation|0|||
146833002|NCT01296555|529559142|FG001|Overall Study|Protocol Violation|0|||
146833003|NCT01296555|529559143|FG002|Overall Study|Protocol Violation|0|||
146833004|NCT01296555|529559144|FG003|Overall Study|Protocol Violation|0|||
146833005|NCT01296555|529559145|FG004|Overall Study|Protocol Violation|0|||
146833006|NCT01296555|529559146|FG005|Overall Study|Protocol Violation|0|||
146833007|NCT01296555|529559147|FG006|Overall Study|Protocol Violation|0|||
146833008|NCT01296555|529559148|FG007|Overall Study|Protocol Violation|0|||
146833009|NCT01296555|529559149|FG008|Overall Study|Protocol Violation|0|||
146833010|NCT01296555|529559150|FG009|Overall Study|Protocol Violation|0|||
146833011|NCT01296555|529559151|FG010|Overall Study|Protocol Violation|0|||
146833012|NCT01296555|529559152|FG011|Overall Study|Protocol Violation|0|||
146833013|NCT01296555|529559153|FG012|Overall Study|Protocol Violation|0|||
146833014|NCT01296555|529559154|FG013|Overall Study|Protocol Violation|1|||
146833015|NCT01296555|529559155|FG014|Overall Study|Protocol Violation|0|||
146833016|NCT01296555|529559156|FG015|Overall Study|Protocol Violation|0|||
146833017|NCT01296555|529559157|FG016|Overall Study|Protocol Violation|0|||
146833018|NCT01296555|529559158|FG017|Overall Study|Protocol Violation|0|||
146833019|NCT01296555|529559159|FG018|Overall Study|Protocol Violation|0|||
146833020|NCT01296555|529559160|FG019|Overall Study|Protocol Violation|0|||
146833021|NCT01296555|529559161|FG020|Overall Study|Protocol Violation|0|||
146833022|NCT01296555|529559162|FG021|Overall Study|Protocol Violation|0|||
146833023|NCT01296555|529559163|FG022|Overall Study|Protocol Violation|0|||
146833024|NCT01296555|529559164|FG023|Overall Study|Protocol Violation|0|||
146833025|NCT01296555|529559165|FG024|Overall Study|Protocol Violation|0|||
146833026|NCT01296555|529559166|FG025|Overall Study|Protocol Violation|0|||
146833027|NCT01296555|529559167|FG026|Overall Study|Protocol Violation|0|||
146833028|NCT01296555|529559168|FG027|Overall Study|Protocol Violation|0|||
146833029|NCT01296555|529559169|FG028|Overall Study|Protocol Violation|0|||
146833030|NCT01296555|529559141|FG000|Overall Study|Study Terminated By Sponsor|0|||
146833031|NCT01296555|529559142|FG001|Overall Study|Study Terminated By Sponsor|0|||
146833032|NCT01296555|529559143|FG002|Overall Study|Study Terminated By Sponsor|0|||
146833033|NCT01296555|529559144|FG003|Overall Study|Study Terminated By Sponsor|0|||
146833034|NCT01296555|529559145|FG004|Overall Study|Study Terminated By Sponsor|0|||
146833035|NCT01296555|529559146|FG005|Overall Study|Study Terminated By Sponsor|0|||
146833036|NCT01296555|529559147|FG006|Overall Study|Study Terminated By Sponsor|0|||
146833037|NCT01296555|529559148|FG007|Overall Study|Study Terminated By Sponsor|0|||
146833038|NCT01296555|529559149|FG008|Overall Study|Study Terminated By Sponsor|0|||
146833039|NCT01296555|529559150|FG009|Overall Study|Study Terminated By Sponsor|0|||
146833040|NCT01296555|529559151|FG010|Overall Study|Study Terminated By Sponsor|0|||
146833041|NCT01296555|529559152|FG011|Overall Study|Study Terminated By Sponsor|0|||
146833042|NCT01296555|529559153|FG012|Overall Study|Study Terminated By Sponsor|0|||
146833043|NCT01296555|529559154|FG013|Overall Study|Study Terminated By Sponsor|0|||
146833044|NCT01296555|529559155|FG014|Overall Study|Study Terminated By Sponsor|0|||
146833045|NCT01296555|529559156|FG015|Overall Study|Study Terminated By Sponsor|0|||
146833046|NCT01296555|529559157|FG016|Overall Study|Study Terminated By Sponsor|0|||
146833047|NCT01296555|529559158|FG017|Overall Study|Study Terminated By Sponsor|0|||
146833048|NCT01296555|529559159|FG018|Overall Study|Study Terminated By Sponsor|0|||
146833049|NCT01296555|529559160|FG019|Overall Study|Study Terminated By Sponsor|0|||
146833050|NCT01296555|529559161|FG020|Overall Study|Study Terminated By Sponsor|0|||
146833051|NCT01296555|529559162|FG021|Overall Study|Study Terminated By Sponsor|0|||
146833052|NCT01296555|529559163|FG022|Overall Study|Study Terminated By Sponsor|0|||
146833053|NCT01296555|529559164|FG023|Overall Study|Study Terminated By Sponsor|0|||
146833054|NCT01296555|529559165|FG024|Overall Study|Study Terminated By Sponsor|0|||
146833055|NCT01296555|529559166|FG025|Overall Study|Study Terminated By Sponsor|1|||
146833056|NCT01296555|529559167|FG026|Overall Study|Study Terminated By Sponsor|0|||
146987480|NCT01498484|530116854|FG008|Overall Study|Withdrawal by Subject|0|||
146987481|NCT01498484|530116846|FG000|Overall Study|Other|5|||
146987482|NCT01498484|530116847|FG001|Overall Study|Other|2|||
146987483|NCT01498484|530116848|FG002|Overall Study|Other|0|||
146987484|NCT01498484|530116849|FG003|Overall Study|Other|0|||
146987485|NCT01498484|530116850|FG004|Overall Study|Other|1|||
146987486|NCT01498484|530116851|FG005|Overall Study|Other|0|||
146987487|NCT01498484|530116852|FG006|Overall Study|Other|3|||
146987488|NCT01498484|530116853|FG007|Overall Study|Other|0|||
146987489|NCT01498484|530116854|FG008|Overall Study|Other|1|||
146987490|NCT03387098|530116855|FG000|Overall Study|progressive disease|1|||
146987491|NCT03387098|530116855|FG000|Overall Study|Withdrawal by Subject|2|||
146833057|NCT01296555|529559168|FG027|Overall Study|Study Terminated By Sponsor|0|||
146833058|NCT01296555|529559169|FG028|Overall Study|Study Terminated By Sponsor|0|||
146833059|NCT01296555|529559141|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146987492|NCT03387098|530116855|FG000|Overall Study|study terminated by sponsor|1|||
146987493|NCT02486796|530116856|FG000|Overall Study|Withdrawal by Subject|1|||
146987494|NCT02486796|530116857|FG001|Overall Study|Withdrawal by Subject|1|||
146987495|NCT02486796|530116856|FG000|Overall Study|Physician Decision|1|||
146833060|NCT01296555|529559142|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833061|NCT01296555|529559143|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146987496|NCT02486796|530116857|FG001|Overall Study|Physician Decision|0|||
146987497|NCT02974153|530116858|FG000|Overall Study|Adverse Event|6|||
146987498|NCT02974153|530116859|FG001|Overall Study|Adverse Event|0|||
146987499|NCT02974153|530116860|FG002|Overall Study|Adverse Event|1|||
146987500|NCT02974153|530116858|FG000|Overall Study|Lack of Efficacy|6|||
146987501|NCT02974153|530116859|FG001|Overall Study|Lack of Efficacy|5|||
146987502|NCT02974153|530116860|FG002|Overall Study|Lack of Efficacy|10|||
146987503|NCT02974153|530116858|FG000|Overall Study|Lost to Follow-up|9|||
146987504|NCT02974153|530116859|FG001|Overall Study|Lost to Follow-up|10|||
146987505|NCT02974153|530116860|FG002|Overall Study|Lost to Follow-up|17|||
146987506|NCT02974153|530116858|FG000|Overall Study|Physician Decision|0|||
146987507|NCT02974153|530116859|FG001|Overall Study|Physician Decision|2|||
146987508|NCT02974153|530116860|FG002|Overall Study|Physician Decision|1|||
146987509|NCT02974153|530116858|FG000|Overall Study|Withdrawal by Subject|9|||
146987510|NCT02974153|530116859|FG001|Overall Study|Withdrawal by Subject|16|||
146987511|NCT02974153|530116860|FG002|Overall Study|Withdrawal by Subject|11|||
146987512|NCT02974153|530116858|FG000|Overall Study|Study Burden|8|||
146987513|NCT02974153|530116859|FG001|Overall Study|Study Burden|7|||
146987514|NCT02974153|530116860|FG002|Overall Study|Study Burden|3|||
146987515|NCT02974153|530116858|FG000|Overall Study|Other|14|||
146987516|NCT02974153|530116859|FG001|Overall Study|Other|8|||
146987517|NCT02974153|530116860|FG002|Overall Study|Other|7|||
146833062|NCT01296555|529559144|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833063|NCT01296555|529559145|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833064|NCT01296555|529559146|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833065|NCT01296555|529559147|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833066|NCT01296555|529559148|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833067|NCT01296555|529559149|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833068|NCT01296555|529559150|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833069|NCT01296555|529559151|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833070|NCT01296555|529559152|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833071|NCT01296555|529559153|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833072|NCT01296555|529559154|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833073|NCT01296555|529559155|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833074|NCT01296555|529559156|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833075|NCT01296555|529559157|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833076|NCT01296555|529559158|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833077|NCT01296555|529559159|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833078|NCT01296555|529559160|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
146833079|NCT01296555|529559161|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833080|NCT01296555|529559162|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833081|NCT01296555|529559163|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833082|NCT01296555|529559164|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146987518|NCT00423800|530116861|FG000|Overall Study|Protocol Violation|0|||
146833083|NCT01296555|529559165|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833084|NCT01296555|529559166|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146987519|NCT00423800|530116862|FG001|Overall Study|Protocol Violation|1|||
146987520|NCT00679783|530116864|FG000|Overall Study|Adverse Event|0|||
146987521|NCT00679783|530116865|FG001|Overall Study|Adverse Event|0|||
146987522|NCT00679783|530116866|FG002|Overall Study|Adverse Event|0|||
146987523|NCT00679783|530116867|FG003|Overall Study|Adverse Event|3|||
146987524|NCT00679783|530116868|FG004|Overall Study|Adverse Event|0|||
146987525|NCT00679783|530116869|FG005|Overall Study|Adverse Event|0|||
146987526|NCT00679783|530116870|FG006|Overall Study|Adverse Event|1|||
146833085|NCT01296555|529559167|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833086|NCT01296555|529559168|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833087|NCT01296555|529559169|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146833088|NCT01296555|529559141|FG000|Overall Study|Death|0|||
146833089|NCT01296555|529559142|FG001|Overall Study|Death|0|||
146833090|NCT01296555|529559143|FG002|Overall Study|Death|0|||
146833091|NCT01296555|529559144|FG003|Overall Study|Death|2|||
146833092|NCT01296555|529559145|FG004|Overall Study|Death|1|||
146833093|NCT01296555|529559146|FG005|Overall Study|Death|0|||
146833094|NCT01296555|529559147|FG006|Overall Study|Death|2|||
146833095|NCT01296555|529559148|FG007|Overall Study|Death|0|||
146833096|NCT01296555|529559149|FG008|Overall Study|Death|0|||
146833097|NCT01296555|529559150|FG009|Overall Study|Death|1|||
146833098|NCT01296555|529559151|FG010|Overall Study|Death|0|||
146833099|NCT01296555|529559152|FG011|Overall Study|Death|1|||
146833100|NCT01296555|529559153|FG012|Overall Study|Death|0|||
146833101|NCT01296555|529559154|FG013|Overall Study|Death|2|||
146833102|NCT01296555|529559155|FG014|Overall Study|Death|27|||
146833103|NCT01296555|529559156|FG015|Overall Study|Death|15|||
146833104|NCT01296555|529559157|FG016|Overall Study|Death|11|||
146833105|NCT01296555|529559158|FG017|Overall Study|Death|11|||
146833106|NCT01296555|529559159|FG018|Overall Study|Death|17|||
146833107|NCT01296555|529559160|FG019|Overall Study|Death|12|||
146833108|NCT01296555|529559161|FG020|Overall Study|Death|13|||
146833109|NCT01296555|529559162|FG021|Overall Study|Death|12|||
146833110|NCT01296555|529559163|FG022|Overall Study|Death|12|||
146833111|NCT01296555|529559164|FG023|Overall Study|Death|13|||
146833112|NCT01296555|529559165|FG024|Overall Study|Death|7|||
146833113|NCT01296555|529559166|FG025|Overall Study|Death|7|||
146833114|NCT01296555|529559167|FG026|Overall Study|Death|35|||
146833115|NCT01296555|529559168|FG027|Overall Study|Death|92|||
146833116|NCT01296555|529559169|FG028|Overall Study|Death|44|||
146833117|NCT01296555|529559141|FG000|Overall Study|Lost to Follow-up|0|||
146833118|NCT01296555|529559142|FG001|Overall Study|Lost to Follow-up|0|||
146833119|NCT01296555|529559143|FG002|Overall Study|Lost to Follow-up|0|||
146833120|NCT01296555|529559144|FG003|Overall Study|Lost to Follow-up|0|||
146833121|NCT01296555|529559145|FG004|Overall Study|Lost to Follow-up|0|||
146833122|NCT01296555|529559146|FG005|Overall Study|Lost to Follow-up|0|||
146833123|NCT01296555|529559147|FG006|Overall Study|Lost to Follow-up|0|||
146833124|NCT01296555|529559148|FG007|Overall Study|Lost to Follow-up|0|||
146833125|NCT01296555|529559149|FG008|Overall Study|Lost to Follow-up|0|||
146833126|NCT01296555|529559150|FG009|Overall Study|Lost to Follow-up|0|||
146833127|NCT01296555|529559151|FG010|Overall Study|Lost to Follow-up|0|||
146833128|NCT01296555|529559152|FG011|Overall Study|Lost to Follow-up|0|||
146833129|NCT01296555|529559153|FG012|Overall Study|Lost to Follow-up|0|||
146833130|NCT01296555|529559154|FG013|Overall Study|Lost to Follow-up|0|||
146833131|NCT01296555|529559155|FG014|Overall Study|Lost to Follow-up|2|||
146833132|NCT01296555|529559156|FG015|Overall Study|Lost to Follow-up|1|||
146833133|NCT01296555|529559157|FG016|Overall Study|Lost to Follow-up|0|||
146833134|NCT01296555|529559158|FG017|Overall Study|Lost to Follow-up|2|||
146833135|NCT01296555|529559159|FG018|Overall Study|Lost to Follow-up|0|||
146833136|NCT01296555|529559160|FG019|Overall Study|Lost to Follow-up|2|||
146833137|NCT01296555|529559161|FG020|Overall Study|Lost to Follow-up|3|||
146833138|NCT01296555|529559162|FG021|Overall Study|Lost to Follow-up|2|||
146833139|NCT01296555|529559163|FG022|Overall Study|Lost to Follow-up|0|||
146833140|NCT01296555|529559164|FG023|Overall Study|Lost to Follow-up|0|||
146833141|NCT01296555|529559165|FG024|Overall Study|Lost to Follow-up|0|||
146833142|NCT01296555|529559166|FG025|Overall Study|Lost to Follow-up|0|||
146833143|NCT01296555|529559167|FG026|Overall Study|Lost to Follow-up|3|||
146833144|NCT01296555|529559168|FG027|Overall Study|Lost to Follow-up|13|||
146833145|NCT01296555|529559169|FG028|Overall Study|Lost to Follow-up|5|||
146833146|NCT01296555|529559141|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146833147|NCT01296555|529559142|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146833148|NCT01296555|529559143|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146833149|NCT01296555|529559144|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146833150|NCT01296555|529559145|FG004|Overall Study|Non-Compliance With Study Drug|0|||
146833151|NCT01296555|529559146|FG005|Overall Study|Non-Compliance With Study Drug|0|||
146833152|NCT01296555|529559147|FG006|Overall Study|Non-Compliance With Study Drug|0|||
146833153|NCT01296555|529559148|FG007|Overall Study|Non-Compliance With Study Drug|1|||
146833154|NCT01296555|529559149|FG008|Overall Study|Non-Compliance With Study Drug|0|||
146833155|NCT01296555|529559150|FG009|Overall Study|Non-Compliance With Study Drug|0|||
146833156|NCT01296555|529559151|FG010|Overall Study|Non-Compliance With Study Drug|0|||
146833157|NCT01296555|529559152|FG011|Overall Study|Non-Compliance With Study Drug|0|||
146833158|NCT01296555|529559153|FG012|Overall Study|Non-Compliance With Study Drug|0|||
146987527|NCT00679783|530116864|FG000|Overall Study|Lack of Efficacy|0|||
146987528|NCT00679783|530116865|FG001|Overall Study|Lack of Efficacy|1|||
146833159|NCT01296555|529559154|FG013|Overall Study|Non-Compliance With Study Drug|0|||
146833160|NCT01296555|529559155|FG014|Overall Study|Non-Compliance With Study Drug|0|||
146833161|NCT01296555|529559156|FG015|Overall Study|Non-Compliance With Study Drug|0|||
146833162|NCT01296555|529559157|FG016|Overall Study|Non-Compliance With Study Drug|0|||
146833163|NCT01296555|529559158|FG017|Overall Study|Non-Compliance With Study Drug|0|||
146833164|NCT01296555|529559159|FG018|Overall Study|Non-Compliance With Study Drug|0|||
146833165|NCT01296555|529559160|FG019|Overall Study|Non-Compliance With Study Drug|0|||
146833166|NCT01296555|529559161|FG020|Overall Study|Non-Compliance With Study Drug|0|||
146833167|NCT01296555|529559162|FG021|Overall Study|Non-Compliance With Study Drug|0|||
146833168|NCT01296555|529559163|FG022|Overall Study|Non-Compliance With Study Drug|0|||
146833169|NCT01296555|529559164|FG023|Overall Study|Non-Compliance With Study Drug|0|||
146833170|NCT01296555|529559165|FG024|Overall Study|Non-Compliance With Study Drug|0|||
146833171|NCT01296555|529559166|FG025|Overall Study|Non-Compliance With Study Drug|0|||
146833172|NCT01296555|529559167|FG026|Overall Study|Non-Compliance With Study Drug|0|||
146833173|NCT01296555|529559168|FG027|Overall Study|Non-Compliance With Study Drug|0|||
146833174|NCT01296555|529559169|FG028|Overall Study|Non-Compliance With Study Drug|0|||
146833175|NCT01296555|529559141|FG000|Overall Study|Withdrawal by Subject|0|||
146833176|NCT01296555|529559142|FG001|Overall Study|Withdrawal by Subject|0|||
146833177|NCT01296555|529559143|FG002|Overall Study|Withdrawal by Subject|0|||
146833178|NCT01296555|529559144|FG003|Overall Study|Withdrawal by Subject|0|||
146833179|NCT01296555|529559145|FG004|Overall Study|Withdrawal by Subject|1|||
146833180|NCT01296555|529559146|FG005|Overall Study|Withdrawal by Subject|0|||
146833181|NCT01296555|529559147|FG006|Overall Study|Withdrawal by Subject|1|||
146833182|NCT01296555|529559148|FG007|Overall Study|Withdrawal by Subject|0|||
146833183|NCT01296555|529559149|FG008|Overall Study|Withdrawal by Subject|0|||
146833184|NCT01296555|529559150|FG009|Overall Study|Withdrawal by Subject|0|||
146833185|NCT01296555|529559151|FG010|Overall Study|Withdrawal by Subject|1|||
146833186|NCT01296555|529559152|FG011|Overall Study|Withdrawal by Subject|1|||
146833187|NCT01296555|529559153|FG012|Overall Study|Withdrawal by Subject|0|||
146833188|NCT01296555|529559154|FG013|Overall Study|Withdrawal by Subject|0|||
146833189|NCT01296555|529559155|FG014|Overall Study|Withdrawal by Subject|3|||
146833190|NCT01296555|529559156|FG015|Overall Study|Withdrawal by Subject|0|||
146833191|NCT01296555|529559157|FG016|Overall Study|Withdrawal by Subject|2|||
146833192|NCT01296555|529559158|FG017|Overall Study|Withdrawal by Subject|1|||
146833193|NCT01296555|529559159|FG018|Overall Study|Withdrawal by Subject|0|||
146833194|NCT01296555|529559160|FG019|Overall Study|Withdrawal by Subject|1|||
146833195|NCT01296555|529559161|FG020|Overall Study|Withdrawal by Subject|1|||
146833196|NCT01296555|529559162|FG021|Overall Study|Withdrawal by Subject|1|||
146833197|NCT01296555|529559163|FG022|Overall Study|Withdrawal by Subject|3|||
146833198|NCT01296555|529559164|FG023|Overall Study|Withdrawal by Subject|0|||
146833199|NCT01296555|529559165|FG024|Overall Study|Withdrawal by Subject|0|||
146833200|NCT01296555|529559166|FG025|Overall Study|Withdrawal by Subject|0|||
146833201|NCT01296555|529559167|FG026|Overall Study|Withdrawal by Subject|8|||
146833202|NCT01296555|529559168|FG027|Overall Study|Withdrawal by Subject|4|||
146833203|NCT01296555|529559169|FG028|Overall Study|Withdrawal by Subject|2|||
146833204|NCT01628692|529559172|FG000|Overall Study|Lack of Efficacy|4|||
146833205|NCT01628692|529559173|FG001|Overall Study|Lack of Efficacy|4|||
146833206|NCT01628692|529559174|FG002|Overall Study|Lack of Efficacy|5|||
146833207|NCT01628692|529559175|FG003|Overall Study|Lack of Efficacy|1|||
146833208|NCT01628692|529559176|FG004|Overall Study|Lack of Efficacy|4|||
146833209|NCT01628692|529559177|FG005|Overall Study|Lack of Efficacy|7|||
146833210|NCT01628692|529559172|FG000|Overall Study|Adverse Event|2|||
146833211|NCT01628692|529559173|FG001|Overall Study|Adverse Event|0|||
146833212|NCT01628692|529559174|FG002|Overall Study|Adverse Event|2|||
146833213|NCT01628692|529559175|FG003|Overall Study|Adverse Event|0|||
146833214|NCT01628692|529559176|FG004|Overall Study|Adverse Event|0|||
146833215|NCT01628692|529559177|FG005|Overall Study|Adverse Event|0|||
146833216|NCT01628692|529559172|FG000|Overall Study|Withdrawal by Subject|0|||
146833217|NCT01628692|529559173|FG001|Overall Study|Withdrawal by Subject|1|||
146833218|NCT01628692|529559174|FG002|Overall Study|Withdrawal by Subject|1|||
146833219|NCT01628692|529559175|FG003|Overall Study|Withdrawal by Subject|0|||
146833220|NCT01628692|529559176|FG004|Overall Study|Withdrawal by Subject|0|||
146833221|NCT01628692|529559177|FG005|Overall Study|Withdrawal by Subject|0|||
146833222|NCT01628692|529559172|FG000|Overall Study|Death|0|||
146833223|NCT01628692|529559173|FG001|Overall Study|Death|1|||
146833224|NCT01628692|529559174|FG002|Overall Study|Death|0|||
146833225|NCT01628692|529559175|FG003|Overall Study|Death|0|||
146833226|NCT01628692|529559176|FG004|Overall Study|Death|0|||
146833227|NCT01628692|529559177|FG005|Overall Study|Death|0|||
146987529|NCT00679783|530116866|FG002|Overall Study|Lack of Efficacy|0|||
146987530|NCT00679783|530116867|FG003|Overall Study|Lack of Efficacy|2|||
146833228|NCT01628692|529559172|FG000|Overall Study|Poor compliance/noncompliance|1|||
146833229|NCT01628692|529559173|FG001|Overall Study|Poor compliance/noncompliance|0|||
146833230|NCT01628692|529559174|FG002|Overall Study|Poor compliance/noncompliance|0|||
146833231|NCT01628692|529559175|FG003|Overall Study|Poor compliance/noncompliance|0|||
146833232|NCT01628692|529559176|FG004|Overall Study|Poor compliance/noncompliance|0|||
146833233|NCT01628692|529559177|FG005|Overall Study|Poor compliance/noncompliance|0|||
146833234|NCT01628692|529559172|FG000|Overall Study|Administrative reason by sponsor|0|||
146833235|NCT01628692|529559173|FG001|Overall Study|Administrative reason by sponsor|0|||
146987531|NCT00679783|530116868|FG004|Overall Study|Lack of Efficacy|0|||
146833236|NCT01628692|529559174|FG002|Overall Study|Administrative reason by sponsor|0|||
146833237|NCT01628692|529559175|FG003|Overall Study|Administrative reason by sponsor|0|||
146833238|NCT01628692|529559176|FG004|Overall Study|Administrative reason by sponsor|0|||
146833239|NCT01628692|529559177|FG005|Overall Study|Administrative reason by sponsor|1|||
146833240|NCT01628692|529559172|FG000|Overall Study|Completed 12 Week only|0|||
146833241|NCT01628692|529559173|FG001|Overall Study|Completed 12 Week only|0|||
146833242|NCT01628692|529559174|FG002|Overall Study|Completed 12 Week only|0|||
146833243|NCT01628692|529559175|FG003|Overall Study|Completed 12 Week only|0|||
146833244|NCT01628692|529559176|FG004|Overall Study|Completed 12 Week only|0|||
146833245|NCT01628692|529559177|FG005|Overall Study|Completed 12 Week only|1|||
146833246|NCT01182181|529559178|FG000|First Intervention|Adverse Event|1|||
146833247|NCT01182181|529559179|FG001|First Intervention|Adverse Event|0|||
146833248|NCT01182181|529559178|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
146833249|NCT01182181|529559179|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
146833250|NCT01101061|529559180|FG000|Overall Study|Adverse Event|0|||
146833251|NCT01101061|529559181|FG001|Overall Study|Adverse Event|0|||
146833252|NCT01101061|529559182|FG002|Overall Study|Adverse Event|1|||
146833253|NCT01101061|529559183|FG003|Overall Study|Adverse Event|0|||
146833254|NCT01101061|529559184|FG004|Overall Study|Adverse Event|0|||
146833255|NCT01101061|529559185|FG005|Overall Study|Adverse Event|0|||
146833256|NCT00857233|529559186|FG000|Overall Study|Adverse Event|24|||
146833257|NCT00857233|529559186|FG000|Overall Study|Lack of Efficacy|1|||
146833258|NCT00857233|529559186|FG000|Overall Study|Non-compliance|1|||
146833259|NCT00857233|529559186|FG000|Overall Study|Withdrawal of Consent|9|||
146833260|NCT00857233|529559186|FG000|Overall Study|Lost to Follow-up|4|||
146833261|NCT00857233|529559186|FG000|Overall Study|Nursing Home Placement|14|||
146833262|NCT00857233|529559186|FG000|Overall Study|Other Reasons|2|||
146833263|NCT01587118|529559187|FG000|Overall Study|Adverse Event|3|||
146833264|NCT01587118|529559187|FG000|Overall Study|Lost to Follow-up|2|||
146833265|NCT01587118|529559187|FG000|Overall Study|Relocation|1|||
146833266|NCT01587118|529559187|FG000|Overall Study|nonresponse|1|||
146833267|NCT00409409|529559188|FG000|Overall Study|Adverse Event|7|||
146987532|NCT00679783|530116869|FG005|Overall Study|Lack of Efficacy|0|||
146987533|NCT00679783|530116870|FG006|Overall Study|Lack of Efficacy|0|||
146987534|NCT00679783|530116864|FG000|Overall Study|Withdrawal by Subject|0|||
146987535|NCT00679783|530116865|FG001|Overall Study|Withdrawal by Subject|0|||
146987536|NCT00679783|530116866|FG002|Overall Study|Withdrawal by Subject|1|||
146987537|NCT00679783|530116867|FG003|Overall Study|Withdrawal by Subject|1|||
146987538|NCT00679783|530116868|FG004|Overall Study|Withdrawal by Subject|0|||
146987539|NCT00679783|530116869|FG005|Overall Study|Withdrawal by Subject|0|||
146987540|NCT00679783|530116870|FG006|Overall Study|Withdrawal by Subject|0|||
146987541|NCT00679783|530116864|FG000|Overall Study|Not Captured|0|||
146987542|NCT00679783|530116865|FG001|Overall Study|Not Captured|0|||
146987543|NCT00679783|530116866|FG002|Overall Study|Not Captured|0|||
146987544|NCT00679783|530116867|FG003|Overall Study|Not Captured|5|||
146987545|NCT00679783|530116868|FG004|Overall Study|Not Captured|0|||
146987546|NCT00679783|530116869|FG005|Overall Study|Not Captured|0|||
146987547|NCT00679783|530116870|FG006|Overall Study|Not Captured|0|||
146987548|NCT00679783|530116864|FG000|Overall Study|Ongoing at data cut-off|2|||
146987549|NCT00679783|530116865|FG001|Overall Study|Ongoing at data cut-off|2|||
146987550|NCT00679783|530116866|FG002|Overall Study|Ongoing at data cut-off|0|||
146987551|NCT00679783|530116867|FG003|Overall Study|Ongoing at data cut-off|9|||
146987552|NCT00679783|530116868|FG004|Overall Study|Ongoing at data cut-off|1|||
146987553|NCT00679783|530116869|FG005|Overall Study|Ongoing at data cut-off|0|||
146987554|NCT00679783|530116870|FG006|Overall Study|Ongoing at data cut-off|0|||
146987555|NCT00814320|530116871|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
146833268|NCT00409409|529559189|FG001|Overall Study|Adverse Event|2|||
146833269|NCT00409409|529559188|FG000|Overall Study|Withdrawal by Subject|1|||
146833270|NCT00409409|529559189|FG001|Overall Study|Withdrawal by Subject|1|||
146833271|NCT00409409|529559188|FG000|Overall Study|Any other reason not above-mentioned|0|||
146833272|NCT00409409|529559189|FG001|Overall Study|Any other reason not above-mentioned|1|||
146833273|NCT00267098|529559190|FG000|Overall Study|Death|0|||
146833274|NCT00267098|529559191|FG001|Overall Study|Death|0|||
146833275|NCT00267098|529559192|FG002|Overall Study|Death|57|||
146987556|NCT00814320|530116872|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
146833276|NCT00267098|529559193|FG003|Overall Study|Death|66|||
146987557|NCT00814320|530116871|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
146987558|NCT00814320|530116872|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
146987559|NCT00814320|530116871|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
146833277|NCT00267098|529559194|FG004|Overall Study|Death|14|||
146833278|NCT00267098|529559195|FG005|Overall Study|Death|23|||
146833279|NCT00267098|529559196|FG006|Overall Study|Death|28|||
146987560|NCT00814320|530116872|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
146987561|NCT00814320|530116871|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
146987562|NCT00814320|530116872|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
146833280|NCT00267098|529559197|FG007|Overall Study|Death|9|||
146833281|NCT00267098|529559190|FG000|Overall Study|Lost to Follow-up|0|||
146833282|NCT00267098|529559191|FG001|Overall Study|Lost to Follow-up|0|||
146833283|NCT00267098|529559192|FG002|Overall Study|Lost to Follow-up|6|||
146833284|NCT00267098|529559193|FG003|Overall Study|Lost to Follow-up|5|||
146833285|NCT00267098|529559194|FG004|Overall Study|Lost to Follow-up|2|||
146833286|NCT00267098|529559195|FG005|Overall Study|Lost to Follow-up|3|||
146987563|NCT00814320|530116871|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
146987564|NCT00814320|530116872|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
146987565|NCT00814320|530116871|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
146987566|NCT00814320|530116872|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
146987567|NCT00814320|530116871|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
146987568|NCT00814320|530116872|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
146987569|NCT00814320|530116871|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
146987570|NCT00814320|530116872|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
146987571|NCT00814320|530116871|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
146987572|NCT00814320|530116872|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
146987573|NCT00814320|530116871|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
146987574|NCT00814320|530116872|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
146987575|NCT00491504|530116873|FG000|Overall Study|Adverse Event|0|||
146833287|NCT00267098|529559196|FG006|Overall Study|Lost to Follow-up|1|||
146833288|NCT00267098|529559197|FG007|Overall Study|Lost to Follow-up|1|||
146833289|NCT00267098|529559190|FG000|Overall Study|Withdrawal by Subject|8|||
146833290|NCT00267098|529559191|FG001|Overall Study|Withdrawal by Subject|0|||
146833291|NCT00267098|529559192|FG002|Overall Study|Withdrawal by Subject|24|||
146833292|NCT00267098|529559193|FG003|Overall Study|Withdrawal by Subject|21|||
146833293|NCT00267098|529559194|FG004|Overall Study|Withdrawal by Subject|12|||
146833294|NCT00267098|529559195|FG005|Overall Study|Withdrawal by Subject|9|||
146833295|NCT00267098|529559196|FG006|Overall Study|Withdrawal by Subject|12|||
146833296|NCT00267098|529559197|FG007|Overall Study|Withdrawal by Subject|5|||
146833297|NCT00267098|529559190|FG000|Overall Study|Physician Decision|5|||
146833298|NCT00267098|529559191|FG001|Overall Study|Physician Decision|0|||
146833299|NCT00267098|529559192|FG002|Overall Study|Physician Decision|7|||
146833300|NCT00267098|529559193|FG003|Overall Study|Physician Decision|11|||
146833301|NCT00267098|529559194|FG004|Overall Study|Physician Decision|5|||
146833302|NCT00267098|529559195|FG005|Overall Study|Physician Decision|4|||
146833303|NCT00267098|529559196|FG006|Overall Study|Physician Decision|3|||
146833304|NCT00267098|529559197|FG007|Overall Study|Physician Decision|0|||
146833305|NCT00267098|529559190|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
146833306|NCT00267098|529559191|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146833307|NCT00267098|529559192|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146833308|NCT00267098|529559193|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146833309|NCT00267098|529559194|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
146833310|NCT00267098|529559195|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146833311|NCT00267098|529559196|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146833312|NCT00267098|529559197|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146833313|NCT00267098|529559190|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
146833314|NCT00267098|529559191|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
146833315|NCT00267098|529559192|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
146833316|NCT00267098|529559193|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
146833317|NCT00267098|529559194|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
146833318|NCT00267098|529559195|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
146833319|NCT00267098|529559196|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
146833320|NCT00267098|529559197|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
146833321|NCT00267098|529559190|FG000|Overall Study|Site closure|0|||
146833322|NCT00267098|529559191|FG001|Overall Study|Site closure|0|||
146833323|NCT00267098|529559192|FG002|Overall Study|Site closure|0|||
146833324|NCT00267098|529559193|FG003|Overall Study|Site closure|1|||
146833325|NCT00267098|529559194|FG004|Overall Study|Site closure|0|||
146833326|NCT00267098|529559195|FG005|Overall Study|Site closure|1|||
146833327|NCT00267098|529559196|FG006|Overall Study|Site closure|1|||
146833328|NCT00267098|529559197|FG007|Overall Study|Site closure|0|||
146833329|NCT00267098|529559190|FG000|Overall Study|Explanted Medtronic device|0|||
146833330|NCT00267098|529559191|FG001|Overall Study|Explanted Medtronic device|0|||
146833331|NCT00267098|529559192|FG002|Overall Study|Explanted Medtronic device|0|||
146833332|NCT00267098|529559193|FG003|Overall Study|Explanted Medtronic device|1|||
146987576|NCT00491504|530116874|FG001|Overall Study|Adverse Event|1|||
146833333|NCT00267098|529559194|FG004|Overall Study|Explanted Medtronic device|0|||
146833334|NCT00267098|529559195|FG005|Overall Study|Explanted Medtronic device|0|||
146833335|NCT00267098|529559196|FG006|Overall Study|Explanted Medtronic device|0|||
146833336|NCT00267098|529559197|FG007|Overall Study|Explanted Medtronic device|0|||
146833337|NCT00267098|529559190|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
146833338|NCT00267098|529559191|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
146833339|NCT00267098|529559192|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
146987577|NCT00491504|530116875|FG002|Overall Study|Adverse Event|0|||
146987578|NCT00491504|530116876|FG003|Overall Study|Adverse Event|0|||
146987579|NCT00491504|530116873|FG000|Overall Study|Withdrawal by Subject|0|||
146987580|NCT00491504|530116874|FG001|Overall Study|Withdrawal by Subject|0|||
146987581|NCT00491504|530116875|FG002|Overall Study|Withdrawal by Subject|1|||
146987582|NCT00491504|530116876|FG003|Overall Study|Withdrawal by Subject|2|||
146987583|NCT00491504|530116873|FG000|Overall Study|Protocol Violation|0|||
146987584|NCT00491504|530116874|FG001|Overall Study|Protocol Violation|0|||
146987585|NCT00491504|530116875|FG002|Overall Study|Protocol Violation|3|||
146987586|NCT00491504|530116876|FG003|Overall Study|Protocol Violation|2|||
146833340|NCT00267098|529559193|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
146833341|NCT00267098|529559194|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
146833342|NCT00267098|529559195|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
146833343|NCT00267098|529559196|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
146833344|NCT00267098|529559197|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
146833345|NCT00267098|529559190|FG000|Overall Study|Subject listed for heart transplant|0|||
146833346|NCT00267098|529559191|FG001|Overall Study|Subject listed for heart transplant|0|||
146833347|NCT00267098|529559192|FG002|Overall Study|Subject listed for heart transplant|0|||
146833348|NCT00267098|529559193|FG003|Overall Study|Subject listed for heart transplant|0|||
146833349|NCT00267098|529559194|FG004|Overall Study|Subject listed for heart transplant|0|||
146833350|NCT00267098|529559195|FG005|Overall Study|Subject listed for heart transplant|0|||
146833351|NCT00267098|529559196|FG006|Overall Study|Subject listed for heart transplant|1|||
146833352|NCT00267098|529559197|FG007|Overall Study|Subject listed for heart transplant|0|||
146833353|NCT00267098|529559190|FG000|Overall Study|Sponsor withdrew subject|0|||
146833354|NCT00267098|529559191|FG001|Overall Study|Sponsor withdrew subject|0|||
146833355|NCT00267098|529559192|FG002|Overall Study|Sponsor withdrew subject|0|||
146833356|NCT00267098|529559193|FG003|Overall Study|Sponsor withdrew subject|1|||
146833357|NCT00267098|529559194|FG004|Overall Study|Sponsor withdrew subject|0|||
146833358|NCT00267098|529559195|FG005|Overall Study|Sponsor withdrew subject|0|||
146833359|NCT00267098|529559196|FG006|Overall Study|Sponsor withdrew subject|0|||
146833360|NCT00267098|529559197|FG007|Overall Study|Sponsor withdrew subject|0|||
146833361|NCT00798304|529559200|FG000|Overall Study|Adverse Event|0|||
146833362|NCT00798304|529559201|FG001|Overall Study|Adverse Event|1|||
146833363|NCT00798304|529559202|FG002|Overall Study|Adverse Event|1|||
146833364|NCT00798304|529559200|FG000|Overall Study|Discontinuation by Sponsor|14|||
146833365|NCT00798304|529559201|FG001|Overall Study|Discontinuation by Sponsor|21|||
146833366|NCT00798304|529559202|FG002|Overall Study|Discontinuation by Sponsor|9|||
146833367|NCT04211389|529559203|FG000|Overall Study|Adverse Event|1|||
146833368|NCT04211389|529559204|FG001|Overall Study|Adverse Event|2|||
146833369|NCT04211389|529559203|FG000|Overall Study|Lost to Follow-up|15|||
146833370|NCT04211389|529559204|FG001|Overall Study|Lost to Follow-up|7|||
146833371|NCT04211389|529559203|FG000|Overall Study|Protocol Violation|0|||
146833372|NCT04211389|529559204|FG001|Overall Study|Protocol Violation|1|||
146833373|NCT04211389|529559203|FG000|Overall Study|Withdrawal by Subject|10|||
146833374|NCT04211389|529559204|FG001|Overall Study|Withdrawal by Subject|11|||
146833375|NCT00547534|529559207|FG000|Overall Study|Adverse Event|7|||
146833376|NCT00547534|529559207|FG000|Overall Study|Disease Progression|4|||
146833377|NCT02688530|529559216|FG000|Overall Study|Withdrawal by Subject|0|||
146833378|NCT02688530|529559217|FG001|Overall Study|Withdrawal by Subject|1|||
146833379|NCT02688530|529559218|FG002|Overall Study|Withdrawal by Subject|0|||
146833380|NCT02688530|529559219|FG003|Overall Study|Withdrawal by Subject|0|||
146833381|NCT02688530|529559216|FG000|Overall Study|Lost to Follow-up|0|||
146833382|NCT02688530|529559217|FG001|Overall Study|Lost to Follow-up|0|||
146833383|NCT02688530|529559218|FG002|Overall Study|Lost to Follow-up|2|||
146833384|NCT02688530|529559219|FG003|Overall Study|Lost to Follow-up|0|||
146833385|NCT01658020|529559220|FG000|Overall Study|Adverse Event|3|||
146833386|NCT01658020|529559221|FG001|Overall Study|Adverse Event|3|||
146833387|NCT01658020|529559220|FG000|Overall Study|Lost to Follow-up|1|||
146833388|NCT01658020|529559221|FG001|Overall Study|Lost to Follow-up|0|||
146833389|NCT01658020|529559220|FG000|Overall Study|Withdrawal by Subject|4|||
146833390|NCT01658020|529559221|FG001|Overall Study|Withdrawal by Subject|5|||
146833391|NCT01658020|529559220|FG000|Overall Study|Protocol Violation|0|||
146833392|NCT01658020|529559221|FG001|Overall Study|Protocol Violation|1|||
146833393|NCT04206085|529559222|FG000|Overall Study|Lost to Follow-up|0|||
146833394|NCT04206085|529559223|FG001|Overall Study|Lost to Follow-up|1|||
146833395|NCT04206085|529559224|FG002|Overall Study|Lost to Follow-up|0|||
146833396|NCT04206085|529559222|FG000|Overall Study|Lost to Follow-up|0|||
146833397|NCT04206085|529559223|FG001|Overall Study|Lost to Follow-up|0|||
146833398|NCT04206085|529559224|FG002|Overall Study|Lost to Follow-up|1|||
146833399|NCT00763451|529559225|FG000|Overall Study|Adverse Event|4|||
146833400|NCT00763451|529559226|FG001|Overall Study|Adverse Event|6|||
146833401|NCT00763451|529559227|FG002|Overall Study|Adverse Event|19|||
146833402|NCT00763451|529559228|FG003|Overall Study|Adverse Event|14|||
146833403|NCT00763451|529559225|FG000|Overall Study|Lack of Efficacy|1|||
146833404|NCT00763451|529559226|FG001|Overall Study|Lack of Efficacy|4|||
146833405|NCT00763451|529559227|FG002|Overall Study|Lack of Efficacy|3|||
146833406|NCT00763451|529559228|FG003|Overall Study|Lack of Efficacy|2|||
146833407|NCT00763451|529559225|FG000|Overall Study|Withdrawal by Subject|1|||
146833408|NCT00763451|529559226|FG001|Overall Study|Withdrawal by Subject|6|||
146833409|NCT00763451|529559227|FG002|Overall Study|Withdrawal by Subject|9|||
146833410|NCT00763451|529559228|FG003|Overall Study|Withdrawal by Subject|7|||
146833411|NCT00763451|529559225|FG000|Overall Study|Protocol Violation|0|||
146833412|NCT00763451|529559226|FG001|Overall Study|Protocol Violation|0|||
146833413|NCT00763451|529559227|FG002|Overall Study|Protocol Violation|1|||
146833414|NCT00763451|529559228|FG003|Overall Study|Protocol Violation|0|||
146833415|NCT00763451|529559225|FG000|Overall Study|Poor Compliance to Protocol|1|||
146833416|NCT00763451|529559226|FG001|Overall Study|Poor Compliance to Protocol|1|||
146833417|NCT00763451|529559227|FG002|Overall Study|Poor Compliance to Protocol|2|||
146833418|NCT00763451|529559228|FG003|Overall Study|Poor Compliance to Protocol|2|||
146833419|NCT00763451|529559225|FG000|Overall Study|Familial and Personal Reasons|5|||
146833420|NCT00763451|529559226|FG001|Overall Study|Familial and Personal Reasons|3|||
146833421|NCT00763451|529559227|FG002|Overall Study|Familial and Personal Reasons|5|||
146833422|NCT00763451|529559228|FG003|Overall Study|Familial and Personal Reasons|4|||
146833423|NCT00763451|529559225|FG000|Overall Study|Randomized but not Treated|1|||
146833424|NCT00763451|529559226|FG001|Overall Study|Randomized but not Treated|1|||
146833425|NCT00763451|529559227|FG002|Overall Study|Randomized but not Treated|0|||
146833426|NCT00763451|529559228|FG003|Overall Study|Randomized but not Treated|0|||
146833427|NCT00763451|529559225|FG000|Overall Study|Study Site Reason|0|||
146833428|NCT00763451|529559226|FG001|Overall Study|Study Site Reason|1|||
146833429|NCT00763451|529559227|FG002|Overall Study|Study Site Reason|1|||
146833430|NCT00763451|529559228|FG003|Overall Study|Study Site Reason|1|||
146833431|NCT00725543|529559232|FG000|Overall Study|Adverse Event|10|||
146833432|NCT00725543|529559232|FG000|Overall Study|Lack of Efficacy|3|||
146833433|NCT00725543|529559232|FG000|Overall Study|Withdrawal by Subject|10|||
146833434|NCT00725543|529559232|FG000|Overall Study|Physician Decision|5|||
146833435|NCT00725543|529559232|FG000|Overall Study|Lost to Follow-up|4|||
146833436|NCT00725543|529559232|FG000|Overall Study|Non-compliance|2|||
146833437|NCT00725543|529559232|FG000|Overall Study|Other|119|||
146833438|NCT05594589|529559235|FG000|Overall Study|Other|0|||
146833439|NCT05594589|529559236|FG001|Overall Study|Other|1|||
146833440|NCT05594589|529559237|FG002|Overall Study|Other|0|||
146833441|NCT01062971|529559245|FG000|Overall Study|Protocol Violation|1|||
146833442|NCT01062971|529559246|FG001|Overall Study|Protocol Violation|3|||
146833443|NCT01062971|529559245|FG000|Overall Study|Lost to Follow-up|3|||
146833444|NCT01062971|529559246|FG001|Overall Study|Lost to Follow-up|4|||
146833445|NCT02760485|529559247|FG000|Phase 1|Death|3|||
146833446|NCT02760485|529559248|FG001|Phase 1|Death|6|||
146833447|NCT02760485|529559249|FG002|Phase 1|Death|0|||
146833448|NCT02760485|529559247|FG000|Phase 1|Withdrawal by Subject|2|||
146833449|NCT02760485|529559248|FG001|Phase 1|Withdrawal by Subject|0|||
146833450|NCT02760485|529559249|FG002|Phase 1|Withdrawal by Subject|0|||
146833451|NCT02760485|529559247|FG000|Phase 1|Progressive Disease|1|||
146833452|NCT02760485|529559248|FG001|Phase 1|Progressive Disease|0|||
146833453|NCT02760485|529559249|FG002|Phase 1|Progressive Disease|0|||
146833454|NCT02760485|529559247|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
146833455|NCT02760485|529559248|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
146833456|NCT02760485|529559249|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
146833457|NCT02760485|529559247|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
146833458|NCT02760485|529559248|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
146833459|NCT02760485|529559249|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
146833460|NCT02760485|529559247|FG000|Phase 2|Death|0|||
146833461|NCT02760485|529559248|FG001|Phase 2|Death|0|||
146833462|NCT02760485|529559249|FG002|Phase 2|Death|12|||
146833463|NCT02760485|529559247|FG000|Phase 2|Withdrawal by Subject|0|||
146833464|NCT02760485|529559248|FG001|Phase 2|Withdrawal by Subject|0|||
146833465|NCT02760485|529559249|FG002|Phase 2|Withdrawal by Subject|3|||
146833466|NCT02760485|529559247|FG000|Phase 2|Progressive Disease|0|||
146833467|NCT02760485|529559248|FG001|Phase 2|Progressive Disease|0|||
146833468|NCT02760485|529559249|FG002|Phase 2|Progressive Disease|1|||
146833469|NCT02760485|529559247|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
146833470|NCT02760485|529559248|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
146833471|NCT02760485|529559249|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
146833472|NCT01182207|529559250|FG000|First Intervention|Positive Hepatitis Results|0|||
146833473|NCT01182207|529559251|FG001|First Intervention|Positive Hepatitis Results|1|||
146833474|NCT01182207|529559250|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
146833475|NCT01182207|529559251|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
146833476|NCT02581059|529559256|FG000|Study Treatment|Disease Progression|1|||
146833477|NCT02581059|529559257|FG001|Study Treatment|Disease Progression|1|||
146833478|NCT02581059|529559256|FG000|Study Treatment|Adverse Event|2|||
146833479|NCT02581059|529559257|FG001|Study Treatment|Adverse Event|1|||
146833480|NCT02581059|529559256|FG000|Study Treatment|Death|1|||
146833481|NCT02581059|529559257|FG001|Study Treatment|Death|1|||
146833482|NCT02581059|529559256|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
146833483|NCT02581059|529559257|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
146833484|NCT02581059|529559256|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
146833485|NCT02581059|529559257|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
146833486|NCT02581059|529559256|FG000|Follow up|Death|1|||
146833487|NCT02581059|529559257|FG001|Follow up|Death|3|||
146833488|NCT02581059|529559256|FG000|Follow up|study terminated|1|||
146833489|NCT02581059|529559257|FG001|Follow up|study terminated|1|||
146833490|NCT02581059|529559256|FG000|Follow up|screen failure|0|||
146833491|NCT02581059|529559257|FG001|Follow up|screen failure|1|||
146833492|NCT02581059|529559256|FG000|Follow up|Patient started new clinical trial|1|||
146833493|NCT02581059|529559257|FG001|Follow up|Patient started new clinical trial|0|||
146833494|NCT03569891|529559259|FG000|Lead-in|Ineligible during lead-in|8|||
146833495|NCT03569891|529559259|FG000|Lead-in|Withdrawal by Subject|3|||
146833496|NCT03569891|529559259|FG000|Lead-in|Risks related to COVID-19|2|||
146833497|NCT03569891|529559259|FG000|AMT-061|Adverse Event|1|||
146987613|NCT03111147|530116881|FG000|Overall Study|Lost to Follow-up|2|||
146987614|NCT03111147|530116882|FG001|Overall Study|Lost to Follow-up|5|||
146987615|NCT03111147|530116881|FG000|Overall Study|Withdrawal by Subject|4|||
146987616|NCT03111147|530116882|FG001|Overall Study|Withdrawal by Subject|3|||
146987617|NCT03111147|530116881|FG000|Overall Study|Protocol Violation|2|||
146987618|NCT03111147|530116882|FG001|Overall Study|Protocol Violation|1|||
146987619|NCT03111147|530116881|FG000|Overall Study|Death|1|||
146987620|NCT03111147|530116882|FG001|Overall Study|Death|1|||
146987621|NCT01463683|530116883|FG000|Overall Study|Adverse Event|2|||
146987622|NCT01463683|530116884|FG001|Overall Study|Adverse Event|0|||
146987623|NCT01463683|530116885|FG002|Overall Study|Adverse Event|0|||
146987624|NCT01463683|530116883|FG000|Overall Study|Lost to Follow-up|10|||
146987625|NCT01463683|530116884|FG001|Overall Study|Lost to Follow-up|9|||
146987626|NCT01463683|530116885|FG002|Overall Study|Lost to Follow-up|7|||
146987627|NCT01463683|530116883|FG000|Overall Study|Physician Decision|0|||
146987628|NCT01463683|530116884|FG001|Overall Study|Physician Decision|3|||
146987629|NCT01463683|530116885|FG002|Overall Study|Physician Decision|1|||
146987630|NCT01463683|530116883|FG000|Overall Study|Pregnancy|2|||
146987631|NCT01463683|530116884|FG001|Overall Study|Pregnancy|2|||
146987632|NCT01463683|530116885|FG002|Overall Study|Pregnancy|1|||
146987633|NCT01463683|530116883|FG000|Overall Study|Withdrawal by Subject|5|||
146987634|NCT01463683|530116884|FG001|Overall Study|Withdrawal by Subject|17|||
146987635|NCT01463683|530116885|FG002|Overall Study|Withdrawal by Subject|2|||
146987636|NCT01565083|530116886|FG000|Overall Study|Withdrawal by Subject|6|||
146833498|NCT04750577|529559260|FG000|Overall Study|Adverse Event|2|||
146833499|NCT04750577|529559261|FG001|Overall Study|Adverse Event|10|||
146833500|NCT04750577|529559262|FG002|Overall Study|Adverse Event|8|||
146833501|NCT04750577|529559263|FG003|Overall Study|Adverse Event|1|||
146833502|NCT04750577|529559260|FG000|Overall Study|Change of residence|0|||
146833503|NCT04750577|529559261|FG001|Overall Study|Change of residence|0|||
146987637|NCT01565083|530116887|FG001|Overall Study|Withdrawal by Subject|4|||
146987638|NCT01565083|530116886|FG000|Overall Study|Lost to Follow-up|2|||
146987639|NCT01565083|530116887|FG001|Overall Study|Lost to Follow-up|7|||
146987640|NCT01565083|530116886|FG000|Overall Study|Death|22|||
146833504|NCT04750577|529559262|FG002|Overall Study|Change of residence|1|||
146833505|NCT04750577|529559263|FG003|Overall Study|Change of residence|0|||
146833506|NCT04750577|529559260|FG000|Overall Study|Burden of study procedures|0|||
146987641|NCT01565083|530116887|FG001|Overall Study|Death|23|||
146987642|NCT01565083|530116886|FG000|Overall Study|Other|3|||
146987643|NCT01565083|530116887|FG001|Overall Study|Other|5|||
146987644|NCT01118728|530116888|FG000|Overall Study|Adverse Event|17|||
146987645|NCT01118728|530116888|FG000|Overall Study|Lack of Efficacy|27|||
146987646|NCT01118728|530116888|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
146987647|NCT01118728|530116888|FG000|Overall Study|Withdrawal by Subject|3|||
146987648|NCT01118728|530116888|FG000|Overall Study|Lost to Follow-up|4|||
146987649|NCT01048333|530116889|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
146987650|NCT01048333|530116890|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
146987651|NCT01048333|530116891|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
146987652|NCT01048333|530116892|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
146987653|NCT01048333|530116893|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
146987654|NCT01048333|530116894|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
146987655|NCT02260492|530116895|FG000|Overall Study|Adverse Event|6|||
146987656|NCT02260492|530116896|FG001|Overall Study|Adverse Event|1|||
146833507|NCT04750577|529559261|FG001|Overall Study|Burden of study procedures|2|||
146833508|NCT04750577|529559262|FG002|Overall Study|Burden of study procedures|2|||
146987657|NCT02260492|530116897|FG002|Overall Study|Adverse Event|2|||
146987658|NCT02260492|530116895|FG000|Overall Study|Death|0|||
146987659|NCT02260492|530116896|FG001|Overall Study|Death|1|||
146833509|NCT04750577|529559263|FG003|Overall Study|Burden of study procedures|0|||
146833510|NCT04750577|529559260|FG000|Overall Study|Prematurely discontinued|0|||
146833511|NCT04750577|529559261|FG001|Overall Study|Prematurely discontinued|0|||
146833512|NCT04750577|529559262|FG002|Overall Study|Prematurely discontinued|0|||
146987660|NCT02260492|530116897|FG002|Overall Study|Death|0|||
146987661|NCT02260492|530116895|FG000|Overall Study|Lost to Follow-up|12|||
146987662|NCT02260492|530116896|FG001|Overall Study|Lost to Follow-up|9|||
146987663|NCT02260492|530116897|FG002|Overall Study|Lost to Follow-up|0|||
146987664|NCT02260492|530116895|FG000|Overall Study|Physician Decision|2|||
146987665|NCT02260492|530116896|FG001|Overall Study|Physician Decision|0|||
146987666|NCT02260492|530116897|FG002|Overall Study|Physician Decision|1|||
146987667|NCT02260492|530116895|FG000|Overall Study|Withdrawal by Subject|3|||
146987668|NCT02260492|530116896|FG001|Overall Study|Withdrawal by Subject|2|||
146987669|NCT02260492|530116897|FG002|Overall Study|Withdrawal by Subject|2|||
146987670|NCT03131999|530116898|FG000|Overall Study|Withdrawal by Subject|0|||
146987671|NCT03131999|530116899|FG001|Overall Study|Withdrawal by Subject|1|||
146987672|NCT00266409|530118628|FG000|Overall Study|Lack of Efficacy|2|||
146987673|NCT00266409|530118629|FG001|Overall Study|Lack of Efficacy|6|||
146987674|NCT00266409|530118630|FG002|Overall Study|Lack of Efficacy|1|||
146987675|NCT00266409|530118631|FG003|Overall Study|Lack of Efficacy|2|||
146987676|NCT00266409|530118628|FG000|Overall Study|Adverse Event|7|||
146987677|NCT00266409|530118629|FG001|Overall Study|Adverse Event|2|||
146987678|NCT00266409|530118630|FG002|Overall Study|Adverse Event|1|||
146833513|NCT04750577|529559263|FG003|Overall Study|Prematurely discontinued|2|||
146833514|NCT04750577|529559260|FG000|Overall Study|Protocol deviation|1|||
146833515|NCT04750577|529559261|FG001|Overall Study|Protocol deviation|1|||
146833516|NCT04750577|529559262|FG002|Overall Study|Protocol deviation|1|||
146833517|NCT04750577|529559263|FG003|Overall Study|Protocol deviation|1|||
146833518|NCT04750577|529559260|FG000|Overall Study|Other than listed|3|||
146833519|NCT04750577|529559261|FG001|Overall Study|Other than listed|2|||
146833520|NCT04750577|529559262|FG002|Overall Study|Other than listed|2|||
146833521|NCT04750577|529559263|FG003|Overall Study|Other than listed|1|||
146833522|NCT04750577|529559260|FG000|Overall Study|Not treated|0|||
146833523|NCT04750577|529559261|FG001|Overall Study|Not treated|0|||
146833524|NCT04750577|529559262|FG002|Overall Study|Not treated|0|||
146833525|NCT04750577|529559263|FG003|Overall Study|Not treated|2|||
146833526|NCT02647645|529559268|FG000|Overall Study|Lost to Follow-up|2|||
146833527|NCT02647645|529559269|FG001|Overall Study|Lost to Follow-up|1|||
146833528|NCT02037256|529559270|FG000|Overall Study|Protocol Violation|0|||
146833529|NCT02037256|529559271|FG001|Overall Study|Protocol Violation|1|||
146833530|NCT02037256|529559270|FG000|Overall Study|Withdrawn prior to Velcade|0|||
146833531|NCT02037256|529559271|FG001|Overall Study|Withdrawn prior to Velcade|2|||
146987679|NCT00266409|530118631|FG003|Overall Study|Adverse Event|1|||
146987680|NCT00266409|530118628|FG000|Overall Study|Lost to Follow-up|18|||
146987681|NCT00266409|530118629|FG001|Overall Study|Lost to Follow-up|21|||
146987682|NCT00266409|530118630|FG002|Overall Study|Lost to Follow-up|6|||
146987683|NCT00266409|530118631|FG003|Overall Study|Lost to Follow-up|8|||
146987684|NCT00266409|530118628|FG000|Overall Study|Withdrawal by Subject|6|||
146987685|NCT00266409|530118629|FG001|Overall Study|Withdrawal by Subject|10|||
146987686|NCT00266409|530118630|FG002|Overall Study|Withdrawal by Subject|3|||
146987687|NCT00266409|530118631|FG003|Overall Study|Withdrawal by Subject|9|||
146987688|NCT00266409|530118628|FG000|Overall Study|Protocol Violation|5|||
146833532|NCT01466790|529559274|FG000|Overall Study|Adverse Event|1|||
146833533|NCT01466790|529559275|FG001|Overall Study|Adverse Event|0|||
146833534|NCT01466790|529559276|FG002|Overall Study|Adverse Event|0|||
146833535|NCT01466790|529559277|FG003|Overall Study|Adverse Event|0|||
146833536|NCT01466790|529559278|FG004|Overall Study|Adverse Event|2|||
146833537|NCT01466790|529559279|FG005|Overall Study|Adverse Event|0|||
146833538|NCT01466790|529559280|FG006|Overall Study|Adverse Event|0|||
146833539|NCT01466790|529559281|FG007|Overall Study|Adverse Event|0|||
146833540|NCT01466790|529559274|FG000|Overall Study|Lost to Follow-up|2|||
146833541|NCT01466790|529559275|FG001|Overall Study|Lost to Follow-up|0|||
146833542|NCT01466790|529559276|FG002|Overall Study|Lost to Follow-up|0|||
146833543|NCT01466790|529559277|FG003|Overall Study|Lost to Follow-up|0|||
146833544|NCT01466790|529559278|FG004|Overall Study|Lost to Follow-up|0|||
146833545|NCT01466790|529559279|FG005|Overall Study|Lost to Follow-up|0|||
146833546|NCT01466790|529559280|FG006|Overall Study|Lost to Follow-up|0|||
146833547|NCT01466790|529559281|FG007|Overall Study|Lost to Follow-up|0|||
146833548|NCT01466790|529559274|FG000|Overall Study|Withdrawal by Subject|1|||
146833549|NCT01466790|529559275|FG001|Overall Study|Withdrawal by Subject|1|||
146833550|NCT01466790|529559276|FG002|Overall Study|Withdrawal by Subject|0|||
146833551|NCT01466790|529559277|FG003|Overall Study|Withdrawal by Subject|0|||
146833552|NCT01466790|529559278|FG004|Overall Study|Withdrawal by Subject|1|||
146833553|NCT01466790|529559279|FG005|Overall Study|Withdrawal by Subject|0|||
146833554|NCT01466790|529559280|FG006|Overall Study|Withdrawal by Subject|1|||
146833555|NCT01466790|529559281|FG007|Overall Study|Withdrawal by Subject|1|||
146833556|NCT00826228|529560911|FG000|Overall Study|Withdrawal by Subject|1|||
146833557|NCT00321685|529560913|FG000|Overall Study|Adverse Event|18|||
146833558|NCT00321685|529560913|FG000|Overall Study|Death|2|||
146833559|NCT00321685|529560913|FG000|Overall Study|Withdrawal by Subject|8|||
146833560|NCT00321685|529560913|FG000|Overall Study|Alternative therapy|1|||
146833561|NCT00321685|529560913|FG000|Overall Study|Complicating disese|1|||
146833562|NCT00321685|529560913|FG000|Overall Study|Other|5|||
146833563|NCT00321685|529560913|FG000|Overall Study|Not start protocol therapy|2|||
146833564|NCT00321685|529560913|FG000|Overall Study|Ineligible|2|||
146833565|NCT02366143|529560917|FG000|Overall Study|Death|307|||
146833566|NCT02366143|529560918|FG001|Overall Study|Death|278|||
146833567|NCT02366143|529560919|FG002|Overall Study|Death|280|||
146833568|NCT02366143|529560917|FG000|Overall Study|Lost to Follow-up|2|||
146833569|NCT02366143|529560918|FG001|Overall Study|Lost to Follow-up|4|||
146833570|NCT02366143|529560919|FG002|Overall Study|Lost to Follow-up|2|||
146833571|NCT02366143|529560917|FG000|Overall Study|Physician Decision|1|||
146833572|NCT02366143|529560918|FG001|Overall Study|Physician Decision|2|||
146833573|NCT02366143|529560919|FG002|Overall Study|Physician Decision|1|||
146833574|NCT02366143|529560917|FG000|Overall Study|Protocol Violation|0|||
146833575|NCT02366143|529560918|FG001|Overall Study|Protocol Violation|0|||
146833576|NCT02366143|529560919|FG002|Overall Study|Protocol Violation|2|||
146833577|NCT02366143|529560917|FG000|Overall Study|Withdrawal by Subject|16|||
146833578|NCT02366143|529560918|FG001|Overall Study|Withdrawal by Subject|17|||
146833579|NCT02366143|529560919|FG002|Overall Study|Withdrawal by Subject|22|||
146833580|NCT02366143|529560917|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
146833581|NCT02366143|529560918|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
146833582|NCT02366143|529560919|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
146833583|NCT02366143|529560917|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
146833584|NCT02366143|529560918|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
146833585|NCT02366143|529560919|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
146833586|NCT02366143|529560917|FG000|Overall Study|Randomization Error|1|||
146833587|NCT02366143|529560918|FG001|Overall Study|Randomization Error|0|||
146833588|NCT02366143|529560919|FG002|Overall Study|Randomization Error|0|||
146833589|NCT02366143|529560917|FG000|Overall Study|PI Move and Site Closure|1|||
146833590|NCT02366143|529560918|FG001|Overall Study|PI Move and Site Closure|0|||
146833591|NCT02366143|529560919|FG002|Overall Study|PI Move and Site Closure|1|||
146833592|NCT02366143|529560917|FG000|Overall Study|Study Terminated By Sponsor|0|||
146833593|NCT02366143|529560918|FG001|Overall Study|Study Terminated By Sponsor|0|||
146833594|NCT02366143|529560919|FG002|Overall Study|Study Terminated By Sponsor|2|||
146833595|NCT02366143|529560917|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
146833596|NCT02366143|529560918|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
146833597|NCT02366143|529560919|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
146833598|NCT02366143|529560917|FG000|Overall Study|Patient moved to roll-over study|1|||
146833599|NCT02366143|529560918|FG001|Overall Study|Patient moved to roll-over study|19|||
146833600|NCT02366143|529560919|FG002|Overall Study|Patient moved to roll-over study|28|||
146833601|NCT02366143|529560917|FG000|Overall Study|Patient moved to commercial stock|0|||
146833602|NCT02366143|529560918|FG001|Overall Study|Patient moved to commercial stock|0|||
146833603|NCT02366143|529560919|FG002|Overall Study|Patient moved to commercial stock|1|||
146833604|NCT02366143|529560917|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
146833605|NCT02366143|529560918|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
146987689|NCT00266409|530118629|FG001|Overall Study|Protocol Violation|3|||
146987690|NCT00266409|530118630|FG002|Overall Study|Protocol Violation|4|||
146833606|NCT02366143|529560919|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
146833607|NCT02366143|529560917|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
146833608|NCT02366143|529560918|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
146833609|NCT02366143|529560919|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
146833610|NCT02366143|529560917|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
146833611|NCT02366143|529560918|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
146833612|NCT02366143|529560919|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
146833613|NCT02366143|529560917|FG000|Overall Study|Requester's instructions|1|||
146833614|NCT02366143|529560918|FG001|Overall Study|Requester's instructions|1|||
146833615|NCT02366143|529560919|FG002|Overall Study|Requester's instructions|1|||
146833616|NCT02366143|529560917|FG000|Overall Study|Uneligible|0|||
146833617|NCT02366143|529560918|FG001|Overall Study|Uneligible|1|||
146833618|NCT02366143|529560919|FG002|Overall Study|Uneligible|0|||
146833619|NCT02366143|529560917|FG000|Overall Study|Post Trial Migration|0|||
146833620|NCT02366143|529560918|FG001|Overall Study|Post Trial Migration|1|||
146833621|NCT02366143|529560919|FG002|Overall Study|Post Trial Migration|0|||
146833622|NCT02366143|529560917|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
146833623|NCT02366143|529560918|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
146833624|NCT02366143|529560919|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
146833625|NCT02366143|529560917|FG000|Overall Study|Patient switched to PTAP|0|||
146833626|NCT02366143|529560918|FG001|Overall Study|Patient switched to PTAP|1|||
146833627|NCT02366143|529560919|FG002|Overall Study|Patient switched to PTAP|0|||
146833628|NCT02366143|529560917|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
146833629|NCT02366143|529560918|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
146833630|NCT02366143|529560919|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
146833631|NCT02172911|529560920|FG000|Overall Study|Serious Adverse Event|0|||
146833632|NCT02172911|529560921|FG001|Overall Study|Serious Adverse Event|1|||
146833633|NCT02172911|529560920|FG000|Overall Study|Progression of Disease|0|||
146833634|NCT02172911|529560921|FG001|Overall Study|Progression of Disease|1|||
146833635|NCT02172911|529560920|FG000|Overall Study|Loss of insurance coverage|1|||
146833636|NCT02172911|529560921|FG001|Overall Study|Loss of insurance coverage|0|||
146833637|NCT04795336|529560924|FG000|Overall Study|Withdrawal by Subject|3|||
146833638|NCT04795336|529560925|FG001|Overall Study|Withdrawal by Subject|4|||
146833639|NCT04795336|529560926|FG002|Overall Study|Withdrawal by Subject|3|||
146833640|NCT04795336|529560927|FG003|Overall Study|Withdrawal by Subject|12|||
146833641|NCT04795336|529560924|FG000|Overall Study|Lost study logs|0|||
146833642|NCT04795336|529560925|FG001|Overall Study|Lost study logs|1|||
146833643|NCT04795336|529560926|FG002|Overall Study|Lost study logs|0|||
146833644|NCT04795336|529560927|FG003|Overall Study|Lost study logs|2|||
146833645|NCT04795336|529560924|FG000|Overall Study|Did not take study medication|2|||
146833646|NCT04795336|529560925|FG001|Overall Study|Did not take study medication|0|||
146833647|NCT04795336|529560926|FG002|Overall Study|Did not take study medication|0|||
146833648|NCT04795336|529560927|FG003|Overall Study|Did not take study medication|0|||
146833649|NCT01234883|529560928|FG000|Overall Study|Early treatment release|8|||
146833650|NCT01234883|529560929|FG001|Overall Study|Early treatment release|10|||
146833651|NCT01234883|529560928|FG000|Overall Study|Parent/guardian withdrew consent|1|||
146833652|NCT01234883|529560929|FG001|Overall Study|Parent/guardian withdrew consent|2|||
146833653|NCT01234883|529560928|FG000|Overall Study|Technical difficulties with IV infusion|0|||
146833654|NCT01234883|529560929|FG001|Overall Study|Technical difficulties with IV infusion|1|||
146833655|NCT01234883|529560928|FG000|Overall Study|Inclusion/exclusion failure|1|||
146833656|NCT01234883|529560929|FG001|Overall Study|Inclusion/exclusion failure|0|||
146987691|NCT00266409|530118631|FG003|Overall Study|Protocol Violation|2|||
146987692|NCT00266409|530118628|FG000|Overall Study|Other|7|||
146987693|NCT00266409|530118629|FG001|Overall Study|Other|4|||
146987694|NCT00266409|530118630|FG002|Overall Study|Other|2|||
146987695|NCT00266409|530118631|FG003|Overall Study|Other|0|||
146987696|NCT00712010|530118632|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
146987697|NCT01179919|530118633|FG000|Overall Study|Protocol Violation|1|||
146833657|NCT01013961|529560930|FG000|Overall Study|Adverse Event|2|||
146833658|NCT01013961|529560931|FG001|Overall Study|Adverse Event|2|||
146833659|NCT01013961|529560930|FG000|Overall Study|Withdrawal by Subject|1|||
146833660|NCT01013961|529560931|FG001|Overall Study|Withdrawal by Subject|0|||
146833661|NCT01013961|529560930|FG000|Overall Study|Physician Decision|0|||
146833662|NCT01013961|529560931|FG001|Overall Study|Physician Decision|1|||
146833663|NCT04071301|529560937|FG000|Overall Study|Withdrawal by Subject|6|||
146833664|NCT04071301|529560937|FG000|Overall Study|Death|1|||
146987698|NCT01179919|530118633|FG000|Overall Study|Adverse Event|1|||
146987699|NCT00698685|530118637|FG000|Overall Study|Sister withdrew as donor|1|||
146833665|NCT01850589|529560943|FG000|Overall Study|Withdrawal by Subject|8|||
146833666|NCT01850589|529560944|FG001|Overall Study|Withdrawal by Subject|0|||
146833667|NCT03721705|529560948|FG000|Overall Study|Adverse Event|2|||
146833668|NCT03721705|529560949|FG001|Overall Study|Adverse Event|0|||
146987700|NCT00698685|530118637|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
146833669|NCT03721705|529560948|FG000|Overall Study|Withdrawal by Subject|4|||
146833670|NCT03721705|529560949|FG001|Overall Study|Withdrawal by Subject|10|||
146833671|NCT03721705|529560948|FG000|Overall Study|No Suitable Study Partner|1|||
146987701|NCT01513148|530118639|FG000|Overall Study|Protocol Violation|2|||
146833672|NCT03721705|529560949|FG001|Overall Study|No Suitable Study Partner|0|||
146833673|NCT03721705|529560948|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
146833674|NCT03721705|529560949|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
146833675|NCT03721705|529560948|FG000|Overall Study|Death|0|||
146833676|NCT03721705|529560949|FG001|Overall Study|Death|1|||
146833677|NCT01843777|529560950|FG000|Overall Study|Withdrawal by Subject|1|||
146833678|NCT01843777|529560951|FG001|Overall Study|Withdrawal by Subject|0|||
146833679|NCT03721172|529560953|FG000|Placebo-controlled Phase|Adverse Event|7|||
146833680|NCT03721172|529560954|FG001|Placebo-controlled Phase|Adverse Event|7|||
146833681|NCT03721172|529560955|FG002|Placebo-controlled Phase|Adverse Event|0|||
146833682|NCT03721172|529560953|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
146833683|NCT03721172|529560954|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
146833684|NCT03721172|529560955|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
146833685|NCT03721172|529560953|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
146833686|NCT03721172|529560954|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
146833687|NCT03721172|529560955|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
146833688|NCT03721172|529560953|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
146833689|NCT03721172|529560954|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
146833690|NCT03721172|529560955|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
146833691|NCT03721172|529560953|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
146833692|NCT03721172|529560954|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
146833693|NCT03721172|529560955|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
146833694|NCT03721172|529560953|FG000|Placebo-controlled Phase|Other|3|||
146833695|NCT03721172|529560954|FG001|Placebo-controlled Phase|Other|0|||
146987702|NCT01513148|530118640|FG001|Overall Study|Protocol Violation|2|||
146987703|NCT02795104|530118641|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
146987704|NCT02795104|530118642|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
146987705|NCT02795104|530118643|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
146987706|NCT02795104|530118641|FG000|Overall Study|Withdrawal by Subject|0|||
146987707|NCT02795104|530118642|FG001|Overall Study|Withdrawal by Subject|2|||
146987708|NCT02795104|530118643|FG002|Overall Study|Withdrawal by Subject|0|||
146987709|NCT02795104|530118641|FG000|Overall Study|Lost to Follow-up|0|||
146987710|NCT02795104|530118642|FG001|Overall Study|Lost to Follow-up|0|||
146987711|NCT02795104|530118643|FG002|Overall Study|Lost to Follow-up|1|||
146987712|NCT01654380|530118644|FG000|Part B, Period 1|Physician Decision|0|||
146987713|NCT01654380|530118645|FG001|Part B, Period 1|Physician Decision|0|||
146987714|NCT01654380|530118646|FG002|Part B, Period 1|Physician Decision|1|||
146987715|NCT01654380|530118647|FG003|Part B, Period 1|Physician Decision|0|||
146987716|NCT04128007|530118650|FG000|Overall Study|Withdrawal by Subject|9|||
146987717|NCT04128007|530118651|FG001|Overall Study|Withdrawal by Subject|6|||
146987718|NCT04128007|530118650|FG000|Overall Study|Protocol Violation|1|||
146987719|NCT04128007|530118651|FG001|Overall Study|Protocol Violation|0|||
146987720|NCT04128007|530118650|FG000|Overall Study|Lost to Follow-up|8|||
146987721|NCT04128007|530118651|FG001|Overall Study|Lost to Follow-up|7|||
146987722|NCT04128007|530118650|FG000|Overall Study|Adverse Event|5|||
146987723|NCT04128007|530118651|FG001|Overall Study|Adverse Event|2|||
146987724|NCT04128007|530118650|FG000|Overall Study|Not reported|0|||
146987725|NCT04128007|530118651|FG001|Overall Study|Not reported|2|||
146987726|NCT00429923|530118658|FG000|Overall Study|Adverse Event|0|||
146987727|NCT00429923|530118659|FG001|Overall Study|Adverse Event|2|||
146987728|NCT00429923|530118660|FG002|Overall Study|Adverse Event|3|||
146987729|NCT00429923|530118658|FG000|Overall Study|Lack of Efficacy|4|||
146987730|NCT00429923|530118659|FG001|Overall Study|Lack of Efficacy|1|||
146987731|NCT00429923|530118660|FG002|Overall Study|Lack of Efficacy|33|||
146987732|NCT00429923|530118658|FG000|Overall Study|Lost to Follow-up|0|||
146987733|NCT00429923|530118659|FG001|Overall Study|Lost to Follow-up|0|||
146987734|NCT00429923|530118660|FG002|Overall Study|Lost to Follow-up|2|||
146987735|NCT00429923|530118658|FG000|Overall Study|Withdrew Consent|1|||
146987736|NCT00429923|530118659|FG001|Overall Study|Withdrew Consent|0|||
146987737|NCT00429923|530118660|FG002|Overall Study|Withdrew Consent|1|||
146987738|NCT00429923|530118658|FG000|Overall Study|Early Termination|0|||
146987739|NCT00429923|530118659|FG001|Overall Study|Early Termination|1|||
146987740|NCT00429923|530118660|FG002|Overall Study|Early Termination|0|||
146987741|NCT01265784|530118661|FG000|Overall Study|Lost to Follow-up|5|||
146987742|NCT01265784|530118662|FG001|Overall Study|Lost to Follow-up|3|||
146987743|NCT01265784|530118663|FG002|Overall Study|Lost to Follow-up|2|||
146987744|NCT01265784|530118661|FG000|Overall Study|Withdrawal by Subject|0|||
146987745|NCT01265784|530118662|FG001|Overall Study|Withdrawal by Subject|5|||
146833696|NCT03721172|529560955|FG002|Placebo-controlled Phase|Other|0|||
146833697|NCT03721172|529560953|FG000|Apremilast Extension Phase|Adverse Event|0|||
146833698|NCT03721172|529560954|FG001|Apremilast Extension Phase|Adverse Event|0|||
146833699|NCT03721172|529560955|FG002|Apremilast Extension Phase|Adverse Event|10|||
146833700|NCT03721172|529560953|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
146987746|NCT01265784|530118663|FG002|Overall Study|Withdrawal by Subject|0|||
146987747|NCT01265784|530118661|FG000|Overall Study|Physician Decision|1|||
146987748|NCT01265784|530118662|FG001|Overall Study|Physician Decision|0|||
146987749|NCT01265784|530118663|FG002|Overall Study|Physician Decision|1|||
146987750|NCT01265784|530118661|FG000|Overall Study|Adverse Event|1|||
146987751|NCT01265784|530118662|FG001|Overall Study|Adverse Event|0|||
146987752|NCT01265784|530118663|FG002|Overall Study|Adverse Event|0|||
146987753|NCT01265784|530118661|FG000|Overall Study|Death|3|||
146987754|NCT01265784|530118662|FG001|Overall Study|Death|0|||
146987755|NCT01265784|530118663|FG002|Overall Study|Death|0|||
146987756|NCT01265784|530118661|FG000|Overall Study|Protocol Violation|2|||
146987757|NCT01265784|530118662|FG001|Overall Study|Protocol Violation|0|||
146987758|NCT01265784|530118663|FG002|Overall Study|Protocol Violation|0|||
146987759|NCT01265784|530118661|FG000|Overall Study|Incorrectly Randomized|0|||
146987760|NCT01265784|530118662|FG001|Overall Study|Incorrectly Randomized|0|||
146987761|NCT01265784|530118663|FG002|Overall Study|Incorrectly Randomized|1|||
146987762|NCT01937364|530118664|FG000|Overall Study|Adverse Event|2|||
146987763|NCT01937364|530118665|FG001|Overall Study|Adverse Event|1|||
146987764|NCT04799158|530118666|FG000|Run-In Period|Adverse Event|6|||
146987765|NCT04799158|530118667|FG001|Run-In Period|Adverse Event|0|||
146987766|NCT04799158|530118668|FG002|Run-In Period|Adverse Event|0|||
146987767|NCT04799158|530118669|FG003|Run-In Period|Adverse Event|0|||
146987768|NCT04799158|530118670|FG004|Run-In Period|Adverse Event|0|||
146987769|NCT04799158|530118666|FG000|Run-In Period|Lost to Follow-up|4|||
146987770|NCT04799158|530118667|FG001|Run-In Period|Lost to Follow-up|0|||
146987771|NCT04799158|530118668|FG002|Run-In Period|Lost to Follow-up|0|||
146987772|NCT04799158|530118669|FG003|Run-In Period|Lost to Follow-up|0|||
146987773|NCT04799158|530118670|FG004|Run-In Period|Lost to Follow-up|0|||
146987774|NCT04799158|530118666|FG000|Run-In Period|Significant Protocol Deviation|1|||
146987775|NCT04799158|530118667|FG001|Run-In Period|Significant Protocol Deviation|0|||
146987776|NCT04799158|530118668|FG002|Run-In Period|Significant Protocol Deviation|0|||
146987777|NCT04799158|530118669|FG003|Run-In Period|Significant Protocol Deviation|0|||
146987778|NCT04799158|530118670|FG004|Run-In Period|Significant Protocol Deviation|0|||
146987779|NCT04799158|530118666|FG000|Run-In Period|Withdrawal by Subject|11|||
146987780|NCT04799158|530118667|FG001|Run-In Period|Withdrawal by Subject|0|||
146987781|NCT04799158|530118668|FG002|Run-In Period|Withdrawal by Subject|0|||
146987782|NCT04799158|530118669|FG003|Run-In Period|Withdrawal by Subject|0|||
146987783|NCT04799158|530118670|FG004|Run-In Period|Withdrawal by Subject|0|||
146987784|NCT04799158|530118666|FG000|Run-In Period|Miscellaneous|3|||
146987785|NCT04799158|530118667|FG001|Run-In Period|Miscellaneous|0|||
146987786|NCT04799158|530118668|FG002|Run-In Period|Miscellaneous|0|||
146987787|NCT04799158|530118669|FG003|Run-In Period|Miscellaneous|0|||
146987788|NCT04799158|530118670|FG004|Run-In Period|Miscellaneous|0|||
146987789|NCT04799158|530118666|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
146987790|NCT04799158|530118667|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
146987791|NCT04799158|530118668|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
146987792|NCT04799158|530118669|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
146987793|NCT04799158|530118670|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
146987794|NCT04799158|530118666|FG000|On-Demand Treatment Period|Adverse Event|0|||
146987795|NCT04799158|530118667|FG001|On-Demand Treatment Period|Adverse Event|1|||
146987796|NCT04799158|530118668|FG002|On-Demand Treatment Period|Adverse Event|0|||
146987797|NCT04799158|530118669|FG003|On-Demand Treatment Period|Adverse Event|0|||
146987798|NCT04799158|530118670|FG004|On-Demand Treatment Period|Adverse Event|1|||
146987799|NCT04799158|530118666|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
146987800|NCT04799158|530118667|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
146987801|NCT04799158|530118668|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
146987802|NCT04799158|530118669|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
146987803|NCT04799158|530118670|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
146987804|NCT04799158|530118666|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
146987805|NCT04799158|530118667|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
146987806|NCT04799158|530118668|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
146987807|NCT04799158|530118669|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
146987808|NCT04799158|530118670|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
146987809|NCT04799158|530118666|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
146987810|NCT04799158|530118667|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
146987811|NCT04799158|530118668|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
146987812|NCT04799158|530118669|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
146987813|NCT04799158|530118670|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
146987814|NCT04799158|530118666|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
146987815|NCT04799158|530118667|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
146987816|NCT04799158|530118668|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
146987817|NCT04799158|530118669|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
146987818|NCT04799158|530118670|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
146987819|NCT04799158|530118666|FG000|On-Demand Treatment Period|Miscellaneous|0|||
146987820|NCT04799158|530118667|FG001|On-Demand Treatment Period|Miscellaneous|0|||
146987821|NCT04799158|530118668|FG002|On-Demand Treatment Period|Miscellaneous|0|||
146833701|NCT03721172|529560954|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
146987822|NCT04799158|530118669|FG003|On-Demand Treatment Period|Miscellaneous|0|||
146987823|NCT04799158|530118670|FG004|On-Demand Treatment Period|Miscellaneous|1|||
146987824|NCT04104646|530118674|FG000|Overall Study|Withdrawal by Subject|1|||
146987825|NCT04104646|530118675|FG001|Overall Study|Withdrawal by Subject|1|||
146987826|NCT04104646|530118674|FG000|Overall Study|Lost to Follow-up|1|||
146987827|NCT04104646|530118675|FG001|Overall Study|Lost to Follow-up|0|||
146987828|NCT04104646|530118674|FG000|Overall Study|Physician Decision|2|||
146987829|NCT04104646|530118675|FG001|Overall Study|Physician Decision|0|||
146987830|NCT01199601|530118676|FG000|Overall Study|Lost to Follow-up|47|||
146987831|NCT01199601|530118677|FG001|Overall Study|Lost to Follow-up|66|||
146987832|NCT01199601|530118676|FG000|Overall Study|Withdrawal by Subject|15|||
146987833|NCT01199601|530118677|FG001|Overall Study|Withdrawal by Subject|3|||
146987834|NCT01199601|530118676|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
146987835|NCT01199601|530118677|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
146987836|NCT02607800|530118678|FG000|Overall Study|Lost to Follow-up|7|||
146987837|NCT02607800|530118679|FG001|Overall Study|Lost to Follow-up|10|||
146987838|NCT02607800|530118678|FG000|Overall Study|Withdrew Consent|2|||
146987839|NCT02607800|530118679|FG001|Overall Study|Withdrew Consent|0|||
146987840|NCT02607800|530118678|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
146987841|NCT02607800|530118679|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
146987842|NCT01656889|530118680|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
146987843|NCT01656889|530118681|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
146987844|NCT01656889|530118680|FG000|Treatment Period, 12 Weeks|Death|0|||
146987845|NCT01656889|530118681|FG001|Treatment Period, 12 Weeks|Death|1|||
146987846|NCT01656889|530118680|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
146987847|NCT01656889|530118681|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
146987848|NCT01656889|530118680|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
146987849|NCT01656889|530118681|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
146987850|NCT01656889|530118680|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
146987851|NCT01656889|530118681|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
146987852|NCT01656889|530118680|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
146987853|NCT01656889|530118681|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
146987854|NCT01656889|530118680|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
146987855|NCT01656889|530118681|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
146987856|NCT01656889|530118680|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
146987857|NCT01656889|530118681|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
146987858|NCT01656889|530118680|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
146987859|NCT01656889|530118681|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
146987860|NCT01656889|530118680|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
146987861|NCT01656889|530118681|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
146987862|NCT02521948|530118682|FG000|Overall Study|Adverse Event|2|||
146987863|NCT02521948|530118682|FG000|Overall Study|Death|4|||
146987864|NCT02521948|530118682|FG000|Overall Study|Lost to Follow-up|1|||
146987865|NCT02521948|530118682|FG000|Overall Study|Did not attend one or both follow-ups|6|||
146833702|NCT03721172|529560955|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
146833703|NCT03721172|529560953|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
146987866|NCT02568384|530118686|FG000|Overall Study|Mobile devices incompatible with App|2|||
146987867|NCT01485536|530118687|FG000|Overall Study|Withdrawal by Subject|3|||
146987868|NCT01485536|530118687|FG000|Overall Study|Adverse Event|1|||
146987869|NCT00329602|530118688|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
146987870|NCT00329602|530118689|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
146987871|NCT00329602|530118690|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
146987872|NCT00329602|530118688|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
146987873|NCT00329602|530118689|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
146987874|NCT00329602|530118690|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
146987875|NCT00329602|530118688|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
146987876|NCT00329602|530118689|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
146987877|NCT00329602|530118690|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
146987878|NCT00329602|530118688|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
146987879|NCT00329602|530118689|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
146987880|NCT00329602|530118690|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
146987881|NCT00329602|530118688|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
146987882|NCT00329602|530118689|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
146987883|NCT00329602|530118690|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
146987884|NCT00329602|530118688|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
146987885|NCT00329602|530118689|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
146987886|NCT00329602|530118690|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
146987887|NCT00510510|530118691|FG000|Overall Study|Adverse Event|4|||
146987888|NCT00510510|530118692|FG001|Overall Study|Adverse Event|3|||
146833704|NCT03721172|529560954|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
146987889|NCT00510510|530118693|FG002|Overall Study|Adverse Event|6|||
146987890|NCT00510510|530118691|FG000|Overall Study|Lack of Efficacy|0|||
146987891|NCT00510510|530118692|FG001|Overall Study|Lack of Efficacy|1|||
146987892|NCT00510510|530118693|FG002|Overall Study|Lack of Efficacy|1|||
146987893|NCT00510510|530118691|FG000|Overall Study|Subjects no longer requires study drug|0|||
146987894|NCT00510510|530118692|FG001|Overall Study|Subjects no longer requires study drug|0|||
146987895|NCT00510510|530118693|FG002|Overall Study|Subjects no longer requires study drug|2|||
146987896|NCT00510510|530118691|FG000|Overall Study|Withdrawal by Subject|1|||
146987897|NCT00510510|530118692|FG001|Overall Study|Withdrawal by Subject|2|||
146987898|NCT00510510|530118693|FG002|Overall Study|Withdrawal by Subject|3|||
146987899|NCT00510510|530118691|FG000|Overall Study|Lost to Follow-up|0|||
146987900|NCT00510510|530118692|FG001|Overall Study|Lost to Follow-up|0|||
146987901|NCT00510510|530118693|FG002|Overall Study|Lost to Follow-up|1|||
146987902|NCT00510510|530118691|FG000|Overall Study|Protocol Violation|0|||
146987903|NCT00510510|530118692|FG001|Overall Study|Protocol Violation|3|||
146987904|NCT00510510|530118693|FG002|Overall Study|Protocol Violation|4|||
146987905|NCT01066052|530118694|FG000|Overall Study|Enrolled But Not Treated|3|||
146987906|NCT01066052|530118695|FG001|Overall Study|Enrolled But Not Treated|0|||
146987907|NCT01200394|530118696|FG000|Overall Study|Adverse Event|0|||
146987908|NCT01200394|530118697|FG001|Overall Study|Adverse Event|14|||
146987909|NCT01200394|530118696|FG000|Overall Study|Death|1|||
146987910|NCT01200394|530118697|FG001|Overall Study|Death|0|||
146987911|NCT01200394|530118696|FG000|Overall Study|Lost to Follow-up|0|||
146987912|NCT01200394|530118697|FG001|Overall Study|Lost to Follow-up|1|||
146987913|NCT01200394|530118696|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
146987914|NCT01200394|530118697|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
146987915|NCT01200394|530118696|FG000|Overall Study|Protocol Violation|0|||
146987916|NCT01200394|530118697|FG001|Overall Study|Protocol Violation|3|||
146987917|NCT01200394|530118696|FG000|Overall Study|Withdrawal by Subject|0|||
146987918|NCT01200394|530118697|FG001|Overall Study|Withdrawal by Subject|5|||
146987919|NCT01200394|530118696|FG000|Overall Study|Other|0|||
146987920|NCT01200394|530118697|FG001|Overall Study|Other|1|||
146987921|NCT01835145|530118702|FG000|Overall Study|Ineligible prior to treatment|1|||
146987922|NCT01835145|530118703|FG001|Overall Study|Ineligible prior to treatment|0|||
146987923|NCT02729896|530118704|FG000|Overall Study|Death|0|||
146987924|NCT02729896|530118705|FG001|Overall Study|Death|2|||
146987925|NCT02729896|530118706|FG002|Overall Study|Death|13|||
146987926|NCT02729896|530118704|FG000|Overall Study|Lost to Follow-up|0|||
146987927|NCT02729896|530118705|FG001|Overall Study|Lost to Follow-up|2|||
146987928|NCT02729896|530118706|FG002|Overall Study|Lost to Follow-up|3|||
146987929|NCT02729896|530118704|FG000|Overall Study|Other|0|||
146987930|NCT02729896|530118705|FG001|Overall Study|Other|2|||
146987931|NCT02729896|530118706|FG002|Overall Study|Other|0|||
146987932|NCT02729896|530118704|FG000|Overall Study|Physician Decision|1|||
146987933|NCT02729896|530118705|FG001|Overall Study|Physician Decision|2|||
146987934|NCT02729896|530118706|FG002|Overall Study|Physician Decision|3|||
146987935|NCT02729896|530118704|FG000|Overall Study|Progressive Disease|0|||
146987936|NCT02729896|530118705|FG001|Overall Study|Progressive Disease|1|||
146987937|NCT02729896|530118706|FG002|Overall Study|Progressive Disease|0|||
146987938|NCT02729896|530118704|FG000|Overall Study|Withdrawal by Subject|1|||
146987939|NCT02729896|530118705|FG001|Overall Study|Withdrawal by Subject|0|||
146987940|NCT02729896|530118706|FG002|Overall Study|Withdrawal by Subject|3|||
146987941|NCT00582309|530118707|FG000|Overall Study|Protocol Violation|0|||
146987942|NCT00582309|530118708|FG001|Overall Study|Protocol Violation|0|||
146987943|NCT00582309|530118709|FG002|Overall Study|Protocol Violation|2|||
146987944|NCT04094870|530118713|FG000|Overall Study|Lost to Follow-up|1|||
146987945|NCT04094870|530118714|FG001|Overall Study|Lost to Follow-up|1|||
146987946|NCT02708277|530118716|FG000|Overall Study|Lost to Follow-up|7|||
146987947|NCT02708277|530118717|FG001|Overall Study|Lost to Follow-up|4|||
146987948|NCT01058421|530118718|FG000|1 Month Outcomes|Death|10|||
146987949|NCT01058421|530118719|FG001|1 Month Outcomes|Death|6|||
146987950|NCT01058421|530118718|FG000|1 Month Outcomes|Lost to Follow-up|8|||
146987951|NCT01058421|530118719|FG001|1 Month Outcomes|Lost to Follow-up|7|||
146987952|NCT01058421|530118718|FG000|1 Month Outcomes|Remained in Hospital|5|||
146987953|NCT01058421|530118719|FG001|1 Month Outcomes|Remained in Hospital|12|||
146987954|NCT01058421|530118718|FG000|1 Month Outcomes|Remained in Other Facility|16|||
146987955|NCT01058421|530118719|FG001|1 Month Outcomes|Remained in Other Facility|17|||
146987956|NCT01058421|530118718|FG000|3 Month Outcomes|Death|3|||
146987957|NCT01058421|530118719|FG001|3 Month Outcomes|Death|5|||
146987958|NCT01058421|530118718|FG000|3 Month Outcomes|Lost to Follow-up|12|||
146987959|NCT01058421|530118719|FG001|3 Month Outcomes|Lost to Follow-up|11|||
146987960|NCT01058421|530118718|FG000|3 Month Outcomes|Remained in Hospital|0|||
146987961|NCT01058421|530118719|FG001|3 Month Outcomes|Remained in Hospital|2|||
146987962|NCT01058421|530118718|FG000|3 Month Outcomes|Remained in Other Facility|5|||
146987963|NCT01058421|530118719|FG001|3 Month Outcomes|Remained in Other Facility|8|||
146987964|NCT01058421|530118718|FG000|6 Month Outcomes|Death|2|||
146987965|NCT01058421|530118719|FG001|6 Month Outcomes|Death|2|||
146987966|NCT01058421|530118718|FG000|6 Month Outcomes|Lost to Follow-up|16|||
146987967|NCT01058421|530118719|FG001|6 Month Outcomes|Lost to Follow-up|21|||
146987968|NCT01058421|530118718|FG000|6 Month Outcomes|Remained in Other Facility|1|||
146987969|NCT01058421|530118719|FG001|6 Month Outcomes|Remained in Other Facility|3|||
146987970|NCT02984683|530118722|FG000|Overall Study|Adverse Event|3|||
146987971|NCT02984683|530118723|FG001|Overall Study|Adverse Event|3|||
146987972|NCT02984683|530118722|FG000|Overall Study|Withdrawal by Subject|1|||
146987973|NCT02984683|530118723|FG001|Overall Study|Withdrawal by Subject|0|||
146987974|NCT02984683|530118722|FG000|Overall Study|Disease progression|7|||
146987975|NCT02984683|530118723|FG001|Overall Study|Disease progression|9|||
146987976|NCT02415959|530118728|FG000|Overall Study|Adverse Event|0|||
146987977|NCT02415959|530118729|FG001|Overall Study|Adverse Event|1|||
146987978|NCT02415959|530118730|FG002|Overall Study|Adverse Event|0|||
146987979|NCT02415959|530118731|FG003|Overall Study|Adverse Event|0|||
146987980|NCT02415959|530118732|FG004|Overall Study|Adverse Event|0|||
146987981|NCT02415959|530118728|FG000|Overall Study|Protocol Violation|0|||
146987982|NCT02415959|530118729|FG001|Overall Study|Protocol Violation|0|||
146987983|NCT02415959|530118730|FG002|Overall Study|Protocol Violation|0|||
146987984|NCT02415959|530118731|FG003|Overall Study|Protocol Violation|1|||
146987985|NCT02415959|530118732|FG004|Overall Study|Protocol Violation|0|||
146987986|NCT03008460|530118737|FG000|Overall Study|Protocol deviation|0|||
146987987|NCT03008460|530118738|FG001|Overall Study|Protocol deviation|2|||
146987988|NCT03008460|530118737|FG000|Overall Study|Study drug not dispensed|0|||
146987989|NCT03008460|530118738|FG001|Overall Study|Study drug not dispensed|1|||
146987990|NCT03008460|530118737|FG000|Overall Study|Adverse Event|0|||
146987991|NCT03008460|530118738|FG001|Overall Study|Adverse Event|1|||
146987992|NCT03008460|530118737|FG000|Overall Study|Withdrawal by Subject|5|||
146987993|NCT03008460|530118738|FG001|Overall Study|Withdrawal by Subject|6|||
146987994|NCT03008460|530118737|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
146987995|NCT03008460|530118738|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
146987996|NCT03008460|530118737|FG000|Overall Study|End of study visit outside permitted time window|0|||
146987997|NCT03008460|530118738|FG001|Overall Study|End of study visit outside permitted time window|1|||
146987998|NCT03008460|530118737|FG000|Overall Study|Lost to Follow-up|1|||
146987999|NCT03008460|530118738|FG001|Overall Study|Lost to Follow-up|3|||
146988000|NCT03495869|530118745|FG000|Overall Study|Lost to Follow-up|4|||
146988001|NCT03495869|530118746|FG001|Overall Study|Lost to Follow-up|17|||
146988002|NCT03495869|530118747|FG002|Overall Study|Lost to Follow-up|8|||
146988003|NCT03495869|530118748|FG003|Overall Study|Lost to Follow-up|14|||
146988004|NCT03495869|530118745|FG000|Overall Study|Withdrawal by Subject|0|||
146988005|NCT03495869|530118746|FG001|Overall Study|Withdrawal by Subject|3|||
146988006|NCT03495869|530118747|FG002|Overall Study|Withdrawal by Subject|0|||
146988007|NCT03495869|530118748|FG003|Overall Study|Withdrawal by Subject|3|||
146988008|NCT03495869|530118745|FG000|Overall Study|Dropped from study|0|||
146988009|NCT03495869|530118746|FG001|Overall Study|Dropped from study|7|||
146988010|NCT03495869|530118747|FG002|Overall Study|Dropped from study|2|||
146988011|NCT03495869|530118748|FG003|Overall Study|Dropped from study|4|||
146988012|NCT04634409|530118749|FG000|Overall Study|Death|0|||
146988013|NCT04634409|530118750|FG001|Overall Study|Death|0|||
146988014|NCT04634409|530118751|FG002|Overall Study|Death|0|||
146988015|NCT04634409|530118752|FG003|Overall Study|Death|0|||
146988016|NCT04634409|530118753|FG004|Overall Study|Death|0|||
146988017|NCT04634409|530118754|FG005|Overall Study|Death|0|||
146988018|NCT04634409|530118755|FG006|Overall Study|Death|0|||
146988019|NCT04634409|530118756|FG007|Overall Study|Death|0|||
146988020|NCT04634409|530118757|FG008|Overall Study|Death|0|||
146988021|NCT04634409|530118758|FG009|Overall Study|Death|0|||
146988022|NCT04634409|530118759|FG010|Overall Study|Death|1|||
146988023|NCT04634409|530118760|FG011|Overall Study|Death|0|||
146988024|NCT04634409|530118761|FG012|Overall Study|Death|1|||
146988025|NCT04634409|530118762|FG013|Overall Study|Death|0|||
146988026|NCT04634409|530118763|FG014|Overall Study|Death|0|||
146988027|NCT04634409|530118764|FG015|Overall Study|Death|0|||
146988028|NCT04634409|530118765|FG016|Overall Study|Death|0|||
146988029|NCT04634409|530118766|FG017|Overall Study|Death|0|||
146988030|NCT04634409|530118767|FG018|Overall Study|Death|0|||
146988031|NCT04634409|530118768|FG019|Overall Study|Death|0|||
146988032|NCT04634409|530118769|FG020|Overall Study|Death|0|||
146988033|NCT04634409|530118770|FG021|Overall Study|Death|0|||
146988034|NCT04634409|530118771|FG022|Overall Study|Death|0|||
146988035|NCT04634409|530118772|FG023|Overall Study|Death|0|||
146988036|NCT04634409|530118773|FG024|Overall Study|Death|0|||
146988037|NCT04634409|530118774|FG025|Overall Study|Death|0|||
146988038|NCT04634409|530118775|FG026|Overall Study|Death|0|||
146988039|NCT04634409|530118749|FG000|Overall Study|Adverse Event|0|||
146988040|NCT04634409|530118750|FG001|Overall Study|Adverse Event|0|||
146988041|NCT04634409|530118751|FG002|Overall Study|Adverse Event|1|||
146988042|NCT04634409|530118752|FG003|Overall Study|Adverse Event|0|||
146988043|NCT04634409|530118753|FG004|Overall Study|Adverse Event|0|||
146988044|NCT04634409|530118754|FG005|Overall Study|Adverse Event|1|||
146988045|NCT04634409|530118755|FG006|Overall Study|Adverse Event|0|||
146988046|NCT04634409|530118756|FG007|Overall Study|Adverse Event|0|||
146988047|NCT04634409|530118757|FG008|Overall Study|Adverse Event|0|||
146988048|NCT04634409|530118758|FG009|Overall Study|Adverse Event|0|||
146988049|NCT04634409|530118759|FG010|Overall Study|Adverse Event|0|||
146988050|NCT04634409|530118760|FG011|Overall Study|Adverse Event|0|||
146988051|NCT04634409|530118761|FG012|Overall Study|Adverse Event|0|||
146988052|NCT04634409|530118762|FG013|Overall Study|Adverse Event|0|||
146988053|NCT04634409|530118763|FG014|Overall Study|Adverse Event|0|||
146988054|NCT04634409|530118764|FG015|Overall Study|Adverse Event|0|||
146988055|NCT04634409|530118765|FG016|Overall Study|Adverse Event|0|||
146988056|NCT04634409|530118766|FG017|Overall Study|Adverse Event|0|||
146988057|NCT04634409|530118767|FG018|Overall Study|Adverse Event|0|||
146988058|NCT04634409|530118768|FG019|Overall Study|Adverse Event|0|||
146988059|NCT04634409|530118769|FG020|Overall Study|Adverse Event|0|||
146988060|NCT04634409|530118770|FG021|Overall Study|Adverse Event|0|||
146988061|NCT04634409|530118771|FG022|Overall Study|Adverse Event|0|||
146988062|NCT04634409|530118772|FG023|Overall Study|Adverse Event|0|||
146988063|NCT04634409|530118773|FG024|Overall Study|Adverse Event|0|||
146988064|NCT04634409|530118774|FG025|Overall Study|Adverse Event|0|||
146988065|NCT04634409|530118775|FG026|Overall Study|Adverse Event|0|||
146988066|NCT04634409|530118749|FG000|Overall Study|Lost to Follow-up|3|||
146988067|NCT04634409|530118750|FG001|Overall Study|Lost to Follow-up|1|||
146988068|NCT04634409|530118751|FG002|Overall Study|Lost to Follow-up|1|||
146988069|NCT04634409|530118752|FG003|Overall Study|Lost to Follow-up|3|||
146988070|NCT04634409|530118753|FG004|Overall Study|Lost to Follow-up|1|||
146988071|NCT04634409|530118754|FG005|Overall Study|Lost to Follow-up|1|||
146988072|NCT04634409|530118755|FG006|Overall Study|Lost to Follow-up|1|||
146988073|NCT04634409|530118756|FG007|Overall Study|Lost to Follow-up|3|||
146988074|NCT04634409|530118757|FG008|Overall Study|Lost to Follow-up|3|||
146988075|NCT04634409|530118758|FG009|Overall Study|Lost to Follow-up|11|||
146988076|NCT04634409|530118759|FG010|Overall Study|Lost to Follow-up|8|||
146988077|NCT04634409|530118760|FG011|Overall Study|Lost to Follow-up|15|||
146988078|NCT04634409|530118761|FG012|Overall Study|Lost to Follow-up|3|||
146988079|NCT04634409|530118762|FG013|Overall Study|Lost to Follow-up|2|||
146988080|NCT04634409|530118763|FG014|Overall Study|Lost to Follow-up|7|||
146988081|NCT04634409|530118764|FG015|Overall Study|Lost to Follow-up|0|||
146988082|NCT04634409|530118765|FG016|Overall Study|Lost to Follow-up|0|||
146988083|NCT04634409|530118766|FG017|Overall Study|Lost to Follow-up|0|||
146988084|NCT04634409|530118767|FG018|Overall Study|Lost to Follow-up|0|||
146988085|NCT04634409|530118768|FG019|Overall Study|Lost to Follow-up|0|||
146988086|NCT04634409|530118769|FG020|Overall Study|Lost to Follow-up|0|||
146988087|NCT04634409|530118770|FG021|Overall Study|Lost to Follow-up|0|||
146988088|NCT04634409|530118771|FG022|Overall Study|Lost to Follow-up|0|||
146988089|NCT04634409|530118772|FG023|Overall Study|Lost to Follow-up|0|||
146988090|NCT04634409|530118773|FG024|Overall Study|Lost to Follow-up|0|||
146988091|NCT04634409|530118774|FG025|Overall Study|Lost to Follow-up|0|||
146988092|NCT04634409|530118775|FG026|Overall Study|Lost to Follow-up|0|||
146988093|NCT04634409|530118749|FG000|Overall Study|Withdrawal by Subject|3|||
146988094|NCT04634409|530118750|FG001|Overall Study|Withdrawal by Subject|1|||
146988095|NCT04634409|530118751|FG002|Overall Study|Withdrawal by Subject|6|||
146988096|NCT04634409|530118752|FG003|Overall Study|Withdrawal by Subject|4|||
146988097|NCT04634409|530118753|FG004|Overall Study|Withdrawal by Subject|2|||
146988098|NCT04634409|530118754|FG005|Overall Study|Withdrawal by Subject|0|||
146988099|NCT04634409|530118755|FG006|Overall Study|Withdrawal by Subject|0|||
146988100|NCT04634409|530118756|FG007|Overall Study|Withdrawal by Subject|2|||
146988101|NCT04634409|530118757|FG008|Overall Study|Withdrawal by Subject|3|||
146988102|NCT04634409|530118758|FG009|Overall Study|Withdrawal by Subject|2|||
146988103|NCT04634409|530118759|FG010|Overall Study|Withdrawal by Subject|3|||
146988104|NCT04634409|530118760|FG011|Overall Study|Withdrawal by Subject|2|||
146988105|NCT04634409|530118761|FG012|Overall Study|Withdrawal by Subject|2|||
146988106|NCT04634409|530118762|FG013|Overall Study|Withdrawal by Subject|1|||
146988107|NCT04634409|530118763|FG014|Overall Study|Withdrawal by Subject|5|||
146988108|NCT04634409|530118764|FG015|Overall Study|Withdrawal by Subject|0|||
146988109|NCT04634409|530118765|FG016|Overall Study|Withdrawal by Subject|0|||
146988110|NCT04634409|530118766|FG017|Overall Study|Withdrawal by Subject|1|||
146988111|NCT04634409|530118767|FG018|Overall Study|Withdrawal by Subject|0|||
146988112|NCT04634409|530118768|FG019|Overall Study|Withdrawal by Subject|0|||
146988113|NCT04634409|530118769|FG020|Overall Study|Withdrawal by Subject|0|||
146988114|NCT04634409|530118770|FG021|Overall Study|Withdrawal by Subject|0|||
146988115|NCT04634409|530118771|FG022|Overall Study|Withdrawal by Subject|0|||
146988116|NCT04634409|530118772|FG023|Overall Study|Withdrawal by Subject|1|||
146988117|NCT04634409|530118773|FG024|Overall Study|Withdrawal by Subject|0|||
146988118|NCT04634409|530118774|FG025|Overall Study|Withdrawal by Subject|0|||
146988119|NCT04634409|530118775|FG026|Overall Study|Withdrawal by Subject|0|||
146988120|NCT04634409|530118749|FG000|Overall Study|Other - As reported by Investigator|1|||
146988121|NCT04634409|530118750|FG001|Overall Study|Other - As reported by Investigator|0|||
146988122|NCT04634409|530118751|FG002|Overall Study|Other - As reported by Investigator|0|||
146988123|NCT04634409|530118752|FG003|Overall Study|Other - As reported by Investigator|0|||
146988124|NCT04634409|530118753|FG004|Overall Study|Other - As reported by Investigator|0|||
146988125|NCT04634409|530118754|FG005|Overall Study|Other - As reported by Investigator|0|||
146988126|NCT04634409|530118755|FG006|Overall Study|Other - As reported by Investigator|0|||
146988127|NCT04634409|530118756|FG007|Overall Study|Other - As reported by Investigator|6|||
146988128|NCT04634409|530118757|FG008|Overall Study|Other - As reported by Investigator|4|||
146988129|NCT04634409|530118758|FG009|Overall Study|Other - As reported by Investigator|0|||
146988130|NCT04634409|530118759|FG010|Overall Study|Other - As reported by Investigator|1|||
146988131|NCT04634409|530118760|FG011|Overall Study|Other - As reported by Investigator|2|||
146988132|NCT04634409|530118761|FG012|Overall Study|Other - As reported by Investigator|2|||
146988133|NCT04634409|530118762|FG013|Overall Study|Other - As reported by Investigator|1|||
146988134|NCT04634409|530118763|FG014|Overall Study|Other - As reported by Investigator|0|||
146988135|NCT04634409|530118764|FG015|Overall Study|Other - As reported by Investigator|0|||
146988136|NCT04634409|530118765|FG016|Overall Study|Other - As reported by Investigator|0|||
146988137|NCT04634409|530118766|FG017|Overall Study|Other - As reported by Investigator|0|||
146988138|NCT04634409|530118767|FG018|Overall Study|Other - As reported by Investigator|0|||
146988139|NCT04634409|530118768|FG019|Overall Study|Other - As reported by Investigator|0|||
146988140|NCT04634409|530118769|FG020|Overall Study|Other - As reported by Investigator|0|||
146988141|NCT04634409|530118770|FG021|Overall Study|Other - As reported by Investigator|0|||
146988142|NCT04634409|530118771|FG022|Overall Study|Other - As reported by Investigator|0|||
146988143|NCT04634409|530118772|FG023|Overall Study|Other - As reported by Investigator|0|||
146988144|NCT04634409|530118773|FG024|Overall Study|Other - As reported by Investigator|0|||
146988145|NCT04634409|530118774|FG025|Overall Study|Other - As reported by Investigator|0|||
146988146|NCT04634409|530118775|FG026|Overall Study|Other - As reported by Investigator|0|||
146988147|NCT01497938|530118776|FG000|Overall Study|Adverse Event|0|||
146988148|NCT01497938|530118777|FG001|Overall Study|Adverse Event|1|||
146988149|NCT01497938|530118776|FG000|Overall Study|Physician Decision|0|||
146988150|NCT01497938|530118777|FG001|Overall Study|Physician Decision|1|||
146988151|NCT01497938|530118776|FG000|Overall Study|Withdrawal by Subject|4|||
146988152|NCT01497938|530118777|FG001|Overall Study|Withdrawal by Subject|0|||
146988153|NCT01497938|530118776|FG000|Overall Study|Device Violation|1|||
146988154|NCT01497938|530118777|FG001|Overall Study|Device Violation|0|||
146988155|NCT00365352|530118778|FG000|Overall Study|Adverse Event|6|||
146988156|NCT00365352|530118779|FG001|Overall Study|Adverse Event|7|||
146988157|NCT00365352|530118780|FG002|Overall Study|Adverse Event|8|||
146988158|NCT00365352|530118778|FG000|Overall Study|Participant Withdrew Consent|8|||
146988159|NCT00365352|530118779|FG001|Overall Study|Participant Withdrew Consent|3|||
146988160|NCT00365352|530118780|FG002|Overall Study|Participant Withdrew Consent|4|||
146988161|NCT00365352|530118778|FG000|Overall Study|Lack of Efficacy|3|||
146988162|NCT00365352|530118779|FG001|Overall Study|Lack of Efficacy|0|||
146988163|NCT00365352|530118780|FG002|Overall Study|Lack of Efficacy|0|||
146988164|NCT00365352|530118778|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
146988165|NCT00365352|530118779|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
146988166|NCT00365352|530118780|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
146988167|NCT00365352|530118778|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
146988168|NCT00365352|530118779|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
146988169|NCT00365352|530118780|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
146988170|NCT00365352|530118778|FG000|Overall Study|Lost to Follow-up|1|||
146988171|NCT00365352|530118779|FG001|Overall Study|Lost to Follow-up|1|||
146988172|NCT00365352|530118780|FG002|Overall Study|Lost to Follow-up|0|||
146988173|NCT00365352|530118778|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
146988174|NCT00365352|530118779|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
146988175|NCT00365352|530118780|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
146988176|NCT00462982|530118785|FG000|Overall Study|Adverse Event|1|||
146988177|NCT00462982|530118785|FG000|Overall Study|Patient Not Treated|2|||
146988178|NCT02448771|530118788|FG000|Overall Study|Disease Progression|30|||
146988179|NCT02448771|530118788|FG000|Overall Study|Unacceptable Toxicity|1|||
146988180|NCT02448771|530118788|FG000|Overall Study|Physician Decision|3|||
146988181|NCT02448771|530118788|FG000|Overall Study|Started new therapy|2|||
146988182|NCT00770315|530118790|FG000|Overall Study|Adverse Event|11|||
146988183|NCT00770315|530118791|FG001|Overall Study|Adverse Event|17|||
146988184|NCT00770315|530118792|FG002|Overall Study|Adverse Event|16|||
146988185|NCT00770315|530118793|FG003|Overall Study|Adverse Event|6|||
146988186|NCT00770315|530118790|FG000|Overall Study|Lost to Follow-up|9|||
146988187|NCT00770315|530118791|FG001|Overall Study|Lost to Follow-up|5|||
146988188|NCT00770315|530118792|FG002|Overall Study|Lost to Follow-up|10|||
146988189|NCT00770315|530118793|FG003|Overall Study|Lost to Follow-up|3|||
146988190|NCT00770315|530118790|FG000|Overall Study|Withdrawal by Subject|13|||
146988191|NCT00770315|530118791|FG001|Overall Study|Withdrawal by Subject|17|||
146988192|NCT00770315|530118792|FG002|Overall Study|Withdrawal by Subject|24|||
146988193|NCT00770315|530118793|FG003|Overall Study|Withdrawal by Subject|20|||
146988194|NCT00770315|530118790|FG000|Overall Study|Noncompliance with Protocol|7|||
146988195|NCT00770315|530118791|FG001|Overall Study|Noncompliance with Protocol|4|||
146988196|NCT00770315|530118792|FG002|Overall Study|Noncompliance with Protocol|7|||
146988197|NCT00770315|530118793|FG003|Overall Study|Noncompliance with Protocol|9|||
146988198|NCT02683187|530118794|FG000|Overall Study|Failed IV access|3|||
146988199|NCT02683187|530118794|FG000|Overall Study|Withdrawal by Subject|5|||
146988200|NCT04256421|530118797|FG000|Overall Study|Death|171|||
146988201|NCT04256421|530118798|FG001|Overall Study|Death|180|||
146988202|NCT04256421|530118797|FG000|Overall Study|Lost to Follow-up|1|||
146988203|NCT04256421|530118798|FG001|Overall Study|Lost to Follow-up|1|||
146988204|NCT04256421|530118797|FG000|Overall Study|Withdrawal by Subject|9|||
146988205|NCT04256421|530118798|FG001|Overall Study|Withdrawal by Subject|10|||
146988206|NCT04256421|530118797|FG000|Overall Study|Ongoing in Study|66|||
146988207|NCT04256421|530118798|FG001|Overall Study|Ongoing in Study|52|||
146988208|NCT05514119|530120621|FG000|Overall Study|Ineligible due to disease progression|1|||
146988209|NCT01052116|530120622|FG000|Overall Study|Lost to Follow-up|11|||
146988210|NCT01052116|530120623|FG001|Overall Study|Lost to Follow-up|17|||
146988211|NCT01052116|530120622|FG000|Overall Study|Withdrawal by Subject|3|||
146988212|NCT01052116|530120623|FG001|Overall Study|Withdrawal by Subject|6|||
146988213|NCT01052116|530120622|FG000|Overall Study|Spirometry not performed|0|||
146988214|NCT01052116|530120623|FG001|Overall Study|Spirometry not performed|4|||
146988215|NCT00278200|530120624|FG000|Overall Study|Death|1|||
146988216|NCT00278200|530120625|FG001|Overall Study|Death|3|||
146988217|NCT00278200|530120624|FG000|Overall Study|Physician Decision|0|||
146988218|NCT00278200|530120625|FG001|Overall Study|Physician Decision|1|||
146988219|NCT05568225|530120626|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
146988220|NCT05568225|530120627|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
146988221|NCT05568225|530120628|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
146988222|NCT05568225|530120626|FG000|Primary Treatment Period|Physician Decision|0|||
146988223|NCT05568225|530120627|FG001|Primary Treatment Period|Physician Decision|1|||
146988224|NCT05568225|530120628|FG002|Primary Treatment Period|Physician Decision|0|||
146988225|NCT05568225|530120626|FG000|Primary Treatment Period|Disease progression|0|||
146988226|NCT05568225|530120627|FG001|Primary Treatment Period|Disease progression|1|||
146988227|NCT05568225|530120628|FG002|Primary Treatment Period|Disease progression|0|||
146988228|NCT05568225|530120626|FG000|Primary Treatment Period|Lack of Efficacy|0|||
146988229|NCT05568225|530120627|FG001|Primary Treatment Period|Lack of Efficacy|1|||
146988230|NCT05568225|530120628|FG002|Primary Treatment Period|Lack of Efficacy|0|||
146988231|NCT05568225|530120626|FG000|Primary Treatment Period|Withdrawal of conset|1|||
146988232|NCT05568225|530120627|FG001|Primary Treatment Period|Withdrawal of conset|0|||
146988233|NCT05568225|530120628|FG002|Primary Treatment Period|Withdrawal of conset|4|||
146988234|NCT05568225|530120626|FG000|Primary Treatment Period|Adverse Event|1|||
146988235|NCT05568225|530120627|FG001|Primary Treatment Period|Adverse Event|0|||
146988236|NCT05568225|530120628|FG002|Primary Treatment Period|Adverse Event|0|||
146988237|NCT05568225|530120626|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
146988238|NCT05568225|530120627|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
146988239|NCT05568225|530120628|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
146988240|NCT05568225|530120626|FG000|Extension Treatment Period|Protocol Violation|0|||
146988241|NCT05568225|530120627|FG001|Extension Treatment Period|Protocol Violation|0|||
146988242|NCT05568225|530120628|FG002|Extension Treatment Period|Protocol Violation|1|||
146988243|NCT05568225|530120626|FG000|Extension Treatment Period|Lack of Efficacy|0|||
146988244|NCT05568225|530120627|FG001|Extension Treatment Period|Lack of Efficacy|0|||
146988245|NCT05568225|530120628|FG002|Extension Treatment Period|Lack of Efficacy|1|||
146988246|NCT01290263|530120629|FG000|Overall Study|Adverse Event|0|||
146988247|NCT01290263|530120630|FG001|Overall Study|Adverse Event|0|||
146988248|NCT01290263|530120631|FG002|Overall Study|Adverse Event|0|||
146988249|NCT01290263|530120632|FG003|Overall Study|Adverse Event|1|||
146988250|NCT01290263|530120633|FG004|Overall Study|Adverse Event|1|||
146988251|NCT01290263|530120629|FG000|Overall Study|Lack of Efficacy|8|||
146988252|NCT01290263|530120630|FG001|Overall Study|Lack of Efficacy|2|||
146988253|NCT01290263|530120631|FG002|Overall Study|Lack of Efficacy|7|||
146988254|NCT01290263|530120632|FG003|Overall Study|Lack of Efficacy|24|||
146988255|NCT01290263|530120633|FG004|Overall Study|Lack of Efficacy|33|||
146988256|NCT01290263|530120629|FG000|Overall Study|Withdrawal by Subject|3|||
146988257|NCT01290263|530120630|FG001|Overall Study|Withdrawal by Subject|1|||
146988258|NCT01290263|530120631|FG002|Overall Study|Withdrawal by Subject|0|||
146988259|NCT01290263|530120632|FG003|Overall Study|Withdrawal by Subject|1|||
146988260|NCT01290263|530120633|FG004|Overall Study|Withdrawal by Subject|2|||
146988261|NCT01290263|530120629|FG000|Overall Study|Participant Non-Compliance|0|||
146988262|NCT01290263|530120630|FG001|Overall Study|Participant Non-Compliance|0|||
146988263|NCT01290263|530120631|FG002|Overall Study|Participant Non-Compliance|0|||
146988264|NCT01290263|530120632|FG003|Overall Study|Participant Non-Compliance|1|||
146988265|NCT01290263|530120633|FG004|Overall Study|Participant Non-Compliance|1|||
146988266|NCT01521559|530120634|FG000|Overall Study|Adverse Event|0|||
146988267|NCT01521559|530120635|FG001|Overall Study|Adverse Event|4|||
146988268|NCT01521559|530120634|FG000|Overall Study|Death|1|||
146988269|NCT01521559|530120635|FG001|Overall Study|Death|0|||
146988270|NCT01521559|530120634|FG000|Overall Study|Withdrawal by Subject|9|||
146988271|NCT01521559|530120635|FG001|Overall Study|Withdrawal by Subject|11|||
146988272|NCT01521559|530120634|FG000|Overall Study|Lost to Follow-up|3|||
146988273|NCT01521559|530120635|FG001|Overall Study|Lost to Follow-up|1|||
146988274|NCT01521559|530120634|FG000|Overall Study|Protocol Violation|1|||
146988275|NCT01521559|530120635|FG001|Overall Study|Protocol Violation|0|||
146988276|NCT01521559|530120634|FG000|Overall Study|Other|1|||
146988277|NCT01521559|530120635|FG001|Overall Study|Other|2|||
146988278|NCT02228382|530120636|FG000|Overall Study|Death|5|||
146988279|NCT02228382|530120637|FG001|Overall Study|Death|7|||
146988280|NCT02228382|530120638|FG002|Overall Study|Death|5|||
146988281|NCT02228382|530120639|FG003|Overall Study|Death|0|||
146988282|NCT02228382|530120640|FG004|Overall Study|Death|2|||
146988283|NCT02228382|530120636|FG000|Overall Study|Participant refused further follow-up|0|||
146988284|NCT02228382|530120637|FG001|Overall Study|Participant refused further follow-up|0|||
146988285|NCT02228382|530120638|FG002|Overall Study|Participant refused further follow-up|1|||
146988286|NCT02228382|530120639|FG003|Overall Study|Participant refused further follow-up|0|||
146988287|NCT02228382|530120640|FG004|Overall Study|Participant refused further follow-up|0|||
146988288|NCT02228382|530120636|FG000|Overall Study|Study terminated by sponsor|3|||
146988289|NCT02228382|530120637|FG001|Overall Study|Study terminated by sponsor|5|||
146988290|NCT02228382|530120638|FG002|Overall Study|Study terminated by sponsor|7|||
146988291|NCT02228382|530120639|FG003|Overall Study|Study terminated by sponsor|0|||
146988292|NCT02228382|530120640|FG004|Overall Study|Study terminated by sponsor|0|||
146988293|NCT02228382|530120636|FG000|Overall Study|Lost to Follow-up|0|||
146988294|NCT02228382|530120637|FG001|Overall Study|Lost to Follow-up|0|||
146988295|NCT02228382|530120638|FG002|Overall Study|Lost to Follow-up|3|||
146988296|NCT02228382|530120639|FG003|Overall Study|Lost to Follow-up|1|||
146988297|NCT02228382|530120640|FG004|Overall Study|Lost to Follow-up|0|||
146988298|NCT02228382|530120636|FG000|Overall Study|Withdrawal by Subject|0|||
146988299|NCT02228382|530120637|FG001|Overall Study|Withdrawal by Subject|3|||
146988300|NCT02228382|530120638|FG002|Overall Study|Withdrawal by Subject|2|||
146988301|NCT02228382|530120639|FG003|Overall Study|Withdrawal by Subject|1|||
146988302|NCT02228382|530120640|FG004|Overall Study|Withdrawal by Subject|0|||
146988303|NCT02228382|530120636|FG000|Overall Study|Other|2|||
146988304|NCT02228382|530120637|FG001|Overall Study|Other|3|||
146988305|NCT02228382|530120638|FG002|Overall Study|Other|3|||
146988306|NCT02228382|530120639|FG003|Overall Study|Other|0|||
146988307|NCT02228382|530120640|FG004|Overall Study|Other|0|||
146988308|NCT02918162|530120642|FG000|Overall Study|Withdrawal by Subject|1|||
146988309|NCT02918162|530120642|FG000|Overall Study|Omental Disease|1|||
146988310|NCT00395226|530120643|FG000|Overall Study|Adverse Event|4|||
146988311|NCT00395226|530120644|FG001|Overall Study|Adverse Event|3|||
146988312|NCT00395226|530120643|FG000|Overall Study|Withdrawal by Subject|0|||
146988313|NCT00395226|530120644|FG001|Overall Study|Withdrawal by Subject|1|||
146988314|NCT00395226|530120643|FG000|Overall Study|Lost to Follow-up|0|||
146988315|NCT00395226|530120644|FG001|Overall Study|Lost to Follow-up|1|||
146988316|NCT00576381|530120645|FG000|Overall Study|Reoperation|3|||
146988317|NCT00576381|530120645|FG000|Overall Study|Adverse Event|4|||
146988318|NCT01031537|530120649|FG000|Overall Study|medical reasons not related to study|3|||
146988319|NCT01031537|530120649|FG000|Overall Study|Lack of Efficacy|1|||
146988320|NCT01031537|530120649|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
146988321|NCT01031537|530120649|FG000|Overall Study|moved, met exclusion criteria|10|||
146988322|NCT01031537|530120649|FG000|Overall Study|Withdrawal by Subject|5|||
146988323|NCT01031537|530120649|FG000|Overall Study|PI removal, no longer met eligibility|12|||
146988324|NCT02492958|530120657|FG000|Overall Study|Withdrawal by Subject|0|||
146988325|NCT02492958|530120658|FG001|Overall Study|Withdrawal by Subject|0|||
146988326|NCT02492958|530120659|FG002|Overall Study|Withdrawal by Subject|1|||
146988327|NCT02492958|530120660|FG003|Overall Study|Withdrawal by Subject|0|||
146988328|NCT02492958|530120657|FG000|Overall Study|Adverse Event|1|||
146988329|NCT02492958|530120658|FG001|Overall Study|Adverse Event|0|||
146988330|NCT02492958|530120659|FG002|Overall Study|Adverse Event|1|||
146988331|NCT02492958|530120660|FG003|Overall Study|Adverse Event|0|||
146988332|NCT03522948|530120661|FG000|Overall Study|Lost to Follow-up|1|||
146988333|NCT02187042|530120664|FG000|Overall Study|Death|1|||
146988334|NCT02187042|530120665|FG001|Overall Study|Death|1|||
146988335|NCT02187042|530120664|FG000|Overall Study|Toxicity|6|||
146988336|NCT02187042|530120665|FG001|Overall Study|Toxicity|5|||
146988337|NCT02187042|530120664|FG000|Overall Study|Participant choice|1|||
146988338|NCT02187042|530120665|FG001|Overall Study|Participant choice|0|||
146988339|NCT02187042|530120664|FG000|Overall Study|Doctor choice|1|||
146833705|NCT03721172|529560955|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
146988340|NCT02187042|530120665|FG001|Overall Study|Doctor choice|0|||
146988341|NCT02187042|530120664|FG000|Overall Study|Progressive disease|4|||
146988342|NCT02187042|530120665|FG001|Overall Study|Progressive disease|8|||
146988343|NCT00337571|530120668|FG000|Overall Study|Lack of Efficacy|3|||
146988344|NCT00337571|530120669|FG001|Overall Study|Lack of Efficacy|0|||
146988345|NCT00337571|530120670|FG002|Overall Study|Lack of Efficacy|0|||
146988346|NCT00337571|530120671|FG003|Overall Study|Lack of Efficacy|0|||
146988347|NCT00337571|530120668|FG000|Overall Study|Adverse Event|4|||
146988348|NCT00337571|530120669|FG001|Overall Study|Adverse Event|5|||
146988349|NCT00337571|530120670|FG002|Overall Study|Adverse Event|8|||
146988350|NCT00337571|530120671|FG003|Overall Study|Adverse Event|4|||
146988351|NCT00337571|530120668|FG000|Overall Study|Withdrawal by Subject|2|||
146988352|NCT00337571|530120669|FG001|Overall Study|Withdrawal by Subject|2|||
146988353|NCT00337571|530120670|FG002|Overall Study|Withdrawal by Subject|1|||
146988354|NCT00337571|530120671|FG003|Overall Study|Withdrawal by Subject|0|||
146988355|NCT00337571|530120668|FG000|Overall Study|Lost to Follow-up|3|||
146988356|NCT00337571|530120669|FG001|Overall Study|Lost to Follow-up|1|||
146988357|NCT00337571|530120670|FG002|Overall Study|Lost to Follow-up|0|||
146988358|NCT00337571|530120671|FG003|Overall Study|Lost to Follow-up|1|||
146988359|NCT00337571|530120668|FG000|Overall Study|Poor/noncompliance|1|||
146988360|NCT00337571|530120669|FG001|Overall Study|Poor/noncompliance|1|||
146988361|NCT00337571|530120670|FG002|Overall Study|Poor/noncompliance|1|||
146988362|NCT00337571|530120671|FG003|Overall Study|Poor/noncompliance|1|||
146988363|NCT00337571|530120668|FG000|Overall Study|No longer met study criteria|1|||
146988364|NCT00337571|530120669|FG001|Overall Study|No longer met study criteria|0|||
146988365|NCT00337571|530120670|FG002|Overall Study|No longer met study criteria|0|||
146988366|NCT00337571|530120671|FG003|Overall Study|No longer met study criteria|0|||
146988367|NCT00337571|530120668|FG000|Overall Study|High Potassium level|0|||
146988368|NCT00337571|530120669|FG001|Overall Study|High Potassium level|0|||
146988369|NCT00337571|530120670|FG002|Overall Study|High Potassium level|0|||
146988370|NCT00337571|530120671|FG003|Overall Study|High Potassium level|1|||
146988371|NCT00948675|530120673|FG000|Overall Study|Lost to Follow-up|1|||
146988372|NCT00948675|530120674|FG001|Overall Study|Lost to Follow-up|0|||
146988373|NCT03552757|530120675|FG000|Overall Study|Withdrawal by Subject|10|||
146988374|NCT03552757|530120676|FG001|Overall Study|Withdrawal by Subject|5|||
146988375|NCT03552757|530120677|FG002|Overall Study|Withdrawal by Subject|12|||
146988376|NCT03552757|530120675|FG000|Overall Study|Lost to Follow-up|2|||
146988377|NCT03552757|530120676|FG001|Overall Study|Lost to Follow-up|7|||
146988378|NCT03552757|530120677|FG002|Overall Study|Lost to Follow-up|7|||
146988379|NCT03552757|530120675|FG000|Overall Study|Death|1|||
146988380|NCT03552757|530120676|FG001|Overall Study|Death|1|||
146988381|NCT03552757|530120677|FG002|Overall Study|Death|1|||
146988382|NCT00449150|530120678|FG000|Overall Study|Adverse Event|11|||
146988383|NCT00449150|530120679|FG001|Overall Study|Adverse Event|18|||
146988384|NCT00449150|530120680|FG002|Overall Study|Adverse Event|9|||
146988385|NCT00449150|530120678|FG000|Overall Study|Lack of Efficacy|1|||
146988386|NCT00449150|530120679|FG001|Overall Study|Lack of Efficacy|2|||
146988387|NCT00449150|530120680|FG002|Overall Study|Lack of Efficacy|2|||
146988388|NCT00449150|530120678|FG000|Overall Study|Other|16|||
146988389|NCT00449150|530120679|FG001|Overall Study|Other|13|||
146988390|NCT00449150|530120680|FG002|Overall Study|Other|14|||
146988391|NCT00449150|530120678|FG000|Overall Study|Withdrawal by Subject|17|||
146988392|NCT00449150|530120679|FG001|Overall Study|Withdrawal by Subject|18|||
146988393|NCT00449150|530120680|FG002|Overall Study|Withdrawal by Subject|21|||
146988394|NCT00449150|530120678|FG000|Overall Study|Protocol Violation|1|||
146988395|NCT00449150|530120679|FG001|Overall Study|Protocol Violation|2|||
146988396|NCT00449150|530120680|FG002|Overall Study|Protocol Violation|1|||
146988397|NCT06331156|530120681|FG000|Overall Study|Adverse Event|1|||
146988398|NCT06331156|530120682|FG001|Overall Study|Adverse Event|0|||
146988399|NCT06331156|530120681|FG000|Overall Study|Lost to Follow-up|1|||
146988400|NCT06331156|530120682|FG001|Overall Study|Lost to Follow-up|0|||
146988401|NCT06331156|530120681|FG000|Overall Study|Migrated / Moved from the study area|4|||
146988402|NCT06331156|530120682|FG001|Overall Study|Migrated / Moved from the study area|3|||
146988403|NCT06331156|530120681|FG000|Overall Study|Other|7|||
146988404|NCT06331156|530120682|FG001|Overall Study|Other|0|||
146988405|NCT06331156|530120681|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
146988406|NCT06331156|530120682|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
146988407|NCT02978326|530120683|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
146988408|NCT02978326|530120684|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
146988409|NCT02978326|530120685|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
146988410|NCT02978326|530120683|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
146988411|NCT02978326|530120684|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
146988412|NCT02978326|530120685|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
146988413|NCT02978326|530120683|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
146988414|NCT02978326|530120684|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
146988415|NCT02978326|530120685|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
146988416|NCT02978326|530120683|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
146988417|NCT02978326|530120684|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
146988418|NCT02978326|530120685|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
146988419|NCT00865709|530120695|FG000|Treatment|Adverse Event|9|||
146988420|NCT00865709|530120696|FG001|Treatment|Adverse Event|6|||
146988421|NCT00865709|530120695|FG000|Treatment|Withdrawal by Subject|10|||
146988422|NCT00865709|530120696|FG001|Treatment|Withdrawal by Subject|7|||
146988423|NCT00865709|530120695|FG000|Treatment|Physician Decision|3|||
146988424|NCT00865709|530120696|FG001|Treatment|Physician Decision|2|||
146988425|NCT00865709|530120695|FG000|Treatment|Surgery|8|||
146988426|NCT00865709|530120696|FG001|Treatment|Surgery|3|||
146988427|NCT00662129|530120697|FG000|Overall Study|Protocol Violation|1|||
146988428|NCT00662129|530120697|FG000|Overall Study|Cancel prior to beginning treatment|1|||
146833706|NCT03721172|529560953|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
146988429|NCT00662129|530120697|FG000|Overall Study|Ineligible|1|||
146988430|NCT03276975|530120698|FG000|Overall Study|Withdrawal by Subject|1|||
146988431|NCT03276975|530120699|FG001|Overall Study|Withdrawal by Subject|0|||
146988432|NCT02153736|530120704|FG000|Overall Study|Lost to Follow-up|1|||
146988433|NCT02153736|530120705|FG001|Overall Study|Lost to Follow-up|0|||
146988434|NCT02153736|530120704|FG000|Overall Study|Medical status change made ineligible|1|||
146988435|NCT02153736|530120705|FG001|Overall Study|Medical status change made ineligible|0|||
146988436|NCT02153736|530120704|FG000|Overall Study|Death|0|||
146988437|NCT02153736|530120705|FG001|Overall Study|Death|1|||
146988438|NCT02153736|530120704|FG000|Overall Study|Withdrawal by Subject|0|||
146988439|NCT02153736|530120705|FG001|Overall Study|Withdrawal by Subject|1|||
146988440|NCT00796510|530120714|FG000|Overall Study|Death|1|||
146988441|NCT00796510|530120715|FG001|Overall Study|Death|0|||
146988442|NCT00796510|530120714|FG000|Overall Study|Study Terminated|2|||
146988443|NCT00796510|530120715|FG001|Overall Study|Study Terminated|0|||
146988444|NCT01734772|530120716|FG000|Overall Study|Adverse Event|1|||
146988445|NCT01734772|530120717|FG001|Overall Study|Adverse Event|2|||
146988446|NCT01734772|530120716|FG000|Overall Study|Withdrawal by Subject|0|||
146988447|NCT01734772|530120717|FG001|Overall Study|Withdrawal by Subject|1|||
146988448|NCT05030753|530120718|FG000|9-week|Lost to Follow-up|10|||
146988449|NCT05030753|530120719|FG001|9-week|Lost to Follow-up|7|||
146988450|NCT05030753|530120718|FG000|9-week|Withdrawal by Subject|1|||
146988451|NCT05030753|530120719|FG001|9-week|Withdrawal by Subject|0|||
146988452|NCT05030753|530120718|FG000|9-week|Excluded from analysis due to missing covariates|2|||
146988453|NCT05030753|530120719|FG001|9-week|Excluded from analysis due to missing covariates|1|||
146988454|NCT05030753|530120718|FG000|6-month post intervention|Lost to Follow-up|5|||
146988455|NCT05030753|530120719|FG001|6-month post intervention|Lost to Follow-up|4|||
146988456|NCT05030753|530120718|FG000|6-month post intervention|Withdrawal by Subject|4|||
146988457|NCT05030753|530120719|FG001|6-month post intervention|Withdrawal by Subject|0|||
146988458|NCT05030753|530120718|FG000|18-month post intervention|Lost to Follow-up|3|||
146988459|NCT05030753|530120719|FG001|18-month post intervention|Lost to Follow-up|1|||
146988460|NCT00720122|530120728|FG000|Overall Study|Lost to Follow-up|1|||
146988461|NCT00720122|530120728|FG000|Overall Study|Physician Decision|1|||
146988462|NCT00720122|530120728|FG000|Overall Study|Withdrawal by Subject|7|||
146988463|NCT03072459|530120729|FG000|Overall Study|Device revised/removed|1|||
146988464|NCT03072459|530120729|FG000|Overall Study|Subject not able to return|1|||
146988465|NCT02275364|530120730|FG000|Period 1|Withdrawal by Subject|1|||
146988466|NCT02275364|530120731|FG001|Period 1|Withdrawal by Subject|0|||
146988467|NCT02275364|530120730|FG000|Period 1|Other reason|1|||
146988468|NCT02275364|530120731|FG001|Period 1|Other reason|0|||
146988469|NCT03595657|530120736|FG000|Overall Study|Adverse Event|14|||
146988470|NCT03595657|530120736|FG000|Overall Study|Death|1|||
146988471|NCT03595657|530120736|FG000|Overall Study|Lack of Efficacy|40|||
146988472|NCT03595657|530120736|FG000|Overall Study|Withdrawal by Subject|10|||
146988473|NCT03595657|530120736|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
146988474|NCT03595657|530120736|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
146988475|NCT00663871|530120737|FG000|Overall Study|Lost to Follow-up|5|||
146988476|NCT00663871|530120738|FG001|Overall Study|Lost to Follow-up|5|||
146988477|NCT00663871|530120737|FG000|Overall Study|Withdrawal by Subject|5|||
146988478|NCT00663871|530120738|FG001|Overall Study|Withdrawal by Subject|2|||
146988479|NCT03384745|530120739|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
146988480|NCT03384745|530120740|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
146988481|NCT03384745|530120741|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
146988482|NCT03384745|530120742|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
146988483|NCT03384745|530120743|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
146988484|NCT03384745|530120744|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
146988485|NCT03384745|530120739|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
146988486|NCT03384745|530120740|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
146988487|NCT03384745|530120741|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
146988488|NCT03384745|530120742|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
146988489|NCT03384745|530120743|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
146988490|NCT03384745|530120744|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
146988491|NCT03384745|530120739|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
146988492|NCT03384745|530120740|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
146988493|NCT03384745|530120741|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
146988494|NCT03384745|530120742|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
146988495|NCT03384745|530120743|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
146988496|NCT03384745|530120744|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
146988497|NCT03384745|530120739|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
146988498|NCT03384745|530120740|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
146988499|NCT03384745|530120741|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
146988500|NCT03384745|530120742|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
146988501|NCT03384745|530120743|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
146988502|NCT03384745|530120744|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
146988503|NCT03384745|530120739|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
146988504|NCT03384745|530120740|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
146988505|NCT03384745|530120741|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
146988506|NCT03384745|530120742|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
146988507|NCT03384745|530120743|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
146988508|NCT03384745|530120744|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
146988509|NCT03384745|530120739|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
146988510|NCT03384745|530120740|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
146988511|NCT03384745|530120741|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
146988512|NCT03384745|530120742|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
146988513|NCT03384745|530120743|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
146988514|NCT03384745|530120744|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
146988515|NCT03384745|530120739|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
146988516|NCT03384745|530120740|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
146988517|NCT03384745|530120741|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
146988518|NCT03384745|530120742|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
146988519|NCT03384745|530120743|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
146988520|NCT03384745|530120744|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
146988521|NCT03384745|530120739|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
146988522|NCT03384745|530120740|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
146988523|NCT03384745|530120741|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
146988524|NCT03384745|530120742|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
146988525|NCT03384745|530120743|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
146988526|NCT03384745|530120744|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
146988527|NCT03384745|530120739|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
146988528|NCT03384745|530120740|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
146988529|NCT03384745|530120741|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
146988530|NCT03384745|530120742|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
146988531|NCT03384745|530120743|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
146988532|NCT03384745|530120744|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
146988533|NCT03384745|530120739|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
146988534|NCT03384745|530120740|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
146988535|NCT03384745|530120741|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
146988536|NCT03384745|530120742|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
146988537|NCT03384745|530120743|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
146988538|NCT03384745|530120744|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
146988539|NCT03384745|530120739|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
146988540|NCT03384745|530120740|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
146988541|NCT03384745|530120741|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
146988542|NCT03384745|530120742|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
146988543|NCT03384745|530120743|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
146988544|NCT03384745|530120744|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
146988545|NCT01592370|530120747|FG000|Overall Study|Disease Progression|62|||
146988546|NCT01592370|530120748|FG001|Overall Study|Disease Progression|16|||
146988547|NCT01592370|530120749|FG002|Overall Study|Disease Progression|52|||
146988548|NCT01592370|530120750|FG003|Overall Study|Disease Progression|3|||
146988549|NCT01592370|530120751|FG004|Overall Study|Disease Progression|3|||
146988550|NCT01592370|530120752|FG005|Overall Study|Disease Progression|31|||
146988551|NCT01592370|530120753|FG006|Overall Study|Disease Progression|14|||
146988552|NCT01592370|530120747|FG000|Overall Study|Study Drug Toxicity|14|||
146988553|NCT01592370|530120748|FG001|Overall Study|Study Drug Toxicity|3|||
146988554|NCT01592370|530120749|FG002|Overall Study|Study Drug Toxicity|0|||
146988555|NCT01592370|530120750|FG003|Overall Study|Study Drug Toxicity|0|||
146988556|NCT01592370|530120751|FG004|Overall Study|Study Drug Toxicity|0|||
146988557|NCT01592370|530120752|FG005|Overall Study|Study Drug Toxicity|0|||
146988558|NCT01592370|530120753|FG006|Overall Study|Study Drug Toxicity|1|||
146988559|NCT01592370|530120747|FG000|Overall Study|AE unrelated to study drug|4|||
146988560|NCT01592370|530120748|FG001|Overall Study|AE unrelated to study drug|3|||
146988561|NCT01592370|530120749|FG002|Overall Study|AE unrelated to study drug|0|||
146988562|NCT01592370|530120750|FG003|Overall Study|AE unrelated to study drug|0|||
146988563|NCT01592370|530120751|FG004|Overall Study|AE unrelated to study drug|0|||
146988564|NCT01592370|530120752|FG005|Overall Study|AE unrelated to study drug|0|||
146988565|NCT01592370|530120753|FG006|Overall Study|AE unrelated to study drug|1|||
146988566|NCT01592370|530120747|FG000|Overall Study|Request to discontinue study treatment|5|||
146988567|NCT01592370|530120748|FG001|Overall Study|Request to discontinue study treatment|0|||
146833707|NCT03721172|529560954|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
146833708|NCT03721172|529560955|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
146988568|NCT01592370|530120749|FG002|Overall Study|Request to discontinue study treatment|2|||
146988569|NCT01592370|530120750|FG003|Overall Study|Request to discontinue study treatment|0|||
146988570|NCT01592370|530120751|FG004|Overall Study|Request to discontinue study treatment|1|||
146988571|NCT01592370|530120752|FG005|Overall Study|Request to discontinue study treatment|2|||
146988572|NCT01592370|530120753|FG006|Overall Study|Request to discontinue study treatment|0|||
146988573|NCT01592370|530120747|FG000|Overall Study|Withdrew consent|1|||
146988574|NCT01592370|530120748|FG001|Overall Study|Withdrew consent|2|||
146988575|NCT01592370|530120749|FG002|Overall Study|Withdrew consent|1|||
146988576|NCT01592370|530120750|FG003|Overall Study|Withdrew consent|1|||
146988577|NCT01592370|530120751|FG004|Overall Study|Withdrew consent|0|||
146988578|NCT01592370|530120752|FG005|Overall Study|Withdrew consent|0|||
146988579|NCT01592370|530120753|FG006|Overall Study|Withdrew consent|0|||
146988580|NCT01592370|530120747|FG000|Overall Study|Maximum clinical benefit|11|||
146988581|NCT01592370|530120748|FG001|Overall Study|Maximum clinical benefit|1|||
146988582|NCT01592370|530120749|FG002|Overall Study|Maximum clinical benefit|7|||
146988583|NCT01592370|530120750|FG003|Overall Study|Maximum clinical benefit|1|||
146988584|NCT01592370|530120751|FG004|Overall Study|Maximum clinical benefit|0|||
146988585|NCT01592370|530120752|FG005|Overall Study|Maximum clinical benefit|0|||
146988586|NCT01592370|530120753|FG006|Overall Study|Maximum clinical benefit|0|||
146988587|NCT01592370|530120747|FG000|Overall Study|No longer meets study criteria|1|||
146988588|NCT01592370|530120748|FG001|Overall Study|No longer meets study criteria|0|||
146988589|NCT01592370|530120749|FG002|Overall Study|No longer meets study criteria|0|||
146988590|NCT01592370|530120750|FG003|Overall Study|No longer meets study criteria|0|||
146988591|NCT01592370|530120751|FG004|Overall Study|No longer meets study criteria|0|||
146988592|NCT01592370|530120752|FG005|Overall Study|No longer meets study criteria|0|||
146988593|NCT01592370|530120753|FG006|Overall Study|No longer meets study criteria|0|||
146988594|NCT01592370|530120747|FG000|Overall Study|Other Reasons|6|||
146988595|NCT01592370|530120748|FG001|Overall Study|Other Reasons|0|||
146988596|NCT01592370|530120749|FG002|Overall Study|Other Reasons|10|||
146988597|NCT01592370|530120750|FG003|Overall Study|Other Reasons|0|||
146988598|NCT01592370|530120751|FG004|Overall Study|Other Reasons|0|||
146988599|NCT01592370|530120752|FG005|Overall Study|Other Reasons|1|||
146988600|NCT01592370|530120753|FG006|Overall Study|Other Reasons|0|||
146988601|NCT01592370|530120747|FG000|Overall Study|Not Treated|0|||
146988602|NCT01592370|530120748|FG001|Overall Study|Not Treated|0|||
146988603|NCT01592370|530120749|FG002|Overall Study|Not Treated|0|||
146988604|NCT01592370|530120750|FG003|Overall Study|Not Treated|0|||
146988605|NCT01592370|530120751|FG004|Overall Study|Not Treated|2|||
146988606|NCT01592370|530120752|FG005|Overall Study|Not Treated|2|||
146988607|NCT01592370|530120753|FG006|Overall Study|Not Treated|0|||
146988608|NCT00319449|530120756|FG000|Overall Study|Subject did not wish to continue|1|||
146988609|NCT00319449|530120757|FG001|Overall Study|Subject did not wish to continue|0|||
146988610|NCT00319449|530120756|FG000|Overall Study|Noncompliance with the protocol|1|||
146988611|NCT00319449|530120757|FG001|Overall Study|Noncompliance with the protocol|0|||
146988612|NCT00455533|530120758|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
146833709|NCT03721172|529560953|FG000|Apremilast Extension Phase|Protocol Violation|0|||
146833710|NCT03721172|529560954|FG001|Apremilast Extension Phase|Protocol Violation|0|||
146833711|NCT03721172|529560955|FG002|Apremilast Extension Phase|Protocol Violation|1|||
146833712|NCT03721172|529560953|FG000|Apremilast Extension Phase|Physician Decision|0|||
146833713|NCT03721172|529560954|FG001|Apremilast Extension Phase|Physician Decision|0|||
146833714|NCT03721172|529560955|FG002|Apremilast Extension Phase|Physician Decision|1|||
146988613|NCT00455533|530120759|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
146988614|NCT00455533|530120760|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
146988615|NCT00455533|530120758|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
146988616|NCT00455533|530120759|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
146988617|NCT00455533|530120760|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
146988618|NCT00455533|530120758|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
146988619|NCT00455533|530120759|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
146988620|NCT00455533|530120760|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
146988621|NCT00455533|530120758|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
146988622|NCT00455533|530120759|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
146988623|NCT00455533|530120760|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
146988624|NCT00455533|530120758|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
146988625|NCT00455533|530120759|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
146988626|NCT00455533|530120760|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
146988627|NCT00455533|530120758|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
146988628|NCT00455533|530120759|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
146833715|NCT03721172|529560953|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
146988629|NCT00455533|530120760|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
146988630|NCT00455533|530120758|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
146988631|NCT00455533|530120759|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
146988632|NCT00455533|530120760|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
146988633|NCT00455533|530120758|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
146988634|NCT00455533|530120759|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
146988635|NCT00455533|530120760|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
146988636|NCT00455533|530120758|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
146988637|NCT00455533|530120759|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
146988638|NCT00455533|530120760|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
146833716|NCT03721172|529560954|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
146833717|NCT03721172|529560955|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
146833718|NCT03721172|529560953|FG000|Apremilast Extension Phase|Other|0|||
146833719|NCT03721172|529560954|FG001|Apremilast Extension Phase|Other|0|||
146833720|NCT03721172|529560955|FG002|Apremilast Extension Phase|Other|3|||
146833721|NCT03721172|529560953|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
146833722|NCT03721172|529560954|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
146833723|NCT03721172|529560955|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
146833724|NCT01162135|529560957|FG000|Overall Study|Withdrawal by Subject|1|||
146833725|NCT01162135|529560957|FG000|Overall Study|Severe back pain|1|||
146833726|NCT01162135|529560957|FG000|Overall Study|Ineligible|1|||
146833727|NCT00632021|529560961|FG000|Overall Study|Withdrawal/death|4|||
146833728|NCT00632021|529560962|FG001|Overall Study|Withdrawal/death|7|||
146833729|NCT02049515|529560963|FG000|Overall Study|Adverse Event|46|||
146833730|NCT02049515|529560964|FG001|Overall Study|Adverse Event|2|||
146833731|NCT02049515|529560963|FG000|Overall Study|Protocol-specified Disease Progression|23|||
146833732|NCT02049515|529560964|FG001|Overall Study|Protocol-specified Disease Progression|2|||
146833733|NCT02049515|529560963|FG000|Overall Study|Death|6|||
146833734|NCT02049515|529560964|FG001|Overall Study|Death|0|||
146833735|NCT02049515|529560963|FG000|Overall Study|Physician Decision|5|||
146833736|NCT02049515|529560964|FG001|Overall Study|Physician Decision|1|||
146833737|NCT02049515|529560963|FG000|Overall Study|Withdrawal by Subject|3|||
146833738|NCT02049515|529560964|FG001|Overall Study|Withdrawal by Subject|0|||
146833739|NCT02049515|529560963|FG000|Overall Study|Termination of the Study by Sponsor|2|||
146833740|NCT02049515|529560964|FG001|Overall Study|Termination of the Study by Sponsor|0|||
146833741|NCT02049515|529560963|FG000|Overall Study|Protocol Violation|1|||
146833742|NCT02049515|529560964|FG001|Overall Study|Protocol Violation|1|||
146833743|NCT02049515|529560963|FG000|Overall Study|Clinical Deterioration|1|||
146833744|NCT02049515|529560964|FG001|Overall Study|Clinical Deterioration|0|||
146988639|NCT00455533|530120758|FG000|Period Two: Randomized Period|Death|0|||
146988640|NCT00455533|530120759|FG001|Period Two: Randomized Period|Death|0|||
146988641|NCT00455533|530120760|FG002|Period Two: Randomized Period|Death|3|||
146988642|NCT00455533|530120758|FG000|Period Two: Randomized Period|Disease Progression|0|||
146988643|NCT00455533|530120759|FG001|Period Two: Randomized Period|Disease Progression|1|||
146988644|NCT00455533|530120760|FG002|Period Two: Randomized Period|Disease Progression|1|||
146988645|NCT00455533|530120758|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
146988646|NCT00455533|530120759|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
146988647|NCT00455533|530120760|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
146988648|NCT00455533|530120758|FG000|Period Two: Randomized Period|Other - need reasons|0|||
146988649|NCT00455533|530120759|FG001|Period Two: Randomized Period|Other - need reasons|1|||
146988650|NCT00455533|530120760|FG002|Period Two: Randomized Period|Other - need reasons|0|||
146988651|NCT00455533|530120758|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
146988652|NCT00455533|530120759|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
146988653|NCT00455533|530120760|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
146988654|NCT00455533|530120758|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
146988655|NCT00455533|530120759|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
146988656|NCT00455533|530120760|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
146988657|NCT02739984|530120761|FG000|Overall Study|Sponsor Decision|1|||
146988658|NCT02739984|530120762|FG001|Overall Study|Sponsor Decision|0|||
146988659|NCT02739984|530120761|FG000|Overall Study|Withdrawal by Subject|1|||
146988660|NCT02739984|530120762|FG001|Overall Study|Withdrawal by Subject|1|||
146988661|NCT02739984|530120761|FG000|Overall Study|Death|0|||
146988662|NCT02739984|530120762|FG001|Overall Study|Death|1|||
146988663|NCT02739984|530120761|FG000|Overall Study|Lost to Follow-up|3|||
146988664|NCT02739984|530120762|FG001|Overall Study|Lost to Follow-up|0|||
146988665|NCT00767325|530120764|FG000|Overall Study|Lack of Efficacy|2|||
146988666|NCT00767325|530120764|FG000|Overall Study|Adverse Event|7|||
146988667|NCT00767325|530120764|FG000|Overall Study|Lost to Follow-up|3|||
146988668|NCT00767325|530120764|FG000|Overall Study|No longer met study criteria|2|||
146833745|NCT02049515|529560963|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
146833746|NCT02049515|529560964|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
146833747|NCT02049515|529560963|FG000|Overall Study|Treatment Interruption >42 Days|1|||
146988669|NCT00767325|530120764|FG000|Overall Study|Missed visit due to family reasons|1|||
146988670|NCT03538756|530120765|FG000|Long-Term Follow-up|Adverse Event|0|||
146988671|NCT03538756|530120766|FG001|Long-Term Follow-up|Adverse Event|0|||
146833748|NCT02049515|529560964|FG001|Overall Study|Treatment Interruption >42 Days|0|||
146833749|NCT02049515|529560963|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
146833750|NCT02049515|529560964|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
146833751|NCT00224029|529560971|FG000|Overall Study|Lost to Follow-up|1|||
146988672|NCT03538756|530120767|FG002|Long-Term Follow-up|Adverse Event|6|||
146988673|NCT03538756|530120765|FG000|Long-Term Follow-up|Death|0|||
146833752|NCT00224029|529560971|FG000|Overall Study|Withdrawal by Subject|4|||
146988674|NCT03538756|530120766|FG001|Long-Term Follow-up|Death|0|||
146988675|NCT03538756|530120767|FG002|Long-Term Follow-up|Death|1|||
146988676|NCT03538756|530120765|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
146988677|NCT03538756|530120766|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
146988678|NCT03538756|530120767|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
146988679|NCT03538756|530120765|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
146988680|NCT03538756|530120766|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
146988681|NCT03538756|530120767|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
146988682|NCT03538756|530120765|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
146988683|NCT03538756|530120766|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
146988684|NCT03538756|530120767|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
146988685|NCT00752856|530120768|FG000|Overall Study|randomized but did not do viral kinetics|0|||
146988686|NCT00752856|530120769|FG001|Overall Study|randomized but did not do viral kinetics|1|||
146988687|NCT00996736|530120770|FG000|Overall Study|Death|1|||
146988688|NCT00996736|530120771|FG001|Overall Study|Death|1|||
146988689|NCT00996736|530120770|FG000|Overall Study|Lost to Follow-up|15|||
146988690|NCT00996736|530120771|FG001|Overall Study|Lost to Follow-up|14|||
146988691|NCT00996736|530120770|FG000|Overall Study|Visit not within 3-month window|5|||
146988692|NCT00996736|530120771|FG001|Overall Study|Visit not within 3-month window|3|||
146988693|NCT02688608|530120772|FG000|Overall Study|Lost to Follow-up|1|||
146988694|NCT02346201|530120774|FG000|Overall Study|Adverse Event|3|||
146988695|NCT02346201|530120775|FG001|Overall Study|Adverse Event|2|||
146988696|NCT02346201|530120774|FG000|Overall Study|Lost to Follow-up|1|||
146988697|NCT02346201|530120775|FG001|Overall Study|Lost to Follow-up|0|||
146988698|NCT02346201|530120774|FG000|Overall Study|Withdrawal by Subject|6|||
146988699|NCT02346201|530120775|FG001|Overall Study|Withdrawal by Subject|3|||
146988700|NCT02346201|530120774|FG000|Overall Study|Unavailable for future follow-up|0|||
146988701|NCT02346201|530120775|FG001|Overall Study|Unavailable for future follow-up|1|||
146988702|NCT02346201|530120774|FG000|Overall Study|Physician Decision|0|||
146988703|NCT02346201|530120775|FG001|Overall Study|Physician Decision|1|||
146988704|NCT02346201|530120774|FG000|Overall Study|Missed final visit|0|||
146988705|NCT02346201|530120775|FG001|Overall Study|Missed final visit|2|||
146988706|NCT03708211|530120777|FG000|Overall Study|Progressive Disease|10|||
146988707|NCT03708211|530120778|FG001|Overall Study|Progressive Disease|7|||
146988708|NCT03708211|530120777|FG000|Overall Study|Withdrawal by Subject|0|||
146988709|NCT03708211|530120778|FG001|Overall Study|Withdrawal by Subject|1|||
146988710|NCT03708211|530120777|FG000|Overall Study|Other|2|||
146988711|NCT03708211|530120778|FG001|Overall Study|Other|0|||
146988712|NCT00409578|530120781|FG000|Overall Study|Adverse Event|27|||
146988713|NCT00409578|530120782|FG001|Overall Study|Adverse Event|37|||
146988714|NCT00409578|530120783|FG002|Overall Study|Adverse Event|25|||
146988715|NCT00409578|530120784|FG003|Overall Study|Adverse Event|33|||
146988716|NCT00409578|530120781|FG000|Overall Study|Abnormal laboratory value(s)|2|||
146988717|NCT00409578|530120782|FG001|Overall Study|Abnormal laboratory value(s)|2|||
146988718|NCT00409578|530120783|FG002|Overall Study|Abnormal laboratory value(s)|2|||
146988719|NCT00409578|530120784|FG003|Overall Study|Abnormal laboratory value(s)|4|||
146988720|NCT00409578|530120781|FG000|Overall Study|Lack of Efficacy|0|||
146988721|NCT00409578|530120782|FG001|Overall Study|Lack of Efficacy|0|||
146988722|NCT00409578|530120783|FG002|Overall Study|Lack of Efficacy|0|||
146988723|NCT00409578|530120784|FG003|Overall Study|Lack of Efficacy|2|||
146988724|NCT00409578|530120781|FG000|Overall Study|Subject no longer requires study drug|0|||
146988725|NCT00409578|530120782|FG001|Overall Study|Subject no longer requires study drug|0|||
146988726|NCT00409578|530120783|FG002|Overall Study|Subject no longer requires study drug|0|||
146988727|NCT00409578|530120784|FG003|Overall Study|Subject no longer requires study drug|1|||
146988728|NCT00409578|530120781|FG000|Overall Study|Withdrawal by Subject|8|||
146988729|NCT00409578|530120782|FG001|Overall Study|Withdrawal by Subject|15|||
146988730|NCT00409578|530120783|FG002|Overall Study|Withdrawal by Subject|16|||
146988731|NCT00409578|530120784|FG003|Overall Study|Withdrawal by Subject|17|||
146988732|NCT00409578|530120781|FG000|Overall Study|Lost to Follow-up|2|||
146988733|NCT00409578|530120782|FG001|Overall Study|Lost to Follow-up|0|||
146988734|NCT00409578|530120783|FG002|Overall Study|Lost to Follow-up|2|||
146988735|NCT00409578|530120784|FG003|Overall Study|Lost to Follow-up|2|||
146988736|NCT00409578|530120781|FG000|Overall Study|Administrative problems|8|||
146988737|NCT00409578|530120782|FG001|Overall Study|Administrative problems|9|||
146988738|NCT00409578|530120783|FG002|Overall Study|Administrative problems|2|||
146988739|NCT00409578|530120784|FG003|Overall Study|Administrative problems|4|||
146988740|NCT00409578|530120781|FG000|Overall Study|Death|2|||
146988741|NCT00409578|530120782|FG001|Overall Study|Death|4|||
146988742|NCT00409578|530120783|FG002|Overall Study|Death|4|||
146988743|NCT00409578|530120784|FG003|Overall Study|Death|2|||
146988744|NCT00409578|530120781|FG000|Overall Study|Protocol Violation|3|||
146988745|NCT00409578|530120782|FG001|Overall Study|Protocol Violation|2|||
146988746|NCT00409578|530120783|FG002|Overall Study|Protocol Violation|3|||
146988747|NCT00409578|530120784|FG003|Overall Study|Protocol Violation|1|||
146988748|NCT00409578|530120781|FG000|Overall Study|Missing|0|||
146988749|NCT00409578|530120782|FG001|Overall Study|Missing|1|||
146988750|NCT00409578|530120783|FG002|Overall Study|Missing|0|||
146988751|NCT00409578|530120784|FG003|Overall Study|Missing|1|||
146988752|NCT05200858|530120785|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
146988753|NCT05200858|530120786|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
146988754|NCT05200858|530120787|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
146988755|NCT05200858|530120788|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
146988756|NCT02109133|530120789|FG000|Overall Study|Lost to Follow-up|1|||
146988757|NCT02109133|530120790|FG001|Overall Study|Lost to Follow-up|0|||
146988758|NCT01739790|530122129|FG000|Overall Study|Early Trial Termination|2|||
146988759|NCT01739790|530122130|FG001|Overall Study|Early Trial Termination|4|||
146988760|NCT02309099|530122134|FG000|Overall Study|Adverse Event|2|||
146988761|NCT02309099|530122135|FG001|Overall Study|Adverse Event|0|||
146988762|NCT02819362|530122137|FG000|Overall Study|On-site MRI could not be performed|70|||
146988763|NCT05301751|530122138|FG000|Overall Study|Withdrawal by Subject|0|||
146988764|NCT05301751|530122139|FG001|Overall Study|Withdrawal by Subject|0|||
146988765|NCT05301751|530122140|FG002|Overall Study|Withdrawal by Subject|1|||
146988766|NCT05301751|530122141|FG003|Overall Study|Withdrawal by Subject|0|||
146988767|NCT02324465|530122145|FG000|Overall Study|device failure|0|||
146988768|NCT02324465|530122146|FG001|Overall Study|device failure|1|||
146988769|NCT02132247|530122147|FG000|Overall Study|Protocol Violation|1|||
146988770|NCT02132247|530122148|FG001|Overall Study|Protocol Violation|0|||
146988771|NCT00520741|530122155|FG000|Overall Study|Adverse Event|16|||
146988772|NCT00520741|530122156|FG001|Overall Study|Adverse Event|56|||
146988773|NCT00520741|530122155|FG000|Overall Study|Lack of Efficacy|11|||
146988774|NCT00520741|530122156|FG001|Overall Study|Lack of Efficacy|30|||
146988775|NCT00520741|530122155|FG000|Overall Study|Withdrawal by Subject|0|||
146988776|NCT00520741|530122156|FG001|Overall Study|Withdrawal by Subject|11|||
146988777|NCT00520741|530122155|FG000|Overall Study|Protocol Violation|2|||
146988778|NCT00520741|530122156|FG001|Overall Study|Protocol Violation|15|||
146988779|NCT00520741|530122155|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
146988780|NCT00520741|530122156|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
146988781|NCT00520741|530122155|FG000|Overall Study|Lost to Follow-up|4|||
146988782|NCT00520741|530122156|FG001|Overall Study|Lost to Follow-up|4|||
146988783|NCT00520741|530122155|FG000|Overall Study|Other reasons for premature termination|0|||
146988784|NCT00520741|530122156|FG001|Overall Study|Other reasons for premature termination|6|||
146988785|NCT03702621|530122157|FG000|Overall Study|Physician Decision|6|||
146988786|NCT03702621|530122158|FG001|Overall Study|Physician Decision|6|||
146988787|NCT01860976|530122165|FG000|Blinded Treatment|Adverse Event|1|||
146988788|NCT01860976|530122166|FG001|Blinded Treatment|Adverse Event|3|||
146988789|NCT01860976|530122165|FG000|Blinded Treatment|Lack of Efficacy|5|||
146988790|NCT01860976|530122166|FG001|Blinded Treatment|Lack of Efficacy|12|||
146988791|NCT01860976|530122165|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
146988792|NCT01860976|530122166|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
146988793|NCT01860976|530122165|FG000|Blinded Treatment|Withdrawal by Subject|3|||
146988794|NCT01860976|530122166|FG001|Blinded Treatment|Withdrawal by Subject|5|||
146988795|NCT01860976|530122165|FG000|Blinded Treatment|Subject no longer met criteria|1|||
146988796|NCT01860976|530122166|FG001|Blinded Treatment|Subject no longer met criteria|0|||
146988797|NCT01860976|530122165|FG000|Blinded Treatment|Entered Open-Label in error|0|||
146988798|NCT01860976|530122166|FG001|Blinded Treatment|Entered Open-Label in error|1|||
146988799|NCT01860976|530122165|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
146988800|NCT01860976|530122166|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
146988801|NCT01860976|530122165|FG000|Open-Label|Adverse Event|2|||
146988802|NCT01860976|530122166|FG001|Open-Label|Adverse Event|4|||
146988803|NCT01860976|530122165|FG000|Open-Label|Lack of Efficacy|16|||
146988804|NCT01860976|530122166|FG001|Open-Label|Lack of Efficacy|8|||
146988805|NCT01860976|530122165|FG000|Open-Label|Lost to Follow-up|1|||
146988806|NCT01860976|530122166|FG001|Open-Label|Lost to Follow-up|2|||
146988807|NCT01860976|530122165|FG000|Open-Label|Subject request discontinue treatment|4|||
146988808|NCT01860976|530122166|FG001|Open-Label|Subject request discontinue treatment|3|||
146988809|NCT01860976|530122165|FG000|Open-Label|Withdrawal by Subject|4|||
146988810|NCT01860976|530122166|FG001|Open-Label|Withdrawal by Subject|1|||
146988811|NCT01860976|530122165|FG000|Open-Label|Other Reasons|1|||
146988812|NCT01860976|530122166|FG001|Open-Label|Other Reasons|1|||
146988813|NCT01860976|530122165|FG000|Long Term Extension|Adverse Event|4|||
146988814|NCT01860976|530122166|FG001|Long Term Extension|Adverse Event|0|||
146988815|NCT01860976|530122165|FG000|Long Term Extension|Lack of Efficacy|2|||
146988816|NCT01860976|530122166|FG001|Long Term Extension|Lack of Efficacy|0|||
146988817|NCT01860976|530122165|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
146988818|NCT01860976|530122166|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
146988819|NCT01860976|530122165|FG000|Long Term Extension|Lost to Follow-up|2|||
146988820|NCT01860976|530122166|FG001|Long Term Extension|Lost to Follow-up|0|||
146988821|NCT01860976|530122165|FG000|Long Term Extension|subject withdrew consent|7|||
146988822|NCT01860976|530122166|FG001|Long Term Extension|subject withdrew consent|0|||
146988823|NCT02354586|530122169|FG000|Overall Study|Death|230|||
146988824|NCT02354586|530122169|FG000|Overall Study|Withdrawal by Subject|59|||
146988825|NCT02354586|530122169|FG000|Overall Study|Lost to Follow-up|11|||
146988826|NCT02354586|530122169|FG000|Overall Study|Sponsor decision|51|||
146988827|NCT02354586|530122169|FG000|Overall Study|Site closure|2|||
146988828|NCT02354586|530122169|FG000|Overall Study|Intercurrent illness|1|||
146988829|NCT02354586|530122169|FG000|Overall Study|Protocol Violation|3|||
146988830|NCT02354586|530122169|FG000|Overall Study|Physician Decision|13|||
146988831|NCT02354586|530122169|FG000|Overall Study|Lack of Efficacy|86|||
146988832|NCT02354586|530122169|FG000|Overall Study|Adverse Event|7|||
146988833|NCT02402166|530122170|FG000|Overall Study|Adverse Event|2|||
146988834|NCT02402166|530122170|FG000|Overall Study|Withdrawal by Subject|2|||
146988835|NCT02402166|530122170|FG000|Overall Study|Lost to Follow-up|1|||
146988836|NCT02204371|530122172|FG000|Overall Study|Adverse Event|1|||
146988837|NCT03803943|530122181|FG000|Overall Study|Withdrawal by Subject|2|||
146988838|NCT03803943|530122182|FG001|Overall Study|Withdrawal by Subject|2|||
146988839|NCT03803943|530122183|FG002|Overall Study|Withdrawal by Subject|2|||
146988840|NCT03803943|530122184|FG003|Overall Study|Withdrawal by Subject|2|||
146988841|NCT01574248|530122185|FG000|Overall Study|Withdrawal by Subject|2|||
146988842|NCT01574248|530122186|FG001|Overall Study|Withdrawal by Subject|0|||
146988843|NCT01574248|530122185|FG000|Overall Study|Missing primary endpoint data|1|||
146988844|NCT01574248|530122186|FG001|Overall Study|Missing primary endpoint data|0|||
146988845|NCT01781286|530122189|FG000|Overall Study|Lost to Follow-up|0|||
146988846|NCT01781286|530122190|FG001|Overall Study|Lost to Follow-up|0|||
146988847|NCT01781286|530122191|FG002|Overall Study|Lost to Follow-up|0|||
146988848|NCT01781286|530122192|FG003|Overall Study|Lost to Follow-up|0|||
146988849|NCT01781286|530122193|FG004|Overall Study|Lost to Follow-up|0|||
146988850|NCT01781286|530122194|FG005|Overall Study|Lost to Follow-up|1|||
146988851|NCT01781286|530122189|FG000|Overall Study|Time Constraints|2|||
146988852|NCT01781286|530122190|FG001|Overall Study|Time Constraints|0|||
146988853|NCT01781286|530122191|FG002|Overall Study|Time Constraints|2|||
146988854|NCT01781286|530122192|FG003|Overall Study|Time Constraints|0|||
146988855|NCT01781286|530122193|FG004|Overall Study|Time Constraints|0|||
146988856|NCT01781286|530122194|FG005|Overall Study|Time Constraints|0|||
146988857|NCT01781286|530122189|FG000|Overall Study|Noncompliance|0|||
146988858|NCT01781286|530122190|FG001|Overall Study|Noncompliance|0|||
146988859|NCT01781286|530122191|FG002|Overall Study|Noncompliance|0|||
146988860|NCT01781286|530122192|FG003|Overall Study|Noncompliance|1|||
146988861|NCT01781286|530122193|FG004|Overall Study|Noncompliance|0|||
146988862|NCT01781286|530122194|FG005|Overall Study|Noncompliance|0|||
146988863|NCT00995410|530122195|FG000|Overall Study|Adverse Event|51|||
146988864|NCT00995410|530122195|FG000|Overall Study|Withdrawal by Subject|7|||
146988865|NCT00995410|530122195|FG000|Overall Study|Lost to Follow-up|2|||
146988866|NCT00995410|530122195|FG000|Overall Study|Misc|28|||
146988867|NCT03594123|530122196|FG000|Overall Study|Lost to Follow-up|0|||
146988868|NCT03594123|530122197|FG001|Overall Study|Lost to Follow-up|1|||
146988869|NCT03594123|530122196|FG000|Overall Study|Adverse Event|8|||
146988870|NCT03594123|530122197|FG001|Overall Study|Adverse Event|5|||
146988871|NCT03594123|530122196|FG000|Overall Study|Site Terminated by Sponsor|4|||
146988872|NCT03594123|530122197|FG001|Overall Study|Site Terminated by Sponsor|1|||
146988873|NCT03594123|530122196|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
146988874|NCT03594123|530122197|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
146988875|NCT03594123|530122196|FG000|Overall Study|Lack of Efficacy|1|||
146988876|NCT03594123|530122197|FG001|Overall Study|Lack of Efficacy|0|||
146988877|NCT03594123|530122196|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
146988878|NCT03594123|530122197|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
146988879|NCT02483975|530122198|FG000|Overall Study|Adverse Event|0|||
146988880|NCT02483975|530122199|FG001|Overall Study|Adverse Event|1|||
146988881|NCT02483975|530122198|FG000|Overall Study|Lost to Follow-up|0|||
146988882|NCT02483975|530122199|FG001|Overall Study|Lost to Follow-up|1|||
146988883|NCT02483975|530122198|FG000|Overall Study|Physician Decision|2|||
146988884|NCT02483975|530122199|FG001|Overall Study|Physician Decision|0|||
146988885|NCT03365375|530122200|FG000|Overall Study|Withdrawal by Subject|0|||
146988886|NCT03365375|530122201|FG001|Overall Study|Withdrawal by Subject|1|||
146988887|NCT03365375|530122200|FG000|Overall Study|Lost to Follow-up|0|||
146988888|NCT03365375|530122201|FG001|Overall Study|Lost to Follow-up|4|||
146988889|NCT02166697|530122202|FG000|Overall Study|Protocol Violation|347|||
146833753|NCT00224029|529560971|FG000|Overall Study|Other|1|||
146833754|NCT02872012|529560972|FG000|Overall Study|Withdrawal by Subject|1|||
146988890|NCT01505530|530122206|FG000|Overall Study|Progressive Disease|19|||
146988891|NCT01505530|530122207|FG001|Overall Study|Progressive Disease|17|||
146988892|NCT01505530|530122208|FG002|Overall Study|Progressive Disease|18|||
146988893|NCT01505530|530122206|FG000|Overall Study|Adverse Event|1|||
146988894|NCT01505530|530122207|FG001|Overall Study|Adverse Event|1|||
146988895|NCT01505530|530122208|FG002|Overall Study|Adverse Event|0|||
146988896|NCT01505530|530122206|FG000|Overall Study|Withdrawal by Subject|7|||
146988897|NCT01505530|530122207|FG001|Overall Study|Withdrawal by Subject|8|||
146988898|NCT01505530|530122208|FG002|Overall Study|Withdrawal by Subject|6|||
146988899|NCT01505530|530122206|FG000|Overall Study|Physician Decision|6|||
146988900|NCT01505530|530122207|FG001|Overall Study|Physician Decision|2|||
146988901|NCT01505530|530122208|FG002|Overall Study|Physician Decision|5|||
146988902|NCT01505530|530122206|FG000|Overall Study|Sponsor Decision|1|||
146988903|NCT01505530|530122207|FG001|Overall Study|Sponsor Decision|8|||
146988904|NCT01505530|530122208|FG002|Overall Study|Sponsor Decision|7|||
146988905|NCT01505530|530122206|FG000|Overall Study|Death|7|||
146988906|NCT01505530|530122207|FG001|Overall Study|Death|6|||
146988907|NCT01505530|530122208|FG002|Overall Study|Death|5|||
146988908|NCT01505530|530122206|FG000|Overall Study|entry criteria not met|0|||
146988909|NCT01505530|530122207|FG001|Overall Study|entry criteria not met|1|||
146988910|NCT01505530|530122208|FG002|Overall Study|entry criteria not met|0|||
146988911|NCT02720510|530122214|FG000|Overall Study|Study Terminated by the sponsor|2|||
146988912|NCT02720510|530122215|FG001|Overall Study|Study Terminated by the sponsor|0|||
146988913|NCT02720510|530122214|FG000|Overall Study|Adverse Event|0|||
146988914|NCT02720510|530122215|FG001|Overall Study|Adverse Event|1|||
146988915|NCT02720510|530122214|FG000|Overall Study|Physician Decision|1|||
146988916|NCT02720510|530122215|FG001|Overall Study|Physician Decision|2|||
146988917|NCT01618266|530122224|FG000|Overall Study|Lost to Follow-up|9|||
146988918|NCT01618266|530122224|FG000|Overall Study|Treatment satisfaction|10|||
146988919|NCT01618266|530122224|FG000|Overall Study|Other reasons|11|||
146988920|NCT01618266|530122224|FG000|Overall Study|Lack of Efficacy|23|||
146988921|NCT01618266|530122224|FG000|Overall Study|Protocol Violation|43|||
146988922|NCT00625807|530122225|FG000|Overall Study|schedule conflict|2|||
146988923|NCT00625807|530122226|FG001|Overall Study|schedule conflict|8|||
146988924|NCT01966042|530122227|FG000|Overall Study|Death|2|||
146988925|NCT03267264|530122228|FG000|Overall Study|Withdrawal by Subject|1|||
146988926|NCT03267264|530122229|FG001|Overall Study|Withdrawal by Subject|0|||
146988927|NCT03267264|530122230|FG002|Overall Study|Withdrawal by Subject|2|||
146988928|NCT03267264|530122231|FG003|Overall Study|Withdrawal by Subject|4|||
146988929|NCT02224391|530122232|FG000|Overall Study|Lost to Follow-up|26|||
146988930|NCT02224391|530122233|FG001|Overall Study|Lost to Follow-up|19|||
146988931|NCT02224391|530122232|FG000|Overall Study|Withdrawal by Subject|6|||
146988932|NCT02224391|530122233|FG001|Overall Study|Withdrawal by Subject|5|||
146988933|NCT00084084|530122234|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
146988934|NCT00084084|530122234|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
146988935|NCT01802879|530122235|FG000|Overall Study|Administrative problems|2|||
146988936|NCT01802879|530122235|FG000|Overall Study|Disease progression|6|||
146988937|NCT01047345|530122240|FG000|Base Study|Adverse Event|3|||
146988938|NCT01047345|530122241|FG001|Base Study|Adverse Event|0|||
146988939|NCT01047345|530122242|FG002|Base Study|Adverse Event|0|||
146988940|NCT01047345|530122240|FG000|Base Study|Lost to Follow-up|4|||
146988941|NCT01047345|530122241|FG001|Base Study|Lost to Follow-up|1|||
146988942|NCT01047345|530122242|FG002|Base Study|Lost to Follow-up|0|||
146988943|NCT01047345|530122240|FG000|Base Study|Protocol Violation|3|||
146988944|NCT01047345|530122241|FG001|Base Study|Protocol Violation|1|||
146988945|NCT01047345|530122242|FG002|Base Study|Protocol Violation|0|||
146988946|NCT01047345|530122240|FG000|Base Study|Withdrawal by Subject|12|||
146988947|NCT01047345|530122241|FG001|Base Study|Withdrawal by Subject|4|||
146988948|NCT01047345|530122242|FG002|Base Study|Withdrawal by Subject|0|||
146988949|NCT01047345|530122240|FG000|Extension|Withdrawal by Subject|0|||
146988950|NCT01047345|530122241|FG001|Extension|Withdrawal by Subject|0|||
146988951|NCT01047345|530122242|FG002|Extension|Withdrawal by Subject|1|||
146988952|NCT01047345|530122240|FG000|Extension|Lost to Follow-up|0|||
146988953|NCT01047345|530122241|FG001|Extension|Lost to Follow-up|0|||
146988954|NCT01047345|530122242|FG002|Extension|Lost to Follow-up|5|||
146988955|NCT00454636|530122243|FG000|Overall Study|Adverse Event|10|||
146988956|NCT00454636|530122244|FG001|Overall Study|Adverse Event|6|||
146988957|NCT00454636|530122245|FG002|Overall Study|Adverse Event|9|||
146988958|NCT00454636|530122246|FG003|Overall Study|Adverse Event|15|||
146988959|NCT00454636|530122243|FG000|Overall Study|Disease Progression|11|||
146988960|NCT00454636|530122244|FG001|Overall Study|Disease Progression|12|||
146988961|NCT00454636|530122245|FG002|Overall Study|Disease Progression|4|||
146988962|NCT00454636|530122246|FG003|Overall Study|Disease Progression|11|||
146988963|NCT00454636|530122243|FG000|Overall Study|Protocol Violation|3|||
146988964|NCT00454636|530122244|FG001|Overall Study|Protocol Violation|2|||
146988965|NCT00454636|530122245|FG002|Overall Study|Protocol Violation|3|||
146988966|NCT00454636|530122246|FG003|Overall Study|Protocol Violation|3|||
146988967|NCT00454636|530122243|FG000|Overall Study|Death|6|||
146988968|NCT00454636|530122244|FG001|Overall Study|Death|1|||
146988969|NCT00454636|530122245|FG002|Overall Study|Death|1|||
146988970|NCT00454636|530122246|FG003|Overall Study|Death|1|||
146988971|NCT00454636|530122243|FG000|Overall Study|Patient refusal|1|||
146988972|NCT00454636|530122244|FG001|Overall Study|Patient refusal|1|||
146988973|NCT00454636|530122245|FG002|Overall Study|Patient refusal|3|||
146988974|NCT00454636|530122246|FG003|Overall Study|Patient refusal|2|||
146988975|NCT00454636|530122243|FG000|Overall Study|Lost to Follow-up|0|||
146988976|NCT00454636|530122244|FG001|Overall Study|Lost to Follow-up|1|||
146988977|NCT00454636|530122245|FG002|Overall Study|Lost to Follow-up|0|||
146988978|NCT00454636|530122246|FG003|Overall Study|Lost to Follow-up|0|||
146988979|NCT01400113|530122247|FG000|Overall Study|Withdrawal by Subject|1|||
146988980|NCT01400113|530122248|FG001|Overall Study|Withdrawal by Subject|1|||
146988981|NCT00282256|530122249|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
146988982|NCT00282256|530122249|FG000|Extension Treatment Period|Adverse Event|2|||
146988983|NCT01890915|530122254|FG000|Overall Study|Adverse Event|1|||
146988984|NCT01890915|530122255|FG001|Overall Study|Adverse Event|0|||
146988985|NCT01890915|530122254|FG000|Overall Study|Protocol Violation|2|||
146988986|NCT01890915|530122255|FG001|Overall Study|Protocol Violation|0|||
146988987|NCT01890915|530122254|FG000|Overall Study|Equipment Malfunction|0|||
146988988|NCT01890915|530122255|FG001|Overall Study|Equipment Malfunction|1|||
146988989|NCT02114697|530122256|FG000|Overall Study|Study terminated|5|||
146988990|NCT02114697|530122257|FG001|Overall Study|Study terminated|4|||
146988991|NCT01984242|530122258|FG000|Overall Study|Death|52|||
146988992|NCT01984242|530122259|FG001|Overall Study|Death|50|||
146988993|NCT01984242|530122260|FG002|Overall Study|Death|52|||
146988994|NCT01984242|530122258|FG000|Overall Study|Withdrawal by Subject|5|||
146988995|NCT01984242|530122259|FG001|Overall Study|Withdrawal by Subject|3|||
146988996|NCT01984242|530122260|FG002|Overall Study|Withdrawal by Subject|10|||
146958848|NCT02681094|530009854|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
146958849|NCT02681094|530009855|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
146958850|NCT02681094|530009853|FG000|2 - Enrolled Participants Set|Participant decision|7|||
146958851|NCT02681094|530009854|FG001|2 - Enrolled Participants Set|Participant decision|10|||
146958852|NCT02681094|530009855|FG002|2 - Enrolled Participants Set|Participant decision|9|||
146958853|NCT02681094|530009853|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
146958854|NCT02681094|530009854|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
146958855|NCT02681094|530009855|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
146958856|NCT02681094|530009853|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
146958857|NCT02681094|530009854|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
146958858|NCT02681094|530009855|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
146958859|NCT02681094|530009853|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
146958860|NCT02681094|530009854|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
146958861|NCT02681094|530009855|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
146958862|NCT02681094|530009853|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
146958863|NCT02681094|530009854|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
146958864|NCT02681094|530009855|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
146958865|NCT02681094|530009853|FG000|2 - Enrolled Participants Set|Other|6|||
146958866|NCT02681094|530009854|FG001|2 - Enrolled Participants Set|Other|6|||
146958867|NCT02681094|530009855|FG002|2 - Enrolled Participants Set|Other|7|||
146958868|NCT02681094|530009853|FG000|2 - Enrolled Participants Set|No treatment given|0|||
146958869|NCT02681094|530009854|FG001|2 - Enrolled Participants Set|No treatment given|1|||
146958870|NCT02681094|530009855|FG002|2 - Enrolled Participants Set|No treatment given|1|||
146958871|NCT01270139|530009856|FG000|Overall Study|Adverse Event|8|||
146958872|NCT01270139|530009857|FG001|Overall Study|Adverse Event|17|||
146958873|NCT01270139|530009858|FG002|Overall Study|Adverse Event|18|||
146958874|NCT01270139|530009856|FG000|Overall Study|Lost to Follow-up|10|||
146958875|NCT01270139|530009857|FG001|Overall Study|Lost to Follow-up|9|||
146958876|NCT01270139|530009858|FG002|Overall Study|Lost to Follow-up|2|||
146958877|NCT02452320|530009861|FG000|Overall Study|Adverse Event|0|||
146958878|NCT02452320|530009862|FG001|Overall Study|Adverse Event|1|||
146958879|NCT03382639|530009863|FG000|Overall Study|Adverse Event|2|||
146958880|NCT03382639|530009864|FG001|Overall Study|Adverse Event|0|||
146958881|NCT03382639|530009865|FG002|Overall Study|Adverse Event|1|||
146958882|NCT03382639|530009866|FG003|Overall Study|Adverse Event|1|||
146958883|NCT03382639|530009863|FG000|Overall Study|Lost to Follow-up|1|||
146958884|NCT03382639|530009864|FG001|Overall Study|Lost to Follow-up|0|||
146958885|NCT03382639|530009865|FG002|Overall Study|Lost to Follow-up|0|||
146958886|NCT03382639|530009866|FG003|Overall Study|Lost to Follow-up|0|||
146958887|NCT03382639|530009863|FG000|Overall Study|Withdrawal by Subject|4|||
146958888|NCT03382639|530009864|FG001|Overall Study|Withdrawal by Subject|3|||
146958889|NCT03382639|530009865|FG002|Overall Study|Withdrawal by Subject|2|||
146958890|NCT03382639|530009866|FG003|Overall Study|Withdrawal by Subject|3|||
146958891|NCT03382639|530009863|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
146958892|NCT03382639|530009864|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
146958893|NCT03382639|530009865|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
146958894|NCT03382639|530009866|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
146958895|NCT03382639|530009863|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
146958896|NCT03382639|530009864|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
146958897|NCT03382639|530009865|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
146958898|NCT03382639|530009866|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
146958899|NCT03382639|530009863|FG000|Overall Study|Other|2|||
146958900|NCT03382639|530009864|FG001|Overall Study|Other|0|||
146958901|NCT03382639|530009865|FG002|Overall Study|Other|0|||
146958902|NCT03382639|530009866|FG003|Overall Study|Other|3|||
146958903|NCT01072175|530009869|FG000|Part A (Drug-Drug Interaction)|Death|1|||
146958904|NCT01072175|530009870|FG001|Part A (Drug-Drug Interaction)|Death|0|||
146958905|NCT01072175|530009871|FG002|Part A (Drug-Drug Interaction)|Death|0|||
146958906|NCT01072175|530009872|FG003|Part A (Drug-Drug Interaction)|Death|0|||
146958907|NCT01072175|530009873|FG004|Part A (Drug-Drug Interaction)|Death|0|||
146988997|NCT01984242|530122258|FG000|Overall Study|Physician Decision|0|||
146988998|NCT01984242|530122259|FG001|Overall Study|Physician Decision|0|||
146988999|NCT01984242|530122260|FG002|Overall Study|Physician Decision|1|||
146989000|NCT01984242|530122258|FG000|Overall Study|Lost to Follow-up|4|||
146989001|NCT01984242|530122259|FG001|Overall Study|Lost to Follow-up|0|||
146989002|NCT01984242|530122260|FG002|Overall Study|Lost to Follow-up|3|||
146989003|NCT01984242|530122258|FG000|Overall Study|Sponsor Decision|1|||
146989004|NCT01984242|530122259|FG001|Overall Study|Sponsor Decision|0|||
146989005|NCT01984242|530122260|FG002|Overall Study|Sponsor Decision|0|||
146989006|NCT01984242|530122258|FG000|Overall Study|Non-Compliance|1|||
146989007|NCT01984242|530122259|FG001|Overall Study|Non-Compliance|0|||
146989008|NCT01984242|530122260|FG002|Overall Study|Non-Compliance|0|||
146989009|NCT01984242|530122258|FG000|Overall Study|Study terminated by Sponsor|38|||
146989010|NCT01984242|530122259|FG001|Overall Study|Study terminated by Sponsor|50|||
146989011|NCT01984242|530122260|FG002|Overall Study|Study terminated by Sponsor|34|||
146989012|NCT01984242|530122258|FG000|Overall Study|Disease Progression|0|||
146989013|NCT01984242|530122259|FG001|Overall Study|Disease Progression|0|||
146989014|NCT01984242|530122260|FG002|Overall Study|Disease Progression|1|||
146989015|NCT02246478|530122263|FG000|Multiple-dose Phase|Protocol Violation|1|||
146989016|NCT02246478|530122264|FG001|Multiple-dose Phase|Protocol Violation|0|||
146989017|NCT02246478|530122265|FG002|Multiple-dose Phase|Protocol Violation|0|||
146989018|NCT02246478|530122266|FG003|Multiple-dose Phase|Protocol Violation|1|||
146989019|NCT01457053|530122273|FG000|Overall Study|Unable to undergo selected treatment|1|||
146989020|NCT01457053|530122274|FG001|Overall Study|Unable to undergo selected treatment|1|||
146989021|NCT00984295|530122275|FG000|Overall Study|Lost to Follow-up|31|||
146989022|NCT00984295|530122276|FG001|Overall Study|Lost to Follow-up|12|||
146989023|NCT00984295|530122277|FG002|Overall Study|Lost to Follow-up|13|||
146989024|NCT00984295|530122275|FG000|Overall Study|Protocol Violation|2|||
146989025|NCT00984295|530122276|FG001|Overall Study|Protocol Violation|1|||
146989026|NCT00984295|530122277|FG002|Overall Study|Protocol Violation|4|||
146989027|NCT00984295|530122275|FG000|Overall Study|Withdrawal by Subject|18|||
146989028|NCT00984295|530122276|FG001|Overall Study|Withdrawal by Subject|9|||
146989029|NCT00984295|530122277|FG002|Overall Study|Withdrawal by Subject|12|||
146989030|NCT00984295|530122275|FG000|Overall Study|CAE - discontinued test vaccine|0|||
146989031|NCT00984295|530122276|FG001|Overall Study|CAE - discontinued test vaccine|1|||
146989032|NCT00984295|530122277|FG002|Overall Study|CAE - discontinued test vaccine|3|||
146989033|NCT00984295|530122275|FG000|Overall Study|Missed one or more blood samplings|3|||
146989034|NCT00984295|530122276|FG001|Overall Study|Missed one or more blood samplings|7|||
146989035|NCT00984295|530122277|FG002|Overall Study|Missed one or more blood samplings|2|||
146989036|NCT00984295|530122275|FG000|Overall Study|Incomplete safety follow-up|11|||
146989037|NCT00984295|530122276|FG001|Overall Study|Incomplete safety follow-up|2|||
146989038|NCT00984295|530122277|FG002|Overall Study|Incomplete safety follow-up|3|||
146989039|NCT00979628|530122278|FG000|Overall Study|received regimen < 24 hours|7|||
146989040|NCT00979628|530122279|FG001|Overall Study|received regimen < 24 hours|6|||
146989041|NCT00979628|530122280|FG002|Overall Study|received regimen < 24 hours|5|||
146989042|NCT00979628|530122278|FG000|Overall Study|received steroids|1|||
146989043|NCT00979628|530122279|FG001|Overall Study|received steroids|1|||
146989044|NCT00979628|530122280|FG002|Overall Study|received steroids|0|||
146989045|NCT00979628|530122278|FG000|Overall Study|transferred to ICU|1|||
146989046|NCT00979628|530122279|FG001|Overall Study|transferred to ICU|2|||
146989047|NCT00979628|530122280|FG002|Overall Study|transferred to ICU|1|||
146989048|NCT00911859|530122281|FG000|Treatment Period|Adverse Event|3|||
146989049|NCT00911859|530122282|FG001|Treatment Period|Adverse Event|3|||
146989050|NCT00911859|530122283|FG002|Treatment Period|Adverse Event|7|||
146989051|NCT00911859|530122281|FG000|Treatment Period|Death|1|||
146989052|NCT00911859|530122282|FG001|Treatment Period|Death|3|||
146989053|NCT00911859|530122283|FG002|Treatment Period|Death|5|||
146989054|NCT00911859|530122281|FG000|Treatment Period|Lack of Efficacy|1|||
146989055|NCT00911859|530122282|FG001|Treatment Period|Lack of Efficacy|7|||
146989056|NCT00911859|530122283|FG002|Treatment Period|Lack of Efficacy|5|||
146989057|NCT00911859|530122281|FG000|Treatment Period|Physician Decision|3|||
146989058|NCT00911859|530122282|FG001|Treatment Period|Physician Decision|3|||
146989059|NCT00911859|530122283|FG002|Treatment Period|Physician Decision|3|||
146989060|NCT00911859|530122281|FG000|Treatment Period|Withdrawal by Subject|0|||
146989061|NCT00911859|530122282|FG001|Treatment Period|Withdrawal by Subject|4|||
146989062|NCT00911859|530122283|FG002|Treatment Period|Withdrawal by Subject|5|||
146989063|NCT00911859|530122281|FG000|Treatment Period|Did not receive study treatment|0|||
146989064|NCT00911859|530122282|FG001|Treatment Period|Did not receive study treatment|1|||
146989065|NCT00911859|530122283|FG002|Treatment Period|Did not receive study treatment|0|||
146989066|NCT00911859|530122281|FG000|Maintainance Period|Lack of Efficacy|0|||
146989067|NCT00911859|530122282|FG001|Maintainance Period|Lack of Efficacy|0|||
146989068|NCT00911859|530122283|FG002|Maintainance Period|Lack of Efficacy|9|||
146989069|NCT00911859|530122281|FG000|Maintainance Period|Physician Decision|0|||
146989070|NCT00911859|530122282|FG001|Maintainance Period|Physician Decision|0|||
146989071|NCT00911859|530122283|FG002|Maintainance Period|Physician Decision|9|||
146989072|NCT00911859|530122281|FG000|Maintainance Period|Withdrawal by Subject|0|||
146989073|NCT00911859|530122282|FG001|Maintainance Period|Withdrawal by Subject|0|||
146989074|NCT00911859|530122283|FG002|Maintainance Period|Withdrawal by Subject|3|||
146989075|NCT00911859|530122281|FG000|Follow-up Period|Death|5|||
146989076|NCT00911859|530122282|FG001|Follow-up Period|Death|8|||
146989077|NCT00911859|530122283|FG002|Follow-up Period|Death|10|||
146989078|NCT00911859|530122281|FG000|Follow-up Period|Lost to Follow-up|1|||
146989079|NCT00911859|530122282|FG001|Follow-up Period|Lost to Follow-up|1|||
146989080|NCT00911859|530122283|FG002|Follow-up Period|Lost to Follow-up|0|||
146989081|NCT00911859|530122281|FG000|Follow-up Period|Withdrawal by Subject|0|||
146989082|NCT00911859|530122282|FG001|Follow-up Period|Withdrawal by Subject|4|||
146989083|NCT00911859|530122283|FG002|Follow-up Period|Withdrawal by Subject|4|||
146989084|NCT00911859|530122281|FG000|Follow-up Period|Study terminated by sponsor|5|||
146989085|NCT00911859|530122282|FG001|Follow-up Period|Study terminated by sponsor|33|||
146989086|NCT00911859|530122283|FG002|Follow-up Period|Study terminated by sponsor|27|||
146989087|NCT02785913|530124580|FG000|Overall Study|Adverse Event|5|||
146989088|NCT02785913|530124580|FG000|Overall Study|Death|2|||
146989089|NCT02785913|530124580|FG000|Overall Study|Progression|18|||
146989090|NCT02785913|530124580|FG000|Overall Study|Not protocol specified|1|||
146989091|NCT02841709|530124581|FG000|5th Intervention|Adverse Event|2|||
146989092|NCT02841709|530124582|FG001|5th Intervention|Adverse Event|0|||
146989093|NCT02841709|530124583|FG002|5th Intervention|Adverse Event|0|||
146989094|NCT02841709|530124584|FG003|5th Intervention|Adverse Event|0|||
146989095|NCT02841709|530124585|FG004|5th Intervention|Adverse Event|2|||
146989096|NCT01929109|530124586|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
146989097|NCT01929109|530124587|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
146989098|NCT01929109|530124588|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
146989099|NCT01929109|530124589|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
146989100|NCT01929109|530124590|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
146989101|NCT01402908|530124591|FG000|Overall Study|Withdrawal by Subject|30|||
146989102|NCT01402908|530124592|FG001|Overall Study|Withdrawal by Subject|17|||
146989103|NCT01402908|530124591|FG000|Overall Study|Lost to Follow-up|3|||
146989104|NCT01402908|530124592|FG001|Overall Study|Lost to Follow-up|1|||
146989105|NCT01402908|530124591|FG000|Overall Study|Physician Decision|1|||
146989106|NCT01402908|530124592|FG001|Overall Study|Physician Decision|0|||
146989107|NCT02581345|530124593|FG000|Part 1: up to Week 16|Adverse Event|3|||
146989108|NCT02581345|530124594|FG001|Part 1: up to Week 16|Adverse Event|8|||
146989109|NCT02581345|530124595|FG002|Part 1: up to Week 16|Adverse Event|0|||
146989110|NCT02581345|530124596|FG003|Part 1: up to Week 16|Adverse Event|0|||
146989111|NCT02581345|530124593|FG000|Part 1: up to Week 16|Physician Decision|2|||
146989112|NCT02581345|530124594|FG001|Part 1: up to Week 16|Physician Decision|4|||
146989113|NCT02581345|530124595|FG002|Part 1: up to Week 16|Physician Decision|0|||
146989114|NCT02581345|530124596|FG003|Part 1: up to Week 16|Physician Decision|0|||
146989115|NCT02581345|530124593|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
146989116|NCT02581345|530124594|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
146989117|NCT02581345|530124595|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
146989118|NCT02581345|530124596|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
146989119|NCT02581345|530124593|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
146989120|NCT02581345|530124594|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
146989121|NCT02581345|530124595|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
146989122|NCT02581345|530124596|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
146989123|NCT02581345|530124593|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
146989124|NCT02581345|530124594|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
146989125|NCT02581345|530124595|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
146989126|NCT02581345|530124596|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
146989127|NCT02581345|530124593|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
146989128|NCT02581345|530124594|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
146989129|NCT02581345|530124595|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
146989130|NCT02581345|530124596|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
146989131|NCT02581345|530124593|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
146989132|NCT02581345|530124594|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
146989133|NCT02581345|530124595|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
146989134|NCT02581345|530124596|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
146989135|NCT02581345|530124593|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
146989136|NCT02581345|530124594|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
146989137|NCT02581345|530124595|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
146989138|NCT02581345|530124596|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
146989139|NCT02581345|530124593|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
146989140|NCT02581345|530124594|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
146989141|NCT02581345|530124595|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
146989142|NCT02581345|530124596|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
146989143|NCT02581345|530124593|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
146989144|NCT02581345|530124594|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
146989145|NCT02581345|530124595|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
146989146|NCT02581345|530124596|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
146989147|NCT02581345|530124593|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
146989148|NCT02581345|530124594|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
146989149|NCT02581345|530124595|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
146989150|NCT02581345|530124596|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
146989151|NCT02581345|530124593|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
146989152|NCT02581345|530124594|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
146989153|NCT02581345|530124595|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
146989154|NCT02581345|530124596|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
146989155|NCT03471078|530124599|FG000|Overall Study|Withdrawal by Subject|9|||
146989156|NCT03471078|530124600|FG001|Overall Study|Withdrawal by Subject|1|||
146989157|NCT03471078|530124599|FG000|Overall Study|Adverse Event|4|||
146989158|NCT03471078|530124600|FG001|Overall Study|Adverse Event|1|||
146989159|NCT03471078|530124599|FG000|Overall Study|Physician Decision|3|||
146989160|NCT03471078|530124600|FG001|Overall Study|Physician Decision|2|||
146989161|NCT03471078|530124599|FG000|Overall Study|Death|2|||
146989162|NCT03471078|530124600|FG001|Overall Study|Death|0|||
146989163|NCT03471078|530124599|FG000|Overall Study|Other|3|||
146989164|NCT03471078|530124600|FG001|Overall Study|Other|2|||
146989165|NCT00862979|530124610|FG000|Overall Study|Adverse Event|6|||
146989166|NCT00862979|530124611|FG001|Overall Study|Adverse Event|3|||
146989167|NCT00862979|530124610|FG000|Overall Study|Protocol Violation|0|||
146989168|NCT00862979|530124611|FG001|Overall Study|Protocol Violation|1|||
146989169|NCT00862979|530124610|FG000|Overall Study|Patient withdrew consent|2|||
146989170|NCT00862979|530124611|FG001|Overall Study|Patient withdrew consent|1|||
146989171|NCT00862979|530124610|FG000|Overall Study|Administrative problems|0|||
146989172|NCT00862979|530124611|FG001|Overall Study|Administrative problems|1|||
146989173|NCT00862979|530124610|FG000|Overall Study|Death|0|||
146989174|NCT00862979|530124611|FG001|Overall Study|Death|1|||
146989175|NCT01027143|530124614|FG000|Overall Study|Lost to Follow-up|9|||
146989176|NCT01027143|530124615|FG001|Overall Study|Lost to Follow-up|4|||
146989177|NCT00797108|530124624|FG000|Overall Study|Adverse Event|1|||
146989178|NCT00797108|530124625|FG001|Overall Study|Adverse Event|0|||
146989179|NCT00797108|530124626|FG002|Overall Study|Adverse Event|3|||
146989180|NCT00797108|530124624|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
146989181|NCT00797108|530124625|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
146989182|NCT00797108|530124626|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
146989183|NCT00797108|530124624|FG000|Overall Study|Global Deterioration of Health Status|0|||
146989184|NCT00797108|530124625|FG001|Overall Study|Global Deterioration of Health Status|1|||
146989185|NCT00797108|530124626|FG002|Overall Study|Global Deterioration of Health Status|0|||
146989186|NCT00797108|530124624|FG000|Overall Study|Lack of Efficacy|1|||
146989187|NCT00797108|530124625|FG001|Overall Study|Lack of Efficacy|0|||
146989188|NCT00797108|530124626|FG002|Overall Study|Lack of Efficacy|1|||
146989189|NCT00797108|530124624|FG000|Overall Study|Other|0|||
146989190|NCT00797108|530124625|FG001|Overall Study|Other|0|||
146989191|NCT00797108|530124626|FG002|Overall Study|Other|2|||
146989192|NCT00797108|530124624|FG000|Overall Study|Randomized but not Treated|2|||
146989193|NCT00797108|530124625|FG001|Overall Study|Randomized but not Treated|0|||
146989194|NCT00797108|530124626|FG002|Overall Study|Randomized but not Treated|0|||
146989195|NCT02518113|530124627|FG000|Overall Study|Adverse Event|1|||
146989196|NCT02518113|530124628|FG001|Overall Study|Adverse Event|0|||
146989197|NCT02518113|530124629|FG002|Overall Study|Adverse Event|1|||
146989198|NCT02518113|530124630|FG003|Overall Study|Adverse Event|0|||
146989199|NCT02518113|530124627|FG000|Overall Study|Death|1|||
146989200|NCT02518113|530124628|FG001|Overall Study|Death|2|||
146989201|NCT02518113|530124629|FG002|Overall Study|Death|0|||
146989202|NCT02518113|530124630|FG003|Overall Study|Death|0|||
146989203|NCT02518113|530124627|FG000|Overall Study|Physician Decision|0|||
146989204|NCT02518113|530124628|FG001|Overall Study|Physician Decision|1|||
146989205|NCT02518113|530124629|FG002|Overall Study|Physician Decision|0|||
146989206|NCT02518113|530124630|FG003|Overall Study|Physician Decision|0|||
146989207|NCT02518113|530124627|FG000|Overall Study|Progressive Disease|1|||
146989208|NCT02518113|530124628|FG001|Overall Study|Progressive Disease|2|||
146989209|NCT02518113|530124629|FG002|Overall Study|Progressive Disease|3|||
146989210|NCT02518113|530124630|FG003|Overall Study|Progressive Disease|0|||
146989211|NCT00287118|530124631|FG000|Overall Study|Adverse Event|30|||
146989212|NCT00287118|530124631|FG000|Overall Study|Death|1|||
146989213|NCT00287118|530124631|FG000|Overall Study|Lack of Efficacy|11|||
146989214|NCT00287118|530124631|FG000|Overall Study|Lost to Follow-up|1|||
146989215|NCT00287118|530124631|FG000|Overall Study|Protocol Violation|2|||
146989216|NCT00287118|530124631|FG000|Overall Study|Other|7|||
146989217|NCT01631864|530124632|FG000|Overall Study|Withdrawal by Subject|0|||
146989218|NCT01631864|530124633|FG001|Overall Study|Withdrawal by Subject|1|||
146989219|NCT01631864|530124632|FG000|Overall Study|Adverse Event|2|||
146989220|NCT01631864|530124633|FG001|Overall Study|Adverse Event|3|||
146989221|NCT04471207|530124638|FG000|Overall Study|Lost to Follow-up|4|||
146989222|NCT04471207|530124639|FG001|Overall Study|Lost to Follow-up|1|||
146989223|NCT04471207|530124638|FG000|Overall Study|Medication Contraindication|0|||
146989224|NCT04471207|530124639|FG001|Overall Study|Medication Contraindication|1|||
146989225|NCT04471207|530124638|FG000|Overall Study|Loss of Interest|2|||
146989226|NCT04471207|530124639|FG001|Overall Study|Loss of Interest|1|||
146989227|NCT04471207|530124638|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
146989228|NCT04471207|530124639|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
146989229|NCT04471207|530124638|FG000|Overall Study|Scheduling Conflicts|3|||
146989230|NCT04471207|530124639|FG001|Overall Study|Scheduling Conflicts|1|||
146989231|NCT04471207|530124638|FG000|Overall Study|Physician Decision|1|||
146989232|NCT04471207|530124639|FG001|Overall Study|Physician Decision|0|||
146989233|NCT04471207|530124638|FG000|Overall Study|Unwilling to Use System|0|||
146989234|NCT04471207|530124639|FG001|Overall Study|Unwilling to Use System|1|||
146989235|NCT00561730|530124642|FG000|Overall Study|Adverse Event|2|||
146989236|NCT00561730|530124642|FG000|Overall Study|Handling of the drug|1|||
146989237|NCT00561730|530124642|FG000|Overall Study|Lost to Follow-up|5|||
146989238|NCT00561730|530124642|FG000|Overall Study|Not specified reasons|1|||
146989239|NCT04373434|530124659|FG000|Overall Study|Lost to Follow-up|37|||
146989240|NCT04373434|530124660|FG001|Overall Study|Lost to Follow-up|32|||
146989241|NCT04373434|530124659|FG000|Overall Study|Refused at 9 months|1|||
146989242|NCT04373434|530124660|FG001|Overall Study|Refused at 9 months|2|||
146989243|NCT04373434|530124659|FG000|Overall Study|Refused at 4 months|7|||
146989244|NCT04373434|530124660|FG001|Overall Study|Refused at 4 months|3|||
146989245|NCT04373434|530124659|FG000|Overall Study|Excluded|2|||
146989246|NCT04373434|530124660|FG001|Overall Study|Excluded|0|||
146989247|NCT00527423|530124661|FG000|Overall Study|Protocol Violation|1|||
146989248|NCT00527423|530124661|FG000|Overall Study|Adverse Event|5|||
146989249|NCT00527423|530124661|FG000|Overall Study|Physician Decision|4|||
146989250|NCT00527423|530124661|FG000|Overall Study|Withdrawal by Subject|10|||
146989251|NCT00527423|530124661|FG000|Overall Study|Lost to Follow-up|4|||
146989252|NCT00527423|530124661|FG000|Overall Study|OTHER|4|||
146989253|NCT00527423|530124661|FG000|Overall Study|Death|9|||
146989254|NCT03194464|530124665|FG000|Overall Study|data not usable|2|||
146989255|NCT02153398|530124666|FG000|Overall Study|Withdrawal by Subject|1|||
146989256|NCT02153398|530124667|FG001|Overall Study|Withdrawal by Subject|0|||
146989257|NCT02153398|530124668|FG002|Overall Study|Withdrawal by Subject|0|||
146989258|NCT02153398|530124669|FG003|Overall Study|Withdrawal by Subject|0|||
146989259|NCT02153398|530124670|FG004|Overall Study|Withdrawal by Subject|0|||
146989260|NCT02153398|530124666|FG000|Overall Study|Adverse Event|0|||
146989261|NCT02153398|530124667|FG001|Overall Study|Adverse Event|0|||
146989262|NCT02153398|530124668|FG002|Overall Study|Adverse Event|1|||
146989263|NCT02153398|530124669|FG003|Overall Study|Adverse Event|1|||
146989264|NCT02153398|530124670|FG004|Overall Study|Adverse Event|0|||
146989265|NCT01400425|530124671|FG000|Overall Study|Withdrawal by Subject|10|||
146989266|NCT00818883|530124672|FG000|Overall Study|Adverse Event|28|||
146989267|NCT00818883|530124673|FG001|Overall Study|Adverse Event|19|||
146989268|NCT00818883|530124672|FG000|Overall Study|Protocol Violation|2|||
146989269|NCT00818883|530124673|FG001|Overall Study|Protocol Violation|2|||
146989270|NCT00818883|530124672|FG000|Overall Study|Lost to Follow-up|3|||
146989271|NCT00818883|530124673|FG001|Overall Study|Lost to Follow-up|2|||
146989272|NCT00818883|530124672|FG000|Overall Study|Withdrawal by Subject|16|||
146989273|NCT00818883|530124673|FG001|Overall Study|Withdrawal by Subject|14|||
146989274|NCT00818883|530124672|FG000|Overall Study|Lack of Efficacy|0|||
146989275|NCT00818883|530124673|FG001|Overall Study|Lack of Efficacy|2|||
146989276|NCT00818883|530124672|FG000|Overall Study|Other|2|||
146989277|NCT00818883|530124673|FG001|Overall Study|Other|7|||
146989278|NCT00973700|530124674|FG000|Overall Study|Withdrawal by Subject|2|||
146989279|NCT00973700|530124675|FG001|Overall Study|Withdrawal by Subject|2|||
146989280|NCT00973700|530124676|FG002|Overall Study|Withdrawal by Subject|8|||
146989281|NCT00973700|530124677|FG003|Overall Study|Withdrawal by Subject|4|||
146989282|NCT00973700|530124678|FG004|Overall Study|Withdrawal by Subject|4|||
146989283|NCT00973700|530124674|FG000|Overall Study|Lost to Follow-up|5|||
146989284|NCT00973700|530124675|FG001|Overall Study|Lost to Follow-up|0|||
146989285|NCT00973700|530124676|FG002|Overall Study|Lost to Follow-up|1|||
146989286|NCT00973700|530124677|FG003|Overall Study|Lost to Follow-up|8|||
146989287|NCT00973700|530124678|FG004|Overall Study|Lost to Follow-up|5|||
146989288|NCT00973700|530124674|FG000|Overall Study|Inappropriate enrolment|0|||
146989289|NCT00973700|530124675|FG001|Overall Study|Inappropriate enrolment|0|||
146989290|NCT00973700|530124676|FG002|Overall Study|Inappropriate enrolment|0|||
146989291|NCT00973700|530124677|FG003|Overall Study|Inappropriate enrolment|4|||
146989292|NCT00973700|530124678|FG004|Overall Study|Inappropriate enrolment|0|||
146989293|NCT00973700|530124674|FG000|Overall Study|Unable to Classify|0|||
146989294|NCT00973700|530124675|FG001|Overall Study|Unable to Classify|0|||
146989295|NCT00973700|530124676|FG002|Overall Study|Unable to Classify|1|||
146989296|NCT00973700|530124677|FG003|Overall Study|Unable to Classify|2|||
146989297|NCT00973700|530124678|FG004|Overall Study|Unable to Classify|1|||
146989298|NCT00806156|530124680|FG000|Overall Study|Death|35|||
146989299|NCT00806156|530124681|FG001|Overall Study|Death|95|||
146989300|NCT00806156|530124680|FG000|Overall Study|Did not meet eligibility criteria|1|||
146989301|NCT00806156|530124681|FG001|Overall Study|Did not meet eligibility criteria|0|||
146989302|NCT00806156|530124680|FG000|Overall Study|Study terminated by Sponsor|2|||
146989303|NCT00806156|530124681|FG001|Overall Study|Study terminated by Sponsor|40|||
146989304|NCT00806156|530124680|FG000|Overall Study|Consent withdrawn by subject|1|||
146989305|NCT00806156|530124681|FG001|Overall Study|Consent withdrawn by subject|3|||
146989306|NCT00806156|530124680|FG000|Overall Study|Lost to Follow-up|0|||
146989307|NCT00806156|530124681|FG001|Overall Study|Lost to Follow-up|1|||
146989308|NCT00424489|530124685|FG000|Overall Study|Death|3|||
146989309|NCT00770510|530124688|FG000|Overall Study|Lost to Follow-up|2|||
146989310|NCT00770510|530124688|FG000|Overall Study|Pregnancy|1|||
146989311|NCT00770510|530124688|FG000|Overall Study|Withdrawal by Subject|2|||
146989312|NCT00536575|530124691|FG000|Overall Study|Withdrawal by Subject|1|||
146989313|NCT00536575|530124691|FG000|Overall Study|Death|1|||
146989314|NCT01089647|530124692|FG000|Overall Study|Lost to Follow-up|2|||
146989315|NCT01089647|530124693|FG001|Overall Study|Lost to Follow-up|2|||
146989316|NCT01089647|530124692|FG000|Overall Study|Withdrawal by Subject|2|||
146989317|NCT01089647|530124693|FG001|Overall Study|Withdrawal by Subject|1|||
146989318|NCT01089647|530124692|FG000|Overall Study|Adverse Event|0|||
146989319|NCT01089647|530124693|FG001|Overall Study|Adverse Event|1|||
146989320|NCT00927810|530124694|FG000|Overall Study|Withdrawal by Subject|0|||
146989321|NCT00927810|530124695|FG001|Overall Study|Withdrawal by Subject|3|||
146989322|NCT00927810|530124696|FG002|Overall Study|Withdrawal by Subject|0|||
146989323|NCT00927810|530124697|FG003|Overall Study|Withdrawal by Subject|1|||
146989324|NCT00927810|530124694|FG000|Overall Study|Lost to Follow-up|0|||
146989325|NCT00927810|530124695|FG001|Overall Study|Lost to Follow-up|2|||
146989326|NCT00927810|530124696|FG002|Overall Study|Lost to Follow-up|1|||
146989327|NCT00927810|530124697|FG003|Overall Study|Lost to Follow-up|1|||
146989328|NCT00927810|530124694|FG000|Overall Study|Death|0|||
146989329|NCT00927810|530124695|FG001|Overall Study|Death|2|||
146989330|NCT00927810|530124696|FG002|Overall Study|Death|0|||
146989331|NCT00927810|530124697|FG003|Overall Study|Death|0|||
146989332|NCT00927810|530124694|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146989333|NCT00927810|530124695|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146989334|NCT00927810|530124696|FG002|Overall Study|Abnormal laboratory value(s)|0|||
146989335|NCT00927810|530124697|FG003|Overall Study|Abnormal laboratory value(s)|0|||
146989336|NCT00198029|530124698|FG000|Overall Study|Withdrawal by Subject|4|||
146989337|NCT02465567|530124699|FG000|Overall Study|Adverse Event|118|||
146989338|NCT02465567|530124700|FG001|Overall Study|Adverse Event|113|||
146989339|NCT02465567|530124701|FG002|Overall Study|Adverse Event|147|||
146989340|NCT02465567|530124702|FG003|Overall Study|Adverse Event|138|||
146989341|NCT02465567|530124699|FG000|Overall Study|Lack of Efficacy|103|||
146989342|NCT02465567|530124700|FG001|Overall Study|Lack of Efficacy|102|||
146989343|NCT02465567|530124701|FG002|Overall Study|Lack of Efficacy|171|||
146989344|NCT02465567|530124702|FG003|Overall Study|Lack of Efficacy|135|||
146989345|NCT02465567|530124699|FG000|Overall Study|Withdrawal by Subject|104|||
146989346|NCT02465567|530124700|FG001|Overall Study|Withdrawal by Subject|94|||
146989347|NCT02465567|530124701|FG002|Overall Study|Withdrawal by Subject|123|||
146989348|NCT02465567|530124702|FG003|Overall Study|Withdrawal by Subject|130|||
146989349|NCT02465567|530124699|FG000|Overall Study|Physician Decision|23|||
146989350|NCT02465567|530124700|FG001|Overall Study|Physician Decision|33|||
146989351|NCT02465567|530124701|FG002|Overall Study|Physician Decision|38|||
146989352|NCT02465567|530124702|FG003|Overall Study|Physician Decision|28|||
146989353|NCT02465567|530124699|FG000|Overall Study|Major Protocol Deviation|24|||
146989354|NCT02465567|530124700|FG001|Overall Study|Major Protocol Deviation|26|||
146989355|NCT02465567|530124701|FG002|Overall Study|Major Protocol Deviation|22|||
146989356|NCT02465567|530124702|FG003|Overall Study|Major Protocol Deviation|25|||
146989357|NCT02465567|530124699|FG000|Overall Study|Lost to Follow-up|25|||
146989358|NCT02465567|530124700|FG001|Overall Study|Lost to Follow-up|21|||
146989359|NCT02465567|530124701|FG002|Overall Study|Lost to Follow-up|19|||
146989360|NCT02465567|530124702|FG003|Overall Study|Lost to Follow-up|15|||
146989361|NCT02465567|530124699|FG000|Overall Study|Protocol Specified Criteria|20|||
146989362|NCT02465567|530124700|FG001|Overall Study|Protocol Specified Criteria|10|||
146989363|NCT02465567|530124701|FG002|Overall Study|Protocol Specified Criteria|9|||
146989364|NCT02465567|530124702|FG003|Overall Study|Protocol Specified Criteria|12|||
146989365|NCT02465567|530124699|FG000|Overall Study|Administrative Reasons|12|||
146989366|NCT02465567|530124700|FG001|Overall Study|Administrative Reasons|9|||
146833755|NCT02872012|529560973|FG001|Overall Study|Withdrawal by Subject|0|||
146833756|NCT02872012|529560974|FG002|Overall Study|Withdrawal by Subject|0|||
146989367|NCT02465567|530124701|FG002|Overall Study|Administrative Reasons|11|||
146989368|NCT02465567|530124702|FG003|Overall Study|Administrative Reasons|5|||
146989369|NCT02465567|530124699|FG000|Overall Study|Randomized but not treated|1|||
146989370|NCT02465567|530124700|FG001|Overall Study|Randomized but not treated|5|||
146989371|NCT02465567|530124701|FG002|Overall Study|Randomized but not treated|4|||
146989372|NCT02465567|530124702|FG003|Overall Study|Randomized but not treated|5|||
146989373|NCT02465567|530124699|FG000|Overall Study|enrolled in >1 studies|18|||
146833757|NCT02872012|529560975|FG003|Overall Study|Withdrawal by Subject|0|||
146989374|NCT02465567|530124700|FG001|Overall Study|enrolled in >1 studies|11|||
146989375|NCT02465567|530124701|FG002|Overall Study|enrolled in >1 studies|19|||
146989376|NCT02465567|530124702|FG003|Overall Study|enrolled in >1 studies|15|||
146989377|NCT02465567|530124699|FG000|Overall Study|missing PI Signature|1|||
146989378|NCT02465567|530124700|FG001|Overall Study|missing PI Signature|0|||
146989379|NCT02465567|530124701|FG002|Overall Study|missing PI Signature|0|||
146989380|NCT02465567|530124702|FG003|Overall Study|missing PI Signature|0|||
146833758|NCT02872012|529560976|FG004|Overall Study|Withdrawal by Subject|0|||
146833759|NCT01728623|529560977|FG000|Overall Study|Disease progression|26|||
146833760|NCT01728623|529560977|FG000|Overall Study|Adverse Event|1|||
146833761|NCT01728623|529560977|FG000|Overall Study|Withdrawal by Subject|1|||
146833762|NCT03000348|529560978|FG000|Overall Study|Adverse Event|1|||
146833763|NCT03000348|529560979|FG001|Overall Study|Adverse Event|1|||
146833764|NCT03000348|529560980|FG002|Overall Study|Adverse Event|1|||
146833765|NCT03000348|529560981|FG003|Overall Study|Adverse Event|1|||
146833766|NCT03000348|529560982|FG004|Overall Study|Adverse Event|1|||
146833767|NCT03000348|529560983|FG005|Overall Study|Adverse Event|1|||
146833768|NCT03000348|529560978|FG000|Overall Study|Lost to Follow-up|0|||
146833769|NCT03000348|529560979|FG001|Overall Study|Lost to Follow-up|0|||
146833770|NCT03000348|529560980|FG002|Overall Study|Lost to Follow-up|1|||
146833771|NCT03000348|529560981|FG003|Overall Study|Lost to Follow-up|0|||
146833772|NCT03000348|529560982|FG004|Overall Study|Lost to Follow-up|0|||
146833773|NCT03000348|529560983|FG005|Overall Study|Lost to Follow-up|0|||
146833774|NCT03000348|529560978|FG000|Overall Study|Withdrawal by Subject|0|||
146833775|NCT03000348|529560979|FG001|Overall Study|Withdrawal by Subject|1|||
146833776|NCT03000348|529560980|FG002|Overall Study|Withdrawal by Subject|0|||
146833777|NCT03000348|529560981|FG003|Overall Study|Withdrawal by Subject|0|||
146833778|NCT03000348|529560982|FG004|Overall Study|Withdrawal by Subject|0|||
146833779|NCT03000348|529560983|FG005|Overall Study|Withdrawal by Subject|0|||
146833780|NCT03000348|529560978|FG000|Overall Study|Consent|0|||
146833781|NCT03000348|529560979|FG001|Overall Study|Consent|0|||
146833782|NCT03000348|529560980|FG002|Overall Study|Consent|0|||
146833783|NCT03000348|529560981|FG003|Overall Study|Consent|0|||
146989381|NCT02001558|530124703|FG000|Overall Study|Lost to Follow-up|8|||
146989382|NCT02001558|530124704|FG001|Overall Study|Lost to Follow-up|14|||
146989383|NCT04117607|530124705|FG000|Overall Study|Early Termination|0|||
146989384|NCT04117607|530124706|FG001|Overall Study|Early Termination|1|||
146989385|NCT04117607|530124707|FG002|Overall Study|Early Termination|0|||
146989386|NCT04117607|530124708|FG003|Overall Study|Early Termination|0|||
146989387|NCT04117607|530124709|FG004|Overall Study|Early Termination|0|||
146989388|NCT04117607|530124710|FG005|Overall Study|Early Termination|0|||
146989389|NCT04117607|530124711|FG006|Overall Study|Early Termination|1|||
146989390|NCT04117607|530124712|FG007|Overall Study|Early Termination|0|||
146989391|NCT04117607|530124713|FG008|Overall Study|Early Termination|0|||
146989392|NCT04117607|530124714|FG009|Overall Study|Early Termination|0|||
146989393|NCT04117607|530124715|FG010|Overall Study|Early Termination|0|||
146989394|NCT04117607|530124716|FG011|Overall Study|Early Termination|0|||
146989395|NCT04117607|530124717|FG012|Overall Study|Early Termination|0|||
146989396|NCT04117607|530124718|FG013|Overall Study|Early Termination|0|||
146989397|NCT02430870|530124721|FG000|Part 2|Voluntary Withdrawal|0|||
146989398|NCT02430870|530124722|FG001|Part 2|Voluntary Withdrawal|0|||
146989399|NCT02430870|530124723|FG002|Part 2|Voluntary Withdrawal|0|||
146989400|NCT02430870|530124724|FG003|Part 2|Voluntary Withdrawal|0|||
146989401|NCT02430870|530124725|FG004|Part 2|Voluntary Withdrawal|0|||
146989402|NCT02430870|530124726|FG005|Part 2|Voluntary Withdrawal|0|||
146989403|NCT02430870|530124727|FG006|Part 2|Voluntary Withdrawal|1|||
146989404|NCT02430870|530124728|FG007|Part 2|Voluntary Withdrawal|0|||
146989405|NCT02430870|530124721|FG000|Part 2|Other Reason Not Specified|0|||
146989406|NCT02430870|530124722|FG001|Part 2|Other Reason Not Specified|0|||
146989407|NCT02430870|530124723|FG002|Part 2|Other Reason Not Specified|0|||
146989408|NCT02430870|530124724|FG003|Part 2|Other Reason Not Specified|0|||
146989409|NCT02430870|530124725|FG004|Part 2|Other Reason Not Specified|0|||
146989410|NCT02430870|530124726|FG005|Part 2|Other Reason Not Specified|0|||
146989411|NCT02430870|530124727|FG006|Part 2|Other Reason Not Specified|0|||
146989412|NCT02430870|530124728|FG007|Part 2|Other Reason Not Specified|1|||
146989413|NCT02780687|530124729|FG000|Overall Study|Adverse Event|1|||
146989414|NCT02780687|530124730|FG001|Overall Study|Adverse Event|1|||
146989415|NCT02780687|530124729|FG000|Overall Study|Withdrawal by Subject|2|||
146989416|NCT02780687|530124730|FG001|Overall Study|Withdrawal by Subject|1|||
146989417|NCT02780687|530124729|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
146989418|NCT02780687|530124730|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
146989419|NCT02780687|530124729|FG000|Overall Study|progressive disease|29|||
146989420|NCT02780687|530124730|FG001|Overall Study|progressive disease|6|||
146989421|NCT03982433|530124731|FG000|Overall Study|Lost to Follow-up|1|||
146989422|NCT04257929|530124734|FG000|Overall Study|Adverse Event|1|||
146833784|NCT03000348|529560982|FG004|Overall Study|Consent|1|||
146833785|NCT03000348|529560983|FG005|Overall Study|Consent|0|||
146833786|NCT03000348|529560978|FG000|Overall Study|Failure to expectorate sputum|1|||
146833787|NCT03000348|529560979|FG001|Overall Study|Failure to expectorate sputum|0|||
146989423|NCT04257929|530124735|FG001|Overall Study|Adverse Event|0|||
146989424|NCT04257929|530124736|FG002|Overall Study|Adverse Event|1|||
146989425|NCT04257929|530124734|FG000|Overall Study|Withdrawal by Subject|1|||
146833788|NCT03000348|529560980|FG002|Overall Study|Failure to expectorate sputum|1|||
146833789|NCT03000348|529560981|FG003|Overall Study|Failure to expectorate sputum|0|||
146989426|NCT04257929|530124735|FG001|Overall Study|Withdrawal by Subject|0|||
146989427|NCT04257929|530124736|FG002|Overall Study|Withdrawal by Subject|0|||
146989428|NCT04257929|530124734|FG000|Overall Study|COVID-19|0|||
146833790|NCT03000348|529560982|FG004|Overall Study|Failure to expectorate sputum|1|||
146833791|NCT03000348|529560983|FG005|Overall Study|Failure to expectorate sputum|0|||
146833792|NCT03000348|529560978|FG000|Overall Study|No gram negative|1|||
146833793|NCT03000348|529560979|FG001|Overall Study|No gram negative|2|||
146833794|NCT03000348|529560980|FG002|Overall Study|No gram negative|1|||
146833795|NCT03000348|529560981|FG003|Overall Study|No gram negative|1|||
146833796|NCT03000348|529560982|FG004|Overall Study|No gram negative|1|||
146833797|NCT03000348|529560983|FG005|Overall Study|No gram negative|1|||
146833798|NCT03000348|529560978|FG000|Overall Study|Patient had no transport|0|||
146833799|NCT03000348|529560979|FG001|Overall Study|Patient had no transport|0|||
146833800|NCT03000348|529560980|FG002|Overall Study|Patient had no transport|0|||
146833801|NCT03000348|529560981|FG003|Overall Study|Patient had no transport|1|||
146833802|NCT03000348|529560982|FG004|Overall Study|Patient had no transport|0|||
146833803|NCT03000348|529560983|FG005|Overall Study|Patient had no transport|0|||
146833804|NCT03000348|529560978|FG000|Overall Study|Dosing|0|||
146833805|NCT03000348|529560979|FG001|Overall Study|Dosing|0|||
146833806|NCT03000348|529560980|FG002|Overall Study|Dosing|0|||
146833807|NCT03000348|529560981|FG003|Overall Study|Dosing|0|||
146833808|NCT03000348|529560982|FG004|Overall Study|Dosing|1|||
146833809|NCT03000348|529560983|FG005|Overall Study|Dosing|0|||
146833810|NCT01807182|529560985|FG000|Overall Study|Death|1|||
146833811|NCT01807182|529560985|FG000|Overall Study|New therapy|1|||
146833812|NCT01807182|529560985|FG000|Overall Study|Moved to hospice care|1|||
146833813|NCT03513068|529560986|FG000|Overall Study|Death|1|||
146833814|NCT03513068|529560987|FG001|Overall Study|Death|0|||
146833815|NCT03513068|529560986|FG000|Overall Study|Withdrawal by Subject|4|||
146833816|NCT03513068|529560987|FG001|Overall Study|Withdrawal by Subject|6|||
146833817|NCT00745498|529560988|FG000|Overall Study|Lost to Follow-up|1|||
146833818|NCT00745498|529560989|FG001|Overall Study|Lost to Follow-up|1|||
146833819|NCT00745498|529560990|FG002|Overall Study|Lost to Follow-up|3|||
146833820|NCT00745498|529560988|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
146833821|NCT00745498|529560989|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
146833822|NCT00745498|529560990|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
146833823|NCT00745498|529560988|FG000|Overall Study|Non-PDR related VH|0|||
146833824|NCT00745498|529560989|FG001|Overall Study|Non-PDR related VH|1|||
146833825|NCT00745498|529560990|FG002|Overall Study|Non-PDR related VH|1|||
146833826|NCT00745498|529560988|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
146833827|NCT00745498|529560989|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
146833828|NCT00745498|529560990|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
146833829|NCT03174782|529560991|FG000|Overall Study|Protocol Violation|1|||
146833830|NCT03174782|529560992|FG001|Overall Study|Protocol Violation|0|||
146833831|NCT03174782|529560991|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
146833832|NCT03174782|529560992|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
146833833|NCT01791413|529560993|FG000|Overall Study|Lost to Follow-up|5|||
146833834|NCT01791413|529560994|FG001|Overall Study|Lost to Follow-up|1|||
146833835|NCT00778921|529560995|FG000|Overall Study|Adverse Event|9|||
146833836|NCT00778921|529560996|FG001|Overall Study|Adverse Event|10|||
146833837|NCT00778921|529560997|FG002|Overall Study|Adverse Event|14|||
146833838|NCT00778921|529560995|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
146989429|NCT04257929|530124735|FG001|Overall Study|COVID-19|1|||
146989430|NCT04257929|530124736|FG002|Overall Study|COVID-19|1|||
146989431|NCT04257929|530124734|FG000|Overall Study|Lost to Follow-up|0|||
146989432|NCT04257929|530124735|FG001|Overall Study|Lost to Follow-up|0|||
146989433|NCT04257929|530124736|FG002|Overall Study|Lost to Follow-up|1|||
146989434|NCT05049460|530124737|FG000|Overall Study|Withdrawal by Subject|2|||
146989435|NCT05049460|530124738|FG001|Overall Study|Withdrawal by Subject|2|||
146989436|NCT05049460|530124737|FG000|Overall Study|Lost to Follow-up|2|||
146989437|NCT05049460|530124738|FG001|Overall Study|Lost to Follow-up|2|||
146989438|NCT04333095|530124743|FG000|Overall Study|Protocol Violation|4|||
146989439|NCT04333095|530124744|FG001|Overall Study|Protocol Violation|0|||
146989440|NCT04333095|530124743|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
146989441|NCT04333095|530124744|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
146989442|NCT04333095|530124743|FG000|Overall Study|Mini Sternotomy|4|||
146989443|NCT04333095|530124744|FG001|Overall Study|Mini Sternotomy|5|||
146833839|NCT00778921|529560996|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
146833840|NCT00778921|529560997|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
146833841|NCT00778921|529560995|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
146833842|NCT00778921|529560996|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
146833843|NCT00778921|529560997|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
146833844|NCT00778921|529560995|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
146833845|NCT00778921|529560996|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
146833846|NCT00778921|529560997|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
146833847|NCT00778921|529560995|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
146833848|NCT00778921|529560996|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
146989444|NCT03740165|530124745|FG000|Overall Study|Death|232|||
146989445|NCT03740165|530124746|FG001|Overall Study|Death|242|||
146833849|NCT00778921|529560997|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
146833850|NCT00778921|529560995|FG000|Overall Study|Patient withdrew request|3|||
146833851|NCT00778921|529560996|FG001|Overall Study|Patient withdrew request|1|||
146833852|NCT00778921|529560997|FG002|Overall Study|Patient withdrew request|6|||
146833853|NCT00778921|529560995|FG000|Overall Study|Lost to Follow-up|0|||
146833854|NCT00778921|529560996|FG001|Overall Study|Lost to Follow-up|2|||
146833855|NCT00778921|529560997|FG002|Overall Study|Lost to Follow-up|1|||
146833856|NCT00778921|529560995|FG000|Overall Study|Administrative Problems|1|||
146833857|NCT00778921|529560996|FG001|Overall Study|Administrative Problems|2|||
146833858|NCT00778921|529560997|FG002|Overall Study|Administrative Problems|0|||
146833859|NCT00778921|529560995|FG000|Overall Study|Protocol Violation|3|||
146833860|NCT00778921|529560996|FG001|Overall Study|Protocol Violation|0|||
146833861|NCT00778921|529560997|FG002|Overall Study|Protocol Violation|2|||
146833862|NCT00778921|529560995|FG000|Overall Study|Not treated|0|||
146833863|NCT00778921|529560996|FG001|Overall Study|Not treated|2|||
146833864|NCT00778921|529560997|FG002|Overall Study|Not treated|2|||
146833865|NCT03178045|529560998|FG000|Overall Study|Withdrawal by Subject|5|||
146833866|NCT03178045|529560999|FG001|Overall Study|Withdrawal by Subject|7|||
146833867|NCT03178045|529560998|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
146833868|NCT03178045|529560999|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
146833869|NCT03178045|529560998|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
146833870|NCT03178045|529560999|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
146833871|NCT03636373|529561000|FG000|Overall Study|Study closure due to Covid-19|1|||
146833872|NCT03636373|529561001|FG001|Overall Study|Study closure due to Covid-19|0|||
146833873|NCT00572533|529561012|FG000|Overall Study|Death|4|||
146833874|NCT00572533|529561013|FG001|Overall Study|Death|1|||
146833875|NCT00572533|529561012|FG000|Overall Study|Received Kidney Transplant|2|||
146833876|NCT00572533|529561013|FG001|Overall Study|Received Kidney Transplant|1|||
146833877|NCT00572533|529561012|FG000|Overall Study|Social Issues|1|||
146833878|NCT00572533|529561013|FG001|Overall Study|Social Issues|0|||
146833879|NCT00572533|529561012|FG000|Overall Study|Transfer out of Facility|0|||
146833880|NCT00572533|529561013|FG001|Overall Study|Transfer out of Facility|1|||
146833881|NCT01078922|529561014|FG000|Overall Study|Adverse Event|1|||
146833882|NCT02353468|529561015|FG000|Overall Study|Study terminated|3|||
146833883|NCT00003477|529561018|FG000|Overall Study|Not evalauable|4|||
146833884|NCT01236352|529561019|FG000|Overall Study|Death|0|||
146833885|NCT01236352|529561020|FG001|Overall Study|Death|0|||
146833886|NCT01236352|529561021|FG002|Overall Study|Death|0|||
146833887|NCT01236352|529561022|FG003|Overall Study|Death|0|||
146833888|NCT01236352|529561023|FG004|Overall Study|Death|0|||
146833889|NCT01236352|529561024|FG005|Overall Study|Death|0|||
146833890|NCT01236352|529561025|FG006|Overall Study|Death|0|||
146833891|NCT01236352|529561026|FG007|Overall Study|Death|1|||
146833892|NCT01236352|529561027|FG008|Overall Study|Death|0|||
146833893|NCT01236352|529561028|FG009|Overall Study|Death|0|||
146833894|NCT01236352|529561029|FG010|Overall Study|Death|0|||
146833895|NCT01236352|529561019|FG000|Overall Study|Withdrawal by Subject|0|||
146833896|NCT01236352|529561020|FG001|Overall Study|Withdrawal by Subject|0|||
146833897|NCT01236352|529561021|FG002|Overall Study|Withdrawal by Subject|0|||
146833898|NCT01236352|529561022|FG003|Overall Study|Withdrawal by Subject|0|||
146833899|NCT01236352|529561023|FG004|Overall Study|Withdrawal by Subject|0|||
146833900|NCT01236352|529561024|FG005|Overall Study|Withdrawal by Subject|0|||
146833901|NCT01236352|529561025|FG006|Overall Study|Withdrawal by Subject|0|||
146833902|NCT01236352|529561026|FG007|Overall Study|Withdrawal by Subject|0|||
146833903|NCT01236352|529561027|FG008|Overall Study|Withdrawal by Subject|0|||
146833904|NCT01236352|529561028|FG009|Overall Study|Withdrawal by Subject|2|||
146833905|NCT01236352|529561029|FG010|Overall Study|Withdrawal by Subject|1|||
146833906|NCT01236352|529561019|FG000|Overall Study|Adverse Event|0|||
146833907|NCT01236352|529561020|FG001|Overall Study|Adverse Event|0|||
146989446|NCT03740165|530124747|FG002|Overall Study|Death|229|||
146989447|NCT03740165|530124745|FG000|Overall Study|Lost to Follow-up|0|||
146989448|NCT03740165|530124746|FG001|Overall Study|Lost to Follow-up|0|||
146989449|NCT03740165|530124747|FG002|Overall Study|Lost to Follow-up|1|||
146989450|NCT03740165|530124745|FG000|Overall Study|Withdrawal by Subject|7|||
146989451|NCT03740165|530124746|FG001|Overall Study|Withdrawal by Subject|4|||
146833908|NCT01236352|529561021|FG002|Overall Study|Adverse Event|0|||
146833909|NCT01236352|529561022|FG003|Overall Study|Adverse Event|0|||
146833910|NCT01236352|529561023|FG004|Overall Study|Adverse Event|0|||
146833911|NCT01236352|529561024|FG005|Overall Study|Adverse Event|0|||
146833912|NCT01236352|529561025|FG006|Overall Study|Adverse Event|2|||
146833913|NCT01236352|529561026|FG007|Overall Study|Adverse Event|0|||
146833914|NCT01236352|529561027|FG008|Overall Study|Adverse Event|0|||
146833915|NCT01236352|529561028|FG009|Overall Study|Adverse Event|4|||
146833916|NCT01236352|529561029|FG010|Overall Study|Adverse Event|1|||
146833917|NCT01236352|529561019|FG000|Overall Study|Study drug toxicity|0|||
146833918|NCT01236352|529561020|FG001|Overall Study|Study drug toxicity|0|||
146833919|NCT01236352|529561021|FG002|Overall Study|Study drug toxicity|0|||
146833920|NCT01236352|529561022|FG003|Overall Study|Study drug toxicity|0|||
146833921|NCT01236352|529561023|FG004|Overall Study|Study drug toxicity|0|||
146833922|NCT01236352|529561024|FG005|Overall Study|Study drug toxicity|1|||
146833923|NCT01236352|529561025|FG006|Overall Study|Study drug toxicity|1|||
146833924|NCT01236352|529561026|FG007|Overall Study|Study drug toxicity|0|||
146833925|NCT01236352|529561027|FG008|Overall Study|Study drug toxicity|0|||
146833926|NCT01236352|529561028|FG009|Overall Study|Study drug toxicity|2|||
146833927|NCT01236352|529561029|FG010|Overall Study|Study drug toxicity|2|||
146833928|NCT01236352|529561019|FG000|Overall Study|Disease progression|1|||
146833929|NCT01236352|529561020|FG001|Overall Study|Disease progression|2|||
146833930|NCT01236352|529561021|FG002|Overall Study|Disease progression|1|||
146833931|NCT01236352|529561022|FG003|Overall Study|Disease progression|2|||
146833932|NCT01236352|529561023|FG004|Overall Study|Disease progression|2|||
146833933|NCT01236352|529561024|FG005|Overall Study|Disease progression|2|||
146833934|NCT01236352|529561025|FG006|Overall Study|Disease progression|1|||
146833935|NCT01236352|529561026|FG007|Overall Study|Disease progression|3|||
146833936|NCT01236352|529561027|FG008|Overall Study|Disease progression|2|||
146833937|NCT01236352|529561028|FG009|Overall Study|Disease progression|2|||
146833938|NCT01236352|529561029|FG010|Overall Study|Disease progression|2|||
146833939|NCT01236352|529561019|FG000|Overall Study|Poor/Non-compliance|1|||
146833940|NCT01236352|529561020|FG001|Overall Study|Poor/Non-compliance|0|||
146833941|NCT01236352|529561021|FG002|Overall Study|Poor/Non-compliance|0|||
146833942|NCT01236352|529561022|FG003|Overall Study|Poor/Non-compliance|0|||
146833943|NCT01236352|529561023|FG004|Overall Study|Poor/Non-compliance|0|||
146833944|NCT01236352|529561024|FG005|Overall Study|Poor/Non-compliance|0|||
146833945|NCT01236352|529561025|FG006|Overall Study|Poor/Non-compliance|0|||
146833946|NCT01236352|529561026|FG007|Overall Study|Poor/Non-compliance|0|||
146833947|NCT01236352|529561027|FG008|Overall Study|Poor/Non-compliance|0|||
146833948|NCT01236352|529561028|FG009|Overall Study|Poor/Non-compliance|0|||
146833949|NCT01236352|529561029|FG010|Overall Study|Poor/Non-compliance|0|||
146833950|NCT01236352|529561019|FG000|Overall Study|Maximum clinical benefit|1|||
146833951|NCT01236352|529561020|FG001|Overall Study|Maximum clinical benefit|1|||
146833952|NCT01236352|529561021|FG002|Overall Study|Maximum clinical benefit|1|||
146833953|NCT01236352|529561022|FG003|Overall Study|Maximum clinical benefit|0|||
146833954|NCT01236352|529561023|FG004|Overall Study|Maximum clinical benefit|2|||
146833955|NCT01236352|529561024|FG005|Overall Study|Maximum clinical benefit|0|||
146833956|NCT01236352|529561025|FG006|Overall Study|Maximum clinical benefit|3|||
146833957|NCT01236352|529561026|FG007|Overall Study|Maximum clinical benefit|1|||
146833958|NCT01236352|529561027|FG008|Overall Study|Maximum clinical benefit|1|||
146833959|NCT01236352|529561028|FG009|Overall Study|Maximum clinical benefit|4|||
146833960|NCT01236352|529561029|FG010|Overall Study|Maximum clinical benefit|2|||
146833961|NCT01236352|529561019|FG000|Overall Study|Subject request to discontinue treatment|0|||
146833962|NCT01236352|529561020|FG001|Overall Study|Subject request to discontinue treatment|0|||
146833963|NCT01236352|529561021|FG002|Overall Study|Subject request to discontinue treatment|1|||
146833964|NCT01236352|529561022|FG003|Overall Study|Subject request to discontinue treatment|1|||
146833965|NCT01236352|529561023|FG004|Overall Study|Subject request to discontinue treatment|0|||
146833966|NCT01236352|529561024|FG005|Overall Study|Subject request to discontinue treatment|1|||
146833967|NCT01236352|529561025|FG006|Overall Study|Subject request to discontinue treatment|0|||
146833968|NCT01236352|529561026|FG007|Overall Study|Subject request to discontinue treatment|0|||
146833969|NCT01236352|529561027|FG008|Overall Study|Subject request to discontinue treatment|0|||
146833970|NCT01236352|529561028|FG009|Overall Study|Subject request to discontinue treatment|1|||
146833971|NCT01236352|529561029|FG010|Overall Study|Subject request to discontinue treatment|4|||
146833972|NCT01236352|529561019|FG000|Overall Study|Subject to receive drug via EAP|1|||
146833973|NCT01236352|529561020|FG001|Overall Study|Subject to receive drug via EAP|1|||
146833974|NCT01236352|529561021|FG002|Overall Study|Subject to receive drug via EAP|1|||
146833975|NCT01236352|529561022|FG003|Overall Study|Subject to receive drug via EAP|0|||
146833976|NCT01236352|529561023|FG004|Overall Study|Subject to receive drug via EAP|0|||
146833977|NCT01236352|529561024|FG005|Overall Study|Subject to receive drug via EAP|0|||
146833978|NCT01236352|529561025|FG006|Overall Study|Subject to receive drug via EAP|0|||
146833979|NCT01236352|529561026|FG007|Overall Study|Subject to receive drug via EAP|2|||
146833980|NCT01236352|529561027|FG008|Overall Study|Subject to receive drug via EAP|0|||
146833981|NCT01236352|529561028|FG009|Overall Study|Subject to receive drug via EAP|4|||
146833982|NCT01236352|529561029|FG010|Overall Study|Subject to receive drug via EAP|0|||
146989452|NCT03740165|530124747|FG002|Overall Study|Withdrawal by Subject|3|||
146989453|NCT03740165|530124745|FG000|Overall Study|Ongoing in Study|216|||
146989454|NCT03740165|530124746|FG001|Overall Study|Ongoing in Study|212|||
146989455|NCT03740165|530124747|FG002|Overall Study|Ongoing in Study|221|||
146989456|NCT03049618|530124748|FG000|Overall Study|Death|1|||
146989457|NCT03049618|530124749|FG001|Overall Study|Death|0|||
146833983|NCT01236352|529561019|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
146833984|NCT01236352|529561020|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
146833985|NCT01236352|529561021|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
146833986|NCT01236352|529561022|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
146833987|NCT01236352|529561023|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
146833988|NCT01236352|529561024|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
146833989|NCT01236352|529561025|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
146833990|NCT01236352|529561026|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
146833991|NCT01236352|529561027|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
146833992|NCT01236352|529561028|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
146833993|NCT01236352|529561029|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
146833994|NCT01236352|529561019|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146833995|NCT01236352|529561020|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146833996|NCT01236352|529561021|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146833997|NCT01236352|529561022|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146833998|NCT01236352|529561023|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146833999|NCT01236352|529561024|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146834000|NCT01236352|529561025|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146834001|NCT01236352|529561026|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146834002|NCT01236352|529561027|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146834003|NCT01236352|529561028|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146834004|NCT01236352|529561029|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
146834005|NCT01236352|529561019|FG000|Overall Study|Lack of response to drug|0|||
146834006|NCT01236352|529561020|FG001|Overall Study|Lack of response to drug|0|||
146834007|NCT01236352|529561021|FG002|Overall Study|Lack of response to drug|0|||
146834008|NCT01236352|529561022|FG003|Overall Study|Lack of response to drug|0|||
146834009|NCT01236352|529561023|FG004|Overall Study|Lack of response to drug|0|||
146834010|NCT01236352|529561024|FG005|Overall Study|Lack of response to drug|0|||
146834011|NCT01236352|529561025|FG006|Overall Study|Lack of response to drug|0|||
146834012|NCT01236352|529561026|FG007|Overall Study|Lack of response to drug|0|||
146834013|NCT01236352|529561027|FG008|Overall Study|Lack of response to drug|0|||
146834014|NCT01236352|529561028|FG009|Overall Study|Lack of response to drug|1|||
146834015|NCT01236352|529561029|FG010|Overall Study|Lack of response to drug|1|||
146834016|NCT01236352|529561019|FG000|Overall Study|Patient transferred to IST|0|||
146834017|NCT01236352|529561020|FG001|Overall Study|Patient transferred to IST|0|||
146834018|NCT01236352|529561021|FG002|Overall Study|Patient transferred to IST|0|||
146834019|NCT01236352|529561022|FG003|Overall Study|Patient transferred to IST|0|||
146834020|NCT01236352|529561023|FG004|Overall Study|Patient transferred to IST|0|||
146834021|NCT01236352|529561024|FG005|Overall Study|Patient transferred to IST|0|||
146834022|NCT01236352|529561025|FG006|Overall Study|Patient transferred to IST|0|||
146834023|NCT01236352|529561026|FG007|Overall Study|Patient transferred to IST|0|||
146834024|NCT01236352|529561027|FG008|Overall Study|Patient transferred to IST|0|||
146834025|NCT01236352|529561028|FG009|Overall Study|Patient transferred to IST|2|||
146834026|NCT01236352|529561029|FG010|Overall Study|Patient transferred to IST|6|||
146834027|NCT01575873|529561030|FG000|Overall Study|Withdrawal by Subject|15|||
146834028|NCT01575873|529561031|FG001|Overall Study|Withdrawal by Subject|20|||
146834029|NCT01575873|529561032|FG002|Overall Study|Withdrawal by Subject|34|||
146834030|NCT01575873|529561033|FG003|Overall Study|Withdrawal by Subject|34|||
146834031|NCT01575873|529561030|FG000|Overall Study|Adverse Event|7|||
146834032|NCT01575873|529561031|FG001|Overall Study|Adverse Event|7|||
146834033|NCT01575873|529561032|FG002|Overall Study|Adverse Event|9|||
146834034|NCT01575873|529561033|FG003|Overall Study|Adverse Event|12|||
146834035|NCT01575873|529561030|FG000|Overall Study|Lost to Follow-up|1|||
146834036|NCT01575873|529561031|FG001|Overall Study|Lost to Follow-up|3|||
146834037|NCT01575873|529561032|FG002|Overall Study|Lost to Follow-up|13|||
146834038|NCT01575873|529561033|FG003|Overall Study|Lost to Follow-up|5|||
146834039|NCT01575873|529561030|FG000|Overall Study|Death|3|||
146834040|NCT01575873|529561031|FG001|Overall Study|Death|2|||
146834041|NCT01575873|529561032|FG002|Overall Study|Death|8|||
146834042|NCT01575873|529561033|FG003|Overall Study|Death|9|||
146834043|NCT01575873|529561030|FG000|Overall Study|Noncompliance|1|||
146834044|NCT01575873|529561031|FG001|Overall Study|Noncompliance|2|||
146834045|NCT01575873|529561032|FG002|Overall Study|Noncompliance|4|||
146834046|NCT01575873|529561033|FG003|Overall Study|Noncompliance|3|||
146834047|NCT01575873|529561030|FG000|Overall Study|Administrative decision|1|||
146834048|NCT01575873|529561031|FG001|Overall Study|Administrative decision|1|||
146834049|NCT01575873|529561032|FG002|Overall Study|Administrative decision|1|||
146834050|NCT01575873|529561033|FG003|Overall Study|Administrative decision|0|||
146834051|NCT01575873|529561030|FG000|Overall Study|Protocol deviation|0|||
146834052|NCT01575873|529561031|FG001|Overall Study|Protocol deviation|1|||
146834053|NCT01575873|529561032|FG002|Overall Study|Protocol deviation|0|||
146834054|NCT01575873|529561033|FG003|Overall Study|Protocol deviation|1|||
146834055|NCT01575873|529561030|FG000|Overall Study|Requirement for Alternative Therapy|0|||
146834056|NCT01575873|529561031|FG001|Overall Study|Requirement for Alternative Therapy|0|||
146834057|NCT01575873|529561032|FG002|Overall Study|Requirement for Alternative Therapy|1|||
146834058|NCT01575873|529561033|FG003|Overall Study|Requirement for Alternative Therapy|1|||
146834059|NCT01575873|529561030|FG000|Overall Study|Other|0|||
146834060|NCT01575873|529561031|FG001|Overall Study|Other|0|||
146834061|NCT01575873|529561032|FG002|Overall Study|Other|4|||
146834062|NCT01575873|529561033|FG003|Overall Study|Other|2|||
146834063|NCT02031536|529561034|FG000|Overall Study|ineligible|1|||
146834064|NCT02031536|529561035|FG001|Overall Study|ineligible|0|||
146834065|NCT01850030|529561036|FG000|Overall Study|Adverse Event|64|||
146834066|NCT01850030|529561037|FG001|Overall Study|Adverse Event|82|||
146834067|NCT01850030|529561036|FG000|Overall Study|Lack of Efficacy|3|||
146834068|NCT01850030|529561037|FG001|Overall Study|Lack of Efficacy|1|||
146834069|NCT01850030|529561036|FG000|Overall Study|Lost to Follow-up|5|||
146834070|NCT01850030|529561037|FG001|Overall Study|Lost to Follow-up|5|||
146834071|NCT01850030|529561036|FG000|Overall Study|Withdrawal by Subject|3|||
146834072|NCT01850030|529561037|FG001|Overall Study|Withdrawal by Subject|4|||
146834073|NCT01850030|529561036|FG000|Overall Study|Protocol Violation|24|||
146834074|NCT01850030|529561037|FG001|Overall Study|Protocol Violation|28|||
146834075|NCT01850030|529561036|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
146834076|NCT01850030|529561037|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
146834077|NCT03845023|529561045|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
146834078|NCT03845023|529561046|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
146834079|NCT03845023|529561047|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
146834080|NCT03845023|529561048|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
146834081|NCT03845023|529561045|FG000|Follow-Up (14 Days)|Adverse Event|0|||
146834082|NCT03845023|529561046|FG001|Follow-Up (14 Days)|Adverse Event|0|||
146834083|NCT03845023|529561047|FG002|Follow-Up (14 Days)|Adverse Event|1|||
146834084|NCT03845023|529561048|FG003|Follow-Up (14 Days)|Adverse Event|1|||
146834085|NCT02353871|529561049|FG000|Overall Study|Protocol deviation|0|||
146834086|NCT02353871|529561050|FG001|Overall Study|Protocol deviation|1|||
146834087|NCT02353871|529561049|FG000|Overall Study|Consent withdrawn|1|||
146834088|NCT02353871|529561050|FG001|Overall Study|Consent withdrawn|8|||
146834089|NCT02353871|529561049|FG000|Overall Study|Lost to Follow-up|2|||
146834090|NCT02353871|529561050|FG001|Overall Study|Lost to Follow-up|0|||
146834091|NCT00115336|529561051|FG000|Overall Study|Hospital discharge before study drug|0|||
146834092|NCT00115336|529561052|FG001|Overall Study|Hospital discharge before study drug|1|||
146834093|NCT03371823|529561053|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
146834094|NCT03371823|529561054|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
146834095|NCT00356811|529561055|FG000|Overall Study|Death|35|||
146834096|NCT00356811|529561055|FG000|Overall Study|Lost to Follow-up|2|||
146834097|NCT00356811|529561055|FG000|Overall Study|Withdrawal by Subject|6|||
146834098|NCT00356811|529561055|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
146834099|NCT00356811|529561055|FG000|Overall Study|Study Is Terminating|3|||
146834100|NCT00356811|529561055|FG000|Overall Study|Site Closed during Follow-up|2|||
146834101|NCT02386839|529561056|FG000|Overall Study|Death|1|||
146834102|NCT02386839|529561057|FG001|Overall Study|Death|0|||
146834103|NCT02386839|529561056|FG000|Overall Study|Withdrawal by Subject|9|||
146834104|NCT02386839|529561057|FG001|Overall Study|Withdrawal by Subject|10|||
146834105|NCT02386839|529561056|FG000|Overall Study|Lost to Follow-up|4|||
146834106|NCT02386839|529561057|FG001|Overall Study|Lost to Follow-up|4|||
146834107|NCT02386839|529561056|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
146834108|NCT02386839|529561057|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
146834109|NCT02386839|529561056|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
146834110|NCT02386839|529561057|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
146834111|NCT02386839|529561056|FG000|Overall Study|Other (unspecified)|1|||
146834112|NCT02386839|529561057|FG001|Overall Study|Other (unspecified)|0|||
146834113|NCT02242643|529561060|FG000|Overall Study|Protocol Violation|1|||
146834114|NCT02242643|529561061|FG001|Overall Study|Protocol Violation|2|||
146834115|NCT02242643|529561060|FG000|Overall Study|Withdrawal by Subject|15|||
146834116|NCT02242643|529561061|FG001|Overall Study|Withdrawal by Subject|10|||
146834117|NCT02242643|529561060|FG000|Overall Study|Migrated/moved from study area|1|||
146834118|NCT02242643|529561061|FG001|Overall Study|Migrated/moved from study area|3|||
146834119|NCT02242643|529561060|FG000|Overall Study|Lost to Follow-up|54|||
146834120|NCT02242643|529561061|FG001|Overall Study|Lost to Follow-up|61|||
146834121|NCT02242643|529561060|FG000|Overall Study|Child placed in foster care by family|0|||
146989458|NCT03049618|530124748|FG000|Overall Study|Lack of Efficacy|1|||
146989459|NCT03049618|530124749|FG001|Overall Study|Lack of Efficacy|2|||
146989460|NCT04582539|530124750|FG000|Overall Study|Death|1|||
146989461|NCT04582539|530124751|FG001|Overall Study|Death|1|||
146834122|NCT02242643|529561061|FG001|Overall Study|Child placed in foster care by family|1|||
146834123|NCT02242643|529561060|FG000|Overall Study|Non-compliance|1|||
146834124|NCT02242643|529561061|FG001|Overall Study|Non-compliance|0|||
146834125|NCT02242643|529561060|FG000|Overall Study|Consent withdrawal by parent|1|||
146834126|NCT02242643|529561061|FG001|Overall Study|Consent withdrawal by parent|0|||
146834127|NCT02242643|529561060|FG000|Overall Study|Protocol requirements not followed|1|||
146834128|NCT02242643|529561061|FG001|Overall Study|Protocol requirements not followed|0|||
146834129|NCT02242643|529561060|FG000|Overall Study|Language barrier|1|||
146834130|NCT02242643|529561061|FG001|Overall Study|Language barrier|0|||
146834131|NCT02242643|529561060|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
146989462|NCT04582539|530124752|FG002|Overall Study|Death|0|||
146834132|NCT02242643|529561061|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
146834133|NCT02101983|529561062|FG000|Overall Study|Physician Decision|1|||
146834134|NCT02101983|529561063|FG001|Overall Study|Physician Decision|0|||
146989463|NCT04582539|530124753|FG003|Overall Study|Death|1|||
146989464|NCT04582539|530124754|FG004|Overall Study|Death|0|||
146834135|NCT01103232|529561068|FG000|Overall Study|Withdrawal by Subject|1|||
146834136|NCT01103232|529561069|FG001|Overall Study|Withdrawal by Subject|1|||
146834137|NCT01103232|529561068|FG000|Overall Study|Protocol Violation|0|||
146834138|NCT01103232|529561069|FG001|Overall Study|Protocol Violation|1|||
146834139|NCT05093504|529561070|FG000|Overall Study|Death|0|||
146834140|NCT05093504|529561071|FG001|Overall Study|Death|1|||
146834141|NCT05347485|529561076|FG000|Overall Study|Death|14|||
146834142|NCT05347485|529561076|FG000|Overall Study|Lost to Follow-up|2|||
146834143|NCT05347485|529561076|FG000|Overall Study|Withdrawal by Subject|13|||
146834144|NCT05347485|529561076|FG000|Overall Study|Progressive Disease|1|||
146834145|NCT05347485|529561076|FG000|Overall Study|Study Terminated by Sponsor|49|||
146834146|NCT05347485|529561076|FG000|Overall Study|Other|1|||
146834147|NCT05347485|529561076|FG000|Overall Study|Enrolled (consented) but not treated|4|||
146834148|NCT05347485|529561076|FG000|Overall Study|Disease Relapse|2|||
146834149|NCT04886518|529561077|FG000|Overall Study|Noncompliance with study drug|1|||
146834150|NCT04886518|529561078|FG001|Overall Study|Noncompliance with study drug|0|||
146834151|NCT04886518|529561079|FG002|Overall Study|Noncompliance with study drug|0|||
146834152|NCT04886518|529561077|FG000|Overall Study|Adverse Event|0|||
146834153|NCT04886518|529561078|FG001|Overall Study|Adverse Event|1|||
146834154|NCT04886518|529561079|FG002|Overall Study|Adverse Event|0|||
146834155|NCT04886518|529561077|FG000|Overall Study|Withdrawal by Subject|1|||
146834156|NCT04886518|529561078|FG001|Overall Study|Withdrawal by Subject|0|||
146834157|NCT04886518|529561079|FG002|Overall Study|Withdrawal by Subject|0|||
146834158|NCT03733899|529561080|FG000|Period 1|Protocol Violation|0|||
146834159|NCT03733899|529561081|FG001|Period 1|Protocol Violation|0|||
146834160|NCT03733899|529561082|FG002|Period 1|Protocol Violation|0|||
146834161|NCT03733899|529561083|FG003|Period 1|Protocol Violation|0|||
146834162|NCT03733899|529561084|FG004|Period 1|Protocol Violation|0|||
146834163|NCT03733899|529561085|FG005|Period 1|Protocol Violation|1|||
146834164|NCT03733899|529561080|FG000|Period 2|Unscuccessful Treatment|0|||
146834165|NCT03733899|529561081|FG001|Period 2|Unscuccessful Treatment|1|||
146834166|NCT03733899|529561082|FG002|Period 2|Unscuccessful Treatment|0|||
146834167|NCT03733899|529561083|FG003|Period 2|Unscuccessful Treatment|0|||
146834168|NCT03733899|529561084|FG004|Period 2|Unscuccessful Treatment|0|||
146834169|NCT03733899|529561085|FG005|Period 2|Unscuccessful Treatment|0|||
146834170|NCT03733899|529561080|FG000|Period 3|Withdrawal by Subject|1|||
146834171|NCT03733899|529561081|FG001|Period 3|Withdrawal by Subject|0|||
146834172|NCT03733899|529561082|FG002|Period 3|Withdrawal by Subject|0|||
146834173|NCT03733899|529561083|FG003|Period 3|Withdrawal by Subject|0|||
146834174|NCT03733899|529561084|FG004|Period 3|Withdrawal by Subject|0|||
146834175|NCT03733899|529561085|FG005|Period 3|Withdrawal by Subject|0|||
146834176|NCT02035696|529563064|FG000|Overall Study|Lost to Follow-up|0|||
146834177|NCT02035696|529563065|FG001|Overall Study|Lost to Follow-up|3|||
146834178|NCT02035696|529563066|FG002|Overall Study|Lost to Follow-up|1|||
146834179|NCT02035696|529563067|FG003|Overall Study|Lost to Follow-up|2|||
146834180|NCT02035696|529563064|FG000|Overall Study|Withdrawal by Subject|3|||
146834181|NCT02035696|529563065|FG001|Overall Study|Withdrawal by Subject|0|||
146834182|NCT02035696|529563066|FG002|Overall Study|Withdrawal by Subject|2|||
146834183|NCT02035696|529563067|FG003|Overall Study|Withdrawal by Subject|1|||
146834184|NCT01246999|529563069|FG000|Overall Study|Lost to Follow-up|0|||
146834185|NCT01246999|529563070|FG001|Overall Study|Lost to Follow-up|1|||
146834186|NCT01246999|529563071|FG002|Overall Study|Lost to Follow-up|0|||
146834187|NCT01246999|529563072|FG003|Overall Study|Lost to Follow-up|0|||
146834188|NCT01246999|529563069|FG000|Overall Study|Withdrawal by Subject|0|||
146834189|NCT01246999|529563070|FG001|Overall Study|Withdrawal by Subject|0|||
146834190|NCT01246999|529563071|FG002|Overall Study|Withdrawal by Subject|0|||
146834191|NCT01246999|529563072|FG003|Overall Study|Withdrawal by Subject|2|||
146834192|NCT01867047|529563073|FG000|Overall Study|Lost to Follow-up|3|||
146834193|NCT01867047|529563074|FG001|Overall Study|Lost to Follow-up|3|||
146834194|NCT01867047|529563073|FG000|Overall Study|Withdrawal by Subject|2|||
146834195|NCT01867047|529563074|FG001|Overall Study|Withdrawal by Subject|0|||
146834196|NCT01867047|529563073|FG000|Overall Study|Physician Decision|2|||
146989465|NCT04582539|530124750|FG000|Overall Study|Lost to Follow-up|1|||
146989466|NCT04582539|530124751|FG001|Overall Study|Lost to Follow-up|0|||
146989467|NCT04582539|530124752|FG002|Overall Study|Lost to Follow-up|0|||
146989468|NCT04582539|530124753|FG003|Overall Study|Lost to Follow-up|0|||
146834197|NCT01867047|529563074|FG001|Overall Study|Physician Decision|0|||
146834198|NCT01867047|529563073|FG000|Overall Study|surgery not indicated in protocol|1|||
146834199|NCT01867047|529563074|FG001|Overall Study|surgery not indicated in protocol|2|||
146834200|NCT04650698|529563075|FG000|Overall Study|Protocol Violation|2|||
146834201|NCT04650698|529563076|FG001|Overall Study|Protocol Violation|1|||
146834202|NCT04650698|529563075|FG000|Overall Study|Withdrawal by Subject|0|||
146834203|NCT04650698|529563076|FG001|Overall Study|Withdrawal by Subject|1|||
146834204|NCT01090011|529563077|FG000|Overall Study|Progressive disease|128|||
146834205|NCT01090011|529563077|FG000|Overall Study|Adverse Event|32|||
146989469|NCT04582539|530124754|FG004|Overall Study|Lost to Follow-up|0|||
146834206|NCT01090011|529563077|FG000|Overall Study|Protocol Violation|1|||
146989470|NCT04582539|530124750|FG000|Overall Study|Study Terminated by Sponsor|1|||
146834207|NCT01090011|529563077|FG000|Overall Study|Refusal to start/continue medication|5|||
146989471|NCT04582539|530124751|FG001|Overall Study|Study Terminated by Sponsor|3|||
146834208|NCT01090011|529563077|FG000|Overall Study|Other reason not defined above|5|||
146834209|NCT00307047|529563078|FG000|Overall Study|Lost to Follow-up|35|||
146834210|NCT00307047|529563079|FG001|Overall Study|Lost to Follow-up|24|||
146834211|NCT00307047|529563078|FG000|Overall Study|Withdrawal by Subject|6|||
146834212|NCT00307047|529563079|FG001|Overall Study|Withdrawal by Subject|6|||
146834213|NCT00307047|529563078|FG000|Overall Study|Physician Decision|1|||
146834214|NCT00307047|529563079|FG001|Overall Study|Physician Decision|2|||
146834215|NCT00307047|529563078|FG000|Overall Study|Lost to follow-up for other reasons|0|||
146834216|NCT00307047|529563079|FG001|Overall Study|Lost to follow-up for other reasons|1|||
146834217|NCT00307047|529563078|FG000|Overall Study|All death, all MI, all Revascularization|27|||
146834218|NCT00307047|529563079|FG001|Overall Study|All death, all MI, all Revascularization|16|||
146834219|NCT00379769|529563080|FG000|Main Study|Death|57|||
146834220|NCT00379769|529563081|FG001|Main Study|Death|67|||
146834221|NCT00379769|529563082|FG002|Main Study|Death|54|||
146834222|NCT00379769|529563083|FG003|Main Study|Death|72|||
146834223|NCT00379769|529563084|FG004|Main Study|Death|0|||
146834224|NCT00379769|529563085|FG005|Main Study|Death|0|||
146834225|NCT00379769|529563080|FG000|Main Study|Adverse Event|5|||
146834226|NCT00379769|529563081|FG001|Main Study|Adverse Event|8|||
146834227|NCT00379769|529563082|FG002|Main Study|Adverse Event|10|||
146834228|NCT00379769|529563083|FG003|Main Study|Adverse Event|11|||
146834229|NCT00379769|529563084|FG004|Main Study|Adverse Event|0|||
146834230|NCT00379769|529563085|FG005|Main Study|Adverse Event|0|||
146834231|NCT00379769|529563080|FG000|Main Study|Lost to Follow-up|29|||
146834232|NCT00379769|529563081|FG001|Main Study|Lost to Follow-up|29|||
146834233|NCT00379769|529563082|FG002|Main Study|Lost to Follow-up|25|||
146834234|NCT00379769|529563083|FG003|Main Study|Lost to Follow-up|26|||
146834235|NCT00379769|529563084|FG004|Main Study|Lost to Follow-up|0|||
146834236|NCT00379769|529563085|FG005|Main Study|Lost to Follow-up|0|||
146834237|NCT00379769|529563080|FG000|Main Study|Withdrawal by Subject|46|||
146834238|NCT00379769|529563081|FG001|Main Study|Withdrawal by Subject|56|||
146834239|NCT00379769|529563082|FG002|Main Study|Withdrawal by Subject|72|||
146834240|NCT00379769|529563083|FG003|Main Study|Withdrawal by Subject|70|||
146834241|NCT00379769|529563084|FG004|Main Study|Withdrawal by Subject|0|||
146834242|NCT00379769|529563085|FG005|Main Study|Withdrawal by Subject|0|||
146834243|NCT00379769|529563080|FG000|Main Study|Moved to survival status follow-up only|27|||
146834244|NCT00379769|529563081|FG001|Main Study|Moved to survival status follow-up only|25|||
146834245|NCT00379769|529563082|FG002|Main Study|Moved to survival status follow-up only|32|||
146834246|NCT00379769|529563083|FG003|Main Study|Moved to survival status follow-up only|36|||
146834247|NCT00379769|529563084|FG004|Main Study|Moved to survival status follow-up only|0|||
146834248|NCT00379769|529563085|FG005|Main Study|Moved to survival status follow-up only|0|||
146834249|NCT00379769|529563080|FG000|Main Study|Participant moved|3|||
146834250|NCT00379769|529563081|FG001|Main Study|Participant moved|2|||
146834251|NCT00379769|529563082|FG002|Main Study|Participant moved|3|||
146834252|NCT00379769|529563083|FG003|Main Study|Participant moved|3|||
146834253|NCT00379769|529563084|FG004|Main Study|Participant moved|0|||
146834254|NCT00379769|529563085|FG005|Main Study|Participant moved|0|||
146834255|NCT00379769|529563080|FG000|Main Study|Poor compliance|3|||
146834256|NCT00379769|529563081|FG001|Main Study|Poor compliance|2|||
146834257|NCT00379769|529563082|FG002|Main Study|Poor compliance|2|||
146834258|NCT00379769|529563083|FG003|Main Study|Poor compliance|1|||
146989472|NCT04582539|530124752|FG002|Overall Study|Study Terminated by Sponsor|2|||
146989473|NCT04582539|530124753|FG003|Overall Study|Study Terminated by Sponsor|2|||
146989474|NCT04582539|530124754|FG004|Overall Study|Study Terminated by Sponsor|3|||
146989475|NCT04582539|530124750|FG000|Overall Study|Physician Decision|0|||
146989476|NCT04582539|530124751|FG001|Overall Study|Physician Decision|1|||
146989477|NCT04582539|530124752|FG002|Overall Study|Physician Decision|0|||
146989478|NCT04582539|530124753|FG003|Overall Study|Physician Decision|0|||
146989479|NCT04582539|530124754|FG004|Overall Study|Physician Decision|0|||
146989480|NCT04582539|530124750|FG000|Overall Study|Withdrawal by Subject|1|||
146989481|NCT04582539|530124751|FG001|Overall Study|Withdrawal by Subject|0|||
146989482|NCT04582539|530124752|FG002|Overall Study|Withdrawal by Subject|2|||
146989483|NCT04582539|530124753|FG003|Overall Study|Withdrawal by Subject|1|||
146989484|NCT04582539|530124754|FG004|Overall Study|Withdrawal by Subject|0|||
146989485|NCT04582539|530124750|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
146834259|NCT00379769|529563084|FG004|Main Study|Poor compliance|0|||
146834260|NCT00379769|529563085|FG005|Main Study|Poor compliance|0|||
146834261|NCT00379769|529563080|FG000|Main Study|Prohibited glucose lowering medication|0|||
146834262|NCT00379769|529563081|FG001|Main Study|Prohibited glucose lowering medication|3|||
146834263|NCT00379769|529563082|FG002|Main Study|Prohibited glucose lowering medication|0|||
146834264|NCT00379769|529563083|FG003|Main Study|Prohibited glucose lowering medication|1|||
146834265|NCT00379769|529563084|FG004|Main Study|Prohibited glucose lowering medication|0|||
146834266|NCT00379769|529563085|FG005|Main Study|Prohibited glucose lowering medication|0|||
146834267|NCT00379769|529563080|FG000|Main Study|Site closed|4|||
146834268|NCT00379769|529563081|FG001|Main Study|Site closed|4|||
146834269|NCT00379769|529563082|FG002|Main Study|Site closed|4|||
146834270|NCT00379769|529563083|FG003|Main Study|Site closed|8|||
146834271|NCT00379769|529563084|FG004|Main Study|Site closed|0|||
146834272|NCT00379769|529563085|FG005|Main Study|Site closed|0|||
146834273|NCT00379769|529563080|FG000|Main Study|Entry criteria violation|0|||
146834274|NCT00379769|529563081|FG001|Main Study|Entry criteria violation|0|||
146834275|NCT00379769|529563082|FG002|Main Study|Entry criteria violation|1|||
146834276|NCT00379769|529563083|FG003|Main Study|Entry criteria violation|1|||
146834277|NCT00379769|529563084|FG004|Main Study|Entry criteria violation|0|||
146834278|NCT00379769|529563085|FG005|Main Study|Entry criteria violation|0|||
146834279|NCT00379769|529563080|FG000|Main Study|Participant did not take study drug|0|||
146834280|NCT00379769|529563081|FG001|Main Study|Participant did not take study drug|0|||
146834281|NCT00379769|529563082|FG002|Main Study|Participant did not take study drug|1|||
146834282|NCT00379769|529563083|FG003|Main Study|Participant did not take study drug|0|||
146834283|NCT00379769|529563084|FG004|Main Study|Participant did not take study drug|0|||
146834284|NCT00379769|529563085|FG005|Main Study|Participant did not take study drug|0|||
146834285|NCT00379769|529563080|FG000|Main Study|Physician Decision|2|||
146834286|NCT00379769|529563081|FG001|Main Study|Physician Decision|2|||
146834287|NCT00379769|529563082|FG002|Main Study|Physician Decision|1|||
146834288|NCT00379769|529563083|FG003|Main Study|Physician Decision|1|||
146834289|NCT00379769|529563084|FG004|Main Study|Physician Decision|0|||
146834290|NCT00379769|529563085|FG005|Main Study|Physician Decision|0|||
146834291|NCT00379769|529563080|FG000|Main Study|Participant completed study at visit 27|1|||
146834292|NCT00379769|529563081|FG001|Main Study|Participant completed study at visit 27|0|||
146834293|NCT00379769|529563082|FG002|Main Study|Participant completed study at visit 27|0|||
146834294|NCT00379769|529563083|FG003|Main Study|Participant completed study at visit 27|0|||
146834295|NCT00379769|529563084|FG004|Main Study|Participant completed study at visit 27|0|||
146834296|NCT00379769|529563085|FG005|Main Study|Participant completed study at visit 27|0|||
146834297|NCT00379769|529563080|FG000|Main Study|Personal reasons|1|||
146834298|NCT00379769|529563081|FG001|Main Study|Personal reasons|0|||
146834299|NCT00379769|529563082|FG002|Main Study|Personal reasons|0|||
146834300|NCT00379769|529563083|FG003|Main Study|Personal reasons|0|||
146834301|NCT00379769|529563084|FG004|Main Study|Personal reasons|0|||
146834302|NCT00379769|529563085|FG005|Main Study|Personal reasons|0|||
146834303|NCT00379769|529563080|FG000|Main Study|Risk of heart failure|0|||
146834304|NCT00379769|529563081|FG001|Main Study|Risk of heart failure|1|||
146834305|NCT00379769|529563082|FG002|Main Study|Risk of heart failure|0|||
146834306|NCT00379769|529563083|FG003|Main Study|Risk of heart failure|0|||
146834307|NCT00379769|529563084|FG004|Main Study|Risk of heart failure|0|||
146834308|NCT00379769|529563085|FG005|Main Study|Risk of heart failure|0|||
146834309|NCT00379769|529563080|FG000|Main Study|Investigator refused to log temperature|0|||
146834310|NCT00379769|529563081|FG001|Main Study|Investigator refused to log temperature|0|||
146834311|NCT00379769|529563082|FG002|Main Study|Investigator refused to log temperature|1|||
146834312|NCT00379769|529563083|FG003|Main Study|Investigator refused to log temperature|0|||
146834313|NCT00379769|529563084|FG004|Main Study|Investigator refused to log temperature|0|||
146834314|NCT00379769|529563085|FG005|Main Study|Investigator refused to log temperature|0|||
146834315|NCT00379769|529563080|FG000|Main Study|Reason unspecified|0|||
146834316|NCT00379769|529563081|FG001|Main Study|Reason unspecified|0|||
146834317|NCT00379769|529563082|FG002|Main Study|Reason unspecified|1|||
146834318|NCT00379769|529563083|FG003|Main Study|Reason unspecified|0|||
146834319|NCT00379769|529563084|FG004|Main Study|Reason unspecified|0|||
146834320|NCT00379769|529563085|FG005|Main Study|Reason unspecified|0|||
146834321|NCT00379769|529563080|FG000|Observational Follow-up|Death|0|||
146834322|NCT00379769|529563081|FG001|Observational Follow-up|Death|0|||
146834323|NCT00379769|529563082|FG002|Observational Follow-up|Death|0|||
146834324|NCT00379769|529563083|FG003|Observational Follow-up|Death|0|||
146834325|NCT00379769|529563084|FG004|Observational Follow-up|Death|78|||
146834326|NCT00379769|529563085|FG005|Observational Follow-up|Death|70|||
146834327|NCT00379769|529563080|FG000|Observational Follow-up|Adverse Event|0|||
146834328|NCT00379769|529563081|FG001|Observational Follow-up|Adverse Event|0|||
146834329|NCT00379769|529563082|FG002|Observational Follow-up|Adverse Event|0|||
146989486|NCT04582539|530124751|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
146989487|NCT04582539|530124752|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
146989488|NCT04582539|530124753|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
146989489|NCT04582539|530124754|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
146989490|NCT00788957|530124763|FG000|Part 1|Death|8|||
146834330|NCT00379769|529563083|FG003|Observational Follow-up|Adverse Event|0|||
146834331|NCT00379769|529563084|FG004|Observational Follow-up|Adverse Event|1|||
146834332|NCT00379769|529563085|FG005|Observational Follow-up|Adverse Event|0|||
146989491|NCT00788957|530124764|FG001|Part 1|Death|0|||
146989492|NCT00788957|530124765|FG002|Part 1|Death|0|||
146989493|NCT00788957|530124766|FG003|Part 1|Death|0|||
146834333|NCT00379769|529563080|FG000|Observational Follow-up|Lost to Follow-up|0|||
146834334|NCT00379769|529563081|FG001|Observational Follow-up|Lost to Follow-up|0|||
146834335|NCT00379769|529563082|FG002|Observational Follow-up|Lost to Follow-up|0|||
146834336|NCT00379769|529563083|FG003|Observational Follow-up|Lost to Follow-up|0|||
146834337|NCT00379769|529563084|FG004|Observational Follow-up|Lost to Follow-up|25|||
146834338|NCT00379769|529563085|FG005|Observational Follow-up|Lost to Follow-up|27|||
146834339|NCT00379769|529563080|FG000|Observational Follow-up|Withdrawal by Subject|0|||
146834340|NCT00379769|529563081|FG001|Observational Follow-up|Withdrawal by Subject|0|||
146834341|NCT00379769|529563082|FG002|Observational Follow-up|Withdrawal by Subject|0|||
146834342|NCT00379769|529563083|FG003|Observational Follow-up|Withdrawal by Subject|0|||
146834343|NCT00379769|529563084|FG004|Observational Follow-up|Withdrawal by Subject|12|||
146834344|NCT00379769|529563085|FG005|Observational Follow-up|Withdrawal by Subject|12|||
146834345|NCT00379769|529563080|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
146834346|NCT00379769|529563081|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
146834347|NCT00379769|529563082|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
146834348|NCT00379769|529563083|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
146834349|NCT00379769|529563084|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
146834350|NCT00379769|529563085|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
146834351|NCT00379769|529563080|FG000|Observational Follow-up|Physician Decision|0|||
146834352|NCT00379769|529563081|FG001|Observational Follow-up|Physician Decision|0|||
146834353|NCT00379769|529563082|FG002|Observational Follow-up|Physician Decision|0|||
146834354|NCT00379769|529563083|FG003|Observational Follow-up|Physician Decision|0|||
146834355|NCT00379769|529563084|FG004|Observational Follow-up|Physician Decision|8|||
146834356|NCT00379769|529563085|FG005|Observational Follow-up|Physician Decision|8|||
146834357|NCT00379769|529563080|FG000|Observational Follow-up|Site Closed Early|0|||
146834358|NCT00379769|529563081|FG001|Observational Follow-up|Site Closed Early|0|||
146834359|NCT00379769|529563082|FG002|Observational Follow-up|Site Closed Early|0|||
146834360|NCT00379769|529563083|FG003|Observational Follow-up|Site Closed Early|0|||
146834361|NCT00379769|529563084|FG004|Observational Follow-up|Site Closed Early|6|||
146834362|NCT00379769|529563085|FG005|Observational Follow-up|Site Closed Early|7|||
146834363|NCT00379769|529563080|FG000|Observational Follow-up|Participant Moved|0|||
146834364|NCT00379769|529563081|FG001|Observational Follow-up|Participant Moved|0|||
146834365|NCT00379769|529563082|FG002|Observational Follow-up|Participant Moved|0|||
146834366|NCT00379769|529563083|FG003|Observational Follow-up|Participant Moved|0|||
146834367|NCT00379769|529563084|FG004|Observational Follow-up|Participant Moved|0|||
146834368|NCT00379769|529563085|FG005|Observational Follow-up|Participant Moved|1|||
146834369|NCT00379769|529563080|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
146834370|NCT00379769|529563081|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
146834371|NCT00379769|529563082|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
146834372|NCT00379769|529563083|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
146834373|NCT00379769|529563084|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
146834374|NCT00379769|529563085|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
146834375|NCT03778294|529563086|FG000|Overall Study|Death|1|||
146834376|NCT03778294|529563086|FG000|Overall Study|Issues with insurance|1|||
146834377|NCT03778294|529563086|FG000|Overall Study|disease progression before treatment|2|||
146834378|NCT02825251|529563087|FG000|Overall Study|Adverse Event|0|||
146834379|NCT02825251|529563088|FG001|Overall Study|Adverse Event|1|||
146834380|NCT02825251|529563087|FG000|Overall Study|Lost to Follow-up|0|||
146834381|NCT02825251|529563088|FG001|Overall Study|Lost to Follow-up|1|||
146834382|NCT02825251|529563087|FG000|Overall Study|Withdrawal by Subject|1|||
146834383|NCT02825251|529563088|FG001|Overall Study|Withdrawal by Subject|4|||
146834384|NCT02825251|529563087|FG000|Overall Study|Unclassified|2|||
146834385|NCT02825251|529563088|FG001|Overall Study|Unclassified|0|||
146834386|NCT01689363|529563097|FG000|Overall Study|Protocol Violation|0|||
146834387|NCT01689363|529563098|FG001|Overall Study|Protocol Violation|1|||
146834388|NCT01689363|529563099|FG002|Overall Study|Protocol Violation|0|||
146834389|NCT01689363|529563100|FG003|Overall Study|Protocol Violation|0|||
146834390|NCT01689363|529563101|FG004|Overall Study|Protocol Violation|0|||
146834391|NCT01689363|529563102|FG005|Overall Study|Protocol Violation|0|||
146834392|NCT01689363|529563103|FG006|Overall Study|Protocol Violation|0|||
146834393|NCT01689363|529563104|FG007|Overall Study|Protocol Violation|0|||
146834394|NCT02104505|529563105|FG000|First Intervention (14 Days)|Adverse Event|2|||
146834395|NCT02104505|529563106|FG001|First Intervention (14 Days)|Adverse Event|0|||
146834396|NCT02104505|529563105|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
146834397|NCT02104505|529563106|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
146989494|NCT00788957|530124767|FG004|Part 1|Death|0|||
146989495|NCT00788957|530124768|FG005|Part 1|Death|0|||
146834398|NCT02104505|529563105|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
146834399|NCT02104505|529563106|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
146834400|NCT02104505|529563105|FG000|First Intervention (14 Days)|exclusionary condition|0|||
146989496|NCT00788957|530124763|FG000|Part 1|Lost to Follow-up|1|||
146834401|NCT02104505|529563106|FG001|First Intervention (14 Days)|exclusionary condition|1|||
146834402|NCT02104505|529563105|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
146834403|NCT02104505|529563106|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
146834404|NCT02104505|529563105|FG000|Second Intervention (14 Days)|Adverse Event|2|||
146834405|NCT02104505|529563106|FG001|Second Intervention (14 Days)|Adverse Event|0|||
146989497|NCT00788957|530124764|FG001|Part 1|Lost to Follow-up|0|||
146989498|NCT00788957|530124765|FG002|Part 1|Lost to Follow-up|0|||
146834406|NCT01845805|529563107|FG000|Overall Study|Withdrawal by Subject|1|||
146834407|NCT01845805|529563108|FG001|Overall Study|Withdrawal by Subject|2|||
146834408|NCT01845805|529563107|FG000|Overall Study|Disease Progression|13|||
146834409|NCT01845805|529563108|FG001|Overall Study|Disease Progression|14|||
146834410|NCT01845805|529563107|FG000|Overall Study|Drug-related Toxicity|4|||
146834411|NCT01845805|529563108|FG001|Overall Study|Drug-related Toxicity|0|||
146834412|NCT02859064|529563109|FG000|Overall Study|Progressive Disease|3|||
146834413|NCT02859064|529563109|FG000|Overall Study|Physician Decision|1|||
146834414|NCT02859064|529563109|FG000|Overall Study|Withdrawal by Subject|1|||
146834415|NCT02859064|529563109|FG000|Overall Study|Death|1|||
146834416|NCT00127842|529563110|FG000|Overall Study|Adverse Event|15|||
146834417|NCT00127842|529563110|FG000|Overall Study|Withdrawal by Subject|3|||
146834418|NCT00127842|529563110|FG000|Overall Study|Lost to Follow-up|1|||
146834419|NCT00127842|529563110|FG000|Overall Study|Lack of Efficacy|12|||
146834420|NCT00127842|529563110|FG000|Overall Study|Noncompliance|2|||
146834421|NCT00127842|529563110|FG000|Overall Study|Protocol Violation|1|||
146834422|NCT00127842|529563110|FG000|Overall Study|Other|5|||
146834423|NCT01730950|529563111|FG000|Overall Study|Protocol Violation|6|||
146834424|NCT01730950|529563112|FG001|Overall Study|Protocol Violation|6|||
146834425|NCT03023722|529563113|FG000|Overall Study|No follow-up assessment|4|||
146834426|NCT00667459|529563114|FG000|Overall Study|Death|0|||
146834427|NCT00667459|529563115|FG001|Overall Study|Death|2|||
146834428|NCT00667459|529563114|FG000|Overall Study|Lost to Follow-up|8|||
146834429|NCT00667459|529563115|FG001|Overall Study|Lost to Follow-up|43|||
146834430|NCT03616964|529563116|FG000|Overall Study|Adverse Event|15|||
146834431|NCT03616964|529563117|FG001|Overall Study|Adverse Event|10|||
146834432|NCT03616964|529563118|FG002|Overall Study|Adverse Event|16|||
146834433|NCT03616964|529563116|FG000|Overall Study|Death|3|||
146834434|NCT03616964|529563117|FG001|Overall Study|Death|0|||
146834435|NCT03616964|529563118|FG002|Overall Study|Death|4|||
146834436|NCT03616964|529563116|FG000|Overall Study|Lack of Efficacy|4|||
146834437|NCT03616964|529563117|FG001|Overall Study|Lack of Efficacy|8|||
146834438|NCT03616964|529563118|FG002|Overall Study|Lack of Efficacy|8|||
146834439|NCT03616964|529563116|FG000|Overall Study|Lost to Follow-up|2|||
146834440|NCT03616964|529563117|FG001|Overall Study|Lost to Follow-up|1|||
146834441|NCT03616964|529563118|FG002|Overall Study|Lost to Follow-up|3|||
146834442|NCT03616964|529563116|FG000|Overall Study|Withdrawal by Subject|18|||
146834443|NCT03616964|529563117|FG001|Overall Study|Withdrawal by Subject|14|||
146834444|NCT03616964|529563118|FG002|Overall Study|Withdrawal by Subject|21|||
146834445|NCT03616964|529563116|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
146834446|NCT03616964|529563117|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
146834447|NCT03616964|529563118|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
146834448|NCT03616964|529563116|FG000|Overall Study|Sponsor's Decision|1|||
146834449|NCT03616964|529563117|FG001|Overall Study|Sponsor's Decision|0|||
146834450|NCT03616964|529563118|FG002|Overall Study|Sponsor's Decision|0|||
146834451|NCT03616964|529563116|FG000|Overall Study|Physician Decision|0|||
146834452|NCT03616964|529563117|FG001|Overall Study|Physician Decision|2|||
146834453|NCT03616964|529563118|FG002|Overall Study|Physician Decision|0|||
146834454|NCT03616964|529563116|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
146834455|NCT03616964|529563117|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
146834456|NCT03616964|529563118|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
146834457|NCT03616964|529563116|FG000|Overall Study|Protocol Violation|0|||
146834458|NCT03616964|529563117|FG001|Overall Study|Protocol Violation|1|||
146834459|NCT03616964|529563118|FG002|Overall Study|Protocol Violation|0|||
146834460|NCT03616964|529563116|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
146834461|NCT03616964|529563117|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
146834462|NCT03616964|529563118|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
146834463|NCT03616964|529563116|FG000|Overall Study|Randomized but Never Treated|1|||
146834464|NCT03616964|529563117|FG001|Overall Study|Randomized but Never Treated|1|||
146834465|NCT03616964|529563118|FG002|Overall Study|Randomized but Never Treated|1|||
146834466|NCT02568397|529563119|FG000|Period 2|Withdrawal by Subject|0|||
146834467|NCT02568397|529563120|FG001|Period 2|Withdrawal by Subject|1|||
146834468|NCT02568397|529563119|FG000|Period 2|Physician Decision|0|||
146834469|NCT02568397|529563120|FG001|Period 2|Physician Decision|1|||
146834470|NCT01385748|529563121|FG000|Overall Study|Withdrawal by Subject|7|||
146834471|NCT01385748|529563122|FG001|Overall Study|Withdrawal by Subject|4|||
146834472|NCT01385748|529563123|FG002|Overall Study|Withdrawal by Subject|5|||
146834473|NCT01385748|529563121|FG000|Overall Study|Noncompliance|3|||
146834474|NCT01385748|529563122|FG001|Overall Study|Noncompliance|1|||
146834475|NCT01385748|529563123|FG002|Overall Study|Noncompliance|6|||
146834476|NCT01385748|529563121|FG000|Overall Study|Other|1|||
146834477|NCT01385748|529563122|FG001|Overall Study|Other|7|||
146834478|NCT01385748|529563123|FG002|Overall Study|Other|1|||
146834479|NCT01385748|529563121|FG000|Overall Study|Adverse Event|4|||
146834480|NCT01385748|529563122|FG001|Overall Study|Adverse Event|2|||
146834481|NCT01385748|529563123|FG002|Overall Study|Adverse Event|1|||
146834482|NCT02354651|529563124|FG000|Overall Study|Withdrawal by Subject|2|||
146834483|NCT02354651|529563124|FG000|Overall Study|Physician Decision|1|||
146834484|NCT00581893|529563125|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
146834485|NCT00581893|529563126|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
146834486|NCT00590564|529563127|FG000|Overall Study|Withdrawal by Subject|4|||
146834487|NCT00590564|529563127|FG000|Overall Study|Lost to Follow-up|6|||
146834488|NCT00590564|529563127|FG000|Overall Study|Protocol Violation|1|||
146834489|NCT00590564|529563127|FG000|Overall Study|Patient Found to be Ineligible|1|||
146834490|NCT00590564|529563127|FG000|Overall Study|Patient Non-compliance|6|||
146834491|NCT01377389|529563130|FG000|Overall Study|Withdrawal by Subject|1|||
146834492|NCT01377389|529563130|FG000|Overall Study|Screen failure|2|||
146834493|NCT01434680|529563137|FG000|Overall Study|Withdrawal by Subject|1|||
146834494|NCT01434680|529563138|FG001|Overall Study|Withdrawal by Subject|0|||
146834495|NCT01434680|529563139|FG002|Overall Study|Withdrawal by Subject|2|||
146834496|NCT01434680|529563140|FG003|Overall Study|Withdrawal by Subject|0|||
146834497|NCT01434680|529563137|FG000|Overall Study|Lost to Follow-up|1|||
146834498|NCT01434680|529563138|FG001|Overall Study|Lost to Follow-up|1|||
146834499|NCT01434680|529563139|FG002|Overall Study|Lost to Follow-up|0|||
146834500|NCT01434680|529563140|FG003|Overall Study|Lost to Follow-up|0|||
146834501|NCT01434680|529563137|FG000|Overall Study|Protocol Violation|1|||
146834502|NCT01434680|529563138|FG001|Overall Study|Protocol Violation|1|||
146834503|NCT01434680|529563139|FG002|Overall Study|Protocol Violation|0|||
146834504|NCT01434680|529563140|FG003|Overall Study|Protocol Violation|0|||
146834505|NCT00725712|529563142|FG000|Overall Study|Withdrawal by Subject|2|||
146834506|NCT00725712|529563143|FG001|Overall Study|Withdrawal by Subject|1|||
146834507|NCT00725712|529563142|FG000|Overall Study|Protocol Violation|1|||
146834508|NCT00725712|529563143|FG001|Overall Study|Protocol Violation|0|||
146834509|NCT00725712|529563142|FG000|Overall Study|Progressive disease|37|||
146834510|NCT00725712|529563143|FG001|Overall Study|Progressive disease|16|||
146834511|NCT00725712|529563142|FG000|Overall Study|Clinical progression not based on RECIST|0|||
146834512|NCT00725712|529563143|FG001|Overall Study|Clinical progression not based on RECIST|3|||
146834513|NCT00725712|529563142|FG000|Overall Study|Adverse Event|5|||
146834514|NCT00725712|529563143|FG001|Overall Study|Adverse Event|5|||
146834515|NCT00725712|529563142|FG000|Overall Study|Death|2|||
146834516|NCT00725712|529563143|FG001|Overall Study|Death|0|||
146834517|NCT00725712|529563142|FG000|Overall Study|Other: Death|1|||
146834518|NCT00725712|529563143|FG001|Overall Study|Other: Death|0|||
146834519|NCT00725712|529563142|FG000|Overall Study|Hospitalized, unable to continue|0|||
146834520|NCT00725712|529563143|FG001|Overall Study|Hospitalized, unable to continue|1|||
146834521|NCT02684123|529563147|FG000|Phase 1|Lack of Efficacy|5|||
146834522|NCT02684123|529563148|FG001|Phase 1|Lack of Efficacy|0|||
146834523|NCT02684123|529563147|FG000|Phase 1|Adverse Event|3|||
146834524|NCT02684123|529563148|FG001|Phase 1|Adverse Event|0|||
146834525|NCT02684123|529563147|FG000|Phase 1|Lost to Follow-up|0|||
146834526|NCT02684123|529563148|FG001|Phase 1|Lost to Follow-up|1|||
146834527|NCT02684123|529563147|FG000|Phase 2|Lack of Efficacy|1|||
146834528|NCT02684123|529563148|FG001|Phase 2|Lack of Efficacy|8|||
146989499|NCT00788957|530124766|FG003|Part 1|Lost to Follow-up|0|||
146989500|NCT00788957|530124767|FG004|Part 1|Lost to Follow-up|0|||
146989501|NCT00788957|530124768|FG005|Part 1|Lost to Follow-up|0|||
146989502|NCT00788957|530124763|FG000|Part 2|Withdrawal by Subject|0|||
146989503|NCT00788957|530124764|FG001|Part 2|Withdrawal by Subject|9|||
146989504|NCT00788957|530124765|FG002|Part 2|Withdrawal by Subject|5|||
146989505|NCT00788957|530124766|FG003|Part 2|Withdrawal by Subject|3|||
146989506|NCT00788957|530124767|FG004|Part 2|Withdrawal by Subject|0|||
146989507|NCT00788957|530124768|FG005|Part 2|Withdrawal by Subject|0|||
146989508|NCT00788957|530124763|FG000|Part 2|Death|0|||
146989509|NCT00788957|530124764|FG001|Part 2|Death|32|||
146989510|NCT00788957|530124765|FG002|Part 2|Death|35|||
146989511|NCT00788957|530124766|FG003|Part 2|Death|37|||
146989512|NCT00788957|530124767|FG004|Part 2|Death|0|||
146989513|NCT00788957|530124768|FG005|Part 2|Death|0|||
146989514|NCT00788957|530124763|FG000|Part 2|Lost to Follow-up|0|||
146989515|NCT00788957|530124764|FG001|Part 2|Lost to Follow-up|0|||
146989516|NCT00788957|530124765|FG002|Part 2|Lost to Follow-up|3|||
146989517|NCT00788957|530124766|FG003|Part 2|Lost to Follow-up|0|||
146989518|NCT00788957|530124767|FG004|Part 2|Lost to Follow-up|0|||
146989519|NCT00788957|530124768|FG005|Part 2|Lost to Follow-up|0|||
146989520|NCT00788957|530124763|FG000|Part 2|On-study at time of data cut-off|0|||
146989521|NCT00788957|530124764|FG001|Part 2|On-study at time of data cut-off|1|||
146989522|NCT00788957|530124765|FG002|Part 2|On-study at time of data cut-off|1|||
146834529|NCT02037477|529563154|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
146834530|NCT02037477|529563155|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
146834531|NCT02037477|529563156|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
146834532|NCT02037477|529563157|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
146834533|NCT00983749|529563158|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
146834534|NCT00983749|529563159|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
146834535|NCT05765435|529563160|FG000|Overall Study|Lost to Follow-up|0|||
146834536|NCT05765435|529563161|FG001|Overall Study|Lost to Follow-up|1|||
146834537|NCT05765435|529563162|FG002|Overall Study|Lost to Follow-up|0|||
146989523|NCT00788957|530124766|FG003|Part 2|On-study at time of data cut-off|1|||
146989524|NCT00788957|530124767|FG004|Part 2|On-study at time of data cut-off|0|||
146989525|NCT00788957|530124768|FG005|Part 2|On-study at time of data cut-off|0|||
146989526|NCT00788957|530124763|FG000|Part 3|Withdrawal by Subject|0|||
146989527|NCT00788957|530124764|FG001|Part 3|Withdrawal by Subject|0|||
146989528|NCT00788957|530124765|FG002|Part 3|Withdrawal by Subject|0|||
146989529|NCT00788957|530124766|FG003|Part 3|Withdrawal by Subject|0|||
146989530|NCT00788957|530124767|FG004|Part 3|Withdrawal by Subject|0|||
146989531|NCT00788957|530124768|FG005|Part 3|Withdrawal by Subject|2|||
146989532|NCT00788957|530124763|FG000|Part 3|Death|0|||
146989533|NCT00788957|530124764|FG001|Part 3|Death|0|||
146989534|NCT00788957|530124765|FG002|Part 3|Death|0|||
146989535|NCT00788957|530124766|FG003|Part 3|Death|0|||
146989536|NCT00788957|530124767|FG004|Part 3|Death|8|||
146989537|NCT00788957|530124768|FG005|Part 3|Death|8|||
146989538|NCT00788957|530124763|FG000|Part 3|On-study at time of data cut-off|0|||
146989539|NCT00788957|530124764|FG001|Part 3|On-study at time of data cut-off|0|||
146989540|NCT00788957|530124765|FG002|Part 3|On-study at time of data cut-off|0|||
146989541|NCT00788957|530124766|FG003|Part 3|On-study at time of data cut-off|0|||
146989542|NCT00788957|530124767|FG004|Part 3|On-study at time of data cut-off|1|||
146989543|NCT00788957|530124768|FG005|Part 3|On-study at time of data cut-off|0|||
146989544|NCT02579096|530124771|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
146989545|NCT02579096|530124772|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
146989546|NCT02579096|530124771|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
146989547|NCT02579096|530124772|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
146989548|NCT02579096|530124771|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
146989549|NCT02579096|530124772|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
146834538|NCT05765435|529563160|FG000|Overall Study|Withdrawal by Subject|0|||
146834539|NCT05765435|529563161|FG001|Overall Study|Withdrawal by Subject|0|||
146834540|NCT05765435|529563162|FG002|Overall Study|Withdrawal by Subject|1|||
146834541|NCT01952847|529563163|FG000|Overall Study|Ineligible|1|||
146834542|NCT01952847|529563164|FG001|Overall Study|Ineligible|0|||
146834543|NCT01952847|529563165|FG002|Overall Study|Ineligible|0|||
146834544|NCT01952847|529563166|FG003|Overall Study|Ineligible|0|||
146834545|NCT01952847|529563163|FG000|Overall Study|Lack of Insurance Coverage|0|||
146834546|NCT01952847|529563164|FG001|Overall Study|Lack of Insurance Coverage|1|||
146834547|NCT01952847|529563165|FG002|Overall Study|Lack of Insurance Coverage|0|||
146834548|NCT01952847|529563166|FG003|Overall Study|Lack of Insurance Coverage|0|||
146834549|NCT01952847|529563163|FG000|Overall Study|Withdrawal by Subject|1|||
146834550|NCT01952847|529563164|FG001|Overall Study|Withdrawal by Subject|1|||
146989550|NCT02579096|530124771|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
146989551|NCT02579096|530124772|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
146989552|NCT02579096|530124771|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
146989553|NCT02579096|530124772|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
146989554|NCT02579096|530124771|FG000|Phase 2, Weeks 25 - 48|Death|2|||
146989555|NCT02579096|530124772|FG001|Phase 2, Weeks 25 - 48|Death|4|||
146989556|NCT02579096|530124771|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
146989557|NCT02579096|530124772|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
146989558|NCT02579096|530124771|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
146989559|NCT02579096|530124772|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
146989560|NCT02579096|530124771|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
146989561|NCT02579096|530124772|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
146989562|NCT02579096|530124771|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
146989563|NCT02579096|530124772|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
146989564|NCT02579096|530124771|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
146989565|NCT02579096|530124772|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
146989566|NCT02579096|530124771|FG000|Phase 3, Weeks 49 - 72|Death|3|||
146989567|NCT02579096|530124772|FG001|Phase 3, Weeks 49 - 72|Death|2|||
146834551|NCT01952847|529563165|FG002|Overall Study|Withdrawal by Subject|0|||
146834552|NCT01952847|529563166|FG003|Overall Study|Withdrawal by Subject|1|||
146834553|NCT02367352|529563174|FG000|Overall Study|Progressive disease|7|||
146834554|NCT02367352|529563175|FG001|Overall Study|Progressive disease|0|||
146834555|NCT02367352|529563176|FG002|Overall Study|Progressive disease|0|||
146989568|NCT02579096|530124771|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
146989569|NCT02579096|530124772|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
146989570|NCT02579096|530124771|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
146989571|NCT02579096|530124772|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
146989572|NCT02579096|530124771|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
146989573|NCT02579096|530124772|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
146989574|NCT02579096|530124771|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
146989575|NCT02579096|530124772|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
146989576|NCT02579096|530124771|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
146834556|NCT02367352|529563174|FG000|Overall Study|Participant Received Alternative Therapy|1|||
146834557|NCT02367352|529563175|FG001|Overall Study|Participant Received Alternative Therapy|0|||
146834558|NCT02367352|529563176|FG002|Overall Study|Participant Received Alternative Therapy|0|||
146834559|NCT02367352|529563174|FG000|Overall Study|Adverse Event|1|||
146834560|NCT02367352|529563175|FG001|Overall Study|Adverse Event|0|||
146989577|NCT02579096|530124772|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
146989578|NCT02579096|530124771|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
146989579|NCT02579096|530124772|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
146989580|NCT02097121|530124773|FG000|Overall Study|Other, not specified|4|||
146989581|NCT02097121|530124774|FG001|Overall Study|Other, not specified|2|||
146989582|NCT02097121|530124775|FG002|Overall Study|Other, not specified|3|||
146989583|NCT02097121|530124773|FG000|Overall Study|Lack of Efficacy|2|||
146834561|NCT02367352|529563176|FG002|Overall Study|Adverse Event|0|||
146834562|NCT01437423|529563177|FG000|Overall Study|Lost to Follow-up|12|||
146834563|NCT01437423|529563177|FG000|Overall Study|Off label usage|3|||
146834564|NCT05878873|529563178|FG000|Overall Study|Lost to Follow-up|2|||
146834565|NCT05878873|529563179|FG001|Overall Study|Lost to Follow-up|0|||
146834566|NCT02980523|529563180|FG000|Overall Study|Lost to Follow-up|1|||
146834567|NCT02980523|529563181|FG001|Overall Study|Lost to Follow-up|4|||
146834568|NCT02980523|529563182|FG002|Overall Study|Lost to Follow-up|1|||
146834569|NCT02980523|529563183|FG003|Overall Study|Lost to Follow-up|2|||
146834570|NCT02980523|529563184|FG004|Overall Study|Lost to Follow-up|1|||
146989584|NCT02097121|530124774|FG001|Overall Study|Lack of Efficacy|1|||
146989585|NCT02097121|530124775|FG002|Overall Study|Lack of Efficacy|3|||
146989586|NCT02097121|530124773|FG000|Overall Study|Withdrawal by Subject|0|||
146989587|NCT02097121|530124774|FG001|Overall Study|Withdrawal by Subject|1|||
146989588|NCT02097121|530124775|FG002|Overall Study|Withdrawal by Subject|2|||
146989589|NCT02097121|530124773|FG000|Overall Study|Adverse Event|0|||
146989590|NCT02097121|530124774|FG001|Overall Study|Adverse Event|1|||
146989591|NCT02097121|530124775|FG002|Overall Study|Adverse Event|0|||
146989592|NCT02097121|530124773|FG000|Overall Study|Lost to Follow-up|1|||
146989593|NCT02097121|530124774|FG001|Overall Study|Lost to Follow-up|1|||
146989594|NCT02097121|530124775|FG002|Overall Study|Lost to Follow-up|2|||
146989595|NCT03066999|530124776|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
146989596|NCT03066999|530124777|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
146989597|NCT00661999|530124778|FG000|Overall Study|Adverse Event|11|||
146989598|NCT00661999|530124779|FG001|Overall Study|Adverse Event|5|||
146989599|NCT00661999|530124780|FG002|Overall Study|Adverse Event|8|||
146989600|NCT00661999|530124778|FG000|Overall Study|Death|8|||
146989601|NCT00661999|530124779|FG001|Overall Study|Death|6|||
146989602|NCT00661999|530124780|FG002|Overall Study|Death|3|||
146989603|NCT00661999|530124778|FG000|Overall Study|Other Reasons|5|||
146989604|NCT00661999|530124779|FG001|Overall Study|Other Reasons|12|||
146989605|NCT00661999|530124780|FG002|Overall Study|Other Reasons|23|||
146989606|NCT00661999|530124778|FG000|Overall Study|Withdrawal by Subject|30|||
146989607|NCT00661999|530124779|FG001|Overall Study|Withdrawal by Subject|23|||
146989608|NCT00661999|530124780|FG002|Overall Study|Withdrawal by Subject|14|||
146989609|NCT00661999|530124778|FG000|Overall Study|Alternative Treatment|1|||
146989610|NCT00661999|530124779|FG001|Overall Study|Alternative Treatment|0|||
146989611|NCT00661999|530124780|FG002|Overall Study|Alternative Treatment|0|||
146989612|NCT00661999|530124778|FG000|Overall Study|Other Medical Problems|4|||
146989613|NCT00661999|530124779|FG001|Overall Study|Other Medical Problems|4|||
146989614|NCT00661999|530124780|FG002|Overall Study|Other Medical Problems|9|||
146989615|NCT01790568|530124781|FG000|Overall Study|Progression prior to transplant|0|||
146989616|NCT01790568|530124782|FG001|Overall Study|Progression prior to transplant|1|||
146989617|NCT01361126|530124783|FG000|Overall Study|Sponsor decision|0|||
146989618|NCT01361126|530124784|FG001|Overall Study|Sponsor decision|2|||
146989619|NCT02994056|530124785|FG000|Overall Study|Death|8|||
146989620|NCT02994056|530124785|FG000|Overall Study|Withdrew Consent|1|||
146989621|NCT02742181|530124786|FG000|Overall Study|Physician Decision|1|||
146989622|NCT02742181|530124787|FG001|Overall Study|Physician Decision|0|||
146989623|NCT01346410|530124788|FG000|Overall Study|Death|1|||
146989624|NCT02576990|530124789|FG000|Overall Study|Death|29|||
146989625|NCT02576990|530124790|FG001|Overall Study|Death|18|||
146989626|NCT02576990|530124789|FG000|Overall Study|Physician Decision|1|||
146989627|NCT02576990|530124790|FG001|Overall Study|Physician Decision|0|||
146989628|NCT02576990|530124789|FG000|Overall Study|Screen failure|2|||
146989629|NCT02576990|530124790|FG001|Overall Study|Screen failure|0|||
146989630|NCT02576990|530124789|FG000|Overall Study|Sponsor's decision|24|||
146989631|NCT02576990|530124790|FG001|Overall Study|Sponsor's decision|4|||
146989632|NCT02576990|530124789|FG000|Overall Study|Withdrawal by Subject|0|||
146989633|NCT02576990|530124790|FG001|Overall Study|Withdrawal by Subject|2|||
146989634|NCT01508936|530124792|FG000|Overall Study|Adverse Event|11|||
146989635|NCT01508936|530124793|FG001|Overall Study|Adverse Event|32|||
146989636|NCT01508936|530124792|FG000|Overall Study|Lack of Efficacy|0|||
146989637|NCT01508936|530124793|FG001|Overall Study|Lack of Efficacy|1|||
146989638|NCT01508936|530124792|FG000|Overall Study|Withdrawal by Subject|4|||
146989639|NCT01508936|530124793|FG001|Overall Study|Withdrawal by Subject|18|||
146834571|NCT02980523|529563180|FG000|Overall Study|Excluded from analysis|1|||
146834572|NCT02980523|529563181|FG001|Overall Study|Excluded from analysis|3|||
146834573|NCT02980523|529563182|FG002|Overall Study|Excluded from analysis|1|||
146989640|NCT01508936|530124792|FG000|Overall Study|Protocol Violation|2|||
146989641|NCT01508936|530124793|FG001|Overall Study|Protocol Violation|3|||
146834574|NCT02980523|529563183|FG003|Overall Study|Excluded from analysis|1|||
146834575|NCT02980523|529563184|FG004|Overall Study|Excluded from analysis|1|||
146834576|NCT02980523|529563180|FG000|Overall Study|Lack of Efficacy|1|||
146834577|NCT02980523|529563181|FG001|Overall Study|Lack of Efficacy|4|||
146834578|NCT02980523|529563182|FG002|Overall Study|Lack of Efficacy|4|||
146834579|NCT02980523|529563183|FG003|Overall Study|Lack of Efficacy|5|||
146834580|NCT02980523|529563184|FG004|Overall Study|Lack of Efficacy|8|||
146834581|NCT02980523|529563180|FG000|Overall Study|Did not receive intervention|0|||
146834582|NCT02980523|529563181|FG001|Overall Study|Did not receive intervention|0|||
146834583|NCT02980523|529563182|FG002|Overall Study|Did not receive intervention|0|||
146834584|NCT02980523|529563183|FG003|Overall Study|Did not receive intervention|1|||
146834585|NCT02980523|529563184|FG004|Overall Study|Did not receive intervention|0|||
146834586|NCT00633945|529563185|FG000|Overall Study|Physician Decision|2|||
146834587|NCT02552147|529563186|FG000|First Intervention (7 Days)|Protocol Violation|1|||
146834588|NCT02552147|529563187|FG001|First Intervention (7 Days)|Protocol Violation|0|||
146834589|NCT02552147|529563186|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
146834590|NCT02552147|529563187|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
146834591|NCT01790295|529563188|FG000|Overall Study|Adverse Event|1|||
146834592|NCT01790295|529563188|FG000|Overall Study|Death|4|||
146834593|NCT01790295|529563188|FG000|Overall Study|Lack of Efficacy|2|||
146834594|NCT01790295|529563188|FG000|Overall Study|Study closure|4|||
146834595|NCT01318876|529563192|FG000|Day 8 Survey|email address invalid|96|||
146834596|NCT01318876|529563192|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
146834597|NCT01318876|529563192|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
146834598|NCT00443209|529563193|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
146834599|NCT00443209|529563194|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
146834600|NCT00443209|529563193|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
146834601|NCT00443209|529563194|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
146834602|NCT00443209|529563193|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
146834603|NCT00443209|529563194|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
146834604|NCT00443209|529563193|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
146834605|NCT00443209|529563194|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
146834606|NCT00443209|529563193|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
146834607|NCT00443209|529563194|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
146834608|NCT00443209|529563193|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
146834609|NCT00443209|529563194|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
146834610|NCT00443209|529563193|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
146834611|NCT00443209|529563194|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
146834612|NCT00443209|529563193|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
146834613|NCT00443209|529563194|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
146834614|NCT00443209|529563193|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
146834615|NCT00443209|529563194|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
146834616|NCT00443209|529563193|FG000|Months 1 to 12 Treatment Period|Missing|2|||
146834617|NCT00443209|529563194|FG001|Months 1 to 12 Treatment Period|Missing|1|||
146834618|NCT00443209|529563193|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
146834619|NCT00443209|529563194|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
146834620|NCT00443209|529563193|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
146834621|NCT00443209|529563194|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
146834622|NCT00443209|529563193|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
146834623|NCT00443209|529563194|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
146834624|NCT00443209|529563193|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
146834625|NCT00443209|529563194|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
146834626|NCT00443209|529563193|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
146834627|NCT00443209|529563194|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
146834628|NCT00443209|529563193|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
146834629|NCT00443209|529563194|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
146834630|NCT00443209|529563193|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
146834631|NCT00443209|529563194|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
146834632|NCT04016272|529563201|FG000|Overall Study|Withdrawal by Subject|1|||
146834633|NCT04016272|529563202|FG001|Overall Study|Withdrawal by Subject|2|||
146834634|NCT00825305|529563203|FG000|Overall Study|Adverse Event|1|||
146834635|NCT00825305|529563204|FG001|Overall Study|Adverse Event|1|||
146834636|NCT00825305|529563203|FG000|Overall Study|Withdrawal by Subject|6|||
146834637|NCT00825305|529563204|FG001|Overall Study|Withdrawal by Subject|12|||
146834638|NCT00825305|529563203|FG000|Overall Study|Inappropriate inclusion|1|||
146834639|NCT00825305|529563204|FG001|Overall Study|Inappropriate inclusion|0|||
146834640|NCT00825305|529563203|FG000|Overall Study|Protocol Violation|9|||
146834641|NCT00825305|529563204|FG001|Overall Study|Protocol Violation|9|||
146834642|NCT00825305|529563203|FG000|Overall Study|Can not be classified|0|||
146834643|NCT00825305|529563204|FG001|Overall Study|Can not be classified|1|||
146834644|NCT00246090|529563209|FG000|Overall Study|Adverse Event|25|||
146834645|NCT00246090|529563209|FG000|Overall Study|Withdrawal by Subject|7|||
146834646|NCT00246090|529563209|FG000|Overall Study|Progressive Disease|212|||
146834647|NCT00246090|529563209|FG000|Overall Study|Clinical Progression|30|||
146834648|NCT00246090|529563209|FG000|Overall Study|Physician Decision|11|||
146834649|NCT00246090|529563209|FG000|Overall Study|Not Otherwise Specified|10|||
146834650|NCT01827046|529563210|FG000|Overall Study|Lost to Follow-up|1|||
146834651|NCT01827046|529563211|FG001|Overall Study|Lost to Follow-up|5|||
146834652|NCT01827046|529563210|FG000|Overall Study|Withdrawal by Subject|0|||
146834653|NCT01827046|529563211|FG001|Overall Study|Withdrawal by Subject|4|||
146834654|NCT02554383|529563212|FG000|Overall Study|Ineligible|3|||
146834655|NCT02554383|529563213|FG001|Overall Study|Ineligible|2|||
146834656|NCT02554383|529563212|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
146834657|NCT02554383|529563213|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
146834658|NCT02554383|529563212|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
146834659|NCT02554383|529563213|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
146834660|NCT02554383|529563212|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
146834661|NCT02554383|529563213|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
146834662|NCT00715117|529563222|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
146834663|NCT00715117|529563223|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
146834664|NCT02394665|529563227|FG000|Overall Study|Physician Decision|1|||
146834665|NCT02394665|529563228|FG001|Overall Study|Physician Decision|0|||
146834666|NCT02394665|529563229|FG002|Overall Study|Physician Decision|0|||
146834667|NCT01191008|529563230|FG000|Overall Study|Protocol Violation|7|||
146834668|NCT01191008|529563230|FG000|Overall Study|Lost to Follow-up|8|||
146834669|NCT00978562|529563231|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
146834670|NCT02282059|529563236|FG000|Overall Study|Other|15|||
146834671|NCT02282059|529563237|FG001|Overall Study|Other|3|||
146834672|NCT02282059|529563236|FG000|Overall Study|Participant refused further follow-up|8|||
146834673|NCT02282059|529563237|FG001|Overall Study|Participant refused further follow-up|4|||
146834674|NCT02282059|529563236|FG000|Overall Study|Lost to Follow-up|19|||
146834675|NCT02282059|529563237|FG001|Overall Study|Lost to Follow-up|3|||
146834676|NCT02282059|529563236|FG000|Overall Study|Death|40|||
146834677|NCT02282059|529563237|FG001|Overall Study|Death|8|||
146834678|NCT01245140|529564873|FG000|Overall Study|Adverse Event|1|||
146834679|NCT01245140|529564874|FG001|Overall Study|Adverse Event|3|||
146834680|NCT01245140|529564873|FG000|Overall Study|Lack of Efficacy|2|||
146834681|NCT01245140|529564874|FG001|Overall Study|Lack of Efficacy|4|||
146834682|NCT01245140|529564873|FG000|Overall Study|Protocol Violation|0|||
146834683|NCT01245140|529564874|FG001|Overall Study|Protocol Violation|1|||
146834684|NCT01245140|529564873|FG000|Overall Study|Withdrawal by Subject|0|||
146834685|NCT01245140|529564874|FG001|Overall Study|Withdrawal by Subject|1|||
146834686|NCT01245140|529564873|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
146834687|NCT01245140|529564874|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
146834688|NCT02635360|529564875|FG000|Overall Study|Adverse Event|0|||
146834689|NCT02635360|529564876|FG001|Overall Study|Adverse Event|3|||
146834690|NCT02635360|529564875|FG000|Overall Study|Withdrawal by Subject|2|||
146989642|NCT01508936|530124792|FG000|Overall Study|Lost to Follow-up|2|||
146834691|NCT02635360|529564876|FG001|Overall Study|Withdrawal by Subject|0|||
146834692|NCT02635360|529564875|FG000|Overall Study|Non-Compliance|3|||
146834693|NCT02635360|529564876|FG001|Overall Study|Non-Compliance|1|||
146834694|NCT02635360|529564875|FG000|Overall Study|Disease Progression|0|||
146834695|NCT02635360|529564876|FG001|Overall Study|Disease Progression|2|||
146834696|NCT02635360|529564875|FG000|Overall Study|Lost to Follow-up|1|||
146834697|NCT02635360|529564876|FG001|Overall Study|Lost to Follow-up|1|||
146834698|NCT00334542|529564877|FG000|Overall Study|Adverse Event|3|||
146989643|NCT01508936|530124793|FG001|Overall Study|Lost to Follow-up|9|||
146989644|NCT01508936|530124792|FG000|Overall Study|Other|0|||
146989645|NCT01508936|530124793|FG001|Overall Study|Other|5|||
146834699|NCT00334542|529564877|FG000|Overall Study|Withdrawal by Subject|1|||
146834700|NCT00334542|529564877|FG000|Overall Study|New cancer diagnosis|1|||
146834701|NCT01454739|529564882|FG000|Overall Study|Protocol Violation|2|||
146834702|NCT01454739|529564883|FG001|Overall Study|Protocol Violation|3|||
146834703|NCT01454739|529564882|FG000|Overall Study|Withdrawal by Subject|2|||
146834704|NCT01454739|529564883|FG001|Overall Study|Withdrawal by Subject|6|||
146989646|NCT01508936|530124792|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
146834705|NCT01454739|529564882|FG000|Overall Study|Other|3|||
146834706|NCT01454739|529564883|FG001|Overall Study|Other|5|||
146834707|NCT01454739|529564882|FG000|Overall Study|Physician Decision|0|||
146834708|NCT01454739|529564883|FG001|Overall Study|Physician Decision|5|||
146834709|NCT01454739|529564882|FG000|Overall Study|Lost to Follow-up|0|||
146834710|NCT01454739|529564883|FG001|Overall Study|Lost to Follow-up|1|||
146834711|NCT01454739|529564882|FG000|Overall Study|Adverse Event|0|||
146834712|NCT01454739|529564883|FG001|Overall Study|Adverse Event|1|||
146989647|NCT01508936|530124793|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
146834713|NCT01375751|529564884|FG000|Overall Study|Other|0|||
146834714|NCT01375751|529564885|FG001|Overall Study|Other|1|||
146989648|NCT00679367|530124794|FG000|Overall Study|Adverse Event|7|||
146834715|NCT01375751|529564886|FG002|Overall Study|Other|0|||
146834716|NCT02375347|529564888|FG000|Overall Study|Protocol Violation|1|||
146834717|NCT00193479|529564889|FG000|Induction Chemotherapy|Adverse Event|2|||
146834718|NCT00193479|529564889|FG000|Induction Chemotherapy|Disease Progression|1|||
146834719|NCT00193479|529564889|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
146834720|NCT00193479|529564889|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
146834721|NCT00559377|529564890|FG000|Overall Study|Withdrawal by Subject|9|||
146834722|NCT02229227|529564897|FG000|Overall Study|Adverse Event|14|||
146834723|NCT02229227|529564898|FG001|Overall Study|Adverse Event|9|||
146834724|NCT02229227|529564897|FG000|Overall Study|Lack of Efficacy|3|||
146834725|NCT02229227|529564898|FG001|Overall Study|Lack of Efficacy|3|||
146834726|NCT02229227|529564897|FG000|Overall Study|Protocol Violation|6|||
146834727|NCT02229227|529564898|FG001|Overall Study|Protocol Violation|8|||
146834728|NCT02229227|529564897|FG000|Overall Study|Protocol defined stopping criteria|1|||
146834729|NCT02229227|529564898|FG001|Overall Study|Protocol defined stopping criteria|3|||
146834730|NCT02229227|529564897|FG000|Overall Study|Lost to Follow-up|3|||
146834731|NCT02229227|529564898|FG001|Overall Study|Lost to Follow-up|3|||
146834732|NCT02229227|529564897|FG000|Overall Study|Study terminated by sponsor|11|||
146834733|NCT02229227|529564898|FG001|Overall Study|Study terminated by sponsor|11|||
146834734|NCT02229227|529564897|FG000|Overall Study|Withdrawal by Subject|8|||
146834735|NCT02229227|529564898|FG001|Overall Study|Withdrawal by Subject|12|||
146834736|NCT02229227|529564897|FG000|Overall Study|Other|0|||
146834737|NCT02229227|529564898|FG001|Overall Study|Other|1|||
146834738|NCT02229227|529564897|FG000|Overall Study|Physician Decision|5|||
146834739|NCT02229227|529564898|FG001|Overall Study|Physician Decision|12|||
146834740|NCT00872001|529564901|FG000|Overall Study|Adverse Event|34|||
146834741|NCT00872001|529564902|FG001|Overall Study|Adverse Event|23|||
146834742|NCT00872001|529564901|FG000|Overall Study|Protocol Defined Clinical Event|5|||
146834743|NCT00872001|529564902|FG001|Overall Study|Protocol Defined Clinical Event|7|||
146834744|NCT00872001|529564901|FG000|Overall Study|Lost to Follow-up|13|||
146834745|NCT00872001|529564902|FG001|Overall Study|Lost to Follow-up|12|||
146834746|NCT00872001|529564901|FG000|Overall Study|Withdrawal by Subject|18|||
146834747|NCT00872001|529564902|FG001|Overall Study|Withdrawal by Subject|30|||
146834748|NCT00872001|529564901|FG000|Overall Study|Protocol Violation|5|||
146834749|NCT00872001|529564902|FG001|Overall Study|Protocol Violation|8|||
146834750|NCT00872001|529564901|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
146834751|NCT00872001|529564902|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
146834752|NCT00872001|529564901|FG000|Overall Study|Administrative|23|||
146834753|NCT00872001|529564902|FG001|Overall Study|Administrative|15|||
146834754|NCT01453023|529564903|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
146834755|NCT01453023|529564904|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
146834756|NCT01453023|529564903|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
146834757|NCT01453023|529564904|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
146834758|NCT01453023|529564903|FG000|Treatment Period 2|Protocol Violation|0|||
146834759|NCT01453023|529564904|FG001|Treatment Period 2|Protocol Violation|1|||
146834760|NCT04468230|529564908|FG000|Overall Study|Adverse Event|2|||
146834761|NCT00420784|529564911|FG000|Overall Study|Adverse Event|11|||
146834762|NCT00420784|529564912|FG001|Overall Study|Adverse Event|29|||
146834763|NCT00420784|529564913|FG002|Overall Study|Adverse Event|10|||
146834764|NCT00420784|529564914|FG003|Overall Study|Adverse Event|5|||
146834765|NCT00420784|529564911|FG000|Overall Study|Withdrawal by Subject|0|||
146834766|NCT00420784|529564912|FG001|Overall Study|Withdrawal by Subject|1|||
146834767|NCT00420784|529564913|FG002|Overall Study|Withdrawal by Subject|0|||
146834768|NCT00420784|529564914|FG003|Overall Study|Withdrawal by Subject|0|||
146834769|NCT00420784|529564911|FG000|Overall Study|Lost to Follow-up|0|||
146834770|NCT00420784|529564912|FG001|Overall Study|Lost to Follow-up|0|||
146834771|NCT00420784|529564913|FG002|Overall Study|Lost to Follow-up|2|||
146834772|NCT00420784|529564914|FG003|Overall Study|Lost to Follow-up|1|||
146834773|NCT00420784|529564911|FG000|Overall Study|Virologic Stopping Rule|17|||
146834774|NCT00420784|529564912|FG001|Overall Study|Virologic Stopping Rule|26|||
146989649|NCT00679367|530124794|FG000|Overall Study|inability to swallow oral drugs|1|||
146989650|NCT00679367|530124794|FG000|Overall Study|Lack of Efficacy|3|||
146989651|NCT00679367|530124794|FG000|Overall Study|Withdrawal by Subject|1|||
146989652|NCT03365947|530124795|FG000|Overall Study|Lost to Follow-up|0|||
146989653|NCT03365947|530124796|FG001|Overall Study|Lost to Follow-up|0|||
146989654|NCT03365947|530124797|FG002|Overall Study|Lost to Follow-up|0|||
146989655|NCT03365947|530124798|FG003|Overall Study|Lost to Follow-up|0|||
146834775|NCT00420784|529564913|FG002|Overall Study|Virologic Stopping Rule|41|||
146834776|NCT00420784|529564914|FG003|Overall Study|Virologic Stopping Rule|67|||
146834777|NCT00420784|529564911|FG000|Overall Study|Other|1|||
146834778|NCT00420784|529564912|FG001|Overall Study|Other|2|||
146834779|NCT00420784|529564913|FG002|Overall Study|Other|0|||
146989656|NCT03365947|530124799|FG004|Overall Study|Lost to Follow-up|0|||
146989657|NCT03365947|530124800|FG005|Overall Study|Lost to Follow-up|1|||
146834780|NCT00420784|529564914|FG003|Overall Study|Other|5|||
146834781|NCT02417441|529564917|FG000|Overall Study|Inconclusive due to missing data|52|||
146834782|NCT02417441|529564918|FG001|Overall Study|Inconclusive due to missing data|19|||
146834783|NCT00983853|529564919|FG000|Overall Study|Lost to Follow-up|1|||
146834784|NCT00983853|529564920|FG001|Overall Study|Lost to Follow-up|1|||
146834785|NCT00983853|529564921|FG002|Overall Study|Lost to Follow-up|2|||
146834786|NCT00983853|529564922|FG003|Overall Study|Lost to Follow-up|2|||
146834787|NCT00983853|529564923|FG004|Overall Study|Lost to Follow-up|2|||
146834788|NCT00983853|529564924|FG005|Overall Study|Lost to Follow-up|1|||
146834789|NCT00983853|529564919|FG000|Overall Study|Withdrawal by Subject|0|||
146834790|NCT00983853|529564920|FG001|Overall Study|Withdrawal by Subject|0|||
146834791|NCT00983853|529564921|FG002|Overall Study|Withdrawal by Subject|1|||
146834792|NCT00983853|529564922|FG003|Overall Study|Withdrawal by Subject|0|||
146834793|NCT00983853|529564923|FG004|Overall Study|Withdrawal by Subject|1|||
146834794|NCT00983853|529564924|FG005|Overall Study|Withdrawal by Subject|0|||
146834795|NCT00983853|529564919|FG000|Overall Study|Unable to come to study follow-up visits|0|||
146834796|NCT00983853|529564920|FG001|Overall Study|Unable to come to study follow-up visits|1|||
146834797|NCT00983853|529564921|FG002|Overall Study|Unable to come to study follow-up visits|0|||
146834798|NCT00983853|529564922|FG003|Overall Study|Unable to come to study follow-up visits|0|||
146834799|NCT00983853|529564923|FG004|Overall Study|Unable to come to study follow-up visits|0|||
146834800|NCT00983853|529564924|FG005|Overall Study|Unable to come to study follow-up visits|0|||
146834801|NCT03016598|529564929|FG000|Overall Study|Lost to Follow-up|0|||
146834802|NCT03016598|529564930|FG001|Overall Study|Lost to Follow-up|2|||
146834803|NCT01667549|529564932|FG000|Overall Study|Withdrawal by Subject|3|||
146834804|NCT01667549|529564933|FG001|Overall Study|Withdrawal by Subject|5|||
146834805|NCT01667549|529564934|FG002|Overall Study|Withdrawal by Subject|7|||
146834806|NCT01667549|529564935|FG003|Overall Study|Withdrawal by Subject|6|||
146834807|NCT01667549|529564936|FG004|Overall Study|Withdrawal by Subject|1|||
146834808|NCT01407276|529564937|FG000|Overall Study|Withdrawal by Subject|0|||
146834809|NCT01407276|529564938|FG001|Overall Study|Withdrawal by Subject|0|||
146834810|NCT01407276|529564939|FG002|Overall Study|Withdrawal by Subject|0|||
146834811|NCT01407276|529564940|FG003|Overall Study|Withdrawal by Subject|0|||
146834812|NCT01407276|529564941|FG004|Overall Study|Withdrawal by Subject|0|||
146834813|NCT01407276|529564942|FG005|Overall Study|Withdrawal by Subject|0|||
146834814|NCT01407276|529564943|FG006|Overall Study|Withdrawal by Subject|0|||
146834815|NCT01407276|529564944|FG007|Overall Study|Withdrawal by Subject|1|||
146834816|NCT00478205|529564947|FG000|Overall Study|Adverse Event|182|||
146834817|NCT00478205|529564948|FG001|Overall Study|Adverse Event|39|||
146834818|NCT00478205|529564947|FG000|Overall Study|Medication Non-compliance|9|||
146834819|NCT00478205|529564948|FG001|Overall Study|Medication Non-compliance|4|||
146834820|NCT00478205|529564947|FG000|Overall Study|Protocol Violation|15|||
146834821|NCT00478205|529564948|FG001|Overall Study|Protocol Violation|5|||
146834822|NCT00478205|529564947|FG000|Overall Study|Request of Investigator or Sponsor|4|||
146834823|NCT00478205|529564948|FG001|Overall Study|Request of Investigator or Sponsor|5|||
146834824|NCT00478205|529564947|FG000|Overall Study|Withdrawal by Subject|61|||
146834825|NCT00478205|529564948|FG001|Overall Study|Withdrawal by Subject|22|||
146834826|NCT00478205|529564947|FG000|Overall Study|Lack of Efficacy|1|||
146834827|NCT00478205|529564948|FG001|Overall Study|Lack of Efficacy|0|||
146834828|NCT00478205|529564947|FG000|Overall Study|Other|24|||
146834829|NCT00478205|529564948|FG001|Overall Study|Other|12|||
146834830|NCT04092452|529564949|FG000|Overall Study|Adverse Event|1|||
146834831|NCT04092452|529564950|FG001|Overall Study|Adverse Event|3|||
146834832|NCT04092452|529564951|FG002|Overall Study|Adverse Event|3|||
146834833|NCT04092452|529564952|FG003|Overall Study|Adverse Event|7|||
146834834|NCT04092452|529564949|FG000|Overall Study|Lack of Efficacy|1|||
146834835|NCT04092452|529564950|FG001|Overall Study|Lack of Efficacy|1|||
146834836|NCT04092452|529564951|FG002|Overall Study|Lack of Efficacy|1|||
146834837|NCT04092452|529564952|FG003|Overall Study|Lack of Efficacy|0|||
146834838|NCT04092452|529564949|FG000|Overall Study|Lost to Follow-up|4|||
146834839|NCT04092452|529564950|FG001|Overall Study|Lost to Follow-up|3|||
146834840|NCT04092452|529564951|FG002|Overall Study|Lost to Follow-up|5|||
146834841|NCT04092452|529564952|FG003|Overall Study|Lost to Follow-up|1|||
146834842|NCT04092452|529564949|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146834843|NCT04092452|529564950|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146834844|NCT04092452|529564951|FG002|Overall Study|Non-Compliance With Study Drug|1|||
146834845|NCT04092452|529564952|FG003|Overall Study|Non-Compliance With Study Drug|1|||
146834846|NCT04092452|529564949|FG000|Overall Study|Physician Decision|1|||
146834847|NCT04092452|529564950|FG001|Overall Study|Physician Decision|0|||
146834848|NCT04092452|529564951|FG002|Overall Study|Physician Decision|1|||
146834849|NCT04092452|529564952|FG003|Overall Study|Physician Decision|0|||
146834850|NCT04092452|529564949|FG000|Overall Study|Pregnancy|2|||
146834851|NCT04092452|529564950|FG001|Overall Study|Pregnancy|0|||
146834852|NCT04092452|529564951|FG002|Overall Study|Pregnancy|0|||
146834853|NCT04092452|529564952|FG003|Overall Study|Pregnancy|0|||
146834854|NCT04092452|529564949|FG000|Overall Study|Protocol Deviation|1|||
146834855|NCT04092452|529564950|FG001|Overall Study|Protocol Deviation|0|||
146834856|NCT04092452|529564951|FG002|Overall Study|Protocol Deviation|0|||
146834857|NCT04092452|529564952|FG003|Overall Study|Protocol Deviation|0|||
146834858|NCT04092452|529564949|FG000|Overall Study|Withdrawal by Subject|3|||
146834859|NCT04092452|529564950|FG001|Overall Study|Withdrawal by Subject|10|||
146834860|NCT04092452|529564951|FG002|Overall Study|Withdrawal by Subject|3|||
146834861|NCT04092452|529564952|FG003|Overall Study|Withdrawal by Subject|5|||
146834862|NCT04092452|529564949|FG000|Overall Study|Other|0|||
146834863|NCT04092452|529564950|FG001|Overall Study|Other|0|||
146834864|NCT04092452|529564951|FG002|Overall Study|Other|1|||
146834865|NCT04092452|529564952|FG003|Overall Study|Other|2|||
146834866|NCT01012947|529564961|FG000|Overall Study|Lost to Follow-up|131|||
146834867|NCT01012947|529564962|FG001|Overall Study|Lost to Follow-up|135|||
146834868|NCT01012947|529564963|FG002|Overall Study|Lost to Follow-up|130|||
146834869|NCT01012947|529564964|FG003|Overall Study|Lost to Follow-up|118|||
146834870|NCT01012947|529564965|FG004|Overall Study|Lost to Follow-up|142|||
146834871|NCT02127125|529564966|FG000|Overall Study|Lost to Follow-up|0|||
146834872|NCT02127125|529564967|FG001|Overall Study|Lost to Follow-up|0|||
146834873|NCT02127125|529564968|FG002|Overall Study|Lost to Follow-up|0|||
146834874|NCT02127125|529564969|FG003|Overall Study|Lost to Follow-up|0|||
146834875|NCT02127125|529564970|FG004|Overall Study|Lost to Follow-up|2|||
146834876|NCT02127125|529564971|FG005|Overall Study|Lost to Follow-up|1|||
146834877|NCT02127125|529564972|FG006|Overall Study|Lost to Follow-up|0|||
146834878|NCT02127125|529564973|FG007|Overall Study|Lost to Follow-up|0|||
146834879|NCT02127125|529564974|FG008|Overall Study|Lost to Follow-up|0|||
146834880|NCT02127125|529564966|FG000|Overall Study|Withdrawal by Subject|0|||
146834881|NCT02127125|529564967|FG001|Overall Study|Withdrawal by Subject|0|||
146834882|NCT02127125|529564968|FG002|Overall Study|Withdrawal by Subject|0|||
146834883|NCT02127125|529564969|FG003|Overall Study|Withdrawal by Subject|1|||
146834884|NCT02127125|529564970|FG004|Overall Study|Withdrawal by Subject|0|||
146989658|NCT03365947|530124801|FG006|Overall Study|Lost to Follow-up|0|||
146989659|NCT03365947|530124802|FG007|Overall Study|Lost to Follow-up|0|||
146989660|NCT03365947|530124803|FG008|Overall Study|Lost to Follow-up|0|||
146989661|NCT03365947|530124804|FG009|Overall Study|Lost to Follow-up|0|||
146834885|NCT02127125|529564971|FG005|Overall Study|Withdrawal by Subject|0|||
146834886|NCT02127125|529564972|FG006|Overall Study|Withdrawal by Subject|0|||
146834887|NCT02127125|529564973|FG007|Overall Study|Withdrawal by Subject|0|||
146834888|NCT02127125|529564974|FG008|Overall Study|Withdrawal by Subject|0|||
146834889|NCT02127125|529564966|FG000|Overall Study|Physician Decision|0|||
146834890|NCT02127125|529564967|FG001|Overall Study|Physician Decision|0|||
146834891|NCT02127125|529564968|FG002|Overall Study|Physician Decision|1|||
146834892|NCT02127125|529564969|FG003|Overall Study|Physician Decision|0|||
146834893|NCT02127125|529564970|FG004|Overall Study|Physician Decision|1|||
146834894|NCT02127125|529564971|FG005|Overall Study|Physician Decision|2|||
146834895|NCT02127125|529564972|FG006|Overall Study|Physician Decision|0|||
146834896|NCT02127125|529564973|FG007|Overall Study|Physician Decision|0|||
146834897|NCT02127125|529564974|FG008|Overall Study|Physician Decision|0|||
146834898|NCT02493946|529564980|FG000|DB Period|Withdrawal by Subject|8|||
146834899|NCT02493946|529564981|FG001|DB Period|Withdrawal by Subject|5|||
146989662|NCT03365947|530124805|FG010|Overall Study|Lost to Follow-up|0|||
146834900|NCT02493946|529564982|FG002|DB Period|Withdrawal by Subject|0|||
146834901|NCT02493946|529564980|FG000|Open Label Period|Withdrawal by Subject|0|||
146834902|NCT02493946|529564981|FG001|Open Label Period|Withdrawal by Subject|0|||
146834903|NCT02493946|529564982|FG002|Open Label Period|Withdrawal by Subject|74|||
146834904|NCT02493946|529564980|FG000|Open Label Period|Adverse Event|0|||
146834905|NCT02493946|529564981|FG001|Open Label Period|Adverse Event|0|||
146834906|NCT02493946|529564982|FG002|Open Label Period|Adverse Event|4|||
146834907|NCT02493946|529564980|FG000|Open Label Period|Lost to Follow-up|0|||
146834908|NCT02493946|529564981|FG001|Open Label Period|Lost to Follow-up|0|||
146834909|NCT02493946|529564982|FG002|Open Label Period|Lost to Follow-up|1|||
146834910|NCT02493946|529564980|FG000|Open Label Period|Investigator decision, non-compliance|0|||
146989663|NCT03365947|530124806|FG011|Overall Study|Lost to Follow-up|0|||
146989664|NCT03365947|530124807|FG012|Overall Study|Lost to Follow-up|0|||
146989665|NCT03365947|530124808|FG013|Overall Study|Lost to Follow-up|0|||
146834911|NCT02493946|529564981|FG001|Open Label Period|Investigator decision, non-compliance|0|||
146834912|NCT02493946|529564982|FG002|Open Label Period|Investigator decision, non-compliance|2|||
146834913|NCT02493946|529564980|FG000|Open Label Period|Investigator decision, non-availability|0|||
146834914|NCT02493946|529564981|FG001|Open Label Period|Investigator decision, non-availability|0|||
146989666|NCT03365947|530124809|FG014|Overall Study|Lost to Follow-up|0|||
146989667|NCT03365947|530124810|FG015|Overall Study|Lost to Follow-up|0|||
146834915|NCT02493946|529564982|FG002|Open Label Period|Investigator decision, non-availability|1|||
146834916|NCT02493946|529564980|FG000|Open Label Period|Pregnancy|0|||
146834917|NCT02493946|529564981|FG001|Open Label Period|Pregnancy|0|||
146834918|NCT02493946|529564982|FG002|Open Label Period|Pregnancy|3|||
146834919|NCT02493946|529564980|FG000|Open Label Period|Site error|0|||
146834920|NCT02493946|529564981|FG001|Open Label Period|Site error|0|||
146834921|NCT02493946|529564982|FG002|Open Label Period|Site error|1|||
146834922|NCT02165826|529564988|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
146834923|NCT02165826|529564989|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
146834924|NCT02165826|529564990|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
146834925|NCT02165826|529564988|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
146989668|NCT03365947|530124811|FG016|Overall Study|Lost to Follow-up|0|||
146989669|NCT03365947|530124812|FG017|Overall Study|Lost to Follow-up|0|||
146834926|NCT02165826|529564989|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
146834927|NCT02165826|529564990|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
146834928|NCT02165826|529564988|FG000|Main Treatment Period|Lost to Follow-up|4|||
146834929|NCT02165826|529564989|FG001|Main Treatment Period|Lost to Follow-up|2|||
146834930|NCT02165826|529564990|FG002|Main Treatment Period|Lost to Follow-up|1|||
146834931|NCT02165826|529564988|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
146834932|NCT02165826|529564989|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
146834933|NCT02165826|529564990|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
146834934|NCT02165826|529564988|FG000|Main Treatment Period|Lack of Efficacy|2|||
146834935|NCT02165826|529564989|FG001|Main Treatment Period|Lack of Efficacy|0|||
146834936|NCT02165826|529564990|FG002|Main Treatment Period|Lack of Efficacy|0|||
146834937|NCT02165826|529564988|FG000|Main Treatment Period|Reason Not Specified|8|||
146834938|NCT02165826|529564989|FG001|Main Treatment Period|Reason Not Specified|5|||
146834939|NCT02165826|529564990|FG002|Main Treatment Period|Reason Not Specified|16|||
146834940|NCT02165826|529564988|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
146834941|NCT02165826|529564989|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
146834942|NCT02165826|529564990|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
146834943|NCT02165826|529564988|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
146834944|NCT02165826|529564989|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
146834945|NCT02165826|529564990|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
146834946|NCT02165826|529564988|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
146834947|NCT02165826|529564989|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
146834948|NCT02165826|529564990|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
146834949|NCT02165826|529564988|FG000|Down-Titration Period|Reason Not Specified|1|||
146834950|NCT02165826|529564989|FG001|Down-Titration Period|Reason Not Specified|0|||
146834951|NCT02165826|529564990|FG002|Down-Titration Period|Reason Not Specified|2|||
146834952|NCT00250432|529564993|FG000|Overall Study|Adverse Event|25|||
146834953|NCT00250432|529564994|FG001|Overall Study|Adverse Event|29|||
146834954|NCT00250432|529564993|FG000|Overall Study|Lack of Efficacy|2|||
146834955|NCT00250432|529564994|FG001|Overall Study|Lack of Efficacy|1|||
146834956|NCT00250432|529564993|FG000|Overall Study|Lost to Follow-up|6|||
146834957|NCT00250432|529564994|FG001|Overall Study|Lost to Follow-up|5|||
146834958|NCT00250432|529564993|FG000|Overall Study|Patient Moved|0|||
146834959|NCT00250432|529564994|FG001|Overall Study|Patient Moved|1|||
146834960|NCT00250432|529564993|FG000|Overall Study|Protocol Violation|0|||
146834961|NCT00250432|529564994|FG001|Overall Study|Protocol Violation|3|||
146834962|NCT00250432|529564993|FG000|Overall Study|Withdrawal by Subject|6|||
146834963|NCT00250432|529564994|FG001|Overall Study|Withdrawal by Subject|2|||
146834964|NCT00250432|529564993|FG000|Overall Study|Pt died out of posttherapy report period|6|||
146834965|NCT00250432|529564994|FG001|Overall Study|Pt died out of posttherapy report period|5|||
146834966|NCT00250432|529564993|FG000|Overall Study|Pt was considered untreatable|0|||
146834967|NCT00250432|529564994|FG001|Overall Study|Pt was considered untreatable|1|||
146834968|NCT01056263|529564995|FG000|Overall Study|Adverse Event|12|||
146834969|NCT01056263|529564995|FG000|Overall Study|Death|1|||
146834970|NCT01056263|529564995|FG000|Overall Study|Withdrawal by Subject|1|||
146834971|NCT01056263|529564995|FG000|Overall Study|Lack of Efficacy|29|||
146834972|NCT01056263|529564995|FG000|Overall Study|Progressive disease|2|||
146834973|NCT01056263|529564995|FG000|Overall Study|Neoplasm progression|1|||
146834974|NCT01056263|529564995|FG000|Overall Study|Objective progression or relapse|1|||
146834975|NCT01056263|529564995|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
146834976|NCT00658606|529564998|FG000|Overall Study|Adverse Event|2|||
146834977|NCT00658606|529564999|FG001|Overall Study|Adverse Event|1|||
146834978|NCT00658606|529564998|FG000|Overall Study|Lack of Efficacy|6|||
146834979|NCT00658606|529564999|FG001|Overall Study|Lack of Efficacy|3|||
146834980|NCT00658606|529564998|FG000|Overall Study|Lost to Follow-up|1|||
146834981|NCT00658606|529564999|FG001|Overall Study|Lost to Follow-up|0|||
146834982|NCT00658606|529564998|FG000|Overall Study|Withdrawal by Subject|7|||
146834983|NCT00658606|529564999|FG001|Overall Study|Withdrawal by Subject|16|||
146834984|NCT00658606|529564998|FG000|Overall Study|Lack of Compliance|0|||
146834985|NCT00658606|529564999|FG001|Overall Study|Lack of Compliance|3|||
146834986|NCT01068210|529565004|FG000|Overall Study|Lost to Follow-up|1|||
146989670|NCT03365947|530124813|FG018|Overall Study|Lost to Follow-up|0|||
146989671|NCT02518685|530124814|FG000|Overall Study|Adverse Event|29|||
146989672|NCT02518685|530124815|FG001|Overall Study|Adverse Event|1|||
146834987|NCT01068210|529565005|FG001|Overall Study|Lost to Follow-up|2|||
146834988|NCT01068210|529565006|FG002|Overall Study|Lost to Follow-up|2|||
146834989|NCT01068210|529565007|FG003|Overall Study|Lost to Follow-up|1|||
146834990|NCT01068210|529565004|FG000|Overall Study|Second cancer|0|||
146834991|NCT01068210|529565005|FG001|Overall Study|Second cancer|1|||
146834992|NCT01068210|529565006|FG002|Overall Study|Second cancer|0|||
146834993|NCT01068210|529565007|FG003|Overall Study|Second cancer|0|||
146834994|NCT01068210|529565004|FG000|Overall Study|Disease progression|0|||
146834995|NCT01068210|529565005|FG001|Overall Study|Disease progression|0|||
146834996|NCT01068210|529565006|FG002|Overall Study|Disease progression|0|||
146834997|NCT01068210|529565007|FG003|Overall Study|Disease progression|2|||
146834998|NCT00699842|529565008|FG000|Overall Study|Death|0|||
146834999|NCT00699842|529565009|FG001|Overall Study|Death|1|||
146835000|NCT00699842|529565010|FG002|Overall Study|Death|0|||
146835001|NCT01806389|529565013|FG000|Overall Study|Withdrawal by Subject|4|||
146835002|NCT01310699|529565014|FG000|Overall Study|Patients did not complete tandem.|4|||
146835003|NCT01310699|529565015|FG001|Overall Study|Patients did not complete tandem.|6|||
146835004|NCT00926575|529565016|FG000|Overall Study|Adverse Event|1|||
146835005|NCT00926575|529565017|FG001|Overall Study|Adverse Event|1|||
146835006|NCT00926575|529565016|FG000|Overall Study|Death|4|||
146835007|NCT00926575|529565017|FG001|Overall Study|Death|4|||
146835008|NCT00926575|529565016|FG000|Overall Study|Lost to Follow-up|1|||
146835009|NCT00926575|529565017|FG001|Overall Study|Lost to Follow-up|1|||
146835010|NCT00926575|529565016|FG000|Overall Study|Physician Decision|1|||
146835011|NCT00926575|529565017|FG001|Overall Study|Physician Decision|2|||
146835012|NCT00926575|529565016|FG000|Overall Study|Protocol Violation|1|||
146835013|NCT00926575|529565017|FG001|Overall Study|Protocol Violation|0|||
146835014|NCT00926575|529565016|FG000|Overall Study|Withdrawal by Subject|8|||
146835015|NCT00926575|529565017|FG001|Overall Study|Withdrawal by Subject|9|||
146835016|NCT00490698|529565018|FG000|Overall Study|Withdrawal by Subject|1|||
146835017|NCT00490698|529565018|FG000|Overall Study|Disease Progression|7|||
146835018|NCT00490698|529565018|FG000|Overall Study|Physician Decision|2|||
146989673|NCT02518685|530124814|FG000|Overall Study|Withdrawal by Subject|10|||
146989674|NCT02518685|530124815|FG001|Overall Study|Withdrawal by Subject|3|||
146989675|NCT02518685|530124814|FG000|Overall Study|relocation, study fatigue|7|||
146989676|NCT02518685|530124815|FG001|Overall Study|relocation, study fatigue|2|||
146989677|NCT02518685|530124814|FG000|Overall Study|Pregnancy|1|||
146989678|NCT02518685|530124815|FG001|Overall Study|Pregnancy|0|||
146989679|NCT02518685|530124814|FG000|Overall Study|Physician Decision|1|||
146989680|NCT02518685|530124815|FG001|Overall Study|Physician Decision|0|||
146989681|NCT02518685|530124814|FG000|Overall Study|Lost to Follow-up|1|||
146989682|NCT02518685|530124815|FG001|Overall Study|Lost to Follow-up|4|||
146989683|NCT05665595|530127311|FG000|Overall Study|Ongoing|692|||
146989684|NCT05665595|530127312|FG001|Overall Study|Ongoing|698|||
146989685|NCT05665595|530127311|FG000|Overall Study|Withdrawal by Subject|2|||
146989686|NCT05665595|530127312|FG001|Overall Study|Withdrawal by Subject|2|||
146989687|NCT05665595|530127311|FG000|Overall Study|Lost to Follow-up|1|||
146989688|NCT05665595|530127312|FG001|Overall Study|Lost to Follow-up|0|||
146989689|NCT05665595|530127311|FG000|Overall Study|Death|6|||
146989690|NCT05665595|530127312|FG001|Overall Study|Death|1|||
146989691|NCT05771428|530127313|FG000|Overall Study|Adverse Event|0|||
146989692|NCT05771428|530127314|FG001|Overall Study|Adverse Event|1|||
146835019|NCT02201901|529565019|FG000|Overall Study|Randomized but never treated|0|||
146835020|NCT02201901|529565020|FG001|Overall Study|Randomized but never treated|1|||
146835021|NCT02201901|529565021|FG002|Overall Study|Randomized but never treated|0|||
146835022|NCT02201901|529565019|FG000|Overall Study|Lack of Efficacy|7|||
146835023|NCT02201901|529565020|FG001|Overall Study|Lack of Efficacy|1|||
146835024|NCT02201901|529565021|FG002|Overall Study|Lack of Efficacy|6|||
146835025|NCT02201901|529565019|FG000|Overall Study|Death|3|||
146835026|NCT02201901|529565020|FG001|Overall Study|Death|3|||
146835027|NCT02201901|529565021|FG002|Overall Study|Death|3|||
146835028|NCT02201901|529565019|FG000|Overall Study|Lost to Follow-up|2|||
146989693|NCT05771428|530127315|FG002|Overall Study|Adverse Event|1|||
146989694|NCT05771428|530127316|FG003|Overall Study|Adverse Event|1|||
146835029|NCT02201901|529565020|FG001|Overall Study|Lost to Follow-up|3|||
146835030|NCT02201901|529565021|FG002|Overall Study|Lost to Follow-up|2|||
146835031|NCT02201901|529565019|FG000|Overall Study|Withdrew Consent|2|||
146835032|NCT02201901|529565020|FG001|Overall Study|Withdrew Consent|0|||
146835033|NCT02201901|529565021|FG002|Overall Study|Withdrew Consent|2|||
146989695|NCT05771428|530127313|FG000|Overall Study|Withdrawal by Subject|3|||
146989696|NCT05771428|530127314|FG001|Overall Study|Withdrawal by Subject|2|||
146989697|NCT05771428|530127315|FG002|Overall Study|Withdrawal by Subject|1|||
146989698|NCT05771428|530127316|FG003|Overall Study|Withdrawal by Subject|4|||
146989699|NCT05771428|530127313|FG000|Overall Study|Other|0|||
146989700|NCT05771428|530127314|FG001|Overall Study|Other|1|||
146989701|NCT05771428|530127315|FG002|Overall Study|Other|2|||
146989702|NCT05771428|530127316|FG003|Overall Study|Other|1|||
146989703|NCT05771428|530127313|FG000|Overall Study|Randomized but Not Treated|0|||
146835034|NCT02201901|529565019|FG000|Overall Study|Adverse Event|1|||
146835035|NCT02201901|529565020|FG001|Overall Study|Adverse Event|1|||
146835036|NCT02201901|529565021|FG002|Overall Study|Adverse Event|0|||
146835037|NCT00738283|529565027|FG000|Overall Study|Death|1|||
146835038|NCT00738283|529565027|FG000|Overall Study|Transfer to another facility|2|||
146989704|NCT05771428|530127314|FG001|Overall Study|Randomized but Not Treated|0|||
146989705|NCT05771428|530127315|FG002|Overall Study|Randomized but Not Treated|1|||
146989706|NCT05771428|530127316|FG003|Overall Study|Randomized but Not Treated|0|||
146989707|NCT04025229|530127317|FG000|Overall Study|Adverse Event|1|||
146835039|NCT00738283|529565027|FG000|Overall Study|Discharge home prior to end of study|1|||
146835040|NCT02559310|529565030|FG000|Overall Study|Death|4|||
146835041|NCT02559310|529565031|FG001|Overall Study|Death|3|||
146835042|NCT02559310|529565030|FG000|Overall Study|Lost to Follow-up|5|||
146835043|NCT02559310|529565031|FG001|Overall Study|Lost to Follow-up|3|||
146835044|NCT02559310|529565030|FG000|Overall Study|Physician Decision|2|||
146835045|NCT02559310|529565031|FG001|Overall Study|Physician Decision|1|||
146835046|NCT02559310|529565030|FG000|Overall Study|Withdrawal by Subject|13|||
146835047|NCT02559310|529565031|FG001|Overall Study|Withdrawal by Subject|9|||
146835048|NCT02559310|529565030|FG000|Overall Study|Sponsor Decision|0|||
146835049|NCT02559310|529565031|FG001|Overall Study|Sponsor Decision|1|||
146835050|NCT02559310|529565030|FG000|Overall Study|Randomized but not treated|3|||
146835051|NCT02559310|529565031|FG001|Overall Study|Randomized but not treated|2|||
146835052|NCT02633397|529565032|FG000|Overall Study|Adverse Event|8|||
146835053|NCT02633397|529565033|FG001|Overall Study|Adverse Event|8|||
146835054|NCT02633397|529565032|FG000|Overall Study|Study Burden|4|||
146835055|NCT02633397|529565033|FG001|Overall Study|Study Burden|1|||
146835056|NCT02633397|529565032|FG000|Overall Study|Treatment interruption|2|||
146835057|NCT02633397|529565033|FG001|Overall Study|Treatment interruption|5|||
146835058|NCT02633397|529565032|FG000|Overall Study|Death|2|||
146835059|NCT02633397|529565033|FG001|Overall Study|Death|2|||
146835060|NCT02633397|529565032|FG000|Overall Study|Physician Decision|0|||
146835061|NCT02633397|529565033|FG001|Overall Study|Physician Decision|1|||
146835062|NCT03595878|529565034|FG000|Overall Study|Death|2|||
146835063|NCT03595878|529565035|FG001|Overall Study|Death|1|||
146835064|NCT03595878|529565036|FG002|Overall Study|Death|0|||
146835065|NCT03595878|529565034|FG000|Overall Study|Disease progression|2|||
146835066|NCT03595878|529565035|FG001|Overall Study|Disease progression|1|||
146835067|NCT03595878|529565036|FG002|Overall Study|Disease progression|2|||
146835068|NCT00469859|529565037|FG000|Overall Study|Inevaluable|0|||
146835069|NCT00469859|529565038|FG001|Overall Study|Inevaluable|2|||
146835070|NCT03494985|529565039|FG000|Overall Study|Adverse Event|3|||
146835071|NCT03494985|529565040|FG001|Overall Study|Adverse Event|2|||
146835072|NCT03494985|529565041|FG002|Overall Study|Adverse Event|3|||
146835073|NCT03494985|529565042|FG003|Overall Study|Adverse Event|0|||
146835074|NCT03494985|529565039|FG000|Overall Study|Other (Withdrawal of consent)|2|||
146835075|NCT03494985|529565040|FG001|Overall Study|Other (Withdrawal of consent)|3|||
146835076|NCT03494985|529565041|FG002|Overall Study|Other (Withdrawal of consent)|2|||
146835077|NCT03494985|529565042|FG003|Overall Study|Other (Withdrawal of consent)|5|||
146835078|NCT03494985|529565039|FG000|Overall Study|Other (Not specified)|0|||
146835079|NCT03494985|529565040|FG001|Overall Study|Other (Not specified)|1|||
146835080|NCT03494985|529565041|FG002|Overall Study|Other (Not specified)|1|||
146835081|NCT03494985|529565042|FG003|Overall Study|Other (Not specified)|0|||
146835082|NCT04124471|529565043|FG000|Overall Study|screen failure|1|||
146835083|NCT03036124|529565044|FG000|Overall Study|Lost to Follow-up|0|||
146835084|NCT03036124|529565045|FG001|Overall Study|Lost to Follow-up|2|||
146835085|NCT03036124|529565044|FG000|Overall Study|Withdrawal by Subject|5|||
146835086|NCT03036124|529565045|FG001|Overall Study|Withdrawal by Subject|4|||
146835087|NCT02394925|529565046|FG000|Overall Study|Adverse Event|1|||
146835088|NCT02394925|529565046|FG000|Overall Study|Lens Discomfort|3|||
146835089|NCT02394925|529565046|FG000|Overall Study|Lens handling difficulities|5|||
146835090|NCT02394925|529565046|FG000|Overall Study|Lost to Follow-up|9|||
146989708|NCT04025229|530127318|FG001|Overall Study|Adverse Event|0|||
146989709|NCT04025229|530127317|FG000|Overall Study|Withdrawal by Subject|0|||
146989710|NCT04025229|530127318|FG001|Overall Study|Withdrawal by Subject|2|||
146989711|NCT04025229|530127317|FG000|Overall Study|Death|0|||
146989712|NCT04025229|530127318|FG001|Overall Study|Death|1|||
146989713|NCT04025229|530127317|FG000|Overall Study|Physician Decision|0|||
146989714|NCT04025229|530127318|FG001|Overall Study|Physician Decision|1|||
146989715|NCT03815942|530127319|FG000|Overall Study|Withdrawal by Subject|0|||
146989716|NCT03815942|530127320|FG001|Overall Study|Withdrawal by Subject|17|||
146835091|NCT02394925|529565046|FG000|Overall Study|Protocol Violation|5|||
146835092|NCT02394925|529565046|FG000|Overall Study|No longer meet eligibility criteria|1|||
146835093|NCT02394925|529565046|FG000|Overall Study|Unsatisfactory Visual Response|5|||
146835094|NCT02737826|529567302|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
146835095|NCT02737826|529567303|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
146835096|NCT02737826|529567304|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
146835097|NCT00078377|529567305|FG000|Overall Study|Adverse Event|2|||
146835098|NCT00078377|529567306|FG001|Overall Study|Adverse Event|5|||
146835099|NCT00078377|529567307|FG002|Overall Study|Adverse Event|1|||
146835100|NCT00078377|529567305|FG000|Overall Study|Lack of Efficacy|2|||
146835101|NCT00078377|529567306|FG001|Overall Study|Lack of Efficacy|0|||
146835102|NCT00078377|529567307|FG002|Overall Study|Lack of Efficacy|2|||
146835103|NCT00078377|529567305|FG000|Overall Study|Lost to Follow-up|0|||
146835104|NCT00078377|529567306|FG001|Overall Study|Lost to Follow-up|1|||
146835105|NCT00078377|529567307|FG002|Overall Study|Lost to Follow-up|1|||
146835106|NCT00078377|529567305|FG000|Overall Study|Physician Decision|2|||
146835107|NCT00078377|529567306|FG001|Overall Study|Physician Decision|0|||
146835108|NCT00078377|529567307|FG002|Overall Study|Physician Decision|0|||
146835109|NCT00078377|529567305|FG000|Overall Study|Withdrawal by Subject|3|||
146835110|NCT00078377|529567306|FG001|Overall Study|Withdrawal by Subject|4|||
146835111|NCT00078377|529567307|FG002|Overall Study|Withdrawal by Subject|4|||
146989717|NCT01298570|530127321|FG000|Overall Study|Disease progression, relapse during acti|64|||
146989718|NCT01298570|530127322|FG001|Overall Study|Disease progression, relapse during acti|40|||
146989719|NCT01298570|530127321|FG000|Overall Study|Adverse Event|20|||
146989720|NCT01298570|530127322|FG001|Overall Study|Adverse Event|2|||
146989721|NCT01298570|530127321|FG000|Overall Study|Withdrawal by Subject|21|||
146989722|NCT01298570|530127322|FG001|Overall Study|Withdrawal by Subject|6|||
146989723|NCT01298570|530127321|FG000|Overall Study|Treatment delay > 4 weeks|4|||
146989724|NCT01298570|530127322|FG001|Overall Study|Treatment delay > 4 weeks|5|||
146989725|NCT01298570|530127321|FG000|Overall Study|Physician Decision|4|||
146989726|NCT01298570|530127322|FG001|Overall Study|Physician Decision|2|||
146989727|NCT01298570|530127321|FG000|Overall Study|Other complicating disease|2|||
146989728|NCT01298570|530127322|FG001|Overall Study|Other complicating disease|1|||
146989729|NCT01298570|530127321|FG000|Overall Study|Surgery|2|||
146989730|NCT01298570|530127322|FG001|Overall Study|Surgery|1|||
146989731|NCT01298570|530127321|FG000|Overall Study|Symptomatic progression/deterioration|3|||
146989732|NCT01298570|530127322|FG001|Overall Study|Symptomatic progression/deterioration|2|||
146989733|NCT01298570|530127321|FG000|Overall Study|Death|0|||
146989734|NCT01298570|530127322|FG001|Overall Study|Death|1|||
146989735|NCT01298570|530127321|FG000|Overall Study|Ineligibility|0|||
146989736|NCT01298570|530127322|FG001|Overall Study|Ineligibility|1|||
146989737|NCT00076102|530127323|FG000|Overall Study|Clinical progression|1|||
146989738|NCT00076102|530127323|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
146989739|NCT00076102|530127323|FG000|Overall Study|plexiform neurofibroma surgery|1|||
146989740|NCT00076102|530127323|FG000|Overall Study|refusal of further therapy|2|||
146989741|NCT02207231|530127325|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
146989742|NCT02207231|530127326|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
146989743|NCT02207231|530127327|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
146989744|NCT02207231|530127328|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
146989745|NCT02207231|530127325|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
146989746|NCT02207231|530127326|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
146989747|NCT02207231|530127327|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
146989748|NCT02207231|530127328|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
146835112|NCT00078377|529567305|FG000|Overall Study|Miscellaneous|2|||
146835113|NCT00078377|529567306|FG001|Overall Study|Miscellaneous|6|||
146835114|NCT00078377|529567307|FG002|Overall Study|Miscellaneous|1|||
146835115|NCT04546217|529567308|FG000|Overall Study|Withdrawal by Subject|2|||
146835116|NCT04546217|529567309|FG001|Overall Study|Withdrawal by Subject|0|||
146835117|NCT04546217|529567308|FG000|Overall Study|Uncontrolled hypertension|1|||
146835118|NCT04546217|529567309|FG001|Overall Study|Uncontrolled hypertension|0|||
146835119|NCT00863512|529567310|FG000|Overall Study|Adverse Event|2|||
146835120|NCT00863512|529567311|FG001|Overall Study|Adverse Event|0|||
146835121|NCT00863512|529567310|FG000|Overall Study|Withdrawal by Subject|11|||
146835122|NCT00863512|529567311|FG001|Overall Study|Withdrawal by Subject|0|||
146835123|NCT00863512|529567310|FG000|Overall Study|Physician Decision|1|||
146835124|NCT00863512|529567311|FG001|Overall Study|Physician Decision|0|||
146835125|NCT04292470|529567316|FG000|Overall Study|Withdrawal by Subject|0|||
146835126|NCT04292470|529567317|FG001|Overall Study|Withdrawal by Subject|1|||
146835127|NCT04829747|529567336|FG000|Overall Study|Protocol Violation|1|||
146835128|NCT00079339|529567342|FG000|Overall Study|Adverse Event|1|||
146835129|NCT00079339|529567343|FG001|Overall Study|Adverse Event|7|||
146835130|NCT00079339|529567344|FG002|Overall Study|Adverse Event|2|||
146835131|NCT00079339|529567342|FG000|Overall Study|Death|1|||
146835132|NCT00079339|529567343|FG001|Overall Study|Death|0|||
146835133|NCT00079339|529567344|FG002|Overall Study|Death|0|||
146835134|NCT00079339|529567342|FG000|Overall Study|Non-compliance|0|||
146835135|NCT00079339|529567343|FG001|Overall Study|Non-compliance|0|||
146835136|NCT00079339|529567344|FG002|Overall Study|Non-compliance|1|||
146835137|NCT00079339|529567342|FG000|Overall Study|Withdrawal by Subject|0|||
146835138|NCT00079339|529567343|FG001|Overall Study|Withdrawal by Subject|4|||
146989749|NCT02207231|530127325|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
146835139|NCT00079339|529567344|FG002|Overall Study|Withdrawal by Subject|1|||
146835140|NCT00079339|529567342|FG000|Overall Study|Disease progression|3|||
146835141|NCT00079339|529567343|FG001|Overall Study|Disease progression|28|||
146835142|NCT00079339|529567344|FG002|Overall Study|Disease progression|2|||
146989750|NCT02207231|530127326|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
146989751|NCT02207231|530127327|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
146989752|NCT02207231|530127328|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
146989753|NCT02207231|530127325|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
146835143|NCT01547598|529567345|FG000|Overall Study|Withdrew consent|1|||
146835144|NCT01547598|529567346|FG001|Overall Study|Withdrew consent|1|||
146835145|NCT01547598|529567345|FG000|Overall Study|Lost to Follow-up|1|||
146835146|NCT01547598|529567346|FG001|Overall Study|Lost to Follow-up|1|||
146835147|NCT01547598|529567345|FG000|Overall Study|Adverse Event|1|||
146835148|NCT01547598|529567346|FG001|Overall Study|Adverse Event|1|||
146835149|NCT01547598|529567345|FG000|Overall Study|Protocol Violation|1|||
146835150|NCT01547598|529567346|FG001|Overall Study|Protocol Violation|1|||
146835151|NCT01547598|529567345|FG000|Overall Study|Other Miscellaneous Reasons|2|||
146835152|NCT01547598|529567346|FG001|Overall Study|Other Miscellaneous Reasons|1|||
146835153|NCT00340704|529567350|FG000|PK Study|Adverse Event|0|||
146835154|NCT00340704|529567351|FG001|PK Study|Adverse Event|1|||
146835155|NCT00340704|529567352|FG002|PK Study|Adverse Event|0|||
146835156|NCT00340704|529567353|FG003|PK Study|Adverse Event|0|||
146835157|NCT00340704|529567354|FG004|PK Study|Adverse Event|0|||
146835158|NCT00340704|529567355|FG005|PK Study|Adverse Event|0|||
146835159|NCT00340704|529567356|FG006|PK Study|Adverse Event|0|||
146835160|NCT00340704|529567357|FG007|PK Study|Adverse Event|0|||
146835161|NCT00340704|529567358|FG008|PK Study|Adverse Event|0|||
146835162|NCT00340704|529567350|FG000|PK Study|Not treated|0|||
146835163|NCT00340704|529567351|FG001|PK Study|Not treated|0|||
146835164|NCT00340704|529567352|FG002|PK Study|Not treated|1|||
146835165|NCT00340704|529567353|FG003|PK Study|Not treated|0|||
146835166|NCT00340704|529567354|FG004|PK Study|Not treated|0|||
146835167|NCT00340704|529567355|FG005|PK Study|Not treated|0|||
146835168|NCT00340704|529567356|FG006|PK Study|Not treated|0|||
146835169|NCT00340704|529567357|FG007|PK Study|Not treated|0|||
146835170|NCT00340704|529567358|FG008|PK Study|Not treated|0|||
146835171|NCT00340704|529567350|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
146835172|NCT00340704|529567351|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
146835173|NCT00340704|529567352|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
146835174|NCT00340704|529567353|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
146835175|NCT00340704|529567354|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
146835176|NCT00340704|529567355|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
146835177|NCT00340704|529567356|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
146989754|NCT02207231|530127326|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
146989755|NCT02207231|530127327|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
146989756|NCT02207231|530127328|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
146989757|NCT02207231|530127325|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
146989758|NCT02207231|530127326|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
146989759|NCT02207231|530127327|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
146989760|NCT02207231|530127328|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
146989761|NCT02207231|530127325|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
146989762|NCT02207231|530127326|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
146989763|NCT02207231|530127327|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
146989764|NCT02207231|530127328|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
146989765|NCT02207231|530127325|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
146989766|NCT02207231|530127326|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
146835178|NCT00340704|529567357|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
146835179|NCT00340704|529567358|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
146835180|NCT00340704|529567350|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
146835181|NCT00340704|529567351|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
146835182|NCT00340704|529567352|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
146835183|NCT00340704|529567353|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
146835184|NCT00340704|529567354|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
146835185|NCT00340704|529567355|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
146835186|NCT00340704|529567356|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
146835187|NCT00340704|529567357|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
146835188|NCT00340704|529567358|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
146835189|NCT00340704|529567350|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
146835190|NCT00340704|529567351|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
146835191|NCT00340704|529567352|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
146835192|NCT00340704|529567353|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
146835193|NCT00340704|529567354|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
146835194|NCT00340704|529567355|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
146835195|NCT00340704|529567356|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
146989767|NCT02207231|530127327|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
146835196|NCT00340704|529567357|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
146835197|NCT00340704|529567358|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
146989768|NCT02207231|530127328|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
146989769|NCT02207231|530127325|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
146835198|NCT00340704|529567350|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
146835199|NCT00340704|529567351|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
146835200|NCT00340704|529567352|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
146835201|NCT00340704|529567353|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
146835202|NCT00340704|529567354|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
146835203|NCT00340704|529567355|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
146835204|NCT00340704|529567356|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
146835205|NCT00340704|529567357|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
146835206|NCT00340704|529567358|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
146835207|NCT00121667|529567359|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
146835208|NCT00121667|529567360|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
146835209|NCT00121667|529567361|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
146835210|NCT00121667|529567362|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
146835211|NCT00121667|529567359|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
146835212|NCT00121667|529567360|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
146835213|NCT00121667|529567361|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
146835214|NCT00121667|529567362|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
146835215|NCT00121667|529567359|FG000|Short Term (ST) Period|Adverse Event|5|||
146835216|NCT00121667|529567360|FG001|Short Term (ST) Period|Adverse Event|6|||
146835217|NCT00121667|529567361|FG002|Short Term (ST) Period|Adverse Event|5|||
146835218|NCT00121667|529567362|FG003|Short Term (ST) Period|Adverse Event|3|||
146835219|NCT00121667|529567359|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
146835220|NCT00121667|529567360|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
146835221|NCT00121667|529567361|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
146835222|NCT00121667|529567362|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
146835223|NCT00121667|529567359|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
146835224|NCT00121667|529567360|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
146835225|NCT00121667|529567361|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
146835226|NCT00121667|529567362|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
146835227|NCT00121667|529567359|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
146835228|NCT00121667|529567360|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
146835229|NCT00121667|529567361|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
146835230|NCT00121667|529567362|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
146835231|NCT00121667|529567359|FG000|Short Term (ST) Period|Other Reason|3|||
146835232|NCT00121667|529567360|FG001|Short Term (ST) Period|Other Reason|0|||
146835233|NCT00121667|529567361|FG002|Short Term (ST) Period|Other Reason|0|||
146835234|NCT00121667|529567362|FG003|Short Term (ST) Period|Other Reason|0|||
146835235|NCT00121667|529567359|FG000|Short Term (ST) Period|Death|0|||
146835236|NCT00121667|529567360|FG001|Short Term (ST) Period|Death|0|||
146835237|NCT00121667|529567361|FG002|Short Term (ST) Period|Death|0|||
146835238|NCT00121667|529567362|FG003|Short Term (ST) Period|Death|1|||
146835239|NCT00121667|529567359|FG000|Short Term (ST) Period|Pregnancy|0|||
146835240|NCT00121667|529567360|FG001|Short Term (ST) Period|Pregnancy|0|||
146835241|NCT00121667|529567361|FG002|Short Term (ST) Period|Pregnancy|0|||
146835242|NCT00121667|529567362|FG003|Short Term (ST) Period|Pregnancy|1|||
146835243|NCT00121667|529567359|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
146835244|NCT00121667|529567360|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
146835245|NCT00121667|529567361|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
146835246|NCT00121667|529567362|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
146835247|NCT00121667|529567359|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
146835248|NCT00121667|529567360|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
146835249|NCT00121667|529567361|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
146835250|NCT00121667|529567362|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
146835251|NCT00121667|529567359|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
146835252|NCT00121667|529567360|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
146835253|NCT00121667|529567361|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
146835254|NCT00121667|529567362|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
146835255|NCT00121667|529567359|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
146835256|NCT00121667|529567360|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
146835257|NCT00121667|529567361|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
146835258|NCT00121667|529567362|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
146835259|NCT00121667|529567359|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
146835260|NCT00121667|529567360|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
146835261|NCT00121667|529567361|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
146835262|NCT00121667|529567362|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
146835263|NCT00121667|529567359|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
146835264|NCT00121667|529567360|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
146835265|NCT00121667|529567361|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
146835266|NCT00121667|529567362|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
146835267|NCT00121667|529567359|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
146835268|NCT00121667|529567360|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
146835269|NCT00121667|529567361|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
146835270|NCT00121667|529567362|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
146835271|NCT00121667|529567359|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
146835272|NCT00121667|529567360|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
146835273|NCT00121667|529567361|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
146835274|NCT00121667|529567362|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
146835275|NCT00121667|529567359|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
146835276|NCT00121667|529567360|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
146835277|NCT00121667|529567361|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
146835278|NCT00121667|529567362|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
146835279|NCT02879383|529567363|FG000|First 24 Weeks|Physician Decision|0|||
146835280|NCT02879383|529567364|FG001|First 24 Weeks|Physician Decision|1|||
146835281|NCT02879383|529567365|FG002|First 24 Weeks|Physician Decision|0|||
146835282|NCT02879383|529567366|FG003|First 24 Weeks|Physician Decision|0|||
146835283|NCT05186311|529567367|FG000|Part A: Serum|Withdrawal by Subject|1|||
146835284|NCT02125279|529567368|FG000|Overall Study|Lack of Efficacy|2|||
146835285|NCT02125279|529567368|FG000|Overall Study|Withdrawal by Subject|6|||
146835286|NCT02125279|529567368|FG000|Overall Study|Protocol Violation|1|||
146835287|NCT02125279|529567368|FG000|Overall Study|Lost to Follow-up|4|||
146835288|NCT01607879|529567373|FG000|Overall Study|Death|1|||
146835289|NCT01607879|529567374|FG001|Overall Study|Death|0|||
146835290|NCT03845140|529567378|FG000|Overall Study|Participant travelled outside study area|0|||
146835291|NCT03845140|529567379|FG001|Overall Study|Participant travelled outside study area|1|||
146835292|NCT03845140|529567380|FG002|Overall Study|Participant travelled outside study area|0|||
146835293|NCT03845140|529567381|FG003|Overall Study|Participant travelled outside study area|0|||
146835294|NCT03845140|529567382|FG004|Overall Study|Participant travelled outside study area|0|||
146835295|NCT03845140|529567383|FG005|Overall Study|Participant travelled outside study area|0|||
146835296|NCT01592045|529567391|FG000|Overall Study|Disease Progression|1|||
146835297|NCT01592045|529567392|FG001|Overall Study|Disease Progression|1|||
146835298|NCT01592045|529567391|FG000|Overall Study|Adverse Event|1|||
146835299|NCT01592045|529567392|FG001|Overall Study|Adverse Event|1|||
146835300|NCT01592045|529567391|FG000|Overall Study|Withdrawal by Subject|1|||
146835301|NCT01592045|529567392|FG001|Overall Study|Withdrawal by Subject|0|||
146835302|NCT01592045|529567391|FG000|Overall Study|Moved out of country|2|||
146835303|NCT01592045|529567392|FG001|Overall Study|Moved out of country|0|||
146835304|NCT02599688|529567407|FG000|Overall Study|Lack of Efficacy|1|||
146835305|NCT02599688|529567407|FG000|Overall Study|Withdrawal by Subject|1|||
146835306|NCT02599688|529567407|FG000|Overall Study|Termination by Sponsor|2|||
146835307|NCT00742326|529567408|FG000|Overall Study|Physician Decision|0|||
146835308|NCT00742326|529567409|FG001|Overall Study|Physician Decision|1|||
146835309|NCT03635086|529567418|FG000|Overall Study|Withdrawal of consent|0|||
146835310|NCT03635086|529567419|FG001|Overall Study|Withdrawal of consent|0|||
146835311|NCT03635086|529567420|FG002|Overall Study|Withdrawal of consent|1|||
146835312|NCT03635086|529567421|FG003|Overall Study|Withdrawal of consent|0|||
146835313|NCT03635086|529567422|FG004|Overall Study|Withdrawal of consent|0|||
146835314|NCT03635086|529567418|FG000|Overall Study|Adverse Event|0|||
146835315|NCT03635086|529567419|FG001|Overall Study|Adverse Event|1|||
146835316|NCT03635086|529567420|FG002|Overall Study|Adverse Event|0|||
146835317|NCT03635086|529567421|FG003|Overall Study|Adverse Event|0|||
146835318|NCT03635086|529567422|FG004|Overall Study|Adverse Event|0|||
146835319|NCT03635086|529567418|FG000|Overall Study|Lost to Follow-up|1|||
146835320|NCT03635086|529567419|FG001|Overall Study|Lost to Follow-up|0|||
146835321|NCT03635086|529567420|FG002|Overall Study|Lost to Follow-up|0|||
146835322|NCT03635086|529567421|FG003|Overall Study|Lost to Follow-up|0|||
146835323|NCT03635086|529567422|FG004|Overall Study|Lost to Follow-up|0|||
146835324|NCT00723125|529567423|FG000|Overall Study|Met Dx|1|||
146835325|NCT00723125|529567424|FG001|Overall Study|Met Dx|0|||
146835326|NCT00723125|529567423|FG000|Overall Study|Withdrawal by Subject|15|||
146835327|NCT00723125|529567424|FG001|Overall Study|Withdrawal by Subject|6|||
146835328|NCT00723125|529567423|FG000|Overall Study|Adverse Event|2|||
146835329|NCT00723125|529567424|FG001|Overall Study|Adverse Event|0|||
146835330|NCT02196077|529567425|FG000|Overall Study|Adverse Event|4|||
146835331|NCT02196077|529567425|FG000|Overall Study|Lack of Efficacy|1|||
146989770|NCT02207231|530127326|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
146835332|NCT02196077|529567425|FG000|Overall Study|Withdrawal by Subject|14|||
146835333|NCT02196077|529567425|FG000|Overall Study|Physician Decision|1|||
146835334|NCT02196077|529567425|FG000|Overall Study|Lost to Follow-up|3|||
146835335|NCT02196077|529567425|FG000|Overall Study|Protocol Violation|24|||
146835336|NCT04042077|529567428|FG000|Overall Study|Adverse Event|0|||
146835337|NCT04042077|529567429|FG001|Overall Study|Adverse Event|1|||
146835338|NCT04042077|529567428|FG000|Overall Study|Death|2|||
146835339|NCT04042077|529567429|FG001|Overall Study|Death|1|||
146835340|NCT04042077|529567428|FG000|Overall Study|Physician Decision|2|||
146835341|NCT04042077|529567429|FG001|Overall Study|Physician Decision|0|||
146835342|NCT04042077|529567428|FG000|Overall Study|Withdrawal by Subject|3|||
146835343|NCT04042077|529567429|FG001|Overall Study|Withdrawal by Subject|2|||
146835344|NCT04042077|529567428|FG000|Overall Study|Lack of Efficacy|0|||
146835345|NCT04042077|529567429|FG001|Overall Study|Lack of Efficacy|1|||
146835346|NCT03482752|529567432|FG000|Overall Study|Withdrawal by Subject|2|||
146835347|NCT03482752|529567432|FG000|Overall Study|Lost to Follow-up|1|||
146835348|NCT03482752|529567432|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
146835349|NCT01080300|529567433|FG000|Overall Study|Adverse Event|49|||
146835350|NCT01080300|529567434|FG001|Overall Study|Adverse Event|35|||
146835351|NCT01080300|529567433|FG000|Overall Study|Lack of Efficacy|12|||
146835352|NCT01080300|529567434|FG001|Overall Study|Lack of Efficacy|15|||
146835353|NCT01080300|529567433|FG000|Overall Study|Protocol Violation|7|||
146835354|NCT01080300|529567434|FG001|Overall Study|Protocol Violation|13|||
146835355|NCT01080300|529567433|FG000|Overall Study|Lost to Follow-up|10|||
146835356|NCT01080300|529567434|FG001|Overall Study|Lost to Follow-up|6|||
146835357|NCT01080300|529567433|FG000|Overall Study|Death|0|||
146835358|NCT01080300|529567434|FG001|Overall Study|Death|1|||
146835359|NCT01080300|529567433|FG000|Overall Study|Withdrawal by Subject|12|||
146835360|NCT01080300|529567434|FG001|Overall Study|Withdrawal by Subject|28|||
146835361|NCT01080300|529567433|FG000|Overall Study|Reasons not specified|4|||
146835362|NCT01080300|529567434|FG001|Overall Study|Reasons not specified|6|||
146835363|NCT02844777|529567435|FG000|Overall Study|Withdrawal by Subject|2|||
146835364|NCT02844777|529567436|FG001|Overall Study|Withdrawal by Subject|0|||
146835365|NCT02844777|529567437|FG002|Overall Study|Withdrawal by Subject|0|||
146835366|NCT01776008|529567438|FG000|Overall Study|ineligible|2|||
146835367|NCT00150618|529567440|FG000|Overall Study|Adverse Event|2|||
146835368|NCT00150618|529567441|FG001|Overall Study|Adverse Event|2|||
146835369|NCT00150618|529567442|FG002|Overall Study|Adverse Event|6|||
146835370|NCT00150618|529567443|FG003|Overall Study|Adverse Event|9|||
146835371|NCT00150618|529567444|FG004|Overall Study|Adverse Event|5|||
146835372|NCT00150618|529567440|FG000|Overall Study|Withdrawal by Subject|6|||
146835373|NCT00150618|529567441|FG001|Overall Study|Withdrawal by Subject|8|||
146835374|NCT00150618|529567442|FG002|Overall Study|Withdrawal by Subject|8|||
146835375|NCT00150618|529567443|FG003|Overall Study|Withdrawal by Subject|4|||
146835376|NCT00150618|529567444|FG004|Overall Study|Withdrawal by Subject|5|||
146835377|NCT00150618|529567440|FG000|Overall Study|Lost to Follow-up|4|||
146835378|NCT00150618|529567441|FG001|Overall Study|Lost to Follow-up|1|||
146835379|NCT00150618|529567442|FG002|Overall Study|Lost to Follow-up|5|||
146835380|NCT00150618|529567443|FG003|Overall Study|Lost to Follow-up|8|||
146835381|NCT00150618|529567444|FG004|Overall Study|Lost to Follow-up|4|||
146835382|NCT00150618|529567440|FG000|Overall Study|Protocol Violation|1|||
146835383|NCT00150618|529567441|FG001|Overall Study|Protocol Violation|0|||
146835384|NCT00150618|529567442|FG002|Overall Study|Protocol Violation|0|||
146835385|NCT00150618|529567443|FG003|Overall Study|Protocol Violation|0|||
146835386|NCT00150618|529567444|FG004|Overall Study|Protocol Violation|1|||
146835387|NCT00150618|529567440|FG000|Overall Study|Lack of Efficacy|1|||
146835388|NCT00150618|529567441|FG001|Overall Study|Lack of Efficacy|4|||
146835389|NCT00150618|529567442|FG002|Overall Study|Lack of Efficacy|7|||
146835390|NCT00150618|529567443|FG003|Overall Study|Lack of Efficacy|4|||
146835391|NCT00150618|529567444|FG004|Overall Study|Lack of Efficacy|6|||
146835392|NCT00150618|529567440|FG000|Overall Study|No study meds|0|||
146835393|NCT00150618|529567441|FG001|Overall Study|No study meds|0|||
146835394|NCT00150618|529567442|FG002|Overall Study|No study meds|0|||
146835395|NCT00150618|529567443|FG003|Overall Study|No study meds|0|||
146835396|NCT00150618|529567444|FG004|Overall Study|No study meds|2|||
146835397|NCT00150618|529567440|FG000|Overall Study|Physician Decision|0|||
146835398|NCT00150618|529567441|FG001|Overall Study|Physician Decision|2|||
146835399|NCT00150618|529567442|FG002|Overall Study|Physician Decision|0|||
146835400|NCT00150618|529567443|FG003|Overall Study|Physician Decision|0|||
146835401|NCT00150618|529567444|FG004|Overall Study|Physician Decision|1|||
146835402|NCT00150618|529567440|FG000|Overall Study|Lack of compliance|2|||
146835403|NCT00150618|529567441|FG001|Overall Study|Lack of compliance|1|||
146835404|NCT00150618|529567442|FG002|Overall Study|Lack of compliance|1|||
146835405|NCT00150618|529567443|FG003|Overall Study|Lack of compliance|0|||
146835406|NCT00150618|529567444|FG004|Overall Study|Lack of compliance|1|||
146835407|NCT00150618|529567440|FG000|Overall Study|Abnormal ECG|1|||
146835408|NCT00150618|529567441|FG001|Overall Study|Abnormal ECG|0|||
146835409|NCT00150618|529567442|FG002|Overall Study|Abnormal ECG|0|||
146835410|NCT00150618|529567443|FG003|Overall Study|Abnormal ECG|0|||
146835411|NCT00150618|529567444|FG004|Overall Study|Abnormal ECG|0|||
146835412|NCT00150618|529567440|FG000|Overall Study|Sponsor's decision|0|||
146835413|NCT00150618|529567441|FG001|Overall Study|Sponsor's decision|0|||
146835414|NCT00150618|529567442|FG002|Overall Study|Sponsor's decision|0|||
146835415|NCT00150618|529567443|FG003|Overall Study|Sponsor's decision|1|||
146835416|NCT00150618|529567444|FG004|Overall Study|Sponsor's decision|0|||
146835417|NCT01162486|529567446|FG000|Overall Study|low ANC|1|||
146835418|NCT01162486|529567447|FG001|Overall Study|low ANC|0|||
146835419|NCT01162486|529567448|FG002|Overall Study|low ANC|0|||
146835420|NCT01162486|529567449|FG003|Overall Study|low ANC|0|||
146835421|NCT01162486|529567450|FG004|Overall Study|low ANC|0|||
146835422|NCT01162486|529567446|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
146835423|NCT01162486|529567447|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
146835424|NCT01162486|529567448|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
146835425|NCT01162486|529567449|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
146835426|NCT01162486|529567450|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
146835427|NCT01162486|529567446|FG000|Overall Study|elevated LFTs|0|||
146835428|NCT01162486|529567447|FG001|Overall Study|elevated LFTs|0|||
146835429|NCT01162486|529567448|FG002|Overall Study|elevated LFTs|1|||
146835430|NCT01162486|529567449|FG003|Overall Study|elevated LFTs|0|||
146835431|NCT01162486|529567450|FG004|Overall Study|elevated LFTs|0|||
146989771|NCT02207231|530127327|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
146989772|NCT02207231|530127328|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
146989773|NCT02207231|530127325|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
146989774|NCT02207231|530127326|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
146989775|NCT02207231|530127327|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
146989776|NCT02207231|530127328|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
146989777|NCT02207231|530127325|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
146835432|NCT01162486|529567446|FG000|Overall Study|Pregnancy|0|||
146835433|NCT01162486|529567447|FG001|Overall Study|Pregnancy|0|||
146835434|NCT01162486|529567448|FG002|Overall Study|Pregnancy|0|||
146835435|NCT01162486|529567449|FG003|Overall Study|Pregnancy|1|||
146835436|NCT01162486|529567450|FG004|Overall Study|Pregnancy|0|||
146835437|NCT00953615|529567451|FG000|Overall Study|Adverse Event|1|||
146835438|NCT03332784|529567452|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835439|NCT03332784|529567453|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
146835440|NCT03332784|529567454|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835441|NCT03332784|529567455|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835442|NCT03332784|529567456|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835443|NCT03332784|529567457|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835444|NCT03332784|529567458|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835445|NCT03332784|529567459|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835446|NCT03332784|529567460|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835447|NCT03332784|529567461|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835448|NCT03332784|529567462|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835449|NCT03332784|529567463|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835450|NCT03332784|529567464|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835451|NCT03332784|529567465|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835452|NCT03332784|529567466|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
146835453|NCT03332784|529567467|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835454|NCT03332784|529567468|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835455|NCT03332784|529567469|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835456|NCT03332784|529567470|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835457|NCT03332784|529567471|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146835458|NCT01018732|529567483|FG000|Overall Study|Lost to Follow-up|0|||
146835459|NCT01018732|529567484|FG001|Overall Study|Lost to Follow-up|0|||
146835460|NCT01018732|529567485|FG002|Overall Study|Lost to Follow-up|3|||
146835461|NCT01018732|529567483|FG000|Overall Study|Protocol Violation|1|||
146835462|NCT01018732|529567484|FG001|Overall Study|Protocol Violation|1|||
146835463|NCT01018732|529567485|FG002|Overall Study|Protocol Violation|0|||
146835464|NCT01018732|529567483|FG000|Overall Study|Inappropriate Enrollment|0|||
146835465|NCT01018732|529567484|FG001|Overall Study|Inappropriate Enrollment|1|||
146835466|NCT01018732|529567485|FG002|Overall Study|Inappropriate Enrollment|0|||
146835467|NCT01018732|529567483|FG000|Overall Study|Unable to Classify|0|||
146835468|NCT01018732|529567484|FG001|Overall Study|Unable to Classify|0|||
146835469|NCT01018732|529567485|FG002|Overall Study|Unable to Classify|1|||
146835470|NCT01536171|529567486|FG000|Overall Study|Withdrawal by Subject|1|||
146835471|NCT00585078|529567487|FG000|Overall Study|Withdrawal by Subject|4|||
146835472|NCT00585078|529567487|FG000|Overall Study|Poor performance status|1|||
146835473|NCT00585078|529567487|FG000|Overall Study|Disease Progression|24|||
146835474|NCT00585078|529567487|FG000|Overall Study|Adverse Event|10|||
146835475|NCT00585078|529567487|FG000|Overall Study|Death|1|||
146835476|NCT02781311|529567490|FG000|Overall Study|Adverse Event|2|||
146835477|NCT02781311|529567491|FG001|Overall Study|Adverse Event|6|||
146835478|NCT02781311|529567492|FG002|Overall Study|Adverse Event|1|||
146835479|NCT02781311|529567490|FG000|Overall Study|Withdrawal of Consent|11|||
146835480|NCT02781311|529567491|FG001|Overall Study|Withdrawal of Consent|12|||
146835481|NCT02781311|529567492|FG002|Overall Study|Withdrawal of Consent|2|||
146835482|NCT02781311|529567490|FG000|Overall Study|Lost to Follow-up|11|||
146835483|NCT02781311|529567491|FG001|Overall Study|Lost to Follow-up|8|||
146835484|NCT02781311|529567492|FG002|Overall Study|Lost to Follow-up|1|||
146835485|NCT02781311|529567490|FG000|Overall Study|Non-Compliance with Study Drug|2|||
146835486|NCT02781311|529567491|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146835487|NCT02781311|529567492|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146835488|NCT03784820|529567493|FG000|Overall Study|Lost to Follow-up|5|||
146835489|NCT03784820|529567494|FG001|Overall Study|Lost to Follow-up|5|||
146835490|NCT03784820|529567495|FG002|Overall Study|Lost to Follow-up|3|||
146835491|NCT03784820|529567496|FG003|Overall Study|Lost to Follow-up|3|||
146835492|NCT01255761|529567497|FG000|Overall Study|Adverse Event|29|||
146835493|NCT01255761|529567498|FG001|Overall Study|Adverse Event|43|||
146835494|NCT01255761|529567497|FG000|Overall Study|Lack of Efficacy|86|||
146835495|NCT01255761|529567498|FG001|Overall Study|Lack of Efficacy|74|||
146835496|NCT01255761|529567497|FG000|Overall Study|Protocol Violation|9|||
146835497|NCT01255761|529567498|FG001|Overall Study|Protocol Violation|5|||
146835498|NCT01255761|529567497|FG000|Overall Study|Lost to Follow-up|10|||
146835499|NCT01255761|529567498|FG001|Overall Study|Lost to Follow-up|8|||
146835500|NCT01255761|529567497|FG000|Overall Study|Withdrawal by Subject|11|||
146835501|NCT01255761|529567498|FG001|Overall Study|Withdrawal by Subject|27|||
146835502|NCT01255761|529567497|FG000|Overall Study|Other Reasons|37|||
146835503|NCT01255761|529567498|FG001|Overall Study|Other Reasons|18|||
146835504|NCT04147858|529567500|FG000|Overall Study|Adverse Event|6|||
146835505|NCT04147858|529567501|FG001|Overall Study|Adverse Event|6|||
146835506|NCT04147858|529567502|FG002|Overall Study|Adverse Event|6|||
146835507|NCT04147858|529567500|FG000|Overall Study|Lack of Efficacy|3|||
146835508|NCT04147858|529567501|FG001|Overall Study|Lack of Efficacy|3|||
146835509|NCT04147858|529567502|FG002|Overall Study|Lack of Efficacy|1|||
146835510|NCT04147858|529567500|FG000|Overall Study|Lost to Follow-up|1|||
146835511|NCT04147858|529567501|FG001|Overall Study|Lost to Follow-up|6|||
146835512|NCT04147858|529567502|FG002|Overall Study|Lost to Follow-up|2|||
146835513|NCT04147858|529567500|FG000|Overall Study|Withdrawal by Subject|3|||
146835514|NCT04147858|529567501|FG001|Overall Study|Withdrawal by Subject|4|||
146835515|NCT04147858|529567502|FG002|Overall Study|Withdrawal by Subject|10|||
146835516|NCT04147858|529567500|FG000|Overall Study|Subject Noncompliance, Other|4|||
146835517|NCT04147858|529567501|FG001|Overall Study|Subject Noncompliance, Other|3|||
146835518|NCT04147858|529567502|FG002|Overall Study|Subject Noncompliance, Other|1|||
146835519|NCT02336425|529567503|FG000|Overall Study|Study terminated.|2|||
146835520|NCT02336425|529567504|FG001|Overall Study|Study terminated.|2|||
146835521|NCT02336425|529567505|FG002|Overall Study|Study terminated.|3|||
146835522|NCT02336425|529567506|FG003|Overall Study|Study terminated.|3|||
146835523|NCT04905849|529567507|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
146835524|NCT04905849|529567508|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
146835525|NCT00838929|529567514|FG000|Overall Study|Protocol Violation|0|||
146835526|NCT00838929|529567515|FG001|Overall Study|Protocol Violation|1|||
146835527|NCT00838929|529567516|FG002|Overall Study|Protocol Violation|0|||
146835528|NCT00838929|529567514|FG000|Overall Study|Disease progression|0|||
146835529|NCT00838929|529567515|FG001|Overall Study|Disease progression|2|||
146835530|NCT00838929|529567516|FG002|Overall Study|Disease progression|1|||
146835531|NCT01240551|529569488|FG000|Overall Study|Refused further treatment|3|||
146835532|NCT01240551|529569489|FG001|Overall Study|Refused further treatment|2|||
146835533|NCT01240551|529569488|FG000|Overall Study|Lost to Follow-up|1|||
146835534|NCT01240551|529569489|FG001|Overall Study|Lost to Follow-up|1|||
146835535|NCT01439867|529569490|FG000|Overall Study|Non-compliance|0|||
146835536|NCT01439867|529569491|FG001|Overall Study|Non-compliance|1|||
146835537|NCT01439867|529569490|FG000|Overall Study|Withdrawal by Subject|1|||
146835538|NCT01439867|529569491|FG001|Overall Study|Withdrawal by Subject|2|||
146835539|NCT01439867|529569490|FG000|Overall Study|Administrative Decision|4|||
146835540|NCT01439867|529569491|FG001|Overall Study|Administrative Decision|5|||
146835541|NCT01439867|529569490|FG000|Overall Study|Protocol-specified Criteria|1|||
146989778|NCT02207231|530127326|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
146989779|NCT02207231|530127327|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
146989780|NCT02207231|530127328|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
146835542|NCT01439867|529569491|FG001|Overall Study|Protocol-specified Criteria|0|||
146835543|NCT02906020|529569494|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
146835544|NCT02906020|529569495|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
146835545|NCT02906020|529569496|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
146835546|NCT02906020|529569497|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
146835547|NCT02906020|529569498|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
146835548|NCT02906020|529569499|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
146835549|NCT02906020|529569500|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
146835550|NCT02906020|529569501|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
146835551|NCT02906020|529569502|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
146989781|NCT02207231|530127325|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
146835552|NCT02906020|529569503|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
146835553|NCT02906020|529569504|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
146835554|NCT02906020|529569505|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
146835555|NCT02906020|529569506|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
146835556|NCT02906020|529569507|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
146835557|NCT02906020|529569508|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
146835558|NCT02906020|529569509|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
146835559|NCT02906020|529569494|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146835560|NCT02906020|529569495|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146835561|NCT02906020|529569496|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146835562|NCT02906020|529569497|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146835563|NCT02906020|529569498|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146835564|NCT02906020|529569499|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146835565|NCT02906020|529569500|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146835566|NCT02906020|529569501|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146835567|NCT02906020|529569502|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
146835568|NCT02906020|529569503|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
146835569|NCT02906020|529569504|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146835570|NCT02906020|529569505|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146989782|NCT02207231|530127326|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
146989783|NCT02207231|530127327|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
146989784|NCT02207231|530127328|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
146989785|NCT02207231|530127325|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
146989786|NCT02207231|530127326|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
146989787|NCT02207231|530127327|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
146989788|NCT02207231|530127328|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
146989789|NCT02207231|530127325|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
146989790|NCT02207231|530127326|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
146989791|NCT02207231|530127327|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
146989792|NCT02207231|530127328|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
146989793|NCT02207231|530127325|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
146989794|NCT02207231|530127326|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
146989795|NCT02207231|530127327|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
146989796|NCT02207231|530127328|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
146989797|NCT02207231|530127325|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
146989798|NCT02207231|530127326|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
146989799|NCT02207231|530127327|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
146989800|NCT02207231|530127328|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
146989801|NCT02207231|530127325|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
146989802|NCT02207231|530127326|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
146989803|NCT02207231|530127327|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
146989804|NCT02207231|530127328|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
146989805|NCT02207231|530127325|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
146989806|NCT02207231|530127326|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
146989807|NCT02207231|530127327|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
146989808|NCT02207231|530127328|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
146989809|NCT02207231|530127325|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
146989810|NCT02207231|530127326|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
146989811|NCT02207231|530127327|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
146989812|NCT02207231|530127328|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
146989813|NCT02207231|530127325|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
146989814|NCT02207231|530127326|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
146989815|NCT02207231|530127327|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
146989816|NCT02207231|530127328|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
146989817|NCT02207231|530127325|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
146989818|NCT02207231|530127326|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
146989819|NCT02207231|530127327|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
146989820|NCT02207231|530127328|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
146989821|NCT02207231|530127325|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
146989822|NCT02207231|530127326|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
146989823|NCT02207231|530127327|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
146989824|NCT02207231|530127328|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
146989825|NCT00502775|530127332|FG000|Overall Study|Adverse Event|1|||
146989826|NCT00502775|530127333|FG001|Overall Study|Adverse Event|2|||
146989827|NCT00502775|530127334|FG002|Overall Study|Adverse Event|1|||
146989828|NCT00502775|530127332|FG000|Overall Study|Protocol Violation|1|||
146989829|NCT00502775|530127333|FG001|Overall Study|Protocol Violation|5|||
146989830|NCT00502775|530127334|FG002|Overall Study|Protocol Violation|2|||
146989831|NCT00502775|530127332|FG000|Overall Study|Withdrawal by Subject|1|||
146989832|NCT00502775|530127333|FG001|Overall Study|Withdrawal by Subject|1|||
146989833|NCT00502775|530127334|FG002|Overall Study|Withdrawal by Subject|2|||
146835571|NCT02906020|529569506|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146989834|NCT00502775|530127332|FG000|Overall Study|Sponsor Terminated Study|1|||
146989835|NCT00502775|530127333|FG001|Overall Study|Sponsor Terminated Study|0|||
146989836|NCT00502775|530127334|FG002|Overall Study|Sponsor Terminated Study|1|||
146989837|NCT00502775|530127332|FG000|Overall Study|Non-compliance with eDiary|4|||
146989838|NCT00502775|530127333|FG001|Overall Study|Non-compliance with eDiary|1|||
146835572|NCT02906020|529569507|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146989839|NCT00502775|530127334|FG002|Overall Study|Non-compliance with eDiary|1|||
146989840|NCT00502775|530127332|FG000|Overall Study|Subject unable to swallow capsule|1|||
146989841|NCT00502775|530127333|FG001|Overall Study|Subject unable to swallow capsule|0|||
146989842|NCT00502775|530127334|FG002|Overall Study|Subject unable to swallow capsule|1|||
146989843|NCT00502775|530127332|FG000|Overall Study|Logpad compliance <80%|1|||
146989844|NCT00502775|530127333|FG001|Overall Study|Logpad compliance <80%|0|||
146989845|NCT00502775|530127334|FG002|Overall Study|Logpad compliance <80%|0|||
146989846|NCT00502775|530127332|FG000|Overall Study|Randomized in error|0|||
146989847|NCT00502775|530127333|FG001|Overall Study|Randomized in error|1|||
146989848|NCT00502775|530127334|FG002|Overall Study|Randomized in error|1|||
146989849|NCT00502775|530127332|FG000|Overall Study|Non-compliance|0|||
146989850|NCT00502775|530127333|FG001|Overall Study|Non-compliance|2|||
146989851|NCT00502775|530127334|FG002|Overall Study|Non-compliance|2|||
146989852|NCT00502775|530127332|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
146989853|NCT00502775|530127333|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
146989854|NCT00502775|530127334|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
146989855|NCT00502775|530127332|FG000|Overall Study|Declining pollen counts|0|||
146989856|NCT00502775|530127333|FG001|Overall Study|Declining pollen counts|1|||
146989857|NCT00502775|530127334|FG002|Overall Study|Declining pollen counts|1|||
146989858|NCT00502775|530127332|FG000|Overall Study|Subject in jail|0|||
146989859|NCT00502775|530127333|FG001|Overall Study|Subject in jail|1|||
146989860|NCT00502775|530127334|FG002|Overall Study|Subject in jail|0|||
146989861|NCT00502775|530127332|FG000|Overall Study|Subject took disallowed drug|0|||
146989862|NCT00502775|530127333|FG001|Overall Study|Subject took disallowed drug|0|||
146989863|NCT00502775|530127334|FG002|Overall Study|Subject took disallowed drug|1|||
146989864|NCT02016300|530127338|FG000|Overall Study|Lost to Follow-up|0|||
146989865|NCT02016300|530127339|FG001|Overall Study|Lost to Follow-up|3|||
146989866|NCT06165744|530127346|FG000|Overall Study|Non device-related adverse event|1|||
146989867|NCT01545076|530127347|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
146989868|NCT01545076|530127348|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
146989869|NCT01545076|530127349|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
146989870|NCT01545076|530127350|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
146989871|NCT01545076|530127351|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
146989872|NCT01545076|530127347|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
146989873|NCT01545076|530127348|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
146989874|NCT01545076|530127349|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
146989875|NCT01545076|530127350|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
146989876|NCT01545076|530127351|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
146989877|NCT01545076|530127347|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
146989878|NCT01545076|530127348|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
146989879|NCT01545076|530127349|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
146989880|NCT01545076|530127350|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
146989881|NCT01545076|530127351|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
146989882|NCT01545076|530127347|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
146989883|NCT01545076|530127348|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
146989884|NCT01545076|530127349|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
146989885|NCT01545076|530127350|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
146989886|NCT01545076|530127351|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
146989887|NCT01545076|530127347|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
146989888|NCT01545076|530127348|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
146989889|NCT01545076|530127349|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
146989890|NCT01545076|530127350|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
146835573|NCT02906020|529569508|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146989891|NCT01545076|530127351|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
146989892|NCT01545076|530127347|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
146989893|NCT01545076|530127348|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
146989894|NCT01545076|530127349|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
146989895|NCT01545076|530127350|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
146989896|NCT01545076|530127351|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
146989897|NCT01545076|530127347|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
146989898|NCT01545076|530127348|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
146989899|NCT01545076|530127349|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
146989900|NCT01545076|530127350|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
146989901|NCT01545076|530127351|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
146989902|NCT01545076|530127347|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
146989903|NCT01545076|530127348|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
146989904|NCT01545076|530127349|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
146989905|NCT01545076|530127350|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
146989906|NCT01545076|530127351|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
146989907|NCT01545076|530127347|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
146989908|NCT01545076|530127348|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
146989909|NCT01545076|530127349|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
146989910|NCT01545076|530127350|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
146989911|NCT01545076|530127351|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
146989912|NCT01546987|530127352|FG000|Overall Study|Protocol Violation|3|||
146989913|NCT01546987|530127353|FG001|Overall Study|Protocol Violation|4|||
146989914|NCT02270736|530127354|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
146989915|NCT02270736|530127355|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
146989916|NCT02270736|530127356|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
146989917|NCT02270736|530127357|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
146989918|NCT02270736|530127358|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
146989919|NCT02270736|530127354|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
146989920|NCT02270736|530127355|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
146989921|NCT02270736|530127356|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
146989922|NCT02270736|530127357|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
146989923|NCT02270736|530127358|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
146989924|NCT02270736|530127354|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
146989925|NCT02270736|530127355|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
146989926|NCT02270736|530127356|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
146989927|NCT02270736|530127357|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
146989928|NCT02270736|530127358|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
146989929|NCT02270736|530127354|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
146989930|NCT02270736|530127355|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
146989931|NCT02270736|530127356|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
146989932|NCT02270736|530127357|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
146989933|NCT02270736|530127358|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
146989934|NCT02270736|530127354|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
146989935|NCT02270736|530127355|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
146989936|NCT02270736|530127356|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
146989937|NCT02270736|530127357|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
146989938|NCT02270736|530127358|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
146989939|NCT02270736|530127354|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
146989940|NCT02270736|530127355|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
146989941|NCT02270736|530127356|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
146989942|NCT02270736|530127357|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
146989943|NCT02270736|530127358|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
146989944|NCT02270736|530127354|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
146989945|NCT02270736|530127355|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
146989946|NCT02270736|530127356|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
146989947|NCT02270736|530127357|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
146989948|NCT02270736|530127358|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
146989949|NCT02270736|530127354|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
146989950|NCT02270736|530127355|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
146989951|NCT02270736|530127356|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
146989952|NCT02270736|530127357|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
146989953|NCT02270736|530127358|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
146989954|NCT02270736|530127354|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
146989955|NCT02270736|530127355|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
146989956|NCT02270736|530127356|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
146989957|NCT02270736|530127357|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
146989958|NCT02270736|530127358|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
146989959|NCT00262600|530127359|FG000|Overall Study|Lost to Follow-up|17|||
146989960|NCT00262600|530127360|FG001|Overall Study|Lost to Follow-up|31|||
146989961|NCT00262600|530127361|FG002|Overall Study|Lost to Follow-up|41|||
146989962|NCT00262600|530127359|FG000|Overall Study|Withdrawal by Subject|128|||
146989963|NCT00262600|530127360|FG001|Overall Study|Withdrawal by Subject|145|||
146989964|NCT00262600|530127361|FG002|Overall Study|Withdrawal by Subject|139|||
146989965|NCT00262600|530127359|FG000|Overall Study|Not Treated|32|||
146989966|NCT00262600|530127360|FG001|Overall Study|Not Treated|17|||
146989967|NCT00262600|530127361|FG002|Overall Study|Not Treated|24|||
146989968|NCT00262600|530127359|FG000|Overall Study|Other|58|||
146989969|NCT00262600|530127360|FG001|Overall Study|Other|59|||
146989970|NCT00262600|530127361|FG002|Overall Study|Other|62|||
146989971|NCT02710123|530127362|FG000|Overall Study|Lost to Follow-up|3|||
146989972|NCT02710123|530127363|FG001|Overall Study|Lost to Follow-up|4|||
146989973|NCT02710123|530127362|FG000|Overall Study|Withdrawal by Subject|1|||
146989974|NCT02710123|530127363|FG001|Overall Study|Withdrawal by Subject|1|||
146989975|NCT02710123|530127362|FG000|Overall Study|Illness unrelated to study intervention|1|||
146989976|NCT02710123|530127363|FG001|Overall Study|Illness unrelated to study intervention|0|||
146989977|NCT05381948|530127364|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
146989978|NCT05381948|530127365|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
146989979|NCT05381948|530127366|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
146989980|NCT05381948|530127364|FG000|Overall Study|Adverse Event: Non-ocular|0|||
146989981|NCT05381948|530127365|FG001|Overall Study|Adverse Event: Non-ocular|1|||
146989982|NCT05381948|530127366|FG002|Overall Study|Adverse Event: Non-ocular|0|||
146989983|NCT05381948|530127364|FG000|Overall Study|Lost to Follow-up|1|||
146989984|NCT05381948|530127365|FG001|Overall Study|Lost to Follow-up|0|||
146989985|NCT05381948|530127366|FG002|Overall Study|Lost to Follow-up|0|||
146989986|NCT05381948|530127364|FG000|Overall Study|Protocol Deviation|0|||
146989987|NCT05381948|530127365|FG001|Overall Study|Protocol Deviation|2|||
146989988|NCT05381948|530127366|FG002|Overall Study|Protocol Deviation|0|||
146989989|NCT05381948|530127364|FG000|Overall Study|Withdrawal by Subject|1|||
146989990|NCT05381948|530127365|FG001|Overall Study|Withdrawal by Subject|0|||
146989991|NCT05381948|530127366|FG002|Overall Study|Withdrawal by Subject|1|||
146989992|NCT05381948|530127364|FG000|Overall Study|Death|0|||
146989993|NCT05381948|530127365|FG001|Overall Study|Death|2|||
146989994|NCT05381948|530127366|FG002|Overall Study|Death|0|||
146989995|NCT05381948|530127364|FG000|Overall Study|Discontinued study without receiving study drug|0|||
146989996|NCT05381948|530127365|FG001|Overall Study|Discontinued study without receiving study drug|0|||
146989997|NCT05381948|530127366|FG002|Overall Study|Discontinued study without receiving study drug|1|||
146989998|NCT02446132|530127369|FG000|Overall Study|Adverse Event|10|||
146989999|NCT02446132|530127370|FG001|Overall Study|Adverse Event|27|||
146990000|NCT02446132|530127371|FG002|Overall Study|Adverse Event|27|||
146990001|NCT02446132|530127369|FG000|Overall Study|Death|2|||
146990002|NCT02446132|530127370|FG001|Overall Study|Death|13|||
146990003|NCT02446132|530127371|FG002|Overall Study|Death|10|||
146990004|NCT02446132|530127369|FG000|Overall Study|Lack of Efficacy|1|||
146990005|NCT02446132|530127370|FG001|Overall Study|Lack of Efficacy|10|||
146990006|NCT02446132|530127371|FG002|Overall Study|Lack of Efficacy|6|||
146990007|NCT02446132|530127369|FG000|Overall Study|Lost to Follow-up|2|||
146990008|NCT02446132|530127370|FG001|Overall Study|Lost to Follow-up|4|||
146990009|NCT02446132|530127371|FG002|Overall Study|Lost to Follow-up|5|||
146990010|NCT02446132|530127369|FG000|Overall Study|Non-compliance With Study Drug|2|||
146990011|NCT02446132|530127370|FG001|Overall Study|Non-compliance With Study Drug|2|||
146990012|NCT02446132|530127371|FG002|Overall Study|Non-compliance With Study Drug|3|||
146990013|NCT02446132|530127369|FG000|Overall Study|Physician Decision|1|||
146990014|NCT02446132|530127370|FG001|Overall Study|Physician Decision|8|||
146990015|NCT02446132|530127371|FG002|Overall Study|Physician Decision|13|||
146990016|NCT02446132|530127369|FG000|Overall Study|Protocol Deviation|0|||
146990017|NCT02446132|530127370|FG001|Overall Study|Protocol Deviation|0|||
146990018|NCT02446132|530127371|FG002|Overall Study|Protocol Deviation|1|||
146990019|NCT02446132|530127369|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
146990020|NCT02446132|530127370|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
146990021|NCT02446132|530127371|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
146990022|NCT02446132|530127369|FG000|Overall Study|Study Terminated by Sponsor|4|||
146990023|NCT02446132|530127370|FG001|Overall Study|Study Terminated by Sponsor|35|||
146990024|NCT02446132|530127371|FG002|Overall Study|Study Terminated by Sponsor|58|||
146990025|NCT02446132|530127369|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
146990026|NCT02446132|530127370|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
146990027|NCT02446132|530127371|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
146990028|NCT02446132|530127369|FG000|Overall Study|Withdrawal by Subject|11|||
146990029|NCT02446132|530127370|FG001|Overall Study|Withdrawal by Subject|29|||
146990030|NCT02446132|530127371|FG002|Overall Study|Withdrawal by Subject|25|||
146990031|NCT02446132|530127369|FG000|Overall Study|Reason not Specified|4|||
146990032|NCT02446132|530127370|FG001|Overall Study|Reason not Specified|16|||
146990033|NCT02446132|530127371|FG002|Overall Study|Reason not Specified|10|||
146990034|NCT02446132|530127369|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
146990035|NCT02446132|530127370|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
146990036|NCT02446132|530127371|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
146990037|NCT05526248|530127372|FG000|Overall Study|Lost to Follow-up|1|||
146990038|NCT05526248|530127372|FG000|Overall Study|Adverse Event|2|||
146990039|NCT05526248|530127372|FG000|Overall Study|Withdrawal by Subject|1|||
146990040|NCT03444038|530127373|FG000|Overall Study|Adverse Event|12|||
146990041|NCT03444038|530127373|FG000|Overall Study|Withdrawal by Subject|7|||
146990042|NCT03444038|530127373|FG000|Overall Study|Lost to Follow-up|1|||
146990043|NCT03444038|530127373|FG000|Overall Study|Physician Decision|2|||
146990044|NCT03444038|530127373|FG000|Overall Study|Lack of Efficacy|7|||
146990045|NCT00977106|530127374|FG000|Overall Study|Adverse Event|5|||
146990046|NCT00977106|530127375|FG001|Overall Study|Adverse Event|6|||
146990047|NCT00977106|530127374|FG000|Overall Study|Withdrawal by Subject|2|||
146990048|NCT00977106|530127375|FG001|Overall Study|Withdrawal by Subject|2|||
146990049|NCT00977106|530127374|FG000|Overall Study|Lack of Efficacy|2|||
146990050|NCT00977106|530127375|FG001|Overall Study|Lack of Efficacy|2|||
146990051|NCT00977106|530127374|FG000|Overall Study|Protocol Violation|0|||
146990052|NCT00977106|530127375|FG001|Overall Study|Protocol Violation|1|||
146990053|NCT00977106|530127374|FG000|Overall Study|Other|1|||
146990054|NCT00977106|530127375|FG001|Overall Study|Other|0|||
146990055|NCT00436007|530127378|FG000|Overall Study|Withdrawal by Subject|5|||
146990056|NCT00436007|530127379|FG001|Overall Study|Withdrawal by Subject|3|||
146990057|NCT00436007|530127380|FG002|Overall Study|Withdrawal by Subject|4|||
146990058|NCT00436007|530127378|FG000|Overall Study|Lost to Follow-up|14|||
146990059|NCT00436007|530127379|FG001|Overall Study|Lost to Follow-up|10|||
146990060|NCT00436007|530127380|FG002|Overall Study|Lost to Follow-up|13|||
146990061|NCT00436007|530127378|FG000|Overall Study|Physician Decision|0|||
146990062|NCT00436007|530127379|FG001|Overall Study|Physician Decision|0|||
146990063|NCT00436007|530127380|FG002|Overall Study|Physician Decision|2|||
146990064|NCT00436007|530127378|FG000|Overall Study|Death|0|||
146990065|NCT00436007|530127379|FG001|Overall Study|Death|1|||
146990066|NCT00436007|530127380|FG002|Overall Study|Death|3|||
146990067|NCT00436007|530127378|FG000|Overall Study|Other|0|||
146990068|NCT00436007|530127379|FG001|Overall Study|Other|0|||
146990069|NCT00436007|530127380|FG002|Overall Study|Other|1|||
146990070|NCT01957488|530127381|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
146990071|NCT01957488|530127382|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
146990072|NCT01957488|530127383|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
146990073|NCT01957488|530127384|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
146990074|NCT01957488|530127385|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
146990075|NCT01957488|530127386|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
146990076|NCT01957488|530127381|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
146990077|NCT01957488|530127382|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
146990078|NCT01957488|530127383|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
146990079|NCT01957488|530127384|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
146990080|NCT01957488|530127385|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
146990081|NCT01957488|530127386|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
146990082|NCT01957488|530127381|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
146990083|NCT01957488|530127382|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
146990084|NCT01957488|530127383|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
146990085|NCT01957488|530127384|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
146990086|NCT01957488|530127385|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
146990087|NCT01957488|530127386|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
146990088|NCT01957488|530127381|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
146990089|NCT01957488|530127382|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
146990090|NCT01957488|530127383|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
146990091|NCT01957488|530127384|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
146990092|NCT01957488|530127385|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
146990093|NCT01957488|530127386|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
146990094|NCT01957488|530127381|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
146990095|NCT01957488|530127382|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
146990096|NCT01957488|530127383|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
146990097|NCT01957488|530127384|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
146990098|NCT01957488|530127385|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
146990099|NCT01957488|530127386|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
146990100|NCT01957488|530127381|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
146990101|NCT01957488|530127382|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
146990102|NCT01957488|530127383|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
146990103|NCT01957488|530127384|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
146990104|NCT01957488|530127385|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
146990105|NCT01957488|530127386|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
146990106|NCT01957488|530127381|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
146990107|NCT01957488|530127382|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
146990108|NCT01957488|530127383|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
146990109|NCT01957488|530127384|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
146990110|NCT01957488|530127385|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
146990111|NCT01957488|530127386|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
146990112|NCT01957488|530127381|FG000|Test Period 2 (2 Weeks)|Other|1|||
146990113|NCT01957488|530127382|FG001|Test Period 2 (2 Weeks)|Other|0|||
146990114|NCT01957488|530127383|FG002|Test Period 2 (2 Weeks)|Other|0|||
146990115|NCT01957488|530127384|FG003|Test Period 2 (2 Weeks)|Other|0|||
146990116|NCT01957488|530127385|FG004|Test Period 2 (2 Weeks)|Other|0|||
146990117|NCT01957488|530127386|FG005|Test Period 2 (2 Weeks)|Other|0|||
146990118|NCT01957488|530127381|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
146990119|NCT01957488|530127382|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
146990120|NCT01957488|530127383|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
146990121|NCT01957488|530127384|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
146990122|NCT01957488|530127385|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
146990123|NCT01957488|530127386|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
146990124|NCT01957488|530127381|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
146990125|NCT01957488|530127382|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
146990126|NCT01957488|530127383|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
146990127|NCT01957488|530127384|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
146990128|NCT01957488|530127385|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
146990129|NCT01957488|530127386|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
146990130|NCT01957488|530127381|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
146990131|NCT01957488|530127382|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
146835574|NCT02906020|529569509|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146990132|NCT01957488|530127383|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
146990133|NCT01957488|530127384|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
146990134|NCT01957488|530127385|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
146990135|NCT01957488|530127386|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
146990136|NCT01957488|530127381|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
146990137|NCT01957488|530127382|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
146990138|NCT01957488|530127383|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
146990139|NCT01957488|530127384|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
146990140|NCT01957488|530127385|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
146990141|NCT01957488|530127386|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
146990142|NCT01957488|530127381|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
146990143|NCT01957488|530127382|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
146990144|NCT01957488|530127383|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
146990145|NCT01957488|530127384|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
146990146|NCT01957488|530127385|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
146990147|NCT01957488|530127386|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
146990148|NCT00721409|530127387|FG000|Overall Study|Global deterioration of health status|2|||
146990149|NCT00721409|530127388|FG001|Overall Study|Global deterioration of health status|6|||
146990150|NCT00721409|530127389|FG002|Overall Study|Global deterioration of health status|3|||
146990151|NCT00721409|530127387|FG000|Overall Study|Death|0|||
146990152|NCT00721409|530127388|FG001|Overall Study|Death|1|||
146990153|NCT00721409|530127389|FG002|Overall Study|Death|0|||
146990154|NCT00721409|530127387|FG000|Overall Study|Randomized not Treated|0|||
146990155|NCT00721409|530127388|FG001|Overall Study|Randomized not Treated|1|||
146990156|NCT00721409|530127389|FG002|Overall Study|Randomized not Treated|4|||
146990157|NCT00721409|530127387|FG000|Overall Study|Reason not specified|1|||
146990158|NCT00721409|530127388|FG001|Overall Study|Reason not specified|0|||
146990159|NCT00721409|530127389|FG002|Overall Study|Reason not specified|2|||
146990160|NCT00721409|530127387|FG000|Overall Study|Adverse Event|0|||
146990161|NCT00721409|530127388|FG001|Overall Study|Adverse Event|13|||
146990162|NCT00721409|530127389|FG002|Overall Study|Adverse Event|2|||
146990163|NCT00721409|530127387|FG000|Overall Study|Lost to Follow-up|0|||
146990164|NCT00721409|530127388|FG001|Overall Study|Lost to Follow-up|0|||
146990165|NCT00721409|530127389|FG002|Overall Study|Lost to Follow-up|1|||
146990166|NCT00721409|530127387|FG000|Overall Study|Withdrawal by Subject|1|||
146990167|NCT00721409|530127388|FG001|Overall Study|Withdrawal by Subject|6|||
146990168|NCT00721409|530127389|FG002|Overall Study|Withdrawal by Subject|5|||
146990169|NCT00721409|530127387|FG000|Overall Study|Objective progression or relapse|8|||
146990170|NCT00721409|530127388|FG001|Overall Study|Objective progression or relapse|55|||
146990171|NCT00721409|530127389|FG002|Overall Study|Objective progression or relapse|62|||
146990172|NCT02419313|530127391|FG000|First Intervention|Lost to Follow-up|2|||
146990173|NCT02419313|530127392|FG001|First Intervention|Lost to Follow-up|0|||
146990174|NCT02419313|530127391|FG000|Second Intervention|Lost to Follow-up|1|||
146990175|NCT02419313|530127392|FG001|Second Intervention|Lost to Follow-up|0|||
146990176|NCT00810368|530127393|FG000|Overall Study|Lost to Follow-up|4|||
146990177|NCT00810368|530127394|FG001|Overall Study|Lost to Follow-up|2|||
146990178|NCT00810368|530127393|FG000|Overall Study|Lack of Efficacy|2|||
146990179|NCT00810368|530127394|FG001|Overall Study|Lack of Efficacy|0|||
146990180|NCT00623103|530127395|FG000|Overall Study|Adverse Event|70|||
146990181|NCT00623103|530127396|FG001|Overall Study|Adverse Event|60|||
146990182|NCT00623103|530127395|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146990183|NCT00623103|530127396|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
146990184|NCT00623103|530127395|FG000|Overall Study|Withdrawal by Subject|18|||
146990185|NCT00623103|530127396|FG001|Overall Study|Withdrawal by Subject|24|||
146990186|NCT00623103|530127395|FG000|Overall Study|Lost to Follow-up|4|||
146990187|NCT00623103|530127396|FG001|Overall Study|Lost to Follow-up|1|||
146990188|NCT00623103|530127395|FG000|Overall Study|Administrative problems|2|||
146990189|NCT00623103|530127396|FG001|Overall Study|Administrative problems|4|||
146835575|NCT02906020|529569494|FG000|Part 2: Double-blind Treatment Period|Other|0|||
146835576|NCT02906020|529569495|FG001|Part 2: Double-blind Treatment Period|Other|0|||
146990190|NCT00623103|530127395|FG000|Overall Study|Death|11|||
146835577|NCT02906020|529569496|FG002|Part 2: Double-blind Treatment Period|Other|0|||
146835578|NCT02906020|529569497|FG003|Part 2: Double-blind Treatment Period|Other|0|||
146990191|NCT00623103|530127396|FG001|Overall Study|Death|11|||
146990192|NCT00623103|530127395|FG000|Overall Study|Protocol deviation|2|||
146990193|NCT00623103|530127396|FG001|Overall Study|Protocol deviation|1|||
146990194|NCT00442936|530127400|FG000|Overall Study|Protocol Violation|1|||
146990195|NCT00442936|530127401|FG001|Overall Study|Protocol Violation|0|||
146990196|NCT00442936|530127402|FG002|Overall Study|Protocol Violation|1|||
146990197|NCT00442936|530127403|FG003|Overall Study|Protocol Violation|1|||
146990198|NCT00524459|530127405|FG000|Overall Study|Withdrawal by Subject|1|||
146990199|NCT00524459|530127405|FG000|Overall Study|Other|1|||
146990200|NCT02428699|530127406|FG000|Washout Period 1|Screen Failure|1|||
146990201|NCT02428699|530127407|FG001|Washout Period 1|Screen Failure|2|||
146990202|NCT02433678|530127408|FG000|Overall Study|Lost to Follow-up|1|||
146990203|NCT02433678|530127409|FG001|Overall Study|Lost to Follow-up|2|||
146990204|NCT04424407|530127410|FG000|Overall Study|Withdrawal by Subject|2|||
146990205|NCT04424407|530127410|FG000|Overall Study|Lost to Follow-up|1|||
146990206|NCT01424722|530127413|FG000|Overall Study|Sponsor terminated investigation|2258|||
146990207|NCT02684578|530127414|FG000|Overall Study|Withdrawal by Subject|10|||
146990208|NCT02684578|530127415|FG001|Overall Study|Withdrawal by Subject|7|||
146990209|NCT02684578|530127414|FG000|Overall Study|Lost to Follow-up|0|||
146990210|NCT02684578|530127415|FG001|Overall Study|Lost to Follow-up|3|||
146990211|NCT02684578|530127414|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
146990212|NCT02684578|530127415|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
146990213|NCT02684578|530127414|FG000|Overall Study|Missing follow-up data|0|||
146990214|NCT02684578|530127415|FG001|Overall Study|Missing follow-up data|1|||
146990215|NCT01153984|530127416|FG000|Overall Study|Withdrawal by Subject|1|||
146990216|NCT01153984|530127416|FG000|Overall Study|Adverse Event|1|||
146990217|NCT02460159|530127417|FG000|Overall Study|Adverse Event|4|||
146990218|NCT02460159|530127418|FG001|Overall Study|Adverse Event|1|||
146990219|NCT02460159|530127417|FG000|Overall Study|Withdrawal by Subject|2|||
146990220|NCT02460159|530127418|FG001|Overall Study|Withdrawal by Subject|0|||
146990221|NCT03499964|530127419|FG000|Overall Study|Lack of Efficacy|6|||
146990222|NCT03499964|530127420|FG001|Overall Study|Lack of Efficacy|26|||
146990223|NCT03499964|530127419|FG000|Overall Study|Adverse Event|1|||
146990224|NCT03499964|530127420|FG001|Overall Study|Adverse Event|0|||
146990225|NCT03499964|530127419|FG000|Overall Study|Death|1|||
146990226|NCT03499964|530127420|FG001|Overall Study|Death|0|||
146990227|NCT03499964|530127419|FG000|Overall Study|Withdrawal by Subject|2|||
146990228|NCT03499964|530127420|FG001|Overall Study|Withdrawal by Subject|1|||
146990229|NCT03499964|530127419|FG000|Overall Study|Lost to Follow-up|1|||
146990230|NCT03499964|530127420|FG001|Overall Study|Lost to Follow-up|0|||
146990231|NCT01193608|530127421|FG000|Overall Study|Other|0|||
146990232|NCT01193608|530127422|FG001|Overall Study|Other|1|||
146990233|NCT01193608|530127423|FG002|Overall Study|Other|0|||
146990234|NCT01193608|530127424|FG003|Overall Study|Other|0|||
146990235|NCT01193608|530127425|FG004|Overall Study|Other|0|||
146990236|NCT01193608|530127426|FG005|Overall Study|Other|0|||
146990237|NCT01193608|530127421|FG000|Overall Study|Withdrawal by Subject|0|||
146990238|NCT01193608|530127422|FG001|Overall Study|Withdrawal by Subject|1|||
146990239|NCT01193608|530127423|FG002|Overall Study|Withdrawal by Subject|2|||
146990240|NCT01193608|530127424|FG003|Overall Study|Withdrawal by Subject|3|||
146990241|NCT01193608|530127425|FG004|Overall Study|Withdrawal by Subject|3|||
146990242|NCT01193608|530127426|FG005|Overall Study|Withdrawal by Subject|0|||
146990243|NCT01193608|530127421|FG000|Overall Study|Lost to Follow-up|0|||
146990244|NCT01193608|530127422|FG001|Overall Study|Lost to Follow-up|0|||
146990245|NCT01193608|530127423|FG002|Overall Study|Lost to Follow-up|0|||
146990246|NCT01193608|530127424|FG003|Overall Study|Lost to Follow-up|0|||
146990247|NCT01193608|530127425|FG004|Overall Study|Lost to Follow-up|1|||
146990248|NCT01193608|530127426|FG005|Overall Study|Lost to Follow-up|2|||
146990249|NCT01193608|530127421|FG000|Overall Study|Adverse Event|0|||
146990250|NCT01193608|530127422|FG001|Overall Study|Adverse Event|0|||
146990251|NCT01193608|530127423|FG002|Overall Study|Adverse Event|0|||
146990252|NCT01193608|530127424|FG003|Overall Study|Adverse Event|0|||
146990253|NCT01193608|530127425|FG004|Overall Study|Adverse Event|1|||
146990254|NCT01193608|530127426|FG005|Overall Study|Adverse Event|0|||
146990255|NCT01025037|530127430|FG000|Overall Study|Adverse Event|3|||
146990256|NCT01025037|530127430|FG000|Overall Study|Lost to Follow-up|7|||
146990257|NCT01025037|530127430|FG000|Overall Study|Withdrawal by Subject|1|||
146990258|NCT02674334|530127433|FG000|Overall Study|Lost to Follow-up|5|||
146990259|NCT02674334|530127434|FG001|Overall Study|Lost to Follow-up|3|||
146990260|NCT02674334|530127433|FG000|Overall Study|participant difficulty breathing|1|||
146990261|NCT02674334|530127434|FG001|Overall Study|participant difficulty breathing|0|||
146990262|NCT02674334|530127433|FG000|Overall Study|NIRS not recording|1|||
146990263|NCT02674334|530127434|FG001|Overall Study|NIRS not recording|0|||
146835579|NCT02906020|529569498|FG004|Part 2: Double-blind Treatment Period|Other|0|||
146990264|NCT02660242|530127440|FG000|Glucose Tabs|Lost to Follow-up|1|||
146990265|NCT02660242|530127440|FG000|Glucagon Injection|Lost to Follow-up|1|||
146990266|NCT02796664|530127442|FG000|Overall Study|Withdrawal by Subject|0|||
146835580|NCT02906020|529569499|FG005|Part 2: Double-blind Treatment Period|Other|0|||
146990267|NCT02796664|530127443|FG001|Overall Study|Withdrawal by Subject|3|||
146990268|NCT02796664|530127442|FG000|Overall Study|Noncompliance|1|||
146990269|NCT02796664|530127443|FG001|Overall Study|Noncompliance|1|||
146990270|NCT02796664|530127442|FG000|Overall Study|Death|0|||
146990271|NCT02796664|530127443|FG001|Overall Study|Death|1|||
146990272|NCT01531205|530127444|FG000|Overall Study|Did not proceed to surgery|1|||
146990273|NCT00995553|530127445|FG000|Overall Study|Withdrawal by Subject|2|||
146990274|NCT00995553|530127446|FG001|Overall Study|Withdrawal by Subject|6|||
146990275|NCT01626079|530127449|FG000|Overall Study|Death|167|||
146990276|NCT01626079|530127450|FG001|Overall Study|Death|192|||
146990277|NCT01626079|530127451|FG002|Overall Study|Death|39|||
146990278|NCT01626079|530127449|FG000|Overall Study|Withdrawal by Subject|23|||
146990279|NCT01626079|530127450|FG001|Overall Study|Withdrawal by Subject|37|||
146990280|NCT01626079|530127451|FG002|Overall Study|Withdrawal by Subject|5|||
146990281|NCT01626079|530127449|FG000|Overall Study|Lost to Follow-up|7|||
146990282|NCT01626079|530127450|FG001|Overall Study|Lost to Follow-up|4|||
146990283|NCT01626079|530127451|FG002|Overall Study|Lost to Follow-up|2|||
146990284|NCT01626079|530127449|FG000|Overall Study|Missed Visits|1|||
146990285|NCT01626079|530127450|FG001|Overall Study|Missed Visits|4|||
146990286|NCT01626079|530127451|FG002|Overall Study|Missed Visits|6|||
146990287|NCT00814463|530127452|FG000|Overall Study|Lost to Follow-up|1|||
146990288|NCT04803357|530127454|FG000|Overall Study|Withdrawal by Subject|31|||
146990289|NCT04803357|530127455|FG001|Overall Study|Withdrawal by Subject|5|||
146990290|NCT05905783|530127457|FG000|Overall Study|Lost to Follow-up|12|||
146990291|NCT05905783|530127458|FG001|Overall Study|Lost to Follow-up|18|||
146990292|NCT05905783|530127457|FG000|Overall Study|Withdrawal by Subject|29|||
146990293|NCT05905783|530127458|FG001|Overall Study|Withdrawal by Subject|37|||
146990294|NCT05905783|530127457|FG000|Overall Study|Decision by sponsor|69|||
146990295|NCT05905783|530127458|FG001|Overall Study|Decision by sponsor|65|||
146990296|NCT03968224|530127459|FG000|Overall Study|Lost to Follow-up|11|||
146990297|NCT03968224|530127460|FG001|Overall Study|Lost to Follow-up|18|||
146990298|NCT03717064|530128658|FG000|Period 2|Adverse Event|1|||
146990299|NCT03103100|530128659|FG000|Overall Study|Adverse Event|1|||
146990300|NCT03103100|530128660|FG001|Overall Study|Adverse Event|0|||
146990301|NCT03103100|530128661|FG002|Overall Study|Adverse Event|0|||
146835581|NCT02906020|529569500|FG006|Part 2: Double-blind Treatment Period|Other|0|||
146835582|NCT02906020|529569501|FG007|Part 2: Double-blind Treatment Period|Other|0|||
146835583|NCT02906020|529569502|FG008|Part 2: Double-blind Treatment Period|Other|6|||
146835584|NCT02906020|529569503|FG009|Part 2: Double-blind Treatment Period|Other|10|||
146835585|NCT02906020|529569504|FG010|Part 2: Double-blind Treatment Period|Other|0|||
146835586|NCT02906020|529569505|FG011|Part 2: Double-blind Treatment Period|Other|0|||
146835587|NCT02906020|529569506|FG012|Part 2: Double-blind Treatment Period|Other|0|||
146990302|NCT03103100|530128659|FG000|Overall Study|Physician Decision|1|||
146990303|NCT03103100|530128660|FG001|Overall Study|Physician Decision|0|||
146990304|NCT03103100|530128661|FG002|Overall Study|Physician Decision|2|||
146990305|NCT00688064|530128664|FG000|Overall Study|Protocol Violation|0|||
146990306|NCT00688064|530128665|FG001|Overall Study|Protocol Violation|1|||
146990307|NCT00688064|530128664|FG000|Overall Study|Adverse Event|2|||
146990308|NCT00688064|530128665|FG001|Overall Study|Adverse Event|4|||
146990309|NCT00688064|530128664|FG000|Overall Study|Withdrawal by Subject|7|||
146990310|NCT00688064|530128665|FG001|Overall Study|Withdrawal by Subject|7|||
146990311|NCT00688064|530128664|FG000|Overall Study|Lost to Follow-up|10|||
146990312|NCT00688064|530128665|FG001|Overall Study|Lost to Follow-up|10|||
146990313|NCT00688064|530128664|FG000|Overall Study|Lack of Efficacy|0|||
146990314|NCT00688064|530128665|FG001|Overall Study|Lack of Efficacy|1|||
146990315|NCT00688064|530128664|FG000|Overall Study|Pregnancy|1|||
146990316|NCT00688064|530128665|FG001|Overall Study|Pregnancy|0|||
146990317|NCT00688064|530128664|FG000|Overall Study|Any other reasons|1|||
146990318|NCT00688064|530128665|FG001|Overall Study|Any other reasons|3|||
146990319|NCT00950807|530128673|FG000|Treatment Period 1|Lack of Efficacy|1|||
146990320|NCT00950807|530128674|FG001|Treatment Period 1|Lack of Efficacy|0|||
146990321|NCT00950807|530128675|FG002|Treatment Period 1|Lack of Efficacy|0|||
146990322|NCT00950807|530128676|FG003|Treatment Period 1|Lack of Efficacy|0|||
146990323|NCT00950807|530128677|FG004|Treatment Period 1|Lack of Efficacy|0|||
146990324|NCT00950807|530128678|FG005|Treatment Period 1|Lack of Efficacy|1|||
146990325|NCT00950807|530128679|FG006|Treatment Period 1|Lack of Efficacy|0|||
146990326|NCT00950807|530128680|FG007|Treatment Period 1|Lack of Efficacy|0|||
146990327|NCT00950807|530128681|FG008|Treatment Period 1|Lack of Efficacy|0|||
146990328|NCT00950807|530128682|FG009|Treatment Period 1|Lack of Efficacy|0|||
146990329|NCT00950807|530128673|FG000|Treatment Period 1|Protocol Violation|1|||
146990330|NCT00950807|530128674|FG001|Treatment Period 1|Protocol Violation|0|||
146990331|NCT00950807|530128675|FG002|Treatment Period 1|Protocol Violation|0|||
146990332|NCT00950807|530128676|FG003|Treatment Period 1|Protocol Violation|0|||
146990333|NCT00950807|530128677|FG004|Treatment Period 1|Protocol Violation|0|||
146990334|NCT00950807|530128678|FG005|Treatment Period 1|Protocol Violation|0|||
146990335|NCT00950807|530128679|FG006|Treatment Period 1|Protocol Violation|0|||
146990336|NCT00950807|530128680|FG007|Treatment Period 1|Protocol Violation|0|||
146990337|NCT00950807|530128681|FG008|Treatment Period 1|Protocol Violation|0|||
146990338|NCT00950807|530128682|FG009|Treatment Period 1|Protocol Violation|0|||
146990339|NCT00950807|530128673|FG000|Treatment Period 1|Lost to Follow-up|0|||
146990340|NCT00950807|530128674|FG001|Treatment Period 1|Lost to Follow-up|0|||
146990341|NCT00950807|530128675|FG002|Treatment Period 1|Lost to Follow-up|1|||
146990342|NCT00950807|530128676|FG003|Treatment Period 1|Lost to Follow-up|0|||
146990343|NCT00950807|530128677|FG004|Treatment Period 1|Lost to Follow-up|0|||
146990344|NCT00950807|530128678|FG005|Treatment Period 1|Lost to Follow-up|0|||
146990345|NCT00950807|530128679|FG006|Treatment Period 1|Lost to Follow-up|0|||
146990346|NCT00950807|530128680|FG007|Treatment Period 1|Lost to Follow-up|0|||
146990347|NCT00950807|530128681|FG008|Treatment Period 1|Lost to Follow-up|0|||
146990348|NCT00950807|530128682|FG009|Treatment Period 1|Lost to Follow-up|0|||
146990349|NCT00950807|530128673|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146990350|NCT00950807|530128674|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146990351|NCT00950807|530128675|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146990352|NCT00950807|530128676|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146990353|NCT00950807|530128677|FG004|Treatment Period 1|Withdrawal by Subject|1|||
146990354|NCT00950807|530128678|FG005|Treatment Period 1|Withdrawal by Subject|0|||
146990355|NCT00950807|530128679|FG006|Treatment Period 1|Withdrawal by Subject|0|||
146990356|NCT00950807|530128680|FG007|Treatment Period 1|Withdrawal by Subject|0|||
146990357|NCT00950807|530128681|FG008|Treatment Period 1|Withdrawal by Subject|1|||
146990358|NCT00950807|530128682|FG009|Treatment Period 1|Withdrawal by Subject|0|||
146990359|NCT00950807|530128673|FG000|Treatment Period 1|Adverse Event|0|||
146990360|NCT00950807|530128674|FG001|Treatment Period 1|Adverse Event|0|||
146990361|NCT00950807|530128675|FG002|Treatment Period 1|Adverse Event|0|||
146990362|NCT00950807|530128676|FG003|Treatment Period 1|Adverse Event|0|||
146990363|NCT00950807|530128677|FG004|Treatment Period 1|Adverse Event|0|||
146990364|NCT00950807|530128678|FG005|Treatment Period 1|Adverse Event|1|||
146990365|NCT00950807|530128679|FG006|Treatment Period 1|Adverse Event|0|||
146990366|NCT00950807|530128680|FG007|Treatment Period 1|Adverse Event|0|||
146990367|NCT00950807|530128681|FG008|Treatment Period 1|Adverse Event|0|||
146990368|NCT00950807|530128682|FG009|Treatment Period 1|Adverse Event|0|||
146990369|NCT00950807|530128673|FG000|Washout Period 1|Lack of Efficacy|0|||
146990370|NCT00950807|530128674|FG001|Washout Period 1|Lack of Efficacy|0|||
146990371|NCT00950807|530128675|FG002|Washout Period 1|Lack of Efficacy|0|||
146990372|NCT00950807|530128676|FG003|Washout Period 1|Lack of Efficacy|0|||
146990373|NCT00950807|530128677|FG004|Washout Period 1|Lack of Efficacy|0|||
146990374|NCT00950807|530128678|FG005|Washout Period 1|Lack of Efficacy|0|||
146990375|NCT00950807|530128679|FG006|Washout Period 1|Lack of Efficacy|1|||
146990376|NCT00950807|530128680|FG007|Washout Period 1|Lack of Efficacy|0|||
146990377|NCT00950807|530128681|FG008|Washout Period 1|Lack of Efficacy|0|||
146990378|NCT00950807|530128682|FG009|Washout Period 1|Lack of Efficacy|0|||
146990379|NCT00950807|530128673|FG000|Washout Period 1|Withdrawal by Subject|0|||
146990380|NCT00950807|530128674|FG001|Washout Period 1|Withdrawal by Subject|0|||
146990381|NCT00950807|530128675|FG002|Washout Period 1|Withdrawal by Subject|0|||
146990382|NCT00950807|530128676|FG003|Washout Period 1|Withdrawal by Subject|0|||
146990383|NCT00950807|530128677|FG004|Washout Period 1|Withdrawal by Subject|0|||
146990384|NCT00950807|530128678|FG005|Washout Period 1|Withdrawal by Subject|0|||
146990385|NCT00950807|530128679|FG006|Washout Period 1|Withdrawal by Subject|0|||
146990386|NCT00950807|530128680|FG007|Washout Period 1|Withdrawal by Subject|0|||
146990387|NCT00950807|530128681|FG008|Washout Period 1|Withdrawal by Subject|1|||
146990388|NCT00950807|530128682|FG009|Washout Period 1|Withdrawal by Subject|0|||
146990389|NCT00950807|530128673|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
146990390|NCT00950807|530128674|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
146990391|NCT00950807|530128675|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
146990392|NCT00950807|530128676|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
146990393|NCT00950807|530128677|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
146990394|NCT00950807|530128678|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
146990395|NCT00950807|530128679|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
146990396|NCT00950807|530128680|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
146990397|NCT00950807|530128681|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
146990398|NCT00950807|530128682|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
146990399|NCT00950807|530128673|FG000|Washout Period 1|Adverse Event|2|||
146990400|NCT00950807|530128674|FG001|Washout Period 1|Adverse Event|0|||
146990401|NCT00950807|530128675|FG002|Washout Period 1|Adverse Event|0|||
146990402|NCT00950807|530128676|FG003|Washout Period 1|Adverse Event|1|||
146990403|NCT00950807|530128677|FG004|Washout Period 1|Adverse Event|1|||
146990404|NCT00950807|530128678|FG005|Washout Period 1|Adverse Event|0|||
146990405|NCT00950807|530128679|FG006|Washout Period 1|Adverse Event|0|||
146990406|NCT00950807|530128680|FG007|Washout Period 1|Adverse Event|0|||
146990407|NCT00950807|530128681|FG008|Washout Period 1|Adverse Event|0|||
146990408|NCT00950807|530128682|FG009|Washout Period 1|Adverse Event|0|||
146990409|NCT00950807|530128673|FG000|Treatment Period 2|Lack of Efficacy|1|||
146990410|NCT00950807|530128674|FG001|Treatment Period 2|Lack of Efficacy|0|||
146835588|NCT02906020|529569507|FG013|Part 2: Double-blind Treatment Period|Other|0|||
146990411|NCT00950807|530128675|FG002|Treatment Period 2|Lack of Efficacy|0|||
146990412|NCT00950807|530128676|FG003|Treatment Period 2|Lack of Efficacy|0|||
146990413|NCT00950807|530128677|FG004|Treatment Period 2|Lack of Efficacy|0|||
146990414|NCT00950807|530128678|FG005|Treatment Period 2|Lack of Efficacy|0|||
146835589|NCT02906020|529569508|FG014|Part 2: Double-blind Treatment Period|Other|0|||
146990415|NCT00950807|530128679|FG006|Treatment Period 2|Lack of Efficacy|0|||
146835590|NCT02906020|529569509|FG015|Part 2: Double-blind Treatment Period|Other|0|||
146990416|NCT00950807|530128680|FG007|Treatment Period 2|Lack of Efficacy|0|||
146990417|NCT00950807|530128681|FG008|Treatment Period 2|Lack of Efficacy|0|||
146990418|NCT00950807|530128682|FG009|Treatment Period 2|Lack of Efficacy|0|||
146990419|NCT00950807|530128673|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146990420|NCT00950807|530128674|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146990421|NCT00950807|530128675|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146990422|NCT00950807|530128676|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146990423|NCT00950807|530128677|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146990424|NCT00950807|530128678|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146990425|NCT00950807|530128679|FG006|Treatment Period 2|Withdrawal by Subject|1|||
146990426|NCT00950807|530128680|FG007|Treatment Period 2|Withdrawal by Subject|2|||
146990427|NCT00950807|530128681|FG008|Treatment Period 2|Withdrawal by Subject|0|||
146990428|NCT00950807|530128682|FG009|Treatment Period 2|Withdrawal by Subject|0|||
146990429|NCT00950807|530128673|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
146990430|NCT00950807|530128674|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146990431|NCT00950807|530128675|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146990432|NCT00950807|530128676|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146990433|NCT00950807|530128677|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146990434|NCT00950807|530128678|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146990435|NCT00950807|530128679|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146990436|NCT00950807|530128680|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146990437|NCT00950807|530128681|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146990438|NCT00950807|530128682|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146990439|NCT00950807|530128673|FG000|Treatment Period 2|Adverse Event|0|||
146990440|NCT00950807|530128674|FG001|Treatment Period 2|Adverse Event|1|||
146990441|NCT00950807|530128675|FG002|Treatment Period 2|Adverse Event|0|||
146990442|NCT00950807|530128676|FG003|Treatment Period 2|Adverse Event|1|||
146990443|NCT00950807|530128677|FG004|Treatment Period 2|Adverse Event|0|||
146990444|NCT00950807|530128678|FG005|Treatment Period 2|Adverse Event|1|||
146990445|NCT00950807|530128679|FG006|Treatment Period 2|Adverse Event|0|||
146990446|NCT00950807|530128680|FG007|Treatment Period 2|Adverse Event|1|||
146990447|NCT00950807|530128681|FG008|Treatment Period 2|Adverse Event|0|||
146990448|NCT00950807|530128682|FG009|Treatment Period 2|Adverse Event|0|||
146990449|NCT00950807|530128673|FG000|Washout Period 2|Lack of Efficacy|1|||
146990450|NCT00950807|530128674|FG001|Washout Period 2|Lack of Efficacy|0|||
146990451|NCT00950807|530128675|FG002|Washout Period 2|Lack of Efficacy|0|||
146990452|NCT00950807|530128676|FG003|Washout Period 2|Lack of Efficacy|0|||
146990453|NCT00950807|530128677|FG004|Washout Period 2|Lack of Efficacy|0|||
146990454|NCT00950807|530128678|FG005|Washout Period 2|Lack of Efficacy|0|||
146990455|NCT00950807|530128679|FG006|Washout Period 2|Lack of Efficacy|0|||
146990456|NCT00950807|530128680|FG007|Washout Period 2|Lack of Efficacy|0|||
146990457|NCT00950807|530128681|FG008|Washout Period 2|Lack of Efficacy|0|||
146990458|NCT00950807|530128682|FG009|Washout Period 2|Lack of Efficacy|0|||
146990459|NCT00950807|530128673|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
146990460|NCT00950807|530128674|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
146990461|NCT00950807|530128675|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
146990462|NCT00950807|530128676|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
146990463|NCT00950807|530128677|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
146990464|NCT00950807|530128678|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
146990465|NCT00950807|530128679|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
146990466|NCT00950807|530128680|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
146990467|NCT00950807|530128681|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
146990468|NCT00950807|530128682|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
146990469|NCT00950807|530128673|FG000|Washout Period 2|Adverse Event|3|||
146990470|NCT00950807|530128674|FG001|Washout Period 2|Adverse Event|0|||
146990471|NCT00950807|530128675|FG002|Washout Period 2|Adverse Event|0|||
146990472|NCT00950807|530128676|FG003|Washout Period 2|Adverse Event|1|||
146990473|NCT00950807|530128677|FG004|Washout Period 2|Adverse Event|0|||
146990474|NCT00950807|530128678|FG005|Washout Period 2|Adverse Event|0|||
146990475|NCT00950807|530128679|FG006|Washout Period 2|Adverse Event|0|||
146990476|NCT00950807|530128680|FG007|Washout Period 2|Adverse Event|0|||
146990477|NCT00950807|530128681|FG008|Washout Period 2|Adverse Event|0|||
146990478|NCT00950807|530128682|FG009|Washout Period 2|Adverse Event|0|||
146990479|NCT00950807|530128673|FG000|Treatment Period 3|Withdrawal by Subject|0|||
146990480|NCT00950807|530128674|FG001|Treatment Period 3|Withdrawal by Subject|0|||
146990481|NCT00950807|530128675|FG002|Treatment Period 3|Withdrawal by Subject|0|||
146990482|NCT00950807|530128676|FG003|Treatment Period 3|Withdrawal by Subject|0|||
146990483|NCT00950807|530128677|FG004|Treatment Period 3|Withdrawal by Subject|0|||
146990484|NCT00950807|530128678|FG005|Treatment Period 3|Withdrawal by Subject|0|||
146990485|NCT00950807|530128679|FG006|Treatment Period 3|Withdrawal by Subject|0|||
146990486|NCT00950807|530128680|FG007|Treatment Period 3|Withdrawal by Subject|0|||
146990487|NCT00950807|530128681|FG008|Treatment Period 3|Withdrawal by Subject|0|||
146990488|NCT00950807|530128682|FG009|Treatment Period 3|Withdrawal by Subject|1|||
146990489|NCT00950807|530128673|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
146990490|NCT00950807|530128674|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146990491|NCT00950807|530128675|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146990492|NCT00950807|530128676|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146990493|NCT00950807|530128677|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146990494|NCT00950807|530128678|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146990495|NCT00950807|530128679|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146990496|NCT00950807|530128680|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
146990497|NCT00950807|530128681|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146990498|NCT00950807|530128682|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146990499|NCT00950807|530128673|FG000|Treatment Period 3|Adverse Event|0|||
146990500|NCT00950807|530128674|FG001|Treatment Period 3|Adverse Event|0|||
146990501|NCT00950807|530128675|FG002|Treatment Period 3|Adverse Event|0|||
146990502|NCT00950807|530128676|FG003|Treatment Period 3|Adverse Event|0|||
146990503|NCT00950807|530128677|FG004|Treatment Period 3|Adverse Event|0|||
146990504|NCT00950807|530128678|FG005|Treatment Period 3|Adverse Event|0|||
146990505|NCT00950807|530128679|FG006|Treatment Period 3|Adverse Event|1|||
146990506|NCT00950807|530128680|FG007|Treatment Period 3|Adverse Event|0|||
146990507|NCT00950807|530128681|FG008|Treatment Period 3|Adverse Event|0|||
146990508|NCT00950807|530128682|FG009|Treatment Period 3|Adverse Event|0|||
146990509|NCT00337077|530128683|FG000|Overall Study|Progressive disease|25|||
146990510|NCT00337077|530128684|FG001|Overall Study|Progressive disease|37|||
146990511|NCT00337077|530128685|FG002|Overall Study|Progressive disease|19|||
146990512|NCT00337077|530128683|FG000|Overall Study|Adverse Event|7|||
146990513|NCT00337077|530128684|FG001|Overall Study|Adverse Event|7|||
146990514|NCT00337077|530128685|FG002|Overall Study|Adverse Event|1|||
146990515|NCT00337077|530128683|FG000|Overall Study|Death|0|||
146990516|NCT00337077|530128684|FG001|Overall Study|Death|1|||
146990517|NCT00337077|530128685|FG002|Overall Study|Death|0|||
146990518|NCT00337077|530128683|FG000|Overall Study|Withdrawal by Subject|7|||
146990519|NCT00337077|530128684|FG001|Overall Study|Withdrawal by Subject|2|||
146990520|NCT00337077|530128685|FG002|Overall Study|Withdrawal by Subject|2|||
146990521|NCT00337077|530128683|FG000|Overall Study|Alternative therapy|1|||
146990522|NCT00337077|530128684|FG001|Overall Study|Alternative therapy|0|||
146990523|NCT00337077|530128685|FG002|Overall Study|Alternative therapy|0|||
146990524|NCT00337077|530128683|FG000|Overall Study|Physician Decision|1|||
146990525|NCT00337077|530128684|FG001|Overall Study|Physician Decision|4|||
146990526|NCT00337077|530128685|FG002|Overall Study|Physician Decision|2|||
146990527|NCT00337077|530128683|FG000|Overall Study|Never started treatment|1|||
146990528|NCT00337077|530128684|FG001|Overall Study|Never started treatment|1|||
146990529|NCT00337077|530128685|FG002|Overall Study|Never started treatment|0|||
146990530|NCT00337077|530128683|FG000|Overall Study|Ineligible|1|||
146990531|NCT00337077|530128684|FG001|Overall Study|Ineligible|1|||
146990532|NCT00337077|530128685|FG002|Overall Study|Ineligible|1|||
146990533|NCT01492400|530128690|FG000|Overall Study|Miscellaneous Reasons|2|||
146990534|NCT01492400|530128691|FG001|Overall Study|Miscellaneous Reasons|3|||
146990535|NCT01492400|530128690|FG000|Overall Study|Personal Reasons|0|||
146990536|NCT01492400|530128691|FG001|Overall Study|Personal Reasons|5|||
146990537|NCT01492400|530128690|FG000|Overall Study|Lost to Follow-up|3|||
146990538|NCT01492400|530128691|FG001|Overall Study|Lost to Follow-up|1|||
146990539|NCT01492400|530128690|FG000|Overall Study|Pregnancy|0|||
146990540|NCT01492400|530128691|FG001|Overall Study|Pregnancy|1|||
146990541|NCT01492400|530128690|FG000|Overall Study|Lack of Efficacy|1|||
146990542|NCT01492400|530128691|FG001|Overall Study|Lack of Efficacy|1|||
146990543|NCT01492400|530128690|FG000|Overall Study|Adverse Event|10|||
146990544|NCT01492400|530128691|FG001|Overall Study|Adverse Event|5|||
146990545|NCT00659607|530128693|FG000|Overall Study|No blood pressure recorded|147|||
146990546|NCT00659607|530128693|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
146990547|NCT00659607|530128693|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
146990548|NCT00659607|530128693|FG000|Overall Study|No recorded efficacy data|15|||
146990549|NCT00659607|530128693|FG000|Overall Study|Inconsistent BP measuring date|2|||
146990550|NCT02899338|530128694|FG000|Overall Study|Adverse Event|1|||
146990551|NCT02899338|530128695|FG001|Overall Study|Adverse Event|2|||
146990552|NCT02899338|530128694|FG000|Overall Study|Withdrawal by Subject|2|||
146990553|NCT02899338|530128695|FG001|Overall Study|Withdrawal by Subject|0|||
146990554|NCT06179108|530128696|FG000|Overall Study|Withdrawal by Subject|16|||
146990555|NCT06179108|530128697|FG001|Overall Study|Withdrawal by Subject|19|||
146990556|NCT06179108|530128698|FG002|Overall Study|Withdrawal by Subject|10|||
146990557|NCT06179108|530128699|FG003|Overall Study|Withdrawal by Subject|11|||
146990558|NCT06179108|530128696|FG000|Overall Study|Lost to Follow-up|12|||
146990559|NCT06179108|530128697|FG001|Overall Study|Lost to Follow-up|4|||
146990560|NCT06179108|530128698|FG002|Overall Study|Lost to Follow-up|1|||
146990561|NCT06179108|530128699|FG003|Overall Study|Lost to Follow-up|9|||
146990562|NCT06179108|530128696|FG000|Overall Study|Adverse Event|2|||
146990563|NCT06179108|530128697|FG001|Overall Study|Adverse Event|3|||
146990564|NCT06179108|530128698|FG002|Overall Study|Adverse Event|3|||
146990565|NCT06179108|530128699|FG003|Overall Study|Adverse Event|2|||
146990566|NCT06179108|530128696|FG000|Overall Study|Protocol Violation|0|||
146990567|NCT06179108|530128697|FG001|Overall Study|Protocol Violation|1|||
146990568|NCT06179108|530128698|FG002|Overall Study|Protocol Violation|0|||
146990569|NCT06179108|530128699|FG003|Overall Study|Protocol Violation|1|||
146990570|NCT06179108|530128696|FG000|Overall Study|Physician Decision|1|||
146990571|NCT06179108|530128697|FG001|Overall Study|Physician Decision|1|||
146990572|NCT06179108|530128698|FG002|Overall Study|Physician Decision|0|||
146990573|NCT06179108|530128699|FG003|Overall Study|Physician Decision|0|||
146990574|NCT06179108|530128696|FG000|Overall Study|Lack of Efficacy|0|||
146990575|NCT06179108|530128697|FG001|Overall Study|Lack of Efficacy|0|||
146990576|NCT06179108|530128698|FG002|Overall Study|Lack of Efficacy|0|||
146990577|NCT06179108|530128699|FG003|Overall Study|Lack of Efficacy|1|||
146990578|NCT06179108|530128696|FG000|Overall Study|Death|0|||
146990579|NCT06179108|530128697|FG001|Overall Study|Death|0|||
146835591|NCT02906020|529569494|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146835592|NCT02906020|529569495|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146835593|NCT02906020|529569496|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146835594|NCT02906020|529569497|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146835595|NCT02906020|529569498|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146835596|NCT02906020|529569499|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146835597|NCT02906020|529569500|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146835598|NCT02906020|529569501|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146835599|NCT02906020|529569502|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146835600|NCT02906020|529569503|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146835601|NCT02906020|529569504|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146835602|NCT02906020|529569505|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146835603|NCT02906020|529569506|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
146835604|NCT02906020|529569507|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
146835605|NCT02906020|529569508|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146835606|NCT02906020|529569509|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146835607|NCT02906020|529569494|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146835608|NCT02906020|529569495|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146835609|NCT02906020|529569496|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146835610|NCT02906020|529569497|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146835611|NCT02906020|529569498|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146835612|NCT02906020|529569499|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146835613|NCT02906020|529569500|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146835614|NCT02906020|529569501|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146835615|NCT02906020|529569502|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146835616|NCT02906020|529569503|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146835617|NCT02906020|529569504|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146835618|NCT02906020|529569505|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146835619|NCT02906020|529569506|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
146835620|NCT02906020|529569507|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
146835621|NCT02906020|529569508|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146835622|NCT02906020|529569509|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
146835623|NCT02906020|529569494|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146835624|NCT02906020|529569495|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146835625|NCT02906020|529569496|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146835626|NCT02906020|529569497|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146835627|NCT02906020|529569498|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146835628|NCT02906020|529569499|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146835629|NCT02906020|529569500|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146835630|NCT02906020|529569501|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146835631|NCT02906020|529569502|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146835632|NCT02906020|529569503|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146835633|NCT02906020|529569504|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146835634|NCT02906020|529569505|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146835635|NCT02906020|529569506|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
146835636|NCT02906020|529569507|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
146835637|NCT02906020|529569508|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146835638|NCT02906020|529569509|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146835639|NCT02906020|529569494|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146835640|NCT02906020|529569495|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146835641|NCT02906020|529569496|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146835642|NCT02906020|529569497|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146835643|NCT02906020|529569498|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146835644|NCT02906020|529569499|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146835645|NCT02906020|529569500|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146990580|NCT06179108|530128698|FG002|Overall Study|Death|0|||
146990581|NCT06179108|530128699|FG003|Overall Study|Death|1|||
146990582|NCT01370408|530128700|FG000|Overall Study|treatment failure|9|||
146835646|NCT02906020|529569501|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146835647|NCT02906020|529569502|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146835648|NCT02906020|529569503|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146835649|NCT02906020|529569504|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146835650|NCT02906020|529569505|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146835651|NCT02906020|529569506|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
146835652|NCT02906020|529569507|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
146835653|NCT02906020|529569508|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146835654|NCT02906020|529569509|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146835655|NCT02906020|529569494|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146835656|NCT02906020|529569495|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146835657|NCT02906020|529569496|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146835658|NCT02906020|529569497|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146835659|NCT02906020|529569498|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146835660|NCT02906020|529569499|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146835661|NCT02906020|529569500|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146835662|NCT02906020|529569501|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146835663|NCT02906020|529569502|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146835664|NCT02906020|529569503|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146835665|NCT02906020|529569504|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146835666|NCT02906020|529569505|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146835667|NCT02906020|529569506|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
146835668|NCT02906020|529569507|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
146835669|NCT02906020|529569508|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
146835670|NCT02906020|529569509|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
146835671|NCT02906020|529569494|FG000|Part 2: Long-term Follow-up Period|Other|0|||
146835672|NCT02906020|529569495|FG001|Part 2: Long-term Follow-up Period|Other|0|||
146835673|NCT02906020|529569496|FG002|Part 2: Long-term Follow-up Period|Other|0|||
146835674|NCT02906020|529569497|FG003|Part 2: Long-term Follow-up Period|Other|0|||
146835675|NCT02906020|529569498|FG004|Part 2: Long-term Follow-up Period|Other|0|||
146835676|NCT02906020|529569499|FG005|Part 2: Long-term Follow-up Period|Other|0|||
146835677|NCT02906020|529569500|FG006|Part 2: Long-term Follow-up Period|Other|0|||
146835678|NCT02906020|529569501|FG007|Part 2: Long-term Follow-up Period|Other|0|||
146835679|NCT02906020|529569502|FG008|Part 2: Long-term Follow-up Period|Other|0|||
146835680|NCT02906020|529569503|FG009|Part 2: Long-term Follow-up Period|Other|0|||
146835681|NCT02906020|529569504|FG010|Part 2: Long-term Follow-up Period|Other|0|||
146835682|NCT02906020|529569505|FG011|Part 2: Long-term Follow-up Period|Other|0|||
146835683|NCT02906020|529569506|FG012|Part 2: Long-term Follow-up Period|Other|13|||
146835684|NCT02906020|529569507|FG013|Part 2: Long-term Follow-up Period|Other|8|||
146835685|NCT02906020|529569508|FG014|Part 2: Long-term Follow-up Period|Other|3|||
146835686|NCT02906020|529569509|FG015|Part 2: Long-term Follow-up Period|Other|2|||
146835687|NCT04698915|529569510|FG000|Overall Study|Adverse Event|2|||
146835688|NCT04698915|529569511|FG001|Overall Study|Adverse Event|0|||
146835689|NCT04698915|529569510|FG000|Overall Study|Death|23|||
146835690|NCT04698915|529569511|FG001|Overall Study|Death|20|||
146835691|NCT04698915|529569510|FG000|Overall Study|Physician Decision|1|||
146835692|NCT04698915|529569511|FG001|Overall Study|Physician Decision|1|||
146835693|NCT04698915|529569510|FG000|Overall Study|Lost to Follow-up|1|||
146835694|NCT04698915|529569511|FG001|Overall Study|Lost to Follow-up|0|||
146835695|NCT04698915|529569510|FG000|Overall Study|Study Terminated by Sponsor|55|||
146835696|NCT04698915|529569511|FG001|Overall Study|Study Terminated by Sponsor|60|||
146835697|NCT04698915|529569510|FG000|Overall Study|Withdrawal by Subject|2|||
146835698|NCT04698915|529569511|FG001|Overall Study|Withdrawal by Subject|3|||
146835699|NCT00979953|529569512|FG000|Overall Study|Adverse Event|5|||
146835700|NCT00979953|529569513|FG001|Overall Study|Adverse Event|2|||
146835701|NCT00979953|529569514|FG002|Overall Study|Adverse Event|17|||
146835702|NCT00979953|529569515|FG003|Overall Study|Adverse Event|4|||
146835703|NCT00979953|529569512|FG000|Overall Study|Lack of Efficacy|1|||
146835704|NCT00979953|529569513|FG001|Overall Study|Lack of Efficacy|2|||
146835705|NCT00979953|529569514|FG002|Overall Study|Lack of Efficacy|0|||
146835706|NCT00979953|529569515|FG003|Overall Study|Lack of Efficacy|0|||
146835707|NCT00979953|529569512|FG000|Overall Study|Lost to Follow-up|1|||
146835708|NCT00979953|529569513|FG001|Overall Study|Lost to Follow-up|1|||
146835709|NCT00979953|529569514|FG002|Overall Study|Lost to Follow-up|1|||
146835710|NCT00979953|529569515|FG003|Overall Study|Lost to Follow-up|0|||
146835711|NCT00979953|529569512|FG000|Overall Study|Withdrawal by Subject|0|||
146835712|NCT00979953|529569513|FG001|Overall Study|Withdrawal by Subject|0|||
146835713|NCT00979953|529569514|FG002|Overall Study|Withdrawal by Subject|2|||
146835714|NCT00979953|529569515|FG003|Overall Study|Withdrawal by Subject|1|||
146835715|NCT00979953|529569512|FG000|Overall Study|Protocol Violation|1|||
146835716|NCT00979953|529569513|FG001|Overall Study|Protocol Violation|0|||
146835717|NCT00979953|529569514|FG002|Overall Study|Protocol Violation|2|||
146835718|NCT00979953|529569515|FG003|Overall Study|Protocol Violation|2|||
146835719|NCT01124097|529569516|FG000|Overall Study|Withdrawal by Subject|4|||
146835720|NCT01124097|529569517|FG001|Overall Study|Withdrawal by Subject|3|||
146835721|NCT01124097|529569518|FG002|Overall Study|Withdrawal by Subject|2|||
146835722|NCT01124097|529569519|FG003|Overall Study|Withdrawal by Subject|3|||
146835723|NCT01124097|529569516|FG000|Overall Study|Lack of Efficacy|2|||
146835724|NCT01124097|529569517|FG001|Overall Study|Lack of Efficacy|3|||
146835725|NCT01124097|529569518|FG002|Overall Study|Lack of Efficacy|1|||
146835726|NCT01124097|529569519|FG003|Overall Study|Lack of Efficacy|3|||
146835727|NCT01124097|529569516|FG000|Overall Study|Adverse Event|24|||
146835728|NCT01124097|529569517|FG001|Overall Study|Adverse Event|15|||
146835729|NCT01124097|529569518|FG002|Overall Study|Adverse Event|15|||
146835730|NCT01124097|529569519|FG003|Overall Study|Adverse Event|7|||
146835731|NCT01124097|529569516|FG000|Overall Study|Protocol Violation|2|||
146835732|NCT01124097|529569517|FG001|Overall Study|Protocol Violation|0|||
146835733|NCT01124097|529569518|FG002|Overall Study|Protocol Violation|2|||
146835734|NCT01124097|529569519|FG003|Overall Study|Protocol Violation|1|||
146835735|NCT01124097|529569516|FG000|Overall Study|Physician Decision|2|||
146835736|NCT01124097|529569517|FG001|Overall Study|Physician Decision|1|||
146835737|NCT01124097|529569518|FG002|Overall Study|Physician Decision|0|||
146835738|NCT01124097|529569519|FG003|Overall Study|Physician Decision|0|||
146835739|NCT00425607|529569524|FG000|Overall Study|Death|1|||
146835740|NCT00425607|529569524|FG000|Overall Study|Withdrawal by Subject|1|||
146835741|NCT02563548|529569525|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
146835742|NCT02563548|529569526|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
146835743|NCT02563548|529569527|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
146835744|NCT02563548|529569528|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
146835745|NCT02563548|529569529|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
146835746|NCT02563548|529569530|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
146835747|NCT02563548|529569525|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
146835748|NCT02563548|529569526|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
146835749|NCT02563548|529569527|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
146835750|NCT02563548|529569528|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
146835751|NCT02563548|529569529|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
146835752|NCT02563548|529569530|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
146835753|NCT02563548|529569525|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
146835754|NCT02563548|529569526|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
146835755|NCT02563548|529569527|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
146835756|NCT02563548|529569528|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
146835757|NCT02563548|529569529|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
146835758|NCT02563548|529569530|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
146835759|NCT02563548|529569525|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
146835760|NCT02563548|529569526|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
146835761|NCT02563548|529569527|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
146835762|NCT02563548|529569528|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
146835763|NCT02563548|529569529|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
146835764|NCT02563548|529569530|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
146835765|NCT02563548|529569525|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
146835766|NCT02563548|529569526|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
146835767|NCT02563548|529569527|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
146835768|NCT02563548|529569528|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
146835769|NCT02563548|529569529|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
146835770|NCT02563548|529569530|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
146835771|NCT02563548|529569525|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
146835772|NCT02563548|529569526|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
146835773|NCT02563548|529569527|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
146835774|NCT02563548|529569528|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
146835775|NCT02563548|529569529|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
146835776|NCT02563548|529569530|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
146835777|NCT02563548|529569525|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
146835778|NCT02563548|529569526|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
146835779|NCT02563548|529569527|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
146835780|NCT02563548|529569528|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
146835781|NCT02563548|529569529|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
146835782|NCT02563548|529569530|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
146835783|NCT02563548|529569525|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
146835784|NCT02563548|529569526|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
146835785|NCT02563548|529569527|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
146835786|NCT02563548|529569528|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
146835787|NCT02563548|529569529|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
146835788|NCT02563548|529569530|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
146835789|NCT02563548|529569525|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
146835790|NCT02563548|529569526|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
146835791|NCT02563548|529569527|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
146835792|NCT02563548|529569528|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
146835793|NCT02563548|529569529|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
146835794|NCT02563548|529569530|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
146835795|NCT02563548|529569525|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
146835796|NCT02563548|529569526|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
146835797|NCT02563548|529569527|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
146835798|NCT02563548|529569528|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
146835799|NCT02563548|529569529|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
146835800|NCT02563548|529569530|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
146835801|NCT02563548|529569525|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
146835802|NCT02563548|529569526|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
146835803|NCT02563548|529569527|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
146835804|NCT02563548|529569528|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
146835805|NCT02563548|529569529|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
146835806|NCT02563548|529569530|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
146835807|NCT02563548|529569525|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
146835808|NCT02563548|529569526|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
146835809|NCT02563548|529569527|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
146835810|NCT02563548|529569528|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
146835811|NCT02563548|529569529|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
146835812|NCT02563548|529569530|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
146835813|NCT00203047|529569531|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
146835814|NCT00203047|529569532|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
146835815|NCT00203047|529569531|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
146835816|NCT00203047|529569532|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
146835817|NCT00203047|529569531|FG000|Overall Study|Withdrawal by Subject|13|||
146835818|NCT00203047|529569532|FG001|Overall Study|Withdrawal by Subject|47|||
146835819|NCT00203047|529569531|FG000|Overall Study|Teva requested participant withdrawal|1|||
146835820|NCT00203047|529569532|FG001|Overall Study|Teva requested participant withdrawal|1|||
146835821|NCT00203047|529569531|FG000|Overall Study|Physician Decision|8|||
146835822|NCT00203047|529569532|FG001|Overall Study|Physician Decision|7|||
146835823|NCT00203047|529569531|FG000|Overall Study|Non-compliance|4|||
146835824|NCT00203047|529569532|FG001|Overall Study|Non-compliance|8|||
146835825|NCT00203047|529569531|FG000|Overall Study|Protocol Violation|1|||
146835826|NCT00203047|529569532|FG001|Overall Study|Protocol Violation|0|||
146835827|NCT00203047|529569531|FG000|Overall Study|Lost to Follow-up|11|||
146835828|NCT00203047|529569532|FG001|Overall Study|Lost to Follow-up|5|||
146835829|NCT00203047|529569531|FG000|Overall Study|Adverse Event|8|||
146835830|NCT00203047|529569532|FG001|Overall Study|Adverse Event|18|||
146835831|NCT00203047|529569531|FG000|Overall Study|Death|1|||
146835832|NCT00203047|529569532|FG001|Overall Study|Death|2|||
146835833|NCT00203047|529569531|FG000|Overall Study|Pregnancy|3|||
146835834|NCT00203047|529569532|FG001|Overall Study|Pregnancy|0|||
146835835|NCT00203047|529569531|FG000|Overall Study|Other|5|||
146835836|NCT00203047|529569532|FG001|Overall Study|Other|5|||
146835837|NCT01163474|529569536|FG000|Overall Study|Withdrawal by Subject|1|||
146835838|NCT01163474|529569536|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
146835839|NCT01163474|529569536|FG000|Overall Study|Lost to Follow-up|3|||
146835840|NCT00762476|529569538|FG000|Overall Study|Adverse Event|7|||
146835841|NCT00762476|529569539|FG001|Overall Study|Adverse Event|1|||
146835842|NCT00762476|529569538|FG000|Overall Study|Lost to Follow-up|2|||
146835843|NCT00762476|529569539|FG001|Overall Study|Lost to Follow-up|0|||
146835844|NCT00762476|529569538|FG000|Overall Study|Protocol Violation|5|||
146835845|NCT00762476|529569539|FG001|Overall Study|Protocol Violation|6|||
146835846|NCT00762476|529569538|FG000|Overall Study|Physician Decision|2|||
146835847|NCT00762476|529569539|FG001|Overall Study|Physician Decision|14|||
146835848|NCT00762476|529569538|FG000|Overall Study|Withdrawal by Subject|6|||
146835849|NCT00762476|529569539|FG001|Overall Study|Withdrawal by Subject|12|||
146835850|NCT00762476|529569538|FG000|Overall Study|antibiotic use|0|||
146835851|NCT00762476|529569539|FG001|Overall Study|antibiotic use|1|||
146835852|NCT00762476|529569538|FG000|Overall Study|non-compliance with study visits|0|||
146835853|NCT00762476|529569539|FG001|Overall Study|non-compliance with study visits|2|||
146835854|NCT00762476|529569538|FG000|Overall Study|Seasonal allergies|1|||
146835855|NCT00762476|529569539|FG001|Overall Study|Seasonal allergies|0|||
146835856|NCT00965497|529569541|FG000|Overall Study|Physician Decision|1|||
146835857|NCT02878603|529569542|FG000|Overall Study|Lost to Follow-up|4|||
146835858|NCT02878603|529569543|FG001|Overall Study|Lost to Follow-up|1|||
146990583|NCT05014412|530128702|FG000|Overall Study|Death|11|||
146990584|NCT05014412|530128703|FG001|Overall Study|Death|7|||
146835859|NCT02878603|529569542|FG000|Overall Study|Withdrawal by Subject|1|||
146835860|NCT02878603|529569543|FG001|Overall Study|Withdrawal by Subject|1|||
146835861|NCT02878603|529569542|FG000|Overall Study|Death|1|||
146835862|NCT02878603|529569543|FG001|Overall Study|Death|0|||
146835863|NCT02878603|529569542|FG000|Overall Study|Physician Decision|0|||
146835864|NCT02878603|529569543|FG001|Overall Study|Physician Decision|3|||
146835865|NCT02689453|529569544|FG000|Overall Study|Progressive disease|0|||
146835866|NCT02689453|529569545|FG001|Overall Study|Progressive disease|1|||
146835867|NCT02689453|529569546|FG002|Overall Study|Progressive disease|1|||
146835868|NCT02638103|529569547|FG000|Overall Study|Adverse Event|13|||
146835869|NCT02638103|529569548|FG001|Overall Study|Adverse Event|12|||
146835870|NCT02638103|529569549|FG002|Overall Study|Adverse Event|19|||
146835871|NCT02638103|529569550|FG003|Overall Study|Adverse Event|12|||
146835872|NCT02638103|529569547|FG000|Overall Study|Withdrawal by Subject|43|||
146835873|NCT02638103|529569548|FG001|Overall Study|Withdrawal by Subject|53|||
146835874|NCT02638103|529569549|FG002|Overall Study|Withdrawal by Subject|30|||
146835875|NCT02638103|529569550|FG003|Overall Study|Withdrawal by Subject|61|||
146835876|NCT02638103|529569547|FG000|Overall Study|Protocol Violation|1|||
146835877|NCT02638103|529569548|FG001|Overall Study|Protocol Violation|2|||
146835878|NCT02638103|529569549|FG002|Overall Study|Protocol Violation|1|||
146835879|NCT02638103|529569550|FG003|Overall Study|Protocol Violation|4|||
146835880|NCT02638103|529569547|FG000|Overall Study|Pregnancy|2|||
146835881|NCT02638103|529569548|FG001|Overall Study|Pregnancy|3|||
146835882|NCT02638103|529569549|FG002|Overall Study|Pregnancy|0|||
146835883|NCT02638103|529569550|FG003|Overall Study|Pregnancy|1|||
146835884|NCT02638103|529569547|FG000|Overall Study|Non-compliance to Study Procedures|2|||
146835885|NCT02638103|529569548|FG001|Overall Study|Non-compliance to Study Procedures|1|||
146835886|NCT02638103|529569549|FG002|Overall Study|Non-compliance to Study Procedures|1|||
146835887|NCT02638103|529569550|FG003|Overall Study|Non-compliance to Study Procedures|1|||
146835888|NCT02638103|529569547|FG000|Overall Study|Lost to Follow-up|26|||
146835889|NCT02638103|529569548|FG001|Overall Study|Lost to Follow-up|33|||
146835890|NCT02638103|529569549|FG002|Overall Study|Lost to Follow-up|20|||
146835891|NCT02638103|529569550|FG003|Overall Study|Lost to Follow-up|37|||
146835892|NCT02638103|529569547|FG000|Overall Study|Lack of Efficacy|14|||
146835893|NCT02638103|529569548|FG001|Overall Study|Lack of Efficacy|10|||
146835894|NCT02638103|529569549|FG002|Overall Study|Lack of Efficacy|12|||
146835895|NCT02638103|529569550|FG003|Overall Study|Lack of Efficacy|22|||
146835896|NCT02638103|529569547|FG000|Overall Study|Other than specified|5|||
146835897|NCT02638103|529569548|FG001|Overall Study|Other than specified|4|||
146835898|NCT02638103|529569549|FG002|Overall Study|Other than specified|2|||
146835899|NCT02638103|529569550|FG003|Overall Study|Other than specified|4|||
146835900|NCT01358331|529569552|FG000|Overall Study|Lost to Follow-up|0|||
146835901|NCT01358331|529569553|FG001|Overall Study|Lost to Follow-up|0|||
146835902|NCT01358331|529569554|FG002|Overall Study|Lost to Follow-up|0|||
146835903|NCT01358331|529569555|FG003|Overall Study|Lost to Follow-up|1|||
146835904|NCT01358331|529569556|FG004|Overall Study|Lost to Follow-up|0|||
146835905|NCT01358331|529569557|FG005|Overall Study|Lost to Follow-up|0|||
146835906|NCT01358331|529569552|FG000|Overall Study|Withdrawal by Subject|0|||
146835907|NCT01358331|529569553|FG001|Overall Study|Withdrawal by Subject|0|||
146835908|NCT01358331|529569554|FG002|Overall Study|Withdrawal by Subject|0|||
146835909|NCT01358331|529569555|FG003|Overall Study|Withdrawal by Subject|1|||
146835910|NCT01358331|529569556|FG004|Overall Study|Withdrawal by Subject|1|||
146835911|NCT01358331|529569557|FG005|Overall Study|Withdrawal by Subject|1|||
146835912|NCT01358331|529569552|FG000|Overall Study|Adverse Events|1|||
146835913|NCT01358331|529569553|FG001|Overall Study|Adverse Events|1|||
146835914|NCT01358331|529569554|FG002|Overall Study|Adverse Events|1|||
146835915|NCT01358331|529569555|FG003|Overall Study|Adverse Events|0|||
146835916|NCT01358331|529569556|FG004|Overall Study|Adverse Events|1|||
146835917|NCT01358331|529569557|FG005|Overall Study|Adverse Events|5|||
146835918|NCT01358331|529569552|FG000|Overall Study|Symptomatic Deterioration|0|||
146835919|NCT01358331|529569553|FG001|Overall Study|Symptomatic Deterioration|0|||
146835920|NCT01358331|529569554|FG002|Overall Study|Symptomatic Deterioration|0|||
146835921|NCT01358331|529569555|FG003|Overall Study|Symptomatic Deterioration|0|||
146835922|NCT01358331|529569556|FG004|Overall Study|Symptomatic Deterioration|1|||
146835923|NCT01358331|529569557|FG005|Overall Study|Symptomatic Deterioration|0|||
146835924|NCT01358331|529569552|FG000|Overall Study|Participants did not wish to continue|0|||
146835925|NCT01358331|529569553|FG001|Overall Study|Participants did not wish to continue|0|||
146835926|NCT01358331|529569554|FG002|Overall Study|Participants did not wish to continue|0|||
146835927|NCT01358331|529569555|FG003|Overall Study|Participants did not wish to continue|0|||
146835928|NCT01358331|529569556|FG004|Overall Study|Participants did not wish to continue|1|||
146835929|NCT01358331|529569557|FG005|Overall Study|Participants did not wish to continue|0|||
146835930|NCT01358331|529569552|FG000|Overall Study|Progress of disease under investigation|1|||
146835931|NCT01358331|529569553|FG001|Overall Study|Progress of disease under investigation|2|||
146835932|NCT01358331|529569554|FG002|Overall Study|Progress of disease under investigation|3|||
146990585|NCT05014412|530128704|FG002|Overall Study|Death|4|||
146990586|NCT05014412|530128705|FG003|Overall Study|Death|7|||
146835933|NCT01358331|529569555|FG003|Overall Study|Progress of disease under investigation|1|||
146835934|NCT01358331|529569556|FG004|Overall Study|Progress of disease under investigation|3|||
146835935|NCT01358331|529569557|FG005|Overall Study|Progress of disease under investigation|0|||
146835936|NCT04674189|529569558|FG000|Overall Study|Adverse Event|0|||
146835937|NCT04674189|529569559|FG001|Overall Study|Adverse Event|0|||
146835938|NCT04674189|529569560|FG002|Overall Study|Adverse Event|1|||
146835939|NCT04674189|529569558|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
146835940|NCT04674189|529569559|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
146835941|NCT04674189|529569560|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
146835942|NCT04674189|529569558|FG000|Overall Study|Physician Decision|1|||
146835943|NCT04674189|529569559|FG001|Overall Study|Physician Decision|0|||
146835944|NCT04674189|529569560|FG002|Overall Study|Physician Decision|0|||
146835945|NCT04674189|529569558|FG000|Overall Study|Withdrawal by Participant|83|||
146835946|NCT04674189|529569559|FG001|Overall Study|Withdrawal by Participant|71|||
146835947|NCT04674189|529569560|FG002|Overall Study|Withdrawal by Participant|142|||
146835948|NCT04674189|529569558|FG000|Overall Study|Lost to Follow-up|55|||
146835949|NCT04674189|529569559|FG001|Overall Study|Lost to Follow-up|53|||
146835950|NCT04674189|529569560|FG002|Overall Study|Lost to Follow-up|44|||
146835951|NCT04674189|529569558|FG000|Overall Study|Miscellaneous|27|||
146835952|NCT04674189|529569559|FG001|Overall Study|Miscellaneous|23|||
146835953|NCT04674189|529569560|FG002|Overall Study|Miscellaneous|207|||
146835954|NCT04674189|529569558|FG000|Overall Study|Did Not Receive Treatment|3|||
146835955|NCT04674189|529569559|FG001|Overall Study|Did Not Receive Treatment|1|||
146835956|NCT04674189|529569560|FG002|Overall Study|Did Not Receive Treatment|2|||
146835957|NCT02838134|529569561|FG000|Overall Study|Lost to Follow-up|1|||
146835958|NCT02838134|529569562|FG001|Overall Study|Lost to Follow-up|2|||
146835959|NCT02838134|529569561|FG000|Overall Study|logistic problems|1|||
146835960|NCT02838134|529569562|FG001|Overall Study|logistic problems|1|||
146835961|NCT01637077|529569563|FG000|Overall Study|Cancel|1|||
146835962|NCT01637077|529569564|FG001|Overall Study|Cancel|1|||
146835963|NCT01637077|529569563|FG000|Overall Study|Withdrawal by Subject|1|||
146835964|NCT01637077|529569564|FG001|Overall Study|Withdrawal by Subject|0|||
146835965|NCT01637077|529569563|FG000|Overall Study|No cycle 1 questionnaire data|2|||
146835966|NCT01637077|529569564|FG001|Overall Study|No cycle 1 questionnaire data|0|||
146835967|NCT00794924|529569565|FG000|Overall Study|Lost to Follow-up|6|||
146835968|NCT00794924|529569566|FG001|Overall Study|Lost to Follow-up|8|||
146835969|NCT00794924|529569565|FG000|Overall Study|Withdrawal by Subject|48|||
146835970|NCT00794924|529569566|FG001|Overall Study|Withdrawal by Subject|60|||
146835971|NCT00794924|529569565|FG000|Overall Study|Adverse Event|6|||
146835972|NCT00794924|529569566|FG001|Overall Study|Adverse Event|2|||
146835973|NCT03274895|529569567|FG000|Overall Study|Lack of Efficacy|1|||
146835974|NCT03274895|529569568|FG001|Overall Study|Lack of Efficacy|0|||
146835975|NCT03274895|529569567|FG000|Overall Study|Adverse Event|8|||
146835976|NCT03274895|529569568|FG001|Overall Study|Adverse Event|7|||
146835977|NCT03274895|529569567|FG000|Overall Study|Lost to Follow-up|1|||
146835978|NCT03274895|529569568|FG001|Overall Study|Lost to Follow-up|0|||
146835979|NCT03274895|529569567|FG000|Overall Study|Diagnosis not confirmed|3|||
146835980|NCT03274895|529569568|FG001|Overall Study|Diagnosis not confirmed|4|||
146835981|NCT01294436|529569569|FG000|Overall Study|Adverse Event|10|||
146835982|NCT01294436|529569570|FG001|Overall Study|Adverse Event|17|||
146835983|NCT01294436|529569569|FG000|Overall Study|Withdrawal by Subject|11|||
146835984|NCT01294436|529569570|FG001|Overall Study|Withdrawal by Subject|28|||
146835985|NCT01294436|529569569|FG000|Overall Study|subject no longer meets study criteria|5|||
146835986|NCT01294436|529569570|FG001|Overall Study|subject no longer meets study criteria|20|||
146835987|NCT01294436|529569569|FG000|Overall Study|poor/non-compliance|2|||
146835988|NCT01294436|529569570|FG001|Overall Study|poor/non-compliance|5|||
146835989|NCT02389764|529569571|FG000|Overall Study|Lack of Efficacy|9|||
146835990|NCT02498236|529569577|FG000|Overall Study|Did not show for testing|1|||
146835991|NCT02498236|529569578|FG001|Overall Study|Did not show for testing|0|||
146835992|NCT02498236|529569579|FG002|Overall Study|Did not show for testing|0|||
146835993|NCT02498236|529569580|FG003|Overall Study|Did not show for testing|0|||
146835994|NCT02498236|529569581|FG004|Overall Study|Did not show for testing|0|||
146835995|NCT02498236|529569582|FG005|Overall Study|Did not show for testing|0|||
146835996|NCT02498236|529569583|FG006|Overall Study|Did not show for testing|0|||
146835997|NCT02498236|529569584|FG007|Overall Study|Did not show for testing|1|||
146835998|NCT02498236|529569577|FG000|Overall Study|Equipment failure|0|||
146835999|NCT02498236|529569578|FG001|Overall Study|Equipment failure|0|||
146836000|NCT02498236|529569579|FG002|Overall Study|Equipment failure|0|||
146836001|NCT02498236|529569580|FG003|Overall Study|Equipment failure|0|||
146836002|NCT02498236|529569581|FG004|Overall Study|Equipment failure|0|||
146836003|NCT02498236|529569582|FG005|Overall Study|Equipment failure|0|||
146836004|NCT02498236|529569583|FG006|Overall Study|Equipment failure|1|||
146836005|NCT02498236|529569584|FG007|Overall Study|Equipment failure|0|||
146836006|NCT02498236|529569577|FG000|Overall Study|Withdrawal by Subject|0|||
146836007|NCT02498236|529569578|FG001|Overall Study|Withdrawal by Subject|0|||
146836008|NCT02498236|529569579|FG002|Overall Study|Withdrawal by Subject|0|||
146836009|NCT02498236|529569580|FG003|Overall Study|Withdrawal by Subject|0|||
146836010|NCT02498236|529569581|FG004|Overall Study|Withdrawal by Subject|1|||
146836011|NCT02498236|529569582|FG005|Overall Study|Withdrawal by Subject|0|||
146836012|NCT02498236|529569583|FG006|Overall Study|Withdrawal by Subject|0|||
146836013|NCT02498236|529569584|FG007|Overall Study|Withdrawal by Subject|0|||
146836014|NCT02296892|529569585|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
146836015|NCT02296892|529569586|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
146836016|NCT02296892|529569587|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
146836017|NCT02296892|529569585|FG000|Overall Study|Lost to Follow-up|5|||
146836018|NCT02296892|529569586|FG001|Overall Study|Lost to Follow-up|0|||
146836019|NCT02296892|529569587|FG002|Overall Study|Lost to Follow-up|1|||
146836020|NCT00383123|529569590|FG000|Overall Study|Adverse Event|1|||
146836021|NCT00383123|529569591|FG001|Overall Study|Adverse Event|0|||
146836022|NCT00383123|529569590|FG000|Overall Study|Lost to Follow-up|68|||
146836023|NCT00383123|529569591|FG001|Overall Study|Lost to Follow-up|61|||
146836024|NCT00383123|529569590|FG000|Overall Study|Protocol Violation|5|||
146836025|NCT00383123|529569591|FG001|Overall Study|Protocol Violation|1|||
146836026|NCT00383123|529569590|FG000|Overall Study|Withdrawal by Subject|27|||
146836027|NCT00383123|529569591|FG001|Overall Study|Withdrawal by Subject|18|||
146836028|NCT00383123|529569590|FG000|Overall Study|Other reason|10|||
146836029|NCT00383123|529569591|FG001|Overall Study|Other reason|6|||
146836030|NCT01814072|529569592|FG000|Overall Study|Lost to Follow-up|2|||
146836031|NCT01814072|529569593|FG001|Overall Study|Lost to Follow-up|2|||
146836032|NCT01814072|529569594|FG002|Overall Study|Lost to Follow-up|2|||
146836033|NCT01814072|529569595|FG003|Overall Study|Lost to Follow-up|0|||
146836034|NCT01814072|529569596|FG004|Overall Study|Lost to Follow-up|2|||
146836035|NCT01814072|529569597|FG005|Overall Study|Lost to Follow-up|3|||
146836036|NCT01814072|529569598|FG006|Overall Study|Lost to Follow-up|3|||
146836037|NCT01814072|529569599|FG007|Overall Study|Lost to Follow-up|1|||
146836038|NCT01814072|529569600|FG008|Overall Study|Lost to Follow-up|2|||
146836039|NCT01814072|529569601|FG009|Overall Study|Lost to Follow-up|3|||
146836040|NCT01814072|529569602|FG010|Overall Study|Lost to Follow-up|1|||
146836041|NCT01814072|529569603|FG011|Overall Study|Lost to Follow-up|2|||
146836042|NCT01814072|529569604|FG012|Overall Study|Lost to Follow-up|2|||
146836043|NCT01814072|529569605|FG013|Overall Study|Lost to Follow-up|1|||
146836044|NCT01814072|529569606|FG014|Overall Study|Lost to Follow-up|2|||
146836045|NCT01814072|529569607|FG015|Overall Study|Lost to Follow-up|1|||
146836046|NCT01814072|529569608|FG016|Overall Study|Lost to Follow-up|3|||
146836047|NCT01814072|529569609|FG017|Overall Study|Lost to Follow-up|1|||
146836048|NCT01814072|529569610|FG018|Overall Study|Lost to Follow-up|3|||
146836049|NCT01814072|529569611|FG019|Overall Study|Lost to Follow-up|3|||
146836050|NCT01814072|529569612|FG020|Overall Study|Lost to Follow-up|2|||
146836051|NCT01814072|529569613|FG021|Overall Study|Lost to Follow-up|1|||
146836052|NCT01814072|529569614|FG022|Overall Study|Lost to Follow-up|3|||
146836053|NCT01814072|529569615|FG023|Overall Study|Lost to Follow-up|1|||
146836054|NCT01814072|529569616|FG024|Overall Study|Lost to Follow-up|4|||
146836055|NCT01814072|529569617|FG025|Overall Study|Lost to Follow-up|1|||
146836056|NCT01814072|529569618|FG026|Overall Study|Lost to Follow-up|1|||
146836057|NCT01814072|529569619|FG027|Overall Study|Lost to Follow-up|2|||
146836058|NCT01814072|529569620|FG028|Overall Study|Lost to Follow-up|3|||
146836059|NCT01814072|529569621|FG029|Overall Study|Lost to Follow-up|3|||
146836060|NCT01814072|529569622|FG030|Overall Study|Lost to Follow-up|2|||
146836061|NCT01814072|529569623|FG031|Overall Study|Lost to Follow-up|0|||
146836062|NCT01814072|529569592|FG000|Overall Study|Withdrawal by Subject|2|||
146836063|NCT01814072|529569593|FG001|Overall Study|Withdrawal by Subject|0|||
146836064|NCT01814072|529569594|FG002|Overall Study|Withdrawal by Subject|1|||
146836065|NCT01814072|529569595|FG003|Overall Study|Withdrawal by Subject|0|||
146836066|NCT01814072|529569596|FG004|Overall Study|Withdrawal by Subject|2|||
146836067|NCT01814072|529569597|FG005|Overall Study|Withdrawal by Subject|3|||
146836068|NCT01814072|529569598|FG006|Overall Study|Withdrawal by Subject|1|||
146836069|NCT01814072|529569599|FG007|Overall Study|Withdrawal by Subject|0|||
146836070|NCT01814072|529569600|FG008|Overall Study|Withdrawal by Subject|1|||
146836071|NCT01814072|529569601|FG009|Overall Study|Withdrawal by Subject|2|||
146836072|NCT01814072|529569602|FG010|Overall Study|Withdrawal by Subject|0|||
146836073|NCT01814072|529569603|FG011|Overall Study|Withdrawal by Subject|0|||
146990587|NCT05014412|530128702|FG000|Overall Study|Withdrawal by Subject|1|||
146836074|NCT01814072|529569604|FG012|Overall Study|Withdrawal by Subject|1|||
146836075|NCT01814072|529569605|FG013|Overall Study|Withdrawal by Subject|1|||
146836076|NCT01814072|529569606|FG014|Overall Study|Withdrawal by Subject|1|||
146836077|NCT01814072|529569607|FG015|Overall Study|Withdrawal by Subject|1|||
146836078|NCT01814072|529569608|FG016|Overall Study|Withdrawal by Subject|0|||
146836079|NCT01814072|529569609|FG017|Overall Study|Withdrawal by Subject|0|||
146836080|NCT01814072|529569610|FG018|Overall Study|Withdrawal by Subject|0|||
146836081|NCT01814072|529569611|FG019|Overall Study|Withdrawal by Subject|2|||
146836082|NCT01814072|529569612|FG020|Overall Study|Withdrawal by Subject|0|||
146836083|NCT01814072|529569613|FG021|Overall Study|Withdrawal by Subject|0|||
146836084|NCT01814072|529569614|FG022|Overall Study|Withdrawal by Subject|1|||
146836085|NCT01814072|529569615|FG023|Overall Study|Withdrawal by Subject|0|||
146836086|NCT01814072|529569616|FG024|Overall Study|Withdrawal by Subject|2|||
146836087|NCT01814072|529569617|FG025|Overall Study|Withdrawal by Subject|1|||
146836088|NCT01814072|529569618|FG026|Overall Study|Withdrawal by Subject|1|||
146836089|NCT01814072|529569619|FG027|Overall Study|Withdrawal by Subject|2|||
146836090|NCT01814072|529569620|FG028|Overall Study|Withdrawal by Subject|1|||
146836091|NCT01814072|529569621|FG029|Overall Study|Withdrawal by Subject|0|||
146836092|NCT01814072|529569622|FG030|Overall Study|Withdrawal by Subject|0|||
146836093|NCT01814072|529569623|FG031|Overall Study|Withdrawal by Subject|0|||
146836094|NCT03566979|529569625|FG000|Overall Study|Withdrawal by Subject|2|||
146836095|NCT03566979|529569626|FG001|Overall Study|Withdrawal by Subject|0|||
146836096|NCT03566979|529569627|FG002|Overall Study|Withdrawal by Subject|1|||
146836097|NCT03566979|529569628|FG003|Overall Study|Withdrawal by Subject|1|||
146836098|NCT03566979|529569625|FG000|Overall Study|Lost to Follow-up|2|||
146836099|NCT03566979|529569626|FG001|Overall Study|Lost to Follow-up|7|||
146836100|NCT03566979|529569627|FG002|Overall Study|Lost to Follow-up|9|||
146836101|NCT03566979|529569628|FG003|Overall Study|Lost to Follow-up|5|||
146836102|NCT03566979|529569625|FG000|Overall Study|Adverse Event|1|||
146836103|NCT03566979|529569626|FG001|Overall Study|Adverse Event|0|||
146836104|NCT03566979|529569627|FG002|Overall Study|Adverse Event|0|||
146836105|NCT03566979|529569628|FG003|Overall Study|Adverse Event|0|||
146836106|NCT04547023|529569635|FG000|Overall Study|Did Not Receive Intervention|3|||
146836107|NCT04547023|529569636|FG001|Overall Study|Did Not Receive Intervention|2|||
146836108|NCT04547023|529569635|FG000|Overall Study|Lost to Follow-up|1|||
146836109|NCT04547023|529569636|FG001|Overall Study|Lost to Follow-up|1|||
146836110|NCT01011868|529569637|FG000|After Week 18 Follow-up|Adverse Event|8|||
146836111|NCT01011868|529569638|FG001|After Week 18 Follow-up|Adverse Event|6|||
146836112|NCT01011868|529569639|FG002|After Week 18 Follow-up|Adverse Event|13|||
146836113|NCT01011868|529569637|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
146836114|NCT01011868|529569638|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
146836115|NCT01011868|529569639|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
146836116|NCT01011868|529569637|FG000|After Week 18 Follow-up|Protocol Violation|1|||
146836117|NCT01011868|529569638|FG001|After Week 18 Follow-up|Protocol Violation|1|||
146836118|NCT01011868|529569639|FG002|After Week 18 Follow-up|Protocol Violation|1|||
146836119|NCT01011868|529569637|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
146836120|NCT01011868|529569638|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
146836121|NCT01011868|529569639|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
146836122|NCT01011868|529569637|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
146836123|NCT01011868|529569638|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
146836124|NCT01011868|529569639|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
146836125|NCT01011868|529569637|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
146836126|NCT01011868|529569638|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
146836127|NCT01011868|529569639|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
146836128|NCT01011868|529569637|FG000|After Week 78 Follow-up|Adverse Event|14|||
146836129|NCT01011868|529569638|FG001|After Week 78 Follow-up|Adverse Event|18|||
146836130|NCT01011868|529569639|FG002|After Week 78 Follow-up|Adverse Event|21|||
146836131|NCT01011868|529569637|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
146836132|NCT01011868|529569638|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
146836133|NCT01011868|529569639|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
146836134|NCT01011868|529569637|FG000|After Week 78 Follow-up|Protocol Violation|9|||
146836135|NCT01011868|529569638|FG001|After Week 78 Follow-up|Protocol Violation|1|||
146836136|NCT01011868|529569639|FG002|After Week 78 Follow-up|Protocol Violation|2|||
146836137|NCT01011868|529569637|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
146836138|NCT01011868|529569638|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
146836139|NCT01011868|529569639|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
146836140|NCT01011868|529569637|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
146836141|NCT01011868|529569638|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
146836142|NCT01011868|529569639|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
146836143|NCT01011868|529569637|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
146836144|NCT01011868|529569638|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
146836145|NCT01011868|529569639|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
146836146|NCT01262092|529569640|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
146836147|NCT01262092|529569641|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
146836148|NCT01262092|529569640|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
146836149|NCT01262092|529569641|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
146836150|NCT01262092|529569640|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
146836151|NCT01262092|529569641|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
146836152|NCT01262092|529569640|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
146836153|NCT01262092|529569641|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
146836154|NCT04946942|529569642|FG000|Overall Study|Lost to Follow-up|6|||
146836155|NCT04946942|529569643|FG001|Overall Study|Lost to Follow-up|2|||
146836156|NCT04946942|529569644|FG002|Overall Study|Lost to Follow-up|0|||
146836157|NCT04907357|529569645|FG000|Overall Study|Death|0|||
146836158|NCT04907357|529569646|FG001|Overall Study|Death|1|||
146836159|NCT04907357|529569645|FG000|Overall Study|Lost to Follow-up|9|||
146836160|NCT04907357|529569646|FG001|Overall Study|Lost to Follow-up|18|||
146836161|NCT04907357|529569645|FG000|Overall Study|Physician Decision|1|||
146836162|NCT04907357|529569646|FG001|Overall Study|Physician Decision|0|||
146836163|NCT04907357|529569645|FG000|Overall Study|Withdrawal by Subject|0|||
146836164|NCT04907357|529569646|FG001|Overall Study|Withdrawal by Subject|1|||
146836165|NCT04907357|529569645|FG000|Overall Study|Unable to attend visits|1|||
146836166|NCT04907357|529569646|FG001|Overall Study|Unable to attend visits|0|||
146836167|NCT04907357|529569645|FG000|Overall Study|Incarcerated|1|||
146836168|NCT04907357|529569646|FG001|Overall Study|Incarcerated|1|||
146836169|NCT00365547|529569647|FG000|Overall Study|Insurance did not cover Avastin|1|||
146836170|NCT00365547|529569647|FG000|Overall Study|Screen failure|1|||
146836171|NCT00365547|529569647|FG000|Overall Study|Withdrawal by Subject|1|||
146836172|NCT03170518|529569648|FG000|Overall Study|Lost to Follow-up|4|||
146836173|NCT03170518|529569649|FG001|Overall Study|Lost to Follow-up|1|||
146836174|NCT03170518|529569650|FG002|Overall Study|Lost to Follow-up|0|||
146836175|NCT03170518|529569648|FG000|Overall Study|Physician Decision|1|||
146836176|NCT03170518|529569649|FG001|Overall Study|Physician Decision|0|||
146836177|NCT03170518|529569650|FG002|Overall Study|Physician Decision|0|||
146836178|NCT03170518|529569648|FG000|Overall Study|Withdrawal by Subject|4|||
146836179|NCT03170518|529569649|FG001|Overall Study|Withdrawal by Subject|5|||
146836180|NCT03170518|529569650|FG002|Overall Study|Withdrawal by Subject|2|||
146836181|NCT03170518|529569648|FG000|Overall Study|Site terminated by sponsor|0|||
146836182|NCT03170518|529569649|FG001|Overall Study|Site terminated by sponsor|1|||
146836183|NCT03170518|529569650|FG002|Overall Study|Site terminated by sponsor|0|||
146836184|NCT03170518|529569648|FG000|Overall Study|Non-compliance with study drug|1|||
146836185|NCT03170518|529569649|FG001|Overall Study|Non-compliance with study drug|0|||
146836186|NCT03170518|529569650|FG002|Overall Study|Non-compliance with study drug|1|||
146836187|NCT03170518|529569648|FG000|Overall Study|Withdrawal by parent/guardian|2|||
146836188|NCT03170518|529569649|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146836189|NCT03170518|529569650|FG002|Overall Study|Withdrawal by parent/guardian|0|||
146836190|NCT00546078|529569651|FG000|Overall Study|Lost to Follow-up|1|||
146836191|NCT00546078|529569652|FG001|Overall Study|Lost to Follow-up|3|||
146836192|NCT00546078|529569651|FG000|Overall Study|Withdrawal by Subject|2|||
146836193|NCT00546078|529569652|FG001|Overall Study|Withdrawal by Subject|3|||
146836194|NCT00546078|529569651|FG000|Overall Study|Other reason|1|||
146836195|NCT00546078|529569652|FG001|Overall Study|Other reason|1|||
146836196|NCT02257918|529569653|FG000|Overall Study|Lost to Follow-up|4|||
146836197|NCT02257918|529569654|FG001|Overall Study|Lost to Follow-up|1|||
146836198|NCT02257918|529569655|FG002|Overall Study|Lost to Follow-up|0|||
146836199|NCT02257918|529569653|FG000|Overall Study|Withdrawal by Subject|0|||
146836200|NCT02257918|529569654|FG001|Overall Study|Withdrawal by Subject|0|||
146836201|NCT02257918|529569655|FG002|Overall Study|Withdrawal by Subject|1|||
146836202|NCT02257918|529569653|FG000|Overall Study|Pregnancy|0|||
146836203|NCT02257918|529569654|FG001|Overall Study|Pregnancy|0|||
146836204|NCT02257918|529569655|FG002|Overall Study|Pregnancy|1|||
146836205|NCT03023423|529569656|FG000|Overall Study|Death|5|||
146836206|NCT03023423|529569657|FG001|Overall Study|Death|12|||
146836207|NCT03023423|529569658|FG002|Overall Study|Death|20|||
146836208|NCT03023423|529569656|FG000|Overall Study|Other|0|||
146836209|NCT03023423|529569657|FG001|Overall Study|Other|2|||
146836210|NCT03023423|529569658|FG002|Overall Study|Other|2|||
146836211|NCT03023423|529569656|FG000|Overall Study|Ongoing|2|||
146836212|NCT03023423|529569657|FG001|Overall Study|Ongoing|32|||
146836213|NCT03023423|529569658|FG002|Overall Study|Ongoing|24|||
146836214|NCT03512197|529569659|FG000|Overall Study|Guardian decision|1|||
146836215|NCT03512197|529569660|FG001|Overall Study|Guardian decision|1|||
146836216|NCT03512197|529569659|FG000|Overall Study|Lack of Efficacy|19|||
146836217|NCT03512197|529569660|FG001|Overall Study|Lack of Efficacy|11|||
146836218|NCT03512197|529569659|FG000|Overall Study|New Therapy for Study Indication|16|||
146836219|NCT03512197|529569660|FG001|Overall Study|New Therapy for Study Indication|16|||
146836220|NCT03512197|529569659|FG000|Overall Study|Physician Decision|60|||
146836221|NCT03512197|529569660|FG001|Overall Study|Physician Decision|60|||
146836222|NCT03512197|529569659|FG000|Overall Study|Protocol Violation|0|||
146836223|NCT03512197|529569660|FG001|Overall Study|Protocol Violation|2|||
146836224|NCT03512197|529569659|FG000|Overall Study|Terminated by Sponsored|46|||
146836225|NCT03512197|529569660|FG001|Overall Study|Terminated by Sponsored|50|||
146990588|NCT05014412|530128703|FG001|Overall Study|Withdrawal by Subject|1|||
146836226|NCT03512197|529569659|FG000|Overall Study|Subject Decision|15|||
146836227|NCT03512197|529569660|FG001|Overall Study|Subject Decision|12|||
146836228|NCT03512197|529569659|FG000|Overall Study|Withdrawal of informed consent|20|||
146836229|NCT03512197|529569660|FG001|Overall Study|Withdrawal of informed consent|14|||
146990589|NCT05014412|530128704|FG002|Overall Study|Withdrawal by Subject|1|||
146836230|NCT03512197|529569659|FG000|Overall Study|Adverse Event|30|||
146836231|NCT03512197|529569660|FG001|Overall Study|Adverse Event|34|||
146836232|NCT03512197|529569659|FG000|Overall Study|Death|14|||
146836233|NCT03512197|529569660|FG001|Overall Study|Death|9|||
146836234|NCT03512197|529569659|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
146836235|NCT03512197|529569660|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
146836236|NCT03512197|529569659|FG000|Overall Study|Missing|3|||
146836237|NCT03512197|529569660|FG001|Overall Study|Missing|13|||
146836238|NCT03842436|529569661|FG000|Overall Study|Lost to Follow-up|1|||
146836239|NCT01263054|529569665|FG000|Overall Study|Death|1|||
146836240|NCT01263054|529569666|FG001|Overall Study|Death|0|||
146836241|NCT01263054|529569665|FG000|Overall Study|Lost to Follow-up|2|||
146836242|NCT01263054|529569666|FG001|Overall Study|Lost to Follow-up|2|||
146836243|NCT01263054|529569665|FG000|Overall Study|Withdrawal by Subject|1|||
146836244|NCT01263054|529569666|FG001|Overall Study|Withdrawal by Subject|3|||
146836245|NCT01263054|529569665|FG000|Overall Study|Qualification Violation|1|||
146836246|NCT01263054|529569666|FG001|Overall Study|Qualification Violation|0|||
146836247|NCT01263054|529569665|FG000|Overall Study|Other|0|||
146836248|NCT01263054|529569666|FG001|Overall Study|Other|1|||
146836249|NCT00936598|529569667|FG000|Overall Study|Withdrawal by Subject|1|||
146836250|NCT00936598|529569668|FG001|Overall Study|Withdrawal by Subject|0|||
146836251|NCT00936598|529569667|FG000|Overall Study|Ineligible after consent|1|||
146836252|NCT00936598|529569668|FG001|Overall Study|Ineligible after consent|0|||
146836253|NCT04277507|529569670|FG000|Overall Study|Lost to Follow-up|17|||
146836254|NCT04277507|529569670|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
146836255|NCT04277507|529569670|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
146836256|NCT04277507|529569670|FG000|Overall Study|Withdrawal by Subject|3|||
146836257|NCT04277507|529569670|FG000|Overall Study|Death due to COVID-19|1|||
146836258|NCT04277507|529569670|FG000|Overall Study|Data missing for full evaluation|5|||
146836259|NCT03358238|529569673|FG000|Overall Study|Withdrawal by Subject|0|||
146836260|NCT03358238|529569674|FG001|Overall Study|Withdrawal by Subject|1|||
146836261|NCT01431950|529569675|FG000|Overall Study|Study Site Closed/Terminated|7|||
146836262|NCT01431950|529569676|FG001|Overall Study|Study Site Closed/Terminated|3|||
146836263|NCT01431950|529569675|FG000|Overall Study|Withdrawal by Subject|4|||
146836264|NCT01431950|529569676|FG001|Overall Study|Withdrawal by Subject|3|||
146836265|NCT01431950|529569675|FG000|Overall Study|Protocol Violation|2|||
146836266|NCT01431950|529569676|FG001|Overall Study|Protocol Violation|3|||
146836267|NCT01431950|529569675|FG000|Overall Study|Adverse Event|2|||
146836268|NCT01431950|529569676|FG001|Overall Study|Adverse Event|2|||
146836269|NCT01431950|529569675|FG000|Overall Study|Physician Decision|2|||
146836270|NCT01431950|529569676|FG001|Overall Study|Physician Decision|1|||
146836271|NCT01431950|529569675|FG000|Overall Study|Lack of Efficacy|2|||
146836272|NCT01431950|529569676|FG001|Overall Study|Lack of Efficacy|1|||
146836273|NCT01431950|529569675|FG000|Overall Study|Lost to Follow-up|0|||
146836274|NCT01431950|529569676|FG001|Overall Study|Lost to Follow-up|1|||
146836275|NCT01431950|529569675|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
146836276|NCT01431950|529569676|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
146836277|NCT00583947|529569677|FG000|Cross-over Period|Adverse Event|2|||
146836278|NCT00583947|529569678|FG001|Cross-over Period|Adverse Event|0|||
146836279|NCT00583947|529569677|FG000|Cross-over Period|Withdrawal by Subject|2|||
146836280|NCT00583947|529569678|FG001|Cross-over Period|Withdrawal by Subject|0|||
146836281|NCT00583947|529569677|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
146836282|NCT00583947|529569678|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
146836283|NCT00583947|529569677|FG000|Cross-over Period|Other|1|||
146836284|NCT00583947|529569678|FG001|Cross-over Period|Other|1|||
146836285|NCT00486252|529569679|FG000|Overall Study|Adverse Event|7|||
146836286|NCT00486252|529569679|FG000|Overall Study|Lack of Efficacy|9|||
146836287|NCT00486252|529569679|FG000|Overall Study|Lost to Follow-up|24|||
146836288|NCT00486252|529569679|FG000|Overall Study|Other|18|||
146836289|NCT01210651|529569681|FG000|Overall Study|Lost to Follow-up|1|||
146836290|NCT01210651|529569682|FG001|Overall Study|Lost to Follow-up|1|||
146836291|NCT01210651|529569681|FG000|Overall Study|schedule conflicts|1|||
146836292|NCT01210651|529569682|FG001|Overall Study|schedule conflicts|5|||
146836293|NCT01210651|529569681|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
146836294|NCT01210651|529569682|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
146836295|NCT01210651|529569681|FG000|Overall Study|Withdrawal by Subject|1|||
146836296|NCT01210651|529569682|FG001|Overall Study|Withdrawal by Subject|1|||
146836297|NCT01210651|529569681|FG000|Overall Study|Injury outside study|2|||
146836298|NCT01210651|529569682|FG001|Overall Study|Injury outside study|0|||
146836299|NCT01261247|529569683|FG000|Overall Study|Ineligible|2|||
146836300|NCT01740154|529569684|FG000|Overall Study|Adverse Event|1|||
146836301|NCT04013971|529569685|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
146836302|NCT04013971|529569686|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
146836303|NCT04013971|529569685|FG000|Overall Study|Missing biomechanical data|0|||
146836304|NCT04013971|529569686|FG001|Overall Study|Missing biomechanical data|1|||
146836305|NCT01340014|529569689|FG000|Period 1, First 7 Days|Adverse Event|1|||
146836306|NCT01340014|529569690|FG001|Period 1, First 7 Days|Adverse Event|0|||
146836307|NCT01340014|529569689|FG000|Period 1, First 7 Days|Personal Reasons|1|||
146836308|NCT01340014|529569690|FG001|Period 1, First 7 Days|Personal Reasons|0|||
146836309|NCT01340014|529569689|FG000|Period 2, Second 7 Days|Adverse Event|0|||
146836310|NCT01340014|529569690|FG001|Period 2, Second 7 Days|Adverse Event|1|||
146836311|NCT04577573|529569691|FG000|Overall Study|Technical - invalid protocol|0|||
146836312|NCT04577573|529569692|FG001|Overall Study|Technical - invalid protocol|2|||
146836313|NCT04577573|529569693|FG002|Overall Study|Technical - invalid protocol|0|||
146836314|NCT04297618|529569694|FG000|Overall Study|Adverse Event|1|||
146836315|NCT04297618|529569694|FG000|Overall Study|Withdrawal by Subject|1|||
146836316|NCT04949802|529571649|FG000|Overall Study|Lost to Follow-up|3|||
146836317|NCT02358668|529571655|FG000|Overall Study|Adverse Event|2|||
146836318|NCT02358668|529571656|FG001|Overall Study|Adverse Event|0|||
146836319|NCT02358668|529571657|FG002|Overall Study|Adverse Event|0|||
146836320|NCT02358668|529571655|FG000|Overall Study|Withdrawal by Subject|0|||
146836321|NCT02358668|529571656|FG001|Overall Study|Withdrawal by Subject|1|||
146836322|NCT02358668|529571657|FG002|Overall Study|Withdrawal by Subject|0|||
146836323|NCT02419417|529571660|FG000|Overall Study|Disease progression|5|||
146836324|NCT02419417|529571661|FG001|Overall Study|Disease progression|4|||
146836325|NCT02419417|529571662|FG002|Overall Study|Disease progression|13|||
146836326|NCT02419417|529571663|FG003|Overall Study|Disease progression|10|||
146836327|NCT02419417|529571664|FG004|Overall Study|Disease progression|10|||
146836328|NCT02419417|529571665|FG005|Overall Study|Disease progression|3|||
146836329|NCT02419417|529571666|FG006|Overall Study|Disease progression|4|||
146836330|NCT02419417|529571667|FG007|Overall Study|Disease progression|5|||
146836331|NCT02419417|529571668|FG008|Overall Study|Disease progression|13|||
146836332|NCT02419417|529571669|FG009|Overall Study|Disease progression|9|||
146836333|NCT02419417|529571670|FG010|Overall Study|Disease progression|0|||
146836334|NCT02419417|529571660|FG000|Overall Study|Study drug toxicity|0|||
146836335|NCT02419417|529571661|FG001|Overall Study|Study drug toxicity|0|||
146836336|NCT02419417|529571662|FG002|Overall Study|Study drug toxicity|0|||
146836337|NCT02419417|529571663|FG003|Overall Study|Study drug toxicity|0|||
146836338|NCT02419417|529571664|FG004|Overall Study|Study drug toxicity|1|||
146836339|NCT02419417|529571665|FG005|Overall Study|Study drug toxicity|0|||
146836340|NCT02419417|529571666|FG006|Overall Study|Study drug toxicity|0|||
146836341|NCT02419417|529571667|FG007|Overall Study|Study drug toxicity|0|||
146836342|NCT02419417|529571668|FG008|Overall Study|Study drug toxicity|0|||
146836343|NCT02419417|529571669|FG009|Overall Study|Study drug toxicity|0|||
146836344|NCT02419417|529571670|FG010|Overall Study|Study drug toxicity|0|||
146836345|NCT02419417|529571660|FG000|Overall Study|Adverse event unrelated to study drug|0|||
146836346|NCT02419417|529571661|FG001|Overall Study|Adverse event unrelated to study drug|0|||
146836347|NCT02419417|529571662|FG002|Overall Study|Adverse event unrelated to study drug|0|||
146836348|NCT02419417|529571663|FG003|Overall Study|Adverse event unrelated to study drug|0|||
146836349|NCT02419417|529571664|FG004|Overall Study|Adverse event unrelated to study drug|2|||
146836350|NCT02419417|529571665|FG005|Overall Study|Adverse event unrelated to study drug|1|||
146836351|NCT02419417|529571666|FG006|Overall Study|Adverse event unrelated to study drug|0|||
146836352|NCT02419417|529571667|FG007|Overall Study|Adverse event unrelated to study drug|1|||
146836353|NCT02419417|529571668|FG008|Overall Study|Adverse event unrelated to study drug|0|||
146836354|NCT02419417|529571669|FG009|Overall Study|Adverse event unrelated to study drug|0|||
146836355|NCT02419417|529571670|FG010|Overall Study|Adverse event unrelated to study drug|0|||
146836356|NCT02419417|529571660|FG000|Overall Study|Participant request to discontinue|0|||
146836357|NCT02419417|529571661|FG001|Overall Study|Participant request to discontinue|0|||
146836358|NCT02419417|529571662|FG002|Overall Study|Participant request to discontinue|0|||
146836359|NCT02419417|529571663|FG003|Overall Study|Participant request to discontinue|0|||
146836360|NCT02419417|529571664|FG004|Overall Study|Participant request to discontinue|0|||
146836361|NCT02419417|529571665|FG005|Overall Study|Participant request to discontinue|0|||
146836362|NCT02419417|529571666|FG006|Overall Study|Participant request to discontinue|0|||
146836363|NCT02419417|529571667|FG007|Overall Study|Participant request to discontinue|0|||
146836364|NCT02419417|529571668|FG008|Overall Study|Participant request to discontinue|0|||
146836365|NCT02419417|529571669|FG009|Overall Study|Participant request to discontinue|1|||
146836366|NCT02419417|529571670|FG010|Overall Study|Participant request to discontinue|0|||
146836367|NCT02419417|529571660|FG000|Overall Study|Withdrawal by Subject|0|||
146836368|NCT02419417|529571661|FG001|Overall Study|Withdrawal by Subject|0|||
146836369|NCT02419417|529571662|FG002|Overall Study|Withdrawal by Subject|0|||
146836370|NCT02419417|529571663|FG003|Overall Study|Withdrawal by Subject|0|||
146836371|NCT02419417|529571664|FG004|Overall Study|Withdrawal by Subject|0|||
146836372|NCT02419417|529571665|FG005|Overall Study|Withdrawal by Subject|0|||
146836373|NCT02419417|529571666|FG006|Overall Study|Withdrawal by Subject|0|||
146836374|NCT02419417|529571667|FG007|Overall Study|Withdrawal by Subject|0|||
146836375|NCT02419417|529571668|FG008|Overall Study|Withdrawal by Subject|0|||
146990590|NCT05014412|530128705|FG003|Overall Study|Withdrawal by Subject|2|||
146990591|NCT05014412|530128702|FG000|Overall Study|Ongoing|21|||
146990592|NCT05014412|530128703|FG001|Overall Study|Ongoing|4|||
146990593|NCT05014412|530128704|FG002|Overall Study|Ongoing|6|||
146836376|NCT02419417|529571669|FG009|Overall Study|Withdrawal by Subject|0|||
146836377|NCT02419417|529571670|FG010|Overall Study|Withdrawal by Subject|1|||
146836378|NCT01317875|529571674|FG000|Overall Study|Other|0|||
146836379|NCT01317875|529571675|FG001|Overall Study|Other|0|||
146836380|NCT01317875|529571676|FG002|Overall Study|Other|1|||
146836381|NCT01317875|529571677|FG003|Overall Study|Other|0|||
146836382|NCT01317875|529571678|FG004|Overall Study|Other|0|||
146990594|NCT05014412|530128705|FG003|Overall Study|Ongoing|20|||
146990595|NCT02353169|530128706|FG000|Overall Study|QTc > 450 msec|1|||
146836383|NCT01317875|529571679|FG005|Overall Study|Other|0|||
146836384|NCT01317875|529571680|FG006|Overall Study|Other|0|||
146836385|NCT01317875|529571681|FG007|Overall Study|Other|0|||
146836386|NCT01317875|529571682|FG008|Overall Study|Other|0|||
146836387|NCT01317875|529571683|FG009|Overall Study|Other|0|||
146836388|NCT01317875|529571674|FG000|Overall Study|Noncompliance with study drug|0|||
146836389|NCT01317875|529571675|FG001|Overall Study|Noncompliance with study drug|0|||
146836390|NCT01317875|529571676|FG002|Overall Study|Noncompliance with study drug|1|||
146836391|NCT01317875|529571677|FG003|Overall Study|Noncompliance with study drug|0|||
146836392|NCT01317875|529571678|FG004|Overall Study|Noncompliance with study drug|0|||
146836393|NCT01317875|529571679|FG005|Overall Study|Noncompliance with study drug|0|||
146836394|NCT01317875|529571680|FG006|Overall Study|Noncompliance with study drug|0|||
146836395|NCT01317875|529571681|FG007|Overall Study|Noncompliance with study drug|0|||
146836396|NCT01317875|529571682|FG008|Overall Study|Noncompliance with study drug|0|||
146836397|NCT01317875|529571683|FG009|Overall Study|Noncompliance with study drug|0|||
146836398|NCT01317875|529571674|FG000|Overall Study|Progressive Disease|1|||
146836399|NCT01317875|529571675|FG001|Overall Study|Progressive Disease|0|||
146836400|NCT01317875|529571676|FG002|Overall Study|Progressive Disease|2|||
146836401|NCT01317875|529571677|FG003|Overall Study|Progressive Disease|0|||
146836402|NCT01317875|529571678|FG004|Overall Study|Progressive Disease|1|||
146836403|NCT01317875|529571679|FG005|Overall Study|Progressive Disease|0|||
146836404|NCT01317875|529571680|FG006|Overall Study|Progressive Disease|0|||
146836405|NCT01317875|529571681|FG007|Overall Study|Progressive Disease|1|||
146836406|NCT01317875|529571682|FG008|Overall Study|Progressive Disease|0|||
146836407|NCT01317875|529571683|FG009|Overall Study|Progressive Disease|0|||
146836408|NCT01317875|529571674|FG000|Overall Study|Withdrawal by Subject|0|||
146836409|NCT01317875|529571675|FG001|Overall Study|Withdrawal by Subject|0|||
146836410|NCT01317875|529571676|FG002|Overall Study|Withdrawal by Subject|0|||
146836411|NCT01317875|529571677|FG003|Overall Study|Withdrawal by Subject|0|||
146836412|NCT01317875|529571678|FG004|Overall Study|Withdrawal by Subject|1|||
146836413|NCT01317875|529571679|FG005|Overall Study|Withdrawal by Subject|0|||
146836414|NCT01317875|529571680|FG006|Overall Study|Withdrawal by Subject|0|||
146836415|NCT01317875|529571681|FG007|Overall Study|Withdrawal by Subject|3|||
146836416|NCT01317875|529571682|FG008|Overall Study|Withdrawal by Subject|0|||
146836417|NCT01317875|529571683|FG009|Overall Study|Withdrawal by Subject|0|||
146836418|NCT01317875|529571674|FG000|Overall Study|Physician Decision|0|||
146836419|NCT01317875|529571675|FG001|Overall Study|Physician Decision|1|||
146836420|NCT01317875|529571676|FG002|Overall Study|Physician Decision|1|||
146836421|NCT01317875|529571677|FG003|Overall Study|Physician Decision|0|||
146836422|NCT01317875|529571678|FG004|Overall Study|Physician Decision|2|||
146836423|NCT01317875|529571679|FG005|Overall Study|Physician Decision|0|||
146836424|NCT01317875|529571680|FG006|Overall Study|Physician Decision|0|||
146836425|NCT01317875|529571681|FG007|Overall Study|Physician Decision|2|||
146836426|NCT01317875|529571682|FG008|Overall Study|Physician Decision|0|||
146836427|NCT01317875|529571683|FG009|Overall Study|Physician Decision|0|||
146836428|NCT01317875|529571674|FG000|Overall Study|Death|0|||
146836429|NCT01317875|529571675|FG001|Overall Study|Death|0|||
146836430|NCT01317875|529571676|FG002|Overall Study|Death|2|||
146836431|NCT01317875|529571677|FG003|Overall Study|Death|1|||
146836432|NCT01317875|529571678|FG004|Overall Study|Death|0|||
146836433|NCT01317875|529571679|FG005|Overall Study|Death|1|||
146836434|NCT01317875|529571680|FG006|Overall Study|Death|0|||
146836435|NCT01317875|529571681|FG007|Overall Study|Death|4|||
146836436|NCT01317875|529571682|FG008|Overall Study|Death|0|||
146836437|NCT01317875|529571683|FG009|Overall Study|Death|0|||
146836438|NCT01317875|529571674|FG000|Overall Study|Adverse Event|2|||
146836439|NCT01317875|529571675|FG001|Overall Study|Adverse Event|1|||
146836440|NCT01317875|529571676|FG002|Overall Study|Adverse Event|2|||
146836441|NCT01317875|529571677|FG003|Overall Study|Adverse Event|1|||
146836442|NCT01317875|529571678|FG004|Overall Study|Adverse Event|5|||
146836443|NCT01317875|529571679|FG005|Overall Study|Adverse Event|1|||
146836444|NCT01317875|529571680|FG006|Overall Study|Adverse Event|2|||
146836445|NCT01317875|529571681|FG007|Overall Study|Adverse Event|5|||
146836446|NCT01317875|529571682|FG008|Overall Study|Adverse Event|0|||
146836447|NCT01317875|529571683|FG009|Overall Study|Adverse Event|0|||
146836448|NCT00233480|529571684|FG000|Overall Study|Underwent status II heart transplant|0|||
146836449|NCT00233480|529571685|FG001|Overall Study|Underwent status II heart transplant|1|||
146836450|NCT01381575|529571686|FG000|Overall Study|Serious Adverse Event|1|||
146836451|NCT01381575|529571687|FG001|Overall Study|Serious Adverse Event|0|||
146836452|NCT01381575|529571688|FG002|Overall Study|Serious Adverse Event|0|||
146836453|NCT01381575|529571686|FG000|Overall Study|Non-Serious Adverse Event|0|||
146836454|NCT01381575|529571687|FG001|Overall Study|Non-Serious Adverse Event|0|||
146836455|NCT01381575|529571688|FG002|Overall Study|Non-Serious Adverse Event|1|||
146836456|NCT01381575|529571686|FG000|Overall Study|Protocol Violation|0|||
146836457|NCT01381575|529571687|FG001|Overall Study|Protocol Violation|1|||
146836458|NCT01381575|529571688|FG002|Overall Study|Protocol Violation|1|||
146836459|NCT01381575|529571686|FG000|Overall Study|Withdrawal by Subject|15|||
146836460|NCT01381575|529571687|FG001|Overall Study|Withdrawal by Subject|9|||
146836461|NCT01381575|529571688|FG002|Overall Study|Withdrawal by Subject|7|||
146836462|NCT01381575|529571686|FG000|Overall Study|Migrated/moved from study area|2|||
146836463|NCT01381575|529571687|FG001|Overall Study|Migrated/moved from study area|12|||
146836464|NCT01381575|529571688|FG002|Overall Study|Migrated/moved from study area|2|||
146836465|NCT01381575|529571686|FG000|Overall Study|Lost to Follow-up|8|||
146836466|NCT01381575|529571687|FG001|Overall Study|Lost to Follow-up|17|||
146836467|NCT01381575|529571688|FG002|Overall Study|Lost to Follow-up|9|||
146836468|NCT01443403|529571689|FG000|Overall Study|Adverse Event|1|||
146836469|NCT01443403|529571690|FG001|Overall Study|Adverse Event|1|||
146836470|NCT01443403|529571691|FG002|Overall Study|Adverse Event|4|||
146836471|NCT01443403|529571692|FG003|Overall Study|Adverse Event|5|||
146836472|NCT01443403|529571689|FG000|Overall Study|Withdrawal by Subject|0|||
146836473|NCT01443403|529571690|FG001|Overall Study|Withdrawal by Subject|1|||
146836474|NCT01443403|529571691|FG002|Overall Study|Withdrawal by Subject|2|||
146836475|NCT01443403|529571692|FG003|Overall Study|Withdrawal by Subject|1|||
146836476|NCT01443403|529571689|FG000|Overall Study|Lost to Follow-up|0|||
146836477|NCT01443403|529571690|FG001|Overall Study|Lost to Follow-up|0|||
146836478|NCT01443403|529571691|FG002|Overall Study|Lost to Follow-up|0|||
146836479|NCT01443403|529571692|FG003|Overall Study|Lost to Follow-up|1|||
146836480|NCT01443403|529571689|FG000|Overall Study|Protocol Violation|2|||
146836481|NCT01443403|529571690|FG001|Overall Study|Protocol Violation|1|||
146836482|NCT01443403|529571691|FG002|Overall Study|Protocol Violation|1|||
146836483|NCT01443403|529571692|FG003|Overall Study|Protocol Violation|1|||
146836484|NCT01443403|529571689|FG000|Overall Study|Use of Prohibited Treatment|2|||
146836485|NCT01443403|529571690|FG001|Overall Study|Use of Prohibited Treatment|3|||
146836486|NCT01443403|529571691|FG002|Overall Study|Use of Prohibited Treatment|0|||
146836487|NCT01443403|529571692|FG003|Overall Study|Use of Prohibited Treatment|0|||
146836488|NCT01443403|529571689|FG000|Overall Study|Other - Miscellaneous|1|||
146836489|NCT01443403|529571690|FG001|Overall Study|Other - Miscellaneous|0|||
146836490|NCT01443403|529571691|FG002|Overall Study|Other - Miscellaneous|0|||
146836491|NCT01443403|529571692|FG003|Overall Study|Other - Miscellaneous|1|||
146836492|NCT01200342|529571693|FG000|Overall Study|Disease Progression|1|||
146836493|NCT02550938|529571696|FG000|Overall Study|Lost to Follow-up|8|||
146836494|NCT02550938|529571697|FG001|Overall Study|Lost to Follow-up|7|||
146836495|NCT02550938|529571698|FG002|Overall Study|Lost to Follow-up|12|||
146836496|NCT02550938|529571699|FG003|Overall Study|Lost to Follow-up|11|||
146836497|NCT01367847|529571700|FG000|Overall Study|Withdrawal by Subject|2|||
146836498|NCT01367847|529571701|FG001|Overall Study|Withdrawal by Subject|2|||
146836499|NCT02763215|529571702|FG000|Overall Study|Participants withdrew from study|3|||
146836500|NCT02763215|529571702|FG000|Overall Study|Missed visit|1|||
146836501|NCT02763215|529571702|FG000|Overall Study|Visit outside visit-window|1|||
146836502|NCT02763215|529571702|FG000|Overall Study|Death|1|||
146836503|NCT02763215|529571702|FG000|Overall Study|Lost to Follow-up|1|||
146836504|NCT03258723|529571703|FG000|Overall Study|COVID Interruption of study|54|||
146836505|NCT03258723|529571703|FG000|Overall Study|Lost to Follow-up|8|||
146836506|NCT01107899|529571704|FG000|Overall Study|Physician Decision|5|||
146836507|NCT01107899|529571705|FG001|Overall Study|Physician Decision|0|||
146836508|NCT01107899|529571706|FG002|Overall Study|Physician Decision|3|||
146836509|NCT01107899|529571704|FG000|Overall Study|Withdrawal by Subject|0|||
146836510|NCT01107899|529571705|FG001|Overall Study|Withdrawal by Subject|0|||
146836511|NCT01107899|529571706|FG002|Overall Study|Withdrawal by Subject|1|||
146836512|NCT00953771|529571707|FG000|Overall Study|Death|1|||
146836513|NCT00953771|529571708|FG001|Overall Study|Death|0|||
146836514|NCT00974259|529571709|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
146836515|NCT00974259|529571710|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
146836516|NCT00592293|529571712|FG000|Overall Study|Withdrawal by Subject|1|||
146836517|NCT01606319|529571713|FG000|Overall Study|Lost to Follow-up|17|||
146836518|NCT01606319|529571714|FG001|Overall Study|Lost to Follow-up|14|||
146836519|NCT01606319|529571713|FG000|Overall Study|Withdrawal by Subject|9|||
146836520|NCT01606319|529571714|FG001|Overall Study|Withdrawal by Subject|12|||
146836521|NCT01606319|529571713|FG000|Overall Study|Physician Decision|1|||
146836522|NCT01606319|529571714|FG001|Overall Study|Physician Decision|2|||
146836523|NCT01606319|529571713|FG000|Overall Study|Lack of Efficacy|6|||
146836524|NCT01606319|529571714|FG001|Overall Study|Lack of Efficacy|8|||
146836525|NCT01606319|529571713|FG000|Overall Study|Adverse Event|1|||
146836526|NCT01606319|529571714|FG001|Overall Study|Adverse Event|4|||
146836527|NCT01375673|529571724|FG000|Overall Study|Withdrawal by Subject|0|||
146836528|NCT01375673|529571725|FG001|Overall Study|Withdrawal by Subject|1|||
146836529|NCT01784523|529571728|FG000|Overall Study|Study closed early|7|||
146836530|NCT01784523|529571729|FG001|Overall Study|Study closed early|4|||
146836531|NCT02179177|529571732|FG000|Overall Study|Lost to Follow-up|1|||
146836532|NCT02179177|529571733|FG001|Overall Study|Lost to Follow-up|1|||
146836533|NCT02179177|529571732|FG000|Overall Study|Withdrawal by Subject|1|||
146836534|NCT02179177|529571733|FG001|Overall Study|Withdrawal by Subject|1|||
146836535|NCT00022659|529571734|FG000|Overall Study|Ineligible: wrong primary|1|||
146836536|NCT00022659|529571734|FG000|Overall Study|Never treated|1|||
146836537|NCT04340947|529571735|FG000|7-day Washout Period|Lost to Follow-up|5|||
146836538|NCT04340947|529571736|FG001|7-day Washout Period|Lost to Follow-up|4|||
146836539|NCT01907906|529571739|FG000|Overall Study|Withdrawal by Subject|1|||
146836540|NCT01907906|529571740|FG001|Overall Study|Withdrawal by Subject|0|||
146836541|NCT01907906|529571739|FG000|Overall Study|Physician Decision|3|||
146836542|NCT01907906|529571740|FG001|Overall Study|Physician Decision|1|||
146836543|NCT00884650|529571741|FG000|Overall Study|Did not return complete pain diaries|7|||
146836544|NCT00884650|529571742|FG001|Overall Study|Did not return complete pain diaries|7|||
146836545|NCT00884650|529571741|FG000|Overall Study|Admitted Post-Op|1|||
146836546|NCT00884650|529571742|FG001|Overall Study|Admitted Post-Op|0|||
146836547|NCT00884650|529571741|FG000|Overall Study|Femoral Stress Fracture|1|||
146836548|NCT00884650|529571742|FG001|Overall Study|Femoral Stress Fracture|0|||
146836549|NCT00884650|529571741|FG000|Overall Study|Pain Pump Complication|0|||
146836550|NCT00884650|529571742|FG001|Overall Study|Pain Pump Complication|1|||
146836551|NCT04052425|529571751|FG000|24-Week Double-blind Period|Adverse Event|0|||
146836552|NCT04052425|529571752|FG001|24-Week Double-blind Period|Adverse Event|1|||
146836553|NCT04052425|529571753|FG002|24-Week Double-blind Period|Adverse Event|0|||
146836554|NCT04052425|529571754|FG003|24-Week Double-blind Period|Adverse Event|0|||
146836555|NCT04052425|529571751|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
146836556|NCT04052425|529571752|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
146836557|NCT04052425|529571753|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
146836558|NCT04052425|529571754|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
146836559|NCT04052425|529571751|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
146836560|NCT04052425|529571752|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
146836561|NCT04052425|529571753|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
146836562|NCT04052425|529571754|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
146836563|NCT04052425|529571751|FG000|24-Week Double-blind Period|Physician Decision|1|||
146836564|NCT04052425|529571752|FG001|24-Week Double-blind Period|Physician Decision|0|||
146836565|NCT04052425|529571753|FG002|24-Week Double-blind Period|Physician Decision|0|||
146836566|NCT04052425|529571754|FG003|24-Week Double-blind Period|Physician Decision|0|||
146836567|NCT04052425|529571751|FG000|24-Week Double-blind Period|Protocol Violation|1|||
146836568|NCT04052425|529571752|FG001|24-Week Double-blind Period|Protocol Violation|0|||
146836569|NCT04052425|529571753|FG002|24-Week Double-blind Period|Protocol Violation|0|||
146836570|NCT04052425|529571754|FG003|24-Week Double-blind Period|Protocol Violation|0|||
146836571|NCT04052425|529571751|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
146836572|NCT04052425|529571752|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
146836573|NCT04052425|529571753|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
146836574|NCT04052425|529571754|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
146836575|NCT04052425|529571751|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
146836576|NCT04052425|529571752|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
146836577|NCT04052425|529571753|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
146836578|NCT04052425|529571754|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
146836579|NCT04052425|529571751|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
146836580|NCT04052425|529571752|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
146836581|NCT04052425|529571753|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
146836582|NCT04052425|529571754|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
146836583|NCT04052425|529571751|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
146836584|NCT04052425|529571752|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
146836585|NCT04052425|529571753|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
146836586|NCT04052425|529571754|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
146836587|NCT04052425|529571751|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
146836588|NCT04052425|529571752|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
146836589|NCT04052425|529571753|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
146836590|NCT04052425|529571754|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
146836591|NCT04052425|529571751|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
146836592|NCT04052425|529571752|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
146836593|NCT04052425|529571753|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
146836594|NCT04052425|529571754|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
146836595|NCT04052425|529571751|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
146836596|NCT04052425|529571752|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
146836597|NCT04052425|529571753|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
146836598|NCT04052425|529571754|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
146836599|NCT04052425|529571751|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
146836600|NCT04052425|529571752|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
146836601|NCT04052425|529571753|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
146836602|NCT04052425|529571754|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
146836603|NCT04052425|529571751|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
146990596|NCT02353169|530128707|FG001|Overall Study|QTc > 450 msec|1|||
146990597|NCT02353169|530128708|FG002|Overall Study|QTc > 450 msec|1|||
146990598|NCT02353169|530128709|FG003|Overall Study|QTc > 450 msec|1|||
146990599|NCT02353169|530128706|FG000|Overall Study|OR team declined|2|||
146990600|NCT02353169|530128707|FG001|Overall Study|OR team declined|0|||
146836604|NCT04052425|529571752|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
146836605|NCT04052425|529571753|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
146836606|NCT04052425|529571754|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
146836607|NCT04334278|529571755|FG000|Overall Study|Lost to Follow-up|0|||
146836608|NCT04334278|529571756|FG001|Overall Study|Lost to Follow-up|3|||
146836609|NCT04334278|529571755|FG000|Overall Study|Withdrawal by Subject|4|||
146836610|NCT04334278|529571756|FG001|Overall Study|Withdrawal by Subject|2|||
146836611|NCT01821937|529571757|FG000|Overall Study|Adverse Event|0|||
146836612|NCT01821937|529571758|FG001|Overall Study|Adverse Event|3|||
146836613|NCT01677299|529571759|FG000|Overall Study|Adverse Event|0|||
146836614|NCT01677299|529571760|FG001|Overall Study|Adverse Event|2|||
146836615|NCT01677299|529571761|FG002|Overall Study|Adverse Event|1|||
146836616|NCT01677299|529571762|FG003|Overall Study|Adverse Event|0|||
146836617|NCT01677299|529571759|FG000|Overall Study|Withdrawal by Subject|0|||
146836618|NCT01677299|529571760|FG001|Overall Study|Withdrawal by Subject|1|||
146836619|NCT01677299|529571761|FG002|Overall Study|Withdrawal by Subject|0|||
146836620|NCT01677299|529571762|FG003|Overall Study|Withdrawal by Subject|1|||
146836621|NCT02153905|529571763|FG000|Overall Study|Death|1|||
146836622|NCT02153905|529571764|FG001|Overall Study|Death|0|||
146836623|NCT00351377|529571765|FG000|Overall Study|Adverse Event|5|||
146836624|NCT00351377|529571765|FG000|Overall Study|Death|1|||
146836625|NCT00351377|529571765|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146836626|NCT03994731|529571766|FG000|Pegloticase + IMM Period|Death|2|||
146836627|NCT03994731|529571767|FG001|Pegloticase + IMM Period|Death|0|||
146836628|NCT03994731|529571766|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
146836629|NCT03994731|529571767|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
146836630|NCT03994731|529571766|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
146836631|NCT03994731|529571767|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
146836632|NCT02406248|529571774|FG000|Overall Study|Death|7|||
146836633|NCT02406248|529571774|FG000|Overall Study|Withdrawal by Subject|2|||
146836634|NCT01969851|529571775|FG000|Overall Study|Adverse Event|0|||
146836635|NCT01969851|529571776|FG001|Overall Study|Adverse Event|0|||
146836636|NCT01969851|529571777|FG002|Overall Study|Adverse Event|3|||
146836637|NCT01969851|529571775|FG000|Overall Study|Lack of Efficacy|0|||
146836638|NCT01969851|529571776|FG001|Overall Study|Lack of Efficacy|3|||
146836639|NCT01969851|529571777|FG002|Overall Study|Lack of Efficacy|1|||
146836640|NCT01969851|529571775|FG000|Overall Study|Withdrawal by Subject|1|||
146836641|NCT01969851|529571776|FG001|Overall Study|Withdrawal by Subject|0|||
146836642|NCT01969851|529571777|FG002|Overall Study|Withdrawal by Subject|1|||
146836643|NCT01969851|529571775|FG000|Overall Study|No effective dose in Titration period|0|||
146836644|NCT01969851|529571776|FG001|Overall Study|No effective dose in Titration period|0|||
146836645|NCT01969851|529571777|FG002|Overall Study|No effective dose in Titration period|1|||
146836646|NCT01969851|529571775|FG000|Overall Study|Sponsor decision|0|||
146836647|NCT01969851|529571776|FG001|Overall Study|Sponsor decision|0|||
146836648|NCT01969851|529571777|FG002|Overall Study|Sponsor decision|1|||
146836649|NCT05226130|529571778|FG000|Overall Study|Lost to Follow-up|0|||
146836650|NCT05226130|529571779|FG001|Overall Study|Lost to Follow-up|1|||
146836651|NCT05226130|529571778|FG000|Overall Study|Not treatment adherent|0|||
146836652|NCT05226130|529571779|FG001|Overall Study|Not treatment adherent|2|||
146990601|NCT02353169|530128708|FG002|Overall Study|OR team declined|0|||
146836653|NCT02520310|529571780|FG000|At 6 Months Clinical Follow-up|Death|1|||
146836654|NCT02520310|529571780|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
146836655|NCT02520310|529571780|FG000|AT 3 Year Clinical Follow-up|Death|2|||
146836656|NCT02520310|529571780|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
146836657|NCT02520310|529571780|FG000|AT 4 Year Clinical Follow-up|Death|1|||
146836658|NCT02520310|529571780|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
146836659|NCT05101993|529571783|FG000|Overall Study|Withdrawal by Subject|1|||
146836660|NCT01124838|529571784|FG000|Overall Study|Miscellaneous|4|||
146836661|NCT01124838|529571785|FG001|Overall Study|Miscellaneous|2|||
146836662|NCT01124838|529571784|FG000|Overall Study|Adverse Event|7|||
146836663|NCT01124838|529571785|FG001|Overall Study|Adverse Event|11|||
146836664|NCT01124838|529571784|FG000|Overall Study|Lack of Efficacy|2|||
146836665|NCT01124838|529571785|FG001|Overall Study|Lack of Efficacy|0|||
146836666|NCT01124838|529571784|FG000|Overall Study|Withdrawal by Subject|3|||
146836667|NCT01124838|529571785|FG001|Overall Study|Withdrawal by Subject|2|||
146836668|NCT01124838|529571784|FG000|Overall Study|Lost to Follow-up|2|||
146990602|NCT02353169|530128709|FG003|Overall Study|OR team declined|0|||
146836669|NCT01124838|529571785|FG001|Overall Study|Lost to Follow-up|0|||
146836670|NCT02065882|529571786|FG000|Part I: PK/PD|Screening failure|5|||
146836671|NCT02065882|529571786|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
146836672|NCT02065882|529571786|FG000|Part I: PK/PD|Adverse Event|1|||
146836673|NCT02065882|529571786|FG000|Part II: Clinical Efficacy|Screening failure|7|||
146836674|NCT02065882|529571786|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
146836675|NCT02065882|529571786|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
146836676|NCT02065882|529571786|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
146836677|NCT02065882|529571786|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
146836678|NCT02065882|529571786|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
146836679|NCT03816761|529573563|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
146836680|NCT03816761|529573564|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
146836681|NCT03816761|529573565|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
146836682|NCT03816761|529573566|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
146836683|NCT03816761|529573567|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
146836684|NCT03816761|529573568|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
146836685|NCT03816761|529573563|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
146836686|NCT03816761|529573564|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
146836687|NCT03816761|529573565|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
146836688|NCT03816761|529573566|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
146836689|NCT03816761|529573567|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
146836690|NCT03816761|529573568|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
146836691|NCT04991753|529573569|FG000|Overall Study|Withdrawal by Subject|0|||
146836692|NCT04991753|529573570|FG001|Overall Study|Withdrawal by Subject|1|||
146836693|NCT00474526|529573573|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
146836694|NCT00474526|529573574|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
146836695|NCT00474526|529573575|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
146836696|NCT00474526|529573576|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
146836697|NCT00474526|529573577|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
146836698|NCT00474526|529573578|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
146836699|NCT00474526|529573579|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
146836700|NCT00474526|529573580|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
146836701|NCT00474526|529573581|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
146836702|NCT00474526|529573582|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
146836703|NCT00474526|529573583|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
146836704|NCT00474526|529573584|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
146836705|NCT00474526|529573585|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
146836706|NCT00474526|529573586|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
146836707|NCT00474526|529573587|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
146836708|NCT00474526|529573588|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
146836709|NCT00474526|529573589|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
146836710|NCT00474526|529573573|FG000|Overall Study|Adverse Event|2|||
146836711|NCT00474526|529573574|FG001|Overall Study|Adverse Event|0|||
146836712|NCT00474526|529573575|FG002|Overall Study|Adverse Event|2|||
146836713|NCT00474526|529573576|FG003|Overall Study|Adverse Event|4|||
146836714|NCT00474526|529573577|FG004|Overall Study|Adverse Event|2|||
146836715|NCT00474526|529573578|FG005|Overall Study|Adverse Event|1|||
146836716|NCT00474526|529573579|FG006|Overall Study|Adverse Event|1|||
146836717|NCT00474526|529573580|FG007|Overall Study|Adverse Event|0|||
146836718|NCT00474526|529573581|FG008|Overall Study|Adverse Event|0|||
146836719|NCT00474526|529573582|FG009|Overall Study|Adverse Event|0|||
146836720|NCT00474526|529573583|FG010|Overall Study|Adverse Event|0|||
146836721|NCT00474526|529573584|FG011|Overall Study|Adverse Event|0|||
146836722|NCT00474526|529573585|FG012|Overall Study|Adverse Event|0|||
146836723|NCT00474526|529573586|FG013|Overall Study|Adverse Event|0|||
146836724|NCT00474526|529573587|FG014|Overall Study|Adverse Event|1|||
146836725|NCT00474526|529573588|FG015|Overall Study|Adverse Event|1|||
146836726|NCT00474526|529573589|FG016|Overall Study|Adverse Event|0|||
146836727|NCT00474526|529573573|FG000|Overall Study|Death|0|||
146836728|NCT00474526|529573574|FG001|Overall Study|Death|0|||
146836729|NCT00474526|529573575|FG002|Overall Study|Death|0|||
146836730|NCT00474526|529573576|FG003|Overall Study|Death|0|||
146836731|NCT00474526|529573577|FG004|Overall Study|Death|0|||
146836732|NCT00474526|529573578|FG005|Overall Study|Death|0|||
146836733|NCT00474526|529573579|FG006|Overall Study|Death|0|||
146836734|NCT00474526|529573580|FG007|Overall Study|Death|0|||
146836735|NCT00474526|529573581|FG008|Overall Study|Death|0|||
146836736|NCT00474526|529573582|FG009|Overall Study|Death|0|||
146836737|NCT00474526|529573583|FG010|Overall Study|Death|0|||
146836738|NCT00474526|529573584|FG011|Overall Study|Death|0|||
146836739|NCT00474526|529573585|FG012|Overall Study|Death|0|||
146836740|NCT00474526|529573586|FG013|Overall Study|Death|3|||
146990603|NCT02353169|530128706|FG000|Overall Study|Inhalational induction|0|||
146990604|NCT02353169|530128707|FG001|Overall Study|Inhalational induction|2|||
146836741|NCT00474526|529573587|FG014|Overall Study|Death|0|||
146836742|NCT00474526|529573588|FG015|Overall Study|Death|0|||
146836743|NCT00474526|529573589|FG016|Overall Study|Death|0|||
146836744|NCT00474526|529573573|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146836745|NCT00474526|529573574|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
146836746|NCT00474526|529573575|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146836747|NCT00474526|529573576|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
146836748|NCT00474526|529573577|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
146836749|NCT00474526|529573578|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146836750|NCT00474526|529573579|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146836751|NCT00474526|529573580|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146836752|NCT00474526|529573581|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146990605|NCT02353169|530128708|FG002|Overall Study|Inhalational induction|0|||
146836753|NCT00474526|529573582|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146836754|NCT00474526|529573583|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146836755|NCT00474526|529573584|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146836756|NCT00474526|529573585|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146836757|NCT00474526|529573586|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
146836758|NCT00474526|529573587|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
146836759|NCT00474526|529573588|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146836760|NCT00474526|529573589|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146836761|NCT00474526|529573573|FG000|Overall Study|Lost to Follow-up|8|||
146836762|NCT00474526|529573574|FG001|Overall Study|Lost to Follow-up|6|||
146836763|NCT00474526|529573575|FG002|Overall Study|Lost to Follow-up|13|||
146836764|NCT00474526|529573576|FG003|Overall Study|Lost to Follow-up|29|||
146836765|NCT00474526|529573577|FG004|Overall Study|Lost to Follow-up|11|||
146836766|NCT00474526|529573578|FG005|Overall Study|Lost to Follow-up|5|||
146836767|NCT00474526|529573579|FG006|Overall Study|Lost to Follow-up|8|||
146836768|NCT00474526|529573580|FG007|Overall Study|Lost to Follow-up|1|||
146836769|NCT00474526|529573581|FG008|Overall Study|Lost to Follow-up|0|||
146836770|NCT00474526|529573582|FG009|Overall Study|Lost to Follow-up|6|||
146836771|NCT00474526|529573583|FG010|Overall Study|Lost to Follow-up|2|||
146836772|NCT00474526|529573584|FG011|Overall Study|Lost to Follow-up|4|||
146836773|NCT00474526|529573585|FG012|Overall Study|Lost to Follow-up|6|||
146836774|NCT00474526|529573586|FG013|Overall Study|Lost to Follow-up|74|||
146836775|NCT00474526|529573587|FG014|Overall Study|Lost to Follow-up|29|||
146836776|NCT00474526|529573588|FG015|Overall Study|Lost to Follow-up|4|||
146836777|NCT00474526|529573589|FG016|Overall Study|Lost to Follow-up|5|||
146836778|NCT00474526|529573573|FG000|Overall Study|Protocol Violation|2|||
146836779|NCT00474526|529573574|FG001|Overall Study|Protocol Violation|6|||
146836780|NCT00474526|529573575|FG002|Overall Study|Protocol Violation|4|||
146836781|NCT00474526|529573576|FG003|Overall Study|Protocol Violation|12|||
146836782|NCT00474526|529573577|FG004|Overall Study|Protocol Violation|3|||
146836783|NCT00474526|529573578|FG005|Overall Study|Protocol Violation|1|||
146836784|NCT00474526|529573579|FG006|Overall Study|Protocol Violation|3|||
146836785|NCT00474526|529573580|FG007|Overall Study|Protocol Violation|0|||
146836786|NCT00474526|529573581|FG008|Overall Study|Protocol Violation|0|||
146836787|NCT00474526|529573582|FG009|Overall Study|Protocol Violation|4|||
146836788|NCT00474526|529573583|FG010|Overall Study|Protocol Violation|2|||
146836789|NCT00474526|529573584|FG011|Overall Study|Protocol Violation|2|||
146836790|NCT00474526|529573585|FG012|Overall Study|Protocol Violation|4|||
146836791|NCT00474526|529573586|FG013|Overall Study|Protocol Violation|19|||
146836792|NCT00474526|529573587|FG014|Overall Study|Protocol Violation|9|||
146836793|NCT00474526|529573588|FG015|Overall Study|Protocol Violation|6|||
146836794|NCT00474526|529573589|FG016|Overall Study|Protocol Violation|2|||
146836795|NCT00474526|529573573|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
146836796|NCT00474526|529573574|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
146836797|NCT00474526|529573575|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
146836798|NCT00474526|529573576|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
146836799|NCT00474526|529573577|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
146836800|NCT00474526|529573578|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
146836801|NCT00474526|529573579|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
146836802|NCT00474526|529573580|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
146836803|NCT00474526|529573581|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
146836804|NCT00474526|529573582|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
146836805|NCT00474526|529573583|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
146836806|NCT00474526|529573584|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
146836807|NCT00474526|529573585|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
146836808|NCT00474526|529573586|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
146836809|NCT00474526|529573587|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
146836810|NCT00474526|529573588|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
146836811|NCT00474526|529573589|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
146836812|NCT00474526|529573573|FG000|Overall Study|Withdrawal by Subject|9|||
146836813|NCT00474526|529573574|FG001|Overall Study|Withdrawal by Subject|24|||
146836814|NCT00474526|529573575|FG002|Overall Study|Withdrawal by Subject|21|||
146836815|NCT00474526|529573576|FG003|Overall Study|Withdrawal by Subject|52|||
146836816|NCT00474526|529573577|FG004|Overall Study|Withdrawal by Subject|38|||
146836817|NCT00474526|529573578|FG005|Overall Study|Withdrawal by Subject|6|||
146836818|NCT00474526|529573579|FG006|Overall Study|Withdrawal by Subject|12|||
146836819|NCT00474526|529573580|FG007|Overall Study|Withdrawal by Subject|4|||
146836820|NCT00474526|529573581|FG008|Overall Study|Withdrawal by Subject|4|||
146836821|NCT00474526|529573582|FG009|Overall Study|Withdrawal by Subject|13|||
146836822|NCT00474526|529573583|FG010|Overall Study|Withdrawal by Subject|5|||
146836823|NCT00474526|529573584|FG011|Overall Study|Withdrawal by Subject|4|||
146836824|NCT00474526|529573585|FG012|Overall Study|Withdrawal by Subject|4|||
146836825|NCT00474526|529573586|FG013|Overall Study|Withdrawal by Subject|37|||
146836826|NCT00474526|529573587|FG014|Overall Study|Withdrawal by Subject|22|||
146836827|NCT00474526|529573588|FG015|Overall Study|Withdrawal by Subject|1|||
146836828|NCT00474526|529573589|FG016|Overall Study|Withdrawal by Subject|1|||
146836829|NCT02797522|529573590|FG000|Overall Study|Study Terminated by Sponsor|0|||
146836830|NCT02797522|529573591|FG001|Overall Study|Study Terminated by Sponsor|0|||
146836831|NCT02797522|529573592|FG002|Overall Study|Study Terminated by Sponsor|0|||
146836832|NCT02797522|529573593|FG003|Overall Study|Study Terminated by Sponsor|0|||
146836833|NCT02797522|529573594|FG004|Overall Study|Study Terminated by Sponsor|0|||
146836834|NCT02797522|529573595|FG005|Overall Study|Study Terminated by Sponsor|0|||
146836835|NCT02797522|529573596|FG006|Overall Study|Study Terminated by Sponsor|0|||
146836836|NCT02797522|529573597|FG007|Overall Study|Study Terminated by Sponsor|4|||
146836837|NCT02797522|529573598|FG008|Overall Study|Study Terminated by Sponsor|2|||
146836838|NCT02797522|529573599|FG009|Overall Study|Study Terminated by Sponsor|4|||
146836839|NCT02797522|529573600|FG010|Overall Study|Study Terminated by Sponsor|1|||
146836840|NCT00132678|529573603|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
146836841|NCT00132678|529573604|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
146836842|NCT00132678|529573605|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
146836843|NCT00132678|529573603|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
146836844|NCT00132678|529573604|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
146836845|NCT00132678|529573605|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
146836846|NCT00132678|529573603|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
146836847|NCT00132678|529573604|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
146836848|NCT00132678|529573605|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
146836849|NCT00132678|529573603|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
146836850|NCT00132678|529573604|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
146836851|NCT00132678|529573605|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
146836852|NCT00132678|529573603|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
146836853|NCT00132678|529573604|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
146836854|NCT00132678|529573605|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
146836855|NCT00132678|529573603|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
146836856|NCT00132678|529573604|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
146836857|NCT00132678|529573605|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
146836858|NCT00132678|529573603|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
146836859|NCT00132678|529573604|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
146836860|NCT00132678|529573605|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
146836861|NCT00132678|529573603|FG000|Period III (Open-Label Stabilization)|Death|2|||
146836862|NCT00132678|529573604|FG001|Period III (Open-Label Stabilization)|Death|0|||
146836863|NCT00132678|529573605|FG002|Period III (Open-Label Stabilization)|Death|0|||
146836864|NCT00132678|529573603|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
146836865|NCT00132678|529573604|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
146836866|NCT00132678|529573605|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
146836867|NCT00132678|529573603|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
146836868|NCT00132678|529573604|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
146836869|NCT00132678|529573605|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
146836870|NCT00132678|529573603|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
146836871|NCT00132678|529573604|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
146836872|NCT00132678|529573605|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
146836873|NCT00132678|529573603|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
146836874|NCT00132678|529573604|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
146836875|NCT00132678|529573605|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
146836876|NCT00132678|529573603|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
146836877|NCT00132678|529573604|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
146836878|NCT00132678|529573605|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
146836879|NCT00132678|529573603|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
146836880|NCT00132678|529573604|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
146836881|NCT00132678|529573605|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
146836882|NCT00132678|529573603|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
146836883|NCT00132678|529573604|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
146836884|NCT00132678|529573605|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
146836885|NCT00132678|529573603|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
146836886|NCT00132678|529573604|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
146836887|NCT00132678|529573605|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
146836888|NCT00132678|529573603|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
146836889|NCT00132678|529573604|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
146836890|NCT00132678|529573605|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
146836891|NCT00132678|529573603|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
146836892|NCT00132678|529573604|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
146836893|NCT00132678|529573605|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
146836894|NCT00132678|529573603|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
146836895|NCT00132678|529573604|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
146990606|NCT02353169|530128709|FG003|Overall Study|Inhalational induction|0|||
146990607|NCT02353169|530128706|FG000|Overall Study|ECG data error|0|||
146836896|NCT00132678|529573605|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
146836897|NCT00132678|529573603|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
146836898|NCT00132678|529573604|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
146836899|NCT00132678|529573605|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
146836900|NCT00132678|529573603|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
146836901|NCT00132678|529573604|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
146836902|NCT00132678|529573605|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
146836903|NCT00132678|529573603|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
146836904|NCT00132678|529573604|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
146836905|NCT00132678|529573605|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
146836906|NCT00132678|529573603|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
146836907|NCT00132678|529573604|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
146836908|NCT00132678|529573605|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
146836909|NCT00953147|529573608|FG000|Overall Study|Adverse Event|8|||
146836910|NCT00953147|529573609|FG001|Overall Study|Adverse Event|16|||
146836911|NCT00953147|529573610|FG002|Overall Study|Adverse Event|6|||
146836912|NCT00953147|529573608|FG000|Overall Study|Protocol Violation|2|||
146836913|NCT00953147|529573609|FG001|Overall Study|Protocol Violation|8|||
146836914|NCT00953147|529573610|FG002|Overall Study|Protocol Violation|4|||
146836915|NCT00953147|529573608|FG000|Overall Study|Withdrawal by Subject|13|||
146836916|NCT00953147|529573609|FG001|Overall Study|Withdrawal by Subject|15|||
146836917|NCT00953147|529573610|FG002|Overall Study|Withdrawal by Subject|12|||
146836918|NCT00953147|529573608|FG000|Overall Study|Lost to Follow-up|8|||
146836919|NCT00953147|529573609|FG001|Overall Study|Lost to Follow-up|9|||
146836920|NCT00953147|529573610|FG002|Overall Study|Lost to Follow-up|4|||
146836921|NCT00953147|529573608|FG000|Overall Study|Physician Decision|2|||
146836922|NCT00953147|529573609|FG001|Overall Study|Physician Decision|7|||
146836923|NCT00953147|529573610|FG002|Overall Study|Physician Decision|3|||
146836924|NCT00953147|529573608|FG000|Overall Study|Other|4|||
146836925|NCT00953147|529573609|FG001|Overall Study|Other|11|||
146836926|NCT00953147|529573610|FG002|Overall Study|Other|13|||
146836927|NCT01484431|529573612|FG000|Period 1: High Dose|Physician Decision|0|||
146836928|NCT01484431|529573613|FG001|Period 1: High Dose|Physician Decision|1|||
146836929|NCT01484431|529573614|FG002|Period 1: High Dose|Physician Decision|0|||
146836930|NCT01484431|529573612|FG000|Period 2|Death|0|||
146836931|NCT01484431|529573613|FG001|Period 2|Death|1|||
146836932|NCT01484431|529573614|FG002|Period 2|Death|1|||
146836933|NCT01484431|529573612|FG000|Period 2|Physician Decision|0|||
146836934|NCT01484431|529573613|FG001|Period 2|Physician Decision|0|||
146836935|NCT01484431|529573614|FG002|Period 2|Physician Decision|1|||
146836936|NCT01484431|529573612|FG000|Period 2|Non-Compliance with Study Drug|1|||
146836937|NCT01484431|529573613|FG001|Period 2|Non-Compliance with Study Drug|0|||
146836938|NCT01484431|529573614|FG002|Period 2|Non-Compliance with Study Drug|0|||
146836939|NCT01251770|529573615|FG000|Overall Study|Protocol Violation|13|||
146836940|NCT01251770|529573616|FG001|Overall Study|Protocol Violation|7|||
146836941|NCT02514239|529573617|FG000|Overall Study|Refused to continue trial medication|0|||
146836942|NCT02514239|529573618|FG001|Overall Study|Refused to continue trial medication|0|||
146836943|NCT02514239|529573619|FG002|Overall Study|Refused to continue trial medication|0|||
146836944|NCT02514239|529573620|FG003|Overall Study|Refused to continue trial medication|0|||
146836945|NCT02514239|529573621|FG004|Overall Study|Refused to continue trial medication|0|||
146836946|NCT02514239|529573622|FG005|Overall Study|Refused to continue trial medication|0|||
146836947|NCT02514239|529573623|FG006|Overall Study|Refused to continue trial medication|0|||
146836948|NCT02514239|529573624|FG007|Overall Study|Refused to continue trial medication|0|||
146836949|NCT02514239|529573625|FG008|Overall Study|Refused to continue trial medication|0|||
146836950|NCT02514239|529573626|FG009|Overall Study|Refused to continue trial medication|1|||
146836951|NCT02514239|529573617|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
146836952|NCT02514239|529573618|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
146836953|NCT02514239|529573619|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
146836954|NCT02514239|529573620|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
146836955|NCT02514239|529573621|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
146836956|NCT02514239|529573622|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
146836957|NCT02514239|529573623|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
146836958|NCT02514239|529573624|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
146836959|NCT02514239|529573625|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
146836960|NCT02514239|529573626|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
146836961|NCT02514239|529573617|FG000|Overall Study|Not treated|0|||
146836962|NCT02514239|529573618|FG001|Overall Study|Not treated|1|||
146836963|NCT02514239|529573619|FG002|Overall Study|Not treated|0|||
146836964|NCT02514239|529573620|FG003|Overall Study|Not treated|0|||
146836965|NCT02514239|529573621|FG004|Overall Study|Not treated|0|||
146836966|NCT02514239|529573622|FG005|Overall Study|Not treated|0|||
146836967|NCT02514239|529573623|FG006|Overall Study|Not treated|0|||
146836968|NCT02514239|529573624|FG007|Overall Study|Not treated|0|||
146836969|NCT02514239|529573625|FG008|Overall Study|Not treated|0|||
146836970|NCT02514239|529573626|FG009|Overall Study|Not treated|0|||
146836971|NCT02514239|529573617|FG000|Overall Study|Other Adverse Events|2|||
146836972|NCT02514239|529573618|FG001|Overall Study|Other Adverse Events|0|||
146836973|NCT02514239|529573619|FG002|Overall Study|Other Adverse Events|0|||
146836974|NCT02514239|529573620|FG003|Overall Study|Other Adverse Events|1|||
146836975|NCT02514239|529573621|FG004|Overall Study|Other Adverse Events|0|||
146836976|NCT02514239|529573622|FG005|Overall Study|Other Adverse Events|1|||
146836977|NCT02514239|529573623|FG006|Overall Study|Other Adverse Events|0|||
146836978|NCT02514239|529573624|FG007|Overall Study|Other Adverse Events|1|||
146836979|NCT02514239|529573625|FG008|Overall Study|Other Adverse Events|2|||
146836980|NCT02514239|529573626|FG009|Overall Study|Other Adverse Events|0|||
146836981|NCT02514239|529573617|FG000|Overall Study|Progressive disease|3|||
146836982|NCT02514239|529573618|FG001|Overall Study|Progressive disease|3|||
146836983|NCT02514239|529573619|FG002|Overall Study|Progressive disease|2|||
146836984|NCT02514239|529573620|FG003|Overall Study|Progressive disease|2|||
146836985|NCT02514239|529573621|FG004|Overall Study|Progressive disease|3|||
146836986|NCT02514239|529573622|FG005|Overall Study|Progressive disease|3|||
146836987|NCT02514239|529573623|FG006|Overall Study|Progressive disease|4|||
146836988|NCT02514239|529573624|FG007|Overall Study|Progressive disease|2|||
146836989|NCT02514239|529573625|FG008|Overall Study|Progressive disease|5|||
146836990|NCT02514239|529573626|FG009|Overall Study|Progressive disease|0|||
146836991|NCT01888874|529573627|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
146836992|NCT01888874|529573628|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
146836993|NCT01888874|529573629|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
146836994|NCT01888874|529573630|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
146836995|NCT01888874|529573631|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
146836996|NCT01888874|529573632|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
146836997|NCT01888874|529573633|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
146836998|NCT01888874|529573627|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
146836999|NCT01888874|529573628|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
146837000|NCT01888874|529573629|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
146837001|NCT01888874|529573630|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
146837002|NCT01888874|529573631|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
146837003|NCT01888874|529573632|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
146837004|NCT01888874|529573633|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
146837005|NCT01888874|529573627|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
146837006|NCT01888874|529573628|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
146837007|NCT01888874|529573629|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
146837008|NCT01888874|529573630|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
146837009|NCT01888874|529573631|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
146837010|NCT01888874|529573632|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
146837011|NCT01888874|529573633|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
146837012|NCT01888874|529573627|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
146837013|NCT01888874|529573628|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
146837014|NCT01888874|529573629|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
146837015|NCT01888874|529573630|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
146837016|NCT01888874|529573631|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
146837017|NCT01888874|529573632|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
146837018|NCT01888874|529573633|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
146837019|NCT01888874|529573627|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146837020|NCT01888874|529573628|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146837021|NCT01888874|529573629|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146837022|NCT01888874|529573630|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146837023|NCT01888874|529573631|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
146837024|NCT01888874|529573632|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146837025|NCT01888874|529573633|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146837026|NCT01888874|529573627|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
146837027|NCT01888874|529573628|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
146837028|NCT01888874|529573629|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
146837029|NCT01888874|529573630|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
146837030|NCT01888874|529573631|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
146837031|NCT01888874|529573632|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
146837032|NCT01888874|529573633|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
146837033|NCT01888874|529573627|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
146837034|NCT01888874|529573628|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
146837035|NCT01888874|529573629|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
146837036|NCT01888874|529573630|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
146837037|NCT01888874|529573631|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
146990608|NCT02353169|530128707|FG001|Overall Study|ECG data error|3|||
146837038|NCT01888874|529573632|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
146837039|NCT01888874|529573633|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
146837040|NCT01888874|529573627|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
146837041|NCT01888874|529573628|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
146837042|NCT01888874|529573629|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
146837043|NCT01888874|529573630|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
146837044|NCT01888874|529573631|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
146837045|NCT01888874|529573632|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
146837046|NCT01888874|529573633|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
146837047|NCT01888874|529573627|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
146837048|NCT01888874|529573628|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
146837049|NCT01888874|529573629|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
146837050|NCT01888874|529573630|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
146837051|NCT01888874|529573631|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
146837052|NCT01888874|529573632|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
146837053|NCT01888874|529573633|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
146837054|NCT01888874|529573627|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
146837055|NCT01888874|529573628|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
146837056|NCT01888874|529573629|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
146837057|NCT01888874|529573630|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
146837058|NCT01888874|529573631|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
146837059|NCT01888874|529573632|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
146837060|NCT01888874|529573633|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
146837061|NCT01888874|529573627|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
146837062|NCT01888874|529573628|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
146837063|NCT01888874|529573629|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
146837064|NCT01888874|529573630|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
146837065|NCT01888874|529573631|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
146837066|NCT01888874|529573632|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
146837067|NCT01888874|529573633|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
146837068|NCT01888874|529573627|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
146837069|NCT01888874|529573628|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
146837070|NCT01888874|529573629|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
146837071|NCT01888874|529573630|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
146837072|NCT01888874|529573631|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
146837073|NCT01888874|529573632|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
146837074|NCT01888874|529573633|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
146837075|NCT01888874|529573627|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
146837076|NCT01888874|529573628|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
146837077|NCT01888874|529573629|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
146837078|NCT01888874|529573630|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
146837079|NCT01888874|529573631|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
146837080|NCT01888874|529573632|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
146837081|NCT01888874|529573633|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
146837082|NCT00475644|529573634|FG000|Overall Study|Protocol Violation|13|||
146837083|NCT01411241|529573635|FG000|Overall Study|Protocol Violation|0|||
146837084|NCT01411241|529573636|FG001|Overall Study|Protocol Violation|5|||
146837085|NCT01411241|529573635|FG000|Overall Study|Withdrawal by Subject|9|||
146837086|NCT01411241|529573636|FG001|Overall Study|Withdrawal by Subject|10|||
146837087|NCT01411241|529573635|FG000|Overall Study|Serious Adverse Event|0|||
146837088|NCT01411241|529573636|FG001|Overall Study|Serious Adverse Event|3|||
146837089|NCT01411241|529573635|FG000|Overall Study|Lost to Follow-up|2|||
146837090|NCT01411241|529573636|FG001|Overall Study|Lost to Follow-up|4|||
146837091|NCT02980042|529573639|FG000|Overall Study|Lost to Follow-up|5|||
146837092|NCT02980042|529573640|FG001|Overall Study|Lost to Follow-up|0|||
146837093|NCT02980042|529573639|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
146837094|NCT02980042|529573640|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
146837095|NCT00520845|529573646|FG000|Overall Study|Death|3|||
146837096|NCT00520845|529573646|FG000|Overall Study|Adverse Event|4|||
146837097|NCT00520845|529573646|FG000|Overall Study|Disease Progression, relapse|13|||
146837098|NCT00520845|529573646|FG000|Overall Study|Withdrawal by Subject|1|||
146837099|NCT00520845|529573646|FG000|Overall Study|Alternative Therapy|1|||
146837100|NCT01732549|529573649|FG000|Overall Study|Adverse Event|13|||
146837101|NCT01732549|529573650|FG001|Overall Study|Adverse Event|3|||
146837102|NCT01732549|529573649|FG000|Overall Study|Consent withdrawn|13|||
146837103|NCT01732549|529573650|FG001|Overall Study|Consent withdrawn|6|||
146837104|NCT01732549|529573649|FG000|Overall Study|Disease progression|37|||
146837105|NCT01732549|529573650|FG001|Overall Study|Disease progression|50|||
146837106|NCT01732549|529573649|FG000|Overall Study|Other|8|||
146837107|NCT01732549|529573650|FG001|Overall Study|Other|14|||
146837108|NCT01516749|529573651|FG000|Active Therapy|Lost to Follow-up|1|||
146837109|NCT01516749|529573651|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
146837110|NCT02030002|529573652|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
146837111|NCT02030002|529573652|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
146837112|NCT02030002|529573652|FG000|Follow-up|Lost to Follow-up|2|||
146837113|NCT01681992|529573654|FG000|Overall Study|Adverse Event|3|||
146837114|NCT01681992|529573655|FG001|Overall Study|Adverse Event|2|||
146837115|NCT01681992|529573656|FG002|Overall Study|Adverse Event|3|||
146837116|NCT01681992|529573654|FG000|Overall Study|Lost to Follow-up|36|||
146837117|NCT01681992|529573655|FG001|Overall Study|Lost to Follow-up|38|||
146837118|NCT01681992|529573656|FG002|Overall Study|Lost to Follow-up|53|||
146837119|NCT01681992|529573654|FG000|Overall Study|As Per Sponsor Decision|0|||
146837120|NCT01681992|529573655|FG001|Overall Study|As Per Sponsor Decision|0|||
146837121|NCT01681992|529573656|FG002|Overall Study|As Per Sponsor Decision|1|||
146837122|NCT01681992|529573654|FG000|Overall Study|Protocol Violation|0|||
146837123|NCT01681992|529573655|FG001|Overall Study|Protocol Violation|0|||
146837124|NCT01681992|529573656|FG002|Overall Study|Protocol Violation|1|||
146837125|NCT01681992|529573654|FG000|Overall Study|Withdrawal by Subject|27|||
146837126|NCT01681992|529573655|FG001|Overall Study|Withdrawal by Subject|30|||
146837127|NCT01681992|529573656|FG002|Overall Study|Withdrawal by Subject|25|||
146837128|NCT00732992|529573661|FG000|Overall Study|Adverse Event|1|||
146837129|NCT00732992|529573662|FG001|Overall Study|Adverse Event|1|||
146837130|NCT00732992|529573661|FG000|Overall Study|Objective Progression or Relapse|3|||
146837131|NCT00732992|529573662|FG001|Overall Study|Objective Progression or Relapse|5|||
146837132|NCT00732992|529573661|FG000|Overall Study|Global Deterioration of Health Status|1|||
146837133|NCT00732992|529573662|FG001|Overall Study|Global Deterioration of Health Status|0|||
146837134|NCT00732992|529573661|FG000|Overall Study|Withdrawal by Subject|1|||
146837135|NCT00732992|529573662|FG001|Overall Study|Withdrawal by Subject|0|||
146837136|NCT04805073|529573667|FG000|Overall Study|study personnel not available|2|||
146837137|NCT04805073|529573668|FG001|Overall Study|study personnel not available|0|||
146837138|NCT04805073|529573667|FG000|Overall Study|spinal anesthesia failure|0|||
146837139|NCT04805073|529573668|FG001|Overall Study|spinal anesthesia failure|1|||
146837140|NCT04805073|529573667|FG000|Overall Study|Lost to Follow-up|0|||
146837141|NCT04805073|529573668|FG001|Overall Study|Lost to Follow-up|2|||
146837142|NCT03017742|529573671|FG000|Overall Study|Protocol Violation|36|||
146837143|NCT03017742|529573671|FG000|Overall Study|Withdrawal by Subject|37|||
146837144|NCT02975102|529573672|FG000|Overall Study|Adverse Event|2|||
146837145|NCT02975102|529573673|FG001|Overall Study|Adverse Event|1|||
146837146|NCT01825577|529573677|FG000|Overall Study|Physician Decision|2|||
146837147|NCT01825577|529573677|FG000|Overall Study|Withdrawal by Subject|1|||
146837148|NCT01825577|529573677|FG000|Overall Study|Withdrawn by family members|2|||
146837149|NCT01825577|529573677|FG000|Overall Study|Lack of Efficacy|3|||
146837150|NCT01245374|529573684|FG000|Overall Study|Protocol Violation|1|||
146837151|NCT01245374|529573684|FG000|Overall Study|Withdrawal by Subject|3|||
146837152|NCT01782690|529573686|FG000|Overall Study|Not reported|7|||
146837153|NCT01782690|529573686|FG000|Overall Study|Toxicity of gemcitabine|1|||
146837154|NCT01782690|529573686|FG000|Overall Study|Toxicity of erlotinib|1|||
146837155|NCT01782690|529573686|FG000|Overall Study|Lost to Follow-up|31|||
146837156|NCT01782690|529573686|FG000|Overall Study|Withdrawal of informed consent|2|||
146837157|NCT01782690|529573686|FG000|Overall Study|Absent rash|9|||
146837158|NCT01782690|529573686|FG000|Overall Study|Physician Decision|13|||
146837159|NCT01782690|529573686|FG000|Overall Study|Patient's wish|21|||
146837160|NCT01782690|529573686|FG000|Overall Study|Tumor progression|74|||
146837161|NCT01782690|529573686|FG000|Overall Study|Death|133|||
146837162|NCT01782690|529573686|FG000|Overall Study|Study completion unknown|7|||
146837163|NCT04199052|529573689|FG000|Overall Study|Lost to Follow-up|11|||
146837164|NCT04199052|529573690|FG001|Overall Study|Lost to Follow-up|18|||
146837165|NCT01948076|529573691|FG000|Overall Study|Withdrawal by Subject|0|||
146837166|NCT01948076|529573692|FG001|Overall Study|Withdrawal by Subject|1|||
146837167|NCT01151423|529573693|FG000|Overall Study|Study terminated by Sponsor|9|||
146837168|NCT01151423|529573694|FG001|Overall Study|Study terminated by Sponsor|10|||
146837169|NCT01151423|529573693|FG000|Overall Study|Protocol Violation|0|||
146837170|NCT01151423|529573694|FG001|Overall Study|Protocol Violation|1|||
146837171|NCT01151423|529573693|FG000|Overall Study|Physician Decision|1|||
146837172|NCT01151423|529573694|FG001|Overall Study|Physician Decision|1|||
146837173|NCT01151423|529573693|FG000|Overall Study|Pregnancy|0|||
146990609|NCT02353169|530128708|FG002|Overall Study|ECG data error|2|||
146837174|NCT01151423|529573694|FG001|Overall Study|Pregnancy|1|||
146837175|NCT01151423|529573693|FG000|Overall Study|Death|0|||
146990610|NCT02353169|530128709|FG003|Overall Study|ECG data error|2|||
146837176|NCT01151423|529573694|FG001|Overall Study|Death|1|||
146837177|NCT01151423|529573693|FG000|Overall Study|Adverse Event|3|||
146837178|NCT01151423|529573694|FG001|Overall Study|Adverse Event|0|||
146837179|NCT01151423|529573693|FG000|Overall Study|Withdrawal by Subject|1|||
146837180|NCT01151423|529573694|FG001|Overall Study|Withdrawal by Subject|3|||
146837181|NCT01151423|529573693|FG000|Overall Study|Lost to Follow-up|1|||
146837182|NCT01151423|529573694|FG001|Overall Study|Lost to Follow-up|0|||
146837183|NCT01151423|529573693|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
146837184|NCT01151423|529573694|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
146837185|NCT01151423|529573693|FG000|Overall Study|Participated in other clinical trial|1|||
146837186|NCT01151423|529573694|FG001|Overall Study|Participated in other clinical trial|0|||
146837187|NCT00681668|529573695|FG000|Overall Study|Protocol Violation|1|||
146837188|NCT00681668|529573695|FG000|Overall Study|Withdrawal by Subject|1|||
146837189|NCT06719986|529573707|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
146837190|NCT06719986|529573708|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
146837191|NCT06719986|529573709|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
146837192|NCT06719986|529573707|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
146837193|NCT06719986|529573708|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
146837194|NCT06719986|529573709|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
146837195|NCT02600897|529573710|FG000|Overall Study|Death|1|||
146837196|NCT02600897|529573711|FG001|Overall Study|Death|2|||
146837197|NCT02600897|529573712|FG002|Overall Study|Death|1|||
146837198|NCT02600897|529573713|FG003|Overall Study|Death|2|||
146837199|NCT02600897|529573714|FG004|Overall Study|Death|3|||
146837200|NCT02600897|529573715|FG005|Overall Study|Death|2|||
146837201|NCT02600897|529573716|FG006|Overall Study|Death|10|||
146837202|NCT02600897|529573717|FG007|Overall Study|Death|7|||
146837203|NCT02600897|529573718|FG008|Overall Study|Death|20|||
146837204|NCT02600897|529573710|FG000|Overall Study|Lost to Follow-up|1|||
146837205|NCT02600897|529573711|FG001|Overall Study|Lost to Follow-up|0|||
146837206|NCT02600897|529573712|FG002|Overall Study|Lost to Follow-up|0|||
146837207|NCT02600897|529573713|FG003|Overall Study|Lost to Follow-up|0|||
146837208|NCT02600897|529573714|FG004|Overall Study|Lost to Follow-up|0|||
146837209|NCT02600897|529573715|FG005|Overall Study|Lost to Follow-up|0|||
146837210|NCT02600897|529573716|FG006|Overall Study|Lost to Follow-up|0|||
146837211|NCT02600897|529573717|FG007|Overall Study|Lost to Follow-up|1|||
146837212|NCT02600897|529573718|FG008|Overall Study|Lost to Follow-up|0|||
146837213|NCT02600897|529573710|FG000|Overall Study|Withdrawal by Subject|0|||
146837214|NCT02600897|529573711|FG001|Overall Study|Withdrawal by Subject|0|||
146837215|NCT02600897|529573712|FG002|Overall Study|Withdrawal by Subject|0|||
146837216|NCT02600897|529573713|FG003|Overall Study|Withdrawal by Subject|0|||
146837217|NCT02600897|529573714|FG004|Overall Study|Withdrawal by Subject|0|||
146837218|NCT02600897|529573715|FG005|Overall Study|Withdrawal by Subject|0|||
146837219|NCT02600897|529573716|FG006|Overall Study|Withdrawal by Subject|0|||
146837220|NCT02600897|529573717|FG007|Overall Study|Withdrawal by Subject|4|||
146837221|NCT02600897|529573718|FG008|Overall Study|Withdrawal by Subject|2|||
146837222|NCT02600897|529573710|FG000|Overall Study|Reason Not Specified|0|||
146837223|NCT02600897|529573711|FG001|Overall Study|Reason Not Specified|0|||
146837224|NCT02600897|529573712|FG002|Overall Study|Reason Not Specified|0|||
146837225|NCT02600897|529573713|FG003|Overall Study|Reason Not Specified|0|||
146837226|NCT02600897|529573714|FG004|Overall Study|Reason Not Specified|0|||
146837227|NCT02600897|529573715|FG005|Overall Study|Reason Not Specified|0|||
146837228|NCT02600897|529573716|FG006|Overall Study|Reason Not Specified|0|||
146837229|NCT02600897|529573717|FG007|Overall Study|Reason Not Specified|0|||
146837230|NCT02600897|529573718|FG008|Overall Study|Reason Not Specified|1|||
146837231|NCT05992922|529573719|FG000|Overall Study|Adverse Event|6|||
146837232|NCT05992922|529573720|FG001|Overall Study|Adverse Event|0|||
146837233|NCT05992922|529573719|FG000|Overall Study|Sponsor Termination of Study|14|||
146837234|NCT05992922|529573720|FG001|Overall Study|Sponsor Termination of Study|20|||
146837235|NCT02473965|529575373|FG000|Overall Study|Adverse Event|6|||
146837236|NCT02473965|529575374|FG001|Overall Study|Adverse Event|4|||
146837237|NCT02473965|529575373|FG000|Overall Study|MG worsening|4|||
146837238|NCT02473965|529575374|FG001|Overall Study|MG worsening|1|||
146837239|NCT02473965|529575373|FG000|Overall Study|Withdrawal by Subject|2|||
146837240|NCT02473965|529575374|FG001|Overall Study|Withdrawal by Subject|3|||
146837241|NCT02473965|529575373|FG000|Overall Study|Physician Decision|0|||
146837242|NCT02473965|529575374|FG001|Overall Study|Physician Decision|2|||
146837243|NCT01183390|529575375|FG000|First Intervention|Adverse Event|0|||
146990611|NCT02353169|530128706|FG000|Overall Study|Pre-op medication|0|||
146837244|NCT01183390|529575376|FG001|First Intervention|Adverse Event|1|||
146837245|NCT04057573|529575377|FG000|24-Week Double-Blind Period|Adverse Event|2|||
146837246|NCT04057573|529575378|FG001|24-Week Double-Blind Period|Adverse Event|0|||
146837247|NCT04057573|529575379|FG002|24-Week Double-Blind Period|Adverse Event|0|||
146837248|NCT04057573|529575380|FG003|24-Week Double-Blind Period|Adverse Event|0|||
146837249|NCT04057573|529575377|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
146990612|NCT02353169|530128707|FG001|Overall Study|Pre-op medication|0|||
146837250|NCT04057573|529575378|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
146837251|NCT04057573|529575379|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
146837252|NCT04057573|529575380|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
146837253|NCT04057573|529575377|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
146837254|NCT04057573|529575378|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
146837255|NCT04057573|529575379|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
146837256|NCT04057573|529575380|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
146837257|NCT04057573|529575377|FG000|24-Week Double-Blind Period|Physician Decision|1|||
146837258|NCT04057573|529575378|FG001|24-Week Double-Blind Period|Physician Decision|0|||
146837259|NCT04057573|529575379|FG002|24-Week Double-Blind Period|Physician Decision|0|||
146837260|NCT04057573|529575380|FG003|24-Week Double-Blind Period|Physician Decision|0|||
146837261|NCT04057573|529575377|FG000|24-Week Double-Blind Period|Pregnancy|1|||
146837262|NCT04057573|529575378|FG001|24-Week Double-Blind Period|Pregnancy|0|||
146837263|NCT04057573|529575379|FG002|24-Week Double-Blind Period|Pregnancy|0|||
146837264|NCT04057573|529575380|FG003|24-Week Double-Blind Period|Pregnancy|0|||
146837265|NCT04057573|529575377|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
146837266|NCT04057573|529575378|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
146837267|NCT04057573|529575379|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
146837268|NCT04057573|529575380|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
146837269|NCT04057573|529575377|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
146837270|NCT04057573|529575378|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
146837271|NCT04057573|529575379|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
146837272|NCT04057573|529575380|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
146837273|NCT04057573|529575377|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
146837274|NCT04057573|529575378|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
146837275|NCT04057573|529575379|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
146837276|NCT04057573|529575380|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
146837277|NCT04057573|529575377|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
146837278|NCT04057573|529575378|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
146837279|NCT04057573|529575379|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
146837280|NCT04057573|529575380|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
146837281|NCT04057573|529575377|FG000|24-Week Double-Blind Period|Not Treated|1|||
146837282|NCT04057573|529575378|FG001|24-Week Double-Blind Period|Not Treated|0|||
146837283|NCT04057573|529575379|FG002|24-Week Double-Blind Period|Not Treated|0|||
146837284|NCT04057573|529575380|FG003|24-Week Double-Blind Period|Not Treated|0|||
146837285|NCT04057573|529575377|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
146837286|NCT04057573|529575378|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
146837287|NCT04057573|529575379|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
146837288|NCT04057573|529575380|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
146837289|NCT04057573|529575377|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
146837290|NCT04057573|529575378|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
146837291|NCT04057573|529575379|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
146837292|NCT04057573|529575380|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
146837293|NCT04057573|529575377|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
146837294|NCT04057573|529575378|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
146837295|NCT04057573|529575379|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
146837296|NCT04057573|529575380|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
146837297|NCT04057573|529575377|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
146837298|NCT04057573|529575378|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
146837299|NCT04057573|529575379|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
146837300|NCT04057573|529575380|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
146837301|NCT04057573|529575377|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
146837302|NCT04057573|529575378|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
146837303|NCT04057573|529575379|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
146837304|NCT04057573|529575380|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
146837305|NCT02113124|529575381|FG000|Overall Study|Unable to retrieve blood sample|1|||
146837306|NCT02113124|529575382|FG001|Overall Study|Unable to retrieve blood sample|1|||
146837307|NCT03299049|529575383|FG000|Overall Study|On-going|486|||
146837308|NCT03299049|529575384|FG001|Overall Study|On-going|481|||
146837309|NCT03299049|529575383|FG000|Overall Study|Withdrawal by Subject|6|||
146837310|NCT03299049|529575384|FG001|Overall Study|Withdrawal by Subject|21|||
146837311|NCT03299049|529575383|FG000|Overall Study|Physician Decision|5|||
146837312|NCT03299049|529575384|FG001|Overall Study|Physician Decision|1|||
146837313|NCT03299049|529575383|FG000|Overall Study|Lost to Follow-up|2|||
146837314|NCT03299049|529575384|FG001|Overall Study|Lost to Follow-up|0|||
146837315|NCT03299049|529575383|FG000|Overall Study|Pregnancy|1|||
146837316|NCT03299049|529575384|FG001|Overall Study|Pregnancy|3|||
146837317|NCT03299049|529575383|FG000|Overall Study|Protocol Violation|1|||
146837318|NCT03299049|529575384|FG001|Overall Study|Protocol Violation|1|||
146837319|NCT03299049|529575383|FG000|Overall Study|Lack of Efficacy|9|||
146837320|NCT03299049|529575384|FG001|Overall Study|Lack of Efficacy|3|||
146837321|NCT03299049|529575383|FG000|Overall Study|Adverse Event|12|||
146837322|NCT03299049|529575384|FG001|Overall Study|Adverse Event|13|||
146837323|NCT01901419|529575385|FG000|Overall Study|Protocol Violation|2|||
146837324|NCT01901419|529575386|FG001|Overall Study|Protocol Violation|6|||
146837325|NCT01901419|529575385|FG000|Overall Study|unavailable researchers|6|||
146837326|NCT01901419|529575386|FG001|Overall Study|unavailable researchers|3|||
146837327|NCT01020877|529575391|FG000|Second Intervention|Withdrawal by Subject|1|||
146837328|NCT01020877|529575392|FG001|Second Intervention|Withdrawal by Subject|0|||
146837329|NCT00790400|529575393|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
146837330|NCT00790400|529575394|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
146837331|NCT00790400|529575393|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
146837332|NCT00790400|529575394|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
146837333|NCT00790400|529575393|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
146837334|NCT00790400|529575394|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
146837335|NCT00790400|529575393|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
146837336|NCT00790400|529575394|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
146837337|NCT00790400|529575393|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
146837338|NCT00790400|529575394|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
146837339|NCT00790400|529575393|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
146837340|NCT00790400|529575394|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
146837341|NCT00790400|529575393|FG000|Double-blind Period (Core Phase)|Death|1|||
146837342|NCT00790400|529575394|FG001|Double-blind Period (Core Phase)|Death|0|||
146837343|NCT00790400|529575393|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
146837344|NCT00790400|529575394|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
146837345|NCT00790400|529575393|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
146837346|NCT00790400|529575394|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
146837347|NCT00790400|529575393|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
146837348|NCT00790400|529575394|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
146837349|NCT00790400|529575393|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
146837350|NCT00790400|529575394|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
146837351|NCT00790400|529575393|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
146837352|NCT00790400|529575394|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
146837353|NCT00790400|529575393|FG000|Everolimus Period (Core or Extension)|Death|1|||
146837354|NCT00790400|529575394|FG001|Everolimus Period (Core or Extension)|Death|0|||
146837355|NCT00790400|529575393|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
146837356|NCT00790400|529575394|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
146837357|NCT00790400|529575393|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
146837358|NCT00790400|529575394|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
146837359|NCT00790400|529575393|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
146837360|NCT00790400|529575394|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
146837361|NCT01006980|529575396|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
146837362|NCT01006980|529575397|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
146837363|NCT01006980|529575396|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
146837364|NCT01006980|529575397|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
146837365|NCT01006980|529575396|FG000|Vemurafenib and Dacarbazine|Death|13|||
146837366|NCT01006980|529575397|FG001|Vemurafenib and Dacarbazine|Death|12|||
146837367|NCT01006980|529575396|FG000|Vemurafenib and Dacarbazine|Progression|257|||
146837368|NCT01006980|529575397|FG001|Vemurafenib and Dacarbazine|Progression|218|||
146837369|NCT01006980|529575396|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
146837370|NCT01006980|529575397|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
146837371|NCT01006980|529575396|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
146837372|NCT01006980|529575397|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
146837373|NCT01006980|529575396|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
146837374|NCT01006980|529575397|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
146837375|NCT01006980|529575396|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
146837376|NCT01006980|529575397|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
146837377|NCT01006980|529575396|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
146837378|NCT01006980|529575397|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
146837379|NCT01006980|529575396|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
146837380|NCT01006980|529575397|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
146837381|NCT01006980|529575396|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
146837382|NCT01006980|529575397|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
146837383|NCT01006980|529575396|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
146837384|NCT01006980|529575397|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
146837385|NCT01006980|529575396|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
146837386|NCT01006980|529575397|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
146837387|NCT00078338|529575398|FG000|Overall Study|Adverse Event|31|||
146837388|NCT00078338|529575399|FG001|Overall Study|Adverse Event|24|||
146837389|NCT00078338|529575398|FG000|Overall Study|Lost to Follow-up|17|||
146837390|NCT00078338|529575399|FG001|Overall Study|Lost to Follow-up|2|||
146837391|NCT00078338|529575398|FG000|Overall Study|Protocol Violation|2|||
146837392|NCT00078338|529575399|FG001|Overall Study|Protocol Violation|2|||
146837393|NCT00078338|529575398|FG000|Overall Study|Disease Progression|4|||
146837394|NCT00078338|529575399|FG001|Overall Study|Disease Progression|7|||
146990613|NCT02353169|530128708|FG002|Overall Study|Pre-op medication|1|||
146837395|NCT00078338|529575398|FG000|Overall Study|Other|28|||
146837396|NCT00078338|529575399|FG001|Overall Study|Other|16|||
146837397|NCT00078338|529575398|FG000|Overall Study|Subjects randomized, but not treated|3|||
146837398|NCT00078338|529575399|FG001|Overall Study|Subjects randomized, but not treated|3|||
146837399|NCT01483144|529575400|FG000|Overall Study|Adverse Event|9|||
146837400|NCT01483144|529575401|FG001|Overall Study|Adverse Event|4|||
146837401|NCT01483144|529575402|FG002|Overall Study|Adverse Event|6|||
146837402|NCT01483144|529575400|FG000|Overall Study|Withdrawal by Subject|0|||
146837403|NCT01483144|529575401|FG001|Overall Study|Withdrawal by Subject|2|||
146837404|NCT01483144|529575402|FG002|Overall Study|Withdrawal by Subject|5|||
146837405|NCT01483144|529575400|FG000|Overall Study|Physician Decision|1|||
146837406|NCT01483144|529575401|FG001|Overall Study|Physician Decision|0|||
146837407|NCT01483144|529575402|FG002|Overall Study|Physician Decision|0|||
146837408|NCT01483144|529575400|FG000|Overall Study|Lost to Follow-up|2|||
146837409|NCT01483144|529575401|FG001|Overall Study|Lost to Follow-up|4|||
146837410|NCT01483144|529575402|FG002|Overall Study|Lost to Follow-up|1|||
146837411|NCT01483144|529575400|FG000|Overall Study|Protocol Violation|3|||
146837412|NCT01483144|529575401|FG001|Overall Study|Protocol Violation|3|||
146837413|NCT01483144|529575402|FG002|Overall Study|Protocol Violation|3|||
146837414|NCT02460575|529575403|FG000|Overall Study|Lost to Follow-up|1|||
146837415|NCT02460575|529575404|FG001|Overall Study|Lost to Follow-up|0|||
146990614|NCT02353169|530128709|FG003|Overall Study|Pre-op medication|0|||
146990615|NCT00486837|530128712|FG000|Overall Study|Withdrawal by Subject|1|||
146990616|NCT00486837|530128713|FG001|Overall Study|Withdrawal by Subject|0|||
146990617|NCT00486837|530128712|FG000|Overall Study|Adverse Event|1|||
146990618|NCT00486837|530128713|FG001|Overall Study|Adverse Event|1|||
146837416|NCT04307940|529575405|FG000|Overall Study|Adverse Event|1|||
146837417|NCT04307940|529575406|FG001|Overall Study|Adverse Event|0|||
146837418|NCT04307940|529575407|FG002|Overall Study|Adverse Event|0|||
146837419|NCT04307940|529575405|FG000|Overall Study|Withdrawal by Subject|2|||
146837420|NCT04307940|529575406|FG001|Overall Study|Withdrawal by Subject|3|||
146837421|NCT04307940|529575407|FG002|Overall Study|Withdrawal by Subject|1|||
146837422|NCT04307940|529575405|FG000|Overall Study|Lost to Follow-up|2|||
146837423|NCT04307940|529575406|FG001|Overall Study|Lost to Follow-up|0|||
146837424|NCT04307940|529575407|FG002|Overall Study|Lost to Follow-up|1|||
146837425|NCT02521363|529575408|FG000|Overall Study|Withdrawal by Subject|1|||
146837426|NCT02521363|529575409|FG001|Overall Study|Withdrawal by Subject|2|||
146837427|NCT05543174|529575410|FG000|Overall Study|Ongoing|7|||
146837428|NCT03104075|529575411|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
146837429|NCT03104075|529575412|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
146837430|NCT00944229|529575413|FG000|Overall Study|Withdrawal by Subject|11|||
146837431|NCT00944229|529575413|FG000|Overall Study|Physician Decision|14|||
146837432|NCT01810939|529575414|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
146837433|NCT01810939|529575415|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
146837434|NCT01810939|529575416|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
146837435|NCT01810939|529575414|FG000|Part A Treatment Period|Protocol Violation|2|||
146837436|NCT01810939|529575415|FG001|Part A Treatment Period|Protocol Violation|0|||
146837437|NCT01810939|529575416|FG002|Part A Treatment Period|Protocol Violation|0|||
146837438|NCT01810939|529575414|FG000|Part A Treatment Period|Adverse Event|10|||
146837439|NCT01810939|529575415|FG001|Part A Treatment Period|Adverse Event|0|||
146837440|NCT01810939|529575416|FG002|Part A Treatment Period|Adverse Event|0|||
146837441|NCT01810939|529575414|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
146837442|NCT01810939|529575415|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
146837443|NCT01810939|529575416|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
146837444|NCT01810939|529575414|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
146837445|NCT01810939|529575415|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
146837446|NCT01810939|529575416|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
146837447|NCT01810939|529575414|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
146837448|NCT01810939|529575415|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
146837449|NCT01810939|529575416|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
146837450|NCT01810939|529575414|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
146837451|NCT01810939|529575415|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
146837452|NCT01810939|529575416|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
146837453|NCT01810939|529575414|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
146837454|NCT01810939|529575415|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
146837455|NCT01810939|529575416|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
146837456|NCT01810939|529575414|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
146837457|NCT01810939|529575415|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
146837458|NCT01810939|529575416|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
146837459|NCT01810939|529575414|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
146837460|NCT01810939|529575415|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
146837461|NCT01810939|529575416|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
146837462|NCT01810939|529575414|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
146837463|NCT01810939|529575415|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
146837464|NCT01810939|529575416|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
146837465|NCT01810939|529575414|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
146837466|NCT01810939|529575415|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
146837467|NCT01810939|529575416|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
146837468|NCT01810939|529575414|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
146837469|NCT01810939|529575415|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
146837470|NCT01810939|529575416|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
146837471|NCT01810939|529575414|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
146837472|NCT01810939|529575415|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
146837473|NCT01810939|529575416|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
146837474|NCT01810939|529575414|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
146837475|NCT01810939|529575415|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
146837476|NCT01810939|529575416|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
146837477|NCT01810939|529575414|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
146837478|NCT01810939|529575415|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
146837479|NCT01810939|529575416|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
146837480|NCT01810939|529575414|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
146837481|NCT01810939|529575415|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
146837482|NCT01810939|529575416|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
146837483|NCT02963090|529575417|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
146837484|NCT02963090|529575418|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
146837485|NCT00709228|529575419|FG000|Overall Study|Not treated|14|||
146837486|NCT00709228|529575419|FG000|Overall Study|Eligibility criteria not met|281|||
146837487|NCT00709228|529575419|FG000|Overall Study|Adverse events|2|||
146837488|NCT00709228|529575419|FG000|Overall Study|Discontinued treatment|14|||
146837489|NCT00709228|529575419|FG000|Overall Study|Did not enter follow-up|4|||
146837490|NCT00709228|529575419|FG000|Overall Study|Discontinued follow-up|5|||
146837491|NCT00709228|529575419|FG000|Overall Study|Disease progression|1|||
146837492|NCT00709228|529575419|FG000|Overall Study|Lost to Follow-up|6|||
146837493|NCT00709228|529575419|FG000|Overall Study|Non-compliance|5|||
146837494|NCT04400487|529575420|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
146837495|NCT04400487|529575420|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
146837496|NCT04400487|529575420|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
146837497|NCT01594827|529575422|FG000|Overall Study|Adverse Event|1|||
146837498|NCT01594827|529575423|FG001|Overall Study|Adverse Event|0|||
146837499|NCT01594827|529575422|FG000|Overall Study|Physician Decision|3|||
146837500|NCT01594827|529575423|FG001|Overall Study|Physician Decision|0|||
146837501|NCT03334253|529575425|FG000|Overall Study|Withdrawal by Subject|1|||
146837502|NCT03334253|529575426|FG001|Overall Study|Withdrawal by Subject|0|||
146837503|NCT03334253|529575425|FG000|Overall Study|Lost to Follow-up|4|||
146837504|NCT03334253|529575426|FG001|Overall Study|Lost to Follow-up|3|||
146837505|NCT03334253|529575425|FG000|Overall Study|Moved residence|2|||
146837506|NCT03334253|529575426|FG001|Overall Study|Moved residence|2|||
146837507|NCT00945672|529575428|FG000|Overall Study|Withdrawal by Subject|0|||
146837508|NCT00945672|529575429|FG001|Overall Study|Withdrawal by Subject|0|||
146837509|NCT00945672|529575430|FG002|Overall Study|Withdrawal by Subject|0|||
146837510|NCT00945672|529575431|FG003|Overall Study|Withdrawal by Subject|1|||
146837511|NCT03054337|529575433|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
146837512|NCT03054337|529575434|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
146837513|NCT03054337|529575435|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
146837514|NCT03054337|529575436|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
146837515|NCT03054337|529575437|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
146837516|NCT03054337|529575438|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
146837517|NCT00447590|529575441|FG000|Overall Study|Withdrawal by Subject|26|||
146837518|NCT00447590|529575441|FG000|Overall Study|Lost to Follow-up|24|||
146837519|NCT00447590|529575441|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
146837520|NCT00609947|529575445|FG000|Overall Study|Death|1|||
146837521|NCT05569421|529575446|FG000|Overall Study|Withdrawal by Subject|1|||
146837522|NCT05569421|529575447|FG001|Overall Study|Withdrawal by Subject|0|||
146837523|NCT05569421|529575448|FG002|Overall Study|Withdrawal by Subject|0|||
146837524|NCT00504075|529575449|FG000|Overall Study|Adverse Event|1|||
146837525|NCT00504075|529575449|FG000|Overall Study|Lost to Follow-up|5|||
146837526|NCT00504075|529575449|FG000|Overall Study|Withdrawal by Subject|1|||
146837527|NCT00504075|529575449|FG000|Overall Study|Required other therapeutic intervention|1|||
146837528|NCT03812029|529575452|FG000|Overall Study|Protocol Violation|1|||
146837529|NCT03812029|529575453|FG001|Overall Study|Protocol Violation|0|||
146837530|NCT03812029|529575454|FG002|Overall Study|Protocol Violation|0|||
146837531|NCT03812029|529575455|FG003|Overall Study|Protocol Violation|1|||
146837532|NCT03812029|529575456|FG004|Overall Study|Protocol Violation|0|||
146837533|NCT03812029|529575452|FG000|Overall Study|Withdrawal by Subject|1|||
146837534|NCT03812029|529575453|FG001|Overall Study|Withdrawal by Subject|0|||
146837535|NCT03812029|529575454|FG002|Overall Study|Withdrawal by Subject|0|||
146837536|NCT03812029|529575455|FG003|Overall Study|Withdrawal by Subject|2|||
146837537|NCT03812029|529575456|FG004|Overall Study|Withdrawal by Subject|2|||
146837538|NCT03812029|529575452|FG000|Overall Study|Stopping rules|0|||
146837539|NCT03812029|529575453|FG001|Overall Study|Stopping rules|1|||
146837540|NCT03812029|529575454|FG002|Overall Study|Stopping rules|0|||
146837541|NCT03812029|529575455|FG003|Overall Study|Stopping rules|0|||
146837542|NCT03812029|529575456|FG004|Overall Study|Stopping rules|0|||
146837543|NCT03812029|529575452|FG000|Overall Study|Adverse Event|0|||
146837544|NCT03812029|529575453|FG001|Overall Study|Adverse Event|9|||
146837545|NCT03812029|529575454|FG002|Overall Study|Adverse Event|0|||
146837546|NCT03812029|529575455|FG003|Overall Study|Adverse Event|3|||
146837547|NCT03812029|529575456|FG004|Overall Study|Adverse Event|5|||
146837548|NCT03812029|529575452|FG000|Overall Study|Lost to Follow-up|0|||
146837549|NCT03812029|529575453|FG001|Overall Study|Lost to Follow-up|0|||
146837550|NCT03812029|529575454|FG002|Overall Study|Lost to Follow-up|0|||
146837551|NCT03812029|529575455|FG003|Overall Study|Lost to Follow-up|0|||
146837552|NCT03812029|529575456|FG004|Overall Study|Lost to Follow-up|3|||
146837553|NCT00581477|529575457|FG000|Overall Study|Physician Decision|2|||
146837554|NCT03106753|529575458|FG000|Overall Study|Withdrawal by Subject|0|||
146837555|NCT03106753|529575459|FG001|Overall Study|Withdrawal by Subject|1|||
146837556|NCT01643044|529575460|FG000|Overall Study|Lost to Follow-up|1|||
146837557|NCT01643044|529575461|FG001|Overall Study|Lost to Follow-up|1|||
146837558|NCT01643044|529575460|FG000|Overall Study|Miscarried baby|2|||
146837559|NCT01643044|529575461|FG001|Overall Study|Miscarried baby|2|||
146837560|NCT01643044|529575460|FG000|Overall Study|Delivered outside of hospital|1|||
146837561|NCT01643044|529575461|FG001|Overall Study|Delivered outside of hospital|2|||
146837562|NCT03149042|529575462|FG000|Overall Study|Invasive FFR not performed|21|||
146837563|NCT03149042|529575462|FG000|Overall Study|Poor CT Image Quality|1|||
146837564|NCT03149042|529575462|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
146837565|NCT00790205|529575463|FG000|Overall Study|Lost to Follow-up|61|||
146837566|NCT00790205|529575464|FG001|Overall Study|Lost to Follow-up|71|||
146837567|NCT00790205|529575463|FG000|Overall Study|Withdrawal by Subject|299|||
146837568|NCT00790205|529575464|FG001|Overall Study|Withdrawal by Subject|363|||
146837569|NCT02643628|529575465|FG000|Overall Study|Lost to Follow-up|1|||
146837570|NCT02643628|529575466|FG001|Overall Study|Lost to Follow-up|4|||
146837571|NCT02643628|529575465|FG000|Overall Study|Withdrawal by Subject|0|||
146837572|NCT02643628|529575466|FG001|Overall Study|Withdrawal by Subject|1|||
146837573|NCT02643628|529575465|FG000|Overall Study|Relocated out of state|0|||
146837574|NCT02643628|529575466|FG001|Overall Study|Relocated out of state|1|||
146837575|NCT01441635|529575472|FG000|Overall Study|Adverse Event|4|||
146837576|NCT01441635|529575473|FG001|Overall Study|Adverse Event|3|||
146837577|NCT01441635|529575474|FG002|Overall Study|Adverse Event|1|||
146837578|NCT01441635|529575475|FG003|Overall Study|Adverse Event|5|||
146837579|NCT01441635|529575476|FG004|Overall Study|Adverse Event|1|||
146837580|NCT01441635|529575477|FG005|Overall Study|Adverse Event|2|||
146837581|NCT01441635|529575478|FG006|Overall Study|Adverse Event|2|||
146837582|NCT01441635|529575479|FG007|Overall Study|Adverse Event|2|||
146837583|NCT01441635|529575480|FG008|Overall Study|Adverse Event|1|||
146837584|NCT01441635|529575481|FG009|Overall Study|Adverse Event|0|||
146837585|NCT01441635|529575472|FG000|Overall Study|Withdrawal by Subject|1|||
146837586|NCT01441635|529575473|FG001|Overall Study|Withdrawal by Subject|1|||
146837587|NCT01441635|529575474|FG002|Overall Study|Withdrawal by Subject|0|||
146837588|NCT01441635|529575475|FG003|Overall Study|Withdrawal by Subject|1|||
146837589|NCT01441635|529575476|FG004|Overall Study|Withdrawal by Subject|0|||
146837590|NCT01441635|529575477|FG005|Overall Study|Withdrawal by Subject|0|||
146837591|NCT01441635|529575478|FG006|Overall Study|Withdrawal by Subject|2|||
146837592|NCT01441635|529575479|FG007|Overall Study|Withdrawal by Subject|0|||
146837593|NCT01441635|529575480|FG008|Overall Study|Withdrawal by Subject|1|||
146837594|NCT01441635|529575481|FG009|Overall Study|Withdrawal by Subject|1|||
146837595|NCT01441635|529575472|FG000|Overall Study|Lost to Follow-up|0|||
146837596|NCT01441635|529575473|FG001|Overall Study|Lost to Follow-up|1|||
146837597|NCT01441635|529575474|FG002|Overall Study|Lost to Follow-up|1|||
146837598|NCT01441635|529575475|FG003|Overall Study|Lost to Follow-up|1|||
146837599|NCT01441635|529575476|FG004|Overall Study|Lost to Follow-up|1|||
146837600|NCT01441635|529575477|FG005|Overall Study|Lost to Follow-up|3|||
146837601|NCT01441635|529575478|FG006|Overall Study|Lost to Follow-up|1|||
146837602|NCT01441635|529575479|FG007|Overall Study|Lost to Follow-up|1|||
146837603|NCT01441635|529575480|FG008|Overall Study|Lost to Follow-up|0|||
146837604|NCT01441635|529575481|FG009|Overall Study|Lost to Follow-up|1|||
146837605|NCT01441635|529575472|FG000|Overall Study|Noncompliance|0|||
146837606|NCT01441635|529575473|FG001|Overall Study|Noncompliance|1|||
146837607|NCT01441635|529575474|FG002|Overall Study|Noncompliance|0|||
146837608|NCT01441635|529575475|FG003|Overall Study|Noncompliance|0|||
146837609|NCT01441635|529575476|FG004|Overall Study|Noncompliance|0|||
146837610|NCT01441635|529575477|FG005|Overall Study|Noncompliance|0|||
146837611|NCT01441635|529575478|FG006|Overall Study|Noncompliance|1|||
146837612|NCT01441635|529575479|FG007|Overall Study|Noncompliance|0|||
146837613|NCT01441635|529575480|FG008|Overall Study|Noncompliance|0|||
146837614|NCT01441635|529575481|FG009|Overall Study|Noncompliance|0|||
146837615|NCT01441635|529575472|FG000|Overall Study|Surgery or Invasive Intervention|0|||
146837616|NCT01441635|529575473|FG001|Overall Study|Surgery or Invasive Intervention|0|||
146837617|NCT01441635|529575474|FG002|Overall Study|Surgery or Invasive Intervention|1|||
146837618|NCT01441635|529575475|FG003|Overall Study|Surgery or Invasive Intervention|0|||
146837619|NCT01441635|529575476|FG004|Overall Study|Surgery or Invasive Intervention|0|||
146837620|NCT01441635|529575477|FG005|Overall Study|Surgery or Invasive Intervention|0|||
146837621|NCT01441635|529575478|FG006|Overall Study|Surgery or Invasive Intervention|0|||
146837622|NCT01441635|529575479|FG007|Overall Study|Surgery or Invasive Intervention|0|||
146837623|NCT01441635|529575480|FG008|Overall Study|Surgery or Invasive Intervention|0|||
146837624|NCT01441635|529575481|FG009|Overall Study|Surgery or Invasive Intervention|0|||
146837625|NCT01441635|529575472|FG000|Overall Study|Received Exclusionary Medication|1|||
146837626|NCT01441635|529575473|FG001|Overall Study|Received Exclusionary Medication|0|||
146837627|NCT01441635|529575474|FG002|Overall Study|Received Exclusionary Medication|0|||
146837628|NCT01441635|529575475|FG003|Overall Study|Received Exclusionary Medication|0|||
146837629|NCT01441635|529575476|FG004|Overall Study|Received Exclusionary Medication|0|||
146837630|NCT01441635|529575477|FG005|Overall Study|Received Exclusionary Medication|0|||
146837631|NCT01441635|529575478|FG006|Overall Study|Received Exclusionary Medication|0|||
146837632|NCT01441635|529575479|FG007|Overall Study|Received Exclusionary Medication|0|||
146837633|NCT01441635|529575480|FG008|Overall Study|Received Exclusionary Medication|0|||
146837634|NCT01441635|529575481|FG009|Overall Study|Received Exclusionary Medication|0|||
146837635|NCT01441635|529575472|FG000|Overall Study|Other|0|||
146837636|NCT01441635|529575473|FG001|Overall Study|Other|0|||
146837637|NCT01441635|529575474|FG002|Overall Study|Other|0|||
146837638|NCT01441635|529575475|FG003|Overall Study|Other|0|||
146837639|NCT01441635|529575476|FG004|Overall Study|Other|0|||
146837640|NCT01441635|529575477|FG005|Overall Study|Other|0|||
146837641|NCT01441635|529575478|FG006|Overall Study|Other|0|||
146837642|NCT01441635|529575479|FG007|Overall Study|Other|1|||
146837643|NCT01441635|529575480|FG008|Overall Study|Other|0|||
146837644|NCT01441635|529575481|FG009|Overall Study|Other|0|||
146837645|NCT02637323|529575482|FG000|Overall Study|Lost to Follow-up|2|||
146837646|NCT02637323|529575483|FG001|Overall Study|Lost to Follow-up|0|||
146837647|NCT02637323|529575482|FG000|Overall Study|Protocol Violation|0|||
146837648|NCT02637323|529575483|FG001|Overall Study|Protocol Violation|1|||
146837649|NCT00358644|529575484|FG000|Overall Study|Progressive Disease|21|||
146837650|NCT00358644|529575484|FG000|Overall Study|Adverse Event|7|||
146837651|NCT00358644|529575484|FG000|Overall Study|Death|11|||
146837652|NCT00358644|529575484|FG000|Overall Study|Withdrawal by Subject|4|||
146837653|NCT00358644|529575484|FG000|Overall Study|Physician Decision|6|||
146837654|NCT00358644|529575484|FG000|Overall Study|Patient not eligible for study|1|||
146837655|NCT00513708|529575485|FG000|Overall Study|Lost to Follow-up|4|||
146837656|NCT00513708|529575486|FG001|Overall Study|Lost to Follow-up|4|||
146837657|NCT00513708|529575487|FG002|Overall Study|Lost to Follow-up|4|||
146837658|NCT00368875|529575488|FG000|Overall Study|Adverse Event|0|||
146837659|NCT00368875|529575489|FG001|Overall Study|Adverse Event|12|||
146837660|NCT00368875|529575488|FG000|Overall Study|Progressive disease|3|||
146837661|NCT00368875|529575489|FG001|Overall Study|Progressive disease|27|||
146837662|NCT00368875|529575488|FG000|Overall Study|Withdrawal by Subject|2|||
146837663|NCT00368875|529575489|FG001|Overall Study|Withdrawal by Subject|6|||
146837664|NCT00368875|529575488|FG000|Overall Study|Other Reason|0|||
146837665|NCT00368875|529575489|FG001|Overall Study|Other Reason|2|||
146837666|NCT00368875|529575488|FG000|Overall Study|Alternative Therapy|1|||
146837667|NCT00368875|529575489|FG001|Overall Study|Alternative Therapy|1|||
146837668|NCT03327831|529575490|FG000|Overall Study|Lost to Follow-up|2|||
146837669|NCT01564277|529575491|FG000|Overall Study|Protocol Violation|0|||
146837670|NCT01564277|529575492|FG001|Overall Study|Protocol Violation|1|||
146837671|NCT01564277|529575491|FG000|Overall Study|Physician Decision|1|||
146837672|NCT01564277|529575492|FG001|Overall Study|Physician Decision|0|||
146837673|NCT02595372|529575493|FG000|Overall Study|Adverse Event|6|||
146837674|NCT02595372|529575493|FG000|Overall Study|Physician Decision|2|||
146837675|NCT02595372|529575493|FG000|Overall Study|Disease Progression|1|||
146837676|NCT00401258|529575496|FG000|Overall Study|Adverse Event|7|||
146837677|NCT01305239|529575498|FG000|Overall Study|Adverse Event|22|||
146837678|NCT01305239|529575498|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
146837679|NCT02614183|529575504|FG000|Double Blind Treatment Phase|Adverse Event|10|||
146837680|NCT02614183|529575505|FG001|Double Blind Treatment Phase|Adverse Event|9|||
146837681|NCT02614183|529575506|FG002|Double Blind Treatment Phase|Adverse Event|7|||
146837682|NCT02614183|529575504|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
146837683|NCT02614183|529575505|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
146837684|NCT02614183|529575506|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
146837685|NCT02614183|529575504|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
146837686|NCT02614183|529575505|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
146837687|NCT02614183|529575506|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
146837688|NCT02614183|529575504|FG000|Double Blind Treatment Phase|Physician Decision|7|||
146837689|NCT02614183|529575505|FG001|Double Blind Treatment Phase|Physician Decision|3|||
146837690|NCT02614183|529575506|FG002|Double Blind Treatment Phase|Physician Decision|2|||
146837691|NCT02614183|529575504|FG000|Double Blind Treatment Phase|Pregnancy|2|||
146837692|NCT02614183|529575505|FG001|Double Blind Treatment Phase|Pregnancy|1|||
146837693|NCT02614183|529575506|FG002|Double Blind Treatment Phase|Pregnancy|3|||
146837694|NCT02614183|529575504|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
146837695|NCT02614183|529575505|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
146837696|NCT02614183|529575506|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
146837697|NCT02614183|529575504|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
146837698|NCT02614183|529575505|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
146837699|NCT02614183|529575506|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
146837700|NCT02614183|529575504|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
146837701|NCT02614183|529575505|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
146837702|NCT02614183|529575506|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
146837703|NCT02614183|529575504|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
146837704|NCT02614183|529575505|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
146837705|NCT02614183|529575506|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
146837706|NCT02614183|529575504|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
146837707|NCT02614183|529575505|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
146837708|NCT02614183|529575506|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
146837709|NCT02614183|529575504|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
146837710|NCT02614183|529575505|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
146837711|NCT02614183|529575506|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
146837712|NCT02614183|529575504|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
146837713|NCT02614183|529575505|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
146837714|NCT02614183|529575506|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
146837715|NCT02726945|529575507|FG000|Overall Study|Withdrawal by Subject|0|||
146837716|NCT02726945|529575508|FG001|Overall Study|Withdrawal by Subject|0|||
146837717|NCT02726945|529575509|FG002|Overall Study|Withdrawal by Subject|1|||
146837718|NCT02726945|529575507|FG000|Overall Study|Elected to have total knee replacement|0|||
146837719|NCT02726945|529575508|FG001|Overall Study|Elected to have total knee replacement|1|||
146837720|NCT02726945|529575509|FG002|Overall Study|Elected to have total knee replacement|0|||
146837721|NCT00699153|529577979|FG000|Overall Study|Lost to Follow-up|1|||
146837722|NCT00699153|529577980|FG001|Overall Study|Lost to Follow-up|0|||
146837723|NCT00699153|529577979|FG000|Overall Study|Adverse Event|0|||
146837724|NCT00699153|529577980|FG001|Overall Study|Adverse Event|2|||
146837725|NCT00699153|529577979|FG000|Overall Study|Protocol Violation|1|||
146837726|NCT00699153|529577980|FG001|Overall Study|Protocol Violation|0|||
146837727|NCT00699153|529577979|FG000|Overall Study|Travel Problem|1|||
146837728|NCT00699153|529577980|FG001|Overall Study|Travel Problem|0|||
146837729|NCT04896008|529577990|FG000|Overall Study|Ongoing|70|||
146837730|NCT04896008|529577991|FG001|Overall Study|Ongoing|38|||
146837731|NCT04896008|529577990|FG000|Overall Study|Adverse Event|0|||
146837732|NCT04896008|529577991|FG001|Overall Study|Adverse Event|2|||
146837733|NCT04896008|529577990|FG000|Overall Study|Death|5|||
146837734|NCT04896008|529577991|FG001|Overall Study|Death|10|||
146837735|NCT04896008|529577990|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
146837736|NCT04896008|529577991|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
146837737|NCT04896008|529577990|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
146837738|NCT04896008|529577991|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
146837739|NCT04896008|529577990|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
146837740|NCT04896008|529577991|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
146837741|NCT04896008|529577990|FG000|Overall Study|Withdrawal by Subject|1|||
146837742|NCT04896008|529577991|FG001|Overall Study|Withdrawal by Subject|4|||
146837743|NCT04896008|529577990|FG000|Overall Study|Investigator Decision|2|||
146837744|NCT04896008|529577991|FG001|Overall Study|Investigator Decision|0|||
146837745|NCT04896008|529577990|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
146837746|NCT04896008|529577991|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
146837747|NCT04201288|529577994|FG000|Overall Study|Death|1|||
146837748|NCT04201288|529577995|FG001|Overall Study|Death|1|||
146837749|NCT04201288|529577994|FG000|Overall Study|Lost to Follow-up|5|||
146837750|NCT04201288|529577995|FG001|Overall Study|Lost to Follow-up|3|||
146837751|NCT04201288|529577994|FG000|Overall Study|Withdrawal by Subject|1|||
146837752|NCT04201288|529577995|FG001|Overall Study|Withdrawal by Subject|0|||
146837753|NCT01270828|529578000|FG000|Pregabalin CR SB|Reason Unspecified|0|||
146837754|NCT01270828|529578001|FG001|Pregabalin CR SB|Reason Unspecified|0|||
146837755|NCT01270828|529578002|FG002|Pregabalin CR SB|Reason Unspecified|8|||
146837756|NCT01270828|529578000|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
146837757|NCT01270828|529578001|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
146837758|NCT01270828|529578002|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
146837759|NCT01270828|529578000|FG000|Pregabalin CR SB|Related adverse event|0|||
146837760|NCT01270828|529578001|FG001|Pregabalin CR SB|Related adverse event|0|||
146837761|NCT01270828|529578002|FG002|Pregabalin CR SB|Related adverse event|46|||
146837762|NCT01270828|529578000|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
146837763|NCT01270828|529578001|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
146837764|NCT01270828|529578002|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
146837765|NCT01270828|529578000|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
146837766|NCT01270828|529578001|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
146837767|NCT01270828|529578002|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
146837768|NCT01270828|529578000|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
146837769|NCT01270828|529578001|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
146837770|NCT01270828|529578002|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
146837771|NCT01270828|529578000|FG000|Pregabalin CR SB|Unrelated AE|0|||
146837772|NCT01270828|529578001|FG001|Pregabalin CR SB|Unrelated AE|0|||
146837773|NCT01270828|529578002|FG002|Pregabalin CR SB|Unrelated AE|8|||
146837774|NCT01270828|529578000|FG000|Pregabalin CR SB|Protocol Violation|0|||
146837775|NCT01270828|529578001|FG001|Pregabalin CR SB|Protocol Violation|0|||
146837776|NCT01270828|529578002|FG002|Pregabalin CR SB|Protocol Violation|8|||
146837777|NCT01270828|529578000|FG000|Double Blind Phase|Death|0|||
146837778|NCT01270828|529578001|FG001|Double Blind Phase|Death|1|||
146837779|NCT01270828|529578002|FG002|Double Blind Phase|Death|0|||
146837780|NCT01270828|529578000|FG000|Double Blind Phase|Protocol Violation|0|||
146837781|NCT01270828|529578001|FG001|Double Blind Phase|Protocol Violation|1|||
146837782|NCT01270828|529578002|FG002|Double Blind Phase|Protocol Violation|0|||
146837783|NCT01270828|529578000|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
146837784|NCT01270828|529578001|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
146837785|NCT01270828|529578002|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
146837786|NCT01270828|529578000|FG000|Double Blind Phase|Reason Unspecified|7|||
146837787|NCT01270828|529578001|FG001|Double Blind Phase|Reason Unspecified|4|||
146837788|NCT01270828|529578002|FG002|Double Blind Phase|Reason Unspecified|0|||
146837789|NCT01270828|529578000|FG000|Double Blind Phase|Withdrawal by Subject|6|||
146837790|NCT01270828|529578001|FG001|Double Blind Phase|Withdrawal by Subject|15|||
146837791|NCT01270828|529578002|FG002|Double Blind Phase|Withdrawal by Subject|0|||
146837792|NCT01270828|529578000|FG000|Double Blind Phase|Lost to Follow-up|1|||
146837793|NCT01270828|529578001|FG001|Double Blind Phase|Lost to Follow-up|2|||
146837794|NCT01270828|529578002|FG002|Double Blind Phase|Lost to Follow-up|0|||
146837795|NCT01270828|529578000|FG000|Double Blind Phase|Lack of Efficacy|2|||
146837796|NCT01270828|529578001|FG001|Double Blind Phase|Lack of Efficacy|11|||
146837797|NCT01270828|529578002|FG002|Double Blind Phase|Lack of Efficacy|0|||
146837798|NCT01270828|529578000|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
146837799|NCT01270828|529578001|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
146837800|NCT01270828|529578002|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
146837801|NCT01270828|529578000|FG000|Double Blind Phase|Adverse event related to study drug|5|||
146837802|NCT01270828|529578001|FG001|Double Blind Phase|Adverse event related to study drug|7|||
146837803|NCT01270828|529578002|FG002|Double Blind Phase|Adverse event related to study drug|0|||
146837804|NCT02870972|529578008|FG000|Overall Study|Adverse Event|1|||
146837805|NCT02870972|529578009|FG001|Overall Study|Adverse Event|0|||
146837806|NCT02870972|529578010|FG002|Overall Study|Adverse Event|0|||
146837807|NCT02870972|529578011|FG003|Overall Study|Adverse Event|0|||
146837808|NCT02870972|529578012|FG004|Overall Study|Adverse Event|0|||
146837809|NCT01736540|529578015|FG000|Overall Study|Did not complete scan within 45 days|2|||
146837810|NCT01736540|529578015|FG000|Overall Study|Death|1|||
146837811|NCT01736540|529578015|FG000|Overall Study|Abnormal test procedure|1|||
146837812|NCT01736540|529578015|FG000|Overall Study|Withdrawal by Subject|5|||
146837813|NCT01736540|529578015|FG000|Overall Study|Protocol Violation|1|||
146837814|NCT01736540|529578015|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
146837815|NCT01736540|529578015|FG000|Overall Study|No show for MRI appointment|1|||
146837816|NCT01736540|529578015|FG000|Overall Study|Unable to make MRI appointment|3|||
146837817|NCT00479882|529578016|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
146837818|NCT00479882|529578017|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
146837819|NCT00479882|529578018|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
146837820|NCT00479882|529578019|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
146837821|NCT00479882|529578016|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
146837822|NCT00479882|529578017|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
146837823|NCT00479882|529578018|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
146837824|NCT00479882|529578019|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
146837825|NCT00479882|529578016|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
146837826|NCT00479882|529578017|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
146837827|NCT00479882|529578018|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
146837828|NCT00479882|529578019|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
146837829|NCT00479882|529578016|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
146837830|NCT00479882|529578017|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
146837831|NCT00479882|529578018|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
146837832|NCT00479882|529578019|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
146837833|NCT00479882|529578016|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
146837834|NCT00479882|529578017|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
146837835|NCT00479882|529578018|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
146837836|NCT00479882|529578019|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
146837837|NCT00479882|529578016|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
146837838|NCT00479882|529578017|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
146837839|NCT00479882|529578018|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
146837840|NCT00479882|529578019|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
146837841|NCT00479882|529578016|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
146837842|NCT00479882|529578017|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
146837843|NCT00479882|529578018|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
146837844|NCT00479882|529578019|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
146837845|NCT00479882|529578016|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
146837846|NCT00479882|529578017|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
146837847|NCT00479882|529578018|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
146837848|NCT00479882|529578019|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
146837849|NCT00479882|529578016|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
146837850|NCT00479882|529578017|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
146837851|NCT00479882|529578018|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
146837852|NCT00479882|529578019|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
146837853|NCT00479882|529578016|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
146837854|NCT00479882|529578017|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
146837855|NCT00479882|529578018|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
146837856|NCT00479882|529578019|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
146837857|NCT00479882|529578016|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
146837858|NCT00479882|529578017|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
146837859|NCT00479882|529578018|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
146837860|NCT00479882|529578019|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
146837861|NCT00479882|529578016|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
146837862|NCT00479882|529578017|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
146837863|NCT00479882|529578018|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
146837864|NCT00479882|529578019|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
146837865|NCT00479882|529578016|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
146837866|NCT00479882|529578017|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
146837867|NCT00479882|529578018|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
146837868|NCT00479882|529578019|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
146837869|NCT00479882|529578016|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
146837870|NCT00479882|529578017|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
146837871|NCT00479882|529578018|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
146837872|NCT00479882|529578019|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
146837873|NCT03004404|529578034|FG000|Period 2|Adverse Event|0|||
146837874|NCT03004404|529578035|FG001|Period 2|Adverse Event|0|||
146837875|NCT03004404|529578036|FG002|Period 2|Adverse Event|0|||
146837876|NCT03004404|529578037|FG003|Period 2|Adverse Event|0|||
146837877|NCT03004404|529578038|FG004|Period 2|Adverse Event|0|||
146837878|NCT03004404|529578039|FG005|Period 2|Adverse Event|0|||
146837879|NCT03004404|529578040|FG006|Period 2|Adverse Event|0|||
146837880|NCT03004404|529578041|FG007|Period 2|Adverse Event|0|||
146837881|NCT03004404|529578042|FG008|Period 2|Adverse Event|1|||
146837882|NCT03004404|529578043|FG009|Period 2|Adverse Event|0|||
146837883|NCT03004404|529578044|FG010|Period 2|Adverse Event|0|||
146837884|NCT03004404|529578045|FG011|Period 2|Adverse Event|0|||
146837885|NCT03004404|529578046|FG012|Period 2|Adverse Event|0|||
146837886|NCT03004404|529578047|FG013|Period 2|Adverse Event|0|||
146837887|NCT03004404|529578048|FG014|Period 2|Adverse Event|0|||
146837888|NCT03004404|529578049|FG015|Period 2|Adverse Event|1|||
146837889|NCT03933462|529578052|FG000|Overall Study|Adverse Event|2|||
146837890|NCT03933462|529578053|FG001|Overall Study|Adverse Event|0|||
146837891|NCT02522728|529578058|FG000|Overall Study|Withdrawal by Subject|6|||
146837892|NCT02522728|529578059|FG001|Overall Study|Withdrawal by Subject|6|||
146837893|NCT02522728|529578058|FG000|Overall Study|Death|4|||
146837894|NCT02522728|529578059|FG001|Overall Study|Death|3|||
146837895|NCT02522728|529578058|FG000|Overall Study|Adverse Event|2|||
146837896|NCT02522728|529578059|FG001|Overall Study|Adverse Event|1|||
146837897|NCT02522728|529578058|FG000|Overall Study|Did not receive randomized study device|0|||
146837898|NCT02522728|529578059|FG001|Overall Study|Did not receive randomized study device|1|||
146837899|NCT01266161|529578066|FG000|Overall Study|Ineligible|1|||
146837900|NCT01266161|529578067|FG001|Overall Study|Ineligible|0|||
146837901|NCT01266161|529578066|FG000|Overall Study|Lack of Efficacy|0|||
146990619|NCT00486837|530128712|FG000|Overall Study|Protocol Violation|4|||
146837902|NCT01266161|529578067|FG001|Overall Study|Lack of Efficacy|1|||
146837903|NCT01266161|529578066|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
146837904|NCT01266161|529578067|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
146837905|NCT02990468|529578068|FG000|Phase 2: MTD|Change in treatment|0|||
146837906|NCT02990468|529578069|FG001|Phase 2: MTD|Change in treatment|0|||
146837907|NCT02990468|529578070|FG002|Phase 2: MTD|Change in treatment|1|||
146837908|NCT01436305|529578072|FG000|Overall Study|Death|1|||
146837909|NCT01436305|529578073|FG001|Overall Study|Death|0|||
146837910|NCT01436305|529578074|FG002|Overall Study|Death|0|||
146837911|NCT01436305|529578072|FG000|Overall Study|Lost to Follow-up|0|||
146837912|NCT01436305|529578073|FG001|Overall Study|Lost to Follow-up|1|||
146837913|NCT01436305|529578074|FG002|Overall Study|Lost to Follow-up|0|||
146837914|NCT01436305|529578072|FG000|Overall Study|Withdrawal by Subject|1|||
146837915|NCT01436305|529578073|FG001|Overall Study|Withdrawal by Subject|3|||
146837916|NCT01436305|529578074|FG002|Overall Study|Withdrawal by Subject|0|||
146837917|NCT04148651|529578082|FG000|Overall Study|Lost to Follow-up|2|||
146837918|NCT03690427|529578085|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
146837919|NCT03690427|529578086|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
146837920|NCT03519204|529578092|FG000|Overall Study|Lost to Follow-up|3|||
146837921|NCT03519204|529578093|FG001|Overall Study|Lost to Follow-up|8|||
146837922|NCT03519204|529578092|FG000|Overall Study|Withdrawal by Subject|9|||
146837923|NCT03519204|529578093|FG001|Overall Study|Withdrawal by Subject|7|||
146837924|NCT03519204|529578092|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146837925|NCT03519204|529578093|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146837926|NCT01721954|529578094|FG000|Overall Study|Death|58|||
146837927|NCT01721954|529578095|FG001|Overall Study|Death|64|||
146837928|NCT01721954|529578094|FG000|Overall Study|Withdrawal by Subject|8|||
146837929|NCT01721954|529578095|FG001|Overall Study|Withdrawal by Subject|4|||
146837930|NCT01721954|529578094|FG000|Overall Study|Adverse Event|2|||
146837931|NCT01721954|529578095|FG001|Overall Study|Adverse Event|0|||
146837932|NCT01721954|529578094|FG000|Overall Study|Lost to Follow-up|2|||
146837933|NCT01721954|529578095|FG001|Overall Study|Lost to Follow-up|1|||
146837934|NCT02609672|529578096|FG000|Overall Study|Lost to Follow-up|3|||
146837935|NCT02609672|529578097|FG001|Overall Study|Lost to Follow-up|1|||
146837936|NCT03392168|529578098|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
146837937|NCT03392168|529578099|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
146837938|NCT03392168|529578100|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
146837939|NCT03392168|529578101|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
146837940|NCT03392168|529578098|FG000|Period 2: Cohort 2|Other|0|||
146837941|NCT03392168|529578099|FG001|Period 2: Cohort 2|Other|1|||
146837942|NCT03392168|529578100|FG002|Period 2: Cohort 2|Other|0|||
146837943|NCT03392168|529578101|FG003|Period 2: Cohort 2|Other|0|||
146837944|NCT02956837|529578103|FG000|Overall Study|Serious Adverse Events|0|||
146837945|NCT02956837|529578104|FG001|Overall Study|Serious Adverse Events|1|||
146837946|NCT02956837|529578105|FG002|Overall Study|Serious Adverse Events|0|||
146837947|NCT02956837|529578106|FG003|Overall Study|Serious Adverse Events|0|||
146837948|NCT02956837|529578103|FG000|Overall Study|Withdrawal by Subject|0|||
146837949|NCT02956837|529578104|FG001|Overall Study|Withdrawal by Subject|1|||
146837950|NCT02956837|529578105|FG002|Overall Study|Withdrawal by Subject|0|||
146837951|NCT02956837|529578106|FG003|Overall Study|Withdrawal by Subject|3|||
146837952|NCT02956837|529578103|FG000|Overall Study|Lost to Follow-up|0|||
146837953|NCT02956837|529578104|FG001|Overall Study|Lost to Follow-up|1|||
146837954|NCT02956837|529578105|FG002|Overall Study|Lost to Follow-up|2|||
146837955|NCT02956837|529578106|FG003|Overall Study|Lost to Follow-up|0|||
146837956|NCT02597712|529578111|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
146837957|NCT02597712|529578112|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
146837958|NCT02597712|529578111|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
146837959|NCT02597712|529578112|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
146837960|NCT02597712|529578111|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
146837961|NCT02597712|529578112|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
146837962|NCT01727505|529578113|FG000|First 24 Hours|Adverse Event|0|||
146837963|NCT01727505|529578114|FG001|First 24 Hours|Adverse Event|1|||
146837964|NCT01727505|529578113|FG000|Second 24 Hours|Missing data|0|||
146837965|NCT01727505|529578114|FG001|Second 24 Hours|Missing data|1|||
146837966|NCT01594970|529578115|FG000|Overall Study|Non-Adverse Event Related|4|||
146837967|NCT01594970|529578116|FG001|Overall Study|Non-Adverse Event Related|5|||
146837968|NCT01594970|529578117|FG002|Overall Study|Non-Adverse Event Related|6|||
146837969|NCT01594970|529578115|FG000|Overall Study|Adverse Event|17|||
146837970|NCT01594970|529578116|FG001|Overall Study|Adverse Event|23|||
146837971|NCT01594970|529578117|FG002|Overall Study|Adverse Event|23|||
146837972|NCT01594970|529578115|FG000|Overall Study|Lost to Follow-up|54|||
146837973|NCT01594970|529578116|FG001|Overall Study|Lost to Follow-up|54|||
146837974|NCT01594970|529578117|FG002|Overall Study|Lost to Follow-up|37|||
146837975|NCT01427725|529578118|FG000|Overall Study|Lost to Follow-up|17|||
146837976|NCT01427725|529578118|FG000|Overall Study|Protocol Violation|1|||
146837977|NCT01427725|529578118|FG000|Overall Study|Drug not administered|1|||
146837978|NCT01427725|529578118|FG000|Overall Study|Failure to visit|7|||
146837979|NCT01427725|529578118|FG000|Overall Study|Adverse Event|46|||
146837980|NCT01427725|529578118|FG000|Overall Study|Failure to visit after administration|40|||
146837981|NCT01427725|529578118|FG000|Overall Study|Patient's rejection|27|||
146837982|NCT01427725|529578118|FG000|Overall Study|Transfer to a different hospital|17|||
146837983|NCT01427725|529578118|FG000|Overall Study|Lack of Efficacy|8|||
146837984|NCT01427725|529578118|FG000|Overall Study|Death|7|||
146837985|NCT01427725|529578118|FG000|Overall Study|Symptom improvement|6|||
146837986|NCT01427725|529578118|FG000|Overall Study|AE and Patient's rejection|5|||
146837987|NCT01427725|529578118|FG000|Overall Study|Physician Decision|5|||
146837988|NCT01427725|529578118|FG000|Overall Study|Exacerbation of underlying disease|5|||
146837989|NCT01427725|529578118|FG000|Overall Study|Oral feeding difficulty|5|||
146837990|NCT01427725|529578118|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
146837991|NCT01427725|529578118|FG000|Overall Study|Forgetting prescription|1|||
146837992|NCT01427725|529578118|FG000|Overall Study|Other|2|||
146837993|NCT01299480|529578119|FG000|Overall Study|No longer willing to participate|19|||
146837994|NCT01299480|529578120|FG001|Overall Study|No longer willing to participate|17|||
146837995|NCT01299480|529578121|FG002|Overall Study|No longer willing to participate|14|||
146837996|NCT01299480|529578122|FG003|Overall Study|No longer willing to participate|13|||
146837997|NCT01299480|529578123|FG004|Overall Study|No longer willing to participate|10|||
146837998|NCT01299480|529578119|FG000|Overall Study|Protocol Violation|7|||
146837999|NCT01299480|529578120|FG001|Overall Study|Protocol Violation|5|||
146838000|NCT01299480|529578121|FG002|Overall Study|Protocol Violation|8|||
146838001|NCT01299480|529578122|FG003|Overall Study|Protocol Violation|1|||
146838002|NCT01299480|529578123|FG004|Overall Study|Protocol Violation|1|||
146838003|NCT01299480|529578119|FG000|Overall Study|Withdrawal by Subject|3|||
146838004|NCT01299480|529578120|FG001|Overall Study|Withdrawal by Subject|4|||
146838005|NCT01299480|529578121|FG002|Overall Study|Withdrawal by Subject|7|||
146838006|NCT01299480|529578122|FG003|Overall Study|Withdrawal by Subject|3|||
146838007|NCT01299480|529578123|FG004|Overall Study|Withdrawal by Subject|4|||
146838008|NCT01299480|529578119|FG000|Overall Study|Adverse Event|6|||
146838009|NCT01299480|529578120|FG001|Overall Study|Adverse Event|4|||
146838010|NCT01299480|529578121|FG002|Overall Study|Adverse Event|5|||
146838011|NCT01299480|529578122|FG003|Overall Study|Adverse Event|4|||
146838012|NCT01299480|529578123|FG004|Overall Study|Adverse Event|0|||
146838013|NCT01299480|529578119|FG000|Overall Study|Withdrawal due to pregnancy|0|||
146838014|NCT01299480|529578120|FG001|Overall Study|Withdrawal due to pregnancy|1|||
146838015|NCT01299480|529578121|FG002|Overall Study|Withdrawal due to pregnancy|1|||
146838016|NCT01299480|529578122|FG003|Overall Study|Withdrawal due to pregnancy|0|||
146838017|NCT01299480|529578123|FG004|Overall Study|Withdrawal due to pregnancy|0|||
146838018|NCT01299480|529578119|FG000|Overall Study|Physician Decision|1|||
146838019|NCT01299480|529578120|FG001|Overall Study|Physician Decision|1|||
146838020|NCT01299480|529578121|FG002|Overall Study|Physician Decision|0|||
146838021|NCT01299480|529578122|FG003|Overall Study|Physician Decision|2|||
146838022|NCT01299480|529578123|FG004|Overall Study|Physician Decision|0|||
146838023|NCT01299480|529578119|FG000|Overall Study|Lost to Follow-up|3|||
146838024|NCT01299480|529578120|FG001|Overall Study|Lost to Follow-up|1|||
146838025|NCT01299480|529578121|FG002|Overall Study|Lost to Follow-up|2|||
146838026|NCT01299480|529578122|FG003|Overall Study|Lost to Follow-up|1|||
146838027|NCT01299480|529578123|FG004|Overall Study|Lost to Follow-up|2|||
146838028|NCT01299480|529578119|FG000|Overall Study|Other|3|||
146838029|NCT01299480|529578120|FG001|Overall Study|Other|2|||
146838030|NCT01299480|529578121|FG002|Overall Study|Other|3|||
146838031|NCT01299480|529578122|FG003|Overall Study|Other|0|||
146838032|NCT01299480|529578123|FG004|Overall Study|Other|3|||
146838033|NCT01299480|529578119|FG000|Overall Study|Started, but not vaccinated|0|||
146838034|NCT01299480|529578120|FG001|Overall Study|Started, but not vaccinated|0|||
146838035|NCT01299480|529578121|FG002|Overall Study|Started, but not vaccinated|1|||
146838036|NCT01299480|529578122|FG003|Overall Study|Started, but not vaccinated|1|||
146838037|NCT01299480|529578123|FG004|Overall Study|Started, but not vaccinated|0|||
146838038|NCT01430468|529578130|FG000|Overall Study|Physician Decision|2|||
146838039|NCT01430468|529578131|FG001|Overall Study|Physician Decision|1|||
146838040|NCT01430468|529578130|FG000|Overall Study|Withdrawal by Subject|5|||
146838041|NCT01430468|529578131|FG001|Overall Study|Withdrawal by Subject|5|||
146838042|NCT01281839|529578132|FG000|Overall Study|Lost to Follow-up|6|||
146838043|NCT01281839|529578133|FG001|Overall Study|Lost to Follow-up|3|||
146838044|NCT01281839|529578132|FG000|Overall Study|Withdrawal by Subject|4|||
146838045|NCT01281839|529578133|FG001|Overall Study|Withdrawal by Subject|10|||
146838046|NCT01281839|529578132|FG000|Overall Study|Reason not specified|0|||
146838047|NCT01281839|529578133|FG001|Overall Study|Reason not specified|1|||
146838048|NCT00617929|529578135|FG000|Overall Study|Physician Decision|1|||
146838049|NCT03229486|529578136|FG000|Overall Study|Protocol Violation|0|||
146838050|NCT03229486|529578137|FG001|Overall Study|Protocol Violation|1|||
146838051|NCT04855734|529578145|FG000|Overall Study|Lost to Follow-up|2|||
146838052|NCT04855734|529578146|FG001|Overall Study|Lost to Follow-up|2|||
146838053|NCT04535544|529578147|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
146838054|NCT04535544|529578148|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
146838055|NCT04535544|529578149|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
146838056|NCT04535544|529578150|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
146838057|NCT04535544|529578147|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
146838058|NCT04535544|529578148|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
146838059|NCT04535544|529578149|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
146838060|NCT04535544|529578150|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
146838061|NCT04535544|529578147|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
146838062|NCT04535544|529578148|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
146838063|NCT04535544|529578149|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
146838064|NCT04535544|529578150|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
146838065|NCT04535544|529578147|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
146838066|NCT04535544|529578148|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
146838067|NCT04535544|529578149|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
146838068|NCT04535544|529578150|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
146838069|NCT04535544|529578147|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
146838070|NCT04535544|529578148|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
146838071|NCT04535544|529578149|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
146838072|NCT04535544|529578150|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
146838073|NCT04535544|529578147|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
146838074|NCT04535544|529578148|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
146838075|NCT04535544|529578149|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
146838076|NCT04535544|529578150|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
146838077|NCT04535544|529578147|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
146838078|NCT04535544|529578148|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
146838079|NCT04535544|529578149|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
146838080|NCT04535544|529578150|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
146838081|NCT04535544|529578147|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
146838082|NCT04535544|529578148|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
146838083|NCT04535544|529578149|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
146838084|NCT04535544|529578150|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
146838085|NCT00344032|529578151|FG000|Overall Study|Adverse Event|0|||
146838086|NCT00344032|529578152|FG001|Overall Study|Adverse Event|1|||
146838087|NCT00344032|529578151|FG000|Overall Study|Withdrawal by Subject|6|||
146838088|NCT00344032|529578152|FG001|Overall Study|Withdrawal by Subject|2|||
146838089|NCT00344032|529578151|FG000|Overall Study|Lost to Follow-up|4|||
146838090|NCT00344032|529578152|FG001|Overall Study|Lost to Follow-up|6|||
146838091|NCT00344032|529578151|FG000|Overall Study|Physician Decision|4|||
146838092|NCT00344032|529578152|FG001|Overall Study|Physician Decision|1|||
146838093|NCT05131477|529578159|FG000|PART 1|Withdrawal by Subject|2|||
146838094|NCT05131477|529578160|FG001|PART 1|Withdrawal by Subject|9|||
146838095|NCT05131477|529578161|FG002|PART 1|Withdrawal by Subject|6|||
146838096|NCT05131477|529578162|FG003|PART 1|Withdrawal by Subject|2|||
146838097|NCT05131477|529578163|FG004|PART 1|Withdrawal by Subject|8|||
146838098|NCT05131477|529578164|FG005|PART 1|Withdrawal by Subject|0|||
146838099|NCT05131477|529578165|FG006|PART 1|Withdrawal by Subject|0|||
146838100|NCT05131477|529578166|FG007|PART 1|Withdrawal by Subject|0|||
146838101|NCT05131477|529578167|FG008|PART 1|Withdrawal by Subject|0|||
146838102|NCT05131477|529578168|FG009|PART 1|Withdrawal by Subject|0|||
146838103|NCT05131477|529578169|FG010|PART 1|Withdrawal by Subject|0|||
146838104|NCT05131477|529578170|FG011|PART 1|Withdrawal by Subject|0|||
146838105|NCT05131477|529578171|FG012|PART 1|Withdrawal by Subject|0|||
146838106|NCT05131477|529578172|FG013|PART 1|Withdrawal by Subject|0|||
146838107|NCT05131477|529578159|FG000|PART 1|Physician Decision|1|||
146838108|NCT05131477|529578160|FG001|PART 1|Physician Decision|0|||
146838109|NCT05131477|529578161|FG002|PART 1|Physician Decision|0|||
146838110|NCT05131477|529578162|FG003|PART 1|Physician Decision|0|||
146838111|NCT05131477|529578163|FG004|PART 1|Physician Decision|0|||
146838112|NCT05131477|529578164|FG005|PART 1|Physician Decision|0|||
146838113|NCT05131477|529578165|FG006|PART 1|Physician Decision|0|||
146838114|NCT05131477|529578166|FG007|PART 1|Physician Decision|0|||
146838115|NCT05131477|529578167|FG008|PART 1|Physician Decision|0|||
146838116|NCT05131477|529578168|FG009|PART 1|Physician Decision|0|||
146838117|NCT05131477|529578169|FG010|PART 1|Physician Decision|0|||
146838118|NCT05131477|529578170|FG011|PART 1|Physician Decision|0|||
146838119|NCT05131477|529578171|FG012|PART 1|Physician Decision|0|||
146838120|NCT05131477|529578172|FG013|PART 1|Physician Decision|0|||
146838121|NCT05131477|529578159|FG000|PART 1|Adverse Event|3|||
146838122|NCT05131477|529578160|FG001|PART 1|Adverse Event|5|||
146838123|NCT05131477|529578161|FG002|PART 1|Adverse Event|1|||
146838124|NCT05131477|529578162|FG003|PART 1|Adverse Event|6|||
146838125|NCT05131477|529578163|FG004|PART 1|Adverse Event|4|||
146838126|NCT05131477|529578164|FG005|PART 1|Adverse Event|0|||
146838127|NCT05131477|529578165|FG006|PART 1|Adverse Event|0|||
146838128|NCT05131477|529578166|FG007|PART 1|Adverse Event|0|||
146838129|NCT05131477|529578167|FG008|PART 1|Adverse Event|0|||
146838130|NCT05131477|529578168|FG009|PART 1|Adverse Event|0|||
146838131|NCT05131477|529578169|FG010|PART 1|Adverse Event|0|||
146838132|NCT05131477|529578170|FG011|PART 1|Adverse Event|0|||
146838133|NCT05131477|529578171|FG012|PART 1|Adverse Event|0|||
146838134|NCT05131477|529578172|FG013|PART 1|Adverse Event|0|||
146838135|NCT05131477|529578159|FG000|PART 1|unclassified|1|||
146838136|NCT05131477|529578160|FG001|PART 1|unclassified|1|||
146838137|NCT05131477|529578161|FG002|PART 1|unclassified|0|||
146838138|NCT05131477|529578162|FG003|PART 1|unclassified|0|||
146838139|NCT05131477|529578163|FG004|PART 1|unclassified|4|||
146838140|NCT05131477|529578164|FG005|PART 1|unclassified|0|||
146838141|NCT05131477|529578165|FG006|PART 1|unclassified|0|||
146838142|NCT05131477|529578166|FG007|PART 1|unclassified|0|||
146838143|NCT05131477|529578167|FG008|PART 1|unclassified|0|||
146838144|NCT05131477|529578168|FG009|PART 1|unclassified|0|||
146838145|NCT05131477|529578169|FG010|PART 1|unclassified|0|||
146838146|NCT05131477|529578170|FG011|PART 1|unclassified|0|||
146838147|NCT05131477|529578171|FG012|PART 1|unclassified|0|||
146838148|NCT05131477|529578172|FG013|PART 1|unclassified|0|||
146838149|NCT05131477|529578159|FG000|PART 1|Randomized and not treated|0|||
146838150|NCT05131477|529578160|FG001|PART 1|Randomized and not treated|0|||
146838151|NCT05131477|529578161|FG002|PART 1|Randomized and not treated|0|||
146838152|NCT05131477|529578162|FG003|PART 1|Randomized and not treated|1|||
146838153|NCT05131477|529578163|FG004|PART 1|Randomized and not treated|1|||
146838154|NCT05131477|529578164|FG005|PART 1|Randomized and not treated|0|||
146838155|NCT05131477|529578165|FG006|PART 1|Randomized and not treated|0|||
146838156|NCT05131477|529578166|FG007|PART 1|Randomized and not treated|0|||
146838157|NCT05131477|529578167|FG008|PART 1|Randomized and not treated|0|||
146838158|NCT05131477|529578168|FG009|PART 1|Randomized and not treated|0|||
146838159|NCT05131477|529578169|FG010|PART 1|Randomized and not treated|0|||
146838160|NCT05131477|529578170|FG011|PART 1|Randomized and not treated|0|||
146838161|NCT05131477|529578171|FG012|PART 1|Randomized and not treated|0|||
146838162|NCT05131477|529578172|FG013|PART 1|Randomized and not treated|0|||
146838163|NCT05131477|529578159|FG000|PART 1|Protocol Violation|2|||
146838164|NCT05131477|529578160|FG001|PART 1|Protocol Violation|0|||
146838165|NCT05131477|529578161|FG002|PART 1|Protocol Violation|0|||
146838166|NCT05131477|529578162|FG003|PART 1|Protocol Violation|1|||
146838167|NCT05131477|529578163|FG004|PART 1|Protocol Violation|0|||
146838168|NCT05131477|529578164|FG005|PART 1|Protocol Violation|0|||
146838169|NCT05131477|529578165|FG006|PART 1|Protocol Violation|0|||
146838170|NCT05131477|529578166|FG007|PART 1|Protocol Violation|0|||
146838171|NCT05131477|529578167|FG008|PART 1|Protocol Violation|0|||
146838172|NCT05131477|529578168|FG009|PART 1|Protocol Violation|0|||
146838173|NCT05131477|529578169|FG010|PART 1|Protocol Violation|0|||
146838174|NCT05131477|529578170|FG011|PART 1|Protocol Violation|0|||
146838175|NCT05131477|529578171|FG012|PART 1|Protocol Violation|0|||
146838176|NCT05131477|529578172|FG013|PART 1|Protocol Violation|0|||
146838177|NCT05131477|529578159|FG000|PART 1|Lack of Efficacy|0|||
146838178|NCT05131477|529578160|FG001|PART 1|Lack of Efficacy|1|||
146838179|NCT05131477|529578161|FG002|PART 1|Lack of Efficacy|1|||
146838180|NCT05131477|529578162|FG003|PART 1|Lack of Efficacy|2|||
146838181|NCT05131477|529578163|FG004|PART 1|Lack of Efficacy|5|||
146838182|NCT05131477|529578164|FG005|PART 1|Lack of Efficacy|0|||
146838183|NCT05131477|529578165|FG006|PART 1|Lack of Efficacy|0|||
146838184|NCT05131477|529578166|FG007|PART 1|Lack of Efficacy|0|||
146838185|NCT05131477|529578167|FG008|PART 1|Lack of Efficacy|0|||
146838186|NCT05131477|529578168|FG009|PART 1|Lack of Efficacy|0|||
146838187|NCT05131477|529578169|FG010|PART 1|Lack of Efficacy|0|||
146838188|NCT05131477|529578170|FG011|PART 1|Lack of Efficacy|0|||
146838189|NCT05131477|529578171|FG012|PART 1|Lack of Efficacy|0|||
146838190|NCT05131477|529578172|FG013|PART 1|Lack of Efficacy|0|||
146838191|NCT05131477|529578159|FG000|PART 2|Withdrawal by Subject|0|||
146838192|NCT05131477|529578160|FG001|PART 2|Withdrawal by Subject|0|||
146838193|NCT05131477|529578161|FG002|PART 2|Withdrawal by Subject|0|||
146838194|NCT05131477|529578162|FG003|PART 2|Withdrawal by Subject|0|||
146838195|NCT05131477|529578163|FG004|PART 2|Withdrawal by Subject|0|||
146838196|NCT05131477|529578164|FG005|PART 2|Withdrawal by Subject|0|||
146838197|NCT05131477|529578165|FG006|PART 2|Withdrawal by Subject|2|||
146838198|NCT05131477|529578166|FG007|PART 2|Withdrawal by Subject|0|||
146838199|NCT05131477|529578167|FG008|PART 2|Withdrawal by Subject|0|||
146838200|NCT05131477|529578168|FG009|PART 2|Withdrawal by Subject|0|||
146838201|NCT05131477|529578169|FG010|PART 2|Withdrawal by Subject|2|||
146838202|NCT05131477|529578170|FG011|PART 2|Withdrawal by Subject|0|||
146838203|NCT05131477|529578171|FG012|PART 2|Withdrawal by Subject|2|||
146838204|NCT05131477|529578172|FG013|PART 2|Withdrawal by Subject|2|||
146838205|NCT05131477|529578159|FG000|PART 2|Other|0|||
146838206|NCT05131477|529578160|FG001|PART 2|Other|0|||
146838207|NCT05131477|529578161|FG002|PART 2|Other|0|||
146838208|NCT05131477|529578162|FG003|PART 2|Other|0|||
146838209|NCT05131477|529578163|FG004|PART 2|Other|0|||
146838210|NCT05131477|529578164|FG005|PART 2|Other|0|||
146838211|NCT05131477|529578165|FG006|PART 2|Other|0|||
146838212|NCT05131477|529578166|FG007|PART 2|Other|0|||
146838213|NCT05131477|529578167|FG008|PART 2|Other|1|||
146838214|NCT05131477|529578168|FG009|PART 2|Other|1|||
146838215|NCT05131477|529578169|FG010|PART 2|Other|0|||
146838216|NCT05131477|529578170|FG011|PART 2|Other|0|||
146838217|NCT05131477|529578171|FG012|PART 2|Other|1|||
146838218|NCT05131477|529578172|FG013|PART 2|Other|0|||
146838219|NCT05131477|529578159|FG000|PART 2|Lack of Efficacy|0|||
146838220|NCT05131477|529578160|FG001|PART 2|Lack of Efficacy|0|||
146838221|NCT05131477|529578161|FG002|PART 2|Lack of Efficacy|0|||
146838222|NCT05131477|529578162|FG003|PART 2|Lack of Efficacy|0|||
146838223|NCT05131477|529578163|FG004|PART 2|Lack of Efficacy|0|||
146838224|NCT05131477|529578164|FG005|PART 2|Lack of Efficacy|1|||
146838225|NCT05131477|529578165|FG006|PART 2|Lack of Efficacy|1|||
146838226|NCT05131477|529578166|FG007|PART 2|Lack of Efficacy|0|||
146838227|NCT05131477|529578167|FG008|PART 2|Lack of Efficacy|3|||
146838228|NCT05131477|529578168|FG009|PART 2|Lack of Efficacy|0|||
146838229|NCT05131477|529578169|FG010|PART 2|Lack of Efficacy|1|||
146838230|NCT05131477|529578170|FG011|PART 2|Lack of Efficacy|0|||
146838231|NCT05131477|529578171|FG012|PART 2|Lack of Efficacy|2|||
146838232|NCT05131477|529578172|FG013|PART 2|Lack of Efficacy|0|||
146838233|NCT05131477|529578159|FG000|PART 2|Unclassified|0|||
146838234|NCT05131477|529578160|FG001|PART 2|Unclassified|0|||
146838235|NCT05131477|529578161|FG002|PART 2|Unclassified|0|||
146838236|NCT05131477|529578162|FG003|PART 2|Unclassified|0|||
146838237|NCT05131477|529578163|FG004|PART 2|Unclassified|0|||
146838238|NCT05131477|529578164|FG005|PART 2|Unclassified|0|||
146838239|NCT05131477|529578165|FG006|PART 2|Unclassified|0|||
146838240|NCT05131477|529578166|FG007|PART 2|Unclassified|0|||
146838241|NCT05131477|529578167|FG008|PART 2|Unclassified|0|||
146838242|NCT05131477|529578168|FG009|PART 2|Unclassified|0|||
146838243|NCT05131477|529578169|FG010|PART 2|Unclassified|1|||
146838244|NCT05131477|529578170|FG011|PART 2|Unclassified|0|||
146838245|NCT05131477|529578171|FG012|PART 2|Unclassified|0|||
146838246|NCT05131477|529578172|FG013|PART 2|Unclassified|0|||
146838247|NCT05131477|529578159|FG000|PART 2|Re-randomized and not treated|0|||
146838248|NCT05131477|529578160|FG001|PART 2|Re-randomized and not treated|0|||
146838249|NCT05131477|529578161|FG002|PART 2|Re-randomized and not treated|0|||
146838250|NCT05131477|529578162|FG003|PART 2|Re-randomized and not treated|0|||
146838251|NCT05131477|529578163|FG004|PART 2|Re-randomized and not treated|0|||
146838252|NCT05131477|529578164|FG005|PART 2|Re-randomized and not treated|0|||
146838253|NCT05131477|529578165|FG006|PART 2|Re-randomized and not treated|0|||
146838254|NCT05131477|529578166|FG007|PART 2|Re-randomized and not treated|1|||
146838255|NCT05131477|529578167|FG008|PART 2|Re-randomized and not treated|0|||
146838256|NCT05131477|529578168|FG009|PART 2|Re-randomized and not treated|0|||
146838257|NCT05131477|529578169|FG010|PART 2|Re-randomized and not treated|1|||
146838258|NCT05131477|529578170|FG011|PART 2|Re-randomized and not treated|0|||
146838259|NCT05131477|529578171|FG012|PART 2|Re-randomized and not treated|1|||
146838260|NCT05131477|529578172|FG013|PART 2|Re-randomized and not treated|1|||
146838261|NCT02194829|529578173|FG000|Overall Study|Adverse Event|2|||
146838262|NCT02194829|529578174|FG001|Overall Study|Adverse Event|2|||
146838263|NCT02194829|529578173|FG000|Overall Study|Death|0|||
146838264|NCT02194829|529578174|FG001|Overall Study|Death|1|||
146838265|NCT02194829|529578173|FG000|Overall Study|Disease progression|0|||
146838266|NCT02194829|529578174|FG001|Overall Study|Disease progression|1|||
146838267|NCT02194829|529578173|FG000|Overall Study|Withdrawal by Subject|0|||
146838268|NCT02194829|529578174|FG001|Overall Study|Withdrawal by Subject|1|||
146838269|NCT02194829|529578173|FG000|Overall Study|Never started protocol therapy|0|||
146838270|NCT02194829|529578174|FG001|Overall Study|Never started protocol therapy|1|||
146838271|NCT06840769|529578176|FG000|Overall Study|Withdrawal by Subject|1|||
146838272|NCT06840769|529578177|FG001|Overall Study|Withdrawal by Subject|0|||
146838273|NCT06840769|529578178|FG002|Overall Study|Withdrawal by Subject|0|||
146838274|NCT06840769|529578179|FG003|Overall Study|Withdrawal by Subject|0|||
146838275|NCT06840769|529578180|FG004|Overall Study|Withdrawal by Subject|0|||
146838276|NCT04497389|529580146|FG000|Overall Study|Withdrawal by Subject|1|||
146838277|NCT04497389|529580147|FG001|Overall Study|Withdrawal by Subject|0|||
146838278|NCT00789360|529580150|FG000|Overall Study|Protocol Violation|3|||
146838279|NCT00789360|529580151|FG001|Overall Study|Protocol Violation|1|||
146838280|NCT03559062|529580152|FG000|Overall Study|Other|0|||
146838281|NCT03559062|529580153|FG001|Overall Study|Other|1|||
146838282|NCT03559062|529580154|FG002|Overall Study|Other|0|||
146838283|NCT03322540|529580159|FG000|Overall Study|Death|21|||
146838284|NCT03322540|529580160|FG001|Overall Study|Death|28|||
146838285|NCT03322540|529580159|FG000|Overall Study|Lost to Follow-up|0|||
146838286|NCT03322540|529580160|FG001|Overall Study|Lost to Follow-up|1|||
146838287|NCT03322540|529580159|FG000|Overall Study|Physician Decision|7|||
146838288|NCT03322540|529580160|FG001|Overall Study|Physician Decision|6|||
146838289|NCT03322540|529580159|FG000|Overall Study|Withdrawal by Subject|3|||
146838290|NCT03322540|529580160|FG001|Overall Study|Withdrawal by Subject|1|||
146838291|NCT03322540|529580159|FG000|Overall Study|Study terminated by sponsor|0|||
146838292|NCT03322540|529580160|FG001|Overall Study|Study terminated by sponsor|1|||
146838293|NCT03445533|529580161|FG000|Overall Study|Progressive Disease|48|||
146838294|NCT03445533|529580162|FG001|Overall Study|Progressive Disease|81|||
146838295|NCT03445533|529580161|FG000|Overall Study|Adverse Event|60|||
146838296|NCT03445533|529580162|FG001|Overall Study|Adverse Event|64|||
146838297|NCT03445533|529580161|FG000|Overall Study|Death|9|||
146838298|NCT03445533|529580162|FG001|Overall Study|Death|19|||
146838299|NCT03445533|529580161|FG000|Overall Study|Miscellaneous|0|||
146838300|NCT03445533|529580162|FG001|Overall Study|Miscellaneous|16|||
146838301|NCT03445533|529580161|FG000|Overall Study|Withdrawal by Subject|3|||
146838302|NCT03445533|529580162|FG001|Overall Study|Withdrawal by Subject|4|||
146838303|NCT03445533|529580161|FG000|Overall Study|Physician Decision|1|||
146838304|NCT03445533|529580162|FG001|Overall Study|Physician Decision|3|||
146838305|NCT03445533|529580161|FG000|Overall Study|Sponsor Decision|0|||
146838306|NCT03445533|529580162|FG001|Overall Study|Sponsor Decision|1|||
146838307|NCT03445533|529580161|FG000|Overall Study|Lost to Follow-up|0|||
146838308|NCT03445533|529580162|FG001|Overall Study|Lost to Follow-up|1|||
146838309|NCT03445533|529580161|FG000|Overall Study|Never Received any Study Treatment|7|||
146838310|NCT03445533|529580162|FG001|Overall Study|Never Received any Study Treatment|4|||
146838311|NCT02615509|529580163|FG000|Overall Study|Lost to Follow-up|134|||
146838312|NCT02615509|529580163|FG000|Overall Study|Death|4|||
146838313|NCT02615509|529580163|FG000|Overall Study|Withdrawal by Subject|8|||
146838314|NCT03274453|529580164|FG000|Overall Study|Lost to Follow-up|2|||
146838315|NCT03274453|529580165|FG001|Overall Study|Lost to Follow-up|5|||
146838316|NCT03274453|529580166|FG002|Overall Study|Lost to Follow-up|4|||
146838317|NCT03274453|529580167|FG003|Overall Study|Lost to Follow-up|1|||
146838318|NCT03274453|529580164|FG000|Overall Study|Physician Decision|2|||
146838319|NCT03274453|529580165|FG001|Overall Study|Physician Decision|0|||
146838320|NCT03274453|529580166|FG002|Overall Study|Physician Decision|0|||
146838321|NCT03274453|529580167|FG003|Overall Study|Physician Decision|3|||
146838322|NCT03274453|529580164|FG000|Overall Study|Surgery Cancelled|0|||
146838323|NCT03274453|529580165|FG001|Overall Study|Surgery Cancelled|1|||
146838324|NCT03274453|529580166|FG002|Overall Study|Surgery Cancelled|0|||
146838325|NCT03274453|529580167|FG003|Overall Study|Surgery Cancelled|0|||
146838326|NCT00968526|529580169|FG000|Overall Study|Adverse Event|2|||
146838327|NCT00968526|529580170|FG001|Overall Study|Adverse Event|0|||
146838328|NCT00968526|529580169|FG000|Overall Study|Migrated/moved from study area|1|||
146838329|NCT00968526|529580170|FG001|Overall Study|Migrated/moved from study area|0|||
146838330|NCT03926195|529580173|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
146838331|NCT03926195|529580174|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
146838332|NCT03926195|529580173|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
146838333|NCT03926195|529580174|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
146838334|NCT03926195|529580173|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
146838335|NCT03926195|529580174|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
146838336|NCT03926195|529580173|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
146838337|NCT03926195|529580174|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
146838338|NCT03926195|529580173|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
146838339|NCT03926195|529580174|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
146838340|NCT03926195|529580173|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
146838341|NCT03926195|529580174|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
146838342|NCT01967069|529580176|FG000|Overall Study|Adverse Event|2|||
146838343|NCT01967069|529580177|FG001|Overall Study|Adverse Event|2|||
146838344|NCT01967069|529580176|FG000|Overall Study|Lost to Follow-up|5|||
146838345|NCT01967069|529580177|FG001|Overall Study|Lost to Follow-up|2|||
146838346|NCT01967069|529580176|FG000|Overall Study|Withdrawal by Subject|1|||
146838347|NCT01967069|529580177|FG001|Overall Study|Withdrawal by Subject|3|||
146838348|NCT01967069|529580176|FG000|Overall Study|Lack of Efficacy|0|||
146838349|NCT01967069|529580177|FG001|Overall Study|Lack of Efficacy|1|||
146838350|NCT01689857|529580179|FG000|Overall Study|Lost to Follow-up|5|||
146838351|NCT01689857|529580180|FG001|Overall Study|Lost to Follow-up|2|||
146838352|NCT00874731|529580182|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
146838353|NCT00874731|529580183|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
146838354|NCT00874731|529580184|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
146838355|NCT00874731|529580182|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
146838356|NCT00874731|529580183|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
146838357|NCT00874731|529580184|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
146838358|NCT00874731|529580182|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
146838359|NCT00874731|529580183|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
146838360|NCT00874731|529580184|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
146838361|NCT05105087|529580186|FG000|Overall Study|Withdrawal by Subject|2|||
146838362|NCT05105087|529580186|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
146838363|NCT01016262|529580187|FG000|Double-blind Phase|Adverse Event|0|||
146838364|NCT01016262|529580188|FG001|Double-blind Phase|Adverse Event|0|||
146838365|NCT01016262|529580189|FG002|Double-blind Phase|Adverse Event|1|||
146838366|NCT01016262|529580190|FG003|Double-blind Phase|Adverse Event|0|||
146838367|NCT01016262|529580191|FG004|Double-blind Phase|Adverse Event|0|||
146838368|NCT01016262|529580192|FG005|Double-blind Phase|Adverse Event|0|||
146990620|NCT00486837|530128713|FG001|Overall Study|Protocol Violation|2|||
146838369|NCT01016262|529580187|FG000|Double-blind Phase|Lack of Efficacy|1|||
146838370|NCT01016262|529580188|FG001|Double-blind Phase|Lack of Efficacy|0|||
146838371|NCT01016262|529580189|FG002|Double-blind Phase|Lack of Efficacy|5|||
146838372|NCT01016262|529580190|FG003|Double-blind Phase|Lack of Efficacy|0|||
146838373|NCT01016262|529580191|FG004|Double-blind Phase|Lack of Efficacy|0|||
146838374|NCT01016262|529580192|FG005|Double-blind Phase|Lack of Efficacy|0|||
146838375|NCT01016262|529580187|FG000|Double-blind Phase|Disease Progression|0|||
146838376|NCT01016262|529580188|FG001|Double-blind Phase|Disease Progression|1|||
146838377|NCT01016262|529580189|FG002|Double-blind Phase|Disease Progression|2|||
146838378|NCT01016262|529580190|FG003|Double-blind Phase|Disease Progression|0|||
146838379|NCT01016262|529580191|FG004|Double-blind Phase|Disease Progression|0|||
146838380|NCT01016262|529580192|FG005|Double-blind Phase|Disease Progression|0|||
146838381|NCT01016262|529580187|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
146838382|NCT01016262|529580188|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
146838383|NCT01016262|529580189|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
146838384|NCT01016262|529580190|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
146838385|NCT01016262|529580191|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
146838386|NCT01016262|529580192|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
146838387|NCT01016262|529580187|FG000|Open-Label Phase|Adverse Event|0|||
146838388|NCT01016262|529580188|FG001|Open-Label Phase|Adverse Event|0|||
146838389|NCT01016262|529580189|FG002|Open-Label Phase|Adverse Event|0|||
146838390|NCT01016262|529580190|FG003|Open-Label Phase|Adverse Event|1|||
146838391|NCT01016262|529580191|FG004|Open-Label Phase|Adverse Event|0|||
146838392|NCT01016262|529580192|FG005|Open-Label Phase|Adverse Event|0|||
146838393|NCT01016262|529580187|FG000|Open-Label Phase|Lost to Follow-up|0|||
146838394|NCT01016262|529580188|FG001|Open-Label Phase|Lost to Follow-up|0|||
146838395|NCT01016262|529580189|FG002|Open-Label Phase|Lost to Follow-up|0|||
146838396|NCT01016262|529580190|FG003|Open-Label Phase|Lost to Follow-up|0|||
146838397|NCT01016262|529580191|FG004|Open-Label Phase|Lost to Follow-up|1|||
146838398|NCT01016262|529580192|FG005|Open-Label Phase|Lost to Follow-up|0|||
146838399|NCT01016262|529580187|FG000|Open-Label Phase|Lack of Efficacy|0|||
146838400|NCT01016262|529580188|FG001|Open-Label Phase|Lack of Efficacy|0|||
146838401|NCT01016262|529580189|FG002|Open-Label Phase|Lack of Efficacy|0|||
146838402|NCT01016262|529580190|FG003|Open-Label Phase|Lack of Efficacy|1|||
146838403|NCT01016262|529580191|FG004|Open-Label Phase|Lack of Efficacy|0|||
146838404|NCT01016262|529580192|FG005|Open-Label Phase|Lack of Efficacy|0|||
146838405|NCT01016262|529580187|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
146838406|NCT01016262|529580188|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
146838407|NCT01016262|529580189|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
146838408|NCT01016262|529580190|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
146838409|NCT01016262|529580191|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
146838410|NCT01016262|529580192|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
146838411|NCT01730378|529580193|FG000|Overall Study|Lost to Follow-up|1|||
146838412|NCT01730378|529580194|FG001|Overall Study|Lost to Follow-up|0|||
146838413|NCT03199469|529580195|FG000|Overall Study|Randomized, not treated|0|||
146838414|NCT03199469|529580196|FG001|Overall Study|Randomized, not treated|3|||
146838415|NCT03199469|529580195|FG000|Overall Study|Withdrawal by Subject|1|||
146838416|NCT03199469|529580196|FG001|Overall Study|Withdrawal by Subject|0|||
146838417|NCT03199469|529580195|FG000|Overall Study|Death|1|||
146838418|NCT03199469|529580196|FG001|Overall Study|Death|3|||
146838419|NCT03199469|529580195|FG000|Overall Study|Ongoing|5|||
146838420|NCT03199469|529580196|FG001|Overall Study|Ongoing|14|||
146838421|NCT01023958|529580201|FG000|Overall Study|Progressive disease|48|||
146838422|NCT01023958|529580201|FG000|Overall Study|Other adverse event|1|||
146838423|NCT01023958|529580201|FG000|Overall Study|Refused to continue medication|1|||
146838424|NCT01031628|529580202|FG000|Overall Study|Study terminated early|0|||
146838425|NCT01031628|529580203|FG001|Overall Study|Study terminated early|1|||
146838426|NCT01031628|529580204|FG002|Overall Study|Study terminated early|3|||
146838427|NCT01031628|529580205|FG003|Overall Study|Study terminated early|0|||
146838428|NCT03080493|529580206|FG000|Overall Study|Did not provide NRS pain results|1|||
146838429|NCT03080493|529580207|FG001|Overall Study|Did not provide NRS pain results|0|||
146838430|NCT03080493|529580206|FG000|Overall Study|Adverse Event|0|||
146838431|NCT03080493|529580207|FG001|Overall Study|Adverse Event|1|||
146838432|NCT03080493|529580206|FG000|Overall Study|Randomization error (parity group)|0|||
146838433|NCT03080493|529580207|FG001|Overall Study|Randomization error (parity group)|1|||
146838434|NCT00755417|529580210|FG000|Overall Study|Adverse Event|28|||
146838435|NCT00755417|529580211|FG001|Overall Study|Adverse Event|20|||
146838436|NCT00755417|529580212|FG002|Overall Study|Adverse Event|7|||
146838437|NCT00755417|529580210|FG000|Overall Study|Lack of Efficacy|8|||
146990621|NCT00486837|530128712|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
146838438|NCT00755417|529580211|FG001|Overall Study|Lack of Efficacy|4|||
146838439|NCT00755417|529580212|FG002|Overall Study|Lack of Efficacy|9|||
146838440|NCT00755417|529580210|FG000|Overall Study|Protocol Violation|2|||
146838441|NCT00755417|529580211|FG001|Overall Study|Protocol Violation|1|||
146838442|NCT00755417|529580212|FG002|Overall Study|Protocol Violation|1|||
146838443|NCT00755417|529580210|FG000|Overall Study|Lost to Follow-up|3|||
146838444|NCT00755417|529580211|FG001|Overall Study|Lost to Follow-up|0|||
146838445|NCT00755417|529580212|FG002|Overall Study|Lost to Follow-up|1|||
146838446|NCT00755417|529580210|FG000|Overall Study|Withdrawal by Subject|12|||
146838447|NCT00755417|529580211|FG001|Overall Study|Withdrawal by Subject|12|||
146838448|NCT00755417|529580212|FG002|Overall Study|Withdrawal by Subject|12|||
146838449|NCT00755417|529580210|FG000|Overall Study|Not specified or missing data|9|||
146838450|NCT00755417|529580211|FG001|Overall Study|Not specified or missing data|18|||
146838451|NCT00755417|529580212|FG002|Overall Study|Not specified or missing data|12|||
146838452|NCT02362503|529580213|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
146838453|NCT02362503|529580214|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
146838454|NCT02362503|529580215|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
146838455|NCT02362503|529580213|FG000|Double-blind Period-Up to 8 Days|Death|1|||
146838456|NCT02362503|529580214|FG001|Double-blind Period-Up to 8 Days|Death|0|||
146838457|NCT02362503|529580215|FG002|Double-blind Period-Up to 8 Days|Death|0|||
146838458|NCT02362503|529580213|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
146838459|NCT02362503|529580214|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
146838460|NCT02362503|529580215|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
146838461|NCT02362503|529580213|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
146838462|NCT02362503|529580214|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
146838463|NCT02362503|529580215|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
146838464|NCT02362503|529580213|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
146838465|NCT02362503|529580214|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
146838466|NCT02362503|529580215|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
146838467|NCT02362503|529580213|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
146838468|NCT02362503|529580214|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
146838469|NCT02362503|529580215|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
146838470|NCT02362503|529580213|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
146838471|NCT02362503|529580214|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
146838472|NCT02362503|529580215|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
146838473|NCT02362503|529580213|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
146838474|NCT02362503|529580214|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
146838475|NCT02362503|529580215|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
146838476|NCT02362503|529580213|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
146838477|NCT02362503|529580214|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
146838478|NCT02362503|529580215|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
146838479|NCT02362503|529580213|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
146838480|NCT02362503|529580214|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
146838481|NCT02362503|529580215|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
146838482|NCT02362503|529580213|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
146838483|NCT02362503|529580214|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
146838484|NCT02362503|529580215|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
146838485|NCT02362503|529580213|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
146838486|NCT02362503|529580214|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
146838487|NCT02362503|529580215|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
146838488|NCT02362503|529580213|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
146838489|NCT02362503|529580214|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
146838490|NCT02362503|529580215|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
146838491|NCT02362503|529580213|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
146838492|NCT02362503|529580214|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
146838493|NCT02362503|529580215|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
146838494|NCT02803593|529580216|FG000|Overall Study|Lost to Follow-up|17|||
146838495|NCT02803593|529580217|FG001|Overall Study|Lost to Follow-up|35|||
146838496|NCT05143138|529580218|FG000|Overall Study|Death|5|||
146838497|NCT05143138|529580219|FG001|Overall Study|Death|35|||
146838498|NCT05143138|529580220|FG002|Overall Study|Death|1|||
146838499|NCT05143138|529580218|FG000|Overall Study|Lost to Follow-up|2|||
146838500|NCT05143138|529580219|FG001|Overall Study|Lost to Follow-up|4|||
146838501|NCT05143138|529580220|FG002|Overall Study|Lost to Follow-up|0|||
146838502|NCT05143138|529580218|FG000|Overall Study|withdrawal|1|||
146838503|NCT05143138|529580219|FG001|Overall Study|withdrawal|1|||
146838504|NCT05143138|529580220|FG002|Overall Study|withdrawal|0|||
146838505|NCT04245345|529580231|FG000|Overall Study|Death|1|||
146838506|NCT04245345|529580231|FG000|Overall Study|Exited prior to implant|5|||
146838507|NCT04245345|529580231|FG000|Overall Study|Exited prior to 1-month|9|||
146838508|NCT04245345|529580231|FG000|Overall Study|Missed 1-month visit|3|||
146838509|NCT04245345|529580231|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
146838510|NCT04245345|529580231|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
146838511|NCT01834586|529580232|FG000|Overall Study|Adverse Event|1|||
146838512|NCT03443414|529580233|FG000|Overall Study|Adverse Event|6|||
146838513|NCT03443414|529580234|FG001|Overall Study|Adverse Event|0|||
146838514|NCT03443414|529580235|FG002|Overall Study|Adverse Event|4|||
146838515|NCT03443414|529580236|FG003|Overall Study|Adverse Event|2|||
146838516|NCT03443414|529580237|FG004|Overall Study|Adverse Event|3|||
146838517|NCT03443414|529580233|FG000|Overall Study|Withdrawal by Subject|3|||
146838518|NCT03443414|529580234|FG001|Overall Study|Withdrawal by Subject|2|||
146838519|NCT03443414|529580235|FG002|Overall Study|Withdrawal by Subject|2|||
146838520|NCT03443414|529580236|FG003|Overall Study|Withdrawal by Subject|2|||
146838521|NCT03443414|529580237|FG004|Overall Study|Withdrawal by Subject|1|||
146838522|NCT03443414|529580233|FG000|Overall Study|Death|0|||
146838523|NCT03443414|529580234|FG001|Overall Study|Death|1|||
146838524|NCT03443414|529580235|FG002|Overall Study|Death|0|||
146838525|NCT03443414|529580236|FG003|Overall Study|Death|1|||
146838526|NCT03443414|529580237|FG004|Overall Study|Death|0|||
146838527|NCT03443414|529580233|FG000|Overall Study|Reason not specified|2|||
146838528|NCT03443414|529580234|FG001|Overall Study|Reason not specified|0|||
146838529|NCT03443414|529580235|FG002|Overall Study|Reason not specified|0|||
146838530|NCT03443414|529580236|FG003|Overall Study|Reason not specified|0|||
146838531|NCT03443414|529580237|FG004|Overall Study|Reason not specified|1|||
146838532|NCT03325777|529580238|FG000|Overall Study|Lost to Follow-up|9|||
146838533|NCT03325777|529580239|FG001|Overall Study|Lost to Follow-up|12|||
146838534|NCT04210843|529580241|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
146838535|NCT04210843|529580242|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
146838536|NCT04210843|529580241|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
146838537|NCT04210843|529580242|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
146838538|NCT04210843|529580241|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
146838539|NCT04210843|529580242|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
146838540|NCT04210843|529580241|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
146838541|NCT04210843|529580242|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
146838542|NCT04210843|529580241|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
146838543|NCT04210843|529580242|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
146838544|NCT04210843|529580241|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
146838545|NCT04210843|529580242|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
146838546|NCT04210843|529580241|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
146838547|NCT04210843|529580242|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
146838548|NCT04210843|529580241|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
146838549|NCT04210843|529580242|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
146838550|NCT04210843|529580241|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
146838551|NCT04210843|529580242|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
146838552|NCT04210843|529580241|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
146838553|NCT04210843|529580242|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
146838554|NCT04210843|529580241|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
146838555|NCT04210843|529580242|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
146838556|NCT04210843|529580241|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
146838557|NCT04210843|529580242|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
146838558|NCT04210843|529580241|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
146838559|NCT04210843|529580242|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
146838560|NCT04210843|529580241|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
146838561|NCT04210843|529580242|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
146838562|NCT04210843|529580241|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
146838563|NCT04210843|529580242|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
146838564|NCT04210843|529580241|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
146838565|NCT04210843|529580242|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
146838566|NCT04210843|529580241|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
146838567|NCT04210843|529580242|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
146838568|NCT04210843|529580241|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
146838569|NCT04210843|529580242|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
146838570|NCT04210843|529580241|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
146838571|NCT04210843|529580242|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
146838572|NCT04210843|529580241|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
146838573|NCT04210843|529580242|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
146838574|NCT04210843|529580241|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
146838575|NCT04210843|529580242|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
146838576|NCT04210843|529580241|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
146838577|NCT04210843|529580242|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
146838578|NCT04210843|529580241|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
146838579|NCT04210843|529580242|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
146838580|NCT04210843|529580241|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
146838581|NCT04210843|529580242|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
146838582|NCT01099917|529580243|FG000|Overall Study|Adverse Event|3|||
146838583|NCT01099917|529580243|FG000|Overall Study|Not Treated|24|||
146838584|NCT01485120|529580246|FG000|Overall Study|Withdrawal by Subject|2|||
146838585|NCT00422734|529580247|FG000|Overall Study|Physician Decision|1|||
146838586|NCT00422734|529580248|FG001|Overall Study|Physician Decision|1|||
146838587|NCT00422734|529580247|FG000|Overall Study|Protocol Violation|1|||
146838588|NCT00422734|529580248|FG001|Overall Study|Protocol Violation|6|||
146838589|NCT00422734|529580247|FG000|Overall Study|Withdrawal by Subject|12|||
146838590|NCT00422734|529580248|FG001|Overall Study|Withdrawal by Subject|8|||
146838591|NCT00422734|529580247|FG000|Overall Study|Adverse Event|0|||
146838592|NCT00422734|529580248|FG001|Overall Study|Adverse Event|3|||
146838593|NCT00422734|529580247|FG000|Overall Study|Partner Decision|0|||
146838594|NCT00422734|529580248|FG001|Overall Study|Partner Decision|3|||
146838595|NCT02344342|529580249|FG000|Overall Study|Industry partner dropped out|11|||
146838596|NCT02344342|529580250|FG001|Overall Study|Industry partner dropped out|9|||
146838597|NCT02344342|529580251|FG002|Overall Study|Industry partner dropped out|14|||
146838598|NCT02344342|529580252|FG003|Overall Study|Industry partner dropped out|10|||
146838599|NCT00848484|529580253|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
146838600|NCT00848484|529580254|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
146838601|NCT00848484|529580253|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
146838602|NCT00848484|529580254|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
146838603|NCT00848484|529580253|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
146838604|NCT00848484|529580254|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
146838605|NCT00848484|529580253|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
146838606|NCT00848484|529580254|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
146838607|NCT00848484|529580253|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
146838608|NCT00848484|529580254|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
146838609|NCT01081886|529580258|FG000|Overall Study|Study termination|11|||
146838610|NCT01081886|529580259|FG001|Overall Study|Study termination|13|||
146838611|NCT03355209|529580260|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
146838612|NCT03355209|529580261|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
146838613|NCT03355209|529580262|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
146838614|NCT03355209|529580263|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
146838615|NCT03355209|529580264|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
146838616|NCT03355209|529580265|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
146838617|NCT03355209|529580260|FG000|Part 1: Double-Blind Period|Death|0|||
146838618|NCT03355209|529580261|FG001|Part 1: Double-Blind Period|Death|0|||
146838619|NCT03355209|529580262|FG002|Part 1: Double-Blind Period|Death|1|||
146838620|NCT03355209|529580263|FG003|Part 1: Double-Blind Period|Death|0|||
146838621|NCT03355209|529580264|FG004|Part 1: Double-Blind Period|Death|0|||
146838622|NCT03355209|529580265|FG005|Part 1: Double-Blind Period|Death|0|||
146838623|NCT03355209|529580260|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
146838624|NCT03355209|529580261|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
146838625|NCT03355209|529580262|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
146838626|NCT03355209|529580263|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
146838627|NCT03355209|529580264|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
146838628|NCT03355209|529580265|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
146838629|NCT03355209|529580260|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
146838630|NCT03355209|529580261|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
146838631|NCT03355209|529580262|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
146838632|NCT03355209|529580263|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
146838633|NCT03355209|529580264|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
146838634|NCT03355209|529580265|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
146838635|NCT03355209|529580260|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
146838636|NCT03355209|529580261|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
146838637|NCT03355209|529580262|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
146838638|NCT03355209|529580263|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
146838639|NCT03355209|529580264|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
146838640|NCT03355209|529580265|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
146838641|NCT03355209|529580260|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
146838642|NCT03355209|529580261|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
146838643|NCT03355209|529580262|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
146838644|NCT03355209|529580263|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
146838645|NCT03355209|529580264|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
146838646|NCT03355209|529580265|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
146838647|NCT03355209|529580260|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
146838648|NCT03355209|529580261|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
146838649|NCT03355209|529580262|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
146838650|NCT03355209|529580263|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
146838651|NCT03355209|529580264|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
146838652|NCT03355209|529580265|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
146838653|NCT03355209|529580260|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
146838654|NCT03355209|529580261|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
146838655|NCT03355209|529580262|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
146838656|NCT03355209|529580263|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
146990622|NCT00486837|530128713|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
146990623|NCT02468778|530128714|FG000|Overall Study|Death|2|||
146990624|NCT02468778|530128715|FG001|Overall Study|Death|1|||
146990625|NCT02468778|530128716|FG002|Overall Study|Death|0|||
146990626|NCT02468778|530128714|FG000|Overall Study|Lost to Follow-up|1|||
146990627|NCT02468778|530128715|FG001|Overall Study|Lost to Follow-up|2|||
146838657|NCT03355209|529580264|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
146838658|NCT03355209|529580265|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
146838659|NCT03355209|529580260|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
146838660|NCT03355209|529580261|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
146838661|NCT03355209|529580262|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
146838662|NCT03355209|529580263|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
146838663|NCT03355209|529580264|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
146838664|NCT03355209|529580265|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
146838665|NCT03355209|529580260|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
146838666|NCT03355209|529580261|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
146838667|NCT03355209|529580262|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
146838668|NCT03355209|529580263|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
146838669|NCT03355209|529580264|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
146838670|NCT03355209|529580265|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
146838671|NCT03355209|529580260|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
146838672|NCT03355209|529580261|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
146838673|NCT03355209|529580262|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
146838674|NCT03355209|529580263|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
146838675|NCT03355209|529580264|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
146838676|NCT03355209|529580265|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
146838677|NCT02567708|529580266|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
146838678|NCT02567708|529580267|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
146838679|NCT02567708|529580266|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
146838680|NCT02567708|529580267|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
146838681|NCT02567708|529580266|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
146838682|NCT02567708|529580267|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
146838683|NCT02567708|529580266|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
146838684|NCT02567708|529580267|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
146838685|NCT00706654|529580268|FG000|Conversion Phase|Lost to Follow-up|4|||
146838686|NCT00706654|529580269|FG001|Conversion Phase|Lost to Follow-up|0|||
146838687|NCT00706654|529580270|FG002|Conversion Phase|Lost to Follow-up|0|||
146838688|NCT00706654|529580271|FG003|Conversion Phase|Lost to Follow-up|0|||
146838689|NCT00706654|529580268|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
146838690|NCT00706654|529580269|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
146838691|NCT00706654|529580270|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
146838692|NCT00706654|529580271|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
146838693|NCT00706654|529580268|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
146838694|NCT00706654|529580269|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
146838695|NCT00706654|529580270|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
146838696|NCT00706654|529580271|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
146838697|NCT00706654|529580268|FG000|Conversion Phase|Withdrawn by Investigator|14|||
146838698|NCT00706654|529580269|FG001|Conversion Phase|Withdrawn by Investigator|0|||
146838699|NCT00706654|529580270|FG002|Conversion Phase|Withdrawn by Investigator|0|||
146838700|NCT00706654|529580271|FG003|Conversion Phase|Withdrawn by Investigator|0|||
146838701|NCT00706654|529580268|FG000|Conversion Phase|Withdrew Consent|38|||
146838702|NCT00706654|529580269|FG001|Conversion Phase|Withdrew Consent|0|||
146838703|NCT00706654|529580270|FG002|Conversion Phase|Withdrew Consent|0|||
146838704|NCT00706654|529580271|FG003|Conversion Phase|Withdrew Consent|0|||
146838705|NCT00706654|529580268|FG000|Conversion Phase|Adverse Event|18|||
146838706|NCT00706654|529580269|FG001|Conversion Phase|Adverse Event|0|||
146838707|NCT00706654|529580270|FG002|Conversion Phase|Adverse Event|0|||
146838708|NCT00706654|529580271|FG003|Conversion Phase|Adverse Event|0|||
146838709|NCT00706654|529580268|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
146838710|NCT00706654|529580269|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
146838711|NCT00706654|529580270|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
146838712|NCT00706654|529580271|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
146838713|NCT00706654|529580268|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
146838714|NCT00706654|529580269|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
146838715|NCT00706654|529580270|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
146838716|NCT00706654|529580271|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
146838717|NCT00706654|529580268|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
146838718|NCT00706654|529580269|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
146838719|NCT00706654|529580270|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
146838720|NCT00706654|529580271|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
146838721|NCT00706654|529580268|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
146838722|NCT00706654|529580269|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
146838723|NCT00706654|529580270|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
146838724|NCT00706654|529580271|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
146838725|NCT00706654|529580268|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
146838726|NCT00706654|529580269|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
146838727|NCT00706654|529580270|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
146838728|NCT00706654|529580271|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
146838729|NCT00706654|529580268|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
146838730|NCT00706654|529580269|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
146838731|NCT00706654|529580270|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
146838732|NCT00706654|529580271|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
146838733|NCT00706654|529580268|FG000|Oral Stabilization Phase|Withdrew consent|55|||
146838734|NCT00706654|529580269|FG001|Oral Stabilization Phase|Withdrew consent|0|||
146838735|NCT00706654|529580270|FG002|Oral Stabilization Phase|Withdrew consent|0|||
146838736|NCT00706654|529580271|FG003|Oral Stabilization Phase|Withdrew consent|0|||
146838737|NCT00706654|529580268|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
146838738|NCT00706654|529580269|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
146838739|NCT00706654|529580270|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
146838740|NCT00706654|529580271|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
146838741|NCT00706654|529580268|FG000|Oral Stabilization Phase|Adverse Event|21|||
146838742|NCT00706654|529580269|FG001|Oral Stabilization Phase|Adverse Event|0|||
146838743|NCT00706654|529580270|FG002|Oral Stabilization Phase|Adverse Event|0|||
146838744|NCT00706654|529580271|FG003|Oral Stabilization Phase|Adverse Event|0|||
146838745|NCT00706654|529580268|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
146838746|NCT00706654|529580269|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
146838747|NCT00706654|529580270|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
146838748|NCT00706654|529580271|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
146838749|NCT00706654|529580268|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
146838750|NCT00706654|529580269|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
146838751|NCT00706654|529580270|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
146838752|NCT00706654|529580271|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
146838753|NCT00706654|529580268|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
146838754|NCT00706654|529580269|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
146838755|NCT00706654|529580270|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
146838756|NCT00706654|529580271|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
146838757|NCT00706654|529580268|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
146838758|NCT00706654|529580269|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
146838759|NCT00706654|529580270|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
146838760|NCT00706654|529580271|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
146838761|NCT00706654|529580268|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
146838762|NCT00706654|529580269|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
146838763|NCT00706654|529580270|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
146838764|NCT00706654|529580271|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
146838765|NCT00706654|529580268|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
146838766|NCT00706654|529580269|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
146838767|NCT00706654|529580270|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
146838768|NCT00706654|529580271|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
146838769|NCT00706654|529580268|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
146838770|NCT00706654|529580269|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
146838771|NCT00706654|529580270|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
146838772|NCT00706654|529580271|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
146838773|NCT00706654|529580268|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
146838774|NCT00706654|529580269|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
146838775|NCT00706654|529580270|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
146838776|NCT00706654|529580271|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
146838777|NCT00706654|529580268|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
146838778|NCT00706654|529580269|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
146838779|NCT00706654|529580270|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
146838780|NCT00706654|529580271|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
146838781|NCT00706654|529580268|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
146838782|NCT00706654|529580269|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
146838783|NCT00706654|529580270|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
146838784|NCT00706654|529580271|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
146838785|NCT05262751|529580273|FG000|Washout Period 2|Adverse Event|1|||
146838786|NCT05262751|529580274|FG001|Washout Period 2|Adverse Event|0|||
146838787|NCT05262751|529580275|FG002|Washout Period 2|Adverse Event|0|||
146838788|NCT05262751|529580276|FG003|Washout Period 2|Adverse Event|0|||
146990628|NCT02468778|530128716|FG002|Overall Study|Lost to Follow-up|2|||
146990629|NCT02468778|530128714|FG000|Overall Study|Withdrawal by Subject|0|||
146990630|NCT02468778|530128715|FG001|Overall Study|Withdrawal by Subject|1|||
146990631|NCT02468778|530128716|FG002|Overall Study|Withdrawal by Subject|1|||
146838789|NCT05262751|529580277|FG004|Washout Period 2|Adverse Event|0|||
146838790|NCT05262751|529580278|FG005|Washout Period 2|Adverse Event|0|||
146838791|NCT05262751|529580273|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
146838792|NCT05262751|529580274|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
146838793|NCT05262751|529580275|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
146838794|NCT05262751|529580276|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
146838795|NCT05262751|529580277|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
146838796|NCT05262751|529580278|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
146838797|NCT01154140|529580280|FG000|Overall Study|Death|71|||
146838798|NCT01154140|529580281|FG001|Overall Study|Death|81|||
146838799|NCT01154140|529580280|FG000|Overall Study|Lost to Follow-up|4|||
146838800|NCT01154140|529580281|FG001|Overall Study|Lost to Follow-up|5|||
146838801|NCT01154140|529580280|FG000|Overall Study|Withdrawal by Subject|12|||
146838802|NCT01154140|529580281|FG001|Overall Study|Withdrawal by Subject|13|||
146838803|NCT01154140|529580280|FG000|Overall Study|Other|3|||
146838804|NCT01154140|529580281|FG001|Overall Study|Other|1|||
146838805|NCT01154140|529580280|FG000|Overall Study|Randomized but not treated|1|||
146838806|NCT01154140|529580281|FG001|Overall Study|Randomized but not treated|2|||
146838807|NCT04276051|529580284|FG000|Overall Study|Lost to Follow-up|0|||
146838808|NCT04276051|529580285|FG001|Overall Study|Lost to Follow-up|1|||
146838809|NCT04276051|529580284|FG000|Overall Study|Physician Decision|0|||
146838810|NCT04276051|529580285|FG001|Overall Study|Physician Decision|1|||
146838811|NCT04276051|529580284|FG000|Overall Study|Withdrawal by Subject|1|||
146838812|NCT04276051|529580285|FG001|Overall Study|Withdrawal by Subject|1|||
146838813|NCT01912404|529580286|FG000|Overall Study|Due to personal reasons|1|||
146838814|NCT01912404|529580287|FG001|Overall Study|Due to personal reasons|0|||
146838815|NCT01754753|529580288|FG000|Overall Study|Study close|43|||
146838816|NCT01754753|529580289|FG001|Overall Study|Study close|44|||
146838817|NCT01754753|529580288|FG000|Overall Study|Lost to Follow-up|9|||
146838818|NCT01754753|529580289|FG001|Overall Study|Lost to Follow-up|5|||
146838819|NCT00760747|529580297|FG000|Study Period II|Adverse Event|3|||
146838820|NCT00760747|529580298|FG001|Study Period II|Adverse Event|4|||
146838821|NCT00760747|529580297|FG000|Study Period II|Lack of Efficacy|0|||
146838822|NCT00760747|529580298|FG001|Study Period II|Lack of Efficacy|6|||
146838823|NCT00760747|529580297|FG000|Study Period II|Parent/Caregiver Decision|3|||
146838824|NCT00760747|529580298|FG001|Study Period II|Parent/Caregiver Decision|0|||
146838825|NCT00760747|529580297|FG000|Study Period II|Protocol Violation|6|||
146838826|NCT00760747|529580298|FG001|Study Period II|Protocol Violation|3|||
146838827|NCT00760747|529580297|FG000|Study Period II|Withdrawal by Subject|1|||
146838828|NCT00760747|529580298|FG001|Study Period II|Withdrawal by Subject|0|||
146838829|NCT00760747|529580297|FG000|Study Period II|No drug administered|0|||
146838830|NCT00760747|529580298|FG001|Study Period II|No drug administered|1|||
146838831|NCT00760747|529580297|FG000|Study Period III|Adverse Event|1|||
146838832|NCT00760747|529580298|FG001|Study Period III|Adverse Event|0|||
146838833|NCT00760747|529580297|FG000|Study Period III|Lack of Efficacy|1|||
146838834|NCT00760747|529580298|FG001|Study Period III|Lack of Efficacy|0|||
146838835|NCT00760747|529580297|FG000|Study Period III|Parent/Caregiver Decision|0|||
146838836|NCT00760747|529580298|FG001|Study Period III|Parent/Caregiver Decision|1|||
146838837|NCT00760747|529580297|FG000|Study Period III|Protocol Violation|1|||
146838838|NCT00760747|529580298|FG001|Study Period III|Protocol Violation|1|||
146838839|NCT00760747|529580297|FG000|Study Period III|Physician Decision|0|||
146838840|NCT00760747|529580298|FG001|Study Period III|Physician Decision|1|||
146838841|NCT00844597|529580299|FG000|Overall Study|Adverse Event|0|||
146838842|NCT00844597|529580300|FG001|Overall Study|Adverse Event|0|||
146838843|NCT00844597|529580301|FG002|Overall Study|Adverse Event|0|||
146838844|NCT00844597|529580302|FG003|Overall Study|Adverse Event|1|||
146838845|NCT00844597|529580303|FG004|Overall Study|Adverse Event|0|||
146838846|NCT00844597|529580304|FG005|Overall Study|Adverse Event|0|||
146838847|NCT00455741|529580307|FG000|Overall Study|Physician Decision|0|||
146838848|NCT00455741|529580308|FG001|Overall Study|Physician Decision|1|||
146838849|NCT00243074|529580310|FG000|Overall Study|Ineligible|6|||
146838850|NCT00243074|529580310|FG000|Overall Study|Adverse Event|6|||
146838851|NCT00243074|529580310|FG000|Overall Study|Withdrawal by Subject|2|||
146838852|NCT00243074|529580310|FG000|Overall Study|Lack of Efficacy|36|||
146838853|NCT00243074|529580310|FG000|Overall Study|Death|2|||
146838854|NCT00243074|529580310|FG000|Overall Study|not protocol specified|1|||
146838855|NCT00243074|529580310|FG000|Overall Study|Did not receive any treatment|1|||
146838856|NCT00475228|529580311|FG000|Overall Study|Lost to Follow-up|17|||
146838857|NCT00475228|529580312|FG001|Overall Study|Lost to Follow-up|17|||
146838858|NCT02209181|529580313|FG000|Overall Study|Adverse Event|1|||
146838859|NCT02209181|529580314|FG001|Overall Study|Adverse Event|0|||
146838860|NCT02209181|529580315|FG002|Overall Study|Adverse Event|1|||
146838861|NCT02209181|529580316|FG003|Overall Study|Adverse Event|0|||
146838862|NCT02209181|529580313|FG000|Overall Study|Withdrawal by Subject|0|||
146838863|NCT02209181|529580314|FG001|Overall Study|Withdrawal by Subject|1|||
146990632|NCT00414765|530128717|FG000|Overall Study|Adverse Event|5|||
146838864|NCT02209181|529580315|FG002|Overall Study|Withdrawal by Subject|0|||
146838865|NCT02209181|529580316|FG003|Overall Study|Withdrawal by Subject|0|||
146838866|NCT02579772|529580317|FG000|Overall Study|Withdrawal by Subject|0|||
146838867|NCT02579772|529580318|FG001|Overall Study|Withdrawal by Subject|1|||
146838868|NCT02579772|529580317|FG000|Overall Study|Usage of additional antioxidants|1|||
146838869|NCT02579772|529580318|FG001|Overall Study|Usage of additional antioxidants|0|||
146838870|NCT02579772|529580317|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
146838871|NCT02579772|529580318|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
146838872|NCT00862836|529580320|FG000|Overall Study|Withdrawal by Subject|1|||
146838873|NCT04463680|529580323|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
146838874|NCT04463680|529580323|FG000|Overall Study|Not eligible due to implant duration of use|1|||
146838875|NCT04463680|529580323|FG000|Overall Study|Withdrawal by Subject|3|||
146838876|NCT02592707|529580324|FG000|Overall Study|Consent Withdrawn|0|||
146838877|NCT02592707|529580325|FG001|Overall Study|Consent Withdrawn|1|||
146838878|NCT02592707|529580326|FG002|Overall Study|Consent Withdrawn|2|||
146838879|NCT02592707|529580327|FG003|Overall Study|Consent Withdrawn|0|||
146838880|NCT02592707|529580324|FG000|Overall Study|Death|1|||
146838881|NCT02592707|529580325|FG001|Overall Study|Death|0|||
146838882|NCT02592707|529580326|FG002|Overall Study|Death|0|||
146838883|NCT02592707|529580327|FG003|Overall Study|Death|0|||
146838884|NCT02592707|529580324|FG000|Overall Study|Progressive Disease|4|||
146838885|NCT02592707|529580325|FG001|Overall Study|Progressive Disease|4|||
146838886|NCT02592707|529580326|FG002|Overall Study|Progressive Disease|3|||
146838887|NCT02592707|529580327|FG003|Overall Study|Progressive Disease|3|||
146838888|NCT02592707|529580324|FG000|Overall Study|Other|0|||
146838889|NCT02592707|529580325|FG001|Overall Study|Other|0|||
146838890|NCT02592707|529580326|FG002|Overall Study|Other|1|||
146838891|NCT02592707|529580327|FG003|Overall Study|Other|2|||
146838892|NCT02592707|529580324|FG000|Overall Study|Never entered LTFU period|1|||
146838893|NCT02592707|529580325|FG001|Overall Study|Never entered LTFU period|0|||
146838894|NCT02592707|529580326|FG002|Overall Study|Never entered LTFU period|0|||
146838895|NCT02592707|529580327|FG003|Overall Study|Never entered LTFU period|2|||
146838896|NCT02412735|529582260|FG000|Overall Study|Adverse Event|0|||
146838897|NCT02412735|529582261|FG001|Overall Study|Adverse Event|1|||
146838898|NCT02412735|529582262|FG002|Overall Study|Adverse Event|2|||
146838899|NCT02412735|529582260|FG000|Overall Study|Withdrawal by Subject|23|||
146838900|NCT02412735|529582261|FG001|Overall Study|Withdrawal by Subject|27|||
146838901|NCT02412735|529582262|FG002|Overall Study|Withdrawal by Subject|22|||
146838902|NCT02412735|529582260|FG000|Overall Study|Investigator Decision|3|||
146838903|NCT02412735|529582261|FG001|Overall Study|Investigator Decision|3|||
146838904|NCT02412735|529582262|FG002|Overall Study|Investigator Decision|2|||
146838905|NCT02412735|529582260|FG000|Overall Study|Lost to Follow-up|17|||
146838906|NCT02412735|529582261|FG001|Overall Study|Lost to Follow-up|11|||
146838907|NCT02412735|529582262|FG002|Overall Study|Lost to Follow-up|18|||
146838908|NCT02412735|529582260|FG000|Overall Study|Reason not Specified|3|||
146838909|NCT02412735|529582261|FG001|Overall Study|Reason not Specified|2|||
146838910|NCT02412735|529582262|FG002|Overall Study|Reason not Specified|2|||
146838911|NCT01228318|529582263|FG000|Overall Study|Clinic no show to receive intervention|1|||
146838912|NCT01228318|529582264|FG001|Overall Study|Clinic no show to receive intervention|0|||
146838913|NCT01228318|529582263|FG000|Overall Study|Unable to contact|2|||
146838914|NCT01228318|529582264|FG001|Overall Study|Unable to contact|5|||
146838915|NCT01228318|529582263|FG000|Overall Study|Moved|0|||
146838916|NCT01228318|529582264|FG001|Overall Study|Moved|2|||
146838917|NCT01228318|529582263|FG000|Overall Study|Incarcerated|1|||
146838918|NCT01228318|529582264|FG001|Overall Study|Incarcerated|0|||
146838919|NCT00603525|529582269|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
146838920|NCT00603525|529582270|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
146838921|NCT00603525|529582271|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
146838922|NCT00603525|529582269|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
146838923|NCT00603525|529582270|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
146838924|NCT00603525|529582271|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
146838925|NCT00603525|529582269|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
146838926|NCT00603525|529582270|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
146838927|NCT00603525|529582271|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
146838928|NCT00603525|529582269|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146838929|NCT00603525|529582270|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
146838930|NCT00603525|529582271|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146838931|NCT00603525|529582269|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
146838932|NCT00603525|529582270|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
146838933|NCT00603525|529582271|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146838934|NCT00603525|529582269|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
146838935|NCT00603525|529582270|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
146838936|NCT00603525|529582271|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
146990633|NCT00414765|530128718|FG001|Overall Study|Adverse Event|9|||
146990634|NCT00414765|530128717|FG000|Overall Study|Withdrawal by Subject|1|||
146990635|NCT00414765|530128718|FG001|Overall Study|Withdrawal by Subject|1|||
146990636|NCT00414765|530128717|FG000|Overall Study|Disease Progression|0|||
146838937|NCT00603525|529582269|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
146838938|NCT00603525|529582270|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
146838939|NCT00603525|529582271|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
146838940|NCT00603525|529582269|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
146838941|NCT00603525|529582270|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
146838942|NCT00603525|529582271|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
146838943|NCT00603525|529582269|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
146838944|NCT00603525|529582270|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
146838945|NCT00603525|529582271|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
146838946|NCT00603525|529582269|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
146838947|NCT00603525|529582270|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
146838948|NCT00603525|529582271|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
146838949|NCT00603525|529582269|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
146838950|NCT00603525|529582270|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
146838951|NCT00603525|529582271|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
146838952|NCT00603525|529582269|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
146838953|NCT00603525|529582270|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
146838954|NCT00603525|529582271|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
146838955|NCT00603525|529582269|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
146838956|NCT00603525|529582270|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
146838957|NCT00603525|529582271|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
146838958|NCT00603525|529582269|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
146838959|NCT00603525|529582270|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
146838960|NCT00603525|529582271|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
146838961|NCT00603525|529582269|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
146838962|NCT00603525|529582270|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
146838963|NCT00603525|529582271|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
146838964|NCT00770029|529582272|FG000|Overall Study|Lost to Follow-up|2|||
146838965|NCT00770029|529582273|FG001|Overall Study|Lost to Follow-up|0|||
146838966|NCT00770029|529582272|FG000|Overall Study|Withdrawal by Subject|3|||
146838967|NCT00770029|529582273|FG001|Overall Study|Withdrawal by Subject|3|||
146838968|NCT00770029|529582272|FG000|Overall Study|Adverse Event|1|||
146838969|NCT00770029|529582273|FG001|Overall Study|Adverse Event|0|||
146838970|NCT02124811|529582274|FG000|Overall Study|Early termination|2|||
146838971|NCT02124811|529582275|FG001|Overall Study|Early termination|2|||
146838972|NCT02124811|529582274|FG000|Overall Study|Withdrawal by Subject|1|||
146838973|NCT02124811|529582275|FG001|Overall Study|Withdrawal by Subject|0|||
146838974|NCT04043143|529582276|FG000|Overall Study|Lost to Follow-up|5|||
146838975|NCT04043143|529582277|FG001|Overall Study|Lost to Follow-up|5|||
146838976|NCT04043143|529582276|FG000|Overall Study|screen failure|1|||
146838977|NCT04043143|529582277|FG001|Overall Study|screen failure|0|||
146838978|NCT03480932|529582278|FG000|Overall Study|Death|1|||
146838979|NCT03480932|529582279|FG001|Overall Study|Death|1|||
146838980|NCT03480932|529582280|FG002|Overall Study|Death|0|||
146838981|NCT03480932|529582278|FG000|Overall Study|Lost to Follow-up|0|||
146838982|NCT03480932|529582279|FG001|Overall Study|Lost to Follow-up|2|||
146838983|NCT03480932|529582280|FG002|Overall Study|Lost to Follow-up|3|||
146838984|NCT03480932|529582278|FG000|Overall Study|Incarcerated|2|||
146838985|NCT03480932|529582279|FG001|Overall Study|Incarcerated|2|||
146838986|NCT03480932|529582280|FG002|Overall Study|Incarcerated|2|||
146838987|NCT04624243|529582284|FG000|Overall Study|Death|0|||
146838988|NCT04624243|529582285|FG001|Overall Study|Death|1|||
146838989|NCT04624243|529582286|FG002|Overall Study|Death|0|||
146838990|NCT04624243|529582287|FG003|Overall Study|Death|0|||
146838991|NCT04624243|529582288|FG004|Overall Study|Death|0|||
146838992|NCT04624243|529582284|FG000|Overall Study|Lost to Follow-up|2|||
146838993|NCT04624243|529582285|FG001|Overall Study|Lost to Follow-up|3|||
146838994|NCT04624243|529582286|FG002|Overall Study|Lost to Follow-up|7|||
146838995|NCT04624243|529582287|FG003|Overall Study|Lost to Follow-up|1|||
146838996|NCT04624243|529582288|FG004|Overall Study|Lost to Follow-up|3|||
146838997|NCT04624243|529582284|FG000|Overall Study|Physician Decision|3|||
146838998|NCT04624243|529582285|FG001|Overall Study|Physician Decision|8|||
146838999|NCT04624243|529582286|FG002|Overall Study|Physician Decision|15|||
146839000|NCT04624243|529582287|FG003|Overall Study|Physician Decision|2|||
146839001|NCT04624243|529582288|FG004|Overall Study|Physician Decision|11|||
146839002|NCT04624243|529582284|FG000|Overall Study|Withdrawal by Subject|19|||
146839003|NCT04624243|529582285|FG001|Overall Study|Withdrawal by Subject|44|||
146839004|NCT04624243|529582286|FG002|Overall Study|Withdrawal by Subject|40|||
146839005|NCT04624243|529582287|FG003|Overall Study|Withdrawal by Subject|21|||
146839006|NCT04624243|529582288|FG004|Overall Study|Withdrawal by Subject|39|||
146839007|NCT04624243|529582284|FG000|Overall Study|Miscellaneous|3|||
146839008|NCT04624243|529582285|FG001|Overall Study|Miscellaneous|12|||
146839009|NCT04624243|529582286|FG002|Overall Study|Miscellaneous|9|||
146839010|NCT04624243|529582287|FG003|Overall Study|Miscellaneous|4|||
146839011|NCT04624243|529582288|FG004|Overall Study|Miscellaneous|6|||
146839012|NCT04996004|529582289|FG000|Phase I|Death|1|||
146839013|NCT04996004|529582290|FG001|Phase I|Death|2|||
146839014|NCT04996004|529582291|FG002|Phase I|Death|1|||
146839015|NCT04996004|529582292|FG003|Phase I|Death|0|||
146839016|NCT04996004|529582293|FG004|Phase I|Death|0|||
146839017|NCT04996004|529582294|FG005|Phase I|Death|0|||
146839018|NCT04996004|529582289|FG000|Phase I|Study terminated by sponsor|2|||
146839019|NCT04996004|529582290|FG001|Phase I|Study terminated by sponsor|1|||
146839020|NCT04996004|529582291|FG002|Phase I|Study terminated by sponsor|2|||
146839021|NCT04996004|529582292|FG003|Phase I|Study terminated by sponsor|0|||
146839022|NCT04996004|529582293|FG004|Phase I|Study terminated by sponsor|0|||
146839023|NCT04996004|529582294|FG005|Phase I|Study terminated by sponsor|0|||
146839024|NCT04996004|529582289|FG000|Phase II|Study terminated by sponsor|0|||
146839025|NCT04996004|529582290|FG001|Phase II|Study terminated by sponsor|0|||
146839026|NCT04996004|529582291|FG002|Phase II|Study terminated by sponsor|0|||
146839027|NCT04996004|529582292|FG003|Phase II|Study terminated by sponsor|20|||
146839028|NCT04996004|529582293|FG004|Phase II|Study terminated by sponsor|10|||
146839029|NCT04996004|529582294|FG005|Phase II|Study terminated by sponsor|10|||
146839030|NCT04996004|529582289|FG000|Phase II|Withdrawal by Subject|0|||
146839031|NCT04996004|529582290|FG001|Phase II|Withdrawal by Subject|0|||
146839032|NCT04996004|529582291|FG002|Phase II|Withdrawal by Subject|0|||
146839033|NCT04996004|529582292|FG003|Phase II|Withdrawal by Subject|0|||
146839034|NCT04996004|529582293|FG004|Phase II|Withdrawal by Subject|1|||
146839035|NCT04996004|529582294|FG005|Phase II|Withdrawal by Subject|2|||
146839036|NCT04996004|529582289|FG000|Phase II|Death|0|||
146839037|NCT04996004|529582290|FG001|Phase II|Death|0|||
146839038|NCT04996004|529582291|FG002|Phase II|Death|0|||
146839039|NCT04996004|529582292|FG003|Phase II|Death|12|||
146839040|NCT04996004|529582293|FG004|Phase II|Death|2|||
146839041|NCT04996004|529582294|FG005|Phase II|Death|9|||
146839042|NCT04996004|529582289|FG000|Phase II|Other|0|||
146839043|NCT04996004|529582290|FG001|Phase II|Other|0|||
146839044|NCT04996004|529582291|FG002|Phase II|Other|0|||
146839045|NCT04996004|529582292|FG003|Phase II|Other|0|||
146839046|NCT04996004|529582293|FG004|Phase II|Other|0|||
146839047|NCT04996004|529582294|FG005|Phase II|Other|1|||
146839048|NCT03374488|529582297|FG000|Overall Study|Death|13|||
146839049|NCT03374488|529582298|FG001|Overall Study|Death|13|||
146839050|NCT03374488|529582297|FG000|Overall Study|Withdrawal by Subject|3|||
146839051|NCT03374488|529582298|FG001|Overall Study|Withdrawal by Subject|1|||
146839052|NCT03374488|529582297|FG000|Overall Study|Physician Decision|3|||
146839053|NCT03374488|529582298|FG001|Overall Study|Physician Decision|0|||
146839054|NCT04703192|529582302|FG000|Overall Study|Withdrawal by Subject|2|||
146839055|NCT04703192|529582303|FG001|Overall Study|Withdrawal by Subject|0|||
146839056|NCT04703192|529582302|FG000|Overall Study|Death|3|||
146839057|NCT04703192|529582303|FG001|Overall Study|Death|1|||
146839058|NCT04703192|529582302|FG000|Overall Study|Adverse Event|13|||
146839059|NCT04703192|529582303|FG001|Overall Study|Adverse Event|2|||
146839060|NCT04703192|529582302|FG000|Overall Study|Progressive or Relapsed Disease|46|||
146839061|NCT04703192|529582303|FG001|Overall Study|Progressive or Relapsed Disease|7|||
146839062|NCT04703192|529582302|FG000|Overall Study|Clinical Progression|19|||
146839063|NCT04703192|529582303|FG001|Overall Study|Clinical Progression|8|||
146839064|NCT04703192|529582302|FG000|Overall Study|Lost to Follow-up|1|||
146839065|NCT04703192|529582303|FG001|Overall Study|Lost to Follow-up|0|||
146839066|NCT04703192|529582302|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
146839067|NCT04703192|529582303|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
146839068|NCT04703192|529582302|FG000|Overall Study|Other|5|||
146839069|NCT04703192|529582303|FG001|Overall Study|Other|1|||
146839070|NCT02493062|529582304|FG000|Overall Study|Physician Decision|12|||
146839071|NCT01327612|529582305|FG000|Overall Study|Withdrawal by Subject|0|||
146839072|NCT01327612|529582306|FG001|Overall Study|Withdrawal by Subject|0|||
146839073|NCT01327612|529582307|FG002|Overall Study|Withdrawal by Subject|0|||
146839074|NCT01327612|529582308|FG003|Overall Study|Withdrawal by Subject|0|||
146839075|NCT01327612|529582309|FG004|Overall Study|Withdrawal by Subject|0|||
146839076|NCT01327612|529582310|FG005|Overall Study|Withdrawal by Subject|1|||
146839077|NCT01327612|529582311|FG006|Overall Study|Withdrawal by Subject|0|||
146839078|NCT01327612|529582305|FG000|Overall Study|Disease Progression|1|||
146839079|NCT01327612|529582306|FG001|Overall Study|Disease Progression|1|||
146839080|NCT01327612|529582307|FG002|Overall Study|Disease Progression|1|||
146839081|NCT01327612|529582308|FG003|Overall Study|Disease Progression|0|||
146839082|NCT01327612|529582309|FG004|Overall Study|Disease Progression|1|||
146839083|NCT01327612|529582310|FG005|Overall Study|Disease Progression|2|||
146839084|NCT01327612|529582311|FG006|Overall Study|Disease Progression|2|||
146990637|NCT00414765|530128718|FG001|Overall Study|Disease Progression|1|||
146839085|NCT01327612|529582305|FG000|Overall Study|Administrative Decision|0|||
146839086|NCT01327612|529582306|FG001|Overall Study|Administrative Decision|0|||
146839087|NCT01327612|529582307|FG002|Overall Study|Administrative Decision|0|||
146839088|NCT01327612|529582308|FG003|Overall Study|Administrative Decision|1|||
146839089|NCT01327612|529582309|FG004|Overall Study|Administrative Decision|0|||
146839090|NCT01327612|529582310|FG005|Overall Study|Administrative Decision|0|||
146839091|NCT01327612|529582311|FG006|Overall Study|Administrative Decision|0|||
146839092|NCT01327612|529582305|FG000|Overall Study|Death|0|||
146839093|NCT01327612|529582306|FG001|Overall Study|Death|0|||
146839094|NCT01327612|529582307|FG002|Overall Study|Death|0|||
146839095|NCT01327612|529582308|FG003|Overall Study|Death|0|||
146839096|NCT01327612|529582309|FG004|Overall Study|Death|1|||
146839097|NCT01327612|529582310|FG005|Overall Study|Death|0|||
146839098|NCT01327612|529582311|FG006|Overall Study|Death|0|||
146839099|NCT01294397|529582312|FG000|Overall Study|Withdrawal by Subject|1|||
146839100|NCT01294397|529582312|FG000|Overall Study|Administrative Decision|1|||
146839101|NCT01661205|529582313|FG000|Overall Study|Physician Decision|2|||
146839102|NCT00426127|529582314|FG000|Overall Study|Adverse Event|1|||
146839103|NCT00426127|529582314|FG000|Overall Study|Removed due to disease progression|1|||
146839104|NCT03111095|529582318|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
146839105|NCT03111095|529582319|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
146839106|NCT03111095|529582318|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
146839107|NCT03111095|529582319|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
146839108|NCT00955708|529582320|FG000|Overall Study|Death|269|||
146839109|NCT00955708|529582320|FG000|Overall Study|Lost to Follow-up|72|||
146839110|NCT00955708|529582320|FG000|Overall Study|Physician Decision|36|||
146839111|NCT00955708|529582320|FG000|Overall Study|Protocol Violation|134|||
146839112|NCT00955708|529582320|FG000|Overall Study|Registry Conclusion|186|||
146839113|NCT00955708|529582320|FG000|Overall Study|Product removed from service|94|||
146839114|NCT00955708|529582320|FG000|Overall Study|Patient Refused to participate further|116|||
146839115|NCT00955708|529582320|FG000|Overall Study|Closure of study location|60|||
146839116|NCT00955708|529582320|FG000|Overall Study|Patient changed care provider/moved|91|||
146839117|NCT03738475|529582321|FG000|Overall Study|Participant Non-Compliance|1|||
146839118|NCT03738475|529582322|FG001|Overall Study|Participant Non-Compliance|0|||
146839119|NCT00737477|529582323|FG000|Overall Study|Adverse Event|9|||
146839120|NCT00737477|529582323|FG000|Overall Study|Death|9|||
146839121|NCT00737477|529582323|FG000|Overall Study|Treatment Refusal|1|||
146839122|NCT00737477|529582323|FG000|Overall Study|Withdrawal by Subject|1|||
146839123|NCT00737477|529582323|FG000|Overall Study|Renal Transplantation|10|||
146839124|NCT00737477|529582323|FG000|Overall Study|Other|4|||
146839125|NCT01132820|529582324|FG000|Overall Study|Ineligible: wrong cell type|1|||
146839126|NCT01132820|529582324|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
146839127|NCT01132820|529582324|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
146839128|NCT01132820|529582324|FG000|Overall Study|Never treated|1|||
146839129|NCT01132820|529582324|FG000|Overall Study|Inadequate data|1|||
146839130|NCT01370655|529582325|FG000|Period 1|Adverse Event|2|||
146839131|NCT01370655|529582326|FG001|Period 1|Adverse Event|0|||
146839132|NCT01370655|529582327|FG002|Period 1|Adverse Event|0|||
146839133|NCT01370655|529582328|FG003|Period 1|Adverse Event|0|||
146839134|NCT01370655|529582329|FG004|Period 1|Adverse Event|0|||
146839135|NCT01370655|529582330|FG005|Period 1|Adverse Event|0|||
146839136|NCT01370655|529582331|FG006|Period 1|Adverse Event|1|||
146839137|NCT01370655|529582332|FG007|Period 1|Adverse Event|0|||
146839138|NCT01370655|529582333|FG008|Period 1|Adverse Event|0|||
146839139|NCT01370655|529582334|FG009|Period 1|Adverse Event|0|||
146839140|NCT01370655|529582335|FG010|Period 1|Adverse Event|0|||
146839141|NCT01370655|529582336|FG011|Period 1|Adverse Event|0|||
146839142|NCT01370655|529582325|FG000|Period 2|Adverse Event|0|||
146839143|NCT01370655|529582326|FG001|Period 2|Adverse Event|0|||
146839144|NCT01370655|529582327|FG002|Period 2|Adverse Event|1|||
146839145|NCT01370655|529582328|FG003|Period 2|Adverse Event|0|||
146839146|NCT01370655|529582329|FG004|Period 2|Adverse Event|1|||
146839147|NCT01370655|529582330|FG005|Period 2|Adverse Event|0|||
146839148|NCT01370655|529582331|FG006|Period 2|Adverse Event|0|||
146839149|NCT01370655|529582332|FG007|Period 2|Adverse Event|1|||
146839150|NCT01370655|529582333|FG008|Period 2|Adverse Event|0|||
146839151|NCT01370655|529582334|FG009|Period 2|Adverse Event|0|||
146839152|NCT01370655|529582335|FG010|Period 2|Adverse Event|0|||
146839153|NCT01370655|529582336|FG011|Period 2|Adverse Event|0|||
146839154|NCT01370655|529582325|FG000|Period 2|met protocol specified stopping criteria|0|||
146839155|NCT01370655|529582326|FG001|Period 2|met protocol specified stopping criteria|0|||
146839156|NCT01370655|529582327|FG002|Period 2|met protocol specified stopping criteria|1|||
146839157|NCT01370655|529582328|FG003|Period 2|met protocol specified stopping criteria|0|||
146839158|NCT01370655|529582329|FG004|Period 2|met protocol specified stopping criteria|0|||
146839159|NCT01370655|529582330|FG005|Period 2|met protocol specified stopping criteria|0|||
146839160|NCT01370655|529582331|FG006|Period 2|met protocol specified stopping criteria|1|||
146839161|NCT01370655|529582332|FG007|Period 2|met protocol specified stopping criteria|0|||
146839162|NCT01370655|529582333|FG008|Period 2|met protocol specified stopping criteria|1|||
146839163|NCT01370655|529582334|FG009|Period 2|met protocol specified stopping criteria|0|||
146839164|NCT01370655|529582335|FG010|Period 2|met protocol specified stopping criteria|1|||
146839165|NCT01370655|529582336|FG011|Period 2|met protocol specified stopping criteria|0|||
146839166|NCT01370655|529582325|FG000|Period 2|Withdrawal by Subject|0|||
146839167|NCT01370655|529582326|FG001|Period 2|Withdrawal by Subject|0|||
146839168|NCT01370655|529582327|FG002|Period 2|Withdrawal by Subject|0|||
146839169|NCT01370655|529582328|FG003|Period 2|Withdrawal by Subject|0|||
146839170|NCT01370655|529582329|FG004|Period 2|Withdrawal by Subject|0|||
146839171|NCT01370655|529582330|FG005|Period 2|Withdrawal by Subject|0|||
146839172|NCT01370655|529582331|FG006|Period 2|Withdrawal by Subject|0|||
146839173|NCT01370655|529582332|FG007|Period 2|Withdrawal by Subject|0|||
146839174|NCT01370655|529582333|FG008|Period 2|Withdrawal by Subject|1|||
146839175|NCT01370655|529582334|FG009|Period 2|Withdrawal by Subject|0|||
146839176|NCT01370655|529582335|FG010|Period 2|Withdrawal by Subject|0|||
146839177|NCT01370655|529582336|FG011|Period 2|Withdrawal by Subject|0|||
146839178|NCT01735175|529582339|FG000|Overall Study|Withdrawal by Subject|9|||
146839179|NCT01735175|529582340|FG001|Overall Study|Withdrawal by Subject|2|||
146839180|NCT01735175|529582339|FG000|Overall Study|Lost to Follow-up|4|||
146839181|NCT01735175|529582340|FG001|Overall Study|Lost to Follow-up|2|||
146839182|NCT01735175|529582339|FG000|Overall Study|Death|3|||
146839183|NCT01735175|529582340|FG001|Overall Study|Death|2|||
146839184|NCT01735175|529582339|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
146839185|NCT01735175|529582340|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
146839186|NCT01853475|529582341|FG000|Overall Study|Withdrawal by Subject|0|||
146839187|NCT01853475|529582342|FG001|Overall Study|Withdrawal by Subject|1|||
146839188|NCT01853475|529582343|FG002|Overall Study|Withdrawal by Subject|0|||
146839189|NCT00659880|529582344|FG000|Overall Study|Lost to Follow-up|5|||
146839190|NCT02159040|529582345|FG000|Overall Study|Death|1|||
146839191|NCT01304498|529582346|FG000|Overall Study|Adverse Event|1|||
146839192|NCT01304498|529582347|FG001|Overall Study|Adverse Event|1|||
146839193|NCT01304498|529582346|FG000|Overall Study|Withdrawal by Subject|2|||
146839194|NCT01304498|529582347|FG001|Overall Study|Withdrawal by Subject|3|||
146839195|NCT01304498|529582346|FG000|Overall Study|Protocol Violation|1|||
146839196|NCT01304498|529582347|FG001|Overall Study|Protocol Violation|0|||
146839197|NCT01304498|529582346|FG000|Overall Study|Lost to Follow-up|2|||
146839198|NCT01304498|529582347|FG001|Overall Study|Lost to Follow-up|1|||
146839199|NCT01151215|529582348|FG000|Overall Study|Worsening of condition under study|1|||
146839200|NCT01151215|529582349|FG001|Overall Study|Worsening of condition under study|1|||
146839201|NCT01151215|529582350|FG002|Overall Study|Worsening of condition under study|1|||
146839202|NCT01151215|529582348|FG000|Overall Study|Death|16|||
146839203|NCT01151215|529582349|FG001|Overall Study|Death|20|||
146839204|NCT01151215|529582350|FG002|Overall Study|Death|11|||
146839205|NCT01151215|529582348|FG000|Overall Study|Lost to Follow-up|0|||
146839206|NCT01151215|529582349|FG001|Overall Study|Lost to Follow-up|0|||
146839207|NCT01151215|529582350|FG002|Overall Study|Lost to Follow-up|3|||
146839208|NCT01151215|529582348|FG000|Overall Study|Withdrawal by Subject|3|||
146839209|NCT01151215|529582349|FG001|Overall Study|Withdrawal by Subject|1|||
146839210|NCT01151215|529582350|FG002|Overall Study|Withdrawal by Subject|2|||
146839211|NCT01151215|529582348|FG000|Overall Study|Disease progression|0|||
146839212|NCT01151215|529582349|FG001|Overall Study|Disease progression|1|||
146839213|NCT01151215|529582350|FG002|Overall Study|Disease progression|1|||
146839214|NCT01151215|529582348|FG000|Overall Study|Safety as judged by the investigator|0|||
146839215|NCT01151215|529582349|FG001|Overall Study|Safety as judged by the investigator|0|||
146839216|NCT01151215|529582350|FG002|Overall Study|Safety as judged by the investigator|1|||
146839217|NCT01374568|529582353|FG000|Overall Study|Lab unable to analyze BTM|0|||
146839218|NCT01374568|529582354|FG001|Overall Study|Lab unable to analyze BTM|2|||
146839219|NCT02269423|529582355|FG000|Overall Study|Discontinued due to change in residence|0|||
146839220|NCT02269423|529582356|FG001|Overall Study|Discontinued due to change in residence|1|||
146839221|NCT02269423|529582357|FG002|Overall Study|Discontinued due to change in residence|0|||
146839222|NCT02269423|529582358|FG003|Overall Study|Discontinued due to change in residence|1|||
146839223|NCT00856245|529582359|FG000|Overall Study|Was not transplanted|5|||
146839224|NCT01443923|529582360|FG000|Overall Study|Adverse Event|1|||
146839225|NCT01443923|529582361|FG001|Overall Study|Adverse Event|0|||
146839226|NCT04160988|529582364|FG000|Overall Study|poor image quality|28|||
146839227|NCT01250509|529582365|FG000|Overall Study|Lost to Follow-up|5|||
146839228|NCT01250509|529582366|FG001|Overall Study|Lost to Follow-up|2|||
146839229|NCT02670122|529582367|FG000|Overall Study|Lost to Follow-up|4|||
146839230|NCT02762903|529582372|FG000|Overall Study|Lost to Follow-up|0|||
146839231|NCT02762903|529582373|FG001|Overall Study|Lost to Follow-up|1|||
146839232|NCT00108745|529582374|FG000|Overall Study|Withdrawal by Subject|19|||
146839233|NCT00108745|529582375|FG001|Overall Study|Withdrawal by Subject|12|||
146839234|NCT00108745|529582376|FG002|Overall Study|Withdrawal by Subject|12|||
146839235|NCT00108745|529582374|FG000|Overall Study|Never Treated|8|||
146839236|NCT00108745|529582375|FG001|Overall Study|Never Treated|10|||
146839237|NCT00108745|529582376|FG002|Overall Study|Never Treated|12|||
146839238|NCT00108745|529582374|FG000|Overall Study|Ineligible|7|||
146839239|NCT00108745|529582375|FG001|Overall Study|Ineligible|13|||
146839240|NCT00108745|529582376|FG002|Overall Study|Ineligible|13|||
146839241|NCT01228175|529582377|FG000|Overall Study|Lost to Follow-up|64|||
146839242|NCT01228175|529582378|FG001|Overall Study|Lost to Follow-up|50|||
146839243|NCT01228175|529582377|FG000|Overall Study|Withdrawal by Subject|1|||
146839244|NCT01228175|529582378|FG001|Overall Study|Withdrawal by Subject|2|||
146839245|NCT01228175|529582377|FG000|Overall Study|Physician Decision|1|||
146839246|NCT01228175|529582378|FG001|Overall Study|Physician Decision|1|||
146839247|NCT01889069|529582379|FG000|Overall Study|Death|18|||
146839248|NCT01889069|529582379|FG000|Overall Study|Progression of Disease|14|||
146839249|NCT01889069|529582379|FG000|Overall Study|Lost to Follow-up|6|||
146839250|NCT01889069|529582379|FG000|Overall Study|Other|4|||
146839251|NCT01889069|529582379|FG000|Overall Study|Consent Withdrawal|3|||
146839252|NCT01426347|529582383|FG000|Overall Study|Lost to Follow-up|0|||
146839253|NCT01426347|529582384|FG001|Overall Study|Lost to Follow-up|3|||
146839254|NCT01426347|529582383|FG000|Overall Study|Protocol Violation|2|||
146839255|NCT01426347|529582384|FG001|Overall Study|Protocol Violation|0|||
146839256|NCT01426347|529582383|FG000|Overall Study|Withdrawal by Subject|5|||
146839257|NCT01426347|529582384|FG001|Overall Study|Withdrawal by Subject|0|||
146839258|NCT00664534|529582385|FG000|Overall Study|Adverse Event|2|||
146839259|NCT00664534|529582386|FG001|Overall Study|Adverse Event|3|||
146839260|NCT00664534|529582385|FG000|Overall Study|Lost to Follow-up|6|||
146839261|NCT00664534|529582386|FG001|Overall Study|Lost to Follow-up|10|||
146839262|NCT00664534|529582385|FG000|Overall Study|Protocol Violation|10|||
146839263|NCT00664534|529582386|FG001|Overall Study|Protocol Violation|8|||
146839264|NCT00664534|529582385|FG000|Overall Study|Withdrawal by Subject|7|||
146839265|NCT00664534|529582386|FG001|Overall Study|Withdrawal by Subject|6|||
146839266|NCT00664534|529582385|FG000|Overall Study|Physician Decision|8|||
146839267|NCT00664534|529582386|FG001|Overall Study|Physician Decision|0|||
146839268|NCT00664534|529582385|FG000|Overall Study|Sponsor decision|8|||
146839269|NCT00664534|529582386|FG001|Overall Study|Sponsor decision|6|||
146839270|NCT03041792|529582387|FG000|Overall Study|Adverse Event|4|||
146839271|NCT03041792|529582388|FG001|Overall Study|Adverse Event|0|||
146990638|NCT05295953|530128719|FG000|Overall Study|Withdrawal by Subject|0|||
146990639|NCT05295953|530128720|FG001|Overall Study|Withdrawal by Subject|1|||
146990640|NCT05694013|530128722|FG000|Overall Study|Death|6|||
146990641|NCT05694013|530128723|FG001|Overall Study|Death|2|||
146990642|NCT05694013|530128722|FG000|Overall Study|Participant Decision|0|||
146990643|NCT05694013|530128723|FG001|Overall Study|Participant Decision|1|||
146990644|NCT05694013|530128722|FG000|Overall Study|Physician Decision|1|||
146990645|NCT05694013|530128723|FG001|Overall Study|Physician Decision|0|||
146990646|NCT05694013|530128722|FG000|Overall Study|Progressive Disease|0|||
146990647|NCT05694013|530128723|FG001|Overall Study|Progressive Disease|1|||
146990648|NCT05694013|530128722|FG000|Overall Study|Study Terminated by Sponsor|12|||
146990649|NCT05694013|530128723|FG001|Overall Study|Study Terminated by Sponsor|17|||
146990650|NCT05694013|530128722|FG000|Overall Study|Withdrawal by Subject|3|||
146990651|NCT05694013|530128723|FG001|Overall Study|Withdrawal by Subject|0|||
146990652|NCT04817891|530128724|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
146990653|NCT04817891|530128724|FG000|Overall Study|Adverse Event|1|||
146990654|NCT04817891|530128724|FG000|Overall Study|Withdrawal by Subject|1|||
146990655|NCT04534283|530128725|FG000|Overall Study|Physician Decision|2|||
146990656|NCT04534283|530128725|FG000|Overall Study|Withdrawal by Subject|1|||
146839272|NCT03041792|529582387|FG000|Overall Study|Death in the family|0|||
146839273|NCT03041792|529582388|FG001|Overall Study|Death in the family|2|||
146839274|NCT03041792|529582387|FG000|Overall Study|Randomized but not treated|0|||
146839275|NCT03041792|529582388|FG001|Overall Study|Randomized but not treated|1|||
146839276|NCT04978090|529582391|FG000|Overall Study|unable to adequately fit device|2|||
146839277|NCT02227992|529582398|FG000|Overall Study|Lost to Follow-up|1|||
146839278|NCT02227992|529582399|FG001|Overall Study|Lost to Follow-up|1|||
146839279|NCT00935532|529582400|FG000|Overall Study|Adverse Event|11|||
146839280|NCT00935532|529582401|FG001|Overall Study|Adverse Event|6|||
146839281|NCT00935532|529582400|FG000|Overall Study|Death|1|||
146839282|NCT00935532|529582401|FG001|Overall Study|Death|0|||
146839283|NCT00935532|529582400|FG000|Overall Study|Lost to Follow-up|1|||
146839284|NCT00935532|529582401|FG001|Overall Study|Lost to Follow-up|0|||
146839285|NCT00935532|529582400|FG000|Overall Study|Physician Decision|1|||
146839286|NCT00935532|529582401|FG001|Overall Study|Physician Decision|2|||
146839287|NCT00935532|529582400|FG000|Overall Study|Protocol Violation|2|||
146839288|NCT00935532|529582401|FG001|Overall Study|Protocol Violation|1|||
146839289|NCT00935532|529582400|FG000|Overall Study|Subject Decision|2|||
146839290|NCT00935532|529582401|FG001|Overall Study|Subject Decision|1|||
146839291|NCT00935532|529582400|FG000|Overall Study|Sponsor Decision|0|||
146839292|NCT00935532|529582401|FG001|Overall Study|Sponsor Decision|1|||
146990657|NCT04534283|530128725|FG000|Overall Study|Disease Progression|12|||
146990658|NCT04534283|530128725|FG000|Overall Study|Adverse Event|1|||
146990659|NCT03257462|530128728|FG000|Cohort A|Lost to Follow-up|1|||
146990660|NCT03257462|530128729|FG001|Cohort A|Lost to Follow-up|0|||
146839293|NCT00935532|529582400|FG000|Overall Study|Loss Glucose Control|4|||
146839294|NCT00935532|529582401|FG001|Overall Study|Loss Glucose Control|0|||
146839295|NCT01371708|529582404|FG000|Overall Study|Insufficient clinical response|3|||
146839296|NCT01371708|529582405|FG001|Overall Study|Insufficient clinical response|2|||
146839297|NCT01371708|529582406|FG002|Overall Study|Insufficient clinical response|0|||
146839298|NCT01371708|529582404|FG000|Overall Study|Lost to Follow-up|5|||
146839299|NCT01371708|529582405|FG001|Overall Study|Lost to Follow-up|9|||
146839300|NCT01371708|529582406|FG002|Overall Study|Lost to Follow-up|7|||
146839301|NCT01371708|529582404|FG000|Overall Study|Protocol Violation|2|||
146839302|NCT01371708|529582405|FG001|Overall Study|Protocol Violation|1|||
146990661|NCT03257462|530128730|FG002|Cohort A|Lost to Follow-up|0|||
146958908|NCT01072175|530009874|FG005|Part A (Drug-Drug Interaction)|Death|0|||
146958909|NCT01072175|530009875|FG006|Part A (Drug-Drug Interaction)|Death|0|||
146958910|NCT01072175|530009876|FG007|Part A (Drug-Drug Interaction)|Death|0|||
146958911|NCT01072175|530009877|FG008|Part A (Drug-Drug Interaction)|Death|0|||
146958912|NCT01072175|530009878|FG009|Part A (Drug-Drug Interaction)|Death|0|||
146958913|NCT01072175|530009879|FG010|Part A (Drug-Drug Interaction)|Death|0|||
146958914|NCT01072175|530009880|FG011|Part A (Drug-Drug Interaction)|Death|0|||
146958915|NCT01072175|530009881|FG012|Part A (Drug-Drug Interaction)|Death|0|||
146958916|NCT01072175|530009869|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
146958917|NCT01072175|530009870|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146958918|NCT01072175|530009871|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146958919|NCT01072175|530009872|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146958920|NCT01072175|530009873|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146958921|NCT01072175|530009874|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146958922|NCT01072175|530009875|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146958923|NCT01072175|530009876|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146958924|NCT01072175|530009877|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146958925|NCT01072175|530009878|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146958926|NCT01072175|530009879|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146958927|NCT01072175|530009880|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146958928|NCT01072175|530009881|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146958929|NCT01072175|530009869|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
146958930|NCT01072175|530009870|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146958931|NCT01072175|530009871|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146958932|NCT01072175|530009872|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146958933|NCT01072175|530009873|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146958934|NCT01072175|530009874|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146958935|NCT01072175|530009875|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146958936|NCT01072175|530009876|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146958937|NCT01072175|530009877|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146958938|NCT01072175|530009878|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146958939|NCT01072175|530009879|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146958940|NCT01072175|530009880|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146958941|NCT01072175|530009881|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146958942|NCT01072175|530009869|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
146958943|NCT01072175|530009870|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
146958944|NCT01072175|530009871|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
146958945|NCT01072175|530009872|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
146958946|NCT01072175|530009873|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
146958947|NCT01072175|530009874|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
146958948|NCT01072175|530009875|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
146958949|NCT01072175|530009876|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
146958950|NCT01072175|530009877|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
146958951|NCT01072175|530009878|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
146958952|NCT01072175|530009879|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
146958953|NCT01072175|530009880|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
146958954|NCT01072175|530009881|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
146958955|NCT01072175|530009869|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146958956|NCT01072175|530009870|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146958957|NCT01072175|530009871|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
146958958|NCT01072175|530009872|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146958959|NCT01072175|530009873|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
146958960|NCT01072175|530009874|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146958961|NCT01072175|530009875|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146958962|NCT01072175|530009876|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146958963|NCT01072175|530009877|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146958964|NCT01072175|530009878|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146958965|NCT01072175|530009879|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146958966|NCT01072175|530009880|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146958967|NCT01072175|530009881|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146958968|NCT01072175|530009869|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146958969|NCT01072175|530009870|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
146958970|NCT01072175|530009871|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146958971|NCT01072175|530009872|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
146958972|NCT01072175|530009873|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
146958973|NCT01072175|530009874|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146958974|NCT01072175|530009875|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146839303|NCT01371708|529582406|FG002|Overall Study|Protocol Violation|2|||
146958975|NCT01072175|530009876|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146958976|NCT01072175|530009877|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146958977|NCT01072175|530009878|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146958978|NCT01072175|530009879|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146958979|NCT01072175|530009880|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146958980|NCT01072175|530009881|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146958981|NCT01072175|530009869|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146958982|NCT01072175|530009870|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146958983|NCT01072175|530009871|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
146958984|NCT01072175|530009872|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
146958985|NCT01072175|530009873|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
146958986|NCT01072175|530009874|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146958987|NCT01072175|530009875|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146958988|NCT01072175|530009876|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146958989|NCT01072175|530009877|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146958990|NCT01072175|530009878|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146958991|NCT01072175|530009879|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146958992|NCT01072175|530009880|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146958993|NCT01072175|530009881|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146958994|NCT01072175|530009869|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146958995|NCT01072175|530009870|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
146958996|NCT01072175|530009871|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146958997|NCT01072175|530009872|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
146958998|NCT01072175|530009873|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
146958999|NCT01072175|530009874|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146959000|NCT01072175|530009875|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146959001|NCT01072175|530009876|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146959002|NCT01072175|530009877|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146959003|NCT01072175|530009878|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146959004|NCT01072175|530009879|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146959005|NCT01072175|530009880|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146959006|NCT01072175|530009881|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146959007|NCT01072175|530009869|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
146959008|NCT01072175|530009870|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
146959009|NCT01072175|530009871|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
146959010|NCT01072175|530009872|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
146959011|NCT01072175|530009873|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
146959012|NCT01072175|530009874|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
146959013|NCT01072175|530009875|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
146959014|NCT01072175|530009876|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
146959015|NCT01072175|530009877|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
146959016|NCT01072175|530009878|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
146959017|NCT01072175|530009879|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
146959018|NCT01072175|530009880|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
146959019|NCT01072175|530009881|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
146959020|NCT01072175|530009869|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146959021|NCT01072175|530009870|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146959022|NCT01072175|530009871|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146959023|NCT01072175|530009872|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146959024|NCT01072175|530009873|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146959025|NCT01072175|530009874|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
146959026|NCT01072175|530009875|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
146959027|NCT01072175|530009876|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
146959028|NCT01072175|530009877|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146959029|NCT01072175|530009878|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146959030|NCT01072175|530009879|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146959031|NCT01072175|530009880|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146959032|NCT01072175|530009881|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146959033|NCT01072175|530009869|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146959034|NCT01072175|530009870|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146959035|NCT01072175|530009871|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146959036|NCT01072175|530009872|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146959037|NCT01072175|530009873|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146959038|NCT01072175|530009874|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146959039|NCT01072175|530009875|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
146990662|NCT03257462|530128731|FG003|Cohort A|Lost to Follow-up|0|||
146839304|NCT01371708|529582404|FG000|Overall Study|No longer willing to participate|7|||
146839305|NCT01371708|529582405|FG001|Overall Study|No longer willing to participate|7|||
146839306|NCT01371708|529582406|FG002|Overall Study|No longer willing to participate|13|||
146839307|NCT01371708|529582404|FG000|Overall Study|Medication error/not related to AE|0|||
146839308|NCT01371708|529582405|FG001|Overall Study|Medication error/not related to AE|1|||
146839309|NCT01371708|529582406|FG002|Overall Study|Medication error/not related to AE|0|||
146839310|NCT01371708|529582404|FG000|Overall Study|Other|3|||
146839311|NCT01371708|529582405|FG001|Overall Study|Other|2|||
146959040|NCT01072175|530009876|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
146959041|NCT01072175|530009877|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146959042|NCT01072175|530009878|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146959043|NCT01072175|530009879|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146959044|NCT01072175|530009880|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146959045|NCT01072175|530009881|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146959046|NCT01072175|530009869|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146959047|NCT01072175|530009870|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146959048|NCT01072175|530009871|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146959049|NCT01072175|530009872|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146959050|NCT01072175|530009873|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146959051|NCT01072175|530009874|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
146959052|NCT01072175|530009875|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
146959053|NCT01072175|530009876|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
146959054|NCT01072175|530009877|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146959055|NCT01072175|530009878|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146959056|NCT01072175|530009879|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146959057|NCT01072175|530009880|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146959058|NCT01072175|530009881|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146959059|NCT01072175|530009869|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146959060|NCT01072175|530009870|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146959061|NCT01072175|530009871|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146959062|NCT01072175|530009872|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146959063|NCT01072175|530009873|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146959064|NCT01072175|530009874|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
146959065|NCT01072175|530009875|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
146959066|NCT01072175|530009876|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146959067|NCT01072175|530009877|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146959068|NCT01072175|530009878|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146959069|NCT01072175|530009879|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146959070|NCT01072175|530009880|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146959071|NCT01072175|530009881|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146959072|NCT01072175|530009869|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146959073|NCT01072175|530009870|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146959074|NCT01072175|530009871|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146959075|NCT01072175|530009872|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146959076|NCT01072175|530009873|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146959077|NCT01072175|530009874|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146959078|NCT01072175|530009875|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146959079|NCT01072175|530009876|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146959080|NCT01072175|530009877|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
146959081|NCT01072175|530009878|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146959082|NCT01072175|530009879|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146959083|NCT01072175|530009880|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146959084|NCT01072175|530009881|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146959085|NCT01072175|530009869|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146959086|NCT01072175|530009870|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146959087|NCT01072175|530009871|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146959088|NCT01072175|530009872|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146959089|NCT01072175|530009873|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146959090|NCT01072175|530009874|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146959091|NCT01072175|530009875|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146959092|NCT01072175|530009876|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146959093|NCT01072175|530009877|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
146959094|NCT01072175|530009878|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146839312|NCT01371708|529582406|FG002|Overall Study|Other|4|||
146839313|NCT01371708|529582404|FG000|Overall Study|Adverse Event|5|||
146839314|NCT01371708|529582405|FG001|Overall Study|Adverse Event|8|||
146839315|NCT01371708|529582406|FG002|Overall Study|Adverse Event|12|||
146839316|NCT01371708|529582404|FG000|Overall Study|Started but did not receive treatment|1|||
146839317|NCT01371708|529582405|FG001|Overall Study|Started but did not receive treatment|0|||
146839318|NCT01371708|529582406|FG002|Overall Study|Started but did not receive treatment|1|||
146839319|NCT00402051|529582407|FG000|Overall Study|Progressive Disease|13|||
146839320|NCT00402051|529582408|FG001|Overall Study|Progressive Disease|20|||
146839321|NCT00402051|529582407|FG000|Overall Study|Adverse Event|11|||
146839322|NCT00402051|529582408|FG001|Overall Study|Adverse Event|4|||
146839323|NCT00402051|529582407|FG000|Overall Study|Physician Decision|7|||
146839324|NCT00402051|529582408|FG001|Overall Study|Physician Decision|3|||
146839325|NCT00402051|529582407|FG000|Overall Study|Withdrawal by Subject|3|||
146839326|NCT00402051|529582408|FG001|Overall Study|Withdrawal by Subject|3|||
146839327|NCT00402051|529582407|FG000|Overall Study|Death - Related to Study Drug|1|||
146839328|NCT00402051|529582408|FG001|Overall Study|Death - Related to Study Drug|2|||
146839329|NCT00402051|529582407|FG000|Overall Study|Death Due to Study Disease|2|||
146990663|NCT03257462|530128728|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
146990664|NCT03257462|530128729|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
146990665|NCT03257462|530128730|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
146990666|NCT03257462|530128731|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
146990667|NCT00368277|530128732|FG000|Overall Study|Adverse Event|33|||
146990668|NCT00368277|530128733|FG001|Overall Study|Adverse Event|49|||
146990669|NCT00368277|530128732|FG000|Overall Study|Death|2|||
146990670|NCT00368277|530128733|FG001|Overall Study|Death|1|||
146990671|NCT00368277|530128732|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
146990672|NCT00368277|530128733|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
146990673|NCT00368277|530128732|FG000|Overall Study|Protocol deviation|7|||
146990674|NCT00368277|530128733|FG001|Overall Study|Protocol deviation|0|||
146990675|NCT00368277|530128732|FG000|Overall Study|Patient withdrew consent|32|||
146990676|NCT00368277|530128733|FG001|Overall Study|Patient withdrew consent|28|||
146990677|NCT00368277|530128732|FG000|Overall Study|Lost to Follow-up|8|||
146990678|NCT00368277|530128733|FG001|Overall Study|Lost to Follow-up|6|||
146990679|NCT04347239|530128734|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
146990680|NCT04347239|530128735|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
146990681|NCT04347239|530128736|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
146990682|NCT04347239|530128734|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
146990683|NCT04347239|530128735|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
146990684|NCT04347239|530128736|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
146990685|NCT00918567|530128737|FG000|Overall Study|Lack of Efficacy|3|||
146990686|NCT00918567|530128738|FG001|Overall Study|Lack of Efficacy|1|||
146990687|NCT00918567|530128737|FG000|Overall Study|Withdrawal by Subject|1|||
146990688|NCT00918567|530128738|FG001|Overall Study|Withdrawal by Subject|1|||
146990689|NCT00918567|530128737|FG000|Overall Study|Adverse Event|1|||
146990690|NCT00918567|530128738|FG001|Overall Study|Adverse Event|0|||
146990691|NCT03283709|530128748|FG000|Overall Study|trial terminated|0|||
146990692|NCT03283709|530128749|FG001|Overall Study|trial terminated|1|||
146990693|NCT05275998|530128750|FG000|Overall Study|Adverse Event|0|||
146990694|NCT05275998|530128751|FG001|Overall Study|Adverse Event|0|||
146990695|NCT05275998|530128752|FG002|Overall Study|Adverse Event|0|||
146990696|NCT05275998|530128753|FG003|Overall Study|Adverse Event|1|||
146990697|NCT05275998|530128750|FG000|Overall Study|Withdrawal by Subject|0|||
146990698|NCT05275998|530128751|FG001|Overall Study|Withdrawal by Subject|0|||
146990699|NCT05275998|530128752|FG002|Overall Study|Withdrawal by Subject|0|||
146990700|NCT05275998|530128753|FG003|Overall Study|Withdrawal by Subject|1|||
146990701|NCT05275998|530128750|FG000|Overall Study|Physician Decision|0|||
146990702|NCT05275998|530128751|FG001|Overall Study|Physician Decision|0|||
146990703|NCT05275998|530128752|FG002|Overall Study|Physician Decision|0|||
146839330|NCT00402051|529582408|FG001|Overall Study|Death Due to Study Disease|1|||
146839331|NCT00402051|529582407|FG000|Overall Study|Death Due to Adverse Event|0|||
146839332|NCT00402051|529582408|FG001|Overall Study|Death Due to Adverse Event|2|||
146990704|NCT05275998|530128753|FG003|Overall Study|Physician Decision|1|||
146990705|NCT05275998|530128750|FG000|Overall Study|Protocol Violation|0|||
146990706|NCT05275998|530128751|FG001|Overall Study|Protocol Violation|0|||
146990707|NCT05275998|530128752|FG002|Overall Study|Protocol Violation|1|||
146990708|NCT05275998|530128753|FG003|Overall Study|Protocol Violation|0|||
146990709|NCT01867242|530128756|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
146990710|NCT01867242|530128757|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
146990711|NCT01867242|530128758|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
146839333|NCT00402051|529582407|FG000|Overall Study|Lost to Follow-up|1|||
146990712|NCT00264810|530128763|FG000|Baseline|Withdrawal by Subject|10|||
146990713|NCT00264810|530128764|FG001|Baseline|Withdrawal by Subject|10|||
146990714|NCT00264810|530128763|FG000|Baseline|Physician Decision|7|||
146990715|NCT00264810|530128764|FG001|Baseline|Physician Decision|8|||
146990716|NCT00264810|530128763|FG000|Baseline|Subject Compliance Failure|3|||
146839334|NCT00402051|529582408|FG001|Overall Study|Lost to Follow-up|0|||
146990717|NCT00264810|530128764|FG001|Baseline|Subject Compliance Failure|3|||
146990718|NCT00264810|530128763|FG000|Baseline|Insufficient Seizure Frequency|2|||
146990719|NCT00264810|530128764|FG001|Baseline|Insufficient Seizure Frequency|2|||
146990720|NCT00264810|530128763|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
146990721|NCT00264810|530128764|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
146990722|NCT00264810|530128763|FG000|Baseline|Other|0|||
146990723|NCT00264810|530128764|FG001|Baseline|Other|1|||
146990724|NCT00264810|530128763|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
146990725|NCT00264810|530128764|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
146990726|NCT00264810|530128763|FG000|Stimulation Optimization Period|Death|0|||
146990727|NCT00264810|530128764|FG001|Stimulation Optimization Period|Death|1|||
146990728|NCT00264810|530128763|FG000|Blinded Evaluation Period|Explant due to infection|1|||
146990729|NCT00264810|530128764|FG001|Blinded Evaluation Period|Explant due to infection|1|||
146990730|NCT00264810|530128763|FG000|Open Label Evaluation Period|Explant due to infection|1|||
146990731|NCT00264810|530128764|FG001|Open Label Evaluation Period|Explant due to infection|1|||
146990732|NCT00264810|530128763|FG000|Open Label Evaluation Period|Death|3|||
146990733|NCT00264810|530128764|FG001|Open Label Evaluation Period|Death|2|||
146990734|NCT00264810|530128763|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
146990735|NCT00264810|530128764|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
146990736|NCT02879643|530128766|FG000|Overall Study|Adverse Event|0|||
146990737|NCT02879643|530128767|FG001|Overall Study|Adverse Event|0|||
146990738|NCT02879643|530128768|FG002|Overall Study|Adverse Event|1|||
146990739|NCT02879643|530128769|FG003|Overall Study|Adverse Event|1|||
146990740|NCT02879643|530128770|FG004|Overall Study|Adverse Event|0|||
146990741|NCT00182091|530128771|FG000|Overall Study|Withdrawal by Subject|1|||
146990742|NCT00182091|530128772|FG001|Overall Study|Withdrawal by Subject|0|||
146990743|NCT00182091|530128773|FG002|Overall Study|Withdrawal by Subject|0|||
146990744|NCT00182091|530128774|FG003|Overall Study|Withdrawal by Subject|0|||
146990745|NCT02199509|530128775|FG000|Overall Study|Suicidal Ideation|0|||
146990746|NCT02199509|530128776|FG001|Overall Study|Suicidal Ideation|1|||
146990747|NCT02199509|530128775|FG000|Overall Study|Misunderstood titration schedule|1|||
146990748|NCT02199509|530128776|FG001|Overall Study|Misunderstood titration schedule|0|||
146990749|NCT02093689|530128778|FG000|Overall Study|Physician Decision|4|||
146990750|NCT02093689|530128779|FG001|Overall Study|Physician Decision|0|||
146990751|NCT02093689|530128780|FG002|Overall Study|Physician Decision|0|||
146990752|NCT00634179|530128786|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
146990753|NCT04947579|530128787|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
146990754|NCT04947579|530128788|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
146990755|NCT04947579|530128789|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
146990756|NCT04947579|530128790|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
146990757|NCT04947579|530128791|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
146990758|NCT04947579|530128792|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
146990759|NCT04947579|530128787|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
146990760|NCT04947579|530128788|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
146990761|NCT04947579|530128789|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
146990762|NCT04947579|530128790|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
146990763|NCT04947579|530128791|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
146990764|NCT04947579|530128792|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
146990765|NCT04947579|530128787|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
146990766|NCT04947579|530128788|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
146990767|NCT04947579|530128789|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
146990768|NCT04947579|530128790|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
146990769|NCT04947579|530128791|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
146990770|NCT04947579|530128792|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
146990771|NCT04947579|530128787|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
146990772|NCT04947579|530128788|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
146990773|NCT04947579|530128789|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
146990774|NCT04947579|530128790|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
146990775|NCT04947579|530128791|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
146990776|NCT04947579|530128792|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
146990777|NCT04947579|530128787|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
146990778|NCT04947579|530128788|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
146990779|NCT04947579|530128789|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
146990780|NCT04947579|530128790|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
146990781|NCT04947579|530128791|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
146990782|NCT04947579|530128792|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
146990783|NCT04947579|530128787|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
146990784|NCT04947579|530128788|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
146990785|NCT04947579|530128789|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
146990786|NCT04947579|530128790|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
146990787|NCT04947579|530128791|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
146990788|NCT04947579|530128792|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
146990789|NCT04947579|530128787|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
146990790|NCT04947579|530128788|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
146990791|NCT04947579|530128789|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
146990792|NCT04947579|530128790|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
146990793|NCT04947579|530128791|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
146990794|NCT04947579|530128792|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
146990795|NCT04947579|530128787|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
146990796|NCT04947579|530128788|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
146990797|NCT04947579|530128789|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
146990798|NCT04947579|530128790|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
146990799|NCT04947579|530128791|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
146990800|NCT04947579|530128792|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
146990801|NCT04947579|530128787|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
146990802|NCT04947579|530128788|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
146990803|NCT04947579|530128789|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
146990804|NCT04947579|530128790|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
146990805|NCT04947579|530128791|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
146990806|NCT04947579|530128792|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
146990807|NCT04947579|530128787|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
146990808|NCT04947579|530128788|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
146990809|NCT04947579|530128789|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
146990810|NCT04947579|530128790|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
146990811|NCT04947579|530128791|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
146990812|NCT04947579|530128792|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
146990813|NCT04947579|530128787|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
146990814|NCT04947579|530128788|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
146990815|NCT04947579|530128789|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
146990816|NCT04947579|530128790|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
146990817|NCT04947579|530128791|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
146990818|NCT04947579|530128792|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
146990819|NCT04272801|530128793|FG000|Overall Study|Withdrawal by Subject|4|||
146990820|NCT04272801|530128793|FG000|Overall Study|Lost to Follow-up|4|||
146990821|NCT04272801|530128793|FG000|Overall Study|Ineligible|1|||
146990822|NCT00475020|530128794|FG000|Overall Study|Physician Decision|3|||
146990823|NCT00475020|530128794|FG000|Overall Study|Insurance Denial|1|||
146990824|NCT00475020|530128794|FG000|Overall Study|Donor not able to donate the last minute|1|||
146990825|NCT02456909|530128795|FG000|Overall Study|Did not receive allocated intervention|24|||
146990826|NCT02456909|530128796|FG001|Overall Study|Did not receive allocated intervention|26|||
146990827|NCT02456909|530128795|FG000|Overall Study|Did not complete the primary outcome|0|||
146990828|NCT02456909|530128796|FG001|Overall Study|Did not complete the primary outcome|1|||
146990829|NCT01575054|530128797|FG000|Overall Study|Other Reasons|5|||
146990830|NCT01575054|530128798|FG001|Overall Study|Other Reasons|3|||
146990831|NCT01575054|530128797|FG000|Overall Study|Protocol Violation|2|||
146990832|NCT01575054|530128798|FG001|Overall Study|Protocol Violation|1|||
146990833|NCT01575054|530128797|FG000|Overall Study|Personal Reasons|10|||
146990834|NCT01575054|530128798|FG001|Overall Study|Personal Reasons|11|||
146990835|NCT01575054|530128797|FG000|Overall Study|Lost to Follow-up|3|||
146990836|NCT01575054|530128798|FG001|Overall Study|Lost to Follow-up|3|||
146990837|NCT01575054|530128797|FG000|Overall Study|Adverse Event|9|||
146990838|NCT01575054|530128798|FG001|Overall Study|Adverse Event|8|||
146990839|NCT03481309|530128799|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
146990840|NCT03481309|530128800|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
146990841|NCT03481309|530128801|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
146990842|NCT03481309|530128802|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
146990843|NCT03481309|530128803|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
146990844|NCT03481309|530128804|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
146839335|NCT00281320|529582421|FG000|Overall Study|Adverse Event|12|||
146839336|NCT00281320|529582422|FG001|Overall Study|Adverse Event|9|||
146990845|NCT02768298|530128807|FG000|Overall Study|Adverse Event|1|||
146990846|NCT02768298|530128808|FG001|Overall Study|Adverse Event|4|||
146990847|NCT02768298|530128807|FG000|Overall Study|Death|2|||
146990848|NCT02768298|530128808|FG001|Overall Study|Death|1|||
146990849|NCT02768298|530128807|FG000|Overall Study|Non-compliance with study treatment|0|||
146990850|NCT02768298|530128808|FG001|Overall Study|Non-compliance with study treatment|1|||
146990851|NCT02768298|530128807|FG000|Overall Study|Subject/guardian decision|1|||
146839337|NCT00281320|529582421|FG000|Overall Study|Lack of Efficacy|4|||
146990852|NCT02768298|530128808|FG001|Overall Study|Subject/guardian decision|0|||
146990853|NCT02768298|530128807|FG000|Overall Study|Withdrawal of informed consent|0|||
146990854|NCT02768298|530128808|FG001|Overall Study|Withdrawal of informed consent|1|||
146990855|NCT04603937|530128809|FG000|Overall Study|Adverse Event|9|||
146990856|NCT04603937|530128810|FG001|Overall Study|Adverse Event|10|||
146990857|NCT04603937|530128809|FG000|Overall Study|Withdrawal by Subject|7|||
146990858|NCT04603937|530128810|FG001|Overall Study|Withdrawal by Subject|6|||
146990859|NCT04603937|530128809|FG000|Overall Study|Lost to Follow-up|5|||
146990860|NCT04603937|530128810|FG001|Overall Study|Lost to Follow-up|6|||
146990861|NCT04603937|530128809|FG000|Overall Study|Physician Decision|0|||
146990862|NCT04603937|530128810|FG001|Overall Study|Physician Decision|1|||
146990863|NCT04603937|530128809|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
146990864|NCT04603937|530128810|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
146990865|NCT01611090|530128811|FG000|Randomized Period|Lost to Follow-up|8|||
146990866|NCT01611090|530128812|FG001|Randomized Period|Lost to Follow-up|3|||
146990867|NCT01611090|530128813|FG002|Randomized Period|Lost to Follow-up|0|||
146990868|NCT01611090|530128811|FG000|Randomized Period|Withdrawal by Subject|22|||
146990869|NCT01611090|530128812|FG001|Randomized Period|Withdrawal by Subject|26|||
146990870|NCT01611090|530128813|FG002|Randomized Period|Withdrawal by Subject|0|||
146990871|NCT01611090|530128811|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
146990872|NCT01611090|530128812|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
146990873|NCT01611090|530128813|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
146990874|NCT01611090|530128811|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
146990875|NCT01611090|530128812|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
146990876|NCT01611090|530128813|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
146990877|NCT05109234|530128814|FG000|Overall Study|Adverse Event|2|||
146990878|NCT05109234|530128815|FG001|Overall Study|Adverse Event|2|||
146990879|NCT05109234|530128814|FG000|Overall Study|Lack of Efficacy|5|||
146990880|NCT05109234|530128815|FG001|Overall Study|Lack of Efficacy|0|||
146990881|NCT05109234|530128814|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
146990882|NCT05109234|530128815|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
146990883|NCT05109234|530128814|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
146990884|NCT05109234|530128815|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
146990885|NCT05109234|530128814|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
146990886|NCT05109234|530128815|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
146990887|NCT05109234|530128814|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
146990888|NCT05109234|530128815|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
146990889|NCT00336024|530128817|FG000|Overall Study|Death|2|||
146990890|NCT00336024|530128818|FG001|Overall Study|Death|1|||
146990891|NCT00336024|530128817|FG000|Overall Study|Physician Decision|4|||
146990892|NCT00336024|530128818|FG001|Overall Study|Physician Decision|1|||
146990893|NCT00336024|530128817|FG000|Overall Study|Protocol Violation|1|||
146990894|NCT00336024|530128818|FG001|Overall Study|Protocol Violation|0|||
146990895|NCT00336024|530128817|FG000|Overall Study|Withdrawal by Subject|1|||
146990896|NCT00336024|530128818|FG001|Overall Study|Withdrawal by Subject|2|||
146990897|NCT00336024|530128817|FG000|Overall Study|Failure to fulfill consolidation|1|||
146990898|NCT00336024|530128818|FG001|Overall Study|Failure to fulfill consolidation|1|||
146990899|NCT00336024|530128817|FG000|Overall Study|Progressive Disease|4|||
146990900|NCT00336024|530128818|FG001|Overall Study|Progressive Disease|7|||
146990901|NCT00336024|530128817|FG000|Overall Study|Ineligible|7|||
146990902|NCT00336024|530128818|FG001|Overall Study|Ineligible|7|||
146990903|NCT02585258|530128819|FG000|Overall Study|Adverse Event|28|||
146839338|NCT00281320|529582422|FG001|Overall Study|Lack of Efficacy|3|||
146839339|NCT00281320|529582421|FG000|Overall Study|Withdrawal by Subject|5|||
146839340|NCT00281320|529582422|FG001|Overall Study|Withdrawal by Subject|6|||
146990904|NCT02585258|530128820|FG001|Overall Study|Adverse Event|29|||
146990905|NCT02585258|530128819|FG000|Overall Study|Death|3|||
146990906|NCT02585258|530128820|FG001|Overall Study|Death|2|||
146990907|NCT02585258|530128819|FG000|Overall Study|Lack of Efficacy|7|||
146990908|NCT02585258|530128820|FG001|Overall Study|Lack of Efficacy|9|||
146990909|NCT02585258|530128819|FG000|Overall Study|includes covid-related access problems|42|||
146990910|NCT02585258|530128820|FG001|Overall Study|includes covid-related access problems|46|||
146990911|NCT02585258|530128819|FG000|Overall Study|Lost to Follow-up|5|||
146990912|NCT02585258|530128820|FG001|Overall Study|Lost to Follow-up|2|||
146839341|NCT00281320|529582421|FG000|Overall Study|Lost to Follow-up|1|||
146839342|NCT00281320|529582422|FG001|Overall Study|Lost to Follow-up|2|||
146990913|NCT05125952|530128821|FG000|Overall Study|Physician Decision|1|||
146990914|NCT03946449|530128822|FG000|Treatment Extension II|Rolled over to another study|0|||
146990915|NCT03946449|530128823|FG001|Treatment Extension II|Rolled over to another study|0|||
146990916|NCT03946449|530128824|FG002|Treatment Extension II|Rolled over to another study|2|||
146990917|NCT03946449|530128822|FG000|Treatment Extension II|Withdrawal by Subject|0|||
146990918|NCT03946449|530128823|FG001|Treatment Extension II|Withdrawal by Subject|0|||
146990919|NCT03946449|530128824|FG002|Treatment Extension II|Withdrawal by Subject|1|||
146990920|NCT01210001|530130642|FG000|Overall Study|Not treated|1|||
146990921|NCT01210001|530130643|FG001|Overall Study|Not treated|0|||
146990922|NCT01210001|530130644|FG002|Overall Study|Not treated|0|||
146990923|NCT01210001|530130642|FG000|Overall Study|Adverse Event|4|||
146990924|NCT01210001|530130643|FG001|Overall Study|Adverse Event|2|||
146990925|NCT01210001|530130644|FG002|Overall Study|Adverse Event|5|||
146990926|NCT01210001|530130642|FG000|Overall Study|Non compliant with protocol|2|||
146990927|NCT01210001|530130643|FG001|Overall Study|Non compliant with protocol|2|||
146990928|NCT01210001|530130644|FG002|Overall Study|Non compliant with protocol|3|||
146990929|NCT01210001|530130642|FG000|Overall Study|Lost to Follow-up|4|||
146990930|NCT01210001|530130643|FG001|Overall Study|Lost to Follow-up|3|||
146990931|NCT01210001|530130644|FG002|Overall Study|Lost to Follow-up|2|||
146990932|NCT01210001|530130642|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
146990933|NCT01210001|530130643|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
146990934|NCT01210001|530130644|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
146990935|NCT01210001|530130642|FG000|Overall Study|Other reason not defined above|2|||
146990936|NCT01210001|530130643|FG001|Overall Study|Other reason not defined above|2|||
146990937|NCT01210001|530130644|FG002|Overall Study|Other reason not defined above|1|||
146990938|NCT00788125|530130645|FG000|Overall Study|Death|6|||
146990939|NCT02180711|530130650|FG000|Overall Study|Death|0|||
146990940|NCT02180711|530130651|FG001|Overall Study|Death|1|||
146990941|NCT02180711|530130652|FG002|Overall Study|Death|0|||
146990942|NCT02180711|530130653|FG003|Overall Study|Death|0|||
146990943|NCT02180711|530130654|FG004|Overall Study|Death|7|||
146990944|NCT02180711|530130655|FG005|Overall Study|Death|0|||
146990945|NCT02180711|530130656|FG006|Overall Study|Death|1|||
146990946|NCT02180711|530130657|FG007|Overall Study|Death|3|||
146990947|NCT02180711|530130650|FG000|Overall Study|Lost to Follow-up|0|||
146990948|NCT02180711|530130651|FG001|Overall Study|Lost to Follow-up|1|||
146990949|NCT02180711|530130652|FG002|Overall Study|Lost to Follow-up|0|||
146990950|NCT02180711|530130653|FG003|Overall Study|Lost to Follow-up|0|||
146990951|NCT02180711|530130654|FG004|Overall Study|Lost to Follow-up|1|||
146990952|NCT02180711|530130655|FG005|Overall Study|Lost to Follow-up|1|||
146990953|NCT02180711|530130656|FG006|Overall Study|Lost to Follow-up|0|||
146990954|NCT02180711|530130657|FG007|Overall Study|Lost to Follow-up|3|||
146990955|NCT02180711|530130650|FG000|Overall Study|Withdrawal by Subject|2|||
146990956|NCT02180711|530130651|FG001|Overall Study|Withdrawal by Subject|1|||
146990957|NCT02180711|530130652|FG002|Overall Study|Withdrawal by Subject|0|||
146990958|NCT02180711|530130653|FG003|Overall Study|Withdrawal by Subject|4|||
146990959|NCT02180711|530130654|FG004|Overall Study|Withdrawal by Subject|3|||
146990960|NCT02180711|530130655|FG005|Overall Study|Withdrawal by Subject|0|||
146990961|NCT02180711|530130656|FG006|Overall Study|Withdrawal by Subject|3|||
146990962|NCT02180711|530130657|FG007|Overall Study|Withdrawal by Subject|2|||
146990963|NCT02180711|530130650|FG000|Overall Study|- Disease Progression|0|||
146990964|NCT02180711|530130651|FG001|Overall Study|- Disease Progression|1|||
146990965|NCT02180711|530130652|FG002|Overall Study|- Disease Progression|0|||
146990966|NCT02180711|530130653|FG003|Overall Study|- Disease Progression|0|||
146990967|NCT02180711|530130654|FG004|Overall Study|- Disease Progression|0|||
146990968|NCT02180711|530130655|FG005|Overall Study|- Disease Progression|0|||
146990969|NCT02180711|530130656|FG006|Overall Study|- Disease Progression|0|||
146990970|NCT02180711|530130657|FG007|Overall Study|- Disease Progression|0|||
146990971|NCT02180711|530130650|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
146990972|NCT02180711|530130651|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
146990973|NCT02180711|530130652|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
146990974|NCT02180711|530130653|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
146990975|NCT02180711|530130654|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
146990976|NCT02180711|530130655|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
146990977|NCT02180711|530130656|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
146990978|NCT02180711|530130657|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
146990979|NCT02180711|530130650|FG000|Overall Study|- Study Terminated by Sponsor|2|||
146990980|NCT02180711|530130651|FG001|Overall Study|- Study Terminated by Sponsor|3|||
146990981|NCT02180711|530130652|FG002|Overall Study|- Study Terminated by Sponsor|0|||
146990982|NCT02180711|530130653|FG003|Overall Study|- Study Terminated by Sponsor|5|||
146990983|NCT02180711|530130654|FG004|Overall Study|- Study Terminated by Sponsor|32|||
146990984|NCT02180711|530130655|FG005|Overall Study|- Study Terminated by Sponsor|0|||
146990985|NCT02180711|530130656|FG006|Overall Study|- Study Terminated by Sponsor|4|||
146990986|NCT02180711|530130657|FG007|Overall Study|- Study Terminated by Sponsor|13|||
146990987|NCT02180711|530130650|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
146990988|NCT02180711|530130651|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
146990989|NCT02180711|530130652|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
146990990|NCT02180711|530130653|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
146990991|NCT02180711|530130654|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
146990992|NCT02180711|530130655|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
146990993|NCT02180711|530130656|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
146990994|NCT02180711|530130657|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
146990995|NCT02180711|530130650|FG000|Overall Study|- Other|1|||
146990996|NCT02180711|530130651|FG001|Overall Study|- Other|0|||
146990997|NCT02180711|530130652|FG002|Overall Study|- Other|0|||
146990998|NCT02180711|530130653|FG003|Overall Study|- Other|1|||
146990999|NCT02180711|530130654|FG004|Overall Study|- Other|0|||
146991000|NCT02180711|530130655|FG005|Overall Study|- Other|0|||
146991001|NCT02180711|530130656|FG006|Overall Study|- Other|0|||
146991002|NCT02180711|530130657|FG007|Overall Study|- Other|0|||
146991003|NCT02684344|530130665|FG000|Overall Study|Withdrawal by Subject|0|||
146991004|NCT02684344|530130666|FG001|Overall Study|Withdrawal by Subject|1|||
146991005|NCT00863746|530130669|FG000|Treatment|Not treated|4|||
146991006|NCT00863746|530130670|FG001|Treatment|Not treated|2|||
146991007|NCT00863746|530130669|FG000|Treatment|Adverse Event|41|||
146991008|NCT00863746|530130670|FG001|Treatment|Adverse Event|16|||
146991009|NCT00863746|530130669|FG000|Treatment|non-compliant with study medication|4|||
146991010|NCT00863746|530130670|FG001|Treatment|non-compliant with study medication|0|||
146991011|NCT00863746|530130669|FG000|Treatment|Consent withdrawn|15|||
146991012|NCT00863746|530130670|FG001|Treatment|Consent withdrawn|14|||
146991013|NCT00863746|530130669|FG000|Treatment|Lost to Follow-up|1|||
146991014|NCT00863746|530130670|FG001|Treatment|Lost to Follow-up|0|||
146991015|NCT00863746|530130669|FG000|Treatment|Protocol Violation|5|||
146991016|NCT00863746|530130670|FG001|Treatment|Protocol Violation|3|||
146991017|NCT00863746|530130669|FG000|Treatment|Other|1|||
146991018|NCT00863746|530130670|FG001|Treatment|Other|0|||
146991019|NCT00863746|530130669|FG000|Survival Follow up|Death|244|||
146991020|NCT00863746|530130670|FG001|Survival Follow up|Death|271|||
146991021|NCT00863746|530130669|FG000|Survival Follow up|Lost to Follow-up|2|||
146991022|NCT00863746|530130670|FG001|Survival Follow up|Lost to Follow-up|1|||
146991023|NCT00863746|530130669|FG000|Survival Follow up|Consent Withdrawn|7|||
146991024|NCT00863746|530130670|FG001|Survival Follow up|Consent Withdrawn|8|||
146991025|NCT03292653|530130673|FG000|Overall Study|Adverse Event|0|||
146991026|NCT03292653|530130674|FG001|Overall Study|Adverse Event|0|||
146991027|NCT03292653|530130675|FG002|Overall Study|Adverse Event|1|||
146991028|NCT03292653|530130673|FG000|Overall Study|Did not Receive Treatment|1|||
146991029|NCT03292653|530130674|FG001|Overall Study|Did not Receive Treatment|0|||
146991030|NCT03292653|530130675|FG002|Overall Study|Did not Receive Treatment|0|||
146991031|NCT04720664|530130676|FG000|Overall Study|Adverse Event|2|||
146991032|NCT04720664|530130676|FG000|Overall Study|Lack of Efficacy|9|||
146991033|NCT05037097|530130677|FG000|Overall Study|Withdrawal by Subject|0|||
146991034|NCT05037097|530130678|FG001|Overall Study|Withdrawal by Subject|1|||
146991035|NCT05037097|530130679|FG002|Overall Study|Withdrawal by Subject|0|||
146991036|NCT05037097|530130680|FG003|Overall Study|Withdrawal by Subject|1|||
146991037|NCT05037097|530130681|FG004|Overall Study|Withdrawal by Subject|0|||
146991038|NCT05037097|530130682|FG005|Overall Study|Withdrawal by Subject|2|||
146991039|NCT05037097|530130683|FG006|Overall Study|Withdrawal by Subject|0|||
146991040|NCT05037097|530130684|FG007|Overall Study|Withdrawal by Subject|0|||
146991041|NCT05037097|530130677|FG000|Overall Study|Lost to Follow-up|0|||
146991042|NCT05037097|530130678|FG001|Overall Study|Lost to Follow-up|1|||
146991043|NCT05037097|530130679|FG002|Overall Study|Lost to Follow-up|0|||
146991044|NCT05037097|530130680|FG003|Overall Study|Lost to Follow-up|0|||
146991045|NCT05037097|530130681|FG004|Overall Study|Lost to Follow-up|1|||
146991046|NCT05037097|530130682|FG005|Overall Study|Lost to Follow-up|1|||
146991047|NCT05037097|530130683|FG006|Overall Study|Lost to Follow-up|0|||
146991048|NCT05037097|530130684|FG007|Overall Study|Lost to Follow-up|0|||
146991049|NCT02322047|530130685|FG000|Overall Study|Physician Decision|1|||
146991050|NCT02322047|530130686|FG001|Overall Study|Physician Decision|0|||
146991051|NCT02322047|530130687|FG002|Overall Study|Physician Decision|0|||
146839343|NCT00281320|529582421|FG000|Overall Study|Other|3|||
146839344|NCT00281320|529582422|FG001|Overall Study|Other|1|||
146839345|NCT00975676|529582426|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
146991052|NCT02322047|530130688|FG003|Overall Study|Physician Decision|0|||
146991053|NCT02322047|530130685|FG000|Overall Study|Withdrawal by Subject|1|||
146991054|NCT02322047|530130686|FG001|Overall Study|Withdrawal by Subject|0|||
146991055|NCT02322047|530130687|FG002|Overall Study|Withdrawal by Subject|0|||
146991056|NCT02322047|530130688|FG003|Overall Study|Withdrawal by Subject|1|||
146991057|NCT02322047|530130685|FG000|Overall Study|Adverse Event|0|||
146991058|NCT02322047|530130686|FG001|Overall Study|Adverse Event|1|||
146991059|NCT02322047|530130687|FG002|Overall Study|Adverse Event|0|||
146991060|NCT02322047|530130688|FG003|Overall Study|Adverse Event|0|||
146991061|NCT02322047|530130685|FG000|Overall Study|Lost to Follow-up|0|||
146991062|NCT02322047|530130686|FG001|Overall Study|Lost to Follow-up|0|||
146991063|NCT02322047|530130687|FG002|Overall Study|Lost to Follow-up|1|||
146991064|NCT02322047|530130688|FG003|Overall Study|Lost to Follow-up|1|||
146991065|NCT00376220|530130693|FG000|Overall Study|Lost to Follow-up|7|||
146991066|NCT00376220|530130694|FG001|Overall Study|Lost to Follow-up|10|||
146991067|NCT00376220|530130693|FG000|Overall Study|Withdrawal by Subject|3|||
146991068|NCT00376220|530130694|FG001|Overall Study|Withdrawal by Subject|2|||
146991069|NCT03311646|530130695|FG000|Overall Study|Physician Decision|1|||
146991070|NCT03311646|530130695|FG000|Overall Study|Withdrawal by Subject|5|||
146959095|NCT01072175|530009879|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146959096|NCT01072175|530009880|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146959097|NCT01072175|530009881|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146959098|NCT01072175|530009869|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146959099|NCT01072175|530009870|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146959100|NCT01072175|530009871|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146959101|NCT01072175|530009872|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146959102|NCT01072175|530009873|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146959103|NCT01072175|530009874|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146959104|NCT01072175|530009875|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146959105|NCT01072175|530009876|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146959106|NCT01072175|530009877|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
146959107|NCT01072175|530009878|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146959108|NCT01072175|530009879|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146959109|NCT01072175|530009880|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146959110|NCT01072175|530009881|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146959111|NCT01072175|530009869|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146959112|NCT01072175|530009870|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146959113|NCT01072175|530009871|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146959114|NCT01072175|530009872|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146959115|NCT01072175|530009873|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146959116|NCT01072175|530009874|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146959117|NCT01072175|530009875|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146959118|NCT01072175|530009876|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146959119|NCT01072175|530009877|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
146959120|NCT01072175|530009878|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146959121|NCT01072175|530009879|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146959122|NCT01072175|530009880|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146959123|NCT01072175|530009881|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146959124|NCT01072175|530009869|FG000|Part D (HPMC Capsules)|Death|0|||
146959125|NCT01072175|530009870|FG001|Part D (HPMC Capsules)|Death|0|||
146959126|NCT01072175|530009871|FG002|Part D (HPMC Capsules)|Death|0|||
146959127|NCT01072175|530009872|FG003|Part D (HPMC Capsules)|Death|0|||
146959128|NCT01072175|530009873|FG004|Part D (HPMC Capsules)|Death|0|||
146959129|NCT01072175|530009874|FG005|Part D (HPMC Capsules)|Death|0|||
146959130|NCT01072175|530009875|FG006|Part D (HPMC Capsules)|Death|0|||
146959131|NCT01072175|530009876|FG007|Part D (HPMC Capsules)|Death|0|||
146959132|NCT01072175|530009877|FG008|Part D (HPMC Capsules)|Death|0|||
146959133|NCT01072175|530009878|FG009|Part D (HPMC Capsules)|Death|10|||
146959134|NCT01072175|530009879|FG010|Part D (HPMC Capsules)|Death|12|||
146959135|NCT01072175|530009880|FG011|Part D (HPMC Capsules)|Death|28|||
146959136|NCT01072175|530009881|FG012|Part D (HPMC Capsules)|Death|26|||
146959137|NCT01072175|530009869|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
146959138|NCT01072175|530009870|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
146959139|NCT01072175|530009871|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
146959140|NCT01072175|530009872|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
146959141|NCT01072175|530009873|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
146959142|NCT01072175|530009874|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
146959143|NCT01072175|530009875|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
146959144|NCT01072175|530009876|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
146959145|NCT01072175|530009877|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
146959146|NCT01072175|530009878|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
146959147|NCT01072175|530009879|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
146959148|NCT01072175|530009880|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
146959149|NCT01072175|530009881|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
146959150|NCT01072175|530009869|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146959151|NCT01072175|530009870|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146839346|NCT00975676|529582427|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
146839347|NCT02548078|529582428|FG000|Overall Study|Serious adverse event/Adverse event|1|||
146839348|NCT02548078|529582429|FG001|Overall Study|Serious adverse event/Adverse event|0|||
146839349|NCT02548078|529582428|FG000|Overall Study|Moved from study area|3|||
146839350|NCT02548078|529582429|FG001|Overall Study|Moved from study area|3|||
146839351|NCT02548078|529582428|FG000|Overall Study|Lost to Follow-up|1|||
146839352|NCT02548078|529582429|FG001|Overall Study|Lost to Follow-up|3|||
146839353|NCT03128671|529582430|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
146839354|NCT03128671|529582431|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
146959152|NCT01072175|530009871|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146839355|NCT03128671|529582430|FG000|Allocation|Death|1|||
146839356|NCT03128671|529582431|FG001|Allocation|Death|0|||
146991071|NCT03311646|530130695|FG000|Overall Study|Lost to Follow-up|5|||
146991072|NCT03311646|530130695|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
146991073|NCT00531206|530130696|FG000|Overall Study|Adverse Event related|5|||
146991074|NCT00531206|530130696|FG000|Overall Study|Lack of Efficacy|2|||
146991075|NCT00531206|530130696|FG000|Overall Study|Lost to Follow-up|5|||
146991076|NCT00531206|530130696|FG000|Overall Study|including non-related adverse events|8|||
146991077|NCT02906709|530130697|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
146991078|NCT02906709|530130698|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
146991079|NCT02906709|530130697|FG000|Phase A (Week 0 to Week 16)|Death|0|||
146991080|NCT02906709|530130698|FG001|Phase A (Week 0 to Week 16)|Death|1|||
146991081|NCT02906709|530130697|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
146991082|NCT02906709|530130698|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
146991083|NCT02906709|530130697|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
146991084|NCT02906709|530130698|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
146991085|NCT01439165|530130705|FG000|Overall Study|Protocol Violation|3|||
146991086|NCT01439165|530130706|FG001|Overall Study|Protocol Violation|0|||
146991087|NCT01439165|530130705|FG000|Overall Study|Lost to Follow-up|11|||
146991088|NCT01439165|530130706|FG001|Overall Study|Lost to Follow-up|1|||
146991089|NCT01439165|530130705|FG000|Overall Study|Withdrawal by Subject|7|||
146991090|NCT01439165|530130706|FG001|Overall Study|Withdrawal by Subject|1|||
146991091|NCT03331042|530130707|FG000|Overall Study|Protocol Violation|1|||
146991092|NCT03331042|530130708|FG001|Overall Study|Protocol Violation|0|||
146991093|NCT03331042|530130709|FG002|Overall Study|Protocol Violation|0|||
146991094|NCT03331042|530130710|FG003|Overall Study|Protocol Violation|0|||
146991095|NCT03331042|530130707|FG000|Overall Study|Physician Decision|0|||
146991096|NCT03331042|530130708|FG001|Overall Study|Physician Decision|0|||
146991097|NCT03331042|530130709|FG002|Overall Study|Physician Decision|1|||
146991098|NCT03331042|530130710|FG003|Overall Study|Physician Decision|0|||
146991099|NCT03331042|530130707|FG000|Overall Study|Lost to Follow-up|0|||
146991100|NCT03331042|530130708|FG001|Overall Study|Lost to Follow-up|0|||
146991101|NCT03331042|530130709|FG002|Overall Study|Lost to Follow-up|0|||
146991102|NCT03331042|530130710|FG003|Overall Study|Lost to Follow-up|1|||
146991103|NCT00322491|530130716|FG000|Overall Study|Adverse Event|1|||
146991104|NCT00322491|530130717|FG001|Overall Study|Adverse Event|0|||
146991105|NCT00322491|530130716|FG000|Overall Study|Death|1|||
146991106|NCT00322491|530130717|FG001|Overall Study|Death|2|||
146991107|NCT03992196|530130718|FG000|Enrollment|lost to follow-up prior dosing|1|||
146991108|NCT03992196|530130719|FG001|Enrollment|lost to follow-up prior dosing|0|||
146991109|NCT03992196|530130720|FG002|Enrollment|lost to follow-up prior dosing|0|||
146991110|NCT03992196|530130718|FG000|Treatment|Protocol Violation|0|||
146991111|NCT03992196|530130719|FG001|Treatment|Protocol Violation|0|||
146991112|NCT03992196|530130720|FG002|Treatment|Protocol Violation|1|||
146991113|NCT03992196|530130718|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
146991114|NCT03992196|530130719|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
146991115|NCT03992196|530130720|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
146991116|NCT03992196|530130718|FG000|Treatment|Withdrawal due to non-compliance|0|||
146991117|NCT03992196|530130719|FG001|Treatment|Withdrawal due to non-compliance|0|||
146991118|NCT03992196|530130720|FG002|Treatment|Withdrawal due to non-compliance|1|||
146839357|NCT03128671|529582430|FG000|Allocation|Withdrawal by Subject|4|||
146991119|NCT03992196|530130718|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
146991120|NCT03992196|530130719|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
146991121|NCT03992196|530130720|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
146991122|NCT03992196|530130718|FG000|Treatment|Withdrawal by parent/guardian|0|||
146991123|NCT03992196|530130719|FG001|Treatment|Withdrawal by parent/guardian|0|||
146991124|NCT03992196|530130720|FG002|Treatment|Withdrawal by parent/guardian|2|||
146991125|NCT00048048|530130721|FG000|Core Treatment|Withdrawal by Subject|0|||
146991126|NCT00048048|530130722|FG001|Core Treatment|Withdrawal by Subject|0|||
146991127|NCT00048048|530130723|FG002|Core Treatment|Withdrawal by Subject|1|||
146991128|NCT00048048|530130724|FG003|Core Treatment|Withdrawal by Subject|0|||
146991129|NCT00048048|530130725|FG004|Core Treatment|Withdrawal by Subject|0|||
146991130|NCT00048048|530130726|FG005|Core Treatment|Withdrawal by Subject|0|||
146991131|NCT00048048|530130727|FG006|Core Treatment|Withdrawal by Subject|0|||
146991132|NCT00048048|530130728|FG007|Core Treatment|Withdrawal by Subject|0|||
146991133|NCT00048048|530130729|FG008|Core Treatment|Withdrawal by Subject|0|||
146991134|NCT00048048|530130730|FG009|Core Treatment|Withdrawal by Subject|0|||
146991135|NCT00048048|530130731|FG010|Core Treatment|Withdrawal by Subject|0|||
146991136|NCT00048048|530130732|FG011|Core Treatment|Withdrawal by Subject|0|||
146839358|NCT03128671|529582431|FG001|Allocation|Withdrawal by Subject|0|||
146991137|NCT00048048|530130721|FG000|Core Treatment|Adverse Event|0|||
146991138|NCT00048048|530130722|FG001|Core Treatment|Adverse Event|0|||
146991139|NCT00048048|530130723|FG002|Core Treatment|Adverse Event|0|||
146991140|NCT00048048|530130724|FG003|Core Treatment|Adverse Event|0|||
146991141|NCT00048048|530130725|FG004|Core Treatment|Adverse Event|0|||
146991142|NCT00048048|530130726|FG005|Core Treatment|Adverse Event|0|||
146991143|NCT00048048|530130727|FG006|Core Treatment|Adverse Event|0|||
146839359|NCT03128671|529582430|FG000|Intervention|Withdrawal by Subject|11|||
146839360|NCT03128671|529582431|FG001|Intervention|Withdrawal by Subject|10|||
146839361|NCT03128671|529582430|FG000|Intervention|Palliative/hospice care initiated|9|||
146959153|NCT01072175|530009872|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146959154|NCT01072175|530009873|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146959155|NCT01072175|530009874|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146959156|NCT01072175|530009875|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146959157|NCT01072175|530009876|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146959158|NCT01072175|530009877|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146959159|NCT01072175|530009878|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146959160|NCT01072175|530009879|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
146959161|NCT01072175|530009880|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
146959162|NCT01072175|530009881|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
146959163|NCT01072175|530009869|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
146959164|NCT01072175|530009870|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
146959165|NCT01072175|530009871|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
146959166|NCT01072175|530009872|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
146959167|NCT01072175|530009873|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
146959168|NCT01072175|530009874|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
146959169|NCT01072175|530009875|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
146959170|NCT01072175|530009876|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
146959171|NCT01072175|530009877|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
146959172|NCT01072175|530009878|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
146959173|NCT01072175|530009879|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
146959174|NCT01072175|530009880|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
146959175|NCT01072175|530009881|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
146959176|NCT01072175|530009869|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146959177|NCT01072175|530009870|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146959178|NCT01072175|530009871|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146959179|NCT01072175|530009872|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146959180|NCT01072175|530009873|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146959181|NCT01072175|530009874|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146959182|NCT01072175|530009875|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146959183|NCT01072175|530009876|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146959184|NCT01072175|530009877|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146959185|NCT01072175|530009878|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146959186|NCT01072175|530009879|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
146959187|NCT01072175|530009880|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
146959188|NCT01072175|530009881|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146959189|NCT02477215|530009882|FG000|Dose Escalation Phase|Physician Decision|1|||
146959190|NCT02477215|530009883|FG001|Dose Escalation Phase|Physician Decision|2|||
146959191|NCT02477215|530009884|FG002|Dose Escalation Phase|Physician Decision|0|||
146959192|NCT02477215|530009882|FG000|Fixed Dose Phase|Physician Decision|0|||
146959193|NCT02477215|530009883|FG001|Fixed Dose Phase|Physician Decision|7|||
146959194|NCT02477215|530009884|FG002|Fixed Dose Phase|Physician Decision|0|||
146959195|NCT02210559|530009885|FG000|Overall Study|Progressive Disease|3|||
146959196|NCT02210559|530009886|FG001|Overall Study|Progressive Disease|2|||
146959197|NCT02210559|530009885|FG000|Overall Study|Adverse Event|2|||
146959198|NCT02210559|530009886|FG001|Overall Study|Adverse Event|2|||
146959199|NCT02210559|530009885|FG000|Overall Study|Physician Decision|1|||
146839362|NCT03128671|529582431|FG001|Intervention|Palliative/hospice care initiated|10|||
146839363|NCT03128671|529582430|FG000|Intervention|Death|13|||
146839364|NCT03128671|529582431|FG001|Intervention|Death|11|||
146839365|NCT03128671|529582430|FG000|Intervention|Interrupted by hurricane|1|||
146839366|NCT03128671|529582431|FG001|Intervention|Interrupted by hurricane|0|||
146839367|NCT03128671|529582430|FG000|Intervention|Physician Decision|2|||
146839368|NCT03128671|529582431|FG001|Intervention|Physician Decision|3|||
146839369|NCT04641962|529582433|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
146839370|NCT04641962|529582434|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
146839371|NCT04641962|529582435|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
146839372|NCT04641962|529582436|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
146839373|NCT04641962|529582437|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
146839374|NCT04641962|529582433|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
146839375|NCT04641962|529582434|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
146839376|NCT04641962|529582435|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
146839377|NCT04641962|529582436|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
146959200|NCT02210559|530009886|FG001|Overall Study|Physician Decision|0|||
146959201|NCT02210559|530009885|FG000|Overall Study|Withdrawal by Subject|0|||
146959202|NCT02210559|530009886|FG001|Overall Study|Withdrawal by Subject|1|||
146959203|NCT02210559|530009885|FG000|Overall Study|Other than specified|0|||
146959204|NCT02210559|530009886|FG001|Overall Study|Other than specified|1|||
146959205|NCT02546193|530009887|FG000|Overall Study|Withdrawal by Subject|2|||
146959206|NCT02546193|530009888|FG001|Overall Study|Withdrawal by Subject|0|||
146959207|NCT02546193|530009889|FG002|Overall Study|Withdrawal by Subject|1|||
146991144|NCT00048048|530130728|FG007|Core Treatment|Adverse Event|1|||
146991145|NCT00048048|530130729|FG008|Core Treatment|Adverse Event|0|||
146991146|NCT00048048|530130730|FG009|Core Treatment|Adverse Event|0|||
146991147|NCT00048048|530130731|FG010|Core Treatment|Adverse Event|0|||
146991148|NCT00048048|530130732|FG011|Core Treatment|Adverse Event|0|||
146991149|NCT00048048|530130721|FG000|Extension Year 1|Early withdrawals|0|||
146991150|NCT00048048|530130722|FG001|Extension Year 1|Early withdrawals|0|||
146991151|NCT00048048|530130723|FG002|Extension Year 1|Early withdrawals|0|||
146991152|NCT00048048|530130724|FG003|Extension Year 1|Early withdrawals|0|||
146991153|NCT00048048|530130725|FG004|Extension Year 1|Early withdrawals|0|||
146991154|NCT00048048|530130726|FG005|Extension Year 1|Early withdrawals|0|||
146991155|NCT00048048|530130727|FG006|Extension Year 1|Early withdrawals|0|||
146991156|NCT00048048|530130728|FG007|Extension Year 1|Early withdrawals|0|||
146991157|NCT00048048|530130729|FG008|Extension Year 1|Early withdrawals|0|||
146991158|NCT00048048|530130730|FG009|Extension Year 1|Early withdrawals|2|||
146991159|NCT00048048|530130731|FG010|Extension Year 1|Early withdrawals|2|||
146991160|NCT00048048|530130732|FG011|Extension Year 1|Early withdrawals|4|||
146991161|NCT00048048|530130721|FG000|Extension Year 2|Early withdrawals|0|||
146991162|NCT00048048|530130722|FG001|Extension Year 2|Early withdrawals|0|||
146991163|NCT00048048|530130723|FG002|Extension Year 2|Early withdrawals|0|||
146991164|NCT00048048|530130724|FG003|Extension Year 2|Early withdrawals|0|||
146991165|NCT00048048|530130725|FG004|Extension Year 2|Early withdrawals|0|||
146991166|NCT00048048|530130726|FG005|Extension Year 2|Early withdrawals|0|||
146991167|NCT00048048|530130727|FG006|Extension Year 2|Early withdrawals|0|||
146991168|NCT00048048|530130728|FG007|Extension Year 2|Early withdrawals|0|||
146991169|NCT00048048|530130729|FG008|Extension Year 2|Early withdrawals|0|||
146991170|NCT00048048|530130730|FG009|Extension Year 2|Early withdrawals|0|||
146991171|NCT00048048|530130731|FG010|Extension Year 2|Early withdrawals|4|||
146991172|NCT00048048|530130732|FG011|Extension Year 2|Early withdrawals|2|||
146991173|NCT02388763|530130735|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
146991174|NCT02388763|530130736|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
146991175|NCT02388763|530130735|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
146991176|NCT02388763|530130736|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
146991177|NCT05518487|530130737|FG000|Overall Study|Withdrawal by Subject|3|||
146991178|NCT02194998|530130742|FG000|On-HCV Treatment|Did not pick up study medication|0|||
146991179|NCT02194998|530130743|FG001|On-HCV Treatment|Did not pick up study medication|1|||
146991180|NCT02194998|530130744|FG002|On-HCV Treatment|Did not pick up study medication|0|||
146991181|NCT02194998|530130745|FG003|On-HCV Treatment|Did not pick up study medication|0|||
146991182|NCT02194998|530130742|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
146991183|NCT02194998|530130743|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
146991184|NCT02194998|530130744|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
146991185|NCT02194998|530130745|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
146991186|NCT01458405|530130746|FG000|Phase 1 (up to 12 Months)|Other|0|||
146991187|NCT01458405|530130747|FG001|Phase 1 (up to 12 Months)|Other|1|||
146991188|NCT01458405|530130748|FG002|Phase 1 (up to 12 Months)|Other|0|||
146991189|NCT01458405|530130749|FG003|Phase 1 (up to 12 Months)|Other|0|||
146991190|NCT01458405|530130746|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
146991191|NCT01458405|530130747|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
146991192|NCT01458405|530130748|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
146991193|NCT01458405|530130749|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
146991194|NCT01458405|530130746|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
146991195|NCT01458405|530130747|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
146991196|NCT01458405|530130748|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
146991197|NCT01458405|530130749|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
146991198|NCT01458405|530130746|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
146991199|NCT01458405|530130747|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
146991200|NCT01458405|530130748|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
146991201|NCT01458405|530130749|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
146991202|NCT02497781|530130750|FG000|Overall Study|Withdrawal by Subject|2|||
146991203|NCT02497781|530130751|FG001|Overall Study|Withdrawal by Subject|0|||
146991204|NCT02497781|530130750|FG000|Overall Study|Lack of Efficacy|0|||
146991205|NCT02497781|530130751|FG001|Overall Study|Lack of Efficacy|1|||
146991206|NCT02497781|530130750|FG000|Overall Study|Randomised but not treated|1|||
146991207|NCT02497781|530130751|FG001|Overall Study|Randomised but not treated|1|||
146991208|NCT02497781|530130750|FG000|Overall Study|Lost to Follow-up|1|||
146991209|NCT02497781|530130751|FG001|Overall Study|Lost to Follow-up|1|||
146991210|NCT02236130|530130752|FG000|Overall Study|Lost to Follow-up|7|||
146991211|NCT02236130|530130753|FG001|Overall Study|Lost to Follow-up|12|||
146991212|NCT00525590|530130754|FG000|Overall Study|Adverse Event|3|||
146991213|NCT00525590|530130754|FG000|Overall Study|Physician Decision|3|||
146991214|NCT00525590|530130754|FG000|Overall Study|Withdrawal by Subject|16|||
146991215|NCT00525590|530130754|FG000|Overall Study|Lost to Follow-up|1|||
146991216|NCT00525590|530130754|FG000|Overall Study|Death|9|||
146991217|NCT00525590|530130754|FG000|Overall Study|Other|13|||
146991218|NCT01345019|530130763|FG000|Blinded Treatment Phase|Death|147|||
146991219|NCT01345019|530130764|FG001|Blinded Treatment Phase|Death|137|||
146839378|NCT04641962|529582437|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
146839379|NCT04641962|529582433|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
146991220|NCT01345019|530130763|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
146991221|NCT01345019|530130764|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
146991222|NCT01345019|530130763|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
146991223|NCT01345019|530130764|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
146991224|NCT01345019|530130763|FG000|Blinded Treatment Phase|Disease Progression|12|||
146991225|NCT01345019|530130764|FG001|Blinded Treatment Phase|Disease Progression|10|||
146991226|NCT01345019|530130763|FG000|Blinded Treatment Phase|Adverse Event|6|||
146991227|NCT01345019|530130764|FG001|Blinded Treatment Phase|Adverse Event|13|||
146991228|NCT01345019|530130763|FG000|Blinded Treatment Phase|Administrative Decision|10|||
146991229|NCT01345019|530130764|FG001|Blinded Treatment Phase|Administrative Decision|8|||
146991230|NCT01345019|530130763|FG000|Blinded Treatment Phase|Noncompliance|5|||
146991231|NCT01345019|530130764|FG001|Blinded Treatment Phase|Noncompliance|3|||
146991232|NCT01345019|530130763|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
146991233|NCT01345019|530130764|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
146991234|NCT01345019|530130763|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
146991235|NCT01345019|530130764|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
146991236|NCT01345019|530130763|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
146991237|NCT01345019|530130764|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
146991238|NCT01345019|530130763|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
146991239|NCT01345019|530130764|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
146991240|NCT01345019|530130763|FG000|Open Label Treatment Phase|Death|49|||
146991241|NCT01345019|530130764|FG001|Open Label Treatment Phase|Death|48|||
146991242|NCT01345019|530130763|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
146991243|NCT01345019|530130764|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
146991244|NCT01345019|530130763|FG000|Open Label Treatment Phase|Adverse Event|30|||
146991245|NCT01345019|530130764|FG001|Open Label Treatment Phase|Adverse Event|51|||
146991246|NCT01345019|530130763|FG000|Open Label Treatment Phase|Administrative Decision|30|||
146991247|NCT01345019|530130764|FG001|Open Label Treatment Phase|Administrative Decision|15|||
146991248|NCT01345019|530130763|FG000|Open Label Treatment Phase|Disease Progression|17|||
146991249|NCT01345019|530130764|FG001|Open Label Treatment Phase|Disease Progression|18|||
146991250|NCT01345019|530130763|FG000|Open Label Treatment Phase|Noncompliance|5|||
146991251|NCT01345019|530130764|FG001|Open Label Treatment Phase|Noncompliance|4|||
146991252|NCT01345019|530130763|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
146991253|NCT01345019|530130764|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
146991254|NCT01345019|530130763|FG000|Open Label Treatment Phase|Pregnancy|1|||
146991255|NCT01345019|530130764|FG001|Open Label Treatment Phase|Pregnancy|0|||
146991256|NCT01345019|530130763|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
146991257|NCT01345019|530130764|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
146991258|NCT01345019|530130763|FG000|Open Label Treatment Phase|Protocol Violation|0|||
146991259|NCT01345019|530130764|FG001|Open Label Treatment Phase|Protocol Violation|1|||
146991260|NCT03830164|530130765|FG000|Overall Study|Adverse Event|0|||
146991261|NCT03830164|530130766|FG001|Overall Study|Adverse Event|2|||
146991262|NCT03830164|530130767|FG002|Overall Study|Adverse Event|0|||
146991263|NCT03830164|530130765|FG000|Overall Study|Lack of Efficacy|1|||
146991264|NCT03830164|530130766|FG001|Overall Study|Lack of Efficacy|5|||
146991265|NCT03830164|530130767|FG002|Overall Study|Lack of Efficacy|0|||
146991266|NCT03830164|530130765|FG000|Overall Study|Lost to Follow-up|0|||
146991267|NCT03830164|530130766|FG001|Overall Study|Lost to Follow-up|1|||
146991268|NCT03830164|530130767|FG002|Overall Study|Lost to Follow-up|0|||
146991269|NCT03830164|530130765|FG000|Overall Study|Withdrawal by Subject|1|||
146991270|NCT03830164|530130766|FG001|Overall Study|Withdrawal by Subject|0|||
146991271|NCT03830164|530130767|FG002|Overall Study|Withdrawal by Subject|0|||
146991272|NCT00320112|530130768|FG000|Overall Study|Lost to Follow-up|3|||
146991273|NCT00320112|530130769|FG001|Overall Study|Lost to Follow-up|4|||
146991274|NCT00320112|530130768|FG000|Overall Study|Withdrawal by Subject|3|||
146991275|NCT00320112|530130769|FG001|Overall Study|Withdrawal by Subject|0|||
146991276|NCT00320112|530130768|FG000|Overall Study|Death|2|||
146991277|NCT00320112|530130769|FG001|Overall Study|Death|1|||
146991278|NCT01199861|530130771|FG000|Overall Study|Administrative problems|1|||
146991279|NCT01199861|530130772|FG001|Overall Study|Administrative problems|0|||
146991280|NCT01199861|530130771|FG000|Overall Study|Adverse Event|1|||
146991281|NCT01199861|530130772|FG001|Overall Study|Adverse Event|0|||
146991282|NCT04981912|530130773|FG000|Overall Study|Physician Decision|2|||
146991283|NCT00661505|530130774|FG000|Overall Study|Adverse Event|3|||
146991284|NCT00661505|530130774|FG000|Overall Study|Protocol Violation|14|||
146991285|NCT00661505|530130774|FG000|Overall Study|Withdrawal by Subject|8|||
146991286|NCT00661505|530130774|FG000|Overall Study|Lost to Follow-up|3|||
146839380|NCT04641962|529582434|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
146991287|NCT00661505|530130774|FG000|Overall Study|Other|2|||
146991288|NCT05630547|530130775|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
146991289|NCT05630547|530130776|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
146991290|NCT05630547|530130777|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
146991291|NCT05630547|530130778|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
146991292|NCT05630547|530130775|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
146991293|NCT05630547|530130776|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
146991294|NCT05630547|530130777|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
146991295|NCT05630547|530130778|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
146991296|NCT05630547|530130775|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
146991297|NCT05630547|530130776|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
146991298|NCT05630547|530130777|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
146991299|NCT05630547|530130778|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
146991300|NCT05630547|530130775|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
146991301|NCT05630547|530130776|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
146991302|NCT05630547|530130777|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
146991303|NCT05630547|530130778|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
146991304|NCT05630547|530130775|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
146991305|NCT05630547|530130776|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
146991306|NCT05630547|530130777|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
146991307|NCT05630547|530130778|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
146991308|NCT05630547|530130775|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
146991309|NCT05630547|530130776|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
146991310|NCT05630547|530130777|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
146991311|NCT05630547|530130778|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
146991312|NCT05630547|530130775|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
146991313|NCT05630547|530130776|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
146991314|NCT05630547|530130777|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
146991315|NCT05630547|530130778|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
146991316|NCT05630547|530130775|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
146991317|NCT05630547|530130776|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
146991318|NCT05630547|530130777|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
146991319|NCT05630547|530130778|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
146991320|NCT05630547|530130775|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
146991321|NCT05630547|530130776|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
146991322|NCT05630547|530130777|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
146991323|NCT05630547|530130778|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
146991324|NCT05630547|530130775|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
146991325|NCT05630547|530130776|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
146991326|NCT05630547|530130777|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
146991327|NCT05630547|530130778|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
146991328|NCT00977470|530130779|FG000|Overall Study|Lack of Efficacy|32|||
146991329|NCT00977470|530130780|FG001|Overall Study|Lack of Efficacy|30|||
146991330|NCT00977470|530130779|FG000|Overall Study|Physician Decision|2|||
146991331|NCT00977470|530130780|FG001|Overall Study|Physician Decision|0|||
146991332|NCT00977470|530130779|FG000|Overall Study|Adverse Event|1|||
146991333|NCT00977470|530130780|FG001|Overall Study|Adverse Event|2|||
146991334|NCT00977470|530130779|FG000|Overall Study|Protocol Violation|1|||
146991335|NCT00977470|530130780|FG001|Overall Study|Protocol Violation|0|||
146991336|NCT00977470|530130779|FG000|Overall Study|Withdrawal by Subject|0|||
146991337|NCT00977470|530130780|FG001|Overall Study|Withdrawal by Subject|2|||
146991338|NCT00977470|530130779|FG000|Overall Study|Death|0|||
146991339|NCT00977470|530130780|FG001|Overall Study|Death|2|||
146991340|NCT00977470|530130779|FG000|Overall Study|clinical decline|0|||
146991341|NCT00977470|530130780|FG001|Overall Study|clinical decline|1|||
146991342|NCT00977470|530130779|FG000|Overall Study|prolonged recovery post-surgery|0|||
146991343|NCT00977470|530130780|FG001|Overall Study|prolonged recovery post-surgery|1|||
146991344|NCT00977470|530130779|FG000|Overall Study|Still on-study|2|||
146991345|NCT00977470|530130780|FG001|Overall Study|Still on-study|0|||
146991346|NCT00796822|530130781|FG000|Overall Study|Lost to Follow-up|2|||
146991347|NCT00796822|530130782|FG001|Overall Study|Lost to Follow-up|0|||
146991348|NCT00796822|530130781|FG000|Overall Study|Adverse Event|1|||
146991349|NCT00796822|530130782|FG001|Overall Study|Adverse Event|0|||
146991350|NCT02364557|530130783|FG000|Overall Study|Protocol Violation|3|||
146991351|NCT02364557|530130784|FG001|Overall Study|Protocol Violation|1|||
146991352|NCT03978624|530130785|FG000|Overall Study|Protocol Violation|1|||
146991353|NCT03978624|530130786|FG001|Overall Study|Protocol Violation|0|||
146991354|NCT05097989|530130788|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
146991355|NCT05097989|530130789|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
146991356|NCT05097989|530130790|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
146991357|NCT05097989|530130791|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
146991358|NCT05097989|530130792|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
146991359|NCT05097989|530130793|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
146991360|NCT05097989|530130794|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
146991361|NCT05097989|530130795|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
146991362|NCT05097989|530130796|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
146991363|NCT05097989|530130788|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
146991364|NCT05097989|530130789|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
146991365|NCT05097989|530130790|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
146991366|NCT05097989|530130791|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
146991367|NCT05097989|530130792|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
146991368|NCT05097989|530130793|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
146991369|NCT05097989|530130794|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
146991370|NCT05097989|530130795|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
146991371|NCT05097989|530130796|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
146991372|NCT05097989|530130788|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
146991373|NCT05097989|530130789|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
146991374|NCT05097989|530130790|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
146991375|NCT05097989|530130791|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
146991376|NCT05097989|530130792|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
146991377|NCT05097989|530130793|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
146991378|NCT05097989|530130794|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
146991379|NCT05097989|530130795|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
146991380|NCT05097989|530130796|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
146991381|NCT05097989|530130788|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
146991382|NCT05097989|530130789|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
146991383|NCT05097989|530130790|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
146991384|NCT05097989|530130791|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
146991385|NCT05097989|530130792|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
146991386|NCT05097989|530130793|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
146991387|NCT05097989|530130794|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
146991388|NCT05097989|530130795|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
146991389|NCT05097989|530130796|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
146991390|NCT05097989|530130788|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
146991391|NCT05097989|530130789|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
146839381|NCT04641962|529582435|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
146839382|NCT04641962|529582436|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
146839383|NCT04641962|529582437|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
146839384|NCT04641962|529582433|FG000|DBT Period: Up to 52 Weeks|Death|1|||
146839385|NCT04641962|529582434|FG001|DBT Period: Up to 52 Weeks|Death|0|||
146839386|NCT04641962|529582435|FG002|DBT Period: Up to 52 Weeks|Death|0|||
146839387|NCT04641962|529582436|FG003|DBT Period: Up to 52 Weeks|Death|0|||
146839388|NCT04641962|529582437|FG004|DBT Period: Up to 52 Weeks|Death|0|||
146839389|NCT04641962|529582433|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
146839390|NCT04641962|529582434|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
146839391|NCT04641962|529582435|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
146839392|NCT04641962|529582436|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
146839393|NCT04641962|529582437|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
146839394|NCT04641962|529582433|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
146839395|NCT04641962|529582434|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
146839396|NCT04641962|529582435|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
146839397|NCT04641962|529582436|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
146839398|NCT04641962|529582437|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
146839399|NCT04641962|529582433|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
146839400|NCT04641962|529582434|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
146839401|NCT04641962|529582435|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
146839402|NCT04641962|529582436|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
146839403|NCT04641962|529582437|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
146839404|NCT03832595|529582442|FG000|Overall Study|Death|142|||
146839405|NCT03832595|529582443|FG001|Overall Study|Death|130|||
146839406|NCT03832595|529582442|FG000|Overall Study|Medical management without dialysis|37|||
146839407|NCT03832595|529582443|FG001|Overall Study|Medical management without dialysis|1|||
146839408|NCT03277352|529582444|FG000|Overall Study|Study Terminated By Sponsor|2|||
146839409|NCT03277352|529582444|FG000|Overall Study|Withdrawal by Subject|4|||
146839410|NCT03277352|529582444|FG000|Overall Study|Death|4|||
146991392|NCT05097989|530130790|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
146991393|NCT05097989|530130791|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
146991394|NCT05097989|530130792|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
146839411|NCT04147195|529582445|FG000|Overall Study|Adverse Event|0|||
146839412|NCT04147195|529582446|FG001|Overall Study|Adverse Event|3|||
146839413|NCT04147195|529582445|FG000|Overall Study|Study Terminated by Sponsor|4|||
146839414|NCT04147195|529582446|FG001|Overall Study|Study Terminated by Sponsor|2|||
146839415|NCT04147195|529582445|FG000|Overall Study|Withdrawal by Subject|0|||
146839416|NCT04147195|529582446|FG001|Overall Study|Withdrawal by Subject|1|||
146839417|NCT03939689|529584587|FG000|Overall Study|Radiographic progression|14|||
146839418|NCT03939689|529584588|FG001|Overall Study|Radiographic progression|17|||
146839419|NCT03939689|529584587|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
146839420|NCT03939689|529584588|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
146839421|NCT03939689|529584587|FG000|Overall Study|Adverse Event|1|||
146839422|NCT03939689|529584588|FG001|Overall Study|Adverse Event|8|||
146839423|NCT03939689|529584587|FG000|Overall Study|Unequivocal clinical progression|2|||
146839424|NCT03939689|529584588|FG001|Overall Study|Unequivocal clinical progression|5|||
146839425|NCT03939689|529584587|FG000|Overall Study|Other|1|||
146839426|NCT03939689|529584588|FG001|Overall Study|Other|4|||
146839427|NCT03939689|529584587|FG000|Overall Study|Death|0|||
146839428|NCT03939689|529584588|FG001|Overall Study|Death|3|||
146839429|NCT03939689|529584587|FG000|Overall Study|Participant decision|0|||
146839430|NCT03939689|529584588|FG001|Overall Study|Participant decision|3|||
146839431|NCT03939689|529584587|FG000|Overall Study|Withdrawal of consent|2|||
146839432|NCT03939689|529584588|FG001|Overall Study|Withdrawal of consent|1|||
146839433|NCT03939689|529584587|FG000|Overall Study|Investigator decision|1|||
146839434|NCT03939689|529584588|FG001|Overall Study|Investigator decision|0|||
146839435|NCT04427280|529584589|FG000|Overall Study|Withdrawal by Subject|0|||
146839436|NCT04427280|529584590|FG001|Overall Study|Withdrawal by Subject|2|||
146839437|NCT01667926|529584601|FG000|Overall Study|Withdrawal by Subject|1|||
146839438|NCT01667926|529584602|FG001|Overall Study|Withdrawal by Subject|2|||
146839439|NCT01667926|529584603|FG002|Overall Study|Withdrawal by Subject|2|||
146839440|NCT01667926|529584601|FG000|Overall Study|Physician Decision|0|||
146839441|NCT01667926|529584602|FG001|Overall Study|Physician Decision|0|||
146839442|NCT01667926|529584603|FG002|Overall Study|Physician Decision|1|||
146839443|NCT01667926|529584601|FG000|Overall Study|Time committment|0|||
146839444|NCT01667926|529584602|FG001|Overall Study|Time committment|0|||
146839445|NCT01667926|529584603|FG002|Overall Study|Time committment|2|||
146839446|NCT01667926|529584601|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
146839447|NCT01667926|529584602|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
146839448|NCT01667926|529584603|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
146839449|NCT01667926|529584601|FG000|Overall Study|Lost to Follow-up|1|||
146839450|NCT01667926|529584602|FG001|Overall Study|Lost to Follow-up|2|||
146839451|NCT01667926|529584603|FG002|Overall Study|Lost to Follow-up|1|||
146839452|NCT01667926|529584601|FG000|Overall Study|Side effects|3|||
146959208|NCT02546193|530009890|FG003|Overall Study|Withdrawal by Subject|0|||
146959209|NCT02546193|530009887|FG000|Overall Study|Not eligible at time of induction|4|||
146959210|NCT02546193|530009888|FG001|Overall Study|Not eligible at time of induction|6|||
146959211|NCT02546193|530009889|FG002|Overall Study|Not eligible at time of induction|1|||
146959212|NCT02546193|530009890|FG003|Overall Study|Not eligible at time of induction|0|||
146959213|NCT00310440|530009891|FG000|Overall Study|Lost to Follow-up|17|||
146959214|NCT00310440|530009892|FG001|Overall Study|Lost to Follow-up|8|||
146959215|NCT00310440|530009891|FG000|Overall Study|Withdrawal by Subject|2|||
146959216|NCT00310440|530009892|FG001|Overall Study|Withdrawal by Subject|1|||
146959217|NCT00310440|530009891|FG000|Overall Study|Missed 12 Month Visit|7|||
146959218|NCT00310440|530009892|FG001|Overall Study|Missed 12 Month Visit|4|||
146959219|NCT01287403|530009893|FG000|1st Intervention (1 Day)|Adverse Event|1|||
146959220|NCT00148109|530009894|FG000|Overall Study|Lack of Efficacy|10|||
146959221|NCT00148109|530009895|FG001|Overall Study|Lack of Efficacy|18|||
146959222|NCT00148109|530009894|FG000|Overall Study|Adverse Event|0|||
146959223|NCT00148109|530009895|FG001|Overall Study|Adverse Event|2|||
146959224|NCT00148109|530009894|FG000|Overall Study|Withdrawal by Subject|2|||
146959225|NCT00148109|530009895|FG001|Overall Study|Withdrawal by Subject|0|||
146959226|NCT01098266|530009896|FG000|Overall Study|Physician Decision|1|||
146839453|NCT01667926|529584602|FG001|Overall Study|Side effects|0|||
146839454|NCT01667926|529584603|FG002|Overall Study|Side effects|0|||
146839455|NCT02271984|529584606|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146839456|NCT02271984|529584607|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146839457|NCT02271984|529584608|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146839458|NCT02271984|529584609|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146839459|NCT02271984|529584610|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146839460|NCT02271984|529584611|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
146839461|NCT02271984|529584612|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146839462|NCT02271984|529584613|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
146839463|NCT02271984|529584614|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146839464|NCT02271984|529584615|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146959227|NCT01098266|530009897|FG001|Overall Study|Physician Decision|0|||
146959228|NCT01098266|530009896|FG000|Overall Study|Death|3|||
146959229|NCT01098266|530009897|FG001|Overall Study|Death|2|||
146991395|NCT05097989|530130793|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
146959230|NCT01098266|530009896|FG000|Overall Study|Withdrawal by Subject|3|||
146839465|NCT02271984|529584616|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146839466|NCT02271984|529584617|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146839467|NCT01088984|529584618|FG000|Phase 1|Death|2|||
146839468|NCT01088984|529584619|FG001|Phase 1|Death|1|||
146839469|NCT01088984|529584618|FG000|Phase 1|Disease Progression|2|||
146839470|NCT01088984|529584619|FG001|Phase 1|Disease Progression|4|||
146839471|NCT01088984|529584618|FG000|Phase 1|Other|1|||
146839472|NCT01088984|529584619|FG001|Phase 1|Other|1|||
146839473|NCT01088984|529584618|FG000|Phase 2|Death|0|||
146959231|NCT01098266|530009897|FG001|Overall Study|Withdrawal by Subject|5|||
146959232|NCT00438815|530009898|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
146959233|NCT00438815|530009898|FG000|Overall Study|3-month follow-up no longer required|12|||
146959234|NCT00438815|530009898|FG000|Overall Study|Noncompliance with protocol requirements|9|||
146959235|NCT00438815|530009898|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
146959236|NCT00438815|530009898|FG000|Overall Study|Lost to Follow-up|6|||
146959237|NCT00438815|530009898|FG000|Overall Study|Withdrawal by Subject|6|||
146959238|NCT00438815|530009898|FG000|Overall Study|Death|1|||
146959239|NCT01733758|530009899|FG000|Overall Study|Adverse Event|5|||
146959240|NCT01733758|530009900|FG001|Overall Study|Adverse Event|7|||
146959241|NCT01733758|530009901|FG002|Overall Study|Adverse Event|8|||
146959242|NCT01733758|530009902|FG003|Overall Study|Adverse Event|1|||
146959243|NCT01733758|530009899|FG000|Overall Study|Withdrawal by Subject|1|||
146959244|NCT01733758|530009900|FG001|Overall Study|Withdrawal by Subject|1|||
146959245|NCT01733758|530009901|FG002|Overall Study|Withdrawal by Subject|5|||
146959246|NCT01733758|530009902|FG003|Overall Study|Withdrawal by Subject|3|||
146959247|NCT01733758|530009899|FG000|Overall Study|Persistent Hyperglycemia|3|||
146959248|NCT01733758|530009900|FG001|Overall Study|Persistent Hyperglycemia|2|||
146959249|NCT01733758|530009901|FG002|Overall Study|Persistent Hyperglycemia|0|||
146959250|NCT01733758|530009902|FG003|Overall Study|Persistent Hyperglycemia|0|||
146959251|NCT01733758|530009899|FG000|Overall Study|Protocol Violation|0|||
146959252|NCT01733758|530009900|FG001|Overall Study|Protocol Violation|1|||
146959253|NCT01733758|530009901|FG002|Overall Study|Protocol Violation|2|||
146959254|NCT01733758|530009902|FG003|Overall Study|Protocol Violation|2|||
146959255|NCT01733758|530009899|FG000|Overall Study|Non-compliance|1|||
146959256|NCT01733758|530009900|FG001|Overall Study|Non-compliance|0|||
146959257|NCT01733758|530009901|FG002|Overall Study|Non-compliance|0|||
146959258|NCT01733758|530009902|FG003|Overall Study|Non-compliance|0|||
146959259|NCT01733758|530009899|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
146959260|NCT01733758|530009900|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
146959261|NCT01733758|530009901|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
146959262|NCT01733758|530009902|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
146959263|NCT01733758|530009899|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
146959264|NCT01733758|530009900|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
146959265|NCT01733758|530009901|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
146959266|NCT01733758|530009902|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
146959267|NCT02557308|530009905|FG000|Overall Study|Withdrawal by Subject|11|||
146959268|NCT02557308|530009906|FG001|Overall Study|Withdrawal by Subject|3|||
146959269|NCT02557308|530009907|FG002|Overall Study|Withdrawal by Subject|2|||
146959270|NCT02557308|530009908|FG003|Overall Study|Withdrawal by Subject|0|||
146959271|NCT02557308|530009909|FG004|Overall Study|Withdrawal by Subject|1|||
146959272|NCT02557308|530009910|FG005|Overall Study|Withdrawal by Subject|0|||
146959273|NCT02557308|530009911|FG006|Overall Study|Withdrawal by Subject|10|||
146959274|NCT02557308|530009912|FG007|Overall Study|Withdrawal by Subject|1|||
146959275|NCT02557308|530009905|FG000|Overall Study|Disease Progression|0|||
146959276|NCT02557308|530009906|FG001|Overall Study|Disease Progression|1|||
146959277|NCT02557308|530009907|FG002|Overall Study|Disease Progression|0|||
146959278|NCT02557308|530009908|FG003|Overall Study|Disease Progression|0|||
146959279|NCT02557308|530009909|FG004|Overall Study|Disease Progression|0|||
146959280|NCT02557308|530009910|FG005|Overall Study|Disease Progression|0|||
146959281|NCT02557308|530009911|FG006|Overall Study|Disease Progression|0|||
146959282|NCT02557308|530009912|FG007|Overall Study|Disease Progression|0|||
146959283|NCT02557308|530009905|FG000|Overall Study|Lack of Efficacy|3|||
146959284|NCT02557308|530009906|FG001|Overall Study|Lack of Efficacy|0|||
146959285|NCT02557308|530009907|FG002|Overall Study|Lack of Efficacy|0|||
146839474|NCT01088984|529584619|FG001|Phase 2|Death|5|||
146839475|NCT01088984|529584618|FG000|Phase 2|Withdrawal by Subject|0|||
146839476|NCT01088984|529584619|FG001|Phase 2|Withdrawal by Subject|1|||
146959286|NCT02557308|530009908|FG003|Overall Study|Lack of Efficacy|0|||
146959287|NCT02557308|530009909|FG004|Overall Study|Lack of Efficacy|0|||
146959288|NCT02557308|530009910|FG005|Overall Study|Lack of Efficacy|0|||
146959289|NCT02557308|530009911|FG006|Overall Study|Lack of Efficacy|1|||
146959290|NCT02557308|530009912|FG007|Overall Study|Lack of Efficacy|0|||
146959291|NCT02557308|530009905|FG000|Overall Study|Adverse Event|4|||
146959292|NCT02557308|530009906|FG001|Overall Study|Adverse Event|1|||
146959293|NCT02557308|530009907|FG002|Overall Study|Adverse Event|2|||
146959294|NCT02557308|530009908|FG003|Overall Study|Adverse Event|0|||
146959295|NCT02557308|530009909|FG004|Overall Study|Adverse Event|0|||
146959296|NCT02557308|530009910|FG005|Overall Study|Adverse Event|0|||
146839477|NCT01088984|529584618|FG000|Phase 2|DIsease Progression|0|||
146839478|NCT01088984|529584619|FG001|Phase 2|DIsease Progression|25|||
146839479|NCT01088984|529584618|FG000|Phase 2|Other|0|||
146839480|NCT01088984|529584619|FG001|Phase 2|Other|1|||
146839481|NCT04079868|529584624|FG000|Overall Study|Lost to Follow-up|100|||
146959297|NCT02557308|530009911|FG006|Overall Study|Adverse Event|4|||
146959298|NCT02557308|530009912|FG007|Overall Study|Adverse Event|1|||
146959299|NCT02557308|530009905|FG000|Overall Study|Lost to Follow-up|2|||
146959300|NCT02557308|530009906|FG001|Overall Study|Lost to Follow-up|0|||
146959301|NCT02557308|530009907|FG002|Overall Study|Lost to Follow-up|1|||
146959302|NCT02557308|530009908|FG003|Overall Study|Lost to Follow-up|0|||
146959303|NCT02557308|530009909|FG004|Overall Study|Lost to Follow-up|0|||
146959304|NCT02557308|530009910|FG005|Overall Study|Lost to Follow-up|0|||
146959305|NCT02557308|530009911|FG006|Overall Study|Lost to Follow-up|2|||
146959306|NCT02557308|530009912|FG007|Overall Study|Lost to Follow-up|0|||
146959307|NCT02557308|530009905|FG000|Overall Study|Death|1|||
146959308|NCT02557308|530009906|FG001|Overall Study|Death|0|||
146959309|NCT02557308|530009907|FG002|Overall Study|Death|0|||
146959310|NCT02557308|530009908|FG003|Overall Study|Death|0|||
146959311|NCT02557308|530009909|FG004|Overall Study|Death|0|||
146959312|NCT02557308|530009910|FG005|Overall Study|Death|0|||
146959313|NCT02557308|530009911|FG006|Overall Study|Death|0|||
146959314|NCT02557308|530009912|FG007|Overall Study|Death|0|||
146959315|NCT02557308|530009905|FG000|Overall Study|Study Close|98|||
146959316|NCT02557308|530009906|FG001|Overall Study|Study Close|18|||
146959317|NCT02557308|530009907|FG002|Overall Study|Study Close|5|||
146959318|NCT02557308|530009908|FG003|Overall Study|Study Close|3|||
146959319|NCT02557308|530009909|FG004|Overall Study|Study Close|1|||
146959320|NCT02557308|530009910|FG005|Overall Study|Study Close|0|||
146959321|NCT02557308|530009911|FG006|Overall Study|Study Close|123|||
146959322|NCT02557308|530009912|FG007|Overall Study|Study Close|5|||
146959323|NCT02557308|530009905|FG000|Overall Study|Except for study close|5|||
146959324|NCT02557308|530009906|FG001|Overall Study|Except for study close|0|||
146959325|NCT02557308|530009907|FG002|Overall Study|Except for study close|0|||
146959326|NCT02557308|530009908|FG003|Overall Study|Except for study close|0|||
146959327|NCT02557308|530009909|FG004|Overall Study|Except for study close|3|||
146959328|NCT02557308|530009910|FG005|Overall Study|Except for study close|0|||
146959329|NCT02557308|530009911|FG006|Overall Study|Except for study close|6|||
146959330|NCT02557308|530009912|FG007|Overall Study|Except for study close|10|||
146959331|NCT03911401|530009915|FG000|Overall Study|Adverse Event|1|||
146959332|NCT03911401|530009916|FG001|Overall Study|Adverse Event|2|||
146959333|NCT03911401|530009917|FG002|Overall Study|Adverse Event|5|||
146959334|NCT03911401|530009915|FG000|Overall Study|Lack of Efficacy|1|||
146959335|NCT03911401|530009916|FG001|Overall Study|Lack of Efficacy|1|||
146959336|NCT03911401|530009917|FG002|Overall Study|Lack of Efficacy|8|||
146959337|NCT03911401|530009915|FG000|Overall Study|Physician Decision|0|||
146959338|NCT03911401|530009916|FG001|Overall Study|Physician Decision|0|||
146959339|NCT03911401|530009917|FG002|Overall Study|Physician Decision|1|||
146959340|NCT03911401|530009915|FG000|Overall Study|Withdrawal by Subject|1|||
146959341|NCT03911401|530009916|FG001|Overall Study|Withdrawal by Subject|2|||
146959342|NCT03911401|530009917|FG002|Overall Study|Withdrawal by Subject|0|||
146959343|NCT03911401|530009915|FG000|Overall Study|Withdrawal by parent/guardian|4|||
146959344|NCT03911401|530009916|FG001|Overall Study|Withdrawal by parent/guardian|4|||
146959345|NCT03911401|530009917|FG002|Overall Study|Withdrawal by parent/guardian|11|||
146959346|NCT02918968|530009918|FG000|1st Line AAT|Progressive disease|9|||
146959347|NCT02918968|530009919|FG001|1st Line AAT|Progressive disease|4|||
146959348|NCT02918968|530009918|FG000|1st Line AAT|Adverse Event|12|||
146959349|NCT02918968|530009919|FG001|1st Line AAT|Adverse Event|3|||
146959350|NCT02918968|530009918|FG000|1st Line AAT|Physician Decision|4|||
146959351|NCT02918968|530009919|FG001|1st Line AAT|Physician Decision|2|||
146959352|NCT02918968|530009918|FG000|1st Line AAT|Withdrawal by Subject|2|||
146959353|NCT02918968|530009919|FG001|1st Line AAT|Withdrawal by Subject|1|||
146959354|NCT02918968|530009918|FG000|1st Line AAT|Lost to Follow-up|0|||
146959355|NCT02918968|530009919|FG001|1st Line AAT|Lost to Follow-up|1|||
146959356|NCT02918968|530009918|FG000|1st Line AAT|Death|1|||
146959357|NCT02918968|530009919|FG001|1st Line AAT|Death|0|||
146959358|NCT02918968|530009918|FG000|1st Line AAT|Miscellaneous|1|||
146959359|NCT02918968|530009919|FG001|1st Line AAT|Miscellaneous|0|||
146839482|NCT04079868|529584625|FG001|Overall Study|Lost to Follow-up|200|||
146839483|NCT04079868|529584624|FG000|Overall Study|Physician Decision|100|||
146959360|NCT02918968|530009918|FG000|2nd Line AAT|Progressive disease|21|||
146959361|NCT02918968|530009919|FG001|2nd Line AAT|Progressive disease|3|||
146959362|NCT02918968|530009918|FG000|2nd Line AAT|Adverse Event|2|||
146959363|NCT02918968|530009919|FG001|2nd Line AAT|Adverse Event|5|||
146959364|NCT02918968|530009918|FG000|2nd Line AAT|Physician Decision|0|||
146959365|NCT02918968|530009919|FG001|2nd Line AAT|Physician Decision|1|||
146959366|NCT02918968|530009918|FG000|2nd Line AAT|Withdrawal by Subject|2|||
146959367|NCT02918968|530009919|FG001|2nd Line AAT|Withdrawal by Subject|2|||
146959368|NCT02918968|530009918|FG000|2nd Line AAT|Death|0|||
146959369|NCT02918968|530009919|FG001|2nd Line AAT|Death|1|||
146959370|NCT01589185|530009920|FG000|Overall Study|Death|1|||
146959371|NCT01589185|530009921|FG001|Overall Study|Death|2|||
146991396|NCT05097989|530130794|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
146991397|NCT05097989|530130795|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
146991398|NCT05097989|530130796|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
146991399|NCT05097989|530130788|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
146991400|NCT05097989|530130789|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
146991401|NCT05097989|530130790|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
146991402|NCT05097989|530130791|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
146991403|NCT05097989|530130792|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
146991404|NCT05097989|530130793|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
146991405|NCT05097989|530130794|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
146991406|NCT05097989|530130795|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
146991407|NCT05097989|530130796|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
146991408|NCT05097989|530130788|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146991409|NCT05097989|530130789|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146991410|NCT05097989|530130790|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146991411|NCT05097989|530130791|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146991412|NCT05097989|530130792|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146991413|NCT05097989|530130793|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146991414|NCT05097989|530130794|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146991415|NCT05097989|530130795|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146991416|NCT05097989|530130796|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146991417|NCT05097989|530130788|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
146991418|NCT05097989|530130789|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
146991419|NCT05097989|530130790|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
146991420|NCT05097989|530130791|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
146991421|NCT05097989|530130792|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
146991422|NCT05097989|530130793|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
146991423|NCT05097989|530130794|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
146991424|NCT05097989|530130795|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
146991425|NCT05097989|530130796|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
146991426|NCT05097989|530130788|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146991427|NCT05097989|530130789|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
146991428|NCT05097989|530130790|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146991429|NCT05097989|530130791|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
146991430|NCT05097989|530130792|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146991431|NCT05097989|530130793|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146991432|NCT05097989|530130794|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146991433|NCT05097989|530130795|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146991434|NCT05097989|530130796|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146991435|NCT05097989|530130788|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
146991436|NCT05097989|530130789|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
146991437|NCT05097989|530130790|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
146991438|NCT05097989|530130791|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
146991439|NCT05097989|530130792|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
146991440|NCT05097989|530130793|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
146991441|NCT05097989|530130794|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
146991442|NCT05097989|530130795|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
146991443|NCT05097989|530130796|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
146991444|NCT05097989|530130788|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
146991445|NCT05097989|530130789|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
146991446|NCT05097989|530130790|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
146991447|NCT05097989|530130791|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
146991448|NCT05097989|530130792|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
146991449|NCT05097989|530130793|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
146991450|NCT05097989|530130794|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
146991451|NCT05097989|530130795|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
146991452|NCT05097989|530130796|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
146991453|NCT05097989|530130788|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
146991454|NCT05097989|530130789|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
146991455|NCT05097989|530130790|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
146991456|NCT05097989|530130791|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
146991457|NCT05097989|530130792|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
146991458|NCT05097989|530130793|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
146991459|NCT05097989|530130794|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
146991460|NCT05097989|530130795|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
146991461|NCT05097989|530130796|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
146991462|NCT05097989|530130788|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
146991463|NCT05097989|530130789|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
146991464|NCT05097989|530130790|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
146991465|NCT05097989|530130791|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
146991466|NCT05097989|530130792|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
146991467|NCT05097989|530130793|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
146991468|NCT05097989|530130794|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
146991469|NCT05097989|530130795|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
146991470|NCT05097989|530130796|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
146991471|NCT05097989|530130788|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
146991472|NCT05097989|530130789|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
146991473|NCT05097989|530130790|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
146991474|NCT05097989|530130791|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
146991475|NCT05097989|530130792|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
146991476|NCT05097989|530130793|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
146991477|NCT05097989|530130794|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
146991478|NCT05097989|530130795|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
146991479|NCT05097989|530130796|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
146991480|NCT00117949|530130804|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
146991481|NCT00117949|530130805|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
146991482|NCT00117949|530130806|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
146991483|NCT00117949|530130807|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
146991484|NCT00117949|530130804|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
146839484|NCT04079868|529584625|FG001|Overall Study|Physician Decision|0|||
146839485|NCT05000216|529584631|FG000|Stage 1|Lost to Follow-up|0|||
146839486|NCT05000216|529584632|FG001|Stage 1|Lost to Follow-up|0|||
146991485|NCT00117949|530130805|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
146991486|NCT00117949|530130806|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
146991487|NCT00117949|530130807|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
146991488|NCT00117949|530130804|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
146991489|NCT00117949|530130805|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
146991490|NCT00117949|530130806|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
146991491|NCT00117949|530130807|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
146991492|NCT00117949|530130804|FG000|Overall Study|PSA increase >=10ng/mL|0|||
146991493|NCT00117949|530130805|FG001|Overall Study|PSA increase >=10ng/mL|1|||
146991494|NCT00117949|530130806|FG002|Overall Study|PSA increase >=10ng/mL|1|||
146991495|NCT00117949|530130807|FG003|Overall Study|PSA increase >=10ng/mL|0|||
146991496|NCT00117949|530130804|FG000|Overall Study|PSA reduction <=50%|0|||
146991497|NCT00117949|530130805|FG001|Overall Study|PSA reduction <=50%|2|||
146991498|NCT00117949|530130806|FG002|Overall Study|PSA reduction <=50%|2|||
146991499|NCT00117949|530130807|FG003|Overall Study|PSA reduction <=50%|4|||
146991500|NCT00117949|530130804|FG000|Overall Study|Hepatic abnormalities|0|||
146991501|NCT00117949|530130805|FG001|Overall Study|Hepatic abnormalities|1|||
146991502|NCT00117949|530130806|FG002|Overall Study|Hepatic abnormalities|0|||
146991503|NCT00117949|530130807|FG003|Overall Study|Hepatic abnormalities|1|||
146991504|NCT01658943|530130810|FG000|Overall Study|Adverse Event|6|||
146991505|NCT01658943|530130811|FG001|Overall Study|Adverse Event|13|||
146991506|NCT01658943|530130810|FG000|Overall Study|Withdrawal by Subject|9|||
146991507|NCT01658943|530130811|FG001|Overall Study|Withdrawal by Subject|2|||
146991508|NCT01658943|530130810|FG000|Overall Study|Progression/Relapse|39|||
146991509|NCT01658943|530130811|FG001|Overall Study|Progression/Relapse|40|||
146991510|NCT01658943|530130810|FG000|Overall Study|Death|4|||
146991511|NCT01658943|530130811|FG001|Overall Study|Death|2|||
146991512|NCT01658943|530130810|FG000|Overall Study|not protocol specified|4|||
146991513|NCT01658943|530130811|FG001|Overall Study|not protocol specified|1|||
146839487|NCT05000216|529584633|FG002|Stage 1|Lost to Follow-up|0|||
146839488|NCT05000216|529584634|FG003|Stage 1|Lost to Follow-up|0|||
146839489|NCT05000216|529584635|FG004|Stage 1|Lost to Follow-up|0|||
146991514|NCT01658943|530130810|FG000|Overall Study|Not eligible|7|||
146991515|NCT01658943|530130811|FG001|Overall Study|Not eligible|9|||
146991516|NCT01658943|530130810|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
146991517|NCT01658943|530130811|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
146991518|NCT03309956|530130812|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
146991519|NCT02130466|530130813|FG000|Overall Study|Death|4|||
146991520|NCT02130466|530130814|FG001|Overall Study|Death|1|||
146991521|NCT02130466|530130815|FG002|Overall Study|Death|1|||
146991522|NCT02130466|530130816|FG003|Overall Study|Death|3|||
146991523|NCT02130466|530130817|FG004|Overall Study|Death|2|||
146991524|NCT02130466|530130818|FG005|Overall Study|Death|30|||
146991525|NCT02130466|530130819|FG006|Overall Study|Death|45|||
146839490|NCT05000216|529584636|FG005|Stage 1|Lost to Follow-up|0|||
146991526|NCT02130466|530130820|FG007|Overall Study|Death|2|||
146991527|NCT02130466|530130821|FG008|Overall Study|Death|3|||
146991528|NCT02130466|530130822|FG009|Overall Study|Death|4|||
146991529|NCT02130466|530130823|FG010|Overall Study|Death|5|||
146991530|NCT02130466|530130824|FG011|Overall Study|Death|3|||
146991531|NCT02130466|530130825|FG012|Overall Study|Death|11|||
146991532|NCT02130466|530130826|FG013|Overall Study|Death|7|||
146991533|NCT02130466|530130813|FG000|Overall Study|Lost to Follow-up|1|||
146991534|NCT02130466|530130814|FG001|Overall Study|Lost to Follow-up|0|||
146991535|NCT02130466|530130815|FG002|Overall Study|Lost to Follow-up|0|||
146991536|NCT02130466|530130816|FG003|Overall Study|Lost to Follow-up|0|||
146991537|NCT02130466|530130817|FG004|Overall Study|Lost to Follow-up|0|||
146991538|NCT02130466|530130818|FG005|Overall Study|Lost to Follow-up|1|||
146991539|NCT02130466|530130819|FG006|Overall Study|Lost to Follow-up|0|||
146991540|NCT02130466|530130820|FG007|Overall Study|Lost to Follow-up|0|||
146991541|NCT02130466|530130821|FG008|Overall Study|Lost to Follow-up|0|||
146991542|NCT02130466|530130822|FG009|Overall Study|Lost to Follow-up|0|||
146991543|NCT02130466|530130823|FG010|Overall Study|Lost to Follow-up|0|||
146991544|NCT02130466|530130824|FG011|Overall Study|Lost to Follow-up|0|||
146991545|NCT02130466|530130825|FG012|Overall Study|Lost to Follow-up|1|||
146991546|NCT02130466|530130826|FG013|Overall Study|Lost to Follow-up|0|||
146991547|NCT02130466|530130813|FG000|Overall Study|Physician Decision|0|||
146991548|NCT02130466|530130814|FG001|Overall Study|Physician Decision|0|||
146991549|NCT02130466|530130815|FG002|Overall Study|Physician Decision|0|||
146991550|NCT02130466|530130816|FG003|Overall Study|Physician Decision|0|||
146991551|NCT02130466|530130817|FG004|Overall Study|Physician Decision|0|||
146991552|NCT02130466|530130818|FG005|Overall Study|Physician Decision|1|||
146991553|NCT02130466|530130819|FG006|Overall Study|Physician Decision|1|||
146991554|NCT02130466|530130820|FG007|Overall Study|Physician Decision|0|||
146991555|NCT02130466|530130821|FG008|Overall Study|Physician Decision|0|||
146991556|NCT02130466|530130822|FG009|Overall Study|Physician Decision|0|||
146991557|NCT02130466|530130823|FG010|Overall Study|Physician Decision|0|||
146991558|NCT02130466|530130824|FG011|Overall Study|Physician Decision|0|||
146991559|NCT02130466|530130825|FG012|Overall Study|Physician Decision|0|||
146991560|NCT02130466|530130826|FG013|Overall Study|Physician Decision|0|||
146991561|NCT02130466|530130813|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
146991562|NCT02130466|530130814|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
146991563|NCT02130466|530130815|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
146991564|NCT02130466|530130816|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
146991565|NCT02130466|530130817|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
146991566|NCT02130466|530130818|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
146991567|NCT02130466|530130819|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
146991568|NCT02130466|530130820|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
146991569|NCT02130466|530130821|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
146991570|NCT02130466|530130822|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
146991571|NCT02130466|530130823|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
146991572|NCT02130466|530130824|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
146991573|NCT02130466|530130825|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
146991574|NCT02130466|530130826|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
146991575|NCT02130466|530130813|FG000|Overall Study|Withdrawal by Subject|1|||
146991576|NCT02130466|530130814|FG001|Overall Study|Withdrawal by Subject|0|||
146991577|NCT02130466|530130815|FG002|Overall Study|Withdrawal by Subject|0|||
146991578|NCT02130466|530130816|FG003|Overall Study|Withdrawal by Subject|0|||
146839491|NCT05000216|529584637|FG006|Stage 1|Lost to Follow-up|1|||
146839492|NCT05000216|529584638|FG007|Stage 1|Lost to Follow-up|1|||
146839493|NCT05000216|529584639|FG008|Stage 1|Lost to Follow-up|0|||
146839494|NCT05000216|529584640|FG009|Stage 1|Lost to Follow-up|2|||
146991579|NCT02130466|530130817|FG004|Overall Study|Withdrawal by Subject|0|||
146991580|NCT02130466|530130818|FG005|Overall Study|Withdrawal by Subject|1|||
146991581|NCT02130466|530130819|FG006|Overall Study|Withdrawal by Subject|0|||
146991582|NCT02130466|530130820|FG007|Overall Study|Withdrawal by Subject|0|||
146991583|NCT02130466|530130821|FG008|Overall Study|Withdrawal by Subject|1|||
146991584|NCT02130466|530130822|FG009|Overall Study|Withdrawal by Subject|0|||
146991585|NCT02130466|530130823|FG010|Overall Study|Withdrawal by Subject|0|||
146991586|NCT02130466|530130824|FG011|Overall Study|Withdrawal by Subject|0|||
146991587|NCT02130466|530130825|FG012|Overall Study|Withdrawal by Subject|0|||
146991588|NCT02130466|530130826|FG013|Overall Study|Withdrawal by Subject|0|||
146991589|NCT04529109|530130827|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
146839495|NCT05000216|529584641|FG010|Stage 1|Lost to Follow-up|3|||
146991590|NCT04529109|530130828|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
146991591|NCT00922779|530130829|FG000|Overall Study|Adverse Event|67|||
146991592|NCT00922779|530130829|FG000|Overall Study|Pregnancy|7|||
146991593|NCT00922779|530130829|FG000|Overall Study|Withdrawal by Subject|308|||
146991594|NCT00922779|530130829|FG000|Overall Study|Lost to Follow-up|44|||
146991595|NCT00922779|530130829|FG000|Overall Study|Other|27|||
146991596|NCT00922779|530130829|FG000|Overall Study|Missing|1874|||
146991597|NCT01922349|530130830|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
146991598|NCT01922349|530130831|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
146991599|NCT01922349|530130832|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
146991600|NCT01922349|530130833|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
146991601|NCT00993616|530130834|FG000|Overall Study|No tumor at entry|1|||
146991602|NCT00993616|530130834|FG000|Overall Study|Never treated|1|||
146991603|NCT05067504|530130835|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
146991604|NCT05067504|530130836|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
146991605|NCT05067504|530130835|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
146991606|NCT05067504|530130836|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
146991607|NCT05067504|530130835|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
146991608|NCT05067504|530130836|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
146991609|NCT01374919|530132177|FG000|Overall Study|Withdrawal by Subject|2|||
146991610|NCT03805438|530132178|FG000|Overall Study|Lack of Efficacy|1|||
146991611|NCT03805438|530132178|FG000|Overall Study|Protocol Violation|1|||
146991612|NCT00366899|530132179|FG000|Infant Series|Withdrawal by Subject|4|||
146991613|NCT00366899|530132180|FG001|Infant Series|Withdrawal by Subject|7|||
146991614|NCT00366899|530132179|FG000|Infant Series|Protocol Violation|2|||
146991615|NCT00366899|530132180|FG001|Infant Series|Protocol Violation|1|||
146991616|NCT00366899|530132179|FG000|Infant Series|Failed to return|1|||
146991617|NCT00366899|530132180|FG001|Infant Series|Failed to return|1|||
146991618|NCT00366899|530132179|FG000|Infant Series|Lost to Follow-up|0|||
146991619|NCT00366899|530132180|FG001|Infant Series|Lost to Follow-up|2|||
146991620|NCT00366899|530132179|FG000|Infant Series|Adverse Event|0|||
146991621|NCT00366899|530132180|FG001|Infant Series|Adverse Event|1|||
146991622|NCT00366899|530132179|FG000|Infant Series|Physician Decision|1|||
146991623|NCT00366899|530132180|FG001|Infant Series|Physician Decision|0|||
146991624|NCT00366899|530132179|FG000|Infant Series|Randomized but not consented|1|||
146991625|NCT00366899|530132180|FG001|Infant Series|Randomized but not consented|0|||
146991626|NCT00366899|530132179|FG000|After Infant Series|Lost to Follow-up|4|||
146991627|NCT00366899|530132180|FG001|After Infant Series|Lost to Follow-up|3|||
146991628|NCT00366899|530132179|FG000|After Infant Series|Withdrawal by Subject|1|||
146991629|NCT00366899|530132180|FG001|After Infant Series|Withdrawal by Subject|4|||
146991630|NCT00366899|530132179|FG000|After Infant Series|Adverse Event|1|||
146991631|NCT00366899|530132180|FG001|After Infant Series|Adverse Event|2|||
146839496|NCT05000216|529584642|FG011|Stage 1|Lost to Follow-up|0|||
146839497|NCT05000216|529584643|FG012|Stage 1|Lost to Follow-up|0|||
146839498|NCT05000216|529584644|FG013|Stage 1|Lost to Follow-up|0|||
146839499|NCT05000216|529584645|FG014|Stage 1|Lost to Follow-up|0|||
146839500|NCT05000216|529584646|FG015|Stage 1|Lost to Follow-up|0|||
146839501|NCT05000216|529584647|FG016|Stage 1|Lost to Follow-up|0|||
146839502|NCT05000216|529584648|FG017|Stage 1|Lost to Follow-up|0|||
146839503|NCT05000216|529584649|FG018|Stage 1|Lost to Follow-up|0|||
146839504|NCT05000216|529584650|FG019|Stage 1|Lost to Follow-up|0|||
146839505|NCT05000216|529584651|FG020|Stage 1|Lost to Follow-up|0|||
146839506|NCT05000216|529584652|FG021|Stage 1|Lost to Follow-up|0|||
146839507|NCT05000216|529584631|FG000|Stage 1|Physician Decision|0|||
146839508|NCT05000216|529584632|FG001|Stage 1|Physician Decision|0|||
146839509|NCT05000216|529584633|FG002|Stage 1|Physician Decision|0|||
146839510|NCT05000216|529584634|FG003|Stage 1|Physician Decision|0|||
146839511|NCT05000216|529584635|FG004|Stage 1|Physician Decision|0|||
146839512|NCT05000216|529584636|FG005|Stage 1|Physician Decision|0|||
146839513|NCT05000216|529584637|FG006|Stage 1|Physician Decision|0|||
146839514|NCT05000216|529584638|FG007|Stage 1|Physician Decision|1|||
146839515|NCT05000216|529584639|FG008|Stage 1|Physician Decision|1|||
146839516|NCT05000216|529584640|FG009|Stage 1|Physician Decision|0|||
146839517|NCT05000216|529584641|FG010|Stage 1|Physician Decision|0|||
146991632|NCT00366899|530132179|FG000|After Infant Series|Protocol Violation|1|||
146991633|NCT00366899|530132180|FG001|After Infant Series|Protocol Violation|0|||
146991634|NCT00366899|530132179|FG000|Toddler Dose|Withdrawal by Subject|1|||
146991635|NCT00366899|530132180|FG001|Toddler Dose|Withdrawal by Subject|1|||
146991636|NCT00366899|530132179|FG000|Toddler Dose|Protocol Violation|1|||
146991637|NCT00366899|530132180|FG001|Toddler Dose|Protocol Violation|0|||
146991638|NCT01619800|530132181|FG000|Overall Study|study terminated|2|||
146991639|NCT01619800|530132182|FG001|Overall Study|study terminated|0|||
146991640|NCT02848326|530132183|FG000|Treatment Period|Adverse Event|5|||
146839518|NCT05000216|529584642|FG011|Stage 1|Physician Decision|0|||
146839519|NCT05000216|529584643|FG012|Stage 1|Physician Decision|0|||
146991641|NCT02848326|530132184|FG001|Treatment Period|Adverse Event|4|||
146991642|NCT02848326|530132185|FG002|Treatment Period|Adverse Event|11|||
146991643|NCT02848326|530132186|FG003|Treatment Period|Adverse Event|6|||
146991644|NCT02848326|530132187|FG004|Treatment Period|Adverse Event|5|||
146991645|NCT02848326|530132188|FG005|Treatment Period|Adverse Event|7|||
146839520|NCT05000216|529584644|FG013|Stage 1|Physician Decision|0|||
146839521|NCT05000216|529584645|FG014|Stage 1|Physician Decision|0|||
146991646|NCT02848326|530132183|FG000|Treatment Period|Withdrawal of Consent|20|||
146991647|NCT02848326|530132184|FG001|Treatment Period|Withdrawal of Consent|6|||
146839522|NCT05000216|529584646|FG015|Stage 1|Physician Decision|0|||
146839523|NCT05000216|529584647|FG016|Stage 1|Physician Decision|0|||
146839524|NCT05000216|529584648|FG017|Stage 1|Physician Decision|0|||
146839525|NCT05000216|529584649|FG018|Stage 1|Physician Decision|0|||
146839526|NCT05000216|529584650|FG019|Stage 1|Physician Decision|0|||
146991648|NCT02848326|530132185|FG002|Treatment Period|Withdrawal of Consent|9|||
146991649|NCT02848326|530132186|FG003|Treatment Period|Withdrawal of Consent|6|||
146991650|NCT02848326|530132187|FG004|Treatment Period|Withdrawal of Consent|9|||
146991651|NCT02848326|530132188|FG005|Treatment Period|Withdrawal of Consent|6|||
146991652|NCT02848326|530132183|FG000|Treatment Period|Lost to Follow-up|5|||
146991653|NCT02848326|530132184|FG001|Treatment Period|Lost to Follow-up|1|||
146991654|NCT02848326|530132185|FG002|Treatment Period|Lost to Follow-up|11|||
146991655|NCT02848326|530132186|FG003|Treatment Period|Lost to Follow-up|7|||
146991656|NCT02848326|530132187|FG004|Treatment Period|Lost to Follow-up|2|||
146991657|NCT02848326|530132188|FG005|Treatment Period|Lost to Follow-up|3|||
146991658|NCT02848326|530132183|FG000|Treatment Period|Pregnancy|0|||
146991659|NCT02848326|530132184|FG001|Treatment Period|Pregnancy|0|||
146991660|NCT02848326|530132185|FG002|Treatment Period|Pregnancy|1|||
146991661|NCT02848326|530132186|FG003|Treatment Period|Pregnancy|1|||
146991662|NCT02848326|530132187|FG004|Treatment Period|Pregnancy|0|||
146991663|NCT02848326|530132188|FG005|Treatment Period|Pregnancy|1|||
146991664|NCT02848326|530132183|FG000|Treatment Period|Protocol Violation|4|||
146991665|NCT02848326|530132184|FG001|Treatment Period|Protocol Violation|3|||
146991666|NCT02848326|530132185|FG002|Treatment Period|Protocol Violation|4|||
146991667|NCT02848326|530132186|FG003|Treatment Period|Protocol Violation|2|||
146991668|NCT02848326|530132187|FG004|Treatment Period|Protocol Violation|3|||
146991669|NCT02848326|530132188|FG005|Treatment Period|Protocol Violation|3|||
146991670|NCT02848326|530132183|FG000|Treatment Period|Non-compliance with Study Drug|4|||
146991671|NCT02848326|530132184|FG001|Treatment Period|Non-compliance with Study Drug|0|||
146991672|NCT02848326|530132185|FG002|Treatment Period|Non-compliance with Study Drug|0|||
146991673|NCT02848326|530132186|FG003|Treatment Period|Non-compliance with Study Drug|1|||
146991674|NCT02848326|530132187|FG004|Treatment Period|Non-compliance with Study Drug|0|||
146991675|NCT02848326|530132188|FG005|Treatment Period|Non-compliance with Study Drug|0|||
146991676|NCT02848326|530132183|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
146991677|NCT02848326|530132184|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
146991678|NCT02848326|530132185|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
146991679|NCT02848326|530132186|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
146991680|NCT02848326|530132187|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
146991681|NCT02848326|530132188|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
146991682|NCT02848326|530132183|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
146991683|NCT02848326|530132184|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
146991684|NCT02848326|530132185|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
146991685|NCT02848326|530132186|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
146991686|NCT02848326|530132187|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
146991687|NCT02848326|530132188|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
146991688|NCT00414466|530132189|FG000|Overall Study|Adverse Event|0|||
146991689|NCT00414466|530132190|FG001|Overall Study|Adverse Event|0|||
146991690|NCT00414466|530132191|FG002|Overall Study|Adverse Event|1|||
146991691|NCT00414466|530132192|FG003|Overall Study|Adverse Event|1|||
146991692|NCT00414466|530132189|FG000|Overall Study|Lack of Efficacy|1|||
146991693|NCT00414466|530132190|FG001|Overall Study|Lack of Efficacy|0|||
146991694|NCT00414466|530132191|FG002|Overall Study|Lack of Efficacy|0|||
146991695|NCT00414466|530132192|FG003|Overall Study|Lack of Efficacy|0|||
146991696|NCT00414466|530132189|FG000|Overall Study|Withdrawn by Sponsor|1|||
146991697|NCT00414466|530132190|FG001|Overall Study|Withdrawn by Sponsor|0|||
146991698|NCT00414466|530132191|FG002|Overall Study|Withdrawn by Sponsor|0|||
146991699|NCT00414466|530132192|FG003|Overall Study|Withdrawn by Sponsor|0|||
146991700|NCT03480425|530132194|FG000|Overall Study|Force transducer technical failure|1|||
146991701|NCT01451762|530132195|FG000|Overall Study|Lost to Follow-up|3|||
146991702|NCT01451762|530132196|FG001|Overall Study|Lost to Follow-up|6|||
146991703|NCT01451762|530132197|FG002|Overall Study|Lost to Follow-up|6|||
146991704|NCT00630305|530132201|FG000|Overall Study|Withdrawal by Subject|1|||
146839527|NCT05000216|529584651|FG020|Stage 1|Physician Decision|0|||
146839528|NCT05000216|529584652|FG021|Stage 1|Physician Decision|0|||
146839529|NCT05000216|529584631|FG000|Stage 1|Withdrawal by Subject|0|||
146991705|NCT00630305|530132201|FG000|Overall Study|Inability to insert contact lens|1|||
146991706|NCT01085045|530132202|FG000|Part A|Withdrawal by Subject|4|||
146991707|NCT01085045|530132202|FG000|Part A|Adverse Event|6|||
146991708|NCT01085045|530132202|FG000|Part A|Protocol Violation|1|||
146839530|NCT05000216|529584632|FG001|Stage 1|Withdrawal by Subject|1|||
146991709|NCT01085045|530132202|FG000|Part A|Protocol Specified Criteria|7|||
146991710|NCT01085045|530132202|FG000|Part B|Withdrawal by Subject|2|||
146991711|NCT01085045|530132202|FG000|Part B|Protocol Specified Criteria|6|||
146991712|NCT01085045|530132202|FG000|Part B|Lost to Follow-up|1|||
146991713|NCT01085045|530132202|FG000|Part B|Adverse Event|6|||
146839531|NCT05000216|529584633|FG002|Stage 1|Withdrawal by Subject|0|||
146991714|NCT02395822|530132206|FG000|Overall Study|Withdrawal by Subject|1|||
146991715|NCT02395822|530132206|FG000|Overall Study|Death|1|||
146991716|NCT02127281|530132207|FG000|Overall Study|Lost to Follow-up|1|||
146839532|NCT05000216|529584634|FG003|Stage 1|Withdrawal by Subject|0|||
146839533|NCT05000216|529584635|FG004|Stage 1|Withdrawal by Subject|0|||
146839534|NCT05000216|529584636|FG005|Stage 1|Withdrawal by Subject|0|||
146839535|NCT05000216|529584637|FG006|Stage 1|Withdrawal by Subject|0|||
146839536|NCT05000216|529584638|FG007|Stage 1|Withdrawal by Subject|0|||
146839537|NCT05000216|529584639|FG008|Stage 1|Withdrawal by Subject|0|||
146839538|NCT05000216|529584640|FG009|Stage 1|Withdrawal by Subject|3|||
146839539|NCT05000216|529584641|FG010|Stage 1|Withdrawal by Subject|10|||
146839540|NCT05000216|529584642|FG011|Stage 1|Withdrawal by Subject|0|||
146839541|NCT05000216|529584643|FG012|Stage 1|Withdrawal by Subject|0|||
146839542|NCT05000216|529584644|FG013|Stage 1|Withdrawal by Subject|0|||
146839543|NCT05000216|529584645|FG014|Stage 1|Withdrawal by Subject|0|||
146839544|NCT05000216|529584646|FG015|Stage 1|Withdrawal by Subject|0|||
146839545|NCT05000216|529584647|FG016|Stage 1|Withdrawal by Subject|0|||
146839546|NCT05000216|529584648|FG017|Stage 1|Withdrawal by Subject|0|||
146839547|NCT05000216|529584649|FG018|Stage 1|Withdrawal by Subject|0|||
146839548|NCT05000216|529584650|FG019|Stage 1|Withdrawal by Subject|0|||
146839549|NCT05000216|529584651|FG020|Stage 1|Withdrawal by Subject|0|||
146839550|NCT05000216|529584652|FG021|Stage 1|Withdrawal by Subject|0|||
146839551|NCT05000216|529584631|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
146839552|NCT05000216|529584632|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
146839553|NCT05000216|529584633|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
146839554|NCT05000216|529584634|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
146839555|NCT05000216|529584635|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
146839556|NCT05000216|529584636|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
146839557|NCT05000216|529584637|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
146839558|NCT05000216|529584638|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
146839559|NCT05000216|529584639|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
146839560|NCT05000216|529584640|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
146839561|NCT05000216|529584641|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
146839562|NCT05000216|529584642|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
146839563|NCT05000216|529584643|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
146839564|NCT05000216|529584644|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
146839565|NCT05000216|529584645|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
146839566|NCT05000216|529584646|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
146839567|NCT05000216|529584647|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
146839568|NCT05000216|529584648|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
146839569|NCT05000216|529584649|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
146839570|NCT05000216|529584650|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
146839571|NCT05000216|529584651|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
146839572|NCT05000216|529584652|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
146991717|NCT02127281|530132208|FG001|Overall Study|Lost to Follow-up|0|||
146991718|NCT04510857|530132209|FG000|Overall Study|Withdrawal by Subject|1|||
146991719|NCT04510857|530132210|FG001|Overall Study|Withdrawal by Subject|2|||
146991720|NCT02564263|530132213|FG000|Overall Study|Adverse Event|31|||
146991721|NCT02564263|530132214|FG001|Overall Study|Adverse Event|29|||
146991722|NCT02564263|530132213|FG000|Overall Study|Death|270|||
146991723|NCT02564263|530132214|FG001|Overall Study|Death|262|||
146991724|NCT02564263|530132213|FG000|Overall Study|Withdrawal by Subject|4|||
146991725|NCT02564263|530132214|FG001|Overall Study|Withdrawal by Subject|19|||
146991726|NCT02564263|530132213|FG000|Overall Study|Sponsor's decision|9|||
146991727|NCT02564263|530132214|FG001|Overall Study|Sponsor's decision|4|||
146991728|NCT00920140|530132215|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
146991729|NCT00920140|530132216|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
146991730|NCT00920140|530132217|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
146991731|NCT00920140|530132218|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
146991732|NCT00920140|530132219|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
146991733|NCT00920140|530132215|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
146991734|NCT00920140|530132216|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
146991735|NCT00920140|530132217|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
146991736|NCT00920140|530132218|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
146991737|NCT00920140|530132219|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
146991738|NCT00920140|530132215|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146991739|NCT00920140|530132216|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
146991740|NCT00920140|530132217|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146991741|NCT00920140|530132218|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146839573|NCT05000216|529584631|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146839574|NCT05000216|529584632|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146839575|NCT05000216|529584633|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146839576|NCT05000216|529584634|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146839577|NCT05000216|529584635|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146839578|NCT05000216|529584636|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146991742|NCT00920140|530132219|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146991743|NCT00920140|530132215|FG000|Phase 2|Adverse Event|0|||
146991744|NCT00920140|530132216|FG001|Phase 2|Adverse Event|0|||
146839579|NCT05000216|529584637|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146991745|NCT00920140|530132217|FG002|Phase 2|Adverse Event|14|||
146991746|NCT00920140|530132218|FG003|Phase 2|Adverse Event|2|||
146991747|NCT00920140|530132219|FG004|Phase 2|Adverse Event|3|||
146991748|NCT00920140|530132215|FG000|Phase 2|Lack of Efficacy|0|||
146991749|NCT00920140|530132216|FG001|Phase 2|Lack of Efficacy|0|||
146991750|NCT00920140|530132217|FG002|Phase 2|Lack of Efficacy|29|||
146991751|NCT00920140|530132218|FG003|Phase 2|Lack of Efficacy|14|||
146991752|NCT00920140|530132219|FG004|Phase 2|Lack of Efficacy|5|||
146991753|NCT00920140|530132215|FG000|Phase 2|Lost to Follow-up|0|||
146991754|NCT00920140|530132216|FG001|Phase 2|Lost to Follow-up|0|||
146991755|NCT00920140|530132217|FG002|Phase 2|Lost to Follow-up|0|||
146991756|NCT00920140|530132218|FG003|Phase 2|Lost to Follow-up|1|||
146991757|NCT00920140|530132219|FG004|Phase 2|Lost to Follow-up|0|||
146991758|NCT00920140|530132215|FG000|Phase 2|Physician Decision|0|||
146991759|NCT00920140|530132216|FG001|Phase 2|Physician Decision|0|||
146991760|NCT00920140|530132217|FG002|Phase 2|Physician Decision|3|||
146991761|NCT00920140|530132218|FG003|Phase 2|Physician Decision|3|||
146991762|NCT00920140|530132219|FG004|Phase 2|Physician Decision|2|||
146991763|NCT00920140|530132215|FG000|Phase 2|Withdrawal by Subject|0|||
146991764|NCT00920140|530132216|FG001|Phase 2|Withdrawal by Subject|0|||
146991765|NCT00920140|530132217|FG002|Phase 2|Withdrawal by Subject|4|||
146991766|NCT00920140|530132218|FG003|Phase 2|Withdrawal by Subject|2|||
146991767|NCT00920140|530132219|FG004|Phase 2|Withdrawal by Subject|1|||
146991768|NCT01124149|530132220|FG000|Acute Phase|Withdrawal by Subject|22|||
146991769|NCT01124149|530132220|FG000|Acute Phase|Adverse Event|21|||
146991770|NCT01124149|530132220|FG000|Acute Phase|Lack of Efficacy|17|||
146991771|NCT01124149|530132220|FG000|Acute Phase|Protocol Violation|14|||
146991772|NCT01124149|530132220|FG000|Acute Phase|Lost to Follow-up|2|||
146991773|NCT01124149|530132220|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
146991774|NCT01124149|530132220|FG000|Acute Phase|Sponsor request|1|||
146991775|NCT01124149|530132220|FG000|Acute Phase|UC symptoms not ameliorated|1|||
146991776|NCT01124149|530132220|FG000|Acute Phase|Non-compliance|1|||
146991777|NCT01124149|530132220|FG000|Acute Phase|Low hemoglobin|1|||
146991778|NCT01124149|530132220|FG000|Acute Phase|Travelling to another country|1|||
146991779|NCT01124149|530132220|FG000|Acute Phase|Sponsor decision|1|||
146991780|NCT01124149|530132220|FG000|Maintenance Phase|Lack of Efficacy|40|||
146991781|NCT01124149|530132220|FG000|Maintenance Phase|Adverse Event|24|||
146991782|NCT01124149|530132220|FG000|Maintenance Phase|Lost to Follow-up|15|||
146991783|NCT01124149|530132220|FG000|Maintenance Phase|Withdrawal by Subject|10|||
146991784|NCT01124149|530132220|FG000|Maintenance Phase|Protocol Violation|5|||
146991785|NCT01124149|530132220|FG000|Maintenance Phase|Coordinator error|1|||
146991786|NCT01124149|530132220|FG000|Maintenance Phase|Non-compliance|1|||
146991787|NCT01644500|530132221|FG000|Overall Study|Adverse Event|6|||
146991788|NCT01644500|530132222|FG001|Overall Study|Adverse Event|1|||
146991789|NCT01644500|530132223|FG002|Overall Study|Adverse Event|2|||
146991790|NCT01644500|530132221|FG000|Overall Study|Death|0|||
146991791|NCT01644500|530132222|FG001|Overall Study|Death|1|||
146991792|NCT01644500|530132223|FG002|Overall Study|Death|0|||
146991793|NCT01644500|530132221|FG000|Overall Study|Lost to Follow-up|3|||
146991794|NCT01644500|530132222|FG001|Overall Study|Lost to Follow-up|8|||
146991795|NCT01644500|530132223|FG002|Overall Study|Lost to Follow-up|0|||
146991796|NCT01644500|530132221|FG000|Overall Study|Protocol Violation|1|||
146991797|NCT01644500|530132222|FG001|Overall Study|Protocol Violation|1|||
146991798|NCT01644500|530132223|FG002|Overall Study|Protocol Violation|0|||
146991799|NCT01644500|530132221|FG000|Overall Study|Withdrawal by Subject|11|||
146991800|NCT01644500|530132222|FG001|Overall Study|Withdrawal by Subject|12|||
146991801|NCT01644500|530132223|FG002|Overall Study|Withdrawal by Subject|12|||
146991802|NCT01644500|530132221|FG000|Overall Study|Physician Decision|1|||
146991803|NCT01644500|530132222|FG001|Overall Study|Physician Decision|1|||
146991804|NCT01644500|530132223|FG002|Overall Study|Physician Decision|1|||
146991805|NCT00720096|530132230|FG000|Overall Study|Withdrawal by Subject|0|||
146991806|NCT00720096|530132231|FG001|Overall Study|Withdrawal by Subject|2|||
146991807|NCT04557124|530132232|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
146991808|NCT04557124|530132233|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
146991809|NCT04557124|530132232|FG000|Mid-point (1 Month)|Missed testing|5|||
146991810|NCT04557124|530132233|FG001|Mid-point (1 Month)|Missed testing|4|||
146991811|NCT04557124|530132232|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
146991812|NCT04557124|530132233|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
146991813|NCT04557124|530132232|FG000|Post-testing (2 Months)|Missed testing|1|||
146991814|NCT04557124|530132233|FG001|Post-testing (2 Months)|Missed testing|5|||
146991815|NCT04557124|530132232|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
146991816|NCT04557124|530132233|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
146991817|NCT04557124|530132232|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
146991818|NCT04557124|530132233|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
146991819|NCT00001849|530132234|FG000|Overall Study|Death|4|||
146991820|NCT00001849|530132234|FG000|Overall Study|Lost to Follow-up|2|||
146991821|NCT00001849|530132234|FG000|Overall Study|Withdrawal by Subject|2|||
146991822|NCT00001849|530132234|FG000|Overall Study|tumor remained occult|6|||
146991823|NCT03127137|530132239|FG000|Overall Study|Requested sedation after consent|1|||
146991824|NCT03127137|530132240|FG001|Overall Study|Requested sedation after consent|0|||
146839580|NCT05000216|529584638|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146839581|NCT05000216|529584639|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
146839582|NCT05000216|529584640|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146959372|NCT01589185|530009922|FG002|Overall Study|Death|2|||
146959373|NCT01589185|530009923|FG003|Overall Study|Death|0|||
146959374|NCT01589185|530009924|FG004|Overall Study|Death|1|||
146959375|NCT01589185|530009920|FG000|Overall Study|Lost to Follow-up|1|||
146959376|NCT01589185|530009921|FG001|Overall Study|Lost to Follow-up|0|||
146959377|NCT01589185|530009922|FG002|Overall Study|Lost to Follow-up|2|||
146959378|NCT01589185|530009923|FG003|Overall Study|Lost to Follow-up|3|||
146959379|NCT01589185|530009924|FG004|Overall Study|Lost to Follow-up|0|||
146959380|NCT00917553|530009927|FG000|Overall Study|Lost to Follow-up|2|||
146959381|NCT00917553|530009928|FG001|Overall Study|Lost to Follow-up|1|||
146959382|NCT01616173|530009929|FG000|Overall Study|Lost to Follow-up|0|||
146959383|NCT01616173|530009930|FG001|Overall Study|Lost to Follow-up|2|||
146959384|NCT01616173|530009931|FG002|Overall Study|Lost to Follow-up|0|||
146959385|NCT03172026|530009936|FG000|Overall Study|Withdrawal by Subject|1|||
146959386|NCT03172026|530009937|FG001|Overall Study|Withdrawal by Subject|0|||
146959387|NCT03172026|530009936|FG000|Overall Study|COVID restrictions|1|||
146959388|NCT03172026|530009937|FG001|Overall Study|COVID restrictions|0|||
146959389|NCT00504595|530009939|FG000|Overall Study|Lack of Efficacy|1|||
146959390|NCT00504595|530009940|FG001|Overall Study|Lack of Efficacy|0|||
146959391|NCT00504595|530009941|FG002|Overall Study|Lack of Efficacy|0|||
146959392|NCT00504595|530009942|FG003|Overall Study|Lack of Efficacy|0|||
146959393|NCT00504595|530009939|FG000|Overall Study|Other|0|||
146959394|NCT00504595|530009940|FG001|Overall Study|Other|0|||
146959395|NCT00504595|530009941|FG002|Overall Study|Other|2|||
146959396|NCT00504595|530009942|FG003|Overall Study|Other|0|||
146959397|NCT01177943|530009943|FG000|First Intervention|Withdrawal by Subject|2|||
146959398|NCT01177943|530009944|FG001|First Intervention|Withdrawal by Subject|0|||
146959399|NCT04652245|530009945|FG000|Wash-Out Period|Adverse Event|0|||
146959400|NCT04652245|530009946|FG001|Wash-Out Period|Adverse Event|2|||
146959401|NCT04652245|530009945|FG000|Wash-Out Period|Withdrawal by Subject|0|||
146959402|NCT04652245|530009946|FG001|Wash-Out Period|Withdrawal by Subject|2|||
146959403|NCT01303159|530009950|FG000|Overall Study|Death|16|||
146959404|NCT01303159|530009950|FG000|Overall Study|Study Termination|7|||
146959405|NCT01016912|530009951|FG000|End of Treatment Period|Lack of Efficacy|0|||
146959406|NCT01016912|530009952|FG001|End of Treatment Period|Lack of Efficacy|1|||
146959407|NCT01016912|530009953|FG002|End of Treatment Period|Lack of Efficacy|0|||
146959408|NCT01016912|530009954|FG003|End of Treatment Period|Lack of Efficacy|4|||
146959409|NCT01016912|530009955|FG004|End of Treatment Period|Lack of Efficacy|4|||
146959410|NCT01016912|530009951|FG000|End of Treatment Period|Adverse Event|0|||
146959411|NCT01016912|530009952|FG001|End of Treatment Period|Adverse Event|1|||
146959412|NCT01016912|530009953|FG002|End of Treatment Period|Adverse Event|1|||
146959413|NCT01016912|530009954|FG003|End of Treatment Period|Adverse Event|0|||
146959414|NCT01016912|530009955|FG004|End of Treatment Period|Adverse Event|0|||
146959415|NCT01016912|530009951|FG000|End of Treatment Period|Completed double-blind period only|0|||
146959416|NCT01016912|530009952|FG001|End of Treatment Period|Completed double-blind period only|1|||
146959417|NCT01016912|530009953|FG002|End of Treatment Period|Completed double-blind period only|0|||
146959418|NCT01016912|530009954|FG003|End of Treatment Period|Completed double-blind period only|0|||
146959419|NCT01016912|530009955|FG004|End of Treatment Period|Completed double-blind period only|0|||
146959420|NCT01016912|530009951|FG000|Follow-up Period|Other reason|0|||
146959421|NCT01016912|530009952|FG001|Follow-up Period|Other reason|0|||
146959422|NCT01016912|530009953|FG002|Follow-up Period|Other reason|1|||
146959423|NCT01016912|530009954|FG003|Follow-up Period|Other reason|1|||
146959424|NCT01016912|530009955|FG004|Follow-up Period|Other reason|0|||
146959425|NCT00914940|530009959|FG000|D0 to D100 Post-transplant|Death|2|||
146959426|NCT00914940|530009959|FG000|D101 to 2 Years Post-transplant|Death|8|||
146959427|NCT00914940|530009959|FG000|2 Years to 5 Years Post-transplant|Death|3|||
146959428|NCT00496782|530009960|FG000|Overall Study|Protocol Violation|1|||
146959429|NCT00496782|530009961|FG001|Overall Study|Protocol Violation|2|||
146959430|NCT00760994|530009966|FG000|Overall Study|Lost to Follow-up|4|||
146959431|NCT00760994|530009967|FG001|Overall Study|Lost to Follow-up|4|||
146959432|NCT00760994|530009968|FG002|Overall Study|Lost to Follow-up|3|||
146959433|NCT02431559|530009969|FG000|Overall Study|Adverse Event|0|||
146959434|NCT02431559|530009970|FG001|Overall Study|Adverse Event|1|||
146959435|NCT02431559|530009971|FG002|Overall Study|Adverse Event|0|||
146959436|NCT02431559|530009972|FG003|Overall Study|Adverse Event|4|||
146959437|NCT02431559|530009969|FG000|Overall Study|Progressive disease|2|||
146959438|NCT02431559|530009970|FG001|Overall Study|Progressive disease|1|||
146959439|NCT02431559|530009971|FG002|Overall Study|Progressive disease|4|||
146959440|NCT02431559|530009972|FG003|Overall Study|Progressive disease|22|||
146959441|NCT02431559|530009969|FG000|Overall Study|Withdrawal by Subject|0|||
146959442|NCT02431559|530009970|FG001|Overall Study|Withdrawal by Subject|1|||
146959443|NCT02431559|530009971|FG002|Overall Study|Withdrawal by Subject|0|||
146959444|NCT02431559|530009972|FG003|Overall Study|Withdrawal by Subject|4|||
146959445|NCT02431559|530009969|FG000|Overall Study|Physician Decision|0|||
146959446|NCT02431559|530009970|FG001|Overall Study|Physician Decision|0|||
146839583|NCT05000216|529584641|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146959447|NCT02431559|530009971|FG002|Overall Study|Physician Decision|0|||
146959448|NCT02431559|530009972|FG003|Overall Study|Physician Decision|1|||
146959449|NCT00955682|530009978|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
146959450|NCT00955682|530009979|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
146959451|NCT02260791|530009986|FG000|Overall Study|Lost to Follow-up|4|||
146959452|NCT02260791|530009987|FG001|Overall Study|Lost to Follow-up|4|||
146959453|NCT02260791|530009986|FG000|Overall Study|Lack of Efficacy|2|||
146959454|NCT02260791|530009987|FG001|Overall Study|Lack of Efficacy|1|||
146959455|NCT02260791|530009986|FG000|Overall Study|Adverse Event|13|||
146959456|NCT02260791|530009987|FG001|Overall Study|Adverse Event|9|||
146959457|NCT02260791|530009986|FG000|Overall Study|Death|1|||
146959458|NCT02260791|530009987|FG001|Overall Study|Death|0|||
146959459|NCT02260791|530009986|FG000|Overall Study|Withdrawal by Subject|11|||
146959460|NCT02260791|530009987|FG001|Overall Study|Withdrawal by Subject|16|||
146959461|NCT02260791|530009986|FG000|Overall Study|Screen failure|0|||
146959462|NCT02260791|530009987|FG001|Overall Study|Screen failure|1|||
146959463|NCT02260791|530009986|FG000|Overall Study|Protocol deviation|2|||
146959464|NCT02260791|530009987|FG001|Overall Study|Protocol deviation|3|||
146959465|NCT02924129|530009988|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
146959466|NCT02924129|530009989|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
146959467|NCT02924129|530009988|FG000|Overall Study|Withdrawal by Subject|2|||
146959468|NCT02924129|530009989|FG001|Overall Study|Withdrawal by Subject|2|||
146959469|NCT02924129|530009988|FG000|Overall Study|Physician Decision|1|||
146959470|NCT02924129|530009989|FG001|Overall Study|Physician Decision|0|||
146959471|NCT02924129|530009988|FG000|Overall Study|Missed Visit|0|||
146959472|NCT02924129|530009989|FG001|Overall Study|Missed Visit|1|||
146959473|NCT01365468|530009995|FG000|Overall Study|Physician Decision|1|||
146959474|NCT01365468|530009996|FG001|Overall Study|Physician Decision|0|||
146959475|NCT01365468|530009995|FG000|Overall Study|Disease progression|1|||
146959476|NCT01365468|530009996|FG001|Overall Study|Disease progression|0|||
146959477|NCT01365468|530009995|FG000|Overall Study|Lost to Follow-up|2|||
146959478|NCT01365468|530009996|FG001|Overall Study|Lost to Follow-up|0|||
146959479|NCT01482598|530009997|FG000|Overall Study|Death|7|||
146959480|NCT01482598|530009998|FG001|Overall Study|Death|10|||
146959481|NCT01482598|530009997|FG000|Overall Study|Physician Decision|0|||
146959482|NCT01482598|530009998|FG001|Overall Study|Physician Decision|3|||
146959483|NCT01482598|530009997|FG000|Overall Study|Withdrawal by Subject|4|||
146959484|NCT01482598|530009998|FG001|Overall Study|Withdrawal by Subject|5|||
146959485|NCT01482598|530009997|FG000|Overall Study|Lost to Follow-up|5|||
146959486|NCT01482598|530009998|FG001|Overall Study|Lost to Follow-up|4|||
146959487|NCT00423267|530009999|FG000|Period A|Withdrawal by Subject|0|||
146959488|NCT00423267|530010000|FG001|Period A|Withdrawal by Subject|1|||
146959489|NCT00423267|530009999|FG000|Period A|Non-compliance with protocol|1|||
146959490|NCT00423267|530010000|FG001|Period A|Non-compliance with protocol|0|||
146959491|NCT00423267|530009999|FG000|Period A|Administrative|1|||
146959492|NCT00423267|530010000|FG001|Period A|Administrative|0|||
146959493|NCT00827112|530010001|FG000|Overall Study|Adverse Event|2|||
146959494|NCT00827112|530010002|FG001|Overall Study|Adverse Event|0|||
146959495|NCT00827112|530010001|FG000|Overall Study|Lack of Efficacy|2|||
146959496|NCT00827112|530010002|FG001|Overall Study|Lack of Efficacy|0|||
146959497|NCT00827112|530010001|FG000|Overall Study|Lost to Follow-up|3|||
146959498|NCT00827112|530010002|FG001|Overall Study|Lost to Follow-up|2|||
146959499|NCT00827112|530010001|FG000|Overall Study|Pregnancy|0|||
146959500|NCT00827112|530010002|FG001|Overall Study|Pregnancy|1|||
146959501|NCT00827112|530010001|FG000|Overall Study|Protocol Violation|0|||
146959502|NCT00827112|530010002|FG001|Overall Study|Protocol Violation|2|||
146959503|NCT00827112|530010001|FG000|Overall Study|Withdrawal by Subject|2|||
146959504|NCT00827112|530010002|FG001|Overall Study|Withdrawal by Subject|1|||
146959505|NCT00827112|530010001|FG000|Overall Study|Randomized but not treated|5|||
146959506|NCT00827112|530010002|FG001|Overall Study|Randomized but not treated|3|||
146959507|NCT00827112|530010001|FG000|Overall Study|Other|1|||
146959508|NCT00827112|530010002|FG001|Overall Study|Other|3|||
146959509|NCT00689728|530010005|FG000|Double-Blind Treatment|Adverse Event|1|||
146959510|NCT00689728|530010006|FG001|Double-Blind Treatment|Adverse Event|0|||
146959511|NCT00689728|530010007|FG002|Double-Blind Treatment|Adverse Event|0|||
146959512|NCT00689728|530010005|FG000|Double-Blind Treatment|Protocol Violation|0|||
146959513|NCT00689728|530010006|FG001|Double-Blind Treatment|Protocol Violation|0|||
146959514|NCT00689728|530010007|FG002|Double-Blind Treatment|Protocol Violation|1|||
146959515|NCT00689728|530010005|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
146959516|NCT00689728|530010006|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
146959517|NCT00689728|530010007|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
146959518|NCT00689728|530010005|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
146959519|NCT00689728|530010006|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
146959520|NCT00689728|530010007|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
146959521|NCT00689728|530010005|FG000|Rescue|Adverse Event|0|||
146959522|NCT00689728|530010006|FG001|Rescue|Adverse Event|1|||
146959523|NCT00689728|530010007|FG002|Rescue|Adverse Event|0|||
146959524|NCT00689728|530010005|FG000|Rescue|Withdrawal by Subject|1|||
146991825|NCT03127137|530132239|FG000|Overall Study|Malfunction in electronic data collection|1|||
146991826|NCT03127137|530132240|FG001|Overall Study|Malfunction in electronic data collection|0|||
146991827|NCT03127137|530132239|FG000|Overall Study|Post procedure testing could not be obtained|0|||
146991828|NCT03127137|530132240|FG001|Overall Study|Post procedure testing could not be obtained|1|||
146991829|NCT02319148|530132243|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
146991830|NCT02319148|530132244|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
146991831|NCT02319148|530132245|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
146991832|NCT02319148|530132246|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
146991833|NCT02319148|530132243|FG000|Second Intervention Period|No longer willing to participate|0|||
146991834|NCT02319148|530132244|FG001|Second Intervention Period|No longer willing to participate|1|||
146991835|NCT02319148|530132245|FG002|Second Intervention Period|No longer willing to participate|0|||
146991836|NCT02319148|530132246|FG003|Second Intervention Period|No longer willing to participate|0|||
146991837|NCT02319148|530132243|FG000|Second Intervention Period|Other|0|||
146991838|NCT02319148|530132244|FG001|Second Intervention Period|Other|0|||
146991839|NCT02319148|530132245|FG002|Second Intervention Period|Other|0|||
146991840|NCT02319148|530132246|FG003|Second Intervention Period|Other|1|||
146991841|NCT00264797|530132247|FG000|Overall Study|Withdrawal by Subject|11|||
146991842|NCT00264797|530132248|FG001|Overall Study|Withdrawal by Subject|11|||
146991843|NCT00264797|530132247|FG000|Overall Study|Lost to Follow-up|9|||
146991844|NCT00264797|530132248|FG001|Overall Study|Lost to Follow-up|17|||
146991845|NCT00264797|530132247|FG000|Overall Study|Moved from area|3|||
146991846|NCT00264797|530132248|FG001|Overall Study|Moved from area|1|||
146991847|NCT00264797|530132247|FG000|Overall Study|Practical Problems|2|||
146991848|NCT00264797|530132248|FG001|Overall Study|Practical Problems|3|||
146991849|NCT00264797|530132247|FG000|Overall Study|Incarceration|4|||
146991850|NCT00264797|530132248|FG001|Overall Study|Incarceration|5|||
146991851|NCT00264797|530132247|FG000|Overall Study|Pressure/advice from Outsiders|1|||
146991852|NCT00264797|530132248|FG001|Overall Study|Pressure/advice from Outsiders|1|||
146991853|NCT00264797|530132247|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
146991854|NCT00264797|530132248|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
146991855|NCT00264797|530132247|FG000|Overall Study|Other|3|||
146991856|NCT00264797|530132248|FG001|Overall Study|Other|4|||
146991857|NCT01249664|530132249|FG000|Overall Study|Withdrawal by Subject|5|||
146991858|NCT01249664|530132250|FG001|Overall Study|Withdrawal by Subject|0|||
146991859|NCT01249664|530132249|FG000|Overall Study|Adverse Event|1|||
146991860|NCT01249664|530132250|FG001|Overall Study|Adverse Event|0|||
146991861|NCT00762086|530132253|FG000|Overall Study|Adverse Event|2|||
146991862|NCT00762086|530132254|FG001|Overall Study|Adverse Event|0|||
146991863|NCT00762086|530132253|FG000|Overall Study|Lost to Follow-up|0|||
146991864|NCT00762086|530132254|FG001|Overall Study|Lost to Follow-up|2|||
146991865|NCT00762086|530132253|FG000|Overall Study|Non compliance|1|||
146991866|NCT00762086|530132254|FG001|Overall Study|Non compliance|0|||
146991867|NCT00762086|530132253|FG000|Overall Study|Withdrawal by Subject|2|||
146991868|NCT00762086|530132254|FG001|Overall Study|Withdrawal by Subject|2|||
146991869|NCT00762086|530132253|FG000|Overall Study|Ineligible to participate in the study|1|||
146991870|NCT00762086|530132254|FG001|Overall Study|Ineligible to participate in the study|0|||
146991871|NCT00860405|530132255|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
146991872|NCT00860405|530132256|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
146991873|NCT00497796|530132258|FG000|Overall Study|Adverse event (not related)|9|||
146991874|NCT00497796|530132259|FG001|Overall Study|Adverse event (not related)|9|||
146991875|NCT00497796|530132258|FG000|Overall Study|Adverse event (related)|5|||
146991876|NCT00497796|530132259|FG001|Overall Study|Adverse event (related)|4|||
146991877|NCT00497796|530132258|FG000|Overall Study|CMV infection or disease treatment|30|||
146991878|NCT00497796|530132259|FG001|Overall Study|CMV infection or disease treatment|4|||
146991879|NCT00497796|530132258|FG000|Overall Study|Consent withdrawn|10|||
146991880|NCT00497796|530132259|FG001|Overall Study|Consent withdrawn|3|||
146991881|NCT00497796|530132258|FG000|Overall Study|Investigator/sponsor discretion|31|||
146991882|NCT00497796|530132259|FG001|Overall Study|Investigator/sponsor discretion|34|||
146991883|NCT00497796|530132258|FG000|Overall Study|Lost to Follow-up|0|||
146991884|NCT00497796|530132259|FG001|Overall Study|Lost to Follow-up|1|||
146991885|NCT00497796|530132258|FG000|Overall Study|Not applicable (randomized not treated)|0|||
146991886|NCT00497796|530132259|FG001|Overall Study|Not applicable (randomized not treated)|4|||
146991887|NCT01074554|530132260|FG000|Overall Study|Adverse Event|3|||
146991888|NCT01074554|530132261|FG001|Overall Study|Adverse Event|3|||
146991889|NCT01074554|530132260|FG000|Overall Study|Lost to Follow-up|0|||
146991890|NCT01074554|530132261|FG001|Overall Study|Lost to Follow-up|1|||
146991891|NCT04276883|530132262|FG000|Overall Study|Withdrawal by Subject|2|||
146991892|NCT04276883|530132263|FG001|Overall Study|Withdrawal by Subject|3|||
146991893|NCT04276883|530132264|FG002|Overall Study|Withdrawal by Subject|6|||
146991894|NCT04276883|530132262|FG000|Overall Study|Lost to Follow-up|1|||
146991895|NCT04276883|530132263|FG001|Overall Study|Lost to Follow-up|3|||
146991896|NCT04276883|530132264|FG002|Overall Study|Lost to Follow-up|0|||
146991897|NCT04276883|530132262|FG000|Overall Study|Adverse Event|0|||
146839584|NCT05000216|529584642|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146839585|NCT05000216|529584643|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146839586|NCT05000216|529584644|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146839587|NCT05000216|529584645|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146839588|NCT05000216|529584646|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146839589|NCT05000216|529584647|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146959525|NCT00689728|530010006|FG001|Rescue|Withdrawal by Subject|1|||
146959526|NCT00689728|530010007|FG002|Rescue|Withdrawal by Subject|1|||
146959527|NCT00689728|530010005|FG000|Optional Follow-Up|Adverse Event|1|||
146959528|NCT00689728|530010006|FG001|Optional Follow-Up|Adverse Event|0|||
146959529|NCT00689728|530010007|FG002|Optional Follow-Up|Adverse Event|0|||
146959530|NCT00689728|530010005|FG000|Optional Follow-Up|Lack of Efficacy|0|||
146959531|NCT00689728|530010006|FG001|Optional Follow-Up|Lack of Efficacy|1|||
146959532|NCT00689728|530010007|FG002|Optional Follow-Up|Lack of Efficacy|1|||
146959533|NCT00689728|530010005|FG000|Optional Follow-Up|Lost to Follow-up|0|||
146959534|NCT00689728|530010006|FG001|Optional Follow-Up|Lost to Follow-up|1|||
146959535|NCT00689728|530010007|FG002|Optional Follow-Up|Lost to Follow-up|1|||
146959536|NCT00689728|530010005|FG000|Optional Follow-Up|Protocol Violation|0|||
146959537|NCT00689728|530010006|FG001|Optional Follow-Up|Protocol Violation|0|||
146959538|NCT00689728|530010007|FG002|Optional Follow-Up|Protocol Violation|1|||
146959539|NCT00689728|530010005|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
146959540|NCT00689728|530010006|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
146959541|NCT00689728|530010007|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
146959542|NCT00842829|530010008|FG000|Dose Titration Period|Adverse Event|11|||
146959543|NCT00842829|530010009|FG001|Dose Titration Period|Adverse Event|10|||
146959544|NCT00842829|530010010|FG002|Dose Titration Period|Adverse Event|0|||
146959545|NCT00842829|530010008|FG000|Dose Titration Period|Lack of Efficacy|4|||
146959546|NCT00842829|530010009|FG001|Dose Titration Period|Lack of Efficacy|1|||
146959547|NCT00842829|530010010|FG002|Dose Titration Period|Lack of Efficacy|0|||
146959548|NCT00842829|530010008|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
146959549|NCT00842829|530010009|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
146959550|NCT00842829|530010010|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
146959551|NCT00842829|530010008|FG000|Dose Titration Period|Withdrawal by Subject|2|||
146959552|NCT00842829|530010009|FG001|Dose Titration Period|Withdrawal by Subject|6|||
146959553|NCT00842829|530010010|FG002|Dose Titration Period|Withdrawal by Subject|0|||
146959554|NCT00842829|530010008|FG000|Dose Titration Period|Other|5|||
146959555|NCT00842829|530010009|FG001|Dose Titration Period|Other|4|||
146959556|NCT00842829|530010010|FG002|Dose Titration Period|Other|0|||
146959557|NCT00842829|530010008|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
146959558|NCT00842829|530010009|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
146959559|NCT00842829|530010010|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
146959560|NCT00842829|530010008|FG000|Dose Titration Period|Non-compliance to study drug|2|||
146959561|NCT00842829|530010009|FG001|Dose Titration Period|Non-compliance to study drug|1|||
146959562|NCT00842829|530010010|FG002|Dose Titration Period|Non-compliance to study drug|0|||
146959563|NCT00842829|530010008|FG000|Treatment Period|Adverse Event|0|||
146959564|NCT00842829|530010009|FG001|Treatment Period|Adverse Event|0|||
146959565|NCT00842829|530010010|FG002|Treatment Period|Adverse Event|15|||
146959566|NCT00842829|530010008|FG000|Treatment Period|Lack of Efficacy|0|||
146959567|NCT00842829|530010009|FG001|Treatment Period|Lack of Efficacy|0|||
146959568|NCT00842829|530010010|FG002|Treatment Period|Lack of Efficacy|6|||
146959569|NCT00842829|530010008|FG000|Treatment Period|Unstable persistent cancer pain|0|||
146959570|NCT00842829|530010009|FG001|Treatment Period|Unstable persistent cancer pain|0|||
146959571|NCT00842829|530010010|FG002|Treatment Period|Unstable persistent cancer pain|5|||
146959572|NCT00842829|530010008|FG000|Treatment Period|Withdrawal by Subject|0|||
146959573|NCT00842829|530010009|FG001|Treatment Period|Withdrawal by Subject|0|||
146959574|NCT00842829|530010010|FG002|Treatment Period|Withdrawal by Subject|11|||
146959575|NCT00842829|530010008|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
146959576|NCT00842829|530010009|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
146959577|NCT00842829|530010010|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
146959578|NCT00842829|530010008|FG000|Treatment Period|Protocol Violation|0|||
146959579|NCT00842829|530010009|FG001|Treatment Period|Protocol Violation|0|||
146959580|NCT00842829|530010010|FG002|Treatment Period|Protocol Violation|2|||
146839590|NCT05000216|529584648|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146959581|NCT00842829|530010008|FG000|Treatment Period|Other|0|||
146959582|NCT00842829|530010009|FG001|Treatment Period|Other|0|||
146959583|NCT00842829|530010010|FG002|Treatment Period|Other|18|||
146959584|NCT00842829|530010008|FG000|Treatment Period|Non-compliance to study procedures|0|||
146839591|NCT05000216|529584649|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146959585|NCT00842829|530010009|FG001|Treatment Period|Non-compliance to study procedures|0|||
146959586|NCT00842829|530010010|FG002|Treatment Period|Non-compliance to study procedures|4|||
146959587|NCT00842829|530010008|FG000|Treatment Period|Unclear completion status|0|||
146959588|NCT00842829|530010009|FG001|Treatment Period|Unclear completion status|0|||
146959589|NCT00842829|530010010|FG002|Treatment Period|Unclear completion status|1|||
146839592|NCT05000216|529584650|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146839593|NCT05000216|529584651|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146839594|NCT05000216|529584652|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146839595|NCT05000216|529584631|FG000|Stage 1|Other|0|||
146839596|NCT05000216|529584632|FG001|Stage 1|Other|0|||
146839597|NCT05000216|529584633|FG002|Stage 1|Other|0|||
146839598|NCT05000216|529584634|FG003|Stage 1|Other|0|||
146959590|NCT00842829|530010008|FG000|Continuation Period|Adverse Event|0|||
146959591|NCT00842829|530010009|FG001|Continuation Period|Adverse Event|0|||
146959592|NCT00842829|530010010|FG002|Continuation Period|Adverse Event|32|||
146959593|NCT00842829|530010008|FG000|Continuation Period|Lack of Efficacy|0|||
146959594|NCT00842829|530010009|FG001|Continuation Period|Lack of Efficacy|0|||
146959595|NCT00842829|530010010|FG002|Continuation Period|Lack of Efficacy|6|||
146959596|NCT00842829|530010008|FG000|Continuation Period|Unstable persistent cancer pain|0|||
146959597|NCT00842829|530010009|FG001|Continuation Period|Unstable persistent cancer pain|0|||
146959598|NCT00842829|530010010|FG002|Continuation Period|Unstable persistent cancer pain|3|||
146959599|NCT00842829|530010008|FG000|Continuation Period|Withdrawal by Subject|0|||
146959600|NCT00842829|530010009|FG001|Continuation Period|Withdrawal by Subject|0|||
146959601|NCT00842829|530010010|FG002|Continuation Period|Withdrawal by Subject|10|||
146959602|NCT00842829|530010008|FG000|Continuation Period|Other|0|||
146959603|NCT00842829|530010009|FG001|Continuation Period|Other|0|||
146959604|NCT00842829|530010010|FG002|Continuation Period|Other|7|||
146959605|NCT00842829|530010008|FG000|Continuation Period|Non-compliance to study procedures|0|||
146959606|NCT00842829|530010009|FG001|Continuation Period|Non-compliance to study procedures|0|||
146959607|NCT00842829|530010010|FG002|Continuation Period|Non-compliance to study procedures|2|||
146959608|NCT00842829|530010008|FG000|Continuation Period|Non-compliance to study drug|0|||
146959609|NCT00842829|530010009|FG001|Continuation Period|Non-compliance to study drug|0|||
146959610|NCT00842829|530010010|FG002|Continuation Period|Non-compliance to study drug|1|||
146959611|NCT01002573|530012187|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
146959612|NCT01002573|530012188|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
146959613|NCT00690612|530012194|FG000|Overall Study|Adverse Event|1|||
146959614|NCT00690612|530012194|FG000|Overall Study|Withdrawal by Subject|2|||
146959615|NCT02926833|530012195|FG000|Overall Study|Death|1|||
146959616|NCT02926833|530012196|FG001|Overall Study|Death|1|||
146959617|NCT02926833|530012197|FG002|Overall Study|Death|2|||
146959618|NCT02926833|530012198|FG003|Overall Study|Death|13|||
146959619|NCT02926833|530012195|FG000|Overall Study|Lost to Follow-up|1|||
146959620|NCT02926833|530012196|FG001|Overall Study|Lost to Follow-up|2|||
146959621|NCT02926833|530012197|FG002|Overall Study|Lost to Follow-up|0|||
146959622|NCT02926833|530012198|FG003|Overall Study|Lost to Follow-up|3|||
146959623|NCT02926833|530012195|FG000|Overall Study|Full Consent Withdrawal|0|||
146959624|NCT02926833|530012196|FG001|Overall Study|Full Consent Withdrawal|0|||
146959625|NCT02926833|530012197|FG002|Overall Study|Full Consent Withdrawal|0|||
146959626|NCT02926833|530012198|FG003|Overall Study|Full Consent Withdrawal|2|||
146959627|NCT02926833|530012195|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
146959628|NCT02926833|530012196|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
146959629|NCT02926833|530012197|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
146959630|NCT02926833|530012198|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
146959631|NCT02926833|530012195|FG000|Overall Study|Investigator Decision|0|||
146959632|NCT02926833|530012196|FG001|Overall Study|Investigator Decision|1|||
146959633|NCT02926833|530012197|FG002|Overall Study|Investigator Decision|0|||
146959634|NCT02926833|530012198|FG003|Overall Study|Investigator Decision|0|||
146959635|NCT02926833|530012195|FG000|Overall Study|Adverse Event|0|||
146959636|NCT02926833|530012196|FG001|Overall Study|Adverse Event|0|||
146959637|NCT02926833|530012197|FG002|Overall Study|Adverse Event|1|||
146959638|NCT02926833|530012198|FG003|Overall Study|Adverse Event|0|||
146959639|NCT02926833|530012195|FG000|Overall Study|Partial Withdrawal of Consent|0|||
146959640|NCT02926833|530012196|FG001|Overall Study|Partial Withdrawal of Consent|0|||
146959641|NCT02926833|530012197|FG002|Overall Study|Partial Withdrawal of Consent|0|||
146959642|NCT02926833|530012198|FG003|Overall Study|Partial Withdrawal of Consent|1|||
146959643|NCT01945866|530012199|FG000|Overall Study|Eyes did not complete or were dropped|2|||
146959644|NCT01945866|530012200|FG001|Overall Study|Eyes did not complete or were dropped|0|||
146959645|NCT00346775|530012205|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
146959646|NCT00346775|530012206|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
146959647|NCT00346775|530012205|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
146959648|NCT00346775|530012206|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
146959649|NCT00346775|530012205|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
146839599|NCT05000216|529584635|FG004|Stage 1|Other|1|||
146959650|NCT00346775|530012206|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
146959651|NCT02946515|530012207|FG000|Overall Study|Lost to Follow-up|2|||
146839600|NCT05000216|529584636|FG005|Stage 1|Other|0|||
146839601|NCT05000216|529584637|FG006|Stage 1|Other|0|||
146839602|NCT05000216|529584638|FG007|Stage 1|Other|2|||
146959652|NCT02946515|530012208|FG001|Overall Study|Lost to Follow-up|1|||
146959653|NCT03039686|530012213|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
146839603|NCT05000216|529584639|FG008|Stage 1|Other|0|||
146839604|NCT05000216|529584640|FG009|Stage 1|Other|0|||
146839605|NCT05000216|529584641|FG010|Stage 1|Other|1|||
146839606|NCT05000216|529584642|FG011|Stage 1|Other|1|||
146839607|NCT05000216|529584643|FG012|Stage 1|Other|0|||
146839608|NCT05000216|529584644|FG013|Stage 1|Other|0|||
146839609|NCT05000216|529584645|FG014|Stage 1|Other|0|||
146839610|NCT05000216|529584646|FG015|Stage 1|Other|0|||
146839611|NCT05000216|529584647|FG016|Stage 1|Other|0|||
146839612|NCT05000216|529584648|FG017|Stage 1|Other|0|||
146839613|NCT05000216|529584649|FG018|Stage 1|Other|0|||
146839614|NCT05000216|529584650|FG019|Stage 1|Other|0|||
146839615|NCT05000216|529584651|FG020|Stage 1|Other|0|||
146839616|NCT05000216|529584652|FG021|Stage 1|Other|0|||
146839617|NCT05000216|529584631|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
146839618|NCT05000216|529584632|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
146839619|NCT05000216|529584633|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
146839620|NCT05000216|529584634|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
146839621|NCT05000216|529584635|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
146839622|NCT05000216|529584636|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
146839623|NCT05000216|529584637|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
146839624|NCT05000216|529584638|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
146839625|NCT05000216|529584639|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
146839626|NCT05000216|529584640|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
146839627|NCT05000216|529584641|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
146991898|NCT04276883|530132263|FG001|Overall Study|Adverse Event|1|||
146991899|NCT04276883|530132264|FG002|Overall Study|Adverse Event|0|||
146991900|NCT04276883|530132262|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
146991901|NCT04276883|530132263|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
146991902|NCT04276883|530132264|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
146991903|NCT02073643|530132267|FG000|Overall Study|Lost to Follow-up|24|||
146991904|NCT01139164|530132273|FG000|Overall Study|Withdrawn prior to study start|0|||
146991905|NCT01139164|530132274|FG001|Overall Study|Withdrawn prior to study start|2|||
146991906|NCT01139164|530132275|FG002|Overall Study|Withdrawn prior to study start|0|||
146991907|NCT00406848|530132276|FG000|Overall Study|Withdrawal by Subject|27|||
146991908|NCT00406848|530132277|FG001|Overall Study|Withdrawal by Subject|22|||
146991909|NCT00406848|530132276|FG000|Overall Study|Adverse Event|38|||
146991910|NCT00406848|530132277|FG001|Overall Study|Adverse Event|7|||
146991911|NCT00406848|530132276|FG000|Overall Study|Lack of Efficacy|9|||
146991912|NCT00406848|530132277|FG001|Overall Study|Lack of Efficacy|14|||
146991913|NCT00406848|530132276|FG000|Overall Study|Protocol Violation|10|||
146991914|NCT00406848|530132277|FG001|Overall Study|Protocol Violation|6|||
146991915|NCT00406848|530132276|FG000|Overall Study|Lost to Follow-up|6|||
146991916|NCT00406848|530132277|FG001|Overall Study|Lost to Follow-up|2|||
146991917|NCT00406848|530132276|FG000|Overall Study|Physician Decision|2|||
146991918|NCT00406848|530132277|FG001|Overall Study|Physician Decision|2|||
146991919|NCT00406848|530132276|FG000|Overall Study|Sponsor Decision|1|||
146991920|NCT00406848|530132277|FG001|Overall Study|Sponsor Decision|1|||
146991921|NCT01355081|530132278|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
146991922|NCT01355081|530132279|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
146991923|NCT01355081|530132280|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
146991924|NCT01355081|530132278|FG000|Overall Study|Major Protocol Deviation|0|||
146991925|NCT01355081|530132279|FG001|Overall Study|Major Protocol Deviation|1|||
146991926|NCT01355081|530132280|FG002|Overall Study|Major Protocol Deviation|0|||
146991927|NCT01355081|530132278|FG000|Overall Study|Lost to Follow-up|0|||
146991928|NCT01355081|530132279|FG001|Overall Study|Lost to Follow-up|0|||
146991929|NCT01355081|530132280|FG002|Overall Study|Lost to Follow-up|1|||
146991930|NCT01355081|530132278|FG000|Overall Study|Withdrawal of Consent|2|||
146991931|NCT01355081|530132279|FG001|Overall Study|Withdrawal of Consent|3|||
146991932|NCT01355081|530132280|FG002|Overall Study|Withdrawal of Consent|3|||
146991933|NCT01355081|530132278|FG000|Overall Study|Lack of Efficacy|2|||
146991934|NCT01355081|530132279|FG001|Overall Study|Lack of Efficacy|1|||
146991935|NCT01355081|530132280|FG002|Overall Study|Lack of Efficacy|1|||
146991936|NCT01355081|530132278|FG000|Overall Study|Non Compliance with Study Medication|0|||
146839628|NCT05000216|529584642|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
146839629|NCT05000216|529584643|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
146991937|NCT01355081|530132279|FG001|Overall Study|Non Compliance with Study Medication|1|||
146991938|NCT01355081|530132280|FG002|Overall Study|Non Compliance with Study Medication|0|||
146991939|NCT02719522|530132281|FG000|Overall Study|Implant Failure|4|||
146991940|NCT02719522|530132281|FG000|Overall Study|Death|2|||
146839630|NCT05000216|529584644|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
146991941|NCT02719522|530132281|FG000|Overall Study|Lost to Follow-up|5|||
146991942|NCT03184441|530132282|FG000|Overall Study|Withdrawal by Subject|1|||
146991943|NCT00860028|530132285|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
146991944|NCT00860028|530132286|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
146839631|NCT05000216|529584645|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
146839632|NCT05000216|529584646|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
146991945|NCT00936390|530132287|FG000|Overall Study|Protocol Violation|21|||
146991946|NCT00936390|530132288|FG001|Overall Study|Protocol Violation|25|||
146991947|NCT02514174|530132292|FG000|Overall Study|Patient refused to continue medication|1|||
146991948|NCT02514174|530132292|FG000|Overall Study|Adverse Event|2|||
146991949|NCT02514174|530132292|FG000|Overall Study|Study closed by sponsor|9|||
146991950|NCT02514174|530132292|FG000|Overall Study|Progressive disease|11|||
146991951|NCT02514174|530132292|FG000|Overall Study|Treatment change|1|||
146991952|NCT02514174|530132292|FG000|Overall Study|Treated off study with Afatinib.|1|||
146991953|NCT00444145|530134036|FG000|Overall Study|Withdrawal by Subject|2|||
146991954|NCT00444145|530134036|FG000|Overall Study|Lost to Follow-up|1|||
146991955|NCT00444145|530134036|FG000|Overall Study|non-compliant|11|||
146991956|NCT00444145|530134036|FG000|Overall Study|Screen Failures|5|||
146991957|NCT00419770|530134037|FG000|Overall Study|Withdrawal by Subject|5|||
146991958|NCT00419770|530134038|FG001|Overall Study|Withdrawal by Subject|1|||
146991959|NCT02637232|530134040|FG000|Overall Study|Lost to Follow-up|42|||
146991960|NCT02637232|530134040|FG000|Overall Study|Adverse Event|11|||
146991961|NCT02637232|530134040|FG000|Overall Study|patient 's decision|2|||
146991962|NCT01781637|530134041|FG000|Overall Study|Adverse Event|1|||
146991963|NCT01781637|530134042|FG001|Overall Study|Adverse Event|0|||
146991964|NCT01781637|530134041|FG000|Overall Study|Lack of Efficacy|2|||
146991965|NCT01781637|530134042|FG001|Overall Study|Lack of Efficacy|6|||
146991966|NCT01781637|530134041|FG000|Overall Study|Withdrawal by Subject|1|||
146991967|NCT01781637|530134042|FG001|Overall Study|Withdrawal by Subject|0|||
146991968|NCT02999178|530134043|FG000|Overall Study|Adverse Event|85|||
146991969|NCT02999178|530134044|FG001|Overall Study|Adverse Event|62|||
146991970|NCT02999178|530134043|FG000|Overall Study|Protocol Violation|1|||
146991971|NCT02999178|530134044|FG001|Overall Study|Protocol Violation|2|||
146991972|NCT02999178|530134043|FG000|Overall Study|Lost to Follow-up|0|||
146991973|NCT02999178|530134044|FG001|Overall Study|Lost to Follow-up|2|||
146991974|NCT02999178|530134043|FG000|Overall Study|Withdrawal by Subject|21|||
146991975|NCT02999178|530134044|FG001|Overall Study|Withdrawal by Subject|21|||
146991976|NCT02999178|530134043|FG000|Overall Study|Other reason not defined above|7|||
146991977|NCT02999178|530134044|FG001|Overall Study|Other reason not defined above|13|||
146991978|NCT00090857|530134045|FG000|Overall Study|Lost to Follow-up|0|||
146991979|NCT00090857|530134046|FG001|Overall Study|Lost to Follow-up|1|||
146991980|NCT00090857|530134045|FG000|Overall Study|Withdrawal by Subject|2|||
146991981|NCT00090857|530134046|FG001|Overall Study|Withdrawal by Subject|0|||
146991982|NCT00090857|530134045|FG000|Overall Study|Adverse Event|2|||
146991983|NCT00090857|530134046|FG001|Overall Study|Adverse Event|2|||
146991984|NCT05097326|530134047|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
146991985|NCT05097326|530134048|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
146991986|NCT01244126|530134049|FG000|Overall Study|Protocol Violation|3|||
146991987|NCT01244126|530134050|FG001|Overall Study|Protocol Violation|3|||
146991988|NCT01244126|530134051|FG002|Overall Study|Protocol Violation|9|||
146991989|NCT02424188|530134056|FG000|Overall Study|Death|2|||
146991990|NCT02424188|530134057|FG001|Overall Study|Death|2|||
146991991|NCT02424188|530134056|FG000|Overall Study|Lost to Follow-up|1|||
146991992|NCT02424188|530134057|FG001|Overall Study|Lost to Follow-up|3|||
146991993|NCT02424188|530134056|FG000|Overall Study|Incarceration|1|||
146991994|NCT02424188|530134057|FG001|Overall Study|Incarceration|0|||
146991995|NCT01494506|530134066|FG000|Overall Study|Lack of Efficacy|77|||
146991996|NCT01494506|530134067|FG001|Overall Study|Lack of Efficacy|83|||
146991997|NCT01494506|530134068|FG002|Overall Study|Lack of Efficacy|57|||
146991998|NCT01494506|530134066|FG000|Overall Study|Adverse Event|17|||
146991999|NCT01494506|530134067|FG001|Overall Study|Adverse Event|10|||
146992000|NCT01494506|530134068|FG002|Overall Study|Adverse Event|11|||
146992001|NCT01494506|530134066|FG000|Overall Study|Death|9|||
146992002|NCT01494506|530134067|FG001|Overall Study|Death|5|||
146839633|NCT05000216|529584647|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
146839634|NCT05000216|529584648|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
146992003|NCT01494506|530134068|FG002|Overall Study|Death|2|||
146992004|NCT01494506|530134066|FG000|Overall Study|Physician Decision|7|||
146992005|NCT01494506|530134067|FG001|Overall Study|Physician Decision|5|||
146992006|NCT01494506|530134068|FG002|Overall Study|Physician Decision|4|||
146992007|NCT01494506|530134066|FG000|Overall Study|Withdrawal by Subject|17|||
146992008|NCT01494506|530134067|FG001|Overall Study|Withdrawal by Subject|20|||
146992009|NCT01494506|530134068|FG002|Overall Study|Withdrawal by Subject|14|||
146839635|NCT05000216|529584649|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
146839636|NCT05000216|529584650|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
146992010|NCT01494506|530134066|FG000|Overall Study|Clinical Deterioration|21|||
146992011|NCT01494506|530134067|FG001|Overall Study|Clinical Deterioration|17|||
146992012|NCT01494506|530134068|FG002|Overall Study|Clinical Deterioration|13|||
146992013|NCT01494506|530134066|FG000|Overall Study|Sponsor Decision|0|||
146992014|NCT01494506|530134067|FG001|Overall Study|Sponsor Decision|0|||
146992015|NCT01494506|530134068|FG002|Overall Study|Sponsor Decision|1|||
146992016|NCT01494506|530134066|FG000|Overall Study|Other|0|||
146992017|NCT01494506|530134067|FG001|Overall Study|Other|3|||
146992018|NCT01494506|530134068|FG002|Overall Study|Other|1|||
146992019|NCT00755196|530134072|FG000|Overall Study|Lost to Follow-up|1|||
146992020|NCT00755196|530134072|FG000|Overall Study|Lack of Efficiency|1|||
146992021|NCT01604850|530134073|FG000|Overall Study|Enrolled but never treated|0|||
146992022|NCT01604850|530134074|FG001|Overall Study|Enrolled but never treated|1|||
146992023|NCT01604850|530134073|FG000|Overall Study|Efficacy Failure|50|||
146992024|NCT01604850|530134074|FG001|Overall Study|Efficacy Failure|29|||
146992025|NCT01604850|530134073|FG000|Overall Study|Lost to Follow-up|1|||
146992026|NCT01604850|530134074|FG001|Overall Study|Lost to Follow-up|0|||
146992027|NCT01604850|530134073|FG000|Overall Study|Subject withdrew consent|1|||
146992028|NCT01604850|530134074|FG001|Overall Study|Subject withdrew consent|0|||
146992029|NCT01703832|530134075|FG000|Overall Study|Withdrawal by Subject|1|||
146992030|NCT01703832|530134076|FG001|Overall Study|Withdrawal by Subject|0|||
146992031|NCT00243932|530134077|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
146992032|NCT00243932|530134078|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
146992033|NCT00243932|530134079|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
146992034|NCT00543309|530134080|FG000|Overall Study|Physician Decision|0|||
146992035|NCT00543309|530134081|FG001|Overall Study|Physician Decision|1|||
146992036|NCT00543309|530134082|FG002|Overall Study|Physician Decision|0|||
146992037|NCT04538170|530134094|FG000|Overall Study|Withdrawal by Subject|104|||
146992038|NCT04538170|530134095|FG001|Overall Study|Withdrawal by Subject|210|||
146992039|NCT01682083|530134100|FG000|Overall Study|Lost to Follow-up|11|||
146992040|NCT01682083|530134101|FG001|Overall Study|Lost to Follow-up|18|||
146992041|NCT01682083|530134100|FG000|Overall Study|Withdrawal by Subject|31|||
146992042|NCT01682083|530134101|FG001|Overall Study|Withdrawal by Subject|40|||
146992043|NCT01682083|530134100|FG000|Overall Study|Death|60|||
146992044|NCT01682083|530134101|FG001|Overall Study|Death|93|||
146992045|NCT01682083|530134100|FG000|Overall Study|Physician Decision|5|||
146992046|NCT01682083|530134101|FG001|Overall Study|Physician Decision|4|||
146992047|NCT00864097|530134102|FG000|Overall Study|Death|0|||
146992048|NCT00864097|530134103|FG001|Overall Study|Death|1|||
146992049|NCT00864097|530134104|FG002|Overall Study|Death|0|||
146992050|NCT00864097|530134105|FG003|Overall Study|Death|0|||
146992051|NCT00864097|530134102|FG000|Overall Study|Adverse Event|6|||
146992052|NCT00864097|530134103|FG001|Overall Study|Adverse Event|8|||
146992053|NCT00864097|530134104|FG002|Overall Study|Adverse Event|11|||
146992054|NCT00864097|530134105|FG003|Overall Study|Adverse Event|9|||
146992055|NCT00864097|530134102|FG000|Overall Study|Lack of Efficacy|9|||
146992056|NCT00864097|530134103|FG001|Overall Study|Lack of Efficacy|3|||
146992057|NCT00864097|530134104|FG002|Overall Study|Lack of Efficacy|7|||
146992058|NCT00864097|530134105|FG003|Overall Study|Lack of Efficacy|2|||
146992059|NCT00864097|530134102|FG000|Overall Study|Lost to Follow-up|0|||
146992060|NCT00864097|530134103|FG001|Overall Study|Lost to Follow-up|1|||
146992061|NCT00864097|530134104|FG002|Overall Study|Lost to Follow-up|0|||
146992062|NCT00864097|530134105|FG003|Overall Study|Lost to Follow-up|1|||
146992063|NCT00864097|530134102|FG000|Overall Study|Withdrawal by Subject|15|||
146992064|NCT00864097|530134103|FG001|Overall Study|Withdrawal by Subject|11|||
146992065|NCT00864097|530134104|FG002|Overall Study|Withdrawal by Subject|11|||
146992066|NCT00864097|530134105|FG003|Overall Study|Withdrawal by Subject|12|||
146992067|NCT00864097|530134102|FG000|Overall Study|Protocol Violation|2|||
146992068|NCT00864097|530134103|FG001|Overall Study|Protocol Violation|1|||
146992069|NCT00864097|530134104|FG002|Overall Study|Protocol Violation|0|||
146992070|NCT00864097|530134105|FG003|Overall Study|Protocol Violation|1|||
146992071|NCT00864097|530134102|FG000|Overall Study|Terminated by sponsor|105|||
146992072|NCT00864097|530134103|FG001|Overall Study|Terminated by sponsor|112|||
146992073|NCT00864097|530134104|FG002|Overall Study|Terminated by sponsor|102|||
146992074|NCT00864097|530134105|FG003|Overall Study|Terminated by sponsor|99|||
146992075|NCT00864097|530134102|FG000|Overall Study|Randomized but not treated|2|||
146992076|NCT00864097|530134103|FG001|Overall Study|Randomized but not treated|0|||
146992077|NCT00864097|530134104|FG002|Overall Study|Randomized but not treated|1|||
146992078|NCT00864097|530134105|FG003|Overall Study|Randomized but not treated|0|||
146992079|NCT00864097|530134102|FG000|Overall Study|Other|0|||
146992080|NCT00864097|530134103|FG001|Overall Study|Other|0|||
146992081|NCT00864097|530134104|FG002|Overall Study|Other|0|||
146992082|NCT00864097|530134105|FG003|Overall Study|Other|1|||
146992083|NCT05956665|530134117|FG000|Overall Study|Death|1|||
146992084|NCT05956665|530134117|FG000|Overall Study|Withdrawal by Subject|1|||
146992085|NCT01939197|530134118|FG000|Overall Study|Withdrawal by Subject|1|||
146992086|NCT01939197|530134119|FG001|Overall Study|Withdrawal by Subject|0|||
146992087|NCT01939197|530134120|FG002|Overall Study|Withdrawal by Subject|0|||
146992088|NCT01939197|530134121|FG003|Overall Study|Withdrawal by Subject|0|||
146992089|NCT01939197|530134122|FG004|Overall Study|Withdrawal by Subject|1|||
146992090|NCT01939197|530134123|FG005|Overall Study|Withdrawal by Subject|0|||
146992091|NCT01939197|530134124|FG006|Overall Study|Withdrawal by Subject|0|||
146992092|NCT01939197|530134118|FG000|Overall Study|Lost to Follow-up|0|||
146992093|NCT01939197|530134119|FG001|Overall Study|Lost to Follow-up|1|||
146992094|NCT01939197|530134120|FG002|Overall Study|Lost to Follow-up|0|||
146992095|NCT01939197|530134121|FG003|Overall Study|Lost to Follow-up|1|||
146992096|NCT01939197|530134122|FG004|Overall Study|Lost to Follow-up|3|||
146992097|NCT01939197|530134123|FG005|Overall Study|Lost to Follow-up|1|||
146992098|NCT01939197|530134124|FG006|Overall Study|Lost to Follow-up|2|||
146992099|NCT02545998|530134125|FG000|Overall Study|Lost to Follow-up|12|||
146992100|NCT02545998|530134126|FG001|Overall Study|Lost to Follow-up|3|||
146992101|NCT02545998|530134125|FG000|Overall Study|Withdrawal by Subject|3|||
146992102|NCT02545998|530134126|FG001|Overall Study|Withdrawal by Subject|2|||
146992103|NCT02603952|530134135|FG000|Overall Study|Withdrawal by Subject|1|||
146992104|NCT02603952|530134136|FG001|Overall Study|Withdrawal by Subject|0|||
146992105|NCT02603952|530134137|FG002|Overall Study|Withdrawal by Subject|0|||
146992106|NCT02603952|530134138|FG003|Overall Study|Withdrawal by Subject|0|||
146992107|NCT02603952|530134135|FG000|Overall Study|Received oseltamivir by error|0|||
146992108|NCT02603952|530134136|FG001|Overall Study|Received oseltamivir by error|0|||
146992109|NCT02603952|530134137|FG002|Overall Study|Received oseltamivir by error|0|||
146992110|NCT02603952|530134138|FG003|Overall Study|Received oseltamivir by error|1|||
146992111|NCT00958243|530134151|FG000|Overall Study|Withdrawal by Subject|0|||
146992112|NCT00958243|530134152|FG001|Overall Study|Withdrawal by Subject|1|||
146992113|NCT00958243|530134153|FG002|Overall Study|Withdrawal by Subject|3|||
146992114|NCT00958243|530134154|FG003|Overall Study|Withdrawal by Subject|1|||
146992115|NCT00958243|530134155|FG004|Overall Study|Withdrawal by Subject|1|||
146992116|NCT00958243|530134156|FG005|Overall Study|Withdrawal by Subject|5|||
146992117|NCT00958243|530134151|FG000|Overall Study|Lost to Follow-up|2|||
146992118|NCT00958243|530134152|FG001|Overall Study|Lost to Follow-up|5|||
146992119|NCT00958243|530134153|FG002|Overall Study|Lost to Follow-up|11|||
146992120|NCT00958243|530134154|FG003|Overall Study|Lost to Follow-up|2|||
146992121|NCT00958243|530134155|FG004|Overall Study|Lost to Follow-up|8|||
146992122|NCT00958243|530134156|FG005|Overall Study|Lost to Follow-up|5|||
146992123|NCT04646109|530134157|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
146992124|NCT04646109|530134158|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
146992125|NCT06176768|530134159|FG000|Overall Study|Adverse Event|1|||
146992126|NCT06176768|530134160|FG001|Overall Study|Adverse Event|0|||
146992127|NCT06176768|530134159|FG000|Overall Study|Assigned treatment by mistake|1|||
146992128|NCT06176768|530134160|FG001|Overall Study|Assigned treatment by mistake|0|||
146992129|NCT06176768|530134159|FG000|Overall Study|Lost to Follow-up|0|||
146992130|NCT06176768|530134160|FG001|Overall Study|Lost to Follow-up|3|||
146992131|NCT06176768|530134159|FG000|Overall Study|Physician Decision|1|||
146992132|NCT06176768|530134160|FG001|Overall Study|Physician Decision|0|||
146992133|NCT06176768|530134159|FG000|Overall Study|Protocol deviation|3|||
146992134|NCT06176768|530134160|FG001|Overall Study|Protocol deviation|1|||
146992135|NCT06176768|530134159|FG000|Overall Study|Other|1|||
146992136|NCT06176768|530134160|FG001|Overall Study|Other|0|||
146992137|NCT06176768|530134159|FG000|Overall Study|Withdrawal by Subject|6|||
146992138|NCT06176768|530134160|FG001|Overall Study|Withdrawal by Subject|9|||
146992139|NCT01226797|530134161|FG000|Overall Study|Adverse Event|1|||
146992140|NCT01226797|530134162|FG001|Overall Study|Adverse Event|0|||
146992141|NCT01226797|530134161|FG000|Overall Study|No longer willing to participate|1|||
146992142|NCT01226797|530134162|FG001|Overall Study|No longer willing to participate|0|||
146992143|NCT01226797|530134161|FG000|Overall Study|Protocol Violation|0|||
146992144|NCT01226797|530134162|FG001|Overall Study|Protocol Violation|1|||
146992145|NCT00577460|530134165|FG000|Overall Study|Adverse Event|11|||
146992146|NCT00577460|530134166|FG001|Overall Study|Adverse Event|7|||
146992147|NCT00577460|530134167|FG002|Overall Study|Adverse Event|14|||
146992148|NCT00577460|530134165|FG000|Overall Study|Protocol Violation|0|||
146992149|NCT00577460|530134166|FG001|Overall Study|Protocol Violation|1|||
146992150|NCT00577460|530134167|FG002|Overall Study|Protocol Violation|1|||
146992151|NCT00577460|530134165|FG000|Overall Study|Lost to Follow-up|0|||
146992152|NCT00577460|530134166|FG001|Overall Study|Lost to Follow-up|3|||
146992153|NCT00577460|530134167|FG002|Overall Study|Lost to Follow-up|4|||
146992154|NCT00577460|530134165|FG000|Overall Study|Withdrawal by Subject|5|||
146992155|NCT00577460|530134166|FG001|Overall Study|Withdrawal by Subject|5|||
146992156|NCT00577460|530134167|FG002|Overall Study|Withdrawal by Subject|6|||
146992157|NCT00577460|530134165|FG000|Overall Study|Other|0|||
146992158|NCT00577460|530134166|FG001|Overall Study|Other|3|||
146992159|NCT00577460|530134167|FG002|Overall Study|Other|2|||
146992160|NCT01318499|530134170|FG000|Overall Study|Adverse Event|16|||
146992161|NCT01318499|530134171|FG001|Overall Study|Adverse Event|11|||
146992162|NCT01318499|530134172|FG002|Overall Study|Adverse Event|6|||
146992163|NCT01318499|530134170|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
146992164|NCT01318499|530134171|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
146992165|NCT01318499|530134172|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
146992166|NCT01318499|530134170|FG000|Overall Study|Noncompliance|2|||
146992167|NCT01318499|530134171|FG001|Overall Study|Noncompliance|3|||
146992168|NCT01318499|530134172|FG002|Overall Study|Noncompliance|0|||
146992169|NCT01318499|530134170|FG000|Overall Study|Treatment Failure|19|||
146992170|NCT01318499|530134171|FG001|Overall Study|Treatment Failure|19|||
146992171|NCT01318499|530134172|FG002|Overall Study|Treatment Failure|101|||
146992172|NCT01318499|530134170|FG000|Overall Study|Protocol Violation|2|||
146992173|NCT01318499|530134171|FG001|Overall Study|Protocol Violation|4|||
146992174|NCT01318499|530134172|FG002|Overall Study|Protocol Violation|2|||
146992175|NCT01318499|530134170|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
146992176|NCT01318499|530134171|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
146992177|NCT01318499|530134172|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
146992178|NCT01318499|530134170|FG000|Overall Study|Other|7|||
146992179|NCT01318499|530134171|FG001|Overall Study|Other|10|||
146992180|NCT01318499|530134172|FG002|Overall Study|Other|22|||
146992181|NCT01974141|530134178|FG000|Overall Study|Other Reasons|28|||
146992182|NCT01974141|530134179|FG001|Overall Study|Other Reasons|18|||
146992183|NCT01974141|530134178|FG000|Overall Study|Protocol Violation|2|||
146992184|NCT01974141|530134179|FG001|Overall Study|Protocol Violation|6|||
146992185|NCT01974141|530134178|FG000|Overall Study|Personal Reasons|21|||
146992186|NCT01974141|530134179|FG001|Overall Study|Personal Reasons|20|||
146992187|NCT01974141|530134178|FG000|Overall Study|Lost to Follow-up|38|||
146992188|NCT01974141|530134179|FG001|Overall Study|Lost to Follow-up|29|||
146992189|NCT01974141|530134178|FG000|Overall Study|Pregnancy|3|||
146992190|NCT01974141|530134179|FG001|Overall Study|Pregnancy|3|||
146992191|NCT01974141|530134178|FG000|Overall Study|Lack of Efficacy|0|||
146992192|NCT01974141|530134179|FG001|Overall Study|Lack of Efficacy|1|||
146992193|NCT01974141|530134178|FG000|Overall Study|Adverse Event|4|||
146992194|NCT01974141|530134179|FG001|Overall Study|Adverse Event|5|||
146992195|NCT04028843|530134182|FG000|Overall Study|Lost to Follow-up|32|||
146992196|NCT04028843|530134183|FG001|Overall Study|Lost to Follow-up|39|||
146992197|NCT04028843|530134182|FG000|Overall Study|Adverse Event|1|||
146992198|NCT04028843|530134183|FG001|Overall Study|Adverse Event|0|||
146992199|NCT04028843|530134182|FG000|Overall Study|Non-viable Pregnancy|0|||
146992200|NCT04028843|530134183|FG001|Overall Study|Non-viable Pregnancy|1|||
146992201|NCT04028843|530134182|FG000|Overall Study|Withdrawal by Subject|4|||
146992202|NCT04028843|530134183|FG001|Overall Study|Withdrawal by Subject|2|||
146992203|NCT04977336|530134184|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
146992204|NCT04977336|530134185|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
146992205|NCT04977336|530134186|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
146992206|NCT04977336|530134187|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
146992207|NCT04977336|530134188|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
146992208|NCT04977336|530134184|FG000|Overall Study|Lost to Follow-up|0|||
146992209|NCT04977336|530134185|FG001|Overall Study|Lost to Follow-up|0|||
146992210|NCT04977336|530134186|FG002|Overall Study|Lost to Follow-up|1|||
146992211|NCT04977336|530134187|FG003|Overall Study|Lost to Follow-up|0|||
146992212|NCT04977336|530134188|FG004|Overall Study|Lost to Follow-up|0|||
146992213|NCT03298451|530134189|FG000|Overall Study|Death|275|||
146992214|NCT03298451|530134190|FG001|Overall Study|Death|260|||
146992215|NCT03298451|530134191|FG002|Overall Study|Death|122|||
146992216|NCT03298451|530134192|FG003|Overall Study|Death|280|||
146992217|NCT03298451|530134189|FG000|Overall Study|Lost to Follow-up|1|||
146992218|NCT03298451|530134190|FG001|Overall Study|Lost to Follow-up|1|||
146992219|NCT03298451|530134191|FG002|Overall Study|Lost to Follow-up|0|||
146992220|NCT03298451|530134192|FG003|Overall Study|Lost to Follow-up|7|||
146992221|NCT03298451|530134189|FG000|Overall Study|Withdrawal by Subject|9|||
146992222|NCT03298451|530134190|FG001|Overall Study|Withdrawal by Subject|7|||
146992223|NCT03298451|530134191|FG002|Overall Study|Withdrawal by Subject|1|||
146992224|NCT03298451|530134192|FG003|Overall Study|Withdrawal by Subject|20|||
146992225|NCT01347710|530134193|FG000|Overall Study|Withdrawal by Subject|2|||
146992226|NCT01347710|530134193|FG000|Overall Study|Adverse Event|4|||
146992227|NCT01347710|530134193|FG000|Overall Study|Angio or SPECT not completed|18|||
146992228|NCT01347710|530134193|FG000|Overall Study|issue with vitals prior to dosing|1|||
146992229|NCT01347710|530134193|FG000|Overall Study|Lost to Follow-up|1|||
146992230|NCT01347710|530134193|FG000|Overall Study|Physician Decision|2|||
146992231|NCT01347710|530134193|FG000|Overall Study|Other|3|||
146992232|NCT04591626|530134195|FG000|Overall Study|Adverse Event|4|||
146992233|NCT04591626|530134196|FG001|Overall Study|Adverse Event|0|||
146992234|NCT04591626|530134195|FG000|Overall Study|Withdrawal by Subject|5|||
146992235|NCT04591626|530134196|FG001|Overall Study|Withdrawal by Subject|3|||
146992236|NCT04591626|530134195|FG000|Overall Study|Physician Decision|0|||
146992237|NCT04591626|530134196|FG001|Overall Study|Physician Decision|1|||
146992238|NCT04591626|530134195|FG000|Overall Study|Death|0|||
146992239|NCT04591626|530134196|FG001|Overall Study|Death|1|||
146992240|NCT04591626|530134195|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146992241|NCT04591626|530134196|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146992242|NCT01004172|530134200|FG000|Overall Study|Progressive Disease in CNS Only|16|||
146992243|NCT01004172|530134200|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
146992244|NCT01004172|530134200|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
146992245|NCT01004172|530134200|FG000|Overall Study|Adverse Event|1|||
146992246|NCT01004172|530134200|FG000|Overall Study|Physician Decision|1|||
146992247|NCT01004172|530134200|FG000|Overall Study|Symptomatic Deterioration|2|||
146992248|NCT00878995|530134204|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
146992249|NCT00878995|530134205|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
146992250|NCT02480764|530134208|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
146992251|NCT02480764|530134209|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
146959654|NCT03039686|530012214|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
146959655|NCT03039686|530012215|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
146959656|NCT03039686|530012213|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
146959657|NCT03039686|530012214|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
146959658|NCT03039686|530012215|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
146959659|NCT03039686|530012213|FG000|Double-blind Period|Withdrawal by Subject|2|||
146959660|NCT03039686|530012214|FG001|Double-blind Period|Withdrawal by Subject|2|||
146959661|NCT03039686|530012215|FG002|Double-blind Period|Withdrawal by Subject|1|||
146959662|NCT03039686|530012213|FG000|Double-blind Period|Death|0|||
146959663|NCT03039686|530012214|FG001|Double-blind Period|Death|0|||
146959664|NCT03039686|530012215|FG002|Double-blind Period|Death|1|||
146959665|NCT03039686|530012213|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
146959666|NCT03039686|530012214|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
146959667|NCT03039686|530012215|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
146959668|NCT03039686|530012213|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
146959669|NCT03039686|530012214|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
146959670|NCT03039686|530012215|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
146959671|NCT03039686|530012213|FG000|Open Label Period|Withdrawal by Subject|0|||
146959672|NCT03039686|530012214|FG001|Open Label Period|Withdrawal by Subject|3|||
146959673|NCT03039686|530012215|FG002|Open Label Period|Withdrawal by Subject|1|||
146959674|NCT00635804|530012216|FG000|Overall Study|Adverse Event|0|||
146959675|NCT00635804|530012217|FG001|Overall Study|Adverse Event|0|||
146959676|NCT00635804|530012218|FG002|Overall Study|Adverse Event|0|||
146959677|NCT00635804|530012219|FG003|Overall Study|Adverse Event|0|||
146959678|NCT00635804|530012220|FG004|Overall Study|Adverse Event|0|||
146959679|NCT00635804|530012221|FG005|Overall Study|Adverse Event|1|||
146959680|NCT00635804|530012222|FG006|Overall Study|Adverse Event|0|||
146959681|NCT00635804|530012223|FG007|Overall Study|Adverse Event|0|||
146959682|NCT00635804|530012216|FG000|Overall Study|Withdrawal by Subject|1|||
146959683|NCT00635804|530012217|FG001|Overall Study|Withdrawal by Subject|0|||
146959684|NCT00635804|530012218|FG002|Overall Study|Withdrawal by Subject|0|||
146959685|NCT00635804|530012219|FG003|Overall Study|Withdrawal by Subject|0|||
146959686|NCT00635804|530012220|FG004|Overall Study|Withdrawal by Subject|0|||
146959687|NCT00635804|530012221|FG005|Overall Study|Withdrawal by Subject|0|||
146959688|NCT00635804|530012222|FG006|Overall Study|Withdrawal by Subject|0|||
146959689|NCT00635804|530012223|FG007|Overall Study|Withdrawal by Subject|0|||
146959690|NCT00285857|530012231|FG000|Overall Study|Withdrawal by Subject|2|||
146959691|NCT00285857|530012231|FG000|Overall Study|Inadequate initial breast cytology|1|||
146959692|NCT00285857|530012231|FG000|Overall Study|Adverse Event|1|||
146959693|NCT06104423|530012234|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
146959694|NCT06104423|530012235|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
146959695|NCT06104423|530012236|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
146959696|NCT06104423|530012234|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
146959697|NCT06104423|530012235|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
146959698|NCT06104423|530012236|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
146959699|NCT05602818|530012237|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
146959700|NCT05602818|530012238|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
146959701|NCT05602818|530012239|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
146959702|NCT05602818|530012240|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
146959703|NCT05602818|530012241|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
146959704|NCT05602818|530012242|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
146959705|NCT05602818|530012243|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
146959706|NCT05602818|530012244|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
146959707|NCT05602818|530012245|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
146959708|NCT05602818|530012246|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
146959709|NCT05602818|530012247|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
146959710|NCT05602818|530012248|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
146959711|NCT05602818|530012237|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
146959712|NCT05602818|530012238|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
146959713|NCT05602818|530012239|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146959714|NCT05602818|530012240|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146959715|NCT05602818|530012241|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146959716|NCT05602818|530012242|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146959717|NCT05602818|530012243|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146959718|NCT05602818|530012244|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146959719|NCT05602818|530012245|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146959720|NCT05602818|530012246|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146959721|NCT05602818|530012247|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146959722|NCT05602818|530012248|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146959723|NCT05602818|530012237|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
146959724|NCT05602818|530012238|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146959725|NCT05602818|530012239|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146959726|NCT05602818|530012240|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146959727|NCT05602818|530012241|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146959728|NCT05602818|530012242|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146959729|NCT05602818|530012243|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146959730|NCT05602818|530012244|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146959731|NCT05602818|530012245|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146959732|NCT05602818|530012246|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146959733|NCT05602818|530012247|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146959734|NCT05602818|530012248|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146959735|NCT05602818|530012237|FG000|Qualification Phase (3 Days)|Other|1|||
146959736|NCT05602818|530012238|FG001|Qualification Phase (3 Days)|Other|0|||
146959737|NCT05602818|530012239|FG002|Qualification Phase (3 Days)|Other|0|||
146959738|NCT05602818|530012240|FG003|Qualification Phase (3 Days)|Other|0|||
146959739|NCT05602818|530012241|FG004|Qualification Phase (3 Days)|Other|0|||
146959740|NCT05602818|530012242|FG005|Qualification Phase (3 Days)|Other|0|||
146959741|NCT05602818|530012243|FG006|Qualification Phase (3 Days)|Other|0|||
146959742|NCT05602818|530012244|FG007|Qualification Phase (3 Days)|Other|0|||
146959743|NCT05602818|530012245|FG008|Qualification Phase (3 Days)|Other|0|||
146959744|NCT05602818|530012246|FG009|Qualification Phase (3 Days)|Other|0|||
146959745|NCT05602818|530012247|FG010|Qualification Phase (3 Days)|Other|0|||
146959746|NCT05602818|530012248|FG011|Qualification Phase (3 Days)|Other|0|||
146959747|NCT05602818|530012237|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146959748|NCT05602818|530012238|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
146959749|NCT05602818|530012239|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146959750|NCT05602818|530012240|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146959751|NCT05602818|530012241|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146959752|NCT05602818|530012242|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146959753|NCT05602818|530012243|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146959754|NCT05602818|530012244|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146959755|NCT05602818|530012245|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146959756|NCT05602818|530012246|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146959757|NCT05602818|530012247|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146959758|NCT05602818|530012248|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146959759|NCT05602818|530012237|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
146959760|NCT05602818|530012238|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
146959761|NCT05602818|530012239|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
146959762|NCT05602818|530012240|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
146959763|NCT05602818|530012241|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
146959764|NCT05602818|530012242|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
146959765|NCT05602818|530012243|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
146959766|NCT05602818|530012244|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
146959767|NCT05602818|530012245|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
146959768|NCT05602818|530012246|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
146959769|NCT05602818|530012247|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
146959770|NCT05602818|530012248|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
146959771|NCT05602818|530012237|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146959772|NCT05602818|530012238|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146959773|NCT05602818|530012239|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146959774|NCT05602818|530012240|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146959775|NCT05602818|530012241|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146959776|NCT05602818|530012242|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146959777|NCT05602818|530012243|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146959778|NCT05602818|530012244|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146959779|NCT05602818|530012245|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146959780|NCT05602818|530012246|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146959781|NCT05602818|530012247|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
146959782|NCT05602818|530012248|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
146959783|NCT05602818|530012237|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
146959784|NCT05602818|530012238|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
146959785|NCT05602818|530012239|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
146959786|NCT05602818|530012240|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
146959787|NCT05602818|530012241|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
146959788|NCT05602818|530012242|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
146959789|NCT05602818|530012243|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
146992252|NCT02480764|530134210|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
146992253|NCT02480764|530134208|FG000|Overall Study|Major Protocol Deviation|1|||
146992254|NCT02480764|530134209|FG001|Overall Study|Major Protocol Deviation|4|||
146992255|NCT02480764|530134210|FG002|Overall Study|Major Protocol Deviation|3|||
146992256|NCT02480764|530134208|FG000|Overall Study|Lost to Follow-up|0|||
146992257|NCT02480764|530134209|FG001|Overall Study|Lost to Follow-up|1|||
146992258|NCT02480764|530134210|FG002|Overall Study|Lost to Follow-up|2|||
146992259|NCT02480764|530134208|FG000|Overall Study|Voluntary Withdrawal|6|||
146992260|NCT02480764|530134209|FG001|Overall Study|Voluntary Withdrawal|5|||
146992261|NCT02480764|530134210|FG002|Overall Study|Voluntary Withdrawal|10|||
146992262|NCT02480764|530134208|FG000|Overall Study|Lack of Efficacy|0|||
146992263|NCT02480764|530134209|FG001|Overall Study|Lack of Efficacy|3|||
146992264|NCT02480764|530134210|FG002|Overall Study|Lack of Efficacy|3|||
146992265|NCT02480764|530134208|FG000|Overall Study|Reason not Specified|0|||
146992266|NCT02480764|530134209|FG001|Overall Study|Reason not Specified|1|||
146992267|NCT02480764|530134210|FG002|Overall Study|Reason not Specified|0|||
146992268|NCT02457832|530134211|FG000|Training|Lost to Follow-up|10|||
146992269|NCT02457832|530134212|FG001|Training|Lost to Follow-up|6|||
146992270|NCT02457832|530134213|FG002|Training|Lost to Follow-up|3|||
146992271|NCT02457832|530134211|FG000|One Month Washout|Lost to Follow-up|0|||
146992272|NCT02457832|530134212|FG001|One Month Washout|Lost to Follow-up|1|||
146992273|NCT02457832|530134213|FG002|One Month Washout|Lost to Follow-up|1|||
146992274|NCT01868009|530134216|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
146992275|NCT01868009|530134217|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
146992276|NCT01868009|530134216|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
146992277|NCT01868009|530134217|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
146992278|NCT01868009|530134216|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
146992279|NCT01868009|530134217|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
146992280|NCT01691248|530134220|FG000|Overall Study|Protocol Violation|43|||
146992281|NCT01691248|530134221|FG001|Overall Study|Protocol Violation|27|||
146992282|NCT01691248|530134220|FG000|Overall Study|Adverse Event|24|||
146992283|NCT01691248|530134221|FG001|Overall Study|Adverse Event|22|||
146992284|NCT01691248|530134220|FG000|Overall Study|Withdrawal by Subject|20|||
146992285|NCT01691248|530134221|FG001|Overall Study|Withdrawal by Subject|18|||
146992286|NCT01691248|530134220|FG000|Overall Study|Confirmed CDAD|14|||
146992287|NCT01691248|530134221|FG001|Overall Study|Confirmed CDAD|31|||
146992288|NCT01691248|530134220|FG000|Overall Study|Lost to Follow-up|2|||
146992289|NCT01691248|530134221|FG001|Overall Study|Lost to Follow-up|5|||
146992290|NCT01691248|530134220|FG000|Overall Study|Reason not provided|4|||
146992291|NCT01691248|530134221|FG001|Overall Study|Reason not provided|4|||
146992292|NCT01691248|530134220|FG000|Overall Study|Not Treated|4|||
146992293|NCT01691248|530134221|FG001|Overall Study|Not Treated|7|||
146992294|NCT04526210|530135379|FG000|Overall Study|Sponsor decision|7|||
146992295|NCT04526210|530135380|FG001|Overall Study|Sponsor decision|5|||
146992296|NCT04526210|530135379|FG000|Overall Study|Withdrawal by Subject|3|||
146992297|NCT04526210|530135380|FG001|Overall Study|Withdrawal by Subject|2|||
146992298|NCT02924038|530135381|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
146992299|NCT02924038|530135382|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
146992300|NCT02473640|530135385|FG000|Treatment Period 1|Adverse Event|1|||
146992301|NCT02777528|530135388|FG000|Overall Study|Still in study|24|||
146992302|NCT02777528|530135389|FG001|Overall Study|Still in study|10|||
146992303|NCT02777528|530135390|FG002|Overall Study|Still in study|1|||
146992304|NCT02777528|530135388|FG000|Overall Study|Study Device Explanted|1|||
146992305|NCT02777528|530135389|FG001|Overall Study|Study Device Explanted|0|||
146992306|NCT02777528|530135390|FG002|Overall Study|Study Device Explanted|0|||
146992307|NCT02777528|530135388|FG000|Overall Study|Death|14|||
146992308|NCT02777528|530135389|FG001|Overall Study|Death|7|||
146992309|NCT02777528|530135390|FG002|Overall Study|Death|1|||
146992310|NCT02777528|530135388|FG000|Overall Study|Withdrawal by Subject|2|||
146992311|NCT02777528|530135389|FG001|Overall Study|Withdrawal by Subject|2|||
146992312|NCT02777528|530135390|FG002|Overall Study|Withdrawal by Subject|1|||
146839637|NCT05000216|529584651|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
146839638|NCT05000216|529584652|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
146839639|NCT05000216|529584631|FG000|Stage 2|Lost to Follow-up|0|||
146839640|NCT05000216|529584632|FG001|Stage 2|Lost to Follow-up|0|||
146839641|NCT05000216|529584633|FG002|Stage 2|Lost to Follow-up|0|||
146992313|NCT02777528|530135388|FG000|Overall Study|Physician Decision|2|||
146992314|NCT02777528|530135389|FG001|Overall Study|Physician Decision|1|||
146839642|NCT05000216|529584634|FG003|Stage 2|Lost to Follow-up|0|||
146992315|NCT02777528|530135390|FG002|Overall Study|Physician Decision|0|||
146992316|NCT02777528|530135388|FG000|Overall Study|Lost to Follow-up|2|||
146992317|NCT02777528|530135389|FG001|Overall Study|Lost to Follow-up|0|||
146992318|NCT02777528|530135390|FG002|Overall Study|Lost to Follow-up|0|||
146992319|NCT02777528|530135388|FG000|Overall Study|Discontinued due to Other|1|||
146992320|NCT02777528|530135389|FG001|Overall Study|Discontinued due to Other|0|||
146992321|NCT02777528|530135390|FG002|Overall Study|Discontinued due to Other|0|||
146992322|NCT00453362|530135393|FG000|Overall Study|Adverse Event|5|||
146992323|NCT00453362|530135393|FG000|Overall Study|Death|7|||
146992324|NCT00453362|530135393|FG000|Overall Study|Physician Decision|2|||
146992325|NCT00453362|530135393|FG000|Overall Study|Withdrawal by Subject|3|||
146992326|NCT00453362|530135393|FG000|Overall Study|Progression of disease|56|||
146992327|NCT00453362|530135393|FG000|Overall Study|Screening Failure|14|||
146992328|NCT04885296|530135394|FG000|Period 1|Covid-19 Related|1|||
146992329|NCT04885296|530135395|FG001|Period 1|Covid-19 Related|0|||
146992330|NCT04885296|530135394|FG000|Period 1|Adverse Event|0|||
146992331|NCT04885296|530135395|FG001|Period 1|Adverse Event|1|||
146992332|NCT04885296|530135394|FG000|Period 1|Withdrawal by Subject|1|||
146992333|NCT04885296|530135395|FG001|Period 1|Withdrawal by Subject|1|||
146992334|NCT04885296|530135394|FG000|Period 1|Test Article No Longer Available|1|||
146992335|NCT04885296|530135395|FG001|Period 1|Test Article No Longer Available|0|||
146992336|NCT04885296|530135394|FG000|Period 1|Dispensed Study lens in Error|1|||
146992337|NCT04885296|530135395|FG001|Period 1|Dispensed Study lens in Error|0|||
146992338|NCT04885296|530135394|FG000|Period 1|Lost to Follow-up|1|||
146992339|NCT04885296|530135395|FG001|Period 1|Lost to Follow-up|0|||
146992340|NCT04885296|530135394|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
146992341|NCT04885296|530135395|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
146992342|NCT00433147|530135397|FG000|Overall Study|Adverse Event|0|||
146992343|NCT00433147|530135398|FG001|Overall Study|Adverse Event|1|||
146992344|NCT00433147|530135399|FG002|Overall Study|Adverse Event|0|||
146992345|NCT00433147|530135400|FG003|Overall Study|Adverse Event|0|||
146992346|NCT01882647|530135401|FG000|Overall Study|Lost to Follow-up|2|||
146992347|NCT01882647|530135402|FG001|Overall Study|Lost to Follow-up|2|||
146992348|NCT01882647|530135401|FG000|Overall Study|Withdrawal by Subject|0|||
146992349|NCT01882647|530135402|FG001|Overall Study|Withdrawal by Subject|4|||
146992350|NCT02937701|530135403|FG000|Day 1 to Week 22|Adverse Event|11|||
146992351|NCT02937701|530135404|FG001|Day 1 to Week 22|Adverse Event|14|||
146992352|NCT02937701|530135405|FG002|Day 1 to Week 22|Adverse Event|0|||
146992353|NCT02937701|530135406|FG003|Day 1 to Week 22|Adverse Event|0|||
146992354|NCT02937701|530135407|FG004|Day 1 to Week 22|Adverse Event|0|||
146992355|NCT02937701|530135403|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
146992356|NCT02937701|530135404|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
146992357|NCT02937701|530135405|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
146992358|NCT02937701|530135406|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
146992359|NCT02937701|530135407|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
146992360|NCT02937701|530135403|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
146992361|NCT02937701|530135404|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
146992362|NCT02937701|530135405|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
146992363|NCT02937701|530135406|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
146992364|NCT02937701|530135407|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
146992365|NCT02937701|530135403|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
146992366|NCT02937701|530135404|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
146992367|NCT02937701|530135405|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
146992368|NCT02937701|530135406|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
146992369|NCT02937701|530135407|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
146992370|NCT02937701|530135403|FG000|Day 1 to Week 22|Death|1|||
146992371|NCT02937701|530135404|FG001|Day 1 to Week 22|Death|1|||
146992372|NCT02937701|530135405|FG002|Day 1 to Week 22|Death|0|||
146992373|NCT02937701|530135406|FG003|Day 1 to Week 22|Death|0|||
146992374|NCT02937701|530135407|FG004|Day 1 to Week 22|Death|0|||
146992375|NCT02937701|530135403|FG000|Day 1 to Week 22|Protocol Violation|1|||
146992376|NCT02937701|530135404|FG001|Day 1 to Week 22|Protocol Violation|1|||
146992377|NCT02937701|530135405|FG002|Day 1 to Week 22|Protocol Violation|0|||
146992378|NCT02937701|530135406|FG003|Day 1 to Week 22|Protocol Violation|0|||
146992379|NCT02937701|530135407|FG004|Day 1 to Week 22|Protocol Violation|0|||
146992380|NCT02937701|530135403|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
146992381|NCT02937701|530135404|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
146992382|NCT02937701|530135405|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
146992383|NCT02937701|530135406|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
146992384|NCT02937701|530135407|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
146992385|NCT02937701|530135403|FG000|Day 1 to Week 22|Physician Decision|2|||
146992386|NCT02937701|530135404|FG001|Day 1 to Week 22|Physician Decision|0|||
146992387|NCT02937701|530135405|FG002|Day 1 to Week 22|Physician Decision|0|||
146992388|NCT02937701|530135406|FG003|Day 1 to Week 22|Physician Decision|0|||
146992389|NCT02937701|530135407|FG004|Day 1 to Week 22|Physician Decision|0|||
146992390|NCT02937701|530135403|FG000|Day 1 to Week 22|Other|1|||
146992391|NCT02937701|530135404|FG001|Day 1 to Week 22|Other|0|||
146992392|NCT02937701|530135405|FG002|Day 1 to Week 22|Other|0|||
146992393|NCT02937701|530135406|FG003|Day 1 to Week 22|Other|0|||
146992394|NCT02937701|530135407|FG004|Day 1 to Week 22|Other|0|||
146992395|NCT02937701|530135403|FG000|Week 22 to Week 50|Adverse Event|0|||
146992396|NCT02937701|530135404|FG001|Week 22 to Week 50|Adverse Event|0|||
146992397|NCT02937701|530135405|FG002|Week 22 to Week 50|Adverse Event|10|||
146992398|NCT02937701|530135406|FG003|Week 22 to Week 50|Adverse Event|3|||
146992399|NCT02937701|530135407|FG004|Week 22 to Week 50|Adverse Event|3|||
146992400|NCT02937701|530135403|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
146992401|NCT02937701|530135404|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
146992402|NCT02937701|530135405|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
146992403|NCT02937701|530135406|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
146992404|NCT02937701|530135407|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
146992405|NCT02937701|530135403|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
146992406|NCT02937701|530135404|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
146992407|NCT02937701|530135405|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
146992408|NCT02937701|530135406|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
146992409|NCT02937701|530135407|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
146992410|NCT02937701|530135403|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
146992411|NCT02937701|530135404|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
146992412|NCT02937701|530135405|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
146992413|NCT02937701|530135406|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
146992414|NCT02937701|530135407|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
146992415|NCT02937701|530135403|FG000|Week 22 to Week 50|Physician Decision|0|||
146992416|NCT02937701|530135404|FG001|Week 22 to Week 50|Physician Decision|0|||
146992417|NCT02937701|530135405|FG002|Week 22 to Week 50|Physician Decision|2|||
146992418|NCT02937701|530135406|FG003|Week 22 to Week 50|Physician Decision|0|||
146992419|NCT02937701|530135407|FG004|Week 22 to Week 50|Physician Decision|1|||
146992420|NCT02937701|530135403|FG000|Week 22 to Week 50|Other|0|||
146992421|NCT02937701|530135404|FG001|Week 22 to Week 50|Other|0|||
146992422|NCT02937701|530135405|FG002|Week 22 to Week 50|Other|0|||
146992423|NCT02937701|530135406|FG003|Week 22 to Week 50|Other|0|||
146992424|NCT02937701|530135407|FG004|Week 22 to Week 50|Other|1|||
146992425|NCT00416520|530135409|FG000|Open-label Period|Adverse Event|28|||
146992426|NCT00416520|530135410|FG001|Open-label Period|Adverse Event|10|||
146992427|NCT00416520|530135411|FG002|Open-label Period|Adverse Event|0|||
146992428|NCT00416520|530135412|FG003|Open-label Period|Adverse Event|0|||
146992429|NCT00416520|530135409|FG000|Open-label Period|Death|2|||
146992430|NCT00416520|530135410|FG001|Open-label Period|Death|1|||
146992431|NCT00416520|530135411|FG002|Open-label Period|Death|0|||
146839643|NCT05000216|529584635|FG004|Stage 2|Lost to Follow-up|0|||
146839644|NCT05000216|529584636|FG005|Stage 2|Lost to Follow-up|0|||
146839645|NCT05000216|529584637|FG006|Stage 2|Lost to Follow-up|0|||
146839646|NCT05000216|529584638|FG007|Stage 2|Lost to Follow-up|0|||
146839647|NCT05000216|529584639|FG008|Stage 2|Lost to Follow-up|0|||
146839648|NCT05000216|529584640|FG009|Stage 2|Lost to Follow-up|0|||
146839649|NCT05000216|529584641|FG010|Stage 2|Lost to Follow-up|0|||
146839650|NCT05000216|529584642|FG011|Stage 2|Lost to Follow-up|0|||
146992432|NCT00416520|530135412|FG003|Open-label Period|Death|0|||
146992433|NCT00416520|530135409|FG000|Open-label Period|Lack of Efficacy|8|||
146992434|NCT00416520|530135410|FG001|Open-label Period|Lack of Efficacy|1|||
146992435|NCT00416520|530135411|FG002|Open-label Period|Lack of Efficacy|0|||
146992436|NCT00416520|530135412|FG003|Open-label Period|Lack of Efficacy|0|||
146992437|NCT00416520|530135409|FG000|Open-label Period|Protocol Violation|3|||
146992438|NCT00416520|530135410|FG001|Open-label Period|Protocol Violation|3|||
146992439|NCT00416520|530135411|FG002|Open-label Period|Protocol Violation|0|||
146992440|NCT00416520|530135412|FG003|Open-label Period|Protocol Violation|0|||
146992441|NCT00416520|530135409|FG000|Open-label Period|Withdrawal by Subject|16|||
146992442|NCT00416520|530135410|FG001|Open-label Period|Withdrawal by Subject|5|||
146992443|NCT00416520|530135411|FG002|Open-label Period|Withdrawal by Subject|0|||
146992444|NCT00416520|530135412|FG003|Open-label Period|Withdrawal by Subject|0|||
146992445|NCT00416520|530135409|FG000|Open-label Period|Other Reasons|3|||
146992446|NCT00416520|530135410|FG001|Open-label Period|Other Reasons|12|||
146992447|NCT00416520|530135411|FG002|Open-label Period|Other Reasons|0|||
146992448|NCT00416520|530135412|FG003|Open-label Period|Other Reasons|0|||
146992449|NCT00416520|530135409|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
146839651|NCT05000216|529584643|FG012|Stage 2|Lost to Follow-up|0|||
146839652|NCT05000216|529584644|FG013|Stage 2|Lost to Follow-up|0|||
146839653|NCT05000216|529584645|FG014|Stage 2|Lost to Follow-up|0|||
146839654|NCT05000216|529584646|FG015|Stage 2|Lost to Follow-up|0|||
146839655|NCT05000216|529584647|FG016|Stage 2|Lost to Follow-up|4|||
146992450|NCT00416520|530135410|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
146839656|NCT05000216|529584648|FG017|Stage 2|Lost to Follow-up|0|||
146992451|NCT00416520|530135411|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
146992452|NCT00416520|530135412|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
146992453|NCT00416520|530135409|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
146992454|NCT00416520|530135410|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
146992455|NCT00416520|530135411|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
146992456|NCT00416520|530135412|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
146992457|NCT00416520|530135409|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
146992458|NCT00416520|530135410|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
146992459|NCT00416520|530135411|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
146839657|NCT05000216|529584649|FG018|Stage 2|Lost to Follow-up|0|||
146839658|NCT05000216|529584650|FG019|Stage 2|Lost to Follow-up|0|||
146839659|NCT05000216|529584651|FG020|Stage 2|Lost to Follow-up|0|||
146839660|NCT05000216|529584652|FG021|Stage 2|Lost to Follow-up|0|||
146992460|NCT00416520|530135412|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
146992461|NCT03601637|530135413|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
146992462|NCT03601637|530135414|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
146992463|NCT03601637|530135413|FG000|Overall Study|Adverse Event|1|||
146992464|NCT03601637|530135414|FG001|Overall Study|Adverse Event|1|||
146992465|NCT03601637|530135413|FG000|Overall Study|Other|0|||
146992466|NCT03601637|530135414|FG001|Overall Study|Other|1|||
146992467|NCT01108094|530135419|FG000|Overall Study|Adverse Event|2|||
146992468|NCT01108094|530135420|FG001|Overall Study|Adverse Event|0|||
146992469|NCT01108094|530135421|FG002|Overall Study|Adverse Event|0|||
146992470|NCT01108094|530135422|FG003|Overall Study|Adverse Event|0|||
146992471|NCT01108094|530135419|FG000|Overall Study|Withdrawal by Subject|1|||
146992472|NCT01108094|530135420|FG001|Overall Study|Withdrawal by Subject|0|||
146992473|NCT01108094|530135421|FG002|Overall Study|Withdrawal by Subject|0|||
146992474|NCT01108094|530135422|FG003|Overall Study|Withdrawal by Subject|0|||
146992475|NCT05818137|530135432|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
146992476|NCT05818137|530135432|FG000|Extension Treatment Period|Ongoing participants|44|||
146992477|NCT05346055|530135435|FG000|Overall Study|Withdrawal by Subject|1|||
146992478|NCT05346055|530135435|FG000|Overall Study|Protocol Violation|1|||
146992479|NCT05346055|530135435|FG000|Overall Study|Therapist decision|1|||
146992480|NCT00728949|530135436|FG000|Overall Study|Adverse Event|8|||
146992481|NCT00728949|530135437|FG001|Overall Study|Adverse Event|0|||
146992482|NCT00728949|530135436|FG000|Overall Study|Withdrawal by Subject|2|||
146992483|NCT00728949|530135437|FG001|Overall Study|Withdrawal by Subject|2|||
146992484|NCT00728949|530135436|FG000|Overall Study|Abnormal Lab Results|0|||
146992485|NCT00728949|530135437|FG001|Overall Study|Abnormal Lab Results|2|||
146992486|NCT00728949|530135436|FG000|Overall Study|On treatment at cutoff date|1|||
146992487|NCT00728949|530135437|FG001|Overall Study|On treatment at cutoff date|0|||
146992488|NCT01996033|530135438|FG000|Overall Study|Death|1|||
146992489|NCT01996033|530135438|FG000|Overall Study|Physician Decision|1|||
146992490|NCT01996033|530135438|FG000|Overall Study|Withdrawal by Subject|4|||
146992491|NCT01996033|530135438|FG000|Overall Study|Lost to Follow-up|3|||
146992492|NCT01087970|530135443|FG000|Overall Study|Protocol Violation|2|||
146992493|NCT02143102|530135446|FG000|Overall Study|Lost to Follow-up|11|||
146992494|NCT02143102|530135447|FG001|Overall Study|Lost to Follow-up|0|||
146992495|NCT02636907|530135450|FG000|Autoinjector Assessment Period|Adverse Event|2|||
146992496|NCT02636907|530135450|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
146992497|NCT02636907|530135450|FG000|Extension Phase|Adverse Event|2|||
146992498|NCT02636907|530135450|FG000|Extension Phase|Withdrawal by Subject|4|||
146992499|NCT02636907|530135450|FG000|Extension Phase|Physician Decision|1|||
146992500|NCT02636907|530135450|FG000|Extension Phase|Lost to Follow-up|2|||
146992501|NCT02636907|530135450|FG000|Extension Phase|Lack of Efficacy|1|||
146992502|NCT04099888|530135451|FG000|Overall Study|Study terminated by sponsor|9|||
146992503|NCT04099888|530135452|FG001|Overall Study|Study terminated by sponsor|11|||
146992504|NCT04099888|530135451|FG000|Overall Study|Lost to Follow-up|1|||
146992505|NCT04099888|530135452|FG001|Overall Study|Lost to Follow-up|1|||
146992506|NCT04099888|530135451|FG000|Overall Study|Withdrawal by Subject|5|||
146992507|NCT04099888|530135452|FG001|Overall Study|Withdrawal by Subject|6|||
146992508|NCT04099888|530135451|FG000|Overall Study|Death|5|||
146992509|NCT04099888|530135452|FG001|Overall Study|Death|2|||
146992510|NCT04099888|530135451|FG000|Overall Study|Other|1|||
146992511|NCT04099888|530135452|FG001|Overall Study|Other|0|||
146992512|NCT01225146|530135457|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
146992513|NCT01225146|530135458|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
146992514|NCT03661528|530135461|FG000|Overall Study|Death|1|||
146992515|NCT03661528|530135462|FG001|Overall Study|Death|0|||
146992516|NCT03661528|530135461|FG000|Overall Study|Physician Decision|3|||
146992517|NCT03661528|530135462|FG001|Overall Study|Physician Decision|1|||
146992518|NCT03661528|530135461|FG000|Overall Study|Other than Specified|5|||
146992519|NCT03661528|530135462|FG001|Overall Study|Other than Specified|2|||
146992520|NCT03661528|530135461|FG000|Overall Study|Withdrawal by Subject|5|||
146992521|NCT03661528|530135462|FG001|Overall Study|Withdrawal by Subject|3|||
146839661|NCT05000216|529584631|FG000|Stage 2|Physician Decision|0|||
146839662|NCT05000216|529584632|FG001|Stage 2|Physician Decision|0|||
146992522|NCT03661528|530135461|FG000|Overall Study|Disease Progression|8|||
146839663|NCT05000216|529584633|FG002|Stage 2|Physician Decision|0|||
146992523|NCT03661528|530135462|FG001|Overall Study|Disease Progression|13|||
146992524|NCT03661528|530135461|FG000|Overall Study|Adverse Event|61|||
146992525|NCT03661528|530135462|FG001|Overall Study|Adverse Event|55|||
146992526|NCT02732210|530135463|FG000|Overall Study|Site Closed|0|||
146992527|NCT02732210|530135464|FG001|Overall Study|Site Closed|11|||
146992528|NCT02732210|530135463|FG000|Overall Study|Study Ended|13|||
146992529|NCT02732210|530135464|FG001|Overall Study|Study Ended|13|||
146992530|NCT02732210|530135463|FG000|Overall Study|Withdrawal by Subject|28|||
146992531|NCT02732210|530135464|FG001|Overall Study|Withdrawal by Subject|87|||
146992532|NCT02732210|530135463|FG000|Overall Study|Lost to Follow-up|5|||
146992533|NCT02732210|530135464|FG001|Overall Study|Lost to Follow-up|57|||
146992534|NCT02732210|530135463|FG000|Overall Study|Death|4|||
146992535|NCT02732210|530135464|FG001|Overall Study|Death|15|||
146992536|NCT02732210|530135463|FG000|Overall Study|Other|35|||
146992537|NCT02732210|530135464|FG001|Overall Study|Other|103|||
146992538|NCT02732210|530135463|FG000|Overall Study|Missing|0|||
146992539|NCT02732210|530135464|FG001|Overall Study|Missing|8|||
146992540|NCT01876706|530135465|FG000|Overall Study|BPH Intervention|9|||
146992541|NCT01876706|530135465|FG000|Overall Study|Lost to Follow-up|7|||
146992542|NCT01876706|530135465|FG000|Overall Study|Withdrawals|6|||
146992543|NCT01876706|530135465|FG000|Overall Study|Death|3|||
146992544|NCT00604500|530135466|FG000|Overall Study|Adverse Event|2|||
146992545|NCT00604500|530135466|FG000|Overall Study|Protocol Violation|2|||
146992546|NCT00604500|530135466|FG000|Overall Study|Treatment Failure|1|||
146992547|NCT00604500|530135466|FG000|Overall Study|Withdrawal by Subject|4|||
146992548|NCT00604500|530135466|FG000|Overall Study|Administrative|1|||
146992549|NCT00604500|530135466|FG000|Overall Study|Did not meet protocol eligibility|1|||
146992550|NCT02191891|530135467|FG000|Overall Study|Withdrawal by Subject|0|||
146992551|NCT02191891|530135468|FG001|Overall Study|Withdrawal by Subject|1|||
146992552|NCT02191891|530135469|FG002|Overall Study|Withdrawal by Subject|0|||
146992553|NCT02191891|530135470|FG003|Overall Study|Withdrawal by Subject|0|||
146992554|NCT02191891|530135471|FG004|Overall Study|Withdrawal by Subject|1|||
146992555|NCT02191891|530135467|FG000|Overall Study|Adverse Event|0|||
146992556|NCT02191891|530135468|FG001|Overall Study|Adverse Event|1|||
146992557|NCT02191891|530135469|FG002|Overall Study|Adverse Event|0|||
146992558|NCT02191891|530135470|FG003|Overall Study|Adverse Event|0|||
146992559|NCT02191891|530135471|FG004|Overall Study|Adverse Event|2|||
146992560|NCT02191891|530135467|FG000|Overall Study|Disease Progression|4|||
146992561|NCT02191891|530135468|FG001|Overall Study|Disease Progression|10|||
146992562|NCT02191891|530135469|FG002|Overall Study|Disease Progression|4|||
146992563|NCT02191891|530135470|FG003|Overall Study|Disease Progression|2|||
146992564|NCT02191891|530135471|FG004|Overall Study|Disease Progression|7|||
146992565|NCT03883906|530135476|FG000|Overall Study|Withdrawal by Subject|2|||
146992566|NCT03883906|530135476|FG000|Overall Study|Physician Decision|5|||
146992567|NCT00874237|530135477|FG000|Overall Study|Physician Decision|0|||
146992568|NCT00874237|530135478|FG001|Overall Study|Physician Decision|1|||
146992569|NCT00874237|530135479|FG002|Overall Study|Physician Decision|0|||
146992570|NCT00874237|530135480|FG003|Overall Study|Physician Decision|0|||
146992571|NCT00874237|530135481|FG004|Overall Study|Physician Decision|0|||
146992572|NCT00874237|530135482|FG005|Overall Study|Physician Decision|0|||
146992573|NCT00874237|530135477|FG000|Overall Study|Withdrawal by Subject|0|||
146992574|NCT00874237|530135478|FG001|Overall Study|Withdrawal by Subject|0|||
146992575|NCT00874237|530135479|FG002|Overall Study|Withdrawal by Subject|1|||
146992576|NCT00874237|530135480|FG003|Overall Study|Withdrawal by Subject|0|||
146992577|NCT00874237|530135481|FG004|Overall Study|Withdrawal by Subject|0|||
146992578|NCT00874237|530135482|FG005|Overall Study|Withdrawal by Subject|0|||
146992579|NCT02458469|530135486|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
146992580|NCT02458469|530135487|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
146992581|NCT02458469|530135488|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
146992582|NCT02458469|530135489|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
146992583|NCT02458469|530135490|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
146992584|NCT02458469|530135491|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
146992585|NCT02458469|530135486|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
146992586|NCT02458469|530135487|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
146992587|NCT02458469|530135488|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
146992588|NCT02458469|530135489|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
146992589|NCT02458469|530135490|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
146992590|NCT02458469|530135491|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
146992591|NCT02458469|530135486|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
146992592|NCT02458469|530135487|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
146992593|NCT02458469|530135488|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
146992594|NCT02458469|530135489|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
146992595|NCT02458469|530135490|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
146992596|NCT02458469|530135491|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
146992597|NCT03561883|530135494|FG000|Overall Study|Adverse Event|10|||
146992598|NCT03561883|530135495|FG001|Overall Study|Adverse Event|13|||
146992599|NCT03561883|530135494|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146992600|NCT03561883|530135495|FG001|Overall Study|Non-Compliance With Study Drug|2|||
146992601|NCT03561883|530135494|FG000|Overall Study|Protocol Violation|2|||
146992602|NCT03561883|530135495|FG001|Overall Study|Protocol Violation|3|||
146992603|NCT03561883|530135494|FG000|Overall Study|Withdrawal by Subject|14|||
146992604|NCT03561883|530135495|FG001|Overall Study|Withdrawal by Subject|6|||
146992605|NCT03561883|530135494|FG000|Overall Study|Lost to Follow-up|2|||
146992606|NCT03561883|530135495|FG001|Overall Study|Lost to Follow-up|6|||
146992607|NCT03561883|530135494|FG000|Overall Study|Study Terminated by Sponsor|12|||
146992608|NCT03561883|530135495|FG001|Overall Study|Study Terminated by Sponsor|11|||
146992609|NCT03561883|530135494|FG000|Overall Study|Physician Decision|1|||
146992610|NCT03561883|530135495|FG001|Overall Study|Physician Decision|0|||
146992611|NCT03561883|530135494|FG000|Overall Study|Randomized by Mistake|1|||
146992612|NCT03561883|530135495|FG001|Overall Study|Randomized by Mistake|0|||
146992613|NCT03561883|530135494|FG000|Overall Study|Other, Not Specified|3|||
146992614|NCT03561883|530135495|FG001|Overall Study|Other, Not Specified|2|||
146992615|NCT01471522|530135509|FG000|Overall Study|Withdrawal by Subject|28|||
146992616|NCT01471522|530135510|FG001|Overall Study|Withdrawal by Subject|22|||
146992617|NCT01471522|530135509|FG000|Overall Study|Lost to Follow-up|36|||
146992618|NCT01471522|530135510|FG001|Overall Study|Lost to Follow-up|26|||
146992619|NCT02863575|530135511|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
146992620|NCT02863575|530135512|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
146992621|NCT02863575|530135513|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
146992622|NCT02863575|530135511|FG000|Overall Study|Withdrawal by Subject|0|||
146992623|NCT02863575|530135512|FG001|Overall Study|Withdrawal by Subject|1|||
146992624|NCT02863575|530135513|FG002|Overall Study|Withdrawal by Subject|1|||
146992625|NCT02863575|530135511|FG000|Overall Study|Adverse Event|0|||
146992626|NCT02863575|530135512|FG001|Overall Study|Adverse Event|1|||
146992627|NCT02863575|530135513|FG002|Overall Study|Adverse Event|0|||
147013213|NCT02048813|530210053|FG001|Overall Study|Non-protocol therapy|1|||
147013214|NCT02048813|530210052|FG000|Overall Study|Second primary cancer|2|||
147013215|NCT02048813|530210053|FG001|Overall Study|Second primary cancer|0|||
147013216|NCT02048813|530210052|FG000|Overall Study|Insurance|2|||
147013217|NCT02048813|530210053|FG001|Overall Study|Insurance|0|||
146839664|NCT05000216|529584634|FG003|Stage 2|Physician Decision|0|||
146839665|NCT05000216|529584635|FG004|Stage 2|Physician Decision|0|||
146839666|NCT05000216|529584636|FG005|Stage 2|Physician Decision|0|||
146839667|NCT05000216|529584637|FG006|Stage 2|Physician Decision|0|||
146839668|NCT05000216|529584638|FG007|Stage 2|Physician Decision|0|||
146839669|NCT05000216|529584639|FG008|Stage 2|Physician Decision|0|||
146839670|NCT05000216|529584640|FG009|Stage 2|Physician Decision|0|||
146839671|NCT05000216|529584641|FG010|Stage 2|Physician Decision|0|||
146959790|NCT05602818|530012244|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
146959791|NCT05602818|530012245|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
146959792|NCT05602818|530012246|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
146959793|NCT05602818|530012247|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
146959794|NCT05602818|530012248|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
146959795|NCT00727246|530012249|FG000|Overall Study|could not complete MRI|0|||
146959796|NCT00727246|530012250|FG001|Overall Study|could not complete MRI|1|||
146959797|NCT00727246|530012251|FG002|Overall Study|could not complete MRI|0|||
146959798|NCT00727246|530012252|FG003|Overall Study|could not complete MRI|1|||
146959799|NCT00727246|530012249|FG000|Overall Study|incidental finding|0|||
146959800|NCT00727246|530012250|FG001|Overall Study|incidental finding|0|||
146959801|NCT00727246|530012251|FG002|Overall Study|incidental finding|0|||
146959802|NCT00727246|530012252|FG003|Overall Study|incidental finding|1|||
146959803|NCT00727246|530012249|FG000|Overall Study|withdrawn|0|||
146959804|NCT00727246|530012250|FG001|Overall Study|withdrawn|0|||
146959805|NCT00727246|530012251|FG002|Overall Study|withdrawn|1|||
146959806|NCT00727246|530012252|FG003|Overall Study|withdrawn|0|||
146959807|NCT03814499|530012253|FG000|Overall Study|Lost to Follow-up|3|||
146959808|NCT00598442|530012254|FG000|Overall Study|Adverse Event|3|||
146959809|NCT00598442|530012255|FG001|Overall Study|Adverse Event|0|||
146959810|NCT00598442|530012256|FG002|Overall Study|Adverse Event|0|||
146959811|NCT00598442|530012254|FG000|Overall Study|Death|19|||
146959812|NCT00598442|530012255|FG001|Overall Study|Death|11|||
146959813|NCT00598442|530012256|FG002|Overall Study|Death|11|||
146959814|NCT00598442|530012254|FG000|Overall Study|Lost to Follow-up|4|||
146959815|NCT00598442|530012255|FG001|Overall Study|Lost to Follow-up|3|||
146959816|NCT00598442|530012256|FG002|Overall Study|Lost to Follow-up|3|||
146959817|NCT00598442|530012254|FG000|Overall Study|Physician Decision|2|||
146959818|NCT00598442|530012255|FG001|Overall Study|Physician Decision|1|||
146959819|NCT00598442|530012256|FG002|Overall Study|Physician Decision|1|||
146959820|NCT00598442|530012254|FG000|Overall Study|Withdrawal by Subject|8|||
146959821|NCT00598442|530012255|FG001|Overall Study|Withdrawal by Subject|16|||
146959822|NCT00598442|530012256|FG002|Overall Study|Withdrawal by Subject|6|||
146959823|NCT00598442|530012254|FG000|Overall Study|Noncompliance|0|||
146959824|NCT00598442|530012255|FG001|Overall Study|Noncompliance|2|||
146959825|NCT00598442|530012256|FG002|Overall Study|Noncompliance|1|||
146959826|NCT00598442|530012254|FG000|Overall Study|Relocation|1|||
146959827|NCT00598442|530012255|FG001|Overall Study|Relocation|4|||
147013218|NCT02048813|530210052|FG000|Overall Study|Wound infection/healing|2|||
147013219|NCT02048813|530210053|FG001|Overall Study|Wound infection/healing|0|||
146959828|NCT00598442|530012256|FG002|Overall Study|Relocation|0|||
146959829|NCT00598442|530012254|FG000|Overall Study|Renal transplant|0|||
146959830|NCT00598442|530012255|FG001|Overall Study|Renal transplant|0|||
146959831|NCT00598442|530012256|FG002|Overall Study|Renal transplant|1|||
147013220|NCT02048813|530210052|FG000|Overall Study|Missed appointment|3|||
146839672|NCT05000216|529584642|FG011|Stage 2|Physician Decision|0|||
146959832|NCT00598442|530012254|FG000|Overall Study|Site closed by sponsor|5|||
146959833|NCT00598442|530012255|FG001|Overall Study|Site closed by sponsor|2|||
146959834|NCT00598442|530012256|FG002|Overall Study|Site closed by sponsor|1|||
146959835|NCT00598442|530012254|FG000|Overall Study|Started dialysis|1|||
146959836|NCT00598442|530012255|FG001|Overall Study|Started dialysis|0|||
146959837|NCT00598442|530012256|FG002|Overall Study|Started dialysis|0|||
146959838|NCT00267202|530012268|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
146959839|NCT00267202|530012269|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
146959840|NCT00267202|530012268|FG000|Overall Study|Withdrawal by Subject|12|||
146959841|NCT00267202|530012269|FG001|Overall Study|Withdrawal by Subject|15|||
146959842|NCT00267202|530012268|FG000|Overall Study|Adverse Event|13|||
146959843|NCT00267202|530012269|FG001|Overall Study|Adverse Event|7|||
146959844|NCT00267202|530012268|FG000|Overall Study|Protocol Violation|2|||
146959845|NCT00267202|530012269|FG001|Overall Study|Protocol Violation|3|||
146959846|NCT00267202|530012268|FG000|Overall Study|Administrative problems|2|||
146959847|NCT00267202|530012269|FG001|Overall Study|Administrative problems|1|||
146959848|NCT00267202|530012268|FG000|Overall Study|Lost to Follow-up|3|||
146959849|NCT00267202|530012269|FG001|Overall Study|Lost to Follow-up|0|||
146959850|NCT00399542|530012270|FG000|Overall Study|Adverse Event|18|||
146959851|NCT00399542|530012271|FG001|Overall Study|Adverse Event|15|||
146959852|NCT00399542|530012270|FG000|Overall Study|Protocol Violation|13|||
146959853|NCT00399542|530012271|FG001|Overall Study|Protocol Violation|3|||
146959854|NCT00399542|530012270|FG000|Overall Study|Withdrawal by Subject|28|||
146959855|NCT00399542|530012271|FG001|Overall Study|Withdrawal by Subject|10|||
146959856|NCT00399542|530012270|FG000|Overall Study|Lack of Efficacy|18|||
146959857|NCT00399542|530012271|FG001|Overall Study|Lack of Efficacy|8|||
146959858|NCT00399542|530012270|FG000|Overall Study|Lost to Follow-up|6|||
146959859|NCT00399542|530012271|FG001|Overall Study|Lost to Follow-up|6|||
146959860|NCT00399542|530012270|FG000|Overall Study|Other|1|||
146959861|NCT00399542|530012271|FG001|Overall Study|Other|0|||
146959862|NCT00399542|530012270|FG000|Overall Study|Physician Decision|0|||
146959863|NCT00399542|530012271|FG001|Overall Study|Physician Decision|1|||
146959864|NCT00334893|530012272|FG000|Overall Study|Not Treated|1|||
146959865|NCT00334893|530012273|FG001|Overall Study|Not Treated|0|||
146959866|NCT01258803|530012274|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
146959867|NCT01258803|530012275|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
146959868|NCT01258803|530012276|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
146959869|NCT01258803|530012277|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
146959870|NCT01258803|530012278|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
146959871|NCT01258803|530012279|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
146959872|NCT01258803|530012274|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
146959873|NCT01258803|530012275|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
146959874|NCT01258803|530012276|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
146959875|NCT01258803|530012277|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
146959876|NCT01258803|530012278|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
146959877|NCT01258803|530012279|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
146959878|NCT01258803|530012274|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
146959879|NCT01258803|530012275|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
146959880|NCT01258803|530012276|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
146959881|NCT01258803|530012277|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
146959882|NCT01258803|530012278|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
146959883|NCT01258803|530012279|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
146959884|NCT01552408|530012285|FG000|Overall Study|Lost to Follow-up|2|||
146959885|NCT01552408|530012286|FG001|Overall Study|Lost to Follow-up|0|||
146959886|NCT01552408|530012285|FG000|Overall Study|Relocation|0|||
146959887|NCT01552408|530012286|FG001|Overall Study|Relocation|1|||
146959888|NCT01552408|530012285|FG000|Overall Study|Withdrawal by Subject|2|||
146959889|NCT01552408|530012286|FG001|Overall Study|Withdrawal by Subject|1|||
146959890|NCT03604159|530012287|FG000|Overall Study|Lost to Follow-up|6|||
146959891|NCT03604159|530012288|FG001|Overall Study|Lost to Follow-up|7|||
146959892|NCT00851721|530012289|FG000|Overall Study|planned surgery|1|||
146959893|NCT00851721|530012290|FG001|Overall Study|planned surgery|0|||
146959894|NCT00851721|530012289|FG000|Overall Study|Death|1|||
146959895|NCT00851721|530012290|FG001|Overall Study|Death|0|||
146959896|NCT00851721|530012289|FG000|Overall Study|Adverse Event|0|||
146959897|NCT00851721|530012290|FG001|Overall Study|Adverse Event|1|||
146959898|NCT00383292|530012293|FG000|Overall Study|Adverse Event|4|||
146959899|NCT00383292|530012294|FG001|Overall Study|Adverse Event|1|||
146959900|NCT00383292|530012295|FG002|Overall Study|Adverse Event|2|||
146959901|NCT00383292|530012293|FG000|Overall Study|Death|3|||
146959902|NCT00383292|530012294|FG001|Overall Study|Death|3|||
146959903|NCT00383292|530012295|FG002|Overall Study|Death|3|||
146959904|NCT00383292|530012293|FG000|Overall Study|Physician Decision|4|||
146959905|NCT00383292|530012294|FG001|Overall Study|Physician Decision|0|||
146959906|NCT00383292|530012295|FG002|Overall Study|Physician Decision|1|||
146959907|NCT00383292|530012293|FG000|Overall Study|Withdrawal by Subject|3|||
146959908|NCT00383292|530012294|FG001|Overall Study|Withdrawal by Subject|2|||
146959909|NCT00383292|530012295|FG002|Overall Study|Withdrawal by Subject|2|||
146959910|NCT00383292|530012293|FG000|Overall Study|Other|1|||
146959911|NCT00383292|530012294|FG001|Overall Study|Other|0|||
146959912|NCT00383292|530012295|FG002|Overall Study|Other|0|||
146959913|NCT04533204|530012296|FG000|Overall Study|Unable to understand training instructions|1|||
146959914|NCT04533204|530012297|FG001|Overall Study|Unable to understand training instructions|1|||
146959915|NCT01348828|530012305|FG000|Overall Study|Death|20|||
146959916|NCT01348828|530012305|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
146959917|NCT01348828|530012305|FG000|Overall Study|Conversion|2|||
146959918|NCT01348828|530012305|FG000|Overall Study|missed visit|1|||
146959919|NCT02442284|530012308|FG000|Overall Study|Adverse Event|1|||
146959920|NCT02442284|530012308|FG000|Overall Study|Withdrew Consent|2|||
146959921|NCT02442284|530012308|FG000|Overall Study|Lost to Follow-up|3|||
146959922|NCT02442284|530012308|FG000|Overall Study|Other|1|||
146959923|NCT02815670|530012309|FG000|Overall Study|Prematurely discontinued of the trial|1|||
146959924|NCT03137173|530012310|FG000|Overall Study|Withdrawal by Subject|8|||
146959925|NCT03137173|530012311|FG001|Overall Study|Withdrawal by Subject|13|||
146959926|NCT03137173|530012310|FG000|Overall Study|Death|1|||
146959927|NCT03137173|530012311|FG001|Overall Study|Death|3|||
146959928|NCT03137173|530012310|FG000|Overall Study|Physician Decision|1|||
146959929|NCT03137173|530012311|FG001|Overall Study|Physician Decision|0|||
146959930|NCT03137173|530012310|FG000|Overall Study|Lost to Follow-up|13|||
146959931|NCT03137173|530012311|FG001|Overall Study|Lost to Follow-up|18|||
146959932|NCT03137173|530012310|FG000|Overall Study|Other reasons|3|||
146959933|NCT03137173|530012311|FG001|Overall Study|Other reasons|2|||
146959934|NCT00280059|530012314|FG000|Efficacy Assessment Phase|Death|2|||
146959935|NCT00280059|530012315|FG001|Efficacy Assessment Phase|Death|0|||
146959936|NCT00280059|530012314|FG000|Efficacy Assessment Phase|Adverse Event|33|||
146959937|NCT00280059|530012315|FG001|Efficacy Assessment Phase|Adverse Event|31|||
146959938|NCT00280059|530012314|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
146959939|NCT00280059|530012315|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
146959940|NCT00280059|530012314|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
146959941|NCT00280059|530012315|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
146959942|NCT00280059|530012314|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
146959943|NCT00280059|530012315|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
146959944|NCT00280059|530012314|FG000|Efficacy Assessment Phase|Other|7|||
146959945|NCT00280059|530012315|FG001|Efficacy Assessment Phase|Other|8|||
146959946|NCT00280059|530012314|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
146959947|NCT00280059|530012315|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
146959948|NCT02127931|530012316|FG000|Overall Study|Glitch in Game|1|||
146959949|NCT01377194|530012318|FG000|Overall Study|Adverse Event|3|||
146959950|NCT01377194|530012319|FG001|Overall Study|Adverse Event|12|||
146959951|NCT01377194|530012320|FG002|Overall Study|Adverse Event|19|||
146959952|NCT01377194|530012318|FG000|Overall Study|Lack of Efficacy|3|||
146959953|NCT01377194|530012319|FG001|Overall Study|Lack of Efficacy|3|||
146959954|NCT01377194|530012320|FG002|Overall Study|Lack of Efficacy|3|||
146959955|NCT01377194|530012318|FG000|Overall Study|Protocol Violation|4|||
146959956|NCT01377194|530012319|FG001|Overall Study|Protocol Violation|10|||
146959957|NCT01377194|530012320|FG002|Overall Study|Protocol Violation|6|||
146959958|NCT01377194|530012318|FG000|Overall Study|Withdrawal by Subject|8|||
146959959|NCT01377194|530012319|FG001|Overall Study|Withdrawal by Subject|10|||
146959960|NCT01377194|530012320|FG002|Overall Study|Withdrawal by Subject|7|||
146959961|NCT01377194|530012318|FG000|Overall Study|Lost to Follow-up|14|||
146959962|NCT01377194|530012319|FG001|Overall Study|Lost to Follow-up|8|||
146959963|NCT01377194|530012320|FG002|Overall Study|Lost to Follow-up|11|||
146959964|NCT01190839|530012323|FG000|Overall Study|Adverse Event|32|||
146959965|NCT01190839|530012324|FG001|Overall Study|Adverse Event|41|||
146959966|NCT01190839|530012323|FG000|Overall Study|Protocol Violation|2|||
146959967|NCT01190839|530012324|FG001|Overall Study|Protocol Violation|2|||
146959968|NCT01190839|530012323|FG000|Overall Study|Lost to Follow-up|7|||
146959969|NCT01190839|530012324|FG001|Overall Study|Lost to Follow-up|1|||
146959970|NCT01190839|530012323|FG000|Overall Study|Death|1|||
146959971|NCT01190839|530012324|FG001|Overall Study|Death|0|||
146959972|NCT01190839|530012323|FG000|Overall Study|Trial stopped by Sponsor|71|||
146959973|NCT01190839|530012324|FG001|Overall Study|Trial stopped by Sponsor|68|||
146959974|NCT01190839|530012323|FG000|Overall Study|Undefined|35|||
146959975|NCT01190839|530012324|FG001|Overall Study|Undefined|31|||
146959976|NCT01190839|530012323|FG000|Overall Study|Randomized but not treated|2|||
146959977|NCT01190839|530012324|FG001|Overall Study|Randomized but not treated|4|||
146959978|NCT00765726|530012326|FG000|Overall Study|Withdrawal by Subject|1|||
146959979|NCT00765726|530012326|FG000|Overall Study|Discontinuation of study by sponsor|8|||
146959980|NCT02993731|530012327|FG000|Overall Study|Study Termination|101|||
146959981|NCT02993731|530012328|FG001|Overall Study|Study Termination|105|||
146959982|NCT00323479|530012329|FG000|Overall Study|Adverse Event|2|||
146992628|NCT05628675|530137054|FG000|Overall Study|Lost to Follow-up|2|||
146839673|NCT05000216|529584643|FG012|Stage 2|Physician Decision|1|||
146959983|NCT00323479|530012329|FG000|Overall Study|Withdrawal by Subject|2|||
146959984|NCT00323479|530012329|FG000|Overall Study|Protocol Violation|3|||
146959985|NCT00323479|530012329|FG000|Overall Study|house moving|1|||
146959986|NCT01362062|530012330|FG000|Overall Study|Adverse Event|1|||
146959987|NCT01362062|530012331|FG001|Overall Study|Adverse Event|0|||
146959988|NCT01362062|530012330|FG000|Overall Study|Lost to Follow-up|11|||
146959989|NCT01362062|530012331|FG001|Overall Study|Lost to Follow-up|0|||
146992629|NCT05628675|530137054|FG000|Overall Study|Withdrawal by Subject|1|||
146992630|NCT02918877|530137057|FG000|Overall Study|Withdrawal by Subject|2|||
146992631|NCT02918877|530137058|FG001|Overall Study|Withdrawal by Subject|2|||
146992632|NCT02918877|530137057|FG000|Overall Study|Surgery cancelled|1|||
146992633|NCT02918877|530137058|FG001|Overall Study|Surgery cancelled|0|||
146992634|NCT02918877|530137057|FG000|Overall Study|Physician Decision|1|||
146992635|NCT02918877|530137058|FG001|Overall Study|Physician Decision|0|||
146959990|NCT01362062|530012330|FG000|Overall Study|Withdrawal by Subject|2|||
146959991|NCT01362062|530012331|FG001|Overall Study|Withdrawal by Subject|0|||
146959992|NCT01362062|530012330|FG000|Overall Study|Non-compliant participant|2|||
146959993|NCT01362062|530012331|FG001|Overall Study|Non-compliant participant|0|||
146959994|NCT01362062|530012330|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
146959995|NCT01362062|530012331|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
146959996|NCT01362062|530012330|FG000|Overall Study|Had significant improvement|9|||
146959997|NCT01362062|530012331|FG001|Overall Study|Had significant improvement|0|||
146959998|NCT02545504|530012332|FG000|Overall Study|Death|174|||
146959999|NCT02545504|530012333|FG001|Overall Study|Death|168|||
146960000|NCT02545504|530012332|FG000|Overall Study|Unknown reason|30|||
146960001|NCT02545504|530012333|FG001|Overall Study|Unknown reason|32|||
146960002|NCT02545504|530012332|FG000|Overall Study|Withdrew consent|9|||
146960003|NCT02545504|530012333|FG001|Overall Study|Withdrew consent|11|||
146960004|NCT02545504|530012332|FG000|Overall Study|Investigator's discretion|3|||
146960005|NCT02545504|530012333|FG001|Overall Study|Investigator's discretion|1|||
146960006|NCT02545504|530012332|FG000|Overall Study|Lost to Follow-up|2|||
146960007|NCT02545504|530012333|FG001|Overall Study|Lost to Follow-up|2|||
146960008|NCT00967343|530012335|FG000|Overall Study|Study termination by sponsor|12|||
146960009|NCT00967343|530012335|FG000|Overall Study|Death|24|||
146960010|NCT00967343|530012335|FG000|Overall Study|Relapse|1|||
146960011|NCT00967343|530012335|FG000|Overall Study|Lost to Follow-up|1|||
146960012|NCT00950755|530012336|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
146960013|NCT00950755|530012336|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
146960014|NCT00950755|530012336|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
146960015|NCT00950755|530012336|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
146960016|NCT00950755|530012336|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
146960017|NCT00950755|530012336|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
146960018|NCT00950755|530012336|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
146960019|NCT00950755|530012336|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
146960020|NCT00950755|530012336|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
146960021|NCT00950755|530012336|FG000|Long-Term Follow-Up|Death|8|||
146960022|NCT00508820|530012338|FG000|Overall Study|Adverse Event|6|||
146960023|NCT00508820|530012339|FG001|Overall Study|Adverse Event|10|||
146960024|NCT00508820|530012338|FG000|Overall Study|Death|6|||
146960025|NCT00508820|530012339|FG001|Overall Study|Death|8|||
146960026|NCT00508820|530012338|FG000|Overall Study|Lost to Follow-up|1|||
146960027|NCT00508820|530012339|FG001|Overall Study|Lost to Follow-up|1|||
146960028|NCT00508820|530012338|FG000|Overall Study|Physician Decision|8|||
146960029|NCT00508820|530012339|FG001|Overall Study|Physician Decision|2|||
146960030|NCT00508820|530012338|FG000|Overall Study|Pregnancy|0|||
146960031|NCT00508820|530012339|FG001|Overall Study|Pregnancy|2|||
146960032|NCT00508820|530012338|FG000|Overall Study|Protocol Violation|2|||
146960033|NCT00508820|530012339|FG001|Overall Study|Protocol Violation|0|||
146960034|NCT00508820|530012338|FG000|Overall Study|Withdrawal by Subject|10|||
146960035|NCT00508820|530012339|FG001|Overall Study|Withdrawal by Subject|12|||
146960036|NCT00508820|530012338|FG000|Overall Study|Other|11|||
146960037|NCT00508820|530012339|FG001|Overall Study|Other|2|||
146960038|NCT00508820|530012338|FG000|Overall Study|Noncompliance|1|||
146960039|NCT00508820|530012339|FG001|Overall Study|Noncompliance|0|||
146960040|NCT00508820|530012338|FG000|Overall Study|Requirement for alternative therapy|7|||
146960041|NCT00508820|530012339|FG001|Overall Study|Requirement for alternative therapy|15|||
146960042|NCT00508820|530012338|FG000|Overall Study|Protocol-specified Criteria|3|||
146960043|NCT00508820|530012339|FG001|Overall Study|Protocol-specified Criteria|12|||
146960044|NCT04398030|530014267|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
146960045|NCT04398030|530014268|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
146960046|NCT04398030|530014267|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
146960047|NCT04398030|530014268|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
146960048|NCT02713490|530014271|FG000|Overall Study|Withdrawal by Subject|2|||
146960049|NCT02713490|530014272|FG001|Overall Study|Withdrawal by Subject|1|||
146960050|NCT02713490|530014271|FG000|Overall Study|Did not receive study drug|1|||
146960051|NCT02713490|530014272|FG001|Overall Study|Did not receive study drug|0|||
146960052|NCT02713490|530014271|FG000|Overall Study|Met exclusion criteria|0|||
146960053|NCT02713490|530014272|FG001|Overall Study|Met exclusion criteria|1|||
146960054|NCT00548340|530014277|FG000|Overall Study|Protocol Violation|2|||
146992636|NCT02918877|530137057|FG000|Overall Study|Received intraoperative steroids|1|||
146960055|NCT00548340|530014278|FG001|Overall Study|Protocol Violation|3|||
146960056|NCT00548340|530014279|FG002|Overall Study|Protocol Violation|3|||
146960057|NCT00548340|530014277|FG000|Overall Study|Adverse Event|2|||
146992637|NCT02918877|530137058|FG001|Overall Study|Received intraoperative steroids|0|||
146992638|NCT02918877|530137057|FG000|Overall Study|Unable to obtain lab samples|1|||
146992639|NCT02918877|530137058|FG001|Overall Study|Unable to obtain lab samples|0|||
146992640|NCT02918877|530137057|FG000|Overall Study|Unsafe to perform BAL|0|||
146992641|NCT02918877|530137058|FG001|Overall Study|Unsafe to perform BAL|1|||
146992642|NCT01367275|530137059|FG000|Overall Study|Ineligible|1|||
146992643|NCT01367275|530137059|FG000|Overall Study|Disease Progression|2|||
146992644|NCT01648166|530137060|FG000|Overall Study|inadequate toenail samples|53|||
146992645|NCT01648166|530137061|FG001|Overall Study|inadequate toenail samples|100|||
146992646|NCT00883090|530137062|FG000|Overall Study|Sponsor's decision|1|||
146992647|NCT00883090|530137062|FG000|Overall Study|Withdrawal by Subject|1|||
146992648|NCT02532764|530137063|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
146992649|NCT02532764|530137064|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
146992650|NCT02532764|530137065|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
146992651|NCT02532764|530137066|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
146992652|NCT02532764|530137067|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
146992653|NCT02532764|530137068|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
146992654|NCT02532764|530137069|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
146992655|NCT02532764|530137070|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
146992656|NCT02532764|530137071|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
146992657|NCT02532764|530137072|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
146992658|NCT01717976|530137073|FG000|Overall Study|Protocol Violation|0|||
146992659|NCT01717976|530137074|FG001|Overall Study|Protocol Violation|1|||
146992660|NCT00262223|530137077|FG000|Treatment Phase|Withdrawal by Subject|3|||
146992661|NCT00262223|530137078|FG001|Treatment Phase|Withdrawal by Subject|6|||
146992662|NCT00262223|530137077|FG000|Treatment Phase|Adverse Event|1|||
146992663|NCT00262223|530137078|FG001|Treatment Phase|Adverse Event|2|||
146992664|NCT00262223|530137077|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
146992665|NCT00262223|530137078|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
146992666|NCT00262223|530137077|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
146992667|NCT00262223|530137078|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
146992668|NCT00262223|530137077|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
146992669|NCT00262223|530137078|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
146992670|NCT00437658|530137079|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
146992671|NCT00437658|530137080|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
146992672|NCT00437658|530137081|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
146992673|NCT00437658|530137079|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
146992674|NCT00437658|530137080|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
146992675|NCT00437658|530137081|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
146992676|NCT00437658|530137079|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
146992677|NCT00437658|530137080|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
146992678|NCT00437658|530137081|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
146992679|NCT00437658|530137079|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
146992680|NCT00437658|530137080|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
146992681|NCT00437658|530137081|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
146992682|NCT00437658|530137079|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
146992683|NCT00437658|530137080|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
146992684|NCT00437658|530137081|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
146992685|NCT00437658|530137079|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
146992686|NCT00437658|530137080|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
146992687|NCT00437658|530137081|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
146992688|NCT00437658|530137079|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
146992689|NCT00437658|530137080|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
146992690|NCT00437658|530137081|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
146992691|NCT00437658|530137079|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
146992692|NCT00437658|530137080|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
146992693|NCT00437658|530137081|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
146992694|NCT00437658|530137079|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
146992695|NCT00437658|530137080|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
146992696|NCT00437658|530137081|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
146992697|NCT00437658|530137079|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
146992698|NCT00437658|530137080|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
146992699|NCT00437658|530137081|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
146992700|NCT00437658|530137079|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
146992701|NCT00437658|530137080|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
146992702|NCT00437658|530137081|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
146992703|NCT00437658|530137079|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
146992704|NCT00437658|530137080|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
146992705|NCT00437658|530137081|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
146839674|NCT05000216|529584644|FG013|Stage 2|Physician Decision|0|||
146839675|NCT05000216|529584645|FG014|Stage 2|Physician Decision|0|||
146839676|NCT05000216|529584646|FG015|Stage 2|Physician Decision|0|||
146839677|NCT05000216|529584647|FG016|Stage 2|Physician Decision|0|||
146839678|NCT05000216|529584648|FG017|Stage 2|Physician Decision|0|||
146839679|NCT05000216|529584649|FG018|Stage 2|Physician Decision|0|||
146839680|NCT05000216|529584650|FG019|Stage 2|Physician Decision|0|||
146839681|NCT05000216|529584651|FG020|Stage 2|Physician Decision|0|||
146839682|NCT05000216|529584652|FG021|Stage 2|Physician Decision|0|||
146839683|NCT05000216|529584631|FG000|Stage 2|Withdrawal by Subject|0|||
146839684|NCT05000216|529584632|FG001|Stage 2|Withdrawal by Subject|0|||
146839685|NCT05000216|529584633|FG002|Stage 2|Withdrawal by Subject|0|||
146839686|NCT05000216|529584634|FG003|Stage 2|Withdrawal by Subject|0|||
146839687|NCT05000216|529584635|FG004|Stage 2|Withdrawal by Subject|0|||
146839688|NCT05000216|529584636|FG005|Stage 2|Withdrawal by Subject|0|||
146839689|NCT05000216|529584637|FG006|Stage 2|Withdrawal by Subject|0|||
146839690|NCT05000216|529584638|FG007|Stage 2|Withdrawal by Subject|0|||
146839691|NCT05000216|529584639|FG008|Stage 2|Withdrawal by Subject|0|||
146839692|NCT05000216|529584640|FG009|Stage 2|Withdrawal by Subject|0|||
146960058|NCT00548340|530014278|FG001|Overall Study|Adverse Event|2|||
146960059|NCT00548340|530014279|FG002|Overall Study|Adverse Event|2|||
146960060|NCT00548340|530014277|FG000|Overall Study|Lost to Follow-up|1|||
146960061|NCT00548340|530014278|FG001|Overall Study|Lost to Follow-up|1|||
146960062|NCT00548340|530014279|FG002|Overall Study|Lost to Follow-up|0|||
146960063|NCT00548340|530014277|FG000|Overall Study|Withdrawal by Subject|2|||
146960064|NCT00548340|530014278|FG001|Overall Study|Withdrawal by Subject|4|||
146960065|NCT00548340|530014279|FG002|Overall Study|Withdrawal by Subject|3|||
146960066|NCT00548340|530014277|FG000|Overall Study|Other|1|||
146960067|NCT00548340|530014278|FG001|Overall Study|Other|1|||
146960068|NCT00548340|530014279|FG002|Overall Study|Other|1|||
146960069|NCT01096017|530014280|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
146960070|NCT01096017|530014281|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
146960071|NCT02600559|530014282|FG000|Overall Study|Withdrawal by Subject|3|||
146960072|NCT02600559|530014282|FG000|Overall Study|Lost to Follow-up|20|||
146960073|NCT03410693|530014283|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
146960074|NCT03410693|530014284|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
146960075|NCT03410693|530014283|FG000|Overall Study|Disc trt: Lost to follow up|0|||
146960076|NCT03410693|530014284|FG001|Overall Study|Disc trt: Lost to follow up|1|||
146960077|NCT03410693|530014283|FG000|Overall Study|Disc trt: radiological progression|58|||
146960078|NCT03410693|530014284|FG001|Overall Study|Disc trt: radiological progression|50|||
146960079|NCT03410693|530014283|FG000|Overall Study|Disc trt: Other|1|||
146960080|NCT03410693|530014284|FG001|Overall Study|Disc trt: Other|0|||
146960081|NCT03410693|530014283|FG000|Overall Study|Study drug never administered|1|||
146960082|NCT03410693|530014284|FG001|Overall Study|Study drug never administered|6|||
146960083|NCT03410693|530014283|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
146960084|NCT03410693|530014284|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
146960085|NCT03410693|530014283|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
146960086|NCT03410693|530014284|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
146960087|NCT03410693|530014283|FG000|Overall Study|Disc trt: Physician decision|0|||
146960088|NCT03410693|530014284|FG001|Overall Study|Disc trt: Physician decision|5|||
146960089|NCT03410693|530014283|FG000|Overall Study|Disc trt: clinical progression|1|||
146960090|NCT03410693|530014284|FG001|Overall Study|Disc trt: clinical progression|5|||
146960091|NCT03410693|530014283|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
146960092|NCT03410693|530014284|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
146960093|NCT01789476|530014285|FG000|Overall Study|Lack of Efficacy|6|||
146960094|NCT01789476|530014286|FG001|Overall Study|Lack of Efficacy|2|||
146960095|NCT01789476|530014285|FG000|Overall Study|Adverse Event|1|||
146960096|NCT01789476|530014286|FG001|Overall Study|Adverse Event|0|||
146960097|NCT01789476|530014285|FG000|Overall Study|Unable to get IV access|1|||
146960098|NCT01789476|530014286|FG001|Overall Study|Unable to get IV access|0|||
146960099|NCT00953576|530014287|FG000|Overall Study|Adverse Event|0|||
146960100|NCT00953576|530014288|FG001|Overall Study|Adverse Event|1|||
146960101|NCT00953576|530014287|FG000|Overall Study|Ineligible after Consent|2|||
146960102|NCT00953576|530014288|FG001|Overall Study|Ineligible after Consent|0|||
146960103|NCT00501969|530014289|FG000|Overall Study|Major Protocol Violation|4|||
146960104|NCT00501969|530014289|FG000|Overall Study|Lack of Efficacy|29|||
146960105|NCT00501969|530014289|FG000|Overall Study|Adverse Event|76|||
146839693|NCT05000216|529584641|FG010|Stage 2|Withdrawal by Subject|0|||
146839694|NCT05000216|529584642|FG011|Stage 2|Withdrawal by Subject|0|||
146839695|NCT05000216|529584643|FG012|Stage 2|Withdrawal by Subject|0|||
146960106|NCT00501969|530014289|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
146992706|NCT03952143|530137082|FG000|Lead-In Period|Adverse Event|2|||
146992707|NCT03952143|530137083|FG001|Lead-In Period|Adverse Event|0|||
146839696|NCT05000216|529584644|FG013|Stage 2|Withdrawal by Subject|0|||
146960107|NCT00501969|530014289|FG000|Overall Study|Subject withdrew consent|51|||
146992708|NCT03952143|530137084|FG002|Lead-In Period|Adverse Event|0|||
146839697|NCT05000216|529584645|FG014|Stage 2|Withdrawal by Subject|2|||
146992709|NCT03952143|530137082|FG000|Lead-In Period|Lack of Efficacy|2|||
146992710|NCT03952143|530137083|FG001|Lead-In Period|Lack of Efficacy|0|||
146992711|NCT03952143|530137084|FG002|Lead-In Period|Lack of Efficacy|0|||
146992712|NCT03952143|530137082|FG000|Lead-In Period|Physician Decision|5|||
146992713|NCT03952143|530137083|FG001|Lead-In Period|Physician Decision|0|||
146992714|NCT03952143|530137084|FG002|Lead-In Period|Physician Decision|0|||
146992715|NCT03952143|530137082|FG000|Lead-In Period|Protocol Violation|5|||
146992716|NCT03952143|530137083|FG001|Lead-In Period|Protocol Violation|0|||
146992717|NCT03952143|530137084|FG002|Lead-In Period|Protocol Violation|0|||
146992718|NCT03952143|530137082|FG000|Lead-In Period|Withdrawal by Subject|19|||
146992719|NCT03952143|530137083|FG001|Lead-In Period|Withdrawal by Subject|0|||
146992720|NCT03952143|530137084|FG002|Lead-In Period|Withdrawal by Subject|0|||
146992721|NCT03952143|530137082|FG000|Treatment Period|Adverse Event|0|||
146992722|NCT03952143|530137083|FG001|Treatment Period|Adverse Event|0|||
146992723|NCT03952143|530137084|FG002|Treatment Period|Adverse Event|1|||
146992724|NCT03952143|530137082|FG000|Treatment Period|Lost to Follow-up|0|||
146992725|NCT03952143|530137083|FG001|Treatment Period|Lost to Follow-up|2|||
146992726|NCT03952143|530137084|FG002|Treatment Period|Lost to Follow-up|0|||
146992727|NCT03952143|530137082|FG000|Treatment Period|Physician Decision|0|||
146992728|NCT03952143|530137083|FG001|Treatment Period|Physician Decision|0|||
146992729|NCT03952143|530137084|FG002|Treatment Period|Physician Decision|2|||
146992730|NCT03952143|530137082|FG000|Treatment Period|Protocol Violation|0|||
146992731|NCT03952143|530137083|FG001|Treatment Period|Protocol Violation|0|||
146992732|NCT03952143|530137084|FG002|Treatment Period|Protocol Violation|1|||
146992733|NCT03952143|530137082|FG000|Treatment Period|Withdrawal by Subject|0|||
146992734|NCT03952143|530137083|FG001|Treatment Period|Withdrawal by Subject|5|||
146992735|NCT03952143|530137084|FG002|Treatment Period|Withdrawal by Subject|26|||
146992736|NCT03952143|530137082|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
146992737|NCT03952143|530137083|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
146992738|NCT03952143|530137084|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
146992739|NCT03952143|530137082|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
146992740|NCT03952143|530137083|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
146992741|NCT03952143|530137084|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
146992742|NCT01866319|530137085|FG000|Overall Study|Adverse Event|12|||
146992743|NCT01866319|530137086|FG001|Overall Study|Adverse Event|5|||
146992744|NCT01866319|530137087|FG002|Overall Study|Adverse Event|9|||
146992745|NCT01866319|530137085|FG000|Overall Study|Clinical progression|3|||
146992746|NCT01866319|530137086|FG001|Overall Study|Clinical progression|2|||
146992747|NCT01866319|530137087|FG002|Overall Study|Clinical progression|2|||
146992748|NCT01866319|530137085|FG000|Overall Study|Death|153|||
146992749|NCT01866319|530137086|FG001|Overall Study|Death|154|||
146992750|NCT01866319|530137087|FG002|Overall Study|Death|147|||
146992751|NCT01866319|530137085|FG000|Overall Study|Lost to Follow-up|6|||
146992752|NCT01866319|530137086|FG001|Overall Study|Lost to Follow-up|3|||
146992753|NCT01866319|530137087|FG002|Overall Study|Lost to Follow-up|8|||
146992754|NCT01866319|530137085|FG000|Overall Study|Physician Decision|1|||
146992755|NCT01866319|530137086|FG001|Overall Study|Physician Decision|0|||
146992756|NCT01866319|530137087|FG002|Overall Study|Physician Decision|1|||
146992757|NCT01866319|530137085|FG000|Overall Study|Protocol Violation|0|||
146992758|NCT01866319|530137086|FG001|Overall Study|Protocol Violation|0|||
146839698|NCT05000216|529584646|FG015|Stage 2|Withdrawal by Subject|0|||
146839699|NCT05000216|529584647|FG016|Stage 2|Withdrawal by Subject|9|||
146839700|NCT05000216|529584648|FG017|Stage 2|Withdrawal by Subject|0|||
146839701|NCT05000216|529584649|FG018|Stage 2|Withdrawal by Subject|0|||
146839702|NCT05000216|529584650|FG019|Stage 2|Withdrawal by Subject|0|||
146839703|NCT05000216|529584651|FG020|Stage 2|Withdrawal by Subject|0|||
146839704|NCT05000216|529584652|FG021|Stage 2|Withdrawal by Subject|0|||
146839705|NCT05000216|529584631|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
146839706|NCT05000216|529584632|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
146839707|NCT05000216|529584633|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
146839708|NCT05000216|529584634|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
146839709|NCT05000216|529584635|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
146839710|NCT05000216|529584636|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
146839711|NCT05000216|529584637|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
146839712|NCT05000216|529584638|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
146839713|NCT05000216|529584639|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
146839714|NCT05000216|529584640|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
146839715|NCT05000216|529584641|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
146839716|NCT05000216|529584642|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
146839717|NCT05000216|529584643|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
146839718|NCT05000216|529584644|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
146839719|NCT05000216|529584645|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
146992759|NCT01866319|530137087|FG002|Overall Study|Protocol Violation|1|||
146992760|NCT01866319|530137085|FG000|Overall Study|Withdrawal by Subject|32|||
146992761|NCT01866319|530137086|FG001|Overall Study|Withdrawal by Subject|14|||
146992762|NCT01866319|530137087|FG002|Overall Study|Withdrawal by Subject|12|||
146992763|NCT00623779|530137089|FG000|Overall Study|Adverse Event|1|||
146992764|NCT00623779|530137090|FG001|Overall Study|Adverse Event|3|||
146992765|NCT00623779|530137091|FG002|Overall Study|Adverse Event|0|||
146992766|NCT00623779|530137089|FG000|Overall Study|Criteria from CSR|2|||
146992767|NCT00623779|530137090|FG001|Overall Study|Criteria from CSR|0|||
146992768|NCT00623779|530137091|FG002|Overall Study|Criteria from CSR|1|||
146992769|NCT00832377|530137092|FG000|Overall Study|Protocol Violation|1|||
146992770|NCT01273181|530137093|FG000|Phase I, Dose 1|Study termination|1|||
146992771|NCT01273181|530137094|FG001|Phase I, Dose 1|Study termination|0|||
146992772|NCT01273181|530137095|FG002|Phase I, Dose 1|Study termination|0|||
146992773|NCT01273181|530137096|FG003|Phase I, Dose 1|Study termination|0|||
146992774|NCT01273181|530137093|FG000|Phase I, Dose 2|Death during treatment|0|||
146992775|NCT01273181|530137094|FG001|Phase I, Dose 2|Death during treatment|1|||
146992776|NCT01273181|530137095|FG002|Phase I, Dose 2|Death during treatment|0|||
146992777|NCT01273181|530137096|FG003|Phase I, Dose 2|Death during treatment|0|||
146992778|NCT01273181|530137093|FG000|Phase 2, Dose 1|Study termination|0|||
146992779|NCT01273181|530137094|FG001|Phase 2, Dose 1|Study termination|0|||
146992780|NCT01273181|530137095|FG002|Phase 2, Dose 1|Study termination|1|||
146992781|NCT01273181|530137096|FG003|Phase 2, Dose 1|Study termination|0|||
146992782|NCT01273181|530137093|FG000|Phase 2, Dose 2|Death during treatment|0|||
146992783|NCT01273181|530137094|FG001|Phase 2, Dose 2|Death during treatment|0|||
146992784|NCT01273181|530137095|FG002|Phase 2, Dose 2|Death during treatment|0|||
146992785|NCT01273181|530137096|FG003|Phase 2, Dose 2|Death during treatment|1|||
146992786|NCT00944697|530137097|FG000|Overall Study|Withdrawal by Subject|1|||
146992787|NCT00944697|530137098|FG001|Overall Study|Withdrawal by Subject|1|||
146992788|NCT00944697|530137097|FG000|Overall Study|Adverse Event|0|||
146992789|NCT00944697|530137098|FG001|Overall Study|Adverse Event|3|||
146992790|NCT00944697|530137097|FG000|Overall Study|Administrative|1|||
146992791|NCT00944697|530137098|FG001|Overall Study|Administrative|1|||
146992792|NCT01062256|530137103|FG000|Overall Study|Adverse Event|1|||
146992793|NCT01062256|530137104|FG001|Overall Study|Adverse Event|0|||
146992794|NCT01062256|530137105|FG002|Overall Study|Adverse Event|0|||
146992795|NCT01062256|530137103|FG000|Overall Study|Withdrawal by Subject|1|||
146992796|NCT01062256|530137104|FG001|Overall Study|Withdrawal by Subject|1|||
146992797|NCT01062256|530137105|FG002|Overall Study|Withdrawal by Subject|1|||
146992798|NCT01062256|530137103|FG000|Overall Study|Ineligible|1|||
146992799|NCT01062256|530137104|FG001|Overall Study|Ineligible|4|||
146992800|NCT01062256|530137105|FG002|Overall Study|Ineligible|3|||
146992801|NCT01062256|530137103|FG000|Overall Study|Administrative|0|||
146992802|NCT01062256|530137104|FG001|Overall Study|Administrative|2|||
146992803|NCT01062256|530137105|FG002|Overall Study|Administrative|0|||
146992804|NCT03049488|530137106|FG000|Overall Study|Lost to Follow-up|1|||
146992805|NCT03049488|530137107|FG001|Overall Study|Lost to Follow-up|1|||
146992806|NCT03049488|530137108|FG002|Overall Study|Lost to Follow-up|0|||
146992807|NCT03049488|530137109|FG003|Overall Study|Lost to Follow-up|0|||
146992808|NCT03049488|530137110|FG004|Overall Study|Lost to Follow-up|0|||
146992809|NCT03049488|530137111|FG005|Overall Study|Lost to Follow-up|0|||
146992810|NCT03049488|530137106|FG000|Overall Study|Moved from Area|1|||
146992811|NCT03049488|530137107|FG001|Overall Study|Moved from Area|0|||
146992812|NCT03049488|530137108|FG002|Overall Study|Moved from Area|0|||
146992813|NCT03049488|530137109|FG003|Overall Study|Moved from Area|1|||
146992814|NCT03049488|530137110|FG004|Overall Study|Moved from Area|1|||
146992815|NCT03049488|530137111|FG005|Overall Study|Moved from Area|0|||
146992816|NCT03049488|530137106|FG000|Overall Study|Physician Decision|0|||
146992817|NCT03049488|530137107|FG001|Overall Study|Physician Decision|1|||
146992818|NCT03049488|530137108|FG002|Overall Study|Physician Decision|0|||
146992819|NCT03049488|530137109|FG003|Overall Study|Physician Decision|0|||
146992820|NCT03049488|530137110|FG004|Overall Study|Physician Decision|0|||
146992821|NCT03049488|530137111|FG005|Overall Study|Physician Decision|0|||
146992822|NCT03049488|530137106|FG000|Overall Study|Withdrawal by Subject|0|||
146839720|NCT05000216|529584646|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
146839721|NCT05000216|529584647|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
146839722|NCT05000216|529584648|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
146839723|NCT05000216|529584649|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
146992823|NCT03049488|530137107|FG001|Overall Study|Withdrawal by Subject|0|||
146992824|NCT03049488|530137108|FG002|Overall Study|Withdrawal by Subject|0|||
146992825|NCT03049488|530137109|FG003|Overall Study|Withdrawal by Subject|1|||
146992826|NCT03049488|530137110|FG004|Overall Study|Withdrawal by Subject|1|||
146992827|NCT03049488|530137111|FG005|Overall Study|Withdrawal by Subject|0|||
146992828|NCT00891293|530137113|FG000|Overall Study|Adverse Event|2|||
146992829|NCT00891293|530137113|FG000|Overall Study|Protocol Violation|2|||
146992830|NCT00891293|530137113|FG000|Overall Study|Laboratory abnormality|4|||
146992831|NCT00891293|530137113|FG000|Overall Study|Lost to Follow-up|7|||
146992832|NCT00891293|530137113|FG000|Overall Study|Subject withdrew consent|7|||
146992833|NCT00891293|530137113|FG000|Overall Study|Sponsor termination|62|||
146992834|NCT01448057|530137114|FG000|Overall Study|Protocol Violation|3|||
146992835|NCT01448057|530137115|FG001|Overall Study|Protocol Violation|2|||
146992836|NCT01448057|530137114|FG000|Overall Study|Lost to Follow-up|3|||
146992837|NCT01448057|530137115|FG001|Overall Study|Lost to Follow-up|0|||
146992838|NCT01448057|530137114|FG000|Overall Study|Adverse Event|0|||
146992839|NCT01448057|530137115|FG001|Overall Study|Adverse Event|2|||
146992840|NCT01448057|530137114|FG000|Overall Study|Withdrawal by Subject|2|||
146992841|NCT01448057|530137115|FG001|Overall Study|Withdrawal by Subject|0|||
146992842|NCT03912337|530137131|FG000|Overall Study|Withdrawal of Consent From Study|1|||
146992843|NCT03912337|530137132|FG001|Overall Study|Withdrawal of Consent From Study|0|||
146992844|NCT03912337|530137131|FG000|Overall Study|Lost to Follow-up|1|||
146992845|NCT03912337|530137132|FG001|Overall Study|Lost to Follow-up|1|||
146992846|NCT00537030|530137133|FG000|Overall Study|Physician Decision|2|||
146992847|NCT00537030|530137133|FG000|Overall Study|Withdrawal by Subject|2|||
146992848|NCT00537030|530137133|FG000|Overall Study|≥ Grade 2 allergy|7|||
146992849|NCT00537030|530137133|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
146992850|NCT00537030|530137133|FG000|Overall Study|Ineligible|2|||
146992851|NCT00537030|530137133|FG000|Overall Study|Inevaluable|2|||
146992852|NCT01496183|530137135|FG000|Overall Study|Physician Decision|3|||
146992853|NCT01496183|530137136|FG001|Overall Study|Physician Decision|1|||
146992854|NCT01496183|530137135|FG000|Overall Study|Withdrawal by Subject|0|||
146992855|NCT01496183|530137136|FG001|Overall Study|Withdrawal by Subject|1|||
146992856|NCT03130699|530137137|FG000|Overall Study|Lost to Follow-up|34|||
146992857|NCT03130699|530137138|FG001|Overall Study|Lost to Follow-up|37|||
146992858|NCT03130699|530137139|FG002|Overall Study|Lost to Follow-up|26|||
146992859|NCT03130699|530137137|FG000|Overall Study|Withdrawal by Subject|5|||
146992860|NCT03130699|530137138|FG001|Overall Study|Withdrawal by Subject|1|||
146992861|NCT03130699|530137139|FG002|Overall Study|Withdrawal by Subject|0|||
146992862|NCT03130699|530137137|FG000|Overall Study|Withdrawal by PI|1|||
146992863|NCT03130699|530137138|FG001|Overall Study|Withdrawal by PI|2|||
146992864|NCT03130699|530137139|FG002|Overall Study|Withdrawal by PI|5|||
146992865|NCT03130699|530137137|FG000|Overall Study|Death|0|||
146992866|NCT03130699|530137138|FG001|Overall Study|Death|0|||
146992867|NCT03130699|530137139|FG002|Overall Study|Death|1|||
146960108|NCT00501969|530014289|FG000|Overall Study|Lost to Follow-up|4|||
146960109|NCT00501969|530014289|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
146960110|NCT00501969|530014289|FG000|Overall Study|Other: Sponsors Request|10|||
146960111|NCT00501969|530014289|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
146960112|NCT00501969|530014289|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
146960113|NCT00501969|530014289|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
146960114|NCT00501969|530014289|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
146960115|NCT00501969|530014289|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
146960116|NCT00501969|530014289|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
146960117|NCT00501969|530014289|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
146960118|NCT00501969|530014289|FG000|Overall Study|Other: As Required by Local EC|2|||
146960119|NCT00501969|530014289|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
146960120|NCT00501969|530014289|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
146960121|NCT00665366|530014292|FG000|Overall Study|Lack of Efficacy|11|||
146960122|NCT00665366|530014293|FG001|Overall Study|Lack of Efficacy|10|||
146960123|NCT00665366|530014292|FG000|Overall Study|Adverse Event|25|||
146960124|NCT00665366|530014293|FG001|Overall Study|Adverse Event|23|||
146960125|NCT00665366|530014292|FG000|Overall Study|Withdrawal by Subject|11|||
146960126|NCT00665366|530014293|FG001|Overall Study|Withdrawal by Subject|14|||
146960127|NCT00665366|530014292|FG000|Overall Study|Lost to Follow-up|3|||
146960128|NCT00665366|530014293|FG001|Overall Study|Lost to Follow-up|5|||
146960129|NCT00665366|530014292|FG000|Overall Study|Poor compliance/noncompliance|3|||
146960130|NCT00665366|530014293|FG001|Overall Study|Poor compliance/noncompliance|5|||
146960131|NCT00665366|530014292|FG000|Overall Study|Pregnancy|1|||
146960132|NCT00665366|530014293|FG001|Overall Study|Pregnancy|0|||
146960133|NCT00665366|530014292|FG000|Overall Study|No longer meets study criteria|0|||
146960134|NCT00665366|530014293|FG001|Overall Study|No longer meets study criteria|1|||
146960135|NCT00665366|530014292|FG000|Overall Study|Other reasons|4|||
146960136|NCT00665366|530014293|FG001|Overall Study|Other reasons|1|||
146960137|NCT03778021|530014295|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
146960138|NCT03778021|530014296|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
146960139|NCT01545375|530014297|FG000|Overall Study|Adverse Event|2|||
146960140|NCT01545375|530014298|FG001|Overall Study|Adverse Event|1|||
146960141|NCT01545375|530014297|FG000|Overall Study|Lost to Follow-up|34|||
146960142|NCT01545375|530014298|FG001|Overall Study|Lost to Follow-up|31|||
146960143|NCT01545375|530014297|FG000|Overall Study|Protocol Violation|3|||
146960144|NCT01545375|530014298|FG001|Overall Study|Protocol Violation|3|||
146960145|NCT01545375|530014297|FG000|Overall Study|Withdrawal by Subject|58|||
146992868|NCT00669864|530137142|FG000|Overall Study|Lost to Follow-up|2|||
146992869|NCT00669864|530137142|FG000|Overall Study|Protocol Violation|2|||
146992870|NCT00669864|530137142|FG000|Overall Study|Withdrawal by Subject|3|||
146960146|NCT01545375|530014298|FG001|Overall Study|Withdrawal by Subject|55|||
146960147|NCT02687815|530014299|FG000|Overall Study|Lost to Follow-up|2|||
146992871|NCT00669864|530137142|FG000|Overall Study|Other|2|||
146992872|NCT06354270|530137145|FG000|Overall Study|Withdrawal by Subject|1|||
146992873|NCT06354270|530137146|FG001|Overall Study|Withdrawal by Subject|0|||
146992874|NCT00680121|530137147|FG000|Overall Study|Lost to Follow-up|27|||
146960148|NCT02687815|530014300|FG001|Overall Study|Lost to Follow-up|4|||
146960149|NCT02687815|530014299|FG000|Overall Study|Withdrawal by Subject|2|||
146960150|NCT02687815|530014300|FG001|Overall Study|Withdrawal by Subject|4|||
146960151|NCT04177862|530014301|FG000|Overall Study|Protocol Violation|2|||
146960152|NCT04177862|530014302|FG001|Overall Study|Protocol Violation|7|||
146960153|NCT05637515|530014307|FG000|Overall Study|Withdrawal by Subject|17|||
146960154|NCT05637515|530014308|FG001|Overall Study|Withdrawal by Subject|17|||
146960155|NCT00151775|530014309|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
146960156|NCT00151775|530014310|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
146960157|NCT00151775|530014311|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146960158|NCT00151775|530014312|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146960159|NCT00151775|530014313|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146960160|NCT00151775|530014314|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146960161|NCT00151775|530014315|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146960162|NCT00151775|530014316|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146960163|NCT00151775|530014317|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146960164|NCT00151775|530014318|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146960165|NCT00151775|530014319|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146960166|NCT00151775|530014320|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146960167|NCT00151775|530014309|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
146960168|NCT00151775|530014310|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146960169|NCT00151775|530014311|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146960170|NCT00151775|530014312|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146960171|NCT00151775|530014313|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146960172|NCT00151775|530014314|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146960173|NCT00151775|530014315|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
146960174|NCT00151775|530014316|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146960175|NCT00151775|530014317|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146960176|NCT00151775|530014318|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146960177|NCT00151775|530014319|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
146960178|NCT00151775|530014320|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146960179|NCT00151775|530014309|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146960180|NCT00151775|530014310|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
146960181|NCT00151775|530014311|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146960182|NCT00151775|530014312|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146960183|NCT00151775|530014313|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146960184|NCT00151775|530014314|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146960185|NCT00151775|530014315|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146960186|NCT00151775|530014316|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146960187|NCT00151775|530014317|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146960188|NCT00151775|530014318|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146960189|NCT00151775|530014319|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146960190|NCT00151775|530014320|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146960191|NCT00151775|530014309|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
146960192|NCT00151775|530014310|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
146960193|NCT00151775|530014311|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
146960194|NCT00151775|530014312|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
146960195|NCT00151775|530014313|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
146960196|NCT00151775|530014314|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
146960197|NCT00151775|530014315|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
146960198|NCT00151775|530014316|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
146960199|NCT00151775|530014317|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
146960200|NCT00151775|530014318|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
146960201|NCT00151775|530014319|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
146960202|NCT00151775|530014320|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
146960203|NCT00151775|530014309|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146960204|NCT00151775|530014310|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146960205|NCT00151775|530014311|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146960206|NCT00151775|530014312|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146960207|NCT00151775|530014313|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146960208|NCT00151775|530014314|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
146960209|NCT00151775|530014315|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146960210|NCT00151775|530014316|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146960211|NCT00151775|530014317|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146960212|NCT00151775|530014318|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146960213|NCT00151775|530014319|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146992875|NCT00680121|530137148|FG001|Overall Study|Lost to Follow-up|23|||
146992876|NCT00162123|530137149|FG000|Overall Study|Disease progression|27|||
146960214|NCT00151775|530014320|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146960215|NCT00151775|530014309|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146960216|NCT00151775|530014310|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146960217|NCT00151775|530014311|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146960218|NCT00151775|530014312|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146960219|NCT00151775|530014313|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146960220|NCT00151775|530014314|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
146960221|NCT00151775|530014315|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146960222|NCT00151775|530014316|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146960223|NCT00151775|530014317|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146960224|NCT00151775|530014318|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146960225|NCT00151775|530014319|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146960226|NCT00151775|530014320|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146960227|NCT00151775|530014309|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146960228|NCT00151775|530014310|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146960229|NCT00151775|530014311|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146960230|NCT00151775|530014312|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146960231|NCT00151775|530014313|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146960232|NCT00151775|530014314|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146960233|NCT00151775|530014315|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
146960234|NCT00151775|530014316|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146960235|NCT00151775|530014317|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146960236|NCT00151775|530014318|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146960237|NCT00151775|530014319|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146960238|NCT00151775|530014320|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146960239|NCT00151775|530014309|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146960240|NCT00151775|530014310|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146960241|NCT00151775|530014311|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146960242|NCT00151775|530014312|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146960243|NCT00151775|530014313|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146960244|NCT00151775|530014314|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
146960245|NCT00151775|530014315|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146960246|NCT00151775|530014316|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146960247|NCT00151775|530014317|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146960248|NCT00151775|530014318|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146960249|NCT00151775|530014319|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146960250|NCT00151775|530014320|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146960251|NCT00151775|530014309|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
146960252|NCT00151775|530014310|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
146960253|NCT00151775|530014311|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
146960254|NCT00151775|530014312|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
146960255|NCT00151775|530014313|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
146960256|NCT00151775|530014314|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
146960257|NCT00151775|530014315|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
146960258|NCT00151775|530014316|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
146960259|NCT00151775|530014317|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
146960260|NCT00151775|530014318|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
146960261|NCT00151775|530014319|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
146960262|NCT00151775|530014320|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
146960263|NCT00151775|530014309|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146960264|NCT00151775|530014310|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146960265|NCT00151775|530014311|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146960266|NCT00151775|530014312|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146960267|NCT00151775|530014313|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146960268|NCT00151775|530014314|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146960269|NCT00151775|530014315|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
146960270|NCT00151775|530014316|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146960271|NCT00151775|530014317|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146960272|NCT00151775|530014318|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146960273|NCT00151775|530014319|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146960274|NCT00151775|530014320|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146960275|NCT00151775|530014309|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146960276|NCT00151775|530014310|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146992877|NCT00162123|530137150|FG001|Overall Study|Disease progression|19|||
146992878|NCT00162123|530137151|FG002|Overall Study|Disease progression|10|||
146992879|NCT00162123|530137152|FG003|Overall Study|Disease progression|4|||
146992880|NCT00162123|530137153|FG004|Overall Study|Disease progression|8|||
146992881|NCT00162123|530137154|FG005|Overall Study|Disease progression|3|||
146992882|NCT00162123|530137155|FG006|Overall Study|Disease progression|1|||
146992883|NCT00162123|530137156|FG007|Overall Study|Disease progression|0|||
146992884|NCT00162123|530137149|FG000|Overall Study|Study drug toxicity|6|||
146992885|NCT00162123|530137150|FG001|Overall Study|Study drug toxicity|1|||
146992886|NCT00162123|530137151|FG002|Overall Study|Study drug toxicity|5|||
146992887|NCT00162123|530137152|FG003|Overall Study|Study drug toxicity|0|||
146992888|NCT00162123|530137153|FG004|Overall Study|Study drug toxicity|4|||
146992889|NCT00162123|530137154|FG005|Overall Study|Study drug toxicity|1|||
146992890|NCT00162123|530137155|FG006|Overall Study|Study drug toxicity|1|||
146992891|NCT00162123|530137156|FG007|Overall Study|Study drug toxicity|0|||
146992892|NCT00162123|530137149|FG000|Overall Study|Death|3|||
146992893|NCT00162123|530137150|FG001|Overall Study|Death|3|||
146992894|NCT00162123|530137151|FG002|Overall Study|Death|1|||
146992895|NCT00162123|530137152|FG003|Overall Study|Death|1|||
146992896|NCT00162123|530137153|FG004|Overall Study|Death|1|||
146992897|NCT00162123|530137154|FG005|Overall Study|Death|1|||
146992898|NCT00162123|530137155|FG006|Overall Study|Death|0|||
146992899|NCT00162123|530137156|FG007|Overall Study|Death|0|||
146992900|NCT00162123|530137149|FG000|Overall Study|Withdrawal by Subject|2|||
146992901|NCT00162123|530137150|FG001|Overall Study|Withdrawal by Subject|0|||
146992902|NCT00162123|530137151|FG002|Overall Study|Withdrawal by Subject|2|||
146992903|NCT00162123|530137152|FG003|Overall Study|Withdrawal by Subject|1|||
146992904|NCT00162123|530137153|FG004|Overall Study|Withdrawal by Subject|1|||
146992905|NCT00162123|530137154|FG005|Overall Study|Withdrawal by Subject|2|||
146992906|NCT00162123|530137155|FG006|Overall Study|Withdrawal by Subject|1|||
146992907|NCT00162123|530137156|FG007|Overall Study|Withdrawal by Subject|0|||
146992908|NCT00162123|530137149|FG000|Overall Study|Deterioration without progression|2|||
146839724|NCT05000216|529584650|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
146960277|NCT00151775|530014311|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
146960278|NCT00151775|530014312|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146960279|NCT00151775|530014313|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146960280|NCT00151775|530014314|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146960281|NCT00151775|530014315|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146960282|NCT00151775|530014316|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146960283|NCT00151775|530014317|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146960284|NCT00151775|530014318|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146960285|NCT00151775|530014319|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146960286|NCT00151775|530014320|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146960287|NCT00151775|530014309|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146960288|NCT00151775|530014310|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146960289|NCT00151775|530014311|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
146960290|NCT00151775|530014312|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146960291|NCT00151775|530014313|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146960292|NCT00151775|530014314|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146960293|NCT00151775|530014315|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146960294|NCT00151775|530014316|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146960295|NCT00151775|530014317|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146960296|NCT00151775|530014318|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146960297|NCT00151775|530014319|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146960298|NCT00151775|530014320|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146960299|NCT00151775|530014309|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146960300|NCT00151775|530014310|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146960301|NCT00151775|530014311|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146960302|NCT00151775|530014312|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146839725|NCT05000216|529584651|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
146839726|NCT05000216|529584652|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
146839727|NCT05000216|529584631|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146839728|NCT05000216|529584632|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146839729|NCT05000216|529584633|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146839730|NCT05000216|529584634|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146839731|NCT05000216|529584635|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146839732|NCT05000216|529584636|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146960303|NCT00151775|530014313|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146960304|NCT00151775|530014314|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146992909|NCT00162123|530137150|FG001|Overall Study|Deterioration without progression|2|||
146992910|NCT00162123|530137151|FG002|Overall Study|Deterioration without progression|3|||
146992911|NCT00162123|530137152|FG003|Overall Study|Deterioration without progression|0|||
146992912|NCT00162123|530137153|FG004|Overall Study|Deterioration without progression|1|||
146992913|NCT00162123|530137154|FG005|Overall Study|Deterioration without progression|0|||
146992914|NCT00162123|530137155|FG006|Overall Study|Deterioration without progression|0|||
146839733|NCT05000216|529584637|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146839734|NCT05000216|529584638|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146839735|NCT05000216|529584639|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146839736|NCT05000216|529584640|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146960305|NCT00151775|530014315|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146960306|NCT00151775|530014316|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146960307|NCT00151775|530014317|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146960308|NCT00151775|530014318|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146960309|NCT00151775|530014319|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146960310|NCT00151775|530014320|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
146960311|NCT00151775|530014309|FG000|Period 4: Open Label|Increased blood pressure|0|||
146960312|NCT00151775|530014310|FG001|Period 4: Open Label|Increased blood pressure|0|||
146960313|NCT00151775|530014311|FG002|Period 4: Open Label|Increased blood pressure|0|||
146960314|NCT00151775|530014312|FG003|Period 4: Open Label|Increased blood pressure|0|||
146960315|NCT00151775|530014313|FG004|Period 4: Open Label|Increased blood pressure|1|||
146960316|NCT00151775|530014314|FG005|Period 4: Open Label|Increased blood pressure|0|||
146960317|NCT00151775|530014315|FG006|Period 4: Open Label|Increased blood pressure|0|||
146960318|NCT00151775|530014316|FG007|Period 4: Open Label|Increased blood pressure|0|||
146960319|NCT00151775|530014317|FG008|Period 4: Open Label|Increased blood pressure|0|||
146960320|NCT00151775|530014318|FG009|Period 4: Open Label|Increased blood pressure|1|||
146960321|NCT00151775|530014319|FG010|Period 4: Open Label|Increased blood pressure|0|||
146960322|NCT00151775|530014320|FG011|Period 4: Open Label|Increased blood pressure|0|||
146960323|NCT00151775|530014309|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
146960324|NCT00151775|530014310|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
146960325|NCT00151775|530014311|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
146960326|NCT00151775|530014312|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
146960327|NCT00151775|530014313|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
146960328|NCT00151775|530014314|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
146960329|NCT00151775|530014315|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
146960330|NCT00151775|530014316|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
146960331|NCT00151775|530014317|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
146960332|NCT00151775|530014318|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
146960333|NCT00151775|530014319|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
146960334|NCT00151775|530014320|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
146960335|NCT00151775|530014309|FG000|Period 4: Open Label|Adverse Event|0|||
146960336|NCT00151775|530014310|FG001|Period 4: Open Label|Adverse Event|0|||
146960337|NCT00151775|530014311|FG002|Period 4: Open Label|Adverse Event|0|||
146960338|NCT00151775|530014312|FG003|Period 4: Open Label|Adverse Event|0|||
146960339|NCT00151775|530014313|FG004|Period 4: Open Label|Adverse Event|1|||
146960340|NCT00151775|530014314|FG005|Period 4: Open Label|Adverse Event|0|||
146960341|NCT00151775|530014315|FG006|Period 4: Open Label|Adverse Event|0|||
146960342|NCT00151775|530014316|FG007|Period 4: Open Label|Adverse Event|0|||
146960343|NCT00151775|530014317|FG008|Period 4: Open Label|Adverse Event|0|||
146960344|NCT00151775|530014318|FG009|Period 4: Open Label|Adverse Event|2|||
146960345|NCT00151775|530014319|FG010|Period 4: Open Label|Adverse Event|0|||
146960346|NCT00151775|530014320|FG011|Period 4: Open Label|Adverse Event|0|||
146960347|NCT00151775|530014309|FG000|Period 4: Open Label|Lost to Follow-up|0|||
146960348|NCT00151775|530014310|FG001|Period 4: Open Label|Lost to Follow-up|0|||
146960349|NCT00151775|530014311|FG002|Period 4: Open Label|Lost to Follow-up|0|||
146960350|NCT00151775|530014312|FG003|Period 4: Open Label|Lost to Follow-up|0|||
146960351|NCT00151775|530014313|FG004|Period 4: Open Label|Lost to Follow-up|17|||
146960352|NCT00151775|530014314|FG005|Period 4: Open Label|Lost to Follow-up|0|||
146960353|NCT00151775|530014315|FG006|Period 4: Open Label|Lost to Follow-up|0|||
146960354|NCT00151775|530014316|FG007|Period 4: Open Label|Lost to Follow-up|0|||
146960355|NCT00151775|530014317|FG008|Period 4: Open Label|Lost to Follow-up|0|||
146960356|NCT00151775|530014318|FG009|Period 4: Open Label|Lost to Follow-up|7|||
146960357|NCT00151775|530014319|FG010|Period 4: Open Label|Lost to Follow-up|0|||
146960358|NCT00151775|530014320|FG011|Period 4: Open Label|Lost to Follow-up|0|||
146960359|NCT00151775|530014309|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
146960360|NCT00151775|530014310|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
146960361|NCT00151775|530014311|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
146960362|NCT00151775|530014312|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
146960363|NCT00151775|530014313|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
146960364|NCT00151775|530014314|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
146960365|NCT00151775|530014315|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
146960366|NCT00151775|530014316|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
146960367|NCT00151775|530014317|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
146960368|NCT00151775|530014318|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
146960369|NCT00151775|530014319|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
146960370|NCT00151775|530014320|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
146839737|NCT05000216|529584641|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146992915|NCT00162123|530137156|FG007|Overall Study|Deterioration without progression|0|||
146992916|NCT00162123|530137149|FG000|Overall Study|Adverse Event|1|||
146992917|NCT00162123|530137150|FG001|Overall Study|Adverse Event|2|||
146992918|NCT00162123|530137151|FG002|Overall Study|Adverse Event|0|||
146992919|NCT00162123|530137152|FG003|Overall Study|Adverse Event|2|||
146992920|NCT00162123|530137153|FG004|Overall Study|Adverse Event|1|||
146992921|NCT00162123|530137154|FG005|Overall Study|Adverse Event|0|||
146992922|NCT00162123|530137155|FG006|Overall Study|Adverse Event|0|||
146992923|NCT00162123|530137156|FG007|Overall Study|Adverse Event|0|||
146992924|NCT00162123|530137149|FG000|Overall Study|Not specified (before treatment)|2|||
146992925|NCT00162123|530137150|FG001|Overall Study|Not specified (before treatment)|0|||
146992926|NCT00162123|530137151|FG002|Overall Study|Not specified (before treatment)|0|||
146992927|NCT00162123|530137152|FG003|Overall Study|Not specified (before treatment)|0|||
146992928|NCT00162123|530137153|FG004|Overall Study|Not specified (before treatment)|12|||
146992929|NCT00162123|530137154|FG005|Overall Study|Not specified (before treatment)|1|||
146992930|NCT00162123|530137155|FG006|Overall Study|Not specified (before treatment)|0|||
146992931|NCT00162123|530137156|FG007|Overall Study|Not specified (before treatment)|0|||
146992932|NCT00162123|530137149|FG000|Overall Study|Not specified (after start of treatment)|0|||
146992933|NCT00162123|530137150|FG001|Overall Study|Not specified (after start of treatment)|0|||
146992934|NCT00162123|530137151|FG002|Overall Study|Not specified (after start of treatment)|0|||
146992935|NCT00162123|530137152|FG003|Overall Study|Not specified (after start of treatment)|0|||
146992936|NCT00162123|530137153|FG004|Overall Study|Not specified (after start of treatment)|3|||
146992937|NCT00162123|530137154|FG005|Overall Study|Not specified (after start of treatment)|0|||
146992938|NCT00162123|530137155|FG006|Overall Study|Not specified (after start of treatment)|0|||
146992939|NCT00162123|530137156|FG007|Overall Study|Not specified (after start of treatment)|0|||
146992940|NCT00162123|530137149|FG000|Overall Study|Physician Decision|1|||
146992941|NCT00162123|530137150|FG001|Overall Study|Physician Decision|2|||
146992942|NCT00162123|530137151|FG002|Overall Study|Physician Decision|0|||
146992943|NCT00162123|530137152|FG003|Overall Study|Physician Decision|0|||
146992944|NCT00162123|530137153|FG004|Overall Study|Physician Decision|0|||
146992945|NCT00162123|530137154|FG005|Overall Study|Physician Decision|1|||
146992946|NCT00162123|530137155|FG006|Overall Study|Physician Decision|1|||
146992947|NCT00162123|530137156|FG007|Overall Study|Physician Decision|0|||
146992948|NCT00162123|530137149|FG000|Overall Study|Tumor assessment only (not treated)|0|||
146992949|NCT00162123|530137150|FG001|Overall Study|Tumor assessment only (not treated)|0|||
146992950|NCT00162123|530137151|FG002|Overall Study|Tumor assessment only (not treated)|0|||
146992951|NCT00162123|530137152|FG003|Overall Study|Tumor assessment only (not treated)|0|||
146992952|NCT00162123|530137153|FG004|Overall Study|Tumor assessment only (not treated)|0|||
146992953|NCT00162123|530137154|FG005|Overall Study|Tumor assessment only (not treated)|0|||
146992954|NCT00162123|530137155|FG006|Overall Study|Tumor assessment only (not treated)|0|||
146992955|NCT00162123|530137156|FG007|Overall Study|Tumor assessment only (not treated)|1|||
146992956|NCT00162123|530137149|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
146992957|NCT00162123|530137150|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
146992958|NCT00162123|530137151|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
146992959|NCT00162123|530137152|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
146992960|NCT00162123|530137153|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
146992961|NCT00162123|530137154|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
146992962|NCT00162123|530137155|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
146992963|NCT00162123|530137156|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
146992964|NCT02016170|530137157|FG000|Overall Study|Adverse Event|1|||
146992965|NCT02016170|530137158|FG001|Overall Study|Adverse Event|1|||
146992966|NCT02016170|530137159|FG002|Overall Study|Adverse Event|0|||
146992967|NCT02016170|530137157|FG000|Overall Study|Protocol Violation|1|||
146992968|NCT02016170|530137158|FG001|Overall Study|Protocol Violation|0|||
146992969|NCT02016170|530137159|FG002|Overall Study|Protocol Violation|0|||
146992970|NCT02365207|530137163|FG000|Overall Study|Withdrawal by Subject|1|||
146992971|NCT02365207|530137163|FG000|Overall Study|Physician Decision|1|||
146992972|NCT01936948|530137164|FG000|Overall Study|no 30-day follow-up data|0|||
146992973|NCT01936948|530137165|FG001|Overall Study|no 30-day follow-up data|3|||
146992974|NCT01936948|530137166|FG002|Overall Study|no 30-day follow-up data|3|||
146992975|NCT01936948|530137167|FG003|Overall Study|no 30-day follow-up data|3|||
146992976|NCT01395030|530137168|FG000|Overall Study|Did not complete FCH PET/CT|7|||
146992977|NCT01606306|530137171|FG000|Overall Study|Lack of Efficacy|2|||
146992978|NCT01606306|530137172|FG001|Overall Study|Lack of Efficacy|1|||
146992979|NCT01606306|530137173|FG002|Overall Study|Lack of Efficacy|4|||
146992980|NCT01606306|530137174|FG003|Overall Study|Lack of Efficacy|4|||
146992981|NCT01606306|530137175|FG004|Overall Study|Lack of Efficacy|1|||
146992982|NCT01606306|530137176|FG005|Overall Study|Lack of Efficacy|2|||
146992983|NCT01606306|530137171|FG000|Overall Study|Adverse Event|1|||
146992984|NCT01606306|530137172|FG001|Overall Study|Adverse Event|0|||
146992985|NCT01606306|530137173|FG002|Overall Study|Adverse Event|1|||
146992986|NCT01606306|530137174|FG003|Overall Study|Adverse Event|1|||
146992987|NCT01606306|530137175|FG004|Overall Study|Adverse Event|2|||
146992988|NCT01606306|530137176|FG005|Overall Study|Adverse Event|0|||
146960371|NCT00151775|530014309|FG000|Period 4: Open Label|Other|0|||
146960372|NCT00151775|530014310|FG001|Period 4: Open Label|Other|0|||
146960373|NCT00151775|530014311|FG002|Period 4: Open Label|Other|0|||
146960374|NCT00151775|530014312|FG003|Period 4: Open Label|Other|0|||
146960375|NCT00151775|530014313|FG004|Period 4: Open Label|Other|1|||
146960376|NCT00151775|530014314|FG005|Period 4: Open Label|Other|0|||
146960377|NCT00151775|530014315|FG006|Period 4: Open Label|Other|0|||
146960378|NCT00151775|530014316|FG007|Period 4: Open Label|Other|0|||
146960379|NCT00151775|530014317|FG008|Period 4: Open Label|Other|0|||
146960380|NCT00151775|530014318|FG009|Period 4: Open Label|Other|3|||
146960381|NCT00151775|530014319|FG010|Period 4: Open Label|Other|0|||
146960382|NCT00151775|530014320|FG011|Period 4: Open Label|Other|0|||
146960383|NCT00151775|530014309|FG000|Period 4: Open Label|Physician Decision|0|||
146960384|NCT00151775|530014310|FG001|Period 4: Open Label|Physician Decision|0|||
146960385|NCT00151775|530014311|FG002|Period 4: Open Label|Physician Decision|0|||
146960386|NCT00151775|530014312|FG003|Period 4: Open Label|Physician Decision|0|||
146960387|NCT00151775|530014313|FG004|Period 4: Open Label|Physician Decision|0|||
146960388|NCT00151775|530014314|FG005|Period 4: Open Label|Physician Decision|0|||
146960389|NCT00151775|530014315|FG006|Period 4: Open Label|Physician Decision|0|||
146960390|NCT00151775|530014316|FG007|Period 4: Open Label|Physician Decision|0|||
146960391|NCT00151775|530014317|FG008|Period 4: Open Label|Physician Decision|0|||
146960392|NCT00151775|530014318|FG009|Period 4: Open Label|Physician Decision|2|||
146960393|NCT00151775|530014319|FG010|Period 4: Open Label|Physician Decision|0|||
146960394|NCT00151775|530014320|FG011|Period 4: Open Label|Physician Decision|0|||
146960395|NCT00151775|530014309|FG000|Period 4: Open Label|Protocol Violation|0|||
146960396|NCT00151775|530014310|FG001|Period 4: Open Label|Protocol Violation|0|||
146960397|NCT00151775|530014311|FG002|Period 4: Open Label|Protocol Violation|0|||
146960398|NCT00151775|530014312|FG003|Period 4: Open Label|Protocol Violation|0|||
146960399|NCT00151775|530014313|FG004|Period 4: Open Label|Protocol Violation|1|||
146960400|NCT00151775|530014314|FG005|Period 4: Open Label|Protocol Violation|0|||
146960401|NCT00151775|530014315|FG006|Period 4: Open Label|Protocol Violation|0|||
146960402|NCT00151775|530014316|FG007|Period 4: Open Label|Protocol Violation|0|||
146960403|NCT00151775|530014317|FG008|Period 4: Open Label|Protocol Violation|0|||
146960404|NCT00151775|530014318|FG009|Period 4: Open Label|Protocol Violation|0|||
146960405|NCT00151775|530014319|FG010|Period 4: Open Label|Protocol Violation|0|||
146960406|NCT00151775|530014320|FG011|Period 4: Open Label|Protocol Violation|0|||
146960407|NCT04516291|530014321|FG000|Treatment Period (24 Weeks)|Other|1|||
146960408|NCT04516291|530014322|FG001|Treatment Period (24 Weeks)|Other|0|||
146960409|NCT04516291|530014323|FG002|Treatment Period (24 Weeks)|Other|0|||
146960410|NCT04516291|530014324|FG003|Treatment Period (24 Weeks)|Other|2|||
146960411|NCT04516291|530014325|FG004|Treatment Period (24 Weeks)|Other|2|||
146960412|NCT04516291|530014326|FG005|Treatment Period (24 Weeks)|Other|4|||
146960413|NCT04516291|530014327|FG006|Treatment Period (24 Weeks)|Other|2|||
146960414|NCT04516291|530014328|FG007|Treatment Period (24 Weeks)|Other|0|||
146960415|NCT04516291|530014321|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146960416|NCT04516291|530014322|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
146960417|NCT04516291|530014323|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
146960418|NCT04516291|530014324|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146960419|NCT04516291|530014325|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
146960420|NCT04516291|530014326|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146960421|NCT04516291|530014327|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146960422|NCT04516291|530014328|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146960423|NCT04516291|530014321|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
146960424|NCT04516291|530014322|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
146960425|NCT04516291|530014323|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
146960426|NCT04516291|530014324|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
146960427|NCT04516291|530014325|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
146960428|NCT04516291|530014326|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
146960429|NCT04516291|530014327|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
146960430|NCT04516291|530014328|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
146960431|NCT04516291|530014321|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146960432|NCT04516291|530014322|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146960433|NCT04516291|530014323|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146960434|NCT04516291|530014324|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146960435|NCT04516291|530014325|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146960436|NCT04516291|530014326|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146960437|NCT04516291|530014327|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146960438|NCT04516291|530014328|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146960439|NCT04516291|530014321|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
146960440|NCT04516291|530014322|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
146960441|NCT04516291|530014323|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
146960442|NCT04516291|530014324|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
146960443|NCT04516291|530014325|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
146960444|NCT04516291|530014326|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
146960445|NCT04516291|530014327|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
146992989|NCT01606306|530137171|FG000|Overall Study|Lost to Follow-up|7|||
146992990|NCT01606306|530137172|FG001|Overall Study|Lost to Follow-up|4|||
146992991|NCT01606306|530137173|FG002|Overall Study|Lost to Follow-up|5|||
146992992|NCT01606306|530137174|FG003|Overall Study|Lost to Follow-up|4|||
146992993|NCT01606306|530137175|FG004|Overall Study|Lost to Follow-up|3|||
146992994|NCT01606306|530137176|FG005|Overall Study|Lost to Follow-up|5|||
146992995|NCT01606306|530137171|FG000|Overall Study|Withdrawal by Subject|4|||
146992996|NCT01606306|530137172|FG001|Overall Study|Withdrawal by Subject|3|||
146992997|NCT01606306|530137173|FG002|Overall Study|Withdrawal by Subject|4|||
146992998|NCT01606306|530137174|FG003|Overall Study|Withdrawal by Subject|4|||
146992999|NCT01606306|530137175|FG004|Overall Study|Withdrawal by Subject|5|||
146993000|NCT01606306|530137176|FG005|Overall Study|Withdrawal by Subject|4|||
146993001|NCT01606306|530137171|FG000|Overall Study|Physician Decision|1|||
146993002|NCT01606306|530137172|FG001|Overall Study|Physician Decision|2|||
146993003|NCT01606306|530137173|FG002|Overall Study|Physician Decision|0|||
146993004|NCT01606306|530137174|FG003|Overall Study|Physician Decision|0|||
146993005|NCT01606306|530137175|FG004|Overall Study|Physician Decision|0|||
146993006|NCT01606306|530137176|FG005|Overall Study|Physician Decision|0|||
146993007|NCT00950872|530137179|FG000|Overall Study|Withdrawal by Subject|1|||
146993008|NCT00950872|530137179|FG000|Overall Study|Did not have surgery|2|||
146993009|NCT00408902|530137182|FG000|Overall Study|Lack of Efficacy|7|||
146993010|NCT00408902|530137182|FG000|Overall Study|Adverse Event|3|||
146993011|NCT00970281|530137183|FG000|Overall Study|Lack of Efficacy|1|||
146993012|NCT00970281|530137184|FG001|Overall Study|Lack of Efficacy|14|||
146993013|NCT00970281|530137183|FG000|Overall Study|Withdrawal by Subject|0|||
146993014|NCT00970281|530137184|FG001|Overall Study|Withdrawal by Subject|1|||
146993015|NCT00970281|530137183|FG000|Overall Study|Physician Decision|1|||
146993016|NCT00970281|530137184|FG001|Overall Study|Physician Decision|1|||
146993017|NCT01759290|530137185|FG000|Overall Study|Subjects withdrawn consent|5|||
146993018|NCT01759290|530137185|FG000|Overall Study|Physician Decision|2|||
146993019|NCT01759290|530137185|FG000|Overall Study|Death|17|||
146993020|NCT01759290|530137185|FG000|Overall Study|Lost to Follow-up|53|||
146993021|NCT01759290|530137185|FG000|Overall Study|Unknown reason|4|||
146993022|NCT00841100|530137186|FG000|Phase 1 (28 Days)|Adverse Event|1|||
146993023|NCT00841100|530137186|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
146993024|NCT03338972|530137187|FG000|Overall Study|Death|1|||
146993025|NCT03338972|530137188|FG001|Overall Study|Death|1|||
146993026|NCT03338972|530137189|FG002|Overall Study|Death|0|||
146993027|NCT03338972|530137190|FG003|Overall Study|Death|0|||
146993028|NCT03338972|530137187|FG000|Overall Study|Withdrawal by Subject|1|||
146993029|NCT03338972|530137188|FG001|Overall Study|Withdrawal by Subject|0|||
146993030|NCT03338972|530137189|FG002|Overall Study|Withdrawal by Subject|0|||
146993031|NCT03338972|530137190|FG003|Overall Study|Withdrawal by Subject|0|||
146993032|NCT03629249|530137191|FG000|Overall Study|Study terminated by sponsor|197|||
146993033|NCT03629249|530137192|FG001|Overall Study|Study terminated by sponsor|197|||
146993034|NCT03629249|530137193|FG002|Overall Study|Study terminated by sponsor|194|||
146993035|NCT03629249|530137191|FG000|Overall Study|Protocol deviation|0|||
146993036|NCT03629249|530137192|FG001|Overall Study|Protocol deviation|2|||
146993037|NCT03629249|530137193|FG002|Overall Study|Protocol deviation|5|||
146993038|NCT03629249|530137191|FG000|Overall Study|Subject decision|1|||
146993039|NCT03629249|530137192|FG001|Overall Study|Subject decision|1|||
146993040|NCT03629249|530137193|FG002|Overall Study|Subject decision|3|||
146993041|NCT03629249|530137191|FG000|Overall Study|Adverse Event|1|||
146993042|NCT03629249|530137192|FG001|Overall Study|Adverse Event|1|||
146993043|NCT03629249|530137193|FG002|Overall Study|Adverse Event|0|||
146993044|NCT03629249|530137191|FG000|Overall Study|Death|1|||
146993045|NCT03629249|530137192|FG001|Overall Study|Death|0|||
146993046|NCT03629249|530137193|FG002|Overall Study|Death|0|||
146993047|NCT03629249|530137191|FG000|Overall Study|Physician Decision|1|||
146993048|NCT03629249|530137192|FG001|Overall Study|Physician Decision|0|||
146993049|NCT03629249|530137193|FG002|Overall Study|Physician Decision|0|||
146993050|NCT00352690|530137194|FG000|Overall Study|Determined to be ineligible|2|||
146993051|NCT00352690|530137195|FG001|Overall Study|Determined to be ineligible|0|||
146993052|NCT03633721|530137200|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
146993053|NCT03633721|530137201|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
146993054|NCT03633721|530137202|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
146993055|NCT03633721|530137203|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
146993056|NCT01475474|530137207|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
146993057|NCT01475474|530137207|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
146993058|NCT05277389|530137208|FG000|Overall Study|Lost to Follow-up|1|||
146993059|NCT05277389|530137209|FG001|Overall Study|Lost to Follow-up|4|||
146993060|NCT03069937|530137210|FG000|Overall Study|Second primary malignancy noted|1|||
146993061|NCT06096168|530137211|FG000|Overall Study|Death|30|||
146993062|NCT06096168|530137211|FG000|Overall Study|Revision|2|||
146993063|NCT01046253|530137212|FG000|Second Intervention|Adverse Event|0|||
146993064|NCT01046253|530137213|FG001|Second Intervention|Adverse Event|1|||
146993065|NCT01046253|530137212|FG000|Second Intervention|Protocol Violation|0|||
146993066|NCT01046253|530137213|FG001|Second Intervention|Protocol Violation|1|||
146993067|NCT02339909|530137216|FG000|Overall Study|Became ineligible after randomisation|89|||
146993068|NCT02339909|530137217|FG001|Overall Study|Became ineligible after randomisation|63|||
146993069|NCT02339909|530137218|FG002|Overall Study|Became ineligible after randomisation|71|||
146993070|NCT01766778|530137223|FG000|Overall Study|Adverse Event|4|||
146993071|NCT01766778|530137224|FG001|Overall Study|Adverse Event|4|||
146993072|NCT01766778|530137223|FG000|Overall Study|Withdrawal by Subject|1|||
146993073|NCT01766778|530137224|FG001|Overall Study|Withdrawal by Subject|0|||
146993074|NCT01411332|530137225|FG000|Enrollment|Protocol Violation|0|||
146993075|NCT01411332|530137226|FG001|Enrollment|Protocol Violation|1|||
146993076|NCT01411332|530137225|FG000|Enrollment|Withdrawal by Subject|0|||
146993077|NCT01411332|530137226|FG001|Enrollment|Withdrawal by Subject|1|||
146993078|NCT01411332|530137225|FG000|Treatment|Lost to Follow-up|1|||
146993079|NCT01411332|530137226|FG001|Treatment|Lost to Follow-up|0|||
146993080|NCT02079532|530137227|FG000|Overall Study|Adverse Event|7|||
146993081|NCT02079532|530137227|FG000|Overall Study|Additional or changed therapy|2|||
146993082|NCT02079532|530137227|FG000|Overall Study|Lack of Efficacy|9|||
146993083|NCT02079532|530137227|FG000|Overall Study|Protocol Violation|3|||
146993084|NCT02079532|530137227|FG000|Overall Study|Withdrawal by Subject|1|||
146993085|NCT02079532|530137227|FG000|Overall Study|Administrative problems|1|||
146993086|NCT02079532|530137227|FG000|Overall Study|Inclusion into ReFIRST|3|||
146993087|NCT02079532|530137227|FG000|Overall Study|Other|3|||
146993088|NCT01432171|530137228|FG000|Overall Study|Death|1|||
146993089|NCT01432171|530137229|FG001|Overall Study|Death|2|||
146993090|NCT01432171|530137228|FG000|Overall Study|Lost to Follow-up|6|||
146993091|NCT01432171|530137229|FG001|Overall Study|Lost to Follow-up|5|||
146993092|NCT01432171|530137228|FG000|Overall Study|Withdrawal by Subject|3|||
146993093|NCT01432171|530137229|FG001|Overall Study|Withdrawal by Subject|1|||
146993094|NCT01432171|530137228|FG000|Overall Study|Noncompliance|2|||
146993095|NCT01432171|530137229|FG001|Overall Study|Noncompliance|3|||
146993096|NCT01432171|530137228|FG000|Overall Study|Insurance denial trial coverage|1|||
146993097|NCT01432171|530137229|FG001|Overall Study|Insurance denial trial coverage|0|||
146993098|NCT01432171|530137228|FG000|Overall Study|Patient moved to palliative care|1|||
146993099|NCT01432171|530137229|FG001|Overall Study|Patient moved to palliative care|0|||
146993100|NCT01519661|530138887|FG000|Overall Study|Protocol deviation|6|||
146993101|NCT01519661|530138887|FG000|Overall Study|Lost to Follow-up|3|||
146993102|NCT01519661|530138887|FG000|Overall Study|Withdrawal by Subject|17|||
146993103|NCT01519661|530138887|FG000|Overall Study|Lack of Efficacy|6|||
146993104|NCT01519661|530138887|FG000|Overall Study|Adverse Event|29|||
146993105|NCT01139047|530138888|FG000|Overall Study|Withdrawal by Subject|1|||
146993106|NCT00420303|530138889|FG000|Overall Study|Serious Adverse Event|1|||
146993107|NCT00420303|530138890|FG001|Overall Study|Serious Adverse Event|0|||
146993108|NCT00420303|530138889|FG000|Overall Study|Lack of Efficacy|0|||
146993109|NCT00420303|530138890|FG001|Overall Study|Lack of Efficacy|3|||
146993110|NCT00420303|530138889|FG000|Overall Study|Physician Decision|0|||
146993111|NCT00420303|530138890|FG001|Overall Study|Physician Decision|1|||
146993112|NCT00745420|530138891|FG000|Overall Study|Ineligible|1|||
146993113|NCT01941095|530138892|FG000|Overall Study|Insufficient therapeutic response|13|||
146993114|NCT01941095|530138892|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
146993115|NCT01941095|530138892|FG000|Overall Study|Adverse Event|11|||
146993116|NCT01941095|530138892|FG000|Overall Study|Physician Decision|3|||
146993117|NCT01941095|530138892|FG000|Overall Study|Withdrawal by Subject|17|||
146993118|NCT01941095|530138892|FG000|Overall Study|Lost to Follow-up|10|||
146993119|NCT00088829|530138900|FG000|Overall Study|PI left institution and study was close|22|||
146993120|NCT01475838|530138904|FG000|Randomized Phase|Randomized but Not Treated|0|||
146993121|NCT01475838|530138905|FG001|Randomized Phase|Randomized but Not Treated|5|||
146993122|NCT01475838|530138904|FG000|Randomized Phase|Adverse Event|6|||
146993123|NCT01475838|530138905|FG001|Randomized Phase|Adverse Event|1|||
146993124|NCT01475838|530138904|FG000|Randomized Phase|Pregnancy|0|||
146993125|NCT01475838|530138905|FG001|Randomized Phase|Pregnancy|1|||
146993126|NCT01475838|530138904|FG000|Randomized Phase|Investigators Discretion|1|||
146993127|NCT01475838|530138905|FG001|Randomized Phase|Investigators Discretion|2|||
146993128|NCT01475838|530138904|FG000|Randomized Phase|Withdrew Consent|10|||
146993129|NCT01475838|530138905|FG001|Randomized Phase|Withdrew Consent|14|||
146993130|NCT01475838|530138904|FG000|Randomized Phase|Lost to Follow-up|3|||
146839738|NCT05000216|529584642|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146839739|NCT05000216|529584643|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146993131|NCT01475838|530138905|FG001|Randomized Phase|Lost to Follow-up|4|||
146993132|NCT01475838|530138904|FG000|Randomized Phase|Participant Noncompliance|1|||
146993133|NCT01475838|530138905|FG001|Randomized Phase|Participant Noncompliance|5|||
146993134|NCT01475838|530138904|FG000|Randomized Phase|Protocol Violation|9|||
146993135|NCT01475838|530138905|FG001|Randomized Phase|Protocol Violation|4|||
146993136|NCT01475838|530138904|FG000|Extension Phase|Participant Noncompliance|1|||
146993137|NCT01475838|530138905|FG001|Extension Phase|Participant Noncompliance|0|||
146993138|NCT00048568|530138911|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
146993139|NCT00048568|530138912|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
146993140|NCT00048568|530138913|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
146993141|NCT00048568|530138911|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
146993142|NCT00048568|530138912|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
146993143|NCT00048568|530138913|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
146993144|NCT00048568|530138911|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
146993145|NCT00048568|530138912|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
146993146|NCT00048568|530138913|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
146993147|NCT00048568|530138911|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
146993148|NCT00048568|530138912|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
146993149|NCT00048568|530138913|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
146993150|NCT00048568|530138911|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
146993151|NCT00048568|530138912|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
146993152|NCT00048568|530138913|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
146993153|NCT00048568|530138911|FG000|Double-Blind Period Days 170 to 365|Death|1|||
146993154|NCT00048568|530138912|FG001|Double-Blind Period Days 170 to 365|Death|1|||
146993155|NCT00048568|530138913|FG002|Double-Blind Period Days 170 to 365|Death|0|||
146993156|NCT00048568|530138911|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
146993157|NCT00048568|530138912|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
146993158|NCT00048568|530138913|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
146993159|NCT00048568|530138911|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
146993160|NCT00048568|530138912|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
146993161|NCT00048568|530138913|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
146993162|NCT00048568|530138911|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
146993163|NCT00048568|530138912|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
146993164|NCT00048568|530138913|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
146993165|NCT00048568|530138911|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
146993166|NCT00048568|530138912|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
146993167|NCT00048568|530138913|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
146993168|NCT00048568|530138911|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
146993169|NCT00048568|530138912|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
146993170|NCT00048568|530138913|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
146993171|NCT00048568|530138911|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
146993172|NCT00048568|530138912|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
146993173|NCT00048568|530138913|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
146993174|NCT00048568|530138911|FG000|Open-Label Period|Death|0|||
146993175|NCT00048568|530138912|FG001|Open-Label Period|Death|0|||
146993176|NCT00048568|530138913|FG002|Open-Label Period|Death|13|||
146993177|NCT00048568|530138911|FG000|Open-Label Period|Adverse Event|0|||
146993178|NCT00048568|530138912|FG001|Open-Label Period|Adverse Event|0|||
146960446|NCT04516291|530014328|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
146960447|NCT04516291|530014321|FG000|Follow-up Period (12 Weeks)|Other|0|||
146960448|NCT04516291|530014322|FG001|Follow-up Period (12 Weeks)|Other|1|||
146960449|NCT04516291|530014323|FG002|Follow-up Period (12 Weeks)|Other|0|||
146960450|NCT04516291|530014324|FG003|Follow-up Period (12 Weeks)|Other|2|||
146960451|NCT04516291|530014325|FG004|Follow-up Period (12 Weeks)|Other|0|||
146960452|NCT04516291|530014326|FG005|Follow-up Period (12 Weeks)|Other|0|||
146960453|NCT04516291|530014327|FG006|Follow-up Period (12 Weeks)|Other|0|||
146960454|NCT04516291|530014328|FG007|Follow-up Period (12 Weeks)|Other|0|||
146960455|NCT04516291|530014321|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146960456|NCT04516291|530014322|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146960457|NCT04516291|530014323|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146960458|NCT04516291|530014324|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146960459|NCT04516291|530014325|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
146960460|NCT04516291|530014326|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146960461|NCT04516291|530014327|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146960462|NCT04516291|530014328|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146960463|NCT04516291|530014321|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
146960464|NCT04516291|530014322|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
146960465|NCT04516291|530014323|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
146960466|NCT04516291|530014324|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
146960467|NCT04516291|530014325|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
146960468|NCT04516291|530014326|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
146960469|NCT04516291|530014327|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
146960470|NCT04516291|530014328|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
146960471|NCT02158949|530014329|FG000|Overall Study|Withdrawal by Subject|1|||
146960472|NCT02158949|530014330|FG001|Overall Study|Withdrawal by Subject|0|||
146960473|NCT02158949|530014329|FG000|Overall Study|Lost to Follow-up|5|||
146960474|NCT02158949|530014330|FG001|Overall Study|Lost to Follow-up|11|||
146993179|NCT00048568|530138913|FG002|Open-Label Period|Adverse Event|49|||
146993180|NCT00048568|530138911|FG000|Open-Label Period|Lack of Efficacy|0|||
146993181|NCT00048568|530138912|FG001|Open-Label Period|Lack of Efficacy|0|||
146993182|NCT00048568|530138913|FG002|Open-Label Period|Lack of Efficacy|32|||
146993183|NCT00048568|530138911|FG000|Open-Label Period|Withdrawal by Subject|0|||
146993184|NCT00048568|530138912|FG001|Open-Label Period|Withdrawal by Subject|0|||
146993185|NCT00048568|530138913|FG002|Open-Label Period|Withdrawal by Subject|26|||
146993186|NCT00048568|530138911|FG000|Open-Label Period|Pregnancy|0|||
146993187|NCT00048568|530138912|FG001|Open-Label Period|Pregnancy|0|||
146993188|NCT00048568|530138913|FG002|Open-Label Period|Pregnancy|5|||
146993189|NCT00048568|530138911|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
146993190|NCT00048568|530138912|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
146993191|NCT00048568|530138913|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
146993192|NCT00048568|530138911|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
146993193|NCT00048568|530138912|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
146993194|NCT00048568|530138913|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
146993195|NCT00048568|530138911|FG000|Open-Label Period|Unknown Reasons|0|||
146993196|NCT00048568|530138912|FG001|Open-Label Period|Unknown Reasons|0|||
146993197|NCT00048568|530138913|FG002|Open-Label Period|Unknown Reasons|25|||
146993198|NCT00048568|530138911|FG000|Open-Label Period|Lost to Follow-up|0|||
146993199|NCT00048568|530138912|FG001|Open-Label Period|Lost to Follow-up|0|||
146993200|NCT00048568|530138913|FG002|Open-Label Period|Lost to Follow-up|7|||
146993201|NCT03831048|530138914|FG000|Overall Study|Protocol Violation|9|||
146993202|NCT03831048|530138915|FG001|Overall Study|Protocol Violation|3|||
146993203|NCT03831048|530138914|FG000|Overall Study|Death|4|||
146993204|NCT03831048|530138915|FG001|Overall Study|Death|9|||
146993205|NCT03831048|530138914|FG000|Overall Study|Re-transplant|0|||
146993206|NCT03831048|530138915|FG001|Overall Study|Re-transplant|2|||
146993207|NCT03831048|530138914|FG000|Overall Study|Protocol violation and death|1|||
146993208|NCT03831048|530138915|FG001|Overall Study|Protocol violation and death|1|||
146993209|NCT01315249|530138920|FG000|Overall Study|Adverse Event|22|||
146993210|NCT01315249|530138921|FG001|Overall Study|Adverse Event|26|||
146993211|NCT01315249|530138920|FG000|Overall Study|Withdrawal by Subject|11|||
146993212|NCT01315249|530138921|FG001|Overall Study|Withdrawal by Subject|10|||
146993213|NCT01315249|530138920|FG000|Overall Study|Protocol Violation|8|||
146993214|NCT01315249|530138921|FG001|Overall Study|Protocol Violation|5|||
146993215|NCT01315249|530138920|FG000|Overall Study|Abnormal test results|1|||
146993216|NCT01315249|530138921|FG001|Overall Study|Abnormal test results|2|||
146993217|NCT01315249|530138920|FG000|Overall Study|Administrative problems|1|||
146993218|NCT01315249|530138921|FG001|Overall Study|Administrative problems|0|||
146993219|NCT01315249|530138920|FG000|Overall Study|inability to use device|1|||
146993220|NCT01315249|530138921|FG001|Overall Study|inability to use device|0|||
146993221|NCT01315249|530138920|FG000|Overall Study|Lack of Efficacy|0|||
146993222|NCT01315249|530138921|FG001|Overall Study|Lack of Efficacy|1|||
146993223|NCT01315249|530138920|FG000|Overall Study|Lost to Follow-up|0|||
146993224|NCT01315249|530138921|FG001|Overall Study|Lost to Follow-up|2|||
146993225|NCT01315249|530138920|FG000|Overall Study|Death|0|||
146993226|NCT01315249|530138921|FG001|Overall Study|Death|1|||
146993227|NCT03227445|530138922|FG000|Period 1 (28 Days)|Adverse Event|1|||
146993228|NCT03227445|530138923|FG001|Period 1 (28 Days)|Adverse Event|2|||
146993229|NCT03227445|530138924|FG002|Period 1 (28 Days)|Adverse Event|0|||
146993230|NCT03227445|530138925|FG003|Period 1 (28 Days)|Adverse Event|1|||
146993231|NCT03227445|530138922|FG000|Period 1 (28 Days)|Protocol Violation|1|||
146993232|NCT03227445|530138923|FG001|Period 1 (28 Days)|Protocol Violation|0|||
146993233|NCT03227445|530138924|FG002|Period 1 (28 Days)|Protocol Violation|0|||
146993234|NCT03227445|530138925|FG003|Period 1 (28 Days)|Protocol Violation|0|||
146993235|NCT03227445|530138922|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
146993236|NCT03227445|530138923|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
146993237|NCT03227445|530138924|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
146993238|NCT03227445|530138925|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
146993239|NCT03227445|530138922|FG000|Period 2 (28 Days)|Adverse Event|1|||
146993240|NCT03227445|530138923|FG001|Period 2 (28 Days)|Adverse Event|0|||
146993241|NCT03227445|530138924|FG002|Period 2 (28 Days)|Adverse Event|2|||
146993242|NCT03227445|530138925|FG003|Period 2 (28 Days)|Adverse Event|1|||
146993243|NCT03227445|530138922|FG000|Period 2 (28 Days)|Protocol Violation|0|||
146993244|NCT03227445|530138923|FG001|Period 2 (28 Days)|Protocol Violation|0|||
146839740|NCT05000216|529584644|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146839741|NCT05000216|529584645|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
146839742|NCT05000216|529584646|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146839743|NCT05000216|529584647|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
146839744|NCT05000216|529584648|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146839745|NCT05000216|529584649|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146993245|NCT03227445|530138924|FG002|Period 2 (28 Days)|Protocol Violation|0|||
146993246|NCT03227445|530138925|FG003|Period 2 (28 Days)|Protocol Violation|1|||
146993247|NCT03227445|530138922|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
146993248|NCT03227445|530138923|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
146993249|NCT03227445|530138924|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
146993250|NCT03227445|530138925|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
146993251|NCT00365300|530138928|FG000|Open-label Phase|Adverse Event|4|||
146993252|NCT00365300|530138929|FG001|Open-label Phase|Adverse Event|0|||
146993253|NCT00365300|530138928|FG000|Open-label Phase|Failed to Return|1|||
146993254|NCT00365300|530138929|FG001|Open-label Phase|Failed to Return|0|||
146993255|NCT00365300|530138928|FG000|Open-label Phase|Physician Decision|1|||
146993256|NCT00365300|530138929|FG001|Open-label Phase|Physician Decision|0|||
146993257|NCT00365300|530138928|FG000|Open-label Phase|Noncompliance|9|||
146993258|NCT00365300|530138929|FG001|Open-label Phase|Noncompliance|0|||
146993259|NCT00365300|530138928|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
146993260|NCT00365300|530138929|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
146993261|NCT00365300|530138928|FG000|Open-label Phase|Protocol Violation|1|||
146993262|NCT00365300|530138929|FG001|Open-label Phase|Protocol Violation|0|||
146993263|NCT00365300|530138928|FG000|Open-label Phase|Lack of Efficacy|1|||
146993264|NCT00365300|530138929|FG001|Open-label Phase|Lack of Efficacy|0|||
146993265|NCT00365300|530138928|FG000|Open-label Phase|Patient skipped open label phase|1|||
146993266|NCT00365300|530138929|FG001|Open-label Phase|Patient skipped open label phase|0|||
146993267|NCT00365300|530138928|FG000|Double-blind Phase|Failed to return|1|||
146993268|NCT00365300|530138929|FG001|Double-blind Phase|Failed to return|0|||
146993269|NCT00365300|530138928|FG000|Double-blind Phase|Noncompliance|1|||
146993270|NCT00365300|530138929|FG001|Double-blind Phase|Noncompliance|1|||
146993271|NCT00365300|530138928|FG000|Double-blind Phase|Withdrawal by Subject|0|||
146993272|NCT00365300|530138929|FG001|Double-blind Phase|Withdrawal by Subject|1|||
146993273|NCT00365300|530138928|FG000|Double-blind Phase|Protocol Violation|3|||
146993274|NCT00365300|530138929|FG001|Double-blind Phase|Protocol Violation|1|||
146993275|NCT00365300|530138928|FG000|Double-blind Phase|Lack of Efficacy|6|||
146993276|NCT00365300|530138929|FG001|Double-blind Phase|Lack of Efficacy|6|||
146993277|NCT01991470|530138930|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
146993278|NCT01991470|530138930|FG000|Enlite 1 Period|Adverse Event|1|||
146993279|NCT01991470|530138930|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
146993280|NCT01991470|530138930|FG000|Enlite 3 Period|Lost to Follow-up|1|||
146993281|NCT01991470|530138930|FG000|Enlite 3 Period|Physician Decision|2|||
146993282|NCT01991470|530138930|FG000|Enlite 3 Period|Physician Decision|8|||
146993283|NCT01991470|530138930|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
146993284|NCT02896361|530138947|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
146993285|NCT02896361|530138948|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
146993286|NCT02896361|530138949|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
146993287|NCT02896361|530138947|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
146993288|NCT02896361|530138948|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
146993289|NCT02896361|530138949|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
146993290|NCT03164772|530138951|FG000|Overall Study|Death|4|||
146993291|NCT03164772|530138952|FG001|Overall Study|Death|2|||
146993292|NCT03164772|530138951|FG000|Overall Study|Adverse Event|1|||
146993293|NCT03164772|530138952|FG001|Overall Study|Adverse Event|4|||
146993294|NCT03164772|530138951|FG000|Overall Study|Progressive Disease|11|||
146993295|NCT03164772|530138952|FG001|Overall Study|Progressive Disease|21|||
146993296|NCT03164772|530138951|FG000|Overall Study|Physician Decision|2|||
146993297|NCT03164772|530138952|FG001|Overall Study|Physician Decision|0|||
146993298|NCT03164772|530138951|FG000|Overall Study|Withdrawal by Subject|0|||
146993299|NCT03164772|530138952|FG001|Overall Study|Withdrawal by Subject|4|||
146993300|NCT01029353|530138954|FG000|Overall Study|Lost to Follow-up|4|||
146993301|NCT01029353|530138955|FG001|Overall Study|Lost to Follow-up|5|||
146993302|NCT01029353|530138956|FG002|Overall Study|Lost to Follow-up|5|||
146993303|NCT01029353|530138957|FG003|Overall Study|Lost to Follow-up|4|||
146993304|NCT01029353|530138954|FG000|Overall Study|Consent Withdrawn|2|||
146993305|NCT01029353|530138955|FG001|Overall Study|Consent Withdrawn|0|||
146993306|NCT01029353|530138956|FG002|Overall Study|Consent Withdrawn|0|||
146993307|NCT01029353|530138957|FG003|Overall Study|Consent Withdrawn|0|||
146993308|NCT01029353|530138954|FG000|Overall Study|Primary Outcome Indeterminate|1|||
146993309|NCT01029353|530138955|FG001|Overall Study|Primary Outcome Indeterminate|3|||
146993310|NCT01029353|530138956|FG002|Overall Study|Primary Outcome Indeterminate|2|||
146993311|NCT01029353|530138957|FG003|Overall Study|Primary Outcome Indeterminate|0|||
146993312|NCT02932878|530138959|FG000|Overall Study|Due to Lab Results|2|||
146993313|NCT02932878|530138960|FG001|Overall Study|Due to Lab Results|1|||
146993314|NCT00849901|530138961|FG000|Acute Treatment Phase|Adverse Event|9|||
146993315|NCT00849901|530138962|FG001|Acute Treatment Phase|Adverse Event|1|||
146993316|NCT00849901|530138963|FG002|Acute Treatment Phase|Adverse Event|3|||
146993317|NCT00849901|530138961|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
146993318|NCT00849901|530138962|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
146993319|NCT00849901|530138963|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
146993320|NCT00849901|530138961|FG000|Acute Treatment Phase|Protocol Violation|0|||
146993321|NCT00849901|530138962|FG001|Acute Treatment Phase|Protocol Violation|2|||
146993322|NCT00849901|530138963|FG002|Acute Treatment Phase|Protocol Violation|1|||
146993323|NCT00849901|530138961|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
146993324|NCT00849901|530138962|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
146993325|NCT00849901|530138963|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
146993326|NCT00849901|530138961|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
146993327|NCT00849901|530138962|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
146993328|NCT00849901|530138963|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
146993329|NCT00849901|530138961|FG000|Acute Treatment Phase|Physician Decision|1|||
146993330|NCT00849901|530138962|FG001|Acute Treatment Phase|Physician Decision|1|||
146993331|NCT00849901|530138963|FG002|Acute Treatment Phase|Physician Decision|1|||
146993332|NCT00849901|530138961|FG000|Acute Treatment Phase|Sponsor Decision|1|||
146993333|NCT00849901|530138962|FG001|Acute Treatment Phase|Sponsor Decision|0|||
146993334|NCT00849901|530138963|FG002|Acute Treatment Phase|Sponsor Decision|0|||
146993335|NCT00849901|530138961|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
146993336|NCT00849901|530138962|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
146993337|NCT00849901|530138963|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
146993338|NCT00849901|530138961|FG000|Extension Phase|Adverse Event|2|||
146993339|NCT00849901|530138962|FG001|Extension Phase|Adverse Event|8|||
146993340|NCT00849901|530138963|FG002|Extension Phase|Adverse Event|4|||
146993341|NCT00849901|530138961|FG000|Extension Phase|Lost to Follow-up|3|||
146993342|NCT00849901|530138962|FG001|Extension Phase|Lost to Follow-up|0|||
146993343|NCT00849901|530138963|FG002|Extension Phase|Lost to Follow-up|1|||
146993344|NCT00849901|530138961|FG000|Extension Phase|Protocol Violation|2|||
146993345|NCT00849901|530138962|FG001|Extension Phase|Protocol Violation|2|||
146993346|NCT00849901|530138963|FG002|Extension Phase|Protocol Violation|4|||
146993347|NCT00849901|530138961|FG000|Extension Phase|Withdrawal by Subject|7|||
146993348|NCT00849901|530138962|FG001|Extension Phase|Withdrawal by Subject|6|||
146993349|NCT00849901|530138963|FG002|Extension Phase|Withdrawal by Subject|3|||
146993350|NCT00849901|530138961|FG000|Extension Phase|Parent or Caregiver Decision|10|||
146993351|NCT00849901|530138962|FG001|Extension Phase|Parent or Caregiver Decision|4|||
146993352|NCT00849901|530138963|FG002|Extension Phase|Parent or Caregiver Decision|4|||
146993353|NCT00849901|530138961|FG000|Extension Phase|Physician Decision|1|||
146993354|NCT00849901|530138962|FG001|Extension Phase|Physician Decision|2|||
146993355|NCT00849901|530138963|FG002|Extension Phase|Physician Decision|0|||
146993356|NCT00849901|530138961|FG000|Extension Phase|Lack of Efficacy|2|||
146993357|NCT00849901|530138962|FG001|Extension Phase|Lack of Efficacy|4|||
146993358|NCT00849901|530138963|FG002|Extension Phase|Lack of Efficacy|1|||
146993359|NCT02152566|530138966|FG000|Overall Study|Lost to Follow-up|1|||
146993360|NCT02152566|530138966|FG000|Overall Study|Withdrawal by Subject|2|||
146993361|NCT02731157|530138967|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
146993362|NCT01856309|530138968|FG000|Overall Study|Death|4|||
146993363|NCT01856309|530138969|FG001|Overall Study|Death|6|||
146993364|NCT01856309|530138970|FG002|Overall Study|Death|11|||
146993365|NCT01856309|530138971|FG003|Overall Study|Death|6|||
146993366|NCT01856309|530138968|FG000|Overall Study|Lost to Follow-up|6|||
146993367|NCT01856309|530138969|FG001|Overall Study|Lost to Follow-up|2|||
146993368|NCT01856309|530138970|FG002|Overall Study|Lost to Follow-up|4|||
146993369|NCT01856309|530138971|FG003|Overall Study|Lost to Follow-up|8|||
146993370|NCT01856309|530138968|FG000|Overall Study|Withdrawal by Subject|11|||
146993371|NCT01856309|530138969|FG001|Overall Study|Withdrawal by Subject|13|||
146993372|NCT01856309|530138970|FG002|Overall Study|Withdrawal by Subject|28|||
146993373|NCT01856309|530138971|FG003|Overall Study|Withdrawal by Subject|26|||
146993374|NCT01856309|530138968|FG000|Overall Study|Other|227|||
146993375|NCT01856309|530138969|FG001|Overall Study|Other|225|||
146993376|NCT01856309|530138970|FG002|Overall Study|Other|447|||
146993377|NCT01856309|530138971|FG003|Overall Study|Other|469|||
146993378|NCT01856309|530138968|FG000|Overall Study|Lack of Efficacy|14|||
146993379|NCT01856309|530138969|FG001|Overall Study|Lack of Efficacy|9|||
146993380|NCT01856309|530138970|FG002|Overall Study|Lack of Efficacy|40|||
146993381|NCT01856309|530138971|FG003|Overall Study|Lack of Efficacy|25|||
146993382|NCT01856309|530138968|FG000|Overall Study|Adverse Event|31|||
146993383|NCT01856309|530138969|FG001|Overall Study|Adverse Event|31|||
146993384|NCT01856309|530138970|FG002|Overall Study|Adverse Event|55|||
146993385|NCT01856309|530138971|FG003|Overall Study|Adverse Event|65|||
146993386|NCT01856309|530138968|FG000|Overall Study|Pregnancy|0|||
146993387|NCT01856309|530138969|FG001|Overall Study|Pregnancy|0|||
146993388|NCT01856309|530138970|FG002|Overall Study|Pregnancy|0|||
146993389|NCT01856309|530138971|FG003|Overall Study|Pregnancy|1|||
146993390|NCT01856309|530138968|FG000|Overall Study|Physician Decision|6|||
146993391|NCT01856309|530138969|FG001|Overall Study|Physician Decision|1|||
146993392|NCT01856309|530138970|FG002|Overall Study|Physician Decision|6|||
146993393|NCT01856309|530138971|FG003|Overall Study|Physician Decision|8|||
146993394|NCT01856309|530138968|FG000|Overall Study|Noncompliance With Study Drug|0|||
146993395|NCT01856309|530138969|FG001|Overall Study|Noncompliance With Study Drug|1|||
146993396|NCT01856309|530138970|FG002|Overall Study|Noncompliance With Study Drug|4|||
146993397|NCT01856309|530138971|FG003|Overall Study|Noncompliance With Study Drug|1|||
146993398|NCT00220337|530138972|FG000|Overall Study|Adverse Event|70|||
146993399|NCT00220337|530138972|FG000|Overall Study|Lack of Efficacy|17|||
146993400|NCT00220337|530138972|FG000|Overall Study|Withdrawal by Subject|68|||
146993401|NCT00220337|530138972|FG000|Overall Study|Protocol Violation|2|||
146993402|NCT00220337|530138972|FG000|Overall Study|Lost to Follow-up|5|||
146993403|NCT00220337|530138972|FG000|Overall Study|Other|12|||
146993404|NCT00220337|530138972|FG000|Overall Study|Unsatisfactory compliance|5|||
146993405|NCT02327130|530138973|FG000|Overall Study|Discharged in less than 5 days|5|||
146993406|NCT02327130|530138973|FG000|Overall Study|Physician Decision|2|||
146993407|NCT02327130|530138973|FG000|Overall Study|Unable to provide breath sample|1|||
147013221|NCT02048813|530210053|FG001|Overall Study|Missed appointment|0|||
146960475|NCT01161173|530014346|FG000|Overall Study|Protocol Violation|13|||
146960476|NCT01161173|530014346|FG000|Overall Study|Lost to Follow-up|7|||
146960477|NCT01161173|530014346|FG000|Overall Study|Progressive Disease|82|||
146960478|NCT01161173|530014346|FG000|Overall Study|Withdrawal of Consent|5|||
146960479|NCT01161173|530014346|FG000|Overall Study|Unacceptable Toxicity|21|||
146960480|NCT01161173|530014346|FG000|Overall Study|Death|194|||
146960481|NCT01161173|530014346|FG000|Overall Study|End of Study|2|||
146960482|NCT01161173|530014346|FG000|Overall Study|Reasons Not Specified|23|||
146960483|NCT00792467|530014347|FG000|Overall Study|progression of disease|17|||
146960484|NCT00792467|530014347|FG000|Overall Study|Adverse Event|1|||
146960485|NCT00792467|530014347|FG000|Overall Study|patient request|1|||
146960486|NCT00792467|530014347|FG000|Overall Study|Lost to Follow-up|1|||
146960487|NCT00792467|530014347|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
146960488|NCT00792467|530014347|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
146960489|NCT00351611|530014348|FG000|Overall Study|Adverse Event|11|||
146960490|NCT00351611|530014349|FG001|Overall Study|Adverse Event|3|||
146960491|NCT00351611|530014348|FG000|Overall Study|Death|1|||
146960492|NCT00351611|530014349|FG001|Overall Study|Death|0|||
146960493|NCT00351611|530014348|FG000|Overall Study|Lost to Follow-up|1|||
146960494|NCT00351611|530014349|FG001|Overall Study|Lost to Follow-up|0|||
146960495|NCT00351611|530014348|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
146960496|NCT00351611|530014349|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
146960497|NCT00351611|530014348|FG000|Overall Study|Other|1|||
146960498|NCT00351611|530014349|FG001|Overall Study|Other|0|||
146960499|NCT00351611|530014348|FG000|Overall Study|Protocol Violation|0|||
146960500|NCT00351611|530014349|FG001|Overall Study|Protocol Violation|2|||
146960501|NCT02046993|530014350|FG000|Overall Study|Withdrawal by Subject|2|||
146960502|NCT02046993|530014351|FG001|Overall Study|Withdrawal by Subject|10|||
146960503|NCT02046993|530014350|FG000|Overall Study|Lost to Follow-up|1|||
146960504|NCT02046993|530014351|FG001|Overall Study|Lost to Follow-up|1|||
146960505|NCT03781167|530014358|FG000|Overall Study|Adverse Event|23|||
146960506|NCT03781167|530014359|FG001|Overall Study|Adverse Event|25|||
146960507|NCT03781167|530014358|FG000|Overall Study|Withdrew consent|16|||
146960508|NCT03781167|530014359|FG001|Overall Study|Withdrew consent|12|||
146960509|NCT03781167|530014358|FG000|Overall Study|Lost to Follow-up|0|||
146960510|NCT03781167|530014359|FG001|Overall Study|Lost to Follow-up|1|||
146960511|NCT03781167|530014358|FG000|Overall Study|Lack of Efficacy|4|||
146960512|NCT03781167|530014359|FG001|Overall Study|Lack of Efficacy|5|||
146960513|NCT03781167|530014358|FG000|Overall Study|Difficulty with drug delivery system|2|||
146960514|NCT03781167|530014359|FG001|Overall Study|Difficulty with drug delivery system|3|||
146960515|NCT03781167|530014358|FG000|Overall Study|Other, not specified|2|||
146960516|NCT03781167|530014359|FG001|Overall Study|Other, not specified|2|||
146960517|NCT00462501|530014360|FG000|Overall Study|Not treated|3|||
146960518|NCT00462501|530014360|FG000|Overall Study|Adverse Event|2|||
146960519|NCT00679354|530014362|FG000|Overall Study|Death|3|||
146960520|NCT00679354|530014362|FG000|Overall Study|Lack of Efficacy|22|||
146960521|NCT00679354|530014362|FG000|Overall Study|Physician Decision|4|||
146960522|NCT00679354|530014362|FG000|Overall Study|Ineligible|1|||
146960523|NCT00408408|530014363|FG000|Overall Study|No follow up data|2|||
146960524|NCT00408408|530014364|FG001|Overall Study|No follow up data|3|||
146960525|NCT00408408|530014365|FG002|Overall Study|No follow up data|0|||
146960526|NCT00408408|530014366|FG003|Overall Study|No follow up data|7|||
146960527|NCT00408408|530014367|FG004|Overall Study|No follow up data|5|||
146960528|NCT00408408|530014368|FG005|Overall Study|No follow up data|3|||
146960529|NCT00612456|530014371|FG000|Overall Study|Adverse Event|1|||
146960530|NCT00612456|530014372|FG001|Overall Study|Adverse Event|0|||
146960531|NCT00612456|530014373|FG002|Overall Study|Adverse Event|0|||
146960532|NCT00612456|530014371|FG000|Overall Study|Lack of Efficacy|1|||
146960533|NCT00612456|530014372|FG001|Overall Study|Lack of Efficacy|1|||
146960534|NCT00612456|530014373|FG002|Overall Study|Lack of Efficacy|0|||
146960535|NCT00612456|530014371|FG000|Overall Study|Withdrawal by Subject|0|||
146960536|NCT00612456|530014372|FG001|Overall Study|Withdrawal by Subject|1|||
146960537|NCT00612456|530014373|FG002|Overall Study|Withdrawal by Subject|0|||
146960538|NCT00808665|530014374|FG000|Overall Study|Withdrawal by Subject|1|||
146960539|NCT00808665|530014375|FG001|Overall Study|Withdrawal by Subject|0|||
146960540|NCT00808665|530014374|FG000|Overall Study|only required minimally invasive surgery|1|||
146960541|NCT00808665|530014375|FG001|Overall Study|only required minimally invasive surgery|0|||
146960542|NCT00808665|530014374|FG000|Overall Study|surgery cancelled|1|||
146960543|NCT00808665|530014375|FG001|Overall Study|surgery cancelled|0|||
146960544|NCT00808665|530014374|FG000|Overall Study|required an additional procedure|0|||
146960545|NCT00808665|530014375|FG001|Overall Study|required an additional procedure|1|||
146960546|NCT00808665|530014374|FG000|Overall Study|Physician Decision|3|||
146960547|NCT00808665|530014375|FG001|Overall Study|Physician Decision|1|||
146960548|NCT00808665|530014374|FG000|Overall Study|Medication stopped by resident|0|||
146960549|NCT00808665|530014375|FG001|Overall Study|Medication stopped by resident|1|||
146993408|NCT02327130|530138973|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
146993409|NCT02327130|530138973|FG000|Overall Study|Met exclusion criteria|3|||
146993410|NCT05214560|530138975|FG000|Overall Study|Screening Failure|1|||
146993411|NCT05214560|530138975|FG000|Overall Study|Physician Decision|4|||
146993412|NCT05214560|530138975|FG000|Overall Study|Withdrawal by Subject|1|||
146993413|NCT05214560|530138975|FG000|Overall Study|Lost to Follow-up|2|||
146993414|NCT05214560|530138975|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
146993415|NCT05214560|530138975|FG000|Overall Study|Study physician not available for the anesthesia|3|||
146993416|NCT05214560|530138975|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
146993417|NCT05214560|530138975|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
146993418|NCT05214560|530138975|FG000|Overall Study|Surgery not performed|3|||
146993419|NCT02672553|530138976|FG000|Overall Study|Death|3|||
146993420|NCT02672553|530138977|FG001|Overall Study|Death|5|||
146993421|NCT02672553|530138976|FG000|Overall Study|Valve Explant|1|||
146993422|NCT02672553|530138977|FG001|Overall Study|Valve Explant|0|||
146993423|NCT02672553|530138976|FG000|Overall Study|Conversion to Commercial Valve|3|||
146993424|NCT02672553|530138977|FG001|Overall Study|Conversion to Commercial Valve|0|||
146993425|NCT02672553|530138976|FG000|Overall Study|Withdrawal by Subject|3|||
146993426|NCT02672553|530138977|FG001|Overall Study|Withdrawal by Subject|3|||
146993427|NCT02672553|530138976|FG000|Overall Study|Intraoperative screen failure|2|||
146993428|NCT02672553|530138977|FG001|Overall Study|Intraoperative screen failure|0|||
146993429|NCT02003183|530138978|FG000|Overall Study|Lost to Follow-up|0|||
146993430|NCT02003183|530138979|FG001|Overall Study|Lost to Follow-up|2|||
146993431|NCT02343120|530138982|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
146993432|NCT02343120|530138983|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
146993433|NCT02343120|530138984|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
146993434|NCT02343120|530138985|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
146993435|NCT02343120|530138986|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
146993436|NCT02343120|530138982|FG000|Part 1: Dose Escalation|Death|1|||
146993437|NCT02343120|530138983|FG001|Part 1: Dose Escalation|Death|2|||
146993438|NCT02343120|530138984|FG002|Part 1: Dose Escalation|Death|2|||
146993439|NCT02343120|530138985|FG003|Part 1: Dose Escalation|Death|2|||
146993440|NCT02343120|530138986|FG004|Part 1: Dose Escalation|Death|1|||
146993441|NCT02343120|530138982|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
146993442|NCT02343120|530138983|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
146993443|NCT02343120|530138984|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
146993444|NCT02343120|530138985|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
146993445|NCT02343120|530138986|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
146993446|NCT02343120|530138982|FG000|Part 2: Expansion|Sponsor decision|0|||
146993447|NCT02343120|530138983|FG001|Part 2: Expansion|Sponsor decision|0|||
146993448|NCT02343120|530138984|FG002|Part 2: Expansion|Sponsor decision|0|||
146993449|NCT02343120|530138985|FG003|Part 2: Expansion|Sponsor decision|165|||
146993450|NCT02343120|530138986|FG004|Part 2: Expansion|Sponsor decision|67|||
146993451|NCT02343120|530138982|FG000|Part 2: Expansion|Death|0|||
146993452|NCT02343120|530138983|FG001|Part 2: Expansion|Death|0|||
146993453|NCT02343120|530138984|FG002|Part 2: Expansion|Death|0|||
146993454|NCT02343120|530138985|FG003|Part 2: Expansion|Death|74|||
146993455|NCT02343120|530138986|FG004|Part 2: Expansion|Death|17|||
146993456|NCT02343120|530138982|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
146993457|NCT02343120|530138983|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
146993458|NCT02343120|530138984|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
146993459|NCT02343120|530138985|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
146993460|NCT02343120|530138986|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
146993461|NCT02343120|530138982|FG000|Part 2: Expansion|Lost to Follow-up|0|||
146993462|NCT02343120|530138983|FG001|Part 2: Expansion|Lost to Follow-up|0|||
146993463|NCT02343120|530138984|FG002|Part 2: Expansion|Lost to Follow-up|0|||
146993464|NCT02343120|530138985|FG003|Part 2: Expansion|Lost to Follow-up|5|||
146993465|NCT02343120|530138986|FG004|Part 2: Expansion|Lost to Follow-up|2|||
146993466|NCT02343120|530138982|FG000|Part 2: Expansion|Other|0|||
146993467|NCT02343120|530138983|FG001|Part 2: Expansion|Other|0|||
146993468|NCT02343120|530138984|FG002|Part 2: Expansion|Other|0|||
146993469|NCT02343120|530138985|FG003|Part 2: Expansion|Other|1|||
146993470|NCT02343120|530138986|FG004|Part 2: Expansion|Other|5|||
146993471|NCT02343120|530138982|FG000|Part 2: Expansion|Adverse Event|0|||
146993472|NCT02343120|530138983|FG001|Part 2: Expansion|Adverse Event|0|||
146993473|NCT02343120|530138984|FG002|Part 2: Expansion|Adverse Event|0|||
146993474|NCT02343120|530138985|FG003|Part 2: Expansion|Adverse Event|1|||
146993475|NCT02343120|530138986|FG004|Part 2: Expansion|Adverse Event|1|||
146993476|NCT02534493|530138989|FG000|Overall Study|Lost to Follow-up|1|||
146993477|NCT02534493|530138989|FG000|Overall Study|Withdrawal by Subject|1|||
146993478|NCT01054599|530138995|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
146993479|NCT01054599|530138996|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
146993480|NCT01054599|530138995|FG000|Overall Study|Protocol Violation|1|||
146993481|NCT01054599|530138996|FG001|Overall Study|Protocol Violation|0|||
146993482|NCT01054599|530138995|FG000|Overall Study|Spells/seizure-like episodes|1|||
146993483|NCT01054599|530138996|FG001|Overall Study|Spells/seizure-like episodes|1|||
146993484|NCT01054599|530138995|FG000|Overall Study|Timing/scheduling difficulties|1|||
146839746|NCT05000216|529584650|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146839747|NCT05000216|529584651|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146960550|NCT01757821|530014376|FG000|Overall Study|Adverse Event|1|||
146960551|NCT03831282|530014377|FG000|Overall Study|Could not place sensor|1|||
146960552|NCT00920582|530014378|FG000|Overall Study|Lost to Follow-up|5|||
146960553|NCT00920582|530014379|FG001|Overall Study|Lost to Follow-up|1|||
146960554|NCT00920582|530014380|FG002|Overall Study|Lost to Follow-up|2|||
146960555|NCT00920582|530014381|FG003|Overall Study|Lost to Follow-up|0|||
146960556|NCT00920582|530014378|FG000|Overall Study|Withdrawal by Subject|5|||
146960557|NCT00920582|530014379|FG001|Overall Study|Withdrawal by Subject|4|||
146960558|NCT00920582|530014380|FG002|Overall Study|Withdrawal by Subject|6|||
146960559|NCT00920582|530014381|FG003|Overall Study|Withdrawal by Subject|3|||
146960560|NCT00920582|530014378|FG000|Overall Study|Protocol Violation|1|||
146960561|NCT00920582|530014379|FG001|Overall Study|Protocol Violation|0|||
146960562|NCT00920582|530014380|FG002|Overall Study|Protocol Violation|0|||
146960563|NCT00920582|530014381|FG003|Overall Study|Protocol Violation|0|||
146960564|NCT00920582|530014378|FG000|Overall Study|Other|2|||
146960565|NCT00920582|530014379|FG001|Overall Study|Other|1|||
146960566|NCT00920582|530014380|FG002|Overall Study|Other|3|||
146960567|NCT00920582|530014381|FG003|Overall Study|Other|2|||
146960568|NCT05146999|530014383|FG000|Overall Study|Withdrew consent|6|||
146960569|NCT05146999|530014384|FG001|Overall Study|Withdrew consent|1|||
146960570|NCT05146999|530014383|FG000|Overall Study|Lost to Follow-up|3|||
146960571|NCT05146999|530014384|FG001|Overall Study|Lost to Follow-up|2|||
146960572|NCT05146999|530014383|FG000|Overall Study|Other|1|||
146960573|NCT05146999|530014384|FG001|Overall Study|Other|3|||
146960574|NCT03319160|530014385|FG000|Overall Study|Data not available.|7|||
146960575|NCT00665002|530014386|FG000|Overall Study|Progression/relapse during treatment|11|||
146960576|NCT00665002|530014386|FG000|Overall Study|Cytogenetic resistance|1|||
146960577|NCT00697255|530014387|FG000|Stage 1a|Insufficient ovarian response|1|||
146960578|NCT00697255|530014388|FG001|Stage 1a|Insufficient ovarian response|0|||
146960579|NCT00697255|530014387|FG000|Stage 1a|Multifollicular growth|1|||
146960580|NCT00697255|530014388|FG001|Stage 1a|Multifollicular growth|0|||
146960581|NCT00697255|530014387|FG000|Stage 1a|Not growing of dominant follicle|1|||
146960582|NCT00697255|530014388|FG001|Stage 1a|Not growing of dominant follicle|0|||
146960583|NCT00697255|530014387|FG000|Stage 1b|Not growing of dominant follicle|0|||
146960584|NCT00697255|530014388|FG001|Stage 1b|Not growing of dominant follicle|1|||
146960585|NCT00697255|530014387|FG000|Stage 1b|Insufficient ovarian response|0|||
146960586|NCT00697255|530014388|FG001|Stage 1b|Insufficient ovarian response|1|||
146960587|NCT01333501|530014393|FG000|Overall Study|Adverse Event|3|||
146960588|NCT01333501|530014394|FG001|Overall Study|Adverse Event|1|||
146960589|NCT01333501|530014393|FG000|Overall Study|Abnormal laboratory value|2|||
146960590|NCT01333501|530014394|FG001|Overall Study|Abnormal laboratory value|1|||
146960591|NCT01333501|530014393|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146960592|NCT01333501|530014394|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
146960593|NCT01333501|530014393|FG000|Overall Study|Withdrawn consent|3|||
146960594|NCT01333501|530014394|FG001|Overall Study|Withdrawn consent|12|||
146960595|NCT04246996|530014395|FG000|Overall Study|Physician Decision|1|||
146960596|NCT04246996|530014396|FG001|Overall Study|Physician Decision|1|||
146960597|NCT04246996|530014395|FG000|Overall Study|Did not meet eligibility criteria|1|||
146960598|NCT04246996|530014396|FG001|Overall Study|Did not meet eligibility criteria|4|||
146960599|NCT02354599|530014399|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
146960600|NCT02354599|530014400|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
146960601|NCT02354599|530014401|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
146960602|NCT02354599|530014402|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
146960603|NCT02354599|530014403|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
146960604|NCT02354599|530014404|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
146960605|NCT02354599|530014399|FG000|Overall Study|Withdrawal by Subject|1|||
146960606|NCT02354599|530014400|FG001|Overall Study|Withdrawal by Subject|1|||
146960607|NCT02354599|530014401|FG002|Overall Study|Withdrawal by Subject|0|||
146960608|NCT02354599|530014402|FG003|Overall Study|Withdrawal by Subject|0|||
146960609|NCT02354599|530014403|FG004|Overall Study|Withdrawal by Subject|0|||
146960610|NCT02354599|530014404|FG005|Overall Study|Withdrawal by Subject|0|||
146960611|NCT04806334|530014405|FG000|Overall Study|Withdrawal by Subject|1|||
146960612|NCT00660829|530014406|FG000|Overall Study|Adverse Event|3|||
146960613|NCT00660829|530014407|FG001|Overall Study|Adverse Event|4|||
146960614|NCT00660829|530014406|FG000|Overall Study|Lack of Efficacy|2|||
146960615|NCT00660829|530014407|FG001|Overall Study|Lack of Efficacy|3|||
146960616|NCT00660829|530014406|FG000|Overall Study|Non-Compliance|0|||
146960617|NCT00660829|530014407|FG001|Overall Study|Non-Compliance|4|||
146960618|NCT00660829|530014406|FG000|Overall Study|Withdrawal by Subject|1|||
146960619|NCT00660829|530014407|FG001|Overall Study|Withdrawal by Subject|2|||
146960620|NCT00660829|530014406|FG000|Overall Study|Lost to Follow-up|3|||
146960621|NCT00660829|530014407|FG001|Overall Study|Lost to Follow-up|2|||
146960622|NCT00660829|530014406|FG000|Overall Study|Other|9|||
146960623|NCT00660829|530014407|FG001|Overall Study|Other|4|||
146960624|NCT03590613|530014408|FG000|Period 2, 4 Days|Physician Decision|0|||
146960625|NCT03590613|530014409|FG001|Period 2, 4 Days|Physician Decision|0|||
146839748|NCT05000216|529584652|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146839749|NCT05000216|529584631|FG000|Stage 2|Other reason|0|||
146839750|NCT05000216|529584632|FG001|Stage 2|Other reason|0|||
146839751|NCT05000216|529584633|FG002|Stage 2|Other reason|0|||
146993485|NCT01054599|530138996|FG001|Overall Study|Timing/scheduling difficulties|1|||
146993486|NCT01054599|530138995|FG000|Overall Study|Visual impairment, WTAR <80|0|||
146993487|NCT01054599|530138996|FG001|Overall Study|Visual impairment, WTAR <80|1|||
146993488|NCT01054599|530138995|FG000|Overall Study|Lost to Follow-up|0|||
146993489|NCT01054599|530138996|FG001|Overall Study|Lost to Follow-up|2|||
146993490|NCT01054599|530138995|FG000|Overall Study|Adverse Event|0|||
146993491|NCT01054599|530138996|FG001|Overall Study|Adverse Event|1|||
146993492|NCT01054599|530138995|FG000|Overall Study|Withdrawal by Subject|0|||
146993493|NCT01054599|530138996|FG001|Overall Study|Withdrawal by Subject|1|||
146993494|NCT01104662|530138997|FG000|Overall Study|Adverse Event|2|||
146993495|NCT01104662|530138998|FG001|Overall Study|Adverse Event|2|||
146993496|NCT01104662|530138999|FG002|Overall Study|Adverse Event|0|||
146993497|NCT01104662|530139000|FG003|Overall Study|Adverse Event|1|||
146993498|NCT01104662|530139001|FG004|Overall Study|Adverse Event|1|||
146993499|NCT01104662|530139002|FG005|Overall Study|Adverse Event|1|||
146993500|NCT01104662|530139003|FG006|Overall Study|Adverse Event|0|||
146993501|NCT01104662|530139004|FG007|Overall Study|Adverse Event|0|||
146993502|NCT01104662|530138997|FG000|Overall Study|Clinical Failure|1|||
146993503|NCT01104662|530138998|FG001|Overall Study|Clinical Failure|0|||
146993504|NCT01104662|530138999|FG002|Overall Study|Clinical Failure|0|||
146993505|NCT01104662|530139000|FG003|Overall Study|Clinical Failure|0|||
146993506|NCT01104662|530139001|FG004|Overall Study|Clinical Failure|0|||
146993507|NCT01104662|530139002|FG005|Overall Study|Clinical Failure|1|||
146993508|NCT01104662|530139003|FG006|Overall Study|Clinical Failure|0|||
146993509|NCT01104662|530139004|FG007|Overall Study|Clinical Failure|0|||
146993510|NCT01104662|530138997|FG000|Overall Study|Participant left investigator's care|1|||
146993511|NCT01104662|530138998|FG001|Overall Study|Participant left investigator's care|1|||
146993512|NCT01104662|530138999|FG002|Overall Study|Participant left investigator's care|0|||
146993513|NCT01104662|530139000|FG003|Overall Study|Participant left investigator's care|0|||
146993514|NCT01104662|530139001|FG004|Overall Study|Participant left investigator's care|0|||
146993515|NCT01104662|530139002|FG005|Overall Study|Participant left investigator's care|0|||
146993516|NCT01104662|530139003|FG006|Overall Study|Participant left investigator's care|0|||
146993517|NCT01104662|530139004|FG007|Overall Study|Participant left investigator's care|0|||
146993518|NCT01104662|530138997|FG000|Overall Study|Reason not specified|3|||
146993519|NCT01104662|530138998|FG001|Overall Study|Reason not specified|3|||
146993520|NCT01104662|530138999|FG002|Overall Study|Reason not specified|0|||
146993521|NCT01104662|530139000|FG003|Overall Study|Reason not specified|0|||
146993522|NCT01104662|530139001|FG004|Overall Study|Reason not specified|0|||
146993523|NCT01104662|530139002|FG005|Overall Study|Reason not specified|1|||
146993524|NCT01104662|530139003|FG006|Overall Study|Reason not specified|0|||
146993525|NCT01104662|530139004|FG007|Overall Study|Reason not specified|0|||
146993526|NCT01104662|530138997|FG000|Overall Study|Randomized but not treated|3|||
146993527|NCT01104662|530138998|FG001|Overall Study|Randomized but not treated|4|||
146993528|NCT01104662|530138999|FG002|Overall Study|Randomized but not treated|1|||
146993529|NCT01104662|530139000|FG003|Overall Study|Randomized but not treated|0|||
146993530|NCT01104662|530139001|FG004|Overall Study|Randomized but not treated|0|||
146993531|NCT01104662|530139002|FG005|Overall Study|Randomized but not treated|1|||
146993532|NCT01104662|530139003|FG006|Overall Study|Randomized but not treated|0|||
146993533|NCT01104662|530139004|FG007|Overall Study|Randomized but not treated|0|||
146993534|NCT00743197|530139005|FG000|Overall Study|Study terminated due to departure of PI.|1|||
146993535|NCT00743197|530139006|FG001|Overall Study|Study terminated due to departure of PI.|2|||
146993536|NCT01478620|530139007|FG000|Overall Study|Lost to Follow-up|6|||
146839752|NCT05000216|529584634|FG003|Stage 2|Other reason|0|||
146993537|NCT02170688|530139012|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
146993538|NCT02170688|530139013|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
146993539|NCT02170688|530139014|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
146993540|NCT02170688|530139015|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
146993541|NCT02170688|530139016|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
146839753|NCT05000216|529584635|FG004|Stage 2|Other reason|0|||
146839754|NCT05000216|529584636|FG005|Stage 2|Other reason|0|||
146993542|NCT02170688|530139012|FG000|Overall Study|Full dose not received|0|||
146993543|NCT02170688|530139013|FG001|Overall Study|Full dose not received|1|||
146993544|NCT02170688|530139014|FG002|Overall Study|Full dose not received|0|||
146993545|NCT02170688|530139015|FG003|Overall Study|Full dose not received|0|||
146993546|NCT02170688|530139016|FG004|Overall Study|Full dose not received|0|||
146993547|NCT02170688|530139012|FG000|Overall Study|Physician Decision|0|||
146993548|NCT02170688|530139013|FG001|Overall Study|Physician Decision|0|||
146993549|NCT02170688|530139014|FG002|Overall Study|Physician Decision|1|||
146993550|NCT02170688|530139015|FG003|Overall Study|Physician Decision|0|||
146993551|NCT02170688|530139016|FG004|Overall Study|Physician Decision|0|||
146993552|NCT01402947|530139019|FG000|First Intervention|Adverse Event|0|||
146993553|NCT01402947|530139020|FG001|First Intervention|Adverse Event|1|||
146993554|NCT01706926|530139024|FG000|Overall Study|Lost to Follow-up|0|||
146993555|NCT01706926|530139025|FG001|Overall Study|Lost to Follow-up|0|||
146993556|NCT01706926|530139026|FG002|Overall Study|Lost to Follow-up|1|||
146993557|NCT01706926|530139027|FG003|Overall Study|Lost to Follow-up|0|||
146993558|NCT01706926|530139024|FG000|Overall Study|Withdrawal by Subject|2|||
146993559|NCT01706926|530139025|FG001|Overall Study|Withdrawal by Subject|0|||
146993560|NCT01706926|530139026|FG002|Overall Study|Withdrawal by Subject|1|||
146993561|NCT01706926|530139027|FG003|Overall Study|Withdrawal by Subject|2|||
146993562|NCT01706926|530139024|FG000|Overall Study|Other|4|||
146993563|NCT01706926|530139025|FG001|Overall Study|Other|4|||
146993564|NCT01706926|530139026|FG002|Overall Study|Other|4|||
146993565|NCT01706926|530139027|FG003|Overall Study|Other|3|||
146993566|NCT04349917|530140879|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
146993567|NCT04349917|530140880|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
146993568|NCT04349917|530140879|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
146993569|NCT04349917|530140880|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
146993570|NCT04188106|530140881|FG000|Overall Study|Lost to Follow-up|5|||
146993571|NCT04188106|530140881|FG000|Overall Study|Non-Compliance|1|||
146993572|NCT00441467|530140882|FG000|Overall Study|Adverse Event|6|||
146993573|NCT00441467|530140882|FG000|Overall Study|Withdrawal by Subject|3|||
146993574|NCT00441467|530140882|FG000|Overall Study|Progressive disease|9|||
146993575|NCT02289963|530140883|FG000|Overall Study|Adverse Event|1|||
146993576|NCT02289963|530140884|FG001|Overall Study|Adverse Event|2|||
146993577|NCT02289963|530140883|FG000|Overall Study|Poor compliance to protocol|1|||
146993578|NCT02289963|530140884|FG001|Overall Study|Poor compliance to protocol|0|||
146993579|NCT02289963|530140883|FG000|Overall Study|Withdrawal by Subject|1|||
146993580|NCT02289963|530140884|FG001|Overall Study|Withdrawal by Subject|0|||
146993581|NCT02289963|530140883|FG000|Overall Study|Last injection missed|2|||
146993582|NCT02289963|530140884|FG001|Overall Study|Last injection missed|2|||
146993583|NCT02289963|530140883|FG000|Overall Study|End treatment visit outside visit window|0|||
146993584|NCT02289963|530140884|FG001|Overall Study|End treatment visit outside visit window|4|||
146993585|NCT02289963|530140883|FG000|Overall Study|Other than specified above|0|||
146993586|NCT02289963|530140884|FG001|Overall Study|Other than specified above|2|||
146993587|NCT01042522|530140886|FG000|Overall Study|Adverse Event|1|||
146993588|NCT01042522|530140887|FG001|Overall Study|Adverse Event|2|||
146993589|NCT01042522|530140886|FG000|Overall Study|Disease Progression|5|||
146993590|NCT01042522|530140887|FG001|Overall Study|Disease Progression|0|||
146993591|NCT01042522|530140886|FG000|Overall Study|Death|1|||
146993592|NCT01042522|530140887|FG001|Overall Study|Death|0|||
146993593|NCT01042522|530140886|FG000|Overall Study|Patient Refused|0|||
146993594|NCT01042522|530140887|FG001|Overall Study|Patient Refused|3|||
146993595|NCT01042522|530140886|FG000|Overall Study|Withdrawal by Subject|1|||
146993596|NCT01042522|530140887|FG001|Overall Study|Withdrawal by Subject|1|||
146993597|NCT01746017|530140890|FG000|Period 1|Withdrawal by Subject|0|||
146993598|NCT01746017|530140891|FG001|Period 1|Withdrawal by Subject|0|||
146993599|NCT01746017|530140892|FG002|Period 1|Withdrawal by Subject|0|||
146993600|NCT01746017|530140893|FG003|Period 1|Withdrawal by Subject|0|||
146993601|NCT01746017|530140894|FG004|Period 1|Withdrawal by Subject|0|||
146993602|NCT01746017|530140895|FG005|Period 1|Withdrawal by Subject|0|||
146993603|NCT01746017|530140896|FG006|Period 1|Withdrawal by Subject|1|||
146993604|NCT01746017|530140897|FG007|Period 1|Withdrawal by Subject|0|||
146839755|NCT05000216|529584637|FG006|Stage 2|Other reason|0|||
146839756|NCT05000216|529584638|FG007|Stage 2|Other reason|0|||
146993605|NCT01746017|530140898|FG008|Period 1|Withdrawal by Subject|0|||
146993606|NCT01746017|530140899|FG009|Period 1|Withdrawal by Subject|0|||
146993607|NCT01746017|530140900|FG010|Period 1|Withdrawal by Subject|0|||
146993608|NCT01746017|530140890|FG000|Period 3|Withdrawal by Subject|0|||
146839757|NCT05000216|529584639|FG008|Stage 2|Other reason|0|||
146993609|NCT01746017|530140891|FG001|Period 3|Withdrawal by Subject|0|||
146993610|NCT01746017|530140892|FG002|Period 3|Withdrawal by Subject|0|||
146993611|NCT01746017|530140893|FG003|Period 3|Withdrawal by Subject|0|||
146993612|NCT01746017|530140894|FG004|Period 3|Withdrawal by Subject|0|||
146993613|NCT01746017|530140895|FG005|Period 3|Withdrawal by Subject|1|||
146993614|NCT01746017|530140896|FG006|Period 3|Withdrawal by Subject|0|||
146993615|NCT01746017|530140897|FG007|Period 3|Withdrawal by Subject|0|||
146993616|NCT01746017|530140898|FG008|Period 3|Withdrawal by Subject|0|||
146993617|NCT01746017|530140899|FG009|Period 3|Withdrawal by Subject|0|||
146993618|NCT01746017|530140900|FG010|Period 3|Withdrawal by Subject|0|||
146993619|NCT01507051|530140901|FG000|Overall Study|Withdrawal by Subject|1|||
146993620|NCT01507051|530140902|FG001|Overall Study|Withdrawal by Subject|3|||
146993621|NCT01507051|530140903|FG002|Overall Study|Withdrawal by Subject|1|||
146993622|NCT01507051|530140904|FG003|Overall Study|Withdrawal by Subject|6|||
146993623|NCT01507051|530140901|FG000|Overall Study|Physician Decision|0|||
146993624|NCT01507051|530140902|FG001|Overall Study|Physician Decision|0|||
146993625|NCT01507051|530140903|FG002|Overall Study|Physician Decision|0|||
146993626|NCT01507051|530140904|FG003|Overall Study|Physician Decision|1|||
146993627|NCT01507051|530140901|FG000|Overall Study|Adverse Event|1|||
146993628|NCT01507051|530140902|FG001|Overall Study|Adverse Event|0|||
146993629|NCT01507051|530140903|FG002|Overall Study|Adverse Event|0|||
146993630|NCT01507051|530140904|FG003|Overall Study|Adverse Event|0|||
146993631|NCT01675622|530140905|FG000|Overall Study|Withdrawal by Subject|2|||
146993632|NCT01675622|530140906|FG001|Overall Study|Withdrawal by Subject|2|||
146993633|NCT01675622|530140905|FG000|Overall Study|Adverse Event|12|||
146993634|NCT01675622|530140906|FG001|Overall Study|Adverse Event|10|||
146993635|NCT01675622|530140905|FG000|Overall Study|Protocol Violation|4|||
146993636|NCT01675622|530140906|FG001|Overall Study|Protocol Violation|1|||
146993637|NCT01675622|530140905|FG000|Overall Study|Lack of Efficacy|2|||
146993638|NCT01675622|530140906|FG001|Overall Study|Lack of Efficacy|4|||
146993639|NCT01675622|530140905|FG000|Overall Study|Lost to Follow-up|1|||
146993640|NCT01675622|530140906|FG001|Overall Study|Lost to Follow-up|3|||
146993641|NCT01675622|530140905|FG000|Overall Study|Other|5|||
146993642|NCT01675622|530140906|FG001|Overall Study|Other|4|||
146993643|NCT01101022|530140907|FG000|Overall Study|Adverse Event|6|||
146993644|NCT01101022|530140908|FG001|Overall Study|Adverse Event|2|||
146993645|NCT01101022|530140907|FG000|Overall Study|Protocol Violation|4|||
146993646|NCT01101022|530140908|FG001|Overall Study|Protocol Violation|3|||
146993647|NCT01101022|530140907|FG000|Overall Study|Withdrawal by Subject|3|||
146993648|NCT01101022|530140908|FG001|Overall Study|Withdrawal by Subject|8|||
146993649|NCT01101022|530140907|FG000|Overall Study|Lost to Follow-up|1|||
146993650|NCT01101022|530140908|FG001|Overall Study|Lost to Follow-up|4|||
146993651|NCT01101022|530140907|FG000|Overall Study|Lack of Efficacy|0|||
146993652|NCT01101022|530140908|FG001|Overall Study|Lack of Efficacy|7|||
146993653|NCT01101022|530140907|FG000|Overall Study|Sponsor decision|1|||
146993654|NCT01101022|530140908|FG001|Overall Study|Sponsor decision|1|||
146993655|NCT01101022|530140907|FG000|Overall Study|Non-compliance|1|||
146993656|NCT01101022|530140908|FG001|Overall Study|Non-compliance|0|||
146993657|NCT01101022|530140907|FG000|Overall Study|Work schedule|1|||
146993658|NCT01101022|530140908|FG001|Overall Study|Work schedule|1|||
146993659|NCT01101022|530140907|FG000|Overall Study|Vacation|0|||
146993660|NCT01101022|530140908|FG001|Overall Study|Vacation|1|||
146993661|NCT02311361|530140909|FG000|Overall Study|Did not receive treatment|0|||
146993662|NCT02311361|530140910|FG001|Overall Study|Did not receive treatment|1|||
146993663|NCT02311361|530140911|FG002|Overall Study|Did not receive treatment|0|||
146993664|NCT02311361|530140912|FG003|Overall Study|Did not receive treatment|1|||
146993665|NCT04455633|530140914|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
146993666|NCT04455633|530140915|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
146993667|NCT04455633|530140916|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
146993668|NCT04455633|530140914|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
146993669|NCT04455633|530140915|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
146993670|NCT04455633|530140916|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
146993671|NCT04455633|530140914|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
146993672|NCT04455633|530140915|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
146993673|NCT04455633|530140916|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
146993674|NCT04455633|530140914|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
146993675|NCT04455633|530140915|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
146993676|NCT04455633|530140916|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
146993677|NCT03527745|530140917|FG000|Overall Study|Lost to Follow-up|3|||
146993678|NCT03527745|530140918|FG001|Overall Study|Lost to Follow-up|6|||
146993679|NCT03527745|530140919|FG002|Overall Study|Lost to Follow-up|7|||
146993680|NCT03527745|530140920|FG003|Overall Study|Lost to Follow-up|9|||
146993681|NCT03527745|530140921|FG004|Overall Study|Lost to Follow-up|0|||
146993682|NCT03527745|530140922|FG005|Overall Study|Lost to Follow-up|2|||
146993683|NCT03527745|530140923|FG006|Overall Study|Lost to Follow-up|3|||
146993684|NCT03527745|530140924|FG007|Overall Study|Lost to Follow-up|2|||
146993685|NCT03527745|530140925|FG008|Overall Study|Lost to Follow-up|3|||
146993686|NCT03527745|530140926|FG009|Overall Study|Lost to Follow-up|2|||
146993687|NCT03527745|530140927|FG010|Overall Study|Lost to Follow-up|1|||
146993688|NCT03527745|530140928|FG011|Overall Study|Lost to Follow-up|1|||
146993689|NCT03527745|530140929|FG012|Overall Study|Lost to Follow-up|0|||
146993690|NCT03527745|530140930|FG013|Overall Study|Lost to Follow-up|0|||
146993691|NCT03527745|530140931|FG014|Overall Study|Lost to Follow-up|0|||
146993692|NCT03527745|530140932|FG015|Overall Study|Lost to Follow-up|0|||
146993693|NCT03527745|530140933|FG016|Overall Study|Lost to Follow-up|1|||
146993694|NCT03527745|530140934|FG017|Overall Study|Lost to Follow-up|0|||
146993695|NCT03527745|530140935|FG018|Overall Study|Lost to Follow-up|0|||
146993696|NCT03527745|530140936|FG019|Overall Study|Lost to Follow-up|1|||
146993697|NCT03527745|530140937|FG020|Overall Study|Lost to Follow-up|1|||
146993698|NCT03527745|530140938|FG021|Overall Study|Lost to Follow-up|5|||
146993699|NCT03527745|530140939|FG022|Overall Study|Lost to Follow-up|6|||
146993700|NCT03527745|530140940|FG023|Overall Study|Lost to Follow-up|8|||
146993701|NCT03527745|530140941|FG024|Overall Study|Lost to Follow-up|1|||
146993702|NCT03527745|530140942|FG025|Overall Study|Lost to Follow-up|3|||
146993703|NCT02942264|530140947|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
146993704|NCT02942264|530140948|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
146993705|NCT02942264|530140949|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
146993706|NCT02942264|530140950|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
146993707|NCT02942264|530140951|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
146993708|NCT02942264|530140952|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
146993709|NCT02942264|530140953|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
146993710|NCT02942264|530140954|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
146993711|NCT02942264|530140955|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
146993712|NCT02942264|530140947|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
146993713|NCT02942264|530140948|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
146993714|NCT02942264|530140949|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
146993715|NCT02942264|530140950|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
146993716|NCT02942264|530140951|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
146993717|NCT02942264|530140952|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
146993718|NCT02942264|530140953|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
146993719|NCT02942264|530140954|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
146993720|NCT02942264|530140955|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
146993721|NCT01328093|530140956|FG000|Double-Blind Phase|Adverse Event|78|||
146993722|NCT01328093|530140957|FG001|Double-Blind Phase|Adverse Event|15|||
146993723|NCT01328093|530140956|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
146993724|NCT01328093|530140957|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
146993725|NCT01328093|530140956|FG000|Double-Blind Phase|Lost to Follow-up|39|||
146993726|NCT01328093|530140957|FG001|Double-Blind Phase|Lost to Follow-up|14|||
146993727|NCT01328093|530140956|FG000|Double-Blind Phase|Protocol Violation|30|||
146993728|NCT01328093|530140957|FG001|Double-Blind Phase|Protocol Violation|10|||
146993729|NCT01328093|530140956|FG000|Double-Blind Phase|Lack of Efficacy|55|||
146993730|NCT01328093|530140957|FG001|Double-Blind Phase|Lack of Efficacy|13|||
146993731|NCT01328093|530140956|FG000|Double-Blind Phase|Sponsor Decision|17|||
146993732|NCT01328093|530140957|FG001|Double-Blind Phase|Sponsor Decision|3|||
146993733|NCT01328093|530140956|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
146993734|NCT01328093|530140957|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
146993735|NCT01328093|530140956|FG000|Double-Blind Phase|Scheduling conflict|8|||
146993736|NCT01328093|530140957|FG001|Double-Blind Phase|Scheduling conflict|3|||
146993737|NCT01328093|530140956|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
146993738|NCT01328093|530140957|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
146993739|NCT01328093|530140956|FG000|Double-Blind Phase|Death|1|||
146993740|NCT01328093|530140957|FG001|Double-Blind Phase|Death|0|||
146993741|NCT01328093|530140956|FG000|Open-Label Phase|Sponsor Decision|98|||
146993742|NCT01328093|530140957|FG001|Open-Label Phase|Sponsor Decision|34|||
146993743|NCT01328093|530140956|FG000|Open-Label Phase|Protocol Violation|8|||
146993744|NCT01328093|530140957|FG001|Open-Label Phase|Protocol Violation|3|||
146993745|NCT01328093|530140956|FG000|Open-Label Phase|Lost to Follow-up|10|||
146993746|NCT01328093|530140957|FG001|Open-Label Phase|Lost to Follow-up|1|||
146993747|NCT01328093|530140956|FG000|Open-Label Phase|Adverse Event|10|||
146993748|NCT01328093|530140957|FG001|Open-Label Phase|Adverse Event|4|||
146993749|NCT01328093|530140956|FG000|Open-Label Phase|Lack of Efficacy|5|||
146993750|NCT01328093|530140957|FG001|Open-Label Phase|Lack of Efficacy|6|||
146993751|NCT01328093|530140956|FG000|Open-Label Phase|Withdrawal by Subject|4|||
146993752|NCT01328093|530140957|FG001|Open-Label Phase|Withdrawal by Subject|1|||
146993753|NCT01328093|530140956|FG000|Open-Label Phase|Scheduling conflict|2|||
146993754|NCT01328093|530140957|FG001|Open-Label Phase|Scheduling conflict|1|||
146993755|NCT01328093|530140956|FG000|Open-Label Phase|Subject is moving or has moved|2|||
146993756|NCT01328093|530140957|FG001|Open-Label Phase|Subject is moving or has moved|0|||
146993757|NCT01328093|530140956|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
146993758|NCT01328093|530140957|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
146993759|NCT03980483|530140960|FG000|Overall Study|Adverse Event|13|||
146993760|NCT03980483|530140961|FG001|Overall Study|Adverse Event|29|||
146993761|NCT03980483|530140962|FG002|Overall Study|Adverse Event|11|||
146993762|NCT03980483|530140963|FG003|Overall Study|Adverse Event|2|||
146993763|NCT03980483|530140964|FG004|Overall Study|Adverse Event|2|||
146993764|NCT03980483|530140965|FG005|Overall Study|Adverse Event|2|||
146993765|NCT03980483|530140960|FG000|Overall Study|Lack of Efficacy|7|||
146993766|NCT03980483|530140961|FG001|Overall Study|Lack of Efficacy|6|||
146993767|NCT03980483|530140962|FG002|Overall Study|Lack of Efficacy|0|||
146993768|NCT03980483|530140963|FG003|Overall Study|Lack of Efficacy|3|||
146993769|NCT03980483|530140964|FG004|Overall Study|Lack of Efficacy|1|||
146993770|NCT03980483|530140965|FG005|Overall Study|Lack of Efficacy|1|||
146993771|NCT03980483|530140960|FG000|Overall Study|Lost to Follow-up|2|||
146993772|NCT03980483|530140961|FG001|Overall Study|Lost to Follow-up|4|||
146993773|NCT03980483|530140962|FG002|Overall Study|Lost to Follow-up|2|||
146993774|NCT03980483|530140963|FG003|Overall Study|Lost to Follow-up|1|||
146993775|NCT03980483|530140964|FG004|Overall Study|Lost to Follow-up|2|||
146993776|NCT03980483|530140965|FG005|Overall Study|Lost to Follow-up|0|||
146993777|NCT03980483|530140960|FG000|Overall Study|Protocol Violation|4|||
146993778|NCT03980483|530140961|FG001|Overall Study|Protocol Violation|2|||
146993779|NCT03980483|530140962|FG002|Overall Study|Protocol Violation|1|||
146993780|NCT03980483|530140963|FG003|Overall Study|Protocol Violation|1|||
146993781|NCT03980483|530140964|FG004|Overall Study|Protocol Violation|0|||
146993782|NCT03980483|530140965|FG005|Overall Study|Protocol Violation|0|||
146993783|NCT03980483|530140960|FG000|Overall Study|Physician Decision|14|||
146993784|NCT03980483|530140961|FG001|Overall Study|Physician Decision|10|||
146993785|NCT03980483|530140962|FG002|Overall Study|Physician Decision|7|||
146993786|NCT03980483|530140963|FG003|Overall Study|Physician Decision|4|||
146993787|NCT03980483|530140964|FG004|Overall Study|Physician Decision|4|||
146993788|NCT03980483|530140965|FG005|Overall Study|Physician Decision|2|||
146993789|NCT03980483|530140960|FG000|Overall Study|Withdrawal by Subject|38|||
146993790|NCT03980483|530140961|FG001|Overall Study|Withdrawal by Subject|21|||
146993791|NCT03980483|530140962|FG002|Overall Study|Withdrawal by Subject|15|||
146993792|NCT03980483|530140963|FG003|Overall Study|Withdrawal by Subject|5|||
146993793|NCT03980483|530140964|FG004|Overall Study|Withdrawal by Subject|3|||
146993794|NCT03980483|530140965|FG005|Overall Study|Withdrawal by Subject|4|||
146993795|NCT03980483|530140960|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
146993796|NCT03980483|530140961|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
146993797|NCT03980483|530140962|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
146993798|NCT03980483|530140963|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
146993799|NCT03980483|530140964|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
146993800|NCT03980483|530140965|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
146993801|NCT03980483|530140960|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
146993802|NCT03980483|530140961|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
146993803|NCT03980483|530140962|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
146993804|NCT03980483|530140963|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
146993805|NCT03980483|530140964|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
146993806|NCT03980483|530140965|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
146993807|NCT03980483|530140960|FG000|Overall Study|Other|0|||
146993808|NCT03980483|530140961|FG001|Overall Study|Other|1|||
146993809|NCT03980483|530140962|FG002|Overall Study|Other|0|||
146993810|NCT03980483|530140963|FG003|Overall Study|Other|0|||
146993811|NCT03980483|530140964|FG004|Overall Study|Other|0|||
146993812|NCT03980483|530140965|FG005|Overall Study|Other|0|||
146993813|NCT00760266|530140968|FG000|Overall Study|Adverse Event|13|||
146993814|NCT00760266|530140969|FG001|Overall Study|Adverse Event|7|||
146993815|NCT00760266|530140968|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146993816|NCT00760266|530140969|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146993817|NCT00760266|530140968|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146993818|NCT00760266|530140969|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146993819|NCT00760266|530140968|FG000|Overall Study|Lack of Efficacy|2|||
146993820|NCT00760266|530140969|FG001|Overall Study|Lack of Efficacy|2|||
146993821|NCT00760266|530140968|FG000|Overall Study|Protocol deviation|2|||
146993822|NCT00760266|530140969|FG001|Overall Study|Protocol deviation|4|||
146993823|NCT00760266|530140968|FG000|Overall Study|Patient withdrew consent|3|||
146993824|NCT00760266|530140969|FG001|Overall Study|Patient withdrew consent|3|||
146993825|NCT00760266|530140968|FG000|Overall Study|Lost to Follow-up|2|||
146993826|NCT00760266|530140969|FG001|Overall Study|Lost to Follow-up|1|||
146993827|NCT00760266|530140968|FG000|Overall Study|Administrative Problems|0|||
146993828|NCT00760266|530140969|FG001|Overall Study|Administrative Problems|1|||
146993829|NCT01239121|530140970|FG000|Overall Study|Withdrawal by Subject|2|||
146993830|NCT01239121|530140971|FG001|Overall Study|Withdrawal by Subject|4|||
146993831|NCT01239121|530140972|FG002|Overall Study|Withdrawal by Subject|0|||
146993832|NCT03657160|530140973|FG000|Overall Study|Adverse Event|5|||
146993833|NCT03657160|530140974|FG001|Overall Study|Adverse Event|6|||
146993834|NCT03657160|530140973|FG000|Overall Study|Protocol Deviation|3|||
146993835|NCT03657160|530140974|FG001|Overall Study|Protocol Deviation|0|||
146993836|NCT03657160|530140973|FG000|Overall Study|Withdrawal by Subject|18|||
146993837|NCT03657160|530140974|FG001|Overall Study|Withdrawal by Subject|16|||
146993838|NCT03657160|530140973|FG000|Overall Study|Site Termination|1|||
146993839|NCT03657160|530140974|FG001|Overall Study|Site Termination|0|||
146993840|NCT03657160|530140973|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
146993841|NCT03657160|530140974|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
146993842|NCT03657160|530140973|FG000|Overall Study|Death|33|||
146993843|NCT03657160|530140974|FG001|Overall Study|Death|26|||
146993844|NCT03657160|530140973|FG000|Overall Study|Death (COVID-19-Related)|1|||
146993845|NCT03657160|530140974|FG001|Overall Study|Death (COVID-19-Related)|0|||
146993846|NCT03657160|530140973|FG000|Overall Study|Reason Not Specified|5|||
146993847|NCT03657160|530140974|FG001|Overall Study|Reason Not Specified|5|||
146993848|NCT03657160|530140973|FG000|Overall Study|Other (COVID-19-Related)|0|||
146993849|NCT03657160|530140974|FG001|Overall Study|Other (COVID-19-Related)|1|||
146993850|NCT00686959|530140976|FG000|Overall Study|Participants censored (no death events)|124|||
146993851|NCT00686959|530140977|FG001|Overall Study|Participants censored (no death events)|117|||
146993852|NCT01449630|530140978|FG000|Period 1|Physician Decision|1|||
146993853|NCT01449630|530140979|FG001|Period 1|Physician Decision|0|||
146993854|NCT01449630|530140980|FG002|Period 1|Physician Decision|0|||
146993855|NCT01449630|530140981|FG003|Period 1|Physician Decision|1|||
146993856|NCT01449630|530140982|FG004|Period 1|Physician Decision|0|||
146993857|NCT01449630|530140983|FG005|Period 1|Physician Decision|0|||
146993858|NCT01449630|530140984|FG006|Period 1|Physician Decision|0|||
146993859|NCT01449630|530140985|FG007|Period 1|Physician Decision|0|||
146993860|NCT01449630|530140986|FG008|Period 1|Physician Decision|0|||
146993861|NCT01449630|530140978|FG000|Period 1|Sponsor Decision|0|||
146993862|NCT01449630|530140979|FG001|Period 1|Sponsor Decision|0|||
146993863|NCT01449630|530140980|FG002|Period 1|Sponsor Decision|0|||
146993864|NCT01449630|530140981|FG003|Period 1|Sponsor Decision|0|||
146993865|NCT01449630|530140982|FG004|Period 1|Sponsor Decision|0|||
146993866|NCT01449630|530140983|FG005|Period 1|Sponsor Decision|1|||
146993867|NCT01449630|530140984|FG006|Period 1|Sponsor Decision|0|||
146993868|NCT01449630|530140985|FG007|Period 1|Sponsor Decision|0|||
146993869|NCT01449630|530140986|FG008|Period 1|Sponsor Decision|0|||
146993870|NCT01449630|530140978|FG000|Period 2|Sponsor Decision|0|||
146993871|NCT01449630|530140979|FG001|Period 2|Sponsor Decision|0|||
146993872|NCT01449630|530140980|FG002|Period 2|Sponsor Decision|0|||
146993873|NCT01449630|530140981|FG003|Period 2|Sponsor Decision|0|||
146993874|NCT01449630|530140982|FG004|Period 2|Sponsor Decision|0|||
146993875|NCT01449630|530140983|FG005|Period 2|Sponsor Decision|0|||
146993876|NCT01449630|530140984|FG006|Period 2|Sponsor Decision|1|||
146993877|NCT01449630|530140985|FG007|Period 2|Sponsor Decision|0|||
146993878|NCT01449630|530140986|FG008|Period 2|Sponsor Decision|0|||
146993879|NCT01735630|530140988|FG000|Overall Study|Adverse Event|8|||
146993880|NCT01735630|530140989|FG001|Overall Study|Adverse Event|7|||
146993881|NCT01735630|530140988|FG000|Overall Study|Lost to Follow-up|1|||
146993882|NCT01735630|530140989|FG001|Overall Study|Lost to Follow-up|0|||
146993883|NCT01735630|530140988|FG000|Overall Study|Physician Decision|0|||
146993884|NCT01735630|530140989|FG001|Overall Study|Physician Decision|1|||
146993885|NCT01735630|530140988|FG000|Overall Study|Sponsor Decision|2|||
146993886|NCT01735630|530140989|FG001|Overall Study|Sponsor Decision|1|||
146993887|NCT01735630|530140988|FG000|Overall Study|Withdrawal by Subject|7|||
146993888|NCT01735630|530140989|FG001|Overall Study|Withdrawal by Subject|9|||
146993889|NCT01572948|530140990|FG000|Overall Study|Lost to Follow-up|1|||
146993890|NCT01572948|530140991|FG001|Overall Study|Lost to Follow-up|0|||
146993891|NCT01572948|530140990|FG000|Overall Study|unable to contact|0|||
146993892|NCT01572948|530140991|FG001|Overall Study|unable to contact|1|||
146993893|NCT01126736|530140997|FG000|Overall Study|Death|2|||
146993894|NCT01126736|530140998|FG001|Overall Study|Death|2|||
146993895|NCT01126736|530140999|FG002|Overall Study|Death|1|||
146993896|NCT01126736|530141000|FG003|Overall Study|Death|19|||
146993897|NCT01126736|530141001|FG004|Overall Study|Death|19|||
146993898|NCT01126736|530140997|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
146993899|NCT01126736|530140998|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
146993900|NCT01126736|530140999|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
146993901|NCT01126736|530141000|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
146993902|NCT01126736|530141001|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
146993903|NCT01126736|530140997|FG000|Overall Study|Lost to Follow-up|0|||
146993904|NCT01126736|530140998|FG001|Overall Study|Lost to Follow-up|0|||
146993905|NCT01126736|530140999|FG002|Overall Study|Lost to Follow-up|0|||
146993906|NCT01126736|530141000|FG003|Overall Study|Lost to Follow-up|1|||
146993907|NCT01126736|530141001|FG004|Overall Study|Lost to Follow-up|1|||
146993908|NCT01126736|530140997|FG000|Overall Study|Administrative reasons|0|||
146993909|NCT01126736|530140998|FG001|Overall Study|Administrative reasons|0|||
146993910|NCT01126736|530140999|FG002|Overall Study|Administrative reasons|0|||
146993911|NCT01126736|530141000|FG003|Overall Study|Administrative reasons|0|||
146993912|NCT01126736|530141001|FG004|Overall Study|Administrative reasons|1|||
146993913|NCT01126736|530140997|FG000|Overall Study|Progressive disease|0|||
146993914|NCT01126736|530140998|FG001|Overall Study|Progressive disease|0|||
146993915|NCT01126736|530140999|FG002|Overall Study|Progressive disease|0|||
146993916|NCT01126736|530141000|FG003|Overall Study|Progressive disease|2|||
146993917|NCT01126736|530141001|FG004|Overall Study|Progressive disease|1|||
146993918|NCT01126736|530140997|FG000|Overall Study|Withdrawal by Subject|0|||
146993919|NCT01126736|530140998|FG001|Overall Study|Withdrawal by Subject|0|||
146993920|NCT01126736|530140999|FG002|Overall Study|Withdrawal by Subject|0|||
146993921|NCT01126736|530141000|FG003|Overall Study|Withdrawal by Subject|1|||
146993922|NCT01126736|530141001|FG004|Overall Study|Withdrawal by Subject|1|||
146993923|NCT01126736|530140997|FG000|Overall Study|Other|2|||
146993924|NCT01126736|530140998|FG001|Overall Study|Other|4|||
146993925|NCT01126736|530140999|FG002|Overall Study|Other|4|||
146993926|NCT01126736|530141000|FG003|Overall Study|Other|16|||
146839758|NCT05000216|529584640|FG009|Stage 2|Other reason|0|||
146993927|NCT01126736|530141001|FG004|Overall Study|Other|15|||
146993928|NCT01720264|530141006|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
146839759|NCT05000216|529584641|FG010|Stage 2|Other reason|0|||
146993929|NCT01720264|530141006|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
146993930|NCT01720264|530141006|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
146993931|NCT03018249|530141018|FG000|Overall Study|Withdrawal by Subject|2|||
146993932|NCT03018249|530141019|FG001|Overall Study|Withdrawal by Subject|2|||
146993933|NCT01030965|530141021|FG000|Overall Study|Lack of Efficacy|3|||
146993934|NCT01030965|530141022|FG001|Overall Study|Lack of Efficacy|2|||
146993935|NCT01030965|530141023|FG002|Overall Study|Lack of Efficacy|0|||
146993936|NCT01030965|530141024|FG003|Overall Study|Lack of Efficacy|3|||
146993937|NCT01030965|530141021|FG000|Overall Study|Protocol Violation|1|||
146839760|NCT05000216|529584642|FG011|Stage 2|Other reason|0|||
146839761|NCT05000216|529584643|FG012|Stage 2|Other reason|0|||
146839762|NCT05000216|529584644|FG013|Stage 2|Other reason|0|||
146839763|NCT05000216|529584645|FG014|Stage 2|Other reason|0|||
146839764|NCT05000216|529584646|FG015|Stage 2|Other reason|0|||
146839765|NCT05000216|529584647|FG016|Stage 2|Other reason|1|||
146839766|NCT05000216|529584648|FG017|Stage 2|Other reason|0|||
146839767|NCT05000216|529584649|FG018|Stage 2|Other reason|0|||
146839768|NCT05000216|529584650|FG019|Stage 2|Other reason|0|||
146993938|NCT01030965|530141022|FG001|Overall Study|Protocol Violation|1|||
146993939|NCT01030965|530141023|FG002|Overall Study|Protocol Violation|1|||
146993940|NCT01030965|530141024|FG003|Overall Study|Protocol Violation|1|||
146993941|NCT01030965|530141021|FG000|Overall Study|Adverse Event|0|||
146993942|NCT01030965|530141022|FG001|Overall Study|Adverse Event|1|||
146993943|NCT01030965|530141023|FG002|Overall Study|Adverse Event|2|||
146993944|NCT01030965|530141024|FG003|Overall Study|Adverse Event|1|||
146993945|NCT01030965|530141021|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
146993946|NCT01030965|530141022|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
146993947|NCT01030965|530141023|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
146993948|NCT01030965|530141024|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
146993949|NCT01030965|530141021|FG000|Overall Study|Withdrawal by Subject|0|||
146993950|NCT01030965|530141022|FG001|Overall Study|Withdrawal by Subject|1|||
146993951|NCT01030965|530141023|FG002|Overall Study|Withdrawal by Subject|0|||
146993952|NCT01030965|530141024|FG003|Overall Study|Withdrawal by Subject|2|||
146993953|NCT02097290|530141025|FG000|Overall Study|Death|6|||
146993954|NCT02097290|530141025|FG000|Overall Study|Total Withdrawals|3|||
146993955|NCT02097290|530141025|FG000|Overall Study|Attempt|8|||
146993956|NCT00824265|530141026|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
146993957|NCT00824265|530141027|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
146993958|NCT00824265|530141026|FG000|Treatment Phase|Protocol Violation|1|||
146993959|NCT00824265|530141027|FG001|Treatment Phase|Protocol Violation|0|||
146993960|NCT00824265|530141026|FG000|Treatment Phase|Lost to Follow-up|1|||
146993961|NCT00824265|530141027|FG001|Treatment Phase|Lost to Follow-up|1|||
146993962|NCT00824265|530141026|FG000|Treatment Phase|Physician Decision|6|||
146993963|NCT00824265|530141027|FG001|Treatment Phase|Physician Decision|12|||
146993964|NCT00824265|530141026|FG000|Treatment Phase|Withdrawal by Subject|6|||
146839769|NCT05000216|529584651|FG020|Stage 2|Other reason|0|||
146839770|NCT05000216|529584652|FG021|Stage 2|Other reason|0|||
146993965|NCT00824265|530141027|FG001|Treatment Phase|Withdrawal by Subject|15|||
146993966|NCT00824265|530141026|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
146993967|NCT00824265|530141027|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
146993968|NCT00824265|530141026|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
146993969|NCT00824265|530141027|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
146993970|NCT02888171|530141028|FG000|Overall Study|Lost to Follow-up|2|||
146993971|NCT02888171|530141029|FG001|Overall Study|Lost to Follow-up|1|||
146993972|NCT02888171|530141028|FG000|Overall Study|Withdrawal by Subject|3|||
146993973|NCT02888171|530141029|FG001|Overall Study|Withdrawal by Subject|2|||
146993974|NCT02888171|530141028|FG000|Overall Study|Adverse Event|0|||
146993975|NCT02888171|530141029|FG001|Overall Study|Adverse Event|1|||
146993976|NCT02920996|530141030|FG000|Overall Study|Adverse Event|8|||
146993977|NCT02920996|530141031|FG001|Overall Study|Adverse Event|0|||
146993978|NCT02920996|530141030|FG000|Overall Study|Physician Decision|1|||
146993979|NCT02920996|530141031|FG001|Overall Study|Physician Decision|0|||
146993980|NCT02920996|530141030|FG000|Overall Study|Death|1|||
146993981|NCT02920996|530141031|FG001|Overall Study|Death|0|||
146993982|NCT02920996|530141030|FG000|Overall Study|Missing|1|||
146993983|NCT02920996|530141031|FG001|Overall Study|Missing|0|||
146993984|NCT02920996|530141030|FG000|Overall Study|Subject Non-Compliance|1|||
146993985|NCT02920996|530141031|FG001|Overall Study|Subject Non-Compliance|0|||
146993986|NCT00591630|530141032|FG000|Overall Study|Death|0|||
146993987|NCT00591630|530141033|FG001|Overall Study|Death|0|||
146993988|NCT00591630|530141034|FG002|Overall Study|Death|1|||
146993989|NCT00591630|530141035|FG003|Overall Study|Death|0|||
146993990|NCT00485472|530142714|FG000|Overall Study|Adverse Event|8|||
146993991|NCT00485472|530142715|FG001|Overall Study|Adverse Event|5|||
146993992|NCT00485472|530142714|FG000|Overall Study|Lack of Efficacy|5|||
146993993|NCT00485472|530142715|FG001|Overall Study|Lack of Efficacy|4|||
146993994|NCT00485472|530142714|FG000|Overall Study|Withdrawal by Subject|1|||
146993995|NCT00485472|530142715|FG001|Overall Study|Withdrawal by Subject|0|||
146993996|NCT00485472|530142714|FG000|Overall Study|Protocol Violation|0|||
146993997|NCT00485472|530142715|FG001|Overall Study|Protocol Violation|1|||
146993998|NCT00485472|530142714|FG000|Overall Study|Other|2|||
146993999|NCT00485472|530142715|FG001|Overall Study|Other|1|||
146994000|NCT00485472|530142714|FG000|Overall Study|Lost to Follow-up|0|||
146994001|NCT00485472|530142715|FG001|Overall Study|Lost to Follow-up|1|||
146994002|NCT01492361|530142716|FG000|Overall Study|Withdrawal by Subject|281|||
146839771|NCT05000216|529584631|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
146839772|NCT05000216|529584632|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
146839773|NCT05000216|529584633|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
146994003|NCT01492361|530142717|FG001|Overall Study|Withdrawal by Subject|297|||
146994004|NCT01492361|530142716|FG000|Overall Study|Physician Decision|12|||
146994005|NCT01492361|530142717|FG001|Overall Study|Physician Decision|12|||
146994006|NCT01492361|530142716|FG000|Overall Study|Lost to Follow-up|6|||
146994007|NCT01492361|530142717|FG001|Overall Study|Lost to Follow-up|13|||
146994008|NCT01492361|530142716|FG000|Overall Study|Other than specified above|106|||
146994009|NCT01492361|530142717|FG001|Overall Study|Other than specified above|138|||
146994010|NCT04015232|530142718|FG000|Overall Study|Withdrawal by Subject|7|||
146994011|NCT04015232|530142719|FG001|Overall Study|Withdrawal by Subject|4|||
146994012|NCT04015232|530142718|FG000|Overall Study|Protocol Violation|1|||
146994013|NCT04015232|530142719|FG001|Overall Study|Protocol Violation|0|||
146839774|NCT05000216|529584634|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
146839775|NCT05000216|529584635|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
146839776|NCT05000216|529584636|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
146839777|NCT05000216|529584637|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
146839778|NCT05000216|529584638|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
146839779|NCT05000216|529584639|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
146839780|NCT05000216|529584640|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
146839781|NCT05000216|529584641|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
146839782|NCT05000216|529584642|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
146839783|NCT05000216|529584643|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
146839784|NCT05000216|529584644|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
146839785|NCT05000216|529584645|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
146839786|NCT05000216|529584646|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
146839787|NCT05000216|529584647|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
146839788|NCT05000216|529584648|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
146839789|NCT05000216|529584649|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
146839790|NCT05000216|529584650|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
146839791|NCT05000216|529584651|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
146839792|NCT05000216|529584652|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
146839793|NCT05000216|529584631|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839794|NCT05000216|529584632|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839795|NCT05000216|529584633|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839796|NCT05000216|529584634|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839797|NCT05000216|529584635|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839798|NCT05000216|529584636|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839799|NCT05000216|529584637|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839800|NCT05000216|529584638|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839801|NCT05000216|529584639|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839802|NCT05000216|529584640|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839803|NCT05000216|529584641|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839804|NCT05000216|529584642|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839805|NCT05000216|529584643|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839806|NCT05000216|529584644|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839807|NCT05000216|529584645|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839808|NCT05000216|529584646|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
146839809|NCT05000216|529584647|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839810|NCT05000216|529584648|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839811|NCT05000216|529584649|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839812|NCT05000216|529584650|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839813|NCT05000216|529584651|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839814|NCT05000216|529584652|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
146839815|NCT05000216|529584631|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146839816|NCT05000216|529584632|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146839817|NCT05000216|529584633|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146839818|NCT05000216|529584634|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146839819|NCT05000216|529584635|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146839820|NCT05000216|529584636|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146994014|NCT04015232|530142718|FG000|Overall Study|Medical Grounds|3|||
146994015|NCT04015232|530142719|FG001|Overall Study|Medical Grounds|3|||
146994016|NCT05150964|530142724|FG000|Overall Study|Lost to Follow-up|2|||
146994017|NCT01434693|530142727|FG000|Overall Study|Adverse Event|1|||
146994018|NCT01434693|530142728|FG001|Overall Study|Adverse Event|0|||
146839821|NCT05000216|529584637|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146839822|NCT05000216|529584638|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146839823|NCT05000216|529584639|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146839824|NCT05000216|529584640|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146839825|NCT05000216|529584641|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146839826|NCT05000216|529584642|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146994019|NCT01434693|530142729|FG002|Overall Study|Adverse Event|0|||
146994020|NCT01434693|530142730|FG003|Overall Study|Adverse Event|0|||
146839827|NCT05000216|529584643|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146839828|NCT05000216|529584644|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
146839829|NCT05000216|529584645|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146994021|NCT01434693|530142727|FG000|Overall Study|Withdrawal by Subject|1|||
146994022|NCT01434693|530142728|FG001|Overall Study|Withdrawal by Subject|0|||
146994023|NCT01434693|530142729|FG002|Overall Study|Withdrawal by Subject|1|||
146994024|NCT01434693|530142730|FG003|Overall Study|Withdrawal by Subject|1|||
146994025|NCT01434693|530142727|FG000|Overall Study|Lost to Follow-up|1|||
146994026|NCT01434693|530142728|FG001|Overall Study|Lost to Follow-up|0|||
146994027|NCT01434693|530142729|FG002|Overall Study|Lost to Follow-up|0|||
146994028|NCT01434693|530142730|FG003|Overall Study|Lost to Follow-up|0|||
146994029|NCT04006171|530142731|FG000|Overall Study|Withdrawal by Subject|8|||
146994030|NCT04006171|530142732|FG001|Overall Study|Withdrawal by Subject|7|||
146994031|NCT04006171|530142731|FG000|Overall Study|missing serum samples|2|||
146994032|NCT04006171|530142732|FG001|Overall Study|missing serum samples|2|||
146994033|NCT04006171|530142731|FG000|Overall Study|insufficient sample volume|2|||
146994034|NCT04006171|530142732|FG001|Overall Study|insufficient sample volume|3|||
146994035|NCT00912288|530142733|FG000|Overall Study|Death|0|||
146994036|NCT00912288|530142734|FG001|Overall Study|Death|1|||
146994037|NCT00912288|530142733|FG000|Overall Study|Adverse Event|1|||
146994038|NCT00912288|530142734|FG001|Overall Study|Adverse Event|1|||
146994039|NCT00912288|530142733|FG000|Overall Study|Lost to Follow-up|1|||
146994040|NCT00912288|530142734|FG001|Overall Study|Lost to Follow-up|0|||
146994041|NCT00912288|530142733|FG000|Overall Study|Protocol Violation|1|||
146994042|NCT00912288|530142734|FG001|Overall Study|Protocol Violation|0|||
146994043|NCT00912288|530142733|FG000|Overall Study|Withdrawal by Subject|3|||
146994044|NCT00912288|530142734|FG001|Overall Study|Withdrawal by Subject|3|||
146994045|NCT00912288|530142733|FG000|Overall Study|Study terminated by sponsor|34|||
146994046|NCT00912288|530142734|FG001|Overall Study|Study terminated by sponsor|35|||
146994047|NCT00912288|530142733|FG000|Overall Study|Other|1|||
146994048|NCT00912288|530142734|FG001|Overall Study|Other|0|||
146994049|NCT02087904|530142741|FG000|Overall Study|Did Not Receive Study Drug|0|||
146994050|NCT02087904|530142742|FG001|Overall Study|Did Not Receive Study Drug|0|||
146994051|NCT02087904|530142743|FG002|Overall Study|Did Not Receive Study Drug|2|||
146994052|NCT02087904|530142744|FG003|Overall Study|Did Not Receive Study Drug|1|||
146994053|NCT02087904|530142741|FG000|Overall Study|Adverse Event|8|||
146994054|NCT02087904|530142742|FG001|Overall Study|Adverse Event|4|||
146994055|NCT02087904|530142743|FG002|Overall Study|Adverse Event|4|||
146994056|NCT02087904|530142744|FG003|Overall Study|Adverse Event|12|||
146994057|NCT02087904|530142741|FG000|Overall Study|Lack of Efficacy|3|||
146994058|NCT02087904|530142742|FG001|Overall Study|Lack of Efficacy|6|||
146994059|NCT02087904|530142743|FG002|Overall Study|Lack of Efficacy|3|||
146994060|NCT02087904|530142744|FG003|Overall Study|Lack of Efficacy|2|||
146994061|NCT02087904|530142741|FG000|Overall Study|Other|6|||
146994062|NCT02087904|530142742|FG001|Overall Study|Other|2|||
146994063|NCT02087904|530142743|FG002|Overall Study|Other|4|||
146994064|NCT02087904|530142744|FG003|Overall Study|Other|4|||
146994065|NCT02087904|530142741|FG000|Overall Study|Withdrawal by Subject|8|||
146994066|NCT02087904|530142742|FG001|Overall Study|Withdrawal by Subject|3|||
146994067|NCT02087904|530142743|FG002|Overall Study|Withdrawal by Subject|7|||
146994068|NCT02087904|530142744|FG003|Overall Study|Withdrawal by Subject|4|||
146994069|NCT02087904|530142741|FG000|Overall Study|Lost to Follow-up|0|||
146994070|NCT02087904|530142742|FG001|Overall Study|Lost to Follow-up|4|||
146994071|NCT02087904|530142743|FG002|Overall Study|Lost to Follow-up|2|||
146994072|NCT02087904|530142744|FG003|Overall Study|Lost to Follow-up|2|||
146994073|NCT01196052|530142745|FG000|Overall Study|Adverse Event|9|||
146839830|NCT05000216|529584646|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
146839831|NCT05000216|529584647|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146839832|NCT05000216|529584648|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146839833|NCT05000216|529584649|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
146839834|NCT05000216|529584650|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146839835|NCT05000216|529584651|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146839836|NCT05000216|529584652|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146839837|NCT02057575|529584654|FG000|Overall Study|Adverse Event|0|||
146839838|NCT02057575|529584655|FG001|Overall Study|Adverse Event|2|||
146839839|NCT02057575|529584656|FG002|Overall Study|Adverse Event|0|||
146994074|NCT01196052|530142745|FG000|Overall Study|Lost to Follow-up|1|||
146994075|NCT01196052|530142745|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
146994076|NCT01196052|530142745|FG000|Overall Study|Reason not Specified|5|||
146994077|NCT01196052|530142745|FG000|Overall Study|Withdrawal by Subject|6|||
146994078|NCT02178722|530142746|FG000|Overall Study|Withdrawal by Subject|0|||
146994079|NCT02178722|530142747|FG001|Overall Study|Withdrawal by Subject|0|||
146994080|NCT02178722|530142748|FG002|Overall Study|Withdrawal by Subject|0|||
146994081|NCT02178722|530142749|FG003|Overall Study|Withdrawal by Subject|2|||
146994082|NCT02178722|530142750|FG004|Overall Study|Withdrawal by Subject|33|||
146839840|NCT02057575|529584657|FG003|Overall Study|Adverse Event|1|||
146839841|NCT02057575|529584654|FG000|Overall Study|Withdrawal by Subject|1|||
146994083|NCT02178722|530142746|FG000|Overall Study|Death|2|||
146994084|NCT02178722|530142747|FG001|Overall Study|Death|13|||
146994085|NCT02178722|530142748|FG002|Overall Study|Death|12|||
146839842|NCT02057575|529584655|FG001|Overall Study|Withdrawal by Subject|0|||
146994086|NCT02178722|530142749|FG003|Overall Study|Death|12|||
146994087|NCT02178722|530142750|FG004|Overall Study|Death|205|||
146839843|NCT02057575|529584656|FG002|Overall Study|Withdrawal by Subject|0|||
146839844|NCT02057575|529584657|FG003|Overall Study|Withdrawal by Subject|0|||
146839845|NCT02057575|529584654|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
146839846|NCT02057575|529584655|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
146839847|NCT02057575|529584656|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
146960626|NCT03590613|530014410|FG002|Period 2, 4 Days|Physician Decision|0|||
146960627|NCT03590613|530014411|FG003|Period 2, 4 Days|Physician Decision|1|||
146960628|NCT04369742|530014412|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
146960629|NCT04369742|530014413|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
146960630|NCT04369742|530014412|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
146960631|NCT04369742|530014413|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
146960632|NCT00495794|530014416|FG000|Overall Study|Pharmacist did not activate patient|522|||
146960633|NCT00495794|530014417|FG001|Overall Study|Pharmacist did not activate patient|0|||
146960634|NCT01130831|530014418|FG000|Overall Study|Withdrawal by Subject|7|||
146960635|NCT01130831|530014418|FG000|Overall Study|Death|4|||
146960636|NCT01130831|530014418|FG000|Overall Study|Information was missing|3|||
146960637|NCT00951912|530014419|FG000|Overall Study|Lack of Efficacy|1|||
146960638|NCT00951912|530014420|FG001|Overall Study|Lack of Efficacy|0|||
146960639|NCT00951912|530014421|FG002|Overall Study|Lack of Efficacy|0|||
146960640|NCT00951912|530014419|FG000|Overall Study|Adverse Event|0|||
146960641|NCT00951912|530014420|FG001|Overall Study|Adverse Event|1|||
146960642|NCT00951912|530014421|FG002|Overall Study|Adverse Event|1|||
146960643|NCT00951912|530014419|FG000|Overall Study|Lost to Follow-up|2|||
146960644|NCT00951912|530014420|FG001|Overall Study|Lost to Follow-up|2|||
146960645|NCT00951912|530014421|FG002|Overall Study|Lost to Follow-up|0|||
146960646|NCT00951912|530014419|FG000|Overall Study|Physician Decision|1|||
146960647|NCT00951912|530014420|FG001|Overall Study|Physician Decision|0|||
146960648|NCT00951912|530014421|FG002|Overall Study|Physician Decision|1|||
146960649|NCT00951912|530014419|FG000|Overall Study|Withdrawal by Subject|1|||
146960650|NCT00951912|530014420|FG001|Overall Study|Withdrawal by Subject|1|||
146960651|NCT00951912|530014421|FG002|Overall Study|Withdrawal by Subject|0|||
146960652|NCT00951912|530014419|FG000|Overall Study|Other:Depression|1|||
146960653|NCT00951912|530014420|FG001|Overall Study|Other:Depression|0|||
146960654|NCT00951912|530014421|FG002|Overall Study|Other:Depression|0|||
146960655|NCT00951912|530014419|FG000|Overall Study|Other: Colon cancer|1|||
146960656|NCT00951912|530014420|FG001|Overall Study|Other: Colon cancer|0|||
146960657|NCT00951912|530014421|FG002|Overall Study|Other: Colon cancer|0|||
146960658|NCT00951912|530014419|FG000|Overall Study|Other: Stroke|0|||
146960659|NCT00951912|530014420|FG001|Overall Study|Other: Stroke|1|||
146960660|NCT00951912|530014421|FG002|Overall Study|Other: Stroke|0|||
146960661|NCT02173158|530014422|FG000|Efficacy Phase|Adverse Event|1|||
146960662|NCT01728454|530014423|FG000|Stage 1 and 2|Pregnancy|1|||
146960663|NCT01728454|530014424|FG001|Stage 1 and 2|Pregnancy|0|||
146960664|NCT01728454|530014425|FG002|Stage 1 and 2|Pregnancy|0|||
146960665|NCT01728454|530014423|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
146960666|NCT01728454|530014424|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
146960667|NCT01728454|530014425|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
146960668|NCT01728454|530014423|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
146960669|NCT01728454|530014424|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
146960670|NCT01728454|530014425|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
146960671|NCT01728454|530014423|FG000|Stage 1 and 2|Lost to Follow-up|1|||
146960672|NCT01728454|530014424|FG001|Stage 1 and 2|Lost to Follow-up|1|||
146960673|NCT01728454|530014425|FG002|Stage 1 and 2|Lost to Follow-up|0|||
146960674|NCT01728454|530014423|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
146960675|NCT01728454|530014424|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
146960676|NCT01728454|530014425|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
146960677|NCT01728454|530014423|FG000|Stage 3|Reason Missing|0|||
146960678|NCT01728454|530014424|FG001|Stage 3|Reason Missing|0|||
146960679|NCT01728454|530014425|FG002|Stage 3|Reason Missing|1|||
146960680|NCT01728454|530014423|FG000|Stage 3|Subject Required Other Treatment|0|||
146960681|NCT01728454|530014424|FG001|Stage 3|Subject Required Other Treatment|1|||
146960682|NCT01728454|530014425|FG002|Stage 3|Subject Required Other Treatment|0|||
146960683|NCT01728454|530014423|FG000|Stage 3|Pregnancy|1|||
146960684|NCT01728454|530014424|FG001|Stage 3|Pregnancy|0|||
146960685|NCT01728454|530014425|FG002|Stage 3|Pregnancy|0|||
146960686|NCT01728454|530014423|FG000|Stage 3|Withdrew Consent|1|||
146960687|NCT01728454|530014424|FG001|Stage 3|Withdrew Consent|0|||
146960688|NCT01728454|530014425|FG002|Stage 3|Withdrew Consent|1|||
146960689|NCT01728454|530014423|FG000|Stage 3|Non-compliance with Protocol|0|||
146960690|NCT01728454|530014424|FG001|Stage 3|Non-compliance with Protocol|0|||
146960691|NCT01728454|530014425|FG002|Stage 3|Non-compliance with Protocol|1|||
146960692|NCT01728454|530014423|FG000|Stage 3|Lost to Follow-up|0|||
146960693|NCT01728454|530014424|FG001|Stage 3|Lost to Follow-up|3|||
146960694|NCT01728454|530014425|FG002|Stage 3|Lost to Follow-up|1|||
146960695|NCT01728454|530014423|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
146960696|NCT01728454|530014424|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
146960697|NCT01728454|530014425|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
146960698|NCT03077646|530014429|FG000|Overall Study|Lost to Follow-up|29|||
146839848|NCT02057575|529584657|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
146839849|NCT02057575|529584654|FG000|Overall Study|Protocol Violation|0|||
146839850|NCT02057575|529584655|FG001|Overall Study|Protocol Violation|1|||
146839851|NCT02057575|529584656|FG002|Overall Study|Protocol Violation|0|||
146839852|NCT02057575|529584657|FG003|Overall Study|Protocol Violation|0|||
146839853|NCT00332462|529584658|FG000|Overall Study|Adverse Event|5|||
146839854|NCT00332462|529584658|FG000|Overall Study|Abnormal Lab Value|1|||
146839855|NCT00332462|529584658|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146960699|NCT03077646|530014430|FG001|Overall Study|Lost to Follow-up|30|||
146960700|NCT03077646|530014431|FG002|Overall Study|Lost to Follow-up|31|||
146960701|NCT02058966|530014432|FG000|Open-Label Methamphetamine|Adverse Event|1|||
146960702|NCT02058966|530014432|FG000|First Intervention|Withdrawal by Subject|1|||
146960703|NCT01265511|530014433|FG000|Overall Study|Lack of Efficacy|2|||
146960704|NCT01265511|530014434|FG001|Overall Study|Lack of Efficacy|1|||
146960705|NCT01265511|530014433|FG000|Overall Study|Met stopping rules|0|||
146960706|NCT01265511|530014434|FG001|Overall Study|Met stopping rules|2|||
146960707|NCT03044730|530014439|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
146960708|NCT03044730|530014439|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
146960709|NCT03044730|530014439|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
146960710|NCT03044730|530014439|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
146960711|NCT03044730|530014439|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
146960712|NCT03044730|530014439|FG000|Cycles 4 and Beyond|Adverse Event|1|||
146960713|NCT03044730|530014439|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
146960714|NCT03044730|530014439|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
146960715|NCT03044730|530014439|FG000|On Follow-up for 2 Years|Death|17|||
146960716|NCT01674010|530016104|FG000|Open Treatment Phase 1|Adverse Event|10|||
146960717|NCT01674010|530016105|FG001|Open Treatment Phase 1|Adverse Event|0|||
146960718|NCT01674010|530016106|FG002|Open Treatment Phase 1|Adverse Event|0|||
146960719|NCT01674010|530016104|FG000|Open Treatment Phase 1|Death|1|||
146960720|NCT01674010|530016105|FG001|Open Treatment Phase 1|Death|0|||
146960721|NCT01674010|530016106|FG002|Open Treatment Phase 1|Death|0|||
146960722|NCT01674010|530016104|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
146960723|NCT01674010|530016105|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
146960724|NCT01674010|530016106|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
146960725|NCT01674010|530016104|FG000|Open Treatment Phase 1|Physician Decision|9|||
146960726|NCT01674010|530016105|FG001|Open Treatment Phase 1|Physician Decision|0|||
146960727|NCT01674010|530016106|FG002|Open Treatment Phase 1|Physician Decision|0|||
146960728|NCT01674010|530016104|FG000|Open Treatment Phase 1|Protocol Violation|7|||
146960729|NCT01674010|530016105|FG001|Open Treatment Phase 1|Protocol Violation|0|||
146960730|NCT01674010|530016106|FG002|Open Treatment Phase 1|Protocol Violation|0|||
146960731|NCT01674010|530016104|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
146960732|NCT01674010|530016105|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
146960733|NCT01674010|530016106|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
146960734|NCT01674010|530016104|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
146960735|NCT01674010|530016105|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
146960736|NCT01674010|530016106|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
146960737|NCT01674010|530016104|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
146960738|NCT01674010|530016105|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
146960739|NCT01674010|530016106|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
146960740|NCT01674010|530016104|FG000|Randomization Phase 2|Adverse Event|0|||
146960741|NCT01674010|530016105|FG001|Randomization Phase 2|Adverse Event|1|||
146960742|NCT01674010|530016106|FG002|Randomization Phase 2|Adverse Event|1|||
146960743|NCT01674010|530016104|FG000|Randomization Phase 2|Lost to Follow-up|0|||
146960744|NCT01674010|530016105|FG001|Randomization Phase 2|Lost to Follow-up|1|||
146960745|NCT01674010|530016106|FG002|Randomization Phase 2|Lost to Follow-up|2|||
146960746|NCT01674010|530016104|FG000|Randomization Phase 2|Mood episode recurrence|0|||
146960747|NCT01674010|530016105|FG001|Randomization Phase 2|Mood episode recurrence|8|||
146960748|NCT01674010|530016106|FG002|Randomization Phase 2|Mood episode recurrence|2|||
146960749|NCT01674010|530016104|FG000|Randomization Phase 2|Physician Decision|0|||
146960750|NCT01674010|530016105|FG001|Randomization Phase 2|Physician Decision|0|||
146960751|NCT01674010|530016106|FG002|Randomization Phase 2|Physician Decision|2|||
146960752|NCT01674010|530016104|FG000|Randomization Phase 2|Pregnancy|0|||
146960753|NCT01674010|530016105|FG001|Randomization Phase 2|Pregnancy|1|||
146960754|NCT01674010|530016106|FG002|Randomization Phase 2|Pregnancy|1|||
146960755|NCT01674010|530016104|FG000|Randomization Phase 2|Protocol Violation|0|||
146960756|NCT01674010|530016105|FG001|Randomization Phase 2|Protocol Violation|1|||
146960757|NCT01674010|530016106|FG002|Randomization Phase 2|Protocol Violation|1|||
146960758|NCT01674010|530016104|FG000|Randomization Phase 2|Sponsor Decision|0|||
146960759|NCT01674010|530016105|FG001|Randomization Phase 2|Sponsor Decision|42|||
146994088|NCT02178722|530142746|FG000|Overall Study|Lost to Follow-up|0|||
146839856|NCT00332462|529584658|FG000|Overall Study|no longer requires study drug|1|||
146960760|NCT01674010|530016106|FG002|Randomization Phase 2|Sponsor Decision|45|||
146960761|NCT01674010|530016104|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
146994089|NCT02178722|530142747|FG001|Overall Study|Lost to Follow-up|0|||
146839857|NCT00332462|529584658|FG000|Overall Study|Death|3|||
146994090|NCT02178722|530142748|FG002|Overall Study|Lost to Follow-up|0|||
146994091|NCT02178722|530142749|FG003|Overall Study|Lost to Follow-up|2|||
146994092|NCT02178722|530142750|FG004|Overall Study|Lost to Follow-up|11|||
146994093|NCT02178722|530142746|FG000|Overall Study|Study terminated by Sponsor|2|||
146994094|NCT02178722|530142747|FG001|Overall Study|Study terminated by Sponsor|7|||
146994095|NCT02178722|530142748|FG002|Overall Study|Study terminated by Sponsor|6|||
146994096|NCT02178722|530142749|FG003|Overall Study|Study terminated by Sponsor|4|||
146994097|NCT02178722|530142750|FG004|Overall Study|Study terminated by Sponsor|128|||
146994098|NCT02178722|530142746|FG000|Overall Study|Physician Decision|0|||
146994099|NCT02178722|530142747|FG001|Overall Study|Physician Decision|0|||
146994100|NCT02178722|530142748|FG002|Overall Study|Physician Decision|0|||
146994101|NCT02178722|530142749|FG003|Overall Study|Physician Decision|0|||
146994102|NCT02178722|530142750|FG004|Overall Study|Physician Decision|3|||
146994103|NCT02178722|530142746|FG000|Overall Study|Other|0|||
146994104|NCT02178722|530142747|FG001|Overall Study|Other|0|||
146994105|NCT02178722|530142748|FG002|Overall Study|Other|0|||
146994106|NCT02178722|530142749|FG003|Overall Study|Other|0|||
146994107|NCT02178722|530142750|FG004|Overall Study|Other|2|||
146994108|NCT00440557|530142751|FG000|Overall Study|Withdrawal by Subject|10|||
146994109|NCT00440557|530142752|FG001|Overall Study|Withdrawal by Subject|5|||
146994110|NCT00440557|530142753|FG002|Overall Study|Withdrawal by Subject|11|||
146994111|NCT00440557|530142751|FG000|Overall Study|Lost to Follow-up|1|||
146994112|NCT00440557|530142752|FG001|Overall Study|Lost to Follow-up|2|||
146994113|NCT00440557|530142753|FG002|Overall Study|Lost to Follow-up|6|||
146994114|NCT00440557|530142751|FG000|Overall Study|Adverse Event|3|||
146994115|NCT00440557|530142752|FG001|Overall Study|Adverse Event|3|||
146994116|NCT00440557|530142753|FG002|Overall Study|Adverse Event|5|||
146994117|NCT00440557|530142751|FG000|Overall Study|Death|2|||
146994118|NCT00440557|530142752|FG001|Overall Study|Death|6|||
146994119|NCT00440557|530142753|FG002|Overall Study|Death|3|||
146994120|NCT00440557|530142751|FG000|Overall Study|Began Dialysis|4|||
146994121|NCT00440557|530142752|FG001|Overall Study|Began Dialysis|1|||
146994122|NCT00440557|530142753|FG002|Overall Study|Began Dialysis|4|||
146994123|NCT00440557|530142751|FG000|Overall Study|Principal Investigator decision|0|||
146994124|NCT00440557|530142752|FG001|Overall Study|Principal Investigator decision|3|||
146994125|NCT00440557|530142753|FG002|Overall Study|Principal Investigator decision|1|||
146994126|NCT00440557|530142751|FG000|Overall Study|Patient moved|1|||
146994127|NCT00440557|530142752|FG001|Overall Study|Patient moved|2|||
146994128|NCT00440557|530142753|FG002|Overall Study|Patient moved|1|||
146994129|NCT00440557|530142751|FG000|Overall Study|Principal Investigator's office closed|3|||
146994130|NCT00440557|530142752|FG001|Overall Study|Principal Investigator's office closed|6|||
146994131|NCT00440557|530142753|FG002|Overall Study|Principal Investigator's office closed|4|||
146994132|NCT00440557|530142751|FG000|Overall Study|Patient transferred to nursing home|0|||
146994133|NCT00440557|530142752|FG001|Overall Study|Patient transferred to nursing home|1|||
146994134|NCT00440557|530142753|FG002|Overall Study|Patient transferred to nursing home|0|||
146994135|NCT00440557|530142751|FG000|Overall Study|Patient had surgery|1|||
146994136|NCT00440557|530142752|FG001|Overall Study|Patient had surgery|0|||
146994137|NCT00440557|530142753|FG002|Overall Study|Patient had surgery|0|||
146994138|NCT03340727|530142754|FG000|Overall Study|Death|1|||
146994139|NCT03340727|530142755|FG001|Overall Study|Death|0|||
146994140|NCT03340727|530142754|FG000|Overall Study|Lost to Follow-up|31|||
146994141|NCT03340727|530142755|FG001|Overall Study|Lost to Follow-up|35|||
146994142|NCT03340727|530142754|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
146994143|NCT03340727|530142755|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
146994144|NCT03340727|530142754|FG000|Overall Study|Transferred to another facility|10|||
146994145|NCT03340727|530142755|FG001|Overall Study|Transferred to another facility|7|||
146994146|NCT03340727|530142754|FG000|Overall Study|Withdrawal by Subject|28|||
146994147|NCT03340727|530142755|FG001|Overall Study|Withdrawal by Subject|17|||
146994148|NCT00669942|530142756|FG000|Parts 2 and 3|Adverse Event|0|||
146994149|NCT00669942|530142757|FG001|Parts 2 and 3|Adverse Event|0|||
146994150|NCT00669942|530142758|FG002|Parts 2 and 3|Adverse Event|0|||
146994151|NCT00669942|530142759|FG003|Parts 2 and 3|Adverse Event|0|||
146994152|NCT00669942|530142760|FG004|Parts 2 and 3|Adverse Event|0|||
146994153|NCT00669942|530142761|FG005|Parts 2 and 3|Adverse Event|0|||
146994154|NCT00669942|530142762|FG006|Parts 2 and 3|Adverse Event|0|||
146994155|NCT00669942|530142763|FG007|Parts 2 and 3|Adverse Event|2|||
146994156|NCT00669942|530142764|FG008|Parts 2 and 3|Adverse Event|1|||
146994157|NCT00669942|530142765|FG009|Parts 2 and 3|Adverse Event|0|||
146994158|NCT00669942|530142766|FG010|Parts 2 and 3|Adverse Event|0|||
146994159|NCT00669942|530142767|FG011|Parts 2 and 3|Adverse Event|0|||
146994160|NCT00669942|530142756|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
146994161|NCT00669942|530142757|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
146994162|NCT00669942|530142758|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
146994163|NCT00669942|530142759|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
146994164|NCT00669942|530142760|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
146994165|NCT00669942|530142761|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
146994166|NCT00669942|530142762|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
146994167|NCT00669942|530142763|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
146839858|NCT00332462|529584658|FG000|Overall Study|Graft Loss|2|||
146839859|NCT02922023|529584659|FG000|Overall Study|Lost to Follow-up|2|||
146839860|NCT02922023|529584660|FG001|Overall Study|Lost to Follow-up|0|||
146839861|NCT00863681|529584661|FG000|Overall Study|Other|2|||
146839862|NCT00863681|529584662|FG001|Overall Study|Other|0|||
146839863|NCT00863681|529584663|FG002|Overall Study|Other|0|||
146960762|NCT01674010|530016105|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
146960763|NCT01674010|530016106|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
146960764|NCT03159455|530016107|FG000|Overall Study|Adverse Event|0|||
146960765|NCT03159455|530016108|FG001|Overall Study|Adverse Event|0|||
146960766|NCT03159455|530016109|FG002|Overall Study|Adverse Event|0|||
146960767|NCT03159455|530016110|FG003|Overall Study|Adverse Event|0|||
146960768|NCT03159455|530016111|FG004|Overall Study|Adverse Event|0|||
146960769|NCT03159455|530016112|FG005|Overall Study|Adverse Event|1|||
146960770|NCT05056311|530016113|FG000|Overall Study|Lost to Follow-up|14|||
146960771|NCT05056311|530016113|FG000|Overall Study|Withdrawal by Subject|1|||
146960772|NCT05056311|530016113|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
146960773|NCT03799198|530016115|FG000|Overall Study|Lost to Follow-up|4|||
146960774|NCT03799198|530016116|FG001|Overall Study|Lost to Follow-up|8|||
146960775|NCT03799198|530016115|FG000|Overall Study|Death|0|||
146960776|NCT03799198|530016116|FG001|Overall Study|Death|1|||
146960777|NCT00960869|530016117|FG000|Overall Study|Adverse Event|17|||
146960778|NCT00960869|530016118|FG001|Overall Study|Adverse Event|26|||
146960779|NCT00960869|530016117|FG000|Overall Study|Withdrawal by Subject|16|||
146960780|NCT00960869|530016118|FG001|Overall Study|Withdrawal by Subject|14|||
146960781|NCT00960869|530016117|FG000|Overall Study|Lost to Follow-up|1|||
146960782|NCT00960869|530016118|FG001|Overall Study|Lost to Follow-up|4|||
146960783|NCT00960869|530016117|FG000|Overall Study|Misc|19|||
146960784|NCT00960869|530016118|FG001|Overall Study|Misc|18|||
146960785|NCT01714726|530016119|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
146960786|NCT01714726|530016120|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
146960787|NCT01714726|530016121|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
146960788|NCT01714726|530016122|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
146960789|NCT01714726|530016119|FG000|Double-Blinded Induction Period|Adverse Event|0|||
146960790|NCT01714726|530016120|FG001|Double-Blinded Induction Period|Adverse Event|1|||
146960791|NCT01714726|530016121|FG002|Double-Blinded Induction Period|Adverse Event|0|||
146960792|NCT01714726|530016122|FG003|Double-Blinded Induction Period|Adverse Event|0|||
146960793|NCT01714726|530016119|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
146960794|NCT01714726|530016120|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
146960795|NCT01714726|530016121|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
146960796|NCT01714726|530016122|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
146960797|NCT01714726|530016119|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
146960798|NCT01714726|530016120|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
146960799|NCT01714726|530016121|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
146960800|NCT01714726|530016122|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
146960801|NCT01714726|530016119|FG000|Open-Label Period|Other|0|||
146960802|NCT01714726|530016120|FG001|Open-Label Period|Other|0|||
146960803|NCT01714726|530016121|FG002|Open-Label Period|Other|1|||
146960804|NCT01714726|530016122|FG003|Open-Label Period|Other|3|||
146960805|NCT01714726|530016119|FG000|Open-Label Period|Adverse Event|0|||
146960806|NCT01714726|530016120|FG001|Open-Label Period|Adverse Event|0|||
146960807|NCT01714726|530016121|FG002|Open-Label Period|Adverse Event|1|||
146960808|NCT01714726|530016122|FG003|Open-Label Period|Adverse Event|0|||
146960809|NCT01714726|530016119|FG000|Open-Label Period|Withdrawal by Subject|0|||
146960810|NCT01714726|530016120|FG001|Open-Label Period|Withdrawal by Subject|0|||
146960811|NCT01714726|530016121|FG002|Open-Label Period|Withdrawal by Subject|9|||
146960812|NCT01714726|530016122|FG003|Open-Label Period|Withdrawal by Subject|19|||
146960813|NCT01714726|530016119|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
146960814|NCT01714726|530016120|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
146960815|NCT01714726|530016121|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
146960816|NCT01714726|530016122|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
146960817|NCT01714726|530016119|FG000|Open-Label Period|Lost to Follow-up|0|||
146960818|NCT01714726|530016120|FG001|Open-Label Period|Lost to Follow-up|0|||
146960819|NCT01714726|530016121|FG002|Open-Label Period|Lost to Follow-up|3|||
146960820|NCT01714726|530016122|FG003|Open-Label Period|Lost to Follow-up|4|||
146960821|NCT02501642|530016123|FG000|Overall Study|Lost to Follow-up|7|||
146960822|NCT02501642|530016124|FG001|Overall Study|Lost to Follow-up|11|||
146960823|NCT01153971|530016130|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
146994168|NCT00669942|530142764|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
146960824|NCT01153971|530016130|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
146839864|NCT00863681|529584661|FG000|Overall Study|Missing|1|||
146839865|NCT00863681|529584662|FG001|Overall Study|Missing|0|||
146839866|NCT00863681|529584663|FG002|Overall Study|Missing|0|||
146960825|NCT01153971|530016130|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
146960826|NCT01153971|530016130|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
146839867|NCT00863681|529584661|FG000|Overall Study|Death|40|||
146839868|NCT00863681|529584662|FG001|Overall Study|Death|23|||
146839869|NCT00863681|529584663|FG002|Overall Study|Death|6|||
146839870|NCT00863681|529584661|FG000|Overall Study|Withdrawal by Subject|12|||
146960827|NCT01153971|530016130|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
146960828|NCT01153971|530016130|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
146960829|NCT01153971|530016130|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
146960830|NCT03628781|530016131|FG000|Overall Study|Lost to Follow-up|16|||
146960831|NCT03628781|530016132|FG001|Overall Study|Lost to Follow-up|8|||
146960832|NCT03628781|530016131|FG000|Overall Study|Withdrawal by Subject|16|||
146960833|NCT03628781|530016132|FG001|Overall Study|Withdrawal by Subject|1|||
146960834|NCT00679042|530016136|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
146960835|NCT00679042|530016136|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
146960836|NCT00679042|530016136|FG000|5-Year Follow Up|Death|1|||
146960837|NCT00679042|530016136|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
146960838|NCT00679042|530016136|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
146960839|NCT00379639|530016137|FG000|Overall Study|Disease Progression|3|||
146960840|NCT00379639|530016138|FG001|Overall Study|Disease Progression|3|||
146960841|NCT00379639|530016139|FG002|Overall Study|Disease Progression|3|||
146960842|NCT00379639|530016140|FG003|Overall Study|Disease Progression|4|||
146960843|NCT00379639|530016141|FG004|Overall Study|Disease Progression|4|||
146960844|NCT00379639|530016137|FG000|Overall Study|Physician Decision|0|||
146960845|NCT00379639|530016138|FG001|Overall Study|Physician Decision|2|||
146960846|NCT00379639|530016139|FG002|Overall Study|Physician Decision|1|||
146960847|NCT00379639|530016140|FG003|Overall Study|Physician Decision|1|||
146960848|NCT00379639|530016141|FG004|Overall Study|Physician Decision|0|||
146960849|NCT00379639|530016137|FG000|Overall Study|Symptomatic Deterioration|0|||
146960850|NCT00379639|530016138|FG001|Overall Study|Symptomatic Deterioration|0|||
146960851|NCT00379639|530016139|FG002|Overall Study|Symptomatic Deterioration|1|||
146960852|NCT00379639|530016140|FG003|Overall Study|Symptomatic Deterioration|0|||
146960853|NCT00379639|530016141|FG004|Overall Study|Symptomatic Deterioration|1|||
146960854|NCT00379639|530016137|FG000|Overall Study|Adverse Event|0|||
146960855|NCT00379639|530016138|FG001|Overall Study|Adverse Event|0|||
146960856|NCT00379639|530016139|FG002|Overall Study|Adverse Event|1|||
146960857|NCT00379639|530016140|FG003|Overall Study|Adverse Event|0|||
146960858|NCT00379639|530016141|FG004|Overall Study|Adverse Event|1|||
146960859|NCT00379639|530016137|FG000|Overall Study|Lost to Follow-up|0|||
146960860|NCT00379639|530016138|FG001|Overall Study|Lost to Follow-up|0|||
146960861|NCT00379639|530016139|FG002|Overall Study|Lost to Follow-up|0|||
146960862|NCT00379639|530016140|FG003|Overall Study|Lost to Follow-up|1|||
146960863|NCT00379639|530016141|FG004|Overall Study|Lost to Follow-up|0|||
146960864|NCT00379639|530016137|FG000|Overall Study|Other|0|||
146960865|NCT00379639|530016138|FG001|Overall Study|Other|0|||
146960866|NCT00379639|530016139|FG002|Overall Study|Other|3|||
146960867|NCT00379639|530016140|FG003|Overall Study|Other|0|||
146960868|NCT00379639|530016141|FG004|Overall Study|Other|0|||
146960869|NCT03053102|530016142|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
146960870|NCT03053102|530016142|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
146960871|NCT01798056|530016143|FG000|Overall Study|Serious Adverse Event|13|||
146960872|NCT01798056|530016144|FG001|Overall Study|Serious Adverse Event|12|||
146960873|NCT01798056|530016143|FG000|Overall Study|Withdrawal by Subject|12|||
146960874|NCT01798056|530016144|FG001|Overall Study|Withdrawal by Subject|9|||
146960875|NCT01798056|530016143|FG000|Overall Study|Migrated/moved from study area|1|||
146960876|NCT01798056|530016144|FG001|Overall Study|Migrated/moved from study area|1|||
146960877|NCT01798056|530016143|FG000|Overall Study|Lost to Follow-up|1|||
146960878|NCT01798056|530016144|FG001|Overall Study|Lost to Follow-up|1|||
146960879|NCT01798056|530016143|FG000|Overall Study|Other|0|||
146960880|NCT01798056|530016144|FG001|Overall Study|Other|2|||
146960881|NCT01238861|530016147|FG000|Overall Study|Lost to Follow-up|4|||
146960882|NCT01238861|530016148|FG001|Overall Study|Lost to Follow-up|2|||
146960883|NCT01238861|530016149|FG002|Overall Study|Lost to Follow-up|3|||
146960884|NCT01238861|530016150|FG003|Overall Study|Lost to Follow-up|1|||
146960885|NCT01238861|530016151|FG004|Overall Study|Lost to Follow-up|1|||
146960886|NCT01238861|530016152|FG005|Overall Study|Lost to Follow-up|2|||
146960887|NCT01238861|530016147|FG000|Overall Study|Unplanned surgery|1|||
146960888|NCT01238861|530016148|FG001|Overall Study|Unplanned surgery|0|||
146960889|NCT01238861|530016149|FG002|Overall Study|Unplanned surgery|0|||
146960890|NCT01238861|530016150|FG003|Overall Study|Unplanned surgery|0|||
146960891|NCT01238861|530016151|FG004|Overall Study|Unplanned surgery|0|||
146960892|NCT01238861|530016152|FG005|Overall Study|Unplanned surgery|0|||
146960893|NCT01238861|530016147|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
146960894|NCT01238861|530016148|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
146960895|NCT01238861|530016149|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
146960896|NCT01238861|530016150|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
146960897|NCT01238861|530016151|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
146960898|NCT01238861|530016152|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
146960899|NCT01238861|530016147|FG000|Overall Study|Incorrect enrollment/randomization|0|||
146960900|NCT01238861|530016148|FG001|Overall Study|Incorrect enrollment/randomization|0|||
146839871|NCT00863681|529584662|FG001|Overall Study|Withdrawal by Subject|5|||
146839872|NCT00863681|529584663|FG002|Overall Study|Withdrawal by Subject|2|||
146960901|NCT01238861|530016149|FG002|Overall Study|Incorrect enrollment/randomization|1|||
146960902|NCT01238861|530016150|FG003|Overall Study|Incorrect enrollment/randomization|0|||
146960903|NCT01238861|530016151|FG004|Overall Study|Incorrect enrollment/randomization|1|||
146960904|NCT01238861|530016152|FG005|Overall Study|Incorrect enrollment/randomization|0|||
146960905|NCT01238861|530016147|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
146960906|NCT01238861|530016148|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
146960907|NCT01238861|530016149|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
146960908|NCT01238861|530016150|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
146960909|NCT01238861|530016151|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
146960910|NCT01238861|530016152|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
146960911|NCT01238861|530016147|FG000|Overall Study|Subject moved out of state/area|0|||
146960912|NCT01238861|530016148|FG001|Overall Study|Subject moved out of state/area|0|||
146960913|NCT01238861|530016149|FG002|Overall Study|Subject moved out of state/area|1|||
146960914|NCT01238861|530016150|FG003|Overall Study|Subject moved out of state/area|1|||
146960915|NCT01238861|530016151|FG004|Overall Study|Subject moved out of state/area|0|||
146960916|NCT01238861|530016152|FG005|Overall Study|Subject moved out of state/area|0|||
146960917|NCT01238861|530016147|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
146960918|NCT01238861|530016148|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
146960919|NCT01238861|530016149|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
146960920|NCT01238861|530016150|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
146960921|NCT01238861|530016151|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
146960922|NCT01238861|530016152|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
146960923|NCT01238861|530016147|FG000|Overall Study|Personal problems|0|||
146960924|NCT01238861|530016148|FG001|Overall Study|Personal problems|0|||
146960925|NCT01238861|530016149|FG002|Overall Study|Personal problems|0|||
146960926|NCT01238861|530016150|FG003|Overall Study|Personal problems|1|||
146960927|NCT01238861|530016151|FG004|Overall Study|Personal problems|0|||
146960928|NCT01238861|530016152|FG005|Overall Study|Personal problems|0|||
146960929|NCT01238861|530016147|FG000|Overall Study|Unable to continue visits|0|||
146960930|NCT01238861|530016148|FG001|Overall Study|Unable to continue visits|0|||
146960931|NCT01238861|530016149|FG002|Overall Study|Unable to continue visits|0|||
146960932|NCT01238861|530016150|FG003|Overall Study|Unable to continue visits|1|||
146960933|NCT01238861|530016151|FG004|Overall Study|Unable to continue visits|0|||
146960934|NCT01238861|530016152|FG005|Overall Study|Unable to continue visits|1|||
146960935|NCT01238861|530016147|FG000|Overall Study|Serious adverse event|0|||
146960936|NCT01238861|530016148|FG001|Overall Study|Serious adverse event|0|||
146960937|NCT01238861|530016149|FG002|Overall Study|Serious adverse event|0|||
146960938|NCT01238861|530016150|FG003|Overall Study|Serious adverse event|0|||
146960939|NCT01238861|530016151|FG004|Overall Study|Serious adverse event|0|||
146960940|NCT01238861|530016152|FG005|Overall Study|Serious adverse event|1|||
146960941|NCT01238861|530016147|FG000|Overall Study|Lack of compliance|0|||
146960942|NCT01238861|530016148|FG001|Overall Study|Lack of compliance|0|||
146960943|NCT01238861|530016149|FG002|Overall Study|Lack of compliance|0|||
146960944|NCT01238861|530016150|FG003|Overall Study|Lack of compliance|0|||
146960945|NCT01238861|530016151|FG004|Overall Study|Lack of compliance|0|||
146960946|NCT01238861|530016152|FG005|Overall Study|Lack of compliance|1|||
146960947|NCT01238861|530016147|FG000|Overall Study|Adverse Event|0|||
146960948|NCT01238861|530016148|FG001|Overall Study|Adverse Event|1|||
146960949|NCT01238861|530016149|FG002|Overall Study|Adverse Event|0|||
146960950|NCT01238861|530016150|FG003|Overall Study|Adverse Event|0|||
146960951|NCT01238861|530016151|FG004|Overall Study|Adverse Event|0|||
146960952|NCT01238861|530016152|FG005|Overall Study|Adverse Event|0|||
146960953|NCT01238861|530016147|FG000|Overall Study|Withdrawal by Subject|6|||
146960954|NCT01238861|530016148|FG001|Overall Study|Withdrawal by Subject|5|||
146960955|NCT01238861|530016149|FG002|Overall Study|Withdrawal by Subject|4|||
146960956|NCT01238861|530016150|FG003|Overall Study|Withdrawal by Subject|8|||
146960957|NCT01238861|530016151|FG004|Overall Study|Withdrawal by Subject|10|||
146960958|NCT01238861|530016152|FG005|Overall Study|Withdrawal by Subject|9|||
146960959|NCT01269346|530016153|FG000|Treatment Phase|Disease progression|3|||
146960960|NCT01269346|530016153|FG000|Treatment Phase|Adverse Event|3|||
146960961|NCT01269346|530016153|FG000|Treatment Phase|Withdrawal by Subject|1|||
146960962|NCT01269346|530016153|FG000|Treatment Phase|Other|2|||
146960963|NCT01269346|530016153|FG000|Extension Phase|Adverse Event|6|||
146960964|NCT01269346|530016153|FG000|Extension Phase|Withdrawal by Subject|4|||
146960965|NCT01269346|530016153|FG000|Extension Phase|Disease progression|22|||
146960966|NCT01269346|530016153|FG000|Extension Phase|Physician decision or participant choice|9|||
146960967|NCT01269346|530016153|FG000|Extension Phase|Clinical progression|1|||
146960968|NCT01269346|530016153|FG000|Extension Phase|Started a prohibited con med|1|||
146960969|NCT00247416|530016154|FG000|Overall Study|3 patients were found to be ineligible|1|||
146960970|NCT00247416|530016155|FG001|Overall Study|3 patients were found to be ineligible|2|||
146960971|NCT04963231|530016157|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
146839873|NCT00863681|529584661|FG000|Overall Study|Protocol Violation|2|||
146839874|NCT00863681|529584662|FG001|Overall Study|Protocol Violation|0|||
146839875|NCT00863681|529584663|FG002|Overall Study|Protocol Violation|0|||
146839876|NCT00863681|529584661|FG000|Overall Study|Lost to Follow-up|3|||
146839877|NCT00863681|529584662|FG001|Overall Study|Lost to Follow-up|0|||
146839878|NCT00863681|529584663|FG002|Overall Study|Lost to Follow-up|3|||
146839879|NCT00863681|529584661|FG000|Overall Study|Adverse Event|28|||
146839880|NCT00863681|529584662|FG001|Overall Study|Adverse Event|10|||
146839881|NCT00863681|529584663|FG002|Overall Study|Adverse Event|6|||
146839882|NCT00863681|529584661|FG000|Overall Study|Lack of Efficacy|2|||
146839883|NCT00863681|529584662|FG001|Overall Study|Lack of Efficacy|2|||
146839884|NCT00863681|529584663|FG002|Overall Study|Lack of Efficacy|1|||
146839885|NCT00863681|529584661|FG000|Overall Study|Non-compliance with study drug|1|||
146839886|NCT00863681|529584662|FG001|Overall Study|Non-compliance with study drug|3|||
146839887|NCT00863681|529584663|FG002|Overall Study|Non-compliance with study drug|0|||
146839888|NCT03842228|529584664|FG000|Overall Study|Adverse Event|1|||
146839889|NCT03842228|529584665|FG001|Overall Study|Adverse Event|1|||
146839890|NCT03842228|529584666|FG002|Overall Study|Adverse Event|1|||
146839891|NCT03842228|529584667|FG003|Overall Study|Adverse Event|0|||
146839892|NCT03842228|529584668|FG004|Overall Study|Adverse Event|0|||
146839893|NCT03842228|529584669|FG005|Overall Study|Adverse Event|0|||
146839894|NCT03842228|529584670|FG006|Overall Study|Adverse Event|0|||
146839895|NCT03842228|529584664|FG000|Overall Study|Death|0|||
146839896|NCT03842228|529584665|FG001|Overall Study|Death|1|||
146839897|NCT03842228|529584666|FG002|Overall Study|Death|0|||
146839898|NCT03842228|529584667|FG003|Overall Study|Death|0|||
146839899|NCT03842228|529584668|FG004|Overall Study|Death|0|||
146839900|NCT03842228|529584669|FG005|Overall Study|Death|0|||
146839901|NCT03842228|529584670|FG006|Overall Study|Death|0|||
146839902|NCT03842228|529584664|FG000|Overall Study|Withdrawal by Subject|0|||
146839903|NCT03842228|529584665|FG001|Overall Study|Withdrawal by Subject|0|||
146839904|NCT03842228|529584666|FG002|Overall Study|Withdrawal by Subject|2|||
146839905|NCT03842228|529584667|FG003|Overall Study|Withdrawal by Subject|1|||
146960972|NCT04963231|530016158|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
146960973|NCT04963231|530016159|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
146960974|NCT04963231|530016157|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
146960975|NCT04963231|530016158|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
146960976|NCT04963231|530016159|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
146960977|NCT04963231|530016157|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
146960978|NCT04963231|530016158|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
146960979|NCT04963231|530016159|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
146960980|NCT04963231|530016157|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
146960981|NCT04963231|530016158|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
146960982|NCT04963231|530016159|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
146960983|NCT04963231|530016157|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
146960984|NCT04963231|530016158|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
146960985|NCT04963231|530016159|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
146960986|NCT04963231|530016157|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
146960987|NCT04963231|530016158|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
146960988|NCT04963231|530016159|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
146960989|NCT04963231|530016157|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
146960990|NCT04963231|530016158|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
146960991|NCT04963231|530016159|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
146960992|NCT01059175|530016160|FG000|Overall Study|Death|17|||
146960993|NCT01059175|530016161|FG001|Overall Study|Death|17|||
146960994|NCT01059175|530016160|FG000|Overall Study|Adverse Event|4|||
146960995|NCT01059175|530016161|FG001|Overall Study|Adverse Event|2|||
146960996|NCT01059175|530016160|FG000|Overall Study|Lost to Follow-up|0|||
146960997|NCT01059175|530016161|FG001|Overall Study|Lost to Follow-up|1|||
146960998|NCT02957149|530016162|FG000|Overall Study|Withdrawal by Subject|5|||
146960999|NCT01097057|530016168|FG000|Overall Study|Physician Decision|3|||
146961000|NCT03198559|530016172|FG000|Overall Study|Adverse Event|2|||
146961001|NCT03737812|530016173|FG000|Overall Study|Withdrawal by Subject|1|||
146961002|NCT03737812|530016174|FG001|Overall Study|Withdrawal by Subject|2|||
146961003|NCT03737812|530016175|FG002|Overall Study|Withdrawal by Subject|1|||
146961004|NCT03737812|530016173|FG000|Overall Study|Sponsor Discontinued the Study|4|||
146839906|NCT03842228|529584668|FG004|Overall Study|Withdrawal by Subject|0|||
146839907|NCT03842228|529584669|FG005|Overall Study|Withdrawal by Subject|0|||
146839908|NCT03842228|529584670|FG006|Overall Study|Withdrawal by Subject|2|||
146839909|NCT03842228|529584664|FG000|Overall Study|Progression|8|||
146839910|NCT03842228|529584665|FG001|Overall Study|Progression|1|||
146839911|NCT03842228|529584666|FG002|Overall Study|Progression|7|||
146961005|NCT03737812|530016174|FG001|Overall Study|Sponsor Discontinued the Study|3|||
146839912|NCT03842228|529584667|FG003|Overall Study|Progression|5|||
146839913|NCT03842228|529584668|FG004|Overall Study|Progression|4|||
146994169|NCT00669942|530142765|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
146994170|NCT00669942|530142766|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
146994171|NCT00669942|530142767|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
146994172|NCT00669942|530142756|FG000|Parts 2 and 3|Protocol Violation|0|||
146994173|NCT00669942|530142757|FG001|Parts 2 and 3|Protocol Violation|0|||
146994174|NCT00669942|530142758|FG002|Parts 2 and 3|Protocol Violation|0|||
146994175|NCT00669942|530142759|FG003|Parts 2 and 3|Protocol Violation|0|||
146994176|NCT00669942|530142760|FG004|Parts 2 and 3|Protocol Violation|0|||
146994177|NCT00669942|530142761|FG005|Parts 2 and 3|Protocol Violation|1|||
146994178|NCT00669942|530142762|FG006|Parts 2 and 3|Protocol Violation|0|||
146994179|NCT00669942|530142763|FG007|Parts 2 and 3|Protocol Violation|0|||
146994180|NCT00669942|530142764|FG008|Parts 2 and 3|Protocol Violation|0|||
146994181|NCT00669942|530142765|FG009|Parts 2 and 3|Protocol Violation|0|||
146994182|NCT00669942|530142766|FG010|Parts 2 and 3|Protocol Violation|0|||
146994183|NCT00669942|530142767|FG011|Parts 2 and 3|Protocol Violation|0|||
146994184|NCT02107092|530142768|FG000|Overall Study|Miscellaneous|3|||
146994185|NCT02107092|530142768|FG000|Overall Study|Subject compliance|3|||
146994186|NCT02107092|530142768|FG000|Overall Study|Hypo-or hyperkalemia|2|||
146994187|NCT02107092|530142768|FG000|Overall Study|Met ECG withdrawal criteria|3|||
146994188|NCT02107092|530142768|FG000|Overall Study|Physician Decision|3|||
146994189|NCT02107092|530142768|FG000|Overall Study|Lost to Follow-up|2|||
146994190|NCT02107092|530142768|FG000|Overall Study|Withdrawal by Subject|9|||
146994191|NCT02107092|530142768|FG000|Overall Study|Adverse Event|7|||
146994192|NCT02107092|530142768|FG000|Overall Study|Expected progression of CKD|12|||
146994193|NCT04213326|530142773|FG000|Overall Study|Consent withdrawn|51|||
146994194|NCT04213326|530142774|FG001|Overall Study|Consent withdrawn|241|||
146994195|NCT04213326|530142773|FG000|Overall Study|Lost to Follow-up|50|||
146994196|NCT04213326|530142774|FG001|Overall Study|Lost to Follow-up|902|||
146994197|NCT04213326|530142773|FG000|Overall Study|Protocol Violation|3|||
146994198|NCT04213326|530142774|FG001|Overall Study|Protocol Violation|25|||
146994199|NCT04213326|530142773|FG000|Overall Study|Participant eligibility changed|106|||
146994200|NCT04213326|530142774|FG001|Overall Study|Participant eligibility changed|19|||
146994201|NCT04213326|530142773|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
146994202|NCT04213326|530142774|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
146994203|NCT04213326|530142773|FG000|Overall Study|Incomplete study visit|0|||
146994204|NCT04213326|530142774|FG001|Overall Study|Incomplete study visit|367|||
146994205|NCT02549092|530142775|FG000|Treatment Period|Adverse Event|2|||
146994206|NCT02549092|530142776|FG001|Treatment Period|Adverse Event|2|||
146994207|NCT02549092|530142775|FG000|Treatment Period|Withdrawal by Subject|1|||
146994208|NCT02549092|530142776|FG001|Treatment Period|Withdrawal by Subject|3|||
146994209|NCT02549092|530142775|FG000|Treatment Period|Lack of Efficacy|0|||
146994210|NCT02549092|530142776|FG001|Treatment Period|Lack of Efficacy|2|||
146994211|NCT02549092|530142775|FG000|Extension/Transition Period|Adverse Event|1|||
146994212|NCT02549092|530142776|FG001|Extension/Transition Period|Adverse Event|1|||
146994213|NCT02549092|530142775|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
146994214|NCT02549092|530142776|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
146994215|NCT02549092|530142775|FG000|Extension/Transition Period|Other, Not Specified|4|||
146994216|NCT02549092|530142776|FG001|Extension/Transition Period|Other, Not Specified|2|||
146994217|NCT03002077|530142783|FG000|Overall Study|Non-compliance with Study Drug|4|||
146994218|NCT03002077|530142783|FG000|Overall Study|Non-compliance w/Background ADT|1|||
146994219|NCT03002077|530142783|FG000|Overall Study|Study Terminated by Sponsor|257|||
146994220|NCT03002077|530142783|FG000|Overall Study|Site Terminated by Sponsor|5|||
146994221|NCT03002077|530142783|FG000|Overall Study|Miscellaneous Reasons|10|||
146994222|NCT03002077|530142783|FG000|Overall Study|Adverse Event|23|||
146994223|NCT03002077|530142783|FG000|Overall Study|Lack of Efficacy|20|||
146994224|NCT03002077|530142783|FG000|Overall Study|Withdrawal by Subject|72|||
146994225|NCT03002077|530142783|FG000|Overall Study|Lost to Follow-up|21|||
146994226|NCT03002077|530142783|FG000|Overall Study|Pregnancy|4|||
146994227|NCT03002077|530142783|FG000|Overall Study|Protocol Violation|21|||
146994228|NCT04625114|530142794|FG000|Overall Study|Adverse Event|3|||
146994229|NCT04625114|530142795|FG001|Overall Study|Adverse Event|1|||
146994230|NCT04625114|530142794|FG000|Overall Study|Withdrawal by Subject|2|||
146994231|NCT04625114|530142795|FG001|Overall Study|Withdrawal by Subject|0|||
146994232|NCT01629381|530142796|FG000|Overall Study|Withdrawal by Subject|2|||
146994233|NCT01629381|530142797|FG001|Overall Study|Withdrawal by Subject|5|||
146994234|NCT00906347|530142800|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
146994235|NCT00906347|530142801|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
146994236|NCT00906347|530142800|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
146994237|NCT00906347|530142801|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
146994238|NCT00906347|530142800|FG000|Received Study Drug|Refused study drug|1|||
146994239|NCT00906347|530142801|FG001|Received Study Drug|Refused study drug|0|||
146994240|NCT00906347|530142800|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
146994241|NCT00906347|530142801|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
146994242|NCT02849652|530142809|FG000|Overall Study|Lost to Follow-up|104|||
146994243|NCT02849652|530142810|FG001|Overall Study|Lost to Follow-up|35|||
146994244|NCT02849652|530142811|FG002|Overall Study|Lost to Follow-up|116|||
146839914|NCT03842228|529584669|FG005|Overall Study|Progression|2|||
146839915|NCT03842228|529584670|FG006|Overall Study|Progression|3|||
146839916|NCT01263509|529584671|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
146839917|NCT01263509|529584672|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
146839918|NCT01263509|529584673|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
146839919|NCT01263509|529584674|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
146839920|NCT01263509|529584671|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
146839921|NCT01263509|529584672|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
146839922|NCT01263509|529584673|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
146839923|NCT01263509|529584674|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
146839924|NCT01263509|529584671|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
146839925|NCT01263509|529584672|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
146961006|NCT03737812|530016175|FG002|Overall Study|Sponsor Discontinued the Study|2|||
146961007|NCT03737812|530016173|FG000|Overall Study|Adverse Event|0|||
146961008|NCT03737812|530016174|FG001|Overall Study|Adverse Event|1|||
146961009|NCT03737812|530016175|FG002|Overall Study|Adverse Event|0|||
146961010|NCT03737812|530016173|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
146961011|NCT03737812|530016174|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
146961012|NCT03737812|530016175|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
146961013|NCT02624713|530016176|FG000|Overall Study|Lost to Follow-up|14|||
146961014|NCT02624713|530016177|FG001|Overall Study|Lost to Follow-up|0|||
146961015|NCT01911546|530016181|FG000|Overall Study|Lost to Follow-up|1|||
146961016|NCT01911546|530016181|FG000|Overall Study|Everolimus was discontinued|5|||
146961017|NCT01474291|530016186|FG000|Overall Study|Not Evaluable for Efficacy|26|||
146961018|NCT01474291|530016186|FG000|Overall Study|Lack of Treatment Efficacy|88|||
146961019|NCT01474291|530016186|FG000|Overall Study|Adverse Event|53|||
146961020|NCT01474291|530016186|FG000|Overall Study|Lost to Follow-up|29|||
146961021|NCT01474291|530016186|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
146961022|NCT01474291|530016186|FG000|Overall Study|No Reason Reported|10|||
146961023|NCT01474291|530016186|FG000|Overall Study|Death|2|||
146961024|NCT03471507|530016187|FG000|Overall Study|Lost to Follow-up|1|||
146961025|NCT03471507|530016188|FG001|Overall Study|Lost to Follow-up|3|||
146961026|NCT03471507|530016187|FG000|Overall Study|Physician Decision|0|||
146961027|NCT03471507|530016188|FG001|Overall Study|Physician Decision|1|||
146961028|NCT03471507|530016187|FG000|Overall Study|Withdrawal by Subject|2|||
146961029|NCT03471507|530016188|FG001|Overall Study|Withdrawal by Subject|1|||
146961030|NCT02213666|530016189|FG000|Overall Study|Withdrawal by Subject|1|||
146961031|NCT01399619|530016190|FG000|Overall Study|Adverse Event|10|||
146961032|NCT01399619|530016191|FG001|Overall Study|Adverse Event|0|||
146961033|NCT01399619|530016192|FG002|Overall Study|Adverse Event|4|||
146961034|NCT01399619|530016193|FG003|Overall Study|Adverse Event|10|||
146961035|NCT01399619|530016190|FG000|Overall Study|Lack of Efficacy|9|||
146961036|NCT01399619|530016191|FG001|Overall Study|Lack of Efficacy|0|||
146961037|NCT01399619|530016192|FG002|Overall Study|Lack of Efficacy|5|||
146961038|NCT01399619|530016193|FG003|Overall Study|Lack of Efficacy|0|||
146961039|NCT01399619|530016190|FG000|Overall Study|Withdrawal by Subject|6|||
146961040|NCT01399619|530016191|FG001|Overall Study|Withdrawal by Subject|0|||
146961041|NCT01399619|530016192|FG002|Overall Study|Withdrawal by Subject|3|||
146961042|NCT01399619|530016193|FG003|Overall Study|Withdrawal by Subject|4|||
146961043|NCT01399619|530016190|FG000|Overall Study|Protocol Violation|0|||
146961044|NCT01399619|530016191|FG001|Overall Study|Protocol Violation|0|||
146961045|NCT01399619|530016192|FG002|Overall Study|Protocol Violation|0|||
146961046|NCT01399619|530016193|FG003|Overall Study|Protocol Violation|1|||
146961047|NCT01399619|530016190|FG000|Overall Study|Not treated|0|||
146961048|NCT01399619|530016191|FG001|Overall Study|Not treated|0|||
146961049|NCT01399619|530016192|FG002|Overall Study|Not treated|0|||
146961050|NCT01399619|530016193|FG003|Overall Study|Not treated|2|||
146961051|NCT00750061|530016194|FG000|Overall Study|Adverse Event|2|||
146961052|NCT00750061|530016195|FG001|Overall Study|Adverse Event|0|||
146961053|NCT00750061|530016194|FG000|Overall Study|Withdrawal by Subject|0|||
146961054|NCT00750061|530016195|FG001|Overall Study|Withdrawal by Subject|1|||
146961055|NCT00750061|530016194|FG000|Overall Study|Physician Decision|0|||
146961056|NCT00750061|530016195|FG001|Overall Study|Physician Decision|1|||
146961057|NCT01590628|530016219|FG000|Overall Study|Death|2|||
146961058|NCT01590628|530016220|FG001|Overall Study|Death|0|||
146961059|NCT00229931|530016221|FG000|Overall Study|Death|1|||
146961060|NCT00229931|530016222|FG001|Overall Study|Death|0|||
146961061|NCT00229931|530016221|FG000|Overall Study|Lost to Follow-up|3|||
146961062|NCT00229931|530016222|FG001|Overall Study|Lost to Follow-up|2|||
146961063|NCT00475657|530016223|FG000|Overall Study|Death|1|||
146961064|NCT00475657|530016223|FG000|Overall Study|Sponsor's Decision|3|||
146961065|NCT02992743|530016224|FG000|Overall Study|Withdrawal by Subject|1|||
146961066|NCT02992743|530016225|FG001|Overall Study|Withdrawal by Subject|1|||
146961067|NCT02992743|530016224|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
146961068|NCT02992743|530016225|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
146961069|NCT02992743|530016224|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
146961070|NCT02992743|530016225|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
146961071|NCT02992743|530016224|FG000|Overall Study|No measurable disease|1|||
146961072|NCT02992743|530016225|FG001|Overall Study|No measurable disease|0|||
146961073|NCT02992743|530016224|FG000|Overall Study|Lost to Follow-up|0|||
146961074|NCT02992743|530016225|FG001|Overall Study|Lost to Follow-up|1|||
146961075|NCT00998166|530016228|FG000|Overall Study|Early Study Termination|8|||
146961076|NCT04585906|530016241|FG000|Overall Study|Lost to Follow-up|8|||
146961077|NCT04585906|530016242|FG001|Overall Study|Lost to Follow-up|5|||
146961078|NCT03907072|530016243|FG000|Overall Study|Study Terminated by Sponsor|2|||
146961079|NCT03907072|530016244|FG001|Overall Study|Study Terminated by Sponsor|2|||
146961080|NCT03907072|530016245|FG002|Overall Study|Study Terminated by Sponsor|2|||
146961081|NCT02463097|530016248|FG000|Overall Study|Withdrawal by Subject|1|||
146961082|NCT03326323|530016249|FG000|Overall Study|Unable to receive ANH protocol|3|||
146961083|NCT02243306|530016250|FG000|Overall Study|Adverse Event|0|||
146961084|NCT02243306|530016251|FG001|Overall Study|Adverse Event|1|||
146961085|NCT02243306|530016250|FG000|Overall Study|Other: Reached stopping criteria|0|||
146961086|NCT02243306|530016251|FG001|Overall Study|Other: Reached stopping criteria|1|||
146961087|NCT02243306|530016250|FG000|Overall Study|Physician Decision|0|||
146961088|NCT02243306|530016251|FG001|Overall Study|Physician Decision|1|||
146961089|NCT02221882|530016252|FG000|Overall Study|Withdrawal by Subject|0|||
146961090|NCT02221882|530016253|FG001|Overall Study|Withdrawal by Subject|0|||
146961091|NCT02221882|530016254|FG002|Overall Study|Withdrawal by Subject|4|||
146961092|NCT02221882|530016255|FG003|Overall Study|Withdrawal by Subject|2|||
146961093|NCT02221882|530016256|FG004|Overall Study|Withdrawal by Subject|2|||
146961094|NCT02221882|530016257|FG005|Overall Study|Withdrawal by Subject|2|||
146961095|NCT02221882|530016252|FG000|Overall Study|Death|0|||
146961096|NCT02221882|530016253|FG001|Overall Study|Death|1|||
146961097|NCT02221882|530016254|FG002|Overall Study|Death|0|||
146961098|NCT02221882|530016255|FG003|Overall Study|Death|0|||
146961099|NCT02221882|530016256|FG004|Overall Study|Death|0|||
146961100|NCT02221882|530016257|FG005|Overall Study|Death|0|||
146961101|NCT00796367|530016258|FG000|Overall Study|Adverse Event|6|||
146961102|NCT00796367|530016259|FG001|Overall Study|Adverse Event|4|||
146961103|NCT00796367|530016260|FG002|Overall Study|Adverse Event|7|||
146961104|NCT00796367|530016258|FG000|Overall Study|Lost to Follow-up|5|||
146961105|NCT00796367|530016259|FG001|Overall Study|Lost to Follow-up|4|||
146961106|NCT00796367|530016260|FG002|Overall Study|Lost to Follow-up|21|||
146961107|NCT00796367|530016258|FG000|Overall Study|Withdrawal by Subject|9|||
146961108|NCT00796367|530016259|FG001|Overall Study|Withdrawal by Subject|11|||
146961109|NCT00796367|530016260|FG002|Overall Study|Withdrawal by Subject|12|||
146961110|NCT00796367|530016258|FG000|Overall Study|Lack of Efficacy|2|||
146961111|NCT00796367|530016259|FG001|Overall Study|Lack of Efficacy|1|||
146961112|NCT00796367|530016260|FG002|Overall Study|Lack of Efficacy|0|||
146961113|NCT00796367|530016258|FG000|Overall Study|non compliance|3|||
146961114|NCT00796367|530016259|FG001|Overall Study|non compliance|1|||
146961115|NCT00796367|530016260|FG002|Overall Study|non compliance|1|||
146961116|NCT00796367|530016258|FG000|Overall Study|Pregnancy|1|||
146961117|NCT00796367|530016259|FG001|Overall Study|Pregnancy|0|||
146961118|NCT00796367|530016260|FG002|Overall Study|Pregnancy|1|||
146961119|NCT00796367|530016258|FG000|Overall Study|Requirement for restricted medication|2|||
146961120|NCT00796367|530016259|FG001|Overall Study|Requirement for restricted medication|0|||
146961121|NCT00796367|530016260|FG002|Overall Study|Requirement for restricted medication|2|||
146961122|NCT00796367|530016258|FG000|Overall Study|other|2|||
146961123|NCT00796367|530016259|FG001|Overall Study|other|4|||
146961124|NCT00796367|530016260|FG002|Overall Study|other|3|||
146961125|NCT01815099|530016261|FG000|Overall Study|Lack of Efficacy|1|||
146961126|NCT01815099|530016261|FG000|Overall Study|unable to attend study visits|1|||
146961127|NCT01475214|530016262|FG000|Overall Study|Lost to Follow-up|1|||
146961128|NCT01475214|530016263|FG001|Overall Study|Lost to Follow-up|0|||
146961129|NCT01475214|530016264|FG002|Overall Study|Lost to Follow-up|1|||
146961130|NCT01475214|530016262|FG000|Overall Study|Physician Decision|2|||
146961131|NCT01475214|530016263|FG001|Overall Study|Physician Decision|0|||
146994245|NCT02849652|530142812|FG003|Overall Study|Lost to Follow-up|22|||
146994246|NCT02849652|530142809|FG000|Overall Study|Withdrawal by Subject|10|||
146961132|NCT01475214|530016264|FG002|Overall Study|Physician Decision|0|||
146961133|NCT01475214|530016262|FG000|Overall Study|Withdrawal by Subject|2|||
146961134|NCT01475214|530016263|FG001|Overall Study|Withdrawal by Subject|4|||
146961135|NCT01475214|530016264|FG002|Overall Study|Withdrawal by Subject|1|||
146961136|NCT00643851|530016265|FG000|Overall Study|Death|0|||
146961137|NCT00643851|530016266|FG001|Overall Study|Death|1|||
146961138|NCT00643851|530016267|FG002|Overall Study|Death|0|||
146961139|NCT00643851|530016265|FG000|Overall Study|Lack of Efficacy|0|||
146961140|NCT00643851|530016266|FG001|Overall Study|Lack of Efficacy|1|||
146961141|NCT00643851|530016267|FG002|Overall Study|Lack of Efficacy|0|||
146961142|NCT00643851|530016265|FG000|Overall Study|Adverse Event|2|||
146961143|NCT00643851|530016266|FG001|Overall Study|Adverse Event|6|||
146961144|NCT00643851|530016267|FG002|Overall Study|Adverse Event|6|||
146961145|NCT00643851|530016265|FG000|Overall Study|Lost to Follow-up|4|||
146961146|NCT00643851|530016266|FG001|Overall Study|Lost to Follow-up|6|||
146961147|NCT00643851|530016267|FG002|Overall Study|Lost to Follow-up|9|||
146839926|NCT01263509|529584673|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
146839927|NCT01263509|529584674|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
146839928|NCT01263509|529584671|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
146839929|NCT01263509|529584672|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
146839930|NCT01263509|529584673|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146839931|NCT01263509|529584674|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146839932|NCT01263509|529584671|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
146839933|NCT01263509|529584672|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
146839934|NCT01263509|529584673|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
146839935|NCT01263509|529584674|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
146839936|NCT04916730|529584682|FG000|Overall Study|Withdrawal by Subject|4|||
146839937|NCT04916730|529584683|FG001|Overall Study|Withdrawal by Subject|2|||
146839938|NCT04916730|529584682|FG000|Overall Study|Lost to Follow-up|0|||
146839939|NCT04916730|529584683|FG001|Overall Study|Lost to Follow-up|2|||
146839940|NCT04916730|529584682|FG000|Overall Study|Physician Decision|1|||
146839941|NCT04916730|529584683|FG001|Overall Study|Physician Decision|0|||
146839942|NCT02514551|529584686|FG000|Overall Study|Lost to Follow-up|0|||
146839943|NCT02514551|529584687|FG001|Overall Study|Lost to Follow-up|1|||
146839944|NCT02514551|529584686|FG000|Overall Study|Participant Never Treated|0|||
146839945|NCT02514551|529584687|FG001|Overall Study|Participant Never Treated|2|||
146839946|NCT00996606|529584688|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
146839947|NCT00996606|529584688|FG000|Overall Study|Insufficient Therapeutic Response|2|||
146839948|NCT00996606|529584688|FG000|Overall Study|Protocol Violation|1|||
146839949|NCT00996606|529584688|FG000|Overall Study|Withdrawal by Subject|3|||
146839950|NCT00632502|529584693|FG000|Overall Study|Adverse Event|0|||
146839951|NCT00632502|529584694|FG001|Overall Study|Adverse Event|1|||
146839952|NCT00632502|529584693|FG000|Overall Study|Randomized not treated|3|||
146839953|NCT00632502|529584694|FG001|Overall Study|Randomized not treated|0|||
146839954|NCT04954326|529584695|FG000|Overall Study|Protocol Violation|0|||
146839955|NCT04954326|529584696|FG001|Overall Study|Protocol Violation|1|||
146839956|NCT04954326|529584695|FG000|Overall Study|Death|0|||
146839957|NCT04954326|529584696|FG001|Overall Study|Death|2|||
146839958|NCT04954326|529584695|FG000|Overall Study|Physician Decision|0|||
146961148|NCT00643851|530016265|FG000|Overall Study|Withdrawal by Subject|8|||
146994247|NCT02849652|530142810|FG001|Overall Study|Withdrawal by Subject|2|||
146961149|NCT00643851|530016266|FG001|Overall Study|Withdrawal by Subject|15|||
146961150|NCT00643851|530016267|FG002|Overall Study|Withdrawal by Subject|9|||
146961151|NCT00643851|530016265|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
146961152|NCT00643851|530016266|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
146961153|NCT00643851|530016267|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
146961154|NCT00465894|530016268|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
146961155|NCT00465894|530016269|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
146961156|NCT00465894|530016268|FG000|Treatment For 12 Weeks|Family Issues|1|||
146961157|NCT00465894|530016269|FG001|Treatment For 12 Weeks|Family Issues|1|||
146961158|NCT00465894|530016268|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
146961159|NCT00465894|530016269|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
146961160|NCT01636076|530016270|FG000|Overall Study|Terminated by sponsor|1|||
146961161|NCT01636076|530016271|FG001|Overall Study|Terminated by sponsor|1|||
146961162|NCT01636076|530016270|FG000|Overall Study|Lack of Efficacy|0|||
146961163|NCT01636076|530016271|FG001|Overall Study|Lack of Efficacy|1|||
146961164|NCT01636076|530016270|FG000|Overall Study|Lost to Follow-up|1|||
146961165|NCT01636076|530016271|FG001|Overall Study|Lost to Follow-up|0|||
146961166|NCT01636076|530016270|FG000|Overall Study|Physician Decision|1|||
146961167|NCT01636076|530016271|FG001|Overall Study|Physician Decision|1|||
146961168|NCT01636076|530016270|FG000|Overall Study|Non-compliance with study treatment|1|||
146961169|NCT01636076|530016271|FG001|Overall Study|Non-compliance with study treatment|1|||
146961170|NCT01636076|530016270|FG000|Overall Study|Adverse Event|6|||
146961171|NCT01636076|530016271|FG001|Overall Study|Adverse Event|11|||
146961172|NCT01636076|530016270|FG000|Overall Study|Withdrawal by Subject|7|||
146961173|NCT01636076|530016271|FG001|Overall Study|Withdrawal by Subject|10|||
146961174|NCT01159665|530016272|FG000|Overall Study|Withdrawal by Subject|0|||
146994248|NCT02849652|530142811|FG002|Overall Study|Withdrawal by Subject|8|||
146994249|NCT02849652|530142812|FG003|Overall Study|Withdrawal by Subject|4|||
146994250|NCT00472290|530142813|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
146994251|NCT00472290|530142813|FG000|Overall Study|Protocol Specified Criteria|7|||
146994252|NCT00472290|530142813|FG000|Overall Study|Administrative Decision|37|||
146994253|NCT00472290|530142813|FG000|Overall Study|Death|3|||
146994254|NCT00472290|530142813|FG000|Overall Study|Lost to Follow-up|1|||
146994255|NCT00472290|530142813|FG000|Overall Study|Lack of Efficacy|1|||
146839959|NCT04954326|529584696|FG001|Overall Study|Physician Decision|1|||
146961175|NCT01159665|530016273|FG001|Overall Study|Withdrawal by Subject|1|||
146961176|NCT01159665|530016274|FG002|Overall Study|Withdrawal by Subject|0|||
146961177|NCT01159665|530016275|FG003|Overall Study|Withdrawal by Subject|0|||
146961178|NCT01159665|530016276|FG004|Overall Study|Withdrawal by Subject|0|||
146994256|NCT00472290|530142813|FG000|Overall Study|Disease Progression|4|||
146994257|NCT00472290|530142813|FG000|Overall Study|Withdrawal by Subject|5|||
146994258|NCT00472290|530142813|FG000|Overall Study|Adverse Event|6|||
146994259|NCT00472290|530142813|FG000|Overall Study|Requirement for alternative therapy|7|||
146994260|NCT00777829|530142814|FG000|Overall Study|Withdrawal by Subject|0|||
146994261|NCT00777829|530142815|FG001|Overall Study|Withdrawal by Subject|2|||
146994262|NCT00854308|530142824|FG000|Overall Study|Disease progression|42|||
146994263|NCT00854308|530142825|FG001|Overall Study|Disease progression|50|||
146994264|NCT00854308|530142824|FG000|Overall Study|Adverse Event|8|||
146994265|NCT00854308|530142825|FG001|Overall Study|Adverse Event|3|||
146994266|NCT00854308|530142824|FG000|Overall Study|Death|2|||
146994267|NCT00854308|530142825|FG001|Overall Study|Death|5|||
146994268|NCT00854308|530142824|FG000|Overall Study|Physician Decision|6|||
146994269|NCT00854308|530142825|FG001|Overall Study|Physician Decision|6|||
146994270|NCT00854308|530142824|FG000|Overall Study|Withdrawal by Subject|4|||
146994271|NCT00854308|530142825|FG001|Overall Study|Withdrawal by Subject|2|||
146994272|NCT00854308|530142824|FG000|Overall Study|Sponsor's decision to terminate study|0|||
146994273|NCT00854308|530142825|FG001|Overall Study|Sponsor's decision to terminate study|1|||
146994274|NCT01390844|530142826|FG000|Treatment Phase|Adverse Event|12|||
146994275|NCT01390844|530142827|FG001|Treatment Phase|Adverse Event|2|||
146994276|NCT01390844|530142828|FG002|Treatment Phase|Adverse Event|3|||
146994277|NCT01390844|530142829|FG003|Treatment Phase|Adverse Event|2|||
146994278|NCT01390844|530142826|FG000|Treatment Phase|Treatment Failure|23|||
146994279|NCT01390844|530142827|FG001|Treatment Phase|Treatment Failure|25|||
146994280|NCT01390844|530142828|FG002|Treatment Phase|Treatment Failure|10|||
146994281|NCT01390844|530142829|FG003|Treatment Phase|Treatment Failure|13|||
146994282|NCT01390844|530142826|FG000|Treatment Phase|Non-Medical Reasons|5|||
146994283|NCT01390844|530142827|FG001|Treatment Phase|Non-Medical Reasons|1|||
146994284|NCT01390844|530142828|FG002|Treatment Phase|Non-Medical Reasons|8|||
146994285|NCT01390844|530142829|FG003|Treatment Phase|Non-Medical Reasons|1|||
146994286|NCT01390844|530142826|FG000|Treatment Phase|Non-GCP Compliant|0|||
146994287|NCT01390844|530142827|FG001|Treatment Phase|Non-GCP Compliant|0|||
146994288|NCT01390844|530142828|FG002|Treatment Phase|Non-GCP Compliant|10|||
146994289|NCT01390844|530142829|FG003|Treatment Phase|Non-GCP Compliant|3|||
146994290|NCT01390844|530142826|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
146994291|NCT01390844|530142827|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
146994292|NCT01390844|530142828|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
146994293|NCT01390844|530142829|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
146994294|NCT00745095|530142830|FG000|Overall Study|Declined to participate|1|||
146994295|NCT00745095|530142831|FG001|Overall Study|Declined to participate|0|||
146994296|NCT00745095|530142832|FG002|Overall Study|Declined to participate|0|||
146994297|NCT00745095|530142833|FG003|Overall Study|Declined to participate|0|||
146994298|NCT00745095|530142834|FG004|Overall Study|Declined to participate|92|||
146994299|NCT00745095|530142835|FG005|Overall Study|Declined to participate|95|||
146994300|NCT00745095|530142830|FG000|Overall Study|Ineligible due to GFR criteria|0|||
146994301|NCT00745095|530142831|FG001|Overall Study|Ineligible due to GFR criteria|2|||
146994302|NCT00745095|530142832|FG002|Overall Study|Ineligible due to GFR criteria|3|||
146994303|NCT00745095|530142833|FG003|Overall Study|Ineligible due to GFR criteria|3|||
146994304|NCT00745095|530142834|FG004|Overall Study|Ineligible due to GFR criteria|30|||
146994305|NCT00745095|530142835|FG005|Overall Study|Ineligible due to GFR criteria|28|||
146994306|NCT01479439|530142836|FG000|Overall Study|Adverse Event|1|||
146994307|NCT01479439|530142837|FG001|Overall Study|Adverse Event|0|||
146994308|NCT01479439|530142838|FG002|Overall Study|Adverse Event|0|||
146994309|NCT01479439|530142836|FG000|Overall Study|Lost to Follow-up|0|||
146994310|NCT01479439|530142837|FG001|Overall Study|Lost to Follow-up|1|||
146994311|NCT01479439|530142838|FG002|Overall Study|Lost to Follow-up|0|||
146994312|NCT01479439|530142836|FG000|Overall Study|Protocol Violation|0|||
146994313|NCT01479439|530142837|FG001|Overall Study|Protocol Violation|0|||
146994314|NCT01479439|530142838|FG002|Overall Study|Protocol Violation|2|||
146994315|NCT02079766|530142839|FG000|Overall Study|Physician Decision|1|||
146994316|NCT02079766|530142840|FG001|Overall Study|Physician Decision|0|||
146994317|NCT02079766|530142839|FG000|Overall Study|Withdrawal by Subject|1|||
146994318|NCT02079766|530142840|FG001|Overall Study|Withdrawal by Subject|0|||
146994319|NCT00304083|530142843|FG000|Overall Study|Withdrawal by Subject|4|||
146994320|NCT00304083|530142844|FG001|Overall Study|Withdrawal by Subject|2|||
146994321|NCT00304083|530142843|FG000|Overall Study|Physician Decision|8|||
146994322|NCT00304083|530142844|FG001|Overall Study|Physician Decision|3|||
146994323|NCT00304083|530142843|FG000|Overall Study|Disease Progression|5|||
146994324|NCT00304083|530142844|FG001|Overall Study|Disease Progression|1|||
146994325|NCT00304083|530142843|FG000|Overall Study|Other|5|||
146994326|NCT00304083|530142844|FG001|Overall Study|Other|2|||
146994327|NCT01044732|530142845|FG000|Overall Study|Lost to Follow-up|2|||
146994328|NCT01044732|530142846|FG001|Overall Study|Lost to Follow-up|1|||
146994329|NCT01044732|530142845|FG000|Overall Study|Physician Decision|5|||
146994330|NCT01044732|530142846|FG001|Overall Study|Physician Decision|3|||
146994331|NCT01044732|530142845|FG000|Overall Study|Protocol Violation|11|||
146994332|NCT01044732|530142846|FG001|Overall Study|Protocol Violation|12|||
146994333|NCT01044732|530142845|FG000|Overall Study|Withdrawal by Subject|0|||
146994334|NCT01044732|530142846|FG001|Overall Study|Withdrawal by Subject|1|||
146994335|NCT01044732|530142845|FG000|Overall Study|Inadequate bowel preparation|11|||
146994336|NCT01044732|530142846|FG001|Overall Study|Inadequate bowel preparation|17|||
146994337|NCT01044732|530142845|FG000|Overall Study|Inability to reach cecum|5|||
146994338|NCT01044732|530142846|FG001|Overall Study|Inability to reach cecum|2|||
146994339|NCT01044732|530142845|FG000|Overall Study|Technical error or malfunction|15|||
146839960|NCT00277095|529584697|FG000|Overall Study|Death|2|||
146839961|NCT00277095|529584697|FG000|Overall Study|Explanted|7|||
146839962|NCT00277095|529584697|FG000|Overall Study|Lost to Follow-up|2|||
146839963|NCT00277095|529584697|FG000|Overall Study|Missed Follow-up|9|||
146839964|NCT00277095|529584697|FG000|Overall Study|Physician Decision|1|||
146839965|NCT01213524|529584698|FG000|Baseline|Withdrawal by Subject|5|||
146839966|NCT01213524|529584698|FG000|Baseline|high breath alcohol levels|1|||
146839967|NCT01213524|529584698|FG000|Baseline|Physician Decision|1|||
146839968|NCT01213524|529584698|FG000|Session 2|Withdrawal by Subject|5|||
146839969|NCT01213524|529584698|FG000|Session 3|Withdrawal by Subject|4|||
146839970|NCT01213524|529584698|FG000|Session 4|Physician Decision|1|||
146839971|NCT01213524|529584698|FG000|Session 4|Withdrawal by Subject|2|||
146839972|NCT02519348|529584704|FG000|Overall Study|Death|31|||
146839973|NCT02519348|529584705|FG001|Overall Study|Death|74|||
146839974|NCT02519348|529584706|FG002|Overall Study|Death|47|||
146839975|NCT02519348|529584707|FG003|Overall Study|Death|54|||
146839976|NCT02519348|529584708|FG004|Overall Study|Death|63|||
146839977|NCT02519348|529584709|FG005|Overall Study|Death|18|||
146839978|NCT02519348|529584710|FG006|Overall Study|Death|2|||
146839979|NCT02519348|529584711|FG007|Overall Study|Death|5|||
146839980|NCT02519348|529584712|FG008|Overall Study|Death|5|||
146839981|NCT02519348|529584704|FG000|Overall Study|Withdrawal by Subject|4|||
146839982|NCT02519348|529584705|FG001|Overall Study|Withdrawal by Subject|7|||
146839983|NCT02519348|529584706|FG002|Overall Study|Withdrawal by Subject|4|||
146839984|NCT02519348|529584707|FG003|Overall Study|Withdrawal by Subject|3|||
146839985|NCT02519348|529584708|FG004|Overall Study|Withdrawal by Subject|3|||
146839986|NCT02519348|529584709|FG005|Overall Study|Withdrawal by Subject|2|||
146994340|NCT01044732|530142846|FG001|Overall Study|Technical error or malfunction|14|||
146839987|NCT02519348|529584710|FG006|Overall Study|Withdrawal by Subject|0|||
146839988|NCT02519348|529584711|FG007|Overall Study|Withdrawal by Subject|0|||
146839989|NCT02519348|529584712|FG008|Overall Study|Withdrawal by Subject|1|||
146839990|NCT02519348|529584704|FG000|Overall Study|Lost to Follow-up|0|||
146839991|NCT02519348|529584705|FG001|Overall Study|Lost to Follow-up|0|||
146839992|NCT02519348|529584706|FG002|Overall Study|Lost to Follow-up|1|||
146839993|NCT02519348|529584707|FG003|Overall Study|Lost to Follow-up|0|||
146839994|NCT02519348|529584708|FG004|Overall Study|Lost to Follow-up|2|||
146839995|NCT02519348|529584709|FG005|Overall Study|Lost to Follow-up|1|||
146839996|NCT02519348|529584710|FG006|Overall Study|Lost to Follow-up|1|||
146839997|NCT02519348|529584711|FG007|Overall Study|Lost to Follow-up|0|||
146839998|NCT02519348|529584712|FG008|Overall Study|Lost to Follow-up|0|||
146839999|NCT02519348|529584704|FG000|Overall Study|Other|0|||
146840000|NCT02519348|529584705|FG001|Overall Study|Other|3|||
146840001|NCT02519348|529584706|FG002|Overall Study|Other|0|||
146840002|NCT02519348|529584707|FG003|Overall Study|Other|0|||
146840003|NCT02519348|529584708|FG004|Overall Study|Other|1|||
146840004|NCT02519348|529584709|FG005|Overall Study|Other|0|||
146840005|NCT02519348|529584710|FG006|Overall Study|Other|0|||
146840006|NCT02519348|529584711|FG007|Overall Study|Other|0|||
146840007|NCT02519348|529584712|FG008|Overall Study|Other|0|||
146840008|NCT02519348|529584704|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
146840009|NCT02519348|529584705|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
146840010|NCT02519348|529584706|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
146840011|NCT02519348|529584707|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
146840012|NCT02519348|529584708|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
146840013|NCT02519348|529584709|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
146840014|NCT02519348|529584710|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
146840015|NCT02519348|529584711|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
146840016|NCT02519348|529584712|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
146840017|NCT05415748|529584716|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
146840018|NCT05415748|529584717|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
146840019|NCT05415748|529584718|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
146840020|NCT05415748|529584719|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
146840021|NCT05415748|529584716|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
146840022|NCT05415748|529584717|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
146840023|NCT05415748|529584718|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
146840024|NCT05415748|529584719|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
146840025|NCT03075527|529584720|FG000|Overall Study|Death|1|||
146994341|NCT03991494|530142849|FG000|Overall Study|Progressive Disease|4|||
146840026|NCT03075527|529584720|FG000|Overall Study|Withdrawal by Subject|1|||
146840027|NCT03075527|529584720|FG000|Overall Study|Physician Decision|3|||
146840028|NCT03075527|529584720|FG000|Overall Study|Progression/Relapse|14|||
146840029|NCT01447576|529584724|FG000|Overall Study|Lost to Follow-up|52|||
146840030|NCT01447576|529584724|FG000|Overall Study|Adverse Event|127|||
146840031|NCT01447576|529584724|FG000|Overall Study|Participant met withdrawal criteria|40|||
146840032|NCT01447576|529584724|FG000|Overall Study|Withdrawal by Subject|100|||
146840033|NCT01447576|529584724|FG000|Overall Study|Protocol deviation|83|||
146840034|NCT01447576|529584724|FG000|Overall Study|Lack of Efficacy|68|||
146840035|NCT01447576|529584724|FG000|Overall Study|Physician Decision|6|||
146840036|NCT05239598|529584725|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
146840037|NCT05239598|529584726|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
146840038|NCT05239598|529584725|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
146840039|NCT05239598|529584726|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
146840040|NCT02998476|529584729|FG000|Overall Study|Lost to Follow-up|1|||
146840041|NCT02998476|529584730|FG001|Overall Study|Lost to Follow-up|0|||
146840042|NCT02998476|529584729|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
146840043|NCT02998476|529584730|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
146840044|NCT02998476|529584729|FG000|Overall Study|Withdrawal by Subject|1|||
146840045|NCT02998476|529584730|FG001|Overall Study|Withdrawal by Subject|2|||
146840046|NCT02998476|529584729|FG000|Overall Study|Death|45|||
146840047|NCT02998476|529584730|FG001|Overall Study|Death|2|||
146961179|NCT01159665|530016277|FG005|Overall Study|Withdrawal by Subject|0|||
146961180|NCT01018680|530018061|FG000|Overall Study|Adverse Event|23|||
146961181|NCT01018680|530018062|FG001|Overall Study|Adverse Event|40|||
146961182|NCT01018680|530018061|FG000|Overall Study|Withdrawal by Subject|10|||
146961183|NCT01018680|530018062|FG001|Overall Study|Withdrawal by Subject|10|||
146961184|NCT01018680|530018061|FG000|Overall Study|Protocol Violation|5|||
146961185|NCT01018680|530018062|FG001|Overall Study|Protocol Violation|8|||
146961186|NCT01018680|530018061|FG000|Overall Study|Sponsor Decision|6|||
146961187|NCT01018680|530018062|FG001|Overall Study|Sponsor Decision|7|||
146961188|NCT01018680|530018061|FG000|Overall Study|Lack of Efficacy|8|||
146961189|NCT01018680|530018062|FG001|Overall Study|Lack of Efficacy|2|||
146961190|NCT01018680|530018061|FG000|Overall Study|Lost to Follow-up|5|||
146961191|NCT01018680|530018062|FG001|Overall Study|Lost to Follow-up|3|||
146961192|NCT01018680|530018061|FG000|Overall Study|Entry Criteria Not Met|1|||
146961193|NCT01018680|530018062|FG001|Overall Study|Entry Criteria Not Met|4|||
146961194|NCT01018680|530018061|FG000|Overall Study|Physician Decision|3|||
146961195|NCT01018680|530018062|FG001|Overall Study|Physician Decision|1|||
146961196|NCT02930889|530018063|FG000|Overall Study|Lost to Follow-up|2|||
146961197|NCT02930889|530018063|FG000|Overall Study|Withdrawal by Subject|6|||
146961198|NCT02930889|530018063|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
146961199|NCT01846442|530018067|FG000|Overall Study|Adverse Event|2|||
146961200|NCT01846442|530018068|FG001|Overall Study|Adverse Event|4|||
146961201|NCT01846442|530018069|FG002|Overall Study|Adverse Event|2|||
146961202|NCT01846442|530018070|FG003|Overall Study|Adverse Event|1|||
146961203|NCT01846442|530018067|FG000|Overall Study|Lost to Follow-up|0|||
146961204|NCT01846442|530018068|FG001|Overall Study|Lost to Follow-up|0|||
146961205|NCT01846442|530018069|FG002|Overall Study|Lost to Follow-up|1|||
146961206|NCT01846442|530018070|FG003|Overall Study|Lost to Follow-up|0|||
146961207|NCT01846442|530018067|FG000|Overall Study|Withdrawal by Subject|3|||
146961208|NCT01846442|530018068|FG001|Overall Study|Withdrawal by Subject|2|||
146961209|NCT01846442|530018069|FG002|Overall Study|Withdrawal by Subject|0|||
146961210|NCT01846442|530018070|FG003|Overall Study|Withdrawal by Subject|1|||
146961211|NCT01846442|530018067|FG000|Overall Study|Left the city/Lost medication|1|||
146961212|NCT01846442|530018068|FG001|Overall Study|Left the city/Lost medication|0|||
146961213|NCT01846442|530018069|FG002|Overall Study|Left the city/Lost medication|1|||
146961214|NCT01846442|530018070|FG003|Overall Study|Left the city/Lost medication|1|||
146961215|NCT00474994|530018085|FG000|Overall Study|Patient Not treated|1|||
146961216|NCT00474994|530018085|FG000|Overall Study|Patient evaluable for toxicity only|3|||
146961217|NCT00474994|530018085|FG000|Overall Study|Patient found to be ineligible|1|||
146961218|NCT02660489|530018086|FG000|Overall Study|Lost to Follow-up|1|||
146961219|NCT02660489|530018087|FG001|Overall Study|Lost to Follow-up|1|||
146961220|NCT02660489|530018086|FG000|Overall Study|Adverse Event|1|||
146961221|NCT02660489|530018087|FG001|Overall Study|Adverse Event|3|||
146961222|NCT02660489|530018086|FG000|Overall Study|no rhinovirus infection|4|||
146961223|NCT02660489|530018087|FG001|Overall Study|no rhinovirus infection|4|||
146961224|NCT00278473|530018088|FG000|Overall Study|drop out|4|||
146840048|NCT02998476|529584729|FG000|Overall Study|Other|6|||
146840049|NCT02998476|529584730|FG001|Overall Study|Other|1|||
146840050|NCT05855967|529584731|FG000|Overall Study|Withdrawal by Subject|7|||
146840051|NCT05855967|529584732|FG001|Overall Study|Withdrawal by Subject|5|||
146840052|NCT05855967|529584731|FG000|Overall Study|Lost to Follow-up|2|||
146961225|NCT00278473|530018089|FG001|Overall Study|drop out|3|||
146961226|NCT00761761|530018093|FG000|Overall Study|Lost to Follow-up|3|||
146961227|NCT00761761|530018094|FG001|Overall Study|Lost to Follow-up|1|||
146961228|NCT00761761|530018093|FG000|Overall Study|Withdrawal by Subject|3|||
146961229|NCT00761761|530018094|FG001|Overall Study|Withdrawal by Subject|0|||
146961230|NCT03472586|530018101|FG000|Overall Study|Physician Decision|6|||
146961231|NCT03472586|530018101|FG000|Overall Study|Death|6|||
146961232|NCT03472586|530018101|FG000|Overall Study|Adverse Event|1|||
146961233|NCT02706327|530018102|FG000|Overall Study|Lost to Follow-up|1|||
146994342|NCT03144687|530142856|FG000|Overall Study|Death|0|||
146994343|NCT03144687|530142857|FG001|Overall Study|Death|2|||
146994344|NCT03144687|530142856|FG000|Overall Study|Lost to Follow-up|0|||
146994345|NCT03144687|530142857|FG001|Overall Study|Lost to Follow-up|1|||
146994346|NCT03144687|530142856|FG000|Overall Study|Physician Decision|0|||
146994347|NCT03144687|530142857|FG001|Overall Study|Physician Decision|1|||
146994348|NCT03144687|530142856|FG000|Overall Study|Withdrawal by Subject|1|||
146994349|NCT03144687|530142857|FG001|Overall Study|Withdrawal by Subject|3|||
146994350|NCT03144687|530142856|FG000|Overall Study|Not Reported|2|||
146994351|NCT03144687|530142857|FG001|Overall Study|Not Reported|0|||
146994352|NCT00683293|530142860|FG000|Overall Study|Withdrawal by Subject|2|||
146994353|NCT00683293|530142861|FG001|Overall Study|Withdrawal by Subject|3|||
146994354|NCT02507375|530142866|FG000|Overall Study|Progressive Disease|4|||
146994355|NCT02507375|530142867|FG001|Overall Study|Progressive Disease|5|||
146994356|NCT02507375|530142866|FG000|Overall Study|Death|0|||
146994357|NCT02507375|530142867|FG001|Overall Study|Death|1|||
146994358|NCT02507375|530142866|FG000|Overall Study|Refused treatment|0|||
146994359|NCT02507375|530142867|FG001|Overall Study|Refused treatment|1|||
146994360|NCT02507375|530142866|FG000|Overall Study|Adverse Event|0|||
146994361|NCT02507375|530142867|FG001|Overall Study|Adverse Event|1|||
146994362|NCT02158936|530142868|FG000|Overall Study|Study closed/ terminated|57|||
146994363|NCT02158936|530142869|FG001|Overall Study|Study closed/ terminated|77|||
146994364|NCT02158936|530142868|FG000|Overall Study|Azacitidine tx discontinued|53|||
146994365|NCT02158936|530142869|FG001|Overall Study|Azacitidine tx discontinued|46|||
146994366|NCT02158936|530142868|FG000|Overall Study|Adverse Event|39|||
146994367|NCT02158936|530142869|FG001|Overall Study|Adverse Event|24|||
146994368|NCT02158936|530142868|FG000|Overall Study|Withdrawal by Subject|15|||
146994369|NCT02158936|530142869|FG001|Overall Study|Withdrawal by Subject|16|||
146994370|NCT02158936|530142868|FG000|Overall Study|Physician Decision|15|||
146994371|NCT02158936|530142869|FG001|Overall Study|Physician Decision|13|||
146994372|NCT02158936|530142868|FG000|Overall Study|Lost to Follow-up|0|||
146994373|NCT02158936|530142869|FG001|Overall Study|Lost to Follow-up|1|||
146994374|NCT00522457|530142870|FG000|Overall Study|Due to disease progression|16|||
146994375|NCT00522457|530142870|FG000|Overall Study|Adverse Event|2|||
146994376|NCT01387737|530144222|FG000|Overall Study|Adverse Event|20|||
146994377|NCT01387737|530144223|FG001|Overall Study|Adverse Event|30|||
146994378|NCT01387737|530144222|FG000|Overall Study|Lack of Efficacy|1|||
146994379|NCT01387737|530144223|FG001|Overall Study|Lack of Efficacy|0|||
146994380|NCT01387737|530144222|FG000|Overall Study|Physician Decision|3|||
146994381|NCT01387737|530144223|FG001|Overall Study|Physician Decision|10|||
146994382|NCT01387737|530144222|FG000|Overall Study|Withdrawal by Subject|27|||
146994383|NCT01387737|530144223|FG001|Overall Study|Withdrawal by Subject|31|||
146994384|NCT01387737|530144222|FG000|Overall Study|Clearly not eligible for the study|1|||
146994385|NCT01387737|530144223|FG001|Overall Study|Clearly not eligible for the study|3|||
146994386|NCT01248247|530144224|FG000|Overall Study|Adverse Event|2|||
146994387|NCT01248247|530144225|FG001|Overall Study|Adverse Event|4|||
146994388|NCT01248247|530144226|FG002|Overall Study|Adverse Event|4|||
146994389|NCT01248247|530144227|FG003|Overall Study|Adverse Event|2|||
146994390|NCT01248247|530144224|FG000|Overall Study|Death|0|||
146994391|NCT01248247|530144225|FG001|Overall Study|Death|1|||
146994392|NCT01248247|530144226|FG002|Overall Study|Death|4|||
146994393|NCT01248247|530144227|FG003|Overall Study|Death|7|||
146994394|NCT01248247|530144224|FG000|Overall Study|Lost to Follow-up|0|||
146994395|NCT01248247|530144225|FG001|Overall Study|Lost to Follow-up|1|||
146994396|NCT01248247|530144226|FG002|Overall Study|Lost to Follow-up|1|||
146994397|NCT01248247|530144227|FG003|Overall Study|Lost to Follow-up|0|||
146994398|NCT01248247|530144224|FG000|Overall Study|Alternative treatment|0|||
146994399|NCT01248247|530144225|FG001|Overall Study|Alternative treatment|1|||
146994400|NCT01248247|530144226|FG002|Overall Study|Alternative treatment|0|||
146994401|NCT01248247|530144227|FG003|Overall Study|Alternative treatment|0|||
146994402|NCT01248247|530144224|FG000|Overall Study|Other|2|||
146840053|NCT05855967|529584732|FG001|Overall Study|Lost to Follow-up|1|||
146840054|NCT01435772|529584734|FG000|Overall Study|Adverse Event|1|||
146994403|NCT01248247|530144225|FG001|Overall Study|Other|8|||
146994404|NCT01248247|530144226|FG002|Overall Study|Other|8|||
146994405|NCT01248247|530144227|FG003|Overall Study|Other|5|||
146994406|NCT01248247|530144224|FG000|Overall Study|Progression|18|||
146994407|NCT01248247|530144225|FG001|Overall Study|Progression|27|||
146994408|NCT01248247|530144226|FG002|Overall Study|Progression|56|||
146994409|NCT01248247|530144227|FG003|Overall Study|Progression|44|||
146994410|NCT01248247|530144224|FG000|Overall Study|Refuse further treatment|0|||
146994411|NCT01248247|530144225|FG001|Overall Study|Refuse further treatment|0|||
146994412|NCT01248247|530144226|FG002|Overall Study|Refuse further treatment|1|||
146994413|NCT01248247|530144227|FG003|Overall Study|Refuse further treatment|2|||
146994414|NCT01248247|530144224|FG000|Overall Study|Complicating disease|0|||
146994415|NCT01248247|530144225|FG001|Overall Study|Complicating disease|0|||
146994416|NCT01248247|530144226|FG002|Overall Study|Complicating disease|1|||
146840055|NCT01435772|529584735|FG001|Overall Study|Adverse Event|0|||
146994417|NCT01248247|530144227|FG003|Overall Study|Complicating disease|1|||
146994418|NCT00705536|530144229|FG000|Start Period 1|Withdrawal by Subject|0|||
146994419|NCT00705536|530144230|FG001|Start Period 1|Withdrawal by Subject|0|||
146994420|NCT00705536|530144231|FG002|Start Period 1|Withdrawal by Subject|0|||
146994421|NCT00705536|530144232|FG003|Start Period 1|Withdrawal by Subject|1|||
146994422|NCT00549718|530144233|FG000|Overall Study|Insufficient clinical response|20|||
146994423|NCT00549718|530144234|FG001|Overall Study|Insufficient clinical response|7|||
146994424|NCT00549718|530144235|FG002|Overall Study|Insufficient clinical response|18|||
146994425|NCT00549718|530144236|FG003|Overall Study|Insufficient clinical response|32|||
146994426|NCT00549718|530144233|FG000|Overall Study|Adverse Event|6|||
146994427|NCT00549718|530144234|FG001|Overall Study|Adverse Event|8|||
146994428|NCT00549718|530144235|FG002|Overall Study|Adverse Event|7|||
146994429|NCT00549718|530144236|FG003|Overall Study|Adverse Event|3|||
146994430|NCT00549718|530144233|FG000|Overall Study|Lost to Follow-up|4|||
146994431|NCT00549718|530144234|FG001|Overall Study|Lost to Follow-up|2|||
146994432|NCT00549718|530144235|FG002|Overall Study|Lost to Follow-up|0|||
146994433|NCT00549718|530144236|FG003|Overall Study|Lost to Follow-up|6|||
146994434|NCT00549718|530144233|FG000|Overall Study|Withdrawal by Subject|9|||
146994435|NCT00549718|530144234|FG001|Overall Study|Withdrawal by Subject|18|||
146994436|NCT00549718|530144235|FG002|Overall Study|Withdrawal by Subject|12|||
146994437|NCT00549718|530144236|FG003|Overall Study|Withdrawal by Subject|13|||
146994438|NCT00549718|530144233|FG000|Overall Study|Administrative|2|||
146994439|NCT00549718|530144234|FG001|Overall Study|Administrative|2|||
146994440|NCT00549718|530144235|FG002|Overall Study|Administrative|2|||
146994441|NCT00549718|530144236|FG003|Overall Study|Administrative|1|||
146994442|NCT04032977|530144237|FG000|Overall Study|Withdrawal by Subject|6|||
146994443|NCT04032977|530144238|FG001|Overall Study|Withdrawal by Subject|1|||
146994444|NCT04032977|530144237|FG000|Overall Study|Lost to Follow-up|2|||
146994445|NCT04032977|530144238|FG001|Overall Study|Lost to Follow-up|7|||
146994446|NCT04032977|530144237|FG000|Overall Study|Pregnancy|1|||
146994447|NCT04032977|530144238|FG001|Overall Study|Pregnancy|0|||
146994448|NCT03075761|530144240|FG000|Overall Study|Lost to Follow-up|1|||
146994449|NCT03075761|530144241|FG001|Overall Study|Lost to Follow-up|6|||
146994450|NCT02880761|530144242|FG000|Overall Study|Death|6|||
146994451|NCT02880761|530144243|FG001|Overall Study|Death|8|||
146994452|NCT02880761|530144242|FG000|Overall Study|Withdrawal by Subject|3|||
146994453|NCT02880761|530144243|FG001|Overall Study|Withdrawal by Subject|6|||
146994454|NCT02880761|530144242|FG000|Overall Study|Protocol Violation|4|||
146994455|NCT02880761|530144243|FG001|Overall Study|Protocol Violation|3|||
146994456|NCT02880761|530144242|FG000|Overall Study|Lost to Follow-up|3|||
146994457|NCT02880761|530144243|FG001|Overall Study|Lost to Follow-up|4|||
146994458|NCT03597256|530144244|FG000|Overall Study|Lost to Follow-up|3|||
146994459|NCT03597256|530144245|FG001|Overall Study|Lost to Follow-up|1|||
146994460|NCT03597256|530144244|FG000|Overall Study|Withdrawal by Subject|0|||
146994461|NCT03597256|530144245|FG001|Overall Study|Withdrawal by Subject|1|||
146994462|NCT03597256|530144244|FG000|Overall Study|Could not return for treatment|0|||
146994463|NCT03597256|530144245|FG001|Overall Study|Could not return for treatment|1|||
146994464|NCT03597256|530144244|FG000|Overall Study|Moved from location|0|||
146994465|NCT03597256|530144245|FG001|Overall Study|Moved from location|1|||
146994466|NCT03597256|530144244|FG000|Overall Study|Not accepted the treatment|0|||
146994467|NCT03597256|530144245|FG001|Overall Study|Not accepted the treatment|1|||
146994468|NCT02106156|530144246|FG000|Overall Study|Patient Died|19|||
146994469|NCT02106156|530144247|FG001|Overall Study|Patient Died|0|||
146994470|NCT02106156|530144248|FG002|Overall Study|Patient Died|0|||
146994471|NCT02106156|530144246|FG000|Overall Study|Lack of Tolerability|305|||
146994472|NCT02106156|530144247|FG001|Overall Study|Lack of Tolerability|3|||
146994473|NCT02106156|530144248|FG002|Overall Study|Lack of Tolerability|0|||
146994474|NCT02106156|530144246|FG000|Overall Study|Lack of Virological Response|1044|||
146994475|NCT02106156|530144247|FG001|Overall Study|Lack of Virological Response|8|||
146994476|NCT02106156|530144248|FG002|Overall Study|Lack of Virological Response|0|||
146994477|NCT02106156|530144246|FG000|Overall Study|Concomitant Disease|74|||
146994478|NCT02106156|530144247|FG001|Overall Study|Concomitant Disease|2|||
146994479|NCT02106156|530144248|FG002|Overall Study|Concomitant Disease|0|||
146840056|NCT01435772|529584736|FG002|Overall Study|Adverse Event|2|||
146994480|NCT02106156|530144246|FG000|Overall Study|Lack of Compliance|211|||
146840057|NCT01435772|529584734|FG000|Overall Study|Withdrawal by Subject|0|||
146994481|NCT02106156|530144247|FG001|Overall Study|Lack of Compliance|7|||
146994482|NCT02106156|530144248|FG002|Overall Study|Lack of Compliance|0|||
146994483|NCT02106156|530144246|FG000|Overall Study|Patients Request|307|||
146994484|NCT02106156|530144247|FG001|Overall Study|Patients Request|9|||
146994485|NCT02106156|530144248|FG002|Overall Study|Patients Request|0|||
146994486|NCT02106156|530144246|FG000|Overall Study|Lost to Follow-up|451|||
146994487|NCT02106156|530144247|FG001|Overall Study|Lost to Follow-up|8|||
146994488|NCT02106156|530144248|FG002|Overall Study|Lost to Follow-up|0|||
146994489|NCT02106156|530144246|FG000|Overall Study|Unplanned Event|82|||
146994490|NCT02106156|530144247|FG001|Overall Study|Unplanned Event|2|||
146994491|NCT02106156|530144248|FG002|Overall Study|Unplanned Event|0|||
146994492|NCT02106156|530144246|FG000|Overall Study|Change of Laboratory Parameter|10|||
146840058|NCT01435772|529584735|FG001|Overall Study|Withdrawal by Subject|1|||
146994493|NCT02106156|530144247|FG001|Overall Study|Change of Laboratory Parameter|0|||
146994494|NCT02106156|530144248|FG002|Overall Study|Change of Laboratory Parameter|0|||
146994495|NCT02106156|530144246|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
146994496|NCT02106156|530144247|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
146994497|NCT02106156|530144248|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
146994498|NCT02106156|530144246|FG000|Overall Study|Relocation/Change of Physician|40|||
146994499|NCT02106156|530144247|FG001|Overall Study|Relocation/Change of Physician|1|||
146994500|NCT02106156|530144248|FG002|Overall Study|Relocation/Change of Physician|0|||
146994501|NCT00560235|530144258|FG000|Phase 1|Discontinued|8|||
146994502|NCT00560235|530144259|FG001|Phase 1|Discontinued|0|||
146994503|NCT00560235|530144260|FG002|Phase 1|Discontinued|0|||
146994504|NCT00560235|530144258|FG000|Phase 1B|Discontinued|0|||
146994505|NCT00560235|530144259|FG001|Phase 1B|Discontinued|19|||
146994506|NCT00560235|530144260|FG002|Phase 1B|Discontinued|0|||
146994507|NCT00560235|530144258|FG000|Phase 2|Discontinued|0|||
146994508|NCT00560235|530144259|FG001|Phase 2|Discontinued|0|||
146994509|NCT00560235|530144260|FG002|Phase 2|Discontinued|96|||
146994510|NCT00560235|530144258|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
146994511|NCT00560235|530144259|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
146994512|NCT00560235|530144260|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
146994513|NCT03247556|530144262|FG000|Overall Study|Adverse Event|1|||
146994514|NCT03247556|530144263|FG001|Overall Study|Adverse Event|4|||
146994515|NCT03247556|530144264|FG002|Overall Study|Adverse Event|5|||
146994516|NCT03247556|530144262|FG000|Overall Study|Lost to Follow-up|5|||
146994517|NCT03247556|530144263|FG001|Overall Study|Lost to Follow-up|5|||
146994518|NCT03247556|530144264|FG002|Overall Study|Lost to Follow-up|4|||
146994519|NCT03247556|530144262|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
146994520|NCT03247556|530144263|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
146994521|NCT03247556|530144264|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
146994522|NCT03247556|530144262|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
146994523|NCT03247556|530144263|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
146994524|NCT03247556|530144264|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
146994525|NCT03247556|530144262|FG000|Overall Study|Protocol Violation|2|||
146994526|NCT03247556|530144263|FG001|Overall Study|Protocol Violation|0|||
146994527|NCT03247556|530144264|FG002|Overall Study|Protocol Violation|1|||
146994528|NCT03247556|530144262|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
146994529|NCT03247556|530144263|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
146994530|NCT03247556|530144264|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
146994531|NCT00051025|530144268|FG000|Overall Study|Progressive Disease|1|||
146994532|NCT00051025|530144269|FG001|Overall Study|Progressive Disease|1|||
146994533|NCT00051025|530144268|FG000|Overall Study|Adverse Event|1|||
146994534|NCT00051025|530144269|FG001|Overall Study|Adverse Event|1|||
146994535|NCT00051025|530144268|FG000|Overall Study|Withdrawal by Subject|0|||
146994536|NCT00051025|530144269|FG001|Overall Study|Withdrawal by Subject|1|||
146994537|NCT00051025|530144268|FG000|Overall Study|Death|0|||
146994538|NCT00051025|530144269|FG001|Overall Study|Death|1|||
146994539|NCT00274937|530144270|FG000|Overall Study|Physician Decision|10|||
146994540|NCT00274937|530144270|FG000|Overall Study|Withdrawal by Subject|6|||
146994541|NCT00274937|530144270|FG000|Overall Study|Progressive Disease|4|||
146994542|NCT02189941|530144271|FG000|Overall Study|Non-compliance|0|||
146994543|NCT02189941|530144272|FG001|Overall Study|Non-compliance|0|||
146994544|NCT02189941|530144273|FG002|Overall Study|Non-compliance|1|||
146994545|NCT00445003|530144274|FG000|Overall Study|Death|1|||
146994546|NCT00445003|530144275|FG001|Overall Study|Death|2|||
146994547|NCT00445003|530144276|FG002|Overall Study|Death|1|||
146994548|NCT00445003|530144274|FG000|Overall Study|Missed Visit|3|||
146994549|NCT00445003|530144275|FG001|Overall Study|Missed Visit|5|||
146994550|NCT00445003|530144276|FG002|Overall Study|Missed Visit|1|||
146994551|NCT00445003|530144274|FG000|Overall Study|Dropped|1|||
146994552|NCT00445003|530144275|FG001|Overall Study|Dropped|3|||
146994553|NCT00445003|530144276|FG002|Overall Study|Dropped|2|||
146994554|NCT00528606|530144277|FG000|Overall Study|Withdrew consent|4|||
146840059|NCT01435772|529584736|FG002|Overall Study|Withdrawal by Subject|3|||
146840060|NCT01435772|529584734|FG000|Overall Study|Other - study termination|2|||
146840061|NCT01435772|529584735|FG001|Overall Study|Other - study termination|2|||
146994555|NCT00528606|530144278|FG001|Overall Study|Withdrew consent|3|||
146994556|NCT00528606|530144277|FG000|Overall Study|Lost to Follow-up|4|||
146994557|NCT00528606|530144278|FG001|Overall Study|Lost to Follow-up|1|||
146994558|NCT00528606|530144277|FG000|Overall Study|Adverse Event|3|||
146840062|NCT01435772|529584736|FG002|Overall Study|Other - study termination|10|||
146994559|NCT00528606|530144278|FG001|Overall Study|Adverse Event|0|||
146994560|NCT00528606|530144277|FG000|Overall Study|Other|2|||
146994561|NCT00528606|530144278|FG001|Overall Study|Other|0|||
146994562|NCT01918397|530144280|FG000|Overall Study|Never started treatment|2|||
146994563|NCT01918397|530144281|FG001|Overall Study|Never started treatment|1|||
146994564|NCT01918397|530144282|FG002|Overall Study|Never started treatment|0|||
146994565|NCT01918397|530144283|FG003|Overall Study|Never started treatment|0|||
146994566|NCT01918397|530144280|FG000|Overall Study|Adverse Event|1|||
146994567|NCT01918397|530144281|FG001|Overall Study|Adverse Event|1|||
146994568|NCT01918397|530144282|FG002|Overall Study|Adverse Event|1|||
146994569|NCT01918397|530144283|FG003|Overall Study|Adverse Event|0|||
146994570|NCT01918397|530144280|FG000|Overall Study|Lack of compliance|2|||
146994571|NCT01918397|530144281|FG001|Overall Study|Lack of compliance|2|||
146994572|NCT01918397|530144282|FG002|Overall Study|Lack of compliance|3|||
146994573|NCT01918397|530144283|FG003|Overall Study|Lack of compliance|0|||
146994574|NCT01918397|530144280|FG000|Overall Study|Pregnancy|0|||
146994575|NCT01918397|530144281|FG001|Overall Study|Pregnancy|1|||
146994576|NCT01918397|530144282|FG002|Overall Study|Pregnancy|0|||
146994577|NCT01918397|530144283|FG003|Overall Study|Pregnancy|0|||
146994578|NCT01918397|530144280|FG000|Overall Study|Rifampin susceptible|0|||
146994579|NCT01918397|530144281|FG001|Overall Study|Rifampin susceptible|0|||
146994580|NCT01918397|530144282|FG002|Overall Study|Rifampin susceptible|0|||
146994581|NCT01918397|530144283|FG003|Overall Study|Rifampin susceptible|2|||
146994582|NCT01918397|530144280|FG000|Overall Study|Treatment failure|0|||
146994583|NCT01918397|530144281|FG001|Overall Study|Treatment failure|0|||
146994584|NCT01918397|530144282|FG002|Overall Study|Treatment failure|0|||
146994585|NCT01918397|530144283|FG003|Overall Study|Treatment failure|1|||
146994586|NCT01918397|530144280|FG000|Overall Study|Withdrawal by Subject|3|||
146994587|NCT01918397|530144281|FG001|Overall Study|Withdrawal by Subject|2|||
146994588|NCT01918397|530144282|FG002|Overall Study|Withdrawal by Subject|1|||
146994589|NCT01918397|530144283|FG003|Overall Study|Withdrawal by Subject|1|||
146994590|NCT01918397|530144280|FG000|Overall Study|XDR at baseline|0|||
146994591|NCT01918397|530144281|FG001|Overall Study|XDR at baseline|0|||
146994592|NCT01918397|530144282|FG002|Overall Study|XDR at baseline|1|||
146994593|NCT01918397|530144283|FG003|Overall Study|XDR at baseline|0|||
146994594|NCT01918397|530144280|FG000|Overall Study|Lost to Follow-up|2|||
146994595|NCT01918397|530144281|FG001|Overall Study|Lost to Follow-up|1|||
146994596|NCT01918397|530144282|FG002|Overall Study|Lost to Follow-up|1|||
146994597|NCT01918397|530144283|FG003|Overall Study|Lost to Follow-up|1|||
146994598|NCT01918397|530144280|FG000|Overall Study|Increased QTc|1|||
146994599|NCT01918397|530144281|FG001|Overall Study|Increased QTc|0|||
146994600|NCT01918397|530144282|FG002|Overall Study|Increased QTc|0|||
146994601|NCT01918397|530144283|FG003|Overall Study|Increased QTc|1|||
146994602|NCT01918397|530144280|FG000|Overall Study|Death|0|||
146994603|NCT01918397|530144281|FG001|Overall Study|Death|0|||
146994604|NCT01918397|530144282|FG002|Overall Study|Death|1|||
146994605|NCT01918397|530144283|FG003|Overall Study|Death|0|||
146994606|NCT01918397|530144280|FG000|Overall Study|Involved in another investigative trial|0|||
146994607|NCT01918397|530144281|FG001|Overall Study|Involved in another investigative trial|0|||
146994608|NCT01918397|530144282|FG002|Overall Study|Involved in another investigative trial|0|||
146994609|NCT01918397|530144283|FG003|Overall Study|Involved in another investigative trial|1|||
146994610|NCT00880568|530144284|FG000|Overall Study|Disease progression|3|||
146994611|NCT00880568|530144285|FG001|Overall Study|Disease progression|3|||
146994612|NCT00880568|530144286|FG002|Overall Study|Disease progression|3|||
146994613|NCT00880568|530144287|FG003|Overall Study|Disease progression|1|||
146994614|NCT00880568|530144288|FG004|Overall Study|Disease progression|3|||
146994615|NCT00880568|530144289|FG005|Overall Study|Disease progression|3|||
146994616|NCT00880568|530144290|FG006|Overall Study|Disease progression|5|||
146994617|NCT00880568|530144291|FG007|Overall Study|Disease progression|0|||
146994618|NCT00880568|530144292|FG008|Overall Study|Disease progression|3|||
146994619|NCT00880568|530144284|FG000|Overall Study|Adverse Event|0|||
146994620|NCT00880568|530144285|FG001|Overall Study|Adverse Event|0|||
146994621|NCT00880568|530144286|FG002|Overall Study|Adverse Event|0|||
146994622|NCT00880568|530144287|FG003|Overall Study|Adverse Event|0|||
146994623|NCT00880568|530144288|FG004|Overall Study|Adverse Event|0|||
146994624|NCT00880568|530144289|FG005|Overall Study|Adverse Event|0|||
146994625|NCT00880568|530144290|FG006|Overall Study|Adverse Event|1|||
146994626|NCT00880568|530144291|FG007|Overall Study|Adverse Event|1|||
146994627|NCT00880568|530144292|FG008|Overall Study|Adverse Event|0|||
146840063|NCT03238963|529584737|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
146840064|NCT03238963|529584738|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
146840065|NCT03238963|529584737|FG000|Overall Study|Withdrawal by Subject|1|||
146994628|NCT00880568|530144284|FG000|Overall Study|Withdrawal by Subject|0|||
146994629|NCT00880568|530144285|FG001|Overall Study|Withdrawal by Subject|0|||
146994630|NCT00880568|530144286|FG002|Overall Study|Withdrawal by Subject|0|||
146994631|NCT00880568|530144287|FG003|Overall Study|Withdrawal by Subject|0|||
146994632|NCT00880568|530144288|FG004|Overall Study|Withdrawal by Subject|0|||
146994633|NCT00880568|530144289|FG005|Overall Study|Withdrawal by Subject|0|||
146994634|NCT00880568|530144290|FG006|Overall Study|Withdrawal by Subject|0|||
146994635|NCT00880568|530144291|FG007|Overall Study|Withdrawal by Subject|1|||
146994636|NCT00880568|530144292|FG008|Overall Study|Withdrawal by Subject|0|||
146994637|NCT00620022|530144293|FG000|Treatment Period 1|Adverse Event|4|||
146840066|NCT03238963|529584738|FG001|Overall Study|Withdrawal by Subject|1|||
146994638|NCT00620022|530144294|FG001|Treatment Period 1|Adverse Event|6|||
146994639|NCT00620022|530144293|FG000|Treatment Period 1|Subject withdrew consent|1|||
146994640|NCT00620022|530144294|FG001|Treatment Period 1|Subject withdrew consent|0|||
146994641|NCT00620022|530144293|FG000|Treatment Period 2|Adverse Event|2|||
146994642|NCT00620022|530144294|FG001|Treatment Period 2|Adverse Event|2|||
146994643|NCT00496964|530144301|FG000|Overall Study|Withdrawal by Subject|0|||
146994644|NCT00496964|530144302|FG001|Overall Study|Withdrawal by Subject|1|||
146994645|NCT02017964|530144306|FG000|Overall Study|Patient deemed ineligible|1|||
146994646|NCT00150462|530144310|FG000|Overall Study|Disease Progression or Relapse|3|||
146994647|NCT00150462|530144311|FG001|Overall Study|Disease Progression or Relapse|1|||
146994648|NCT00150462|530144312|FG002|Overall Study|Disease Progression or Relapse|2|||
146994649|NCT00150462|530144313|FG003|Overall Study|Disease Progression or Relapse|1|||
146994650|NCT00150462|530144314|FG004|Overall Study|Disease Progression or Relapse|2|||
146994651|NCT00150462|530144315|FG005|Overall Study|Disease Progression or Relapse|2|||
146994652|NCT00150462|530144316|FG006|Overall Study|Disease Progression or Relapse|3|||
146994653|NCT00150462|530144317|FG007|Overall Study|Disease Progression or Relapse|5|||
146994654|NCT00150462|530144318|FG008|Overall Study|Disease Progression or Relapse|5|||
146994655|NCT00150462|530144319|FG009|Overall Study|Disease Progression or Relapse|3|||
146994656|NCT00150462|530144320|FG010|Overall Study|Disease Progression or Relapse|2|||
146994657|NCT00150462|530144310|FG000|Overall Study|Withdrawal by Subject|0|||
146994658|NCT00150462|530144311|FG001|Overall Study|Withdrawal by Subject|1|||
146994659|NCT00150462|530144312|FG002|Overall Study|Withdrawal by Subject|1|||
146994660|NCT00150462|530144313|FG003|Overall Study|Withdrawal by Subject|0|||
146994661|NCT00150462|530144314|FG004|Overall Study|Withdrawal by Subject|1|||
146994662|NCT00150462|530144315|FG005|Overall Study|Withdrawal by Subject|2|||
146994663|NCT00150462|530144316|FG006|Overall Study|Withdrawal by Subject|0|||
146994664|NCT00150462|530144317|FG007|Overall Study|Withdrawal by Subject|1|||
146994665|NCT00150462|530144318|FG008|Overall Study|Withdrawal by Subject|0|||
146994666|NCT00150462|530144319|FG009|Overall Study|Withdrawal by Subject|1|||
146994667|NCT00150462|530144320|FG010|Overall Study|Withdrawal by Subject|0|||
146994668|NCT00150462|530144310|FG000|Overall Study|Death|0|||
146994669|NCT00150462|530144311|FG001|Overall Study|Death|1|||
146994670|NCT00150462|530144312|FG002|Overall Study|Death|0|||
146994671|NCT00150462|530144313|FG003|Overall Study|Death|0|||
146994672|NCT00150462|530144314|FG004|Overall Study|Death|0|||
146994673|NCT00150462|530144315|FG005|Overall Study|Death|0|||
146994674|NCT00150462|530144316|FG006|Overall Study|Death|0|||
146994675|NCT00150462|530144317|FG007|Overall Study|Death|0|||
146994676|NCT00150462|530144318|FG008|Overall Study|Death|1|||
146994677|NCT00150462|530144319|FG009|Overall Study|Death|0|||
146994678|NCT00150462|530144320|FG010|Overall Study|Death|0|||
146994679|NCT00150462|530144310|FG000|Overall Study|Adverse Event|0|||
146994680|NCT00150462|530144311|FG001|Overall Study|Adverse Event|0|||
146994681|NCT00150462|530144312|FG002|Overall Study|Adverse Event|0|||
146994682|NCT00150462|530144313|FG003|Overall Study|Adverse Event|1|||
146994683|NCT00150462|530144314|FG004|Overall Study|Adverse Event|0|||
146994684|NCT00150462|530144315|FG005|Overall Study|Adverse Event|0|||
146994685|NCT00150462|530144316|FG006|Overall Study|Adverse Event|0|||
146994686|NCT00150462|530144317|FG007|Overall Study|Adverse Event|2|||
146994687|NCT00150462|530144318|FG008|Overall Study|Adverse Event|0|||
146994688|NCT00150462|530144319|FG009|Overall Study|Adverse Event|1|||
146994689|NCT00150462|530144320|FG010|Overall Study|Adverse Event|0|||
146994690|NCT00150462|530144310|FG000|Overall Study|Physician Decision|0|||
146994691|NCT00150462|530144311|FG001|Overall Study|Physician Decision|0|||
146994692|NCT00150462|530144312|FG002|Overall Study|Physician Decision|1|||
146994693|NCT00150462|530144313|FG003|Overall Study|Physician Decision|1|||
146994694|NCT00150462|530144314|FG004|Overall Study|Physician Decision|0|||
146994695|NCT00150462|530144315|FG005|Overall Study|Physician Decision|0|||
146994696|NCT00150462|530144316|FG006|Overall Study|Physician Decision|0|||
146994697|NCT00150462|530144317|FG007|Overall Study|Physician Decision|0|||
146994698|NCT00150462|530144318|FG008|Overall Study|Physician Decision|0|||
146994699|NCT00150462|530144319|FG009|Overall Study|Physician Decision|0|||
146994700|NCT00150462|530144320|FG010|Overall Study|Physician Decision|0|||
146994701|NCT00150462|530144310|FG000|Overall Study|Other|0|||
146840067|NCT03238963|529584737|FG000|Overall Study|Lost to Follow-up|1|||
146840068|NCT03238963|529584738|FG001|Overall Study|Lost to Follow-up|0|||
146840069|NCT03238963|529584737|FG000|Overall Study|Protocol Violation|1|||
146840070|NCT03238963|529584738|FG001|Overall Study|Protocol Violation|1|||
146994702|NCT00150462|530144311|FG001|Overall Study|Other|0|||
146994703|NCT00150462|530144312|FG002|Overall Study|Other|0|||
146994704|NCT00150462|530144313|FG003|Overall Study|Other|0|||
146840071|NCT03238963|529584737|FG000|Overall Study|Adverse Event|1|||
146994705|NCT00150462|530144314|FG004|Overall Study|Other|0|||
146994706|NCT00150462|530144315|FG005|Overall Study|Other|0|||
146994707|NCT00150462|530144316|FG006|Overall Study|Other|0|||
146994708|NCT00150462|530144317|FG007|Overall Study|Other|0|||
146840072|NCT03238963|529584738|FG001|Overall Study|Adverse Event|0|||
146840073|NCT06926673|529584739|FG000|Overall Study|Lost to Follow-up|0|||
146994709|NCT00150462|530144318|FG008|Overall Study|Other|0|||
146994710|NCT00150462|530144319|FG009|Overall Study|Other|1|||
146994711|NCT00150462|530144320|FG010|Overall Study|Other|1|||
146994712|NCT00569374|530144323|FG000|Overall Study|Withdrawal by Subject|4|||
146994713|NCT04638153|530144324|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146994714|NCT04638153|530144325|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146994715|NCT04638153|530144326|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146994716|NCT04638153|530144324|FG000|Overall Study|Study terminated by sponsor|4|||
146994717|NCT04638153|530144325|FG001|Overall Study|Study terminated by sponsor|2|||
146994718|NCT04638153|530144326|FG002|Overall Study|Study terminated by sponsor|14|||
146994719|NCT01440283|530144329|FG000|Overall Study|Death|3|||
146994720|NCT01440283|530144329|FG000|Overall Study|Withdrawal by Subject|4|||
146994721|NCT01440283|530144329|FG000|Overall Study|Physician Decision|3|||
146994722|NCT03099538|530144333|FG000|Overall Study|Lack of Efficacy|3|||
146994723|NCT02015390|530144334|FG000|Overall Study|Lost to Follow-up|1|||
146994724|NCT02015390|530144335|FG001|Overall Study|Lost to Follow-up|0|||
146994725|NCT02015390|530144334|FG000|Overall Study|Adverse Event|0|||
146994726|NCT02015390|530144335|FG001|Overall Study|Adverse Event|3|||
146994727|NCT02015390|530144334|FG000|Overall Study|Physician Decision|0|||
146994728|NCT02015390|530144335|FG001|Overall Study|Physician Decision|1|||
146994729|NCT01661686|530144341|FG000|Overall Study|Lost to Follow-up|2|||
146994730|NCT01661686|530144342|FG001|Overall Study|Lost to Follow-up|1|||
146994731|NCT01661686|530144341|FG000|Overall Study|did not receive allocated intervention|0|||
146994732|NCT01661686|530144342|FG001|Overall Study|did not receive allocated intervention|1|||
146994733|NCT00877032|530144345|FG000|Overall Study|Did not meet entrance criteria|0|||
146994734|NCT00877032|530144346|FG001|Overall Study|Did not meet entrance criteria|0|||
146994735|NCT00877032|530144347|FG002|Overall Study|Did not meet entrance criteria|0|||
146994736|NCT00877032|530144348|FG003|Overall Study|Did not meet entrance criteria|1|||
146994737|NCT00877032|530144349|FG004|Overall Study|Did not meet entrance criteria|0|||
146994738|NCT00877032|530144350|FG005|Overall Study|Did not meet entrance criteria|0|||
146994739|NCT00877032|530144351|FG006|Overall Study|Did not meet entrance criteria|2|||
146994740|NCT03752528|530144352|FG000|Part A|Lost to Follow-up|1|||
146994741|NCT03752528|530144352|FG000|Part A|Protocol Violation|1|||
146994742|NCT03752528|530144352|FG000|Part B|Protocol Violation|1|||
146994743|NCT03752528|530144352|FG000|Part B|Study terminated by sponsor|3|||
146994744|NCT00259012|530144354|FG000|Overall Study|Adverse Event|0|||
146994745|NCT00259012|530144355|FG001|Overall Study|Adverse Event|1|||
146994746|NCT00259012|530144354|FG000|Overall Study|Withdrawal by Subject|1|||
146994747|NCT00259012|530144355|FG001|Overall Study|Withdrawal by Subject|0|||
146994748|NCT00259012|530144354|FG000|Overall Study|Physician Decision|0|||
146994749|NCT00259012|530144355|FG001|Overall Study|Physician Decision|1|||
146994750|NCT00259012|530144354|FG000|Overall Study|Lost to Follow-up|0|||
146994751|NCT00259012|530144355|FG001|Overall Study|Lost to Follow-up|1|||
146994752|NCT00259012|530144354|FG000|Overall Study|Protocol Violation|1|||
146994753|NCT00259012|530144355|FG001|Overall Study|Protocol Violation|1|||
146994754|NCT02781727|530144358|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
146994755|NCT02781727|530144359|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
146994756|NCT02781727|530144358|FG000|Treatment Period|Withdrawal by Subject|1|||
146994757|NCT02781727|530144359|FG001|Treatment Period|Withdrawal by Subject|0|||
146994758|NCT02781727|530144358|FG000|Treatment Period|Lost to Follow-up|0|||
146994759|NCT02781727|530144359|FG001|Treatment Period|Lost to Follow-up|1|||
146994760|NCT01378975|530144361|FG000|Overall Study|Death|77|||
146994761|NCT01378975|530144362|FG001|Overall Study|Death|46|||
146994762|NCT01378975|530144361|FG000|Overall Study|Investigator Request|1|||
146994763|NCT01378975|530144362|FG001|Overall Study|Investigator Request|0|||
146994764|NCT01378975|530144361|FG000|Overall Study|Lost to Follow-up|4|||
146994765|NCT01378975|530144362|FG001|Overall Study|Lost to Follow-up|1|||
146994766|NCT01378975|530144361|FG000|Overall Study|Withdrew Consent|4|||
146994767|NCT01378975|530144362|FG001|Overall Study|Withdrew Consent|3|||
146994768|NCT00694551|530144367|FG000|Overall Study|Disease Progression|1|||
146994769|NCT00694551|530144368|FG001|Overall Study|Disease Progression|0|||
146994770|NCT00694551|530144369|FG002|Overall Study|Disease Progression|1|||
146994771|NCT01937390|530144375|FG000|Overall Study|Death|2|||
146994772|NCT01937390|530144375|FG000|Overall Study|Lost to Follow-up|7|||
146994773|NCT01937390|530144375|FG000|Overall Study|Withdrawal by Subject|5|||
146994774|NCT01937390|530144375|FG000|Overall Study|Fail to return|21|||
146994775|NCT02817841|530145862|FG000|Overall Study|Lost to Follow-up|287|||
146994776|NCT02817841|530145862|FG000|Overall Study|Withdrawal by Subject|183|||
146994777|NCT02817841|530145862|FG000|Overall Study|Adverse event not related to bleeding|131|||
146994778|NCT02817841|530145862|FG000|Overall Study|Adverse event related to bleeding|51|||
146994779|NCT02817841|530145862|FG000|Overall Study|Pregnancy|32|||
146994780|NCT02817841|530145862|FG000|Overall Study|Pregnancy wish|17|||
146994781|NCT02817841|530145862|FG000|Overall Study|Other reasons|53|||
146994782|NCT02817841|530145862|FG000|Overall Study|Protocol Violation|94|||
146994783|NCT00397488|530145865|FG000|Overall Study|Withdrawal by Subject|3|||
146994784|NCT00397488|530145865|FG000|Overall Study|Adverse Event|3|||
146994785|NCT00397488|530145865|FG000|Overall Study|Death|1|||
146994786|NCT02424097|530145866|FG000|Overall Study|Lost to Follow-up|1|||
146994787|NCT02424097|530145867|FG001|Overall Study|Lost to Follow-up|2|||
146994788|NCT01215981|530145868|FG000|Overall Study|Physician Decision|0|||
146994789|NCT01215981|530145869|FG001|Overall Study|Physician Decision|1|||
146994790|NCT01215981|530145868|FG000|Overall Study|Protocol Violation|1|||
146994791|NCT01215981|530145869|FG001|Overall Study|Protocol Violation|0|||
146994792|NCT01215981|530145868|FG000|Overall Study|Withdrawal by Subject|1|||
146994793|NCT01215981|530145869|FG001|Overall Study|Withdrawal by Subject|0|||
146994794|NCT02943447|530145870|FG000|Blinded Study Phase|Withdrew Consent|1|||
146994795|NCT02943447|530145871|FG001|Blinded Study Phase|Withdrew Consent|2|||
146994796|NCT02943447|530145872|FG002|Blinded Study Phase|Withdrew Consent|1|||
146994797|NCT02943447|530145870|FG000|Blinded Study Phase|Adverse Event|3|||
146994798|NCT02943447|530145871|FG001|Blinded Study Phase|Adverse Event|0|||
146994799|NCT02943447|530145872|FG002|Blinded Study Phase|Adverse Event|0|||
146994800|NCT02943447|530145870|FG000|Blinded Study Phase|Investigator's discretion|1|||
146840074|NCT06926673|529584740|FG001|Overall Study|Lost to Follow-up|0|||
146840075|NCT06926673|529584741|FG002|Overall Study|Lost to Follow-up|0|||
146840076|NCT06926673|529584742|FG003|Overall Study|Lost to Follow-up|1|||
146840077|NCT06926673|529584743|FG004|Overall Study|Lost to Follow-up|0|||
146840078|NCT06926673|529584744|FG005|Overall Study|Lost to Follow-up|0|||
146840079|NCT06926673|529584745|FG006|Overall Study|Lost to Follow-up|0|||
146840080|NCT06926673|529584739|FG000|Overall Study|Physician Decision|0|||
146840081|NCT06926673|529584740|FG001|Overall Study|Physician Decision|0|||
146840082|NCT06926673|529584741|FG002|Overall Study|Physician Decision|0|||
146840083|NCT06926673|529584742|FG003|Overall Study|Physician Decision|0|||
146840084|NCT06926673|529584743|FG004|Overall Study|Physician Decision|0|||
146840085|NCT06926673|529584744|FG005|Overall Study|Physician Decision|0|||
146840086|NCT06926673|529584745|FG006|Overall Study|Physician Decision|1|||
146994801|NCT02943447|530145871|FG001|Blinded Study Phase|Investigator's discretion|0|||
146994802|NCT02943447|530145872|FG002|Blinded Study Phase|Investigator's discretion|0|||
146994803|NCT02943447|530145870|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
146994804|NCT02943447|530145871|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
146994805|NCT02943447|530145872|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
146994806|NCT02943447|530145870|FG000|Open-Label Extension Phase|Adverse Event|4|||
146994807|NCT02943447|530145871|FG001|Open-Label Extension Phase|Adverse Event|7|||
146994808|NCT02943447|530145872|FG002|Open-Label Extension Phase|Adverse Event|3|||
146994809|NCT02943447|530145870|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
146994810|NCT02943447|530145871|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
146994811|NCT02943447|530145872|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
146994812|NCT02943447|530145870|FG000|Open-Label Extension Phase|Withdrew consent|1|||
146994813|NCT02943447|530145871|FG001|Open-Label Extension Phase|Withdrew consent|1|||
146994814|NCT02943447|530145872|FG002|Open-Label Extension Phase|Withdrew consent|1|||
146994815|NCT02943447|530145870|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
146994816|NCT02943447|530145871|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
146994817|NCT02943447|530145872|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
146994818|NCT00840632|530145874|FG000|First Intervention|Withdrawal by Subject|0|||
146994819|NCT00840632|530145875|FG001|First Intervention|Withdrawal by Subject|1|||
146994820|NCT00840632|530145874|FG000|Washout|Withdrawal by Subject|1|||
146994821|NCT00840632|530145875|FG001|Washout|Withdrawal by Subject|1|||
146994822|NCT01136382|530145878|FG000|Overall Study|Other|8|||
146840087|NCT06926673|529584739|FG000|Overall Study|Withdrawal by Subject|0|||
146840088|NCT06926673|529584740|FG001|Overall Study|Withdrawal by Subject|3|||
146840089|NCT06926673|529584741|FG002|Overall Study|Withdrawal by Subject|2|||
146840090|NCT06926673|529584742|FG003|Overall Study|Withdrawal by Subject|1|||
146840091|NCT06926673|529584743|FG004|Overall Study|Withdrawal by Subject|0|||
146840092|NCT06926673|529584744|FG005|Overall Study|Withdrawal by Subject|2|||
146840093|NCT06926673|529584745|FG006|Overall Study|Withdrawal by Subject|0|||
146840094|NCT01424813|529584746|FG000|Overall Study|Withdrawal by Subject|3|||
146840095|NCT01424813|529584747|FG001|Overall Study|Withdrawal by Subject|0|||
146840096|NCT01424813|529584746|FG000|Overall Study|Protocol Violation|1|||
146840097|NCT01424813|529584747|FG001|Overall Study|Protocol Violation|0|||
146840098|NCT01424813|529584746|FG000|Overall Study|Other|1|||
146840099|NCT01424813|529584747|FG001|Overall Study|Other|2|||
146840100|NCT01920477|529586460|FG000|Overall Study|Adverse Event|0|||
146840101|NCT01920477|529586461|FG001|Overall Study|Adverse Event|1|||
146840102|NCT01920477|529586460|FG000|Overall Study|Lack of Efficacy|1|||
146840103|NCT01920477|529586461|FG001|Overall Study|Lack of Efficacy|0|||
146840104|NCT01920477|529586460|FG000|Overall Study|Study closed/terminated|14|||
146840105|NCT01920477|529586461|FG001|Overall Study|Study closed/terminated|15|||
146840106|NCT01920477|529586460|FG000|Overall Study|Withdrawal by Subject|0|||
146840107|NCT01920477|529586461|FG001|Overall Study|Withdrawal by Subject|1|||
146840108|NCT01681277|529586462|FG000|Overall Study|Adverse Event|1|||
146840109|NCT01681277|529586463|FG001|Overall Study|Adverse Event|0|||
146840110|NCT01681277|529586464|FG002|Overall Study|Adverse Event|0|||
146840111|NCT01681277|529586465|FG003|Overall Study|Adverse Event|0|||
146840112|NCT01681277|529586466|FG004|Overall Study|Adverse Event|0|||
146840113|NCT03838731|529586467|FG000|Overall Study|Pregnancy|0|||
146840114|NCT03838731|529586468|FG001|Overall Study|Pregnancy|1|||
146840115|NCT03838731|529586467|FG000|Overall Study|Withdrawal of consent|1|||
146994823|NCT01136382|530145879|FG001|Overall Study|Other|3|||
146994824|NCT01136382|530145878|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
146840116|NCT03838731|529586468|FG001|Overall Study|Withdrawal of consent|0|||
146840117|NCT04707664|529586469|FG000|Overall Study|Adverse Event|2|||
146994825|NCT01136382|530145879|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
146994826|NCT01136382|530145878|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
146840118|NCT04707664|529586470|FG001|Overall Study|Adverse Event|0|||
146840119|NCT04707664|529586469|FG000|Overall Study|Death|1|||
146840120|NCT04707664|529586470|FG001|Overall Study|Death|2|||
146840121|NCT04707664|529586469|FG000|Overall Study|Withdrawal by Subject|13|||
146840122|NCT04707664|529586470|FG001|Overall Study|Withdrawal by Subject|21|||
146840123|NCT04707664|529586469|FG000|Overall Study|Lost to Follow-up|11|||
146840124|NCT04707664|529586470|FG001|Overall Study|Lost to Follow-up|13|||
146840125|NCT04707664|529586469|FG000|Overall Study|Not treated|2|||
146840126|NCT04707664|529586470|FG001|Overall Study|Not treated|0|||
146840127|NCT01182441|529586471|FG000|Overall Study|Patient Still in Follow-up|152|||
146840128|NCT01182441|529586472|FG001|Overall Study|Patient Still in Follow-up|72|||
146840129|NCT01182441|529586471|FG000|Overall Study|Death|37|||
146840130|NCT01182441|529586472|FG001|Overall Study|Death|25|||
146840131|NCT01182441|529586471|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
146840132|NCT01182441|529586472|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
146840133|NCT01182441|529586471|FG000|Overall Study|Lost to Follow-up|5|||
146994827|NCT01136382|530145879|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
146994828|NCT01136382|530145878|FG000|Overall Study|Withdrawal by Subject|4|||
146994829|NCT01136382|530145879|FG001|Overall Study|Withdrawal by Subject|1|||
146994830|NCT01725529|530145885|FG000|Overall Study|Adverse Event|1|||
146994831|NCT01725529|530145886|FG001|Overall Study|Adverse Event|0|||
146994832|NCT01725529|530145887|FG002|Overall Study|Adverse Event|0|||
146994833|NCT01725529|530145885|FG000|Overall Study|Lost to Follow-up|2|||
146994834|NCT01725529|530145886|FG001|Overall Study|Lost to Follow-up|1|||
146994835|NCT01725529|530145887|FG002|Overall Study|Lost to Follow-up|1|||
146994836|NCT01725529|530145885|FG000|Overall Study|Protocol Violation|0|||
146994837|NCT01725529|530145886|FG001|Overall Study|Protocol Violation|1|||
146994838|NCT01725529|530145887|FG002|Overall Study|Protocol Violation|1|||
146994839|NCT01725529|530145885|FG000|Overall Study|Withdrawal by Subject|12|||
146994840|NCT01725529|530145886|FG001|Overall Study|Withdrawal by Subject|14|||
146994841|NCT01725529|530145887|FG002|Overall Study|Withdrawal by Subject|8|||
146994842|NCT02653664|530145893|FG000|Post-Treatment|Withdrawal by Subject|6|||
146994843|NCT02653664|530145894|FG001|Post-Treatment|Withdrawal by Subject|5|||
146994844|NCT02653664|530145895|FG002|Post-Treatment|Withdrawal by Subject|7|||
146994845|NCT02653664|530145893|FG000|Post-Treatment|Lost to Follow-up|8|||
146994846|NCT02653664|530145894|FG001|Post-Treatment|Lost to Follow-up|1|||
146994847|NCT02653664|530145895|FG002|Post-Treatment|Lost to Follow-up|7|||
146994848|NCT02653664|530145893|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
146994849|NCT02653664|530145894|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
146994850|NCT02653664|530145895|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
146994851|NCT02653664|530145893|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
146994852|NCT02653664|530145894|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
146994853|NCT02653664|530145895|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
146994854|NCT02653664|530145893|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
146994855|NCT02653664|530145894|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
146994856|NCT02653664|530145895|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
146994857|NCT02653664|530145893|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
146994858|NCT02653664|530145894|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
146994859|NCT02653664|530145895|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
146994860|NCT02653664|530145893|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
146994861|NCT02653664|530145894|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
146994862|NCT02653664|530145895|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
146994863|NCT02653664|530145893|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
146994864|NCT02653664|530145894|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
146994865|NCT02653664|530145895|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
146840134|NCT01182441|529586472|FG001|Overall Study|Lost to Follow-up|8|||
146840135|NCT01182441|529586471|FG000|Overall Study|Withdrawal by Subject|6|||
146840136|NCT01182441|529586472|FG001|Overall Study|Withdrawal by Subject|13|||
146840137|NCT01182441|529586471|FG000|Overall Study|Implant Not Attempted|4|||
146840138|NCT01182441|529586472|FG001|Overall Study|Implant Not Attempted|0|||
146840139|NCT01182441|529586471|FG000|Overall Study|Adverse Event|2|||
146840140|NCT01182441|529586472|FG001|Overall Study|Adverse Event|0|||
146840141|NCT01182441|529586471|FG000|Overall Study|Physician Decision|1|||
146994866|NCT02653664|530145893|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
146994867|NCT02653664|530145894|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
146994868|NCT02653664|530145895|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
146840142|NCT01182441|529586472|FG001|Overall Study|Physician Decision|1|||
146840143|NCT05620108|529586473|FG000|Overall Study|Physician Decision|1|||
146840144|NCT05620108|529586474|FG001|Overall Study|Physician Decision|2|||
146840145|NCT02038842|529586475|FG000|Overall Study|Withdrawal by Subject|2|||
146840146|NCT02038842|529586476|FG001|Overall Study|Withdrawal by Subject|2|||
146994869|NCT02653664|530145893|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
146994870|NCT02653664|530145894|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
146994871|NCT02653664|530145895|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
146994872|NCT04657770|530145896|FG000|Overall Study|Withdrawal by Subject|3|||
146840147|NCT02038842|529586477|FG002|Overall Study|Withdrawal by Subject|0|||
146840148|NCT02038842|529586478|FG003|Overall Study|Withdrawal by Subject|0|||
146840149|NCT02038842|529586475|FG000|Overall Study|Participant decision|0|||
146840150|NCT02038842|529586476|FG001|Overall Study|Participant decision|0|||
146840151|NCT02038842|529586477|FG002|Overall Study|Participant decision|2|||
146840152|NCT02038842|529586478|FG003|Overall Study|Participant decision|1|||
146840153|NCT02038842|529586475|FG000|Overall Study|Adverse Event|0|||
146840154|NCT02038842|529586476|FG001|Overall Study|Adverse Event|0|||
146840155|NCT02038842|529586477|FG002|Overall Study|Adverse Event|3|||
146840156|NCT02038842|529586478|FG003|Overall Study|Adverse Event|1|||
146840157|NCT02038842|529586475|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
146840158|NCT02038842|529586476|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
146840159|NCT02038842|529586477|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
146840160|NCT02038842|529586478|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
146840161|NCT01757197|529586483|FG000|Overall Study|Death|2|||
146840162|NCT05332912|529586484|FG000|Overall Study|Withdrawal by Subject|0|||
146840163|NCT05332912|529586485|FG001|Overall Study|Withdrawal by Subject|1|||
146840164|NCT05332912|529586486|FG002|Overall Study|Withdrawal by Subject|2|||
146840165|NCT05332912|529586487|FG003|Overall Study|Withdrawal by Subject|0|||
146840166|NCT05332912|529586484|FG000|Overall Study|Lost to Follow-up|0|||
146840167|NCT05332912|529586485|FG001|Overall Study|Lost to Follow-up|0|||
146840168|NCT05332912|529586486|FG002|Overall Study|Lost to Follow-up|1|||
146840169|NCT05332912|529586487|FG003|Overall Study|Lost to Follow-up|0|||
146840170|NCT01174446|529586488|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
146840171|NCT01174446|529586489|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
146840172|NCT01174446|529586490|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
146840173|NCT01174446|529586491|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
146840174|NCT01174446|529586488|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
146840175|NCT01174446|529586489|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
146840176|NCT01174446|529586490|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
146840177|NCT01174446|529586491|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
146840178|NCT01174446|529586488|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
146840179|NCT01174446|529586489|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
146840180|NCT01174446|529586490|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
146840181|NCT01174446|529586491|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
146840182|NCT01174446|529586488|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
146840183|NCT01174446|529586489|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
146840184|NCT01174446|529586490|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
146840185|NCT01174446|529586491|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
146840186|NCT02088957|529586492|FG000|Overall Study|Lack of Efficacy|1|||
146840187|NCT02088957|529586493|FG001|Overall Study|Lack of Efficacy|0|||
146840188|NCT01923662|529586494|FG000|Overall Study|Withdrawal by Subject|1|||
146840189|NCT00677534|529586499|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
146840190|NCT00677534|529586499|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
146840191|NCT00677534|529586499|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
146840192|NCT00667394|529586500|FG000|Overall Study|Adverse Event|3|||
146840193|NCT00667394|529586501|FG001|Overall Study|Adverse Event|0|||
146840194|NCT00667394|529586500|FG000|Overall Study|Progressive disease|1|||
146840195|NCT00667394|529586501|FG001|Overall Study|Progressive disease|0|||
146840196|NCT04638660|529586503|FG000|Overall Study|Withdrawal by Subject|2|||
146840197|NCT04638660|529586504|FG001|Overall Study|Withdrawal by Subject|0|||
146840198|NCT04638660|529586503|FG000|Overall Study|Lost to Follow-up|1|||
146994873|NCT04657770|530145896|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
146994874|NCT00746798|530145897|FG000|Overall Study|Protocol Violation|0|||
146994875|NCT00746798|530145898|FG001|Overall Study|Protocol Violation|1|||
146994876|NCT00746798|530145899|FG002|Overall Study|Protocol Violation|0|||
146994877|NCT00746798|530145900|FG003|Overall Study|Protocol Violation|0|||
146994878|NCT00746798|530145897|FG000|Overall Study|Withdrawal by Subject|0|||
146994879|NCT00746798|530145898|FG001|Overall Study|Withdrawal by Subject|1|||
146994880|NCT00746798|530145899|FG002|Overall Study|Withdrawal by Subject|1|||
146994881|NCT00746798|530145900|FG003|Overall Study|Withdrawal by Subject|0|||
146994882|NCT00746798|530145897|FG000|Overall Study|Death|0|||
146994883|NCT00746798|530145898|FG001|Overall Study|Death|0|||
146994884|NCT00746798|530145899|FG002|Overall Study|Death|2|||
146994885|NCT00746798|530145900|FG003|Overall Study|Death|0|||
146840199|NCT04638660|529586504|FG001|Overall Study|Lost to Follow-up|0|||
146840200|NCT04481373|529586505|FG000|Overall Study|Protocol Violation|1|||
146840201|NCT04481373|529586506|FG001|Overall Study|Protocol Violation|0|||
146840202|NCT04481373|529586505|FG000|Overall Study|Viral load in hospital not over 1000|2|||
146840203|NCT04481373|529586506|FG001|Overall Study|Viral load in hospital not over 1000|1|||
146994886|NCT00746798|530145897|FG000|Overall Study|Participant unable to return for visit|1|||
146994887|NCT00746798|530145898|FG001|Overall Study|Participant unable to return for visit|0|||
146840204|NCT04481373|529586505|FG000|Overall Study|Death before hospital discharge|1|||
146840205|NCT04481373|529586506|FG001|Overall Study|Death before hospital discharge|0|||
146840206|NCT02224703|529586508|FG000|Overall Study|Adverse Event|0|||
146840207|NCT02224703|529586509|FG001|Overall Study|Adverse Event|5|||
146840208|NCT02224703|529586510|FG002|Overall Study|Adverse Event|0|||
146840209|NCT02224703|529586508|FG000|Overall Study|Withdrawn by investigator|1|||
146840210|NCT02224703|529586509|FG001|Overall Study|Withdrawn by investigator|0|||
146840211|NCT02224703|529586510|FG002|Overall Study|Withdrawn by investigator|0|||
146840212|NCT02224703|529586508|FG000|Overall Study|Advised by medical monitor|1|||
146840213|NCT02224703|529586509|FG001|Overall Study|Advised by medical monitor|0|||
146840214|NCT02224703|529586510|FG002|Overall Study|Advised by medical monitor|0|||
146840215|NCT02224703|529586508|FG000|Overall Study|Withdrawn by parent/guardian|0|||
146840216|NCT02224703|529586509|FG001|Overall Study|Withdrawn by parent/guardian|1|||
146961234|NCT02706327|530018103|FG001|Overall Study|Lost to Follow-up|1|||
146961235|NCT02706327|530018104|FG002|Overall Study|Lost to Follow-up|2|||
146961236|NCT03868410|530018109|FG000|Overall Study|Physician Decision|0|||
146961237|NCT03868410|530018110|FG001|Overall Study|Physician Decision|1|||
146961238|NCT06045026|530018111|FG000|Overall Study|Lost to Follow-up|60|||
146961239|NCT06045026|530018111|FG000|Overall Study|Adverse Event|12|||
146961240|NCT06045026|530018111|FG000|Overall Study|Withdrawal by Subject|3|||
146961241|NCT06045026|530018111|FG000|Overall Study|Enrollment closed|1|||
146961242|NCT04511533|530018112|FG000|Treatment|Other|2|||
146961243|NCT04511533|530018112|FG000|Treatment|Withdrawal by Subject|11|||
146961244|NCT04511533|530018112|FG000|Treatment|Death|5|||
146961245|NCT04511533|530018112|FG000|Treatment|Physician Decision|1|||
146961246|NCT04511533|530018112|FG000|Treatment|Progressive Disease|61|||
146961247|NCT04511533|530018112|FG000|Follow-Up|Other|7|||
146961248|NCT04511533|530018112|FG000|Follow-Up|Withdrawal by Subject|5|||
146961249|NCT04511533|530018112|FG000|Follow-Up|Lost to Follow-up|2|||
146961250|NCT04511533|530018112|FG000|Follow-Up|Death|4|||
146961251|NCT01224171|530018113|FG000|Overall Study|Adverse Event|8|||
146961252|NCT01224171|530018114|FG001|Overall Study|Adverse Event|4|||
146961253|NCT01224171|530018113|FG000|Overall Study|Protocol Violation|0|||
146961254|NCT01224171|530018114|FG001|Overall Study|Protocol Violation|1|||
146961255|NCT01224171|530018113|FG000|Overall Study|Lack of Efficacy|5|||
146961256|NCT01224171|530018114|FG001|Overall Study|Lack of Efficacy|1|||
146961257|NCT01224171|530018113|FG000|Overall Study|Withdrawal of Consent|2|||
146961258|NCT01224171|530018114|FG001|Overall Study|Withdrawal of Consent|4|||
146961259|NCT01224171|530018113|FG000|Overall Study|Lost to Follow-up|0|||
146961260|NCT01224171|530018114|FG001|Overall Study|Lost to Follow-up|3|||
146961261|NCT01928758|530018115|FG000|Overall Study|Lost to Follow-up|14|||
146961262|NCT01928758|530018116|FG001|Overall Study|Lost to Follow-up|9|||
146961263|NCT01928758|530018115|FG000|Overall Study|Withdrawal by Subject|5|||
146961264|NCT01928758|530018116|FG001|Overall Study|Withdrawal by Subject|2|||
146961265|NCT01928758|530018115|FG000|Overall Study|Adverse Event|3|||
146961266|NCT01928758|530018116|FG001|Overall Study|Adverse Event|5|||
146961267|NCT01928758|530018115|FG000|Overall Study|Protocol Violation|3|||
146961268|NCT01928758|530018116|FG001|Overall Study|Protocol Violation|4|||
146961269|NCT02718131|530018117|FG000|Overall Study|Withdrawal by Subject|1|||
146961270|NCT02718131|530018118|FG001|Overall Study|Withdrawal by Subject|0|||
146961271|NCT02718131|530018117|FG000|Overall Study|Adverse Event|1|||
146961272|NCT02718131|530018118|FG001|Overall Study|Adverse Event|0|||
146961273|NCT02718131|530018117|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
146961274|NCT02718131|530018118|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
146961275|NCT03417245|530018120|FG000|Overall Study|Adverse Event|1|||
146961276|NCT03417245|530018121|FG001|Overall Study|Adverse Event|0|||
146961277|NCT03417245|530018120|FG000|Overall Study|Protocol Violation|1|||
146961278|NCT03417245|530018121|FG001|Overall Study|Protocol Violation|0|||
146961279|NCT03417245|530018120|FG000|Overall Study|Withdrawal by Subject|1|||
146961280|NCT03417245|530018121|FG001|Overall Study|Withdrawal by Subject|1|||
146961281|NCT02708524|530018122|FG000|Overall Study|Adverse Event|0|||
146961282|NCT02708524|530018123|FG001|Overall Study|Adverse Event|1|||
146961283|NCT02708524|530018124|FG002|Overall Study|Adverse Event|0|||
146961284|NCT02708524|530018125|FG003|Overall Study|Adverse Event|0|||
146961285|NCT02708524|530018122|FG000|Overall Study|Lens Discomfort|1|||
146961286|NCT02708524|530018123|FG001|Overall Study|Lens Discomfort|0|||
146961287|NCT02708524|530018124|FG002|Overall Study|Lens Discomfort|1|||
146961288|NCT02708524|530018125|FG003|Overall Study|Lens Discomfort|0|||
146961289|NCT02708524|530018122|FG000|Overall Study|Lost to Follow-up|1|||
146840217|NCT02224703|529586510|FG002|Overall Study|Withdrawn by parent/guardian|0|||
146840218|NCT02224703|529586508|FG000|Overall Study|Lack of Efficacy|1|||
146961290|NCT02708524|530018123|FG001|Overall Study|Lost to Follow-up|1|||
146961291|NCT02708524|530018124|FG002|Overall Study|Lost to Follow-up|1|||
146961292|NCT02708524|530018125|FG003|Overall Study|Lost to Follow-up|0|||
146961293|NCT02708524|530018122|FG000|Overall Study|Protocol Violation|0|||
146961294|NCT02708524|530018123|FG001|Overall Study|Protocol Violation|1|||
146961295|NCT02708524|530018124|FG002|Overall Study|Protocol Violation|0|||
146961296|NCT02708524|530018125|FG003|Overall Study|Protocol Violation|0|||
146961297|NCT02708524|530018122|FG000|Overall Study|Withdrawal by Subject|1|||
146994888|NCT00746798|530145899|FG002|Overall Study|Participant unable to return for visit|0|||
146994889|NCT00746798|530145900|FG003|Overall Study|Participant unable to return for visit|0|||
146994890|NCT00633594|530145903|FG000|Overall Study|Adverse Event|0|||
146994891|NCT00633594|530145904|FG001|Overall Study|Adverse Event|4|||
146994892|NCT00633594|530145905|FG002|Overall Study|Adverse Event|7|||
146994893|NCT00633594|530145903|FG000|Overall Study|Death|0|||
146994894|NCT00633594|530145904|FG001|Overall Study|Death|1|||
146994895|NCT00633594|530145905|FG002|Overall Study|Death|2|||
146994896|NCT00633594|530145903|FG000|Overall Study|Disease Progression|0|||
146994897|NCT00633594|530145904|FG001|Overall Study|Disease Progression|0|||
146994898|NCT00633594|530145905|FG002|Overall Study|Disease Progression|1|||
146994899|NCT00727571|530145907|FG000|Overall Study|Ineligibility determined|1|||
146994900|NCT00727571|530145908|FG001|Overall Study|Ineligibility determined|1|||
146994901|NCT00727571|530145909|FG002|Overall Study|Ineligibility determined|1|||
146994902|NCT00727571|530145910|FG003|Overall Study|Ineligibility determined|0|||
146994903|NCT00727571|530145907|FG000|Overall Study|Death|0|||
146994904|NCT00727571|530145908|FG001|Overall Study|Death|19|||
146994905|NCT00727571|530145909|FG002|Overall Study|Death|5|||
146994906|NCT00727571|530145910|FG003|Overall Study|Death|1|||
146994907|NCT00727571|530145907|FG000|Overall Study|Physician Decision|0|||
146994908|NCT00727571|530145908|FG001|Overall Study|Physician Decision|5|||
146994909|NCT00727571|530145909|FG002|Overall Study|Physician Decision|0|||
146994910|NCT00727571|530145910|FG003|Overall Study|Physician Decision|0|||
146994911|NCT00727571|530145907|FG000|Overall Study|Withdrawal by Subject|0|||
146994912|NCT00727571|530145908|FG001|Overall Study|Withdrawal by Subject|10|||
146994913|NCT00727571|530145909|FG002|Overall Study|Withdrawal by Subject|11|||
146994914|NCT00727571|530145910|FG003|Overall Study|Withdrawal by Subject|0|||
146994915|NCT00727571|530145907|FG000|Overall Study|Subject Non Compliance|0|||
146994916|NCT00727571|530145908|FG001|Overall Study|Subject Non Compliance|6|||
146994917|NCT00727571|530145909|FG002|Overall Study|Subject Non Compliance|0|||
146994918|NCT00727571|530145910|FG003|Overall Study|Subject Non Compliance|4|||
146994919|NCT00727571|530145907|FG000|Overall Study|Dismissed from nursing home|0|||
146994920|NCT00727571|530145908|FG001|Overall Study|Dismissed from nursing home|9|||
146994921|NCT00727571|530145909|FG002|Overall Study|Dismissed from nursing home|5|||
146994922|NCT00727571|530145910|FG003|Overall Study|Dismissed from nursing home|0|||
146994923|NCT00727571|530145907|FG000|Overall Study|Hospitalization|0|||
146994924|NCT00727571|530145908|FG001|Overall Study|Hospitalization|1|||
146994925|NCT00727571|530145909|FG002|Overall Study|Hospitalization|0|||
146994926|NCT00727571|530145910|FG003|Overall Study|Hospitalization|1|||
146994927|NCT00727571|530145907|FG000|Overall Study|AE not leading to hospitalization|0|||
146994928|NCT00727571|530145908|FG001|Overall Study|AE not leading to hospitalization|0|||
146994929|NCT00727571|530145909|FG002|Overall Study|AE not leading to hospitalization|2|||
146994930|NCT00727571|530145910|FG003|Overall Study|AE not leading to hospitalization|0|||
146994931|NCT00727571|530145907|FG000|Overall Study|Other|0|||
146994932|NCT00727571|530145908|FG001|Overall Study|Other|4|||
146994933|NCT00727571|530145909|FG002|Overall Study|Other|6|||
146994934|NCT00727571|530145910|FG003|Overall Study|Other|0|||
146994935|NCT01287013|530145911|FG000|Overall Study|Non-evaluable|3|||
146994936|NCT01287013|530145912|FG001|Overall Study|Non-evaluable|5|||
146994937|NCT01287013|530145913|FG002|Overall Study|Non-evaluable|21|||
146994938|NCT01179048|530145914|FG000|Overall Study|Withdrawn - does not allow contact|4|||
146994939|NCT01179048|530145915|FG001|Overall Study|Withdrawn - does not allow contact|8|||
146994940|NCT01179048|530145914|FG000|Overall Study|Lost to Follow-up|8|||
146994941|NCT01179048|530145915|FG001|Overall Study|Lost to Follow-up|9|||
146994942|NCT01179048|530145914|FG000|Overall Study|Alive|127|||
146994943|NCT01179048|530145915|FG001|Overall Study|Alive|142|||
146994944|NCT01900730|530145916|FG000|Overall Study|Withdrawal by Subject|1|||
146994945|NCT01900730|530145917|FG001|Overall Study|Withdrawal by Subject|0|||
146994946|NCT01900730|530145916|FG000|Overall Study|Screen Failure|1|||
146994947|NCT01900730|530145917|FG001|Overall Study|Screen Failure|0|||
146994948|NCT02109042|530145918|FG000|Overall Study|Sponsor Decision|15|||
146994949|NCT03203447|530145923|FG000|Overall Study|Withdrawal by Subject|2|||
146994950|NCT03203447|530145924|FG001|Overall Study|Withdrawal by Subject|1|||
146994951|NCT03203447|530145923|FG000|Overall Study|Lost to Follow-up|1|||
146840219|NCT02224703|529586509|FG001|Overall Study|Lack of Efficacy|0|||
146994952|NCT03203447|530145924|FG001|Overall Study|Lost to Follow-up|10|||
146994953|NCT03203447|530145923|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
146994954|NCT03203447|530145924|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
146994955|NCT00324168|530145925|FG000|Overall Study|Lost to Follow-up|19|||
146994956|NCT00324168|530145926|FG001|Overall Study|Lost to Follow-up|18|||
146994957|NCT00324168|530145925|FG000|Overall Study|Death|3|||
146994958|NCT00324168|530145926|FG001|Overall Study|Death|3|||
146994959|NCT00324168|530145925|FG000|Overall Study|Patient did not visit in f/u window|6|||
146994960|NCT00324168|530145926|FG001|Overall Study|Patient did not visit in f/u window|9|||
146994961|NCT01203878|530145927|FG000|Overall Study|Withdrawal by Subject|0|||
146840220|NCT02224703|529586510|FG002|Overall Study|Lack of Efficacy|0|||
146994962|NCT01203878|530145928|FG001|Overall Study|Withdrawal by Subject|0|||
146994963|NCT01203878|530145929|FG002|Overall Study|Withdrawal by Subject|1|||
146994964|NCT01203878|530145927|FG000|Overall Study|Adverse Event|0|||
146994965|NCT01203878|530145928|FG001|Overall Study|Adverse Event|0|||
146994966|NCT01203878|530145929|FG002|Overall Study|Adverse Event|2|||
146994967|NCT01471093|530145930|FG000|Overall Study|Adverse Event|1|||
146994968|NCT01471093|530145931|FG001|Overall Study|Adverse Event|0|||
146994969|NCT01471093|530145932|FG002|Overall Study|Adverse Event|0|||
146994970|NCT01471093|530145933|FG003|Overall Study|Adverse Event|0|||
146994971|NCT02475954|530145934|FG000|Overall Study|Withdrawal by Subject|2|||
146994972|NCT02475954|530145935|FG001|Overall Study|Withdrawal by Subject|2|||
146994973|NCT02475954|530145934|FG000|Overall Study|Lost to Follow-up|11|||
146994974|NCT02475954|530145935|FG001|Overall Study|Lost to Follow-up|9|||
146994975|NCT02475954|530145934|FG000|Overall Study|Death|1|||
146994976|NCT02475954|530145935|FG001|Overall Study|Death|1|||
146994977|NCT00358449|530145939|FG000|Overall Study|Adverse Event|1|||
146994978|NCT00358449|530145940|FG001|Overall Study|Adverse Event|0|||
146994979|NCT00358449|530145941|FG002|Overall Study|Adverse Event|1|||
146994980|NCT00358449|530145939|FG000|Overall Study|Lost to Follow-up|1|||
146994981|NCT00358449|530145940|FG001|Overall Study|Lost to Follow-up|0|||
146994982|NCT00358449|530145941|FG002|Overall Study|Lost to Follow-up|0|||
146994983|NCT00358449|530145939|FG000|Overall Study|Withdrawal by Subject|2|||
146994984|NCT00358449|530145940|FG001|Overall Study|Withdrawal by Subject|0|||
146994985|NCT00358449|530145941|FG002|Overall Study|Withdrawal by Subject|0|||
146994986|NCT00358449|530145939|FG000|Overall Study|Lack of Efficacy|0|||
146994987|NCT00358449|530145940|FG001|Overall Study|Lack of Efficacy|1|||
146994988|NCT00358449|530145941|FG002|Overall Study|Lack of Efficacy|0|||
146994989|NCT00358449|530145939|FG000|Overall Study|Steriod Inhaler was Increased|0|||
146994990|NCT00358449|530145940|FG001|Overall Study|Steriod Inhaler was Increased|0|||
146994991|NCT00358449|530145941|FG002|Overall Study|Steriod Inhaler was Increased|1|||
146994992|NCT01804270|530145942|FG000|Overall Study|Withdrawal by Subject|1|||
146994993|NCT01804270|530145943|FG001|Overall Study|Withdrawal by Subject|1|||
146994994|NCT04407806|530145948|FG000|Overall Study|Withdrawal by Subject|1|||
146994995|NCT04407806|530145949|FG001|Overall Study|Withdrawal by Subject|2|||
146994996|NCT03478397|530145952|FG000|Overall Study|Refused to participate|31|||
146994997|NCT03478397|530145953|FG001|Overall Study|Refused to participate|7|||
146994998|NCT05327491|530145954|FG000|Periods 1 & 2|Miscellaneous|0|||
146994999|NCT05327491|530145955|FG001|Periods 1 & 2|Miscellaneous|1|||
146995000|NCT05327491|530145956|FG002|Periods 1 & 2|Miscellaneous|0|||
146995001|NCT05327491|530145957|FG003|Periods 1 & 2|Miscellaneous|0|||
146995002|NCT05327491|530145954|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
146995003|NCT05327491|530145955|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
146995004|NCT05327491|530145956|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
146995005|NCT05327491|530145957|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
146995006|NCT04869787|530145958|FG000|Screening|Physician Decision|1|||
146995007|NCT04869787|530145958|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
146995008|NCT00813293|530145959|FG000|Overall Study|Intercurrent illness|1|||
146995009|NCT00813293|530145960|FG001|Overall Study|Intercurrent illness|0|||
146995010|NCT00813293|530145959|FG000|Overall Study|Adverse Event|0|||
146995011|NCT00813293|530145960|FG001|Overall Study|Adverse Event|1|||
146995012|NCT00533273|530145961|FG000|Double-blind|Withdrew consent|0|||
146995013|NCT00533273|530145962|FG001|Double-blind|Withdrew consent|2|||
146995014|NCT00533273|530145961|FG000|Open-label|Withdrawal by Subject|6|||
146995015|NCT00533273|530145962|FG001|Open-label|Withdrawal by Subject|0|||
146995016|NCT02794974|530145963|FG000|Overall Study|Physician Decision|0|||
146995017|NCT02794974|530145964|FG001|Overall Study|Physician Decision|1|||
146995018|NCT01873586|530145966|FG000|Overall Study|Lost to Follow-up|3|||
146995019|NCT02202850|530145967|FG000|Overall Study|Other|2|||
146995020|NCT02202850|530145968|FG001|Overall Study|Other|2|||
146995021|NCT02202850|530145967|FG000|Overall Study|Enbrel treatment discontinued|15|||
146995022|NCT02202850|530145968|FG001|Overall Study|Enbrel treatment discontinued|3|||
146995023|NCT02202850|530145967|FG000|Overall Study|Lost to Follow-up|7|||
146995024|NCT02202850|530145968|FG001|Overall Study|Lost to Follow-up|1|||
146995025|NCT00615069|530145969|FG000|Overall Study|Death|10|||
146995026|NCT00615069|530145969|FG000|Overall Study|Physician Decision|2|||
146995027|NCT00615069|530145969|FG000|Overall Study|Withdrawal by Subject|4|||
146995028|NCT00454909|530145970|FG000|Overall Study|Withdrawal by Subject|1|||
146995029|NCT00454909|530145971|FG001|Overall Study|Withdrawal by Subject|0|||
146995030|NCT00454909|530145972|FG002|Overall Study|Withdrawal by Subject|0|||
146995031|NCT00454909|530145970|FG000|Overall Study|Migrated/moved from study area|0|||
146995032|NCT00454909|530145971|FG001|Overall Study|Migrated/moved from study area|0|||
146995033|NCT00454909|530145972|FG002|Overall Study|Migrated/moved from study area|1|||
146995034|NCT00454909|530145970|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
146995035|NCT00454909|530145971|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
146995036|NCT00454909|530145972|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
146995037|NCT00454909|530145970|FG000|Overall Study|Others|1|||
146995038|NCT00454909|530145971|FG001|Overall Study|Others|0|||
146995039|NCT00454909|530145972|FG002|Overall Study|Others|0|||
146995040|NCT02996682|530145973|FG000|Overall Study|Death|0|||
146995041|NCT02996682|530145974|FG001|Overall Study|Death|3|||
146840221|NCT01886287|529586519|FG000|Overall Study|Radiographic disease progression|1|||
146840222|NCT01886287|529586519|FG000|Overall Study|Clinical progression due to disease|1|||
146840223|NCT03596762|529586520|FG000|Overall Study|Protocol Violation|0|||
146840224|NCT03596762|529586521|FG001|Overall Study|Protocol Violation|0|||
146840225|NCT03596762|529586522|FG002|Overall Study|Protocol Violation|0|||
146840226|NCT03596762|529586523|FG003|Overall Study|Protocol Violation|0|||
146840227|NCT03596762|529586524|FG004|Overall Study|Protocol Violation|1|||
146840228|NCT03596762|529586520|FG000|Overall Study|Adverse Event|2|||
146840229|NCT03596762|529586521|FG001|Overall Study|Adverse Event|0|||
146840230|NCT03596762|529586522|FG002|Overall Study|Adverse Event|1|||
146840231|NCT03596762|529586523|FG003|Overall Study|Adverse Event|0|||
146840232|NCT03596762|529586524|FG004|Overall Study|Adverse Event|5|||
146840233|NCT03596762|529586520|FG000|Overall Study|Withdrawal by Subject|2|||
146840234|NCT03596762|529586521|FG001|Overall Study|Withdrawal by Subject|1|||
146840235|NCT03596762|529586522|FG002|Overall Study|Withdrawal by Subject|0|||
146840236|NCT03596762|529586523|FG003|Overall Study|Withdrawal by Subject|1|||
146840237|NCT03596762|529586524|FG004|Overall Study|Withdrawal by Subject|1|||
146840238|NCT02195479|529586525|FG000|Overall Study|Lost to Follow-up|18|||
146840239|NCT02195479|529586526|FG001|Overall Study|Lost to Follow-up|15|||
146840240|NCT02195479|529586525|FG000|Overall Study|Death|217|||
146840241|NCT02195479|529586526|FG001|Overall Study|Death|171|||
146840242|NCT02195479|529586525|FG000|Overall Study|Physician Decision|1|||
146840243|NCT02195479|529586526|FG001|Overall Study|Physician Decision|0|||
146840244|NCT02195479|529586525|FG000|Overall Study|Withdrawal by Subject|30|||
146840245|NCT02195479|529586526|FG001|Overall Study|Withdrawal by Subject|30|||
146840246|NCT02195479|529586525|FG000|Overall Study|Other|3|||
146840247|NCT02195479|529586526|FG001|Overall Study|Other|4|||
146840248|NCT02195479|529586525|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
146840249|NCT02195479|529586526|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
146840250|NCT05071053|529586527|FG000|Overall Study|Progressive disease|30|||
146840251|NCT05071053|529586527|FG000|Overall Study|Adverse Event|5|||
146840252|NCT02593123|529586528|FG000|Overall Study|Physician Decision|2|||
146840253|NCT02593123|529586529|FG001|Overall Study|Physician Decision|1|||
146840254|NCT02593123|529586528|FG000|Overall Study|Relapse|1|||
146840255|NCT02593123|529586529|FG001|Overall Study|Relapse|1|||
146840256|NCT01602510|529586537|FG000|Open Label Phase|Adverse Event|46|||
146840257|NCT01602510|529586538|FG001|Open Label Phase|Adverse Event|0|||
146840258|NCT01602510|529586539|FG002|Open Label Phase|Adverse Event|0|||
146840259|NCT01602510|529586537|FG000|Open Label Phase|Lack of Efficacy|22|||
146840260|NCT01602510|529586538|FG001|Open Label Phase|Lack of Efficacy|0|||
146840261|NCT01602510|529586539|FG002|Open Label Phase|Lack of Efficacy|0|||
146840262|NCT01602510|529586537|FG000|Open Label Phase|Protocol Violation|15|||
146840263|NCT01602510|529586538|FG001|Open Label Phase|Protocol Violation|0|||
146840264|NCT01602510|529586539|FG002|Open Label Phase|Protocol Violation|0|||
146840265|NCT01602510|529586537|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
146840266|NCT01602510|529586538|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
146840267|NCT01602510|529586539|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
146840268|NCT01602510|529586537|FG000|Open Label Phase|Lost to Follow-up|22|||
146840269|NCT01602510|529586538|FG001|Open Label Phase|Lost to Follow-up|0|||
146840270|NCT01602510|529586539|FG002|Open Label Phase|Lost to Follow-up|0|||
146840271|NCT01602510|529586537|FG000|Open Label Phase|Physician Decision|19|||
146840272|NCT01602510|529586538|FG001|Open Label Phase|Physician Decision|0|||
146840273|NCT01602510|529586539|FG002|Open Label Phase|Physician Decision|0|||
146840274|NCT01602510|529586537|FG000|Open Label Phase|Withdrawal by Subject|57|||
146840275|NCT01602510|529586538|FG001|Open Label Phase|Withdrawal by Subject|0|||
146840276|NCT01602510|529586539|FG002|Open Label Phase|Withdrawal by Subject|0|||
146840277|NCT01602510|529586537|FG000|Randomized Phase|Adverse Event|0|||
146840278|NCT01602510|529586538|FG001|Randomized Phase|Adverse Event|2|||
146840279|NCT01602510|529586539|FG002|Randomized Phase|Adverse Event|6|||
146840280|NCT01602510|529586537|FG000|Randomized Phase|Lack of Efficacy|0|||
146840281|NCT01602510|529586538|FG001|Randomized Phase|Lack of Efficacy|4|||
146840282|NCT01602510|529586539|FG002|Randomized Phase|Lack of Efficacy|4|||
146840283|NCT01602510|529586537|FG000|Randomized Phase|Protocol Violation|0|||
146840284|NCT01602510|529586538|FG001|Randomized Phase|Protocol Violation|3|||
146840285|NCT01602510|529586539|FG002|Randomized Phase|Protocol Violation|3|||
146840286|NCT01602510|529586537|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
146840287|NCT01602510|529586538|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
146840288|NCT01602510|529586539|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
146840289|NCT01602510|529586537|FG000|Randomized Phase|Lost to Follow-up|0|||
146840290|NCT01602510|529586538|FG001|Randomized Phase|Lost to Follow-up|1|||
146840291|NCT01602510|529586539|FG002|Randomized Phase|Lost to Follow-up|3|||
146840292|NCT01602510|529586537|FG000|Randomized Phase|Physician Decision|0|||
146840293|NCT01602510|529586538|FG001|Randomized Phase|Physician Decision|0|||
146840294|NCT01602510|529586539|FG002|Randomized Phase|Physician Decision|2|||
146840295|NCT01602510|529586537|FG000|Randomized Phase|Withdrawal by Subject|0|||
146840296|NCT01602510|529586538|FG001|Randomized Phase|Withdrawal by Subject|6|||
146995042|NCT01981720|530145975|FG000|Overall Study|Adverse Event|1|||
146995043|NCT01981720|530145975|FG000|Overall Study|Withdrawal by Subject|3|||
146995044|NCT01981720|530145975|FG000|Overall Study|Pregnancy|1|||
146995045|NCT00282048|530145976|FG000|Overall Study|Lack of Efficacy|30|||
146995046|NCT00282048|530145976|FG000|Overall Study|Adverse Event|22|||
146995047|NCT00282048|530145976|FG000|Overall Study|Withdrawal by Subject|1|||
146995048|NCT00282048|530145976|FG000|Overall Study|Other|8|||
146995049|NCT00282048|530145976|FG000|Overall Study|Ongoing|1|||
146995050|NCT03048500|530145978|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
146995051|NCT03048500|530145978|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
146995052|NCT03048500|530145978|FG000|Reached 1st Response/Continued Treatment|Death|1|||
146995053|NCT03048500|530145978|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
146995054|NCT03048500|530145978|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
146995055|NCT03048500|530145978|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
146995056|NCT03048500|530145978|FG000|Follow up for 3 Years|Death|12|||
146995057|NCT01941030|530145981|FG000|Overall Study|Death|3|||
146995058|NCT01941030|530145982|FG001|Overall Study|Death|2|||
146995059|NCT01941030|530145981|FG000|Overall Study|Lost to Follow-up|6|||
146995060|NCT01941030|530145982|FG001|Overall Study|Lost to Follow-up|5|||
146995061|NCT01941030|530145981|FG000|Overall Study|Withdrawal by Subject|4|||
146995062|NCT01941030|530145982|FG001|Overall Study|Withdrawal by Subject|6|||
146995063|NCT00870870|530145985|FG000|Overall Study|Withdrawal by Subject|0|||
146995064|NCT00870870|530145986|FG001|Overall Study|Withdrawal by Subject|1|||
146995065|NCT00870870|530145987|FG002|Overall Study|Withdrawal by Subject|1|||
146995066|NCT00870870|530145988|FG003|Overall Study|Withdrawal by Subject|3|||
146995067|NCT00870870|530145985|FG000|Overall Study|Adverse Event|0|||
146995068|NCT00870870|530145986|FG001|Overall Study|Adverse Event|0|||
146995069|NCT00870870|530145987|FG002|Overall Study|Adverse Event|2|||
146995070|NCT00870870|530145988|FG003|Overall Study|Adverse Event|2|||
146995071|NCT03639311|530145993|FG000|Maintenance Phase|Lost to Follow-up|1|||
146995072|NCT03639311|530145994|FG001|Maintenance Phase|Lost to Follow-up|0|||
146995073|NCT03639311|530145995|FG002|Maintenance Phase|Lost to Follow-up|0|||
146995074|NCT03639311|530145993|FG000|Maintenance Phase|Adverse Event|1|||
146995075|NCT03639311|530145994|FG001|Maintenance Phase|Adverse Event|0|||
146995076|NCT03639311|530145995|FG002|Maintenance Phase|Adverse Event|0|||
146995077|NCT03639311|530145993|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
146995078|NCT03639311|530145994|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
146995079|NCT03639311|530145995|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
146995080|NCT03639311|530145993|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
146995081|NCT03639311|530145994|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
146995082|NCT03639311|530145995|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
146995083|NCT03639311|530145993|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
146995084|NCT03639311|530145994|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
146995085|NCT03639311|530145995|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
146995086|NCT03639311|530145993|FG000|Maintenance Phase|Lack of Efficacy|1|||
146995087|NCT03639311|530145994|FG001|Maintenance Phase|Lack of Efficacy|0|||
146995088|NCT03639311|530145995|FG002|Maintenance Phase|Lack of Efficacy|0|||
146995089|NCT00822926|530145996|FG000|Second Injection Visit|Lost to Follow-up|1|||
146995090|NCT00822926|530145997|FG001|Second Injection Visit|Lost to Follow-up|0|||
146995091|NCT00822926|530145996|FG000|Second Injection Visit|Withdrawal by Subject|0|||
146995092|NCT00822926|530145997|FG001|Second Injection Visit|Withdrawal by Subject|1|||
146995093|NCT03125200|530145999|FG000|Overall Study|Study Termination|0|||
146995094|NCT03125200|530146000|FG001|Overall Study|Study Termination|0|||
146995095|NCT03125200|530146001|FG002|Overall Study|Study Termination|0|||
146995096|NCT03125200|530146002|FG003|Overall Study|Study Termination|1|||
146995097|NCT03125200|530146003|FG004|Overall Study|Study Termination|1|||
146995098|NCT03125200|530146004|FG005|Overall Study|Study Termination|2|||
146995099|NCT03125200|530146005|FG006|Overall Study|Study Termination|1|||
146995100|NCT03125200|530145999|FG000|Overall Study|Clinical Progression|0|||
146995101|NCT03125200|530146000|FG001|Overall Study|Clinical Progression|0|||
146995102|NCT03125200|530146001|FG002|Overall Study|Clinical Progression|0|||
146995103|NCT03125200|530146002|FG003|Overall Study|Clinical Progression|1|||
146995104|NCT03125200|530146003|FG004|Overall Study|Clinical Progression|0|||
146995105|NCT03125200|530146004|FG005|Overall Study|Clinical Progression|1|||
146995106|NCT03125200|530146005|FG006|Overall Study|Clinical Progression|0|||
146995107|NCT03125200|530145999|FG000|Overall Study|Progressive Disease|2|||
146995108|NCT03125200|530146000|FG001|Overall Study|Progressive Disease|1|||
146995109|NCT03125200|530146001|FG002|Overall Study|Progressive Disease|2|||
146995110|NCT03125200|530146002|FG003|Overall Study|Progressive Disease|1|||
146995111|NCT03125200|530146003|FG004|Overall Study|Progressive Disease|2|||
146995112|NCT03125200|530146004|FG005|Overall Study|Progressive Disease|0|||
146995113|NCT03125200|530146005|FG006|Overall Study|Progressive Disease|1|||
146995114|NCT03125200|530145999|FG000|Overall Study|Lack of Efficacy|0|||
146995115|NCT03125200|530146000|FG001|Overall Study|Lack of Efficacy|0|||
146995116|NCT03125200|530146001|FG002|Overall Study|Lack of Efficacy|0|||
146840297|NCT01602510|529586539|FG002|Randomized Phase|Withdrawal by Subject|7|||
146840298|NCT01001390|529586540|FG000|Overall Study|Failure to wear AFO device|2|||
146840299|NCT01001390|529586541|FG001|Overall Study|Failure to wear AFO device|0|||
146840300|NCT00895895|529586542|FG000|Period 1|Adverse Event|7|||
146840301|NCT00895895|529586543|FG001|Period 1|Adverse Event|6|||
146840302|NCT00895895|529586544|FG002|Period 1|Adverse Event|4|||
146840303|NCT00895895|529586545|FG003|Period 1|Adverse Event|6|||
146840304|NCT00895895|529586546|FG004|Period 1|Adverse Event|7|||
146840305|NCT00895895|529586542|FG000|Period 1|Death|0|||
146840306|NCT00895895|529586543|FG001|Period 1|Death|0|||
146840307|NCT00895895|529586544|FG002|Period 1|Death|0|||
146840308|NCT00895895|529586545|FG003|Period 1|Death|0|||
146840309|NCT00895895|529586546|FG004|Period 1|Death|1|||
146840310|NCT00895895|529586542|FG000|Period 1|discontinued by sponsor|2|||
146840311|NCT00895895|529586543|FG001|Period 1|discontinued by sponsor|1|||
146840312|NCT00895895|529586544|FG002|Period 1|discontinued by sponsor|2|||
146840313|NCT00895895|529586545|FG003|Period 1|discontinued by sponsor|1|||
146840314|NCT00895895|529586546|FG004|Period 1|discontinued by sponsor|1|||
146840315|NCT00895895|529586542|FG000|Period 1|failed to return|0|||
146840316|NCT00895895|529586543|FG001|Period 1|failed to return|0|||
146840317|NCT00895895|529586544|FG002|Period 1|failed to return|1|||
146840318|NCT00895895|529586545|FG003|Period 1|failed to return|0|||
146840319|NCT00895895|529586546|FG004|Period 1|failed to return|1|||
146995117|NCT03125200|530146002|FG003|Overall Study|Lack of Efficacy|1|||
146995118|NCT03125200|530146003|FG004|Overall Study|Lack of Efficacy|0|||
146995119|NCT03125200|530146004|FG005|Overall Study|Lack of Efficacy|0|||
146995120|NCT03125200|530146005|FG006|Overall Study|Lack of Efficacy|0|||
146995121|NCT03125200|530145999|FG000|Overall Study|Toxicity|0|||
146995122|NCT03125200|530146000|FG001|Overall Study|Toxicity|0|||
146995123|NCT03125200|530146001|FG002|Overall Study|Toxicity|0|||
146995124|NCT03125200|530146002|FG003|Overall Study|Toxicity|1|||
146995125|NCT03125200|530146003|FG004|Overall Study|Toxicity|0|||
146995126|NCT03125200|530146004|FG005|Overall Study|Toxicity|0|||
146995127|NCT03125200|530146005|FG006|Overall Study|Toxicity|0|||
146995128|NCT03125200|530145999|FG000|Overall Study|Consent Withdrawn by Subject|0|||
146995129|NCT03125200|530146000|FG001|Overall Study|Consent Withdrawn by Subject|1|||
146995130|NCT03125200|530146001|FG002|Overall Study|Consent Withdrawn by Subject|0|||
146995131|NCT03125200|530146002|FG003|Overall Study|Consent Withdrawn by Subject|0|||
146995132|NCT03125200|530146003|FG004|Overall Study|Consent Withdrawn by Subject|1|||
146995133|NCT03125200|530146004|FG005|Overall Study|Consent Withdrawn by Subject|0|||
146995134|NCT03125200|530146005|FG006|Overall Study|Consent Withdrawn by Subject|1|||
146995135|NCT03544138|530146008|FG000|Overall Study|Lost to Follow-up|29|||
146995136|NCT05017480|530147531|FG000|Stage 1 Study|Withdrawal by Subject|8|||
146995137|NCT05017480|530147532|FG001|Stage 1 Study|Withdrawal by Subject|6|||
146995138|NCT05017480|530147533|FG002|Stage 1 Study|Withdrawal by Subject|0|||
146995139|NCT05017480|530147534|FG003|Stage 1 Study|Withdrawal by Subject|0|||
146995140|NCT05017480|530147535|FG004|Stage 1 Study|Withdrawal by Subject|0|||
146995141|NCT05017480|530147531|FG000|Stage 1 Study|Adverse Event|1|||
146995142|NCT05017480|530147532|FG001|Stage 1 Study|Adverse Event|1|||
146995143|NCT05017480|530147533|FG002|Stage 1 Study|Adverse Event|0|||
146995144|NCT05017480|530147534|FG003|Stage 1 Study|Adverse Event|0|||
146995145|NCT05017480|530147535|FG004|Stage 1 Study|Adverse Event|0|||
146995146|NCT05017480|530147531|FG000|Stage 1 Study|Poor Compliance|1|||
146995147|NCT05017480|530147532|FG001|Stage 1 Study|Poor Compliance|1|||
146995148|NCT05017480|530147533|FG002|Stage 1 Study|Poor Compliance|0|||
146995149|NCT05017480|530147534|FG003|Stage 1 Study|Poor Compliance|0|||
146995150|NCT05017480|530147535|FG004|Stage 1 Study|Poor Compliance|0|||
146995151|NCT05017480|530147531|FG000|Stage 1 Study|Physician Decision|0|||
146995152|NCT05017480|530147532|FG001|Stage 1 Study|Physician Decision|1|||
146995153|NCT05017480|530147533|FG002|Stage 1 Study|Physician Decision|0|||
146995154|NCT05017480|530147534|FG003|Stage 1 Study|Physician Decision|0|||
146995155|NCT05017480|530147535|FG004|Stage 1 Study|Physician Decision|0|||
146995156|NCT05017480|530147531|FG000|Stage 2 Study|Withdrawal by Subject|0|||
146995157|NCT05017480|530147532|FG001|Stage 2 Study|Withdrawal by Subject|0|||
146995158|NCT05017480|530147533|FG002|Stage 2 Study|Withdrawal by Subject|6|||
146840320|NCT00895895|529586542|FG000|Period 1|investigator request|0|||
146840321|NCT00895895|529586543|FG001|Period 1|investigator request|1|||
146840322|NCT00895895|529586544|FG002|Period 1|investigator request|0|||
146840323|NCT00895895|529586545|FG003|Period 1|investigator request|0|||
146840324|NCT00895895|529586546|FG004|Period 1|investigator request|0|||
146840325|NCT00895895|529586542|FG000|Period 1|Lost to Follow-up|2|||
146840326|NCT00895895|529586543|FG001|Period 1|Lost to Follow-up|1|||
146840327|NCT00895895|529586544|FG002|Period 1|Lost to Follow-up|3|||
146840328|NCT00895895|529586545|FG003|Period 1|Lost to Follow-up|2|||
146995159|NCT05017480|530147534|FG003|Stage 2 Study|Withdrawal by Subject|9|||
146995160|NCT05017480|530147535|FG004|Stage 2 Study|Withdrawal by Subject|11|||
146995161|NCT05017480|530147531|FG000|Stage 2 Study|Lost to Follow-up|0|||
146995162|NCT05017480|530147532|FG001|Stage 2 Study|Lost to Follow-up|0|||
146995163|NCT05017480|530147533|FG002|Stage 2 Study|Lost to Follow-up|0|||
146995164|NCT05017480|530147534|FG003|Stage 2 Study|Lost to Follow-up|2|||
146995165|NCT05017480|530147535|FG004|Stage 2 Study|Lost to Follow-up|1|||
146840329|NCT00895895|529586546|FG004|Period 1|Lost to Follow-up|3|||
146840330|NCT00895895|529586542|FG000|Period 1|Other|1|||
146840331|NCT00895895|529586543|FG001|Period 1|Other|2|||
146840332|NCT00895895|529586544|FG002|Period 1|Other|1|||
146995166|NCT05017480|530147531|FG000|Stage 2 Study|Adverse Event|0|||
146995167|NCT05017480|530147532|FG001|Stage 2 Study|Adverse Event|0|||
146995168|NCT05017480|530147533|FG002|Stage 2 Study|Adverse Event|0|||
146995169|NCT05017480|530147534|FG003|Stage 2 Study|Adverse Event|1|||
146995170|NCT05017480|530147535|FG004|Stage 2 Study|Adverse Event|0|||
146995171|NCT05017480|530147531|FG000|Stage 2 Study|COVID-19|0|||
146995172|NCT05017480|530147532|FG001|Stage 2 Study|COVID-19|0|||
146995173|NCT05017480|530147533|FG002|Stage 2 Study|COVID-19|0|||
146995174|NCT05017480|530147534|FG003|Stage 2 Study|COVID-19|1|||
146995175|NCT05017480|530147535|FG004|Stage 2 Study|COVID-19|0|||
146995176|NCT05017480|530147531|FG000|Stage 2 Study|Pregnancy|0|||
146995177|NCT05017480|530147532|FG001|Stage 2 Study|Pregnancy|0|||
146995178|NCT05017480|530147533|FG002|Stage 2 Study|Pregnancy|0|||
146995179|NCT05017480|530147534|FG003|Stage 2 Study|Pregnancy|0|||
146995180|NCT05017480|530147535|FG004|Stage 2 Study|Pregnancy|1|||
146995181|NCT02028715|530147538|FG000|Overall Study|Adverse Event|2|||
146995182|NCT02028715|530147539|FG001|Overall Study|Adverse Event|2|||
146995183|NCT02028715|530147538|FG000|Overall Study|Physician Decision|1|||
146995184|NCT02028715|530147539|FG001|Overall Study|Physician Decision|0|||
146995185|NCT02028715|530147538|FG000|Overall Study|Did not complete satisfaction surveys|2|||
146995186|NCT02028715|530147539|FG001|Overall Study|Did not complete satisfaction surveys|2|||
146995187|NCT01710657|530147542|FG000|Overall Study|Lost to Follow-up|2|||
146995188|NCT01710657|530147543|FG001|Overall Study|Lost to Follow-up|0|||
146995189|NCT01710657|530147544|FG002|Overall Study|Lost to Follow-up|1|||
146995190|NCT01710657|530147542|FG000|Overall Study|Protocol Violation|2|||
146995191|NCT01710657|530147543|FG001|Overall Study|Protocol Violation|2|||
146995192|NCT01710657|530147544|FG002|Overall Study|Protocol Violation|0|||
146995193|NCT01710657|530147542|FG000|Overall Study|Adverse Event|14|||
146995194|NCT01710657|530147543|FG001|Overall Study|Adverse Event|8|||
146995195|NCT01710657|530147544|FG002|Overall Study|Adverse Event|28|||
146995196|NCT01710657|530147542|FG000|Overall Study|Withdrawal by Subject|0|||
146995197|NCT01710657|530147543|FG001|Overall Study|Withdrawal by Subject|1|||
146995198|NCT01710657|530147544|FG002|Overall Study|Withdrawal by Subject|2|||
146995199|NCT01710657|530147542|FG000|Overall Study|Lack of Efficacy|0|||
146995200|NCT01710657|530147543|FG001|Overall Study|Lack of Efficacy|1|||
146995201|NCT01710657|530147544|FG002|Overall Study|Lack of Efficacy|1|||
146995202|NCT02188303|530147545|FG000|Overall Study|Adverse Event|0|||
146995203|NCT02188303|530147546|FG001|Overall Study|Adverse Event|0|||
146995204|NCT02188303|530147547|FG002|Overall Study|Adverse Event|0|||
146995205|NCT02188303|530147548|FG003|Overall Study|Adverse Event|0|||
146995206|NCT02188303|530147549|FG004|Overall Study|Adverse Event|0|||
146995207|NCT02188303|530147550|FG005|Overall Study|Adverse Event|2|||
146995208|NCT02188303|530147551|FG006|Overall Study|Adverse Event|0|||
146995209|NCT02188303|530147552|FG007|Overall Study|Adverse Event|2|||
146995210|NCT02188303|530147545|FG000|Overall Study|Dose Termination Criteria Met|0|||
146995211|NCT02188303|530147546|FG001|Overall Study|Dose Termination Criteria Met|0|||
146995212|NCT02188303|530147547|FG002|Overall Study|Dose Termination Criteria Met|0|||
146995213|NCT02188303|530147548|FG003|Overall Study|Dose Termination Criteria Met|0|||
146995214|NCT02188303|530147549|FG004|Overall Study|Dose Termination Criteria Met|0|||
146995215|NCT02188303|530147550|FG005|Overall Study|Dose Termination Criteria Met|0|||
146995216|NCT02188303|530147551|FG006|Overall Study|Dose Termination Criteria Met|2|||
146995217|NCT02188303|530147552|FG007|Overall Study|Dose Termination Criteria Met|4|||
146995218|NCT04206332|530147554|FG000|Part A|Lost to Follow-up|0|||
146995219|NCT04206332|530147555|FG001|Part A|Lost to Follow-up|1|||
146995220|NCT04206332|530147556|FG002|Part A|Lost to Follow-up|0|||
146995221|NCT04206332|530147557|FG003|Part A|Lost to Follow-up|0|||
146995222|NCT04206332|530147558|FG004|Part A|Lost to Follow-up|0|||
146995223|NCT04206332|530147559|FG005|Part A|Lost to Follow-up|0|||
146995224|NCT04206332|530147560|FG006|Part A|Lost to Follow-up|0|||
146995225|NCT04206332|530147561|FG007|Part A|Lost to Follow-up|0|||
146995226|NCT04206332|530147562|FG008|Part A|Lost to Follow-up|0|||
146840333|NCT00895895|529586545|FG003|Period 1|Other|1|||
146840334|NCT00895895|529586546|FG004|Period 1|Other|1|||
146995227|NCT04206332|530147563|FG009|Part A|Lost to Follow-up|0|||
146840335|NCT00895895|529586542|FG000|Period 1|Protocol Violation|0|||
146840336|NCT00895895|529586543|FG001|Period 1|Protocol Violation|1|||
146840337|NCT00895895|529586544|FG002|Period 1|Protocol Violation|0|||
146995228|NCT04206332|530147564|FG010|Part A|Lost to Follow-up|0|||
146995229|NCT04206332|530147565|FG011|Part A|Lost to Follow-up|0|||
146995230|NCT04206332|530147566|FG012|Part A|Lost to Follow-up|0|||
146995231|NCT04206332|530147567|FG013|Part A|Lost to Follow-up|0|||
146995232|NCT04206332|530147568|FG014|Part A|Lost to Follow-up|0|||
146995233|NCT04206332|530147569|FG015|Part A|Lost to Follow-up|0|||
146995234|NCT04206332|530147570|FG016|Part A|Lost to Follow-up|0|||
146840338|NCT00895895|529586545|FG003|Period 1|Protocol Violation|0|||
146840339|NCT00895895|529586546|FG004|Period 1|Protocol Violation|0|||
146995235|NCT04206332|530147554|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146995236|NCT04206332|530147555|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146995237|NCT04206332|530147556|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146995238|NCT04206332|530147557|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146995239|NCT04206332|530147558|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146995240|NCT04206332|530147559|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
146995241|NCT04206332|530147560|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146995242|NCT04206332|530147561|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146995243|NCT04206332|530147562|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146995244|NCT04206332|530147563|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146995245|NCT04206332|530147564|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146995246|NCT04206332|530147565|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146840340|NCT00895895|529586542|FG000|Period 1|Withdrawal by Subject|6|||
146840341|NCT00895895|529586543|FG001|Period 1|Withdrawal by Subject|6|||
146840342|NCT00895895|529586544|FG002|Period 1|Withdrawal by Subject|8|||
146840343|NCT00895895|529586545|FG003|Period 1|Withdrawal by Subject|2|||
146840344|NCT00895895|529586546|FG004|Period 1|Withdrawal by Subject|4|||
146840345|NCT00895895|529586542|FG000|Period 1|unsatisfactory response-efficacy|2|||
146840346|NCT00895895|529586543|FG001|Period 1|unsatisfactory response-efficacy|0|||
146840347|NCT00895895|529586544|FG002|Period 1|unsatisfactory response-efficacy|0|||
146840348|NCT00895895|529586545|FG003|Period 1|unsatisfactory response-efficacy|0|||
146840349|NCT00895895|529586546|FG004|Period 1|unsatisfactory response-efficacy|0|||
146840350|NCT00895895|529586542|FG000|Period 1|randomized and not treated|1|||
146840351|NCT00895895|529586543|FG001|Period 1|randomized and not treated|3|||
146840352|NCT00895895|529586544|FG002|Period 1|randomized and not treated|1|||
146840353|NCT00895895|529586545|FG003|Period 1|randomized and not treated|1|||
146840354|NCT00895895|529586546|FG004|Period 1|randomized and not treated|2|||
146840355|NCT00895895|529586542|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
146840356|NCT00895895|529586543|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
146840357|NCT00895895|529586544|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
146840358|NCT00895895|529586545|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
146840359|NCT00895895|529586546|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
146840360|NCT00895895|529586542|FG000|After Period 1, Prior to Period 2|Other|0|||
146840361|NCT00895895|529586543|FG001|After Period 1, Prior to Period 2|Other|0|||
146995247|NCT04206332|530147566|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146995248|NCT04206332|530147567|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146995249|NCT04206332|530147568|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146995250|NCT04206332|530147569|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146995251|NCT04206332|530147570|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146995252|NCT04206332|530147554|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995253|NCT04206332|530147555|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995254|NCT04206332|530147556|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995255|NCT04206332|530147557|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995256|NCT04206332|530147558|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995257|NCT04206332|530147559|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995258|NCT04206332|530147560|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995259|NCT04206332|530147561|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
146995260|NCT04206332|530147562|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995261|NCT04206332|530147563|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995262|NCT04206332|530147564|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
147013222|NCT02048813|530210052|FG000|Overall Study|Never started treatment|2|||
146840362|NCT00895895|529586544|FG002|After Period 1, Prior to Period 2|Other|1|||
146840363|NCT00895895|529586545|FG003|After Period 1, Prior to Period 2|Other|0|||
146840364|NCT00895895|529586546|FG004|After Period 1, Prior to Period 2|Other|0|||
146840365|NCT00895895|529586542|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
146840366|NCT00895895|529586543|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
146840367|NCT00895895|529586544|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
146840368|NCT00895895|529586545|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
146840369|NCT00895895|529586546|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
146840370|NCT00895895|529586542|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
146840371|NCT00895895|529586543|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
146840372|NCT00895895|529586544|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
146840373|NCT00895895|529586545|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
146840374|NCT00895895|529586546|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
146840375|NCT00895895|529586542|FG000|Period 2|Adverse Event|3|||
146840376|NCT00895895|529586543|FG001|Period 2|Adverse Event|3|||
146840377|NCT00895895|529586544|FG002|Period 2|Adverse Event|5|||
146840378|NCT00895895|529586545|FG003|Period 2|Adverse Event|2|||
146840379|NCT00895895|529586546|FG004|Period 2|Adverse Event|5|||
146840380|NCT00895895|529586542|FG000|Period 2|Death|0|||
146840381|NCT00895895|529586543|FG001|Period 2|Death|0|||
146840382|NCT00895895|529586544|FG002|Period 2|Death|1|||
146840383|NCT00895895|529586545|FG003|Period 2|Death|0|||
146840384|NCT00895895|529586546|FG004|Period 2|Death|0|||
146840385|NCT00895895|529586542|FG000|Period 2|discontinued by sponsor|44|||
146840386|NCT00895895|529586543|FG001|Period 2|discontinued by sponsor|44|||
146840387|NCT00895895|529586544|FG002|Period 2|discontinued by sponsor|38|||
146840388|NCT00895895|529586545|FG003|Period 2|discontinued by sponsor|46|||
146840389|NCT00895895|529586546|FG004|Period 2|discontinued by sponsor|37|||
146840390|NCT00895895|529586542|FG000|Period 2|failed to return|2|||
146840391|NCT00895895|529586543|FG001|Period 2|failed to return|0|||
146840392|NCT00895895|529586544|FG002|Period 2|failed to return|0|||
146840393|NCT00895895|529586545|FG003|Period 2|failed to return|0|||
146840394|NCT00895895|529586546|FG004|Period 2|failed to return|0|||
146840395|NCT00895895|529586542|FG000|Period 2|investigator request|2|||
146840396|NCT00895895|529586543|FG001|Period 2|investigator request|0|||
146840397|NCT00895895|529586544|FG002|Period 2|investigator request|0|||
146840398|NCT00895895|529586545|FG003|Period 2|investigator request|0|||
146840399|NCT00895895|529586546|FG004|Period 2|investigator request|0|||
146840400|NCT00895895|529586542|FG000|Period 2|Lost to Follow-up|1|||
146840401|NCT00895895|529586543|FG001|Period 2|Lost to Follow-up|2|||
146840402|NCT00895895|529586544|FG002|Period 2|Lost to Follow-up|1|||
146840403|NCT00895895|529586545|FG003|Period 2|Lost to Follow-up|1|||
146840404|NCT00895895|529586546|FG004|Period 2|Lost to Follow-up|0|||
146840405|NCT00895895|529586542|FG000|Period 2|Other|1|||
146840406|NCT00895895|529586543|FG001|Period 2|Other|1|||
146840407|NCT00895895|529586544|FG002|Period 2|Other|3|||
146840408|NCT00895895|529586545|FG003|Period 2|Other|1|||
146840409|NCT00895895|529586546|FG004|Period 2|Other|1|||
146840410|NCT00895895|529586542|FG000|Period 2|Protocol Violation|1|||
146840411|NCT00895895|529586543|FG001|Period 2|Protocol Violation|0|||
146840412|NCT00895895|529586544|FG002|Period 2|Protocol Violation|1|||
146840413|NCT00895895|529586545|FG003|Period 2|Protocol Violation|1|||
146840414|NCT00895895|529586546|FG004|Period 2|Protocol Violation|1|||
146840415|NCT00895895|529586542|FG000|Period 2|Withdrawal by Subject|0|||
146840416|NCT00895895|529586543|FG001|Period 2|Withdrawal by Subject|2|||
146840417|NCT00895895|529586544|FG002|Period 2|Withdrawal by Subject|0|||
146840418|NCT00895895|529586545|FG003|Period 2|Withdrawal by Subject|3|||
146840419|NCT00895895|529586546|FG004|Period 2|Withdrawal by Subject|5|||
146840420|NCT00895895|529586542|FG000|Period 2|unsatisfactory response-efficacy|2|||
146840421|NCT00895895|529586543|FG001|Period 2|unsatisfactory response-efficacy|1|||
146840422|NCT00895895|529586544|FG002|Period 2|unsatisfactory response-efficacy|0|||
146840423|NCT00895895|529586545|FG003|Period 2|unsatisfactory response-efficacy|0|||
146840424|NCT00895895|529586546|FG004|Period 2|unsatisfactory response-efficacy|0|||
146840425|NCT01261000|529586547|FG000|Overall Study|Screen failure|1|||
146840426|NCT03019640|529586548|FG000|Overall Study|Screen Failures|4|||
146840427|NCT03019640|529586548|FG000|Overall Study|Adverse Event|3|||
146840428|NCT03019640|529586548|FG000|Overall Study|Participant Relapsed|1|||
146840429|NCT00504777|529586549|FG000|Overall Study|Adverse Event|1|||
146840430|NCT01195623|529586553|FG000|Overall Study|Lost to Follow-up|35|||
146840431|NCT01195623|529586554|FG001|Overall Study|Lost to Follow-up|37|||
146840432|NCT00214019|529586559|FG000|Overall Study|Lost to Follow-up|11|||
146840433|NCT00214019|529586559|FG000|Overall Study|Withdrawal by Subject|2|||
146840434|NCT00214019|529586559|FG000|Overall Study|Screen Failed prior to randomization|17|||
146840435|NCT00477490|529586560|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
146840436|NCT00477490|529586561|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
146961298|NCT02708524|530018123|FG001|Overall Study|Withdrawal by Subject|1|||
146961299|NCT02708524|530018124|FG002|Overall Study|Withdrawal by Subject|0|||
146961300|NCT02708524|530018125|FG003|Overall Study|Withdrawal by Subject|0|||
146961301|NCT02708524|530018122|FG000|Overall Study|Dispensed incorrect study lens|0|||
146961302|NCT02708524|530018123|FG001|Overall Study|Dispensed incorrect study lens|1|||
146961303|NCT02708524|530018124|FG002|Overall Study|Dispensed incorrect study lens|1|||
146961304|NCT02708524|530018125|FG003|Overall Study|Dispensed incorrect study lens|0|||
146961305|NCT02708524|530018122|FG000|Overall Study|Did not wear lens at final visit|0|||
146961306|NCT02708524|530018123|FG001|Overall Study|Did not wear lens at final visit|1|||
146961307|NCT02708524|530018124|FG002|Overall Study|Did not wear lens at final visit|0|||
146961308|NCT02708524|530018125|FG003|Overall Study|Did not wear lens at final visit|0|||
146840437|NCT00477490|529586562|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
146840438|NCT00477490|529586563|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
146840439|NCT00477490|529586564|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
146840440|NCT00477490|529586565|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
146840441|NCT00477490|529586566|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
146840442|NCT00477490|529586567|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
146840443|NCT00477490|529586568|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
146840444|NCT00477490|529586560|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
146840445|NCT00477490|529586561|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
146840446|NCT00477490|529586562|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
146840447|NCT00477490|529586563|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
146840448|NCT00477490|529586564|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
146840449|NCT00477490|529586565|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
146840450|NCT00477490|529586566|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
146840451|NCT00477490|529586567|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
146840452|NCT00477490|529586568|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
146840453|NCT00477490|529586560|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
146840454|NCT00477490|529586561|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
146840455|NCT00477490|529586562|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
146840456|NCT00477490|529586563|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
146840457|NCT00477490|529586564|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
146840458|NCT00477490|529586565|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
146840459|NCT00477490|529586566|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
146840460|NCT00477490|529586567|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
146840461|NCT00477490|529586568|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
146840462|NCT00477490|529586560|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
146840463|NCT00477490|529586561|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
146840464|NCT00477490|529586562|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
146840465|NCT00477490|529586563|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
146840466|NCT00477490|529586564|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
146840467|NCT00477490|529586565|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
146840468|NCT00477490|529586566|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
146840469|NCT00477490|529586567|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
146840470|NCT00477490|529586568|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
146840471|NCT00477490|529586560|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
146840472|NCT00477490|529586561|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
146840473|NCT00477490|529586562|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
146840474|NCT00477490|529586563|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
146840475|NCT00477490|529586564|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
146840476|NCT00477490|529586565|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
146840477|NCT00477490|529586566|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
146961309|NCT02708524|530018122|FG000|Overall Study|Subject lost study lens|1|||
146961310|NCT02708524|530018123|FG001|Overall Study|Subject lost study lens|0|||
146961311|NCT02708524|530018124|FG002|Overall Study|Subject lost study lens|0|||
146961312|NCT02708524|530018125|FG003|Overall Study|Subject lost study lens|0|||
146961313|NCT00761735|530018130|FG000|Overall Study|Lost to Follow-up|6|||
146961314|NCT00761735|530018130|FG000|Overall Study|Withdrawal by Subject|6|||
146961315|NCT00761735|530018130|FG000|Overall Study|Non-compliance with protocol|1|||
146961316|NCT00761735|530018130|FG000|Overall Study|Administrative|1|||
146961317|NCT03290131|530018131|FG000|Overall Study|Adverse Event|22|||
146961318|NCT03290131|530018132|FG001|Overall Study|Adverse Event|57|||
146961319|NCT03290131|530018133|FG002|Overall Study|Adverse Event|11|||
146961320|NCT03290131|530018131|FG000|Overall Study|Withdrawal by Subject|18|||
146961321|NCT03290131|530018132|FG001|Overall Study|Withdrawal by Subject|13|||
146961322|NCT03290131|530018133|FG002|Overall Study|Withdrawal by Subject|8|||
146961323|NCT03290131|530018131|FG000|Overall Study|MS Relapse|2|||
146961324|NCT03290131|530018132|FG001|Overall Study|MS Relapse|1|||
146961325|NCT03290131|530018133|FG002|Overall Study|MS Relapse|0|||
146961326|NCT03290131|530018131|FG000|Overall Study|Unknown reason|0|||
146961327|NCT03290131|530018132|FG001|Overall Study|Unknown reason|1|||
146961328|NCT03290131|530018133|FG002|Overall Study|Unknown reason|0|||
146961329|NCT00381680|530018134|FG000|Overall Study|Adverse Event|9|||
146961330|NCT00381680|530018135|FG001|Overall Study|Adverse Event|3|||
146961331|NCT00381680|530018134|FG000|Overall Study|Death|10|||
146961332|NCT00381680|530018135|FG001|Overall Study|Death|7|||
146961333|NCT00381680|530018134|FG000|Overall Study|Lost to Follow-up|3|||
146961334|NCT00381680|530018135|FG001|Overall Study|Lost to Follow-up|2|||
146961335|NCT00381680|530018134|FG000|Overall Study|Physician Decision|25|||
146961336|NCT00381680|530018135|FG001|Overall Study|Physician Decision|6|||
146961337|NCT00381680|530018134|FG000|Overall Study|Withdrawal by Subject|3|||
146840478|NCT00477490|529586567|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
146840479|NCT00477490|529586568|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
146840480|NCT00477490|529586560|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
146840481|NCT00477490|529586561|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
146840482|NCT00477490|529586562|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
146840483|NCT00477490|529586563|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
146961338|NCT00381680|530018135|FG001|Overall Study|Withdrawal by Subject|1|||
146961339|NCT00381680|530018134|FG000|Overall Study|Entry onto another COG Trial|1|||
146840484|NCT00477490|529586564|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
146840485|NCT00477490|529586565|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
146840486|NCT00477490|529586566|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
146995263|NCT04206332|530147565|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995264|NCT04206332|530147566|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995265|NCT04206332|530147567|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995266|NCT04206332|530147568|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995267|NCT04206332|530147569|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995268|NCT04206332|530147570|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995269|NCT04206332|530147554|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995270|NCT04206332|530147555|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995271|NCT04206332|530147556|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995272|NCT04206332|530147557|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995273|NCT04206332|530147558|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995274|NCT04206332|530147559|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995275|NCT04206332|530147560|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995276|NCT04206332|530147561|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995277|NCT04206332|530147562|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995278|NCT04206332|530147563|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995279|NCT04206332|530147564|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995280|NCT04206332|530147565|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995281|NCT04206332|530147566|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995282|NCT04206332|530147567|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995283|NCT04206332|530147568|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995284|NCT04206332|530147569|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146995285|NCT04206332|530147570|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
146995286|NCT04206332|530147554|FG000|Part C|Withdrawal by Subject|0|||
146995287|NCT04206332|530147555|FG001|Part C|Withdrawal by Subject|0|||
146995288|NCT04206332|530147556|FG002|Part C|Withdrawal by Subject|0|||
146995289|NCT04206332|530147557|FG003|Part C|Withdrawal by Subject|0|||
146995290|NCT04206332|530147558|FG004|Part C|Withdrawal by Subject|0|||
146995291|NCT04206332|530147559|FG005|Part C|Withdrawal by Subject|0|||
146995292|NCT04206332|530147560|FG006|Part C|Withdrawal by Subject|0|||
146995293|NCT04206332|530147561|FG007|Part C|Withdrawal by Subject|0|||
146995294|NCT04206332|530147562|FG008|Part C|Withdrawal by Subject|0|||
146995295|NCT04206332|530147563|FG009|Part C|Withdrawal by Subject|0|||
146995296|NCT04206332|530147564|FG010|Part C|Withdrawal by Subject|0|||
146995297|NCT04206332|530147565|FG011|Part C|Withdrawal by Subject|0|||
146995298|NCT04206332|530147566|FG012|Part C|Withdrawal by Subject|0|||
146995299|NCT04206332|530147567|FG013|Part C|Withdrawal by Subject|0|||
146995300|NCT04206332|530147568|FG014|Part C|Withdrawal by Subject|2|||
146995301|NCT04206332|530147569|FG015|Part C|Withdrawal by Subject|0|||
146995302|NCT04206332|530147570|FG016|Part C|Withdrawal by Subject|0|||
146995303|NCT02334722|530147571|FG000|Overall Study|Lost to Follow-up|4|||
146995304|NCT02334722|530147572|FG001|Overall Study|Lost to Follow-up|0|||
146995305|NCT02334722|530147571|FG000|Overall Study|6 week questionnaire not completed|2|||
146995306|NCT02334722|530147572|FG001|Overall Study|6 week questionnaire not completed|0|||
146995307|NCT02334722|530147571|FG000|Overall Study|Unable to obtain medication|1|||
146995308|NCT02334722|530147572|FG001|Overall Study|Unable to obtain medication|1|||
146995309|NCT02334722|530147571|FG000|Overall Study|Withdrawal by Subject|0|||
146995310|NCT02334722|530147572|FG001|Overall Study|Withdrawal by Subject|3|||
146995311|NCT02334722|530147571|FG000|Overall Study|Adverse Event|0|||
146995312|NCT02334722|530147572|FG001|Overall Study|Adverse Event|2|||
146995313|NCT02334722|530147571|FG000|Overall Study|Physician Decision|0|||
146995314|NCT02334722|530147572|FG001|Overall Study|Physician Decision|1|||
146995315|NCT05612724|530147574|FG000|Overall Study|Lost to Follow-up|4|||
146995316|NCT04000815|530147581|FG000|Overall Study|Lost to Follow-up|9|||
146995317|NCT04000815|530147582|FG001|Overall Study|Lost to Follow-up|2|||
146840487|NCT00477490|529586567|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
146840488|NCT00477490|529586568|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
146840489|NCT00477490|529586560|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
146840490|NCT00477490|529586561|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
146840491|NCT00477490|529586562|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
146840492|NCT00477490|529586563|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
146840493|NCT00477490|529586564|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
146840494|NCT00477490|529586565|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
146840495|NCT00477490|529586566|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
146840496|NCT00477490|529586567|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
146840497|NCT00477490|529586568|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
146840498|NCT00477490|529586560|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
146840499|NCT00477490|529586561|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
146840500|NCT00477490|529586562|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
146840501|NCT00477490|529586563|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
146840502|NCT00477490|529586564|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
146840503|NCT00477490|529586565|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
146840504|NCT00477490|529586566|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
146840505|NCT00477490|529586567|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
146840506|NCT00477490|529586568|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
146840507|NCT00477490|529586560|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
146995318|NCT04000815|530147583|FG002|Overall Study|Lost to Follow-up|3|||
146995319|NCT04000815|530147581|FG000|Overall Study|Withdrawal by Subject|4|||
146995320|NCT04000815|530147582|FG001|Overall Study|Withdrawal by Subject|3|||
146995321|NCT04000815|530147583|FG002|Overall Study|Withdrawal by Subject|2|||
146995322|NCT04000815|530147581|FG000|Overall Study|Right ovarian cyst occured|1|||
146840508|NCT00477490|529586561|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
146840509|NCT00477490|529586562|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
146840510|NCT00477490|529586563|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
146840511|NCT00477490|529586564|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
146840512|NCT00477490|529586565|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
146840513|NCT00477490|529586566|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
146840514|NCT00477490|529586567|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
146840515|NCT00477490|529586568|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
146840516|NCT00477490|529586560|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
146840517|NCT00477490|529586561|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
146840518|NCT00477490|529586562|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
146995323|NCT04000815|530147582|FG001|Overall Study|Right ovarian cyst occured|0|||
146995324|NCT04000815|530147583|FG002|Overall Study|Right ovarian cyst occured|0|||
146995325|NCT04000815|530147581|FG000|Overall Study|Hypertension occured on follow up|0|||
146995326|NCT04000815|530147582|FG001|Overall Study|Hypertension occured on follow up|0|||
146995327|NCT04000815|530147583|FG002|Overall Study|Hypertension occured on follow up|2|||
146995328|NCT00239577|530147584|FG000|Primary Phase|Adverse Event|0|||
146995329|NCT00239577|530147585|FG001|Primary Phase|Adverse Event|0|||
146995330|NCT00239577|530147586|FG002|Primary Phase|Adverse Event|1|||
146995331|NCT00239577|530147587|FG003|Primary Phase|Adverse Event|0|||
146995332|NCT00239577|530147584|FG000|Primary Phase|Other|5|||
146995333|NCT00239577|530147585|FG001|Primary Phase|Other|3|||
146995334|NCT00239577|530147586|FG002|Primary Phase|Other|2|||
146995335|NCT00239577|530147587|FG003|Primary Phase|Other|0|||
146995336|NCT02422264|530147590|FG000|Overall Study|Serious Adverse Event|1|||
146995337|NCT02422264|530147591|FG001|Overall Study|Serious Adverse Event|0|||
146995338|NCT02422264|530147590|FG000|Overall Study|Withdrawal by Subject|1|||
146995339|NCT02422264|530147591|FG001|Overall Study|Withdrawal by Subject|2|||
146995340|NCT02422264|530147590|FG000|Overall Study|Migrated/moved from study area|3|||
146995341|NCT02422264|530147591|FG001|Overall Study|Migrated/moved from study area|1|||
146995342|NCT02422264|530147590|FG000|Overall Study|Subject vaccinated outside of the study|0|||
146995343|NCT02422264|530147591|FG001|Overall Study|Subject vaccinated outside of the study|1|||
146995344|NCT03021018|530147594|FG000|Overall Study|Adverse Event|1|||
146995345|NCT03021018|530147595|FG001|Overall Study|Adverse Event|0|||
146995346|NCT03021018|530147596|FG002|Overall Study|Adverse Event|0|||
146995347|NCT03021018|530147594|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
146995348|NCT03021018|530147595|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
146995349|NCT03021018|530147596|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
146995350|NCT00856388|530147597|FG000|Overall Study|Other|1|||
146995351|NCT01617668|530147599|FG000|Overall Study|Adverse Event|7|||
146995352|NCT01617668|530147600|FG001|Overall Study|Adverse Event|0|||
146995353|NCT01617668|530147601|FG002|Overall Study|Adverse Event|12|||
146995354|NCT01617668|530147602|FG003|Overall Study|Adverse Event|5|||
146840519|NCT00477490|529586563|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
146840520|NCT00477490|529586564|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
146995355|NCT01617668|530147599|FG000|Overall Study|Physician Decision|1|||
146995356|NCT01617668|530147600|FG001|Overall Study|Physician Decision|2|||
146995357|NCT01617668|530147601|FG002|Overall Study|Physician Decision|3|||
146995358|NCT01617668|530147602|FG003|Overall Study|Physician Decision|0|||
146995359|NCT01617668|530147599|FG000|Overall Study|Progressive Disease|4|||
146995360|NCT01617668|530147600|FG001|Overall Study|Progressive Disease|4|||
146995361|NCT01617668|530147601|FG002|Overall Study|Progressive Disease|6|||
146840521|NCT00477490|529586565|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
146840522|NCT00477490|529586566|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
146840523|NCT00477490|529586567|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
146840524|NCT00477490|529586568|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
146840525|NCT00477490|529586560|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
146840526|NCT00477490|529586561|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
146840527|NCT00477490|529586562|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
146840528|NCT00477490|529586563|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
146840529|NCT00477490|529586564|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
146840530|NCT00477490|529586565|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
146840531|NCT00477490|529586566|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
146840532|NCT00477490|529586567|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
146840533|NCT00477490|529586568|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
146840534|NCT00477490|529586560|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
146840535|NCT00477490|529586561|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
146840536|NCT00477490|529586562|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
146840537|NCT00477490|529586563|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
146840538|NCT00477490|529586564|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
146840539|NCT00477490|529586565|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
146840540|NCT00477490|529586566|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
146840541|NCT00477490|529586567|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
146840542|NCT00477490|529586568|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
146840543|NCT00477490|529586560|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
146840544|NCT00477490|529586561|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
146840545|NCT00477490|529586562|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
146840546|NCT00477490|529586563|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
146840547|NCT00477490|529586564|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
146840548|NCT00477490|529586565|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
146840549|NCT00477490|529586566|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
146840550|NCT00477490|529586567|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
146840551|NCT00477490|529586568|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
146840552|NCT00477490|529586560|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
146840553|NCT00477490|529586561|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
146840554|NCT00477490|529586562|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
146840555|NCT00477490|529586563|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
146840556|NCT00477490|529586564|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
146840557|NCT00477490|529586565|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
146840558|NCT00477490|529586566|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
146840559|NCT00477490|529586567|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
146840560|NCT00477490|529586568|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
146840561|NCT00669877|529586571|FG000|Overall Study|Disease Progression/Death|4|||
146840562|NCT01110408|529586572|FG000|Overall Study|Protocol Violation|1|||
146840563|NCT01110408|529586573|FG001|Overall Study|Protocol Violation|0|||
146840564|NCT01646177|529586574|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
146840565|NCT01646177|529586575|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
146840566|NCT01646177|529586576|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
146840567|NCT01646177|529586577|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
146840568|NCT01646177|529586578|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
146961340|NCT00381680|530018135|FG001|Overall Study|Entry onto another COG Trial|2|||
146961341|NCT00381680|530018134|FG000|Overall Study|Alternative Therapy|11|||
146961342|NCT00381680|530018135|FG001|Overall Study|Alternative Therapy|5|||
146961343|NCT00381680|530018134|FG000|Overall Study|Secondary Malignancy|3|||
146961344|NCT00381680|530018135|FG001|Overall Study|Secondary Malignancy|0|||
146961345|NCT00381680|530018134|FG000|Overall Study|Delay initiation|1|||
146961346|NCT00381680|530018135|FG001|Overall Study|Delay initiation|0|||
146961347|NCT00381680|530018134|FG000|Overall Study|Stem Cell Transplant|26|||
146961348|NCT00381680|530018135|FG001|Overall Study|Stem Cell Transplant|10|||
146961349|NCT00381680|530018134|FG000|Overall Study|Relapse|18|||
146961350|NCT00381680|530018135|FG001|Overall Study|Relapse|9|||
146961351|NCT00381680|530018134|FG000|Overall Study|Induction Failure|4|||
146961352|NCT00381680|530018135|FG001|Overall Study|Induction Failure|1|||
146961353|NCT00381680|530018134|FG000|Overall Study|Progression|1|||
146961354|NCT00381680|530018135|FG001|Overall Study|Progression|1|||
146961355|NCT00381680|530018134|FG000|Overall Study|Other not otherwise specified|7|||
146840569|NCT01646177|529586579|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
146961356|NCT00381680|530018135|FG001|Overall Study|Other not otherwise specified|2|||
146961357|NCT00381680|530018134|FG000|Overall Study|Ineligible|3|||
146961358|NCT00381680|530018135|FG001|Overall Study|Ineligible|1|||
146840570|NCT01646177|529586580|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
146840571|NCT01646177|529586581|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
146840572|NCT01646177|529586582|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
146840573|NCT01646177|529586583|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
146840574|NCT01646177|529586584|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
146840575|NCT01646177|529586585|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
146840576|NCT01646177|529586574|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
146840577|NCT01646177|529586575|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
146840578|NCT01646177|529586576|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
146840579|NCT01646177|529586577|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
146840580|NCT01646177|529586578|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
146840581|NCT01646177|529586579|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
146840582|NCT01646177|529586580|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
146840583|NCT01646177|529586581|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
146840584|NCT01646177|529586582|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
146840585|NCT01646177|529586583|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
146840586|NCT01646177|529586584|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
146840587|NCT01646177|529586585|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
146840588|NCT01646177|529586574|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
146840589|NCT01646177|529586575|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
146840590|NCT01646177|529586576|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
146840591|NCT01646177|529586577|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
146840592|NCT01646177|529586578|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
146840593|NCT01646177|529586579|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
146840594|NCT01646177|529586580|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
146840595|NCT01646177|529586581|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
146840596|NCT01646177|529586582|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
146840597|NCT01646177|529586583|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
146840598|NCT01646177|529586584|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
146840599|NCT01646177|529586585|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
146840600|NCT01646177|529586574|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
146840601|NCT01646177|529586575|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
146840602|NCT01646177|529586576|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
146840603|NCT01646177|529586577|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
146840604|NCT01646177|529586578|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
146840605|NCT01646177|529586579|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
146840606|NCT01646177|529586580|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
146840607|NCT01646177|529586581|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
146840608|NCT01646177|529586582|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
146840609|NCT01646177|529586583|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
146840610|NCT01646177|529586584|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
146840611|NCT01646177|529586585|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
146840612|NCT01646177|529586574|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146840613|NCT01646177|529586575|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146840614|NCT01646177|529586576|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
146840615|NCT01646177|529586577|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
146840616|NCT01646177|529586578|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146840617|NCT01646177|529586579|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146840618|NCT01646177|529586580|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146840619|NCT01646177|529586581|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146840620|NCT01646177|529586582|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146840621|NCT01646177|529586583|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146840622|NCT01646177|529586584|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146840623|NCT01646177|529586585|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146840624|NCT01646177|529586574|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
146840625|NCT01646177|529586575|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
146840626|NCT01646177|529586576|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
146840627|NCT01646177|529586577|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146840628|NCT01646177|529586578|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146840629|NCT01646177|529586579|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146840630|NCT01646177|529586580|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146840631|NCT01646177|529586581|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146840632|NCT01646177|529586582|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146840633|NCT01646177|529586583|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146961359|NCT00361504|530018138|FG000|Overall Study|Withdrawal by Subject|94|||
146840634|NCT01646177|529586584|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146840635|NCT01646177|529586585|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146840636|NCT01646177|529586574|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
146840637|NCT01646177|529586575|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
146840638|NCT01646177|529586576|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
146840639|NCT01646177|529586577|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
146840640|NCT01646177|529586578|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
146840641|NCT01646177|529586579|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
146840642|NCT01646177|529586580|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
146840643|NCT01646177|529586581|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
146840644|NCT01646177|529586582|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
146840645|NCT01646177|529586583|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
146840646|NCT01646177|529586584|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
146840647|NCT01646177|529586585|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
146840648|NCT01646177|529586574|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
146840649|NCT01646177|529586575|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
146840650|NCT01646177|529586576|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
146840651|NCT01646177|529586577|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
146840652|NCT01646177|529586578|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
146840653|NCT01646177|529586579|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
146840654|NCT01646177|529586580|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
146840655|NCT01646177|529586581|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
146840656|NCT01646177|529586582|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
146840657|NCT01646177|529586583|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
146840658|NCT01646177|529586584|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
146840659|NCT01646177|529586585|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
146840660|NCT01646177|529586574|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
146840661|NCT01646177|529586575|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
146840662|NCT01646177|529586576|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
146840663|NCT01646177|529586577|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
146840664|NCT01646177|529586578|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
146840665|NCT01646177|529586579|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
146840666|NCT01646177|529586580|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
146840667|NCT01646177|529586581|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
146840668|NCT01646177|529586582|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
146840669|NCT01646177|529586583|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
146840670|NCT01646177|529586584|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
146840671|NCT01646177|529586585|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
146840672|NCT01646177|529586574|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
146840673|NCT01646177|529586575|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
146840674|NCT01646177|529586576|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
146840675|NCT01646177|529586577|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
146840676|NCT01646177|529586578|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
146840677|NCT01646177|529586579|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
146840678|NCT01646177|529586580|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
146840679|NCT01646177|529586581|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
146840680|NCT01646177|529586582|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
146840681|NCT01646177|529586583|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
146840682|NCT01646177|529586584|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
146840683|NCT01646177|529586585|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
146840684|NCT01646177|529586574|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
146840685|NCT01646177|529586575|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
146840686|NCT01646177|529586576|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
146840687|NCT01646177|529586577|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
146840688|NCT01646177|529586578|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
146840689|NCT01646177|529586579|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
146840690|NCT01646177|529586580|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
146840691|NCT01646177|529586581|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
146840692|NCT01646177|529586582|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
146840693|NCT01646177|529586583|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
146961360|NCT00361504|530018139|FG001|Overall Study|Withdrawal by Subject|31|||
146961361|NCT00361504|530018138|FG000|Overall Study|Lost to Follow-up|40|||
146961362|NCT00361504|530018139|FG001|Overall Study|Lost to Follow-up|7|||
146961363|NCT00361504|530018138|FG000|Overall Study|Adverse Event|203|||
146840694|NCT01646177|529586584|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
146840695|NCT01646177|529586585|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
146840696|NCT01646177|529586574|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146840697|NCT01646177|529586575|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146840698|NCT01646177|529586576|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146840699|NCT01646177|529586577|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146840700|NCT01646177|529586578|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
146840701|NCT01646177|529586579|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
146840702|NCT01646177|529586580|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146840703|NCT01646177|529586581|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
146840704|NCT01646177|529586582|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146840705|NCT01646177|529586583|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146840706|NCT01646177|529586584|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146840707|NCT01646177|529586585|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146840708|NCT01646177|529586574|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
146840709|NCT01646177|529586575|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
146840710|NCT01646177|529586576|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
146840711|NCT01646177|529586577|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
146840712|NCT01646177|529586578|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
146840713|NCT01646177|529586579|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
146840714|NCT01646177|529586580|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
146840715|NCT01646177|529586581|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
146840716|NCT01646177|529586582|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
146840717|NCT01646177|529586583|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
146840718|NCT01646177|529586584|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
146840719|NCT01646177|529586585|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
146840720|NCT01646177|529586574|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
146840721|NCT01646177|529586575|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
146840722|NCT01646177|529586576|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
146840723|NCT01646177|529586577|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
146840724|NCT01646177|529586578|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
146840725|NCT01646177|529586579|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
146840726|NCT01646177|529586580|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
146840727|NCT01646177|529586581|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
146840728|NCT01646177|529586582|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
146840729|NCT01646177|529586583|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
146840730|NCT01646177|529586584|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
146840731|NCT01646177|529586585|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
146840732|NCT01646177|529586574|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
146840733|NCT01646177|529586575|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
146840734|NCT01646177|529586576|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
146840735|NCT01646177|529586577|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
146840736|NCT01646177|529586578|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
146840737|NCT01646177|529586579|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
146840738|NCT01646177|529586580|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
146840739|NCT01646177|529586581|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
146840740|NCT01646177|529586582|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
146840741|NCT01646177|529586583|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
146840742|NCT01646177|529586584|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
146840743|NCT01646177|529586585|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
146840744|NCT01646177|529586574|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146840745|NCT01646177|529586575|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146840746|NCT01646177|529586576|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146840747|NCT01646177|529586577|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146840748|NCT01646177|529586578|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146840749|NCT01646177|529586579|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146840750|NCT01646177|529586580|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146840751|NCT01646177|529586581|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
146840752|NCT01646177|529586582|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146840753|NCT01646177|529586583|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146840754|NCT01646177|529586584|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146840755|NCT01646177|529586585|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146840756|NCT01646177|529586574|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146840757|NCT01646177|529586575|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146840758|NCT01646177|529586576|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146840759|NCT01646177|529586577|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146840760|NCT01646177|529586578|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146840761|NCT01646177|529586579|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
146840762|NCT01646177|529586580|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
146840763|NCT01646177|529586581|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
146840764|NCT01646177|529586582|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146840765|NCT01646177|529586583|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146840766|NCT01646177|529586584|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146840767|NCT01646177|529586585|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146840768|NCT01646177|529586574|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
146840769|NCT01646177|529586575|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
146840770|NCT01646177|529586576|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
146840771|NCT01646177|529586577|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
146840772|NCT01646177|529586578|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
146840773|NCT01646177|529586579|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
146840774|NCT01646177|529586580|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
146840775|NCT01646177|529586581|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
146840776|NCT01646177|529586582|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
146840777|NCT01646177|529586583|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
146840778|NCT01646177|529586584|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
146840779|NCT01646177|529586585|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
146840780|NCT01646177|529586574|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
146840781|NCT01646177|529586575|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
146840782|NCT01646177|529586576|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
146840783|NCT01646177|529586577|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
146840784|NCT01646177|529586578|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
146840785|NCT01646177|529586579|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
146840786|NCT01646177|529586580|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
146840787|NCT01646177|529586581|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
146840788|NCT01646177|529586582|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
146840789|NCT01646177|529586583|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
146840790|NCT01646177|529586584|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
146840791|NCT01646177|529586585|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
146840792|NCT01646177|529586574|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
146840793|NCT01646177|529586575|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
146840794|NCT01646177|529586576|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
146840795|NCT01646177|529586577|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
146840796|NCT01646177|529586578|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
146840797|NCT01646177|529586579|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
146840798|NCT01646177|529586580|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
146840799|NCT01646177|529586581|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
146840800|NCT01646177|529586582|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
146840801|NCT01646177|529586583|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
146840802|NCT01646177|529586584|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
146840803|NCT01646177|529586585|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
146840804|NCT01646177|529586574|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
146840805|NCT01646177|529586575|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
146840806|NCT01646177|529586576|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
146840807|NCT01646177|529586577|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
146840808|NCT01646177|529586578|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
146840809|NCT01646177|529586579|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
146840810|NCT01646177|529586580|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
146840811|NCT01646177|529586581|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
146840812|NCT01646177|529586582|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
146840813|NCT01646177|529586583|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
146840814|NCT01646177|529586584|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
146840815|NCT01646177|529586585|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
146840816|NCT01646177|529586574|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
146840817|NCT01646177|529586575|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
146840818|NCT01646177|529586576|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
146840819|NCT01646177|529586577|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
146961364|NCT00361504|530018139|FG001|Overall Study|Adverse Event|82|||
146961365|NCT00361504|530018138|FG000|Overall Study|Lack of Efficacy|72|||
146961366|NCT00361504|530018139|FG001|Overall Study|Lack of Efficacy|7|||
146840820|NCT01646177|529586578|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
146840821|NCT01646177|529586579|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
146840822|NCT01646177|529586580|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
146840823|NCT01646177|529586581|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
146840824|NCT01646177|529586582|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
146840825|NCT01646177|529586583|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
146840826|NCT01646177|529586584|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
146840827|NCT01646177|529586585|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
146840828|NCT01646177|529586574|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
146840829|NCT01646177|529586575|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
146840830|NCT01646177|529586576|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
146840831|NCT01646177|529586577|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
146840832|NCT01646177|529586578|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
146840833|NCT01646177|529586579|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
146840834|NCT01646177|529586580|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
146840835|NCT01646177|529586581|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
146840836|NCT01646177|529586582|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
146840837|NCT01646177|529586583|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
146840838|NCT01646177|529586584|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
146840839|NCT01646177|529586585|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
146840840|NCT01646177|529586574|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146840841|NCT01646177|529586575|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146840842|NCT01646177|529586576|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146840843|NCT01646177|529586577|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146840844|NCT01646177|529586578|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146840845|NCT01646177|529586579|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146840846|NCT01646177|529586580|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146840847|NCT01646177|529586581|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146840848|NCT01646177|529586582|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146840849|NCT01646177|529586583|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
146840850|NCT01646177|529586584|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
146840851|NCT01646177|529586585|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
146840852|NCT01646177|529586574|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146840853|NCT01646177|529586575|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146840854|NCT01646177|529586576|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146840855|NCT01646177|529586577|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146840856|NCT01646177|529586578|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146840857|NCT01646177|529586579|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146840858|NCT01646177|529586580|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146840859|NCT01646177|529586581|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146840860|NCT01646177|529586582|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146840861|NCT01646177|529586583|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
146840862|NCT01646177|529586584|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
146840863|NCT01646177|529586585|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
146840864|NCT01646177|529586574|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146840865|NCT01646177|529586575|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146840866|NCT01646177|529586576|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146840867|NCT01646177|529586577|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146840868|NCT01646177|529586578|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146840869|NCT01646177|529586579|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146840870|NCT01646177|529586580|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146840871|NCT01646177|529586581|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146840872|NCT01646177|529586582|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
146840873|NCT01646177|529586583|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146840874|NCT01646177|529586584|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
146840875|NCT01646177|529586585|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
146840876|NCT01646177|529586574|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146840877|NCT01646177|529586575|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146840878|NCT01646177|529586576|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146840879|NCT01646177|529586577|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146840880|NCT01646177|529586578|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146840881|NCT01646177|529586579|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146840882|NCT01646177|529586580|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146840883|NCT01646177|529586581|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146840884|NCT01646177|529586582|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146995362|NCT01617668|530147602|FG003|Overall Study|Progressive Disease|9|||
146840885|NCT01646177|529586583|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146840886|NCT01646177|529586584|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
146840887|NCT01646177|529586585|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
146840888|NCT02920970|529586586|FG000|First Intervention|Protocol Violation|0|||
146840889|NCT02920970|529586587|FG001|First Intervention|Protocol Violation|1|||
146840890|NCT02920970|529586586|FG000|First Intervention|Adverse Event|0|||
146840891|NCT02920970|529586587|FG001|First Intervention|Adverse Event|1|||
146840892|NCT02920970|529586586|FG000|Second Intervention|Poor Lens Fit|1|||
146840893|NCT02920970|529586587|FG001|Second Intervention|Poor Lens Fit|0|||
146840894|NCT01711853|529586590|FG000|Overall Study|Not treated|3|||
146840895|NCT01277887|529586591|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
146840896|NCT01277887|529586592|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
146840897|NCT01277887|529586591|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
146840898|NCT01277887|529586592|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
146840899|NCT01277887|529586591|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
146840900|NCT01277887|529586592|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
146840901|NCT03651700|529586593|FG000|Overall Study|Withdrawal by Subject|1|||
146840902|NCT03651700|529586594|FG001|Overall Study|Withdrawal by Subject|0|||
146840903|NCT05479734|529586597|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
146840904|NCT05479734|529586598|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
146840905|NCT05479734|529586597|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
146840906|NCT05479734|529586598|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
146840907|NCT05479734|529586597|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
146840908|NCT05479734|529586598|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
146840909|NCT05479734|529586597|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
146840910|NCT05479734|529586598|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
146840911|NCT00600613|529586599|FG000|Overall Study|Protocol Deviation|1|||
146840912|NCT01509547|529586602|FG000|Overall Study|Lost to Follow-up|24|||
146840913|NCT01509547|529586603|FG001|Overall Study|Lost to Follow-up|14|||
146840914|NCT01509547|529586602|FG000|Overall Study|Withdrawal by Subject|11|||
146840915|NCT01509547|529586603|FG001|Overall Study|Withdrawal by Subject|24|||
146840916|NCT01509547|529586602|FG000|Overall Study|Physician Decision|0|||
146840917|NCT01509547|529586603|FG001|Overall Study|Physician Decision|1|||
146840918|NCT01399918|529586604|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
146840919|NCT00570908|529586605|FG000|Overall Study|Adverse Event|5|||
146840920|NCT00570908|529586605|FG000|Overall Study|Withdrawal by Subject|2|||
146840921|NCT04103892|529586606|FG000|Overall Study|Adverse Event|0|||
146840922|NCT04103892|529586607|FG001|Overall Study|Adverse Event|0|||
146840923|NCT04103892|529586608|FG002|Overall Study|Adverse Event|0|||
146840924|NCT04103892|529586609|FG003|Overall Study|Adverse Event|3|||
146840925|NCT04103892|529586606|FG000|Overall Study|Lost to Follow-up|0|||
146840926|NCT04103892|529586607|FG001|Overall Study|Lost to Follow-up|0|||
146840927|NCT04103892|529586608|FG002|Overall Study|Lost to Follow-up|2|||
146840928|NCT04103892|529586609|FG003|Overall Study|Lost to Follow-up|0|||
146840929|NCT04103892|529586606|FG000|Overall Study|Protocol Violation|0|||
146840930|NCT04103892|529586607|FG001|Overall Study|Protocol Violation|0|||
146840931|NCT04103892|529586608|FG002|Overall Study|Protocol Violation|1|||
146840932|NCT04103892|529586609|FG003|Overall Study|Protocol Violation|1|||
146840933|NCT04103892|529586606|FG000|Overall Study|Withdrawal by Subject|1|||
146840934|NCT04103892|529586607|FG001|Overall Study|Withdrawal by Subject|0|||
146840935|NCT04103892|529586608|FG002|Overall Study|Withdrawal by Subject|2|||
146840936|NCT04103892|529586609|FG003|Overall Study|Withdrawal by Subject|5|||
146840937|NCT04103892|529586606|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
146840938|NCT04103892|529586607|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
146840939|NCT04103892|529586608|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
146840940|NCT04103892|529586609|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
146840941|NCT03008005|529586610|FG000|Overall Study|Physician Decision|1|||
146840942|NCT03008005|529586611|FG001|Overall Study|Physician Decision|0|||
146840943|NCT03008005|529586612|FG002|Overall Study|Physician Decision|0|||
146961367|NCT00361504|530018138|FG000|Overall Study|Resolution of Pain|2|||
146961368|NCT00361504|530018139|FG001|Overall Study|Resolution of Pain|0|||
146961369|NCT00361504|530018138|FG000|Overall Study|Study medication non compliant|42|||
146961370|NCT00361504|530018139|FG001|Overall Study|Study medication non compliant|15|||
146961371|NCT00361504|530018138|FG000|Overall Study|All other|28|||
146961372|NCT00361504|530018139|FG001|Overall Study|All other|3|||
146961373|NCT01374516|530018145|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
146961374|NCT01374516|530018146|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
146961375|NCT01374516|530018145|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
146840944|NCT03008005|529586610|FG000|Overall Study|Withdrawal by Subject|1|||
146840945|NCT03008005|529586611|FG001|Overall Study|Withdrawal by Subject|0|||
146840946|NCT03008005|529586612|FG002|Overall Study|Withdrawal by Subject|0|||
146840947|NCT03008005|529586610|FG000|Overall Study|Ineligible|0|||
146840948|NCT03008005|529586611|FG001|Overall Study|Ineligible|1|||
146840949|NCT03008005|529586612|FG002|Overall Study|Ineligible|0|||
146840950|NCT04942366|529588693|FG000|Overall Study|Withdrawal by Subject|5|||
146840951|NCT04942366|529588694|FG001|Overall Study|Withdrawal by Subject|5|||
146840952|NCT02706405|529588700|FG000|Overall Study|Death|3|||
146840953|NCT02706405|529588701|FG001|Overall Study|Death|2|||
146840954|NCT02706405|529588702|FG002|Overall Study|Death|0|||
146840955|NCT02706405|529588703|FG003|Overall Study|Death|1|||
146840956|NCT02706405|529588704|FG004|Overall Study|Death|0|||
146840957|NCT02706405|529588705|FG005|Overall Study|Death|0|||
146840958|NCT02706405|529588706|FG006|Overall Study|Death|3|||
146840959|NCT02706405|529588707|FG007|Overall Study|Death|4|||
146840960|NCT02706405|529588700|FG000|Overall Study|Disease progression|0|||
146840961|NCT02706405|529588701|FG001|Overall Study|Disease progression|0|||
146840962|NCT02706405|529588702|FG002|Overall Study|Disease progression|0|||
146840963|NCT02706405|529588703|FG003|Overall Study|Disease progression|0|||
146840964|NCT02706405|529588704|FG004|Overall Study|Disease progression|0|||
146840965|NCT02706405|529588705|FG005|Overall Study|Disease progression|0|||
146840966|NCT02706405|529588706|FG006|Overall Study|Disease progression|0|||
146840967|NCT02706405|529588707|FG007|Overall Study|Disease progression|1|||
146840968|NCT02706405|529588700|FG000|Overall Study|Pt moved to new therapy|0|||
146840969|NCT02706405|529588701|FG001|Overall Study|Pt moved to new therapy|0|||
146840970|NCT02706405|529588702|FG002|Overall Study|Pt moved to new therapy|0|||
146840971|NCT02706405|529588703|FG003|Overall Study|Pt moved to new therapy|0|||
146840972|NCT02706405|529588704|FG004|Overall Study|Pt moved to new therapy|0|||
146840973|NCT02706405|529588705|FG005|Overall Study|Pt moved to new therapy|1|||
146840974|NCT02706405|529588706|FG006|Overall Study|Pt moved to new therapy|0|||
146840975|NCT02706405|529588707|FG007|Overall Study|Pt moved to new therapy|1|||
146840976|NCT02706405|529588700|FG000|Overall Study|Physician Decision|1|||
146840977|NCT02706405|529588701|FG001|Overall Study|Physician Decision|0|||
146840978|NCT02706405|529588702|FG002|Overall Study|Physician Decision|0|||
146840979|NCT02706405|529588703|FG003|Overall Study|Physician Decision|0|||
146840980|NCT02706405|529588704|FG004|Overall Study|Physician Decision|0|||
146840981|NCT02706405|529588705|FG005|Overall Study|Physician Decision|0|||
146840982|NCT02706405|529588706|FG006|Overall Study|Physician Decision|0|||
146840983|NCT02706405|529588707|FG007|Overall Study|Physician Decision|0|||
146840984|NCT02304705|529588708|FG000|Overall Study|Withdrawal by Subject|2|||
146840985|NCT02304705|529588709|FG001|Overall Study|Withdrawal by Subject|0|||
146840986|NCT02304705|529588708|FG000|Overall Study|Physician Decision|2|||
146840987|NCT02304705|529588709|FG001|Overall Study|Physician Decision|4|||
146840988|NCT02304705|529588708|FG000|Overall Study|Death|0|||
146840989|NCT02304705|529588709|FG001|Overall Study|Death|1|||
146840990|NCT02304705|529588708|FG000|Overall Study|Lost to Follow-up|0|||
146840991|NCT02304705|529588709|FG001|Overall Study|Lost to Follow-up|2|||
146840992|NCT01195948|529588710|FG000|Overall Study|Lost to Follow-up|0|||
146840993|NCT01195948|529588711|FG001|Overall Study|Lost to Follow-up|1|||
146840994|NCT01195948|529588712|FG002|Overall Study|Lost to Follow-up|2|||
146840995|NCT03140280|529588713|FG000|Overall Study|Physician Decision|5|||
146840996|NCT05577715|529588722|FG000|Overall Study|Withdrawal by Subject|1|||
146840997|NCT05577715|529588722|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
146840998|NCT05577715|529588722|FG000|Overall Study|Lost to Follow-up|1|||
146840999|NCT05577715|529588722|FG000|Overall Study|Death|6|||
146841000|NCT03412773|529588723|FG000|Overall Study|Lost to Follow-up|0|||
146841001|NCT03412773|529588724|FG001|Overall Study|Lost to Follow-up|7|||
146841002|NCT03412773|529588725|FG002|Overall Study|Lost to Follow-up|6|||
146841003|NCT03412773|529588723|FG000|Overall Study|Withdrawal by Subject|0|||
146841004|NCT03412773|529588724|FG001|Overall Study|Withdrawal by Subject|15|||
146841005|NCT03412773|529588725|FG002|Overall Study|Withdrawal by Subject|19|||
146841006|NCT03412773|529588723|FG000|Overall Study|Study Closed By Sponsor|3|||
146841007|NCT03412773|529588724|FG001|Overall Study|Study Closed By Sponsor|46|||
146841008|NCT03412773|529588725|FG002|Overall Study|Study Closed By Sponsor|33|||
146841009|NCT03412773|529588723|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
146961376|NCT01374516|530018146|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
146961377|NCT01374516|530018145|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
146961378|NCT01374516|530018146|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
146961379|NCT01374516|530018145|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
146961380|NCT01374516|530018146|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
146961381|NCT01374516|530018145|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
146841010|NCT03412773|529588724|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
146841011|NCT03412773|529588725|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
146841012|NCT03412773|529588723|FG000|Overall Study|Death|7|||
146841013|NCT03412773|529588724|FG001|Overall Study|Death|259|||
146841014|NCT03412773|529588725|FG002|Overall Study|Death|273|||
146841015|NCT03412773|529588723|FG000|Overall Study|Physician Decision|0|||
146841016|NCT03412773|529588724|FG001|Overall Study|Physician Decision|0|||
146841017|NCT03412773|529588725|FG002|Overall Study|Physician Decision|1|||
146841018|NCT03057847|529588730|FG000|Overall Study|Lost to Follow-up|16|||
146841019|NCT01706705|529588734|FG000|Overall Study|Death|1|||
146841020|NCT01706705|529588734|FG000|Overall Study|Lack of Efficacy|13|||
146841021|NCT01706705|529588734|FG000|Overall Study|Non-clinical|6|||
146841022|NCT03510455|529588735|FG000|Overall Study|Physician Decision|1|||
146995363|NCT01617668|530147599|FG000|Overall Study|Subject/guardian decision|1|||
146841023|NCT00384189|529588736|FG000|Overall Study|Reason Not Specified|50|||
146841024|NCT00384189|529588737|FG001|Overall Study|Reason Not Specified|57|||
146841025|NCT00384189|529588738|FG002|Overall Study|Reason Not Specified|58|||
146841026|NCT00384189|529588739|FG003|Overall Study|Reason Not Specified|40|||
146841027|NCT04958642|529588740|FG000|Overall Study|Transferred to OLEX program|3|||
146841028|NCT04958642|529588741|FG001|Overall Study|Transferred to OLEX program|0|||
146841029|NCT04958642|529588742|FG002|Overall Study|Transferred to OLEX program|5|||
146841030|NCT04958642|529588740|FG000|Overall Study|Death|0|||
146841031|NCT04958642|529588741|FG001|Overall Study|Death|0|||
146841032|NCT04958642|529588742|FG002|Overall Study|Death|1|||
146841033|NCT04958642|529588740|FG000|Overall Study|Withdrawal by Subject|4|||
146841034|NCT04958642|529588741|FG001|Overall Study|Withdrawal by Subject|9|||
146841035|NCT04958642|529588742|FG002|Overall Study|Withdrawal by Subject|13|||
146841036|NCT04958642|529588740|FG000|Overall Study|Investigator's Decision|0|||
146841037|NCT04958642|529588741|FG001|Overall Study|Investigator's Decision|0|||
146841038|NCT04958642|529588742|FG002|Overall Study|Investigator's Decision|1|||
146841039|NCT04958642|529588740|FG000|Overall Study|Adverse Event|1|||
146841040|NCT04958642|529588741|FG001|Overall Study|Adverse Event|0|||
146841041|NCT04958642|529588742|FG002|Overall Study|Adverse Event|1|||
146841042|NCT04958642|529588740|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
146841043|NCT04958642|529588741|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
146841044|NCT04958642|529588742|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
146841045|NCT04958642|529588740|FG000|Overall Study|Lost to Follow-up|1|||
146841046|NCT04958642|529588741|FG001|Overall Study|Lost to Follow-up|0|||
146841047|NCT04958642|529588742|FG002|Overall Study|Lost to Follow-up|0|||
146841048|NCT04958642|529588740|FG000|Overall Study|Transferred to EAP following study termination|0|||
146841049|NCT04958642|529588741|FG001|Overall Study|Transferred to EAP following study termination|0|||
146841050|NCT04958642|529588742|FG002|Overall Study|Transferred to EAP following study termination|1|||
146841051|NCT04958642|529588740|FG000|Overall Study|Transferred to Expanded Access Program|1|||
146841052|NCT04958642|529588741|FG001|Overall Study|Transferred to Expanded Access Program|0|||
146841053|NCT04958642|529588742|FG002|Overall Study|Transferred to Expanded Access Program|0|||
146841054|NCT02942004|529588743|FG000|Overall Study|Withdrawal by Subject|0|||
146841055|NCT02942004|529588744|FG001|Overall Study|Withdrawal by Subject|2|||
146841056|NCT02942004|529588745|FG002|Overall Study|Withdrawal by Subject|3|||
146841057|NCT02942004|529588743|FG000|Overall Study|Lost to Follow-up|1|||
146841058|NCT02942004|529588744|FG001|Overall Study|Lost to Follow-up|1|||
146841059|NCT02942004|529588745|FG002|Overall Study|Lost to Follow-up|2|||
146841060|NCT02942004|529588743|FG000|Overall Study|Randomized but not dosed|3|||
146841061|NCT02942004|529588744|FG001|Overall Study|Randomized but not dosed|9|||
146841062|NCT02942004|529588745|FG002|Overall Study|Randomized but not dosed|4|||
146841063|NCT05627258|529588746|FG000|Overall Study|Lost to Follow-up|1|||
146841064|NCT05627258|529588747|FG001|Overall Study|Lost to Follow-up|0|||
146841065|NCT05627258|529588748|FG002|Overall Study|Lost to Follow-up|0|||
146841066|NCT05627258|529588749|FG003|Overall Study|Lost to Follow-up|0|||
146841067|NCT05627258|529588750|FG004|Overall Study|Lost to Follow-up|0|||
146841068|NCT05627258|529588751|FG005|Overall Study|Lost to Follow-up|0|||
146841069|NCT05627258|529588746|FG000|Overall Study|Withdrawal by Subject|0|||
146841070|NCT05627258|529588747|FG001|Overall Study|Withdrawal by Subject|0|||
146841071|NCT05627258|529588748|FG002|Overall Study|Withdrawal by Subject|0|||
146841072|NCT05627258|529588749|FG003|Overall Study|Withdrawal by Subject|0|||
146841073|NCT05627258|529588750|FG004|Overall Study|Withdrawal by Subject|2|||
146841074|NCT05627258|529588751|FG005|Overall Study|Withdrawal by Subject|0|||
146841075|NCT05627258|529588746|FG000|Overall Study|Enrolled, but product not administered|1|||
146841076|NCT05627258|529588747|FG001|Overall Study|Enrolled, but product not administered|0|||
146841077|NCT05627258|529588748|FG002|Overall Study|Enrolled, but product not administered|0|||
146961382|NCT01374516|530018146|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
146961383|NCT01374516|530018145|FG000|Surveillance Expansion Period|Protocol Violation|386|||
146961384|NCT01374516|530018146|FG001|Surveillance Expansion Period|Protocol Violation|217|||
146961385|NCT01374516|530018145|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
146961386|NCT01374516|530018146|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
146961387|NCT01374516|530018145|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
146961388|NCT01374516|530018146|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
146995364|NCT01617668|530147600|FG001|Overall Study|Subject/guardian decision|3|||
146841078|NCT05627258|529588749|FG003|Overall Study|Enrolled, but product not administered|0|||
146841079|NCT05627258|529588750|FG004|Overall Study|Enrolled, but product not administered|0|||
146841080|NCT05627258|529588751|FG005|Overall Study|Enrolled, but product not administered|0|||
146841081|NCT05627258|529588746|FG000|Overall Study|Other subject illness/injury|1|||
146841082|NCT05627258|529588747|FG001|Overall Study|Other subject illness/injury|0|||
146961389|NCT01374516|530018145|FG000|Surveillance Expansion Period|Serious adverse event|20|||
146841083|NCT05627258|529588748|FG002|Overall Study|Other subject illness/injury|0|||
146841084|NCT05627258|529588749|FG003|Overall Study|Other subject illness/injury|0|||
146841085|NCT05627258|529588750|FG004|Overall Study|Other subject illness/injury|0|||
146841086|NCT05627258|529588751|FG005|Overall Study|Other subject illness/injury|0|||
146841087|NCT05627258|529588746|FG000|Overall Study|Subject moved from area|0|||
146841088|NCT05627258|529588747|FG001|Overall Study|Subject moved from area|0|||
146841089|NCT05627258|529588748|FG002|Overall Study|Subject moved from area|1|||
146841090|NCT05627258|529588749|FG003|Overall Study|Subject moved from area|0|||
146841091|NCT05627258|529588750|FG004|Overall Study|Subject moved from area|0|||
146841092|NCT05627258|529588751|FG005|Overall Study|Subject moved from area|0|||
146841093|NCT04517669|529588752|FG000|Overall Study|Lost to Follow-up|2|||
146841094|NCT04517669|529588752|FG000|Overall Study|Withdrawal by Subject|3|||
146841095|NCT04517669|529588752|FG000|Overall Study|Drug withdrawn|44|||
146841096|NCT04517669|529588752|FG000|Overall Study|Other|1|||
146841097|NCT04517669|529588752|FG000|Overall Study|Eligibility criteria not met|4|||
146841098|NCT04517669|529588752|FG000|Overall Study|Did not receive treatment|3|||
146841099|NCT02138786|529588753|FG000|Overall Study|Adverse Event|0|||
146841100|NCT02138786|529588754|FG001|Overall Study|Adverse Event|2|||
146841101|NCT02138786|529588755|FG002|Overall Study|Adverse Event|1|||
146841102|NCT02138786|529588753|FG000|Overall Study|Death|1|||
146841103|NCT02138786|529588754|FG001|Overall Study|Death|7|||
146841104|NCT02138786|529588755|FG002|Overall Study|Death|2|||
146841105|NCT02138786|529588753|FG000|Overall Study|Disease Progression|1|||
146841106|NCT02138786|529588754|FG001|Overall Study|Disease Progression|1|||
146841107|NCT02138786|529588755|FG002|Overall Study|Disease Progression|3|||
146841108|NCT02138786|529588753|FG000|Overall Study|Withdrawal by Subject|1|||
146841109|NCT02138786|529588754|FG001|Overall Study|Withdrawal by Subject|2|||
146841110|NCT02138786|529588755|FG002|Overall Study|Withdrawal by Subject|0|||
146841111|NCT02138786|529588753|FG000|Overall Study|Patient's Wish|0|||
146841112|NCT02138786|529588754|FG001|Overall Study|Patient's Wish|2|||
146841113|NCT02138786|529588755|FG002|Overall Study|Patient's Wish|0|||
146841114|NCT02138786|529588753|FG000|Overall Study|Sponsor Terminated Study|0|||
146841115|NCT02138786|529588754|FG001|Overall Study|Sponsor Terminated Study|1|||
146841116|NCT02138786|529588755|FG002|Overall Study|Sponsor Terminated Study|1|||
146841117|NCT02138786|529588753|FG000|Overall Study|Non-Compliance|0|||
146841118|NCT02138786|529588754|FG001|Overall Study|Non-Compliance|0|||
146841119|NCT02138786|529588755|FG002|Overall Study|Non-Compliance|1|||
146841120|NCT01199068|529588759|FG000|Overall Study|Unacceptable toxicity|0|||
146841121|NCT01199068|529588760|FG001|Overall Study|Unacceptable toxicity|0|||
146841122|NCT01199068|529588761|FG002|Overall Study|Unacceptable toxicity|2|||
146841123|NCT01199068|529588759|FG000|Overall Study|Progressive disease|3|||
146841124|NCT01199068|529588760|FG001|Overall Study|Progressive disease|3|||
146841125|NCT01199068|529588761|FG002|Overall Study|Progressive disease|6|||
146841126|NCT01199068|529588759|FG000|Overall Study|Withdrawal by Subject|0|||
146841127|NCT01199068|529588760|FG001|Overall Study|Withdrawal by Subject|0|||
146841128|NCT01199068|529588761|FG002|Overall Study|Withdrawal by Subject|1|||
146841129|NCT01250925|529588762|FG000|Overall Study|Lost to Follow-up|1|||
146841130|NCT01250925|529588763|FG001|Overall Study|Lost to Follow-up|1|||
146841131|NCT01250925|529588764|FG002|Overall Study|Lost to Follow-up|0|||
146841132|NCT01250925|529588762|FG000|Overall Study|Withdrawal by Subject|2|||
146841133|NCT01250925|529588763|FG001|Overall Study|Withdrawal by Subject|0|||
146841134|NCT01250925|529588764|FG002|Overall Study|Withdrawal by Subject|0|||
146841135|NCT01250925|529588762|FG000|Overall Study|Protocol Violation|2|||
146841136|NCT01250925|529588763|FG001|Overall Study|Protocol Violation|0|||
146841137|NCT01250925|529588764|FG002|Overall Study|Protocol Violation|0|||
146841138|NCT01250925|529588762|FG000|Overall Study|Physician Decision|0|||
146841139|NCT01250925|529588763|FG001|Overall Study|Physician Decision|2|||
146841140|NCT01250925|529588764|FG002|Overall Study|Physician Decision|1|||
146841141|NCT01250925|529588762|FG000|Overall Study|Adverse Event|0|||
146841142|NCT01250925|529588763|FG001|Overall Study|Adverse Event|0|||
146841143|NCT01250925|529588764|FG002|Overall Study|Adverse Event|1|||
146841144|NCT00678301|529588765|FG000|Overall Study|Non-compliance with study procedures|0|||
146841145|NCT00678301|529588766|FG001|Overall Study|Non-compliance with study procedures|1|||
146841146|NCT00678301|529588765|FG000|Overall Study|Adverse Event|1|||
146995365|NCT01617668|530147601|FG002|Overall Study|Subject/guardian decision|2|||
146841147|NCT00678301|529588766|FG001|Overall Study|Adverse Event|0|||
146841148|NCT00678301|529588765|FG000|Overall Study|Withdrawal by Subject|4|||
146841149|NCT00678301|529588766|FG001|Overall Study|Withdrawal by Subject|0|||
146841150|NCT00678301|529588765|FG000|Overall Study|Lost to Follow-up|3|||
146841151|NCT00678301|529588766|FG001|Overall Study|Lost to Follow-up|1|||
146841152|NCT03338296|529588767|FG000|Overall Study|Adverse Event|0|||
146841153|NCT03338296|529588768|FG001|Overall Study|Adverse Event|1|||
146841154|NCT03338296|529588767|FG000|Overall Study|Withdrawal by Subject|14|||
146841155|NCT03338296|529588768|FG001|Overall Study|Withdrawal by Subject|13|||
146841156|NCT03338296|529588767|FG000|Overall Study|Lost to Follow-up|10|||
146841157|NCT03338296|529588768|FG001|Overall Study|Lost to Follow-up|10|||
146841158|NCT03338296|529588767|FG000|Overall Study|Study Terminated by Sponsor|77|||
146841159|NCT03338296|529588768|FG001|Overall Study|Study Terminated by Sponsor|76|||
146841160|NCT03338296|529588767|FG000|Overall Study|Other|2|||
146841161|NCT03338296|529588768|FG001|Overall Study|Other|7|||
146841162|NCT03338296|529588767|FG000|Overall Study|Missing|0|||
146841163|NCT03338296|529588768|FG001|Overall Study|Missing|1|||
146841164|NCT01939353|529588769|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
146841165|NCT01939353|529588769|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
146841166|NCT01939353|529588769|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
146841167|NCT01939353|529588769|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
146841168|NCT01939353|529588769|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
146841169|NCT04421950|529588775|FG000|Overall Study|Dropped or lost to follow up|4|||
146841170|NCT04421950|529588776|FG001|Overall Study|Dropped or lost to follow up|2|||
146841171|NCT05048238|529588777|FG000|Overall Study|Withdrawal by Subject|1|||
146841172|NCT00335140|529588780|FG000|Overall Study|Ineligible|1|||
146841173|NCT04546425|529588781|FG000|Overall Study|Protocol Violation|1|||
146841174|NCT04546425|529588782|FG001|Overall Study|Protocol Violation|1|||
146841175|NCT04546425|529588783|FG002|Overall Study|Protocol Violation|0|||
146841176|NCT04546425|529588784|FG003|Overall Study|Protocol Violation|0|||
146841177|NCT04546425|529588781|FG000|Overall Study|Adverse Event|3|||
146841178|NCT04546425|529588782|FG001|Overall Study|Adverse Event|0|||
146841179|NCT04546425|529588783|FG002|Overall Study|Adverse Event|0|||
146841180|NCT04546425|529588784|FG003|Overall Study|Adverse Event|0|||
146841181|NCT04546425|529588781|FG000|Overall Study|Lost to Follow-up|5|||
146841182|NCT04546425|529588782|FG001|Overall Study|Lost to Follow-up|4|||
146841183|NCT04546425|529588783|FG002|Overall Study|Lost to Follow-up|0|||
146841184|NCT04546425|529588784|FG003|Overall Study|Lost to Follow-up|0|||
146841185|NCT04546425|529588781|FG000|Overall Study|No Longer met eligibility criteria|3|||
146995366|NCT01617668|530147602|FG003|Overall Study|Subject/guardian decision|1|||
146995367|NCT00925769|530147603|FG000|Overall Study|Major toxicity|1|||
146995368|NCT00925769|530147604|FG001|Overall Study|Major toxicity|0|||
146995369|NCT00925769|530147605|FG002|Overall Study|Major toxicity|1|||
146995370|NCT00925769|530147606|FG003|Overall Study|Major toxicity|1|||
146995371|NCT00925769|530147607|FG004|Overall Study|Major toxicity|0|||
146995372|NCT00925769|530147608|FG005|Overall Study|Major toxicity|0|||
146841186|NCT04546425|529588782|FG001|Overall Study|No Longer met eligibility criteria|3|||
146841187|NCT04546425|529588783|FG002|Overall Study|No Longer met eligibility criteria|1|||
146841188|NCT04546425|529588784|FG003|Overall Study|No Longer met eligibility criteria|1|||
146841189|NCT04546425|529588781|FG000|Overall Study|Withdrawal by parent/guardian|6|||
146841190|NCT04546425|529588782|FG001|Overall Study|Withdrawal by parent/guardian|5|||
146841191|NCT04546425|529588783|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146841192|NCT04546425|529588784|FG003|Overall Study|Withdrawal by parent/guardian|1|||
146841193|NCT02687035|529588785|FG000|Overall Study|Withdrawal by Subject|1|||
146841194|NCT02687035|529588785|FG000|Overall Study|Death|87|||
146841195|NCT02687035|529588785|FG000|Overall Study|Lost to Follow-up|1|||
146841196|NCT02687035|529588785|FG000|Overall Study|Missed Visit|87|||
146841197|NCT02687035|529588785|FG000|Overall Study|Did not receive Study Device|8|||
146841198|NCT04076943|529588795|FG000|Overall Study|Withdrawal by Subject|12|||
146841199|NCT04076943|529588795|FG000|Overall Study|Adverse Event|1|||
146841200|NCT04076943|529588795|FG000|Overall Study|Progressive Disease|2|||
146841201|NCT04076943|529588795|FG000|Overall Study|Death|13|||
146841202|NCT04076943|529588795|FG000|Overall Study|Other than specified|6|||
146841203|NCT02766777|529588802|FG000|Overall Study|Adverse Event|12|||
146841204|NCT02766777|529588802|FG000|Overall Study|Lost to Follow-up|16|||
146841205|NCT02766777|529588802|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146841206|NCT02766777|529588802|FG000|Overall Study|Protocol Violation|1|||
146841207|NCT02766777|529588802|FG000|Overall Study|Withdrawal by Subject|4|||
146841208|NCT01572740|529588803|FG000|Overall Study|Adverse Event|1|||
146841209|NCT01572740|529588804|FG001|Overall Study|Adverse Event|1|||
146841210|NCT01572740|529588803|FG000|Overall Study|Withdrawal by Subject|1|||
146841211|NCT01572740|529588804|FG001|Overall Study|Withdrawal by Subject|1|||
146841212|NCT01572740|529588803|FG000|Overall Study|unclassified|4|||
146841213|NCT01572740|529588804|FG001|Overall Study|unclassified|3|||
146841214|NCT03635099|529588807|FG000|Period 1|Adverse Event|1|||
146841215|NCT03635099|529588808|FG001|Period 1|Adverse Event|0|||
146841216|NCT03635099|529588809|FG002|Period 1|Adverse Event|0|||
146841217|NCT03635099|529588810|FG003|Period 1|Adverse Event|1|||
146995373|NCT00925769|530147603|FG000|Overall Study|Disease progression|4|||
146995374|NCT00925769|530147604|FG001|Overall Study|Disease progression|5|||
146995375|NCT00925769|530147605|FG002|Overall Study|Disease progression|3|||
146841218|NCT03635099|529588811|FG004|Period 1|Adverse Event|0|||
146841219|NCT03635099|529588812|FG005|Period 1|Adverse Event|0|||
146841220|NCT03635099|529588813|FG006|Period 1|Adverse Event|0|||
146841221|NCT03635099|529588814|FG007|Period 1|Adverse Event|0|||
146841222|NCT03635099|529588807|FG000|Period 1|Protocol Violation|0|||
146841223|NCT03635099|529588808|FG001|Period 1|Protocol Violation|0|||
146841224|NCT03635099|529588809|FG002|Period 1|Protocol Violation|1|||
146841225|NCT03635099|529588810|FG003|Period 1|Protocol Violation|0|||
146841226|NCT03635099|529588811|FG004|Period 1|Protocol Violation|0|||
146841227|NCT03635099|529588812|FG005|Period 1|Protocol Violation|0|||
146841228|NCT03635099|529588813|FG006|Period 1|Protocol Violation|0|||
146841229|NCT03635099|529588814|FG007|Period 1|Protocol Violation|0|||
146841230|NCT03635099|529588807|FG000|Period 1|Lost to Follow-up|0|||
146841231|NCT03635099|529588808|FG001|Period 1|Lost to Follow-up|0|||
146841232|NCT03635099|529588809|FG002|Period 1|Lost to Follow-up|1|||
146841233|NCT03635099|529588810|FG003|Period 1|Lost to Follow-up|2|||
146841234|NCT03635099|529588811|FG004|Period 1|Lost to Follow-up|1|||
146841235|NCT03635099|529588812|FG005|Period 1|Lost to Follow-up|0|||
146841236|NCT03635099|529588813|FG006|Period 1|Lost to Follow-up|1|||
146995376|NCT00925769|530147606|FG003|Overall Study|Disease progression|4|||
146995377|NCT00925769|530147607|FG004|Overall Study|Disease progression|2|||
146995378|NCT00925769|530147608|FG005|Overall Study|Disease progression|3|||
146995379|NCT00925769|530147603|FG000|Overall Study|Death|0|||
146995380|NCT00925769|530147604|FG001|Overall Study|Death|0|||
146995381|NCT00925769|530147605|FG002|Overall Study|Death|1|||
146995382|NCT00925769|530147606|FG003|Overall Study|Death|0|||
146995383|NCT00925769|530147607|FG004|Overall Study|Death|0|||
146995384|NCT00925769|530147608|FG005|Overall Study|Death|0|||
146995385|NCT00925769|530147603|FG000|Overall Study|Physician Decision|1|||
146995386|NCT00925769|530147604|FG001|Overall Study|Physician Decision|0|||
146995387|NCT00925769|530147605|FG002|Overall Study|Physician Decision|0|||
146995388|NCT00925769|530147606|FG003|Overall Study|Physician Decision|0|||
146995389|NCT00925769|530147607|FG004|Overall Study|Physician Decision|0|||
146995390|NCT00925769|530147608|FG005|Overall Study|Physician Decision|0|||
146841237|NCT03635099|529588814|FG007|Period 1|Lost to Follow-up|2|||
146841238|NCT03635099|529588807|FG000|Period 1|Withdrawal by Subject|3|||
146841239|NCT03635099|529588808|FG001|Period 1|Withdrawal by Subject|3|||
146841240|NCT03635099|529588809|FG002|Period 1|Withdrawal by Subject|5|||
146841241|NCT03635099|529588810|FG003|Period 1|Withdrawal by Subject|2|||
146841242|NCT03635099|529588811|FG004|Period 1|Withdrawal by Subject|2|||
146841243|NCT03635099|529588812|FG005|Period 1|Withdrawal by Subject|0|||
146841244|NCT03635099|529588813|FG006|Period 1|Withdrawal by Subject|3|||
146841245|NCT03635099|529588814|FG007|Period 1|Withdrawal by Subject|0|||
146841246|NCT03635099|529588807|FG000|Period 1|History of suicidal ideation|0|||
146841247|NCT03635099|529588808|FG001|Period 1|History of suicidal ideation|0|||
146841248|NCT03635099|529588809|FG002|Period 1|History of suicidal ideation|1|||
146841249|NCT03635099|529588810|FG003|Period 1|History of suicidal ideation|0|||
146841250|NCT03635099|529588811|FG004|Period 1|History of suicidal ideation|0|||
146841251|NCT03635099|529588812|FG005|Period 1|History of suicidal ideation|0|||
146841252|NCT03635099|529588813|FG006|Period 1|History of suicidal ideation|0|||
146841253|NCT03635099|529588814|FG007|Period 1|History of suicidal ideation|0|||
146841254|NCT03635099|529588807|FG000|Period 1|pursue other treatment options|0|||
146841255|NCT03635099|529588808|FG001|Period 1|pursue other treatment options|0|||
146841256|NCT03635099|529588809|FG002|Period 1|pursue other treatment options|0|||
146841257|NCT03635099|529588810|FG003|Period 1|pursue other treatment options|0|||
146841258|NCT03635099|529588811|FG004|Period 1|pursue other treatment options|0|||
146841259|NCT03635099|529588812|FG005|Period 1|pursue other treatment options|1|||
146841260|NCT03635099|529588813|FG006|Period 1|pursue other treatment options|0|||
146841261|NCT03635099|529588814|FG007|Period 1|pursue other treatment options|0|||
146841262|NCT03635099|529588807|FG000|Not Eligible for Period 2|Pregnancy|0|||
146841263|NCT03635099|529588808|FG001|Not Eligible for Period 2|Pregnancy|0|||
146841264|NCT03635099|529588809|FG002|Not Eligible for Period 2|Pregnancy|0|||
146961390|NCT01374516|530018146|FG001|Surveillance Expansion Period|Serious adverse event|5|||
146961391|NCT00450814|530018148|FG000|Overall Study|Failed to complete the initial therapy|0|||
146961392|NCT00450814|530018149|FG001|Overall Study|Failed to complete the initial therapy|0|||
146961393|NCT00450814|530018150|FG002|Overall Study|Failed to complete the initial therapy|0|||
146961394|NCT00450814|530018151|FG003|Overall Study|Failed to complete the initial therapy|1|||
146961395|NCT00450814|530018152|FG004|Overall Study|Failed to complete the initial therapy|1|||
146961396|NCT00450814|530018153|FG005|Overall Study|Failed to complete the initial therapy|1|||
146961397|NCT00450814|530018154|FG006|Overall Study|Failed to complete the initial therapy|0|||
146961398|NCT00450814|530018155|FG007|Overall Study|Failed to complete the initial therapy|0|||
146961399|NCT00450814|530018156|FG008|Overall Study|Failed to complete the initial therapy|0|||
146961400|NCT00450814|530018157|FG009|Overall Study|Failed to complete the initial therapy|0|||
146961401|NCT00450814|530018158|FG010|Overall Study|Failed to complete the initial therapy|0|||
146961402|NCT00450814|530018148|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
146961403|NCT00450814|530018149|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
146961404|NCT00450814|530018150|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
146961405|NCT00450814|530018151|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
146961406|NCT00450814|530018152|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
146961407|NCT00450814|530018153|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
146961408|NCT00450814|530018154|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
146961409|NCT00450814|530018155|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
146995391|NCT00925769|530147603|FG000|Overall Study|Missing documentation|0|||
146841265|NCT03635099|529588810|FG003|Not Eligible for Period 2|Pregnancy|1|||
146841266|NCT03635099|529588811|FG004|Not Eligible for Period 2|Pregnancy|0|||
146841267|NCT03635099|529588812|FG005|Not Eligible for Period 2|Pregnancy|0|||
146841268|NCT03635099|529588813|FG006|Not Eligible for Period 2|Pregnancy|0|||
146841269|NCT03635099|529588814|FG007|Not Eligible for Period 2|Pregnancy|0|||
146841270|NCT03635099|529588807|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
146841271|NCT03635099|529588808|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
146841272|NCT03635099|529588809|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
146841273|NCT03635099|529588810|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
146841274|NCT03635099|529588811|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
146841275|NCT03635099|529588812|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
146841276|NCT03635099|529588813|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
146841277|NCT03635099|529588814|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
146841278|NCT03635099|529588807|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
146841279|NCT03635099|529588808|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
146841280|NCT03635099|529588809|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
146841281|NCT03635099|529588810|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
146841282|NCT03635099|529588811|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
146841283|NCT03635099|529588812|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
146841284|NCT03635099|529588813|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
146841285|NCT03635099|529588814|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
146841286|NCT03635099|529588807|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
146841287|NCT03635099|529588808|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
146841288|NCT03635099|529588809|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
146841289|NCT03635099|529588810|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
146841290|NCT03635099|529588811|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
146841291|NCT03635099|529588812|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
146841292|NCT03635099|529588813|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
146841293|NCT03635099|529588814|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
146841294|NCT03635099|529588807|FG000|Period 2|Adverse Event|0|||
146841295|NCT03635099|529588808|FG001|Period 2|Adverse Event|0|||
146841296|NCT03635099|529588809|FG002|Period 2|Adverse Event|1|||
146841297|NCT03635099|529588810|FG003|Period 2|Adverse Event|0|||
146841298|NCT03635099|529588811|FG004|Period 2|Adverse Event|1|||
146841299|NCT03635099|529588812|FG005|Period 2|Adverse Event|0|||
146841300|NCT03635099|529588813|FG006|Period 2|Adverse Event|0|||
146841301|NCT03635099|529588814|FG007|Period 2|Adverse Event|0|||
146841302|NCT03635099|529588807|FG000|Period 2|Lost to Follow-up|0|||
146841303|NCT03635099|529588808|FG001|Period 2|Lost to Follow-up|0|||
146841304|NCT03635099|529588809|FG002|Period 2|Lost to Follow-up|1|||
146841305|NCT03635099|529588810|FG003|Period 2|Lost to Follow-up|0|||
146841306|NCT03635099|529588811|FG004|Period 2|Lost to Follow-up|4|||
146841307|NCT03635099|529588812|FG005|Period 2|Lost to Follow-up|0|||
146841308|NCT03635099|529588813|FG006|Period 2|Lost to Follow-up|0|||
146841309|NCT03635099|529588814|FG007|Period 2|Lost to Follow-up|0|||
146841310|NCT03635099|529588807|FG000|Period 2|Withdrawal by Subject|0|||
146841311|NCT03635099|529588808|FG001|Period 2|Withdrawal by Subject|0|||
146841312|NCT03635099|529588809|FG002|Period 2|Withdrawal by Subject|7|||
146841313|NCT03635099|529588810|FG003|Period 2|Withdrawal by Subject|4|||
146841314|NCT03635099|529588811|FG004|Period 2|Withdrawal by Subject|7|||
146841315|NCT03635099|529588812|FG005|Period 2|Withdrawal by Subject|0|||
146841316|NCT03635099|529588813|FG006|Period 2|Withdrawal by Subject|0|||
146841317|NCT03635099|529588814|FG007|Period 2|Withdrawal by Subject|0|||
146841318|NCT01465763|529588815|FG000|Overall Study|Withdrawal by Subject|4|||
146841319|NCT01465763|529588816|FG001|Overall Study|Withdrawal by Subject|0|||
146841320|NCT01465763|529588817|FG002|Overall Study|Withdrawal by Subject|1|||
146841321|NCT01465763|529588815|FG000|Overall Study|Insufficient Clinical Response|11|||
146841322|NCT01465763|529588816|FG001|Overall Study|Insufficient Clinical Response|0|||
146841323|NCT01465763|529588817|FG002|Overall Study|Insufficient Clinical Response|1|||
146841324|NCT01465763|529588815|FG000|Overall Study|Adverse Event|9|||
146841325|NCT01465763|529588816|FG001|Overall Study|Adverse Event|0|||
146841326|NCT01465763|529588817|FG002|Overall Study|Adverse Event|1|||
146841327|NCT01465763|529588815|FG000|Overall Study|Other|2|||
146841328|NCT01465763|529588816|FG001|Overall Study|Other|0|||
146841329|NCT01465763|529588817|FG002|Overall Study|Other|0|||
146841330|NCT01465763|529588815|FG000|Overall Study|Protocol Violation|4|||
146841331|NCT01465763|529588816|FG001|Overall Study|Protocol Violation|1|||
146841332|NCT01465763|529588817|FG002|Overall Study|Protocol Violation|1|||
146841333|NCT01465763|529588815|FG000|Overall Study|Death|1|||
146841334|NCT01465763|529588816|FG001|Overall Study|Death|0|||
146961410|NCT00450814|530018156|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
146961411|NCT00450814|530018157|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
146961412|NCT00450814|530018158|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
146961413|NCT04145531|530018159|FG000|Part A|Adverse Event|2|||
146961414|NCT04145531|530018160|FG001|Part A|Adverse Event|12|||
146961415|NCT04145531|530018161|FG002|Part A|Adverse Event|6|||
146961416|NCT04145531|530018162|FG003|Part A|Adverse Event|0|||
146841335|NCT01465763|529588817|FG002|Overall Study|Death|0|||
146841336|NCT02807272|529588820|FG000|Overall Study|Death|9|||
146841337|NCT02807272|529588821|FG001|Overall Study|Death|5|||
146841338|NCT02807272|529588822|FG002|Overall Study|Death|2|||
146841339|NCT02807272|529588823|FG003|Overall Study|Death|0|||
146841340|NCT02807272|529588824|FG004|Overall Study|Death|1|||
146841341|NCT02807272|529588820|FG000|Overall Study|Lost to Follow-up|1|||
146841342|NCT02807272|529588821|FG001|Overall Study|Lost to Follow-up|0|||
146841343|NCT02807272|529588822|FG002|Overall Study|Lost to Follow-up|0|||
146841344|NCT02807272|529588823|FG003|Overall Study|Lost to Follow-up|0|||
146841345|NCT02807272|529588824|FG004|Overall Study|Lost to Follow-up|0|||
146841346|NCT02807272|529588820|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
146841347|NCT02807272|529588821|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
146841348|NCT02807272|529588822|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
146841349|NCT02807272|529588823|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
146841350|NCT02807272|529588824|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
146841351|NCT02807272|529588820|FG000|Overall Study|Protocol-defined Disease Progression|0|||
146841352|NCT02807272|529588821|FG001|Overall Study|Protocol-defined Disease Progression|1|||
146841353|NCT02807272|529588822|FG002|Overall Study|Protocol-defined Disease Progression|0|||
146841354|NCT02807272|529588823|FG003|Overall Study|Protocol-defined Disease Progression|0|||
146841355|NCT02807272|529588824|FG004|Overall Study|Protocol-defined Disease Progression|1|||
146841356|NCT02807272|529588820|FG000|Overall Study|Study Terminated by Sponsor|1|||
146841357|NCT02807272|529588821|FG001|Overall Study|Study Terminated by Sponsor|0|||
146841358|NCT02807272|529588822|FG002|Overall Study|Study Terminated by Sponsor|0|||
146841359|NCT02807272|529588823|FG003|Overall Study|Study Terminated by Sponsor|1|||
146841360|NCT02807272|529588824|FG004|Overall Study|Study Terminated by Sponsor|0|||
146841361|NCT02807272|529588820|FG000|Overall Study|Other|1|||
146841362|NCT02807272|529588821|FG001|Overall Study|Other|0|||
146841363|NCT02807272|529588822|FG002|Overall Study|Other|0|||
146841364|NCT02807272|529588823|FG003|Overall Study|Other|0|||
146841365|NCT02807272|529588824|FG004|Overall Study|Other|1|||
146841366|NCT04191616|529588825|FG000|Pre-assignment Period|Did not receive study treatment|2|||
146841367|NCT04191616|529588825|FG000|Treatment Period|Death|37|||
146841368|NCT04191616|529588825|FG000|Treatment Period|Sponsor decision|11|||
146841369|NCT04191616|529588825|FG000|Treatment Period|Withdrawal by Subject|4|||
146841370|NCT04230122|529588826|FG000|Overall Study|Lost to Follow-up|1|||
146841371|NCT04230122|529588827|FG001|Overall Study|Lost to Follow-up|0|||
146841372|NCT02202785|529588831|FG000|Overall Study|Study Terminated by Sponsor|1|||
146841373|NCT02202785|529588832|FG001|Overall Study|Study Terminated by Sponsor|6|||
146841374|NCT02202785|529588833|FG002|Overall Study|Study Terminated by Sponsor|4|||
146841375|NCT02202785|529588831|FG000|Overall Study|Withdrawal by Subject|0|||
146841376|NCT02202785|529588832|FG001|Overall Study|Withdrawal by Subject|1|||
146841377|NCT02202785|529588833|FG002|Overall Study|Withdrawal by Subject|0|||
146841378|NCT02202785|529588831|FG000|Overall Study|Lost to Follow-up|0|||
146841379|NCT02202785|529588832|FG001|Overall Study|Lost to Follow-up|1|||
146841380|NCT02202785|529588833|FG002|Overall Study|Lost to Follow-up|0|||
146841381|NCT02202785|529588831|FG000|Overall Study|Reason not Specified|10|||
146841382|NCT02202785|529588832|FG001|Overall Study|Reason not Specified|7|||
146841383|NCT02202785|529588833|FG002|Overall Study|Reason not Specified|13|||
146841384|NCT02180243|529588834|FG000|Overall Study|Withdrawal by Subject|12|||
146841385|NCT02180243|529588835|FG001|Overall Study|Withdrawal by Subject|12|||
146841386|NCT02180243|529588834|FG000|Overall Study|Lost to Follow-up|12|||
146841387|NCT02180243|529588835|FG001|Overall Study|Lost to Follow-up|2|||
146841388|NCT01137578|529588836|FG000|Overall Study|Participant requested to Discontinue|3|||
146841389|NCT01137578|529588837|FG001|Overall Study|Participant requested to Discontinue|0|||
146841390|NCT01137578|529588838|FG002|Overall Study|Participant requested to Discontinue|0|||
146841391|NCT01137578|529588836|FG000|Overall Study|Withdrawal by Subject|1|||
146841392|NCT01137578|529588837|FG001|Overall Study|Withdrawal by Subject|0|||
146841393|NCT01137578|529588838|FG002|Overall Study|Withdrawal by Subject|0|||
146841394|NCT01137578|529588836|FG000|Overall Study|Other|12|||
146841395|NCT01137578|529588837|FG001|Overall Study|Other|2|||
146841396|NCT01137578|529588838|FG002|Overall Study|Other|6|||
146841397|NCT03945825|529588839|FG000|Overall Study|Enrolled but treatment not administered|0|||
146841398|NCT03945825|529588840|FG001|Overall Study|Enrolled but treatment not administered|0|||
146841399|NCT03945825|529588841|FG002|Overall Study|Enrolled but treatment not administered|0|||
146841400|NCT03945825|529588842|FG003|Overall Study|Enrolled but treatment not administered|0|||
146841401|NCT03945825|529588843|FG004|Overall Study|Enrolled but treatment not administered|1|||
146841402|NCT03945825|529588844|FG005|Overall Study|Enrolled but treatment not administered|0|||
146841403|NCT03945825|529588839|FG000|Overall Study|Lost to Follow-up|1|||
146841404|NCT03945825|529588840|FG001|Overall Study|Lost to Follow-up|5|||
146841405|NCT03945825|529588841|FG002|Overall Study|Lost to Follow-up|0|||
146841406|NCT03945825|529588842|FG003|Overall Study|Lost to Follow-up|1|||
146841407|NCT03945825|529588843|FG004|Overall Study|Lost to Follow-up|2|||
146841408|NCT03945825|529588844|FG005|Overall Study|Lost to Follow-up|2|||
146841409|NCT03945825|529588839|FG000|Overall Study|Withdrawal by Subject|1|||
146841410|NCT03945825|529588840|FG001|Overall Study|Withdrawal by Subject|0|||
146841411|NCT03945825|529588841|FG002|Overall Study|Withdrawal by Subject|1|||
146841412|NCT03945825|529588842|FG003|Overall Study|Withdrawal by Subject|1|||
146841413|NCT03945825|529588843|FG004|Overall Study|Withdrawal by Subject|0|||
146841414|NCT03945825|529588844|FG005|Overall Study|Withdrawal by Subject|1|||
146841415|NCT01461005|529588845|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
146841416|NCT04844879|529588848|FG000|Overall Study|Death|1|||
146841417|NCT04844879|529588848|FG000|Overall Study|Withdrawal by Subject|1|||
146841418|NCT04844879|529588848|FG000|Overall Study|Adverse Event|1|||
146841419|NCT04520659|529588849|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
146841420|NCT04520659|529588850|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
146841421|NCT04520659|529588851|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
146841422|NCT04520659|529588852|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
146841423|NCT04879849|529588857|FG000|Overall Study|Lost to Follow-up|0|||
146841424|NCT04879849|529588858|FG001|Overall Study|Lost to Follow-up|0|||
146841425|NCT04879849|529588859|FG002|Overall Study|Lost to Follow-up|0|||
146841426|NCT04879849|529588860|FG003|Overall Study|Lost to Follow-up|1|||
146841427|NCT04879849|529588861|FG004|Overall Study|Lost to Follow-up|0|||
146841428|NCT04879849|529588862|FG005|Overall Study|Lost to Follow-up|0|||
146841429|NCT04879849|529588863|FG006|Overall Study|Lost to Follow-up|0|||
146841430|NCT04879849|529588864|FG007|Overall Study|Lost to Follow-up|0|||
146841431|NCT04879849|529588857|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
146841432|NCT04879849|529588858|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
146841433|NCT04879849|529588859|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
146841434|NCT04879849|529588860|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
146841435|NCT04879849|529588861|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
146841436|NCT04879849|529588862|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
146841437|NCT04879849|529588863|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
146841438|NCT04879849|529588864|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
146841439|NCT04879849|529588857|FG000|Overall Study|Withdrawal by Subject|0|||
146841440|NCT04879849|529588858|FG001|Overall Study|Withdrawal by Subject|0|||
146841441|NCT04879849|529588859|FG002|Overall Study|Withdrawal by Subject|0|||
146841442|NCT04879849|529588860|FG003|Overall Study|Withdrawal by Subject|0|||
146841443|NCT04879849|529588861|FG004|Overall Study|Withdrawal by Subject|2|||
146841444|NCT04879849|529588862|FG005|Overall Study|Withdrawal by Subject|0|||
146841445|NCT04879849|529588863|FG006|Overall Study|Withdrawal by Subject|1|||
146841446|NCT04879849|529588864|FG007|Overall Study|Withdrawal by Subject|0|||
146841447|NCT04879849|529588857|FG000|Overall Study|Progressive Disease|0|||
146841448|NCT04879849|529588858|FG001|Overall Study|Progressive Disease|0|||
146841449|NCT04879849|529588859|FG002|Overall Study|Progressive Disease|1|||
146841450|NCT04879849|529588860|FG003|Overall Study|Progressive Disease|0|||
146841451|NCT04879849|529588861|FG004|Overall Study|Progressive Disease|0|||
146841452|NCT04879849|529588862|FG005|Overall Study|Progressive Disease|0|||
146841453|NCT04879849|529588863|FG006|Overall Study|Progressive Disease|0|||
146841454|NCT04879849|529588864|FG007|Overall Study|Progressive Disease|0|||
146841455|NCT04879849|529588857|FG000|Overall Study|Death|0|||
146841456|NCT04879849|529588858|FG001|Overall Study|Death|0|||
146841457|NCT04879849|529588859|FG002|Overall Study|Death|1|||
146841458|NCT04879849|529588860|FG003|Overall Study|Death|1|||
146841459|NCT04879849|529588861|FG004|Overall Study|Death|1|||
146841460|NCT04879849|529588862|FG005|Overall Study|Death|2|||
146841461|NCT04879849|529588863|FG006|Overall Study|Death|1|||
146841462|NCT04879849|529588864|FG007|Overall Study|Death|2|||
146841463|NCT04879849|529588857|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
146841464|NCT04879849|529588858|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
146841465|NCT04879849|529588859|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
146841466|NCT04879849|529588860|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
146841467|NCT04879849|529588861|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
146841468|NCT04879849|529588862|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
146841469|NCT04879849|529588863|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
146841470|NCT04879849|529588864|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
146841471|NCT04879849|529588857|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
146841472|NCT04879849|529588858|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
146841473|NCT04879849|529588859|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
146841474|NCT04879849|529588860|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
146841475|NCT04879849|529588861|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
146841476|NCT04879849|529588862|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
146841477|NCT04879849|529588863|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
146841478|NCT04879849|529588864|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
146735777|NCT03145766|529205176|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
146735778|NCT03145766|529205177|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
146735779|NCT03145766|529205178|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
146735780|NCT03145766|529205174|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
146735781|NCT03145766|529205175|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
146735782|NCT03145766|529205176|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
146735783|NCT03145766|529205177|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
146735784|NCT03145766|529205178|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
146735785|NCT03145766|529205174|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
146735786|NCT03145766|529205175|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
146735787|NCT03145766|529205176|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
146735788|NCT03145766|529205177|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
146735789|NCT03145766|529205178|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
146735790|NCT03145766|529205174|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
146735791|NCT03145766|529205175|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
146735792|NCT03145766|529205176|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
146735793|NCT03145766|529205177|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
146735794|NCT03145766|529205178|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
146735795|NCT03145766|529205174|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
146735796|NCT03145766|529205175|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
146735797|NCT03145766|529205176|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
146735798|NCT03145766|529205177|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
146735799|NCT03145766|529205178|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
146735800|NCT03145766|529205174|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
146735801|NCT03145766|529205175|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
146735802|NCT03145766|529205176|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
146735803|NCT03145766|529205177|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
146735804|NCT03145766|529205178|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
146735805|NCT02801669|529205180|FG000|Overall Study|Death|66|||
146735806|NCT02801669|529205181|FG001|Overall Study|Death|69|||
146735807|NCT02801669|529205180|FG000|Overall Study|Withdrawal by Subject|81|||
146735808|NCT02801669|529205181|FG001|Overall Study|Withdrawal by Subject|77|||
146735809|NCT02801669|529205180|FG000|Overall Study|Other|4|||
146735810|NCT02801669|529205181|FG001|Overall Study|Other|6|||
146735811|NCT04461795|529205183|FG000|Overall Study|Lost to Follow-up|2|||
146735812|NCT04461795|529205183|FG000|Overall Study|Withdrawal by Subject|2|||
146735813|NCT04461795|529205183|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
146735814|NCT00615264|529205184|FG000|Overall Study|Withdrawal by Subject|17|||
146735815|NCT00615264|529205185|FG001|Overall Study|Withdrawal by Subject|19|||
146735816|NCT00615264|529205184|FG000|Overall Study|Lost to Follow-up|6|||
146735817|NCT00615264|529205185|FG001|Overall Study|Lost to Follow-up|13|||
146735818|NCT00615264|529205184|FG000|Overall Study|Adverse Event|8|||
146735819|NCT00615264|529205185|FG001|Overall Study|Adverse Event|5|||
146735820|NCT00615264|529205184|FG000|Overall Study|Death|1|||
146735821|NCT00615264|529205185|FG001|Overall Study|Death|1|||
146735822|NCT00615264|529205184|FG000|Overall Study|Protocol Violation|11|||
146735823|NCT00615264|529205185|FG001|Overall Study|Protocol Violation|7|||
146735824|NCT00615264|529205184|FG000|Overall Study|Not defined|7|||
146735825|NCT00615264|529205185|FG001|Overall Study|Not defined|4|||
146735826|NCT00615264|529205184|FG000|Overall Study|Dermal Hypersensitivity|0|||
146735827|NCT00615264|529205185|FG001|Overall Study|Dermal Hypersensitivity|3|||
146735828|NCT00185640|529205186|FG000|Overall Study|Not Eligible|4|||
146735829|NCT00185640|529205186|FG000|Overall Study|Withdrawal by Subject|3|||
146735830|NCT00185640|529205186|FG000|Overall Study|Death|138|||
146735831|NCT00058422|529205187|FG000|Overall Study|Not treated|2|||
146735832|NCT02396537|529205196|FG000|Overall Study|Protocol Violation|0|||
146735833|NCT02396537|529205197|FG001|Overall Study|Protocol Violation|1|||
146735834|NCT01982435|529205198|FG000|Overall Study|Adverse Event|1|||
146735835|NCT01982435|529205199|FG001|Overall Study|Adverse Event|0|||
146735836|NCT00871403|529205200|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
146735837|NCT00871403|529205201|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
146735838|NCT00871403|529205202|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
146735839|NCT00871403|529205200|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
146735840|NCT00871403|529205201|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
146735841|NCT00871403|529205202|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
146735842|NCT00871403|529205200|FG000|Combination Treatment Phase|Adverse Event|0|||
146735843|NCT00871403|529205201|FG001|Combination Treatment Phase|Adverse Event|17|||
146735844|NCT00871403|529205202|FG002|Combination Treatment Phase|Adverse Event|2|||
146735845|NCT00871403|529205200|FG000|Combination Treatment Phase|Disease Progression|0|||
146735846|NCT00871403|529205201|FG001|Combination Treatment Phase|Disease Progression|8|||
146735847|NCT00871403|529205202|FG002|Combination Treatment Phase|Disease Progression|5|||
146735848|NCT00871403|529205200|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
146735849|NCT00871403|529205201|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
146735850|NCT00871403|529205202|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
146735851|NCT00871403|529205200|FG000|Combination Treatment Phase|Physician Decision|0|||
146735852|NCT00871403|529205201|FG001|Combination Treatment Phase|Physician Decision|1|||
146735853|NCT00871403|529205202|FG002|Combination Treatment Phase|Physician Decision|3|||
146735854|NCT00871403|529205200|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
146735855|NCT00871403|529205201|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
146735856|NCT00871403|529205202|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
146735857|NCT00871403|529205200|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
146735858|NCT00871403|529205201|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
146735859|NCT00871403|529205202|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
146735860|NCT00985985|529205208|FG000|Overall Study|Adverse Event|4|||
146735861|NCT00985985|529205209|FG001|Overall Study|Adverse Event|2|||
146735862|NCT00985985|529205210|FG002|Overall Study|Adverse Event|2|||
146735863|NCT00985985|529205211|FG003|Overall Study|Adverse Event|2|||
146735864|NCT00985985|529205208|FG000|Overall Study|Lost to Follow-up|4|||
146735865|NCT00985985|529205209|FG001|Overall Study|Lost to Follow-up|11|||
146735866|NCT00985985|529205210|FG002|Overall Study|Lost to Follow-up|2|||
146735867|NCT00985985|529205211|FG003|Overall Study|Lost to Follow-up|3|||
146735868|NCT00985985|529205208|FG000|Overall Study|Protocol Violation|1|||
146735869|NCT00985985|529205209|FG001|Overall Study|Protocol Violation|2|||
146735870|NCT00985985|529205210|FG002|Overall Study|Protocol Violation|0|||
146735871|NCT00985985|529205211|FG003|Overall Study|Protocol Violation|1|||
146735872|NCT00985985|529205208|FG000|Overall Study|Lack of Efficacy|5|||
146735873|NCT00985985|529205209|FG001|Overall Study|Lack of Efficacy|6|||
146735874|NCT00985985|529205210|FG002|Overall Study|Lack of Efficacy|1|||
146735875|NCT00985985|529205211|FG003|Overall Study|Lack of Efficacy|3|||
146735876|NCT00985985|529205208|FG000|Overall Study|Withdrawal by Subject|4|||
146735877|NCT00985985|529205209|FG001|Overall Study|Withdrawal by Subject|2|||
146735878|NCT00985985|529205210|FG002|Overall Study|Withdrawal by Subject|2|||
146735879|NCT00985985|529205211|FG003|Overall Study|Withdrawal by Subject|2|||
146735880|NCT00985985|529205208|FG000|Overall Study|Other Reason|6|||
146735881|NCT00985985|529205209|FG001|Overall Study|Other Reason|1|||
146735882|NCT00985985|529205210|FG002|Overall Study|Other Reason|4|||
146735883|NCT00985985|529205211|FG003|Overall Study|Other Reason|2|||
146735884|NCT00509236|529205214|FG000|Overall Study|Adverse Event|7|||
146735885|NCT00509236|529205215|FG001|Overall Study|Adverse Event|9|||
146735886|NCT00509236|529205214|FG000|Overall Study|Withdrawal by Subject|5|||
146735887|NCT00509236|529205215|FG001|Overall Study|Withdrawal by Subject|10|||
146735888|NCT00509236|529205214|FG000|Overall Study|Protocol Violation|3|||
146735889|NCT00509236|529205215|FG001|Overall Study|Protocol Violation|0|||
146735890|NCT00509236|529205214|FG000|Overall Study|Excluded Medication|1|||
146735891|NCT00509236|529205215|FG001|Overall Study|Excluded Medication|1|||
146735892|NCT00509236|529205214|FG000|Overall Study|Scheduled Kidney Transplant|1|||
146735893|NCT00509236|529205215|FG001|Overall Study|Scheduled Kidney Transplant|0|||
146735894|NCT00927355|529205216|FG000|Overall Study|Adverse Event|1|||
146735895|NCT00927355|529205217|FG001|Overall Study|Adverse Event|1|||
146735896|NCT01572389|529205218|FG000|Overall Study|Death|1|||
146735897|NCT01572389|529205219|FG001|Overall Study|Death|3|||
146735898|NCT01572389|529205218|FG000|Overall Study|Withdrawal by Subject|14|||
146735899|NCT01572389|529205219|FG001|Overall Study|Withdrawal by Subject|2|||
146735900|NCT01572389|529205218|FG000|Overall Study|Lost to Follow-up|25|||
146735901|NCT01572389|529205219|FG001|Overall Study|Lost to Follow-up|14|||
146735902|NCT01572389|529205218|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
146735903|NCT01572389|529205219|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
146735904|NCT03954743|529205220|FG000|Overall Study|Adverse Event|1|||
146735905|NCT03954743|529205221|FG001|Overall Study|Adverse Event|0|||
146735906|NCT03954743|529205220|FG000|Overall Study|Lost to Follow-up|6|||
146735907|NCT03954743|529205221|FG001|Overall Study|Lost to Follow-up|4|||
146735908|NCT03954743|529205220|FG000|Overall Study|Protocol Violation|1|||
146735909|NCT03954743|529205221|FG001|Overall Study|Protocol Violation|0|||
146735910|NCT03954743|529205220|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
146735911|NCT03954743|529205221|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
146735912|NCT03954743|529205220|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
146735913|NCT03954743|529205221|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146735914|NCT01781390|529205232|FG000|Overall Study|Withdrawal of Consent|0|||
146735915|NCT01781390|529205233|FG001|Overall Study|Withdrawal of Consent|3|||
146735916|NCT01781390|529205234|FG002|Overall Study|Withdrawal of Consent|1|||
146735917|NCT01781390|529205232|FG000|Overall Study|Lost to Follow-up|1|||
146995392|NCT00925769|530147604|FG001|Overall Study|Missing documentation|1|||
146841479|NCT04879849|529588857|FG000|Overall Study|Reason Not Specified|1|||
146841480|NCT04879849|529588858|FG001|Overall Study|Reason Not Specified|0|||
146841481|NCT04879849|529588859|FG002|Overall Study|Reason Not Specified|0|||
146841482|NCT04879849|529588860|FG003|Overall Study|Reason Not Specified|0|||
146841483|NCT04879849|529588861|FG004|Overall Study|Reason Not Specified|0|||
146841484|NCT04879849|529588862|FG005|Overall Study|Reason Not Specified|0|||
146841485|NCT04879849|529588863|FG006|Overall Study|Reason Not Specified|0|||
146841486|NCT04879849|529588864|FG007|Overall Study|Reason Not Specified|0|||
146841487|NCT07149155|529588871|FG000|Overall Study|Lost to Follow-up|10|||
146841488|NCT03345576|529588872|FG000|Overall Study|Withdrawal by Subject|2|||
146841489|NCT03345576|529588873|FG001|Overall Study|Withdrawal by Subject|2|||
146841490|NCT03345576|529588872|FG000|Overall Study|Adverse Event|1|||
146841491|NCT03345576|529588873|FG001|Overall Study|Adverse Event|0|||
146841492|NCT03829501|529590491|FG000|Overall Study|Withdrawal of Consent|2|||
146841493|NCT03829501|529590492|FG001|Overall Study|Withdrawal of Consent|0|||
146841494|NCT03829501|529590493|FG002|Overall Study|Withdrawal of Consent|3|||
146841495|NCT03829501|529590494|FG003|Overall Study|Withdrawal of Consent|0|||
146841496|NCT03829501|529590495|FG004|Overall Study|Withdrawal of Consent|1|||
146841497|NCT03829501|529590496|FG005|Overall Study|Withdrawal of Consent|1|||
146841498|NCT03829501|529590497|FG006|Overall Study|Withdrawal of Consent|0|||
146841499|NCT03829501|529590498|FG007|Overall Study|Withdrawal of Consent|10|||
146841500|NCT03829501|529590499|FG008|Overall Study|Withdrawal of Consent|10|||
146841501|NCT03829501|529590500|FG009|Overall Study|Withdrawal of Consent|3|||
146841502|NCT03829501|529590501|FG010|Overall Study|Withdrawal of Consent|4|||
146841503|NCT03829501|529590502|FG011|Overall Study|Withdrawal of Consent|4|||
146841504|NCT03829501|529590503|FG012|Overall Study|Withdrawal of Consent|4|||
146841505|NCT03829501|529590504|FG013|Overall Study|Withdrawal of Consent|0|||
146841506|NCT03829501|529590505|FG014|Overall Study|Withdrawal of Consent|3|||
146841507|NCT03829501|529590506|FG015|Overall Study|Withdrawal of Consent|0|||
146841508|NCT03829501|529590507|FG016|Overall Study|Withdrawal of Consent|1|||
146841509|NCT03829501|529590508|FG017|Overall Study|Withdrawal of Consent|1|||
146841510|NCT03829501|529590509|FG018|Overall Study|Withdrawal of Consent|0|||
146841511|NCT03829501|529590510|FG019|Overall Study|Withdrawal of Consent|0|||
146841512|NCT03829501|529590511|FG020|Overall Study|Withdrawal of Consent|3|||
146841513|NCT03829501|529590512|FG021|Overall Study|Withdrawal of Consent|0|||
146841514|NCT03829501|529590513|FG022|Overall Study|Withdrawal of Consent|1|||
146841515|NCT03829501|529590491|FG000|Overall Study|PD|0|||
146841516|NCT03829501|529590492|FG001|Overall Study|PD|0|||
146841517|NCT03829501|529590493|FG002|Overall Study|PD|0|||
146841518|NCT03829501|529590494|FG003|Overall Study|PD|2|||
146841519|NCT03829501|529590495|FG004|Overall Study|PD|0|||
146841520|NCT03829501|529590496|FG005|Overall Study|PD|0|||
146841521|NCT03829501|529590497|FG006|Overall Study|PD|0|||
146841522|NCT03829501|529590498|FG007|Overall Study|PD|0|||
146841523|NCT03829501|529590499|FG008|Overall Study|PD|0|||
146841524|NCT03829501|529590500|FG009|Overall Study|PD|0|||
146841525|NCT03829501|529590501|FG010|Overall Study|PD|0|||
146841526|NCT03829501|529590502|FG011|Overall Study|PD|0|||
146841527|NCT03829501|529590503|FG012|Overall Study|PD|0|||
146995393|NCT00925769|530147605|FG002|Overall Study|Missing documentation|0|||
146995394|NCT00925769|530147606|FG003|Overall Study|Missing documentation|0|||
146995395|NCT00925769|530147607|FG004|Overall Study|Missing documentation|0|||
146995396|NCT00925769|530147608|FG005|Overall Study|Missing documentation|0|||
146995397|NCT00925769|530147603|FG000|Overall Study|End of study visit not done|0|||
146995398|NCT00925769|530147604|FG001|Overall Study|End of study visit not done|0|||
146995399|NCT00925769|530147605|FG002|Overall Study|End of study visit not done|1|||
146995400|NCT00925769|530147606|FG003|Overall Study|End of study visit not done|0|||
146995401|NCT00925769|530147607|FG004|Overall Study|End of study visit not done|0|||
146995402|NCT00925769|530147608|FG005|Overall Study|End of study visit not done|0|||
146995403|NCT00925769|530147603|FG000|Overall Study|Participant is unable to swallow drug|0|||
146995404|NCT00925769|530147604|FG001|Overall Study|Participant is unable to swallow drug|0|||
146995405|NCT00925769|530147605|FG002|Overall Study|Participant is unable to swallow drug|0|||
146995406|NCT00925769|530147606|FG003|Overall Study|Participant is unable to swallow drug|1|||
146995407|NCT00925769|530147607|FG004|Overall Study|Participant is unable to swallow drug|0|||
146841528|NCT03829501|529590504|FG013|Overall Study|PD|0|||
146841529|NCT03829501|529590505|FG014|Overall Study|PD|0|||
146841530|NCT03829501|529590506|FG015|Overall Study|PD|1|||
146841531|NCT03829501|529590507|FG016|Overall Study|PD|0|||
146841532|NCT03829501|529590508|FG017|Overall Study|PD|0|||
146841533|NCT03829501|529590509|FG018|Overall Study|PD|0|||
146995408|NCT00925769|530147608|FG005|Overall Study|Participant is unable to swallow drug|0|||
146841534|NCT03829501|529590510|FG019|Overall Study|PD|0|||
146841535|NCT03829501|529590511|FG020|Overall Study|PD|1|||
146841536|NCT03829501|529590512|FG021|Overall Study|PD|0|||
146841537|NCT03829501|529590513|FG022|Overall Study|PD|0|||
146841538|NCT03829501|529590491|FG000|Overall Study|Study Terminated by Sponsor|0|||
146841539|NCT03829501|529590492|FG001|Overall Study|Study Terminated by Sponsor|0|||
146841540|NCT03829501|529590493|FG002|Overall Study|Study Terminated by Sponsor|0|||
146841541|NCT03829501|529590494|FG003|Overall Study|Study Terminated by Sponsor|0|||
146995409|NCT00925769|530147603|FG000|Overall Study|Adverse Event|0|||
146995410|NCT00925769|530147604|FG001|Overall Study|Adverse Event|0|||
146995411|NCT00925769|530147605|FG002|Overall Study|Adverse Event|0|||
146995412|NCT00925769|530147606|FG003|Overall Study|Adverse Event|0|||
146995413|NCT00925769|530147607|FG004|Overall Study|Adverse Event|1|||
146995414|NCT00925769|530147608|FG005|Overall Study|Adverse Event|0|||
146995415|NCT01038856|530147611|FG000|Overall Study|Adverse Event|2|||
146995416|NCT02300103|530147612|FG000|Overall Study|Lack of Efficacy|3|||
146995417|NCT02300103|530147612|FG000|Overall Study|Protocol Violation|1|||
146995418|NCT02300103|530147612|FG000|Overall Study|Withdrew Consent|2|||
146995419|NCT04091971|530147613|FG000|Overall Study|Withdrawal by Subject|1|||
146995420|NCT04091971|530147613|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
146995421|NCT04091971|530147613|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
146995422|NCT01666730|530147614|FG000|Overall Study|Adverse Event|16|||
146995423|NCT01666730|530147614|FG000|Overall Study|Death|2|||
146995424|NCT01666730|530147614|FG000|Overall Study|Physician Decision|5|||
146995425|NCT01666730|530147614|FG000|Overall Study|Withdrawal by Subject|9|||
146995426|NCT01666730|530147614|FG000|Overall Study|Disease progression/relapse|18|||
146995427|NCT03553823|530147615|FG000|Overall Study|Physician Decision|0|||
146995428|NCT03553823|530147616|FG001|Overall Study|Physician Decision|1|||
146995429|NCT03603314|530147617|FG000|Overall Study|Lost to Follow-up|0|||
146995430|NCT03603314|530147618|FG001|Overall Study|Lost to Follow-up|3|||
146995431|NCT03603314|530147619|FG002|Overall Study|Lost to Follow-up|0|||
146995432|NCT03603314|530147617|FG000|Overall Study|Protocol Violation|0|||
146995433|NCT03603314|530147618|FG001|Overall Study|Protocol Violation|1|||
146995434|NCT03603314|530147619|FG002|Overall Study|Protocol Violation|0|||
146995435|NCT03603314|530147617|FG000|Overall Study|Adverse Event|2|||
146995436|NCT03603314|530147618|FG001|Overall Study|Adverse Event|0|||
146735918|NCT01781390|529205233|FG001|Overall Study|Lost to Follow-up|1|||
146735919|NCT01781390|529205234|FG002|Overall Study|Lost to Follow-up|1|||
146735920|NCT01781390|529205232|FG000|Overall Study|Adverse Event|1|||
146735921|NCT01781390|529205233|FG001|Overall Study|Adverse Event|2|||
146735922|NCT01781390|529205234|FG002|Overall Study|Adverse Event|1|||
146735923|NCT01781390|529205232|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
146735924|NCT01781390|529205233|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
146735925|NCT01781390|529205234|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
146735926|NCT00622713|529205235|FG000|Overall Study|Adverse Event|35|||
146735927|NCT00622713|529205235|FG000|Overall Study|Administrative problems|4|||
146735928|NCT00622713|529205235|FG000|Overall Study|Withdrawal by Subject|11|||
146735929|NCT00622713|529205235|FG000|Overall Study|Lost to Follow-up|5|||
146735930|NCT00622713|529205235|FG000|Overall Study|Death|2|||
146735931|NCT00622713|529205235|FG000|Overall Study|Subject no longer required study drug|1|||
146735932|NCT00622713|529205235|FG000|Overall Study|Did not meet eligibility criteria|1|||
146735933|NCT01719237|529205236|FG000|Overall Study|Physician Decision|0|||
146735934|NCT01719237|529205237|FG001|Overall Study|Physician Decision|1|||
146735935|NCT02914314|529205241|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
146735936|NCT02914314|529205242|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
146735937|NCT02914314|529205243|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
146735938|NCT02914314|529205244|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
146735939|NCT02914314|529205241|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
146735940|NCT02914314|529205242|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
146735941|NCT02914314|529205243|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
146735942|NCT02914314|529205244|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
146735943|NCT02914314|529205241|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
146735944|NCT02914314|529205242|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
146735945|NCT02914314|529205243|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
146735946|NCT02914314|529205244|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
146735947|NCT02914314|529205241|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
146735948|NCT02914314|529205242|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
146735949|NCT02914314|529205243|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
146735950|NCT02914314|529205244|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
146735951|NCT02914314|529205241|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
146735952|NCT02914314|529205242|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
146735953|NCT02914314|529205243|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
146735954|NCT02914314|529205244|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
146735955|NCT03489057|529205250|FG000|Overall Study|Lost to Follow-up|16|||
146735956|NCT03489057|529205251|FG001|Overall Study|Lost to Follow-up|16|||
146735957|NCT03489057|529205252|FG002|Overall Study|Lost to Follow-up|14|||
146735958|NCT03489057|529205253|FG003|Overall Study|Lost to Follow-up|14|||
146735959|NCT03489057|529205250|FG000|Overall Study|Withdrawal by Subject|12|||
146735960|NCT03489057|529205251|FG001|Overall Study|Withdrawal by Subject|12|||
146735961|NCT03489057|529205252|FG002|Overall Study|Withdrawal by Subject|8|||
146995437|NCT03603314|530147619|FG002|Overall Study|Adverse Event|0|||
146995438|NCT03603314|530147617|FG000|Overall Study|Physician Decision|1|||
146995439|NCT03603314|530147618|FG001|Overall Study|Physician Decision|1|||
146995440|NCT03603314|530147619|FG002|Overall Study|Physician Decision|0|||
146995441|NCT03603314|530147617|FG000|Overall Study|Withdrawal by Subject|4|||
146995442|NCT03603314|530147618|FG001|Overall Study|Withdrawal by Subject|5|||
146995443|NCT03603314|530147619|FG002|Overall Study|Withdrawal by Subject|3|||
146995444|NCT03603314|530147617|FG000|Overall Study|Other|0|||
146995445|NCT03603314|530147618|FG001|Overall Study|Other|1|||
146995446|NCT03603314|530147619|FG002|Overall Study|Other|0|||
146841542|NCT03829501|529590495|FG004|Overall Study|Study Terminated by Sponsor|0|||
146841543|NCT03829501|529590496|FG005|Overall Study|Study Terminated by Sponsor|0|||
146841544|NCT03829501|529590497|FG006|Overall Study|Study Terminated by Sponsor|0|||
146841545|NCT03829501|529590498|FG007|Overall Study|Study Terminated by Sponsor|3|||
146841546|NCT03829501|529590499|FG008|Overall Study|Study Terminated by Sponsor|1|||
146841547|NCT03829501|529590500|FG009|Overall Study|Study Terminated by Sponsor|0|||
146841548|NCT03829501|529590501|FG010|Overall Study|Study Terminated by Sponsor|0|||
146841549|NCT03829501|529590502|FG011|Overall Study|Study Terminated by Sponsor|0|||
146841550|NCT03829501|529590503|FG012|Overall Study|Study Terminated by Sponsor|0|||
146841551|NCT03829501|529590504|FG013|Overall Study|Study Terminated by Sponsor|0|||
146841552|NCT03829501|529590505|FG014|Overall Study|Study Terminated by Sponsor|3|||
146841553|NCT03829501|529590506|FG015|Overall Study|Study Terminated by Sponsor|2|||
146841554|NCT03829501|529590507|FG016|Overall Study|Study Terminated by Sponsor|2|||
146841555|NCT03829501|529590508|FG017|Overall Study|Study Terminated by Sponsor|0|||
146841556|NCT03829501|529590509|FG018|Overall Study|Study Terminated by Sponsor|0|||
146841557|NCT03829501|529590510|FG019|Overall Study|Study Terminated by Sponsor|0|||
146841558|NCT03829501|529590511|FG020|Overall Study|Study Terminated by Sponsor|1|||
146841559|NCT03829501|529590512|FG021|Overall Study|Study Terminated by Sponsor|0|||
146841560|NCT03829501|529590513|FG022|Overall Study|Study Terminated by Sponsor|3|||
146841561|NCT03829501|529590491|FG000|Overall Study|Lost to Follow Up|0|||
146841562|NCT03829501|529590492|FG001|Overall Study|Lost to Follow Up|0|||
146841563|NCT03829501|529590493|FG002|Overall Study|Lost to Follow Up|0|||
146841564|NCT03829501|529590494|FG003|Overall Study|Lost to Follow Up|0|||
146841565|NCT03829501|529590495|FG004|Overall Study|Lost to Follow Up|1|||
146841566|NCT03829501|529590496|FG005|Overall Study|Lost to Follow Up|0|||
146841567|NCT03829501|529590497|FG006|Overall Study|Lost to Follow Up|0|||
146841568|NCT03829501|529590498|FG007|Overall Study|Lost to Follow Up|2|||
146841569|NCT03829501|529590499|FG008|Overall Study|Lost to Follow Up|2|||
146841570|NCT03829501|529590500|FG009|Overall Study|Lost to Follow Up|0|||
146841571|NCT03829501|529590501|FG010|Overall Study|Lost to Follow Up|2|||
146841572|NCT03829501|529590502|FG011|Overall Study|Lost to Follow Up|1|||
146841573|NCT03829501|529590503|FG012|Overall Study|Lost to Follow Up|0|||
146841574|NCT03829501|529590504|FG013|Overall Study|Lost to Follow Up|1|||
146841575|NCT03829501|529590505|FG014|Overall Study|Lost to Follow Up|1|||
146841576|NCT03829501|529590506|FG015|Overall Study|Lost to Follow Up|0|||
146841577|NCT03829501|529590507|FG016|Overall Study|Lost to Follow Up|0|||
146841578|NCT03829501|529590508|FG017|Overall Study|Lost to Follow Up|0|||
146841579|NCT03829501|529590509|FG018|Overall Study|Lost to Follow Up|0|||
146841580|NCT03829501|529590510|FG019|Overall Study|Lost to Follow Up|0|||
146995447|NCT01389102|530147620|FG000|Overall Study|Adverse Event|1|||
146995448|NCT01389102|530147621|FG001|Overall Study|Adverse Event|3|||
146995449|NCT01389102|530147622|FG002|Overall Study|Adverse Event|2|||
146995450|NCT01389102|530147623|FG003|Overall Study|Adverse Event|2|||
146841581|NCT03829501|529590511|FG020|Overall Study|Lost to Follow Up|0|||
146841582|NCT03829501|529590512|FG021|Overall Study|Lost to Follow Up|0|||
146841583|NCT03829501|529590513|FG022|Overall Study|Lost to Follow Up|1|||
146841584|NCT03829501|529590491|FG000|Overall Study|Death|2|||
146841585|NCT03829501|529590492|FG001|Overall Study|Death|4|||
146841586|NCT03829501|529590493|FG002|Overall Study|Death|5|||
146841587|NCT03829501|529590494|FG003|Overall Study|Death|6|||
146995451|NCT01389102|530147624|FG004|Overall Study|Adverse Event|2|||
146995452|NCT01389102|530147625|FG005|Overall Study|Adverse Event|2|||
146995453|NCT01389102|530147620|FG000|Overall Study|Hurricane Katrina|4|||
146995454|NCT01389102|530147621|FG001|Overall Study|Hurricane Katrina|2|||
146995455|NCT01389102|530147622|FG002|Overall Study|Hurricane Katrina|3|||
146995456|NCT01389102|530147623|FG003|Overall Study|Hurricane Katrina|0|||
146841588|NCT03829501|529590495|FG004|Overall Study|Death|5|||
146841589|NCT03829501|529590496|FG005|Overall Study|Death|4|||
146841590|NCT03829501|529590497|FG006|Overall Study|Death|5|||
146841591|NCT03829501|529590498|FG007|Overall Study|Death|24|||
146841592|NCT03829501|529590499|FG008|Overall Study|Death|22|||
146841593|NCT03829501|529590500|FG009|Overall Study|Death|6|||
146841594|NCT03829501|529590501|FG010|Overall Study|Death|3|||
146841595|NCT03829501|529590502|FG011|Overall Study|Death|10|||
146841596|NCT03829501|529590503|FG012|Overall Study|Death|10|||
146841597|NCT03829501|529590504|FG013|Overall Study|Death|5|||
146841598|NCT03829501|529590505|FG014|Overall Study|Death|7|||
146995457|NCT01389102|530147624|FG004|Overall Study|Hurricane Katrina|3|||
146841599|NCT03829501|529590506|FG015|Overall Study|Death|2|||
146841600|NCT03829501|529590507|FG016|Overall Study|Death|2|||
146995458|NCT01389102|530147625|FG005|Overall Study|Hurricane Katrina|1|||
146841601|NCT03829501|529590508|FG017|Overall Study|Death|1|||
146841602|NCT03829501|529590509|FG018|Overall Study|Death|1|||
146841603|NCT03829501|529590510|FG019|Overall Study|Death|1|||
146841604|NCT03829501|529590511|FG020|Overall Study|Death|1|||
146841605|NCT03829501|529590512|FG021|Overall Study|Death|2|||
146995459|NCT01389102|530147620|FG000|Overall Study|Lost to Follow-up|4|||
146995460|NCT01389102|530147621|FG001|Overall Study|Lost to Follow-up|1|||
146995461|NCT01389102|530147622|FG002|Overall Study|Lost to Follow-up|1|||
146995462|NCT01389102|530147623|FG003|Overall Study|Lost to Follow-up|2|||
146995463|NCT01389102|530147624|FG004|Overall Study|Lost to Follow-up|4|||
146995464|NCT01389102|530147625|FG005|Overall Study|Lost to Follow-up|1|||
146995465|NCT01389102|530147620|FG000|Overall Study|Protocol Violation|0|||
146995466|NCT01389102|530147621|FG001|Overall Study|Protocol Violation|0|||
146995467|NCT01389102|530147622|FG002|Overall Study|Protocol Violation|3|||
146995468|NCT01389102|530147623|FG003|Overall Study|Protocol Violation|0|||
146995469|NCT01389102|530147624|FG004|Overall Study|Protocol Violation|1|||
146995470|NCT01389102|530147625|FG005|Overall Study|Protocol Violation|1|||
146995471|NCT01389102|530147620|FG000|Overall Study|Withdrawal by Subject|7|||
146995472|NCT01389102|530147621|FG001|Overall Study|Withdrawal by Subject|4|||
146995473|NCT01389102|530147622|FG002|Overall Study|Withdrawal by Subject|9|||
146995474|NCT01389102|530147623|FG003|Overall Study|Withdrawal by Subject|2|||
146995475|NCT01389102|530147624|FG004|Overall Study|Withdrawal by Subject|3|||
146995476|NCT01389102|530147625|FG005|Overall Study|Withdrawal by Subject|3|||
146995477|NCT01389102|530147620|FG000|Overall Study|Subject Traveling Out of Country|0|||
146995478|NCT01389102|530147621|FG001|Overall Study|Subject Traveling Out of Country|0|||
146995479|NCT01389102|530147622|FG002|Overall Study|Subject Traveling Out of Country|0|||
146995480|NCT01389102|530147623|FG003|Overall Study|Subject Traveling Out of Country|1|||
146995481|NCT01389102|530147624|FG004|Overall Study|Subject Traveling Out of Country|0|||
146995482|NCT01389102|530147625|FG005|Overall Study|Subject Traveling Out of Country|0|||
146995483|NCT01389102|530147620|FG000|Overall Study|Subject Moved|2|||
146995484|NCT01389102|530147621|FG001|Overall Study|Subject Moved|0|||
146995485|NCT01389102|530147622|FG002|Overall Study|Subject Moved|1|||
146995486|NCT01389102|530147623|FG003|Overall Study|Subject Moved|0|||
146995487|NCT01389102|530147624|FG004|Overall Study|Subject Moved|0|||
146995488|NCT01389102|530147625|FG005|Overall Study|Subject Moved|0|||
146995489|NCT01389102|530147620|FG000|Overall Study|Unavailable due to husband's illness|0|||
146995490|NCT01389102|530147621|FG001|Overall Study|Unavailable due to husband's illness|1|||
146995491|NCT01389102|530147622|FG002|Overall Study|Unavailable due to husband's illness|0|||
146995492|NCT01389102|530147623|FG003|Overall Study|Unavailable due to husband's illness|0|||
146995493|NCT01389102|530147624|FG004|Overall Study|Unavailable due to husband's illness|0|||
146995494|NCT01389102|530147625|FG005|Overall Study|Unavailable due to husband's illness|0|||
146995495|NCT01389102|530147620|FG000|Overall Study|Investigator Judgement|0|||
146995496|NCT01389102|530147621|FG001|Overall Study|Investigator Judgement|1|||
146995497|NCT01389102|530147622|FG002|Overall Study|Investigator Judgement|0|||
146995498|NCT01389102|530147623|FG003|Overall Study|Investigator Judgement|0|||
146995499|NCT01389102|530147624|FG004|Overall Study|Investigator Judgement|0|||
146995500|NCT01389102|530147625|FG005|Overall Study|Investigator Judgement|0|||
146995501|NCT03450070|530147626|FG000|Overall Study|Withdrawal by Subject|8|||
146995502|NCT00050778|530147627|FG000|Overall Study|Adverse Event|13|||
146995503|NCT00050778|530147628|FG001|Overall Study|Adverse Event|3|||
146995504|NCT00050778|530147629|FG002|Overall Study|Adverse Event|2|||
146995505|NCT00050778|530147627|FG000|Overall Study|Death|0|||
146995506|NCT00050778|530147628|FG001|Overall Study|Death|1|||
146995507|NCT00050778|530147629|FG002|Overall Study|Death|1|||
146995508|NCT00050778|530147627|FG000|Overall Study|Lack of Efficacy|16|||
146995509|NCT00050778|530147628|FG001|Overall Study|Lack of Efficacy|2|||
146995510|NCT00050778|530147629|FG002|Overall Study|Lack of Efficacy|2|||
146995511|NCT00050778|530147627|FG000|Overall Study|Lost to Follow-up|0|||
146995512|NCT00050778|530147628|FG001|Overall Study|Lost to Follow-up|2|||
146995513|NCT00050778|530147629|FG002|Overall Study|Lost to Follow-up|4|||
146995514|NCT00050778|530147627|FG000|Overall Study|Physician Decision|3|||
146995515|NCT00050778|530147628|FG001|Overall Study|Physician Decision|0|||
146995516|NCT00050778|530147629|FG002|Overall Study|Physician Decision|2|||
146841606|NCT03829501|529590513|FG022|Overall Study|Death|3|||
146995517|NCT00050778|530147627|FG000|Overall Study|Protocol Violation|2|||
146995518|NCT00050778|530147628|FG001|Overall Study|Protocol Violation|0|||
146995519|NCT00050778|530147629|FG002|Overall Study|Protocol Violation|1|||
146995520|NCT00050778|530147627|FG000|Overall Study|Withdrawal by Subject|6|||
146995521|NCT00050778|530147628|FG001|Overall Study|Withdrawal by Subject|8|||
146995522|NCT00050778|530147629|FG002|Overall Study|Withdrawal by Subject|4|||
146995523|NCT00050778|530147627|FG000|Overall Study|Randomized but not treated|4|||
146995524|NCT00050778|530147628|FG001|Overall Study|Randomized but not treated|5|||
146841607|NCT03829501|529590491|FG000|Overall Study|Miscellaneous|0|||
146841608|NCT03829501|529590492|FG001|Overall Study|Miscellaneous|0|||
146995525|NCT00050778|530147629|FG002|Overall Study|Randomized but not treated|2|||
146995526|NCT00050778|530147627|FG000|Overall Study|Familial and personal reasons|1|||
146841609|NCT03829501|529590493|FG002|Overall Study|Miscellaneous|1|||
146841610|NCT03829501|529590494|FG003|Overall Study|Miscellaneous|0|||
146995527|NCT00050778|530147628|FG001|Overall Study|Familial and personal reasons|0|||
146995528|NCT00050778|530147629|FG002|Overall Study|Familial and personal reasons|0|||
146841611|NCT03829501|529590495|FG004|Overall Study|Miscellaneous|0|||
146841612|NCT03829501|529590496|FG005|Overall Study|Miscellaneous|0|||
146841613|NCT03829501|529590497|FG006|Overall Study|Miscellaneous|0|||
146841614|NCT03829501|529590498|FG007|Overall Study|Miscellaneous|1|||
146841615|NCT03829501|529590499|FG008|Overall Study|Miscellaneous|0|||
146841616|NCT03829501|529590500|FG009|Overall Study|Miscellaneous|0|||
146841617|NCT03829501|529590501|FG010|Overall Study|Miscellaneous|0|||
146995529|NCT02910037|530147632|FG000|Overall Study|Withdrawal by Subject|4|||
146995530|NCT02910037|530147632|FG000|Overall Study|Lost to Follow-up|6|||
146995531|NCT00436553|530147633|FG000|Overall Study|Adverse Event|4|||
146995532|NCT00436553|530147634|FG001|Overall Study|Adverse Event|3|||
146995533|NCT00436553|530147635|FG002|Overall Study|Adverse Event|4|||
146995534|NCT00436553|530147633|FG000|Overall Study|Death|3|||
146995535|NCT00436553|530147634|FG001|Overall Study|Death|1|||
146995536|NCT00436553|530147635|FG002|Overall Study|Death|3|||
146995537|NCT00436553|530147633|FG000|Overall Study|Lost to Follow-up|0|||
146995538|NCT00436553|530147634|FG001|Overall Study|Lost to Follow-up|2|||
146995539|NCT00436553|530147635|FG002|Overall Study|Lost to Follow-up|0|||
146995540|NCT00436553|530147633|FG000|Overall Study|Protocol Violation|1|||
146995541|NCT00436553|530147634|FG001|Overall Study|Protocol Violation|0|||
146841618|NCT03829501|529590502|FG011|Overall Study|Miscellaneous|0|||
146841619|NCT03829501|529590503|FG012|Overall Study|Miscellaneous|0|||
146841620|NCT03829501|529590504|FG013|Overall Study|Miscellaneous|0|||
146841621|NCT03829501|529590505|FG014|Overall Study|Miscellaneous|0|||
146841622|NCT03829501|529590506|FG015|Overall Study|Miscellaneous|0|||
146841623|NCT03829501|529590507|FG016|Overall Study|Miscellaneous|0|||
146841624|NCT03829501|529590508|FG017|Overall Study|Miscellaneous|0|||
146841625|NCT03829501|529590509|FG018|Overall Study|Miscellaneous|0|||
146841626|NCT03829501|529590510|FG019|Overall Study|Miscellaneous|0|||
146995542|NCT00436553|530147635|FG002|Overall Study|Protocol Violation|0|||
146995543|NCT00436553|530147633|FG000|Overall Study|Withdrawal by Subject|5|||
146995544|NCT00436553|530147634|FG001|Overall Study|Withdrawal by Subject|6|||
146995545|NCT00436553|530147635|FG002|Overall Study|Withdrawal by Subject|3|||
146995546|NCT01035060|530147636|FG000|Overall Study|Lost to Follow-up|0|||
146995547|NCT01035060|530147637|FG001|Overall Study|Lost to Follow-up|7|||
146995548|NCT01035060|530147636|FG000|Overall Study|Did not quality after 2nd screening|14|||
146995549|NCT01035060|530147637|FG001|Overall Study|Did not quality after 2nd screening|1|||
146995550|NCT01035060|530147636|FG000|Overall Study|Withdrawal by Subject|8|||
146995551|NCT01035060|530147637|FG001|Overall Study|Withdrawal by Subject|6|||
146995552|NCT01035060|530147636|FG000|Overall Study|Physician Decision|2|||
146995553|NCT01035060|530147637|FG001|Overall Study|Physician Decision|0|||
146995554|NCT00064753|530147639|FG000|Overall Study|Death|251|||
146995555|NCT00064753|530147640|FG001|Overall Study|Death|242|||
146995556|NCT00064753|530147639|FG000|Overall Study|Withdrawal by Subject|198|||
146995557|NCT00064753|530147640|FG001|Overall Study|Withdrawal by Subject|171|||
146995558|NCT00064753|530147639|FG000|Overall Study|Lost to Follow-up|225|||
146995559|NCT00064753|530147640|FG001|Overall Study|Lost to Follow-up|235|||
146995560|NCT02193880|530147643|FG000|Overall Study|patients did not collect enough HPC|3|||
146995561|NCT03522675|530147644|FG000|Overall Study|Screen fail|1|||
146995562|NCT03522675|530147644|FG000|Overall Study|Non-reactive to histamine|1|||
146995563|NCT00707161|530147645|FG000|Overall Study|Physician Decision|6|||
146995564|NCT02674477|530147646|FG000|Overall Study|Protocol Violation|8|||
146995565|NCT02674477|530147647|FG001|Overall Study|Protocol Violation|2|||
146995566|NCT00296647|530147648|FG000|Overall Study|Death|4|||
146995567|NCT00296647|530147649|FG001|Overall Study|Death|1|||
146995568|NCT00296647|530147650|FG002|Overall Study|Death|2|||
146995569|NCT00296647|530147651|FG003|Overall Study|Death|1|||
146995570|NCT00296647|530147652|FG004|Overall Study|Death|1|||
146995571|NCT00296647|530147648|FG000|Overall Study|Withdrawal by Subject|28|||
146995572|NCT00296647|530147649|FG001|Overall Study|Withdrawal by Subject|27|||
146995573|NCT00296647|530147650|FG002|Overall Study|Withdrawal by Subject|32|||
146995574|NCT00296647|530147651|FG003|Overall Study|Withdrawal by Subject|16|||
146995575|NCT00296647|530147652|FG004|Overall Study|Withdrawal by Subject|19|||
146995576|NCT00565448|530147653|FG000|Overall Study|Adverse Event|1|||
146995577|NCT00565448|530147654|FG001|Overall Study|Adverse Event|2|||
146995578|NCT00565448|530147653|FG000|Overall Study|Disease progression|1|||
146995579|NCT00565448|530147654|FG001|Overall Study|Disease progression|0|||
146995580|NCT00565448|530147653|FG000|Overall Study|Withdrawal by Subject|1|||
146841627|NCT03829501|529590511|FG020|Overall Study|Miscellaneous|0|||
146841628|NCT03829501|529590512|FG021|Overall Study|Miscellaneous|0|||
146841629|NCT03829501|529590513|FG022|Overall Study|Miscellaneous|1|||
146995581|NCT00565448|530147654|FG001|Overall Study|Withdrawal by Subject|0|||
146995582|NCT01863745|530147655|FG000|Overall Study|Disease Progression|9|||
146995583|NCT01863745|530147655|FG000|Overall Study|Adverse Event|2|||
146995584|NCT01863745|530147655|FG000|Overall Study|Death|1|||
146995585|NCT01863745|530147655|FG000|Overall Study|Withdrawal by Subject|1|||
146995586|NCT00193609|530147656|FG000|Overall Study|Lack of Efficacy|2|||
146995587|NCT00193609|530147656|FG000|Overall Study|Adverse Event|2|||
146841630|NCT03301155|529590523|FG000|Overall Study|Сompliance with exclusion criteria|8|||
146841631|NCT03301155|529590524|FG001|Overall Study|Сompliance with exclusion criteria|7|||
146841632|NCT01685229|529590531|FG000|Overall Study|Subjects missing Study Exit form|3|||
146841633|NCT01685229|529590532|FG001|Overall Study|Subjects missing Study Exit form|1|||
146841634|NCT01685229|529590531|FG000|Overall Study|Lost to Follow-up|16|||
146841635|NCT01685229|529590532|FG001|Overall Study|Lost to Follow-up|10|||
146841636|NCT01685229|529590531|FG000|Overall Study|Withdrawal by Subject|6|||
146841637|NCT01685229|529590532|FG001|Overall Study|Withdrawal by Subject|5|||
146841638|NCT01685229|529590531|FG000|Overall Study|Death|1|||
146841639|NCT01685229|529590532|FG001|Overall Study|Death|0|||
146841640|NCT02964325|529590538|FG000|Overall Study|Lost to Follow-up|3|||
146841641|NCT02964325|529590539|FG001|Overall Study|Lost to Follow-up|3|||
146841642|NCT02964325|529590538|FG000|Overall Study|Physician Decision|5|||
146841643|NCT02964325|529590539|FG001|Overall Study|Physician Decision|4|||
146841644|NCT02964325|529590538|FG000|Overall Study|Death|1|||
146841645|NCT02964325|529590539|FG001|Overall Study|Death|3|||
146841646|NCT02964325|529590538|FG000|Overall Study|Withdrawal by Subject|2|||
146841647|NCT02964325|529590539|FG001|Overall Study|Withdrawal by Subject|1|||
146841648|NCT02964325|529590538|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
146841649|NCT02964325|529590539|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
146841650|NCT01371825|529590544|FG000|Overall Study|Death|4|||
146841651|NCT00534495|529590545|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
146841652|NCT00534495|529590546|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
146841653|NCT00534495|529590547|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
146841654|NCT00534495|529590545|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
146841655|NCT00534495|529590546|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
146841656|NCT00534495|529590547|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
146841657|NCT00534495|529590545|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
146841658|NCT00534495|529590546|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
146841659|NCT00534495|529590547|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
146841660|NCT00534495|529590545|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
146841661|NCT00534495|529590546|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
146841662|NCT00534495|529590547|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
146841663|NCT00534495|529590545|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
146841664|NCT00534495|529590546|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
146841665|NCT00534495|529590547|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
146841666|NCT00534495|529590545|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
146841667|NCT00534495|529590546|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
146841668|NCT00534495|529590547|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
146841669|NCT00534495|529590545|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
146841670|NCT00534495|529590546|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
146841671|NCT00534495|529590547|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
146841672|NCT00534495|529590545|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
146841673|NCT00534495|529590546|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
146841674|NCT00534495|529590547|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
146841675|NCT00534495|529590545|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
146841676|NCT00534495|529590546|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
146841677|NCT00534495|529590547|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
146841678|NCT04868539|529590548|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
146841679|NCT04868539|529590549|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
146961417|NCT04145531|530018159|FG000|Part A|Death|1|||
146961418|NCT04145531|530018160|FG001|Part A|Death|2|||
146961419|NCT04145531|530018161|FG002|Part A|Death|0|||
146961420|NCT04145531|530018162|FG003|Part A|Death|0|||
146961421|NCT04145531|530018159|FG000|Part A|Physician Decision|2|||
146961422|NCT04145531|530018160|FG001|Part A|Physician Decision|5|||
146961423|NCT04145531|530018161|FG002|Part A|Physician Decision|2|||
146961424|NCT04145531|530018162|FG003|Part A|Physician Decision|0|||
146961425|NCT04145531|530018159|FG000|Part A|Progressive disease|0|||
146961426|NCT04145531|530018160|FG001|Part A|Progressive disease|2|||
146961427|NCT04145531|530018161|FG002|Part A|Progressive disease|1|||
146961428|NCT04145531|530018162|FG003|Part A|Progressive disease|0|||
146961429|NCT04145531|530018159|FG000|Part A|Protocol deviation|0|||
146961430|NCT04145531|530018160|FG001|Part A|Protocol deviation|0|||
146841680|NCT01038427|529590550|FG000|Overall Study|Lost to follow up|1|||
146961431|NCT04145531|530018161|FG002|Part A|Protocol deviation|1|||
146961432|NCT04145531|530018162|FG003|Part A|Protocol deviation|0|||
146961433|NCT04145531|530018159|FG000|Part A|Withdrawal by parent or guardian|1|||
146961434|NCT04145531|530018160|FG001|Part A|Withdrawal by parent or guardian|0|||
146961435|NCT04145531|530018161|FG002|Part A|Withdrawal by parent or guardian|0|||
146961436|NCT04145531|530018162|FG003|Part A|Withdrawal by parent or guardian|0|||
146961437|NCT04145531|530018159|FG000|Part A|Withdrawal by participant|0|||
146995588|NCT00735904|530147658|FG000|Overall Study|Adverse Event|3|||
146841681|NCT01038427|529590551|FG001|Overall Study|Lost to follow up|1|||
146841682|NCT01038427|529590552|FG002|Overall Study|Lost to follow up|0|||
146841683|NCT01038427|529590550|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
146841684|NCT01038427|529590551|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
146841685|NCT01038427|529590552|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
146841686|NCT01038427|529590550|FG000|Overall Study|Withdrew consent|0|||
146841687|NCT01038427|529590551|FG001|Overall Study|Withdrew consent|0|||
146841688|NCT01038427|529590552|FG002|Overall Study|Withdrew consent|1|||
146841689|NCT01038427|529590550|FG000|Overall Study|Adverse Event|2|||
146841690|NCT01038427|529590551|FG001|Overall Study|Adverse Event|2|||
146841691|NCT01038427|529590552|FG002|Overall Study|Adverse Event|1|||
146841692|NCT01038427|529590550|FG000|Overall Study|Enrolled in error|0|||
146841693|NCT01038427|529590551|FG001|Overall Study|Enrolled in error|1|||
146841694|NCT01038427|529590552|FG002|Overall Study|Enrolled in error|1|||
146841695|NCT01038427|529590550|FG000|Overall Study|Other|0|||
146841696|NCT01038427|529590551|FG001|Overall Study|Other|2|||
146841697|NCT01038427|529590552|FG002|Overall Study|Other|0|||
146841698|NCT00604708|529590553|FG000|Overall Study|Withdrawal by Subject|9|||
146841699|NCT00604708|529590554|FG001|Overall Study|Withdrawal by Subject|10|||
146841700|NCT00604708|529590553|FG000|Overall Study|Protocol Violation|2|||
146841701|NCT00604708|529590554|FG001|Overall Study|Protocol Violation|8|||
146841702|NCT00604708|529590553|FG000|Overall Study|Lost to Follow-up|5|||
146841703|NCT00604708|529590554|FG001|Overall Study|Lost to Follow-up|5|||
146841704|NCT00604708|529590553|FG000|Overall Study|administrative reasons|9|||
146841705|NCT00604708|529590554|FG001|Overall Study|administrative reasons|11|||
146841706|NCT00604708|529590553|FG000|Overall Study|Adverse Event|6|||
146841707|NCT00604708|529590554|FG001|Overall Study|Adverse Event|6|||
146841708|NCT03995316|529590555|FG000|Overall Study|Lost to Follow-up|10|||
146841709|NCT03995316|529590556|FG001|Overall Study|Lost to Follow-up|3|||
146841710|NCT00415051|529590558|FG000|Overall Study|Protocol Violation|1|||
146841711|NCT03197766|529590559|FG000|Overall Study|Withdrawal by Subject|2|||
146841712|NCT03197766|529590560|FG001|Overall Study|Withdrawal by Subject|0|||
146841713|NCT01436253|529590561|FG000|Overall Study|Lost to Follow-up|182|||
146841714|NCT01436253|529590561|FG000|Overall Study|Not meeting all eligibility criteria|117|||
146841715|NCT03083665|529590563|FG000|Double-Blind Period|Adverse Event|5|||
146841716|NCT03083665|529590564|FG001|Double-Blind Period|Adverse Event|4|||
146841717|NCT03083665|529590565|FG002|Double-Blind Period|Adverse Event|5|||
146841718|NCT03083665|529590566|FG003|Double-Blind Period|Adverse Event|0|||
146841719|NCT03083665|529590567|FG004|Double-Blind Period|Adverse Event|0|||
146841720|NCT03083665|529590568|FG005|Double-Blind Period|Adverse Event|0|||
146841721|NCT03083665|529590563|FG000|Double-Blind Period|Lack of Efficacy|0|||
146841722|NCT03083665|529590564|FG001|Double-Blind Period|Lack of Efficacy|0|||
146841723|NCT03083665|529590565|FG002|Double-Blind Period|Lack of Efficacy|1|||
146841724|NCT03083665|529590566|FG003|Double-Blind Period|Lack of Efficacy|0|||
146841725|NCT03083665|529590567|FG004|Double-Blind Period|Lack of Efficacy|0|||
146841726|NCT03083665|529590568|FG005|Double-Blind Period|Lack of Efficacy|0|||
146841727|NCT03083665|529590563|FG000|Double-Blind Period|Protocol Violation|1|||
146841728|NCT03083665|529590564|FG001|Double-Blind Period|Protocol Violation|0|||
146841729|NCT03083665|529590565|FG002|Double-Blind Period|Protocol Violation|1|||
146841730|NCT03083665|529590566|FG003|Double-Blind Period|Protocol Violation|0|||
146841731|NCT03083665|529590567|FG004|Double-Blind Period|Protocol Violation|0|||
146841732|NCT03083665|529590568|FG005|Double-Blind Period|Protocol Violation|0|||
146841733|NCT03083665|529590563|FG000|Double-Blind Period|Lost to Follow-up|1|||
146841734|NCT03083665|529590564|FG001|Double-Blind Period|Lost to Follow-up|0|||
146841735|NCT03083665|529590565|FG002|Double-Blind Period|Lost to Follow-up|1|||
146841736|NCT03083665|529590566|FG003|Double-Blind Period|Lost to Follow-up|0|||
146841737|NCT03083665|529590567|FG004|Double-Blind Period|Lost to Follow-up|0|||
146841738|NCT03083665|529590568|FG005|Double-Blind Period|Lost to Follow-up|0|||
146841739|NCT03083665|529590563|FG000|Double-Blind Period|Withdrawal by Subject|3|||
146841740|NCT03083665|529590564|FG001|Double-Blind Period|Withdrawal by Subject|0|||
146841741|NCT03083665|529590565|FG002|Double-Blind Period|Withdrawal by Subject|0|||
146841742|NCT03083665|529590566|FG003|Double-Blind Period|Withdrawal by Subject|0|||
146841743|NCT03083665|529590567|FG004|Double-Blind Period|Withdrawal by Subject|0|||
146841744|NCT03083665|529590568|FG005|Double-Blind Period|Withdrawal by Subject|0|||
146841745|NCT03083665|529590563|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
146841746|NCT03083665|529590564|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
146841747|NCT03083665|529590565|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
146841748|NCT03083665|529590566|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
146841749|NCT03083665|529590567|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
146841750|NCT03083665|529590568|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
146841751|NCT03083665|529590563|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
146841752|NCT03083665|529590564|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
146841753|NCT03083665|529590565|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
146841754|NCT03083665|529590566|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
146841755|NCT03083665|529590567|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
146841756|NCT03083665|529590568|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
146841757|NCT03083665|529590563|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
146841758|NCT03083665|529590564|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
146841759|NCT03083665|529590565|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
146841760|NCT03083665|529590566|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
146841761|NCT03083665|529590567|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
146841762|NCT03083665|529590568|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
146841763|NCT03083665|529590563|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
146841764|NCT03083665|529590564|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
146841765|NCT03083665|529590565|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
146841766|NCT03083665|529590566|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
146841767|NCT03083665|529590567|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
146841768|NCT03083665|529590568|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
146841769|NCT03083665|529590563|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
146841770|NCT03083665|529590564|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
146841771|NCT03083665|529590565|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
146841772|NCT03083665|529590566|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
146841773|NCT03083665|529590567|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
146841774|NCT03083665|529590568|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
146841775|NCT03083665|529590563|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
146841776|NCT03083665|529590564|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
146841777|NCT03083665|529590565|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
146841778|NCT03083665|529590566|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
146841779|NCT03083665|529590567|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
146841780|NCT03083665|529590568|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
146841781|NCT03083665|529590563|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
146841782|NCT03083665|529590564|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
146841783|NCT03083665|529590565|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
146841784|NCT03083665|529590566|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
146841785|NCT03083665|529590567|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
146841786|NCT03083665|529590568|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
146841787|NCT03083665|529590563|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
146841788|NCT03083665|529590564|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
146841789|NCT03083665|529590565|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
146841790|NCT03083665|529590566|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
146841791|NCT03083665|529590567|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
146841792|NCT03083665|529590568|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
146841793|NCT03083665|529590563|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
146841794|NCT03083665|529590564|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
146841795|NCT03083665|529590565|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
146841796|NCT03083665|529590566|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
146841797|NCT03083665|529590567|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
146841798|NCT03083665|529590568|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
146841799|NCT06285240|529590569|FG000|Overall Study|Withdrawal by Subject|2|||
146841800|NCT06285240|529590570|FG001|Overall Study|Withdrawal by Subject|0|||
146841801|NCT06285240|529590571|FG002|Overall Study|Withdrawal by Subject|0|||
146841802|NCT06285240|529590572|FG003|Overall Study|Withdrawal by Subject|0|||
146841803|NCT06285240|529590569|FG000|Overall Study|Serious Adverse Event|0|||
146841804|NCT06285240|529590570|FG001|Overall Study|Serious Adverse Event|0|||
146841805|NCT06285240|529590571|FG002|Overall Study|Serious Adverse Event|1|||
146841806|NCT06285240|529590572|FG003|Overall Study|Serious Adverse Event|0|||
146961438|NCT04145531|530018160|FG001|Part A|Withdrawal by participant|0|||
146961439|NCT04145531|530018161|FG002|Part A|Withdrawal by participant|1|||
146961440|NCT04145531|530018162|FG003|Part A|Withdrawal by participant|0|||
146961441|NCT04145531|530018159|FG000|Part A|Other|0|||
146961442|NCT04145531|530018160|FG001|Part A|Other|0|||
146841807|NCT05140915|529590573|FG000|Overall Study|Lost to Follow-up|2|||
146841808|NCT05140915|529590574|FG001|Overall Study|Lost to Follow-up|1|||
146841809|NCT04485611|529590575|FG000|Prehabilitation|Physician Decision|1|||
146841810|NCT03361865|529590576|FG000|Overall Study|Death|17|||
146841811|NCT03361865|529590577|FG001|Overall Study|Death|18|||
146961443|NCT04145531|530018161|FG002|Part A|Other|1|||
146961444|NCT04145531|530018162|FG003|Part A|Other|0|||
146961445|NCT04145531|530018159|FG000|Part B|Adverse Event|0|||
146961446|NCT04145531|530018160|FG001|Part B|Adverse Event|0|||
146841812|NCT03361865|529590576|FG000|Overall Study|Physician Decision|1|||
146841813|NCT03361865|529590577|FG001|Overall Study|Physician Decision|9|||
146841814|NCT03361865|529590576|FG000|Overall Study|Withdrawal by Subject|1|||
146841815|NCT03361865|529590577|FG001|Overall Study|Withdrawal by Subject|0|||
146841816|NCT04201262|529590579|FG000|Primary Treatment Period|Adverse Event|1|||
146841817|NCT04201262|529590580|FG001|Primary Treatment Period|Adverse Event|2|||
146841818|NCT04201262|529590579|FG000|Primary Treatment Period|Physician Decision|1|||
146841819|NCT04201262|529590580|FG001|Primary Treatment Period|Physician Decision|1|||
146841820|NCT04201262|529590579|FG000|Long-term Extension Period|Death|1|||
146841821|NCT04201262|529590580|FG001|Long-term Extension Period|Death|0|||
146841822|NCT02819024|529590582|FG000|Overall Study|Withdrawal by Subject|1|||
146841823|NCT05576662|529590583|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
146841824|NCT05576662|529590584|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
146841825|NCT05576662|529590583|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
146841826|NCT05576662|529590584|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
146841827|NCT05576662|529590583|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
146841828|NCT05576662|529590584|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
146841829|NCT05576662|529590583|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
146841830|NCT05576662|529590584|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
146841831|NCT05217641|529590589|FG000|Overall Study|Lost to Follow-up|1|||
146841832|NCT05217641|529590590|FG001|Overall Study|Lost to Follow-up|1|||
146841833|NCT05217641|529590591|FG002|Overall Study|Lost to Follow-up|0|||
146841834|NCT05217641|529590592|FG003|Overall Study|Lost to Follow-up|1|||
146841835|NCT05217641|529590593|FG004|Overall Study|Lost to Follow-up|1|||
146841836|NCT05217641|529590594|FG005|Overall Study|Lost to Follow-up|0|||
146841837|NCT05217641|529590589|FG000|Overall Study|Withdrawal by Subject|0|||
146841838|NCT05217641|529590590|FG001|Overall Study|Withdrawal by Subject|0|||
146841839|NCT05217641|529590591|FG002|Overall Study|Withdrawal by Subject|0|||
146841840|NCT05217641|529590592|FG003|Overall Study|Withdrawal by Subject|3|||
146841841|NCT05217641|529590593|FG004|Overall Study|Withdrawal by Subject|1|||
146841842|NCT05217641|529590594|FG005|Overall Study|Withdrawal by Subject|0|||
146841843|NCT05217641|529590589|FG000|Overall Study|Other: participant did not specify reason|0|||
146841844|NCT05217641|529590590|FG001|Overall Study|Other: participant did not specify reason|0|||
146841845|NCT05217641|529590591|FG002|Overall Study|Other: participant did not specify reason|0|||
146841846|NCT05217641|529590592|FG003|Overall Study|Other: participant did not specify reason|0|||
146841847|NCT05217641|529590593|FG004|Overall Study|Other: participant did not specify reason|1|||
146841848|NCT05217641|529590594|FG005|Overall Study|Other: participant did not specify reason|0|||
146841849|NCT05217641|529590589|FG000|Overall Study|Extended Follow up|1|||
146841850|NCT05217641|529590590|FG001|Overall Study|Extended Follow up|1|||
146841851|NCT05217641|529590591|FG002|Overall Study|Extended Follow up|0|||
146841852|NCT05217641|529590592|FG003|Overall Study|Extended Follow up|0|||
146841853|NCT05217641|529590593|FG004|Overall Study|Extended Follow up|1|||
146841854|NCT05217641|529590594|FG005|Overall Study|Extended Follow up|0|||
146841855|NCT05292586|529590595|FG000|Overall Study|Withdrawal by Subject|3|||
146841856|NCT05292586|529590596|FG001|Overall Study|Withdrawal by Subject|10|||
146841857|NCT05292586|529590595|FG000|Overall Study|Randomization error|3|||
146841858|NCT05292586|529590596|FG001|Overall Study|Randomization error|7|||
146841859|NCT05292586|529590595|FG000|Overall Study|Adverse Event|3|||
146841860|NCT05292586|529590596|FG001|Overall Study|Adverse Event|0|||
146841861|NCT05292586|529590595|FG000|Overall Study|Lost to Follow-up|0|||
146841862|NCT05292586|529590596|FG001|Overall Study|Lost to Follow-up|1|||
146841863|NCT05292586|529590595|FG000|Overall Study|Patient refused treatment|1|||
146841864|NCT05292586|529590596|FG001|Overall Study|Patient refused treatment|0|||
146841865|NCT05292586|529590595|FG000|Overall Study|Patient could not travel to the study site|1|||
146841866|NCT05292586|529590596|FG001|Overall Study|Patient could not travel to the study site|0|||
146841867|NCT05292586|529590595|FG000|Overall Study|Technical issues with the masterscope|0|||
146841868|NCT05292586|529590596|FG001|Overall Study|Technical issues with the masterscope|3|||
146841869|NCT05292586|529590595|FG000|Overall Study|Patient moved to a different state|0|||
146841870|NCT05292586|529590596|FG001|Overall Study|Patient moved to a different state|1|||
146841871|NCT03633799|529590613|FG000|Overall Study|Adverse Event|349|||
146995589|NCT00735904|530147658|FG000|Overall Study|Death|20|||
146841872|NCT03633799|529590613|FG000|Overall Study|Withdrawal by Subject|288|||
146841873|NCT03633799|529590613|FG000|Overall Study|Lost to Follow-up|97|||
146841874|NCT03633799|529590613|FG000|Overall Study|Physician Decision|9|||
146841875|NCT03633799|529590613|FG000|Overall Study|Protocol Violation|4|||
146841876|NCT03633799|529590613|FG000|Overall Study|Pregnancy|20|||
146841877|NCT03633799|529590613|FG000|Overall Study|other|39|||
146841878|NCT03633799|529590613|FG000|Overall Study|ongoing within third year of study|106|||
146841879|NCT03633799|529590613|FG000|Overall Study|unsuccessful study drug placement|19|||
146841880|NCT02477618|529590616|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
146841881|NCT02477618|529590617|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
146841882|NCT02477618|529590616|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
146995590|NCT00735904|530147658|FG000|Overall Study|Protocol Violation|1|||
146841883|NCT02477618|529590617|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
146841884|NCT02477618|529590616|FG000|Overall Study|Adverse Event|1|||
146841885|NCT02477618|529590617|FG001|Overall Study|Adverse Event|1|||
146841886|NCT02477618|529590616|FG000|Overall Study|Transferred Away from Study Site|1|||
146841887|NCT02477618|529590617|FG001|Overall Study|Transferred Away from Study Site|0|||
146841888|NCT02477618|529590616|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
146841889|NCT02477618|529590617|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
146841890|NCT02446821|529590618|FG000|Overall Study|Adverse Event|28|||
146841891|NCT02446821|529590618|FG000|Overall Study|Withdrawal by Subject|6|||
146841892|NCT02446821|529590618|FG000|Overall Study|Lost to Follow-up|22|||
146841893|NCT02446821|529590618|FG000|Overall Study|other|9|||
146841894|NCT02446821|529590618|FG000|Overall Study|insertion failure|3|||
146841895|NCT03007420|529590619|FG000|Overall Study|Withdrawal by Subject|0|||
146841896|NCT03007420|529590620|FG001|Overall Study|Withdrawal by Subject|2|||
146841897|NCT03007420|529590619|FG000|Overall Study|Physician Decision|0|||
146841898|NCT03007420|529590620|FG001|Overall Study|Physician Decision|1|||
146841899|NCT02284009|529590623|FG000|Overall Study|Adverse Event|3|||
146841900|NCT02284009|529590624|FG001|Overall Study|Adverse Event|0|||
146841901|NCT02284009|529590623|FG000|Overall Study|Lost to Follow-up|1|||
146841902|NCT02284009|529590624|FG001|Overall Study|Lost to Follow-up|3|||
146841903|NCT02284009|529590623|FG000|Overall Study|Physician Decision|0|||
146841904|NCT02284009|529590624|FG001|Overall Study|Physician Decision|2|||
146841905|NCT02284009|529590623|FG000|Overall Study|Withdrawal by Subject|2|||
146841906|NCT02284009|529590624|FG001|Overall Study|Withdrawal by Subject|5|||
146841907|NCT02397447|529590625|FG000|Overall Study|Lost to Follow-up|2|||
146841908|NCT02397447|529590626|FG001|Overall Study|Lost to Follow-up|2|||
146841909|NCT02994069|529590627|FG000|Overall Study|Death|7|||
146841910|NCT02994069|529590628|FG001|Overall Study|Death|13|||
146841911|NCT02994069|529590627|FG000|Overall Study|Adverse Event|1|||
146841912|NCT02994069|529590628|FG001|Overall Study|Adverse Event|0|||
146841913|NCT02994069|529590627|FG000|Overall Study|Other|2|||
146841914|NCT02994069|529590628|FG001|Overall Study|Other|0|||
146841915|NCT02994069|529590627|FG000|Overall Study|still on follow up/treatment|5|||
146841916|NCT02994069|529590628|FG001|Overall Study|still on follow up/treatment|6|||
146841917|NCT05823012|529590629|FG000|Titration Period|Adverse Event|1|||
146841918|NCT05823012|529590629|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
146841919|NCT05823012|529590629|FG000|Maintenance Period|Adverse Event|1|||
146841920|NCT05823012|529590629|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
146841921|NCT05823012|529590629|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
146841922|NCT00747227|529592052|FG000|Overall Study|Death|3|||
146841923|NCT00747227|529592053|FG001|Overall Study|Death|1|||
146841924|NCT00747227|529592052|FG000|Overall Study|Withdrawal by Subject|1|||
146841925|NCT00747227|529592053|FG001|Overall Study|Withdrawal by Subject|0|||
146841926|NCT00747227|529592052|FG000|Overall Study|Lost to Follow-up|1|||
146841927|NCT00747227|529592053|FG001|Overall Study|Lost to Follow-up|2|||
146841928|NCT00747227|529592052|FG000|Overall Study|Illness|1|||
146841929|NCT00747227|529592053|FG001|Overall Study|Illness|1|||
146841930|NCT03554629|529592054|FG000|Overall Study|Inadequate data|6|||
146841931|NCT00663702|529592059|FG000|Overall Study|Adverse Event|8|||
146841932|NCT00663702|529592060|FG001|Overall Study|Adverse Event|4|||
146841933|NCT00663702|529592059|FG000|Overall Study|Withdrawal by Subject|3|||
146841934|NCT00663702|529592060|FG001|Overall Study|Withdrawal by Subject|1|||
146841935|NCT00663702|529592059|FG000|Overall Study|Pregnancy|0|||
146841936|NCT00663702|529592060|FG001|Overall Study|Pregnancy|1|||
146841937|NCT00663702|529592059|FG000|Overall Study|Lost to Follow-up|3|||
146841938|NCT00663702|529592060|FG001|Overall Study|Lost to Follow-up|0|||
146841939|NCT00663702|529592059|FG000|Overall Study|Death|1|||
146841940|NCT00663702|529592060|FG001|Overall Study|Death|1|||
146841941|NCT00663702|529592059|FG000|Overall Study|Lack of Efficacy|3|||
146841942|NCT00663702|529592060|FG001|Overall Study|Lack of Efficacy|3|||
146841943|NCT03056300|529592061|FG000|Overall Study|Surgical reason per study protocol|3|||
146841944|NCT00461981|529592066|FG000|Overall Study|Lost to Follow-up|9|||
146841945|NCT00461981|529592067|FG001|Overall Study|Lost to Follow-up|6|||
146841946|NCT00461981|529592066|FG000|Overall Study|Withdrawal by Subject|2|||
146841947|NCT00461981|529592067|FG001|Overall Study|Withdrawal by Subject|3|||
146841948|NCT01077128|529592070|FG000|Overall Study|Adverse Event|8|||
146841949|NCT01077128|529592070|FG000|Overall Study|Lack of Efficacy|1|||
146841950|NCT01077128|529592070|FG000|Overall Study|Disease exacerbation|1|||
146841951|NCT01077128|529592070|FG000|Overall Study|Adverse event and consent withdrawal|1|||
146841952|NCT01077128|529592070|FG000|Overall Study|Adverse event and disease exacerbation|1|||
146841953|NCT01077128|529592070|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
146841954|NCT01077128|529592070|FG000|Overall Study|Other|54|||
146841955|NCT00847626|529592071|FG000|Overall Study|Adverse Event|10|||
146841956|NCT00847626|529592072|FG001|Overall Study|Adverse Event|10|||
146841957|NCT00847626|529592073|FG002|Overall Study|Adverse Event|6|||
146841958|NCT00847626|529592074|FG003|Overall Study|Adverse Event|19|||
146841959|NCT00847626|529592075|FG004|Overall Study|Adverse Event|11|||
146961447|NCT04145531|530018161|FG002|Part B|Adverse Event|0|||
146841960|NCT00847626|529592076|FG005|Overall Study|Adverse Event|22|||
146841961|NCT00847626|529592077|FG006|Overall Study|Adverse Event|4|||
146841962|NCT00847626|529592078|FG007|Overall Study|Adverse Event|6|||
146841963|NCT00847626|529592079|FG008|Overall Study|Adverse Event|3|||
146841964|NCT00847626|529592080|FG009|Overall Study|Adverse Event|6|||
146841965|NCT00847626|529592081|FG010|Overall Study|Adverse Event|6|||
146841966|NCT00847626|529592071|FG000|Overall Study|Protocol Violation|2|||
146841967|NCT00847626|529592072|FG001|Overall Study|Protocol Violation|1|||
146841968|NCT00847626|529592073|FG002|Overall Study|Protocol Violation|2|||
146841969|NCT00847626|529592074|FG003|Overall Study|Protocol Violation|1|||
146841970|NCT00847626|529592075|FG004|Overall Study|Protocol Violation|1|||
146841971|NCT00847626|529592076|FG005|Overall Study|Protocol Violation|1|||
146841972|NCT00847626|529592077|FG006|Overall Study|Protocol Violation|1|||
146841973|NCT00847626|529592078|FG007|Overall Study|Protocol Violation|1|||
146841974|NCT00847626|529592079|FG008|Overall Study|Protocol Violation|0|||
146841975|NCT00847626|529592080|FG009|Overall Study|Protocol Violation|1|||
146841976|NCT00847626|529592081|FG010|Overall Study|Protocol Violation|1|||
146841977|NCT00847626|529592071|FG000|Overall Study|Lost to Follow-up|0|||
146841978|NCT00847626|529592072|FG001|Overall Study|Lost to Follow-up|1|||
146841979|NCT00847626|529592073|FG002|Overall Study|Lost to Follow-up|1|||
146841980|NCT00847626|529592074|FG003|Overall Study|Lost to Follow-up|1|||
146841981|NCT00847626|529592075|FG004|Overall Study|Lost to Follow-up|0|||
146841982|NCT00847626|529592076|FG005|Overall Study|Lost to Follow-up|3|||
146841983|NCT00847626|529592077|FG006|Overall Study|Lost to Follow-up|1|||
146841984|NCT00847626|529592078|FG007|Overall Study|Lost to Follow-up|3|||
146841985|NCT00847626|529592079|FG008|Overall Study|Lost to Follow-up|1|||
146841986|NCT00847626|529592080|FG009|Overall Study|Lost to Follow-up|0|||
146841987|NCT00847626|529592081|FG010|Overall Study|Lost to Follow-up|1|||
146841988|NCT00847626|529592071|FG000|Overall Study|Withdrawal by Subject|5|||
146841989|NCT00847626|529592072|FG001|Overall Study|Withdrawal by Subject|5|||
146841990|NCT00847626|529592073|FG002|Overall Study|Withdrawal by Subject|3|||
146841991|NCT00847626|529592074|FG003|Overall Study|Withdrawal by Subject|8|||
146841992|NCT00847626|529592075|FG004|Overall Study|Withdrawal by Subject|12|||
146841993|NCT00847626|529592076|FG005|Overall Study|Withdrawal by Subject|9|||
146841994|NCT00847626|529592077|FG006|Overall Study|Withdrawal by Subject|8|||
146841995|NCT00847626|529592078|FG007|Overall Study|Withdrawal by Subject|4|||
146841996|NCT00847626|529592079|FG008|Overall Study|Withdrawal by Subject|4|||
146841997|NCT00847626|529592080|FG009|Overall Study|Withdrawal by Subject|5|||
146841998|NCT00847626|529592081|FG010|Overall Study|Withdrawal by Subject|2|||
146841999|NCT00847626|529592071|FG000|Overall Study|Lack of Efficacy|3|||
146842000|NCT00847626|529592072|FG001|Overall Study|Lack of Efficacy|1|||
146842001|NCT00847626|529592073|FG002|Overall Study|Lack of Efficacy|0|||
146842002|NCT00847626|529592074|FG003|Overall Study|Lack of Efficacy|1|||
146842003|NCT00847626|529592075|FG004|Overall Study|Lack of Efficacy|2|||
146842004|NCT00847626|529592076|FG005|Overall Study|Lack of Efficacy|0|||
146842005|NCT00847626|529592077|FG006|Overall Study|Lack of Efficacy|6|||
146842006|NCT00847626|529592078|FG007|Overall Study|Lack of Efficacy|2|||
146842007|NCT00847626|529592079|FG008|Overall Study|Lack of Efficacy|5|||
146842008|NCT00847626|529592080|FG009|Overall Study|Lack of Efficacy|1|||
146842009|NCT00847626|529592081|FG010|Overall Study|Lack of Efficacy|7|||
146842010|NCT00847626|529592071|FG000|Overall Study|Other|1|||
146842011|NCT00847626|529592072|FG001|Overall Study|Other|5|||
146842012|NCT00847626|529592073|FG002|Overall Study|Other|4|||
146842013|NCT00847626|529592074|FG003|Overall Study|Other|1|||
146842014|NCT00847626|529592075|FG004|Overall Study|Other|2|||
146842015|NCT00847626|529592076|FG005|Overall Study|Other|2|||
146842016|NCT00847626|529592077|FG006|Overall Study|Other|2|||
146842017|NCT00847626|529592078|FG007|Overall Study|Other|3|||
146842018|NCT00847626|529592079|FG008|Overall Study|Other|1|||
146842019|NCT00847626|529592080|FG009|Overall Study|Other|1|||
146842020|NCT00847626|529592081|FG010|Overall Study|Other|3|||
146842021|NCT03031496|529592084|FG000|Period 1|Adverse Event|2|||
146842022|NCT03031496|529592085|FG001|Period 1|Adverse Event|0|||
146842023|NCT03031496|529592084|FG000|Period 1|Withdrawal by Subject|0|||
146842024|NCT03031496|529592085|FG001|Period 1|Withdrawal by Subject|2|||
146842025|NCT02979249|529592087|FG000|Overall Study|Lost to Follow-up|2|||
146842026|NCT02979249|529592087|FG000|Overall Study|Withdrawal by Subject|4|||
146842027|NCT01125046|529592088|FG000|First 6 Months of Treatment|Death|1|||
146842028|NCT01125046|529592088|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
146842029|NCT01125046|529592088|FG000|First 6 Months of Treatment|Non-compliance|1|||
146842030|NCT01125046|529592088|FG000|First 6 Months of Treatment|Surgery|1|||
146842031|NCT01125046|529592088|FG000|First 6 Months of Treatment|Progressive Disease|7|||
146842032|NCT01125046|529592088|FG000|First 6 Months of Treatment|Adverse Event|2|||
146842033|NCT01125046|529592088|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
146842034|NCT01125046|529592088|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
146842035|NCT01125046|529592088|FG000|Follow-up/Data Cut Off Point|Death|29|||
146842036|NCT01125046|529592088|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
146842037|NCT03868787|529592089|FG000|Overall Study|Withdrawal by Subject|2|||
146842038|NCT03868787|529592090|FG001|Overall Study|Withdrawal by Subject|1|||
146842039|NCT01399697|529592091|FG000|Overall Study|Adverse Event|13|||
146842040|NCT01399697|529592092|FG001|Overall Study|Adverse Event|3|||
146842041|NCT01399697|529592093|FG002|Overall Study|Adverse Event|1|||
146842042|NCT01399697|529592091|FG000|Overall Study|Lost to Follow-up|2|||
146842043|NCT01399697|529592092|FG001|Overall Study|Lost to Follow-up|0|||
146842044|NCT01399697|529592093|FG002|Overall Study|Lost to Follow-up|0|||
146842045|NCT01399697|529592091|FG000|Overall Study|Withdrawal by Subject|8|||
146842046|NCT01399697|529592092|FG001|Overall Study|Withdrawal by Subject|0|||
146842047|NCT01399697|529592093|FG002|Overall Study|Withdrawal by Subject|0|||
146842048|NCT01399697|529592091|FG000|Overall Study|Investigator Decisión|1|||
146842049|NCT01399697|529592092|FG001|Overall Study|Investigator Decisión|0|||
146842050|NCT01399697|529592093|FG002|Overall Study|Investigator Decisión|2|||
146842051|NCT01399697|529592091|FG000|Overall Study|Lack of Efficacy|9|||
146842052|NCT01399697|529592092|FG001|Overall Study|Lack of Efficacy|0|||
146842053|NCT01399697|529592093|FG002|Overall Study|Lack of Efficacy|1|||
146842054|NCT01399697|529592091|FG000|Overall Study|Protocol Violation|2|||
146842055|NCT01399697|529592092|FG001|Overall Study|Protocol Violation|0|||
146842056|NCT01399697|529592093|FG002|Overall Study|Protocol Violation|0|||
146842057|NCT01399697|529592091|FG000|Overall Study|Non-Compliant|1|||
146842058|NCT01399697|529592092|FG001|Overall Study|Non-Compliant|0|||
146842059|NCT01399697|529592093|FG002|Overall Study|Non-Compliant|0|||
146842060|NCT01399697|529592091|FG000|Overall Study|Inclusion Error|2|||
146842061|NCT01399697|529592092|FG001|Overall Study|Inclusion Error|0|||
146842062|NCT01399697|529592093|FG002|Overall Study|Inclusion Error|0|||
146842063|NCT01399697|529592091|FG000|Overall Study|Positive result for hepatitis B|1|||
146842064|NCT01399697|529592092|FG001|Overall Study|Positive result for hepatitis B|0|||
146842065|NCT01399697|529592093|FG002|Overall Study|Positive result for hepatitis B|0|||
146842066|NCT01399697|529592091|FG000|Overall Study|Clinical RA remission|1|||
146842067|NCT01399697|529592092|FG001|Overall Study|Clinical RA remission|0|||
146842068|NCT01399697|529592093|FG002|Overall Study|Clinical RA remission|0|||
146842069|NCT01399697|529592091|FG000|Overall Study|Sponsor Decision|1|||
146842070|NCT01399697|529592092|FG001|Overall Study|Sponsor Decision|0|||
146842071|NCT01399697|529592093|FG002|Overall Study|Sponsor Decision|0|||
146842072|NCT02510040|529592094|FG000|Overall Study|Deemed no longer eligible|18|||
146842073|NCT02510040|529592095|FG001|Overall Study|Deemed no longer eligible|3|||
146842074|NCT02510040|529592096|FG002|Overall Study|Deemed no longer eligible|1|||
146842075|NCT00967005|529592098|FG000|Overall Study|Lost to Follow-up|7|||
146842076|NCT00967005|529592099|FG001|Overall Study|Lost to Follow-up|10|||
146842077|NCT01289210|529592102|FG000|Overall Study|Adverse Event|1|||
146842078|NCT01401153|529592105|FG000|First Test Day|Learning disabilities; illness|1|||
146842079|NCT01401153|529592106|FG001|First Test Day|Learning disabilities; illness|10|||
146842080|NCT01401153|529592105|FG000|Second Test Day|illness|0|||
146842081|NCT01401153|529592106|FG001|Second Test Day|illness|5|||
146842082|NCT01818531|529592109|FG000|Overall Study|Withdrawn for case delay after block|1|||
146842083|NCT01818531|529592110|FG001|Overall Study|Withdrawn for case delay after block|0|||
146842084|NCT01818531|529592109|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
146842085|NCT01818531|529592110|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
146842086|NCT01818531|529592109|FG000|Overall Study|Withdrawn for failure to place block|0|||
146842087|NCT01818531|529592110|FG001|Overall Study|Withdrawn for failure to place block|1|||
146842088|NCT01677767|529592111|FG000|Overall Study|Adverse Event|1|||
146842089|NCT01677767|529592111|FG000|Overall Study|Death|4|||
146842090|NCT01677767|529592111|FG000|Overall Study|Protocol Violation|4|||
146842091|NCT01677767|529592111|FG000|Overall Study|Withdrawal by Subject|10|||
146842092|NCT01677767|529592111|FG000|Overall Study|Non-compliance by the participants|3|||
146842093|NCT01068665|529592112|FG000|Overall Study|Adverse Event|5|||
146842094|NCT01068665|529592113|FG001|Overall Study|Adverse Event|4|||
146842095|NCT01068665|529592112|FG000|Overall Study|Lack of Efficacy|0|||
146842096|NCT01068665|529592113|FG001|Overall Study|Lack of Efficacy|2|||
146842097|NCT01068665|529592112|FG000|Overall Study|Protocol Violation|5|||
146842098|NCT01068665|529592113|FG001|Overall Study|Protocol Violation|2|||
146842099|NCT01068665|529592112|FG000|Overall Study|Withdrawal Criteria|3|||
146842100|NCT01068665|529592113|FG001|Overall Study|Withdrawal Criteria|9|||
146842101|NCT01068665|529592112|FG000|Overall Study|Other|17|||
146842102|NCT01068665|529592113|FG001|Overall Study|Other|12|||
146995591|NCT00735904|530147658|FG000|Overall Study|Withdrawal by Subject|1|||
146842103|NCT01162863|529592116|FG000|Overall Study|Lack of Efficacy|1|||
146842104|NCT01162863|529592117|FG001|Overall Study|Lack of Efficacy|0|||
146842105|NCT01162863|529592118|FG002|Overall Study|Lack of Efficacy|0|||
146842106|NCT01162863|529592116|FG000|Overall Study|Adverse Event|0|||
146842107|NCT01162863|529592117|FG001|Overall Study|Adverse Event|1|||
146842108|NCT01162863|529592118|FG002|Overall Study|Adverse Event|0|||
146842109|NCT02992691|529592119|FG000|Overall Study|Adverse Event|2|||
146842110|NCT02992691|529592119|FG000|Overall Study|Withdrawal by Subject|1|||
146842111|NCT00588692|529592120|FG000|Overall Study|Withdrawal by Subject|4|||
146842112|NCT00588692|529592121|FG001|Overall Study|Withdrawal by Subject|2|||
146842113|NCT00588692|529592120|FG000|Overall Study|Hip Surgery|0|||
146842114|NCT00588692|529592121|FG001|Overall Study|Hip Surgery|1|||
146842115|NCT00588692|529592120|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
146842116|NCT00588692|529592121|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
146842117|NCT00588692|529592120|FG000|Overall Study|Cancer|1|||
146842118|NCT00588692|529592121|FG001|Overall Study|Cancer|0|||
146842119|NCT00588692|529592120|FG000|Overall Study|Death|1|||
146842120|NCT00588692|529592121|FG001|Overall Study|Death|0|||
146842121|NCT00392925|529592123|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
146842122|NCT00392925|529592124|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
146842123|NCT00392925|529592125|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
146842124|NCT00392925|529592126|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
146842125|NCT00392925|529592123|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
146842126|NCT00392925|529592124|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
146842127|NCT00392925|529592125|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
146842128|NCT00392925|529592126|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
146842129|NCT00392925|529592123|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
146842130|NCT00392925|529592124|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
146842131|NCT00392925|529592125|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
146842132|NCT00392925|529592126|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
146842133|NCT00392925|529592123|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
146842134|NCT00392925|529592124|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
146842135|NCT00392925|529592125|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
146842136|NCT00392925|529592126|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
146842137|NCT00392925|529592123|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
146842138|NCT00392925|529592124|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
146842139|NCT00392925|529592125|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
146961448|NCT04145531|530018162|FG003|Part B|Adverse Event|21|||
146961449|NCT04145531|530018159|FG000|Part B|Physician Decision|0|||
146961450|NCT04145531|530018160|FG001|Part B|Physician Decision|0|||
146961451|NCT04145531|530018161|FG002|Part B|Physician Decision|0|||
146961452|NCT04145531|530018162|FG003|Part B|Physician Decision|7|||
146961453|NCT04145531|530018159|FG000|Part B|Progressive disease|0|||
146961454|NCT04145531|530018160|FG001|Part B|Progressive disease|0|||
146961455|NCT04145531|530018161|FG002|Part B|Progressive disease|0|||
146961456|NCT04145531|530018162|FG003|Part B|Progressive disease|1|||
146961457|NCT04145531|530018159|FG000|Part B|Recurrent disease|0|||
146961458|NCT04145531|530018160|FG001|Part B|Recurrent disease|0|||
146961459|NCT04145531|530018161|FG002|Part B|Recurrent disease|0|||
146961460|NCT04145531|530018162|FG003|Part B|Recurrent disease|1|||
146961461|NCT04145531|530018159|FG000|Part B|Withdrawal by parent or guardian|0|||
146961462|NCT04145531|530018160|FG001|Part B|Withdrawal by parent or guardian|0|||
146961463|NCT04145531|530018161|FG002|Part B|Withdrawal by parent or guardian|0|||
146961464|NCT04145531|530018162|FG003|Part B|Withdrawal by parent or guardian|3|||
146961465|NCT04145531|530018159|FG000|Part B|Withdrawal by participant|0|||
146961466|NCT04145531|530018160|FG001|Part B|Withdrawal by participant|0|||
146961467|NCT04145531|530018161|FG002|Part B|Withdrawal by participant|0|||
146961468|NCT04145531|530018162|FG003|Part B|Withdrawal by participant|1|||
146961469|NCT04145531|530018159|FG000|Part B|Other|0|||
146961470|NCT04145531|530018160|FG001|Part B|Other|0|||
146961471|NCT04145531|530018161|FG002|Part B|Other|0|||
146961472|NCT04145531|530018162|FG003|Part B|Other|1|||
146961473|NCT04988035|530018163|FG000|Overall Study|Death|19|||
146961474|NCT04988035|530018164|FG001|Overall Study|Death|13|||
146961475|NCT04988035|530018163|FG000|Overall Study|Lost to Follow-up|12|||
146961476|NCT04988035|530018164|FG001|Overall Study|Lost to Follow-up|6|||
146961477|NCT04988035|530018163|FG000|Overall Study|Protocol Violation|0|||
146961478|NCT04988035|530018164|FG001|Overall Study|Protocol Violation|1|||
146961479|NCT04988035|530018163|FG000|Overall Study|Withdrawal by Subject|2|||
146961480|NCT04988035|530018164|FG001|Overall Study|Withdrawal by Subject|4|||
146961481|NCT04988035|530018163|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
146961482|NCT04988035|530018164|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
146961483|NCT03602976|530018165|FG000|Overall Study|Withdrawal by Subject|1|||
146961484|NCT03732534|530018166|FG000|Overall Study|Study terminated by Sponsor|6|||
146961485|NCT02190604|530018167|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961486|NCT02190604|530018168|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961487|NCT02190604|530018169|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961488|NCT02190604|530018170|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961489|NCT02190604|530018171|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961490|NCT02190604|530018172|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961491|NCT02190604|530018173|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961492|NCT02190604|530018174|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961493|NCT02190604|530018175|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961494|NCT02190604|530018176|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961495|NCT02190604|530018177|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961496|NCT02190604|530018178|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961497|NCT02190604|530018179|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146995592|NCT00735904|530147658|FG000|Overall Study|Study Terminated by Sponsor|5|||
146995593|NCT00735904|530147658|FG000|Overall Study|Other|8|||
146995594|NCT03361228|530147662|FG000|Overall Study|Other|1|||
146995595|NCT03361228|530147663|FG001|Overall Study|Other|1|||
146995596|NCT03361228|530147662|FG000|Overall Study|Death|3|||
146995597|NCT03361228|530147663|FG001|Overall Study|Death|0|||
146995598|NCT03693430|530147671|FG000|Overall Study|Lost to Follow-up|3|||
146995599|NCT03693430|530147672|FG001|Overall Study|Lost to Follow-up|14|||
146995600|NCT03693430|530147671|FG000|Overall Study|Death|1|||
146995601|NCT03693430|530147672|FG001|Overall Study|Death|0|||
146995602|NCT03693430|530147671|FG000|Overall Study|Withdrawal by Subject|0|||
146995603|NCT03693430|530147672|FG001|Overall Study|Withdrawal by Subject|4|||
146995604|NCT02930005|530147673|FG000|Overall Study|Lost to Follow-up|1|||
146995605|NCT02930005|530147674|FG001|Overall Study|Lost to Follow-up|5|||
146995606|NCT00585689|530147675|FG000|Overall Study|Received different ABI-007 schedule|3|||
146995607|NCT00585689|530147675|FG000|Overall Study|Adverse Event|1|||
146995608|NCT00585689|530147675|FG000|Overall Study|Patient Declined Surgery|1|||
146995609|NCT00585689|530147675|FG000|Overall Study|Patient had unresectable disease|1|||
146995610|NCT00585689|530147675|FG000|Overall Study|Death|1|||
146995611|NCT02373098|530147676|FG000|Overall Study|Lost to Follow-up|1|||
146995612|NCT02373098|530147677|FG001|Overall Study|Lost to Follow-up|0|||
146995613|NCT02373098|530147676|FG000|Overall Study|Protocol Violation|3|||
146995614|NCT02373098|530147677|FG001|Overall Study|Protocol Violation|0|||
146995615|NCT02373098|530147676|FG000|Overall Study|Withdrawal by Subject|5|||
146995616|NCT02373098|530147677|FG001|Overall Study|Withdrawal by Subject|0|||
146995617|NCT02373098|530147676|FG000|Overall Study|Adverse Event|3|||
146995618|NCT02373098|530147677|FG001|Overall Study|Adverse Event|0|||
146995619|NCT00855738|530147684|FG000|Overall Study|Lost to Follow-up|2|||
146995620|NCT00855738|530147684|FG000|Overall Study|Adverse Event|1|||
146995621|NCT00855738|530147684|FG000|Overall Study|Subject Defaulted|1|||
146995622|NCT00855738|530147684|FG000|Overall Study|Death|1|||
146995623|NCT00319735|530147697|FG000|Overall Study|Death|2|||
146995624|NCT00119379|530147703|FG000|Overall Study|Adverse Event|4|||
146995625|NCT00119379|530147704|FG001|Overall Study|Adverse Event|1|||
146995626|NCT00154102|530147705|FG000|Overall Study|investigational study phase ongoing|7|||
146995627|NCT00154102|530147706|FG001|Overall Study|investigational study phase ongoing|2|||
146995628|NCT01811953|530149237|FG000|Overall Study|Adverse Event|0|||
146995629|NCT01811953|530149238|FG001|Overall Study|Adverse Event|0|||
146995630|NCT01811953|530149239|FG002|Overall Study|Adverse Event|0|||
146995631|NCT01811953|530149240|FG003|Overall Study|Adverse Event|1|||
146995632|NCT01811953|530149241|FG004|Overall Study|Adverse Event|0|||
146995633|NCT01811953|530149242|FG005|Overall Study|Adverse Event|1|||
146995634|NCT01811953|530149237|FG000|Overall Study|Protocol Violation|0|||
146995635|NCT01811953|530149238|FG001|Overall Study|Protocol Violation|0|||
146995636|NCT01811953|530149239|FG002|Overall Study|Protocol Violation|0|||
146995637|NCT01811953|530149240|FG003|Overall Study|Protocol Violation|0|||
146995638|NCT01811953|530149241|FG004|Overall Study|Protocol Violation|1|||
146995639|NCT01811953|530149242|FG005|Overall Study|Protocol Violation|0|||
146995640|NCT02533258|530149247|FG000|Overall Study|Adverse Event|1|||
146995641|NCT02533258|530149247|FG000|Overall Study|Death|2|||
146995642|NCT02533258|530149247|FG000|Overall Study|Other|1|||
146995643|NCT02533258|530149247|FG000|Overall Study|Economic factor|1|||
146995644|NCT02533258|530149247|FG000|Overall Study|Progression of pleural effusion|1|||
146995645|NCT02533258|530149247|FG000|Overall Study|Lack of Efficacy|2|||
146995646|NCT03655106|530149248|FG000|Overall Study|Withdrawal by Subject|3|||
146995647|NCT03655106|530149249|FG001|Overall Study|Withdrawal by Subject|2|||
146995648|NCT03655106|530149248|FG000|Overall Study|Lost to Follow-up|2|||
146995649|NCT03655106|530149249|FG001|Overall Study|Lost to Follow-up|1|||
146995650|NCT03655106|530149248|FG000|Overall Study|Duplicate Enrollment|1|||
146995651|NCT03655106|530149249|FG001|Overall Study|Duplicate Enrollment|1|||
146995652|NCT03655106|530149248|FG000|Overall Study|Protocol Violation|3|||
146995653|NCT03655106|530149249|FG001|Overall Study|Protocol Violation|0|||
146995654|NCT01049334|530149251|FG000|Overall Study|Withdrawal by Subject|5|||
146995655|NCT01049334|530149252|FG001|Overall Study|Withdrawal by Subject|3|||
146995656|NCT01049334|530149251|FG000|Overall Study|Adverse Event|2|||
146995657|NCT01049334|530149252|FG001|Overall Study|Adverse Event|3|||
146995658|NCT01049334|530149251|FG000|Overall Study|Physician Decision|2|||
146995659|NCT01049334|530149252|FG001|Overall Study|Physician Decision|0|||
146995660|NCT01049334|530149251|FG000|Overall Study|Protocol Violation|0|||
146995661|NCT01049334|530149252|FG001|Overall Study|Protocol Violation|1|||
146995662|NCT01367457|530149255|FG000|Overall Study|Death|2|||
146995663|NCT01367457|530149256|FG001|Overall Study|Death|0|||
146995664|NCT01367457|530149257|FG002|Overall Study|Death|0|||
146995665|NCT01367457|530149255|FG000|Overall Study|Investigator's decision|2|||
146995666|NCT01367457|530149256|FG001|Overall Study|Investigator's decision|0|||
146995667|NCT01367457|530149257|FG002|Overall Study|Investigator's decision|0|||
146995668|NCT01367457|530149255|FG000|Overall Study|Clinical decline (CD)|2|||
146995669|NCT01367457|530149256|FG001|Overall Study|Clinical decline (CD)|0|||
146995670|NCT01367457|530149257|FG002|Overall Study|Clinical decline (CD)|0|||
146995671|NCT01367457|530149255|FG000|Overall Study|Progression and death|8|||
146995672|NCT01367457|530149256|FG001|Overall Study|Progression and death|0|||
146995673|NCT01367457|530149257|FG002|Overall Study|Progression and death|0|||
146995674|NCT01367457|530149255|FG000|Overall Study|Toxicity|16|||
146995675|NCT01367457|530149256|FG001|Overall Study|Toxicity|0|||
146995676|NCT01367457|530149257|FG002|Overall Study|Toxicity|0|||
146995677|NCT01367457|530149255|FG000|Overall Study|Progression|137|||
146995678|NCT01367457|530149256|FG001|Overall Study|Progression|0|||
146995679|NCT01367457|530149257|FG002|Overall Study|Progression|0|||
146995680|NCT01367457|530149255|FG000|Overall Study|Patient asks for rest + slow progression|1|||
146995681|NCT01367457|530149256|FG001|Overall Study|Patient asks for rest + slow progression|0|||
146995682|NCT01367457|530149257|FG002|Overall Study|Patient asks for rest + slow progression|0|||
146995683|NCT01367457|530149255|FG000|Overall Study|Investigator's opinion, stable disease|1|||
146995684|NCT01367457|530149256|FG001|Overall Study|Investigator's opinion, stable disease|0|||
146995685|NCT01367457|530149257|FG002|Overall Study|Investigator's opinion, stable disease|0|||
146995686|NCT01367457|530149255|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
146995687|NCT01367457|530149256|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
146995688|NCT01367457|530149257|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
146995689|NCT01367457|530149255|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
146995690|NCT01367457|530149256|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
146995691|NCT01367457|530149257|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
146995692|NCT01367457|530149255|FG000|Overall Study|low grade toxicities + stable disease|1|||
146995693|NCT01367457|530149256|FG001|Overall Study|low grade toxicities + stable disease|0|||
146995694|NCT01367457|530149257|FG002|Overall Study|low grade toxicities + stable disease|0|||
146995695|NCT01367457|530149255|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
146995696|NCT01367457|530149256|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
146995697|NCT01367457|530149257|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
146995698|NCT01367457|530149255|FG000|Overall Study|Withdrawal by Subject|1|||
146995699|NCT01367457|530149256|FG001|Overall Study|Withdrawal by Subject|0|||
146995700|NCT01367457|530149257|FG002|Overall Study|Withdrawal by Subject|0|||
146995701|NCT01367457|530149255|FG000|Overall Study|CD, associated leukaemia|1|||
146995702|NCT01367457|530149256|FG001|Overall Study|CD, associated leukaemia|0|||
146995703|NCT01367457|530149257|FG002|Overall Study|CD, associated leukaemia|0|||
146995704|NCT01367457|530149255|FG000|Overall Study|Uncontrolled pain|1|||
146995705|NCT01367457|530149256|FG001|Overall Study|Uncontrolled pain|0|||
146995706|NCT01367457|530149257|FG002|Overall Study|Uncontrolled pain|0|||
146995707|NCT01367457|530149255|FG000|Overall Study|Overall status worsens to grade 4|1|||
146995708|NCT01367457|530149256|FG001|Overall Study|Overall status worsens to grade 4|0|||
146995709|NCT01367457|530149257|FG002|Overall Study|Overall status worsens to grade 4|0|||
146995710|NCT01367457|530149255|FG000|Overall Study|Stabilisation + frequent infections|1|||
146995711|NCT01367457|530149256|FG001|Overall Study|Stabilisation + frequent infections|0|||
146995712|NCT01367457|530149257|FG002|Overall Study|Stabilisation + frequent infections|0|||
146995713|NCT01367457|530149255|FG000|Overall Study|No clinical benefit|1|||
146995714|NCT01367457|530149256|FG001|Overall Study|No clinical benefit|0|||
146995715|NCT01367457|530149257|FG002|Overall Study|No clinical benefit|0|||
146995716|NCT01367457|530149255|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
146995717|NCT01367457|530149256|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
146995718|NCT01367457|530149257|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
146995719|NCT01367457|530149255|FG000|Overall Study|Overall decline|1|||
146995720|NCT01367457|530149256|FG001|Overall Study|Overall decline|0|||
146995721|NCT01367457|530149257|FG002|Overall Study|Overall decline|0|||
146995722|NCT01367457|530149255|FG000|Overall Study|Rejection of treatment|1|||
146995723|NCT01367457|530149256|FG001|Overall Study|Rejection of treatment|0|||
146995724|NCT01367457|530149257|FG002|Overall Study|Rejection of treatment|0|||
146995725|NCT01367457|530149255|FG000|Overall Study|Lost to Follow-up|1|||
146995726|NCT01367457|530149256|FG001|Overall Study|Lost to Follow-up|0|||
146995727|NCT01367457|530149257|FG002|Overall Study|Lost to Follow-up|0|||
146995728|NCT01367457|530149255|FG000|Overall Study|Death from septic shock|1|||
146995729|NCT01367457|530149256|FG001|Overall Study|Death from septic shock|0|||
146995730|NCT01367457|530149257|FG002|Overall Study|Death from septic shock|0|||
146995731|NCT01367457|530149255|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
146995732|NCT01367457|530149256|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
146995733|NCT01367457|530149257|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
146995734|NCT01367457|530149255|FG000|Overall Study|Patient's Wish|1|||
146995735|NCT01367457|530149256|FG001|Overall Study|Patient's Wish|0|||
146995736|NCT01367457|530149257|FG002|Overall Study|Patient's Wish|0|||
146995737|NCT01367457|530149255|FG000|Overall Study|Palliative. Overall decline|1|||
146995738|NCT01367457|530149256|FG001|Overall Study|Palliative. Overall decline|0|||
146995739|NCT01367457|530149257|FG002|Overall Study|Palliative. Overall decline|0|||
146995740|NCT01367457|530149255|FG000|Overall Study|Suspected DP/suspected active infection|1|||
146995741|NCT01367457|530149256|FG001|Overall Study|Suspected DP/suspected active infection|0|||
146995742|NCT01367457|530149257|FG002|Overall Study|Suspected DP/suspected active infection|0|||
146995743|NCT03447262|530149258|FG000|Overall Study|Adverse Event|7|||
146995744|NCT03447262|530149258|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
146842140|NCT00392925|529592126|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
146842141|NCT00392925|529592123|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
146961498|NCT02190604|530018180|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961499|NCT02190604|530018181|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
146961500|NCT02190604|530018182|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961501|NCT02190604|530018183|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961502|NCT02190604|530018184|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961503|NCT02190604|530018185|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146961504|NCT02190604|530018167|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961505|NCT02190604|530018168|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961506|NCT02190604|530018169|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961507|NCT02190604|530018170|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961508|NCT02190604|530018171|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961509|NCT02190604|530018172|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961510|NCT02190604|530018173|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961511|NCT02190604|530018174|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961512|NCT02190604|530018175|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961513|NCT02190604|530018176|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961514|NCT02190604|530018177|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961515|NCT02190604|530018178|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961516|NCT02190604|530018179|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961517|NCT02190604|530018180|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
146961518|NCT02190604|530018181|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961519|NCT02190604|530018182|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961520|NCT02190604|530018183|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961521|NCT02190604|530018184|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961522|NCT02190604|530018185|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146961523|NCT02797951|530018186|FG000|Overall Study|Adverse Event|4|||
146961524|NCT02797951|530018186|FG000|Overall Study|Death|1|||
146961525|NCT02797951|530018186|FG000|Overall Study|Lack of Efficacy|19|||
146961526|NCT02797951|530018186|FG000|Overall Study|Lost to Follow-up|4|||
146961527|NCT02797951|530018186|FG000|Overall Study|Physician Decision|6|||
146961528|NCT02797951|530018186|FG000|Overall Study|Withdrawal by Subject|15|||
146961529|NCT03735849|530018187|FG000|Overall Study|Lost to Follow-up|1|||
146961530|NCT03735849|530018188|FG001|Overall Study|Lost to Follow-up|0|||
146961531|NCT03735849|530018189|FG002|Overall Study|Lost to Follow-up|0|||
146961532|NCT03735849|530018187|FG000|Overall Study|Participant unable to adhere to visit|1|||
146961533|NCT03735849|530018188|FG001|Overall Study|Participant unable to adhere to visit|0|||
146961534|NCT03735849|530018189|FG002|Overall Study|Participant unable to adhere to visit|0|||
146961535|NCT03735849|530018187|FG000|Overall Study|Not Randomized|0|||
146961536|NCT03735849|530018188|FG001|Overall Study|Not Randomized|0|||
146961537|NCT03735849|530018189|FG002|Overall Study|Not Randomized|4|||
146961538|NCT04626947|530018192|FG000|Overall Study|Study terminated|14|||
146961539|NCT03556202|530018202|FG000|Extension Treatment Period|Adverse Event|18|||
146961540|NCT03556202|530018203|FG001|Extension Treatment Period|Adverse Event|14|||
146961541|NCT03556202|530018204|FG002|Extension Treatment Period|Adverse Event|9|||
146961542|NCT03556202|530018202|FG000|Extension Treatment Period|Death|2|||
146961543|NCT03556202|530018203|FG001|Extension Treatment Period|Death|6|||
146961544|NCT03556202|530018204|FG002|Extension Treatment Period|Death|0|||
146961545|NCT03556202|530018202|FG000|Extension Treatment Period|Lack of Efficacy|5|||
146961546|NCT03556202|530018203|FG001|Extension Treatment Period|Lack of Efficacy|12|||
146961547|NCT03556202|530018204|FG002|Extension Treatment Period|Lack of Efficacy|18|||
146961548|NCT03556202|530018202|FG000|Extension Treatment Period|Lost to Follow-up|9|||
146961549|NCT03556202|530018203|FG001|Extension Treatment Period|Lost to Follow-up|20|||
146961550|NCT03556202|530018204|FG002|Extension Treatment Period|Lost to Follow-up|2|||
146961551|NCT03556202|530018202|FG000|Extension Treatment Period|Pregnancy|2|||
146961552|NCT03556202|530018203|FG001|Extension Treatment Period|Pregnancy|4|||
146961553|NCT03556202|530018204|FG002|Extension Treatment Period|Pregnancy|3|||
146961554|NCT03556202|530018202|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
146961555|NCT03556202|530018203|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
146961556|NCT03556202|530018204|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
146961557|NCT03556202|530018202|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
146961558|NCT03556202|530018203|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
146961559|NCT03556202|530018204|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
146842142|NCT00392925|529592124|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
146842143|NCT00392925|529592125|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
146961560|NCT03556202|530018202|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
146961561|NCT03556202|530018203|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
146961562|NCT03556202|530018204|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
146961563|NCT03556202|530018202|FG000|Extension Treatment Period|Physician Decision|0|||
146842144|NCT00392925|529592126|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
146842145|NCT00392925|529592123|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
146961564|NCT03556202|530018203|FG001|Extension Treatment Period|Physician Decision|8|||
146961565|NCT03556202|530018204|FG002|Extension Treatment Period|Physician Decision|2|||
146961566|NCT03556202|530018202|FG000|Extension Treatment Period|Protocol Violation|0|||
146961567|NCT03556202|530018203|FG001|Extension Treatment Period|Protocol Violation|1|||
146961568|NCT03556202|530018204|FG002|Extension Treatment Period|Protocol Violation|1|||
146961569|NCT03556202|530018202|FG000|Extension Treatment Period|Sponsor Decision|0|||
146961570|NCT03556202|530018203|FG001|Extension Treatment Period|Sponsor Decision|1|||
146961571|NCT03556202|530018204|FG002|Extension Treatment Period|Sponsor Decision|0|||
146961572|NCT03556202|530018202|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
146961573|NCT03556202|530018203|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
146961574|NCT03556202|530018204|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
146961575|NCT03556202|530018202|FG000|Follow-Up Period (12 Weeks)|Death|1|||
146961576|NCT03556202|530018203|FG001|Follow-Up Period (12 Weeks)|Death|0|||
146961577|NCT03556202|530018204|FG002|Follow-Up Period (12 Weeks)|Death|0|||
146961578|NCT03556202|530018202|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
146961579|NCT03556202|530018203|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
146961580|NCT03556202|530018204|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
146961581|NCT03556202|530018202|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
146961582|NCT03556202|530018203|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
146961583|NCT03556202|530018204|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
146961584|NCT03556202|530018202|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
146961585|NCT03556202|530018203|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
146961586|NCT03556202|530018204|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
146961587|NCT03556202|530018202|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
146961588|NCT03556202|530018203|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
146961589|NCT03556202|530018204|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
146961590|NCT03556202|530018202|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
146961591|NCT03556202|530018203|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
146961592|NCT03556202|530018204|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
146961593|NCT03556202|530018202|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
146961594|NCT03556202|530018203|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
146961595|NCT03556202|530018204|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
146961596|NCT03556202|530018202|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
146961597|NCT03556202|530018203|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
146961598|NCT03556202|530018204|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
146961599|NCT03556202|530018202|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
146961600|NCT03556202|530018203|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
146961601|NCT03556202|530018204|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
146961602|NCT03556202|530018202|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
146961603|NCT03556202|530018203|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
146961604|NCT03556202|530018204|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
146961605|NCT03556202|530018202|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
146961606|NCT03556202|530018203|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
146961607|NCT03556202|530018204|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
146961608|NCT03556202|530018202|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
146961609|NCT03556202|530018203|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
146961610|NCT03556202|530018204|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
146961611|NCT03556202|530018202|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
146961612|NCT03556202|530018203|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
146961613|NCT03556202|530018204|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
146961614|NCT03289676|530018207|FG000|Overall Study|Withdrawal by Subject|2|||
146961615|NCT03289676|530018208|FG001|Overall Study|Withdrawal by Subject|0|||
146961616|NCT03289676|530018207|FG000|Overall Study|Protocol Violation|2|||
146961617|NCT03289676|530018208|FG001|Overall Study|Protocol Violation|0|||
146961618|NCT03289676|530018207|FG000|Overall Study|Lost to Follow-up|0|||
146961619|NCT03289676|530018208|FG001|Overall Study|Lost to Follow-up|1|||
146961620|NCT02576652|530018209|FG000|Overall Study|Withdrawal by Subject|2|||
146961621|NCT02811640|530018214|FG000|Overall Study|Technology malfunction|2|||
146961622|NCT04557189|530018219|FG000|Overall Study|Adverse Event|0|||
146961623|NCT04557189|530018220|FG001|Overall Study|Adverse Event|1|||
146961624|NCT04557189|530018219|FG000|Overall Study|Lost to Follow-up|1|||
146842146|NCT00392925|529592124|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
146961625|NCT04557189|530018220|FG001|Overall Study|Lost to Follow-up|1|||
146961626|NCT04557189|530018219|FG000|Overall Study|Withdrawal by Subject|2|||
146961627|NCT04557189|530018220|FG001|Overall Study|Withdrawal by Subject|1|||
146961628|NCT04557189|530018219|FG000|Overall Study|Reason not Specified|3|||
146961629|NCT04557189|530018220|FG001|Overall Study|Reason not Specified|6|||
146995745|NCT03447262|530149258|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
146842147|NCT00392925|529592125|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
146842148|NCT00392925|529592126|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
146842149|NCT00392925|529592123|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
146995746|NCT03447262|530149258|FG000|Overall Study|Death|2|||
146995747|NCT03447262|530149258|FG000|Overall Study|Study Termination by Sponsor|455|||
146995748|NCT03447262|530149258|FG000|Overall Study|Other|4|||
146995749|NCT02058498|530149259|FG000|Overall Study|Withdrawal by Subject|4|||
146995750|NCT03988803|530149260|FG000|Period 2|Prematurely discontinued from medication|2|||
146995751|NCT03988803|530149260|FG000|Period 2|Adverse Event|1|||
146995752|NCT05038293|530149270|FG000|Overall Study|device was not operating properly for one subject.|1|||
146995753|NCT05038293|530149271|FG001|Overall Study|device was not operating properly for one subject.|0|||
146995754|NCT05038293|530149270|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
146995755|NCT05038293|530149271|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
146995756|NCT01171989|530149272|FG000|Overall Study|Lost to Follow-up|0|||
146995757|NCT01171989|530149273|FG001|Overall Study|Lost to Follow-up|0|||
146995758|NCT01171989|530149274|FG002|Overall Study|Lost to Follow-up|1|||
146995759|NCT02822235|530149275|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
146995760|NCT02822235|530149276|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
146995761|NCT02822235|530149275|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
146995762|NCT02822235|530149276|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
146995763|NCT02822235|530149275|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
146995764|NCT02822235|530149276|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
146995765|NCT02822235|530149275|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
146995766|NCT02822235|530149276|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
146995767|NCT02822235|530149275|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
146995768|NCT02822235|530149276|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
146995769|NCT02822235|530149275|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
146995770|NCT02822235|530149276|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
146995771|NCT00627016|530149277|FG000|Overall Study|Adverse Event|1|||
146995772|NCT00627016|530149278|FG001|Overall Study|Adverse Event|1|||
146995773|NCT00627016|530149277|FG000|Overall Study|Protocol Violation|0|||
146995774|NCT00627016|530149278|FG001|Overall Study|Protocol Violation|2|||
146995775|NCT00627016|530149277|FG000|Overall Study|Lost to Follow-up|0|||
146995776|NCT00627016|530149278|FG001|Overall Study|Lost to Follow-up|1|||
146995777|NCT00627016|530149277|FG000|Overall Study|Withdrawal by Subject|2|||
146995778|NCT00627016|530149278|FG001|Overall Study|Withdrawal by Subject|1|||
146995779|NCT00627016|530149277|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
146995780|NCT00627016|530149278|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
146995781|NCT00627016|530149277|FG000|Overall Study|Lack of Efficacy|1|||
146995782|NCT00627016|530149278|FG001|Overall Study|Lack of Efficacy|0|||
146995783|NCT00627016|530149277|FG000|Overall Study|Placed on Excluded Drugs|1|||
146995784|NCT00627016|530149278|FG001|Overall Study|Placed on Excluded Drugs|0|||
146995785|NCT00627016|530149277|FG000|Overall Study|Pregnancy|1|||
146995786|NCT00627016|530149278|FG001|Overall Study|Pregnancy|0|||
146995787|NCT00829530|530149279|FG000|First Intervention|Adverse Event|0|||
146995788|NCT00829530|530149280|FG001|First Intervention|Adverse Event|1|||
146995789|NCT00829530|530149279|FG000|First Intervention|Intolerance to Venopuncture|0|||
146995790|NCT00829530|530149280|FG001|First Intervention|Intolerance to Venopuncture|1|||
146995791|NCT00829530|530149279|FG000|Second Intervention|Intolerance to Venopuncture|1|||
146995792|NCT00829530|530149280|FG001|Second Intervention|Intolerance to Venopuncture|0|||
146995793|NCT04466111|530149282|FG000|Prior to Trial Phase|Physician Decision|1|||
146995794|NCT02511782|530149291|FG000|Overall Study|Withdrawal by Subject|1|||
146842150|NCT00392925|529592124|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
146842151|NCT00392925|529592125|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
146842152|NCT00392925|529592126|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
146842153|NCT00392925|529592123|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
146842154|NCT00392925|529592124|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
146842155|NCT00392925|529592125|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
146842156|NCT00392925|529592126|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
146842157|NCT00820170|529592127|FG000|Overall Study|Adverse Event|0|||
146842158|NCT00820170|529592128|FG001|Overall Study|Adverse Event|0|||
146842159|NCT00820170|529592129|FG002|Overall Study|Adverse Event|0|||
146995795|NCT02511782|530149292|FG001|Overall Study|Withdrawal by Subject|0|||
146995796|NCT02511782|530149293|FG002|Overall Study|Withdrawal by Subject|0|||
146995797|NCT00112463|530149294|FG000|Overall Study|Physician Decision|1|||
146995798|NCT00112463|530149294|FG000|Overall Study|Progression|30|||
146995799|NCT00112463|530149294|FG000|Overall Study|Second Primary|1|||
146995800|NCT00112463|530149294|FG000|Overall Study|Toxicity|3|||
146995801|NCT00112463|530149294|FG000|Overall Study|Withdrawal by Subject|2|||
146995802|NCT00112463|530149294|FG000|Overall Study|Never started treatment|2|||
146995803|NCT01171963|530149295|FG000|Overall Study|Adverse Event|10|||
146995804|NCT01171963|530149296|FG001|Overall Study|Adverse Event|15|||
146995805|NCT01171963|530149295|FG000|Overall Study|Lost to Follow-up|23|||
146995806|NCT01171963|530149296|FG001|Overall Study|Lost to Follow-up|24|||
146995807|NCT01171963|530149295|FG000|Overall Study|Other - diarrhoea|1|||
146995808|NCT01171963|530149296|FG001|Overall Study|Other - diarrhoea|0|||
146995809|NCT01171963|530149295|FG000|Overall Study|Withdrawal by Subject|114|||
146995810|NCT01171963|530149296|FG001|Overall Study|Withdrawal by Subject|129|||
146995811|NCT05093205|530149297|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
146995812|NCT05093205|530149298|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
146995813|NCT05093205|530149299|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
146995814|NCT05093205|530149300|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
146995815|NCT05093205|530149301|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
146995816|NCT05093205|530149302|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
146995817|NCT05093205|530149303|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
146995818|NCT05093205|530149304|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
146995819|NCT05093205|530149305|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
146995820|NCT05093205|530149306|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
146995821|NCT05093205|530149307|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
146995822|NCT05093205|530149308|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
146995823|NCT05093205|530149309|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
146995824|NCT05093205|530149297|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146995825|NCT05093205|530149298|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146995826|NCT05093205|530149299|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
146995827|NCT05093205|530149300|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146995828|NCT05093205|530149301|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146995829|NCT05093205|530149302|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146995830|NCT05093205|530149303|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146995831|NCT05093205|530149304|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146995832|NCT05093205|530149305|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146995833|NCT05093205|530149306|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146995834|NCT05093205|530149307|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146995835|NCT05093205|530149308|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146995836|NCT05093205|530149309|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146995837|NCT05093205|530149297|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
146995838|NCT05093205|530149298|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
146995839|NCT05093205|530149299|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
146995840|NCT05093205|530149300|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
146842160|NCT00820170|529592130|FG003|Overall Study|Adverse Event|0|||
146995841|NCT05093205|530149301|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
146995842|NCT05093205|530149302|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
146995843|NCT05093205|530149303|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
146995844|NCT05093205|530149304|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
146995845|NCT05093205|530149305|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
146995846|NCT05093205|530149306|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
146995847|NCT05093205|530149307|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
146995848|NCT05093205|530149308|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
146995849|NCT05093205|530149309|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
146995850|NCT05093205|530149297|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
146995851|NCT05093205|530149298|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
146995852|NCT05093205|530149299|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
146842161|NCT00820170|529592131|FG004|Overall Study|Adverse Event|2|||
146842162|NCT00820170|529592127|FG000|Overall Study|Progressive Disease|0|||
146842163|NCT00820170|529592128|FG001|Overall Study|Progressive Disease|0|||
146842164|NCT00820170|529592129|FG002|Overall Study|Progressive Disease|0|||
146842165|NCT00820170|529592130|FG003|Overall Study|Progressive Disease|0|||
146842166|NCT00820170|529592131|FG004|Overall Study|Progressive Disease|2|||
146842167|NCT03552523|529592132|FG000|Overall Study|Withdrawal by Subject|1|||
146842168|NCT03552523|529592133|FG001|Overall Study|Withdrawal by Subject|1|||
146842169|NCT03538938|529592134|FG000|Overall Study|Death|0|||
146842170|NCT03538938|529592135|FG001|Overall Study|Death|0|||
146842171|NCT03538938|529592136|FG002|Overall Study|Death|2|||
146842172|NCT03538938|529592137|FG003|Overall Study|Death|0|||
146842173|NCT03538938|529592138|FG004|Overall Study|Death|0|||
146842174|NCT03538938|529592139|FG005|Overall Study|Death|1|||
146995853|NCT05093205|530149300|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
146995854|NCT05093205|530149301|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
146995855|NCT05093205|530149302|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
146995856|NCT05093205|530149303|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
146995857|NCT05093205|530149304|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
146842175|NCT03538938|529592140|FG006|Overall Study|Death|0|||
146842176|NCT03538938|529592141|FG007|Overall Study|Death|1|||
146842177|NCT03538938|529592142|FG008|Overall Study|Death|1|||
146995858|NCT05093205|530149305|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
146995859|NCT05093205|530149306|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
146995860|NCT05093205|530149307|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
146995861|NCT05093205|530149308|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
146995862|NCT05093205|530149309|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
146995863|NCT05093205|530149297|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
146995864|NCT05093205|530149298|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
146995865|NCT05093205|530149299|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
146995866|NCT05093205|530149300|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
146995867|NCT05093205|530149301|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
146995868|NCT05093205|530149302|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
146995869|NCT05093205|530149303|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
146995870|NCT05093205|530149304|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
146995871|NCT05093205|530149305|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
146995872|NCT05093205|530149306|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
146995873|NCT05093205|530149307|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
146995874|NCT05093205|530149308|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
146995875|NCT05093205|530149309|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
146995876|NCT05093205|530149297|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
146995877|NCT05093205|530149298|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
146995878|NCT05093205|530149299|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
146995879|NCT05093205|530149300|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
146995880|NCT05093205|530149301|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
146995881|NCT05093205|530149302|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
146995882|NCT05093205|530149303|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
146995883|NCT05093205|530149304|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
146995884|NCT05093205|530149305|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
146995885|NCT05093205|530149306|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
146995886|NCT05093205|530149307|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
146995887|NCT05093205|530149308|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
146995888|NCT05093205|530149309|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
146995889|NCT05093205|530149297|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
146995890|NCT05093205|530149298|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
146995891|NCT05093205|530149299|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
146995892|NCT05093205|530149300|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
146995893|NCT05093205|530149301|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
146995894|NCT05093205|530149302|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
146995895|NCT05093205|530149303|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
146995896|NCT05093205|530149304|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
146995897|NCT05093205|530149305|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
146995898|NCT05093205|530149306|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
146995899|NCT05093205|530149307|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
146995900|NCT05093205|530149308|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
146995901|NCT05093205|530149309|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
146995902|NCT05093205|530149297|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
146995903|NCT05093205|530149298|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
146995904|NCT05093205|530149299|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
146995905|NCT05093205|530149300|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
146842178|NCT03538938|529592143|FG009|Overall Study|Death|1|||
146842179|NCT03538938|529592144|FG010|Overall Study|Death|0|||
146842180|NCT03538938|529592145|FG011|Overall Study|Death|0|||
146842181|NCT03538938|529592146|FG012|Overall Study|Death|1|||
146842182|NCT03538938|529592147|FG013|Overall Study|Death|1|||
146842183|NCT03538938|529592148|FG014|Overall Study|Death|0|||
146842184|NCT03538938|529592149|FG015|Overall Study|Death|1|||
146842185|NCT03538938|529592134|FG000|Overall Study|Withdrawal by Subject|4|||
146995906|NCT05093205|530149301|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
146995907|NCT05093205|530149302|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
146995908|NCT05093205|530149303|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
146995909|NCT05093205|530149304|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
146995910|NCT05093205|530149305|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
146995911|NCT05093205|530149306|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
146995912|NCT05093205|530149307|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
146842186|NCT03538938|529592135|FG001|Overall Study|Withdrawal by Subject|6|||
146842187|NCT03538938|529592136|FG002|Overall Study|Withdrawal by Subject|5|||
146842188|NCT03538938|529592137|FG003|Overall Study|Withdrawal by Subject|3|||
146842189|NCT03538938|529592138|FG004|Overall Study|Withdrawal by Subject|0|||
146995913|NCT05093205|530149308|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
146995914|NCT05093205|530149309|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
146995915|NCT05093205|530149297|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146995916|NCT05093205|530149298|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146995917|NCT05093205|530149299|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146995918|NCT05093205|530149300|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146995919|NCT05093205|530149301|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146842190|NCT03538938|529592139|FG005|Overall Study|Withdrawal by Subject|0|||
146842191|NCT03538938|529592140|FG006|Overall Study|Withdrawal by Subject|3|||
146842192|NCT03538938|529592141|FG007|Overall Study|Withdrawal by Subject|1|||
146842193|NCT03538938|529592142|FG008|Overall Study|Withdrawal by Subject|5|||
146842194|NCT03538938|529592143|FG009|Overall Study|Withdrawal by Subject|1|||
146842195|NCT03538938|529592144|FG010|Overall Study|Withdrawal by Subject|2|||
146842196|NCT03538938|529592145|FG011|Overall Study|Withdrawal by Subject|1|||
146842197|NCT03538938|529592146|FG012|Overall Study|Withdrawal by Subject|3|||
146842198|NCT03538938|529592147|FG013|Overall Study|Withdrawal by Subject|0|||
146842199|NCT03538938|529592148|FG014|Overall Study|Withdrawal by Subject|2|||
146842200|NCT03538938|529592149|FG015|Overall Study|Withdrawal by Subject|4|||
146961630|NCT01087944|530018236|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
146961631|NCT01087944|530018237|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
146961632|NCT01087944|530018236|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
146961633|NCT01087944|530018237|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
146961634|NCT00540228|530018238|FG000|Overall Study|Adverse Event|2|||
146961635|NCT00540228|530018239|FG001|Overall Study|Adverse Event|0|||
146961636|NCT00540228|530018240|FG002|Overall Study|Adverse Event|0|||
146961637|NCT00540228|530018241|FG003|Overall Study|Adverse Event|0|||
146961638|NCT00540228|530018242|FG004|Overall Study|Adverse Event|0|||
146961639|NCT00540228|530018238|FG000|Overall Study|Lost to Follow-up|1|||
146961640|NCT00540228|530018239|FG001|Overall Study|Lost to Follow-up|1|||
146961641|NCT00540228|530018240|FG002|Overall Study|Lost to Follow-up|0|||
146961642|NCT00540228|530018241|FG003|Overall Study|Lost to Follow-up|0|||
146961643|NCT00540228|530018242|FG004|Overall Study|Lost to Follow-up|0|||
146961644|NCT01883362|530018243|FG000|Treatment|Adverse Event|1|||
146961645|NCT01883362|530018244|FG001|Treatment|Adverse Event|8|||
146961646|NCT01883362|530018243|FG000|Treatment|Withdrawal by Subject|6|||
146961647|NCT01883362|530018244|FG001|Treatment|Withdrawal by Subject|2|||
146961648|NCT01883362|530018243|FG000|Treatment|Administrative problems|4|||
146961649|NCT01883362|530018244|FG001|Treatment|Administrative problems|1|||
146961650|NCT01883362|530018243|FG000|Treatment|Relapse|4|||
146961651|NCT01883362|530018244|FG001|Treatment|Relapse|2|||
146961652|NCT01883362|530018243|FG000|Treatment|Randomized, not treated|1|||
146961653|NCT01883362|530018244|FG001|Treatment|Randomized, not treated|1|||
146961654|NCT01883362|530018243|FG000|Post Treatment Follow-up|Protocol Violation|0|||
146961655|NCT01883362|530018244|FG001|Post Treatment Follow-up|Protocol Violation|1|||
146961656|NCT01883362|530018243|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
146961657|NCT01883362|530018244|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
146961658|NCT01883362|530018243|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
146961659|NCT01883362|530018244|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
146961660|NCT01883362|530018243|FG000|Post Treatment Follow-up|Administrative problems|2|||
146961661|NCT01883362|530018244|FG001|Post Treatment Follow-up|Administrative problems|0|||
146961662|NCT01883362|530018243|FG000|Post Treatment Follow-up|Death|8|||
146961663|NCT01883362|530018244|FG001|Post Treatment Follow-up|Death|4|||
146961664|NCT01883362|530018243|FG000|Post Treatment Follow-up|Relapse|1|||
146961665|NCT01883362|530018244|FG001|Post Treatment Follow-up|Relapse|2|||
146961666|NCT02451137|530018245|FG000|Overall Study|Randomized but not treated|19|||
146961667|NCT02451137|530018246|FG001|Overall Study|Randomized but not treated|27|||
146961668|NCT02451137|530018245|FG000|Overall Study|Adverse Event|43|||
146961669|NCT02451137|530018246|FG001|Overall Study|Adverse Event|42|||
146961670|NCT02451137|530018245|FG000|Overall Study|Lack of Efficacy|4|||
146961671|NCT02451137|530018246|FG001|Overall Study|Lack of Efficacy|9|||
146961672|NCT02451137|530018245|FG000|Overall Study|Participant decision:discontinue insulin|41|||
146961673|NCT02451137|530018246|FG001|Overall Study|Participant decision:discontinue insulin|43|||
146961674|NCT02451137|530018245|FG000|Overall Study|Hypoglycemia|2|||
146961675|NCT02451137|530018246|FG001|Overall Study|Hypoglycemia|1|||
146961676|NCT02451137|530018245|FG000|Overall Study|Investigator's decision|23|||
146961677|NCT02451137|530018246|FG001|Overall Study|Investigator's decision|19|||
146961678|NCT02451137|530018245|FG000|Overall Study|Lost to Follow-up|53|||
146961679|NCT02451137|530018246|FG001|Overall Study|Lost to Follow-up|61|||
146961680|NCT02451137|530018245|FG000|Overall Study|Physician Decision|6|||
146961681|NCT02451137|530018246|FG001|Overall Study|Physician Decision|5|||
146961682|NCT02451137|530018245|FG000|Overall Study|Sponsor decision|13|||
146961683|NCT02451137|530018246|FG001|Overall Study|Sponsor decision|25|||
146961684|NCT02451137|530018245|FG000|Overall Study|Withdrawal by Subject|40|||
146961685|NCT02451137|530018246|FG001|Overall Study|Withdrawal by Subject|63|||
146961686|NCT02451137|530018245|FG000|Overall Study|Other than specified above|2|||
146961687|NCT02451137|530018246|FG001|Overall Study|Other than specified above|3|||
146961688|NCT01977573|530018249|FG000|Overall Study|Adverse Event|7|||
146961689|NCT01977573|530018250|FG001|Overall Study|Adverse Event|0|||
146961690|NCT01977573|530018251|FG002|Overall Study|Adverse Event|2|||
146961691|NCT01977573|530018252|FG003|Overall Study|Adverse Event|1|||
146961692|NCT01977573|530018249|FG000|Overall Study|Lost to Follow-up|1|||
146842201|NCT03538938|529592134|FG000|Overall Study|Incarcerated|0|||
146842202|NCT03538938|529592135|FG001|Overall Study|Incarcerated|0|||
146961693|NCT01977573|530018250|FG001|Overall Study|Lost to Follow-up|0|||
146961694|NCT01977573|530018251|FG002|Overall Study|Lost to Follow-up|0|||
146961695|NCT01977573|530018252|FG003|Overall Study|Lost to Follow-up|1|||
146961696|NCT01977573|530018249|FG000|Overall Study|Physician Decision|1|||
146961697|NCT01977573|530018250|FG001|Overall Study|Physician Decision|0|||
146961698|NCT01977573|530018251|FG002|Overall Study|Physician Decision|0|||
146995920|NCT05093205|530149302|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146995921|NCT05093205|530149303|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146995922|NCT05093205|530149304|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146842203|NCT03538938|529592136|FG002|Overall Study|Incarcerated|0|||
146842204|NCT03538938|529592137|FG003|Overall Study|Incarcerated|0|||
146842205|NCT03538938|529592138|FG004|Overall Study|Incarcerated|0|||
146842206|NCT03538938|529592139|FG005|Overall Study|Incarcerated|0|||
146842207|NCT03538938|529592140|FG006|Overall Study|Incarcerated|0|||
146842208|NCT03538938|529592141|FG007|Overall Study|Incarcerated|0|||
146842209|NCT03538938|529592142|FG008|Overall Study|Incarcerated|0|||
146842210|NCT03538938|529592143|FG009|Overall Study|Incarcerated|0|||
146842211|NCT03538938|529592144|FG010|Overall Study|Incarcerated|0|||
146842212|NCT03538938|529592145|FG011|Overall Study|Incarcerated|1|||
146995923|NCT05093205|530149305|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146995924|NCT05093205|530149306|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
146995925|NCT05093205|530149307|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146995926|NCT05093205|530149308|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146995927|NCT05093205|530149309|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146995928|NCT05093205|530149297|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
146995929|NCT05093205|530149298|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
146995930|NCT05093205|530149299|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
146995931|NCT05093205|530149300|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
146995932|NCT05093205|530149301|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
146995933|NCT05093205|530149302|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
146995934|NCT05093205|530149303|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
146995935|NCT05093205|530149304|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
146995936|NCT05093205|530149305|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
146995937|NCT05093205|530149306|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
146995938|NCT05093205|530149307|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
146995939|NCT05093205|530149308|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
146995940|NCT05093205|530149309|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
146995941|NCT05093205|530149297|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146995942|NCT05093205|530149298|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146995943|NCT05093205|530149299|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146995944|NCT05093205|530149300|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146995945|NCT05093205|530149301|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146995946|NCT05093205|530149302|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146995947|NCT05093205|530149303|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146995948|NCT05093205|530149304|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146995949|NCT05093205|530149305|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146995950|NCT05093205|530149306|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146995951|NCT05093205|530149307|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
146995952|NCT05093205|530149308|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146995953|NCT05093205|530149309|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146995954|NCT05093205|530149297|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146995955|NCT05093205|530149298|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146995956|NCT05093205|530149299|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146995957|NCT05093205|530149300|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146995958|NCT05093205|530149301|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146995959|NCT05093205|530149302|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146995960|NCT05093205|530149303|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146995961|NCT05093205|530149304|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146995962|NCT05093205|530149305|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146995963|NCT05093205|530149306|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146995964|NCT05093205|530149307|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146995965|NCT05093205|530149308|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
146995966|NCT05093205|530149309|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146995967|NCT05093205|530149297|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
146995968|NCT05093205|530149298|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
146995969|NCT05093205|530149299|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
146995970|NCT05093205|530149300|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
146995971|NCT05093205|530149301|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
146995972|NCT05093205|530149302|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
146842213|NCT03538938|529592146|FG012|Overall Study|Incarcerated|0|||
146995973|NCT05093205|530149303|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
146995974|NCT05093205|530149304|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
146995975|NCT05093205|530149305|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
146995976|NCT05093205|530149306|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
146995977|NCT05093205|530149307|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
146842214|NCT03538938|529592147|FG013|Overall Study|Incarcerated|0|||
146995978|NCT05093205|530149308|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
146995979|NCT05093205|530149309|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
146842215|NCT03538938|529592148|FG014|Overall Study|Incarcerated|0|||
146995980|NCT05093205|530149297|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146995981|NCT05093205|530149298|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146995982|NCT05093205|530149299|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146995983|NCT05093205|530149300|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146995984|NCT05093205|530149301|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146995985|NCT05093205|530149302|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146995986|NCT05093205|530149303|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146995987|NCT05093205|530149304|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146995988|NCT05093205|530149305|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146995989|NCT05093205|530149306|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146842216|NCT03538938|529592149|FG015|Overall Study|Incarcerated|0|||
146842217|NCT00755105|529592150|FG000|Overall Study|Withdrawal by Subject|9|||
146842218|NCT00755105|529592151|FG001|Overall Study|Withdrawal by Subject|11|||
146842219|NCT00755105|529592152|FG002|Overall Study|Withdrawal by Subject|4|||
146842220|NCT01361594|529592154|FG000|Overall Study|Withdrawal by Subject|1|||
146842221|NCT01361594|529592155|FG001|Overall Study|Withdrawal by Subject|2|||
146995990|NCT05093205|530149307|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146995991|NCT05093205|530149308|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
146995992|NCT05093205|530149309|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146995993|NCT02979353|530149314|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
146995994|NCT02979353|530149315|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
146995995|NCT02979353|530149314|FG000|Overall Study|Withdrawal by Subject|16|||
146995996|NCT02979353|530149315|FG001|Overall Study|Withdrawal by Subject|12|||
146995997|NCT02979353|530149314|FG000|Overall Study|Death|10|||
146995998|NCT02979353|530149315|FG001|Overall Study|Death|11|||
146995999|NCT02979353|530149314|FG000|Overall Study|Transfer to Hospice Care|19|||
146996000|NCT02979353|530149315|FG001|Overall Study|Transfer to Hospice Care|14|||
146996001|NCT02979353|530149314|FG000|Overall Study|Lost to Follow-up|1|||
146842222|NCT01518153|529592160|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
146842223|NCT01518153|529592161|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
146842224|NCT01518153|529592162|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
146842225|NCT01518153|529592160|FG000|Stem Cell Transplant|Death|2|||
146842226|NCT01518153|529592161|FG001|Stem Cell Transplant|Death|0|||
146842227|NCT01518153|529592162|FG002|Stem Cell Transplant|Death|0|||
146996002|NCT02979353|530149315|FG001|Overall Study|Lost to Follow-up|5|||
146996003|NCT01722877|530149318|FG000|Overall Study|Death|1|||
146996004|NCT01722877|530149318|FG000|Overall Study|Lost to Follow-up|1|||
146996005|NCT05067647|530149321|FG000|Overall Study|Lost to Follow-up|1|||
146842228|NCT01518153|529592160|FG000|Stem Cell Transplant|Secondary graft failure|1|||
146842229|NCT01518153|529592161|FG001|Stem Cell Transplant|Secondary graft failure|0|||
146842230|NCT01518153|529592162|FG002|Stem Cell Transplant|Secondary graft failure|0|||
146842231|NCT01518153|529592160|FG000|Stem Cell Transplant|Adverse Event|1|||
146996006|NCT03897088|530149322|FG000|Overall Study|Withdrawal by Subject|12|||
146996007|NCT03897088|530149323|FG001|Overall Study|Withdrawal by Subject|12|||
146996008|NCT03897088|530149322|FG000|Overall Study|Lost to Follow-up|7|||
146996009|NCT03897088|530149323|FG001|Overall Study|Lost to Follow-up|15|||
146996010|NCT03897088|530149322|FG000|Overall Study|Sponsor Decision|1|||
146996011|NCT03897088|530149323|FG001|Overall Study|Sponsor Decision|2|||
146996012|NCT03897088|530149322|FG000|Overall Study|COVID-19|2|||
146996013|NCT03897088|530149323|FG001|Overall Study|COVID-19|0|||
146996014|NCT03897088|530149322|FG000|Overall Study|Other|3|||
146996015|NCT03897088|530149323|FG001|Overall Study|Other|0|||
146996016|NCT03897088|530149322|FG000|Overall Study|Non-compliance with Study Drug|1|||
146996017|NCT03897088|530149323|FG001|Overall Study|Non-compliance with Study Drug|1|||
146996018|NCT03897088|530149322|FG000|Overall Study|Pregnancy|0|||
146996019|NCT03897088|530149323|FG001|Overall Study|Pregnancy|1|||
146996020|NCT04320849|530149328|FG000|Overall Study|Withdrawal by Subject|4|||
146842232|NCT01518153|529592161|FG001|Stem Cell Transplant|Adverse Event|0|||
146842233|NCT01518153|529592162|FG002|Stem Cell Transplant|Adverse Event|0|||
146842234|NCT01518153|529592160|FG000|Donor Lymphocyte Infusion|Death|0|||
146996021|NCT04320849|530149328|FG000|Overall Study|Imaging data unavailable|2|||
146996022|NCT04320849|530149328|FG000|Overall Study|Incomplete imaging|2|||
146996023|NCT03929393|530149331|FG000|Overall Study|Death|1|||
146996024|NCT03929393|530149332|FG001|Overall Study|Death|0|||
146996025|NCT03929393|530149331|FG000|Overall Study|Time Commitment|2|||
146996026|NCT03929393|530149332|FG001|Overall Study|Time Commitment|5|||
146996027|NCT03929393|530149331|FG000|Overall Study|Motor Vehicle Accident|0|||
146996028|NCT03929393|530149332|FG001|Overall Study|Motor Vehicle Accident|1|||
146996029|NCT03929393|530149331|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
146996030|NCT03929393|530149332|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
146996031|NCT03929393|530149331|FG000|Overall Study|Other|1|||
146996032|NCT03929393|530149332|FG001|Overall Study|Other|3|||
146842235|NCT01518153|529592161|FG001|Donor Lymphocyte Infusion|Death|2|||
146842236|NCT01518153|529592162|FG002|Donor Lymphocyte Infusion|Death|1|||
146996033|NCT01569152|530149339|FG000|Phase IIa, Period 1|Early Escape|5|||
146996034|NCT01569152|530149340|FG001|Phase IIa, Period 1|Early Escape|22|||
146842237|NCT01840410|529592163|FG000|Overall Study|Physician Decision|1|||
146842238|NCT01840410|529592164|FG001|Overall Study|Physician Decision|2|||
146842239|NCT01840410|529592163|FG000|Overall Study|Pregnancy|1|||
146842240|NCT01840410|529592164|FG001|Overall Study|Pregnancy|0|||
146842241|NCT01840410|529592163|FG000|Overall Study|Protocol deviation|1|||
146961699|NCT01977573|530018252|FG003|Overall Study|Physician Decision|0|||
146961700|NCT01977573|530018249|FG000|Overall Study|Protocol Violation|3|||
146961701|NCT01977573|530018250|FG001|Overall Study|Protocol Violation|1|||
146961702|NCT01977573|530018251|FG002|Overall Study|Protocol Violation|0|||
146961703|NCT01977573|530018252|FG003|Overall Study|Protocol Violation|0|||
146961704|NCT01977573|530018249|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
146961705|NCT01977573|530018250|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
146961706|NCT01977573|530018251|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
146961707|NCT01977573|530018252|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
146961708|NCT01977573|530018249|FG000|Overall Study|Withdrawal by Subject|6|||
146961709|NCT01977573|530018250|FG001|Overall Study|Withdrawal by Subject|1|||
146961710|NCT01977573|530018251|FG002|Overall Study|Withdrawal by Subject|1|||
146961711|NCT01977573|530018252|FG003|Overall Study|Withdrawal by Subject|1|||
146961712|NCT00198107|530019774|FG000|Double-Blind Period|Adverse Event|1|||
146961713|NCT00198107|530019775|FG001|Double-Blind Period|Adverse Event|1|||
146961714|NCT00198107|530019776|FG002|Double-Blind Period|Adverse Event|0|||
146961715|NCT00198107|530019774|FG000|Double-Blind Period|Lack of Efficacy|2|||
146961716|NCT00198107|530019775|FG001|Double-Blind Period|Lack of Efficacy|0|||
146961717|NCT00198107|530019776|FG002|Double-Blind Period|Lack of Efficacy|0|||
146961718|NCT00198107|530019774|FG000|Double-Blind Period|Lost to Follow-up|2|||
146961719|NCT00198107|530019775|FG001|Double-Blind Period|Lost to Follow-up|1|||
146961720|NCT00198107|530019776|FG002|Double-Blind Period|Lost to Follow-up|0|||
146961721|NCT00198107|530019774|FG000|Double-Blind Period|Physician Decision|1|||
146961722|NCT00198107|530019775|FG001|Double-Blind Period|Physician Decision|0|||
146961723|NCT00198107|530019776|FG002|Double-Blind Period|Physician Decision|0|||
146961724|NCT00198107|530019774|FG000|Double-Blind Period|Withdrawal by Subject|0|||
146961725|NCT00198107|530019775|FG001|Double-Blind Period|Withdrawal by Subject|1|||
146961726|NCT00198107|530019776|FG002|Double-Blind Period|Withdrawal by Subject|0|||
146961727|NCT00198107|530019774|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
146961728|NCT00198107|530019775|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
146961729|NCT00198107|530019776|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
146961730|NCT02513732|530019777|FG000|Overall Study|Lost to Follow-up|11|||
146961731|NCT02513732|530019777|FG000|Overall Study|Death|9|||
146961732|NCT02513732|530019777|FG000|Overall Study|Changing hospital|2|||
146961733|NCT00934661|530019778|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
146961734|NCT00934661|530019779|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
146961735|NCT00656669|530019791|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
146961736|NCT00656669|530019791|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
146961737|NCT00656669|530019791|FG000|AC (Cycles 6-9)|Adverse Event|1|||
146961738|NCT00656669|530019791|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
146961739|NCT02777554|530019792|FG000|Overall Study|Adverse Event|4|||
146961740|NCT02777554|530019793|FG001|Overall Study|Adverse Event|4|||
146961741|NCT02777554|530019794|FG002|Overall Study|Adverse Event|0|||
146961742|NCT02777554|530019795|FG003|Overall Study|Adverse Event|1|||
146961743|NCT02777554|530019796|FG004|Overall Study|Adverse Event|0|||
146961744|NCT02777554|530019797|FG005|Overall Study|Adverse Event|0|||
146961745|NCT02777554|530019792|FG000|Overall Study|Withdrawal by Subject|3|||
146961746|NCT02777554|530019793|FG001|Overall Study|Withdrawal by Subject|1|||
146961747|NCT02777554|530019794|FG002|Overall Study|Withdrawal by Subject|1|||
146961748|NCT02777554|530019795|FG003|Overall Study|Withdrawal by Subject|0|||
146961749|NCT02777554|530019796|FG004|Overall Study|Withdrawal by Subject|0|||
146961750|NCT02777554|530019797|FG005|Overall Study|Withdrawal by Subject|0|||
146961751|NCT02777554|530019792|FG000|Overall Study|Discharged early due to hurricane|22|||
146961752|NCT02777554|530019793|FG001|Overall Study|Discharged early due to hurricane|20|||
146961753|NCT02777554|530019794|FG002|Overall Study|Discharged early due to hurricane|0|||
146961754|NCT02777554|530019795|FG003|Overall Study|Discharged early due to hurricane|0|||
146961755|NCT02777554|530019796|FG004|Overall Study|Discharged early due to hurricane|0|||
146961756|NCT02777554|530019797|FG005|Overall Study|Discharged early due to hurricane|0|||
146961757|NCT02777554|530019792|FG000|Overall Study|Other - Miscellaneous|1|||
146961758|NCT02777554|530019793|FG001|Overall Study|Other - Miscellaneous|0|||
146961759|NCT02777554|530019794|FG002|Overall Study|Other - Miscellaneous|0|||
146961760|NCT02777554|530019795|FG003|Overall Study|Other - Miscellaneous|0|||
146961761|NCT02777554|530019796|FG004|Overall Study|Other - Miscellaneous|0|||
146961762|NCT02777554|530019797|FG005|Overall Study|Other - Miscellaneous|0|||
146961763|NCT01458535|530019798|FG000|Overall Study|Other|0|||
146961764|NCT01458535|530019799|FG001|Overall Study|Other|0|||
146961765|NCT01458535|530019800|FG002|Overall Study|Other|0|||
146842242|NCT01840410|529592164|FG001|Overall Study|Protocol deviation|0|||
146961766|NCT01458535|530019801|FG003|Overall Study|Other|0|||
146961767|NCT01458535|530019802|FG004|Overall Study|Other|1|||
146961768|NCT01458535|530019803|FG005|Overall Study|Other|1|||
146996035|NCT01569152|530149341|FG002|Phase IIa, Period 1|Early Escape|0|||
146996036|NCT01569152|530149339|FG000|Phase IIa, Period 1|Adverse Event|4|||
146996037|NCT01569152|530149340|FG001|Phase IIa, Period 1|Adverse Event|0|||
146996038|NCT01569152|530149341|FG002|Phase IIa, Period 1|Adverse Event|0|||
146996039|NCT01569152|530149339|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
146996040|NCT01569152|530149340|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
146996041|NCT01569152|530149341|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
146996042|NCT01569152|530149339|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
146996043|NCT01569152|530149340|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
146996044|NCT01569152|530149341|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
146996045|NCT01569152|530149339|FG000|Phase IIa, Period 1|Protocol Violation|0|||
146996046|NCT01569152|530149340|FG001|Phase IIa, Period 1|Protocol Violation|1|||
146996047|NCT01569152|530149341|FG002|Phase IIa, Period 1|Protocol Violation|0|||
146996048|NCT01569152|530149339|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
146996049|NCT01569152|530149340|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
146996050|NCT01569152|530149341|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
146996051|NCT01569152|530149339|FG000|Safety Extension, Period 3|Adverse Event|0|||
146996052|NCT01569152|530149340|FG001|Safety Extension, Period 3|Adverse Event|0|||
146996053|NCT01569152|530149341|FG002|Safety Extension, Period 3|Adverse Event|4|||
146996054|NCT01569152|530149339|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
146996055|NCT01569152|530149340|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
146996056|NCT01569152|530149341|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
146996057|NCT01569152|530149339|FG000|Safety Extension, Period 3|Physician Decision|0|||
146996058|NCT01569152|530149340|FG001|Safety Extension, Period 3|Physician Decision|0|||
146996059|NCT01569152|530149341|FG002|Safety Extension, Period 3|Physician Decision|2|||
146996060|NCT01569152|530149339|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
146996061|NCT01569152|530149340|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
146996062|NCT01569152|530149341|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
146996063|NCT01706536|530149342|FG000|Overall Study|Withdrawal by Subject|1|||
146996064|NCT01706536|530149343|FG001|Overall Study|Withdrawal by Subject|0|||
146996065|NCT01706536|530149344|FG002|Overall Study|Withdrawal by Subject|1|||
146996066|NCT01706536|530149345|FG003|Overall Study|Withdrawal by Subject|0|||
146996067|NCT01706536|530149346|FG004|Overall Study|Withdrawal by Subject|0|||
146996068|NCT01706536|530149342|FG000|Overall Study|Adverse Event|2|||
146996069|NCT01706536|530149343|FG001|Overall Study|Adverse Event|3|||
146996070|NCT01706536|530149344|FG002|Overall Study|Adverse Event|4|||
146996071|NCT01706536|530149345|FG003|Overall Study|Adverse Event|3|||
146996072|NCT01706536|530149346|FG004|Overall Study|Adverse Event|2|||
146996073|NCT01706536|530149342|FG000|Overall Study|Lack of Efficacy|1|||
146996074|NCT01706536|530149343|FG001|Overall Study|Lack of Efficacy|0|||
146996075|NCT01706536|530149344|FG002|Overall Study|Lack of Efficacy|0|||
146996076|NCT01706536|530149345|FG003|Overall Study|Lack of Efficacy|1|||
146996077|NCT01706536|530149346|FG004|Overall Study|Lack of Efficacy|0|||
146842243|NCT01840410|529592163|FG000|Overall Study|Lost to Follow-up|1|||
146842244|NCT01840410|529592164|FG001|Overall Study|Lost to Follow-up|0|||
146842245|NCT01840410|529592163|FG000|Overall Study|Withdrawal by Subject|2|||
146842246|NCT01840410|529592164|FG001|Overall Study|Withdrawal by Subject|1|||
146842247|NCT01840410|529592163|FG000|Overall Study|Adverse Event|1|||
146842248|NCT01840410|529592164|FG001|Overall Study|Adverse Event|1|||
146842249|NCT01647542|529592165|FG000|Overall Study|Major Protocol Deviation|1|||
146842250|NCT01647542|529592166|FG001|Overall Study|Major Protocol Deviation|0|||
146842251|NCT01647542|529592167|FG002|Overall Study|Major Protocol Deviation|0|||
146842252|NCT01647542|529592165|FG000|Overall Study|Adverse Event|4|||
146842253|NCT01647542|529592166|FG001|Overall Study|Adverse Event|5|||
146842254|NCT01647542|529592167|FG002|Overall Study|Adverse Event|4|||
146842255|NCT01647542|529592165|FG000|Overall Study|Lost to Follow-up|0|||
146842256|NCT01647542|529592166|FG001|Overall Study|Lost to Follow-up|2|||
146842257|NCT01647542|529592167|FG002|Overall Study|Lost to Follow-up|2|||
146842258|NCT01647542|529592165|FG000|Overall Study|Withdrawal by Subject|6|||
146842259|NCT01647542|529592166|FG001|Overall Study|Withdrawal by Subject|4|||
146842260|NCT01647542|529592167|FG002|Overall Study|Withdrawal by Subject|0|||
146842261|NCT01647542|529592165|FG000|Overall Study|Study Termination|64|||
146996078|NCT01706536|530149342|FG000|Overall Study|non compliance|0|||
146842262|NCT01647542|529592166|FG001|Overall Study|Study Termination|61|||
146996079|NCT01706536|530149343|FG001|Overall Study|non compliance|1|||
146996080|NCT01706536|530149344|FG002|Overall Study|non compliance|0|||
146996081|NCT01706536|530149345|FG003|Overall Study|non compliance|0|||
146996082|NCT01706536|530149346|FG004|Overall Study|non compliance|0|||
146996083|NCT03262012|530149347|FG000|Overall Study|Withdrawal by Subject|15|||
146996084|NCT03262012|530149348|FG001|Overall Study|Withdrawal by Subject|13|||
146842263|NCT01647542|529592167|FG002|Overall Study|Study Termination|65|||
146842264|NCT01647542|529592165|FG000|Overall Study|Lack of Efficacy|1|||
146842265|NCT01647542|529592166|FG001|Overall Study|Lack of Efficacy|1|||
146842266|NCT01647542|529592167|FG002|Overall Study|Lack of Efficacy|0|||
146842267|NCT01647542|529592165|FG000|Overall Study|Death|0|||
146996085|NCT03262012|530149349|FG002|Overall Study|Withdrawal by Subject|8|||
146996086|NCT03262012|530149350|FG003|Overall Study|Withdrawal by Subject|7|||
146842268|NCT01647542|529592166|FG001|Overall Study|Death|0|||
146842269|NCT01647542|529592167|FG002|Overall Study|Death|1|||
146961769|NCT01458535|530019798|FG000|Overall Study|Withdrawal by Subject|0|||
146961770|NCT01458535|530019799|FG001|Overall Study|Withdrawal by Subject|0|||
146961771|NCT01458535|530019800|FG002|Overall Study|Withdrawal by Subject|2|||
146961772|NCT01458535|530019801|FG003|Overall Study|Withdrawal by Subject|0|||
146961773|NCT01458535|530019802|FG004|Overall Study|Withdrawal by Subject|1|||
146961774|NCT01458535|530019803|FG005|Overall Study|Withdrawal by Subject|1|||
146961775|NCT01458535|530019798|FG000|Overall Study|Lost to Follow-up|0|||
146961776|NCT01458535|530019799|FG001|Overall Study|Lost to Follow-up|2|||
146961777|NCT01458535|530019800|FG002|Overall Study|Lost to Follow-up|0|||
146961778|NCT01458535|530019801|FG003|Overall Study|Lost to Follow-up|3|||
146961779|NCT01458535|530019802|FG004|Overall Study|Lost to Follow-up|2|||
146961780|NCT01458535|530019803|FG005|Overall Study|Lost to Follow-up|2|||
146961781|NCT01458535|530019798|FG000|Overall Study|Adverse Event|0|||
146961782|NCT01458535|530019799|FG001|Overall Study|Adverse Event|0|||
146961783|NCT01458535|530019800|FG002|Overall Study|Adverse Event|0|||
146961784|NCT01458535|530019801|FG003|Overall Study|Adverse Event|1|||
146961785|NCT01458535|530019802|FG004|Overall Study|Adverse Event|0|||
146961786|NCT01458535|530019803|FG005|Overall Study|Adverse Event|0|||
146961787|NCT00344968|530019807|FG000|Overall Study|Adverse Event|5|||
146961788|NCT00344968|530019808|FG001|Overall Study|Adverse Event|4|||
146961789|NCT00344968|530019809|FG002|Overall Study|Adverse Event|15|||
146961790|NCT00344968|530019807|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
146961791|NCT00344968|530019808|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146961792|NCT00344968|530019809|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
146961793|NCT00344968|530019807|FG000|Overall Study|Protocol Violation|2|||
146961794|NCT00344968|530019808|FG001|Overall Study|Protocol Violation|2|||
146961795|NCT00344968|530019809|FG002|Overall Study|Protocol Violation|5|||
146961796|NCT00344968|530019807|FG000|Overall Study|Withdrawal by Subject|14|||
146961797|NCT00344968|530019808|FG001|Overall Study|Withdrawal by Subject|31|||
146961798|NCT00344968|530019809|FG002|Overall Study|Withdrawal by Subject|27|||
146961799|NCT00344968|530019807|FG000|Overall Study|Lost to Follow-up|24|||
146961800|NCT00344968|530019808|FG001|Overall Study|Lost to Follow-up|37|||
146961801|NCT00344968|530019809|FG002|Overall Study|Lost to Follow-up|37|||
146961802|NCT00344968|530019807|FG000|Overall Study|Death|11|||
146961803|NCT00344968|530019808|FG001|Overall Study|Death|27|||
146961804|NCT00344968|530019809|FG002|Overall Study|Death|31|||
146961805|NCT00344968|530019807|FG000|Overall Study|Other|0|||
146961806|NCT00344968|530019808|FG001|Overall Study|Other|1|||
146961807|NCT00344968|530019809|FG002|Overall Study|Other|0|||
146961808|NCT03735680|530019810|FG000|Overall Study|Withdrawal by Subject|0|||
146961809|NCT03735680|530019811|FG001|Overall Study|Withdrawal by Subject|1|||
146961810|NCT03735680|530019812|FG002|Overall Study|Withdrawal by Subject|0|||
146961811|NCT03735680|530019813|FG003|Overall Study|Withdrawal by Subject|0|||
146961812|NCT03735680|530019814|FG004|Overall Study|Withdrawal by Subject|0|||
146961813|NCT03735680|530019815|FG005|Overall Study|Withdrawal by Subject|1|||
146961814|NCT03735680|530019810|FG000|Overall Study|Patient unable or unwilling to continue|0|||
146961815|NCT03735680|530019811|FG001|Overall Study|Patient unable or unwilling to continue|0|||
146961816|NCT03735680|530019812|FG002|Overall Study|Patient unable or unwilling to continue|1|||
146961817|NCT03735680|530019813|FG003|Overall Study|Patient unable or unwilling to continue|0|||
146961818|NCT03735680|530019814|FG004|Overall Study|Patient unable or unwilling to continue|0|||
146961819|NCT03735680|530019815|FG005|Overall Study|Patient unable or unwilling to continue|0|||
146961820|NCT04001790|530019816|FG000|Overall Study|Withdrawal by Subject|1|||
146961821|NCT04001790|530019817|FG001|Overall Study|Withdrawal by Subject|2|||
146961822|NCT05028816|530019819|FG000|Overall Study|Lost to Follow-up|5|||
146961823|NCT05028816|530019820|FG001|Overall Study|Lost to Follow-up|3|||
146961824|NCT05028816|530019819|FG000|Overall Study|Withdrawal by Subject|4|||
146961825|NCT05028816|530019820|FG001|Overall Study|Withdrawal by Subject|1|||
146961826|NCT05028816|530019819|FG000|Overall Study|Physician Decision|1|||
146961827|NCT05028816|530019820|FG001|Overall Study|Physician Decision|0|||
146961828|NCT05064436|530019821|FG000|Overall Study|Other Reasons|1|||
146961829|NCT05064436|530019822|FG001|Overall Study|Other Reasons|0|||
146961830|NCT01711736|530019823|FG000|Overall Study|Lost to Follow-up|4|||
146961831|NCT01711736|530019824|FG001|Overall Study|Lost to Follow-up|1|||
146961832|NCT01711736|530019823|FG000|Overall Study|Withdrawal by Subject|6|||
146961833|NCT01711736|530019824|FG001|Overall Study|Withdrawal by Subject|6|||
146961834|NCT01711736|530019823|FG000|Overall Study|Migrated/moved from study area|2|||
146961835|NCT01711736|530019824|FG001|Overall Study|Migrated/moved from study area|1|||
146842270|NCT01040169|529592168|FG000|Overall Study|Lost to Follow-up|3|||
146961836|NCT01342445|530019825|FG000|Overall Study|Experienced side effects|0|||
146961837|NCT01342445|530019826|FG001|Overall Study|Experienced side effects|2|||
146961838|NCT02652793|530019827|FG000|Overall Study|Adverse Event|1|||
146961839|NCT02652793|530019827|FG000|Overall Study|Lost to Follow-up|2|||
146961840|NCT02652793|530019827|FG000|Overall Study|Withdrawal by Subject|1|||
146961841|NCT05450198|530019832|FG000|Overall Study|Withdrawal by Subject|1|||
146842271|NCT01040169|529592169|FG001|Overall Study|Lost to Follow-up|8|||
146842272|NCT00350727|529592170|FG000|Phase I: Dose Escalation|Adverse Event|4|||
146842273|NCT00350727|529592171|FG001|Phase I: Dose Escalation|Adverse Event|0|||
146842274|NCT00350727|529592172|FG002|Phase I: Dose Escalation|Adverse Event|0|||
146842275|NCT00350727|529592170|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
146842276|NCT00350727|529592171|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
146842277|NCT00350727|529592172|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
146842278|NCT00350727|529592170|FG000|Phase I: Dose Escalation|Death|1|||
146842279|NCT00350727|529592171|FG001|Phase I: Dose Escalation|Death|0|||
146842280|NCT00350727|529592172|FG002|Phase I: Dose Escalation|Death|0|||
146842281|NCT00350727|529592170|FG000|Phase I: Dose Escalation|Physician Decision|1|||
146842282|NCT00350727|529592171|FG001|Phase I: Dose Escalation|Physician Decision|0|||
146842283|NCT00350727|529592172|FG002|Phase I: Dose Escalation|Physician Decision|0|||
146842284|NCT00350727|529592170|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
146842285|NCT00350727|529592171|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
146842286|NCT00350727|529592172|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
146842287|NCT00350727|529592170|FG000|Phase II|Disease Progression|0|||
146842288|NCT00350727|529592171|FG001|Phase II|Disease Progression|15|||
146842289|NCT00350727|529592172|FG002|Phase II|Disease Progression|16|||
146842290|NCT00350727|529592170|FG000|Phase II|Clinical Deterioration|0|||
146842291|NCT00350727|529592171|FG001|Phase II|Clinical Deterioration|1|||
146842292|NCT00350727|529592172|FG002|Phase II|Clinical Deterioration|0|||
146842293|NCT00350727|529592170|FG000|Phase II|Withdrawal by Subject|0|||
146961842|NCT05450198|530019833|FG001|Overall Study|Withdrawal by Subject|1|||
146961843|NCT05450198|530019834|FG002|Overall Study|Withdrawal by Subject|2|||
146961844|NCT05450198|530019835|FG003|Overall Study|Withdrawal by Subject|0|||
146961845|NCT05450198|530019832|FG000|Overall Study|Lost to Follow-up|1|||
146961846|NCT05450198|530019833|FG001|Overall Study|Lost to Follow-up|0|||
146961847|NCT05450198|530019834|FG002|Overall Study|Lost to Follow-up|2|||
146961848|NCT05450198|530019835|FG003|Overall Study|Lost to Follow-up|1|||
146961849|NCT01319422|530019836|FG000|Overall Study|Withdrawal by Subject|1|||
146961850|NCT01319422|530019837|FG001|Overall Study|Withdrawal by Subject|0|||
146961851|NCT00933543|530019838|FG000|Overall Study|Adverse Event|2|||
146961852|NCT00933543|530019839|FG001|Overall Study|Adverse Event|1|||
146961853|NCT00933543|530019838|FG000|Overall Study|Lost to Follow-up|0|||
146961854|NCT00933543|530019839|FG001|Overall Study|Lost to Follow-up|1|||
146961855|NCT00933543|530019838|FG000|Overall Study|Withdrawal by Subject|0|||
146961856|NCT00933543|530019839|FG001|Overall Study|Withdrawal by Subject|1|||
146961857|NCT00933543|530019838|FG000|Overall Study|Lack of Efficacy|0|||
146961858|NCT00933543|530019839|FG001|Overall Study|Lack of Efficacy|3|||
146961859|NCT00933543|530019838|FG000|Overall Study|Other|1|||
146961860|NCT00933543|530019839|FG001|Overall Study|Other|1|||
146961861|NCT04837807|530019842|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
146961862|NCT04837807|530019843|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
146961863|NCT00308555|530019844|FG000|Overall Study|Withdrawal by Subject|1|||
146961864|NCT00308555|530019845|FG001|Overall Study|Withdrawal by Subject|0|||
146961865|NCT00308555|530019844|FG000|Overall Study|Physician Decision|2|||
146961866|NCT00308555|530019845|FG001|Overall Study|Physician Decision|0|||
146961867|NCT00814502|530019846|FG000|Overall Study|Adverse Event|1|||
146961868|NCT00814502|530019847|FG001|Overall Study|Adverse Event|0|||
146961869|NCT00814502|530019846|FG000|Overall Study|Withdrawal by Subject|0|||
146961870|NCT00814502|530019847|FG001|Overall Study|Withdrawal by Subject|2|||
146961871|NCT01012765|530019854|FG000|Treatment Period 1|Adverse Event|1|||
146961872|NCT01012765|530019855|FG001|Treatment Period 1|Adverse Event|0|||
146961873|NCT01012765|530019856|FG002|Treatment Period 1|Adverse Event|1|||
146961874|NCT01012765|530019857|FG003|Treatment Period 1|Adverse Event|0|||
146961875|NCT01012765|530019858|FG004|Treatment Period 1|Adverse Event|0|||
146961876|NCT01012765|530019859|FG005|Treatment Period 1|Adverse Event|0|||
146961877|NCT01012765|530019854|FG000|Treatment Period 1|Withdrawal by Subject|2|||
146961878|NCT01012765|530019855|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146961879|NCT01012765|530019856|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146961880|NCT01012765|530019857|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146961881|NCT01012765|530019858|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146961882|NCT01012765|530019859|FG005|Treatment Period 1|Withdrawal by Subject|0|||
146961883|NCT01012765|530019854|FG000|Treatment Period 1|Administrative problems|0|||
146961884|NCT01012765|530019855|FG001|Treatment Period 1|Administrative problems|0|||
146961885|NCT01012765|530019856|FG002|Treatment Period 1|Administrative problems|1|||
146961886|NCT01012765|530019857|FG003|Treatment Period 1|Administrative problems|1|||
146842294|NCT00350727|529592171|FG001|Phase II|Withdrawal by Subject|2|||
146961887|NCT01012765|530019858|FG004|Treatment Period 1|Administrative problems|1|||
146961888|NCT01012765|530019859|FG005|Treatment Period 1|Administrative problems|0|||
146842295|NCT00350727|529592172|FG002|Phase II|Withdrawal by Subject|1|||
146842296|NCT00350727|529592170|FG000|Phase II|Adverse Event|0|||
146842297|NCT00350727|529592171|FG001|Phase II|Adverse Event|1|||
146842298|NCT00350727|529592172|FG002|Phase II|Adverse Event|1|||
146961889|NCT01012765|530019854|FG000|Treatment Period 1|Protocol Violation|0|||
146961890|NCT01012765|530019855|FG001|Treatment Period 1|Protocol Violation|0|||
146961891|NCT01012765|530019856|FG002|Treatment Period 1|Protocol Violation|0|||
146842299|NCT00350727|529592170|FG000|Phase II|Death|0|||
146842300|NCT00350727|529592171|FG001|Phase II|Death|0|||
146842301|NCT00350727|529592172|FG002|Phase II|Death|2|||
146842302|NCT00350727|529592170|FG000|Phase II|Sponsor Terminated Study|0|||
146842303|NCT00350727|529592171|FG001|Phase II|Sponsor Terminated Study|0|||
146842304|NCT00350727|529592172|FG002|Phase II|Sponsor Terminated Study|1|||
146842305|NCT00350727|529592170|FG000|Phase II|Enrolled in Rollover Study|0|||
146842306|NCT00350727|529592171|FG001|Phase II|Enrolled in Rollover Study|0|||
146842307|NCT00350727|529592172|FG002|Phase II|Enrolled in Rollover Study|1|||
146842308|NCT03551691|529592177|FG000|Overall Study|Withdrawal by Subject|3|||
146842309|NCT03551691|529592178|FG001|Overall Study|Withdrawal by Subject|3|||
146842310|NCT02367040|529592179|FG000|Overall Study|Lost to Follow-up|1|||
146842311|NCT02367040|529592180|FG001|Overall Study|Lost to Follow-up|1|||
146842312|NCT02367040|529592179|FG000|Overall Study|Lack of Efficacy|1|||
146842313|NCT02367040|529592180|FG001|Overall Study|Lack of Efficacy|0|||
146842314|NCT02367040|529592179|FG000|Overall Study|Additional primary malignancy|1|||
146842315|NCT02367040|529592180|FG001|Overall Study|Additional primary malignancy|1|||
146842316|NCT02367040|529592179|FG000|Overall Study|AE not associated with clinical disease progression|117|||
146842317|NCT02367040|529592180|FG001|Overall Study|AE not associated with clinical disease progression|12|||
146842318|NCT02367040|529592179|FG000|Overall Study|AE associated with clinical disease progression|1|||
146842319|NCT02367040|529592180|FG001|Overall Study|AE associated with clinical disease progression|4|||
146842320|NCT02367040|529592179|FG000|Overall Study|Physician Decision|2|||
146842321|NCT02367040|529592180|FG001|Overall Study|Physician Decision|8|||
146842322|NCT02367040|529592179|FG000|Overall Study|Non-compliance to study drug|1|||
146842323|NCT02367040|529592180|FG001|Overall Study|Non-compliance to study drug|0|||
146842324|NCT02367040|529592179|FG000|Overall Study|Failure to meet continuation criteria|1|||
146842325|NCT02367040|529592180|FG001|Overall Study|Failure to meet continuation criteria|0|||
146842326|NCT02367040|529592179|FG000|Overall Study|Switching to other therapy|2|||
146842327|NCT02367040|529592180|FG001|Overall Study|Switching to other therapy|0|||
146842328|NCT02367040|529592179|FG000|Overall Study|Withdrawal by Subject|51|||
146842329|NCT02367040|529592180|FG001|Overall Study|Withdrawal by Subject|16|||
146996087|NCT03262012|530149347|FG000|Overall Study|Adverse Event|10|||
146996088|NCT03262012|530149348|FG001|Overall Study|Adverse Event|12|||
146996089|NCT03262012|530149349|FG002|Overall Study|Adverse Event|4|||
146996090|NCT03262012|530149350|FG003|Overall Study|Adverse Event|6|||
146996091|NCT03262012|530149347|FG000|Overall Study|Physician Decision|2|||
146996092|NCT03262012|530149348|FG001|Overall Study|Physician Decision|5|||
146996093|NCT03262012|530149349|FG002|Overall Study|Physician Decision|1|||
146996094|NCT03262012|530149350|FG003|Overall Study|Physician Decision|0|||
146996095|NCT03262012|530149347|FG000|Overall Study|Lack of Efficacy|0|||
146996096|NCT03262012|530149348|FG001|Overall Study|Lack of Efficacy|5|||
146996097|NCT03262012|530149349|FG002|Overall Study|Lack of Efficacy|1|||
146996098|NCT03262012|530149350|FG003|Overall Study|Lack of Efficacy|2|||
146996099|NCT03262012|530149347|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
146996100|NCT03262012|530149348|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
146996101|NCT03262012|530149349|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
146996102|NCT03262012|530149350|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
146996103|NCT01469546|530149353|FG000|Received 5 mg Dose|Adverse Event|13|||
146996104|NCT01469546|530149353|FG000|Received 5 mg Dose|Death|2|||
146996105|NCT01469546|530149353|FG000|Received 5 mg Dose|Protocol Violation|2|||
146996106|NCT01469546|530149353|FG000|Received 5 mg Dose|Progressive Disease|3|||
146996107|NCT01469546|530149353|FG000|Received 5 mg Dose|Physician Decision|3|||
146996108|NCT00385684|530149356|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
146996109|NCT00385684|530149357|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
146996110|NCT00385684|530149356|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
146996111|NCT00385684|530149357|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
146996112|NCT00385684|530149356|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
146996113|NCT00385684|530149357|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
146996114|NCT02801877|530149358|FG000|Overall Study|Lost to Follow-up|1|||
146996115|NCT02801877|530149359|FG001|Overall Study|Lost to Follow-up|1|||
146996116|NCT02801877|530149360|FG002|Overall Study|Lost to Follow-up|2|||
146996117|NCT02801877|530149361|FG003|Overall Study|Lost to Follow-up|0|||
146996118|NCT02801877|530149358|FG000|Overall Study|Never Started Treatment|2|||
146996119|NCT02801877|530149359|FG001|Overall Study|Never Started Treatment|0|||
146996120|NCT02801877|530149360|FG002|Overall Study|Never Started Treatment|4|||
146996121|NCT02801877|530149361|FG003|Overall Study|Never Started Treatment|0|||
146996122|NCT00463606|530149362|FG000|Overall Study|Adverse Event|21|||
146996123|NCT00463606|530149363|FG001|Overall Study|Adverse Event|18|||
146996124|NCT00463606|530149364|FG002|Overall Study|Adverse Event|11|||
146996125|NCT00463606|530149362|FG000|Overall Study|Withdrawal by Subject|11|||
146996126|NCT00463606|530149363|FG001|Overall Study|Withdrawal by Subject|11|||
146842330|NCT02367040|529592179|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
146842331|NCT02367040|529592180|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
146842332|NCT02367040|529592179|FG000|Overall Study|Patient decision|40|||
146842333|NCT02367040|529592180|FG001|Overall Study|Patient decision|14|||
146842334|NCT02367040|529592179|FG000|Overall Study|Required procedure failed|1|||
146996127|NCT00463606|530149364|FG002|Overall Study|Withdrawal by Subject|5|||
146996128|NCT00463606|530149362|FG000|Overall Study|Lost to Follow-up|2|||
146996129|NCT00463606|530149363|FG001|Overall Study|Lost to Follow-up|2|||
146996130|NCT00463606|530149364|FG002|Overall Study|Lost to Follow-up|3|||
146996131|NCT00463606|530149362|FG000|Overall Study|Subject noncompliance|1|||
146996132|NCT00463606|530149363|FG001|Overall Study|Subject noncompliance|1|||
146996133|NCT00463606|530149364|FG002|Overall Study|Subject noncompliance|0|||
146996134|NCT00463606|530149362|FG000|Overall Study|Subject moved out of town|1|||
146996135|NCT00463606|530149363|FG001|Overall Study|Subject moved out of town|0|||
146996136|NCT00463606|530149364|FG002|Overall Study|Subject moved out of town|0|||
146996137|NCT00463606|530149362|FG000|Overall Study|Physician Decision|0|||
146996138|NCT00463606|530149363|FG001|Overall Study|Physician Decision|1|||
146996139|NCT00463606|530149364|FG002|Overall Study|Physician Decision|0|||
146996140|NCT00463606|530149362|FG000|Overall Study|Sponsor request|0|||
146996141|NCT00463606|530149363|FG001|Overall Study|Sponsor request|1|||
146996142|NCT00463606|530149364|FG002|Overall Study|Sponsor request|0|||
146996143|NCT00463606|530149362|FG000|Overall Study|Exclusion criteria violation|2|||
146996144|NCT00463606|530149363|FG001|Overall Study|Exclusion criteria violation|0|||
146996145|NCT00463606|530149364|FG002|Overall Study|Exclusion criteria violation|0|||
146996146|NCT00463606|530149362|FG000|Overall Study|Coordinator error|1|||
146996147|NCT00463606|530149363|FG001|Overall Study|Coordinator error|0|||
146996148|NCT00463606|530149364|FG002|Overall Study|Coordinator error|0|||
146996149|NCT00463606|530149362|FG000|Overall Study|Patient randomized in error|1|||
146996150|NCT00463606|530149363|FG001|Overall Study|Patient randomized in error|0|||
146996151|NCT00463606|530149364|FG002|Overall Study|Patient randomized in error|0|||
146996152|NCT00463606|530149362|FG000|Overall Study|Participation in another ABT-335 trial|1|||
146996153|NCT00463606|530149363|FG001|Overall Study|Participation in another ABT-335 trial|0|||
146996154|NCT00463606|530149364|FG002|Overall Study|Participation in another ABT-335 trial|0|||
146996155|NCT00463606|530149362|FG000|Overall Study|Protocol Violation|0|||
146996156|NCT00463606|530149363|FG001|Overall Study|Protocol Violation|0|||
146996157|NCT00463606|530149364|FG002|Overall Study|Protocol Violation|1|||
146996158|NCT01223365|530149365|FG000|Open-label Titration Period|Enrolled but not treated|1|||
146996159|NCT01223365|530149365|FG000|Open-label Titration Period|Adverse Event|23|||
146996160|NCT01223365|530149365|FG000|Open-label Titration Period|Lack of Efficacy|3|||
146996161|NCT01223365|530149365|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
146996162|NCT01223365|530149365|FG000|Open-label Titration Period|Protocol Violation|1|||
146996163|NCT01223365|530149365|FG000|Open-label Titration Period|Lost to Follow-up|2|||
146996164|NCT01223365|530149365|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
146996165|NCT01223365|530149365|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
146996166|NCT01223365|530149365|FG000|Open-label Titration Period|Starting physical therapy|1|||
146996167|NCT01223365|530149365|FG000|Open-label Treatment Period|Adverse Event|39|||
146996168|NCT01223365|530149365|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
146996169|NCT01223365|530149365|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
146996170|NCT01223365|530149365|FG000|Open-label Treatment Period|Protocol Violation|15|||
146996171|NCT01223365|530149365|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
146996172|NCT01223365|530149365|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
146996173|NCT01223365|530149365|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
146996174|NCT01223365|530149365|FG000|Open-label Treatment Period|Moved out of area|2|||
146996175|NCT01223365|530149365|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
146996176|NCT01223365|530149365|FG000|Open-label Treatment Period|"Out of window"|1|||
146996177|NCT01223365|530149365|FG000|Open-label Treatment Period|Starting physical therapy|1|||
146996178|NCT01223365|530149365|FG000|Open-label Treatment Period|Physician Decision|2|||
146996179|NCT02682602|530149366|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
146996180|NCT02682602|530149367|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
146996181|NCT02682602|530149366|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
146996182|NCT02682602|530149367|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
146996183|NCT02140060|530149368|FG000|Overall Study|Adverse Event|0|||
146996184|NCT02140060|530149369|FG001|Overall Study|Adverse Event|0|||
146996185|NCT02140060|530149370|FG002|Overall Study|Adverse Event|0|||
146996186|NCT02140060|530149371|FG003|Overall Study|Adverse Event|1|||
146996187|NCT02140060|530149372|FG004|Overall Study|Adverse Event|1|||
146996188|NCT02140060|530149373|FG005|Overall Study|Adverse Event|1|||
146996189|NCT02140060|530149368|FG000|Overall Study|Lack of Efficacy|0|||
146996190|NCT02140060|530149369|FG001|Overall Study|Lack of Efficacy|0|||
146996191|NCT02140060|530149370|FG002|Overall Study|Lack of Efficacy|0|||
146996192|NCT02140060|530149371|FG003|Overall Study|Lack of Efficacy|1|||
146996193|NCT02140060|530149372|FG004|Overall Study|Lack of Efficacy|0|||
146996194|NCT02140060|530149373|FG005|Overall Study|Lack of Efficacy|0|||
146996195|NCT00520130|530151484|FG000|Overall Study|Disease progression on study|4|||
146996196|NCT00520130|530151485|FG001|Overall Study|Disease progression on study|0|||
146996197|NCT00520130|530151484|FG000|Overall Study|Physician Decision|1|||
146996198|NCT00520130|530151485|FG001|Overall Study|Physician Decision|1|||
146996199|NCT04915755|530151486|FG000|Overall Study|Physician Decision|3|||
146996200|NCT04915755|530151487|FG001|Overall Study|Physician Decision|2|||
146996201|NCT04915755|530151486|FG000|Overall Study|Withdrawal by Subject|1|||
146996202|NCT04915755|530151487|FG001|Overall Study|Withdrawal by Subject|1|||
146996203|NCT04915755|530151486|FG000|Overall Study|Ongoing for PACT|3|||
146996204|NCT04915755|530151487|FG001|Overall Study|Ongoing for PACT|2|||
146996205|NCT04915755|530151486|FG000|Overall Study|Other|7|||
146996206|NCT04915755|530151487|FG001|Overall Study|Other|11|||
146996207|NCT01993030|530151491|FG000|Overall Study|Adverse Event|0|||
146996208|NCT01993030|530151492|FG001|Overall Study|Adverse Event|4|||
146996209|NCT02736721|530151493|FG000|Overall Study|Adverse Event|8|||
146996210|NCT02736721|530151493|FG000|Overall Study|Lost to Follow-up|3|||
146996211|NCT02736721|530151493|FG000|Overall Study|Other|5|||
146996212|NCT01034358|530151494|FG000|Overall Study|Withdrawal by Subject|1|||
146996213|NCT01034358|530151494|FG000|Overall Study|Protocol Violation|1|||
146996214|NCT01838941|530151495|FG000|Overall Study|Adverse Event|1|||
146996215|NCT01838941|530151495|FG000|Overall Study|Withdrawal by Subject|1|||
146996216|NCT01534663|530151498|FG000|Overall Study|Lost to Follow-up|0|||
146996217|NCT01534663|530151499|FG001|Overall Study|Lost to Follow-up|2|||
146996218|NCT01534663|530151498|FG000|Overall Study|Adverse Event|2|||
146996219|NCT01534663|530151499|FG001|Overall Study|Adverse Event|1|||
146996220|NCT04088760|530151502|FG000|Overall Study|Physician Decision|1|||
146996221|NCT00377260|530151503|FG000|Overall Study|Lost to Follow-up|0|||
146996222|NCT00377260|530151504|FG001|Overall Study|Lost to Follow-up|1|||
146996223|NCT00377260|530151503|FG000|Overall Study|Withdrawal by Subject|2|||
146996224|NCT00377260|530151504|FG001|Overall Study|Withdrawal by Subject|4|||
146996225|NCT01391793|530151505|FG000|Overall Study|Ineligible|3|||
146996226|NCT01391793|530151506|FG001|Overall Study|Ineligible|0|||
146842335|NCT02367040|529592180|FG001|Overall Study|Required procedure failed|0|||
146842336|NCT02367040|529592179|FG000|Overall Study|Randomized by mistake with study treatment|1|||
146842337|NCT02367040|529592180|FG001|Overall Study|Randomized by mistake with study treatment|0|||
146842338|NCT02367040|529592179|FG000|Overall Study|Protocol Violation|1|||
146842339|NCT02367040|529592180|FG001|Overall Study|Protocol Violation|0|||
146842340|NCT02367040|529592179|FG000|Overall Study|Progressive disease - radiological progression|54|||
146842341|NCT02367040|529592180|FG001|Overall Study|Progressive disease - radiological progression|80|||
146842342|NCT02367040|529592179|FG000|Overall Study|Progressive disease - clinical progression|6|||
146842343|NCT02367040|529592180|FG001|Overall Study|Progressive disease - clinical progression|6|||
146842344|NCT02367040|529592179|FG000|Overall Study|Drug not administered|3|||
146996227|NCT01391793|530151505|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
146996228|NCT01391793|530151506|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
146996229|NCT01391793|530151505|FG000|Overall Study|No DMSA|73|||
146996230|NCT01391793|530151506|FG001|Overall Study|No DMSA|57|||
146996231|NCT01015625|530151507|FG000|Overall Study|Lost to Follow-up|3|||
146996232|NCT01015625|530151508|FG001|Overall Study|Lost to Follow-up|1|||
146996233|NCT01015625|530151507|FG000|Overall Study|Withdrawal by Subject|2|||
146996234|NCT01015625|530151508|FG001|Overall Study|Withdrawal by Subject|3|||
146996235|NCT01015625|530151507|FG000|Overall Study|Physician Decision|2|||
146996236|NCT01015625|530151508|FG001|Overall Study|Physician Decision|0|||
146842345|NCT02367040|529592180|FG001|Overall Study|Drug not administered|2|||
146842346|NCT02367040|529592179|FG000|Overall Study|Progressive disease|0|||
146842347|NCT02367040|529592180|FG001|Overall Study|Progressive disease|1|||
146842348|NCT02367040|529592179|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
146842349|NCT02367040|529592180|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
146842350|NCT02367040|529592179|FG000|Overall Study|Death|2|||
146842351|NCT02367040|529592180|FG001|Overall Study|Death|0|||
146842352|NCT02367040|529592179|FG000|Overall Study|Study terminated by sponsor|19|||
146842353|NCT02367040|529592180|FG001|Overall Study|Study terminated by sponsor|2|||
146842354|NCT01876082|529593856|FG000|Overall Study|Withdrawal by Subject|0|||
146842355|NCT01876082|529593857|FG001|Overall Study|Withdrawal by Subject|2|||
146842356|NCT01876082|529593856|FG000|Overall Study|Protocol Violation|1|||
146842357|NCT01876082|529593857|FG001|Overall Study|Protocol Violation|0|||
146842358|NCT01876082|529593856|FG000|Overall Study|Adverse Event|1|||
146842359|NCT01876082|529593857|FG001|Overall Study|Adverse Event|1|||
146842360|NCT01876082|529593856|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
146996237|NCT01015625|530151507|FG000|Overall Study|Death|30|||
146996238|NCT01015625|530151508|FG001|Overall Study|Death|22|||
146996239|NCT03136380|530151510|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
146996240|NCT03136380|530151511|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
146996241|NCT03136380|530151512|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
146996242|NCT03136380|530151513|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
146996243|NCT03136380|530151514|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
146996244|NCT02419937|530151518|FG000|Overall Study|Lost to Follow-up|1|||
146996245|NCT02419937|530151519|FG001|Overall Study|Lost to Follow-up|0|||
146842361|NCT01876082|529593857|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
146842362|NCT02964013|529593858|FG000|Overall Study|Death|58|||
146842363|NCT02964013|529593859|FG001|Overall Study|Death|239|||
146996246|NCT00286754|530151520|FG000|Overall Study|Adverse Event|2|||
146842364|NCT02964013|529593860|FG002|Overall Study|Death|38|||
146842365|NCT02964013|529593861|FG003|Overall Study|Death|10|||
146842366|NCT02964013|529593862|FG004|Overall Study|Death|33|||
146842367|NCT02964013|529593858|FG000|Overall Study|Lost to Follow-up|1|||
146842368|NCT02964013|529593859|FG001|Overall Study|Lost to Follow-up|4|||
146842369|NCT02964013|529593860|FG002|Overall Study|Lost to Follow-up|2|||
146842370|NCT02964013|529593861|FG003|Overall Study|Lost to Follow-up|0|||
146842371|NCT02964013|529593862|FG004|Overall Study|Lost to Follow-up|0|||
146842372|NCT02964013|529593858|FG000|Overall Study|Physician Decision|0|||
146842373|NCT02964013|529593859|FG001|Overall Study|Physician Decision|1|||
146842374|NCT02964013|529593860|FG002|Overall Study|Physician Decision|0|||
146842375|NCT02964013|529593861|FG003|Overall Study|Physician Decision|0|||
146842376|NCT02964013|529593862|FG004|Overall Study|Physician Decision|0|||
146842377|NCT02964013|529593858|FG000|Overall Study|Sponsor Decision|3|||
146842378|NCT02964013|529593859|FG001|Overall Study|Sponsor Decision|22|||
146842379|NCT02964013|529593860|FG002|Overall Study|Sponsor Decision|11|||
146842380|NCT02964013|529593861|FG003|Overall Study|Sponsor Decision|0|||
146842381|NCT02964013|529593862|FG004|Overall Study|Sponsor Decision|7|||
146842382|NCT02964013|529593858|FG000|Overall Study|Withdrawal by Subject|6|||
146842383|NCT02964013|529593859|FG001|Overall Study|Withdrawal by Subject|27|||
146842384|NCT02964013|529593860|FG002|Overall Study|Withdrawal by Subject|9|||
146842385|NCT02964013|529593861|FG003|Overall Study|Withdrawal by Subject|0|||
146842386|NCT02964013|529593862|FG004|Overall Study|Withdrawal by Subject|0|||
146842387|NCT02964013|529593858|FG000|Overall Study|Not Treated|0|||
146842388|NCT02964013|529593859|FG001|Overall Study|Not Treated|2|||
146842389|NCT02964013|529593860|FG002|Overall Study|Not Treated|0|||
146842390|NCT02964013|529593861|FG003|Overall Study|Not Treated|1|||
146842391|NCT02964013|529593862|FG004|Overall Study|Not Treated|0|||
146996247|NCT00286754|530151521|FG001|Overall Study|Adverse Event|2|||
146996248|NCT00286754|530151522|FG002|Overall Study|Adverse Event|3|||
146996249|NCT00286754|530151520|FG000|Overall Study|Withdrawal by Subject|6|||
146996250|NCT00286754|530151521|FG001|Overall Study|Withdrawal by Subject|2|||
146996251|NCT00286754|530151522|FG002|Overall Study|Withdrawal by Subject|0|||
146996252|NCT00286754|530151520|FG000|Overall Study|Lost to Follow-up|12|||
146996253|NCT00286754|530151521|FG001|Overall Study|Lost to Follow-up|14|||
146842392|NCT01123070|529593863|FG000|Part B Double Blind Period|Protocol Violation|0|||
146842393|NCT01123070|529593864|FG001|Part B Double Blind Period|Protocol Violation|0|||
146842394|NCT01123070|529593865|FG002|Part B Double Blind Period|Protocol Violation|0|||
146842395|NCT01123070|529593866|FG003|Part B Double Blind Period|Protocol Violation|1|||
146842396|NCT01123070|529593863|FG000|Part B Double Blind Period|Adverse Event|0|||
146842397|NCT01123070|529593864|FG001|Part B Double Blind Period|Adverse Event|0|||
146842398|NCT01123070|529593865|FG002|Part B Double Blind Period|Adverse Event|2|||
146842399|NCT01123070|529593866|FG003|Part B Double Blind Period|Adverse Event|0|||
146842400|NCT01123070|529593863|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
146842401|NCT01123070|529593864|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
146842402|NCT01123070|529593865|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
146842403|NCT01123070|529593866|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
146842404|NCT03284229|529593867|FG000|Overall Study|Lost to Follow-up|3|||
146842405|NCT01977677|529593868|FG000|Overall Study|Unrelated Adverse Event|0|||
146842406|NCT01977677|529593869|FG001|Overall Study|Unrelated Adverse Event|0|||
146842407|NCT01977677|529593870|FG002|Overall Study|Unrelated Adverse Event|1|||
146842408|NCT01498887|529593871|FG000|Overall Study|Administrative problems|1|||
146842409|NCT01498887|529593872|FG001|Overall Study|Administrative problems|0|||
146842410|NCT01498887|529593871|FG000|Overall Study|Lost to Follow-up|1|||
146842411|NCT01498887|529593872|FG001|Overall Study|Lost to Follow-up|1|||
146842412|NCT01498887|529593871|FG000|Overall Study|Withdrawal by Subject|1|||
146842413|NCT01498887|529593872|FG001|Overall Study|Withdrawal by Subject|0|||
146842414|NCT01498887|529593871|FG000|Overall Study|Protocol Violation|1|||
146842415|NCT01498887|529593872|FG001|Overall Study|Protocol Violation|3|||
146842416|NCT01498887|529593871|FG000|Overall Study|Lack of Efficacy|5|||
146842417|NCT01498887|529593872|FG001|Overall Study|Lack of Efficacy|3|||
146842418|NCT01498887|529593871|FG000|Overall Study|Abnormal result from test procedure|1|||
146842419|NCT01498887|529593872|FG001|Overall Study|Abnormal result from test procedure|1|||
146842420|NCT01498887|529593871|FG000|Overall Study|Abnormal laboratory value|2|||
146842421|NCT01498887|529593872|FG001|Overall Study|Abnormal laboratory value|2|||
146842422|NCT01498887|529593871|FG000|Overall Study|Adverse Event|4|||
146842423|NCT01498887|529593872|FG001|Overall Study|Adverse Event|1|||
146842424|NCT00667225|529593877|FG000|Overall Study|Subject had no more lesions to treat.|1|||
146842425|NCT00667225|529593878|FG001|Overall Study|Subject had no more lesions to treat.|0|||
146842426|NCT00667225|529593877|FG000|Overall Study|Lost to Follow-up|0|||
146842427|NCT00667225|529593878|FG001|Overall Study|Lost to Follow-up|1|||
146842428|NCT02993406|529593885|FG000|Overall Study|Withdrawal by Subject|170|||
146842429|NCT02993406|529593886|FG001|Overall Study|Withdrawal by Subject|196|||
146842430|NCT02993406|529593885|FG000|Overall Study|Physician Decision|3|||
146842431|NCT02993406|529593886|FG001|Overall Study|Physician Decision|5|||
146842432|NCT02993406|529593885|FG000|Overall Study|Lost to Follow-up|12|||
146842433|NCT02993406|529593886|FG001|Overall Study|Lost to Follow-up|13|||
146996254|NCT00286754|530151522|FG002|Overall Study|Lost to Follow-up|6|||
146842434|NCT02993406|529593885|FG000|Overall Study|Unclassifiable Response|105|||
146842435|NCT02993406|529593886|FG001|Overall Study|Unclassifiable Response|139|||
146842436|NCT02993406|529593885|FG000|Overall Study|Administrative decision|1|||
146842437|NCT02993406|529593886|FG001|Overall Study|Administrative decision|0|||
146842438|NCT02993406|529593885|FG000|Overall Study|Sponsor decision|4|||
146842439|NCT02993406|529593886|FG001|Overall Study|Sponsor decision|5|||
146842440|NCT03563157|529593887|FG000|Overall Study|Progressive Disease|2|||
146842441|NCT02248818|529593888|FG000|Screening|Protocol Violation|0|||
146842442|NCT02248818|529593889|FG001|Screening|Protocol Violation|0|||
146842443|NCT02248818|529593890|FG002|Screening|Protocol Violation|0|||
146842444|NCT02248818|529593891|FG003|Screening|Protocol Violation|0|||
146842445|NCT02248818|529593892|FG004|Screening|Protocol Violation|0|||
146842446|NCT02248818|529593893|FG005|Screening|Protocol Violation|0|||
146842447|NCT02248818|529593894|FG006|Screening|Protocol Violation|0|||
146842448|NCT02248818|529593895|FG007|Screening|Protocol Violation|0|||
146842449|NCT02248818|529593896|FG008|Screening|Protocol Violation|7|||
146842450|NCT02248818|529593888|FG000|Screening|Study fully enrolled|0|||
146842451|NCT02248818|529593889|FG001|Screening|Study fully enrolled|0|||
146842452|NCT02248818|529593890|FG002|Screening|Study fully enrolled|0|||
146996255|NCT00286754|530151520|FG000|Overall Study|Moved out of state|0|||
146996256|NCT00286754|530151521|FG001|Overall Study|Moved out of state|0|||
146996257|NCT00286754|530151522|FG002|Overall Study|Moved out of state|1|||
146996258|NCT02661295|530151523|FG000|Overall Study|Death|1|||
146996259|NCT02661295|530151523|FG000|Overall Study|Transferred Out|1|||
146996260|NCT02661295|530151523|FG000|Overall Study|Kidney Transplant|1|||
146996261|NCT02661295|530151523|FG000|Overall Study|Withdrawn due to side effects|8|||
146996262|NCT02661295|530151523|FG000|Overall Study|Withdrawn due to access type|1|||
146996263|NCT02661295|530151523|FG000|Overall Study|Withdrawn due to allergies|1|||
146996264|NCT02661295|530151523|FG000|Overall Study|Withdrawn due to non-compliance|1|||
146996265|NCT02661295|530151523|FG000|Overall Study|Withdrawal by Subject|3|||
146996266|NCT02661295|530151523|FG000|Overall Study|Failed screening|2|||
146996267|NCT00910663|530151524|FG000|Period 1|Withdrawal by Subject|0|||
146996268|NCT00910663|530151525|FG001|Period 1|Withdrawal by Subject|1|||
146996269|NCT02726581|530151526|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
146996270|NCT02726581|530151527|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
146996271|NCT02726581|530151528|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
146996272|NCT02726581|530151526|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
146996273|NCT02726581|530151527|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
146996274|NCT02726581|530151528|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
146996275|NCT02726581|530151526|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
146996276|NCT02726581|530151527|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146996277|NCT02726581|530151528|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146996278|NCT02726581|530151526|FG000|Treatment Period|Disease progression|47|||
146996279|NCT02726581|530151527|FG001|Treatment Period|Disease progression|50|||
146996280|NCT02726581|530151528|FG002|Treatment Period|Disease progression|16|||
146996281|NCT02726581|530151526|FG000|Treatment Period|Other reasons|9|||
146996282|NCT02726581|530151527|FG001|Treatment Period|Other reasons|8|||
146996283|NCT02726581|530151528|FG002|Treatment Period|Other reasons|2|||
146996284|NCT02726581|530151526|FG000|Treatment Period|Study drug toxicity|6|||
146996285|NCT02726581|530151527|FG001|Treatment Period|Study drug toxicity|3|||
146996286|NCT02726581|530151528|FG002|Treatment Period|Study drug toxicity|2|||
146996287|NCT02726581|530151526|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
146996288|NCT02726581|530151527|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
146996289|NCT02726581|530151528|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
146996290|NCT02726581|530151526|FG000|Treatment Period|Participant withdrew consent|3|||
146996291|NCT02726581|530151527|FG001|Treatment Period|Participant withdrew consent|1|||
146996292|NCT02726581|530151528|FG002|Treatment Period|Participant withdrew consent|1|||
146842453|NCT02248818|529593891|FG003|Screening|Study fully enrolled|0|||
146842454|NCT02248818|529593892|FG004|Screening|Study fully enrolled|0|||
146996293|NCT02726581|530151526|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
146996294|NCT02726581|530151527|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
146996295|NCT02726581|530151528|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
146996296|NCT02726581|530151526|FG000|Treatment Period|Maximum clinical benefit|0|||
146996297|NCT02726581|530151527|FG001|Treatment Period|Maximum clinical benefit|2|||
146996298|NCT02726581|530151528|FG002|Treatment Period|Maximum clinical benefit|0|||
146996299|NCT02726581|530151526|FG000|Treatment Period|Death|1|||
146996300|NCT02726581|530151527|FG001|Treatment Period|Death|0|||
146996301|NCT02726581|530151528|FG002|Treatment Period|Death|0|||
146996302|NCT02726581|530151526|FG000|Treatment Period|Poor/non-compliance|1|||
146996303|NCT02726581|530151527|FG001|Treatment Period|Poor/non-compliance|0|||
146996304|NCT02726581|530151528|FG002|Treatment Period|Poor/non-compliance|0|||
146842455|NCT02248818|529593893|FG005|Screening|Study fully enrolled|0|||
146842456|NCT02248818|529593894|FG006|Screening|Study fully enrolled|0|||
146842457|NCT02248818|529593895|FG007|Screening|Study fully enrolled|0|||
146996305|NCT02726581|530151526|FG000|Treatment Period|Participant no longer meets study criteria|0|||
146996306|NCT02726581|530151527|FG001|Treatment Period|Participant no longer meets study criteria|1|||
146996307|NCT02726581|530151528|FG002|Treatment Period|Participant no longer meets study criteria|0|||
146996308|NCT02865850|530151529|FG000|Overall Study|Death|15|||
146842458|NCT02248818|529593896|FG008|Screening|Study fully enrolled|14|||
146842459|NCT02248818|529593888|FG000|Screening|Physician Decision|0|||
146842460|NCT02248818|529593889|FG001|Screening|Physician Decision|0|||
146842461|NCT02248818|529593890|FG002|Screening|Physician Decision|0|||
146842462|NCT02248818|529593891|FG003|Screening|Physician Decision|0|||
146842463|NCT02248818|529593892|FG004|Screening|Physician Decision|0|||
146842464|NCT02248818|529593893|FG005|Screening|Physician Decision|0|||
146842465|NCT02248818|529593894|FG006|Screening|Physician Decision|0|||
146842466|NCT02248818|529593895|FG007|Screening|Physician Decision|0|||
146842467|NCT02248818|529593896|FG008|Screening|Physician Decision|73|||
146996309|NCT02865850|530151530|FG001|Overall Study|Death|19|||
146996310|NCT02865850|530151529|FG000|Overall Study|Withdrawal by Subject|3|||
146996311|NCT02865850|530151530|FG001|Overall Study|Withdrawal by Subject|2|||
146996312|NCT02865850|530151529|FG000|Overall Study|Lost to Follow-up|3|||
146996313|NCT02865850|530151530|FG001|Overall Study|Lost to Follow-up|2|||
146996314|NCT01844375|530151534|FG000|Overall Study|Protocol Violation|1|||
146996315|NCT01844375|530151535|FG001|Overall Study|Protocol Violation|1|||
146996316|NCT01772537|530151537|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
146996317|NCT01772537|530151538|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
146996318|NCT01772537|530151539|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
146996319|NCT03627091|530151540|FG000|Overall Study|Adverse Event|0|||
146996320|NCT03627091|530151541|FG001|Overall Study|Adverse Event|0|||
146996321|NCT03627091|530151542|FG002|Overall Study|Adverse Event|2|||
146996322|NCT03627091|530151540|FG000|Overall Study|Withdrawal by Subject|2|||
146996323|NCT03627091|530151541|FG001|Overall Study|Withdrawal by Subject|0|||
146996324|NCT03627091|530151542|FG002|Overall Study|Withdrawal by Subject|2|||
146996325|NCT03627091|530151540|FG000|Overall Study|Physician Decision|2|||
146996326|NCT03627091|530151541|FG001|Overall Study|Physician Decision|0|||
146996327|NCT03627091|530151542|FG002|Overall Study|Physician Decision|0|||
146996328|NCT03627091|530151540|FG000|Overall Study|Site terminated by sponsor|0|||
146996329|NCT03627091|530151541|FG001|Overall Study|Site terminated by sponsor|1|||
146996330|NCT03627091|530151542|FG002|Overall Study|Site terminated by sponsor|0|||
146996331|NCT03627091|530151540|FG000|Overall Study|Disease relapse|7|||
146996332|NCT03627091|530151541|FG001|Overall Study|Disease relapse|5|||
146996333|NCT03627091|530151542|FG002|Overall Study|Disease relapse|1|||
146996334|NCT03627091|530151540|FG000|Overall Study|Other|1|||
146996335|NCT03627091|530151541|FG001|Overall Study|Other|0|||
146996336|NCT03627091|530151542|FG002|Overall Study|Other|0|||
146996337|NCT00450190|530151543|FG000|Overall Study|Withdrawal by Subject|2|||
146996338|NCT01536574|530151544|FG000|Overall Study|Adverse Event|4|||
146996339|NCT01536574|530151545|FG001|Overall Study|Adverse Event|5|||
146996340|NCT01536574|530151544|FG000|Overall Study|Withdrawal by Subject|1|||
146996341|NCT01536574|530151545|FG001|Overall Study|Withdrawal by Subject|2|||
146996342|NCT01536574|530151544|FG000|Overall Study|Lack of Efficacy|1|||
146996343|NCT01536574|530151545|FG001|Overall Study|Lack of Efficacy|0|||
146996344|NCT01376167|530151546|FG000|Overall Study|Lost to Follow-up|2|||
146996345|NCT01376167|530151547|FG001|Overall Study|Lost to Follow-up|4|||
146996346|NCT01376167|530151548|FG002|Overall Study|Lost to Follow-up|2|||
146996347|NCT01376167|530151546|FG000|Overall Study|Physician Decision|1|||
146996348|NCT01376167|530151547|FG001|Overall Study|Physician Decision|1|||
146996349|NCT01376167|530151548|FG002|Overall Study|Physician Decision|0|||
146996350|NCT01376167|530151546|FG000|Overall Study|Withdrawal by Subject|1|||
146996351|NCT01376167|530151547|FG001|Overall Study|Withdrawal by Subject|5|||
146996352|NCT01376167|530151548|FG002|Overall Study|Withdrawal by Subject|4|||
146996353|NCT00834756|530151549|FG000|First Intervention|Adverse Event|1|||
146996354|NCT00834756|530151550|FG001|First Intervention|Adverse Event|0|||
146996355|NCT00834756|530151549|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
146996356|NCT00834756|530151550|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
146842468|NCT02248818|529593888|FG000|Screening|Withdrawal by Subject|0|||
146842469|NCT02248818|529593889|FG001|Screening|Withdrawal by Subject|0|||
146842470|NCT02248818|529593890|FG002|Screening|Withdrawal by Subject|0|||
146996357|NCT02193165|530151553|FG000|4 Week Product Use|Lost to Follow-up|1|||
146996358|NCT02193165|530151554|FG001|4 Week Product Use|Lost to Follow-up|1|||
146996359|NCT02193165|530151555|FG002|4 Week Product Use|Lost to Follow-up|1|||
146842471|NCT02248818|529593891|FG003|Screening|Withdrawal by Subject|0|||
146842472|NCT02248818|529593892|FG004|Screening|Withdrawal by Subject|0|||
146996360|NCT02193165|530151553|FG000|6 Week Product Use|Lost to Follow-up|0|||
146996361|NCT02193165|530151554|FG001|6 Week Product Use|Lost to Follow-up|1|||
146996362|NCT02193165|530151555|FG002|6 Week Product Use|Lost to Follow-up|0|||
146996363|NCT04239872|530151556|FG000|Overall Study|Lost to Follow-up|0|||
146996364|NCT04239872|530151557|FG001|Overall Study|Lost to Follow-up|1|||
146996365|NCT01498120|530151561|FG000|Overall Study|Lost to Follow-up|1|||
146996366|NCT01498120|530151561|FG000|Overall Study|Withdrawal by Subject|5|||
146996367|NCT01498120|530151561|FG000|Overall Study|AE, non-serious non-fatal|3|||
146996368|NCT01498120|530151561|FG000|Overall Study|Other|4|||
146996369|NCT01173692|530151562|FG000|Overall Study|Adverse Event|1|||
146996370|NCT01173692|530151563|FG001|Overall Study|Adverse Event|2|||
146996371|NCT01173692|530151562|FG000|Overall Study|Withdrawal by Subject|1|||
146996372|NCT01173692|530151563|FG001|Overall Study|Withdrawal by Subject|3|||
146996373|NCT01472341|530151564|FG000|Overall Study|Started insulin therapy|55|||
146996374|NCT01472341|530151564|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
146996375|NCT01472341|530151564|FG000|Overall Study|Withdrawal by Subject|39|||
146996376|NCT01472341|530151564|FG000|Overall Study|Lost to Follow-up|52|||
146996377|NCT01472341|530151564|FG000|Overall Study|Laboratory parameters unavailable|25|||
146996378|NCT01472341|530151564|FG000|Overall Study|Death|9|||
146996379|NCT00579670|530151565|FG000|Overall Study|Death|1|||
146996380|NCT00579670|530151566|FG001|Overall Study|Death|0|||
146996381|NCT00579670|530151567|FG002|Overall Study|Death|0|||
146996382|NCT00579670|530151568|FG003|Overall Study|Death|0|||
146996383|NCT00579670|530151569|FG004|Overall Study|Death|0|||
146996384|NCT00579670|530151565|FG000|Overall Study|Adverse Event|1|||
146996385|NCT00579670|530151566|FG001|Overall Study|Adverse Event|0|||
146996386|NCT00579670|530151567|FG002|Overall Study|Adverse Event|1|||
146996387|NCT00579670|530151568|FG003|Overall Study|Adverse Event|2|||
146996388|NCT00579670|530151569|FG004|Overall Study|Adverse Event|0|||
146996389|NCT00579670|530151565|FG000|Overall Study|Lack of Efficacy|0|||
146996390|NCT00579670|530151566|FG001|Overall Study|Lack of Efficacy|0|||
146996391|NCT00579670|530151567|FG002|Overall Study|Lack of Efficacy|1|||
146996392|NCT00579670|530151568|FG003|Overall Study|Lack of Efficacy|14|||
146996393|NCT00579670|530151569|FG004|Overall Study|Lack of Efficacy|0|||
146996394|NCT00579670|530151565|FG000|Overall Study|Lost to Follow-up|0|||
146996395|NCT00579670|530151566|FG001|Overall Study|Lost to Follow-up|1|||
146996396|NCT00579670|530151567|FG002|Overall Study|Lost to Follow-up|0|||
146996397|NCT00579670|530151568|FG003|Overall Study|Lost to Follow-up|4|||
146996398|NCT00579670|530151569|FG004|Overall Study|Lost to Follow-up|0|||
146996399|NCT00579670|530151565|FG000|Overall Study|Other|0|||
146996400|NCT00579670|530151566|FG001|Overall Study|Other|0|||
146996401|NCT00579670|530151567|FG002|Overall Study|Other|1|||
146996402|NCT00579670|530151568|FG003|Overall Study|Other|2|||
146996403|NCT00579670|530151569|FG004|Overall Study|Other|0|||
146996404|NCT00579670|530151565|FG000|Overall Study|Withdrawal by Subject|0|||
146996405|NCT00579670|530151566|FG001|Overall Study|Withdrawal by Subject|0|||
146996406|NCT00579670|530151567|FG002|Overall Study|Withdrawal by Subject|1|||
146996407|NCT00579670|530151568|FG003|Overall Study|Withdrawal by Subject|0|||
146996408|NCT00579670|530151569|FG004|Overall Study|Withdrawal by Subject|0|||
146996409|NCT01118312|530151575|FG000|Overall Study|Lost to Follow-up|33|||
146996410|NCT01118312|530151576|FG001|Overall Study|Lost to Follow-up|32|||
146996411|NCT01118312|530151575|FG000|Overall Study|Withdrawal by Subject|1|||
146996412|NCT01118312|530151576|FG001|Overall Study|Withdrawal by Subject|3|||
146996413|NCT00678639|530151577|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
146996414|NCT00678639|530151578|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
146996415|NCT01546545|530151581|FG000|Overall Study|Withdrawal by Subject|1|||
146996416|NCT04060147|530151582|FG000|Overall Study|Withdrew consent|1|||
146996417|NCT00986245|530151583|FG000|First Intervention|Poor compliance|8|||
146996418|NCT00986245|530151584|FG001|First Intervention|Poor compliance|4|||
146996419|NCT00986245|530151583|FG000|First Intervention|Lack of Efficacy|1|||
146996420|NCT00986245|530151584|FG001|First Intervention|Lack of Efficacy|2|||
146996421|NCT00986245|530151583|FG000|First Intervention|Withdrawal by Subject|0|||
146996422|NCT00986245|530151584|FG001|First Intervention|Withdrawal by Subject|1|||
146996423|NCT00986245|530151583|FG000|First Intervention|Protocol Violation|0|||
146996424|NCT00986245|530151584|FG001|First Intervention|Protocol Violation|1|||
146996425|NCT00986245|530151583|FG000|First Intervention|Out of indication|1|||
146996426|NCT00986245|530151584|FG001|First Intervention|Out of indication|0|||
146996427|NCT00986245|530151583|FG000|Second Intervention|Poor compliance|1|||
146996428|NCT00986245|530151584|FG001|Second Intervention|Poor compliance|0|||
146996429|NCT00986245|530151583|FG000|Second Intervention|Lost to Follow-up|1|||
146996430|NCT00986245|530151584|FG001|Second Intervention|Lost to Follow-up|0|||
146996431|NCT00986245|530151583|FG000|Second Intervention|Protocol Violation|0|||
146996432|NCT00986245|530151584|FG001|Second Intervention|Protocol Violation|1|||
146996433|NCT01214850|530151585|FG000|Overall Study|Withdrawal by Subject|38|||
146996434|NCT01214850|530151586|FG001|Overall Study|Withdrawal by Subject|31|||
146996435|NCT01214850|530151587|FG002|Overall Study|Withdrawal by Subject|28|||
146996436|NCT01214850|530151585|FG000|Overall Study|Lost to Follow-up|124|||
146996437|NCT01214850|530151586|FG001|Overall Study|Lost to Follow-up|98|||
146996438|NCT01214850|530151587|FG002|Overall Study|Lost to Follow-up|123|||
146996439|NCT01214850|530151585|FG000|Overall Study|Protocol Violation|5|||
146996440|NCT01214850|530151586|FG001|Overall Study|Protocol Violation|5|||
146996441|NCT01214850|530151587|FG002|Overall Study|Protocol Violation|6|||
146996442|NCT01214850|530151585|FG000|Overall Study|Adverse event or death|11|||
146996443|NCT01214850|530151586|FG001|Overall Study|Adverse event or death|8|||
146996444|NCT01214850|530151587|FG002|Overall Study|Adverse event or death|3|||
146996445|NCT01214850|530151585|FG000|Overall Study|Inappropriate enrollment|2|||
146996446|NCT01214850|530151586|FG001|Overall Study|Inappropriate enrollment|1|||
146996447|NCT01214850|530151587|FG002|Overall Study|Inappropriate enrollment|0|||
146996448|NCT01214850|530151585|FG000|Overall Study|Administrative reason|1|||
146996449|NCT01214850|530151586|FG001|Overall Study|Administrative reason|0|||
146996450|NCT01214850|530151587|FG002|Overall Study|Administrative reason|0|||
146996451|NCT01214850|530151585|FG000|Overall Study|Unable to classify|2|||
146996452|NCT01214850|530151586|FG001|Overall Study|Unable to classify|1|||
146996453|NCT01214850|530151587|FG002|Overall Study|Unable to classify|1|||
146996454|NCT00610363|530151588|FG000|Overall Study|Non-compliance with protocol|0|||
146996455|NCT00610363|530151589|FG001|Overall Study|Non-compliance with protocol|1|||
146996456|NCT00610363|530151588|FG000|Overall Study|Adverse Event|3|||
146996457|NCT00610363|530151589|FG001|Overall Study|Adverse Event|1|||
146996458|NCT00610363|530151588|FG000|Overall Study|Lack of Efficacy|2|||
146996459|NCT00610363|530151589|FG001|Overall Study|Lack of Efficacy|0|||
146996460|NCT00610363|530151588|FG000|Overall Study|Lost to Follow-up|4|||
146996461|NCT00610363|530151589|FG001|Overall Study|Lost to Follow-up|0|||
146996462|NCT00610363|530151588|FG000|Overall Study|Withdrawal by Subject|1|||
146996463|NCT00610363|530151589|FG001|Overall Study|Withdrawal by Subject|0|||
146996464|NCT00610363|530151588|FG000|Overall Study|Other than specified above|1|||
146996465|NCT00610363|530151589|FG001|Overall Study|Other than specified above|1|||
146996466|NCT03204539|530151590|FG000|Overall Study|Loss of funding|0|||
146996467|NCT03204539|530151591|FG001|Overall Study|Loss of funding|1|||
146996468|NCT00302952|530151605|FG000|Overall Study|Physician Decision|1|||
146996469|NCT00302952|530151606|FG001|Overall Study|Physician Decision|1|||
146996470|NCT00302952|530151605|FG000|Overall Study|Withdrawal by Subject|2|||
146996471|NCT00302952|530151606|FG001|Overall Study|Withdrawal by Subject|3|||
146996472|NCT00302952|530151605|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
146996473|NCT00302952|530151606|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
146996474|NCT00336479|530151607|FG000|Overall Study|Adverse Event|8|||
146996475|NCT00336479|530151608|FG001|Overall Study|Adverse Event|11|||
146996476|NCT00336479|530151609|FG002|Overall Study|Adverse Event|18|||
146996477|NCT00336479|530151610|FG003|Overall Study|Adverse Event|4|||
146996478|NCT00336479|530151607|FG000|Overall Study|Noncompliant|1|||
146996479|NCT00336479|530151608|FG001|Overall Study|Noncompliant|7|||
146996480|NCT00336479|530151609|FG002|Overall Study|Noncompliant|3|||
146996481|NCT00336479|530151610|FG003|Overall Study|Noncompliant|0|||
146996482|NCT00336479|530151607|FG000|Overall Study|Physician Decision|2|||
146996483|NCT00336479|530151608|FG001|Overall Study|Physician Decision|3|||
146996484|NCT00336479|530151609|FG002|Overall Study|Physician Decision|1|||
146996485|NCT00336479|530151610|FG003|Overall Study|Physician Decision|0|||
146996486|NCT00336479|530151607|FG000|Overall Study|Lost to Follow-up|3|||
146996487|NCT00336479|530151608|FG001|Overall Study|Lost to Follow-up|2|||
146996488|NCT00336479|530151609|FG002|Overall Study|Lost to Follow-up|0|||
146996489|NCT00336479|530151610|FG003|Overall Study|Lost to Follow-up|0|||
146996490|NCT00336479|530151607|FG000|Overall Study|Withdrawal by Subject|3|||
146996491|NCT00336479|530151608|FG001|Overall Study|Withdrawal by Subject|2|||
146996492|NCT00336479|530151609|FG002|Overall Study|Withdrawal by Subject|3|||
146996493|NCT00336479|530151610|FG003|Overall Study|Withdrawal by Subject|0|||
146996494|NCT00336479|530151607|FG000|Overall Study|Other|0|||
146996495|NCT00336479|530151608|FG001|Overall Study|Other|0|||
146996496|NCT00336479|530151609|FG002|Overall Study|Other|1|||
146996497|NCT00336479|530151610|FG003|Overall Study|Other|0|||
146996498|NCT00336479|530151607|FG000|Overall Study|Virologic Stopping Rule|20|||
146996499|NCT00336479|530151608|FG001|Overall Study|Virologic Stopping Rule|0|||
146996500|NCT00336479|530151609|FG002|Overall Study|Virologic Stopping Rule|0|||
146996501|NCT00336479|530151610|FG003|Overall Study|Virologic Stopping Rule|0|||
146996502|NCT00550537|530151611|FG000|Overall Study|Death|18|||
146996503|NCT00550537|530151611|FG000|Overall Study|Adverse Event|20|||
146996504|NCT00550537|530151611|FG000|Overall Study|Disease progression before|46|||
146996505|NCT00550537|530151611|FG000|Overall Study|Withdrawal by Subject|7|||
146996506|NCT00550537|530151611|FG000|Overall Study|Change in treatment plan|4|||
146996507|NCT00550537|530151611|FG000|Overall Study|Other complicating ilness|3|||
146996508|NCT00550537|530151611|FG000|Overall Study|Declining performance status|2|||
146996509|NCT00550537|530151611|FG000|Overall Study|Treated closer to home|4|||
146842473|NCT02248818|529593893|FG005|Screening|Withdrawal by Subject|0|||
146842474|NCT02248818|529593894|FG006|Screening|Withdrawal by Subject|0|||
146996510|NCT02008565|530151612|FG000|Overall Study|Protocol Violation|1|||
146996511|NCT02008565|530151613|FG001|Overall Study|Protocol Violation|1|||
146996512|NCT02008565|530151614|FG002|Overall Study|Protocol Violation|2|||
146996513|NCT02008565|530151615|FG003|Overall Study|Protocol Violation|0|||
146996514|NCT00268905|530151616|FG000|Overall Study|Adverse Event|3|||
146996515|NCT00268905|530151617|FG001|Overall Study|Adverse Event|0|||
146996516|NCT00268905|530151618|FG002|Overall Study|Adverse Event|4|||
146996517|NCT00268905|530151616|FG000|Overall Study|Lost to Follow-up|0|||
146996518|NCT00268905|530151617|FG001|Overall Study|Lost to Follow-up|1|||
146996519|NCT00268905|530151618|FG002|Overall Study|Lost to Follow-up|0|||
146996520|NCT00268905|530151616|FG000|Overall Study|Withdrawal by Subject|0|||
146996521|NCT00268905|530151617|FG001|Overall Study|Withdrawal by Subject|0|||
146996522|NCT00268905|530151618|FG002|Overall Study|Withdrawal by Subject|3|||
146996523|NCT00268905|530151616|FG000|Overall Study|Progressive Disease|28|||
146842475|NCT02248818|529593895|FG007|Screening|Withdrawal by Subject|0|||
146842476|NCT02248818|529593896|FG008|Screening|Withdrawal by Subject|6|||
146842477|NCT02248818|529593888|FG000|Screening|Lost to Follow-up|0|||
146842478|NCT02248818|529593889|FG001|Screening|Lost to Follow-up|0|||
146842479|NCT02248818|529593890|FG002|Screening|Lost to Follow-up|0|||
146842480|NCT02248818|529593891|FG003|Screening|Lost to Follow-up|0|||
146842481|NCT02248818|529593892|FG004|Screening|Lost to Follow-up|0|||
146842482|NCT02248818|529593893|FG005|Screening|Lost to Follow-up|0|||
146842483|NCT02248818|529593894|FG006|Screening|Lost to Follow-up|0|||
146842484|NCT02248818|529593895|FG007|Screening|Lost to Follow-up|0|||
146842485|NCT02248818|529593896|FG008|Screening|Lost to Follow-up|7|||
146842486|NCT02248818|529593888|FG000|Randomised Study|Administrative - randomization error|0|||
146842487|NCT02248818|529593889|FG001|Randomised Study|Administrative - randomization error|0|||
146842488|NCT02248818|529593890|FG002|Randomised Study|Administrative - randomization error|0|||
146842489|NCT02248818|529593891|FG003|Randomised Study|Administrative - randomization error|0|||
146842490|NCT02248818|529593892|FG004|Randomised Study|Administrative - randomization error|0|||
146842491|NCT02248818|529593893|FG005|Randomised Study|Administrative - randomization error|8|||
146842492|NCT02248818|529593894|FG006|Randomised Study|Administrative - randomization error|0|||
146842493|NCT02248818|529593895|FG007|Randomised Study|Administrative - randomization error|0|||
146842494|NCT02248818|529593896|FG008|Randomised Study|Administrative - randomization error|0|||
146842495|NCT05262517|529593897|FG000|Overall Study|Randomized but not treated|5|||
146842496|NCT05262517|529593898|FG001|Overall Study|Randomized but not treated|11|||
146842497|NCT02942277|529593899|FG000|Year 1|Withdrawal by Subject|0|||
146842498|NCT02942277|529593900|FG001|Year 1|Withdrawal by Subject|0|||
146842499|NCT02942277|529593901|FG002|Year 1|Withdrawal by Subject|0|||
146842500|NCT02942277|529593902|FG003|Year 1|Withdrawal by Subject|0|||
146842501|NCT02942277|529593903|FG004|Year 1|Withdrawal by Subject|1|||
146842502|NCT02942277|529593904|FG005|Year 1|Withdrawal by Subject|3|||
146842503|NCT02942277|529593905|FG006|Year 1|Withdrawal by Subject|0|||
146842504|NCT02942277|529593906|FG007|Year 1|Withdrawal by Subject|1|||
146842505|NCT02942277|529593907|FG008|Year 1|Withdrawal by Subject|0|||
146842506|NCT02942277|529593908|FG009|Year 1|Withdrawal by Subject|0|||
146842507|NCT02942277|529593909|FG010|Year 1|Withdrawal by Subject|3|||
146842508|NCT02942277|529593899|FG000|Year 1|Travel|0|||
146842509|NCT02942277|529593900|FG001|Year 1|Travel|1|||
146842510|NCT02942277|529593901|FG002|Year 1|Travel|0|||
146842511|NCT02942277|529593902|FG003|Year 1|Travel|0|||
146842512|NCT02942277|529593903|FG004|Year 1|Travel|4|||
146842513|NCT02942277|529593904|FG005|Year 1|Travel|5|||
146842514|NCT02942277|529593905|FG006|Year 1|Travel|0|||
146842515|NCT02942277|529593906|FG007|Year 1|Travel|0|||
146842516|NCT02942277|529593907|FG008|Year 1|Travel|0|||
146842517|NCT02942277|529593908|FG009|Year 1|Travel|0|||
146842518|NCT02942277|529593909|FG010|Year 1|Travel|8|||
146842519|NCT02942277|529593899|FG000|Year 1|Joined Army|0|||
146842520|NCT02942277|529593900|FG001|Year 1|Joined Army|1|||
146842521|NCT02942277|529593901|FG002|Year 1|Joined Army|0|||
146842522|NCT02942277|529593902|FG003|Year 1|Joined Army|0|||
146842523|NCT02942277|529593903|FG004|Year 1|Joined Army|0|||
146842524|NCT02942277|529593904|FG005|Year 1|Joined Army|0|||
146842525|NCT02942277|529593905|FG006|Year 1|Joined Army|0|||
146842526|NCT02942277|529593906|FG007|Year 1|Joined Army|0|||
146842527|NCT02942277|529593907|FG008|Year 1|Joined Army|0|||
146842528|NCT02942277|529593908|FG009|Year 1|Joined Army|0|||
146842529|NCT02942277|529593909|FG010|Year 1|Joined Army|0|||
146842530|NCT02942277|529593899|FG000|Year 1|Subject met withdrawal criteria|0|||
146842531|NCT02942277|529593900|FG001|Year 1|Subject met withdrawal criteria|0|||
146996524|NCT00268905|530151617|FG001|Overall Study|Progressive Disease|4|||
146996525|NCT00268905|530151618|FG002|Overall Study|Progressive Disease|3|||
146996526|NCT00268905|530151616|FG000|Overall Study|Physician Decision|3|||
146996527|NCT00268905|530151617|FG001|Overall Study|Physician Decision|0|||
146996528|NCT00268905|530151618|FG002|Overall Study|Physician Decision|1|||
146996529|NCT00268905|530151616|FG000|Overall Study|Clinical Progression|9|||
146996530|NCT00268905|530151617|FG001|Overall Study|Clinical Progression|4|||
146996531|NCT00268905|530151618|FG002|Overall Study|Clinical Progression|1|||
146996532|NCT00617305|530151619|FG000|Overall Study|Adverse Event|4|||
146996533|NCT00617305|530151620|FG001|Overall Study|Adverse Event|0|||
146996534|NCT00617305|530151621|FG002|Overall Study|Adverse Event|0|||
146842532|NCT02942277|529593901|FG002|Year 1|Subject met withdrawal criteria|0|||
146842533|NCT02942277|529593902|FG003|Year 1|Subject met withdrawal criteria|1|||
146842534|NCT02942277|529593903|FG004|Year 1|Subject met withdrawal criteria|0|||
146842535|NCT02942277|529593904|FG005|Year 1|Subject met withdrawal criteria|0|||
146842536|NCT02942277|529593905|FG006|Year 1|Subject met withdrawal criteria|0|||
146842537|NCT02942277|529593906|FG007|Year 1|Subject met withdrawal criteria|0|||
146842538|NCT02942277|529593907|FG008|Year 1|Subject met withdrawal criteria|0|||
146842539|NCT02942277|529593908|FG009|Year 1|Subject met withdrawal criteria|0|||
146842540|NCT02942277|529593909|FG010|Year 1|Subject met withdrawal criteria|0|||
146842541|NCT02942277|529593899|FG000|Year 1|Lost to Follow-up|0|||
146842542|NCT02942277|529593900|FG001|Year 1|Lost to Follow-up|0|||
146996535|NCT00617305|530151619|FG000|Overall Study|Death|1|||
146996536|NCT00617305|530151620|FG001|Overall Study|Death|0|||
146842543|NCT02942277|529593901|FG002|Year 1|Lost to Follow-up|0|||
146842544|NCT02942277|529593902|FG003|Year 1|Lost to Follow-up|0|||
146842545|NCT02942277|529593903|FG004|Year 1|Lost to Follow-up|1|||
146842546|NCT02942277|529593904|FG005|Year 1|Lost to Follow-up|0|||
146842547|NCT02942277|529593905|FG006|Year 1|Lost to Follow-up|0|||
146842548|NCT02942277|529593906|FG007|Year 1|Lost to Follow-up|0|||
146842549|NCT02942277|529593907|FG008|Year 1|Lost to Follow-up|0|||
146842550|NCT02942277|529593908|FG009|Year 1|Lost to Follow-up|0|||
146842551|NCT02942277|529593909|FG010|Year 1|Lost to Follow-up|2|||
146842552|NCT02942277|529593899|FG000|Year 1|Protocol Violation|0|||
146842553|NCT02942277|529593900|FG001|Year 1|Protocol Violation|0|||
146842554|NCT02942277|529593901|FG002|Year 1|Protocol Violation|0|||
146842555|NCT02942277|529593902|FG003|Year 1|Protocol Violation|0|||
146842556|NCT02942277|529593903|FG004|Year 1|Protocol Violation|1|||
146842557|NCT02942277|529593904|FG005|Year 1|Protocol Violation|1|||
146842558|NCT02942277|529593905|FG006|Year 1|Protocol Violation|0|||
146842559|NCT02942277|529593906|FG007|Year 1|Protocol Violation|0|||
146842560|NCT02942277|529593907|FG008|Year 1|Protocol Violation|0|||
146842561|NCT02942277|529593908|FG009|Year 1|Protocol Violation|0|||
146842562|NCT02942277|529593909|FG010|Year 1|Protocol Violation|2|||
146842563|NCT02942277|529593899|FG000|Year 1|Pregnancy|0|||
146842564|NCT02942277|529593900|FG001|Year 1|Pregnancy|0|||
146842565|NCT02942277|529593901|FG002|Year 1|Pregnancy|0|||
146842566|NCT02942277|529593902|FG003|Year 1|Pregnancy|0|||
146842567|NCT02942277|529593903|FG004|Year 1|Pregnancy|0|||
146842568|NCT02942277|529593904|FG005|Year 1|Pregnancy|1|||
146842569|NCT02942277|529593905|FG006|Year 1|Pregnancy|0|||
146842570|NCT02942277|529593906|FG007|Year 1|Pregnancy|0|||
146842571|NCT02942277|529593907|FG008|Year 1|Pregnancy|0|||
146842572|NCT02942277|529593908|FG009|Year 1|Pregnancy|0|||
146842573|NCT02942277|529593909|FG010|Year 1|Pregnancy|0|||
146842574|NCT02942277|529593899|FG000|Year 2|Lost to Follow-up|0|||
146842575|NCT02942277|529593900|FG001|Year 2|Lost to Follow-up|0|||
146842576|NCT02942277|529593901|FG002|Year 2|Lost to Follow-up|0|||
146842577|NCT02942277|529593902|FG003|Year 2|Lost to Follow-up|0|||
146842578|NCT02942277|529593903|FG004|Year 2|Lost to Follow-up|2|||
146842579|NCT02942277|529593904|FG005|Year 2|Lost to Follow-up|1|||
146842580|NCT02942277|529593905|FG006|Year 2|Lost to Follow-up|0|||
146842581|NCT02942277|529593906|FG007|Year 2|Lost to Follow-up|0|||
146842582|NCT02942277|529593907|FG008|Year 2|Lost to Follow-up|0|||
146842583|NCT02942277|529593908|FG009|Year 2|Lost to Follow-up|0|||
146842584|NCT02942277|529593909|FG010|Year 2|Lost to Follow-up|0|||
146842585|NCT02942277|529593899|FG000|Year 2|Did not rescreen|0|||
146842586|NCT02942277|529593900|FG001|Year 2|Did not rescreen|0|||
146842587|NCT02942277|529593901|FG002|Year 2|Did not rescreen|1|||
146842588|NCT02942277|529593902|FG003|Year 2|Did not rescreen|1|||
146842589|NCT02942277|529593903|FG004|Year 2|Did not rescreen|9|||
146842590|NCT02942277|529593904|FG005|Year 2|Did not rescreen|6|||
146842591|NCT02942277|529593905|FG006|Year 2|Did not rescreen|0|||
146842592|NCT02942277|529593906|FG007|Year 2|Did not rescreen|1|||
146842593|NCT02942277|529593907|FG008|Year 2|Did not rescreen|0|||
146842594|NCT02942277|529593908|FG009|Year 2|Did not rescreen|0|||
146842595|NCT02942277|529593909|FG010|Year 2|Did not rescreen|21|||
146842596|NCT02942277|529593899|FG000|Year 2|Met withdrawal criteria|0|||
146842597|NCT02942277|529593900|FG001|Year 2|Met withdrawal criteria|0|||
146996537|NCT00617305|530151621|FG002|Overall Study|Death|0|||
146996538|NCT00617305|530151619|FG000|Overall Study|Physician Decision|1|||
146996539|NCT00617305|530151620|FG001|Overall Study|Physician Decision|0|||
146996540|NCT00617305|530151621|FG002|Overall Study|Physician Decision|0|||
146996541|NCT00617305|530151619|FG000|Overall Study|Protocol Violation|1|||
146996542|NCT00617305|530151620|FG001|Overall Study|Protocol Violation|0|||
146996543|NCT00617305|530151621|FG002|Overall Study|Protocol Violation|1|||
146996544|NCT00617305|530151619|FG000|Overall Study|Withdrawal by Subject|1|||
146996545|NCT00617305|530151620|FG001|Overall Study|Withdrawal by Subject|0|||
146996546|NCT00617305|530151621|FG002|Overall Study|Withdrawal by Subject|0|||
146996547|NCT02193178|530151622|FG000|Overall Study|Lost to Follow-up|1|||
146996548|NCT02193178|530151622|FG000|Overall Study|Dry eyes|1|||
146996549|NCT03435081|530151623|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
146996550|NCT03435081|530151624|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
146842598|NCT02942277|529593901|FG002|Year 2|Met withdrawal criteria|0|||
146842599|NCT02942277|529593902|FG003|Year 2|Met withdrawal criteria|0|||
146842600|NCT02942277|529593903|FG004|Year 2|Met withdrawal criteria|1|||
146842601|NCT02942277|529593904|FG005|Year 2|Met withdrawal criteria|2|||
146842602|NCT02942277|529593905|FG006|Year 2|Met withdrawal criteria|0|||
146842603|NCT02942277|529593906|FG007|Year 2|Met withdrawal criteria|0|||
146842604|NCT02942277|529593907|FG008|Year 2|Met withdrawal criteria|0|||
146842605|NCT02942277|529593908|FG009|Year 2|Met withdrawal criteria|0|||
146842606|NCT02942277|529593909|FG010|Year 2|Met withdrawal criteria|1|||
146842607|NCT02942277|529593899|FG000|Year 2|Travel|0|||
146842608|NCT02942277|529593900|FG001|Year 2|Travel|1|||
146842609|NCT02942277|529593901|FG002|Year 2|Travel|0|||
146842610|NCT02942277|529593902|FG003|Year 2|Travel|0|||
146842611|NCT02942277|529593903|FG004|Year 2|Travel|0|||
146842612|NCT02942277|529593904|FG005|Year 2|Travel|1|||
146996551|NCT03435081|530151625|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
146996552|NCT03435081|530151623|FG000|Week 0 to Week 16|Adverse Event|2|||
146996553|NCT03435081|530151624|FG001|Week 0 to Week 16|Adverse Event|2|||
146842613|NCT02942277|529593905|FG006|Year 2|Travel|0|||
146842614|NCT02942277|529593906|FG007|Year 2|Travel|0|||
146842615|NCT02942277|529593907|FG008|Year 2|Travel|0|||
146842616|NCT02942277|529593908|FG009|Year 2|Travel|1|||
146842617|NCT02942277|529593909|FG010|Year 2|Travel|3|||
146842618|NCT02942277|529593899|FG000|Year 2|Non-compliant|0|||
146842619|NCT02942277|529593900|FG001|Year 2|Non-compliant|0|||
146842620|NCT02942277|529593901|FG002|Year 2|Non-compliant|0|||
146842621|NCT02942277|529593902|FG003|Year 2|Non-compliant|0|||
146842622|NCT02942277|529593903|FG004|Year 2|Non-compliant|1|||
146842623|NCT02942277|529593904|FG005|Year 2|Non-compliant|1|||
146842624|NCT02942277|529593905|FG006|Year 2|Non-compliant|0|||
146842625|NCT02942277|529593906|FG007|Year 2|Non-compliant|0|||
146842626|NCT02942277|529593907|FG008|Year 2|Non-compliant|0|||
146842627|NCT02942277|529593908|FG009|Year 2|Non-compliant|0|||
146842628|NCT02942277|529593909|FG010|Year 2|Non-compliant|0|||
146842629|NCT02942277|529593899|FG000|Year 2|Withdrawal by Subject|0|||
146842630|NCT02942277|529593900|FG001|Year 2|Withdrawal by Subject|0|||
146842631|NCT02942277|529593901|FG002|Year 2|Withdrawal by Subject|0|||
146842632|NCT02942277|529593902|FG003|Year 2|Withdrawal by Subject|0|||
146842633|NCT02942277|529593903|FG004|Year 2|Withdrawal by Subject|0|||
146842634|NCT02942277|529593904|FG005|Year 2|Withdrawal by Subject|0|||
146842635|NCT02942277|529593905|FG006|Year 2|Withdrawal by Subject|1|||
146842636|NCT02942277|529593906|FG007|Year 2|Withdrawal by Subject|0|||
146842637|NCT02942277|529593907|FG008|Year 2|Withdrawal by Subject|0|||
146842638|NCT02942277|529593908|FG009|Year 2|Withdrawal by Subject|0|||
146842639|NCT02942277|529593909|FG010|Year 2|Withdrawal by Subject|0|||
146842640|NCT05602727|529593910|FG000|Overall Study|Physician Decision|0|||
146842641|NCT05602727|529593911|FG001|Overall Study|Physician Decision|1|||
146842642|NCT05602727|529593912|FG002|Overall Study|Physician Decision|0|||
146842643|NCT05602727|529593910|FG000|Overall Study|Randomized by mistake without study medication|1|||
146842644|NCT05602727|529593911|FG001|Overall Study|Randomized by mistake without study medication|0|||
146842645|NCT05602727|529593912|FG002|Overall Study|Randomized by mistake without study medication|0|||
146842646|NCT05602727|529593910|FG000|Overall Study|Study termination by Sponsor|18|||
146842647|NCT05602727|529593911|FG001|Overall Study|Study termination by Sponsor|15|||
146842648|NCT05602727|529593912|FG002|Overall Study|Study termination by Sponsor|19|||
146842649|NCT05602727|529593910|FG000|Overall Study|Withdrawal by Subject|2|||
146842650|NCT05602727|529593911|FG001|Overall Study|Withdrawal by Subject|1|||
146842651|NCT05602727|529593912|FG002|Overall Study|Withdrawal by Subject|1|||
146842652|NCT05602727|529593910|FG000|Overall Study|Various reasons|1|||
146842653|NCT05602727|529593911|FG001|Overall Study|Various reasons|6|||
146842654|NCT05602727|529593912|FG002|Overall Study|Various reasons|1|||
146961892|NCT01012765|530019857|FG003|Treatment Period 1|Protocol Violation|2|||
146961893|NCT01012765|530019858|FG004|Treatment Period 1|Protocol Violation|1|||
146961894|NCT01012765|530019859|FG005|Treatment Period 1|Protocol Violation|0|||
146961895|NCT01012765|530019854|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
146961896|NCT01012765|530019855|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
146961897|NCT01012765|530019856|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
146961898|NCT01012765|530019857|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
146961899|NCT01012765|530019858|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
146961900|NCT01012765|530019859|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
146961901|NCT01012765|530019854|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146961902|NCT01012765|530019855|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146961903|NCT01012765|530019856|FG002|Treatment Period 2|Withdrawal by Subject|1|||
146961904|NCT01012765|530019857|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146961905|NCT01012765|530019858|FG004|Treatment Period 2|Withdrawal by Subject|1|||
146961906|NCT01012765|530019859|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146961907|NCT01012765|530019854|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
146961908|NCT01012765|530019855|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
146961909|NCT01012765|530019856|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
146961910|NCT01012765|530019857|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
146961911|NCT01012765|530019858|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
146961912|NCT01012765|530019859|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
146961913|NCT01012765|530019854|FG000|Treatment Period 2|Adverse Event|0|||
146961914|NCT01012765|530019855|FG001|Treatment Period 2|Adverse Event|1|||
146961915|NCT01012765|530019856|FG002|Treatment Period 2|Adverse Event|1|||
146961916|NCT01012765|530019857|FG003|Treatment Period 2|Adverse Event|0|||
146961917|NCT01012765|530019858|FG004|Treatment Period 2|Adverse Event|0|||
146961918|NCT01012765|530019859|FG005|Treatment Period 2|Adverse Event|0|||
146996554|NCT03435081|530151625|FG002|Week 0 to Week 16|Adverse Event|2|||
146842655|NCT02187159|529593913|FG000|Overall Study|Protocol Violation|4|||
146842656|NCT02187159|529593914|FG001|Overall Study|Protocol Violation|6|||
146842657|NCT02187159|529593915|FG002|Overall Study|Protocol Violation|3|||
146842658|NCT02187159|529593916|FG003|Overall Study|Protocol Violation|4|||
146842659|NCT02187159|529593913|FG000|Overall Study|Lack of Efficacy|10|||
146961919|NCT01012765|530019854|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
146842660|NCT02187159|529593914|FG001|Overall Study|Lack of Efficacy|5|||
146842661|NCT02187159|529593915|FG002|Overall Study|Lack of Efficacy|4|||
146842662|NCT02187159|529593916|FG003|Overall Study|Lack of Efficacy|7|||
146842663|NCT02187159|529593913|FG000|Overall Study|Adverse Event|28|||
146842664|NCT02187159|529593914|FG001|Overall Study|Adverse Event|33|||
146842665|NCT02187159|529593915|FG002|Overall Study|Adverse Event|42|||
146842666|NCT02187159|529593916|FG003|Overall Study|Adverse Event|50|||
146842667|NCT02187159|529593913|FG000|Overall Study|Withdrawal by Subject|24|||
146842668|NCT02187159|529593914|FG001|Overall Study|Withdrawal by Subject|28|||
146842669|NCT02187159|529593915|FG002|Overall Study|Withdrawal by Subject|25|||
146842670|NCT02187159|529593916|FG003|Overall Study|Withdrawal by Subject|26|||
146842671|NCT02187159|529593913|FG000|Overall Study|Other|3|||
146842672|NCT02187159|529593914|FG001|Overall Study|Other|7|||
146842673|NCT02187159|529593915|FG002|Overall Study|Other|3|||
146842674|NCT02187159|529593916|FG003|Overall Study|Other|9|||
146842675|NCT04325282|529593917|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
146842676|NCT04325282|529593918|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
146842677|NCT04325282|529593917|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
146842678|NCT04325282|529593918|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
146842679|NCT01283152|529593922|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
146842680|NCT01283152|529593923|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
146842681|NCT01283152|529593922|FG000|Overall Study|Refused HESA|1|||
146842682|NCT01283152|529593923|FG001|Overall Study|Refused HESA|0|||
146842683|NCT04020185|529593926|FG000|Overall Study|Death|0|||
146842684|NCT04020185|529593927|FG001|Overall Study|Death|0|||
146842685|NCT04020185|529593928|FG002|Overall Study|Death|1|||
146842686|NCT04020185|529593929|FG003|Overall Study|Death|2|||
146842687|NCT04020185|529593930|FG004|Overall Study|Death|1|||
146842688|NCT04020185|529593931|FG005|Overall Study|Death|0|||
146842689|NCT04020185|529593932|FG006|Overall Study|Death|1|||
146842690|NCT04020185|529593933|FG007|Overall Study|Death|0|||
146842691|NCT04020185|529593926|FG000|Overall Study|Consent withdrawn|1|||
146842692|NCT04020185|529593927|FG001|Overall Study|Consent withdrawn|0|||
146842693|NCT04020185|529593928|FG002|Overall Study|Consent withdrawn|0|||
146842694|NCT04020185|529593929|FG003|Overall Study|Consent withdrawn|0|||
146842695|NCT04020185|529593930|FG004|Overall Study|Consent withdrawn|2|||
146842696|NCT04020185|529593931|FG005|Overall Study|Consent withdrawn|0|||
146842697|NCT04020185|529593932|FG006|Overall Study|Consent withdrawn|1|||
146842698|NCT04020185|529593933|FG007|Overall Study|Consent withdrawn|1|||
146842699|NCT04020185|529593926|FG000|Overall Study|Patient in hospice|0|||
146842700|NCT04020185|529593927|FG001|Overall Study|Patient in hospice|1|||
146842701|NCT04020185|529593928|FG002|Overall Study|Patient in hospice|0|||
146842702|NCT04020185|529593929|FG003|Overall Study|Patient in hospice|0|||
146842703|NCT04020185|529593930|FG004|Overall Study|Patient in hospice|0|||
146842704|NCT04020185|529593931|FG005|Overall Study|Patient in hospice|0|||
146842705|NCT04020185|529593932|FG006|Overall Study|Patient in hospice|0|||
146842706|NCT04020185|529593933|FG007|Overall Study|Patient in hospice|0|||
146842707|NCT04020185|529593926|FG000|Overall Study|Continuing on expanded access|0|||
146842708|NCT04020185|529593927|FG001|Overall Study|Continuing on expanded access|0|||
146842709|NCT04020185|529593928|FG002|Overall Study|Continuing on expanded access|0|||
146842710|NCT04020185|529593929|FG003|Overall Study|Continuing on expanded access|0|||
146842711|NCT04020185|529593930|FG004|Overall Study|Continuing on expanded access|0|||
146842712|NCT04020185|529593931|FG005|Overall Study|Continuing on expanded access|0|||
146842713|NCT04020185|529593932|FG006|Overall Study|Continuing on expanded access|1|||
146842714|NCT04020185|529593933|FG007|Overall Study|Continuing on expanded access|1|||
146842715|NCT02643303|529593936|FG000|Overall Study|Progressive Disease|4|||
146842716|NCT02643303|529593937|FG001|Overall Study|Progressive Disease|4|||
146842717|NCT02643303|529593938|FG002|Overall Study|Progressive Disease|1|||
146842718|NCT02643303|529593939|FG003|Overall Study|Progressive Disease|12|||
146842719|NCT02643303|529593940|FG004|Overall Study|Progressive Disease|6|||
146842720|NCT02643303|529593941|FG005|Overall Study|Progressive Disease|4|||
146842721|NCT02643303|529593942|FG006|Overall Study|Progressive Disease|8|||
146842722|NCT02643303|529593943|FG007|Overall Study|Progressive Disease|2|||
146842723|NCT02643303|529593944|FG008|Overall Study|Progressive Disease|6|||
146842724|NCT02643303|529593936|FG000|Overall Study|Adverse Event|0|||
146842725|NCT02643303|529593937|FG001|Overall Study|Adverse Event|1|||
146842726|NCT02643303|529593938|FG002|Overall Study|Adverse Event|0|||
146842727|NCT02643303|529593939|FG003|Overall Study|Adverse Event|0|||
146842728|NCT02643303|529593940|FG004|Overall Study|Adverse Event|1|||
146842729|NCT02643303|529593941|FG005|Overall Study|Adverse Event|0|||
146842730|NCT02643303|529593942|FG006|Overall Study|Adverse Event|0|||
146842731|NCT02643303|529593943|FG007|Overall Study|Adverse Event|0|||
146842732|NCT02643303|529593944|FG008|Overall Study|Adverse Event|0|||
146842733|NCT02643303|529593936|FG000|Overall Study|Withdrawal by Subject|0|||
146842734|NCT02643303|529593937|FG001|Overall Study|Withdrawal by Subject|0|||
146842735|NCT02643303|529593938|FG002|Overall Study|Withdrawal by Subject|0|||
146842736|NCT02643303|529593939|FG003|Overall Study|Withdrawal by Subject|1|||
146842737|NCT02643303|529593940|FG004|Overall Study|Withdrawal by Subject|0|||
146842738|NCT02643303|529593941|FG005|Overall Study|Withdrawal by Subject|0|||
146842739|NCT02643303|529593942|FG006|Overall Study|Withdrawal by Subject|1|||
146842740|NCT02643303|529593943|FG007|Overall Study|Withdrawal by Subject|1|||
146842741|NCT02643303|529593944|FG008|Overall Study|Withdrawal by Subject|1|||
146842742|NCT00626197|529593947|FG000|Overall Study|Did not cooperate|2|||
146842743|NCT00626197|529593948|FG001|Overall Study|Did not cooperate|6|||
146842744|NCT00626197|529593949|FG002|Overall Study|Did not cooperate|1|||
146842745|NCT00626197|529593947|FG000|Overall Study|Failure to return|6|||
146842746|NCT00626197|529593948|FG001|Overall Study|Failure to return|5|||
146842747|NCT00626197|529593949|FG002|Overall Study|Failure to return|6|||
146842748|NCT00626197|529593947|FG000|Overall Study|Adverse event, serious fatal|3|||
146842749|NCT00626197|529593948|FG001|Overall Study|Adverse event, serious fatal|6|||
146842750|NCT00626197|529593949|FG002|Overall Study|Adverse event, serious fatal|6|||
146842751|NCT00626197|529593947|FG000|Overall Study|Adverse Event|1|||
146842752|NCT00626197|529593948|FG001|Overall Study|Adverse Event|1|||
146842753|NCT00626197|529593949|FG002|Overall Study|Adverse Event|2|||
146842754|NCT00626197|529593947|FG000|Overall Study|Withdrawal by Subject|17|||
146842755|NCT00626197|529593948|FG001|Overall Study|Withdrawal by Subject|17|||
146842756|NCT00626197|529593949|FG002|Overall Study|Withdrawal by Subject|7|||
146842757|NCT00626197|529593947|FG000|Overall Study|Administrative reasons|15|||
146842758|NCT00626197|529593948|FG001|Overall Study|Administrative reasons|19|||
146842759|NCT00626197|529593949|FG002|Overall Study|Administrative reasons|55|||
146842760|NCT04833127|529593950|FG000|Overall Study|Lost to Follow-up|1|||
146842761|NCT04833127|529593951|FG001|Overall Study|Lost to Follow-up|1|||
146842762|NCT04335591|529593956|FG000|Overall Study|Adverse Event|5|||
146842763|NCT04335591|529593957|FG001|Overall Study|Adverse Event|2|||
146842764|NCT04335591|529593958|FG002|Overall Study|Adverse Event|3|||
146842765|NCT04335591|529593959|FG003|Overall Study|Adverse Event|2|||
146842766|NCT04335591|529593956|FG000|Overall Study|Protocol Violation|1|||
146842767|NCT04335591|529593957|FG001|Overall Study|Protocol Violation|0|||
146842768|NCT04335591|529593958|FG002|Overall Study|Protocol Violation|0|||
146842769|NCT04335591|529593959|FG003|Overall Study|Protocol Violation|0|||
146842770|NCT04335591|529593956|FG000|Overall Study|Withdrawal by Subject|8|||
146842771|NCT04335591|529593957|FG001|Overall Study|Withdrawal by Subject|4|||
146842772|NCT04335591|529593958|FG002|Overall Study|Withdrawal by Subject|4|||
146842773|NCT04335591|529593959|FG003|Overall Study|Withdrawal by Subject|5|||
146842774|NCT04335591|529593956|FG000|Overall Study|Subject planning pregnancy|0|||
146842775|NCT04335591|529593957|FG001|Overall Study|Subject planning pregnancy|1|||
146842776|NCT04335591|529593958|FG002|Overall Study|Subject planning pregnancy|0|||
146842777|NCT04335591|529593959|FG003|Overall Study|Subject planning pregnancy|0|||
146842778|NCT04335591|529593956|FG000|Overall Study|Ukrainian Russian war conflict|4|||
146842779|NCT04335591|529593957|FG001|Overall Study|Ukrainian Russian war conflict|5|||
146842780|NCT04335591|529593958|FG002|Overall Study|Ukrainian Russian war conflict|2|||
146842781|NCT04335591|529593959|FG003|Overall Study|Ukrainian Russian war conflict|0|||
146842782|NCT05282121|529593960|FG000|Overall Study|Adverse Event|1|||
146842783|NCT05282121|529593961|FG001|Overall Study|Adverse Event|1|||
146842784|NCT05282121|529593962|FG002|Overall Study|Adverse Event|4|||
146842785|NCT05282121|529593963|FG003|Overall Study|Adverse Event|1|||
146842786|NCT05282121|529593960|FG000|Overall Study|Study Terminated by Sponsor|1|||
146842787|NCT05282121|529593961|FG001|Overall Study|Study Terminated by Sponsor|2|||
146842788|NCT05282121|529593962|FG002|Overall Study|Study Terminated by Sponsor|2|||
146842789|NCT05282121|529593963|FG003|Overall Study|Study Terminated by Sponsor|2|||
146842790|NCT05282121|529593960|FG000|Overall Study|Other than listed|0|||
146996555|NCT03435081|530151623|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
146996556|NCT03435081|530151624|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
146996557|NCT03435081|530151625|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
146996558|NCT03435081|530151623|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
146996559|NCT03435081|530151624|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
146996560|NCT03435081|530151625|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
146996561|NCT03435081|530151623|FG000|Week 0 to Week 16|Pregnancy|1|||
146842791|NCT05282121|529593961|FG001|Overall Study|Other than listed|0|||
146842792|NCT05282121|529593962|FG002|Overall Study|Other than listed|1|||
146842793|NCT05282121|529593963|FG003|Overall Study|Other than listed|0|||
146842794|NCT05282121|529593960|FG000|Overall Study|No reason available|0|||
146842795|NCT05282121|529593961|FG001|Overall Study|No reason available|0|||
146842796|NCT05282121|529593962|FG002|Overall Study|No reason available|1|||
146842797|NCT05282121|529593963|FG003|Overall Study|No reason available|0|||
146842798|NCT03809039|529593969|FG000|Part 1|Withdrawal by Subject|1|||
146842799|NCT03809039|529593970|FG001|Part 1|Withdrawal by Subject|0|||
146842800|NCT03809039|529593971|FG002|Part 1|Withdrawal by Subject|0|||
146842801|NCT03809039|529593972|FG003|Part 1|Withdrawal by Subject|1|||
146842802|NCT03809039|529593973|FG004|Part 1|Withdrawal by Subject|0|||
146842803|NCT03809039|529593974|FG005|Part 1|Withdrawal by Subject|0|||
146842804|NCT03809039|529593975|FG006|Part 1|Withdrawal by Subject|0|||
146842805|NCT03809039|529593976|FG007|Part 1|Withdrawal by Subject|0|||
146842806|NCT03809039|529593977|FG008|Part 1|Withdrawal by Subject|0|||
146842807|NCT03809039|529593969|FG000|Part 3|Withdrawn by study termination|0|||
146842808|NCT03809039|529593970|FG001|Part 3|Withdrawn by study termination|0|||
146842809|NCT03809039|529593971|FG002|Part 3|Withdrawn by study termination|0|||
146842810|NCT03809039|529593972|FG003|Part 3|Withdrawn by study termination|0|||
146996562|NCT03435081|530151624|FG001|Week 0 to Week 16|Pregnancy|0|||
146996563|NCT03435081|530151625|FG002|Week 0 to Week 16|Pregnancy|0|||
146996564|NCT03435081|530151623|FG000|Week 0 to Week 16|Non-compliance|1|||
146996565|NCT03435081|530151624|FG001|Week 0 to Week 16|Non-compliance|0|||
146996566|NCT03435081|530151625|FG002|Week 0 to Week 16|Non-compliance|2|||
146996567|NCT03435081|530151623|FG000|Week 0 to Week 16|Inadequate Response|0|||
146996568|NCT03435081|530151624|FG001|Week 0 to Week 16|Inadequate Response|1|||
146996569|NCT03435081|530151625|FG002|Week 0 to Week 16|Inadequate Response|0|||
146996570|NCT03435081|530151623|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
146996571|NCT03435081|530151624|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
146996572|NCT03435081|530151625|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
146996573|NCT03435081|530151623|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
146996574|NCT03435081|530151624|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
146996575|NCT03435081|530151625|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
146996576|NCT03435081|530151623|FG000|Week 16 to Week 104|Adverse Event|1|||
146996577|NCT03435081|530151624|FG001|Week 16 to Week 104|Adverse Event|0|||
146996578|NCT03435081|530151625|FG002|Week 16 to Week 104|Adverse Event|2|||
146996579|NCT03435081|530151623|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
146996580|NCT03435081|530151624|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
146996581|NCT03435081|530151625|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
146996582|NCT03435081|530151623|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
146996583|NCT03435081|530151624|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
146996584|NCT03435081|530151625|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
146996585|NCT03435081|530151623|FG000|Week 16 to Week 104|Non--Compliance|0|||
146996586|NCT03435081|530151624|FG001|Week 16 to Week 104|Non--Compliance|0|||
146996587|NCT03435081|530151625|FG002|Week 16 to Week 104|Non--Compliance|1|||
146996588|NCT00420238|530151626|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
146996589|NCT00420238|530151627|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
146996590|NCT00420238|530151626|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
146996591|NCT00420238|530151627|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
146996592|NCT00420238|530151626|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
146996593|NCT00420238|530151627|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
146996594|NCT00420238|530151626|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
146996595|NCT00420238|530151627|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
146996596|NCT00420238|530151626|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
146996597|NCT00420238|530151627|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
146996598|NCT00420238|530151626|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
146996599|NCT00420238|530151627|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
146996600|NCT00048581|530151628|FG000|Double-Blind Period|Adverse Event|9|||
146996601|NCT00048581|530151629|FG001|Double-Blind Period|Adverse Event|5|||
146996602|NCT00048581|530151630|FG002|Double-Blind Period|Adverse Event|0|||
146996603|NCT00048581|530151628|FG000|Double-Blind Period|Lack of Efficacy|14|||
146996604|NCT00048581|530151629|FG001|Double-Blind Period|Lack of Efficacy|27|||
146996605|NCT00048581|530151630|FG002|Double-Blind Period|Lack of Efficacy|0|||
146996606|NCT00048581|530151628|FG000|Double-Blind Period|Lost to Follow-up|5|||
146996607|NCT00048581|530151629|FG001|Double-Blind Period|Lost to Follow-up|0|||
146996608|NCT00048581|530151630|FG002|Double-Blind Period|Lost to Follow-up|0|||
146996609|NCT00048581|530151628|FG000|Double-Blind Period|Withdrawal by Subject|5|||
146996610|NCT00048581|530151629|FG001|Double-Blind Period|Withdrawal by Subject|2|||
146996611|NCT00048581|530151630|FG002|Double-Blind Period|Withdrawal by Subject|0|||
146996612|NCT00048581|530151628|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
146996613|NCT00048581|530151629|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
146996614|NCT00048581|530151630|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
146996615|NCT00048581|530151628|FG000|Double-Blind Period|Investigator Decision|1|||
146996616|NCT00048581|530151629|FG001|Double-Blind Period|Investigator Decision|0|||
146996617|NCT00048581|530151630|FG002|Double-Blind Period|Investigator Decision|0|||
146996618|NCT00048581|530151628|FG000|Open-Label Period|Death|0|||
146996619|NCT00048581|530151629|FG001|Open-Label Period|Death|0|||
146996620|NCT00048581|530151630|FG002|Open-Label Period|Death|4|||
146996621|NCT00048581|530151628|FG000|Open-Label Period|Adverse Event|0|||
146996622|NCT00048581|530151629|FG001|Open-Label Period|Adverse Event|0|||
146996623|NCT00048581|530151630|FG002|Open-Label Period|Adverse Event|37|||
146996624|NCT00048581|530151628|FG000|Open-Label Period|Lack of Efficacy|0|||
146996625|NCT00048581|530151629|FG001|Open-Label Period|Lack of Efficacy|0|||
146996626|NCT00048581|530151630|FG002|Open-Label Period|Lack of Efficacy|69|||
146996627|NCT00048581|530151628|FG000|Open-Label Period|Lost to Follow-up|0|||
146842811|NCT03809039|529593973|FG004|Part 3|Withdrawn by study termination|0|||
146996628|NCT00048581|530151629|FG001|Open-Label Period|Lost to Follow-up|0|||
146996629|NCT00048581|530151630|FG002|Open-Label Period|Lost to Follow-up|14|||
146996630|NCT00048581|530151628|FG000|Open-Label Period|Withdrawal by Subject|0|||
146996631|NCT00048581|530151629|FG001|Open-Label Period|Withdrawal by Subject|0|||
146996632|NCT00048581|530151630|FG002|Open-Label Period|Withdrawal by Subject|20|||
146996633|NCT00048581|530151628|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
146842812|NCT03809039|529593974|FG005|Part 3|Withdrawn by study termination|0|||
146996634|NCT00048581|530151629|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
146996635|NCT00048581|530151630|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
146996636|NCT00048581|530151628|FG000|Open-Label Period|Poor/Non-compliance|0|||
146996637|NCT00048581|530151629|FG001|Open-Label Period|Poor/Non-compliance|0|||
146996638|NCT00048581|530151630|FG002|Open-Label Period|Poor/Non-compliance|5|||
146996639|NCT00048581|530151628|FG000|Open-Label Period|Pregnancy|0|||
146996640|NCT00048581|530151629|FG001|Open-Label Period|Pregnancy|0|||
146996641|NCT00048581|530151630|FG002|Open-Label Period|Pregnancy|7|||
146996642|NCT00048581|530151628|FG000|Open-Label Period|Study Site Closure|0|||
146996643|NCT00048581|530151629|FG001|Open-Label Period|Study Site Closure|0|||
146996644|NCT00048581|530151630|FG002|Open-Label Period|Study Site Closure|2|||
146996645|NCT00048581|530151628|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
146996646|NCT00048581|530151629|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
146996647|NCT00048581|530151630|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
146996648|NCT00048581|530151628|FG000|Open-Label Period|Problem With Transportation To Site|0|||
146996649|NCT00048581|530151629|FG001|Open-Label Period|Problem With Transportation To Site|0|||
146996650|NCT00048581|530151630|FG002|Open-Label Period|Problem With Transportation To Site|1|||
146996651|NCT00048581|530151628|FG000|Open-Label Period|Primary Investigator Retired|0|||
146996652|NCT00048581|530151629|FG001|Open-Label Period|Primary Investigator Retired|0|||
146996653|NCT00048581|530151630|FG002|Open-Label Period|Primary Investigator Retired|2|||
146996654|NCT00048581|530151628|FG000|Open-Label Period|Study Ended By Sponsor|0|||
146996655|NCT00048581|530151629|FG001|Open-Label Period|Study Ended By Sponsor|0|||
146996656|NCT00048581|530151630|FG002|Open-Label Period|Study Ended By Sponsor|1|||
146996657|NCT01406795|530151631|FG000|Overall Study|Withdrawal by Subject|1|||
146996658|NCT03966365|530151632|FG000|Overall Study|Protocol Violation|1|||
146996659|NCT03966365|530151633|FG001|Overall Study|Protocol Violation|0|||
146996660|NCT03567174|530151635|FG000|Overall Study|Death|24|||
146996661|NCT03567174|530151636|FG001|Overall Study|Death|31|||
146996662|NCT03567174|530151635|FG000|Overall Study|Lost to Follow-up|165|||
146996663|NCT03567174|530151636|FG001|Overall Study|Lost to Follow-up|174|||
146996664|NCT06358820|530153257|FG000|Overall Study|Adverse Event|11|||
146996665|NCT06358820|530153257|FG000|Overall Study|kidney transplantation|3|||
146996666|NCT06358820|530153257|FG000|Overall Study|patient voluntary withdrawal|6|||
146996667|NCT06358820|530153257|FG000|Overall Study|Physician Decision|1|||
146996668|NCT05376319|530153262|FG000|Overall Study|Funding termination|2|||
146996669|NCT05376319|530153263|FG001|Overall Study|Funding termination|4|||
146996670|NCT01124175|530153264|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
146996671|NCT01124175|530153265|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
146996672|NCT00942968|530153266|FG000|Overall Study|Adverse Event|60|||
146996673|NCT00942968|530153266|FG000|Overall Study|Death|76|||
146996674|NCT00942968|530153266|FG000|Overall Study|Protocol Violation|9|||
146996675|NCT00942968|530153266|FG000|Overall Study|Lost to Follow-up|4|||
146996676|NCT00942968|530153266|FG000|Overall Study|Withdrawal by Subject|44|||
146996677|NCT00942968|530153266|FG000|Overall Study|Sponsor request|5|||
146996678|NCT00942968|530153266|FG000|Overall Study|Physician Decision|11|||
146996679|NCT00942968|530153266|FG000|Overall Study|Progression of disease|12|||
146996680|NCT00942968|530153266|FG000|Overall Study|Inferior vena cava filter placement|4|||
146996681|NCT00942968|530153266|FG000|Overall Study|Pulmonary embolism (PE)|1|||
146996682|NCT00942968|530153266|FG000|Overall Study|Participant required pancreatic biopsy|1|||
146996683|NCT00942968|530153266|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
146996684|NCT01340495|530153271|FG000|Overall Study|Withdrawal by Subject|1|||
146996685|NCT00070291|530153272|FG000|Step 1|Withdrawal by Subject|1|||
146996686|NCT00070291|530153272|FG000|Step 1|Adverse Event|1|||
146996687|NCT00070291|530153272|FG000|Step 2|Adverse Event|1|||
146996688|NCT02262377|530153273|FG000|Overall Study|Lost to Follow-up|5|||
146996689|NCT02262377|530153274|FG001|Overall Study|Lost to Follow-up|6|||
146996690|NCT02262377|530153273|FG000|Overall Study|Found ineligible after enrollment|3|||
146996691|NCT02262377|530153274|FG001|Overall Study|Found ineligible after enrollment|0|||
146996692|NCT02262377|530153273|FG000|Overall Study|Withdrawal by Subject|4|||
146996693|NCT02262377|530153274|FG001|Overall Study|Withdrawal by Subject|0|||
146996694|NCT01045096|530153275|FG000|Overall Study|Withdrawal by Subject|2|||
146996695|NCT01045096|530153276|FG001|Overall Study|Withdrawal by Subject|0|||
146996696|NCT01045096|530153277|FG002|Overall Study|Withdrawal by Subject|0|||
146996697|NCT01045096|530153275|FG000|Overall Study|Other|1|||
146996698|NCT01045096|530153276|FG001|Overall Study|Other|0|||
146996699|NCT01045096|530153277|FG002|Overall Study|Other|0|||
146996700|NCT01511939|530153279|FG000|Overall Study|Withdrawal by Subject|2|||
146996701|NCT01511939|530153280|FG001|Overall Study|Withdrawal by Subject|1|||
146996702|NCT01511939|530153281|FG002|Overall Study|Withdrawal by Subject|0|||
146996703|NCT03497897|530153284|FG000|Overall Study|Adverse Event|1|||
146996704|NCT03497897|530153285|FG001|Overall Study|Adverse Event|1|||
146996705|NCT03497897|530153286|FG002|Overall Study|Adverse Event|1|||
146996706|NCT03497897|530153284|FG000|Overall Study|Lost to Follow-up|2|||
146996707|NCT03497897|530153285|FG001|Overall Study|Lost to Follow-up|0|||
146996708|NCT03497897|530153286|FG002|Overall Study|Lost to Follow-up|2|||
146996709|NCT03497897|530153284|FG000|Overall Study|Physician Decision|1|||
146996710|NCT03497897|530153285|FG001|Overall Study|Physician Decision|0|||
146996711|NCT03497897|530153286|FG002|Overall Study|Physician Decision|0|||
146996712|NCT03497897|530153284|FG000|Overall Study|Subject/Guardian Decision|2|||
146996713|NCT03497897|530153285|FG001|Overall Study|Subject/Guardian Decision|1|||
146996714|NCT03497897|530153286|FG002|Overall Study|Subject/Guardian Decision|3|||
146996715|NCT00723528|530153290|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
146996716|NCT00723528|530153291|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
146996717|NCT00723528|530153292|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
146842813|NCT03809039|529593975|FG006|Part 3|Withdrawn by study termination|0|||
146842814|NCT03809039|529593976|FG007|Part 3|Withdrawn by study termination|2|||
146842815|NCT03809039|529593977|FG008|Part 3|Withdrawn by study termination|6|||
146842816|NCT02476175|529593980|FG000|Overall Study|Adverse Event|2|||
146842817|NCT00818779|529593983|FG000|Overall Study|Protocol Violation|1|||
146842818|NCT00818779|529593984|FG001|Overall Study|Protocol Violation|0|||
146842819|NCT00818779|529593983|FG000|Overall Study|Lost to Follow-up|1|||
146842820|NCT00818779|529593984|FG001|Overall Study|Lost to Follow-up|0|||
146842821|NCT00818779|529593983|FG000|Overall Study|Adverse Event|4|||
146842822|NCT00818779|529593984|FG001|Overall Study|Adverse Event|1|||
146842823|NCT00839956|529593988|FG000|Overall Study|Adverse Event|2|||
146842824|NCT00839956|529593988|FG000|Overall Study|Lack of Efficacy|6|||
146842825|NCT00839956|529593988|FG000|Overall Study|Physician Decision|1|||
146842826|NCT00839956|529593988|FG000|Overall Study|Withdrawal by Subject|3|||
146842827|NCT00245960|529593990|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
146842828|NCT00245960|529593991|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
146842829|NCT00245960|529593990|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
146842830|NCT00245960|529593991|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
146842831|NCT00245960|529593990|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
146842832|NCT00245960|529593991|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
146842833|NCT00245960|529593990|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
146842834|NCT00245960|529593991|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
146996718|NCT00723528|530153293|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
146996719|NCT00723528|530153294|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
146996720|NCT00723528|530153295|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
146996721|NCT00723528|530153296|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
146996722|NCT00723528|530153290|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
146996723|NCT00723528|530153291|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
146996724|NCT00723528|530153292|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
146996725|NCT00723528|530153293|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
146996726|NCT00723528|530153294|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
146996727|NCT00723528|530153295|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
146996728|NCT00723528|530153296|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
146996729|NCT00723528|530153290|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
146996730|NCT00723528|530153291|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
146996731|NCT00723528|530153292|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
146996732|NCT00723528|530153293|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
146996733|NCT00723528|530153294|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
146996734|NCT00723528|530153295|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
146996735|NCT00723528|530153296|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
146842835|NCT00245960|529593990|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
146996736|NCT00723528|530153290|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
146996737|NCT00723528|530153291|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
146996738|NCT00723528|530153292|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
146996739|NCT00723528|530153293|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
146996740|NCT00723528|530153294|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
146996741|NCT00723528|530153295|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
146996742|NCT00723528|530153296|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
146996743|NCT00723528|530153290|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
146996744|NCT00723528|530153291|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
146996745|NCT00723528|530153292|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
146996746|NCT00723528|530153293|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
146996747|NCT00723528|530153294|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
146996748|NCT00723528|530153295|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
146842836|NCT00245960|529593991|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
146842837|NCT00245960|529593990|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
146996749|NCT00723528|530153296|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
146842838|NCT00245960|529593991|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
146842839|NCT00245960|529593990|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
146842840|NCT00245960|529593991|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
146996750|NCT00723528|530153290|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
146996751|NCT00723528|530153291|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
146996752|NCT00723528|530153292|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
146996753|NCT00723528|530153293|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
146996754|NCT00723528|530153294|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
146996755|NCT00723528|530153295|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
146996756|NCT00723528|530153296|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
146996757|NCT00723528|530153290|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
146996758|NCT00723528|530153291|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
146996759|NCT00723528|530153292|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
146996760|NCT00723528|530153293|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
146996761|NCT00723528|530153294|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
146996762|NCT00723528|530153295|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
146996763|NCT00723528|530153296|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
146996764|NCT00723528|530153290|FG000|Period 2: After Controlled Period|Other|0|||
146996765|NCT00723528|530153291|FG001|Period 2: After Controlled Period|Other|0|||
146996766|NCT00723528|530153292|FG002|Period 2: After Controlled Period|Other|0|||
146996767|NCT00723528|530153293|FG003|Period 2: After Controlled Period|Other|0|||
146996768|NCT00723528|530153294|FG004|Period 2: After Controlled Period|Other|1|||
146996769|NCT00723528|530153295|FG005|Period 2: After Controlled Period|Other|4|||
146996770|NCT00723528|530153296|FG006|Period 2: After Controlled Period|Other|0|||
146996771|NCT00723528|530153290|FG000|Period 2: After Controlled Period|Adverse Event|0|||
146996772|NCT00723528|530153291|FG001|Period 2: After Controlled Period|Adverse Event|0|||
146996773|NCT00723528|530153292|FG002|Period 2: After Controlled Period|Adverse Event|0|||
146996774|NCT00723528|530153293|FG003|Period 2: After Controlled Period|Adverse Event|0|||
146996775|NCT00723528|530153294|FG004|Period 2: After Controlled Period|Adverse Event|1|||
146996776|NCT00723528|530153295|FG005|Period 2: After Controlled Period|Adverse Event|0|||
146996777|NCT00723528|530153296|FG006|Period 2: After Controlled Period|Adverse Event|1|||
146996778|NCT00723528|530153290|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
146996779|NCT00723528|530153291|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
146996780|NCT00723528|530153292|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
146996781|NCT00723528|530153293|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
146996782|NCT00723528|530153294|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
146996783|NCT00723528|530153295|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
146996784|NCT00723528|530153296|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
146996785|NCT00723528|530153290|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
146996786|NCT00723528|530153291|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
146996787|NCT00723528|530153292|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
146996788|NCT00723528|530153293|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
146996789|NCT00723528|530153294|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
146996790|NCT00723528|530153295|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
146996791|NCT00723528|530153296|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
146996792|NCT01591785|530153301|FG000|Overall Study|worsening condition|1|||
146996793|NCT01591785|530153302|FG001|Overall Study|worsening condition|2|||
146996794|NCT01591785|530153301|FG000|Overall Study|Protocol Violation|2|||
146996795|NCT01591785|530153302|FG001|Overall Study|Protocol Violation|0|||
146996796|NCT01591785|530153301|FG000|Overall Study|Lost to Follow-up|1|||
146996797|NCT01591785|530153302|FG001|Overall Study|Lost to Follow-up|0|||
146996798|NCT00667862|530153303|FG000|Overall Study|Adverse Event|9|||
146996799|NCT00667862|530153303|FG000|Overall Study|Death|1|||
146996800|NCT00667862|530153303|FG000|Overall Study|Disease Progression|22|||
146996801|NCT00667862|530153303|FG000|Overall Study|Withdrawal by Subject|3|||
146996802|NCT02495857|530153310|FG000|Overall Study|Adverse Event|5|||
146996803|NCT02495857|530153311|FG001|Overall Study|Adverse Event|0|||
146996804|NCT02495857|530153312|FG002|Overall Study|Adverse Event|1|||
146996805|NCT02495857|530153310|FG000|Overall Study|Withdrawal by Subject|9|||
146996806|NCT02495857|530153311|FG001|Overall Study|Withdrawal by Subject|6|||
146996807|NCT02495857|530153312|FG002|Overall Study|Withdrawal by Subject|10|||
146996808|NCT02495857|530153310|FG000|Overall Study|Physician Decision|0|||
146996809|NCT02495857|530153311|FG001|Overall Study|Physician Decision|1|||
146996810|NCT02495857|530153312|FG002|Overall Study|Physician Decision|0|||
146996811|NCT02495857|530153310|FG000|Overall Study|Protocol Violation|1|||
146996812|NCT02495857|530153311|FG001|Overall Study|Protocol Violation|1|||
146996813|NCT02495857|530153312|FG002|Overall Study|Protocol Violation|2|||
146996814|NCT02495857|530153310|FG000|Overall Study|Lost to Follow-up|4|||
146996815|NCT02495857|530153311|FG001|Overall Study|Lost to Follow-up|5|||
146996816|NCT02495857|530153312|FG002|Overall Study|Lost to Follow-up|3|||
146996817|NCT02495857|530153310|FG000|Overall Study|Other|3|||
146996818|NCT02495857|530153311|FG001|Overall Study|Other|3|||
146961920|NCT01012765|530019855|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
146961921|NCT01012765|530019856|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
146961922|NCT01012765|530019857|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
146961923|NCT01012765|530019858|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
146961924|NCT01012765|530019859|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
146961925|NCT01326312|530019860|FG000|Overall Study|Adverse Event|11|||
146961926|NCT01326312|530019861|FG001|Overall Study|Adverse Event|11|||
146961927|NCT01326312|530019862|FG002|Overall Study|Adverse Event|1|||
146961928|NCT01326312|530019860|FG000|Overall Study|Withdrawal by Subject|1|||
146961929|NCT01326312|530019861|FG001|Overall Study|Withdrawal by Subject|2|||
146961930|NCT01326312|530019862|FG002|Overall Study|Withdrawal by Subject|1|||
146961931|NCT01326312|530019860|FG000|Overall Study|Protocol Violation|0|||
146961932|NCT01326312|530019861|FG001|Overall Study|Protocol Violation|1|||
146961933|NCT01326312|530019862|FG002|Overall Study|Protocol Violation|0|||
146961934|NCT01326312|530019860|FG000|Overall Study|Lack of Efficacy|13|||
146961935|NCT01326312|530019861|FG001|Overall Study|Lack of Efficacy|7|||
146961936|NCT01326312|530019862|FG002|Overall Study|Lack of Efficacy|1|||
146961937|NCT01326312|530019860|FG000|Overall Study|Death|1|||
146961938|NCT01326312|530019861|FG001|Overall Study|Death|0|||
146961939|NCT01326312|530019862|FG002|Overall Study|Death|1|||
146961940|NCT01326312|530019860|FG000|Overall Study|progressive disease|0|||
146996819|NCT02495857|530153312|FG002|Overall Study|Other|2|||
146996820|NCT02883452|530153314|FG000|Overall Study|Withdrawal by Subject|1|||
146996821|NCT02883452|530153315|FG001|Overall Study|Withdrawal by Subject|1|||
146996822|NCT02883452|530153316|FG002|Overall Study|Withdrawal by Subject|3|||
146996823|NCT02883452|530153317|FG003|Overall Study|Withdrawal by Subject|0|||
146996824|NCT02883452|530153318|FG004|Overall Study|Withdrawal by Subject|2|||
146996825|NCT02883452|530153319|FG005|Overall Study|Withdrawal by Subject|5|||
146996826|NCT02883452|530153314|FG000|Overall Study|Disease progression|1|||
146996827|NCT02883452|530153315|FG001|Overall Study|Disease progression|0|||
146996828|NCT02883452|530153316|FG002|Overall Study|Disease progression|0|||
146996829|NCT02883452|530153317|FG003|Overall Study|Disease progression|1|||
146996830|NCT02883452|530153318|FG004|Overall Study|Disease progression|4|||
146996831|NCT02883452|530153319|FG005|Overall Study|Disease progression|5|||
146996832|NCT02883452|530153314|FG000|Overall Study|Adverse Event|2|||
146996833|NCT02883452|530153315|FG001|Overall Study|Adverse Event|1|||
146996834|NCT02883452|530153316|FG002|Overall Study|Adverse Event|1|||
146996835|NCT02883452|530153317|FG003|Overall Study|Adverse Event|1|||
146996836|NCT02883452|530153318|FG004|Overall Study|Adverse Event|1|||
146996837|NCT02883452|530153319|FG005|Overall Study|Adverse Event|3|||
146961941|NCT01326312|530019861|FG001|Overall Study|progressive disease|1|||
146961942|NCT01326312|530019862|FG002|Overall Study|progressive disease|1|||
146961943|NCT01326312|530019860|FG000|Overall Study|Study terminated by Sponsor|8|||
146961944|NCT01326312|530019861|FG001|Overall Study|Study terminated by Sponsor|32|||
146961945|NCT01326312|530019862|FG002|Overall Study|Study terminated by Sponsor|46|||
146961946|NCT01326312|530019860|FG000|Overall Study|Treatment arm terminated|19|||
146961947|NCT01326312|530019861|FG001|Overall Study|Treatment arm terminated|0|||
146961948|NCT01326312|530019862|FG002|Overall Study|Treatment arm terminated|0|||
146961949|NCT01326312|530019860|FG000|Overall Study|QTc > 500|0|||
146961950|NCT01326312|530019861|FG001|Overall Study|QTc > 500|1|||
146961951|NCT01326312|530019862|FG002|Overall Study|QTc > 500|0|||
146961952|NCT00499694|530019873|FG000|Overall Study|Patient never received treatment.|1|||
146961953|NCT02370173|530019882|FG000|Overall Study|Protocol Violation|1|||
146961954|NCT02370173|530019883|FG001|Overall Study|Protocol Violation|1|||
146961955|NCT02370173|530019882|FG000|Overall Study|Withdrawal by Subject|2|||
146961956|NCT02370173|530019883|FG001|Overall Study|Withdrawal by Subject|2|||
146961957|NCT04034225|530019884|FG000|Overall Study|Death|3|||
146961958|NCT04034225|530019884|FG000|Overall Study|Withdrawal by Subject|2|||
146961959|NCT04034225|530019884|FG000|Overall Study|Study termination by Sponsor|18|||
146961960|NCT04034225|530019884|FG000|Overall Study|Physician Decision|1|||
146961961|NCT04034225|530019884|FG000|Overall Study|Lack of Efficacy|1|||
146961962|NCT00307736|530019890|FG000|Overall Study|Adverse Event|0|||
146961963|NCT00307736|530019891|FG001|Overall Study|Adverse Event|0|||
146961964|NCT00307736|530019892|FG002|Overall Study|Adverse Event|1|||
146961965|NCT00307736|530019893|FG003|Overall Study|Adverse Event|3|||
146961966|NCT00307736|530019890|FG000|Overall Study|Withdrawal by Subject|0|||
146961967|NCT00307736|530019891|FG001|Overall Study|Withdrawal by Subject|0|||
146961968|NCT00307736|530019892|FG002|Overall Study|Withdrawal by Subject|2|||
146961969|NCT00307736|530019893|FG003|Overall Study|Withdrawal by Subject|0|||
146961970|NCT01365182|530019895|FG000|Overall Study|Withdrawal by Subject|10|||
146961971|NCT01365182|530019896|FG001|Overall Study|Withdrawal by Subject|13|||
146961972|NCT01365182|530019897|FG002|Overall Study|Withdrawal by Subject|12|||
146961973|NCT00736840|530019898|FG000|Overall Study|Lost to Follow-up|13|||
146961974|NCT01411917|530019899|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
146961975|NCT01411917|530019900|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
146961976|NCT01728194|530019905|FG000|Overall Study|Lost to Follow-up|4|||
146996838|NCT02883452|530153314|FG000|Overall Study|Physician Decision|0|||
146996839|NCT02883452|530153315|FG001|Overall Study|Physician Decision|0|||
146842841|NCT00245960|529593990|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
146842842|NCT00245960|529593991|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
146961977|NCT01728194|530019906|FG001|Overall Study|Lost to Follow-up|3|||
146961978|NCT01728194|530019905|FG000|Overall Study|Physician Decision|4|||
146961979|NCT01728194|530019906|FG001|Overall Study|Physician Decision|0|||
146961980|NCT01728194|530019905|FG000|Overall Study|Withdrawal by Subject|7|||
146961981|NCT01728194|530019906|FG001|Overall Study|Withdrawal by Subject|3|||
146961982|NCT01728194|530019905|FG000|Overall Study|Perceived Medication Side Effects|4|||
146961983|NCT01728194|530019906|FG001|Overall Study|Perceived Medication Side Effects|0|||
146961984|NCT01728194|530019905|FG000|Overall Study|Family Member Request|1|||
146961985|NCT01728194|530019906|FG001|Overall Study|Family Member Request|0|||
146961986|NCT02309372|530019909|FG000|Overall Study|Lost to Follow-up|3|||
146961987|NCT02309372|530019910|FG001|Overall Study|Lost to Follow-up|2|||
146961988|NCT00242658|530019911|FG000|Overall Study|Lost to Follow-up|22|||
146961989|NCT00242658|530019912|FG001|Overall Study|Lost to Follow-up|19|||
146961990|NCT04604015|530019915|FG000|Overall Study|Incomplete Data Collection|33|||
146961991|NCT00553319|530019921|FG000|Overall Study|Lost to Follow-up|10|||
146961992|NCT00553319|530019922|FG001|Overall Study|Lost to Follow-up|9|||
146961993|NCT00553319|530019923|FG002|Overall Study|Lost to Follow-up|5|||
146961994|NCT00553319|530019921|FG000|Overall Study|wanted treatment elsewhere|2|||
146961995|NCT00553319|530019922|FG001|Overall Study|wanted treatment elsewhere|1|||
146961996|NCT00553319|530019923|FG002|Overall Study|wanted treatment elsewhere|1|||
146961997|NCT00553319|530019921|FG000|Overall Study|non-compliance|0|||
146961998|NCT00553319|530019922|FG001|Overall Study|non-compliance|0|||
146961999|NCT00553319|530019923|FG002|Overall Study|non-compliance|2|||
146962000|NCT00553319|530019921|FG000|Overall Study|incarceration|1|||
146962001|NCT00553319|530019922|FG001|Overall Study|incarceration|0|||
146962002|NCT00553319|530019923|FG002|Overall Study|incarceration|0|||
146962003|NCT00553319|530019921|FG000|Overall Study|moved|1|||
146962004|NCT00553319|530019922|FG001|Overall Study|moved|0|||
146962005|NCT00553319|530019923|FG002|Overall Study|moved|1|||
146962006|NCT01731600|530019929|FG000|Overall Study|Adverse Event|2|||
146962007|NCT01731600|530019930|FG001|Overall Study|Adverse Event|0|||
146962008|NCT01731600|530019929|FG000|Overall Study|Withdrawal criteria|1|||
146962009|NCT01731600|530019930|FG001|Overall Study|Withdrawal criteria|0|||
146962010|NCT01731600|530019929|FG000|Overall Study|Other reasons|3|||
146962011|NCT01731600|530019930|FG001|Overall Study|Other reasons|0|||
146962012|NCT03575975|530019931|FG000|Overall Study|Lost to Follow-up|1|||
146962013|NCT03575975|530019932|FG001|Overall Study|Lost to Follow-up|0|||
146962014|NCT03575975|530019933|FG002|Overall Study|Lost to Follow-up|0|||
146962015|NCT00129220|530019936|FG000|Study Period II|Adverse Event|9|||
146962016|NCT00129220|530019937|FG001|Study Period II|Adverse Event|5|||
146962017|NCT00129220|530019938|FG002|Study Period II|Adverse Event|7|||
146962018|NCT00129220|530019936|FG000|Study Period II|Lack of Efficacy|15|||
146962019|NCT00129220|530019937|FG001|Study Period II|Lack of Efficacy|1|||
146962020|NCT00129220|530019938|FG002|Study Period II|Lack of Efficacy|28|||
146962021|NCT00129220|530019936|FG000|Study Period II|Entry Criteria Not Met|2|||
146962022|NCT00129220|530019937|FG001|Study Period II|Entry Criteria Not Met|0|||
146962023|NCT00129220|530019938|FG002|Study Period II|Entry Criteria Not Met|2|||
146962024|NCT00129220|530019936|FG000|Study Period II|Protocol Violation|4|||
146962025|NCT00129220|530019937|FG001|Study Period II|Protocol Violation|2|||
146962026|NCT00129220|530019938|FG002|Study Period II|Protocol Violation|1|||
146962027|NCT00129220|530019936|FG000|Study Period II|Physician Decision|0|||
146962028|NCT00129220|530019937|FG001|Study Period II|Physician Decision|1|||
146962029|NCT00129220|530019938|FG002|Study Period II|Physician Decision|0|||
146962030|NCT00129220|530019936|FG000|Study Period II|Withdrawal by Subject|1|||
146962031|NCT00129220|530019937|FG001|Study Period II|Withdrawal by Subject|3|||
146962032|NCT00129220|530019938|FG002|Study Period II|Withdrawal by Subject|4|||
146962033|NCT00129220|530019936|FG000|Study Period II|Reason Not Specified|2|||
146962034|NCT00129220|530019937|FG001|Study Period II|Reason Not Specified|0|||
146962035|NCT00129220|530019938|FG002|Study Period II|Reason Not Specified|5|||
146962036|NCT00129220|530019936|FG000|Study Period III|Adverse Event|1|||
146962037|NCT00129220|530019937|FG001|Study Period III|Adverse Event|0|||
146962038|NCT00129220|530019938|FG002|Study Period III|Adverse Event|3|||
146962039|NCT00129220|530019936|FG000|Study Period III|Protocol Violation|1|||
146962040|NCT00129220|530019937|FG001|Study Period III|Protocol Violation|1|||
146962041|NCT00129220|530019938|FG002|Study Period III|Protocol Violation|2|||
146962042|NCT00129220|530019936|FG000|Study Period III|Withdrawal by Subject|1|||
146962043|NCT00129220|530019937|FG001|Study Period III|Withdrawal by Subject|0|||
146962044|NCT00129220|530019938|FG002|Study Period III|Withdrawal by Subject|3|||
146962045|NCT00129220|530019936|FG000|Study Period III|Sponsor Decision|1|||
146962046|NCT00129220|530019937|FG001|Study Period III|Sponsor Decision|0|||
146962047|NCT00129220|530019938|FG002|Study Period III|Sponsor Decision|0|||
146962048|NCT00129220|530019936|FG000|Study Period III|Reason Not Specified|9|||
146962049|NCT00129220|530019937|FG001|Study Period III|Reason Not Specified|0|||
146962050|NCT00129220|530019938|FG002|Study Period III|Reason Not Specified|2|||
146962051|NCT01230489|530019940|FG000|Overall Study|Death|2|||
146962052|NCT01230489|530019940|FG000|Overall Study|Adverse Event|2|||
146962053|NCT01230489|530019940|FG000|Overall Study|Treatment modality changed|1|||
146962054|NCT03996694|530021469|FG000|First Washout (7 Days)|positive urine drug screen|0|||
146962055|NCT03996694|530021470|FG001|First Washout (7 Days)|positive urine drug screen|0|||
146962056|NCT03996694|530021471|FG002|First Washout (7 Days)|positive urine drug screen|1|||
146962057|NCT03996694|530021472|FG003|First Washout (7 Days)|positive urine drug screen|0|||
146962058|NCT03996694|530021473|FG004|First Washout (7 Days)|positive urine drug screen|0|||
146962059|NCT03996694|530021474|FG005|First Washout (7 Days)|positive urine drug screen|0|||
146962060|NCT03996694|530021469|FG000|First Washout (7 Days)|Adverse Event|0|||
146962061|NCT03996694|530021470|FG001|First Washout (7 Days)|Adverse Event|1|||
146962062|NCT03996694|530021471|FG002|First Washout (7 Days)|Adverse Event|0|||
146962063|NCT03996694|530021472|FG003|First Washout (7 Days)|Adverse Event|0|||
146962064|NCT03996694|530021473|FG004|First Washout (7 Days)|Adverse Event|0|||
146962065|NCT03996694|530021474|FG005|First Washout (7 Days)|Adverse Event|0|||
146962066|NCT03996694|530021469|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
146962067|NCT03996694|530021470|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
146962068|NCT03996694|530021471|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
146962069|NCT03996694|530021472|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
146962070|NCT03996694|530021473|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
146962071|NCT03996694|530021474|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
146962072|NCT03996694|530021469|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
146962073|NCT03996694|530021470|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
146962074|NCT03996694|530021471|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
146962075|NCT03996694|530021472|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
146962076|NCT03996694|530021473|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
146962077|NCT03996694|530021474|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
146996840|NCT02883452|530153316|FG002|Overall Study|Physician Decision|0|||
146996841|NCT02883452|530153317|FG003|Overall Study|Physician Decision|0|||
146996842|NCT02883452|530153318|FG004|Overall Study|Physician Decision|4|||
146996843|NCT02883452|530153319|FG005|Overall Study|Physician Decision|1|||
146996844|NCT02883452|530153314|FG000|Overall Study|Death|1|||
146996845|NCT02883452|530153315|FG001|Overall Study|Death|0|||
146996846|NCT02883452|530153316|FG002|Overall Study|Death|1|||
146996847|NCT02883452|530153317|FG003|Overall Study|Death|0|||
146996848|NCT02883452|530153318|FG004|Overall Study|Death|0|||
146996849|NCT02883452|530153319|FG005|Overall Study|Death|0|||
146996850|NCT02883452|530153314|FG000|Overall Study|Other|0|||
146996851|NCT02883452|530153315|FG001|Overall Study|Other|0|||
146996852|NCT02883452|530153316|FG002|Overall Study|Other|0|||
146996853|NCT02883452|530153317|FG003|Overall Study|Other|0|||
146996854|NCT02883452|530153318|FG004|Overall Study|Other|0|||
146996855|NCT02883452|530153319|FG005|Overall Study|Other|1|||
146996856|NCT00667095|530153329|FG000|Overall Study|Withdrawal by Subject|0|||
146996857|NCT00667095|530153330|FG001|Overall Study|Withdrawal by Subject|1|||
146996858|NCT01520909|530153331|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
146996859|NCT01520909|530153332|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
146996860|NCT01520909|530153333|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
146996861|NCT01520909|530153331|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
146996862|NCT01520909|530153332|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
146996863|NCT01520909|530153333|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
146996864|NCT01520909|530153331|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
146996865|NCT01520909|530153332|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
146996866|NCT01520909|530153333|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
146996867|NCT01520909|530153331|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
146996868|NCT01520909|530153332|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
146996869|NCT01520909|530153333|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
146996870|NCT01882257|530153334|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
146996871|NCT01882257|530153335|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
146996872|NCT01882257|530153336|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
146996873|NCT01882257|530153334|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
146996874|NCT01882257|530153335|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
146996875|NCT01882257|530153336|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
146996876|NCT00830206|530153338|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
146996877|NCT00830206|530153339|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
146996878|NCT00905346|530153346|FG000|Period 1|Withdrawal by Subject|1|||
146996879|NCT00905346|530153347|FG001|Period 1|Withdrawal by Subject|0|||
146996880|NCT01435265|530153348|FG000|Overall Study|Lost to Follow-up|0|||
146996881|NCT01435265|530153349|FG001|Overall Study|Lost to Follow-up|1|||
146996882|NCT00909610|530153352|FG000|Period: First Intervention|Adverse Event|0|||
146996883|NCT00909610|530153353|FG001|Period: First Intervention|Adverse Event|1|||
146962078|NCT00066573|530021481|FG000|Overall Study|Did not received protocol treatment|28|||
146962079|NCT00066573|530021482|FG001|Overall Study|Did not received protocol treatment|28|||
146996884|NCT00909610|530153352|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
146996885|NCT00909610|530153353|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
146996886|NCT00909610|530153352|FG000|Period: Second Intervention|Adverse Event|1|||
146996887|NCT00909610|530153353|FG001|Period: Second Intervention|Adverse Event|0|||
146996888|NCT04123548|530153357|FG000|Overall Study|Withdrawal by Subject|1|||
146996889|NCT04123548|530153357|FG000|Overall Study|Lost to Follow-up|8|||
146996890|NCT04123548|530153357|FG000|Overall Study|Death|4|||
146996891|NCT04123548|530153357|FG000|Overall Study|Reason Not Specified|1|||
146996892|NCT04166630|530153359|FG000|Overall Study|Withdrawal by Subject|0|||
146996893|NCT04166630|530153360|FG001|Overall Study|Withdrawal by Subject|1|||
146996894|NCT03107091|530153361|FG000|Overall Study|Physician Decision|1|||
146996895|NCT00105196|530153366|FG000|Overall Study|Lack of Efficacy|2|||
146996896|NCT00105196|530153367|FG001|Overall Study|Lack of Efficacy|3|||
146996897|NCT00105196|530153366|FG000|Overall Study|Adverse Event|11|||
146996898|NCT00105196|530153367|FG001|Overall Study|Adverse Event|3|||
146996899|NCT00105196|530153366|FG000|Overall Study|Withdrawal by Subject|6|||
146996900|NCT00105196|530153367|FG001|Overall Study|Withdrawal by Subject|6|||
146996901|NCT00105196|530153366|FG000|Overall Study|Lost to Follow-up|3|||
146996902|NCT00105196|530153367|FG001|Overall Study|Lost to Follow-up|2|||
146996903|NCT00105196|530153366|FG000|Overall Study|Poor/noncompliance|3|||
146996904|NCT00105196|530153367|FG001|Overall Study|Poor/noncompliance|4|||
146996905|NCT00105196|530153366|FG000|Overall Study|Protocol Violation|5|||
146996906|NCT00105196|530153367|FG001|Overall Study|Protocol Violation|2|||
146996907|NCT00105196|530153366|FG000|Overall Study|pending surgery|0|||
146996908|NCT00105196|530153367|FG001|Overall Study|pending surgery|1|||
146996909|NCT00105196|530153366|FG000|Overall Study|marijuana use|0|||
146996910|NCT00105196|530153367|FG001|Overall Study|marijuana use|1|||
146996911|NCT00105196|530153366|FG000|Overall Study|Subject became unblinded|0|||
146996912|NCT00105196|530153367|FG001|Overall Study|Subject became unblinded|1|||
146996913|NCT00893464|530153368|FG000|Overall Study|Did not complete therapy/experience PD|0|||
146996914|NCT00893464|530153369|FG001|Overall Study|Did not complete therapy/experience PD|0|||
146996915|NCT00893464|530153370|FG002|Overall Study|Did not complete therapy/experience PD|0|||
146996916|NCT00893464|530153371|FG003|Overall Study|Did not complete therapy/experience PD|0|||
146996917|NCT00893464|530153372|FG004|Overall Study|Did not complete therapy/experience PD|0|||
146996918|NCT00893464|530153373|FG005|Overall Study|Did not complete therapy/experience PD|0|||
146996919|NCT00893464|530153374|FG006|Overall Study|Did not complete therapy/experience PD|2|||
146996920|NCT00893464|530153375|FG007|Overall Study|Did not complete therapy/experience PD|2|||
146996921|NCT01544127|530153376|FG000|Overall Study|Lost to Follow-up|4|||
146996922|NCT01544127|530153377|FG001|Overall Study|Lost to Follow-up|2|||
146996923|NCT01544127|530153378|FG002|Overall Study|Lost to Follow-up|9|||
146996924|NCT01544127|530153376|FG000|Overall Study|Withdrawal by Subject|2|||
146996925|NCT01544127|530153377|FG001|Overall Study|Withdrawal by Subject|2|||
146996926|NCT01544127|530153378|FG002|Overall Study|Withdrawal by Subject|1|||
146996927|NCT01544127|530153376|FG000|Overall Study|Discharged out of catchment area|1|||
146996928|NCT01544127|530153377|FG001|Overall Study|Discharged out of catchment area|1|||
146996929|NCT01544127|530153378|FG002|Overall Study|Discharged out of catchment area|1|||
146996930|NCT01544127|530153376|FG000|Overall Study|Death|1|||
146996931|NCT01544127|530153377|FG001|Overall Study|Death|0|||
146996932|NCT01544127|530153378|FG002|Overall Study|Death|0|||
146996933|NCT01544127|530153376|FG000|Overall Study|Jail or Prison|1|||
146996934|NCT01544127|530153377|FG001|Overall Study|Jail or Prison|1|||
146996935|NCT01544127|530153378|FG002|Overall Study|Jail or Prison|2|||
146996936|NCT01544127|530153376|FG000|Overall Study|Became Psychotic|1|||
146996937|NCT01544127|530153377|FG001|Overall Study|Became Psychotic|0|||
146996938|NCT01544127|530153378|FG002|Overall Study|Became Psychotic|0|||
146996939|NCT01544127|530153376|FG000|Overall Study|Researcher withdrew|1|||
146996940|NCT01544127|530153377|FG001|Overall Study|Researcher withdrew|0|||
146996941|NCT01544127|530153378|FG002|Overall Study|Researcher withdrew|0|||
146996942|NCT01544127|530153376|FG000|Overall Study|Went active duty|0|||
146996943|NCT01544127|530153377|FG001|Overall Study|Went active duty|0|||
146996944|NCT01544127|530153378|FG002|Overall Study|Went active duty|1|||
146996945|NCT01256684|530153379|FG000|Overall Study|Adverse Event|1|||
146996946|NCT01256684|530153380|FG001|Overall Study|Adverse Event|4|||
146996947|NCT01256684|530153381|FG002|Overall Study|Adverse Event|2|||
146996948|NCT01256684|530153379|FG000|Overall Study|Withdrawal by Subject|4|||
146996949|NCT01256684|530153380|FG001|Overall Study|Withdrawal by Subject|0|||
146996950|NCT01256684|530153381|FG002|Overall Study|Withdrawal by Subject|2|||
146996951|NCT01256684|530153379|FG000|Overall Study|Physician Decision|0|||
146996952|NCT01256684|530153380|FG001|Overall Study|Physician Decision|1|||
146996953|NCT01256684|530153381|FG002|Overall Study|Physician Decision|0|||
146996954|NCT01256684|530153379|FG000|Overall Study|Lack of Efficacy|0|||
146996955|NCT01256684|530153380|FG001|Overall Study|Lack of Efficacy|1|||
146996956|NCT01256684|530153381|FG002|Overall Study|Lack of Efficacy|1|||
146996957|NCT01256684|530153379|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
146996958|NCT01256684|530153380|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
146996959|NCT01256684|530153381|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
146996960|NCT02914600|530153382|FG000|Overall Study|Adverse Event|298|||
146996961|NCT02914600|530153383|FG001|Overall Study|Adverse Event|35|||
146996962|NCT02914600|530153384|FG002|Overall Study|Adverse Event|25|||
146996963|NCT02914600|530153382|FG000|Overall Study|Sponsors decision|287|||
146996964|NCT02914600|530153383|FG001|Overall Study|Sponsors decision|41|||
146996965|NCT02914600|530153384|FG002|Overall Study|Sponsors decision|12|||
146996966|NCT02914600|530153382|FG000|Overall Study|Withdrawal by Subject|158|||
146842843|NCT00245960|529593990|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
146842844|NCT00245960|529593991|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
146842845|NCT00245960|529593990|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
146842846|NCT00245960|529593991|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
146842847|NCT00245960|529593990|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
146842848|NCT00245960|529593991|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
146842849|NCT00245960|529593990|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
146842850|NCT00245960|529593991|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
146842851|NCT01077518|529593993|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
146996967|NCT02914600|530153383|FG001|Overall Study|Withdrawal by Subject|20|||
146996968|NCT02914600|530153384|FG002|Overall Study|Withdrawal by Subject|18|||
146996969|NCT02914600|530153382|FG000|Overall Study|Investigators discretion|169|||
146996970|NCT02914600|530153383|FG001|Overall Study|Investigators discretion|14|||
146996971|NCT02914600|530153384|FG002|Overall Study|Investigators discretion|13|||
146996972|NCT02914600|530153382|FG000|Overall Study|Lost to Follow-up|10|||
146996973|NCT02914600|530153383|FG001|Overall Study|Lost to Follow-up|4|||
146996974|NCT02914600|530153384|FG002|Overall Study|Lost to Follow-up|0|||
146996975|NCT02914600|530153382|FG000|Overall Study|Pregnancy|8|||
146996976|NCT02914600|530153383|FG001|Overall Study|Pregnancy|0|||
146996977|NCT02914600|530153384|FG002|Overall Study|Pregnancy|0|||
146996978|NCT02914600|530153382|FG000|Overall Study|Protocol Violation|5|||
146996979|NCT02914600|530153383|FG001|Overall Study|Protocol Violation|3|||
146996980|NCT02914600|530153384|FG002|Overall Study|Protocol Violation|0|||
146996981|NCT02914600|530153382|FG000|Overall Study|Non-compliance with study drug|6|||
146996982|NCT02914600|530153383|FG001|Overall Study|Non-compliance with study drug|1|||
146996983|NCT02914600|530153384|FG002|Overall Study|Non-compliance with study drug|0|||
146996984|NCT02914600|530153382|FG000|Overall Study|Death|3|||
146996985|NCT02914600|530153383|FG001|Overall Study|Death|1|||
146996986|NCT02914600|530153384|FG002|Overall Study|Death|1|||
146996987|NCT02914600|530153382|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
146996988|NCT02914600|530153383|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
146996989|NCT02914600|530153384|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
146996990|NCT02914600|530153382|FG000|Overall Study|Enrolled but not treated|1|||
146996991|NCT02914600|530153383|FG001|Overall Study|Enrolled but not treated|0|||
146996992|NCT02914600|530153384|FG002|Overall Study|Enrolled but not treated|0|||
146996993|NCT02457520|530153385|FG000|Active Treatment Phase|Adverse Event|10|||
146996994|NCT02457520|530153385|FG000|Active Treatment Phase|Lost to Follow-up|8|||
146996995|NCT02457520|530153385|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
146996996|NCT02457520|530153385|FG000|Active Treatment Phase|other|4|||
146996997|NCT02457520|530153385|FG000|Active Treatment Phase|Physician Decision|1|||
146996998|NCT02457520|530153385|FG000|Active Treatment Phase|Protocol Violation|1|||
146996999|NCT02457520|530153385|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
146997000|NCT02457520|530153385|FG000|Post-treatment Period|Other: Retreatment Required|7|||
146997001|NCT02457520|530153385|FG000|Post-treatment Period|Lost to Follow-up|23|||
146997002|NCT02457520|530153385|FG000|Post-treatment Period|Other|3|||
146997003|NCT02457520|530153385|FG000|Post-treatment Period|Physician Decision|1|||
146997004|NCT02457520|530153385|FG000|Post-treatment Period|Withdrawal by Subject|14|||
146997005|NCT01185548|530153386|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
146997006|NCT00184600|530153389|FG000|Overall Study|Adverse Event|9|||
146997007|NCT00184600|530153390|FG001|Overall Study|Adverse Event|0|||
146997008|NCT00184600|530153391|FG002|Overall Study|Adverse Event|5|||
146997009|NCT00184600|530153389|FG000|Overall Study|Death|3|||
146997010|NCT00184600|530153390|FG001|Overall Study|Death|9|||
146997011|NCT00184600|530153391|FG002|Overall Study|Death|7|||
146997012|NCT00184600|530153389|FG000|Overall Study|Lack of Efficacy|3|||
146997013|NCT00184600|530153390|FG001|Overall Study|Lack of Efficacy|1|||
146997014|NCT00184600|530153391|FG002|Overall Study|Lack of Efficacy|3|||
146997015|NCT00184600|530153389|FG000|Overall Study|Lost to Follow-up|4|||
146997016|NCT00184600|530153390|FG001|Overall Study|Lost to Follow-up|6|||
146997017|NCT00184600|530153391|FG002|Overall Study|Lost to Follow-up|1|||
146997018|NCT00184600|530153389|FG000|Overall Study|Protocol Violation|2|||
146997019|NCT00184600|530153390|FG001|Overall Study|Protocol Violation|2|||
146997020|NCT00184600|530153391|FG002|Overall Study|Protocol Violation|3|||
146842852|NCT01077518|529593994|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
146997021|NCT00184600|530153389|FG000|Overall Study|Withdrawal by Subject|20|||
146997022|NCT00184600|530153390|FG001|Overall Study|Withdrawal by Subject|28|||
146997023|NCT00184600|530153391|FG002|Overall Study|Withdrawal by Subject|12|||
146997024|NCT00184600|530153389|FG000|Overall Study|Unclassified|4|||
146997025|NCT00184600|530153390|FG001|Overall Study|Unclassified|5|||
146997026|NCT00184600|530153391|FG002|Overall Study|Unclassified|3|||
146997027|NCT00696020|530153394|FG000|Overall Study|Adverse Event|3|||
146997028|NCT00696020|530153395|FG001|Overall Study|Adverse Event|1|||
146997029|NCT00696020|530153396|FG002|Overall Study|Adverse Event|2|||
146997030|NCT00696020|530153397|FG003|Overall Study|Adverse Event|1|||
146997031|NCT00696020|530153394|FG000|Overall Study|Lack of Efficacy|1|||
146842853|NCT01077518|529593995|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
146842854|NCT01077518|529593993|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
146842855|NCT01077518|529593994|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
146842856|NCT01077518|529593995|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
146842857|NCT01077518|529593993|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
146842858|NCT01077518|529593994|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
146842859|NCT01077518|529593995|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
146842860|NCT01077518|529593993|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
146842861|NCT01077518|529593994|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
146842862|NCT01077518|529593995|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
146842863|NCT01077518|529593993|FG000|Optional Ofa Phase|Physician Decision|0|||
146842864|NCT01077518|529593994|FG001|Optional Ofa Phase|Physician Decision|0|||
146842865|NCT01077518|529593995|FG002|Optional Ofa Phase|Physician Decision|1|||
146842866|NCT01077518|529593993|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
146842867|NCT01077518|529593994|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
146842868|NCT01077518|529593995|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
146842869|NCT01077518|529593993|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
146842870|NCT01077518|529593994|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
146842871|NCT01077518|529593995|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
146842872|NCT01495598|529593996|FG000|Overall Study|Death during follow up period|2|||
146842873|NCT01495598|529593996|FG000|Overall Study|Death on study|1|||
146842874|NCT01495598|529593996|FG000|Overall Study|Lost to Follow-up|3|||
146842875|NCT01495598|529593996|FG000|Overall Study|Physician Decision|8|||
146842876|NCT03852719|529593997|FG000|Overall Study|Withdrawal of consent|8|||
146842877|NCT03852719|529593998|FG001|Overall Study|Withdrawal of consent|8|||
146842878|NCT03852719|529593999|FG002|Overall Study|Withdrawal of consent|9|||
146842879|NCT03852719|529593997|FG000|Overall Study|Physician Decision|5|||
146842880|NCT03852719|529593998|FG001|Overall Study|Physician Decision|4|||
146842881|NCT03852719|529593999|FG002|Overall Study|Physician Decision|1|||
146842882|NCT03852719|529593997|FG000|Overall Study|Pregnancy|2|||
146842883|NCT03852719|529593998|FG001|Overall Study|Pregnancy|1|||
146842884|NCT03852719|529593999|FG002|Overall Study|Pregnancy|0|||
146842885|NCT03852719|529593997|FG000|Overall Study|Death|1|||
146842886|NCT03852719|529593998|FG001|Overall Study|Death|0|||
146842887|NCT03852719|529593999|FG002|Overall Study|Death|0|||
146842888|NCT03852719|529593997|FG000|Overall Study|Reason not Specified|3|||
146842889|NCT03852719|529593998|FG001|Overall Study|Reason not Specified|3|||
146842890|NCT03852719|529593999|FG002|Overall Study|Reason not Specified|5|||
146842891|NCT03852719|529593997|FG000|Overall Study|Adverse Event|2|||
146842892|NCT03852719|529593998|FG001|Overall Study|Adverse Event|1|||
146842893|NCT03852719|529593999|FG002|Overall Study|Adverse Event|4|||
146842894|NCT03852719|529593997|FG000|Overall Study|Progressive disease|1|||
146842895|NCT03852719|529593998|FG001|Overall Study|Progressive disease|4|||
146842896|NCT03852719|529593999|FG002|Overall Study|Progressive disease|1|||
146842897|NCT03852719|529593997|FG000|Overall Study|Lost to Follow-up|1|||
146842898|NCT03852719|529593998|FG001|Overall Study|Lost to Follow-up|0|||
146842899|NCT03852719|529593999|FG002|Overall Study|Lost to Follow-up|0|||
146842900|NCT03086655|529594000|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
146962080|NCT02147132|530021483|FG000|Overall Study|Lost to Follow-up|1|||
146962081|NCT02147132|530021484|FG001|Overall Study|Lost to Follow-up|0|||
146962082|NCT02147132|530021485|FG002|Overall Study|Lost to Follow-up|0|||
146962083|NCT02147132|530021486|FG003|Overall Study|Lost to Follow-up|0|||
146962084|NCT01013207|530021487|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
146962085|NCT01541644|530021492|FG000|Overall Study|Withdrawal by Subject|3|||
146962086|NCT02842736|530021495|FG000|Overall Study|Lost to Follow-up|13|||
146962087|NCT02842736|530021495|FG000|Overall Study|Intervention for menstrual bleeding|17|||
146962088|NCT02842736|530021495|FG000|Overall Study|Withdrawal by Subject|4|||
146962089|NCT02842736|530021495|FG000|Overall Study|Pregnancy|3|||
146962090|NCT02842736|530021495|FG000|Overall Study|Hysterectomy for fibroids|2|||
146962091|NCT02842736|530021495|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
146962092|NCT02842736|530021495|FG000|Overall Study|IUD: Mirena|1|||
146962093|NCT02064231|530021496|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
146962094|NCT02064231|530021497|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
146962095|NCT02064231|530021498|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
146962096|NCT02064231|530021499|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
146962097|NCT02064231|530021496|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
146962098|NCT02064231|530021497|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
146962099|NCT02064231|530021498|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
146842901|NCT03086655|529594001|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
146842902|NCT03086655|529594000|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
146842903|NCT03086655|529594001|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
146842904|NCT03086655|529594000|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
146842905|NCT03086655|529594001|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
146842906|NCT03086655|529594000|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
146842907|NCT03086655|529594001|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
146842908|NCT03086655|529594000|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
146842909|NCT03086655|529594001|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
146842910|NCT03086655|529594000|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
146842911|NCT03086655|529594001|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
146842912|NCT03086655|529594000|FG000|12 Month Follow-up = Final Assessment|Death|0|||
146842913|NCT03086655|529594001|FG001|12 Month Follow-up = Final Assessment|Death|1|||
146842914|NCT03841526|529594003|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
146842915|NCT03841526|529594004|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
146842916|NCT03841526|529594005|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
146842917|NCT03841526|529594006|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
146842918|NCT03841526|529594007|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
146842919|NCT03841526|529594008|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
146842920|NCT03841526|529594003|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
146842921|NCT03841526|529594004|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
146842922|NCT03841526|529594005|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
146842923|NCT03841526|529594006|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
146842924|NCT03841526|529594007|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
146842925|NCT03841526|529594008|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
146842926|NCT03841526|529594003|FG000|Outpatient Phase Treatment|Physician Decision|0|||
146842927|NCT03841526|529594004|FG001|Outpatient Phase Treatment|Physician Decision|1|||
146842928|NCT03841526|529594005|FG002|Outpatient Phase Treatment|Physician Decision|0|||
146842929|NCT03841526|529594006|FG003|Outpatient Phase Treatment|Physician Decision|0|||
146842930|NCT03841526|529594007|FG004|Outpatient Phase Treatment|Physician Decision|0|||
146842931|NCT03841526|529594008|FG005|Outpatient Phase Treatment|Physician Decision|0|||
146842932|NCT03841526|529594003|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
146997032|NCT00696020|530153395|FG001|Overall Study|Lack of Efficacy|0|||
146997033|NCT00696020|530153396|FG002|Overall Study|Lack of Efficacy|0|||
146997034|NCT00696020|530153397|FG003|Overall Study|Lack of Efficacy|0|||
146997035|NCT00696020|530153394|FG000|Overall Study|Protocol Violation|0|||
146997036|NCT00696020|530153395|FG001|Overall Study|Protocol Violation|0|||
146997037|NCT00696020|530153396|FG002|Overall Study|Protocol Violation|0|||
146997038|NCT00696020|530153397|FG003|Overall Study|Protocol Violation|1|||
146997039|NCT00696020|530153394|FG000|Overall Study|Withdrawal by Subject|0|||
146997040|NCT00696020|530153395|FG001|Overall Study|Withdrawal by Subject|1|||
146997041|NCT00696020|530153396|FG002|Overall Study|Withdrawal by Subject|0|||
146997042|NCT00696020|530153397|FG003|Overall Study|Withdrawal by Subject|1|||
146997043|NCT00696020|530153394|FG000|Overall Study|Other not stated above|0|||
146997044|NCT00696020|530153395|FG001|Overall Study|Other not stated above|0|||
146997045|NCT00696020|530153396|FG002|Overall Study|Other not stated above|1|||
146997046|NCT00696020|530153397|FG003|Overall Study|Other not stated above|1|||
146997047|NCT00624065|530153398|FG000|Overall Study|Adverse Event|5|||
146997048|NCT00624065|530153399|FG001|Overall Study|Adverse Event|6|||
146997049|NCT00624065|530153398|FG000|Overall Study|Lost to Follow-up|4|||
146997050|NCT00624065|530153399|FG001|Overall Study|Lost to Follow-up|1|||
146997051|NCT00624065|530153398|FG000|Overall Study|Consent withdrawn|6|||
146997052|NCT00624065|530153399|FG001|Overall Study|Consent withdrawn|5|||
146997053|NCT00624065|530153398|FG000|Overall Study|Lack of Efficacy|0|||
146997054|NCT00624065|530153399|FG001|Overall Study|Lack of Efficacy|3|||
146997055|NCT00624065|530153398|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
146997056|NCT00624065|530153399|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
146997057|NCT01387022|530153400|FG000|Overall Study|Death|1|||
146997058|NCT01387022|530153401|FG001|Overall Study|Death|1|||
146997059|NCT01387022|530153400|FG000|Overall Study|Lost to Follow-up|0|||
146997060|NCT01387022|530153401|FG001|Overall Study|Lost to Follow-up|3|||
146997061|NCT02076022|530153403|FG000|Overall Study|Withdrawal by Subject|2|||
146997062|NCT02076022|530153404|FG001|Overall Study|Withdrawal by Subject|0|||
146997063|NCT00312663|530153407|FG000|Immunization Phase|Adverse Event|0|||
146997064|NCT00312663|530153408|FG001|Immunization Phase|Adverse Event|1|||
146997065|NCT00312663|530153409|FG002|Immunization Phase|Adverse Event|0|||
146997066|NCT02336165|530153413|FG000|Overall Study|Death|3|||
146997067|NCT02336165|530153414|FG001|Overall Study|Death|0|||
146997068|NCT02336165|530153415|FG002|Overall Study|Death|0|||
146997069|NCT02336165|530153416|FG003|Overall Study|Death|0|||
146997070|NCT02336165|530153417|FG004|Overall Study|Death|1|||
146997071|NCT02336165|530153413|FG000|Overall Study|Physician Decision|2|||
146997072|NCT02336165|530153414|FG001|Overall Study|Physician Decision|2|||
146997073|NCT02336165|530153415|FG002|Overall Study|Physician Decision|1|||
146997074|NCT02336165|530153416|FG003|Overall Study|Physician Decision|1|||
146842933|NCT03841526|529594004|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
146842934|NCT03841526|529594005|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
146842935|NCT03841526|529594006|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
146842936|NCT03841526|529594007|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
146842937|NCT03841526|529594008|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
146842938|NCT03524092|529594013|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
146842939|NCT03524092|529594014|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
146842940|NCT03524092|529594015|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
146842941|NCT03524092|529594016|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
146842942|NCT03524092|529594017|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
146842943|NCT03524092|529594018|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
146842944|NCT03524092|529594013|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
146842945|NCT03524092|529594014|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
146842946|NCT03524092|529594015|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
146842947|NCT03524092|529594016|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
146842948|NCT03524092|529594017|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
146842949|NCT03524092|529594018|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
146842950|NCT03524092|529594013|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
146842951|NCT03524092|529594014|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
146842952|NCT03524092|529594015|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
146842953|NCT03524092|529594016|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
146842954|NCT03524092|529594017|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
146842955|NCT03524092|529594018|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
146842956|NCT03524092|529594013|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
146842957|NCT03524092|529594014|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
146842958|NCT03524092|529594015|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
146842959|NCT03524092|529594016|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
146842960|NCT03524092|529594017|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
146842961|NCT03524092|529594018|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
146842962|NCT03524092|529594013|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
146842963|NCT03524092|529594014|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
146842964|NCT03524092|529594015|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
146842965|NCT03524092|529594016|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
146842966|NCT03524092|529594017|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
146842967|NCT03524092|529594018|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
146842968|NCT03524092|529594013|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
146842969|NCT03524092|529594014|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
146842970|NCT03524092|529594015|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
146842971|NCT03524092|529594016|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
146842972|NCT03524092|529594017|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
146842973|NCT03524092|529594018|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
146842974|NCT03524092|529594013|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
146842975|NCT03524092|529594014|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
146842976|NCT03524092|529594015|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
146842977|NCT03524092|529594016|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
146842978|NCT03524092|529594017|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
146842979|NCT03524092|529594018|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
146842980|NCT03524092|529594013|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
146842981|NCT03524092|529594014|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
146842982|NCT03524092|529594015|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
146842983|NCT03524092|529594016|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
146842984|NCT03524092|529594017|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
146842985|NCT03524092|529594018|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
146842986|NCT03524092|529594013|FG000|Loss of Response Rescue Period|Adverse Event|0|||
146842987|NCT03524092|529594014|FG001|Loss of Response Rescue Period|Adverse Event|0|||
146842988|NCT03524092|529594015|FG002|Loss of Response Rescue Period|Adverse Event|0|||
146842989|NCT03524092|529594016|FG003|Loss of Response Rescue Period|Adverse Event|2|||
146842990|NCT03524092|529594017|FG004|Loss of Response Rescue Period|Adverse Event|0|||
146842991|NCT03524092|529594018|FG005|Loss of Response Rescue Period|Adverse Event|0|||
146842992|NCT03524092|529594013|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
146842993|NCT03524092|529594014|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
146842994|NCT03524092|529594015|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
146842995|NCT03524092|529594016|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
146842996|NCT03524092|529594017|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
146842997|NCT03524092|529594018|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
146842998|NCT03524092|529594013|FG000|Loss of Response Rescue Period|Pregnancy|0|||
146842999|NCT03524092|529594014|FG001|Loss of Response Rescue Period|Pregnancy|0|||
146843000|NCT03524092|529594015|FG002|Loss of Response Rescue Period|Pregnancy|0|||
146843001|NCT03524092|529594016|FG003|Loss of Response Rescue Period|Pregnancy|1|||
146843002|NCT03524092|529594017|FG004|Loss of Response Rescue Period|Pregnancy|0|||
146843003|NCT03524092|529594018|FG005|Loss of Response Rescue Period|Pregnancy|0|||
146843004|NCT03524092|529594013|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
146843005|NCT03524092|529594014|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
146843006|NCT03524092|529594015|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
146843007|NCT03524092|529594016|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
146843008|NCT03524092|529594017|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
146843009|NCT03524092|529594018|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
146843010|NCT03524092|529594013|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
146843011|NCT03524092|529594014|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
146843012|NCT03524092|529594015|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
146843013|NCT03524092|529594016|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
146843014|NCT03524092|529594017|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
146843015|NCT03524092|529594018|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
146843016|NCT03524092|529594013|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
146843017|NCT03524092|529594014|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
146843018|NCT03524092|529594015|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
146843019|NCT03524092|529594016|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
146843020|NCT03524092|529594017|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
146843021|NCT03524092|529594018|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
146843022|NCT03524092|529594013|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
146843023|NCT03524092|529594014|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
146843024|NCT03524092|529594015|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
146843025|NCT03524092|529594016|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
146843026|NCT03524092|529594017|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
146843027|NCT03524092|529594018|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
146843028|NCT03524092|529594013|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
146843029|NCT03524092|529594014|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
146843030|NCT03524092|529594015|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
146843031|NCT03524092|529594016|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
146843032|NCT03524092|529594017|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
146843033|NCT03524092|529594018|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
146843034|NCT03524092|529594013|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
146843035|NCT03524092|529594014|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
146843036|NCT03524092|529594015|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
146843037|NCT03524092|529594016|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
146997075|NCT02336165|530153417|FG004|Overall Study|Physician Decision|0|||
146997076|NCT02336165|530153413|FG000|Overall Study|Withdrawal by Subject|0|||
146997077|NCT02336165|530153414|FG001|Overall Study|Withdrawal by Subject|0|||
146997078|NCT02336165|530153415|FG002|Overall Study|Withdrawal by Subject|1|||
146997079|NCT02336165|530153416|FG003|Overall Study|Withdrawal by Subject|0|||
146997080|NCT02336165|530153417|FG004|Overall Study|Withdrawal by Subject|1|||
146997081|NCT02336165|530153413|FG000|Overall Study|Adverse Event|4|||
146997082|NCT02336165|530153414|FG001|Overall Study|Adverse Event|1|||
146997083|NCT02336165|530153415|FG002|Overall Study|Adverse Event|2|||
146997084|NCT02336165|530153416|FG003|Overall Study|Adverse Event|4|||
146997085|NCT02336165|530153417|FG004|Overall Study|Adverse Event|1|||
146997086|NCT02336165|530153413|FG000|Overall Study|Progressive disease|23|||
146997087|NCT02336165|530153414|FG001|Overall Study|Progressive disease|22|||
146997088|NCT02336165|530153415|FG002|Overall Study|Progressive disease|27|||
146997089|NCT02336165|530153416|FG003|Overall Study|Progressive disease|24|||
146997090|NCT02336165|530153417|FG004|Overall Study|Progressive disease|19|||
146997091|NCT02336165|530153413|FG000|Overall Study|Non-compliance|1|||
146997092|NCT02336165|530153414|FG001|Overall Study|Non-compliance|0|||
146997093|NCT02336165|530153415|FG002|Overall Study|Non-compliance|0|||
146997094|NCT02336165|530153416|FG003|Overall Study|Non-compliance|1|||
146997095|NCT02336165|530153417|FG004|Overall Study|Non-compliance|0|||
146997096|NCT02336165|530153413|FG000|Overall Study|Other|1|||
146997097|NCT02336165|530153414|FG001|Overall Study|Other|0|||
146997098|NCT02336165|530153415|FG002|Overall Study|Other|0|||
146997099|NCT02336165|530153416|FG003|Overall Study|Other|1|||
146997100|NCT02336165|530153417|FG004|Overall Study|Other|0|||
146997101|NCT01010542|530153422|FG000|Overall Study|Adverse Event|0|||
146997102|NCT01010542|530153423|FG001|Overall Study|Adverse Event|1|||
146997103|NCT01010542|530153424|FG002|Overall Study|Adverse Event|0|||
146997104|NCT01010542|530153422|FG000|Overall Study|Lost to Follow-up|0|||
146997105|NCT01010542|530153423|FG001|Overall Study|Lost to Follow-up|1|||
146997106|NCT01010542|530153424|FG002|Overall Study|Lost to Follow-up|0|||
146843038|NCT03524092|529594017|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
146843039|NCT03524092|529594018|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
146843040|NCT03524092|529594013|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
146843041|NCT03524092|529594014|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
146843042|NCT03524092|529594015|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
146843043|NCT03524092|529594016|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
146843044|NCT03524092|529594017|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
146843045|NCT03524092|529594018|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
146843046|NCT03524092|529594013|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
146843047|NCT03524092|529594014|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
146843048|NCT03524092|529594015|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
146843049|NCT03524092|529594016|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
146843050|NCT03524092|529594017|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
146843051|NCT03524092|529594018|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
146843052|NCT03524092|529594013|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
146843053|NCT03524092|529594014|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
146843054|NCT03524092|529594015|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
146843055|NCT03524092|529594016|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
146843056|NCT03524092|529594017|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
146843057|NCT03524092|529594018|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
146843058|NCT03524092|529594013|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
146843059|NCT03524092|529594014|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
146843060|NCT03524092|529594015|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
146843061|NCT03524092|529594016|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
146843062|NCT03524092|529594017|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
146843063|NCT03524092|529594018|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
146843064|NCT03524092|529594013|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
146843065|NCT03524092|529594014|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
146843066|NCT03524092|529594015|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
146843067|NCT03524092|529594016|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
146843068|NCT03524092|529594017|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
146843069|NCT03524092|529594018|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
146843070|NCT03524092|529594013|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
146843071|NCT03524092|529594014|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
146843072|NCT03524092|529594015|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
146843073|NCT03524092|529594016|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
146843074|NCT03524092|529594017|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
146843075|NCT03524092|529594018|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
146843076|NCT04303780|529594019|FG000|Overall Study|Death|104|||
146843077|NCT04303780|529594020|FG001|Overall Study|Death|85|||
146843078|NCT04303780|529594019|FG000|Overall Study|Lost to Follow-up|5|||
146843079|NCT04303780|529594020|FG001|Overall Study|Lost to Follow-up|2|||
146843080|NCT04303780|529594019|FG000|Overall Study|Withdrawal by Subject|12|||
146997107|NCT01010542|530153422|FG000|Overall Study|Withdrawal by Subject|0|||
146997108|NCT01010542|530153423|FG001|Overall Study|Withdrawal by Subject|3|||
146997109|NCT01010542|530153424|FG002|Overall Study|Withdrawal by Subject|2|||
146997110|NCT00857623|530153425|FG000|Overall Study|Adverse Event|5|||
146997111|NCT00857623|530153426|FG001|Overall Study|Adverse Event|2|||
146997112|NCT00857623|530153425|FG000|Overall Study|Study-specific discontinuation criteria|5|||
146997113|NCT00857623|530153426|FG001|Overall Study|Study-specific discontinuation criteria|3|||
146997114|NCT00857623|530153425|FG000|Overall Study|Withdrawal by Subject|2|||
146997115|NCT00857623|530153426|FG001|Overall Study|Withdrawal by Subject|1|||
146997116|NCT00857623|530153425|FG000|Overall Study|Lack of Efficacy|1|||
146997117|NCT00857623|530153426|FG001|Overall Study|Lack of Efficacy|1|||
146997118|NCT00857623|530153425|FG000|Overall Study|Severe non-compliance to protocol|1|||
146997119|NCT00857623|530153426|FG001|Overall Study|Severe non-compliance to protocol|1|||
146997120|NCT00857623|530153425|FG000|Overall Study|Intake of prohibited medication|0|||
146997121|NCT00857623|530153426|FG001|Overall Study|Intake of prohibited medication|1|||
146997122|NCT00857623|530153425|FG000|Overall Study|Positive for HEP C|0|||
146997123|NCT00857623|530153426|FG001|Overall Study|Positive for HEP C|1|||
146997124|NCT04185909|530153427|FG000|Overall Study|Lost to Follow-up|1|||
146997125|NCT04510285|530153430|FG000|Overall Study|Death|1|||
146997126|NCT00626548|530153431|FG000|Overall Study|Adverse Event|164|||
146997127|NCT00626548|530153432|FG001|Overall Study|Adverse Event|44|||
146997128|NCT00626548|530153431|FG000|Overall Study|Withdrawal by Subject|42|||
146997129|NCT00626548|530153432|FG001|Overall Study|Withdrawal by Subject|46|||
146997130|NCT00626548|530153431|FG000|Overall Study|Protocol Violation|4|||
146843081|NCT04303780|529594020|FG001|Overall Study|Withdrawal by Subject|39|||
146843082|NCT04303780|529594019|FG000|Overall Study|Ongoing in study|50|||
146843083|NCT04303780|529594020|FG001|Overall Study|Ongoing in study|45|||
146843084|NCT04893460|529594021|FG000|Overall Study|Lost to Follow-up|18|||
146843085|NCT05718466|529595435|FG000|Overall Study|Withdrawal by Subject|1|||
146843086|NCT05718466|529595436|FG001|Overall Study|Withdrawal by Subject|2|||
146843087|NCT05718466|529595435|FG000|Overall Study|Death|0|||
146843088|NCT05718466|529595436|FG001|Overall Study|Death|1|||
146843089|NCT00387426|529595437|FG000|Overall Study|Lack of Response|7|||
146843090|NCT00387426|529595437|FG000|Overall Study|Toxicities|4|||
146843091|NCT00387426|529595437|FG000|Overall Study|Disease Progression|3|||
146843092|NCT01253135|529595438|FG000|Original Protocol|Protocol Amendment|15|||
146843093|NCT01253135|529595438|FG000|Amended Protocol|Non-compliance|1|||
146843094|NCT01901432|529595439|FG000|Overall Study|Adverse Event|0|||
146843095|NCT01901432|529595440|FG001|Overall Study|Adverse Event|1|||
146843096|NCT01901432|529595441|FG002|Overall Study|Adverse Event|1|||
146843097|NCT01901432|529595442|FG003|Overall Study|Adverse Event|0|||
146843098|NCT01901432|529595443|FG004|Overall Study|Adverse Event|1|||
146843099|NCT01901432|529595439|FG000|Overall Study|Withdrawal by Subject|0|||
146843100|NCT01901432|529595440|FG001|Overall Study|Withdrawal by Subject|0|||
146843101|NCT01901432|529595441|FG002|Overall Study|Withdrawal by Subject|1|||
146843102|NCT01901432|529595442|FG003|Overall Study|Withdrawal by Subject|0|||
146843103|NCT01901432|529595443|FG004|Overall Study|Withdrawal by Subject|5|||
146843104|NCT01901432|529595439|FG000|Overall Study|Physician Decision|0|||
146843105|NCT01901432|529595440|FG001|Overall Study|Physician Decision|0|||
146843106|NCT01901432|529595441|FG002|Overall Study|Physician Decision|0|||
146843107|NCT01901432|529595442|FG003|Overall Study|Physician Decision|0|||
146843108|NCT01901432|529595443|FG004|Overall Study|Physician Decision|2|||
146843109|NCT01901432|529595439|FG000|Overall Study|Patient decision to stop study drug|0|||
146843110|NCT01901432|529595440|FG001|Overall Study|Patient decision to stop study drug|0|||
146843111|NCT01901432|529595441|FG002|Overall Study|Patient decision to stop study drug|0|||
146843112|NCT01901432|529595442|FG003|Overall Study|Patient decision to stop study drug|0|||
146843113|NCT01901432|529595443|FG004|Overall Study|Patient decision to stop study drug|1|||
146843114|NCT00379288|529595444|FG000|Overall Study|Adverse Event|5|||
146843115|NCT00379288|529595445|FG001|Overall Study|Adverse Event|6|||
146843116|NCT00379288|529595446|FG002|Overall Study|Adverse Event|2|||
146843117|NCT00379288|529595447|FG003|Overall Study|Adverse Event|0|||
146843118|NCT00379288|529595444|FG000|Overall Study|Treatment Failure|0|||
146843119|NCT00379288|529595445|FG001|Overall Study|Treatment Failure|1|||
146843120|NCT00379288|529595446|FG002|Overall Study|Treatment Failure|0|||
146843121|NCT00379288|529595447|FG003|Overall Study|Treatment Failure|1|||
146843122|NCT00379288|529595444|FG000|Overall Study|Lost to Follow-up|3|||
146843123|NCT00379288|529595445|FG001|Overall Study|Lost to Follow-up|3|||
146843124|NCT00379288|529595446|FG002|Overall Study|Lost to Follow-up|2|||
146843125|NCT00379288|529595447|FG003|Overall Study|Lost to Follow-up|0|||
146843126|NCT00379288|529595444|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
146843127|NCT00379288|529595445|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
146843128|NCT00379288|529595446|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
146843129|NCT00379288|529595447|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
146843130|NCT00379288|529595444|FG000|Overall Study|Subject withdrew-related to study drug|1|||
146843131|NCT00379288|529595445|FG001|Overall Study|Subject withdrew-related to study drug|0|||
146843132|NCT00379288|529595446|FG002|Overall Study|Subject withdrew-related to study drug|0|||
146843133|NCT00379288|529595447|FG003|Overall Study|Subject withdrew-related to study drug|1|||
146843134|NCT00379288|529595444|FG000|Overall Study|Noncompliance with protocol|8|||
146843135|NCT00379288|529595445|FG001|Overall Study|Noncompliance with protocol|6|||
146843136|NCT00379288|529595446|FG002|Overall Study|Noncompliance with protocol|2|||
146843137|NCT00379288|529595447|FG003|Overall Study|Noncompliance with protocol|1|||
146843138|NCT00379288|529595444|FG000|Overall Study|Did not meet protocol eligibility|0|||
146843139|NCT00379288|529595445|FG001|Overall Study|Did not meet protocol eligibility|1|||
146843140|NCT00379288|529595446|FG002|Overall Study|Did not meet protocol eligibility|0|||
146843141|NCT00379288|529595447|FG003|Overall Study|Did not meet protocol eligibility|2|||
146843142|NCT00379288|529595444|FG000|Overall Study|Administrative|2|||
146843143|NCT00379288|529595445|FG001|Overall Study|Administrative|2|||
146843144|NCT00379288|529595446|FG002|Overall Study|Administrative|0|||
146843145|NCT00379288|529595447|FG003|Overall Study|Administrative|1|||
146843146|NCT00918879|529595448|FG000|Overall Study|Withdrawal by Subject|4|||
146997131|NCT00626548|530153432|FG001|Overall Study|Protocol Violation|11|||
146997132|NCT00626548|530153431|FG000|Overall Study|Lost to Follow-up|2|||
146997133|NCT00626548|530153432|FG001|Overall Study|Lost to Follow-up|2|||
146997134|NCT00626548|530153431|FG000|Overall Study|Other termination reason|493|||
146997135|NCT00626548|530153432|FG001|Overall Study|Other termination reason|613|||
146843147|NCT00918879|529595449|FG001|Overall Study|Withdrawal by Subject|4|||
146843148|NCT00918879|529595448|FG000|Overall Study|Lost to Follow-up|1|||
146997136|NCT01066143|530155354|FG000|Overall Study|ineligible for the study|8|||
146843149|NCT00918879|529595449|FG001|Overall Study|Lost to Follow-up|1|||
146843150|NCT00918879|529595448|FG000|Overall Study|Severe non-compliance to protocol|1|||
146997137|NCT01294787|530155355|FG000|Period 1|Adverse Event|0|||
146843151|NCT00918879|529595449|FG001|Overall Study|Severe non-compliance to protocol|1|||
146843152|NCT00357110|529595452|FG000|Overall Study|Early study termination|5|||
146843153|NCT00357110|529595453|FG001|Overall Study|Early study termination|5|||
146843154|NCT01255631|529595458|FG000|Overall Study|poor enrollment, no data analyzed|9|||
146843155|NCT01255631|529595459|FG001|Overall Study|poor enrollment, no data analyzed|6|||
146843156|NCT03339245|529595460|FG000|Overall Study|Adverse Event|1|||
146843157|NCT03339245|529595461|FG001|Overall Study|Adverse Event|1|||
146843158|NCT03339245|529595460|FG000|Overall Study|Withdrawal by Subject|1|||
146843159|NCT03339245|529595461|FG001|Overall Study|Withdrawal by Subject|0|||
146843160|NCT00515671|529595462|FG000|Overall Study|Lost to Follow-up|13|||
146843161|NCT00515671|529595463|FG001|Overall Study|Lost to Follow-up|10|||
146843162|NCT00515671|529595462|FG000|Overall Study|Withdrawal by Subject|3|||
146843163|NCT00515671|529595463|FG001|Overall Study|Withdrawal by Subject|5|||
146843164|NCT00515671|529595462|FG000|Overall Study|incarcerated|1|||
146843165|NCT00515671|529595463|FG001|Overall Study|incarcerated|2|||
146843166|NCT00527787|529595471|FG000|Overall Study|Adverse Event|14|||
146843167|NCT00527787|529595472|FG001|Overall Study|Adverse Event|24|||
146843168|NCT00527787|529595471|FG000|Overall Study|Withdrawal by Subject|13|||
146843169|NCT00527787|529595472|FG001|Overall Study|Withdrawal by Subject|25|||
146843170|NCT00527787|529595471|FG000|Overall Study|Lost to Follow-up|5|||
146843171|NCT00527787|529595472|FG001|Overall Study|Lost to Follow-up|2|||
146843172|NCT00527787|529595471|FG000|Overall Study|Duodenal Ulcer|1|||
146843173|NCT00527787|529595472|FG001|Overall Study|Duodenal Ulcer|10|||
146843174|NCT00527787|529595471|FG000|Overall Study|misc|5|||
146843175|NCT00527787|529595472|FG001|Overall Study|misc|2|||
146843176|NCT01736189|529595475|FG000|Overall Study|Violation of registration criteria|41|||
146843177|NCT01736189|529595475|FG000|Overall Study|Protocol Violation|4|||
146843178|NCT01736189|529595475|FG000|Overall Study|Criteria and protocol violations|1|||
146843179|NCT01499303|529595478|FG000|Overall Study|Ongoing|2|||
146843180|NCT01499303|529595479|FG001|Overall Study|Ongoing|1|||
146843181|NCT01499303|529595478|FG000|Overall Study|Withdrawal by Subject|0|||
146843182|NCT01499303|529595479|FG001|Overall Study|Withdrawal by Subject|1|||
146843183|NCT01499303|529595478|FG000|Overall Study|Adverse Event|1|||
146843184|NCT01499303|529595479|FG001|Overall Study|Adverse Event|4|||
146843185|NCT01499303|529595478|FG000|Overall Study|Other|0|||
146843186|NCT01499303|529595479|FG001|Overall Study|Other|1|||
146843187|NCT00608868|529595480|FG000|Overall Study|Withdrawal by Subject|7|||
146843188|NCT00608868|529595480|FG000|Overall Study|Protocol Violation|3|||
146843189|NCT00608868|529595480|FG000|Overall Study|Lost to Follow-up|2|||
146843190|NCT00608868|529595480|FG000|Overall Study|Adverse Event|1|||
146843191|NCT00608868|529595480|FG000|Overall Study|Physician Decision|2|||
146843192|NCT03853551|529595484|FG000|Overall Study|Death|2|||
146843193|NCT03853551|529595484|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
146843194|NCT01252355|529595485|FG000|Overall Study|Adverse Event|9|||
146843195|NCT01252355|529595486|FG001|Overall Study|Adverse Event|17|||
146843196|NCT01252355|529595487|FG002|Overall Study|Adverse Event|22|||
146843197|NCT01252355|529595485|FG000|Overall Study|Lack of Efficacy|6|||
146843198|NCT01252355|529595486|FG001|Overall Study|Lack of Efficacy|4|||
146843199|NCT01252355|529595487|FG002|Overall Study|Lack of Efficacy|2|||
146843200|NCT01252355|529595485|FG000|Overall Study|Lost to Follow-up|0|||
146843201|NCT01252355|529595486|FG001|Overall Study|Lost to Follow-up|0|||
146843202|NCT01252355|529595487|FG002|Overall Study|Lost to Follow-up|1|||
146843203|NCT01252355|529595485|FG000|Overall Study|Poor Compliance to Protocol|1|||
146843204|NCT01252355|529595486|FG001|Overall Study|Poor Compliance to Protocol|1|||
146843205|NCT01252355|529595487|FG002|Overall Study|Poor Compliance to Protocol|1|||
146843206|NCT01252355|529595485|FG000|Overall Study|Progressive Disease|2|||
146843207|NCT01252355|529595486|FG001|Overall Study|Progressive Disease|0|||
146843208|NCT01252355|529595487|FG002|Overall Study|Progressive Disease|0|||
146843209|NCT01252355|529595485|FG000|Overall Study|Sponsor Early Termination of Study|149|||
146843210|NCT01252355|529595486|FG001|Overall Study|Sponsor Early Termination of Study|149|||
146843211|NCT01252355|529595487|FG002|Overall Study|Sponsor Early Termination of Study|146|||
146843212|NCT01252355|529595485|FG000|Overall Study|Randomized but not Treated|2|||
146843213|NCT01252355|529595486|FG001|Overall Study|Randomized but not Treated|0|||
146843214|NCT01252355|529595487|FG002|Overall Study|Randomized but not Treated|0|||
146843215|NCT01252355|529595485|FG000|Overall Study|Other Than Above|8|||
146843216|NCT01252355|529595486|FG001|Overall Study|Other Than Above|7|||
146843217|NCT01252355|529595487|FG002|Overall Study|Other Than Above|7|||
146843218|NCT01876901|529595488|FG000|Overall Study|Protocol Violation|10|||
146843219|NCT01876901|529595489|FG001|Overall Study|Protocol Violation|2|||
146843220|NCT01876901|529595488|FG000|Overall Study|No or other surgical intervention|7|||
146843221|NCT01876901|529595489|FG001|Overall Study|No or other surgical intervention|5|||
146843222|NCT02242097|529595490|FG000|Ibrutinib Treatment|Adverse Event|16|||
146843223|NCT02242097|529595490|FG000|Ibrutinib Treatment|Physician Decision|1|||
146843224|NCT02242097|529595490|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
146843225|NCT02242097|529595490|FG000|Ibrutinib Treatment|Death|1|||
146843226|NCT02242097|529595490|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
146843227|NCT02242097|529595490|FG000|Post Therapy Follow Up|Death|3|||
146843228|NCT02242097|529595490|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
146843229|NCT03435692|529595493|FG000|Overall Study|Lack of Efficacy|2|||
146843230|NCT03435692|529595494|FG001|Overall Study|Lack of Efficacy|2|||
146843231|NCT03435692|529595495|FG002|Overall Study|Lack of Efficacy|0|||
146843232|NCT04313608|529595496|FG000|Overall Study|Death|12|||
146843233|NCT04313608|529595497|FG001|Overall Study|Death|3|||
146843234|NCT01145898|529595498|FG000|3-year Treatment|medication change by treating physician|3|||
146843235|NCT01145898|529595499|FG001|3-year Treatment|medication change by treating physician|16|||
146843236|NCT01712061|529595500|FG000|Overall Study|Adverse Event|4|||
146843237|NCT01712061|529595501|FG001|Overall Study|Adverse Event|9|||
146843238|NCT01712061|529595502|FG002|Overall Study|Adverse Event|5|||
146843239|NCT01712061|529595500|FG000|Overall Study|Death|0|||
146843240|NCT01712061|529595501|FG001|Overall Study|Death|0|||
146843241|NCT01712061|529595502|FG002|Overall Study|Death|1|||
146843242|NCT01712061|529595500|FG000|Overall Study|Lost to Follow-up|1|||
146843243|NCT01712061|529595501|FG001|Overall Study|Lost to Follow-up|0|||
146843244|NCT01712061|529595502|FG002|Overall Study|Lost to Follow-up|1|||
146843245|NCT01712061|529595500|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
146843246|NCT01712061|529595501|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
146843247|NCT01712061|529595502|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
146843248|NCT01712061|529595500|FG000|Overall Study|Medication Error Without Associated AE|0|||
146843249|NCT01712061|529595501|FG001|Overall Study|Medication Error Without Associated AE|1|||
146843250|NCT01712061|529595502|FG002|Overall Study|Medication Error Without Associated AE|0|||
146843251|NCT01712061|529595500|FG000|Overall Study|Withdrawal by Subject|1|||
146843252|NCT01712061|529595501|FG001|Overall Study|Withdrawal by Subject|7|||
146843253|NCT01712061|529595502|FG002|Overall Study|Withdrawal by Subject|1|||
146843254|NCT01712061|529595500|FG000|Overall Study|Other|0|||
146843255|NCT01712061|529595501|FG001|Overall Study|Other|3|||
146843256|NCT01712061|529595502|FG002|Overall Study|Other|0|||
146843257|NCT00879775|529595505|FG000|Overall Study|Lost to Follow-up|2|||
146843258|NCT00879775|529595506|FG001|Overall Study|Lost to Follow-up|1|||
146843259|NCT02440425|529595507|FG000|Overall Study|Death likely due to disease progression|1|||
146843260|NCT02440425|529595507|FG000|Overall Study|Withdrawal by Subject|2|||
146843261|NCT02440425|529595507|FG000|Overall Study|Adverse Event|1|||
146843262|NCT02440425|529595507|FG000|Overall Study|Adverse Event/Ineligible|1|||
146843263|NCT00842244|529595508|FG000|Overall Study|Death|3|||
146843264|NCT00842244|529595508|FG000|Overall Study|Withdrawal by Subject|1|||
146843265|NCT00842244|529595508|FG000|Overall Study|Other|17|||
146843266|NCT04145700|529595509|FG000|Overall Study|Withdrawal by Subject|8|||
146843267|NCT04145700|529595510|FG001|Overall Study|Withdrawal by Subject|3|||
146843268|NCT00780559|529595511|FG000|Overall Study|Lost to Follow-up|2|||
146843269|NCT00780559|529595512|FG001|Overall Study|Lost to Follow-up|7|||
146843270|NCT00780559|529595511|FG000|Overall Study|Death|1|||
146843271|NCT00780559|529595512|FG001|Overall Study|Death|0|||
146843272|NCT01327846|529595514|FG000|Core Phase|Subject decision (vital status: missing)|1|||
146843273|NCT01327846|529595515|FG001|Core Phase|Subject decision (vital status: missing)|2|||
146843274|NCT01327846|529595516|FG002|Core Phase|Subject decision (vital status: missing)|2|||
146843275|NCT01327846|529595517|FG003|Core Phase|Subject decision (vital status: missing)|1|||
146843276|NCT01327846|529595514|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
146843277|NCT01327846|529595515|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
146843278|NCT01327846|529595516|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
146843279|NCT01327846|529595517|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
146843280|NCT01327846|529595514|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
146843281|NCT01327846|529595515|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
146997138|NCT01294787|530155356|FG001|Period 1|Adverse Event|0|||
146997139|NCT01294787|530155357|FG002|Period 1|Adverse Event|0|||
146997140|NCT01294787|530155358|FG003|Period 1|Adverse Event|0|||
146997141|NCT01294787|530155359|FG004|Period 1|Adverse Event|1|||
146997142|NCT01294787|530155360|FG005|Period 1|Adverse Event|0|||
146997143|NCT01294787|530155355|FG000|Period 1|Withdrawal by Subject|0|||
146997144|NCT01294787|530155356|FG001|Period 1|Withdrawal by Subject|0|||
146997145|NCT01294787|530155357|FG002|Period 1|Withdrawal by Subject|0|||
146997146|NCT01294787|530155358|FG003|Period 1|Withdrawal by Subject|1|||
146843282|NCT01327846|529595516|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
146843283|NCT01327846|529595517|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
146843284|NCT01327846|529595514|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
146843285|NCT01327846|529595515|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
146997147|NCT01294787|530155359|FG004|Period 1|Withdrawal by Subject|1|||
146997148|NCT01294787|530155360|FG005|Period 1|Withdrawal by Subject|1|||
146843286|NCT01327846|529595516|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
146843287|NCT01327846|529595517|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
146843288|NCT01327846|529595514|FG000|Core Phase|Lost to Follow-up|3|||
146997149|NCT01294787|530155355|FG000|Period 1|Administrative problem|0|||
146997150|NCT01294787|530155356|FG001|Period 1|Administrative problem|0|||
146997151|NCT01294787|530155357|FG002|Period 1|Administrative problem|1|||
146997152|NCT01294787|530155358|FG003|Period 1|Administrative problem|0|||
146997153|NCT01294787|530155359|FG004|Period 1|Administrative problem|0|||
146997154|NCT01294787|530155360|FG005|Period 1|Administrative problem|1|||
146997155|NCT01294787|530155355|FG000|Period 2|Adverse Event|0|||
146997156|NCT01294787|530155356|FG001|Period 2|Adverse Event|3|||
146997157|NCT01294787|530155357|FG002|Period 2|Adverse Event|0|||
146997158|NCT01294787|530155358|FG003|Period 2|Adverse Event|1|||
146997159|NCT01294787|530155359|FG004|Period 2|Adverse Event|0|||
146997160|NCT01294787|530155360|FG005|Period 2|Adverse Event|0|||
146997161|NCT01294787|530155355|FG000|Period 2|No longer needs study drug|0|||
146997162|NCT01294787|530155356|FG001|Period 2|No longer needs study drug|0|||
146997163|NCT01294787|530155357|FG002|Period 2|No longer needs study drug|0|||
146997164|NCT01294787|530155358|FG003|Period 2|No longer needs study drug|1|||
146997165|NCT01294787|530155359|FG004|Period 2|No longer needs study drug|0|||
146997166|NCT01294787|530155360|FG005|Period 2|No longer needs study drug|0|||
146997167|NCT01294787|530155355|FG000|Period 3|Adverse Event|0|||
146997168|NCT01294787|530155356|FG001|Period 3|Adverse Event|0|||
146997169|NCT01294787|530155357|FG002|Period 3|Adverse Event|0|||
146997170|NCT01294787|530155358|FG003|Period 3|Adverse Event|0|||
146997171|NCT01294787|530155359|FG004|Period 3|Adverse Event|1|||
146997172|NCT01294787|530155360|FG005|Period 3|Adverse Event|0|||
146997173|NCT03785548|530155361|FG000|Overall Study|age > 80|1|||
146997174|NCT03785548|530155362|FG001|Overall Study|age > 80|0|||
146997175|NCT03785548|530155361|FG000|Overall Study|no Postop queries|1|||
146997176|NCT03785548|530155362|FG001|Overall Study|no Postop queries|0|||
146997177|NCT00396279|530155363|FG000|Overall Study|Ongoing in study|26|||
146997178|NCT00396279|530155363|FG000|Overall Study|Disease progression|2|||
146997179|NCT00396279|530155363|FG000|Overall Study|Withdrawal by Subject|1|||
146997180|NCT00396279|530155363|FG000|Overall Study|Physician Decision|1|||
146997181|NCT03351335|530155365|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
146997182|NCT03351335|530155366|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
146997183|NCT03351335|530155367|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
146997184|NCT04605094|530155368|FG000|Overall Study|Adverse Event|2|||
146997185|NCT04605094|530155369|FG001|Overall Study|Adverse Event|2|||
146997186|NCT04605094|530155368|FG000|Overall Study|Lost to Follow-up|1|||
146997187|NCT04605094|530155369|FG001|Overall Study|Lost to Follow-up|4|||
146997188|NCT04605094|530155368|FG000|Overall Study|Physician Decision|2|||
146997189|NCT04605094|530155369|FG001|Overall Study|Physician Decision|2|||
146997190|NCT04605094|530155368|FG000|Overall Study|Study terminated by Sponsor|31|||
146997191|NCT04605094|530155369|FG001|Overall Study|Study terminated by Sponsor|33|||
146843289|NCT01327846|529595515|FG001|Core Phase|Lost to Follow-up|3|||
146843290|NCT01327846|529595516|FG002|Core Phase|Lost to Follow-up|4|||
146843291|NCT01327846|529595517|FG003|Core Phase|Lost to Follow-up|5|||
146843292|NCT01327846|529595514|FG000|Extension Phase|Study terminated by sponsor|1073|||
146843293|NCT01327846|529595515|FG001|Extension Phase|Study terminated by sponsor|1124|||
146843294|NCT01327846|529595516|FG002|Extension Phase|Study terminated by sponsor|1067|||
146843295|NCT01327846|529595517|FG003|Extension Phase|Study terminated by sponsor|1660|||
146843296|NCT01327846|529595514|FG000|Extension Phase|Withdrawal by Subject|20|||
146843297|NCT01327846|529595515|FG001|Extension Phase|Withdrawal by Subject|13|||
146843298|NCT01327846|529595516|FG002|Extension Phase|Withdrawal by Subject|19|||
146843299|NCT01327846|529595517|FG003|Extension Phase|Withdrawal by Subject|37|||
146843300|NCT01327846|529595514|FG000|Extension Phase|Lost to Follow-up|4|||
146843301|NCT01327846|529595515|FG001|Extension Phase|Lost to Follow-up|3|||
146843302|NCT01327846|529595516|FG002|Extension Phase|Lost to Follow-up|4|||
146843303|NCT01327846|529595517|FG003|Extension Phase|Lost to Follow-up|7|||
146843304|NCT01327846|529595514|FG000|Extension Phase|Technical Problems|2|||
146997192|NCT04605094|530155368|FG000|Overall Study|Withdrawal by Subject|22|||
146997193|NCT04605094|530155369|FG001|Overall Study|Withdrawal by Subject|19|||
146997194|NCT04605094|530155368|FG000|Overall Study|Other|1|||
146843305|NCT01327846|529595515|FG001|Extension Phase|Technical Problems|4|||
146997195|NCT04605094|530155369|FG001|Overall Study|Other|1|||
146997196|NCT02724462|530155370|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
146997197|NCT02724462|530155371|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
146997198|NCT02724462|530155370|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
146843306|NCT01327846|529595516|FG002|Extension Phase|Technical Problems|2|||
146997199|NCT02724462|530155371|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
146843307|NCT01327846|529595517|FG003|Extension Phase|Technical Problems|2|||
146997200|NCT02724462|530155370|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
146997201|NCT02724462|530155371|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
146997202|NCT02724462|530155370|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
146997203|NCT02724462|530155371|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
146997204|NCT02724462|530155370|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
146997205|NCT02724462|530155371|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
146997206|NCT02724462|530155370|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
146997207|NCT02724462|530155371|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
146843308|NCT00203268|529595523|FG000|Early Treatment|only treated one headache|2|||
146843309|NCT00203268|529595523|FG000|Early Treatment|Lost to Follow-up|1|||
146843310|NCT00203268|529595523|FG000|Early Treatment|Withdrawal by Subject|1|||
146997208|NCT01900691|530155372|FG000|Overall Study|Death|7|||
146997209|NCT01900691|530155372|FG000|Overall Study|Lost to Follow-up|4|||
146997210|NCT01900691|530155372|FG000|Overall Study|Study Device Not Placed|3|||
146997211|NCT01900691|530155372|FG000|Overall Study|Non study stent placed|2|||
146997212|NCT01900691|530155372|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
146997213|NCT01900691|530155372|FG000|Overall Study|Complete stent migration through digestive tract|1|||
146997214|NCT00469417|530155375|FG000|Overall Study|Treatment failure all lesions|18|||
146997215|NCT00469417|530155376|FG001|Overall Study|Treatment failure all lesions|11|||
146997216|NCT00469417|530155375|FG000|Overall Study|Consent withdrawn|1|||
146997217|NCT00469417|530155376|FG001|Overall Study|Consent withdrawn|1|||
146997218|NCT00469417|530155375|FG000|Overall Study|Adverse Event|8|||
146997219|NCT00469417|530155376|FG001|Overall Study|Adverse Event|2|||
146997220|NCT00469417|530155375|FG000|Overall Study|Lost to Follow-up|1|||
146997221|NCT00469417|530155376|FG001|Overall Study|Lost to Follow-up|2|||
146997222|NCT00469417|530155375|FG000|Overall Study|Intercurrent disease|0|||
146997223|NCT00469417|530155376|FG001|Overall Study|Intercurrent disease|1|||
146997224|NCT00469417|530155375|FG000|Overall Study|Randomized but not treated|2|||
146997225|NCT00469417|530155376|FG001|Overall Study|Randomized but not treated|0|||
146997226|NCT01954394|530155377|FG000|Overall Study|Enrolled but not treated|1|||
146997227|NCT01954394|530155378|FG001|Overall Study|Enrolled but not treated|0|||
146997228|NCT01954394|530155377|FG000|Overall Study|Adverse Event|10|||
146997229|NCT01954394|530155378|FG001|Overall Study|Adverse Event|23|||
146997230|NCT01954394|530155377|FG000|Overall Study|Poor compliance to protocol|7|||
146997231|NCT01954394|530155378|FG001|Overall Study|Poor compliance to protocol|7|||
146997232|NCT01954394|530155377|FG000|Overall Study|Participant Moved|0|||
146997233|NCT01954394|530155378|FG001|Overall Study|Participant Moved|4|||
146997234|NCT01954394|530155377|FG000|Overall Study|Related to Study Drug administration|2|||
146997235|NCT01954394|530155378|FG001|Overall Study|Related to Study Drug administration|2|||
146997236|NCT01954394|530155377|FG000|Overall Study|Other than specified above|10|||
146997237|NCT01954394|530155378|FG001|Overall Study|Other than specified above|21|||
146997238|NCT04089735|530155383|FG000|Overall Study|Adverse Event|1|||
146997239|NCT04089735|530155384|FG001|Overall Study|Adverse Event|0|||
146997240|NCT04089735|530155385|FG002|Overall Study|Adverse Event|1|||
146997241|NCT04089735|530155386|FG003|Overall Study|Adverse Event|1|||
146997242|NCT04089735|530155387|FG004|Overall Study|Adverse Event|0|||
146997243|NCT04089735|530155388|FG005|Overall Study|Adverse Event|0|||
146997244|NCT04089735|530155383|FG000|Overall Study|Physician Decision|0|||
146997245|NCT04089735|530155384|FG001|Overall Study|Physician Decision|3|||
146997246|NCT04089735|530155385|FG002|Overall Study|Physician Decision|0|||
146997247|NCT04089735|530155386|FG003|Overall Study|Physician Decision|0|||
146997248|NCT04089735|530155387|FG004|Overall Study|Physician Decision|0|||
146997249|NCT04089735|530155388|FG005|Overall Study|Physician Decision|0|||
146997250|NCT04089735|530155383|FG000|Overall Study|Withdrawal by Subject|0|||
146997251|NCT04089735|530155384|FG001|Overall Study|Withdrawal by Subject|0|||
146997252|NCT04089735|530155385|FG002|Overall Study|Withdrawal by Subject|1|||
146997253|NCT04089735|530155386|FG003|Overall Study|Withdrawal by Subject|0|||
146997254|NCT04089735|530155387|FG004|Overall Study|Withdrawal by Subject|0|||
146997255|NCT04089735|530155388|FG005|Overall Study|Withdrawal by Subject|0|||
146997256|NCT04089735|530155383|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
146997257|NCT04089735|530155384|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
146997258|NCT04089735|530155385|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
146997259|NCT04089735|530155386|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
146997260|NCT04089735|530155387|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
146997261|NCT04089735|530155388|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
146997262|NCT02128997|530155390|FG000|Overall Study|Lost to Follow-up|6|||
146997263|NCT02128997|530155391|FG001|Overall Study|Lost to Follow-up|11|||
146997264|NCT00418184|530155398|FG000|Double-blind Phase|Withdrawal by Subject|22|||
146997265|NCT00418184|530155399|FG001|Double-blind Phase|Withdrawal by Subject|9|||
146997266|NCT00418184|530155398|FG000|Double-blind Phase|Adverse Event|2|||
146997267|NCT00418184|530155399|FG001|Double-blind Phase|Adverse Event|1|||
146997268|NCT00418184|530155398|FG000|Double-blind Phase|Poor compliance|3|||
146997269|NCT00418184|530155399|FG001|Double-blind Phase|Poor compliance|1|||
146997270|NCT01247701|530155401|FG000|Overall Study|Death|2|||
146997271|NCT01247701|530155401|FG000|Overall Study|Relapsed|8|||
146997272|NCT00096447|530155402|FG000|Overall Study|Never treated|1|||
146997273|NCT02246166|530155405|FG000|Overall Study|Protocol Violation|1|||
146997274|NCT02246166|530155406|FG001|Overall Study|Protocol Violation|0|||
146997275|NCT00834743|530155407|FG000|Second Intervention|Withdrawal by Subject|1|||
146997276|NCT00834743|530155408|FG001|Second Intervention|Withdrawal by Subject|0|||
146997277|NCT04112823|530155411|FG000|Overall Study|Lost to Follow-up|2|||
146997278|NCT04112823|530155412|FG001|Overall Study|Lost to Follow-up|3|||
146997279|NCT03025880|530155415|FG000|Overall Study|Adverse Event|1|||
146997280|NCT03025880|530155416|FG001|Overall Study|Adverse Event|0|||
146997281|NCT03025880|530155415|FG000|Overall Study|Death|1|||
146997282|NCT03025880|530155416|FG001|Overall Study|Death|1|||
146997283|NCT03025880|530155415|FG000|Overall Study|Withdrawal by Subject|0|||
146997284|NCT03025880|530155416|FG001|Overall Study|Withdrawal by Subject|1|||
146997285|NCT03025880|530155415|FG000|Overall Study|Physician Decision|0|||
146997286|NCT03025880|530155416|FG001|Overall Study|Physician Decision|1|||
146997287|NCT03025880|530155415|FG000|Overall Study|Progressive Disease|12|||
146997288|NCT03025880|530155416|FG001|Overall Study|Progressive Disease|19|||
146997289|NCT00625443|530155418|FG000|Overall Study|Adverse Event|1|||
146997290|NCT00625443|530155419|FG001|Overall Study|Adverse Event|4|||
146997291|NCT00625443|530155420|FG002|Overall Study|Adverse Event|0|||
146997292|NCT00625443|530155418|FG000|Overall Study|Non-compliance with protocol|0|||
146997293|NCT00625443|530155419|FG001|Overall Study|Non-compliance with protocol|1|||
146997294|NCT00625443|530155420|FG002|Overall Study|Non-compliance with protocol|0|||
146997295|NCT00625443|530155418|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
146997296|NCT00625443|530155419|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
146997297|NCT00625443|530155420|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
146997298|NCT00625443|530155418|FG000|Overall Study|Withdrawal by Subject|0|||
146997299|NCT00625443|530155419|FG001|Overall Study|Withdrawal by Subject|1|||
146997300|NCT00625443|530155420|FG002|Overall Study|Withdrawal by Subject|2|||
146997301|NCT00625443|530155418|FG000|Overall Study|Physician Decision|0|||
146997302|NCT00625443|530155419|FG001|Overall Study|Physician Decision|4|||
146997303|NCT00625443|530155420|FG002|Overall Study|Physician Decision|2|||
146997304|NCT00625443|530155418|FG000|Overall Study|Other|0|||
146997305|NCT00625443|530155419|FG001|Overall Study|Other|1|||
146997306|NCT00625443|530155420|FG002|Overall Study|Other|1|||
146997307|NCT02728102|530155421|FG000|Overall Study|Death|3|||
146997308|NCT02728102|530155422|FG001|Overall Study|Death|0|||
146997309|NCT02728102|530155423|FG002|Overall Study|Death|1|||
146997310|NCT02728102|530155421|FG000|Overall Study|Withdrawal by Subject|0|||
146843311|NCT04343976|529595524|FG000|Overall Study|Withdrawal by Subject|0|||
146843312|NCT04343976|529595525|FG001|Overall Study|Withdrawal by Subject|1|||
146997311|NCT02728102|530155422|FG001|Overall Study|Withdrawal by Subject|2|||
146997312|NCT02728102|530155423|FG002|Overall Study|Withdrawal by Subject|3|||
146997313|NCT02728102|530155421|FG000|Overall Study|Physician Decision|1|||
146997314|NCT02728102|530155422|FG001|Overall Study|Physician Decision|1|||
146997315|NCT02728102|530155423|FG002|Overall Study|Physician Decision|0|||
146997316|NCT02728102|530155421|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
146997317|NCT02728102|530155422|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
146997318|NCT02728102|530155423|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
146997319|NCT02728102|530155421|FG000|Overall Study|Covid|0|||
146997320|NCT02728102|530155422|FG001|Overall Study|Covid|0|||
146843313|NCT02807883|529595526|FG000|Overall Study|Withdrawal by Subject|2|||
146843314|NCT00594880|529595527|FG000|Overall Study|Withdrawal by Subject|1|||
146843315|NCT00594880|529595528|FG001|Overall Study|Withdrawal by Subject|1|||
146843316|NCT00594880|529595527|FG000|Overall Study|Lost to Follow-up|1|||
146843317|NCT00594880|529595528|FG001|Overall Study|Lost to Follow-up|0|||
146843318|NCT00694109|529595529|FG000|Overall Study|Physician Decision|3|||
146843319|NCT00694109|529595529|FG000|Overall Study|Adverse Event|74|||
146843320|NCT00694109|529595529|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
146843321|NCT00694109|529595529|FG000|Overall Study|Lack of Efficacy|2|||
146843322|NCT00694109|529595529|FG000|Overall Study|Withdrawal by Subject|13|||
146843323|NCT00694109|529595529|FG000|Overall Study|Pregnancy|1|||
146843324|NCT00694109|529595529|FG000|Overall Study|Enrolled but not treated|1|||
146843325|NCT00694109|529595529|FG000|Overall Study|Other|2|||
146843326|NCT00694109|529595529|FG000|Overall Study|Consented but no additional treatment|3|||
146843327|NCT01254747|529595532|FG000|Overall Study|Unacceptable subjective vision|0|||
146843328|NCT01254747|529595533|FG001|Overall Study|Unacceptable subjective vision|0|||
146843329|NCT01254747|529595534|FG002|Overall Study|Unacceptable subjective vision|0|||
146843330|NCT01254747|529595535|FG003|Overall Study|Unacceptable subjective vision|2|||
146843331|NCT01254747|529595532|FG000|Overall Study|Difficult removal handling|0|||
146843332|NCT01254747|529595533|FG001|Overall Study|Difficult removal handling|0|||
146843333|NCT01254747|529595534|FG002|Overall Study|Difficult removal handling|1|||
146997321|NCT02728102|530155423|FG002|Overall Study|Covid|1|||
146843334|NCT01254747|529595535|FG003|Overall Study|Difficult removal handling|0|||
146997322|NCT02924883|530155425|FG000|Overall Study|Death|39|||
146997323|NCT02924883|530155426|FG001|Overall Study|Death|20|||
146997324|NCT02924883|530155425|FG000|Overall Study|Lost to Follow-up|1|||
146997325|NCT02924883|530155426|FG001|Overall Study|Lost to Follow-up|0|||
146997326|NCT02924883|530155425|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
146997327|NCT02924883|530155426|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
146997328|NCT02924883|530155425|FG000|Overall Study|Protocol Violation|1|||
146997329|NCT02924883|530155426|FG001|Overall Study|Protocol Violation|0|||
146997330|NCT02924883|530155425|FG000|Overall Study|Withdrawal by Subject|22|||
146843335|NCT01254747|529595532|FG000|Overall Study|Symptoms and problems|0|||
146843336|NCT01254747|529595533|FG001|Overall Study|Symptoms and problems|2|||
146843337|NCT01254747|529595534|FG002|Overall Study|Symptoms and problems|1|||
146843338|NCT01254747|529595535|FG003|Overall Study|Symptoms and problems|0|||
146843339|NCT01254747|529595532|FG000|Overall Study|Lost to Follow-up|0|||
146843340|NCT01254747|529595533|FG001|Overall Study|Lost to Follow-up|0|||
146843341|NCT01254747|529595534|FG002|Overall Study|Lost to Follow-up|1|||
146843342|NCT01254747|529595535|FG003|Overall Study|Lost to Follow-up|0|||
146843343|NCT01254747|529595532|FG000|Overall Study|Biomicroscopy|0|||
146843344|NCT01254747|529595533|FG001|Overall Study|Biomicroscopy|0|||
146843345|NCT01254747|529595534|FG002|Overall Study|Biomicroscopy|1|||
146843346|NCT01254747|529595535|FG003|Overall Study|Biomicroscopy|0|||
146843347|NCT01254747|529595532|FG000|Overall Study|Discomfort|0|||
146843348|NCT01254747|529595533|FG001|Overall Study|Discomfort|4|||
146843349|NCT01254747|529595534|FG002|Overall Study|Discomfort|0|||
146843350|NCT01254747|529595535|FG003|Overall Study|Discomfort|0|||
146843351|NCT00846807|529595536|FG000|Overall Study|Adverse Event|270|||
146843352|NCT00846807|529595536|FG000|Overall Study|Lost to Follow-up|94|||
146843353|NCT00846807|529595536|FG000|Overall Study|Withdrawal by Subject|56|||
146843354|NCT00846807|529595536|FG000|Overall Study|Non compliant with European label|7|||
146843355|NCT00846807|529595536|FG000|Overall Study|Switch to other anticoagulants|89|||
146843356|NCT00846807|529595536|FG000|Overall Study|No prescription after hospital discharge|56|||
146843357|NCT00846807|529595536|FG000|Overall Study|Other|60|||
146843358|NCT00737698|529595537|FG000|Overall Study|Withdrawal by Subject|6|||
146843359|NCT00737698|529595538|FG001|Overall Study|Withdrawal by Subject|5|||
146843360|NCT00737698|529595539|FG002|Overall Study|Withdrawal by Subject|3|||
146843361|NCT00737698|529595537|FG000|Overall Study|Death|0|||
146843362|NCT00737698|529595538|FG001|Overall Study|Death|0|||
146843363|NCT00737698|529595539|FG002|Overall Study|Death|1|||
146843364|NCT01067846|529595540|FG000|Overall Study|Lost to Follow-up|17|||
146843365|NCT01067846|529595541|FG001|Overall Study|Lost to Follow-up|19|||
146843366|NCT01067846|529595540|FG000|Overall Study|Withdrawal by Subject|1|||
146843367|NCT01067846|529595541|FG001|Overall Study|Withdrawal by Subject|0|||
146843368|NCT01067846|529595540|FG000|Overall Study|participation in other tx study|1|||
146843369|NCT01067846|529595541|FG001|Overall Study|participation in other tx study|0|||
146843370|NCT02817906|529595542|FG000|Overall Study|Adverse Event|3|||
146843371|NCT02817906|529595543|FG001|Overall Study|Adverse Event|0|||
146843372|NCT02817906|529595542|FG000|Overall Study|Lack of Efficacy|1|||
146843373|NCT02817906|529595543|FG001|Overall Study|Lack of Efficacy|0|||
146843374|NCT02817906|529595542|FG000|Overall Study|Protocol Violation|1|||
146843375|NCT02817906|529595543|FG001|Overall Study|Protocol Violation|1|||
146843376|NCT02817906|529595542|FG000|Overall Study|Study Terminated by Sponsor|2|||
146843377|NCT02817906|529595543|FG001|Overall Study|Study Terminated by Sponsor|2|||
146843378|NCT02817906|529595542|FG000|Overall Study|Withdrawal by Subject|7|||
146843379|NCT02817906|529595543|FG001|Overall Study|Withdrawal by Subject|0|||
146843380|NCT02817906|529595542|FG000|Overall Study|Other|2|||
146843381|NCT02817906|529595543|FG001|Overall Study|Other|2|||
146843382|NCT03686423|529595551|FG000|Overall Study|Withdrawal by Subject|9|||
146843383|NCT03686423|529595551|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
146843384|NCT02833077|529595552|FG000|Overall Study|Adverse Event|1|||
146843385|NCT02833077|529595553|FG001|Overall Study|Adverse Event|2|||
146843386|NCT02833077|529595552|FG000|Overall Study|Lost to Follow-up|10|||
146843387|NCT02833077|529595553|FG001|Overall Study|Lost to Follow-up|1|||
146843388|NCT02833077|529595552|FG000|Overall Study|Personal Reasons|6|||
146843389|NCT02833077|529595553|FG001|Overall Study|Personal Reasons|4|||
146843390|NCT02833077|529595552|FG000|Overall Study|Protocol Deviation|0|||
146843391|NCT02833077|529595553|FG001|Overall Study|Protocol Deviation|1|||
146843392|NCT04608773|529595554|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
146843393|NCT04608773|529595555|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
146843394|NCT04608773|529595554|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
146843395|NCT04608773|529595555|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
146843396|NCT04608773|529595554|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
146843397|NCT04608773|529595555|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
146843398|NCT04608773|529595554|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
146843399|NCT04608773|529595555|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
146843400|NCT04608773|529595554|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
146843401|NCT04608773|529595555|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
146843402|NCT00972322|529595558|FG000|Overall Study|Adverse Event|2|||
146843403|NCT00972322|529595559|FG001|Overall Study|Adverse Event|1|||
146843404|NCT00972322|529595558|FG000|Overall Study|Positive drug screen|0|||
146843405|NCT00972322|529595559|FG001|Overall Study|Positive drug screen|1|||
146843406|NCT00972322|529595558|FG000|Overall Study|Lost to Follow-up|0|||
146843407|NCT00972322|529595559|FG001|Overall Study|Lost to Follow-up|1|||
146843408|NCT00972322|529595558|FG000|Overall Study|Consistently high glucose values|1|||
146843409|NCT00972322|529595559|FG001|Overall Study|Consistently high glucose values|0|||
146843410|NCT04958200|529595560|FG000|Overall Study|Withdrawal by Subject|0|||
146843411|NCT04958200|529595561|FG001|Overall Study|Withdrawal by Subject|2|||
146843412|NCT04958200|529595560|FG000|Overall Study|Lost to Follow-up|3|||
146843413|NCT04958200|529595561|FG001|Overall Study|Lost to Follow-up|2|||
146843414|NCT02387970|529595562|FG000|Overall Study|Did not complete 1-year follow up|1|||
146843415|NCT02387970|529595563|FG001|Overall Study|Did not complete 1-year follow up|2|||
146843416|NCT00316017|529595570|FG000|Overall Study|Protocol Violation|11|||
146843417|NCT00316017|529595571|FG001|Overall Study|Protocol Violation|13|||
146843418|NCT00316017|529595572|FG002|Overall Study|Protocol Violation|19|||
146843419|NCT05511038|529595584|FG000|Overall|Withdrawal by Subject|5|||
146843420|NCT05511038|529595585|FG001|Overall|Withdrawal by Subject|3|||
146843421|NCT05511038|529595584|FG000|Overall|Screen Failure|20|||
146843422|NCT05511038|529595585|FG001|Overall|Screen Failure|1|||
146843423|NCT05511038|529595584|FG000|Overall|Physician Decision|3|||
146843424|NCT05511038|529595585|FG001|Overall|Physician Decision|0|||
146843425|NCT05511038|529595584|FG000|Overall|Lost to Follow-up|3|||
146843426|NCT05511038|529595585|FG001|Overall|Lost to Follow-up|0|||
146843427|NCT05511038|529595584|FG000|Overall|Death|1|||
146843428|NCT05511038|529595585|FG001|Overall|Death|0|||
146843429|NCT05511038|529595584|FG000|Screening|Withdrawal by Subject|1|||
146843430|NCT05511038|529595585|FG001|Screening|Withdrawal by Subject|0|||
146843431|NCT05511038|529595584|FG000|Screening|Lost to Follow Up (1 participant)|1|||
146843432|NCT05511038|529595585|FG001|Screening|Lost to Follow Up (1 participant)|0|||
146843433|NCT05511038|529595584|FG000|Screening|Screen Failure|3|||
146843434|NCT05511038|529595585|FG001|Screening|Screen Failure|0|||
146843435|NCT05511038|529595584|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
146843436|NCT05511038|529595585|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
146843437|NCT05511038|529595584|FG000|Treatment|Withdrawal by Subject|5|||
146843438|NCT05511038|529595585|FG001|Treatment|Withdrawal by Subject|3|||
146843439|NCT05511038|529595584|FG000|Treatment|Physician Decision|4|||
146843440|NCT05511038|529595585|FG001|Treatment|Physician Decision|0|||
146843441|NCT05511038|529595584|FG000|Treatment|Lost to Follow-up|2|||
146843442|NCT05511038|529595585|FG001|Treatment|Lost to Follow-up|0|||
146843443|NCT05511038|529595584|FG000|Treatment|Death|1|||
146843444|NCT05511038|529595585|FG001|Treatment|Death|0|||
146843445|NCT05511038|529595584|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
146843446|NCT05511038|529595585|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
146843447|NCT05511038|529595584|FG000|Treatment|Refuse by subject|1|||
146843448|NCT05511038|529595585|FG001|Treatment|Refuse by subject|0|||
146997331|NCT02924883|530155426|FG001|Overall Study|Withdrawal by Subject|16|||
146997332|NCT02924883|530155425|FG000|Overall Study|Progressive Disease|1|||
146997333|NCT02924883|530155426|FG001|Overall Study|Progressive Disease|0|||
146997334|NCT02924883|530155425|FG000|Overall Study|Study Terminated by Sponsor|69|||
146997335|NCT02924883|530155426|FG001|Overall Study|Study Terminated by Sponsor|32|||
146997336|NCT00553280|530155427|FG000|Overall Study|Adverse Event|19|||
146997337|NCT00553280|530155427|FG000|Overall Study|Lack of Efficacy|3|||
146997338|NCT00553280|530155427|FG000|Overall Study|Withdrawal by Subject|3|||
146997339|NCT00553280|530155427|FG000|Overall Study|Physician Decision|1|||
146997340|NCT01182415|530155428|FG000|Overall Study|Lost to Follow-up|1|||
146997341|NCT02587962|530155433|FG000|Overall Study|Adverse Event|0|||
146997342|NCT02587962|530155434|FG001|Overall Study|Adverse Event|0|||
146997343|NCT02587962|530155435|FG002|Overall Study|Adverse Event|1|||
146997344|NCT02587962|530155436|FG003|Overall Study|Adverse Event|0|||
146997345|NCT02587962|530155437|FG004|Overall Study|Adverse Event|0|||
146997346|NCT02587962|530155433|FG000|Overall Study|Withdrawal by Subject|0|||
146997347|NCT02587962|530155434|FG001|Overall Study|Withdrawal by Subject|0|||
146997348|NCT02587962|530155435|FG002|Overall Study|Withdrawal by Subject|1|||
146997349|NCT02587962|530155436|FG003|Overall Study|Withdrawal by Subject|1|||
146997350|NCT02587962|530155437|FG004|Overall Study|Withdrawal by Subject|4|||
146997351|NCT02587962|530155433|FG000|Overall Study|Radiological progression|2|||
146997352|NCT02587962|530155434|FG001|Overall Study|Radiological progression|2|||
146997353|NCT02587962|530155435|FG002|Overall Study|Radiological progression|2|||
146997354|NCT02587962|530155436|FG003|Overall Study|Radiological progression|5|||
146997355|NCT02587962|530155437|FG004|Overall Study|Radiological progression|10|||
146997356|NCT02587962|530155433|FG000|Overall Study|Clinical progression|0|||
146997357|NCT02587962|530155434|FG001|Overall Study|Clinical progression|1|||
146997358|NCT02587962|530155435|FG002|Overall Study|Clinical progression|2|||
146997359|NCT02587962|530155436|FG003|Overall Study|Clinical progression|0|||
146843449|NCT05511038|529595584|FG000|Treatment|Subject did not go to the site for visit|1|||
146843450|NCT05511038|529595585|FG001|Treatment|Subject did not go to the site for visit|0|||
146843451|NCT05543187|529595588|FG000|Overall Study|Ongoing|3|||
146843452|NCT05543187|529595589|FG001|Overall Study|Ongoing|2|||
146843453|NCT04777864|529595590|FG000|Overall Study|Lost to Follow-up|8|||
146843454|NCT04777864|529595591|FG001|Overall Study|Lost to Follow-up|19|||
146843455|NCT00288639|529597171|FG000|Overall Study|Adverse Event|5|||
146843456|NCT00288639|529597171|FG000|Overall Study|Lack of Efficacy|4|||
146843457|NCT00288639|529597171|FG000|Overall Study|Withdrawal by Subject|2|||
146997360|NCT02587962|530155437|FG004|Overall Study|Clinical progression|1|||
146997361|NCT01422538|530155440|FG000|Overall Study|Lost to Follow-up|0|||
146997362|NCT01422538|530155441|FG001|Overall Study|Lost to Follow-up|1|||
146997363|NCT01422538|530155442|FG002|Overall Study|Lost to Follow-up|1|||
146997364|NCT01422538|530155440|FG000|Overall Study|Missed visit|0|||
146997365|NCT01422538|530155441|FG001|Overall Study|Missed visit|1|||
146843458|NCT00288639|529597171|FG000|Overall Study|Other|1|||
146843459|NCT02815579|529597177|FG000|Overall Study|Non-payment of loan down-payment|16|||
146843460|NCT02815579|529597178|FG001|Overall Study|Non-payment of loan down-payment|0|||
146843461|NCT02815579|529597177|FG000|Overall Study|Withdrawal by Subject|7|||
146843462|NCT02815579|529597178|FG001|Overall Study|Withdrawal by Subject|1|||
146843463|NCT02815579|529597177|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
146843464|NCT02815579|529597178|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
146843465|NCT02815579|529597177|FG000|Overall Study|Lost to Follow-up|7|||
146843466|NCT02815579|529597178|FG001|Overall Study|Lost to Follow-up|4|||
146843467|NCT02815579|529597177|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
146843468|NCT02815579|529597178|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
146843469|NCT02815579|529597177|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
146843470|NCT02815579|529597178|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
146843471|NCT02815579|529597177|FG000|Overall Study|Death|5|||
146843472|NCT02815579|529597178|FG001|Overall Study|Death|4|||
146843473|NCT02815579|529597177|FG000|Overall Study|Imprisoned|0|||
146843474|NCT02815579|529597178|FG001|Overall Study|Imprisoned|2|||
146843475|NCT02815579|529597177|FG000|Overall Study|Did not meet enrollment criteria|0|||
146843476|NCT02815579|529597178|FG001|Overall Study|Did not meet enrollment criteria|1|||
146843477|NCT02311673|529597179|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
146843478|NCT02311673|529597180|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
146843479|NCT02311673|529597181|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
146843480|NCT02311673|529597182|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
146843481|NCT01014208|529597186|FG000|Overall Study|Lost to Follow-up|2|||
146843482|NCT01014208|529597187|FG001|Overall Study|Lost to Follow-up|5|||
146843483|NCT01014208|529597186|FG000|Overall Study|Participant Withdrew Consent|12|||
146843484|NCT01014208|529597187|FG001|Overall Study|Participant Withdrew Consent|12|||
146843485|NCT01014208|529597186|FG000|Overall Study|Did Not Receive Study Drug|2|||
146843486|NCT01014208|529597187|FG001|Overall Study|Did Not Receive Study Drug|0|||
146843487|NCT01014208|529597186|FG000|Overall Study|Study Closed/terminated|78|||
146843488|NCT01014208|529597187|FG001|Overall Study|Study Closed/terminated|83|||
146843489|NCT00414908|529597190|FG000|Overall Study|Protocol Violation|1|||
146843490|NCT00414908|529597191|FG001|Overall Study|Protocol Violation|1|||
146843491|NCT01076153|529597192|FG000|Overall Study|Symptoms improved/resolved|10|||
146843492|NCT01076153|529597192|FG000|Overall Study|Adverse Event|1|||
146843493|NCT03330405|529597193|FG000|Overall Study|Other|1|||
146843494|NCT03330405|529597194|FG001|Overall Study|Other|3|||
146843495|NCT03330405|529597195|FG002|Overall Study|Other|1|||
146843496|NCT03330405|529597196|FG003|Overall Study|Other|0|||
146843497|NCT03330405|529597197|FG004|Overall Study|Other|2|||
146843498|NCT03330405|529597198|FG005|Overall Study|Other|0|||
146843499|NCT03330405|529597199|FG006|Overall Study|Other|1|||
146843500|NCT03330405|529597200|FG007|Overall Study|Other|0|||
146843501|NCT03330405|529597201|FG008|Overall Study|Other|0|||
146843502|NCT03330405|529597202|FG009|Overall Study|Other|0|||
146843503|NCT03330405|529597203|FG010|Overall Study|Other|0|||
146843504|NCT03330405|529597193|FG000|Overall Study|Progressive disease|8|||
146843505|NCT03330405|529597194|FG001|Overall Study|Progressive disease|27|||
146843506|NCT03330405|529597195|FG002|Overall Study|Progressive disease|4|||
146843507|NCT03330405|529597196|FG003|Overall Study|Progressive disease|18|||
146843508|NCT03330405|529597197|FG004|Overall Study|Progressive disease|16|||
146843509|NCT03330405|529597198|FG005|Overall Study|Progressive disease|14|||
146843510|NCT03330405|529597199|FG006|Overall Study|Progressive disease|7|||
146843511|NCT03330405|529597200|FG007|Overall Study|Progressive disease|29|||
146843512|NCT03330405|529597201|FG008|Overall Study|Progressive disease|9|||
146843513|NCT03330405|529597202|FG009|Overall Study|Progressive disease|11|||
146843514|NCT03330405|529597203|FG010|Overall Study|Progressive disease|5|||
146843515|NCT03330405|529597193|FG000|Overall Study|Withdrawal by Subject|1|||
146843516|NCT03330405|529597194|FG001|Overall Study|Withdrawal by Subject|4|||
146843517|NCT03330405|529597195|FG002|Overall Study|Withdrawal by Subject|0|||
146843518|NCT03330405|529597196|FG003|Overall Study|Withdrawal by Subject|1|||
146843519|NCT03330405|529597197|FG004|Overall Study|Withdrawal by Subject|1|||
146843520|NCT03330405|529597198|FG005|Overall Study|Withdrawal by Subject|1|||
146843521|NCT03330405|529597199|FG006|Overall Study|Withdrawal by Subject|0|||
146843522|NCT03330405|529597200|FG007|Overall Study|Withdrawal by Subject|2|||
146843523|NCT03330405|529597201|FG008|Overall Study|Withdrawal by Subject|2|||
146843524|NCT03330405|529597202|FG009|Overall Study|Withdrawal by Subject|1|||
146843525|NCT03330405|529597203|FG010|Overall Study|Withdrawal by Subject|1|||
146843526|NCT03330405|529597193|FG000|Overall Study|Global deterioration of health status|2|||
146843527|NCT03330405|529597194|FG001|Overall Study|Global deterioration of health status|3|||
146843528|NCT03330405|529597195|FG002|Overall Study|Global deterioration of health status|0|||
146843529|NCT03330405|529597196|FG003|Overall Study|Global deterioration of health status|2|||
146843530|NCT03330405|529597197|FG004|Overall Study|Global deterioration of health status|3|||
146997366|NCT01422538|530155442|FG002|Overall Study|Missed visit|1|||
146843531|NCT03330405|529597198|FG005|Overall Study|Global deterioration of health status|3|||
146843532|NCT03330405|529597199|FG006|Overall Study|Global deterioration of health status|0|||
146843533|NCT03330405|529597200|FG007|Overall Study|Global deterioration of health status|2|||
146843534|NCT03330405|529597201|FG008|Overall Study|Global deterioration of health status|8|||
146843535|NCT03330405|529597202|FG009|Overall Study|Global deterioration of health status|4|||
146843536|NCT03330405|529597203|FG010|Overall Study|Global deterioration of health status|1|||
146843537|NCT03330405|529597193|FG000|Overall Study|Adverse Event|0|||
146843538|NCT03330405|529597194|FG001|Overall Study|Adverse Event|1|||
146843539|NCT03330405|529597195|FG002|Overall Study|Adverse Event|0|||
146843540|NCT03330405|529597196|FG003|Overall Study|Adverse Event|1|||
146843541|NCT03330405|529597197|FG004|Overall Study|Adverse Event|1|||
146843542|NCT03330405|529597198|FG005|Overall Study|Adverse Event|1|||
146843543|NCT03330405|529597199|FG006|Overall Study|Adverse Event|3|||
146843544|NCT03330405|529597200|FG007|Overall Study|Adverse Event|4|||
146843545|NCT03330405|529597201|FG008|Overall Study|Adverse Event|2|||
146843546|NCT03330405|529597202|FG009|Overall Study|Adverse Event|2|||
146843547|NCT03330405|529597203|FG010|Overall Study|Adverse Event|2|||
146843548|NCT03330405|529597193|FG000|Overall Study|Death|0|||
146843549|NCT03330405|529597194|FG001|Overall Study|Death|4|||
146997367|NCT01536405|530155443|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
146997368|NCT01536405|530155444|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
146997369|NCT01536405|530155443|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
146997370|NCT01536405|530155444|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
146843550|NCT03330405|529597195|FG002|Overall Study|Death|0|||
146843551|NCT03330405|529597196|FG003|Overall Study|Death|0|||
146843552|NCT03330405|529597197|FG004|Overall Study|Death|0|||
146843553|NCT03330405|529597198|FG005|Overall Study|Death|1|||
146843554|NCT03330405|529597199|FG006|Overall Study|Death|0|||
146843555|NCT03330405|529597200|FG007|Overall Study|Death|2|||
146843556|NCT03330405|529597201|FG008|Overall Study|Death|0|||
146843557|NCT03330405|529597202|FG009|Overall Study|Death|0|||
146843558|NCT03330405|529597203|FG010|Overall Study|Death|0|||
146843559|NCT03330405|529597193|FG000|Overall Study|Physician Decision|0|||
146843560|NCT03330405|529597194|FG001|Overall Study|Physician Decision|0|||
146843561|NCT03330405|529597195|FG002|Overall Study|Physician Decision|0|||
146843562|NCT03330405|529597196|FG003|Overall Study|Physician Decision|0|||
146843563|NCT03330405|529597197|FG004|Overall Study|Physician Decision|0|||
146843564|NCT03330405|529597198|FG005|Overall Study|Physician Decision|0|||
146843565|NCT03330405|529597199|FG006|Overall Study|Physician Decision|0|||
146843566|NCT03330405|529597200|FG007|Overall Study|Physician Decision|1|||
146843567|NCT03330405|529597201|FG008|Overall Study|Physician Decision|0|||
146843568|NCT03330405|529597202|FG009|Overall Study|Physician Decision|0|||
146843569|NCT03330405|529597203|FG010|Overall Study|Physician Decision|0|||
146843570|NCT04187326|529597210|FG000|Overall Study|Lost to Follow-up|2|||
146843571|NCT04187326|529597211|FG001|Overall Study|Lost to Follow-up|1|||
146843572|NCT04187326|529597210|FG000|Overall Study|Computer error- task was only partially completed.|0|||
146843573|NCT04187326|529597211|FG001|Overall Study|Computer error- task was only partially completed.|1|||
146843574|NCT05235269|529597220|FG000|Overall Study|Adverse Event|1|||
146843575|NCT05235269|529597220|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
146843576|NCT05235269|529597220|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
146843577|NCT03810235|529597221|FG000|Overall Study|Withdrawal by Subject|2|||
146843578|NCT03810235|529597222|FG001|Overall Study|Withdrawal by Subject|0|||
146843579|NCT00798434|529597223|FG000|Double-Blind|Adverse Event|22|||
146843580|NCT00798434|529597224|FG001|Double-Blind|Adverse Event|46|||
146843581|NCT00798434|529597223|FG000|Double-Blind|Death|0|||
146843582|NCT00798434|529597224|FG001|Double-Blind|Death|1|||
146843583|NCT00798434|529597223|FG000|Double-Blind|Lost to Follow-up|1|||
146843584|NCT00798434|529597224|FG001|Double-Blind|Lost to Follow-up|0|||
146843585|NCT00798434|529597223|FG000|Double-Blind|Lack of Efficacy|8|||
146843586|NCT00798434|529597224|FG001|Double-Blind|Lack of Efficacy|12|||
146843587|NCT00798434|529597223|FG000|Double-Blind|Withdrawal by Subject|17|||
146843588|NCT00798434|529597224|FG001|Double-Blind|Withdrawal by Subject|14|||
146843589|NCT00798434|529597223|FG000|Double-Blind|Protocol Violation|1|||
146843590|NCT00798434|529597224|FG001|Double-Blind|Protocol Violation|4|||
146843591|NCT00798434|529597223|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
146843592|NCT00798434|529597224|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
146843593|NCT00798434|529597223|FG000|Double-Blind|Other|1|||
146843594|NCT00798434|529597224|FG001|Double-Blind|Other|0|||
146843595|NCT00798434|529597223|FG000|Double-Blind|Not Treated|3|||
146843596|NCT00798434|529597224|FG001|Double-Blind|Not Treated|6|||
146843597|NCT00798434|529597223|FG000|Open-Label|Adverse Event|33|||
146843598|NCT00798434|529597224|FG001|Open-Label|Adverse Event|11|||
146843599|NCT00798434|529597223|FG000|Open-Label|Lack of Efficacy|5|||
146843600|NCT00798434|529597224|FG001|Open-Label|Lack of Efficacy|11|||
146843601|NCT00798434|529597223|FG000|Open-Label|Withdrawal by Subject|2|||
146843602|NCT00798434|529597224|FG001|Open-Label|Withdrawal by Subject|7|||
146843603|NCT00798434|529597223|FG000|Open-Label|Protocol Violation|1|||
146843604|NCT00798434|529597224|FG001|Open-Label|Protocol Violation|0|||
146843605|NCT00798434|529597223|FG000|Open-Label|Other|1|||
146843606|NCT00798434|529597224|FG001|Open-Label|Other|2|||
146843607|NCT00798434|529597223|FG000|Open-Label|Not Treated|0|||
146843608|NCT00798434|529597224|FG001|Open-Label|Not Treated|1|||
146843609|NCT03682185|529597230|FG000|Overall Study|Lost to Follow-up|4|||
146843610|NCT03682185|529597231|FG001|Overall Study|Lost to Follow-up|7|||
146843611|NCT03682185|529597232|FG002|Overall Study|Lost to Follow-up|4|||
146843612|NCT03682185|529597233|FG003|Overall Study|Lost to Follow-up|7|||
146843613|NCT03682185|529597234|FG004|Overall Study|Lost to Follow-up|1|||
146843614|NCT03682185|529597230|FG000|Overall Study|Withdrawal by Subject|7|||
146843615|NCT03682185|529597231|FG001|Overall Study|Withdrawal by Subject|3|||
146843616|NCT03682185|529597232|FG002|Overall Study|Withdrawal by Subject|7|||
146843617|NCT03682185|529597233|FG003|Overall Study|Withdrawal by Subject|3|||
146843618|NCT03682185|529597234|FG004|Overall Study|Withdrawal by Subject|0|||
146843619|NCT04908631|529597235|FG000|Overall Study|Lost to Follow-up|1|||
146843620|NCT04908631|529597235|FG000|Overall Study|Physician Decision|1|||
146843621|NCT04908631|529597235|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
146843622|NCT02336451|529597239|FG000|Overall Study|Adverse Event|1|||
146843623|NCT02336451|529597240|FG001|Overall Study|Adverse Event|2|||
146843624|NCT02336451|529597241|FG002|Overall Study|Adverse Event|0|||
146843625|NCT02336451|529597242|FG003|Overall Study|Adverse Event|6|||
146843626|NCT02336451|529597243|FG004|Overall Study|Adverse Event|4|||
146843627|NCT02336451|529597239|FG000|Overall Study|Death|6|||
146843628|NCT02336451|529597240|FG001|Overall Study|Death|2|||
146843629|NCT02336451|529597241|FG002|Overall Study|Death|3|||
146843630|NCT02336451|529597242|FG003|Overall Study|Death|6|||
146843631|NCT02336451|529597243|FG004|Overall Study|Death|6|||
146843632|NCT02336451|529597239|FG000|Overall Study|Physician Decision|9|||
146843633|NCT02336451|529597240|FG001|Overall Study|Physician Decision|6|||
146843634|NCT02336451|529597241|FG002|Overall Study|Physician Decision|7|||
146843635|NCT02336451|529597242|FG003|Overall Study|Physician Decision|16|||
146843636|NCT02336451|529597243|FG004|Overall Study|Physician Decision|3|||
146843637|NCT02336451|529597239|FG000|Overall Study|Progressive disease|23|||
146843638|NCT02336451|529597240|FG001|Overall Study|Progressive disease|26|||
146843639|NCT02336451|529597241|FG002|Overall Study|Progressive disease|2|||
146843640|NCT02336451|529597242|FG003|Overall Study|Progressive disease|14|||
146843641|NCT02336451|529597243|FG004|Overall Study|Progressive disease|4|||
146843642|NCT02336451|529597239|FG000|Overall Study|Protocol Violation|1|||
146843643|NCT02336451|529597240|FG001|Overall Study|Protocol Violation|0|||
146843644|NCT02336451|529597241|FG002|Overall Study|Protocol Violation|0|||
146843645|NCT02336451|529597242|FG003|Overall Study|Protocol Violation|0|||
146843646|NCT02336451|529597243|FG004|Overall Study|Protocol Violation|0|||
146843647|NCT02336451|529597239|FG000|Overall Study|Patient/guardian decision|2|||
146843648|NCT02336451|529597240|FG001|Overall Study|Patient/guardian decision|4|||
146843649|NCT02336451|529597241|FG002|Overall Study|Patient/guardian decision|0|||
146843650|NCT02336451|529597242|FG003|Overall Study|Patient/guardian decision|2|||
146843651|NCT02336451|529597243|FG004|Overall Study|Patient/guardian decision|1|||
146843652|NCT03520712|529597245|FG000|Overall Study|Early termination of the study by Sponsor|2|||
146843653|NCT02344290|529597252|FG000|Overall Study|Withdrawal by Subject|315|||
146843654|NCT02344290|529597253|FG001|Overall Study|Withdrawal by Subject|324|||
146843655|NCT02344290|529597252|FG000|Overall Study|Lost to Follow-up|258|||
146843656|NCT02344290|529597253|FG001|Overall Study|Lost to Follow-up|249|||
146843657|NCT02344290|529597252|FG000|Overall Study|Unable to get to clinic|69|||
146843658|NCT02344290|529597253|FG001|Overall Study|Unable to get to clinic|60|||
146843659|NCT02344290|529597252|FG000|Overall Study|Physician Decision|25|||
146843660|NCT02344290|529597253|FG001|Overall Study|Physician Decision|25|||
146843661|NCT02344290|529597252|FG000|Overall Study|Site Closure|15|||
146843662|NCT02344290|529597253|FG001|Overall Study|Site Closure|19|||
146843663|NCT02344290|529597252|FG000|Overall Study|Other|5|||
146843664|NCT02344290|529597253|FG001|Overall Study|Other|3|||
146843665|NCT04998812|529597254|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
146843666|NCT04998812|529597255|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
146843667|NCT04998812|529597254|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
146843668|NCT04998812|529597255|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
146843669|NCT04998812|529597254|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
146843670|NCT04998812|529597255|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
146843671|NCT04998812|529597254|FG000|Vaccination Period|Ongoing in study|23|||
146843672|NCT04998812|529597255|FG001|Vaccination Period|Ongoing in study|23|||
146843673|NCT04047862|529597262|FG000|Overall Study|Death|0|||
146843674|NCT04047862|529597263|FG001|Overall Study|Death|0|||
146843675|NCT04047862|529597264|FG002|Overall Study|Death|4|||
146843676|NCT04047862|529597265|FG003|Overall Study|Death|7|||
146843677|NCT04047862|529597266|FG004|Overall Study|Death|2|||
146843678|NCT04047862|529597267|FG005|Overall Study|Death|4|||
146843679|NCT04047862|529597268|FG006|Overall Study|Death|3|||
146843680|NCT04047862|529597269|FG007|Overall Study|Death|24|||
146843681|NCT04047862|529597270|FG008|Overall Study|Death|24|||
146843682|NCT04047862|529597271|FG009|Overall Study|Death|22|||
146843683|NCT04047862|529597272|FG010|Overall Study|Death|35|||
146843684|NCT04047862|529597273|FG011|Overall Study|Death|18|||
146843685|NCT04047862|529597274|FG012|Overall Study|Death|14|||
146843686|NCT04047862|529597275|FG013|Overall Study|Death|6|||
146843687|NCT04047862|529597276|FG014|Overall Study|Death|19|||
146843688|NCT04047862|529597277|FG015|Overall Study|Death|42|||
146843689|NCT04047862|529597278|FG016|Overall Study|Death|9|||
146843690|NCT04047862|529597279|FG017|Overall Study|Death|8|||
146843691|NCT04047862|529597280|FG018|Overall Study|Death|10|||
146843692|NCT04047862|529597262|FG000|Overall Study|Withdrawal by Subject|0|||
146843693|NCT04047862|529597263|FG001|Overall Study|Withdrawal by Subject|0|||
146843694|NCT04047862|529597264|FG002|Overall Study|Withdrawal by Subject|0|||
146843695|NCT04047862|529597265|FG003|Overall Study|Withdrawal by Subject|5|||
146843696|NCT04047862|529597266|FG004|Overall Study|Withdrawal by Subject|2|||
146843697|NCT04047862|529597267|FG005|Overall Study|Withdrawal by Subject|0|||
146843698|NCT04047862|529597268|FG006|Overall Study|Withdrawal by Subject|1|||
146843699|NCT04047862|529597269|FG007|Overall Study|Withdrawal by Subject|0|||
146843700|NCT04047862|529597270|FG008|Overall Study|Withdrawal by Subject|4|||
146843701|NCT04047862|529597271|FG009|Overall Study|Withdrawal by Subject|4|||
146843702|NCT04047862|529597272|FG010|Overall Study|Withdrawal by Subject|4|||
146843703|NCT04047862|529597273|FG011|Overall Study|Withdrawal by Subject|2|||
146843704|NCT04047862|529597274|FG012|Overall Study|Withdrawal by Subject|3|||
146843705|NCT04047862|529597275|FG013|Overall Study|Withdrawal by Subject|0|||
146843706|NCT04047862|529597276|FG014|Overall Study|Withdrawal by Subject|9|||
146843707|NCT04047862|529597277|FG015|Overall Study|Withdrawal by Subject|5|||
146843708|NCT04047862|529597278|FG016|Overall Study|Withdrawal by Subject|1|||
146843709|NCT04047862|529597279|FG017|Overall Study|Withdrawal by Subject|3|||
146843710|NCT04047862|529597280|FG018|Overall Study|Withdrawal by Subject|1|||
146843711|NCT04047862|529597262|FG000|Overall Study|Lost to Follow-up|0|||
146843712|NCT04047862|529597263|FG001|Overall Study|Lost to Follow-up|0|||
146843713|NCT04047862|529597264|FG002|Overall Study|Lost to Follow-up|1|||
146843714|NCT04047862|529597265|FG003|Overall Study|Lost to Follow-up|0|||
146843715|NCT04047862|529597266|FG004|Overall Study|Lost to Follow-up|0|||
146843716|NCT04047862|529597267|FG005|Overall Study|Lost to Follow-up|0|||
146843717|NCT04047862|529597268|FG006|Overall Study|Lost to Follow-up|0|||
146843718|NCT04047862|529597269|FG007|Overall Study|Lost to Follow-up|1|||
146843719|NCT04047862|529597270|FG008|Overall Study|Lost to Follow-up|0|||
146843720|NCT04047862|529597271|FG009|Overall Study|Lost to Follow-up|1|||
146843721|NCT04047862|529597272|FG010|Overall Study|Lost to Follow-up|0|||
146843722|NCT04047862|529597273|FG011|Overall Study|Lost to Follow-up|3|||
146843723|NCT04047862|529597274|FG012|Overall Study|Lost to Follow-up|0|||
146843724|NCT04047862|529597275|FG013|Overall Study|Lost to Follow-up|0|||
146843725|NCT04047862|529597276|FG014|Overall Study|Lost to Follow-up|2|||
146843726|NCT04047862|529597277|FG015|Overall Study|Lost to Follow-up|2|||
146843727|NCT04047862|529597278|FG016|Overall Study|Lost to Follow-up|1|||
146843728|NCT04047862|529597279|FG017|Overall Study|Lost to Follow-up|0|||
146843729|NCT04047862|529597280|FG018|Overall Study|Lost to Follow-up|0|||
146843730|NCT04047862|529597262|FG000|Overall Study|Physician Decision|0|||
146843731|NCT04047862|529597263|FG001|Overall Study|Physician Decision|0|||
146843732|NCT04047862|529597264|FG002|Overall Study|Physician Decision|0|||
146843733|NCT04047862|529597265|FG003|Overall Study|Physician Decision|1|||
146843734|NCT04047862|529597266|FG004|Overall Study|Physician Decision|0|||
146843735|NCT04047862|529597267|FG005|Overall Study|Physician Decision|0|||
146843736|NCT04047862|529597268|FG006|Overall Study|Physician Decision|0|||
146843737|NCT04047862|529597269|FG007|Overall Study|Physician Decision|0|||
146843738|NCT04047862|529597270|FG008|Overall Study|Physician Decision|0|||
146843739|NCT04047862|529597271|FG009|Overall Study|Physician Decision|0|||
146843740|NCT04047862|529597272|FG010|Overall Study|Physician Decision|0|||
146843741|NCT04047862|529597273|FG011|Overall Study|Physician Decision|0|||
146843742|NCT04047862|529597274|FG012|Overall Study|Physician Decision|0|||
146843743|NCT04047862|529597275|FG013|Overall Study|Physician Decision|0|||
146843744|NCT04047862|529597276|FG014|Overall Study|Physician Decision|1|||
146843745|NCT04047862|529597277|FG015|Overall Study|Physician Decision|0|||
146843746|NCT04047862|529597278|FG016|Overall Study|Physician Decision|1|||
146843747|NCT04047862|529597279|FG017|Overall Study|Physician Decision|0|||
146843748|NCT04047862|529597280|FG018|Overall Study|Physician Decision|0|||
146997371|NCT01536405|530155443|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
146997372|NCT01536405|530155444|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
146997373|NCT01536405|530155443|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
146997374|NCT01536405|530155444|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
146997375|NCT01536405|530155443|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
146997376|NCT01536405|530155444|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
146997377|NCT01536405|530155443|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
146997378|NCT01536405|530155444|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
146997379|NCT01536405|530155443|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
146997380|NCT01536405|530155444|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
146843749|NCT04047862|529597262|FG000|Overall Study|Completed all Assessments|1|||
146843750|NCT04047862|529597263|FG001|Overall Study|Completed all Assessments|3|||
146843751|NCT04047862|529597264|FG002|Overall Study|Completed all Assessments|1|||
146843752|NCT04047862|529597265|FG003|Overall Study|Completed all Assessments|3|||
146843753|NCT04047862|529597266|FG004|Overall Study|Completed all Assessments|2|||
146843754|NCT04047862|529597267|FG005|Overall Study|Completed all Assessments|5|||
146843755|NCT04047862|529597268|FG006|Overall Study|Completed all Assessments|7|||
146843756|NCT04047862|529597269|FG007|Overall Study|Completed all Assessments|0|||
146843757|NCT04047862|529597270|FG008|Overall Study|Completed all Assessments|0|||
146843758|NCT04047862|529597271|FG009|Overall Study|Completed all Assessments|0|||
146843759|NCT04047862|529597272|FG010|Overall Study|Completed all Assessments|0|||
146843760|NCT04047862|529597273|FG011|Overall Study|Completed all Assessments|0|||
146843761|NCT04047862|529597274|FG012|Overall Study|Completed all Assessments|0|||
146843762|NCT04047862|529597275|FG013|Overall Study|Completed all Assessments|0|||
146843763|NCT04047862|529597276|FG014|Overall Study|Completed all Assessments|0|||
146843764|NCT04047862|529597277|FG015|Overall Study|Completed all Assessments|0|||
146843765|NCT04047862|529597278|FG016|Overall Study|Completed all Assessments|0|||
146843766|NCT04047862|529597279|FG017|Overall Study|Completed all Assessments|0|||
146843767|NCT04047862|529597280|FG018|Overall Study|Completed all Assessments|0|||
146843768|NCT04047862|529597262|FG000|Overall Study|Sponsor Decision|0|||
146843769|NCT04047862|529597263|FG001|Overall Study|Sponsor Decision|0|||
146843770|NCT04047862|529597264|FG002|Overall Study|Sponsor Decision|0|||
146843771|NCT04047862|529597265|FG003|Overall Study|Sponsor Decision|0|||
146843772|NCT04047862|529597266|FG004|Overall Study|Sponsor Decision|0|||
146843773|NCT04047862|529597267|FG005|Overall Study|Sponsor Decision|0|||
146843774|NCT04047862|529597268|FG006|Overall Study|Sponsor Decision|0|||
146843775|NCT04047862|529597269|FG007|Overall Study|Sponsor Decision|13|||
146843776|NCT04047862|529597270|FG008|Overall Study|Sponsor Decision|10|||
146843777|NCT04047862|529597271|FG009|Overall Study|Sponsor Decision|18|||
146843778|NCT04047862|529597272|FG010|Overall Study|Sponsor Decision|3|||
146843779|NCT04047862|529597273|FG011|Overall Study|Sponsor Decision|3|||
146843780|NCT04047862|529597274|FG012|Overall Study|Sponsor Decision|4|||
146843781|NCT04047862|529597275|FG013|Overall Study|Sponsor Decision|0|||
146843782|NCT04047862|529597276|FG014|Overall Study|Sponsor Decision|7|||
146843783|NCT04047862|529597277|FG015|Overall Study|Sponsor Decision|8|||
146843784|NCT04047862|529597278|FG016|Overall Study|Sponsor Decision|9|||
146843785|NCT04047862|529597279|FG017|Overall Study|Sponsor Decision|7|||
146843786|NCT04047862|529597280|FG018|Overall Study|Sponsor Decision|8|||
146843787|NCT04047862|529597262|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146843788|NCT04047862|529597263|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146843789|NCT04047862|529597264|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146843790|NCT04047862|529597265|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146843791|NCT04047862|529597266|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146843792|NCT04047862|529597267|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146843793|NCT04047862|529597268|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146843794|NCT04047862|529597269|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
146843795|NCT04047862|529597270|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
146997381|NCT01536405|530155443|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
146997382|NCT01536405|530155444|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
146997383|NCT01536405|530155443|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
146997384|NCT01536405|530155444|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
146997385|NCT01536405|530155443|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
146997386|NCT01536405|530155444|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
146843796|NCT04047862|529597271|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146843797|NCT04047862|529597272|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
146843798|NCT04047862|529597273|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146843799|NCT04047862|529597274|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146843800|NCT04047862|529597275|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146843801|NCT04047862|529597276|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
146843802|NCT04047862|529597277|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
146843803|NCT04047862|529597278|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
146843804|NCT04047862|529597279|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
146843805|NCT04047862|529597280|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
146843806|NCT04047862|529597262|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146843807|NCT04047862|529597263|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146843808|NCT04047862|529597264|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146843809|NCT04047862|529597265|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146843810|NCT04047862|529597266|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146843811|NCT04047862|529597267|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146997387|NCT01536405|530155443|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
146997388|NCT01536405|530155444|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
146997389|NCT01536405|530155443|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
146997390|NCT01536405|530155444|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
146843812|NCT04047862|529597268|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146843813|NCT04047862|529597269|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146843814|NCT04047862|529597270|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146843815|NCT04047862|529597271|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146843816|NCT04047862|529597272|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146843817|NCT04047862|529597273|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146843818|NCT04047862|529597274|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146843819|NCT04047862|529597275|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146843820|NCT04047862|529597276|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146843821|NCT04047862|529597277|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
146843822|NCT04047862|529597278|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146843823|NCT04047862|529597279|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146843824|NCT04047862|529597280|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
146843825|NCT04047862|529597262|FG000|Overall Study|Other|0|||
146843826|NCT04047862|529597263|FG001|Overall Study|Other|0|||
146843827|NCT04047862|529597264|FG002|Overall Study|Other|0|||
146843828|NCT04047862|529597265|FG003|Overall Study|Other|0|||
146843829|NCT04047862|529597266|FG004|Overall Study|Other|0|||
146843830|NCT04047862|529597267|FG005|Overall Study|Other|0|||
146843831|NCT04047862|529597268|FG006|Overall Study|Other|0|||
146843832|NCT04047862|529597269|FG007|Overall Study|Other|0|||
146843833|NCT04047862|529597270|FG008|Overall Study|Other|0|||
146843834|NCT04047862|529597271|FG009|Overall Study|Other|0|||
146843835|NCT04047862|529597272|FG010|Overall Study|Other|0|||
146843836|NCT04047862|529597273|FG011|Overall Study|Other|0|||
146843837|NCT04047862|529597274|FG012|Overall Study|Other|0|||
146843838|NCT04047862|529597275|FG013|Overall Study|Other|0|||
146843839|NCT04047862|529597276|FG014|Overall Study|Other|2|||
146843840|NCT04047862|529597277|FG015|Overall Study|Other|1|||
146843841|NCT04047862|529597278|FG016|Overall Study|Other|1|||
146843842|NCT04047862|529597279|FG017|Overall Study|Other|1|||
146843843|NCT04047862|529597280|FG018|Overall Study|Other|0|||
146843844|NCT06748729|529597286|FG000|Overall Study|Withdrawal by Subject|1|||
146843845|NCT03578887|529597287|FG000|Overall Study|Withdrawal by Subject|7|||
146843846|NCT03578887|529597288|FG001|Overall Study|Withdrawal by Subject|2|||
146843847|NCT03578887|529597289|FG002|Overall Study|Withdrawal by Subject|1|||
146843848|NCT03578887|529597287|FG000|Overall Study|Lost to Follow-up|13|||
146843849|NCT03578887|529597288|FG001|Overall Study|Lost to Follow-up|1|||
146843850|NCT03578887|529597289|FG002|Overall Study|Lost to Follow-up|4|||
146843851|NCT03578887|529597287|FG000|Overall Study|Physician Decision|0|||
146843852|NCT03578887|529597288|FG001|Overall Study|Physician Decision|1|||
146843853|NCT03578887|529597289|FG002|Overall Study|Physician Decision|1|||
146843854|NCT01015560|529598430|FG000|Overall Study|Adverse Event|1|||
146843855|NCT01015560|529598430|FG000|Overall Study|Not protocol specified|1|||
146843856|NCT01015560|529598430|FG000|Overall Study|Withdrawal by Subject|1|||
146843857|NCT04165031|529598435|FG000|Overall Study|Adverse Event|1|||
146843858|NCT04165031|529598436|FG001|Overall Study|Adverse Event|1|||
146843859|NCT04165031|529598437|FG002|Overall Study|Adverse Event|0|||
146843860|NCT04165031|529598438|FG003|Overall Study|Adverse Event|0|||
146843861|NCT04165031|529598439|FG004|Overall Study|Adverse Event|0|||
146843862|NCT04165031|529598440|FG005|Overall Study|Adverse Event|0|||
146843863|NCT04165031|529598435|FG000|Overall Study|Withdrawal by Subject|0|||
146843864|NCT04165031|529598436|FG001|Overall Study|Withdrawal by Subject|0|||
146843865|NCT04165031|529598437|FG002|Overall Study|Withdrawal by Subject|1|||
146843866|NCT04165031|529598438|FG003|Overall Study|Withdrawal by Subject|0|||
146843867|NCT04165031|529598439|FG004|Overall Study|Withdrawal by Subject|0|||
146843868|NCT04165031|529598440|FG005|Overall Study|Withdrawal by Subject|0|||
146843869|NCT01332630|529598441|FG000|Overall Study|Withdrawal by Subject|3|||
146843870|NCT02787044|529598449|FG000|Overall Study|Lost to Follow-up|15|||
146843871|NCT02787044|529598450|FG001|Overall Study|Lost to Follow-up|19|||
146843872|NCT00567567|529598451|FG000|Overall Study|Adverse Event|0|||
146843873|NCT00567567|529598452|FG001|Overall Study|Adverse Event|2|||
146843874|NCT00567567|529598453|FG002|Overall Study|Adverse Event|5|||
146843875|NCT00567567|529598451|FG000|Overall Study|Death|8|||
146843876|NCT00567567|529598452|FG001|Overall Study|Death|1|||
146997391|NCT01536405|530155443|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
146997392|NCT01536405|530155444|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
146997393|NCT01263704|530155447|FG000|Overall Study|Progressive disease|18|||
146843877|NCT00567567|529598453|FG002|Overall Study|Death|5|||
146843878|NCT00567567|529598451|FG000|Overall Study|Lack of Efficacy|16|||
146843879|NCT00567567|529598452|FG001|Overall Study|Lack of Efficacy|17|||
146843880|NCT00567567|529598453|FG002|Overall Study|Lack of Efficacy|48|||
146843881|NCT00567567|529598451|FG000|Overall Study|Lost to Follow-up|0|||
146843882|NCT00567567|529598452|FG001|Overall Study|Lost to Follow-up|0|||
146843883|NCT00567567|529598453|FG002|Overall Study|Lost to Follow-up|1|||
146843884|NCT00567567|529598451|FG000|Overall Study|Physician Decision|16|||
146843885|NCT00567567|529598452|FG001|Overall Study|Physician Decision|18|||
146843886|NCT00567567|529598453|FG002|Overall Study|Physician Decision|84|||
146843887|NCT00567567|529598451|FG000|Overall Study|Withdrawal by Subject|0|||
146843888|NCT00567567|529598452|FG001|Overall Study|Withdrawal by Subject|0|||
146843889|NCT00567567|529598453|FG002|Overall Study|Withdrawal by Subject|2|||
146843890|NCT00567567|529598451|FG000|Overall Study|Ineligible|4|||
146843891|NCT00567567|529598452|FG001|Overall Study|Ineligible|0|||
146843892|NCT00567567|529598453|FG002|Overall Study|Ineligible|9|||
146843893|NCT00567567|529598451|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
146843894|NCT00567567|529598452|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
146843895|NCT00567567|529598453|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
146843896|NCT00567567|529598451|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
146843897|NCT00567567|529598452|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
146843898|NCT00567567|529598453|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
146843899|NCT00567567|529598451|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
146843900|NCT00567567|529598452|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
146843901|NCT00567567|529598453|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
146843902|NCT03433677|529598454|FG000|Period 1|Protocol Violation|1|||
146997394|NCT01263704|530155447|FG000|Overall Study|Adverse Event|3|||
146997395|NCT01263704|530155447|FG000|Overall Study|Death|2|||
146997396|NCT01263704|530155447|FG000|Overall Study|Patient withdrew consent|2|||
146997397|NCT01263704|530155447|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
146997398|NCT01263704|530155447|FG000|Overall Study|Lost to Follow-up|1|||
146997399|NCT01263704|530155447|FG000|Overall Study|Colon metastases|1|||
146843903|NCT03433677|529598455|FG001|Period 1|Protocol Violation|0|||
146843904|NCT03433677|529598454|FG000|Period 2|Withdrawal by Subject|1|||
146843905|NCT03433677|529598455|FG001|Period 2|Withdrawal by Subject|1|||
146843906|NCT03889704|529598457|FG000|Overall Study|Study terminated due to pandemic|1|||
146843907|NCT04552899|529598458|FG000|Overall Study|Adverse Event|4|||
146843908|NCT04552899|529598459|FG001|Overall Study|Adverse Event|3|||
146843909|NCT04552899|529598458|FG000|Overall Study|Death|4|||
146843910|NCT04552899|529598459|FG001|Overall Study|Death|4|||
146843911|NCT04552899|529598458|FG000|Overall Study|Lost to Follow-up|8|||
146843912|NCT04552899|529598459|FG001|Overall Study|Lost to Follow-up|13|||
146843913|NCT04552899|529598458|FG000|Overall Study|Lung Transplant|4|||
146843914|NCT04552899|529598459|FG001|Overall Study|Lung Transplant|3|||
146843915|NCT04552899|529598458|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
146843916|NCT04552899|529598459|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
146843917|NCT04552899|529598458|FG000|Overall Study|Physician Decision|3|||
146843918|NCT04552899|529598459|FG001|Overall Study|Physician Decision|4|||
146843919|NCT04552899|529598458|FG000|Overall Study|Study Terminated By Sponsor|237|||
146843920|NCT04552899|529598459|FG001|Overall Study|Study Terminated By Sponsor|239|||
146843921|NCT04552899|529598458|FG000|Overall Study|Withdrawal by Subject|15|||
146997400|NCT01263704|530155447|FG000|Overall Study|Principal Investigator (PI) decision|1|||
146997401|NCT01061866|530155448|FG000|Overall Study|Adverse Event|2|||
146997402|NCT02255097|530155449|FG000|Overall Study|Death|151|||
146997403|NCT02255097|530155449|FG000|Overall Study|Lost to Follow-up|5|||
146997404|NCT02255097|530155449|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
146997405|NCT02255097|530155449|FG000|Overall Study|Withdrawal by Subject|7|||
146997406|NCT02255097|530155449|FG000|Overall Study|Allocated but not treated|1|||
146997407|NCT02514122|530155450|FG000|Overall Study|Withdrawal by Subject|2|||
146997408|NCT02514122|530155451|FG001|Overall Study|Withdrawal by Subject|0|||
146997409|NCT01675765|530155452|FG000|Overall Study|Progressive disease|4|||
146997410|NCT01675765|530155453|FG001|Overall Study|Progressive disease|4|||
146997411|NCT01675765|530155452|FG000|Overall Study|Adverse Event|1|||
146997412|NCT01675765|530155453|FG001|Overall Study|Adverse Event|2|||
146997413|NCT01675765|530155452|FG000|Overall Study|Withdrawal by Subject|2|||
146843922|NCT04552899|529598459|FG001|Overall Study|Withdrawal by Subject|17|||
146843923|NCT00731133|529598462|FG000|Overall Study|Withdrawal by Subject|10|||
146843924|NCT00702962|529598463|FG000|Overall Study|Progressive disease|0|||
146843925|NCT00702962|529598464|FG001|Overall Study|Progressive disease|1|||
146843926|NCT00702962|529598463|FG000|Overall Study|Hospitalized for other health disorder|1|||
146843927|NCT00702962|529598464|FG001|Overall Study|Hospitalized for other health disorder|0|||
146843928|NCT02175641|529598466|FG000|Overall Study|Death|3|||
146843929|NCT02175641|529598467|FG001|Overall Study|Death|4|||
146843930|NCT02175641|529598466|FG000|Overall Study|Lost to Follow-up|4|||
146843931|NCT02175641|529598467|FG001|Overall Study|Lost to Follow-up|4|||
146997414|NCT01675765|530155453|FG001|Overall Study|Withdrawal by Subject|0|||
146997415|NCT01675765|530155452|FG000|Overall Study|Death|1|||
146997416|NCT01675765|530155453|FG001|Overall Study|Death|0|||
146997417|NCT01675765|530155452|FG000|Overall Study|Clinical progression|3|||
146997418|NCT01675765|530155453|FG001|Overall Study|Clinical progression|2|||
146997419|NCT03965091|530155454|FG000|Overall Study|Adverse Event|0|||
146997420|NCT03965091|530155455|FG001|Overall Study|Adverse Event|2|||
146843932|NCT02175641|529598466|FG000|Overall Study|Withdrawal by Subject|7|||
146843933|NCT02175641|529598467|FG001|Overall Study|Withdrawal by Subject|4|||
146997421|NCT03965091|530155456|FG002|Overall Study|Adverse Event|3|||
146843934|NCT02175641|529598466|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
146843935|NCT02175641|529598467|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
146843936|NCT02175641|529598466|FG000|Overall Study|Developed Contraindicated Condition|8|||
146843937|NCT02175641|529598467|FG001|Overall Study|Developed Contraindicated Condition|0|||
146843938|NCT01725126|529598468|FG000|Overall Study|Protocol Violation|0|||
146843939|NCT01725126|529598469|FG001|Overall Study|Protocol Violation|1|||
146843940|NCT01725126|529598470|FG002|Overall Study|Protocol Violation|0|||
146843941|NCT01725126|529598471|FG003|Overall Study|Protocol Violation|0|||
146843942|NCT01725126|529598472|FG004|Overall Study|Protocol Violation|0|||
146843943|NCT01725126|529598473|FG005|Overall Study|Protocol Violation|0|||
146843944|NCT01725126|529598468|FG000|Overall Study|Withdrawal by Subject|0|||
146843945|NCT01725126|529598469|FG001|Overall Study|Withdrawal by Subject|0|||
146843946|NCT01725126|529598470|FG002|Overall Study|Withdrawal by Subject|0|||
146843947|NCT01725126|529598471|FG003|Overall Study|Withdrawal by Subject|1|||
146843948|NCT01725126|529598472|FG004|Overall Study|Withdrawal by Subject|0|||
146843949|NCT01725126|529598473|FG005|Overall Study|Withdrawal by Subject|0|||
146843950|NCT01923467|529598478|FG000|Overall Study|Lost to Follow-up|62|||
146843951|NCT01923467|529598478|FG000|Overall Study|Subject non-interest|479|||
146843952|NCT01240915|529598481|FG000|Overall Study|Adverse Event|0|||
146843953|NCT01240915|529598482|FG001|Overall Study|Adverse Event|0|||
146843954|NCT01240915|529598483|FG002|Overall Study|Adverse Event|0|||
146843955|NCT01240915|529598484|FG003|Overall Study|Adverse Event|1|||
146843956|NCT01240915|529598485|FG004|Overall Study|Adverse Event|0|||
146843957|NCT01240915|529598486|FG005|Overall Study|Adverse Event|2|||
146843958|NCT01240915|529598487|FG006|Overall Study|Adverse Event|0|||
146843959|NCT01240915|529598488|FG007|Overall Study|Adverse Event|0|||
146843960|NCT01240915|529598489|FG008|Overall Study|Adverse Event|1|||
146843961|NCT01240915|529598481|FG000|Overall Study|Lost to Follow-up|0|||
146843962|NCT01240915|529598482|FG001|Overall Study|Lost to Follow-up|0|||
146843963|NCT01240915|529598483|FG002|Overall Study|Lost to Follow-up|0|||
146843964|NCT01240915|529598484|FG003|Overall Study|Lost to Follow-up|0|||
146843965|NCT01240915|529598485|FG004|Overall Study|Lost to Follow-up|1|||
146843966|NCT01240915|529598486|FG005|Overall Study|Lost to Follow-up|1|||
146843967|NCT01240915|529598487|FG006|Overall Study|Lost to Follow-up|0|||
146843968|NCT01240915|529598488|FG007|Overall Study|Lost to Follow-up|1|||
146843969|NCT01240915|529598489|FG008|Overall Study|Lost to Follow-up|1|||
146843970|NCT01240915|529598481|FG000|Overall Study|Withdrawal by Subject|2|||
146843971|NCT01240915|529598482|FG001|Overall Study|Withdrawal by Subject|1|||
146843972|NCT01240915|529598483|FG002|Overall Study|Withdrawal by Subject|0|||
146843973|NCT01240915|529598484|FG003|Overall Study|Withdrawal by Subject|2|||
146843974|NCT01240915|529598485|FG004|Overall Study|Withdrawal by Subject|0|||
146843975|NCT01240915|529598486|FG005|Overall Study|Withdrawal by Subject|4|||
146843976|NCT01240915|529598487|FG006|Overall Study|Withdrawal by Subject|2|||
146843977|NCT01240915|529598488|FG007|Overall Study|Withdrawal by Subject|3|||
146843978|NCT01240915|529598489|FG008|Overall Study|Withdrawal by Subject|3|||
146843979|NCT01240915|529598481|FG000|Overall Study|Other|0|||
146843980|NCT01240915|529598482|FG001|Overall Study|Other|0|||
146843981|NCT01240915|529598483|FG002|Overall Study|Other|0|||
146843982|NCT01240915|529598484|FG003|Overall Study|Other|0|||
146843983|NCT01240915|529598485|FG004|Overall Study|Other|2|||
146843984|NCT01240915|529598486|FG005|Overall Study|Other|0|||
146997422|NCT03965091|530155454|FG000|Overall Study|Withdrawal by Subject|11|||
146997423|NCT03965091|530155455|FG001|Overall Study|Withdrawal by Subject|3|||
146997424|NCT03965091|530155456|FG002|Overall Study|Withdrawal by Subject|5|||
146843985|NCT01240915|529598487|FG006|Overall Study|Other|0|||
146843986|NCT01240915|529598488|FG007|Overall Study|Other|0|||
146997425|NCT03965091|530155454|FG000|Overall Study|Non-compliance with study drug|0|||
146843987|NCT01240915|529598489|FG008|Overall Study|Other|0|||
146843988|NCT01240915|529598481|FG000|Overall Study|Insufficient Clinical Response|0|||
146843989|NCT01240915|529598482|FG001|Overall Study|Insufficient Clinical Response|0|||
146843990|NCT01240915|529598483|FG002|Overall Study|Insufficient Clinical Response|0|||
146843991|NCT01240915|529598484|FG003|Overall Study|Insufficient Clinical Response|0|||
146843992|NCT01240915|529598485|FG004|Overall Study|Insufficient Clinical Response|1|||
146843993|NCT01240915|529598486|FG005|Overall Study|Insufficient Clinical Response|3|||
146843994|NCT01240915|529598487|FG006|Overall Study|Insufficient Clinical Response|6|||
146843995|NCT01240915|529598488|FG007|Overall Study|Insufficient Clinical Response|0|||
146843996|NCT01240915|529598489|FG008|Overall Study|Insufficient Clinical Response|3|||
146843997|NCT01598662|529598491|FG000|Overall Study|Lost to Follow-up|10|||
146843998|NCT01598662|529598492|FG001|Overall Study|Lost to Follow-up|17|||
146997426|NCT03965091|530155455|FG001|Overall Study|Non-compliance with study drug|0|||
146997427|NCT03965091|530155456|FG002|Overall Study|Non-compliance with study drug|1|||
146997428|NCT03965091|530155454|FG000|Overall Study|Lost to Follow-up|1|||
146997429|NCT03965091|530155455|FG001|Overall Study|Lost to Follow-up|1|||
146997430|NCT03965091|530155456|FG002|Overall Study|Lost to Follow-up|1|||
146997431|NCT03965091|530155454|FG000|Overall Study|Lack of Efficacy|2|||
146843999|NCT01598662|529598491|FG000|Overall Study|Physician Decision|1|||
146844000|NCT01598662|529598492|FG001|Overall Study|Physician Decision|2|||
146844001|NCT01598662|529598491|FG000|Overall Study|IUD expelled before month 6|0|||
146844002|NCT01598662|529598492|FG001|Overall Study|IUD expelled before month 6|2|||
146844003|NCT02574845|529598493|FG000|Overall Study|Consent withdrawn further participation|0|||
146844004|NCT02574845|529598494|FG001|Overall Study|Consent withdrawn further participation|0|||
146844005|NCT02574845|529598495|FG002|Overall Study|Consent withdrawn further participation|0|||
146844006|NCT02574845|529598496|FG003|Overall Study|Consent withdrawn further participation|0|||
146844007|NCT02574845|529598497|FG004|Overall Study|Consent withdrawn further participation|1|||
146844008|NCT02574845|529598498|FG005|Overall Study|Consent withdrawn further participation|0|||
146844009|NCT02574845|529598493|FG000|Overall Study|Adverse Event|0|||
146844010|NCT02574845|529598494|FG001|Overall Study|Adverse Event|1|||
146844011|NCT02574845|529598495|FG002|Overall Study|Adverse Event|0|||
146844012|NCT02574845|529598496|FG003|Overall Study|Adverse Event|0|||
146844013|NCT02574845|529598497|FG004|Overall Study|Adverse Event|0|||
146844014|NCT02574845|529598498|FG005|Overall Study|Adverse Event|1|||
146844015|NCT02781090|529598502|FG000|3-Month Follow-Up|Missed Visit|20|||
146844016|NCT02781090|529598503|FG001|3-Month Follow-Up|Missed Visit|20|||
146844017|NCT02781090|529598502|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
146844018|NCT02781090|529598503|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
146844019|NCT02781090|529598502|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
146844020|NCT02781090|529598503|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
146844021|NCT02781090|529598502|FG000|3-Month Follow-Up|Death|1|||
146844022|NCT02781090|529598503|FG001|3-Month Follow-Up|Death|0|||
146844023|NCT02781090|529598502|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
146844024|NCT02781090|529598503|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
146844025|NCT02781090|529598502|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
146844026|NCT02781090|529598503|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
146844027|NCT02781090|529598502|FG000|6-Month Follow-Up|Death|0|||
146844028|NCT02781090|529598503|FG001|6-Month Follow-Up|Death|1|||
146844029|NCT01867333|529598504|FG000|Overall Study|Withdrawal by Subject|1|||
146844030|NCT01867333|529598505|FG001|Overall Study|Withdrawal by Subject|0|||
146844031|NCT01867333|529598504|FG000|Overall Study|Adverse Event|1|||
146844032|NCT01867333|529598505|FG001|Overall Study|Adverse Event|0|||
146844033|NCT01867333|529598504|FG000|Overall Study|Participant choice|1|||
146844034|NCT01867333|529598505|FG001|Overall Study|Participant choice|2|||
146844035|NCT01867333|529598504|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
146844036|NCT01867333|529598505|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
146844037|NCT01867333|529598504|FG000|Overall Study|Death|0|||
146844038|NCT01867333|529598505|FG001|Overall Study|Death|1|||
146844039|NCT01867333|529598504|FG000|Overall Study|Physician Decision|3|||
146844040|NCT01867333|529598505|FG001|Overall Study|Physician Decision|2|||
146844041|NCT01867333|529598504|FG000|Overall Study|Switched to alternative treatment|1|||
146844042|NCT01867333|529598505|FG001|Overall Study|Switched to alternative treatment|0|||
146844043|NCT02683785|529598508|FG000|Overall Study|Withdrawal by Subject|1|||
146844044|NCT02683785|529598509|FG001|Overall Study|Withdrawal by Subject|1|||
146844045|NCT02683785|529598508|FG000|Overall Study|Lost to Follow-up|0|||
146844046|NCT02683785|529598509|FG001|Overall Study|Lost to Follow-up|1|||
146844047|NCT02683785|529598508|FG000|Overall Study|Adverse Event|0|||
146844048|NCT02683785|529598509|FG001|Overall Study|Adverse Event|2|||
146844049|NCT00368927|529598512|FG000|Overall Study|Lost to Follow-up|2|||
146844050|NCT00368927|529598513|FG001|Overall Study|Lost to Follow-up|0|||
146844051|NCT00368927|529598512|FG000|Overall Study|Adverse Event|1|||
146844052|NCT00368927|529598513|FG001|Overall Study|Adverse Event|1|||
146844053|NCT00368927|529598512|FG000|Overall Study|Withdrawal by Subject|1|||
146844054|NCT00368927|529598513|FG001|Overall Study|Withdrawal by Subject|2|||
146844055|NCT00368927|529598512|FG000|Overall Study|Physician Decision|1|||
146844056|NCT00368927|529598513|FG001|Overall Study|Physician Decision|0|||
146997432|NCT03965091|530155455|FG001|Overall Study|Lack of Efficacy|0|||
146844057|NCT04462289|529598514|FG000|Overall Study|Lost to Follow-up|4|||
146844058|NCT04462289|529598515|FG001|Overall Study|Lost to Follow-up|5|||
146844059|NCT04462289|529598514|FG000|Overall Study|Death|0|||
146844060|NCT04462289|529598515|FG001|Overall Study|Death|3|||
146844061|NCT04462289|529598514|FG000|Overall Study|Withdrawal by Subject|1|||
146844062|NCT04462289|529598515|FG001|Overall Study|Withdrawal by Subject|3|||
146844063|NCT03309813|529598516|FG000|Main Randomized Study|Withdrawal by Subject|1|||
146844064|NCT03309813|529598517|FG001|Main Randomized Study|Withdrawal by Subject|0|||
146844065|NCT04978493|529598518|FG000|Overall Study|No reason available|0|||
146844066|NCT04978493|529598519|FG001|Overall Study|No reason available|1|||
146844067|NCT04978493|529598518|FG000|Overall Study|Adverse Event|1|||
146844068|NCT04978493|529598519|FG001|Overall Study|Adverse Event|0|||
146844069|NCT01128114|529598520|FG000|Overall Study|Treatment Withdrawn|6|||
146844070|NCT01128114|529598520|FG000|Overall Study|Screening Failed|2|||
146844071|NCT02206061|529598521|FG000|Overall Study|Withdrawal by Subject|4|||
146844072|NCT02206061|529598522|FG001|Overall Study|Withdrawal by Subject|7|||
146844073|NCT02206061|529598523|FG002|Overall Study|Withdrawal by Subject|1|||
146844074|NCT02206061|529598521|FG000|Overall Study|Lost to Follow-up|14|||
146844075|NCT02206061|529598522|FG001|Overall Study|Lost to Follow-up|7|||
146844076|NCT02206061|529598523|FG002|Overall Study|Lost to Follow-up|20|||
146844077|NCT02738853|529598526|FG000|Enrollment|Inclusion/Exclusion not met|21|||
146844078|NCT02738853|529598526|FG000|Enrollment|Withdrawal by Subject|3|||
146844079|NCT02738853|529598526|FG000|Enrollment|Subject treated with commercially available device|6|||
146844080|NCT02738853|529598526|FG000|Enrollment|Study Enrollment Closed|3|||
146844081|NCT02738853|529598526|FG000|Procedure|Death|1|||
146844082|NCT02738853|529598526|FG000|1 Month|Death|2|||
146844083|NCT02738853|529598526|FG000|6 Month|Death|4|||
146844084|NCT02738853|529598526|FG000|6 Month|Withdrawal by Subject|2|||
146844085|NCT02738853|529598526|FG000|1 Year|Death|6|||
146844086|NCT02738853|529598526|FG000|1 Year|Withdrawal by Subject|1|||
146844087|NCT02738853|529598526|FG000|2 Year|Death|2|||
146844088|NCT02738853|529598526|FG000|2 Year|Lost to Follow-up|1|||
146844089|NCT02738853|529598526|FG000|3 Year|Death|2|||
146844090|NCT02738853|529598526|FG000|3 Year|Withdrawal by Subject|1|||
146844091|NCT02738853|529598526|FG000|4 Year|Death|9|||
146844092|NCT02738853|529598526|FG000|5 Year|Lost to Follow-up|4|||
146844093|NCT04157400|529598528|FG000|Overall Study|Withdrawal by Subject|1|||
146844094|NCT04157400|529598528|FG000|Overall Study|Lost to Follow-up|3|||
146844095|NCT01803282|529598530|FG000|Overall Study|Progressive Disease|4|||
146844096|NCT01803282|529598531|FG001|Overall Study|Progressive Disease|3|||
146844097|NCT01803282|529598532|FG002|Overall Study|Progressive Disease|6|||
146844098|NCT01803282|529598533|FG003|Overall Study|Progressive Disease|22|||
146844099|NCT01803282|529598534|FG004|Overall Study|Progressive Disease|5|||
146844100|NCT01803282|529598535|FG005|Overall Study|Progressive Disease|8|||
146844101|NCT01803282|529598536|FG006|Overall Study|Progressive Disease|23|||
146844102|NCT01803282|529598537|FG007|Overall Study|Progressive Disease|24|||
146844103|NCT01803282|529598538|FG008|Overall Study|Progressive Disease|3|||
146844104|NCT01803282|529598539|FG009|Overall Study|Progressive Disease|29|||
146844105|NCT01803282|529598540|FG010|Overall Study|Progressive Disease|6|||
146844106|NCT01803282|529598541|FG011|Overall Study|Progressive Disease|11|||
146844107|NCT01803282|529598530|FG000|Overall Study|Death|0|||
146844108|NCT01803282|529598531|FG001|Overall Study|Death|0|||
146844109|NCT01803282|529598532|FG002|Overall Study|Death|0|||
146844110|NCT01803282|529598533|FG003|Overall Study|Death|0|||
146844111|NCT01803282|529598534|FG004|Overall Study|Death|2|||
146844112|NCT01803282|529598535|FG005|Overall Study|Death|1|||
146844113|NCT01803282|529598536|FG006|Overall Study|Death|1|||
146844114|NCT01803282|529598537|FG007|Overall Study|Death|5|||
146844115|NCT01803282|529598538|FG008|Overall Study|Death|1|||
146844116|NCT01803282|529598539|FG009|Overall Study|Death|1|||
146844117|NCT01803282|529598540|FG010|Overall Study|Death|0|||
146844118|NCT01803282|529598541|FG011|Overall Study|Death|0|||
146844119|NCT01803282|529598530|FG000|Overall Study|Withdrew Consent|0|||
146844120|NCT01803282|529598531|FG001|Overall Study|Withdrew Consent|0|||
146844121|NCT01803282|529598532|FG002|Overall Study|Withdrew Consent|0|||
146844122|NCT01803282|529598533|FG003|Overall Study|Withdrew Consent|6|||
146844123|NCT01803282|529598534|FG004|Overall Study|Withdrew Consent|1|||
146844124|NCT01803282|529598535|FG005|Overall Study|Withdrew Consent|0|||
146844125|NCT01803282|529598536|FG006|Overall Study|Withdrew Consent|8|||
146844126|NCT01803282|529598537|FG007|Overall Study|Withdrew Consent|3|||
146844127|NCT01803282|529598538|FG008|Overall Study|Withdrew Consent|1|||
146844128|NCT01803282|529598539|FG009|Overall Study|Withdrew Consent|5|||
146844129|NCT01803282|529598540|FG010|Overall Study|Withdrew Consent|0|||
146844130|NCT01803282|529598541|FG011|Overall Study|Withdrew Consent|1|||
146844131|NCT01803282|529598530|FG000|Overall Study|Investigator's Discretion|0|||
146844132|NCT01803282|529598531|FG001|Overall Study|Investigator's Discretion|0|||
146844133|NCT01803282|529598532|FG002|Overall Study|Investigator's Discretion|0|||
146844134|NCT01803282|529598533|FG003|Overall Study|Investigator's Discretion|7|||
146844135|NCT01803282|529598534|FG004|Overall Study|Investigator's Discretion|2|||
146844136|NCT01803282|529598535|FG005|Overall Study|Investigator's Discretion|1|||
146844137|NCT01803282|529598536|FG006|Overall Study|Investigator's Discretion|7|||
146844138|NCT01803282|529598537|FG007|Overall Study|Investigator's Discretion|10|||
146997433|NCT03965091|530155456|FG002|Overall Study|Lack of Efficacy|0|||
146997434|NCT03965091|530155454|FG000|Overall Study|Other than specified|9|||
146997435|NCT03965091|530155455|FG001|Overall Study|Other than specified|11|||
146997436|NCT03965091|530155456|FG002|Overall Study|Other than specified|8|||
146997437|NCT01534520|530155459|FG000|Overall Study|Adverse Event|0|||
146997438|NCT01534520|530155460|FG001|Overall Study|Adverse Event|1|||
146997439|NCT01417078|530155461|FG000|Overall Study|Withdrawal by Subject|1|||
146997440|NCT01059903|530155463|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
146997441|NCT01059903|530155464|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
146997442|NCT03725605|530155465|FG000|Overall Study|Unsuccessful TIL expansion|2|||
146997443|NCT03555305|530155466|FG000|Period 1|Physician Decision|0|||
146997444|NCT03555305|530155467|FG001|Period 1|Physician Decision|1|||
146997445|NCT03555305|530155466|FG000|Period 1|Adverse Event|0|||
146844139|NCT01803282|529598538|FG008|Overall Study|Investigator's Discretion|6|||
146844140|NCT01803282|529598539|FG009|Overall Study|Investigator's Discretion|7|||
146844141|NCT01803282|529598540|FG010|Overall Study|Investigator's Discretion|1|||
146844142|NCT01803282|529598541|FG011|Overall Study|Investigator's Discretion|0|||
146844143|NCT01803282|529598530|FG000|Overall Study|Adverse Event|0|||
146997446|NCT03555305|530155467|FG001|Period 1|Adverse Event|1|||
146997447|NCT03135834|530155473|FG000|Stage 1|Adverse Event|1|||
146997448|NCT03135834|530155474|FG001|Stage 1|Adverse Event|2|||
146997449|NCT03135834|530155475|FG002|Stage 1|Adverse Event|2|||
146844144|NCT01803282|529598531|FG001|Overall Study|Adverse Event|0|||
146844145|NCT01803282|529598532|FG002|Overall Study|Adverse Event|0|||
146844146|NCT01803282|529598533|FG003|Overall Study|Adverse Event|0|||
146844147|NCT01803282|529598534|FG004|Overall Study|Adverse Event|0|||
146844148|NCT01803282|529598535|FG005|Overall Study|Adverse Event|0|||
146844149|NCT01803282|529598536|FG006|Overall Study|Adverse Event|1|||
146844150|NCT01803282|529598537|FG007|Overall Study|Adverse Event|2|||
146844151|NCT01803282|529598538|FG008|Overall Study|Adverse Event|0|||
146844152|NCT01803282|529598539|FG009|Overall Study|Adverse Event|1|||
146844153|NCT01803282|529598540|FG010|Overall Study|Adverse Event|0|||
146844154|NCT01803282|529598541|FG011|Overall Study|Adverse Event|3|||
146844155|NCT01803282|529598530|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146844156|NCT01803282|529598531|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146844157|NCT01803282|529598532|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146844158|NCT01803282|529598533|FG003|Overall Study|Non-Compliance with Study Drug|1|||
146844159|NCT01803282|529598534|FG004|Overall Study|Non-Compliance with Study Drug|0|||
146844160|NCT01803282|529598535|FG005|Overall Study|Non-Compliance with Study Drug|0|||
146844161|NCT01803282|529598536|FG006|Overall Study|Non-Compliance with Study Drug|0|||
146844162|NCT01803282|529598537|FG007|Overall Study|Non-Compliance with Study Drug|0|||
146844163|NCT01803282|529598538|FG008|Overall Study|Non-Compliance with Study Drug|0|||
146844164|NCT01803282|529598539|FG009|Overall Study|Non-Compliance with Study Drug|0|||
146844165|NCT01803282|529598540|FG010|Overall Study|Non-Compliance with Study Drug|0|||
146844166|NCT01803282|529598541|FG011|Overall Study|Non-Compliance with Study Drug|0|||
146844167|NCT01803282|529598530|FG000|Overall Study|Unknown Reason|0|||
146844168|NCT01803282|529598531|FG001|Overall Study|Unknown Reason|0|||
146844169|NCT01803282|529598532|FG002|Overall Study|Unknown Reason|0|||
146844170|NCT01803282|529598533|FG003|Overall Study|Unknown Reason|0|||
146844171|NCT01803282|529598534|FG004|Overall Study|Unknown Reason|0|||
146844172|NCT01803282|529598535|FG005|Overall Study|Unknown Reason|0|||
146844173|NCT01803282|529598536|FG006|Overall Study|Unknown Reason|0|||
146844174|NCT01803282|529598537|FG007|Overall Study|Unknown Reason|1|||
146844175|NCT01803282|529598538|FG008|Overall Study|Unknown Reason|0|||
146844176|NCT01803282|529598539|FG009|Overall Study|Unknown Reason|0|||
146844177|NCT01803282|529598540|FG010|Overall Study|Unknown Reason|0|||
146844178|NCT01803282|529598541|FG011|Overall Study|Unknown Reason|0|||
146844179|NCT01803282|529598530|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
146844180|NCT01803282|529598531|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
146844181|NCT01803282|529598532|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
146844182|NCT01803282|529598533|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
146844183|NCT01803282|529598534|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
146844184|NCT01803282|529598535|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
146844185|NCT01803282|529598536|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
146844186|NCT01803282|529598537|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
146997450|NCT03135834|530155476|FG003|Stage 1|Adverse Event|1|||
146997451|NCT03135834|530155473|FG000|Stage 1|Death|1|||
146997452|NCT03135834|530155474|FG001|Stage 1|Death|0|||
146997453|NCT03135834|530155475|FG002|Stage 1|Death|0|||
146997454|NCT03135834|530155476|FG003|Stage 1|Death|0|||
146997455|NCT03135834|530155473|FG000|Stage 1|Lost to Follow-up|17|||
146997456|NCT03135834|530155474|FG001|Stage 1|Lost to Follow-up|24|||
146997457|NCT03135834|530155475|FG002|Stage 1|Lost to Follow-up|21|||
146997458|NCT03135834|530155476|FG003|Stage 1|Lost to Follow-up|38|||
146997459|NCT03135834|530155473|FG000|Stage 1|No longer met eligibility criteria|1|||
146997460|NCT03135834|530155474|FG001|Stage 1|No longer met eligibility criteria|6|||
146997461|NCT03135834|530155475|FG002|Stage 1|No longer met eligibility criteria|2|||
146997462|NCT03135834|530155476|FG003|Stage 1|No longer met eligibility criteria|5|||
146997463|NCT03135834|530155473|FG000|Stage 1|Other|0|||
146997464|NCT03135834|530155474|FG001|Stage 1|Other|2|||
146997465|NCT03135834|530155475|FG002|Stage 1|Other|1|||
146997466|NCT03135834|530155476|FG003|Stage 1|Other|0|||
146997467|NCT03135834|530155473|FG000|Stage 1|Physician Decision|0|||
146997468|NCT03135834|530155474|FG001|Stage 1|Physician Decision|1|||
146997469|NCT03135834|530155475|FG002|Stage 1|Physician Decision|0|||
146997470|NCT03135834|530155476|FG003|Stage 1|Physician Decision|0|||
146997471|NCT03135834|530155473|FG000|Stage 1|Pregnancy|0|||
146997472|NCT03135834|530155474|FG001|Stage 1|Pregnancy|4|||
146997473|NCT03135834|530155475|FG002|Stage 1|Pregnancy|2|||
146997474|NCT03135834|530155476|FG003|Stage 1|Pregnancy|4|||
146997475|NCT03135834|530155473|FG000|Stage 1|Protocol Violation|1|||
146844187|NCT01803282|529598538|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
146844188|NCT01803282|529598539|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
146844189|NCT01803282|529598540|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
146844190|NCT01803282|529598541|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
146844191|NCT01803282|529598530|FG000|Overall Study|Enrolled but Never Treated|0|||
146997476|NCT03135834|530155474|FG001|Stage 1|Protocol Violation|1|||
146997477|NCT03135834|530155475|FG002|Stage 1|Protocol Violation|2|||
146844192|NCT01803282|529598531|FG001|Overall Study|Enrolled but Never Treated|0|||
146997478|NCT03135834|530155476|FG003|Stage 1|Protocol Violation|1|||
146997479|NCT03135834|530155473|FG000|Stage 1|Withdrawal by parent/guardian|2|||
146844193|NCT01803282|529598532|FG002|Overall Study|Enrolled but Never Treated|0|||
146844194|NCT01803282|529598533|FG003|Overall Study|Enrolled but Never Treated|0|||
146844195|NCT01803282|529598534|FG004|Overall Study|Enrolled but Never Treated|1|||
146844196|NCT01803282|529598535|FG005|Overall Study|Enrolled but Never Treated|0|||
146844197|NCT01803282|529598536|FG006|Overall Study|Enrolled but Never Treated|1|||
146844198|NCT01803282|529598537|FG007|Overall Study|Enrolled but Never Treated|1|||
146844199|NCT01803282|529598538|FG008|Overall Study|Enrolled but Never Treated|0|||
146844200|NCT01803282|529598539|FG009|Overall Study|Enrolled but Never Treated|1|||
146844201|NCT01803282|529598540|FG010|Overall Study|Enrolled but Never Treated|0|||
146844202|NCT01803282|529598541|FG011|Overall Study|Enrolled but Never Treated|0|||
146844203|NCT02671500|529598542|FG000|Overall Study|Lack of Efficacy|12|||
146844204|NCT02671500|529598542|FG000|Overall Study|Lost to Follow-up|2|||
146844205|NCT01217437|529598543|FG000|Overall Study|Adverse Event|0|||
146844206|NCT01217437|529598544|FG001|Overall Study|Adverse Event|8|||
146844207|NCT01217437|529598543|FG000|Overall Study|Death|5|||
146844208|NCT01217437|529598544|FG001|Overall Study|Death|0|||
146844209|NCT01217437|529598543|FG000|Overall Study|Lack of Efficacy|29|||
146844210|NCT01217437|529598544|FG001|Overall Study|Lack of Efficacy|25|||
146844211|NCT01217437|529598543|FG000|Overall Study|Physician Decision|8|||
146844212|NCT01217437|529598544|FG001|Overall Study|Physician Decision|5|||
146844213|NCT01217437|529598543|FG000|Overall Study|Withdrawal by Subject|0|||
146844214|NCT01217437|529598544|FG001|Overall Study|Withdrawal by Subject|2|||
146844215|NCT01217437|529598543|FG000|Overall Study|Ineligible|1|||
146844216|NCT01217437|529598544|FG001|Overall Study|Ineligible|1|||
146844217|NCT04531982|529598547|FG000|Overall Study|Withdrawal by Subject|10|||
146844218|NCT04531982|529598548|FG001|Overall Study|Withdrawal by Subject|11|||
146844219|NCT04531982|529598547|FG000|Overall Study|Adverse Event|6|||
146844220|NCT04531982|529598548|FG001|Overall Study|Adverse Event|14|||
146844221|NCT04531982|529598547|FG000|Overall Study|Protocol Violation|6|||
146844222|NCT04531982|529598548|FG001|Overall Study|Protocol Violation|9|||
146844223|NCT04531982|529598547|FG000|Overall Study|Non-compliance with study drug|3|||
146844224|NCT04531982|529598548|FG001|Overall Study|Non-compliance with study drug|2|||
146844225|NCT04531982|529598547|FG000|Overall Study|Use of prohibited medication|2|||
146844226|NCT04531982|529598548|FG001|Overall Study|Use of prohibited medication|0|||
146844227|NCT04531982|529598547|FG000|Overall Study|Lost to Follow-up|0|||
146844228|NCT04531982|529598548|FG001|Overall Study|Lost to Follow-up|1|||
146844229|NCT04531982|529598547|FG000|Overall Study|Geopolitical conflict|2|||
146844230|NCT04531982|529598548|FG001|Overall Study|Geopolitical conflict|0|||
146844231|NCT04531982|529598547|FG000|Overall Study|Lack of Efficacy|3|||
146844232|NCT04531982|529598548|FG001|Overall Study|Lack of Efficacy|1|||
146844233|NCT06655558|529598549|FG000|Overall Study|Protocol Violation|1|||
146844234|NCT00890695|529600785|FG000|Overall Study|Protocol Violation|1|||
146844235|NCT00890695|529600786|FG001|Overall Study|Protocol Violation|0|||
146844236|NCT00833261|529600795|FG000|Overall Study|Withdrawal by Subject|4|||
146844237|NCT03439254|529600796|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
146844238|NCT03439254|529600797|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
146844239|NCT03439254|529600798|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
146844240|NCT03439254|529600799|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
146844241|NCT03439254|529600800|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
146844242|NCT03439254|529600801|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
146844243|NCT03439254|529600796|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
146844244|NCT03439254|529600797|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
146844245|NCT03439254|529600798|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
146844246|NCT03439254|529600799|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
146844247|NCT03439254|529600800|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
146844248|NCT03439254|529600801|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
146844249|NCT03439254|529600796|FG000|Double-blind Phase (18 Months)|Death|1|||
146844250|NCT03439254|529600797|FG001|Double-blind Phase (18 Months)|Death|2|||
146844251|NCT03439254|529600798|FG002|Double-blind Phase (18 Months)|Death|2|||
146997480|NCT03135834|530155474|FG001|Stage 1|Withdrawal by parent/guardian|10|||
146997481|NCT03135834|530155475|FG002|Stage 1|Withdrawal by parent/guardian|2|||
146997482|NCT03135834|530155476|FG003|Stage 1|Withdrawal by parent/guardian|1|||
146997483|NCT03135834|530155473|FG000|Stage 1|Withdrawal by Subject|16|||
146997484|NCT03135834|530155474|FG001|Stage 1|Withdrawal by Subject|22|||
146844252|NCT03439254|529600799|FG003|Double-blind Phase (18 Months)|Death|0|||
146844253|NCT03439254|529600800|FG004|Double-blind Phase (18 Months)|Death|0|||
146844254|NCT03439254|529600801|FG005|Double-blind Phase (18 Months)|Death|0|||
146844255|NCT03439254|529600796|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
146844256|NCT03439254|529600797|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
146997485|NCT03135834|530155475|FG002|Stage 1|Withdrawal by Subject|7|||
146844257|NCT03439254|529600798|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
146844258|NCT03439254|529600799|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
146844259|NCT03439254|529600800|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
146844260|NCT03439254|529600801|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
146844261|NCT03439254|529600796|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
146844262|NCT03439254|529600797|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
146844263|NCT03439254|529600798|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
146844264|NCT03439254|529600799|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
146844265|NCT03439254|529600800|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
146844266|NCT03439254|529600801|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
146844267|NCT03439254|529600796|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
146844268|NCT03439254|529600797|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
146844269|NCT03439254|529600798|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
146844270|NCT03439254|529600799|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
146844271|NCT03439254|529600800|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
146844272|NCT03439254|529600801|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
146844273|NCT03439254|529600796|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
146844274|NCT03439254|529600797|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
146844275|NCT03439254|529600798|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
146844276|NCT03439254|529600799|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
146844277|NCT03439254|529600800|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
146844278|NCT03439254|529600801|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
146844279|NCT03439254|529600796|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
146844280|NCT03439254|529600797|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
146844281|NCT03439254|529600798|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
146844282|NCT03439254|529600799|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
146844283|NCT03439254|529600800|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
146844284|NCT03439254|529600801|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
146844285|NCT03439254|529600796|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
146844286|NCT03439254|529600797|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
146844287|NCT03439254|529600798|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
146844288|NCT03439254|529600799|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
146844289|NCT03439254|529600800|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
146844290|NCT03439254|529600801|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
146844291|NCT03439254|529600796|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
146844292|NCT03439254|529600797|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
146844293|NCT03439254|529600798|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
146844294|NCT03439254|529600799|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
146844295|NCT03439254|529600800|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
146844296|NCT03439254|529600801|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
146844297|NCT03439254|529600796|FG000|Double-blind Phase (18 Months)|Site closure|0|||
146844298|NCT03439254|529600797|FG001|Double-blind Phase (18 Months)|Site closure|0|||
146844299|NCT03439254|529600798|FG002|Double-blind Phase (18 Months)|Site closure|1|||
146844300|NCT03439254|529600799|FG003|Double-blind Phase (18 Months)|Site closure|0|||
146844301|NCT03439254|529600800|FG004|Double-blind Phase (18 Months)|Site closure|0|||
146844302|NCT03439254|529600801|FG005|Double-blind Phase (18 Months)|Site closure|0|||
146844303|NCT03439254|529600796|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
146844304|NCT03439254|529600797|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
146844305|NCT03439254|529600798|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
146844306|NCT03439254|529600799|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
146844307|NCT03439254|529600800|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
146844308|NCT03439254|529600801|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
146844309|NCT03439254|529600796|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
146844310|NCT03439254|529600797|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
146844311|NCT03439254|529600798|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
146844312|NCT03439254|529600799|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
146997486|NCT03135834|530155476|FG003|Stage 1|Withdrawal by Subject|10|||
146997487|NCT03135834|530155473|FG000|Stage 1|Randomized but not Vaccinated|0|||
146997488|NCT03135834|530155474|FG001|Stage 1|Randomized but not Vaccinated|3|||
146997489|NCT03135834|530155475|FG002|Stage 1|Randomized but not Vaccinated|1|||
146997490|NCT03135834|530155476|FG003|Stage 1|Randomized but not Vaccinated|6|||
146997491|NCT03135834|530155473|FG000|Stage 2|Lost to Follow-up|0|||
146997492|NCT03135834|530155474|FG001|Stage 2|Lost to Follow-up|1|||
146997493|NCT03135834|530155475|FG002|Stage 2|Lost to Follow-up|0|||
146997494|NCT03135834|530155476|FG003|Stage 2|Lost to Follow-up|0|||
146997495|NCT03135834|530155473|FG000|Stage 2|Withdrawal by Subject|0|||
146844313|NCT03439254|529600800|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
146844314|NCT03439254|529600801|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
146844315|NCT03439254|529600796|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
146844316|NCT03439254|529600797|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
146844317|NCT03439254|529600798|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
146844318|NCT03439254|529600799|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
146844319|NCT03439254|529600800|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
146844320|NCT03439254|529600801|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
146844321|NCT03439254|529600796|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
146844322|NCT03439254|529600797|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
146844323|NCT03439254|529600798|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
146844324|NCT03439254|529600799|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
146844325|NCT03439254|529600800|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
146844326|NCT03439254|529600801|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
146844327|NCT03439254|529600796|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
146844328|NCT03439254|529600797|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
146844329|NCT03439254|529600798|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
146844330|NCT03439254|529600799|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
146844331|NCT03439254|529600800|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
146844332|NCT03439254|529600801|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
146844333|NCT03439254|529600796|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
146844334|NCT03439254|529600797|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
146844335|NCT03439254|529600798|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
146844336|NCT03439254|529600799|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
146844337|NCT03439254|529600800|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
146844338|NCT03439254|529600801|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
146844339|NCT03439254|529600796|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
146844340|NCT03439254|529600797|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
146844341|NCT03439254|529600798|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
146844342|NCT03439254|529600799|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
146844343|NCT03439254|529600800|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
146844344|NCT03439254|529600801|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
146844345|NCT03439254|529600796|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
146844346|NCT03439254|529600797|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
146844347|NCT03439254|529600798|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
146844348|NCT03439254|529600799|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
146844349|NCT03439254|529600800|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
146844350|NCT03439254|529600801|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
146844351|NCT03439254|529600796|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
146844352|NCT03439254|529600797|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
146844353|NCT03439254|529600798|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
146844354|NCT03439254|529600799|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
146844355|NCT03439254|529600800|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
146844356|NCT03439254|529600801|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
146844357|NCT03439254|529600796|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
146844358|NCT03439254|529600797|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
146844359|NCT03439254|529600798|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
146844360|NCT03439254|529600799|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
146844361|NCT03439254|529600800|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
146844362|NCT03439254|529600801|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
146844363|NCT03439254|529600796|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
146844364|NCT03439254|529600797|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
146844365|NCT03439254|529600798|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
146844366|NCT03439254|529600799|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
146844367|NCT03439254|529600800|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
146997496|NCT03135834|530155474|FG001|Stage 2|Withdrawal by Subject|1|||
146997497|NCT03135834|530155475|FG002|Stage 2|Withdrawal by Subject|0|||
146997498|NCT03135834|530155476|FG003|Stage 2|Withdrawal by Subject|0|||
146997499|NCT03135834|530155473|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
146997500|NCT03135834|530155474|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
146997501|NCT03135834|530155475|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
146997502|NCT03135834|530155476|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
146997503|NCT03135834|530155473|FG000|Stage 2|Did not receive Booster Vaccination|1|||
146997504|NCT03135834|530155474|FG001|Stage 2|Did not receive Booster Vaccination|1|||
146997505|NCT03135834|530155475|FG002|Stage 2|Did not receive Booster Vaccination|0|||
146844368|NCT03439254|529600801|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
146844369|NCT03439254|529600796|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
146844370|NCT03439254|529600797|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
146844371|NCT03439254|529600798|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
146844372|NCT03439254|529600799|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
146844373|NCT03439254|529600800|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
146844374|NCT03439254|529600801|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
146844375|NCT00568178|529600802|FG000|Double Blind Base Study|Adverse Event|0|||
146844376|NCT00568178|529600803|FG001|Double Blind Base Study|Adverse Event|2|||
146844377|NCT00568178|529600804|FG002|Double Blind Base Study|Adverse Event|1|||
146844378|NCT00568178|529600805|FG003|Double Blind Base Study|Adverse Event|2|||
146844379|NCT00568178|529600806|FG004|Double Blind Base Study|Adverse Event|0|||
146844380|NCT00568178|529600807|FG005|Double Blind Base Study|Adverse Event|0|||
146844381|NCT00568178|529600802|FG000|Double Blind Base Study|Lost to Follow-up|1|||
146844382|NCT00568178|529600803|FG001|Double Blind Base Study|Lost to Follow-up|0|||
146844383|NCT00568178|529600804|FG002|Double Blind Base Study|Lost to Follow-up|0|||
146844384|NCT00568178|529600805|FG003|Double Blind Base Study|Lost to Follow-up|1|||
146844385|NCT00568178|529600806|FG004|Double Blind Base Study|Lost to Follow-up|0|||
146844386|NCT00568178|529600807|FG005|Double Blind Base Study|Lost to Follow-up|0|||
146844387|NCT00568178|529600802|FG000|Double Blind Base Study|Physician Decision|1|||
146844388|NCT00568178|529600803|FG001|Double Blind Base Study|Physician Decision|1|||
146844389|NCT00568178|529600804|FG002|Double Blind Base Study|Physician Decision|0|||
146844390|NCT00568178|529600805|FG003|Double Blind Base Study|Physician Decision|1|||
146844391|NCT00568178|529600806|FG004|Double Blind Base Study|Physician Decision|0|||
146844392|NCT00568178|529600807|FG005|Double Blind Base Study|Physician Decision|0|||
146844393|NCT00568178|529600802|FG000|Double Blind Base Study|Protocol Violation|3|||
146844394|NCT00568178|529600803|FG001|Double Blind Base Study|Protocol Violation|2|||
146844395|NCT00568178|529600804|FG002|Double Blind Base Study|Protocol Violation|0|||
146844396|NCT00568178|529600805|FG003|Double Blind Base Study|Protocol Violation|0|||
146844397|NCT00568178|529600806|FG004|Double Blind Base Study|Protocol Violation|0|||
146844398|NCT00568178|529600807|FG005|Double Blind Base Study|Protocol Violation|0|||
146844399|NCT00568178|529600802|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
146844400|NCT00568178|529600803|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
146844401|NCT00568178|529600804|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
146844402|NCT00568178|529600805|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
146844403|NCT00568178|529600806|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
146844404|NCT00568178|529600807|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
146844405|NCT00568178|529600802|FG000|Double Blind Base Study|Progressive Disease|0|||
146844406|NCT00568178|529600803|FG001|Double Blind Base Study|Progressive Disease|0|||
146844407|NCT00568178|529600804|FG002|Double Blind Base Study|Progressive Disease|0|||
146844408|NCT00568178|529600805|FG003|Double Blind Base Study|Progressive Disease|1|||
146844409|NCT00568178|529600806|FG004|Double Blind Base Study|Progressive Disease|0|||
146844410|NCT00568178|529600807|FG005|Double Blind Base Study|Progressive Disease|0|||
146844411|NCT00568178|529600802|FG000|Open Label Extension|Adverse Event|0|||
146844412|NCT00568178|529600803|FG001|Open Label Extension|Adverse Event|0|||
146844413|NCT00568178|529600804|FG002|Open Label Extension|Adverse Event|0|||
146844414|NCT00568178|529600805|FG003|Open Label Extension|Adverse Event|0|||
146844415|NCT00568178|529600806|FG004|Open Label Extension|Adverse Event|11|||
146844416|NCT00568178|529600807|FG005|Open Label Extension|Adverse Event|8|||
146844417|NCT00568178|529600802|FG000|Open Label Extension|Protocol Violation|0|||
146844418|NCT00568178|529600803|FG001|Open Label Extension|Protocol Violation|0|||
146844419|NCT00568178|529600804|FG002|Open Label Extension|Protocol Violation|0|||
146844420|NCT00568178|529600805|FG003|Open Label Extension|Protocol Violation|0|||
146844421|NCT00568178|529600806|FG004|Open Label Extension|Protocol Violation|1|||
146844422|NCT00568178|529600807|FG005|Open Label Extension|Protocol Violation|0|||
146844423|NCT00568178|529600802|FG000|Open Label Extension|Lost to Follow-up|0|||
146844424|NCT00568178|529600803|FG001|Open Label Extension|Lost to Follow-up|0|||
146844425|NCT00568178|529600804|FG002|Open Label Extension|Lost to Follow-up|0|||
146844426|NCT00568178|529600805|FG003|Open Label Extension|Lost to Follow-up|0|||
146844427|NCT00568178|529600806|FG004|Open Label Extension|Lost to Follow-up|6|||
146844428|NCT00568178|529600807|FG005|Open Label Extension|Lost to Follow-up|11|||
146844429|NCT00568178|529600802|FG000|Open Label Extension|Physician Decision|0|||
146844430|NCT00568178|529600803|FG001|Open Label Extension|Physician Decision|0|||
146844431|NCT00568178|529600804|FG002|Open Label Extension|Physician Decision|0|||
146844432|NCT00568178|529600805|FG003|Open Label Extension|Physician Decision|0|||
146844433|NCT00568178|529600806|FG004|Open Label Extension|Physician Decision|9|||
146844434|NCT00568178|529600807|FG005|Open Label Extension|Physician Decision|8|||
146844435|NCT00568178|529600802|FG000|Open Label Extension|Pregnancy|0|||
146844436|NCT00568178|529600803|FG001|Open Label Extension|Pregnancy|0|||
146844437|NCT00568178|529600804|FG002|Open Label Extension|Pregnancy|0|||
146844438|NCT00568178|529600805|FG003|Open Label Extension|Pregnancy|0|||
146844439|NCT00568178|529600806|FG004|Open Label Extension|Pregnancy|0|||
146844440|NCT00568178|529600807|FG005|Open Label Extension|Pregnancy|1|||
146844441|NCT00568178|529600802|FG000|Open Label Extension|Progressive Disease|0|||
146844442|NCT00568178|529600803|FG001|Open Label Extension|Progressive Disease|0|||
146844443|NCT00568178|529600804|FG002|Open Label Extension|Progressive Disease|0|||
146844444|NCT00568178|529600805|FG003|Open Label Extension|Progressive Disease|0|||
146844445|NCT00568178|529600806|FG004|Open Label Extension|Progressive Disease|3|||
146844446|NCT00568178|529600807|FG005|Open Label Extension|Progressive Disease|1|||
146844447|NCT00568178|529600802|FG000|Open Label Extension|Termination of Trial|0|||
146844448|NCT00568178|529600803|FG001|Open Label Extension|Termination of Trial|0|||
146844449|NCT00568178|529600804|FG002|Open Label Extension|Termination of Trial|0|||
146844450|NCT00568178|529600805|FG003|Open Label Extension|Termination of Trial|0|||
146844451|NCT00568178|529600806|FG004|Open Label Extension|Termination of Trial|45|||
146844452|NCT00568178|529600807|FG005|Open Label Extension|Termination of Trial|47|||
146844453|NCT00568178|529600802|FG000|Open Label Extension|Withdrawal by Subject|0|||
146844454|NCT00568178|529600803|FG001|Open Label Extension|Withdrawal by Subject|0|||
146844455|NCT00568178|529600804|FG002|Open Label Extension|Withdrawal by Subject|0|||
146844456|NCT00568178|529600805|FG003|Open Label Extension|Withdrawal by Subject|0|||
146844457|NCT00568178|529600806|FG004|Open Label Extension|Withdrawal by Subject|4|||
146844458|NCT00568178|529600807|FG005|Open Label Extension|Withdrawal by Subject|4|||
146844459|NCT01531673|529600808|FG000|Overall Study|Non-Compliance|0|||
146844460|NCT01531673|529600809|FG001|Overall Study|Non-Compliance|0|||
146844461|NCT01531673|529600810|FG002|Overall Study|Non-Compliance|0|||
146844462|NCT01531673|529600811|FG003|Overall Study|Non-Compliance|0|||
146844463|NCT01531673|529600812|FG004|Overall Study|Non-Compliance|0|||
146844464|NCT01531673|529600813|FG005|Overall Study|Non-Compliance|1|||
146844465|NCT01531673|529600814|FG006|Overall Study|Non-Compliance|0|||
146844466|NCT01531673|529600815|FG007|Overall Study|Non-Compliance|0|||
146844467|NCT01531673|529600816|FG008|Overall Study|Non-Compliance|0|||
146844468|NCT01531673|529600817|FG009|Overall Study|Non-Compliance|0|||
146844469|NCT01531673|529600818|FG010|Overall Study|Non-Compliance|0|||
146844470|NCT01531673|529600819|FG011|Overall Study|Non-Compliance|0|||
146844471|NCT01531673|529600820|FG012|Overall Study|Non-Compliance|0|||
146844472|NCT01531673|529600808|FG000|Overall Study|Adverse Event|0|||
146844473|NCT01531673|529600809|FG001|Overall Study|Adverse Event|1|||
146844474|NCT01531673|529600810|FG002|Overall Study|Adverse Event|0|||
146844475|NCT01531673|529600811|FG003|Overall Study|Adverse Event|0|||
146844476|NCT01531673|529600812|FG004|Overall Study|Adverse Event|0|||
146844477|NCT01531673|529600813|FG005|Overall Study|Adverse Event|0|||
146844478|NCT01531673|529600814|FG006|Overall Study|Adverse Event|0|||
146844479|NCT01531673|529600815|FG007|Overall Study|Adverse Event|0|||
146844480|NCT01531673|529600816|FG008|Overall Study|Adverse Event|0|||
146844481|NCT01531673|529600817|FG009|Overall Study|Adverse Event|0|||
146844482|NCT01531673|529600818|FG010|Overall Study|Adverse Event|0|||
146844483|NCT01531673|529600819|FG011|Overall Study|Adverse Event|0|||
146844484|NCT01531673|529600820|FG012|Overall Study|Adverse Event|0|||
146844485|NCT01531673|529600808|FG000|Overall Study|Lost to Follow-up|0|||
146844486|NCT01531673|529600809|FG001|Overall Study|Lost to Follow-up|0|||
146844487|NCT01531673|529600810|FG002|Overall Study|Lost to Follow-up|0|||
146844488|NCT01531673|529600811|FG003|Overall Study|Lost to Follow-up|0|||
146844489|NCT01531673|529600812|FG004|Overall Study|Lost to Follow-up|1|||
146844490|NCT01531673|529600813|FG005|Overall Study|Lost to Follow-up|0|||
146844491|NCT01531673|529600814|FG006|Overall Study|Lost to Follow-up|0|||
146844492|NCT01531673|529600815|FG007|Overall Study|Lost to Follow-up|0|||
146844493|NCT01531673|529600816|FG008|Overall Study|Lost to Follow-up|0|||
146844494|NCT01531673|529600817|FG009|Overall Study|Lost to Follow-up|0|||
146844495|NCT01531673|529600818|FG010|Overall Study|Lost to Follow-up|0|||
146844496|NCT01531673|529600819|FG011|Overall Study|Lost to Follow-up|0|||
146844497|NCT01531673|529600820|FG012|Overall Study|Lost to Follow-up|0|||
146844498|NCT01531673|529600808|FG000|Overall Study|Other|0|||
146844499|NCT01531673|529600809|FG001|Overall Study|Other|0|||
146844500|NCT01531673|529600810|FG002|Overall Study|Other|0|||
146844501|NCT01531673|529600811|FG003|Overall Study|Other|1|||
146844502|NCT01531673|529600812|FG004|Overall Study|Other|0|||
146844503|NCT01531673|529600813|FG005|Overall Study|Other|0|||
146844504|NCT01531673|529600814|FG006|Overall Study|Other|0|||
146844505|NCT01531673|529600815|FG007|Overall Study|Other|0|||
146844506|NCT01531673|529600816|FG008|Overall Study|Other|0|||
146844507|NCT01531673|529600817|FG009|Overall Study|Other|1|||
146844508|NCT01531673|529600818|FG010|Overall Study|Other|0|||
146844509|NCT01531673|529600819|FG011|Overall Study|Other|0|||
146844510|NCT01531673|529600820|FG012|Overall Study|Other|0|||
146844511|NCT00264303|529600821|FG000|Overall Study|Adverse Event|4|||
146844512|NCT00264303|529600822|FG001|Overall Study|Adverse Event|3|||
146844513|NCT00264303|529600821|FG000|Overall Study|Lack of Efficacy|10|||
146844514|NCT00264303|529600822|FG001|Overall Study|Lack of Efficacy|13|||
146844515|NCT00264303|529600821|FG000|Overall Study|Lost to Follow-up|3|||
146844516|NCT00264303|529600822|FG001|Overall Study|Lost to Follow-up|3|||
146844517|NCT00264303|529600821|FG000|Overall Study|Withdrawal by Subject|2|||
146844518|NCT00264303|529600822|FG001|Overall Study|Withdrawal by Subject|3|||
146844519|NCT00264303|529600821|FG000|Overall Study|Various reasons listed in study report|6|||
146844520|NCT00264303|529600822|FG001|Overall Study|Various reasons listed in study report|7|||
146844521|NCT02389452|529600823|FG000|Overall Study|Lost to Follow-up|13|||
146844522|NCT02389452|529600823|FG000|Overall Study|Adverse Event|1|||
146844523|NCT02389452|529600823|FG000|Overall Study|Withdrawal by Subject|5|||
146997506|NCT03135834|530155476|FG003|Stage 2|Did not receive Booster Vaccination|0|||
146997507|NCT02100228|530155477|FG000|Overall Study|Other|19|||
146997508|NCT02100228|530155478|FG001|Overall Study|Other|19|||
146997509|NCT02100228|530155477|FG000|Overall Study|Administrative reason|0|||
146997510|NCT02100228|530155478|FG001|Overall Study|Administrative reason|1|||
146997511|NCT02100228|530155477|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
146997512|NCT02100228|530155478|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
146997513|NCT02100228|530155477|FG000|Overall Study|Non-compliance|0|||
146997514|NCT02100228|530155478|FG001|Overall Study|Non-compliance|3|||
146997515|NCT02100228|530155477|FG000|Overall Study|Lost to Follow-up|0|||
146997516|NCT02100228|530155478|FG001|Overall Study|Lost to Follow-up|1|||
146997517|NCT02100228|530155477|FG000|Overall Study|Withdrawal by Subject|27|||
146997518|NCT02100228|530155478|FG001|Overall Study|Withdrawal by Subject|37|||
146997519|NCT02100228|530155477|FG000|Overall Study|Adverse Event|16|||
146997520|NCT02100228|530155478|FG001|Overall Study|Adverse Event|12|||
146997521|NCT02100228|530155477|FG000|Overall Study|Death|1|||
146844524|NCT02389452|529600823|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
146844525|NCT00837694|529600826|FG000|Overall Study|Lost to Follow-up|2|||
146844526|NCT00837694|529600827|FG001|Overall Study|Lost to Follow-up|0|||
146844527|NCT00837694|529600828|FG002|Overall Study|Lost to Follow-up|2|||
146844528|NCT00837694|529600829|FG003|Overall Study|Lost to Follow-up|1|||
146844529|NCT00837694|529600830|FG004|Overall Study|Lost to Follow-up|1|||
146844530|NCT00837694|529600831|FG005|Overall Study|Lost to Follow-up|1|||
146844531|NCT00818168|529600837|FG000|Overall Study|Lack of Efficacy|18|||
146844532|NCT00818168|529600837|FG000|Overall Study|Pregnancy|2|||
146844533|NCT00818168|529600837|FG000|Overall Study|Withdrawal by Subject|16|||
146844534|NCT00818168|529600837|FG000|Overall Study|Lost to Follow-up|7|||
146844535|NCT00818168|529600837|FG000|Overall Study|Adverse Event|19|||
146844536|NCT00818168|529600837|FG000|Overall Study|Reason for Non-completion Not reported|6|||
146844537|NCT00818168|529600837|FG000|Overall Study|Participant Moved|2|||
146844538|NCT01008553|529600838|FG000|Period 1 (Titration Period)|Physician Decision|2|||
146844539|NCT01008553|529600839|FG001|Period 1 (Titration Period)|Physician Decision|0|||
146844540|NCT01008553|529600840|FG002|Period 1 (Titration Period)|Physician Decision|0|||
146844541|NCT01008553|529600838|FG000|Period 1 (Titration Period)|Adverse Event|33|||
146844542|NCT01008553|529600839|FG001|Period 1 (Titration Period)|Adverse Event|0|||
146844543|NCT01008553|529600840|FG002|Period 1 (Titration Period)|Adverse Event|0|||
146844544|NCT01008553|529600838|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
146844545|NCT01008553|529600839|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
146844546|NCT01008553|529600840|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
146844547|NCT01008553|529600838|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
146844548|NCT01008553|529600839|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
146844549|NCT01008553|529600840|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
146844550|NCT01008553|529600838|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
146844551|NCT01008553|529600839|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
146844552|NCT01008553|529600840|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
146844553|NCT01008553|529600838|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
146844554|NCT01008553|529600839|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
146844555|NCT01008553|529600840|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
146844556|NCT01008553|529600838|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
146844557|NCT01008553|529600839|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
146844558|NCT01008553|529600840|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
146844559|NCT01008553|529600838|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
146844560|NCT01008553|529600839|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
146844561|NCT01008553|529600840|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
146844562|NCT01008553|529600838|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
146844563|NCT01008553|529600839|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
146844564|NCT01008553|529600840|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
146844565|NCT01008553|529600838|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
146844566|NCT01008553|529600839|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
146844567|NCT01008553|529600840|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
146997522|NCT02100228|530155478|FG001|Overall Study|Death|1|||
146997523|NCT00214422|530155479|FG000|Overall Study|Physician Decision|2|||
146844568|NCT01008553|529600838|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
146997524|NCT00214422|530155480|FG001|Overall Study|Physician Decision|0|||
146997525|NCT00214422|530155481|FG002|Overall Study|Physician Decision|0|||
146997526|NCT00214422|530155479|FG000|Overall Study|Developed esophageal ca|1|||
146997527|NCT00214422|530155480|FG001|Overall Study|Developed esophageal ca|0|||
146997528|NCT00214422|530155481|FG002|Overall Study|Developed esophageal ca|0|||
146997529|NCT00214422|530155479|FG000|Overall Study|Pt taken off study|1|||
146997530|NCT00214422|530155480|FG001|Overall Study|Pt taken off study|1|||
146997531|NCT00214422|530155481|FG002|Overall Study|Pt taken off study|0|||
146997532|NCT00214422|530155479|FG000|Overall Study|Disease progression on study|1|||
146997533|NCT00214422|530155480|FG001|Overall Study|Disease progression on study|0|||
146997534|NCT00214422|530155481|FG002|Overall Study|Disease progression on study|0|||
146997535|NCT00214422|530155479|FG000|Overall Study|Unable to make a radiation treatment|0|||
146997536|NCT00214422|530155480|FG001|Overall Study|Unable to make a radiation treatment|0|||
146997537|NCT00214422|530155481|FG002|Overall Study|Unable to make a radiation treatment|1|||
146997538|NCT02612337|530155483|FG000|Overall Study|Lack of Efficacy|1|||
146997539|NCT02612337|530155484|FG001|Overall Study|Lack of Efficacy|0|||
146997540|NCT02612337|530155483|FG000|Overall Study|Withdrawal by Subject|2|||
146997541|NCT02612337|530155484|FG001|Overall Study|Withdrawal by Subject|2|||
146997542|NCT02612337|530155483|FG000|Overall Study|Did not receive study drug|0|||
146997543|NCT02612337|530155484|FG001|Overall Study|Did not receive study drug|1|||
146997544|NCT02421952|530155487|FG000|Overall Study|Diary Not Returned|93|||
146997545|NCT02421952|530155487|FG000|Overall Study|Failed seriation task|13|||
146997546|NCT02421952|530155487|FG000|Overall Study|Subject uncooperative for baseline test|2|||
146997547|NCT02421952|530155487|FG000|Overall Study|Surgery cancelled|1|||
146997548|NCT00854100|530155488|FG000|Overall Study|Inability to complete the study visits|0|||
146997549|NCT00854100|530155489|FG001|Overall Study|Inability to complete the study visits|0|||
146997550|NCT00854100|530155490|FG002|Overall Study|Inability to complete the study visits|1|||
146997551|NCT00854100|530155488|FG000|Overall Study|Lost to Follow-up|2|||
146997552|NCT00854100|530155489|FG001|Overall Study|Lost to Follow-up|0|||
146997553|NCT00854100|530155490|FG002|Overall Study|Lost to Follow-up|3|||
146997554|NCT00854100|530155488|FG000|Overall Study|Withdrawal by Subject|3|||
146997555|NCT00854100|530155489|FG001|Overall Study|Withdrawal by Subject|1|||
146997556|NCT00854100|530155490|FG002|Overall Study|Withdrawal by Subject|2|||
146997557|NCT00854100|530155488|FG000|Overall Study|Protocol Violation|2|||
146997558|NCT00854100|530155489|FG001|Overall Study|Protocol Violation|4|||
146844569|NCT01008553|529600839|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
146844570|NCT01008553|529600840|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
146844571|NCT01008553|529600838|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
146844572|NCT01008553|529600839|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
146997559|NCT00854100|530155490|FG002|Overall Study|Protocol Violation|3|||
146997560|NCT00854100|530155488|FG000|Overall Study|Adverse Event|2|||
146997561|NCT00854100|530155489|FG001|Overall Study|Adverse Event|1|||
146997562|NCT00854100|530155490|FG002|Overall Study|Adverse Event|2|||
146997563|NCT02216071|530155502|FG000|Overall Study|Withdrawal by Subject|7|||
146997564|NCT02216071|530155503|FG001|Overall Study|Withdrawal by Subject|2|||
146997565|NCT02216071|530155502|FG000|Overall Study|Lost to Follow-up|3|||
146997566|NCT02216071|530155503|FG001|Overall Study|Lost to Follow-up|3|||
146997567|NCT02216071|530155502|FG000|Overall Study|Protocol Violation|3|||
146997568|NCT02216071|530155503|FG001|Overall Study|Protocol Violation|5|||
146997569|NCT02216071|530155502|FG000|Overall Study|Other|2|||
146997570|NCT02216071|530155503|FG001|Overall Study|Other|2|||
146997571|NCT04753437|530155504|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
146997572|NCT04753437|530155505|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
146997573|NCT04753437|530155504|FG000|Overall Study|Liver Function Test Abnormalities|2|||
146997574|NCT04753437|530155505|FG001|Overall Study|Liver Function Test Abnormalities|4|||
146997575|NCT02865122|530155506|FG000|Overall Study|Adverse Event|1|||
146997576|NCT02865122|530155507|FG001|Overall Study|Adverse Event|0|||
146997577|NCT02865122|530155508|FG002|Overall Study|Adverse Event|0|||
146997578|NCT01948258|530156657|FG000|Overall Study|Pregnancy|41|||
146997579|NCT01948258|530156657|FG000|Overall Study|Did not complete by cut-off date|35|||
146997580|NCT01948258|530156657|FG000|Overall Study|Lost to Follow-up|27|||
146997581|NCT01948258|530156657|FG000|Overall Study|Withdrawal by SPD|8|||
146997582|NCT01948258|530156657|FG000|Overall Study|Withdrawal by Subject|6|||
146997583|NCT01948258|530156657|FG000|Overall Study|Health Care Professional|43|||
146997584|NCT01948258|530156657|FG000|Overall Study|Removed from statistical analysis|2|||
146997585|NCT01466166|530156661|FG000|Overall Study|Death|1|||
146844573|NCT01008553|529600840|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
146997586|NCT01466166|530156661|FG000|Overall Study|Lost to Follow-up|7|||
146997587|NCT01466166|530156661|FG000|Overall Study|Infusion Reaction (IR)|27|||
146997588|NCT01466166|530156661|FG000|Overall Study|Adverse Event (Other than IR)|11|||
146997589|NCT01466166|530156661|FG000|Overall Study|Elevated Serum Uric Acid|78|||
146997590|NCT01466166|530156661|FG000|Overall Study|Withdrawal by Subject|13|||
146997591|NCT01466166|530156661|FG000|Overall Study|Sponsor Decision|4|||
146997592|NCT01466166|530156661|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
146997593|NCT01466166|530156661|FG000|Overall Study|Other|20|||
146997594|NCT00851877|530156669|FG000|Phase I-1|Death|1|||
146997595|NCT00851877|530156670|FG001|Phase I-1|Death|0|||
146997596|NCT00851877|530156671|FG002|Phase I-1|Death|0|||
146997597|NCT00851877|530156669|FG000|Phase II|Withdrawal by Subject|0|||
146997598|NCT00851877|530156670|FG001|Phase II|Withdrawal by Subject|0|||
146997599|NCT00851877|530156671|FG002|Phase II|Withdrawal by Subject|3|||
146844574|NCT01008553|529600838|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
146844575|NCT01008553|529600839|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
146844576|NCT01008553|529600840|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
146844577|NCT01008553|529600838|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
146844578|NCT01008553|529600839|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
146844579|NCT01008553|529600840|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
146844580|NCT01008410|529600841|FG000|Overall Study|Adverse Event|13|||
146844581|NCT01008410|529600842|FG001|Overall Study|Adverse Event|7|||
146844582|NCT01008410|529600841|FG000|Overall Study|Withdrawal by Subject|6|||
146844583|NCT01008410|529600842|FG001|Overall Study|Withdrawal by Subject|2|||
146844584|NCT01008410|529600841|FG000|Overall Study|Lost to Follow-up|1|||
146844585|NCT01008410|529600842|FG001|Overall Study|Lost to Follow-up|0|||
146844586|NCT01008410|529600841|FG000|Overall Study|Noncompliance|1|||
146844587|NCT01008410|529600842|FG001|Overall Study|Noncompliance|0|||
146844588|NCT01008410|529600841|FG000|Overall Study|Low Cortisol|2|||
146844589|NCT01008410|529600842|FG001|Overall Study|Low Cortisol|0|||
146844590|NCT01008410|529600841|FG000|Overall Study|Lack of Efficacy|2|||
146844591|NCT01008410|529600842|FG001|Overall Study|Lack of Efficacy|6|||
146844592|NCT01008410|529600841|FG000|Overall Study|Met Exclusion Criterion|0|||
146844593|NCT01008410|529600842|FG001|Overall Study|Met Exclusion Criterion|1|||
146844594|NCT03482466|529600847|FG000|Overall Study|Protocol Violation|2|||
146844595|NCT03268603|529600848|FG000|Overall Study|Withdrawal by Subject|6|||
146844596|NCT03268603|529600848|FG000|Overall Study|Physician Decision|1|||
146844597|NCT03268603|529600848|FG000|Overall Study|Withdrawn due to disease progression|2|||
146844598|NCT02591953|529600849|FG000|Overall Study|Lost to Follow-up|6|||
146844599|NCT02591953|529600850|FG001|Overall Study|Lost to Follow-up|6|||
146844600|NCT02060370|529600851|FG000|Overall Study|Physician Decision|1|||
146844601|NCT04939701|529600852|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
146844602|NCT04939701|529600853|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
146844603|NCT04939701|529600854|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
146844604|NCT04939701|529600852|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
146844605|NCT04939701|529600853|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
146844606|NCT04939701|529600854|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
146844607|NCT04939701|529600852|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
146844608|NCT04939701|529600853|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
146997600|NCT00620074|530156672|FG000|Overall Study|Adverse Event|1|||
146997601|NCT00829673|530156673|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
146997602|NCT00829673|530156674|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
146997603|NCT00829790|530156675|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
146997604|NCT00829790|530156676|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
146997605|NCT03214952|530156677|FG000|Overall Study|Protocol Deviation|45|||
146997606|NCT03214952|530156677|FG000|Overall Study|Case Report Forms Uncollected|13|||
146997607|NCT03769896|530156678|FG000|Open-label Phase|Lack of Efficacy|5|||
146997608|NCT03769896|530156679|FG001|Open-label Phase|Lack of Efficacy|0|||
146997609|NCT03769896|530156678|FG000|Open-label Phase|Adverse Event|3|||
146997610|NCT03769896|530156679|FG001|Open-label Phase|Adverse Event|0|||
146997611|NCT03769896|530156678|FG000|Open-label Phase|Withdrawal by Subject|1|||
146997612|NCT03769896|530156679|FG001|Open-label Phase|Withdrawal by Subject|0|||
146997613|NCT00086996|530156683|FG000|Overall Study|Adverse Event|29|||
146997614|NCT00086996|530156683|FG000|Overall Study|Death|4|||
146997615|NCT00086996|530156683|FG000|Overall Study|progression/relapse|7|||
146997616|NCT00086996|530156683|FG000|Overall Study|Withdrawal by Subject|13|||
146997617|NCT00086996|530156683|FG000|Overall Study|Other|6|||
146997618|NCT00086996|530156683|FG000|Overall Study|not eligible|5|||
146997619|NCT00004562|530156684|FG000|Overall Study|Lost to Follow-up|102|||
146997620|NCT00004562|530156685|FG001|Overall Study|Lost to Follow-up|91|||
146997621|NCT02770820|530156686|FG000|Overall Study|Death|1|||
146997622|NCT02770820|530156686|FG000|Overall Study|Physician Decision|2|||
146997623|NCT00301366|530156687|FG000|Overall Study|Adverse Event|1|||
146997624|NCT00552669|530156690|FG000|Overall Study|Death|3|||
146997625|NCT00552669|530156691|FG001|Overall Study|Death|7|||
146997626|NCT03195491|530156692|FG000|Overall Study|Study drug toxicity|25|||
146997627|NCT03195491|530156693|FG001|Overall Study|Study drug toxicity|3|||
146997628|NCT03195491|530156692|FG000|Overall Study|Maximum clinical benefit|5|||
146997629|NCT03195491|530156693|FG001|Overall Study|Maximum clinical benefit|0|||
146997630|NCT03195491|530156692|FG000|Overall Study|Lost to Follow-up|1|||
146997631|NCT03195491|530156693|FG001|Overall Study|Lost to Follow-up|0|||
146997632|NCT03195491|530156692|FG000|Overall Study|Death|3|||
146997633|NCT03195491|530156693|FG001|Overall Study|Death|0|||
146997634|NCT03195491|530156692|FG000|Overall Study|Adverse event unrelated to study drug|19|||
146997635|NCT03195491|530156693|FG001|Overall Study|Adverse event unrelated to study drug|2|||
146997636|NCT03195491|530156692|FG000|Overall Study|Disease progression|266|||
146997637|NCT03195491|530156693|FG001|Overall Study|Disease progression|8|||
146997638|NCT03195491|530156692|FG000|Overall Study|Other reasons|10|||
146997639|NCT03195491|530156693|FG001|Overall Study|Other reasons|0|||
146844609|NCT04939701|529600854|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
146844610|NCT04939701|529600852|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
146844611|NCT04939701|529600853|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
146844612|NCT04939701|529600854|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
146844613|NCT04939701|529600852|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
146844614|NCT04939701|529600853|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
146844615|NCT04939701|529600854|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
146844616|NCT04939701|529600852|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
146844617|NCT04939701|529600853|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
146844618|NCT04939701|529600854|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
146844619|NCT04939701|529600852|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
146844620|NCT04939701|529600853|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
146844621|NCT04939701|529600854|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
146844622|NCT02383940|529600859|FG000|Overall Study|Adverse Event|1|||
146844623|NCT02383940|529600860|FG001|Overall Study|Adverse Event|0|||
146844624|NCT02383940|529600859|FG000|Overall Study|Lost to Follow-up|2|||
146844625|NCT02383940|529600860|FG001|Overall Study|Lost to Follow-up|2|||
146844626|NCT02383940|529600859|FG000|Overall Study|Physician Decision|2|||
146844627|NCT02383940|529600860|FG001|Overall Study|Physician Decision|0|||
146844628|NCT02383940|529600859|FG000|Overall Study|Withdrawal by Subject|1|||
146844629|NCT02383940|529600860|FG001|Overall Study|Withdrawal by Subject|1|||
146844630|NCT02383940|529600859|FG000|Overall Study|Randomized but not treated|2|||
146844631|NCT02383940|529600860|FG001|Overall Study|Randomized but not treated|0|||
146844632|NCT02383940|529600859|FG000|Overall Study|Other than specified above|1|||
146844633|NCT02383940|529600860|FG001|Overall Study|Other than specified above|0|||
146844634|NCT01517295|529600861|FG000|Overall Study|Physician Decision|1|||
146844635|NCT01517295|529600862|FG001|Overall Study|Physician Decision|0|||
146844636|NCT02672852|529600864|FG000|Part A1|Disease Worsening|1|||
146844637|NCT02672852|529600865|FG001|Part A1|Disease Worsening|0|||
146844638|NCT02672852|529600866|FG002|Part A1|Disease Worsening|0|||
146844639|NCT02672852|529600867|FG003|Part A1|Disease Worsening|0|||
146844640|NCT02672852|529600868|FG004|Part A1|Disease Worsening|0|||
146844641|NCT02672852|529600869|FG005|Part A1|Disease Worsening|0|||
146844642|NCT02672852|529600870|FG006|Part A1|Disease Worsening|0|||
146844643|NCT02672852|529600864|FG000|Part A1|Adverse Event|0|||
146844644|NCT02672852|529600865|FG001|Part A1|Adverse Event|1|||
146844645|NCT02672852|529600866|FG002|Part A1|Adverse Event|0|||
146844646|NCT02672852|529600867|FG003|Part A1|Adverse Event|0|||
146844647|NCT02672852|529600868|FG004|Part A1|Adverse Event|0|||
146844648|NCT02672852|529600869|FG005|Part A1|Adverse Event|0|||
146844649|NCT02672852|529600870|FG006|Part A1|Adverse Event|0|||
146844650|NCT02672852|529600864|FG000|Part A1|Lost to Follow-up|1|||
146844651|NCT02672852|529600865|FG001|Part A1|Lost to Follow-up|2|||
146844652|NCT02672852|529600866|FG002|Part A1|Lost to Follow-up|0|||
146844653|NCT02672852|529600867|FG003|Part A1|Lost to Follow-up|0|||
146844654|NCT02672852|529600868|FG004|Part A1|Lost to Follow-up|0|||
146844655|NCT02672852|529600869|FG005|Part A1|Lost to Follow-up|0|||
146844656|NCT02672852|529600870|FG006|Part A1|Lost to Follow-up|0|||
146844657|NCT02672852|529600864|FG000|Part A1|Withdrawal by Subject|1|||
146844658|NCT02672852|529600865|FG001|Part A1|Withdrawal by Subject|1|||
146844659|NCT02672852|529600866|FG002|Part A1|Withdrawal by Subject|0|||
146844660|NCT02672852|529600867|FG003|Part A1|Withdrawal by Subject|0|||
146844661|NCT02672852|529600868|FG004|Part A1|Withdrawal by Subject|0|||
146844662|NCT02672852|529600869|FG005|Part A1|Withdrawal by Subject|0|||
146844663|NCT02672852|529600870|FG006|Part A1|Withdrawal by Subject|0|||
146844664|NCT02672852|529600864|FG000|Part A2|Disease worsening|0|||
146844665|NCT02672852|529600865|FG001|Part A2|Disease worsening|0|||
146844666|NCT02672852|529600866|FG002|Part A2|Disease worsening|1|||
146844667|NCT02672852|529600867|FG003|Part A2|Disease worsening|0|||
146844668|NCT02672852|529600868|FG004|Part A2|Disease worsening|0|||
146844669|NCT02672852|529600869|FG005|Part A2|Disease worsening|0|||
146844670|NCT02672852|529600870|FG006|Part A2|Disease worsening|0|||
146844671|NCT02672852|529600864|FG000|Part A2|Adverse Event|0|||
146844672|NCT02672852|529600865|FG001|Part A2|Adverse Event|0|||
146844673|NCT02672852|529600866|FG002|Part A2|Adverse Event|3|||
146844674|NCT02672852|529600867|FG003|Part A2|Adverse Event|0|||
146997640|NCT03195491|530156692|FG000|Overall Study|Participant withdrew consent|8|||
146844675|NCT02672852|529600868|FG004|Part A2|Adverse Event|0|||
146844676|NCT02672852|529600869|FG005|Part A2|Adverse Event|0|||
146844677|NCT02672852|529600870|FG006|Part A2|Adverse Event|0|||
146844678|NCT02672852|529600864|FG000|Part A2|Lost to Follow-up|0|||
146844679|NCT02672852|529600865|FG001|Part A2|Lost to Follow-up|0|||
146844680|NCT02672852|529600866|FG002|Part A2|Lost to Follow-up|2|||
146844681|NCT02672852|529600867|FG003|Part A2|Lost to Follow-up|0|||
146844682|NCT02672852|529600868|FG004|Part A2|Lost to Follow-up|0|||
146844683|NCT02672852|529600869|FG005|Part A2|Lost to Follow-up|0|||
146844684|NCT02672852|529600870|FG006|Part A2|Lost to Follow-up|0|||
146844685|NCT02672852|529600864|FG000|Part A2|Withdrawal by Subject|0|||
146844686|NCT02672852|529600865|FG001|Part A2|Withdrawal by Subject|0|||
146844687|NCT02672852|529600866|FG002|Part A2|Withdrawal by Subject|1|||
146844688|NCT02672852|529600867|FG003|Part A2|Withdrawal by Subject|0|||
146844689|NCT02672852|529600868|FG004|Part A2|Withdrawal by Subject|0|||
146844690|NCT02672852|529600869|FG005|Part A2|Withdrawal by Subject|0|||
146844691|NCT02672852|529600870|FG006|Part A2|Withdrawal by Subject|0|||
146844692|NCT02672852|529600864|FG000|Part A2|Other|0|||
146844693|NCT02672852|529600865|FG001|Part A2|Other|0|||
146844694|NCT02672852|529600866|FG002|Part A2|Other|3|||
146844695|NCT02672852|529600867|FG003|Part A2|Other|0|||
146844696|NCT02672852|529600868|FG004|Part A2|Other|0|||
146844697|NCT02672852|529600869|FG005|Part A2|Other|0|||
146844698|NCT02672852|529600870|FG006|Part A2|Other|0|||
146844699|NCT02672852|529600864|FG000|Part A2|Not entered in Part B|0|||
146844700|NCT02672852|529600865|FG001|Part A2|Not entered in Part B|0|||
146844701|NCT02672852|529600866|FG002|Part A2|Not entered in Part B|0|||
146844702|NCT02672852|529600867|FG003|Part A2|Not entered in Part B|4|||
146844703|NCT02672852|529600868|FG004|Part A2|Not entered in Part B|0|||
146844704|NCT02672852|529600869|FG005|Part A2|Not entered in Part B|0|||
146844705|NCT02672852|529600870|FG006|Part A2|Not entered in Part B|0|||
146844706|NCT02672852|529600864|FG000|Part B|Disease worsening|0|||
146844707|NCT02672852|529600865|FG001|Part B|Disease worsening|0|||
146844708|NCT02672852|529600866|FG002|Part B|Disease worsening|0|||
146844709|NCT02672852|529600867|FG003|Part B|Disease worsening|0|||
146844710|NCT02672852|529600868|FG004|Part B|Disease worsening|1|||
146844711|NCT02672852|529600869|FG005|Part B|Disease worsening|0|||
146844712|NCT02672852|529600870|FG006|Part B|Disease worsening|1|||
146844713|NCT02672852|529600864|FG000|Part B|Worsening pre-existing condition|0|||
146844714|NCT02672852|529600865|FG001|Part B|Worsening pre-existing condition|0|||
146844715|NCT02672852|529600866|FG002|Part B|Worsening pre-existing condition|0|||
146844716|NCT02672852|529600867|FG003|Part B|Worsening pre-existing condition|0|||
146997641|NCT03195491|530156693|FG001|Overall Study|Participant withdrew consent|1|||
146997642|NCT03195491|530156692|FG000|Overall Study|Participant no longer meets study criteria|0|||
146997643|NCT03195491|530156693|FG001|Overall Study|Participant no longer meets study criteria|1|||
146997644|NCT03195491|530156692|FG000|Overall Study|Participant request to discontinue study treatment|10|||
146997645|NCT03195491|530156693|FG001|Overall Study|Participant request to discontinue study treatment|0|||
146997646|NCT01270503|530156694|FG000|Overall Study|Lost to Follow-up|1|||
146997647|NCT02459951|530156695|FG000|Overall Study|Unable to meet holding requirement|1|||
146997648|NCT00252720|530156697|FG000|Overall Study|Withdrawal by Subject|95|||
146997649|NCT00252720|530156698|FG001|Overall Study|Withdrawal by Subject|97|||
146997650|NCT00252720|530156697|FG000|Overall Study|Death|7|||
146997651|NCT00252720|530156698|FG001|Overall Study|Death|8|||
146997652|NCT00252720|530156697|FG000|Overall Study|Moving|23|||
146997653|NCT00252720|530156698|FG001|Overall Study|Moving|42|||
146997654|NCT00252720|530156697|FG000|Overall Study|Mainly patients lost to follow-up|7|||
146997655|NCT00252720|530156698|FG001|Overall Study|Mainly patients lost to follow-up|18|||
146997656|NCT00102440|530156699|FG000|Overall Study|Lost to Follow-up|25|||
146997657|NCT00102440|530156700|FG001|Overall Study|Lost to Follow-up|18|||
146997658|NCT00102440|530156701|FG002|Overall Study|Lost to Follow-up|21|||
146997659|NCT00102440|530156699|FG000|Overall Study|Adverse Event|16|||
146997660|NCT00102440|530156700|FG001|Overall Study|Adverse Event|23|||
146997661|NCT00102440|530156701|FG002|Overall Study|Adverse Event|8|||
146997662|NCT00102440|530156699|FG000|Overall Study|Gout Flare|10|||
146997663|NCT00102440|530156700|FG001|Overall Study|Gout Flare|28|||
146997664|NCT00102440|530156701|FG002|Overall Study|Gout Flare|9|||
146997665|NCT00102440|530156699|FG000|Overall Study|Personal Reason(s)|19|||
146997666|NCT00102440|530156700|FG001|Overall Study|Personal Reason(s)|13|||
146997667|NCT00102440|530156701|FG002|Overall Study|Personal Reason(s)|13|||
146997668|NCT00102440|530156699|FG000|Overall Study|Other|11|||
146997669|NCT00102440|530156700|FG001|Overall Study|Other|14|||
146997670|NCT00102440|530156701|FG002|Overall Study|Other|14|||
146997671|NCT00102440|530156699|FG000|Overall Study|Protocol Violation|7|||
146997672|NCT00102440|530156700|FG001|Overall Study|Protocol Violation|2|||
146997673|NCT00102440|530156701|FG002|Overall Study|Protocol Violation|1|||
146997674|NCT00772941|530156702|FG000|Overall Study|CRFs not available|195|||
146997675|NCT00772941|530156702|FG000|Overall Study|Study not completed|16|||
146997676|NCT00772941|530156702|FG000|Overall Study|Missed Visits|374|||
146997677|NCT00772941|530156702|FG000|Overall Study|Poor Compliance|7|||
146997678|NCT00772941|530156702|FG000|Overall Study|GPSP Violation|90|||
146997679|NCT04786184|530156704|FG000|Overall Study|Adverse Event|4|||
146997680|NCT04786184|530156705|FG001|Overall Study|Adverse Event|0|||
146997681|NCT04786184|530156704|FG000|Overall Study|Withdrawal by Subject|3|||
146997682|NCT04786184|530156705|FG001|Overall Study|Withdrawal by Subject|1|||
146997683|NCT04786184|530156704|FG000|Overall Study|Lost to Follow-up|4|||
146997684|NCT04786184|530156705|FG001|Overall Study|Lost to Follow-up|2|||
146997685|NCT01745120|530156706|FG000|Overall Study|Investigator decision|1|||
146997686|NCT01745120|530156707|FG001|Overall Study|Investigator decision|0|||
146997687|NCT01185821|530156709|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146844717|NCT02672852|529600868|FG004|Part B|Worsening pre-existing condition|0|||
146844718|NCT02672852|529600869|FG005|Part B|Worsening pre-existing condition|1|||
146997688|NCT01185821|530156710|FG001|Overall Study|Abnormal laboratory value(s)|2|||
146844719|NCT02672852|529600870|FG006|Part B|Worsening pre-existing condition|0|||
146844720|NCT02672852|529600864|FG000|Part B|Other adverse event|0|||
146844721|NCT02672852|529600865|FG001|Part B|Other adverse event|0|||
146997689|NCT01185821|530156711|FG002|Overall Study|Abnormal laboratory value(s)|1|||
146997690|NCT01185821|530156712|FG003|Overall Study|Abnormal laboratory value(s)|0|||
146997691|NCT01185821|530156713|FG004|Overall Study|Abnormal laboratory value(s)|0|||
146997692|NCT01185821|530156709|FG000|Overall Study|Protocol Violation|0|||
146997693|NCT01185821|530156710|FG001|Overall Study|Protocol Violation|0|||
146997694|NCT01185821|530156711|FG002|Overall Study|Protocol Violation|0|||
146997695|NCT01185821|530156712|FG003|Overall Study|Protocol Violation|1|||
146997696|NCT01185821|530156713|FG004|Overall Study|Protocol Violation|1|||
146997697|NCT01185821|530156709|FG000|Overall Study|Abnormal test procedure result|0|||
146997698|NCT01185821|530156710|FG001|Overall Study|Abnormal test procedure result|0|||
146997699|NCT01185821|530156711|FG002|Overall Study|Abnormal test procedure result|0|||
146997700|NCT01185821|530156712|FG003|Overall Study|Abnormal test procedure result|0|||
146997701|NCT01185821|530156713|FG004|Overall Study|Abnormal test procedure result|1|||
146997702|NCT01185821|530156709|FG000|Overall Study|Death|0|||
146997703|NCT01185821|530156710|FG001|Overall Study|Death|1|||
146997704|NCT01185821|530156711|FG002|Overall Study|Death|0|||
146997705|NCT01185821|530156712|FG003|Overall Study|Death|0|||
146997706|NCT01185821|530156713|FG004|Overall Study|Death|0|||
146997707|NCT01185821|530156709|FG000|Overall Study|Condition no longer required study drug|0|||
146997708|NCT01185821|530156710|FG001|Overall Study|Condition no longer required study drug|0|||
146997709|NCT01185821|530156711|FG002|Overall Study|Condition no longer required study drug|0|||
146997710|NCT01185821|530156712|FG003|Overall Study|Condition no longer required study drug|0|||
146997711|NCT01185821|530156713|FG004|Overall Study|Condition no longer required study drug|1|||
146997712|NCT01185821|530156709|FG000|Overall Study|Adverse Event|2|||
146997713|NCT01185821|530156710|FG001|Overall Study|Adverse Event|3|||
146997714|NCT01185821|530156711|FG002|Overall Study|Adverse Event|1|||
146997715|NCT01185821|530156712|FG003|Overall Study|Adverse Event|2|||
146997716|NCT01185821|530156713|FG004|Overall Study|Adverse Event|5|||
146997717|NCT01185821|530156709|FG000|Overall Study|Lack of Efficacy|0|||
146997718|NCT01185821|530156710|FG001|Overall Study|Lack of Efficacy|0|||
146997719|NCT01185821|530156711|FG002|Overall Study|Lack of Efficacy|3|||
146997720|NCT01185821|530156712|FG003|Overall Study|Lack of Efficacy|0|||
146997721|NCT01185821|530156713|FG004|Overall Study|Lack of Efficacy|9|||
146997722|NCT01185821|530156709|FG000|Overall Study|Withdrawal by Subject|3|||
146997723|NCT01185821|530156710|FG001|Overall Study|Withdrawal by Subject|2|||
146997724|NCT01185821|530156711|FG002|Overall Study|Withdrawal by Subject|2|||
146997725|NCT01185821|530156712|FG003|Overall Study|Withdrawal by Subject|1|||
146997726|NCT01185821|530156713|FG004|Overall Study|Withdrawal by Subject|3|||
146997727|NCT01185821|530156709|FG000|Overall Study|Lost to Follow-up|1|||
146997728|NCT01185821|530156710|FG001|Overall Study|Lost to Follow-up|1|||
146997729|NCT01185821|530156711|FG002|Overall Study|Lost to Follow-up|2|||
146997730|NCT01185821|530156712|FG003|Overall Study|Lost to Follow-up|1|||
146997731|NCT01185821|530156713|FG004|Overall Study|Lost to Follow-up|2|||
146997732|NCT01185821|530156709|FG000|Overall Study|Administrative problems|0|||
146997733|NCT01185821|530156710|FG001|Overall Study|Administrative problems|0|||
146997734|NCT01185821|530156711|FG002|Overall Study|Administrative problems|1|||
146997735|NCT01185821|530156712|FG003|Overall Study|Administrative problems|1|||
146997736|NCT01185821|530156713|FG004|Overall Study|Administrative problems|2|||
146997737|NCT02392000|530156726|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
146997738|NCT02392000|530156726|FG000|Overall Study|Withdrawal by Subject|1|||
146997739|NCT02392000|530156726|FG000|Overall Study|Lost to Follow-up|8|||
146997740|NCT00385593|530156727|FG000|Overall Study|Adverse Event|3|||
146844722|NCT02672852|529600866|FG002|Part B|Other adverse event|0|||
146844723|NCT02672852|529600867|FG003|Part B|Other adverse event|0|||
146844724|NCT02672852|529600868|FG004|Part B|Other adverse event|3|||
146844725|NCT02672852|529600869|FG005|Part B|Other adverse event|5|||
146844726|NCT02672852|529600870|FG006|Part B|Other adverse event|1|||
146844727|NCT02672852|529600864|FG000|Part B|Lost to Follow-up|0|||
146844728|NCT02672852|529600865|FG001|Part B|Lost to Follow-up|0|||
146997741|NCT00385593|530156728|FG001|Overall Study|Adverse Event|2|||
146997742|NCT00385593|530156727|FG000|Overall Study|Withdrawal by Subject|17|||
146997743|NCT00385593|530156728|FG001|Overall Study|Withdrawal by Subject|7|||
146997744|NCT00385593|530156727|FG000|Overall Study|Lost to Follow-up|12|||
146997745|NCT00385593|530156728|FG001|Overall Study|Lost to Follow-up|8|||
146997746|NCT00385593|530156727|FG000|Overall Study|Protocol Violation|7|||
146997747|NCT00385593|530156728|FG001|Overall Study|Protocol Violation|4|||
146997748|NCT00385593|530156727|FG000|Overall Study|Several reasons|17|||
146997749|NCT00385593|530156728|FG001|Overall Study|Several reasons|15|||
146997750|NCT00385593|530156727|FG000|Overall Study|Incorrect inclusion|2|||
146997751|NCT00385593|530156728|FG001|Overall Study|Incorrect inclusion|0|||
146997752|NCT00385593|530156727|FG000|Overall Study|Incorrect randomization|0|||
146997753|NCT00385593|530156728|FG001|Overall Study|Incorrect randomization|1|||
146997754|NCT04384978|530156729|FG000|Overall Study|Withdrawal by Subject|4|||
146997755|NCT04384978|530156730|FG001|Overall Study|Withdrawal by Subject|0|||
146997756|NCT03586726|530156735|FG000|Overall Study|Withdrawal by Subject|1|||
146844729|NCT02672852|529600866|FG002|Part B|Lost to Follow-up|0|||
146844730|NCT02672852|529600867|FG003|Part B|Lost to Follow-up|0|||
146844731|NCT02672852|529600868|FG004|Part B|Lost to Follow-up|3|||
146997757|NCT00965185|530156736|FG000|Overall Study|Lost to Follow-up|2|||
146997758|NCT00965185|530156737|FG001|Overall Study|Lost to Follow-up|0|||
146997759|NCT00965185|530156736|FG000|Overall Study|Withdrawal by Subject|0|||
146997760|NCT00965185|530156737|FG001|Overall Study|Withdrawal by Subject|1|||
146997761|NCT03197883|530156738|FG000|Overall Study|Adverse Event|1|||
146997762|NCT03197883|530156739|FG001|Overall Study|Adverse Event|1|||
146997763|NCT03197883|530156738|FG000|Overall Study|Lost to Follow-up|1|||
146997764|NCT03197883|530156739|FG001|Overall Study|Lost to Follow-up|0|||
146997765|NCT03197883|530156738|FG000|Overall Study|Protocol Violation|1|||
146997766|NCT03197883|530156739|FG001|Overall Study|Protocol Violation|0|||
146997767|NCT03197883|530156738|FG000|Overall Study|Other (Not Specified)|0|||
146997768|NCT03197883|530156739|FG001|Overall Study|Other (Not Specified)|5|||
146997769|NCT00389064|530156746|FG000|Overall Study|Adverse Event|11|||
146997770|NCT00389064|530156747|FG001|Overall Study|Adverse Event|3|||
146997771|NCT00389064|530156746|FG000|Overall Study|Lack of Efficacy|3|||
146997772|NCT00389064|530156747|FG001|Overall Study|Lack of Efficacy|14|||
146997773|NCT00389064|530156746|FG000|Overall Study|Withdrawal by Subject|17|||
146997774|NCT00389064|530156747|FG001|Overall Study|Withdrawal by Subject|27|||
146997775|NCT00389064|530156746|FG000|Overall Study|Physician Decision|2|||
146997776|NCT00389064|530156747|FG001|Overall Study|Physician Decision|2|||
146997777|NCT00389064|530156746|FG000|Overall Study|Lost to Follow-up|1|||
146997778|NCT00389064|530156747|FG001|Overall Study|Lost to Follow-up|2|||
146997779|NCT00389064|530156746|FG000|Overall Study|Protocol Violation|2|||
146997780|NCT00389064|530156747|FG001|Overall Study|Protocol Violation|0|||
146997781|NCT00389064|530156746|FG000|Overall Study|Multiple Reasons|9|||
146997782|NCT00389064|530156747|FG001|Overall Study|Multiple Reasons|11|||
146997783|NCT05275205|530156756|FG000|Overall Study|Adverse Event|1|||
146997784|NCT05275205|530156757|FG001|Overall Study|Adverse Event|2|||
146997785|NCT05275205|530156756|FG000|Overall Study|Physician Decision|1|||
146997786|NCT05275205|530156757|FG001|Overall Study|Physician Decision|1|||
146997787|NCT05275205|530156756|FG000|Overall Study|Withdrawal by Subject|2|||
146997788|NCT05275205|530156757|FG001|Overall Study|Withdrawal by Subject|3|||
146997789|NCT05275205|530156756|FG000|Overall Study|Death|1|||
146997790|NCT05275205|530156757|FG001|Overall Study|Death|0|||
146997791|NCT05275205|530156756|FG000|Overall Study|Patient unable to attend visits|1|||
146997792|NCT05275205|530156757|FG001|Overall Study|Patient unable to attend visits|0|||
146997793|NCT02963259|530156760|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
146997794|NCT02963259|530156760|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
146997795|NCT02963259|530156760|FG000|Overall Study|Death|1|||
146997796|NCT02963259|530156760|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
146997797|NCT03243630|530156762|FG000|Overall Study|Protocol Violation|1|||
146997798|NCT03243630|530156762|FG000|Overall Study|Physician Decision|1|||
146997799|NCT00939003|530156763|FG000|Double-blind Treatment Period|Adverse Event|1|||
146997800|NCT00939003|530156764|FG001|Double-blind Treatment Period|Adverse Event|1|||
146997801|NCT00939003|530156763|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
146997802|NCT00939003|530156764|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
146997803|NCT00939003|530156763|FG000|Double-blind Treatment Period|Pregnancy|0|||
146997804|NCT00939003|530156764|FG001|Double-blind Treatment Period|Pregnancy|1|||
146997805|NCT00939003|530156763|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
146997806|NCT00939003|530156764|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
146997807|NCT00939003|530156763|FG000|Open-label Treatment Period|Adverse Event|4|||
146997808|NCT00939003|530156764|FG001|Open-label Treatment Period|Adverse Event|8|||
146997809|NCT00939003|530156763|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
146997810|NCT00939003|530156764|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
146997811|NCT00939003|530156763|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
146997812|NCT00939003|530156764|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
146997813|NCT00939003|530156763|FG000|Open-label Treatment Period|Pregnancy|1|||
146997814|NCT00939003|530156764|FG001|Open-label Treatment Period|Pregnancy|1|||
146997815|NCT00939003|530156763|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
146997816|NCT00939003|530156764|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
146997817|NCT00939003|530156763|FG000|Open-label Treatment Period|Site Closure|3|||
146997818|NCT00939003|530156764|FG001|Open-label Treatment Period|Site Closure|4|||
146997819|NCT02131129|530156765|FG000|Overall Study|Withdrawal by Subject|1|||
146997820|NCT02131129|530156766|FG001|Overall Study|Withdrawal by Subject|0|||
146997821|NCT03707912|530156767|FG000|Overall Study|Violation of inclusion criteria|1|||
146997822|NCT03707912|530156768|FG001|Overall Study|Violation of inclusion criteria|0|||
146997823|NCT05369208|530158135|FG000|Core Phase|Prohibited Medication Required|2|||
146997824|NCT05369208|530158135|FG000|Core Phase|Adverse Event|1|||
146997825|NCT05369208|530158135|FG000|Core Phase|Lack of Efficacy|1|||
146997826|NCT04934722|530158136|FG000|Overall Study|Death|4|||
146997827|NCT04934722|530158137|FG001|Overall Study|Death|3|||
146997828|NCT04934722|530158136|FG000|Overall Study|Participants Ongoing|88|||
146997829|NCT04934722|530158137|FG001|Overall Study|Participants Ongoing|91|||
146997830|NCT00371839|530158138|FG000|Overall Study|Death|4|||
146997831|NCT00371839|530158139|FG001|Overall Study|Death|0|||
146997832|NCT00371839|530158140|FG002|Overall Study|Death|0|||
146997833|NCT00371839|530158138|FG000|Overall Study|Withdrawal by Subject|7|||
146997834|NCT00371839|530158139|FG001|Overall Study|Withdrawal by Subject|4|||
146997835|NCT00371839|530158140|FG002|Overall Study|Withdrawal by Subject|0|||
146997836|NCT00371839|530158138|FG000|Overall Study|Lost to Follow-up|6|||
146997837|NCT00371839|530158139|FG001|Overall Study|Lost to Follow-up|3|||
146997838|NCT00371839|530158140|FG002|Overall Study|Lost to Follow-up|2|||
146997839|NCT01149473|530158141|FG000|First Intervention|Adverse Event|1|||
146997840|NCT01149473|530158142|FG001|First Intervention|Adverse Event|1|||
146997841|NCT01149473|530158141|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
146997842|NCT01149473|530158142|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
146997843|NCT00834249|530158146|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
146997844|NCT00834249|530158147|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
146997845|NCT00834249|530158146|FG000|Second Intervention|Adverse Event|1|||
146997846|NCT00834249|530158147|FG001|Second Intervention|Adverse Event|0|||
146997847|NCT03450057|530158148|FG000|Overall Study|Death|17|||
146997848|NCT03450057|530158148|FG000|Overall Study|ICF withdrawal|4|||
146997849|NCT03450057|530158148|FG000|Overall Study|Lost to Follow-up|2|||
146997850|NCT00573066|530158149|FG000|Overall Study|Exclusion criteria|18|||
146997851|NCT00573066|530158149|FG000|Overall Study|IV malfunction|1|||
146997852|NCT00573066|530158149|FG000|Overall Study|Postoperative bleeding|1|||
146997853|NCT05755282|530158150|FG000|Overall Study|Protocol Violation|0|||
146997854|NCT05755282|530158151|FG001|Overall Study|Protocol Violation|1|||
146997855|NCT01015703|530158152|FG000|Overall Study|Withdrawal by Subject|0|||
146997856|NCT01015703|530158153|FG001|Overall Study|Withdrawal by Subject|1|||
146997857|NCT01015703|530158154|FG002|Overall Study|Withdrawal by Subject|0|||
146997858|NCT01015703|530158155|FG003|Overall Study|Withdrawal by Subject|0|||
146997859|NCT01015703|530158156|FG004|Overall Study|Withdrawal by Subject|0|||
146997860|NCT01015703|530158152|FG000|Overall Study|Adverse Event|1|||
146997861|NCT01015703|530158153|FG001|Overall Study|Adverse Event|0|||
146997862|NCT01015703|530158154|FG002|Overall Study|Adverse Event|0|||
146997863|NCT01015703|530158155|FG003|Overall Study|Adverse Event|0|||
146997864|NCT01015703|530158156|FG004|Overall Study|Adverse Event|0|||
146997865|NCT01015703|530158152|FG000|Overall Study|Protocol Violation|1|||
146997866|NCT01015703|530158153|FG001|Overall Study|Protocol Violation|0|||
146997867|NCT01015703|530158154|FG002|Overall Study|Protocol Violation|0|||
146997868|NCT01015703|530158155|FG003|Overall Study|Protocol Violation|0|||
146997869|NCT01015703|530158156|FG004|Overall Study|Protocol Violation|0|||
146997870|NCT01693523|530158157|FG000|Overall Study|Adverse Event|2|||
146997871|NCT01693523|530158158|FG001|Overall Study|Adverse Event|1|||
146997872|NCT01693523|530158159|FG002|Overall Study|Adverse Event|0|||
146997873|NCT01693523|530158157|FG000|Overall Study|Death|0|||
146997874|NCT01693523|530158158|FG001|Overall Study|Death|1|||
146997875|NCT01693523|530158159|FG002|Overall Study|Death|1|||
146997876|NCT01693523|530158157|FG000|Overall Study|Lost to Follow-up|0|||
146997877|NCT01693523|530158158|FG001|Overall Study|Lost to Follow-up|0|||
146997878|NCT01693523|530158159|FG002|Overall Study|Lost to Follow-up|4|||
146997879|NCT01693523|530158157|FG000|Overall Study|Physician Decision|0|||
146997880|NCT01693523|530158158|FG001|Overall Study|Physician Decision|0|||
146997881|NCT01693523|530158159|FG002|Overall Study|Physician Decision|1|||
146997882|NCT01693523|530158157|FG000|Overall Study|Withdrawal by Subject|1|||
146997883|NCT01693523|530158158|FG001|Overall Study|Withdrawal by Subject|2|||
146997884|NCT01693523|530158159|FG002|Overall Study|Withdrawal by Subject|2|||
146997885|NCT01693523|530158157|FG000|Overall Study|Lack of compliance study medication|1|||
146997886|NCT01693523|530158158|FG001|Overall Study|Lack of compliance study medication|2|||
146997887|NCT01693523|530158159|FG002|Overall Study|Lack of compliance study medication|0|||
146997888|NCT01693523|530158157|FG000|Overall Study|Chemotherapy was held|1|||
146997889|NCT01693523|530158158|FG001|Overall Study|Chemotherapy was held|2|||
146997890|NCT01693523|530158159|FG002|Overall Study|Chemotherapy was held|0|||
146997891|NCT00834418|530158160|FG000|Overall Study|Adverse Event|0|||
146997892|NCT00834418|530158161|FG001|Overall Study|Adverse Event|2|||
146997893|NCT02331394|530158163|FG000|Overall Study|Disease progression|1|||
146997894|NCT02098876|530158166|FG000|Overall Study|Withdrawal by Subject|5|||
146997895|NCT02098876|530158167|FG001|Overall Study|Withdrawal by Subject|5|||
146997896|NCT01602419|530158170|FG000|Overall Study|Not treated with Wilate|9|||
146997897|NCT01602419|530158170|FG000|Overall Study|Adverse Drug Reaction|4|||
146997898|NCT01602419|530158170|FG000|Overall Study|Insurance issues|3|||
146997899|NCT01602419|530158170|FG000|Overall Study|Changed treatment centre|1|||
146844732|NCT02672852|529600869|FG005|Part B|Lost to Follow-up|4|||
146844733|NCT02672852|529600870|FG006|Part B|Lost to Follow-up|1|||
146844734|NCT02672852|529600864|FG000|Part B|Withdrawal by Subject|0|||
146997900|NCT01602419|530158170|FG000|Overall Study|Treatment centre closed|1|||
146844735|NCT02672852|529600865|FG001|Part B|Withdrawal by Subject|0|||
146844736|NCT02672852|529600866|FG002|Part B|Withdrawal by Subject|0|||
146844737|NCT02672852|529600867|FG003|Part B|Withdrawal by Subject|0|||
146997901|NCT01602419|530158170|FG000|Overall Study|Withdrawal by Subject|5|||
146997902|NCT01602419|530158170|FG000|Overall Study|Lost to Follow-up|6|||
146997903|NCT01792635|530158171|FG000|Part B|Adverse Event|0|||
146997904|NCT01792635|530158172|FG001|Part B|Adverse Event|0|||
146997905|NCT01792635|530158173|FG002|Part B|Adverse Event|1|||
146997906|NCT01792635|530158171|FG000|Part B|Study terminated|0|||
146997907|NCT01792635|530158172|FG001|Part B|Study terminated|4|||
146997908|NCT01792635|530158173|FG002|Part B|Study terminated|3|||
146997909|NCT02714062|530158177|FG000|Overall Study|Adverse Event|0|||
146997910|NCT02714062|530158178|FG001|Overall Study|Adverse Event|0|||
146997911|NCT02714062|530158179|FG002|Overall Study|Adverse Event|2|||
146997912|NCT02714062|530158177|FG000|Overall Study|Withdrawal by Subject|1|||
146997913|NCT02714062|530158178|FG001|Overall Study|Withdrawal by Subject|0|||
146997914|NCT02714062|530158179|FG002|Overall Study|Withdrawal by Subject|1|||
146997915|NCT02714062|530158177|FG000|Overall Study|Protocol Violation|0|||
146997916|NCT02714062|530158178|FG001|Overall Study|Protocol Violation|1|||
146997917|NCT02714062|530158179|FG002|Overall Study|Protocol Violation|0|||
146997918|NCT03956862|530158180|FG000|Overall Study|Lost to Follow-up|1|||
146997919|NCT03956862|530158181|FG001|Overall Study|Lost to Follow-up|1|||
146997920|NCT03956862|530158180|FG000|Overall Study|Withdrawal by Subject|1|||
146997921|NCT03956862|530158181|FG001|Overall Study|Withdrawal by Subject|1|||
146997922|NCT00850174|530158182|FG000|Washout: One Week|Withdrawal by Subject|0|||
146997923|NCT00850174|530158183|FG001|Washout: One Week|Withdrawal by Subject|2|||
146997924|NCT00850174|530158182|FG000|Second Intervention|Withdrawal by Subject|1|||
146997925|NCT00850174|530158183|FG001|Second Intervention|Withdrawal by Subject|0|||
146997926|NCT02682784|530158193|FG000|Overall Study|Withdrawal by Subject|0|||
146997927|NCT02682784|530158194|FG001|Overall Study|Withdrawal by Subject|2|||
146997928|NCT02682784|530158195|FG002|Overall Study|Withdrawal by Subject|1|||
146997929|NCT02682784|530158196|FG003|Overall Study|Withdrawal by Subject|2|||
146997930|NCT02682784|530158193|FG000|Overall Study|Physician Decision|1|||
146997931|NCT02682784|530158194|FG001|Overall Study|Physician Decision|0|||
146997932|NCT02682784|530158195|FG002|Overall Study|Physician Decision|1|||
146997933|NCT02682784|530158196|FG003|Overall Study|Physician Decision|1|||
146997934|NCT01702987|530158197|FG000|Overall Study|Withdrawal by Subject|1|||
146997935|NCT01702987|530158198|FG001|Overall Study|Withdrawal by Subject|0|||
146997936|NCT02017223|530158199|FG000|Overall Study|Algorithm problems|2|||
146997937|NCT01401647|530158200|FG000|Overall Study|Withdrawal by Subject|1|||
146997938|NCT01401647|530158201|FG001|Overall Study|Withdrawal by Subject|5|||
146997939|NCT01401647|530158202|FG002|Overall Study|Withdrawal by Subject|2|||
146997940|NCT01401647|530158200|FG000|Overall Study|Lost to Follow-up|3|||
146997941|NCT01401647|530158201|FG001|Overall Study|Lost to Follow-up|3|||
146997942|NCT01401647|530158202|FG002|Overall Study|Lost to Follow-up|1|||
146997943|NCT00365846|530158207|FG000|Overall Study|Lost to Follow-up|1|||
146997944|NCT04263649|530158212|FG000|Overall Study|Adverse Event|53|||
146997945|NCT04263649|530158212|FG000|Overall Study|Lost to Follow-up|3|||
146997946|NCT04263649|530158212|FG000|Overall Study|Death|29|||
146997947|NCT04263649|530158212|FG000|Overall Study|Device deficiency|19|||
146997948|NCT04263649|530158212|FG000|Overall Study|other reasons|11|||
146997949|NCT02057458|530158213|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
146997950|NCT02057458|530158214|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
146997951|NCT02057458|530158215|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
146997952|NCT02057458|530158213|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
146997953|NCT02057458|530158214|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
146997954|NCT02057458|530158215|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
146997955|NCT02057458|530158213|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
146997956|NCT02057458|530158214|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
146997957|NCT02057458|530158215|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
146997958|NCT04400890|530158219|FG000|Overall Study|Withdrawal by Subject|3|||
146997959|NCT04400890|530158220|FG001|Overall Study|Withdrawal by Subject|2|||
146997960|NCT00846495|530158225|FG000|Overall Study|Lost to Follow-up|1|||
146997961|NCT00846495|530158226|FG001|Overall Study|Lost to Follow-up|0|||
146997962|NCT00846495|530158225|FG000|Overall Study|Adverse Event|5|||
146997963|NCT00846495|530158226|FG001|Overall Study|Adverse Event|1|||
146997964|NCT00846495|530158225|FG000|Overall Study|Lack of Efficacy|1|||
146997965|NCT00846495|530158226|FG001|Overall Study|Lack of Efficacy|2|||
146997966|NCT00846495|530158225|FG000|Overall Study|Physician Decision|1|||
146997967|NCT00846495|530158226|FG001|Overall Study|Physician Decision|0|||
146844738|NCT02672852|529600868|FG004|Part B|Withdrawal by Subject|5|||
146844739|NCT02672852|529600869|FG005|Part B|Withdrawal by Subject|0|||
146844740|NCT02672852|529600870|FG006|Part B|Withdrawal by Subject|7|||
146844741|NCT02672852|529600864|FG000|Part B|Other|0|||
146844742|NCT02672852|529600865|FG001|Part B|Other|0|||
146844743|NCT02672852|529600866|FG002|Part B|Other|0|||
146997968|NCT01265056|530158227|FG000|Initial Study Period|Withdrawal by Subject|1|||
146997969|NCT01265056|530158228|FG001|Initial Study Period|Withdrawal by Subject|1|||
146997970|NCT01265056|530158227|FG000|Initial Study Period|Withdrawal by Subject|1|||
146997971|NCT01265056|530158228|FG001|Initial Study Period|Withdrawal by Subject|1|||
146844744|NCT02672852|529600867|FG003|Part B|Other|0|||
146997972|NCT01265056|530158227|FG000|Follow up|Lost to Follow-up|7|||
146997973|NCT01265056|530158228|FG001|Follow up|Lost to Follow-up|3|||
146997974|NCT00537979|530158234|FG000|Overall Study|Adverse Event|2|||
146997975|NCT00537979|530158235|FG001|Overall Study|Adverse Event|2|||
146844745|NCT02672852|529600868|FG004|Part B|Other|4|||
146997976|NCT00537979|530158234|FG000|Overall Study|Withdrawal by Subject|1|||
146844746|NCT02672852|529600869|FG005|Part B|Other|1|||
146997977|NCT00537979|530158235|FG001|Overall Study|Withdrawal by Subject|4|||
146997978|NCT00537979|530158234|FG000|Overall Study|Lost to Follow-up|1|||
146997979|NCT00537979|530158235|FG001|Overall Study|Lost to Follow-up|4|||
146997980|NCT00537979|530158234|FG000|Overall Study|Lack of Efficacy|0|||
146997981|NCT00537979|530158235|FG001|Overall Study|Lack of Efficacy|1|||
146997982|NCT00537979|530158234|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
146997983|NCT00537979|530158235|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
146997984|NCT00537979|530158234|FG000|Overall Study|Death|0|||
146997985|NCT00537979|530158235|FG001|Overall Study|Death|3|||
146997986|NCT00537979|530158234|FG000|Overall Study|Kidney transplant|0|||
146997987|NCT00537979|530158235|FG001|Overall Study|Kidney transplant|3|||
146997988|NCT00537979|530158234|FG000|Overall Study|Heart failure|0|||
146997989|NCT00537979|530158235|FG001|Overall Study|Heart failure|1|||
146997990|NCT02601560|530158236|FG000|Overall Study|Other|0|||
146997991|NCT02601560|530158237|FG001|Overall Study|Other|0|||
146997992|NCT02601560|530158238|FG002|Overall Study|Other|0|||
146997993|NCT02601560|530158239|FG003|Overall Study|Other|0|||
146997994|NCT02601560|530158240|FG004|Overall Study|Other|0|||
146997995|NCT02601560|530158241|FG005|Overall Study|Other|0|||
146997996|NCT02601560|530158242|FG006|Overall Study|Other|1|||
146997997|NCT02601560|530158243|FG007|Overall Study|Other|0|||
146997998|NCT03459807|530158244|FG000|Overall Study|Withdrawal due to transplant|0|||
146997999|NCT03459807|530158245|FG001|Overall Study|Withdrawal due to transplant|1|||
146998000|NCT00576056|530158249|FG000|Overall Study|Adverse Event|1|||
146998001|NCT00576056|530158249|FG000|Overall Study|Death|1|||
146998002|NCT00576056|530158249|FG000|Overall Study|Lack of Efficacy|1|||
146998003|NCT00576056|530158249|FG000|Overall Study|Withdrawal by Subject|2|||
146998004|NCT00576056|530158249|FG000|Overall Study|did not meet eligibility criteria|8|||
146998005|NCT00576056|530158249|FG000|Overall Study|Physician Decision|1|||
146998006|NCT00858845|530158250|FG000|Overall Study|Patient underwent heart transplant.|0|||
146998007|NCT00858845|530158251|FG001|Overall Study|Patient underwent heart transplant.|1|||
146998008|NCT03420300|530158257|FG000|Overall Study|Death|2|||
146998009|NCT03500692|530158261|FG000|Overall Study|Death|163|||
146998010|NCT03500692|530158261|FG000|Overall Study|Lost to Follow-up|75|||
146998011|NCT03500692|530158261|FG000|Overall Study|Termination Reasons|3|||
146998012|NCT04149964|530158262|FG000|Overall Study|Lost to Follow-up|19|||
146998013|NCT04149964|530158263|FG001|Overall Study|Lost to Follow-up|18|||
146998014|NCT03041025|530158266|FG000|Overall Study|Adverse Event|0|||
146998015|NCT03041025|530158267|FG001|Overall Study|Adverse Event|0|||
146998016|NCT03041025|530158268|FG002|Overall Study|Adverse Event|1|||
146998017|NCT03041025|530158266|FG000|Overall Study|Lost to Follow-up|1|||
146998018|NCT03041025|530158267|FG001|Overall Study|Lost to Follow-up|0|||
146998019|NCT03041025|530158268|FG002|Overall Study|Lost to Follow-up|0|||
146998020|NCT03041025|530158266|FG000|Overall Study|Withdrawal by Subject|0|||
146998021|NCT03041025|530158267|FG001|Overall Study|Withdrawal by Subject|0|||
146998022|NCT03041025|530158268|FG002|Overall Study|Withdrawal by Subject|1|||
146998023|NCT03880266|530158270|FG000|Overall Study|Withdrawal by Subject|0|||
146998024|NCT03880266|530158271|FG001|Overall Study|Withdrawal by Subject|1|||
146998025|NCT03880266|530158272|FG002|Overall Study|Withdrawal by Subject|1|||
146998026|NCT03880266|530158273|FG003|Overall Study|Withdrawal by Subject|0|||
146998027|NCT03880266|530158274|FG004|Overall Study|Withdrawal by Subject|0|||
146998028|NCT03880266|530158275|FG005|Overall Study|Withdrawal by Subject|0|||
146998029|NCT03880266|530158276|FG006|Overall Study|Withdrawal by Subject|0|||
146998030|NCT03880266|530158277|FG007|Overall Study|Withdrawal by Subject|0|||
146998031|NCT01577381|530158281|FG000|Overall Study|Discontinued|2|||
146998032|NCT01577381|530158282|FG001|Overall Study|Discontinued|1|||
146998033|NCT01577381|530158283|FG002|Overall Study|Discontinued|2|||
146998034|NCT01577381|530158284|FG003|Overall Study|Discontinued|2|||
146998035|NCT01577381|530158281|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
146998036|NCT01577381|530158282|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
146998037|NCT01577381|530158283|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
146998038|NCT01577381|530158284|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
146998039|NCT02186821|530158285|FG000|Overall Study|Adverse Event|9|||
146998040|NCT02186821|530158285|FG000|Overall Study|Death|2|||
146998041|NCT02186821|530158285|FG000|Overall Study|Disease progression|32|||
146998042|NCT02186821|530158285|FG000|Overall Study|Protocol Violation|1|||
146998043|NCT02186821|530158285|FG000|Overall Study|Physician Decision|1|||
146998044|NCT02186821|530158285|FG000|Overall Study|Study terminated by sponsor|2|||
146998045|NCT01313780|530158286|FG000|Overall Study|Lack of Efficacy|4|||
146998046|NCT01313780|530158287|FG001|Overall Study|Lack of Efficacy|2|||
146998047|NCT01313780|530158286|FG000|Overall Study|Adverse Event|6|||
146998048|NCT01313780|530158287|FG001|Overall Study|Adverse Event|11|||
146998049|NCT01313780|530158286|FG000|Overall Study|Withdrawal by Subject|2|||
146998050|NCT01313780|530158287|FG001|Overall Study|Withdrawal by Subject|8|||
146998051|NCT01313780|530158286|FG000|Overall Study|Protocol Violation|10|||
146998052|NCT01313780|530158287|FG001|Overall Study|Protocol Violation|4|||
146998053|NCT01313780|530158286|FG000|Overall Study|missing data|3|||
146998054|NCT01313780|530158287|FG001|Overall Study|missing data|3|||
146998055|NCT00467896|530159696|FG000|Overall Study|Consent Withdrawal|18|||
146998056|NCT00467896|530159696|FG000|Overall Study|Adverse Event|7|||
146998057|NCT00467896|530159696|FG000|Overall Study|Serious Adverse Event|13|||
146998058|NCT00467896|530159696|FG000|Overall Study|Non-compliance|3|||
146998059|NCT00467896|530159696|FG000|Overall Study|Changed therapy|2|||
146998060|NCT00467896|530159696|FG000|Overall Study|Patient received transplant|2|||
146998061|NCT00467896|530159696|FG000|Overall Study|Patient had atrial septostomy|1|||
146998062|NCT00467896|530159696|FG000|Overall Study|Patient weaned off iloprost|1|||
146998063|NCT00467896|530159696|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
146998064|NCT00467896|530159696|FG000|Overall Study|Started intravenous prostacyclin|1|||
146998065|NCT00467896|530159696|FG000|Overall Study|Started inhaled Remodulin|1|||
146998066|NCT00467896|530159696|FG000|Overall Study|Patient had no improvement|1|||
146998067|NCT03772522|530159697|FG000|Pre-intervention|Withdrawal by Subject|3|||
146998068|NCT03772522|530159698|FG001|Pre-intervention|Withdrawal by Subject|4|||
146998069|NCT03772522|530159697|FG000|Intervention|Withdrawal by Subject|1|||
146998070|NCT03772522|530159698|FG001|Intervention|Withdrawal by Subject|0|||
146998071|NCT03772522|530159697|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
146998072|NCT03772522|530159698|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
146998073|NCT03818581|530159701|FG000|Overall Study|Adverse Event|1|||
146998074|NCT03818581|530159702|FG001|Overall Study|Adverse Event|0|||
146998075|NCT03818581|530159703|FG002|Overall Study|Adverse Event|0|||
146998076|NCT03818581|530159704|FG003|Overall Study|Adverse Event|0|||
146998077|NCT03818581|530159705|FG004|Overall Study|Adverse Event|0|||
146998078|NCT03818581|530159701|FG000|Overall Study|Covid-19|2|||
146998079|NCT03818581|530159702|FG001|Overall Study|Covid-19|0|||
146998080|NCT03818581|530159703|FG002|Overall Study|Covid-19|0|||
146998081|NCT03818581|530159704|FG003|Overall Study|Covid-19|0|||
146998082|NCT03818581|530159705|FG004|Overall Study|Covid-19|1|||
146998083|NCT03818581|530159701|FG000|Overall Study|Withdrawal by Subject|0|||
146998084|NCT03818581|530159702|FG001|Overall Study|Withdrawal by Subject|0|||
146998085|NCT03818581|530159703|FG002|Overall Study|Withdrawal by Subject|0|||
146998086|NCT03818581|530159704|FG003|Overall Study|Withdrawal by Subject|0|||
146998087|NCT03818581|530159705|FG004|Overall Study|Withdrawal by Subject|1|||
146998088|NCT03818581|530159701|FG000|Overall Study|No longer met study criteria|0|||
146998089|NCT03818581|530159702|FG001|Overall Study|No longer met study criteria|0|||
146998090|NCT03818581|530159703|FG002|Overall Study|No longer met study criteria|0|||
146998091|NCT03818581|530159704|FG003|Overall Study|No longer met study criteria|0|||
146998092|NCT03818581|530159705|FG004|Overall Study|No longer met study criteria|1|||
146998093|NCT02096211|530159708|FG000|Overall Study|Death|2|||
146998094|NCT02096211|530159708|FG000|Overall Study|Withdrawal by Subject|8|||
146998095|NCT02096211|530159708|FG000|Overall Study|Revision of implant|7|||
146998096|NCT02096211|530159708|FG000|Overall Study|Lost to Follow-up|43|||
146998097|NCT01439880|530159713|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
146998098|NCT01439880|530159714|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
146998099|NCT01439880|530159713|FG000|SOC-controlled Period (Year 1)|Death|2|||
146998100|NCT01439880|530159714|FG001|SOC-controlled Period (Year 1)|Death|1|||
146998101|NCT01439880|530159713|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
146998102|NCT01439880|530159714|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
146998103|NCT01439880|530159713|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
146998104|NCT01439880|530159714|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
146998105|NCT01439880|530159713|FG000|SOC-controlled Period (Year 1)|Other|8|||
146998106|NCT01439880|530159714|FG001|SOC-controlled Period (Year 1)|Other|13|||
146998107|NCT01439880|530159713|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
146998108|NCT01439880|530159714|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
146998109|NCT01439880|530159713|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
146998110|NCT01439880|530159714|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
146998111|NCT01439880|530159713|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
146998112|NCT01439880|530159714|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
146998113|NCT01439880|530159713|FG000|All-IP Period (Years 2 to 5)|Death|3|||
146998114|NCT01439880|530159714|FG001|All-IP Period (Years 2 to 5)|Death|13|||
146844747|NCT02672852|529600870|FG006|Part B|Other|2|||
146844748|NCT03248882|529600871|FG000|Overall Study|Adverse Event|3|||
146844749|NCT03248882|529600872|FG001|Overall Study|Adverse Event|3|||
146998115|NCT01439880|530159713|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
146998116|NCT01439880|530159714|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
146998117|NCT01439880|530159713|FG000|All-IP Period (Years 2 to 5)|Other|14|||
146844750|NCT03248882|529600873|FG002|Overall Study|Adverse Event|2|||
146844751|NCT03248882|529600874|FG003|Overall Study|Adverse Event|6|||
146844752|NCT03248882|529600875|FG004|Overall Study|Adverse Event|9|||
146844753|NCT03248882|529600871|FG000|Overall Study|Lost to Follow-up|0|||
146998118|NCT01439880|530159714|FG001|All-IP Period (Years 2 to 5)|Other|31|||
146998119|NCT01439880|530159713|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
146998120|NCT01439880|530159714|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
146998121|NCT00328926|530159715|FG000|Overall Study|Pregnancy|2|||
146998122|NCT00328926|530159716|FG001|Overall Study|Pregnancy|1|||
146998123|NCT00328926|530159717|FG002|Overall Study|Pregnancy|0|||
146998124|NCT00328926|530159715|FG000|Overall Study|Lost to Follow-up|0|||
146998125|NCT00328926|530159716|FG001|Overall Study|Lost to Follow-up|1|||
146998126|NCT00328926|530159717|FG002|Overall Study|Lost to Follow-up|0|||
146998127|NCT00328926|530159715|FG000|Overall Study|Death|0|||
146998128|NCT00328926|530159716|FG001|Overall Study|Death|0|||
146998129|NCT00328926|530159717|FG002|Overall Study|Death|1|||
146998130|NCT00328926|530159715|FG000|Overall Study|In vitro fertilization treatment|0|||
146998131|NCT00328926|530159716|FG001|Overall Study|In vitro fertilization treatment|0|||
146998132|NCT00328926|530159717|FG002|Overall Study|In vitro fertilization treatment|1|||
146998133|NCT00328926|530159715|FG000|Overall Study|Lack of ovarian response|0|||
146998134|NCT00328926|530159716|FG001|Overall Study|Lack of ovarian response|1|||
146998135|NCT00328926|530159717|FG002|Overall Study|Lack of ovarian response|0|||
146998136|NCT02269657|530159718|FG000|Overall Study|Protocol Violation|3|||
146998137|NCT02956460|530159721|FG000|Lens 1|Lost to Follow-up|1|||
146998138|NCT02956460|530159722|FG001|Lens 1|Lost to Follow-up|0|||
146998139|NCT02440711|530159723|FG000|Second Intervention|Lost to Follow-up|1|||
146998140|NCT02440711|530159724|FG001|Second Intervention|Lost to Follow-up|0|||
146998141|NCT04129346|530159727|FG000|Overall Study|Death|1|||
146998142|NCT04129346|530159728|FG001|Overall Study|Death|0|||
146998143|NCT02646124|530159729|FG000|Overall Study|Lost to Follow-up|0|||
146998144|NCT02646124|530159730|FG001|Overall Study|Lost to Follow-up|2|||
146998145|NCT03154047|530159731|FG000|Overall Study|Death|1|||
146998146|NCT03154047|530159731|FG000|Overall Study|Study terminated by sponsor|76|||
146998147|NCT03154047|530159731|FG000|Overall Study|Withdrawal by Subject|3|||
146998148|NCT00857454|530159732|FG000|Overall Study|Withdrawal by Subject|2|||
146998149|NCT00857454|530159732|FG000|Overall Study|Lost to Follow-up|1|||
146998150|NCT00857454|530159732|FG000|Overall Study|Adverse Event|2|||
146998151|NCT00857454|530159732|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
146998152|NCT00857454|530159732|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
146998153|NCT00857454|530159732|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
146998154|NCT00365365|530159733|FG000|Overall Study|Randomized but not treated|0|||
146998155|NCT00365365|530159734|FG001|Overall Study|Randomized but not treated|2|||
146998156|NCT00365365|530159735|FG002|Overall Study|Randomized but not treated|0|||
146998157|NCT00365365|530159733|FG000|Overall Study|Poor compliance to protocol|0|||
146998158|NCT00365365|530159734|FG001|Overall Study|Poor compliance to protocol|1|||
146998159|NCT00365365|530159735|FG002|Overall Study|Poor compliance to protocol|0|||
146998160|NCT00365365|530159733|FG000|Overall Study|Lost to Follow-up|3|||
146998161|NCT00365365|530159734|FG001|Overall Study|Lost to Follow-up|3|||
146998162|NCT00365365|530159735|FG002|Overall Study|Lost to Follow-up|3|||
146998163|NCT00365365|530159733|FG000|Overall Study|Death|1|||
146998164|NCT00365365|530159734|FG001|Overall Study|Death|3|||
146998165|NCT00365365|530159735|FG002|Overall Study|Death|0|||
146998166|NCT00365365|530159733|FG000|Overall Study|Subject's request|11|||
146998167|NCT00365365|530159734|FG001|Overall Study|Subject's request|13|||
146998168|NCT00365365|530159735|FG002|Overall Study|Subject's request|1|||
146998169|NCT00365365|530159733|FG000|Overall Study|Disease progression/relapse|9|||
146998170|NCT00365365|530159734|FG001|Overall Study|Disease progression/relapse|6|||
146998171|NCT00365365|530159735|FG002|Overall Study|Disease progression/relapse|7|||
146998172|NCT00365365|530159733|FG000|Overall Study|Adverse Event|6|||
146998173|NCT00365365|530159734|FG001|Overall Study|Adverse Event|6|||
146998174|NCT00365365|530159735|FG002|Overall Study|Adverse Event|3|||
146998175|NCT00365365|530159733|FG000|Overall Study|Moved|2|||
146998176|NCT00365365|530159734|FG001|Overall Study|Moved|0|||
146998177|NCT00365365|530159735|FG002|Overall Study|Moved|0|||
146998178|NCT00365365|530159733|FG000|Overall Study|New cancer|1|||
146998179|NCT00365365|530159734|FG001|Overall Study|New cancer|0|||
146998180|NCT00365365|530159735|FG002|Overall Study|New cancer|0|||
146998181|NCT00365365|530159733|FG000|Overall Study|Withdrew consent|1|||
146998182|NCT00365365|530159734|FG001|Overall Study|Withdrew consent|1|||
146998183|NCT00365365|530159735|FG002|Overall Study|Withdrew consent|0|||
146998184|NCT00365365|530159733|FG000|Overall Study|Second malignancy|0|||
146998185|NCT00365365|530159734|FG001|Overall Study|Second malignancy|1|||
146998186|NCT00365365|530159735|FG002|Overall Study|Second malignancy|0|||
146998187|NCT00365365|530159733|FG000|Overall Study|Patient/physician decision|0|||
146998188|NCT00365365|530159734|FG001|Overall Study|Patient/physician decision|0|||
146998189|NCT00365365|530159735|FG002|Overall Study|Patient/physician decision|1|||
146998190|NCT01083693|530159738|FG000|Overall Study|Adverse Event|1|||
146998191|NCT01083693|530159739|FG001|Overall Study|Adverse Event|1|||
146998192|NCT01083693|530159740|FG002|Overall Study|Adverse Event|0|||
146998193|NCT01083693|530159738|FG000|Overall Study|Lost to Follow-up|2|||
146998194|NCT01083693|530159739|FG001|Overall Study|Lost to Follow-up|0|||
146735962|NCT03489057|529205253|FG003|Overall Study|Withdrawal by Subject|8|||
146735963|NCT03489057|529205250|FG000|Overall Study|Protocol Violation|7|||
146735964|NCT03489057|529205251|FG001|Overall Study|Protocol Violation|7|||
146998195|NCT01083693|530159740|FG002|Overall Study|Lost to Follow-up|2|||
146998196|NCT01083693|530159738|FG000|Overall Study|Lack of effectiveness|13|||
146998197|NCT01083693|530159739|FG001|Overall Study|Lack of effectiveness|2|||
146998198|NCT01083693|530159740|FG002|Overall Study|Lack of effectiveness|2|||
146998199|NCT01083693|530159738|FG000|Overall Study|Patient Moved|0|||
146998200|NCT01083693|530159739|FG001|Overall Study|Patient Moved|1|||
146998201|NCT01083693|530159740|FG002|Overall Study|Patient Moved|0|||
146998202|NCT01083693|530159738|FG000|Overall Study|Complete remission|0|||
146998203|NCT01083693|530159739|FG001|Overall Study|Complete remission|1|||
146998204|NCT01083693|530159740|FG002|Overall Study|Complete remission|0|||
146998205|NCT01083693|530159738|FG000|Overall Study|Other medical condition/surgery|1|||
146998206|NCT01083693|530159739|FG001|Overall Study|Other medical condition/surgery|1|||
146998207|NCT01083693|530159740|FG002|Overall Study|Other medical condition/surgery|0|||
146998208|NCT01083693|530159738|FG000|Overall Study|Withdrawal by Subject|3|||
146998209|NCT01083693|530159739|FG001|Overall Study|Withdrawal by Subject|0|||
146998210|NCT01083693|530159740|FG002|Overall Study|Withdrawal by Subject|2|||
146998211|NCT01083693|530159738|FG000|Overall Study|Reason unknown|0|||
146998212|NCT01083693|530159739|FG001|Overall Study|Reason unknown|0|||
146998213|NCT01083693|530159740|FG002|Overall Study|Reason unknown|1|||
146998214|NCT04567186|530159741|FG000|Period 1|COVID-19 related|1|||
146998215|NCT04567186|530159742|FG001|Period 1|COVID-19 related|0|||
146998216|NCT04567186|530159741|FG000|Period 1|Protocol Violation|0|||
146998217|NCT04567186|530159742|FG001|Period 1|Protocol Violation|1|||
146998218|NCT04567186|530159741|FG000|Period 1|Adverse Event|0|||
146998219|NCT04567186|530159742|FG001|Period 1|Adverse Event|2|||
146998220|NCT04567186|530159741|FG000|Period 2|COVID-19 Related|0|||
146998221|NCT04567186|530159742|FG001|Period 2|COVID-19 Related|1|||
146998222|NCT04567186|530159741|FG000|Period 2|Protocol Violation|0|||
146998223|NCT04567186|530159742|FG001|Period 2|Protocol Violation|1|||
146998224|NCT04567186|530159741|FG000|Period 2|Lost to Follow-up|0|||
146998225|NCT04567186|530159742|FG001|Period 2|Lost to Follow-up|1|||
146998226|NCT04567186|530159741|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
146998227|NCT04567186|530159742|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
146998228|NCT04274686|530159743|FG000|Overall Study|Physician Decision|1|||
146998229|NCT04274686|530159744|FG001|Overall Study|Physician Decision|0|||
146998230|NCT00376623|530159745|FG000|Overall Study|Progressive disease|35|||
146998231|NCT00376623|530159746|FG001|Overall Study|Progressive disease|22|||
146998232|NCT00376623|530159747|FG002|Overall Study|Progressive disease|17|||
146998233|NCT00376623|530159745|FG000|Overall Study|Lost to Follow-up|0|||
146998234|NCT00376623|530159746|FG001|Overall Study|Lost to Follow-up|1|||
146998235|NCT00376623|530159747|FG002|Overall Study|Lost to Follow-up|0|||
146998236|NCT00376623|530159745|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
146998237|NCT00376623|530159746|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
146998238|NCT00376623|530159747|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
146998239|NCT00376623|530159745|FG000|Overall Study|Not treated with BI 2536|1|||
146998240|NCT00376623|530159746|FG001|Overall Study|Not treated with BI 2536|0|||
146998241|NCT00376623|530159747|FG002|Overall Study|Not treated with BI 2536|0|||
146998242|NCT00376623|530159745|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
146998243|NCT00376623|530159746|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
146998244|NCT00376623|530159747|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
146998245|NCT00376623|530159745|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
146998246|NCT00376623|530159746|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
146998247|NCT00376623|530159747|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
146998248|NCT00376623|530159745|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
146998249|NCT00376623|530159746|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
146998250|NCT00376623|530159747|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
146998251|NCT00376623|530159745|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
146998252|NCT00376623|530159746|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
146844754|NCT03248882|529600872|FG001|Overall Study|Lost to Follow-up|0|||
146998253|NCT00376623|530159747|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
146998254|NCT00376623|530159745|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
146998255|NCT00376623|530159746|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
146998256|NCT00376623|530159747|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
146998257|NCT00376623|530159745|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
146998258|NCT00376623|530159746|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
146998259|NCT00376623|530159747|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
146998260|NCT00376623|530159745|FG000|Overall Study|Increase of tumour markers|0|||
146998261|NCT00376623|530159746|FG001|Overall Study|Increase of tumour markers|1|||
146735965|NCT03489057|529205252|FG002|Overall Study|Protocol Violation|2|||
146735966|NCT03489057|529205253|FG003|Overall Study|Protocol Violation|2|||
146735967|NCT02034708|529205254|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
146735968|NCT02034708|529205255|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
146735969|NCT02034708|529205254|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
146735970|NCT02034708|529205255|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
146735971|NCT02034708|529205254|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
146998262|NCT00376623|530159747|FG002|Overall Study|Increase of tumour markers|0|||
146998263|NCT00376623|530159745|FG000|Overall Study|Bone metastasis|1|||
146998264|NCT00376623|530159746|FG001|Overall Study|Bone metastasis|0|||
146998265|NCT00376623|530159747|FG002|Overall Study|Bone metastasis|0|||
146998266|NCT04247282|530159748|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
146998267|NCT04247282|530159749|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
146998268|NCT04247282|530159750|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
146998269|NCT04247282|530159751|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
146998270|NCT04247282|530159748|FG000|Overall Study|Refused further treatment|0|||
146998271|NCT04247282|530159749|FG001|Overall Study|Refused further treatment|1|||
146998272|NCT04247282|530159750|FG002|Overall Study|Refused further treatment|0|||
146998273|NCT04247282|530159751|FG003|Overall Study|Refused further treatment|0|||
146998274|NCT01313273|530159752|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
146998275|NCT01313273|530159753|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
146998276|NCT01313273|530159752|FG000|Overall Study|Withdrawal by Subject|1|||
146998277|NCT01313273|530159753|FG001|Overall Study|Withdrawal by Subject|0|||
146998278|NCT01313273|530159752|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
146998279|NCT01313273|530159753|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
146998280|NCT03687736|530159754|FG000|Overall Study|Lost to Follow-up|7|||
146998281|NCT03687736|530159754|FG000|Overall Study|Withdrawal by Subject|3|||
146998282|NCT03496623|530159757|FG000|Run-In Period (2 Weeks)|Death|1|||
146998283|NCT03496623|530159758|FG001|Run-In Period (2 Weeks)|Death|0|||
146998284|NCT03496623|530159759|FG002|Run-In Period (2 Weeks)|Death|0|||
146998285|NCT03496623|530159760|FG003|Run-In Period (2 Weeks)|Death|0|||
146998286|NCT03496623|530159761|FG004|Run-In Period (2 Weeks)|Death|0|||
146998287|NCT03496623|530159757|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
146998288|NCT03496623|530159758|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
146998289|NCT03496623|530159759|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
146998290|NCT03496623|530159760|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
146998291|NCT03496623|530159761|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
146998292|NCT03496623|530159757|FG000|Period 1 (12 Weeks)|Death|0|||
146998293|NCT03496623|530159758|FG001|Period 1 (12 Weeks)|Death|3|||
146998294|NCT03496623|530159759|FG002|Period 1 (12 Weeks)|Death|0|||
146998295|NCT03496623|530159760|FG003|Period 1 (12 Weeks)|Death|0|||
146844755|NCT03248882|529600873|FG002|Overall Study|Lost to Follow-up|0|||
146844756|NCT03248882|529600874|FG003|Overall Study|Lost to Follow-up|0|||
146844757|NCT03248882|529600875|FG004|Overall Study|Lost to Follow-up|1|||
146844758|NCT03248882|529600871|FG000|Overall Study|Protocol Violation|2|||
146844759|NCT03248882|529600872|FG001|Overall Study|Protocol Violation|0|||
146844760|NCT03248882|529600873|FG002|Overall Study|Protocol Violation|2|||
146844761|NCT03248882|529600874|FG003|Overall Study|Protocol Violation|0|||
146844762|NCT03248882|529600875|FG004|Overall Study|Protocol Violation|1|||
146844763|NCT03248882|529600871|FG000|Overall Study|Withdrawal by Subject|2|||
146998296|NCT03496623|530159761|FG004|Period 1 (12 Weeks)|Death|0|||
146998297|NCT03496623|530159757|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
146998298|NCT03496623|530159758|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
146998299|NCT03496623|530159759|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
146998300|NCT03496623|530159760|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
146998301|NCT03496623|530159761|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
146998302|NCT03496623|530159757|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146998303|NCT03496623|530159758|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
146998304|NCT03496623|530159759|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
146998305|NCT03496623|530159760|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146998306|NCT03496623|530159761|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146998307|NCT03496623|530159757|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
146844764|NCT03248882|529600872|FG001|Overall Study|Withdrawal by Subject|2|||
146844765|NCT03248882|529600873|FG002|Overall Study|Withdrawal by Subject|3|||
146844766|NCT03248882|529600874|FG003|Overall Study|Withdrawal by Subject|4|||
146998308|NCT03496623|530159758|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
146998309|NCT03496623|530159759|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
146998310|NCT03496623|530159760|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
146998311|NCT03496623|530159761|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
146998312|NCT03496623|530159757|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
146998313|NCT03496623|530159758|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
146998314|NCT03496623|530159759|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
146998315|NCT03496623|530159760|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
146998316|NCT03496623|530159761|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
146844767|NCT03248882|529600875|FG004|Overall Study|Withdrawal by Subject|2|||
146844768|NCT04308590|529600876|FG000|Overall Study|Adverse Event|12|||
146844769|NCT04308590|529600877|FG001|Overall Study|Adverse Event|2|||
146844770|NCT04308590|529600876|FG000|Overall Study|Withdrawal by Subject|10|||
146844771|NCT04308590|529600877|FG001|Overall Study|Withdrawal by Subject|4|||
146844772|NCT04308590|529600876|FG000|Overall Study|Death|1|||
146998317|NCT03496623|530159757|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
146844773|NCT04308590|529600877|FG001|Overall Study|Death|0|||
146844774|NCT04308590|529600876|FG000|Overall Study|Lost to Follow-up|1|||
146844775|NCT04308590|529600877|FG001|Overall Study|Lost to Follow-up|1|||
146844776|NCT04308590|529600876|FG000|Overall Study|Physician Decision|1|||
146844777|NCT04308590|529600877|FG001|Overall Study|Physician Decision|0|||
146844778|NCT04308590|529600876|FG000|Overall Study|Subject does not want to continue with Pi|0|||
146844779|NCT04308590|529600877|FG001|Overall Study|Subject does not want to continue with Pi|1|||
146998318|NCT03496623|530159758|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
146998319|NCT03496623|530159759|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
146998320|NCT03496623|530159760|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
146998321|NCT03496623|530159761|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
146998322|NCT03496623|530159757|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146998323|NCT03496623|530159758|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
146998324|NCT03496623|530159759|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146998325|NCT03496623|530159760|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146998326|NCT03496623|530159761|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146998327|NCT02543203|530159762|FG000|Overall Study|Unpalatable Fragrance|2|||
146998328|NCT02543203|530159763|FG001|Overall Study|Unpalatable Fragrance|2|||
146998329|NCT02543203|530159762|FG000|Overall Study|Lost to Follow-up|1|||
146998330|NCT02543203|530159763|FG001|Overall Study|Lost to Follow-up|0|||
146998331|NCT02543203|530159762|FG000|Overall Study|Increased Irritability|1|||
146998332|NCT02543203|530159763|FG001|Overall Study|Increased Irritability|0|||
146998333|NCT02543203|530159762|FG000|Overall Study|Family|1|||
146998334|NCT02543203|530159763|FG001|Overall Study|Family|2|||
146998335|NCT02543203|530159762|FG000|Overall Study|Negative Behavior|1|||
146998336|NCT02543203|530159763|FG001|Overall Study|Negative Behavior|0|||
146998337|NCT02543203|530159762|FG000|Overall Study|Withdrawal by Subject|0|||
146998338|NCT02543203|530159763|FG001|Overall Study|Withdrawal by Subject|1|||
146998339|NCT03020615|530159764|FG000|Overall Study|Physician Decision|3|||
146998340|NCT03020615|530159765|FG001|Overall Study|Physician Decision|1|||
146998341|NCT03020615|530159766|FG002|Overall Study|Physician Decision|2|||
146998342|NCT03020615|530159764|FG000|Overall Study|Parent/guardian/patient choice|3|||
146998343|NCT03020615|530159765|FG001|Overall Study|Parent/guardian/patient choice|0|||
146998344|NCT03020615|530159766|FG002|Overall Study|Parent/guardian/patient choice|4|||
146998345|NCT03020615|530159764|FG000|Overall Study|Screen failure|0|||
146998346|NCT03020615|530159765|FG001|Overall Study|Screen failure|0|||
146998347|NCT03020615|530159766|FG002|Overall Study|Screen failure|1|||
146998348|NCT03020615|530159764|FG000|Overall Study|Death|1|||
146998349|NCT03020615|530159765|FG001|Overall Study|Death|0|||
146998350|NCT03020615|530159766|FG002|Overall Study|Death|0|||
146998351|NCT03020615|530159764|FG000|Overall Study|Lost to Follow-up|0|||
146998352|NCT03020615|530159765|FG001|Overall Study|Lost to Follow-up|1|||
146998353|NCT03020615|530159766|FG002|Overall Study|Lost to Follow-up|0|||
146998354|NCT00089661|530159767|FG000|Overall Study|Adverse Event|0|||
146998355|NCT00089661|530159768|FG001|Overall Study|Adverse Event|2|||
146998356|NCT00089661|530159767|FG000|Overall Study|Death|1|||
146998357|NCT00089661|530159768|FG001|Overall Study|Death|0|||
146998358|NCT00089661|530159767|FG000|Overall Study|Lost to Follow-up|0|||
146998359|NCT00089661|530159768|FG001|Overall Study|Lost to Follow-up|3|||
146998360|NCT00089661|530159767|FG000|Overall Study|Withdrawal by Subject|11|||
146998361|NCT00089661|530159768|FG001|Overall Study|Withdrawal by Subject|9|||
146998362|NCT00089661|530159767|FG000|Overall Study|Disease progression|1|||
146998363|NCT00089661|530159768|FG001|Overall Study|Disease progression|3|||
146998364|NCT00089661|530159767|FG000|Overall Study|Ineligibility determined|4|||
146998365|NCT00089661|530159768|FG001|Overall Study|Ineligibility determined|4|||
146998366|NCT00089661|530159767|FG000|Overall Study|Noncompliance|2|||
146998367|NCT00089661|530159768|FG001|Overall Study|Noncompliance|4|||
146998368|NCT00089661|530159767|FG000|Overall Study|Other|2|||
146998369|NCT00089661|530159768|FG001|Overall Study|Other|1|||
146998370|NCT02077465|530159773|FG000|Overall Study|Withdrew Consent|0|||
146844780|NCT00356408|529600878|FG000|Overall Study|Adverse Event|9|||
146844781|NCT00356408|529600878|FG000|Overall Study|Lack of Efficacy|36|||
146998371|NCT02077465|530159774|FG001|Overall Study|Withdrew Consent|1|||
146998372|NCT02077465|530159773|FG000|Overall Study|Lost to Follow-up|1|||
146998373|NCT02077465|530159774|FG001|Overall Study|Lost to Follow-up|0|||
146998374|NCT02481830|530159775|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
146998375|NCT02481830|530159776|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
146998376|NCT02481830|530159775|FG000|Pre-treatment|Withdrawal by Subject|0|||
146998377|NCT02481830|530159776|FG001|Pre-treatment|Withdrawal by Subject|10|||
146998378|NCT02481830|530159775|FG000|Pre-treatment|Disease Progression|1|||
146998379|NCT02481830|530159776|FG001|Pre-treatment|Disease Progression|1|||
146998380|NCT02481830|530159775|FG000|Pre-treatment|Other reasons|0|||
146998381|NCT02481830|530159776|FG001|Pre-treatment|Other reasons|1|||
146998382|NCT02481830|530159775|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
146998383|NCT02481830|530159776|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
146844782|NCT00356408|529600878|FG000|Overall Study|Lost to Follow-up|2|||
146998384|NCT02481830|530159775|FG000|Treatment|Disease Progression|233|||
146998385|NCT02481830|530159776|FG001|Treatment|Disease Progression|171|||
146844783|NCT00356408|529600878|FG000|Overall Study|Withdrawal by Subject|6|||
146844784|NCT00356408|529600878|FG000|Overall Study|Other: Principal investigator discretion|3|||
146998386|NCT02481830|530159775|FG000|Treatment|Study drug toxicity|18|||
146998387|NCT02481830|530159776|FG001|Treatment|Study drug toxicity|38|||
146998388|NCT02481830|530159775|FG000|Treatment|Death|1|||
146998389|NCT02481830|530159776|FG001|Treatment|Death|1|||
146998390|NCT02481830|530159775|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
146998391|NCT02481830|530159776|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
146998392|NCT02481830|530159775|FG000|Treatment|Participants request to discontinue Study treatment|6|||
146998393|NCT02481830|530159776|FG001|Treatment|Participants request to discontinue Study treatment|34|||
146998394|NCT02481830|530159775|FG000|Treatment|Withdrawal by Subject|2|||
146998395|NCT02481830|530159776|FG001|Treatment|Withdrawal by Subject|3|||
146998396|NCT02481830|530159775|FG000|Treatment|Lost to Follow-up|1|||
146998397|NCT02481830|530159776|FG001|Treatment|Lost to Follow-up|0|||
146998398|NCT02481830|530159775|FG000|Treatment|Maximum Clinical Benefit|0|||
146998399|NCT02481830|530159776|FG001|Treatment|Maximum Clinical Benefit|5|||
146998400|NCT02481830|530159775|FG000|Treatment|Administrative reason by sponsor|1|||
146998401|NCT02481830|530159776|FG001|Treatment|Administrative reason by sponsor|1|||
146998402|NCT02481830|530159775|FG000|Treatment|Other reasons|6|||
146998403|NCT02481830|530159776|FG001|Treatment|Other reasons|1|||
146998404|NCT04627038|530159777|FG000|Overall Study|Adverse Event|36|||
146998405|NCT04627038|530159778|FG001|Overall Study|Adverse Event|8|||
146998406|NCT04627038|530159777|FG000|Overall Study|Lost to Follow-up|1|||
146998407|NCT04627038|530159778|FG001|Overall Study|Lost to Follow-up|0|||
146998408|NCT04627038|530159777|FG000|Overall Study|Physician Decision|0|||
146998409|NCT04627038|530159778|FG001|Overall Study|Physician Decision|1|||
146998410|NCT04627038|530159777|FG000|Overall Study|Protocol Violation|3|||
146998411|NCT04627038|530159778|FG001|Overall Study|Protocol Violation|1|||
146998412|NCT04627038|530159777|FG000|Overall Study|Withdrawal by Subject|13|||
146998413|NCT04627038|530159778|FG001|Overall Study|Withdrawal by Subject|3|||
146998414|NCT04627038|530159777|FG000|Overall Study|Non-compliance with study drug|0|||
146998415|NCT04627038|530159778|FG001|Overall Study|Non-compliance with study drug|1|||
146998416|NCT04627038|530159777|FG000|Overall Study|Prohibited Concomitant Medication|1|||
146998417|NCT04627038|530159778|FG001|Overall Study|Prohibited Concomitant Medication|0|||
146998418|NCT00794963|530159783|FG000|Overall Study|Withdrawal by Subject|1|||
146998419|NCT00794963|530159784|FG001|Overall Study|Withdrawal by Subject|4|||
146998420|NCT03375463|530159785|FG000|Period 1|Lost to Follow-up|0|||
146998421|NCT03375463|530159786|FG001|Period 1|Lost to Follow-up|0|||
146998422|NCT03375463|530159787|FG002|Period 1|Lost to Follow-up|1|||
146998423|NCT03375463|530159788|FG003|Period 1|Lost to Follow-up|0|||
146998424|NCT03375463|530159789|FG004|Period 1|Lost to Follow-up|0|||
146998425|NCT03375463|530159790|FG005|Period 1|Lost to Follow-up|0|||
146998426|NCT03375463|530159785|FG000|Period 1|Adverse Event|0|||
146998427|NCT03375463|530159786|FG001|Period 1|Adverse Event|0|||
146998428|NCT03375463|530159787|FG002|Period 1|Adverse Event|0|||
146998429|NCT03375463|530159788|FG003|Period 1|Adverse Event|0|||
146998430|NCT03375463|530159789|FG004|Period 1|Adverse Event|1|||
146998431|NCT03375463|530159790|FG005|Period 1|Adverse Event|0|||
146998432|NCT03375463|530159785|FG000|Period 2|Lost to Follow-up|1|||
146998433|NCT03375463|530159786|FG001|Period 2|Lost to Follow-up|1|||
146998434|NCT03375463|530159787|FG002|Period 2|Lost to Follow-up|0|||
146998435|NCT03375463|530159788|FG003|Period 2|Lost to Follow-up|0|||
146998436|NCT03375463|530159789|FG004|Period 2|Lost to Follow-up|0|||
146998437|NCT03375463|530159790|FG005|Period 2|Lost to Follow-up|0|||
146998438|NCT01827163|530159791|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
146998439|NCT01827163|530159791|FG000|Overall Study|Adverse Event|9|||
146998440|NCT01037114|530159792|FG000|Year 20|Others|1|||
146998441|NCT02294604|530159800|FG000|Overall Study|Did not provide samples for culture|0|||
146998442|NCT02294604|530159801|FG001|Overall Study|Did not provide samples for culture|1|||
146998443|NCT02294604|530159802|FG002|Overall Study|Did not provide samples for culture|0|||
146998444|NCT02294604|530159800|FG000|Overall Study|Culture contamination|1|||
146844785|NCT00356408|529600878|FG000|Overall Study|Other: Sponsor request|1|||
146998445|NCT02294604|530159801|FG001|Overall Study|Culture contamination|2|||
146998446|NCT02294604|530159802|FG002|Overall Study|Culture contamination|0|||
146998447|NCT01513174|530159805|FG000|Overall Study|Inclusion Error|1|||
146998448|NCT01513174|530159806|FG001|Overall Study|Inclusion Error|7|||
146998449|NCT01513174|530159805|FG000|Overall Study|Not receive study treatment|3|||
146998450|NCT01513174|530159806|FG001|Overall Study|Not receive study treatment|1|||
146998451|NCT01363765|530159807|FG000|Overall Study|non-diagnostic|2621|||
146998452|NCT01363765|530159808|FG001|Overall Study|non-diagnostic|1124|||
146998453|NCT01363765|530159807|FG000|Overall Study|duplicate records|736|||
146998454|NCT01363765|530159808|FG001|Overall Study|duplicate records|3177|||
146998455|NCT01363765|530159807|FG000|Overall Study|non-resident|156|||
146998456|NCT01363765|530159808|FG001|Overall Study|non-resident|76|||
146998457|NCT01363765|530159807|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
146998458|NCT01363765|530159808|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
146998459|NCT01363765|530159807|FG000|Overall Study|smear during intervention|2170|||
146998460|NCT01363765|530159808|FG001|Overall Study|smear during intervention|0|||
146998461|NCT01900626|530159809|FG000|Overall Study|study was closed due to low enrollment|1|||
146998462|NCT01900626|530159810|FG001|Overall Study|study was closed due to low enrollment|1|||
146998463|NCT04533594|530159811|FG000|Overall Study|Death|26|||
146998464|NCT01975948|530159815|FG000|Overall Study|Withdrawal by Subject|17|||
146998465|NCT01975948|530159816|FG001|Overall Study|Withdrawal by Subject|21|||
146998466|NCT01975948|530159817|FG002|Overall Study|Withdrawal by Subject|7|||
146998467|NCT01975948|530159818|FG003|Overall Study|Withdrawal by Subject|6|||
146998468|NCT05169710|530159821|FG000|Overall Study|Adverse Event|1|||
146998469|NCT05169710|530159822|FG001|Overall Study|Adverse Event|2|||
146998470|NCT05169710|530159823|FG002|Overall Study|Adverse Event|2|||
146998471|NCT05169710|530159821|FG000|Overall Study|Lost to Follow-up|0|||
146998472|NCT05169710|530159822|FG001|Overall Study|Lost to Follow-up|0|||
146998473|NCT05169710|530159823|FG002|Overall Study|Lost to Follow-up|1|||
146998474|NCT05169710|530159821|FG000|Overall Study|Withdrawal by Subject|2|||
146998475|NCT05169710|530159822|FG001|Overall Study|Withdrawal by Subject|1|||
146998476|NCT05169710|530159823|FG002|Overall Study|Withdrawal by Subject|0|||
146998477|NCT05169710|530159821|FG000|Overall Study|Other Study Discontinuation Reason|0|||
146998478|NCT05169710|530159822|FG001|Overall Study|Other Study Discontinuation Reason|2|||
146998479|NCT05169710|530159823|FG002|Overall Study|Other Study Discontinuation Reason|0|||
146998480|NCT00836056|530159825|FG000|First Intervention|Adverse Event|1|||
146998481|NCT00836056|530159826|FG001|First Intervention|Adverse Event|0|||
146998482|NCT02158663|530159827|FG000|Overall Study|Withdrawal by Subject|5|||
146998483|NCT02158663|530159828|FG001|Overall Study|Withdrawal by Subject|4|||
146998484|NCT02711852|530159829|FG000|Overall Study|Death|5|||
146998485|NCT02711852|530159829|FG000|Overall Study|Lost to Follow-up|1|||
146998486|NCT02711852|530159829|FG000|Overall Study|Completed follow-up|3|||
146998487|NCT02711852|530159829|FG000|Overall Study|Withdrawal by Subject|1|||
146998488|NCT03616106|530159831|FG000|Overall Study|Removed by PI|6|||
146998489|NCT03616106|530159832|FG001|Overall Study|Removed by PI|0|||
146998490|NCT03616106|530159831|FG000|Overall Study|Withdrawal by Subject|1|||
146998491|NCT03616106|530159832|FG001|Overall Study|Withdrawal by Subject|1|||
146998492|NCT03616106|530159831|FG000|Overall Study|Lost to Follow-up|7|||
146998493|NCT03616106|530159832|FG001|Overall Study|Lost to Follow-up|0|||
146998494|NCT01880593|530159833|FG000|Overall Study|Adverse Event|1|||
146998495|NCT01880593|530159834|FG001|Overall Study|Adverse Event|0|||
146998496|NCT01880593|530159833|FG000|Overall Study|Lack of Efficacy|1|||
146998497|NCT01880593|530159834|FG001|Overall Study|Lack of Efficacy|5|||
146998498|NCT01880593|530159833|FG000|Overall Study|Withdrawal by Subject|6|||
146998499|NCT01880593|530159834|FG001|Overall Study|Withdrawal by Subject|1|||
146998500|NCT02272777|530159835|FG000|Overall Study|Adverse Event|0|||
146998501|NCT02272777|530159836|FG001|Overall Study|Adverse Event|1|||
146998502|NCT02272777|530159835|FG000|Overall Study|Withdrawal by Subject|0|||
146998503|NCT02272777|530159836|FG001|Overall Study|Withdrawal by Subject|3|||
146998504|NCT02272777|530159835|FG000|Overall Study|Lost to Follow-up|2|||
146998505|NCT02272777|530159836|FG001|Overall Study|Lost to Follow-up|0|||
146998506|NCT02272777|530159835|FG000|Overall Study|Other|2|||
146998507|NCT02272777|530159836|FG001|Overall Study|Other|0|||
146998508|NCT00440297|530159840|FG000|Overall Study|Adverse Event|8|||
146998509|NCT00440297|530159841|FG001|Overall Study|Adverse Event|5|||
146998510|NCT00440297|530159840|FG000|Overall Study|Lost to Follow-up|1|||
146998511|NCT00440297|530159841|FG001|Overall Study|Lost to Follow-up|0|||
146998512|NCT00440297|530159840|FG000|Overall Study|Physician Decision|1|||
146998513|NCT00440297|530159841|FG001|Overall Study|Physician Decision|0|||
146998514|NCT00440297|530159840|FG000|Overall Study|Protocol Violation|11|||
146998515|NCT00440297|530159841|FG001|Overall Study|Protocol Violation|7|||
146998516|NCT00440297|530159840|FG000|Overall Study|Withdrawal by Subject|1|||
146998517|NCT00440297|530159841|FG001|Overall Study|Withdrawal by Subject|6|||
146998518|NCT00440297|530159840|FG000|Overall Study|Randomized by mistake|1|||
146998519|NCT00440297|530159841|FG001|Overall Study|Randomized by mistake|0|||
146998520|NCT03206177|530159842|FG000|Overall Study|Withdrawal by Subject|1|||
146998521|NCT02445339|530159843|FG000|Overall Study|Physician Decision|1|||
146998522|NCT02445339|530159844|FG001|Overall Study|Physician Decision|0|||
146998523|NCT02445339|530159843|FG000|Overall Study|Lost to Follow-up|11|||
146998524|NCT02445339|530159844|FG001|Overall Study|Lost to Follow-up|15|||
146998525|NCT02024932|530159845|FG000|Overall Study|Adverse Event|2|||
146998526|NCT02024932|530159846|FG001|Overall Study|Adverse Event|3|||
146998527|NCT02024932|530159847|FG002|Overall Study|Adverse Event|0|||
146998528|NCT02024932|530159848|FG003|Overall Study|Adverse Event|0|||
146998529|NCT02024932|530159849|FG004|Overall Study|Adverse Event|2|||
146998530|NCT02024932|530159850|FG005|Overall Study|Adverse Event|0|||
146998531|NCT02024932|530159845|FG000|Overall Study|Abnormal laboratory value|0|||
146998532|NCT02024932|530159846|FG001|Overall Study|Abnormal laboratory value|0|||
146998533|NCT02024932|530159847|FG002|Overall Study|Abnormal laboratory value|0|||
146998534|NCT02024932|530159848|FG003|Overall Study|Abnormal laboratory value|2|||
146998535|NCT02024932|530159849|FG004|Overall Study|Abnormal laboratory value|0|||
146998536|NCT02024932|530159850|FG005|Overall Study|Abnormal laboratory value|0|||
146998537|NCT03020641|530159851|FG000|Overall Study|Lost to Follow-up|0|||
146998538|NCT03020641|530159852|FG001|Overall Study|Lost to Follow-up|1|||
146998539|NCT03020641|530159851|FG000|Overall Study|Converted to open surgery|2|||
146998540|NCT03020641|530159852|FG001|Overall Study|Converted to open surgery|1|||
146998541|NCT03020641|530159851|FG000|Overall Study|for surgery not performed|0|||
146998542|NCT03020641|530159852|FG001|Overall Study|for surgery not performed|1|||
146998543|NCT04611789|530159853|FG000|Overall Study|Lost to Follow-up|1|||
146998544|NCT04611789|530159854|FG001|Overall Study|Lost to Follow-up|0|||
146998545|NCT04611789|530159855|FG002|Overall Study|Lost to Follow-up|0|||
146998546|NCT05472038|530161586|FG000|Overall Study|Adverse Event|0|||
146998547|NCT05472038|530161587|FG001|Overall Study|Adverse Event|0|||
146998548|NCT05472038|530161588|FG002|Overall Study|Adverse Event|1|||
146998549|NCT05472038|530161589|FG003|Overall Study|Adverse Event|0|||
146998550|NCT05472038|530161590|FG004|Overall Study|Adverse Event|0|||
146998551|NCT05472038|530161591|FG005|Overall Study|Adverse Event|0|||
146998552|NCT05472038|530161592|FG006|Overall Study|Adverse Event|0|||
146998553|NCT05472038|530161593|FG007|Overall Study|Adverse Event|0|||
146998554|NCT05472038|530161594|FG008|Overall Study|Adverse Event|0|||
146998555|NCT05472038|530161595|FG009|Overall Study|Adverse Event|0|||
146998556|NCT05472038|530161596|FG010|Overall Study|Adverse Event|0|||
146998557|NCT05472038|530161597|FG011|Overall Study|Adverse Event|0|||
146998558|NCT05472038|530161586|FG000|Overall Study|Death|0|||
146998559|NCT05472038|530161587|FG001|Overall Study|Death|0|||
146998560|NCT05472038|530161588|FG002|Overall Study|Death|0|||
146998561|NCT05472038|530161589|FG003|Overall Study|Death|0|||
146998562|NCT05472038|530161590|FG004|Overall Study|Death|0|||
146998563|NCT05472038|530161591|FG005|Overall Study|Death|1|||
146998564|NCT05472038|530161592|FG006|Overall Study|Death|0|||
146998565|NCT05472038|530161593|FG007|Overall Study|Death|0|||
146998566|NCT05472038|530161594|FG008|Overall Study|Death|0|||
146998567|NCT05472038|530161595|FG009|Overall Study|Death|0|||
146998568|NCT05472038|530161596|FG010|Overall Study|Death|0|||
146998569|NCT05472038|530161597|FG011|Overall Study|Death|0|||
146998570|NCT05472038|530161586|FG000|Overall Study|Lost to Follow-up|1|||
146998571|NCT05472038|530161587|FG001|Overall Study|Lost to Follow-up|3|||
146998572|NCT05472038|530161588|FG002|Overall Study|Lost to Follow-up|3|||
146998573|NCT05472038|530161589|FG003|Overall Study|Lost to Follow-up|9|||
146998574|NCT05472038|530161590|FG004|Overall Study|Lost to Follow-up|2|||
146998575|NCT05472038|530161591|FG005|Overall Study|Lost to Follow-up|2|||
146998576|NCT05472038|530161592|FG006|Overall Study|Lost to Follow-up|1|||
146998577|NCT05472038|530161593|FG007|Overall Study|Lost to Follow-up|0|||
146998578|NCT05472038|530161594|FG008|Overall Study|Lost to Follow-up|1|||
146998579|NCT05472038|530161595|FG009|Overall Study|Lost to Follow-up|0|||
146998580|NCT05472038|530161596|FG010|Overall Study|Lost to Follow-up|2|||
146998581|NCT05472038|530161597|FG011|Overall Study|Lost to Follow-up|1|||
146998582|NCT05472038|530161586|FG000|Overall Study|Physician Decision|0|||
146998583|NCT05472038|530161587|FG001|Overall Study|Physician Decision|0|||
146998584|NCT05472038|530161588|FG002|Overall Study|Physician Decision|0|||
146998585|NCT05472038|530161589|FG003|Overall Study|Physician Decision|0|||
146998586|NCT05472038|530161590|FG004|Overall Study|Physician Decision|1|||
146998587|NCT05472038|530161591|FG005|Overall Study|Physician Decision|0|||
146998588|NCT05472038|530161592|FG006|Overall Study|Physician Decision|0|||
146998589|NCT05472038|530161593|FG007|Overall Study|Physician Decision|0|||
146998590|NCT05472038|530161594|FG008|Overall Study|Physician Decision|0|||
146998591|NCT05472038|530161595|FG009|Overall Study|Physician Decision|0|||
146998592|NCT05472038|530161596|FG010|Overall Study|Physician Decision|0|||
146998593|NCT05472038|530161597|FG011|Overall Study|Physician Decision|0|||
146998594|NCT05472038|530161586|FG000|Overall Study|Withdrawal by Subject|1|||
146998595|NCT05472038|530161587|FG001|Overall Study|Withdrawal by Subject|3|||
146998596|NCT05472038|530161588|FG002|Overall Study|Withdrawal by Subject|1|||
146998597|NCT05472038|530161589|FG003|Overall Study|Withdrawal by Subject|6|||
146998598|NCT05472038|530161590|FG004|Overall Study|Withdrawal by Subject|1|||
146998599|NCT05472038|530161591|FG005|Overall Study|Withdrawal by Subject|3|||
146998600|NCT05472038|530161592|FG006|Overall Study|Withdrawal by Subject|0|||
146998601|NCT05472038|530161593|FG007|Overall Study|Withdrawal by Subject|2|||
146998602|NCT05472038|530161594|FG008|Overall Study|Withdrawal by Subject|3|||
146998603|NCT05472038|530161595|FG009|Overall Study|Withdrawal by Subject|1|||
146998604|NCT05472038|530161596|FG010|Overall Study|Withdrawal by Subject|2|||
146998605|NCT05472038|530161597|FG011|Overall Study|Withdrawal by Subject|2|||
146998606|NCT05472038|530161586|FG000|Overall Study|Protocol Violation|0|||
146998607|NCT05472038|530161587|FG001|Overall Study|Protocol Violation|0|||
146998608|NCT05472038|530161588|FG002|Overall Study|Protocol Violation|0|||
146998609|NCT05472038|530161589|FG003|Overall Study|Protocol Violation|0|||
146998610|NCT05472038|530161590|FG004|Overall Study|Protocol Violation|0|||
146998611|NCT05472038|530161591|FG005|Overall Study|Protocol Violation|0|||
146998612|NCT05472038|530161592|FG006|Overall Study|Protocol Violation|0|||
146998613|NCT05472038|530161593|FG007|Overall Study|Protocol Violation|1|||
146998614|NCT05472038|530161594|FG008|Overall Study|Protocol Violation|1|||
146998615|NCT05472038|530161595|FG009|Overall Study|Protocol Violation|1|||
146998616|NCT05472038|530161596|FG010|Overall Study|Protocol Violation|1|||
146998617|NCT05472038|530161597|FG011|Overall Study|Protocol Violation|1|||
146998618|NCT05472038|530161586|FG000|Overall Study|Not vaccinated|0|||
146998619|NCT05472038|530161587|FG001|Overall Study|Not vaccinated|0|||
146998620|NCT05472038|530161588|FG002|Overall Study|Not vaccinated|0|||
146998621|NCT05472038|530161589|FG003|Overall Study|Not vaccinated|1|||
146998622|NCT05472038|530161590|FG004|Overall Study|Not vaccinated|0|||
146998623|NCT05472038|530161591|FG005|Overall Study|Not vaccinated|0|||
146998624|NCT05472038|530161592|FG006|Overall Study|Not vaccinated|0|||
146998625|NCT05472038|530161593|FG007|Overall Study|Not vaccinated|0|||
146998626|NCT05472038|530161594|FG008|Overall Study|Not vaccinated|0|||
146998627|NCT05472038|530161595|FG009|Overall Study|Not vaccinated|0|||
146998628|NCT05472038|530161596|FG010|Overall Study|Not vaccinated|0|||
146998629|NCT05472038|530161597|FG011|Overall Study|Not vaccinated|0|||
146998630|NCT03235739|530161600|FG000|Overall Study|Withdrawal by Subject|2|||
146998631|NCT03235739|530161601|FG001|Overall Study|Withdrawal by Subject|2|||
146998632|NCT03235739|530161600|FG000|Overall Study|Physician Decision|0|||
146998633|NCT03235739|530161601|FG001|Overall Study|Physician Decision|1|||
146998634|NCT02847650|530161602|FG000|Overall Study|Adverse Event|2|||
146998635|NCT02847650|530161603|FG001|Overall Study|Adverse Event|4|||
146998636|NCT02847650|530161602|FG000|Overall Study|Lost to Follow-up|1|||
146998637|NCT02847650|530161603|FG001|Overall Study|Lost to Follow-up|0|||
146998638|NCT02847650|530161602|FG000|Overall Study|Protocol Violation|0|||
146998639|NCT02847650|530161603|FG001|Overall Study|Protocol Violation|1|||
146998640|NCT02847650|530161602|FG000|Overall Study|Withdrawal by Subject|1|||
146998641|NCT02847650|530161603|FG001|Overall Study|Withdrawal by Subject|1|||
146998642|NCT00218257|530161604|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
146998643|NCT00218257|530161605|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
146998644|NCT02175095|530161608|FG000|Overall Study|Withdrawal by Subject|3|||
146998645|NCT00462345|530161609|FG000|Overall Study|Withdrawal by Subject|2|||
146998646|NCT00462345|530161609|FG000|Overall Study|Did not complete second course|1|||
146998647|NCT03255733|530161610|FG000|Overall Study|Lost to Follow-up|4|||
146998648|NCT03874715|530161614|FG000|Overall Study|Adverse Event|2|||
146998649|NCT03874715|530161615|FG001|Overall Study|Adverse Event|0|||
146998650|NCT03874715|530161614|FG000|Overall Study|Poor compliance to protocol|5|||
146998651|NCT03874715|530161615|FG001|Overall Study|Poor compliance to protocol|1|||
146998652|NCT03874715|530161614|FG000|Overall Study|Withdrawal by Subject|1|||
146998653|NCT03874715|530161615|FG001|Overall Study|Withdrawal by Subject|0|||
146998654|NCT03874715|530161614|FG000|Overall Study|Other-unspecified|1|||
146998655|NCT03874715|530161615|FG001|Overall Study|Other-unspecified|0|||
146998656|NCT00461786|530161618|FG000|Overall Study|Entry Criteria Not Met|2|||
146998657|NCT00461786|530161618|FG000|Overall Study|Inevaluable (Never Treated)|1|||
146998658|NCT00835991|530161621|FG000|First Intervention|Adverse Event|0|||
146998659|NCT00835991|530161622|FG001|First Intervention|Adverse Event|1|||
146998660|NCT00835991|530161621|FG000|Washout|Protocol Violation|0|||
146998661|NCT00835991|530161622|FG001|Washout|Protocol Violation|2|||
146998662|NCT00835991|530161621|FG000|Washout|Withdrawal by Subject|3|||
146998663|NCT00835991|530161622|FG001|Washout|Withdrawal by Subject|1|||
146998664|NCT02378935|530161623|FG000|Overall Study|Lack of Efficacy|10|||
146998665|NCT02378935|530161624|FG001|Overall Study|Lack of Efficacy|0|||
146998666|NCT02378935|530161625|FG002|Overall Study|Lack of Efficacy|2|||
146998667|NCT02378935|530161626|FG003|Overall Study|Lack of Efficacy|6|||
146998668|NCT02378935|530161627|FG004|Overall Study|Lack of Efficacy|0|||
146998669|NCT02378935|530161628|FG005|Overall Study|Lack of Efficacy|0|||
146998670|NCT02378935|530161629|FG006|Overall Study|Lack of Efficacy|0|||
146998671|NCT02378935|530161623|FG000|Overall Study|Death|0|||
146998672|NCT02378935|530161624|FG001|Overall Study|Death|0|||
146998673|NCT02378935|530161625|FG002|Overall Study|Death|1|||
146998674|NCT02378935|530161626|FG003|Overall Study|Death|0|||
146998675|NCT02378935|530161627|FG004|Overall Study|Death|0|||
146998676|NCT02378935|530161628|FG005|Overall Study|Death|0|||
146998677|NCT02378935|530161629|FG006|Overall Study|Death|0|||
146998678|NCT00272779|530161630|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
146998679|NCT00272779|530161631|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
146998680|NCT00272779|530161630|FG000|Baseline Through Week 48|Death before Week 48|4|||
146998681|NCT00272779|530161631|FG001|Baseline Through Week 48|Death before Week 48|4|||
146998682|NCT00272779|530161630|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
146998683|NCT00272779|530161631|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
146998684|NCT00272779|530161630|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
146998685|NCT00272779|530161631|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
146844786|NCT00356408|529600878|FG000|Overall Study|Other: Azathioprine stopped|1|||
146844787|NCT00356408|529600878|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
146844788|NCT00356408|529600878|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
146998686|NCT00272779|530161630|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
146998687|NCT00272779|530161631|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
146998688|NCT00272779|530161630|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
146998689|NCT00272779|530161631|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
146998690|NCT00272779|530161630|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
146998691|NCT00272779|530161631|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
146844789|NCT01156376|529600880|FG000|Overall Study|Adverse Event|1|||
146998692|NCT00272779|530161630|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
146998693|NCT00272779|530161631|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
146998694|NCT00272779|530161630|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
146998695|NCT00272779|530161631|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
146998696|NCT00272779|530161630|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
146998697|NCT00272779|530161631|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
146998698|NCT00272779|530161630|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
146998699|NCT00272779|530161631|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
146998700|NCT00272779|530161630|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
146998701|NCT00272779|530161631|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
146998702|NCT00272779|530161630|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
146998703|NCT00272779|530161631|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
146998704|NCT00272779|530161630|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
146998705|NCT00272779|530161631|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
146998706|NCT00272779|530161630|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
146998707|NCT00272779|530161631|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
146998708|NCT00272779|530161630|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
146998709|NCT00272779|530161631|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
146998710|NCT00272779|530161630|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
146998711|NCT00272779|530161631|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
146998712|NCT00272779|530161630|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
146998713|NCT00272779|530161631|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
146998714|NCT00272779|530161630|FG000|Baseline Through Week 48|Continuing treatment|385|||
146998715|NCT00272779|530161631|FG001|Baseline Through Week 48|Continuing treatment|368|||
146998716|NCT00272779|530161630|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
146998717|NCT00272779|530161631|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
146998718|NCT00272779|530161630|FG000|Baseline Through Week 48|Never treated|2|||
146998719|NCT00272779|530161631|FG001|Baseline Through Week 48|Never treated|3|||
146998720|NCT00272779|530161630|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
146998721|NCT00272779|530161631|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
146998722|NCT00272779|530161630|FG000|Baseline Through Week 96|Death before Week 96|6|||
146998723|NCT00272779|530161631|FG001|Baseline Through Week 96|Death before Week 96|5|||
146998724|NCT00272779|530161630|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
146998725|NCT00272779|530161631|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
146998726|NCT00272779|530161630|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
146998727|NCT00272779|530161631|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
146998728|NCT00272779|530161630|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
146998729|NCT00272779|530161631|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
146998730|NCT00272779|530161630|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
146998731|NCT00272779|530161631|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
146998732|NCT00272779|530161630|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
146998733|NCT00272779|530161631|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
146998734|NCT00272779|530161630|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
146998735|NCT00272779|530161631|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
146998736|NCT00272779|530161630|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
146998737|NCT00272779|530161631|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
146998738|NCT00272779|530161630|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
146998739|NCT00272779|530161631|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
146998740|NCT00272779|530161630|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
146998741|NCT00272779|530161631|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
146998742|NCT00272779|530161630|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
146998743|NCT00272779|530161631|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
146998744|NCT00272779|530161630|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
146998745|NCT00272779|530161631|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
146998746|NCT00272779|530161630|FG000|Baseline Through Week 96|Never treated|2|||
146844790|NCT01156376|529600881|FG001|Overall Study|Adverse Event|0|||
146844791|NCT01156376|529600882|FG002|Overall Study|Adverse Event|1|||
146998747|NCT00272779|530161631|FG001|Baseline Through Week 96|Never treated|3|||
146998748|NCT00272779|530161630|FG000|Baseline Through Week 96|Continuing on treatment|61|||
146998749|NCT00272779|530161631|FG001|Baseline Through Week 96|Continuing on treatment|38|||
146998750|NCT02146105|530161636|FG000|Overall Study|Adverse Event|1|||
146998751|NCT02146105|530161636|FG000|Overall Study|Withdrawal by Subject|5|||
146998752|NCT03935880|530161638|FG000|Overall Study|Lost to Follow-up|0|||
146998753|NCT03935880|530161639|FG001|Overall Study|Lost to Follow-up|1|||
146998754|NCT02476994|530161640|FG000|Overall Study|Based on feedback from FDA|1|||
146844792|NCT01156376|529600880|FG000|Overall Study|Withdrawal by Subject|0|||
146844793|NCT01156376|529600881|FG001|Overall Study|Withdrawal by Subject|0|||
146998755|NCT02476994|530161641|FG001|Overall Study|Based on feedback from FDA|0|||
146998756|NCT02563561|530161642|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
146998757|NCT02563561|530161643|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
146998758|NCT02563561|530161644|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
146998759|NCT02563561|530161642|FG000|Overall Study|Withdrew of Consent|1|||
146998760|NCT02563561|530161643|FG001|Overall Study|Withdrew of Consent|1|||
146998761|NCT02563561|530161644|FG002|Overall Study|Withdrew of Consent|2|||
146998762|NCT02563561|530161642|FG000|Overall Study|Lost to Follow-up|1|||
146998763|NCT02563561|530161643|FG001|Overall Study|Lost to Follow-up|1|||
146998764|NCT02563561|530161644|FG002|Overall Study|Lost to Follow-up|0|||
146998765|NCT02563561|530161642|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
146998766|NCT02563561|530161643|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
146998767|NCT02563561|530161644|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
146998768|NCT02563561|530161642|FG000|Overall Study|Investigator Decision|3|||
146998769|NCT02563561|530161643|FG001|Overall Study|Investigator Decision|4|||
146998770|NCT02563561|530161644|FG002|Overall Study|Investigator Decision|2|||
146998771|NCT02563561|530161642|FG000|Overall Study|Sponsor Decision|5|||
146998772|NCT02563561|530161643|FG001|Overall Study|Sponsor Decision|2|||
146998773|NCT02563561|530161644|FG002|Overall Study|Sponsor Decision|4|||
146998774|NCT02563561|530161642|FG000|Overall Study|Other|1|||
146998775|NCT02563561|530161643|FG001|Overall Study|Other|5|||
146998776|NCT02563561|530161644|FG002|Overall Study|Other|2|||
146998777|NCT03122535|530161647|FG000|Overall Study|Lost to Follow-up|68|||
146998778|NCT03122535|530161648|FG001|Overall Study|Lost to Follow-up|68|||
146998779|NCT03122535|530161647|FG000|Overall Study|Physician Decision|3|||
146998780|NCT03122535|530161648|FG001|Overall Study|Physician Decision|3|||
146998781|NCT03122535|530161647|FG000|Overall Study|Withdrawal by Subject|2|||
146998782|NCT03122535|530161648|FG001|Overall Study|Withdrawal by Subject|2|||
146998783|NCT02718326|530161649|FG000|Overall Study|Adverse Event|4|||
146998784|NCT02718326|530161650|FG001|Overall Study|Adverse Event|9|||
146998785|NCT02718326|530161651|FG002|Overall Study|Adverse Event|0|||
146998786|NCT02718326|530161649|FG000|Overall Study|Death|8|||
146998787|NCT02718326|530161650|FG001|Overall Study|Death|1|||
146998788|NCT02718326|530161651|FG002|Overall Study|Death|2|||
146998789|NCT02718326|530161649|FG000|Overall Study|Withdrawal by Subject|4|||
146998790|NCT02718326|530161650|FG001|Overall Study|Withdrawal by Subject|9|||
146998791|NCT02718326|530161651|FG002|Overall Study|Withdrawal by Subject|6|||
146998792|NCT02718326|530161649|FG000|Overall Study|Lost to Follow-up|18|||
146998793|NCT02718326|530161650|FG001|Overall Study|Lost to Follow-up|5|||
146998794|NCT02718326|530161651|FG002|Overall Study|Lost to Follow-up|14|||
146998795|NCT02718326|530161649|FG000|Overall Study|Protocol Deviation|1|||
146998796|NCT02718326|530161650|FG001|Overall Study|Protocol Deviation|0|||
146998797|NCT02718326|530161651|FG002|Overall Study|Protocol Deviation|0|||
146998798|NCT02718326|530161649|FG000|Overall Study|Pregnancy|1|||
146998799|NCT02718326|530161650|FG001|Overall Study|Pregnancy|0|||
146998800|NCT02718326|530161651|FG002|Overall Study|Pregnancy|0|||
146998801|NCT00984022|530161655|FG000|Overall Study|Lost to Follow-up|10|||
146998802|NCT00984022|530161656|FG001|Overall Study|Lost to Follow-up|14|||
146998803|NCT00573443|530161657|FG000|Double-Blind Phase|Lost to Follow-up|1|||
146998804|NCT00573443|530161658|FG001|Double-Blind Phase|Lost to Follow-up|3|||
146998805|NCT00573443|530161659|FG002|Double-Blind Phase|Lost to Follow-up|2|||
146998806|NCT00573443|530161657|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
146998807|NCT00573443|530161658|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
146998808|NCT00573443|530161659|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
146998809|NCT00573443|530161657|FG000|Double-Blind Phase|Adverse Event|1|||
146998810|NCT00573443|530161658|FG001|Double-Blind Phase|Adverse Event|5|||
146998811|NCT00573443|530161659|FG002|Double-Blind Phase|Adverse Event|0|||
146998812|NCT00573443|530161657|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
146998813|NCT00573443|530161658|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
146998814|NCT00573443|530161659|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
146998815|NCT00573443|530161657|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
146998816|NCT00573443|530161658|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
146998817|NCT00573443|530161659|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
146998818|NCT00573443|530161657|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
146998819|NCT00573443|530161658|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
146998820|NCT00573443|530161659|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
146998821|NCT00573443|530161657|FG000|Double-Blind Phase|Protocol Violation|0|||
146998822|NCT00573443|530161658|FG001|Double-Blind Phase|Protocol Violation|2|||
146998823|NCT00573443|530161659|FG002|Double-Blind Phase|Protocol Violation|1|||
146998824|NCT00573443|530161657|FG000|Double-Blind Phase|Other|0|||
146998825|NCT00573443|530161658|FG001|Double-Blind Phase|Other|2|||
146998826|NCT00573443|530161659|FG002|Double-Blind Phase|Other|3|||
146998827|NCT00573443|530161657|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
146998828|NCT00573443|530161658|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
146998829|NCT00573443|530161659|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
146998830|NCT00573443|530161657|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
146998831|NCT00573443|530161658|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
146998832|NCT00573443|530161659|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
146998833|NCT00573443|530161657|FG000|Open-Label Extension Phase|Adverse Event|3|||
146998834|NCT00573443|530161658|FG001|Open-Label Extension Phase|Adverse Event|0|||
146998835|NCT00573443|530161659|FG002|Open-Label Extension Phase|Adverse Event|0|||
146998836|NCT00573443|530161657|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
146998837|NCT00573443|530161658|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
146998838|NCT00573443|530161659|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
146998839|NCT00573443|530161657|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
146998840|NCT00573443|530161658|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
146998841|NCT00573443|530161659|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
146998842|NCT00573443|530161657|FG000|Open-Label Extension Phase|Protocol Violation|2|||
146998843|NCT00573443|530161658|FG001|Open-Label Extension Phase|Protocol Violation|0|||
146998844|NCT00573443|530161659|FG002|Open-Label Extension Phase|Protocol Violation|0|||
146998845|NCT00573443|530161657|FG000|Open-Label Extension Phase|Other|2|||
146998846|NCT00573443|530161658|FG001|Open-Label Extension Phase|Other|0|||
146998847|NCT00573443|530161659|FG002|Open-Label Extension Phase|Other|0|||
146998848|NCT01796171|530161665|FG000|Enrolled|Death|0|||
146998849|NCT01796171|530161666|FG001|Enrolled|Death|0|||
146998850|NCT01796171|530161667|FG002|Enrolled|Death|0|||
146998851|NCT01796171|530161668|FG003|Enrolled|Death|0|||
146998852|NCT01796171|530161669|FG004|Enrolled|Death|0|||
146998853|NCT01796171|530161670|FG005|Enrolled|Death|0|||
146998854|NCT01796171|530161671|FG006|Enrolled|Death|0|||
146998855|NCT01796171|530161672|FG007|Enrolled|Death|0|||
146998856|NCT01796171|530161673|FG008|Enrolled|Death|0|||
146998857|NCT01796171|530161674|FG009|Enrolled|Death|0|||
146998858|NCT01796171|530161675|FG010|Enrolled|Death|0|||
146998859|NCT01796171|530161676|FG011|Enrolled|Death|0|||
146998860|NCT01796171|530161677|FG012|Enrolled|Death|0|||
146998861|NCT01796171|530161678|FG013|Enrolled|Death|0|||
146998862|NCT01796171|530161679|FG014|Enrolled|Death|1|||
146998863|NCT01796171|530161665|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
146998864|NCT01796171|530161666|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
146998865|NCT01796171|530161667|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
146998866|NCT01796171|530161668|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
146998867|NCT01796171|530161669|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
146998868|NCT01796171|530161670|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
146998869|NCT01796171|530161671|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
146998870|NCT01796171|530161672|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
146998871|NCT01796171|530161673|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
146998872|NCT01796171|530161674|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
146998873|NCT01796171|530161675|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
146998874|NCT01796171|530161676|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
146998875|NCT01796171|530161677|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
146998876|NCT01796171|530161678|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
146998877|NCT01796171|530161679|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
146998878|NCT01796171|530161665|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146998879|NCT01796171|530161666|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146998880|NCT01796171|530161667|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146998881|NCT01796171|530161668|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146998882|NCT01796171|530161669|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146998883|NCT01796171|530161670|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146998884|NCT01796171|530161671|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146998885|NCT01796171|530161672|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146998886|NCT01796171|530161673|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146998887|NCT01796171|530161674|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146998888|NCT01796171|530161675|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146998889|NCT01796171|530161676|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146998890|NCT01796171|530161677|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146998891|NCT01796171|530161678|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
146998892|NCT01796171|530161679|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146998893|NCT01796171|530161665|FG000|Treatment Period With Betalutin|Progressive disease|0|||
146998894|NCT01796171|530161666|FG001|Treatment Period With Betalutin|Progressive disease|1|||
146998895|NCT01796171|530161667|FG002|Treatment Period With Betalutin|Progressive disease|0|||
146998896|NCT01796171|530161668|FG003|Treatment Period With Betalutin|Progressive disease|0|||
146998897|NCT01796171|530161669|FG004|Treatment Period With Betalutin|Progressive disease|0|||
146998898|NCT01796171|530161670|FG005|Treatment Period With Betalutin|Progressive disease|0|||
146998899|NCT01796171|530161671|FG006|Treatment Period With Betalutin|Progressive disease|0|||
146998900|NCT01796171|530161672|FG007|Treatment Period With Betalutin|Progressive disease|0|||
146998901|NCT01796171|530161673|FG008|Treatment Period With Betalutin|Progressive disease|0|||
146998902|NCT01796171|530161674|FG009|Treatment Period With Betalutin|Progressive disease|0|||
146998903|NCT01796171|530161675|FG010|Treatment Period With Betalutin|Progressive disease|0|||
146998904|NCT01796171|530161676|FG011|Treatment Period With Betalutin|Progressive disease|0|||
146998905|NCT01796171|530161677|FG012|Treatment Period With Betalutin|Progressive disease|0|||
146998906|NCT01796171|530161678|FG013|Treatment Period With Betalutin|Progressive disease|0|||
146998907|NCT01796171|530161679|FG014|Treatment Period With Betalutin|Progressive disease|0|||
146998908|NCT01796171|530161665|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146998909|NCT01796171|530161666|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146998910|NCT01796171|530161667|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146998911|NCT01796171|530161668|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146998912|NCT01796171|530161669|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146998913|NCT01796171|530161670|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146998914|NCT01796171|530161671|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146998915|NCT01796171|530161672|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146998916|NCT01796171|530161673|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
146998917|NCT01796171|530161674|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146998918|NCT01796171|530161675|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
146998919|NCT01796171|530161676|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
146998920|NCT01796171|530161677|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146998921|NCT01796171|530161678|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146998922|NCT01796171|530161679|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146998923|NCT01796171|530161665|FG000|Treatment Period With Betalutin|Physician Decision|0|||
146998924|NCT01796171|530161666|FG001|Treatment Period With Betalutin|Physician Decision|0|||
146998925|NCT01796171|530161667|FG002|Treatment Period With Betalutin|Physician Decision|0|||
146998926|NCT01796171|530161668|FG003|Treatment Period With Betalutin|Physician Decision|0|||
146998927|NCT01796171|530161669|FG004|Treatment Period With Betalutin|Physician Decision|0|||
146998928|NCT01796171|530161670|FG005|Treatment Period With Betalutin|Physician Decision|0|||
146998929|NCT01796171|530161671|FG006|Treatment Period With Betalutin|Physician Decision|0|||
146998930|NCT01796171|530161672|FG007|Treatment Period With Betalutin|Physician Decision|0|||
146998931|NCT01796171|530161673|FG008|Treatment Period With Betalutin|Physician Decision|0|||
146998932|NCT01796171|530161674|FG009|Treatment Period With Betalutin|Physician Decision|0|||
146998933|NCT01796171|530161675|FG010|Treatment Period With Betalutin|Physician Decision|5|||
146998934|NCT01796171|530161676|FG011|Treatment Period With Betalutin|Physician Decision|1|||
146998935|NCT01796171|530161677|FG012|Treatment Period With Betalutin|Physician Decision|1|||
146998936|NCT01796171|530161678|FG013|Treatment Period With Betalutin|Physician Decision|0|||
146998937|NCT01796171|530161679|FG014|Treatment Period With Betalutin|Physician Decision|0|||
146998938|NCT01796171|530161665|FG000|Treatment Period With Betalutin|Death|0|||
146998939|NCT01796171|530161666|FG001|Treatment Period With Betalutin|Death|0|||
146998940|NCT01796171|530161667|FG002|Treatment Period With Betalutin|Death|0|||
146998941|NCT01796171|530161668|FG003|Treatment Period With Betalutin|Death|0|||
146998942|NCT01796171|530161669|FG004|Treatment Period With Betalutin|Death|0|||
146998943|NCT01796171|530161670|FG005|Treatment Period With Betalutin|Death|0|||
146998944|NCT01796171|530161671|FG006|Treatment Period With Betalutin|Death|0|||
146998945|NCT01796171|530161672|FG007|Treatment Period With Betalutin|Death|0|||
146998946|NCT01796171|530161673|FG008|Treatment Period With Betalutin|Death|0|||
146998947|NCT01796171|530161674|FG009|Treatment Period With Betalutin|Death|0|||
146998948|NCT01796171|530161675|FG010|Treatment Period With Betalutin|Death|2|||
146998949|NCT01796171|530161676|FG011|Treatment Period With Betalutin|Death|0|||
146998950|NCT01796171|530161677|FG012|Treatment Period With Betalutin|Death|0|||
146998951|NCT01796171|530161678|FG013|Treatment Period With Betalutin|Death|0|||
146998952|NCT01796171|530161679|FG014|Treatment Period With Betalutin|Death|0|||
146998953|NCT01796171|530161665|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
146998954|NCT01796171|530161666|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
146998955|NCT01796171|530161667|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
146998956|NCT01796171|530161668|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
146998957|NCT01796171|530161669|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
146998958|NCT01796171|530161670|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
146998959|NCT01796171|530161671|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
146998960|NCT01796171|530161672|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
146998961|NCT01796171|530161673|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
146998962|NCT01796171|530161674|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
146998963|NCT01796171|530161675|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
146998964|NCT01796171|530161676|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
146998965|NCT01796171|530161677|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
146998966|NCT01796171|530161678|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
146998967|NCT01796171|530161679|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
146998968|NCT01796171|530161665|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146998969|NCT01796171|530161666|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146844794|NCT01156376|529600882|FG002|Overall Study|Withdrawal by Subject|3|||
146844795|NCT05487586|529600883|FG000|Overall Study|Death|22|||
146844796|NCT05487586|529600883|FG000|Overall Study|Physician Decision|1|||
146998970|NCT01796171|530161667|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146998971|NCT01796171|530161668|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146998972|NCT01796171|530161669|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146998973|NCT01796171|530161670|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146998974|NCT01796171|530161671|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146998975|NCT01796171|530161672|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146998976|NCT01796171|530161673|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146998977|NCT01796171|530161674|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146998978|NCT01796171|530161675|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
146998979|NCT01796171|530161676|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
146998980|NCT01796171|530161677|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146998981|NCT01796171|530161678|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146998982|NCT01796171|530161679|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146998983|NCT01796171|530161665|FG000|Follow-up Period|Start of further anticancer therapy|4|||
146998984|NCT01796171|530161666|FG001|Follow-up Period|Start of further anticancer therapy|25|||
146998985|NCT01796171|530161667|FG002|Follow-up Period|Start of further anticancer therapy|2|||
146998986|NCT01796171|530161668|FG003|Follow-up Period|Start of further anticancer therapy|1|||
146998987|NCT01796171|530161669|FG004|Follow-up Period|Start of further anticancer therapy|2|||
146998988|NCT01796171|530161670|FG005|Follow-up Period|Start of further anticancer therapy|2|||
146998989|NCT01796171|530161671|FG006|Follow-up Period|Start of further anticancer therapy|1|||
146998990|NCT01796171|530161672|FG007|Follow-up Period|Start of further anticancer therapy|15|||
146998991|NCT01796171|530161673|FG008|Follow-up Period|Start of further anticancer therapy|2|||
146998992|NCT01796171|530161674|FG009|Follow-up Period|Start of further anticancer therapy|0|||
146998993|NCT01796171|530161675|FG010|Follow-up Period|Start of further anticancer therapy|0|||
146998994|NCT01796171|530161676|FG011|Follow-up Period|Start of further anticancer therapy|0|||
146998995|NCT01796171|530161677|FG012|Follow-up Period|Start of further anticancer therapy|0|||
146998996|NCT01796171|530161678|FG013|Follow-up Period|Start of further anticancer therapy|0|||
146998997|NCT01796171|530161679|FG014|Follow-up Period|Start of further anticancer therapy|0|||
146998998|NCT01796171|530161665|FG000|Follow-up Period|Progressive disease|0|||
146998999|NCT01796171|530161666|FG001|Follow-up Period|Progressive disease|1|||
146999000|NCT01796171|530161667|FG002|Follow-up Period|Progressive disease|0|||
146999001|NCT01796171|530161668|FG003|Follow-up Period|Progressive disease|0|||
146999002|NCT01796171|530161669|FG004|Follow-up Period|Progressive disease|0|||
146999003|NCT01796171|530161670|FG005|Follow-up Period|Progressive disease|0|||
146999004|NCT01796171|530161671|FG006|Follow-up Period|Progressive disease|0|||
146999005|NCT01796171|530161672|FG007|Follow-up Period|Progressive disease|3|||
146999006|NCT01796171|530161673|FG008|Follow-up Period|Progressive disease|0|||
146999007|NCT01796171|530161674|FG009|Follow-up Period|Progressive disease|0|||
146999008|NCT01796171|530161675|FG010|Follow-up Period|Progressive disease|0|||
146999009|NCT01796171|530161676|FG011|Follow-up Period|Progressive disease|0|||
146999010|NCT01796171|530161677|FG012|Follow-up Period|Progressive disease|0|||
146999011|NCT01796171|530161678|FG013|Follow-up Period|Progressive disease|0|||
146999012|NCT01796171|530161679|FG014|Follow-up Period|Progressive disease|0|||
146999013|NCT01796171|530161665|FG000|Follow-up Period|Physician Decision|0|||
146999014|NCT01796171|530161666|FG001|Follow-up Period|Physician Decision|2|||
146999015|NCT01796171|530161667|FG002|Follow-up Period|Physician Decision|0|||
146999016|NCT01796171|530161668|FG003|Follow-up Period|Physician Decision|0|||
146999017|NCT01796171|530161669|FG004|Follow-up Period|Physician Decision|0|||
146999018|NCT01796171|530161670|FG005|Follow-up Period|Physician Decision|0|||
146999019|NCT01796171|530161671|FG006|Follow-up Period|Physician Decision|0|||
146999020|NCT01796171|530161672|FG007|Follow-up Period|Physician Decision|0|||
146999021|NCT01796171|530161673|FG008|Follow-up Period|Physician Decision|0|||
146999022|NCT01796171|530161674|FG009|Follow-up Period|Physician Decision|0|||
146999023|NCT01796171|530161675|FG010|Follow-up Period|Physician Decision|5|||
146999024|NCT01796171|530161676|FG011|Follow-up Period|Physician Decision|0|||
146999025|NCT01796171|530161677|FG012|Follow-up Period|Physician Decision|0|||
146999026|NCT01796171|530161678|FG013|Follow-up Period|Physician Decision|0|||
146999027|NCT01796171|530161679|FG014|Follow-up Period|Physician Decision|0|||
146999028|NCT01796171|530161665|FG000|Follow-up Period|Withdrawal by Subject|0|||
146999029|NCT01796171|530161666|FG001|Follow-up Period|Withdrawal by Subject|1|||
146999030|NCT01796171|530161667|FG002|Follow-up Period|Withdrawal by Subject|0|||
146999031|NCT01796171|530161668|FG003|Follow-up Period|Withdrawal by Subject|0|||
146999032|NCT01796171|530161669|FG004|Follow-up Period|Withdrawal by Subject|0|||
146999033|NCT01796171|530161670|FG005|Follow-up Period|Withdrawal by Subject|1|||
146999034|NCT01796171|530161671|FG006|Follow-up Period|Withdrawal by Subject|0|||
146999035|NCT01796171|530161672|FG007|Follow-up Period|Withdrawal by Subject|0|||
146999036|NCT01796171|530161673|FG008|Follow-up Period|Withdrawal by Subject|0|||
146999037|NCT01796171|530161674|FG009|Follow-up Period|Withdrawal by Subject|0|||
146999038|NCT01796171|530161675|FG010|Follow-up Period|Withdrawal by Subject|3|||
146999039|NCT01796171|530161676|FG011|Follow-up Period|Withdrawal by Subject|1|||
146735972|NCT02034708|529205255|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
146999040|NCT01796171|530161677|FG012|Follow-up Period|Withdrawal by Subject|0|||
146999041|NCT01796171|530161678|FG013|Follow-up Period|Withdrawal by Subject|0|||
146999042|NCT01796171|530161679|FG014|Follow-up Period|Withdrawal by Subject|0|||
146999043|NCT01796171|530161665|FG000|Follow-up Period|Death|0|||
146999044|NCT01796171|530161666|FG001|Follow-up Period|Death|0|||
146999045|NCT01796171|530161667|FG002|Follow-up Period|Death|0|||
146999046|NCT01796171|530161668|FG003|Follow-up Period|Death|0|||
146999047|NCT01796171|530161669|FG004|Follow-up Period|Death|0|||
146999048|NCT01796171|530161670|FG005|Follow-up Period|Death|0|||
146999049|NCT01796171|530161671|FG006|Follow-up Period|Death|1|||
146999050|NCT01796171|530161672|FG007|Follow-up Period|Death|0|||
146999051|NCT01796171|530161673|FG008|Follow-up Period|Death|0|||
146999052|NCT01796171|530161674|FG009|Follow-up Period|Death|0|||
146999053|NCT01796171|530161675|FG010|Follow-up Period|Death|17|||
146999054|NCT01796171|530161676|FG011|Follow-up Period|Death|9|||
146999055|NCT01796171|530161677|FG012|Follow-up Period|Death|1|||
146999056|NCT01796171|530161678|FG013|Follow-up Period|Death|0|||
146999057|NCT01796171|530161679|FG014|Follow-up Period|Death|0|||
146999058|NCT01796171|530161665|FG000|Follow-up Period|Patient transferred to other hospital|0|||
146999059|NCT01796171|530161666|FG001|Follow-up Period|Patient transferred to other hospital|1|||
146999060|NCT01796171|530161667|FG002|Follow-up Period|Patient transferred to other hospital|0|||
146999061|NCT01796171|530161668|FG003|Follow-up Period|Patient transferred to other hospital|0|||
146999062|NCT01796171|530161669|FG004|Follow-up Period|Patient transferred to other hospital|0|||
146999063|NCT01796171|530161670|FG005|Follow-up Period|Patient transferred to other hospital|0|||
146999064|NCT01796171|530161671|FG006|Follow-up Period|Patient transferred to other hospital|0|||
146999065|NCT01796171|530161672|FG007|Follow-up Period|Patient transferred to other hospital|0|||
146999066|NCT01796171|530161673|FG008|Follow-up Period|Patient transferred to other hospital|0|||
146999067|NCT01796171|530161674|FG009|Follow-up Period|Patient transferred to other hospital|0|||
146999068|NCT01796171|530161675|FG010|Follow-up Period|Patient transferred to other hospital|0|||
146999069|NCT01796171|530161676|FG011|Follow-up Period|Patient transferred to other hospital|0|||
146999070|NCT01796171|530161677|FG012|Follow-up Period|Patient transferred to other hospital|0|||
146999071|NCT01796171|530161678|FG013|Follow-up Period|Patient transferred to other hospital|0|||
146999072|NCT01796171|530161679|FG014|Follow-up Period|Patient transferred to other hospital|0|||
146999073|NCT01796171|530161665|FG000|Follow-up Period|Sponsor Decision|0|||
146999074|NCT01796171|530161666|FG001|Follow-up Period|Sponsor Decision|0|||
146999075|NCT01796171|530161667|FG002|Follow-up Period|Sponsor Decision|0|||
146999076|NCT01796171|530161668|FG003|Follow-up Period|Sponsor Decision|0|||
146999077|NCT01796171|530161669|FG004|Follow-up Period|Sponsor Decision|0|||
146999078|NCT01796171|530161670|FG005|Follow-up Period|Sponsor Decision|0|||
146999079|NCT01796171|530161671|FG006|Follow-up Period|Sponsor Decision|0|||
146999080|NCT01796171|530161672|FG007|Follow-up Period|Sponsor Decision|0|||
146999081|NCT01796171|530161673|FG008|Follow-up Period|Sponsor Decision|0|||
146999082|NCT01796171|530161674|FG009|Follow-up Period|Sponsor Decision|0|||
146999083|NCT01796171|530161675|FG010|Follow-up Period|Sponsor Decision|40|||
146999084|NCT01796171|530161676|FG011|Follow-up Period|Sponsor Decision|15|||
146999085|NCT01796171|530161677|FG012|Follow-up Period|Sponsor Decision|7|||
146999086|NCT01796171|530161678|FG013|Follow-up Period|Sponsor Decision|0|||
146999087|NCT01796171|530161679|FG014|Follow-up Period|Sponsor Decision|0|||
146999088|NCT00418561|530161680|FG000|Overall Study|Participant's (guardian's) decision|0|||
146999089|NCT00418561|530161681|FG001|Overall Study|Participant's (guardian's) decision|1|||
146999090|NCT00418561|530161682|FG002|Overall Study|Participant's (guardian's) decision|0|||
146999091|NCT01705574|530161683|FG000|Double-Blind Phase|Lost to Follow-up|12|||
146999092|NCT01705574|530161684|FG001|Double-Blind Phase|Lost to Follow-up|16|||
146999093|NCT01705574|530161685|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146999094|NCT01705574|530161686|FG003|Double-Blind Phase|Lost to Follow-up|0|||
146999095|NCT01705574|530161683|FG000|Double-Blind Phase|Adverse Event|3|||
146999096|NCT01705574|530161684|FG001|Double-Blind Phase|Adverse Event|10|||
146999097|NCT01705574|530161685|FG002|Double-Blind Phase|Adverse Event|0|||
146999098|NCT01705574|530161686|FG003|Double-Blind Phase|Adverse Event|0|||
146999099|NCT01705574|530161683|FG000|Double-Blind Phase|Withdrew Consent|8|||
146999100|NCT01705574|530161684|FG001|Double-Blind Phase|Withdrew Consent|5|||
146999101|NCT01705574|530161685|FG002|Double-Blind Phase|Withdrew Consent|0|||
146999102|NCT01705574|530161686|FG003|Double-Blind Phase|Withdrew Consent|0|||
146999103|NCT01705574|530161683|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
146999104|NCT01705574|530161684|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
146999105|NCT01705574|530161685|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
146999106|NCT01705574|530161686|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
146999107|NCT01705574|530161683|FG000|Double-Blind Phase|Pregnancy|1|||
146999108|NCT01705574|530161684|FG001|Double-Blind Phase|Pregnancy|1|||
146999109|NCT01705574|530161685|FG002|Double-Blind Phase|Pregnancy|0|||
146999110|NCT01705574|530161686|FG003|Double-Blind Phase|Pregnancy|0|||
146999111|NCT01705574|530161683|FG000|Double-Blind Phase|Protocol Violation|1|||
146999112|NCT01705574|530161684|FG001|Double-Blind Phase|Protocol Violation|0|||
146999113|NCT01705574|530161685|FG002|Double-Blind Phase|Protocol Violation|0|||
146999114|NCT01705574|530161686|FG003|Double-Blind Phase|Protocol Violation|0|||
146999115|NCT01705574|530161683|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
146844797|NCT05487586|529600883|FG000|Overall Study|Transfer to another hospital|4|||
146844798|NCT05487586|529600883|FG000|Overall Study|Other|1|||
146844799|NCT01493427|529600884|FG000|Overall Study|Adverse Event|10|||
146844800|NCT01493427|529600884|FG000|Overall Study|Personal Reasons|4|||
146999116|NCT01705574|530161684|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
146999117|NCT01705574|530161685|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
146999118|NCT01705574|530161686|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
146999119|NCT01705574|530161683|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
146999120|NCT01705574|530161684|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
146999121|NCT01705574|530161685|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
146999122|NCT01705574|530161686|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
146999123|NCT01705574|530161683|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
146999124|NCT01705574|530161684|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
146999125|NCT01705574|530161685|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
146999126|NCT01705574|530161686|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
146999127|NCT01705574|530161683|FG000|Open-Label Extension Phase|Adverse Event|3|||
146999128|NCT01705574|530161684|FG001|Open-Label Extension Phase|Adverse Event|0|||
146999129|NCT01705574|530161685|FG002|Open-Label Extension Phase|Adverse Event|0|||
146999130|NCT01705574|530161686|FG003|Open-Label Extension Phase|Adverse Event|1|||
146999131|NCT01705574|530161683|FG000|Open-Label Extension Phase|Death|2|||
146999132|NCT01705574|530161684|FG001|Open-Label Extension Phase|Death|0|||
146999133|NCT01705574|530161685|FG002|Open-Label Extension Phase|Death|1|||
146999134|NCT01705574|530161686|FG003|Open-Label Extension Phase|Death|0|||
146999135|NCT01705574|530161683|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
146999136|NCT01705574|530161684|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
146999137|NCT01705574|530161685|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
146999138|NCT01705574|530161686|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
146999139|NCT01705574|530161683|FG000|Open-Label Extension Phase|Physician Decision|0|||
146999140|NCT01705574|530161684|FG001|Open-Label Extension Phase|Physician Decision|0|||
146999141|NCT01705574|530161685|FG002|Open-Label Extension Phase|Physician Decision|2|||
146999142|NCT01705574|530161686|FG003|Open-Label Extension Phase|Physician Decision|0|||
146999143|NCT01705574|530161683|FG000|Open-Label Extension Phase|Pregnancy|0|||
146999144|NCT01705574|530161684|FG001|Open-Label Extension Phase|Pregnancy|0|||
146999145|NCT01705574|530161685|FG002|Open-Label Extension Phase|Pregnancy|1|||
146999146|NCT01705574|530161686|FG003|Open-Label Extension Phase|Pregnancy|1|||
146999147|NCT00777023|530161687|FG000|Overall Study|Adverse Event|15|||
146999148|NCT00777023|530161688|FG001|Overall Study|Adverse Event|21|||
146999149|NCT00777023|530161689|FG002|Overall Study|Adverse Event|8|||
146999150|NCT00777023|530161687|FG000|Overall Study|Lack of Efficacy|1|||
146999151|NCT00777023|530161688|FG001|Overall Study|Lack of Efficacy|0|||
146999152|NCT00777023|530161689|FG002|Overall Study|Lack of Efficacy|14|||
146999153|NCT00777023|530161687|FG000|Overall Study|Protocol Violation|2|||
146999154|NCT00777023|530161688|FG001|Overall Study|Protocol Violation|1|||
146999155|NCT00777023|530161689|FG002|Overall Study|Protocol Violation|1|||
146999156|NCT00777023|530161687|FG000|Overall Study|Lost to Follow-up|2|||
146999157|NCT00777023|530161688|FG001|Overall Study|Lost to Follow-up|3|||
146999158|NCT00777023|530161689|FG002|Overall Study|Lost to Follow-up|3|||
146999159|NCT00777023|530161687|FG000|Overall Study|Death|0|||
146999160|NCT00777023|530161688|FG001|Overall Study|Death|1|||
146999161|NCT00777023|530161689|FG002|Overall Study|Death|0|||
146999162|NCT00777023|530161687|FG000|Overall Study|Withdrawal by Subject|7|||
146999163|NCT00777023|530161688|FG001|Overall Study|Withdrawal by Subject|7|||
146999164|NCT00777023|530161689|FG002|Overall Study|Withdrawal by Subject|8|||
146999165|NCT00777023|530161687|FG000|Overall Study|Missing data|1|||
146999166|NCT00777023|530161688|FG001|Overall Study|Missing data|1|||
146999167|NCT00777023|530161689|FG002|Overall Study|Missing data|0|||
146999168|NCT00777023|530161687|FG000|Overall Study|Reasons not specified|4|||
146999169|NCT00777023|530161688|FG001|Overall Study|Reasons not specified|4|||
146999170|NCT00777023|530161689|FG002|Overall Study|Reasons not specified|2|||
146999171|NCT00777023|530161687|FG000|Overall Study|Last dose date unknown|3|||
146999172|NCT00777023|530161688|FG001|Overall Study|Last dose date unknown|3|||
146999173|NCT00777023|530161689|FG002|Overall Study|Last dose date unknown|1|||
146999174|NCT02659150|530161692|FG000|Subject Enrollment|Physician Decision|3|||
146999175|NCT02659150|530161692|FG000|Subject Enrollment|Withdrawal by Subject|2|||
146999176|NCT02659150|530161692|FG000|Baseline Imaging|Withdrawal by Subject|1|||
146999177|NCT02659150|530161692|FG000|Baseline Imaging|Physician Decision|1|||
146999178|NCT02659150|530161692|FG000|Study Drug Dosing|Adverse Event|1|||
146999179|NCT02472366|530161695|FG000|Overall Study|Lost to Follow-up|1|||
146999180|NCT02472366|530161696|FG001|Overall Study|Lost to Follow-up|0|||
146999181|NCT03699020|530161699|FG000|Overall Study|Withdrawal by Subject|3|||
146999182|NCT03699020|530161700|FG001|Overall Study|Withdrawal by Subject|2|||
146999183|NCT03620747|530161704|FG000|Overall Study|Participant decision|7|||
146999184|NCT03620747|530161704|FG000|Overall Study|Adverse Event|6|||
146999185|NCT03620747|530161704|FG000|Overall Study|Lack of Efficacy|1|||
146999186|NCT03620747|530161704|FG000|Overall Study|Poor compliance to protocol|2|||
146999187|NCT03620747|530161704|FG000|Overall Study|Other-unspecified|3|||
146999188|NCT00635492|530161713|FG000|Overall Study|Death|12|||
146999189|NCT00635492|530161714|FG001|Overall Study|Death|40|||
146999190|NCT00635492|530161713|FG000|Overall Study|Lost to Follow-up|151|||
146999191|NCT00635492|530161714|FG001|Overall Study|Lost to Follow-up|172|||
146999192|NCT00635492|530161713|FG000|Overall Study|Physician Decision|32|||
146999193|NCT00635492|530161714|FG001|Overall Study|Physician Decision|22|||
146999194|NCT00635492|530161713|FG000|Overall Study|Sponsor decision|2|||
146999195|NCT00635492|530161714|FG001|Overall Study|Sponsor decision|3|||
146999196|NCT00635492|530161713|FG000|Overall Study|Withdrawal by Subject|82|||
146999197|NCT00635492|530161714|FG001|Overall Study|Withdrawal by Subject|45|||
146999198|NCT00467363|530161720|FG000|Overall Study|Lost to Follow-up|80|||
146999199|NCT00467363|530161721|FG001|Overall Study|Lost to Follow-up|70|||
146999200|NCT00473330|530161722|FG000|Core Study|Adverse Event|4|||
146999201|NCT00473330|530161723|FG001|Core Study|Adverse Event|4|||
146999202|NCT00473330|530161724|FG002|Core Study|Adverse Event|1|||
146999203|NCT00473330|530161722|FG000|Core Study|Death|6|||
146999204|NCT00473330|530161723|FG001|Core Study|Death|4|||
146999205|NCT00473330|530161724|FG002|Core Study|Death|4|||
146999206|NCT00473330|530161722|FG000|Core Study|Lost to Follow-up|5|||
146999207|NCT00473330|530161723|FG001|Core Study|Lost to Follow-up|5|||
146999208|NCT00473330|530161724|FG002|Core Study|Lost to Follow-up|10|||
146999209|NCT00473330|530161722|FG000|Core Study|Physician Decision|2|||
146999210|NCT00473330|530161723|FG001|Core Study|Physician Decision|1|||
146999211|NCT00473330|530161724|FG002|Core Study|Physician Decision|3|||
146999212|NCT00473330|530161722|FG000|Core Study|Subject Non-compliance|1|||
146999213|NCT00473330|530161723|FG001|Core Study|Subject Non-compliance|2|||
146999214|NCT00473330|530161724|FG002|Core Study|Subject Non-compliance|1|||
146999215|NCT00473330|530161722|FG000|Core Study|Subject Required Other Therapy|0|||
146999216|NCT00473330|530161723|FG001|Core Study|Subject Required Other Therapy|1|||
146999217|NCT00473330|530161724|FG002|Core Study|Subject Required Other Therapy|3|||
146999218|NCT00473330|530161722|FG000|Core Study|Subject's Decision|9|||
146999219|NCT00473330|530161723|FG001|Core Study|Subject's Decision|8|||
146999220|NCT00473330|530161724|FG002|Core Study|Subject's Decision|19|||
146999221|NCT00473330|530161722|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
146999222|NCT00473330|530161723|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
146999223|NCT00473330|530161724|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
146999224|NCT00473330|530161722|FG000|Open-label Extension Through Month 48|Death|2|||
146999225|NCT00473330|530161723|FG001|Open-label Extension Through Month 48|Death|0|||
146999226|NCT00473330|530161724|FG002|Open-label Extension Through Month 48|Death|0|||
146999227|NCT00473330|530161722|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
146999228|NCT00473330|530161723|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
146999229|NCT00473330|530161724|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
146999230|NCT00473330|530161722|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
146999231|NCT00473330|530161723|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
146999232|NCT00473330|530161724|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
146999233|NCT00473330|530161722|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
146999234|NCT00473330|530161723|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
146999235|NCT00473330|530161724|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
146999236|NCT00473330|530161722|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
146999237|NCT00473330|530161723|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
146999238|NCT00473330|530161724|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
146999239|NCT00473330|530161722|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
146999240|NCT00473330|530161723|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
146999241|NCT00473330|530161724|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
146999242|NCT00473330|530161722|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
146999243|NCT00473330|530161723|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
146999244|NCT00473330|530161724|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
146999245|NCT00473330|530161722|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
146999246|NCT00473330|530161723|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
146999247|NCT00473330|530161724|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
146999248|NCT00473330|530161722|FG000|Open-label Extension Through Month 60|Death|2|||
146999249|NCT00473330|530161723|FG001|Open-label Extension Through Month 60|Death|2|||
146999250|NCT00473330|530161724|FG002|Open-label Extension Through Month 60|Death|1|||
146999251|NCT00473330|530161722|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
146999252|NCT00473330|530161723|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
146999253|NCT00473330|530161724|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
146999254|NCT00473330|530161722|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
146999255|NCT00473330|530161723|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
146999256|NCT00473330|530161724|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
146999257|NCT00473330|530161722|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
146999258|NCT00473330|530161723|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
146999259|NCT00473330|530161724|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
146999260|NCT00473330|530161722|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
146999261|NCT00473330|530161723|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
146999262|NCT00473330|530161724|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
146999263|NCT00473330|530161722|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
146999264|NCT00473330|530161723|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
146999265|NCT00473330|530161724|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
146999266|NCT00473330|530161722|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
146999267|NCT00473330|530161723|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
146999268|NCT00473330|530161724|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
146999269|NCT05615935|530161725|FG000|Overall Study|Lost to Follow-up|1|||
146999270|NCT05615935|530161726|FG001|Overall Study|Lost to Follow-up|1|||
146999271|NCT03925532|530161727|FG000|Overall Study|Lost to Follow-up|1|||
146999272|NCT01079988|530161728|FG000|Overall Study|Lost to Follow-up|0|||
146999273|NCT01079988|530161729|FG001|Overall Study|Lost to Follow-up|0|||
146999274|NCT01079988|530161730|FG002|Overall Study|Lost to Follow-up|0|||
146999275|NCT01079988|530161731|FG003|Overall Study|Lost to Follow-up|1|||
146999276|NCT01079988|530161732|FG004|Overall Study|Lost to Follow-up|0|||
146999277|NCT01079988|530161728|FG000|Overall Study|Lack of Efficacy|1|||
146999278|NCT01079988|530161729|FG001|Overall Study|Lack of Efficacy|0|||
146999279|NCT01079988|530161730|FG002|Overall Study|Lack of Efficacy|0|||
146999280|NCT01079988|530161731|FG003|Overall Study|Lack of Efficacy|0|||
146999281|NCT01079988|530161732|FG004|Overall Study|Lack of Efficacy|0|||
146999282|NCT01079988|530161728|FG000|Overall Study|Other|0|||
146999283|NCT01079988|530161729|FG001|Overall Study|Other|0|||
146999284|NCT01079988|530161730|FG002|Overall Study|Other|0|||
146999285|NCT01079988|530161731|FG003|Overall Study|Other|2|||
146999286|NCT01079988|530161732|FG004|Overall Study|Other|1|||
146999287|NCT01001208|530161733|FG000|Overall Study|Adverse Event|10|||
146999288|NCT01001208|530161734|FG001|Overall Study|Adverse Event|5|||
146999289|NCT01001208|530161733|FG000|Overall Study|Lost to Follow-up|5|||
146999290|NCT01001208|530161734|FG001|Overall Study|Lost to Follow-up|9|||
146999291|NCT01001208|530161733|FG000|Overall Study|Physician Decision|1|||
146999292|NCT01001208|530161734|FG001|Overall Study|Physician Decision|0|||
146999293|NCT01001208|530161733|FG000|Overall Study|Withdrawal by Subject|4|||
146999294|NCT01001208|530161734|FG001|Overall Study|Withdrawal by Subject|5|||
146999295|NCT01001208|530161733|FG000|Overall Study|Ineligibility Determined|4|||
146999296|NCT01001208|530161734|FG001|Overall Study|Ineligibility Determined|2|||
146999297|NCT01001208|530161733|FG000|Overall Study|Noncompliance|4|||
146999298|NCT01001208|530161734|FG001|Overall Study|Noncompliance|7|||
146999299|NCT01001208|530161733|FG000|Overall Study|Disease Progression|0|||
146999300|NCT01001208|530161734|FG001|Overall Study|Disease Progression|3|||
146999301|NCT01001208|530161733|FG000|Overall Study|Other|0|||
146999302|NCT01001208|530161734|FG001|Overall Study|Other|2|||
146999303|NCT00833937|530161735|FG000|Washout|Withdrawal by Subject|1|||
146999304|NCT00833937|530161736|FG001|Washout|Withdrawal by Subject|0|||
146999305|NCT00095212|530161737|FG000|Overall Study|Withdrawal by Subject|1|||
146999306|NCT00095212|530161738|FG001|Overall Study|Withdrawal by Subject|3|||
146999307|NCT02032888|530161742|FG000|Treatment Period|Poor compliance/noncompliance|1|||
146999308|NCT02032888|530161743|FG001|Treatment Period|Poor compliance/noncompliance|1|||
146999309|NCT02032888|530161744|FG002|Treatment Period|Poor compliance/noncompliance|0|||
146999310|NCT02032888|530161742|FG000|Treatment Period|Other|1|||
146999311|NCT02032888|530161743|FG001|Treatment Period|Other|1|||
146999312|NCT02032888|530161744|FG002|Treatment Period|Other|0|||
146999313|NCT02032888|530161742|FG000|Follow-up Period|Lost to Follow-up|1|||
146999314|NCT02032888|530161743|FG001|Follow-up Period|Lost to Follow-up|1|||
146999315|NCT02032888|530161744|FG002|Follow-up Period|Lost to Follow-up|0|||
146999316|NCT02032888|530161742|FG000|Follow-up Period|Death|1|||
146999317|NCT02032888|530161743|FG001|Follow-up Period|Death|1|||
146999318|NCT02032888|530161744|FG002|Follow-up Period|Death|0|||
146999319|NCT02032888|530161742|FG000|Follow-up Period|Other|1|||
146999320|NCT02032888|530161743|FG001|Follow-up Period|Other|0|||
146999321|NCT02032888|530161744|FG002|Follow-up Period|Other|0|||
146999322|NCT01697696|530161745|FG000|Overall Study|Study terminated by sponsor|0|||
146999323|NCT01697696|530161746|FG001|Overall Study|Study terminated by sponsor|3|||
146999324|NCT01697696|530161745|FG000|Overall Study|Protocol deviation|1|||
146999325|NCT01697696|530161746|FG001|Overall Study|Protocol deviation|0|||
146999326|NCT01697696|530161745|FG000|Overall Study|Physician Decision|1|||
146999327|NCT01697696|530161746|FG001|Overall Study|Physician Decision|0|||
146999328|NCT01697696|530161745|FG000|Overall Study|Death|4|||
146999329|NCT01697696|530161746|FG001|Overall Study|Death|2|||
146999330|NCT01697696|530161745|FG000|Overall Study|Lost to Follow-up|10|||
146999331|NCT01697696|530161746|FG001|Overall Study|Lost to Follow-up|7|||
146999332|NCT01697696|530161745|FG000|Overall Study|Subject/guardian decision|31|||
146999333|NCT01697696|530161746|FG001|Overall Study|Subject/guardian decision|35|||
146999334|NCT02066922|530161747|FG000|Overall Study|Adverse Event|1|||
146999335|NCT00727961|530161749|FG000|Overall Study|Lost to Follow-up|1|||
146999336|NCT00727961|530161749|FG000|Overall Study|Adverse Event|4|||
146999337|NCT00727961|530161749|FG000|Overall Study|Patient's refusal|2|||
146999338|NCT00727961|530161749|FG000|Overall Study|Progression|30|||
146999339|NCT03161405|530161750|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
146999340|NCT00837486|530161751|FG000|Blinded-treatment Phase|Physician Decision|1|||
146999341|NCT00837486|530161752|FG001|Blinded-treatment Phase|Physician Decision|0|||
146999342|NCT00837486|530161751|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
146999343|NCT00837486|530161752|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
146999344|NCT00837486|530161751|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
146999345|NCT00837486|530161752|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
146999346|NCT00837486|530161751|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
146999347|NCT00837486|530161752|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
146999348|NCT02655679|530161753|FG000|Overall Study|Adverse Event|0|||
146999349|NCT02655679|530161754|FG001|Overall Study|Adverse Event|1|||
146999350|NCT02655679|530161755|FG002|Overall Study|Adverse Event|0|||
146999351|NCT02655679|530161756|FG003|Overall Study|Adverse Event|0|||
146999352|NCT02655679|530161757|FG004|Overall Study|Adverse Event|0|||
146999353|NCT02655679|530161753|FG000|Overall Study|Withdrawal by Subject|1|||
146999354|NCT02655679|530161754|FG001|Overall Study|Withdrawal by Subject|1|||
146999355|NCT02655679|530161755|FG002|Overall Study|Withdrawal by Subject|0|||
146999356|NCT02655679|530161756|FG003|Overall Study|Withdrawal by Subject|3|||
146999357|NCT02655679|530161757|FG004|Overall Study|Withdrawal by Subject|1|||
146999358|NCT02655679|530161753|FG000|Overall Study|Inability to Comply with the Protocol|1|||
146999359|NCT02655679|530161754|FG001|Overall Study|Inability to Comply with the Protocol|0|||
146999360|NCT02655679|530161755|FG002|Overall Study|Inability to Comply with the Protocol|0|||
146999361|NCT02655679|530161756|FG003|Overall Study|Inability to Comply with the Protocol|0|||
146999362|NCT02655679|530161757|FG004|Overall Study|Inability to Comply with the Protocol|0|||
146999363|NCT02655679|530161753|FG000|Overall Study|Lost to Follow-up|0|||
146999364|NCT02655679|530161754|FG001|Overall Study|Lost to Follow-up|1|||
146999365|NCT02655679|530161755|FG002|Overall Study|Lost to Follow-up|1|||
146999366|NCT02655679|530161756|FG003|Overall Study|Lost to Follow-up|1|||
146999367|NCT02655679|530161757|FG004|Overall Study|Lost to Follow-up|0|||
146999368|NCT02655679|530161753|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146999369|NCT02655679|530161754|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146999370|NCT02655679|530161755|FG002|Overall Study|Other Miscellaneous Reasons|0|||
146999371|NCT02655679|530161756|FG003|Overall Study|Other Miscellaneous Reasons|0|||
146999372|NCT02655679|530161757|FG004|Overall Study|Other Miscellaneous Reasons|0|||
146999373|NCT01421277|530161758|FG000|Overall Study|Lack of qualifying event|0|||
146999374|NCT01421277|530161759|FG001|Overall Study|Lack of qualifying event|61|||
146999375|NCT01421277|530161758|FG000|Overall Study|Incomplete baseline data|0|||
146999376|NCT01421277|530161759|FG001|Overall Study|Incomplete baseline data|31|||
146999377|NCT02039908|530161760|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
146999378|NCT02039908|530161761|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
146999379|NCT02039908|530161762|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
146999380|NCT02039908|530161763|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
146999381|NCT02039908|530161760|FG000|Phase 1-Summer|Protocol Violation|6|||
146999382|NCT02039908|530161761|FG001|Phase 1-Summer|Protocol Violation|0|||
146999383|NCT02039908|530161762|FG002|Phase 1-Summer|Protocol Violation|0|||
146999384|NCT02039908|530161763|FG003|Phase 1-Summer|Protocol Violation|0|||
146999385|NCT02039908|530161760|FG000|Phase 2-School Year|Lost to Follow-up|0|||
146999386|NCT02039908|530161761|FG001|Phase 2-School Year|Lost to Follow-up|0|||
146999387|NCT02039908|530161762|FG002|Phase 2-School Year|Lost to Follow-up|1|||
146999388|NCT02039908|530161763|FG003|Phase 2-School Year|Lost to Follow-up|3|||
146999389|NCT02039908|530161760|FG000|Phase 2-School Year|Protocol Violation|0|||
146999390|NCT02039908|530161761|FG001|Phase 2-School Year|Protocol Violation|0|||
146999391|NCT02039908|530161762|FG002|Phase 2-School Year|Protocol Violation|3|||
146999392|NCT02039908|530161763|FG003|Phase 2-School Year|Protocol Violation|0|||
146999393|NCT02039908|530161760|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
146999394|NCT02039908|530161761|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
146999395|NCT02039908|530161762|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
146999396|NCT02039908|530161763|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
146999397|NCT00829309|530163258|FG000|Washout: 7 Days|Protocol Violation|1|||
146999398|NCT00829309|530163259|FG001|Washout: 7 Days|Protocol Violation|0|||
146999399|NCT02246920|530163261|FG000|Overall Study|Adverse Event|3|||
146999400|NCT02246920|530163262|FG001|Overall Study|Adverse Event|1|||
146999401|NCT02246920|530163263|FG002|Overall Study|Adverse Event|1|||
146844801|NCT01493427|529600884|FG000|Overall Study|Lost to Follow-up|2|||
146844802|NCT01493427|529600884|FG000|Overall Study|Inability to Follow Instructions|2|||
146844803|NCT01493427|529600884|FG000|Overall Study|Other|2|||
146999402|NCT02246920|530163261|FG000|Overall Study|Lost to Follow-up|2|||
146999403|NCT02246920|530163262|FG001|Overall Study|Lost to Follow-up|1|||
146844804|NCT00565773|529600885|FG000|Overall Study|Withdrawal by Subject|1|||
146999404|NCT02246920|530163263|FG002|Overall Study|Lost to Follow-up|0|||
146999405|NCT02246920|530163261|FG000|Overall Study|Protocol Violation|2|||
146999406|NCT02246920|530163262|FG001|Overall Study|Protocol Violation|5|||
146999407|NCT02246920|530163263|FG002|Overall Study|Protocol Violation|1|||
146999408|NCT02246920|530163261|FG000|Overall Study|Withdrawal by Subject|0|||
146999409|NCT02246920|530163262|FG001|Overall Study|Withdrawal by Subject|0|||
146999410|NCT02246920|530163263|FG002|Overall Study|Withdrawal by Subject|1|||
146999411|NCT02678286|530163264|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
146999412|NCT02678286|530163265|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
146999413|NCT02678286|530163264|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
146999414|NCT02678286|530163265|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
146999415|NCT02678286|530163264|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
146999416|NCT02678286|530163265|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
146999417|NCT02678286|530163264|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
146999418|NCT02678286|530163265|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
146999419|NCT02678286|530163264|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
146999420|NCT02678286|530163265|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
146999421|NCT00448019|530163266|FG000|Overall Study|Withdrawal by Subject|3|||
146999422|NCT00448019|530163266|FG000|Overall Study|Disease progression|1|||
146999423|NCT00448019|530163266|FG000|Overall Study|Death|2|||
146999424|NCT00448019|530163266|FG000|Overall Study|Insurance Issues|1|||
146999425|NCT01273805|530163267|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
146999426|NCT01273805|530163268|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
146999427|NCT02647944|530163273|FG000|Overall Study|Withdrawal by Subject|0|||
146999428|NCT02647944|530163274|FG001|Overall Study|Withdrawal by Subject|3|||
146999429|NCT02647944|530163273|FG000|Overall Study|Adverse Event|2|||
146999430|NCT02647944|530163274|FG001|Overall Study|Adverse Event|0|||
146999431|NCT02760368|530163276|FG000|Overall Study|Withdrawal by Subject|8|||
146999432|NCT02760368|530163277|FG001|Overall Study|Withdrawal by Subject|12|||
146999433|NCT02760368|530163278|FG002|Overall Study|Withdrawal by Subject|9|||
146999434|NCT02760368|530163276|FG000|Overall Study|Screen Failure|0|||
146999435|NCT02760368|530163277|FG001|Overall Study|Screen Failure|0|||
146999436|NCT02760368|530163278|FG002|Overall Study|Screen Failure|1|||
146999437|NCT02760368|530163276|FG000|Overall Study|Death|0|||
146999438|NCT02760368|530163277|FG001|Overall Study|Death|1|||
146999439|NCT02760368|530163278|FG002|Overall Study|Death|0|||
146999440|NCT02760368|530163276|FG000|Overall Study|Withdrawal by Sponsor|0|||
146999441|NCT02760368|530163277|FG001|Overall Study|Withdrawal by Sponsor|0|||
146999442|NCT02760368|530163278|FG002|Overall Study|Withdrawal by Sponsor|1|||
146999443|NCT02902211|530163286|FG000|First Three Months|Withdrawal by Subject|7|||
146999444|NCT02902211|530163287|FG001|First Three Months|Withdrawal by Subject|3|||
146999445|NCT01200810|530163288|FG000|Overall Study|Physician Decision|1|||
146999446|NCT01200810|530163289|FG001|Overall Study|Physician Decision|0|||
146999447|NCT01200810|530163288|FG000|Overall Study|Withdrawal by Subject|1|||
146999448|NCT01200810|530163289|FG001|Overall Study|Withdrawal by Subject|2|||
146999449|NCT01200810|530163288|FG000|Overall Study|Sponsor stopped making study drug|3|||
146999450|NCT01200810|530163289|FG001|Overall Study|Sponsor stopped making study drug|3|||
146999451|NCT00904215|530163291|FG000|Overall Study|Adverse Event|25|||
146999452|NCT00904215|530163291|FG000|Overall Study|Protocol Violation|10|||
146999453|NCT00904215|530163291|FG000|Overall Study|Lost to Follow-up|63|||
146999454|NCT00904215|530163291|FG000|Overall Study|Withdrawal by Subject|9|||
146999455|NCT00904215|530163291|FG000|Overall Study|Other|28|||
146999456|NCT00838630|530163292|FG000|First Intervention|Adverse Event|1|||
146999457|NCT00838630|530163293|FG001|First Intervention|Adverse Event|0|||
146999458|NCT00838630|530163292|FG000|Washout: 7 Days|Protocol Violation|1|||
146999459|NCT00838630|530163293|FG001|Washout: 7 Days|Protocol Violation|0|||
146999460|NCT00448591|530163294|FG000|Overall Study|Withdrawal by Subject|178|||
146999461|NCT00448591|530163294|FG000|Overall Study|Progressive Disease|1382|||
146999462|NCT00448591|530163294|FG000|Overall Study|Adverse Event|382|||
146999463|NCT00448591|530163294|FG000|Overall Study|Protocol Violation|41|||
146999464|NCT00448591|530163294|FG000|Overall Study|Lost to Follow-up|19|||
146999465|NCT00448591|530163294|FG000|Overall Study|Treatment Regimen Completed|70|||
146999466|NCT00448591|530163294|FG000|Overall Study|Other|154|||
146999467|NCT00448591|530163294|FG000|Overall Study|Termination of Study|70|||
146999468|NCT00640562|530163295|FG000|Overall Study|Adverse Event|8|||
146999469|NCT00640562|530163296|FG001|Overall Study|Adverse Event|5|||
146999470|NCT00640562|530163295|FG000|Overall Study|Lack of Efficacy|1|||
146844805|NCT00565773|529600885|FG000|Overall Study|Physician Decision|1|||
146999471|NCT00640562|530163296|FG001|Overall Study|Lack of Efficacy|4|||
146999472|NCT00640562|530163295|FG000|Overall Study|Protocol Violation|2|||
146999473|NCT00640562|530163296|FG001|Overall Study|Protocol Violation|4|||
146999474|NCT00640562|530163295|FG000|Overall Study|Withdrawal by Subject|6|||
146999475|NCT00640562|530163296|FG001|Overall Study|Withdrawal by Subject|10|||
146999476|NCT00640562|530163295|FG000|Overall Study|Known risperidone intolerance|0|||
146999477|NCT00640562|530163296|FG001|Overall Study|Known risperidone intolerance|1|||
146999478|NCT00640562|530163295|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
146999479|NCT00640562|530163296|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
146999480|NCT00640562|530163295|FG000|Overall Study|Low study drug dose|0|||
146999481|NCT00640562|530163296|FG001|Overall Study|Low study drug dose|1|||
146999482|NCT00640562|530163295|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
146999483|NCT00640562|530163296|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
146999484|NCT02937870|530163297|FG000|Overall Study|Adverse Event|1|||
146999485|NCT02937870|530163297|FG000|Overall Study|Protocol Deviation|2|||
146999486|NCT03098394|530163301|FG000|Overall Study|Pregnancy|0|||
146999487|NCT03098394|530163302|FG001|Overall Study|Pregnancy|1|||
146999488|NCT00609674|530163303|FG000|Overall Study|Adverse Event|1|||
146999489|NCT00609674|530163304|FG001|Overall Study|Adverse Event|1|||
146999490|NCT00609674|530163303|FG000|Overall Study|Protocol Violation|3|||
146999491|NCT00609674|530163304|FG001|Overall Study|Protocol Violation|5|||
146999492|NCT00609674|530163303|FG000|Overall Study|Lost to Follow-up|1|||
146999493|NCT00609674|530163304|FG001|Overall Study|Lost to Follow-up|0|||
146999494|NCT00609674|530163303|FG000|Overall Study|Withdrew consent|2|||
146999495|NCT00609674|530163304|FG001|Overall Study|Withdrew consent|1|||
146999496|NCT00244764|530163308|FG000|Overall Study|Adverse Event|37|||
146999497|NCT00244764|530163308|FG000|Overall Study|Lost to Follow-up|23|||
146999498|NCT00244764|530163308|FG000|Overall Study|Withdrawal by Subject|12|||
146999499|NCT00244764|530163308|FG000|Overall Study|Disease Progression|13|||
146999500|NCT00244764|530163308|FG000|Overall Study|Protocol Violation|2|||
146999501|NCT00244764|530163308|FG000|Overall Study|Death|1|||
146999502|NCT00244764|530163308|FG000|Overall Study|Off Study Medication for >21 Days|1|||
146999503|NCT00244764|530163308|FG000|Overall Study|Declining Performance Status|1|||
146999504|NCT00244764|530163308|FG000|Overall Study|Participant was Hospitalized until Death|1|||
146999505|NCT00244764|530163308|FG000|Overall Study|Primary Investigator Discretion|2|||
146999506|NCT00244764|530163308|FG000|Overall Study|Sponsor Terminated Study|2|||
146999507|NCT00244764|530163308|FG000|Overall Study|Developed Secondary Malignancy|1|||
146999508|NCT02648438|530163314|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146999509|NCT02648438|530163315|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
146999510|NCT02648438|530163316|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
146999511|NCT02648438|530163314|FG000|Overall Study|Protocol Violation|2|||
146999512|NCT02648438|530163315|FG001|Overall Study|Protocol Violation|0|||
146999513|NCT02648438|530163316|FG002|Overall Study|Protocol Violation|0|||
146999514|NCT02648438|530163314|FG000|Overall Study|Withdrawal by Subject|1|||
146999515|NCT02648438|530163315|FG001|Overall Study|Withdrawal by Subject|1|||
146999516|NCT02648438|530163316|FG002|Overall Study|Withdrawal by Subject|0|||
146999517|NCT03138967|530163317|FG000|Overall Study|Death|0|||
146999518|NCT03138967|530163318|FG001|Overall Study|Death|1|||
146999519|NCT03138967|530163317|FG000|Overall Study|Physician Decision|1|||
146999520|NCT03138967|530163318|FG001|Overall Study|Physician Decision|3|||
146999521|NCT04604275|530163319|FG000|Washout-1 Week|Withdrawal by Subject|1|||
146999522|NCT04604275|530163320|FG001|Washout-1 Week|Withdrawal by Subject|0|||
146999523|NCT02689505|530163321|FG000|Overall Study|Progressive disease|2|||
146999524|NCT02689505|530163322|FG001|Overall Study|Progressive disease|2|||
146999525|NCT02689505|530163323|FG002|Overall Study|Progressive disease|3|||
146999526|NCT02689505|530163324|FG003|Overall Study|Progressive disease|9|||
146999527|NCT02689505|530163325|FG004|Overall Study|Progressive disease|1|||
146999528|NCT02689505|530163321|FG000|Overall Study|Dose Limiting Toxicity|0|||
146999529|NCT02689505|530163322|FG001|Overall Study|Dose Limiting Toxicity|1|||
146999530|NCT02689505|530163323|FG002|Overall Study|Dose Limiting Toxicity|0|||
146999531|NCT02689505|530163324|FG003|Overall Study|Dose Limiting Toxicity|0|||
146999532|NCT02689505|530163325|FG004|Overall Study|Dose Limiting Toxicity|2|||
146999533|NCT02689505|530163321|FG000|Overall Study|Other AE or clinical progression|0|||
146999534|NCT02689505|530163322|FG001|Overall Study|Other AE or clinical progression|2|||
146999535|NCT02689505|530163323|FG002|Overall Study|Other AE or clinical progression|0|||
146999536|NCT02689505|530163324|FG003|Overall Study|Other AE or clinical progression|2|||
146999537|NCT02689505|530163325|FG004|Overall Study|Other AE or clinical progression|0|||
146999538|NCT04405570|530163329|FG000|Overall Study|Adverse Event|0|||
146999539|NCT04405570|530163330|FG001|Overall Study|Adverse Event|1|||
146999540|NCT04405570|530163331|FG002|Overall Study|Adverse Event|1|||
146999541|NCT04405570|530163332|FG003|Overall Study|Adverse Event|1|||
146999542|NCT04405570|530163329|FG000|Overall Study|Lost to Follow-up|0|||
146844806|NCT05775991|529600886|FG000|Overall Study|Withdrawal by Subject|0|||
146844807|NCT05775991|529600887|FG001|Overall Study|Withdrawal by Subject|0|||
146844808|NCT05775991|529600888|FG002|Overall Study|Withdrawal by Subject|2|||
146999543|NCT04405570|530163330|FG001|Overall Study|Lost to Follow-up|1|||
146999544|NCT04405570|530163331|FG002|Overall Study|Lost to Follow-up|0|||
146999545|NCT04405570|530163332|FG003|Overall Study|Lost to Follow-up|0|||
146999546|NCT04405570|530163329|FG000|Overall Study|Physician Decision|0|||
146999547|NCT04405570|530163330|FG001|Overall Study|Physician Decision|0|||
146999548|NCT04405570|530163331|FG002|Overall Study|Physician Decision|1|||
146999549|NCT04405570|530163332|FG003|Overall Study|Physician Decision|0|||
146999550|NCT04405570|530163329|FG000|Overall Study|Withdrawal by Subject|0|||
146999551|NCT04405570|530163330|FG001|Overall Study|Withdrawal by Subject|1|||
146999552|NCT04405570|530163331|FG002|Overall Study|Withdrawal by Subject|1|||
146999553|NCT04405570|530163332|FG003|Overall Study|Withdrawal by Subject|0|||
146999554|NCT04405570|530163329|FG000|Overall Study|Randomized not dosed|0|||
146999555|NCT04405570|530163330|FG001|Overall Study|Randomized not dosed|2|||
146999556|NCT04405570|530163331|FG002|Overall Study|Randomized not dosed|0|||
146999557|NCT04405570|530163332|FG003|Overall Study|Randomized not dosed|0|||
146999558|NCT00723710|530163333|FG000|Overall Study|Disease progression|48|||
146999559|NCT00723710|530163333|FG000|Overall Study|Adverse Event|88|||
146999560|NCT00723710|530163333|FG000|Overall Study|Withdrawal by Subject|36|||
146999561|NCT00723710|530163333|FG000|Overall Study|Physician Decision|2|||
146999562|NCT04499963|530163334|FG000|Overall Study|Adverse Event|3|||
146999563|NCT04499963|530163335|FG001|Overall Study|Adverse Event|0|||
146999564|NCT04499963|530163334|FG000|Overall Study|Death|3|||
146999565|NCT04499963|530163335|FG001|Overall Study|Death|0|||
146999566|NCT04499963|530163334|FG000|Overall Study|Lack of Efficacy|7|||
146999567|NCT04499963|530163335|FG001|Overall Study|Lack of Efficacy|0|||
146999568|NCT04499963|530163334|FG000|Overall Study|Lost to Follow-up|2|||
146999569|NCT04499963|530163335|FG001|Overall Study|Lost to Follow-up|0|||
146999570|NCT03546842|530163336|FG000|Overall Study|Protocol Violation|1|||
146999571|NCT03546842|530163336|FG000|Overall Study|Withdrawal by Subject|2|||
146999572|NCT03031847|530163347|FG000|Overall Study|Death|1|||
146999573|NCT03031847|530163348|FG001|Overall Study|Death|1|||
146999574|NCT03031847|530163349|FG002|Overall Study|Death|2|||
146999575|NCT03031847|530163350|FG003|Overall Study|Death|3|||
146999576|NCT03031847|530163347|FG000|Overall Study|Lost to Follow-up|1|||
146999577|NCT03031847|530163348|FG001|Overall Study|Lost to Follow-up|1|||
146999578|NCT03031847|530163349|FG002|Overall Study|Lost to Follow-up|2|||
146999579|NCT03031847|530163350|FG003|Overall Study|Lost to Follow-up|3|||
146999580|NCT01353664|530163351|FG000|Overall Study|Other|3|||
146999581|NCT01353664|530163351|FG000|Overall Study|Disease Progression|16|||
146999582|NCT03273153|530163352|FG000|Overall Study|Adverse Event|1|||
146999583|NCT03273153|530163353|FG001|Overall Study|Adverse Event|2|||
146999584|NCT03273153|530163352|FG000|Overall Study|Missing|0|||
146999585|NCT03273153|530163353|FG001|Overall Study|Missing|2|||
146999586|NCT03273153|530163352|FG000|Overall Study|Other|3|||
146999587|NCT03273153|530163353|FG001|Overall Study|Other|2|||
146999588|NCT03273153|530163352|FG000|Overall Study|Symptomatic Deterioration|0|||
146999589|NCT03273153|530163353|FG001|Overall Study|Symptomatic Deterioration|1|||
146999590|NCT03273153|530163352|FG000|Overall Study|Progressive Disease|6|||
146999591|NCT03273153|530163353|FG001|Overall Study|Progressive Disease|5|||
146999592|NCT03273153|530163352|FG000|Overall Study|Physician Decision|1|||
146999593|NCT03273153|530163353|FG001|Overall Study|Physician Decision|3|||
146999594|NCT03273153|530163352|FG000|Overall Study|Study Terminated by Sponsor|112|||
146999595|NCT03273153|530163353|FG001|Overall Study|Study Terminated by Sponsor|102|||
146999596|NCT03273153|530163352|FG000|Overall Study|Withdrawal by Subject|26|||
146999597|NCT03273153|530163353|FG001|Overall Study|Withdrawal by Subject|25|||
146999598|NCT03273153|530163352|FG000|Overall Study|Protocol Deviation|3|||
146999599|NCT03273153|530163353|FG001|Overall Study|Protocol Deviation|0|||
146999600|NCT03273153|530163352|FG000|Overall Study|Lost to Follow-up|6|||
146999601|NCT03273153|530163353|FG001|Overall Study|Lost to Follow-up|11|||
146999602|NCT03273153|530163352|FG000|Overall Study|Death|66|||
146999603|NCT03273153|530163353|FG001|Overall Study|Death|69|||
146999604|NCT01237054|530163356|FG000|Overall Study|imaging 10C0096|1|||
146999605|NCT00838539|530163357|FG000|Overall Study|Disease Progression|2|||
146999606|NCT00838539|530163358|FG001|Overall Study|Disease Progression|4|||
146999607|NCT00838539|530163359|FG002|Overall Study|Disease Progression|3|||
146999608|NCT00838539|530163360|FG003|Overall Study|Disease Progression|2|||
146999609|NCT00838539|530163361|FG004|Overall Study|Disease Progression|4|||
146999610|NCT00838539|530163362|FG005|Overall Study|Disease Progression|2|||
146999611|NCT00838539|530163363|FG006|Overall Study|Disease Progression|3|||
146999612|NCT00838539|530163364|FG007|Overall Study|Disease Progression|4|||
146999613|NCT00838539|530163365|FG008|Overall Study|Disease Progression|4|||
146999614|NCT00838539|530163366|FG009|Overall Study|Disease Progression|5|||
146999615|NCT00838539|530163367|FG010|Overall Study|Disease Progression|1|||
146999616|NCT00838539|530163368|FG011|Overall Study|Disease Progression|4|||
146999617|NCT00838539|530163357|FG000|Overall Study|Adverse Event|1|||
146999618|NCT00838539|530163358|FG001|Overall Study|Adverse Event|1|||
146999619|NCT00838539|530163359|FG002|Overall Study|Adverse Event|1|||
146999620|NCT00838539|530163360|FG003|Overall Study|Adverse Event|1|||
146999621|NCT00838539|530163361|FG004|Overall Study|Adverse Event|2|||
146999622|NCT00838539|530163362|FG005|Overall Study|Adverse Event|1|||
146844809|NCT01075958|529600889|FG000|Overall Study|Blood sample could not be obtained|44|||
146844810|NCT00643617|529600890|FG000|Overall Study|Death|6|||
146844811|NCT00643617|529600891|FG001|Overall Study|Death|9|||
146844812|NCT00643617|529600890|FG000|Overall Study|Lost to Follow-up|42|||
146999623|NCT00838539|530163363|FG006|Overall Study|Adverse Event|0|||
146999624|NCT00838539|530163364|FG007|Overall Study|Adverse Event|2|||
146999625|NCT00838539|530163365|FG008|Overall Study|Adverse Event|0|||
146999626|NCT00838539|530163366|FG009|Overall Study|Adverse Event|1|||
146999627|NCT00838539|530163367|FG010|Overall Study|Adverse Event|2|||
146999628|NCT00838539|530163368|FG011|Overall Study|Adverse Event|0|||
146999629|NCT00838539|530163357|FG000|Overall Study|Withdrawal by Subject|0|||
146999630|NCT00838539|530163358|FG001|Overall Study|Withdrawal by Subject|1|||
146999631|NCT00838539|530163359|FG002|Overall Study|Withdrawal by Subject|0|||
146999632|NCT00838539|530163360|FG003|Overall Study|Withdrawal by Subject|0|||
146999633|NCT00838539|530163361|FG004|Overall Study|Withdrawal by Subject|0|||
146999634|NCT00838539|530163362|FG005|Overall Study|Withdrawal by Subject|0|||
146999635|NCT00838539|530163363|FG006|Overall Study|Withdrawal by Subject|0|||
146999636|NCT00838539|530163364|FG007|Overall Study|Withdrawal by Subject|0|||
146999637|NCT00838539|530163365|FG008|Overall Study|Withdrawal by Subject|0|||
146999638|NCT00838539|530163366|FG009|Overall Study|Withdrawal by Subject|1|||
146999639|NCT00838539|530163367|FG010|Overall Study|Withdrawal by Subject|2|||
146999640|NCT00838539|530163368|FG011|Overall Study|Withdrawal by Subject|0|||
146999641|NCT00838539|530163357|FG000|Overall Study|Death|0|||
146999642|NCT00838539|530163358|FG001|Overall Study|Death|0|||
146999643|NCT00838539|530163359|FG002|Overall Study|Death|0|||
146999644|NCT00838539|530163360|FG003|Overall Study|Death|0|||
146999645|NCT00838539|530163361|FG004|Overall Study|Death|0|||
146999646|NCT00838539|530163362|FG005|Overall Study|Death|0|||
146999647|NCT00838539|530163363|FG006|Overall Study|Death|1|||
146999648|NCT00838539|530163364|FG007|Overall Study|Death|0|||
146999649|NCT00838539|530163365|FG008|Overall Study|Death|0|||
146999650|NCT00838539|530163366|FG009|Overall Study|Death|0|||
146999651|NCT00838539|530163367|FG010|Overall Study|Death|0|||
146999652|NCT00838539|530163368|FG011|Overall Study|Death|0|||
146999653|NCT00838539|530163357|FG000|Overall Study|Physician Decision|0|||
146999654|NCT00838539|530163358|FG001|Overall Study|Physician Decision|0|||
146999655|NCT00838539|530163359|FG002|Overall Study|Physician Decision|0|||
146999656|NCT00838539|530163360|FG003|Overall Study|Physician Decision|0|||
146999657|NCT00838539|530163361|FG004|Overall Study|Physician Decision|0|||
146999658|NCT00838539|530163362|FG005|Overall Study|Physician Decision|0|||
146999659|NCT00838539|530163363|FG006|Overall Study|Physician Decision|0|||
146999660|NCT00838539|530163364|FG007|Overall Study|Physician Decision|0|||
146999661|NCT00838539|530163365|FG008|Overall Study|Physician Decision|1|||
146999662|NCT00838539|530163366|FG009|Overall Study|Physician Decision|0|||
146999663|NCT00838539|530163367|FG010|Overall Study|Physician Decision|0|||
146999664|NCT00838539|530163368|FG011|Overall Study|Physician Decision|0|||
146999665|NCT00838539|530163357|FG000|Overall Study|Clinical Progression|0|||
146999666|NCT00838539|530163358|FG001|Overall Study|Clinical Progression|0|||
146999667|NCT00838539|530163359|FG002|Overall Study|Clinical Progression|0|||
146999668|NCT00838539|530163360|FG003|Overall Study|Clinical Progression|0|||
146999669|NCT00838539|530163361|FG004|Overall Study|Clinical Progression|0|||
146999670|NCT00838539|530163362|FG005|Overall Study|Clinical Progression|0|||
146999671|NCT00838539|530163363|FG006|Overall Study|Clinical Progression|1|||
146999672|NCT00838539|530163364|FG007|Overall Study|Clinical Progression|0|||
146999673|NCT00838539|530163365|FG008|Overall Study|Clinical Progression|0|||
146999674|NCT00838539|530163366|FG009|Overall Study|Clinical Progression|0|||
146999675|NCT00838539|530163367|FG010|Overall Study|Clinical Progression|0|||
146999676|NCT00838539|530163368|FG011|Overall Study|Clinical Progression|0|||
146999677|NCT00838539|530163357|FG000|Overall Study|Symptomatic Deterioration|0|||
146999678|NCT00838539|530163358|FG001|Overall Study|Symptomatic Deterioration|0|||
146999679|NCT00838539|530163359|FG002|Overall Study|Symptomatic Deterioration|1|||
146999680|NCT00838539|530163360|FG003|Overall Study|Symptomatic Deterioration|1|||
146999681|NCT00838539|530163361|FG004|Overall Study|Symptomatic Deterioration|0|||
146999682|NCT00838539|530163362|FG005|Overall Study|Symptomatic Deterioration|1|||
146999683|NCT00838539|530163363|FG006|Overall Study|Symptomatic Deterioration|0|||
146999684|NCT00838539|530163364|FG007|Overall Study|Symptomatic Deterioration|0|||
146999685|NCT00838539|530163365|FG008|Overall Study|Symptomatic Deterioration|0|||
146999686|NCT00838539|530163366|FG009|Overall Study|Symptomatic Deterioration|1|||
146999687|NCT00838539|530163367|FG010|Overall Study|Symptomatic Deterioration|0|||
146999688|NCT00838539|530163368|FG011|Overall Study|Symptomatic Deterioration|0|||
146999689|NCT01908205|530163369|FG000|Overall Study|Lost to Follow-up|2|||
146999690|NCT01908205|530163370|FG001|Overall Study|Lost to Follow-up|0|||
146999691|NCT01908205|530163369|FG000|Overall Study|Withdrawal by Subject|3|||
146999692|NCT01908205|530163370|FG001|Overall Study|Withdrawal by Subject|1|||
146999693|NCT05323396|530163371|FG000|Overall Study|Lost to Follow-up|1|||
146735973|NCT02034708|529205254|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
146844813|NCT00643617|529600891|FG001|Overall Study|Lost to Follow-up|51|||
146844814|NCT02075073|529600892|FG000|Overall Study|Withdrawal by Subject|0|||
146844815|NCT02075073|529600893|FG001|Overall Study|Withdrawal by Subject|1|||
146844816|NCT02075073|529600894|FG002|Overall Study|Withdrawal by Subject|0|||
146844817|NCT02233803|529600895|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
146844818|NCT02233803|529600896|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
146844819|NCT02233803|529600895|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
146844820|NCT02233803|529600896|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
146844821|NCT02233803|529600895|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
146844822|NCT02233803|529600896|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
146844823|NCT02233803|529600895|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
146844824|NCT02233803|529600896|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
146844825|NCT02233803|529600895|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
146844826|NCT02233803|529600896|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
146844827|NCT02233803|529600895|FG000|Washout Period (4-Wks)|Physician Decision|1|||
146844828|NCT02233803|529600896|FG001|Washout Period (4-Wks)|Physician Decision|0|||
146999694|NCT05323396|530163372|FG001|Overall Study|Lost to Follow-up|35|||
146999695|NCT05323396|530163371|FG000|Overall Study|Pregnancy|1|||
146999696|NCT05323396|530163372|FG001|Overall Study|Pregnancy|0|||
146999697|NCT03134222|530163373|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
146999698|NCT03134222|530163374|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
146999699|NCT03134222|530163375|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
146999700|NCT03134222|530163376|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
146999701|NCT03134222|530163377|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
146999702|NCT03134222|530163373|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
146999703|NCT03134222|530163374|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
146999704|NCT03134222|530163375|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
146999705|NCT03134222|530163376|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
146999706|NCT03134222|530163377|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
146999707|NCT03134222|530163373|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
146999708|NCT03134222|530163374|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
146999709|NCT03134222|530163375|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
146999710|NCT03134222|530163376|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
146999711|NCT03134222|530163377|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
146999712|NCT03134222|530163373|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
146999713|NCT03134222|530163374|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
146999714|NCT03134222|530163375|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
146999715|NCT03134222|530163376|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
146999716|NCT03134222|530163377|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
146999717|NCT03134222|530163373|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
146999718|NCT03134222|530163374|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
146999719|NCT03134222|530163375|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
146999720|NCT03134222|530163376|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
146999721|NCT03134222|530163377|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
146999722|NCT03134222|530163373|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
146999723|NCT03134222|530163374|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
146999724|NCT03134222|530163375|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
146999725|NCT03134222|530163376|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
146999726|NCT03134222|530163377|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
146999727|NCT03134222|530163373|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
146999728|NCT03134222|530163374|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
146999729|NCT03134222|530163375|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
146999730|NCT03134222|530163376|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
146999731|NCT03134222|530163377|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
146999732|NCT03134222|530163373|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
146999733|NCT03134222|530163374|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
146999734|NCT03134222|530163375|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
146999735|NCT03134222|530163376|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
146999736|NCT03134222|530163377|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
146999737|NCT02089997|530163386|FG000|Overall Study|Case report forms uncollected|99|||
146999738|NCT02089997|530163386|FG000|Overall Study|Protocol Violation|147|||
146999739|NCT02242201|530163391|FG000|Overall Study|preoperative identified neuropathy|2|||
146999740|NCT02242201|530163392|FG001|Overall Study|preoperative identified neuropathy|0|||
146999741|NCT02242201|530163393|FG002|Overall Study|preoperative identified neuropathy|0|||
146999742|NCT02242201|530163391|FG000|Overall Study|planned post-op anticoagulation|1|||
146999743|NCT02242201|530163392|FG001|Overall Study|planned post-op anticoagulation|0|||
146999744|NCT02242201|530163393|FG002|Overall Study|planned post-op anticoagulation|0|||
146999745|NCT02242201|530163391|FG000|Overall Study|changed surgical procedure|1|||
146999746|NCT02242201|530163392|FG001|Overall Study|changed surgical procedure|0|||
146999747|NCT02242201|530163393|FG002|Overall Study|changed surgical procedure|0|||
146999748|NCT02242201|530163391|FG000|Overall Study|postponed surgery|0|||
146999749|NCT02242201|530163392|FG001|Overall Study|postponed surgery|0|||
146999750|NCT02242201|530163393|FG002|Overall Study|postponed surgery|1|||
146999751|NCT02242201|530163391|FG000|Overall Study|preoperative opioid consumption|0|||
146999752|NCT02242201|530163392|FG001|Overall Study|preoperative opioid consumption|1|||
146735974|NCT02034708|529205255|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
146735975|NCT00654901|529205256|FG000|Overall Study|Lost to Follow-up|1|||
146735976|NCT00654901|529205257|FG001|Overall Study|Lost to Follow-up|0|||
146735977|NCT00654901|529205258|FG002|Overall Study|Lost to Follow-up|1|||
146735978|NCT00654901|529205259|FG003|Overall Study|Lost to Follow-up|0|||
146735979|NCT00654901|529205256|FG000|Overall Study|Withdrawal by Subject|3|||
146735980|NCT00654901|529205257|FG001|Overall Study|Withdrawal by Subject|0|||
146735981|NCT00654901|529205258|FG002|Overall Study|Withdrawal by Subject|1|||
146735982|NCT00654901|529205259|FG003|Overall Study|Withdrawal by Subject|0|||
146735983|NCT04843930|529205260|FG000|Randomization|Withdrawal by Subject|6|||
146735984|NCT04843930|529205261|FG001|Randomization|Withdrawal by Subject|6|||
146844829|NCT02233803|529600895|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
146844830|NCT02233803|529600896|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
146844831|NCT02233803|529600895|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
146844832|NCT02233803|529600896|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
146844833|NCT02233803|529600895|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
146844834|NCT02233803|529600896|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
146844835|NCT01696045|529600902|FG000|Overall Study|Study drug toxicity|1|||
146844836|NCT01696045|529600903|FG001|Overall Study|Study drug toxicity|5|||
146844837|NCT01696045|529600902|FG000|Overall Study|Disease progression|2|||
146844838|NCT01696045|529600903|FG001|Overall Study|Disease progression|2|||
146844839|NCT01559129|529600904|FG000|Treatment Phase|Adverse Event|0|||
146844840|NCT01559129|529600905|FG001|Treatment Phase|Adverse Event|2|||
146844841|NCT01559129|529600904|FG000|Treatment Phase|Progressive Disease|1|||
146844842|NCT01559129|529600905|FG001|Treatment Phase|Progressive Disease|1|||
146844843|NCT01559129|529600904|FG000|Treatment Phase|Lack of Efficacy|0|||
146844844|NCT01559129|529600905|FG001|Treatment Phase|Lack of Efficacy|1|||
146844845|NCT01559129|529600904|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
146844846|NCT01559129|529600905|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
146844847|NCT01559129|529600904|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
146844848|NCT01559129|529600905|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
146844849|NCT01559129|529600904|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
146844850|NCT01559129|529600905|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
146844851|NCT01559129|529600904|FG000|Open-label Extension Period|Adverse Event|1|||
146844852|NCT01559129|529600905|FG001|Open-label Extension Period|Adverse Event|0|||
146844853|NCT01559129|529600904|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
146844854|NCT01559129|529600905|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
146844855|NCT01152814|529600906|FG000|Overall Study|Lost to Follow-up|2|||
146844856|NCT03525392|529600907|FG000|Overall Study|Adverse Event|1|||
146844857|NCT03525392|529600908|FG001|Overall Study|Adverse Event|0|||
146844858|NCT03525392|529600909|FG002|Overall Study|Adverse Event|2|||
146844859|NCT03525392|529600910|FG003|Overall Study|Adverse Event|0|||
146844860|NCT03525392|529600911|FG004|Overall Study|Adverse Event|0|||
146844861|NCT03525392|529600907|FG000|Overall Study|Progressive disease|0|||
146844862|NCT03525392|529600908|FG001|Overall Study|Progressive disease|1|||
146844863|NCT03525392|529600909|FG002|Overall Study|Progressive disease|1|||
146844864|NCT03525392|529600910|FG003|Overall Study|Progressive disease|3|||
146844865|NCT03525392|529600911|FG004|Overall Study|Progressive disease|1|||
146844866|NCT03284203|529600912|FG000|Overall Study|Lost to Follow-up|3|||
146844867|NCT00831129|529600915|FG000|Overall Study|Adverse Event|0|||
146844868|NCT00831129|529600916|FG001|Overall Study|Adverse Event|1|||
146844869|NCT00831129|529600915|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
146844870|NCT00831129|529600916|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
146844871|NCT01877239|529600917|FG000|Overall Study|Adverse Event|4|||
146844872|NCT01877239|529600917|FG000|Overall Study|Disease Remission|1|||
146844873|NCT01877239|529600917|FG000|Overall Study|Withdrawal by Subject|4|||
146844874|NCT01877239|529600917|FG000|Overall Study|Other|2|||
146844875|NCT01877239|529600917|FG000|Overall Study|Lack of Efficacy|4|||
146844876|NCT01877239|529600917|FG000|Overall Study|Data not available|35|||
146844877|NCT01204710|529600921|FG000|Randomization Treatment|Lost to Follow-up|1|||
146844878|NCT01204710|529600922|FG001|Randomization Treatment|Lost to Follow-up|0|||
146844879|NCT01204710|529600921|FG000|Randomization Treatment|Withdrawal by Subject|6|||
146844880|NCT01204710|529600922|FG001|Randomization Treatment|Withdrawal by Subject|5|||
146844881|NCT01204710|529600921|FG000|Randomization Treatment|Physician Decision|3|||
146844882|NCT01204710|529600922|FG001|Randomization Treatment|Physician Decision|2|||
146844883|NCT01204710|529600921|FG000|Randomization Treatment|Entry criteria not met|0|||
146844884|NCT01204710|529600922|FG001|Randomization Treatment|Entry criteria not met|1|||
146844885|NCT01204710|529600921|FG000|Randomization Treatment|Adverse Event|4|||
146844886|NCT01204710|529600922|FG001|Randomization Treatment|Adverse Event|2|||
146844887|NCT01204710|529600921|FG000|Randomization Treatment|Sponsor Decision|0|||
146844888|NCT01204710|529600922|FG001|Randomization Treatment|Sponsor Decision|1|||
146844889|NCT01204710|529600921|FG000|Randomization Treatment|Worsening of General condition|0|||
146844890|NCT01204710|529600922|FG001|Randomization Treatment|Worsening of General condition|1|||
146844891|NCT01204710|529600921|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
146844892|NCT01204710|529600922|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
146999753|NCT02242201|530163393|FG002|Overall Study|preoperative opioid consumption|0|||
146999754|NCT02335658|530163394|FG000|Overall Study|Adverse Event|18|||
146999755|NCT02335658|530163395|FG001|Overall Study|Adverse Event|12|||
146844893|NCT01204710|529600921|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
146844894|NCT01204710|529600922|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
146844895|NCT01204710|529600921|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
146999756|NCT02335658|530163394|FG000|Overall Study|Lack of Efficacy|4|||
146999757|NCT02335658|530163395|FG001|Overall Study|Lack of Efficacy|5|||
146999758|NCT02335658|530163394|FG000|Overall Study|Pregnancy|1|||
146999759|NCT02335658|530163395|FG001|Overall Study|Pregnancy|0|||
146999760|NCT02335658|530163394|FG000|Overall Study|Withdrawal by Subject|13|||
146999761|NCT02335658|530163395|FG001|Overall Study|Withdrawal by Subject|21|||
146999762|NCT02335658|530163394|FG000|Overall Study|non-compliance|2|||
146999763|NCT02335658|530163395|FG001|Overall Study|non-compliance|3|||
146999764|NCT02335658|530163394|FG000|Overall Study|other reason|2|||
146999765|NCT02335658|530163395|FG001|Overall Study|other reason|3|||
146999766|NCT01424644|530163396|FG000|Overall Study|Adverse Event|2|||
146999767|NCT01424644|530163397|FG001|Overall Study|Adverse Event|0|||
146999768|NCT01424644|530163396|FG000|Overall Study|Withdrawal by Subject|9|||
146999769|NCT01424644|530163397|FG001|Overall Study|Withdrawal by Subject|12|||
146999770|NCT01424644|530163396|FG000|Overall Study|Lost to Follow-up|16|||
146999771|NCT01424644|530163397|FG001|Overall Study|Lost to Follow-up|12|||
146999772|NCT01424644|530163396|FG000|Overall Study|Protocol Violation|4|||
146999773|NCT01424644|530163397|FG001|Overall Study|Protocol Violation|3|||
146999774|NCT01424644|530163396|FG000|Overall Study|Administrative Reason|1|||
146999775|NCT01424644|530163397|FG001|Overall Study|Administrative Reason|0|||
146999776|NCT01424644|530163396|FG000|Overall Study|Unable to Classify|1|||
146999777|NCT01424644|530163397|FG001|Overall Study|Unable to Classify|0|||
146999778|NCT05593965|530163398|FG000|1st Intervention (1 Day)|Technical error|1|||
146999779|NCT05593965|530163399|FG001|1st Intervention (1 Day)|Technical error|0|||
146999780|NCT03238781|530163402|FG000|Overall Study|Adverse Event|1|||
146999781|NCT03238781|530163403|FG001|Overall Study|Adverse Event|1|||
146999782|NCT03238781|530163404|FG002|Overall Study|Adverse Event|2|||
146999783|NCT03238781|530163402|FG000|Overall Study|Lost to Follow-up|2|||
146999784|NCT03238781|530163403|FG001|Overall Study|Lost to Follow-up|1|||
146999785|NCT03238781|530163404|FG002|Overall Study|Lost to Follow-up|2|||
146999786|NCT03238781|530163402|FG000|Overall Study|Withdrawal by Subject|23|||
146999787|NCT03238781|530163403|FG001|Overall Study|Withdrawal by Subject|14|||
146999788|NCT03238781|530163404|FG002|Overall Study|Withdrawal by Subject|16|||
146999789|NCT03238781|530163402|FG000|Overall Study|Decision by sponsor|0|||
146999790|NCT03238781|530163403|FG001|Overall Study|Decision by sponsor|1|||
146999791|NCT03238781|530163404|FG002|Overall Study|Decision by sponsor|0|||
146999792|NCT01597245|530163405|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
146999793|NCT01597245|530163406|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
146999794|NCT01597245|530163407|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
146999795|NCT01597245|530163408|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
146999796|NCT01597245|530163409|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999797|NCT01597245|530163410|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999798|NCT01597245|530163411|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999799|NCT01597245|530163412|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999800|NCT01597245|530163413|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999801|NCT01597245|530163414|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999802|NCT01597245|530163415|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999803|NCT01597245|530163416|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999804|NCT01597245|530163417|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999805|NCT01597245|530163418|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999806|NCT01597245|530163419|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999807|NCT01597245|530163420|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999808|NCT01597245|530163421|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999809|NCT01597245|530163422|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999810|NCT01597245|530163423|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999811|NCT01597245|530163424|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999812|NCT01597245|530163425|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146999813|NCT01597245|530163405|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
146999814|NCT01597245|530163406|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
146999815|NCT01597245|530163407|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
146999816|NCT01597245|530163408|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
146999817|NCT01597245|530163409|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999818|NCT01597245|530163410|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999819|NCT01597245|530163411|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999820|NCT01597245|530163412|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999821|NCT01597245|530163413|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999822|NCT01597245|530163414|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999823|NCT01597245|530163415|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999824|NCT01597245|530163416|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999825|NCT01597245|530163417|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999826|NCT01597245|530163418|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999827|NCT01597245|530163419|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999828|NCT01597245|530163420|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999829|NCT01597245|530163421|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999830|NCT01597245|530163422|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999831|NCT01597245|530163423|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999832|NCT01597245|530163424|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999833|NCT01597245|530163425|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146999834|NCT01597245|530163405|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
146999835|NCT01597245|530163406|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
146999836|NCT01597245|530163407|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
146999837|NCT01597245|530163408|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
146999838|NCT01597245|530163409|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999839|NCT01597245|530163410|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999840|NCT01597245|530163411|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999841|NCT01597245|530163412|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999842|NCT01597245|530163413|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999843|NCT01597245|530163414|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999844|NCT01597245|530163415|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999845|NCT01597245|530163416|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999846|NCT01597245|530163417|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999847|NCT01597245|530163418|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999848|NCT01597245|530163419|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999849|NCT01597245|530163420|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999850|NCT01597245|530163421|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999851|NCT01597245|530163422|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999852|NCT01597245|530163423|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999853|NCT01597245|530163424|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999854|NCT01597245|530163425|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146999855|NCT01597245|530163405|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
146999856|NCT01597245|530163406|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
146999857|NCT01597245|530163407|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
146999858|NCT01597245|530163408|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999859|NCT01597245|530163409|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999860|NCT01597245|530163410|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999861|NCT01597245|530163411|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999862|NCT01597245|530163412|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999863|NCT01597245|530163413|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999864|NCT01597245|530163414|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999865|NCT01597245|530163415|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999866|NCT01597245|530163416|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999867|NCT01597245|530163417|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999868|NCT01597245|530163418|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999869|NCT01597245|530163419|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999870|NCT01597245|530163420|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999871|NCT01597245|530163421|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999872|NCT01597245|530163422|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999873|NCT01597245|530163423|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999874|NCT01597245|530163424|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999875|NCT01597245|530163425|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146999876|NCT01597245|530163405|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
146999877|NCT01597245|530163406|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999878|NCT01597245|530163407|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999879|NCT01597245|530163408|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
146999880|NCT01597245|530163409|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999881|NCT01597245|530163410|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999882|NCT01597245|530163411|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999883|NCT01597245|530163412|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999884|NCT01597245|530163413|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999885|NCT01597245|530163414|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999886|NCT01597245|530163415|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999887|NCT01597245|530163416|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999888|NCT01597245|530163417|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999889|NCT01597245|530163418|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999890|NCT01597245|530163419|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999891|NCT01597245|530163420|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999892|NCT01597245|530163421|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999893|NCT01597245|530163422|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999894|NCT01597245|530163423|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999895|NCT01597245|530163424|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999896|NCT01597245|530163425|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146999897|NCT01597245|530163405|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
146999898|NCT01597245|530163406|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
146999899|NCT01597245|530163407|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
146999900|NCT01597245|530163408|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999901|NCT01597245|530163409|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999902|NCT01597245|530163410|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999903|NCT01597245|530163411|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999904|NCT01597245|530163412|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999905|NCT01597245|530163413|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999906|NCT01597245|530163414|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999907|NCT01597245|530163415|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999908|NCT01597245|530163416|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999909|NCT01597245|530163417|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999910|NCT01597245|530163418|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999911|NCT01597245|530163419|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999912|NCT01597245|530163420|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999913|NCT01597245|530163421|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999914|NCT01597245|530163422|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999915|NCT01597245|530163423|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999916|NCT01597245|530163424|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999917|NCT01597245|530163425|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146999918|NCT01597245|530163405|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999919|NCT01597245|530163406|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999920|NCT01597245|530163407|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999921|NCT01597245|530163408|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999922|NCT01597245|530163409|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999923|NCT01597245|530163410|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
146999924|NCT01597245|530163411|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
146999925|NCT01597245|530163412|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999926|NCT01597245|530163413|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999927|NCT01597245|530163414|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999928|NCT01597245|530163415|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999929|NCT01597245|530163416|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999930|NCT01597245|530163417|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999931|NCT01597245|530163418|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999932|NCT01597245|530163419|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999933|NCT01597245|530163420|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999934|NCT01597245|530163421|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999935|NCT01597245|530163422|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999936|NCT01597245|530163423|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999937|NCT01597245|530163424|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999938|NCT01597245|530163425|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146999939|NCT01597245|530163405|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146999940|NCT01597245|530163406|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146999941|NCT01597245|530163407|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146999942|NCT01597245|530163408|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146999943|NCT01597245|530163409|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
146999944|NCT01597245|530163410|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
146999945|NCT01597245|530163411|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
146999946|NCT01597245|530163412|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
146999947|NCT01597245|530163413|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146999948|NCT01597245|530163414|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
146999949|NCT01597245|530163415|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146999950|NCT01597245|530163416|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146999951|NCT01597245|530163417|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146999952|NCT01597245|530163418|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146999953|NCT01597245|530163419|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146999954|NCT01597245|530163420|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146999955|NCT01597245|530163421|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146999956|NCT01597245|530163422|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146999957|NCT01597245|530163423|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146999958|NCT01597245|530163424|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146999959|NCT01597245|530163425|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146999960|NCT01597245|530163405|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146999961|NCT01597245|530163406|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146999962|NCT01597245|530163407|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146999963|NCT01597245|530163408|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146999964|NCT01597245|530163409|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146999965|NCT01597245|530163410|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
146999966|NCT01597245|530163411|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146999967|NCT01597245|530163412|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146999968|NCT01597245|530163413|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
146999969|NCT01597245|530163414|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146999970|NCT01597245|530163415|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
146999971|NCT01597245|530163416|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
146999972|NCT01597245|530163417|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
146999973|NCT01597245|530163418|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146999974|NCT01597245|530163419|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146999975|NCT01597245|530163420|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146999976|NCT01597245|530163421|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146999977|NCT01597245|530163422|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146999978|NCT01597245|530163423|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146999979|NCT01597245|530163424|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146999980|NCT01597245|530163425|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146999981|NCT01597245|530163405|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146999982|NCT01597245|530163406|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146999983|NCT01597245|530163407|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146999984|NCT01597245|530163408|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146999985|NCT01597245|530163409|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
146999986|NCT01597245|530163410|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
146844896|NCT01204710|529600922|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
146844897|NCT01204710|529600921|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
146844898|NCT01204710|529600922|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
146844899|NCT00743431|529600923|FG000|Overall Study|Toxicity|6|||
146844900|NCT00743431|529600923|FG000|Overall Study|Tumor progression|56|||
146844901|NCT00743431|529600923|FG000|Overall Study|Withdrawal by Subject|13|||
146844902|NCT00743431|529600923|FG000|Overall Study|Death|9|||
146999987|NCT01597245|530163411|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
146999988|NCT01597245|530163412|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
146999989|NCT01597245|530163413|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
146999990|NCT01597245|530163414|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
146999991|NCT01597245|530163415|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
146999992|NCT01597245|530163416|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
146999993|NCT01597245|530163417|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
146999994|NCT01597245|530163418|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146999995|NCT01597245|530163419|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146999996|NCT01597245|530163420|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146999997|NCT01597245|530163421|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146999998|NCT01597245|530163422|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146999999|NCT01597245|530163423|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
147000000|NCT01597245|530163424|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
147000001|NCT01597245|530163425|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
147000002|NCT01597245|530163405|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147000003|NCT01597245|530163406|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147000004|NCT01597245|530163407|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147000005|NCT01597245|530163408|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147000006|NCT01597245|530163409|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
147000007|NCT01597245|530163410|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
147000008|NCT01597245|530163411|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
147000009|NCT01597245|530163412|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147000010|NCT01597245|530163413|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
147000011|NCT01597245|530163414|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
147000012|NCT01597245|530163415|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
147000013|NCT01597245|530163416|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
147000014|NCT01597245|530163417|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
147000015|NCT01597245|530163418|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147000016|NCT01597245|530163419|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147000017|NCT01597245|530163420|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147000018|NCT01597245|530163421|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147000019|NCT01597245|530163422|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
146844903|NCT00743431|529600923|FG000|Overall Study|Reason for discontinuation not specified|29|||
147000020|NCT01597245|530163423|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147000021|NCT01597245|530163424|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147000022|NCT01597245|530163425|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147000023|NCT01597245|530163405|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147000024|NCT01597245|530163406|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147000025|NCT01597245|530163407|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147000026|NCT01597245|530163408|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147000027|NCT01597245|530163409|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
147000028|NCT01597245|530163410|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147000029|NCT01597245|530163411|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147000030|NCT01597245|530163412|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147000031|NCT01597245|530163413|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
147000032|NCT01597245|530163414|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
147000033|NCT01597245|530163415|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
147000034|NCT01597245|530163416|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147000035|NCT01597245|530163417|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
147000036|NCT01597245|530163418|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147000037|NCT01597245|530163419|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147000038|NCT01597245|530163420|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147000039|NCT01597245|530163421|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147000040|NCT01597245|530163422|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147000041|NCT01597245|530163423|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147000042|NCT01597245|530163424|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147000043|NCT01597245|530163425|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147000044|NCT01597245|530163405|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147000045|NCT01597245|530163406|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147000046|NCT01597245|530163407|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147000047|NCT01597245|530163408|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147000048|NCT01597245|530163409|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
147000049|NCT01597245|530163410|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
147000050|NCT01597245|530163411|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
147000051|NCT01597245|530163412|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147000052|NCT01597245|530163413|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
147000053|NCT01597245|530163414|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
147000054|NCT01597245|530163415|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
147000055|NCT01597245|530163416|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
147000056|NCT01597245|530163417|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
147000057|NCT01597245|530163418|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147000058|NCT01597245|530163419|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147000059|NCT01597245|530163420|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147000060|NCT01597245|530163421|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147000061|NCT01597245|530163422|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147000062|NCT01597245|530163423|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147000063|NCT01597245|530163424|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147000064|NCT01597245|530163425|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147000065|NCT01597245|530163405|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147000066|NCT01597245|530163406|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147000067|NCT01597245|530163407|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147000068|NCT01597245|530163408|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147000069|NCT01597245|530163409|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147000070|NCT01597245|530163410|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
147000071|NCT01597245|530163411|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147000072|NCT01597245|530163412|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147000073|NCT01597245|530163413|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
147000074|NCT01597245|530163414|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
147000075|NCT01597245|530163415|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
147000076|NCT01597245|530163416|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
147000077|NCT01597245|530163417|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147000078|NCT01597245|530163418|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147000079|NCT01597245|530163419|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147000080|NCT01597245|530163420|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147000081|NCT01597245|530163421|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147000082|NCT01597245|530163422|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147000083|NCT01597245|530163423|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147000084|NCT01597245|530163424|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147000085|NCT01597245|530163425|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147000086|NCT01597245|530163405|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000087|NCT01597245|530163406|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000088|NCT01597245|530163407|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000089|NCT01597245|530163408|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000090|NCT01597245|530163409|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000091|NCT01597245|530163410|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000092|NCT01597245|530163411|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000093|NCT01597245|530163412|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000094|NCT01597245|530163413|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000095|NCT01597245|530163414|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000096|NCT01597245|530163415|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
147000097|NCT01597245|530163416|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000098|NCT01597245|530163417|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000099|NCT01597245|530163418|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000100|NCT01597245|530163419|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000101|NCT01597245|530163420|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000102|NCT01597245|530163421|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000103|NCT01597245|530163422|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000104|NCT01597245|530163423|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000105|NCT01597245|530163424|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000106|NCT01597245|530163425|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147000107|NCT01597245|530163405|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000108|NCT01597245|530163406|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000109|NCT01597245|530163407|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000110|NCT01597245|530163408|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000111|NCT01597245|530163409|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000112|NCT01597245|530163410|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000113|NCT01597245|530163411|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000114|NCT01597245|530163412|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000115|NCT01597245|530163413|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000116|NCT01597245|530163414|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000117|NCT01597245|530163415|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000118|NCT01597245|530163416|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146735985|NCT04843930|529205262|FG002|Randomization|Withdrawal by Subject|0|||
146735986|NCT04843930|529205263|FG003|Randomization|Withdrawal by Subject|0|||
147000119|NCT01597245|530163417|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000120|NCT01597245|530163418|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
147000121|NCT01597245|530163419|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
147000122|NCT01597245|530163420|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
147000123|NCT01597245|530163421|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000124|NCT01597245|530163422|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000125|NCT01597245|530163423|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000126|NCT01597245|530163424|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000127|NCT01597245|530163425|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147000128|NCT01597245|530163405|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000129|NCT01597245|530163406|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000130|NCT01597245|530163407|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000131|NCT01597245|530163408|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000132|NCT01597245|530163409|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000133|NCT01597245|530163410|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000134|NCT01597245|530163411|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000135|NCT01597245|530163412|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000136|NCT01597245|530163413|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000137|NCT01597245|530163414|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000138|NCT01597245|530163415|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000139|NCT01597245|530163416|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000140|NCT01597245|530163417|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000141|NCT01597245|530163418|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
147000142|NCT01597245|530163419|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
147000143|NCT01597245|530163420|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
147000144|NCT01597245|530163421|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000145|NCT01597245|530163422|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000146|NCT01597245|530163423|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000147|NCT01597245|530163424|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000148|NCT01597245|530163425|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147000149|NCT01597245|530163405|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000150|NCT01597245|530163406|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000151|NCT01597245|530163407|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000152|NCT01597245|530163408|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000153|NCT01597245|530163409|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000154|NCT01597245|530163410|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000155|NCT01597245|530163411|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000156|NCT01597245|530163412|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000157|NCT01597245|530163413|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000158|NCT01597245|530163414|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000159|NCT01597245|530163415|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000160|NCT01597245|530163416|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000161|NCT01597245|530163417|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000162|NCT01597245|530163418|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000163|NCT01597245|530163419|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
147000164|NCT01597245|530163420|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
147000165|NCT01597245|530163421|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000166|NCT01597245|530163422|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000167|NCT01597245|530163423|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000168|NCT01597245|530163424|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000169|NCT01597245|530163425|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147000170|NCT01597245|530163405|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000171|NCT01597245|530163406|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000172|NCT01597245|530163407|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000173|NCT01597245|530163408|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000174|NCT01597245|530163409|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000175|NCT01597245|530163410|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146844904|NCT00743431|529600923|FG000|Overall Study|No documentation available|13|||
146844905|NCT03291288|529600924|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
146844906|NCT03291288|529600925|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
147000176|NCT01597245|530163411|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000177|NCT01597245|530163412|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000178|NCT01597245|530163413|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000179|NCT01597245|530163414|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000180|NCT01597245|530163415|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000181|NCT01597245|530163416|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000182|NCT01597245|530163417|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000183|NCT01597245|530163418|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000184|NCT01597245|530163419|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
147000185|NCT01597245|530163420|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
147000186|NCT01597245|530163421|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000187|NCT01597245|530163422|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000188|NCT01597245|530163423|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000189|NCT01597245|530163424|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000190|NCT01597245|530163425|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147000191|NCT01597245|530163405|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147000192|NCT01597245|530163406|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147000193|NCT01597245|530163407|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147000194|NCT01597245|530163408|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147000195|NCT01597245|530163409|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147000196|NCT01597245|530163410|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146844907|NCT03291288|529600924|FG000|Drug-drug Interaction Phase|Disease progression|1|||
146844908|NCT03291288|529600925|FG001|Drug-drug Interaction Phase|Disease progression|0|||
146844909|NCT03291288|529600924|FG000|Drug-drug Interaction Phase|Other|3|||
147000197|NCT01597245|530163411|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147000198|NCT01597245|530163412|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147000199|NCT01597245|530163413|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147000200|NCT01597245|530163414|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147000201|NCT01597245|530163415|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146844910|NCT03291288|529600925|FG001|Drug-drug Interaction Phase|Other|0|||
147000202|NCT01597245|530163416|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147000203|NCT01597245|530163417|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147000204|NCT01597245|530163418|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
147000205|NCT01597245|530163419|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
147000206|NCT01597245|530163420|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
147000207|NCT01597245|530163421|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147000208|NCT01597245|530163422|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147000209|NCT01597245|530163423|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147000210|NCT01597245|530163424|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147000211|NCT01597245|530163425|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147000212|NCT01597245|530163405|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000213|NCT01597245|530163406|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000214|NCT01597245|530163407|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000215|NCT01597245|530163408|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000216|NCT01597245|530163409|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000217|NCT01597245|530163410|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000218|NCT01597245|530163411|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000219|NCT01597245|530163412|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000220|NCT01597245|530163413|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000221|NCT01597245|530163414|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000222|NCT01597245|530163415|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000223|NCT01597245|530163416|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000224|NCT01597245|530163417|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000225|NCT01597245|530163418|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000226|NCT01597245|530163419|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
147000227|NCT01597245|530163420|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
147000228|NCT01597245|530163421|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000229|NCT01597245|530163422|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000230|NCT01597245|530163423|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000231|NCT01597245|530163424|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000232|NCT01597245|530163425|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
147000233|NCT01597245|530163405|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000234|NCT01597245|530163406|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000235|NCT01597245|530163407|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000236|NCT01597245|530163408|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000237|NCT01597245|530163409|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000238|NCT01597245|530163410|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000239|NCT01597245|530163411|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000240|NCT01597245|530163412|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000241|NCT01597245|530163413|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000242|NCT01597245|530163414|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000243|NCT01597245|530163415|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000244|NCT01597245|530163416|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000245|NCT01597245|530163417|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000246|NCT01597245|530163418|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000247|NCT01597245|530163419|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
147000248|NCT01597245|530163420|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
147000249|NCT01597245|530163421|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000250|NCT01597245|530163422|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000251|NCT01597245|530163423|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000252|NCT01597245|530163424|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000253|NCT01597245|530163425|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147000254|NCT01597245|530163405|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000255|NCT01597245|530163406|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000256|NCT01597245|530163407|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000257|NCT01597245|530163408|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000258|NCT01597245|530163409|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000259|NCT01597245|530163410|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146735987|NCT04843930|529205260|FG000|Week 6 Assessment|Adverse Event|3|||
146735988|NCT04843930|529205261|FG001|Week 6 Assessment|Adverse Event|0|||
146735989|NCT04843930|529205262|FG002|Week 6 Assessment|Adverse Event|0|||
146735990|NCT04843930|529205263|FG003|Week 6 Assessment|Adverse Event|0|||
146735991|NCT04843930|529205260|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
146735992|NCT04843930|529205261|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
146735993|NCT04843930|529205262|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
146844911|NCT03291288|529600924|FG000|Pexidartinib Only|Ongoing|0|||
147000260|NCT01597245|530163411|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000261|NCT01597245|530163412|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000262|NCT01597245|530163413|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000263|NCT01597245|530163414|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000264|NCT01597245|530163415|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000265|NCT01597245|530163416|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000266|NCT01597245|530163417|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000267|NCT01597245|530163418|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000268|NCT01597245|530163419|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
147000269|NCT01597245|530163420|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
147000270|NCT01597245|530163421|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000271|NCT01597245|530163422|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000272|NCT01597245|530163423|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000273|NCT01597245|530163424|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000274|NCT01597245|530163425|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147000275|NCT01597245|530163405|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000276|NCT01597245|530163406|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000277|NCT01597245|530163407|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000278|NCT01597245|530163408|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000279|NCT01597245|530163409|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000280|NCT01597245|530163410|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000281|NCT01597245|530163411|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000282|NCT01597245|530163412|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000283|NCT01597245|530163413|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000284|NCT01597245|530163414|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000285|NCT01597245|530163415|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000286|NCT01597245|530163416|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000287|NCT01597245|530163417|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000288|NCT01597245|530163418|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000289|NCT01597245|530163419|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
147000290|NCT01597245|530163420|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
147000291|NCT01597245|530163421|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000292|NCT01597245|530163422|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000293|NCT01597245|530163423|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000294|NCT01597245|530163424|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000295|NCT01597245|530163425|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147000296|NCT01597245|530163405|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000297|NCT01597245|530163406|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000298|NCT01597245|530163407|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000299|NCT01597245|530163408|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000300|NCT01597245|530163409|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146844912|NCT03291288|529600925|FG001|Pexidartinib Only|Ongoing|2|||
146844913|NCT04276415|529600926|FG000|Overall Study|Adverse Event|0|||
146844914|NCT04276415|529600927|FG001|Overall Study|Adverse Event|0|||
146844915|NCT04276415|529600928|FG002|Overall Study|Adverse Event|0|||
146844916|NCT04276415|529600929|FG003|Overall Study|Adverse Event|3|||
146844917|NCT04276415|529600930|FG004|Overall Study|Adverse Event|0|||
146844918|NCT04276415|529600931|FG005|Overall Study|Adverse Event|0|||
146844919|NCT04276415|529600926|FG000|Overall Study|Clinical progression|1|||
146844920|NCT04276415|529600927|FG001|Overall Study|Clinical progression|1|||
146844921|NCT04276415|529600928|FG002|Overall Study|Clinical progression|0|||
146844922|NCT04276415|529600929|FG003|Overall Study|Clinical progression|0|||
146844923|NCT04276415|529600930|FG004|Overall Study|Clinical progression|1|||
146844924|NCT04276415|529600931|FG005|Overall Study|Clinical progression|0|||
146844925|NCT04276415|529600926|FG000|Overall Study|Other|0|||
147000301|NCT01597245|530163410|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000302|NCT01597245|530163411|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000303|NCT01597245|530163412|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000304|NCT01597245|530163413|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146844926|NCT04276415|529600927|FG001|Overall Study|Other|0|||
147000305|NCT01597245|530163414|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000306|NCT01597245|530163415|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000307|NCT01597245|530163416|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000308|NCT01597245|530163417|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000309|NCT01597245|530163418|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
147000310|NCT01597245|530163419|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146844927|NCT04276415|529600928|FG002|Overall Study|Other|0|||
147000311|NCT01597245|530163420|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000312|NCT01597245|530163421|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000313|NCT01597245|530163422|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000314|NCT01597245|530163423|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000315|NCT01597245|530163424|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000316|NCT01597245|530163425|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147000317|NCT01597245|530163405|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147000318|NCT01597245|530163406|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147000319|NCT01597245|530163407|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147000320|NCT01597245|530163408|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147000321|NCT01597245|530163409|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147000322|NCT01597245|530163410|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147000323|NCT01597245|530163411|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147000324|NCT01597245|530163412|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147000325|NCT01597245|530163413|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147000326|NCT01597245|530163414|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147000327|NCT01597245|530163415|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147000328|NCT01597245|530163416|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147000329|NCT01597245|530163417|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147000330|NCT01597245|530163418|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147000331|NCT01597245|530163419|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147000332|NCT01597245|530163420|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147000333|NCT01597245|530163421|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
147000334|NCT01597245|530163422|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
147000335|NCT01597245|530163423|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
147000336|NCT01597245|530163424|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
147000337|NCT01597245|530163425|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
147000338|NCT01597245|530163405|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000339|NCT01597245|530163406|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000340|NCT01597245|530163407|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000341|NCT01597245|530163408|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000342|NCT01597245|530163409|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000343|NCT01597245|530163410|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000344|NCT01597245|530163411|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000345|NCT01597245|530163412|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000346|NCT01597245|530163413|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000347|NCT01597245|530163414|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000348|NCT01597245|530163415|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000349|NCT01597245|530163416|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000350|NCT01597245|530163417|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000351|NCT01597245|530163418|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000352|NCT01597245|530163419|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000353|NCT01597245|530163420|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000354|NCT01597245|530163421|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147000355|NCT01597245|530163422|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
147000356|NCT01597245|530163423|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
147000357|NCT01597245|530163424|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
147000358|NCT01597245|530163425|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
147000359|NCT01597245|530163405|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000360|NCT01597245|530163406|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000361|NCT01597245|530163407|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000362|NCT01597245|530163408|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000363|NCT01597245|530163409|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000364|NCT01597245|530163410|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000365|NCT01597245|530163411|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000366|NCT01597245|530163412|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000367|NCT01597245|530163413|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000368|NCT01597245|530163414|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000369|NCT01597245|530163415|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000370|NCT01597245|530163416|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146844928|NCT04276415|529600929|FG003|Overall Study|Other|1|||
146844929|NCT04276415|529600930|FG004|Overall Study|Other|0|||
147000371|NCT01597245|530163417|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000372|NCT01597245|530163418|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000373|NCT01597245|530163419|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000374|NCT01597245|530163420|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000375|NCT01597245|530163421|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
147000376|NCT01597245|530163422|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000377|NCT01597245|530163423|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147000378|NCT01597245|530163424|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
147000379|NCT01597245|530163425|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
147000380|NCT01597245|530163405|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000381|NCT01597245|530163406|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000382|NCT01597245|530163407|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000383|NCT01597245|530163408|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000384|NCT01597245|530163409|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000385|NCT01597245|530163410|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000386|NCT01597245|530163411|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000387|NCT01597245|530163412|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000388|NCT01597245|530163413|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000389|NCT01597245|530163414|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000390|NCT01597245|530163415|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000391|NCT01597245|530163416|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000392|NCT01597245|530163417|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000393|NCT01597245|530163418|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000394|NCT01597245|530163419|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000395|NCT01597245|530163420|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000396|NCT01597245|530163421|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000397|NCT01597245|530163422|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147000398|NCT01597245|530163423|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
147000399|NCT01597245|530163424|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
147000400|NCT01597245|530163425|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
147000401|NCT01597245|530163405|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000402|NCT01597245|530163406|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000403|NCT01597245|530163407|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000404|NCT01597245|530163408|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000405|NCT01597245|530163409|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000406|NCT01597245|530163410|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000407|NCT01597245|530163411|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000408|NCT01597245|530163412|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000409|NCT01597245|530163413|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000410|NCT01597245|530163414|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000411|NCT01597245|530163415|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000412|NCT01597245|530163416|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000413|NCT01597245|530163417|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000414|NCT01597245|530163418|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000415|NCT01597245|530163419|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000416|NCT01597245|530163420|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000417|NCT01597245|530163421|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
147000418|NCT01597245|530163422|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000419|NCT01597245|530163423|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147000420|NCT01597245|530163424|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
147000421|NCT01597245|530163425|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
147000422|NCT01597245|530163405|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000423|NCT01597245|530163406|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000424|NCT01597245|530163407|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000425|NCT01597245|530163408|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000426|NCT01597245|530163409|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000427|NCT01597245|530163410|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000428|NCT01597245|530163411|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000429|NCT01597245|530163412|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000430|NCT01597245|530163413|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000431|NCT01597245|530163414|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000432|NCT01597245|530163415|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000433|NCT01597245|530163416|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146735994|NCT04843930|529205263|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
146844930|NCT04276415|529600931|FG005|Overall Study|Other|0|||
146844931|NCT04276415|529600926|FG000|Overall Study|Physician Decision|0|||
146844932|NCT04276415|529600927|FG001|Overall Study|Physician Decision|0|||
146844933|NCT04276415|529600928|FG002|Overall Study|Physician Decision|1|||
147000434|NCT01597245|530163417|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000435|NCT01597245|530163418|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000436|NCT01597245|530163419|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000437|NCT01597245|530163420|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000438|NCT01597245|530163421|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
147000439|NCT01597245|530163422|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000440|NCT01597245|530163423|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147000441|NCT01597245|530163424|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
147000442|NCT01597245|530163425|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
147000443|NCT01597245|530163405|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000444|NCT01597245|530163406|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000445|NCT01597245|530163407|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000446|NCT01597245|530163408|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000447|NCT01597245|530163409|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000448|NCT01597245|530163410|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000449|NCT01597245|530163411|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000450|NCT01597245|530163412|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000451|NCT01597245|530163413|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000452|NCT01597245|530163414|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000453|NCT01597245|530163415|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000454|NCT01597245|530163416|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000455|NCT01597245|530163417|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000456|NCT01597245|530163418|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000457|NCT01597245|530163419|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000458|NCT01597245|530163420|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000459|NCT01597245|530163421|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
147000460|NCT01597245|530163422|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000461|NCT01597245|530163423|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000462|NCT01597245|530163424|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
147000463|NCT01597245|530163425|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147000464|NCT01597245|530163405|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000465|NCT01597245|530163406|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000466|NCT01597245|530163407|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000467|NCT01597245|530163408|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000468|NCT01597245|530163409|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000469|NCT01597245|530163410|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000470|NCT01597245|530163411|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000471|NCT01597245|530163412|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000472|NCT01597245|530163413|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000473|NCT01597245|530163414|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000474|NCT01597245|530163415|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000475|NCT01597245|530163416|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000476|NCT01597245|530163417|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000477|NCT01597245|530163418|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000478|NCT01597245|530163419|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000479|NCT01597245|530163420|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000480|NCT01597245|530163421|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
147000481|NCT01597245|530163422|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000482|NCT01597245|530163423|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000483|NCT01597245|530163424|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
147000484|NCT01597245|530163425|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147000485|NCT01597245|530163405|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000486|NCT01597245|530163406|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000487|NCT01597245|530163407|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000488|NCT01597245|530163408|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000489|NCT01597245|530163409|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000490|NCT01597245|530163410|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000491|NCT01597245|530163411|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146844934|NCT04276415|529600929|FG003|Overall Study|Physician Decision|3|||
146844935|NCT04276415|529600930|FG004|Overall Study|Physician Decision|2|||
147000492|NCT01597245|530163412|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000493|NCT01597245|530163413|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000494|NCT01597245|530163414|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000495|NCT01597245|530163415|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000496|NCT01597245|530163416|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000497|NCT01597245|530163417|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000498|NCT01597245|530163418|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000499|NCT01597245|530163419|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000500|NCT01597245|530163420|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000501|NCT01597245|530163421|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000502|NCT01597245|530163422|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000503|NCT01597245|530163423|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000504|NCT01597245|530163424|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
147000505|NCT01597245|530163425|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147000506|NCT00731783|530163426|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
147000507|NCT00731783|530163427|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
147000508|NCT00731783|530163426|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
147000509|NCT00731783|530163427|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
147000510|NCT00731783|530163426|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
147000511|NCT00731783|530163427|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
147000512|NCT00731783|530163426|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
147000513|NCT00731783|530163427|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
147000514|NCT02222818|530164944|FG000|Period 1|Eligibility criteria not met|0|||
147000515|NCT02222818|530164945|FG001|Period 1|Eligibility criteria not met|3|||
147000516|NCT00934050|530164946|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
147000517|NCT00934050|530164947|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
147000518|NCT00934050|530164948|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
147000519|NCT00934050|530164949|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
147000520|NCT00934050|530164950|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
147000521|NCT00934050|530164951|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
147000522|NCT00934050|530164946|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
147000523|NCT00934050|530164947|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
147000524|NCT00934050|530164948|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
147000525|NCT00934050|530164949|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
147000526|NCT00934050|530164950|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
147000527|NCT00934050|530164951|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
147000528|NCT00934050|530164946|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
147000529|NCT00934050|530164947|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
147000530|NCT00934050|530164948|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
147000531|NCT00934050|530164949|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
147000532|NCT00934050|530164950|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
147000533|NCT00934050|530164951|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
147000534|NCT00934050|530164946|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
147000535|NCT00934050|530164947|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
147000536|NCT00934050|530164948|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
147000537|NCT00934050|530164949|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
147000538|NCT00934050|530164950|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
147000539|NCT00934050|530164951|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
147000540|NCT00934050|530164946|FG000|Enrolled After 15 Dec 2009|Death|0|||
147000541|NCT00934050|530164947|FG001|Enrolled After 15 Dec 2009|Death|0|||
147000542|NCT00934050|530164948|FG002|Enrolled After 15 Dec 2009|Death|0|||
147000543|NCT00934050|530164949|FG003|Enrolled After 15 Dec 2009|Death|0|||
147000544|NCT00934050|530164950|FG004|Enrolled After 15 Dec 2009|Death|0|||
147000545|NCT00934050|530164951|FG005|Enrolled After 15 Dec 2009|Death|1|||
147000546|NCT00934050|530164946|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
147000547|NCT00934050|530164947|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
147000548|NCT00934050|530164948|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
147000549|NCT00934050|530164949|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
147000550|NCT00934050|530164950|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
147000551|NCT00934050|530164951|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
147000552|NCT00934050|530164946|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
147000553|NCT00934050|530164947|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
147000554|NCT00934050|530164948|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
147000555|NCT00934050|530164949|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
147000556|NCT00934050|530164950|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
147000557|NCT00934050|530164951|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
147000558|NCT02149420|530164954|FG000|Core Study|Administrative problems|0|||
147000559|NCT02149420|530164955|FG001|Core Study|Administrative problems|1|||
147000560|NCT02149420|530164956|FG002|Core Study|Administrative problems|2|||
147000561|NCT02149420|530164954|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
147000562|NCT02149420|530164955|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
147000563|NCT02149420|530164956|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
147000564|NCT03181594|530164957|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
147000565|NCT03181594|530164957|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
147000566|NCT03181594|530164957|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
147000567|NCT03181594|530164957|FG000|Initial Study Protocol (12-month FU)|Death|1|||
147000568|NCT03181594|530164957|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
147000569|NCT03181594|530164957|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
147000570|NCT00960297|530164960|FG000|Overall Study|Physician Decision|1|||
147000571|NCT00960297|530164960|FG000|Overall Study|Venous port infection|1|||
147000572|NCT00960297|530164960|FG000|Overall Study|Disease progression|1|||
147000573|NCT03247972|530164970|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
147000574|NCT03247972|530164970|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
147000575|NCT02576938|530164971|FG000|Overall Study|Adverse Event|5|||
147000576|NCT02576938|530164972|FG001|Overall Study|Adverse Event|3|||
147000577|NCT02576938|530164973|FG002|Overall Study|Adverse Event|6|||
147000578|NCT02576938|530164971|FG000|Overall Study|Protocol Violation|1|||
147000579|NCT02576938|530164972|FG001|Overall Study|Protocol Violation|1|||
147000580|NCT02576938|530164973|FG002|Overall Study|Protocol Violation|1|||
147000581|NCT02576938|530164971|FG000|Overall Study|Withdrawal by Subject|3|||
147000582|NCT02576938|530164972|FG001|Overall Study|Withdrawal by Subject|2|||
147000583|NCT02576938|530164973|FG002|Overall Study|Withdrawal by Subject|4|||
147000584|NCT02576938|530164971|FG000|Overall Study|Lack of Efficacy|9|||
147000585|NCT02576938|530164972|FG001|Overall Study|Lack of Efficacy|4|||
147000586|NCT02576938|530164973|FG002|Overall Study|Lack of Efficacy|0|||
147000587|NCT02576938|530164971|FG000|Overall Study|Lost to Follow-up|2|||
147000588|NCT02576938|530164972|FG001|Overall Study|Lost to Follow-up|0|||
147000589|NCT02576938|530164973|FG002|Overall Study|Lost to Follow-up|1|||
147000590|NCT02576938|530164971|FG000|Overall Study|Physician Decision|0|||
147000591|NCT02576938|530164972|FG001|Overall Study|Physician Decision|1|||
147000592|NCT02576938|530164973|FG002|Overall Study|Physician Decision|0|||
147000593|NCT02576938|530164971|FG000|Overall Study|Met Exclusion Criteria|0|||
147000594|NCT02576938|530164972|FG001|Overall Study|Met Exclusion Criteria|1|||
147000595|NCT02576938|530164973|FG002|Overall Study|Met Exclusion Criteria|0|||
147000596|NCT00968812|530164974|FG000|Overall Study|Adverse Event|30|||
147000597|NCT00968812|530164975|FG001|Overall Study|Adverse Event|46|||
147000598|NCT00968812|530164976|FG002|Overall Study|Adverse Event|33|||
147000599|NCT00968812|530164974|FG000|Overall Study|Death|2|||
147000600|NCT00968812|530164975|FG001|Overall Study|Death|2|||
147000601|NCT00968812|530164976|FG002|Overall Study|Death|1|||
147000602|NCT00968812|530164974|FG000|Overall Study|Lack of Efficacy|9|||
147000603|NCT00968812|530164975|FG001|Overall Study|Lack of Efficacy|7|||
147000604|NCT00968812|530164976|FG002|Overall Study|Lack of Efficacy|16|||
147000605|NCT00968812|530164974|FG000|Overall Study|Lost to Follow-up|17|||
147000606|NCT00968812|530164975|FG001|Overall Study|Lost to Follow-up|12|||
147000607|NCT00968812|530164976|FG002|Overall Study|Lost to Follow-up|11|||
147000608|NCT00968812|530164974|FG000|Overall Study|Physician Decision|8|||
147000609|NCT00968812|530164975|FG001|Overall Study|Physician Decision|5|||
147000610|NCT00968812|530164976|FG002|Overall Study|Physician Decision|9|||
147000611|NCT00968812|530164974|FG000|Overall Study|Protocol Violation|7|||
147000612|NCT00968812|530164975|FG001|Overall Study|Protocol Violation|4|||
147000613|NCT00968812|530164976|FG002|Overall Study|Protocol Violation|3|||
147000614|NCT00968812|530164974|FG000|Overall Study|Withdrawal by Subject|17|||
147000615|NCT00968812|530164975|FG001|Overall Study|Withdrawal by Subject|23|||
147000616|NCT00968812|530164976|FG002|Overall Study|Withdrawal by Subject|25|||
147000617|NCT00968812|530164974|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
147000618|NCT00968812|530164975|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
147000619|NCT00968812|530164976|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
147000620|NCT00968812|530164974|FG000|Overall Study|Noncompliance with study drug|4|||
146844936|NCT04276415|529600931|FG005|Overall Study|Physician Decision|0|||
146844937|NCT04276415|529600926|FG000|Overall Study|Progressive disease|3|||
146844938|NCT04276415|529600927|FG001|Overall Study|Progressive disease|3|||
146844939|NCT04276415|529600928|FG002|Overall Study|Progressive disease|4|||
146844940|NCT04276415|529600929|FG003|Overall Study|Progressive disease|5|||
147000621|NCT00968812|530164975|FG001|Overall Study|Noncompliance with study drug|1|||
147000622|NCT00968812|530164976|FG002|Overall Study|Noncompliance with study drug|6|||
147000623|NCT00968812|530164974|FG000|Overall Study|Unable to take rescue therapy|12|||
147000624|NCT00968812|530164975|FG001|Overall Study|Unable to take rescue therapy|12|||
147000625|NCT00968812|530164976|FG002|Overall Study|Unable to take rescue therapy|17|||
147000626|NCT00968812|530164974|FG000|Overall Study|Other|25|||
147000627|NCT00968812|530164975|FG001|Overall Study|Other|37|||
147000628|NCT00968812|530164976|FG002|Overall Study|Other|40|||
147000629|NCT03500341|530164979|FG000|Overall Study|Withdrawn prior to Completion|2|||
147000630|NCT00571064|530164982|FG000|Overall Study|Adverse Event|13|||
146844941|NCT04276415|529600930|FG004|Overall Study|Progressive disease|1|||
146844942|NCT04276415|529600931|FG005|Overall Study|Progressive disease|2|||
147000631|NCT00571064|530164982|FG000|Overall Study|Protocol Violation|4|||
147000632|NCT00571064|530164982|FG000|Overall Study|Withdrawal by Subject|2|||
147000633|NCT00571064|530164982|FG000|Overall Study|Other|2|||
147000634|NCT00003659|530164989|FG000|Overall Study|Withdrawal by Subject|3|||
147000635|NCT04022954|530164990|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
147000636|NCT04022954|530164990|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
147000637|NCT04022954|530164990|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
147000638|NCT03017885|530164991|FG000|Overall Study|Adverse Event|2|||
147000639|NCT03017885|530164992|FG001|Overall Study|Adverse Event|0|||
147000640|NCT03017885|530164993|FG002|Overall Study|Adverse Event|0|||
147000641|NCT03017885|530164994|FG003|Overall Study|Adverse Event|0|||
147000642|NCT03017885|530164995|FG004|Overall Study|Adverse Event|0|||
147000643|NCT03017885|530164996|FG005|Overall Study|Adverse Event|0|||
147000644|NCT03017885|530164991|FG000|Overall Study|Progression of disease|4|||
147000645|NCT03017885|530164992|FG001|Overall Study|Progression of disease|3|||
147000646|NCT03017885|530164993|FG002|Overall Study|Progression of disease|4|||
147000647|NCT03017885|530164994|FG003|Overall Study|Progression of disease|0|||
147000648|NCT03017885|530164995|FG004|Overall Study|Progression of disease|0|||
147000649|NCT03017885|530164996|FG005|Overall Study|Progression of disease|0|||
147000650|NCT03017885|530164991|FG000|Overall Study|Other than listed|1|||
147000651|NCT03017885|530164992|FG001|Overall Study|Other than listed|2|||
147000652|NCT03017885|530164993|FG002|Overall Study|Other than listed|1|||
147000653|NCT03017885|530164994|FG003|Overall Study|Other than listed|0|||
147000654|NCT03017885|530164995|FG004|Overall Study|Other than listed|0|||
147000655|NCT03017885|530164996|FG005|Overall Study|Other than listed|0|||
147000656|NCT03017885|530164991|FG000|Overall Study|Lost to Follow-up|2|||
147000657|NCT03017885|530164992|FG001|Overall Study|Lost to Follow-up|0|||
147000658|NCT03017885|530164993|FG002|Overall Study|Lost to Follow-up|3|||
147000659|NCT03017885|530164994|FG003|Overall Study|Lost to Follow-up|0|||
147000660|NCT03017885|530164995|FG004|Overall Study|Lost to Follow-up|0|||
147000661|NCT03017885|530164996|FG005|Overall Study|Lost to Follow-up|0|||
147000662|NCT03017885|530164991|FG000|Overall Study|Change to other anti-cancer therapy|0|||
147000663|NCT03017885|530164992|FG001|Overall Study|Change to other anti-cancer therapy|0|||
147000664|NCT03017885|530164993|FG002|Overall Study|Change to other anti-cancer therapy|1|||
147000665|NCT03017885|530164994|FG003|Overall Study|Change to other anti-cancer therapy|0|||
147000666|NCT03017885|530164995|FG004|Overall Study|Change to other anti-cancer therapy|0|||
147000667|NCT03017885|530164996|FG005|Overall Study|Change to other anti-cancer therapy|0|||
147000668|NCT02258074|530164998|FG000|Overall Study|Withdrawal by Subject|1|||
147000669|NCT02258074|530164999|FG001|Overall Study|Withdrawal by Subject|0|||
147000670|NCT02258074|530165000|FG002|Overall Study|Withdrawal by Subject|0|||
147000671|NCT02258074|530165001|FG003|Overall Study|Withdrawal by Subject|0|||
147000672|NCT05446870|530165002|FG000|Overall Study|Death|6|||
147000673|NCT05446870|530165003|FG001|Overall Study|Death|5|||
147000674|NCT05446870|530165002|FG000|Overall Study|Lost to Follow-up|0|||
147000675|NCT05446870|530165003|FG001|Overall Study|Lost to Follow-up|1|||
147000676|NCT05446870|530165002|FG000|Overall Study|Physician Decision|52|||
147000677|NCT05446870|530165003|FG001|Overall Study|Physician Decision|53|||
147000678|NCT05446870|530165002|FG000|Overall Study|Withdrawal by Subject|3|||
147000679|NCT05446870|530165003|FG001|Overall Study|Withdrawal by Subject|3|||
147000680|NCT04108858|530165005|FG000|Overall Study|Adverse Event|1|||
147000681|NCT01005745|530165006|FG000|Overall Study|No TIL growth|1|||
147000682|NCT01005745|530165006|FG000|Overall Study|Disease progressed during TIL growth|3|||
147000683|NCT01005745|530165006|FG000|Overall Study|Death prior to treatment|1|||
147000684|NCT01005745|530165006|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
147000685|NCT01208337|530165011|FG000|Overall Study|Death|3|||
147000686|NCT03663179|530165015|FG000|Overall Study|Withdrawal by Subject|2|||
147000687|NCT03663179|530165016|FG001|Overall Study|Withdrawal by Subject|0|||
147000688|NCT03663179|530165015|FG000|Overall Study|Lost to Follow-up|1|||
147000689|NCT03663179|530165016|FG001|Overall Study|Lost to Follow-up|1|||
147000690|NCT03663179|530165015|FG000|Overall Study|Revealed exclusionary condition|1|||
147000691|NCT03663179|530165016|FG001|Overall Study|Revealed exclusionary condition|0|||
147000692|NCT01615198|530165020|FG000|Overall Study|Withdrawal by Subject|5|||
147000693|NCT01615198|530165021|FG001|Overall Study|Withdrawal by Subject|5|||
147000694|NCT01615198|530165020|FG000|Overall Study|Protocol deviation|1|||
147000695|NCT01615198|530165021|FG001|Overall Study|Protocol deviation|1|||
147000696|NCT01615198|530165020|FG000|Overall Study|Physician Decision|5|||
147000697|NCT01615198|530165021|FG001|Overall Study|Physician Decision|1|||
147000698|NCT01615198|530165020|FG000|Overall Study|Lost to Follow-up|1|||
147000699|NCT01615198|530165021|FG001|Overall Study|Lost to Follow-up|1|||
147000700|NCT01615198|530165020|FG000|Overall Study|Lack of Efficacy|1|||
147000701|NCT01615198|530165021|FG001|Overall Study|Lack of Efficacy|6|||
147000702|NCT01615198|530165020|FG000|Overall Study|Adverse Event|11|||
147000703|NCT01615198|530165021|FG001|Overall Study|Adverse Event|5|||
147000704|NCT01686438|530165022|FG000|Overall Study|Lost to Follow-up|8|||
147000705|NCT01686438|530165023|FG001|Overall Study|Lost to Follow-up|9|||
147000706|NCT01686438|530165024|FG002|Overall Study|Lost to Follow-up|10|||
147000707|NCT01686438|530165022|FG000|Overall Study|Adverse Event|0|||
147000708|NCT01686438|530165023|FG001|Overall Study|Adverse Event|0|||
147000709|NCT01686438|530165024|FG002|Overall Study|Adverse Event|1|||
147000710|NCT01686438|530165022|FG000|Overall Study|Protocol Violation|0|||
147000711|NCT01686438|530165023|FG001|Overall Study|Protocol Violation|0|||
147000712|NCT01686438|530165024|FG002|Overall Study|Protocol Violation|1|||
147000713|NCT01686438|530165022|FG000|Overall Study|Withdrawal by Subject|0|||
147000714|NCT01686438|530165023|FG001|Overall Study|Withdrawal by Subject|0|||
147000715|NCT01686438|530165024|FG002|Overall Study|Withdrawal by Subject|1|||
147000716|NCT00984126|530165025|FG000|Overall Study|Protocol Violation|0|||
147000717|NCT00984126|530165026|FG001|Overall Study|Protocol Violation|0|||
147000718|NCT00984126|530165027|FG002|Overall Study|Protocol Violation|1|||
147000719|NCT00984126|530165028|FG003|Overall Study|Protocol Violation|2|||
147000720|NCT00984126|530165025|FG000|Overall Study|Adverse Event|0|||
147000721|NCT00984126|530165026|FG001|Overall Study|Adverse Event|0|||
147000722|NCT00984126|530165027|FG002|Overall Study|Adverse Event|0|||
147000723|NCT00984126|530165028|FG003|Overall Study|Adverse Event|2|||
147000724|NCT00984126|530165025|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
147000725|NCT00984126|530165026|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
147000726|NCT00984126|530165027|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
147000727|NCT00984126|530165028|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
147000728|NCT00984126|530165025|FG000|Overall Study|Withdrawal criteria|0|||
147000729|NCT00984126|530165026|FG001|Overall Study|Withdrawal criteria|1|||
147000730|NCT00984126|530165027|FG002|Overall Study|Withdrawal criteria|3|||
147000731|NCT00984126|530165028|FG003|Overall Study|Withdrawal criteria|9|||
147000732|NCT01029340|530165032|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
147000733|NCT01029340|530165033|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
147000734|NCT01029340|530165034|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
147000735|NCT01029340|530165035|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
147000736|NCT01029340|530165036|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
147000737|NCT01029340|530165037|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
147000738|NCT01029340|530165032|FG000|Part B Treatment Period|Protocol Violation|0|||
147000739|NCT01029340|530165033|FG001|Part B Treatment Period|Protocol Violation|0|||
147000740|NCT01029340|530165034|FG002|Part B Treatment Period|Protocol Violation|1|||
147000741|NCT01029340|530165035|FG003|Part B Treatment Period|Protocol Violation|0|||
147000742|NCT01029340|530165036|FG004|Part B Treatment Period|Protocol Violation|0|||
147000743|NCT01029340|530165037|FG005|Part B Treatment Period|Protocol Violation|0|||
147000744|NCT01029340|530165032|FG000|Extension Period|Adverse Event|0|||
147000745|NCT01029340|530165033|FG001|Extension Period|Adverse Event|0|||
147000746|NCT01029340|530165034|FG002|Extension Period|Adverse Event|0|||
147000747|NCT01029340|530165035|FG003|Extension Period|Adverse Event|0|||
147000748|NCT01029340|530165036|FG004|Extension Period|Adverse Event|0|||
147000749|NCT01029340|530165037|FG005|Extension Period|Adverse Event|1|||
147000750|NCT01029340|530165032|FG000|Extension Period|starting another study|0|||
147000751|NCT01029340|530165033|FG001|Extension Period|starting another study|0|||
147000752|NCT01029340|530165034|FG002|Extension Period|starting another study|0|||
147000753|NCT01029340|530165035|FG003|Extension Period|starting another study|0|||
147000754|NCT01029340|530165036|FG004|Extension Period|starting another study|0|||
147000755|NCT01029340|530165037|FG005|Extension Period|starting another study|8|||
147000756|NCT01029340|530165032|FG000|Extension Period|non-compliance|0|||
147000757|NCT01029340|530165033|FG001|Extension Period|non-compliance|0|||
147000758|NCT01029340|530165034|FG002|Extension Period|non-compliance|0|||
147000759|NCT01029340|530165035|FG003|Extension Period|non-compliance|0|||
147000760|NCT01029340|530165036|FG004|Extension Period|non-compliance|0|||
147000761|NCT01029340|530165037|FG005|Extension Period|non-compliance|1|||
147000762|NCT01029340|530165032|FG000|Extension Period|Withdrawal by Subject|0|||
147000763|NCT01029340|530165033|FG001|Extension Period|Withdrawal by Subject|0|||
147000764|NCT01029340|530165034|FG002|Extension Period|Withdrawal by Subject|0|||
147000765|NCT01029340|530165035|FG003|Extension Period|Withdrawal by Subject|0|||
147000766|NCT01029340|530165036|FG004|Extension Period|Withdrawal by Subject|0|||
147000767|NCT01029340|530165037|FG005|Extension Period|Withdrawal by Subject|1|||
147000768|NCT01029340|530165032|FG000|Extension Period|Physician Decision|0|||
147000769|NCT01029340|530165033|FG001|Extension Period|Physician Decision|0|||
147000770|NCT01029340|530165034|FG002|Extension Period|Physician Decision|0|||
147000771|NCT01029340|530165035|FG003|Extension Period|Physician Decision|0|||
147000772|NCT01029340|530165036|FG004|Extension Period|Physician Decision|0|||
147000773|NCT01029340|530165037|FG005|Extension Period|Physician Decision|1|||
147000774|NCT01864174|530165038|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
147000775|NCT01864174|530165039|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
147000776|NCT01864174|530165038|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
147000777|NCT01864174|530165039|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
147000778|NCT01864174|530165038|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
147000779|NCT01864174|530165039|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
147000780|NCT01864174|530165038|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
147000781|NCT01864174|530165039|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
147000782|NCT01864174|530165038|FG000|Double Blind - Compliant Randomized|Death|1|||
147000783|NCT01864174|530165039|FG001|Double Blind - Compliant Randomized|Death|0|||
147000784|NCT01864174|530165038|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
147000785|NCT01864174|530165039|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
147000786|NCT01864174|530165038|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
147000787|NCT01864174|530165039|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
147000788|NCT01864174|530165038|FG000|Double Blind - Compliant Randomized|Other|6|||
147000789|NCT01864174|530165039|FG001|Double Blind - Compliant Randomized|Other|10|||
147000790|NCT01864174|530165038|FG000|Off Treatment Follow-Up|Other|2|||
147000791|NCT01864174|530165039|FG001|Off Treatment Follow-Up|Other|0|||
147000792|NCT01864174|530165038|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
147000793|NCT01864174|530165039|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
147000794|NCT02648347|530165040|FG000|Overall Study|Death|174|||
147000795|NCT02648347|530165041|FG001|Overall Study|Death|167|||
147000796|NCT02648347|530165040|FG000|Overall Study|Withdrawal by Subject|16|||
147000797|NCT02648347|530165041|FG001|Overall Study|Withdrawal by Subject|9|||
147000798|NCT02648347|530165040|FG000|Overall Study|Lost to Follow-up|18|||
147000799|NCT02648347|530165041|FG001|Overall Study|Lost to Follow-up|21|||
147000800|NCT02648347|530165040|FG000|Overall Study|Missing|1|||
147000801|NCT02648347|530165041|FG001|Overall Study|Missing|0|||
147000802|NCT02739997|530165049|FG000|Overall Study|Death|1|||
147000803|NCT02739997|530165049|FG000|Overall Study|Withdrawal by Subject|1|||
147000804|NCT01723397|530165052|FG000|Study Period 1|Protocol Violation|0|||
147000805|NCT01723397|530165053|FG001|Study Period 1|Protocol Violation|1|||
147000806|NCT01723397|530165052|FG000|Study Period 2|Protocol Violation|0|||
147000807|NCT01723397|530165053|FG001|Study Period 2|Protocol Violation|1|||
147000808|NCT00468286|530165054|FG000|Overall Study|Adverse Event|1|||
147000809|NCT00468286|530165055|FG001|Overall Study|Adverse Event|6|||
147000810|NCT00468286|530165054|FG000|Overall Study|Protocol Violation|2|||
147000811|NCT00468286|530165055|FG001|Overall Study|Protocol Violation|2|||
147000812|NCT00468286|530165054|FG000|Overall Study|Withdrawal by Subject|4|||
147000813|NCT00468286|530165055|FG001|Overall Study|Withdrawal by Subject|3|||
147000814|NCT00468286|530165054|FG000|Overall Study|Physician Decision|0|||
147000815|NCT00468286|530165055|FG001|Overall Study|Physician Decision|1|||
147000816|NCT02196675|530165056|FG000|Overall Study|Withdrawal by Subject|1|||
147000817|NCT02196675|530165057|FG001|Overall Study|Withdrawal by Subject|0|||
147000818|NCT02196675|530165058|FG002|Overall Study|Withdrawal by Subject|0|||
147000819|NCT02196675|530165056|FG000|Overall Study|Intra-operative surgical exclusion|1|||
147000820|NCT02196675|530165057|FG001|Overall Study|Intra-operative surgical exclusion|1|||
147000821|NCT02196675|530165058|FG002|Overall Study|Intra-operative surgical exclusion|0|||
147000822|NCT02196675|530165056|FG000|Overall Study|Protocol Violation|0|||
147000823|NCT02196675|530165057|FG001|Overall Study|Protocol Violation|1|||
147000824|NCT02196675|530165058|FG002|Overall Study|Protocol Violation|0|||
147000825|NCT02196675|530165056|FG000|Overall Study|Death|0|||
147000826|NCT02196675|530165057|FG001|Overall Study|Death|0|||
147000827|NCT02196675|530165058|FG002|Overall Study|Death|1|||
147000828|NCT00359281|530165059|FG000|Overall Study|Adverse Event|1|||
147000829|NCT00359281|530165060|FG001|Overall Study|Adverse Event|0|||
147000830|NCT00359281|530165061|FG002|Overall Study|Adverse Event|0|||
147000831|NCT00359281|530165062|FG003|Overall Study|Adverse Event|0|||
147000832|NCT00359281|530165063|FG004|Overall Study|Adverse Event|0|||
147000833|NCT00359281|530165064|FG005|Overall Study|Adverse Event|0|||
147000834|NCT00359281|530165065|FG006|Overall Study|Adverse Event|1|||
147000835|NCT00359281|530165066|FG007|Overall Study|Adverse Event|0|||
147000836|NCT00359281|530165067|FG008|Overall Study|Adverse Event|0|||
147000837|NCT00359281|530165059|FG000|Overall Study|Withdrawal by Subject|0|||
147000838|NCT00359281|530165060|FG001|Overall Study|Withdrawal by Subject|0|||
147000839|NCT00359281|530165061|FG002|Overall Study|Withdrawal by Subject|0|||
147000840|NCT00359281|530165062|FG003|Overall Study|Withdrawal by Subject|0|||
147000841|NCT00359281|530165063|FG004|Overall Study|Withdrawal by Subject|0|||
147000842|NCT00359281|530165064|FG005|Overall Study|Withdrawal by Subject|0|||
147000843|NCT00359281|530165065|FG006|Overall Study|Withdrawal by Subject|1|||
147000844|NCT00359281|530165066|FG007|Overall Study|Withdrawal by Subject|0|||
147000845|NCT00359281|530165067|FG008|Overall Study|Withdrawal by Subject|0|||
147000846|NCT01474551|530165068|FG000|Overall Study|Death|1|||
147000847|NCT03686033|530165080|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
147000848|NCT03686033|530165081|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
147000849|NCT03686033|530165082|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
147000850|NCT03686033|530165083|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
147000851|NCT03686033|530165084|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
147000852|NCT03686033|530165085|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
146735995|NCT04843930|529205260|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
147000853|NCT01045161|530165086|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
147000854|NCT01045161|530165087|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
147000855|NCT01045161|530165088|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
147000856|NCT01045161|530165086|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
147000857|NCT01045161|530165087|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
147000858|NCT01045161|530165088|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
147000859|NCT01045161|530165086|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
147000860|NCT01045161|530165087|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
147000861|NCT01045161|530165088|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
147000862|NCT01045161|530165086|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
147000863|NCT01045161|530165087|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
147000864|NCT01045161|530165088|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
147000865|NCT01045161|530165086|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
147000866|NCT01045161|530165087|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
147000867|NCT01045161|530165088|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
147000868|NCT01045161|530165086|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
147000869|NCT01045161|530165087|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
147000870|NCT01045161|530165088|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
147000871|NCT01045161|530165086|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
147000872|NCT01045161|530165087|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
147000873|NCT01045161|530165088|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
147000874|NCT01045161|530165086|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
147000875|NCT01045161|530165087|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
147000876|NCT01045161|530165088|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
147000877|NCT01045161|530165086|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
147000878|NCT01045161|530165087|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
147000879|NCT01045161|530165088|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
147000880|NCT01045161|530165086|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
147000881|NCT01045161|530165087|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
147000882|NCT01045161|530165088|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
147000883|NCT01045161|530165086|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
147000884|NCT01045161|530165087|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
147000885|NCT01045161|530165088|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
147000886|NCT01045161|530165086|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
147000887|NCT01045161|530165087|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
147000888|NCT01045161|530165088|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
147000889|NCT01045161|530165086|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
147000890|NCT01045161|530165087|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
147000891|NCT01045161|530165088|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
147000892|NCT01045161|530165086|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
147000893|NCT01045161|530165087|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
147000894|NCT01045161|530165088|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
147000895|NCT01854047|530165089|FG000|Overall Study|Lack of Efficacy|1|||
147000896|NCT01854047|530165090|FG001|Overall Study|Lack of Efficacy|0|||
147000897|NCT01854047|530165091|FG002|Overall Study|Lack of Efficacy|0|||
147000898|NCT01854047|530165092|FG003|Overall Study|Lack of Efficacy|0|||
147000899|NCT01854047|530165093|FG004|Overall Study|Lack of Efficacy|0|||
147000900|NCT01854047|530165089|FG000|Overall Study|Poor compliance to protocol|3|||
147000901|NCT01854047|530165090|FG001|Overall Study|Poor compliance to protocol|0|||
147000902|NCT01854047|530165091|FG002|Overall Study|Poor compliance to protocol|2|||
147000903|NCT01854047|530165092|FG003|Overall Study|Poor compliance to protocol|0|||
147000904|NCT01854047|530165093|FG004|Overall Study|Poor compliance to protocol|0|||
147000905|NCT01854047|530165089|FG000|Overall Study|Adverse Event|5|||
147000906|NCT01854047|530165090|FG001|Overall Study|Adverse Event|4|||
147000907|NCT01854047|530165091|FG002|Overall Study|Adverse Event|6|||
147000908|NCT01854047|530165092|FG003|Overall Study|Adverse Event|10|||
147000909|NCT01854047|530165093|FG004|Overall Study|Adverse Event|7|||
147000910|NCT01854047|530165089|FG000|Overall Study|Randomized but not treated|0|||
147000911|NCT01854047|530165090|FG001|Overall Study|Randomized but not treated|1|||
147000912|NCT01854047|530165091|FG002|Overall Study|Randomized but not treated|2|||
147000913|NCT01854047|530165092|FG003|Overall Study|Randomized but not treated|0|||
147000914|NCT01854047|530165093|FG004|Overall Study|Randomized but not treated|4|||
147000915|NCT01854047|530165089|FG000|Overall Study|Other than specified above|3|||
146844943|NCT04276415|529600926|FG000|Overall Study|Withdrawal by patient|0|||
146844944|NCT04276415|529600927|FG001|Overall Study|Withdrawal by patient|0|||
146844945|NCT04276415|529600928|FG002|Overall Study|Withdrawal by patient|0|||
146844946|NCT04276415|529600929|FG003|Overall Study|Withdrawal by patient|1|||
146844947|NCT04276415|529600930|FG004|Overall Study|Withdrawal by patient|2|||
146844948|NCT04276415|529600931|FG005|Overall Study|Withdrawal by patient|0|||
147000916|NCT01854047|530165090|FG001|Overall Study|Other than specified above|3|||
147000917|NCT01854047|530165091|FG002|Overall Study|Other than specified above|3|||
147000918|NCT01854047|530165092|FG003|Overall Study|Other than specified above|5|||
146844949|NCT00208325|529600932|FG000|Overall Study|Death|18|||
146844950|NCT00208325|529600933|FG001|Overall Study|Death|19|||
147000919|NCT01854047|530165093|FG004|Overall Study|Other than specified above|8|||
147000920|NCT04659603|530165099|FG000|Overall Study|Study terminated by sponsor|0|||
147000921|NCT04659603|530165100|FG001|Overall Study|Study terminated by sponsor|0|||
147000922|NCT04659603|530165101|FG002|Overall Study|Study terminated by sponsor|2|||
147000923|NCT04659603|530165099|FG000|Overall Study|Withdrawal by Subject|0|||
147000924|NCT04659603|530165100|FG001|Overall Study|Withdrawal by Subject|5|||
147000925|NCT04659603|530165101|FG002|Overall Study|Withdrawal by Subject|0|||
147000926|NCT04659603|530165099|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
147000927|NCT04659603|530165100|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
147000928|NCT04659603|530165101|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
147000929|NCT02374853|530165104|FG000|Overall Study|Surgery Cancelled|5|||
147000930|NCT02374853|530165105|FG001|Overall Study|Surgery Cancelled|11|||
147000931|NCT02281084|530165106|FG000|Overall Study|Death|21|||
147000932|NCT02281084|530165107|FG001|Overall Study|Death|18|||
147000933|NCT02281084|530165108|FG002|Overall Study|Death|3|||
147000934|NCT02281084|530165109|FG003|Overall Study|Death|5|||
147000935|NCT02281084|530165106|FG000|Overall Study|Adverse Event|1|||
147000936|NCT02281084|530165107|FG001|Overall Study|Adverse Event|0|||
147000937|NCT02281084|530165108|FG002|Overall Study|Adverse Event|0|||
147000938|NCT02281084|530165109|FG003|Overall Study|Adverse Event|0|||
147000939|NCT02281084|530165106|FG000|Overall Study|Withdrawal by Subject|2|||
147000940|NCT02281084|530165107|FG001|Overall Study|Withdrawal by Subject|2|||
147000941|NCT02281084|530165108|FG002|Overall Study|Withdrawal by Subject|0|||
147000942|NCT02281084|530165109|FG003|Overall Study|Withdrawal by Subject|0|||
147000943|NCT02281084|530165106|FG000|Overall Study|Site Closure by Sponsor|5|||
147000944|NCT02281084|530165107|FG001|Overall Study|Site Closure by Sponsor|1|||
147000945|NCT02281084|530165108|FG002|Overall Study|Site Closure by Sponsor|2|||
147000946|NCT02281084|530165109|FG003|Overall Study|Site Closure by Sponsor|0|||
147000947|NCT03681470|530165110|FG000|Overall Study|Lack of Efficacy|3|||
147000948|NCT03681470|530165110|FG000|Overall Study|Lost to Follow-up|1|||
147000949|NCT03681470|530165110|FG000|Overall Study|Protocol Violation|3|||
147000950|NCT03681470|530165110|FG000|Overall Study|Withdrawal by Subject|1|||
147000951|NCT02305758|530165111|FG000|Overall Study|Death|27|||
147000952|NCT02305758|530165112|FG001|Overall Study|Death|27|||
147000953|NCT02305758|530165111|FG000|Overall Study|Withdrew consent|9|||
147000954|NCT02305758|530165112|FG001|Overall Study|Withdrew consent|2|||
147000955|NCT02305758|530165111|FG000|Overall Study|Lost to Follow-up|6|||
147000956|NCT02305758|530165112|FG001|Overall Study|Lost to Follow-up|1|||
147000957|NCT02305758|530165111|FG000|Overall Study|Study Terminated by Sponsor|21|||
147000958|NCT02305758|530165112|FG001|Overall Study|Study Terminated by Sponsor|34|||
147000959|NCT02305758|530165111|FG000|Overall Study|Other, not specified|2|||
147000960|NCT02305758|530165112|FG001|Overall Study|Other, not specified|1|||
147000961|NCT00811655|530165127|FG000|Overall Study|Physician Decision|1|||
147000962|NCT02820350|530165128|FG000|Overall Study|Withdrawal by Subject|3|||
147000963|NCT02820350|530165128|FG000|Overall Study|Death|4|||
147000964|NCT01754597|530165129|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
147000965|NCT01754597|530165130|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
147000966|NCT01802320|530165131|FG000|Overall Study|Death|1|||
147000967|NCT01802320|530165131|FG000|Overall Study|Withdrawal by Subject|1|||
147000968|NCT02674152|530166665|FG000|Overall Study|Personal Reasons|1|||
147000969|NCT02674152|530166666|FG001|Overall Study|Personal Reasons|0|||
147000970|NCT02674152|530166667|FG002|Overall Study|Personal Reasons|0|||
147000971|NCT02674152|530166668|FG003|Overall Study|Personal Reasons|1|||
147000972|NCT02674152|530166669|FG004|Overall Study|Personal Reasons|1|||
147000973|NCT02674152|530166665|FG000|Overall Study|Other adverse event or clinical progression|0|||
147000974|NCT02674152|530166666|FG001|Overall Study|Other adverse event or clinical progression|1|||
147000975|NCT02674152|530166667|FG002|Overall Study|Other adverse event or clinical progression|0|||
147000976|NCT02674152|530166668|FG003|Overall Study|Other adverse event or clinical progression|3|||
147000977|NCT02674152|530166669|FG004|Overall Study|Other adverse event or clinical progression|0|||
147000978|NCT02674152|530166665|FG000|Overall Study|Dose-limiting toxicity|0|||
147000979|NCT02674152|530166666|FG001|Overall Study|Dose-limiting toxicity|0|||
147000980|NCT02674152|530166667|FG002|Overall Study|Dose-limiting toxicity|0|||
147000981|NCT02674152|530166668|FG003|Overall Study|Dose-limiting toxicity|0|||
147000982|NCT02674152|530166669|FG004|Overall Study|Dose-limiting toxicity|1|||
147000983|NCT02674152|530166665|FG000|Overall Study|Progressive Disease|2|||
147000984|NCT02674152|530166666|FG001|Overall Study|Progressive Disease|1|||
147000985|NCT02674152|530166667|FG002|Overall Study|Progressive Disease|1|||
147000986|NCT02674152|530166668|FG003|Overall Study|Progressive Disease|13|||
147000987|NCT02674152|530166669|FG004|Overall Study|Progressive Disease|2|||
147000988|NCT02674152|530166665|FG000|Overall Study|Adverse Event|0|||
146735996|NCT04843930|529205261|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
147000989|NCT02674152|530166666|FG001|Overall Study|Adverse Event|0|||
147000990|NCT02674152|530166667|FG002|Overall Study|Adverse Event|1|||
147000991|NCT02674152|530166668|FG003|Overall Study|Adverse Event|0|||
147000992|NCT02674152|530166669|FG004|Overall Study|Adverse Event|1|||
147000993|NCT05265624|530166670|FG000|Overall Study|Lost to Follow-up|3|||
146735997|NCT04843930|529205262|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
147000994|NCT05265624|530166671|FG001|Overall Study|Lost to Follow-up|0|||
147000995|NCT05265624|530166670|FG000|Overall Study|Withdrawal by Subject|1|||
147000996|NCT05265624|530166671|FG001|Overall Study|Withdrawal by Subject|0|||
147000997|NCT00001703|530166672|FG000|Overall Study|progressed disease|2|||
147000998|NCT00001703|530166672|FG000|Overall Study|No evidence of disease|1|||
147000999|NCT00001703|530166672|FG000|Overall Study|recurrent disease|2|||
147001000|NCT03071575|530166673|FG000|Overall Study|Death|0|||
147001001|NCT03071575|530166674|FG001|Overall Study|Death|1|||
146735998|NCT04843930|529205263|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
146735999|NCT02552238|529205266|FG000|Overall Study|Withdrawal by Subject|2|||
146736000|NCT02552238|529205266|FG000|Overall Study|Adverse Event|2|||
146736001|NCT05158296|529205267|FG000|Overall Study|Sponsor Decision|2|||
147001002|NCT03071575|530166673|FG000|Overall Study|Lost to Follow-up|5|||
147001003|NCT03071575|530166674|FG001|Overall Study|Lost to Follow-up|11|||
147001004|NCT03071575|530166673|FG000|Overall Study|Withdrawal by Subject|4|||
147001005|NCT03071575|530166674|FG001|Overall Study|Withdrawal by Subject|2|||
147001006|NCT00834795|530166679|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
147001007|NCT00834795|530166680|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
147001008|NCT00834795|530166679|FG000|Second Intervention|Adverse Event|1|||
147001009|NCT00834795|530166680|FG001|Second Intervention|Adverse Event|0|||
147001010|NCT00579345|530166681|FG000|Overall Study|Withdrawal by Subject|2|||
147001011|NCT00579345|530166682|FG001|Overall Study|Withdrawal by Subject|0|||
147001012|NCT00579345|530166683|FG002|Overall Study|Withdrawal by Subject|0|||
147001013|NCT00579345|530166684|FG003|Overall Study|Withdrawal by Subject|0|||
147001014|NCT00579345|530166685|FG004|Overall Study|Withdrawal by Subject|0|||
147001015|NCT00579345|530166686|FG005|Overall Study|Withdrawal by Subject|0|||
147001016|NCT00579345|530166687|FG006|Overall Study|Withdrawal by Subject|0|||
147001017|NCT00579345|530166688|FG007|Overall Study|Withdrawal by Subject|1|||
147001018|NCT00579345|530166681|FG000|Overall Study|Lost to Follow-up|1|||
147001019|NCT00579345|530166682|FG001|Overall Study|Lost to Follow-up|0|||
147001020|NCT00579345|530166683|FG002|Overall Study|Lost to Follow-up|0|||
147001021|NCT00579345|530166684|FG003|Overall Study|Lost to Follow-up|0|||
147001022|NCT00579345|530166685|FG004|Overall Study|Lost to Follow-up|0|||
147001023|NCT00579345|530166686|FG005|Overall Study|Lost to Follow-up|0|||
147001024|NCT00579345|530166687|FG006|Overall Study|Lost to Follow-up|0|||
147001025|NCT00579345|530166688|FG007|Overall Study|Lost to Follow-up|0|||
147001026|NCT00579345|530166681|FG000|Overall Study|Adverse Event|0|||
147001027|NCT00579345|530166682|FG001|Overall Study|Adverse Event|0|||
147001028|NCT00579345|530166683|FG002|Overall Study|Adverse Event|1|||
147001029|NCT00579345|530166684|FG003|Overall Study|Adverse Event|0|||
147001030|NCT00579345|530166685|FG004|Overall Study|Adverse Event|0|||
147001031|NCT00579345|530166686|FG005|Overall Study|Adverse Event|0|||
147001032|NCT00579345|530166687|FG006|Overall Study|Adverse Event|0|||
147001033|NCT00579345|530166688|FG007|Overall Study|Adverse Event|0|||
147001034|NCT00579345|530166681|FG000|Overall Study|Protocol Violation|1|||
147001035|NCT00579345|530166682|FG001|Overall Study|Protocol Violation|0|||
147001036|NCT00579345|530166683|FG002|Overall Study|Protocol Violation|0|||
147001037|NCT00579345|530166684|FG003|Overall Study|Protocol Violation|0|||
147001038|NCT00579345|530166685|FG004|Overall Study|Protocol Violation|0|||
147001039|NCT00579345|530166686|FG005|Overall Study|Protocol Violation|0|||
147001040|NCT00579345|530166687|FG006|Overall Study|Protocol Violation|0|||
147001041|NCT00579345|530166688|FG007|Overall Study|Protocol Violation|1|||
147001042|NCT00579345|530166681|FG000|Overall Study|Death|1|||
147001043|NCT00579345|530166682|FG001|Overall Study|Death|1|||
147001044|NCT00579345|530166683|FG002|Overall Study|Death|1|||
147001045|NCT00579345|530166684|FG003|Overall Study|Death|1|||
147001046|NCT00579345|530166685|FG004|Overall Study|Death|0|||
147001047|NCT00579345|530166686|FG005|Overall Study|Death|0|||
147001048|NCT00579345|530166687|FG006|Overall Study|Death|0|||
147001049|NCT00579345|530166688|FG007|Overall Study|Death|0|||
147001050|NCT03447353|530166692|FG000|Overall Study|Failure at Screening Visit|2|||
147001051|NCT03447353|530166692|FG000|Overall Study|Lost to Follow-up|4|||
147001052|NCT03447353|530166692|FG000|Overall Study|Scheduling Conflicts|3|||
147001053|NCT03447353|530166692|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
147001054|NCT02057835|530166693|FG000|Overall Study|Withdrawal by Subject|0|||
147001055|NCT02057835|530166694|FG001|Overall Study|Withdrawal by Subject|2|||
147001056|NCT02057835|530166695|FG002|Overall Study|Withdrawal by Subject|0|||
147001057|NCT02057835|530166696|FG003|Overall Study|Withdrawal by Subject|0|||
147001058|NCT02057835|530166697|FG004|Overall Study|Withdrawal by Subject|0|||
147001059|NCT02057835|530166698|FG005|Overall Study|Withdrawal by Subject|0|||
147001060|NCT02057835|530166699|FG006|Overall Study|Withdrawal by Subject|0|||
147001061|NCT02057835|530166700|FG007|Overall Study|Withdrawal by Subject|0|||
147001062|NCT02057835|530166701|FG008|Overall Study|Withdrawal by Subject|0|||
147001063|NCT02057835|530166702|FG009|Overall Study|Withdrawal by Subject|0|||
147001064|NCT02267187|530166703|FG000|Overall Study|Physician Decision|2|||
147001065|NCT02267187|530166703|FG000|Overall Study|Screen fail|3|||
147001066|NCT04299087|530166704|FG000|Overall Study|Lost to Follow-up|2|||
147001067|NCT04299087|530166705|FG001|Overall Study|Lost to Follow-up|1|||
147001068|NCT03025087|530166706|FG000|Overall Study|Physician Decision|3|||
147001069|NCT03025087|530166707|FG001|Overall Study|Physician Decision|3|||
147001070|NCT03025087|530166708|FG002|Overall Study|Physician Decision|0|||
147001071|NCT03025087|530166709|FG003|Overall Study|Physician Decision|0|||
147001072|NCT03025087|530166710|FG004|Overall Study|Physician Decision|0|||
147001073|NCT03025087|530166706|FG000|Overall Study|Withdrawal by Subject|1|||
147001074|NCT03025087|530166707|FG001|Overall Study|Withdrawal by Subject|1|||
147001075|NCT03025087|530166708|FG002|Overall Study|Withdrawal by Subject|0|||
147001076|NCT03025087|530166709|FG003|Overall Study|Withdrawal by Subject|0|||
147001077|NCT03025087|530166710|FG004|Overall Study|Withdrawal by Subject|0|||
147001078|NCT03025087|530166706|FG000|Overall Study|Unable to complete MRI|2|||
147001079|NCT03025087|530166707|FG001|Overall Study|Unable to complete MRI|2|||
147001080|NCT03025087|530166708|FG002|Overall Study|Unable to complete MRI|0|||
147001081|NCT03025087|530166709|FG003|Overall Study|Unable to complete MRI|0|||
147001082|NCT03025087|530166710|FG004|Overall Study|Unable to complete MRI|0|||
147001083|NCT00508651|530166711|FG000|Overall Study|Lost to Follow-up|3|||
147001084|NCT00508651|530166712|FG001|Overall Study|Lost to Follow-up|1|||
147001085|NCT00508651|530166711|FG000|Overall Study|Withdrawal by Subject|1|||
147001086|NCT00508651|530166712|FG001|Overall Study|Withdrawal by Subject|1|||
147001087|NCT01376037|530166714|FG000|Overall Study|Lost to Follow-up|0|||
147001088|NCT01376037|530166715|FG001|Overall Study|Lost to Follow-up|2|||
147001089|NCT01111461|530166716|FG000|Overall Study|Adverse Event|32|||
147001090|NCT01111461|530166716|FG000|Overall Study|Participant choice|11|||
147001091|NCT01111461|530166716|FG000|Overall Study|Lost to Follow-up|1|||
147001092|NCT01111461|530166716|FG000|Overall Study|Withdrawal by Subject|1|||
147001093|NCT01111461|530166716|FG000|Overall Study|Other|6|||
147001094|NCT00834067|530166719|FG000|Washout of 21 Days|Protocol Violation|0|||
147001095|NCT00834067|530166720|FG001|Washout of 21 Days|Protocol Violation|1|||
147001096|NCT00440518|530166722|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
147001097|NCT00440518|530166723|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
147001098|NCT00440518|530166724|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
147001099|NCT00440518|530166722|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
147001100|NCT00440518|530166723|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
147001101|NCT00440518|530166724|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
147001102|NCT00440518|530166722|FG000|Randomized /Titration Period|Protocol Deviation|1|||
147001103|NCT00440518|530166723|FG001|Randomized /Titration Period|Protocol Deviation|0|||
147001104|NCT00440518|530166724|FG002|Randomized /Titration Period|Protocol Deviation|0|||
147001105|NCT00440518|530166722|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
147001106|NCT00440518|530166723|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
147001107|NCT00440518|530166724|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
147001108|NCT00440518|530166722|FG000|Randomized /Titration Period|Other|1|||
147001109|NCT00440518|530166723|FG001|Randomized /Titration Period|Other|0|||
147001110|NCT00440518|530166724|FG002|Randomized /Titration Period|Other|0|||
147001111|NCT00440518|530166722|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
147001112|NCT00440518|530166723|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
147001113|NCT00440518|530166724|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
147001114|NCT00440518|530166722|FG000|Randomized /Titration Period|Adverse Event|2|||
147001115|NCT00440518|530166723|FG001|Randomized /Titration Period|Adverse Event|3|||
147001116|NCT00440518|530166724|FG002|Randomized /Titration Period|Adverse Event|0|||
147001117|NCT00440518|530166722|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
147001118|NCT00440518|530166723|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
147001119|NCT00440518|530166724|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
147001120|NCT00440518|530166722|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
147001121|NCT00440518|530166723|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
147001122|NCT00440518|530166724|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
147001123|NCT00440518|530166722|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
147001124|NCT00440518|530166723|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
147001125|NCT00440518|530166724|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
147001126|NCT00440518|530166722|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
146844951|NCT00208325|529600934|FG002|Overall Study|Death|7|||
146844952|NCT00208325|529600935|FG003|Overall Study|Death|5|||
146844953|NCT00208325|529600932|FG000|Overall Study|Withdrawal by Subject|0|||
146844954|NCT00208325|529600933|FG001|Overall Study|Withdrawal by Subject|1|||
147001127|NCT00440518|530166723|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
147001128|NCT00440518|530166724|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
147001129|NCT00440518|530166722|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
147001130|NCT00440518|530166723|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
147001131|NCT00440518|530166724|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
147001132|NCT00440518|530166722|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
147001133|NCT00440518|530166723|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
147001134|NCT00440518|530166724|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
147001135|NCT03570749|530166725|FG000|Overall Study|Ongoing|26|||
146844955|NCT00208325|529600934|FG002|Overall Study|Withdrawal by Subject|0|||
147001136|NCT03570749|530166726|FG001|Overall Study|Ongoing|25|||
147001137|NCT03570749|530166727|FG002|Overall Study|Ongoing|25|||
147001138|NCT03570749|530166728|FG003|Overall Study|Ongoing|26|||
147001139|NCT03570749|530166729|FG004|Overall Study|Ongoing|140|||
147001140|NCT03570749|530166730|FG005|Overall Study|Ongoing|142|||
147001141|NCT03570749|530166731|FG006|Overall Study|Ongoing|220|||
147001142|NCT03570749|530166725|FG000|Overall Study|Adverse Event|0|||
147001143|NCT03570749|530166726|FG001|Overall Study|Adverse Event|0|||
147001144|NCT03570749|530166727|FG002|Overall Study|Adverse Event|0|||
147001145|NCT03570749|530166728|FG003|Overall Study|Adverse Event|0|||
147001146|NCT03570749|530166729|FG004|Overall Study|Adverse Event|2|||
147001147|NCT03570749|530166730|FG005|Overall Study|Adverse Event|3|||
147001148|NCT03570749|530166731|FG006|Overall Study|Adverse Event|6|||
147001149|NCT03570749|530166725|FG000|Overall Study|Lack of Efficacy|0|||
147001150|NCT03570749|530166726|FG001|Overall Study|Lack of Efficacy|0|||
147001151|NCT03570749|530166727|FG002|Overall Study|Lack of Efficacy|0|||
147001152|NCT03570749|530166728|FG003|Overall Study|Lack of Efficacy|0|||
146844956|NCT00208325|529600935|FG003|Overall Study|Withdrawal by Subject|0|||
146844957|NCT00208325|529600932|FG000|Overall Study|Revision|4|||
146844958|NCT00208325|529600933|FG001|Overall Study|Revision|1|||
146844959|NCT00208325|529600934|FG002|Overall Study|Revision|0|||
146844960|NCT00208325|529600935|FG003|Overall Study|Revision|4|||
146844961|NCT00208325|529600932|FG000|Overall Study|Lost to Follow-up|1|||
146844962|NCT00208325|529600933|FG001|Overall Study|Lost to Follow-up|0|||
146844963|NCT00208325|529600934|FG002|Overall Study|Lost to Follow-up|2|||
146844964|NCT00208325|529600935|FG003|Overall Study|Lost to Follow-up|0|||
146844965|NCT00208325|529600932|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
146844966|NCT00208325|529600933|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
146844967|NCT00208325|529600934|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
146844968|NCT00208325|529600935|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
146844969|NCT00208325|529600932|FG000|Overall Study|Does not wish to Continue in Study|5|||
146844970|NCT00208325|529600933|FG001|Overall Study|Does not wish to Continue in Study|8|||
146844971|NCT00208325|529600934|FG002|Overall Study|Does not wish to Continue in Study|3|||
146844972|NCT00208325|529600935|FG003|Overall Study|Does not wish to Continue in Study|2|||
146844973|NCT00208325|529600932|FG000|Overall Study|Other|2|||
146844974|NCT00208325|529600933|FG001|Overall Study|Other|1|||
146844975|NCT00208325|529600934|FG002|Overall Study|Other|1|||
146844976|NCT00208325|529600935|FG003|Overall Study|Other|0|||
146844977|NCT00208325|529600932|FG000|Overall Study|Mis-Randomized|17|||
146844978|NCT00208325|529600933|FG001|Overall Study|Mis-Randomized|20|||
146844979|NCT00208325|529600934|FG002|Overall Study|Mis-Randomized|0|||
146844980|NCT00208325|529600935|FG003|Overall Study|Mis-Randomized|0|||
146844981|NCT00586612|529600936|FG000|Primary Phase|Protocol Violation|1|||
146844982|NCT00586612|529600937|FG001|Primary Phase|Protocol Violation|0|||
146844983|NCT00586612|529600936|FG000|Primary Phase|Lost to Follow-up|0|||
146844984|NCT00586612|529600937|FG001|Primary Phase|Lost to Follow-up|1|||
146844985|NCT00586612|529600936|FG000|Primary Phase|Withdrawal by Subject|0|||
146844986|NCT00586612|529600937|FG001|Primary Phase|Withdrawal by Subject|2|||
146844987|NCT00586612|529600936|FG000|Booster Phase|Lost to Follow-up|3|||
146844988|NCT00586612|529600937|FG001|Booster Phase|Lost to Follow-up|1|||
146844989|NCT00623805|529600938|FG000|Overall Study|Adverse Event|9|||
146844990|NCT00623805|529600939|FG001|Overall Study|Adverse Event|6|||
146844991|NCT00623805|529600938|FG000|Overall Study|Death|2|||
146844992|NCT00623805|529600939|FG001|Overall Study|Death|0|||
147001153|NCT03570749|530166729|FG004|Overall Study|Lack of Efficacy|8|||
147001154|NCT03570749|530166730|FG005|Overall Study|Lack of Efficacy|2|||
147001155|NCT03570749|530166731|FG006|Overall Study|Lack of Efficacy|7|||
146844993|NCT00623805|529600938|FG000|Overall Study|Lack of Efficacy|3|||
146844994|NCT00623805|529600939|FG001|Overall Study|Lack of Efficacy|7|||
146844995|NCT00623805|529600938|FG000|Overall Study|Lost to Follow-up|2|||
146844996|NCT00623805|529600939|FG001|Overall Study|Lost to Follow-up|2|||
146844997|NCT00623805|529600938|FG000|Overall Study|Protocol Violation|1|||
146844998|NCT00623805|529600939|FG001|Overall Study|Protocol Violation|1|||
147001156|NCT03570749|530166725|FG000|Overall Study|Lost to Follow-up|0|||
147001157|NCT03570749|530166726|FG001|Overall Study|Lost to Follow-up|0|||
147001158|NCT03570749|530166727|FG002|Overall Study|Lost to Follow-up|0|||
147001159|NCT03570749|530166728|FG003|Overall Study|Lost to Follow-up|0|||
147001160|NCT03570749|530166729|FG004|Overall Study|Lost to Follow-up|5|||
147001161|NCT03570749|530166730|FG005|Overall Study|Lost to Follow-up|10|||
147001162|NCT03570749|530166731|FG006|Overall Study|Lost to Follow-up|10|||
147001163|NCT03570749|530166725|FG000|Overall Study|Pregnancy|0|||
146844999|NCT00623805|529600938|FG000|Overall Study|Reason not Specified|3|||
146845000|NCT00623805|529600939|FG001|Overall Study|Reason not Specified|6|||
147001164|NCT03570749|530166726|FG001|Overall Study|Pregnancy|0|||
147001165|NCT03570749|530166727|FG002|Overall Study|Pregnancy|0|||
146845001|NCT03548220|529600944|FG000|Overall Study|Lost to Follow-up|1|||
146845002|NCT03548220|529600945|FG001|Overall Study|Lost to Follow-up|0|||
146845003|NCT03548220|529600946|FG002|Overall Study|Lost to Follow-up|0|||
147001166|NCT03570749|530166728|FG003|Overall Study|Pregnancy|0|||
147001167|NCT03570749|530166729|FG004|Overall Study|Pregnancy|0|||
147001168|NCT03570749|530166730|FG005|Overall Study|Pregnancy|1|||
146845004|NCT03548220|529600947|FG003|Overall Study|Lost to Follow-up|0|||
146845005|NCT02906007|529600948|FG000|Overall Study|Physician Decision|0|||
146845006|NCT02906007|529600949|FG001|Overall Study|Physician Decision|0|||
146845007|NCT02906007|529600950|FG002|Overall Study|Physician Decision|1|||
147001169|NCT03570749|530166731|FG006|Overall Study|Pregnancy|1|||
147001170|NCT03570749|530166725|FG000|Overall Study|Screen Fail|0|||
147001171|NCT03570749|530166726|FG001|Overall Study|Screen Fail|0|||
147001172|NCT03570749|530166727|FG002|Overall Study|Screen Fail|0|||
147001173|NCT03570749|530166728|FG003|Overall Study|Screen Fail|0|||
147001174|NCT03570749|530166729|FG004|Overall Study|Screen Fail|0|||
147001175|NCT03570749|530166730|FG005|Overall Study|Screen Fail|0|||
147001176|NCT03570749|530166731|FG006|Overall Study|Screen Fail|1|||
147001177|NCT03570749|530166725|FG000|Overall Study|Withdrawal by Subject|2|||
147001178|NCT03570749|530166726|FG001|Overall Study|Withdrawal by Subject|3|||
147001179|NCT03570749|530166727|FG002|Overall Study|Withdrawal by Subject|2|||
147001180|NCT03570749|530166728|FG003|Overall Study|Withdrawal by Subject|1|||
147001181|NCT03570749|530166729|FG004|Overall Study|Withdrawal by Subject|17|||
147001182|NCT03570749|530166730|FG005|Overall Study|Withdrawal by Subject|12|||
147001183|NCT03570749|530166731|FG006|Overall Study|Withdrawal by Subject|15|||
147001184|NCT03570749|530166725|FG000|Overall Study|Other|0|||
147001185|NCT03570749|530166726|FG001|Overall Study|Other|0|||
147001186|NCT03570749|530166727|FG002|Overall Study|Other|0|||
147001187|NCT03570749|530166728|FG003|Overall Study|Other|0|||
147001188|NCT03570749|530166729|FG004|Overall Study|Other|17|||
147001189|NCT03570749|530166730|FG005|Overall Study|Other|14|||
147001190|NCT03570749|530166731|FG006|Overall Study|Other|21|||
147001191|NCT00561015|530166732|FG000|Overall Study|Adverse Event|0|||
147001192|NCT00561015|530166733|FG001|Overall Study|Adverse Event|0|||
147001193|NCT00561015|530166734|FG002|Overall Study|Adverse Event|0|||
147001194|NCT00561015|530166735|FG003|Overall Study|Adverse Event|0|||
147001195|NCT00561015|530166736|FG004|Overall Study|Adverse Event|1|||
147001196|NCT00561015|530166737|FG005|Overall Study|Adverse Event|0|||
147001197|NCT00561015|530166732|FG000|Overall Study|Lost to Follow-up|2|||
147001198|NCT00561015|530166733|FG001|Overall Study|Lost to Follow-up|0|||
147001199|NCT00561015|530166734|FG002|Overall Study|Lost to Follow-up|0|||
147001200|NCT00561015|530166735|FG003|Overall Study|Lost to Follow-up|1|||
147001201|NCT00561015|530166736|FG004|Overall Study|Lost to Follow-up|0|||
147001202|NCT00561015|530166737|FG005|Overall Study|Lost to Follow-up|3|||
147001203|NCT00561015|530166732|FG000|Overall Study|Participant non-compliance|2|||
147001204|NCT00561015|530166733|FG001|Overall Study|Participant non-compliance|0|||
147001205|NCT00561015|530166734|FG002|Overall Study|Participant non-compliance|0|||
147001206|NCT00561015|530166735|FG003|Overall Study|Participant non-compliance|0|||
147001207|NCT00561015|530166736|FG004|Overall Study|Participant non-compliance|0|||
147001208|NCT00561015|530166737|FG005|Overall Study|Participant non-compliance|0|||
147001209|NCT03616535|530166738|FG000|Overall Study|Death|2|||
147001210|NCT03616535|530166739|FG001|Overall Study|Death|0|||
147001211|NCT03616535|530166740|FG002|Overall Study|Death|0|||
147001212|NCT03616535|530166741|FG003|Overall Study|Death|1|||
147001213|NCT03616535|530166738|FG000|Overall Study|Lost to Follow-up|2|||
147001214|NCT03616535|530166739|FG001|Overall Study|Lost to Follow-up|1|||
147001215|NCT03616535|530166740|FG002|Overall Study|Lost to Follow-up|0|||
147001216|NCT03616535|530166741|FG003|Overall Study|Lost to Follow-up|2|||
147001217|NCT03616535|530166738|FG000|Overall Study|Withdrawal by Subject|1|||
147001218|NCT03616535|530166739|FG001|Overall Study|Withdrawal by Subject|2|||
147001219|NCT03616535|530166740|FG002|Overall Study|Withdrawal by Subject|5|||
147001220|NCT03616535|530166741|FG003|Overall Study|Withdrawal by Subject|1|||
147001221|NCT03616535|530166738|FG000|Overall Study|Not specified or change in eligibility|2|||
147001222|NCT03616535|530166739|FG001|Overall Study|Not specified or change in eligibility|3|||
147001223|NCT03616535|530166740|FG002|Overall Study|Not specified or change in eligibility|3|||
147001224|NCT03616535|530166741|FG003|Overall Study|Not specified or change in eligibility|1|||
147001225|NCT00804856|530166742|FG000|Overall Study|Progressive Disease|3|||
147001226|NCT00804856|530166743|FG001|Overall Study|Progressive Disease|2|||
147001227|NCT00804856|530166744|FG002|Overall Study|Progressive Disease|4|||
147001228|NCT00804856|530166745|FG003|Overall Study|Progressive Disease|6|||
147001229|NCT00804856|530166746|FG004|Overall Study|Progressive Disease|4|||
147001230|NCT00804856|530166747|FG005|Overall Study|Progressive Disease|1|||
147001231|NCT00804856|530166748|FG006|Overall Study|Progressive Disease|8|||
147001232|NCT00804856|530166749|FG007|Overall Study|Progressive Disease|2|||
147001233|NCT00804856|530166750|FG008|Overall Study|Progressive Disease|4|||
147001234|NCT00804856|530166751|FG009|Overall Study|Progressive Disease|5|||
147001235|NCT00804856|530166752|FG010|Overall Study|Progressive Disease|12|||
147001236|NCT00804856|530166753|FG011|Overall Study|Progressive Disease|2|||
147001237|NCT00804856|530166754|FG012|Overall Study|Progressive Disease|2|||
147001238|NCT00804856|530166755|FG013|Overall Study|Progressive Disease|26|||
147001239|NCT00804856|530166756|FG014|Overall Study|Progressive Disease|20|||
147001240|NCT00804856|530166742|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147001241|NCT00804856|530166743|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147001242|NCT00804856|530166744|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147001243|NCT00804856|530166745|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147001244|NCT00804856|530166746|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
147001245|NCT00804856|530166747|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147001246|NCT00804856|530166748|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147001247|NCT00804856|530166749|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147001248|NCT00804856|530166750|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147001249|NCT00804856|530166751|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147001250|NCT00804856|530166752|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147001251|NCT00804856|530166753|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147001252|NCT00804856|530166754|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147001253|NCT00804856|530166755|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147001254|NCT00804856|530166756|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
147001255|NCT00804856|530166742|FG000|Overall Study|Other Adverse Event|1|||
147001256|NCT00804856|530166743|FG001|Overall Study|Other Adverse Event|1|||
147001257|NCT00804856|530166744|FG002|Overall Study|Other Adverse Event|1|||
147001258|NCT00804856|530166745|FG003|Overall Study|Other Adverse Event|2|||
147001259|NCT00804856|530166746|FG004|Overall Study|Other Adverse Event|2|||
147001260|NCT00804856|530166747|FG005|Overall Study|Other Adverse Event|1|||
147001261|NCT00804856|530166748|FG006|Overall Study|Other Adverse Event|3|||
147001262|NCT00804856|530166749|FG007|Overall Study|Other Adverse Event|0|||
147001263|NCT00804856|530166750|FG008|Overall Study|Other Adverse Event|0|||
147001264|NCT00804856|530166751|FG009|Overall Study|Other Adverse Event|1|||
147001265|NCT00804856|530166752|FG010|Overall Study|Other Adverse Event|5|||
147001266|NCT00804856|530166753|FG011|Overall Study|Other Adverse Event|2|||
147001267|NCT00804856|530166754|FG012|Overall Study|Other Adverse Event|0|||
147001268|NCT00804856|530166755|FG013|Overall Study|Other Adverse Event|6|||
147001269|NCT00804856|530166756|FG014|Overall Study|Other Adverse Event|13|||
147001270|NCT00804856|530166742|FG000|Overall Study|Non compliance with protocol|0|||
147001271|NCT00804856|530166743|FG001|Overall Study|Non compliance with protocol|0|||
147001272|NCT00804856|530166744|FG002|Overall Study|Non compliance with protocol|0|||
147001273|NCT00804856|530166745|FG003|Overall Study|Non compliance with protocol|0|||
147001274|NCT00804856|530166746|FG004|Overall Study|Non compliance with protocol|0|||
147001275|NCT00804856|530166747|FG005|Overall Study|Non compliance with protocol|0|||
147001276|NCT00804856|530166748|FG006|Overall Study|Non compliance with protocol|0|||
147001277|NCT00804856|530166749|FG007|Overall Study|Non compliance with protocol|0|||
147001278|NCT00804856|530166750|FG008|Overall Study|Non compliance with protocol|0|||
147001279|NCT00804856|530166751|FG009|Overall Study|Non compliance with protocol|0|||
147001280|NCT00804856|530166752|FG010|Overall Study|Non compliance with protocol|0|||
147001281|NCT00804856|530166753|FG011|Overall Study|Non compliance with protocol|0|||
147001282|NCT00804856|530166754|FG012|Overall Study|Non compliance with protocol|0|||
147001283|NCT00804856|530166755|FG013|Overall Study|Non compliance with protocol|2|||
147001284|NCT00804856|530166756|FG014|Overall Study|Non compliance with protocol|0|||
147001285|NCT00804856|530166742|FG000|Overall Study|Refused to continue medication|0|||
147001286|NCT00804856|530166743|FG001|Overall Study|Refused to continue medication|0|||
147001287|NCT00804856|530166744|FG002|Overall Study|Refused to continue medication|0|||
147001288|NCT00804856|530166745|FG003|Overall Study|Refused to continue medication|1|||
146845008|NCT02906007|529600948|FG000|Overall Study|Died|1|||
146845009|NCT02906007|529600949|FG001|Overall Study|Died|0|||
146845010|NCT02906007|529600950|FG002|Overall Study|Died|0|||
146845011|NCT03820947|529600957|FG000|Overall Study|Physician Decision|0|||
146845012|NCT03820947|529600958|FG001|Overall Study|Physician Decision|1|||
146845013|NCT03820947|529600959|FG002|Overall Study|Physician Decision|1|||
146845014|NCT03820947|529600960|FG003|Overall Study|Physician Decision|0|||
146845015|NCT03820947|529600961|FG004|Overall Study|Physician Decision|3|||
146845016|NCT03820947|529600957|FG000|Overall Study|Withdrawal by Subject|6|||
146845017|NCT03820947|529600958|FG001|Overall Study|Withdrawal by Subject|10|||
146845018|NCT03820947|529600959|FG002|Overall Study|Withdrawal by Subject|3|||
146845019|NCT03820947|529600960|FG003|Overall Study|Withdrawal by Subject|8|||
146845020|NCT03820947|529600961|FG004|Overall Study|Withdrawal by Subject|5|||
146845021|NCT03820947|529600957|FG000|Overall Study|Procedure Not Attempted|0|||
146845022|NCT03820947|529600958|FG001|Overall Study|Procedure Not Attempted|2|||
146845023|NCT03820947|529600959|FG002|Overall Study|Procedure Not Attempted|1|||
147001289|NCT00804856|530166746|FG004|Overall Study|Refused to continue medication|1|||
147001290|NCT00804856|530166747|FG005|Overall Study|Refused to continue medication|0|||
147001291|NCT00804856|530166748|FG006|Overall Study|Refused to continue medication|0|||
147001292|NCT00804856|530166749|FG007|Overall Study|Refused to continue medication|0|||
147001293|NCT00804856|530166750|FG008|Overall Study|Refused to continue medication|0|||
147001294|NCT00804856|530166751|FG009|Overall Study|Refused to continue medication|0|||
147001295|NCT00804856|530166752|FG010|Overall Study|Refused to continue medication|3|||
147001296|NCT00804856|530166753|FG011|Overall Study|Refused to continue medication|0|||
147001297|NCT00804856|530166754|FG012|Overall Study|Refused to continue medication|1|||
147001298|NCT00804856|530166755|FG013|Overall Study|Refused to continue medication|1|||
147001299|NCT00804856|530166756|FG014|Overall Study|Refused to continue medication|5|||
147001300|NCT00804856|530166742|FG000|Overall Study|Other reason than listed above|0|||
147001301|NCT00804856|530166743|FG001|Overall Study|Other reason than listed above|0|||
147001302|NCT00804856|530166744|FG002|Overall Study|Other reason than listed above|0|||
147001303|NCT00804856|530166745|FG003|Overall Study|Other reason than listed above|0|||
147001304|NCT00804856|530166746|FG004|Overall Study|Other reason than listed above|0|||
147001305|NCT00804856|530166747|FG005|Overall Study|Other reason than listed above|1|||
147001306|NCT00804856|530166748|FG006|Overall Study|Other reason than listed above|0|||
147001307|NCT00804856|530166749|FG007|Overall Study|Other reason than listed above|0|||
147001308|NCT00804856|530166750|FG008|Overall Study|Other reason than listed above|1|||
147001309|NCT00804856|530166751|FG009|Overall Study|Other reason than listed above|0|||
147001310|NCT00804856|530166752|FG010|Overall Study|Other reason than listed above|3|||
147001311|NCT00804856|530166753|FG011|Overall Study|Other reason than listed above|1|||
147001312|NCT00804856|530166754|FG012|Overall Study|Other reason than listed above|1|||
147001313|NCT00804856|530166755|FG013|Overall Study|Other reason than listed above|10|||
147001314|NCT00804856|530166756|FG014|Overall Study|Other reason than listed above|3|||
147001315|NCT00455312|530166757|FG000|Overall Study|Death|0|||
147001316|NCT00455312|530166758|FG001|Overall Study|Death|1|||
147001317|NCT03343535|530166759|FG000|Overall Study|Lost to Follow-up|1|||
147001318|NCT03343535|530166759|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
147001319|NCT03343535|530166759|FG000|Overall Study|Death|12|||
147001320|NCT03868891|530166760|FG000|Overall Study|Adverse Event|1|||
147001321|NCT03868891|530166761|FG001|Overall Study|Adverse Event|0|||
147001322|NCT03868891|530166760|FG000|Overall Study|Lost to Follow-up|2|||
147001323|NCT03868891|530166761|FG001|Overall Study|Lost to Follow-up|1|||
147001324|NCT03868891|530166760|FG000|Overall Study|COVID-19 Restrictions|1|||
147001325|NCT03868891|530166761|FG001|Overall Study|COVID-19 Restrictions|2|||
146736002|NCT05158296|529205268|FG001|Overall Study|Sponsor Decision|3|||
146736003|NCT05158296|529205269|FG002|Overall Study|Sponsor Decision|2|||
146736004|NCT02010632|529205270|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
146736005|NCT02010632|529205271|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
146736006|NCT03324880|529205272|FG000|Overall Study|Adverse Event|0|||
146736007|NCT03324880|529205273|FG001|Overall Study|Adverse Event|2|||
146736008|NCT03324880|529205272|FG000|Overall Study|Withdrawal by Subject|2|||
146736009|NCT03324880|529205273|FG001|Overall Study|Withdrawal by Subject|2|||
146736010|NCT03324880|529205272|FG000|Overall Study|Lost to Follow-up|0|||
146736011|NCT03324880|529205273|FG001|Overall Study|Lost to Follow-up|1|||
147001326|NCT01518972|530166762|FG000|Overall Study|Lost to Follow-up|2|||
147001327|NCT01518972|530166763|FG001|Overall Study|Lost to Follow-up|1|||
147001328|NCT01518972|530166762|FG000|Overall Study|Withdrawal by Subject|1|||
147001329|NCT01518972|530166763|FG001|Overall Study|Withdrawal by Subject|0|||
147001330|NCT01518972|530166762|FG000|Overall Study|Moved from area|1|||
147001331|NCT01518972|530166763|FG001|Overall Study|Moved from area|0|||
147001332|NCT01518972|530166762|FG000|Overall Study|Transportation problems|1|||
147001333|NCT01518972|530166763|FG001|Overall Study|Transportation problems|0|||
147001334|NCT01518972|530166762|FG000|Overall Study|Exclusionary medical condition|1|||
147001335|NCT01518972|530166763|FG001|Overall Study|Exclusionary medical condition|0|||
147001336|NCT01518972|530166762|FG000|Overall Study|Missed safety visits|0|||
147001337|NCT01518972|530166763|FG001|Overall Study|Missed safety visits|1|||
147001338|NCT01518972|530166762|FG000|Overall Study|Exclusionary medication|0|||
147001339|NCT01518972|530166763|FG001|Overall Study|Exclusionary medication|1|||
147001340|NCT01518972|530166762|FG000|Overall Study|Declined medication starting on day 12|0|||
147001341|NCT01518972|530166763|FG001|Overall Study|Declined medication starting on day 12|1|||
147001342|NCT02159950|530166768|FG000|Overall Study|Adverse Event|0|||
147001343|NCT02159950|530166769|FG001|Overall Study|Adverse Event|1|||
147001344|NCT02159950|530166768|FG000|Overall Study|Progression|0|||
147001345|NCT02159950|530166769|FG001|Overall Study|Progression|1|||
147001346|NCT02009163|530166775|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
147001347|NCT02009163|530166776|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
147001348|NCT02009163|530166777|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
147001349|NCT02009163|530166775|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
147001350|NCT02009163|530166776|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
147001351|NCT02009163|530166777|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
147001352|NCT02009163|530166775|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
147001353|NCT02009163|530166776|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
147001354|NCT02009163|530166777|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
147001355|NCT02009163|530166775|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
147001356|NCT02009163|530166776|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
147001357|NCT02009163|530166777|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
147001358|NCT02009163|530166775|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
147001359|NCT02009163|530166776|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
147001360|NCT02009163|530166777|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
147001361|NCT02009163|530166775|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
147001362|NCT02009163|530166776|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
147001363|NCT02009163|530166777|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
147001364|NCT02009163|530166775|FG000|Open-label Period (Non-randomized)|Other|13|||
147001365|NCT02009163|530166776|FG001|Open-label Period (Non-randomized)|Other|0|||
147001366|NCT02009163|530166777|FG002|Open-label Period (Non-randomized)|Other|0|||
147001367|NCT02009163|530166775|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
147001368|NCT02009163|530166776|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
147001369|NCT02009163|530166777|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
147001370|NCT02009163|530166775|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
147001371|NCT02009163|530166776|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
147001372|NCT02009163|530166777|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
147001373|NCT02009163|530166775|FG000|Randomized-withdrawal Period|Adverse Event|0|||
147001374|NCT02009163|530166776|FG001|Randomized-withdrawal Period|Adverse Event|0|||
147001375|NCT02009163|530166777|FG002|Randomized-withdrawal Period|Adverse Event|6|||
147001376|NCT02009163|530166775|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
147001377|NCT02009163|530166776|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
147001378|NCT02009163|530166777|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
147001379|NCT02009163|530166775|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
147001380|NCT02009163|530166776|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
147001381|NCT02009163|530166777|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
147001382|NCT02009163|530166775|FG000|Randomized-withdrawal Period|Pregnancy|0|||
147001383|NCT02009163|530166776|FG001|Randomized-withdrawal Period|Pregnancy|0|||
147001384|NCT02009163|530166777|FG002|Randomized-withdrawal Period|Pregnancy|2|||
147001385|NCT02009163|530166775|FG000|Randomized-withdrawal Period|Other|0|||
147001386|NCT02009163|530166776|FG001|Randomized-withdrawal Period|Other|9|||
147001387|NCT02009163|530166777|FG002|Randomized-withdrawal Period|Other|5|||
147001388|NCT02453386|530166780|FG000|Overall Study|Adverse Event|22|||
147001389|NCT02453386|530166781|FG001|Overall Study|Adverse Event|30|||
147001390|NCT02453386|530166782|FG002|Overall Study|Adverse Event|15|||
147001391|NCT02453386|530166780|FG000|Overall Study|Protocol Violation|1|||
147001392|NCT02453386|530166781|FG001|Overall Study|Protocol Violation|0|||
147001393|NCT02453386|530166782|FG002|Overall Study|Protocol Violation|1|||
147001394|NCT02453386|530166780|FG000|Overall Study|Withdrawal by Subject|10|||
147001395|NCT02453386|530166781|FG001|Overall Study|Withdrawal by Subject|9|||
147001396|NCT02453386|530166782|FG002|Overall Study|Withdrawal by Subject|9|||
147001397|NCT02453386|530166780|FG000|Overall Study|Sponsor Terminated Study|14|||
147001398|NCT02453386|530166781|FG001|Overall Study|Sponsor Terminated Study|8|||
147001399|NCT02453386|530166782|FG002|Overall Study|Sponsor Terminated Study|11|||
147001400|NCT02453386|530166780|FG000|Overall Study|Subject Terminated by Sponsor|1|||
147001401|NCT02453386|530166781|FG001|Overall Study|Subject Terminated by Sponsor|1|||
147001402|NCT02453386|530166782|FG002|Overall Study|Subject Terminated by Sponsor|1|||
147001403|NCT02453386|530166780|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
147001404|NCT02453386|530166781|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
147001405|NCT02453386|530166782|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
147001406|NCT02453386|530166780|FG000|Overall Study|Lost to Follow-up|0|||
147001407|NCT02453386|530166781|FG001|Overall Study|Lost to Follow-up|0|||
147001408|NCT02453386|530166782|FG002|Overall Study|Lost to Follow-up|1|||
147001409|NCT02453386|530166780|FG000|Overall Study|Other|1|||
147001410|NCT02453386|530166781|FG001|Overall Study|Other|0|||
147001411|NCT02453386|530166782|FG002|Overall Study|Other|1|||
147001412|NCT02601625|530166783|FG000|Overall Study|Lost to Follow-up|0|||
147001413|NCT02601625|530166784|FG001|Overall Study|Lost to Follow-up|0|||
147001414|NCT02601625|530166785|FG002|Overall Study|Lost to Follow-up|1|||
147001415|NCT02601625|530166786|FG003|Overall Study|Lost to Follow-up|1|||
147001416|NCT00838279|530166791|FG000|Washout|Protocol Violation|1|||
147001417|NCT00838279|530166792|FG001|Washout|Protocol Violation|0|||
147001418|NCT00838279|530166791|FG000|Washout|Withdrawal by Subject|0|||
147001419|NCT00838279|530166792|FG001|Washout|Withdrawal by Subject|1|||
147001420|NCT01415986|530166793|FG000|Overall Study|Lost to Follow-up|1|||
147001421|NCT03792477|530166796|FG000|Overall Study|Adverse Event|0|||
147001422|NCT03792477|530166797|FG001|Overall Study|Adverse Event|0|||
147001423|NCT03792477|530166798|FG002|Overall Study|Adverse Event|0|||
147001424|NCT03792477|530166799|FG003|Overall Study|Adverse Event|1|||
147001425|NCT03792477|530166800|FG004|Overall Study|Adverse Event|0|||
147001426|NCT03792477|530166796|FG000|Overall Study|Lost to Follow-up|0|||
147001427|NCT03792477|530166797|FG001|Overall Study|Lost to Follow-up|0|||
147001428|NCT03792477|530166798|FG002|Overall Study|Lost to Follow-up|2|||
147001429|NCT03792477|530166799|FG003|Overall Study|Lost to Follow-up|0|||
147001430|NCT03792477|530166800|FG004|Overall Study|Lost to Follow-up|0|||
147001431|NCT03792477|530166796|FG000|Overall Study|Other|0|||
147001432|NCT03792477|530166797|FG001|Overall Study|Other|0|||
147001433|NCT03792477|530166798|FG002|Overall Study|Other|0|||
147001434|NCT03792477|530166799|FG003|Overall Study|Other|0|||
147001435|NCT03792477|530166800|FG004|Overall Study|Other|1|||
147001436|NCT00840411|530166802|FG000|First Intervention|Adverse Event|1|||
147001437|NCT00840411|530166803|FG001|First Intervention|Adverse Event|0|||
147001438|NCT00840411|530166802|FG000|Washout|Withdrawal by Subject|1|||
147001439|NCT00840411|530166803|FG001|Washout|Withdrawal by Subject|0|||
147001440|NCT04419311|530166804|FG000|Overall Study|Lost to Follow-up|1|||
147001441|NCT04419311|530166805|FG001|Overall Study|Lost to Follow-up|0|||
147001442|NCT00465270|530166806|FG000|Overall Study|Death|7|||
147001443|NCT00465270|530166807|FG001|Overall Study|Death|11|||
147001444|NCT00465270|530166806|FG000|Overall Study|Withdrawal by Subject|34|||
147001445|NCT00465270|530166807|FG001|Overall Study|Withdrawal by Subject|78|||
147001446|NCT00465270|530166806|FG000|Overall Study|Lost to Follow-up|60|||
147001447|NCT00465270|530166807|FG001|Overall Study|Lost to Follow-up|67|||
147001448|NCT00465270|530166806|FG000|Overall Study|Investigator request|3|||
147001449|NCT00465270|530166807|FG001|Overall Study|Investigator request|4|||
147001450|NCT03122457|530166808|FG000|Overall Study|Withdrawal by Subject|6|||
147001451|NCT02388191|530166810|FG000|Overall Study|Patient did not receive IUD|1|||
147001452|NCT02388191|530166811|FG001|Overall Study|Patient did not receive IUD|0|||
147001453|NCT01921062|530166812|FG000|Overall Study|Withdrawal by Subject|0|||
147001454|NCT01921062|530166813|FG001|Overall Study|Withdrawal by Subject|7|||
147001455|NCT01921062|530166812|FG000|Overall Study|Adverse Event|5|||
147001456|NCT01921062|530166813|FG001|Overall Study|Adverse Event|6|||
147001457|NCT01921062|530166812|FG000|Overall Study|Protocol Violation|0|||
147001458|NCT01921062|530166813|FG001|Overall Study|Protocol Violation|1|||
147001459|NCT01921062|530166812|FG000|Overall Study|VMIQ score > 72|4|||
147001460|NCT01921062|530166813|FG001|Overall Study|VMIQ score > 72|1|||
147001461|NCT01921062|530166812|FG000|Overall Study|Logistic error|0|||
147001462|NCT01921062|530166813|FG001|Overall Study|Logistic error|1|||
147001463|NCT01911676|530166814|FG000|Period 1 of Study|Withdrawal by Subject|4|||
147001464|NCT01911676|530166815|FG001|Period 1 of Study|Withdrawal by Subject|2|||
147001465|NCT01911676|530166816|FG002|Period 1 of Study|Withdrawal by Subject|1|||
147001466|NCT01911676|530166817|FG003|Period 1 of Study|Withdrawal by Subject|2|||
147001467|NCT01911676|530166814|FG000|Period 1 of Study|Physician Decision|2|||
147001468|NCT01911676|530166815|FG001|Period 1 of Study|Physician Decision|0|||
147001469|NCT01911676|530166816|FG002|Period 1 of Study|Physician Decision|0|||
147001470|NCT01911676|530166817|FG003|Period 1 of Study|Physician Decision|1|||
147001471|NCT01911676|530166814|FG000|Period 2 of Study|Physician Decision|2|||
147001472|NCT01911676|530166815|FG001|Period 2 of Study|Physician Decision|0|||
147001473|NCT01911676|530166816|FG002|Period 2 of Study|Physician Decision|0|||
147001474|NCT01911676|530166817|FG003|Period 2 of Study|Physician Decision|1|||
147001475|NCT01911676|530166814|FG000|Period 2 of Study|Lost to Follow-up|0|||
147001476|NCT01911676|530166815|FG001|Period 2 of Study|Lost to Follow-up|0|||
147001477|NCT01911676|530166816|FG002|Period 2 of Study|Lost to Follow-up|0|||
147001478|NCT01911676|530166817|FG003|Period 2 of Study|Lost to Follow-up|1|||
147001479|NCT00657553|530166820|FG000|Overall Study|low accrual, no analysis run|5|||
147001480|NCT00657553|530166821|FG001|Overall Study|low accrual, no analysis run|5|||
147001481|NCT03173547|530166822|FG000|Overall Study|Adverse Event|2|||
147001482|NCT03173547|530166823|FG001|Overall Study|Adverse Event|0|||
147001483|NCT03173547|530166822|FG000|Overall Study|Withdrawal by Subject|2|||
147001484|NCT03173547|530166823|FG001|Overall Study|Withdrawal by Subject|2|||
147001485|NCT01169558|530166824|FG000|Overall Study|Disease progression|98|||
147001486|NCT01169558|530166824|FG000|Overall Study|Adverse Event|25|||
147001487|NCT01169558|530166824|FG000|Overall Study|Withdrawal of Consent|8|||
147001488|NCT01169558|530166824|FG000|Overall Study|Medical Decision|7|||
147001489|NCT01169558|530166824|FG000|Overall Study|Stable Disease|4|||
147001490|NCT01169558|530166824|FG000|Overall Study|Lost to Follow-up|4|||
147001491|NCT01169558|530166824|FG000|Overall Study|Need for Surgery|4|||
147001492|NCT01169558|530166824|FG000|Overall Study|Non-compliance|2|||
147001493|NCT01169558|530166824|FG000|Overall Study|Protocol Violation|2|||
147001494|NCT01169558|530166824|FG000|Overall Study|Partial response|2|||
147001495|NCT03482882|530166829|FG000|Overall Study|Adverse Event|3|||
147001496|NCT03482882|530166829|FG000|Overall Study|Lost to Follow-up|1|||
147001497|NCT03482882|530166829|FG000|Overall Study|Protocol Violation|2|||
147001498|NCT03482882|530166829|FG000|Overall Study|Not further specified|1|||
147001499|NCT01110005|530166832|FG000|Overall Study|ineligible|1|||
147001500|NCT01110005|530166833|FG001|Overall Study|ineligible|2|||
147001501|NCT01110005|530166832|FG000|Overall Study|missing consent|3|||
147001502|NCT01110005|530166833|FG001|Overall Study|missing consent|2|||
147001503|NCT01110005|530166832|FG000|Overall Study|Withdrawal by Subject|0|||
147001504|NCT01110005|530166833|FG001|Overall Study|Withdrawal by Subject|1|||
147001505|NCT01136174|530166834|FG000|Overall Study|Adverse Event|0|||
147001506|NCT01136174|530166835|FG001|Overall Study|Adverse Event|0|||
147001507|NCT01136174|530166836|FG002|Overall Study|Adverse Event|0|||
146845024|NCT03820947|529600960|FG003|Overall Study|Procedure Not Attempted|0|||
147001508|NCT01136174|530166837|FG003|Overall Study|Adverse Event|4|||
147001509|NCT00819741|530166840|FG000|Overall Study|Adverse Event|5|||
147001510|NCT00819741|530166841|FG001|Overall Study|Adverse Event|2|||
147001511|NCT00819741|530166840|FG000|Overall Study|Lack of Efficacy|0|||
147001512|NCT00819741|530166841|FG001|Overall Study|Lack of Efficacy|2|||
147001513|NCT00819741|530166840|FG000|Overall Study|Lost to Follow-up|3|||
147001514|NCT00819741|530166841|FG001|Overall Study|Lost to Follow-up|1|||
147001515|NCT00819741|530166840|FG000|Overall Study|Protocol Violation|3|||
147001516|NCT00819741|530166841|FG001|Overall Study|Protocol Violation|4|||
147001517|NCT00819741|530166840|FG000|Overall Study|Withdrawal by Subject|2|||
147001518|NCT00819741|530166841|FG001|Overall Study|Withdrawal by Subject|2|||
147001519|NCT00819741|530166840|FG000|Overall Study|Unclassified|6|||
147001520|NCT00819741|530166841|FG001|Overall Study|Unclassified|0|||
147001521|NCT00819741|530166840|FG000|Overall Study|Reasons unknown|3|||
147001522|NCT00819741|530166841|FG001|Overall Study|Reasons unknown|3|||
147001523|NCT00119015|530166842|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
147001524|NCT00119015|530166843|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
147001525|NCT00119015|530166844|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
147001526|NCT05604170|530168447|FG000|Overall Study|Lack of Efficacy|5|||
147001527|NCT05604170|530168447|FG000|Overall Study|Adverse Event|6|||
147001528|NCT05604170|530168447|FG000|Overall Study|Physician Decision|6|||
147001529|NCT05604170|530168447|FG000|Overall Study|Lost to Follow-up|6|||
147001530|NCT05604170|530168447|FG000|Overall Study|Withdrawal by Subject|11|||
147001531|NCT05604170|530168447|FG000|Overall Study|Early study termination by sponsor|77|||
147001532|NCT05604170|530168447|FG000|Overall Study|Other|6|||
147001533|NCT03697109|530168448|FG000|Open-label (OL) Phase|Adverse Event|24|||
147001534|NCT03697109|530168449|FG001|Open-label (OL) Phase|Adverse Event|0|||
147001535|NCT03697109|530168450|FG002|Open-label (OL) Phase|Adverse Event|0|||
147001536|NCT03697109|530168448|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
147001537|NCT03697109|530168449|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
147001538|NCT03697109|530168450|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
147001539|NCT03697109|530168448|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
147001540|NCT03697109|530168449|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
147001541|NCT03697109|530168450|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
147001542|NCT03697109|530168448|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
147001543|NCT03697109|530168449|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
147001544|NCT03697109|530168450|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
147001545|NCT03697109|530168448|FG000|Open-label (OL) Phase|Physician Decision|2|||
147001546|NCT03697109|530168449|FG001|Open-label (OL) Phase|Physician Decision|0|||
147001547|NCT03697109|530168450|FG002|Open-label (OL) Phase|Physician Decision|0|||
147001548|NCT03697109|530168448|FG000|Open-label (OL) Phase|Death|2|||
147001549|NCT03697109|530168449|FG001|Open-label (OL) Phase|Death|0|||
147001550|NCT03697109|530168450|FG002|Open-label (OL) Phase|Death|0|||
147001551|NCT03697109|530168448|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
147001552|NCT03697109|530168449|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
147001553|NCT03697109|530168450|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
147001554|NCT03697109|530168448|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
147001555|NCT03697109|530168449|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
147001556|NCT03697109|530168450|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
147001557|NCT03697109|530168448|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
147001558|NCT03697109|530168449|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
147001559|NCT03697109|530168450|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
147001560|NCT03032172|530168451|FG000|Treatment Period|Adverse Event|0|||
147001561|NCT03032172|530168452|FG001|Treatment Period|Adverse Event|1|||
147001562|NCT03032172|530168453|FG002|Treatment Period|Adverse Event|0|||
147001563|NCT03032172|530168454|FG003|Treatment Period|Adverse Event|0|||
147001564|NCT03032172|530168455|FG004|Treatment Period|Adverse Event|0|||
147001565|NCT03032172|530168456|FG005|Treatment Period|Adverse Event|0|||
147001566|NCT03032172|530168457|FG006|Treatment Period|Adverse Event|0|||
147001567|NCT03032172|530168458|FG007|Treatment Period|Adverse Event|0|||
147001568|NCT03032172|530168451|FG000|Treatment Period|Lack of Efficacy|0|||
147001569|NCT03032172|530168452|FG001|Treatment Period|Lack of Efficacy|1|||
147001570|NCT03032172|530168453|FG002|Treatment Period|Lack of Efficacy|0|||
147001571|NCT03032172|530168454|FG003|Treatment Period|Lack of Efficacy|0|||
147001572|NCT03032172|530168455|FG004|Treatment Period|Lack of Efficacy|0|||
147001573|NCT03032172|530168456|FG005|Treatment Period|Lack of Efficacy|0|||
147001574|NCT03032172|530168457|FG006|Treatment Period|Lack of Efficacy|0|||
147001575|NCT03032172|530168458|FG007|Treatment Period|Lack of Efficacy|0|||
147001576|NCT03032172|530168451|FG000|Treatment Period|Non-compliance With Study Drug|0|||
147001577|NCT03032172|530168452|FG001|Treatment Period|Non-compliance With Study Drug|1|||
147001578|NCT03032172|530168453|FG002|Treatment Period|Non-compliance With Study Drug|0|||
147001579|NCT03032172|530168454|FG003|Treatment Period|Non-compliance With Study Drug|0|||
147001580|NCT03032172|530168455|FG004|Treatment Period|Non-compliance With Study Drug|0|||
147001581|NCT03032172|530168456|FG005|Treatment Period|Non-compliance With Study Drug|0|||
146845025|NCT03820947|529600961|FG004|Overall Study|Procedure Not Attempted|0|||
146845026|NCT03820947|529600957|FG000|Overall Study|Other Exit|1|||
147001582|NCT03032172|530168457|FG006|Treatment Period|Non-compliance With Study Drug|0|||
147001583|NCT03032172|530168458|FG007|Treatment Period|Non-compliance With Study Drug|0|||
147001584|NCT03032172|530168451|FG000|Treatment Period|Reason Not Specified|0|||
147001585|NCT03032172|530168452|FG001|Treatment Period|Reason Not Specified|4|||
147001586|NCT03032172|530168453|FG002|Treatment Period|Reason Not Specified|1|||
147001587|NCT03032172|530168454|FG003|Treatment Period|Reason Not Specified|0|||
147001588|NCT03032172|530168455|FG004|Treatment Period|Reason Not Specified|0|||
147001589|NCT03032172|530168456|FG005|Treatment Period|Reason Not Specified|0|||
147001590|NCT03032172|530168457|FG006|Treatment Period|Reason Not Specified|0|||
147001591|NCT03032172|530168458|FG007|Treatment Period|Reason Not Specified|0|||
147001592|NCT03032172|530168451|FG000|Treatment Period|Physician Decision|0|||
147001593|NCT03032172|530168452|FG001|Treatment Period|Physician Decision|2|||
147001594|NCT03032172|530168453|FG002|Treatment Period|Physician Decision|1|||
147001595|NCT03032172|530168454|FG003|Treatment Period|Physician Decision|0|||
147001596|NCT03032172|530168455|FG004|Treatment Period|Physician Decision|0|||
147001597|NCT03032172|530168456|FG005|Treatment Period|Physician Decision|0|||
147001598|NCT03032172|530168457|FG006|Treatment Period|Physician Decision|0|||
147001599|NCT03032172|530168458|FG007|Treatment Period|Physician Decision|0|||
147001600|NCT03032172|530168451|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
147001601|NCT03032172|530168452|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
147001602|NCT03032172|530168453|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
147001603|NCT03032172|530168454|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
147001604|NCT03032172|530168455|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
146845027|NCT03820947|529600958|FG001|Overall Study|Other Exit|3|||
146845028|NCT03820947|529600959|FG002|Overall Study|Other Exit|3|||
146845029|NCT03820947|529600960|FG003|Overall Study|Other Exit|3|||
146845030|NCT03820947|529600961|FG004|Overall Study|Other Exit|0|||
146845031|NCT03820947|529600957|FG000|Overall Study|Follow-up Not Done|10|||
146845032|NCT03820947|529600958|FG001|Overall Study|Follow-up Not Done|13|||
146845033|NCT03820947|529600959|FG002|Overall Study|Follow-up Not Done|2|||
146845034|NCT03820947|529600960|FG003|Overall Study|Follow-up Not Done|3|||
146845035|NCT03820947|529600961|FG004|Overall Study|Follow-up Not Done|12|||
146845036|NCT03820947|529600957|FG000|Overall Study|Death|0|||
146845037|NCT03820947|529600958|FG001|Overall Study|Death|0|||
146845038|NCT03820947|529600959|FG002|Overall Study|Death|0|||
146845039|NCT03820947|529600960|FG003|Overall Study|Death|0|||
146845040|NCT03820947|529600961|FG004|Overall Study|Death|9|||
146845041|NCT03820947|529600957|FG000|Overall Study|Lost to Follow-up|4|||
146845042|NCT03820947|529600958|FG001|Overall Study|Lost to Follow-up|6|||
146845043|NCT03820947|529600959|FG002|Overall Study|Lost to Follow-up|0|||
146845044|NCT03820947|529600960|FG003|Overall Study|Lost to Follow-up|0|||
146845045|NCT03820947|529600961|FG004|Overall Study|Lost to Follow-up|9|||
146845046|NCT04500769|529602644|FG000|Overall Study|Withdrawal by Subject|5|||
146845047|NCT01967147|529602645|FG000|Overall Study|Adverse Event|5|||
146845048|NCT01967147|529602646|FG001|Overall Study|Adverse Event|2|||
146845049|NCT01967147|529602645|FG000|Overall Study|Lack of Efficacy|1|||
146845050|NCT01967147|529602646|FG001|Overall Study|Lack of Efficacy|4|||
146845051|NCT01967147|529602645|FG000|Overall Study|Lost to Follow-up|1|||
146845052|NCT01967147|529602646|FG001|Overall Study|Lost to Follow-up|2|||
146845053|NCT01967147|529602645|FG000|Overall Study|Withdrawal by Subject|2|||
146845054|NCT01967147|529602646|FG001|Overall Study|Withdrawal by Subject|4|||
146845055|NCT01967147|529602645|FG000|Overall Study|Non-compliance with Study Drug|0|||
146845056|NCT01967147|529602646|FG001|Overall Study|Non-compliance with Study Drug|3|||
146845057|NCT01967147|529602645|FG000|Overall Study|Other|4|||
146845058|NCT01967147|529602646|FG001|Overall Study|Other|5|||
146845059|NCT03843554|529602647|FG000|Overall Study|Physician Decision|0|||
146845060|NCT03843554|529602648|FG001|Overall Study|Physician Decision|2|||
146845061|NCT01099215|529602649|FG000|Overall Study|Withdrawal by Subject|1|||
146845062|NCT01099215|529602650|FG001|Overall Study|Withdrawal by Subject|0|||
146845063|NCT01099215|529602649|FG000|Overall Study|Adverse Event|0|||
146845064|NCT01099215|529602650|FG001|Overall Study|Adverse Event|1|||
146845065|NCT04396366|529602655|FG000|Overall Study|Adverse Event|1|||
146845066|NCT04396366|529602656|FG001|Overall Study|Adverse Event|0|||
146845067|NCT00166712|529602657|FG000|Overall Study|Death|0|||
146845068|NCT00166712|529602658|FG001|Overall Study|Death|1|||
146845069|NCT00166712|529602657|FG000|Overall Study|Adverse Event|1|||
146845070|NCT00166712|529602658|FG001|Overall Study|Adverse Event|0|||
146845071|NCT00166712|529602657|FG000|Overall Study|Withdrawal by Subject|1|||
146845072|NCT00166712|529602658|FG001|Overall Study|Withdrawal by Subject|2|||
146845073|NCT00166712|529602657|FG000|Overall Study|Physician Decision|0|||
146845074|NCT00166712|529602658|FG001|Overall Study|Physician Decision|2|||
146845075|NCT04684394|529602659|FG000|Overall Study|Death|1|||
146845076|NCT04684394|529602660|FG001|Overall Study|Death|2|||
146845077|NCT04684394|529602659|FG000|Overall Study|Lost to Follow-up|1|||
147001605|NCT03032172|530168456|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
147001606|NCT03032172|530168457|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
146845078|NCT04684394|529602660|FG001|Overall Study|Lost to Follow-up|0|||
146845079|NCT04684394|529602659|FG000|Overall Study|Withdrawal by Subject|2|||
146845080|NCT04684394|529602660|FG001|Overall Study|Withdrawal by Subject|0|||
146845081|NCT04684394|529602659|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
146845082|NCT04684394|529602660|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
146845083|NCT03986944|529602661|FG000|Overall Study|Adverse Event|1|||
146845084|NCT03986944|529602662|FG001|Overall Study|Adverse Event|2|||
146845085|NCT03986944|529602663|FG002|Overall Study|Adverse Event|3|||
146845086|NCT03986944|529602661|FG000|Overall Study|Protocol Violation|0|||
146845087|NCT03986944|529602662|FG001|Overall Study|Protocol Violation|1|||
146845088|NCT03986944|529602663|FG002|Overall Study|Protocol Violation|1|||
146845089|NCT03986944|529602661|FG000|Overall Study|Withdrawal by Subject|3|||
146845090|NCT03986944|529602662|FG001|Overall Study|Withdrawal by Subject|5|||
146845091|NCT03986944|529602663|FG002|Overall Study|Withdrawal by Subject|5|||
146845092|NCT03986944|529602661|FG000|Overall Study|Study termination|10|||
146845093|NCT03986944|529602662|FG001|Overall Study|Study termination|10|||
146845094|NCT03986944|529602663|FG002|Overall Study|Study termination|10|||
146845095|NCT03986944|529602661|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
146845096|NCT03986944|529602662|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
146845097|NCT03986944|529602663|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
146845098|NCT03986944|529602661|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
146845099|NCT03986944|529602662|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
146845100|NCT03986944|529602663|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
146845101|NCT03002220|529602665|FG000|Overall Study|Lack of Efficacy|2|||
146845102|NCT03002220|529602665|FG000|Overall Study|Withdrawal by Subject|3|||
147001607|NCT03032172|530168458|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
147001608|NCT03032172|530168451|FG000|Treatment Period|Withdrawal by Subject|2|||
147001609|NCT03032172|530168452|FG001|Treatment Period|Withdrawal by Subject|0|||
147001610|NCT03032172|530168453|FG002|Treatment Period|Withdrawal by Subject|3|||
147001611|NCT03032172|530168454|FG003|Treatment Period|Withdrawal by Subject|0|||
147001612|NCT03032172|530168455|FG004|Treatment Period|Withdrawal by Subject|0|||
147001613|NCT03032172|530168456|FG005|Treatment Period|Withdrawal by Subject|0|||
147001614|NCT03032172|530168457|FG006|Treatment Period|Withdrawal by Subject|0|||
147001615|NCT03032172|530168458|FG007|Treatment Period|Withdrawal by Subject|0|||
147001616|NCT03032172|530168451|FG000|Open-label Extension Period|Death|0|||
147001617|NCT03032172|530168452|FG001|Open-label Extension Period|Death|0|||
147001618|NCT03032172|530168453|FG002|Open-label Extension Period|Death|0|||
147001619|NCT03032172|530168454|FG003|Open-label Extension Period|Death|0|||
147001620|NCT03032172|530168455|FG004|Open-label Extension Period|Death|0|||
147001621|NCT03032172|530168456|FG005|Open-label Extension Period|Death|0|||
147001622|NCT03032172|530168457|FG006|Open-label Extension Period|Death|0|||
147001623|NCT03032172|530168458|FG007|Open-label Extension Period|Death|2|||
147001624|NCT03032172|530168451|FG000|Open-label Extension Period|Reason Not Specified|0|||
147001625|NCT03032172|530168452|FG001|Open-label Extension Period|Reason Not Specified|0|||
147001626|NCT03032172|530168453|FG002|Open-label Extension Period|Reason Not Specified|0|||
147001627|NCT03032172|530168454|FG003|Open-label Extension Period|Reason Not Specified|0|||
147001628|NCT03032172|530168455|FG004|Open-label Extension Period|Reason Not Specified|0|||
147001629|NCT03032172|530168456|FG005|Open-label Extension Period|Reason Not Specified|5|||
147001630|NCT03032172|530168457|FG006|Open-label Extension Period|Reason Not Specified|3|||
147001631|NCT03032172|530168458|FG007|Open-label Extension Period|Reason Not Specified|0|||
147001632|NCT03032172|530168451|FG000|Open-label Extension Period|Pregnancy|0|||
147001633|NCT03032172|530168452|FG001|Open-label Extension Period|Pregnancy|0|||
147001634|NCT03032172|530168453|FG002|Open-label Extension Period|Pregnancy|0|||
147001635|NCT03032172|530168454|FG003|Open-label Extension Period|Pregnancy|0|||
147001636|NCT03032172|530168455|FG004|Open-label Extension Period|Pregnancy|0|||
147001637|NCT03032172|530168456|FG005|Open-label Extension Period|Pregnancy|0|||
147001638|NCT03032172|530168457|FG006|Open-label Extension Period|Pregnancy|1|||
147001639|NCT03032172|530168458|FG007|Open-label Extension Period|Pregnancy|0|||
147001640|NCT03032172|530168451|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
147001641|NCT03032172|530168452|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
147001642|NCT03032172|530168453|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
147001643|NCT03032172|530168454|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
147001644|NCT03032172|530168455|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
147001645|NCT03032172|530168456|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
147001646|NCT03032172|530168457|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
147001647|NCT03032172|530168458|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
147001648|NCT06284525|530168459|FG000|Overall Study|Withdrawal by Subject|1|||
146845103|NCT03002220|529602665|FG000|Overall Study|Adverse Event|2|||
146845104|NCT03002220|529602665|FG000|Overall Study|Disease progression|13|||
147001649|NCT02545283|530168462|FG000|Overall Study|Lost to Follow-up|2|||
147001650|NCT02545283|530168463|FG001|Overall Study|Lost to Follow-up|4|||
146845105|NCT03002220|529602665|FG000|Overall Study|Physician Decision|1|||
146845106|NCT01183260|529602667|FG000|Overall Study|Intraop screen failure|2|||
146845107|NCT01183260|529602668|FG001|Overall Study|Intraop screen failure|0|||
146845108|NCT01183260|529602667|FG000|Overall Study|Withdrawal by Subject|1|||
147001651|NCT02545283|530168462|FG000|Overall Study|Withdrawal by Subject|5|||
147001652|NCT02545283|530168463|FG001|Overall Study|Withdrawal by Subject|9|||
147001653|NCT02545283|530168462|FG000|Overall Study|Death|109|||
146845109|NCT01183260|529602668|FG001|Overall Study|Withdrawal by Subject|1|||
147001654|NCT02545283|530168463|FG001|Overall Study|Death|211|||
147001655|NCT02545283|530168462|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
147001656|NCT02545283|530168463|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
147001657|NCT02545283|530168462|FG000|Overall Study|Study Terminated By Sponsor|33|||
147001658|NCT02545283|530168463|FG001|Overall Study|Study Terminated By Sponsor|71|||
147001659|NCT02436005|530168464|FG000|Second Intervention|Adverse Event|0|||
147001660|NCT02436005|530168465|FG001|Second Intervention|Adverse Event|1|||
147001661|NCT00583453|530168466|FG000|Overall Study|discontinued intervention|0|||
147001662|NCT00583453|530168467|FG001|Overall Study|discontinued intervention|2|||
147001663|NCT00905606|530168468|FG000|Period 1|Adverse Event|0|||
147001664|NCT00905606|530168469|FG001|Period 1|Adverse Event|1|||
147001665|NCT00905606|530168468|FG000|Washout|Withdrawal by Subject|1|||
147001666|NCT00905606|530168469|FG001|Washout|Withdrawal by Subject|0|||
147001667|NCT03635320|530168470|FG000|Overall Study|not implanted the device|1|||
147001668|NCT03635320|530168471|FG001|Overall Study|not implanted the device|2|||
147001669|NCT03635320|530168470|FG000|Overall Study|Withdrawal by Subject|11|||
147001670|NCT03635320|530168471|FG001|Overall Study|Withdrawal by Subject|6|||
147001671|NCT01558635|530168475|FG000|Overall Study|Death|1|||
147001672|NCT01558635|530168475|FG000|Overall Study|Withdrawal by Subject|2|||
147001673|NCT01558635|530168475|FG000|Overall Study|Physician Decision|1|||
147001674|NCT01558635|530168475|FG000|Overall Study|Subject received other treatment|1|||
147001675|NCT01558635|530168475|FG000|Overall Study|Reveal XT was explanted|1|||
147001676|NCT01158118|530168476|FG000|Overall Study|Screen failure|1|||
147001677|NCT01158118|530168477|FG001|Overall Study|Screen failure|0|||
147001678|NCT01158118|530168476|FG000|Overall Study|Donor match was a screen failure|0|||
147001679|NCT01158118|530168477|FG001|Overall Study|Donor match was a screen failure|1|||
147001680|NCT01158118|530168476|FG000|Overall Study|Suffered stroke prior to transplant|0|||
147001681|NCT01158118|530168477|FG001|Overall Study|Suffered stroke prior to transplant|1|||
147001682|NCT01158118|530168476|FG000|Overall Study|Death|0|||
147001683|NCT01158118|530168477|FG001|Overall Study|Death|1|||
147001684|NCT04994535|530168478|FG000|Overall Study|Lost to Follow-up|7|||
147001685|NCT04994535|530168479|FG001|Overall Study|Lost to Follow-up|7|||
147001686|NCT04994535|530168478|FG000|Overall Study|Withdrawal by Subject|10|||
147001687|NCT04994535|530168479|FG001|Overall Study|Withdrawal by Subject|7|||
147001688|NCT04994535|530168478|FG000|Overall Study|Other|1|||
147001689|NCT04994535|530168479|FG001|Overall Study|Other|1|||
147001690|NCT00905840|530168482|FG000|Overall Study|Lost to Follow-up|11|||
147001691|NCT00905840|530168482|FG000|Overall Study|Death|3|||
147001692|NCT00905840|530168482|FG000|Overall Study|Withdrawal by Subject|1|||
147001693|NCT00905840|530168482|FG000|Overall Study|Adverse Event|1|||
147001694|NCT01667679|530168488|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
147001695|NCT01667679|530168489|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
147001696|NCT01667679|530168488|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
147001697|NCT01667679|530168489|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
147001698|NCT01667679|530168488|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
147001699|NCT01667679|530168489|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
147001700|NCT01667679|530168488|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
147001701|NCT01667679|530168489|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
147001702|NCT01667679|530168488|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
147001703|NCT01667679|530168489|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
147001704|NCT01667679|530168488|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
147001705|NCT01667679|530168489|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
147001706|NCT01667679|530168488|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
147001707|NCT01667679|530168489|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
147001708|NCT01667679|530168488|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
147001709|NCT01667679|530168489|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
147001710|NCT01667679|530168488|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
147001711|NCT01667679|530168489|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
147001712|NCT01667679|530168488|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
147001713|NCT01667679|530168489|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
147001714|NCT01667679|530168488|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
147001715|NCT01667679|530168489|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
147001716|NCT01667679|530168488|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
147001717|NCT01667679|530168489|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
147001718|NCT01667679|530168488|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
147001719|NCT01667679|530168489|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
147001720|NCT01667679|530168488|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
147001721|NCT01667679|530168489|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
147001722|NCT01667679|530168488|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
147001723|NCT01667679|530168489|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
147001724|NCT01667679|530168488|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
147001725|NCT01667679|530168489|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
147001726|NCT01667679|530168488|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
147001727|NCT01667679|530168489|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
147001728|NCT01667679|530168488|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
147001729|NCT01667679|530168489|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
147001730|NCT01667679|530168488|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
147001731|NCT01667679|530168489|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
147001732|NCT01667679|530168488|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
147001733|NCT01667679|530168489|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
147001734|NCT01667679|530168488|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
147001735|NCT01667679|530168489|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
147001736|NCT03872128|530168496|FG000|Overall Study|Dropped out before treatment|1|||
147001737|NCT03872128|530168497|FG001|Overall Study|Dropped out before treatment|0|||
147001738|NCT03872128|530168498|FG002|Overall Study|Dropped out before treatment|4|||
147001739|NCT03872128|530168496|FG000|Overall Study|Lost to Follow-up|2|||
147001740|NCT03872128|530168497|FG001|Overall Study|Lost to Follow-up|5|||
147001741|NCT03872128|530168498|FG002|Overall Study|Lost to Follow-up|8|||
147001742|NCT03419403|530168504|FG000|Overall Study|Withdrawal by Subject|5|||
147001743|NCT03419403|530168505|FG001|Overall Study|Withdrawal by Subject|2|||
147001744|NCT03419403|530168506|FG002|Overall Study|Withdrawal by Subject|5|||
147001745|NCT03419403|530168507|FG003|Overall Study|Withdrawal by Subject|1|||
147001746|NCT03419403|530168504|FG000|Overall Study|Progressive disease (per protocol)|0|||
147001747|NCT03419403|530168505|FG001|Overall Study|Progressive disease (per protocol)|2|||
147001748|NCT03419403|530168506|FG002|Overall Study|Progressive disease (per protocol)|2|||
147001749|NCT03419403|530168507|FG003|Overall Study|Progressive disease (per protocol)|0|||
147001750|NCT03419403|530168504|FG000|Overall Study|Other, not specified|6|||
147001751|NCT03419403|530168505|FG001|Overall Study|Other, not specified|4|||
147001752|NCT03419403|530168506|FG002|Overall Study|Other, not specified|5|||
147001753|NCT03419403|530168507|FG003|Overall Study|Other, not specified|1|||
147001754|NCT03419403|530168504|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
147001755|NCT03419403|530168505|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
147001756|NCT03419403|530168506|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
147001757|NCT03419403|530168507|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
147001758|NCT03552393|530168510|FG000|Core Period|Kidney Transplant|1|||
147001759|NCT03552393|530168510|FG000|Core Period|Prohibited Medication|1|||
147001760|NCT03552393|530168510|FG000|Safety Extension Period|Kidney Transplant|4|||
147001761|NCT01289262|530168512|FG000|Overall Study|Lost to Follow-up|29|||
147001762|NCT01289262|530168513|FG001|Overall Study|Lost to Follow-up|16|||
147001763|NCT01289262|530168512|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
147001764|NCT01289262|530168513|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
147001765|NCT04887415|530168514|FG000|Overall Study|Lost to Follow-up|2|||
147001766|NCT04608188|530168515|FG000|Overall Study|Withdrawal by Subject|4|||
147001767|NCT04608188|530168516|FG001|Overall Study|Withdrawal by Subject|8|||
147001768|NCT01250912|530168520|FG000|Overall Study|Lost to Follow-up|1|||
147001769|NCT05646251|530168523|FG000|Overall Study|Physician Decision|1|||
147001770|NCT05646251|530168524|FG001|Overall Study|Physician Decision|0|||
147001771|NCT05646251|530168525|FG002|Overall Study|Physician Decision|2|||
147001772|NCT01218867|530168526|FG000|Overall Study|Death during treatment|0|||
147001773|NCT01218867|530168527|FG001|Overall Study|Death during treatment|0|||
147001774|NCT01218867|530168528|FG002|Overall Study|Death during treatment|0|||
147001775|NCT01218867|530168529|FG003|Overall Study|Death during treatment|0|||
147001776|NCT01218867|530168530|FG004|Overall Study|Death during treatment|0|||
147001777|NCT01218867|530168531|FG005|Overall Study|Death during treatment|0|||
147001778|NCT01218867|530168532|FG006|Overall Study|Death during treatment|1|||
147001779|NCT01218867|530168533|FG007|Overall Study|Death during treatment|0|||
147001780|NCT01218867|530168534|FG008|Overall Study|Death during treatment|0|||
147001781|NCT01218867|530168535|FG009|Overall Study|Death during treatment|0|||
147001782|NCT01218867|530168536|FG010|Overall Study|Death during treatment|0|||
147001783|NCT03233724|530168540|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
147001784|NCT03233724|530168541|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
147001785|NCT03233724|530168542|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
147001786|NCT03233724|530168543|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
147001787|NCT03233724|530168544|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
147001788|NCT03233724|530168540|FG000|Phase I Dose Escalation|Best interest of participant|1|||
147001789|NCT03233724|530168541|FG001|Phase I Dose Escalation|Best interest of participant|1|||
147001790|NCT03233724|530168542|FG002|Phase I Dose Escalation|Best interest of participant|1|||
147001791|NCT03233724|530168543|FG003|Phase I Dose Escalation|Best interest of participant|0|||
147001792|NCT03233724|530168544|FG004|Phase I Dose Escalation|Best interest of participant|0|||
147001793|NCT03233724|530168540|FG000|Phase I Dose Escalation|Physician Decision|0|||
147001794|NCT03233724|530168541|FG001|Phase I Dose Escalation|Physician Decision|0|||
147001795|NCT03233724|530168542|FG002|Phase I Dose Escalation|Physician Decision|1|||
147001796|NCT03233724|530168543|FG003|Phase I Dose Escalation|Physician Decision|0|||
147001797|NCT03233724|530168544|FG004|Phase I Dose Escalation|Physician Decision|0|||
147001798|NCT03233724|530168540|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
147001799|NCT03233724|530168541|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
147001800|NCT03233724|530168542|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
147001801|NCT03233724|530168543|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
147001802|NCT03233724|530168544|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
147001803|NCT00651820|530168547|FG000|Overall Study|Lost to Follow-up|2|||
147001804|NCT00773253|530168548|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
147001805|NCT00773253|530168549|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
147001806|NCT01566721|530168550|FG000|Treatment Period|Withdrawal by Subject|35|||
147001807|NCT01566721|530168551|FG001|Treatment Period|Withdrawal by Subject|9|||
147001808|NCT01566721|530168550|FG000|Treatment Period|Disease Progression/Recurrence|37|||
147001809|NCT01566721|530168551|FG001|Treatment Period|Disease Progression/Recurrence|13|||
147001810|NCT01566721|530168550|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
147001811|NCT01566721|530168551|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
147001812|NCT01566721|530168550|FG000|Treatment Period|Other|13|||
147001813|NCT01566721|530168551|FG001|Treatment Period|Other|2|||
147001814|NCT01566721|530168550|FG000|Treatment Period|Lack of Compliance|5|||
147001815|NCT01566721|530168551|FG001|Treatment Period|Lack of Compliance|1|||
147001816|NCT01566721|530168550|FG000|Treatment Period|Adverse Event|100|||
147001817|NCT01566721|530168551|FG001|Treatment Period|Adverse Event|30|||
147001818|NCT01566721|530168550|FG000|Treatment Period|Pregnancy|1|||
147001819|NCT01566721|530168551|FG001|Treatment Period|Pregnancy|0|||
147001820|NCT01566721|530168550|FG000|Safety Follow-up|Physician Decision|6|||
147001821|NCT01566721|530168551|FG001|Safety Follow-up|Physician Decision|4|||
147001822|NCT01566721|530168550|FG000|Safety Follow-up|Lost to Follow-up|101|||
147001823|NCT01566721|530168551|FG001|Safety Follow-up|Lost to Follow-up|48|||
147001824|NCT01566721|530168550|FG000|Safety Follow-up|Withdrawal by Subject|155|||
147001825|NCT01566721|530168551|FG001|Safety Follow-up|Withdrawal by Subject|49|||
147001826|NCT01566721|530168550|FG000|Safety Follow-up|Death|28|||
147001827|NCT01566721|530168551|FG001|Safety Follow-up|Death|4|||
147001828|NCT01566721|530168550|FG000|Safety Follow-up|Non-compliance|7|||
147001829|NCT01566721|530168551|FG001|Safety Follow-up|Non-compliance|3|||
147001830|NCT01566721|530168550|FG000|Safety Follow-up|Protocol Violation|7|||
147001831|NCT01566721|530168551|FG001|Safety Follow-up|Protocol Violation|0|||
147001832|NCT01566721|530168550|FG000|Safety Follow-up|Site closure|2|||
147001833|NCT01566721|530168551|FG001|Safety Follow-up|Site closure|3|||
147001834|NCT01566721|530168550|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
147001835|NCT01566721|530168551|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
147001836|NCT01566721|530168550|FG000|Safety Follow-up|Missing|7|||
147001837|NCT01566721|530168551|FG001|Safety Follow-up|Missing|2|||
147001838|NCT01566721|530168550|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
147001839|NCT01566721|530168551|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
147001840|NCT01566721|530168550|FG000|Safety Follow-up|Sponsor decision|1|||
147001841|NCT01566721|530168551|FG001|Safety Follow-up|Sponsor decision|0|||
147001842|NCT01566721|530168550|FG000|Safety Follow-up|Adverse Event|8|||
147001843|NCT01566721|530168551|FG001|Safety Follow-up|Adverse Event|4|||
147001844|NCT00446563|530168552|FG000|Overall Study|Adverse Event|4|||
147001845|NCT00446563|530168553|FG001|Overall Study|Adverse Event|3|||
147001846|NCT00446563|530168552|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147001847|NCT00446563|530168553|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147001848|NCT00446563|530168552|FG000|Overall Study|Abnormal test procedure result(s)|1|||
147001849|NCT00446563|530168553|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147001850|NCT00446563|530168552|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147001851|NCT00446563|530168553|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
147001852|NCT00446563|530168552|FG000|Overall Study|Withdrawal by Subject|2|||
147001853|NCT00446563|530168553|FG001|Overall Study|Withdrawal by Subject|1|||
147001854|NCT00446563|530168552|FG000|Overall Study|Administrative problems|0|||
147001855|NCT00446563|530168553|FG001|Overall Study|Administrative problems|1|||
147001856|NCT02911701|530168554|FG000|Overall Study|Withdrawal by Subject|2|||
147001857|NCT02911701|530168555|FG001|Overall Study|Withdrawal by Subject|4|||
147001858|NCT02911701|530168554|FG000|Overall Study|Adverse Event|1|||
147001859|NCT02911701|530168555|FG001|Overall Study|Adverse Event|0|||
147001860|NCT01302548|530168556|FG000|Overall Study|Lost to Follow-up|2|||
147001861|NCT01302548|530168557|FG001|Overall Study|Lost to Follow-up|1|||
147001862|NCT02409355|530168560|FG000|Overall Study|Withdrawal by Subject|1|||
147001863|NCT02409355|530168561|FG001|Overall Study|Withdrawal by Subject|0|||
147001864|NCT02409355|530168560|FG000|Overall Study|Death|1|||
147001865|NCT02409355|530168561|FG001|Overall Study|Death|1|||
147001866|NCT02409355|530168560|FG000|Overall Study|Study terminated by Sponsor|2|||
147001867|NCT02409355|530168561|FG001|Overall Study|Study terminated by Sponsor|3|||
147001868|NCT02605928|530168562|FG000|Overall Study|Model tuning phase|28|||
147001869|NCT02605928|530168562|FG000|Overall Study|Lack of Efficacy|5|||
146736012|NCT03324880|529205272|FG000|Overall Study|Product Recall|0|||
147001870|NCT02530905|530168565|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
147001871|NCT02530905|530168566|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
147001872|NCT02530905|530168567|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
147001873|NCT01231906|530168569|FG000|Overall Study|Lack of Efficacy|75|||
147001874|NCT01231906|530168570|FG001|Overall Study|Lack of Efficacy|68|||
147001875|NCT01231906|530168569|FG000|Overall Study|Lost to Follow-up|1|||
147001876|NCT01231906|530168570|FG001|Overall Study|Lost to Follow-up|0|||
147001877|NCT01231906|530168569|FG000|Overall Study|Physician Decision|34|||
147001878|NCT01231906|530168570|FG001|Overall Study|Physician Decision|24|||
147001879|NCT01231906|530168569|FG000|Overall Study|Withdrawal by Subject|0|||
147001880|NCT01231906|530168570|FG001|Overall Study|Withdrawal by Subject|4|||
147001881|NCT01231906|530168569|FG000|Overall Study|Ineligible|10|||
147001882|NCT01231906|530168570|FG001|Overall Study|Ineligible|3|||
147001883|NCT01231906|530168569|FG000|Overall Study|No treatment|1|||
147001884|NCT01231906|530168570|FG001|Overall Study|No treatment|2|||
147001885|NCT04646213|530168571|FG000|Overall Study|Physician Decision|3|||
147001886|NCT04646213|530168571|FG000|Overall Study|Withdrawal by Subject|2|||
147001887|NCT02441309|530168574|FG000|Overall Study|Disease progression|2|||
147001888|NCT02441309|530168575|FG001|Overall Study|Disease progression|1|||
147001889|NCT02441309|530168576|FG002|Overall Study|Disease progression|2|||
147001890|NCT02441309|530168574|FG000|Overall Study|Adverse Event|0|||
147001891|NCT02441309|530168575|FG001|Overall Study|Adverse Event|1|||
147001892|NCT02441309|530168576|FG002|Overall Study|Adverse Event|0|||
147001893|NCT02441309|530168574|FG000|Overall Study|Withdrawal by Subject|1|||
147001894|NCT02441309|530168575|FG001|Overall Study|Withdrawal by Subject|0|||
147001895|NCT02441309|530168576|FG002|Overall Study|Withdrawal by Subject|1|||
147001896|NCT00415363|530168577|FG000|Overall Study|Withdrawal by Subject|4|||
147001897|NCT00415363|530168578|FG001|Overall Study|Withdrawal by Subject|4|||
147001898|NCT00415363|530168577|FG000|Overall Study|Adverse Event|4|||
147001899|NCT00415363|530168578|FG001|Overall Study|Adverse Event|4|||
147001900|NCT00415363|530168577|FG000|Overall Study|Lost to Follow-up|2|||
147001901|NCT00415363|530168578|FG001|Overall Study|Lost to Follow-up|1|||
147001902|NCT00415363|530168577|FG000|Overall Study|Physician Decision|3|||
147001903|NCT00415363|530168578|FG001|Overall Study|Physician Decision|1|||
147001904|NCT00415363|530168577|FG000|Overall Study|Death|16|||
147001905|NCT00415363|530168578|FG001|Overall Study|Death|12|||
147001906|NCT00415363|530168577|FG000|Overall Study|Progressive disease|26|||
147001907|NCT00415363|530168578|FG001|Overall Study|Progressive disease|32|||
147001908|NCT02658084|530168583|FG000|Overall Study|Withdrawal by Subject|1|||
147001909|NCT02658084|530168584|FG001|Overall Study|Withdrawal by Subject|0|||
147001910|NCT02658084|530168583|FG000|Overall Study|Study Termination|1|||
147001911|NCT02658084|530168584|FG001|Overall Study|Study Termination|0|||
147001912|NCT03290781|530168586|FG000|Overall Study|Adverse Event|5|||
147001913|NCT03290781|530168587|FG001|Overall Study|Adverse Event|7|||
147001914|NCT03290781|530168588|FG002|Overall Study|Adverse Event|4|||
147001915|NCT03290781|530168589|FG003|Overall Study|Adverse Event|1|||
147001916|NCT03290781|530168590|FG004|Overall Study|Adverse Event|0|||
147001917|NCT03290781|530168591|FG005|Overall Study|Adverse Event|0|||
147001918|NCT03290781|530168592|FG006|Overall Study|Adverse Event|0|||
147001919|NCT03290781|530168586|FG000|Overall Study|Death|0|||
147001920|NCT03290781|530168587|FG001|Overall Study|Death|0|||
147001921|NCT03290781|530168588|FG002|Overall Study|Death|1|||
147001922|NCT03290781|530168589|FG003|Overall Study|Death|0|||
147001923|NCT03290781|530168590|FG004|Overall Study|Death|1|||
147001924|NCT03290781|530168591|FG005|Overall Study|Death|0|||
147001925|NCT03290781|530168592|FG006|Overall Study|Death|0|||
147001926|NCT03290781|530168586|FG000|Overall Study|Withdrawal by Subject|6|||
147001927|NCT03290781|530168587|FG001|Overall Study|Withdrawal by Subject|5|||
147001928|NCT03290781|530168588|FG002|Overall Study|Withdrawal by Subject|9|||
147001929|NCT03290781|530168589|FG003|Overall Study|Withdrawal by Subject|10|||
147001930|NCT03290781|530168590|FG004|Overall Study|Withdrawal by Subject|1|||
147001931|NCT03290781|530168591|FG005|Overall Study|Withdrawal by Subject|2|||
147001932|NCT03290781|530168592|FG006|Overall Study|Withdrawal by Subject|0|||
147001933|NCT03290781|530168586|FG000|Overall Study|Physician Decision|0|||
147001934|NCT03290781|530168587|FG001|Overall Study|Physician Decision|1|||
146845110|NCT01183260|529602667|FG000|Overall Study|Revised within 30 days|0|||
146845111|NCT01183260|529602668|FG001|Overall Study|Revised within 30 days|1|||
147001935|NCT03290781|530168588|FG002|Overall Study|Physician Decision|0|||
147001936|NCT03290781|530168589|FG003|Overall Study|Physician Decision|0|||
147001937|NCT03290781|530168590|FG004|Overall Study|Physician Decision|0|||
147001938|NCT03290781|530168591|FG005|Overall Study|Physician Decision|0|||
147001939|NCT03290781|530168592|FG006|Overall Study|Physician Decision|0|||
147001940|NCT03290781|530168586|FG000|Overall Study|Site Terminated by Sponsor|1|||
147001941|NCT03290781|530168587|FG001|Overall Study|Site Terminated by Sponsor|0|||
147001942|NCT03290781|530168588|FG002|Overall Study|Site Terminated by Sponsor|2|||
147001943|NCT03290781|530168589|FG003|Overall Study|Site Terminated by Sponsor|1|||
147001944|NCT03290781|530168590|FG004|Overall Study|Site Terminated by Sponsor|0|||
147001945|NCT03290781|530168591|FG005|Overall Study|Site Terminated by Sponsor|0|||
147001946|NCT03290781|530168592|FG006|Overall Study|Site Terminated by Sponsor|0|||
147001947|NCT03290781|530168586|FG000|Overall Study|Lost to Follow-up|0|||
147001948|NCT03290781|530168587|FG001|Overall Study|Lost to Follow-up|0|||
147001949|NCT03290781|530168588|FG002|Overall Study|Lost to Follow-up|0|||
147001950|NCT03290781|530168589|FG003|Overall Study|Lost to Follow-up|1|||
147001951|NCT03290781|530168590|FG004|Overall Study|Lost to Follow-up|0|||
147001952|NCT03290781|530168591|FG005|Overall Study|Lost to Follow-up|0|||
147001953|NCT03290781|530168592|FG006|Overall Study|Lost to Follow-up|0|||
147001954|NCT03290781|530168586|FG000|Overall Study|Protocol Deviation|2|||
147001955|NCT03290781|530168587|FG001|Overall Study|Protocol Deviation|0|||
147001956|NCT03290781|530168588|FG002|Overall Study|Protocol Deviation|0|||
147001957|NCT03290781|530168589|FG003|Overall Study|Protocol Deviation|1|||
147001958|NCT03290781|530168590|FG004|Overall Study|Protocol Deviation|0|||
147001959|NCT03290781|530168591|FG005|Overall Study|Protocol Deviation|0|||
147001960|NCT03290781|530168592|FG006|Overall Study|Protocol Deviation|0|||
147001961|NCT03290781|530168586|FG000|Overall Study|Disease Relapse|32|||
147001962|NCT03290781|530168587|FG001|Overall Study|Disease Relapse|5|||
147001963|NCT03290781|530168588|FG002|Overall Study|Disease Relapse|38|||
147001964|NCT03290781|530168589|FG003|Overall Study|Disease Relapse|7|||
147001965|NCT03290781|530168590|FG004|Overall Study|Disease Relapse|3|||
147001966|NCT03290781|530168591|FG005|Overall Study|Disease Relapse|1|||
147001967|NCT03290781|530168592|FG006|Overall Study|Disease Relapse|4|||
147001968|NCT03290781|530168586|FG000|Overall Study|Other|3|||
147001969|NCT03290781|530168587|FG001|Overall Study|Other|0|||
147001970|NCT03290781|530168588|FG002|Overall Study|Other|2|||
147001971|NCT03290781|530168589|FG003|Overall Study|Other|2|||
147001972|NCT03290781|530168590|FG004|Overall Study|Other|0|||
147001973|NCT03290781|530168591|FG005|Overall Study|Other|0|||
147001974|NCT03290781|530168592|FG006|Overall Study|Other|0|||
147001975|NCT01588236|530168601|FG000|Overall Study|Adverse Event|5|||
147001976|NCT01588236|530168602|FG001|Overall Study|Adverse Event|4|||
147001977|NCT01588236|530168603|FG002|Overall Study|Adverse Event|1|||
147001978|NCT01588236|530168601|FG000|Overall Study|Lost to Follow-up|8|||
147001979|NCT01588236|530168602|FG001|Overall Study|Lost to Follow-up|13|||
147001980|NCT01588236|530168603|FG002|Overall Study|Lost to Follow-up|6|||
147001981|NCT01588236|530168601|FG000|Overall Study|Physician Decision|1|||
147001982|NCT01588236|530168602|FG001|Overall Study|Physician Decision|2|||
147001983|NCT01588236|530168603|FG002|Overall Study|Physician Decision|0|||
147001984|NCT01588236|530168601|FG000|Overall Study|Protocol Violation|0|||
147001985|NCT01588236|530168602|FG001|Overall Study|Protocol Violation|1|||
147001986|NCT01588236|530168603|FG002|Overall Study|Protocol Violation|1|||
147001987|NCT01588236|530168601|FG000|Overall Study|Withdrawal by Subject|14|||
147001988|NCT01588236|530168602|FG001|Overall Study|Withdrawal by Subject|16|||
147001989|NCT01588236|530168603|FG002|Overall Study|Withdrawal by Subject|18|||
147001990|NCT01588236|530168601|FG000|Overall Study|Exclusion Criteria met during study|2|||
147001991|NCT01588236|530168602|FG001|Overall Study|Exclusion Criteria met during study|1|||
147001992|NCT01588236|530168603|FG002|Overall Study|Exclusion Criteria met during study|0|||
147001993|NCT01588236|530168601|FG000|Overall Study|sponsor decision|1|||
147001994|NCT01588236|530168602|FG001|Overall Study|sponsor decision|6|||
147001995|NCT01588236|530168603|FG002|Overall Study|sponsor decision|2|||
147001996|NCT04115293|530170083|FG000|Overall Study|Adverse Event|0|||
147001997|NCT04115293|530170084|FG001|Overall Study|Adverse Event|2|||
147001998|NCT04115293|530170083|FG000|Overall Study|Withdrawal by Subject|2|||
147001999|NCT04115293|530170084|FG001|Overall Study|Withdrawal by Subject|1|||
147002000|NCT04115293|530170083|FG000|Overall Study|Physician Decision|1|||
147002001|NCT04115293|530170084|FG001|Overall Study|Physician Decision|0|||
147002002|NCT04115293|530170083|FG000|Overall Study|Death|1|||
147002003|NCT04115293|530170084|FG001|Overall Study|Death|1|||
147002004|NCT02571907|530170085|FG000|Overall Study|Death|4|||
147002005|NCT02571907|530170085|FG000|Overall Study|Lost to Follow-up|3|||
147002006|NCT02571907|530170085|FG000|Overall Study|Withdrawal by Subject|3|||
147002007|NCT02286739|530170086|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
147002008|NCT02286739|530170087|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
147002009|NCT02286739|530170086|FG000|Overall Study|No Verasense type documented|0|||
147002010|NCT02286739|530170087|FG001|Overall Study|No Verasense type documented|23|||
147002011|NCT02286739|530170086|FG000|Overall Study|Adverse Event|1|||
147002012|NCT02286739|530170087|FG001|Overall Study|Adverse Event|2|||
147002013|NCT02286739|530170086|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
147002014|NCT02286739|530170087|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
147002015|NCT02635750|530170092|FG000|Part 1, Period 2|Adverse Event|1|||
147002016|NCT02635750|530170093|FG001|Part 1, Period 2|Adverse Event|0|||
147002017|NCT02635750|530170094|FG002|Part 1, Period 2|Adverse Event|0|||
147002018|NCT02642653|530170098|FG000|Overall Study|Adverse Event|2|||
147002019|NCT02642653|530170099|FG001|Overall Study|Adverse Event|0|||
147002020|NCT02875392|530170100|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
147002021|NCT02875392|530170101|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
147002022|NCT00834717|530170107|FG000|First Intervention|Adverse Event|1|||
147002023|NCT00834717|530170108|FG001|First Intervention|Adverse Event|0|||
147002024|NCT00834717|530170107|FG000|First Intervention|Withdrawal by Subject|0|||
147002025|NCT00834717|530170108|FG001|First Intervention|Withdrawal by Subject|1|||
147002026|NCT01701674|530170109|FG000|Overall Study|Unable to safely complete treatment|1|||
147002027|NCT00834522|530170112|FG000|Washout|Adverse Event|1|||
147002028|NCT00834522|530170113|FG001|Washout|Adverse Event|0|||
147002029|NCT00834522|530170112|FG000|Washout|Withdrawal by Subject|2|||
147002030|NCT00834522|530170113|FG001|Washout|Withdrawal by Subject|1|||
147002031|NCT04516967|530170114|FG000|Core Phase|Adverse Event|2|||
147002032|NCT04516967|530170115|FG001|Core Phase|Adverse Event|1|||
147002033|NCT04516967|530170116|FG002|Core Phase|Adverse Event|0|||
147002034|NCT04516967|530170114|FG000|Core Phase|Physician Decision|1|||
147002035|NCT04516967|530170115|FG001|Core Phase|Physician Decision|1|||
147002036|NCT04516967|530170116|FG002|Core Phase|Physician Decision|0|||
147002037|NCT04516967|530170114|FG000|Core Phase|Lack of Efficacy|7|||
147002038|NCT04516967|530170115|FG001|Core Phase|Lack of Efficacy|18|||
147002039|NCT04516967|530170116|FG002|Core Phase|Lack of Efficacy|0|||
147002040|NCT00519194|530170117|FG000|Overall Study|Withdrawal by Subject|9|||
147002041|NCT00519194|530170117|FG000|Overall Study|Death|9|||
147002042|NCT00519194|530170117|FG000|Overall Study|Lost to Follow-up|3|||
147002043|NCT03165994|530170118|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
147002044|NCT03165994|530170118|FG000|Overall Study|Death|2|||
147002045|NCT03165994|530170118|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
147002046|NCT03165994|530170118|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
147002047|NCT03165994|530170118|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
147002048|NCT03165994|530170118|FG000|Overall Study|Miscellaneous|1|||
147002049|NCT01175018|530170125|FG000|Overall Study|Adverse Event|3|||
147002050|NCT01175018|530170126|FG001|Overall Study|Adverse Event|1|||
147002051|NCT03285594|530170127|FG000|Overall Study|At the Participant's Own Request|10|||
147002052|NCT03285594|530170128|FG001|Overall Study|At the Participant's Own Request|5|||
147002053|NCT03285594|530170129|FG002|Overall Study|At the Participant's Own Request|21|||
147002054|NCT03285594|530170127|FG000|Overall Study|Adverse Event|2|||
147002055|NCT03285594|530170128|FG001|Overall Study|Adverse Event|2|||
147002056|NCT03285594|530170129|FG002|Overall Study|Adverse Event|6|||
147002057|NCT03285594|530170127|FG000|Overall Study|Poor Compliance to Protocol|0|||
147002058|NCT03285594|530170128|FG001|Overall Study|Poor Compliance to Protocol|0|||
147002059|NCT03285594|530170129|FG002|Overall Study|Poor Compliance to Protocol|1|||
147002060|NCT03285594|530170127|FG000|Overall Study|Lost to Follow-up|0|||
147002061|NCT03285594|530170128|FG001|Overall Study|Lost to Follow-up|0|||
147002062|NCT03285594|530170129|FG002|Overall Study|Lost to Follow-up|1|||
147002063|NCT03285594|530170127|FG000|Overall Study|Reason Not Specified|3|||
147002064|NCT03285594|530170128|FG001|Overall Study|Reason Not Specified|4|||
147002065|NCT03285594|530170129|FG002|Overall Study|Reason Not Specified|8|||
147002066|NCT02558491|530170130|FG000|First Invention|Withdrawal by Subject|3|||
147002067|NCT02558491|530170131|FG001|First Invention|Withdrawal by Subject|1|||
147002068|NCT02558491|530170130|FG000|First Invention|Data collection issues|1|||
147002069|NCT02558491|530170131|FG001|First Invention|Data collection issues|0|||
147002070|NCT02558491|530170130|FG000|First Invention|Stopping criteria|0|||
147002071|NCT02558491|530170131|FG001|First Invention|Stopping criteria|1|||
147002072|NCT02558491|530170130|FG000|First Invention|Changed parameters during trial|1|||
147002073|NCT02558491|530170131|FG001|First Invention|Changed parameters during trial|0|||
147002074|NCT02558491|530170130|FG000|Second Intervention|Withdrawal by Subject|1|||
147002075|NCT02558491|530170131|FG001|Second Intervention|Withdrawal by Subject|0|||
147002076|NCT02558491|530170130|FG000|Second Intervention|Stopping Criteria|1|||
147002077|NCT02558491|530170131|FG001|Second Intervention|Stopping Criteria|0|||
147002078|NCT00834431|530170132|FG000|First Intervention|Adverse Event|0|||
147002079|NCT00834431|530170133|FG001|First Intervention|Adverse Event|1|||
147002080|NCT00834431|530170132|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
147002081|NCT00834431|530170133|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
147002082|NCT03733444|530170136|FG000|Overall Study|Adverse Event|8|||
147002083|NCT03733444|530170137|FG001|Overall Study|Adverse Event|10|||
147002084|NCT03733444|530170138|FG002|Overall Study|Adverse Event|5|||
147002085|NCT03733444|530170136|FG000|Overall Study|Death|20|||
147002086|NCT03733444|530170137|FG001|Overall Study|Death|19|||
147002087|NCT03733444|530170138|FG002|Overall Study|Death|11|||
147002088|NCT03733444|530170136|FG000|Overall Study|Lost to Follow-up|3|||
147002089|NCT03733444|530170137|FG001|Overall Study|Lost to Follow-up|0|||
147002090|NCT03733444|530170138|FG002|Overall Study|Lost to Follow-up|1|||
147002091|NCT03733444|530170136|FG000|Overall Study|Lack of Efficacy|0|||
147002092|NCT03733444|530170137|FG001|Overall Study|Lack of Efficacy|1|||
147002093|NCT03733444|530170138|FG002|Overall Study|Lack of Efficacy|1|||
147002094|NCT03733444|530170136|FG000|Overall Study|Physician Decision|2|||
147002095|NCT03733444|530170137|FG001|Overall Study|Physician Decision|1|||
147002096|NCT03733444|530170138|FG002|Overall Study|Physician Decision|0|||
146736013|NCT03324880|529205273|FG001|Overall Study|Product Recall|1|||
147002097|NCT03733444|530170136|FG000|Overall Study|Protocol Violation|2|||
147002098|NCT03733444|530170137|FG001|Overall Study|Protocol Violation|1|||
147002099|NCT03733444|530170138|FG002|Overall Study|Protocol Violation|0|||
147002100|NCT03733444|530170136|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
147002101|NCT03733444|530170137|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
147002102|NCT03733444|530170138|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
147002103|NCT03733444|530170136|FG000|Overall Study|Study Terminated by Sponsor|203|||
147002104|NCT03733444|530170137|FG001|Overall Study|Study Terminated by Sponsor|209|||
147002105|NCT03733444|530170138|FG002|Overall Study|Study Terminated by Sponsor|221|||
147002106|NCT03733444|530170136|FG000|Overall Study|Withdrawal by Subject|19|||
147002107|NCT03733444|530170137|FG001|Overall Study|Withdrawal by Subject|18|||
147002108|NCT03733444|530170138|FG002|Overall Study|Withdrawal by Subject|16|||
147002109|NCT03733444|530170136|FG000|Overall Study|Miscellaneous|1|||
147002110|NCT03733444|530170137|FG001|Overall Study|Miscellaneous|0|||
147002111|NCT03733444|530170138|FG002|Overall Study|Miscellaneous|1|||
147002112|NCT03733444|530170136|FG000|Overall Study|Not Treated|1|||
147002113|NCT03733444|530170137|FG001|Overall Study|Not Treated|2|||
147002114|NCT03733444|530170138|FG002|Overall Study|Not Treated|1|||
147002115|NCT03637764|530170139|FG000|Overall Study|Adverse Event|2|||
147002116|NCT03637764|530170140|FG001|Overall Study|Adverse Event|0|||
147002117|NCT03637764|530170141|FG002|Overall Study|Adverse Event|0|||
147002118|NCT03637764|530170142|FG003|Overall Study|Adverse Event|1|||
147002119|NCT03637764|530170139|FG000|Overall Study|Progressive Disease|23|||
147002120|NCT03637764|530170140|FG001|Overall Study|Progressive Disease|23|||
147002121|NCT03637764|530170141|FG002|Overall Study|Progressive Disease|18|||
147002122|NCT03637764|530170142|FG003|Overall Study|Progressive Disease|31|||
147002123|NCT03637764|530170139|FG000|Overall Study|Withdrawal by Subject|1|||
147002124|NCT03637764|530170140|FG001|Overall Study|Withdrawal by Subject|3|||
147002125|NCT03637764|530170141|FG002|Overall Study|Withdrawal by Subject|0|||
147002126|NCT03637764|530170142|FG003|Overall Study|Withdrawal by Subject|1|||
147002127|NCT00835263|530170143|FG000|Second Intervention|Adverse Event|1|||
147002128|NCT00835263|530170144|FG001|Second Intervention|Adverse Event|0|||
147002129|NCT01020474|530170145|FG000|Overall Study|Adverse Event|4|||
147002130|NCT01020474|530170146|FG001|Overall Study|Adverse Event|4|||
147002131|NCT01020474|530170145|FG000|Overall Study|Protocol Violation|0|||
147002132|NCT01020474|530170146|FG001|Overall Study|Protocol Violation|2|||
147002133|NCT01020474|530170145|FG000|Overall Study|Withdrawal by Subject|5|||
147002134|NCT01020474|530170146|FG001|Overall Study|Withdrawal by Subject|7|||
147002135|NCT01020474|530170145|FG000|Overall Study|Other Reasons|1|||
147002136|NCT01020474|530170146|FG001|Overall Study|Other Reasons|1|||
147002137|NCT01020474|530170145|FG000|Overall Study|Insufficient Clinical Response|0|||
147002138|NCT01020474|530170146|FG001|Overall Study|Insufficient Clinical Response|3|||
147002139|NCT03987191|530170147|FG000|Overall Study|COVID-19 related research disruption|0|||
147002140|NCT03987191|530170148|FG001|Overall Study|COVID-19 related research disruption|2|||
147002141|NCT02838420|530170151|FG000|Overall Study|Ongoing in Study|113|||
147002142|NCT02838420|530170152|FG001|Overall Study|Ongoing in Study|45|||
147002143|NCT02838420|530170151|FG000|Overall Study|Lost to Follow-up|1|||
147002144|NCT02838420|530170152|FG001|Overall Study|Lost to Follow-up|0|||
147002145|NCT02838420|530170151|FG000|Overall Study|Withdrawal by Subject|3|||
147002146|NCT02838420|530170152|FG001|Overall Study|Withdrawal by Subject|4|||
147002147|NCT02838420|530170151|FG000|Overall Study|Death|8|||
147002148|NCT02838420|530170152|FG001|Overall Study|Death|13|||
147002149|NCT00796653|530170153|FG000|Overall Study|Adverse Event|19|||
147002150|NCT00796653|530170154|FG001|Overall Study|Adverse Event|16|||
147002151|NCT00796653|530170155|FG002|Overall Study|Adverse Event|16|||
147002152|NCT00796653|530170156|FG003|Overall Study|Adverse Event|16|||
147002153|NCT00796653|530170153|FG000|Overall Study|Lost to Follow-up|2|||
147002154|NCT00796653|530170154|FG001|Overall Study|Lost to Follow-up|1|||
147002155|NCT00796653|530170155|FG002|Overall Study|Lost to Follow-up|2|||
147002156|NCT00796653|530170156|FG003|Overall Study|Lost to Follow-up|3|||
147002157|NCT00796653|530170153|FG000|Overall Study|Withdrawal by Subject|16|||
147002158|NCT00796653|530170154|FG001|Overall Study|Withdrawal by Subject|8|||
147002159|NCT00796653|530170155|FG002|Overall Study|Withdrawal by Subject|8|||
147002160|NCT00796653|530170156|FG003|Overall Study|Withdrawal by Subject|13|||
147002161|NCT00796653|530170153|FG000|Overall Study|Lack of Efficacy|8|||
147002162|NCT00796653|530170154|FG001|Overall Study|Lack of Efficacy|1|||
147002163|NCT00796653|530170155|FG002|Overall Study|Lack of Efficacy|3|||
147002164|NCT00796653|530170156|FG003|Overall Study|Lack of Efficacy|2|||
147002165|NCT00796653|530170153|FG000|Overall Study|Non compliance with protocol|2|||
147002166|NCT00796653|530170154|FG001|Overall Study|Non compliance with protocol|2|||
147002167|NCT00796653|530170155|FG002|Overall Study|Non compliance with protocol|0|||
147002168|NCT00796653|530170156|FG003|Overall Study|Non compliance with protocol|2|||
147002169|NCT00796653|530170153|FG000|Overall Study|Other reason not described above|4|||
147002170|NCT00796653|530170154|FG001|Overall Study|Other reason not described above|9|||
147002171|NCT00796653|530170155|FG002|Overall Study|Other reason not described above|7|||
147002172|NCT00796653|530170156|FG003|Overall Study|Other reason not described above|4|||
147002173|NCT01940341|530170159|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
147002174|NCT01940341|530170160|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
147002175|NCT01940341|530170161|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
147002176|NCT01940341|530170162|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
147002177|NCT01940341|530170159|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
147002178|NCT01940341|530170160|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
147002179|NCT01940341|530170161|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
147002180|NCT01940341|530170162|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
147002181|NCT01940341|530170159|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
147002182|NCT01940341|530170160|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
147002183|NCT01940341|530170161|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
147002184|NCT01940341|530170162|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
147002185|NCT01940341|530170159|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
147002186|NCT01940341|530170160|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
147002187|NCT01940341|530170161|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
147002188|NCT01940341|530170162|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
147002189|NCT01940341|530170159|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
147002190|NCT01940341|530170160|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
147002191|NCT01940341|530170161|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
147002192|NCT01940341|530170162|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
147002193|NCT01940341|530170159|FG000|Period 1: Double-blind Phase|Death|0|||
147002194|NCT01940341|530170160|FG001|Period 1: Double-blind Phase|Death|1|||
147002195|NCT01940341|530170161|FG002|Period 1: Double-blind Phase|Death|0|||
147002196|NCT01940341|530170162|FG003|Period 1: Double-blind Phase|Death|0|||
147002197|NCT01940341|530170159|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
147002198|NCT01940341|530170160|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
147002199|NCT01940341|530170161|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
147002200|NCT01940341|530170162|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
147002201|NCT01940341|530170159|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
147002202|NCT01940341|530170160|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
147002203|NCT01940341|530170161|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
147002204|NCT01940341|530170162|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
147002205|NCT01940341|530170159|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
147002206|NCT01940341|530170160|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
147002207|NCT01940341|530170161|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
147002208|NCT01940341|530170162|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
147002209|NCT01940341|530170159|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
147002210|NCT01940341|530170160|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
147002211|NCT01940341|530170161|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
147002212|NCT01940341|530170162|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
147002213|NCT01940341|530170159|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
147002214|NCT01940341|530170160|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
147002215|NCT01940341|530170161|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
147002216|NCT01940341|530170162|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
147002217|NCT01940341|530170159|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
147002218|NCT01940341|530170160|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
147002219|NCT01940341|530170161|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
147002220|NCT01940341|530170162|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
147002221|NCT01940341|530170159|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
147002222|NCT01940341|530170160|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
147002223|NCT01940341|530170161|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
147002224|NCT01940341|530170162|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
147002225|NCT01940341|530170159|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
147002226|NCT01940341|530170160|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
147002227|NCT01940341|530170161|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
147002228|NCT01940341|530170162|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
147002229|NCT01940341|530170159|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
147002230|NCT01940341|530170160|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
147002231|NCT01940341|530170161|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
147002232|NCT01940341|530170162|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
147002233|NCT01940341|530170159|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
147002234|NCT01940341|530170160|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
147002235|NCT01940341|530170161|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
147002236|NCT01940341|530170162|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
147002237|NCT01940341|530170159|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
147002238|NCT01940341|530170160|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
147002239|NCT01940341|530170161|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
147002240|NCT01940341|530170162|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
147002241|NCT01940341|530170159|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
147002242|NCT01940341|530170160|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
147002243|NCT01940341|530170161|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
147002244|NCT01940341|530170162|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
147002245|NCT01940341|530170159|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
147002246|NCT01940341|530170160|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
147002247|NCT01940341|530170161|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
147002248|NCT01940341|530170162|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
147002249|NCT02414152|530170163|FG000|Overall Study|Withdrawal by Subject|1|||
147002250|NCT02414152|530170163|FG000|Overall Study|Lack of Efficacy|1|||
146845112|NCT01183260|529602667|FG000|Overall Study|Death|1|||
146845113|NCT01183260|529602668|FG001|Overall Study|Death|0|||
146845114|NCT01202903|529602672|FG000|Overall Study|Administrative Probelms|1|||
146845115|NCT01202903|529602673|FG001|Overall Study|Administrative Probelms|4|||
146845116|NCT01202903|529602672|FG000|Overall Study|Protocol Violation|0|||
146845117|NCT01202903|529602673|FG001|Overall Study|Protocol Violation|1|||
146845118|NCT01202903|529602672|FG000|Overall Study|Death|1|||
146845119|NCT01202903|529602673|FG001|Overall Study|Death|0|||
146845120|NCT01202903|529602672|FG000|Overall Study|Lost to Follow-up|1|||
146845121|NCT01202903|529602673|FG001|Overall Study|Lost to Follow-up|1|||
146845122|NCT01202903|529602672|FG000|Overall Study|Lack of Efficacy|1|||
146845123|NCT01202903|529602673|FG001|Overall Study|Lack of Efficacy|3|||
146845124|NCT01202903|529602672|FG000|Overall Study|Adverse Event|3|||
146845125|NCT01202903|529602673|FG001|Overall Study|Adverse Event|3|||
146845126|NCT01202903|529602672|FG000|Overall Study|Withdrawal by Subject|4|||
147002251|NCT01576042|530170167|FG000|Overall Study|Physician Decision|2|||
147002252|NCT01576042|530170168|FG001|Overall Study|Physician Decision|0|||
147002253|NCT03769025|530170174|FG000|Overall Study|Withdrawal by Subject|1|||
147002254|NCT03769025|530170175|FG001|Overall Study|Withdrawal by Subject|1|||
147002255|NCT03769025|530170174|FG000|Overall Study|Lost to Follow-up|4|||
147002256|NCT03769025|530170175|FG001|Overall Study|Lost to Follow-up|3|||
147002257|NCT05341622|530170184|FG000|Overall Study|Death|0|||
147002258|NCT05341622|530170185|FG001|Overall Study|Death|0|||
147002259|NCT05341622|530170186|FG002|Overall Study|Death|0|||
147002260|NCT05341622|530170187|FG003|Overall Study|Death|0|||
147002261|NCT05341622|530170188|FG004|Overall Study|Death|1|||
147002262|NCT05341622|530170189|FG005|Overall Study|Death|0|||
147002263|NCT05341622|530170190|FG006|Overall Study|Death|0|||
147002264|NCT05341622|530170191|FG007|Overall Study|Death|1|||
147002265|NCT05341622|530170184|FG000|Overall Study|Invalid Address|0|||
147002266|NCT05341622|530170185|FG001|Overall Study|Invalid Address|1|||
147002267|NCT05341622|530170186|FG002|Overall Study|Invalid Address|0|||
147002268|NCT05341622|530170187|FG003|Overall Study|Invalid Address|0|||
147002269|NCT05341622|530170188|FG004|Overall Study|Invalid Address|0|||
147002270|NCT05341622|530170189|FG005|Overall Study|Invalid Address|0|||
147002271|NCT05341622|530170190|FG006|Overall Study|Invalid Address|0|||
147002272|NCT05341622|530170191|FG007|Overall Study|Invalid Address|0|||
147002273|NCT05341622|530170184|FG000|Overall Study|Ineligible|26|||
147002274|NCT05341622|530170185|FG001|Overall Study|Ineligible|21|||
147002275|NCT05341622|530170186|FG002|Overall Study|Ineligible|28|||
147002276|NCT05341622|530170187|FG003|Overall Study|Ineligible|24|||
147002277|NCT05341622|530170188|FG004|Overall Study|Ineligible|29|||
147002278|NCT05341622|530170189|FG005|Overall Study|Ineligible|31|||
147002279|NCT05341622|530170190|FG006|Overall Study|Ineligible|28|||
147002280|NCT05341622|530170191|FG007|Overall Study|Ineligible|26|||
147002281|NCT02957942|530170192|FG000|Overall Study|Withdrawal by Subject|0|||
147002282|NCT02957942|530170193|FG001|Overall Study|Withdrawal by Subject|1|||
147002283|NCT02957942|530170192|FG000|Overall Study|Practicing experiment protocol|0|||
147002284|NCT02957942|530170193|FG001|Overall Study|Practicing experiment protocol|6|||
147002285|NCT03801707|530170204|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
147002286|NCT00787254|530170205|FG000|Overall Study|Adverse Event|24|||
147002287|NCT00787254|530170206|FG001|Overall Study|Adverse Event|23|||
147002288|NCT00787254|530170205|FG000|Overall Study|Protocol Violation|26|||
146845127|NCT01202903|529602673|FG001|Overall Study|Withdrawal by Subject|4|||
146845128|NCT01302080|529602674|FG000|Overall Study|Withdrew Consent|92|||
146845129|NCT01302080|529602675|FG001|Overall Study|Withdrew Consent|39|||
146845130|NCT01302080|529602674|FG000|Overall Study|Patient/Family Moved|28|||
147002289|NCT00787254|530170206|FG001|Overall Study|Protocol Violation|23|||
147002290|NCT00787254|530170205|FG000|Overall Study|Withdrawal by Subject|16|||
147002291|NCT00787254|530170206|FG001|Overall Study|Withdrawal by Subject|11|||
147002292|NCT00787254|530170205|FG000|Overall Study|Lack of Efficacy|4|||
146845131|NCT01302080|529602675|FG001|Overall Study|Patient/Family Moved|3|||
146845132|NCT01302080|529602674|FG000|Overall Study|Lost to Follow-up|192|||
147002293|NCT00787254|530170206|FG001|Overall Study|Lack of Efficacy|15|||
147002294|NCT00787254|530170205|FG000|Overall Study|NSAIDs discontinuation|1|||
146845133|NCT01302080|529602675|FG001|Overall Study|Lost to Follow-up|93|||
147002295|NCT00787254|530170206|FG001|Overall Study|NSAIDs discontinuation|2|||
147002296|NCT00787254|530170205|FG000|Overall Study|Institution closed|1|||
147002297|NCT00787254|530170206|FG001|Overall Study|Institution closed|0|||
147002298|NCT00787254|530170205|FG000|Overall Study|Physician Decision|4|||
147002299|NCT00787254|530170206|FG001|Overall Study|Physician Decision|8|||
147002300|NCT03761173|530170209|FG000|Overall Study|Lost to Follow-up|93|||
147002301|NCT03761173|530170209|FG000|Overall Study|Withdrawal by Subject|74|||
147002302|NCT03761173|530170209|FG000|Overall Study|Death|45|||
147002303|NCT03761173|530170209|FG000|Overall Study|Withdrawal for Other Reasons|29|||
147002304|NCT03761173|530170209|FG000|Overall Study|Protocol Violation|1|||
147002305|NCT00316186|530170210|FG000|Overall Study|Adverse Event|6|||
147002306|NCT00316186|530170210|FG000|Overall Study|Disease Progression|4|||
147002307|NCT00316186|530170210|FG000|Overall Study|Lost to Follow-up|1|||
147002308|NCT00316186|530170210|FG000|Overall Study|Other|1|||
147002309|NCT00594035|530172089|FG000|Overall Study|Lost to Follow-up|1|||
147002310|NCT00594035|530172090|FG001|Overall Study|Lost to Follow-up|1|||
147002311|NCT00594035|530172089|FG000|Overall Study|Withdrawal by Subject|1|||
147002312|NCT00594035|530172090|FG001|Overall Study|Withdrawal by Subject|0|||
147002313|NCT00594035|530172089|FG000|Overall Study|Subject transferred to nursing home|0|||
147002314|NCT00594035|530172090|FG001|Overall Study|Subject transferred to nursing home|1|||
147002315|NCT00594035|530172089|FG000|Overall Study|Subject couldn't return due to job|0|||
147002316|NCT00594035|530172090|FG001|Overall Study|Subject couldn't return due to job|1|||
147002317|NCT00795821|530172093|FG000|Acute Treatment Phase|Adverse Event|23|||
147002318|NCT00795821|530172094|FG001|Acute Treatment Phase|Adverse Event|4|||
147002319|NCT00795821|530172093|FG000|Acute Treatment Phase|Death|1|||
147002320|NCT00795821|530172094|FG001|Acute Treatment Phase|Death|0|||
147002321|NCT00795821|530172093|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
147002322|NCT00795821|530172094|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
147002323|NCT00795821|530172093|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
147002324|NCT00795821|530172094|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
147002325|NCT00795821|530172093|FG000|Acute Treatment Phase|Physician Decision|1|||
147002326|NCT00795821|530172094|FG001|Acute Treatment Phase|Physician Decision|1|||
147002327|NCT00795821|530172093|FG000|Acute Treatment Phase|Protocol Violation|1|||
147002328|NCT00795821|530172094|FG001|Acute Treatment Phase|Protocol Violation|2|||
147002329|NCT00795821|530172093|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
147002330|NCT00795821|530172094|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
147002331|NCT00795821|530172093|FG000|Long-term Extension Phase|Adverse Event|25|||
147002332|NCT00795821|530172094|FG001|Long-term Extension Phase|Adverse Event|32|||
147002333|NCT00795821|530172093|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
147002334|NCT00795821|530172094|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
147002335|NCT00795821|530172093|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
147002336|NCT00795821|530172094|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
147002337|NCT00795821|530172093|FG000|Long-term Extension Phase|Physician Decision|1|||
147002338|NCT00795821|530172094|FG001|Long-term Extension Phase|Physician Decision|2|||
147002339|NCT00795821|530172093|FG000|Long-term Extension Phase|Protocol Violation|3|||
147002340|NCT00795821|530172094|FG001|Long-term Extension Phase|Protocol Violation|5|||
147002341|NCT00795821|530172093|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
147002342|NCT00795821|530172094|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
147002343|NCT00795821|530172093|FG000|Taper Phase|Adverse Event|2|||
147002344|NCT00795821|530172094|FG001|Taper Phase|Adverse Event|0|||
147002345|NCT00795821|530172093|FG000|Taper Phase|Lost to Follow-up|1|||
147002346|NCT00795821|530172094|FG001|Taper Phase|Lost to Follow-up|0|||
147002347|NCT00795821|530172093|FG000|Taper Phase|Physician Decision|2|||
147002348|NCT00795821|530172094|FG001|Taper Phase|Physician Decision|0|||
147002349|NCT00795821|530172093|FG000|Taper Phase|Withdrawal by Subject|4|||
147002350|NCT00795821|530172094|FG001|Taper Phase|Withdrawal by Subject|0|||
147002351|NCT00712959|530172101|FG000|Overall Study|Protocol Violation|3|||
146736014|NCT01412801|529205274|FG000|Overall Study|Death|0|||
146736015|NCT01412801|529205275|FG001|Overall Study|Death|1|||
146736016|NCT01412801|529205276|FG002|Overall Study|Death|0|||
146736017|NCT01412801|529205277|FG003|Overall Study|Death|4|||
146736018|NCT01412801|529205278|FG004|Overall Study|Death|2|||
146736019|NCT01412801|529205279|FG005|Overall Study|Death|2|||
146736020|NCT01412801|529205274|FG000|Overall Study|Lost to Follow-up|1|||
146736021|NCT01412801|529205275|FG001|Overall Study|Lost to Follow-up|2|||
146736022|NCT01412801|529205276|FG002|Overall Study|Lost to Follow-up|4|||
146736023|NCT01412801|529205277|FG003|Overall Study|Lost to Follow-up|0|||
146736024|NCT01412801|529205278|FG004|Overall Study|Lost to Follow-up|1|||
146736025|NCT01412801|529205279|FG005|Overall Study|Lost to Follow-up|1|||
146736026|NCT01412801|529205274|FG000|Overall Study|Withdrawal by Subject|3|||
146736027|NCT01412801|529205275|FG001|Overall Study|Withdrawal by Subject|2|||
146736028|NCT01412801|529205276|FG002|Overall Study|Withdrawal by Subject|1|||
146736029|NCT01412801|529205277|FG003|Overall Study|Withdrawal by Subject|0|||
146736030|NCT01412801|529205278|FG004|Overall Study|Withdrawal by Subject|0|||
146736031|NCT01412801|529205279|FG005|Overall Study|Withdrawal by Subject|0|||
146736032|NCT01412801|529205274|FG000|Overall Study|Relocated to another area|0|||
146736033|NCT01412801|529205275|FG001|Overall Study|Relocated to another area|0|||
146736034|NCT01412801|529205276|FG002|Overall Study|Relocated to another area|2|||
146736035|NCT01412801|529205277|FG003|Overall Study|Relocated to another area|0|||
147002352|NCT00712959|530172102|FG001|Overall Study|Protocol Violation|1|||
147002353|NCT00712959|530172101|FG000|Overall Study|Lost to Follow-up|13|||
147002354|NCT00712959|530172102|FG001|Overall Study|Lost to Follow-up|2|||
147002355|NCT00712959|530172101|FG000|Overall Study|Withdrawal by Subject|3|||
147002356|NCT00712959|530172102|FG001|Overall Study|Withdrawal by Subject|0|||
147002357|NCT02255149|530172103|FG000|Overall Study|Lost to Follow-up|2|||
147002358|NCT02255149|530172103|FG000|Overall Study|Withdrawal by Subject|1|||
147002359|NCT02255149|530172103|FG000|Overall Study|Withdrawal by PI|1|||
147002360|NCT02255149|530172103|FG000|Overall Study|Implant Failure|1|||
147002361|NCT02301975|530172113|FG000|Overall Study|Adverse Event|8|||
147002362|NCT02301975|530172114|FG001|Overall Study|Adverse Event|3|||
147002363|NCT02301975|530172115|FG002|Overall Study|Adverse Event|2|||
147002364|NCT02301975|530172113|FG000|Overall Study|Lack of Efficacy|1|||
147002365|NCT02301975|530172114|FG001|Overall Study|Lack of Efficacy|1|||
147002366|NCT02301975|530172115|FG002|Overall Study|Lack of Efficacy|1|||
147002367|NCT02301975|530172113|FG000|Overall Study|Protocol Violation|3|||
147002368|NCT02301975|530172114|FG001|Overall Study|Protocol Violation|5|||
147002369|NCT02301975|530172115|FG002|Overall Study|Protocol Violation|3|||
147002370|NCT02301975|530172113|FG000|Overall Study|Lost to Follow-up|0|||
147002371|NCT02301975|530172114|FG001|Overall Study|Lost to Follow-up|2|||
147002372|NCT02301975|530172115|FG002|Overall Study|Lost to Follow-up|2|||
147002373|NCT02301975|530172113|FG000|Overall Study|Physician Decision|4|||
147002374|NCT02301975|530172114|FG001|Overall Study|Physician Decision|2|||
147002375|NCT02301975|530172115|FG002|Overall Study|Physician Decision|3|||
147002376|NCT02301975|530172113|FG000|Overall Study|Withdrawal by Subject|15|||
147002377|NCT02301975|530172114|FG001|Overall Study|Withdrawal by Subject|12|||
147002378|NCT02301975|530172115|FG002|Overall Study|Withdrawal by Subject|11|||
147002379|NCT04278560|530172117|FG000|Overall Study|Adverse Event|1|||
147002380|NCT04278560|530172118|FG001|Overall Study|Adverse Event|2|||
147002381|NCT04278560|530172117|FG000|Overall Study|Withdrawal by Subject|0|||
147002382|NCT04278560|530172118|FG001|Overall Study|Withdrawal by Subject|1|||
147002383|NCT00163657|530172119|FG000|Overall Study|Death|12|||
147002384|NCT00163657|530172120|FG001|Overall Study|Death|14|||
147002385|NCT00163657|530172121|FG002|Overall Study|Death|19|||
147002386|NCT00163657|530172119|FG000|Overall Study|graft loss|4|||
147002387|NCT00163657|530172120|FG001|Overall Study|graft loss|1|||
147002388|NCT00163657|530172121|FG002|Overall Study|graft loss|2|||
147002389|NCT00163657|530172119|FG000|Overall Study|Withdrawal by Subject|2|||
147002390|NCT00163657|530172120|FG001|Overall Study|Withdrawal by Subject|3|||
147002391|NCT00163657|530172121|FG002|Overall Study|Withdrawal by Subject|2|||
147002392|NCT00163657|530172119|FG000|Overall Study|Physician Decision|0|||
147002393|NCT00163657|530172120|FG001|Overall Study|Physician Decision|1|||
147002394|NCT00163657|530172121|FG002|Overall Study|Physician Decision|1|||
147002395|NCT00163657|530172119|FG000|Overall Study|Non Compliance|1|||
147002396|NCT00163657|530172120|FG001|Overall Study|Non Compliance|0|||
147002397|NCT00163657|530172121|FG002|Overall Study|Non Compliance|0|||
147002398|NCT00163657|530172119|FG000|Overall Study|Lost to Follow-up|1|||
147002399|NCT00163657|530172120|FG001|Overall Study|Lost to Follow-up|3|||
147002400|NCT00163657|530172121|FG002|Overall Study|Lost to Follow-up|10|||
147002401|NCT00163657|530172119|FG000|Overall Study|Other reason|0|||
147002402|NCT00163657|530172120|FG001|Overall Study|Other reason|1|||
147002403|NCT00163657|530172121|FG002|Overall Study|Other reason|3|||
146845134|NCT01302080|529602674|FG000|Overall Study|Death|1|||
146845135|NCT01302080|529602675|FG001|Overall Study|Death|0|||
146845136|NCT01302080|529602674|FG000|Overall Study|Other|52|||
146845137|NCT01302080|529602675|FG001|Overall Study|Other|8|||
146845138|NCT01302080|529602674|FG000|Overall Study|Reason Missing For Discontinuation|1|||
146845139|NCT01302080|529602675|FG001|Overall Study|Reason Missing For Discontinuation|0|||
146845140|NCT01896557|529602680|FG000|Clopidogrel Alone|Adverse Event|1|||
146845141|NCT01896557|529602681|FG001|Clopidogrel Alone|Adverse Event|0|||
146845142|NCT01896557|529602680|FG000|Clopidogrel + GI Protector|low adherence|1|||
146845143|NCT01896557|529602681|FG001|Clopidogrel + GI Protector|low adherence|1|||
146845144|NCT01896557|529602680|FG000|Clopidogrel + GI Protector|Reading error|1|||
146845145|NCT01896557|529602681|FG001|Clopidogrel + GI Protector|Reading error|3|||
147002404|NCT01319383|530172124|FG000|Overall Study|No ex vivo or in vivo response|4|||
147002405|NCT01319383|530172125|FG001|Overall Study|No ex vivo or in vivo response|0|||
146845146|NCT02182947|529602682|FG000|Overall Study|Withdrawal by Subject|7|||
146845147|NCT02182947|529602682|FG000|Overall Study|Lost to Follow-up|3|||
146845148|NCT02182947|529602682|FG000|Overall Study|Failed screening activities|8|||
147002406|NCT01319383|530172124|FG000|Overall Study|Physician Decision|3|||
147002407|NCT01319383|530172125|FG001|Overall Study|Physician Decision|0|||
147002408|NCT01319383|530172124|FG000|Overall Study|Lack of Efficacy|5|||
147002409|NCT01319383|530172125|FG001|Overall Study|Lack of Efficacy|9|||
147002410|NCT01319383|530172124|FG000|Overall Study|No in vivo response to interval doses|0|||
147002411|NCT01319383|530172125|FG001|Overall Study|No in vivo response to interval doses|1|||
147002412|NCT01531894|530172128|FG000|Overall Study|Physician Decision|8|||
147002413|NCT01531894|530172128|FG000|Overall Study|Death|1|||
147002414|NCT03086460|530172129|FG000|Study Participants|Lost to Follow-up|2|||
147002415|NCT03086460|530172129|FG000|Study Participants|Protocol Violation|1|||
146845149|NCT01072630|529602690|FG000|Overall Study|Adverse Event|11|||
146845150|NCT01072630|529602691|FG001|Overall Study|Adverse Event|19|||
146845151|NCT01072630|529602692|FG002|Overall Study|Adverse Event|2|||
146845152|NCT01072630|529602690|FG000|Overall Study|Lack of Efficacy|10|||
146845153|NCT01072630|529602691|FG001|Overall Study|Lack of Efficacy|10|||
146845154|NCT01072630|529602692|FG002|Overall Study|Lack of Efficacy|1|||
146845155|NCT01072630|529602690|FG000|Overall Study|Withdrawal by Subject|8|||
146845156|NCT01072630|529602691|FG001|Overall Study|Withdrawal by Subject|7|||
146845157|NCT01072630|529602692|FG002|Overall Study|Withdrawal by Subject|2|||
146845158|NCT01072630|529602690|FG000|Overall Study|Protocol Violation|10|||
147002416|NCT03086460|530172129|FG000|Study Participants|Withdrawal by Subject|6|||
147002417|NCT03086460|530172129|FG000|Treatment A|Lost to Follow-up|1|||
147002418|NCT03086460|530172129|FG000|Treatment A|Protocol Violation|1|||
147002419|NCT03086460|530172129|FG000|Treatment A|Withdrawal by Subject|2|||
147002420|NCT03086460|530172129|FG000|Treatment C|Withdrawal by Subject|2|||
147002421|NCT03086460|530172129|FG000|Treatment E|Lost to Follow-up|1|||
147002422|NCT03086460|530172129|FG000|Treatment E|Withdrawal by Subject|3|||
147002423|NCT03600805|530172138|FG000|Overall Study|Adverse Event|2|||
147002424|NCT03600805|530172139|FG001|Overall Study|Adverse Event|1|||
147002425|NCT03600805|530172140|FG002|Overall Study|Adverse Event|1|||
147002426|NCT03600805|530172141|FG003|Overall Study|Adverse Event|7|||
147002427|NCT03600805|530172138|FG000|Overall Study|Lack of Efficacy|2|||
147002428|NCT03600805|530172139|FG001|Overall Study|Lack of Efficacy|1|||
147002429|NCT03600805|530172140|FG002|Overall Study|Lack of Efficacy|0|||
147002430|NCT03600805|530172141|FG003|Overall Study|Lack of Efficacy|0|||
147002431|NCT03600805|530172138|FG000|Overall Study|Withdrawal by Subject|1|||
147002432|NCT03600805|530172139|FG001|Overall Study|Withdrawal by Subject|0|||
147002433|NCT03600805|530172140|FG002|Overall Study|Withdrawal by Subject|0|||
147002434|NCT03600805|530172141|FG003|Overall Study|Withdrawal by Subject|1|||
147002435|NCT03600805|530172138|FG000|Overall Study|Other unspecified|14|||
147002436|NCT03600805|530172139|FG001|Overall Study|Other unspecified|6|||
147002437|NCT03600805|530172140|FG002|Overall Study|Other unspecified|7|||
147002438|NCT03600805|530172141|FG003|Overall Study|Other unspecified|11|||
147002439|NCT06195579|530172142|FG000|Overall Study|Withdrawal by Subject|1|||
147002440|NCT01735994|530172144|FG000|Overall Study|Withdrawal by Subject|6|||
147002441|NCT01735994|530172145|FG001|Overall Study|Withdrawal by Subject|4|||
147002442|NCT01735994|530172144|FG000|Overall Study|Injury|2|||
147002443|NCT01735994|530172145|FG001|Overall Study|Injury|0|||
147002444|NCT01735994|530172144|FG000|Overall Study|Kicked off team|5|||
147002445|NCT01735994|530172145|FG001|Overall Study|Kicked off team|0|||
147002446|NCT01735994|530172144|FG000|Overall Study|Lost to Follow-up|50|||
147002447|NCT01735994|530172145|FG001|Overall Study|Lost to Follow-up|62|||
147002448|NCT03123094|530172146|FG000|Overall Study|Withdrawal by Subject|0|||
147002449|NCT03123094|530172147|FG001|Overall Study|Withdrawal by Subject|2|||
147002450|NCT03123094|530172148|FG002|Overall Study|Withdrawal by Subject|1|||
147002451|NCT03123094|530172149|FG003|Overall Study|Withdrawal by Subject|0|||
147002452|NCT03123094|530172150|FG004|Overall Study|Withdrawal by Subject|1|||
147002453|NCT00736190|530172152|FG000|Overall Study|Pregnancy|1|||
147002454|NCT00736190|530172152|FG000|Overall Study|Withdrawal by Subject|1|||
147002455|NCT00736190|530172152|FG000|Overall Study|Adverse Event|1|||
147002456|NCT03128723|530172156|FG000|Overall Study|Withdrawal by Subject|2|||
147002457|NCT02909907|530172158|FG000|Overall Study|Withdrawal by Subject|0|||
147002458|NCT02909907|530172159|FG001|Overall Study|Withdrawal by Subject|1|||
147002459|NCT00395694|530172165|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
147002460|NCT00395694|530172166|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
147002461|NCT00395694|530172165|FG000|Continuation Phase|Adverse Event|1|||
147002462|NCT00395694|530172166|FG001|Continuation Phase|Adverse Event|0|||
147002463|NCT00395694|530172165|FG000|Continuation Phase|Lack of Efficacy|12|||
147002464|NCT00395694|530172166|FG001|Continuation Phase|Lack of Efficacy|11|||
147002465|NCT00395694|530172165|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
147002466|NCT00395694|530172166|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
146845159|NCT01072630|529602691|FG001|Overall Study|Protocol Violation|8|||
146845160|NCT01072630|529602692|FG002|Overall Study|Protocol Violation|4|||
146845161|NCT01072630|529602690|FG000|Overall Study|Lost to Follow-up|11|||
147002467|NCT00395694|530172165|FG000|Continuation Phase|Poor Compliance|1|||
147002468|NCT00395694|530172166|FG001|Continuation Phase|Poor Compliance|0|||
147002469|NCT00395694|530172165|FG000|Continuation Phase|Withdrawal by Subject|0|||
147002470|NCT00395694|530172166|FG001|Continuation Phase|Withdrawal by Subject|2|||
147002471|NCT02699866|530172167|FG000|Overall Study|Withdrawal by Subject|3|||
147002472|NCT02699866|530172167|FG000|Overall Study|Physician Decision|2|||
147002473|NCT02699866|530172167|FG000|Overall Study|Adverse Event|3|||
147002474|NCT02849457|530172168|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
147002475|NCT02849457|530172169|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
147002476|NCT02849457|530172170|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
147013223|NCT02048813|530210053|FG001|Overall Study|Never started treatment|17|||
147002477|NCT02849457|530172171|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
146845162|NCT01072630|529602691|FG001|Overall Study|Lost to Follow-up|11|||
146845163|NCT01072630|529602692|FG002|Overall Study|Lost to Follow-up|1|||
146845164|NCT01072630|529602690|FG000|Overall Study|Noncompliance with study medication|1|||
146845165|NCT01072630|529602691|FG001|Overall Study|Noncompliance with study medication|1|||
147002478|NCT04238754|530172175|FG000|Washout - 1 Week|Lost to Follow-up|1|||
147002479|NCT04238754|530172176|FG001|Washout - 1 Week|Lost to Follow-up|0|||
147002480|NCT01294917|530172179|FG000|Overall Study|Relocation|5|||
147002481|NCT01294917|530172179|FG000|Overall Study|Inconvenience|1|||
147002482|NCT03406156|530172181|FG000|Overall Study|Death|9|||
147002483|NCT03406156|530172182|FG001|Overall Study|Death|3|||
147002484|NCT03406156|530172181|FG000|Overall Study|Withdrawal by Subject|1|||
147002485|NCT03406156|530172182|FG001|Overall Study|Withdrawal by Subject|2|||
147002486|NCT03406156|530172181|FG000|Overall Study|COVID-19 infection|1|||
147002487|NCT03406156|530172182|FG001|Overall Study|COVID-19 infection|0|||
147002488|NCT03406156|530172181|FG000|Overall Study|Non-compliance with study procedures|1|||
147002489|NCT03406156|530172182|FG001|Overall Study|Non-compliance with study procedures|1|||
147002490|NCT03406156|530172181|FG000|Overall Study|Lost to Follow-up|0|||
147002491|NCT03406156|530172182|FG001|Overall Study|Lost to Follow-up|2|||
147002492|NCT03406156|530172181|FG000|Overall Study|Other, not specified|72|||
147002493|NCT03406156|530172182|FG001|Overall Study|Other, not specified|28|||
147002494|NCT00835536|530172183|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
147002495|NCT00835536|530172184|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
147002496|NCT03123471|530172187|FG000|Placebo-controlled Phase|Adverse Event|3|||
147002497|NCT03123471|530172188|FG001|Placebo-controlled Phase|Adverse Event|8|||
147002498|NCT03123471|530172187|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
147002499|NCT03123471|530172188|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
147002500|NCT03123471|530172187|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
147002501|NCT03123471|530172188|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
147002502|NCT03123471|530172187|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
147002503|NCT03123471|530172188|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
147002504|NCT03123471|530172187|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
147002505|NCT03123471|530172188|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
147002506|NCT03123471|530172187|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
147002507|NCT03123471|530172188|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
147002508|NCT03123471|530172187|FG000|Placebo-controlled Phase|Miscellaneous|0|||
147002509|NCT03123471|530172188|FG001|Placebo-controlled Phase|Miscellaneous|1|||
147002510|NCT03123471|530172187|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
147002511|NCT03123471|530172188|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
147002512|NCT03123471|530172187|FG000|Apremilast Extension Phase|Adverse Event|1|||
147002513|NCT03123471|530172188|FG001|Apremilast Extension Phase|Adverse Event|5|||
147002514|NCT03123471|530172187|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
147002515|NCT03123471|530172188|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
147002516|NCT03123471|530172187|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
147002517|NCT03123471|530172188|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
147002518|NCT01686477|530172189|FG000|Feeding Intervention|Death|1|||
147002519|NCT01686477|530172190|FG001|Feeding Intervention|Death|0|||
147002520|NCT01686477|530172191|FG002|Feeding Intervention|Death|1|||
147002521|NCT01686477|530172189|FG000|Feeding Intervention|Withdrawal by Subject|0|||
147002522|NCT01686477|530172190|FG001|Feeding Intervention|Withdrawal by Subject|6|||
147002523|NCT01686477|530172191|FG002|Feeding Intervention|Withdrawal by Subject|0|||
147002524|NCT01686477|530172189|FG000|Feeding Intervention|Physician Decision|1|||
147002525|NCT01686477|530172190|FG001|Feeding Intervention|Physician Decision|2|||
147002526|NCT01686477|530172191|FG002|Feeding Intervention|Physician Decision|0|||
147002527|NCT01686477|530172189|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
147002528|NCT01686477|530172190|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
147002529|NCT01686477|530172191|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
147002530|NCT01686477|530172189|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
147002531|NCT01686477|530172190|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
147002532|NCT01686477|530172191|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
147002533|NCT01686477|530172189|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
147002534|NCT01686477|530172190|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
147002535|NCT01686477|530172191|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
147002536|NCT01686477|530172189|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
147002537|NCT01686477|530172190|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
147002538|NCT01686477|530172191|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
147002539|NCT01686477|530172189|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
147002540|NCT01686477|530172190|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
147002541|NCT01686477|530172191|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
147002542|NCT01686477|530172189|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
146845166|NCT01072630|529602692|FG002|Overall Study|Noncompliance with study medication|1|||
147002543|NCT01686477|530172190|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
147002544|NCT01686477|530172191|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
147002545|NCT01686477|530172189|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
147002546|NCT01686477|530172190|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
147002547|NCT01686477|530172191|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
147002548|NCT01249651|530172196|FG000|Overall Study|Withdrawal by Subject|4|||
147002549|NCT01249651|530172196|FG000|Overall Study|Adverse Event|1|||
147002550|NCT01249651|530172196|FG000|Overall Study|Protocol Violation|1|||
147002551|NCT01249651|530172196|FG000|Overall Study|Sponsor Decision|1|||
147002552|NCT00813592|530172197|FG000|Overall Study|Disease assessment was not completed per|2|||
147002553|NCT03873272|530172200|FG000|Overall Study|Withdrawal by Subject|2|||
147002554|NCT03873272|530172201|FG001|Overall Study|Withdrawal by Subject|0|||
147002555|NCT03873272|530172202|FG002|Overall Study|Withdrawal by Subject|1|||
147002556|NCT03873272|530172200|FG000|Overall Study|Death|0|||
147002557|NCT03873272|530172201|FG001|Overall Study|Death|2|||
147002558|NCT03873272|530172202|FG002|Overall Study|Death|1|||
147002559|NCT04544410|530172203|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
147002560|NCT04544410|530172204|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
147002561|NCT04544410|530172203|FG000|Double-blind Treatment Period|Adverse Event|1|||
147002562|NCT04544410|530172204|FG001|Double-blind Treatment Period|Adverse Event|0|||
147002563|NCT04544410|530172203|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
147002564|NCT04544410|530172204|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
147002565|NCT04544410|530172203|FG000|Double-blind Treatment Period|Protocol Violation|1|||
147002566|NCT04544410|530172204|FG001|Double-blind Treatment Period|Protocol Violation|0|||
147002567|NCT04544410|530172203|FG000|Open-Label Treatment Period|Study Terminated|15|||
147002568|NCT04544410|530172204|FG001|Open-Label Treatment Period|Study Terminated|19|||
147002569|NCT04544410|530172203|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
147002570|NCT04544410|530172204|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
147002571|NCT04544410|530172203|FG000|Open-Label Treatment Period|Adverse Event|0|||
147002572|NCT04544410|530172204|FG001|Open-Label Treatment Period|Adverse Event|1|||
147002573|NCT04544410|530172203|FG000|Open-Label Treatment Period|Physician Decision|1|||
147002574|NCT04544410|530172204|FG001|Open-Label Treatment Period|Physician Decision|0|||
147002575|NCT04544410|530172203|FG000|Open-Label Treatment Period|Other|0|||
147002576|NCT04544410|530172204|FG001|Open-Label Treatment Period|Other|1|||
147002577|NCT02430480|530172205|FG000|Overall Study|Death|1|||
147002578|NCT02430480|530172205|FG000|Overall Study|Anesthesia concerns|1|||
147002579|NCT02430480|530172205|FG000|Overall Study|Progressed on treatment|1|||
147002580|NCT04493684|530172206|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
147002581|NCT04493684|530172207|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147002582|NCT04493684|530172208|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
147002583|NCT04493684|530172209|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147002584|NCT04493684|530172210|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147002585|NCT04493684|530172211|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
147002586|NCT04493684|530172212|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147002587|NCT04493684|530172213|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147002588|NCT04493684|530172214|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147002589|NCT04493684|530172215|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147002590|NCT04493684|530172216|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147002591|NCT04493684|530172217|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147002592|NCT04493684|530172218|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147002593|NCT04493684|530172219|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147002594|NCT04493684|530172220|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147002595|NCT04493684|530172221|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147002596|NCT04493684|530172222|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147002597|NCT04493684|530172206|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
147002598|NCT04493684|530172207|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147002599|NCT04493684|530172208|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147002600|NCT04493684|530172209|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147002601|NCT04493684|530172210|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147002602|NCT04493684|530172211|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147002603|NCT04493684|530172212|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147002604|NCT04493684|530172213|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147002605|NCT04493684|530172214|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147002606|NCT04493684|530172215|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147002607|NCT04493684|530172216|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147002608|NCT04493684|530172217|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147002609|NCT04493684|530172218|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147002610|NCT04493684|530172219|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147002611|NCT04493684|530172220|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147002612|NCT04493684|530172221|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147002613|NCT04493684|530172222|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147002614|NCT04493684|530172206|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147002615|NCT04493684|530172207|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147002616|NCT04493684|530172208|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147002617|NCT04493684|530172209|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147002618|NCT04493684|530172210|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147002619|NCT04493684|530172211|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146845167|NCT01072630|529602690|FG000|Overall Study|Noncompliance with study procedures|1|||
146845168|NCT01072630|529602691|FG001|Overall Study|Noncompliance with study procedures|2|||
146845169|NCT01072630|529602692|FG002|Overall Study|Noncompliance with study procedures|1|||
146845170|NCT01072630|529602690|FG000|Overall Study|Other|3|||
146845171|NCT01072630|529602691|FG001|Overall Study|Other|2|||
146845172|NCT01072630|529602692|FG002|Overall Study|Other|1|||
146845173|NCT00416195|529602712|FG000|Overall Study|Adverse Event|1|||
147002620|NCT04493684|530172212|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
147002621|NCT04493684|530172213|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147002622|NCT04493684|530172214|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147002623|NCT04493684|530172215|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147002624|NCT04493684|530172216|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147002625|NCT04493684|530172217|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147002626|NCT04493684|530172218|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147002627|NCT04493684|530172219|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147002628|NCT04493684|530172220|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147002629|NCT04493684|530172221|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147002630|NCT04493684|530172222|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147002631|NCT04493684|530172206|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
147002632|NCT04493684|530172207|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147002633|NCT04493684|530172208|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147002634|NCT04493684|530172209|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147002635|NCT04493684|530172210|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147002636|NCT04493684|530172211|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
146845174|NCT00416195|529602713|FG001|Overall Study|Adverse Event|2|||
146845175|NCT00416195|529602712|FG000|Overall Study|Protocol Violation|1|||
147002637|NCT04493684|530172212|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147002638|NCT04493684|530172213|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147002639|NCT04493684|530172214|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147002640|NCT04493684|530172215|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147002641|NCT04493684|530172216|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147002642|NCT04493684|530172217|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147002643|NCT04493684|530172218|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147002644|NCT04493684|530172219|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147002645|NCT04493684|530172220|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147002646|NCT04493684|530172221|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147002647|NCT04493684|530172222|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147002648|NCT04493684|530172206|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147002649|NCT04493684|530172207|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147002650|NCT04493684|530172208|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147002651|NCT04493684|530172209|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147002652|NCT04493684|530172210|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147002653|NCT04493684|530172211|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
147002654|NCT04493684|530172212|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147002655|NCT04493684|530172213|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147002656|NCT04493684|530172214|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147002657|NCT04493684|530172215|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147002658|NCT04493684|530172216|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147002659|NCT04493684|530172217|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147002660|NCT04493684|530172218|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147002661|NCT04493684|530172219|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147002662|NCT04493684|530172220|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147002663|NCT04493684|530172221|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147013224|NCT01708954|530210054|FG000|Step 1|Disease progression|26|||
146845176|NCT00416195|529602713|FG001|Overall Study|Protocol Violation|1|||
147002664|NCT04493684|530172222|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147002665|NCT04493684|530172206|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147002666|NCT04493684|530172207|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147002667|NCT04493684|530172208|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147002668|NCT04493684|530172209|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147002669|NCT04493684|530172210|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147002670|NCT04493684|530172211|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147002671|NCT04493684|530172212|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147002672|NCT04493684|530172213|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147002673|NCT04493684|530172214|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147002674|NCT04493684|530172215|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147002675|NCT04493684|530172216|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147002676|NCT04493684|530172217|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
147002677|NCT04493684|530172218|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147002678|NCT04493684|530172219|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147002679|NCT04493684|530172220|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147002680|NCT04493684|530172221|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147002681|NCT04493684|530172222|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147002682|NCT04493684|530172206|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147002683|NCT04493684|530172207|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147002684|NCT04493684|530172208|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147002685|NCT04493684|530172209|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147002686|NCT04493684|530172210|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147002687|NCT04493684|530172211|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147002688|NCT04493684|530172212|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147002689|NCT04493684|530172213|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147002690|NCT04493684|530172214|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147002691|NCT04493684|530172215|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147002692|NCT04493684|530172216|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147002693|NCT04493684|530172217|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147002694|NCT04493684|530172218|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147002695|NCT04493684|530172219|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147002696|NCT04493684|530172220|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147002697|NCT04493684|530172221|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
147002698|NCT04493684|530172222|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147002699|NCT04493684|530172206|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147002700|NCT04493684|530172207|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147002701|NCT04493684|530172208|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147002702|NCT04493684|530172209|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147002703|NCT04493684|530172210|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147002704|NCT04493684|530172211|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147002705|NCT04493684|530172212|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147002706|NCT04493684|530172213|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147002707|NCT04493684|530172214|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147002708|NCT04493684|530172215|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147002709|NCT04493684|530172216|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147002710|NCT04493684|530172217|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147002711|NCT04493684|530172218|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147002712|NCT04493684|530172219|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147002713|NCT04493684|530172220|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147002714|NCT04493684|530172221|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
147002715|NCT04493684|530172222|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147002716|NCT01963728|530172223|FG000|Overall Study|Study terminated early|0|||
147002717|NCT01963728|530172224|FG001|Overall Study|Study terminated early|1|||
147002718|NCT05152576|530172227|FG000|Overall Study|Lost to Follow-up|3|||
147002719|NCT05152576|530172228|FG001|Overall Study|Lost to Follow-up|0|||
147002720|NCT05152576|530172229|FG002|Overall Study|Lost to Follow-up|0|||
147002721|NCT05152576|530172230|FG003|Overall Study|Lost to Follow-up|1|||
147002722|NCT05152576|530172227|FG000|Overall Study|Withdrawal by Subject|0|||
147002723|NCT05152576|530172228|FG001|Overall Study|Withdrawal by Subject|1|||
147002724|NCT05152576|530172229|FG002|Overall Study|Withdrawal by Subject|0|||
147002725|NCT05152576|530172230|FG003|Overall Study|Withdrawal by Subject|1|||
147002726|NCT05152576|530172227|FG000|Overall Study|Other|2|||
147002727|NCT05152576|530172228|FG001|Overall Study|Other|0|||
147002728|NCT05152576|530172229|FG002|Overall Study|Other|0|||
147002729|NCT05152576|530172230|FG003|Overall Study|Other|0|||
147002730|NCT00859430|530172231|FG000|First Intervention|Withdrawal by Subject|0|||
147002731|NCT00859430|530172232|FG001|First Intervention|Withdrawal by Subject|1|||
147002732|NCT01660243|530173597|FG000|Overall Study|Adverse Event|1|||
147002733|NCT01660243|530173598|FG001|Overall Study|Adverse Event|0|||
147002734|NCT01660243|530173599|FG002|Overall Study|Adverse Event|1|||
147002735|NCT01660243|530173600|FG003|Overall Study|Adverse Event|0|||
147002736|NCT01660243|530173597|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
147002737|NCT01660243|530173598|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
147002738|NCT01660243|530173599|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
147002739|NCT01660243|530173600|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
147002740|NCT01660243|530173597|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
147002741|NCT01660243|530173598|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
147002742|NCT01660243|530173599|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
147002743|NCT01660243|530173600|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
147002744|NCT01660243|530173597|FG000|Overall Study|Randomization error|0|||
147002745|NCT01660243|530173598|FG001|Overall Study|Randomization error|0|||
147002746|NCT01660243|530173599|FG002|Overall Study|Randomization error|0|||
147002747|NCT01660243|530173600|FG003|Overall Study|Randomization error|1|||
147002748|NCT02328040|530173618|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
147002749|NCT02328040|530173619|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
147002750|NCT00604162|530173620|FG000|Overall Study|Physician Decision|3|||
147002751|NCT00604162|530173620|FG000|Overall Study|Withdrawal by Subject|1|||
147002752|NCT02682238|530173627|FG000|Overall Study|Lost to Follow-up|0|||
147002753|NCT02682238|530173628|FG001|Overall Study|Lost to Follow-up|2|||
147002754|NCT02682238|530173627|FG000|Overall Study|Withdrawal by Subject|1|||
147002755|NCT02682238|530173628|FG001|Overall Study|Withdrawal by Subject|0|||
147002756|NCT02682238|530173627|FG000|Overall Study|Adverse Event|1|||
147002757|NCT02682238|530173628|FG001|Overall Study|Adverse Event|0|||
147002758|NCT02682238|530173627|FG000|Overall Study|Non-compliance with Study Drug|1|||
147002759|NCT02682238|530173628|FG001|Overall Study|Non-compliance with Study Drug|0|||
147002760|NCT02682238|530173627|FG000|Overall Study|Non-compliance with Protocol|0|||
147002761|NCT02682238|530173628|FG001|Overall Study|Non-compliance with Protocol|2|||
147002762|NCT01370317|530173629|FG000|Overall Study|Participant withdrew consent|1|||
147002763|NCT01370317|530173630|FG001|Overall Study|Participant withdrew consent|0|||
147002764|NCT01370317|530173629|FG000|Overall Study|Protocol deviation|0|||
147002765|NCT01370317|530173630|FG001|Overall Study|Protocol deviation|1|||
147002766|NCT00075478|530173631|FG000|Overall Study|not eligible|1|||
147002767|NCT00075478|530173632|FG001|Overall Study|not eligible|0|||
147002768|NCT00075478|530173631|FG000|Overall Study|Physician Decision|0|||
147002769|NCT00075478|530173632|FG001|Overall Study|Physician Decision|1|||
147002770|NCT02075463|530173635|FG000|Overall Study|Adverse Event|3|||
147002771|NCT02075463|530173635|FG000|Overall Study|Par. reached stopping criteria|4|||
147002772|NCT02075463|530173635|FG000|Overall Study|Withdrawal by Subject|1|||
147002773|NCT00673660|530173636|FG000|Overall Study|Lost to Follow-up|107|||
147002774|NCT01527006|530173637|FG000|Core Study|Adverse Event|0|||
147002775|NCT01527006|530173638|FG001|Core Study|Adverse Event|2|||
147002776|NCT01527006|530173637|FG000|Core Study|Lost to Follow-up|0|||
147002777|NCT01527006|530173638|FG001|Core Study|Lost to Follow-up|1|||
147002778|NCT01527006|530173637|FG000|Core Study|Subject Choice|1|||
147002779|NCT01527006|530173638|FG001|Core Study|Subject Choice|0|||
147002780|NCT01527006|530173637|FG000|Core Study|Inadequate Therapeutic Effect|1|||
147002781|NCT01527006|530173638|FG001|Core Study|Inadequate Therapeutic Effect|0|||
147002782|NCT01527006|530173637|FG000|Core Study|Withdrawal by Subject|0|||
147002783|NCT01527006|530173638|FG001|Core Study|Withdrawal by Subject|1|||
147002784|NCT01527006|530173637|FG000|Core Study|Other|0|||
146845177|NCT00416195|529602712|FG000|Overall Study|Other|0|||
146845178|NCT00416195|529602713|FG001|Overall Study|Other|1|||
146845179|NCT03361605|529602718|FG000|Overall Study|Analyzable data not available|3|||
146845180|NCT01305408|529602719|FG000|Overall Study|Adverse Event|10|||
146845181|NCT01305408|529602720|FG001|Overall Study|Adverse Event|7|||
146845182|NCT01305408|529602719|FG000|Overall Study|Lack of Efficacy|3|||
147002785|NCT01527006|530173638|FG001|Core Study|Other|2|||
147002786|NCT01527006|530173637|FG000|Extension Phase|Adverse Event|4|||
147002787|NCT01527006|530173638|FG001|Extension Phase|Adverse Event|2|||
147002788|NCT01527006|530173637|FG000|Extension Phase|Lost to Follow-up|0|||
147002789|NCT01527006|530173638|FG001|Extension Phase|Lost to Follow-up|1|||
147002790|NCT01527006|530173637|FG000|Extension Phase|Subject Choice|1|||
147002791|NCT01527006|530173638|FG001|Extension Phase|Subject Choice|1|||
147002792|NCT01527006|530173637|FG000|Extension Phase|Inadequate therapeutic effect|1|||
147002793|NCT01527006|530173638|FG001|Extension Phase|Inadequate therapeutic effect|1|||
147002794|NCT01527006|530173637|FG000|Extension Phase|Other|0|||
146845183|NCT01305408|529602720|FG001|Overall Study|Lack of Efficacy|4|||
147002795|NCT01527006|530173638|FG001|Extension Phase|Other|3|||
147002796|NCT00834340|530173640|FG000|Washout|Adverse Event|1|||
147002797|NCT00834340|530173641|FG001|Washout|Adverse Event|0|||
147002798|NCT00834340|530173640|FG000|Washout|Withdrawal by Subject|1|||
147002799|NCT00834340|530173641|FG001|Washout|Withdrawal by Subject|0|||
147002800|NCT00392665|530173642|FG000|Overall Study|Death|16|||
147002801|NCT00392665|530173643|FG001|Overall Study|Death|14|||
147002802|NCT00392665|530173642|FG000|Overall Study|Lost to Follow-up|1|||
146845184|NCT01305408|529602719|FG000|Overall Study|Withdrawal by Subject|9|||
146845185|NCT01305408|529602720|FG001|Overall Study|Withdrawal by Subject|9|||
146845186|NCT01305408|529602719|FG000|Overall Study|Protocol Violation|4|||
146845187|NCT01305408|529602720|FG001|Overall Study|Protocol Violation|6|||
147002803|NCT00392665|530173643|FG001|Overall Study|Lost to Follow-up|1|||
147002804|NCT03673670|530173646|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
147002805|NCT03673670|530173647|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
147002806|NCT03673670|530173648|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
147002807|NCT03673670|530173649|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
147002808|NCT03673670|530173650|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
147002809|NCT03673670|530173651|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
147002810|NCT03673670|530173646|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
147002811|NCT03673670|530173647|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
147002812|NCT03673670|530173648|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
147002813|NCT03673670|530173649|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
147002814|NCT03673670|530173650|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
147002815|NCT03673670|530173651|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
147002816|NCT03673670|530173646|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
147002817|NCT03673670|530173647|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
147002818|NCT03673670|530173648|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
147002819|NCT03673670|530173649|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
147002820|NCT03673670|530173650|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
147002821|NCT03673670|530173651|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
147002822|NCT03673670|530173646|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
147002823|NCT03673670|530173647|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
147002824|NCT03673670|530173648|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
147002825|NCT03673670|530173649|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
147002826|NCT03673670|530173650|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
147002827|NCT03673670|530173651|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
147002828|NCT03673670|530173646|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
147002829|NCT03673670|530173647|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
147002830|NCT03673670|530173648|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
147002831|NCT03673670|530173649|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
147002832|NCT03673670|530173650|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
147002833|NCT03673670|530173651|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
147002834|NCT03673670|530173646|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
147002835|NCT03673670|530173647|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
147002836|NCT03673670|530173648|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
147002837|NCT03673670|530173649|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
147002838|NCT03673670|530173650|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
147002839|NCT03673670|530173651|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
147002840|NCT03673670|530173646|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
147002841|NCT03673670|530173647|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
147002842|NCT03673670|530173648|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
147002843|NCT03673670|530173649|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
147002844|NCT03673670|530173650|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
147002845|NCT03673670|530173651|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
147002846|NCT03437265|530173654|FG000|Overall Study|Protocol Violation|6|||
147002847|NCT02294786|530173655|FG000|Overall Study|Withdrawal by Subject|0|||
147002848|NCT02294786|530173656|FG001|Overall Study|Withdrawal by Subject|1|||
147002849|NCT02294786|530173655|FG000|Overall Study|Physician Decision|6|||
147002850|NCT02294786|530173656|FG001|Overall Study|Physician Decision|7|||
147002851|NCT02294786|530173655|FG000|Overall Study|Lost to Follow-up|1|||
147002852|NCT02294786|530173656|FG001|Overall Study|Lost to Follow-up|2|||
147002853|NCT02294786|530173655|FG000|Overall Study|Protocol Violation|1|||
147002854|NCT02294786|530173656|FG001|Overall Study|Protocol Violation|0|||
147002855|NCT02294786|530173655|FG000|Overall Study|Adverse Event|1|||
147002856|NCT02294786|530173656|FG001|Overall Study|Adverse Event|1|||
147002857|NCT02294786|530173655|FG000|Overall Study|Death|2|||
147002858|NCT02294786|530173656|FG001|Overall Study|Death|3|||
146845188|NCT01305408|529602719|FG000|Overall Study|Lost to Follow-up|5|||
147002859|NCT01778010|530173657|FG000|Overall Study|Withdrawal by Subject|2|||
147002860|NCT01778010|530173657|FG000|Overall Study|abnormal ECG before meds|1|||
147002861|NCT01778010|530173657|FG000|Overall Study|Arrested|1|||
147002862|NCT01778010|530173657|FG000|Overall Study|rash while on placebo|1|||
147002863|NCT02159183|530173665|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
147002864|NCT02159183|530173666|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
147002865|NCT02159183|530173665|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
147002866|NCT02159183|530173666|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
147002867|NCT02159183|530173665|FG000|Analysis After the 36 Months Follow-up|Death|0|||
147002868|NCT02159183|530173666|FG001|Analysis After the 36 Months Follow-up|Death|1|||
147002869|NCT02159183|530173665|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
147002870|NCT02159183|530173666|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
147002871|NCT02159183|530173665|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
147002872|NCT02159183|530173666|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
147002873|NCT01244620|530173670|FG000|Overall Study|Study terminated|4|||
147002874|NCT01244620|530173671|FG001|Overall Study|Study terminated|4|||
147002875|NCT01244620|530173672|FG002|Overall Study|Study terminated|4|||
147002876|NCT01244620|530173673|FG003|Overall Study|Study terminated|4|||
147002877|NCT00840073|530173675|FG000|Second Intervention|Missed 72 hour blood draw|1|||
147002878|NCT00840073|530173676|FG001|Second Intervention|Missed 72 hour blood draw|1|||
147002879|NCT02321098|530173677|FG000|12 Weeks Treament|Lost to Follow-up|1|||
147002880|NCT02321098|530173678|FG001|12 Weeks Treament|Lost to Follow-up|1|||
147002881|NCT02321098|530173679|FG002|12 Weeks Treament|Lost to Follow-up|0|||
147002882|NCT02321098|530173677|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
147002883|NCT02321098|530173678|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
147002884|NCT02321098|530173679|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
147002885|NCT02321098|530173677|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
147002886|NCT02321098|530173678|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
147002887|NCT02321098|530173679|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
147002888|NCT02321098|530173677|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
147002889|NCT02321098|530173678|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
147002890|NCT02321098|530173679|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
147002891|NCT01663233|530173680|FG000|Overall Study|Withdrawal by Subject|3|||
147002892|NCT01663233|530173681|FG001|Overall Study|Withdrawal by Subject|2|||
147002893|NCT01663233|530173680|FG000|Overall Study|Protocol Deviation|1|||
147002894|NCT01663233|530173681|FG001|Overall Study|Protocol Deviation|4|||
147002895|NCT01663233|530173680|FG000|Overall Study|Lost to Follow-up|0|||
147002896|NCT01663233|530173681|FG001|Overall Study|Lost to Follow-up|1|||
147002897|NCT01788423|530173684|FG000|Overall Study|See Comments in Completed (above)|0|||
147002898|NCT01788423|530173685|FG001|Overall Study|See Comments in Completed (above)|4|||
147002899|NCT01788423|530173686|FG002|Overall Study|See Comments in Completed (above)|5|||
147002900|NCT03249454|530173687|FG000|Overall Study|Withdrawal by Subject|0|||
147002901|NCT03249454|530173688|FG001|Overall Study|Withdrawal by Subject|0|||
147002902|NCT03249454|530173689|FG002|Overall Study|Withdrawal by Subject|0|||
147002903|NCT03249454|530173690|FG003|Overall Study|Withdrawal by Subject|0|||
147002904|NCT03249454|530173691|FG004|Overall Study|Withdrawal by Subject|0|||
147002905|NCT03249454|530173692|FG005|Overall Study|Withdrawal by Subject|0|||
147002906|NCT03249454|530173693|FG006|Overall Study|Withdrawal by Subject|0|||
147002907|NCT03249454|530173694|FG007|Overall Study|Withdrawal by Subject|0|||
147002908|NCT03249454|530173695|FG008|Overall Study|Withdrawal by Subject|0|||
147002909|NCT03249454|530173696|FG009|Overall Study|Withdrawal by Subject|1|||
147002910|NCT03249454|530173697|FG010|Overall Study|Withdrawal by Subject|1|||
147002911|NCT01913405|530173698|FG000|Overall Study|Withdrawal by Subject|1|||
147002912|NCT01913405|530173698|FG000|Overall Study|Adverse Event|1|||
147002913|NCT00705666|530173703|FG000|Overall Study|No post-treatment questionnaire|279|||
147002914|NCT00705666|530173703|FG000|Overall Study|Withdrawal by Subject|21|||
147002915|NCT00705666|530173703|FG000|Overall Study|Physician Decision|7|||
147002916|NCT00705666|530173703|FG000|Overall Study|Lost to Follow-up|5|||
147002917|NCT00705666|530173703|FG000|Overall Study|Death|1|||
147002918|NCT00705666|530173703|FG000|Overall Study|Adverse Event|4|||
147002919|NCT00705666|530173703|FG000|Overall Study|Other|12|||
147002920|NCT00705666|530173703|FG000|Overall Study|Other|2|||
147002921|NCT00705666|530173703|FG000|Overall Study|Lack of data|3|||
147002922|NCT00705666|530173703|FG000|Overall Study|Untreated|5|||
147002923|NCT02105272|530173710|FG000|Overall Study|Adverse Event|1|||
147002924|NCT02105272|530173711|FG001|Overall Study|Adverse Event|2|||
146845189|NCT01305408|529602720|FG001|Overall Study|Lost to Follow-up|3|||
147002925|NCT02105272|530173710|FG000|Overall Study|Physician Decision|0|||
147002926|NCT02105272|530173711|FG001|Overall Study|Physician Decision|1|||
147002927|NCT02105272|530173710|FG000|Overall Study|Protocol Violation|2|||
147002928|NCT02105272|530173711|FG001|Overall Study|Protocol Violation|0|||
147002929|NCT02105272|530173710|FG000|Overall Study|Withdrawal by Subject|2|||
147002930|NCT02105272|530173711|FG001|Overall Study|Withdrawal by Subject|0|||
147002931|NCT02964039|530173716|FG000|Overall Study|Medical reason unrelated to study participation|1|||
147002932|NCT02964039|530173717|FG001|Overall Study|Medical reason unrelated to study participation|0|||
147002933|NCT02964039|530173718|FG002|Overall Study|Medical reason unrelated to study participation|3|||
147002934|NCT02964039|530173716|FG000|Overall Study|Research shutdown due to pandemic|2|||
147002935|NCT02964039|530173717|FG001|Overall Study|Research shutdown due to pandemic|0|||
147002936|NCT02964039|530173718|FG002|Overall Study|Research shutdown due to pandemic|1|||
147002937|NCT02964039|530173716|FG000|Overall Study|Withdrawal by Subject|0|||
147002938|NCT02964039|530173717|FG001|Overall Study|Withdrawal by Subject|1|||
147002939|NCT02964039|530173718|FG002|Overall Study|Withdrawal by Subject|0|||
147002940|NCT02964039|530173716|FG000|Overall Study|Lost to Follow-up|1|||
147002941|NCT02964039|530173717|FG001|Overall Study|Lost to Follow-up|0|||
147002942|NCT02964039|530173718|FG002|Overall Study|Lost to Follow-up|1|||
147002943|NCT05479058|530173719|FG000|Overall Study|Withdrawal by Subject|1|||
147002944|NCT05479058|530173720|FG001|Overall Study|Withdrawal by Subject|1|||
147002945|NCT05479058|530173719|FG000|Overall Study|Study terminated by sponsor|10|||
147002946|NCT05479058|530173720|FG001|Overall Study|Study terminated by sponsor|10|||
147002947|NCT05630885|530173721|FG000|Study Completion|Took prohibited medications|2|||
147002948|NCT05630885|530173722|FG001|Study Completion|Took prohibited medications|0|||
147002949|NCT05630885|530173721|FG000|Study Completion|Non-compliance with study drug|1|||
147002950|NCT05630885|530173722|FG001|Study Completion|Non-compliance with study drug|0|||
147002951|NCT05630885|530173721|FG000|Study Completion|Adverse Event|1|||
147002952|NCT05630885|530173722|FG001|Study Completion|Adverse Event|0|||
147002953|NCT05630885|530173721|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
147002954|NCT05630885|530173722|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
147002955|NCT05630885|530173721|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
147002956|NCT05630885|530173722|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
147002957|NCT01103713|530173723|FG000|Overall Study|Lost to Follow-up|2|||
147002958|NCT01103713|530173723|FG000|Overall Study|Withdrawal by Subject|8|||
147002959|NCT01103713|530173723|FG000|Overall Study|Study terminated by sponsor|2|||
147002960|NCT01103713|530173723|FG000|Overall Study|Other|1|||
147002961|NCT01929863|530173726|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
147002962|NCT01929863|530173727|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
146845190|NCT01305408|529602719|FG000|Overall Study|Noncompliance with study medication|0|||
146845191|NCT01305408|529602720|FG001|Overall Study|Noncompliance with study medication|1|||
146845192|NCT01305408|529602719|FG000|Overall Study|Noncompliance with study procedures|0|||
146845193|NCT01305408|529602720|FG001|Overall Study|Noncompliance with study procedures|1|||
146845194|NCT01305408|529602719|FG000|Overall Study|Other|1|||
146845195|NCT01305408|529602720|FG001|Overall Study|Other|0|||
146845196|NCT03101462|529602721|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
146845197|NCT03101462|529602722|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
146845198|NCT02530970|529602723|FG000|Overall Study|Adverse Event|8|||
146845199|NCT02530970|529602723|FG000|Overall Study|Lost to Follow-up|88|||
146845200|NCT02530970|529602723|FG000|Overall Study|Physician Decision|5|||
146845201|NCT02530970|529602723|FG000|Overall Study|Withdrawal by Subject|14|||
146845202|NCT02530970|529602723|FG000|Overall Study|Death|6|||
146845203|NCT02530970|529602723|FG000|Overall Study|Hospitalization|1|||
146845204|NCT02530970|529602723|FG000|Overall Study|Insurance|2|||
146845205|NCT02530970|529602723|FG000|Overall Study|Explant|2|||
146845206|NCT02530970|529602723|FG000|Overall Study|Change in Provider|5|||
147002963|NCT01929863|530173726|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
147002964|NCT01929863|530173727|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
147002965|NCT01929863|530173726|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
147002966|NCT01929863|530173727|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
147002967|NCT00251979|530173728|FG000|Overall Study|Protocol Violation|3|||
147002968|NCT00251979|530173729|FG001|Overall Study|Protocol Violation|5|||
147002969|NCT00251979|530173728|FG000|Overall Study|Adverse Event|11|||
147002970|NCT00251979|530173729|FG001|Overall Study|Adverse Event|17|||
147002971|NCT00251979|530173728|FG000|Overall Study|Withdrawal by Subject|13|||
147002972|NCT00251979|530173729|FG001|Overall Study|Withdrawal by Subject|7|||
147002973|NCT00251979|530173728|FG000|Overall Study|Lost to Follow-up|8|||
147002974|NCT00251979|530173729|FG001|Overall Study|Lost to Follow-up|6|||
147002975|NCT00251979|530173728|FG000|Overall Study|Death|3|||
147002976|NCT00251979|530173729|FG001|Overall Study|Death|5|||
147002977|NCT01878292|530173730|FG000|Randomized|Protocol Violation|1|||
147002978|NCT01878292|530173731|FG001|Randomized|Protocol Violation|0|||
147002979|NCT01878292|530173732|FG002|Randomized|Protocol Violation|0|||
147002980|NCT01878292|530173730|FG000|Randomized|Lost to Follow-up|1|||
147002981|NCT01878292|530173731|FG001|Randomized|Lost to Follow-up|0|||
147002982|NCT01878292|530173732|FG002|Randomized|Lost to Follow-up|0|||
147002983|NCT01878292|530173730|FG000|Randomized|Adverse Event|1|||
147002984|NCT01878292|530173731|FG001|Randomized|Adverse Event|0|||
147002985|NCT01878292|530173732|FG002|Randomized|Adverse Event|0|||
147002986|NCT01878292|530173730|FG000|Double-blind Treatment Period|Other Reasons|2|||
147002987|NCT01878292|530173731|FG001|Double-blind Treatment Period|Other Reasons|0|||
147002988|NCT01878292|530173732|FG002|Double-blind Treatment Period|Other Reasons|0|||
147002989|NCT01878292|530173730|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
147002990|NCT01878292|530173731|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
147002991|NCT01878292|530173732|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
147002992|NCT01878292|530173730|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
146845207|NCT02530970|529602723|FG000|Overall Study|Relocation|3|||
147002993|NCT01878292|530173731|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
147002994|NCT01878292|530173732|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
147002995|NCT01878292|530173730|FG000|Double-blind Treatment Period|Protocol Violation|3|||
147002996|NCT01878292|530173731|FG001|Double-blind Treatment Period|Protocol Violation|4|||
147002997|NCT01878292|530173732|FG002|Double-blind Treatment Period|Protocol Violation|2|||
147002998|NCT01878292|530173730|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
147002999|NCT01878292|530173731|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
147003000|NCT01878292|530173732|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
147003001|NCT01878292|530173730|FG000|Double-blind Treatment Period|Adverse Event|4|||
147003002|NCT01878292|530173731|FG001|Double-blind Treatment Period|Adverse Event|9|||
147003003|NCT01878292|530173732|FG002|Double-blind Treatment Period|Adverse Event|8|||
147003004|NCT01878292|530173730|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
147003005|NCT01878292|530173731|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
147003006|NCT01878292|530173732|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
147003007|NCT01983969|530173734|FG000|Overall Study|Disease Progression|0|||
147003008|NCT01983969|530173735|FG001|Overall Study|Disease Progression|1|||
147003009|NCT01983969|530173736|FG002|Overall Study|Disease Progression|0|||
147003010|NCT00268203|530173737|FG000|Overall Study|Lost to Follow-up|92|||
147003011|NCT00268203|530173737|FG000|Overall Study|Withdrawal by Subject|9|||
147003012|NCT00268203|530173737|FG000|Overall Study|Received Other NHL Therapy|7|||
147003013|NCT00268203|530173737|FG000|Overall Study|Progressive Disease|359|||
147003014|NCT00268203|530173737|FG000|Overall Study|Death|84|||
147003015|NCT00268203|530173737|FG000|Overall Study|Reason Not Specified|34|||
147003016|NCT00268203|530173737|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
147003017|NCT00950989|530173738|FG000|Overall Study|Death|0|||
147003018|NCT00950989|530173739|FG001|Overall Study|Death|0|||
147003019|NCT00950989|530173740|FG002|Overall Study|Death|1|||
147003020|NCT00950989|530173741|FG003|Overall Study|Death|0|||
147003021|NCT00950989|530173738|FG000|Overall Study|Administrative Decision|0|||
147003022|NCT00950989|530173739|FG001|Overall Study|Administrative Decision|1|||
147003023|NCT00950989|530173740|FG002|Overall Study|Administrative Decision|0|||
147003024|NCT00950989|530173741|FG003|Overall Study|Administrative Decision|0|||
147003025|NCT00950989|530173738|FG000|Overall Study|Disease Progression|0|||
147003026|NCT00950989|530173739|FG001|Overall Study|Disease Progression|0|||
147003027|NCT00950989|530173740|FG002|Overall Study|Disease Progression|1|||
147003028|NCT00950989|530173741|FG003|Overall Study|Disease Progression|0|||
147003029|NCT00950989|530173738|FG000|Overall Study|Withdrawal by Subject|2|||
147003030|NCT00950989|530173739|FG001|Overall Study|Withdrawal by Subject|1|||
147003031|NCT00950989|530173740|FG002|Overall Study|Withdrawal by Subject|0|||
147003032|NCT00950989|530173741|FG003|Overall Study|Withdrawal by Subject|0|||
147003033|NCT00950989|530173738|FG000|Overall Study|Adverse Event|2|||
147003034|NCT00950989|530173739|FG001|Overall Study|Adverse Event|1|||
147003035|NCT00950989|530173740|FG002|Overall Study|Adverse Event|1|||
147003036|NCT00950989|530173741|FG003|Overall Study|Adverse Event|0|||
147003037|NCT00730691|530173742|FG000|Overall Study|Adverse Event|4|||
147003038|NCT00730691|530173743|FG001|Overall Study|Adverse Event|8|||
147003039|NCT00730691|530173744|FG002|Overall Study|Adverse Event|11|||
147003040|NCT00730691|530173745|FG003|Overall Study|Adverse Event|11|||
147003041|NCT00730691|530173746|FG004|Overall Study|Adverse Event|23|||
147003042|NCT00730691|530173742|FG000|Overall Study|Lack of Efficacy|4|||
147003043|NCT00730691|530173743|FG001|Overall Study|Lack of Efficacy|4|||
147003044|NCT00730691|530173744|FG002|Overall Study|Lack of Efficacy|2|||
147003045|NCT00730691|530173745|FG003|Overall Study|Lack of Efficacy|1|||
147003046|NCT00730691|530173746|FG004|Overall Study|Lack of Efficacy|1|||
147003047|NCT00730691|530173742|FG000|Overall Study|Non-compliance with Study Drug|6|||
147003048|NCT00730691|530173743|FG001|Overall Study|Non-compliance with Study Drug|1|||
147003049|NCT00730691|530173744|FG002|Overall Study|Non-compliance with Study Drug|6|||
147003050|NCT00730691|530173745|FG003|Overall Study|Non-compliance with Study Drug|3|||
147003051|NCT00730691|530173746|FG004|Overall Study|Non-compliance with Study Drug|3|||
147003052|NCT00730691|530173742|FG000|Overall Study|Protocol Deviations|3|||
147003053|NCT00730691|530173743|FG001|Overall Study|Protocol Deviations|5|||
147003054|NCT00730691|530173744|FG002|Overall Study|Protocol Deviations|3|||
147003055|NCT00730691|530173745|FG003|Overall Study|Protocol Deviations|7|||
147003056|NCT00730691|530173746|FG004|Overall Study|Protocol Deviations|5|||
147003057|NCT00730691|530173742|FG000|Overall Study|Withdrawal of Consent|7|||
147003058|NCT00730691|530173743|FG001|Overall Study|Withdrawal of Consent|9|||
147003059|NCT00730691|530173744|FG002|Overall Study|Withdrawal of Consent|3|||
147003060|NCT00730691|530173745|FG003|Overall Study|Withdrawal of Consent|6|||
147003061|NCT00730691|530173746|FG004|Overall Study|Withdrawal of Consent|3|||
147003062|NCT00730691|530173742|FG000|Overall Study|Lost to Follow-up|11|||
147003063|NCT00730691|530173743|FG001|Overall Study|Lost to Follow-up|8|||
147003064|NCT00730691|530173744|FG002|Overall Study|Lost to Follow-up|13|||
147003065|NCT00730691|530173745|FG003|Overall Study|Lost to Follow-up|15|||
147003066|NCT00730691|530173746|FG004|Overall Study|Lost to Follow-up|13|||
146845208|NCT02770612|529602725|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
147003067|NCT00730691|530173742|FG000|Overall Study|Other|1|||
147003068|NCT00730691|530173743|FG001|Overall Study|Other|1|||
147003069|NCT00730691|530173744|FG002|Overall Study|Other|1|||
147003070|NCT00730691|530173745|FG003|Overall Study|Other|2|||
147003071|NCT00730691|530173746|FG004|Overall Study|Other|2|||
147003072|NCT05776901|530175543|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
147003073|NCT00682461|530175545|FG000|Overall Study|Adverse Event|5|||
147003074|NCT00682461|530175546|FG001|Overall Study|Adverse Event|7|||
147003075|NCT00682461|530175545|FG000|Overall Study|Lost to Follow-up|8|||
147003076|NCT00682461|530175546|FG001|Overall Study|Lost to Follow-up|5|||
147003077|NCT00682461|530175545|FG000|Overall Study|Withdrawal by Subject|12|||
147003078|NCT00682461|530175546|FG001|Overall Study|Withdrawal by Subject|19|||
147003079|NCT00835705|530175547|FG000|First Intervention|Difficulty with vein|1|||
147003080|NCT00835705|530175548|FG001|First Intervention|Difficulty with vein|0|||
147003081|NCT00835705|530175547|FG000|Second Intervention|Difficulty with vein|1|||
147003082|NCT00835705|530175548|FG001|Second Intervention|Difficulty with vein|0|||
147003083|NCT00665925|530175549|FG000|Overall Study|Lack of Efficacy|10|||
147003084|NCT00665925|530175550|FG001|Overall Study|Lack of Efficacy|8|||
147003085|NCT00665925|530175551|FG002|Overall Study|Lack of Efficacy|9|||
147003086|NCT00665925|530175552|FG003|Overall Study|Lack of Efficacy|8|||
147003087|NCT00665925|530175549|FG000|Overall Study|Lost to Follow-up|1|||
147003088|NCT00665925|530175550|FG001|Overall Study|Lost to Follow-up|2|||
147003089|NCT00665925|530175551|FG002|Overall Study|Lost to Follow-up|2|||
147003090|NCT00665925|530175552|FG003|Overall Study|Lost to Follow-up|2|||
147003091|NCT00665925|530175549|FG000|Overall Study|Withdrawal by Subject|2|||
147003092|NCT00665925|530175550|FG001|Overall Study|Withdrawal by Subject|2|||
147003093|NCT00665925|530175551|FG002|Overall Study|Withdrawal by Subject|3|||
147003094|NCT00665925|530175552|FG003|Overall Study|Withdrawal by Subject|2|||
147003095|NCT00665925|530175549|FG000|Overall Study|Physician Decision|0|||
147003096|NCT00665925|530175550|FG001|Overall Study|Physician Decision|0|||
147003097|NCT00665925|530175551|FG002|Overall Study|Physician Decision|1|||
147003098|NCT00665925|530175552|FG003|Overall Study|Physician Decision|2|||
147003099|NCT00665925|530175549|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
147003100|NCT00665925|530175550|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
147003101|NCT00665925|530175551|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
147003102|NCT00665925|530175552|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
147003103|NCT00665925|530175549|FG000|Overall Study|Adverse Event|1|||
147003104|NCT00665925|530175550|FG001|Overall Study|Adverse Event|5|||
147003105|NCT00665925|530175551|FG002|Overall Study|Adverse Event|10|||
147003106|NCT00665925|530175552|FG003|Overall Study|Adverse Event|5|||
147003107|NCT00665925|530175549|FG000|Overall Study|Enrolled by mistake|0|||
147003108|NCT00665925|530175550|FG001|Overall Study|Enrolled by mistake|0|||
147003109|NCT00665925|530175551|FG002|Overall Study|Enrolled by mistake|0|||
147003110|NCT00665925|530175552|FG003|Overall Study|Enrolled by mistake|1|||
147003111|NCT00665925|530175549|FG000|Overall Study|Due to exclusion criteria|1|||
147003112|NCT00665925|530175550|FG001|Overall Study|Due to exclusion criteria|0|||
147003113|NCT00665925|530175551|FG002|Overall Study|Due to exclusion criteria|0|||
147003114|NCT00665925|530175552|FG003|Overall Study|Due to exclusion criteria|0|||
147003115|NCT04035187|530175553|FG000|Overall Study|Withdrawal by Subject|2|||
147003116|NCT04035187|530175554|FG001|Overall Study|Withdrawal by Subject|1|||
147003117|NCT04035187|530175555|FG002|Overall Study|Withdrawal by Subject|0|||
147003118|NCT04035187|530175556|FG003|Overall Study|Withdrawal by Subject|0|||
147003119|NCT04035187|530175553|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
147003120|NCT04035187|530175554|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
147003121|NCT04035187|530175555|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
147003122|NCT04035187|530175556|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
147003123|NCT01987765|530175565|FG000|Overall Study|Protocol Violation|65|||
147003124|NCT01987765|530175565|FG000|Overall Study|Lost to Follow-up|37|||
147003125|NCT03049748|530175568|FG000|Overall Study|Lost to Follow-up|1|||
147003126|NCT03049748|530175569|FG001|Overall Study|Lost to Follow-up|0|||
147003127|NCT03049748|530175568|FG000|Overall Study|Death|3|||
147003128|NCT03049748|530175569|FG001|Overall Study|Death|0|||
147003129|NCT03049748|530175568|FG000|Overall Study|Withdrawal by Subject|0|||
147003130|NCT03049748|530175569|FG001|Overall Study|Withdrawal by Subject|3|||
147003131|NCT03049748|530175568|FG000|Overall Study|Protocol Violation|0|||
147003132|NCT03049748|530175569|FG001|Overall Study|Protocol Violation|2|||
147003133|NCT03049748|530175568|FG000|Overall Study|Moved out of state (relocation)|0|||
147003134|NCT03049748|530175569|FG001|Overall Study|Moved out of state (relocation)|1|||
147003135|NCT03502811|530175572|FG000|Overall Study|Death|157|||
147003136|NCT03502811|530175572|FG000|Overall Study|Withdrawal by Subject|105|||
147003137|NCT03502811|530175572|FG000|Overall Study|Lost to Follow-up|26|||
147003138|NCT03502811|530175572|FG000|Overall Study|No Visits (Missed)|31|||
147003139|NCT01492439|530175573|FG000|Overall Study|Withdrew from RTE|4|||
147003140|NCT01492439|530175574|FG001|Overall Study|Withdrew from RTE|9|||
147003141|NCT00824291|530175577|FG000|Overall Study|Adverse Event|15|||
147003142|NCT00824291|530175578|FG001|Overall Study|Adverse Event|6|||
147003143|NCT00824291|530175577|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
147003144|NCT00824291|530175578|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
147003145|NCT00824291|530175577|FG000|Overall Study|Lost to Follow-up|11|||
147003146|NCT00824291|530175578|FG001|Overall Study|Lost to Follow-up|9|||
147003147|NCT00824291|530175577|FG000|Overall Study|Non-compliance|1|||
147003148|NCT00824291|530175578|FG001|Overall Study|Non-compliance|1|||
147003149|NCT00824291|530175577|FG000|Overall Study|Protocol Violation|4|||
147003150|NCT00824291|530175578|FG001|Overall Study|Protocol Violation|1|||
147003151|NCT00824291|530175577|FG000|Overall Study|Withdrawal by Subject|14|||
147003152|NCT00824291|530175578|FG001|Overall Study|Withdrawal by Subject|8|||
147003153|NCT00824291|530175577|FG000|Overall Study|Lack of Efficacy|7|||
147003154|NCT00824291|530175578|FG001|Overall Study|Lack of Efficacy|8|||
147003155|NCT00824291|530175577|FG000|Overall Study|Participant on prohibited medication|1|||
147003156|NCT00824291|530175578|FG001|Overall Study|Participant on prohibited medication|0|||
147003157|NCT00123734|530175579|FG000|Overall Study|Death|3|||
147003158|NCT00123734|530175579|FG000|Overall Study|Lost to Follow-up|3|||
147003159|NCT00123734|530175579|FG000|Overall Study|Dropout|1|||
147003160|NCT00123734|530175579|FG000|Overall Study|Withdrawal by Subject|1|||
147003161|NCT00113386|530175580|FG000|Overall Study|Withdrawal by Subject|1|||
147003162|NCT00113386|530175581|FG001|Overall Study|Withdrawal by Subject|0|||
147003163|NCT00113386|530175580|FG000|Overall Study|Physician Decision|0|||
147003164|NCT00113386|530175581|FG001|Overall Study|Physician Decision|1|||
147003165|NCT00113386|530175580|FG000|Overall Study|Toxicity|3|||
147003166|NCT00113386|530175581|FG001|Overall Study|Toxicity|0|||
147003167|NCT00113386|530175580|FG000|Overall Study|Ineligible|1|||
147003168|NCT00113386|530175581|FG001|Overall Study|Ineligible|2|||
147003169|NCT00113386|530175580|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
147003170|NCT00113386|530175581|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
147003171|NCT01648582|530175582|FG000|Overall Study|Adverse Event|6|||
147003172|NCT01648582|530175583|FG001|Overall Study|Adverse Event|11|||
147003173|NCT01648582|530175584|FG002|Overall Study|Adverse Event|2|||
147003174|NCT01648582|530175582|FG000|Overall Study|Lost to Follow-up|9|||
147003175|NCT01648582|530175583|FG001|Overall Study|Lost to Follow-up|6|||
147003176|NCT01648582|530175584|FG002|Overall Study|Lost to Follow-up|8|||
147003177|NCT01648582|530175582|FG000|Overall Study|Protocol Violation|1|||
147003178|NCT01648582|530175583|FG001|Overall Study|Protocol Violation|2|||
147003179|NCT01648582|530175584|FG002|Overall Study|Protocol Violation|1|||
147003180|NCT01648582|530175582|FG000|Overall Study|Withdrawal by Subject|15|||
147003181|NCT01648582|530175583|FG001|Overall Study|Withdrawal by Subject|17|||
147003182|NCT01648582|530175584|FG002|Overall Study|Withdrawal by Subject|17|||
147003183|NCT01648582|530175582|FG000|Overall Study|Physician Decision|0|||
147003184|NCT01648582|530175583|FG001|Overall Study|Physician Decision|1|||
147003185|NCT01648582|530175584|FG002|Overall Study|Physician Decision|3|||
147003186|NCT01648582|530175582|FG000|Overall Study|Death|1|||
147003187|NCT01648582|530175583|FG001|Overall Study|Death|0|||
147003188|NCT01648582|530175584|FG002|Overall Study|Death|0|||
147003189|NCT01648582|530175582|FG000|Overall Study|Sponsor Decision|0|||
147003190|NCT01648582|530175583|FG001|Overall Study|Sponsor Decision|1|||
147003191|NCT01648582|530175584|FG002|Overall Study|Sponsor Decision|1|||
147003192|NCT04408794|530175585|FG000|Overall Study|Adverse Event|43|||
147003193|NCT04408794|530175585|FG000|Overall Study|Infrequent study drug usage|43|||
147003194|NCT04408794|530175585|FG000|Overall Study|Lack of Efficacy|61|||
147003195|NCT04408794|530175585|FG000|Overall Study|Lost to Follow-up|33|||
146845209|NCT03846453|529602727|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
146845210|NCT03846453|529602728|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
147003196|NCT04408794|530175585|FG000|Overall Study|Non-compliance|6|||
147003197|NCT04408794|530175585|FG000|Overall Study|Physician Decision|1|||
147003198|NCT04408794|530175585|FG000|Overall Study|Pregnancy|6|||
147003199|NCT04408794|530175585|FG000|Overall Study|Protocol Deviation|9|||
147003200|NCT04408794|530175585|FG000|Overall Study|Sheehan-STS Result|1|||
147003201|NCT04408794|530175585|FG000|Overall Study|Withdrawal by Subject|57|||
147003202|NCT04408794|530175585|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
147003203|NCT04408794|530175585|FG000|Overall Study|Never Treated Migraine|5|||
147003204|NCT01444378|530175590|FG000|Overall Study|Lost to Follow-up|1|||
147003205|NCT01444378|530175590|FG000|Overall Study|Withdrawal by Subject|1|||
147003206|NCT01444378|530175590|FG000|Overall Study|Death|3|||
147003207|NCT01444378|530175590|FG000|Overall Study|Administrative Closure Of The Study|2|||
147003208|NCT01444378|530175590|FG000|Overall Study|Missed Visits|10|||
147003209|NCT00556322|530175591|FG000|Overall Study|Insufficient therapeutic response|158|||
147003210|NCT00556322|530175592|FG001|Overall Study|Insufficient therapeutic response|168|||
147003211|NCT00556322|530175591|FG000|Overall Study|Adverse Event|7|||
147003212|NCT00556322|530175592|FG001|Overall Study|Adverse Event|4|||
147003213|NCT00556322|530175591|FG000|Overall Study|Other|4|||
147003214|NCT00556322|530175592|FG001|Overall Study|Other|1|||
147003215|NCT00556322|530175591|FG000|Overall Study|Lost to Follow-up|5|||
147003216|NCT00556322|530175592|FG001|Overall Study|Lost to Follow-up|3|||
147003217|NCT00556322|530175591|FG000|Overall Study|Withdrawal by Subject|19|||
147003218|NCT00556322|530175592|FG001|Overall Study|Withdrawal by Subject|7|||
147003219|NCT00556322|530175591|FG000|Overall Study|Protocol Violation|5|||
147003220|NCT00556322|530175592|FG001|Overall Study|Protocol Violation|1|||
147003221|NCT00556322|530175591|FG000|Overall Study|Ongoing at data cutoff|3|||
147003222|NCT00556322|530175592|FG001|Overall Study|Ongoing at data cutoff|5|||
147003223|NCT00556322|530175591|FG000|Overall Study|Death|20|||
147003224|NCT00556322|530175592|FG001|Overall Study|Death|14|||
147003225|NCT03261167|530175595|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
147003226|NCT03261167|530175596|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
147003227|NCT03261167|530175595|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
147003228|NCT03261167|530175596|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
147003229|NCT03261167|530175595|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
147003230|NCT03261167|530175596|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
147003231|NCT03261167|530175595|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
147003232|NCT03261167|530175596|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
147003233|NCT03261167|530175595|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
147003234|NCT03261167|530175596|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
147003235|NCT03256695|530175599|FG000|Overall Study|Adverse Event|8|||
147003236|NCT03256695|530175599|FG000|Overall Study|Death|2|||
147003237|NCT03256695|530175599|FG000|Overall Study|Withdrawal by Subject|14|||
147003238|NCT03256695|530175599|FG000|Overall Study|Non-compliance with study drug|1|||
147003239|NCT03256695|530175599|FG000|Overall Study|Lost to Follow-up|3|||
147003240|NCT03256695|530175599|FG000|Overall Study|Lack of Efficacy|3|||
147003241|NCT03256695|530175599|FG000|Overall Study|Protocol Violation|5|||
147003242|NCT03256695|530175599|FG000|Overall Study|Other than specified|3|||
147003243|NCT00318461|530175600|FG000|Double-Blind, 6 Months|Adverse Event|11|||
147003244|NCT00318461|530175601|FG001|Double-Blind, 6 Months|Adverse Event|23|||
147003245|NCT00318461|530175602|FG002|Double-Blind, 6 Months|Adverse Event|29|||
147003246|NCT00318461|530175603|FG003|Double-Blind, 6 Months|Adverse Event|2|||
147003247|NCT00318461|530175604|FG004|Double-Blind, 6 Months|Adverse Event|8|||
147003248|NCT00318461|530175600|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
147003249|NCT00318461|530175601|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
147003250|NCT00318461|530175602|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
147003251|NCT00318461|530175603|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
147003252|NCT00318461|530175604|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
147003253|NCT00318461|530175600|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
147003254|NCT00318461|530175601|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
147003255|NCT00318461|530175602|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
147003256|NCT00318461|530175603|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
147003257|NCT00318461|530175604|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
147003258|NCT00318461|530175600|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
147003259|NCT00318461|530175601|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
147003260|NCT00318461|530175602|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
147003261|NCT00318461|530175603|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
147003262|NCT00318461|530175604|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
147003263|NCT00318461|530175600|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
147003264|NCT00318461|530175601|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
147003265|NCT00318461|530175602|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
147003266|NCT00318461|530175603|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
147003267|NCT00318461|530175604|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
147003268|NCT00318461|530175600|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
147003269|NCT00318461|530175601|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
147003270|NCT00318461|530175602|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
147003271|NCT00318461|530175603|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
147003272|NCT00318461|530175604|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
147003273|NCT00318461|530175600|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
147003274|NCT00318461|530175601|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
147003275|NCT00318461|530175602|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
147003276|NCT00318461|530175603|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
147003277|NCT00318461|530175604|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
147003278|NCT00318461|530175600|FG000|Double-Blind, 6 Months|Move|0|||
147003279|NCT00318461|530175601|FG001|Double-Blind, 6 Months|Move|1|||
147003280|NCT00318461|530175602|FG002|Double-Blind, 6 Months|Move|0|||
146845211|NCT03846453|529602729|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
146845212|NCT03846453|529602727|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
147003281|NCT00318461|530175603|FG003|Double-Blind, 6 Months|Move|0|||
147003282|NCT00318461|530175604|FG004|Double-Blind, 6 Months|Move|0|||
147003283|NCT00318461|530175600|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
147003284|NCT00318461|530175601|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
147003285|NCT00318461|530175602|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
147003286|NCT00318461|530175603|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
147003287|NCT00318461|530175604|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
147003288|NCT00318461|530175600|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
147003289|NCT00318461|530175601|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
147003290|NCT00318461|530175602|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
147003291|NCT00318461|530175603|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
147003292|NCT00318461|530175604|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
147003293|NCT00318461|530175600|FG000|Double-Blind, 6 Months|Work commitment|0|||
147003294|NCT00318461|530175601|FG001|Double-Blind, 6 Months|Work commitment|0|||
147003295|NCT00318461|530175602|FG002|Double-Blind, 6 Months|Work commitment|0|||
147003296|NCT00318461|530175603|FG003|Double-Blind, 6 Months|Work commitment|0|||
147003297|NCT00318461|530175604|FG004|Double-Blind, 6 Months|Work commitment|1|||
147003298|NCT00318461|530175600|FG000|Double-Blind, 6 Months|Investigator decision|0|||
147003299|NCT00318461|530175601|FG001|Double-Blind, 6 Months|Investigator decision|0|||
147003300|NCT00318461|530175602|FG002|Double-Blind, 6 Months|Investigator decision|0|||
147003301|NCT00318461|530175603|FG003|Double-Blind, 6 Months|Investigator decision|0|||
147003302|NCT00318461|530175604|FG004|Double-Blind, 6 Months|Investigator decision|1|||
147003303|NCT00318461|530175600|FG000|Double-Blind, 6 Months|Lack of time|1|||
147003304|NCT00318461|530175601|FG001|Double-Blind, 6 Months|Lack of time|0|||
147003305|NCT00318461|530175602|FG002|Double-Blind, 6 Months|Lack of time|0|||
147003306|NCT00318461|530175603|FG003|Double-Blind, 6 Months|Lack of time|0|||
147003307|NCT00318461|530175604|FG004|Double-Blind, 6 Months|Lack of time|0|||
147003308|NCT00318461|530175600|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
147003309|NCT00318461|530175601|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
147003310|NCT00318461|530175602|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
147003311|NCT00318461|530175603|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
147003312|NCT00318461|530175604|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
147003313|NCT00318461|530175600|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
147003314|NCT00318461|530175601|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
147003315|NCT00318461|530175602|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
147003316|NCT00318461|530175603|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
147003317|NCT00318461|530175604|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
147003318|NCT00318461|530175600|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
147003319|NCT00318461|530175601|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
147003320|NCT00318461|530175602|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
147003321|NCT00318461|530175603|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
147003322|NCT00318461|530175604|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
147003323|NCT00318461|530175600|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
147003324|NCT00318461|530175601|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
147003325|NCT00318461|530175602|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
147003326|NCT00318461|530175603|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
147003327|NCT00318461|530175604|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
147003328|NCT00318461|530175600|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
147003329|NCT00318461|530175601|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
147003330|NCT00318461|530175602|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
147003331|NCT00318461|530175603|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
147003332|NCT00318461|530175604|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
147003333|NCT00318461|530175600|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
147003334|NCT00318461|530175601|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
147003335|NCT00318461|530175602|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
147003336|NCT00318461|530175603|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
147003337|NCT00318461|530175604|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
147003338|NCT00318461|530175600|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
147003339|NCT00318461|530175601|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
147003340|NCT00318461|530175602|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
147003341|NCT00318461|530175603|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
147003342|NCT00318461|530175604|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
147003343|NCT00318461|530175600|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
147003344|NCT00318461|530175601|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
147003345|NCT00318461|530175602|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
147003346|NCT00318461|530175603|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
147003347|NCT00318461|530175604|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
147003348|NCT01848938|530175613|FG000|Overall Study|Lost to Follow-up|1|||
147003349|NCT01848938|530175614|FG001|Overall Study|Lost to Follow-up|1|||
147003350|NCT01757392|530175615|FG000|Overall Study|Withdrawal by Subject|1|||
147003351|NCT01757392|530175615|FG000|Overall Study|Screen Fail|3|||
147003352|NCT00207090|530175620|FG000|Overall Study|Study drug toxicity|3|||
147003353|NCT00207090|530175620|FG000|Overall Study|Chest wall mass larger|1|||
147003354|NCT00207090|530175620|FG000|Overall Study|Disease progression/relapse|2|||
147003355|NCT00207090|530175620|FG000|Overall Study|Physician Decision|1|||
147003356|NCT00841698|530175623|FG000|First Intervention|Withdrawal by Subject|1|||
147003357|NCT00841698|530175624|FG001|First Intervention|Withdrawal by Subject|0|||
147003358|NCT01348789|530175636|FG000|Overall Study|Protocol Violation|2|||
146736036|NCT01412801|529205278|FG004|Overall Study|Relocated to another area|0|||
147003359|NCT01348789|530175636|FG000|Overall Study|Withdrawal by Subject|2|||
147003360|NCT00323882|530175637|FG000|Overall Study|Adverse Event|2|||
147003361|NCT00323882|530175638|FG001|Overall Study|Adverse Event|1|||
147003362|NCT00323882|530175639|FG002|Overall Study|Adverse Event|1|||
147003363|NCT00323882|530175640|FG003|Overall Study|Adverse Event|1|||
147003364|NCT00323882|530175641|FG004|Overall Study|Adverse Event|3|||
147003365|NCT00323882|530175637|FG000|Overall Study|Disease Progression|6|||
147003366|NCT00323882|530175638|FG001|Overall Study|Disease Progression|4|||
147003367|NCT00323882|530175639|FG002|Overall Study|Disease Progression|10|||
147003368|NCT00323882|530175640|FG003|Overall Study|Disease Progression|5|||
147003369|NCT00323882|530175641|FG004|Overall Study|Disease Progression|22|||
147003370|NCT00323882|530175637|FG000|Overall Study|Death|0|||
147003371|NCT00323882|530175638|FG001|Overall Study|Death|1|||
147003372|NCT00323882|530175639|FG002|Overall Study|Death|1|||
147003373|NCT00323882|530175640|FG003|Overall Study|Death|0|||
147003374|NCT00323882|530175641|FG004|Overall Study|Death|5|||
147003375|NCT00323882|530175637|FG000|Overall Study|Lost to Follow-up|0|||
147003376|NCT00323882|530175638|FG001|Overall Study|Lost to Follow-up|0|||
147003377|NCT00323882|530175639|FG002|Overall Study|Lost to Follow-up|1|||
147003378|NCT00323882|530175640|FG003|Overall Study|Lost to Follow-up|0|||
147003379|NCT00323882|530175641|FG004|Overall Study|Lost to Follow-up|1|||
147003380|NCT00323882|530175637|FG000|Overall Study|Other|0|||
147003381|NCT00323882|530175638|FG001|Overall Study|Other|0|||
147003382|NCT00323882|530175639|FG002|Overall Study|Other|0|||
147003383|NCT00323882|530175640|FG003|Overall Study|Other|1|||
147003384|NCT00323882|530175641|FG004|Overall Study|Other|1|||
147003385|NCT00830024|530175648|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
147003386|NCT00830024|530175649|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
147003387|NCT00429416|530175650|FG000|Overall Study|Death|1|||
147003388|NCT02619682|530175651|FG000|Overall Study|Withdrawal by Subject|3|||
147003389|NCT02619682|530175651|FG000|Overall Study|Lack of Efficacy|8|||
147003390|NCT02619682|530175651|FG000|Overall Study|new secondary cancer|1|||
147003391|NCT02619682|530175651|FG000|Overall Study|post surgery complications|2|||
147003392|NCT03600376|530175652|FG000|Overall Study|Adverse Event|1|||
147003393|NCT03600376|530175653|FG001|Overall Study|Adverse Event|1|||
147003394|NCT03600376|530175652|FG000|Overall Study|Transferred to other facility|1|||
147003395|NCT03600376|530175653|FG001|Overall Study|Transferred to other facility|0|||
147003396|NCT03600376|530175652|FG000|Overall Study|Investigator Decision|0|||
147003397|NCT03600376|530175653|FG001|Overall Study|Investigator Decision|4|||
147003398|NCT03600376|530175652|FG000|Overall Study|Determined to be ineligible for study|0|||
146736037|NCT01412801|529205279|FG005|Overall Study|Relocated to another area|0|||
147003399|NCT03600376|530175653|FG001|Overall Study|Determined to be ineligible for study|1|||
147003400|NCT02358538|530175654|FG000|Through Week 26|Adverse Event|0|||
147003401|NCT02358538|530175655|FG001|Through Week 26|Adverse Event|1|||
147003402|NCT02358538|530175656|FG002|Through Week 26|Adverse Event|1|||
147003403|NCT02358538|530175657|FG003|Through Week 26|Adverse Event|2|||
147003404|NCT02358538|530175654|FG000|Through Week 26|Lack of Efficacy|1|||
147003405|NCT02358538|530175655|FG001|Through Week 26|Lack of Efficacy|1|||
147003406|NCT02358538|530175656|FG002|Through Week 26|Lack of Efficacy|3|||
147003407|NCT02358538|530175657|FG003|Through Week 26|Lack of Efficacy|3|||
147003408|NCT02358538|530175654|FG000|Through Week 26|Withdrawal by Subject|1|||
147003409|NCT02358538|530175655|FG001|Through Week 26|Withdrawal by Subject|0|||
147003410|NCT02358538|530175656|FG002|Through Week 26|Withdrawal by Subject|0|||
147003411|NCT02358538|530175657|FG003|Through Week 26|Withdrawal by Subject|0|||
147003412|NCT02358538|530175654|FG000|Through Week 26|Non-Compliance|0|||
147003413|NCT02358538|530175655|FG001|Through Week 26|Non-Compliance|0|||
147003414|NCT02358538|530175656|FG002|Through Week 26|Non-Compliance|1|||
147003415|NCT02358538|530175657|FG003|Through Week 26|Non-Compliance|0|||
147003416|NCT02358538|530175654|FG000|Through Week 26|Family did not see benefit from IP|1|||
147003417|NCT02358538|530175655|FG001|Through Week 26|Family did not see benefit from IP|0|||
147003418|NCT02358538|530175656|FG002|Through Week 26|Family did not see benefit from IP|0|||
147003419|NCT02358538|530175657|FG003|Through Week 26|Family did not see benefit from IP|0|||
147003420|NCT02358538|530175654|FG000|52 Week Extension Period|Lack of Efficacy|0|||
147003421|NCT02358538|530175655|FG001|52 Week Extension Period|Lack of Efficacy|0|||
147003422|NCT02358538|530175656|FG002|52 Week Extension Period|Lack of Efficacy|2|||
147003423|NCT02358538|530175657|FG003|52 Week Extension Period|Lack of Efficacy|4|||
147003424|NCT06999265|530175658|FG000|Overall Study|Lost to Follow-up|1|||
147003425|NCT06999265|530175659|FG001|Overall Study|Lost to Follow-up|1|||
147003426|NCT02178787|530175660|FG000|Overall Study|Lost to Follow-up|1|||
147003427|NCT02178787|530175661|FG001|Overall Study|Lost to Follow-up|0|||
147003428|NCT02178787|530175660|FG000|Overall Study|Withdrawal by Subject|0|||
147003429|NCT02178787|530175661|FG001|Overall Study|Withdrawal by Subject|2|||
147003430|NCT02178787|530175660|FG000|Overall Study|No TCD window|3|||
147003431|NCT02178787|530175661|FG001|Overall Study|No TCD window|7|||
147003432|NCT02178787|530175660|FG000|Overall Study|Physician Decision|1|||
147003433|NCT02178787|530175661|FG001|Overall Study|Physician Decision|0|||
147003434|NCT02554890|530175662|FG000|Double-blind|Adverse Event|45|||
147003435|NCT02554890|530175663|FG001|Double-blind|Adverse Event|51|||
147003436|NCT02554890|530175662|FG000|Double-blind|Death|6|||
147003437|NCT02554890|530175663|FG001|Double-blind|Death|4|||
147003438|NCT02554890|530175662|FG000|Double-blind|Protocol Violation|1|||
147003439|NCT02554890|530175663|FG001|Double-blind|Protocol Violation|1|||
147003440|NCT02554890|530175662|FG000|Double-blind|Physician Decision|4|||
147003441|NCT02554890|530175663|FG001|Double-blind|Physician Decision|3|||
147003442|NCT02554890|530175662|FG000|Double-blind|Subject/Guardian decision|21|||
147003443|NCT02554890|530175663|FG001|Double-blind|Subject/Guardian decision|16|||
147003444|NCT02554890|530175662|FG000|Double-blind|Lost to Follow-up|7|||
147003445|NCT02554890|530175663|FG001|Double-blind|Lost to Follow-up|5|||
147003446|NCT02554890|530175662|FG000|Double-blind|Technical problems|1|||
147003447|NCT02554890|530175663|FG001|Double-blind|Technical problems|0|||
147003448|NCT02554890|530175662|FG000|Double-blind|Withdrawal by Subject|5|||
147003449|NCT02554890|530175663|FG001|Double-blind|Withdrawal by Subject|6|||
147003450|NCT02554890|530175662|FG000|Double-blind|Noncompliance with study treatment|6|||
147003451|NCT02554890|530175663|FG001|Double-blind|Noncompliance with study treatment|5|||
147003452|NCT02554890|530175662|FG000|Open-label|Adverse Event|0|||
147003453|NCT02554890|530175663|FG001|Open-label|Adverse Event|30|||
147003454|NCT02554890|530175662|FG000|Open-label|Death|0|||
147003455|NCT02554890|530175663|FG001|Open-label|Death|1|||
147003456|NCT02554890|530175662|FG000|Open-label|Physician Decision|0|||
147003457|NCT02554890|530175663|FG001|Open-label|Physician Decision|1|||
147003458|NCT02554890|530175662|FG000|Open-label|Subject/Guardian decision|0|||
147003459|NCT02554890|530175663|FG001|Open-label|Subject/Guardian decision|11|||
147003460|NCT02554890|530175662|FG000|Open-label|Lost to Follow-up|0|||
147003461|NCT02554890|530175663|FG001|Open-label|Lost to Follow-up|7|||
147003462|NCT02554890|530175662|FG000|Open-label|Technical problems|0|||
147003463|NCT02554890|530175663|FG001|Open-label|Technical problems|1|||
147003464|NCT02554890|530175662|FG000|Open-label|Withdrawal by Subject|0|||
147003465|NCT02554890|530175663|FG001|Open-label|Withdrawal by Subject|1|||
147003466|NCT03649477|530175669|FG000|Overall Study|Adverse Event|2|||
147003467|NCT03649477|530175670|FG001|Overall Study|Adverse Event|0|||
147003468|NCT03649477|530175671|FG002|Overall Study|Adverse Event|0|||
147003469|NCT01030133|530175672|FG000|Overall Study|failed to experience pain at level 7/10|2|||
147003470|NCT01030133|530175673|FG001|Overall Study|failed to experience pain at level 7/10|2|||
147003471|NCT01750294|530177002|FG000|Overall Study|Withdrawal by Subject|1|||
147003472|NCT01750294|530177002|FG000|Overall Study|Safety Endpoint|1|||
147003473|NCT01116739|530177003|FG000|Overall Study|Child had 2 years of HS|110|||
147003474|NCT01116739|530177004|FG001|Overall Study|Child had 2 years of HS|128|||
147003475|NCT01116739|530177003|FG000|Overall Study|Withdrawal by Subject|6|||
147003476|NCT01116739|530177004|FG001|Overall Study|Withdrawal by Subject|0|||
147003477|NCT01116739|530177003|FG000|Overall Study|child too young|2|||
147003478|NCT01116739|530177004|FG001|Overall Study|child too young|6|||
147003479|NCT01116739|530177003|FG000|Overall Study|child not enrolled in head start|10|||
147003480|NCT01116739|530177004|FG001|Overall Study|child not enrolled in head start|2|||
147003481|NCT01116739|530177003|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
147003482|NCT01116739|530177004|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
147003483|NCT01624233|530177005|FG000|Period 2 - Induction|Adverse Event|1|||
147003484|NCT01624233|530177005|FG000|Period 3 - Maintenance|Adverse Event|2|||
147003485|NCT01624233|530177005|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
147003486|NCT01624233|530177005|FG000|Period 3 - Maintenance|Physician Decision|2|||
147003487|NCT01624233|530177005|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
147003488|NCT01624233|530177005|FG000|Period 4 - Drug Free Period|Relapsed|61|||
147003489|NCT01624233|530177005|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
147003490|NCT01624233|530177005|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
147003491|NCT01624233|530177005|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
147003492|NCT01624233|530177005|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
147003493|NCT01624233|530177005|FG000|Period 6: Follow-up|Adverse Event|3|||
147003494|NCT01624233|530177005|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
147003495|NCT01624233|530177005|FG000|Period 6: Follow-up|Physician Decision|1|||
147003496|NCT01624233|530177005|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
147003497|NCT05090839|530177006|FG000|Overall Study|Lost to Follow-up|2|||
147003498|NCT05090839|530177007|FG001|Overall Study|Lost to Follow-up|3|||
147003499|NCT05090839|530177008|FG002|Overall Study|Lost to Follow-up|1|||
147003500|NCT05090839|530177009|FG003|Overall Study|Lost to Follow-up|1|||
147003501|NCT05710718|530177010|FG000|Overall Study|Withdrawal by Subject|5|||
146845213|NCT03846453|529602728|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
147003502|NCT05710718|530177011|FG001|Overall Study|Withdrawal by Subject|1|||
147003503|NCT05710718|530177010|FG000|Overall Study|Lost to Follow-up|0|||
147003504|NCT05710718|530177011|FG001|Overall Study|Lost to Follow-up|1|||
147003505|NCT05710718|530177010|FG000|Overall Study|Death|0|||
147003506|NCT05710718|530177011|FG001|Overall Study|Death|1|||
147003507|NCT01528696|530177013|FG000|Overall Study|See detailed description|18|||
147003508|NCT01528696|530177014|FG001|Overall Study|See detailed description|19|||
147003509|NCT01056484|530177015|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
147003510|NCT01056484|530177016|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
147003511|NCT01056484|530177015|FG000|Randomized Controlled Trial|Physician Decision|1|||
147003512|NCT01056484|530177016|FG001|Randomized Controlled Trial|Physician Decision|0|||
147003513|NCT01056484|530177015|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
147003514|NCT01056484|530177016|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
147003515|NCT00835575|530177018|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
147003516|NCT00835575|530177019|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
147003517|NCT03606174|530177024|FG000|Overall Study|Death|37|||
147003518|NCT03606174|530177025|FG001|Overall Study|Death|15|||
147003519|NCT03606174|530177026|FG002|Overall Study|Death|15|||
147003520|NCT03606174|530177027|FG003|Overall Study|Death|7|||
147003521|NCT03606174|530177028|FG004|Overall Study|Death|35|||
147003522|NCT03606174|530177029|FG005|Overall Study|Death|12|||
147003523|NCT03606174|530177030|FG006|Overall Study|Death|35|||
147003524|NCT03606174|530177031|FG007|Overall Study|Death|8|||
147003525|NCT03606174|530177032|FG008|Overall Study|Death|5|||
147003526|NCT03606174|530177033|FG009|Overall Study|Death|3|||
147003527|NCT03606174|530177034|FG010|Overall Study|Death|0|||
147003528|NCT03606174|530177024|FG000|Overall Study|Lost to Follow-up|0|||
147003529|NCT03606174|530177025|FG001|Overall Study|Lost to Follow-up|0|||
147003530|NCT03606174|530177026|FG002|Overall Study|Lost to Follow-up|0|||
147003531|NCT03606174|530177027|FG003|Overall Study|Lost to Follow-up|0|||
147003532|NCT03606174|530177028|FG004|Overall Study|Lost to Follow-up|1|||
147003533|NCT03606174|530177029|FG005|Overall Study|Lost to Follow-up|1|||
147003534|NCT03606174|530177030|FG006|Overall Study|Lost to Follow-up|0|||
147003535|NCT03606174|530177031|FG007|Overall Study|Lost to Follow-up|0|||
147003536|NCT03606174|530177032|FG008|Overall Study|Lost to Follow-up|0|||
147003537|NCT03606174|530177033|FG009|Overall Study|Lost to Follow-up|0|||
147003538|NCT03606174|530177034|FG010|Overall Study|Lost to Follow-up|0|||
147003539|NCT03606174|530177024|FG000|Overall Study|Withdrawal by Subject|6|||
147003540|NCT03606174|530177025|FG001|Overall Study|Withdrawal by Subject|0|||
147003541|NCT03606174|530177026|FG002|Overall Study|Withdrawal by Subject|0|||
147003542|NCT03606174|530177027|FG003|Overall Study|Withdrawal by Subject|1|||
147003543|NCT03606174|530177028|FG004|Overall Study|Withdrawal by Subject|2|||
147003544|NCT03606174|530177029|FG005|Overall Study|Withdrawal by Subject|1|||
147003545|NCT03606174|530177030|FG006|Overall Study|Withdrawal by Subject|4|||
147003546|NCT03606174|530177031|FG007|Overall Study|Withdrawal by Subject|0|||
147003547|NCT03606174|530177032|FG008|Overall Study|Withdrawal by Subject|0|||
147003548|NCT03606174|530177033|FG009|Overall Study|Withdrawal by Subject|0|||
147003549|NCT03606174|530177034|FG010|Overall Study|Withdrawal by Subject|1|||
147003550|NCT03606174|530177024|FG000|Overall Study|Study Terminated by Sponsor|5|||
147003551|NCT03606174|530177025|FG001|Overall Study|Study Terminated by Sponsor|7|||
147003552|NCT03606174|530177026|FG002|Overall Study|Study Terminated by Sponsor|3|||
147003553|NCT03606174|530177027|FG003|Overall Study|Study Terminated by Sponsor|0|||
147003554|NCT03606174|530177028|FG004|Overall Study|Study Terminated by Sponsor|11|||
147003555|NCT03606174|530177029|FG005|Overall Study|Study Terminated by Sponsor|6|||
147003556|NCT03606174|530177030|FG006|Overall Study|Study Terminated by Sponsor|12|||
147003557|NCT03606174|530177031|FG007|Overall Study|Study Terminated by Sponsor|1|||
147003558|NCT03606174|530177032|FG008|Overall Study|Study Terminated by Sponsor|3|||
147003559|NCT03606174|530177033|FG009|Overall Study|Study Terminated by Sponsor|1|||
147003560|NCT03606174|530177034|FG010|Overall Study|Study Terminated by Sponsor|2|||
147003561|NCT03606174|530177024|FG000|Overall Study|Miscellaneous|1|||
147003562|NCT03606174|530177025|FG001|Overall Study|Miscellaneous|1|||
147003563|NCT03606174|530177026|FG002|Overall Study|Miscellaneous|0|||
147003564|NCT03606174|530177027|FG003|Overall Study|Miscellaneous|1|||
147003565|NCT03606174|530177028|FG004|Overall Study|Miscellaneous|4|||
147003566|NCT03606174|530177029|FG005|Overall Study|Miscellaneous|7|||
147003567|NCT03606174|530177030|FG006|Overall Study|Miscellaneous|5|||
147003568|NCT03606174|530177031|FG007|Overall Study|Miscellaneous|0|||
147003569|NCT03606174|530177032|FG008|Overall Study|Miscellaneous|0|||
147003570|NCT03606174|530177033|FG009|Overall Study|Miscellaneous|0|||
147003571|NCT03606174|530177034|FG010|Overall Study|Miscellaneous|1|||
147003572|NCT02241551|530177037|FG000|Overall Study|Adverse Event|1|||
147003573|NCT02241551|530177038|FG001|Overall Study|Adverse Event|0|||
147003574|NCT03246503|530177039|FG000|Overall Study|Lost to Follow-up|23|||
147003575|NCT03246503|530177039|FG000|Overall Study|Withdrawal by Subject|20|||
147003576|NCT03246503|530177039|FG000|Overall Study|Physician Decision|5|||
147003577|NCT03246503|530177039|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
146845214|NCT03846453|529602729|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
146845215|NCT03846453|529602727|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
146845216|NCT03846453|529602728|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
146845217|NCT03846453|529602729|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
147003578|NCT01896934|530177047|FG000|Overall Study|Adverse Event|1|||
147003579|NCT01896934|530177047|FG000|Overall Study|Withdrawal by Subject|1|||
147003580|NCT02197416|530177048|FG000|Overall Study|Other reasons|0|||
147003581|NCT02197416|530177049|FG001|Overall Study|Other reasons|2|||
147003582|NCT02197416|530177050|FG002|Overall Study|Other reasons|5|||
147003583|NCT02197416|530177048|FG000|Overall Study|Withdrawal by Subject|0|||
147003584|NCT02197416|530177049|FG001|Overall Study|Withdrawal by Subject|2|||
147003585|NCT02197416|530177050|FG002|Overall Study|Withdrawal by Subject|1|||
147003586|NCT02197416|530177048|FG000|Overall Study|Protocol Violation|1|||
147003587|NCT02197416|530177049|FG001|Overall Study|Protocol Violation|0|||
147003588|NCT02197416|530177050|FG002|Overall Study|Protocol Violation|1|||
147003589|NCT02197416|530177048|FG000|Overall Study|Adverse Event|0|||
147003590|NCT02197416|530177049|FG001|Overall Study|Adverse Event|0|||
147003591|NCT02197416|530177050|FG002|Overall Study|Adverse Event|1|||
147003592|NCT00716625|530177051|FG000|Overall Study|Safety was not Assessable|1|||
147003593|NCT05014828|530177052|FG000|Overall Study|Study Completed by Sponsor|16|||
147003594|NCT05014828|530177053|FG001|Overall Study|Study Completed by Sponsor|16|||
147003595|NCT05014828|530177054|FG002|Overall Study|Study Completed by Sponsor|3|||
147003596|NCT05014828|530177055|FG003|Overall Study|Study Completed by Sponsor|3|||
147003597|NCT05014828|530177052|FG000|Overall Study|Death|11|||
147003598|NCT05014828|530177053|FG001|Overall Study|Death|6|||
147003599|NCT05014828|530177054|FG002|Overall Study|Death|0|||
147003600|NCT05014828|530177055|FG003|Overall Study|Death|0|||
147003601|NCT05014828|530177052|FG000|Overall Study|Lost to Follow-up|0|||
146845218|NCT03846453|529602727|FG000|Placebo Run-in (14 Days)|Other|2|||
146845219|NCT03846453|529602728|FG001|Placebo Run-in (14 Days)|Other|0|||
146845220|NCT03846453|529602729|FG002|Placebo Run-in (14 Days)|Other|0|||
146845221|NCT03846453|529602727|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
146845222|NCT03846453|529602728|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
146845223|NCT03846453|529602729|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
146845224|NCT03846453|529602727|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
146845225|NCT03846453|529602728|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
146845226|NCT03846453|529602729|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
146845227|NCT03846453|529602727|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
146845228|NCT03846453|529602728|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
146845229|NCT03846453|529602729|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
147003602|NCT05014828|530177053|FG001|Overall Study|Lost to Follow-up|0|||
147003603|NCT05014828|530177054|FG002|Overall Study|Lost to Follow-up|2|||
147003604|NCT05014828|530177055|FG003|Overall Study|Lost to Follow-up|0|||
147003605|NCT05014828|530177052|FG000|Overall Study|Miscellaneous.|0|||
147003606|NCT05014828|530177053|FG001|Overall Study|Miscellaneous.|1|||
147003607|NCT05014828|530177054|FG002|Overall Study|Miscellaneous.|0|||
147003608|NCT05014828|530177055|FG003|Overall Study|Miscellaneous.|0|||
147003609|NCT04590027|530177056|FG000|Overall Study|Lost to Follow-up|17|||
147003610|NCT04590027|530177057|FG001|Overall Study|Lost to Follow-up|14|||
147003611|NCT04590027|530177056|FG000|Overall Study|Protocol Violation|0|||
147003612|NCT04590027|530177057|FG001|Overall Study|Protocol Violation|3|||
147003613|NCT00933686|530177058|FG000|Overall Study|Protocol Violation|0|||
147003614|NCT00933686|530177059|FG001|Overall Study|Protocol Violation|1|||
147003615|NCT00933686|530177058|FG000|Overall Study|Lost to Follow-up|2|||
147003616|NCT00933686|530177059|FG001|Overall Study|Lost to Follow-up|2|||
147003617|NCT00933686|530177058|FG000|Overall Study|Withdrawal by Subject|6|||
147003618|NCT00933686|530177059|FG001|Overall Study|Withdrawal by Subject|5|||
147003619|NCT00933686|530177058|FG000|Overall Study|Adverse Event|1|||
147003620|NCT00933686|530177059|FG001|Overall Study|Adverse Event|1|||
147003621|NCT00933686|530177058|FG000|Overall Study|Physician Decision|1|||
147003622|NCT00933686|530177059|FG001|Overall Study|Physician Decision|0|||
147003623|NCT00933686|530177058|FG000|Overall Study|Failure to show up at endpoint visits|0|||
147003624|NCT00933686|530177059|FG001|Overall Study|Failure to show up at endpoint visits|2|||
147003625|NCT01383486|530177060|FG000|Overall Study|Lost to Follow-up|10|||
147003626|NCT01383486|530177060|FG000|Overall Study|Incomplete information for analysis|2|||
147003627|NCT01383486|530177060|FG000|Overall Study|Did not take any product|6|||
147003628|NCT03276754|530177062|FG000|Overall Study|Withdrawal of informed consent|4|||
147003629|NCT03276754|530177062|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
147003630|NCT03276754|530177062|FG000|Overall Study|Lost to Follow-up|27|||
147003631|NCT03276754|530177062|FG000|Overall Study|No data reported at Month 24|31|||
147003632|NCT03276754|530177062|FG000|Overall Study|Death|39|||
147003633|NCT02911792|530177065|FG000|Overall Study|Lost to Follow-up|3|||
147003634|NCT02911792|530177066|FG001|Overall Study|Lost to Follow-up|3|||
147003635|NCT02911792|530177067|FG002|Overall Study|Lost to Follow-up|3|||
146845230|NCT03846453|529602727|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
146845231|NCT03846453|529602728|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
146845232|NCT03846453|529602729|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
146845233|NCT03846453|529602727|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
147003636|NCT02911792|530177068|FG003|Overall Study|Lost to Follow-up|3|||
147003637|NCT00927069|530177069|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
147003638|NCT00927069|530177070|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
146845234|NCT03846453|529602728|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
147003639|NCT00927069|530177071|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
147003640|NCT00927069|530177072|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
146845235|NCT03846453|529602729|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
147003641|NCT00927069|530177069|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
147003642|NCT00927069|530177070|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
147003643|NCT00927069|530177071|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
147003644|NCT00927069|530177072|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
147003645|NCT00927069|530177069|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
147003646|NCT00927069|530177070|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
147003647|NCT00927069|530177071|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
147003648|NCT00927069|530177072|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
147003649|NCT00927069|530177069|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
147003650|NCT00927069|530177070|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
147003651|NCT00927069|530177071|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
147003652|NCT00927069|530177072|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
147003653|NCT00927069|530177069|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
147003654|NCT00927069|530177070|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
147003655|NCT00927069|530177071|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
147003656|NCT00927069|530177072|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
147003657|NCT00796328|530177073|FG000|Overall Study|experienced hypotension requiring tx|6|||
147003658|NCT00466167|530177079|FG000|Overall Study|Adverse Event|8|||
147003659|NCT00466167|530177080|FG001|Overall Study|Adverse Event|8|||
147003660|NCT00466167|530177081|FG002|Overall Study|Adverse Event|7|||
147003661|NCT00466167|530177079|FG000|Overall Study|Lack of Efficacy|2|||
147003662|NCT00466167|530177080|FG001|Overall Study|Lack of Efficacy|0|||
147003663|NCT00466167|530177081|FG002|Overall Study|Lack of Efficacy|3|||
147003664|NCT00466167|530177079|FG000|Overall Study|Protocol Violation|1|||
147003665|NCT00466167|530177080|FG001|Overall Study|Protocol Violation|1|||
147003666|NCT00466167|530177081|FG002|Overall Study|Protocol Violation|2|||
147003667|NCT00466167|530177079|FG000|Overall Study|Lost to Follow-up|3|||
147003668|NCT00466167|530177080|FG001|Overall Study|Lost to Follow-up|2|||
147003669|NCT00466167|530177081|FG002|Overall Study|Lost to Follow-up|2|||
147003670|NCT00466167|530177079|FG000|Overall Study|Withdrawal by Subject|4|||
147003671|NCT00466167|530177080|FG001|Overall Study|Withdrawal by Subject|1|||
147003672|NCT00466167|530177081|FG002|Overall Study|Withdrawal by Subject|6|||
147003673|NCT00466167|530177079|FG000|Overall Study|patient did not meet inclusion criteria|1|||
147003674|NCT00466167|530177080|FG001|Overall Study|patient did not meet inclusion criteria|0|||
147003675|NCT00466167|530177081|FG002|Overall Study|patient did not meet inclusion criteria|1|||
147003676|NCT00466167|530177079|FG000|Overall Study|Not treated|1|||
147003677|NCT00466167|530177080|FG001|Overall Study|Not treated|0|||
147003678|NCT00466167|530177081|FG002|Overall Study|Not treated|0|||
147003679|NCT03199963|530177082|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
147003680|NCT03199963|530177083|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
147003681|NCT03199963|530177082|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
147003682|NCT03199963|530177083|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
147003683|NCT03199963|530177082|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
147003684|NCT03199963|530177083|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
147003685|NCT03199963|530177082|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
147003686|NCT03199963|530177083|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
147003687|NCT03199963|530177082|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
147003688|NCT03199963|530177083|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
147003689|NCT03199963|530177082|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
147003690|NCT03199963|530177083|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
147003691|NCT00107991|530177086|FG000|Eligibility Assessment|Disease not severe enough|7|||
147003692|NCT00107991|530177086|FG000|Eligibility Assessment|Unwilling to participate|7|||
147003693|NCT00107991|530177086|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
147003694|NCT00107991|530177086|FG000|Eligibility Assessment|Abnormal labs|2|||
147003695|NCT00107991|530177086|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
147003696|NCT00107991|530177086|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
147003697|NCT00107991|530177086|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
147003698|NCT00107991|530177086|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
147003699|NCT00107991|530177086|FG000|12 Week Treatment Period|Adverse Event|1|||
147003700|NCT00107991|530177086|FG000|12 Week Treatment Period|Protocol Violation|1|||
147003701|NCT00107991|530177086|FG000|12 Week Treatment Period|Incarcerated|1|||
147003702|NCT00107991|530177086|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
147003703|NCT01535222|530177087|FG000|Overall Study|Inclusion/exclusion|0|||
147003704|NCT01535222|530177088|FG001|Overall Study|Inclusion/exclusion|0|||
147003705|NCT01535222|530177089|FG002|Overall Study|Inclusion/exclusion|1|||
147003706|NCT01535222|530177090|FG003|Overall Study|Inclusion/exclusion|0|||
146736038|NCT01547299|529205280|FG000|Overall Study|Withdrawal by Subject|2|||
146736039|NCT01547299|529205281|FG001|Overall Study|Withdrawal by Subject|2|||
146845236|NCT00468143|529602730|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
147003707|NCT01535222|530177091|FG004|Overall Study|Inclusion/exclusion|0|||
147003708|NCT01535222|530177092|FG005|Overall Study|Inclusion/exclusion|0|||
147003709|NCT03669861|530177093|FG000|Overall Study|Disease Flare|5|||
147003710|NCT03669861|530177093|FG000|Overall Study|Lack of Efficacy|2|||
147003711|NCT02760927|530177094|FG000|Overall Study|Tube Slippage from Device|1|||
147003712|NCT03930732|530177095|FG000|Overall Study|Adverse Event|9|||
147003713|NCT03930732|530177096|FG001|Overall Study|Adverse Event|7|||
147003714|NCT03930732|530177095|FG000|Overall Study|Poor compliance to protocol|0|||
147003715|NCT03930732|530177096|FG001|Overall Study|Poor compliance to protocol|1|||
147003716|NCT03930732|530177095|FG000|Overall Study|Withdrawal by Subject|23|||
147003717|NCT03930732|530177096|FG001|Overall Study|Withdrawal by Subject|11|||
147003718|NCT03930732|530177095|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
147003719|NCT03930732|530177096|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
147003720|NCT03930732|530177095|FG000|Overall Study|Other reason not related to COVID-19|5|||
147003721|NCT03930732|530177096|FG001|Overall Study|Other reason not related to COVID-19|8|||
147003722|NCT02645409|530177105|FG000|Overall Study|Withdrawal by Subject|3|||
147003723|NCT02645409|530177106|FG001|Overall Study|Withdrawal by Subject|0|||
147003724|NCT02645409|530177105|FG000|Overall Study|Physician Decision|1|||
147003725|NCT02645409|530177106|FG001|Overall Study|Physician Decision|0|||
147003726|NCT02089685|530177109|FG000|Overall Study|Adverse Event|1|||
147003727|NCT02089685|530177110|FG001|Overall Study|Adverse Event|0|||
147003728|NCT02089685|530177111|FG002|Overall Study|Adverse Event|0|||
147003729|NCT02089685|530177112|FG003|Overall Study|Adverse Event|0|||
147003730|NCT02089685|530177113|FG004|Overall Study|Adverse Event|1|||
147003731|NCT02089685|530177114|FG005|Overall Study|Adverse Event|0|||
147003732|NCT02089685|530177109|FG000|Overall Study|Clinical Progression|4|||
146845237|NCT00468143|529602731|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
146845238|NCT00468143|529602730|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
146845239|NCT00468143|529602731|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
146845240|NCT01606670|529602732|FG000|Overall Study|Adverse Event|6|||
147003733|NCT02089685|530177110|FG001|Overall Study|Clinical Progression|0|||
147003734|NCT02089685|530177111|FG002|Overall Study|Clinical Progression|0|||
147003735|NCT02089685|530177112|FG003|Overall Study|Clinical Progression|5|||
147003736|NCT02089685|530177113|FG004|Overall Study|Clinical Progression|1|||
147003737|NCT02089685|530177114|FG005|Overall Study|Clinical Progression|2|||
147003738|NCT02089685|530177109|FG000|Overall Study|Excluded Medication|1|||
147003739|NCT02089685|530177110|FG001|Overall Study|Excluded Medication|0|||
147003740|NCT02089685|530177111|FG002|Overall Study|Excluded Medication|0|||
147003741|NCT02089685|530177112|FG003|Overall Study|Excluded Medication|11|||
147003742|NCT02089685|530177113|FG004|Overall Study|Excluded Medication|2|||
147003743|NCT02089685|530177114|FG005|Overall Study|Excluded Medication|1|||
147003744|NCT02089685|530177109|FG000|Overall Study|Progressive disease|13|||
147003745|NCT02089685|530177110|FG001|Overall Study|Progressive disease|10|||
147003746|NCT02089685|530177111|FG002|Overall Study|Progressive disease|3|||
147003747|NCT02089685|530177112|FG003|Overall Study|Progressive disease|51|||
147003748|NCT02089685|530177113|FG004|Overall Study|Progressive disease|17|||
147003749|NCT02089685|530177114|FG005|Overall Study|Progressive disease|12|||
147003750|NCT02089685|530177109|FG000|Overall Study|Follow up ended by sponsor|2|||
147003751|NCT02089685|530177110|FG001|Overall Study|Follow up ended by sponsor|2|||
147003752|NCT02089685|530177111|FG002|Overall Study|Follow up ended by sponsor|0|||
147003753|NCT02089685|530177112|FG003|Overall Study|Follow up ended by sponsor|70|||
147003754|NCT02089685|530177113|FG004|Overall Study|Follow up ended by sponsor|26|||
147003755|NCT02089685|530177114|FG005|Overall Study|Follow up ended by sponsor|26|||
147003756|NCT02089685|530177109|FG000|Overall Study|Withdrawal by Subject|0|||
147003757|NCT02089685|530177110|FG001|Overall Study|Withdrawal by Subject|2|||
147003758|NCT02089685|530177111|FG002|Overall Study|Withdrawal by Subject|0|||
147003759|NCT02089685|530177112|FG003|Overall Study|Withdrawal by Subject|8|||
147003760|NCT02089685|530177113|FG004|Overall Study|Withdrawal by Subject|1|||
147003761|NCT02089685|530177114|FG005|Overall Study|Withdrawal by Subject|1|||
147003762|NCT02089685|530177109|FG000|Overall Study|Status not recorded|1|||
147003763|NCT02089685|530177110|FG001|Overall Study|Status not recorded|0|||
147003764|NCT02089685|530177111|FG002|Overall Study|Status not recorded|0|||
147003765|NCT02089685|530177112|FG003|Overall Study|Status not recorded|0|||
147003766|NCT02089685|530177113|FG004|Overall Study|Status not recorded|1|||
147003767|NCT02089685|530177114|FG005|Overall Study|Status not recorded|0|||
147003768|NCT02089685|530177109|FG000|Overall Study|Death|0|||
147003769|NCT02089685|530177110|FG001|Overall Study|Death|0|||
147003770|NCT02089685|530177111|FG002|Overall Study|Death|0|||
147003771|NCT02089685|530177112|FG003|Overall Study|Death|7|||
147003772|NCT02089685|530177113|FG004|Overall Study|Death|2|||
146845241|NCT01606670|529602732|FG000|Overall Study|Lack of Efficacy|2|||
146845242|NCT01606670|529602732|FG000|Overall Study|Lost to Follow-up|3|||
147003773|NCT02089685|530177114|FG005|Overall Study|Death|5|||
147003774|NCT02089685|530177109|FG000|Overall Study|Lost to Follow-up|0|||
147003775|NCT02089685|530177110|FG001|Overall Study|Lost to Follow-up|0|||
147003776|NCT02089685|530177111|FG002|Overall Study|Lost to Follow-up|0|||
147003777|NCT02089685|530177112|FG003|Overall Study|Lost to Follow-up|1|||
147003778|NCT02089685|530177113|FG004|Overall Study|Lost to Follow-up|0|||
147003779|NCT02089685|530177114|FG005|Overall Study|Lost to Follow-up|0|||
147003780|NCT02089685|530177109|FG000|Overall Study|Physician Decision|0|||
147003781|NCT02089685|530177110|FG001|Overall Study|Physician Decision|0|||
147003782|NCT02089685|530177111|FG002|Overall Study|Physician Decision|0|||
147003783|NCT02089685|530177112|FG003|Overall Study|Physician Decision|0|||
147003784|NCT02089685|530177113|FG004|Overall Study|Physician Decision|0|||
147003785|NCT02089685|530177114|FG005|Overall Study|Physician Decision|4|||
147003786|NCT02089685|530177109|FG000|Overall Study|Screen failure|1|||
147003787|NCT02089685|530177110|FG001|Overall Study|Screen failure|0|||
147003788|NCT02089685|530177111|FG002|Overall Study|Screen failure|0|||
147003789|NCT02089685|530177112|FG003|Overall Study|Screen failure|0|||
147003790|NCT02089685|530177113|FG004|Overall Study|Screen failure|0|||
147003791|NCT02089685|530177114|FG005|Overall Study|Screen failure|0|||
147003792|NCT03084471|530177124|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
147003793|NCT03084471|530177124|FG000|Overall Study|Condition under investigation worsened|84|||
147003794|NCT03084471|530177124|FG000|Overall Study|Lack of therapeutic response|2|||
147003795|NCT03084471|530177124|FG000|Overall Study|Protocol Violation|1|||
146962100|NCT02064231|530021499|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
146962101|NCT02064231|530021496|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
146962102|NCT02064231|530021497|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
146962103|NCT02064231|530021498|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
146962104|NCT02064231|530021499|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
146962105|NCT02064231|530021496|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
146962106|NCT02064231|530021497|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
146962107|NCT02064231|530021498|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
146962108|NCT02064231|530021499|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
146962109|NCT04854421|530021501|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
146962110|NCT04854421|530021502|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
146962111|NCT02322866|530021503|FG000|Overall Study|Adverse Event|6|||
146962112|NCT02322866|530021504|FG001|Overall Study|Adverse Event|11|||
146962113|NCT02322866|530021503|FG000|Overall Study|Withdrawal of Consent|16|||
146962114|NCT02322866|530021504|FG001|Overall Study|Withdrawal of Consent|25|||
146962115|NCT02322866|530021503|FG000|Overall Study|Lost to Follow-up|36|||
146962116|NCT02322866|530021504|FG001|Overall Study|Lost to Follow-up|39|||
146962117|NCT02322866|530021503|FG000|Overall Study|Protocol Violation|1|||
146962118|NCT02322866|530021504|FG001|Overall Study|Protocol Violation|0|||
146962119|NCT02322866|530021503|FG000|Overall Study|Noncompliance with Treatment|3|||
146736052|NCT04241094|529205285|FG000|Overall Study|Dropped out of treatment|4|||
146736053|NCT04241094|529205285|FG000|Overall Study|Ineligible after clinical assessment|2|||
146736054|NCT04241094|529205285|FG000|Overall Study|Lost to Follow-up|2|||
146736055|NCT01669798|529205286|FG000|Overall Study|Physician Decision|5|||
146962120|NCT02322866|530021504|FG001|Overall Study|Noncompliance with Treatment|4|||
146962121|NCT02322866|530021503|FG000|Overall Study|Lack of Efficacy|3|||
146962122|NCT02322866|530021504|FG001|Overall Study|Lack of Efficacy|1|||
146962123|NCT02322866|530021503|FG000|Overall Study|Other Miscellaneous Reasons|6|||
146962124|NCT02322866|530021504|FG001|Overall Study|Other Miscellaneous Reasons|6|||
146962125|NCT00718809|530021505|FG000|Overall Study|Disease progression|9|||
146962126|NCT00718809|530021506|FG001|Overall Study|Disease progression|7|||
146962127|NCT00718809|530021505|FG000|Overall Study|Adverse Event|1|||
146962128|NCT00718809|530021506|FG001|Overall Study|Adverse Event|1|||
146962129|NCT00718809|530021505|FG000|Overall Study|Withdrawal by Subject|0|||
146962130|NCT00718809|530021506|FG001|Overall Study|Withdrawal by Subject|1|||
146962131|NCT00718809|530021505|FG000|Overall Study|Lost to Follow-up|1|||
146962132|NCT00718809|530021506|FG001|Overall Study|Lost to Follow-up|0|||
146962133|NCT00718809|530021505|FG000|Overall Study|Noncompliance|1|||
146962134|NCT00718809|530021506|FG001|Overall Study|Noncompliance|0|||
146962135|NCT00463385|530021507|FG000|Overall Study|Other|4|||
146962136|NCT00463385|530021508|FG001|Overall Study|Other|3|||
146962137|NCT00463385|530021509|FG002|Overall Study|Other|6|||
146962138|NCT00463385|530021510|FG003|Overall Study|Other|4|||
146962139|NCT00463385|530021507|FG000|Overall Study|Adverse Event|5|||
146962140|NCT00463385|530021508|FG001|Overall Study|Adverse Event|8|||
146962141|NCT00463385|530021509|FG002|Overall Study|Adverse Event|4|||
146962142|NCT00463385|530021510|FG003|Overall Study|Adverse Event|2|||
146962143|NCT00463385|530021507|FG000|Overall Study|Lack of Efficacy|6|||
146962144|NCT00463385|530021508|FG001|Overall Study|Lack of Efficacy|6|||
146962145|NCT00463385|530021509|FG002|Overall Study|Lack of Efficacy|7|||
146962146|NCT00463385|530021510|FG003|Overall Study|Lack of Efficacy|9|||
146962147|NCT00463385|530021507|FG000|Overall Study|Withdrawal by Subject|3|||
146962148|NCT00463385|530021508|FG001|Overall Study|Withdrawal by Subject|3|||
146962149|NCT00463385|530021509|FG002|Overall Study|Withdrawal by Subject|3|||
147003796|NCT03084471|530177124|FG000|Overall Study|Adverse Event|73|||
147003797|NCT03084471|530177124|FG000|Overall Study|Withdrawal by Subject|12|||
147003798|NCT03084471|530177124|FG000|Overall Study|Disease relapse|181|||
147003799|NCT03084471|530177124|FG000|Overall Study|Subjective disease progression|359|||
147003800|NCT03084471|530177124|FG000|Overall Study|Other (as recorded)|33|||
147003801|NCT03084471|530177124|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
147003802|NCT00505622|530177125|FG000|Overall Study|Adverse Event|5|||
147003803|NCT00505622|530177126|FG001|Overall Study|Adverse Event|6|||
147003804|NCT00505622|530177127|FG002|Overall Study|Adverse Event|4|||
147003805|NCT00505622|530177125|FG000|Overall Study|Protocol Violation|1|||
147003806|NCT00505622|530177126|FG001|Overall Study|Protocol Violation|1|||
147003807|NCT00505622|530177127|FG002|Overall Study|Protocol Violation|0|||
147003808|NCT00505622|530177125|FG000|Overall Study|Withdrawal by Subject|0|||
147003809|NCT00505622|530177126|FG001|Overall Study|Withdrawal by Subject|3|||
147003810|NCT00505622|530177127|FG002|Overall Study|Withdrawal by Subject|2|||
147003811|NCT00505622|530177125|FG000|Overall Study|Study termination by sponsor|115|||
147003812|NCT00505622|530177126|FG001|Overall Study|Study termination by sponsor|98|||
147003813|NCT00505622|530177127|FG002|Overall Study|Study termination by sponsor|90|||
147003814|NCT00835692|530177128|FG000|First Intervention|Withdrawal by Subject|1|||
147003815|NCT00835692|530177129|FG001|First Intervention|Withdrawal by Subject|0|||
147003816|NCT04078022|530177132|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
147003817|NCT04078022|530177133|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
147003818|NCT00191815|530177134|FG000|Overall Study|Adverse Event|2|||
147003819|NCT00191815|530177134|FG000|Overall Study|Disease progression or relapse|24|||
147003820|NCT00191815|530177134|FG000|Overall Study|Death|2|||
147003821|NCT00191815|530177134|FG000|Overall Study|Protocol Violation|3|||
147003822|NCT00191815|530177134|FG000|Overall Study|Physician Decision|2|||
147003823|NCT00191815|530177134|FG000|Overall Study|Withdrawal by Subject|7|||
147003824|NCT03808376|530177135|FG000|Overall Study|Withdrawal by Subject|10|||
147003825|NCT03644550|530177136|FG000|Overall Study|Withdrawal by Subject|3|||
147003826|NCT03644550|530177136|FG000|Overall Study|Progressive disease|15|||
147003827|NCT03804983|530177137|FG000|Overall Study|Adverse Event|0|||
147003828|NCT03804983|530177138|FG001|Overall Study|Adverse Event|1|||
147003829|NCT03804983|530177137|FG000|Overall Study|Family Obligation|1|||
147003830|NCT03804983|530177138|FG001|Overall Study|Family Obligation|0|||
147003831|NCT02152163|530177139|FG000|Overall Study|Physician Decision|12|||
147003832|NCT02152163|530177140|FG001|Overall Study|Physician Decision|13|||
147003833|NCT03114891|530177154|FG000|First Treatment Round|Lost to Follow-up|0|||
147003834|NCT03114891|530177155|FG001|First Treatment Round|Lost to Follow-up|1|||
147003835|NCT03114891|530177156|FG002|First Treatment Round|Lost to Follow-up|1|||
147003836|NCT03114891|530177157|FG003|First Treatment Round|Lost to Follow-up|0|||
147003837|NCT03114891|530177154|FG000|First Treatment Round|Withdrawal by Subject|0|||
147003838|NCT03114891|530177155|FG001|First Treatment Round|Withdrawal by Subject|2|||
147003839|NCT03114891|530177156|FG002|First Treatment Round|Withdrawal by Subject|0|||
147003840|NCT03114891|530177157|FG003|First Treatment Round|Withdrawal by Subject|1|||
147003841|NCT03114891|530177154|FG000|3 Week Break|Lost to Follow-up|1|||
147003842|NCT03114891|530177155|FG001|3 Week Break|Lost to Follow-up|0|||
147003843|NCT03114891|530177156|FG002|3 Week Break|Lost to Follow-up|0|||
147003844|NCT03114891|530177157|FG003|3 Week Break|Lost to Follow-up|1|||
147003845|NCT03114891|530177154|FG000|3 Week Break|Withdrawal by Subject|0|||
147003846|NCT03114891|530177155|FG001|3 Week Break|Withdrawal by Subject|1|||
147003847|NCT03114891|530177156|FG002|3 Week Break|Withdrawal by Subject|0|||
147003848|NCT03114891|530177157|FG003|3 Week Break|Withdrawal by Subject|0|||
147003849|NCT03114891|530177154|FG000|Second Treatment Round|Lost to Follow-up|1|||
147003850|NCT03114891|530177155|FG001|Second Treatment Round|Lost to Follow-up|0|||
147003851|NCT03114891|530177156|FG002|Second Treatment Round|Lost to Follow-up|0|||
147003852|NCT03114891|530177157|FG003|Second Treatment Round|Lost to Follow-up|0|||
147003853|NCT03114891|530177154|FG000|Second Treatment Round|Physician Decision|1|||
147003854|NCT03114891|530177155|FG001|Second Treatment Round|Physician Decision|0|||
147003855|NCT03114891|530177156|FG002|Second Treatment Round|Physician Decision|0|||
147003856|NCT03114891|530177157|FG003|Second Treatment Round|Physician Decision|0|||
147003857|NCT05511935|530179032|FG000|Overall Study|Lost to Follow-up|9|||
147003858|NCT05511935|530179033|FG001|Overall Study|Lost to Follow-up|27|||
147003859|NCT00373256|530179034|FG000|Overall Study|Adverse Event (AE)|1|||
147003860|NCT00373256|530179035|FG001|Overall Study|Adverse Event (AE)|5|||
147003861|NCT00373256|530179034|FG000|Overall Study|Lost to Follow-up|2|||
147003862|NCT00373256|530179035|FG001|Overall Study|Lost to Follow-up|1|||
147003863|NCT00373256|530179034|FG000|Overall Study|Death|9|||
147003864|NCT00373256|530179035|FG001|Overall Study|Death|8|||
147003865|NCT00373256|530179034|FG000|Overall Study|Objective Progression or Relapse|111|||
147003866|NCT00373256|530179035|FG001|Overall Study|Objective Progression or Relapse|104|||
147003867|NCT00373256|530179034|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
147003868|NCT00373256|530179035|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
147003869|NCT00373256|530179034|FG000|Overall Study|Other|73|||
147003870|NCT00373256|530179035|FG001|Overall Study|Other|107|||
147003871|NCT00373256|530179034|FG000|Overall Study|Protocol Violation|0|||
147003872|NCT00373256|530179035|FG001|Overall Study|Protocol Violation|2|||
147003873|NCT00373256|530179034|FG000|Overall Study|Study Terminated by Sponsor|41|||
147003874|NCT00373256|530179035|FG001|Overall Study|Study Terminated by Sponsor|13|||
147003875|NCT00334815|530179036|FG000|Overall Study|Adverse Event|3|||
147003876|NCT00334815|530179037|FG001|Overall Study|Adverse Event|2|||
147003877|NCT00334815|530179036|FG000|Overall Study|Death|0|||
147003878|NCT00334815|530179037|FG001|Overall Study|Death|2|||
147003879|NCT00334815|530179036|FG000|Overall Study|Progression|1|||
147003880|NCT00334815|530179037|FG001|Overall Study|Progression|0|||
147003881|NCT00334815|530179036|FG000|Overall Study|ineligible|1|||
147003882|NCT00334815|530179037|FG001|Overall Study|ineligible|1|||
147003883|NCT00334815|530179036|FG000|Overall Study|patient refused treatment|0|||
147003884|NCT00334815|530179037|FG001|Overall Study|patient refused treatment|1|||
147003885|NCT00334815|530179036|FG000|Overall Study|Physician Decision|2|||
147003886|NCT00334815|530179037|FG001|Overall Study|Physician Decision|4|||
147003887|NCT03121586|530179038|FG000|Overall Study|Study terminated by sponsor|0|||
147003888|NCT03121586|530179039|FG001|Overall Study|Study terminated by sponsor|0|||
147003889|NCT03121586|530179040|FG002|Overall Study|Study terminated by sponsor|99|||
147003890|NCT03121586|530179038|FG000|Overall Study|Withdrawal by Subject|37|||
147003891|NCT03121586|530179039|FG001|Overall Study|Withdrawal by Subject|14|||
147003892|NCT03121586|530179040|FG002|Overall Study|Withdrawal by Subject|9|||
147003893|NCT03121586|530179038|FG000|Overall Study|Not further specified|6|||
147003894|NCT03121586|530179039|FG001|Overall Study|Not further specified|11|||
147003895|NCT03121586|530179040|FG002|Overall Study|Not further specified|10|||
147003896|NCT03121586|530179038|FG000|Overall Study|Adverse Event|16|||
147003897|NCT03121586|530179039|FG001|Overall Study|Adverse Event|5|||
147003898|NCT03121586|530179040|FG002|Overall Study|Adverse Event|6|||
147003899|NCT03121586|530179038|FG000|Overall Study|Protocol Violation|0|||
147003900|NCT03121586|530179039|FG001|Overall Study|Protocol Violation|5|||
147003901|NCT03121586|530179040|FG002|Overall Study|Protocol Violation|0|||
147003902|NCT03121586|530179038|FG000|Overall Study|Lack of Efficacy|3|||
147003903|NCT03121586|530179039|FG001|Overall Study|Lack of Efficacy|3|||
147003904|NCT03121586|530179040|FG002|Overall Study|Lack of Efficacy|1|||
147003905|NCT03121586|530179038|FG000|Overall Study|Physician Decision|2|||
147003906|NCT03121586|530179039|FG001|Overall Study|Physician Decision|2|||
147003907|NCT03121586|530179040|FG002|Overall Study|Physician Decision|0|||
147003908|NCT03121586|530179038|FG000|Overall Study|Noncompliance with study drug|5|||
147003909|NCT03121586|530179039|FG001|Overall Study|Noncompliance with study drug|3|||
147003910|NCT03121586|530179040|FG002|Overall Study|Noncompliance with study drug|5|||
147003911|NCT03121586|530179038|FG000|Overall Study|Lost to Follow-up|4|||
147003912|NCT03121586|530179039|FG001|Overall Study|Lost to Follow-up|2|||
147003913|NCT03121586|530179040|FG002|Overall Study|Lost to Follow-up|0|||
147003914|NCT03121586|530179038|FG000|Overall Study|Death|2|||
147003915|NCT03121586|530179039|FG001|Overall Study|Death|0|||
147003916|NCT03121586|530179040|FG002|Overall Study|Death|0|||
147003917|NCT06381102|530179041|FG000|Washout 5 Days|Withdrawal by Subject|0|||
147003918|NCT06381102|530179042|FG001|Washout 5 Days|Withdrawal by Subject|2|||
147003919|NCT00446966|530179045|FG000|Overall Study|Lost to Follow-up|10|||
147003920|NCT00446966|530179046|FG001|Overall Study|Lost to Follow-up|7|||
147003921|NCT01440803|530179047|FG000|Overall Study|Met study stopping rule|2|||
147003922|NCT01440803|530179048|FG001|Overall Study|Met study stopping rule|1|||
147003923|NCT01440803|530179047|FG000|Overall Study|Lost to Follow-up|0|||
147003924|NCT01440803|530179048|FG001|Overall Study|Lost to Follow-up|2|||
147003925|NCT01440803|530179047|FG000|Overall Study|Withdrawal by Subject|0|||
147003926|NCT01440803|530179048|FG001|Overall Study|Withdrawal by Subject|1|||
147003927|NCT01564394|530179049|FG000|Overall Study|Withdrawal by Subject|6|||
147003928|NCT01564394|530179050|FG001|Overall Study|Withdrawal by Subject|10|||
147003929|NCT00443651|530179051|FG000|Overall Study|Death|1|||
147003930|NCT00443651|530179052|FG001|Overall Study|Death|5|||
147003931|NCT00443651|530179051|FG000|Overall Study|Adverse Event|5|||
147003932|NCT00443651|530179052|FG001|Overall Study|Adverse Event|6|||
147003933|NCT00443651|530179051|FG000|Overall Study|Lost to Follow-up|18|||
147003934|NCT00443651|530179052|FG001|Overall Study|Lost to Follow-up|12|||
147003935|NCT00443651|530179051|FG000|Overall Study|Patient's/Guardian's Decision|58|||
147003936|NCT00443651|530179052|FG001|Overall Study|Patient's/Guardian's Decision|30|||
147003937|NCT00443651|530179051|FG000|Overall Study|Physician Decision|13|||
147003938|NCT00443651|530179052|FG001|Overall Study|Physician Decision|4|||
147003939|NCT00443651|530179051|FG000|Overall Study|Pregnancy|0|||
147003940|NCT00443651|530179052|FG001|Overall Study|Pregnancy|1|||
147003941|NCT00859521|530179053|FG000|Washout|Withdrawal by Subject|0|||
147003942|NCT00859521|530179054|FG001|Washout|Withdrawal by Subject|1|||
147003943|NCT01609257|530179055|FG000|Overall Study|Lost to Follow-up|2|||
147003944|NCT01609257|530179056|FG001|Overall Study|Lost to Follow-up|1|||
147003945|NCT01609257|530179055|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
147003946|NCT01609257|530179056|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
147003947|NCT01609257|530179055|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
147003948|NCT01609257|530179056|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
147003949|NCT02125461|530179057|FG000|Overall Study|Withdrawal by Subject|30|||
147003950|NCT02125461|530179058|FG001|Overall Study|Withdrawal by Subject|16|||
147003951|NCT02125461|530179057|FG000|Overall Study|Lost to Follow-up|8|||
147003952|NCT02125461|530179058|FG001|Overall Study|Lost to Follow-up|3|||
147003953|NCT02125461|530179057|FG000|Overall Study|Death|260|||
147003954|NCT02125461|530179058|FG001|Overall Study|Death|149|||
147003955|NCT02125461|530179057|FG000|Overall Study|Missing Termination Reason|0|||
147003956|NCT02125461|530179058|FG001|Overall Study|Missing Termination Reason|1|||
147003957|NCT02888756|530179059|FG000|Analytical Treatment Interruption|Physician Decision|10|||
147003958|NCT02888756|530179060|FG001|Analytical Treatment Interruption|Physician Decision|6|||
147003959|NCT02888756|530179061|FG002|Analytical Treatment Interruption|Physician Decision|5|||
147003960|NCT01547286|530179071|FG000|Overall Study|Did not meet all eligibility criteria|1|||
147003961|NCT01547286|530179071|FG000|Overall Study|Physician Decision|1|||
147003962|NCT03415308|530179075|FG000|Overall Study|Lost to Follow-up|0|||
147003963|NCT03415308|530179076|FG001|Overall Study|Lost to Follow-up|0|||
147003964|NCT03415308|530179077|FG002|Overall Study|Lost to Follow-up|1|||
147003965|NCT03415308|530179075|FG000|Overall Study|Scheduling Conflicts|0|||
147003966|NCT03415308|530179076|FG001|Overall Study|Scheduling Conflicts|0|||
147003967|NCT03415308|530179077|FG002|Overall Study|Scheduling Conflicts|7|||
147003968|NCT01471353|530179078|FG000|Overall Study|remain on study|3|||
147003969|NCT00836472|530179079|FG000|Washout|Adverse Event|1|||
147003970|NCT00836472|530179080|FG001|Washout|Adverse Event|2|||
147003971|NCT00836472|530179079|FG000|Washout|Withdrawal by Subject|1|||
147003972|NCT00836472|530179080|FG001|Washout|Withdrawal by Subject|1|||
147003973|NCT01695239|530179081|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
147003974|NCT01695239|530179082|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
147003975|NCT01695239|530179083|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
147003976|NCT01695239|530179084|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
147003977|NCT01695239|530179085|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147003978|NCT01695239|530179086|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147003979|NCT01695239|530179087|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147003980|NCT01695239|530179088|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147003981|NCT01695239|530179089|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147003982|NCT01695239|530179090|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147003983|NCT01695239|530179091|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147003984|NCT01695239|530179092|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147003985|NCT01695239|530179093|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147003986|NCT01695239|530179094|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147003987|NCT01695239|530179081|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
147003988|NCT01695239|530179082|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
147003989|NCT01695239|530179083|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
147003990|NCT01695239|530179084|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
147003991|NCT01695239|530179085|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147003992|NCT01695239|530179086|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147003993|NCT01695239|530179087|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147003994|NCT01695239|530179088|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147003995|NCT01695239|530179089|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147003996|NCT01695239|530179090|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147003997|NCT01695239|530179091|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147003998|NCT01695239|530179092|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147003999|NCT01695239|530179093|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147004000|NCT01695239|530179094|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147004001|NCT01695239|530179081|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
147004002|NCT01695239|530179082|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147004003|NCT01695239|530179083|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
147004004|NCT01695239|530179084|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147004005|NCT01695239|530179085|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147004006|NCT01695239|530179086|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147004007|NCT01695239|530179087|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147004008|NCT01695239|530179088|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147013225|NCT01708954|530210055|FG001|Step 1|Disease progression|17|||
146736056|NCT05918978|529205290|FG000|Overall Study|Study Terminated by Sponsor|17|||
146736057|NCT05918978|529205291|FG001|Overall Study|Study Terminated by Sponsor|11|||
146736058|NCT05918978|529205290|FG000|Overall Study|Withdrawal by Subject|1|||
146736059|NCT05918978|529205291|FG001|Overall Study|Withdrawal by Subject|1|||
146736060|NCT05918978|529205290|FG000|Overall Study|Adverse Event|1|||
146736061|NCT05918978|529205291|FG001|Overall Study|Adverse Event|0|||
146736062|NCT05918978|529205290|FG000|Overall Study|Other|0|||
146736063|NCT05918978|529205291|FG001|Overall Study|Other|1|||
146736064|NCT00622180|529205292|FG000|Overall Study|Lost to Follow-up|1|||
146736065|NCT00622180|529205293|FG001|Overall Study|Lost to Follow-up|2|||
146736066|NCT06387472|529205296|FG000|Overall Study|Withdrawal by Subject|1|||
146736067|NCT06387472|529205296|FG000|Overall Study|Lost to Follow-up|2|||
146736068|NCT06387472|529205296|FG000|Overall Study|Physician Decision|1|||
146736069|NCT02332590|529205299|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
147004009|NCT01695239|530179089|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147004010|NCT01695239|530179090|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147004011|NCT01695239|530179091|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147004012|NCT01695239|530179092|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147004013|NCT01695239|530179093|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147004014|NCT01695239|530179094|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147004015|NCT01695239|530179081|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
147004016|NCT01695239|530179082|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
147004017|NCT01695239|530179083|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
147004018|NCT01695239|530179084|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147004019|NCT01695239|530179085|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147004020|NCT01695239|530179086|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147004021|NCT01695239|530179087|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147004022|NCT01695239|530179088|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147004023|NCT01695239|530179089|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147004024|NCT01695239|530179090|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147004025|NCT01695239|530179091|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147004026|NCT01695239|530179092|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147004027|NCT01695239|530179093|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147004028|NCT01695239|530179094|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147004029|NCT01695239|530179081|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
147004030|NCT01695239|530179082|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147004031|NCT01695239|530179083|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
147004032|NCT01695239|530179084|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147004033|NCT01695239|530179085|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147004034|NCT01695239|530179086|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147004035|NCT01695239|530179087|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147004036|NCT01695239|530179088|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147004037|NCT01695239|530179089|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147004038|NCT01695239|530179090|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147004039|NCT01695239|530179091|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147004040|NCT01695239|530179092|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147004041|NCT01695239|530179093|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147004042|NCT01695239|530179094|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147004043|NCT01695239|530179081|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
147004044|NCT01695239|530179082|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147004045|NCT01695239|530179083|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
147004046|NCT01695239|530179084|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147004047|NCT01695239|530179085|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147004048|NCT01695239|530179086|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147004049|NCT01695239|530179087|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147004050|NCT01695239|530179088|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147004051|NCT01695239|530179089|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147004052|NCT01695239|530179090|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147004053|NCT01695239|530179091|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147004054|NCT01695239|530179092|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147004055|NCT01695239|530179093|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147004056|NCT01695239|530179094|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147004057|NCT01695239|530179081|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
147004058|NCT01695239|530179082|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147004059|NCT01695239|530179083|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147004060|NCT01695239|530179084|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147004061|NCT01695239|530179085|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147004062|NCT01695239|530179086|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147004063|NCT01695239|530179087|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147004064|NCT01695239|530179088|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147004065|NCT01695239|530179089|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147004066|NCT01695239|530179090|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147004067|NCT01695239|530179091|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147004068|NCT01695239|530179092|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147004069|NCT01695239|530179093|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147004070|NCT01695239|530179094|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147004071|NCT01695239|530179081|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147004072|NCT01695239|530179082|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147004073|NCT01695239|530179083|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147013226|NCT01708954|530210056|FG002|Step 1|Disease progression|14|||
147004074|NCT01695239|530179084|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147004075|NCT01695239|530179085|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147004076|NCT01695239|530179086|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147004077|NCT01695239|530179087|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147004078|NCT01695239|530179088|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
147004079|NCT01695239|530179089|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147004080|NCT01695239|530179090|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147004081|NCT01695239|530179091|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147004082|NCT01695239|530179092|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147004083|NCT01695239|530179093|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147004084|NCT01695239|530179094|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147004085|NCT01695239|530179081|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147004086|NCT01695239|530179082|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147004087|NCT01695239|530179083|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
146845243|NCT01606670|529602732|FG000|Overall Study|Withdrawal by Subject|3|||
146845244|NCT01606670|529602732|FG000|Overall Study|Other Reason|2|||
146845245|NCT02636725|529602733|FG000|Overall Study|Adverse Event|1|||
146845246|NCT03653208|529602736|FG000|Overall Study|Withdrawal by Subject|0|||
147004088|NCT01695239|530179084|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147004089|NCT01695239|530179085|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147004090|NCT01695239|530179086|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147004091|NCT01695239|530179087|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147004092|NCT01695239|530179088|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
147004093|NCT01695239|530179089|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147004094|NCT01695239|530179090|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147004095|NCT01695239|530179091|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147004096|NCT01695239|530179092|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147004097|NCT01695239|530179093|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147004098|NCT01695239|530179094|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147004099|NCT01695239|530179081|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147004100|NCT01695239|530179082|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147004101|NCT01695239|530179083|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147004102|NCT01695239|530179084|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147004103|NCT01695239|530179085|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147004104|NCT01695239|530179086|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147004105|NCT01695239|530179087|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147004106|NCT01695239|530179088|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
147004107|NCT01695239|530179089|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147004108|NCT01695239|530179090|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147004109|NCT01695239|530179091|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147004110|NCT01695239|530179092|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147004111|NCT01695239|530179093|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147004112|NCT01695239|530179094|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147004113|NCT01695239|530179081|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147004114|NCT01695239|530179082|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147004115|NCT01695239|530179083|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147004116|NCT01695239|530179084|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147004117|NCT01695239|530179085|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147004118|NCT01695239|530179086|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147004119|NCT01695239|530179087|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147004120|NCT01695239|530179088|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147004121|NCT01695239|530179089|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
147004122|NCT01695239|530179090|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
147004123|NCT01695239|530179091|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147004124|NCT01695239|530179092|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147004125|NCT01695239|530179093|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147004126|NCT01695239|530179094|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147004127|NCT01695239|530179081|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
147004128|NCT01695239|530179082|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
147004129|NCT01695239|530179083|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
147004130|NCT01695239|530179084|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
147004131|NCT01695239|530179085|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
147004132|NCT01695239|530179086|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
146845247|NCT03653208|529602737|FG001|Overall Study|Withdrawal by Subject|0|||
146845248|NCT03653208|529602738|FG002|Overall Study|Withdrawal by Subject|0|||
147004133|NCT01695239|530179087|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
147004134|NCT01695239|530179088|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
147004135|NCT01695239|530179089|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
147004136|NCT01695239|530179090|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
147004137|NCT01695239|530179091|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
147004138|NCT01695239|530179092|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
147004139|NCT01695239|530179093|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
147004140|NCT01695239|530179094|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
147004141|NCT01695239|530179081|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147004142|NCT01695239|530179082|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147004143|NCT01695239|530179083|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147004144|NCT01695239|530179084|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147004145|NCT01695239|530179085|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147004146|NCT01695239|530179086|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147004147|NCT01695239|530179087|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147004148|NCT01695239|530179088|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147004149|NCT01695239|530179089|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
147004150|NCT01695239|530179090|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
147004151|NCT01695239|530179091|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147004152|NCT01695239|530179092|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147004153|NCT01695239|530179093|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147004154|NCT01695239|530179094|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147004155|NCT01695239|530179081|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
147004156|NCT01695239|530179082|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
147004157|NCT01695239|530179083|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
147004158|NCT01695239|530179084|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
147004159|NCT01695239|530179085|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
147004160|NCT01695239|530179086|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
147004161|NCT01695239|530179087|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
147004162|NCT01695239|530179088|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
147004163|NCT01695239|530179089|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
147004164|NCT01695239|530179090|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
147004165|NCT01695239|530179091|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
147004166|NCT01695239|530179092|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
147004167|NCT01695239|530179093|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
147004168|NCT01695239|530179094|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
147004169|NCT01695239|530179081|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147004170|NCT01695239|530179082|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147004171|NCT01695239|530179083|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147004172|NCT01695239|530179084|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147004173|NCT01695239|530179085|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147004174|NCT01695239|530179086|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147004175|NCT01695239|530179087|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147004176|NCT01695239|530179088|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147004177|NCT01695239|530179089|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
147004178|NCT01695239|530179090|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
147004179|NCT01695239|530179091|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147004180|NCT01695239|530179092|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147004181|NCT01695239|530179093|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147004182|NCT01695239|530179094|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147004183|NCT01695239|530179081|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147004184|NCT01695239|530179082|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147004185|NCT01695239|530179083|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147004186|NCT01695239|530179084|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147004187|NCT01695239|530179085|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147004188|NCT01695239|530179086|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147004189|NCT01695239|530179087|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147004190|NCT01695239|530179088|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147004191|NCT01695239|530179089|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
147004192|NCT01695239|530179090|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
147004193|NCT01695239|530179091|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147004194|NCT01695239|530179092|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147004195|NCT01695239|530179093|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
146845249|NCT03653208|529602739|FG003|Overall Study|Withdrawal by Subject|0|||
146845250|NCT03653208|529602740|FG004|Overall Study|Withdrawal by Subject|1|||
147004196|NCT01695239|530179094|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147004197|NCT01695239|530179081|FG000|Extension Long-Term Extension Periods|Death|0|||
147004198|NCT01695239|530179082|FG001|Extension Long-Term Extension Periods|Death|0|||
147004199|NCT01695239|530179083|FG002|Extension Long-Term Extension Periods|Death|0|||
147004200|NCT01695239|530179084|FG003|Extension Long-Term Extension Periods|Death|0|||
147004201|NCT01695239|530179085|FG004|Extension Long-Term Extension Periods|Death|0|||
147004202|NCT01695239|530179086|FG005|Extension Long-Term Extension Periods|Death|0|||
147004203|NCT01695239|530179087|FG006|Extension Long-Term Extension Periods|Death|0|||
147004204|NCT01695239|530179088|FG007|Extension Long-Term Extension Periods|Death|0|||
147004205|NCT01695239|530179089|FG008|Extension Long-Term Extension Periods|Death|1|||
147004206|NCT01695239|530179090|FG009|Extension Long-Term Extension Periods|Death|0|||
147004207|NCT01695239|530179091|FG010|Extension Long-Term Extension Periods|Death|0|||
147004208|NCT01695239|530179092|FG011|Extension Long-Term Extension Periods|Death|0|||
147004209|NCT01695239|530179093|FG012|Extension Long-Term Extension Periods|Death|0|||
147004210|NCT01695239|530179094|FG013|Extension Long-Term Extension Periods|Death|0|||
147004211|NCT01695239|530179081|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147004212|NCT01695239|530179082|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147004213|NCT01695239|530179083|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147004214|NCT01695239|530179084|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147004215|NCT01695239|530179085|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147004216|NCT01695239|530179086|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147004217|NCT01695239|530179087|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147004218|NCT01695239|530179088|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147004219|NCT01695239|530179089|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147004220|NCT01695239|530179090|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147004221|NCT01695239|530179091|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147004222|NCT01695239|530179092|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
147004223|NCT01695239|530179093|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
147004224|NCT01695239|530179094|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
147004225|NCT01695239|530179081|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147004226|NCT01695239|530179082|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147004227|NCT01695239|530179083|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147004228|NCT01695239|530179084|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147004229|NCT01695239|530179085|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147004230|NCT01695239|530179086|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147004231|NCT01695239|530179087|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147004232|NCT01695239|530179088|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147004233|NCT01695239|530179089|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147004234|NCT01695239|530179090|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147004235|NCT01695239|530179091|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147004236|NCT01695239|530179092|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147004237|NCT01695239|530179093|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
147004238|NCT01695239|530179094|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
147004239|NCT01695239|530179081|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
147004240|NCT01695239|530179082|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
147004241|NCT01695239|530179083|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
147004242|NCT01695239|530179084|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
147004243|NCT01695239|530179085|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
147004244|NCT01695239|530179086|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
147004245|NCT01695239|530179087|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
147004246|NCT01695239|530179088|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
147004247|NCT01695239|530179089|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
147004248|NCT01695239|530179090|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
147004249|NCT01695239|530179091|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
147004250|NCT01695239|530179092|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
147004251|NCT01695239|530179093|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
147004252|NCT01695239|530179094|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
147004253|NCT01695239|530179081|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147004254|NCT01695239|530179082|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147004255|NCT01695239|530179083|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147004256|NCT01695239|530179084|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147004257|NCT01695239|530179085|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147004258|NCT01695239|530179086|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147004259|NCT01695239|530179087|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147004260|NCT01695239|530179088|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147004261|NCT01695239|530179089|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147004262|NCT01695239|530179090|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147004263|NCT01695239|530179091|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147004264|NCT01695239|530179092|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147004265|NCT01695239|530179093|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147004266|NCT01695239|530179094|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
147004267|NCT03913377|530179097|FG000|Period 1|Test Article no longer available|0|||
147004268|NCT03913377|530179098|FG001|Period 1|Test Article no longer available|1|||
147004269|NCT03913377|530179099|FG002|Period 1|Test Article no longer available|0|||
147004270|NCT03913377|530179097|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
147004271|NCT03913377|530179098|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
147004272|NCT03913377|530179099|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
147004273|NCT05239195|530179100|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
147004274|NCT05239195|530179101|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
147004275|NCT03552484|530179104|FG000|Overall Study|Death|6|||
147004276|NCT03552484|530179105|FG001|Overall Study|Death|4|||
147004277|NCT03552484|530179104|FG000|Overall Study|Lost to Follow-up|0|||
147004278|NCT03552484|530179105|FG001|Overall Study|Lost to Follow-up|16|||
147004279|NCT03499353|530179106|FG000|Treatment|Adverse Event|3|||
147004280|NCT03499353|530179106|FG000|Treatment|Progressive Disease|10|||
147004281|NCT03499353|530179106|FG000|Treatment|Other|1|||
147004282|NCT03499353|530179106|FG000|Treatment|Withdrawal by Subject|2|||
147004283|NCT03499353|530179106|FG000|Long-Term Follow-up|Death|2|||
147004284|NCT03499353|530179106|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
147004285|NCT03499353|530179106|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
147004286|NCT01015287|530179109|FG000|Overall Study|Death|21|||
147004287|NCT01015287|530179110|FG001|Overall Study|Death|16|||
147004288|NCT01015287|530179109|FG000|Overall Study|Adverse Event|1|||
147004289|NCT01015287|530179110|FG001|Overall Study|Adverse Event|0|||
147004290|NCT01015287|530179109|FG000|Overall Study|Sponsor Decision|3|||
147004291|NCT01015287|530179110|FG001|Overall Study|Sponsor Decision|7|||
147004292|NCT01015287|530179109|FG000|Overall Study|Physician Decision|19|||
147004293|NCT01015287|530179110|FG001|Overall Study|Physician Decision|21|||
147004294|NCT01015287|530179109|FG000|Overall Study|Withdrawal by Subject|14|||
147004295|NCT01015287|530179110|FG001|Overall Study|Withdrawal by Subject|19|||
147004296|NCT01015287|530179109|FG000|Overall Study|Entry Criteria not Met|11|||
147004297|NCT01015287|530179110|FG001|Overall Study|Entry Criteria not Met|14|||
147004298|NCT01015287|530179109|FG000|Overall Study|Lost to Follow-up|2|||
147004299|NCT01015287|530179110|FG001|Overall Study|Lost to Follow-up|1|||
147004300|NCT01015287|530179109|FG000|Overall Study|Protocol Violation|1|||
147004301|NCT01015287|530179110|FG001|Overall Study|Protocol Violation|1|||
147004302|NCT01592240|530179111|FG000|Overall Study|Adverse Event|1|||
147004303|NCT01592240|530179112|FG001|Overall Study|Adverse Event|0|||
147004304|NCT01592240|530179113|FG002|Overall Study|Adverse Event|0|||
147004305|NCT01592240|530179114|FG003|Overall Study|Adverse Event|1|||
147004306|NCT01592240|530179115|FG004|Overall Study|Adverse Event|1|||
147004307|NCT01592240|530179116|FG005|Overall Study|Adverse Event|0|||
147004308|NCT01592240|530179117|FG006|Overall Study|Adverse Event|0|||
147004309|NCT01592240|530179111|FG000|Overall Study|Death|0|||
147004310|NCT01592240|530179112|FG001|Overall Study|Death|1|||
147004311|NCT01592240|530179113|FG002|Overall Study|Death|0|||
147004312|NCT01592240|530179114|FG003|Overall Study|Death|0|||
147004313|NCT01592240|530179115|FG004|Overall Study|Death|0|||
147004314|NCT01592240|530179116|FG005|Overall Study|Death|0|||
147004315|NCT01592240|530179117|FG006|Overall Study|Death|0|||
147004316|NCT01592240|530179111|FG000|Overall Study|Lost to Follow-up|1|||
147004317|NCT01592240|530179112|FG001|Overall Study|Lost to Follow-up|3|||
147004318|NCT01592240|530179113|FG002|Overall Study|Lost to Follow-up|1|||
147004319|NCT01592240|530179114|FG003|Overall Study|Lost to Follow-up|0|||
147004320|NCT01592240|530179115|FG004|Overall Study|Lost to Follow-up|3|||
147004321|NCT01592240|530179116|FG005|Overall Study|Lost to Follow-up|2|||
147004322|NCT01592240|530179117|FG006|Overall Study|Lost to Follow-up|0|||
147004323|NCT01592240|530179111|FG000|Overall Study|Protocol Violation|0|||
147004324|NCT01592240|530179112|FG001|Overall Study|Protocol Violation|0|||
147004325|NCT01592240|530179113|FG002|Overall Study|Protocol Violation|0|||
147004326|NCT01592240|530179114|FG003|Overall Study|Protocol Violation|0|||
147004327|NCT01592240|530179115|FG004|Overall Study|Protocol Violation|0|||
147004328|NCT01592240|530179116|FG005|Overall Study|Protocol Violation|1|||
147004329|NCT01592240|530179117|FG006|Overall Study|Protocol Violation|0|||
147004330|NCT01592240|530179111|FG000|Overall Study|Withdrawal by Subject|0|||
146736070|NCT02332590|529205300|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
147004331|NCT01592240|530179112|FG001|Overall Study|Withdrawal by Subject|4|||
147004332|NCT01592240|530179113|FG002|Overall Study|Withdrawal by Subject|4|||
147004333|NCT01592240|530179114|FG003|Overall Study|Withdrawal by Subject|1|||
147004334|NCT01592240|530179115|FG004|Overall Study|Withdrawal by Subject|3|||
147004335|NCT01592240|530179116|FG005|Overall Study|Withdrawal by Subject|0|||
147004336|NCT01592240|530179117|FG006|Overall Study|Withdrawal by Subject|2|||
147004337|NCT01592240|530179111|FG000|Overall Study|Other|0|||
147004338|NCT01592240|530179112|FG001|Overall Study|Other|3|||
147004339|NCT01592240|530179113|FG002|Overall Study|Other|1|||
147004340|NCT01592240|530179114|FG003|Overall Study|Other|1|||
147004341|NCT01592240|530179115|FG004|Overall Study|Other|0|||
147004342|NCT01592240|530179116|FG005|Overall Study|Other|0|||
147004343|NCT01592240|530179117|FG006|Overall Study|Other|1|||
147004344|NCT01592240|530179111|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
147004345|NCT01592240|530179112|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
147004346|NCT01592240|530179113|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
147004347|NCT01592240|530179114|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
147004348|NCT01592240|530179115|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
147004349|NCT01592240|530179116|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
147004350|NCT01592240|530179117|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
147004351|NCT01117623|530179118|FG000|Overall Study|Adverse Event|0|||
147004352|NCT01117623|530179119|FG001|Overall Study|Adverse Event|2|||
147004353|NCT01117623|530179120|FG002|Overall Study|Adverse Event|4|||
147004354|NCT01117623|530179121|FG003|Overall Study|Adverse Event|0|||
147004355|NCT01117623|530179122|FG004|Overall Study|Adverse Event|2|||
147004356|NCT01117623|530179123|FG005|Overall Study|Adverse Event|0|||
147004357|NCT01117623|530179124|FG006|Overall Study|Adverse Event|0|||
147004358|NCT01117623|530179125|FG007|Overall Study|Adverse Event|2|||
147004359|NCT01117623|530179118|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
147004360|NCT01117623|530179119|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
147004361|NCT01117623|530179120|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
147004362|NCT01117623|530179121|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
147004363|NCT01117623|530179122|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
147004364|NCT01117623|530179123|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
147004365|NCT01117623|530179124|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
147004366|NCT01117623|530179125|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
147004367|NCT01117623|530179118|FG000|Overall Study|Withdrawal by Subject|0|||
147004368|NCT01117623|530179119|FG001|Overall Study|Withdrawal by Subject|0|||
147004369|NCT01117623|530179120|FG002|Overall Study|Withdrawal by Subject|2|||
147004370|NCT01117623|530179121|FG003|Overall Study|Withdrawal by Subject|0|||
147004371|NCT01117623|530179122|FG004|Overall Study|Withdrawal by Subject|0|||
147004372|NCT01117623|530179123|FG005|Overall Study|Withdrawal by Subject|1|||
147004373|NCT01117623|530179124|FG006|Overall Study|Withdrawal by Subject|1|||
147004374|NCT01117623|530179125|FG007|Overall Study|Withdrawal by Subject|1|||
147004375|NCT01117623|530179118|FG000|Overall Study|Non-compliance with study medication|0|||
147004376|NCT01117623|530179119|FG001|Overall Study|Non-compliance with study medication|0|||
147004377|NCT01117623|530179120|FG002|Overall Study|Non-compliance with study medication|0|||
147004378|NCT01117623|530179121|FG003|Overall Study|Non-compliance with study medication|0|||
147004379|NCT01117623|530179122|FG004|Overall Study|Non-compliance with study medication|0|||
147004380|NCT01117623|530179123|FG005|Overall Study|Non-compliance with study medication|0|||
147004381|NCT01117623|530179124|FG006|Overall Study|Non-compliance with study medication|0|||
147004382|NCT01117623|530179125|FG007|Overall Study|Non-compliance with study medication|1|||
147004383|NCT01117623|530179118|FG000|Overall Study|Invest. text: completed all planned txs|0|||
147004384|NCT01117623|530179119|FG001|Overall Study|Invest. text: completed all planned txs|0|||
147004385|NCT01117623|530179120|FG002|Overall Study|Invest. text: completed all planned txs|0|||
147004386|NCT01117623|530179121|FG003|Overall Study|Invest. text: completed all planned txs|0|||
147004387|NCT01117623|530179122|FG004|Overall Study|Invest. text: completed all planned txs|0|||
147004388|NCT01117623|530179123|FG005|Overall Study|Invest. text: completed all planned txs|1|||
147004389|NCT01117623|530179124|FG006|Overall Study|Invest. text: completed all planned txs|0|||
147004390|NCT01117623|530179125|FG007|Overall Study|Invest. text: completed all planned txs|0|||
147004391|NCT00469898|530179133|FG000|Overall Study|Adverse Event|7|||
147004392|NCT00469898|530179133|FG000|Overall Study|Withdrawal by Subject|4|||
147004393|NCT00469898|530179133|FG000|Overall Study|Death|4|||
147004394|NCT00469898|530179133|FG000|Overall Study|Disease progression|9|||
147004395|NCT00469898|530179133|FG000|Overall Study|Decreased performance status|1|||
147004396|NCT01205035|530179138|FG000|Overall Study|Withdrawal by Subject|1|||
147004397|NCT01205035|530179139|FG001|Overall Study|Withdrawal by Subject|0|||
147004398|NCT01205035|530179138|FG000|Overall Study|Physician Decision|1|||
147004399|NCT01205035|530179139|FG001|Overall Study|Physician Decision|0|||
147004400|NCT02751424|530179140|FG000|Part 2|Adverse Event|0|||
147004401|NCT02751424|530179141|FG001|Part 2|Adverse Event|0|||
147004402|NCT02751424|530179142|FG002|Part 2|Adverse Event|0|||
147004403|NCT02751424|530179143|FG003|Part 2|Adverse Event|0|||
147004404|NCT02751424|530179144|FG004|Part 2|Adverse Event|0|||
147004405|NCT02751424|530179145|FG005|Part 2|Adverse Event|0|||
147004406|NCT02751424|530179146|FG006|Part 2|Adverse Event|0|||
147004407|NCT02751424|530179147|FG007|Part 2|Adverse Event|5|||
147004408|NCT02751424|530179148|FG008|Part 2|Adverse Event|0|||
147004409|NCT01204294|530179149|FG000|Overall Study|Adverse Event|2|||
147004410|NCT01204294|530179150|FG001|Overall Study|Adverse Event|6|||
147004411|NCT01204294|530179151|FG002|Overall Study|Adverse Event|0|||
147004412|NCT01204294|530179152|FG003|Overall Study|Adverse Event|7|||
147004413|NCT01204294|530179153|FG004|Overall Study|Adverse Event|1|||
147004414|NCT01204294|530179154|FG005|Overall Study|Adverse Event|4|||
147004415|NCT01204294|530179155|FG006|Overall Study|Adverse Event|0|||
147004416|NCT01204294|530179149|FG000|Overall Study|Protocol Violation|1|||
147004417|NCT01204294|530179150|FG001|Overall Study|Protocol Violation|0|||
147004418|NCT01204294|530179151|FG002|Overall Study|Protocol Violation|2|||
147004419|NCT01204294|530179152|FG003|Overall Study|Protocol Violation|1|||
147004420|NCT01204294|530179153|FG004|Overall Study|Protocol Violation|0|||
147004421|NCT01204294|530179154|FG005|Overall Study|Protocol Violation|0|||
147004422|NCT01204294|530179155|FG006|Overall Study|Protocol Violation|0|||
147004423|NCT01204294|530179149|FG000|Overall Study|Withdrawal by Subject|0|||
147004424|NCT01204294|530179150|FG001|Overall Study|Withdrawal by Subject|2|||
147004425|NCT01204294|530179151|FG002|Overall Study|Withdrawal by Subject|2|||
147004426|NCT01204294|530179152|FG003|Overall Study|Withdrawal by Subject|1|||
147004427|NCT01204294|530179153|FG004|Overall Study|Withdrawal by Subject|1|||
147004428|NCT01204294|530179154|FG005|Overall Study|Withdrawal by Subject|1|||
147004429|NCT01204294|530179155|FG006|Overall Study|Withdrawal by Subject|2|||
147004430|NCT01204294|530179149|FG000|Overall Study|Lack of Efficacy|0|||
147004431|NCT01204294|530179150|FG001|Overall Study|Lack of Efficacy|0|||
147004432|NCT01204294|530179151|FG002|Overall Study|Lack of Efficacy|0|||
147004433|NCT01204294|530179152|FG003|Overall Study|Lack of Efficacy|2|||
147004434|NCT01204294|530179153|FG004|Overall Study|Lack of Efficacy|0|||
147004435|NCT01204294|530179154|FG005|Overall Study|Lack of Efficacy|0|||
147004436|NCT01204294|530179155|FG006|Overall Study|Lack of Efficacy|0|||
147004437|NCT01204294|530179149|FG000|Overall Study|Other (house moving)|0|||
147004438|NCT01204294|530179150|FG001|Overall Study|Other (house moving)|0|||
147004439|NCT01204294|530179151|FG002|Overall Study|Other (house moving)|1|||
147004440|NCT01204294|530179152|FG003|Overall Study|Other (house moving)|0|||
147004441|NCT01204294|530179153|FG004|Overall Study|Other (house moving)|0|||
147004442|NCT01204294|530179154|FG005|Overall Study|Other (house moving)|0|||
147004443|NCT01204294|530179155|FG006|Overall Study|Other (house moving)|0|||
147004444|NCT00245063|530179156|FG000|Overall Study|Adverse Event|6|||
147004445|NCT00245063|530179157|FG001|Overall Study|Adverse Event|5|||
147004446|NCT00245063|530179156|FG000|Overall Study|Death|1|||
147004447|NCT00245063|530179157|FG001|Overall Study|Death|0|||
147004448|NCT01839279|530179158|FG000|Overall Study|Adverse Event|4|||
147004449|NCT01839279|530179159|FG001|Overall Study|Adverse Event|1|||
147004450|NCT01839279|530179160|FG002|Overall Study|Adverse Event|1|||
147004451|NCT01839279|530179158|FG000|Overall Study|Withdrawal by Subject|4|||
147004452|NCT01839279|530179159|FG001|Overall Study|Withdrawal by Subject|1|||
147004453|NCT01839279|530179160|FG002|Overall Study|Withdrawal by Subject|1|||
147004454|NCT01839279|530179158|FG000|Overall Study|Classified as 'Other'|5|||
147004455|NCT01839279|530179159|FG001|Overall Study|Classified as 'Other'|0|||
147004456|NCT01839279|530179160|FG002|Overall Study|Classified as 'Other'|0|||
147004457|NCT00840216|530179164|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
147004458|NCT00840216|530179165|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
147004459|NCT01058668|530179166|FG000|Double-blind Treatment Phase|Adverse Event|8|||
147004460|NCT01058668|530179167|FG001|Double-blind Treatment Phase|Adverse Event|15|||
147004461|NCT01058668|530179168|FG002|Double-blind Treatment Phase|Adverse Event|25|||
147004462|NCT01058668|530179166|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
147004463|NCT01058668|530179167|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
147004464|NCT01058668|530179168|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
147004465|NCT01058668|530179166|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
147004466|NCT01058668|530179167|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
147004467|NCT01058668|530179168|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
147004468|NCT01058668|530179166|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
147004469|NCT01058668|530179167|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
147004470|NCT01058668|530179168|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
147004471|NCT01058668|530179166|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
147004472|NCT01058668|530179167|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
147004473|NCT01058668|530179168|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
147004474|NCT01058668|530179166|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
147004475|NCT01058668|530179167|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
147004476|NCT01058668|530179168|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
147004477|NCT00316277|530179169|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
147004478|NCT00316277|530179170|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
147004479|NCT00316277|530179169|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
147004480|NCT00316277|530179170|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
147004481|NCT00316277|530179169|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
147004482|NCT00316277|530179170|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
147004483|NCT00316277|530179169|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
147004484|NCT00316277|530179170|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
147004485|NCT00316277|530179169|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
147004486|NCT00316277|530179170|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
147004487|NCT00848536|530179173|FG000|Overall Study|Adverse Event|2|||
146845251|NCT03653208|529602741|FG005|Overall Study|Withdrawal by Subject|0|||
147004488|NCT00848536|530179174|FG001|Overall Study|Adverse Event|2|||
147004489|NCT00848536|530179173|FG000|Overall Study|Withdrawal by Subject|0|||
147004490|NCT00848536|530179174|FG001|Overall Study|Withdrawal by Subject|1|||
147004491|NCT00848536|530179173|FG000|Overall Study|Protocol Violation|0|||
147004492|NCT00848536|530179174|FG001|Overall Study|Protocol Violation|1|||
147004493|NCT00848536|530179173|FG000|Overall Study|Noncompliance|1|||
147004494|NCT00848536|530179174|FG001|Overall Study|Noncompliance|0|||
147004495|NCT00848536|530179173|FG000|Overall Study|Inadequate Control of IOP|1|||
147004496|NCT00848536|530179174|FG001|Overall Study|Inadequate Control of IOP|1|||
147004497|NCT00848536|530179173|FG000|Overall Study|Patient Moved|0|||
147004498|NCT00848536|530179174|FG001|Overall Study|Patient Moved|2|||
147004499|NCT01370733|530179175|FG000|Overall Study|Withdrawal by Subject|8|||
147004500|NCT01370733|530179176|FG001|Overall Study|Withdrawal by Subject|8|||
147004501|NCT01370733|530179175|FG000|Overall Study|Lost to Follow-up|3|||
147004502|NCT01370733|530179176|FG001|Overall Study|Lost to Follow-up|0|||
147004503|NCT01370733|530179175|FG000|Overall Study|Adverse Event|2|||
147004504|NCT01370733|530179176|FG001|Overall Study|Adverse Event|4|||
147004505|NCT01370733|530179175|FG000|Overall Study|Lack of Efficacy|3|||
147004506|NCT01370733|530179176|FG001|Overall Study|Lack of Efficacy|5|||
147004507|NCT01370733|530179175|FG000|Overall Study|Physician Decision|0|||
147004508|NCT01370733|530179176|FG001|Overall Study|Physician Decision|2|||
147004509|NCT01370733|530179175|FG000|Overall Study|Protocol Violation|1|||
147004510|NCT01370733|530179176|FG001|Overall Study|Protocol Violation|3|||
147004511|NCT06539676|530179177|FG000|Overall Study|Early study termination|1|||
147004512|NCT06539676|530179178|FG001|Overall Study|Early study termination|0|||
147004513|NCT06539676|530179179|FG002|Overall Study|Early study termination|6|||
147004514|NCT03214588|530179180|FG000|Overall Study|Adverse Event|1|||
147004515|NCT03214588|530179181|FG001|Overall Study|Adverse Event|0|||
147004516|NCT03214588|530179182|FG002|Overall Study|Adverse Event|2|||
147004517|NCT03214588|530179180|FG000|Overall Study|Reason Not Specified|0|||
147004518|NCT03214588|530179181|FG001|Overall Study|Reason Not Specified|1|||
147004519|NCT03214588|530179182|FG002|Overall Study|Reason Not Specified|0|||
147004520|NCT00700739|530179185|FG000|Overall Study|Lost to Follow-up|4|||
147004521|NCT00700739|530179186|FG001|Overall Study|Lost to Follow-up|4|||
147004522|NCT00185458|530179188|FG000|Contraception Phase|Adverse Event|37|||
147004523|NCT00185458|530179188|FG000|Contraception Phase|Lost to Follow-up|10|||
147004524|NCT00185458|530179188|FG000|Contraception Phase|Protocol Violation|2|||
147004525|NCT00185458|530179188|FG000|Contraception Phase|Physician Decision|2|||
147004526|NCT00185458|530179188|FG000|Contraception Phase|Withdrawal by Subject|7|||
147004527|NCT00185458|530179188|FG000|HRT Phase|Adverse Event|18|||
147004528|NCT00185458|530179188|FG000|HRT Phase|Lost to Follow-up|4|||
147004529|NCT00185458|530179188|FG000|HRT Phase|Protocol Violation|2|||
147004530|NCT00185458|530179188|FG000|HRT Phase|Withdrawal by Subject|3|||
147004531|NCT03503318|530179189|FG000|Overall Study|Death|1|||
147004532|NCT03503318|530179190|FG001|Overall Study|Death|0|||
147004533|NCT03503318|530179191|FG002|Overall Study|Death|4|||
147004534|NCT03503318|530179189|FG000|Overall Study|Adverse Event|3|||
147004535|NCT03503318|530179190|FG001|Overall Study|Adverse Event|4|||
147004536|NCT03503318|530179191|FG002|Overall Study|Adverse Event|2|||
147004537|NCT03503318|530179189|FG000|Overall Study|Withdrawal by Subject|12|||
147004538|NCT03503318|530179190|FG001|Overall Study|Withdrawal by Subject|17|||
147004539|NCT03503318|530179191|FG002|Overall Study|Withdrawal by Subject|16|||
147004540|NCT03503318|530179189|FG000|Overall Study|Protocol Violation|5|||
147004541|NCT03503318|530179190|FG001|Overall Study|Protocol Violation|0|||
147004542|NCT03503318|530179191|FG002|Overall Study|Protocol Violation|3|||
147004543|NCT03503318|530179189|FG000|Overall Study|Lost to Follow-up|17|||
147004544|NCT03503318|530179190|FG001|Overall Study|Lost to Follow-up|15|||
147004545|NCT03503318|530179191|FG002|Overall Study|Lost to Follow-up|12|||
147004546|NCT03503318|530179189|FG000|Overall Study|Other than specified|1|||
147004547|NCT03503318|530179190|FG001|Overall Study|Other than specified|3|||
147004548|NCT03503318|530179191|FG002|Overall Study|Other than specified|3|||
147004549|NCT00424047|530179196|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
147004550|NCT00424047|530179197|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
147004551|NCT00424047|530179196|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
147004552|NCT00424047|530179197|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
147004553|NCT00424047|530179196|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
147004554|NCT00424047|530179197|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
147004555|NCT00424047|530179196|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
147004556|NCT00424047|530179197|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
147004557|NCT00424047|530179196|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
147004558|NCT00424047|530179197|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
147004559|NCT00424047|530179196|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
147004560|NCT00424047|530179197|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
147004561|NCT00424047|530179196|FG000|On Study at Time of Unblinding|Adverse Event|22|||
147004562|NCT00424047|530179197|FG001|On Study at Time of Unblinding|Adverse Event|12|||
147004563|NCT00424047|530179196|FG000|On Study at Time of Unblinding|Progression of disease|92|||
147004564|NCT00424047|530179197|FG001|On Study at Time of Unblinding|Progression of disease|128|||
147004565|NCT00424047|530179196|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
147004566|NCT00424047|530179197|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
147004567|NCT00424047|530179196|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
147004568|NCT00424047|530179197|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
147004569|NCT00424047|530179196|FG000|On Study at Time of Unblinding|Death|11|||
147004570|NCT00424047|530179197|FG001|On Study at Time of Unblinding|Death|11|||
147004571|NCT00424047|530179196|FG000|On Study at Time of Unblinding|Other|5|||
147004572|NCT00424047|530179197|FG001|On Study at Time of Unblinding|Other|4|||
147004573|NCT00424047|530179196|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
147004574|NCT00424047|530179197|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
147004575|NCT00424047|530179196|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
147004576|NCT00424047|530179197|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
147004577|NCT00424047|530179196|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
147004578|NCT00424047|530179197|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
147004579|NCT00424047|530179196|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
147004580|NCT00424047|530179197|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
147004581|NCT00424047|530179196|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
147004582|NCT00424047|530179197|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
147004583|NCT01010503|530179199|FG000|Overall Study|Adverse Event|1|||
147004584|NCT01010503|530179199|FG000|Overall Study|Death|1|||
147004585|NCT01154231|530179200|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
147004586|NCT01154231|530179200|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
147004587|NCT01097577|530179201|FG000|Overall Study|Adverse Event|0|||
147004588|NCT01097577|530179202|FG001|Overall Study|Adverse Event|1|||
147004589|NCT01952691|530180700|FG000|Overall Study|Lost to Follow-up|2|||
147004590|NCT00199901|530180701|FG000|Overall Study|Protocol Violation|2|||
147004591|NCT00199901|530180702|FG001|Overall Study|Protocol Violation|0|||
147004592|NCT00199901|530180701|FG000|Overall Study|Withdrawal by Subject|1|||
147004593|NCT00199901|530180702|FG001|Overall Study|Withdrawal by Subject|0|||
147004594|NCT00199901|530180701|FG000|Overall Study|Progressive Disease|24|||
147004595|NCT00199901|530180702|FG001|Overall Study|Progressive Disease|24|||
147004596|NCT01958294|530180712|FG000|Overall Study|Clinical Circumstances|2|||
147004597|NCT02566850|530180713|FG000|Overall Study|Protocol Violation|1|||
147004598|NCT03599193|530180714|FG000|Overall Study|Adverse Event|0|||
147004599|NCT03599193|530180715|FG001|Overall Study|Adverse Event|2|||
147004600|NCT03599193|530180714|FG000|Overall Study|Withdrawal by Subject|1|||
147004601|NCT03599193|530180715|FG001|Overall Study|Withdrawal by Subject|0|||
147004602|NCT03599193|530180714|FG000|Overall Study|Protocol Violation|1|||
147004603|NCT03599193|530180715|FG001|Overall Study|Protocol Violation|0|||
147004604|NCT03599193|530180714|FG000|Overall Study|Lost to Follow-up|0|||
147004605|NCT03599193|530180715|FG001|Overall Study|Lost to Follow-up|1|||
147004606|NCT04372238|530180718|FG000|Overall Study|Duplicate|3|||
147004607|NCT04372238|530180719|FG001|Overall Study|Duplicate|3|||
147004608|NCT04372238|530180718|FG000|Overall Study|Did not consent for data linkage|6|||
147004609|NCT04372238|530180719|FG001|Overall Study|Did not consent for data linkage|10|||
147004610|NCT04241458|530180720|FG000|Overall Study|Withdrawal by Subject|0|||
147004611|NCT04241458|530180721|FG001|Overall Study|Withdrawal by Subject|0|||
147004612|NCT04241458|530180722|FG002|Overall Study|Withdrawal by Subject|0|||
147004613|NCT04241458|530180723|FG003|Overall Study|Withdrawal by Subject|0|||
147004614|NCT04241458|530180724|FG004|Overall Study|Withdrawal by Subject|1|||
147004615|NCT06144424|530180725|FG000|Overall Study|Withdrawal by Subject|2|||
147004616|NCT06144424|530180726|FG001|Overall Study|Withdrawal by Subject|0|||
147004617|NCT06144424|530180725|FG000|Overall Study|Incarceration|1|||
147004618|NCT06144424|530180726|FG001|Overall Study|Incarceration|0|||
147004619|NCT02832063|530180727|FG000|Overall Study|Adverse Event|2|||
147004620|NCT02832063|530180728|FG001|Overall Study|Adverse Event|1|||
147004621|NCT02832063|530180727|FG000|Overall Study|Physician Decision|5|||
147004622|NCT02832063|530180728|FG001|Overall Study|Physician Decision|7|||
147004623|NCT02832063|530180727|FG000|Overall Study|Lost to Follow-up|15|||
147004624|NCT02832063|530180728|FG001|Overall Study|Lost to Follow-up|8|||
147004625|NCT02832063|530180727|FG000|Overall Study|Withdrawal by Subject|10|||
147004626|NCT02832063|530180728|FG001|Overall Study|Withdrawal by Subject|21|||
147004627|NCT02832063|530180727|FG000|Overall Study|Other|2|||
147004628|NCT02832063|530180728|FG001|Overall Study|Other|1|||
147004629|NCT03733730|530180729|FG000|Overall Study|Lost to Follow-up|1|||
147004630|NCT03733730|530180730|FG001|Overall Study|Lost to Follow-up|32|||
147004631|NCT03733730|530180729|FG000|Overall Study|Other|1|||
147004632|NCT03733730|530180730|FG001|Overall Study|Other|0|||
147004633|NCT03733730|530180729|FG000|Overall Study|Adverse Event|0|||
147004634|NCT03733730|530180730|FG001|Overall Study|Adverse Event|4|||
147004635|NCT03733730|530180729|FG000|Overall Study|Death|0|||
147004636|NCT03733730|530180730|FG001|Overall Study|Death|5|||
147004637|NCT03733730|530180729|FG000|Overall Study|Withdrawal by Subject|0|||
147004638|NCT03733730|530180730|FG001|Overall Study|Withdrawal by Subject|8|||
147004639|NCT00772603|530180731|FG000|Overall Study|Withdrawal by Subject|11|||
147004640|NCT00772603|530180732|FG001|Overall Study|Withdrawal by Subject|10|||
147004641|NCT00772603|530180733|FG002|Overall Study|Withdrawal by Subject|6|||
147004642|NCT00772603|530180731|FG000|Overall Study|Adverse Event|37|||
147004643|NCT00772603|530180732|FG001|Overall Study|Adverse Event|18|||
147004644|NCT00772603|530180733|FG002|Overall Study|Adverse Event|10|||
147004645|NCT00772603|530180731|FG000|Overall Study|Subject Non-compliance|1|||
147004646|NCT00772603|530180732|FG001|Overall Study|Subject Non-compliance|6|||
147004647|NCT00772603|530180733|FG002|Overall Study|Subject Non-compliance|4|||
147004648|NCT00772603|530180731|FG000|Overall Study|Protocol Violation|0|||
147004649|NCT00772603|530180732|FG001|Overall Study|Protocol Violation|1|||
147004650|NCT00772603|530180733|FG002|Overall Study|Protocol Violation|1|||
147004651|NCT00772603|530180731|FG000|Overall Study|Lost to Follow-up|1|||
147004652|NCT00772603|530180732|FG001|Overall Study|Lost to Follow-up|5|||
147004653|NCT00772603|530180733|FG002|Overall Study|Lost to Follow-up|2|||
147004654|NCT00772603|530180731|FG000|Overall Study|Physician Decision|0|||
147004655|NCT00772603|530180732|FG001|Overall Study|Physician Decision|0|||
147004656|NCT00772603|530180733|FG002|Overall Study|Physician Decision|1|||
147004657|NCT00772603|530180731|FG000|Overall Study|Other|2|||
147004658|NCT00772603|530180732|FG001|Overall Study|Other|0|||
147004659|NCT00772603|530180733|FG002|Overall Study|Other|2|||
147004660|NCT00081653|530180737|FG000|Overall Study|Adverse Event|23|||
147004661|NCT00081653|530180738|FG001|Overall Study|Adverse Event|17|||
147004662|NCT00081653|530180737|FG000|Overall Study|Lost to Follow-up|2|||
147004663|NCT00081653|530180738|FG001|Overall Study|Lost to Follow-up|4|||
147004664|NCT00081653|530180737|FG000|Overall Study|Refused Treatment|18|||
147004665|NCT00081653|530180738|FG001|Overall Study|Refused Treatment|14|||
147004666|NCT00081653|530180737|FG000|Overall Study|Low bone mineral density|1|||
147004667|NCT00081653|530180738|FG001|Overall Study|Low bone mineral density|0|||
147004668|NCT00081653|530180737|FG000|Overall Study|Bone loss|2|||
147004669|NCT00081653|530180738|FG001|Overall Study|Bone loss|0|||
147004670|NCT00081653|530180737|FG000|Overall Study|Participant leaving country|1|||
147004671|NCT00081653|530180738|FG001|Overall Study|Participant leaving country|0|||
147004672|NCT00081653|530180737|FG000|Overall Study|Loss of bone mass|0|||
147004673|NCT00081653|530180738|FG001|Overall Study|Loss of bone mass|2|||
147004674|NCT02663349|530180740|FG000|Overall Study|Withdrawal by Subject|6|||
147004675|NCT00928057|530180741|FG000|Overall Study|Adverse Event|1|||
147004676|NCT00928057|530180742|FG001|Overall Study|Adverse Event|2|||
147004677|NCT00928057|530180741|FG000|Overall Study|Withdrawal by Subject|1|||
147004678|NCT00928057|530180742|FG001|Overall Study|Withdrawal by Subject|0|||
147004679|NCT00928057|530180741|FG000|Overall Study|Lost to Follow-up|0|||
147004680|NCT00928057|530180742|FG001|Overall Study|Lost to Follow-up|1|||
147004681|NCT00928057|530180741|FG000|Overall Study|Protocol Violation|0|||
147004682|NCT00928057|530180742|FG001|Overall Study|Protocol Violation|1|||
147004683|NCT02451696|530180743|FG000|Overall Study|Surgery postponed|1|||
147004684|NCT02451696|530180744|FG001|Overall Study|Surgery postponed|0|||
146845252|NCT03653208|529602742|FG006|Overall Study|Withdrawal by Subject|0|||
146845253|NCT03653208|529602743|FG007|Overall Study|Withdrawal by Subject|1|||
146845254|NCT03653208|529602744|FG008|Overall Study|Withdrawal by Subject|1|||
146845255|NCT01283516|529602746|FG000|Overall Study|Adverse Event|0|||
146845256|NCT01283516|529602747|FG001|Overall Study|Adverse Event|0|||
146845257|NCT01283516|529602748|FG002|Overall Study|Adverse Event|0|||
146845258|NCT01283516|529602749|FG003|Overall Study|Adverse Event|0|||
146845259|NCT01283516|529602750|FG004|Overall Study|Adverse Event|0|||
146845260|NCT01283516|529602751|FG005|Overall Study|Adverse Event|0|||
146845261|NCT01283516|529602752|FG006|Overall Study|Adverse Event|2|||
146845262|NCT01283516|529602753|FG007|Overall Study|Adverse Event|0|||
146845263|NCT01283516|529602754|FG008|Overall Study|Adverse Event|28|||
146845264|NCT01283516|529602746|FG000|Overall Study|Death|0|||
146845265|NCT01283516|529602747|FG001|Overall Study|Death|0|||
146845266|NCT01283516|529602748|FG002|Overall Study|Death|0|||
147004685|NCT01557751|530180745|FG000|Overall Study|Physician Decision|3|||
147004686|NCT03674892|530180747|FG000|Overall Study|Lack of Efficacy|5|||
147004687|NCT03674892|530180747|FG000|Overall Study|Lost to Follow-up|3|||
146845267|NCT01283516|529602749|FG003|Overall Study|Death|0|||
147004688|NCT03674892|530180747|FG000|Overall Study|Migraine|2|||
147004689|NCT03674892|530180747|FG000|Overall Study|Excessive Tearing|1|||
147004690|NCT03674892|530180747|FG000|Overall Study|Increased Eye Pain|1|||
147004691|NCT03674892|530180747|FG000|Overall Study|Increased Facial Pain|1|||
147004692|NCT03674892|530180747|FG000|Overall Study|Sinus Irritation|1|||
146845268|NCT01283516|529602750|FG004|Overall Study|Death|0|||
146845269|NCT01283516|529602751|FG005|Overall Study|Death|1|||
146845270|NCT01283516|529602752|FG006|Overall Study|Death|0|||
147004693|NCT03674892|530180747|FG000|Overall Study|Sinus Infection|1|||
146845271|NCT01283516|529602753|FG007|Overall Study|Death|1|||
147004694|NCT05099380|530180748|FG000|Overall Study|Subject enrolled in error|1|||
147004695|NCT05099380|530180749|FG001|Overall Study|Subject enrolled in error|0|||
147004696|NCT05099380|530180748|FG000|Overall Study|Study Procedure|1|||
147004697|NCT05099380|530180749|FG001|Overall Study|Study Procedure|0|||
147004698|NCT05099380|530180748|FG000|Overall Study|Protocol Violation|1|||
147004699|NCT05099380|530180749|FG001|Overall Study|Protocol Violation|0|||
147004700|NCT05099380|530180748|FG000|Overall Study|Adverse Event|1|||
146845272|NCT01283516|529602754|FG008|Overall Study|Death|12|||
146845273|NCT01283516|529602746|FG000|Overall Study|Disease Progression|2|||
146845274|NCT01283516|529602747|FG001|Overall Study|Disease Progression|2|||
146845275|NCT01283516|529602748|FG002|Overall Study|Disease Progression|3|||
146845276|NCT01283516|529602749|FG003|Overall Study|Disease Progression|3|||
146845277|NCT01283516|529602750|FG004|Overall Study|Disease Progression|13|||
146845278|NCT01283516|529602751|FG005|Overall Study|Disease Progression|8|||
146845279|NCT01283516|529602752|FG006|Overall Study|Disease Progression|6|||
146845280|NCT01283516|529602753|FG007|Overall Study|Disease Progression|3|||
146845281|NCT01283516|529602754|FG008|Overall Study|Disease Progression|139|||
146845282|NCT01283516|529602746|FG000|Overall Study|Withdrawal by Subject|0|||
146845283|NCT01283516|529602747|FG001|Overall Study|Withdrawal by Subject|0|||
146845284|NCT01283516|529602748|FG002|Overall Study|Withdrawal by Subject|0|||
147004701|NCT05099380|530180749|FG001|Overall Study|Adverse Event|1|||
147004702|NCT05099380|530180748|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
147004703|NCT05099380|530180749|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
147004704|NCT02842853|530180750|FG000|Overall Study|Non-compliance with the protocol|3|||
147004705|NCT02842853|530180751|FG001|Overall Study|Non-compliance with the protocol|7|||
147004706|NCT02842853|530180752|FG002|Overall Study|Non-compliance with the protocol|2|||
147004707|NCT02842853|530180753|FG003|Overall Study|Non-compliance with the protocol|5|||
147004708|NCT02842853|530180750|FG000|Overall Study|Subject met exclusion criteria|0|||
147004709|NCT02842853|530180751|FG001|Overall Study|Subject met exclusion criteria|1|||
147004710|NCT02842853|530180752|FG002|Overall Study|Subject met exclusion criteria|0|||
147004711|NCT02842853|530180753|FG003|Overall Study|Subject met exclusion criteria|0|||
147004712|NCT02842853|530180750|FG000|Overall Study|Withdrawal by Subject|11|||
147004713|NCT02842853|530180751|FG001|Overall Study|Withdrawal by Subject|13|||
147004714|NCT02842853|530180752|FG002|Overall Study|Withdrawal by Subject|9|||
147004715|NCT02842853|530180753|FG003|Overall Study|Withdrawal by Subject|8|||
147004716|NCT02842853|530180750|FG000|Overall Study|Lost to Follow-up|9|||
147004717|NCT02842853|530180751|FG001|Overall Study|Lost to Follow-up|13|||
147004718|NCT02842853|530180752|FG002|Overall Study|Lost to Follow-up|10|||
147004719|NCT02842853|530180753|FG003|Overall Study|Lost to Follow-up|11|||
147004720|NCT04089553|530180754|FG000|Overall Study|Death|1|||
147004721|NCT04089553|530180755|FG001|Overall Study|Death|1|||
147004722|NCT04089553|530180754|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
147004723|NCT04089553|530180755|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
147004724|NCT04089553|530180754|FG000|Overall Study|Withdrawal by Subject|3|||
147004725|NCT04089553|530180755|FG001|Overall Study|Withdrawal by Subject|3|||
147004726|NCT04089553|530180754|FG000|Overall Study|Physician Decision|1|||
147004727|NCT04089553|530180755|FG001|Overall Study|Physician Decision|0|||
147004728|NCT04089553|530180754|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
147004729|NCT04089553|530180755|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
147004730|NCT04089553|530180754|FG000|Overall Study|Other|1|||
147004731|NCT04089553|530180755|FG001|Overall Study|Other|0|||
147004732|NCT04089553|530180754|FG000|Overall Study|Adverse Event|1|||
147004733|NCT04089553|530180755|FG001|Overall Study|Adverse Event|1|||
147004734|NCT01175135|530180763|FG000|Overall Study|Adverse Event|2|||
147004735|NCT01175135|530180764|FG001|Overall Study|Adverse Event|5|||
147004736|NCT01175135|530180765|FG002|Overall Study|Adverse Event|3|||
147004737|NCT01175135|530180766|FG003|Overall Study|Adverse Event|4|||
147004738|NCT01175135|530180763|FG000|Overall Study|Death|1|||
147004739|NCT01175135|530180764|FG001|Overall Study|Death|0|||
147004740|NCT01175135|530180765|FG002|Overall Study|Death|0|||
147004741|NCT01175135|530180766|FG003|Overall Study|Death|0|||
147004742|NCT01175135|530180763|FG000|Overall Study|Lack of Efficacy|4|||
147004743|NCT01175135|530180764|FG001|Overall Study|Lack of Efficacy|5|||
147004744|NCT01175135|530180765|FG002|Overall Study|Lack of Efficacy|0|||
147004745|NCT01175135|530180766|FG003|Overall Study|Lack of Efficacy|5|||
147004746|NCT01175135|530180763|FG000|Overall Study|Lost to Follow-up|1|||
147004747|NCT01175135|530180764|FG001|Overall Study|Lost to Follow-up|2|||
147004748|NCT01175135|530180765|FG002|Overall Study|Lost to Follow-up|0|||
146845285|NCT01283516|529602749|FG003|Overall Study|Withdrawal by Subject|0|||
146845286|NCT01283516|529602750|FG004|Overall Study|Withdrawal by Subject|1|||
147004749|NCT01175135|530180766|FG003|Overall Study|Lost to Follow-up|0|||
147004750|NCT01175135|530180763|FG000|Overall Study|Protocol Violation|1|||
147004751|NCT01175135|530180764|FG001|Overall Study|Protocol Violation|1|||
147004752|NCT01175135|530180765|FG002|Overall Study|Protocol Violation|0|||
147004753|NCT01175135|530180766|FG003|Overall Study|Protocol Violation|0|||
146845287|NCT01283516|529602751|FG005|Overall Study|Withdrawal by Subject|0|||
147004754|NCT01175135|530180763|FG000|Overall Study|Withdrawal by Subject|4|||
147004755|NCT01175135|530180764|FG001|Overall Study|Withdrawal by Subject|8|||
146845288|NCT01283516|529602752|FG006|Overall Study|Withdrawal by Subject|1|||
146845289|NCT01283516|529602753|FG007|Overall Study|Withdrawal by Subject|0|||
146845290|NCT01283516|529602754|FG008|Overall Study|Withdrawal by Subject|36|||
147004756|NCT01175135|530180765|FG002|Overall Study|Withdrawal by Subject|5|||
147004757|NCT01175135|530180766|FG003|Overall Study|Withdrawal by Subject|5|||
146845291|NCT01283516|529602746|FG000|Overall Study|Administrative problems|0|||
147004758|NCT01175135|530180763|FG000|Overall Study|Other|3|||
147004759|NCT01175135|530180764|FG001|Overall Study|Other|1|||
147004760|NCT01175135|530180765|FG002|Overall Study|Other|3|||
147004761|NCT01175135|530180766|FG003|Overall Study|Other|0|||
147004762|NCT01175135|530180763|FG000|Overall Study|Randomized But Not Treated|0|||
147004763|NCT01175135|530180764|FG001|Overall Study|Randomized But Not Treated|0|||
147004764|NCT01175135|530180765|FG002|Overall Study|Randomized But Not Treated|1|||
147004765|NCT01175135|530180766|FG003|Overall Study|Randomized But Not Treated|0|||
147004766|NCT01572662|530180767|FG000|Overall Study|Withdrawal by Subject|1|||
147004767|NCT01572662|530180768|FG001|Overall Study|Withdrawal by Subject|0|||
147004768|NCT01572662|530180767|FG000|Overall Study|Physician Decision|0|||
147004769|NCT01572662|530180768|FG001|Overall Study|Physician Decision|1|||
147004770|NCT03364192|530180769|FG000|Overall Study|Ineligible|10|||
147004771|NCT03364192|530180769|FG000|Overall Study|Withdrawal by Subject|5|||
147004772|NCT03364192|530180769|FG000|Overall Study|Lost to Follow-up|1|||
147004773|NCT04547192|530180772|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
147004774|NCT04547192|530180773|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
147004775|NCT04547192|530180774|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
147004776|NCT04547192|530180775|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
147004777|NCT04547192|530180772|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
147004778|NCT04547192|530180773|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
147004779|NCT04547192|530180774|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
147004780|NCT04547192|530180775|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
147004781|NCT04547192|530180772|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
147004782|NCT04547192|530180773|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
147004783|NCT04547192|530180774|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
147004784|NCT04547192|530180775|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
147004785|NCT04547192|530180772|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
147004786|NCT04547192|530180773|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
147004787|NCT04547192|530180774|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
147004788|NCT04547192|530180775|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
147004789|NCT04547192|530180772|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
147004790|NCT04547192|530180773|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
147004791|NCT04547192|530180774|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
147004792|NCT04547192|530180775|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
147004793|NCT00935012|530180778|FG000|Overall Study|Death|19|||
147004794|NCT00935012|530180778|FG000|Overall Study|Withdrawal by Subject|3|||
147004795|NCT00935012|530180778|FG000|Overall Study|Other|5|||
147004796|NCT00935012|530180778|FG000|Overall Study|Adverse Event|2|||
147004797|NCT01442155|530180779|FG000|Overall Study|Complete remission|35|||
147004798|NCT01442155|530180779|FG000|Overall Study|Recurrence|26|||
147004799|NCT01442155|530180779|FG000|Overall Study|Adverse Event|2|||
147004800|NCT01442155|530180779|FG000|Overall Study|Lost to Follow-up|2|||
147004801|NCT01590563|530180788|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
147004802|NCT02699463|530180791|FG000|Overall Study|Lost to Follow-up|11|||
147004803|NCT02699463|530180792|FG001|Overall Study|Lost to Follow-up|8|||
147004804|NCT02699463|530180791|FG000|Overall Study|Withdrawal by Subject|4|||
147004805|NCT02699463|530180792|FG001|Overall Study|Withdrawal by Subject|1|||
147004806|NCT02294981|530180793|FG000|Overall Study|Lost to Follow-up|1|||
147004807|NCT00909038|530180796|FG000|Overall Study|Protocol Violation|187|||
147004808|NCT00909038|530180796|FG000|Overall Study|Non-evaluable Subjects|230|||
147004809|NCT00909753|530180799|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
147004810|NCT00909753|530180800|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
147004811|NCT00909753|530180799|FG000|Period: Second Intervention|Protocol Violation|1|||
147004812|NCT00909753|530180800|FG001|Period: Second Intervention|Protocol Violation|0|||
147004813|NCT01895335|530180801|FG000|Overall Study|Adverse Event|106|||
147004814|NCT01895335|530180801|FG000|Overall Study|Lack of Efficacy|53|||
147004815|NCT01895335|530180801|FG000|Overall Study|Poor Compliance to Protocol|11|||
147004816|NCT01895335|530180801|FG000|Overall Study|Included But Not treated|1|||
147004817|NCT01895335|530180801|FG000|Overall Study|Other than Specified Above|44|||
147004818|NCT01647828|530180802|FG000|Overall Study|Death|3|||
147004819|NCT01647828|530180803|FG001|Overall Study|Death|4|||
147004820|NCT01647828|530180804|FG002|Overall Study|Death|4|||
147004821|NCT01647828|530180805|FG003|Overall Study|Death|5|||
147004822|NCT01647828|530180806|FG004|Overall Study|Death|6|||
147004823|NCT01647828|530180807|FG005|Overall Study|Death|3|||
147004824|NCT01647828|530180808|FG006|Overall Study|Death|10|||
147004825|NCT01647828|530180809|FG007|Overall Study|Death|60|||
147004826|NCT01647828|530180810|FG008|Overall Study|Death|71|||
147004827|NCT01647828|530180802|FG000|Overall Study|Withdrawal by Subject|2|||
147004828|NCT01647828|530180803|FG001|Overall Study|Withdrawal by Subject|0|||
147004829|NCT01647828|530180804|FG002|Overall Study|Withdrawal by Subject|0|||
147004830|NCT01647828|530180805|FG003|Overall Study|Withdrawal by Subject|1|||
147004831|NCT01647828|530180806|FG004|Overall Study|Withdrawal by Subject|0|||
147004832|NCT01647828|530180807|FG005|Overall Study|Withdrawal by Subject|0|||
147004833|NCT01647828|530180808|FG006|Overall Study|Withdrawal by Subject|1|||
147004834|NCT01647828|530180809|FG007|Overall Study|Withdrawal by Subject|0|||
147004835|NCT01647828|530180810|FG008|Overall Study|Withdrawal by Subject|2|||
147004836|NCT01647828|530180802|FG000|Overall Study|Study terminated by Sponsor|0|||
146845292|NCT01283516|529602747|FG001|Overall Study|Administrative problems|0|||
146845293|NCT01283516|529602748|FG002|Overall Study|Administrative problems|0|||
146845294|NCT01283516|529602749|FG003|Overall Study|Administrative problems|0|||
146845295|NCT01283516|529602750|FG004|Overall Study|Administrative problems|0|||
146845296|NCT01283516|529602751|FG005|Overall Study|Administrative problems|1|||
146845297|NCT01283516|529602752|FG006|Overall Study|Administrative problems|1|||
147004837|NCT01647828|530180803|FG001|Overall Study|Study terminated by Sponsor|0|||
147004838|NCT01647828|530180804|FG002|Overall Study|Study terminated by Sponsor|0|||
146845298|NCT01283516|529602753|FG007|Overall Study|Administrative problems|1|||
146845299|NCT01283516|529602754|FG008|Overall Study|Administrative problems|39|||
147004839|NCT01647828|530180805|FG003|Overall Study|Study terminated by Sponsor|0|||
147004840|NCT01647828|530180806|FG004|Overall Study|Study terminated by Sponsor|0|||
147004841|NCT01647828|530180807|FG005|Overall Study|Study terminated by Sponsor|0|||
147004842|NCT01647828|530180808|FG006|Overall Study|Study terminated by Sponsor|1|||
147004843|NCT01647828|530180809|FG007|Overall Study|Study terminated by Sponsor|26|||
147004844|NCT01647828|530180810|FG008|Overall Study|Study terminated by Sponsor|16|||
147004845|NCT01647828|530180802|FG000|Overall Study|Lost to Follow-up|0|||
147004846|NCT01647828|530180803|FG001|Overall Study|Lost to Follow-up|0|||
147004847|NCT01647828|530180804|FG002|Overall Study|Lost to Follow-up|0|||
147004848|NCT01647828|530180805|FG003|Overall Study|Lost to Follow-up|0|||
147004849|NCT01647828|530180806|FG004|Overall Study|Lost to Follow-up|0|||
147004850|NCT01647828|530180807|FG005|Overall Study|Lost to Follow-up|0|||
147004851|NCT01647828|530180808|FG006|Overall Study|Lost to Follow-up|0|||
147004852|NCT01647828|530180809|FG007|Overall Study|Lost to Follow-up|2|||
147004853|NCT01647828|530180810|FG008|Overall Study|Lost to Follow-up|0|||
147004854|NCT00205777|530180813|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
147004855|NCT00205777|530180814|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
147004856|NCT00205777|530180815|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
147004857|NCT00205777|530180816|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
147004858|NCT00205777|530180817|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
147004859|NCT00205777|530180818|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
147004860|NCT00205777|530180813|FG000|Core Study (Up to 3 Years)|Death|9|||
147004861|NCT00205777|530180814|FG001|Core Study (Up to 3 Years)|Death|7|||
147004862|NCT00205777|530180815|FG002|Core Study (Up to 3 Years)|Death|14|||
147004863|NCT00205777|530180816|FG003|Core Study (Up to 3 Years)|Death|7|||
147004864|NCT00205777|530180817|FG004|Core Study (Up to 3 Years)|Death|0|||
147004865|NCT00205777|530180818|FG005|Core Study (Up to 3 Years)|Death|0|||
147004866|NCT00205777|530180813|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
147004867|NCT00205777|530180814|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
147004868|NCT00205777|530180815|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
147004869|NCT00205777|530180816|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
147004870|NCT00205777|530180817|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
147004871|NCT00205777|530180818|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
147004872|NCT00205777|530180813|FG000|Core Study (Up to 3 Years)|Other Event|49|||
147004873|NCT00205777|530180814|FG001|Core Study (Up to 3 Years)|Other Event|52|||
147004874|NCT00205777|530180815|FG002|Core Study (Up to 3 Years)|Other Event|41|||
147004875|NCT00205777|530180816|FG003|Core Study (Up to 3 Years)|Other Event|58|||
147004876|NCT00205777|530180817|FG004|Core Study (Up to 3 Years)|Other Event|0|||
147004877|NCT00205777|530180818|FG005|Core Study (Up to 3 Years)|Other Event|0|||
147004878|NCT00205777|530180813|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
147004879|NCT00205777|530180814|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
147004880|NCT00205777|530180815|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
147004881|NCT00205777|530180816|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
147004882|NCT00205777|530180817|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
147004883|NCT00205777|530180818|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
147004884|NCT00205777|530180813|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
147004885|NCT00205777|530180814|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
147004886|NCT00205777|530180815|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
147004887|NCT00205777|530180816|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
147004888|NCT00205777|530180817|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
147004889|NCT00205777|530180818|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
147004890|NCT00205777|530180813|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
147004891|NCT00205777|530180814|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
147004892|NCT00205777|530180815|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
147004893|NCT00205777|530180816|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
147004894|NCT00205777|530180817|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
147004895|NCT00205777|530180818|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
146845300|NCT01283516|529602746|FG000|Overall Study|Lost to Follow-up|0|||
147004896|NCT00205777|530180813|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
147004897|NCT00205777|530180814|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
147004898|NCT00205777|530180815|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
147004899|NCT00205777|530180816|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
147004900|NCT00205777|530180817|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
147004901|NCT00205777|530180818|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
147004902|NCT00205777|530180813|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
147004903|NCT00205777|530180814|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
147004904|NCT00205777|530180815|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
147004905|NCT00205777|530180816|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
147004906|NCT00205777|530180817|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
147004907|NCT00205777|530180818|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
147004908|NCT00205777|530180813|FG000|Completed Core Study, Entered SE I|Other Event|52|||
147004909|NCT00205777|530180814|FG001|Completed Core Study, Entered SE I|Other Event|46|||
147004910|NCT00205777|530180815|FG002|Completed Core Study, Entered SE I|Other Event|47|||
147004911|NCT00205777|530180816|FG003|Completed Core Study, Entered SE I|Other Event|50|||
147004912|NCT00205777|530180817|FG004|Completed Core Study, Entered SE I|Other Event|0|||
147004913|NCT00205777|530180818|FG005|Completed Core Study, Entered SE I|Other Event|0|||
147004914|NCT00205777|530180813|FG000|Study Extension I|Adverse Event|57|||
147004915|NCT00205777|530180814|FG001|Study Extension I|Adverse Event|0|||
147004916|NCT00205777|530180815|FG002|Study Extension I|Adverse Event|0|||
147004917|NCT00205777|530180816|FG003|Study Extension I|Adverse Event|61|||
147004918|NCT00205777|530180817|FG004|Study Extension I|Adverse Event|58|||
147004919|NCT00205777|530180818|FG005|Study Extension I|Adverse Event|0|||
147004920|NCT00205777|530180813|FG000|Study Extension I|Death|5|||
147004921|NCT00205777|530180814|FG001|Study Extension I|Death|0|||
147004922|NCT00205777|530180815|FG002|Study Extension I|Death|0|||
147004923|NCT00205777|530180816|FG003|Study Extension I|Death|1|||
147004924|NCT00205777|530180817|FG004|Study Extension I|Death|2|||
147004925|NCT00205777|530180818|FG005|Study Extension I|Death|0|||
147004926|NCT00205777|530180813|FG000|Study Extension I|Withdrawal by Subject|99|||
147004927|NCT00205777|530180814|FG001|Study Extension I|Withdrawal by Subject|0|||
147004928|NCT00205777|530180815|FG002|Study Extension I|Withdrawal by Subject|0|||
147004929|NCT00205777|530180816|FG003|Study Extension I|Withdrawal by Subject|106|||
147004930|NCT00205777|530180817|FG004|Study Extension I|Withdrawal by Subject|89|||
147004931|NCT00205777|530180818|FG005|Study Extension I|Withdrawal by Subject|0|||
147004932|NCT00205777|530180813|FG000|Study Extension I|Protocol Violation|4|||
147004933|NCT00205777|530180814|FG001|Study Extension I|Protocol Violation|0|||
147004934|NCT00205777|530180815|FG002|Study Extension I|Protocol Violation|0|||
147004935|NCT00205777|530180816|FG003|Study Extension I|Protocol Violation|8|||
147004936|NCT00205777|530180817|FG004|Study Extension I|Protocol Violation|8|||
147004937|NCT00205777|530180818|FG005|Study Extension I|Protocol Violation|0|||
147004938|NCT00205777|530180813|FG000|Study Extension I|Lack of Efficacy|0|||
147004939|NCT00205777|530180814|FG001|Study Extension I|Lack of Efficacy|0|||
147004940|NCT00205777|530180815|FG002|Study Extension I|Lack of Efficacy|0|||
147004941|NCT00205777|530180816|FG003|Study Extension I|Lack of Efficacy|1|||
147004942|NCT00205777|530180817|FG004|Study Extension I|Lack of Efficacy|2|||
147004943|NCT00205777|530180818|FG005|Study Extension I|Lack of Efficacy|0|||
147004944|NCT00205777|530180813|FG000|Study Extension I|Failed to return|15|||
147004945|NCT00205777|530180814|FG001|Study Extension I|Failed to return|0|||
147004946|NCT00205777|530180815|FG002|Study Extension I|Failed to return|0|||
147004947|NCT00205777|530180816|FG003|Study Extension I|Failed to return|17|||
147004948|NCT00205777|530180817|FG004|Study Extension I|Failed to return|13|||
147004949|NCT00205777|530180818|FG005|Study Extension I|Failed to return|0|||
147004950|NCT00205777|530180813|FG000|Study Extension I|Other Event|34|||
147004951|NCT00205777|530180814|FG001|Study Extension I|Other Event|0|||
147004952|NCT00205777|530180815|FG002|Study Extension I|Other Event|0|||
147004953|NCT00205777|530180816|FG003|Study Extension I|Other Event|34|||
147004954|NCT00205777|530180817|FG004|Study Extension I|Other Event|29|||
147004955|NCT00205777|530180818|FG005|Study Extension I|Other Event|0|||
147004956|NCT00205777|530180813|FG000|Study Extension I|Withdrawn as per protocol|0|||
147004957|NCT00205777|530180814|FG001|Study Extension I|Withdrawn as per protocol|0|||
147004958|NCT00205777|530180815|FG002|Study Extension I|Withdrawn as per protocol|1070|||
147004959|NCT00205777|530180816|FG003|Study Extension I|Withdrawn as per protocol|0|||
146845301|NCT01283516|529602747|FG001|Overall Study|Lost to Follow-up|0|||
146845302|NCT01283516|529602748|FG002|Overall Study|Lost to Follow-up|0|||
146845303|NCT01283516|529602749|FG003|Overall Study|Lost to Follow-up|0|||
146845304|NCT01283516|529602750|FG004|Overall Study|Lost to Follow-up|0|||
147004960|NCT00205777|530180817|FG004|Study Extension I|Withdrawn as per protocol|0|||
147004961|NCT00205777|530180818|FG005|Study Extension I|Withdrawn as per protocol|0|||
147004962|NCT00205777|530180813|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
147004963|NCT00205777|530180814|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
147004964|NCT00205777|530180815|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
147004965|NCT00205777|530180816|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
147004966|NCT00205777|530180817|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
146845305|NCT01283516|529602751|FG005|Overall Study|Lost to Follow-up|0|||
147004967|NCT00205777|530180818|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
147004968|NCT00205777|530180813|FG000|Study Extension II|Adverse Event|0|||
147004969|NCT00205777|530180814|FG001|Study Extension II|Adverse Event|0|||
147004970|NCT00205777|530180815|FG002|Study Extension II|Adverse Event|0|||
146845306|NCT01283516|529602752|FG006|Overall Study|Lost to Follow-up|0|||
146845307|NCT01283516|529602753|FG007|Overall Study|Lost to Follow-up|0|||
146845308|NCT01283516|529602754|FG008|Overall Study|Lost to Follow-up|1|||
146845309|NCT00132873|529602757|FG000|Overall Study|Adverse Event|3|||
146845310|NCT00132873|529602757|FG000|Overall Study|Lost to Follow-up|1|||
147004971|NCT00205777|530180816|FG003|Study Extension II|Adverse Event|14|||
147004972|NCT00205777|530180817|FG004|Study Extension II|Adverse Event|0|||
147004973|NCT00205777|530180818|FG005|Study Extension II|Adverse Event|30|||
147004974|NCT00205777|530180813|FG000|Study Extension II|Death|0|||
147004975|NCT00205777|530180814|FG001|Study Extension II|Death|0|||
147004976|NCT00205777|530180815|FG002|Study Extension II|Death|0|||
147004977|NCT00205777|530180816|FG003|Study Extension II|Death|2|||
147004978|NCT00205777|530180817|FG004|Study Extension II|Death|0|||
147004979|NCT00205777|530180818|FG005|Study Extension II|Death|5|||
147004980|NCT00205777|530180813|FG000|Study Extension II|Withdrawal by Subject|0|||
147004981|NCT00205777|530180814|FG001|Study Extension II|Withdrawal by Subject|0|||
147004982|NCT00205777|530180815|FG002|Study Extension II|Withdrawal by Subject|0|||
147004983|NCT00205777|530180816|FG003|Study Extension II|Withdrawal by Subject|35|||
147004984|NCT00205777|530180817|FG004|Study Extension II|Withdrawal by Subject|0|||
147004985|NCT00205777|530180818|FG005|Study Extension II|Withdrawal by Subject|59|||
147004986|NCT00205777|530180813|FG000|Study Extension II|Protocol Violation|0|||
147004987|NCT00205777|530180814|FG001|Study Extension II|Protocol Violation|0|||
147004988|NCT00205777|530180815|FG002|Study Extension II|Protocol Violation|0|||
147004989|NCT00205777|530180816|FG003|Study Extension II|Protocol Violation|1|||
147004990|NCT00205777|530180817|FG004|Study Extension II|Protocol Violation|0|||
147004991|NCT00205777|530180818|FG005|Study Extension II|Protocol Violation|10|||
147004992|NCT00205777|530180813|FG000|Study Extension II|Lack of Efficacy|0|||
147004993|NCT00205777|530180814|FG001|Study Extension II|Lack of Efficacy|0|||
147004994|NCT00205777|530180815|FG002|Study Extension II|Lack of Efficacy|0|||
147004995|NCT00205777|530180816|FG003|Study Extension II|Lack of Efficacy|0|||
147004996|NCT00205777|530180817|FG004|Study Extension II|Lack of Efficacy|0|||
147004997|NCT00205777|530180818|FG005|Study Extension II|Lack of Efficacy|1|||
147004998|NCT00205777|530180813|FG000|Study Extension II|Failed to return|0|||
147004999|NCT00205777|530180814|FG001|Study Extension II|Failed to return|0|||
147005000|NCT00205777|530180815|FG002|Study Extension II|Failed to return|0|||
147005001|NCT00205777|530180816|FG003|Study Extension II|Failed to return|14|||
147005002|NCT00205777|530180817|FG004|Study Extension II|Failed to return|0|||
147005003|NCT00205777|530180818|FG005|Study Extension II|Failed to return|26|||
147005004|NCT00205777|530180813|FG000|Study Extension II|Other Event|0|||
147005005|NCT00205777|530180814|FG001|Study Extension II|Other Event|0|||
147005006|NCT00205777|530180815|FG002|Study Extension II|Other Event|0|||
147005007|NCT00205777|530180816|FG003|Study Extension II|Other Event|12|||
147005008|NCT00205777|530180817|FG004|Study Extension II|Other Event|0|||
147005009|NCT00205777|530180818|FG005|Study Extension II|Other Event|20|||
147005010|NCT00205777|530180813|FG000|Study Extension II|Enrolled but not treated|0|||
147005011|NCT00205777|530180814|FG001|Study Extension II|Enrolled but not treated|0|||
147005012|NCT00205777|530180815|FG002|Study Extension II|Enrolled but not treated|0|||
147005013|NCT00205777|530180816|FG003|Study Extension II|Enrolled but not treated|71|||
147005014|NCT00205777|530180817|FG004|Study Extension II|Enrolled but not treated|0|||
147005015|NCT00205777|530180818|FG005|Study Extension II|Enrolled but not treated|131|||
147005016|NCT01794845|530180821|FG000|Overall Study|Withdrawal by Subject|1|||
147005017|NCT02139826|530180822|FG000|Overall Study|Adverse Event|1|||
147005018|NCT00436163|530180825|FG000|Overall Study|Lost to Follow-up|2|||
147005019|NCT00436163|530180825|FG000|Overall Study|Adverse Event|1|||
147005020|NCT03719040|530180826|FG000|Overall Study|Withdrawal by Subject|177|||
147005021|NCT03719040|530180826|FG000|Overall Study|Lost to Follow-up|26|||
147005022|NCT06647173|530180827|FG000|Overall Study|Lost to Follow-up|24|||
147005023|NCT01841554|530180828|FG000|Overall Study|Death|7|||
147005024|NCT01841554|530180828|FG000|Overall Study|No Implantation|1|||
147005025|NCT01841554|530180828|FG000|Overall Study|Discontinued Follow Up|5|||
147005026|NCT01841554|530180828|FG000|Overall Study|Study exit due to secondary intervention|6|||
147005027|NCT01473953|530180831|FG000|Overall Study|Other|1|||
147005028|NCT01473953|530180832|FG001|Overall Study|Other|0|||
146845311|NCT00132873|529602757|FG000|Overall Study|Lack of Efficacy|1|||
147005029|NCT01473953|530180833|FG002|Overall Study|Other|0|||
147005030|NCT01473953|530180834|FG003|Overall Study|Other|0|||
147005031|NCT01473953|530180835|FG004|Overall Study|Other|0|||
147005032|NCT00312897|530180838|FG000|Overall Study|Adverse Event|1|||
147005033|NCT00312897|530180839|FG001|Overall Study|Adverse Event|0|||
147005034|NCT00312897|530180838|FG000|Overall Study|Lost to Follow-up|2|||
147005035|NCT00312897|530180839|FG001|Overall Study|Lost to Follow-up|0|||
147005036|NCT00312897|530180838|FG000|Overall Study|Physician Decision|1|||
147005037|NCT00312897|530180839|FG001|Overall Study|Physician Decision|0|||
146845312|NCT00132873|529602757|FG000|Overall Study|Withdrawal by Subject|3|||
147005038|NCT00312897|530180838|FG000|Overall Study|Withdrawal by Subject|1|||
147005039|NCT00312897|530180839|FG001|Overall Study|Withdrawal by Subject|3|||
147005040|NCT00312897|530180838|FG000|Overall Study|Pregnancy|1|||
147005041|NCT00312897|530180839|FG001|Overall Study|Pregnancy|0|||
147013227|NCT01708954|530210054|FG000|Step 1|Adverse Event|3|||
147005042|NCT00312897|530180838|FG000|Overall Study|discontinued prior to getting treatment|0|||
147005043|NCT00312897|530180839|FG001|Overall Study|discontinued prior to getting treatment|3|||
147005044|NCT03100344|530180840|FG000|Overall Study|Adverse Event|0|||
147005045|NCT03100344|530180841|FG001|Overall Study|Adverse Event|3|||
147005046|NCT03100344|530180842|FG002|Overall Study|Adverse Event|2|||
147005047|NCT03100344|530180843|FG003|Overall Study|Adverse Event|3|||
147005048|NCT03100344|530180840|FG000|Overall Study|Lack of Efficacy|2|||
147005049|NCT03100344|530180841|FG001|Overall Study|Lack of Efficacy|0|||
147005050|NCT03100344|530180842|FG002|Overall Study|Lack of Efficacy|0|||
147005051|NCT03100344|530180843|FG003|Overall Study|Lack of Efficacy|0|||
147005052|NCT03100344|530180840|FG000|Overall Study|Protocol Violation|1|||
147005053|NCT03100344|530180841|FG001|Overall Study|Protocol Violation|0|||
147005054|NCT03100344|530180842|FG002|Overall Study|Protocol Violation|0|||
147005055|NCT03100344|530180843|FG003|Overall Study|Protocol Violation|0|||
147005056|NCT03100344|530180840|FG000|Overall Study|Withdrawal by Subject|10|||
147005057|NCT03100344|530180841|FG001|Overall Study|Withdrawal by Subject|7|||
147005058|NCT03100344|530180842|FG002|Overall Study|Withdrawal by Subject|4|||
147005059|NCT03100344|530180843|FG003|Overall Study|Withdrawal by Subject|8|||
147005060|NCT03100344|530180840|FG000|Overall Study|Lost to Follow-up|1|||
147005061|NCT03100344|530180841|FG001|Overall Study|Lost to Follow-up|1|||
147005062|NCT03100344|530180842|FG002|Overall Study|Lost to Follow-up|1|||
147005063|NCT03100344|530180843|FG003|Overall Study|Lost to Follow-up|1|||
147005064|NCT04633564|530180844|FG000|Period 1|Adverse Event|28|||
147005065|NCT04633564|530180845|FG001|Period 1|Adverse Event|19|||
147005066|NCT04633564|530180844|FG000|Period 1|Death|8|||
147005067|NCT04633564|530180845|FG001|Period 1|Death|7|||
147005068|NCT04633564|530180844|FG000|Period 1|Lost to Follow-up|3|||
147005069|NCT04633564|530180845|FG001|Period 1|Lost to Follow-up|5|||
147005070|NCT04633564|530180844|FG000|Period 1|Physician Decision|4|||
147005071|NCT04633564|530180845|FG001|Period 1|Physician Decision|12|||
147005072|NCT04633564|530180844|FG000|Period 1|Protocol Violation|0|||
147005073|NCT04633564|530180845|FG001|Period 1|Protocol Violation|1|||
147005074|NCT04633564|530180844|FG000|Period 1|Withdrawal by Subject|10|||
147005075|NCT04633564|530180845|FG001|Period 1|Withdrawal by Subject|8|||
147005076|NCT04633564|530180844|FG000|Period 1|Progressive disease|47|||
147005077|NCT04633564|530180845|FG001|Period 1|Progressive disease|51|||
147005078|NCT04633564|530180844|FG000|Period 1|Terminated by Sponsor|8|||
147005079|NCT04633564|530180845|FG001|Period 1|Terminated by Sponsor|6|||
147005080|NCT04633564|530180844|FG000|Period 2|Adverse Event|3|||
147005081|NCT04633564|530180845|FG001|Period 2|Adverse Event|4|||
147005082|NCT04633564|530180844|FG000|Period 2|Death|0|||
147005083|NCT04633564|530180845|FG001|Period 2|Death|2|||
147005084|NCT04633564|530180844|FG000|Period 2|Lost to Follow-up|0|||
147005085|NCT04633564|530180845|FG001|Period 2|Lost to Follow-up|1|||
147005086|NCT04633564|530180844|FG000|Period 2|Physician Decision|2|||
147005087|NCT04633564|530180845|FG001|Period 2|Physician Decision|4|||
147005088|NCT04633564|530180844|FG000|Period 2|Withdrawal by Subject|5|||
147005089|NCT04633564|530180845|FG001|Period 2|Withdrawal by Subject|1|||
147005090|NCT04633564|530180844|FG000|Period 2|Progressive Disease|74|||
147005091|NCT04633564|530180845|FG001|Period 2|Progressive Disease|82|||
147005092|NCT04633564|530180844|FG000|Period 2|Terminated by Sponsor|9|||
147005093|NCT04633564|530180845|FG001|Period 2|Terminated by Sponsor|3|||
147005094|NCT02011945|530180846|FG000|Overall Study|Participant requested to Discontinue|0|||
147005095|NCT02011945|530180847|FG001|Overall Study|Participant requested to Discontinue|1|||
147005096|NCT02011945|530180848|FG002|Overall Study|Participant requested to Discontinue|1|||
147005097|NCT02011945|530180846|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
147005098|NCT02011945|530180847|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
147005099|NCT02011945|530180848|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
147005100|NCT02011945|530180846|FG000|Overall Study|Study Drug Toxicity|0|||
147005101|NCT02011945|530180847|FG001|Overall Study|Study Drug Toxicity|0|||
147005102|NCT02011945|530180848|FG002|Overall Study|Study Drug Toxicity|1|||
147005103|NCT02011945|530180846|FG000|Overall Study|Treatment Failure|0|||
147005104|NCT02011945|530180847|FG001|Overall Study|Treatment Failure|7|||
147005105|NCT02011945|530180848|FG002|Overall Study|Treatment Failure|6|||
147005106|NCT02011945|530180846|FG000|Overall Study|No Longer Meets Study Criteria|1|||
147005107|NCT02011945|530180847|FG001|Overall Study|No Longer Meets Study Criteria|0|||
147005108|NCT02011945|530180848|FG002|Overall Study|No Longer Meets Study Criteria|0|||
147005109|NCT02011945|530180846|FG000|Overall Study|Proceeded to stem cell transplant|0|||
147005110|NCT02011945|530180847|FG001|Overall Study|Proceeded to stem cell transplant|0|||
147005111|NCT02011945|530180848|FG002|Overall Study|Proceeded to stem cell transplant|1|||
147005112|NCT02011945|530180846|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
147005113|NCT02011945|530180847|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
147005114|NCT02011945|530180848|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
147005115|NCT00902538|530180849|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
147005116|NCT00902538|530180850|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
147005117|NCT00902538|530180851|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
147005118|NCT00902538|530180852|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
147005119|NCT00902538|530180853|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
147005120|NCT00902538|530180854|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
147005121|NCT00902538|530180849|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
147005122|NCT00902538|530180850|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
147005123|NCT00902538|530180851|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
147005124|NCT00902538|530180852|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
147005125|NCT00902538|530180853|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
147005126|NCT00902538|530180854|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
147005127|NCT00902538|530180849|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
146845313|NCT00132873|529602757|FG000|Overall Study|Planned Pregnancy|1|||
146845314|NCT01896726|529602761|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
146845315|NCT01896726|529602761|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
146845316|NCT02406677|529602762|FG000|Overall Study|Death|16|||
146845317|NCT02406677|529602763|FG001|Overall Study|Death|8|||
146845318|NCT02406677|529602762|FG000|Overall Study|Discharged without P2Y12|1|||
147005128|NCT00902538|530180850|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
147005129|NCT00902538|530180851|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
147005130|NCT00902538|530180852|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
147005131|NCT00902538|530180853|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
147005132|NCT00902538|530180854|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
147005133|NCT00902538|530180849|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
147005134|NCT00902538|530180850|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
147005135|NCT00902538|530180851|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
147005136|NCT00902538|530180852|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
147005137|NCT00902538|530180853|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
147005138|NCT00902538|530180854|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
147005139|NCT00902538|530180849|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
147005140|NCT00902538|530180850|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
147005141|NCT00902538|530180851|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
147005142|NCT00902538|530180852|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
147005143|NCT00902538|530180853|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
147005144|NCT00902538|530180854|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
147005145|NCT00902538|530180849|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
147005146|NCT00902538|530180850|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
147005147|NCT00902538|530180851|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
147005148|NCT00902538|530180852|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
147005149|NCT00902538|530180853|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
147005150|NCT00902538|530180854|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
147005151|NCT00902538|530180849|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
146845319|NCT02406677|529602763|FG001|Overall Study|Discharged without P2Y12|3|||
146845320|NCT02406677|529602762|FG000|Overall Study|Discharged on prasugrel|283|||
146845321|NCT02406677|529602763|FG001|Overall Study|Discharged on prasugrel|587|||
146845322|NCT02406677|529602762|FG000|Overall Study|Withdrawal by Subject|1|||
146845323|NCT02406677|529602763|FG001|Overall Study|Withdrawal by Subject|0|||
146845324|NCT01114880|529602764|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
146845325|NCT01114880|529602765|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
146845326|NCT01114880|529602764|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
146845327|NCT01114880|529602765|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
146845328|NCT01114880|529602764|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
146845329|NCT01114880|529602765|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
146845330|NCT01114880|529602764|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
146845331|NCT01114880|529602765|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
147005152|NCT00902538|530180850|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
147005153|NCT00902538|530180851|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
147005154|NCT00902538|530180852|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
147005155|NCT00902538|530180853|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
147005156|NCT00902538|530180854|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
147005157|NCT00902538|530180849|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
147005158|NCT00902538|530180850|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
147005159|NCT00902538|530180851|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
147005160|NCT00902538|530180852|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
147005161|NCT00902538|530180853|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
147005162|NCT00902538|530180854|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
147005163|NCT00902538|530180849|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
147005164|NCT00902538|530180850|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
146845332|NCT01114880|529602764|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
146845333|NCT01114880|529602765|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
147005165|NCT00902538|530180851|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
147005166|NCT00902538|530180852|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
147005167|NCT00902538|530180853|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
147005168|NCT00902538|530180854|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
147005169|NCT00902538|530180849|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
147005170|NCT00902538|530180850|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
147005171|NCT00902538|530180851|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
147005172|NCT00902538|530180852|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
147005173|NCT00902538|530180853|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
147005174|NCT00902538|530180854|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
147005175|NCT00902538|530180849|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
147005176|NCT00902538|530180850|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
147005177|NCT00902538|530180851|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
147005178|NCT00902538|530180852|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
147005179|NCT00902538|530180853|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
147005180|NCT00902538|530180854|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
147005181|NCT00902538|530180849|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
147005182|NCT00902538|530180850|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
147005183|NCT00902538|530180851|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
147005184|NCT00902538|530180852|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
147005185|NCT00902538|530180853|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
147005186|NCT00902538|530180854|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
147005187|NCT00902538|530180849|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
147005188|NCT00902538|530180850|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
147005189|NCT00902538|530180851|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
147005190|NCT00902538|530180852|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
147005191|NCT00902538|530180853|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
147005192|NCT00902538|530180854|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
147005193|NCT00902538|530180849|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
147005194|NCT00902538|530180850|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
147005195|NCT00902538|530180851|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
147005196|NCT00902538|530180852|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
147005197|NCT00902538|530180853|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
147005198|NCT00902538|530180854|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
147005199|NCT00902538|530180849|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
147005200|NCT00902538|530180850|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
147005201|NCT00902538|530180851|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
147005202|NCT00902538|530180852|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
147005203|NCT00902538|530180853|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
147005204|NCT00902538|530180854|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
147005205|NCT00902538|530180849|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
147005206|NCT00902538|530180850|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
147005207|NCT00902538|530180851|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
147005208|NCT00902538|530180852|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
147005209|NCT00902538|530180853|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
147005210|NCT00902538|530180854|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
147005211|NCT00902538|530180849|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
147005212|NCT00902538|530180850|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
147005213|NCT00902538|530180851|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
147005214|NCT00902538|530180852|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
147005215|NCT00902538|530180853|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
147005216|NCT00902538|530180854|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
147005217|NCT00830258|530182315|FG000|First Intervention|Adverse Event|1|||
147005218|NCT00830258|530182316|FG001|First Intervention|Adverse Event|0|||
147005219|NCT00830258|530182315|FG000|Washout: 7 Days|Protocol Violation|1|||
147005220|NCT00830258|530182316|FG001|Washout: 7 Days|Protocol Violation|0|||
147005221|NCT00798603|530182317|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
147005222|NCT00798603|530182317|FG000|Overall Study|Withdrawal by Subject|10|||
147005223|NCT00798603|530182317|FG000|Overall Study|Adverse Event|22|||
147005224|NCT00798603|530182317|FG000|Overall Study|Physician Decision|1|||
147005225|NCT00798603|530182317|FG000|Overall Study|Lack of insurance coverage|1|||
147005226|NCT03206749|530182320|FG000|Overall Study|Withdrawal of consent|5|||
146736071|NCT02332590|529205299|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
146736072|NCT02332590|529205300|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
146736073|NCT02332590|529205299|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
146736074|NCT02332590|529205300|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
146736075|NCT02332590|529205299|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
147005227|NCT03206749|530182321|FG001|Overall Study|Withdrawal of consent|3|||
147005228|NCT03206749|530182322|FG002|Overall Study|Withdrawal of consent|6|||
147005229|NCT03206749|530182320|FG000|Overall Study|Lost to Follow-up|0|||
147005230|NCT03206749|530182321|FG001|Overall Study|Lost to Follow-up|0|||
147005231|NCT03206749|530182322|FG002|Overall Study|Lost to Follow-up|1|||
147005232|NCT02752074|530182323|FG000|Overall Study|Lost to Follow-up|1|||
147005233|NCT02752074|530182324|FG001|Overall Study|Lost to Follow-up|4|||
147005234|NCT02752074|530182323|FG000|Overall Study|Death|146|||
147005235|NCT02752074|530182324|FG001|Overall Study|Death|129|||
147005236|NCT02752074|530182323|FG000|Overall Study|Withdrawal by Subject|9|||
147005237|NCT02752074|530182324|FG001|Overall Study|Withdrawal by Subject|10|||
147005238|NCT00488774|530182325|FG000|Overall Study|Withdrawal of consent|2|||
147005239|NCT00488774|530182326|FG001|Overall Study|Withdrawal of consent|2|||
147005240|NCT00488774|530182327|FG002|Overall Study|Withdrawal of consent|2|||
147005241|NCT00488774|530182328|FG003|Overall Study|Withdrawal of consent|0|||
147005242|NCT00488774|530182325|FG000|Overall Study|Other|6|||
147005243|NCT00488774|530182326|FG001|Overall Study|Other|3|||
147005244|NCT00488774|530182327|FG002|Overall Study|Other|2|||
147005245|NCT00488774|530182328|FG003|Overall Study|Other|2|||
147005246|NCT00488774|530182325|FG000|Overall Study|Lost to Follow-up|0|||
147005247|NCT00488774|530182326|FG001|Overall Study|Lost to Follow-up|0|||
147005248|NCT00488774|530182327|FG002|Overall Study|Lost to Follow-up|1|||
147005249|NCT00488774|530182328|FG003|Overall Study|Lost to Follow-up|1|||
147005250|NCT05523895|530182329|FG000|Overall Study|Adverse Event|2|||
147005251|NCT05523895|530182330|FG001|Overall Study|Adverse Event|1|||
147005252|NCT05523895|530182331|FG002|Overall Study|Adverse Event|1|||
147005253|NCT05523895|530182329|FG000|Overall Study|Lost to Follow-up|0|||
147005254|NCT05523895|530182330|FG001|Overall Study|Lost to Follow-up|1|||
147005255|NCT05523895|530182331|FG002|Overall Study|Lost to Follow-up|2|||
147005256|NCT05523895|530182329|FG000|Overall Study|Noncompliance with study drug|1|||
147005257|NCT05523895|530182330|FG001|Overall Study|Noncompliance with study drug|1|||
147005258|NCT05523895|530182331|FG002|Overall Study|Noncompliance with study drug|1|||
147005259|NCT05523895|530182329|FG000|Overall Study|Protocol Violation|0|||
147005260|NCT05523895|530182330|FG001|Overall Study|Protocol Violation|2|||
147005261|NCT05523895|530182331|FG002|Overall Study|Protocol Violation|0|||
147005262|NCT05523895|530182329|FG000|Overall Study|Withdrawal by Subject|1|||
147005263|NCT05523895|530182330|FG001|Overall Study|Withdrawal by Subject|3|||
147005264|NCT05523895|530182331|FG002|Overall Study|Withdrawal by Subject|1|||
147005265|NCT05523895|530182329|FG000|Overall Study|Not further specified|0|||
147005266|NCT05523895|530182330|FG001|Overall Study|Not further specified|3|||
147005267|NCT05523895|530182331|FG002|Overall Study|Not further specified|1|||
147005268|NCT01959672|530182334|FG000|Overall Study|Death|1|||
147005269|NCT05041361|530182335|FG000|Overall Study|Lost to Follow-up|1|||
147005270|NCT05041361|530182336|FG001|Overall Study|Lost to Follow-up|3|||
147005271|NCT01919112|530182337|FG000|Secondary Analysis-day 30|Death|1|||
147005272|NCT01919112|530182338|FG001|Secondary Analysis-day 30|Death|1|||
147005273|NCT01919112|530182339|FG002|Secondary Analysis-day 30|Death|1|||
147005274|NCT01919112|530182337|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
147005275|NCT01919112|530182338|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
147005276|NCT01919112|530182339|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
147005277|NCT04692155|530182342|FG000|Overall Study|Death|1|||
147005278|NCT02554877|530182343|FG000|Overall Study|Adverse Event|2|||
147005279|NCT02554877|530182344|FG001|Overall Study|Adverse Event|0|||
147005280|NCT02554877|530182345|FG002|Overall Study|Adverse Event|0|||
147005281|NCT02554877|530182346|FG003|Overall Study|Adverse Event|1|||
147005282|NCT02554877|530182343|FG000|Overall Study|Lost to Follow-up|1|||
147005283|NCT02554877|530182344|FG001|Overall Study|Lost to Follow-up|1|||
147005284|NCT02554877|530182345|FG002|Overall Study|Lost to Follow-up|1|||
147005285|NCT02554877|530182346|FG003|Overall Study|Lost to Follow-up|2|||
146845334|NCT01114880|529602764|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
147005286|NCT02554877|530182343|FG000|Overall Study|Did not meet entrance criteria|0|||
147005287|NCT02554877|530182344|FG001|Overall Study|Did not meet entrance criteria|0|||
146845335|NCT01114880|529602765|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
147005288|NCT02554877|530182345|FG002|Overall Study|Did not meet entrance criteria|1|||
147005289|NCT02554877|530182346|FG003|Overall Study|Did not meet entrance criteria|0|||
147005290|NCT02554877|530182343|FG000|Overall Study|No longer met eligibility criteria|1|||
147005291|NCT02554877|530182344|FG001|Overall Study|No longer met eligibility criteria|0|||
146845336|NCT04531098|529602769|FG000|Stage I|Adverse Event|0|||
146845337|NCT04531098|529602770|FG001|Stage I|Adverse Event|0|||
146845338|NCT04531098|529602771|FG002|Stage I|Adverse Event|3|||
146845339|NCT04531098|529602769|FG000|Stage I|Protocol Violation|0|||
147005292|NCT02554877|530182345|FG002|Overall Study|No longer met eligibility criteria|1|||
147005293|NCT02554877|530182346|FG003|Overall Study|No longer met eligibility criteria|1|||
147005294|NCT02554877|530182343|FG000|Overall Study|Protocol Violation|3|||
147005295|NCT02554877|530182344|FG001|Overall Study|Protocol Violation|1|||
147005296|NCT02554877|530182345|FG002|Overall Study|Protocol Violation|1|||
147005297|NCT02554877|530182346|FG003|Overall Study|Protocol Violation|0|||
147005298|NCT02554877|530182343|FG000|Overall Study|Other|1|||
147005299|NCT02554877|530182344|FG001|Overall Study|Other|3|||
147005300|NCT02554877|530182345|FG002|Overall Study|Other|0|||
147005301|NCT02554877|530182346|FG003|Overall Study|Other|3|||
147005302|NCT02554877|530182343|FG000|Overall Study|Insufficient clinical response|4|||
147005303|NCT02554877|530182344|FG001|Overall Study|Insufficient clinical response|0|||
147005304|NCT02554877|530182345|FG002|Overall Study|Insufficient clinical response|0|||
147005305|NCT02554877|530182346|FG003|Overall Study|Insufficient clinical response|0|||
147005306|NCT02554877|530182343|FG000|Overall Study|No longer willing to participate|0|||
147005307|NCT02554877|530182344|FG001|Overall Study|No longer willing to participate|2|||
147005308|NCT02554877|530182345|FG002|Overall Study|No longer willing to participate|2|||
147005309|NCT02554877|530182346|FG003|Overall Study|No longer willing to participate|0|||
147005310|NCT00274651|530182347|FG000|Overall Study|Adverse Event|6|||
147005311|NCT00274651|530182348|FG001|Overall Study|Adverse Event|3|||
147005312|NCT00274651|530182347|FG000|Overall Study|Lack of Efficacy|13|||
147005313|NCT00274651|530182348|FG001|Overall Study|Lack of Efficacy|6|||
147005314|NCT00274651|530182347|FG000|Overall Study|Death|1|||
147005315|NCT00274651|530182348|FG001|Overall Study|Death|3|||
147005316|NCT00274651|530182347|FG000|Overall Study|Withdrawal by Subject|0|||
147005317|NCT00274651|530182348|FG001|Overall Study|Withdrawal by Subject|1|||
147005318|NCT00274651|530182347|FG000|Overall Study|Physician Decision|8|||
147005319|NCT00274651|530182348|FG001|Overall Study|Physician Decision|7|||
147005320|NCT03446768|530182349|FG000|Overall Study|Withdrawal by Subject|0|||
147005321|NCT03446768|530182350|FG001|Overall Study|Withdrawal by Subject|1|||
147005322|NCT02488239|530182353|FG000|Overall Study|Death|3|||
147005323|NCT02488239|530182353|FG000|Overall Study|Withdrawal by Subject|3|||
147005324|NCT02488239|530182353|FG000|Overall Study|Physician Decision|2|||
147005325|NCT02488239|530182353|FG000|Overall Study|Consent ineligible|1|||
147005326|NCT02488239|530182353|FG000|Overall Study|Did not undergo implant procedure|1|||
147005327|NCT04345653|530182357|FG000|Overall Study|Withdrawal by Subject|2|||
147005328|NCT03480763|530182362|FG000|Overall Study|Withdrawal by Subject|18|||
147005329|NCT03480763|530182363|FG001|Overall Study|Withdrawal by Subject|10|||
147005330|NCT03480763|530182362|FG000|Overall Study|Lost to Follow-up|4|||
147005331|NCT03480763|530182363|FG001|Overall Study|Lost to Follow-up|7|||
147005332|NCT03480763|530182362|FG000|Overall Study|non-study pneumococcal vaccine|1|||
147005333|NCT03480763|530182363|FG001|Overall Study|non-study pneumococcal vaccine|0|||
147005334|NCT03480763|530182362|FG000|Overall Study|oncological treatment|0|||
147005335|NCT03480763|530182363|FG001|Overall Study|oncological treatment|2|||
147005336|NCT03480763|530182362|FG000|Overall Study|pain with vaccination|1|||
147005337|NCT03480763|530182363|FG001|Overall Study|pain with vaccination|0|||
147005338|NCT00418938|530182364|FG000|Overall Study|Reimbursement|1|||
147005339|NCT00418938|530182365|FG001|Overall Study|Reimbursement|0|||
147005340|NCT00418938|530182364|FG000|Overall Study|Administrative decision|3|||
147005341|NCT00418938|530182365|FG001|Overall Study|Administrative decision|3|||
147005342|NCT00418938|530182364|FG000|Overall Study|Withdrawal by Subject|16|||
147005343|NCT00418938|530182365|FG001|Overall Study|Withdrawal by Subject|15|||
147005344|NCT00418938|530182364|FG000|Overall Study|Lost to Follow-up|1|||
147005345|NCT00418938|530182365|FG001|Overall Study|Lost to Follow-up|3|||
147005346|NCT00418938|530182364|FG000|Overall Study|Adverse Event|1|||
147005347|NCT00418938|530182365|FG001|Overall Study|Adverse Event|1|||
147005348|NCT00418938|530182364|FG000|Overall Study|On-going|1|||
147005349|NCT00418938|530182365|FG001|Overall Study|On-going|1|||
147005350|NCT00418938|530182364|FG000|Overall Study|Ineligibility Determined|1|||
147005351|NCT00418938|530182365|FG001|Overall Study|Ineligibility Determined|0|||
147005352|NCT00115063|530182368|FG000|Overall Study|Lost to Follow-up|98|||
147005353|NCT00115063|530182369|FG001|Overall Study|Lost to Follow-up|104|||
147005354|NCT00115063|530182368|FG000|Overall Study|Death|1|||
147005355|NCT00115063|530182369|FG001|Overall Study|Death|0|||
147005356|NCT01316055|530182370|FG000|Overall Study|Lost to Follow-up|1|||
147005357|NCT01316055|530182371|FG001|Overall Study|Lost to Follow-up|0|||
147005358|NCT01316055|530182372|FG002|Overall Study|Lost to Follow-up|0|||
147005359|NCT00003470|530182373|FG000|Overall Study|Not evaluable|6|||
147005360|NCT00748566|530182377|FG000|Overall Study|Adverse Event|49|||
147005361|NCT00748566|530182377|FG000|Overall Study|Death|1|||
147005362|NCT00748566|530182377|FG000|Overall Study|Lack of Efficacy|12|||
147005363|NCT00748566|530182377|FG000|Overall Study|Lost to Follow-up|1|||
147005364|NCT00748566|530182377|FG000|Overall Study|Protocol Violation|13|||
147005365|NCT00748566|530182377|FG000|Overall Study|Withdrawal by Subject|22|||
147005366|NCT00748566|530182377|FG000|Overall Study|Study terminated by sponsor|5|||
147005367|NCT00748566|530182377|FG000|Overall Study|Other|9|||
147005368|NCT01442376|530182380|FG000|Overall Study|Adverse Event|0|||
147005369|NCT01442376|530182381|FG001|Overall Study|Adverse Event|3|||
147005370|NCT01442376|530182382|FG002|Overall Study|Adverse Event|2|||
147005371|NCT01442376|530182380|FG000|Overall Study|Death|0|||
147005372|NCT01442376|530182381|FG001|Overall Study|Death|1|||
147005373|NCT01442376|530182382|FG002|Overall Study|Death|1|||
147005374|NCT01442376|530182380|FG000|Overall Study|Withdrawal of consent|0|||
147005375|NCT01442376|530182381|FG001|Overall Study|Withdrawal of consent|0|||
147005376|NCT01442376|530182382|FG002|Overall Study|Withdrawal of consent|1|||
146845340|NCT04531098|529602770|FG001|Stage I|Protocol Violation|0|||
147005377|NCT01442376|530182380|FG000|Overall Study|Patients not treated|2|||
146845341|NCT04531098|529602771|FG002|Stage I|Protocol Violation|5|||
146845342|NCT04531098|529602769|FG000|Stage I|Withdrawal by Subject|0|||
146845343|NCT04531098|529602770|FG001|Stage I|Withdrawal by Subject|5|||
146845344|NCT04531098|529602771|FG002|Stage I|Withdrawal by Subject|10|||
146845345|NCT04531098|529602769|FG000|Stage II|Adverse Event|1|||
146845346|NCT04531098|529602770|FG001|Stage II|Adverse Event|2|||
147005378|NCT01442376|530182381|FG001|Overall Study|Patients not treated|3|||
147005379|NCT01442376|530182382|FG002|Overall Study|Patients not treated|1|||
147005380|NCT01442376|530182380|FG000|Overall Study|Not eligible for subsequent cycles|1|||
147005381|NCT01442376|530182381|FG001|Overall Study|Not eligible for subsequent cycles|2|||
147005382|NCT01442376|530182382|FG002|Overall Study|Not eligible for subsequent cycles|0|||
147005383|NCT00863330|530182383|FG000|Overall Study|study terminated early due to administra|6|||
147005384|NCT04404725|530182384|FG000|First Intervention|Withdrawal by Subject|0|||
147005385|NCT04404725|530182385|FG001|First Intervention|Withdrawal by Subject|2|||
147005386|NCT04404725|530182384|FG000|Second Intervention|Adverse Event|1|||
147005387|NCT04404725|530182385|FG001|Second Intervention|Adverse Event|1|||
147005388|NCT04404725|530182384|FG000|Second Intervention|Withdrawal by Subject|0|||
147005389|NCT04404725|530182385|FG001|Second Intervention|Withdrawal by Subject|1|||
147005390|NCT01075516|530182386|FG000|Overall Study|Death|5|||
147005391|NCT01075516|530182387|FG001|Overall Study|Death|9|||
147005392|NCT01075516|530182386|FG000|Overall Study|Lost to Follow-up|10|||
147005393|NCT01075516|530182387|FG001|Overall Study|Lost to Follow-up|2|||
147005394|NCT01075516|530182386|FG000|Overall Study|Withdrawal by Subject|3|||
147005395|NCT01075516|530182387|FG001|Overall Study|Withdrawal by Subject|5|||
147005396|NCT02252016|530182388|FG000|Overall Study|Lost to Follow-up|2|||
147005397|NCT02252016|530182389|FG001|Overall Study|Lost to Follow-up|1|||
147005398|NCT02252016|530182388|FG000|Overall Study|Physician Decision|1|||
147005399|NCT02252016|530182389|FG001|Overall Study|Physician Decision|0|||
147005400|NCT02252016|530182388|FG000|Overall Study|Withdrawal by Subject|0|||
147005401|NCT02252016|530182389|FG001|Overall Study|Withdrawal by Subject|2|||
147005402|NCT01825798|530182391|FG000|Overall Study|Adverse Event|1|||
147005403|NCT01825798|530182392|FG001|Overall Study|Adverse Event|5|||
147005404|NCT01825798|530182391|FG000|Overall Study|Lost to Follow-up|1|||
147005405|NCT01825798|530182392|FG001|Overall Study|Lost to Follow-up|0|||
147005406|NCT00834873|530182399|FG000|First Intervention|Adverse Event|0|||
147005407|NCT00834873|530182400|FG001|First Intervention|Adverse Event|1|||
147005408|NCT02055547|530182401|FG000|Overall Study|Protocol Violation|0|||
147005409|NCT02055547|530182402|FG001|Overall Study|Protocol Violation|0|||
147005410|NCT02055547|530182403|FG002|Overall Study|Protocol Violation|1|||
147005411|NCT02055547|530182404|FG003|Overall Study|Protocol Violation|0|||
147005412|NCT02055547|530182405|FG004|Overall Study|Protocol Violation|0|||
147005413|NCT02055547|530182406|FG005|Overall Study|Protocol Violation|0|||
147005414|NCT02055547|530182407|FG006|Overall Study|Protocol Violation|1|||
147005415|NCT02055547|530182408|FG007|Overall Study|Protocol Violation|0|||
147005416|NCT02055547|530182409|FG008|Overall Study|Protocol Violation|0|||
147005417|NCT02055547|530182410|FG009|Overall Study|Protocol Violation|0|||
147005418|NCT02055547|530182411|FG010|Overall Study|Protocol Violation|0|||
147005419|NCT02055547|530182412|FG011|Overall Study|Protocol Violation|0|||
147005420|NCT02055547|530182413|FG012|Overall Study|Protocol Violation|0|||
147005421|NCT02055547|530182414|FG013|Overall Study|Protocol Violation|0|||
147005422|NCT02055547|530182415|FG014|Overall Study|Protocol Violation|0|||
147005423|NCT02055547|530182416|FG015|Overall Study|Protocol Violation|0|||
147005424|NCT02055547|530182417|FG016|Overall Study|Protocol Violation|0|||
147005425|NCT02055547|530182418|FG017|Overall Study|Protocol Violation|0|||
147005426|NCT02055547|530182419|FG018|Overall Study|Protocol Violation|0|||
147005427|NCT02055547|530182401|FG000|Overall Study|Physician Decision|0|||
147005428|NCT02055547|530182402|FG001|Overall Study|Physician Decision|1|||
147005429|NCT02055547|530182403|FG002|Overall Study|Physician Decision|1|||
147005430|NCT02055547|530182404|FG003|Overall Study|Physician Decision|0|||
147005431|NCT02055547|530182405|FG004|Overall Study|Physician Decision|1|||
147005432|NCT02055547|530182406|FG005|Overall Study|Physician Decision|0|||
147005433|NCT02055547|530182407|FG006|Overall Study|Physician Decision|0|||
147005434|NCT02055547|530182408|FG007|Overall Study|Physician Decision|0|||
147005435|NCT02055547|530182409|FG008|Overall Study|Physician Decision|0|||
147005436|NCT02055547|530182410|FG009|Overall Study|Physician Decision|1|||
147005437|NCT02055547|530182411|FG010|Overall Study|Physician Decision|1|||
147005438|NCT02055547|530182412|FG011|Overall Study|Physician Decision|0|||
146845347|NCT04531098|529602771|FG002|Stage II|Adverse Event|0|||
146845348|NCT04531098|529602769|FG000|Stage II|Protocol Violation|1|||
146845349|NCT04531098|529602770|FG001|Stage II|Protocol Violation|2|||
146845350|NCT04531098|529602771|FG002|Stage II|Protocol Violation|0|||
147005439|NCT02055547|530182413|FG012|Overall Study|Physician Decision|0|||
147005440|NCT02055547|530182414|FG013|Overall Study|Physician Decision|0|||
147005441|NCT02055547|530182415|FG014|Overall Study|Physician Decision|0|||
147005442|NCT02055547|530182416|FG015|Overall Study|Physician Decision|0|||
147005443|NCT02055547|530182417|FG016|Overall Study|Physician Decision|0|||
147005444|NCT02055547|530182418|FG017|Overall Study|Physician Decision|0|||
147005445|NCT02055547|530182419|FG018|Overall Study|Physician Decision|0|||
147005446|NCT02055547|530182401|FG000|Overall Study|Adverse Event|0|||
147005447|NCT02055547|530182402|FG001|Overall Study|Adverse Event|0|||
147005448|NCT02055547|530182403|FG002|Overall Study|Adverse Event|0|||
147005449|NCT02055547|530182404|FG003|Overall Study|Adverse Event|0|||
147005450|NCT02055547|530182405|FG004|Overall Study|Adverse Event|0|||
147005451|NCT02055547|530182406|FG005|Overall Study|Adverse Event|0|||
147005452|NCT02055547|530182407|FG006|Overall Study|Adverse Event|1|||
147005453|NCT02055547|530182408|FG007|Overall Study|Adverse Event|0|||
147005454|NCT02055547|530182409|FG008|Overall Study|Adverse Event|1|||
147005455|NCT02055547|530182410|FG009|Overall Study|Adverse Event|0|||
147005456|NCT02055547|530182411|FG010|Overall Study|Adverse Event|0|||
147005457|NCT02055547|530182412|FG011|Overall Study|Adverse Event|0|||
147005458|NCT02055547|530182413|FG012|Overall Study|Adverse Event|0|||
147005459|NCT02055547|530182414|FG013|Overall Study|Adverse Event|0|||
147005460|NCT02055547|530182415|FG014|Overall Study|Adverse Event|0|||
146845351|NCT04531098|529602769|FG000|Stage II|Withdrawal by Subject|3|||
146845352|NCT04531098|529602770|FG001|Stage II|Withdrawal by Subject|1|||
146845353|NCT04531098|529602771|FG002|Stage II|Withdrawal by Subject|0|||
146845354|NCT04531098|529602769|FG000|Stage II|Moved from study area|8|||
146845355|NCT04531098|529602770|FG001|Stage II|Moved from study area|5|||
146845356|NCT04531098|529602771|FG002|Stage II|Moved from study area|0|||
147005461|NCT02055547|530182416|FG015|Overall Study|Adverse Event|0|||
147005462|NCT02055547|530182417|FG016|Overall Study|Adverse Event|0|||
147005463|NCT02055547|530182418|FG017|Overall Study|Adverse Event|0|||
147005464|NCT02055547|530182419|FG018|Overall Study|Adverse Event|0|||
147005465|NCT02055547|530182401|FG000|Overall Study|Withdrawal by Subject|0|||
147005466|NCT02055547|530182402|FG001|Overall Study|Withdrawal by Subject|0|||
147005467|NCT02055547|530182403|FG002|Overall Study|Withdrawal by Subject|0|||
147005468|NCT02055547|530182404|FG003|Overall Study|Withdrawal by Subject|0|||
147005469|NCT02055547|530182405|FG004|Overall Study|Withdrawal by Subject|0|||
147005470|NCT02055547|530182406|FG005|Overall Study|Withdrawal by Subject|1|||
147005471|NCT02055547|530182407|FG006|Overall Study|Withdrawal by Subject|0|||
147005472|NCT02055547|530182408|FG007|Overall Study|Withdrawal by Subject|0|||
147005473|NCT02055547|530182409|FG008|Overall Study|Withdrawal by Subject|1|||
147005474|NCT02055547|530182410|FG009|Overall Study|Withdrawal by Subject|0|||
147005475|NCT02055547|530182411|FG010|Overall Study|Withdrawal by Subject|0|||
147005476|NCT02055547|530182412|FG011|Overall Study|Withdrawal by Subject|0|||
147005477|NCT02055547|530182413|FG012|Overall Study|Withdrawal by Subject|0|||
147005478|NCT02055547|530182414|FG013|Overall Study|Withdrawal by Subject|1|||
147005479|NCT02055547|530182415|FG014|Overall Study|Withdrawal by Subject|0|||
147005480|NCT02055547|530182416|FG015|Overall Study|Withdrawal by Subject|1|||
147005481|NCT02055547|530182417|FG016|Overall Study|Withdrawal by Subject|0|||
147005482|NCT02055547|530182418|FG017|Overall Study|Withdrawal by Subject|0|||
147005483|NCT02055547|530182419|FG018|Overall Study|Withdrawal by Subject|0|||
147005484|NCT02055547|530182401|FG000|Overall Study|Lost to Follow-up|0|||
147005485|NCT02055547|530182402|FG001|Overall Study|Lost to Follow-up|0|||
147005486|NCT02055547|530182403|FG002|Overall Study|Lost to Follow-up|1|||
147005487|NCT02055547|530182404|FG003|Overall Study|Lost to Follow-up|0|||
147005488|NCT02055547|530182405|FG004|Overall Study|Lost to Follow-up|0|||
147005489|NCT02055547|530182406|FG005|Overall Study|Lost to Follow-up|0|||
147005490|NCT02055547|530182407|FG006|Overall Study|Lost to Follow-up|0|||
147005491|NCT02055547|530182408|FG007|Overall Study|Lost to Follow-up|0|||
147005492|NCT02055547|530182409|FG008|Overall Study|Lost to Follow-up|0|||
147005493|NCT02055547|530182410|FG009|Overall Study|Lost to Follow-up|0|||
147005494|NCT02055547|530182411|FG010|Overall Study|Lost to Follow-up|0|||
147005495|NCT02055547|530182412|FG011|Overall Study|Lost to Follow-up|0|||
147005496|NCT02055547|530182413|FG012|Overall Study|Lost to Follow-up|0|||
147005497|NCT02055547|530182414|FG013|Overall Study|Lost to Follow-up|0|||
147005498|NCT02055547|530182415|FG014|Overall Study|Lost to Follow-up|0|||
147005499|NCT02055547|530182416|FG015|Overall Study|Lost to Follow-up|0|||
147005500|NCT02055547|530182417|FG016|Overall Study|Lost to Follow-up|0|||
147005501|NCT02055547|530182418|FG017|Overall Study|Lost to Follow-up|0|||
147005502|NCT02055547|530182419|FG018|Overall Study|Lost to Follow-up|0|||
147005503|NCT02911025|530182420|FG000|Overall Study|Lost to Follow-up|3|||
147005504|NCT02923349|530182424|FG000|Overall Study|Other|1|||
147005505|NCT02923349|530182425|FG001|Overall Study|Other|2|||
147005506|NCT02923349|530182426|FG002|Overall Study|Other|4|||
147005507|NCT02923349|530182427|FG003|Overall Study|Other|1|||
147005508|NCT02923349|530182428|FG004|Overall Study|Other|3|||
147005509|NCT02923349|530182429|FG005|Overall Study|Other|0|||
147005510|NCT02923349|530182430|FG006|Overall Study|Other|1|||
147005511|NCT02923349|530182424|FG000|Overall Study|Withdrawal by Subject|2|||
146845357|NCT04531904|529602772|FG000|Overall Study|Lost to Follow-up|1|||
146845358|NCT04531904|529602772|FG000|Overall Study|Death|14|||
146845359|NCT02628028|529602773|FG000|Dosing Period|Withdrawal by Subject|0|||
146845360|NCT02628028|529602774|FG001|Dosing Period|Withdrawal by Subject|0|||
146845361|NCT02628028|529602775|FG002|Dosing Period|Withdrawal by Subject|1|||
147005512|NCT02923349|530182425|FG001|Overall Study|Withdrawal by Subject|2|||
147005513|NCT02923349|530182426|FG002|Overall Study|Withdrawal by Subject|8|||
147005514|NCT02923349|530182427|FG003|Overall Study|Withdrawal by Subject|10|||
147005515|NCT02923349|530182428|FG004|Overall Study|Withdrawal by Subject|12|||
147005516|NCT02923349|530182429|FG005|Overall Study|Withdrawal by Subject|3|||
146845362|NCT02628028|529602776|FG003|Dosing Period|Withdrawal by Subject|0|||
146845363|NCT02628028|529602777|FG004|Dosing Period|Withdrawal by Subject|2|||
146845364|NCT02628028|529602778|FG005|Dosing Period|Withdrawal by Subject|4|||
146845365|NCT02628028|529602779|FG006|Dosing Period|Withdrawal by Subject|1|||
146845366|NCT02628028|529602780|FG007|Dosing Period|Withdrawal by Subject|1|||
146845367|NCT02628028|529602773|FG000|Dosing Period|Adverse Event|0|||
147005517|NCT02923349|530182430|FG006|Overall Study|Withdrawal by Subject|0|||
147005518|NCT02923349|530182424|FG000|Overall Study|Physician Decision|0|||
147005519|NCT02923349|530182425|FG001|Overall Study|Physician Decision|0|||
147005520|NCT02923349|530182426|FG002|Overall Study|Physician Decision|0|||
147005521|NCT02923349|530182427|FG003|Overall Study|Physician Decision|1|||
147005522|NCT02923349|530182428|FG004|Overall Study|Physician Decision|1|||
147005523|NCT02923349|530182429|FG005|Overall Study|Physician Decision|0|||
147005524|NCT02923349|530182430|FG006|Overall Study|Physician Decision|2|||
147005525|NCT02923349|530182424|FG000|Overall Study|Lost to Follow-up|0|||
147005526|NCT02923349|530182425|FG001|Overall Study|Lost to Follow-up|0|||
147005527|NCT02923349|530182426|FG002|Overall Study|Lost to Follow-up|3|||
147005528|NCT02923349|530182427|FG003|Overall Study|Lost to Follow-up|0|||
147005529|NCT02923349|530182428|FG004|Overall Study|Lost to Follow-up|1|||
147005530|NCT02923349|530182429|FG005|Overall Study|Lost to Follow-up|1|||
147005531|NCT02923349|530182430|FG006|Overall Study|Lost to Follow-up|0|||
147005532|NCT02923349|530182424|FG000|Overall Study|Death|1|||
147005533|NCT02923349|530182425|FG001|Overall Study|Death|0|||
147005534|NCT02923349|530182426|FG002|Overall Study|Death|2|||
147005535|NCT02923349|530182427|FG003|Overall Study|Death|4|||
147005536|NCT02923349|530182428|FG004|Overall Study|Death|2|||
147005537|NCT02923349|530182429|FG005|Overall Study|Death|3|||
147005538|NCT02923349|530182430|FG006|Overall Study|Death|0|||
147005539|NCT01120028|530182433|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
147005540|NCT01120028|530182434|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
147005541|NCT01120028|530182435|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
147005542|NCT01120028|530182436|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
147005543|NCT01120028|530182433|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
147005544|NCT01120028|530182434|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
147005545|NCT01120028|530182435|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
147005546|NCT01120028|530182436|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
147005547|NCT03250117|530182437|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
147005548|NCT03250117|530182438|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
147005549|NCT03250117|530182439|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
147005550|NCT03250117|530182440|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
147005551|NCT04063878|530182441|FG000|Overall Study|Withdrawal by Subject|2|||
147005552|NCT04063878|530182441|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
147005553|NCT02751827|530182442|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
147005554|NCT02751827|530182443|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
147005555|NCT02751827|530182444|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
147005556|NCT01248728|530182445|FG000|Overall Study|Adverse Event|1|||
147005557|NCT01248728|530182446|FG001|Overall Study|Adverse Event|1|||
147005558|NCT01248728|530182445|FG000|Overall Study|Withdrawal by Subject|2|||
147005559|NCT01248728|530182446|FG001|Overall Study|Withdrawal by Subject|1|||
147005560|NCT01248728|530182445|FG000|Overall Study|Lack of Efficacy|1|||
147005561|NCT01248728|530182446|FG001|Overall Study|Lack of Efficacy|0|||
147005562|NCT01838681|530182447|FG000|Period A|Adverse Event|39|||
147005563|NCT01838681|530182448|FG001|Period A|Adverse Event|0|||
147005564|NCT01838681|530182449|FG002|Period A|Adverse Event|0|||
147005565|NCT01838681|530182450|FG003|Period A|Adverse Event|0|||
147005566|NCT01838681|530182447|FG000|Period A|Lack of Efficacy|21|||
147005567|NCT01838681|530182448|FG001|Period A|Lack of Efficacy|0|||
147005568|NCT01838681|530182449|FG002|Period A|Lack of Efficacy|0|||
147005569|NCT01838681|530182450|FG003|Period A|Lack of Efficacy|0|||
147005570|NCT01838681|530182447|FG000|Period A|Early response|148|||
147005571|NCT01838681|530182448|FG001|Period A|Early response|0|||
147005572|NCT01838681|530182449|FG002|Period A|Early response|0|||
147005573|NCT01838681|530182450|FG003|Period A|Early response|0|||
147005574|NCT01838681|530182447|FG000|Period A|Withdrawal by Subject|70|||
146845368|NCT02628028|529602774|FG001|Dosing Period|Adverse Event|0|||
146845369|NCT02628028|529602775|FG002|Dosing Period|Adverse Event|0|||
146845370|NCT02628028|529602776|FG003|Dosing Period|Adverse Event|0|||
147005575|NCT01838681|530182448|FG001|Period A|Withdrawal by Subject|0|||
147005576|NCT01838681|530182449|FG002|Period A|Withdrawal by Subject|0|||
147005577|NCT01838681|530182450|FG003|Period A|Withdrawal by Subject|0|||
147005578|NCT01838681|530182447|FG000|Period A|Protocol Violation|16|||
147005579|NCT01838681|530182448|FG001|Period A|Protocol Violation|0|||
147005580|NCT01838681|530182449|FG002|Period A|Protocol Violation|0|||
147005581|NCT01838681|530182450|FG003|Period A|Protocol Violation|0|||
147005582|NCT01838681|530182447|FG000|Period A|Non-compliance with IMP|6|||
147005583|NCT01838681|530182448|FG001|Period A|Non-compliance with IMP|0|||
147005584|NCT01838681|530182449|FG002|Period A|Non-compliance with IMP|0|||
147005585|NCT01838681|530182450|FG003|Period A|Non-compliance with IMP|0|||
147005586|NCT01838681|530182447|FG000|Period A|Lost to Follow-up|4|||
147005587|NCT01838681|530182448|FG001|Period A|Lost to Follow-up|0|||
147005588|NCT01838681|530182449|FG002|Period A|Lost to Follow-up|0|||
147005589|NCT01838681|530182450|FG003|Period A|Lost to Follow-up|0|||
147005590|NCT01838681|530182447|FG000|Period A|Withdrawal before treatment|4|||
147005591|NCT01838681|530182448|FG001|Period A|Withdrawal before treatment|0|||
147005592|NCT01838681|530182449|FG002|Period A|Withdrawal before treatment|0|||
147005593|NCT01838681|530182450|FG003|Period A|Withdrawal before treatment|0|||
147005594|NCT01838681|530182447|FG000|Period A|Administrative or other reasons|17|||
147005595|NCT01838681|530182448|FG001|Period A|Administrative or other reasons|0|||
147005596|NCT01838681|530182449|FG002|Period A|Administrative or other reasons|0|||
147005597|NCT01838681|530182450|FG003|Period A|Administrative or other reasons|0|||
147005598|NCT01838681|530182447|FG000|Period B/A+|Adverse Event|0|||
147005599|NCT01838681|530182448|FG001|Period B/A+|Adverse Event|13|||
147005600|NCT01838681|530182449|FG002|Period B/A+|Adverse Event|27|||
147005601|NCT01838681|530182450|FG003|Period B/A+|Adverse Event|16|||
147005602|NCT01838681|530182447|FG000|Period B/A+|Lack of Efficacy|0|||
147005603|NCT01838681|530182448|FG001|Period B/A+|Lack of Efficacy|9|||
147005604|NCT01838681|530182449|FG002|Period B/A+|Lack of Efficacy|11|||
147005605|NCT01838681|530182450|FG003|Period B/A+|Lack of Efficacy|6|||
147005606|NCT01838681|530182447|FG000|Period B/A+|Withdrawal by Subject|0|||
147005607|NCT01838681|530182448|FG001|Period B/A+|Withdrawal by Subject|28|||
147005608|NCT01838681|530182449|FG002|Period B/A+|Withdrawal by Subject|35|||
147005609|NCT01838681|530182450|FG003|Period B/A+|Withdrawal by Subject|47|||
147005610|NCT01838681|530182447|FG000|Period B/A+|Protocol Violation|0|||
147005611|NCT01838681|530182448|FG001|Period B/A+|Protocol Violation|1|||
147005612|NCT01838681|530182449|FG002|Period B/A+|Protocol Violation|4|||
147005613|NCT01838681|530182450|FG003|Period B/A+|Protocol Violation|6|||
147005614|NCT01838681|530182447|FG000|Period B/A+|Non-compliance with IMP|0|||
147005615|NCT01838681|530182448|FG001|Period B/A+|Non-compliance with IMP|2|||
147005616|NCT01838681|530182449|FG002|Period B/A+|Non-compliance with IMP|3|||
147005617|NCT01838681|530182450|FG003|Period B/A+|Non-compliance with IMP|3|||
147005618|NCT01838681|530182447|FG000|Period B/A+|Lost to Follow-up|0|||
147005619|NCT01838681|530182448|FG001|Period B/A+|Lost to Follow-up|2|||
147005620|NCT01838681|530182449|FG002|Period B/A+|Lost to Follow-up|5|||
147005621|NCT01838681|530182450|FG003|Period B/A+|Lost to Follow-up|11|||
147005622|NCT01838681|530182447|FG000|Period B/A+|Withdrawal before treatment|0|||
147005623|NCT01838681|530182448|FG001|Period B/A+|Withdrawal before treatment|1|||
147005624|NCT01838681|530182449|FG002|Period B/A+|Withdrawal before treatment|0|||
147005625|NCT01838681|530182450|FG003|Period B/A+|Withdrawal before treatment|0|||
147005626|NCT01838681|530182447|FG000|Period B/A+|Administrative or other reasons|0|||
147005627|NCT01838681|530182448|FG001|Period B/A+|Administrative or other reasons|6|||
147005628|NCT01838681|530182449|FG002|Period B/A+|Administrative or other reasons|10|||
147005629|NCT01838681|530182450|FG003|Period B/A+|Administrative or other reasons|28|||
147005630|NCT00796562|530182451|FG000|Overall Study|Death|49|||
147005631|NCT04198363|530182453|FG000|Overall Study|Adverse Event|1|||
147005632|NCT04198363|530182454|FG001|Overall Study|Adverse Event|1|||
147005633|NCT04198363|530182453|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
147005634|NCT04198363|530182454|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
147005635|NCT04198363|530182453|FG000|Overall Study|Reason not Specified|1|||
147005636|NCT04198363|530182454|FG001|Overall Study|Reason not Specified|0|||
147005637|NCT03067987|530182456|FG000|Overall Study|Lost to Follow-up|7|||
147005638|NCT03067987|530182457|FG001|Overall Study|Lost to Follow-up|10|||
147005639|NCT03067987|530182456|FG000|Overall Study|Protocol Violation|1|||
147005640|NCT03067987|530182457|FG001|Overall Study|Protocol Violation|2|||
147005641|NCT03067987|530182456|FG000|Overall Study|Withdrawal by Subject|2|||
147005642|NCT03067987|530182457|FG001|Overall Study|Withdrawal by Subject|1|||
147005643|NCT04827394|530182458|FG000|Overall Study|Physician Decision|0|||
146845371|NCT02628028|529602777|FG004|Dosing Period|Adverse Event|2|||
147005644|NCT04827394|530182459|FG001|Overall Study|Physician Decision|2|||
147005645|NCT01404988|530182460|FG000|Overall Study|Death|2|||
147005646|NCT01404988|530182461|FG001|Overall Study|Death|0|||
147005647|NCT01404988|530182462|FG002|Overall Study|Death|2|||
147005648|NCT01404988|530182460|FG000|Overall Study|Adverse Event|1|||
147005649|NCT01404988|530182461|FG001|Overall Study|Adverse Event|0|||
146845372|NCT02628028|529602778|FG005|Dosing Period|Adverse Event|1|||
147005650|NCT01404988|530182462|FG002|Overall Study|Adverse Event|0|||
146845373|NCT02628028|529602779|FG006|Dosing Period|Adverse Event|3|||
146845374|NCT02628028|529602780|FG007|Dosing Period|Adverse Event|2|||
147005651|NCT01404988|530182460|FG000|Overall Study|Withdrawal by Subject|2|||
147005652|NCT01404988|530182461|FG001|Overall Study|Withdrawal by Subject|2|||
147005653|NCT01404988|530182462|FG002|Overall Study|Withdrawal by Subject|0|||
147005654|NCT01404988|530182460|FG000|Overall Study|Lost to Follow-up|1|||
147005655|NCT01404988|530182461|FG001|Overall Study|Lost to Follow-up|2|||
147005656|NCT01404988|530182462|FG002|Overall Study|Lost to Follow-up|1|||
147005657|NCT00829764|530182463|FG000|First Intervention|Adverse Event|1|||
147005658|NCT00829764|530182464|FG001|First Intervention|Adverse Event|0|||
147005659|NCT00829764|530182463|FG000|First Intervention|Withdrawal by Subject|1|||
147005660|NCT00829764|530182464|FG001|First Intervention|Withdrawal by Subject|1|||
147005661|NCT04594252|530182465|FG000|Overall Study|Adverse Event|0|||
147005662|NCT04594252|530182466|FG001|Overall Study|Adverse Event|2|||
147005663|NCT00477594|530182467|FG000|Year 1 and Year 2|Adverse Event|4|||
147005664|NCT00477594|530182468|FG001|Year 1 and Year 2|Adverse Event|2|||
147005665|NCT00477594|530182467|FG000|Year 1 and Year 2|Physician Decision|2|||
147005666|NCT00477594|530182468|FG001|Year 1 and Year 2|Physician Decision|1|||
147005667|NCT00477594|530182467|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
147005668|NCT00477594|530182468|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
147005669|NCT00477594|530182467|FG000|Year 1 and Year 2|Other|1|||
147005670|NCT00477594|530182468|FG001|Year 1 and Year 2|Other|0|||
147005671|NCT00477594|530182467|FG000|Year 3|Adverse Event|1|||
147005672|NCT00477594|530182468|FG001|Year 3|Adverse Event|0|||
147005673|NCT00477594|530182467|FG000|Year 3|Withdrawal by Subject|1|||
147005674|NCT00477594|530182468|FG001|Year 3|Withdrawal by Subject|0|||
147005675|NCT00477594|530182467|FG000|Follow-up Period|Withdrawal by Subject|2|||
147005676|NCT00477594|530182468|FG001|Follow-up Period|Withdrawal by Subject|1|||
147005677|NCT00477594|530182467|FG000|Follow-up Period|Other|1|||
147005678|NCT00477594|530182468|FG001|Follow-up Period|Other|0|||
147005679|NCT00640341|530184495|FG000|Overall Study|Adverse Event|0|||
147005680|NCT00640341|530184496|FG001|Overall Study|Adverse Event|0|||
147005681|NCT00640341|530184497|FG002|Overall Study|Adverse Event|1|||
147005682|NCT00640341|530184495|FG000|Overall Study|Positive Slit Lamp Findings|0|||
147005683|NCT00640341|530184496|FG001|Overall Study|Positive Slit Lamp Findings|0|||
147005684|NCT00640341|530184497|FG002|Overall Study|Positive Slit Lamp Findings|1|||
147005685|NCT00640341|530184495|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
147005686|NCT00640341|530184496|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
147005687|NCT00640341|530184497|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
147005688|NCT00640341|530184495|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
147005689|NCT00640341|530184496|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
147005690|NCT00640341|530184497|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
147005691|NCT00640341|530184495|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
147005692|NCT00640341|530184496|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
147005693|NCT00640341|530184497|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
147005694|NCT00640341|530184495|FG000|Overall Study|Lost to Follow-up|2|||
147005695|NCT00640341|530184496|FG001|Overall Study|Lost to Follow-up|0|||
147005696|NCT00640341|530184497|FG002|Overall Study|Lost to Follow-up|0|||
147005697|NCT00640341|530184495|FG000|Overall Study|Withdrawal by Subject|4|||
147005698|NCT00640341|530184496|FG001|Overall Study|Withdrawal by Subject|0|||
147005699|NCT00640341|530184497|FG002|Overall Study|Withdrawal by Subject|1|||
147005700|NCT00640341|530184495|FG000|Overall Study|Unacceptable Lens Movement|1|||
147005701|NCT00640341|530184496|FG001|Overall Study|Unacceptable Lens Movement|0|||
147005702|NCT00640341|530184497|FG002|Overall Study|Unacceptable Lens Movement|0|||
147005703|NCT00640341|530184495|FG000|Overall Study|Poor fit/Uncomfortable|4|||
147005704|NCT00640341|530184496|FG001|Overall Study|Poor fit/Uncomfortable|0|||
147005705|NCT00640341|530184497|FG002|Overall Study|Poor fit/Uncomfortable|0|||
147005706|NCT00640341|530184495|FG000|Overall Study|Ineligable at Baseline|5|||
147005707|NCT00640341|530184496|FG001|Overall Study|Ineligable at Baseline|3|||
147005708|NCT00640341|530184497|FG002|Overall Study|Ineligable at Baseline|2|||
147005709|NCT00640341|530184495|FG000|Overall Study|Adverse event and positive slit lamp|1|||
147005710|NCT00640341|530184496|FG001|Overall Study|Adverse event and positive slit lamp|0|||
147005711|NCT00640341|530184497|FG002|Overall Study|Adverse event and positive slit lamp|0|||
147005712|NCT03578809|530184498|FG000|Overall Study|Death|0|||
147005713|NCT03578809|530184499|FG001|Overall Study|Death|2|||
147005714|NCT03578809|530184500|FG002|Overall Study|Death|0|||
147005715|NCT03578809|530184501|FG003|Overall Study|Death|1|||
147005716|NCT03578809|530184498|FG000|Overall Study|Lost to Follow-up|0|||
147005717|NCT03578809|530184499|FG001|Overall Study|Lost to Follow-up|1|||
147005718|NCT03578809|530184500|FG002|Overall Study|Lost to Follow-up|0|||
147005719|NCT03578809|530184501|FG003|Overall Study|Lost to Follow-up|0|||
147005720|NCT03578809|530184498|FG000|Overall Study|Withdrawal by Subject|3|||
147005721|NCT03578809|530184499|FG001|Overall Study|Withdrawal by Subject|5|||
147005722|NCT03578809|530184500|FG002|Overall Study|Withdrawal by Subject|2|||
147005723|NCT03578809|530184501|FG003|Overall Study|Withdrawal by Subject|0|||
147005724|NCT03578809|530184498|FG000|Overall Study|Other|3|||
147005725|NCT03578809|530184499|FG001|Overall Study|Other|6|||
147005726|NCT03578809|530184500|FG002|Overall Study|Other|2|||
147005727|NCT03578809|530184501|FG003|Overall Study|Other|8|||
147005728|NCT02488109|530184502|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
147005729|NCT02488109|530184503|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
147005730|NCT02488109|530184502|FG000|12-month Follow-Up|Lost to Follow-up|4|||
147005731|NCT02488109|530184503|FG001|12-month Follow-Up|Lost to Follow-up|7|||
147005732|NCT02302716|530184504|FG000|Overall Study|Adverse Event|1|||
147005733|NCT02302716|530184505|FG001|Overall Study|Adverse Event|1|||
147005734|NCT02302716|530184504|FG000|Overall Study|Death|0|||
147005735|NCT02302716|530184505|FG001|Overall Study|Death|1|||
147005736|NCT02302716|530184504|FG000|Overall Study|Lack of Efficacy|0|||
147005737|NCT02302716|530184505|FG001|Overall Study|Lack of Efficacy|1|||
147005738|NCT02302716|530184504|FG000|Overall Study|Lost to Follow-up|2|||
147005739|NCT02302716|530184505|FG001|Overall Study|Lost to Follow-up|4|||
147005740|NCT02302716|530184504|FG000|Overall Study|Physician Decision|3|||
147005741|NCT02302716|530184505|FG001|Overall Study|Physician Decision|4|||
147005742|NCT02302716|530184504|FG000|Overall Study|Withdrawal by Subject|13|||
147005743|NCT02302716|530184505|FG001|Overall Study|Withdrawal by Subject|7|||
147005744|NCT02302716|530184504|FG000|Overall Study|Protocol Violation|0|||
147005745|NCT02302716|530184505|FG001|Overall Study|Protocol Violation|1|||
147005746|NCT00557245|530184509|FG000|Overall Study|Lost to Follow-up|7|||
147005747|NCT00557245|530184510|FG001|Overall Study|Lost to Follow-up|8|||
147005748|NCT00557245|530184511|FG002|Overall Study|Lost to Follow-up|10|||
147005749|NCT00557245|530184509|FG000|Overall Study|Ineligible|5|||
147005750|NCT00557245|530184510|FG001|Overall Study|Ineligible|4|||
147005751|NCT00557245|530184511|FG002|Overall Study|Ineligible|2|||
147005752|NCT00521586|530184512|FG000|Initial Vaccination (Year 0)|Subject request|8|||
147005753|NCT00521586|530184513|FG001|Initial Vaccination (Year 0)|Subject request|11|||
147005754|NCT00521586|530184512|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
147005755|NCT00521586|530184513|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
147005756|NCT00521586|530184512|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
147005757|NCT00521586|530184513|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
147005758|NCT00521586|530184512|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
147005759|NCT00521586|530184513|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
147005760|NCT00521586|530184512|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
147005761|NCT00521586|530184513|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
147005762|NCT00521586|530184512|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
147005763|NCT00521586|530184513|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
147005764|NCT00521586|530184512|FG000|Initial Vaccination (Year 0)|Death|1|||
147005765|NCT00521586|530184513|FG001|Initial Vaccination (Year 0)|Death|0|||
147005766|NCT00521586|530184512|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
147005767|NCT00521586|530184513|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
147005768|NCT00521586|530184512|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
147005769|NCT00521586|530184513|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
147005770|NCT00521586|530184512|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
147005771|NCT00521586|530184513|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
147005772|NCT00521586|530184512|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
147005773|NCT00521586|530184513|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
147005774|NCT00521586|530184512|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
147005775|NCT00521586|530184513|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
147005776|NCT00521586|530184512|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
147005777|NCT00521586|530184513|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
147005778|NCT00521586|530184512|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
147005779|NCT00521586|530184513|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
147005780|NCT00521586|530184512|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
147005781|NCT00521586|530184513|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
147005782|NCT00521586|530184512|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
147005783|NCT00521586|530184513|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
147005784|NCT00521586|530184512|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
147005785|NCT00521586|530184513|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
147005786|NCT00521586|530184512|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
147005787|NCT00521586|530184513|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
147005788|NCT00521586|530184512|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
147005789|NCT00521586|530184513|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
147005790|NCT02392195|530184523|FG000|Overall Study|Lost to Follow-up|4|||
147005791|NCT02392195|530184523|FG000|Overall Study|Withdrawal by Subject|4|||
147005792|NCT00545792|530184526|FG000|Overall Study|Withdrawal by Subject|1|||
147005793|NCT01642277|530184527|FG000|Overall Study|Adverse Event|10|||
147005794|NCT01642277|530184528|FG001|Overall Study|Adverse Event|0|||
147005795|NCT01642277|530184527|FG000|Overall Study|Physician Decision|2|||
147005796|NCT01642277|530184528|FG001|Overall Study|Physician Decision|0|||
147005797|NCT01642277|530184527|FG000|Overall Study|Protocol Violation|1|||
146845375|NCT02628028|529602773|FG000|Dosing Period|Death|0|||
146845376|NCT02628028|529602774|FG001|Dosing Period|Death|0|||
147005798|NCT01642277|530184528|FG001|Overall Study|Protocol Violation|0|||
147005799|NCT01642277|530184527|FG000|Overall Study|Withdrawal by Subject|11|||
147005800|NCT01642277|530184528|FG001|Overall Study|Withdrawal by Subject|0|||
147005801|NCT03679598|530184529|FG000|Overall Study|Adverse Event|2|||
147005802|NCT03679598|530184530|FG001|Overall Study|Adverse Event|0|||
147005803|NCT03605342|530184531|FG000|Overall Study|Withdrawal by Subject|9|||
147005804|NCT03605342|530184532|FG001|Overall Study|Withdrawal by Subject|7|||
147005805|NCT03605342|530184531|FG000|Overall Study|Lost to Follow-up|1|||
147005806|NCT03605342|530184532|FG001|Overall Study|Lost to Follow-up|1|||
147005807|NCT01403194|530184535|FG000|Overall Study|Screen Failure|2|||
147005808|NCT01403194|530184535|FG000|Overall Study|Lost to Follow-up|8|||
147005809|NCT03428750|530184538|FG000|Overall Study|Withdrawal by Subject|11|||
147005810|NCT03428750|530184539|FG001|Overall Study|Withdrawal by Subject|10|||
147005811|NCT03428750|530184538|FG000|Overall Study|Lost to Follow-up|3|||
147005812|NCT03428750|530184539|FG001|Overall Study|Lost to Follow-up|9|||
147005813|NCT03428750|530184538|FG000|Overall Study|Adverse Event|9|||
147005814|NCT03428750|530184539|FG001|Overall Study|Adverse Event|1|||
147005815|NCT03428750|530184538|FG000|Overall Study|Protocol Violation|1|||
147005816|NCT03428750|530184539|FG001|Overall Study|Protocol Violation|0|||
147005817|NCT03428750|530184538|FG000|Overall Study|Administrative|0|||
147005818|NCT03428750|530184539|FG001|Overall Study|Administrative|1|||
147005819|NCT04474405|530184540|FG000|Overall Study|Withdrawal by Subject|0|||
147005820|NCT04474405|530184541|FG001|Overall Study|Withdrawal by Subject|0|||
147005821|NCT04474405|530184542|FG002|Overall Study|Withdrawal by Subject|1|||
147005822|NCT04474405|530184543|FG003|Overall Study|Withdrawal by Subject|0|||
147005823|NCT04474405|530184544|FG004|Overall Study|Withdrawal by Subject|1|||
147005824|NCT04474405|530184545|FG005|Overall Study|Withdrawal by Subject|0|||
147005825|NCT04474405|530184540|FG000|Overall Study|Other|0|||
147005826|NCT04474405|530184541|FG001|Overall Study|Other|0|||
147005827|NCT04474405|530184542|FG002|Overall Study|Other|0|||
147005828|NCT04474405|530184543|FG003|Overall Study|Other|0|||
147005829|NCT04474405|530184544|FG004|Overall Study|Other|3|||
147005830|NCT04474405|530184545|FG005|Overall Study|Other|0|||
147005831|NCT00918645|530184546|FG000|Overall Study|Withdrawal by Subject|1|||
147005832|NCT05133180|530184547|FG000|Overall Study|Withdrawal of consent|1|||
147005833|NCT05133180|530184548|FG001|Overall Study|Withdrawal of consent|1|||
147005834|NCT05133180|530184547|FG000|Overall Study|Lost to Follow-up|1|||
147005835|NCT05133180|530184548|FG001|Overall Study|Lost to Follow-up|1|||
147005836|NCT05133180|530184547|FG000|Overall Study|Documented disease progression|0|||
147005837|NCT05133180|530184548|FG001|Overall Study|Documented disease progression|1|||
147005838|NCT01604941|530184549|FG000|Overall Study|Adverse Event|1|||
147005839|NCT01604941|530184550|FG001|Overall Study|Adverse Event|2|||
147005840|NCT01604941|530184551|FG002|Overall Study|Adverse Event|0|||
147005841|NCT01604941|530184552|FG003|Overall Study|Adverse Event|0|||
147005842|NCT01604941|530184553|FG004|Overall Study|Adverse Event|1|||
147005843|NCT01604941|530184554|FG005|Overall Study|Adverse Event|5|||
147005844|NCT01604941|530184549|FG000|Overall Study|Non-compliance|1|||
147005845|NCT01604941|530184550|FG001|Overall Study|Non-compliance|0|||
147005846|NCT01604941|530184551|FG002|Overall Study|Non-compliance|0|||
147005847|NCT01604941|530184552|FG003|Overall Study|Non-compliance|0|||
147005848|NCT01604941|530184553|FG004|Overall Study|Non-compliance|0|||
147005849|NCT01604941|530184554|FG005|Overall Study|Non-compliance|0|||
147005850|NCT01604941|530184549|FG000|Overall Study|Participant Decision|0|||
147005851|NCT01604941|530184550|FG001|Overall Study|Participant Decision|0|||
147005852|NCT01604941|530184551|FG002|Overall Study|Participant Decision|0|||
147005853|NCT01604941|530184552|FG003|Overall Study|Participant Decision|0|||
147005854|NCT01604941|530184553|FG004|Overall Study|Participant Decision|0|||
147005855|NCT01604941|530184554|FG005|Overall Study|Participant Decision|2|||
147005856|NCT01604941|530184549|FG000|Overall Study|Early Study Termination|9|||
147005857|NCT01604941|530184550|FG001|Overall Study|Early Study Termination|2|||
147005858|NCT01604941|530184551|FG002|Overall Study|Early Study Termination|3|||
147005859|NCT01604941|530184552|FG003|Overall Study|Early Study Termination|3|||
147005860|NCT01604941|530184553|FG004|Overall Study|Early Study Termination|0|||
147005861|NCT01604941|530184554|FG005|Overall Study|Early Study Termination|0|||
147005862|NCT03366792|530184555|FG000|Overall Study|Withdrawal by Subject|7|||
147005863|NCT03366792|530184555|FG000|Overall Study|Lost to Follow-up|2|||
146845377|NCT02628028|529602775|FG002|Dosing Period|Death|0|||
146845378|NCT02628028|529602776|FG003|Dosing Period|Death|0|||
146845379|NCT02628028|529602777|FG004|Dosing Period|Death|0|||
146845380|NCT02628028|529602778|FG005|Dosing Period|Death|0|||
146845381|NCT02628028|529602779|FG006|Dosing Period|Death|0|||
146845382|NCT02628028|529602780|FG007|Dosing Period|Death|1|||
146845383|NCT02628028|529602773|FG000|Dosing Period|Lack of Efficacy|0|||
146845384|NCT02628028|529602774|FG001|Dosing Period|Lack of Efficacy|0|||
146845385|NCT02628028|529602775|FG002|Dosing Period|Lack of Efficacy|0|||
147005864|NCT03366792|530184555|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
147005865|NCT03366792|530184555|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
147005866|NCT03325881|530184559|FG000|Overall Study|Protocol Violation|0|||
147005867|NCT03325881|530184560|FG001|Overall Study|Protocol Violation|1|||
147005868|NCT03325881|530184559|FG000|Overall Study|Withdrawal by Subject|0|||
147005869|NCT03325881|530184560|FG001|Overall Study|Withdrawal by Subject|2|||
147005870|NCT03325881|530184559|FG000|Overall Study|Lack of Efficacy|2|||
147005871|NCT03325881|530184560|FG001|Overall Study|Lack of Efficacy|0|||
147005872|NCT03325881|530184559|FG000|Overall Study|Not treated|1|||
147005873|NCT03325881|530184560|FG001|Overall Study|Not treated|0|||
147005874|NCT03676634|530184561|FG000|Overall Study|Red blood cell loss|1|||
147005875|NCT03676634|530184561|FG000|Overall Study|Out-of-limit pulse|2|||
147005876|NCT01188681|530184565|FG000|Overall Study|bladder cancer|0|||
147005877|NCT01188681|530184566|FG001|Overall Study|bladder cancer|0|||
147005878|NCT01188681|530184567|FG002|Overall Study|bladder cancer|1|||
147005879|NCT01188681|530184568|FG003|Overall Study|bladder cancer|0|||
146845386|NCT02628028|529602776|FG003|Dosing Period|Lack of Efficacy|0|||
146845387|NCT02628028|529602777|FG004|Dosing Period|Lack of Efficacy|3|||
146845388|NCT02628028|529602778|FG005|Dosing Period|Lack of Efficacy|0|||
146845389|NCT02628028|529602779|FG006|Dosing Period|Lack of Efficacy|1|||
146845390|NCT02628028|529602780|FG007|Dosing Period|Lack of Efficacy|0|||
146845391|NCT02628028|529602773|FG000|Dosing Period|Study Terminated by Sponsor|0|||
146845392|NCT02628028|529602774|FG001|Dosing Period|Study Terminated by Sponsor|0|||
146845393|NCT02628028|529602775|FG002|Dosing Period|Study Terminated by Sponsor|0|||
146845394|NCT02628028|529602776|FG003|Dosing Period|Study Terminated by Sponsor|0|||
146845395|NCT02628028|529602777|FG004|Dosing Period|Study Terminated by Sponsor|7|||
146845396|NCT02628028|529602778|FG005|Dosing Period|Study Terminated by Sponsor|6|||
146845397|NCT02628028|529602779|FG006|Dosing Period|Study Terminated by Sponsor|7|||
146845398|NCT02628028|529602780|FG007|Dosing Period|Study Terminated by Sponsor|7|||
146845399|NCT02628028|529602773|FG000|Dosing Period|Physician Decision|0|||
146845400|NCT02628028|529602774|FG001|Dosing Period|Physician Decision|0|||
146845401|NCT02628028|529602775|FG002|Dosing Period|Physician Decision|0|||
146845402|NCT02628028|529602776|FG003|Dosing Period|Physician Decision|0|||
146845403|NCT02628028|529602777|FG004|Dosing Period|Physician Decision|0|||
147005880|NCT01188681|530184565|FG000|Overall Study|Withdrawal by Subject|0|||
147005881|NCT01188681|530184566|FG001|Overall Study|Withdrawal by Subject|0|||
147005882|NCT01188681|530184567|FG002|Overall Study|Withdrawal by Subject|0|||
147005883|NCT01188681|530184568|FG003|Overall Study|Withdrawal by Subject|1|||
147005884|NCT00216736|530184572|FG000|Overall Study|Lost to Follow-up|1|||
147005885|NCT00216736|530184573|FG001|Overall Study|Lost to Follow-up|1|||
147005886|NCT02622386|530184574|FG000|First Assignment|Withdrawal by Subject|3|||
147005887|NCT02622386|530184575|FG001|First Assignment|Withdrawal by Subject|2|||
147005888|NCT02622386|530184574|FG000|Washout|Withdrawal by Subject|4|||
147005889|NCT02622386|530184575|FG001|Washout|Withdrawal by Subject|4|||
147005890|NCT02622386|530184574|FG000|Second Assignment|Withdrawal by Subject|0|||
147005891|NCT02622386|530184575|FG001|Second Assignment|Withdrawal by Subject|2|||
147005892|NCT02890992|530184576|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
147005893|NCT02890992|530184577|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
147005894|NCT02890992|530184578|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
147005895|NCT02890992|530184579|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
147005896|NCT02890992|530184580|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
147005897|NCT02890992|530184581|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
147005898|NCT02890992|530184582|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
147005899|NCT02890992|530184583|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
147005900|NCT02890992|530184576|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
147005901|NCT02890992|530184577|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
147005902|NCT02890992|530184578|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
147005903|NCT02890992|530184579|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
147005904|NCT02890992|530184580|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
147005905|NCT02890992|530184581|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
147005906|NCT02890992|530184582|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
147005907|NCT02890992|530184583|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
147005908|NCT02890992|530184576|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
147005909|NCT02890992|530184577|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
147005910|NCT02890992|530184578|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
147005911|NCT02890992|530184579|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
147005912|NCT02890992|530184580|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
147005913|NCT02890992|530184581|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
147005914|NCT02890992|530184582|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
147005915|NCT02890992|530184583|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
147005916|NCT03236311|530184584|FG000|Overall Study|Study terminated by sponsor|0|||
147005917|NCT03236311|530184585|FG001|Overall Study|Study terminated by sponsor|2|||
147005918|NCT03236311|530184584|FG000|Overall Study|Adverse Event|0|||
146845404|NCT02628028|529602778|FG005|Dosing Period|Physician Decision|1|||
146845405|NCT02628028|529602779|FG006|Dosing Period|Physician Decision|0|||
146845406|NCT02628028|529602780|FG007|Dosing Period|Physician Decision|0|||
146845407|NCT02628028|529602773|FG000|Dosing Period|Site Terminated by Sponsor|0|||
146845408|NCT02628028|529602774|FG001|Dosing Period|Site Terminated by Sponsor|0|||
147005919|NCT03236311|530184585|FG001|Overall Study|Adverse Event|1|||
147005920|NCT00918684|530184587|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
147005921|NCT00918684|530184587|FG000|Treatment Phase|Lack of Efficacy|6|||
146845409|NCT02628028|529602775|FG002|Dosing Period|Site Terminated by Sponsor|0|||
146845410|NCT02628028|529602776|FG003|Dosing Period|Site Terminated by Sponsor|0|||
147005922|NCT00918684|530184587|FG000|Treatment Phase|Lost to Follow-up|2|||
147005923|NCT00918684|530184587|FG000|Treatment Phase|Physician Decision|8|||
147005924|NCT00918684|530184587|FG000|Treatment Phase|Protocol Violation|1|||
147005925|NCT00918684|530184587|FG000|Treatment Phase|Withdrawal by Subject|8|||
147005926|NCT01051349|530184588|FG000|Overall Study|Adverse Event|88|||
147005927|NCT01051349|530184588|FG000|Overall Study|Consent Withdrawn|54|||
147005928|NCT01051349|530184588|FG000|Overall Study|Investigator Decision|6|||
147005929|NCT01051349|530184588|FG000|Overall Study|Lost to Follow-up|6|||
147005930|NCT01051349|530184588|FG000|Overall Study|Subject non-compliance|7|||
147005931|NCT01051349|530184588|FG000|Overall Study|Reason not Specified|12|||
147005932|NCT00402103|530184589|FG000|Overall Study|Adverse Event|60|||
147005933|NCT00402103|530184590|FG001|Overall Study|Adverse Event|7|||
147005934|NCT00402103|530184589|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147005935|NCT00402103|530184590|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147005936|NCT00402103|530184589|FG000|Overall Study|Condition no longer requires study drug|2|||
147005937|NCT00402103|530184590|FG001|Overall Study|Condition no longer requires study drug|0|||
147005938|NCT00402103|530184589|FG000|Overall Study|Protocol Deviation|8|||
147005939|NCT00402103|530184590|FG001|Overall Study|Protocol Deviation|0|||
147005940|NCT00402103|530184589|FG000|Overall Study|Patient withdrew consent|12|||
147005941|NCT00402103|530184590|FG001|Overall Study|Patient withdrew consent|1|||
147005942|NCT00402103|530184589|FG000|Overall Study|Lost to Follow-up|6|||
147005943|NCT00402103|530184590|FG001|Overall Study|Lost to Follow-up|3|||
147005944|NCT00402103|530184589|FG000|Overall Study|Administrative problems|2|||
147005945|NCT00402103|530184590|FG001|Overall Study|Administrative problems|0|||
147005946|NCT00484679|530184591|FG000|Overall Study|Withdrawal by Subject|3|||
147005947|NCT00841542|530184592|FG000|Period 1|Adverse Event|1|||
147005948|NCT00841542|530184593|FG001|Period 1|Adverse Event|0|||
147005949|NCT00418145|530184594|FG000|Overall Study|study terminated|6|||
147005950|NCT02462837|530184595|FG000|Overall Study|pt developed hives|1|||
147005951|NCT02462837|530184596|FG001|Overall Study|pt developed hives|0|||
147005952|NCT02462837|530184595|FG000|Overall Study|Withdrawal by Subject|1|||
147005953|NCT02462837|530184596|FG001|Overall Study|Withdrawal by Subject|0|||
147005954|NCT01075282|530184600|FG000|Overall Study|Withdrawal by Subject|11|||
147005955|NCT01075282|530184601|FG001|Overall Study|Withdrawal by Subject|7|||
147005956|NCT01075282|530184602|FG002|Overall Study|Withdrawal by Subject|11|||
147005957|NCT01075282|530184600|FG000|Overall Study|Adverse Event|9|||
147005958|NCT01075282|530184601|FG001|Overall Study|Adverse Event|8|||
147005959|NCT01075282|530184602|FG002|Overall Study|Adverse Event|5|||
147005960|NCT01075282|530184600|FG000|Overall Study|Entry Criteria Not Met|3|||
147005961|NCT01075282|530184601|FG001|Overall Study|Entry Criteria Not Met|2|||
147005962|NCT01075282|530184602|FG002|Overall Study|Entry Criteria Not Met|0|||
147005963|NCT01075282|530184600|FG000|Overall Study|Lost to Follow-up|3|||
147005964|NCT01075282|530184601|FG001|Overall Study|Lost to Follow-up|3|||
147005965|NCT01075282|530184602|FG002|Overall Study|Lost to Follow-up|3|||
147005966|NCT01075282|530184600|FG000|Overall Study|Physician Decision|3|||
147005967|NCT01075282|530184601|FG001|Overall Study|Physician Decision|3|||
146845411|NCT02628028|529602777|FG004|Dosing Period|Site Terminated by Sponsor|0|||
146845412|NCT02628028|529602778|FG005|Dosing Period|Site Terminated by Sponsor|1|||
146845413|NCT02628028|529602779|FG006|Dosing Period|Site Terminated by Sponsor|1|||
146845414|NCT02628028|529602780|FG007|Dosing Period|Site Terminated by Sponsor|0|||
146845415|NCT02628028|529602773|FG000|Dosing Period|Lost to Follow-up|0|||
146845416|NCT02628028|529602774|FG001|Dosing Period|Lost to Follow-up|0|||
146845417|NCT02628028|529602775|FG002|Dosing Period|Lost to Follow-up|0|||
146845418|NCT02628028|529602776|FG003|Dosing Period|Lost to Follow-up|0|||
146845419|NCT02628028|529602777|FG004|Dosing Period|Lost to Follow-up|0|||
146845420|NCT02628028|529602778|FG005|Dosing Period|Lost to Follow-up|0|||
146845421|NCT02628028|529602779|FG006|Dosing Period|Lost to Follow-up|1|||
146845422|NCT02628028|529602780|FG007|Dosing Period|Lost to Follow-up|0|||
146845423|NCT02628028|529602773|FG000|Dosing Period|Other|0|||
146845424|NCT02628028|529602774|FG001|Dosing Period|Other|0|||
146845425|NCT02628028|529602775|FG002|Dosing Period|Other|0|||
146845426|NCT02628028|529602776|FG003|Dosing Period|Other|0|||
146845427|NCT02628028|529602777|FG004|Dosing Period|Other|2|||
146845428|NCT02628028|529602778|FG005|Dosing Period|Other|1|||
147005968|NCT01075282|530184602|FG002|Overall Study|Physician Decision|3|||
147005969|NCT01075282|530184600|FG000|Overall Study|Lack of Efficacy|1|||
147005970|NCT01075282|530184601|FG001|Overall Study|Lack of Efficacy|1|||
147005971|NCT01075282|530184602|FG002|Overall Study|Lack of Efficacy|0|||
147005972|NCT01075282|530184600|FG000|Overall Study|Treatment Non-compliance|1|||
147005973|NCT01075282|530184601|FG001|Overall Study|Treatment Non-compliance|2|||
147005974|NCT01075282|530184602|FG002|Overall Study|Treatment Non-compliance|2|||
146845429|NCT02628028|529602779|FG006|Dosing Period|Other|2|||
146845430|NCT02628028|529602780|FG007|Dosing Period|Other|4|||
146845431|NCT02628028|529602773|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
146845432|NCT02628028|529602774|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
147005975|NCT01075282|530184600|FG000|Overall Study|Protocol Violation|0|||
147005976|NCT01075282|530184601|FG001|Overall Study|Protocol Violation|2|||
147005977|NCT01075282|530184602|FG002|Overall Study|Protocol Violation|1|||
146845433|NCT02628028|529602775|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
147005978|NCT01075282|530184600|FG000|Overall Study|Death|0|||
146845434|NCT02628028|529602776|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
146845435|NCT02628028|529602777|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
146845436|NCT02628028|529602778|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
146845437|NCT02628028|529602779|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
146845438|NCT02628028|529602780|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
146845439|NCT02628028|529602773|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
146845440|NCT02628028|529602774|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
146845441|NCT02628028|529602775|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
146845442|NCT02628028|529602776|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
146845443|NCT02628028|529602777|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
146845444|NCT02628028|529602778|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
146845445|NCT02628028|529602779|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
146845446|NCT02628028|529602780|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
146845447|NCT02628028|529602773|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
146845448|NCT02628028|529602774|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
146845449|NCT02628028|529602775|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
146845450|NCT02628028|529602776|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
146845451|NCT02628028|529602777|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
146845452|NCT02628028|529602778|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
146845453|NCT02628028|529602779|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
146845454|NCT02628028|529602780|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
146845455|NCT02628028|529602773|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
146845456|NCT02628028|529602774|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
146845457|NCT02628028|529602775|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
146845458|NCT02628028|529602776|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
146845459|NCT02628028|529602777|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
146845460|NCT02628028|529602778|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
146845461|NCT02628028|529602779|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
146845462|NCT02628028|529602780|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
146845463|NCT02628028|529602773|FG000|Long-term Extension (LTE) Period|Other|0|||
146845464|NCT02628028|529602774|FG001|Long-term Extension (LTE) Period|Other|0|||
146845465|NCT02628028|529602775|FG002|Long-term Extension (LTE) Period|Other|0|||
146845466|NCT02628028|529602776|FG003|Long-term Extension (LTE) Period|Other|0|||
146845467|NCT02628028|529602777|FG004|Long-term Extension (LTE) Period|Other|0|||
146845468|NCT02628028|529602778|FG005|Long-term Extension (LTE) Period|Other|3|||
146845469|NCT02628028|529602779|FG006|Long-term Extension (LTE) Period|Other|4|||
146845470|NCT02628028|529602780|FG007|Long-term Extension (LTE) Period|Other|3|||
146845471|NCT00283244|529602781|FG000|Overall Study|Adverse Event|0|||
146845472|NCT00283244|529602782|FG001|Overall Study|Adverse Event|8|||
146845473|NCT00283244|529602783|FG002|Overall Study|Adverse Event|11|||
146845474|NCT00283244|529602781|FG000|Overall Study|Death|4|||
146845475|NCT00283244|529602782|FG001|Overall Study|Death|3|||
146845476|NCT00283244|529602783|FG002|Overall Study|Death|2|||
146845477|NCT00283244|529602781|FG000|Overall Study|Lack of Efficacy|8|||
146845478|NCT00283244|529602782|FG001|Overall Study|Lack of Efficacy|32|||
146845479|NCT00283244|529602783|FG002|Overall Study|Lack of Efficacy|26|||
146845480|NCT00283244|529602781|FG000|Overall Study|Withdrawal by Subject|1|||
146845481|NCT00283244|529602782|FG001|Overall Study|Withdrawal by Subject|2|||
146845482|NCT00283244|529602783|FG002|Overall Study|Withdrawal by Subject|2|||
146845483|NCT00283244|529602781|FG000|Overall Study|Physician Decision|0|||
146845484|NCT00283244|529602782|FG001|Overall Study|Physician Decision|0|||
146845485|NCT00283244|529602783|FG002|Overall Study|Physician Decision|1|||
146845486|NCT00283244|529602781|FG000|Overall Study|Medical illness (other complicating dz)|4|||
146845487|NCT00283244|529602782|FG001|Overall Study|Medical illness (other complicating dz)|3|||
146845488|NCT00283244|529602783|FG002|Overall Study|Medical illness (other complicating dz)|6|||
146845489|NCT00283244|529602781|FG000|Overall Study|Clinical deterioration|1|||
146845490|NCT00283244|529602782|FG001|Overall Study|Clinical deterioration|3|||
146845491|NCT00283244|529602783|FG002|Overall Study|Clinical deterioration|3|||
146845492|NCT02145468|529602784|FG000|Overall Study|Withdrawal by Subject|5|||
147005979|NCT01075282|530184601|FG001|Overall Study|Death|1|||
147005980|NCT01075282|530184602|FG002|Overall Study|Death|2|||
147005981|NCT02679729|530184603|FG000|Overall Study|Lost to Follow-up|0|||
147005982|NCT02679729|530184604|FG001|Overall Study|Lost to Follow-up|1|||
146845493|NCT02145468|529602785|FG001|Overall Study|Withdrawal by Subject|8|||
147005983|NCT02679729|530184605|FG002|Overall Study|Lost to Follow-up|0|||
146845494|NCT04372121|529602792|FG000|Overall Study|Lost to Follow-up|0|||
146845495|NCT04372121|529602793|FG001|Overall Study|Lost to Follow-up|0|||
146845496|NCT04372121|529602794|FG002|Overall Study|Lost to Follow-up|0|||
146845497|NCT04372121|529602795|FG003|Overall Study|Lost to Follow-up|1|||
146845498|NCT04372121|529602792|FG000|Overall Study|Protocol Violation|0|||
146845499|NCT04372121|529602793|FG001|Overall Study|Protocol Violation|0|||
146845500|NCT04372121|529602794|FG002|Overall Study|Protocol Violation|1|||
147005984|NCT02679729|530184606|FG003|Overall Study|Lost to Follow-up|0|||
146845501|NCT04372121|529602795|FG003|Overall Study|Protocol Violation|0|||
146845502|NCT04372121|529602792|FG000|Overall Study|Withdrawal by Subject|3|||
146845503|NCT04372121|529602793|FG001|Overall Study|Withdrawal by Subject|1|||
146845504|NCT04372121|529602794|FG002|Overall Study|Withdrawal by Subject|0|||
146845505|NCT04372121|529602795|FG003|Overall Study|Withdrawal by Subject|0|||
146845506|NCT04372121|529602792|FG000|Overall Study|Study termination|6|||
146845507|NCT04372121|529602793|FG001|Overall Study|Study termination|5|||
146845508|NCT04372121|529602794|FG002|Overall Study|Study termination|1|||
146845509|NCT04372121|529602795|FG003|Overall Study|Study termination|1|||
146845510|NCT04372121|529602792|FG000|Overall Study|Hysterectomy planned|1|||
146845511|NCT04372121|529602793|FG001|Overall Study|Hysterectomy planned|0|||
146845512|NCT04372121|529602794|FG002|Overall Study|Hysterectomy planned|0|||
146845513|NCT04372121|529602795|FG003|Overall Study|Hysterectomy planned|0|||
146845514|NCT03333876|529604370|FG000|Screening Period|Screen Failure|4|||
146845515|NCT03333876|529604370|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
146845516|NCT03333876|529604370|FG000|Mandibular Advancement|Adverse Event|2|||
146845517|NCT03333876|529604370|FG000|Mandibular Advancement|Product Damage|2|||
146845518|NCT05020327|529604373|FG000|Overall Study|Physician Decision|3|||
146845519|NCT05020327|529604374|FG001|Overall Study|Physician Decision|0|||
146845520|NCT05020327|529604375|FG002|Overall Study|Physician Decision|0|||
146845521|NCT05020327|529604373|FG000|Overall Study|Withdrawal by Subject|1|||
146845522|NCT05020327|529604374|FG001|Overall Study|Withdrawal by Subject|1|||
146845523|NCT05020327|529604375|FG002|Overall Study|Withdrawal by Subject|0|||
146845524|NCT05020327|529604373|FG000|Overall Study|personal/cultural, ineligible|12|||
146845525|NCT05020327|529604374|FG001|Overall Study|personal/cultural, ineligible|0|||
146845526|NCT05020327|529604375|FG002|Overall Study|personal/cultural, ineligible|0|||
146845527|NCT00297427|529604383|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
146845528|NCT00297427|529604384|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
146845529|NCT00297427|529604383|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
146845530|NCT00297427|529604384|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
146845531|NCT00297427|529604383|FG000|Phase 1: Initial Intervention|Death|0|||
146845532|NCT00297427|529604384|FG001|Phase 1: Initial Intervention|Death|1|||
146845533|NCT00297427|529604383|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
146845534|NCT00297427|529604384|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
146845535|NCT00297427|529604383|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
146845536|NCT00297427|529604384|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
146845537|NCT00297427|529604383|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
146845538|NCT00297427|529604384|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
146845539|NCT00297427|529604383|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
146845540|NCT00297427|529604384|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
146845541|NCT00297427|529604383|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
146845542|NCT00297427|529604384|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
146845543|NCT01127893|529604385|FG000|Overall Study|Study Termination by the Sponsor|1|||
146845544|NCT01262677|529604386|FG000|Overall Study|Does not meet entrance criteria|0|||
146845545|NCT01262677|529604387|FG001|Overall Study|Does not meet entrance criteria|2|||
146845546|NCT01262677|529604388|FG002|Overall Study|Does not meet entrance criteria|0|||
146845547|NCT01262677|529604386|FG000|Overall Study|Insufficient clinical response|0|||
146845548|NCT01262677|529604387|FG001|Overall Study|Insufficient clinical response|0|||
146845549|NCT01262677|529604388|FG002|Overall Study|Insufficient clinical response|1|||
146845550|NCT01262677|529604386|FG000|Overall Study|Lost to Follow-up|1|||
146845551|NCT01262677|529604387|FG001|Overall Study|Lost to Follow-up|0|||
146845552|NCT01262677|529604388|FG002|Overall Study|Lost to Follow-up|2|||
146845553|NCT01262677|529604386|FG000|Overall Study|No longer willing to participate|3|||
146845554|NCT01262677|529604387|FG001|Overall Study|No longer willing to participate|3|||
146845555|NCT01262677|529604388|FG002|Overall Study|No longer willing to participate|2|||
146845556|NCT01262677|529604386|FG000|Overall Study|Reason not provided|2|||
146845557|NCT01262677|529604387|FG001|Overall Study|Reason not provided|1|||
146845558|NCT01262677|529604388|FG002|Overall Study|Reason not provided|3|||
146845559|NCT01262677|529604386|FG000|Overall Study|Protocol Violation|0|||
146845560|NCT01262677|529604387|FG001|Overall Study|Protocol Violation|1|||
146845561|NCT01262677|529604388|FG002|Overall Study|Protocol Violation|1|||
146845562|NCT01262677|529604386|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
146845563|NCT01262677|529604387|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
146845564|NCT01262677|529604388|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
146845565|NCT05816330|529604396|FG000|Overall Study|Withdrawal by Subject|4|||
147005985|NCT02679729|530184607|FG004|Overall Study|Lost to Follow-up|1|||
146845566|NCT05816330|529604397|FG001|Overall Study|Withdrawal by Subject|1|||
146845567|NCT04488770|529604406|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146845568|NCT04488770|529604407|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146845569|NCT04488770|529604408|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146845570|NCT04488770|529604409|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
146845571|NCT04488770|529604410|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146845572|NCT04488770|529604411|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146845573|NCT04488770|529604412|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146845574|NCT04488770|529604413|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146845575|NCT04488770|529604414|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146845576|NCT04488770|529604415|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146845577|NCT04488770|529604416|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146845578|NCT04488770|529604417|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146845579|NCT04488770|529604418|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146845580|NCT04488770|529604406|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
146845581|NCT04488770|529604407|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146845582|NCT04488770|529604408|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146845583|NCT04488770|529604409|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146845584|NCT04488770|529604410|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146845585|NCT04488770|529604411|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146845586|NCT04488770|529604412|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146845587|NCT04488770|529604413|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146845588|NCT04488770|529604414|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146845589|NCT04488770|529604415|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146845590|NCT04488770|529604416|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146845591|NCT04488770|529604417|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146845592|NCT04488770|529604418|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146845593|NCT04488770|529604406|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146845594|NCT04488770|529604407|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146845595|NCT04488770|529604408|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146845596|NCT04488770|529604409|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146845597|NCT04488770|529604410|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146845598|NCT04488770|529604411|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
146845599|NCT04488770|529604412|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
146845600|NCT04488770|529604413|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146845601|NCT04488770|529604414|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146845602|NCT04488770|529604415|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146845603|NCT04488770|529604416|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146845604|NCT04488770|529604417|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146845605|NCT04488770|529604418|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146845606|NCT04488770|529604406|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146845607|NCT04488770|529604407|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146845608|NCT04488770|529604408|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146845609|NCT04488770|529604409|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146845610|NCT04488770|529604410|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
146845611|NCT04488770|529604411|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146845612|NCT04488770|529604412|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146845613|NCT04488770|529604413|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146845614|NCT04488770|529604414|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146845615|NCT04488770|529604415|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146845616|NCT04488770|529604416|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146845617|NCT04488770|529604417|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146845618|NCT04488770|529604418|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146845619|NCT01208103|529604419|FG000|Overall Study|Adverse Event|1|||
146845620|NCT01208103|529604419|FG000|Overall Study|Withdrawal by Subject|1|||
146845621|NCT00886795|529604420|FG000|Overall Study|Lack of Efficacy|1|||
146845622|NCT01669577|529604426|FG000|Overall Study|Death|22|||
146845623|NCT01669577|529604426|FG000|Overall Study|Lost to Follow-up|78|||
146845624|NCT01669577|529604426|FG000|Overall Study|Physician Decision|34|||
146845625|NCT00444275|529604430|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
146845626|NCT00444275|529604431|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
146845627|NCT00444275|529604432|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
146845628|NCT00444275|529604433|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
146845629|NCT00444275|529604434|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
146845630|NCT00444275|529604430|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
146845631|NCT00444275|529604431|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
146845632|NCT00444275|529604432|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
146845633|NCT00444275|529604433|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
146845634|NCT00444275|529604434|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
146845635|NCT00444275|529604430|FG000|Maintenance Treatment Phase|Adverse Event|0|||
146845636|NCT00444275|529604431|FG001|Maintenance Treatment Phase|Adverse Event|0|||
146845637|NCT00444275|529604432|FG002|Maintenance Treatment Phase|Adverse Event|3|||
146845638|NCT00444275|529604433|FG003|Maintenance Treatment Phase|Adverse Event|2|||
146845639|NCT00444275|529604434|FG004|Maintenance Treatment Phase|Adverse Event|13|||
146845640|NCT00444275|529604430|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
146845641|NCT00444275|529604431|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
146845642|NCT00444275|529604432|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
146845643|NCT00444275|529604433|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
146845644|NCT00444275|529604434|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
146845645|NCT00444275|529604430|FG000|Maintenance Treatment Phase|Patient's wish|0|||
146845646|NCT00444275|529604431|FG001|Maintenance Treatment Phase|Patient's wish|0|||
146845647|NCT00444275|529604432|FG002|Maintenance Treatment Phase|Patient's wish|19|||
146845648|NCT00444275|529604433|FG003|Maintenance Treatment Phase|Patient's wish|9|||
146845649|NCT00444275|529604434|FG004|Maintenance Treatment Phase|Patient's wish|20|||
146845650|NCT00444275|529604430|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
146845651|NCT00444275|529604431|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
146845652|NCT00444275|529604432|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
146845653|NCT00444275|529604433|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
146845654|NCT00444275|529604434|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
146845655|NCT00444275|529604430|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
146845656|NCT00444275|529604431|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
146845657|NCT00444275|529604432|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
146845658|NCT00444275|529604433|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
146845659|NCT00444275|529604434|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
146845660|NCT04662931|529604437|FG000|Overall Study|Withdrawal by Subject|17|||
146845661|NCT04662931|529604437|FG000|Overall Study|Death|3|||
146845662|NCT04662931|529604437|FG000|Overall Study|Lost to Follow-up|3|||
146845663|NCT04662931|529604437|FG000|Overall Study|Guardian Decision|1|||
146845664|NCT01989169|529604438|FG000|Period 2|Adverse Event|0|||
146845665|NCT01989169|529604439|FG001|Period 2|Adverse Event|1|||
146845666|NCT01585155|529604440|FG000|Overall Study|Adverse Event|1|||
146845667|NCT01585155|529604440|FG000|Overall Study|Lack of Efficacy|2|||
146845668|NCT01585155|529604440|FG000|Overall Study|Worsening ulcerative colitis|2|||
146845669|NCT02235311|529604445|FG000|Overall Study|Lost to Follow-up|0|||
146845670|NCT02235311|529604446|FG001|Overall Study|Lost to Follow-up|1|||
146845671|NCT02235311|529604445|FG000|Overall Study|Protocol Violation|0|||
146845672|NCT02235311|529604446|FG001|Overall Study|Protocol Violation|1|||
146845673|NCT04655027|529604447|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
146845674|NCT04655027|529604448|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
146845675|NCT00658788|529604449|FG000|Overall Study|Adverse Event|11|||
146845676|NCT00658788|529604449|FG000|Overall Study|Withdrawal by Subject|13|||
146845677|NCT00658788|529604449|FG000|Overall Study|Lost to Follow-up|18|||
146845678|NCT00658788|529604449|FG000|Overall Study|Treatment Discontinuation|32|||
146845679|NCT00653523|529604450|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
146845680|NCT00653523|529604450|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
146845681|NCT00653523|529604450|FG000|Overall Study|Adverse Event|7|||
146845682|NCT00653523|529604450|FG000|Overall Study|Withdrawal by Subject|6|||
146845683|NCT00653523|529604450|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
146845684|NCT00653523|529604450|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
146845685|NCT03519997|529604453|FG000|Overall Study|Adverse Event|4|||
146845686|NCT03519997|529604453|FG000|Overall Study|Withdrawal by Subject|2|||
146845687|NCT03519997|529604453|FG000|Overall Study|Protocol Violation|1|||
146845688|NCT05543707|529604454|FG000|Overall Study|Study drug non-compliance/|5|||
146845689|NCT05543707|529604455|FG001|Overall Study|Study drug non-compliance/|0|||
146845690|NCT05543707|529604454|FG000|Overall Study|Withdrawal by Subject|1|||
146845691|NCT05543707|529604455|FG001|Overall Study|Withdrawal by Subject|1|||
146845692|NCT05543707|529604454|FG000|Overall Study|Adverse Event|1|||
146845693|NCT05543707|529604455|FG001|Overall Study|Adverse Event|0|||
146845694|NCT05543707|529604454|FG000|Overall Study|concurrent illness|0|||
146845695|NCT05543707|529604455|FG001|Overall Study|concurrent illness|1|||
146845696|NCT05543707|529604454|FG000|Overall Study|Pregnancy|1|||
146845697|NCT05543707|529604455|FG001|Overall Study|Pregnancy|1|||
146845698|NCT00186888|529604456|FG000|Overall Study|Toxicity|0|||
146845699|NCT00186888|529604457|FG001|Overall Study|Toxicity|1|||
146845700|NCT00186888|529604458|FG002|Overall Study|Toxicity|0|||
146845701|NCT00186888|529604456|FG000|Overall Study|Relapse or progression of disease|4|||
146845702|NCT00186888|529604457|FG001|Overall Study|Relapse or progression of disease|2|||
146845703|NCT00186888|529604458|FG002|Overall Study|Relapse or progression of disease|0|||
146845704|NCT03006848|529604459|FG000|Overall Study|Adverse Event|1|||
146845705|NCT03006848|529604459|FG000|Overall Study|Physician Decision|1|||
146845706|NCT03006848|529604459|FG000|Overall Study|Lack of Efficacy|16|||
146845707|NCT05384938|529604460|FG000|Overall Study|Withdrawal by Subject|8|||
146845708|NCT05384938|529604460|FG000|Overall Study|Lost to Follow-up|6|||
146845709|NCT05384938|529604460|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
146845710|NCT03898167|529604461|FG000|Overall Study|Terminated phone call early|7|||
146845711|NCT03898167|529604462|FG001|Overall Study|Terminated phone call early|0|||
146845712|NCT03898167|529604463|FG002|Overall Study|Terminated phone call early|0|||
146845713|NCT03898167|529604461|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
146845714|NCT03898167|529604462|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
146845715|NCT03898167|529604463|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
146845716|NCT00384397|529604465|FG000|Overall Study|Adverse Event|0|||
146845717|NCT00384397|529604466|FG001|Overall Study|Adverse Event|1|||
146845718|NCT00384397|529604467|FG002|Overall Study|Adverse Event|2|||
146845719|NCT00384397|529604465|FG000|Overall Study|Protocol Violation|7|||
146845720|NCT00384397|529604466|FG001|Overall Study|Protocol Violation|15|||
146845721|NCT00384397|529604467|FG002|Overall Study|Protocol Violation|13|||
146845722|NCT00384397|529604465|FG000|Overall Study|Lost to Follow-up|11|||
146845723|NCT00384397|529604466|FG001|Overall Study|Lost to Follow-up|13|||
146845724|NCT00384397|529604467|FG002|Overall Study|Lost to Follow-up|3|||
146845725|NCT00384397|529604465|FG000|Overall Study|Withdrawal by Subject|14|||
146845726|NCT00384397|529604466|FG001|Overall Study|Withdrawal by Subject|17|||
146845727|NCT00384397|529604467|FG002|Overall Study|Withdrawal by Subject|15|||
146845728|NCT01525238|529604468|FG000|Overall Study|Withdrawal by Subject|1|||
146845729|NCT01525238|529604469|FG001|Overall Study|Withdrawal by Subject|0|||
146845730|NCT01525238|529604470|FG002|Overall Study|Withdrawal by Subject|0|||
146845731|NCT01214642|529604471|FG000|Overall Study|Progressive Disease|3|||
146845732|NCT01214642|529604472|FG001|Overall Study|Progressive Disease|2|||
146845733|NCT01214642|529604473|FG002|Overall Study|Progressive Disease|3|||
146845734|NCT01214642|529604474|FG003|Overall Study|Progressive Disease|5|||
146845735|NCT01214642|529604475|FG004|Overall Study|Progressive Disease|5|||
146845736|NCT01214642|529604476|FG005|Overall Study|Progressive Disease|3|||
146845737|NCT01214642|529604477|FG006|Overall Study|Progressive Disease|5|||
146845738|NCT01214642|529604478|FG007|Overall Study|Progressive Disease|3|||
146845739|NCT01214642|529604479|FG008|Overall Study|Progressive Disease|10|||
146845740|NCT01214642|529604480|FG009|Overall Study|Progressive Disease|2|||
146845741|NCT01214642|529604481|FG010|Overall Study|Progressive Disease|1|||
146845742|NCT01214642|529604482|FG011|Overall Study|Progressive Disease|4|||
146845743|NCT01214642|529604471|FG000|Overall Study|Adverse Event|0|||
146845744|NCT01214642|529604472|FG001|Overall Study|Adverse Event|1|||
146845745|NCT01214642|529604473|FG002|Overall Study|Adverse Event|0|||
146845746|NCT01214642|529604474|FG003|Overall Study|Adverse Event|0|||
146845747|NCT01214642|529604475|FG004|Overall Study|Adverse Event|0|||
146845748|NCT01214642|529604476|FG005|Overall Study|Adverse Event|0|||
146845749|NCT01214642|529604477|FG006|Overall Study|Adverse Event|1|||
146845750|NCT01214642|529604478|FG007|Overall Study|Adverse Event|0|||
146845751|NCT01214642|529604479|FG008|Overall Study|Adverse Event|0|||
146845752|NCT01214642|529604480|FG009|Overall Study|Adverse Event|1|||
146845753|NCT01214642|529604481|FG010|Overall Study|Adverse Event|1|||
146845754|NCT01214642|529604482|FG011|Overall Study|Adverse Event|0|||
146845755|NCT01214642|529604471|FG000|Overall Study|Death|0|||
146845756|NCT01214642|529604472|FG001|Overall Study|Death|0|||
146845757|NCT01214642|529604473|FG002|Overall Study|Death|1|||
146845758|NCT01214642|529604474|FG003|Overall Study|Death|0|||
146845759|NCT01214642|529604475|FG004|Overall Study|Death|0|||
146845760|NCT01214642|529604476|FG005|Overall Study|Death|0|||
146845761|NCT01214642|529604477|FG006|Overall Study|Death|0|||
146845762|NCT01214642|529604478|FG007|Overall Study|Death|0|||
146845763|NCT01214642|529604479|FG008|Overall Study|Death|0|||
146845764|NCT01214642|529604480|FG009|Overall Study|Death|0|||
146845765|NCT01214642|529604481|FG010|Overall Study|Death|1|||
146845766|NCT01214642|529604482|FG011|Overall Study|Death|0|||
146845767|NCT01214642|529604471|FG000|Overall Study|Withdrawal by Subject|0|||
146845768|NCT01214642|529604472|FG001|Overall Study|Withdrawal by Subject|0|||
146845769|NCT01214642|529604473|FG002|Overall Study|Withdrawal by Subject|1|||
146845770|NCT01214642|529604474|FG003|Overall Study|Withdrawal by Subject|0|||
146845771|NCT01214642|529604475|FG004|Overall Study|Withdrawal by Subject|0|||
146845772|NCT01214642|529604476|FG005|Overall Study|Withdrawal by Subject|0|||
146845773|NCT01214642|529604477|FG006|Overall Study|Withdrawal by Subject|0|||
146845774|NCT01214642|529604478|FG007|Overall Study|Withdrawal by Subject|0|||
146845775|NCT01214642|529604479|FG008|Overall Study|Withdrawal by Subject|3|||
146845776|NCT01214642|529604480|FG009|Overall Study|Withdrawal by Subject|1|||
146845777|NCT01214642|529604481|FG010|Overall Study|Withdrawal by Subject|1|||
146845778|NCT01214642|529604482|FG011|Overall Study|Withdrawal by Subject|0|||
146845779|NCT01214642|529604471|FG000|Overall Study|Physician Decision|0|||
146845780|NCT01214642|529604472|FG001|Overall Study|Physician Decision|0|||
146845781|NCT01214642|529604473|FG002|Overall Study|Physician Decision|1|||
146845782|NCT01214642|529604474|FG003|Overall Study|Physician Decision|1|||
146845783|NCT01214642|529604475|FG004|Overall Study|Physician Decision|1|||
146845784|NCT01214642|529604476|FG005|Overall Study|Physician Decision|0|||
146845785|NCT01214642|529604477|FG006|Overall Study|Physician Decision|0|||
146845786|NCT01214642|529604478|FG007|Overall Study|Physician Decision|0|||
146845787|NCT01214642|529604479|FG008|Overall Study|Physician Decision|0|||
146845788|NCT01214642|529604480|FG009|Overall Study|Physician Decision|0|||
146845789|NCT01214642|529604481|FG010|Overall Study|Physician Decision|0|||
146845790|NCT01214642|529604482|FG011|Overall Study|Physician Decision|2|||
146845791|NCT04696653|529604485|FG000|Overall Study|left organization|18|||
146845792|NCT04696653|529604485|FG000|Overall Study|Lost to Follow-up|3|||
146845793|NCT01946529|529604486|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
146845794|NCT01946529|529604487|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
146845795|NCT01946529|529604488|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
146845796|NCT01946529|529604486|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
146845797|NCT01946529|529604487|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
146845798|NCT01946529|529604488|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
146845799|NCT03826030|529604498|FG000|Overall Study|Withdrawal by Subject|2|||
146845800|NCT03826030|529604499|FG001|Overall Study|Withdrawal by Subject|0|||
146845801|NCT03826030|529604500|FG002|Overall Study|Withdrawal by Subject|1|||
146845802|NCT03826030|529604498|FG000|Overall Study|Lost to Follow-up|1|||
146845803|NCT03826030|529604499|FG001|Overall Study|Lost to Follow-up|1|||
146845804|NCT03826030|529604500|FG002|Overall Study|Lost to Follow-up|1|||
146845805|NCT03826030|529604498|FG000|Overall Study|Too busy to return for visits|1|||
146845806|NCT03826030|529604499|FG001|Overall Study|Too busy to return for visits|0|||
146845807|NCT03826030|529604500|FG002|Overall Study|Too busy to return for visits|0|||
146845808|NCT02218606|529606560|FG000|Overall Study|Adverse Event|1|||
146845809|NCT02218606|529606561|FG001|Overall Study|Adverse Event|1|||
146845810|NCT02218606|529606560|FG000|Overall Study|Death|15|||
146845811|NCT02218606|529606561|FG001|Overall Study|Death|28|||
146845812|NCT02218606|529606560|FG000|Overall Study|Physician Decision|0|||
146845813|NCT02218606|529606561|FG001|Overall Study|Physician Decision|1|||
146845814|NCT02218606|529606560|FG000|Overall Study|Withdrawal by Subject|4|||
146845815|NCT02218606|529606561|FG001|Overall Study|Withdrawal by Subject|0|||
146845816|NCT02218606|529606560|FG000|Overall Study|Noncompliance|1|||
146845817|NCT02218606|529606561|FG001|Overall Study|Noncompliance|0|||
146845818|NCT02218606|529606560|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
146845819|NCT02218606|529606561|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
146845820|NCT02218606|529606560|FG000|Overall Study|Other|2|||
146845821|NCT02218606|529606561|FG001|Overall Study|Other|1|||
146845822|NCT02218606|529606560|FG000|Overall Study|Never started treatment|0|||
146845823|NCT02218606|529606561|FG001|Overall Study|Never started treatment|1|||
146845824|NCT03203473|529606562|FG000|Induction Phase|Never started primary treatment|2|||
146845825|NCT03203473|529606563|FG001|Induction Phase|Never started primary treatment|0|||
146845826|NCT03203473|529606564|FG002|Induction Phase|Never started primary treatment|0|||
146845827|NCT03203473|529606562|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
146845828|NCT03203473|529606563|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
146845829|NCT03203473|529606564|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
146845830|NCT03203473|529606562|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
146845831|NCT03203473|529606563|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
146845832|NCT03203473|529606564|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
146845833|NCT03203473|529606562|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
146845834|NCT03203473|529606563|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
146845835|NCT03203473|529606564|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
146845836|NCT03203473|529606562|FG000|Arm Allocation Phase|started salvage therapy|0|||
146845837|NCT03203473|529606563|FG001|Arm Allocation Phase|started salvage therapy|5|||
146845838|NCT03203473|529606564|FG002|Arm Allocation Phase|started salvage therapy|0|||
146845839|NCT03203473|529606562|FG000|Arm Allocation Phase|Disease progression|0|||
146845840|NCT03203473|529606563|FG001|Arm Allocation Phase|Disease progression|0|||
146845841|NCT03203473|529606564|FG002|Arm Allocation Phase|Disease progression|37|||
147005986|NCT02679729|530184608|FG005|Overall Study|Lost to Follow-up|0|||
147005987|NCT02679729|530184609|FG006|Overall Study|Lost to Follow-up|0|||
147005988|NCT02679729|530184610|FG007|Overall Study|Lost to Follow-up|0|||
147005989|NCT02679729|530184611|FG008|Overall Study|Lost to Follow-up|0|||
146845842|NCT03203473|529606562|FG000|Arm Allocation Phase|Adverse Event|0|||
146845843|NCT03203473|529606563|FG001|Arm Allocation Phase|Adverse Event|0|||
147005990|NCT02679729|530184603|FG000|Overall Study|Participant decision|0|||
147005991|NCT02679729|530184604|FG001|Overall Study|Participant decision|1|||
147005992|NCT02679729|530184605|FG002|Overall Study|Participant decision|0|||
147005993|NCT02679729|530184606|FG003|Overall Study|Participant decision|0|||
147005994|NCT02679729|530184607|FG004|Overall Study|Participant decision|0|||
147005995|NCT02679729|530184608|FG005|Overall Study|Participant decision|0|||
147005996|NCT02679729|530184609|FG006|Overall Study|Participant decision|1|||
147005997|NCT02679729|530184610|FG007|Overall Study|Participant decision|0|||
147005998|NCT02679729|530184611|FG008|Overall Study|Participant decision|0|||
146845844|NCT03203473|529606564|FG002|Arm Allocation Phase|Adverse Event|11|||
146845845|NCT03203473|529606562|FG000|Arm Allocation Phase|Physician Decision|0|||
146845846|NCT03203473|529606563|FG001|Arm Allocation Phase|Physician Decision|0|||
146845847|NCT03203473|529606564|FG002|Arm Allocation Phase|Physician Decision|3|||
146845848|NCT03203473|529606562|FG000|Arm Allocation Phase|Death|0|||
146845849|NCT03203473|529606563|FG001|Arm Allocation Phase|Death|0|||
146845850|NCT03203473|529606564|FG002|Arm Allocation Phase|Death|1|||
146845851|NCT03203473|529606562|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
146845852|NCT03203473|529606563|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
146845853|NCT03203473|529606564|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
146845854|NCT03203473|529606562|FG000|Arm Allocation Phase|Intercurrent illness|0|||
146845855|NCT03203473|529606563|FG001|Arm Allocation Phase|Intercurrent illness|0|||
146845856|NCT03203473|529606564|FG002|Arm Allocation Phase|Intercurrent illness|1|||
146845857|NCT03203473|529606562|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
146845858|NCT03203473|529606563|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
146845859|NCT03203473|529606564|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
146845860|NCT02314780|529606569|FG000|Overall Study|organizational reasons|0|||
146845861|NCT02314780|529606570|FG001|Overall Study|organizational reasons|2|||
146845862|NCT02314780|529606571|FG002|Overall Study|organizational reasons|0|||
146845863|NCT02314780|529606569|FG000|Overall Study|Adverse Event|0|||
146845864|NCT02314780|529606570|FG001|Overall Study|Adverse Event|1|||
146845865|NCT02314780|529606571|FG002|Overall Study|Adverse Event|0|||
146845866|NCT01077271|529606575|FG000|Overall Study|Parental desire|8|||
146845867|NCT01077271|529606575|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
146845868|NCT01077271|529606575|FG000|Overall Study|Noncompliance|2|||
146845869|NCT01077271|529606575|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
146845870|NCT01077271|529606575|FG000|Overall Study|Changed doctors|2|||
146845871|NCT01077271|529606575|FG000|Overall Study|Parents thought too many injections|2|||
146845872|NCT01077271|529606575|FG000|Overall Study|End of RSV season nearly reached|1|||
146845873|NCT01077271|529606575|FG000|Overall Study|Mother unconvinced of the necessity|1|||
146845874|NCT00215137|529606576|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
146845875|NCT00215137|529606577|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
146845876|NCT00215137|529606578|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
146845877|NCT00215137|529606576|FG000|Randomization Period|Lost to Follow-up|0|||
146845878|NCT00215137|529606577|FG001|Randomization Period|Lost to Follow-up|1|||
146845879|NCT00215137|529606578|FG002|Randomization Period|Lost to Follow-up|0|||
146845880|NCT00215137|529606576|FG000|Randomization Period|Withdrawal by Subject|0|||
146845881|NCT00215137|529606577|FG001|Randomization Period|Withdrawal by Subject|1|||
146845882|NCT00215137|529606578|FG002|Randomization Period|Withdrawal by Subject|0|||
146845883|NCT00095498|529606580|FG000|Overall Study|Physician Decision|9|||
146845884|NCT00095498|529606581|FG001|Overall Study|Physician Decision|10|||
146845885|NCT00095498|529606582|FG002|Overall Study|Physician Decision|8|||
146845886|NCT00095498|529606580|FG000|Overall Study|Adverse Event|1|||
146845887|NCT00095498|529606581|FG001|Overall Study|Adverse Event|0|||
146845888|NCT00095498|529606582|FG002|Overall Study|Adverse Event|1|||
146845889|NCT00095498|529606580|FG000|Overall Study|Withdrawal by Subject|15|||
146845890|NCT00095498|529606581|FG001|Overall Study|Withdrawal by Subject|16|||
146845891|NCT00095498|529606582|FG002|Overall Study|Withdrawal by Subject|15|||
146845892|NCT00095498|529606580|FG000|Overall Study|Disease progression|0|||
146845893|NCT00095498|529606581|FG001|Overall Study|Disease progression|1|||
146845894|NCT00095498|529606582|FG002|Overall Study|Disease progression|1|||
146845895|NCT00095498|529606580|FG000|Overall Study|Ineligibility determined|3|||
146845896|NCT00095498|529606581|FG001|Overall Study|Ineligibility determined|0|||
146845897|NCT00095498|529606582|FG002|Overall Study|Ineligibility determined|2|||
146845898|NCT00095498|529606580|FG000|Overall Study|Lost to Follow-up|1|||
146845899|NCT00095498|529606581|FG001|Overall Study|Lost to Follow-up|1|||
146845900|NCT00095498|529606582|FG002|Overall Study|Lost to Follow-up|2|||
146845901|NCT00095498|529606580|FG000|Overall Study|Noncompliance|1|||
146845902|NCT00095498|529606581|FG001|Overall Study|Noncompliance|0|||
146845903|NCT00095498|529606582|FG002|Overall Study|Noncompliance|1|||
146845904|NCT00095498|529606580|FG000|Overall Study|Other|6|||
146845905|NCT00095498|529606581|FG001|Overall Study|Other|7|||
146845906|NCT00095498|529606582|FG002|Overall Study|Other|6|||
146845907|NCT00095498|529606580|FG000|Overall Study|Protocol Violation|0|||
146845908|NCT00095498|529606581|FG001|Overall Study|Protocol Violation|0|||
146845909|NCT00095498|529606582|FG002|Overall Study|Protocol Violation|1|||
146845910|NCT00095498|529606580|FG000|Overall Study|Requirement for alternative therapy|1|||
146845911|NCT00095498|529606581|FG001|Overall Study|Requirement for alternative therapy|0|||
146845912|NCT00095498|529606582|FG002|Overall Study|Requirement for alternative therapy|2|||
146845913|NCT00640133|529606584|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
146845914|NCT00640133|529606585|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
146845915|NCT00640133|529606584|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
147005999|NCT00906399|530184629|FG000|Year 1|Randomized But Not Treated|0|||
146845916|NCT00640133|529606585|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
146845917|NCT00640133|529606584|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
146845918|NCT00640133|529606585|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
146845919|NCT00128102|529606586|FG000|Overall Study|Site Discontinued|3|||
146845920|NCT00128102|529606587|FG001|Overall Study|Site Discontinued|6|||
146845921|NCT00128102|529606586|FG000|Overall Study|Other|0|||
146845922|NCT00128102|529606587|FG001|Overall Study|Other|1|||
146845923|NCT00128102|529606586|FG000|Overall Study|Progressive Disease|255|||
146845924|NCT00128102|529606587|FG001|Overall Study|Progressive Disease|285|||
146845925|NCT00128102|529606586|FG000|Overall Study|Adverse Event|34|||
146845926|NCT00128102|529606587|FG001|Overall Study|Adverse Event|11|||
146845927|NCT00128102|529606586|FG000|Overall Study|Death|12|||
146845928|NCT00128102|529606587|FG001|Overall Study|Death|13|||
146845929|NCT00128102|529606586|FG000|Overall Study|Physician Decision|3|||
146845930|NCT00128102|529606587|FG001|Overall Study|Physician Decision|3|||
146845931|NCT00128102|529606586|FG000|Overall Study|Withdrawal by Subject|19|||
146845932|NCT00128102|529606587|FG001|Overall Study|Withdrawal by Subject|11|||
146845933|NCT00128102|529606586|FG000|Overall Study|Protocol Violation|2|||
146845934|NCT00128102|529606587|FG001|Overall Study|Protocol Violation|2|||
146845935|NCT00306670|529606592|FG000|Overall Study|patients recruited; Genentech, the st|0|||
146845936|NCT00306670|529606593|FG001|Overall Study|patients recruited; Genentech, the st|2|||
146845937|NCT00503139|529606594|FG000|Overall Study|Case Report Forms were not collected|4|||
146845938|NCT00503139|529606594|FG000|Overall Study|Protocol Violation|4|||
146845939|NCT00833833|529606598|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
146845940|NCT00833833|529606599|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
146845941|NCT00833833|529606600|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
146845942|NCT00833833|529606601|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
147006000|NCT00906399|530184630|FG001|Year 1|Randomized But Not Treated|1|||
147006001|NCT00906399|530184631|FG002|Year 1|Randomized But Not Treated|3|||
147006002|NCT00906399|530184632|FG003|Year 1|Randomized But Not Treated|0|||
147006003|NCT00906399|530184633|FG004|Year 1|Randomized But Not Treated|0|||
147006004|NCT00906399|530184634|FG005|Year 1|Randomized But Not Treated|0|||
147006005|NCT00906399|530184635|FG006|Year 1|Randomized But Not Treated|0|||
147006006|NCT00906399|530184629|FG000|Year 1|Adverse Event|4|||
146845943|NCT00833833|529606602|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
146845944|NCT00833833|529606603|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
146845945|NCT00833833|529606598|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
146845946|NCT00833833|529606599|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
146845947|NCT00833833|529606600|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
146845948|NCT00833833|529606601|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
146845949|NCT00833833|529606602|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
146845950|NCT00833833|529606603|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
146845951|NCT00833833|529606598|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
146845952|NCT00833833|529606599|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
146845953|NCT00833833|529606600|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
146845954|NCT00833833|529606601|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
146845955|NCT00833833|529606602|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
146845956|NCT00833833|529606603|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
146845957|NCT00833833|529606598|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
146845958|NCT00833833|529606599|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
146845959|NCT00833833|529606600|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
146845960|NCT00833833|529606601|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
146845961|NCT00833833|529606602|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
146845962|NCT00833833|529606603|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
146845963|NCT00833833|529606598|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
146845964|NCT00833833|529606599|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
146845965|NCT00833833|529606600|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
146845966|NCT00833833|529606601|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
146845967|NCT00833833|529606602|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
146845968|NCT00833833|529606603|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
146845969|NCT00833833|529606598|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
146845970|NCT00833833|529606599|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
146845971|NCT00833833|529606600|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
146845972|NCT00833833|529606601|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
146845973|NCT00833833|529606602|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
146845974|NCT00833833|529606603|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
146845975|NCT00833833|529606598|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
146845976|NCT00833833|529606599|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
146845977|NCT00833833|529606600|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
146845978|NCT00833833|529606601|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
146845979|NCT00833833|529606602|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
147006007|NCT00906399|530184630|FG001|Year 1|Adverse Event|22|||
146845980|NCT00833833|529606603|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
146845981|NCT00833833|529606598|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
146845982|NCT00833833|529606599|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
146845983|NCT00833833|529606600|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
147006008|NCT00906399|530184631|FG002|Year 1|Adverse Event|24|||
146845984|NCT00833833|529606601|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
146845985|NCT00833833|529606602|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
147006009|NCT00906399|530184632|FG003|Year 1|Adverse Event|0|||
147006010|NCT00906399|530184633|FG004|Year 1|Adverse Event|0|||
147006011|NCT00906399|530184634|FG005|Year 1|Adverse Event|0|||
146845986|NCT00833833|529606603|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
146845987|NCT00833833|529606598|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
146845988|NCT00833833|529606599|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
146845989|NCT00833833|529606600|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
146845990|NCT00833833|529606601|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
146845991|NCT00833833|529606602|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
146845992|NCT00833833|529606603|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
146845993|NCT00833833|529606598|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
146845994|NCT00833833|529606599|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
146845995|NCT00833833|529606600|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
146845996|NCT00833833|529606601|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
146845997|NCT00833833|529606602|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
146845998|NCT00833833|529606603|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
146845999|NCT00833833|529606598|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
146846000|NCT00833833|529606599|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
146846001|NCT00833833|529606600|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
146846002|NCT00833833|529606601|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
146846003|NCT00833833|529606602|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
146846004|NCT00833833|529606603|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
146846005|NCT00833833|529606598|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
146846006|NCT00833833|529606599|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
146846007|NCT00833833|529606600|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
146846008|NCT00833833|529606601|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
146846009|NCT00833833|529606602|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
146846010|NCT00833833|529606603|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
146846011|NCT00833833|529606598|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
146846012|NCT00833833|529606599|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
146846013|NCT00833833|529606600|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
146846014|NCT00833833|529606601|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
146846015|NCT00833833|529606602|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
146846016|NCT00833833|529606603|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
146846017|NCT02040259|529606604|FG000|Overall Study|Death|280|||
146846018|NCT02040259|529606604|FG000|Overall Study|Lost to Follow-up|76|||
146846019|NCT02040259|529606604|FG000|Overall Study|Assessment not completed|3|||
146846020|NCT02040259|529606604|FG000|Overall Study|Withdrawal by Subject|4|||
146846021|NCT04476251|529606605|FG000|Overall Study|Not treated|1|||
146846022|NCT00996476|529606620|FG000|Overall Study|Withdrawal by Subject|1|||
146846023|NCT00996476|529606621|FG001|Overall Study|Withdrawal by Subject|2|||
146846024|NCT00996476|529606622|FG002|Overall Study|Withdrawal by Subject|1|||
146846025|NCT00996476|529606623|FG003|Overall Study|Withdrawal by Subject|0|||
146846026|NCT00996476|529606624|FG004|Overall Study|Withdrawal by Subject|1|||
146846027|NCT00996476|529606620|FG000|Overall Study|Adverse Event|0|||
146846028|NCT00996476|529606621|FG001|Overall Study|Adverse Event|1|||
146846029|NCT00996476|529606622|FG002|Overall Study|Adverse Event|0|||
146846030|NCT00996476|529606623|FG003|Overall Study|Adverse Event|0|||
146846031|NCT00996476|529606624|FG004|Overall Study|Adverse Event|1|||
146846032|NCT01470001|529606625|FG000|Overall Study|Lost to Follow-up|1|||
146846033|NCT01470001|529606626|FG001|Overall Study|Lost to Follow-up|1|||
146846034|NCT01470001|529606625|FG000|Overall Study|Physician Decision|2|||
146846035|NCT01470001|529606626|FG001|Overall Study|Physician Decision|0|||
147006012|NCT00906399|530184635|FG006|Year 1|Adverse Event|0|||
147006013|NCT00906399|530184629|FG000|Year 1|Lost to Follow-up|4|||
147006014|NCT00906399|530184630|FG001|Year 1|Lost to Follow-up|4|||
147006015|NCT00906399|530184631|FG002|Year 1|Lost to Follow-up|2|||
147006016|NCT00906399|530184632|FG003|Year 1|Lost to Follow-up|0|||
147006017|NCT00906399|530184633|FG004|Year 1|Lost to Follow-up|0|||
147006018|NCT00906399|530184634|FG005|Year 1|Lost to Follow-up|0|||
147006019|NCT00906399|530184635|FG006|Year 1|Lost to Follow-up|0|||
146846036|NCT01470001|529606625|FG000|Overall Study|Withdrawal by Subject|2|||
146846037|NCT01470001|529606626|FG001|Overall Study|Withdrawal by Subject|1|||
146846038|NCT01895101|529606627|FG000|Overall Study|OPCAB procedure|1|||
146846039|NCT01895101|529606628|FG001|Overall Study|OPCAB procedure|1|||
147006020|NCT00906399|530184629|FG000|Year 1|Withdrawal by Subject|30|||
147006021|NCT00906399|530184630|FG001|Year 1|Withdrawal by Subject|32|||
146846040|NCT01895101|529606629|FG002|Overall Study|OPCAB procedure|3|||
147006022|NCT00906399|530184631|FG002|Year 1|Withdrawal by Subject|36|||
147006023|NCT00906399|530184632|FG003|Year 1|Withdrawal by Subject|0|||
147006024|NCT00906399|530184633|FG004|Year 1|Withdrawal by Subject|0|||
146846041|NCT01895101|529606627|FG000|Overall Study|Withdrawal by Subject|0|||
146846042|NCT01895101|529606628|FG001|Overall Study|Withdrawal by Subject|1|||
146846043|NCT01895101|529606629|FG002|Overall Study|Withdrawal by Subject|2|||
146846044|NCT01895101|529606627|FG000|Overall Study|another study, enrolled in other study|0|||
146846045|NCT01895101|529606628|FG001|Overall Study|another study, enrolled in other study|1|||
146846046|NCT01895101|529606629|FG002|Overall Study|another study, enrolled in other study|0|||
147006025|NCT00906399|530184634|FG005|Year 1|Withdrawal by Subject|0|||
146846047|NCT01895101|529606627|FG000|Overall Study|Death|0|||
146846048|NCT01895101|529606628|FG001|Overall Study|Death|1|||
146846049|NCT01895101|529606629|FG002|Overall Study|Death|0|||
146846050|NCT01895101|529606627|FG000|Overall Study|coagulation disorder|0|||
146846051|NCT01895101|529606628|FG001|Overall Study|coagulation disorder|1|||
146846052|NCT01895101|529606629|FG002|Overall Study|coagulation disorder|0|||
146846053|NCT03896152|529606633|FG000|Overall Study|Patient/guardian decision|1|||
146846054|NCT03896152|529606634|FG001|Overall Study|Patient/guardian decision|1|||
146846055|NCT03896152|529606633|FG000|Overall Study|Adverse Event|0|||
146846056|NCT03896152|529606634|FG001|Overall Study|Adverse Event|1|||
146846057|NCT03896152|529606633|FG000|Overall Study|Physician Decision|1|||
146846058|NCT03896152|529606634|FG001|Overall Study|Physician Decision|0|||
146846059|NCT03896152|529606633|FG000|Overall Study|Technical problems|1|||
146846060|NCT03896152|529606634|FG001|Overall Study|Technical problems|0|||
146846061|NCT00436852|529606635|FG000|Overall Study|Death|23|||
146846062|NCT00436852|529606636|FG001|Overall Study|Death|34|||
146846063|NCT00436852|529606635|FG000|Overall Study|Lack of Efficacy|9|||
146846064|NCT00436852|529606636|FG001|Overall Study|Lack of Efficacy|7|||
146846065|NCT00436852|529606635|FG000|Overall Study|Withdrawal by Subject|2|||
146846066|NCT00436852|529606636|FG001|Overall Study|Withdrawal by Subject|4|||
146846067|NCT00436852|529606635|FG000|Overall Study|Ineligible|1|||
146846068|NCT00436852|529606636|FG001|Overall Study|Ineligible|0|||
146846069|NCT03339583|529606637|FG000|First Intervention (14 Days)|Adverse Event|1|||
146846070|NCT03339583|529606638|FG001|First Intervention (14 Days)|Adverse Event|0|||
146846071|NCT03339583|529606637|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
146846072|NCT03339583|529606638|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
146846073|NCT03339583|529606637|FG000|Second Intervention (14 Days)|Adverse Event|0|||
146846074|NCT03339583|529606638|FG001|Second Intervention (14 Days)|Adverse Event|1|||
146846075|NCT03339583|529606637|FG000|Follow-up (14 Days)|Physician Decision|6|||
146846076|NCT03339583|529606638|FG001|Follow-up (14 Days)|Physician Decision|3|||
146846077|NCT00734591|529606639|FG000|Screening for Prospective Period|Site did not participate|1604|||
146846078|NCT00734591|529606640|FG001|Screening for Prospective Period|Site did not participate|1488|||
146846079|NCT00734591|529606639|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
146846080|NCT00734591|529606640|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
146846081|NCT00734591|529606639|FG000|Prospective Period|Withdrawal by Subject|11|||
146846082|NCT00734591|529606640|FG001|Prospective Period|Withdrawal by Subject|9|||
146846083|NCT00734591|529606639|FG000|Prospective Period|Lost to Follow-up|37|||
146846084|NCT00734591|529606640|FG001|Prospective Period|Lost to Follow-up|33|||
146846085|NCT00734591|529606639|FG000|Prospective Period|Study Terminated|1|||
146846086|NCT00734591|529606640|FG001|Prospective Period|Study Terminated|0|||
146846087|NCT00734591|529606639|FG000|Prospective Period|Other|2|||
146846088|NCT00734591|529606640|FG001|Prospective Period|Other|2|||
146846089|NCT01656200|529606641|FG000|Overall Study|Withdrawal by Subject|1|||
146846090|NCT02236988|529606642|FG000|Overall Study|Lost to Follow-up|0|||
146846091|NCT02236988|529606643|FG001|Overall Study|Lost to Follow-up|0|||
146846092|NCT02236988|529606644|FG002|Overall Study|Lost to Follow-up|0|||
146846093|NCT02236988|529606645|FG003|Overall Study|Lost to Follow-up|1|||
146846094|NCT02236988|529606642|FG000|Overall Study|Unable to Comply with Study Visits|0|||
146846095|NCT02236988|529606643|FG001|Overall Study|Unable to Comply with Study Visits|0|||
146846096|NCT02236988|529606644|FG002|Overall Study|Unable to Comply with Study Visits|0|||
146846097|NCT02236988|529606645|FG003|Overall Study|Unable to Comply with Study Visits|2|||
146846098|NCT00730275|529606646|FG000|Overall Study|Withdrawal by Subject|0|||
147006026|NCT00906399|530184635|FG006|Year 1|Withdrawal by Subject|0|||
147006027|NCT00906399|530184629|FG000|Year 1|Physician Decision|0|||
147006028|NCT00906399|530184630|FG001|Year 1|Physician Decision|1|||
147006029|NCT00906399|530184631|FG002|Year 1|Physician Decision|3|||
147006030|NCT00906399|530184632|FG003|Year 1|Physician Decision|0|||
147006031|NCT00906399|530184633|FG004|Year 1|Physician Decision|0|||
147006032|NCT00906399|530184634|FG005|Year 1|Physician Decision|0|||
147006033|NCT00906399|530184635|FG006|Year 1|Physician Decision|0|||
147006034|NCT00906399|530184629|FG000|Year 1|Death|2|||
147006035|NCT00906399|530184630|FG001|Year 1|Death|1|||
146846099|NCT00730275|529606647|FG001|Overall Study|Withdrawal by Subject|0|||
147006036|NCT00906399|530184631|FG002|Year 1|Death|1|||
147006037|NCT00906399|530184632|FG003|Year 1|Death|0|||
147006038|NCT00906399|530184633|FG004|Year 1|Death|0|||
147006039|NCT00906399|530184634|FG005|Year 1|Death|0|||
147006040|NCT00906399|530184635|FG006|Year 1|Death|0|||
146846100|NCT00730275|529606648|FG002|Overall Study|Withdrawal by Subject|0|||
147006041|NCT00906399|530184629|FG000|Year 1|Other|4|||
146846101|NCT00730275|529606649|FG003|Overall Study|Withdrawal by Subject|1|||
146846102|NCT03921723|529606655|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
146846103|NCT03921723|529606655|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
146846104|NCT01461811|529606656|FG000|Overall Study|Adverse Event|2|||
147006042|NCT00906399|530184630|FG001|Year 1|Other|2|||
147006043|NCT00906399|530184631|FG002|Year 1|Other|7|||
147006044|NCT00906399|530184632|FG003|Year 1|Other|0|||
147006045|NCT00906399|530184633|FG004|Year 1|Other|0|||
147006046|NCT00906399|530184634|FG005|Year 1|Other|0|||
147006047|NCT00906399|530184635|FG006|Year 1|Other|0|||
146846105|NCT01461811|529606657|FG001|Overall Study|Adverse Event|1|||
146846106|NCT01461811|529606656|FG000|Overall Study|Subject decision unrelated to an AE|1|||
146846107|NCT01461811|529606657|FG001|Overall Study|Subject decision unrelated to an AE|1|||
146846108|NCT01461811|529606656|FG000|Overall Study|Noncompliance|1|||
146846109|NCT01461811|529606657|FG001|Overall Study|Noncompliance|1|||
146846110|NCT03015129|529606658|FG000|Overall Study|Death|2|||
146846111|NCT03015129|529606659|FG001|Overall Study|Death|2|||
147006048|NCT00906399|530184629|FG000|Year 2|Adverse Event|0|||
147006049|NCT00906399|530184630|FG001|Year 2|Adverse Event|0|||
147006050|NCT00906399|530184631|FG002|Year 2|Adverse Event|0|||
147006051|NCT00906399|530184632|FG003|Year 2|Adverse Event|9|||
147006052|NCT00906399|530184633|FG004|Year 2|Adverse Event|8|||
147006053|NCT00906399|530184634|FG005|Year 2|Adverse Event|11|||
147006054|NCT00906399|530184635|FG006|Year 2|Adverse Event|6|||
147006055|NCT00906399|530184629|FG000|Year 2|Lost to Follow-up|0|||
147006056|NCT00906399|530184630|FG001|Year 2|Lost to Follow-up|0|||
147006057|NCT00906399|530184631|FG002|Year 2|Lost to Follow-up|0|||
147006058|NCT00906399|530184632|FG003|Year 2|Lost to Follow-up|1|||
147006059|NCT00906399|530184633|FG004|Year 2|Lost to Follow-up|4|||
147006060|NCT00906399|530184634|FG005|Year 2|Lost to Follow-up|2|||
147006061|NCT00906399|530184635|FG006|Year 2|Lost to Follow-up|4|||
147006062|NCT00906399|530184629|FG000|Year 2|Withdrawal by Subject|0|||
147006063|NCT00906399|530184630|FG001|Year 2|Withdrawal by Subject|0|||
147006064|NCT00906399|530184631|FG002|Year 2|Withdrawal by Subject|0|||
147006065|NCT00906399|530184632|FG003|Year 2|Withdrawal by Subject|17|||
147006066|NCT00906399|530184633|FG004|Year 2|Withdrawal by Subject|18|||
147006067|NCT00906399|530184634|FG005|Year 2|Withdrawal by Subject|27|||
146846112|NCT03015129|529606658|FG000|Overall Study|Lost to Follow-up|0|||
146846113|NCT03015129|529606659|FG001|Overall Study|Lost to Follow-up|1|||
146846114|NCT03015129|529606658|FG000|Overall Study|Progression of disease|38|||
146846115|NCT03015129|529606659|FG001|Overall Study|Progression of disease|33|||
146846116|NCT03015129|529606658|FG000|Overall Study|Adverse Event|0|||
146846117|NCT03015129|529606659|FG001|Overall Study|Adverse Event|4|||
146846118|NCT00338962|529606661|FG000|Overall Study|Lost to Follow-up|3|||
146846119|NCT00338962|529606662|FG001|Overall Study|Lost to Follow-up|3|||
146846120|NCT00338962|529606663|FG002|Overall Study|Lost to Follow-up|2|||
146846121|NCT00338962|529606664|FG003|Overall Study|Lost to Follow-up|3|||
146846122|NCT00338962|529606661|FG000|Overall Study|Withdrawal by Subject|1|||
146846123|NCT00338962|529606662|FG001|Overall Study|Withdrawal by Subject|0|||
146846124|NCT00338962|529606663|FG002|Overall Study|Withdrawal by Subject|0|||
146846125|NCT00338962|529606664|FG003|Overall Study|Withdrawal by Subject|0|||
146846126|NCT00338962|529606661|FG000|Overall Study|No Transportation|2|||
146846127|NCT00338962|529606662|FG001|Overall Study|No Transportation|0|||
146846128|NCT00338962|529606663|FG002|Overall Study|No Transportation|0|||
146846129|NCT00338962|529606664|FG003|Overall Study|No Transportation|0|||
146846130|NCT00338962|529606661|FG000|Overall Study|Time Constraint|2|||
146846131|NCT00338962|529606662|FG001|Overall Study|Time Constraint|0|||
146846132|NCT00338962|529606663|FG002|Overall Study|Time Constraint|0|||
146846133|NCT00338962|529606664|FG003|Overall Study|Time Constraint|0|||
146846134|NCT00338962|529606661|FG000|Overall Study|Moved|0|||
146846135|NCT00338962|529606662|FG001|Overall Study|Moved|1|||
146846136|NCT00338962|529606663|FG002|Overall Study|Moved|0|||
146846137|NCT00338962|529606664|FG003|Overall Study|Moved|0|||
146846138|NCT00338962|529606661|FG000|Overall Study|Adverse Event|0|||
146846139|NCT00338962|529606662|FG001|Overall Study|Adverse Event|0|||
146846140|NCT00338962|529606663|FG002|Overall Study|Adverse Event|2|||
146846141|NCT00338962|529606664|FG003|Overall Study|Adverse Event|0|||
146846142|NCT00338962|529606661|FG000|Overall Study|Poor Compliance|0|||
146846143|NCT00338962|529606662|FG001|Overall Study|Poor Compliance|0|||
146846144|NCT00338962|529606663|FG002|Overall Study|Poor Compliance|2|||
146962150|NCT00463385|530021510|FG003|Overall Study|Withdrawal by Subject|4|||
146962151|NCT00463385|530021507|FG000|Overall Study|Lost to Follow-up|0|||
146846145|NCT00338962|529606664|FG003|Overall Study|Poor Compliance|0|||
146846146|NCT03733314|529606665|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
146962152|NCT00463385|530021508|FG001|Overall Study|Lost to Follow-up|0|||
146962153|NCT00463385|530021509|FG002|Overall Study|Lost to Follow-up|0|||
146962154|NCT00463385|530021510|FG003|Overall Study|Lost to Follow-up|1|||
146962155|NCT00463385|530021507|FG000|Overall Study|Death|2|||
146962156|NCT00463385|530021508|FG001|Overall Study|Death|1|||
146846147|NCT03733314|529606666|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
146846148|NCT03733314|529606665|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
146846149|NCT03733314|529606666|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
146846150|NCT03733314|529606665|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
146846151|NCT03733314|529606666|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
146846152|NCT03733314|529606665|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
146962157|NCT00463385|530021509|FG002|Overall Study|Death|2|||
147006068|NCT00906399|530184635|FG006|Year 2|Withdrawal by Subject|13|||
147006069|NCT00906399|530184629|FG000|Year 2|Physician Decision|0|||
147006070|NCT00906399|530184630|FG001|Year 2|Physician Decision|0|||
147006071|NCT00906399|530184631|FG002|Year 2|Physician Decision|0|||
147006072|NCT00906399|530184632|FG003|Year 2|Physician Decision|0|||
146846153|NCT03733314|529606666|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
146846154|NCT03733314|529606665|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
146846155|NCT03733314|529606666|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
146846156|NCT03733314|529606665|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
146846157|NCT03733314|529606666|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
146846158|NCT03046121|529606667|FG000|Overall Study|Death|32|||
146846159|NCT03046121|529606668|FG001|Overall Study|Death|60|||
146846160|NCT03046121|529606667|FG000|Overall Study|Withdrawal by Subject|14|||
146846161|NCT03046121|529606668|FG001|Overall Study|Withdrawal by Subject|12|||
146846162|NCT03214640|529606669|FG000|Overall Study|Protocol Violation|1|||
146846163|NCT03214640|529606670|FG001|Overall Study|Protocol Violation|2|||
146846164|NCT03214640|529606671|FG002|Overall Study|Protocol Violation|1|||
146846165|NCT03214640|529606672|FG003|Overall Study|Protocol Violation|4|||
146846166|NCT04155047|529606673|FG000|Overall Study|Adverse Event|1|||
146846167|NCT04155047|529606674|FG001|Overall Study|Adverse Event|0|||
146846168|NCT04155047|529606673|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
146846169|NCT04155047|529606674|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
146846170|NCT04514510|529606675|FG000|Overall Study|Lost to Follow-up|0|||
146846171|NCT04514510|529606676|FG001|Overall Study|Lost to Follow-up|1|||
146846172|NCT04514510|529606675|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
146846173|NCT04514510|529606676|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
146846174|NCT00821587|529606677|FG000|Overall Study|Physician Decision|0|||
146846175|NCT00821587|529606678|FG001|Overall Study|Physician Decision|1|||
146846176|NCT03466073|529606679|FG000|Overall Study|Death|1|||
146846177|NCT03466073|529606680|FG001|Overall Study|Death|0|||
146846178|NCT03466073|529606681|FG002|Overall Study|Death|0|||
146846179|NCT03466073|529606682|FG003|Overall Study|Death|0|||
146846180|NCT03466073|529606683|FG004|Overall Study|Death|0|||
146846181|NCT03466073|529606684|FG005|Overall Study|Death|1|||
146846182|NCT02045875|529606685|FG000|Overall Study|Lost to Follow-up|3|||
146846183|NCT02045875|529606686|FG001|Overall Study|Lost to Follow-up|0|||
146846184|NCT02045875|529606685|FG000|Overall Study|Withdrawal by Subject|4|||
146846185|NCT02045875|529606686|FG001|Overall Study|Withdrawal by Subject|3|||
146846186|NCT01276379|529606687|FG000|Overall Study|Screening failure|40|||
146846187|NCT00864253|529606688|FG000|Overall Study|Adverse Event|56|||
146846188|NCT00864253|529606689|FG001|Overall Study|Adverse Event|11|||
146846189|NCT00864253|529606688|FG000|Overall Study|Unrelated Adverse Event|3|||
146846190|NCT00864253|529606689|FG001|Overall Study|Unrelated Adverse Event|1|||
146846191|NCT00864253|529606688|FG000|Overall Study|Physician Decision|11|||
146846192|NCT00864253|529606689|FG001|Overall Study|Physician Decision|15|||
146846193|NCT00864253|529606688|FG000|Overall Study|Protocol Violation|0|||
146846194|NCT00864253|529606689|FG001|Overall Study|Protocol Violation|2|||
146846195|NCT00864253|529606688|FG000|Overall Study|Lost to Follow-up|1|||
146846196|NCT00864253|529606689|FG001|Overall Study|Lost to Follow-up|1|||
146846197|NCT00864253|529606688|FG000|Overall Study|Withdrawal by Subject|18|||
146846198|NCT00864253|529606689|FG001|Overall Study|Withdrawal by Subject|18|||
146846199|NCT00864253|529606688|FG000|Overall Study|Death|1|||
146846200|NCT00864253|529606689|FG001|Overall Study|Death|0|||
146846201|NCT00864253|529606688|FG000|Overall Study|Ongoing|2|||
146846202|NCT00864253|529606689|FG001|Overall Study|Ongoing|3|||
146846203|NCT00864253|529606688|FG000|Overall Study|Untreated|7|||
146846204|NCT00864253|529606689|FG001|Overall Study|Untreated|7|||
146846205|NCT01111240|529606690|FG000|Overall Study|Adverse Event|190|||
146846206|NCT01111240|529606690|FG000|Overall Study|Lack of Efficacy|545|||
146846207|NCT01111240|529606690|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
146846208|NCT01111240|529606690|FG000|Overall Study|Other|312|||
146846209|NCT01743989|529606691|FG000|Treatment Phase|Unstable MR4.0|0|||
146846210|NCT01743989|529606692|FG001|Treatment Phase|Unstable MR4.0|6|||
146846211|NCT01743989|529606693|FG002|Treatment Phase|Unstable MR4.0|263|||
146846212|NCT01743989|529606691|FG000|Treatment Phase|Adverse Event|0|||
146846213|NCT01743989|529606692|FG001|Treatment Phase|Adverse Event|4|||
146846214|NCT01743989|529606693|FG002|Treatment Phase|Adverse Event|67|||
146846215|NCT01743989|529606691|FG000|Treatment Phase|Withdrawal by Subject|1|||
146846216|NCT01743989|529606692|FG001|Treatment Phase|Withdrawal by Subject|3|||
146846217|NCT01743989|529606693|FG002|Treatment Phase|Withdrawal by Subject|28|||
146846218|NCT01743989|529606691|FG000|Treatment Phase|Death|0|||
146846219|NCT01743989|529606692|FG001|Treatment Phase|Death|1|||
146846220|NCT01743989|529606693|FG002|Treatment Phase|Death|3|||
146846221|NCT01743989|529606691|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
146846222|NCT01743989|529606692|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
146846223|NCT01743989|529606693|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
146846224|NCT01743989|529606691|FG000|Treatment Phase|Protocol deviation|0|||
146846225|NCT01743989|529606692|FG001|Treatment Phase|Protocol deviation|0|||
146846226|NCT01743989|529606693|FG002|Treatment Phase|Protocol deviation|3|||
146846227|NCT01743989|529606691|FG000|Treatment Phase|Pregnancy|0|||
146846228|NCT01743989|529606692|FG001|Treatment Phase|Pregnancy|0|||
146846229|NCT01743989|529606693|FG002|Treatment Phase|Pregnancy|2|||
146846230|NCT01743989|529606691|FG000|Treatment Phase|Lost to Follow-up|0|||
146846231|NCT01743989|529606692|FG001|Treatment Phase|Lost to Follow-up|0|||
146846232|NCT01743989|529606693|FG002|Treatment Phase|Lost to Follow-up|2|||
146846233|NCT01743989|529606691|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
146846234|NCT01743989|529606692|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
146846235|NCT01743989|529606693|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
146846236|NCT01743989|529606691|FG000|Treatment Phase|Administrative problems|0|||
146846237|NCT01743989|529606692|FG001|Treatment Phase|Administrative problems|0|||
146846238|NCT01743989|529606693|FG002|Treatment Phase|Administrative problems|1|||
146846239|NCT01743989|529606691|FG000|Treatment Phase|New cancer (CML) therapy|0|||
146846240|NCT01743989|529606692|FG001|Treatment Phase|New cancer (CML) therapy|1|||
146846241|NCT01743989|529606693|FG002|Treatment Phase|New cancer (CML) therapy|0|||
146846242|NCT01743989|529606691|FG000|Treatment Phase|Physician Decision|0|||
146846243|NCT01743989|529606692|FG001|Treatment Phase|Physician Decision|0|||
146846244|NCT01743989|529606693|FG002|Treatment Phase|Physician Decision|3|||
146846245|NCT01743989|529606691|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
146846246|NCT01743989|529606692|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
146846247|NCT01743989|529606693|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
146846248|NCT01743989|529606691|FG000|Treatment Phase|Not randomized by mistake|0|||
146846249|NCT01743989|529606692|FG001|Treatment Phase|Not randomized by mistake|0|||
146846250|NCT01743989|529606693|FG002|Treatment Phase|Not randomized by mistake|1|||
146846251|NCT01743989|529606691|FG000|Treatment Phase|Included by mistake|0|||
146846252|NCT01743989|529606692|FG001|Treatment Phase|Included by mistake|0|||
146846253|NCT01743989|529606693|FG002|Treatment Phase|Included by mistake|1|||
146846254|NCT01743989|529606691|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
146846255|NCT01743989|529606692|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
146846256|NCT01743989|529606693|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
146846257|NCT01743989|529606691|FG000|TFR Phase|Adverse Event|0|||
146846258|NCT01743989|529606692|FG001|TFR Phase|Adverse Event|1|||
146962158|NCT00463385|530021510|FG003|Overall Study|Death|0|||
146962159|NCT00463385|530021507|FG000|Overall Study|Missing|2|||
146962160|NCT00463385|530021508|FG001|Overall Study|Missing|0|||
146962161|NCT00463385|530021509|FG002|Overall Study|Missing|0|||
146962162|NCT00463385|530021510|FG003|Overall Study|Missing|2|||
146962163|NCT00463385|530021507|FG000|Overall Study|1 participant received commercial drug|0|||
146962164|NCT00463385|530021508|FG001|Overall Study|1 participant received commercial drug|1|||
146962165|NCT00463385|530021509|FG002|Overall Study|1 participant received commercial drug|0|||
146962166|NCT00463385|530021510|FG003|Overall Study|1 participant received commercial drug|0|||
146962167|NCT00798161|530021511|FG000|Overall Study|Adverse Event|3|||
146962168|NCT00798161|530021512|FG001|Overall Study|Adverse Event|4|||
146962169|NCT00798161|530021513|FG002|Overall Study|Adverse Event|6|||
146962170|NCT00798161|530021514|FG003|Overall Study|Adverse Event|6|||
146962171|NCT00798161|530021515|FG004|Overall Study|Adverse Event|5|||
146962172|NCT00798161|530021516|FG005|Overall Study|Adverse Event|2|||
146962173|NCT00798161|530021517|FG006|Overall Study|Adverse Event|4|||
146962174|NCT00798161|530021511|FG000|Overall Study|Protocol Violation|2|||
146962175|NCT00798161|530021512|FG001|Overall Study|Protocol Violation|1|||
146962176|NCT00798161|530021513|FG002|Overall Study|Protocol Violation|3|||
146962177|NCT00798161|530021514|FG003|Overall Study|Protocol Violation|3|||
146962178|NCT00798161|530021515|FG004|Overall Study|Protocol Violation|3|||
146962179|NCT00798161|530021516|FG005|Overall Study|Protocol Violation|2|||
146962180|NCT00798161|530021517|FG006|Overall Study|Protocol Violation|0|||
146962181|NCT00798161|530021511|FG000|Overall Study|Lost to Follow-up|1|||
146962182|NCT00798161|530021512|FG001|Overall Study|Lost to Follow-up|3|||
146962183|NCT00798161|530021513|FG002|Overall Study|Lost to Follow-up|4|||
146962184|NCT00798161|530021514|FG003|Overall Study|Lost to Follow-up|3|||
146962185|NCT00798161|530021515|FG004|Overall Study|Lost to Follow-up|4|||
146962186|NCT00798161|530021516|FG005|Overall Study|Lost to Follow-up|0|||
146962187|NCT00798161|530021517|FG006|Overall Study|Lost to Follow-up|0|||
146962188|NCT00798161|530021511|FG000|Overall Study|Withdrawal by Subject|5|||
146962189|NCT00798161|530021512|FG001|Overall Study|Withdrawal by Subject|4|||
146962190|NCT00798161|530021513|FG002|Overall Study|Withdrawal by Subject|5|||
146962191|NCT00798161|530021514|FG003|Overall Study|Withdrawal by Subject|4|||
146962192|NCT00798161|530021515|FG004|Overall Study|Withdrawal by Subject|2|||
146962193|NCT00798161|530021516|FG005|Overall Study|Withdrawal by Subject|3|||
146962194|NCT00798161|530021517|FG006|Overall Study|Withdrawal by Subject|1|||
146962195|NCT00798161|530021511|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
146846259|NCT01743989|529606693|FG002|TFR Phase|Adverse Event|0|||
146846260|NCT01743989|529606691|FG000|TFR Phase|Lost to Follow-up|0|||
146846261|NCT01743989|529606692|FG001|TFR Phase|Lost to Follow-up|2|||
146846262|NCT01743989|529606693|FG002|TFR Phase|Lost to Follow-up|0|||
146846263|NCT01743989|529606691|FG000|TFR Phase|Physician Decision|0|||
146962196|NCT00798161|530021512|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
146962197|NCT00798161|530021513|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
146962198|NCT00798161|530021514|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
146962199|NCT00798161|530021515|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
146962200|NCT00798161|530021516|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
146846264|NCT01743989|529606692|FG001|TFR Phase|Physician Decision|1|||
146846265|NCT01743989|529606693|FG002|TFR Phase|Physician Decision|0|||
146846266|NCT01743989|529606691|FG000|TFR Phase|Logistical problems|0|||
146846267|NCT01743989|529606692|FG001|TFR Phase|Logistical problems|2|||
146846268|NCT01743989|529606693|FG002|TFR Phase|Logistical problems|0|||
146846269|NCT01743989|529606691|FG000|TFR Phase|Protocol deviation|0|||
146846270|NCT01743989|529606692|FG001|TFR Phase|Protocol deviation|1|||
146846271|NCT01743989|529606693|FG002|TFR Phase|Protocol deviation|0|||
146846272|NCT01743989|529606691|FG000|TFR Phase|Withdrawal by Subject|0|||
146846273|NCT01743989|529606692|FG001|TFR Phase|Withdrawal by Subject|2|||
146846274|NCT01743989|529606693|FG002|TFR Phase|Withdrawal by Subject|0|||
146846275|NCT01743989|529606691|FG000|Re-treatment Phase|Adverse Event|8|||
146846276|NCT01743989|529606692|FG001|Re-treatment Phase|Adverse Event|4|||
146846277|NCT01743989|529606693|FG002|Re-treatment Phase|Adverse Event|0|||
146846278|NCT01743989|529606691|FG000|Re-treatment Phase|Death|1|||
146846279|NCT01743989|529606692|FG001|Re-treatment Phase|Death|1|||
146846280|NCT01743989|529606693|FG002|Re-treatment Phase|Death|0|||
146846281|NCT01743989|529606691|FG000|Re-treatment Phase|Administrative problems|1|||
146846282|NCT01743989|529606692|FG001|Re-treatment Phase|Administrative problems|1|||
146846283|NCT01743989|529606693|FG002|Re-treatment Phase|Administrative problems|0|||
146846284|NCT01743989|529606691|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
146846285|NCT01743989|529606692|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
146846286|NCT01743989|529606693|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
146846287|NCT01743989|529606691|FG000|Re-treatment Phase|Unstable MR|1|||
146846288|NCT01743989|529606692|FG001|Re-treatment Phase|Unstable MR|0|||
146846289|NCT01743989|529606693|FG002|Re-treatment Phase|Unstable MR|0|||
146846290|NCT01743989|529606691|FG000|Re-treatment Phase|Physician Decision|0|||
146846291|NCT01743989|529606692|FG001|Re-treatment Phase|Physician Decision|1|||
146846292|NCT01743989|529606693|FG002|Re-treatment Phase|Physician Decision|0|||
146846293|NCT01743989|529606691|FG000|Re-treatment Phase|Lost to Follow-up|0|||
146846294|NCT01743989|529606692|FG001|Re-treatment Phase|Lost to Follow-up|1|||
146846295|NCT01743989|529606693|FG002|Re-treatment Phase|Lost to Follow-up|0|||
146846296|NCT02108964|529606696|FG000|Overall Study|Progressive disease|15|||
146846297|NCT02108964|529606697|FG001|Overall Study|Progressive disease|31|||
146846298|NCT02108964|529606698|FG002|Overall Study|Progressive disease|54|||
146846299|NCT02108964|529606699|FG003|Overall Study|Progressive disease|7|||
146846300|NCT02108964|529606700|FG004|Overall Study|Progressive disease|20|||
146846301|NCT02108964|529606701|FG005|Overall Study|Progressive disease|4|||
146846302|NCT02108964|529606702|FG006|Overall Study|Progressive disease|6|||
146846303|NCT02108964|529606703|FG007|Overall Study|Progressive disease|33|||
146846304|NCT02108964|529606696|FG000|Overall Study|Physician Decision|1|||
146846305|NCT02108964|529606697|FG001|Overall Study|Physician Decision|5|||
146846306|NCT02108964|529606698|FG002|Overall Study|Physician Decision|7|||
146846307|NCT02108964|529606699|FG003|Overall Study|Physician Decision|1|||
146846308|NCT02108964|529606700|FG004|Overall Study|Physician Decision|2|||
146846309|NCT02108964|529606701|FG005|Overall Study|Physician Decision|1|||
146846310|NCT02108964|529606702|FG006|Overall Study|Physician Decision|1|||
146846311|NCT02108964|529606703|FG007|Overall Study|Physician Decision|3|||
146846312|NCT02108964|529606696|FG000|Overall Study|Adverse Event|0|||
146846313|NCT02108964|529606697|FG001|Overall Study|Adverse Event|0|||
146846314|NCT02108964|529606698|FG002|Overall Study|Adverse Event|4|||
146846315|NCT02108964|529606699|FG003|Overall Study|Adverse Event|0|||
146846316|NCT02108964|529606700|FG004|Overall Study|Adverse Event|1|||
146846317|NCT02108964|529606701|FG005|Overall Study|Adverse Event|0|||
146846318|NCT02108964|529606702|FG006|Overall Study|Adverse Event|3|||
146846319|NCT02108964|529606703|FG007|Overall Study|Adverse Event|2|||
146962201|NCT00798161|530021517|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
146962202|NCT04576702|530021530|FG000|Overall Study|Death|1|||
146962203|NCT04576702|530021531|FG001|Overall Study|Death|0|||
146962204|NCT04576702|530021532|FG002|Overall Study|Death|0|||
146846320|NCT02108964|529606696|FG000|Overall Study|Death|1|||
146846321|NCT02108964|529606697|FG001|Overall Study|Death|1|||
146846322|NCT02108964|529606698|FG002|Overall Study|Death|4|||
146846323|NCT02108964|529606699|FG003|Overall Study|Death|0|||
146846324|NCT02108964|529606700|FG004|Overall Study|Death|3|||
146846325|NCT02108964|529606701|FG005|Overall Study|Death|0|||
146846326|NCT02108964|529606702|FG006|Overall Study|Death|0|||
146846327|NCT02108964|529606703|FG007|Overall Study|Death|2|||
146846328|NCT02108964|529606696|FG000|Overall Study|Subject/Guardian decision|0|||
146846329|NCT02108964|529606697|FG001|Overall Study|Subject/Guardian decision|1|||
146846330|NCT02108964|529606698|FG002|Overall Study|Subject/Guardian decision|4|||
146846331|NCT02108964|529606699|FG003|Overall Study|Subject/Guardian decision|0|||
146846332|NCT02108964|529606700|FG004|Overall Study|Subject/Guardian decision|2|||
146846333|NCT02108964|529606701|FG005|Overall Study|Subject/Guardian decision|0|||
146846334|NCT02108964|529606702|FG006|Overall Study|Subject/Guardian decision|1|||
146962205|NCT04576702|530021533|FG003|Overall Study|Death|0|||
146962206|NCT04576702|530021530|FG000|Overall Study|Withdrawal by Subject|0|||
146962207|NCT04576702|530021531|FG001|Overall Study|Withdrawal by Subject|2|||
146962208|NCT04576702|530021532|FG002|Overall Study|Withdrawal by Subject|1|||
146962209|NCT04576702|530021533|FG003|Overall Study|Withdrawal by Subject|0|||
146846335|NCT02108964|529606703|FG007|Overall Study|Subject/Guardian decision|2|||
146846336|NCT02108964|529606696|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
146846337|NCT02108964|529606697|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
146846338|NCT02108964|529606698|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
146846339|NCT02108964|529606699|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
146846340|NCT02108964|529606700|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
146846341|NCT02108964|529606701|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
146846342|NCT02108964|529606702|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
146846343|NCT02108964|529606703|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
146846344|NCT01732822|529609087|FG000|Overall Study|Withdrawal by Subject|123|||
146846345|NCT01732822|529609088|FG001|Overall Study|Withdrawal by Subject|113|||
146846346|NCT00591370|529609089|FG000|Overall Study|Not Treated|2|||
146846347|NCT02735577|529609092|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
146846348|NCT02735577|529609092|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
146846349|NCT00316602|529609093|FG000|Overall Study|Withdrawal by Subject|3|||
146846350|NCT00316602|529609094|FG001|Overall Study|Withdrawal by Subject|2|||
146846351|NCT00316602|529609093|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
146846352|NCT00316602|529609094|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
146846353|NCT00316602|529609093|FG000|Overall Study|Adverse Event|1|||
146846354|NCT00316602|529609094|FG001|Overall Study|Adverse Event|0|||
146846355|NCT00316602|529609093|FG000|Overall Study|Other|3|||
146846356|NCT00316602|529609094|FG001|Overall Study|Other|6|||
146846357|NCT01142232|529609095|FG000|Overall Study|Adverse Event|1|||
146846358|NCT01142232|529609096|FG001|Overall Study|Adverse Event|2|||
146846359|NCT01142232|529609097|FG002|Overall Study|Adverse Event|1|||
146846360|NCT01142232|529609098|FG003|Overall Study|Adverse Event|0|||
146846361|NCT01142232|529609099|FG004|Overall Study|Adverse Event|4|||
146846362|NCT01142232|529609095|FG000|Overall Study|Death|0|||
146846363|NCT01142232|529609096|FG001|Overall Study|Death|0|||
146846364|NCT01142232|529609097|FG002|Overall Study|Death|0|||
146846365|NCT01142232|529609098|FG003|Overall Study|Death|0|||
147006073|NCT00906399|530184633|FG004|Year 2|Physician Decision|2|||
147006074|NCT00906399|530184634|FG005|Year 2|Physician Decision|6|||
147006075|NCT00906399|530184635|FG006|Year 2|Physician Decision|3|||
147006076|NCT00906399|530184629|FG000|Year 2|Death|0|||
147006077|NCT00906399|530184630|FG001|Year 2|Death|0|||
147006078|NCT00906399|530184631|FG002|Year 2|Death|0|||
147006079|NCT00906399|530184632|FG003|Year 2|Death|1|||
147006080|NCT00906399|530184633|FG004|Year 2|Death|0|||
147006081|NCT00906399|530184634|FG005|Year 2|Death|0|||
147006082|NCT00906399|530184635|FG006|Year 2|Death|3|||
146846366|NCT01142232|529609099|FG004|Overall Study|Death|1|||
146846367|NCT01142232|529609095|FG000|Overall Study|Disease Progression|2|||
146846368|NCT01142232|529609096|FG001|Overall Study|Disease Progression|0|||
146846369|NCT01142232|529609097|FG002|Overall Study|Disease Progression|1|||
146846370|NCT01142232|529609098|FG003|Overall Study|Disease Progression|2|||
146846371|NCT01142232|529609099|FG004|Overall Study|Disease Progression|12|||
146846372|NCT01142232|529609095|FG000|Overall Study|Withdrawal by Subject|0|||
146846373|NCT01142232|529609096|FG001|Overall Study|Withdrawal by Subject|0|||
146846374|NCT01142232|529609097|FG002|Overall Study|Withdrawal by Subject|0|||
146846375|NCT01142232|529609098|FG003|Overall Study|Withdrawal by Subject|1|||
146846376|NCT01142232|529609099|FG004|Overall Study|Withdrawal by Subject|3|||
146846377|NCT01142232|529609095|FG000|Overall Study|Physician Decision|0|||
146846378|NCT01142232|529609096|FG001|Overall Study|Physician Decision|1|||
146846379|NCT01142232|529609097|FG002|Overall Study|Physician Decision|0|||
146846380|NCT01142232|529609098|FG003|Overall Study|Physician Decision|2|||
146846381|NCT01142232|529609099|FG004|Overall Study|Physician Decision|10|||
146846382|NCT01142232|529609095|FG000|Overall Study|Alternative Therapy|0|||
146846383|NCT01142232|529609096|FG001|Overall Study|Alternative Therapy|1|||
146846384|NCT01142232|529609097|FG002|Overall Study|Alternative Therapy|1|||
146846385|NCT01142232|529609098|FG003|Overall Study|Alternative Therapy|0|||
146846386|NCT01142232|529609099|FG004|Overall Study|Alternative Therapy|1|||
147006083|NCT00906399|530184629|FG000|Year 2|Other|0|||
146846387|NCT01142232|529609095|FG000|Overall Study|Off Trt for other complicating disease|0|||
147006084|NCT00906399|530184630|FG001|Year 2|Other|0|||
147006085|NCT00906399|530184631|FG002|Year 2|Other|0|||
147006086|NCT00906399|530184632|FG003|Year 2|Other|2|||
146846388|NCT01142232|529609096|FG001|Overall Study|Off Trt for other complicating disease|0|||
146846389|NCT01142232|529609097|FG002|Overall Study|Off Trt for other complicating disease|0|||
147006087|NCT00906399|530184633|FG004|Year 2|Other|3|||
147006088|NCT00906399|530184634|FG005|Year 2|Other|1|||
146846390|NCT01142232|529609098|FG003|Overall Study|Off Trt for other complicating disease|0|||
147006089|NCT00906399|530184635|FG006|Year 2|Other|0|||
147006090|NCT00624286|530184636|FG000|Overall Study|Protocol Deviation|7|||
147006091|NCT00624286|530184637|FG001|Overall Study|Protocol Deviation|9|||
146846391|NCT01142232|529609099|FG004|Overall Study|Off Trt for other complicating disease|1|||
146846392|NCT01142232|529609095|FG000|Overall Study|Noncompliance|0|||
146846393|NCT01142232|529609096|FG001|Overall Study|Noncompliance|0|||
146846394|NCT01142232|529609097|FG002|Overall Study|Noncompliance|0|||
146846395|NCT01142232|529609098|FG003|Overall Study|Noncompliance|0|||
146846396|NCT01142232|529609099|FG004|Overall Study|Noncompliance|2|||
146846397|NCT00626990|529609100|FG000|Overall Study|Lack of Efficacy|6|||
146846398|NCT00626990|529609101|FG001|Overall Study|Lack of Efficacy|7|||
146846399|NCT00626990|529609102|FG002|Overall Study|Lack of Efficacy|49|||
146846400|NCT00626990|529609103|FG003|Overall Study|Lack of Efficacy|40|||
146846401|NCT00626990|529609100|FG000|Overall Study|Adverse Event|1|||
146846402|NCT00626990|529609101|FG001|Overall Study|Adverse Event|7|||
146846403|NCT00626990|529609102|FG002|Overall Study|Adverse Event|14|||
146846404|NCT00626990|529609103|FG003|Overall Study|Adverse Event|28|||
146846405|NCT00626990|529609100|FG000|Overall Study|Death|0|||
146846406|NCT00626990|529609101|FG001|Overall Study|Death|1|||
146846407|NCT00626990|529609102|FG002|Overall Study|Death|0|||
146846408|NCT00626990|529609103|FG003|Overall Study|Death|0|||
146846409|NCT00626990|529609100|FG000|Overall Study|Withdrawal by Subject|3|||
146846410|NCT00626990|529609101|FG001|Overall Study|Withdrawal by Subject|1|||
146846411|NCT00626990|529609102|FG002|Overall Study|Withdrawal by Subject|5|||
146846412|NCT00626990|529609103|FG003|Overall Study|Withdrawal by Subject|11|||
146846413|NCT00626990|529609100|FG000|Overall Study|Protocol Violation|0|||
146846414|NCT00626990|529609101|FG001|Overall Study|Protocol Violation|1|||
146846415|NCT00626990|529609102|FG002|Overall Study|Protocol Violation|1|||
146846416|NCT00626990|529609103|FG003|Overall Study|Protocol Violation|0|||
146846417|NCT00626990|529609100|FG000|Overall Study|Various different reasons/missing|4|||
146846418|NCT00626990|529609101|FG001|Overall Study|Various different reasons/missing|8|||
146846419|NCT00626990|529609102|FG002|Overall Study|Various different reasons/missing|8|||
146846420|NCT00626990|529609103|FG003|Overall Study|Various different reasons/missing|16|||
146846421|NCT04138576|529609104|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
146846422|NCT01994837|529609105|FG000|Overall Study|Progressive disease per protocol|23|||
146846423|NCT01994837|529609105|FG000|Overall Study|Adv event related to progressive disease|3|||
146846424|NCT01994837|529609105|FG000|Overall Study|Fatal progressive disease|2|||
146846425|NCT01994837|529609105|FG000|Overall Study|Adverse event not related to progression|1|||
146846426|NCT01994837|529609105|FG000|Overall Study|Chose palliative care|1|||
146846427|NCT01994837|529609105|FG000|Overall Study|Proceeded to transplant|1|||
146846428|NCT01994837|529609105|FG000|Overall Study|Removed from study due to no response|1|||
146846429|NCT00574873|529609107|FG000|Overall Study|Withdrawal by Subject|18|||
146846430|NCT00574873|529609108|FG001|Overall Study|Withdrawal by Subject|19|||
146846431|NCT00574873|529609107|FG000|Overall Study|Investigator request|18|||
146846432|NCT00574873|529609108|FG001|Overall Study|Investigator request|8|||
146846433|NCT00574873|529609107|FG000|Overall Study|Death|15|||
146846434|NCT00574873|529609108|FG001|Overall Study|Death|14|||
146846435|NCT00574873|529609107|FG000|Overall Study|Lost to Follow-up|14|||
146846436|NCT00574873|529609108|FG001|Overall Study|Lost to Follow-up|5|||
146846437|NCT00574873|529609107|FG000|Overall Study|Other|40|||
146846438|NCT00574873|529609108|FG001|Overall Study|Other|4|||
146846439|NCT00574873|529609107|FG000|Overall Study|Discontinuation of study by sponsor|5|||
146846440|NCT00574873|529609108|FG001|Overall Study|Discontinuation of study by sponsor|199|||
146846441|NCT00574873|529609107|FG000|Overall Study|Blank, site closed per local regulations|2|||
146846442|NCT00574873|529609108|FG001|Overall Study|Blank, site closed per local regulations|2|||
146846443|NCT00574873|529609107|FG000|Overall Study|Extension Study|126|||
146846444|NCT00574873|529609108|FG001|Overall Study|Extension Study|0|||
146846445|NCT00581555|529609109|FG000|Overall Study|Adverse Event|4|||
146846446|NCT00581555|529609110|FG001|Overall Study|Adverse Event|3|||
146846447|NCT00581555|529609109|FG000|Overall Study|Physician Decision|3|||
146846448|NCT00581555|529609110|FG001|Overall Study|Physician Decision|2|||
146846449|NCT00581555|529609109|FG000|Overall Study|Withdrawal by Subject|18|||
147006092|NCT00624286|530184636|FG000|Overall Study|Adverse Event|6|||
147006093|NCT00624286|530184637|FG001|Overall Study|Adverse Event|3|||
147006094|NCT00624286|530184636|FG000|Overall Study|Withdrawal by Subject|5|||
147006095|NCT00624286|530184637|FG001|Overall Study|Withdrawal by Subject|4|||
147006096|NCT00624286|530184636|FG000|Overall Study|Lost to Follow-up|3|||
146846450|NCT00581555|529609110|FG001|Overall Study|Withdrawal by Subject|9|||
146846451|NCT00581555|529609109|FG000|Overall Study|Lost to Follow-up|2|||
147006097|NCT00624286|530184637|FG001|Overall Study|Lost to Follow-up|2|||
146846452|NCT00581555|529609110|FG001|Overall Study|Lost to Follow-up|2|||
146846453|NCT00581555|529609109|FG000|Overall Study|Other reasons|16|||
146846454|NCT00581555|529609110|FG001|Overall Study|Other reasons|4|||
146846455|NCT00201643|529609111|FG000|Overall Study|Withdrawal by Subject|5|||
146846456|NCT00201643|529609112|FG001|Overall Study|Withdrawal by Subject|4|||
146846457|NCT03446781|529609116|FG000|Overall Study|Lost to Follow-up|11|||
146846458|NCT03446781|529609117|FG001|Overall Study|Lost to Follow-up|5|||
146846459|NCT03446781|529609116|FG000|Overall Study|Withdrawal by Subject|9|||
146846460|NCT03446781|529609117|FG001|Overall Study|Withdrawal by Subject|7|||
146846461|NCT03446781|529609116|FG000|Overall Study|Adverse Event|8|||
146846462|NCT03446781|529609117|FG001|Overall Study|Adverse Event|2|||
146846463|NCT03446781|529609116|FG000|Overall Study|Protocol Violation|0|||
146846464|NCT03446781|529609117|FG001|Overall Study|Protocol Violation|3|||
146846465|NCT03568318|529609118|FG000|Overall Study|Adverse Event|3|||
146846466|NCT03568318|529609119|FG001|Overall Study|Adverse Event|1|||
146846467|NCT03568318|529609120|FG002|Overall Study|Adverse Event|1|||
146846468|NCT03568318|529609121|FG003|Overall Study|Adverse Event|0|||
146846469|NCT03568318|529609122|FG004|Overall Study|Adverse Event|1|||
146846470|NCT03568318|529609123|FG005|Overall Study|Adverse Event|0|||
146846471|NCT03568318|529609118|FG000|Overall Study|Withdrawal by Subject|6|||
146846472|NCT03568318|529609119|FG001|Overall Study|Withdrawal by Subject|5|||
146846473|NCT03568318|529609120|FG002|Overall Study|Withdrawal by Subject|2|||
146846474|NCT03568318|529609121|FG003|Overall Study|Withdrawal by Subject|1|||
146846475|NCT03568318|529609122|FG004|Overall Study|Withdrawal by Subject|0|||
146846476|NCT03568318|529609123|FG005|Overall Study|Withdrawal by Subject|0|||
146846477|NCT03568318|529609118|FG000|Overall Study|Lost to Follow-up|3|||
146846478|NCT03568318|529609119|FG001|Overall Study|Lost to Follow-up|2|||
146846479|NCT03568318|529609120|FG002|Overall Study|Lost to Follow-up|2|||
146846480|NCT03568318|529609121|FG003|Overall Study|Lost to Follow-up|2|||
146846481|NCT03568318|529609122|FG004|Overall Study|Lost to Follow-up|1|||
146846482|NCT03568318|529609123|FG005|Overall Study|Lost to Follow-up|0|||
146846483|NCT03568318|529609118|FG000|Overall Study|Other|3|||
146846484|NCT03568318|529609119|FG001|Overall Study|Other|1|||
146846485|NCT03568318|529609120|FG002|Overall Study|Other|3|||
146846486|NCT03568318|529609121|FG003|Overall Study|Other|0|||
146846487|NCT03568318|529609122|FG004|Overall Study|Other|0|||
146846488|NCT03568318|529609123|FG005|Overall Study|Other|0|||
146846489|NCT03568318|529609118|FG000|Overall Study|Ongoing at Time of Analysis|5|||
146846490|NCT03568318|529609119|FG001|Overall Study|Ongoing at Time of Analysis|3|||
146846491|NCT03568318|529609120|FG002|Overall Study|Ongoing at Time of Analysis|2|||
146846492|NCT03568318|529609121|FG003|Overall Study|Ongoing at Time of Analysis|1|||
146846493|NCT03568318|529609122|FG004|Overall Study|Ongoing at Time of Analysis|0|||
146846494|NCT03568318|529609123|FG005|Overall Study|Ongoing at Time of Analysis|0|||
146846495|NCT02898077|529609124|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
146846496|NCT02898077|529609125|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
146846497|NCT02898077|529609124|FG000|Overall Study|Lost to Follow-up|4|||
146846498|NCT02898077|529609125|FG001|Overall Study|Lost to Follow-up|3|||
146846499|NCT02898077|529609124|FG000|Overall Study|Physician Decision|0|||
146846500|NCT02898077|529609125|FG001|Overall Study|Physician Decision|2|||
146846501|NCT02898077|529609124|FG000|Overall Study|Sponsor Decision|32|||
146846502|NCT02898077|529609125|FG001|Overall Study|Sponsor Decision|13|||
146846503|NCT02898077|529609124|FG000|Overall Study|Withdrawal by Subject|6|||
147006098|NCT00624286|530184636|FG000|Overall Study|Administrative problems|3|||
147006099|NCT00624286|530184637|FG001|Overall Study|Administrative problems|0|||
147006100|NCT00624286|530184636|FG000|Overall Study|Lack of Efficacy|1|||
147006101|NCT00624286|530184637|FG001|Overall Study|Lack of Efficacy|6|||
147006102|NCT00624286|530184636|FG000|Overall Study|Not stated|0|||
147006103|NCT00624286|530184637|FG001|Overall Study|Not stated|1|||
147006104|NCT00624286|530184636|FG000|Overall Study|Abnormal test procedure result(s)|0|||
147006105|NCT00624286|530184637|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147006106|NCT00624286|530184636|FG000|Overall Study|Death|0|||
147006107|NCT00624286|530184637|FG001|Overall Study|Death|1|||
147006108|NCT03488108|530184641|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
147006109|NCT03488108|530184642|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
147006110|NCT03488108|530184641|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
147006111|NCT03488108|530184642|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
147006112|NCT00674128|530184647|FG000|Overall Study|Withdrawal by Subject|25|||
146846504|NCT02898077|529609125|FG001|Overall Study|Withdrawal by Subject|3|||
146846505|NCT02898077|529609124|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
147006113|NCT00674128|530184648|FG001|Overall Study|Withdrawal by Subject|23|||
147006114|NCT04631562|530184657|FG000|Overall Study|Withdrawal by Subject|0|||
147006115|NCT04631562|530184658|FG001|Overall Study|Withdrawal by Subject|0|||
146846506|NCT02898077|529609125|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
146846507|NCT02898077|529609124|FG000|Overall Study|Ended extension period|3|||
146846508|NCT02898077|529609125|FG001|Overall Study|Ended extension period|0|||
146846509|NCT04410523|529609126|FG000|Overall Study|Study terminated by sponsor|1|||
146846510|NCT04410523|529609127|FG001|Overall Study|Study terminated by sponsor|3|||
146846511|NCT04410523|529609128|FG002|Overall Study|Study terminated by sponsor|2|||
146846512|NCT04410523|529609129|FG003|Overall Study|Study terminated by sponsor|6|||
147006116|NCT04631562|530184659|FG002|Overall Study|Withdrawal by Subject|0|||
146846513|NCT04410523|529609130|FG004|Overall Study|Study terminated by sponsor|3|||
146846514|NCT04410523|529609131|FG005|Overall Study|Study terminated by sponsor|4|||
146846515|NCT04410523|529609126|FG000|Overall Study|Adverse Event|1|||
146846516|NCT04410523|529609127|FG001|Overall Study|Adverse Event|0|||
147006117|NCT04631562|530184660|FG003|Overall Study|Withdrawal by Subject|0|||
147006118|NCT04631562|530184661|FG004|Overall Study|Withdrawal by Subject|0|||
146846517|NCT04410523|529609128|FG002|Overall Study|Adverse Event|0|||
147006119|NCT04631562|530184662|FG005|Overall Study|Withdrawal by Subject|0|||
147006120|NCT04631562|530184663|FG006|Overall Study|Withdrawal by Subject|0|||
147006121|NCT04631562|530184664|FG007|Overall Study|Withdrawal by Subject|1|||
147006122|NCT04631562|530184665|FG008|Overall Study|Withdrawal by Subject|0|||
147006123|NCT04631562|530184657|FG000|Overall Study|Other|0|||
147006124|NCT04631562|530184658|FG001|Overall Study|Other|0|||
147006125|NCT04631562|530184659|FG002|Overall Study|Other|0|||
147006126|NCT04631562|530184660|FG003|Overall Study|Other|0|||
147006127|NCT04631562|530184661|FG004|Overall Study|Other|0|||
147006128|NCT04631562|530184662|FG005|Overall Study|Other|0|||
147006129|NCT04631562|530184663|FG006|Overall Study|Other|0|||
147006130|NCT04631562|530184664|FG007|Overall Study|Other|0|||
147006131|NCT04631562|530184665|FG008|Overall Study|Other|1|||
147006132|NCT04631562|530184657|FG000|Overall Study|Lost to Follow-up|0|||
147006133|NCT04631562|530184658|FG001|Overall Study|Lost to Follow-up|0|||
147006134|NCT04631562|530184659|FG002|Overall Study|Lost to Follow-up|0|||
147006135|NCT04631562|530184660|FG003|Overall Study|Lost to Follow-up|1|||
147006136|NCT04631562|530184661|FG004|Overall Study|Lost to Follow-up|0|||
147006137|NCT04631562|530184662|FG005|Overall Study|Lost to Follow-up|0|||
147006138|NCT04631562|530184663|FG006|Overall Study|Lost to Follow-up|0|||
147006139|NCT04631562|530184664|FG007|Overall Study|Lost to Follow-up|0|||
147006140|NCT04631562|530184665|FG008|Overall Study|Lost to Follow-up|0|||
147006141|NCT04631562|530184657|FG000|Overall Study|Adverse Event|0|||
147006142|NCT04631562|530184658|FG001|Overall Study|Adverse Event|0|||
147006143|NCT04631562|530184659|FG002|Overall Study|Adverse Event|0|||
147006144|NCT04631562|530184660|FG003|Overall Study|Adverse Event|0|||
147006145|NCT04631562|530184661|FG004|Overall Study|Adverse Event|0|||
147006146|NCT04631562|530184662|FG005|Overall Study|Adverse Event|0|||
147006147|NCT04631562|530184663|FG006|Overall Study|Adverse Event|1|||
147006148|NCT04631562|530184664|FG007|Overall Study|Adverse Event|0|||
146846518|NCT04410523|529609129|FG003|Overall Study|Adverse Event|0|||
146846519|NCT04410523|529609130|FG004|Overall Study|Adverse Event|0|||
146846520|NCT04410523|529609131|FG005|Overall Study|Adverse Event|2|||
146846521|NCT04410523|529609126|FG000|Overall Study|Lost to Follow-up|0|||
146846522|NCT04410523|529609127|FG001|Overall Study|Lost to Follow-up|1|||
146846523|NCT04410523|529609128|FG002|Overall Study|Lost to Follow-up|0|||
146846524|NCT04410523|529609129|FG003|Overall Study|Lost to Follow-up|0|||
146846525|NCT04410523|529609130|FG004|Overall Study|Lost to Follow-up|0|||
146846526|NCT04410523|529609131|FG005|Overall Study|Lost to Follow-up|0|||
146846527|NCT04410523|529609126|FG000|Overall Study|Physician Decision|0|||
146846528|NCT04410523|529609127|FG001|Overall Study|Physician Decision|1|||
146846529|NCT04410523|529609128|FG002|Overall Study|Physician Decision|0|||
146846530|NCT04410523|529609129|FG003|Overall Study|Physician Decision|0|||
146846531|NCT04410523|529609130|FG004|Overall Study|Physician Decision|0|||
146846532|NCT04410523|529609131|FG005|Overall Study|Physician Decision|0|||
146846533|NCT04410523|529609126|FG000|Overall Study|Pregnancy|0|||
146846534|NCT04410523|529609127|FG001|Overall Study|Pregnancy|0|||
146846535|NCT04410523|529609128|FG002|Overall Study|Pregnancy|0|||
146846536|NCT04410523|529609129|FG003|Overall Study|Pregnancy|0|||
146846537|NCT04410523|529609130|FG004|Overall Study|Pregnancy|0|||
146846538|NCT04410523|529609131|FG005|Overall Study|Pregnancy|1|||
146846539|NCT04410523|529609126|FG000|Overall Study|Protocol deviation|0|||
146846540|NCT04410523|529609127|FG001|Overall Study|Protocol deviation|0|||
146846541|NCT04410523|529609128|FG002|Overall Study|Protocol deviation|0|||
146846542|NCT04410523|529609129|FG003|Overall Study|Protocol deviation|0|||
146846543|NCT04410523|529609130|FG004|Overall Study|Protocol deviation|0|||
146846544|NCT04410523|529609131|FG005|Overall Study|Protocol deviation|2|||
146846545|NCT04410523|529609126|FG000|Overall Study|Subject decision|2|||
146846546|NCT04410523|529609127|FG001|Overall Study|Subject decision|0|||
146846547|NCT04410523|529609128|FG002|Overall Study|Subject decision|0|||
146846548|NCT04410523|529609129|FG003|Overall Study|Subject decision|1|||
146846549|NCT04410523|529609130|FG004|Overall Study|Subject decision|0|||
147006149|NCT04631562|530184665|FG008|Overall Study|Adverse Event|0|||
146846550|NCT04410523|529609131|FG005|Overall Study|Subject decision|1|||
146846551|NCT01638429|529609134|FG000|Overall Study|Withdrawal by Subject|1|||
146846552|NCT03207451|529609135|FG000|Overall Study|scheduling conflict|1|||
146846553|NCT03207451|529609136|FG001|Overall Study|scheduling conflict|0|||
146846554|NCT03207451|529609137|FG002|Overall Study|scheduling conflict|2|||
146846555|NCT03207451|529609138|FG003|Overall Study|scheduling conflict|2|||
146846556|NCT03207451|529609135|FG000|Overall Study|Adverse Event|0|||
147006150|NCT02615249|530184666|FG000|Overall Study|Withdrawal by Subject|1|||
147006151|NCT00849797|530184672|FG000|First Intervention|bad veins|1|||
147006152|NCT00849797|530184673|FG001|First Intervention|bad veins|0|||
146846557|NCT03207451|529609136|FG001|Overall Study|Adverse Event|0|||
147006153|NCT00849797|530184672|FG000|First Intervention|Adverse Event|0|||
147006154|NCT00849797|530184673|FG001|First Intervention|Adverse Event|1|||
147006155|NCT00849797|530184672|FG000|Washout: One Week|Withdrawal by Subject|0|||
147006156|NCT00849797|530184673|FG001|Washout: One Week|Withdrawal by Subject|2|||
147006157|NCT00679081|530184674|FG000|Overall Study|Lost to Follow-up|1|||
147006158|NCT00725322|530184675|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
146846558|NCT03207451|529609137|FG002|Overall Study|Adverse Event|0|||
146846559|NCT03207451|529609138|FG003|Overall Study|Adverse Event|1|||
146846560|NCT02040584|529609140|FG000|Overall Study|Adverse Event|13|||
146846561|NCT02040584|529609141|FG001|Overall Study|Adverse Event|6|||
146846562|NCT02040584|529609140|FG000|Overall Study|Protocol Violation|9|||
146846563|NCT02040584|529609141|FG001|Overall Study|Protocol Violation|11|||
146846564|NCT02040584|529609140|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146846565|NCT02040584|529609141|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146846566|NCT02040584|529609140|FG000|Overall Study|Death|6|||
146846567|NCT02040584|529609141|FG001|Overall Study|Death|3|||
146846568|NCT02040584|529609140|FG000|Overall Study|Transplant rejection/retransplant|0|||
146846569|NCT02040584|529609141|FG001|Overall Study|Transplant rejection/retransplant|1|||
146846570|NCT02040584|529609140|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
146846571|NCT02040584|529609141|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
146846572|NCT01802567|529609142|FG000|Overall Study|Withdrawal by Subject|2|||
146846573|NCT01802567|529609142|FG000|Overall Study|Physician Decision|1|||
146846574|NCT01802567|529609142|FG000|Overall Study|Lack of Efficacy|7|||
146846575|NCT01802567|529609142|FG000|Overall Study|Consented but did not start therapy|7|||
146846576|NCT01802567|529609142|FG000|Overall Study|Protocol Violation|1|||
146846577|NCT01940939|529609143|FG000|Overall Study|Withdrawal by Subject|2|||
146846578|NCT01940939|529609144|FG001|Overall Study|Withdrawal by Subject|8|||
146846579|NCT00370682|529609145|FG000|Overall Study|Moved from area|0|||
146846580|NCT00370682|529609146|FG001|Overall Study|Moved from area|2|||
146846581|NCT00370682|529609147|FG002|Overall Study|Moved from area|0|||
146846582|NCT00370682|529609145|FG000|Overall Study|Lost to Follow-up|0|||
146846583|NCT00370682|529609146|FG001|Overall Study|Lost to Follow-up|1|||
146846584|NCT00370682|529609147|FG002|Overall Study|Lost to Follow-up|1|||
146846585|NCT03167359|529609148|FG000|Overall Study|Physician Decision|1|||
146846586|NCT03167359|529609148|FG000|Overall Study|Lost to Follow-up|1|||
146846587|NCT00943852|529609149|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146846588|NCT00943852|529609150|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146846589|NCT00943852|529609151|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146846590|NCT00943852|529609152|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
146846591|NCT00943852|529609153|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146846592|NCT00943852|529609154|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146846593|NCT00943852|529609155|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146846594|NCT00943852|529609156|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146846595|NCT00943852|529609157|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146846596|NCT00943852|529609158|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146846597|NCT00943852|529609149|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146846598|NCT00943852|529609150|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146846599|NCT00943852|529609151|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146846600|NCT00943852|529609152|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146846601|NCT00943852|529609153|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146846602|NCT00943852|529609154|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
146846603|NCT00943852|529609155|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146846604|NCT00943852|529609156|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146846605|NCT00943852|529609157|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146846606|NCT00943852|529609158|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146846607|NCT00943852|529609149|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146846608|NCT00943852|529609150|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146846609|NCT00943852|529609151|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146846610|NCT00943852|529609152|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146846611|NCT00943852|529609153|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146846612|NCT00943852|529609154|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146846613|NCT00943852|529609155|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
146846614|NCT00943852|529609156|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146846615|NCT00943852|529609157|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146846616|NCT00943852|529609158|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
147006159|NCT00725322|530184676|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
147006160|NCT00725322|530184675|FG000|Washout (28 Days)|Protocol Violation|0|||
146846617|NCT00943852|529609149|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146846618|NCT00943852|529609150|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146846619|NCT00943852|529609151|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146846620|NCT00943852|529609152|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146846621|NCT00943852|529609153|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146846622|NCT00943852|529609154|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146846623|NCT00943852|529609155|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146846624|NCT00943852|529609156|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
146846625|NCT00943852|529609157|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146846626|NCT00943852|529609158|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146846627|NCT00943852|529609149|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
146846628|NCT00943852|529609150|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
146846629|NCT00943852|529609151|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
146846630|NCT00943852|529609152|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
146846631|NCT00943852|529609153|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
146846632|NCT00943852|529609154|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
146846633|NCT00943852|529609155|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
146846634|NCT00943852|529609156|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
146846635|NCT00943852|529609157|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
146846636|NCT00943852|529609158|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
146846637|NCT00772330|529609159|FG000|Overall Study|Lost to Follow-up|3|||
146846638|NCT01519089|529609160|FG000|Overall Study|Adverse Event|4|||
146846639|NCT01519089|529609161|FG001|Overall Study|Adverse Event|4|||
146846640|NCT01519089|529609160|FG000|Overall Study|Lack of Efficacy|0|||
146846641|NCT01519089|529609161|FG001|Overall Study|Lack of Efficacy|2|||
146846642|NCT01519089|529609160|FG000|Overall Study|Lost to Follow-up|1|||
146846643|NCT01519089|529609161|FG001|Overall Study|Lost to Follow-up|0|||
146846644|NCT01519089|529609160|FG000|Overall Study|Withdrawal by Subject|0|||
146846645|NCT01519089|529609161|FG001|Overall Study|Withdrawal by Subject|2|||
146846646|NCT01519089|529609160|FG000|Overall Study|Other|2|||
146846647|NCT01519089|529609161|FG001|Overall Study|Other|6|||
146846648|NCT01519089|529609160|FG000|Overall Study|Not received study drug|0|||
146846649|NCT01519089|529609161|FG001|Overall Study|Not received study drug|1|||
146846650|NCT00127205|529609162|FG000|Overall Study|Adverse Event|228|||
146846651|NCT00127205|529609163|FG001|Overall Study|Adverse Event|387|||
146846652|NCT00127205|529609164|FG002|Overall Study|Adverse Event|273|||
146846653|NCT00127205|529609162|FG000|Overall Study|Death|8|||
146846654|NCT00127205|529609163|FG001|Overall Study|Death|6|||
146846655|NCT00127205|529609164|FG002|Overall Study|Death|5|||
146846656|NCT00127205|529609162|FG000|Overall Study|Withdrawal by Subject|318|||
146846657|NCT00127205|529609163|FG001|Overall Study|Withdrawal by Subject|310|||
146846658|NCT00127205|529609164|FG002|Overall Study|Withdrawal by Subject|172|||
146846659|NCT00127205|529609162|FG000|Overall Study|Other-non protocol specified|142|||
146846660|NCT00127205|529609163|FG001|Overall Study|Other-non protocol specified|129|||
146846661|NCT00127205|529609164|FG002|Overall Study|Other-non protocol specified|77|||
146846662|NCT00127205|529609162|FG000|Overall Study|Data not reported|6|||
146846663|NCT00127205|529609163|FG001|Overall Study|Data not reported|10|||
146846664|NCT00127205|529609164|FG002|Overall Study|Data not reported|1|||
146846665|NCT00127205|529609162|FG000|Overall Study|Progression|127|||
146846666|NCT00127205|529609163|FG001|Overall Study|Progression|131|||
146846667|NCT00127205|529609164|FG002|Overall Study|Progression|84|||
146846668|NCT01353859|529609167|FG000|Overall Study|Adverse Event|3|||
146846669|NCT01353859|529609167|FG000|Overall Study|Lack of Efficacy|1|||
146846670|NCT01659853|529609168|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
146846671|NCT01659853|529609169|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
146846672|NCT01659853|529609168|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
146846673|NCT01659853|529609169|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
146846674|NCT05032872|529609170|FG000|Overall Study|Adverse Event|1|||
146846675|NCT05032872|529609171|FG001|Overall Study|Adverse Event|0|||
146846676|NCT05032872|529609170|FG000|Overall Study|Lost to Follow-up|2|||
146846677|NCT05032872|529609171|FG001|Overall Study|Lost to Follow-up|4|||
146846678|NCT05032872|529609170|FG000|Overall Study|Withdrawal by Subject|4|||
146846679|NCT05032872|529609171|FG001|Overall Study|Withdrawal by Subject|3|||
146846680|NCT00910039|529609172|FG000|Overall Study|Physician Decision|1|||
146846681|NCT00406692|529609177|FG000|Overall Study|Withdrawal by Subject|4|||
146846682|NCT00406692|529609177|FG000|Overall Study|Physician Decision|1|||
146846683|NCT00406692|529609177|FG000|Overall Study|Adverse Event|1|||
146846684|NCT00406692|529609177|FG000|Overall Study|Lack of Efficacy|1|||
146846685|NCT00400725|529609178|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
146846686|NCT00400725|529609179|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
146846687|NCT00400725|529609180|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
146846688|NCT00400725|529609178|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
146846689|NCT00400725|529609179|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
146846690|NCT00400725|529609180|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
146846691|NCT00400725|529609178|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
147006161|NCT00725322|530184676|FG001|Washout (28 Days)|Protocol Violation|1|||
146846692|NCT00400725|529609179|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
146846693|NCT00400725|529609180|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
146846694|NCT00400725|529609178|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
146846695|NCT00400725|529609179|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
146846696|NCT00400725|529609180|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
146846697|NCT00400725|529609178|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
146846698|NCT00400725|529609179|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
146846699|NCT00400725|529609180|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
146846700|NCT00400725|529609178|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
146846701|NCT00400725|529609179|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
146846702|NCT00400725|529609180|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
146846703|NCT00400725|529609178|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
146846704|NCT00400725|529609179|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
146846705|NCT00400725|529609180|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
146846706|NCT00400725|529609178|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
146846707|NCT00400725|529609179|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
146846708|NCT00400725|529609180|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
146846709|NCT00400725|529609178|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
146846710|NCT00400725|529609179|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
146846711|NCT00400725|529609180|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
146846712|NCT03547739|529609181|FG000|Overall Study|Death|0|||
146846713|NCT03547739|529609182|FG001|Overall Study|Death|1|||
146846714|NCT03547739|529609183|FG002|Overall Study|Death|5|||
146846715|NCT03547739|529609181|FG000|Overall Study|Adverse Event|24|||
146846716|NCT03547739|529609182|FG001|Overall Study|Adverse Event|11|||
146846717|NCT03547739|529609183|FG002|Overall Study|Adverse Event|13|||
146846718|NCT03547739|529609181|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
146846719|NCT03547739|529609182|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
146846720|NCT03547739|529609183|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
146846721|NCT03547739|529609181|FG000|Overall Study|Lost to Follow-up|80|||
146846722|NCT03547739|529609182|FG001|Overall Study|Lost to Follow-up|84|||
146846723|NCT03547739|529609183|FG002|Overall Study|Lost to Follow-up|116|||
146846724|NCT01744392|529609190|FG000|Overall Study|Physician Decision|1|||
146846725|NCT00635661|529609196|FG000|Overall Study|Withdrawal by Subject|4|||
146846726|NCT00403767|529609204|FG000|Overall Study|Adverse Event|993|||
146846727|NCT00403767|529609205|FG001|Overall Study|Adverse Event|919|||
146846728|NCT00403767|529609204|FG000|Overall Study|Non-compliant with study medication|134|||
146846729|NCT00403767|529609205|FG001|Overall Study|Non-compliant with study medication|164|||
146846730|NCT00403767|529609204|FG000|Overall Study|Consent withdrawn|671|||
146846731|NCT00403767|529609205|FG001|Overall Study|Consent withdrawn|673|||
146846732|NCT00403767|529609204|FG000|Overall Study|Investigator dec./not protocol-related|191|||
146846733|NCT00403767|529609205|FG001|Overall Study|Investigator dec./not protocol-related|178|||
146846734|NCT00403767|529609204|FG000|Overall Study|Lost to Follow-up|6|||
146846735|NCT00403767|529609205|FG001|Overall Study|Lost to Follow-up|8|||
146846736|NCT00403767|529609204|FG000|Overall Study|Protocol Violation|142|||
146846737|NCT00403767|529609205|FG001|Overall Study|Protocol Violation|124|||
146846738|NCT00403767|529609204|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
146846739|NCT00403767|529609205|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
146846740|NCT00403767|529609204|FG000|Overall Study|Study terminated by sponsor|82|||
146846741|NCT00403767|529609205|FG001|Overall Study|Study terminated by sponsor|69|||
146846742|NCT00403767|529609204|FG000|Overall Study|Missing/incomplete data|1|||
146846743|NCT00403767|529609205|FG001|Overall Study|Missing/incomplete data|1|||
146846744|NCT03192475|529609212|FG000|Overall Study|Death|0|||
146846745|NCT03192475|529609213|FG001|Overall Study|Death|1|||
146846746|NCT03192475|529609212|FG000|Overall Study|Lost to Follow-up|13|||
146846747|NCT03192475|529609213|FG001|Overall Study|Lost to Follow-up|8|||
146846748|NCT01641159|529609214|FG000|Overall Study|Lost to Follow-up|2|||
146846749|NCT01641159|529609215|FG001|Overall Study|Lost to Follow-up|1|||
146846750|NCT01641159|529609214|FG000|Overall Study|Withdrawal by Subject|0|||
146846751|NCT01641159|529609215|FG001|Overall Study|Withdrawal by Subject|1|||
146846752|NCT00798590|529609216|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
146846753|NCT00798590|529609217|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
146846754|NCT05330676|529609220|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
146846755|NCT05330676|529609221|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
146846756|NCT00573859|529609226|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
146846757|NCT00573859|529609226|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
146846758|NCT02229851|529609227|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
146846759|NCT02229851|529609228|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
146846760|NCT02229851|529609229|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
146846761|NCT02229851|529609230|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
146846762|NCT02229851|529609231|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
146846763|NCT02229851|529609232|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
146846764|NCT02229851|529609233|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
147006162|NCT01279486|530184679|FG000|Overall Study|Lost to Follow-up|1|||
146846765|NCT02229851|529609227|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
146846766|NCT02229851|529609228|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
146846767|NCT02229851|529609229|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
146846768|NCT02229851|529609230|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
146846769|NCT02229851|529609231|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
146846770|NCT02229851|529609232|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
146846771|NCT02229851|529609233|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
146846772|NCT02229851|529609227|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
146846773|NCT02229851|529609228|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
146846774|NCT02229851|529609229|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
146846775|NCT02229851|529609230|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
146846776|NCT02229851|529609231|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
146846777|NCT02229851|529609232|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
146846778|NCT02229851|529609233|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
146846779|NCT02229851|529609227|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
146846780|NCT02229851|529609228|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
146846781|NCT02229851|529609229|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
146846782|NCT02229851|529609230|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
146846783|NCT02229851|529609231|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
146846784|NCT02229851|529609232|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
146846785|NCT02229851|529609233|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
146846786|NCT02229851|529609227|FG000|Main Phase (Double-blind Phase)|Death|1|||
146846787|NCT02229851|529609228|FG001|Main Phase (Double-blind Phase)|Death|1|||
146846788|NCT02229851|529609229|FG002|Main Phase (Double-blind Phase)|Death|0|||
146846789|NCT02229851|529609230|FG003|Main Phase (Double-blind Phase)|Death|0|||
146846790|NCT02229851|529609231|FG004|Main Phase (Double-blind Phase)|Death|0|||
146846791|NCT02229851|529609232|FG005|Main Phase (Double-blind Phase)|Death|0|||
146846792|NCT02229851|529609233|FG006|Main Phase (Double-blind Phase)|Death|0|||
146846793|NCT02229851|529609227|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
146846794|NCT02229851|529609228|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
146846795|NCT02229851|529609229|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
146846796|NCT02229851|529609230|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
146846797|NCT02229851|529609231|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
146846798|NCT02229851|529609232|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
146846799|NCT02229851|529609233|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
146846800|NCT02229851|529609227|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
146846801|NCT02229851|529609228|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
146846802|NCT02229851|529609229|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
146846803|NCT02229851|529609230|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
146846804|NCT02229851|529609231|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
146846805|NCT02229851|529609232|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
146846806|NCT02229851|529609233|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
146846807|NCT02229851|529609227|FG000|Extension Phase (Open-label Phase)|Death|0|||
146846808|NCT02229851|529609228|FG001|Extension Phase (Open-label Phase)|Death|0|||
146846809|NCT02229851|529609229|FG002|Extension Phase (Open-label Phase)|Death|0|||
146846810|NCT02229851|529609230|FG003|Extension Phase (Open-label Phase)|Death|1|||
146846811|NCT02229851|529609231|FG004|Extension Phase (Open-label Phase)|Death|0|||
146846812|NCT02229851|529609232|FG005|Extension Phase (Open-label Phase)|Death|1|||
146846813|NCT02229851|529609233|FG006|Extension Phase (Open-label Phase)|Death|1|||
146846814|NCT03541200|529609234|FG000|Overall Study|Adverse Event|19|||
146846815|NCT03541200|529609234|FG000|Overall Study|Death|1|||
146846816|NCT03541200|529609234|FG000|Overall Study|Lost to Follow-up|10|||
146846817|NCT03541200|529609234|FG000|Overall Study|Physician Decision|1|||
146846818|NCT03541200|529609234|FG000|Overall Study|Protocol Violation|51|||
146846819|NCT03541200|529609234|FG000|Overall Study|Withdrawal by Subject|23|||
146846820|NCT03541200|529609234|FG000|Overall Study|other|8|||
146846821|NCT01607476|529609236|FG000|Overall Study|Withdrawal by Subject|1|||
146846822|NCT01607476|529609237|FG001|Overall Study|Withdrawal by Subject|0|||
146846823|NCT01607476|529609238|FG002|Overall Study|Withdrawal by Subject|1|||
146846824|NCT01607476|529609236|FG000|Overall Study|Lost to Follow-up|0|||
146846825|NCT01607476|529609237|FG001|Overall Study|Lost to Follow-up|0|||
146846826|NCT01607476|529609238|FG002|Overall Study|Lost to Follow-up|2|||
146846827|NCT04445987|529609239|FG000|Overall Study|Adverse Event|0|||
146846828|NCT04445987|529609240|FG001|Overall Study|Adverse Event|0|||
146846829|NCT04445987|529609241|FG002|Overall Study|Adverse Event|1|||
146846830|NCT04445987|529609242|FG003|Overall Study|Adverse Event|0|||
146846831|NCT04445987|529609243|FG004|Overall Study|Adverse Event|4|||
146846832|NCT04445987|529609244|FG005|Overall Study|Adverse Event|0|||
146846833|NCT04445987|529609239|FG000|Overall Study|Lost to Follow-up|4|||
146846834|NCT04445987|529609240|FG001|Overall Study|Lost to Follow-up|3|||
146846835|NCT04445987|529609241|FG002|Overall Study|Lost to Follow-up|1|||
146846836|NCT04445987|529609242|FG003|Overall Study|Lost to Follow-up|1|||
146846837|NCT04445987|529609243|FG004|Overall Study|Lost to Follow-up|29|||
146846838|NCT04445987|529609244|FG005|Overall Study|Lost to Follow-up|0|||
146846839|NCT04445987|529609239|FG000|Overall Study|Physician Decision|0|||
146846840|NCT04445987|529609240|FG001|Overall Study|Physician Decision|0|||
146846841|NCT04445987|529609241|FG002|Overall Study|Physician Decision|0|||
146846842|NCT04445987|529609242|FG003|Overall Study|Physician Decision|0|||
146846843|NCT04445987|529609243|FG004|Overall Study|Physician Decision|1|||
146846844|NCT04445987|529609244|FG005|Overall Study|Physician Decision|0|||
146846845|NCT04445987|529609239|FG000|Overall Study|Protocol Violation|1|||
146846846|NCT04445987|529609240|FG001|Overall Study|Protocol Violation|0|||
146846847|NCT04445987|529609241|FG002|Overall Study|Protocol Violation|0|||
146846848|NCT04445987|529609242|FG003|Overall Study|Protocol Violation|0|||
146846849|NCT04445987|529609243|FG004|Overall Study|Protocol Violation|2|||
146846850|NCT04445987|529609244|FG005|Overall Study|Protocol Violation|0|||
146846851|NCT04445987|529609239|FG000|Overall Study|Withdrawal by Subject|4|||
146846852|NCT04445987|529609240|FG001|Overall Study|Withdrawal by Subject|0|||
146846853|NCT04445987|529609241|FG002|Overall Study|Withdrawal by Subject|1|||
146846854|NCT04445987|529609242|FG003|Overall Study|Withdrawal by Subject|0|||
146846855|NCT04445987|529609243|FG004|Overall Study|Withdrawal by Subject|18|||
146846856|NCT04445987|529609244|FG005|Overall Study|Withdrawal by Subject|1|||
146846857|NCT04445987|529609239|FG000|Overall Study|Other reason|0|||
146846858|NCT04445987|529609240|FG001|Overall Study|Other reason|0|||
146846859|NCT04445987|529609241|FG002|Overall Study|Other reason|1|||
146846860|NCT04445987|529609242|FG003|Overall Study|Other reason|0|||
146846861|NCT04445987|529609243|FG004|Overall Study|Other reason|2|||
146846862|NCT04445987|529609244|FG005|Overall Study|Other reason|0|||
146846863|NCT00293059|529609247|FG000|Overall Study|Adverse Event|12|||
146846864|NCT00293059|529609248|FG001|Overall Study|Adverse Event|4|||
146846865|NCT00293059|529609247|FG000|Overall Study|Lack of Efficacy|2|||
146846866|NCT00293059|529609248|FG001|Overall Study|Lack of Efficacy|0|||
146846867|NCT00293059|529609247|FG000|Overall Study|Lost to Follow-up|2|||
146846868|NCT00293059|529609248|FG001|Overall Study|Lost to Follow-up|3|||
146846869|NCT00293059|529609247|FG000|Overall Study|Pregnancy|1|||
146846870|NCT00293059|529609248|FG001|Overall Study|Pregnancy|1|||
146846871|NCT00293059|529609247|FG000|Overall Study|Protocol Violation|2|||
146846872|NCT00293059|529609248|FG001|Overall Study|Protocol Violation|0|||
146846873|NCT00293059|529609247|FG000|Overall Study|Withdrawal by Subject|11|||
146846874|NCT00293059|529609248|FG001|Overall Study|Withdrawal by Subject|5|||
146846875|NCT00293059|529609247|FG000|Overall Study|Participant moved out of state|1|||
146846876|NCT00293059|529609248|FG001|Overall Study|Participant moved out of state|0|||
146846877|NCT00293059|529609247|FG000|Overall Study|Participant stopped study drug|1|||
146846878|NCT00293059|529609248|FG001|Overall Study|Participant stopped study drug|0|||
146846879|NCT00293059|529609247|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
146846880|NCT00293059|529609248|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
146846881|NCT00293059|529609247|FG000|Overall Study|missing|3|||
146846882|NCT00293059|529609248|FG001|Overall Study|missing|5|||
146846883|NCT02001064|529609249|FG000|Overall Study|Withdrawal by Subject|2|||
146846884|NCT02001064|529609250|FG001|Overall Study|Withdrawal by Subject|1|||
146846885|NCT00680992|529609251|FG000|Overall Study|Complete Resection (as per protocol)|25|||
146846886|NCT00680992|529609252|FG001|Overall Study|Complete Resection (as per protocol)|121|||
146846887|NCT00680992|529609253|FG002|Overall Study|Complete Resection (as per protocol)|0|||
146846888|NCT00680992|529609251|FG000|Overall Study|Administrative Decision|83|||
146846889|NCT00680992|529609252|FG001|Overall Study|Administrative Decision|42|||
146846890|NCT00680992|529609253|FG002|Overall Study|Administrative Decision|5|||
146846891|NCT00680992|529609251|FG000|Overall Study|End of Trial|32|||
146846892|NCT00680992|529609252|FG001|Overall Study|End of Trial|12|||
146846893|NCT00680992|529609253|FG002|Overall Study|End of Trial|3|||
146846894|NCT00680992|529609251|FG000|Overall Study|Withdrawal by Subject|33|||
146846895|NCT00680992|529609252|FG001|Overall Study|Withdrawal by Subject|11|||
146846896|NCT00680992|529609253|FG002|Overall Study|Withdrawal by Subject|1|||
146846897|NCT00680992|529609251|FG000|Overall Study|Adverse Event|21|||
146846898|NCT00680992|529609252|FG001|Overall Study|Adverse Event|19|||
146846899|NCT00680992|529609253|FG002|Overall Study|Adverse Event|1|||
146846900|NCT00680992|529609251|FG000|Overall Study|Other|19|||
146846901|NCT00680992|529609252|FG001|Overall Study|Other|14|||
147006163|NCT03500094|530184683|FG000|Overall Study|Withdrawal by Subject|1|||
146846902|NCT00680992|529609253|FG002|Overall Study|Other|1|||
146846903|NCT00680992|529609251|FG000|Overall Study|Disease Progression|21|||
146846904|NCT00680992|529609252|FG001|Overall Study|Disease Progression|9|||
146846905|NCT00680992|529609253|FG002|Overall Study|Disease Progression|0|||
146846906|NCT00680992|529609251|FG000|Overall Study|Lost to Follow-up|12|||
146846907|NCT00680992|529609252|FG001|Overall Study|Lost to Follow-up|14|||
146846908|NCT00680992|529609253|FG002|Overall Study|Lost to Follow-up|0|||
146846909|NCT00680992|529609251|FG000|Overall Study|Noncompliance|4|||
146846910|NCT00680992|529609252|FG001|Overall Study|Noncompliance|6|||
146846911|NCT00680992|529609253|FG002|Overall Study|Noncompliance|0|||
146846912|NCT00680992|529609251|FG000|Overall Study|Requirement for Alternative Therapy|8|||
146846913|NCT00680992|529609252|FG001|Overall Study|Requirement for Alternative Therapy|2|||
146846914|NCT00680992|529609253|FG002|Overall Study|Requirement for Alternative Therapy|0|||
146846915|NCT00680992|529609251|FG000|Overall Study|Pregnancy|5|||
146846916|NCT00680992|529609252|FG001|Overall Study|Pregnancy|0|||
146846917|NCT00680992|529609253|FG002|Overall Study|Pregnancy|1|||
146846918|NCT00680992|529609251|FG000|Overall Study|Death|5|||
146846919|NCT00680992|529609252|FG001|Overall Study|Death|1|||
146846920|NCT00680992|529609253|FG002|Overall Study|Death|0|||
146846921|NCT00680992|529609251|FG000|Overall Study|Ineligibility Determined|0|||
146846922|NCT00680992|529609252|FG001|Overall Study|Ineligibility Determined|1|||
146846923|NCT00680992|529609253|FG002|Overall Study|Ineligibility Determined|0|||
146846924|NCT02425904|529609254|FG000|Overall Study|Lost to Follow-up|1|||
146846925|NCT02425904|529609255|FG001|Overall Study|Lost to Follow-up|0|||
146846926|NCT02425904|529609254|FG000|Overall Study|Withdrawal by Subject|2|||
146846927|NCT02425904|529609255|FG001|Overall Study|Withdrawal by Subject|0|||
146846928|NCT02425904|529609254|FG000|Overall Study|Death|0|||
146846929|NCT02425904|529609255|FG001|Overall Study|Death|3|||
146846930|NCT05148962|529609256|FG000|Overall Study|Withdrawal by Subject|1|||
146846931|NCT05148962|529609257|FG001|Overall Study|Withdrawal by Subject|1|||
146846932|NCT05148962|529609258|FG002|Overall Study|Withdrawal by Subject|0|||
146846933|NCT05148962|529609259|FG003|Overall Study|Withdrawal by Subject|1|||
146846934|NCT05148962|529609260|FG004|Overall Study|Withdrawal by Subject|0|||
146846935|NCT05148962|529609256|FG000|Overall Study|Participant was early terminated per protocol|0|||
146846936|NCT05148962|529609257|FG001|Overall Study|Participant was early terminated per protocol|0|||
146846937|NCT05148962|529609258|FG002|Overall Study|Participant was early terminated per protocol|3|||
146846938|NCT05148962|529609259|FG003|Overall Study|Participant was early terminated per protocol|5|||
146846939|NCT05148962|529609260|FG004|Overall Study|Participant was early terminated per protocol|2|||
146846940|NCT05148962|529609256|FG000|Overall Study|Miscellaneous|0|||
146846941|NCT05148962|529609257|FG001|Overall Study|Miscellaneous|0|||
146846942|NCT05148962|529609258|FG002|Overall Study|Miscellaneous|0|||
146846943|NCT05148962|529609259|FG003|Overall Study|Miscellaneous|1|||
146846944|NCT05148962|529609260|FG004|Overall Study|Miscellaneous|0|||
146846945|NCT00095056|529610827|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
146846946|NCT00095056|529610828|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
146846947|NCT00095056|529610827|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
146846948|NCT00095056|529610828|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
146846949|NCT00095056|529610827|FG000|Phase A (Weeks 0-12)|Death|1|||
146846950|NCT00095056|529610828|FG001|Phase A (Weeks 0-12)|Death|0|||
146846951|NCT00095056|529610827|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
146846952|NCT00095056|529610828|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
146846953|NCT00095056|529610827|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
146846954|NCT00095056|529610828|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
146846955|NCT00095056|529610827|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
146846956|NCT00095056|529610828|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
146846957|NCT00095056|529610827|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
146846958|NCT00095056|529610828|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
146846959|NCT00095056|529610827|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
146846960|NCT00095056|529610828|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
146846961|NCT00095056|529610827|FG000|Phase B (Weeks 12-54)|Death|3|||
146846962|NCT00095056|529610828|FG001|Phase B (Weeks 12-54)|Death|1|||
146846963|NCT00095056|529610827|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
146846964|NCT00095056|529610828|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
146846965|NCT00095056|529610827|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
146846966|NCT00095056|529610828|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
146846967|NCT02731690|529610832|FG000|Overall Study|Adverse Event|1|||
146846968|NCT02731690|529610832|FG000|Overall Study|Withdrawal by Subject|3|||
146846969|NCT02731690|529610832|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
146846970|NCT02141620|529610833|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
146846971|NCT02141620|529610834|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
146846972|NCT03582943|529610835|FG000|Allocated to Groups|Withdrawal by Subject|1|||
146846973|NCT03582943|529610836|FG001|Allocated to Groups|Withdrawal by Subject|1|||
146846974|NCT03582943|529610835|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
146846975|NCT03582943|529610836|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
146846976|NCT03582943|529610835|FG000|Analyzed|Protocol Violation|4|||
146846977|NCT03582943|529610836|FG001|Analyzed|Protocol Violation|1|||
146846978|NCT03527550|529610837|FG000|Overall Study|Lost to Follow-up|4|||
146846979|NCT03527550|529610838|FG001|Overall Study|Lost to Follow-up|2|||
146846980|NCT03527550|529610837|FG000|Overall Study|Withdrawal by Subject|4|||
146846981|NCT03527550|529610838|FG001|Overall Study|Withdrawal by Subject|1|||
146846982|NCT03527550|529610837|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
146846983|NCT03527550|529610838|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
146846984|NCT03053518|529610841|FG000|Overall Study|Withdrawal by Subject|3|||
146846985|NCT03053518|529610841|FG000|Overall Study|Lost to Follow-up|2|||
146846986|NCT03053518|529610841|FG000|Overall Study|Ineligible|5|||
146846987|NCT02683876|529610842|FG000|Overall Study|samples damaged during shipping|2|||
146846988|NCT02683876|529610843|FG001|Overall Study|samples damaged during shipping|0|||
147006164|NCT03500094|530184683|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
147006165|NCT03500094|530184683|FG000|Overall Study|Lost to Follow-up|1|||
147006166|NCT02727192|530186518|FG000|Overall Study|Lost to Follow-up|1|||
147006167|NCT02727192|530186519|FG001|Overall Study|Lost to Follow-up|0|||
147006168|NCT02727192|530186520|FG002|Overall Study|Lost to Follow-up|0|||
147006169|NCT01380782|530186522|FG000|Overall Study|Adverse Event|0|||
147006170|NCT01380782|530186523|FG001|Overall Study|Adverse Event|1|||
147006171|NCT01380782|530186524|FG002|Overall Study|Adverse Event|0|||
147006172|NCT01380782|530186525|FG003|Overall Study|Adverse Event|0|||
147006173|NCT01380782|530186522|FG000|Overall Study|Death|1|||
147006174|NCT01380782|530186523|FG001|Overall Study|Death|0|||
147006175|NCT01380782|530186524|FG002|Overall Study|Death|0|||
147006176|NCT01380782|530186525|FG003|Overall Study|Death|0|||
147006177|NCT01380782|530186522|FG000|Overall Study|Lack of Efficacy|10|||
147006178|NCT01380782|530186523|FG001|Overall Study|Lack of Efficacy|9|||
147006179|NCT01380782|530186524|FG002|Overall Study|Lack of Efficacy|10|||
147006180|NCT01380782|530186525|FG003|Overall Study|Lack of Efficacy|3|||
147006181|NCT01380782|530186522|FG000|Overall Study|Physician Decision|1|||
147006182|NCT01380782|530186523|FG001|Overall Study|Physician Decision|0|||
147006183|NCT01380782|530186524|FG002|Overall Study|Physician Decision|0|||
147006184|NCT01380782|530186525|FG003|Overall Study|Physician Decision|0|||
147006185|NCT01380782|530186522|FG000|Overall Study|Withdrawal by Subject|0|||
147006186|NCT01380782|530186523|FG001|Overall Study|Withdrawal by Subject|0|||
147006187|NCT01380782|530186524|FG002|Overall Study|Withdrawal by Subject|1|||
147006188|NCT01380782|530186525|FG003|Overall Study|Withdrawal by Subject|1|||
147006189|NCT01701063|530186526|FG000|Overall Study|Lost to Follow-up|0|||
147006190|NCT01701063|530186527|FG001|Overall Study|Lost to Follow-up|1|||
147006191|NCT01701063|530186528|FG002|Overall Study|Lost to Follow-up|0|||
147006192|NCT01701063|530186526|FG000|Overall Study|Withdrawal by Subject|0|||
147006193|NCT01701063|530186527|FG001|Overall Study|Withdrawal by Subject|0|||
147006194|NCT01701063|530186528|FG002|Overall Study|Withdrawal by Subject|1|||
147006195|NCT01701063|530186526|FG000|Overall Study|Other|0|||
147006196|NCT01701063|530186527|FG001|Overall Study|Other|0|||
147006197|NCT01701063|530186528|FG002|Overall Study|Other|1|||
147006198|NCT02043132|530186529|FG000|Overall Study|Lost to Follow-up|1|||
147006199|NCT02043132|530186530|FG001|Overall Study|Lost to Follow-up|1|||
147006200|NCT02043132|530186529|FG000|Overall Study|screen failures|4|||
147006201|NCT02043132|530186530|FG001|Overall Study|screen failures|8|||
147006202|NCT04194801|530186531|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
147006203|NCT04194801|530186532|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
147006204|NCT04194801|530186533|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
147006205|NCT04194801|530186531|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
147006206|NCT04194801|530186532|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
147006207|NCT04194801|530186533|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
147006208|NCT04194801|530186531|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
147006209|NCT04194801|530186532|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
147006210|NCT04194801|530186533|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
147006211|NCT04194801|530186531|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
147006212|NCT04194801|530186532|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
147006213|NCT04194801|530186533|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
147006214|NCT04194801|530186531|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
147006215|NCT04194801|530186532|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
147006216|NCT04194801|530186533|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
147006217|NCT04194801|530186531|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
147006218|NCT04194801|530186532|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
147006219|NCT04194801|530186533|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
147006220|NCT04194801|530186531|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
147006221|NCT04194801|530186532|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
147006222|NCT04194801|530186533|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
147006223|NCT04194801|530186531|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
147006224|NCT04194801|530186532|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
147006225|NCT04194801|530186533|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
147006226|NCT04194801|530186531|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
147006227|NCT04194801|530186532|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
147006228|NCT04194801|530186533|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
147006229|NCT04194801|530186531|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
147006230|NCT04194801|530186532|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
147006231|NCT04194801|530186533|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
147006232|NCT04194801|530186531|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
147006233|NCT04194801|530186532|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
147006234|NCT04194801|530186533|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
147006235|NCT04194801|530186531|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
147006236|NCT04194801|530186532|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
147006237|NCT04194801|530186533|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
147006238|NCT04194801|530186531|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
147006239|NCT04194801|530186532|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
147006240|NCT04194801|530186533|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
147006241|NCT04194801|530186531|FG000|Part Ib/II End of Study|Death|2|||
147006242|NCT04194801|530186532|FG001|Part Ib/II End of Study|Death|3|||
147006243|NCT04194801|530186533|FG002|Part Ib/II End of Study|Death|3|||
147006244|NCT04194801|530186531|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
147006245|NCT04194801|530186532|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
147006246|NCT04194801|530186533|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
147006247|NCT04194801|530186531|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
147006248|NCT04194801|530186532|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
147006249|NCT04194801|530186533|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
147006250|NCT04194801|530186531|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
147006251|NCT04194801|530186532|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
147006252|NCT04194801|530186533|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
147006253|NCT04194801|530186531|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
147006254|NCT04194801|530186532|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
147006255|NCT04194801|530186533|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
147006256|NCT00506831|530186534|FG000|Overall Study|Death|1|||
147006257|NCT00506831|530186534|FG000|Overall Study|Withdrawal by Subject|1|||
147006258|NCT01410227|530186538|FG000|Overall Study|Adverse Event|1|||
147006259|NCT01410227|530186539|FG001|Overall Study|Adverse Event|0|||
147006260|NCT01410227|530186540|FG002|Overall Study|Adverse Event|0|||
147006261|NCT01410227|530186541|FG003|Overall Study|Adverse Event|0|||
147006262|NCT01410227|530186538|FG000|Overall Study|Withdrawal by Subject|3|||
147006263|NCT01410227|530186539|FG001|Overall Study|Withdrawal by Subject|0|||
147006264|NCT01410227|530186540|FG002|Overall Study|Withdrawal by Subject|1|||
147006265|NCT01410227|530186541|FG003|Overall Study|Withdrawal by Subject|0|||
147006266|NCT01410227|530186538|FG000|Overall Study|Pregnancy|0|||
147006267|NCT01410227|530186539|FG001|Overall Study|Pregnancy|0|||
147006268|NCT01410227|530186540|FG002|Overall Study|Pregnancy|0|||
147006269|NCT01410227|530186541|FG003|Overall Study|Pregnancy|1|||
147006270|NCT01410227|530186538|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
147006271|NCT01410227|530186539|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
147006272|NCT01410227|530186540|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
147006273|NCT01410227|530186541|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
147006274|NCT01808651|530186542|FG000|Study Period 1|Lost to Follow-up|1|||
147006275|NCT01808651|530186543|FG001|Study Period 1|Lost to Follow-up|3|||
147006276|NCT01808651|530186544|FG002|Study Period 1|Lost to Follow-up|0|||
147006277|NCT01808651|530186542|FG000|Study Period 1|Protocol Violation|1|||
147006278|NCT01808651|530186543|FG001|Study Period 1|Protocol Violation|0|||
147006279|NCT01808651|530186544|FG002|Study Period 1|Protocol Violation|1|||
147006280|NCT01808651|530186542|FG000|Study Period 1|Physician Decision|3|||
147006281|NCT01808651|530186543|FG001|Study Period 1|Physician Decision|2|||
147006282|NCT01808651|530186544|FG002|Study Period 1|Physician Decision|0|||
147006283|NCT01808651|530186542|FG000|Study Period 1|Lack of Efficacy|2|||
147006284|NCT01808651|530186543|FG001|Study Period 1|Lack of Efficacy|1|||
147006285|NCT01808651|530186544|FG002|Study Period 1|Lack of Efficacy|0|||
147006286|NCT01808651|530186542|FG000|Study Period 1|Adverse Event|10|||
147006287|NCT01808651|530186543|FG001|Study Period 1|Adverse Event|4|||
147006288|NCT01808651|530186544|FG002|Study Period 1|Adverse Event|1|||
147006289|NCT01808651|530186542|FG000|Study Period 1|Participant Decision|9|||
147006290|NCT01808651|530186543|FG001|Study Period 1|Participant Decision|7|||
147006291|NCT01808651|530186544|FG002|Study Period 1|Participant Decision|3|||
147006292|NCT00585286|530186547|FG000|Overall Study|Lost to Follow-up|1|||
147006293|NCT00608322|530186549|FG000|Overall Study|Death|2|||
147006294|NCT00608322|530186550|FG001|Overall Study|Death|1|||
147006295|NCT03497130|530186551|FG000|Overall Study|Lost to Follow-up|1|||
147006296|NCT03497130|530186552|FG001|Overall Study|Lost to Follow-up|1|||
147006297|NCT04002648|530186553|FG000|Overall Study|Lost to Follow-up|2|||
147006298|NCT04002648|530186554|FG001|Overall Study|Lost to Follow-up|0|||
147006299|NCT00829712|530186560|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
147006300|NCT00829712|530186561|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
147006301|NCT00606281|530186562|FG000|Overall Study|Adverse Event|11|||
147006302|NCT00606281|530186563|FG001|Overall Study|Adverse Event|12|||
147006303|NCT00606281|530186562|FG000|Overall Study|Death|1|||
147006304|NCT00606281|530186563|FG001|Overall Study|Death|0|||
147006305|NCT00606281|530186562|FG000|Overall Study|Lack of Efficacy|28|||
147006306|NCT00606281|530186563|FG001|Overall Study|Lack of Efficacy|35|||
147006307|NCT00606281|530186562|FG000|Overall Study|Physician Decision|0|||
147006308|NCT00606281|530186563|FG001|Overall Study|Physician Decision|1|||
147006309|NCT00606281|530186562|FG000|Overall Study|Protocol Violation|3|||
147006310|NCT00606281|530186563|FG001|Overall Study|Protocol Violation|3|||
147006311|NCT00606281|530186562|FG000|Overall Study|Withdrawal by Subject|11|||
147006312|NCT00606281|530186563|FG001|Overall Study|Withdrawal by Subject|13|||
147006313|NCT00606281|530186562|FG000|Overall Study|Progression to depressive phase|1|||
147006314|NCT00606281|530186563|FG001|Overall Study|Progression to depressive phase|1|||
147006315|NCT00606281|530186562|FG000|Overall Study|Change of residence or other commitments|1|||
147006316|NCT00606281|530186563|FG001|Overall Study|Change of residence or other commitments|1|||
147006317|NCT03131895|530186565|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
147006318|NCT03131895|530186566|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
147006319|NCT03131895|530186567|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
147006320|NCT03131895|530186568|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
147006321|NCT03131895|530186565|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
147006322|NCT03131895|530186566|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
147006323|NCT03131895|530186567|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
147006324|NCT03131895|530186568|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
147006325|NCT03131895|530186565|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
147006326|NCT03131895|530186566|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
147006327|NCT03131895|530186567|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
147006328|NCT03131895|530186568|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
147006329|NCT03131895|530186565|FG000|Washout Period (at Least 5 Days)|Other|0|||
147006330|NCT03131895|530186566|FG001|Washout Period (at Least 5 Days)|Other|0|||
147006331|NCT03131895|530186567|FG002|Washout Period (at Least 5 Days)|Other|2|||
147006332|NCT03131895|530186568|FG003|Washout Period (at Least 5 Days)|Other|0|||
147006333|NCT03131895|530186565|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
147006334|NCT03131895|530186566|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
147006335|NCT03131895|530186567|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
147006336|NCT03131895|530186568|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
147006337|NCT03131895|530186565|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
147006338|NCT03131895|530186566|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
147006339|NCT03131895|530186567|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
147006340|NCT03131895|530186568|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
147006341|NCT02213263|530186571|FG000|Overall Study|Insufficient clinical response|4|||
147006342|NCT02213263|530186572|FG001|Overall Study|Insufficient clinical response|3|||
147006343|NCT02213263|530186571|FG000|Overall Study|Lost to Follow-up|0|||
147006344|NCT02213263|530186572|FG001|Overall Study|Lost to Follow-up|1|||
147006345|NCT02213263|530186571|FG000|Overall Study|No longer willing to participate|3|||
147006346|NCT02213263|530186572|FG001|Overall Study|No longer willing to participate|4|||
147006347|NCT02213263|530186571|FG000|Overall Study|Progressive disease|20|||
147006348|NCT02213263|530186572|FG001|Overall Study|Progressive disease|14|||
146846989|NCT02071290|529610844|FG000|Overall Study|Death|1|||
146846990|NCT02071290|529610845|FG001|Overall Study|Death|0|||
146846991|NCT02071290|529610844|FG000|Overall Study|Withdrawal by Subject|0|||
146962210|NCT04576702|530021530|FG000|Overall Study|Lost to Follow-up|3|||
146962211|NCT04576702|530021531|FG001|Overall Study|Lost to Follow-up|3|||
146962212|NCT04576702|530021532|FG002|Overall Study|Lost to Follow-up|3|||
146962213|NCT04576702|530021533|FG003|Overall Study|Lost to Follow-up|4|||
146962214|NCT02985996|530021537|FG000|Overall Study|Withdrawal by Subject|0|||
146962215|NCT02985996|530021538|FG001|Overall Study|Withdrawal by Subject|0|||
146962216|NCT02985996|530021539|FG002|Overall Study|Withdrawal by Subject|1|||
146962217|NCT02985996|530021540|FG003|Overall Study|Withdrawal by Subject|0|||
146962218|NCT02985996|530021541|FG004|Overall Study|Withdrawal by Subject|0|||
146962219|NCT02985996|530021537|FG000|Overall Study|Protocol Violation|0|||
146962220|NCT02985996|530021538|FG001|Overall Study|Protocol Violation|1|||
146962221|NCT02985996|530021539|FG002|Overall Study|Protocol Violation|0|||
146962222|NCT02985996|530021540|FG003|Overall Study|Protocol Violation|0|||
146962223|NCT02985996|530021541|FG004|Overall Study|Protocol Violation|0|||
146962224|NCT00401726|530021542|FG000|Overall Study|Adverse Event|34|||
146962225|NCT00401726|530021543|FG001|Overall Study|Adverse Event|45|||
146962226|NCT00401726|530021542|FG000|Overall Study|Death|0|||
146962227|NCT00401726|530021543|FG001|Overall Study|Death|3|||
146962228|NCT00401726|530021542|FG000|Overall Study|Sponsor Request|0|||
146962229|NCT00401726|530021543|FG001|Overall Study|Sponsor Request|1|||
146962230|NCT00401726|530021542|FG000|Overall Study|Physician Decision|3|||
146962231|NCT00401726|530021543|FG001|Overall Study|Physician Decision|6|||
146962232|NCT00401726|530021542|FG000|Overall Study|Lost to Follow-up|23|||
146962233|NCT00401726|530021543|FG001|Overall Study|Lost to Follow-up|20|||
146962234|NCT00401726|530021542|FG000|Overall Study|Protocol Violation|6|||
146962235|NCT00401726|530021543|FG001|Overall Study|Protocol Violation|3|||
146962236|NCT00401726|530021542|FG000|Overall Study|Withdrawal by Subject|18|||
146962237|NCT00401726|530021543|FG001|Overall Study|Withdrawal by Subject|24|||
146962238|NCT00401726|530021542|FG000|Overall Study|Lack of Efficacy|4|||
146962239|NCT00401726|530021543|FG001|Overall Study|Lack of Efficacy|6|||
146962240|NCT00401726|530021542|FG000|Overall Study|Protocol Deviation|9|||
146962241|NCT00401726|530021543|FG001|Overall Study|Protocol Deviation|4|||
146962242|NCT02067728|530021544|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
146962243|NCT02067728|530021545|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
147006349|NCT02213263|530186571|FG000|Overall Study|Protocol Violation|0|||
147006350|NCT02213263|530186572|FG001|Overall Study|Protocol Violation|1|||
147006351|NCT02213263|530186571|FG000|Overall Study|Adverse Event|1|||
147006352|NCT02213263|530186572|FG001|Overall Study|Adverse Event|3|||
147006353|NCT05752721|530186573|FG000|Overall Study|Lost to Follow-up|22|||
147006354|NCT05752721|530186574|FG001|Overall Study|Lost to Follow-up|20|||
147006355|NCT05752721|530186573|FG000|Overall Study|Withdrawal by Subject|15|||
147006356|NCT05752721|530186574|FG001|Overall Study|Withdrawal by Subject|12|||
147006357|NCT03158727|530186583|FG000|Overall Study|Withdrawal by Subject|2|||
147006358|NCT03158727|530186584|FG001|Overall Study|Withdrawal by Subject|6|||
147006359|NCT03158727|530186583|FG000|Overall Study|Death|11|||
147006360|NCT03158727|530186584|FG001|Overall Study|Death|12|||
147006361|NCT03158727|530186583|FG000|Overall Study|Lost to Follow-up|1|||
147006362|NCT03158727|530186584|FG001|Overall Study|Lost to Follow-up|0|||
147006363|NCT03158727|530186583|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
147006364|NCT03158727|530186584|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
147006365|NCT03158727|530186583|FG000|Overall Study|Visit 11 not done by mistake|0|||
147006366|NCT03158727|530186584|FG001|Overall Study|Visit 11 not done by mistake|1|||
147006367|NCT03158727|530186583|FG000|Overall Study|Enrolled, not treated|1|||
147006368|NCT03158727|530186584|FG001|Overall Study|Enrolled, not treated|0|||
147006369|NCT00669162|530186585|FG000|Overall Study|Withdrawal by Subject|1|||
147006370|NCT00807495|530186586|FG000|Overall Study|Adverse Event|6|||
147006371|NCT00807495|530186587|FG001|Overall Study|Adverse Event|3|||
147006372|NCT00807495|530186588|FG002|Overall Study|Adverse Event|1|||
147006373|NCT00807495|530186589|FG003|Overall Study|Adverse Event|1|||
147006374|NCT00807495|530186590|FG004|Overall Study|Adverse Event|2|||
147006375|NCT00807495|530186586|FG000|Overall Study|Withdrawal by Patient|2|||
147006376|NCT00807495|530186587|FG001|Overall Study|Withdrawal by Patient|0|||
147006377|NCT00807495|530186588|FG002|Overall Study|Withdrawal by Patient|1|||
147006378|NCT00807495|530186589|FG003|Overall Study|Withdrawal by Patient|0|||
147006379|NCT00807495|530186590|FG004|Overall Study|Withdrawal by Patient|0|||
147006380|NCT00807495|530186586|FG000|Overall Study|Reason Not Specified|0|||
147006381|NCT00807495|530186587|FG001|Overall Study|Reason Not Specified|3|||
147006382|NCT00807495|530186588|FG002|Overall Study|Reason Not Specified|2|||
147006383|NCT00807495|530186589|FG003|Overall Study|Reason Not Specified|0|||
147006384|NCT00807495|530186590|FG004|Overall Study|Reason Not Specified|3|||
147006385|NCT00985439|530186591|FG000|Overall Study|Adverse Event|0|||
147006386|NCT00985439|530186592|FG001|Overall Study|Adverse Event|0|||
147006387|NCT00985439|530186593|FG002|Overall Study|Adverse Event|1|||
147006388|NCT00985439|530186594|FG003|Overall Study|Adverse Event|0|||
147006389|NCT00463684|530186599|FG000|Overall Study|Withdrawal by Subject|1|||
147006390|NCT00463684|530186599|FG000|Overall Study|Lost to Follow-up|3|||
147006391|NCT01906372|530186600|FG000|Overall Study|Withdrawal by Subject|2|||
147006392|NCT00924638|530186602|FG000|Overall Study|Death|3|||
147006393|NCT00924638|530186603|FG001|Overall Study|Death|2|||
147006394|NCT00924638|530186602|FG000|Overall Study|Lost to Follow-up|1|||
147006395|NCT00924638|530186603|FG001|Overall Study|Lost to Follow-up|1|||
147006396|NCT00924638|530186602|FG000|Overall Study|Withdrawal by Subject|5|||
147006397|NCT00924638|530186603|FG001|Overall Study|Withdrawal by Subject|7|||
147006398|NCT00924638|530186602|FG000|Overall Study|Physician Decision|3|||
147006399|NCT00924638|530186603|FG001|Overall Study|Physician Decision|3|||
147006400|NCT00367133|530186604|FG000|2 Years|Death|20|||
147006401|NCT00367133|530186605|FG001|2 Years|Death|12|||
147006402|NCT00367133|530186606|FG002|2 Years|Death|12|||
147006403|NCT00367133|530186604|FG000|2 Years|Dropped|34|||
147006404|NCT00367133|530186605|FG001|2 Years|Dropped|19|||
147006405|NCT00367133|530186606|FG002|2 Years|Dropped|33|||
147006406|NCT00367133|530186604|FG000|2 Years|Missed visit|4|||
147006407|NCT00367133|530186605|FG001|2 Years|Missed visit|5|||
147006408|NCT00367133|530186606|FG002|2 Years|Missed visit|4|||
147006409|NCT00847535|530186612|FG000|Overall Study|Withdrawal by Subject|2|||
147006410|NCT00847535|530186613|FG001|Overall Study|Withdrawal by Subject|1|||
147006411|NCT00847535|530186614|FG002|Overall Study|Withdrawal by Subject|1|||
147006412|NCT00847535|530186612|FG000|Overall Study|Lost to Follow-up|0|||
147006413|NCT00847535|530186613|FG001|Overall Study|Lost to Follow-up|1|||
147006414|NCT00847535|530186614|FG002|Overall Study|Lost to Follow-up|0|||
147006415|NCT02336074|530186615|FG000|Overall Study|Adverse Event|0|||
147006416|NCT02336074|530186616|FG001|Overall Study|Adverse Event|2|||
147006417|NCT01252953|530186617|FG000|Overall Study|Withdrawal by Subject|16|||
147006418|NCT01252953|530186618|FG001|Overall Study|Withdrawal by Subject|17|||
147006419|NCT01252953|530186617|FG000|Overall Study|Lost to Follow-up|22|||
147006420|NCT01252953|530186618|FG001|Overall Study|Lost to Follow-up|21|||
147006421|NCT02054715|530186621|FG000|Baseline/Follow-up 1|Refused|1|||
147006422|NCT02054715|530186622|FG001|Baseline/Follow-up 1|Refused|3|||
147006423|NCT02054715|530186621|FG000|Baseline/Follow-up 1|Medical|0|||
147006424|NCT02054715|530186622|FG001|Baseline/Follow-up 1|Medical|1|||
147006425|NCT02054715|530186621|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
147006426|NCT02054715|530186622|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
147006427|NCT02054715|530186621|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
147006428|NCT02054715|530186622|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
147006429|NCT02054715|530186621|FG000|Baseline/Follow-up 1|No Reason|0|||
147006430|NCT02054715|530186622|FG001|Baseline/Follow-up 1|No Reason|1|||
147006431|NCT02054715|530186621|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
147006432|NCT02054715|530186622|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
147006433|NCT02054715|530186621|FG000|Baseline/Follow-up 1|Ineligible|3|||
147006434|NCT02054715|530186622|FG001|Baseline/Follow-up 1|Ineligible|0|||
147006435|NCT02054715|530186621|FG000|Baseline/Follow-up 1|Hospitalization|1|||
147006436|NCT02054715|530186622|FG001|Baseline/Follow-up 1|Hospitalization|0|||
147006437|NCT02054715|530186621|FG000|Baseline/Follow-up 1|Changed Mind|1|||
147006438|NCT02054715|530186622|FG001|Baseline/Follow-up 1|Changed Mind|0|||
147006439|NCT02054715|530186621|FG000|Follow-up 2|Lost to Followup|3|||
147006440|NCT02054715|530186622|FG001|Follow-up 2|Lost to Followup|1|||
147006441|NCT02054715|530186621|FG000|Follow-up 2|Refused|3|||
147006442|NCT02054715|530186622|FG001|Follow-up 2|Refused|2|||
147006443|NCT02054715|530186621|FG000|Follow-up 2|Followup Not Completed|3|||
147006444|NCT02054715|530186622|FG001|Follow-up 2|Followup Not Completed|4|||
147006445|NCT02054715|530186621|FG000|Follow-up 2|Ineligible|4|||
147006446|NCT02054715|530186622|FG001|Follow-up 2|Ineligible|5|||
147006447|NCT02054715|530186621|FG000|Follow-up 2|Death|3|||
147006448|NCT02054715|530186622|FG001|Follow-up 2|Death|3|||
147006449|NCT02054715|530186621|FG000|Follow-up 2|Hospitalization|0|||
147006450|NCT02054715|530186622|FG001|Follow-up 2|Hospitalization|2|||
147006451|NCT02054715|530186621|FG000|Follow-up 2|Changed MD/Facility|0|||
147006452|NCT02054715|530186622|FG001|Follow-up 2|Changed MD/Facility|1|||
147006453|NCT02054715|530186621|FG000|Follow-up 2|Changed Mind|0|||
147006454|NCT02054715|530186622|FG001|Follow-up 2|Changed Mind|1|||
147006455|NCT02054715|530186621|FG000|Follow-up 2|No Reason|2|||
147006456|NCT02054715|530186622|FG001|Follow-up 2|No Reason|0|||
147006457|NCT02054715|530186621|FG000|Follow-up 2|Treatment Change or Delay|1|||
147006458|NCT02054715|530186622|FG001|Follow-up 2|Treatment Change or Delay|0|||
147006459|NCT00858780|530186623|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
147006460|NCT00858780|530186624|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
147006461|NCT00858780|530186625|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
147006462|NCT00858780|530186626|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
147006463|NCT00858780|530186627|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
147006464|NCT00858780|530186623|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
147006465|NCT00858780|530186624|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
147006466|NCT00858780|530186625|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
147006467|NCT00858780|530186626|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
147006468|NCT00858780|530186627|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
147006469|NCT00858780|530186623|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
147006470|NCT00858780|530186624|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
147006471|NCT00858780|530186625|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
147006472|NCT00858780|530186626|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
147006473|NCT00858780|530186627|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
147006474|NCT00858780|530186623|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
147006475|NCT00858780|530186624|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
147006476|NCT00858780|530186625|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
147006477|NCT00858780|530186626|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
147006478|NCT00858780|530186627|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
147006479|NCT00858780|530186623|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
147006480|NCT00858780|530186624|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
147006481|NCT00858780|530186625|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
147006482|NCT00858780|530186626|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
147006483|NCT00858780|530186627|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
147006484|NCT00858780|530186623|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
147006485|NCT00858780|530186624|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
147006486|NCT00858780|530186625|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
147006487|NCT00858780|530186626|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
147006488|NCT00858780|530186627|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
147006489|NCT05098743|530186631|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
147006490|NCT05098743|530186632|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
147006491|NCT05098743|530186631|FG000|Overall Study|Lost to Follow-up|1|||
147006492|NCT05098743|530186632|FG001|Overall Study|Lost to Follow-up|2|||
147006493|NCT01456221|530186633|FG000|Overall Study|Withdrawal by Subject|56|||
147006494|NCT01456221|530186634|FG001|Overall Study|Withdrawal by Subject|49|||
147006495|NCT01456221|530186633|FG000|Overall Study|Lost to Follow-up|1|||
147006496|NCT01456221|530186634|FG001|Overall Study|Lost to Follow-up|4|||
147006497|NCT01456221|530186633|FG000|Overall Study|Received medication|3|||
147006498|NCT01456221|530186634|FG001|Overall Study|Received medication|2|||
147006499|NCT01456221|530186633|FG000|Overall Study|Incomplete data|4|||
147006500|NCT01456221|530186634|FG001|Overall Study|Incomplete data|2|||
147006501|NCT04025021|530186635|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
147006502|NCT04025021|530186636|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
147006503|NCT03498560|530186637|FG000|Overall Study|Found Ineligible|2|||
147006504|NCT03498560|530186637|FG000|Overall Study|Withdrawal by Subject|14|||
147006505|NCT03498560|530186637|FG000|Overall Study|Lost to Follow-up|4|||
147006506|NCT03498560|530186637|FG000|Overall Study|Death|1|||
147006507|NCT00867360|530186642|FG000|Overall Study|Withdrawal by Subject|1|||
147006508|NCT00867360|530186643|FG001|Overall Study|Withdrawal by Subject|0|||
147006509|NCT00867360|530186642|FG000|Overall Study|Physician Decision|0|||
147006510|NCT00867360|530186643|FG001|Overall Study|Physician Decision|1|||
147006511|NCT01004510|530186644|FG000|Overall Study|Adverse Event|1|||
147006512|NCT00112437|530186647|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
147006513|NCT00112437|530186648|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
147006514|NCT00112437|530186649|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
147006515|NCT00112437|530186650|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
147006516|NCT00112437|530186651|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
147006517|NCT00112437|530186652|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006518|NCT00112437|530186653|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006519|NCT00112437|530186654|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006520|NCT00112437|530186655|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006521|NCT00112437|530186656|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006522|NCT00112437|530186657|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006523|NCT00112437|530186658|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006524|NCT00112437|530186659|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006525|NCT00112437|530186660|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006526|NCT00112437|530186661|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006527|NCT00112437|530186662|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006528|NCT00112437|530186663|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006529|NCT00112437|530186664|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006530|NCT00112437|530186665|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006531|NCT00112437|530186666|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006532|NCT00112437|530186667|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006533|NCT00112437|530186668|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006534|NCT00112437|530186669|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006535|NCT00112437|530186670|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006536|NCT00112437|530186671|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006537|NCT00112437|530186672|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
147006538|NCT00112437|530186647|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006539|NCT00112437|530186648|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
147006540|NCT00112437|530186649|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006541|NCT00112437|530186650|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006542|NCT00112437|530186651|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006543|NCT00112437|530186652|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006544|NCT00112437|530186653|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006545|NCT00112437|530186654|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006546|NCT00112437|530186655|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006547|NCT00112437|530186656|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006548|NCT00112437|530186657|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006549|NCT00112437|530186658|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006550|NCT00112437|530186659|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006551|NCT00112437|530186660|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006552|NCT00112437|530186661|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006553|NCT00112437|530186662|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006554|NCT00112437|530186663|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006555|NCT00112437|530186664|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006556|NCT00112437|530186665|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006557|NCT00112437|530186666|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006558|NCT00112437|530186667|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006559|NCT00112437|530186668|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006560|NCT00112437|530186669|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006561|NCT00112437|530186670|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006562|NCT00112437|530186671|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006563|NCT00112437|530186672|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147006564|NCT00112437|530186647|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006565|NCT00112437|530186648|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
147006566|NCT00112437|530186649|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006567|NCT00112437|530186650|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006568|NCT00112437|530186651|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006569|NCT00112437|530186652|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006570|NCT00112437|530186653|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006571|NCT00112437|530186654|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006572|NCT00112437|530186655|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006573|NCT00112437|530186656|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006574|NCT00112437|530186657|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006575|NCT00112437|530186658|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006576|NCT00112437|530186659|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006577|NCT00112437|530186660|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006578|NCT00112437|530186661|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006579|NCT00112437|530186662|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006580|NCT00112437|530186663|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006581|NCT00112437|530186664|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006582|NCT00112437|530186665|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006583|NCT00112437|530186666|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006584|NCT00112437|530186667|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006585|NCT00112437|530186668|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006586|NCT00112437|530186669|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006587|NCT00112437|530186670|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006588|NCT00112437|530186671|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006589|NCT00112437|530186672|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147006590|NCT00112437|530186647|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
147006591|NCT00112437|530186648|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006592|NCT00112437|530186649|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
147006593|NCT00112437|530186650|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
147006594|NCT00112437|530186651|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
147006595|NCT00112437|530186652|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006596|NCT00112437|530186653|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006597|NCT00112437|530186654|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006598|NCT00112437|530186655|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006599|NCT00112437|530186656|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006600|NCT00112437|530186657|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006601|NCT00112437|530186658|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006602|NCT00112437|530186659|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006603|NCT00112437|530186660|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006604|NCT00112437|530186661|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006605|NCT00112437|530186662|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006606|NCT00112437|530186663|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006607|NCT00112437|530186664|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006608|NCT00112437|530186665|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006609|NCT00112437|530186666|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006610|NCT00112437|530186667|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006611|NCT00112437|530186668|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006612|NCT00112437|530186669|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006613|NCT00112437|530186670|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006614|NCT00112437|530186671|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006615|NCT00112437|530186672|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147006616|NCT00112437|530186647|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
147006617|NCT00112437|530186648|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
147006618|NCT00112437|530186649|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
147006619|NCT00112437|530186650|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
147006620|NCT00112437|530186651|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
147006621|NCT00112437|530186652|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006622|NCT00112437|530186653|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006623|NCT00112437|530186654|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006624|NCT00112437|530186655|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006625|NCT00112437|530186656|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006626|NCT00112437|530186657|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006627|NCT00112437|530186658|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006628|NCT00112437|530186659|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006629|NCT00112437|530186660|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006630|NCT00112437|530186661|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006631|NCT00112437|530186662|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006632|NCT00112437|530186663|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006633|NCT00112437|530186664|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006634|NCT00112437|530186665|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006635|NCT00112437|530186666|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006636|NCT00112437|530186667|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006637|NCT00112437|530186668|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146846992|NCT02071290|529610845|FG001|Overall Study|Withdrawal by Subject|1|||
147006638|NCT00112437|530186669|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006639|NCT00112437|530186670|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006640|NCT00112437|530186671|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006641|NCT00112437|530186672|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147006642|NCT00112437|530186647|FG000|Year 1 (12-Month Base Study)|moved|0|||
147006643|NCT00112437|530186648|FG001|Year 1 (12-Month Base Study)|moved|1|||
147006644|NCT00112437|530186649|FG002|Year 1 (12-Month Base Study)|moved|1|||
147006645|NCT00112437|530186650|FG003|Year 1 (12-Month Base Study)|moved|0|||
147006646|NCT00112437|530186651|FG004|Year 1 (12-Month Base Study)|moved|0|||
147006647|NCT00112437|530186652|FG005|Year 1 (12-Month Base Study)|moved|0|||
147006648|NCT00112437|530186653|FG006|Year 1 (12-Month Base Study)|moved|0|||
147006649|NCT00112437|530186654|FG007|Year 1 (12-Month Base Study)|moved|0|||
147006650|NCT00112437|530186655|FG008|Year 1 (12-Month Base Study)|moved|0|||
147006651|NCT00112437|530186656|FG009|Year 1 (12-Month Base Study)|moved|0|||
147006652|NCT00112437|530186657|FG010|Year 1 (12-Month Base Study)|moved|0|||
147006653|NCT00112437|530186658|FG011|Year 1 (12-Month Base Study)|moved|0|||
147006654|NCT00112437|530186659|FG012|Year 1 (12-Month Base Study)|moved|0|||
147006655|NCT00112437|530186660|FG013|Year 1 (12-Month Base Study)|moved|0|||
147006656|NCT00112437|530186661|FG014|Year 1 (12-Month Base Study)|moved|0|||
147006657|NCT00112437|530186662|FG015|Year 1 (12-Month Base Study)|moved|0|||
147006658|NCT00112437|530186663|FG016|Year 1 (12-Month Base Study)|moved|0|||
147006659|NCT00112437|530186664|FG017|Year 1 (12-Month Base Study)|moved|0|||
147006660|NCT00112437|530186665|FG018|Year 1 (12-Month Base Study)|moved|0|||
147006661|NCT00112437|530186666|FG019|Year 1 (12-Month Base Study)|moved|0|||
147006662|NCT00112437|530186667|FG020|Year 1 (12-Month Base Study)|moved|0|||
147006663|NCT00112437|530186668|FG021|Year 1 (12-Month Base Study)|moved|0|||
147006664|NCT00112437|530186669|FG022|Year 1 (12-Month Base Study)|moved|0|||
147006665|NCT00112437|530186670|FG023|Year 1 (12-Month Base Study)|moved|0|||
147006666|NCT00112437|530186671|FG024|Year 1 (12-Month Base Study)|moved|0|||
147006667|NCT00112437|530186672|FG025|Year 1 (12-Month Base Study)|moved|0|||
147006668|NCT00112437|530186647|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006669|NCT00112437|530186648|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006670|NCT00112437|530186649|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006671|NCT00112437|530186650|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
147006672|NCT00112437|530186651|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006673|NCT00112437|530186652|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006674|NCT00112437|530186653|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006675|NCT00112437|530186654|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006676|NCT00112437|530186655|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006677|NCT00112437|530186656|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006678|NCT00112437|530186657|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006679|NCT00112437|530186658|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006680|NCT00112437|530186659|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006681|NCT00112437|530186660|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006682|NCT00112437|530186661|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006683|NCT00112437|530186662|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006684|NCT00112437|530186663|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006685|NCT00112437|530186664|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006686|NCT00112437|530186665|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006687|NCT00112437|530186666|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006688|NCT00112437|530186667|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006689|NCT00112437|530186668|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006690|NCT00112437|530186669|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006691|NCT00112437|530186670|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006692|NCT00112437|530186671|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006693|NCT00112437|530186672|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147006694|NCT00112437|530186647|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006695|NCT00112437|530186648|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006696|NCT00112437|530186649|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006697|NCT00112437|530186650|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006698|NCT00112437|530186651|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
147006699|NCT00112437|530186652|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006700|NCT00112437|530186653|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006701|NCT00112437|530186654|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146846993|NCT02071290|529610844|FG000|Overall Study|Protocol Violation|3|||
147006702|NCT00112437|530186655|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006703|NCT00112437|530186656|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006704|NCT00112437|530186657|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006705|NCT00112437|530186658|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006706|NCT00112437|530186659|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006707|NCT00112437|530186660|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006708|NCT00112437|530186661|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006709|NCT00112437|530186662|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006710|NCT00112437|530186663|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006711|NCT00112437|530186664|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006712|NCT00112437|530186665|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006713|NCT00112437|530186666|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006714|NCT00112437|530186667|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006715|NCT00112437|530186668|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006716|NCT00112437|530186669|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006717|NCT00112437|530186670|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006718|NCT00112437|530186671|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006719|NCT00112437|530186672|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147006720|NCT00112437|530186647|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
147006721|NCT00112437|530186648|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
147006722|NCT00112437|530186649|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
147006723|NCT00112437|530186650|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
147006724|NCT00112437|530186651|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
147006725|NCT00112437|530186652|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
147006726|NCT00112437|530186653|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
147006727|NCT00112437|530186654|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
147006728|NCT00112437|530186655|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
147006729|NCT00112437|530186656|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
147006730|NCT00112437|530186657|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
147006731|NCT00112437|530186658|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
147006732|NCT00112437|530186659|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
147006733|NCT00112437|530186660|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
147006734|NCT00112437|530186661|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
147006735|NCT00112437|530186662|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
147006736|NCT00112437|530186663|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
147006737|NCT00112437|530186664|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
147006738|NCT00112437|530186665|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
147006739|NCT00112437|530186666|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
147006740|NCT00112437|530186667|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
147006741|NCT00112437|530186668|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
147006742|NCT00112437|530186669|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
147006743|NCT00112437|530186670|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
147006744|NCT00112437|530186671|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
147006745|NCT00112437|530186672|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
147006746|NCT00112437|530186647|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006747|NCT00112437|530186648|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006748|NCT00112437|530186649|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006749|NCT00112437|530186650|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006750|NCT00112437|530186651|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006751|NCT00112437|530186652|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
147006752|NCT00112437|530186653|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
146736076|NCT02332590|529205300|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
147006753|NCT00112437|530186654|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006754|NCT00112437|530186655|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006755|NCT00112437|530186656|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
147006756|NCT00112437|530186657|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006757|NCT00112437|530186658|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006758|NCT00112437|530186659|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006759|NCT00112437|530186660|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006760|NCT00112437|530186661|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006761|NCT00112437|530186662|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006762|NCT00112437|530186663|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006763|NCT00112437|530186664|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006764|NCT00112437|530186665|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006765|NCT00112437|530186666|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006766|NCT00112437|530186667|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006767|NCT00112437|530186668|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006768|NCT00112437|530186669|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006769|NCT00112437|530186670|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006770|NCT00112437|530186671|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146846994|NCT02071290|529610845|FG001|Overall Study|Protocol Violation|5|||
146846995|NCT02071290|529610844|FG000|Overall Study|Physician Decision|0|||
146846996|NCT02071290|529610845|FG001|Overall Study|Physician Decision|1|||
146846997|NCT00939822|529610846|FG000|Overall Study|Lost to Follow-up|1|||
146846998|NCT00939822|529610847|FG001|Overall Study|Lost to Follow-up|0|||
146846999|NCT00939822|529610846|FG000|Overall Study|withdrew from study due to busy schedule|1|||
146847000|NCT00939822|529610847|FG001|Overall Study|withdrew from study due to busy schedule|1|||
146847001|NCT00939822|529610846|FG000|Overall Study|Mental health issues|0|||
146847002|NCT00939822|529610847|FG001|Overall Study|Mental health issues|2|||
146847003|NCT01232738|529610848|FG000|Overall Study|Death|3|||
146847004|NCT01232738|529610848|FG000|Overall Study|Physician Decision|2|||
146847005|NCT01232738|529610848|FG000|Overall Study|Lost to Follow-up|1|||
146847006|NCT01232738|529610848|FG000|Overall Study|Withdrawal by Subject|2|||
146847007|NCT01232738|529610848|FG000|Overall Study|Adverse Event|5|||
146847008|NCT01365481|529610856|FG000|Overall Study|Adverse Event|6|||
146847009|NCT01365481|529610857|FG001|Overall Study|Adverse Event|9|||
146847010|NCT01365481|529610858|FG002|Overall Study|Adverse Event|0|||
146847011|NCT01365481|529610859|FG003|Overall Study|Adverse Event|2|||
146847012|NCT01365481|529610856|FG000|Overall Study|Withdrawal by Subject|0|||
146847013|NCT01365481|529610857|FG001|Overall Study|Withdrawal by Subject|2|||
146847014|NCT01365481|529610858|FG002|Overall Study|Withdrawal by Subject|1|||
146847015|NCT01365481|529610859|FG003|Overall Study|Withdrawal by Subject|1|||
146847016|NCT01365481|529610856|FG000|Overall Study|Lost to Follow-up|1|||
146847017|NCT01365481|529610857|FG001|Overall Study|Lost to Follow-up|1|||
146847018|NCT01365481|529610858|FG002|Overall Study|Lost to Follow-up|2|||
146847019|NCT01365481|529610859|FG003|Overall Study|Lost to Follow-up|3|||
146847020|NCT01365481|529610856|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146847021|NCT01365481|529610857|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146847022|NCT01365481|529610858|FG002|Overall Study|Abnormal laboratory value(s)|0|||
146847023|NCT01365481|529610859|FG003|Overall Study|Abnormal laboratory value(s)|0|||
146847024|NCT01365481|529610856|FG000|Overall Study|Administrative problems|0|||
146847025|NCT01365481|529610857|FG001|Overall Study|Administrative problems|1|||
146847026|NCT01365481|529610858|FG002|Overall Study|Administrative problems|0|||
146847027|NCT01365481|529610859|FG003|Overall Study|Administrative problems|0|||
146847028|NCT01365481|529610856|FG000|Overall Study|Protocol deviation|0|||
146847029|NCT01365481|529610857|FG001|Overall Study|Protocol deviation|1|||
146847030|NCT01365481|529610858|FG002|Overall Study|Protocol deviation|0|||
146847031|NCT01365481|529610859|FG003|Overall Study|Protocol deviation|1|||
147006771|NCT00112437|530186672|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147006772|NCT00112437|530186647|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006773|NCT00112437|530186648|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006774|NCT00112437|530186649|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006775|NCT00112437|530186650|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006776|NCT00112437|530186651|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006777|NCT00112437|530186652|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006778|NCT00112437|530186653|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006779|NCT00112437|530186654|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006780|NCT00112437|530186655|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
147006781|NCT00112437|530186656|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006782|NCT00112437|530186657|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006783|NCT00112437|530186658|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006784|NCT00112437|530186659|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006785|NCT00112437|530186660|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006786|NCT00112437|530186661|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006787|NCT00112437|530186662|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006788|NCT00112437|530186663|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006789|NCT00112437|530186664|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146847032|NCT01365481|529610856|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146847033|NCT01365481|529610857|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146847034|NCT01365481|529610858|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
146847035|NCT01365481|529610859|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
146847036|NCT00958841|529610864|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146847037|NCT00958841|529610864|FG000|Overall Study|Abnormal test procedure result(s)|3|||
146847038|NCT00958841|529610864|FG000|Overall Study|Administrative problems|1|||
146847039|NCT00958841|529610864|FG000|Overall Study|Adverse Event|8|||
146847040|NCT00958841|529610864|FG000|Overall Study|New cancer therapy|5|||
147006790|NCT00112437|530186665|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006791|NCT00112437|530186666|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006792|NCT00112437|530186667|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006793|NCT00112437|530186668|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006794|NCT00112437|530186669|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006795|NCT00112437|530186670|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146847041|NCT00958841|529610864|FG000|Overall Study|Withdrawal by Subject|1|||
146847042|NCT00958841|529610864|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
146847043|NCT00958841|529610864|FG000|Overall Study|Completed M6/did not enter extension|27|||
146847044|NCT00958841|529610864|FG000|Overall Study|Discontinued prior to M*|28|||
146847045|NCT00436605|529610868|FG000|Overall Study|Protocol Violation|3|||
146847046|NCT03014011|529610869|FG000|First Intervention|Withdrawal by Subject|1|||
146847047|NCT03014011|529610870|FG001|First Intervention|Withdrawal by Subject|0|||
146847048|NCT03014011|529610869|FG000|Washout|Withdrawal by Subject|1|||
146847049|NCT03014011|529610870|FG001|Washout|Withdrawal by Subject|0|||
146847050|NCT01259089|529610880|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
146847051|NCT01259089|529610881|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
146847052|NCT01259089|529610882|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
146847053|NCT01259089|529610883|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
146847054|NCT01259089|529610884|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
146847055|NCT01259089|529610885|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
146847056|NCT01259089|529610880|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
146847057|NCT01259089|529610881|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
146847058|NCT01259089|529610882|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
146847059|NCT01259089|529610883|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
146847060|NCT01259089|529610884|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
146847061|NCT01259089|529610885|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
146847062|NCT01259089|529610880|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
146847063|NCT01259089|529610881|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
146847064|NCT01259089|529610882|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
146847065|NCT01259089|529610883|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
146847066|NCT01259089|529610884|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
146847067|NCT01259089|529610885|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
146847068|NCT01259089|529610880|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
146847069|NCT01259089|529610881|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
146847070|NCT01259089|529610882|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
146847071|NCT01259089|529610883|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
146847072|NCT01259089|529610884|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
146847073|NCT01259089|529610885|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
146847074|NCT01259089|529610880|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
146847075|NCT01259089|529610881|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
146847076|NCT01259089|529610882|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
146847077|NCT01259089|529610883|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
146847078|NCT01259089|529610884|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
146847079|NCT01259089|529610885|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
146847080|NCT01259089|529610880|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
146847081|NCT01259089|529610881|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
146847082|NCT01259089|529610882|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
146847083|NCT01259089|529610883|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
146847084|NCT01259089|529610884|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
146847085|NCT01259089|529610885|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
146847086|NCT01259089|529610880|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
146847087|NCT01259089|529610881|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
146847088|NCT01259089|529610882|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
146847089|NCT01259089|529610883|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
146847090|NCT01259089|529610884|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
146847091|NCT01259089|529610885|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
146847092|NCT01259089|529610880|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
146847093|NCT01259089|529610881|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
146847094|NCT01259089|529610882|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
146847095|NCT01259089|529610883|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
146847096|NCT01259089|529610884|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
146847097|NCT01259089|529610885|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
146847098|NCT01259089|529610880|FG000|Survival Follow up for Two Years|Death|3|||
146847099|NCT01259089|529610881|FG001|Survival Follow up for Two Years|Death|2|||
147006796|NCT00112437|530186671|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146847100|NCT01259089|529610882|FG002|Survival Follow up for Two Years|Death|2|||
147006797|NCT00112437|530186672|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147006798|NCT00112437|530186647|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006799|NCT00112437|530186648|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006800|NCT00112437|530186649|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006801|NCT00112437|530186650|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006802|NCT00112437|530186651|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006803|NCT00112437|530186652|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006804|NCT00112437|530186653|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
146847101|NCT01259089|529610883|FG003|Survival Follow up for Two Years|Death|3|||
146847102|NCT01259089|529610884|FG004|Survival Follow up for Two Years|Death|6|||
146847103|NCT01259089|529610885|FG005|Survival Follow up for Two Years|Death|13|||
146847104|NCT01259089|529610880|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
146847105|NCT01259089|529610881|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
146847106|NCT01259089|529610882|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
146847107|NCT01259089|529610883|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
146847108|NCT01259089|529610884|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
146847109|NCT01259089|529610885|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
146847110|NCT01259089|529610880|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
146847111|NCT01259089|529610881|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
146847112|NCT01259089|529610882|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
146847113|NCT01259089|529610883|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
146847114|NCT01259089|529610884|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
147006805|NCT00112437|530186654|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006806|NCT00112437|530186655|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
147006807|NCT00112437|530186656|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006808|NCT00112437|530186657|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006809|NCT00112437|530186658|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006810|NCT00112437|530186659|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006811|NCT00112437|530186660|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006812|NCT00112437|530186661|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006813|NCT00112437|530186662|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006814|NCT00112437|530186663|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006815|NCT00112437|530186664|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006816|NCT00112437|530186665|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006817|NCT00112437|530186666|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006818|NCT00112437|530186667|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006819|NCT00112437|530186668|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006820|NCT00112437|530186669|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006821|NCT00112437|530186670|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006822|NCT00112437|530186671|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006823|NCT00112437|530186672|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
147006824|NCT00112437|530186647|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006825|NCT00112437|530186648|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006826|NCT00112437|530186649|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006827|NCT00112437|530186650|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006828|NCT00112437|530186651|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006829|NCT00112437|530186652|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
147006830|NCT00112437|530186653|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
147006831|NCT00112437|530186654|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
147006832|NCT00112437|530186655|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
147006833|NCT00112437|530186656|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
147006834|NCT00112437|530186657|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006835|NCT00112437|530186658|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006836|NCT00112437|530186659|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006837|NCT00112437|530186660|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006838|NCT00112437|530186661|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006839|NCT00112437|530186662|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006840|NCT00112437|530186663|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006841|NCT00112437|530186664|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006842|NCT00112437|530186665|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006843|NCT00112437|530186666|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006844|NCT00112437|530186667|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006845|NCT00112437|530186668|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006846|NCT00112437|530186669|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006847|NCT00112437|530186670|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006848|NCT00112437|530186671|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006849|NCT00112437|530186672|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147006850|NCT00112437|530186647|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006851|NCT00112437|530186648|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146847115|NCT01259089|529610885|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
147006852|NCT00112437|530186649|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006853|NCT00112437|530186650|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146847116|NCT02310100|529610890|FG000|Overall Study|Physician Decision|3|||
147006854|NCT00112437|530186651|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006855|NCT00112437|530186652|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147013228|NCT01708954|530210055|FG001|Step 1|Adverse Event|11|||
146847117|NCT02310100|529610890|FG000|Overall Study|Withdrawal by Subject|10|||
147006856|NCT00112437|530186653|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006857|NCT00112437|530186654|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006858|NCT00112437|530186655|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006859|NCT00112437|530186656|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
147006860|NCT00112437|530186657|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006861|NCT00112437|530186658|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006862|NCT00112437|530186659|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006863|NCT00112437|530186660|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006864|NCT00112437|530186661|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006865|NCT00112437|530186662|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006866|NCT00112437|530186663|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006867|NCT00112437|530186664|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006868|NCT00112437|530186665|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006869|NCT00112437|530186666|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006870|NCT00112437|530186667|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006871|NCT00112437|530186668|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006872|NCT00112437|530186669|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006873|NCT00112437|530186670|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006874|NCT00112437|530186671|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006875|NCT00112437|530186672|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147006876|NCT00112437|530186647|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006877|NCT00112437|530186648|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006878|NCT00112437|530186649|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006879|NCT00112437|530186650|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006880|NCT00112437|530186651|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006881|NCT00112437|530186652|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006882|NCT00112437|530186653|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006883|NCT00112437|530186654|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006884|NCT00112437|530186655|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006885|NCT00112437|530186656|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
147006886|NCT00112437|530186657|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006887|NCT00112437|530186658|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006888|NCT00112437|530186659|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006889|NCT00112437|530186660|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006890|NCT00112437|530186661|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006891|NCT00112437|530186662|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006892|NCT00112437|530186663|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006893|NCT00112437|530186664|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006894|NCT00112437|530186665|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006895|NCT00112437|530186666|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006896|NCT00112437|530186667|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006897|NCT00112437|530186668|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006898|NCT00112437|530186669|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006899|NCT00112437|530186670|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006900|NCT00112437|530186671|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006901|NCT00112437|530186672|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
147006902|NCT00112437|530186647|FG000|Year 2 (12-Month Extension)|Moved|0|||
147006903|NCT00112437|530186648|FG001|Year 2 (12-Month Extension)|Moved|0|||
147006904|NCT00112437|530186649|FG002|Year 2 (12-Month Extension)|Moved|0|||
147006905|NCT00112437|530186650|FG003|Year 2 (12-Month Extension)|Moved|0|||
147006906|NCT00112437|530186651|FG004|Year 2 (12-Month Extension)|Moved|0|||
147006907|NCT00112437|530186652|FG005|Year 2 (12-Month Extension)|Moved|0|||
147006908|NCT00112437|530186653|FG006|Year 2 (12-Month Extension)|Moved|0|||
147006909|NCT00112437|530186654|FG007|Year 2 (12-Month Extension)|Moved|0|||
147006910|NCT00112437|530186655|FG008|Year 2 (12-Month Extension)|Moved|0|||
147006911|NCT00112437|530186656|FG009|Year 2 (12-Month Extension)|Moved|1|||
147006912|NCT00112437|530186657|FG010|Year 2 (12-Month Extension)|Moved|0|||
147006913|NCT00112437|530186658|FG011|Year 2 (12-Month Extension)|Moved|0|||
147006914|NCT00112437|530186659|FG012|Year 2 (12-Month Extension)|Moved|0|||
147006915|NCT00112437|530186660|FG013|Year 2 (12-Month Extension)|Moved|0|||
147006916|NCT00112437|530186661|FG014|Year 2 (12-Month Extension)|Moved|0|||
147006917|NCT00112437|530186662|FG015|Year 2 (12-Month Extension)|Moved|0|||
147006918|NCT00112437|530186663|FG016|Year 2 (12-Month Extension)|Moved|0|||
147006919|NCT00112437|530186664|FG017|Year 2 (12-Month Extension)|Moved|0|||
147006920|NCT00112437|530186665|FG018|Year 2 (12-Month Extension)|Moved|0|||
147006921|NCT00112437|530186666|FG019|Year 2 (12-Month Extension)|Moved|0|||
147006922|NCT00112437|530186667|FG020|Year 2 (12-Month Extension)|Moved|0|||
147006923|NCT00112437|530186668|FG021|Year 2 (12-Month Extension)|Moved|0|||
147006924|NCT00112437|530186669|FG022|Year 2 (12-Month Extension)|Moved|0|||
147006925|NCT00112437|530186670|FG023|Year 2 (12-Month Extension)|Moved|0|||
147006926|NCT00112437|530186671|FG024|Year 2 (12-Month Extension)|Moved|0|||
147006927|NCT00112437|530186672|FG025|Year 2 (12-Month Extension)|Moved|0|||
147006928|NCT00112437|530186647|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
147006929|NCT00112437|530186648|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
147006930|NCT00112437|530186649|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
147006931|NCT00112437|530186650|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
147006932|NCT00112437|530186651|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
147006933|NCT00112437|530186652|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
147006934|NCT00112437|530186653|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
147006935|NCT00112437|530186654|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
147006936|NCT00112437|530186655|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
147006937|NCT00112437|530186656|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
147006938|NCT00112437|530186657|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
147006939|NCT00112437|530186658|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
147006940|NCT00112437|530186659|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
147006941|NCT00112437|530186660|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
147006942|NCT00112437|530186661|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
147006943|NCT00112437|530186662|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
147006944|NCT00112437|530186663|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
147006945|NCT00112437|530186664|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
147006946|NCT00112437|530186665|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
147006947|NCT00112437|530186666|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
147006948|NCT00112437|530186667|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
147006949|NCT00112437|530186668|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
147006950|NCT00112437|530186669|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
147006951|NCT00112437|530186670|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
147006952|NCT00112437|530186671|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
147006953|NCT00112437|530186672|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
147006954|NCT00112437|530186647|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006955|NCT00112437|530186648|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006956|NCT00112437|530186649|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006957|NCT00112437|530186650|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006958|NCT00112437|530186651|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006959|NCT00112437|530186652|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006960|NCT00112437|530186653|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006961|NCT00112437|530186654|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006962|NCT00112437|530186655|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006963|NCT00112437|530186656|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006964|NCT00112437|530186657|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006965|NCT00112437|530186658|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
147006966|NCT00112437|530186659|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006967|NCT00112437|530186660|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
147006968|NCT00112437|530186661|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006969|NCT00112437|530186662|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
147006970|NCT00112437|530186663|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006971|NCT00112437|530186664|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006972|NCT00112437|530186665|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
147006973|NCT00112437|530186666|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006974|NCT00112437|530186667|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006975|NCT00112437|530186668|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006976|NCT00112437|530186669|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006977|NCT00112437|530186670|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006978|NCT00112437|530186671|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006979|NCT00112437|530186672|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147006980|NCT00112437|530186647|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147006981|NCT00112437|530186648|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147006982|NCT00112437|530186649|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147006983|NCT00112437|530186650|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147006984|NCT00112437|530186651|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147006985|NCT00112437|530186652|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147006986|NCT00112437|530186653|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146962244|NCT02067728|530021544|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
146962245|NCT02067728|530021545|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
146962246|NCT02067728|530021544|FG000|6 Month Measurements|Unable to attend|114|||
146962247|NCT02067728|530021545|FG001|6 Month Measurements|Unable to attend|97|||
146962248|NCT03532048|530021548|FG000|Overall Study|Lost to Follow-up|12|||
146962249|NCT03532048|530021549|FG001|Overall Study|Lost to Follow-up|17|||
146962250|NCT03532048|530021548|FG000|Overall Study|Withdrawal by Subject|7|||
147006987|NCT00112437|530186654|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147006988|NCT00112437|530186655|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146962251|NCT03532048|530021549|FG001|Overall Study|Withdrawal by Subject|0|||
146962252|NCT04629534|530021550|FG000|Overall Study|Physician Decision|1|||
146962253|NCT04629534|530021551|FG001|Overall Study|Physician Decision|0|||
146962254|NCT04629534|530021550|FG000|Overall Study|Protocol Violation|0|||
146962255|NCT04629534|530021551|FG001|Overall Study|Protocol Violation|2|||
146962256|NCT01901393|530021552|FG000|Overall Study|Adverse Event|1|||
147006989|NCT00112437|530186656|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147006990|NCT00112437|530186657|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147006991|NCT00112437|530186658|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147006992|NCT00112437|530186659|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147006993|NCT00112437|530186660|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147006994|NCT00112437|530186661|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147006995|NCT00112437|530186662|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
147006996|NCT00112437|530186663|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147006997|NCT00112437|530186664|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147006998|NCT00112437|530186665|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147006999|NCT00112437|530186666|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147007000|NCT00112437|530186667|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147007001|NCT00112437|530186668|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147007002|NCT00112437|530186669|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147007003|NCT00112437|530186670|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147007004|NCT00112437|530186671|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147007005|NCT00112437|530186672|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147007006|NCT00112437|530186647|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007007|NCT00112437|530186648|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007008|NCT00112437|530186649|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007009|NCT00112437|530186650|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007010|NCT00112437|530186651|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007011|NCT00112437|530186652|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007012|NCT00112437|530186653|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007013|NCT00112437|530186654|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007014|NCT00112437|530186655|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007015|NCT00112437|530186656|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007016|NCT00112437|530186657|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
146962257|NCT01901393|530021553|FG001|Overall Study|Adverse Event|0|||
146962258|NCT04113746|530021558|FG000|Overall Study|Lost to Follow-up|4|||
146962259|NCT04113746|530021559|FG001|Overall Study|Lost to Follow-up|4|||
146962260|NCT03125382|530021560|FG000|Randomization|screening failure|1|||
146962261|NCT03125382|530021561|FG001|Randomization|screening failure|4|||
146962262|NCT03125382|530021562|FG002|Randomization|screening failure|2|||
146962263|NCT03125382|530021563|FG003|Randomization|screening failure|0|||
146962264|NCT03125382|530021560|FG000|Follow-up|Death|1|||
146962265|NCT03125382|530021561|FG001|Follow-up|Death|2|||
146962266|NCT03125382|530021562|FG002|Follow-up|Death|1|||
146962267|NCT03125382|530021563|FG003|Follow-up|Death|2|||
146962268|NCT03125382|530021560|FG000|Follow-up|Lost to Follow-up|1|||
146962269|NCT03125382|530021561|FG001|Follow-up|Lost to Follow-up|4|||
146962270|NCT03125382|530021562|FG002|Follow-up|Lost to Follow-up|3|||
146962271|NCT03125382|530021563|FG003|Follow-up|Lost to Follow-up|1|||
146962272|NCT04246593|530021569|FG000|Overall Study|Withdrawal by Subject|14|||
146962273|NCT04246593|530021570|FG001|Overall Study|Withdrawal by Subject|13|||
146962274|NCT04246593|530021569|FG000|Overall Study|Lost to Follow-up|124|||
146962275|NCT04246593|530021570|FG001|Overall Study|Lost to Follow-up|71|||
146962276|NCT04246593|530021569|FG000|Overall Study|Moved out of area/became ineligible|3|||
146962277|NCT04246593|530021570|FG001|Overall Study|Moved out of area/became ineligible|1|||
146962278|NCT04246593|530021569|FG000|Overall Study|Reason unknown|4|||
146962279|NCT04246593|530021570|FG001|Overall Study|Reason unknown|2|||
146962280|NCT00265109|530021571|FG000|Overall Study|Withdrawal by Subject|5|||
146962281|NCT00265109|530021571|FG000|Overall Study|Adverse Event|1|||
146962282|NCT01049360|530021574|FG000|Period 1|Adverse Event|0|||
146962283|NCT01049360|530021575|FG001|Period 1|Adverse Event|1|||
146962284|NCT01049360|530021576|FG002|Period 1|Adverse Event|0|||
146962285|NCT01049360|530021577|FG003|Period 1|Adverse Event|1|||
146962286|NCT01049360|530021578|FG004|Period 1|Adverse Event|0|||
146962287|NCT01049360|530021579|FG005|Period 1|Adverse Event|0|||
146962288|NCT01049360|530021580|FG006|Period 1|Adverse Event|0|||
146962289|NCT01049360|530021581|FG007|Period 1|Adverse Event|1|||
146962290|NCT01049360|530021582|FG008|Period 1|Adverse Event|0|||
146962291|NCT01049360|530021583|FG009|Period 1|Adverse Event|0|||
146962292|NCT01049360|530021584|FG010|Period 1|Adverse Event|0|||
146962293|NCT01049360|530021585|FG011|Period 1|Adverse Event|0|||
146962294|NCT01049360|530021586|FG012|Period 1|Adverse Event|1|||
146962295|NCT01049360|530021587|FG013|Period 1|Adverse Event|1|||
146962296|NCT01049360|530021588|FG014|Period 1|Adverse Event|0|||
146962297|NCT01049360|530021589|FG015|Period 1|Adverse Event|0|||
146962298|NCT01049360|530021590|FG016|Period 1|Adverse Event|1|||
146962299|NCT01049360|530021591|FG017|Period 1|Adverse Event|0|||
146962300|NCT01049360|530021592|FG018|Period 1|Adverse Event|1|||
146962301|NCT01049360|530021593|FG019|Period 1|Adverse Event|0|||
146962302|NCT01049360|530021574|FG000|Period 1|Did not meet inc/exc criteria|0|||
147007017|NCT00112437|530186658|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007018|NCT00112437|530186659|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007019|NCT00112437|530186660|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007020|NCT00112437|530186661|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007021|NCT00112437|530186662|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
147007022|NCT00112437|530186663|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007023|NCT00112437|530186664|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007024|NCT00112437|530186665|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007025|NCT00112437|530186666|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007026|NCT00112437|530186667|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007027|NCT00112437|530186668|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007028|NCT00112437|530186669|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007029|NCT00112437|530186670|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007030|NCT00112437|530186671|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007031|NCT00112437|530186672|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
147007032|NCT00112437|530186647|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007033|NCT00112437|530186648|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007034|NCT00112437|530186649|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007035|NCT00112437|530186650|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007036|NCT00112437|530186651|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007037|NCT00112437|530186652|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007038|NCT00112437|530186653|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007039|NCT00112437|530186654|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007040|NCT00112437|530186655|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007041|NCT00112437|530186656|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007042|NCT00112437|530186657|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007043|NCT00112437|530186658|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
147007044|NCT00112437|530186659|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007045|NCT00112437|530186660|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007046|NCT00112437|530186661|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
147007047|NCT00112437|530186662|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007048|NCT00112437|530186663|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007049|NCT00112437|530186664|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007050|NCT00112437|530186665|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007051|NCT00112437|530186666|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007052|NCT00112437|530186667|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007053|NCT00112437|530186668|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007054|NCT00112437|530186669|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007055|NCT00112437|530186670|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007056|NCT00112437|530186671|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007057|NCT00112437|530186672|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147007058|NCT00112437|530186647|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007059|NCT00112437|530186648|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007060|NCT00112437|530186649|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007061|NCT00112437|530186650|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007062|NCT00112437|530186651|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007063|NCT00112437|530186652|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007064|NCT00112437|530186653|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007065|NCT00112437|530186654|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007066|NCT00112437|530186655|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007067|NCT00112437|530186656|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007068|NCT00112437|530186657|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
147007069|NCT00112437|530186658|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
147007070|NCT00112437|530186659|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007071|NCT00112437|530186660|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007072|NCT00112437|530186661|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007073|NCT00112437|530186662|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007074|NCT00112437|530186663|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007075|NCT00112437|530186664|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007076|NCT00112437|530186665|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007077|NCT00112437|530186666|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007078|NCT00112437|530186667|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007079|NCT00112437|530186668|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007080|NCT00112437|530186669|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007081|NCT00112437|530186670|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007082|NCT00112437|530186671|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147013229|NCT01708954|530210056|FG002|Step 1|Adverse Event|13|||
147007083|NCT00112437|530186672|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147007084|NCT00112437|530186647|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007085|NCT00112437|530186648|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007086|NCT00112437|530186649|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007087|NCT00112437|530186650|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007088|NCT00112437|530186651|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007089|NCT00112437|530186652|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007090|NCT00112437|530186653|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007091|NCT00112437|530186654|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007092|NCT00112437|530186655|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007093|NCT00112437|530186656|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007094|NCT00112437|530186657|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007095|NCT00112437|530186658|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007096|NCT00112437|530186659|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007097|NCT00112437|530186660|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007098|NCT00112437|530186661|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007099|NCT00112437|530186662|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007100|NCT00112437|530186663|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007101|NCT00112437|530186664|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007102|NCT00112437|530186665|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007103|NCT00112437|530186666|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007104|NCT00112437|530186667|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
147007105|NCT00112437|530186668|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
147007106|NCT00112437|530186669|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007107|NCT00112437|530186670|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007108|NCT00112437|530186671|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007109|NCT00112437|530186672|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147007110|NCT00112437|530186647|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007111|NCT00112437|530186648|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007112|NCT00112437|530186649|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007113|NCT00112437|530186650|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007114|NCT00112437|530186651|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007115|NCT00112437|530186652|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007116|NCT00112437|530186653|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007117|NCT00112437|530186654|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007118|NCT00112437|530186655|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007119|NCT00112437|530186656|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007120|NCT00112437|530186657|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007121|NCT00112437|530186658|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007122|NCT00112437|530186659|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007123|NCT00112437|530186660|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007124|NCT00112437|530186661|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007125|NCT00112437|530186662|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007126|NCT00112437|530186663|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007127|NCT00112437|530186664|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007128|NCT00112437|530186665|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007129|NCT00112437|530186666|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007130|NCT00112437|530186667|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
147007131|NCT00112437|530186668|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007132|NCT00112437|530186669|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007133|NCT00112437|530186670|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007134|NCT00112437|530186671|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007135|NCT00112437|530186672|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147007136|NCT00112437|530186647|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007137|NCT00112437|530186648|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007138|NCT00112437|530186649|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007139|NCT00112437|530186650|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007140|NCT00112437|530186651|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007141|NCT00112437|530186652|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007142|NCT00112437|530186653|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146847118|NCT02310100|529610890|FG000|Overall Study|Enrollment closure|1|||
146847119|NCT02310100|529610890|FG000|Overall Study|Unapproved ablation operator|1|||
147007143|NCT00112437|530186654|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007144|NCT00112437|530186655|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007145|NCT00112437|530186656|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007146|NCT00112437|530186657|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007147|NCT00112437|530186658|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007148|NCT00112437|530186659|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007149|NCT00112437|530186660|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007150|NCT00112437|530186661|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007151|NCT00112437|530186662|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007152|NCT00112437|530186663|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007153|NCT00112437|530186664|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007154|NCT00112437|530186665|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007155|NCT00112437|530186666|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007156|NCT00112437|530186667|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007157|NCT00112437|530186668|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
147007158|NCT00112437|530186669|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007159|NCT00112437|530186670|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007160|NCT00112437|530186671|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007161|NCT00112437|530186672|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147007162|NCT00112437|530186647|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007163|NCT00112437|530186648|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007164|NCT00112437|530186649|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007165|NCT00112437|530186650|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007166|NCT00112437|530186651|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007167|NCT00112437|530186652|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007168|NCT00112437|530186653|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007169|NCT00112437|530186654|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007170|NCT00112437|530186655|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007171|NCT00112437|530186656|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
146847120|NCT02310100|529610890|FG000|Overall Study|Visit compliance|1|||
147007172|NCT00112437|530186657|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007173|NCT00112437|530186658|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007174|NCT00112437|530186659|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007175|NCT00112437|530186660|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007176|NCT00112437|530186661|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007177|NCT00112437|530186662|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007178|NCT00112437|530186663|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007179|NCT00112437|530186664|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007180|NCT00112437|530186665|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007181|NCT00112437|530186666|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007182|NCT00112437|530186667|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007183|NCT00112437|530186668|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
147007184|NCT00112437|530186669|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007185|NCT00112437|530186670|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007186|NCT00112437|530186671|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007187|NCT00112437|530186672|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
147007188|NCT00112437|530186647|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146847121|NCT02310100|529610890|FG000|Overall Study|Lost to Follow-up|2|||
146847122|NCT00688870|529610891|FG000|Infant Series|Parent or legal guardian request|4|||
146847123|NCT00688870|529610892|FG001|Infant Series|Parent or legal guardian request|0|||
146847124|NCT01253018|529610898|FG000|Overall Study|Lost to Follow-up|1|||
146847125|NCT01253018|529610899|FG001|Overall Study|Lost to Follow-up|1|||
146847126|NCT01253018|529610898|FG000|Overall Study|Robot Repair Issues|2|||
146847127|NCT01253018|529610899|FG001|Overall Study|Robot Repair Issues|0|||
146847128|NCT01253018|529610898|FG000|Overall Study|Withdrawal by Subject|1|||
146847129|NCT01253018|529610899|FG001|Overall Study|Withdrawal by Subject|1|||
146847130|NCT03449901|529610900|FG000|Overall Study|Progression|57|||
146847131|NCT03449901|529610901|FG001|Overall Study|Progression|12|||
146847132|NCT03449901|529610900|FG000|Overall Study|Adverse Event|3|||
146847133|NCT03449901|529610901|FG001|Overall Study|Adverse Event|0|||
146847134|NCT03449901|529610900|FG000|Overall Study|Death|6|||
146847135|NCT03449901|529610901|FG001|Overall Study|Death|2|||
146847136|NCT03449901|529610900|FG000|Overall Study|Withdrawal by Subject|12|||
146847137|NCT03449901|529610901|FG001|Overall Study|Withdrawal by Subject|1|||
146847138|NCT03449901|529610900|FG000|Overall Study|Physician Decision|1|||
146847139|NCT03449901|529610901|FG001|Overall Study|Physician Decision|0|||
147007189|NCT00112437|530186648|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007190|NCT00112437|530186649|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007191|NCT00112437|530186650|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007192|NCT00112437|530186651|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007193|NCT00112437|530186652|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007194|NCT00112437|530186653|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007195|NCT00112437|530186654|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007196|NCT00112437|530186655|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007197|NCT00112437|530186656|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007198|NCT00112437|530186657|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007199|NCT00112437|530186658|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007200|NCT00112437|530186659|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007201|NCT00112437|530186660|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007202|NCT00112437|530186661|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007203|NCT00112437|530186662|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007204|NCT00112437|530186663|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007205|NCT00112437|530186664|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007206|NCT00112437|530186665|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007207|NCT00112437|530186666|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007208|NCT00112437|530186667|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
147007209|NCT00112437|530186668|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
147007210|NCT00112437|530186669|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007211|NCT00112437|530186670|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007212|NCT00112437|530186671|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007213|NCT00112437|530186672|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147007214|NCT00112437|530186647|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007215|NCT00112437|530186648|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007216|NCT00112437|530186649|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007217|NCT00112437|530186650|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007218|NCT00112437|530186651|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007219|NCT00112437|530186652|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007220|NCT00112437|530186653|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007221|NCT00112437|530186654|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007222|NCT00112437|530186655|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007223|NCT00112437|530186656|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007224|NCT00112437|530186657|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007225|NCT00112437|530186658|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007226|NCT00112437|530186659|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007227|NCT00112437|530186660|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007228|NCT00112437|530186661|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007229|NCT00112437|530186662|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007230|NCT00112437|530186663|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007231|NCT00112437|530186664|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007232|NCT00112437|530186665|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007233|NCT00112437|530186666|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007234|NCT00112437|530186667|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007235|NCT00112437|530186668|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007236|NCT00112437|530186669|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
147007237|NCT00112437|530186670|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
147007238|NCT00112437|530186671|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147007239|NCT00112437|530186672|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
147007240|NCT00112437|530186647|FG000|Years 6-10 (60-Month Extension)|Death|0|||
147007241|NCT00112437|530186648|FG001|Years 6-10 (60-Month Extension)|Death|0|||
147007242|NCT00112437|530186649|FG002|Years 6-10 (60-Month Extension)|Death|0|||
147007243|NCT00112437|530186650|FG003|Years 6-10 (60-Month Extension)|Death|0|||
147007244|NCT00112437|530186651|FG004|Years 6-10 (60-Month Extension)|Death|0|||
147007245|NCT00112437|530186652|FG005|Years 6-10 (60-Month Extension)|Death|0|||
147007246|NCT00112437|530186653|FG006|Years 6-10 (60-Month Extension)|Death|0|||
147007247|NCT00112437|530186654|FG007|Years 6-10 (60-Month Extension)|Death|0|||
147007248|NCT00112437|530186655|FG008|Years 6-10 (60-Month Extension)|Death|0|||
147007249|NCT00112437|530186656|FG009|Years 6-10 (60-Month Extension)|Death|0|||
147007250|NCT00112437|530186657|FG010|Years 6-10 (60-Month Extension)|Death|0|||
146847140|NCT03449901|529610900|FG000|Overall Study|Patient elected for surgical intervention|1|||
146847141|NCT03449901|529610901|FG001|Overall Study|Patient elected for surgical intervention|0|||
146847142|NCT03449901|529610900|FG000|Overall Study|Patient off for other complicating disease|1|||
146847143|NCT03449901|529610901|FG001|Overall Study|Patient off for other complicating disease|0|||
146847144|NCT00744757|529610902|FG000|Overall Study|Objective disease progression|7|||
146847145|NCT00744757|529610902|FG000|Overall Study|Physician Decision|5|||
146847146|NCT00744757|529610902|FG000|Overall Study|Withdrawal by Subject|1|||
146847147|NCT00744757|529610902|FG000|Overall Study|Death|6|||
147007251|NCT00112437|530186658|FG011|Years 6-10 (60-Month Extension)|Death|0|||
147007252|NCT00112437|530186659|FG012|Years 6-10 (60-Month Extension)|Death|0|||
147007253|NCT00112437|530186660|FG013|Years 6-10 (60-Month Extension)|Death|0|||
147007254|NCT00112437|530186661|FG014|Years 6-10 (60-Month Extension)|Death|0|||
147007255|NCT00112437|530186662|FG015|Years 6-10 (60-Month Extension)|Death|0|||
146847148|NCT00744757|529610902|FG000|Overall Study|Adverse Event|2|||
147007256|NCT00112437|530186663|FG016|Years 6-10 (60-Month Extension)|Death|0|||
147007257|NCT00112437|530186664|FG017|Years 6-10 (60-Month Extension)|Death|0|||
147007258|NCT00112437|530186665|FG018|Years 6-10 (60-Month Extension)|Death|0|||
147007259|NCT00112437|530186666|FG019|Years 6-10 (60-Month Extension)|Death|0|||
147007260|NCT00112437|530186667|FG020|Years 6-10 (60-Month Extension)|Death|0|||
147007261|NCT00112437|530186668|FG021|Years 6-10 (60-Month Extension)|Death|0|||
147007262|NCT00112437|530186669|FG022|Years 6-10 (60-Month Extension)|Death|0|||
147007263|NCT00112437|530186670|FG023|Years 6-10 (60-Month Extension)|Death|2|||
147007264|NCT00112437|530186671|FG024|Years 6-10 (60-Month Extension)|Death|0|||
147007265|NCT00112437|530186672|FG025|Years 6-10 (60-Month Extension)|Death|0|||
147007266|NCT00112437|530186647|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007267|NCT00112437|530186648|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007268|NCT00112437|530186649|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007269|NCT00112437|530186650|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007270|NCT00112437|530186651|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007271|NCT00112437|530186652|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007272|NCT00112437|530186653|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007273|NCT00112437|530186654|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007274|NCT00112437|530186655|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007275|NCT00112437|530186656|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007276|NCT00112437|530186657|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007277|NCT00112437|530186658|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007278|NCT00112437|530186659|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007279|NCT00112437|530186660|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007280|NCT00112437|530186661|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007281|NCT00112437|530186662|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007282|NCT00112437|530186663|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007283|NCT00112437|530186664|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007284|NCT00112437|530186665|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007285|NCT00112437|530186666|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007286|NCT00112437|530186667|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007287|NCT00112437|530186668|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007288|NCT00112437|530186669|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007289|NCT00112437|530186670|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007290|NCT00112437|530186671|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147007291|NCT00112437|530186672|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
147007292|NCT00112437|530186647|FG000|Years 6-10 (60-Month Extension)|Other|0|||
147007293|NCT00112437|530186648|FG001|Years 6-10 (60-Month Extension)|Other|0|||
147007294|NCT00112437|530186649|FG002|Years 6-10 (60-Month Extension)|Other|0|||
147007295|NCT00112437|530186650|FG003|Years 6-10 (60-Month Extension)|Other|0|||
147007296|NCT00112437|530186651|FG004|Years 6-10 (60-Month Extension)|Other|0|||
147007297|NCT00112437|530186652|FG005|Years 6-10 (60-Month Extension)|Other|0|||
147007298|NCT00112437|530186653|FG006|Years 6-10 (60-Month Extension)|Other|0|||
147007299|NCT00112437|530186654|FG007|Years 6-10 (60-Month Extension)|Other|0|||
147007300|NCT00112437|530186655|FG008|Years 6-10 (60-Month Extension)|Other|0|||
147007301|NCT00112437|530186656|FG009|Years 6-10 (60-Month Extension)|Other|0|||
147007302|NCT00112437|530186657|FG010|Years 6-10 (60-Month Extension)|Other|0|||
147007303|NCT00112437|530186658|FG011|Years 6-10 (60-Month Extension)|Other|0|||
147007304|NCT00112437|530186659|FG012|Years 6-10 (60-Month Extension)|Other|0|||
147007305|NCT00112437|530186660|FG013|Years 6-10 (60-Month Extension)|Other|0|||
147007306|NCT00112437|530186661|FG014|Years 6-10 (60-Month Extension)|Other|0|||
147007307|NCT00112437|530186662|FG015|Years 6-10 (60-Month Extension)|Other|0|||
147007308|NCT00112437|530186663|FG016|Years 6-10 (60-Month Extension)|Other|0|||
147007309|NCT00112437|530186664|FG017|Years 6-10 (60-Month Extension)|Other|0|||
147007310|NCT00112437|530186665|FG018|Years 6-10 (60-Month Extension)|Other|0|||
147007311|NCT00112437|530186666|FG019|Years 6-10 (60-Month Extension)|Other|0|||
147007312|NCT00112437|530186667|FG020|Years 6-10 (60-Month Extension)|Other|0|||
147007313|NCT00112437|530186668|FG021|Years 6-10 (60-Month Extension)|Other|0|||
147007314|NCT00112437|530186669|FG022|Years 6-10 (60-Month Extension)|Other|0|||
147007315|NCT00112437|530186670|FG023|Years 6-10 (60-Month Extension)|Other|0|||
147007316|NCT00112437|530186671|FG024|Years 6-10 (60-Month Extension)|Other|1|||
147007317|NCT00112437|530186672|FG025|Years 6-10 (60-Month Extension)|Other|0|||
147007318|NCT00112437|530186647|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007319|NCT00112437|530186648|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007320|NCT00112437|530186649|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007321|NCT00112437|530186650|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007322|NCT00112437|530186651|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007323|NCT00112437|530186652|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007324|NCT00112437|530186653|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007325|NCT00112437|530186654|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007326|NCT00112437|530186655|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007327|NCT00112437|530186656|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007328|NCT00112437|530186657|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007329|NCT00112437|530186658|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007330|NCT00112437|530186659|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007331|NCT00112437|530186660|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007332|NCT00112437|530186661|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007333|NCT00112437|530186662|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007334|NCT00112437|530186663|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007335|NCT00112437|530186664|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007336|NCT00112437|530186665|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007337|NCT00112437|530186666|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007338|NCT00112437|530186667|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007339|NCT00112437|530186668|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007340|NCT00112437|530186669|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007341|NCT00112437|530186670|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
147007342|NCT00112437|530186671|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007343|NCT00112437|530186672|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147007344|NCT00112437|530186647|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007345|NCT00112437|530186648|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007346|NCT00112437|530186649|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007347|NCT00112437|530186650|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007348|NCT00112437|530186651|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007349|NCT00112437|530186652|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007350|NCT00112437|530186653|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007351|NCT00112437|530186654|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007352|NCT00112437|530186655|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007353|NCT00112437|530186656|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007354|NCT00112437|530186657|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007355|NCT00112437|530186658|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007356|NCT00112437|530186659|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007357|NCT00112437|530186660|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146847149|NCT03682302|529610903|FG000|Overall Study|Lost to Follow-up|1|||
146847150|NCT03682302|529610904|FG001|Overall Study|Lost to Follow-up|2|||
146847151|NCT03682302|529610905|FG002|Overall Study|Lost to Follow-up|0|||
146847152|NCT03682302|529610906|FG003|Overall Study|Lost to Follow-up|1|||
146847153|NCT03682302|529610903|FG000|Overall Study|Study drug was not administered|0|||
146847154|NCT03682302|529610904|FG001|Overall Study|Study drug was not administered|0|||
146847155|NCT03682302|529610905|FG002|Overall Study|Study drug was not administered|1|||
146847156|NCT03682302|529610906|FG003|Overall Study|Study drug was not administered|1|||
146847157|NCT00532493|529610907|FG000|Overall Study|Death|1|||
146847158|NCT00532493|529610908|FG001|Overall Study|Death|1|||
146847159|NCT00532493|529610907|FG000|Overall Study|Lost to Follow-up|10|||
146847160|NCT00532493|529610908|FG001|Overall Study|Lost to Follow-up|7|||
146847161|NCT00532493|529610907|FG000|Overall Study|Withdrawal by Subject|7|||
146847162|NCT00532493|529610908|FG001|Overall Study|Withdrawal by Subject|9|||
147007358|NCT00112437|530186661|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007359|NCT00112437|530186662|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007360|NCT00112437|530186663|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007361|NCT00112437|530186664|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007362|NCT00112437|530186665|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007363|NCT00112437|530186666|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007364|NCT00112437|530186667|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007365|NCT00112437|530186668|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007366|NCT00112437|530186669|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
147007367|NCT00112437|530186670|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
147007368|NCT00112437|530186671|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147007369|NCT00112437|530186672|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
147007370|NCT01824576|530186674|FG000|Overall Study|Device deficiency|2|||
147007371|NCT03218787|530186675|FG000|Overall Study|Lost to Follow-up|12|||
147007372|NCT03218787|530186675|FG000|Overall Study|Withdrawal by Subject|72|||
147007373|NCT03218787|530186675|FG000|Overall Study|Physician Decision|11|||
147007374|NCT03218787|530186675|FG000|Overall Study|Death|111|||
147007375|NCT03531827|530186676|FG000|Overall Study|Adverse Event|2|||
147007376|NCT03531827|530186677|FG001|Overall Study|Adverse Event|0|||
147007377|NCT03531827|530186676|FG000|Overall Study|Progressive disease|1|||
147007378|NCT03531827|530186677|FG001|Overall Study|Progressive disease|0|||
147007379|NCT01494532|530186680|FG000|Overall Study|Adverse Event|4|||
147007380|NCT01494532|530186681|FG001|Overall Study|Adverse Event|1|||
147007381|NCT01494532|530186682|FG002|Overall Study|Adverse Event|8|||
147007382|NCT01494532|530186683|FG003|Overall Study|Adverse Event|6|||
147007383|NCT01494532|530186684|FG004|Overall Study|Adverse Event|5|||
147007384|NCT01494532|530186685|FG005|Overall Study|Adverse Event|0|||
147007385|NCT01494532|530186680|FG000|Overall Study|Lack of Efficacy|0|||
147007386|NCT01494532|530186681|FG001|Overall Study|Lack of Efficacy|0|||
147007387|NCT01494532|530186682|FG002|Overall Study|Lack of Efficacy|0|||
146847163|NCT00532493|529610907|FG000|Overall Study|Physician Decision|1|||
146847164|NCT00532493|529610908|FG001|Overall Study|Physician Decision|6|||
146847165|NCT00532493|529610907|FG000|Overall Study|Adverse Event|6|||
146847166|NCT00532493|529610908|FG001|Overall Study|Adverse Event|5|||
147007388|NCT01494532|530186683|FG003|Overall Study|Lack of Efficacy|0|||
147007389|NCT01494532|530186684|FG004|Overall Study|Lack of Efficacy|2|||
147007390|NCT01494532|530186685|FG005|Overall Study|Lack of Efficacy|0|||
147007391|NCT01494532|530186680|FG000|Overall Study|Protocol deviation|2|||
147007392|NCT01494532|530186681|FG001|Overall Study|Protocol deviation|1|||
147007393|NCT01494532|530186682|FG002|Overall Study|Protocol deviation|3|||
147007394|NCT01494532|530186683|FG003|Overall Study|Protocol deviation|2|||
147007395|NCT01494532|530186684|FG004|Overall Study|Protocol deviation|3|||
147007396|NCT01494532|530186685|FG005|Overall Study|Protocol deviation|0|||
147007397|NCT01494532|530186680|FG000|Overall Study|Protocol-defined stopping criteria|0|||
147007398|NCT01494532|530186681|FG001|Overall Study|Protocol-defined stopping criteria|0|||
147007399|NCT01494532|530186682|FG002|Overall Study|Protocol-defined stopping criteria|1|||
147007400|NCT01494532|530186683|FG003|Overall Study|Protocol-defined stopping criteria|0|||
147007401|NCT01494532|530186684|FG004|Overall Study|Protocol-defined stopping criteria|0|||
147007402|NCT01494532|530186685|FG005|Overall Study|Protocol-defined stopping criteria|0|||
147007403|NCT01494532|530186680|FG000|Overall Study|Lost to Follow-up|1|||
147007404|NCT01494532|530186681|FG001|Overall Study|Lost to Follow-up|0|||
147007405|NCT01494532|530186682|FG002|Overall Study|Lost to Follow-up|0|||
147007406|NCT01494532|530186683|FG003|Overall Study|Lost to Follow-up|2|||
147007407|NCT01494532|530186684|FG004|Overall Study|Lost to Follow-up|0|||
147007408|NCT01494532|530186685|FG005|Overall Study|Lost to Follow-up|0|||
147007409|NCT01494532|530186680|FG000|Overall Study|Physician Decision|0|||
147007410|NCT01494532|530186681|FG001|Overall Study|Physician Decision|1|||
147007411|NCT01494532|530186682|FG002|Overall Study|Physician Decision|1|||
147007412|NCT01494532|530186683|FG003|Overall Study|Physician Decision|2|||
147007413|NCT01494532|530186684|FG004|Overall Study|Physician Decision|0|||
147007414|NCT01494532|530186685|FG005|Overall Study|Physician Decision|0|||
147007415|NCT01494532|530186680|FG000|Overall Study|Withdrawal by Subject|3|||
147007416|NCT01494532|530186681|FG001|Overall Study|Withdrawal by Subject|1|||
147007417|NCT01494532|530186682|FG002|Overall Study|Withdrawal by Subject|4|||
147007418|NCT01494532|530186683|FG003|Overall Study|Withdrawal by Subject|3|||
147007419|NCT01494532|530186684|FG004|Overall Study|Withdrawal by Subject|2|||
147007420|NCT01494532|530186685|FG005|Overall Study|Withdrawal by Subject|0|||
147007421|NCT03247686|530188618|FG000|Overall Study|Withdrawal by Subject|1|||
147007422|NCT03247686|530188619|FG001|Overall Study|Withdrawal by Subject|2|||
147007423|NCT01541215|530188622|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
147007424|NCT01541215|530188623|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
147007425|NCT01541215|530188622|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
147007426|NCT01541215|530188623|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
147007427|NCT01541215|530188622|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
147007428|NCT01541215|530188623|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
147007429|NCT01541215|530188622|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
147007430|NCT01541215|530188623|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
147007431|NCT01541215|530188622|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
147007432|NCT01541215|530188623|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
147007433|NCT01541215|530188622|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
147007434|NCT01541215|530188623|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
147007435|NCT02316223|530188634|FG000|Overall Study|Lack of Efficacy|0|||
147007436|NCT02316223|530188635|FG001|Overall Study|Lack of Efficacy|1|||
147007437|NCT02316223|530188636|FG002|Overall Study|Lack of Efficacy|1|||
147007438|NCT02316223|530188634|FG000|Overall Study|Lost to Follow-up|27|||
147007439|NCT02316223|530188635|FG001|Overall Study|Lost to Follow-up|34|||
147007440|NCT02316223|530188636|FG002|Overall Study|Lost to Follow-up|36|||
147007441|NCT02316223|530188634|FG000|Overall Study|COPD Diagnosis|3|||
146847167|NCT00532493|529610907|FG000|Overall Study|Protocol Deviation|1|||
146847168|NCT00532493|529610908|FG001|Overall Study|Protocol Deviation|0|||
146847169|NCT00532493|529610907|FG000|Overall Study|Subject Moved Away|3|||
146847170|NCT00532493|529610908|FG001|Overall Study|Subject Moved Away|1|||
147007442|NCT02316223|530188635|FG001|Overall Study|COPD Diagnosis|2|||
147007443|NCT02316223|530188636|FG002|Overall Study|COPD Diagnosis|3|||
147007444|NCT02316223|530188634|FG000|Overall Study|Reside outside study area|1|||
147007445|NCT02316223|530188635|FG001|Overall Study|Reside outside study area|1|||
147007446|NCT02316223|530188636|FG002|Overall Study|Reside outside study area|1|||
147007447|NCT02316223|530188634|FG000|Overall Study|No asthma|2|||
147007448|NCT02316223|530188635|FG001|Overall Study|No asthma|0|||
147007449|NCT02316223|530188636|FG002|Overall Study|No asthma|0|||
146847171|NCT00532493|529610907|FG000|Overall Study|Contraindicative Medication|1|||
147007450|NCT02316223|530188634|FG000|Overall Study|Discontinued by PI|11|||
147007451|NCT02316223|530188635|FG001|Overall Study|Discontinued by PI|19|||
147007452|NCT02316223|530188636|FG002|Overall Study|Discontinued by PI|3|||
147007453|NCT00529763|530188638|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
147007454|NCT00529763|530188639|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
147007455|NCT00529763|530188640|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
147007456|NCT00529763|530188638|FG000|Overall Study|Death|1|||
147007457|NCT00529763|530188639|FG001|Overall Study|Death|1|||
147007458|NCT00529763|530188640|FG002|Overall Study|Death|1|||
147007459|NCT00529763|530188638|FG000|Overall Study|Disease Progression|10|||
147007460|NCT00529763|530188639|FG001|Overall Study|Disease Progression|16|||
147007461|NCT00529763|530188640|FG002|Overall Study|Disease Progression|11|||
147007462|NCT00529763|530188638|FG000|Overall Study|Lost to Follow-up|1|||
147007463|NCT00529763|530188639|FG001|Overall Study|Lost to Follow-up|2|||
147007464|NCT00529763|530188640|FG002|Overall Study|Lost to Follow-up|3|||
147007465|NCT00529763|530188638|FG000|Overall Study|Stem Cell Transplant|0|||
147007466|NCT00529763|530188639|FG001|Overall Study|Stem Cell Transplant|3|||
147007467|NCT00529763|530188640|FG002|Overall Study|Stem Cell Transplant|1|||
147007468|NCT00529763|530188638|FG000|Overall Study|Study Drug Toxicity|3|||
147007469|NCT00529763|530188639|FG001|Overall Study|Study Drug Toxicity|6|||
147007470|NCT00529763|530188640|FG002|Overall Study|Study Drug Toxicity|4|||
147007471|NCT00529763|530188638|FG000|Overall Study|Participant Withdrew Consent|2|||
147007472|NCT00529763|530188639|FG001|Overall Study|Participant Withdrew Consent|3|||
147007473|NCT00529763|530188640|FG002|Overall Study|Participant Withdrew Consent|4|||
147007474|NCT00529763|530188638|FG000|Overall Study|Other reasons|2|||
147007475|NCT00529763|530188639|FG001|Overall Study|Other reasons|0|||
147007476|NCT00529763|530188640|FG002|Overall Study|Other reasons|2|||
147007477|NCT00529763|530188638|FG000|Overall Study|Participant request to discontinue treatment|1|||
147007478|NCT00529763|530188639|FG001|Overall Study|Participant request to discontinue treatment|1|||
147007479|NCT00529763|530188640|FG002|Overall Study|Participant request to discontinue treatment|3|||
147007480|NCT03669250|530188641|FG000|Overall Study|Adverse Event|0|||
147007481|NCT03669250|530188642|FG001|Overall Study|Adverse Event|0|||
147007482|NCT03669250|530188643|FG002|Overall Study|Adverse Event|0|||
147007483|NCT03669250|530188644|FG003|Overall Study|Adverse Event|0|||
147007484|NCT03669250|530188645|FG004|Overall Study|Adverse Event|1|||
147007485|NCT03669250|530188646|FG005|Overall Study|Adverse Event|0|||
147007486|NCT03669250|530188641|FG000|Overall Study|Withdrawal by Subject|0|||
147007487|NCT03669250|530188642|FG001|Overall Study|Withdrawal by Subject|1|||
147007488|NCT03669250|530188643|FG002|Overall Study|Withdrawal by Subject|0|||
147007489|NCT03669250|530188644|FG003|Overall Study|Withdrawal by Subject|1|||
147007490|NCT03669250|530188645|FG004|Overall Study|Withdrawal by Subject|0|||
147007491|NCT03669250|530188646|FG005|Overall Study|Withdrawal by Subject|0|||
147007492|NCT00828321|530188647|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
147007493|NCT00828321|530188648|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
147007494|NCT00828321|530188647|FG000|Second Intervention|Protocol Violation|0|||
147007495|NCT00828321|530188648|FG001|Second Intervention|Protocol Violation|1|||
147007496|NCT02997176|530188649|FG000|Overall Study|Adverse Event|0|||
147007497|NCT02997176|530188650|FG001|Overall Study|Adverse Event|0|||
147007498|NCT02997176|530188651|FG002|Overall Study|Adverse Event|0|||
147007499|NCT02997176|530188652|FG003|Overall Study|Adverse Event|8|||
147007500|NCT02997176|530188649|FG000|Overall Study|Progressive Disease|1|||
147007501|NCT02997176|530188650|FG001|Overall Study|Progressive Disease|0|||
147007502|NCT02997176|530188651|FG002|Overall Study|Progressive Disease|1|||
147007503|NCT02997176|530188652|FG003|Overall Study|Progressive Disease|1|||
146847172|NCT00532493|529610908|FG001|Overall Study|Contraindicative Medication|0|||
146847173|NCT01769326|529610914|FG000|Overall Study|Lost to Follow-up|1|||
146847174|NCT01769326|529610915|FG001|Overall Study|Lost to Follow-up|2|||
146847175|NCT01769326|529610916|FG002|Overall Study|Lost to Follow-up|0|||
146847176|NCT01769326|529610917|FG003|Overall Study|Lost to Follow-up|0|||
146847177|NCT01769326|529610914|FG000|Overall Study|unrelated injry|1|||
146847178|NCT01769326|529610915|FG001|Overall Study|unrelated injry|1|||
146847179|NCT01769326|529610916|FG002|Overall Study|unrelated injry|0|||
146847180|NCT01769326|529610917|FG003|Overall Study|unrelated injry|0|||
146847181|NCT01769326|529610914|FG000|Overall Study|got a job|0|||
147007504|NCT02997176|530188649|FG000|Overall Study|Death|0|||
147007505|NCT02997176|530188650|FG001|Overall Study|Death|0|||
147007506|NCT02997176|530188651|FG002|Overall Study|Death|1|||
146847182|NCT01769326|529610915|FG001|Overall Study|got a job|1|||
146847183|NCT01769326|529610916|FG002|Overall Study|got a job|0|||
146847184|NCT01769326|529610917|FG003|Overall Study|got a job|0|||
146847185|NCT01769326|529610914|FG000|Overall Study|Got sick and could not complete study|0|||
147007507|NCT02997176|530188652|FG003|Overall Study|Death|1|||
147007508|NCT02997176|530188649|FG000|Overall Study|Withdrawal by Subject|0|||
147007509|NCT02997176|530188650|FG001|Overall Study|Withdrawal by Subject|2|||
147007510|NCT02997176|530188651|FG002|Overall Study|Withdrawal by Subject|0|||
147007511|NCT02997176|530188652|FG003|Overall Study|Withdrawal by Subject|1|||
147007512|NCT01630616|530188657|FG000|Overall Study|Adverse Event|0|||
147007513|NCT01630616|530188658|FG001|Overall Study|Adverse Event|0|||
147007514|NCT01630616|530188659|FG002|Overall Study|Adverse Event|0|||
147007515|NCT01630616|530188660|FG003|Overall Study|Adverse Event|1|||
147007516|NCT01630616|530188661|FG004|Overall Study|Adverse Event|0|||
147007517|NCT01630616|530188662|FG005|Overall Study|Adverse Event|0|||
146847186|NCT01769326|529610915|FG001|Overall Study|Got sick and could not complete study|0|||
146847187|NCT01769326|529610916|FG002|Overall Study|Got sick and could not complete study|1|||
147007518|NCT01630616|530188657|FG000|Overall Study|Withdrawal by Subject|0|||
147007519|NCT01630616|530188658|FG001|Overall Study|Withdrawal by Subject|0|||
147007520|NCT01630616|530188659|FG002|Overall Study|Withdrawal by Subject|0|||
147007521|NCT01630616|530188660|FG003|Overall Study|Withdrawal by Subject|2|||
147007522|NCT01630616|530188661|FG004|Overall Study|Withdrawal by Subject|0|||
147007523|NCT01630616|530188662|FG005|Overall Study|Withdrawal by Subject|0|||
147007524|NCT00691704|530188663|FG000|Induction Therapy|Disease Progression|1|||
147007525|NCT00691704|530188663|FG000|Induction Therapy|Active Hepatitis|1|||
147007526|NCT00691704|530188663|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
147007527|NCT00691704|530188663|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
147007528|NCT00691704|530188663|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
147007529|NCT04406194|530188665|FG000|Period 1|Withdrawal by Subject|0|||
147007530|NCT04406194|530188666|FG001|Period 1|Withdrawal by Subject|1|||
147007531|NCT04102345|530188668|FG000|Overall Study|Withdrawal by Subject|1|||
147007532|NCT04102345|530188669|FG001|Overall Study|Withdrawal by Subject|0|||
147007533|NCT00385736|530188674|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
147007534|NCT00385736|530188675|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
147007535|NCT00385736|530188676|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
147007536|NCT00385736|530188674|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
147007537|NCT00385736|530188675|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
147007538|NCT00385736|530188676|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
147007539|NCT00385736|530188674|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
147007540|NCT00385736|530188675|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
147007541|NCT00385736|530188676|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
147007542|NCT00385736|530188674|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
147007543|NCT00385736|530188675|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
147007544|NCT00385736|530188676|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
147007545|NCT00385736|530188674|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
147007546|NCT00385736|530188675|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
147007547|NCT00385736|530188676|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
147007548|NCT00385736|530188674|FG000|Efficacy Analysis Set - Induction|Other|0|||
147007549|NCT00385736|530188675|FG001|Efficacy Analysis Set - Induction|Other|0|||
147007550|NCT00385736|530188676|FG002|Efficacy Analysis Set - Induction|Other|1|||
147007551|NCT00385736|530188674|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
147007552|NCT00385736|530188675|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
147007553|NCT00385736|530188676|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
147007554|NCT00385736|530188674|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
147007555|NCT00385736|530188675|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
147007556|NCT00385736|530188676|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
147007557|NCT00385736|530188674|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
147007558|NCT00385736|530188675|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
147007559|NCT00385736|530188676|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
147007560|NCT00385736|530188674|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
147007561|NCT00385736|530188675|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
147007562|NCT00385736|530188676|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
147007563|NCT00385736|530188674|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
147007564|NCT00385736|530188675|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
147007565|NCT00385736|530188676|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
147007566|NCT00385736|530188674|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
147007567|NCT00385736|530188675|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
147007568|NCT00385736|530188676|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
147007569|NCT00385736|530188674|FG000|Safety Analysis Set|Adverse Event|23|||
147007570|NCT00385736|530188675|FG001|Safety Analysis Set|Adverse Event|15|||
147007571|NCT00385736|530188676|FG002|Safety Analysis Set|Adverse Event|23|||
147007572|NCT00385736|530188674|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
147007573|NCT00385736|530188675|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
147007574|NCT00385736|530188676|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
147007575|NCT00385736|530188674|FG000|Safety Analysis Set|Lost to Follow-up|0|||
147007576|NCT00385736|530188675|FG001|Safety Analysis Set|Lost to Follow-up|2|||
147007577|NCT00385736|530188676|FG002|Safety Analysis Set|Lost to Follow-up|2|||
147007578|NCT00385736|530188674|FG000|Safety Analysis Set|Lack of Efficacy|38|||
147007579|NCT00385736|530188675|FG001|Safety Analysis Set|Lack of Efficacy|16|||
147007580|NCT00385736|530188676|FG002|Safety Analysis Set|Lack of Efficacy|31|||
147007581|NCT00385736|530188674|FG000|Safety Analysis Set|Protocol Violation|2|||
147007582|NCT00385736|530188675|FG001|Safety Analysis Set|Protocol Violation|1|||
147007583|NCT00385736|530188676|FG002|Safety Analysis Set|Protocol Violation|6|||
147007584|NCT00385736|530188674|FG000|Safety Analysis Set|Other|1|||
147007585|NCT00385736|530188675|FG001|Safety Analysis Set|Other|4|||
147007586|NCT00385736|530188676|FG002|Safety Analysis Set|Other|4|||
147007587|NCT05497557|530188677|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
147007588|NCT05497557|530188678|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
147007589|NCT05497557|530188679|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
147007590|NCT03827395|530188680|FG000|Overall Study|Lost to Follow-up|1|||
147007591|NCT03827395|530188681|FG001|Overall Study|Lost to Follow-up|0|||
147007592|NCT03827395|530188680|FG000|Overall Study|Protocol Violation|1|||
147007593|NCT03827395|530188681|FG001|Overall Study|Protocol Violation|0|||
147007594|NCT03827395|530188680|FG000|Overall Study|Became ineligible after enrollment|1|||
147007595|NCT03827395|530188681|FG001|Overall Study|Became ineligible after enrollment|2|||
147007596|NCT01923740|530188682|FG000|Overall Study|Lost to Follow-up|4|||
147007597|NCT01923740|530188683|FG001|Overall Study|Lost to Follow-up|9|||
147007598|NCT01923740|530188682|FG000|Overall Study|Withdrawal by Subject|2|||
147007599|NCT01923740|530188683|FG001|Overall Study|Withdrawal by Subject|0|||
147007600|NCT01537887|530188684|FG000|Period 1|Physician Decision|0|||
147007601|NCT01537887|530188685|FG001|Period 1|Physician Decision|0|||
147007602|NCT01537887|530188686|FG002|Period 1|Physician Decision|0|||
147007603|NCT01537887|530188687|FG003|Period 1|Physician Decision|0|||
147007604|NCT01537887|530188688|FG004|Period 1|Physician Decision|1|||
147007605|NCT01537887|530188689|FG005|Period 1|Physician Decision|1|||
147007606|NCT01537887|530188684|FG000|Period 1|Did not receive treatment|0|||
147007607|NCT01537887|530188685|FG001|Period 1|Did not receive treatment|0|||
147007608|NCT01537887|530188686|FG002|Period 1|Did not receive treatment|1|||
147007609|NCT01537887|530188687|FG003|Period 1|Did not receive treatment|0|||
147007610|NCT01537887|530188688|FG004|Period 1|Did not receive treatment|0|||
147007611|NCT01537887|530188689|FG005|Period 1|Did not receive treatment|0|||
147007612|NCT01537887|530188684|FG000|Period 2|Withdrawal by Subject|0|||
147007613|NCT01537887|530188685|FG001|Period 2|Withdrawal by Subject|1|||
147007614|NCT01537887|530188686|FG002|Period 2|Withdrawal by Subject|0|||
147007615|NCT01537887|530188687|FG003|Period 2|Withdrawal by Subject|0|||
147007616|NCT01537887|530188688|FG004|Period 2|Withdrawal by Subject|0|||
147007617|NCT01537887|530188689|FG005|Period 2|Withdrawal by Subject|0|||
147007618|NCT01537887|530188684|FG000|Period 3|Adverse Event|0|||
147007619|NCT01537887|530188685|FG001|Period 3|Adverse Event|0|||
147007620|NCT01537887|530188686|FG002|Period 3|Adverse Event|1|||
147007621|NCT01537887|530188687|FG003|Period 3|Adverse Event|0|||
147007622|NCT01537887|530188688|FG004|Period 3|Adverse Event|0|||
147007623|NCT01537887|530188689|FG005|Period 3|Adverse Event|0|||
147007624|NCT01537887|530188684|FG000|Period 3|Withdrawal by Subject|0|||
147007625|NCT01537887|530188685|FG001|Period 3|Withdrawal by Subject|1|||
147007626|NCT01537887|530188686|FG002|Period 3|Withdrawal by Subject|0|||
147007627|NCT01537887|530188687|FG003|Period 3|Withdrawal by Subject|0|||
147007628|NCT01537887|530188688|FG004|Period 3|Withdrawal by Subject|0|||
147007629|NCT01537887|530188689|FG005|Period 3|Withdrawal by Subject|0|||
147007630|NCT04723693|530188690|FG000|Overall Study|Withdrawal by Subject|2|||
147007631|NCT00294047|530188691|FG000|Month 48|Adverse Event|28|||
147007632|NCT00294047|530188692|FG001|Month 48|Adverse Event|13|||
147007633|NCT00294047|530188691|FG000|Month 48|Protocol Violation|4|||
147007634|NCT00294047|530188692|FG001|Month 48|Protocol Violation|4|||
147007635|NCT00294047|530188691|FG000|Month 48|Withdrawal by Subject|111|||
147007636|NCT00294047|530188692|FG001|Month 48|Withdrawal by Subject|115|||
147007637|NCT00294047|530188691|FG000|Month 48|Lost to Follow-up|272|||
147007638|NCT00294047|530188692|FG001|Month 48|Lost to Follow-up|287|||
147007639|NCT00294047|530188691|FG000|Month 48|Other|10|||
147007640|NCT00294047|530188692|FG001|Month 48|Other|14|||
147007641|NCT00294047|530188691|FG000|Month 84|Adverse Event|4|||
147007642|NCT00294047|530188692|FG001|Month 84|Adverse Event|2|||
147007643|NCT00294047|530188691|FG000|Month 84|Protocol Violation|1|||
147007644|NCT00294047|530188692|FG001|Month 84|Protocol Violation|1|||
147007645|NCT00294047|530188691|FG000|Month 84|Withdrawal by Subject|33|||
147007646|NCT00294047|530188692|FG001|Month 84|Withdrawal by Subject|31|||
147007647|NCT00294047|530188691|FG000|Month 84|Lost to Follow-up|187|||
147007648|NCT00294047|530188692|FG001|Month 84|Lost to Follow-up|190|||
147007649|NCT00294047|530188691|FG000|Month 84|Absent Cervix|2|||
147007650|NCT00294047|530188692|FG001|Month 84|Absent Cervix|0|||
147007651|NCT00294047|530188691|FG000|Month 84|Work related reasons|4|||
147007652|NCT00294047|530188692|FG001|Month 84|Work related reasons|2|||
146847188|NCT01769326|529610917|FG003|Overall Study|Got sick and could not complete study|0|||
146847189|NCT00888927|529610918|FG000|Overall Study|Adverse Event|0|||
147007653|NCT00294047|530188691|FG000|Month 84|Center closed, subject did not transfer|1|||
147007654|NCT00294047|530188692|FG001|Month 84|Center closed, subject did not transfer|0|||
146847190|NCT00888927|529610919|FG001|Overall Study|Adverse Event|0|||
146847191|NCT00888927|529610920|FG002|Overall Study|Adverse Event|0|||
146847192|NCT00888927|529610921|FG003|Overall Study|Adverse Event|1|||
146847193|NCT00888927|529610918|FG000|Overall Study|Withdrawal of consent|0|||
147007655|NCT00294047|530188691|FG000|Month 84|Family problems|2|||
147007656|NCT00294047|530188692|FG001|Month 84|Family problems|2|||
147007657|NCT00294047|530188691|FG000|Month 84|Lack of time|3|||
147007658|NCT00294047|530188692|FG001|Month 84|Lack of time|1|||
147007659|NCT00294047|530188691|FG000|Month 84|Personal reason|2|||
147007660|NCT00294047|530188692|FG001|Month 84|Personal reason|4|||
147007661|NCT00294047|530188691|FG000|Month 84|Subject does not want male physician|1|||
147007662|NCT00294047|530188692|FG001|Month 84|Subject does not want male physician|0|||
147007663|NCT00294047|530188691|FG000|Month 84|Transport reimbursement delayed|0|||
147007664|NCT00294047|530188692|FG001|Month 84|Transport reimbursement delayed|1|||
147007665|NCT00294047|530188691|FG000|Month 84|Unable to reach study site|1|||
147007666|NCT00294047|530188692|FG001|Month 84|Unable to reach study site|0|||
147007667|NCT00294047|530188691|FG000|Month 84|Under investigation locally|1|||
147007668|NCT00294047|530188692|FG001|Month 84|Under investigation locally|0|||
147007669|NCT00294047|530188691|FG000|Month 84|Visit missed|0|||
147007670|NCT00294047|530188692|FG001|Month 84|Visit missed|1|||
147007671|NCT00294047|530188691|FG000|Month 84|No consent for Month 84 Follow-up|731|||
147007672|NCT00294047|530188692|FG001|Month 84|No consent for Month 84 Follow-up|754|||
147007673|NCT02157974|530188693|FG000|Overall Study|Withdrawal by Subject|0|||
147007674|NCT02157974|530188694|FG001|Overall Study|Withdrawal by Subject|1|||
147007675|NCT02157974|530188695|FG002|Overall Study|Withdrawal by Subject|0|||
147007676|NCT02157974|530188696|FG003|Overall Study|Withdrawal by Subject|0|||
147007677|NCT02157974|530188697|FG004|Overall Study|Withdrawal by Subject|0|||
147007678|NCT02157974|530188693|FG000|Overall Study|Screen Failure|0|||
147007679|NCT02157974|530188694|FG001|Overall Study|Screen Failure|1|||
147007680|NCT02157974|530188695|FG002|Overall Study|Screen Failure|0|||
147007681|NCT02157974|530188696|FG003|Overall Study|Screen Failure|0|||
147007682|NCT02157974|530188697|FG004|Overall Study|Screen Failure|0|||
147007683|NCT02157974|530188693|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
147007684|NCT02157974|530188694|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
147007685|NCT02157974|530188695|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
147007686|NCT02157974|530188696|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
147007687|NCT02157974|530188697|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
147007688|NCT00540423|530188700|FG000|Double-Blind Treatment Period|Adverse Event|0|||
147007689|NCT00540423|530188701|FG001|Double-Blind Treatment Period|Adverse Event|1|||
147007690|NCT00540423|530188702|FG002|Double-Blind Treatment Period|Adverse Event|0|||
147007691|NCT00540423|530188700|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
147007692|NCT00540423|530188701|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
147007693|NCT00540423|530188702|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
147007694|NCT02280863|530188706|FG000|Integrated Platform|Met stopping criteria|0|||
147007695|NCT02280863|530188707|FG001|Integrated Platform|Met stopping criteria|1|||
147007696|NCT00263588|530188708|FG000|Overall Study|Death|54|||
147007697|NCT00263588|530188709|FG001|Overall Study|Death|90|||
147007698|NCT00263588|530188708|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
147007699|NCT00263588|530188709|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
147007700|NCT00263588|530188708|FG000|Overall Study|Lost to Follow-up|7|||
147007701|NCT00263588|530188709|FG001|Overall Study|Lost to Follow-up|10|||
147007702|NCT00263588|530188708|FG000|Overall Study|Withdrawal by Subject|3|||
147007703|NCT00263588|530188709|FG001|Overall Study|Withdrawal by Subject|4|||
147007704|NCT00263588|530188708|FG000|Overall Study|Protocol Violation|0|||
147007705|NCT00263588|530188709|FG001|Overall Study|Protocol Violation|1|||
147007706|NCT00263588|530188708|FG000|Overall Study|Investigator decision|7|||
147007707|NCT00263588|530188709|FG001|Overall Study|Investigator decision|15|||
147007708|NCT00263588|530188708|FG000|Overall Study|Sponsor terminated study|0|||
147007709|NCT00263588|530188709|FG001|Overall Study|Sponsor terminated study|1|||
147007710|NCT02412852|530188710|FG000|Overall Study|Withdrawal by Subject|0|||
147007711|NCT02412852|530188711|FG001|Overall Study|Withdrawal by Subject|1|||
147007712|NCT02412852|530188712|FG002|Overall Study|Withdrawal by Subject|0|||
147007713|NCT02412852|530188713|FG003|Overall Study|Withdrawal by Subject|0|||
147007714|NCT02412852|530188710|FG000|Overall Study|Physician Decision|0|||
147007715|NCT02412852|530188711|FG001|Overall Study|Physician Decision|0|||
147007716|NCT02412852|530188712|FG002|Overall Study|Physician Decision|0|||
147007717|NCT02412852|530188713|FG003|Overall Study|Physician Decision|1|||
147007718|NCT05274763|530188714|FG000|Overall Study|Lost to Follow-up|1|||
147007719|NCT01174186|530188715|FG000|Overall Study|Lost to Follow-up|0|||
147007720|NCT01174186|530188716|FG001|Overall Study|Lost to Follow-up|1|||
147007721|NCT01174186|530188715|FG000|Overall Study|Withdrawal by Subject|0|||
147007722|NCT01174186|530188716|FG001|Overall Study|Withdrawal by Subject|2|||
147007723|NCT03629054|530188717|FG000|Period 2 (4 Days)|Not treated|0|||
147007724|NCT03629054|530188718|FG001|Period 2 (4 Days)|Not treated|1|||
147007725|NCT02121184|530188719|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
146847194|NCT00888927|529610919|FG001|Overall Study|Withdrawal of consent|0|||
147007726|NCT02121184|530188720|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
147007727|NCT02121184|530188719|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
147007728|NCT02121184|530188720|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
147007729|NCT02121184|530188719|FG000|Overall Study|Emergency cesarean section required|0|||
147007730|NCT02121184|530188720|FG001|Overall Study|Emergency cesarean section required|2|||
147007731|NCT02121184|530188719|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
147007732|NCT02121184|530188720|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
147007733|NCT00101439|530188725|FG000|Period 2|Withdrawal by Subject|0|||
147007734|NCT00101439|530188726|FG001|Period 2|Withdrawal by Subject|2|||
147007735|NCT01867658|530188727|FG000|Overall Study|Withdrawal by Subject|6|||
147007736|NCT01867658|530188727|FG000|Overall Study|Death|2|||
147007737|NCT01867658|530188727|FG000|Overall Study|Subject could not be contacted|1|||
147007738|NCT01496118|530188728|FG000|Overall Study|Disease progression|3|||
147007739|NCT01496118|530188729|FG001|Overall Study|Disease progression|2|||
147007740|NCT01496118|530188730|FG002|Overall Study|Disease progression|3|||
147007741|NCT01496118|530188731|FG003|Overall Study|Disease progression|1|||
147007742|NCT01496118|530188732|FG004|Overall Study|Disease progression|2|||
147007743|NCT01496118|530188733|FG005|Overall Study|Disease progression|2|||
147007744|NCT01496118|530188734|FG006|Overall Study|Disease progression|14|||
147007745|NCT01496118|530188735|FG007|Overall Study|Disease progression|10|||
147007746|NCT01496118|530188728|FG000|Overall Study|Physician Decision|0|||
147007747|NCT01496118|530188729|FG001|Overall Study|Physician Decision|0|||
147007748|NCT01496118|530188730|FG002|Overall Study|Physician Decision|0|||
147007749|NCT01496118|530188731|FG003|Overall Study|Physician Decision|0|||
147007750|NCT01496118|530188732|FG004|Overall Study|Physician Decision|1|||
147007751|NCT01496118|530188733|FG005|Overall Study|Physician Decision|0|||
147007752|NCT01496118|530188734|FG006|Overall Study|Physician Decision|3|||
147007753|NCT01496118|530188735|FG007|Overall Study|Physician Decision|6|||
147007754|NCT01496118|530188728|FG000|Overall Study|Adverse Event|1|||
147007755|NCT01496118|530188729|FG001|Overall Study|Adverse Event|1|||
147007756|NCT01496118|530188730|FG002|Overall Study|Adverse Event|0|||
147007757|NCT01496118|530188731|FG003|Overall Study|Adverse Event|0|||
147007758|NCT01496118|530188732|FG004|Overall Study|Adverse Event|0|||
147007759|NCT01496118|530188733|FG005|Overall Study|Adverse Event|0|||
147007760|NCT01496118|530188734|FG006|Overall Study|Adverse Event|6|||
147007761|NCT01496118|530188735|FG007|Overall Study|Adverse Event|10|||
147007762|NCT01496118|530188728|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
147007763|NCT01496118|530188729|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
147007764|NCT01496118|530188730|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
147007765|NCT01496118|530188731|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
147007766|NCT01496118|530188732|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
147007767|NCT01496118|530188733|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
147007768|NCT01496118|530188734|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
147007769|NCT01496118|530188735|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
147007770|NCT01496118|530188728|FG000|Overall Study|Death|0|||
147007771|NCT01496118|530188729|FG001|Overall Study|Death|0|||
147007772|NCT01496118|530188730|FG002|Overall Study|Death|0|||
147007773|NCT01496118|530188731|FG003|Overall Study|Death|0|||
147007774|NCT01496118|530188732|FG004|Overall Study|Death|0|||
147007775|NCT01496118|530188733|FG005|Overall Study|Death|0|||
147007776|NCT01496118|530188734|FG006|Overall Study|Death|1|||
147007777|NCT01496118|530188735|FG007|Overall Study|Death|1|||
147007778|NCT01496118|530188728|FG000|Overall Study|Withdrawal by Subject|0|||
147007779|NCT01496118|530188729|FG001|Overall Study|Withdrawal by Subject|0|||
147007780|NCT01496118|530188730|FG002|Overall Study|Withdrawal by Subject|0|||
147007781|NCT01496118|530188731|FG003|Overall Study|Withdrawal by Subject|2|||
147007782|NCT01496118|530188732|FG004|Overall Study|Withdrawal by Subject|0|||
147007783|NCT01496118|530188733|FG005|Overall Study|Withdrawal by Subject|1|||
147007784|NCT01496118|530188734|FG006|Overall Study|Withdrawal by Subject|6|||
147007785|NCT01496118|530188735|FG007|Overall Study|Withdrawal by Subject|3|||
147007786|NCT02845336|530188736|FG000|Overall Study|Lost to Follow-up|3|||
147007787|NCT02845336|530188737|FG001|Overall Study|Lost to Follow-up|1|||
147007788|NCT02845336|530188736|FG000|Overall Study|Inability to get medication|2|||
147007789|NCT02845336|530188737|FG001|Overall Study|Inability to get medication|0|||
147007790|NCT01151618|530188746|FG000|Overall Study|Adverse Event|2|||
147007791|NCT01151618|530188746|FG000|Overall Study|Withdrawal by Subject|7|||
147007792|NCT00562718|530188747|FG000|Overall Study|Death|1|||
147007793|NCT00562718|530188747|FG000|Overall Study|Withdrawal by Subject|3|||
147007794|NCT00562718|530188747|FG000|Overall Study|Adverse Event|4|||
147007795|NCT00562718|530188747|FG000|Overall Study|Lack of Efficacy|2|||
147007796|NCT00562718|530188747|FG000|Overall Study|not stated|1|||
147007797|NCT02227238|530188748|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
147007798|NCT02227238|530188749|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
147007799|NCT02227238|530188750|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
147007800|NCT02227238|530188748|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
147007801|NCT02227238|530188749|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
147007802|NCT02227238|530188750|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
147007803|NCT02227238|530188748|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
147007804|NCT02227238|530188749|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
147007805|NCT02227238|530188750|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
147007806|NCT02227238|530188748|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
147007807|NCT02227238|530188749|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
147007808|NCT02227238|530188750|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
147007809|NCT02227238|530188748|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
147007810|NCT02227238|530188749|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
147007811|NCT02227238|530188750|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
147007812|NCT02227238|530188748|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
147007813|NCT02227238|530188749|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
147007814|NCT02227238|530188750|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
147007815|NCT02227238|530188748|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
147007816|NCT02227238|530188749|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
147007817|NCT02227238|530188750|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
147007818|NCT02227238|530188748|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
147007819|NCT02227238|530188749|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
147007820|NCT02227238|530188750|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
147007821|NCT02227238|530188748|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
147007822|NCT02227238|530188749|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
147007823|NCT02227238|530188750|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
147007824|NCT02227238|530188748|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
147007825|NCT02227238|530188749|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
147007826|NCT02227238|530188750|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
147007827|NCT02227238|530188748|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
147007828|NCT02227238|530188749|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
147007829|NCT02227238|530188750|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
147007830|NCT02227238|530188748|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
147007831|NCT02227238|530188749|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
147007832|NCT02227238|530188750|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
147007833|NCT02227238|530188748|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
147007834|NCT02227238|530188749|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
147007835|NCT02227238|530188750|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
147007836|NCT02227238|530188748|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
147007837|NCT02227238|530188749|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
147007838|NCT02227238|530188750|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
147007839|NCT01507662|530188751|FG000|Overall Study|Death|26|||
147007840|NCT01507662|530188752|FG001|Overall Study|Death|18|||
147007841|NCT01507662|530188751|FG000|Overall Study|Withdrawal by Subject|290|||
147007842|NCT01507662|530188752|FG001|Overall Study|Withdrawal by Subject|287|||
147007843|NCT01507662|530188751|FG000|Overall Study|Lost to Follow-up|498|||
147007844|NCT01507662|530188752|FG001|Overall Study|Lost to Follow-up|523|||
147007845|NCT01507662|530188751|FG000|Overall Study|Proxy interview done|2|||
147007846|NCT01507662|530188752|FG001|Overall Study|Proxy interview done|3|||
147007847|NCT02896296|530188756|FG000|Overall Study|Adverse Event|1|||
147007848|NCT02896296|530188756|FG000|Overall Study|Lost to Follow-up|19|||
147007849|NCT02896296|530188756|FG000|Overall Study|Pregnancy|1|||
147007850|NCT02896296|530188756|FG000|Overall Study|Physician Decision|2|||
147007851|NCT02896296|530188756|FG000|Overall Study|Withdrawal by Subject|10|||
147007852|NCT02896296|530188756|FG000|Overall Study|Site closing|7|||
147007853|NCT02896296|530188756|FG000|Overall Study|Incarceration|1|||
147007854|NCT02896296|530188756|FG000|Overall Study|Relocation|1|||
147007855|NCT02264977|530188758|FG000|Overall Study|Death|3|||
147007856|NCT02264977|530188758|FG000|Overall Study|Physician Decision|1|||
147007857|NCT02264977|530188758|FG000|Overall Study|Refuse to return|1|||
147007858|NCT00243347|530188759|FG000|Overall Study|Lack of Efficacy|4|||
147007859|NCT00243347|530188759|FG000|Overall Study|Adverse Event|2|||
147007860|NCT00243347|530188759|FG000|Overall Study|Death|1|||
147007861|NCT00243347|530188759|FG000|Overall Study|Withdrawal by Subject|5|||
147007862|NCT00243347|530188759|FG000|Overall Study|Condition worsened|7|||
147007863|NCT03961204|530188763|FG000|Overall Study|Withdrawal by Subject|2|||
147007864|NCT03961204|530188763|FG000|Overall Study|Lost to Follow-up|3|||
147007865|NCT03961204|530188763|FG000|Overall Study|Other|1|||
147007866|NCT03961204|530188763|FG000|Overall Study|Missing|1|||
147007867|NCT00147498|530188766|FG000|Overall Study|Adverse Event|1|||
147007868|NCT00147498|530188767|FG001|Overall Study|Adverse Event|6|||
147007869|NCT00147498|530188768|FG002|Overall Study|Adverse Event|7|||
147007870|NCT00147498|530188769|FG003|Overall Study|Adverse Event|3|||
147007871|NCT00147498|530188766|FG000|Overall Study|Lack of Efficacy|1|||
147007872|NCT00147498|530188767|FG001|Overall Study|Lack of Efficacy|1|||
147007873|NCT00147498|530188768|FG002|Overall Study|Lack of Efficacy|1|||
147007874|NCT00147498|530188769|FG003|Overall Study|Lack of Efficacy|8|||
147007875|NCT00147498|530188766|FG000|Overall Study|Laboratory abnormality|0|||
147007876|NCT00147498|530188767|FG001|Overall Study|Laboratory abnormality|0|||
147007877|NCT00147498|530188768|FG002|Overall Study|Laboratory abnormality|2|||
147007878|NCT00147498|530188769|FG003|Overall Study|Laboratory abnormality|0|||
147007879|NCT00147498|530188766|FG000|Overall Study|Participant defaulted|0|||
147007880|NCT00147498|530188767|FG001|Overall Study|Participant defaulted|1|||
147007881|NCT00147498|530188768|FG002|Overall Study|Participant defaulted|4|||
147007882|NCT00147498|530188769|FG003|Overall Study|Participant defaulted|3|||
147007883|NCT00147498|530188766|FG000|Overall Study|Other|1|||
147007884|NCT00147498|530188767|FG001|Overall Study|Other|1|||
147007885|NCT00147498|530188768|FG002|Overall Study|Other|3|||
147007886|NCT00147498|530188769|FG003|Overall Study|Other|3|||
147007887|NCT02452463|530188770|FG000|Overall Study|Death|1|||
147007888|NCT02452463|530188771|FG001|Overall Study|Death|0|||
147007889|NCT02452463|530188772|FG002|Overall Study|Death|0|||
147007890|NCT02452463|530188770|FG000|Overall Study|Study Suspended|1|||
147007891|NCT02452463|530188771|FG001|Overall Study|Study Suspended|0|||
147007892|NCT02452463|530188772|FG002|Overall Study|Study Suspended|0|||
147007893|NCT02452463|530188770|FG000|Overall Study|Recommended by DSMB|0|||
147007894|NCT02452463|530188771|FG001|Overall Study|Recommended by DSMB|1|||
147007895|NCT02452463|530188772|FG002|Overall Study|Recommended by DSMB|0|||
147007896|NCT02452463|530188770|FG000|Overall Study|Withdrawal by Subject|0|||
147007897|NCT02452463|530188771|FG001|Overall Study|Withdrawal by Subject|1|||
147007898|NCT02452463|530188772|FG002|Overall Study|Withdrawal by Subject|0|||
147007899|NCT01229150|530188773|FG000|Overall Study|Toxicity|2|||
147007900|NCT01229150|530188774|FG001|Overall Study|Toxicity|2|||
147007901|NCT01229150|530188775|FG002|Overall Study|Toxicity|0|||
147007902|NCT01229150|530188776|FG003|Overall Study|Toxicity|0|||
147007903|NCT03506633|530189992|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
147007904|NCT03506633|530189993|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
147007905|NCT00258856|530189997|FG000|Overall Study|Lost to Follow-up|1|||
147007906|NCT00258856|530189998|FG001|Overall Study|Lost to Follow-up|0|||
147007907|NCT00258856|530189999|FG002|Overall Study|Lost to Follow-up|2|||
147007908|NCT00258856|530190000|FG003|Overall Study|Lost to Follow-up|0|||
147007909|NCT00258856|530189997|FG000|Overall Study|Non-compliance|2|||
147007910|NCT00258856|530189998|FG001|Overall Study|Non-compliance|0|||
147007911|NCT00258856|530189999|FG002|Overall Study|Non-compliance|0|||
147007912|NCT00258856|530190000|FG003|Overall Study|Non-compliance|1|||
147007913|NCT01109849|530190001|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
147007914|NCT01109849|530190002|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
147007915|NCT01109849|530190003|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
147007916|NCT01109849|530190004|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
147007917|NCT01109849|530190005|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
147007918|NCT01109849|530190001|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
147007919|NCT01109849|530190002|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
147007920|NCT01109849|530190003|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
147007921|NCT01109849|530190004|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
147007922|NCT01109849|530190005|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
147007923|NCT01109849|530190001|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
147007924|NCT01109849|530190002|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
147007925|NCT01109849|530190003|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
147007926|NCT01109849|530190004|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
147007927|NCT01109849|530190005|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
147007928|NCT01109849|530190001|FG000|Initial Randomization: ADHD Treatment|move away|2|||
147007929|NCT01109849|530190002|FG001|Initial Randomization: ADHD Treatment|move away|7|||
147007930|NCT01109849|530190003|FG002|Initial Randomization: ADHD Treatment|move away|0|||
147007931|NCT01109849|530190004|FG003|Initial Randomization: ADHD Treatment|move away|0|||
147007932|NCT01109849|530190005|FG004|Initial Randomization: ADHD Treatment|move away|0|||
147007933|NCT01109849|530190001|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
147007934|NCT01109849|530190002|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
147007935|NCT01109849|530190003|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
147007936|NCT01109849|530190004|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
147007937|NCT01109849|530190005|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
147007938|NCT01109849|530190001|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
147007939|NCT01109849|530190002|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
147007940|NCT01109849|530190003|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
147007941|NCT01109849|530190004|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
147007942|NCT01109849|530190005|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
147007943|NCT03969641|530190013|FG000|Overall Study|Lost to Follow-up|5|||
147007944|NCT03969641|530190014|FG001|Overall Study|Lost to Follow-up|3|||
147007945|NCT03969641|530190013|FG000|Overall Study|Withdrawal by Subject|1|||
147007946|NCT03969641|530190014|FG001|Overall Study|Withdrawal by Subject|2|||
147007947|NCT03969641|530190013|FG000|Overall Study|Found to be ineligible|1|||
147007948|NCT03969641|530190014|FG001|Overall Study|Found to be ineligible|1|||
147007949|NCT03969641|530190013|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
147007950|NCT03969641|530190014|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
147007951|NCT03969641|530190013|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
147007952|NCT03969641|530190014|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
147007953|NCT03969641|530190013|FG000|Overall Study|Elective termination|0|||
147007954|NCT03969641|530190014|FG001|Overall Study|Elective termination|1|||
147007955|NCT00754052|530190018|FG000|Overall Study|Study terminated by Sponsor|5|||
147007956|NCT00754052|530190019|FG001|Overall Study|Study terminated by Sponsor|3|||
147007957|NCT02658019|530190021|FG000|Overall Study|Adverse Event|1|||
147007958|NCT03234907|530190022|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
147007959|NCT03234907|530190023|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
147007960|NCT03234907|530190024|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
147007961|NCT03234907|530190025|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
147007962|NCT03234907|530190026|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
147007963|NCT03234907|530190027|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
147007964|NCT03234907|530190022|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
147007965|NCT03234907|530190023|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
147007966|NCT03234907|530190024|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
147007967|NCT03234907|530190025|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
147007968|NCT03234907|530190026|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
147007969|NCT03234907|530190027|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
147007970|NCT03234907|530190022|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
147007971|NCT03234907|530190023|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
147007972|NCT03234907|530190024|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
147007973|NCT03234907|530190025|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
147007974|NCT03234907|530190026|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
147007975|NCT03234907|530190027|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
147007976|NCT03234907|530190022|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
147007977|NCT03234907|530190023|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
147007978|NCT03234907|530190024|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
147007979|NCT03234907|530190025|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
147007980|NCT03234907|530190026|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
147007981|NCT03234907|530190027|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
147007982|NCT03234907|530190022|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
147007983|NCT03234907|530190023|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
147007984|NCT03234907|530190024|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
147007985|NCT03234907|530190025|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
147007986|NCT03234907|530190026|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
147007987|NCT03234907|530190027|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
147007988|NCT03234907|530190022|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
147007989|NCT03234907|530190023|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
147007990|NCT03234907|530190024|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
147007991|NCT03234907|530190025|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
147007992|NCT03234907|530190026|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
147007993|NCT03234907|530190027|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
147007994|NCT03234907|530190022|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
147007995|NCT03234907|530190023|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
147007996|NCT03234907|530190024|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
147007997|NCT03234907|530190025|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
147007998|NCT03234907|530190026|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
147007999|NCT03234907|530190027|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
147008000|NCT02986139|530190028|FG000|Overall Study|Sponsor Decision|1|||
147008001|NCT02986139|530190029|FG001|Overall Study|Sponsor Decision|2|||
147008002|NCT02986139|530190028|FG000|Overall Study|Withdrawal by Subject|0|||
147008003|NCT02986139|530190029|FG001|Overall Study|Withdrawal by Subject|1|||
147008004|NCT02986139|530190028|FG000|Overall Study|Lost to Follow-up|0|||
147008005|NCT02986139|530190029|FG001|Overall Study|Lost to Follow-up|1|||
147008006|NCT00414726|530190030|FG000|Overall Study|Withdrawal by Subject|0|||
147008007|NCT00414726|530190031|FG001|Overall Study|Withdrawal by Subject|1|||
147008008|NCT02107196|530190032|FG000|12-week Treatment Period|Adverse Event|6|||
147008009|NCT02107196|530190033|FG001|12-week Treatment Period|Adverse Event|3|||
147008010|NCT02107196|530190032|FG000|12-week Treatment Period|Lack of Efficacy|2|||
147008011|NCT02107196|530190033|FG001|12-week Treatment Period|Lack of Efficacy|1|||
147008012|NCT02107196|530190032|FG000|12-week Treatment Period|Lost to Follow-up|3|||
147008013|NCT02107196|530190033|FG001|12-week Treatment Period|Lost to Follow-up|6|||
147008014|NCT02107196|530190032|FG000|12-week Treatment Period|Physician Decision|0|||
147008015|NCT02107196|530190033|FG001|12-week Treatment Period|Physician Decision|1|||
147008016|NCT02107196|530190032|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
147008017|NCT02107196|530190033|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
147008018|NCT02107196|530190032|FG000|12-week Treatment Period|Protocol Violation|7|||
147008019|NCT02107196|530190033|FG001|12-week Treatment Period|Protocol Violation|8|||
147008020|NCT02107196|530190032|FG000|12-week Treatment Period|Reason Missing|11|||
147008021|NCT02107196|530190033|FG001|12-week Treatment Period|Reason Missing|8|||
147008022|NCT02107196|530190032|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
147008023|NCT02107196|530190033|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
147008024|NCT02107196|530190032|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
147008025|NCT02107196|530190033|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
147008026|NCT02107196|530190032|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
147008027|NCT02107196|530190033|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
147008028|NCT02107196|530190032|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
147008029|NCT02107196|530190033|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
147008030|NCT01993186|530190034|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
147008031|NCT01993186|530190035|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
147008032|NCT01993186|530190034|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
147008033|NCT01993186|530190035|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
147008034|NCT01993186|530190034|FG000|Open-Label Extension Period|Other, Not Specified|0|||
147008035|NCT01993186|530190035|FG001|Open-Label Extension Period|Other, Not Specified|1|||
147008036|NCT01993186|530190034|FG000|Open-Label Extension Period|Adverse Event|1|||
147008037|NCT01993186|530190035|FG001|Open-Label Extension Period|Adverse Event|0|||
147008038|NCT01993186|530190034|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
147008039|NCT01993186|530190035|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
147008040|NCT01993186|530190034|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
147008041|NCT01993186|530190035|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
147008042|NCT01993186|530190034|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
147008043|NCT01993186|530190035|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
147008044|NCT04158687|530190036|FG000|Overall Study|Adverse Event|2|||
147008045|NCT04158687|530190037|FG001|Overall Study|Adverse Event|3|||
147008046|NCT04158687|530190038|FG002|Overall Study|Adverse Event|0|||
147008047|NCT04158687|530190039|FG003|Overall Study|Adverse Event|3|||
147008048|NCT04158687|530190036|FG000|Overall Study|Lost to Follow-up|5|||
147008049|NCT04158687|530190037|FG001|Overall Study|Lost to Follow-up|12|||
147008050|NCT04158687|530190038|FG002|Overall Study|Lost to Follow-up|4|||
147008051|NCT04158687|530190039|FG003|Overall Study|Lost to Follow-up|5|||
147008052|NCT04158687|530190036|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
147008053|NCT04158687|530190037|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
147008054|NCT04158687|530190038|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
147008055|NCT04158687|530190039|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
147008056|NCT04158687|530190036|FG000|Overall Study|Non-Compliance with Study Medication|2|||
147008057|NCT04158687|530190037|FG001|Overall Study|Non-Compliance with Study Medication|2|||
147008058|NCT04158687|530190038|FG002|Overall Study|Non-Compliance with Study Medication|3|||
147008059|NCT04158687|530190039|FG003|Overall Study|Non-Compliance with Study Medication|0|||
147008060|NCT04158687|530190036|FG000|Overall Study|Investigator Decision|0|||
147008061|NCT04158687|530190037|FG001|Overall Study|Investigator Decision|0|||
147008062|NCT04158687|530190038|FG002|Overall Study|Investigator Decision|2|||
147008063|NCT04158687|530190039|FG003|Overall Study|Investigator Decision|0|||
147008064|NCT04158687|530190036|FG000|Overall Study|Protocol Violation|0|||
147008065|NCT04158687|530190037|FG001|Overall Study|Protocol Violation|2|||
147008066|NCT04158687|530190038|FG002|Overall Study|Protocol Violation|1|||
147008067|NCT04158687|530190039|FG003|Overall Study|Protocol Violation|0|||
147008068|NCT04158687|530190036|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
147008069|NCT04158687|530190037|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
147008070|NCT04158687|530190038|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
147008071|NCT04158687|530190039|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
147008072|NCT04158687|530190036|FG000|Overall Study|Reason not Specified|3|||
147008073|NCT04158687|530190037|FG001|Overall Study|Reason not Specified|2|||
147008074|NCT04158687|530190038|FG002|Overall Study|Reason not Specified|4|||
147008075|NCT04158687|530190039|FG003|Overall Study|Reason not Specified|4|||
147008076|NCT04523480|530190040|FG000|Overall Study|Lost to Follow-up|30|||
147008077|NCT04523480|530190041|FG001|Overall Study|Lost to Follow-up|35|||
147008078|NCT04523480|530190042|FG002|Overall Study|Lost to Follow-up|0|||
147008079|NCT00640393|530190043|FG000|Part 1|Lost to Follow-up|2|||
147008080|NCT00640393|530190044|FG001|Part 1|Lost to Follow-up|0|||
147008081|NCT00640393|530190045|FG002|Part 1|Lost to Follow-up|0|||
147008082|NCT00640393|530190043|FG000|Part 1|Withdrawal by Subject|3|||
147008083|NCT00640393|530190044|FG001|Part 1|Withdrawal by Subject|0|||
147008084|NCT00640393|530190045|FG002|Part 1|Withdrawal by Subject|0|||
147008085|NCT00640393|530190043|FG000|Randomization|Withdrawn per protocol|17|||
147008086|NCT00640393|530190044|FG001|Randomization|Withdrawn per protocol|0|||
147008087|NCT00640393|530190045|FG002|Randomization|Withdrawn per protocol|0|||
147008088|NCT00640393|530190043|FG000|Randomization|Never randomized by site|2|||
147008089|NCT00640393|530190044|FG001|Randomization|Never randomized by site|0|||
146847195|NCT00888927|529610920|FG002|Overall Study|Withdrawal of consent|0|||
147008090|NCT00640393|530190045|FG002|Randomization|Never randomized by site|0|||
147008091|NCT00640393|530190043|FG000|Part 2|Lost to Follow-up|0|||
147008092|NCT00640393|530190044|FG001|Part 2|Lost to Follow-up|2|||
147008093|NCT00640393|530190045|FG002|Part 2|Lost to Follow-up|2|||
147008094|NCT00640393|530190043|FG000|Part 2|Withdrawal by Subject|0|||
147008095|NCT00640393|530190044|FG001|Part 2|Withdrawal by Subject|6|||
147008096|NCT00640393|530190045|FG002|Part 2|Withdrawal by Subject|1|||
147008097|NCT00640393|530190043|FG000|Part 2|Non-adherence|0|||
147008098|NCT00640393|530190044|FG001|Part 2|Non-adherence|1|||
147008099|NCT00640393|530190045|FG002|Part 2|Non-adherence|0|||
147008100|NCT00640393|530190043|FG000|Part 2|Adverse Event|0|||
147008101|NCT00640393|530190044|FG001|Part 2|Adverse Event|1|||
147008102|NCT00640393|530190045|FG002|Part 2|Adverse Event|0|||
147008103|NCT03540160|530190050|FG000|Overall Study|Protocol Violation|1|||
147008104|NCT03540160|530190050|FG000|Overall Study|Physician Decision|8|||
147008105|NCT03540160|530190050|FG000|Overall Study|Lack of Efficacy|60|||
147008106|NCT03540160|530190050|FG000|Overall Study|Pregnancy|1|||
147008107|NCT03540160|530190050|FG000|Overall Study|Adverse Event|20|||
147008108|NCT03540160|530190050|FG000|Overall Study|Withdrawal by Subject|68|||
147008109|NCT03540160|530190050|FG000|Overall Study|COVID-19|2|||
147008110|NCT03540160|530190050|FG000|Overall Study|Study Closure|10|||
147008111|NCT03540160|530190050|FG000|Overall Study|Lost to Follow-up|18|||
147008112|NCT03540160|530190050|FG000|Overall Study|Sponsor decision|191|||
147008113|NCT00198133|530190051|FG000|Overall Study|Disease progression|2|||
147008114|NCT00198133|530190052|FG001|Overall Study|Disease progression|5|||
147008115|NCT00198133|530190051|FG000|Overall Study|Adverse Event|1|||
147008116|NCT00198133|530190052|FG001|Overall Study|Adverse Event|3|||
147008117|NCT00198133|530190051|FG000|Overall Study|Withdrawal by Subject|1|||
147008118|NCT00198133|530190052|FG001|Overall Study|Withdrawal by Subject|0|||
147008119|NCT00198133|530190051|FG000|Overall Study|Physician Decision|1|||
147008120|NCT00198133|530190052|FG001|Overall Study|Physician Decision|0|||
147008121|NCT00835666|530190055|FG000|Washout|Protocol Violation|1|||
147008122|NCT00835666|530190056|FG001|Washout|Protocol Violation|0|||
147008123|NCT00835666|530190055|FG000|Washout|Withdrawal by Subject|1|||
147008124|NCT00835666|530190056|FG001|Washout|Withdrawal by Subject|0|||
147008125|NCT00635648|530190057|FG000|Overall Study|Adverse Event|12|||
147008126|NCT00635648|530190057|FG000|Overall Study|Withdrawal by Subject|9|||
147008127|NCT00635648|530190057|FG000|Overall Study|Physician Decision|4|||
147008128|NCT00635648|530190057|FG000|Overall Study|Rapid progression of baseline disease|4|||
147008129|NCT00635648|530190057|FG000|Overall Study|Use of other antifungal agent needed|1|||
147008130|NCT00635648|530190057|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
147008131|NCT00635648|530190057|FG000|Overall Study|Noncompliance with protocol|1|||
147008132|NCT00635648|530190057|FG000|Overall Study|Other reason|2|||
147008133|NCT02450539|530190061|FG000|Overall Study|Withdrawal by Subject|12|||
147008134|NCT02450539|530190062|FG001|Overall Study|Withdrawal by Subject|6|||
147008135|NCT02450539|530190061|FG000|Overall Study|Lost to Follow-up|4|||
147008136|NCT02450539|530190062|FG001|Overall Study|Lost to Follow-up|1|||
147008137|NCT01484912|530190065|FG000|Overall Study|Withdrawal by Subject|1|||
147008138|NCT01484912|530190066|FG001|Overall Study|Withdrawal by Subject|0|||
147008139|NCT01484912|530190065|FG000|Overall Study|Physician Decision|0|||
147008140|NCT01484912|530190066|FG001|Overall Study|Physician Decision|1|||
147008141|NCT00472212|530190069|FG000|Overall Study|Lost to Follow-up|6|||
147008142|NCT00472212|530190070|FG001|Overall Study|Lost to Follow-up|4|||
147008143|NCT00958724|530190079|FG000|Overall Study|Disease Progression|6|||
147008144|NCT05604014|530190080|FG000|Overall Study|Lost to Follow-up|13|||
147008145|NCT00840203|530190081|FG000|First Intervention|Protocol Violation|1|||
147008146|NCT00840203|530190082|FG001|First Intervention|Protocol Violation|1|||
147008147|NCT00840203|530190081|FG000|Washout|Protocol Violation|1|||
147008148|NCT00840203|530190082|FG001|Washout|Protocol Violation|0|||
147008149|NCT00989950|530190094|FG000|Randomized Phase|Protocol Violation|1|||
147008150|NCT00989950|530190095|FG001|Randomized Phase|Protocol Violation|0|||
147008151|NCT00989950|530190096|FG002|Randomized Phase|Protocol Violation|0|||
147008152|NCT00989950|530190097|FG003|Randomized Phase|Protocol Violation|0|||
147008153|NCT00989950|530190094|FG000|Randomized Phase|Adverse Event|0|||
147008154|NCT00989950|530190095|FG001|Randomized Phase|Adverse Event|1|||
147008155|NCT00989950|530190096|FG002|Randomized Phase|Adverse Event|0|||
147008156|NCT00989950|530190097|FG003|Randomized Phase|Adverse Event|0|||
147008157|NCT03101358|530190101|FG000|Overall Study|Non-compliance with study schedule|1|||
147008158|NCT03101358|530190102|FG001|Overall Study|Non-compliance with study schedule|0|||
147008159|NCT03101358|530190103|FG002|Overall Study|Non-compliance with study schedule|0|||
147008160|NCT03101358|530190104|FG003|Overall Study|Non-compliance with study schedule|1|||
147008161|NCT03101358|530190101|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
147008162|NCT03101358|530190102|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
147008163|NCT03101358|530190103|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
147008164|NCT03101358|530190104|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
147008165|NCT03101358|530190101|FG000|Overall Study|Physician Decision|1|||
147008166|NCT03101358|530190102|FG001|Overall Study|Physician Decision|0|||
147008167|NCT03101358|530190103|FG002|Overall Study|Physician Decision|0|||
147008168|NCT03101358|530190104|FG003|Overall Study|Physician Decision|3|||
147008169|NCT03101358|530190101|FG000|Overall Study|Adverse Event|0|||
147008170|NCT03101358|530190102|FG001|Overall Study|Adverse Event|0|||
147008171|NCT03101358|530190103|FG002|Overall Study|Adverse Event|1|||
147008172|NCT03101358|530190104|FG003|Overall Study|Adverse Event|0|||
147008173|NCT03101358|530190101|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
147008174|NCT03101358|530190102|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
147008175|NCT03101358|530190103|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
147008176|NCT03101358|530190104|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
147008177|NCT03101358|530190101|FG000|Overall Study|Lost to Follow-up|1|||
147008178|NCT03101358|530190102|FG001|Overall Study|Lost to Follow-up|0|||
147008179|NCT03101358|530190103|FG002|Overall Study|Lost to Follow-up|0|||
147008180|NCT03101358|530190104|FG003|Overall Study|Lost to Follow-up|1|||
147008181|NCT02426918|530190105|FG000|Overall Study|Adverse Event|2|||
147008182|NCT02426918|530190106|FG001|Overall Study|Adverse Event|2|||
147008183|NCT02426918|530190107|FG002|Overall Study|Adverse Event|0|||
147008184|NCT02426918|530190105|FG000|Overall Study|Physician Decision|1|||
147008185|NCT02426918|530190106|FG001|Overall Study|Physician Decision|1|||
147008186|NCT02426918|530190107|FG002|Overall Study|Physician Decision|1|||
147008187|NCT02426918|530190105|FG000|Overall Study|Withdrawal by Subject|5|||
147008188|NCT02426918|530190106|FG001|Overall Study|Withdrawal by Subject|5|||
147008189|NCT02426918|530190107|FG002|Overall Study|Withdrawal by Subject|4|||
147008190|NCT02426918|530190105|FG000|Overall Study|Other|9|||
147008191|NCT02426918|530190106|FG001|Overall Study|Other|11|||
147008192|NCT02426918|530190107|FG002|Overall Study|Other|9|||
147008193|NCT01190865|530190113|FG000|Overall Study|Withdrawal by Subject|1|||
147008194|NCT01190865|530190113|FG000|Overall Study|Non-compliance|2|||
147008195|NCT00829452|530190114|FG000|First Intervention|Withdrawal by Subject|0|||
147008196|NCT00829452|530190115|FG001|First Intervention|Withdrawal by Subject|1|||
147008197|NCT00829452|530190114|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
146736077|NCT02332590|529205299|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
146736078|NCT02332590|529205300|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
146736079|NCT02332590|529205299|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
146736080|NCT02332590|529205300|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
146736081|NCT02332590|529205299|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
146736082|NCT02332590|529205300|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
146736083|NCT02332590|529205299|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
146736084|NCT02332590|529205300|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
146736085|NCT02332590|529205299|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
146736086|NCT02332590|529205300|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
146736087|NCT00279201|529205301|FG000|Initiation|Death|1|||
146736088|NCT00279201|529205302|FG001|Initiation|Death|5|||
146736089|NCT00279201|529205303|FG002|Initiation|Death|0|||
146736090|NCT00279201|529205304|FG003|Initiation|Death|0|||
146736091|NCT00279201|529205305|FG004|Initiation|Death|0|||
146736092|NCT00279201|529205306|FG005|Initiation|Death|0|||
146736093|NCT00279201|529205301|FG000|Initiation|Adverse Event|6|||
146736094|NCT00279201|529205302|FG001|Initiation|Adverse Event|15|||
146736095|NCT00279201|529205303|FG002|Initiation|Adverse Event|0|||
146736096|NCT00279201|529205304|FG003|Initiation|Adverse Event|0|||
146736097|NCT00279201|529205305|FG004|Initiation|Adverse Event|0|||
146736098|NCT00279201|529205306|FG005|Initiation|Adverse Event|0|||
146736099|NCT00279201|529205301|FG000|Initiation|Lost to Follow-up|42|||
146736100|NCT00279201|529205302|FG001|Initiation|Lost to Follow-up|41|||
146736101|NCT00279201|529205303|FG002|Initiation|Lost to Follow-up|0|||
146736102|NCT00279201|529205304|FG003|Initiation|Lost to Follow-up|0|||
146736103|NCT00279201|529205305|FG004|Initiation|Lost to Follow-up|0|||
146736104|NCT00279201|529205306|FG005|Initiation|Lost to Follow-up|0|||
146736105|NCT00279201|529205301|FG000|Initiation|Entry Criteria Exclusion|7|||
146736106|NCT00279201|529205302|FG001|Initiation|Entry Criteria Exclusion|9|||
146736107|NCT00279201|529205303|FG002|Initiation|Entry Criteria Exclusion|0|||
146736108|NCT00279201|529205304|FG003|Initiation|Entry Criteria Exclusion|0|||
146736109|NCT00279201|529205305|FG004|Initiation|Entry Criteria Exclusion|0|||
146736110|NCT00279201|529205306|FG005|Initiation|Entry Criteria Exclusion|0|||
146736111|NCT00279201|529205301|FG000|Initiation|Protocol Violation|9|||
146736112|NCT00279201|529205302|FG001|Initiation|Protocol Violation|10|||
146736113|NCT00279201|529205303|FG002|Initiation|Protocol Violation|0|||
146736114|NCT00279201|529205304|FG003|Initiation|Protocol Violation|0|||
146736115|NCT00279201|529205305|FG004|Initiation|Protocol Violation|0|||
146736116|NCT00279201|529205306|FG005|Initiation|Protocol Violation|0|||
146736117|NCT00279201|529205301|FG000|Initiation|Withdrawal by Subject|35|||
146736118|NCT00279201|529205302|FG001|Initiation|Withdrawal by Subject|41|||
146736119|NCT00279201|529205303|FG002|Initiation|Withdrawal by Subject|0|||
146736120|NCT00279201|529205304|FG003|Initiation|Withdrawal by Subject|0|||
146736121|NCT00279201|529205305|FG004|Initiation|Withdrawal by Subject|0|||
146736122|NCT00279201|529205306|FG005|Initiation|Withdrawal by Subject|0|||
146736123|NCT00279201|529205301|FG000|Initiation|Physician Decision|15|||
146847196|NCT00888927|529610921|FG003|Overall Study|Withdrawal of consent|1|||
146847197|NCT03459443|529610922|FG000|Overall Study|Lack of Efficacy|3|||
146847198|NCT03459443|529610922|FG000|Overall Study|Adverse Event|1|||
146847199|NCT03459443|529610922|FG000|Overall Study|Sponsor's decision to close the study|18|||
146847200|NCT02153073|529610923|FG000|Overall Study|Case Report Forms Uncollected|230|||
147008198|NCT00829452|530190115|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
147008199|NCT00829452|530190114|FG000|Second Intervention|Physician Decision|0|||
147008200|NCT00829452|530190115|FG001|Second Intervention|Physician Decision|1|||
147008201|NCT00574847|530190118|FG000|Overall Study|Adverse Event|2|||
147008202|NCT00574847|530190119|FG001|Overall Study|Adverse Event|0|||
147008203|NCT00574847|530190118|FG000|Overall Study|Death|1|||
147008204|NCT00574847|530190119|FG001|Overall Study|Death|0|||
147008205|NCT00574847|530190118|FG000|Overall Study|Withdrawal by Subject|2|||
147008206|NCT00574847|530190119|FG001|Overall Study|Withdrawal by Subject|2|||
147008207|NCT00574847|530190118|FG000|Overall Study|Physician Decision|1|||
147008208|NCT00574847|530190119|FG001|Overall Study|Physician Decision|0|||
147008209|NCT00574847|530190118|FG000|Overall Study|Did not receive medication (declined)|2|||
147008210|NCT00574847|530190119|FG001|Overall Study|Did not receive medication (declined)|5|||
147008211|NCT02471807|530190124|FG000|Overall Study|Death|14|||
147008212|NCT02471807|530190124|FG000|Overall Study|Withdrawal by Subject|2|||
147008213|NCT02471807|530190124|FG000|Overall Study|Explant|5|||
147008214|NCT02471807|530190124|FG000|Overall Study|Lost to Follow-up|1|||
147008215|NCT01559363|530190127|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
147008216|NCT01559363|530190128|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
147008217|NCT01559363|530190129|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
147008218|NCT01559363|530190130|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
147008219|NCT01559363|530190131|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
147008220|NCT01559363|530190132|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
147008221|NCT01559363|530190127|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
147008222|NCT01559363|530190128|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
147008223|NCT01559363|530190129|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
147008224|NCT01559363|530190130|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
147008225|NCT01559363|530190131|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
147008226|NCT01559363|530190132|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
147008227|NCT01559363|530190127|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
147008228|NCT01559363|530190128|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
147008229|NCT01559363|530190129|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
147008230|NCT01559363|530190130|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
147008231|NCT01559363|530190131|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
147008232|NCT01559363|530190132|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
147008233|NCT01559363|530190127|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
147008234|NCT01559363|530190128|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
147008235|NCT01559363|530190129|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
147008236|NCT01559363|530190130|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
147008237|NCT01559363|530190131|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
147008238|NCT01559363|530190132|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
147008239|NCT01559363|530190127|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
147008240|NCT01559363|530190128|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
147008241|NCT01559363|530190129|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
147008242|NCT01559363|530190130|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
147008243|NCT01559363|530190131|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
147008244|NCT01559363|530190132|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
147008245|NCT01559363|530190127|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
147008246|NCT01559363|530190128|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
147008247|NCT01559363|530190129|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
147008248|NCT01559363|530190130|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
147008249|NCT01559363|530190131|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
147008250|NCT01559363|530190132|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
147008251|NCT01559363|530190127|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
147008252|NCT01559363|530190128|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
147008253|NCT01559363|530190129|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
147008254|NCT01559363|530190130|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
147008255|NCT01559363|530190131|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
147008256|NCT01559363|530190132|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
147008257|NCT00957021|530190135|FG000|Overall Study|Death|5|||
147008258|NCT00957021|530190135|FG000|Overall Study|Lost to Follow-up|8|||
147008259|NCT00957021|530190135|FG000|Overall Study|Withdrawal by Subject|34|||
147008260|NCT00957021|530190135|FG000|Overall Study|No 2 yr ROM data|35|||
147008261|NCT00957021|530190135|FG000|Overall Study|Revised study component by 2 yr visit|8|||
147008262|NCT00957021|530190135|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
147008263|NCT00957021|530190135|FG000|Overall Study|Surgery Cancelled|9|||
147008264|NCT00957021|530190135|FG000|Overall Study|Termination due to language issue|2|||
147008265|NCT00487435|530190140|FG000|Overall Study|Adverse Event|146|||
147008266|NCT00487435|530190140|FG000|Overall Study|Death|2|||
147008267|NCT00487435|530190140|FG000|Overall Study|Lack of Efficacy|33|||
147008268|NCT00487435|530190140|FG000|Overall Study|Lost to Follow-up|54|||
147008269|NCT00487435|530190140|FG000|Overall Study|Pregnancy|2|||
147008270|NCT00487435|530190140|FG000|Overall Study|Withdrawal by Subject|132|||
147008271|NCT00487435|530190140|FG000|Overall Study|Resolution Of Pain|1|||
147008272|NCT00487435|530190140|FG000|Overall Study|Study Medication Non-Compliant|32|||
147008273|NCT00487435|530190140|FG000|Overall Study|Other|83|||
147008274|NCT00868998|530190148|FG000|Overall Study|Screen Failure|1|||
147008275|NCT00868998|530190148|FG000|Overall Study|Withdrawal by Subject|1|||
147008276|NCT00868998|530190148|FG000|Overall Study|Progression of disease|2|||
147008277|NCT00868998|530190148|FG000|Overall Study|Death|1|||
147008278|NCT01483820|530190150|FG000|Overall Study|Lack of Efficacy|6|||
147008279|NCT01483820|530190150|FG000|Overall Study|Adverse Event|1|||
147008280|NCT01483820|530190150|FG000|Overall Study|Death|1|||
147008281|NCT01395017|530190153|FG000|Overall Study|Lost to Follow-up|1|||
147008282|NCT01395017|530190154|FG001|Overall Study|Lost to Follow-up|0|||
147008283|NCT01395017|530190153|FG000|Overall Study|Adverse Event|26|||
147008284|NCT01395017|530190154|FG001|Overall Study|Adverse Event|12|||
147008285|NCT01395017|530190153|FG000|Overall Study|Physician Decision|11|||
147008286|NCT01395017|530190154|FG001|Overall Study|Physician Decision|15|||
147008287|NCT01395017|530190153|FG000|Overall Study|Withdrawal by Subject|14|||
147008288|NCT01395017|530190154|FG001|Overall Study|Withdrawal by Subject|8|||
147008289|NCT01395017|530190153|FG000|Overall Study|Protocol deviation|1|||
147008290|NCT01395017|530190154|FG001|Overall Study|Protocol deviation|2|||
147008291|NCT01395017|530190153|FG000|Overall Study|Death|4|||
147008292|NCT01395017|530190154|FG001|Overall Study|Death|3|||
147008293|NCT01395017|530190153|FG000|Overall Study|Disease progression|42|||
147008294|NCT01395017|530190154|FG001|Overall Study|Disease progression|58|||
147008295|NCT01395017|530190153|FG000|Overall Study|Sponsor discontinued study|1|||
147008296|NCT01395017|530190154|FG001|Overall Study|Sponsor discontinued study|4|||
147008297|NCT00858403|530190156|FG000|Overall Study|Withdrawal by Subject|1|||
147008298|NCT00858403|530190156|FG000|Overall Study|Death|3|||
147008299|NCT00858403|530190156|FG000|Overall Study|Disease Progression|1|||
147008300|NCT01018862|530190163|FG000|Overall Study|Adverse Event|2|||
147008301|NCT01018862|530190164|FG001|Overall Study|Adverse Event|0|||
147008302|NCT01018862|530190165|FG002|Overall Study|Adverse Event|6|||
147008303|NCT01018862|530190163|FG000|Overall Study|Lack of Efficacy|1|||
147008304|NCT01018862|530190164|FG001|Overall Study|Lack of Efficacy|0|||
147008305|NCT01018862|530190165|FG002|Overall Study|Lack of Efficacy|2|||
147008306|NCT01018862|530190163|FG000|Overall Study|Lost to Follow-up|3|||
147008307|NCT01018862|530190164|FG001|Overall Study|Lost to Follow-up|1|||
147008308|NCT01018862|530190165|FG002|Overall Study|Lost to Follow-up|0|||
147008309|NCT01018862|530190163|FG000|Overall Study|Protocol Violation|1|||
147008310|NCT01018862|530190164|FG001|Overall Study|Protocol Violation|3|||
147008311|NCT01018862|530190165|FG002|Overall Study|Protocol Violation|3|||
147008312|NCT01018862|530190163|FG000|Overall Study|Withdrawal by Subject|1|||
147008313|NCT01018862|530190164|FG001|Overall Study|Withdrawal by Subject|2|||
147008314|NCT01018862|530190165|FG002|Overall Study|Withdrawal by Subject|1|||
147008315|NCT01018862|530190163|FG000|Overall Study|administrative problems|5|||
147008316|NCT01018862|530190164|FG001|Overall Study|administrative problems|4|||
147008317|NCT01018862|530190165|FG002|Overall Study|administrative problems|4|||
147008318|NCT01968031|530190169|FG000|Overall Study|Adverse Event|13|||
147008319|NCT01968031|530190170|FG001|Overall Study|Adverse Event|10|||
147008320|NCT01968031|530190171|FG002|Overall Study|Adverse Event|22|||
147008321|NCT01968031|530190169|FG000|Overall Study|Withdrawal by Subject|3|||
147008322|NCT01968031|530190170|FG001|Overall Study|Withdrawal by Subject|7|||
147008323|NCT01968031|530190171|FG002|Overall Study|Withdrawal by Subject|3|||
147008324|NCT01968031|530190169|FG000|Overall Study|Did not meet entry criteria|1|||
146847201|NCT02153073|529610923|FG000|Overall Study|Protocol Deviation|68|||
146847202|NCT03702231|529610924|FG000|Overall Study|Withdrawal by Subject|1|||
147008325|NCT01968031|530190170|FG001|Overall Study|Did not meet entry criteria|1|||
147008326|NCT01968031|530190171|FG002|Overall Study|Did not meet entry criteria|1|||
147008327|NCT01968031|530190169|FG000|Overall Study|Noncompliance|0|||
147008328|NCT01968031|530190170|FG001|Overall Study|Noncompliance|0|||
147008329|NCT01968031|530190171|FG002|Overall Study|Noncompliance|2|||
147008330|NCT01968031|530190169|FG000|Overall Study|Failed inclusion criteria|0|||
147008331|NCT01968031|530190170|FG001|Overall Study|Failed inclusion criteria|2|||
147008332|NCT01968031|530190171|FG002|Overall Study|Failed inclusion criteria|0|||
147008333|NCT01968031|530190169|FG000|Overall Study|Death|0|||
147008334|NCT01968031|530190170|FG001|Overall Study|Death|0|||
147008335|NCT01968031|530190171|FG002|Overall Study|Death|1|||
147008336|NCT01968031|530190169|FG000|Overall Study|Prohibited concomitant medication|1|||
147008337|NCT01968031|530190170|FG001|Overall Study|Prohibited concomitant medication|0|||
147008338|NCT01968031|530190171|FG002|Overall Study|Prohibited concomitant medication|0|||
147008339|NCT00874276|530190172|FG000|Overall Study|Withdrawal by Subject|1|||
147008340|NCT00874276|530190173|FG001|Overall Study|Withdrawal by Subject|1|||
147008341|NCT02485158|530192065|FG000|Overall Study|Withdrawal by Subject|3|||
147008342|NCT02485158|530192065|FG000|Overall Study|expected drug side effect|1|||
147008343|NCT00834444|530192066|FG000|First Intervention|Adverse Event|1|||
147008344|NCT00834444|530192067|FG001|First Intervention|Adverse Event|0|||
147008345|NCT00834444|530192066|FG000|First Intervention|Intolerance to Venopuncture|0|||
147008346|NCT00834444|530192067|FG001|First Intervention|Intolerance to Venopuncture|1|||
147008347|NCT00834444|530192066|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
147008348|NCT00834444|530192067|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
147008349|NCT00834444|530192066|FG000|Second Intervention|Adverse Event|1|||
147008350|NCT00834444|530192067|FG001|Second Intervention|Adverse Event|0|||
147008351|NCT00731939|530192071|FG000|Overall Study|Adverse Event|6|||
147008352|NCT00731939|530192071|FG000|Overall Study|Lost to Follow-up|15|||
147008353|NCT00731939|530192071|FG000|Overall Study|Not implanted with study device|9|||
147008354|NCT00731939|530192071|FG000|Overall Study|Withdrawal by Subject|2|||
147008355|NCT00731939|530192071|FG000|Overall Study|Did not meet enrollment criteria|2|||
147008356|NCT02704091|530192072|FG000|Overall Study|Adverse Event|4|||
147008357|NCT02704091|530192073|FG001|Overall Study|Adverse Event|3|||
147008358|NCT02704091|530192072|FG000|Overall Study|Protocol Violation|5|||
147008359|NCT02704091|530192073|FG001|Overall Study|Protocol Violation|3|||
147008360|NCT02704091|530192072|FG000|Overall Study|Consent withdrawn|4|||
147008361|NCT02704091|530192073|FG001|Overall Study|Consent withdrawn|4|||
147008362|NCT02704091|530192072|FG000|Overall Study|Lost to Follow-up|13|||
147008363|NCT02704091|530192073|FG001|Overall Study|Lost to Follow-up|5|||
147008364|NCT02704091|530192072|FG000|Overall Study|Other|2|||
147008365|NCT02704091|530192073|FG001|Overall Study|Other|8|||
147008366|NCT01634139|530192074|FG000|Overall Study|Non compliant with protocol|1|||
147008367|NCT01634139|530192075|FG001|Overall Study|Non compliant with protocol|0|||
147008368|NCT01634139|530192076|FG002|Overall Study|Non compliant with protocol|0|||
147008369|NCT01634139|530192074|FG000|Overall Study|Consent withdrawn not due to AE|4|||
147008370|NCT01634139|530192075|FG001|Overall Study|Consent withdrawn not due to AE|3|||
147008371|NCT01634139|530192076|FG002|Overall Study|Consent withdrawn not due to AE|2|||
147008372|NCT01634139|530192074|FG000|Overall Study|Other|4|||
147008373|NCT01634139|530192075|FG001|Overall Study|Other|0|||
147008374|NCT01634139|530192076|FG002|Overall Study|Other|3|||
147008375|NCT01634139|530192074|FG000|Overall Study|Lost to Follow-up|0|||
147008376|NCT01634139|530192075|FG001|Overall Study|Lost to Follow-up|2|||
147008377|NCT01634139|530192076|FG002|Overall Study|Lost to Follow-up|0|||
147008378|NCT01634139|530192074|FG000|Overall Study|Not treated|1|||
147008379|NCT01634139|530192075|FG001|Overall Study|Not treated|1|||
147008380|NCT01634139|530192076|FG002|Overall Study|Not treated|0|||
147008381|NCT00425308|530192077|FG000|Overall Study|Adverse Event|2|||
147008382|NCT00425308|530192078|FG001|Overall Study|Adverse Event|1|||
147008383|NCT00425308|530192077|FG000|Overall Study|Withdrawal by Subject|1|||
147008384|NCT00425308|530192078|FG001|Overall Study|Withdrawal by Subject|0|||
147008385|NCT00425308|530192077|FG000|Overall Study|Death|1|||
147008386|NCT00425308|530192078|FG001|Overall Study|Death|0|||
147008387|NCT04411680|530192079|FG000|Treatment Period|Adverse Event|3|||
147008388|NCT04411680|530192080|FG001|Treatment Period|Adverse Event|0|||
147008389|NCT04411680|530192079|FG000|Treatment Period|Discharged from hospital|18|||
147008390|NCT04411680|530192080|FG001|Treatment Period|Discharged from hospital|7|||
147008391|NCT04411680|530192079|FG000|Treatment Period|Missed 1 or more doses|8|||
147008392|NCT04411680|530192080|FG001|Treatment Period|Missed 1 or more doses|0|||
147008393|NCT04411680|530192079|FG000|Treatment Period|Transferred to another hospital|0|||
147008394|NCT04411680|530192080|FG001|Treatment Period|Transferred to another hospital|1|||
147008395|NCT04411680|530192079|FG000|Follow up Period|Withdrawal by Subject|2|||
147008396|NCT04411680|530192080|FG001|Follow up Period|Withdrawal by Subject|0|||
147008397|NCT04411680|530192079|FG000|Follow up Period|Lost to Follow-up|5|||
147008398|NCT04411680|530192080|FG001|Follow up Period|Lost to Follow-up|6|||
147008399|NCT04411680|530192079|FG000|Follow up Period|Death|11|||
147008400|NCT04411680|530192080|FG001|Follow up Period|Death|8|||
147008401|NCT00841659|530192081|FG000|Washout: 2 Weeks|Protocol Violation|1|||
147008402|NCT00841659|530192082|FG001|Washout: 2 Weeks|Protocol Violation|0|||
147008403|NCT02420353|530192083|FG000|Overall Study|Withdrawal by Subject|0|||
147008404|NCT02420353|530192084|FG001|Overall Study|Withdrawal by Subject|1|||
147008405|NCT00073307|530192090|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
147008406|NCT00073307|530192091|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
147008407|NCT00073307|530192092|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
147008408|NCT00073307|530192090|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
147008409|NCT00073307|530192091|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
147008410|NCT00073307|530192092|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
147008411|NCT00073307|530192090|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
147008412|NCT00073307|530192091|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
147008413|NCT00073307|530192092|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
147008414|NCT00073307|530192090|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
147008415|NCT00073307|530192091|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
147008416|NCT00073307|530192092|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
147008417|NCT00073307|530192090|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
147008418|NCT00073307|530192091|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
147008419|NCT00073307|530192092|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
147008420|NCT00073307|530192090|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
147008421|NCT00073307|530192091|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
147008422|NCT00073307|530192092|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
147008423|NCT00073307|530192090|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
147008424|NCT00073307|530192091|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
147008425|NCT00073307|530192092|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
147008426|NCT00073307|530192090|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
147008427|NCT00073307|530192091|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
147008428|NCT00073307|530192092|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
147008429|NCT00073307|530192090|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
147008430|NCT00073307|530192091|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
147008431|NCT00073307|530192092|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
147008432|NCT00073307|530192090|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
147008433|NCT00073307|530192091|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
147008434|NCT00073307|530192092|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
147008435|NCT00073307|530192090|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
147008436|NCT00073307|530192091|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
147008437|NCT00073307|530192092|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
147008438|NCT00073307|530192090|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
147008439|NCT00073307|530192091|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
147008440|NCT00073307|530192092|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
147008441|NCT00073307|530192090|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
147008442|NCT00073307|530192091|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
147008443|NCT00073307|530192092|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
147008444|NCT00073307|530192090|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
147008445|NCT00073307|530192091|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
147008446|NCT00073307|530192092|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
147008447|NCT00073307|530192090|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
147008448|NCT00073307|530192091|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
147008449|NCT00073307|530192092|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
147008450|NCT00073307|530192090|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
147008451|NCT00073307|530192091|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
147008452|NCT00073307|530192092|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
147008453|NCT00073307|530192090|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
147008454|NCT00073307|530192091|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
147008455|NCT00073307|530192092|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
147008456|NCT00073307|530192090|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
147008457|NCT00073307|530192091|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
147008458|NCT00073307|530192092|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
147008459|NCT00073307|530192090|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
147008460|NCT00073307|530192091|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
147008461|NCT00073307|530192092|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
147008462|NCT01438060|530192093|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
147008463|NCT01438060|530192094|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
147008464|NCT01438060|530192093|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
147008465|NCT01438060|530192094|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
147008466|NCT01438060|530192093|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
147008467|NCT01438060|530192094|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
147008468|NCT01438060|530192093|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
147008469|NCT01438060|530192094|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
147008470|NCT01438060|530192093|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
147008471|NCT01438060|530192094|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
147008472|NCT01438060|530192093|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
147008473|NCT01438060|530192094|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
147008474|NCT01438060|530192093|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
147008475|NCT01438060|530192094|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
147008476|NCT01438060|530192093|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
147008477|NCT01438060|530192094|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
147013230|NCT01708954|530210054|FG000|Step 1|Death|3|||
147008478|NCT01438060|530192093|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
147008479|NCT01438060|530192094|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
147008480|NCT01438060|530192093|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
147008481|NCT01438060|530192094|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
147008482|NCT01438060|530192093|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
147008483|NCT01438060|530192094|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
147008484|NCT01438060|530192093|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
147008485|NCT01438060|530192094|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
147008486|NCT01438060|530192093|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
147008487|NCT01438060|530192094|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
147008488|NCT01438060|530192093|FG000|On Study Beyond Week 140|Adverse Event|0|||
147008489|NCT01438060|530192094|FG001|On Study Beyond Week 140|Adverse Event|2|||
147008490|NCT01438060|530192093|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
147008491|NCT01438060|530192094|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
147008492|NCT01438060|530192093|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
147008493|NCT01438060|530192094|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
147008494|NCT01438060|530192093|FG000|On Study Beyond Week 140|Death|0|||
147008495|NCT01438060|530192094|FG001|On Study Beyond Week 140|Death|1|||
147008496|NCT01438060|530192093|FG000|On Study Beyond Week 140|Other Reason|0|||
147008497|NCT01438060|530192094|FG001|On Study Beyond Week 140|Other Reason|3|||
147008498|NCT01964950|530192095|FG000|Overall Study|Protocol Violation|25|||
147008499|NCT01149057|530192096|FG000|Overall Study|Lack of Efficacy|16|||
147008500|NCT01149057|530192096|FG000|Overall Study|Adverse Event|13|||
147008501|NCT01149057|530192096|FG000|Overall Study|Withdrawal by Subject|9|||
147008502|NCT01149057|530192096|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
147008503|NCT01149057|530192096|FG000|Overall Study|B Cell Depletion|4|||
147008504|NCT01149057|530192096|FG000|Overall Study|Participant Non-Compliance|2|||
147008505|NCT01149057|530192096|FG000|Overall Study|Lost to Follow-up|1|||
147008506|NCT01149057|530192096|FG000|Overall Study|High Parathyroid Hormone Value|1|||
147008507|NCT01149057|530192096|FG000|Overall Study|Other|6|||
147008508|NCT03499873|530192097|FG000|Overall Study|Withdrawal by Subject|4|||
147008509|NCT03499873|530192098|FG001|Overall Study|Withdrawal by Subject|6|||
147008510|NCT03499873|530192099|FG002|Overall Study|Withdrawal by Subject|1|||
147008511|NCT03499873|530192097|FG000|Overall Study|Subjects condition worsened|0|||
147008512|NCT03499873|530192098|FG001|Overall Study|Subjects condition worsened|3|||
147008513|NCT03499873|530192099|FG002|Overall Study|Subjects condition worsened|11|||
147008514|NCT03499873|530192097|FG000|Overall Study|Adverse Event|8|||
147008515|NCT03499873|530192098|FG001|Overall Study|Adverse Event|3|||
147008516|NCT03499873|530192099|FG002|Overall Study|Adverse Event|6|||
147008517|NCT03499873|530192097|FG000|Overall Study|Physician Decision|1|||
147008518|NCT03499873|530192098|FG001|Overall Study|Physician Decision|0|||
147008519|NCT03499873|530192099|FG002|Overall Study|Physician Decision|0|||
147008520|NCT03499873|530192097|FG000|Overall Study|Administrative reasons|0|||
147008521|NCT03499873|530192098|FG001|Overall Study|Administrative reasons|1|||
147008522|NCT03499873|530192099|FG002|Overall Study|Administrative reasons|0|||
147008523|NCT03499873|530192097|FG000|Overall Study|Concomitant therapy|5|||
147008524|NCT03499873|530192098|FG001|Overall Study|Concomitant therapy|4|||
147008525|NCT03499873|530192099|FG002|Overall Study|Concomitant therapy|7|||
147008526|NCT03499873|530192097|FG000|Overall Study|Miscellaneous|1|||
147008527|NCT03499873|530192098|FG001|Overall Study|Miscellaneous|2|||
147008528|NCT03499873|530192099|FG002|Overall Study|Miscellaneous|2|||
147008529|NCT03499873|530192097|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
147008530|NCT03499873|530192098|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
147008531|NCT03499873|530192099|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
147008532|NCT04608448|530192100|FG000|Overall Study|Withdrawal by Subject|1|||
147008533|NCT04608448|530192100|FG000|Overall Study|Adverse Event|1|||
147008534|NCT03602339|530192101|FG000|Overall Study|Withdrawal by Subject|9|||
147008535|NCT03602339|530192101|FG000|Overall Study|Physician Decision|2|||
147008536|NCT03602339|530192101|FG000|Overall Study|Other reason|4|||
147008537|NCT01297504|530192102|FG000|Overall Study|Invalid Consent|1|||
146847203|NCT03702231|529610925|FG001|Overall Study|Withdrawal by Subject|0|||
146847204|NCT03702231|529610926|FG002|Overall Study|Withdrawal by Subject|0|||
146847205|NCT03702231|529610924|FG000|Overall Study|Protocol Violation|0|||
147008538|NCT01297504|530192102|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
146847206|NCT03702231|529610925|FG001|Overall Study|Protocol Violation|0|||
146847207|NCT03702231|529610926|FG002|Overall Study|Protocol Violation|1|||
147008539|NCT01297504|530192102|FG000|Overall Study|No Study Visits|4|||
147008540|NCT01297504|530192102|FG000|Overall Study|Death|3|||
147008541|NCT01297504|530192102|FG000|Overall Study|Lost to Follow-up|43|||
147008542|NCT01297504|530192102|FG000|Overall Study|Withdrawal by Subject|9|||
147008543|NCT01297504|530192102|FG000|Overall Study|Site Closure|3|||
147008544|NCT01297504|530192102|FG000|Overall Study|Protocol Violation|3|||
147008545|NCT00654186|530192103|FG000|Overall Study|Withdrawal by Subject|5|||
147008546|NCT01024855|530192108|FG000|Overall Study|Inclusion/exclusion criteria|1|||
147008547|NCT03306277|530192110|FG000|Overall Study|Death|1|||
147008548|NCT03306277|530192110|FG000|Overall Study|Adverse Event|1|||
147008549|NCT03306277|530192110|FG000|Overall Study|Withdrawal by Subject|1|||
147008550|NCT01968551|530192112|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
147008551|NCT01968551|530192113|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
147008552|NCT01968551|530192114|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
147008553|NCT01968551|530192112|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
147008554|NCT01968551|530192113|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
147008555|NCT01968551|530192114|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
147008556|NCT01968551|530192112|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
147008557|NCT01968551|530192113|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
147008558|NCT01968551|530192114|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
147008559|NCT01968551|530192112|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
147008560|NCT01968551|530192113|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
147008561|NCT01968551|530192114|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
147008562|NCT01968551|530192112|FG000|Extension Phase|Adverse Event|0|||
147008563|NCT01968551|530192113|FG001|Extension Phase|Adverse Event|0|||
147008564|NCT01968551|530192114|FG002|Extension Phase|Adverse Event|2|||
147008565|NCT01968551|530192112|FG000|Extension Phase|Death|0|||
147008566|NCT01968551|530192113|FG001|Extension Phase|Death|1|||
147008567|NCT01968551|530192114|FG002|Extension Phase|Death|0|||
147008568|NCT01968551|530192112|FG000|Extension Phase|Withdrew Consent|0|||
147008569|NCT01968551|530192113|FG001|Extension Phase|Withdrew Consent|0|||
147008570|NCT01968551|530192114|FG002|Extension Phase|Withdrew Consent|1|||
147008571|NCT01968551|530192112|FG000|Extension Phase|Lost to Follow-up|1|||
147008572|NCT01968551|530192113|FG001|Extension Phase|Lost to Follow-up|0|||
147008573|NCT01968551|530192114|FG002|Extension Phase|Lost to Follow-up|1|||
147008574|NCT04060251|530192115|FG000|Overall Study|Study terminated due to low enrollment.|7|||
147008575|NCT04060251|530192116|FG001|Overall Study|Study terminated due to low enrollment.|5|||
147008576|NCT04060251|530192117|FG002|Overall Study|Study terminated due to low enrollment.|7|||
147008577|NCT04060251|530192115|FG000|Overall Study|Adverse Event|1|||
147008578|NCT04060251|530192116|FG001|Overall Study|Adverse Event|1|||
147008579|NCT04060251|530192117|FG002|Overall Study|Adverse Event|0|||
147008580|NCT01155531|530192118|FG000|Overall Study|Adverse Event|0|||
147008581|NCT01155531|530192119|FG001|Overall Study|Adverse Event|0|||
147008582|NCT01155531|530192120|FG002|Overall Study|Adverse Event|1|||
147008583|NCT01155531|530192121|FG003|Overall Study|Adverse Event|0|||
147008584|NCT01155531|530192118|FG000|Overall Study|Lost to Follow-up|0|||
147008585|NCT01155531|530192119|FG001|Overall Study|Lost to Follow-up|0|||
147008586|NCT01155531|530192120|FG002|Overall Study|Lost to Follow-up|0|||
147008587|NCT01155531|530192121|FG003|Overall Study|Lost to Follow-up|1|||
147008588|NCT01155531|530192118|FG000|Overall Study|Withdrawal by Subject|1|||
147008589|NCT01155531|530192119|FG001|Overall Study|Withdrawal by Subject|0|||
147008590|NCT01155531|530192120|FG002|Overall Study|Withdrawal by Subject|1|||
147008591|NCT01155531|530192121|FG003|Overall Study|Withdrawal by Subject|0|||
147008592|NCT01087502|530192122|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
147008593|NCT01087502|530192123|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
147008594|NCT01087502|530192122|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
147008595|NCT01087502|530192123|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
147008596|NCT01087502|530192122|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
147008597|NCT01087502|530192123|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
147008598|NCT01087502|530192122|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
147008599|NCT01087502|530192123|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
147008600|NCT01087502|530192122|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
147008601|NCT01087502|530192123|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
147008602|NCT01087502|530192122|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
147008603|NCT01087502|530192123|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
147008604|NCT01087502|530192122|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
147008605|NCT01087502|530192123|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
147008606|NCT01087502|530192122|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
147008607|NCT01087502|530192123|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
147008608|NCT01087502|530192122|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
147008609|NCT01087502|530192123|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
146736124|NCT00279201|529205302|FG001|Initiation|Physician Decision|18|||
146736125|NCT00279201|529205303|FG002|Initiation|Physician Decision|0|||
146736126|NCT00279201|529205304|FG003|Initiation|Physician Decision|0|||
146736127|NCT00279201|529205305|FG004|Initiation|Physician Decision|0|||
146736128|NCT00279201|529205306|FG005|Initiation|Physician Decision|0|||
146736129|NCT00279201|529205301|FG000|Initiation|Sponsor Decision|13|||
147008610|NCT01087502|530192122|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
146736130|NCT00279201|529205302|FG001|Initiation|Sponsor Decision|5|||
147008611|NCT01087502|530192123|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
147008612|NCT01087502|530192122|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
147008613|NCT01087502|530192123|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
147008614|NCT01087502|530192122|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
147008615|NCT01087502|530192123|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
147008616|NCT01653704|530192124|FG000|Overall Study|Technical failure during recording|1|||
147008617|NCT01653704|530192125|FG001|Overall Study|Technical failure during recording|1|||
147008618|NCT01653704|530192124|FG000|Overall Study|Performance not reflective of training|1|||
147008619|NCT01653704|530192125|FG001|Overall Study|Performance not reflective of training|0|||
147008620|NCT02705716|530192126|FG000|Overall Study|Adverse Event|0|||
147008621|NCT02705716|530192127|FG001|Overall Study|Adverse Event|1|||
147008622|NCT02705716|530192126|FG000|Overall Study|Protocol Violation|3|||
147008623|NCT02705716|530192127|FG001|Overall Study|Protocol Violation|0|||
147008624|NCT02705716|530192126|FG000|Overall Study|Withdrawal of Consent|1|||
147008625|NCT02705716|530192127|FG001|Overall Study|Withdrawal of Consent|1|||
147008626|NCT01986647|530192128|FG000|Overall Study|Lost to Follow-up|4|||
147008627|NCT01986647|530192129|FG001|Overall Study|Lost to Follow-up|1|||
147008628|NCT01986647|530192130|FG002|Overall Study|Lost to Follow-up|4|||
147008629|NCT01986647|530192131|FG003|Overall Study|Lost to Follow-up|4|||
147008630|NCT01986647|530192128|FG000|Overall Study|Withdrawal by Subject|1|||
147008631|NCT01986647|530192129|FG001|Overall Study|Withdrawal by Subject|3|||
147008632|NCT01986647|530192130|FG002|Overall Study|Withdrawal by Subject|2|||
147008633|NCT01986647|530192131|FG003|Overall Study|Withdrawal by Subject|3|||
147008634|NCT01986647|530192128|FG000|Overall Study|Health|5|||
147008635|NCT01986647|530192129|FG001|Overall Study|Health|3|||
147008636|NCT01986647|530192130|FG002|Overall Study|Health|6|||
147008637|NCT01986647|530192131|FG003|Overall Study|Health|4|||
147008638|NCT01663896|530192134|FG000|Overall Study|Various reasons|43|||
147008639|NCT00999687|530192135|FG000|First Intervention|Withdrawal by Subject|1|||
147008640|NCT00999687|530192135|FG000|Second Intervention|Withdrawal by Subject|2|||
147008641|NCT00999687|530192135|FG000|Second Intervention|Lack of Efficacy|1|||
147008642|NCT03541252|530192138|FG000|Overall Study|Withdrawal by Subject|1|||
147008643|NCT01960296|530192145|FG000|Overall Study|Postponed surgery|1|||
147008644|NCT01960296|530192146|FG001|Overall Study|Postponed surgery|0|||
147008645|NCT01960296|530192145|FG000|Overall Study|Received different procedure|1|||
147008646|NCT01960296|530192146|FG001|Overall Study|Received different procedure|3|||
147008647|NCT02003391|530192147|FG000|Overall Study|Withdrawal by Subject|2|||
147008648|NCT02003391|530192148|FG001|Overall Study|Withdrawal by Subject|1|||
147008649|NCT02003391|530192147|FG000|Overall Study|Protocol Violation|0|||
147008650|NCT02003391|530192148|FG001|Overall Study|Protocol Violation|1|||
147008651|NCT02003391|530192147|FG000|Overall Study|Adverse Event|1|||
147008652|NCT02003391|530192148|FG001|Overall Study|Adverse Event|0|||
147008653|NCT02272803|530192149|FG000|Overall Study|Disease progression|16|||
147008654|NCT02272803|530192150|FG001|Overall Study|Disease progression|8|||
147008655|NCT02272803|530192149|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
147008656|NCT02272803|530192150|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
147008657|NCT02272803|530192149|FG000|Overall Study|Study drug toxicity|4|||
147008658|NCT02272803|530192150|FG001|Overall Study|Study drug toxicity|9|||
147008659|NCT02272803|530192149|FG000|Overall Study|Participant request to discontinue study treatment|3|||
147008660|NCT02272803|530192150|FG001|Overall Study|Participant request to discontinue study treatment|7|||
147008661|NCT02272803|530192149|FG000|Overall Study|Maximum clinical benefit|4|||
147008662|NCT02272803|530192150|FG001|Overall Study|Maximum clinical benefit|2|||
147008663|NCT02272803|530192149|FG000|Overall Study|Poor/non-compliance|2|||
147008664|NCT02272803|530192150|FG001|Overall Study|Poor/non-compliance|2|||
147008665|NCT02272803|530192149|FG000|Overall Study|Withdrawal by Subject|2|||
147008666|NCT02272803|530192150|FG001|Overall Study|Withdrawal by Subject|1|||
147008667|NCT02272803|530192149|FG000|Overall Study|Death|0|||
147008668|NCT02272803|530192150|FG001|Overall Study|Death|1|||
147008669|NCT02272803|530192149|FG000|Overall Study|Other reasons|1|||
147008670|NCT02272803|530192150|FG001|Overall Study|Other reasons|3|||
147008671|NCT02272803|530192149|FG000|Overall Study|Administrative reason by sponsor|5|||
147008672|NCT02272803|530192150|FG001|Overall Study|Administrative reason by sponsor|4|||
147008673|NCT02611323|530192151|FG000|Overall Study|Death|3|||
147008674|NCT02611323|530192152|FG001|Overall Study|Death|1|||
147008675|NCT02611323|530192153|FG002|Overall Study|Death|0|||
147008676|NCT02611323|530192154|FG003|Overall Study|Death|0|||
147008677|NCT02611323|530192155|FG004|Overall Study|Death|1|||
147008678|NCT02611323|530192156|FG005|Overall Study|Death|1|||
147008679|NCT02611323|530192157|FG006|Overall Study|Death|8|||
147008680|NCT02611323|530192158|FG007|Overall Study|Death|0|||
147008681|NCT02611323|530192159|FG008|Overall Study|Death|4|||
147008682|NCT02611323|530192160|FG009|Overall Study|Death|6|||
147008683|NCT02611323|530192161|FG010|Overall Study|Death|26|||
147008684|NCT02611323|530192151|FG000|Overall Study|Lost to Follow-up|1|||
147008685|NCT02611323|530192152|FG001|Overall Study|Lost to Follow-up|0|||
147008686|NCT02611323|530192153|FG002|Overall Study|Lost to Follow-up|0|||
147008687|NCT02611323|530192154|FG003|Overall Study|Lost to Follow-up|0|||
147008688|NCT02611323|530192155|FG004|Overall Study|Lost to Follow-up|0|||
147008689|NCT02611323|530192156|FG005|Overall Study|Lost to Follow-up|0|||
147008690|NCT02611323|530192157|FG006|Overall Study|Lost to Follow-up|3|||
147008691|NCT02611323|530192158|FG007|Overall Study|Lost to Follow-up|0|||
147008692|NCT02611323|530192159|FG008|Overall Study|Lost to Follow-up|0|||
147008693|NCT02611323|530192160|FG009|Overall Study|Lost to Follow-up|0|||
147008694|NCT02611323|530192161|FG010|Overall Study|Lost to Follow-up|2|||
147008695|NCT02611323|530192151|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
147008696|NCT02611323|530192152|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
147008697|NCT02611323|530192153|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
147008698|NCT02611323|530192154|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
147008699|NCT02611323|530192155|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
147008700|NCT02611323|530192156|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
147008701|NCT02611323|530192157|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
147008702|NCT02611323|530192158|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
147008703|NCT02611323|530192159|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
147008704|NCT02611323|530192160|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
147008705|NCT02611323|530192161|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
147008706|NCT02611323|530192151|FG000|Overall Study|Progressive Disease|0|||
147008707|NCT02611323|530192152|FG001|Overall Study|Progressive Disease|0|||
147008708|NCT02611323|530192153|FG002|Overall Study|Progressive Disease|0|||
147008709|NCT02611323|530192154|FG003|Overall Study|Progressive Disease|0|||
147008710|NCT02611323|530192155|FG004|Overall Study|Progressive Disease|0|||
147008711|NCT02611323|530192156|FG005|Overall Study|Progressive Disease|0|||
147008712|NCT02611323|530192157|FG006|Overall Study|Progressive Disease|0|||
147008713|NCT02611323|530192158|FG007|Overall Study|Progressive Disease|0|||
147008714|NCT02611323|530192159|FG008|Overall Study|Progressive Disease|0|||
147008715|NCT02611323|530192160|FG009|Overall Study|Progressive Disease|0|||
147008716|NCT02611323|530192161|FG010|Overall Study|Progressive Disease|1|||
147008717|NCT02611323|530192151|FG000|Overall Study|Withdrawal by Subject|1|||
147008718|NCT02611323|530192152|FG001|Overall Study|Withdrawal by Subject|0|||
147008719|NCT02611323|530192153|FG002|Overall Study|Withdrawal by Subject|0|||
147008720|NCT02611323|530192154|FG003|Overall Study|Withdrawal by Subject|0|||
147008721|NCT02611323|530192155|FG004|Overall Study|Withdrawal by Subject|0|||
147008722|NCT02611323|530192156|FG005|Overall Study|Withdrawal by Subject|0|||
147008723|NCT02611323|530192157|FG006|Overall Study|Withdrawal by Subject|0|||
147008724|NCT02611323|530192158|FG007|Overall Study|Withdrawal by Subject|1|||
147008725|NCT02611323|530192159|FG008|Overall Study|Withdrawal by Subject|0|||
147008726|NCT02611323|530192160|FG009|Overall Study|Withdrawal by Subject|1|||
147008727|NCT02611323|530192161|FG010|Overall Study|Withdrawal by Subject|0|||
147008728|NCT02597049|530192162|FG000|Overall Study|Lost to Follow-up|0|||
147008729|NCT02597049|530192163|FG001|Overall Study|Lost to Follow-up|3|||
147008730|NCT02597049|530192164|FG002|Overall Study|Lost to Follow-up|2|||
147008731|NCT02597049|530192162|FG000|Overall Study|Withdrawal by Subject|2|||
147008732|NCT02597049|530192163|FG001|Overall Study|Withdrawal by Subject|2|||
147008733|NCT02597049|530192164|FG002|Overall Study|Withdrawal by Subject|1|||
147008734|NCT02597049|530192162|FG000|Overall Study|Adverse Event|2|||
147008735|NCT02597049|530192163|FG001|Overall Study|Adverse Event|0|||
147008736|NCT02597049|530192164|FG002|Overall Study|Adverse Event|0|||
147008737|NCT02597049|530192162|FG000|Overall Study|Death|2|||
147008738|NCT02597049|530192163|FG001|Overall Study|Death|0|||
147008739|NCT02597049|530192164|FG002|Overall Study|Death|0|||
147008740|NCT02597049|530192162|FG000|Overall Study|Noncompliant with Study Visits|1|||
147008741|NCT02597049|530192163|FG001|Overall Study|Noncompliant with Study Visits|0|||
147008742|NCT02597049|530192164|FG002|Overall Study|Noncompliant with Study Visits|0|||
147008743|NCT03573544|530192167|FG000|Overall Study|Adverse Event|0|||
147008744|NCT03573544|530192168|FG001|Overall Study|Adverse Event|0|||
147008745|NCT03573544|530192169|FG002|Overall Study|Adverse Event|0|||
147008746|NCT03573544|530192170|FG003|Overall Study|Adverse Event|3|||
147008747|NCT03573544|530192171|FG004|Overall Study|Adverse Event|1|||
147008748|NCT03573544|530192172|FG005|Overall Study|Adverse Event|0|||
147008749|NCT03573544|530192173|FG006|Overall Study|Adverse Event|2|||
147008750|NCT03573544|530192174|FG007|Overall Study|Adverse Event|0|||
147008751|NCT03573544|530192167|FG000|Overall Study|Physician Decision|0|||
147008752|NCT03573544|530192168|FG001|Overall Study|Physician Decision|0|||
147008753|NCT03573544|530192169|FG002|Overall Study|Physician Decision|0|||
147008754|NCT03573544|530192170|FG003|Overall Study|Physician Decision|0|||
147008755|NCT03573544|530192171|FG004|Overall Study|Physician Decision|0|||
147008756|NCT03573544|530192172|FG005|Overall Study|Physician Decision|0|||
147008757|NCT03573544|530192173|FG006|Overall Study|Physician Decision|1|||
147008758|NCT03573544|530192174|FG007|Overall Study|Physician Decision|0|||
147008759|NCT03573544|530192167|FG000|Overall Study|Withdrawal by Subject|2|||
147008760|NCT03573544|530192168|FG001|Overall Study|Withdrawal by Subject|0|||
147008761|NCT03573544|530192169|FG002|Overall Study|Withdrawal by Subject|0|||
147008762|NCT03573544|530192170|FG003|Overall Study|Withdrawal by Subject|1|||
147008763|NCT03573544|530192171|FG004|Overall Study|Withdrawal by Subject|1|||
147008764|NCT03573544|530192172|FG005|Overall Study|Withdrawal by Subject|1|||
147008765|NCT03573544|530192173|FG006|Overall Study|Withdrawal by Subject|0|||
147008766|NCT03573544|530192174|FG007|Overall Study|Withdrawal by Subject|1|||
147008767|NCT03573544|530192167|FG000|Overall Study|Disease progression|3|||
147008768|NCT03573544|530192168|FG001|Overall Study|Disease progression|3|||
147008769|NCT03573544|530192169|FG002|Overall Study|Disease progression|6|||
147008770|NCT03573544|530192170|FG003|Overall Study|Disease progression|4|||
146847208|NCT03702231|529610924|FG000|Overall Study|Change in CLL Treatment|0|||
146847209|NCT03702231|529610925|FG001|Overall Study|Change in CLL Treatment|0|||
146847210|NCT03702231|529610926|FG002|Overall Study|Change in CLL Treatment|1|||
146847211|NCT03702231|529610924|FG000|Overall Study|COVID Pandemic|1|||
146847212|NCT03702231|529610925|FG001|Overall Study|COVID Pandemic|4|||
146847213|NCT03702231|529610926|FG002|Overall Study|COVID Pandemic|1|||
146847214|NCT03702231|529610924|FG000|Overall Study|Non-compliance|0|||
146847215|NCT03702231|529610925|FG001|Overall Study|Non-compliance|0|||
146847216|NCT03702231|529610926|FG002|Overall Study|Non-compliance|1|||
146847217|NCT01609062|529610930|FG000|Extension Phase|Terminated by Sponsor|14|||
146847218|NCT01609062|529610931|FG001|Extension Phase|Terminated by Sponsor|9|||
146847219|NCT01609062|529610930|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
146847220|NCT01609062|529610931|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
146847221|NCT01609062|529610930|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
146847222|NCT01609062|529610931|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
146847223|NCT03772587|529610932|FG000|Overall Study|COVID-19|0|||
146847224|NCT03772587|529610933|FG001|Overall Study|COVID-19|0|||
146847225|NCT03772587|529610934|FG002|Overall Study|COVID-19|1|||
147008771|NCT03573544|530192171|FG004|Overall Study|Disease progression|5|||
147008772|NCT03573544|530192172|FG005|Overall Study|Disease progression|7|||
147008773|NCT03573544|530192173|FG006|Overall Study|Disease progression|6|||
147008774|NCT03573544|530192174|FG007|Overall Study|Disease progression|7|||
147008775|NCT01899053|530192175|FG000|Overall Study|Progressive Disease|4|||
147008776|NCT01899053|530192176|FG001|Overall Study|Progressive Disease|0|||
147008777|NCT01899053|530192177|FG002|Overall Study|Progressive Disease|3|||
147008778|NCT01899053|530192178|FG003|Overall Study|Progressive Disease|0|||
147008779|NCT01899053|530192179|FG004|Overall Study|Progressive Disease|3|||
147008780|NCT01899053|530192180|FG005|Overall Study|Progressive Disease|1|||
147008781|NCT01899053|530192181|FG006|Overall Study|Progressive Disease|1|||
147008782|NCT01899053|530192182|FG007|Overall Study|Progressive Disease|1|||
147008783|NCT01899053|530192183|FG008|Overall Study|Progressive Disease|4|||
147008784|NCT01899053|530192184|FG009|Overall Study|Progressive Disease|3|||
147008785|NCT01899053|530192185|FG010|Overall Study|Progressive Disease|12|||
147008786|NCT01899053|530192186|FG011|Overall Study|Progressive Disease|5|||
147008787|NCT01899053|530192187|FG012|Overall Study|Progressive Disease|8|||
147008788|NCT01899053|530192188|FG013|Overall Study|Progressive Disease|17|||
147008789|NCT01899053|530192175|FG000|Overall Study|Adverse Event|1|||
147008790|NCT01899053|530192176|FG001|Overall Study|Adverse Event|1|||
147008791|NCT01899053|530192177|FG002|Overall Study|Adverse Event|1|||
147008792|NCT01899053|530192178|FG003|Overall Study|Adverse Event|3|||
147008793|NCT01899053|530192179|FG004|Overall Study|Adverse Event|1|||
147008794|NCT01899053|530192180|FG005|Overall Study|Adverse Event|1|||
147008795|NCT01899053|530192181|FG006|Overall Study|Adverse Event|1|||
147008796|NCT01899053|530192182|FG007|Overall Study|Adverse Event|0|||
147008797|NCT01899053|530192183|FG008|Overall Study|Adverse Event|2|||
147008798|NCT01899053|530192184|FG009|Overall Study|Adverse Event|0|||
147008799|NCT01899053|530192185|FG010|Overall Study|Adverse Event|3|||
147008800|NCT01899053|530192186|FG011|Overall Study|Adverse Event|1|||
147008801|NCT01899053|530192187|FG012|Overall Study|Adverse Event|2|||
147008802|NCT01899053|530192188|FG013|Overall Study|Adverse Event|2|||
147008803|NCT01899053|530192175|FG000|Overall Study|Reason Not Specified|0|||
147008804|NCT01899053|530192176|FG001|Overall Study|Reason Not Specified|0|||
147008805|NCT01899053|530192177|FG002|Overall Study|Reason Not Specified|0|||
147008806|NCT01899053|530192178|FG003|Overall Study|Reason Not Specified|0|||
147008807|NCT01899053|530192179|FG004|Overall Study|Reason Not Specified|0|||
147008808|NCT01899053|530192180|FG005|Overall Study|Reason Not Specified|0|||
147008809|NCT01899053|530192181|FG006|Overall Study|Reason Not Specified|1|||
147008810|NCT01899053|530192182|FG007|Overall Study|Reason Not Specified|0|||
147008811|NCT01899053|530192183|FG008|Overall Study|Reason Not Specified|0|||
147008812|NCT01899053|530192184|FG009|Overall Study|Reason Not Specified|0|||
147008813|NCT01899053|530192185|FG010|Overall Study|Reason Not Specified|0|||
146847226|NCT03772587|529610935|FG003|Overall Study|COVID-19|1|||
146847227|NCT03772587|529610936|FG004|Overall Study|COVID-19|0|||
146847228|NCT03772587|529610932|FG000|Overall Study|Withdrawal by Subject|1|||
146847229|NCT03772587|529610933|FG001|Overall Study|Withdrawal by Subject|0|||
147008814|NCT01899053|530192186|FG011|Overall Study|Reason Not Specified|0|||
147008815|NCT01899053|530192187|FG012|Overall Study|Reason Not Specified|1|||
147008816|NCT01899053|530192188|FG013|Overall Study|Reason Not Specified|0|||
147008817|NCT01899053|530192175|FG000|Overall Study|Withdrawal by Subject|1|||
147008818|NCT01899053|530192176|FG001|Overall Study|Withdrawal by Subject|1|||
147008819|NCT01899053|530192177|FG002|Overall Study|Withdrawal by Subject|2|||
147008820|NCT01899053|530192178|FG003|Overall Study|Withdrawal by Subject|0|||
147008821|NCT01899053|530192179|FG004|Overall Study|Withdrawal by Subject|2|||
147008822|NCT01899053|530192180|FG005|Overall Study|Withdrawal by Subject|0|||
147008823|NCT01899053|530192181|FG006|Overall Study|Withdrawal by Subject|0|||
147008824|NCT01899053|530192182|FG007|Overall Study|Withdrawal by Subject|1|||
147008825|NCT01899053|530192183|FG008|Overall Study|Withdrawal by Subject|0|||
147008826|NCT01899053|530192184|FG009|Overall Study|Withdrawal by Subject|0|||
147008827|NCT01899053|530192185|FG010|Overall Study|Withdrawal by Subject|0|||
147008828|NCT01899053|530192186|FG011|Overall Study|Withdrawal by Subject|0|||
147008829|NCT01899053|530192187|FG012|Overall Study|Withdrawal by Subject|1|||
147008830|NCT01899053|530192188|FG013|Overall Study|Withdrawal by Subject|1|||
147008831|NCT01899053|530192175|FG000|Overall Study|Protocol Violation|0|||
147008832|NCT01899053|530192176|FG001|Overall Study|Protocol Violation|0|||
147008833|NCT01899053|530192177|FG002|Overall Study|Protocol Violation|1|||
147008834|NCT01899053|530192178|FG003|Overall Study|Protocol Violation|0|||
147008835|NCT01899053|530192179|FG004|Overall Study|Protocol Violation|0|||
147008836|NCT01899053|530192180|FG005|Overall Study|Protocol Violation|0|||
147008837|NCT01899053|530192181|FG006|Overall Study|Protocol Violation|0|||
147008838|NCT01899053|530192182|FG007|Overall Study|Protocol Violation|0|||
147008839|NCT01899053|530192183|FG008|Overall Study|Protocol Violation|0|||
147008840|NCT01899053|530192184|FG009|Overall Study|Protocol Violation|0|||
147008841|NCT01899053|530192185|FG010|Overall Study|Protocol Violation|0|||
147008842|NCT01899053|530192186|FG011|Overall Study|Protocol Violation|0|||
147008843|NCT01899053|530192187|FG012|Overall Study|Protocol Violation|0|||
147008844|NCT01899053|530192188|FG013|Overall Study|Protocol Violation|0|||
147008845|NCT01899053|530192175|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
147008846|NCT01899053|530192176|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
147008847|NCT01899053|530192177|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
147008848|NCT01899053|530192178|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
147008849|NCT01899053|530192179|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
147008850|NCT01899053|530192180|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
147008851|NCT01899053|530192181|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
147008852|NCT01899053|530192182|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
147008853|NCT01899053|530192183|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
147008854|NCT01899053|530192184|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
147008855|NCT01899053|530192185|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
147008856|NCT01899053|530192186|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
147008857|NCT01899053|530192187|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
147008858|NCT01899053|530192188|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
147008859|NCT01899053|530192175|FG000|Overall Study|Symptomatic Deterioration|0|||
147008860|NCT01899053|530192176|FG001|Overall Study|Symptomatic Deterioration|0|||
147008861|NCT01899053|530192177|FG002|Overall Study|Symptomatic Deterioration|0|||
147008862|NCT01899053|530192178|FG003|Overall Study|Symptomatic Deterioration|0|||
147008863|NCT01899053|530192179|FG004|Overall Study|Symptomatic Deterioration|0|||
147008864|NCT01899053|530192180|FG005|Overall Study|Symptomatic Deterioration|1|||
147008865|NCT01899053|530192181|FG006|Overall Study|Symptomatic Deterioration|0|||
147008866|NCT01899053|530192182|FG007|Overall Study|Symptomatic Deterioration|1|||
147008867|NCT01899053|530192183|FG008|Overall Study|Symptomatic Deterioration|0|||
147008868|NCT01899053|530192184|FG009|Overall Study|Symptomatic Deterioration|0|||
147008869|NCT01899053|530192185|FG010|Overall Study|Symptomatic Deterioration|0|||
147008870|NCT01899053|530192186|FG011|Overall Study|Symptomatic Deterioration|1|||
146736131|NCT00279201|529205303|FG002|Initiation|Sponsor Decision|0|||
146736132|NCT00279201|529205304|FG003|Initiation|Sponsor Decision|0|||
146736133|NCT00279201|529205305|FG004|Initiation|Sponsor Decision|0|||
146736134|NCT00279201|529205306|FG005|Initiation|Sponsor Decision|0|||
146736135|NCT00279201|529205301|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
146736136|NCT00279201|529205302|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
146736137|NCT00279201|529205303|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
146736138|NCT00279201|529205304|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
146736139|NCT00279201|529205305|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
146736140|NCT00279201|529205306|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
146736141|NCT00279201|529205301|FG000|Maintenance|Lack of Efficacy|32|||
146736142|NCT00279201|529205302|FG001|Maintenance|Lack of Efficacy|30|||
146736143|NCT00279201|529205303|FG002|Maintenance|Lack of Efficacy|0|||
146736144|NCT00279201|529205304|FG003|Maintenance|Lack of Efficacy|0|||
146736145|NCT00279201|529205305|FG004|Maintenance|Lack of Efficacy|0|||
146736146|NCT00279201|529205306|FG005|Maintenance|Lack of Efficacy|0|||
146736147|NCT00279201|529205301|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
146736148|NCT00279201|529205302|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
146736149|NCT00279201|529205303|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
146736150|NCT00279201|529205304|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
146736151|NCT00279201|529205305|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
146736152|NCT00279201|529205306|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
146736153|NCT00279201|529205301|FG000|Maintenance|Adverse Event|4|||
146736154|NCT00279201|529205302|FG001|Maintenance|Adverse Event|4|||
146736155|NCT00279201|529205303|FG002|Maintenance|Adverse Event|0|||
146736156|NCT00279201|529205304|FG003|Maintenance|Adverse Event|0|||
146736157|NCT00279201|529205305|FG004|Maintenance|Adverse Event|0|||
147008871|NCT01899053|530192187|FG012|Overall Study|Symptomatic Deterioration|2|||
147008872|NCT01899053|530192188|FG013|Overall Study|Symptomatic Deterioration|0|||
147008873|NCT03105297|530192189|FG000|Baseline Phase (Day 1)|Other|21|||
147008874|NCT03105297|530192189|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
147008875|NCT03105297|530192189|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
147008876|NCT00227370|530192191|FG000|Overall Study|Withdrawal by Subject|1|||
147008877|NCT00227370|530192192|FG001|Overall Study|Withdrawal by Subject|2|||
147008878|NCT00227370|530192191|FG000|Overall Study|Death|3|||
147008879|NCT00227370|530192192|FG001|Overall Study|Death|4|||
147008880|NCT00227370|530192191|FG000|Overall Study|Adverse Event|6|||
147008881|NCT00227370|530192192|FG001|Overall Study|Adverse Event|11|||
147008882|NCT00227370|530192191|FG000|Overall Study|Physician Decision|9|||
147008883|NCT00227370|530192192|FG001|Overall Study|Physician Decision|6|||
147008884|NCT00227370|530192191|FG000|Overall Study|Other reasons|2|||
147008885|NCT00227370|530192192|FG001|Overall Study|Other reasons|1|||
147008886|NCT03846193|530192193|FG000|Overall Study|Physician Decision|0|||
147008887|NCT03846193|530192194|FG001|Overall Study|Physician Decision|0|||
147008888|NCT03846193|530192195|FG002|Overall Study|Physician Decision|1|||
147008889|NCT03846193|530192196|FG003|Overall Study|Physician Decision|0|||
147008890|NCT03846193|530192197|FG004|Overall Study|Physician Decision|0|||
147008891|NCT03846193|530192193|FG000|Overall Study|Lost to Follow-up|0|||
147008892|NCT03846193|530192194|FG001|Overall Study|Lost to Follow-up|0|||
147008893|NCT03846193|530192195|FG002|Overall Study|Lost to Follow-up|0|||
147008894|NCT03846193|530192196|FG003|Overall Study|Lost to Follow-up|0|||
147008895|NCT03846193|530192197|FG004|Overall Study|Lost to Follow-up|1|||
147008896|NCT03846193|530192193|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
147008897|NCT03846193|530192194|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
147008898|NCT03846193|530192195|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
147008899|NCT03846193|530192196|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
147008900|NCT03846193|530192197|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
147008901|NCT01401062|530192199|FG000|Overall Study|Death|9|||
147008902|NCT01401062|530192200|FG001|Overall Study|Death|7|||
147008903|NCT01401062|530192199|FG000|Overall Study|Physician Decision|1|||
147008904|NCT01401062|530192200|FG001|Overall Study|Physician Decision|0|||
147008905|NCT01401062|530192199|FG000|Overall Study|Withdrawal by Subject|1|||
147008906|NCT01401062|530192200|FG001|Overall Study|Withdrawal by Subject|1|||
147008907|NCT01131260|530192203|FG000|Overall Study|Randomization error|5|||
147008908|NCT01131260|530192204|FG001|Overall Study|Randomization error|1|||
147008909|NCT01131260|530192203|FG000|Overall Study|Declined to continue participation|8|||
147008910|NCT01131260|530192204|FG001|Overall Study|Declined to continue participation|13|||
147008911|NCT01131260|530192203|FG000|Overall Study|Physician Decision|22|||
147008912|NCT01131260|530192204|FG001|Overall Study|Physician Decision|24|||
147008913|NCT01131260|530192203|FG000|Overall Study|Technical problems|7|||
147008914|NCT01131260|530192204|FG001|Overall Study|Technical problems|6|||
147008915|NCT01131260|530192203|FG000|Overall Study|Staff error|2|||
147008916|NCT01131260|530192204|FG001|Overall Study|Staff error|1|||
147008917|NCT01131260|530192203|FG000|Overall Study|Ineligible|0|||
147008918|NCT01131260|530192204|FG001|Overall Study|Ineligible|2|||
147008919|NCT03684928|530192208|FG000|First Intervention|Lost to Follow-up|0|||
147008920|NCT03684928|530192209|FG001|First Intervention|Lost to Follow-up|1|||
147008921|NCT03684928|530192208|FG000|First Intervention|Withdrawal by Subject|0|||
147008922|NCT03684928|530192209|FG001|First Intervention|Withdrawal by Subject|2|||
147008923|NCT03684928|530192208|FG000|Second Intervention|Soft Tissue Injury|1|||
147008924|NCT03684928|530192209|FG001|Second Intervention|Soft Tissue Injury|0|||
147008925|NCT01891357|530192210|FG000|Overall Study|Protocol Violation|3|||
147008926|NCT00840879|530192211|FG000|Second Intervention|Withdrawal by Subject|1|||
147008927|NCT00840879|530192212|FG001|Second Intervention|Withdrawal by Subject|0|||
147008928|NCT03733145|530192213|FG000|Overall Study|screenfail|3|||
147008929|NCT03733145|530192214|FG001|Overall Study|screenfail|3|||
147008930|NCT03733145|530192215|FG002|Overall Study|screenfail|2|||
147008931|NCT01098851|530193686|FG000|Overall Study|Equipment failure|1|||
147008932|NCT01098851|530193687|FG001|Overall Study|Equipment failure|0|||
147008933|NCT03087786|530193688|FG000|Overall Study|Withdrawal by Subject|2|||
147008934|NCT03087786|530193689|FG001|Overall Study|Withdrawal by Subject|0|||
147008935|NCT00516295|530193695|FG000|Overall Study|Lack of Efficacy|2|||
147008936|NCT00516295|530193696|FG001|Overall Study|Lack of Efficacy|0|||
147008937|NCT00516295|530193697|FG002|Overall Study|Lack of Efficacy|0|||
147008938|NCT00516295|530193695|FG000|Overall Study|Ineligible|1|||
147008939|NCT00516295|530193696|FG001|Overall Study|Ineligible|0|||
147008940|NCT00516295|530193697|FG002|Overall Study|Ineligible|0|||
147008941|NCT02034513|530193700|FG000|Overall Study|Adverse Event|11|||
147008942|NCT02034513|530193701|FG001|Overall Study|Adverse Event|10|||
147008943|NCT02034513|530193700|FG000|Overall Study|Lack of Efficacy|0|||
147008944|NCT02034513|530193701|FG001|Overall Study|Lack of Efficacy|1|||
147008945|NCT02034513|530193700|FG000|Overall Study|Lost to Follow-up|6|||
147008946|NCT02034513|530193701|FG001|Overall Study|Lost to Follow-up|7|||
147008947|NCT02034513|530193700|FG000|Overall Study|Pregnancy|0|||
147008948|NCT02034513|530193701|FG001|Overall Study|Pregnancy|3|||
147008949|NCT02034513|530193700|FG000|Overall Study|Protocol Violation|7|||
147008950|NCT02034513|530193701|FG001|Overall Study|Protocol Violation|10|||
147008951|NCT02034513|530193700|FG000|Overall Study|Withdrawal by Subject|25|||
147008952|NCT02034513|530193701|FG001|Overall Study|Withdrawal by Subject|25|||
147008953|NCT02034513|530193700|FG000|Overall Study|Unclassified|0|||
147008954|NCT02034513|530193701|FG001|Overall Study|Unclassified|1|||
147008955|NCT04661202|530193702|FG000|Overall Study|Withdrawal by Subject|1|||
147008956|NCT04661202|530193703|FG001|Overall Study|Withdrawal by Subject|1|||
147008957|NCT04661202|530193702|FG000|Overall Study|Lack of Efficacy|2|||
146847230|NCT03772587|529610934|FG002|Overall Study|Withdrawal by Subject|0|||
146847231|NCT03772587|529610935|FG003|Overall Study|Withdrawal by Subject|0|||
146847232|NCT03772587|529610936|FG004|Overall Study|Withdrawal by Subject|0|||
146847233|NCT05260021|529610937|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
146847234|NCT05260021|529610938|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
146847235|NCT05260021|529610939|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
146847236|NCT05260021|529610937|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
146847237|NCT05260021|529610938|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
146847238|NCT05260021|529610939|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
146847239|NCT05260021|529610937|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
146847240|NCT05260021|529610938|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
146847241|NCT05260021|529610939|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
146847242|NCT05260021|529610937|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
146847243|NCT05260021|529610938|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
146847244|NCT05260021|529610939|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
146847245|NCT05260021|529610937|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
146847246|NCT05260021|529610938|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
146847247|NCT05260021|529610939|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
146847248|NCT03842358|529610940|FG000|Overall Study|Poor DOT probe contact with breast|2|||
146847249|NCT03842358|529610940|FG000|Overall Study|DOT system problem|1|||
146847250|NCT03842358|529610940|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
146847251|NCT03842358|529610940|FG000|Overall Study|No biopsy after physician review|4|||
146847252|NCT03842358|529610940|FG000|Overall Study|Patient withdrew|2|||
146847253|NCT02626455|529610941|FG000|Overall Study|Other|1|||
146847254|NCT02626455|529610942|FG001|Overall Study|Other|1|||
146847255|NCT02626455|529610943|FG002|Overall Study|Other|0|||
146847256|NCT02626455|529610944|FG003|Overall Study|Other|0|||
146847257|NCT02626455|529610945|FG004|Overall Study|Other|0|||
146847258|NCT02626455|529610946|FG005|Overall Study|Other|17|||
146847259|NCT02626455|529610947|FG006|Overall Study|Other|23|||
146847260|NCT02626455|529610941|FG000|Overall Study|Withdrawal by Subject|1|||
146847261|NCT02626455|529610942|FG001|Overall Study|Withdrawal by Subject|0|||
146847262|NCT02626455|529610943|FG002|Overall Study|Withdrawal by Subject|0|||
146847263|NCT02626455|529610944|FG003|Overall Study|Withdrawal by Subject|0|||
146847264|NCT02626455|529610945|FG004|Overall Study|Withdrawal by Subject|0|||
146847265|NCT02626455|529610946|FG005|Overall Study|Withdrawal by Subject|10|||
146847266|NCT02626455|529610947|FG006|Overall Study|Withdrawal by Subject|6|||
146847267|NCT02626455|529610941|FG000|Overall Study|Physician Decision|0|||
146847268|NCT02626455|529610942|FG001|Overall Study|Physician Decision|2|||
146847269|NCT02626455|529610943|FG002|Overall Study|Physician Decision|2|||
146847270|NCT02626455|529610944|FG003|Overall Study|Physician Decision|2|||
146847271|NCT02626455|529610945|FG004|Overall Study|Physician Decision|1|||
146847272|NCT02626455|529610946|FG005|Overall Study|Physician Decision|10|||
146847273|NCT02626455|529610947|FG006|Overall Study|Physician Decision|3|||
146847274|NCT02626455|529610941|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
146847275|NCT02626455|529610942|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
146847276|NCT02626455|529610943|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
146847277|NCT02626455|529610944|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
146847278|NCT02626455|529610945|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
146847279|NCT02626455|529610946|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
146847280|NCT02626455|529610947|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
147008958|NCT04661202|530193703|FG001|Overall Study|Lack of Efficacy|0|||
146847281|NCT02626455|529610941|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
146847282|NCT02626455|529610942|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
146847283|NCT02626455|529610943|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
146847284|NCT02626455|529610944|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
146847285|NCT02626455|529610945|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
146847286|NCT02626455|529610946|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
146847287|NCT02626455|529610947|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
147008959|NCT02578641|530193704|FG000|Overall Study|Adverse Event|5|||
147008960|NCT02578641|530193705|FG001|Overall Study|Adverse Event|15|||
147008961|NCT02578641|530193704|FG000|Overall Study|Death|16|||
147008962|NCT02578641|530193705|FG001|Overall Study|Death|8|||
147008963|NCT02578641|530193704|FG000|Overall Study|Lost to Follow-up|0|||
146847288|NCT02626455|529610941|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
146847289|NCT02626455|529610942|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
146847290|NCT02626455|529610943|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
146847291|NCT02626455|529610944|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
146847292|NCT02626455|529610945|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
146847293|NCT02626455|529610946|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
146847294|NCT02626455|529610947|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
146847295|NCT02626455|529610941|FG000|Overall Study|Patient decision|0|||
146847296|NCT02626455|529610942|FG001|Overall Study|Patient decision|1|||
146847297|NCT02626455|529610943|FG002|Overall Study|Patient decision|0|||
146847298|NCT02626455|529610944|FG003|Overall Study|Patient decision|0|||
146847299|NCT02626455|529610945|FG004|Overall Study|Patient decision|1|||
146847300|NCT02626455|529610946|FG005|Overall Study|Patient decision|36|||
146847301|NCT02626455|529610947|FG006|Overall Study|Patient decision|22|||
146847302|NCT02626455|529610941|FG000|Overall Study|Protocol Violation|0|||
146847303|NCT02626455|529610942|FG001|Overall Study|Protocol Violation|0|||
146847304|NCT02626455|529610943|FG002|Overall Study|Protocol Violation|0|||
146847305|NCT02626455|529610944|FG003|Overall Study|Protocol Violation|0|||
146847306|NCT02626455|529610945|FG004|Overall Study|Protocol Violation|0|||
146847307|NCT02626455|529610946|FG005|Overall Study|Protocol Violation|0|||
146847308|NCT02626455|529610947|FG006|Overall Study|Protocol Violation|1|||
146847309|NCT02626455|529610941|FG000|Overall Study|Progressive disease - radiological progression|0|||
147008964|NCT02578641|530193705|FG001|Overall Study|Lost to Follow-up|1|||
147008965|NCT02578641|530193704|FG000|Overall Study|Withdrawal by Subject|14|||
147008966|NCT02578641|530193705|FG001|Overall Study|Withdrawal by Subject|7|||
147008967|NCT02578641|530193704|FG000|Overall Study|Progressive Disease|69|||
147008968|NCT02578641|530193705|FG001|Overall Study|Progressive Disease|21|||
147008969|NCT02578641|530193704|FG000|Overall Study|No Study Drug|2|||
147008970|NCT02578641|530193705|FG001|Overall Study|No Study Drug|0|||
147008971|NCT02578641|530193704|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
147008972|NCT02578641|530193705|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
147008973|NCT02578641|530193704|FG000|Overall Study|Non-compliance with Study Schedule|1|||
147008974|NCT02578641|530193705|FG001|Overall Study|Non-compliance with Study Schedule|0|||
147008975|NCT02578641|530193704|FG000|Overall Study|Other|1|||
147008976|NCT02578641|530193705|FG001|Overall Study|Other|10|||
147008977|NCT02578641|530193704|FG000|Overall Study|Not treated|1|||
147008978|NCT02578641|530193705|FG001|Overall Study|Not treated|4|||
147008979|NCT02313558|530193708|FG000|Overall Study|Withdrawal by Subject|2|||
147008980|NCT02313558|530193709|FG001|Overall Study|Withdrawal by Subject|0|||
147008981|NCT02313558|530193708|FG000|Overall Study|Lost to Follow-up|4|||
147008982|NCT02313558|530193709|FG001|Overall Study|Lost to Follow-up|4|||
147008983|NCT02694536|530193716|FG000|Overall Study|Progressive Disease|40|||
147008984|NCT02694536|530193716|FG000|Overall Study|Lost to Follow-up|1|||
147008985|NCT02694536|530193716|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
147008986|NCT02694536|530193716|FG000|Overall Study|Withdrawal by Subject|8|||
147008987|NCT02694536|530193716|FG000|Overall Study|Death|8|||
147008988|NCT02694536|530193716|FG000|Overall Study|Other|22|||
147008989|NCT01911429|530193717|FG000|Overall Study|Adverse Event|5|||
147008990|NCT01911429|530193718|FG001|Overall Study|Adverse Event|3|||
147008991|NCT01911429|530193719|FG002|Overall Study|Adverse Event|9|||
147008992|NCT01911429|530193717|FG000|Overall Study|Lack of Efficacy|1|||
147008993|NCT01911429|530193718|FG001|Overall Study|Lack of Efficacy|2|||
147008994|NCT01911429|530193719|FG002|Overall Study|Lack of Efficacy|4|||
147008995|NCT01911429|530193717|FG000|Overall Study|Lost to Follow-up|0|||
147008996|NCT01911429|530193718|FG001|Overall Study|Lost to Follow-up|0|||
147008997|NCT01911429|530193719|FG002|Overall Study|Lost to Follow-up|1|||
147008998|NCT01911429|530193717|FG000|Overall Study|Protocol Violation|0|||
147008999|NCT01911429|530193718|FG001|Overall Study|Protocol Violation|0|||
147009000|NCT01911429|530193719|FG002|Overall Study|Protocol Violation|1|||
146847310|NCT02626455|529610942|FG001|Overall Study|Progressive disease - radiological progression|0|||
146847311|NCT02626455|529610943|FG002|Overall Study|Progressive disease - radiological progression|0|||
146847312|NCT02626455|529610944|FG003|Overall Study|Progressive disease - radiological progression|0|||
146847313|NCT02626455|529610945|FG004|Overall Study|Progressive disease - radiological progression|0|||
146847314|NCT02626455|529610946|FG005|Overall Study|Progressive disease - radiological progression|11|||
146847315|NCT02626455|529610947|FG006|Overall Study|Progressive disease - radiological progression|22|||
147009001|NCT01911429|530193717|FG000|Overall Study|Withdrawal by Subject|5|||
147009002|NCT01911429|530193718|FG001|Overall Study|Withdrawal by Subject|5|||
147009003|NCT01911429|530193719|FG002|Overall Study|Withdrawal by Subject|4|||
147009004|NCT01911429|530193717|FG000|Overall Study|Accidental randomization|0|||
147009005|NCT01911429|530193718|FG001|Overall Study|Accidental randomization|0|||
147009006|NCT01911429|530193719|FG002|Overall Study|Accidental randomization|1|||
147009007|NCT01911429|530193717|FG000|Overall Study|subject left study|1|||
147009008|NCT01911429|530193718|FG001|Overall Study|subject left study|0|||
147009009|NCT01911429|530193719|FG002|Overall Study|subject left study|0|||
147009010|NCT03707587|530193722|FG000|Overall Study|Death|0|||
147009011|NCT03707587|530193723|FG001|Overall Study|Death|1|||
146847316|NCT02626455|529610941|FG000|Overall Study|Progressive disease - clinical progression|0|||
146847317|NCT02626455|529610942|FG001|Overall Study|Progressive disease - clinical progression|0|||
146847318|NCT02626455|529610943|FG002|Overall Study|Progressive disease - clinical progression|0|||
146847319|NCT02626455|529610944|FG003|Overall Study|Progressive disease - clinical progression|0|||
146847320|NCT02626455|529610945|FG004|Overall Study|Progressive disease - clinical progression|0|||
146847321|NCT02626455|529610946|FG005|Overall Study|Progressive disease - clinical progression|1|||
146847322|NCT02626455|529610947|FG006|Overall Study|Progressive disease - clinical progression|2|||
146847323|NCT02626455|529610941|FG000|Overall Study|Lost to Follow-up|0|||
146847324|NCT02626455|529610942|FG001|Overall Study|Lost to Follow-up|0|||
146847325|NCT02626455|529610943|FG002|Overall Study|Lost to Follow-up|0|||
146847326|NCT02626455|529610944|FG003|Overall Study|Lost to Follow-up|0|||
146847327|NCT02626455|529610945|FG004|Overall Study|Lost to Follow-up|0|||
146847328|NCT02626455|529610946|FG005|Overall Study|Lost to Follow-up|1|||
146847329|NCT02626455|529610947|FG006|Overall Study|Lost to Follow-up|0|||
146847330|NCT02626455|529610941|FG000|Overall Study|AE not associated with clinical disease progression|1|||
146847331|NCT02626455|529610942|FG001|Overall Study|AE not associated with clinical disease progression|1|||
146847332|NCT02626455|529610943|FG002|Overall Study|AE not associated with clinical disease progression|0|||
146847333|NCT02626455|529610944|FG003|Overall Study|AE not associated with clinical disease progression|2|||
146847334|NCT02626455|529610945|FG004|Overall Study|AE not associated with clinical disease progression|1|||
146847335|NCT02626455|529610946|FG005|Overall Study|AE not associated with clinical disease progression|65|||
146847336|NCT02626455|529610947|FG006|Overall Study|AE not associated with clinical disease progression|21|||
146847337|NCT02626455|529610941|FG000|Overall Study|AE associated with clinical disease progression|0|||
146847338|NCT02626455|529610942|FG001|Overall Study|AE associated with clinical disease progression|0|||
146847339|NCT02626455|529610943|FG002|Overall Study|AE associated with clinical disease progression|0|||
146847340|NCT02626455|529610944|FG003|Overall Study|AE associated with clinical disease progression|0|||
146847341|NCT02626455|529610945|FG004|Overall Study|AE associated with clinical disease progression|0|||
146847342|NCT02626455|529610946|FG005|Overall Study|AE associated with clinical disease progression|1|||
146847343|NCT02626455|529610947|FG006|Overall Study|AE associated with clinical disease progression|2|||
146847344|NCT02626455|529610941|FG000|Overall Study|Study intervention never administered|0|||
146847345|NCT02626455|529610942|FG001|Overall Study|Study intervention never administered|0|||
146847346|NCT02626455|529610943|FG002|Overall Study|Study intervention never administered|0|||
146847347|NCT02626455|529610944|FG003|Overall Study|Study intervention never administered|0|||
146847348|NCT02626455|529610945|FG004|Overall Study|Study intervention never administered|0|||
146847349|NCT02626455|529610946|FG005|Overall Study|Study intervention never administered|1|||
146847350|NCT02626455|529610947|FG006|Overall Study|Study intervention never administered|3|||
146847351|NCT06665919|529610948|FG000|Overall Study|Withdrawal by Subject|4|||
146847352|NCT06665919|529610949|FG001|Overall Study|Withdrawal by Subject|4|||
146847353|NCT06665919|529610950|FG002|Overall Study|Withdrawal by Subject|4|||
146847354|NCT06665919|529610948|FG000|Overall Study|Non-compliance to Treatment|4|||
146847355|NCT06665919|529610949|FG001|Overall Study|Non-compliance to Treatment|1|||
146847356|NCT06665919|529610950|FG002|Overall Study|Non-compliance to Treatment|6|||
146847357|NCT06665919|529610948|FG000|Overall Study|Lost to Follow-up|3|||
146847358|NCT06665919|529610949|FG001|Overall Study|Lost to Follow-up|0|||
146847359|NCT06665919|529610950|FG002|Overall Study|Lost to Follow-up|2|||
146847360|NCT06665919|529610948|FG000|Overall Study|Physician Decision|4|||
146847361|NCT06665919|529610949|FG001|Overall Study|Physician Decision|0|||
146847362|NCT06665919|529610950|FG002|Overall Study|Physician Decision|1|||
146847363|NCT01200290|529610951|FG000|Treatment Period|Adverse Event|1|||
146847364|NCT01200290|529610951|FG000|Post-Treatment Follow-Up Period|Death|2|||
146847365|NCT01144377|529610952|FG000|52 Week Treatment Period|Adverse Event|0|||
146847366|NCT01144377|529610953|FG001|52 Week Treatment Period|Adverse Event|0|||
146847367|NCT01144377|529610954|FG002|52 Week Treatment Period|Adverse Event|3|||
146847368|NCT01144377|529610955|FG003|52 Week Treatment Period|Adverse Event|2|||
146847369|NCT01144377|529610956|FG004|52 Week Treatment Period|Adverse Event|1|||
146847370|NCT01144377|529610952|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
146847371|NCT01144377|529610953|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
146847372|NCT01144377|529610954|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
146847373|NCT01144377|529610955|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
146847374|NCT01144377|529610956|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
146847375|NCT01144377|529610952|FG000|52 Week Treatment Period|Protocol Violation|0|||
146847376|NCT01144377|529610953|FG001|52 Week Treatment Period|Protocol Violation|0|||
147009012|NCT01266902|530193727|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
146847377|NCT01144377|529610954|FG002|52 Week Treatment Period|Protocol Violation|0|||
146847378|NCT01144377|529610955|FG003|52 Week Treatment Period|Protocol Violation|0|||
146847379|NCT01144377|529610956|FG004|52 Week Treatment Period|Protocol Violation|1|||
146847380|NCT01144377|529610952|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
146847381|NCT01144377|529610953|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
147013231|NCT01708954|530210055|FG001|Step 1|Death|2|||
146847382|NCT01144377|529610954|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
146847383|NCT01144377|529610955|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
146847384|NCT01144377|529610956|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
147009013|NCT01266902|530193728|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
147009014|NCT01266902|530193729|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
147009015|NCT01266902|530193727|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
147009016|NCT01266902|530193728|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
147009017|NCT01266902|530193729|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
147009018|NCT01266902|530193727|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
147009019|NCT01266902|530193728|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
147009020|NCT01266902|530193729|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
147009021|NCT01266902|530193727|FG000|Period 1 (Main Study)|Adverse Event|3|||
147009022|NCT01266902|530193728|FG001|Period 1 (Main Study)|Adverse Event|11|||
147009023|NCT01266902|530193729|FG002|Period 1 (Main Study)|Adverse Event|0|||
147009024|NCT01266902|530193727|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
147009025|NCT01266902|530193728|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
147009026|NCT01266902|530193729|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
147009027|NCT01266902|530193727|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
146847385|NCT01144377|529610952|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
146847386|NCT01144377|529610953|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
146847387|NCT01144377|529610954|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
146847388|NCT01144377|529610955|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
146847389|NCT01144377|529610956|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
147009028|NCT01266902|530193728|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
147009029|NCT01266902|530193729|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
147009030|NCT01266902|530193727|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
147009031|NCT01266902|530193728|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
147009032|NCT01266902|530193729|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
147009033|NCT01266902|530193727|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
147009034|NCT01266902|530193728|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
147009035|NCT01266902|530193729|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
146847390|NCT01144377|529610952|FG000|52 Week Treatment Period|Sponsor Decision|0|||
146847391|NCT01144377|529610953|FG001|52 Week Treatment Period|Sponsor Decision|0|||
147009036|NCT01266902|530193727|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
147009037|NCT01266902|530193728|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
147009038|NCT01266902|530193729|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
147009039|NCT01266902|530193727|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
147009040|NCT01266902|530193728|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
147009041|NCT01266902|530193729|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
147009042|NCT05562011|530193732|FG000|Overall Study|Withdrawal by Subject|3|||
147009043|NCT05562011|530193732|FG000|Overall Study|Lost to Follow-up|1|||
147009044|NCT05562011|530193732|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
147009045|NCT05562011|530193732|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
147009046|NCT05562011|530193732|FG000|Overall Study|Device malfunction|13|||
147009047|NCT04567329|530193733|FG000|Overall Study|Withdrawal by Subject|5|||
147009048|NCT04567329|530193734|FG001|Overall Study|Withdrawal by Subject|6|||
147009049|NCT04567329|530193733|FG000|Overall Study|Protocol Violation|2|||
147009050|NCT04567329|530193734|FG001|Overall Study|Protocol Violation|3|||
147009051|NCT04567329|530193733|FG000|Overall Study|Discontinued|2|||
147009052|NCT04567329|530193734|FG001|Overall Study|Discontinued|2|||
147009053|NCT04567329|530193733|FG000|Overall Study|Lost to Follow-up|0|||
147009054|NCT04567329|530193734|FG001|Overall Study|Lost to Follow-up|1|||
147009055|NCT04567329|530193733|FG000|Overall Study|Lack of Efficacy|0|||
147009056|NCT04567329|530193734|FG001|Overall Study|Lack of Efficacy|1|||
147009057|NCT00881751|530193760|FG000|Overall Study|Physician Decision|0|||
147009058|NCT00881751|530193761|FG001|Overall Study|Physician Decision|1|||
147009059|NCT00881751|530193760|FG000|Overall Study|Adverse Event|0|||
147009060|NCT00881751|530193761|FG001|Overall Study|Adverse Event|2|||
146847392|NCT01144377|529610954|FG002|52 Week Treatment Period|Sponsor Decision|0|||
146847393|NCT01144377|529610955|FG003|52 Week Treatment Period|Sponsor Decision|0|||
146847394|NCT01144377|529610956|FG004|52 Week Treatment Period|Sponsor Decision|1|||
147009061|NCT00881751|530193760|FG000|Overall Study|Withdrawal by Subject|0|||
147009062|NCT00881751|530193761|FG001|Overall Study|Withdrawal by Subject|2|||
147009063|NCT02436200|530193764|FG000|Overall Study|Significant outlier|1|||
146847395|NCT01144377|529610952|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
146847396|NCT01144377|529610953|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
146847397|NCT01144377|529610954|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
147009064|NCT00672984|530193767|FG000|First Intervention|Adverse Event|5|||
147009065|NCT00672984|530193768|FG001|First Intervention|Adverse Event|0|||
147009066|NCT00672984|530193769|FG002|First Intervention|Adverse Event|0|||
146847398|NCT01144377|529610955|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
147009067|NCT00672984|530193767|FG000|First Intervention|Withdrawal by Subject|1|||
147009068|NCT00672984|530193768|FG001|First Intervention|Withdrawal by Subject|2|||
147013232|NCT01708954|530210056|FG002|Step 1|Death|3|||
146847399|NCT01144377|529610956|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
146847400|NCT01144377|529610952|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
146847401|NCT01144377|529610953|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
146847402|NCT01144377|529610954|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
146847403|NCT01144377|529610955|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
146847404|NCT01144377|529610956|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
146847405|NCT01144377|529610952|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
146847406|NCT01144377|529610953|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
146847407|NCT01144377|529610954|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
146847408|NCT01144377|529610955|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
146847409|NCT01144377|529610956|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
146847410|NCT00607724|529610957|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
146847411|NCT00607724|529610958|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
146847412|NCT00607724|529610959|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
146847413|NCT00607724|529610960|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
146847414|NCT00607724|529610961|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
146847415|NCT00607724|529610962|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
146847416|NCT00607724|529610963|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
146847417|NCT00607724|529610957|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
146847418|NCT00607724|529610958|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
146847419|NCT00607724|529610959|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
146847420|NCT00607724|529610960|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
146847421|NCT00607724|529610961|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
146847422|NCT00607724|529610962|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
146847423|NCT00607724|529610963|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
146847424|NCT00607724|529610957|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
147009069|NCT00672984|530193769|FG002|First Intervention|Withdrawal by Subject|2|||
147009070|NCT00672984|530193767|FG000|First Intervention|Sponsor decision|3|||
147009071|NCT00672984|530193768|FG001|First Intervention|Sponsor decision|0|||
147009072|NCT00672984|530193769|FG002|First Intervention|Sponsor decision|0|||
147009073|NCT00672984|530193767|FG000|Second Intervention|Non-compliance with facility policies|0|||
147009074|NCT00672984|530193768|FG001|Second Intervention|Non-compliance with facility policies|2|||
147009075|NCT00672984|530193769|FG002|Second Intervention|Non-compliance with facility policies|0|||
147009076|NCT00672984|530193767|FG000|Second Intervention|Withdrawal by Subject|0|||
147009077|NCT00672984|530193768|FG001|Second Intervention|Withdrawal by Subject|3|||
147009078|NCT00672984|530193769|FG002|Second Intervention|Withdrawal by Subject|0|||
147009079|NCT00672984|530193767|FG000|Second Intervention|Protocol Violation|0|||
147009080|NCT00672984|530193768|FG001|Second Intervention|Protocol Violation|1|||
147009081|NCT00672984|530193769|FG002|Second Intervention|Protocol Violation|1|||
147009082|NCT00672984|530193767|FG000|Third Intervention|Adverse Event|1|||
146736158|NCT00279201|529205306|FG005|Maintenance|Adverse Event|0|||
146736159|NCT00279201|529205301|FG000|Maintenance|Death|4|||
146736160|NCT00279201|529205302|FG001|Maintenance|Death|4|||
146736161|NCT00279201|529205303|FG002|Maintenance|Death|0|||
146736162|NCT00279201|529205304|FG003|Maintenance|Death|0|||
146736163|NCT00279201|529205305|FG004|Maintenance|Death|0|||
146736164|NCT00279201|529205306|FG005|Maintenance|Death|0|||
146736165|NCT00279201|529205301|FG000|Maintenance|Lost to Follow-up|17|||
146736166|NCT00279201|529205302|FG001|Maintenance|Lost to Follow-up|13|||
146736167|NCT00279201|529205303|FG002|Maintenance|Lost to Follow-up|0|||
146736168|NCT00279201|529205304|FG003|Maintenance|Lost to Follow-up|0|||
146736169|NCT00279201|529205305|FG004|Maintenance|Lost to Follow-up|0|||
146736170|NCT00279201|529205306|FG005|Maintenance|Lost to Follow-up|0|||
146736171|NCT00279201|529205301|FG000|Maintenance|Entry Criteria Exclusion|1|||
146736172|NCT00279201|529205302|FG001|Maintenance|Entry Criteria Exclusion|4|||
146736173|NCT00279201|529205303|FG002|Maintenance|Entry Criteria Exclusion|0|||
146736174|NCT00279201|529205304|FG003|Maintenance|Entry Criteria Exclusion|0|||
146736175|NCT00279201|529205305|FG004|Maintenance|Entry Criteria Exclusion|0|||
146736176|NCT00279201|529205306|FG005|Maintenance|Entry Criteria Exclusion|0|||
146736177|NCT00279201|529205301|FG000|Maintenance|Protocol Violation|16|||
146736178|NCT00279201|529205302|FG001|Maintenance|Protocol Violation|24|||
146736179|NCT00279201|529205303|FG002|Maintenance|Protocol Violation|0|||
146736180|NCT00279201|529205304|FG003|Maintenance|Protocol Violation|0|||
146736181|NCT00279201|529205305|FG004|Maintenance|Protocol Violation|0|||
146736182|NCT00279201|529205306|FG005|Maintenance|Protocol Violation|0|||
146736183|NCT00279201|529205301|FG000|Maintenance|Withdrawal by Subject|18|||
146736184|NCT00279201|529205302|FG001|Maintenance|Withdrawal by Subject|18|||
146736185|NCT00279201|529205303|FG002|Maintenance|Withdrawal by Subject|0|||
146736186|NCT00279201|529205304|FG003|Maintenance|Withdrawal by Subject|0|||
146736187|NCT00279201|529205305|FG004|Maintenance|Withdrawal by Subject|0|||
146736188|NCT00279201|529205306|FG005|Maintenance|Withdrawal by Subject|0|||
146736189|NCT00279201|529205301|FG000|Maintenance|Physician Decision|9|||
146736190|NCT00279201|529205302|FG001|Maintenance|Physician Decision|9|||
146847425|NCT00607724|529610958|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
146847426|NCT00607724|529610959|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
146847427|NCT00607724|529610960|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
146847428|NCT00607724|529610961|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
146847429|NCT00607724|529610962|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
146847430|NCT00607724|529610963|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
146847431|NCT00607724|529610957|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
146847432|NCT00607724|529610958|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
146847433|NCT00607724|529610959|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
146847434|NCT00607724|529610960|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
146847435|NCT00607724|529610961|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
146847436|NCT00607724|529610962|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
146847437|NCT00607724|529610963|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
146847438|NCT00607724|529610957|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
146847439|NCT00607724|529610958|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
146847440|NCT00607724|529610959|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
146847441|NCT00607724|529610960|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
146847442|NCT00607724|529610961|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
146847443|NCT00607724|529610962|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
147009083|NCT00672984|530193768|FG001|Third Intervention|Adverse Event|0|||
147009084|NCT00672984|530193769|FG002|Third Intervention|Adverse Event|1|||
147009085|NCT00009945|530193770|FG000|Overall Study|no follow up data|7|||
147009086|NCT00009945|530193771|FG001|Overall Study|no follow up data|5|||
147009087|NCT00819169|530193772|FG000|Overall Study|Withdrawal by Subject|2|||
147009088|NCT00819169|530193773|FG001|Overall Study|Withdrawal by Subject|0|||
147009089|NCT00819169|530193774|FG002|Overall Study|Withdrawal by Subject|0|||
147009090|NCT00819169|530193775|FG003|Overall Study|Withdrawal by Subject|1|||
147009091|NCT00819169|530193776|FG004|Overall Study|Withdrawal by Subject|1|||
147009092|NCT00819169|530193777|FG005|Overall Study|Withdrawal by Subject|1|||
147009093|NCT00819169|530193778|FG006|Overall Study|Withdrawal by Subject|5|||
147009094|NCT00819169|530193779|FG007|Overall Study|Withdrawal by Subject|1|||
147009095|NCT00819169|530193780|FG008|Overall Study|Withdrawal by Subject|4|||
147009096|NCT00819169|530193772|FG000|Overall Study|Lost to Follow-up|0|||
147009097|NCT00819169|530193773|FG001|Overall Study|Lost to Follow-up|2|||
147009098|NCT00819169|530193774|FG002|Overall Study|Lost to Follow-up|0|||
147009099|NCT00819169|530193775|FG003|Overall Study|Lost to Follow-up|1|||
147009100|NCT00819169|530193776|FG004|Overall Study|Lost to Follow-up|0|||
147009101|NCT00819169|530193777|FG005|Overall Study|Lost to Follow-up|6|||
147009102|NCT00819169|530193778|FG006|Overall Study|Lost to Follow-up|2|||
147009103|NCT00819169|530193779|FG007|Overall Study|Lost to Follow-up|2|||
147009104|NCT00819169|530193780|FG008|Overall Study|Lost to Follow-up|1|||
147009105|NCT00819169|530193772|FG000|Overall Study|Death|1|||
147009106|NCT00819169|530193773|FG001|Overall Study|Death|1|||
147009107|NCT00819169|530193774|FG002|Overall Study|Death|3|||
147009108|NCT00819169|530193775|FG003|Overall Study|Death|8|||
147009109|NCT00819169|530193776|FG004|Overall Study|Death|5|||
147009110|NCT00819169|530193777|FG005|Overall Study|Death|7|||
147009111|NCT00819169|530193778|FG006|Overall Study|Death|9|||
147009112|NCT00819169|530193779|FG007|Overall Study|Death|4|||
147009113|NCT00819169|530193780|FG008|Overall Study|Death|7|||
147009114|NCT00819169|530193772|FG000|Overall Study|Ineligibility determined|0|||
147009115|NCT00819169|530193773|FG001|Overall Study|Ineligibility determined|0|||
147009116|NCT00819169|530193774|FG002|Overall Study|Ineligibility determined|0|||
147009117|NCT00819169|530193775|FG003|Overall Study|Ineligibility determined|2|||
147009118|NCT00819169|530193776|FG004|Overall Study|Ineligibility determined|0|||
147009119|NCT00819169|530193777|FG005|Overall Study|Ineligibility determined|0|||
147009120|NCT00819169|530193778|FG006|Overall Study|Ineligibility determined|0|||
147009121|NCT00819169|530193779|FG007|Overall Study|Ineligibility determined|0|||
147009122|NCT00819169|530193780|FG008|Overall Study|Ineligibility determined|1|||
147009123|NCT00819169|530193772|FG000|Overall Study|Adverse Event|0|||
147009124|NCT00819169|530193773|FG001|Overall Study|Adverse Event|0|||
146736191|NCT00279201|529205303|FG002|Maintenance|Physician Decision|0|||
146736192|NCT00279201|529205304|FG003|Maintenance|Physician Decision|0|||
146736193|NCT00279201|529205305|FG004|Maintenance|Physician Decision|0|||
146736194|NCT00279201|529205306|FG005|Maintenance|Physician Decision|0|||
146736195|NCT00279201|529205301|FG000|Maintenance|Sponsor Decision|4|||
146736196|NCT00279201|529205302|FG001|Maintenance|Sponsor Decision|0|||
146736197|NCT00279201|529205303|FG002|Maintenance|Sponsor Decision|0|||
146736198|NCT00279201|529205304|FG003|Maintenance|Sponsor Decision|0|||
146736199|NCT00279201|529205305|FG004|Maintenance|Sponsor Decision|0|||
146736200|NCT00279201|529205306|FG005|Maintenance|Sponsor Decision|0|||
146736201|NCT00279201|529205301|FG000|Maintenance|HbA1c>7.5%|123|||
146736202|NCT00279201|529205302|FG001|Maintenance|HbA1c>7.5%|126|||
146736203|NCT00279201|529205303|FG002|Maintenance|HbA1c>7.5%|0|||
146736204|NCT00279201|529205304|FG003|Maintenance|HbA1c>7.5%|0|||
146736205|NCT00279201|529205305|FG004|Maintenance|HbA1c>7.5%|0|||
146847444|NCT00607724|529610963|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
146847445|NCT00151281|529610964|FG000|Overall Study|Not evaluable|3|||
146847446|NCT01133418|529610967|FG000|Overall Study|Lost to Follow-up|5|||
146847447|NCT01133418|529610968|FG001|Overall Study|Lost to Follow-up|6|||
146847448|NCT04150068|529610969|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
146847449|NCT04150068|529610970|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
146847450|NCT04150068|529610971|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
146847451|NCT04150068|529610969|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
146847452|NCT04150068|529610970|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
146847453|NCT04150068|529610971|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
146847454|NCT05316701|529610972|FG000|Overall Study|Adverse Event|0|||
146847455|NCT05316701|529610973|FG001|Overall Study|Adverse Event|1|||
146847456|NCT05316701|529610972|FG000|Overall Study|Death|3|||
146847457|NCT05316701|529610973|FG001|Overall Study|Death|9|||
146847458|NCT05316701|529610972|FG000|Overall Study|Lost to Follow-up|1|||
146847459|NCT05316701|529610973|FG001|Overall Study|Lost to Follow-up|0|||
146847460|NCT05316701|529610972|FG000|Overall Study|Physician Decision|1|||
146847461|NCT05316701|529610973|FG001|Overall Study|Physician Decision|4|||
146847462|NCT05316701|529610972|FG000|Overall Study|Withdrawal by Subject|3|||
146847463|NCT05316701|529610973|FG001|Overall Study|Withdrawal by Subject|5|||
146847464|NCT05316701|529610972|FG000|Overall Study|Progression/Relapse|14|||
146847465|NCT05316701|529610973|FG001|Overall Study|Progression/Relapse|9|||
146847466|NCT05316701|529610972|FG000|Overall Study|Received Standard of Care|1|||
146847467|NCT05316701|529610973|FG001|Overall Study|Received Standard of Care|0|||
146847468|NCT05316701|529610972|FG000|Overall Study|Ongoing|70|||
146847469|NCT05316701|529610973|FG001|Overall Study|Ongoing|64|||
146847470|NCT04679935|529610974|FG000|Overall Study|Death|0|||
146847471|NCT04679935|529610975|FG001|Overall Study|Death|1|||
146847472|NCT04362189|529610979|FG000|Overall Study|Lost to Follow-up|0|||
146847473|NCT04362189|529610980|FG001|Overall Study|Lost to Follow-up|1|||
146847474|NCT04362189|529610979|FG000|Overall Study|Withdrawal by Subject|1|||
146847475|NCT04362189|529610980|FG001|Overall Study|Withdrawal by Subject|0|||
146847476|NCT04362189|529610979|FG000|Overall Study|FDA Clinical Hold|7|||
146847477|NCT04362189|529610980|FG001|Overall Study|FDA Clinical Hold|2|||
146847478|NCT04362189|529610979|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
146847479|NCT04362189|529610980|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
146847480|NCT04362189|529610979|FG000|Overall Study|Adverse Event|0|||
146847481|NCT04362189|529610980|FG001|Overall Study|Adverse Event|2|||
146847482|NCT04362189|529610979|FG000|Overall Study|Death|4|||
146847483|NCT04362189|529610980|FG001|Overall Study|Death|1|||
146847484|NCT02111681|529610981|FG000|Overall Study|Death|5|||
146847485|NCT02111681|529610981|FG000|Overall Study|Lack of Efficacy|2|||
146847486|NCT02111681|529610981|FG000|Overall Study|Progression of disease|4|||
146847487|NCT00969709|529612213|FG000|Overall Study|Adverse Event|3|||
146847488|NCT00969709|529612214|FG001|Overall Study|Adverse Event|13|||
146847489|NCT00969709|529612215|FG002|Overall Study|Adverse Event|26|||
146847490|NCT00969709|529612216|FG003|Overall Study|Adverse Event|12|||
146847491|NCT00969709|529612213|FG000|Overall Study|Lack of Efficacy|7|||
147009125|NCT00819169|530193774|FG002|Overall Study|Adverse Event|0|||
147009126|NCT00819169|530193775|FG003|Overall Study|Adverse Event|0|||
147009127|NCT00819169|530193776|FG004|Overall Study|Adverse Event|1|||
147009128|NCT00819169|530193777|FG005|Overall Study|Adverse Event|0|||
147009129|NCT00819169|530193778|FG006|Overall Study|Adverse Event|0|||
147009130|NCT00819169|530193779|FG007|Overall Study|Adverse Event|0|||
147009131|NCT00819169|530193780|FG008|Overall Study|Adverse Event|0|||
147009132|NCT00819169|530193772|FG000|Overall Study|Administrative Decision|0|||
147009133|NCT00819169|530193773|FG001|Overall Study|Administrative Decision|0|||
147009134|NCT00819169|530193774|FG002|Overall Study|Administrative Decision|0|||
147009135|NCT00819169|530193775|FG003|Overall Study|Administrative Decision|0|||
147009136|NCT00819169|530193776|FG004|Overall Study|Administrative Decision|1|||
147009137|NCT00819169|530193777|FG005|Overall Study|Administrative Decision|2|||
147009138|NCT00819169|530193778|FG006|Overall Study|Administrative Decision|0|||
147009139|NCT00819169|530193779|FG007|Overall Study|Administrative Decision|2|||
147009140|NCT00819169|530193780|FG008|Overall Study|Administrative Decision|0|||
147009141|NCT00406393|530193781|FG000|Overall Study|Did not undergo transplantation|2|||
147009142|NCT00406393|530193782|FG001|Overall Study|Did not undergo transplantation|1|||
147009143|NCT01632306|530193783|FG000|Overall Study|Protocol Violation|1|||
146847492|NCT00969709|529612214|FG001|Overall Study|Lack of Efficacy|4|||
146847493|NCT00969709|529612215|FG002|Overall Study|Lack of Efficacy|1|||
146847494|NCT00969709|529612216|FG003|Overall Study|Lack of Efficacy|3|||
146847495|NCT00969709|529612213|FG000|Overall Study|Protocol Violation|9|||
146847496|NCT00969709|529612214|FG001|Overall Study|Protocol Violation|5|||
146847497|NCT00969709|529612215|FG002|Overall Study|Protocol Violation|9|||
146847498|NCT00969709|529612216|FG003|Overall Study|Protocol Violation|10|||
146847499|NCT00969709|529612213|FG000|Overall Study|Withdrawal by Subject|9|||
147009144|NCT01632306|530193784|FG001|Overall Study|Protocol Violation|0|||
147009145|NCT01632306|530193785|FG002|Overall Study|Protocol Violation|0|||
147009146|NCT03966911|530193786|FG000|Overall Study|Adverse Event|1|||
146847500|NCT00969709|529612214|FG001|Overall Study|Withdrawal by Subject|12|||
146847501|NCT00969709|529612215|FG002|Overall Study|Withdrawal by Subject|11|||
146847502|NCT00969709|529612216|FG003|Overall Study|Withdrawal by Subject|23|||
146847503|NCT00969709|529612213|FG000|Overall Study|Lost to Follow-up|10|||
146847504|NCT00969709|529612214|FG001|Overall Study|Lost to Follow-up|14|||
146847505|NCT00969709|529612215|FG002|Overall Study|Lost to Follow-up|8|||
146847506|NCT00969709|529612216|FG003|Overall Study|Lost to Follow-up|15|||
146847507|NCT00969709|529612213|FG000|Overall Study|Other reasons|0|||
146847508|NCT00969709|529612214|FG001|Overall Study|Other reasons|0|||
146847509|NCT00969709|529612215|FG002|Overall Study|Other reasons|3|||
146847510|NCT00969709|529612216|FG003|Overall Study|Other reasons|0|||
146847511|NCT03828747|529612224|FG000|Double-Blind Treatment Period|Adverse Event|6|||
146847512|NCT03828747|529612225|FG001|Double-Blind Treatment Period|Adverse Event|6|||
146847513|NCT03828747|529612224|FG000|Double-Blind Treatment Period|Death|1|||
146847514|NCT03828747|529612225|FG001|Double-Blind Treatment Period|Death|1|||
146847515|NCT03828747|529612224|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146847516|NCT03828747|529612225|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
146847517|NCT03828747|529612224|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
146847518|NCT03828747|529612225|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
146847519|NCT03828747|529612224|FG000|Double-Blind Treatment Period|Physician Decision|1|||
146847520|NCT03828747|529612225|FG001|Double-Blind Treatment Period|Physician Decision|4|||
146847521|NCT03828747|529612224|FG000|Double-Blind Treatment Period|Various reasons|5|||
146847522|NCT03828747|529612225|FG001|Double-Blind Treatment Period|Various reasons|3|||
146847523|NCT03828747|529612224|FG000|Open-Label Extension|Adverse Event|9|||
146847524|NCT03828747|529612225|FG001|Open-Label Extension|Adverse Event|7|||
146847525|NCT03828747|529612224|FG000|Open-Label Extension|Death|0|||
146847526|NCT03828747|529612225|FG001|Open-Label Extension|Death|2|||
146847527|NCT03828747|529612224|FG000|Open-Label Extension|Lost to Follow-up|4|||
146847528|NCT03828747|529612225|FG001|Open-Label Extension|Lost to Follow-up|0|||
146847529|NCT03828747|529612224|FG000|Open-Label Extension|Withdrawal by Subject|31|||
146847530|NCT03828747|529612225|FG001|Open-Label Extension|Withdrawal by Subject|30|||
146847531|NCT03828747|529612224|FG000|Open-Label Extension|Various reasons|4|||
146847532|NCT03828747|529612225|FG001|Open-Label Extension|Various reasons|4|||
146847533|NCT03828747|529612224|FG000|Open-Label Extension|Physician Decision|6|||
146847534|NCT03828747|529612225|FG001|Open-Label Extension|Physician Decision|2|||
146847535|NCT00836745|529612230|FG000|Overall Study|Death|2|||
146847536|NCT00836745|529612230|FG000|Overall Study|Lost to Follow-up|10|||
146847537|NCT00836745|529612230|FG000|Overall Study|Adverse Event|3|||
146847538|NCT00836745|529612230|FG000|Overall Study|Objective progression or relapse|4|||
146847539|NCT00836745|529612230|FG000|Overall Study|Other|2|||
146847540|NCT02366468|529612231|FG000|Overall Study|Adverse Event|2|||
146847541|NCT02366468|529612232|FG001|Overall Study|Adverse Event|0|||
146847542|NCT02366468|529612231|FG000|Overall Study|Withdrawal by Subject|1|||
146847543|NCT02366468|529612232|FG001|Overall Study|Withdrawal by Subject|5|||
146847544|NCT02366468|529612231|FG000|Overall Study|Lost to Follow-up|2|||
146847545|NCT02366468|529612232|FG001|Overall Study|Lost to Follow-up|0|||
146847546|NCT02366468|529612231|FG000|Overall Study|Death|1|||
146847547|NCT02366468|529612232|FG001|Overall Study|Death|2|||
146847548|NCT02366468|529612231|FG000|Overall Study|Other|0|||
146847549|NCT02366468|529612232|FG001|Overall Study|Other|2|||
146847550|NCT00490490|529612233|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
146847551|NCT00490490|529612233|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
146847552|NCT05540717|529612234|FG000|Overall Study|Lost to Follow-up|2|||
146847553|NCT05540717|529612235|FG001|Overall Study|Lost to Follow-up|5|||
146847554|NCT05540717|529612234|FG000|Overall Study|Withdrawal by Subject|6|||
146847555|NCT05540717|529612235|FG001|Overall Study|Withdrawal by Subject|6|||
146847556|NCT05540717|529612234|FG000|Overall Study|Sponsor request|1|||
146847557|NCT05540717|529612235|FG001|Overall Study|Sponsor request|0|||
146847558|NCT05540717|529612234|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
146847559|NCT05540717|529612235|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
146847560|NCT05540717|529612234|FG000|Overall Study|Other|0|||
146847561|NCT05540717|529612235|FG001|Overall Study|Other|1|||
146847562|NCT03651622|529612236|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
146847563|NCT03651622|529612237|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
146847564|NCT03651622|529612238|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
146847565|NCT03651622|529612236|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
146847566|NCT03651622|529612237|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
146847567|NCT03651622|529612238|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
146847568|NCT03651622|529612236|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
146847569|NCT03651622|529612237|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
146847570|NCT03651622|529612238|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
146847571|NCT03651622|529612236|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
146847572|NCT03651622|529612237|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
146847573|NCT03651622|529612238|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
146847574|NCT03651622|529612236|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
146847575|NCT03651622|529612237|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
146847576|NCT03651622|529612238|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
146847577|NCT00307684|529612242|FG000|Open Label Phase|Lack of Efficacy|0|||
146847578|NCT00307684|529612243|FG001|Open Label Phase|Lack of Efficacy|0|||
146847579|NCT00307684|529612244|FG002|Open Label Phase|Lack of Efficacy|3|||
146847580|NCT00307684|529612242|FG000|Open Label Phase|Adverse Event|0|||
146847581|NCT00307684|529612243|FG001|Open Label Phase|Adverse Event|0|||
146847582|NCT00307684|529612244|FG002|Open Label Phase|Adverse Event|16|||
146847583|NCT00307684|529612242|FG000|Open Label Phase|Withdrawal by Subject|0|||
146847584|NCT00307684|529612243|FG001|Open Label Phase|Withdrawal by Subject|0|||
146847585|NCT00307684|529612244|FG002|Open Label Phase|Withdrawal by Subject|15|||
146847586|NCT00307684|529612242|FG000|Open Label Phase|Lost to Follow-up|0|||
146847587|NCT00307684|529612243|FG001|Open Label Phase|Lost to Follow-up|0|||
146847588|NCT00307684|529612244|FG002|Open Label Phase|Lost to Follow-up|11|||
146847589|NCT00307684|529612242|FG000|Open Label Phase|non compliance|0|||
146847590|NCT00307684|529612243|FG001|Open Label Phase|non compliance|0|||
146847591|NCT00307684|529612244|FG002|Open Label Phase|non compliance|5|||
146847592|NCT00307684|529612242|FG000|Open Label Phase|other|0|||
146847593|NCT00307684|529612243|FG001|Open Label Phase|other|0|||
146847594|NCT00307684|529612244|FG002|Open Label Phase|other|6|||
146847595|NCT00307684|529612242|FG000|Double Blind Phase|Lack of Efficacy|2|||
146847596|NCT00307684|529612243|FG001|Double Blind Phase|Lack of Efficacy|5|||
146847597|NCT00307684|529612244|FG002|Double Blind Phase|Lack of Efficacy|0|||
146847598|NCT02580305|529612245|FG000|Overall Study|Adverse Event|15|||
146847599|NCT02580305|529612246|FG001|Overall Study|Adverse Event|19|||
146847600|NCT02580305|529612247|FG002|Overall Study|Adverse Event|10|||
146847601|NCT02580305|529612245|FG000|Overall Study|Lack of Efficacy|5|||
146847602|NCT02580305|529612246|FG001|Overall Study|Lack of Efficacy|0|||
146847603|NCT02580305|529612247|FG002|Overall Study|Lack of Efficacy|2|||
146847604|NCT02580305|529612245|FG000|Overall Study|Protocol Violation|4|||
146847605|NCT02580305|529612246|FG001|Overall Study|Protocol Violation|9|||
146847606|NCT02580305|529612247|FG002|Overall Study|Protocol Violation|6|||
146847607|NCT02580305|529612245|FG000|Overall Study|Lost to Follow-up|4|||
146847608|NCT02580305|529612246|FG001|Overall Study|Lost to Follow-up|4|||
146847609|NCT02580305|529612247|FG002|Overall Study|Lost to Follow-up|2|||
146847610|NCT02580305|529612245|FG000|Overall Study|Withdrawal by Subject|11|||
146847611|NCT02580305|529612246|FG001|Overall Study|Withdrawal by Subject|9|||
146847612|NCT02580305|529612247|FG002|Overall Study|Withdrawal by Subject|7|||
146847613|NCT02580305|529612245|FG000|Overall Study|Randomized in error and never treated|4|||
146847614|NCT02580305|529612246|FG001|Overall Study|Randomized in error and never treated|8|||
146847615|NCT02580305|529612247|FG002|Overall Study|Randomized in error and never treated|5|||
146847616|NCT00224887|529612248|FG000|Overall Study|Pregnancy|6|||
146847617|NCT00224887|529612249|FG001|Overall Study|Pregnancy|6|||
146847618|NCT04032613|529612252|FG000|Overall Study|Did not complete post-program assessment|5|||
146847619|NCT04032613|529612253|FG001|Overall Study|Did not complete post-program assessment|2|||
146847620|NCT00859222|529612259|FG000|Overall Study|Adverse Event|2|||
146847621|NCT00859222|529612260|FG001|Overall Study|Adverse Event|3|||
146847622|NCT00859222|529612261|FG002|Overall Study|Adverse Event|6|||
146847623|NCT00859222|529612262|FG003|Overall Study|Adverse Event|24|||
146847624|NCT00859222|529612263|FG004|Overall Study|Adverse Event|15|||
146847625|NCT00859222|529612259|FG000|Overall Study|DLT|1|||
146847626|NCT00859222|529612260|FG001|Overall Study|DLT|0|||
146847627|NCT00859222|529612261|FG002|Overall Study|DLT|0|||
146847628|NCT00859222|529612262|FG003|Overall Study|DLT|0|||
146847629|NCT00859222|529612263|FG004|Overall Study|DLT|0|||
146847630|NCT00488475|529612264|FG000|Overall Study|Other|1754|||
146847631|NCT03174431|529612275|FG000|Overall Study|Withdrawal by Subject|14|||
146847632|NCT03174431|529612276|FG001|Overall Study|Withdrawal by Subject|11|||
146847633|NCT03174431|529612275|FG000|Overall Study|alternative treatment|2|||
146847634|NCT03174431|529612276|FG001|Overall Study|alternative treatment|0|||
146847635|NCT03174431|529612275|FG000|Overall Study|Lost to Follow-up|1|||
146847636|NCT03174431|529612276|FG001|Overall Study|Lost to Follow-up|5|||
146847637|NCT04075994|529612279|FG000|Overall Study|Withdrawal by Subject|8|||
146847638|NCT04075994|529612280|FG001|Overall Study|Withdrawal by Subject|9|||
146847639|NCT04075994|529612279|FG000|Overall Study|Adverse Event|2|||
146847640|NCT04075994|529612280|FG001|Overall Study|Adverse Event|2|||
146847641|NCT04075994|529612279|FG000|Overall Study|Investigator withdrew|3|||
146847642|NCT04075994|529612280|FG001|Overall Study|Investigator withdrew|1|||
146847643|NCT00757627|529612281|FG000|Overall Study|Adverse Event|15|||
146847644|NCT00757627|529612281|FG000|Overall Study|Lack of Efficacy|10|||
146847645|NCT00757627|529612281|FG000|Overall Study|Lost to Follow-up|28|||
146847646|NCT00757627|529612281|FG000|Overall Study|Withdrawal by Subject|27|||
146847647|NCT00757627|529612281|FG000|Overall Study|Other|1|||
146847648|NCT01696955|529612285|FG000|Main Study|Protocol Violation|1|||
146847649|NCT01696955|529612286|FG001|Main Study|Protocol Violation|0|||
146847650|NCT01696955|529612285|FG000|Main Study|Withdrawal by Subject|1|||
146847651|NCT01696955|529612286|FG001|Main Study|Withdrawal by Subject|1|||
146847652|NCT02755818|529612287|FG000|Overall Study|Withdrawal by Subject|0|||
146847653|NCT02755818|529612288|FG001|Overall Study|Withdrawal by Subject|0|||
147009147|NCT03966911|530193787|FG001|Overall Study|Adverse Event|1|||
147009148|NCT03966911|530193786|FG000|Overall Study|Withdrawal by Subject|8|||
147009149|NCT03966911|530193787|FG001|Overall Study|Withdrawal by Subject|2|||
147009150|NCT03966911|530193786|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
147009151|NCT03966911|530193787|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
147009152|NCT00985751|530193790|FG000|Overall Study|Adverse Event|0|||
147009153|NCT00985751|530193791|FG001|Overall Study|Adverse Event|0|||
147009154|NCT00985751|530193792|FG002|Overall Study|Adverse Event|0|||
147009155|NCT00985751|530193793|FG003|Overall Study|Adverse Event|0|||
147009156|NCT00985751|530193794|FG004|Overall Study|Adverse Event|1|||
147009157|NCT00380588|530193795|FG000|Overall Study|Unequivocal Disease Progression|25|||
147009158|NCT00380588|530193796|FG001|Overall Study|Unequivocal Disease Progression|34|||
147009159|NCT00380588|530193795|FG000|Overall Study|Next Cycle Not Started|4|||
147009160|NCT00380588|530193796|FG001|Overall Study|Next Cycle Not Started|0|||
147009161|NCT00380588|530193795|FG000|Overall Study|Adverse Event|7|||
147009162|NCT00380588|530193796|FG001|Overall Study|Adverse Event|3|||
147009163|NCT00380588|530193795|FG000|Overall Study|Withdrawal by Subject|1|||
147009164|NCT00380588|530193796|FG001|Overall Study|Withdrawal by Subject|3|||
147009165|NCT00380588|530193795|FG000|Overall Study|Physician Decision|2|||
147009166|NCT00380588|530193796|FG001|Overall Study|Physician Decision|0|||
147009167|NCT02905435|530193797|FG000|Overall Study|Death|2|||
147009168|NCT02905435|530193797|FG000|Overall Study|Physician Decision|1|||
147009169|NCT02905435|530193797|FG000|Overall Study|Lost to Follow-up|4|||
147009170|NCT01046084|530193805|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
147009171|NCT01046084|530193806|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
147009172|NCT00474188|530193807|FG000|Overall Study|Withdrawal by Subject|1|||
147009173|NCT00474188|530193807|FG000|Overall Study|Study discontinued by sponsor|5|||
147009174|NCT03614728|530193808|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
147009175|NCT03614728|530193809|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
147009176|NCT03614728|530193810|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
147009177|NCT03614728|530193811|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
147009178|NCT03614728|530193808|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
147009179|NCT03614728|530193809|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
147009180|NCT03614728|530193810|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
147009181|NCT03614728|530193811|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
147009182|NCT00842309|530193816|FG000|Overall Study|Withdrawal by Subject|3|||
147009183|NCT00842309|530193817|FG001|Overall Study|Withdrawal by Subject|1|||
147009184|NCT01962298|530193818|FG000|Overall Study|Protocol Violation|1|||
147009185|NCT01962298|530193819|FG001|Overall Study|Protocol Violation|0|||
147009186|NCT01962298|530193820|FG002|Overall Study|Protocol Violation|1|||
147009187|NCT01962298|530193821|FG003|Overall Study|Protocol Violation|1|||
146847654|NCT02755818|529612289|FG002|Overall Study|Withdrawal by Subject|0|||
146847655|NCT02755818|529612290|FG003|Overall Study|Withdrawal by Subject|2|||
146847656|NCT02755818|529612287|FG000|Overall Study|withdrawal by PI|0|||
146847657|NCT02755818|529612288|FG001|Overall Study|withdrawal by PI|0|||
146847658|NCT02755818|529612289|FG002|Overall Study|withdrawal by PI|1|||
146847659|NCT02755818|529612290|FG003|Overall Study|withdrawal by PI|1|||
146847660|NCT02416453|529612291|FG000|Overall Study|Adverse Event|0|||
146847661|NCT02416453|529612292|FG001|Overall Study|Adverse Event|0|||
146847662|NCT02416453|529612293|FG002|Overall Study|Adverse Event|0|||
146847663|NCT02416453|529612294|FG003|Overall Study|Adverse Event|2|||
146847664|NCT02416453|529612295|FG004|Overall Study|Adverse Event|0|||
146847665|NCT02416453|529612296|FG005|Overall Study|Adverse Event|1|||
146847666|NCT02416453|529612297|FG006|Overall Study|Adverse Event|0|||
146847667|NCT02416453|529612298|FG007|Overall Study|Adverse Event|0|||
146847668|NCT02416453|529612299|FG008|Overall Study|Adverse Event|0|||
146847669|NCT02416453|529612300|FG009|Overall Study|Adverse Event|0|||
146847670|NCT02416453|529612301|FG010|Overall Study|Adverse Event|0|||
146847671|NCT02416453|529612291|FG000|Overall Study|Lost to Follow-up|1|||
146847672|NCT02416453|529612292|FG001|Overall Study|Lost to Follow-up|3|||
146847673|NCT02416453|529612293|FG002|Overall Study|Lost to Follow-up|0|||
146847674|NCT02416453|529612294|FG003|Overall Study|Lost to Follow-up|8|||
146847675|NCT02416453|529612295|FG004|Overall Study|Lost to Follow-up|0|||
146847676|NCT02416453|529612296|FG005|Overall Study|Lost to Follow-up|5|||
147009188|NCT01962298|530193822|FG004|Overall Study|Protocol Violation|0|||
147009189|NCT01962298|530193818|FG000|Overall Study|Data quality insufficient|2|||
147009190|NCT01962298|530193819|FG001|Overall Study|Data quality insufficient|0|||
147009191|NCT01962298|530193820|FG002|Overall Study|Data quality insufficient|3|||
147009192|NCT01962298|530193821|FG003|Overall Study|Data quality insufficient|1|||
147009193|NCT01962298|530193822|FG004|Overall Study|Data quality insufficient|4|||
147009194|NCT01962298|530193818|FG000|Overall Study|Insufficient data|0|||
147009195|NCT01962298|530193819|FG001|Overall Study|Insufficient data|2|||
147009196|NCT01962298|530193820|FG002|Overall Study|Insufficient data|1|||
146847677|NCT02416453|529612297|FG006|Overall Study|Lost to Follow-up|1|||
146847678|NCT02416453|529612298|FG007|Overall Study|Lost to Follow-up|3|||
146847679|NCT02416453|529612299|FG008|Overall Study|Lost to Follow-up|1|||
146847680|NCT02416453|529612300|FG009|Overall Study|Lost to Follow-up|0|||
146847681|NCT02416453|529612301|FG010|Overall Study|Lost to Follow-up|0|||
146847682|NCT02416453|529612291|FG000|Overall Study|Physician Decision|0|||
146847683|NCT02416453|529612292|FG001|Overall Study|Physician Decision|0|||
146847684|NCT02416453|529612293|FG002|Overall Study|Physician Decision|0|||
146847685|NCT02416453|529612294|FG003|Overall Study|Physician Decision|0|||
147009197|NCT01962298|530193821|FG003|Overall Study|Insufficient data|0|||
147009198|NCT01962298|530193822|FG004|Overall Study|Insufficient data|1|||
146847686|NCT02416453|529612295|FG004|Overall Study|Physician Decision|0|||
146847687|NCT02416453|529612296|FG005|Overall Study|Physician Decision|1|||
146847688|NCT02416453|529612297|FG006|Overall Study|Physician Decision|1|||
146847689|NCT02416453|529612298|FG007|Overall Study|Physician Decision|1|||
146847690|NCT02416453|529612299|FG008|Overall Study|Physician Decision|0|||
146847691|NCT02416453|529612300|FG009|Overall Study|Physician Decision|0|||
146847692|NCT02416453|529612301|FG010|Overall Study|Physician Decision|0|||
146847693|NCT02416453|529612291|FG000|Overall Study|Withdrawal by Subject|2|||
146847694|NCT02416453|529612292|FG001|Overall Study|Withdrawal by Subject|0|||
146847695|NCT02416453|529612293|FG002|Overall Study|Withdrawal by Subject|0|||
146847696|NCT02416453|529612294|FG003|Overall Study|Withdrawal by Subject|5|||
146847697|NCT02416453|529612295|FG004|Overall Study|Withdrawal by Subject|1|||
146847698|NCT02416453|529612296|FG005|Overall Study|Withdrawal by Subject|8|||
146847699|NCT02416453|529612297|FG006|Overall Study|Withdrawal by Subject|0|||
146847700|NCT02416453|529612298|FG007|Overall Study|Withdrawal by Subject|8|||
146847701|NCT02416453|529612299|FG008|Overall Study|Withdrawal by Subject|4|||
146847702|NCT02416453|529612300|FG009|Overall Study|Withdrawal by Subject|0|||
146847703|NCT02416453|529612301|FG010|Overall Study|Withdrawal by Subject|0|||
146847704|NCT02416453|529612291|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146847705|NCT02416453|529612292|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146847706|NCT02416453|529612293|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
146847707|NCT02416453|529612294|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146847708|NCT02416453|529612295|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146847709|NCT02416453|529612296|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146847710|NCT02416453|529612297|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146847711|NCT02416453|529612298|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146847712|NCT02416453|529612299|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146847713|NCT02416453|529612300|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146847714|NCT02416453|529612301|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146847715|NCT02416453|529612291|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146847716|NCT02416453|529612292|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146847717|NCT02416453|529612293|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146847718|NCT02416453|529612294|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146847719|NCT02416453|529612295|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146847720|NCT02416453|529612296|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
146847721|NCT02416453|529612297|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146847722|NCT02416453|529612298|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146847723|NCT02416453|529612299|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146847724|NCT02416453|529612300|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146847725|NCT02416453|529612301|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146847726|NCT01280357|529612306|FG000|Overall Study|Excluded no internal monitoring|14|||
146847727|NCT01280357|529612306|FG000|Overall Study|IInsufficient data/No data supplied|12|||
146847728|NCT00992225|529612307|FG000|Overall Study|Entry Criteria Not Met|8|||
146847729|NCT00992225|529612307|FG000|Overall Study|Adverse Event|2|||
147009199|NCT01962298|530193818|FG000|Overall Study|Incorrect data recorded|0|||
147009200|NCT01962298|530193819|FG001|Overall Study|Incorrect data recorded|1|||
147009201|NCT01962298|530193820|FG002|Overall Study|Incorrect data recorded|0|||
147009202|NCT01962298|530193821|FG003|Overall Study|Incorrect data recorded|0|||
146847730|NCT01036438|529612311|FG000|Overall Study|Adverse Event|7|||
146847731|NCT01036438|529612312|FG001|Overall Study|Adverse Event|8|||
146847732|NCT01036438|529612311|FG000|Overall Study|Death|0|||
146847733|NCT01036438|529612312|FG001|Overall Study|Death|1|||
146847734|NCT01036438|529612311|FG000|Overall Study|No effect of study treatment|3|||
146847735|NCT01036438|529612312|FG001|Overall Study|No effect of study treatment|1|||
146847736|NCT03592745|529612313|FG000|Overall Study|Adverse Event|0|||
146847737|NCT03592745|529612314|FG001|Overall Study|Adverse Event|2|||
146847738|NCT03592745|529612313|FG000|Overall Study|Lost to Follow-up|2|||
146847739|NCT03592745|529612314|FG001|Overall Study|Lost to Follow-up|0|||
146847740|NCT03592745|529612313|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
147009203|NCT01962298|530193822|FG004|Overall Study|Incorrect data recorded|0|||
147009204|NCT01962298|530193818|FG000|Overall Study|Physician Decision|0|||
146847741|NCT03592745|529612314|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
146847742|NCT02729831|529612316|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
147009205|NCT01962298|530193819|FG001|Overall Study|Physician Decision|1|||
147009206|NCT01962298|530193820|FG002|Overall Study|Physician Decision|0|||
147009207|NCT01962298|530193821|FG003|Overall Study|Physician Decision|0|||
147009208|NCT01962298|530193822|FG004|Overall Study|Physician Decision|1|||
147009209|NCT04476277|530193823|FG000|Overall Study|Withdrawal by Subject|0|||
147009210|NCT04476277|530193824|FG001|Overall Study|Withdrawal by Subject|0|||
147009211|NCT04476277|530193825|FG002|Overall Study|Withdrawal by Subject|1|||
147009212|NCT04476277|530193826|FG003|Overall Study|Withdrawal by Subject|0|||
147009213|NCT01576705|530193827|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
147009214|NCT01576705|530193828|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
147009215|NCT01576705|530193829|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
147009216|NCT01576705|530193830|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
147009217|NCT01576705|530193827|FG000|Overall Study|invalid ICF|0|||
147009218|NCT01576705|530193828|FG001|Overall Study|invalid ICF|1|||
147009219|NCT01576705|530193829|FG002|Overall Study|invalid ICF|0|||
147009220|NCT01576705|530193830|FG003|Overall Study|invalid ICF|0|||
147009221|NCT03727139|530193831|FG000|Overall Study|Protocol Violation|60|||
147009222|NCT00566722|530193832|FG000|Overall Study|Adverse Event|0|||
147009223|NCT00566722|530193833|FG001|Overall Study|Adverse Event|1|||
147009224|NCT00566722|530193834|FG002|Overall Study|Adverse Event|0|||
147009225|NCT00566722|530193832|FG000|Overall Study|Withdrawal by Subject|0|||
147009226|NCT00566722|530193833|FG001|Overall Study|Withdrawal by Subject|0|||
147009227|NCT00566722|530193834|FG002|Overall Study|Withdrawal by Subject|1|||
147009228|NCT00566722|530193832|FG000|Overall Study|Lost to Follow-up|1|||
147009229|NCT00566722|530193833|FG001|Overall Study|Lost to Follow-up|1|||
147009230|NCT00566722|530193834|FG002|Overall Study|Lost to Follow-up|1|||
147009231|NCT00566722|530193832|FG000|Overall Study|Lack of Efficacy|1|||
147009232|NCT00566722|530193833|FG001|Overall Study|Lack of Efficacy|2|||
147009233|NCT00566722|530193834|FG002|Overall Study|Lack of Efficacy|4|||
147009234|NCT00566722|530193832|FG000|Overall Study|Did not meet exclusion criteria|0|||
147009235|NCT00566722|530193833|FG001|Overall Study|Did not meet exclusion criteria|0|||
147009236|NCT00566722|530193834|FG002|Overall Study|Did not meet exclusion criteria|2|||
147009237|NCT00566722|530193832|FG000|Overall Study|Serious adverse event|0|||
147009238|NCT00566722|530193833|FG001|Overall Study|Serious adverse event|1|||
147009239|NCT00566722|530193834|FG002|Overall Study|Serious adverse event|0|||
147009240|NCT00566722|530193832|FG000|Overall Study|Noncompliant with drug administration|0|||
147009241|NCT00566722|530193833|FG001|Overall Study|Noncompliant with drug administration|0|||
147009242|NCT00566722|530193834|FG002|Overall Study|Noncompliant with drug administration|1|||
147009243|NCT01390948|530193835|FG000|Overall Study|End of Study|1|||
147009244|NCT01390948|530193836|FG001|Overall Study|End of Study|0|||
147009245|NCT01390948|530193837|FG002|Overall Study|End of Study|0|||
147009246|NCT01390948|530193835|FG000|Overall Study|Withdrew consent|2|||
147009247|NCT01390948|530193836|FG001|Overall Study|Withdrew consent|2|||
147009248|NCT01390948|530193837|FG002|Overall Study|Withdrew consent|0|||
147009249|NCT01390948|530193835|FG000|Overall Study|Progressive Disease|2|||
147009250|NCT01390948|530193836|FG001|Overall Study|Progressive Disease|5|||
147009251|NCT01390948|530193837|FG002|Overall Study|Progressive Disease|0|||
147009252|NCT01390948|530193835|FG000|Overall Study|Death during follow-up|10|||
147009253|NCT01390948|530193836|FG001|Overall Study|Death during follow-up|11|||
146736206|NCT00279201|529205306|FG005|Maintenance|HbA1c>7.5%|0|||
146736207|NCT00279201|529205301|FG000|Intensification Addendum|Withdrawal by Subject|0|||
146736208|NCT00279201|529205302|FG001|Intensification Addendum|Withdrawal by Subject|0|||
146736209|NCT00279201|529205303|FG002|Intensification Addendum|Withdrawal by Subject|12|||
146736210|NCT00279201|529205304|FG003|Intensification Addendum|Withdrawal by Subject|14|||
146736211|NCT00279201|529205305|FG004|Intensification Addendum|Withdrawal by Subject|9|||
146736212|NCT00279201|529205306|FG005|Intensification Addendum|Withdrawal by Subject|18|||
146736213|NCT00279201|529205301|FG000|Intensification Addendum|Lost to Follow-up|0|||
146736214|NCT00279201|529205302|FG001|Intensification Addendum|Lost to Follow-up|0|||
146736215|NCT00279201|529205303|FG002|Intensification Addendum|Lost to Follow-up|4|||
146736216|NCT00279201|529205304|FG003|Intensification Addendum|Lost to Follow-up|6|||
146736217|NCT00279201|529205305|FG004|Intensification Addendum|Lost to Follow-up|7|||
146736218|NCT00279201|529205306|FG005|Intensification Addendum|Lost to Follow-up|7|||
146736219|NCT00279201|529205301|FG000|Intensification Addendum|Protocol Violation|0|||
146736220|NCT00279201|529205302|FG001|Intensification Addendum|Protocol Violation|0|||
146736221|NCT00279201|529205303|FG002|Intensification Addendum|Protocol Violation|2|||
146736222|NCT00279201|529205304|FG003|Intensification Addendum|Protocol Violation|2|||
146736223|NCT00279201|529205305|FG004|Intensification Addendum|Protocol Violation|6|||
146736224|NCT00279201|529205306|FG005|Intensification Addendum|Protocol Violation|6|||
146736225|NCT00279201|529205301|FG000|Intensification Addendum|Adverse Event|0|||
146736226|NCT00279201|529205302|FG001|Intensification Addendum|Adverse Event|0|||
146736227|NCT00279201|529205303|FG002|Intensification Addendum|Adverse Event|0|||
146736228|NCT00279201|529205304|FG003|Intensification Addendum|Adverse Event|4|||
146736229|NCT00279201|529205305|FG004|Intensification Addendum|Adverse Event|1|||
146736230|NCT00279201|529205306|FG005|Intensification Addendum|Adverse Event|3|||
146736231|NCT00279201|529205301|FG000|Intensification Addendum|Physician Decision|0|||
146736232|NCT00279201|529205302|FG001|Intensification Addendum|Physician Decision|0|||
146736233|NCT00279201|529205303|FG002|Intensification Addendum|Physician Decision|4|||
146847743|NCT02729831|529612317|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
146847744|NCT02729831|529612318|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
146847745|NCT02729831|529612319|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
146847746|NCT02729831|529612316|FG000|1 Week Post-visit|Lost to Follow-up|43|||
146847747|NCT02729831|529612317|FG001|1 Week Post-visit|Lost to Follow-up|40|||
146847748|NCT02729831|529612318|FG002|1 Week Post-visit|Lost to Follow-up|38|||
146847749|NCT02729831|529612319|FG003|1 Week Post-visit|Lost to Follow-up|36|||
146847750|NCT02729831|529612316|FG000|6 Month Follow-up|Lost to Follow-up|54|||
146847751|NCT02729831|529612317|FG001|6 Month Follow-up|Lost to Follow-up|51|||
146847752|NCT02729831|529612318|FG002|6 Month Follow-up|Lost to Follow-up|48|||
146847753|NCT02729831|529612319|FG003|6 Month Follow-up|Lost to Follow-up|42|||
146847754|NCT02729831|529612316|FG000|6 Month Follow-up|Death|1|||
146847755|NCT02729831|529612317|FG001|6 Month Follow-up|Death|3|||
146847756|NCT02729831|529612318|FG002|6 Month Follow-up|Death|0|||
146847757|NCT02729831|529612319|FG003|6 Month Follow-up|Death|1|||
146847758|NCT01413503|529612320|FG000|Overall Study|Lost to Follow-up|1|||
146847759|NCT05051462|529612327|FG000|Overall Study|Lost to Follow-up|1|||
146847760|NCT05051462|529612328|FG001|Overall Study|Lost to Follow-up|8|||
146847761|NCT05051462|529612327|FG000|Overall Study|Withdrawal by Subject|1|||
146847762|NCT05051462|529612328|FG001|Overall Study|Withdrawal by Subject|0|||
146847763|NCT05051462|529612327|FG000|Overall Study|Protocol Violation|0|||
146847764|NCT05051462|529612328|FG001|Overall Study|Protocol Violation|2|||
146847765|NCT05597787|529612334|FG000|Overall Study|Withdrawal by Subject|0|||
146847766|NCT05597787|529612335|FG001|Overall Study|Withdrawal by Subject|0|||
146847767|NCT05597787|529612336|FG002|Overall Study|Withdrawal by Subject|1|||
146847768|NCT01241604|529612337|FG000|Screening Period|Screen Failure|3|||
146847769|NCT01241604|529612338|FG001|Screening Period|Screen Failure|0|||
146847770|NCT01241604|529612339|FG002|Screening Period|Screen Failure|0|||
146847771|NCT04349631|529612341|FG000|Overall Study|Lost to Follow-up|3|||
146847772|NCT04349631|529612341|FG000|Overall Study|Withdrawal by Subject|7|||
146847773|NCT00775463|529613929|FG000|Overall Study|Withdrawal by Subject|0|||
146847774|NCT00775463|529613930|FG001|Overall Study|Withdrawal by Subject|1|||
146847775|NCT00775463|529613929|FG000|Overall Study|Adverse Event|7|||
146847776|NCT00775463|529613930|FG001|Overall Study|Adverse Event|9|||
146847777|NCT00775463|529613929|FG000|Overall Study|Protocol Violation|2|||
146847778|NCT00775463|529613930|FG001|Overall Study|Protocol Violation|2|||
146847779|NCT00775463|529613929|FG000|Overall Study|Lost to Follow-up|1|||
146847780|NCT00775463|529613930|FG001|Overall Study|Lost to Follow-up|0|||
146847781|NCT00775463|529613929|FG000|Overall Study|Lack of Efficacy|1|||
146847782|NCT00775463|529613930|FG001|Overall Study|Lack of Efficacy|1|||
147009254|NCT01390948|530193837|FG002|Overall Study|Death during follow-up|1|||
147009255|NCT02218216|530193840|FG000|Overall Study|Study terminated before completed|6|||
147009256|NCT02218216|530193841|FG001|Overall Study|Study terminated before completed|0|||
147009257|NCT02218216|530193842|FG002|Overall Study|Study terminated before completed|0|||
147009258|NCT05740098|530193847|FG000|Overall Study|Lost to Follow-up|26|||
147009259|NCT05740098|530193848|FG001|Overall Study|Lost to Follow-up|17|||
147009260|NCT05740098|530193849|FG002|Overall Study|Lost to Follow-up|21|||
147009261|NCT03867760|530193850|FG000|Overall Study|Lost to Follow-up|2|||
147009262|NCT03867760|530193851|FG001|Overall Study|Lost to Follow-up|3|||
147009263|NCT03867760|530193850|FG000|Overall Study|Withdrawal by Subject|1|||
147009264|NCT03867760|530193851|FG001|Overall Study|Withdrawal by Subject|2|||
147009265|NCT03867760|530193850|FG000|Overall Study|subject could not meet study logistics|3|||
147009266|NCT03867760|530193851|FG001|Overall Study|subject could not meet study logistics|3|||
147009267|NCT01073631|530193852|FG000|Overall Study|Death|82|||
147009268|NCT01073631|530193852|FG000|Overall Study|Adverse Event|24|||
147009269|NCT01073631|530193852|FG000|Overall Study|Other|63|||
147009270|NCT04573309|530195193|FG000|Overall Study|Protocol Violation|1|||
147009271|NCT04573309|530195194|FG001|Overall Study|Protocol Violation|0|||
147009272|NCT01691430|530195197|FG000|Overall Study|Death|17|||
147009273|NCT01691430|530195198|FG001|Overall Study|Death|16|||
147009274|NCT01691430|530195197|FG000|Overall Study|Withdrawal by Subject|5|||
147009275|NCT01691430|530195198|FG001|Overall Study|Withdrawal by Subject|1|||
147009276|NCT01691430|530195197|FG000|Overall Study|Lost to Follow-up|0|||
147009277|NCT01691430|530195198|FG001|Overall Study|Lost to Follow-up|3|||
147009278|NCT01894230|530195199|FG000|Overall Study|Lost to Follow-up|2|||
147009279|NCT01894230|530195200|FG001|Overall Study|Lost to Follow-up|2|||
146847783|NCT02980731|529613931|FG000|Overall Study|Death|63|||
146847784|NCT02980731|529613931|FG000|Overall Study|Withdrawal by Subject|6|||
146847785|NCT02980731|529613931|FG000|Overall Study|Lost to Follow-up|5|||
146847786|NCT02980731|529613931|FG000|Overall Study|Study terminated by Sponsor|4|||
147009280|NCT01894230|530195199|FG000|Overall Study|Withdrawal by Subject|4|||
147009281|NCT01894230|530195200|FG001|Overall Study|Withdrawal by Subject|4|||
147009282|NCT01894230|530195199|FG000|Overall Study|Non-adherent|0|||
147009283|NCT01894230|530195200|FG001|Overall Study|Non-adherent|1|||
147009284|NCT01894230|530195199|FG000|Overall Study|Death|1|||
147009285|NCT01894230|530195200|FG001|Overall Study|Death|0|||
147009286|NCT02219009|530195203|FG000|Overall Study|Withdrawal by Subject|5|||
147009287|NCT02219009|530195204|FG001|Overall Study|Withdrawal by Subject|1|||
146847787|NCT02980731|529613931|FG000|Overall Study|Completed survival follow-up period|65|||
146847788|NCT02980731|529613931|FG000|Overall Study|COVID-19 infection|1|||
146847789|NCT02980731|529613931|FG000|Overall Study|Other, not specified|66|||
146847790|NCT02075476|529613932|FG000|Overall Study|Death|2|||
146847791|NCT02075476|529613933|FG001|Overall Study|Death|2|||
146847792|NCT02075476|529613932|FG000|Overall Study|Lost to Follow-up|1|||
146847793|NCT02075476|529613933|FG001|Overall Study|Lost to Follow-up|3|||
146847794|NCT00091169|529613934|FG000|Overall Study|Disease progression|3|||
146847795|NCT00091169|529613935|FG001|Overall Study|Disease progression|1|||
146847796|NCT00091169|529613934|FG000|Overall Study|Adverse Event|11|||
146847797|NCT00091169|529613935|FG001|Overall Study|Adverse Event|17|||
146847798|NCT00091169|529613934|FG000|Overall Study|Death|4|||
146847799|NCT00091169|529613935|FG001|Overall Study|Death|1|||
146847800|NCT00091169|529613934|FG000|Overall Study|Withdrawal by Subject|10|||
146847801|NCT00091169|529613935|FG001|Overall Study|Withdrawal by Subject|13|||
146847802|NCT00091169|529613934|FG000|Overall Study|Other|3|||
146847803|NCT00091169|529613935|FG001|Overall Study|Other|4|||
146847804|NCT00091169|529613934|FG000|Overall Study|Not start protocol therapy|26|||
146847805|NCT00091169|529613935|FG001|Overall Study|Not start protocol therapy|17|||
146847806|NCT03809429|529613936|FG000|Overall Study|Withdrawal by Subject|7|||
146847807|NCT03809429|529613937|FG001|Overall Study|Withdrawal by Subject|3|||
146847808|NCT03809429|529613936|FG000|Overall Study|Adverse Event|6|||
146847809|NCT03809429|529613937|FG001|Overall Study|Adverse Event|9|||
146847810|NCT03809429|529613936|FG000|Overall Study|COVID-19|3|||
146847811|NCT03809429|529613937|FG001|Overall Study|COVID-19|1|||
146847812|NCT03809429|529613936|FG000|Overall Study|Participant was discontinued by investigator|12|||
146847813|NCT03809429|529613937|FG001|Overall Study|Participant was discontinued by investigator|7|||
146847814|NCT03377699|529613943|FG000|Overall Study|Withdrawal by Subject|2|||
146847815|NCT03377699|529613944|FG001|Overall Study|Withdrawal by Subject|9|||
146847816|NCT03377699|529613943|FG000|Overall Study|Lost to Follow-up|1|||
146847817|NCT03377699|529613944|FG001|Overall Study|Lost to Follow-up|1|||
146847818|NCT03377699|529613943|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
146847819|NCT03377699|529613944|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
146847820|NCT03377699|529613943|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
146847821|NCT03377699|529613944|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
146847822|NCT03377699|529613943|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
146847823|NCT03377699|529613944|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
146847824|NCT03377699|529613943|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
146847825|NCT03377699|529613944|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
146847826|NCT00774930|529613947|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
146847827|NCT00774930|529613948|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
146847828|NCT00774930|529613947|FG000|DB Phase|Adverse Event|1|||
146847829|NCT00774930|529613948|FG001|DB Phase|Adverse Event|2|||
146847830|NCT00774930|529613947|FG000|DB Phase|Subject Decision|1|||
146847831|NCT00774930|529613948|FG001|DB Phase|Subject Decision|5|||
146847832|NCT00774930|529613947|FG000|DB Phase|Sponsor Decision|0|||
146847833|NCT00774930|529613948|FG001|DB Phase|Sponsor Decision|1|||
146847834|NCT00774930|529613947|FG000|DB Phase|Disease Progression|1|||
146847835|NCT00774930|529613948|FG001|DB Phase|Disease Progression|1|||
146847836|NCT00774930|529613947|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
146847837|NCT00774930|529613948|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
146847838|NCT00774930|529613947|FG000|IOL Phase|Adverse Event|1|||
146847839|NCT00774930|529613948|FG001|IOL Phase|Adverse Event|1|||
146847840|NCT00774930|529613947|FG000|IOL Phase|Subject Decision|4|||
146847841|NCT00774930|529613948|FG001|IOL Phase|Subject Decision|3|||
146847842|NCT00774930|529613947|FG000|IOL Phase|Physician Decision|3|||
146847843|NCT00774930|529613948|FG001|IOL Phase|Physician Decision|2|||
146847844|NCT00774930|529613947|FG000|IOL Phase|Sponsor Decision|1|||
146847845|NCT00774930|529613948|FG001|IOL Phase|Sponsor Decision|0|||
146847846|NCT00774930|529613947|FG000|IOL Phase|Disease Progression|2|||
146847847|NCT00774930|529613948|FG001|IOL Phase|Disease Progression|1|||
146847848|NCT00774930|529613947|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
146847849|NCT00774930|529613948|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
146847850|NCT00774930|529613947|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
146847851|NCT00774930|529613948|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
147009288|NCT02219009|530195203|FG000|Overall Study|Adverse Event|2|||
147009289|NCT02219009|530195204|FG001|Overall Study|Adverse Event|4|||
147009290|NCT02219009|530195203|FG000|Overall Study|Lost to Follow-up|2|||
147009291|NCT02219009|530195204|FG001|Overall Study|Lost to Follow-up|2|||
147009292|NCT02219009|530195203|FG000|Overall Study|Protocol deviation|1|||
147009293|NCT02219009|530195204|FG001|Overall Study|Protocol deviation|0|||
147009294|NCT02219009|530195203|FG000|Overall Study|Physician Decision|0|||
147009295|NCT02219009|530195204|FG001|Overall Study|Physician Decision|1|||
147009296|NCT00660387|530195205|FG000|Overall Study|Adverse Event|1|||
147009297|NCT00660387|530195206|FG001|Overall Study|Adverse Event|2|||
146847852|NCT00774930|529613947|FG000|IOL Phase|Other|1|||
146847853|NCT00774930|529613948|FG001|IOL Phase|Other|0|||
146847854|NCT00774930|529613947|FG000|IOL Phase|Brain radiation|0|||
146847855|NCT00774930|529613948|FG001|IOL Phase|Brain radiation|1|||
146847856|NCT00774930|529613947|FG000|LTOLE Phase|Adverse Event|7|||
146847857|NCT00774930|529613948|FG001|LTOLE Phase|Adverse Event|3|||
146847858|NCT00774930|529613947|FG000|LTOLE Phase|Subject decision|0|||
146847859|NCT00774930|529613948|FG001|LTOLE Phase|Subject decision|5|||
146847860|NCT00774930|529613947|FG000|LTOLE Phase|Physician Decision|4|||
147009298|NCT00660387|530195205|FG000|Overall Study|Lack of Efficacy|0|||
147009299|NCT00660387|530195206|FG001|Overall Study|Lack of Efficacy|1|||
147009300|NCT00660387|530195205|FG000|Overall Study|Protocol Violation|1|||
147009301|NCT00660387|530195206|FG001|Overall Study|Protocol Violation|0|||
147009302|NCT02966340|530195207|FG000|Overall Study|Adverse Event|0|||
147009303|NCT02966340|530195208|FG001|Overall Study|Adverse Event|1|||
146847861|NCT00774930|529613948|FG001|LTOLE Phase|Physician Decision|1|||
146847862|NCT00774930|529613947|FG000|LTOLE Phase|Sponsor decision|2|||
146847863|NCT00774930|529613948|FG001|LTOLE Phase|Sponsor decision|1|||
146847864|NCT00774930|529613947|FG000|LTOLE Phase|Disease Progression|2|||
146847865|NCT00774930|529613948|FG001|LTOLE Phase|Disease Progression|5|||
146847866|NCT00774930|529613947|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
146847867|NCT00774930|529613948|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
146847868|NCT00774930|529613947|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
147009304|NCT02966340|530195207|FG000|Overall Study|Lost to Follow-up|0|||
147009305|NCT02966340|530195208|FG001|Overall Study|Lost to Follow-up|1|||
147009306|NCT02966340|530195207|FG000|Overall Study|Withdrawal by Subject|1|||
147009307|NCT02966340|530195208|FG001|Overall Study|Withdrawal by Subject|0|||
147009308|NCT02966340|530195207|FG000|Overall Study|data acquisition error|1|||
147009309|NCT02966340|530195208|FG001|Overall Study|data acquisition error|0|||
146847869|NCT00774930|529613948|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
146847870|NCT01153321|529613949|FG000|Overall Study|Development of study withdrawal criteria|0|||
146847871|NCT01153321|529613950|FG001|Overall Study|Development of study withdrawal criteria|1|||
146847872|NCT01153321|529613949|FG000|Overall Study|Withdrawal by Subject|0|||
146847873|NCT01153321|529613950|FG001|Overall Study|Withdrawal by Subject|1|||
146847874|NCT01153321|529613949|FG000|Overall Study|Adverse Event|1|||
146847875|NCT01153321|529613950|FG001|Overall Study|Adverse Event|1|||
146847876|NCT01177800|529613951|FG000|Overall Study|Adverse Event|9|||
146847877|NCT01177800|529613952|FG001|Overall Study|Adverse Event|3|||
146847878|NCT01177800|529613951|FG000|Overall Study|Protocol Violation|0|||
146847879|NCT01177800|529613952|FG001|Overall Study|Protocol Violation|1|||
146847880|NCT01177800|529613951|FG000|Overall Study|Physician Decision|1|||
146847881|NCT01177800|529613952|FG001|Overall Study|Physician Decision|0|||
146847882|NCT01177800|529613951|FG000|Overall Study|Withdrawal of informed consent|0|||
146847883|NCT01177800|529613952|FG001|Overall Study|Withdrawal of informed consent|1|||
146847884|NCT00424385|529613953|FG000|Cohort 0|Withdrawal by Subject|5|||
146847885|NCT00424385|529613953|FG000|Cohort 0|Physician Decision|1|||
147009310|NCT02966340|530195207|FG000|Overall Study|startle non-responder|1|||
147009311|NCT02966340|530195208|FG001|Overall Study|startle non-responder|1|||
147009312|NCT02259348|530195209|FG000|Overall Study|Donors|6|||
147009313|NCT02259348|530195209|FG000|Overall Study|Death|4|||
147009314|NCT01622660|530195210|FG000|Overall Study|Adverse Event|1|||
147009315|NCT04211766|530195211|FG000|Overall Study|Withdrawal by Subject|5|||
147009316|NCT04211766|530195212|FG001|Overall Study|Withdrawal by Subject|1|||
147009317|NCT00202839|530195213|FG000|Overall Study|Adverse Event|1|||
147009318|NCT00202839|530195214|FG001|Overall Study|Adverse Event|5|||
147009319|NCT00202839|530195213|FG000|Overall Study|Physician Decision|12|||
147009320|NCT00202839|530195214|FG001|Overall Study|Physician Decision|0|||
146847886|NCT00424385|529613953|FG000|Cohort 1|Withdrawal by Subject|1|||
146847887|NCT05560243|529613954|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
146847888|NCT05870228|529613955|FG000|Overall Study|Lost to Follow-up|2|||
147009321|NCT00202839|530195213|FG000|Overall Study|Withdrawal by Subject|6|||
147009322|NCT00202839|530195214|FG001|Overall Study|Withdrawal by Subject|2|||
147009323|NCT00202839|530195213|FG000|Overall Study|Protocol Violation|2|||
147009324|NCT00202839|530195214|FG001|Overall Study|Protocol Violation|1|||
147009325|NCT00202839|530195213|FG000|Overall Study|Lost to Follow-up|3|||
147009326|NCT00202839|530195214|FG001|Overall Study|Lost to Follow-up|2|||
146847889|NCT05870228|529613956|FG001|Overall Study|Lost to Follow-up|0|||
146847890|NCT05870228|529613955|FG000|Overall Study|Withdrawal by Subject|1|||
146847891|NCT05870228|529613956|FG001|Overall Study|Withdrawal by Subject|0|||
146847892|NCT03231800|529613961|FG000|Overall Study|Lost to Follow-up|0|||
146847893|NCT03231800|529613962|FG001|Overall Study|Lost to Follow-up|2|||
146847894|NCT03231800|529613961|FG000|Overall Study|Protocol Violation|1|||
147009327|NCT00642993|530195215|FG000|Overall Study|Adverse Event|85|||
147009328|NCT00642993|530195216|FG001|Overall Study|Adverse Event|4|||
147009329|NCT00642993|530195215|FG000|Overall Study|Lost to Follow-up|8|||
147009330|NCT00642993|530195216|FG001|Overall Study|Lost to Follow-up|4|||
146847895|NCT03231800|529613962|FG001|Overall Study|Protocol Violation|1|||
146847896|NCT03231800|529613961|FG000|Overall Study|reason not provided|2|||
146847897|NCT03231800|529613962|FG001|Overall Study|reason not provided|0|||
146847898|NCT00941070|529613963|FG000|Overall Study|Patient non-compliant|1|||
146847899|NCT01941719|529613971|FG000|Overall Study|Lost to Follow-up|20|||
146847900|NCT01941719|529613972|FG001|Overall Study|Lost to Follow-up|19|||
146847901|NCT00252577|529613973|FG000|Overall Study|Lost to Follow-up|20|||
146847902|NCT02797080|529613976|FG000|Overall Study|Lost to Follow-up|1|||
146847903|NCT02797080|529613976|FG000|Overall Study|Withdrawal by Subject|1|||
146847904|NCT04035499|529613979|FG000|Overall Study|Death|2|||
146847905|NCT04035499|529613979|FG000|Overall Study|Withdrawal by Subject|1|||
146847906|NCT00951015|529613980|FG000|Randomization Phase 96 Week|Adverse Event|1|||
146847907|NCT00951015|529613981|FG001|Randomization Phase 96 Week|Adverse Event|1|||
146847908|NCT00951015|529613982|FG002|Randomization Phase 96 Week|Adverse Event|2|||
146847909|NCT00951015|529613983|FG003|Randomization Phase 96 Week|Adverse Event|5|||
146847910|NCT00951015|529613984|FG004|Randomization Phase 96 Week|Adverse Event|0|||
146847911|NCT00951015|529613980|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
146847912|NCT00951015|529613981|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
146847913|NCT00951015|529613982|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
146847914|NCT00951015|529613983|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
146847915|NCT00951015|529613984|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
146847916|NCT00951015|529613980|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
146847917|NCT00951015|529613981|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
146847918|NCT00951015|529613982|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
146847919|NCT00951015|529613983|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
146847920|NCT00951015|529613984|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
146847921|NCT00951015|529613980|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
146847922|NCT00951015|529613981|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
146847923|NCT00951015|529613982|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
146847924|NCT00951015|529613983|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
146847925|NCT00951015|529613984|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
146847926|NCT00951015|529613980|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
146847927|NCT00951015|529613981|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
146847928|NCT00951015|529613982|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
146847929|NCT00951015|529613983|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
146847930|NCT00951015|529613984|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
146847931|NCT00951015|529613980|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
146847932|NCT00951015|529613981|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
146847933|NCT00951015|529613982|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
146847934|NCT00951015|529613983|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
146847935|NCT00951015|529613984|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
147009331|NCT00642993|530195215|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
147009332|NCT00642993|530195216|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
147009333|NCT00642993|530195215|FG000|Overall Study|Protocol Violation|1|||
147009334|NCT00642993|530195216|FG001|Overall Study|Protocol Violation|4|||
147009335|NCT00642993|530195215|FG000|Overall Study|Did not meet protocol eligibility|0|||
147009336|NCT00642993|530195216|FG001|Overall Study|Did not meet protocol eligibility|1|||
147009337|NCT00642993|530195215|FG000|Overall Study|Administrative|1|||
147009338|NCT00642993|530195216|FG001|Overall Study|Administrative|0|||
147009339|NCT02583048|530195217|FG000|Overall Study|Withdrawal by Subject|0|||
147009340|NCT02583048|530195218|FG001|Overall Study|Withdrawal by Subject|1|||
147009341|NCT02583048|530195219|FG002|Overall Study|Withdrawal by Subject|0|||
147009342|NCT02583048|530195217|FG000|Overall Study|Failed to meet eligibility criterion|0|||
147009343|NCT02583048|530195218|FG001|Overall Study|Failed to meet eligibility criterion|0|||
147009344|NCT02583048|530195219|FG002|Overall Study|Failed to meet eligibility criterion|1|||
147009345|NCT00960154|530195220|FG000|Overall Study|Study termination|25|||
147009346|NCT00960154|530195221|FG001|Overall Study|Study termination|25|||
147009347|NCT03119662|530195222|FG000|Overall Study|Withdrawal by Subject|0|||
147009348|NCT03119662|530195223|FG001|Overall Study|Withdrawal by Subject|1|||
147009349|NCT00757705|530195224|FG000|Overall Study|Adverse Event|19|||
147009350|NCT00757705|530195224|FG000|Overall Study|Lost to Follow-up|16|||
147009351|NCT00757705|530195224|FG000|Overall Study|Withdrawal by Subject|25|||
147009352|NCT00757705|530195224|FG000|Overall Study|Insufficient Response|26|||
146847936|NCT00951015|529613980|FG000|Open-label Phase|Adverse Event|0|||
146847937|NCT00951015|529613981|FG001|Open-label Phase|Adverse Event|0|||
146847938|NCT00951015|529613982|FG002|Open-label Phase|Adverse Event|0|||
146847939|NCT00951015|529613983|FG003|Open-label Phase|Adverse Event|0|||
147009353|NCT00757705|530195224|FG000|Overall Study|Ineligible to continue|8|||
147009354|NCT00757705|530195224|FG000|Overall Study|Non-compliant|9|||
147009355|NCT00757705|530195224|FG000|Overall Study|Other|18|||
146847940|NCT00951015|529613984|FG004|Open-label Phase|Adverse Event|3|||
146847941|NCT00951015|529613980|FG000|Open-label Phase|Lack of Efficacy|0|||
146847942|NCT00951015|529613981|FG001|Open-label Phase|Lack of Efficacy|0|||
146847943|NCT00951015|529613982|FG002|Open-label Phase|Lack of Efficacy|0|||
146847944|NCT00951015|529613983|FG003|Open-label Phase|Lack of Efficacy|0|||
147009356|NCT02817828|530195225|FG000|Overall Study|Lost to Follow-up|41|||
147009357|NCT02817828|530195225|FG000|Overall Study|Adverse event not related to bleeding|104|||
146847945|NCT00951015|529613984|FG004|Open-label Phase|Lack of Efficacy|1|||
146847946|NCT00951015|529613980|FG000|Open-label Phase|Protocol Violation|0|||
146847947|NCT00951015|529613981|FG001|Open-label Phase|Protocol Violation|0|||
146847948|NCT00951015|529613982|FG002|Open-label Phase|Protocol Violation|0|||
146847949|NCT00951015|529613983|FG003|Open-label Phase|Protocol Violation|0|||
146847950|NCT00951015|529613984|FG004|Open-label Phase|Protocol Violation|12|||
146847951|NCT00951015|529613980|FG000|Open-label Phase|Lost to Follow-up|0|||
146847952|NCT00951015|529613981|FG001|Open-label Phase|Lost to Follow-up|0|||
146847953|NCT00951015|529613982|FG002|Open-label Phase|Lost to Follow-up|0|||
146847954|NCT00951015|529613983|FG003|Open-label Phase|Lost to Follow-up|0|||
146847955|NCT00951015|529613984|FG004|Open-label Phase|Lost to Follow-up|12|||
146847956|NCT00951015|529613980|FG000|Open-label Phase|Withdrawal by Subject|0|||
146847957|NCT00951015|529613981|FG001|Open-label Phase|Withdrawal by Subject|0|||
146847958|NCT00951015|529613982|FG002|Open-label Phase|Withdrawal by Subject|0|||
146847959|NCT00951015|529613983|FG003|Open-label Phase|Withdrawal by Subject|0|||
146847960|NCT00951015|529613984|FG004|Open-label Phase|Withdrawal by Subject|14|||
146847961|NCT00951015|529613980|FG000|Open-label Phase|Physician Decision|0|||
146847962|NCT00951015|529613981|FG001|Open-label Phase|Physician Decision|0|||
146847963|NCT00951015|529613982|FG002|Open-label Phase|Physician Decision|0|||
146847964|NCT00951015|529613983|FG003|Open-label Phase|Physician Decision|0|||
146847965|NCT00951015|529613984|FG004|Open-label Phase|Physician Decision|8|||
146847966|NCT03819634|529613986|FG000|Overall Study|Physician Decision|2|||
146847967|NCT00299494|529613987|FG000|Overall Study|Withdrawal by Subject|0|||
146847968|NCT00299494|529613988|FG001|Overall Study|Withdrawal by Subject|0|||
146847969|NCT00299494|529613989|FG002|Overall Study|Withdrawal by Subject|0|||
146847970|NCT00299494|529613990|FG003|Overall Study|Withdrawal by Subject|3|||
146847971|NCT00299494|529613991|FG004|Overall Study|Withdrawal by Subject|1|||
146847972|NCT00299494|529613992|FG005|Overall Study|Withdrawal by Subject|4|||
146847973|NCT00299494|529613987|FG000|Overall Study|Physician Decision|0|||
146847974|NCT00299494|529613988|FG001|Overall Study|Physician Decision|0|||
146847975|NCT00299494|529613989|FG002|Overall Study|Physician Decision|0|||
146847976|NCT00299494|529613990|FG003|Overall Study|Physician Decision|0|||
146847977|NCT00299494|529613991|FG004|Overall Study|Physician Decision|1|||
146847978|NCT00299494|529613992|FG005|Overall Study|Physician Decision|0|||
146847979|NCT00299494|529613987|FG000|Overall Study|Death|3|||
146847980|NCT00299494|529613988|FG001|Overall Study|Death|1|||
146847981|NCT00299494|529613989|FG002|Overall Study|Death|4|||
146847982|NCT00299494|529613990|FG003|Overall Study|Death|6|||
146847983|NCT00299494|529613991|FG004|Overall Study|Death|18|||
146847984|NCT00299494|529613992|FG005|Overall Study|Death|19|||
146847985|NCT00299494|529613987|FG000|Overall Study|Lost to Follow-up|0|||
146847986|NCT00299494|529613988|FG001|Overall Study|Lost to Follow-up|0|||
146847987|NCT00299494|529613989|FG002|Overall Study|Lost to Follow-up|0|||
146847988|NCT00299494|529613990|FG003|Overall Study|Lost to Follow-up|0|||
146847989|NCT00299494|529613991|FG004|Overall Study|Lost to Follow-up|3|||
146847990|NCT00299494|529613992|FG005|Overall Study|Lost to Follow-up|1|||
146847991|NCT00299494|529613987|FG000|Overall Study|Other - Unspecified|0|||
146847992|NCT00299494|529613988|FG001|Overall Study|Other - Unspecified|0|||
146847993|NCT00299494|529613989|FG002|Overall Study|Other - Unspecified|0|||
146847994|NCT00299494|529613990|FG003|Overall Study|Other - Unspecified|0|||
146847995|NCT00299494|529613991|FG004|Overall Study|Other - Unspecified|3|||
146847996|NCT00299494|529613992|FG005|Overall Study|Other - Unspecified|1|||
146847997|NCT00299494|529613987|FG000|Overall Study|Other - site closure|0|||
146847998|NCT00299494|529613988|FG001|Overall Study|Other - site closure|0|||
146847999|NCT00299494|529613989|FG002|Overall Study|Other - site closure|0|||
146848000|NCT00299494|529613990|FG003|Overall Study|Other - site closure|1|||
146848001|NCT00299494|529613991|FG004|Overall Study|Other - site closure|1|||
146848002|NCT00299494|529613992|FG005|Overall Study|Other - site closure|1|||
146848003|NCT01417104|529613996|FG000|Overall Study|Withdrawal by Subject|5|||
146848004|NCT01417104|529613997|FG001|Overall Study|Withdrawal by Subject|1|||
146848005|NCT01417104|529613996|FG000|Overall Study|Failure to make contact|0|||
146848006|NCT01417104|529613997|FG001|Overall Study|Failure to make contact|1|||
146848007|NCT01417104|529613996|FG000|Overall Study|Adverse Event|1|||
146848008|NCT01417104|529613997|FG001|Overall Study|Adverse Event|0|||
146848009|NCT01416389|529613998|FG000|Overall Study|Lost to Follow-up|1|||
146848010|NCT01416389|529613999|FG001|Overall Study|Lost to Follow-up|0|||
146848011|NCT01416389|529613998|FG000|Overall Study|Started New Therapy|2|||
146848012|NCT01416389|529613999|FG001|Overall Study|Started New Therapy|0|||
146848013|NCT01125514|529614000|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
146848014|NCT01125514|529614000|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
146848015|NCT01125514|529614000|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
146848016|NCT01125514|529614000|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
146848017|NCT01125514|529614000|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
146848018|NCT01125514|529614000|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
146848019|NCT00858364|529614001|FG000|Overall Study|Administrative Decision|3|||
146848020|NCT00858364|529614002|FG001|Overall Study|Administrative Decision|2|||
146848021|NCT00858364|529614001|FG000|Overall Study|Adverse Event|5|||
146848022|NCT00858364|529614002|FG001|Overall Study|Adverse Event|2|||
146848023|NCT00858364|529614001|FG000|Overall Study|Withdrawal by Subject|44|||
146848024|NCT00858364|529614002|FG001|Overall Study|Withdrawal by Subject|118|||
146848025|NCT00858364|529614001|FG000|Overall Study|Ineligibility Determined|1|||
146848026|NCT00858364|529614002|FG001|Overall Study|Ineligibility Determined|10|||
146848027|NCT00858364|529614001|FG000|Overall Study|Lost to Follow-up|24|||
146848028|NCT00858364|529614002|FG001|Overall Study|Lost to Follow-up|54|||
146848029|NCT00858364|529614001|FG000|Overall Study|Noncompliance|3|||
146848030|NCT00858364|529614002|FG001|Overall Study|Noncompliance|4|||
146848031|NCT00858364|529614001|FG000|Overall Study|Protocol Deviation|0|||
146848032|NCT00858364|529614002|FG001|Overall Study|Protocol Deviation|2|||
146848033|NCT00858364|529614001|FG000|Overall Study|Other|9|||
146848034|NCT00858364|529614002|FG001|Overall Study|Other|17|||
146848035|NCT00858364|529614001|FG000|Overall Study|Missing|1|||
146848036|NCT00858364|529614002|FG001|Overall Study|Missing|1|||
146848037|NCT00858364|529614001|FG000|Overall Study|Still on-study|114|||
146848038|NCT00858364|529614002|FG001|Overall Study|Still on-study|247|||
146848039|NCT03980808|529614003|FG000|Overall Study|Lost to Follow-up|2|||
146848040|NCT03980808|529614004|FG001|Overall Study|Lost to Follow-up|2|||
146848041|NCT01655693|529614005|FG000|Overall Study|Progression of Disease|92|||
147009358|NCT02817828|530195225|FG000|Overall Study|Adverse event related to bleeding|53|||
147009359|NCT02817828|530195225|FG000|Overall Study|Protocol Violation|11|||
147009360|NCT02817828|530195225|FG000|Overall Study|Pregnancy|7|||
147009361|NCT02817828|530195225|FG000|Overall Study|Pregnancy wish|15|||
147009362|NCT02817828|530195225|FG000|Overall Study|Withdrawal by Subject|78|||
147009363|NCT02817828|530195225|FG000|Overall Study|Other|26|||
147009364|NCT00659815|530195232|FG000|Overall Study|Study related symptoms and complaints|2|||
147009365|NCT00659815|530195233|FG001|Overall Study|Study related symptoms and complaints|1|||
147009366|NCT00659815|530195232|FG000|Overall Study|Inability to maintain wearing schedule|1|||
147009367|NCT00659815|530195233|FG001|Overall Study|Inability to maintain wearing schedule|2|||
147009368|NCT00659815|530195232|FG000|Overall Study|Withdrawal by Subject|1|||
147009369|NCT00659815|530195233|FG001|Overall Study|Withdrawal by Subject|1|||
147009370|NCT02651987|530195234|FG000|Overall Study|Adverse Event|2|||
147009371|NCT02651987|530195235|FG001|Overall Study|Adverse Event|2|||
147009372|NCT02651987|530195234|FG000|Overall Study|Consent Withdrawn|2|||
147009373|NCT02651987|530195235|FG001|Overall Study|Consent Withdrawn|0|||
147009374|NCT02651987|530195234|FG000|Overall Study|Local PD|0|||
147009375|NCT02651987|530195235|FG001|Overall Study|Local PD|2|||
147009376|NCT02651987|530195234|FG000|Overall Study|Investigator Decision|1|||
147009377|NCT02651987|530195235|FG001|Overall Study|Investigator Decision|1|||
147009378|NCT04408924|530195236|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
147009379|NCT04408924|530195236|FG000|Overall Study|Lost to Follow-up|3|||
147009380|NCT04408924|530195236|FG000|Overall Study|Withdrawal by Subject|5|||
147009381|NCT04408924|530195236|FG000|Overall Study|Sponsor Decision|2|||
147009382|NCT02998541|530195238|FG000|Overall Study|Adverse Event|4|||
147009383|NCT02998541|530195239|FG001|Overall Study|Adverse Event|5|||
147009384|NCT02998541|530195240|FG002|Overall Study|Adverse Event|1|||
147009385|NCT02998541|530195238|FG000|Overall Study|Protocol Violation|1|||
147009386|NCT02998541|530195239|FG001|Overall Study|Protocol Violation|0|||
147009387|NCT02998541|530195240|FG002|Overall Study|Protocol Violation|0|||
147009388|NCT02998541|530195238|FG000|Overall Study|Withdrawal by Subject|3|||
147009389|NCT02998541|530195239|FG001|Overall Study|Withdrawal by Subject|1|||
147009390|NCT02998541|530195240|FG002|Overall Study|Withdrawal by Subject|0|||
147009391|NCT02998541|530195238|FG000|Overall Study|Lost to Follow-up|0|||
147009392|NCT02998541|530195239|FG001|Overall Study|Lost to Follow-up|3|||
147009393|NCT02998541|530195240|FG002|Overall Study|Lost to Follow-up|1|||
147009394|NCT02998541|530195238|FG000|Overall Study|Physician Decision|0|||
147009395|NCT02998541|530195239|FG001|Overall Study|Physician Decision|0|||
147009396|NCT02998541|530195240|FG002|Overall Study|Physician Decision|3|||
147009397|NCT02998541|530195238|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147009398|NCT02998541|530195239|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147009399|NCT02998541|530195240|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
147009400|NCT01513239|530195246|FG000|Period 1: Main Phase|Adverse Event|1|||
147009401|NCT01513239|530195247|FG001|Period 1: Main Phase|Adverse Event|1|||
147009402|NCT01513239|530195248|FG002|Period 1: Main Phase|Adverse Event|2|||
147009403|NCT01513239|530195249|FG003|Period 1: Main Phase|Adverse Event|0|||
147009404|NCT01513239|530195250|FG004|Period 1: Main Phase|Adverse Event|0|||
147009405|NCT01513239|530195251|FG005|Period 1: Main Phase|Adverse Event|0|||
147009406|NCT01513239|530195246|FG000|Period 1: Main Phase|Death|29|||
147009407|NCT01513239|530195247|FG001|Period 1: Main Phase|Death|22|||
147009408|NCT01513239|530195248|FG002|Period 1: Main Phase|Death|32|||
147009409|NCT01513239|530195249|FG003|Period 1: Main Phase|Death|0|||
147009410|NCT01513239|530195250|FG004|Period 1: Main Phase|Death|0|||
147009411|NCT01513239|530195251|FG005|Period 1: Main Phase|Death|0|||
146848042|NCT01655693|529614006|FG001|Overall Study|Progression of Disease|76|||
146848043|NCT01655693|529614007|FG002|Overall Study|Progression of Disease|58|||
146848044|NCT01655693|529614005|FG000|Overall Study|Death|8|||
146848045|NCT01655693|529614006|FG001|Overall Study|Death|9|||
147009412|NCT01513239|530195246|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
147009413|NCT01513239|530195247|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
147009414|NCT01513239|530195248|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
147009415|NCT01513239|530195249|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
147009416|NCT01513239|530195250|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
147009417|NCT01513239|530195251|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
147009418|NCT01513239|530195246|FG000|Period 1: Main Phase|Physician Decision|4|||
147009419|NCT01513239|530195247|FG001|Period 1: Main Phase|Physician Decision|4|||
147009420|NCT01513239|530195248|FG002|Period 1: Main Phase|Physician Decision|4|||
147009421|NCT01513239|530195249|FG003|Period 1: Main Phase|Physician Decision|0|||
147009422|NCT01513239|530195250|FG004|Period 1: Main Phase|Physician Decision|0|||
147009423|NCT01513239|530195251|FG005|Period 1: Main Phase|Physician Decision|0|||
147009424|NCT01513239|530195246|FG000|Period 1: Main Phase|Protocol Violation|2|||
147009425|NCT01513239|530195247|FG001|Period 1: Main Phase|Protocol Violation|2|||
147009426|NCT01513239|530195248|FG002|Period 1: Main Phase|Protocol Violation|2|||
147009427|NCT01513239|530195249|FG003|Period 1: Main Phase|Protocol Violation|0|||
147009428|NCT01513239|530195250|FG004|Period 1: Main Phase|Protocol Violation|0|||
147009429|NCT01513239|530195251|FG005|Period 1: Main Phase|Protocol Violation|0|||
147009430|NCT01513239|530195246|FG000|Period 1: Main Phase|Technical Problems|1|||
147009431|NCT01513239|530195247|FG001|Period 1: Main Phase|Technical Problems|2|||
147009432|NCT01513239|530195248|FG002|Period 1: Main Phase|Technical Problems|0|||
147009433|NCT01513239|530195249|FG003|Period 1: Main Phase|Technical Problems|0|||
147009434|NCT01513239|530195250|FG004|Period 1: Main Phase|Technical Problems|0|||
147009435|NCT01513239|530195251|FG005|Period 1: Main Phase|Technical Problems|0|||
147009436|NCT01513239|530195246|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
147009437|NCT01513239|530195247|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
147009438|NCT01513239|530195248|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
147009439|NCT01513239|530195249|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
147009440|NCT01513239|530195250|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
147009441|NCT01513239|530195251|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
147009442|NCT01513239|530195246|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
147009443|NCT01513239|530195247|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
147009444|NCT01513239|530195248|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
147009445|NCT01513239|530195249|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
147009446|NCT01513239|530195250|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
147009447|NCT01513239|530195251|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
147009448|NCT01513239|530195246|FG000|Period 2: 9 Month Extension Phase|Death|0|||
147009449|NCT01513239|530195247|FG001|Period 2: 9 Month Extension Phase|Death|0|||
147009450|NCT01513239|530195248|FG002|Period 2: 9 Month Extension Phase|Death|0|||
147009451|NCT01513239|530195249|FG003|Period 2: 9 Month Extension Phase|Death|2|||
147009452|NCT01513239|530195250|FG004|Period 2: 9 Month Extension Phase|Death|5|||
147009453|NCT01513239|530195251|FG005|Period 2: 9 Month Extension Phase|Death|2|||
147009454|NCT01513239|530195246|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
147009455|NCT01513239|530195247|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
147009456|NCT01513239|530195248|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
147009457|NCT01513239|530195249|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
147009458|NCT01513239|530195250|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
147009459|NCT01513239|530195251|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
147009460|NCT01513239|530195246|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
147009461|NCT01513239|530195247|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
147009462|NCT01513239|530195248|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
147009463|NCT01513239|530195249|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
147009464|NCT01513239|530195250|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
147009465|NCT01513239|530195251|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
147009466|NCT01513239|530195246|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
147009467|NCT01513239|530195247|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
147009468|NCT01513239|530195248|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
147009469|NCT01513239|530195249|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
147009470|NCT01513239|530195250|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
147009471|NCT01513239|530195251|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
147009472|NCT00396162|530195252|FG000|Overall Study|Withdrawal by Subject|2|||
147009473|NCT00396162|530195253|FG001|Overall Study|Withdrawal by Subject|3|||
147009474|NCT01741545|530195254|FG000|Treatment Period|Lack of Efficacy|0|||
147009475|NCT01741545|530195255|FG001|Treatment Period|Lack of Efficacy|1|||
147009476|NCT01741545|530195254|FG000|Treatment Period|Adverse event, non-fatal|1|||
147009477|NCT01741545|530195255|FG001|Treatment Period|Adverse event, non-fatal|3|||
147009478|NCT01741545|530195254|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
147009479|NCT01741545|530195255|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
147009480|NCT01741545|530195254|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
147009481|NCT01741545|530195255|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
147009482|NCT01456962|530195256|FG000|Overall Study|Lost to Follow-up|2|||
147009483|NCT01456962|530195257|FG001|Overall Study|Lost to Follow-up|1|||
147009484|NCT03358147|530195260|FG000|Overall Study|Withdrawal by Subject|13|||
147009485|NCT03358147|530195261|FG001|Overall Study|Withdrawal by Subject|19|||
147009486|NCT03358147|530195262|FG002|Overall Study|Withdrawal by Subject|16|||
147009487|NCT03358147|530195263|FG003|Overall Study|Withdrawal by Subject|10|||
147009488|NCT03358147|530195264|FG004|Overall Study|Withdrawal by Subject|5|||
147009489|NCT03358147|530195260|FG000|Overall Study|Adverse Event|3|||
147009490|NCT03358147|530195261|FG001|Overall Study|Adverse Event|9|||
147009491|NCT03358147|530195262|FG002|Overall Study|Adverse Event|7|||
147009492|NCT03358147|530195263|FG003|Overall Study|Adverse Event|5|||
147009493|NCT03358147|530195264|FG004|Overall Study|Adverse Event|2|||
147009494|NCT03358147|530195260|FG000|Overall Study|Lost to Follow-up|4|||
147009495|NCT03358147|530195261|FG001|Overall Study|Lost to Follow-up|3|||
147009496|NCT03358147|530195262|FG002|Overall Study|Lost to Follow-up|7|||
147009497|NCT03358147|530195263|FG003|Overall Study|Lost to Follow-up|6|||
147009498|NCT03358147|530195264|FG004|Overall Study|Lost to Follow-up|4|||
147009499|NCT03358147|530195260|FG000|Overall Study|Major Protocol Deviation|11|||
147009500|NCT03358147|530195261|FG001|Overall Study|Major Protocol Deviation|3|||
147009501|NCT03358147|530195262|FG002|Overall Study|Major Protocol Deviation|2|||
147009502|NCT03358147|530195263|FG003|Overall Study|Major Protocol Deviation|3|||
147009503|NCT03358147|530195264|FG004|Overall Study|Major Protocol Deviation|1|||
147009504|NCT03358147|530195260|FG000|Overall Study|Protocol specified criteria|2|||
147009505|NCT03358147|530195261|FG001|Overall Study|Protocol specified criteria|3|||
147009506|NCT03358147|530195262|FG002|Overall Study|Protocol specified criteria|0|||
147009507|NCT03358147|530195263|FG003|Overall Study|Protocol specified criteria|3|||
147009508|NCT03358147|530195264|FG004|Overall Study|Protocol specified criteria|1|||
147009509|NCT03358147|530195260|FG000|Overall Study|Physician Decision|1|||
147009510|NCT03358147|530195261|FG001|Overall Study|Physician Decision|0|||
147009511|NCT03358147|530195262|FG002|Overall Study|Physician Decision|1|||
147009512|NCT03358147|530195263|FG003|Overall Study|Physician Decision|6|||
147009513|NCT03358147|530195264|FG004|Overall Study|Physician Decision|1|||
147009514|NCT03358147|530195260|FG000|Overall Study|Administrative reasons|0|||
147009515|NCT03358147|530195261|FG001|Overall Study|Administrative reasons|1|||
147009516|NCT03358147|530195262|FG002|Overall Study|Administrative reasons|0|||
147009517|NCT03358147|530195263|FG003|Overall Study|Administrative reasons|3|||
147009518|NCT03358147|530195264|FG004|Overall Study|Administrative reasons|0|||
147009519|NCT03358147|530195260|FG000|Overall Study|Lack of Efficacy|0|||
147009520|NCT03358147|530195261|FG001|Overall Study|Lack of Efficacy|1|||
147009521|NCT03358147|530195262|FG002|Overall Study|Lack of Efficacy|1|||
147009522|NCT03358147|530195263|FG003|Overall Study|Lack of Efficacy|0|||
147009523|NCT03358147|530195264|FG004|Overall Study|Lack of Efficacy|0|||
147009524|NCT02933060|530195265|FG000|Overall Study|Withdrawal by Subject|0|||
147009525|NCT02933060|530195266|FG001|Overall Study|Withdrawal by Subject|1|||
147009526|NCT01945580|530195269|FG000|Overall Study|Withdrawal by Subject|13|||
147009527|NCT01945580|530195270|FG001|Overall Study|Withdrawal by Subject|35|||
147009528|NCT01945580|530195269|FG000|Overall Study|Physician Decision|3|||
147009529|NCT01945580|530195270|FG001|Overall Study|Physician Decision|2|||
147009530|NCT01945580|530195269|FG000|Overall Study|Lost to Follow-up|26|||
147009531|NCT01945580|530195270|FG001|Overall Study|Lost to Follow-up|39|||
147009532|NCT01945580|530195269|FG000|Overall Study|Death|7|||
147009533|NCT01945580|530195270|FG001|Overall Study|Death|2|||
147009534|NCT01945580|530195269|FG000|Overall Study|Patient moved out of state|0|||
147009535|NCT01945580|530195270|FG001|Overall Study|Patient moved out of state|1|||
147009536|NCT01945580|530195269|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
147009537|NCT01945580|530195270|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
147009538|NCT01945580|530195269|FG000|Overall Study|Family illness - unable to return|0|||
147009539|NCT01945580|530195270|FG001|Overall Study|Family illness - unable to return|1|||
147009540|NCT01945580|530195269|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
147009541|NCT01945580|530195270|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
147009542|NCT01945580|530195269|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
147009543|NCT01945580|530195270|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
147009544|NCT01945580|530195269|FG000|Overall Study|Noncompliance with 36 month visit|1|||
147009545|NCT01945580|530195270|FG001|Overall Study|Noncompliance with 36 month visit|0|||
147009546|NCT01945580|530195269|FG000|Overall Study|The patient moved.|1|||
147009547|NCT01945580|530195270|FG001|Overall Study|The patient moved.|0|||
147009548|NCT01945580|530195269|FG000|Overall Study|No data available|0|||
147009549|NCT01945580|530195270|FG001|Overall Study|No data available|2|||
147009550|NCT05034874|530195271|FG000|Overall Study|Withdrawal by Subject|6|||
147009551|NCT05034874|530195272|FG001|Overall Study|Withdrawal by Subject|6|||
147009552|NCT05034874|530195271|FG000|Overall Study|Lost to Follow-up|18|||
147009553|NCT05034874|530195272|FG001|Overall Study|Lost to Follow-up|8|||
147009554|NCT05034874|530195271|FG000|Overall Study|Physician Decision|0|||
147009555|NCT05034874|530195272|FG001|Overall Study|Physician Decision|1|||
147009556|NCT05034874|530195271|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
147009557|NCT05034874|530195272|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
147009558|NCT00474058|530195273|FG000|Overall Study|Adverse Event|11|||
147009559|NCT00474058|530195274|FG001|Overall Study|Adverse Event|6|||
147009560|NCT00474058|530195273|FG000|Overall Study|Lack of Efficacy|0|||
147009561|NCT00474058|530195274|FG001|Overall Study|Lack of Efficacy|4|||
147009562|NCT00474058|530195273|FG000|Overall Study|Withdrawal by Subject|11|||
147009563|NCT00474058|530195274|FG001|Overall Study|Withdrawal by Subject|7|||
147009564|NCT00474058|530195273|FG000|Overall Study|Other|2|||
147009565|NCT00474058|530195274|FG001|Overall Study|Other|0|||
147009566|NCT02640235|530195275|FG000|Overall Study|Withdrawal by Subject|7|||
147009567|NCT02640235|530195276|FG001|Overall Study|Withdrawal by Subject|6|||
147009568|NCT02640235|530195275|FG000|Overall Study|Lost to Follow-up|4|||
147009569|NCT02640235|530195276|FG001|Overall Study|Lost to Follow-up|3|||
147009570|NCT02640235|530195275|FG000|Overall Study|Death|2|||
147009571|NCT02640235|530195276|FG001|Overall Study|Death|3|||
147009572|NCT02640235|530195275|FG000|Overall Study|Other|1|||
147009573|NCT02640235|530195276|FG001|Overall Study|Other|2|||
147009574|NCT00503867|530195279|FG000|Overall Study|Lost to Follow-up|1|||
147009575|NCT00503867|530195279|FG000|Overall Study|Adverse Event|1|||
147009576|NCT05616728|530195280|FG000|Overall Study|Lost to Follow-up|0|||
147009577|NCT05616728|530195281|FG001|Overall Study|Lost to Follow-up|0|||
147009578|NCT05616728|530195282|FG002|Overall Study|Lost to Follow-up|1|||
147009579|NCT05616728|530195280|FG000|Overall Study|Withdrawal by Subject|1|||
147009580|NCT05616728|530195281|FG001|Overall Study|Withdrawal by Subject|1|||
147009581|NCT05616728|530195282|FG002|Overall Study|Withdrawal by Subject|0|||
147009582|NCT05616728|530195280|FG000|Overall Study|Physician Decision|1|||
147009583|NCT05616728|530195281|FG001|Overall Study|Physician Decision|1|||
147009584|NCT05616728|530195282|FG002|Overall Study|Physician Decision|1|||
147009585|NCT05616728|530195280|FG000|Overall Study|Other|0|||
147009586|NCT05616728|530195281|FG001|Overall Study|Other|2|||
147009587|NCT05616728|530195282|FG002|Overall Study|Other|0|||
147009588|NCT00577655|530195283|FG000|Overall Study|Patient Request|0|||
147009589|NCT00577655|530195284|FG001|Overall Study|Patient Request|2|||
147009590|NCT00577655|530195283|FG000|Overall Study|Protocol Violation|0|||
147009591|NCT00577655|530195284|FG001|Overall Study|Protocol Violation|1|||
147009592|NCT00577655|530195283|FG000|Overall Study|Lost to Follow-up|1|||
147009593|NCT00577655|530195284|FG001|Overall Study|Lost to Follow-up|1|||
147009594|NCT00875524|530195286|FG000|Overall Study|Serious adverse event|0|||
147009595|NCT00875524|530195287|FG001|Overall Study|Serious adverse event|1|||
147009596|NCT00875524|530195286|FG000|Overall Study|Protocol Violation|4|||
147009597|NCT00875524|530195287|FG001|Overall Study|Protocol Violation|0|||
147009598|NCT00875524|530195286|FG000|Overall Study|Lost to Follow-up|1|||
147009599|NCT00875524|530195287|FG001|Overall Study|Lost to Follow-up|0|||
147009600|NCT00875524|530195286|FG000|Overall Study|Withdrawal by Subject|3|||
147009601|NCT00875524|530195287|FG001|Overall Study|Withdrawal by Subject|5|||
147009602|NCT01370863|530195288|FG000|Overall Study|Adverse Event|1|||
147009603|NCT01370863|530195289|FG001|Overall Study|Adverse Event|1|||
147009604|NCT01370863|530195288|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
147009605|NCT01370863|530195289|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
147009606|NCT01370863|530195288|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
147009607|NCT01370863|530195289|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
147009608|NCT02096705|530195295|FG000|Treatment|Adverse Event|6|||
147009609|NCT02096705|530195296|FG001|Treatment|Adverse Event|3|||
147009610|NCT02096705|530195295|FG000|Treatment|Subject request to discontinue treatment|1|||
147009611|NCT02096705|530195296|FG001|Treatment|Subject request to discontinue treatment|1|||
147009612|NCT02096705|530195295|FG000|Treatment|Withdrawal by Subject|1|||
147009613|NCT02096705|530195296|FG001|Treatment|Withdrawal by Subject|0|||
147009614|NCT02096705|530195295|FG000|Treatment|Other|1|||
147009615|NCT02096705|530195296|FG001|Treatment|Other|1|||
147009616|NCT02096705|530195295|FG000|Follow-up|Withdrawal by Subject|1|||
147009617|NCT02096705|530195296|FG001|Follow-up|Withdrawal by Subject|0|||
147009618|NCT02096705|530195295|FG000|Follow-up|Adverse Event|2|||
147009619|NCT02096705|530195296|FG001|Follow-up|Adverse Event|2|||
147009620|NCT02096705|530195295|FG000|Follow-up|Subjects not reporting status|1|||
147009621|NCT02096705|530195296|FG001|Follow-up|Subjects not reporting status|2|||
147009622|NCT02377349|530195297|FG000|Overall Study|Serious Adverse Event|1|||
147009623|NCT02377349|530195298|FG001|Overall Study|Serious Adverse Event|0|||
147009624|NCT02377349|530195297|FG000|Overall Study|Protocol Violation|3|||
147009625|NCT02377349|530195298|FG001|Overall Study|Protocol Violation|2|||
147009626|NCT02377349|530195297|FG000|Overall Study|Withdrawal by Subject|5|||
147009627|NCT02377349|530195298|FG001|Overall Study|Withdrawal by Subject|3|||
147009628|NCT02377349|530195297|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
147009629|NCT02377349|530195298|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
147009630|NCT02377349|530195297|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
147009631|NCT02377349|530195298|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
147009632|NCT02377349|530195297|FG000|Overall Study|Other|0|||
146848046|NCT01655693|529614007|FG002|Overall Study|Death|12|||
147009633|NCT02377349|530195298|FG001|Overall Study|Other|1|||
147009634|NCT03277248|530195301|FG000|Overall Study|Adverse Event|3|||
147009635|NCT03277248|530195302|FG001|Overall Study|Adverse Event|1|||
147009636|NCT03277248|530195301|FG000|Overall Study|Subject Withdrawal of Consent|6|||
147009637|NCT03277248|530195302|FG001|Overall Study|Subject Withdrawal of Consent|23|||
147009638|NCT03277248|530195301|FG000|Overall Study|Investigator/Sponsor Decision|2|||
147009639|NCT03277248|530195302|FG001|Overall Study|Investigator/Sponsor Decision|2|||
147009640|NCT03277248|530195301|FG000|Overall Study|Pregnancy|4|||
147009641|NCT03277248|530195302|FG001|Overall Study|Pregnancy|1|||
147009642|NCT03277248|530195301|FG000|Overall Study|Lost to Follow-up|0|||
147009643|NCT03277248|530195302|FG001|Overall Study|Lost to Follow-up|2|||
147009644|NCT03277248|530195301|FG000|Overall Study|Lack of Efficacy|0|||
147009645|NCT03277248|530195302|FG001|Overall Study|Lack of Efficacy|2|||
147009646|NCT03277248|530195301|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
147009647|NCT03277248|530195302|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
147009648|NCT01971645|530195309|FG000|Overall Study|Adverse Event|1|||
147009649|NCT01971645|530195310|FG001|Overall Study|Adverse Event|0|||
147009650|NCT01971645|530195311|FG002|Overall Study|Adverse Event|0|||
147009651|NCT01971645|530195309|FG000|Overall Study|Lost to Follow-up|1|||
147009652|NCT01971645|530195310|FG001|Overall Study|Lost to Follow-up|0|||
147009653|NCT01971645|530195311|FG002|Overall Study|Lost to Follow-up|1|||
147009654|NCT01971645|530195309|FG000|Overall Study|Protocol Violation|0|||
147009655|NCT01971645|530195310|FG001|Overall Study|Protocol Violation|0|||
147009656|NCT01971645|530195311|FG002|Overall Study|Protocol Violation|1|||
147009657|NCT02119936|530195312|FG000|Overall Study|Lost to Follow-up|10|||
147009658|NCT01566435|530195315|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
147009659|NCT04236596|530195316|FG000|Overall Study|Withdrawal by Subject|1|||
147009660|NCT04236596|530195316|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
147009661|NCT04236596|530195316|FG000|Overall Study|Participants did not receive implant at all|4|||
147009662|NCT02957331|530195317|FG000|Overall Study|Protocol Violation|1|||
147009663|NCT02957331|530195318|FG001|Overall Study|Protocol Violation|0|||
147009664|NCT02588339|530195319|FG000|Overall Study|Withdrawal by Subject|1|||
147009665|NCT02588339|530195319|FG000|Overall Study|GVHD Progression prior to treatment|2|||
147009666|NCT01120899|530196801|FG000|Overall Study|Withdrawal by Subject|3|||
147009667|NCT02664415|530196802|FG000|Overall Study|Adverse Event|1|||
147009668|NCT02664415|530196803|FG001|Overall Study|Adverse Event|0|||
147009669|NCT01151280|530196804|FG000|Overall Study|Adverse Event|1|||
147009670|NCT01151280|530196804|FG000|Overall Study|Lack of Efficacy|3|||
147009671|NCT00660660|530196805|FG000|Overall Study|Adverse Event|1|||
147009672|NCT00660660|530196806|FG001|Overall Study|Adverse Event|0|||
147009673|NCT00660660|530196805|FG000|Overall Study|Lost to Follow-up|0|||
147009674|NCT00660660|530196806|FG001|Overall Study|Lost to Follow-up|6|||
147009675|NCT00660660|530196805|FG000|Overall Study|Lack of Efficacy|0|||
147009676|NCT00660660|530196806|FG001|Overall Study|Lack of Efficacy|2|||
147009677|NCT00660660|530196805|FG000|Overall Study|Withdrawal by Subject|3|||
147009678|NCT00660660|530196806|FG001|Overall Study|Withdrawal by Subject|0|||
147009679|NCT00660660|530196805|FG000|Overall Study|Incorrect enrollment and other|0|||
147009680|NCT00660660|530196806|FG001|Overall Study|Incorrect enrollment and other|1|||
147009681|NCT00660660|530196805|FG000|Overall Study|New medication after randomization|1|||
147009682|NCT00660660|530196806|FG001|Overall Study|New medication after randomization|0|||
147009683|NCT02308241|530196807|FG000|Overall Study|Withdrawal by Subject|3|||
147009684|NCT00486434|530196808|FG000|Overall Study|Withdrawal by Subject|34|||
147009685|NCT00486434|530196809|FG001|Overall Study|Withdrawal by Subject|39|||
147009686|NCT00486434|530196808|FG000|Overall Study|Adverse Event|118|||
147009687|NCT00486434|530196809|FG001|Overall Study|Adverse Event|44|||
147009688|NCT00486434|530196808|FG000|Overall Study|Protocol Violation|22|||
147009689|NCT00486434|530196809|FG001|Overall Study|Protocol Violation|21|||
147009690|NCT00486434|530196808|FG000|Overall Study|Lack of Efficacy|12|||
147009691|NCT00486434|530196809|FG001|Overall Study|Lack of Efficacy|19|||
147009692|NCT00486434|530196808|FG000|Overall Study|Lost to Follow-up|2|||
147009693|NCT00486434|530196809|FG001|Overall Study|Lost to Follow-up|3|||
147009694|NCT00486434|530196808|FG000|Overall Study|Death|1|||
147009695|NCT00486434|530196809|FG001|Overall Study|Death|2|||
147009696|NCT00486434|530196808|FG000|Overall Study|Personal reasons|5|||
147009697|NCT00486434|530196809|FG001|Overall Study|Personal reasons|6|||
147009698|NCT02218541|530196810|FG000|Overall Study|Lost to Follow-up|2|||
147009699|NCT02218541|530196811|FG001|Overall Study|Lost to Follow-up|1|||
147009700|NCT02218541|530196810|FG000|Overall Study|Implant Failure|4|||
147009701|NCT02218541|530196811|FG001|Overall Study|Implant Failure|1|||
147009702|NCT00856349|530196812|FG000|Overall Study|Death|418|||
147009703|NCT00856349|530196812|FG000|Overall Study|Withdrawal by Subject|116|||
147009704|NCT00856349|530196812|FG000|Overall Study|Lost to Follow-up|91|||
147009705|NCT00856349|530196812|FG000|Overall Study|Protocol Violation|38|||
147009706|NCT00856349|530196812|FG000|Overall Study|Physician Decision|13|||
147009707|NCT00856349|530196812|FG000|Overall Study|Subject relocation|104|||
147009708|NCT00856349|530196812|FG000|Overall Study|Device explant|33|||
147009709|NCT00856349|530196812|FG000|Overall Study|Site closure|78|||
147009710|NCT00856349|530196812|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
147009711|NCT02725515|530196813|FG000|Overall Study|Refused infusion (no study treatment)|1|||
147009712|NCT02725515|530196814|FG001|Overall Study|Refused infusion (no study treatment)|0|||
147009713|NCT02725515|530196813|FG000|Overall Study|Loss of Improvement per Protocol|14|||
147009714|NCT02725515|530196814|FG001|Overall Study|Loss of Improvement per Protocol|25|||
147009715|NCT02725515|530196813|FG000|Overall Study|Withdrawal by Subject|2|||
147009716|NCT02725515|530196814|FG001|Overall Study|Withdrawal by Subject|1|||
147009717|NCT02725515|530196813|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147009718|NCT02725515|530196814|FG001|Overall Study|Non-Compliance With Study Drug|3|||
147009719|NCT02725515|530196813|FG000|Overall Study|Lost to Follow-up|1|||
147009720|NCT02725515|530196814|FG001|Overall Study|Lost to Follow-up|1|||
147009721|NCT02725515|530196813|FG000|Overall Study|Adverse Event|7|||
147009722|NCT02725515|530196814|FG001|Overall Study|Adverse Event|2|||
147009723|NCT02725515|530196813|FG000|Overall Study|No Documented Disease Improvement|0|||
147009724|NCT02725515|530196814|FG001|Overall Study|No Documented Disease Improvement|1|||
147009725|NCT02725515|530196813|FG000|Overall Study|Completed Study Under Original Protocol|0|||
147009726|NCT02725515|530196814|FG001|Overall Study|Completed Study Under Original Protocol|1|||
147009727|NCT02725515|530196813|FG000|Overall Study|Lack of Response|0|||
147009728|NCT02725515|530196814|FG001|Overall Study|Lack of Response|1|||
147009729|NCT00183196|530196824|FG000|Overall Study|Withdrawal by Subject|18|||
147009730|NCT00183196|530196825|FG001|Overall Study|Withdrawal by Subject|11|||
147009731|NCT00183196|530196826|FG002|Overall Study|Withdrawal by Subject|13|||
147009732|NCT00183196|530196824|FG000|Overall Study|Adverse Event|1|||
147009733|NCT00183196|530196825|FG001|Overall Study|Adverse Event|2|||
147009734|NCT00183196|530196826|FG002|Overall Study|Adverse Event|2|||
147009735|NCT00183196|530196824|FG000|Overall Study|Legal event|1|||
147009736|NCT00183196|530196825|FG001|Overall Study|Legal event|1|||
147009737|NCT00183196|530196826|FG002|Overall Study|Legal event|1|||
147009738|NCT00183196|530196824|FG000|Overall Study|Required more intensive care|0|||
147009739|NCT00183196|530196825|FG001|Overall Study|Required more intensive care|1|||
147009740|NCT00183196|530196826|FG002|Overall Study|Required more intensive care|2|||
147009741|NCT03387462|530196827|FG000|Overall Study|Lost to Follow-up|1|||
147009742|NCT01460628|530196828|FG000|Overall Study|Adverse Event|3|||
147009743|NCT01460628|530196828|FG000|Overall Study|Withdrawal by Subject|2|||
147009744|NCT01664039|530196832|FG000|Overall Study|Adverse Event|3|||
147009745|NCT01664039|530196833|FG001|Overall Study|Adverse Event|4|||
147009746|NCT01664039|530196832|FG000|Overall Study|Lost to Follow-up|1|||
147009747|NCT01664039|530196833|FG001|Overall Study|Lost to Follow-up|1|||
147009748|NCT01664039|530196832|FG000|Overall Study|Withdrawal by Subject|1|||
147009749|NCT01664039|530196833|FG001|Overall Study|Withdrawal by Subject|3|||
147009750|NCT01664039|530196832|FG000|Overall Study|Noncompliance|1|||
147009751|NCT01664039|530196833|FG001|Overall Study|Noncompliance|1|||
147009752|NCT01853176|530196836|FG000|Overall Study|Study terminated|4|||
147009753|NCT01853176|530196837|FG001|Overall Study|Study terminated|0|||
147009754|NCT01944722|530196838|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
147009755|NCT01944722|530196838|FG000|Overall Study|Specimen Shipping Issues|34|||
147009756|NCT01944722|530196838|FG000|Overall Study|Improper Storage/Transport|5|||
147009757|NCT01944722|530196838|FG000|Overall Study|Insufficient Volume for Test|1|||
147009758|NCT01944722|530196838|FG000|Overall Study|Missing Specimens|3|||
147009759|NCT01944722|530196838|FG000|Overall Study|Specimens Mislabeled|2|||
147009760|NCT01944722|530196838|FG000|Overall Study|Withdrawal by Subject|8|||
147009761|NCT01944722|530196838|FG000|Overall Study|NILM Subjects <30 years old|8106|||
147009762|NCT01944722|530196838|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
147009763|NCT01944722|530196838|FG000|Overall Study|>ASCUS Cytology|1122|||
147009764|NCT02906917|530196842|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
147009765|NCT02906917|530196843|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
147009766|NCT02906917|530196842|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
147009767|NCT02906917|530196843|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
147009768|NCT02906917|530196842|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
147009769|NCT02906917|530196843|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
147009770|NCT02906917|530196842|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
147009771|NCT02906917|530196843|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
147009772|NCT02906917|530196842|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
147009773|NCT02906917|530196843|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
147009774|NCT02906917|530196842|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
147009775|NCT02906917|530196843|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
147009776|NCT02906917|530196842|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
147009777|NCT02906917|530196843|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
147009778|NCT02906917|530196842|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
147009779|NCT02906917|530196843|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
147009780|NCT00687739|530196845|FG000|Overall Study|Lost to Follow-up|2|||
146848047|NCT01655693|529614005|FG000|Overall Study|Serious Adverse Event|3|||
146848048|NCT01655693|529614006|FG001|Overall Study|Serious Adverse Event|15|||
146848049|NCT01655693|529614007|FG002|Overall Study|Serious Adverse Event|11|||
146848050|NCT01655693|529614005|FG000|Overall Study|Withdrawal by Subject|3|||
147009781|NCT00687739|530196846|FG001|Overall Study|Lost to Follow-up|2|||
146848051|NCT01655693|529614006|FG001|Overall Study|Withdrawal by Subject|2|||
146848052|NCT01655693|529614007|FG002|Overall Study|Withdrawal by Subject|20|||
146848053|NCT01655693|529614005|FG000|Overall Study|Adverse Event|3|||
146848054|NCT01655693|529614006|FG001|Overall Study|Adverse Event|11|||
147009782|NCT00687739|530196847|FG002|Overall Study|Lost to Follow-up|1|||
147009783|NCT00687739|530196848|FG003|Overall Study|Lost to Follow-up|2|||
147009784|NCT00687739|530196845|FG000|Overall Study|Adverse Event|0|||
147009785|NCT00687739|530196846|FG001|Overall Study|Adverse Event|1|||
147009786|NCT00687739|530196847|FG002|Overall Study|Adverse Event|1|||
147009787|NCT00687739|530196848|FG003|Overall Study|Adverse Event|0|||
147009788|NCT05387408|530196853|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
147009789|NCT03599362|530196857|FG000|Overall Study|Screen Failure|3|||
147009790|NCT01370083|530196859|FG000|Overall Study|Lost to Follow-up|2|||
147009791|NCT01370083|530196860|FG001|Overall Study|Lost to Follow-up|0|||
147009792|NCT01370083|530196859|FG000|Overall Study|Adverse Event|0|||
147009793|NCT01370083|530196860|FG001|Overall Study|Adverse Event|1|||
147009794|NCT02072096|530196862|FG000|Overall Study|Lack of Efficacy|18|||
147009795|NCT02072096|530196863|FG001|Overall Study|Lack of Efficacy|29|||
147009796|NCT02072096|530196862|FG000|Overall Study|Protocol Violation|7|||
147009797|NCT02072096|530196863|FG001|Overall Study|Protocol Violation|7|||
147009798|NCT02072096|530196862|FG000|Overall Study|Withdrawal by Subject|5|||
147009799|NCT02072096|530196863|FG001|Overall Study|Withdrawal by Subject|7|||
147009800|NCT02072096|530196862|FG000|Overall Study|Adverse Event|5|||
147009801|NCT02072096|530196863|FG001|Overall Study|Adverse Event|2|||
147009802|NCT02072096|530196862|FG000|Overall Study|No Reason Provided|4|||
147009803|NCT02072096|530196863|FG001|Overall Study|No Reason Provided|2|||
147009804|NCT02072096|530196862|FG000|Overall Study|Death|2|||
147009805|NCT02072096|530196863|FG001|Overall Study|Death|0|||
147009806|NCT02072096|530196862|FG000|Overall Study|Physician Decision|0|||
147009807|NCT02072096|530196863|FG001|Overall Study|Physician Decision|1|||
147009808|NCT02072096|530196862|FG000|Overall Study|Study Terminated by Sponsor|43|||
147009809|NCT02072096|530196863|FG001|Overall Study|Study Terminated by Sponsor|30|||
147009810|NCT02072096|530196862|FG000|Overall Study|Lost to Follow-up|1|||
147009811|NCT02072096|530196863|FG001|Overall Study|Lost to Follow-up|0|||
147009812|NCT01168856|530196873|FG000|Overall Study|Lost to Follow-up|4|||
147009813|NCT01168856|530196874|FG001|Overall Study|Lost to Follow-up|34|||
147009814|NCT01168856|530196873|FG000|Overall Study|Withdrawal by Subject|6|||
147009815|NCT01168856|530196874|FG001|Overall Study|Withdrawal by Subject|8|||
147009816|NCT01168856|530196873|FG000|Overall Study|Physician Decision|2|||
147009817|NCT01168856|530196874|FG001|Overall Study|Physician Decision|1|||
147009818|NCT01168856|530196873|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
147009819|NCT01168856|530196874|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
147009820|NCT01168856|530196873|FG000|Overall Study|Participant received anti-HCV treatment|1|||
147009821|NCT01168856|530196874|FG001|Overall Study|Participant received anti-HCV treatment|0|||
147009822|NCT01168856|530196873|FG000|Overall Study|Death|0|||
147009823|NCT01168856|530196874|FG001|Overall Study|Death|2|||
147009824|NCT01168856|530196873|FG000|Overall Study|Other|1|||
147009825|NCT01168856|530196874|FG001|Overall Study|Other|291|||
147009826|NCT01168856|530196873|FG000|Overall Study|Protocol Violation|4|||
147009827|NCT01168856|530196874|FG001|Overall Study|Protocol Violation|6|||
147009828|NCT04442503|530196875|FG000|Overall Study|Adverse Event|1|||
147009829|NCT04442503|530196876|FG001|Overall Study|Adverse Event|1|||
147009830|NCT04442503|530196875|FG000|Overall Study|Lost to Follow-up|8|||
147009831|NCT04442503|530196876|FG001|Overall Study|Lost to Follow-up|6|||
147009832|NCT04442503|530196875|FG000|Overall Study|Physician Decision|0|||
147009833|NCT04442503|530196876|FG001|Overall Study|Physician Decision|2|||
147009834|NCT04442503|530196875|FG000|Overall Study|Withdrawal by Subject|3|||
147009835|NCT04442503|530196876|FG001|Overall Study|Withdrawal by Subject|4|||
147009836|NCT04442503|530196875|FG000|Overall Study|Reason not Specified|0|||
147009837|NCT04442503|530196876|FG001|Overall Study|Reason not Specified|1|||
147009838|NCT04442503|530196875|FG000|Overall Study|Randomized but not Treated|3|||
147009839|NCT04442503|530196876|FG001|Overall Study|Randomized but not Treated|1|||
147009840|NCT00387153|530196877|FG000|Overall Study|Adverse Event|1|||
147009841|NCT00387153|530196877|FG000|Overall Study|Disease Progression|3|||
146848055|NCT01655693|529614007|FG002|Overall Study|Adverse Event|3|||
146848056|NCT01655693|529614005|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
147009842|NCT00387153|530196877|FG000|Overall Study|Lack of Response|4|||
147009843|NCT00301964|530196882|FG000|Overall Study|Second primary|2|||
147009844|NCT00301964|530196882|FG000|Overall Study|Wrong primary|1|||
147009845|NCT00301964|530196882|FG000|Overall Study|Inadequate pathology|1|||
147009846|NCT02385708|530196883|FG000|Overall Study|Withdrawal by Subject|0|||
147009847|NCT02385708|530196884|FG001|Overall Study|Withdrawal by Subject|2|||
147009848|NCT02385708|530196883|FG000|Overall Study|Withdrawn - surgery canceled|2|||
147009849|NCT02385708|530196884|FG001|Overall Study|Withdrawn - surgery canceled|5|||
147009850|NCT02385708|530196883|FG000|Overall Study|Investigator decision|5|||
147009851|NCT02385708|530196884|FG001|Overall Study|Investigator decision|7|||
147009852|NCT02385708|530196883|FG000|Overall Study|Protocol Violation|1|||
146848057|NCT01655693|529614006|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
147009853|NCT02385708|530196884|FG001|Overall Study|Protocol Violation|1|||
147009854|NCT03504085|530196886|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
147009855|NCT03504085|530196887|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
147009856|NCT03504085|530196886|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
147009857|NCT03504085|530196887|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
147009858|NCT01143337|530196888|FG000|Overall Study|Adverse Event|3|||
147009859|NCT01143337|530196889|FG001|Overall Study|Adverse Event|9|||
147009860|NCT01143337|530196890|FG002|Overall Study|Adverse Event|5|||
147009861|NCT01143337|530196888|FG000|Overall Study|Lack of Efficacy|6|||
147009862|NCT01143337|530196889|FG001|Overall Study|Lack of Efficacy|2|||
147009863|NCT01143337|530196890|FG002|Overall Study|Lack of Efficacy|1|||
147009864|NCT01143337|530196888|FG000|Overall Study|Protocol Violation|1|||
147009865|NCT01143337|530196889|FG001|Overall Study|Protocol Violation|0|||
147009866|NCT01143337|530196890|FG002|Overall Study|Protocol Violation|0|||
147009867|NCT01143337|530196888|FG000|Overall Study|Withdrawal by Subject|0|||
147009868|NCT01143337|530196889|FG001|Overall Study|Withdrawal by Subject|0|||
147009869|NCT01143337|530196890|FG002|Overall Study|Withdrawal by Subject|1|||
147009870|NCT01143337|530196888|FG000|Overall Study|Other reason|0|||
147009871|NCT01143337|530196889|FG001|Overall Study|Other reason|0|||
147009872|NCT01143337|530196890|FG002|Overall Study|Other reason|5|||
147009873|NCT02761915|530196891|FG000|Overall Study|Death|3|||
147009874|NCT02761915|530196892|FG001|Overall Study|Death|1|||
147009875|NCT02761915|530196893|FG002|Overall Study|Death|1|||
147009876|NCT02761915|530196894|FG003|Overall Study|Death|1|||
147009877|NCT02761915|530196895|FG004|Overall Study|Death|0|||
147009878|NCT02761915|530196896|FG005|Overall Study|Death|1|||
147009879|NCT02761915|530196891|FG000|Overall Study|Withdrawal by Subject|1|||
147009880|NCT02761915|530196892|FG001|Overall Study|Withdrawal by Subject|0|||
147009881|NCT02761915|530196893|FG002|Overall Study|Withdrawal by Subject|0|||
147009882|NCT02761915|530196894|FG003|Overall Study|Withdrawal by Subject|0|||
147009883|NCT02761915|530196895|FG004|Overall Study|Withdrawal by Subject|1|||
147009884|NCT02761915|530196896|FG005|Overall Study|Withdrawal by Subject|2|||
147009885|NCT02761915|530196891|FG000|Overall Study|Disease Progression|0|||
147009886|NCT02761915|530196892|FG001|Overall Study|Disease Progression|0|||
147009887|NCT02761915|530196893|FG002|Overall Study|Disease Progression|0|||
147009888|NCT02761915|530196894|FG003|Overall Study|Disease Progression|2|||
147009889|NCT02761915|530196895|FG004|Overall Study|Disease Progression|2|||
147009890|NCT02761915|530196896|FG005|Overall Study|Disease Progression|2|||
147009891|NCT01926119|530196907|FG000|Overall Study|Withdrawal by Subject|1|||
147009892|NCT02654145|530196911|FG000|Overall Study|Lack of Efficacy|1|||
147009893|NCT02654145|530196911|FG000|Overall Study|Protocol Violation|1|||
147009894|NCT02654145|530196911|FG000|Overall Study|Withdrawal by Subject|5|||
147009895|NCT00354835|530196912|FG000|Overall Study|Death|1|||
147009896|NCT00354835|530196913|FG001|Overall Study|Death|1|||
147009897|NCT00354835|530196912|FG000|Overall Study|Physician Decision|8|||
147009898|NCT00354835|530196913|FG001|Overall Study|Physician Decision|13|||
147009899|NCT00354835|530196912|FG000|Overall Study|Withdrawal by Subject|2|||
147009900|NCT00354835|530196913|FG001|Overall Study|Withdrawal by Subject|1|||
147009901|NCT00354835|530196912|FG000|Overall Study|Ineligible|17|||
147009902|NCT00354835|530196913|FG001|Overall Study|Ineligible|16|||
147009903|NCT00354835|530196912|FG000|Overall Study|Disease progression or relapse|15|||
147009904|NCT00354835|530196913|FG001|Overall Study|Disease progression or relapse|22|||
147009905|NCT00354835|530196912|FG000|Overall Study|Adverse Event|6|||
147009906|NCT00354835|530196913|FG001|Overall Study|Adverse Event|0|||
147009907|NCT00354835|530196912|FG000|Overall Study|Refusal of further therapy|3|||
147009908|NCT00354835|530196913|FG001|Overall Study|Refusal of further therapy|8|||
147009909|NCT00645853|530196914|FG000|Overall Study|Adverse Event|18|||
147009910|NCT00645853|530196915|FG001|Overall Study|Adverse Event|7|||
147009911|NCT00645853|530196914|FG000|Overall Study|AZ study closure in Hungary|60|||
147009912|NCT00645853|530196915|FG001|Overall Study|AZ study closure in Hungary|40|||
147009913|NCT00645853|530196914|FG000|Overall Study|Withdrawal by Subject|5|||
147009914|NCT00645853|530196915|FG001|Overall Study|Withdrawal by Subject|2|||
147009915|NCT00645853|530196914|FG000|Overall Study|Protocol Violation|0|||
147009916|NCT00645853|530196915|FG001|Overall Study|Protocol Violation|2|||
147009917|NCT00645853|530196914|FG000|Overall Study|Discontinuation criteria|2|||
147009918|NCT00645853|530196915|FG001|Overall Study|Discontinuation criteria|2|||
147009919|NCT00645853|530196914|FG000|Overall Study|recall of ICF, planned operation, death|7|||
147009920|NCT00645853|530196915|FG001|Overall Study|recall of ICF, planned operation, death|4|||
147009921|NCT02637141|530196918|FG000|Overall Study|Adverse Event|1|||
147009922|NCT02637141|530196919|FG001|Overall Study|Adverse Event|1|||
147009923|NCT02637141|530196920|FG002|Overall Study|Adverse Event|0|||
147009924|NCT02637141|530196918|FG000|Overall Study|Withdrawal by Subject|1|||
147009925|NCT02637141|530196919|FG001|Overall Study|Withdrawal by Subject|1|||
147009926|NCT02637141|530196920|FG002|Overall Study|Withdrawal by Subject|1|||
147009927|NCT01597791|530196921|FG000|Overall Study|Physician Decision|2|||
147009928|NCT01597791|530196922|FG001|Overall Study|Physician Decision|1|||
147009929|NCT01597791|530196921|FG000|Overall Study|Cesarean Section|6|||
147009930|NCT01597791|530196922|FG001|Overall Study|Cesarean Section|7|||
147009931|NCT01597791|530196921|FG000|Overall Study|Subject withdrawal|0|||
147009932|NCT01597791|530196922|FG001|Overall Study|Subject withdrawal|1|||
147009933|NCT01597791|530196921|FG000|Overall Study|Protocol Violation|0|||
147009934|NCT01597791|530196922|FG001|Overall Study|Protocol Violation|1|||
147009935|NCT01728116|530196923|FG000|Overall Study|Sponsor Terminated Study|106|||
147009936|NCT01728116|530196924|FG001|Overall Study|Sponsor Terminated Study|35|||
147009937|NCT01728116|530196923|FG000|Overall Study|Withdrawal by Subject|16|||
147009938|NCT01728116|530196924|FG001|Overall Study|Withdrawal by Subject|9|||
147009939|NCT01728116|530196923|FG000|Overall Study|Adverse Event|13|||
147009940|NCT01728116|530196924|FG001|Overall Study|Adverse Event|0|||
147009941|NCT01728116|530196923|FG000|Overall Study|Procedure/device failure|7|||
147009942|NCT01728116|530196924|FG001|Overall Study|Procedure/device failure|0|||
147009943|NCT01728116|530196923|FG000|Overall Study|Lost to Follow-up|9|||
147009944|NCT01728116|530196924|FG001|Overall Study|Lost to Follow-up|2|||
147009945|NCT01728116|530196923|FG000|Overall Study|Physician Decision|2|||
147009946|NCT01728116|530196924|FG001|Overall Study|Physician Decision|0|||
147009947|NCT01728116|530196923|FG000|Overall Study|Subject Non-Compliance|2|||
147009948|NCT01728116|530196924|FG001|Overall Study|Subject Non-Compliance|0|||
147009949|NCT01728116|530196923|FG000|Overall Study|Inter-current finding at procedure|1|||
147009950|NCT01728116|530196924|FG001|Overall Study|Inter-current finding at procedure|0|||
147009951|NCT01728116|530196923|FG000|Overall Study|Incorrectly enrolled in Study|0|||
147009952|NCT01728116|530196924|FG001|Overall Study|Incorrectly enrolled in Study|1|||
147009953|NCT01728116|530196923|FG000|Overall Study|various not noted previously|5|||
147009954|NCT01728116|530196924|FG001|Overall Study|various not noted previously|0|||
147009955|NCT01868243|530196925|FG000|Overall Study|Death|0|||
147009956|NCT01868243|530196926|FG001|Overall Study|Death|1|||
147009957|NCT00467597|530196927|FG000|Overall Study|Withdrawal by Subject|2|||
147009958|NCT00467597|530196928|FG001|Overall Study|Withdrawal by Subject|0|||
147009959|NCT00379353|530196931|FG000|Overall Study|Hospitalization|3|||
147009960|NCT00379353|530196932|FG001|Overall Study|Hospitalization|3|||
147009961|NCT00379353|530196931|FG000|Overall Study|Withdrawal by Subject|5|||
147009962|NCT00379353|530196932|FG001|Overall Study|Withdrawal by Subject|2|||
147009963|NCT00379353|530196931|FG000|Overall Study|Death|1|||
147009964|NCT00379353|530196932|FG001|Overall Study|Death|0|||
147009965|NCT00379353|530196931|FG000|Overall Study|Cardiac Tamponade|1|||
147009966|NCT00379353|530196932|FG001|Overall Study|Cardiac Tamponade|0|||
147009967|NCT00379353|530196931|FG000|Overall Study|Non-compliance|1|||
147009968|NCT00379353|530196932|FG001|Overall Study|Non-compliance|0|||
147009969|NCT00379353|530196931|FG000|Overall Study|Conflicting drug treatment|0|||
147009970|NCT00379353|530196932|FG001|Overall Study|Conflicting drug treatment|1|||
147009971|NCT05412121|530196935|FG000|Overall Study|Withdrawal by Subject|4|||
147009972|NCT05412121|530196935|FG000|Overall Study|Physician Decision|1|||
147009973|NCT05412121|530196935|FG000|Overall Study|Lost to Follow-up|5|||
147009974|NCT02670551|530196936|FG000|Overall Study|Adverse Event|4|||
147009975|NCT02670551|530196937|FG001|Overall Study|Adverse Event|7|||
147009976|NCT02670551|530196938|FG002|Overall Study|Adverse Event|9|||
147009977|NCT02670551|530196936|FG000|Overall Study|Lack of Efficacy|2|||
147009978|NCT02670551|530196937|FG001|Overall Study|Lack of Efficacy|0|||
147009979|NCT02670551|530196938|FG002|Overall Study|Lack of Efficacy|3|||
147009980|NCT02670551|530196936|FG000|Overall Study|Withdrawal of Consent|6|||
147009981|NCT02670551|530196937|FG001|Overall Study|Withdrawal of Consent|3|||
147009982|NCT02670551|530196938|FG002|Overall Study|Withdrawal of Consent|8|||
147009983|NCT02670551|530196936|FG000|Overall Study|Lost to Follow-up|5|||
147009984|NCT02670551|530196937|FG001|Overall Study|Lost to Follow-up|7|||
147009985|NCT02670551|530196938|FG002|Overall Study|Lost to Follow-up|6|||
147009986|NCT02670551|530196936|FG000|Overall Study|Protocol Violation|1|||
147009987|NCT02670551|530196937|FG001|Overall Study|Protocol Violation|0|||
147009988|NCT02670551|530196938|FG002|Overall Study|Protocol Violation|0|||
147009989|NCT02670551|530196936|FG000|Overall Study|Noncompliance with study drug|3|||
147009990|NCT02670551|530196937|FG001|Overall Study|Noncompliance with study drug|3|||
147009991|NCT02670551|530196938|FG002|Overall Study|Noncompliance with study drug|2|||
147009992|NCT02670551|530196936|FG000|Overall Study|Other Miscellaneous Reasons|2|||
147009993|NCT02670551|530196937|FG001|Overall Study|Other Miscellaneous Reasons|3|||
147009994|NCT02670551|530196938|FG002|Overall Study|Other Miscellaneous Reasons|3|||
147009995|NCT02670551|530196936|FG000|Overall Study|Did Not Receive Treatment|5|||
147009996|NCT02670551|530196937|FG001|Overall Study|Did Not Receive Treatment|3|||
147009997|NCT02670551|530196938|FG002|Overall Study|Did Not Receive Treatment|0|||
147009998|NCT05315713|530196939|FG000|Overall Study|Death|5|||
147009999|NCT05315713|530196939|FG000|Overall Study|Progressive disease|1|||
147010000|NCT05315713|530196939|FG000|Overall Study|Withdrawal by Subject|1|||
147010001|NCT05315713|530196939|FG000|Overall Study|Study terminated by sponsor|1|||
147010002|NCT02535923|530196940|FG000|Overall Study|Lost to Follow-up|5|||
147010003|NCT02535923|530196941|FG001|Overall Study|Lost to Follow-up|5|||
147010004|NCT02535923|530196940|FG000|Overall Study|Withdrawal by Subject|4|||
147010005|NCT02535923|530196941|FG001|Overall Study|Withdrawal by Subject|3|||
147010006|NCT00685334|530196947|FG000|Overall Study|Withdrawal by Subject|5|||
147010007|NCT00685334|530196948|FG001|Overall Study|Withdrawal by Subject|6|||
147010008|NCT00685334|530196947|FG000|Overall Study|Lost to Follow-up|4|||
147010009|NCT00685334|530196948|FG001|Overall Study|Lost to Follow-up|0|||
147010010|NCT00685334|530196947|FG000|Overall Study|Chose to enter hospital|1|||
147010011|NCT00685334|530196948|FG001|Overall Study|Chose to enter hospital|1|||
147010012|NCT03694197|530196949|FG000|Overall Study|Adverse Event|9|||
147010013|NCT03694197|530196949|FG000|Overall Study|Protocol became inconvenient to participate|1|||
147010014|NCT03694197|530196949|FG000|Overall Study|Physician Decision|4|||
147010015|NCT03694197|530196949|FG000|Overall Study|Study terminated by sponsor|1350|||
147010016|NCT03694197|530196949|FG000|Overall Study|Participant moved|5|||
147010017|NCT03694197|530196949|FG000|Overall Study|Participant withdrew consent|10|||
147010018|NCT03694197|530196949|FG000|Overall Study|Related to IMP administration|1|||
147010019|NCT03694197|530196949|FG000|Overall Study|Not disclosed|5|||
147010020|NCT02300987|530198242|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
147010021|NCT02300987|530198243|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
147010022|NCT02300987|530198242|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
147010023|NCT02300987|530198243|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
147010024|NCT02300987|530198242|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
147010025|NCT02300987|530198243|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
147010026|NCT02300987|530198242|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
147010027|NCT02300987|530198243|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
147010028|NCT02300987|530198242|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
147010029|NCT02300987|530198243|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
147010030|NCT03086135|530198244|FG000|Overall Study|Adverse Event|1|||
147010031|NCT03086135|530198244|FG000|Overall Study|Lost to Follow-up|2|||
147010032|NCT01023061|530198245|FG000|Overall Study|Withdrawal prior to treatment|2|||
147010033|NCT04590781|530198247|FG000|Overall Study|Death|0|||
147010034|NCT04590781|530198248|FG001|Overall Study|Death|2|||
147010035|NCT04590781|530198247|FG000|Overall Study|Withdrawal by Subject|2|||
147010036|NCT04590781|530198248|FG001|Overall Study|Withdrawal by Subject|0|||
147010037|NCT00820599|530198251|FG000|Overall Study|Death|129|||
147010038|NCT00820599|530198251|FG000|Overall Study|Withdrawal by Subject|2|||
147010039|NCT03686215|530198252|FG000|Overall Study|Adverse Event|0|||
147010040|NCT03686215|530198253|FG001|Overall Study|Adverse Event|0|||
147010041|NCT03686215|530198254|FG002|Overall Study|Adverse Event|7|||
147010042|NCT03686215|530198252|FG000|Overall Study|Physician Decision|0|||
147010043|NCT03686215|530198253|FG001|Overall Study|Physician Decision|0|||
147010044|NCT03686215|530198254|FG002|Overall Study|Physician Decision|1|||
147010045|NCT03686215|530198252|FG000|Overall Study|Protocol Violation|0|||
147010046|NCT03686215|530198253|FG001|Overall Study|Protocol Violation|0|||
147010047|NCT03686215|530198254|FG002|Overall Study|Protocol Violation|4|||
147010048|NCT03686215|530198252|FG000|Overall Study|Device issue|1|||
147010049|NCT03686215|530198253|FG001|Overall Study|Device issue|0|||
147010050|NCT03686215|530198254|FG002|Overall Study|Device issue|2|||
147010051|NCT00522041|530198255|FG000|Overall Study|Adverse Event|9|||
147010052|NCT00522041|530198256|FG001|Overall Study|Adverse Event|3|||
147010053|NCT00522041|530198255|FG000|Overall Study|Protocol Violation|2|||
147010054|NCT00522041|530198256|FG001|Overall Study|Protocol Violation|0|||
147010055|NCT00522041|530198255|FG000|Overall Study|Lost to Follow-up|1|||
147010056|NCT00522041|530198256|FG001|Overall Study|Lost to Follow-up|4|||
147010057|NCT00522041|530198255|FG000|Overall Study|Voluntary withdrawal|5|||
147010058|NCT00522041|530198256|FG001|Overall Study|Voluntary withdrawal|4|||
147010059|NCT00522041|530198255|FG000|Overall Study|Did not receive treatment|0|||
147010060|NCT00522041|530198256|FG001|Overall Study|Did not receive treatment|1|||
147010061|NCT00874549|530198257|FG000|Overall Study|Adverse Event|0|||
147010062|NCT00874549|530198258|FG001|Overall Study|Adverse Event|0|||
147010063|NCT00874549|530198259|FG002|Overall Study|Adverse Event|1|||
147010064|NCT00874549|530198260|FG003|Overall Study|Adverse Event|0|||
147010065|NCT00874549|530198257|FG000|Overall Study|Protocol Violation|1|||
147010066|NCT00874549|530198258|FG001|Overall Study|Protocol Violation|0|||
147010067|NCT00874549|530198259|FG002|Overall Study|Protocol Violation|2|||
147010068|NCT00874549|530198260|FG003|Overall Study|Protocol Violation|1|||
147010069|NCT00874549|530198257|FG000|Overall Study|Lost to Follow-up|0|||
147010070|NCT00874549|530198258|FG001|Overall Study|Lost to Follow-up|0|||
147010071|NCT00874549|530198259|FG002|Overall Study|Lost to Follow-up|1|||
147010072|NCT00874549|530198260|FG003|Overall Study|Lost to Follow-up|0|||
147010073|NCT00874549|530198257|FG000|Overall Study|Withdrawal by Subject|0|||
147010074|NCT00874549|530198258|FG001|Overall Study|Withdrawal by Subject|1|||
147010075|NCT00874549|530198259|FG002|Overall Study|Withdrawal by Subject|0|||
147010076|NCT00874549|530198260|FG003|Overall Study|Withdrawal by Subject|1|||
147010077|NCT01710358|530198261|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
147010078|NCT01710358|530198262|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
147010079|NCT01710358|530198263|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
147010080|NCT01710358|530198261|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
147010081|NCT01710358|530198262|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
147010082|NCT01710358|530198263|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
147010083|NCT01710358|530198261|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
147010084|NCT01710358|530198262|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
147010085|NCT01710358|530198263|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
147010086|NCT01710358|530198261|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
147010087|NCT01710358|530198262|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
147010088|NCT01710358|530198263|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
147010089|NCT01710358|530198261|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
147010090|NCT01710358|530198262|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
147010091|NCT01710358|530198263|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
147010092|NCT01710358|530198261|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
147010093|NCT01710358|530198262|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
147010094|NCT01710358|530198263|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
147010095|NCT01710358|530198261|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
147010096|NCT01710358|530198262|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
147010097|NCT01710358|530198263|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
147010098|NCT01710358|530198261|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
147010099|NCT01710358|530198262|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
147010100|NCT01710358|530198263|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
147010101|NCT01710358|530198261|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
147010102|NCT01710358|530198262|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
147010103|NCT01710358|530198263|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
147010104|NCT01710358|530198261|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
147010105|NCT01710358|530198262|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
147010106|NCT01710358|530198263|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
147010107|NCT01710358|530198261|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
147010108|NCT01710358|530198262|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
147010109|NCT01710358|530198263|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
147010110|NCT01710358|530198261|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
147010111|NCT01710358|530198262|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
147010112|NCT01710358|530198263|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
147010113|NCT01710358|530198261|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
147010114|NCT01710358|530198262|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
147010115|NCT01710358|530198263|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
147010116|NCT01710358|530198261|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
147010117|NCT01710358|530198262|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
147010118|NCT01710358|530198263|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
147010119|NCT01710358|530198261|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
147010120|NCT01710358|530198262|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
147010121|NCT01710358|530198263|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
147010122|NCT01710358|530198261|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
147010123|NCT01710358|530198262|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
147010124|NCT01710358|530198263|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
147010125|NCT01710358|530198261|FG000|Rescue Period|Adverse Event|0|||
147010126|NCT01710358|530198262|FG001|Rescue Period|Adverse Event|15|||
147010127|NCT01710358|530198263|FG002|Rescue Period|Adverse Event|0|||
147010128|NCT01710358|530198261|FG000|Rescue Period|Death|0|||
147010129|NCT01710358|530198262|FG001|Rescue Period|Death|1|||
147010130|NCT01710358|530198263|FG002|Rescue Period|Death|0|||
147010131|NCT01710358|530198261|FG000|Rescue Period|Lack of Efficacy|0|||
147010132|NCT01710358|530198262|FG001|Rescue Period|Lack of Efficacy|7|||
147010133|NCT01710358|530198263|FG002|Rescue Period|Lack of Efficacy|0|||
147010134|NCT01710358|530198261|FG000|Rescue Period|Withdrawal by Subject|0|||
147010135|NCT01710358|530198262|FG001|Rescue Period|Withdrawal by Subject|8|||
147010136|NCT01710358|530198263|FG002|Rescue Period|Withdrawal by Subject|0|||
147010137|NCT00084864|530198264|FG000|Overall Study|Adverse Event|1|||
147010138|NCT00084864|530198265|FG001|Overall Study|Adverse Event|0|||
147010139|NCT00084864|530198266|FG002|Overall Study|Adverse Event|0|||
147010140|NCT00084864|530198267|FG003|Overall Study|Adverse Event|0|||
147010141|NCT01721772|530198272|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
147010142|NCT01721772|530198273|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
147010143|NCT01721772|530198272|FG000|Pre-Treatment|Poor/non-compliance|0|||
147010144|NCT01721772|530198273|FG001|Pre-Treatment|Poor/non-compliance|1|||
147010145|NCT01721772|530198272|FG000|Pre-Treatment|Participant withdrew consent|0|||
147010146|NCT01721772|530198273|FG001|Pre-Treatment|Participant withdrew consent|1|||
147010147|NCT01721772|530198272|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
147010148|NCT01721772|530198273|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
147010149|NCT01721772|530198272|FG000|Treatment|Disease progression|119|||
147010150|NCT01721772|530198273|FG001|Treatment|Disease progression|168|||
147010151|NCT01721772|530198272|FG000|Treatment|Study drug toxicity|19|||
147010152|NCT01721772|530198273|FG001|Treatment|Study drug toxicity|10|||
147010153|NCT01721772|530198272|FG000|Treatment|Adverse event unrelated to study drug|7|||
147010154|NCT01721772|530198273|FG001|Treatment|Adverse event unrelated to study drug|7|||
147010155|NCT01721772|530198272|FG000|Treatment|Maximum clinical benefit|16|||
147010156|NCT01721772|530198273|FG001|Treatment|Maximum clinical benefit|4|||
147010157|NCT01721772|530198272|FG000|Treatment|Other|19|||
147010158|NCT01721772|530198273|FG001|Treatment|Other|2|||
147010159|NCT01721772|530198272|FG000|Treatment|Participant withdrew consent|2|||
147010160|NCT01721772|530198273|FG001|Treatment|Participant withdrew consent|5|||
147010161|NCT01721772|530198272|FG000|Treatment|Participant request to discontinue study treatment|21|||
147010162|NCT01721772|530198273|FG001|Treatment|Participant request to discontinue study treatment|8|||
147010163|NCT01721772|530198272|FG000|Treatment|Death|1|||
147010164|NCT01721772|530198273|FG001|Treatment|Death|0|||
147010165|NCT01721772|530198272|FG000|Treatment|Not reported|1|||
147010166|NCT01721772|530198273|FG001|Treatment|Not reported|0|||
147010167|NCT01721772|530198272|FG000|Treatment|Poor/non-compliance|1|||
147010168|NCT01721772|530198273|FG001|Treatment|Poor/non-compliance|0|||
147010169|NCT01721772|530198272|FG000|Treatment|Lost to Follow-up|0|||
147010170|NCT01721772|530198273|FG001|Treatment|Lost to Follow-up|1|||
147010171|NCT04542694|530198274|FG000|Overall Study|The need for prohibited therapy|2|||
147010172|NCT04542694|530198275|FG001|Overall Study|The need for prohibited therapy|0|||
147010173|NCT04542694|530198274|FG000|Overall Study|Adverse Event|1|||
147010174|NCT04542694|530198275|FG001|Overall Study|Adverse Event|0|||
147010175|NCT04542694|530198274|FG000|Overall Study|Protocol Violation|1|||
147010176|NCT04542694|530198275|FG001|Overall Study|Protocol Violation|0|||
147010177|NCT00969124|530198276|FG000|Overall Study|Protocol Violation|2|||
147010178|NCT00969124|530198276|FG000|Overall Study|Inadequate bowel preparation|15|||
147010179|NCT00969124|530198276|FG000|Overall Study|Inability to reach cecum|9|||
147010180|NCT00969124|530198276|FG000|Overall Study|Previously unrecognized disease|3|||
147010181|NCT00969124|530198276|FG000|Overall Study|Technical error|1|||
147010182|NCT00874822|530198277|FG000|Overall Study|excluded by criteria|8|||
147010183|NCT02854800|530198278|FG000|Overall Study|Protocol Violation|16|||
147010184|NCT02854800|530198279|FG001|Overall Study|Protocol Violation|11|||
147010185|NCT02854800|530198280|FG002|Overall Study|Protocol Violation|3|||
147010186|NCT02854800|530198278|FG000|Overall Study|Withdrawal by Subject|4|||
147010187|NCT02854800|530198279|FG001|Overall Study|Withdrawal by Subject|2|||
147010188|NCT02854800|530198280|FG002|Overall Study|Withdrawal by Subject|3|||
147010189|NCT05278858|530198282|FG000|Overall Study|Withdrawal by Subject|1|||
147010190|NCT00840658|530198283|FG000|Overall Study|Death|2|||
147010191|NCT00840658|530198284|FG001|Overall Study|Death|2|||
147010192|NCT00840658|530198285|FG002|Overall Study|Death|3|||
147010193|NCT00840658|530198286|FG003|Overall Study|Death|3|||
147010194|NCT00840658|530198283|FG000|Overall Study|Lost to Follow-up|3|||
147010195|NCT00840658|530198284|FG001|Overall Study|Lost to Follow-up|1|||
147010196|NCT00840658|530198285|FG002|Overall Study|Lost to Follow-up|2|||
147010197|NCT00840658|530198286|FG003|Overall Study|Lost to Follow-up|1|||
147010198|NCT01859598|530198288|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
147010199|NCT00573313|530198289|FG000|Overall Study|Protocol Violation|5|||
147010200|NCT00573313|530198290|FG001|Overall Study|Protocol Violation|0|||
147010201|NCT00573313|530198291|FG002|Overall Study|Protocol Violation|6|||
147010202|NCT00573313|530198292|FG003|Overall Study|Protocol Violation|0|||
147010203|NCT00295490|530198295|FG000|Overall Study|Protocol Violation|0|||
147010204|NCT00295490|530198296|FG001|Overall Study|Protocol Violation|0|||
147010205|NCT00295490|530198297|FG002|Overall Study|Protocol Violation|3|||
147010206|NCT00295490|530198298|FG003|Overall Study|Protocol Violation|3|||
147010207|NCT00295490|530198295|FG000|Overall Study|Withdrawal by Subject|0|||
147010208|NCT00295490|530198296|FG001|Overall Study|Withdrawal by Subject|2|||
147010209|NCT00295490|530198297|FG002|Overall Study|Withdrawal by Subject|0|||
147010210|NCT00295490|530198298|FG003|Overall Study|Withdrawal by Subject|1|||
147010211|NCT00295490|530198295|FG000|Overall Study|Lost to Follow-up|0|||
147010212|NCT00295490|530198296|FG001|Overall Study|Lost to Follow-up|0|||
147010213|NCT00295490|530198297|FG002|Overall Study|Lost to Follow-up|1|||
147010214|NCT00295490|530198298|FG003|Overall Study|Lost to Follow-up|0|||
147010215|NCT00295490|530198295|FG000|Overall Study|Adverse Event|1|||
147010216|NCT00295490|530198296|FG001|Overall Study|Adverse Event|0|||
147010217|NCT00295490|530198297|FG002|Overall Study|Adverse Event|0|||
147010218|NCT00295490|530198298|FG003|Overall Study|Adverse Event|0|||
147010219|NCT00295490|530198295|FG000|Overall Study|Other|0|||
147010220|NCT00295490|530198296|FG001|Overall Study|Other|2|||
147010221|NCT00295490|530198297|FG002|Overall Study|Other|0|||
147010222|NCT00295490|530198298|FG003|Overall Study|Other|1|||
147010223|NCT03885934|530198299|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
147010224|NCT03885934|530198300|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
147010225|NCT03885934|530198301|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
147010226|NCT03885934|530198302|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
147010227|NCT03885934|530198303|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
147010228|NCT03885934|530198304|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
147010229|NCT03255980|530198305|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
147010230|NCT03255980|530198306|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
147010231|NCT03255980|530198307|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
147010232|NCT03255980|530198308|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
147010233|NCT03255980|530198305|FG000|Overall Study|Adverse Event|1|||
147010234|NCT03255980|530198306|FG001|Overall Study|Adverse Event|1|||
147010235|NCT03255980|530198307|FG002|Overall Study|Adverse Event|0|||
147010236|NCT03255980|530198308|FG003|Overall Study|Adverse Event|1|||
147010237|NCT03255980|530198305|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
147010238|NCT03255980|530198306|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
147010239|NCT03255980|530198307|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
147010240|NCT03255980|530198308|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
147010241|NCT03255980|530198305|FG000|Overall Study|Lost to Follow-up|1|||
147010242|NCT03255980|530198306|FG001|Overall Study|Lost to Follow-up|1|||
147010243|NCT03255980|530198307|FG002|Overall Study|Lost to Follow-up|0|||
147010244|NCT03255980|530198308|FG003|Overall Study|Lost to Follow-up|3|||
147010245|NCT03255980|530198305|FG000|Overall Study|Withdrawal by Subject|0|||
147010246|NCT03255980|530198306|FG001|Overall Study|Withdrawal by Subject|1|||
147010247|NCT03255980|530198307|FG002|Overall Study|Withdrawal by Subject|0|||
147010248|NCT03255980|530198308|FG003|Overall Study|Withdrawal by Subject|3|||
147010249|NCT04473326|530198309|FG000|Overall Study|Death|0|||
147010250|NCT04473326|530198310|FG001|Overall Study|Death|1|||
147010251|NCT04473326|530198309|FG000|Overall Study|Withdrawal by Subject|1|||
147010252|NCT04473326|530198310|FG001|Overall Study|Withdrawal by Subject|2|||
147010253|NCT01451541|530198313|FG000|Overall Study|Adverse Event|4|||
147010254|NCT01451541|530198314|FG001|Overall Study|Adverse Event|3|||
147010255|NCT01451541|530198315|FG002|Overall Study|Adverse Event|6|||
147010256|NCT01451541|530198313|FG000|Overall Study|Lack of Efficacy|2|||
147010257|NCT01451541|530198314|FG001|Overall Study|Lack of Efficacy|0|||
147010258|NCT01451541|530198315|FG002|Overall Study|Lack of Efficacy|0|||
147010259|NCT01451541|530198313|FG000|Overall Study|Lost to Follow-up|4|||
147010260|NCT01451541|530198314|FG001|Overall Study|Lost to Follow-up|4|||
147010261|NCT01451541|530198315|FG002|Overall Study|Lost to Follow-up|7|||
147010262|NCT01451541|530198313|FG000|Overall Study|Withdrawal by Subject|15|||
147010263|NCT01451541|530198314|FG001|Overall Study|Withdrawal by Subject|8|||
147010264|NCT01451541|530198315|FG002|Overall Study|Withdrawal by Subject|6|||
147010265|NCT01451541|530198313|FG000|Overall Study|randomization error, noncompliance|11|||
147010266|NCT01451541|530198314|FG001|Overall Study|randomization error, noncompliance|10|||
147010267|NCT01451541|530198315|FG002|Overall Study|randomization error, noncompliance|8|||
147010268|NCT04164758|530198316|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
147010269|NCT04164758|530198317|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
147010270|NCT04164758|530198318|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
147010271|NCT04164758|530198316|FG000|Overall Study|Adverse Event|0|||
147010272|NCT04164758|530198317|FG001|Overall Study|Adverse Event|1|||
147010273|NCT04164758|530198318|FG002|Overall Study|Adverse Event|0|||
147010274|NCT03366428|530198323|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
147010275|NCT03366428|530198323|FG000|Overall Study|Adverse Event|12|||
147010276|NCT03366428|530198323|FG000|Overall Study|Clinical progression|2|||
147010277|NCT03366428|530198323|FG000|Overall Study|Withdrawal by Subject|4|||
147010278|NCT02166606|530198324|FG000|Overall Study|Adverse Event|3|||
147010279|NCT02166606|530198324|FG000|Overall Study|Death|31|||
147010280|NCT02166606|530198324|FG000|Overall Study|Protocol Violation|7|||
147010281|NCT02166606|530198324|FG000|Overall Study|Lost to Follow-up|30|||
147010282|NCT02166606|530198324|FG000|Overall Study|Withdrawal by Subject|1|||
147010283|NCT02166606|530198324|FG000|Overall Study|Physician Decision|1|||
147010284|NCT02166606|530198324|FG000|Overall Study|Device upgrade|1|||
147010285|NCT02166606|530198324|FG000|Overall Study|Enrolled after End of Enrollment|4|||
147010286|NCT01958476|530198329|FG000|Overall Study|Parent requested exclusion from analysis|1|||
147010287|NCT01958476|530198330|FG001|Overall Study|Parent requested exclusion from analysis|0|||
147010288|NCT00537095|530198332|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
147010289|NCT00537095|530198333|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
147010290|NCT00537095|530198332|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
147010291|NCT00537095|530198333|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
147010292|NCT00537095|530198332|FG000|Randomized Treatment Period (433 Days)|Death|3|||
147010293|NCT00537095|530198333|FG001|Randomized Treatment Period (433 Days)|Death|1|||
147010294|NCT00537095|530198332|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
147010295|NCT00537095|530198333|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
146848058|NCT01655693|529614007|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
147010296|NCT00537095|530198332|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
147010297|NCT00537095|530198333|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
147010298|NCT00537095|530198332|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
147010299|NCT00537095|530198333|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
147010300|NCT00537095|530198332|FG000|Open-label Period (590 Days)|Adverse Event|2|||
146848059|NCT01655693|529614005|FG000|Overall Study|Non-Compliance|0|||
147010301|NCT00537095|530198333|FG001|Open-label Period (590 Days)|Adverse Event|11|||
147010302|NCT00537095|530198332|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
147010303|NCT00537095|530198333|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
147010304|NCT00537095|530198332|FG000|Open-label Period (590 Days)|Death|2|||
147010305|NCT00537095|530198333|FG001|Open-label Period (590 Days)|Death|2|||
147010306|NCT00537095|530198332|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
147010307|NCT00537095|530198333|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
147010308|NCT00537095|530198332|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
147010309|NCT00537095|530198333|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
147010310|NCT00533507|530198334|FG000|Overall Study|Withdrawal by Subject|1|||
147010311|NCT02943096|530198335|FG000|Overall Study|Lack of Efficacy|0|||
147010312|NCT02943096|530198336|FG001|Overall Study|Lack of Efficacy|1|||
147010313|NCT05065619|530198337|FG000|Up to Day 42|Lost to Follow-up|1|||
147010314|NCT05065619|530198338|FG001|Up to Day 42|Lost to Follow-up|0|||
147010315|NCT05065619|530198337|FG000|Up to Day 42|Withdrawal by Subject|1|||
147010316|NCT05065619|530198338|FG001|Up to Day 42|Withdrawal by Subject|0|||
147010317|NCT05065619|530198337|FG000|After Day 43|Lost to Follow-up|1|||
147010318|NCT05065619|530198338|FG001|After Day 43|Lost to Follow-up|0|||
147010319|NCT05065619|530198337|FG000|After Day 43|Physician Decision|3|||
147010320|NCT05065619|530198338|FG001|After Day 43|Physician Decision|0|||
147010321|NCT05065619|530198337|FG000|After Day 43|Withdrawal by Subject|1|||
147010322|NCT05065619|530198338|FG001|After Day 43|Withdrawal by Subject|2|||
147010323|NCT05065619|530198337|FG000|After Day 43|Public vaccination|6|||
147010324|NCT05065619|530198338|FG001|After Day 43|Public vaccination|8|||
147010325|NCT05065619|530198337|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
147010326|NCT05065619|530198338|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
147010327|NCT05065619|530198337|FG000|After Day 43|Study Terminated by Sponsor|88|||
147010328|NCT05065619|530198338|FG001|After Day 43|Study Terminated by Sponsor|16|||
147010329|NCT00714051|530198340|FG000|Overall Study|Withdrawal by Subject|1|||
147010330|NCT00714051|530198341|FG001|Overall Study|Withdrawal by Subject|0|||
147010331|NCT00714051|530198340|FG000|Overall Study|Death|0|||
147010332|NCT00714051|530198341|FG001|Overall Study|Death|1|||
147010333|NCT00570128|530198350|FG000|Overall Study|Adverse Event|1|||
147010334|NCT00570128|530198351|FG001|Overall Study|Adverse Event|0|||
147010335|NCT00570128|530198350|FG000|Overall Study|Lost to Follow-up|1|||
147010336|NCT00570128|530198351|FG001|Overall Study|Lost to Follow-up|0|||
147010337|NCT00570128|530198350|FG000|Overall Study|Withdrawal by Subject|2|||
147010338|NCT00570128|530198351|FG001|Overall Study|Withdrawal by Subject|0|||
147010339|NCT03868631|530198352|FG000|Baseline to Week 6|Adverse Event|0|||
147010340|NCT03868631|530198353|FG001|Baseline to Week 6|Adverse Event|3|||
147010341|NCT03868631|530198352|FG000|Baseline to Week 6|Protocol Violation|1|||
147010342|NCT03868631|530198353|FG001|Baseline to Week 6|Protocol Violation|1|||
147010343|NCT03868631|530198352|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
147010344|NCT03868631|530198353|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
147010345|NCT03868631|530198352|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
147010346|NCT03868631|530198353|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
147010347|NCT03868631|530198352|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
147010348|NCT03868631|530198353|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
147010349|NCT03868631|530198352|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
147010350|NCT03868631|530198353|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
147010351|NCT01929681|530198354|FG000|Overall Study|Withdrawal by Subject|1|||
147010352|NCT01929681|530198355|FG001|Overall Study|Withdrawal by Subject|0|||
147010353|NCT01929681|530198354|FG000|Overall Study|Physician Decision|1|||
147010354|NCT01929681|530198355|FG001|Overall Study|Physician Decision|1|||
147010355|NCT03555695|530198356|FG000|Overall Study|Withdrawal by Subject|1|||
147010356|NCT03555695|530198356|FG000|Overall Study|Lost to Follow-up|1|||
147010357|NCT03555695|530198356|FG000|Overall Study|appendicitis (unrelated)|1|||
147010358|NCT03555695|530198356|FG000|Overall Study|pre-existing sciatica|1|||
147010359|NCT01426854|530198357|FG000|Overall Study|Adverse Event|1|||
147010360|NCT01426854|530198358|FG001|Overall Study|Adverse Event|5|||
147010361|NCT01426854|530198357|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
147010362|NCT01426854|530198358|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
147010363|NCT01426854|530198357|FG000|Overall Study|Lost to Follow-up|3|||
147010364|NCT01426854|530198358|FG001|Overall Study|Lost to Follow-up|0|||
147010365|NCT01426854|530198357|FG000|Overall Study|Noncompliance|0|||
147010366|NCT01426854|530198358|FG001|Overall Study|Noncompliance|1|||
147010367|NCT01426854|530198357|FG000|Overall Study|Treatment Failure|0|||
146848060|NCT01655693|529614006|FG001|Overall Study|Non-Compliance|0|||
147010368|NCT01426854|530198358|FG001|Overall Study|Treatment Failure|16|||
147010369|NCT01426854|530198357|FG000|Overall Study|Protocol Deviation|0|||
147010370|NCT01426854|530198358|FG001|Overall Study|Protocol Deviation|1|||
147010371|NCT01426854|530198357|FG000|Overall Study|Other|3|||
147010372|NCT01426854|530198358|FG001|Overall Study|Other|2|||
147010373|NCT01971554|530198359|FG000|Overall Study|Lost to Follow-up|1|||
147010374|NCT01971554|530198360|FG001|Overall Study|Lost to Follow-up|0|||
147010375|NCT01971554|530198361|FG002|Overall Study|Lost to Follow-up|0|||
147010376|NCT01971554|530198362|FG003|Overall Study|Lost to Follow-up|0|||
147010377|NCT01942135|530198366|FG000|Overall Study|Adverse Event|21|||
147010378|NCT01942135|530198367|FG001|Overall Study|Adverse Event|7|||
147010379|NCT01942135|530198366|FG000|Overall Study|Global Deterioration of Health Status|9|||
147010380|NCT01942135|530198367|FG001|Overall Study|Global Deterioration of Health Status|6|||
147010381|NCT01942135|530198366|FG000|Overall Study|Randomized Not Treated|2|||
147010382|NCT01942135|530198367|FG001|Overall Study|Randomized Not Treated|2|||
147010383|NCT01942135|530198366|FG000|Overall Study|Death|2|||
147010384|NCT01942135|530198367|FG001|Overall Study|Death|1|||
147010385|NCT01942135|530198366|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
147010386|NCT01942135|530198367|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
147010387|NCT01942135|530198366|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
147010388|NCT01942135|530198367|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
147010389|NCT01942135|530198366|FG000|Overall Study|Withdrawal by Subject|4|||
147010390|NCT01942135|530198367|FG001|Overall Study|Withdrawal by Subject|3|||
147010391|NCT01942135|530198366|FG000|Overall Study|Protocol Violation|1|||
147010392|NCT01942135|530198367|FG001|Overall Study|Protocol Violation|0|||
147010393|NCT01942135|530198366|FG000|Overall Study|Other|19|||
147010394|NCT01942135|530198367|FG001|Overall Study|Other|4|||
147010395|NCT01717040|530198368|FG000|Overall Study|Lost to Follow-up|2|||
147010396|NCT01717040|530198369|FG001|Overall Study|Lost to Follow-up|3|||
147010397|NCT01717040|530198368|FG000|Overall Study|Lack of Efficacy|1|||
147010398|NCT01717040|530198369|FG001|Overall Study|Lack of Efficacy|1|||
147010399|NCT01717040|530198368|FG000|Overall Study|Adverse Event|1|||
147010400|NCT01717040|530198369|FG001|Overall Study|Adverse Event|0|||
147010401|NCT01717040|530198368|FG000|Overall Study|Required Medication Change|0|||
147010402|NCT01717040|530198369|FG001|Overall Study|Required Medication Change|1|||
147010403|NCT01717040|530198368|FG000|Overall Study|New Substance Use Disorder|1|||
146848061|NCT01655693|529614007|FG002|Overall Study|Non-Compliance|7|||
146848062|NCT01655693|529614005|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
146848063|NCT01655693|529614006|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
146848064|NCT01655693|529614007|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
146848065|NCT01655693|529614005|FG000|Overall Study|Protocol Violation|1|||
146848066|NCT01655693|529614006|FG001|Overall Study|Protocol Violation|0|||
147010404|NCT01717040|530198369|FG001|Overall Study|New Substance Use Disorder|0|||
147010405|NCT03196284|530198370|FG000|Main Part|Withdrawal by Subject|0|||
147010406|NCT03196284|530198371|FG001|Main Part|Withdrawal by Subject|1|||
147010407|NCT03196284|530198372|FG002|Main Part|Withdrawal by Subject|0|||
147010408|NCT03196284|530198370|FG000|Extension Part|Lack of Efficacy|0|||
147010409|NCT03196284|530198371|FG001|Extension Part|Lack of Efficacy|0|||
147010410|NCT03196284|530198372|FG002|Extension Part|Lack of Efficacy|1|||
147010411|NCT03196284|530198370|FG000|Extension Part|Withdrawal by Subject|0|||
147010412|NCT03196284|530198371|FG001|Extension Part|Withdrawal by Subject|0|||
147010413|NCT03196284|530198372|FG002|Extension Part|Withdrawal by Subject|1|||
147010414|NCT03196284|530198370|FG000|Extension Part|Physician Decision|0|||
147010415|NCT03196284|530198371|FG001|Extension Part|Physician Decision|0|||
147010416|NCT03196284|530198372|FG002|Extension Part|Physician Decision|1|||
147010417|NCT01675596|530198373|FG000|Overall Study|Death|6|||
147010418|NCT01675596|530198373|FG000|Overall Study|Exit with other reason|1|||
147010419|NCT01675596|530198373|FG000|Overall Study|Missed Visit|1|||
147010420|NCT01139762|530198374|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
147010421|NCT01139762|530198375|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
147010422|NCT01139762|530198376|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
147010423|NCT01139762|530198374|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
147010424|NCT01139762|530198375|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
147010425|NCT01139762|530198376|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
147010426|NCT01139762|530198374|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
147010427|NCT01139762|530198375|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
146848067|NCT01655693|529614007|FG002|Overall Study|Protocol Violation|3|||
146848068|NCT01655693|529614005|FG000|Overall Study|Lost to Follow-up|1|||
146848069|NCT01655693|529614006|FG001|Overall Study|Lost to Follow-up|0|||
146848070|NCT01655693|529614007|FG002|Overall Study|Lost to Follow-up|1|||
146848071|NCT01655693|529614005|FG000|Overall Study|Screening Failure|1|||
146848072|NCT01655693|529614006|FG001|Overall Study|Screening Failure|0|||
146848073|NCT01655693|529614007|FG002|Overall Study|Screening Failure|0|||
146848074|NCT01655693|529614005|FG000|Overall Study|Other|8|||
146848075|NCT01655693|529614006|FG001|Overall Study|Other|6|||
146848076|NCT01655693|529614007|FG002|Overall Study|Other|15|||
146848077|NCT00929110|529614010|FG000|Overall Study|Adverse Event|40|||
146848078|NCT00929110|529614011|FG001|Overall Study|Adverse Event|29|||
146848079|NCT00929110|529614012|FG002|Overall Study|Adverse Event|18|||
146848080|NCT00929110|529614010|FG000|Overall Study|Subject withdrew consent|40|||
146848081|NCT00929110|529614011|FG001|Overall Study|Subject withdrew consent|23|||
146848082|NCT00929110|529614012|FG002|Overall Study|Subject withdrew consent|26|||
146848083|NCT00929110|529614010|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
146848084|NCT00929110|529614011|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
147010428|NCT01139762|530198376|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
147010429|NCT01139762|530198374|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
147010430|NCT01139762|530198375|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
147010431|NCT01139762|530198376|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
147010432|NCT01139762|530198374|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
147010433|NCT01139762|530198375|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
147010434|NCT01139762|530198376|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
147010435|NCT01139762|530198374|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
147010436|NCT01139762|530198375|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
147010437|NCT01139762|530198376|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
147010438|NCT01139762|530198374|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
147010439|NCT01139762|530198375|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
147010440|NCT01139762|530198376|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
147010441|NCT01139762|530198374|FG000|Double-Blind Randomized Active Treatment|Death|0|||
147010442|NCT01139762|530198375|FG001|Double-Blind Randomized Active Treatment|Death|1|||
147010443|NCT01139762|530198376|FG002|Double-Blind Randomized Active Treatment|Death|1|||
147010444|NCT01139762|530198374|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
147010445|NCT01139762|530198375|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
147010446|NCT01139762|530198376|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
147010447|NCT01139762|530198374|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
147010448|NCT01139762|530198375|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
147010449|NCT01139762|530198376|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
147010450|NCT01139762|530198374|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
147010451|NCT01139762|530198375|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
147010452|NCT01139762|530198376|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
147010453|NCT01139762|530198374|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
147010454|NCT01139762|530198375|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
147010455|NCT01139762|530198376|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
147010456|NCT01139762|530198374|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
147010457|NCT01139762|530198375|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
147010458|NCT01139762|530198376|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
147010459|NCT01139762|530198374|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
147010460|NCT01139762|530198375|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
147010461|NCT01139762|530198376|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
147010462|NCT01139762|530198374|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
147010463|NCT01139762|530198375|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
147010464|NCT01139762|530198376|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
147010465|NCT00087529|530198378|FG000|Overall Study|Death|1|||
147010466|NCT00087529|530198379|FG001|Overall Study|Death|0|||
147010467|NCT00087529|530198378|FG000|Overall Study|Adverse Event|0|||
147010468|NCT00087529|530198379|FG001|Overall Study|Adverse Event|8|||
147010469|NCT00087529|530198378|FG000|Overall Study|Pregnancy|0|||
147010470|NCT00087529|530198379|FG001|Overall Study|Pregnancy|1|||
147010471|NCT00087529|530198378|FG000|Overall Study|Lost to Follow-up|2|||
147010472|NCT00087529|530198379|FG001|Overall Study|Lost to Follow-up|3|||
147010473|NCT00087529|530198378|FG000|Overall Study|Participant Decision|14|||
147010474|NCT00087529|530198379|FG001|Overall Study|Participant Decision|37|||
147010475|NCT00087529|530198378|FG000|Overall Study|Physician Decision|4|||
147010476|NCT00087529|530198379|FG001|Overall Study|Physician Decision|8|||
147010477|NCT00087529|530198378|FG000|Overall Study|Initiation of Excluded Therapy|0|||
147010478|NCT00087529|530198379|FG001|Overall Study|Initiation of Excluded Therapy|1|||
147010479|NCT00087529|530198378|FG000|Overall Study|Participant Noncompliance|0|||
147010480|NCT00087529|530198379|FG001|Overall Study|Participant Noncompliance|1|||
147010481|NCT00087529|530198378|FG000|Overall Study|Disease Progression|5|||
147010482|NCT00087529|530198379|FG001|Overall Study|Disease Progression|4|||
147010483|NCT00087529|530198378|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
147010484|NCT00087529|530198379|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
147010485|NCT01662024|530200119|FG000|Overall Study|Pregnancy|2|||
147010486|NCT01662024|530200119|FG000|Overall Study|Withdrawal by Subject|3|||
147010487|NCT00927251|530200120|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
147010488|NCT01813435|530200121|FG000|Overall Study|did not finish experimental regimen|1902|||
147010489|NCT01813435|530200122|FG001|Overall Study|did not finish experimental regimen|770|||
147010490|NCT01813435|530200121|FG000|Overall Study|Lost to Follow-up|268|||
147010491|NCT01813435|530200122|FG001|Overall Study|Lost to Follow-up|237|||
147010492|NCT01490190|530200123|FG000|Overall Study|Withdrawal by Subject|9|||
147010493|NCT01490190|530200123|FG000|Overall Study|Adverse Event|17|||
147010494|NCT01490190|530200123|FG000|Overall Study|Protocol Violation|5|||
147010495|NCT01490190|530200123|FG000|Overall Study|Lost to Follow-up|13|||
147010496|NCT01490190|530200123|FG000|Overall Study|Relocation|1|||
147010497|NCT01490190|530200123|FG000|Overall Study|Inconvenience|1|||
147010498|NCT01490190|530200123|FG000|Overall Study|Ring expulsion|2|||
147010499|NCT02435433|530200126|FG000|Overall Study|Withdrawal by Subject|2|||
147010500|NCT02435433|530200127|FG001|Overall Study|Withdrawal by Subject|3|||
147010501|NCT02435433|530200128|FG002|Overall Study|Withdrawal by Subject|1|||
147010502|NCT02435433|530200129|FG003|Overall Study|Withdrawal by Subject|0|||
147010503|NCT02435433|530200130|FG004|Overall Study|Withdrawal by Subject|0|||
147010504|NCT02435433|530200126|FG000|Overall Study|Lost to Follow-up|2|||
147010505|NCT02435433|530200127|FG001|Overall Study|Lost to Follow-up|2|||
147010506|NCT02435433|530200128|FG002|Overall Study|Lost to Follow-up|4|||
147010507|NCT02435433|530200129|FG003|Overall Study|Lost to Follow-up|1|||
147010508|NCT02435433|530200130|FG004|Overall Study|Lost to Follow-up|0|||
147010509|NCT01243151|530200131|FG000|Overall Study|Adverse Event|0|||
147010510|NCT01243151|530200132|FG001|Overall Study|Adverse Event|1|||
147010511|NCT01243151|530200133|FG002|Overall Study|Adverse Event|0|||
147010512|NCT01243151|530200134|FG003|Overall Study|Adverse Event|0|||
147010513|NCT01243151|530200135|FG004|Overall Study|Adverse Event|0|||
147010514|NCT01243151|530200131|FG000|Overall Study|Protocol Violation|0|||
147010515|NCT01243151|530200132|FG001|Overall Study|Protocol Violation|0|||
147010516|NCT01243151|530200133|FG002|Overall Study|Protocol Violation|1|||
147010517|NCT01243151|530200134|FG003|Overall Study|Protocol Violation|0|||
147010518|NCT01243151|530200135|FG004|Overall Study|Protocol Violation|0|||
147010519|NCT01243151|530200131|FG000|Overall Study|Other|0|||
147010520|NCT01243151|530200132|FG001|Overall Study|Other|0|||
147010521|NCT01243151|530200133|FG002|Overall Study|Other|0|||
147010522|NCT01243151|530200134|FG003|Overall Study|Other|1|||
147010523|NCT01243151|530200135|FG004|Overall Study|Other|0|||
147010524|NCT01243151|530200131|FG000|Overall Study|Randomized but not treated|0|||
147010525|NCT01243151|530200132|FG001|Overall Study|Randomized but not treated|0|||
147010526|NCT01243151|530200133|FG002|Overall Study|Randomized but not treated|0|||
147010527|NCT01243151|530200134|FG003|Overall Study|Randomized but not treated|1|||
147010528|NCT01243151|530200135|FG004|Overall Study|Randomized but not treated|0|||
147010529|NCT00210639|530200141|FG000|Overall Study|Lost to Follow-up|37|||
147010530|NCT00210639|530200142|FG001|Overall Study|Lost to Follow-up|29|||
147010531|NCT00210639|530200141|FG000|Overall Study|Withdrawal by Subject|8|||
147010532|NCT00210639|530200142|FG001|Overall Study|Withdrawal by Subject|1|||
147010533|NCT00210639|530200141|FG000|Overall Study|Other|18|||
147010534|NCT00210639|530200142|FG001|Overall Study|Other|12|||
147010535|NCT02786953|530200148|FG000|Overall Study|Withdrawal by Subject|3|||
147010536|NCT02786953|530200149|FG001|Overall Study|Withdrawal by Subject|0|||
147010537|NCT02786953|530200148|FG000|Overall Study|Physician Decision|0|||
147010538|NCT02786953|530200149|FG001|Overall Study|Physician Decision|1|||
147010539|NCT04697173|530200157|FG000|Overall Study|Withdrawal by Subject|34|||
147010540|NCT04697173|530200158|FG001|Overall Study|Withdrawal by Subject|38|||
147010541|NCT05004649|530200159|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
147010542|NCT05004649|530200159|FG000|Overall Study|Lost to Follow-up|1|||
147010543|NCT05004649|530200159|FG000|Overall Study|Withdrawal by Subject|2|||
147010544|NCT05004649|530200159|FG000|Overall Study|COVID-19|1|||
147010545|NCT04133311|530200161|FG000|Period 1 Double Masked Treatment Period|Death|1|||
147010546|NCT04133311|530200162|FG001|Period 1 Double Masked Treatment Period|Death|0|||
147010547|NCT04133311|530200163|FG002|Period 1 Double Masked Treatment Period|Death|0|||
147010548|NCT04133311|530200164|FG003|Period 1 Double Masked Treatment Period|Death|0|||
147010549|NCT04133311|530200161|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
147010550|NCT04133311|530200162|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
147010551|NCT04133311|530200163|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
147010552|NCT04133311|530200164|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
147010553|NCT04133311|530200161|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
147010554|NCT04133311|530200162|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
147010555|NCT04133311|530200163|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
147010556|NCT04133311|530200164|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
147010557|NCT04133311|530200161|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
147010558|NCT04133311|530200162|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
147010559|NCT04133311|530200163|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
147010560|NCT04133311|530200164|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
147010561|NCT04133311|530200161|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
147010562|NCT04133311|530200162|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
147010563|NCT04133311|530200163|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
147010564|NCT04133311|530200164|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
147010565|NCT04133311|530200161|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
147010566|NCT04133311|530200162|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
147010567|NCT04133311|530200163|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
147010568|NCT04133311|530200164|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
147010569|NCT04133311|530200161|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
147010570|NCT04133311|530200162|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
147010571|NCT04133311|530200163|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
147010572|NCT04133311|530200164|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
147010573|NCT04133311|530200161|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
147010574|NCT04133311|530200162|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
147010575|NCT04133311|530200163|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
147010576|NCT04133311|530200164|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
147010577|NCT00728754|530200167|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
147010578|NCT00728754|530200168|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
147010579|NCT00728754|530200167|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
147010580|NCT00728754|530200168|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
147010581|NCT00728754|530200167|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
147010582|NCT00728754|530200168|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
147010583|NCT01532908|530200178|FG000|Overall Study|Not Transplanted|1|||
147010584|NCT01532908|530200179|FG001|Overall Study|Not Transplanted|0|||
147010585|NCT01993940|530200180|FG000|Overall Study|Adverse Event|16|||
147010586|NCT01993940|530200181|FG001|Overall Study|Adverse Event|11|||
147010587|NCT01993940|530200180|FG000|Overall Study|Withdrawal by Subject|15|||
147010588|NCT01993940|530200181|FG001|Overall Study|Withdrawal by Subject|19|||
147010589|NCT01993940|530200180|FG000|Overall Study|Lost to Follow-up|2|||
147010590|NCT01993940|530200181|FG001|Overall Study|Lost to Follow-up|5|||
147010591|NCT01993940|530200180|FG000|Overall Study|Protocol Violation|5|||
147010592|NCT01993940|530200181|FG001|Overall Study|Protocol Violation|8|||
147010593|NCT01993940|530200180|FG000|Overall Study|Death|1|||
147010594|NCT01993940|530200181|FG001|Overall Study|Death|0|||
147010595|NCT01993940|530200180|FG000|Overall Study|Other - Miscellaneous|1|||
147010596|NCT01993940|530200181|FG001|Overall Study|Other - Miscellaneous|1|||
147010597|NCT01824498|530200182|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
147010598|NCT01824498|530200183|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
147010599|NCT01824498|530200184|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
147010600|NCT01824498|530200185|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
147010601|NCT01824498|530200186|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
147010602|NCT01824498|530200187|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
147010603|NCT01567527|530200188|FG000|Conversion Phase.|Protocol deviation|3|||
147010604|NCT01567527|530200189|FG001|Conversion Phase.|Protocol deviation|0|||
147010605|NCT01567527|530200190|FG002|Conversion Phase.|Protocol deviation|0|||
147010606|NCT01567527|530200191|FG003|Conversion Phase.|Protocol deviation|0|||
147010607|NCT01567527|530200192|FG004|Conversion Phase.|Protocol deviation|0|||
147010608|NCT01567527|530200188|FG000|Conversion Phase.|Met withdrawal criteria|10|||
147010609|NCT01567527|530200189|FG001|Conversion Phase.|Met withdrawal criteria|0|||
147010610|NCT01567527|530200190|FG002|Conversion Phase.|Met withdrawal criteria|0|||
147010611|NCT01567527|530200191|FG003|Conversion Phase.|Met withdrawal criteria|0|||
147010612|NCT01567527|530200192|FG004|Conversion Phase.|Met withdrawal criteria|0|||
147010613|NCT01567527|530200188|FG000|Conversion Phase.|Withdrawal by Subject|32|||
147010614|NCT01567527|530200189|FG001|Conversion Phase.|Withdrawal by Subject|0|||
147010615|NCT01567527|530200190|FG002|Conversion Phase.|Withdrawal by Subject|0|||
147010616|NCT01567527|530200191|FG003|Conversion Phase.|Withdrawal by Subject|0|||
147010617|NCT01567527|530200192|FG004|Conversion Phase.|Withdrawal by Subject|0|||
147010618|NCT01567527|530200188|FG000|Conversion Phase.|Lost to Follow-up|16|||
147010619|NCT01567527|530200189|FG001|Conversion Phase.|Lost to Follow-up|0|||
147010620|NCT01567527|530200190|FG002|Conversion Phase.|Lost to Follow-up|0|||
147010621|NCT01567527|530200191|FG003|Conversion Phase.|Lost to Follow-up|0|||
147010622|NCT01567527|530200192|FG004|Conversion Phase.|Lost to Follow-up|0|||
147010623|NCT01567527|530200188|FG000|Conversion Phase.|Lack of Efficacy|2|||
147010624|NCT01567527|530200189|FG001|Conversion Phase.|Lack of Efficacy|0|||
147010625|NCT01567527|530200190|FG002|Conversion Phase.|Lack of Efficacy|0|||
147010626|NCT01567527|530200191|FG003|Conversion Phase.|Lack of Efficacy|0|||
147010627|NCT01567527|530200192|FG004|Conversion Phase.|Lack of Efficacy|0|||
147010628|NCT01567527|530200188|FG000|Conversion Phase.|Adverse Event|33|||
147010629|NCT01567527|530200189|FG001|Conversion Phase.|Adverse Event|0|||
147010630|NCT01567527|530200190|FG002|Conversion Phase.|Adverse Event|0|||
147010631|NCT01567527|530200191|FG003|Conversion Phase.|Adverse Event|0|||
147010632|NCT01567527|530200192|FG004|Conversion Phase.|Adverse Event|0|||
147010633|NCT01567527|530200188|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
146848085|NCT00929110|529614012|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
146848086|NCT00929110|529614010|FG000|Overall Study|Lost to Follow-up|7|||
147010634|NCT01567527|530200189|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
147010635|NCT01567527|530200190|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
147010636|NCT01567527|530200191|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
147010637|NCT01567527|530200192|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
147010638|NCT01567527|530200188|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
147010639|NCT01567527|530200189|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
147010640|NCT01567527|530200190|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
147010641|NCT01567527|530200191|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
146848087|NCT00929110|529614011|FG001|Overall Study|Lost to Follow-up|7|||
147010642|NCT01567527|530200192|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
147010643|NCT01567527|530200188|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
147010644|NCT01567527|530200189|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
147010645|NCT01567527|530200190|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
147010646|NCT01567527|530200191|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
147010647|NCT01567527|530200192|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
147010648|NCT01567527|530200188|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
147010649|NCT01567527|530200189|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
147010650|NCT01567527|530200190|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
147010651|NCT01567527|530200191|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
147010652|NCT01567527|530200192|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
147010653|NCT01567527|530200188|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
147010654|NCT01567527|530200189|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
147010655|NCT01567527|530200190|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
147010656|NCT01567527|530200191|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
147010657|NCT01567527|530200192|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
147010658|NCT01567527|530200188|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
147010659|NCT01567527|530200189|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
147010660|NCT01567527|530200190|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
147010661|NCT01567527|530200191|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
147010662|NCT01567527|530200192|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
147010663|NCT01567527|530200188|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
147010664|NCT01567527|530200189|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
147010665|NCT01567527|530200190|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
147010666|NCT01567527|530200191|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
147010667|NCT01567527|530200192|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
147010668|NCT01567527|530200188|FG000|IM Depot Stabilization.|Protocol deviation|0|||
147010669|NCT01567527|530200189|FG001|IM Depot Stabilization.|Protocol deviation|0|||
147010670|NCT01567527|530200190|FG002|IM Depot Stabilization.|Protocol deviation|5|||
147010671|NCT01567527|530200191|FG003|IM Depot Stabilization.|Protocol deviation|0|||
147010672|NCT01567527|530200192|FG004|IM Depot Stabilization.|Protocol deviation|0|||
147010673|NCT01567527|530200188|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
147010674|NCT01567527|530200189|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
147010675|NCT01567527|530200190|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
147010676|NCT01567527|530200191|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
147010677|NCT01567527|530200192|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
147010678|NCT01567527|530200188|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
147010679|NCT01567527|530200189|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
147010680|NCT01567527|530200190|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
147010681|NCT01567527|530200191|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
147010682|NCT01567527|530200192|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
147010683|NCT01567527|530200188|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
147010684|NCT01567527|530200189|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
147010685|NCT01567527|530200190|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
147010686|NCT01567527|530200191|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
147010687|NCT01567527|530200192|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
147010688|NCT01567527|530200188|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
147010689|NCT01567527|530200189|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
147010690|NCT01567527|530200190|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
147010691|NCT01567527|530200191|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
147010692|NCT01567527|530200192|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
147010693|NCT01567527|530200188|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
147010694|NCT01567527|530200189|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
147010695|NCT01567527|530200190|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
147010696|NCT01567527|530200191|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
147010697|NCT01567527|530200192|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
147010698|NCT01567527|530200188|FG000|IM Depot Stabilization.|Adverse Event|0|||
147010699|NCT01567527|530200189|FG001|IM Depot Stabilization.|Adverse Event|0|||
147010700|NCT01567527|530200190|FG002|IM Depot Stabilization.|Adverse Event|37|||
147010701|NCT01567527|530200191|FG003|IM Depot Stabilization.|Adverse Event|0|||
147010702|NCT01567527|530200192|FG004|IM Depot Stabilization.|Adverse Event|0|||
147010703|NCT01567527|530200188|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
147010704|NCT01567527|530200189|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
147010705|NCT01567527|530200190|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
147010706|NCT01567527|530200191|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
147010707|NCT01567527|530200192|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
147010708|NCT01567527|530200188|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
147010709|NCT01567527|530200189|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
147010710|NCT01567527|530200190|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
147010711|NCT01567527|530200191|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
147010712|NCT01567527|530200192|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
147010713|NCT01567527|530200188|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
147010714|NCT01567527|530200189|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
147010715|NCT01567527|530200190|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
147010716|NCT01567527|530200191|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
147010717|NCT01567527|530200192|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
147010718|NCT01567527|530200188|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
147010719|NCT01567527|530200189|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
147010720|NCT01567527|530200190|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
147010721|NCT01567527|530200191|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
147010722|NCT01567527|530200192|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
147010723|NCT01567527|530200188|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
147010724|NCT01567527|530200189|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
147010725|NCT01567527|530200190|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
147010726|NCT01567527|530200191|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
147010727|NCT01567527|530200192|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
147010728|NCT01567527|530200188|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
147010729|NCT01567527|530200189|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
147010730|NCT01567527|530200190|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
147010731|NCT01567527|530200191|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
147010732|NCT01567527|530200192|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
147010733|NCT01567527|530200188|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
147010734|NCT01567527|530200189|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
147010735|NCT01567527|530200190|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
147010736|NCT01567527|530200191|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
147010737|NCT01567527|530200192|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
147010738|NCT01567527|530200188|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
147010739|NCT01567527|530200189|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
147010740|NCT01567527|530200190|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
147010741|NCT01567527|530200191|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
147010742|NCT01567527|530200192|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
147010743|NCT01567527|530200188|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
147010744|NCT01567527|530200189|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
147010745|NCT01567527|530200190|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
147010746|NCT01567527|530200191|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
147010747|NCT01567527|530200192|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
147010748|NCT02311894|530200194|FG000|Overall Study|Discontinued in error|1|||
147010749|NCT02311894|530200194|FG000|Overall Study|Lost to Follow-up|1|||
147010750|NCT02311894|530200194|FG000|Overall Study|Adverse Event|1|||
147010751|NCT02311894|530200194|FG000|Overall Study|Withdrawal by Subject|1|||
147010752|NCT01050764|530200197|FG000|Overall Study|Death, before HSCT|1|||
147010753|NCT01050764|530200197|FG000|Overall Study|Donor mobilization failure, death|1|||
147010754|NCT01050764|530200197|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
147010755|NCT01528735|530200207|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
147010756|NCT01528735|530200208|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
147010757|NCT01528735|530200207|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
147010758|NCT01528735|530200208|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
147010759|NCT00556673|530200209|FG000|Overall Study|Protocol deviation|3|||
147010760|NCT00556673|530200210|FG001|Overall Study|Protocol deviation|2|||
147010761|NCT00757172|530200211|FG000|Overall Study|Withdrawal by Subject|4|||
147010762|NCT00757172|530200211|FG000|Overall Study|Physician Decision|3|||
147010763|NCT00757172|530200211|FG000|Overall Study|Progression|4|||
147010764|NCT00494013|530200212|FG000|Overall Study|Adverse Event|0|||
147010765|NCT00494013|530200213|FG001|Overall Study|Adverse Event|1|||
147010766|NCT00494013|530200212|FG000|Overall Study|Entry Criteria Not Met|1|||
147010767|NCT00494013|530200213|FG001|Overall Study|Entry Criteria Not Met|4|||
147010768|NCT00494013|530200212|FG000|Overall Study|Lost to Follow-up|5|||
147010769|NCT00494013|530200213|FG001|Overall Study|Lost to Follow-up|6|||
147010770|NCT00494013|530200212|FG000|Overall Study|Physician Decision|3|||
147010771|NCT00494013|530200213|FG001|Overall Study|Physician Decision|5|||
147010772|NCT00494013|530200212|FG000|Overall Study|Protocol Violation|8|||
147010773|NCT00494013|530200213|FG001|Overall Study|Protocol Violation|5|||
147010774|NCT00494013|530200212|FG000|Overall Study|Withdrawal by Subject|13|||
147010775|NCT00494013|530200213|FG001|Overall Study|Withdrawal by Subject|14|||
147010776|NCT00494013|530200212|FG000|Overall Study|Sponsor Decision|0|||
147010777|NCT00494013|530200213|FG001|Overall Study|Sponsor Decision|1|||
147010778|NCT04194151|530200214|FG000|Overall Study|Physician Decision|1|||
147010779|NCT04194151|530200215|FG001|Overall Study|Physician Decision|1|||
147010780|NCT04194151|530200216|FG002|Overall Study|Physician Decision|1|||
147010781|NCT04194151|530200217|FG003|Overall Study|Physician Decision|1|||
147010782|NCT04194151|530200218|FG004|Overall Study|Physician Decision|0|||
147010783|NCT04194151|530200219|FG005|Overall Study|Physician Decision|1|||
147010784|NCT04194151|530200214|FG000|Overall Study|Monitorization problem|0|||
147010785|NCT04194151|530200215|FG001|Overall Study|Monitorization problem|1|||
147010786|NCT04194151|530200216|FG002|Overall Study|Monitorization problem|0|||
147010787|NCT04194151|530200217|FG003|Overall Study|Monitorization problem|0|||
147010788|NCT04194151|530200218|FG004|Overall Study|Monitorization problem|0|||
147010789|NCT04194151|530200219|FG005|Overall Study|Monitorization problem|0|||
147010790|NCT04203823|530200220|FG000|Overall Study|Withdrawal by Subject|2|||
147010791|NCT04203823|530200221|FG001|Overall Study|Withdrawal by Subject|2|||
147010792|NCT04203823|530200220|FG000|Overall Study|Adverse Event|1|||
147010793|NCT04203823|530200221|FG001|Overall Study|Adverse Event|1|||
147010794|NCT04203823|530200220|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147010795|NCT04203823|530200221|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
147010796|NCT01499043|530200222|FG000|Overall Study|Progressive disease (radiographic)|2|||
147010797|NCT01499043|530200222|FG000|Overall Study|Progressive disease (clinical)|1|||
147010798|NCT01499043|530200222|FG000|Overall Study|Withdrawal by Subject|2|||
147010799|NCT01499043|530200222|FG000|Overall Study|Adverse Event|1|||
147010800|NCT03193021|530200223|FG000|Overall Study|Lost to Follow-up|1|||
147010801|NCT03193021|530200224|FG001|Overall Study|Lost to Follow-up|1|||
147010802|NCT02286466|530200225|FG000|Overall Study|Death|1|||
147010803|NCT02286466|530200226|FG001|Overall Study|Death|3|||
147010804|NCT02286466|530200225|FG000|Overall Study|Withdrawal by Subject|5|||
147010805|NCT02286466|530200226|FG001|Overall Study|Withdrawal by Subject|2|||
147010806|NCT02286466|530200225|FG000|Overall Study|Lost to Follow-up|1|||
147010807|NCT02286466|530200226|FG001|Overall Study|Lost to Follow-up|4|||
147010808|NCT02286466|530200225|FG000|Overall Study|Declined Clinician Assessment|0|||
147010809|NCT02286466|530200226|FG001|Overall Study|Declined Clinician Assessment|1|||
147010810|NCT00835081|530200227|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
147010811|NCT00835081|530200228|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
147010812|NCT00421304|530200229|FG000|Overall Study|Lost to Follow-up|5|||
147010813|NCT00421304|530200230|FG001|Overall Study|Lost to Follow-up|2|||
147010814|NCT00421304|530200231|FG002|Overall Study|Lost to Follow-up|5|||
147010815|NCT00421304|530200229|FG000|Overall Study|Withdrawal by Subject|2|||
147010816|NCT00421304|530200230|FG001|Overall Study|Withdrawal by Subject|2|||
147010817|NCT00421304|530200231|FG002|Overall Study|Withdrawal by Subject|2|||
147010818|NCT00421304|530200229|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
147010819|NCT00421304|530200230|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
147010820|NCT00421304|530200231|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
147010821|NCT00421304|530200229|FG000|Overall Study|Did not attend Day 360 visit|0|||
147010822|NCT00421304|530200230|FG001|Overall Study|Did not attend Day 360 visit|0|||
147010823|NCT00421304|530200231|FG002|Overall Study|Did not attend Day 360 visit|1|||
147010824|NCT04750239|530200232|FG000|Overall Study|Withdrawal by Subject|2|||
147010825|NCT04750239|530200232|FG000|Overall Study|Trial terminated by sponsor|1|||
147010826|NCT01912807|530200233|FG000|Overall Study|Did not meet elegibility criteria|6|||
147010827|NCT01912807|530200234|FG001|Overall Study|Did not meet elegibility criteria|4|||
147010828|NCT01912807|530200233|FG000|Overall Study|Lost to Follow-up|36|||
147010829|NCT01912807|530200234|FG001|Overall Study|Lost to Follow-up|37|||
147010830|NCT00919711|530200235|FG000|Overall Study|Withdrawal by Subject|15|||
147010831|NCT00919711|530200236|FG001|Overall Study|Withdrawal by Subject|7|||
147010832|NCT00919711|530200235|FG000|Overall Study|Adverse Event|13|||
147010833|NCT00919711|530200236|FG001|Overall Study|Adverse Event|3|||
147010834|NCT00919711|530200235|FG000|Overall Study|Other|1|||
147010835|NCT00919711|530200236|FG001|Overall Study|Other|2|||
147010836|NCT00919711|530200235|FG000|Overall Study|Administrative Decision|0|||
147010837|NCT00919711|530200236|FG001|Overall Study|Administrative Decision|1|||
147010838|NCT00919711|530200235|FG000|Overall Study|Lost to Follow-up|2|||
147010839|NCT00919711|530200236|FG001|Overall Study|Lost to Follow-up|0|||
147010840|NCT00919711|530200235|FG000|Overall Study|Death|1|||
147010841|NCT00919711|530200236|FG001|Overall Study|Death|0|||
147010842|NCT00919711|530200235|FG000|Overall Study|Noncompliance|1|||
147010843|NCT00919711|530200236|FG001|Overall Study|Noncompliance|0|||
147010844|NCT02614196|530200237|FG000|Double Blind Treatment Phase|Adverse Event|8|||
147010845|NCT02614196|530200238|FG001|Double Blind Treatment Phase|Adverse Event|5|||
147010846|NCT02614196|530200239|FG002|Double Blind Treatment Phase|Adverse Event|9|||
147010847|NCT02614196|530200240|FG003|Double Blind Treatment Phase|Adverse Event|0|||
147010848|NCT02614196|530200241|FG004|Double Blind Treatment Phase|Adverse Event|0|||
147010849|NCT02614196|530200242|FG005|Double Blind Treatment Phase|Adverse Event|0|||
147010850|NCT02614196|530200237|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
147010851|NCT02614196|530200238|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
147010852|NCT02614196|530200239|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
147010853|NCT02614196|530200240|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
147010854|NCT02614196|530200241|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
147010855|NCT02614196|530200242|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
147010856|NCT02614196|530200237|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
147010857|NCT02614196|530200238|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
147010858|NCT02614196|530200239|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
147010859|NCT02614196|530200240|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
147010860|NCT02614196|530200241|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
147010861|NCT02614196|530200242|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
147010862|NCT02614196|530200237|FG000|Double Blind Treatment Phase|Physician Decision|4|||
147010863|NCT02614196|530200238|FG001|Double Blind Treatment Phase|Physician Decision|0|||
147010864|NCT02614196|530200239|FG002|Double Blind Treatment Phase|Physician Decision|2|||
147010865|NCT02614196|530200240|FG003|Double Blind Treatment Phase|Physician Decision|0|||
147010866|NCT02614196|530200241|FG004|Double Blind Treatment Phase|Physician Decision|0|||
147010867|NCT02614196|530200242|FG005|Double Blind Treatment Phase|Physician Decision|0|||
147010868|NCT02614196|530200237|FG000|Double Blind Treatment Phase|Pregnancy|1|||
147010869|NCT02614196|530200238|FG001|Double Blind Treatment Phase|Pregnancy|2|||
147010870|NCT02614196|530200239|FG002|Double Blind Treatment Phase|Pregnancy|0|||
147010871|NCT02614196|530200240|FG003|Double Blind Treatment Phase|Pregnancy|0|||
147010872|NCT02614196|530200241|FG004|Double Blind Treatment Phase|Pregnancy|0|||
147010873|NCT02614196|530200242|FG005|Double Blind Treatment Phase|Pregnancy|0|||
147010874|NCT02614196|530200237|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
147010875|NCT02614196|530200238|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
147010876|NCT02614196|530200239|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
147010877|NCT02614196|530200240|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
147010878|NCT02614196|530200241|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
147010879|NCT02614196|530200242|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
147010880|NCT02614196|530200237|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
147010881|NCT02614196|530200238|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
147010882|NCT02614196|530200239|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
147010883|NCT02614196|530200240|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
147010884|NCT02614196|530200241|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
147010885|NCT02614196|530200242|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
147010886|NCT02614196|530200237|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
147010887|NCT02614196|530200238|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
147010888|NCT02614196|530200239|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
147010889|NCT02614196|530200240|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
147010890|NCT02614196|530200241|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
147010891|NCT02614196|530200242|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
147010892|NCT02614196|530200237|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
147010893|NCT02614196|530200238|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
147010894|NCT02614196|530200239|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
147010895|NCT02614196|530200240|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
147010896|NCT02614196|530200241|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
147010897|NCT02614196|530200242|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
147010898|NCT02614196|530200237|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
147010899|NCT02614196|530200238|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
147010900|NCT02614196|530200239|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
147010901|NCT02614196|530200240|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
147010902|NCT02614196|530200241|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
147010903|NCT02614196|530200242|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
147010904|NCT02614196|530200237|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
147010905|NCT02614196|530200238|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
147010906|NCT02614196|530200239|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
147010907|NCT02614196|530200240|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
147010908|NCT02614196|530200241|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
147010909|NCT02614196|530200242|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
146848088|NCT00929110|529614012|FG002|Overall Study|Lost to Follow-up|3|||
146848089|NCT00929110|529614010|FG000|Overall Study|Protocol deviation|5|||
147010910|NCT02614196|530200237|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
147010911|NCT02614196|530200238|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
147010912|NCT02614196|530200239|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
147010913|NCT02614196|530200240|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
147010914|NCT02614196|530200241|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
147010915|NCT02614196|530200242|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
147010916|NCT02614196|530200237|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
147010917|NCT02614196|530200238|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
147010918|NCT02614196|530200239|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
147010919|NCT02614196|530200240|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
147010920|NCT02614196|530200241|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
147010921|NCT02614196|530200242|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
147010922|NCT00903877|530200243|FG000|Overall Study|Did not meet study criteria|33|||
147010923|NCT00903877|530200243|FG000|Overall Study|Withdrawal by Subject|3|||
147010924|NCT00903877|530200243|FG000|Overall Study|Adverse Event|2|||
147010925|NCT00903877|530200243|FG000|Overall Study|Lost to Follow-up|1|||
147010926|NCT00903877|530200243|FG000|Overall Study|Participation put on hold|4|||
147010927|NCT01562613|530200244|FG000|Overall Study|Lost to Follow-up|2|||
147010928|NCT01562613|530200244|FG000|Overall Study|Withdrawal by Subject|2|||
147010929|NCT04388787|530200245|FG000|Blinded Period|Patient could not follow instructions|1|||
147010930|NCT04388787|530200245|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
147010931|NCT00663234|530200246|FG000|Overall Study|Not willing to adhere to requirements|1|||
147010932|NCT01253564|530200249|FG000|Overall Study|Disease Progression|22|||
147010933|NCT01253564|530200249|FG000|Overall Study|Withdrawal by Subject|1|||
147010934|NCT01253564|530200249|FG000|Overall Study|Serious Adverse Event|1|||
147010935|NCT01751087|530200252|FG000|Overall Study|Withdrawal by Subject|1|||
147010936|NCT01751087|530200253|FG001|Overall Study|Withdrawal by Subject|0|||
147010937|NCT01751087|530200254|FG002|Overall Study|Withdrawal by Subject|0|||
147010938|NCT01751087|530200252|FG000|Overall Study|Physician Decision|0|||
147010939|NCT01751087|530200253|FG001|Overall Study|Physician Decision|0|||
147010940|NCT01751087|530200254|FG002|Overall Study|Physician Decision|1|||
147010941|NCT01520987|530201911|FG000|Overall Study|Withdrawal by Subject|1|||
147010942|NCT01520987|530201912|FG001|Overall Study|Withdrawal by Subject|0|||
147010943|NCT01520987|530201913|FG002|Overall Study|Withdrawal by Subject|0|||
147010944|NCT01520987|530201914|FG003|Overall Study|Withdrawal by Subject|0|||
147010945|NCT01520987|530201915|FG004|Overall Study|Withdrawal by Subject|0|||
147010946|NCT01520987|530201916|FG005|Overall Study|Withdrawal by Subject|1|||
147010947|NCT01520987|530201917|FG006|Overall Study|Withdrawal by Subject|0|||
147010948|NCT01520987|530201918|FG007|Overall Study|Withdrawal by Subject|0|||
147010949|NCT02005562|530201919|FG000|Overall Study|Death|2|||
147010950|NCT02005562|530201920|FG001|Overall Study|Death|2|||
147010951|NCT02005562|530201919|FG000|Overall Study|Graft loss|7|||
147010952|NCT02005562|530201920|FG001|Overall Study|Graft loss|6|||
147010953|NCT02005562|530201919|FG000|Overall Study|Withdrawal by Subject|2|||
147010954|NCT02005562|530201920|FG001|Overall Study|Withdrawal by Subject|2|||
147010955|NCT02005562|530201919|FG000|Overall Study|No transplant|1|||
147010956|NCT02005562|530201920|FG001|Overall Study|No transplant|4|||
147010957|NCT02005562|530201919|FG000|Overall Study|Physician Decision|0|||
147010958|NCT02005562|530201920|FG001|Overall Study|Physician Decision|1|||
147010959|NCT04729101|530201921|FG000|Overall Study|Adverse Event|1|||
147010960|NCT04729101|530201922|FG001|Overall Study|Adverse Event|0|||
147010961|NCT04729101|530201921|FG000|Overall Study|Physician Decision|1|||
147010962|NCT04729101|530201922|FG001|Overall Study|Physician Decision|0|||
147010963|NCT04729101|530201921|FG000|Overall Study|Withdrawal by Subject|1|||
147010964|NCT04729101|530201922|FG001|Overall Study|Withdrawal by Subject|0|||
147010965|NCT02940522|530201923|FG000|Overall Study|Lost to Follow-up|1|||
147010966|NCT02940522|530201924|FG001|Overall Study|Lost to Follow-up|2|||
147010967|NCT02940522|530201923|FG000|Overall Study|Withdrawal by Subject|1|||
147010968|NCT02940522|530201924|FG001|Overall Study|Withdrawal by Subject|0|||
147010969|NCT00274625|530201925|FG000|Overall Study|Lost to Follow-up|46|||
147010970|NCT00274625|530201926|FG001|Overall Study|Lost to Follow-up|54|||
147010971|NCT00274625|530201925|FG000|Overall Study|Excluded from analysis|14|||
147010972|NCT00274625|530201926|FG001|Overall Study|Excluded from analysis|8|||
147010973|NCT00762411|530201929|FG000|Initial Treatment|Death|7|||
147010974|NCT00762411|530201930|FG001|Initial Treatment|Death|6|||
147010975|NCT00762411|530201929|FG000|Initial Treatment|Adverse Event|132|||
147010976|NCT00762411|530201930|FG001|Initial Treatment|Adverse Event|40|||
147010977|NCT00762411|530201929|FG000|Initial Treatment|Protocol Violation|4|||
147010978|NCT00762411|530201930|FG001|Initial Treatment|Protocol Violation|1|||
147010979|NCT00762411|530201929|FG000|Initial Treatment|Withdrawal by Subject|65|||
147010980|NCT00762411|530201930|FG001|Initial Treatment|Withdrawal by Subject|52|||
147010981|NCT00762411|530201929|FG000|Initial Treatment|Physician Decision|1|||
147010982|NCT00762411|530201930|FG001|Initial Treatment|Physician Decision|0|||
147010983|NCT00762411|530201929|FG000|Initial Treatment|Sponsor Decision|293|||
147010984|NCT00762411|530201930|FG001|Initial Treatment|Sponsor Decision|401|||
147010985|NCT00762411|530201929|FG000|Initial Treatment|Lost to Follow-up|5|||
147010986|NCT00762411|530201930|FG001|Initial Treatment|Lost to Follow-up|0|||
147010987|NCT00762411|530201929|FG000|Initial Treatment|Caregiver Decision|21|||
147010988|NCT00762411|530201930|FG001|Initial Treatment|Caregiver Decision|16|||
147010989|NCT00762411|530201929|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
147010990|NCT00762411|530201930|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
147010991|NCT00762411|530201929|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
147010992|NCT00762411|530201930|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
147010993|NCT00762411|530201929|FG000|Delayed Start|Adverse Event|0|||
146848090|NCT00929110|529614011|FG001|Overall Study|Protocol deviation|2|||
147010994|NCT00762411|530201930|FG001|Delayed Start|Adverse Event|4|||
147010995|NCT00762411|530201929|FG000|Delayed Start|Protocol Violation|0|||
147010996|NCT00762411|530201930|FG001|Delayed Start|Protocol Violation|1|||
147010997|NCT00762411|530201929|FG000|Delayed Start|Sponsor Decision|16|||
147010998|NCT00762411|530201930|FG001|Delayed Start|Sponsor Decision|20|||
147010999|NCT00762411|530201929|FG000|Delayed Start|Caregiver Decision|1|||
147011000|NCT00762411|530201930|FG001|Delayed Start|Caregiver Decision|1|||
147011001|NCT00762411|530201929|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
147011002|NCT00762411|530201930|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
147011003|NCT00762411|530201929|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
147011004|NCT00762411|530201930|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
147011005|NCT00762411|530201929|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
147011006|NCT00762411|530201930|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
147011007|NCT00762411|530201929|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
147011008|NCT00762411|530201930|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
147011009|NCT00762411|530201929|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
147011010|NCT00762411|530201930|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
147011011|NCT00762411|530201929|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
147011012|NCT00762411|530201930|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
147011013|NCT02710214|530201934|FG000|Overall Study|Lost to Follow-up|1|||
147011014|NCT02710214|530201935|FG001|Overall Study|Lost to Follow-up|0|||
147011015|NCT02710214|530201934|FG000|Overall Study|Lack of Efficacy|0|||
147011016|NCT02710214|530201935|FG001|Overall Study|Lack of Efficacy|1|||
147011017|NCT02710214|530201934|FG000|Overall Study|Death|0|||
147011018|NCT02710214|530201935|FG001|Overall Study|Death|1|||
147011019|NCT02832167|530201936|FG000|Treatment Period 1|Disease progression|90|||
147011020|NCT02832167|530201936|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
147011021|NCT02832167|530201936|FG000|Treatment Period 1|Death|2|||
147011022|NCT02832167|530201936|FG000|Treatment Period 1|Study Drug Toxicity|6|||
147011023|NCT02832167|530201936|FG000|Treatment Period 1|Participant request to discontinue|9|||
147011024|NCT02832167|530201936|FG000|Treatment Period 1|No longer meet study criteria|1|||
147011025|NCT02832167|530201936|FG000|Treatment Period 1|Participant withdrew consent|3|||
147011026|NCT02832167|530201936|FG000|Treatment Period 1|Other reasons|6|||
147011027|NCT02832167|530201936|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
147011028|NCT02832167|530201936|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
147011029|NCT02832167|530201936|FG000|Transition From Period 1 to Period 2|Death|2|||
147011030|NCT02832167|530201936|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
147011031|NCT02832167|530201936|FG000|Treatment Period 2|Disease progression|69|||
147011032|NCT02832167|530201936|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
147011033|NCT02832167|530201936|FG000|Treatment Period 2|Maximum clinical benefit|1|||
147011034|NCT02832167|530201936|FG000|Treatment Period 2|Study Drug Toxicity|5|||
147011035|NCT02832167|530201936|FG000|Treatment Period 2|Participant request to discontinue|2|||
147011036|NCT02832167|530201936|FG000|Treatment Period 2|Participant withdrew consent|3|||
147011037|NCT02832167|530201936|FG000|Treatment Period 2|Other reasons|3|||
147011038|NCT01754376|530201937|FG000|Overall Study|Adverse Event|1|||
147011039|NCT01754376|530201937|FG000|Overall Study|Lack of Efficacy|2|||
147011040|NCT04556734|530201938|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
147011041|NCT04556734|530201939|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
147011042|NCT04556734|530201940|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
147011043|NCT04556734|530201941|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147011044|NCT04556734|530201942|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147011045|NCT04556734|530201943|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147011046|NCT04556734|530201944|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147011047|NCT04556734|530201945|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147011048|NCT04556734|530201938|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
147011049|NCT04556734|530201939|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
147011050|NCT04556734|530201940|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
147011051|NCT04556734|530201941|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
147011052|NCT04556734|530201942|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
147011053|NCT04556734|530201943|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
147011054|NCT04556734|530201944|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
147011055|NCT04556734|530201945|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
147011056|NCT04556734|530201938|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
147011057|NCT04556734|530201939|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147011058|NCT04556734|530201940|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
147011059|NCT04556734|530201941|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147011060|NCT04556734|530201942|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147011061|NCT04556734|530201943|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147011062|NCT04556734|530201944|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147011063|NCT04556734|530201945|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146848091|NCT00929110|529614012|FG002|Overall Study|Protocol deviation|4|||
147011064|NCT04556734|530201938|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
147011065|NCT04556734|530201939|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147011066|NCT04556734|530201940|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147011067|NCT04556734|530201941|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147011068|NCT04556734|530201942|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147011069|NCT04556734|530201943|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147011070|NCT04556734|530201944|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147011071|NCT04556734|530201945|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147011072|NCT04556734|530201938|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
147011073|NCT04556734|530201939|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
147011074|NCT04556734|530201940|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
147011075|NCT04556734|530201941|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
147011076|NCT04556734|530201942|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
147011077|NCT04556734|530201943|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
147011078|NCT04556734|530201944|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
147011079|NCT04556734|530201945|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
147011080|NCT04556734|530201938|FG000|OLE Period (28 Weeks)|Not reported|0|||
147011081|NCT04556734|530201939|FG001|OLE Period (28 Weeks)|Not reported|0|||
147011082|NCT04556734|530201940|FG002|OLE Period (28 Weeks)|Not reported|0|||
147011083|NCT04556734|530201941|FG003|OLE Period (28 Weeks)|Not reported|0|||
147011084|NCT04556734|530201942|FG004|OLE Period (28 Weeks)|Not reported|0|||
147011085|NCT04556734|530201943|FG005|OLE Period (28 Weeks)|Not reported|1|||
147011086|NCT04556734|530201944|FG006|OLE Period (28 Weeks)|Not reported|0|||
147011087|NCT04556734|530201945|FG007|OLE Period (28 Weeks)|Not reported|0|||
147011088|NCT04556734|530201938|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147011089|NCT04556734|530201939|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147011090|NCT04556734|530201940|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147011091|NCT04556734|530201941|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147011092|NCT04556734|530201942|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147011093|NCT04556734|530201943|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147011094|NCT04556734|530201944|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147011095|NCT04556734|530201945|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
147011096|NCT04556734|530201938|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
147011097|NCT04556734|530201939|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
147011098|NCT04556734|530201940|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
147011099|NCT04556734|530201941|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
147011100|NCT04556734|530201942|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
147011101|NCT04556734|530201943|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
147011102|NCT04556734|530201944|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
147011103|NCT04556734|530201945|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
147011104|NCT04556734|530201938|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
147011105|NCT04556734|530201939|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
147011106|NCT04556734|530201940|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
147011107|NCT04556734|530201941|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
147011108|NCT04556734|530201942|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
147011109|NCT04556734|530201943|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
147011110|NCT04556734|530201944|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
147011111|NCT04556734|530201945|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
147011112|NCT04264819|530201951|FG000|Overall Study|Physician Decision|19|||
147011113|NCT04264819|530201951|FG000|Overall Study|Adverse Event|12|||
147011114|NCT04264819|530201951|FG000|Overall Study|Withdrawal by Subject|11|||
147011115|NCT04264819|530201951|FG000|Overall Study|Lost to Follow-up|2|||
147011116|NCT04264819|530201951|FG000|Overall Study|Death|2|||
147011117|NCT01680016|530201952|FG000|Overall Study|Adverse Event|0|||
147011118|NCT01680016|530201953|FG001|Overall Study|Adverse Event|0|||
147011119|NCT01680016|530201954|FG002|Overall Study|Adverse Event|1|||
147011120|NCT01680016|530201955|FG003|Overall Study|Adverse Event|4|||
147011121|NCT01680016|530201952|FG000|Overall Study|The Subject went out of The Trial|1|||
147011122|NCT01680016|530201953|FG001|Overall Study|The Subject went out of The Trial|0|||
147011123|NCT01680016|530201954|FG002|Overall Study|The Subject went out of The Trial|3|||
147011124|NCT01680016|530201955|FG003|Overall Study|The Subject went out of The Trial|0|||
147011125|NCT01680016|530201952|FG000|Overall Study|Protocol Violation|0|||
146848092|NCT00929110|529614010|FG000|Overall Study|Administrative problems|4|||
147011126|NCT01680016|530201953|FG001|Overall Study|Protocol Violation|1|||
147011127|NCT01680016|530201954|FG002|Overall Study|Protocol Violation|0|||
147011128|NCT01680016|530201955|FG003|Overall Study|Protocol Violation|0|||
146848093|NCT00929110|529614011|FG001|Overall Study|Administrative problems|1|||
147011129|NCT01680016|530201952|FG000|Overall Study|Withdrawal by Subject|5|||
147011130|NCT01680016|530201953|FG001|Overall Study|Withdrawal by Subject|7|||
147011131|NCT01680016|530201954|FG002|Overall Study|Withdrawal by Subject|1|||
147011132|NCT01680016|530201955|FG003|Overall Study|Withdrawal by Subject|1|||
147011133|NCT02846883|530201961|FG000|Overall Study|Death|0|||
147011134|NCT02846883|530201962|FG001|Overall Study|Death|1|||
147011135|NCT02846883|530201963|FG002|Overall Study|Death|1|||
147011136|NCT02846883|530201961|FG000|Overall Study|Lost to Follow-up|0|||
147011137|NCT02846883|530201962|FG001|Overall Study|Lost to Follow-up|0|||
147011138|NCT02846883|530201963|FG002|Overall Study|Lost to Follow-up|1|||
147011139|NCT02846883|530201961|FG000|Overall Study|Withdrawal by Subject|1|||
147011140|NCT02846883|530201962|FG001|Overall Study|Withdrawal by Subject|0|||
147011141|NCT02846883|530201963|FG002|Overall Study|Withdrawal by Subject|0|||
147011142|NCT02846883|530201961|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
147011143|NCT02846883|530201962|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
147011144|NCT02846883|530201963|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
147011145|NCT02846883|530201961|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
147011146|NCT02846883|530201962|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
147011147|NCT02846883|530201963|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
147011148|NCT04768296|530201965|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
147011149|NCT04768296|530201966|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
147011150|NCT02655224|530201973|FG000|Overall Study|Adverse Event|1|||
147011151|NCT02655224|530201974|FG001|Overall Study|Adverse Event|1|||
147011152|NCT01119625|530201975|FG000|Overall Study|Lost to Follow-up|1|||
147011153|NCT01119625|530201976|FG001|Overall Study|Lost to Follow-up|2|||
147011154|NCT01119625|530201975|FG000|Overall Study|Withdrawal by Subject|2|||
147011155|NCT01119625|530201976|FG001|Overall Study|Withdrawal by Subject|1|||
147011156|NCT01119625|530201975|FG000|Overall Study|Other|0|||
147011157|NCT01119625|530201976|FG001|Overall Study|Other|1|||
147011158|NCT00397254|530201979|FG000|Overall Study|Lost to Follow-up|2|||
147011159|NCT00397254|530201980|FG001|Overall Study|Lost to Follow-up|2|||
147011160|NCT02627963|530201981|FG000|Overall Study|Randomized but not treated|2|||
147011161|NCT02627963|530201982|FG001|Overall Study|Randomized but not treated|6|||
147011162|NCT03073798|530201986|FG000|Overall Study|Adverse Event|1|||
147011163|NCT03073798|530201986|FG000|Overall Study|Withdrawal by Subject|1|||
147011164|NCT02372006|530201991|FG000|Overall Study|Progressive disease|8|||
147011165|NCT02372006|530201992|FG001|Overall Study|Progressive disease|7|||
147011166|NCT02372006|530201993|FG002|Overall Study|Progressive disease|34|||
147011167|NCT02372006|530201991|FG000|Overall Study|Dose limiting toxicity|0|||
147011168|NCT02372006|530201992|FG001|Overall Study|Dose limiting toxicity|1|||
147011169|NCT02372006|530201993|FG002|Overall Study|Dose limiting toxicity|0|||
147011170|NCT02372006|530201991|FG000|Overall Study|Adverse Event|0|||
147011171|NCT02372006|530201992|FG001|Overall Study|Adverse Event|0|||
147011172|NCT02372006|530201993|FG002|Overall Study|Adverse Event|3|||
147011173|NCT02372006|530201991|FG000|Overall Study|Withdrawal by Subject|0|||
147011174|NCT02372006|530201992|FG001|Overall Study|Withdrawal by Subject|1|||
147011175|NCT02372006|530201993|FG002|Overall Study|Withdrawal by Subject|1|||
147011176|NCT02372006|530201991|FG000|Overall Study|Other reason for not completing|0|||
147011177|NCT02372006|530201992|FG001|Overall Study|Other reason for not completing|0|||
147011178|NCT02372006|530201993|FG002|Overall Study|Other reason for not completing|1|||
147011179|NCT02611362|530201998|FG000|Overall Study|Withdrawal by Subject|7|||
147011180|NCT02611362|530201999|FG001|Overall Study|Withdrawal by Subject|2|||
147011181|NCT02611362|530201998|FG000|Overall Study|Lost to Follow-up|2|||
147011182|NCT02611362|530201999|FG001|Overall Study|Lost to Follow-up|4|||
147011183|NCT00354159|530202000|FG000|Randomized Study Period|Withdrawal by Subject|5|||
147011184|NCT00354159|530202001|FG001|Randomized Study Period|Withdrawal by Subject|3|||
147011185|NCT00354159|530202000|FG000|Randomized Study Period|Physician Decision|6|||
147011186|NCT00354159|530202001|FG001|Randomized Study Period|Physician Decision|10|||
147011187|NCT00354159|530202000|FG000|Randomized Study Period|Lost to Follow-up|4|||
147011188|NCT00354159|530202001|FG001|Randomized Study Period|Lost to Follow-up|0|||
147011189|NCT00354159|530202000|FG000|Randomized Study Period|Death|7|||
147011190|NCT00354159|530202001|FG001|Randomized Study Period|Death|9|||
147011191|NCT00354159|530202000|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
147011192|NCT00354159|530202001|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
147011193|NCT00354159|530202000|FG000|Long-term Follow-up|Physician Decision|127|||
147011194|NCT00354159|530202001|FG001|Long-term Follow-up|Physician Decision|122|||
147011195|NCT00354159|530202000|FG000|Long-term Follow-up|Lost to Follow-up|1|||
147011196|NCT00354159|530202001|FG001|Long-term Follow-up|Lost to Follow-up|0|||
147011197|NCT00354159|530202000|FG000|Long-term Follow-up|Death|14|||
147011198|NCT00354159|530202001|FG001|Long-term Follow-up|Death|11|||
147011199|NCT00354159|530202000|FG000|Long-term Follow-up|Study Closed|29|||
147011200|NCT00354159|530202001|FG001|Long-term Follow-up|Study Closed|34|||
147011201|NCT02229084|530202003|FG000|Overall Study|Adverse Event|1|||
147011202|NCT02229084|530202004|FG001|Overall Study|Adverse Event|0|||
147011203|NCT02229084|530202005|FG002|Overall Study|Adverse Event|0|||
147011204|NCT02229084|530202006|FG003|Overall Study|Adverse Event|0|||
147011205|NCT02229084|530202007|FG004|Overall Study|Adverse Event|0|||
147011206|NCT02229084|530202008|FG005|Overall Study|Adverse Event|0|||
147011207|NCT02229084|530202009|FG006|Overall Study|Adverse Event|0|||
147011208|NCT02229084|530202003|FG000|Overall Study|Lost to Follow-up|0|||
147011209|NCT02229084|530202004|FG001|Overall Study|Lost to Follow-up|0|||
147011210|NCT02229084|530202005|FG002|Overall Study|Lost to Follow-up|1|||
147011211|NCT02229084|530202006|FG003|Overall Study|Lost to Follow-up|1|||
147011212|NCT02229084|530202007|FG004|Overall Study|Lost to Follow-up|0|||
147011213|NCT02229084|530202008|FG005|Overall Study|Lost to Follow-up|0|||
147011214|NCT02229084|530202009|FG006|Overall Study|Lost to Follow-up|1|||
147011215|NCT02229084|530202003|FG000|Overall Study|Physician Decision|0|||
147011216|NCT02229084|530202004|FG001|Overall Study|Physician Decision|0|||
147011217|NCT02229084|530202005|FG002|Overall Study|Physician Decision|0|||
147011218|NCT02229084|530202006|FG003|Overall Study|Physician Decision|1|||
147011219|NCT02229084|530202007|FG004|Overall Study|Physician Decision|3|||
147011220|NCT02229084|530202008|FG005|Overall Study|Physician Decision|0|||
147011221|NCT02229084|530202009|FG006|Overall Study|Physician Decision|1|||
147011222|NCT02229084|530202003|FG000|Overall Study|Withdrawal by Subject|0|||
147011223|NCT02229084|530202004|FG001|Overall Study|Withdrawal by Subject|0|||
147011224|NCT02229084|530202005|FG002|Overall Study|Withdrawal by Subject|1|||
147011225|NCT02229084|530202006|FG003|Overall Study|Withdrawal by Subject|0|||
147011226|NCT02229084|530202007|FG004|Overall Study|Withdrawal by Subject|1|||
147011227|NCT02229084|530202008|FG005|Overall Study|Withdrawal by Subject|1|||
147011228|NCT02229084|530202009|FG006|Overall Study|Withdrawal by Subject|1|||
147011229|NCT02229084|530202003|FG000|Overall Study|Death|0|||
147011230|NCT02229084|530202004|FG001|Overall Study|Death|0|||
147011231|NCT02229084|530202005|FG002|Overall Study|Death|0|||
147011232|NCT02229084|530202006|FG003|Overall Study|Death|0|||
147011233|NCT02229084|530202007|FG004|Overall Study|Death|0|||
147011234|NCT02229084|530202008|FG005|Overall Study|Death|0|||
147011235|NCT02229084|530202009|FG006|Overall Study|Death|1|||
147011236|NCT01559116|530202019|FG000|Overall Study|Adverse Event|10|||
147011237|NCT01559116|530202019|FG000|Overall Study|Lack of Efficacy|1|||
147011238|NCT01559116|530202019|FG000|Overall Study|Lost to Follow-up|1|||
147011239|NCT01559116|530202019|FG000|Overall Study|Protocol Violation|1|||
147011240|NCT01559116|530202019|FG000|Overall Study|Withdrawal by Subject|4|||
147011241|NCT01559116|530202019|FG000|Overall Study|other than stated above|9|||
147011242|NCT04610580|530202020|FG000|Two-way Crossover Period|Adverse Event|1|||
147011243|NCT04610580|530202021|FG001|Two-way Crossover Period|Adverse Event|0|||
147011244|NCT04610580|530202022|FG002|Two-way Crossover Period|Adverse Event|0|||
147011245|NCT04610580|530202023|FG003|Two-way Crossover Period|Adverse Event|0|||
147011246|NCT04610580|530202024|FG004|Two-way Crossover Period|Adverse Event|0|||
147011247|NCT04610580|530202025|FG005|Two-way Crossover Period|Adverse Event|0|||
147011248|NCT04610580|530202020|FG000|Two-way Crossover Period|Physician Decision|1|||
147011249|NCT04610580|530202021|FG001|Two-way Crossover Period|Physician Decision|0|||
147011250|NCT04610580|530202022|FG002|Two-way Crossover Period|Physician Decision|0|||
147011251|NCT04610580|530202023|FG003|Two-way Crossover Period|Physician Decision|0|||
147011252|NCT04610580|530202024|FG004|Two-way Crossover Period|Physician Decision|0|||
147011253|NCT04610580|530202025|FG005|Two-way Crossover Period|Physician Decision|0|||
147011254|NCT04610580|530202020|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
147011255|NCT04610580|530202021|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
147011256|NCT04610580|530202022|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
147011257|NCT04610580|530202023|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
147011258|NCT04610580|530202024|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
147011259|NCT04610580|530202025|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
147011260|NCT04610580|530202020|FG000|Two-way Crossover Period|Other than specified|0|||
147011261|NCT04610580|530202021|FG001|Two-way Crossover Period|Other than specified|1|||
147011262|NCT04610580|530202022|FG002|Two-way Crossover Period|Other than specified|0|||
147011263|NCT04610580|530202023|FG003|Two-way Crossover Period|Other than specified|0|||
147011264|NCT04610580|530202024|FG004|Two-way Crossover Period|Other than specified|0|||
147011265|NCT04610580|530202025|FG005|Two-way Crossover Period|Other than specified|0|||
147011266|NCT04610580|530202020|FG000|Washout Before Extension Period|Other than specified|0|||
147011267|NCT04610580|530202021|FG001|Washout Before Extension Period|Other than specified|1|||
147011268|NCT04610580|530202022|FG002|Washout Before Extension Period|Other than specified|0|||
147011269|NCT04610580|530202023|FG003|Washout Before Extension Period|Other than specified|0|||
147011270|NCT04610580|530202024|FG004|Washout Before Extension Period|Other than specified|0|||
147011271|NCT04610580|530202025|FG005|Washout Before Extension Period|Other than specified|0|||
147011272|NCT04610580|530202020|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
147011273|NCT04610580|530202021|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
147011274|NCT04610580|530202022|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
147011275|NCT04610580|530202023|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
147011276|NCT04610580|530202024|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
147011277|NCT04610580|530202025|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
147011278|NCT04610580|530202020|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
147011279|NCT04610580|530202021|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
147011280|NCT04610580|530202022|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
147011281|NCT04610580|530202023|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
147011282|NCT04610580|530202024|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
147011283|NCT04610580|530202025|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
147011284|NCT02179190|530202026|FG000|Enrollment|Exit Prior to Device Attempt|11|||
147011285|NCT02179190|530202026|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
147011286|NCT02179190|530202026|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
147011287|NCT02179190|530202026|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
147011288|NCT02179190|530202026|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
147011289|NCT02179190|530202026|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
147011290|NCT00881569|530202029|FG000|Overall Study|Disease progression|1|||
147011291|NCT00881569|530202030|FG001|Overall Study|Disease progression|1|||
147011292|NCT03480022|530202031|FG000|Overall Study|Pregnancy|2|||
147011293|NCT03480022|530202032|FG001|Overall Study|Pregnancy|0|||
147011294|NCT03480022|530202031|FG000|Overall Study|Adverse Event|6|||
147011295|NCT03480022|530202032|FG001|Overall Study|Adverse Event|0|||
147011296|NCT03480022|530202031|FG000|Overall Study|Lack of Efficacy|0|||
147011297|NCT03480022|530202032|FG001|Overall Study|Lack of Efficacy|2|||
147011298|NCT03480022|530202031|FG000|Overall Study|Physician Decision|0|||
147011299|NCT03480022|530202032|FG001|Overall Study|Physician Decision|1|||
147011300|NCT03480022|530202031|FG000|Overall Study|Withdrawal by Subject|2|||
147011301|NCT03480022|530202032|FG001|Overall Study|Withdrawal by Subject|0|||
147011302|NCT03480022|530202031|FG000|Overall Study|Medication concerns|1|||
147011303|NCT03480022|530202032|FG001|Overall Study|Medication concerns|0|||
147011304|NCT03480022|530202031|FG000|Overall Study|Family member COVID exposure|0|||
147011305|NCT03480022|530202032|FG001|Overall Study|Family member COVID exposure|1|||
147011306|NCT01670097|530202037|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
147011307|NCT01670097|530202038|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
147011308|NCT01670097|530202037|FG000|Overall Study|Study burden|1|||
147011309|NCT01670097|530202038|FG001|Overall Study|Study burden|0|||
147011310|NCT01670097|530202037|FG000|Overall Study|COPD exacerbation|0|||
147011311|NCT01670097|530202038|FG001|Overall Study|COPD exacerbation|1|||
147011312|NCT01670097|530202037|FG000|Overall Study|Neutropenia|0|||
147011313|NCT01670097|530202038|FG001|Overall Study|Neutropenia|1|||
147011314|NCT01670097|530202037|FG000|Overall Study|Clinical deterioration|0|||
147011315|NCT01670097|530202038|FG001|Overall Study|Clinical deterioration|1|||
147011316|NCT01670097|530202037|FG000|Overall Study|Disease progression|0|||
147011317|NCT01670097|530202038|FG001|Overall Study|Disease progression|1|||
147011318|NCT03259165|530202039|FG000|Overall Study|COVID 19 pandemic|1|||
147011319|NCT03259165|530202040|FG001|Overall Study|COVID 19 pandemic|1|||
147011320|NCT01949532|530202041|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
147011321|NCT01949532|530202042|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
147011322|NCT05665387|530202043|FG000|Overall Study|Withdrawal by Subject|1|||
147011323|NCT05665387|530202044|FG001|Overall Study|Withdrawal by Subject|0|||
147011324|NCT05665387|530202045|FG002|Overall Study|Withdrawal by Subject|1|||
147011325|NCT00884390|530202046|FG000|Overall Study|Adverse Event|0|||
147011326|NCT00884390|530202047|FG001|Overall Study|Adverse Event|1|||
147011327|NCT00884390|530202046|FG000|Overall Study|Lost to Follow-up|0|||
147011328|NCT00884390|530202047|FG001|Overall Study|Lost to Follow-up|1|||
147011329|NCT00884390|530202046|FG000|Overall Study|Physician Decision|2|||
147011330|NCT00884390|530202047|FG001|Overall Study|Physician Decision|1|||
147011331|NCT00884390|530202046|FG000|Overall Study|Protocol Violation|4|||
147011332|NCT00884390|530202047|FG001|Overall Study|Protocol Violation|1|||
147011333|NCT00884390|530202046|FG000|Overall Study|Withdrawal by Subject|4|||
147011334|NCT00884390|530202047|FG001|Overall Study|Withdrawal by Subject|1|||
147011335|NCT00884390|530202046|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
147011336|NCT00884390|530202047|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
147011337|NCT00884390|530202046|FG000|Overall Study|Other|11|||
147011338|NCT00884390|530202047|FG001|Overall Study|Other|1|||
147011339|NCT03980522|530202051|FG000|Treatment Period|Adverse Event|1|||
147011340|NCT03980522|530202052|FG001|Treatment Period|Adverse Event|0|||
147011341|NCT03980522|530202053|FG002|Treatment Period|Adverse Event|0|||
146848094|NCT00929110|529614012|FG002|Overall Study|Administrative problems|2|||
146848095|NCT00929110|529614010|FG000|Overall Study|Death|2|||
146848096|NCT00929110|529614011|FG001|Overall Study|Death|2|||
146848097|NCT00929110|529614012|FG002|Overall Study|Death|2|||
146848098|NCT00929110|529614010|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146848099|NCT00929110|529614011|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147011342|NCT03980522|530202054|FG003|Treatment Period|Adverse Event|0|||
147011343|NCT03980522|530202055|FG004|Treatment Period|Adverse Event|0|||
147011344|NCT01874535|530202056|FG000|Overall Study|Lost to Follow-up|10|||
147011345|NCT01874535|530202057|FG001|Overall Study|Lost to Follow-up|9|||
147011346|NCT01874535|530202056|FG000|Overall Study|incomplete symptom resolution|45|||
147011347|NCT01874535|530202057|FG001|Overall Study|incomplete symptom resolution|35|||
147011348|NCT01215721|530202058|FG000|Overall Study|Adverse Event|2|||
147011349|NCT00045162|530202059|FG000|Overall Study|Ineligible|12|||
147011350|NCT00045162|530202060|FG001|Overall Study|Ineligible|8|||
147011351|NCT00045162|530202059|FG000|Overall Study|Not treated|7|||
147011352|NCT00045162|530202060|FG001|Overall Study|Not treated|2|||
147011353|NCT00045162|530202059|FG000|Overall Study|Adverse Event|55|||
147011354|NCT00045162|530202060|FG001|Overall Study|Adverse Event|50|||
146848100|NCT00929110|529614012|FG002|Overall Study|Abnormal laboratory value(s)|0|||
146848101|NCT00929110|529614010|FG000|Overall Study|Abnormal test procedure result(s)|0|||
147011355|NCT00045162|530202059|FG000|Overall Study|Lack of Efficacy|32|||
147011356|NCT00045162|530202060|FG001|Overall Study|Lack of Efficacy|29|||
147011357|NCT00045162|530202059|FG000|Overall Study|Death|10|||
147011358|NCT00045162|530202060|FG001|Overall Study|Death|10|||
147011359|NCT00045162|530202059|FG000|Overall Study|Withdrawal by Subject|5|||
147011360|NCT00045162|530202060|FG001|Overall Study|Withdrawal by Subject|3|||
147011361|NCT00045162|530202059|FG000|Overall Study|Other|21|||
147011362|NCT00045162|530202060|FG001|Overall Study|Other|16|||
147011363|NCT01044433|530202061|FG000|Overall Study|Lost to Follow-up|3|||
147011364|NCT01044433|530202061|FG000|Overall Study|Withdrawal by Subject|3|||
147011365|NCT02616380|530202062|FG000|Overall Study|Lost to Follow-up|1|||
147011366|NCT02616380|530202062|FG000|Overall Study|Other|2|||
147011367|NCT00939523|530202067|FG000|Overall Study|Lack of Efficacy|1|||
147011368|NCT00939523|530202067|FG000|Overall Study|Physician Decision|2|||
147011369|NCT00024258|530202068|FG000|Overall Study|Withdrawal by Subject|1|||
147011370|NCT00024258|530202068|FG000|Overall Study|Disease Progression|8|||
147011371|NCT00442351|530203397|FG000|Overall Study|Administrative|6|||
147011372|NCT00442351|530203398|FG001|Overall Study|Administrative|5|||
147011373|NCT00442351|530203397|FG000|Overall Study|Did not meet protocol eligibility|1|||
147011374|NCT00442351|530203398|FG001|Overall Study|Did not meet protocol eligibility|0|||
147011375|NCT00442351|530203397|FG000|Overall Study|Other|0|||
147011376|NCT00442351|530203398|FG001|Overall Study|Other|1|||
147011377|NCT00108628|530203405|FG000|Overall Study|Withdrawal by Subject|17|||
147011378|NCT00108628|530203406|FG001|Overall Study|Withdrawal by Subject|9|||
147011379|NCT00108628|530203405|FG000|Overall Study|Lack of Efficacy|2|||
147011380|NCT00108628|530203406|FG001|Overall Study|Lack of Efficacy|1|||
147011381|NCT00108628|530203405|FG000|Overall Study|Death|1|||
147011382|NCT00108628|530203406|FG001|Overall Study|Death|0|||
147011383|NCT01453153|530203407|FG000|Overall Study|Physician Decision|0|||
147011384|NCT01453153|530203408|FG001|Overall Study|Physician Decision|0|||
147011385|NCT01453153|530203409|FG002|Overall Study|Physician Decision|1|||
147011386|NCT01453153|530203407|FG000|Overall Study|Progressive Disease|3|||
147011387|NCT01453153|530203408|FG001|Overall Study|Progressive Disease|2|||
147011388|NCT01453153|530203409|FG002|Overall Study|Progressive Disease|16|||
147011389|NCT01453153|530203407|FG000|Overall Study|Withdrawal by Subject|0|||
147011390|NCT01453153|530203408|FG001|Overall Study|Withdrawal by Subject|1|||
147011391|NCT01453153|530203409|FG002|Overall Study|Withdrawal by Subject|2|||
147011392|NCT01453153|530203407|FG000|Overall Study|Adverse Event|1|||
147011393|NCT01453153|530203408|FG001|Overall Study|Adverse Event|1|||
147011394|NCT01453153|530203409|FG002|Overall Study|Adverse Event|1|||
147011395|NCT03547635|530203410|FG000|Overall Study|Adverse Event|5|||
147011396|NCT03547635|530203411|FG001|Overall Study|Adverse Event|2|||
147011397|NCT03547635|530203412|FG002|Overall Study|Adverse Event|3|||
147011398|NCT03547635|530203410|FG000|Overall Study|Lost to Follow-up|1|||
147011399|NCT03547635|530203411|FG001|Overall Study|Lost to Follow-up|3|||
147011400|NCT03547635|530203412|FG002|Overall Study|Lost to Follow-up|4|||
147011401|NCT03547635|530203410|FG000|Overall Study|Withdrawal by Subject|1|||
147011402|NCT03547635|530203411|FG001|Overall Study|Withdrawal by Subject|0|||
147011403|NCT03547635|530203412|FG002|Overall Study|Withdrawal by Subject|0|||
147011404|NCT03547635|530203410|FG000|Overall Study|Withdrawal By PI|0|||
147011405|NCT03547635|530203411|FG001|Overall Study|Withdrawal By PI|1|||
147011406|NCT03547635|530203412|FG002|Overall Study|Withdrawal By PI|0|||
147011407|NCT03547635|530203410|FG000|Overall Study|Withdrawal by Sponsor|0|||
147011408|NCT03547635|530203411|FG001|Overall Study|Withdrawal by Sponsor|0|||
147011409|NCT03547635|530203412|FG002|Overall Study|Withdrawal by Sponsor|1|||
147011410|NCT03547635|530203410|FG000|Overall Study|Errant Randomization before Treatment|0|||
147011411|NCT03547635|530203411|FG001|Overall Study|Errant Randomization before Treatment|1|||
147011412|NCT03547635|530203412|FG002|Overall Study|Errant Randomization before Treatment|0|||
147011413|NCT03547635|530203410|FG000|Overall Study|Withdrawal by Subject|1|||
147011414|NCT03547635|530203411|FG001|Overall Study|Withdrawal by Subject|0|||
147011415|NCT03547635|530203412|FG002|Overall Study|Withdrawal by Subject|0|||
147011416|NCT02415387|530203417|FG000|Overall Study|Withdrawal by Subject|6|||
147011417|NCT02415387|530203418|FG001|Overall Study|Withdrawal by Subject|1|||
147011418|NCT02415387|530203417|FG000|Overall Study|blood draw problem|0|||
147011419|NCT02415387|530203418|FG001|Overall Study|blood draw problem|1|||
147011420|NCT02415387|530203417|FG000|Overall Study|Protocol Violation|1|||
147011421|NCT02415387|530203418|FG001|Overall Study|Protocol Violation|0|||
147011422|NCT03035890|530203419|FG000|Overall Study|Death|1|||
147011423|NCT03243396|530203420|FG000|Overall Study|Lost to Follow-up|2|||
147011424|NCT03243396|530203421|FG001|Overall Study|Lost to Follow-up|3|||
147011425|NCT03243396|530203422|FG002|Overall Study|Lost to Follow-up|15|||
147011426|NCT03243396|530203423|FG003|Overall Study|Lost to Follow-up|8|||
147011427|NCT03243396|530203424|FG004|Overall Study|Lost to Follow-up|1|||
147011428|NCT03243396|530203425|FG005|Overall Study|Lost to Follow-up|4|||
147011429|NCT03243396|530203426|FG006|Overall Study|Lost to Follow-up|9|||
147011430|NCT00452348|530203429|FG000|Overall Study|Adverse Event|6|||
147011431|NCT00452348|530203430|FG001|Overall Study|Adverse Event|9|||
147011432|NCT00452348|530203429|FG000|Overall Study|Lack of Efficacy|10|||
147011433|NCT00452348|530203430|FG001|Overall Study|Lack of Efficacy|9|||
147011434|NCT00452348|530203429|FG000|Overall Study|Lost to Follow-up|14|||
147011435|NCT00452348|530203430|FG001|Overall Study|Lost to Follow-up|8|||
147011436|NCT00452348|530203429|FG000|Overall Study|Protocol Violation|22|||
147011437|NCT00452348|530203430|FG001|Overall Study|Protocol Violation|28|||
147011438|NCT00452348|530203429|FG000|Overall Study|Withdrawal by Subject|18|||
146848102|NCT00929110|529614011|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146848103|NCT00929110|529614012|FG002|Overall Study|Abnormal test procedure result(s)|1|||
146848104|NCT00929110|529614010|FG000|Overall Study|Patient inability to use the device|0|||
146848105|NCT00929110|529614011|FG001|Overall Study|Patient inability to use the device|1|||
146848106|NCT00929110|529614012|FG002|Overall Study|Patient inability to use the device|0|||
146848107|NCT01163292|529614016|FG000|Overall Study|Lack of Efficacy|9|||
146848108|NCT01163292|529614017|FG001|Overall Study|Lack of Efficacy|0|||
147011439|NCT00452348|530203430|FG001|Overall Study|Withdrawal by Subject|21|||
147011440|NCT00452348|530203429|FG000|Overall Study|Other|9|||
147011441|NCT00452348|530203430|FG001|Overall Study|Other|9|||
147011442|NCT00544167|530203434|FG000|Overall Study|Adverse Event|21|||
147011443|NCT00544167|530203434|FG000|Overall Study|Physician Decision|8|||
147011444|NCT03343639|530203437|FG000|Overall Study|Withdrawal by Subject|10|||
147011445|NCT03343639|530203438|FG001|Overall Study|Withdrawal by Subject|6|||
147011446|NCT03343639|530203437|FG000|Overall Study|Lost to Follow-up|4|||
147011447|NCT03343639|530203438|FG001|Overall Study|Lost to Follow-up|5|||
147011448|NCT03343639|530203437|FG000|Overall Study|Protocol Violation|0|||
147011449|NCT03343639|530203438|FG001|Overall Study|Protocol Violation|1|||
147011450|NCT00735696|530203445|FG000|Overall Study|Withdrawal by Subject|1|||
147011451|NCT00735696|530203445|FG000|Overall Study|Enrolled but never Treated|1|||
147011452|NCT02274558|530203447|FG000|Overall Study|Adverse Event|2|||
147011453|NCT02274558|530203448|FG001|Overall Study|Adverse Event|4|||
147011454|NCT02274558|530203449|FG002|Overall Study|Adverse Event|2|||
147011455|NCT02274558|530203447|FG000|Overall Study|Non-compliance|2|||
147011456|NCT02274558|530203448|FG001|Overall Study|Non-compliance|1|||
147011457|NCT02274558|530203449|FG002|Overall Study|Non-compliance|0|||
147011458|NCT02274558|530203447|FG000|Overall Study|Withdrawal by Subject|1|||
147011459|NCT02274558|530203448|FG001|Overall Study|Withdrawal by Subject|5|||
147011460|NCT02274558|530203449|FG002|Overall Study|Withdrawal by Subject|4|||
147011461|NCT02274558|530203447|FG000|Overall Study|Death|0|||
147011462|NCT02274558|530203448|FG001|Overall Study|Death|0|||
147011463|NCT02274558|530203449|FG002|Overall Study|Death|1|||
147011464|NCT02274558|530203447|FG000|Overall Study|Lost to Follow-up|2|||
147011465|NCT02274558|530203448|FG001|Overall Study|Lost to Follow-up|1|||
147011466|NCT02274558|530203449|FG002|Overall Study|Lost to Follow-up|1|||
147011467|NCT02274558|530203447|FG000|Overall Study|Physician Decision|0|||
147011468|NCT02274558|530203448|FG001|Overall Study|Physician Decision|2|||
147011469|NCT02274558|530203449|FG002|Overall Study|Physician Decision|1|||
147011470|NCT02460835|530203450|FG000|Overall Study|Disease progression prior to treatment|3|||
147011471|NCT02460835|530203450|FG000|Overall Study|Unable to complete planning scans|2|||
147011472|NCT02460835|530203450|FG000|Overall Study|Decrease in performance status|1|||
147011473|NCT02460835|530203450|FG000|Overall Study|Withdrawal by Subject|3|||
147011474|NCT02460835|530203450|FG000|Overall Study|Underwent fractionated RT|10|||
147011475|NCT02460835|530203450|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
147011476|NCT02733627|530203457|FG000|Overall Study|Adverse Event|0|||
147011477|NCT02733627|530203458|FG001|Overall Study|Adverse Event|1|||
147011478|NCT02733627|530203459|FG002|Overall Study|Adverse Event|1|||
147011479|NCT02733627|530203460|FG003|Overall Study|Adverse Event|0|||
147011480|NCT02733627|530203457|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
147011481|NCT02733627|530203458|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
147011482|NCT02733627|530203459|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
147011483|NCT02733627|530203460|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
147011484|NCT00059332|530203461|FG000|Overall Study|Withdrawal by Subject|2|||
147011485|NCT00059332|530203462|FG001|Overall Study|Withdrawal by Subject|1|||
147011486|NCT00059332|530203461|FG000|Overall Study|Lost to Follow-up|1|||
147011487|NCT00059332|530203462|FG001|Overall Study|Lost to Follow-up|1|||
147011488|NCT02587143|530203463|FG000|Overall Study|Adverse Event|1|||
147011489|NCT02587143|530203464|FG001|Overall Study|Adverse Event|0|||
147011490|NCT02754492|530203465|FG000|Overall Study|Protocol Violation|2|||
147011491|NCT02754492|530203466|FG001|Overall Study|Protocol Violation|2|||
147011492|NCT02754492|530203467|FG002|Overall Study|Protocol Violation|0|||
147011493|NCT02754492|530203468|FG003|Overall Study|Protocol Violation|1|||
147011494|NCT02754492|530203465|FG000|Overall Study|Withdrawal by Subject|2|||
147011495|NCT02754492|530203466|FG001|Overall Study|Withdrawal by Subject|0|||
147011496|NCT02754492|530203467|FG002|Overall Study|Withdrawal by Subject|0|||
147011497|NCT02754492|530203468|FG003|Overall Study|Withdrawal by Subject|0|||
147011498|NCT02754492|530203465|FG000|Overall Study|Equipment malfuntion|0|||
147011499|NCT02754492|530203466|FG001|Overall Study|Equipment malfuntion|0|||
147011500|NCT02754492|530203467|FG002|Overall Study|Equipment malfuntion|2|||
146848109|NCT01163292|529614016|FG000|Overall Study|Adverse Event|6|||
147011501|NCT02754492|530203468|FG003|Overall Study|Equipment malfuntion|5|||
147011502|NCT02754492|530203465|FG000|Overall Study|Adverse Event|0|||
147011503|NCT02754492|530203466|FG001|Overall Study|Adverse Event|0|||
147011504|NCT02754492|530203467|FG002|Overall Study|Adverse Event|0|||
147011505|NCT02754492|530203468|FG003|Overall Study|Adverse Event|13|||
147011506|NCT02754492|530203465|FG000|Overall Study|Venous access issues not resulting in AE|0|||
147011507|NCT02754492|530203466|FG001|Overall Study|Venous access issues not resulting in AE|0|||
147011508|NCT02754492|530203467|FG002|Overall Study|Venous access issues not resulting in AE|0|||
147011509|NCT02754492|530203468|FG003|Overall Study|Venous access issues not resulting in AE|4|||
147011510|NCT00487695|530203469|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
147011511|NCT00487695|530203470|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
147011512|NCT00487695|530203469|FG000|First Procedure|active wheezing (did not have procedure)|1|||
147011513|NCT00487695|530203470|FG001|First Procedure|active wheezing (did not have procedure)|0|||
147011514|NCT00487695|530203469|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
147011515|NCT00487695|530203470|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
147011516|NCT00487695|530203469|FG000|Second Procedure|active wheezing|0|||
147011517|NCT00487695|530203470|FG001|Second Procedure|active wheezing|1|||
147011518|NCT00487695|530203469|FG000|Second Procedure|Withdrawal by Subject|1|||
147011519|NCT00487695|530203470|FG001|Second Procedure|Withdrawal by Subject|2|||
147011520|NCT01186458|530203475|FG000|Overall Study|Adverse Event|1|||
147011521|NCT04281472|530203476|FG000|Stage A|Lack of Efficacy|8|||
147011522|NCT04281472|530203477|FG001|Stage A|Lack of Efficacy|0|||
147011523|NCT04281472|530203478|FG002|Stage A|Lack of Efficacy|0|||
147011524|NCT04281472|530203476|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
147011525|NCT04281472|530203477|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
147011526|NCT04281472|530203478|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
147011527|NCT04281472|530203476|FG000|Stage A|Adverse Event|20|||
147011528|NCT04281472|530203477|FG001|Stage A|Adverse Event|0|||
147011529|NCT04281472|530203478|FG002|Stage A|Adverse Event|0|||
147011530|NCT04281472|530203476|FG000|Stage A|Death|1|||
147011531|NCT04281472|530203477|FG001|Stage A|Death|0|||
147011532|NCT04281472|530203478|FG002|Stage A|Death|0|||
147011533|NCT04281472|530203476|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
147011534|NCT04281472|530203477|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
147011535|NCT04281472|530203478|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
147011536|NCT04281472|530203476|FG000|Stage A|Lost to Follow-up|2|||
147011537|NCT04281472|530203477|FG001|Stage A|Lost to Follow-up|0|||
147011538|NCT04281472|530203478|FG002|Stage A|Lost to Follow-up|0|||
147011539|NCT04281472|530203476|FG000|Stage A|Non-compliance with study drug|1|||
147011540|NCT04281472|530203477|FG001|Stage A|Non-compliance with study drug|0|||
147011541|NCT04281472|530203478|FG002|Stage A|Non-compliance with study drug|0|||
147011542|NCT04281472|530203476|FG000|Stage A|Physician Decision|1|||
147011543|NCT04281472|530203477|FG001|Stage A|Physician Decision|0|||
147011544|NCT04281472|530203478|FG002|Stage A|Physician Decision|0|||
147011545|NCT04281472|530203476|FG000|Stage A|Prohibited medications|2|||
147011546|NCT04281472|530203477|FG001|Stage A|Prohibited medications|0|||
147011547|NCT04281472|530203478|FG002|Stage A|Prohibited medications|0|||
147011548|NCT04281472|530203476|FG000|Stage A|Withdrawal by Subject|11|||
147011549|NCT04281472|530203477|FG001|Stage A|Withdrawal by Subject|0|||
147011550|NCT04281472|530203478|FG002|Stage A|Withdrawal by Subject|0|||
147011551|NCT04281472|530203476|FG000|Stage A|Other|5|||
147011552|NCT04281472|530203477|FG001|Stage A|Other|0|||
147011553|NCT04281472|530203478|FG002|Stage A|Other|0|||
147011554|NCT04281472|530203476|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
147011555|NCT04281472|530203477|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
147011556|NCT04281472|530203478|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
147011557|NCT04281472|530203476|FG000|Stage B|Adverse Event|0|||
147011558|NCT04281472|530203477|FG001|Stage B|Adverse Event|3|||
147011559|NCT04281472|530203478|FG002|Stage B|Adverse Event|0|||
147011560|NCT04281472|530203476|FG000|Stage B|Death|0|||
147011561|NCT04281472|530203477|FG001|Stage B|Death|0|||
147011562|NCT04281472|530203478|FG002|Stage B|Death|1|||
147011563|NCT04281472|530203476|FG000|Stage B|Lack of Efficacy|0|||
147011564|NCT04281472|530203477|FG001|Stage B|Lack of Efficacy|0|||
147011565|NCT04281472|530203478|FG002|Stage B|Lack of Efficacy|1|||
147011566|NCT04281472|530203476|FG000|Stage B|Lost to Follow-up|0|||
147011567|NCT04281472|530203477|FG001|Stage B|Lost to Follow-up|0|||
147011568|NCT04281472|530203478|FG002|Stage B|Lost to Follow-up|2|||
147011569|NCT04281472|530203476|FG000|Stage B|Prohibited medications|0|||
147011570|NCT04281472|530203477|FG001|Stage B|Prohibited medications|2|||
147011571|NCT04281472|530203478|FG002|Stage B|Prohibited medications|1|||
147011572|NCT04281472|530203476|FG000|Stage B|Protocol Violation|0|||
147011573|NCT04281472|530203477|FG001|Stage B|Protocol Violation|1|||
147011574|NCT04281472|530203478|FG002|Stage B|Protocol Violation|1|||
147011575|NCT04281472|530203476|FG000|Stage B|Sponsor decision|0|||
147011576|NCT04281472|530203477|FG001|Stage B|Sponsor decision|0|||
147011577|NCT04281472|530203478|FG002|Stage B|Sponsor decision|1|||
147011578|NCT04281472|530203476|FG000|Stage B|Withdrawal by Subject|0|||
147011579|NCT04281472|530203477|FG001|Stage B|Withdrawal by Subject|3|||
147011580|NCT04281472|530203478|FG002|Stage B|Withdrawal by Subject|3|||
147011581|NCT04281472|530203476|FG000|Stage B|Other|0|||
147011582|NCT04281472|530203477|FG001|Stage B|Other|3|||
147011583|NCT04281472|530203478|FG002|Stage B|Other|0|||
147011584|NCT00152451|530203479|FG000|Overall Study|Adverse Event|4|||
147011585|NCT00323258|530203481|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
147011586|NCT00323258|530203482|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
147011587|NCT00323258|530203481|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
147011588|NCT00323258|530203482|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
147011589|NCT00323258|530203481|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
147011590|NCT00323258|530203482|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
147011591|NCT00323258|530203481|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
147011592|NCT00323258|530203482|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
147011593|NCT00323258|530203481|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
147011594|NCT00323258|530203482|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
147011595|NCT00323258|530203481|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
147011596|NCT00323258|530203482|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
147011597|NCT00323258|530203481|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
147011598|NCT00323258|530203482|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
147011599|NCT01055834|530203483|FG000|Treatment Period I|Adverse Event|1|||
147011600|NCT01055834|530203484|FG001|Treatment Period I|Adverse Event|0|||
147011601|NCT01717313|530203485|FG000|Phase A (Weeks 0 to 24)|Death|0|||
147011602|NCT01717313|530203486|FG001|Phase A (Weeks 0 to 24)|Death|1|||
147011603|NCT01717313|530203485|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
147011604|NCT01717313|530203486|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
147011605|NCT01717313|530203485|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
147011606|NCT01717313|530203486|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
147011607|NCT01717313|530203485|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
147011608|NCT01717313|530203486|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
147011609|NCT01717313|530203485|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
147011610|NCT01717313|530203486|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
147011611|NCT01717313|530203485|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
147011612|NCT01717313|530203486|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
147011613|NCT01717313|530203485|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
147011614|NCT01717313|530203486|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
147011615|NCT01717313|530203485|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
147011616|NCT01717313|530203486|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
147011617|NCT01717313|530203485|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
147011618|NCT01717313|530203486|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
147011619|NCT00743145|530203488|FG000|Overall Study|Withdrawal by Subject|1|||
147011620|NCT00743145|530203488|FG000|Overall Study|Adverse Event|2|||
147011621|NCT00743145|530203488|FG000|Overall Study|Pregnancy|1|||
147011622|NCT01745094|530203489|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
147011623|NCT01745094|530203490|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
147011624|NCT01745094|530203491|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
147011625|NCT01745094|530203492|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
147011626|NCT01745094|530203489|FG000|Overall Study|Adverse Event|0|||
147011627|NCT01745094|530203490|FG001|Overall Study|Adverse Event|0|||
147011628|NCT01745094|530203491|FG002|Overall Study|Adverse Event|3|||
147011629|NCT01745094|530203492|FG003|Overall Study|Adverse Event|0|||
147011630|NCT01745094|530203489|FG000|Overall Study|Withdrawal by Subject|2|||
147011631|NCT01745094|530203490|FG001|Overall Study|Withdrawal by Subject|0|||
147011632|NCT01745094|530203491|FG002|Overall Study|Withdrawal by Subject|1|||
147011633|NCT01745094|530203492|FG003|Overall Study|Withdrawal by Subject|2|||
147011634|NCT01745094|530203489|FG000|Overall Study|Protocol Violation|1|||
147011635|NCT01745094|530203490|FG001|Overall Study|Protocol Violation|0|||
146848110|NCT01163292|529614017|FG001|Overall Study|Adverse Event|0|||
146848111|NCT01163292|529614016|FG000|Overall Study|Initiation of biological therapy|0|||
147011636|NCT01745094|530203491|FG002|Overall Study|Protocol Violation|3|||
146848112|NCT01163292|529614017|FG001|Overall Study|Initiation of biological therapy|15|||
146848113|NCT01163292|529614016|FG000|Overall Study|Sufficient response to adalimumab|8|||
146848114|NCT01163292|529614017|FG001|Overall Study|Sufficient response to adalimumab|0|||
146848115|NCT01163292|529614016|FG000|Overall Study|Refusal to receive adalimumab|7|||
146848116|NCT01163292|529614017|FG001|Overall Study|Refusal to receive adalimumab|0|||
147011637|NCT01745094|530203492|FG003|Overall Study|Protocol Violation|1|||
146848117|NCT01163292|529614016|FG000|Overall Study|Economic reasons|6|||
147011638|NCT01745094|530203489|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
147011639|NCT01745094|530203490|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
147011640|NCT01745094|530203491|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
146848118|NCT01163292|529614017|FG001|Overall Study|Economic reasons|0|||
146848119|NCT01163292|529614016|FG000|Overall Study|No further visits|5|||
147011641|NCT01745094|530203492|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
147011642|NCT01745094|530203489|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
147011643|NCT01745094|530203490|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
147011644|NCT01745094|530203491|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
147011645|NCT01745094|530203492|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
147011646|NCT01745094|530203489|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
147011647|NCT01745094|530203490|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
147011648|NCT01745094|530203491|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
147011649|NCT01745094|530203492|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
147011650|NCT01097694|530203493|FG000|Overall Study|Adverse Event|5|||
147011651|NCT01097694|530203494|FG001|Overall Study|Adverse Event|0|||
147011652|NCT01097694|530203493|FG000|Overall Study|Lost to Follow-up|0|||
147011653|NCT01097694|530203494|FG001|Overall Study|Lost to Follow-up|3|||
147011654|NCT01097694|530203493|FG000|Overall Study|Withdrawal by Subject|3|||
147011655|NCT01097694|530203494|FG001|Overall Study|Withdrawal by Subject|1|||
147011656|NCT03922750|530203495|FG000|Overall Study|Unclassified|0|||
147011657|NCT03922750|530203496|FG001|Overall Study|Unclassified|0|||
147011658|NCT03922750|530203497|FG002|Overall Study|Unclassified|1|||
147011659|NCT03922750|530203495|FG000|Overall Study|Adverse Event|0|||
147011660|NCT03922750|530203496|FG001|Overall Study|Adverse Event|1|||
147011661|NCT03922750|530203497|FG002|Overall Study|Adverse Event|0|||
147011662|NCT00668395|530203498|FG000|Overall Study|Withdrawal by Subject|4|||
147011663|NCT00668395|530203499|FG001|Overall Study|Withdrawal by Subject|4|||
147011664|NCT00668395|530203500|FG002|Overall Study|Withdrawal by Subject|1|||
147011665|NCT00668395|530203498|FG000|Overall Study|Adverse Event|1|||
147011666|NCT00668395|530203499|FG001|Overall Study|Adverse Event|1|||
147011667|NCT00668395|530203500|FG002|Overall Study|Adverse Event|0|||
147011668|NCT00668395|530203498|FG000|Overall Study|Physician Decision|1|||
147011669|NCT00668395|530203499|FG001|Overall Study|Physician Decision|1|||
147011670|NCT00668395|530203500|FG002|Overall Study|Physician Decision|0|||
147011671|NCT00697827|530203501|FG000|Overall Study|enrolled but not treated|2|||
147011672|NCT00697827|530203502|FG001|Overall Study|enrolled but not treated|1|||
147011673|NCT03732833|530203503|FG000|Overall Study|Adverse Event|0|||
147011674|NCT03732833|530203504|FG001|Overall Study|Adverse Event|3|||
147011675|NCT03732833|530203505|FG002|Overall Study|Adverse Event|1|||
147011676|NCT03732833|530203503|FG000|Overall Study|Withdrawal by Subject|11|||
147011677|NCT03732833|530203504|FG001|Overall Study|Withdrawal by Subject|13|||
147011678|NCT03732833|530203505|FG002|Overall Study|Withdrawal by Subject|8|||
147011679|NCT03732833|530203503|FG000|Overall Study|Lost to Follow-up|3|||
147011680|NCT03732833|530203504|FG001|Overall Study|Lost to Follow-up|5|||
147011681|NCT03732833|530203505|FG002|Overall Study|Lost to Follow-up|4|||
147011682|NCT03732833|530203503|FG000|Overall Study|Pregnancy|0|||
147011683|NCT03732833|530203504|FG001|Overall Study|Pregnancy|2|||
147011684|NCT03732833|530203505|FG002|Overall Study|Pregnancy|0|||
147011685|NCT03732833|530203503|FG000|Overall Study|Physician Decision|2|||
147011686|NCT03732833|530203504|FG001|Overall Study|Physician Decision|3|||
147011687|NCT03732833|530203505|FG002|Overall Study|Physician Decision|1|||
147011688|NCT03732833|530203503|FG000|Overall Study|Covid-19 related and other reasons|2|||
147011689|NCT03732833|530203504|FG001|Overall Study|Covid-19 related and other reasons|7|||
147011690|NCT03732833|530203505|FG002|Overall Study|Covid-19 related and other reasons|3|||
147011691|NCT01691612|530203508|FG000|Overall Study|deemed ineligible after 1st visit|6|||
147011692|NCT01691612|530203508|FG000|Overall Study|Adverse Event|1|||
147011693|NCT02623218|530203509|FG000|Overall Study|Lost to Follow-up|0|||
147011694|NCT02623218|530203510|FG001|Overall Study|Lost to Follow-up|1|||
147011695|NCT02623218|530203511|FG002|Overall Study|Lost to Follow-up|0|||
147011696|NCT02623218|530203512|FG003|Overall Study|Lost to Follow-up|0|||
147011697|NCT02623218|530203513|FG004|Overall Study|Lost to Follow-up|0|||
147011698|NCT01726803|530203514|FG000|Overall Study|Lost to Follow-up|6|||
147011699|NCT01726803|530203515|FG001|Overall Study|Lost to Follow-up|1|||
147011700|NCT01726803|530203514|FG000|Overall Study|Withdrawal by Subject|1|||
147011701|NCT01726803|530203515|FG001|Overall Study|Withdrawal by Subject|0|||
146848120|NCT01163292|529614017|FG001|Overall Study|No further visits|7|||
146848121|NCT02535091|529614018|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
147011702|NCT02005276|530203517|FG000|Overall Study|No longer interested|5|||
147011703|NCT02005276|530203518|FG001|Overall Study|No longer interested|2|||
147011704|NCT02005276|530203519|FG002|Overall Study|No longer interested|3|||
147011705|NCT02005276|530203520|FG003|Overall Study|No longer interested|3|||
147011706|NCT01970592|530203521|FG000|Overall Study|Withdrawal by Subject|4|||
147011707|NCT01970592|530203521|FG000|Overall Study|Physician Decision|1|||
147011708|NCT01970592|530203521|FG000|Overall Study|Adverse Event|1|||
147011709|NCT01091363|530203524|FG000|Overall Study|Withdrawal by Subject|11|||
147011710|NCT01091363|530203525|FG001|Overall Study|Withdrawal by Subject|15|||
147011711|NCT01091363|530203524|FG000|Overall Study|Lost to Follow-up|2|||
147011712|NCT01091363|530203525|FG001|Overall Study|Lost to Follow-up|2|||
147011713|NCT00021541|530203526|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
147011714|NCT00021541|530203527|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
147011715|NCT00021541|530203526|FG000|Period 1-First Treatment|Adverse Event|2|||
147011716|NCT00021541|530203527|FG001|Period 1-First Treatment|Adverse Event|1|||
147011717|NCT00021541|530203526|FG000|Period 1-First Treatment|non-adherence|3|||
147011718|NCT00021541|530203527|FG001|Period 1-First Treatment|non-adherence|0|||
147011719|NCT00021541|530203526|FG000|Period 1-First Treatment|Death|1|||
147011720|NCT00021541|530203527|FG001|Period 1-First Treatment|Death|0|||
147011721|NCT00021541|530203526|FG000|Period 1-First Treatment|Pts that did not progress|2|||
147011722|NCT00021541|530203527|FG001|Period 1-First Treatment|Pts that did not progress|2|||
147011723|NCT00021541|530203526|FG000|Period 1-First Treatment|Ineligible|0|||
147011724|NCT00021541|530203527|FG001|Period 1-First Treatment|Ineligible|2|||
147011725|NCT00021541|530203526|FG000|Period 2-crossover|refused phase B|2|||
147011726|NCT00021541|530203527|FG001|Period 2-crossover|refused phase B|2|||
147011727|NCT00021541|530203526|FG000|Period 2-crossover|Withdrawal by Subject|3|||
147011728|NCT00021541|530203527|FG001|Period 2-crossover|Withdrawal by Subject|4|||
147011729|NCT00021541|530203526|FG000|Period 2-crossover|Adverse Event|2|||
147011730|NCT00021541|530203527|FG001|Period 2-crossover|Adverse Event|2|||
147011731|NCT00021541|530203526|FG000|Period 2-crossover|non-adherence|1|||
147011732|NCT00021541|530203527|FG001|Period 2-crossover|non-adherence|0|||
147011733|NCT00021541|530203526|FG000|Period 2-crossover|Pts that did not progress|2|||
147011734|NCT00021541|530203527|FG001|Period 2-crossover|Pts that did not progress|3|||
147011735|NCT05263505|530203531|FG000|Overall Study|Adverse Event|0|||
147011736|NCT05263505|530203532|FG001|Overall Study|Adverse Event|1|||
147011737|NCT00826241|530203533|FG000|Overall Study|Withdrawal from Follow-up|1|||
147011738|NCT00826241|530203533|FG000|Overall Study|Withdrew consent|2|||
147011739|NCT00826241|530203533|FG000|Overall Study|Death|4|||
147011740|NCT00826241|530203533|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
147011741|NCT00826241|530203533|FG000|Overall Study|Non-compliance|1|||
147011742|NCT00826241|530203533|FG000|Overall Study|Progression of disease|1|||
147011743|NCT00826241|530203533|FG000|Overall Study|Patient refused follow-up|3|||
147011744|NCT00826241|530203533|FG000|Overall Study|Lost to Follow-up|9|||
147011745|NCT00826241|530203533|FG000|Overall Study|Could not obtain records|1|||
147011746|NCT00826241|530203533|FG000|Overall Study|Screen failure|2|||
147011747|NCT00826241|530203533|FG000|Overall Study|Pt unable to proceed to registration|1|||
147011748|NCT00826241|530203533|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
147011749|NCT01898598|530203534|FG000|Overall Study|Adverse Event|1|||
147011750|NCT01898598|530203535|FG001|Overall Study|Adverse Event|0|||
147011751|NCT01898598|530203534|FG000|Overall Study|Withdrawal by Subject|3|||
147011752|NCT01898598|530203535|FG001|Overall Study|Withdrawal by Subject|0|||
147011753|NCT01898598|530203534|FG000|Overall Study|Lost to Follow-up|0|||
147011754|NCT01898598|530203535|FG001|Overall Study|Lost to Follow-up|1|||
147011755|NCT01898598|530203534|FG000|Overall Study|Other|0|||
147011756|NCT01898598|530203535|FG001|Overall Study|Other|1|||
147011757|NCT03833427|530203536|FG000|Overall Study|Death|4|||
147011758|NCT03833427|530203537|FG001|Overall Study|Death|2|||
147011759|NCT03833427|530203538|FG002|Overall Study|Death|9|||
147011760|NCT03833427|530203539|FG003|Overall Study|Death|11|||
147011761|NCT03833427|530203540|FG004|Overall Study|Death|0|||
147011762|NCT03833427|530203541|FG005|Overall Study|Death|0|||
147011763|NCT03833427|530203542|FG006|Overall Study|Death|0|||
147011764|NCT03833427|530203536|FG000|Overall Study|Withdrawal by Subject|0|||
147011765|NCT03833427|530203537|FG001|Overall Study|Withdrawal by Subject|1|||
147011766|NCT03833427|530203538|FG002|Overall Study|Withdrawal by Subject|1|||
147011767|NCT03833427|530203539|FG003|Overall Study|Withdrawal by Subject|0|||
147011768|NCT03833427|530203540|FG004|Overall Study|Withdrawal by Subject|0|||
147011769|NCT03833427|530203541|FG005|Overall Study|Withdrawal by Subject|0|||
147011770|NCT03833427|530203542|FG006|Overall Study|Withdrawal by Subject|0|||
147011771|NCT03833427|530203536|FG000|Overall Study|Sponsor Decision|0|||
147011772|NCT03833427|530203537|FG001|Overall Study|Sponsor Decision|0|||
147011773|NCT03833427|530203538|FG002|Overall Study|Sponsor Decision|1|||
147011774|NCT03833427|530203539|FG003|Overall Study|Sponsor Decision|3|||
147011775|NCT03833427|530203540|FG004|Overall Study|Sponsor Decision|0|||
147011776|NCT03833427|530203541|FG005|Overall Study|Sponsor Decision|0|||
147011777|NCT03833427|530203542|FG006|Overall Study|Sponsor Decision|0|||
147011778|NCT00950300|530203549|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
147011779|NCT00950300|530203550|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
147011780|NCT00950300|530203549|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
147011781|NCT00950300|530203550|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
147011782|NCT00950300|530203549|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
147011783|NCT00950300|530203550|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
147011784|NCT00950300|530203549|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
147011785|NCT00950300|530203550|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
147011786|NCT00950300|530203549|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
147011787|NCT00950300|530203550|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
147011788|NCT00950300|530203549|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
147011789|NCT00950300|530203550|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
147013233|NCT01708954|530210054|FG000|Step 1|Withdrawal by Subject|2|||
147011790|NCT00950300|530203549|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
147011791|NCT00950300|530203550|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
147011792|NCT00950300|530203549|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
147011793|NCT00950300|530203550|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
147011794|NCT00950300|530203549|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
147011795|NCT00950300|530203550|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
147011796|NCT00950300|530203549|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
147011797|NCT00950300|530203550|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
147011798|NCT00950300|530203549|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
147011799|NCT00950300|530203550|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
147011800|NCT00950300|530203549|FG000|TFFU Period|Death|4|||
147011801|NCT00950300|530203550|FG001|TFFU Period|Death|1|||
147011802|NCT00950300|530203549|FG000|TFFU Period|Refused Treatment|10|||
147011803|NCT00950300|530203550|FG001|TFFU Period|Refused Treatment|11|||
147011804|NCT00950300|530203549|FG000|TFFU Period|Failure to Return|16|||
147011805|NCT00950300|530203550|FG001|TFFU Period|Failure to Return|16|||
147011806|NCT00950300|530203549|FG000|TFFU Period|Recurrence of Disease|63|||
147011807|NCT00950300|530203550|FG001|TFFU Period|Recurrence of Disease|72|||
147011808|NCT00950300|530203549|FG000|TFFU Period|Other|4|||
147011809|NCT00950300|530203550|FG001|TFFU Period|Other|3|||
147011810|NCT00950300|530203549|FG000|SFU Period|Death|44|||
147011811|NCT00950300|530203550|FG001|SFU Period|Death|42|||
147011812|NCT00950300|530203549|FG000|SFU Period|Lost to Follow-up|30|||
147011813|NCT00950300|530203550|FG001|SFU Period|Lost to Follow-up|28|||
147011814|NCT00950300|530203549|FG000|SFU Period|Withdrawal by Subject|4|||
147011815|NCT00950300|530203550|FG001|SFU Period|Withdrawal by Subject|8|||
147011816|NCT01596127|530203551|FG000|Overall Study|Patient Ineligible|1|||
147011817|NCT00438633|530203552|FG000|Overall Study|Withdrawal by Subject|1|||
147011818|NCT00438633|530203553|FG001|Overall Study|Withdrawal by Subject|0|||
147011819|NCT00438633|530203552|FG000|Overall Study|Lost to Follow-up|15|||
147011820|NCT00438633|530203553|FG001|Overall Study|Lost to Follow-up|17|||
147011821|NCT01539239|530203554|FG000|Overall Study|Death|5|||
147011822|NCT01539239|530203555|FG001|Overall Study|Death|5|||
147011823|NCT01539239|530203554|FG000|Overall Study|Lost to Follow-up|7|||
147011824|NCT01539239|530203555|FG001|Overall Study|Lost to Follow-up|12|||
147011825|NCT05135273|530205329|FG000|Overall Study|Recruited into the army|0|||
147011826|NCT05135273|530205330|FG001|Overall Study|Recruited into the army|0|||
147011827|NCT05135273|530205331|FG002|Overall Study|Recruited into the army|0|||
147011828|NCT05135273|530205332|FG003|Overall Study|Recruited into the army|0|||
147011829|NCT05135273|530205333|FG004|Overall Study|Recruited into the army|1|||
147011830|NCT05135273|530205334|FG005|Overall Study|Recruited into the army|0|||
147011831|NCT05135273|530205335|FG006|Overall Study|Recruited into the army|0|||
147011832|NCT05135273|530205336|FG007|Overall Study|Recruited into the army|0|||
147011833|NCT05135273|530205329|FG000|Overall Study|Moved away from study site|0|||
147011834|NCT05135273|530205330|FG001|Overall Study|Moved away from study site|0|||
147011835|NCT05135273|530205331|FG002|Overall Study|Moved away from study site|0|||
147011836|NCT05135273|530205332|FG003|Overall Study|Moved away from study site|0|||
147011837|NCT05135273|530205333|FG004|Overall Study|Moved away from study site|0|||
147011838|NCT05135273|530205334|FG005|Overall Study|Moved away from study site|1|||
147011839|NCT05135273|530205335|FG006|Overall Study|Moved away from study site|1|||
147011840|NCT05135273|530205336|FG007|Overall Study|Moved away from study site|0|||
147011841|NCT05135273|530205329|FG000|Overall Study|Travel|0|||
147011842|NCT05135273|530205330|FG001|Overall Study|Travel|0|||
147011843|NCT05135273|530205331|FG002|Overall Study|Travel|0|||
147011844|NCT05135273|530205332|FG003|Overall Study|Travel|0|||
147011845|NCT05135273|530205333|FG004|Overall Study|Travel|0|||
147011846|NCT05135273|530205334|FG005|Overall Study|Travel|0|||
147011847|NCT05135273|530205335|FG006|Overall Study|Travel|0|||
147011848|NCT05135273|530205336|FG007|Overall Study|Travel|1|||
147011849|NCT01350934|530205365|FG000|Base Study|Adverse Event|6|||
147011850|NCT01350934|530205366|FG001|Base Study|Adverse Event|0|||
147011851|NCT01350934|530205365|FG000|Base Study|Lost to Follow-up|1|||
147011852|NCT01350934|530205366|FG001|Base Study|Lost to Follow-up|0|||
147011853|NCT01350934|530205365|FG000|Base Study|Protocol Violation|1|||
147011854|NCT01350934|530205366|FG001|Base Study|Protocol Violation|1|||
147011855|NCT01350934|530205365|FG000|Base Study|Withdrawal by Subject|1|||
147011856|NCT01350934|530205366|FG001|Base Study|Withdrawal by Subject|2|||
147011857|NCT01350934|530205365|FG000|Base Study|Non-Compliance With Study Drug|2|||
147011858|NCT01350934|530205366|FG001|Base Study|Non-Compliance With Study Drug|0|||
147011859|NCT01350934|530205365|FG000|Extension Study|Adverse Event|2|||
147011860|NCT01350934|530205366|FG001|Extension Study|Adverse Event|1|||
147011861|NCT01350934|530205365|FG000|Extension Study|Lost to Follow-up|2|||
147011862|NCT01350934|530205366|FG001|Extension Study|Lost to Follow-up|0|||
147011863|NCT01350934|530205365|FG000|Extension Study|Protocol Violation|1|||
147011864|NCT01350934|530205366|FG001|Extension Study|Protocol Violation|1|||
147011865|NCT01350934|530205365|FG000|Extension Study|Lack of Efficacy|0|||
147011866|NCT01350934|530205366|FG001|Extension Study|Lack of Efficacy|1|||
147011867|NCT01350934|530205365|FG000|Extension Study|Withdrawal by Subject|0|||
147011868|NCT01350934|530205366|FG001|Extension Study|Withdrawal by Subject|1|||
147011869|NCT01011335|530205369|FG000|Overall Study|Lost to Follow-up|0|||
147011870|NCT01011335|530205370|FG001|Overall Study|Lost to Follow-up|0|||
147011871|NCT01011335|530205371|FG002|Overall Study|Lost to Follow-up|1|||
147011872|NCT01011335|530205372|FG003|Overall Study|Lost to Follow-up|1|||
147011873|NCT01011335|530205373|FG004|Overall Study|Lost to Follow-up|1|||
147011874|NCT01011335|530205374|FG005|Overall Study|Lost to Follow-up|1|||
147011875|NCT01011335|530205375|FG006|Overall Study|Lost to Follow-up|2|||
147011876|NCT01011335|530205376|FG007|Overall Study|Lost to Follow-up|2|||
147011877|NCT01011335|530205377|FG008|Overall Study|Lost to Follow-up|1|||
147011878|NCT01011335|530205378|FG009|Overall Study|Lost to Follow-up|0|||
147011879|NCT01011335|530205379|FG010|Overall Study|Lost to Follow-up|0|||
147011880|NCT01011335|530205380|FG011|Overall Study|Lost to Follow-up|1|||
147011881|NCT01011335|530205381|FG012|Overall Study|Lost to Follow-up|2|||
147011882|NCT01011335|530205369|FG000|Overall Study|Protocol Violation|0|||
147011883|NCT01011335|530205370|FG001|Overall Study|Protocol Violation|1|||
147011884|NCT01011335|530205371|FG002|Overall Study|Protocol Violation|0|||
147011885|NCT01011335|530205372|FG003|Overall Study|Protocol Violation|0|||
147011886|NCT01011335|530205373|FG004|Overall Study|Protocol Violation|0|||
147011887|NCT01011335|530205374|FG005|Overall Study|Protocol Violation|0|||
147011888|NCT01011335|530205375|FG006|Overall Study|Protocol Violation|0|||
147011889|NCT01011335|530205376|FG007|Overall Study|Protocol Violation|0|||
147011890|NCT01011335|530205377|FG008|Overall Study|Protocol Violation|0|||
147011891|NCT01011335|530205378|FG009|Overall Study|Protocol Violation|0|||
147011892|NCT01011335|530205379|FG010|Overall Study|Protocol Violation|0|||
147011893|NCT01011335|530205380|FG011|Overall Study|Protocol Violation|0|||
147011894|NCT01011335|530205381|FG012|Overall Study|Protocol Violation|0|||
147011895|NCT01011335|530205369|FG000|Overall Study|Moved/deployed or no booster|1|||
147011896|NCT01011335|530205370|FG001|Overall Study|Moved/deployed or no booster|0|||
147011897|NCT01011335|530205371|FG002|Overall Study|Moved/deployed or no booster|0|||
147011898|NCT01011335|530205372|FG003|Overall Study|Moved/deployed or no booster|1|||
147011899|NCT01011335|530205373|FG004|Overall Study|Moved/deployed or no booster|0|||
147011900|NCT01011335|530205374|FG005|Overall Study|Moved/deployed or no booster|0|||
147011901|NCT01011335|530205375|FG006|Overall Study|Moved/deployed or no booster|1|||
147011902|NCT01011335|530205376|FG007|Overall Study|Moved/deployed or no booster|0|||
147011903|NCT01011335|530205377|FG008|Overall Study|Moved/deployed or no booster|1|||
147011904|NCT01011335|530205378|FG009|Overall Study|Moved/deployed or no booster|0|||
147011905|NCT01011335|530205379|FG010|Overall Study|Moved/deployed or no booster|2|||
147011906|NCT01011335|530205380|FG011|Overall Study|Moved/deployed or no booster|0|||
147011907|NCT01011335|530205381|FG012|Overall Study|Moved/deployed or no booster|0|||
147011908|NCT01011335|530205369|FG000|Overall Study|Adverse Event|0|||
147011909|NCT01011335|530205370|FG001|Overall Study|Adverse Event|0|||
147011910|NCT01011335|530205371|FG002|Overall Study|Adverse Event|0|||
147011911|NCT01011335|530205372|FG003|Overall Study|Adverse Event|0|||
147011912|NCT01011335|530205373|FG004|Overall Study|Adverse Event|0|||
147011913|NCT01011335|530205374|FG005|Overall Study|Adverse Event|0|||
147011914|NCT01011335|530205375|FG006|Overall Study|Adverse Event|0|||
147011915|NCT01011335|530205376|FG007|Overall Study|Adverse Event|0|||
147011916|NCT01011335|530205377|FG008|Overall Study|Adverse Event|0|||
147011917|NCT01011335|530205378|FG009|Overall Study|Adverse Event|0|||
147011918|NCT01011335|530205379|FG010|Overall Study|Adverse Event|4|||
147011919|NCT01011335|530205380|FG011|Overall Study|Adverse Event|0|||
147011920|NCT01011335|530205381|FG012|Overall Study|Adverse Event|1|||
147011921|NCT01765751|530205389|FG000|Overall Study|Lost to Follow-up|0|||
147011922|NCT01765751|530205390|FG001|Overall Study|Lost to Follow-up|2|||
147011923|NCT01765751|530205391|FG002|Overall Study|Lost to Follow-up|1|||
147011924|NCT01257581|530205395|FG000|Overall Study|Early Termination|3|||
147011925|NCT01257581|530205396|FG001|Overall Study|Early Termination|1|||
147011926|NCT01257581|530205397|FG002|Overall Study|Early Termination|2|||
147011927|NCT01257581|530205395|FG000|Overall Study|Death|2|||
147011928|NCT01257581|530205396|FG001|Overall Study|Death|2|||
147011929|NCT01257581|530205397|FG002|Overall Study|Death|4|||
147011930|NCT00517192|530205404|FG000|Overall Study|Adverse Event|1|||
147011931|NCT00517192|530205405|FG001|Overall Study|Adverse Event|1|||
147011932|NCT00517192|530205404|FG000|Overall Study|Lost to Follow-up|1|||
147011933|NCT00517192|530205405|FG001|Overall Study|Lost to Follow-up|1|||
147011934|NCT00517192|530205404|FG000|Overall Study|Withdrawal by Subject|1|||
147011935|NCT00517192|530205405|FG001|Overall Study|Withdrawal by Subject|0|||
147011936|NCT00517192|530205404|FG000|Overall Study|Early termination of the trial|16|||
147011937|NCT00517192|530205405|FG001|Overall Study|Early termination of the trial|18|||
147011938|NCT03167606|530205414|FG000|Overall Study|Lost to Follow-up|73|||
147011939|NCT03167606|530205415|FG001|Overall Study|Lost to Follow-up|64|||
147011940|NCT03167606|530205414|FG000|Overall Study|Withdrawal by Subject|6|||
147011941|NCT03167606|530205415|FG001|Overall Study|Withdrawal by Subject|5|||
147011942|NCT03167606|530205414|FG000|Overall Study|Withdrawal by Investigator|0|||
147011943|NCT03167606|530205415|FG001|Overall Study|Withdrawal by Investigator|2|||
147011944|NCT02483416|530205416|FG000|Overall Study|Other reason|0|||
147011945|NCT02483416|530205417|FG001|Overall Study|Other reason|1|||
147011946|NCT02483416|530205416|FG000|Overall Study|Treatment stop|3|||
147011947|NCT02483416|530205417|FG001|Overall Study|Treatment stop|0|||
147011948|NCT04633642|530205421|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
147011949|NCT04633642|530205422|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
147011950|NCT00611884|530205423|FG000|Overall Study|Adverse Event|1|||
147011951|NCT00611884|530205424|FG001|Overall Study|Adverse Event|0|||
147011952|NCT00611884|530205425|FG002|Overall Study|Adverse Event|0|||
147011953|NCT00611884|530205426|FG003|Overall Study|Adverse Event|1|||
147011954|NCT00611884|530205423|FG000|Overall Study|Non-Compliance|1|||
147011955|NCT00611884|530205424|FG001|Overall Study|Non-Compliance|4|||
147011956|NCT00611884|530205425|FG002|Overall Study|Non-Compliance|2|||
147011957|NCT00611884|530205426|FG003|Overall Study|Non-Compliance|2|||
147011958|NCT00611884|530205423|FG000|Overall Study|Lack of Efficacy|0|||
147011959|NCT00611884|530205424|FG001|Overall Study|Lack of Efficacy|1|||
147011960|NCT00611884|530205425|FG002|Overall Study|Lack of Efficacy|0|||
147011961|NCT00611884|530205426|FG003|Overall Study|Lack of Efficacy|0|||
147011962|NCT00611884|530205423|FG000|Overall Study|Unclassified|7|||
147011963|NCT00611884|530205424|FG001|Overall Study|Unclassified|4|||
147011964|NCT00611884|530205425|FG002|Overall Study|Unclassified|2|||
147011965|NCT00611884|530205426|FG003|Overall Study|Unclassified|3|||
147011966|NCT00981799|530205427|FG000|Overall Study|Adverse Event|1|||
147011967|NCT00981799|530205428|FG001|Overall Study|Adverse Event|1|||
147011968|NCT00981799|530205429|FG002|Overall Study|Adverse Event|0|||
147011969|NCT00981799|530205430|FG003|Overall Study|Adverse Event|0|||
147011970|NCT02167594|530205431|FG000|Overall Study|Withdrawal by Subject|2|||
147011971|NCT02167594|530205432|FG001|Overall Study|Withdrawal by Subject|0|||
147011972|NCT02167594|530205433|FG002|Overall Study|Withdrawal by Subject|0|||
147011973|NCT02167594|530205431|FG000|Overall Study|Death|0|||
147011974|NCT02167594|530205432|FG001|Overall Study|Death|1|||
147011975|NCT02167594|530205433|FG002|Overall Study|Death|0|||
147011976|NCT03433703|530205434|FG000|Overall Study|Study terminated by Sponsor|2|||
147011977|NCT01943435|530205447|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
147011978|NCT01943435|530205448|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
147011979|NCT01943435|530205449|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
147011980|NCT01943435|530205447|FG000|Intervention Period|Withdrawal by Subject|3|||
147011981|NCT01943435|530205448|FG001|Intervention Period|Withdrawal by Subject|3|||
147011982|NCT01943435|530205449|FG002|Intervention Period|Withdrawal by Subject|4|||
147011983|NCT01943435|530205447|FG000|2 Month Follow up|Lost to Follow-up|2|||
147011984|NCT01943435|530205448|FG001|2 Month Follow up|Lost to Follow-up|3|||
147011985|NCT01943435|530205449|FG002|2 Month Follow up|Lost to Follow-up|0|||
147011986|NCT01943435|530205447|FG000|6 Month Follow up|Lost to Follow-up|12|||
147011987|NCT01943435|530205448|FG001|6 Month Follow up|Lost to Follow-up|7|||
147011988|NCT01943435|530205449|FG002|6 Month Follow up|Lost to Follow-up|15|||
147011989|NCT01617096|530205456|FG000|Overall Study|Withdrawal by Subject|96|||
147011990|NCT01617096|530205457|FG001|Overall Study|Withdrawal by Subject|81|||
147011991|NCT01617096|530205456|FG000|Overall Study|Lost to Follow-up|37|||
147011992|NCT01617096|530205457|FG001|Overall Study|Lost to Follow-up|32|||
147011993|NCT01617096|530205456|FG000|Overall Study|Physician Decision|10|||
147011994|NCT01617096|530205457|FG001|Overall Study|Physician Decision|18|||
147011995|NCT01617096|530205456|FG000|Overall Study|Death|4|||
147011996|NCT01617096|530205457|FG001|Overall Study|Death|3|||
147011997|NCT01617096|530205456|FG000|Overall Study|Other|1|||
147011998|NCT01617096|530205457|FG001|Overall Study|Other|3|||
147011999|NCT02046122|530205462|FG000|Overall Study|Physician Decision|8|||
147012000|NCT02046122|530205462|FG000|Overall Study|Withdrawal by Subject|1|||
147012001|NCT04535986|530205465|FG000|Overall Study|Death|4|||
147012002|NCT04535986|530205466|FG001|Overall Study|Death|5|||
147012003|NCT04535986|530205465|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
147012004|NCT04535986|530205466|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
147012005|NCT04535986|530205465|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
147012006|NCT04535986|530205466|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
147012007|NCT04535986|530205465|FG000|Overall Study|Adverse Event|10|||
147012008|NCT04535986|530205466|FG001|Overall Study|Adverse Event|1|||
147012009|NCT04535986|530205465|FG000|Overall Study|Lack of Efficacy|3|||
147012010|NCT04535986|530205466|FG001|Overall Study|Lack of Efficacy|2|||
147012011|NCT04535986|530205465|FG000|Overall Study|Investigator discretion|3|||
147012012|NCT04535986|530205466|FG001|Overall Study|Investigator discretion|0|||
147012013|NCT04535986|530205465|FG000|Overall Study|Withdrawal by Subject|32|||
147012014|NCT04535986|530205466|FG001|Overall Study|Withdrawal by Subject|14|||
147012015|NCT04535986|530205465|FG000|Overall Study|Lost to Follow-up|5|||
147012016|NCT04535986|530205466|FG001|Overall Study|Lost to Follow-up|3|||
147012017|NCT04535986|530205465|FG000|Overall Study|Other|7|||
147012018|NCT04535986|530205466|FG001|Overall Study|Other|3|||
147012019|NCT01196390|530205467|FG000|Overall Study|Protocol Violation|4|||
147012020|NCT01196390|530205468|FG001|Overall Study|Protocol Violation|5|||
147012021|NCT03141151|530205477|FG000|Overall Study|Lost to Follow-up|3|||
147012022|NCT03141151|530205478|FG001|Overall Study|Lost to Follow-up|2|||
147012023|NCT03141151|530205477|FG000|Overall Study|Withdrawal by Subject|3|||
147012024|NCT03141151|530205478|FG001|Overall Study|Withdrawal by Subject|2|||
147013234|NCT01708954|530210055|FG001|Step 1|Withdrawal by Subject|5|||
147012025|NCT04561115|530205479|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
147012026|NCT04561115|530205480|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
147012027|NCT04561115|530205479|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
147012028|NCT04561115|530205480|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
147012029|NCT04561115|530205479|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
147012030|NCT04561115|530205480|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
147012031|NCT02985398|530205481|FG000|Overall Study|Adverse Event|1|||
147012032|NCT02985398|530205481|FG000|Overall Study|Lost to Follow-up|4|||
147012033|NCT02985398|530205481|FG000|Overall Study|Withdrawal by Subject|8|||
147012034|NCT02985398|530205481|FG000|Overall Study|Study Burden|9|||
147012035|NCT00283842|530205486|FG000|Overall Study|Adverse Event|8|||
147012036|NCT00283842|530205487|FG001|Overall Study|Adverse Event|7|||
147012037|NCT00283842|530205488|FG002|Overall Study|Adverse Event|21|||
147012038|NCT00283842|530205489|FG003|Overall Study|Adverse Event|21|||
147012039|NCT00283842|530205490|FG004|Overall Study|Adverse Event|5|||
147012040|NCT00283842|530205486|FG000|Overall Study|Protocol Violation|1|||
147012041|NCT00283842|530205487|FG001|Overall Study|Protocol Violation|5|||
147012042|NCT00283842|530205488|FG002|Overall Study|Protocol Violation|4|||
147012043|NCT00283842|530205489|FG003|Overall Study|Protocol Violation|0|||
147012044|NCT00283842|530205490|FG004|Overall Study|Protocol Violation|0|||
147012045|NCT00283842|530205486|FG000|Overall Study|Protocol deviation|0|||
147012046|NCT00283842|530205487|FG001|Overall Study|Protocol deviation|0|||
147012047|NCT00283842|530205488|FG002|Overall Study|Protocol deviation|0|||
147012048|NCT00283842|530205489|FG003|Overall Study|Protocol deviation|0|||
147012049|NCT00283842|530205490|FG004|Overall Study|Protocol deviation|2|||
147012050|NCT00283842|530205486|FG000|Overall Study|Withdrawal by Subject|2|||
147012051|NCT00283842|530205487|FG001|Overall Study|Withdrawal by Subject|1|||
147012052|NCT00283842|530205488|FG002|Overall Study|Withdrawal by Subject|1|||
147012053|NCT00283842|530205489|FG003|Overall Study|Withdrawal by Subject|5|||
147012054|NCT00283842|530205490|FG004|Overall Study|Withdrawal by Subject|4|||
147012055|NCT00283842|530205486|FG000|Overall Study|Lack of Efficacy|1|||
147012056|NCT00283842|530205487|FG001|Overall Study|Lack of Efficacy|3|||
147012057|NCT00283842|530205488|FG002|Overall Study|Lack of Efficacy|1|||
147012058|NCT00283842|530205489|FG003|Overall Study|Lack of Efficacy|0|||
147012059|NCT00283842|530205490|FG004|Overall Study|Lack of Efficacy|3|||
147012060|NCT00283842|530205486|FG000|Overall Study|Lost to Follow-up|0|||
147012061|NCT00283842|530205487|FG001|Overall Study|Lost to Follow-up|2|||
147012062|NCT00283842|530205488|FG002|Overall Study|Lost to Follow-up|4|||
147012063|NCT00283842|530205489|FG003|Overall Study|Lost to Follow-up|1|||
147012064|NCT00283842|530205490|FG004|Overall Study|Lost to Follow-up|1|||
147012065|NCT02004691|530205491|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
147012066|NCT02004691|530205492|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
147012067|NCT02004691|530205491|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
147012068|NCT02004691|530205492|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
147012069|NCT02004691|530205491|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
147012070|NCT02004691|530205492|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
147012071|NCT02004691|530205491|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
147012072|NCT02004691|530205492|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
147012073|NCT02004691|530205491|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
147012074|NCT02004691|530205492|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
147012075|NCT02004691|530205491|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
147012076|NCT02004691|530205492|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
147012077|NCT02472639|530205493|FG000|Overall Study|Physician Decision|4|||
146848122|NCT02535091|529614019|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
146848123|NCT02535091|529614020|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
146848124|NCT02535091|529614018|FG000|Overall Study|Withdrawal by Subject|14|||
147012078|NCT02472639|530205494|FG001|Overall Study|Physician Decision|3|||
147012079|NCT00751023|530205495|FG000|Overall Study|Lost to Follow-up|11|||
147012080|NCT00751023|530205496|FG001|Overall Study|Lost to Follow-up|7|||
147012081|NCT01211262|530205498|FG000|Overall Study|Progressive Disease|18|||
147012082|NCT01211262|530205499|FG001|Overall Study|Progressive Disease|9|||
147012083|NCT01211262|530205498|FG000|Overall Study|Adverse Event|4|||
147012084|NCT01211262|530205499|FG001|Overall Study|Adverse Event|0|||
147012085|NCT01211262|530205498|FG000|Overall Study|Withdrawal of Consent|1|||
146848125|NCT02535091|529614019|FG001|Overall Study|Withdrawal by Subject|5|||
146848126|NCT02535091|529614020|FG002|Overall Study|Withdrawal by Subject|121|||
146848127|NCT02535091|529614018|FG000|Overall Study|Adverse Event|9|||
146848128|NCT02535091|529614019|FG001|Overall Study|Adverse Event|4|||
146848129|NCT02535091|529614020|FG002|Overall Study|Adverse Event|170|||
146848130|NCT02535091|529614018|FG000|Overall Study|Other|4|||
146848131|NCT02535091|529614019|FG001|Overall Study|Other|3|||
146848132|NCT02535091|529614020|FG002|Overall Study|Other|81|||
147012086|NCT01211262|530205499|FG001|Overall Study|Withdrawal of Consent|0|||
147012087|NCT01211262|530205498|FG000|Overall Study|Other|0|||
147012088|NCT01211262|530205499|FG001|Overall Study|Other|1|||
147012089|NCT01277510|530205502|FG000|Double-blind Phase|Non-compliance|0|||
147012090|NCT01277510|530205503|FG001|Double-blind Phase|Non-compliance|1|||
147012091|NCT01277510|530205502|FG000|Double-blind Phase|Adverse Event|1|||
147012092|NCT01277510|530205503|FG001|Double-blind Phase|Adverse Event|0|||
147012093|NCT01277510|530205502|FG000|Double-blind Phase|Withdrawal by Subject|2|||
147012094|NCT01277510|530205503|FG001|Double-blind Phase|Withdrawal by Subject|0|||
147012095|NCT01277510|530205502|FG000|Double-blind Phase|Administrative decision|7|||
147012096|NCT01277510|530205503|FG001|Double-blind Phase|Administrative decision|9|||
147012097|NCT01277510|530205502|FG000|Double-blind Phase|Death|0|||
147012098|NCT01277510|530205503|FG001|Double-blind Phase|Death|1|||
147012099|NCT01277510|530205502|FG000|Double-blind Phase|Protocol-specified criteria|2|||
147012100|NCT01277510|530205503|FG001|Double-blind Phase|Protocol-specified criteria|6|||
147012101|NCT01277510|530205502|FG000|Double-blind Phase|Other|1|||
147012102|NCT01277510|530205503|FG001|Double-blind Phase|Other|1|||
147012103|NCT01277510|530205502|FG000|Open-label Phase|Administrative decision|4|||
147012104|NCT01277510|530205503|FG001|Open-label Phase|Administrative decision|3|||
147012105|NCT01277510|530205502|FG000|Open-label Phase|Protocol-specified criteria|1|||
147012106|NCT01277510|530205503|FG001|Open-label Phase|Protocol-specified criteria|0|||
147012107|NCT01277510|530205502|FG000|Open-label Phase|Never received investigational product|2|||
147012108|NCT01277510|530205503|FG001|Open-label Phase|Never received investigational product|0|||
147012109|NCT01685008|530205504|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
147012110|NCT01685008|530205505|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
147012111|NCT01685008|530205506|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
147012112|NCT01685008|530205507|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
147012113|NCT01685008|530205504|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
147012114|NCT01685008|530205505|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
147012115|NCT01685008|530205506|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
147012116|NCT01685008|530205507|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
147012117|NCT01685008|530205504|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
147012118|NCT01685008|530205505|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
147012119|NCT01685008|530205506|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
147012120|NCT01685008|530205507|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
147012121|NCT01685008|530205504|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
147012122|NCT01685008|530205505|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
147012123|NCT01685008|530205506|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
147012124|NCT01685008|530205507|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
147012125|NCT01685008|530205504|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
147012126|NCT01685008|530205505|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
147012127|NCT01685008|530205506|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
147012128|NCT01685008|530205507|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
147012129|NCT04049097|530205508|FG000|Overall Study|Adverse Event|18|||
147012130|NCT04049097|530205508|FG000|Overall Study|Death|2|||
147012131|NCT04049097|530205508|FG000|Overall Study|Lost to Follow-up|1|||
147012132|NCT04049097|530205508|FG000|Overall Study|Physician Decision|2|||
147012133|NCT04049097|530205508|FG000|Overall Study|Withdrawal by Subject|9|||
147012134|NCT04049097|530205508|FG000|Overall Study|Protocol Violation|2|||
147012135|NCT04049097|530205508|FG000|Overall Study|Other|1|||
147012136|NCT04049097|530205508|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
147012137|NCT01320722|530205509|FG000|Overall Study|Did not Receive Intervention|3|||
147012138|NCT01320722|530205510|FG001|Overall Study|Did not Receive Intervention|2|||
147012139|NCT01320722|530205511|FG002|Overall Study|Did not Receive Intervention|1|||
147012140|NCT01320722|530205512|FG003|Overall Study|Did not Receive Intervention|1|||
147012141|NCT01320722|530205513|FG004|Overall Study|Did not Receive Intervention|2|||
147012142|NCT01320722|530205509|FG000|Overall Study|Lost to Follow-up|0|||
147012143|NCT01320722|530205510|FG001|Overall Study|Lost to Follow-up|1|||
147012144|NCT01320722|530205511|FG002|Overall Study|Lost to Follow-up|0|||
147012145|NCT01320722|530205512|FG003|Overall Study|Lost to Follow-up|1|||
147012146|NCT01320722|530205513|FG004|Overall Study|Lost to Follow-up|3|||
147012147|NCT01320722|530205509|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
147012148|NCT01320722|530205510|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
147012149|NCT01320722|530205511|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
147012150|NCT01320722|530205512|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
147012151|NCT01320722|530205513|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
147012152|NCT01320722|530205509|FG000|Overall Study|Participant Developed a Rash|0|||
147012153|NCT01320722|530205510|FG001|Overall Study|Participant Developed a Rash|0|||
147012154|NCT01320722|530205511|FG002|Overall Study|Participant Developed a Rash|2|||
147012155|NCT01320722|530205512|FG003|Overall Study|Participant Developed a Rash|1|||
147012156|NCT01320722|530205513|FG004|Overall Study|Participant Developed a Rash|1|||
147012157|NCT01320722|530205509|FG000|Overall Study|Non-compliant with Medication|0|||
147012158|NCT01320722|530205510|FG001|Overall Study|Non-compliant with Medication|0|||
147012159|NCT01320722|530205511|FG002|Overall Study|Non-compliant with Medication|1|||
147012160|NCT01320722|530205512|FG003|Overall Study|Non-compliant with Medication|0|||
147012161|NCT01320722|530205513|FG004|Overall Study|Non-compliant with Medication|0|||
147012162|NCT01320722|530205509|FG000|Overall Study|Adverse Event|0|||
147012163|NCT01320722|530205510|FG001|Overall Study|Adverse Event|0|||
147012164|NCT01320722|530205511|FG002|Overall Study|Adverse Event|3|||
147012165|NCT01320722|530205512|FG003|Overall Study|Adverse Event|6|||
147012166|NCT01320722|530205513|FG004|Overall Study|Adverse Event|0|||
147012167|NCT01320722|530205509|FG000|Overall Study|Not Compliant with Study Procedures|0|||
147012168|NCT01320722|530205510|FG001|Overall Study|Not Compliant with Study Procedures|0|||
147012169|NCT01320722|530205511|FG002|Overall Study|Not Compliant with Study Procedures|0|||
147012170|NCT01320722|530205512|FG003|Overall Study|Not Compliant with Study Procedures|4|||
147012171|NCT01320722|530205513|FG004|Overall Study|Not Compliant with Study Procedures|0|||
147012172|NCT01320722|530205509|FG000|Overall Study|Pregnancy|0|||
147012173|NCT01320722|530205510|FG001|Overall Study|Pregnancy|0|||
147012174|NCT01320722|530205511|FG002|Overall Study|Pregnancy|0|||
147012175|NCT01320722|530205512|FG003|Overall Study|Pregnancy|1|||
147012176|NCT01320722|530205513|FG004|Overall Study|Pregnancy|0|||
147012177|NCT01320722|530205509|FG000|Overall Study|Started an Exclusionary Medication|0|||
147012178|NCT01320722|530205510|FG001|Overall Study|Started an Exclusionary Medication|0|||
147012179|NCT01320722|530205511|FG002|Overall Study|Started an Exclusionary Medication|0|||
147012180|NCT01320722|530205512|FG003|Overall Study|Started an Exclusionary Medication|0|||
147012181|NCT01320722|530205513|FG004|Overall Study|Started an Exclusionary Medication|1|||
147012182|NCT01320722|530205509|FG000|Overall Study|Withdrew due to Health Condition|0|||
147012183|NCT01320722|530205510|FG001|Overall Study|Withdrew due to Health Condition|0|||
147012184|NCT01320722|530205511|FG002|Overall Study|Withdrew due to Health Condition|0|||
147012185|NCT01320722|530205512|FG003|Overall Study|Withdrew due to Health Condition|0|||
147012186|NCT01320722|530205513|FG004|Overall Study|Withdrew due to Health Condition|1|||
147012187|NCT01341405|530205518|FG000|Overall Study|Adverse Event|0|||
147012188|NCT01341405|530205519|FG001|Overall Study|Adverse Event|1|||
147012189|NCT01341405|530205520|FG002|Overall Study|Adverse Event|1|||
147012190|NCT01341405|530205518|FG000|Overall Study|Withdrawal by Subject|3|||
147012191|NCT01341405|530205519|FG001|Overall Study|Withdrawal by Subject|2|||
147012192|NCT01341405|530205520|FG002|Overall Study|Withdrawal by Subject|1|||
147012193|NCT03407729|530205521|FG000|Overall Study|Lost to Follow-up|2|||
147012194|NCT03407729|530205522|FG001|Overall Study|Lost to Follow-up|0|||
147012195|NCT03407729|530205521|FG000|Overall Study|Unable to schedule|0|||
147012196|NCT03407729|530205522|FG001|Overall Study|Unable to schedule|3|||
147012197|NCT03950674|530205523|FG000|Overall Study|Death|16|||
147012198|NCT03950674|530205524|FG001|Overall Study|Death|15|||
147012199|NCT03950674|530205523|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
147012200|NCT03950674|530205524|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
147012201|NCT03428945|530205526|FG000|Overall Study|Lost to Follow-up|5|||
147012202|NCT03428945|530205527|FG001|Overall Study|Lost to Follow-up|3|||
147012203|NCT03428945|530205526|FG000|Overall Study|Withdrawal by Subject|10|||
147012204|NCT03428945|530205527|FG001|Overall Study|Withdrawal by Subject|10|||
147012205|NCT00982228|530205528|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
147012206|NCT00982228|530205529|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
147012207|NCT00982228|530205528|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
147012208|NCT00982228|530205529|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
147012209|NCT00982228|530205528|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
147012210|NCT00982228|530205529|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
147012211|NCT00982228|530205528|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
147012212|NCT00982228|530205529|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
147012213|NCT00982228|530205528|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
147012214|NCT00982228|530205529|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
147012215|NCT00982228|530205528|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
147012216|NCT00982228|530205529|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
147012217|NCT00982228|530205528|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
147012218|NCT00982228|530205529|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
147012219|NCT00982228|530205528|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
147012220|NCT00982228|530205529|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
147012221|NCT00982228|530205528|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
147012222|NCT00982228|530205529|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
147012223|NCT00982228|530205528|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
147012224|NCT00982228|530205529|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
147012225|NCT00360490|530205533|FG000|Overall Study|Adverse Event|4|||
147012226|NCT00360490|530205534|FG001|Overall Study|Adverse Event|2|||
147012227|NCT00360490|530205533|FG000|Overall Study|Lost to Follow-up|2|||
147012228|NCT00360490|530205534|FG001|Overall Study|Lost to Follow-up|1|||
147012229|NCT00360490|530205533|FG000|Overall Study|Physician Decision|2|||
147012230|NCT00360490|530205534|FG001|Overall Study|Physician Decision|1|||
147012231|NCT00360490|530205533|FG000|Overall Study|Protocol Violation|0|||
147012232|NCT00360490|530205534|FG001|Overall Study|Protocol Violation|4|||
147012233|NCT00360490|530205533|FG000|Overall Study|Withdrawal by Subject|1|||
147012234|NCT00360490|530205534|FG001|Overall Study|Withdrawal by Subject|3|||
147012235|NCT00633022|530205536|FG000|Overall Study|Adverse Event|1|||
147012236|NCT00633022|530205537|FG001|Overall Study|Adverse Event|0|||
147012237|NCT00633022|530205538|FG002|Overall Study|Adverse Event|5|||
147012238|NCT00633022|530205536|FG000|Overall Study|Physician Decision|0|||
147012239|NCT00633022|530205537|FG001|Overall Study|Physician Decision|1|||
147012240|NCT00633022|530205538|FG002|Overall Study|Physician Decision|0|||
147012241|NCT01958060|530206916|FG000|Overall Study|Not treated|2|||
147012242|NCT01958060|530206917|FG001|Overall Study|Not treated|0|||
147012243|NCT01958060|530206918|FG002|Overall Study|Not treated|0|||
147012244|NCT01958060|530206919|FG003|Overall Study|Not treated|0|||
147012245|NCT01958060|530206920|FG004|Overall Study|Not treated|1|||
147012246|NCT01958060|530206921|FG005|Overall Study|Not treated|0|||
147012247|NCT01705717|530206922|FG000|Overall Study|Adverse Event|2|||
147012248|NCT01705717|530206923|FG001|Overall Study|Adverse Event|2|||
147012249|NCT01705717|530206922|FG000|Overall Study|Lack of Efficacy|0|||
147012250|NCT01705717|530206923|FG001|Overall Study|Lack of Efficacy|1|||
147012251|NCT01705717|530206922|FG000|Overall Study|Other|0|||
147012252|NCT01705717|530206923|FG001|Overall Study|Other|2|||
147012253|NCT00500318|530206928|FG000|Overall Study|Adverse Event|3|||
147012254|NCT00500318|530206929|FG001|Overall Study|Adverse Event|8|||
147012255|NCT00500318|530206928|FG000|Overall Study|Protocol Violation|1|||
147012256|NCT00500318|530206929|FG001|Overall Study|Protocol Violation|3|||
147012257|NCT00500318|530206928|FG000|Overall Study|Withdrawal by Subject|1|||
147012258|NCT00500318|530206929|FG001|Overall Study|Withdrawal by Subject|2|||
147012259|NCT00500318|530206928|FG000|Overall Study|Lack of Efficacy|0|||
147012260|NCT00500318|530206929|FG001|Overall Study|Lack of Efficacy|3|||
147012261|NCT00500318|530206928|FG000|Overall Study|Other Reason|0|||
147012262|NCT00500318|530206929|FG001|Overall Study|Other Reason|1|||
147012263|NCT00799708|530206930|FG000|Overall Study|non-compliance|1|||
147012264|NCT00799708|530206931|FG001|Overall Study|non-compliance|0|||
147012265|NCT00799708|530206932|FG002|Overall Study|non-compliance|0|||
147012266|NCT00880334|530206933|FG000|Randomized Phase|Physician Decision|1|||
147012267|NCT00880334|530206934|FG001|Randomized Phase|Physician Decision|0|||
147012268|NCT00880334|530206933|FG000|Randomized Phase|Withdrawal by Subject|2|||
147012269|NCT00880334|530206934|FG001|Randomized Phase|Withdrawal by Subject|1|||
147012270|NCT00880334|530206933|FG000|Randomized Phase|Inadequate Labs|1|||
147012271|NCT00880334|530206934|FG001|Randomized Phase|Inadequate Labs|1|||
147012272|NCT00880334|530206933|FG000|Randomized Phase|Brain Metastasis|0|||
147012273|NCT00880334|530206934|FG001|Randomized Phase|Brain Metastasis|1|||
147012274|NCT00880334|530206933|FG000|Randomized Phase|Crossover Participants|0|||
147012275|NCT00880334|530206934|FG001|Randomized Phase|Crossover Participants|37|||
147012276|NCT02473393|530206935|FG000|Overall Study|Adverse Event|0|||
147012277|NCT02473393|530206936|FG001|Overall Study|Adverse Event|0|||
147012278|NCT02473393|530206937|FG002|Overall Study|Adverse Event|1|||
147012279|NCT02473393|530206938|FG003|Overall Study|Adverse Event|0|||
147012280|NCT02473393|530206935|FG000|Overall Study|Withdrawal by Subject|0|||
147012281|NCT02473393|530206936|FG001|Overall Study|Withdrawal by Subject|0|||
147012282|NCT02473393|530206937|FG002|Overall Study|Withdrawal by Subject|1|||
147012283|NCT02473393|530206938|FG003|Overall Study|Withdrawal by Subject|1|||
147012284|NCT01157234|530206941|FG000|Overall Study|Withdrawal by Subject|1|||
147012285|NCT01157234|530206942|FG001|Overall Study|Withdrawal by Subject|0|||
147012286|NCT00063258|530206948|FG000|Overall Study|Physician Decision|2|||
147012287|NCT00063258|530206949|FG001|Overall Study|Physician Decision|0|||
147012288|NCT00063258|530206948|FG000|Overall Study|Lack of Efficacy|2|||
147012289|NCT00063258|530206949|FG001|Overall Study|Lack of Efficacy|0|||
147012290|NCT02246764|530206950|FG000|Overall Study|Adverse Event|15|||
147012291|NCT02246764|530206951|FG001|Overall Study|Adverse Event|29|||
147012292|NCT02246764|530206952|FG002|Overall Study|Adverse Event|1|||
147012293|NCT02246764|530206950|FG000|Overall Study|Withdrawal by Subject|0|||
147012294|NCT02246764|530206951|FG001|Overall Study|Withdrawal by Subject|0|||
147012295|NCT02246764|530206952|FG002|Overall Study|Withdrawal by Subject|1|||
147012296|NCT02246764|530206950|FG000|Overall Study|Disallowed Concomitant Medication|1|||
147012297|NCT02246764|530206951|FG001|Overall Study|Disallowed Concomitant Medication|0|||
147012298|NCT02246764|530206952|FG002|Overall Study|Disallowed Concomitant Medication|0|||
147012299|NCT02246764|530206950|FG000|Overall Study|Physician Decision|0|||
147012300|NCT02246764|530206951|FG001|Overall Study|Physician Decision|2|||
147012301|NCT02246764|530206952|FG002|Overall Study|Physician Decision|1|||
147012302|NCT02246764|530206950|FG000|Overall Study|Protocol Violation|2|||
147012303|NCT02246764|530206951|FG001|Overall Study|Protocol Violation|1|||
147012304|NCT02246764|530206952|FG002|Overall Study|Protocol Violation|1|||
147012305|NCT05393271|530206953|FG000|Overall Study|Physician Decision|0|||
147012306|NCT05393271|530206954|FG001|Overall Study|Physician Decision|0|||
147012307|NCT05393271|530206955|FG002|Overall Study|Physician Decision|0|||
147012308|NCT05393271|530206956|FG003|Overall Study|Physician Decision|0|||
147012309|NCT05393271|530206957|FG004|Overall Study|Physician Decision|0|||
147012310|NCT05393271|530206958|FG005|Overall Study|Physician Decision|0|||
147012311|NCT05393271|530206959|FG006|Overall Study|Physician Decision|1|||
147012312|NCT05393271|530206960|FG007|Overall Study|Physician Decision|0|||
147012313|NCT05393271|530206961|FG008|Overall Study|Physician Decision|0|||
147012314|NCT05393271|530206962|FG009|Overall Study|Physician Decision|0|||
147012315|NCT05393271|530206963|FG010|Overall Study|Physician Decision|0|||
147012316|NCT00413049|530206968|FG000|Overall Study|Adverse Event|10|||
147012317|NCT00413049|530206969|FG001|Overall Study|Adverse Event|8|||
147012318|NCT00413049|530206968|FG000|Overall Study|Withdrawal by Subject|7|||
147012319|NCT00413049|530206969|FG001|Overall Study|Withdrawal by Subject|5|||
147012320|NCT00413049|530206968|FG000|Overall Study|Lost to Follow-up|2|||
147012321|NCT00413049|530206969|FG001|Overall Study|Lost to Follow-up|3|||
147012322|NCT00413049|530206968|FG000|Overall Study|Protocol Violation|3|||
147012323|NCT00413049|530206969|FG001|Overall Study|Protocol Violation|1|||
147012324|NCT00413049|530206968|FG000|Overall Study|Subject no longer requires study drug|0|||
147012325|NCT00413049|530206969|FG001|Overall Study|Subject no longer requires study drug|1|||
147012326|NCT00413049|530206968|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147012327|NCT00413049|530206969|FG001|Overall Study|Abnormal laboratory value(s)|0|||
147012328|NCT00413049|530206968|FG000|Overall Study|Lack of Efficacy|1|||
147012329|NCT00413049|530206969|FG001|Overall Study|Lack of Efficacy|0|||
147012330|NCT03314857|530206972|FG000|Overall Study|Death|4|||
147012331|NCT03314857|530206972|FG000|Overall Study|Physician Decision|1|||
147012332|NCT01408888|530206975|FG000|First Intervention|Adverse Event|0|||
147012333|NCT01408888|530206976|FG001|First Intervention|Adverse Event|1|||
147012334|NCT01408888|530206975|FG000|First Intervention|Withdrawal by Subject|0|||
147012335|NCT01408888|530206976|FG001|First Intervention|Withdrawal by Subject|2|||
147012336|NCT01408888|530206975|FG000|Second Intervention|Withdrawal by Subject|1|||
147012337|NCT01408888|530206976|FG001|Second Intervention|Withdrawal by Subject|0|||
147012338|NCT01408888|530206975|FG000|Second Intervention|Adverse Event|1|||
147012339|NCT01408888|530206976|FG001|Second Intervention|Adverse Event|0|||
147012340|NCT00695110|530206981|FG000|Treatment Period 1|Adverse Event|1|||
147012341|NCT00695110|530206981|FG000|Treatment Period 1|Withdrawal by Subject|2|||
147012342|NCT00695110|530206981|FG000|Treatment Period 3|Withdrawal by Subject|1|||
147012343|NCT00695110|530206981|FG000|Treatment Period 4|Adverse Event|1|||
147012344|NCT02104817|530206982|FG000|Overall Study|Death|363|||
147012345|NCT02104817|530206983|FG001|Overall Study|Death|330|||
147012346|NCT02104817|530206982|FG000|Overall Study|Lost to Follow-up|3|||
147012347|NCT02104817|530206983|FG001|Overall Study|Lost to Follow-up|2|||
147012348|NCT02104817|530206982|FG000|Overall Study|Protocol Violation|0|||
147012349|NCT02104817|530206983|FG001|Overall Study|Protocol Violation|1|||
147012350|NCT02104817|530206982|FG000|Overall Study|Study terminated by sponsor|5854|||
147012351|NCT02104817|530206983|FG001|Overall Study|Study terminated by sponsor|5901|||
147012352|NCT02104817|530206982|FG000|Overall Study|Withdrawal by Subject|111|||
147012353|NCT02104817|530206983|FG001|Overall Study|Withdrawal by Subject|78|||
147012354|NCT02104817|530206982|FG000|Overall Study|Other reasons|128|||
147012355|NCT02104817|530206983|FG001|Overall Study|Other reasons|135|||
147012356|NCT02575339|530206987|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
147012357|NCT02575339|530206988|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
147012358|NCT02575339|530206989|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
147012359|NCT02575339|530206987|FG000|Study Treatment|Disease Progression|5|||
147012360|NCT02575339|530206988|FG001|Study Treatment|Disease Progression|2|||
147012361|NCT02575339|530206989|FG002|Study Treatment|Disease Progression|0|||
147012362|NCT02575339|530206987|FG000|Study Treatment|Adverse Event|1|||
147012363|NCT02575339|530206988|FG001|Study Treatment|Adverse Event|2|||
147012364|NCT02575339|530206989|FG002|Study Treatment|Adverse Event|0|||
147012365|NCT02575339|530206987|FG000|Follow up|Death|6|||
147012366|NCT02575339|530206988|FG001|Follow up|Death|2|||
147012367|NCT02575339|530206989|FG002|Follow up|Death|0|||
147012368|NCT02575339|530206987|FG000|Follow up|Study Terminated|0|||
147012369|NCT02575339|530206988|FG001|Follow up|Study Terminated|2|||
147012370|NCT02575339|530206989|FG002|Follow up|Study Terminated|0|||
147012371|NCT02575339|530206987|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
147012372|NCT02575339|530206988|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
147012373|NCT02575339|530206989|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
147012374|NCT04768114|530206994|FG000|Overall Study|Lost to Follow-up|5|||
147012375|NCT04768114|530206995|FG001|Overall Study|Lost to Follow-up|10|||
147012376|NCT04768114|530206994|FG000|Overall Study|Withdrawal by Subject|0|||
147012377|NCT04768114|530206995|FG001|Overall Study|Withdrawal by Subject|1|||
147012378|NCT01963260|530207000|FG000|Overall Study|Withdrawal by Subject|2|||
147012379|NCT01963260|530207001|FG001|Overall Study|Withdrawal by Subject|0|||
147012380|NCT01963260|530207002|FG002|Overall Study|Withdrawal by Subject|0|||
147012381|NCT01963260|530207003|FG003|Overall Study|Withdrawal by Subject|1|||
147012382|NCT01963260|530207004|FG004|Overall Study|Withdrawal by Subject|2|||
147012383|NCT01963260|530207005|FG005|Overall Study|Withdrawal by Subject|0|||
147012384|NCT01963260|530207006|FG006|Overall Study|Withdrawal by Subject|0|||
147012385|NCT01963260|530207007|FG007|Overall Study|Withdrawal by Subject|0|||
147012386|NCT01963260|530207008|FG008|Overall Study|Withdrawal by Subject|0|||
147012387|NCT01963260|530207009|FG009|Overall Study|Withdrawal by Subject|0|||
147012388|NCT00160524|530207010|FG000|Overall Study|Adverse Event|119|||
147012389|NCT00160524|530207010|FG000|Overall Study|Adverse Event and Other|94|||
147012390|NCT00160524|530207010|FG000|Overall Study|Protocol Violation|16|||
147012391|NCT00160524|530207010|FG000|Overall Study|Protocol Violation and Other|2|||
147012392|NCT00160524|530207010|FG000|Overall Study|Withdrawal by Subject|141|||
147012393|NCT00160524|530207010|FG000|Overall Study|Withdrawal by Subject and Other|17|||
147012394|NCT00160524|530207010|FG000|Overall Study|Physician Decision|27|||
147012395|NCT00160524|530207010|FG000|Overall Study|Physician Decision and Other|6|||
147012396|NCT00160524|530207010|FG000|Overall Study|Lost to Follow-up|13|||
147012397|NCT00160524|530207010|FG000|Overall Study|Lost to Follow-up and Other|1|||
147012398|NCT00160524|530207010|FG000|Overall Study|Lack of Efficacy|21|||
147012399|NCT00160524|530207010|FG000|Overall Study|Lack of Efficacy and Other|1|||
147012400|NCT00160524|530207010|FG000|Overall Study|Other|20|||
147012401|NCT04892147|530207011|FG000|Overall Study|Withdrawal by Subject|2|||
147012402|NCT04892147|530207012|FG001|Overall Study|Withdrawal by Subject|0|||
147012403|NCT03828539|530207016|FG000|Overall Study|Adverse Event|3|||
147012404|NCT03828539|530207017|FG001|Overall Study|Adverse Event|12|||
147012405|NCT03828539|530207016|FG000|Overall Study|Patient's/guardian's decision|3|||
147012406|NCT03828539|530207017|FG001|Overall Study|Patient's/guardian's decision|5|||
147012407|NCT03828539|530207016|FG000|Overall Study|Lost to Follow-up|4|||
147012408|NCT03828539|530207017|FG001|Overall Study|Lost to Follow-up|2|||
147012409|NCT03828539|530207016|FG000|Overall Study|Protocol Violation|3|||
147012410|NCT03828539|530207017|FG001|Overall Study|Protocol Violation|2|||
147012411|NCT03828539|530207016|FG000|Overall Study|Withdrawal of informed consent|2|||
147012412|NCT03828539|530207017|FG001|Overall Study|Withdrawal of informed consent|1|||
147012413|NCT03828539|530207016|FG000|Overall Study|New therapy for study indication|1|||
147012414|NCT03828539|530207017|FG001|Overall Study|New therapy for study indication|0|||
147012415|NCT00057941|530207018|FG000|Overall Study|Death|1|||
147012416|NCT00057941|530207019|FG001|Overall Study|Death|2|||
147012417|NCT00057941|530207018|FG000|Overall Study|Adverse Event|7|||
147012418|NCT00057941|530207019|FG001|Overall Study|Adverse Event|9|||
147012419|NCT00057941|530207018|FG000|Overall Study|Lack of Efficacy|54|||
147012420|NCT00057941|530207019|FG001|Overall Study|Lack of Efficacy|53|||
147012421|NCT00057941|530207018|FG000|Overall Study|Withdrawal by Subject|6|||
147012422|NCT00057941|530207019|FG001|Overall Study|Withdrawal by Subject|1|||
147012423|NCT00057941|530207018|FG000|Overall Study|still on treatment|3|||
147012424|NCT00057941|530207019|FG001|Overall Study|still on treatment|1|||
147012425|NCT00057941|530207018|FG000|Overall Study|insurance, symptomatic deterioration|1|||
147012426|NCT00057941|530207019|FG001|Overall Study|insurance, symptomatic deterioration|3|||
147012427|NCT00057941|530207018|FG000|Overall Study|Ineligible|2|||
147012428|NCT00057941|530207019|FG001|Overall Study|Ineligible|5|||
147012429|NCT02760433|530207020|FG000|Overall Study|Lost to Follow-up|1|||
147012430|NCT02760433|530207021|FG001|Overall Study|Lost to Follow-up|0|||
147012431|NCT02760433|530207022|FG002|Overall Study|Lost to Follow-up|1|||
147012432|NCT02760433|530207023|FG003|Overall Study|Lost to Follow-up|0|||
147012433|NCT02760433|530207024|FG004|Overall Study|Lost to Follow-up|0|||
147012434|NCT02760433|530207020|FG000|Overall Study|Withdrawal by Subject|23|||
147012435|NCT02760433|530207021|FG001|Overall Study|Withdrawal by Subject|9|||
147012436|NCT02760433|530207022|FG002|Overall Study|Withdrawal by Subject|0|||
147012437|NCT02760433|530207023|FG003|Overall Study|Withdrawal by Subject|2|||
147012438|NCT02760433|530207024|FG004|Overall Study|Withdrawal by Subject|9|||
147012439|NCT02760433|530207020|FG000|Overall Study|Lack of Response At Week 14|0|||
147012440|NCT02760433|530207021|FG001|Overall Study|Lack of Response At Week 14|0|||
147012441|NCT02760433|530207022|FG002|Overall Study|Lack of Response At Week 14|0|||
147012442|NCT02760433|530207023|FG003|Overall Study|Lack of Response At Week 14|0|||
147012443|NCT02760433|530207024|FG004|Overall Study|Lack of Response At Week 14|1|||
147012444|NCT02760433|530207020|FG000|Overall Study|Subject refused to continue the study|1|||
147012445|NCT02760433|530207021|FG001|Overall Study|Subject refused to continue the study|0|||
147012446|NCT02760433|530207022|FG002|Overall Study|Subject refused to continue the study|0|||
147012447|NCT02760433|530207023|FG003|Overall Study|Subject refused to continue the study|0|||
147012448|NCT02760433|530207024|FG004|Overall Study|Subject refused to continue the study|0|||
147012449|NCT02760433|530207020|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
147012450|NCT02760433|530207021|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
147012451|NCT02760433|530207022|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
147012452|NCT02760433|530207023|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
147012453|NCT02760433|530207024|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
147012454|NCT02760433|530207020|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
147012455|NCT02760433|530207021|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
147012456|NCT02760433|530207022|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
147012457|NCT02760433|530207023|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
147012458|NCT02760433|530207024|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
147012459|NCT00766493|530207025|FG000|30 Days Post-Procedure|Discontinued|7|||
147012460|NCT00766493|530207025|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
147012461|NCT00766493|530207025|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
147012462|NCT01849458|530207027|FG000|Overall Study|Lost to Follow-up|4|||
147012463|NCT03439085|530207028|FG000|Overall Study|Death|2|||
147012464|NCT03439085|530207028|FG000|Overall Study|Screen Failure|20|||
147012465|NCT01863433|530207029|FG000|Overall Study|Protocol Violation|1|||
147012466|NCT02224053|530207030|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
147012467|NCT02224053|530207030|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
147012468|NCT02224053|530207030|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
147012469|NCT02224053|530207030|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
147012470|NCT02224053|530207030|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
147012471|NCT03448692|530207031|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
147012472|NCT03448692|530207032|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
147012473|NCT03448692|530207031|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
147012474|NCT03448692|530207032|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
147012475|NCT03448692|530207031|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
147012476|NCT03448692|530207032|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
147012477|NCT03448692|530207031|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
147012478|NCT03448692|530207032|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
147012479|NCT03448692|530207031|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
147012480|NCT03448692|530207032|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
147012481|NCT02786927|530207033|FG000|Overall Study|Adverse Event|1|||
147012482|NCT02786927|530207033|FG000|Overall Study|Protocol Violation|4|||
147012483|NCT01801917|530207034|FG000|Period 1 - Randomized|Adverse Event|1|||
147012484|NCT01801917|530207035|FG001|Period 1 - Randomized|Adverse Event|0|||
147012485|NCT01801917|530207036|FG002|Period 1 - Randomized|Adverse Event|1|||
147012486|NCT01801917|530207037|FG003|Period 1 - Randomized|Adverse Event|0|||
147012487|NCT03919695|530207038|FG000|3-month Follow-up|Death|1|||
147012488|NCT03919695|530207039|FG001|3-month Follow-up|Death|1|||
147012489|NCT03919695|530207038|FG000|3-month Follow-up|unable to contact|0|||
147012490|NCT03919695|530207039|FG001|3-month Follow-up|unable to contact|3|||
147012491|NCT03919695|530207038|FG000|3-month Follow-up|in prison|0|||
147012492|NCT03919695|530207039|FG001|3-month Follow-up|in prison|1|||
147012493|NCT03919695|530207038|FG000|6-month Follow-up|Death|0|||
147012494|NCT03919695|530207039|FG001|6-month Follow-up|Death|1|||
147012495|NCT03919695|530207038|FG000|6-month Follow-up|Lost to Follow-up|1|||
147012496|NCT03919695|530207039|FG001|6-month Follow-up|Lost to Follow-up|2|||
147012497|NCT03919695|530207038|FG000|6-month Follow-up|in prison|0|||
147012498|NCT03919695|530207039|FG001|6-month Follow-up|in prison|2|||
147012499|NCT03919695|530207038|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
147012500|NCT03919695|530207039|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
147012501|NCT03919695|530207038|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
147012502|NCT03919695|530207039|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
147012503|NCT02416934|530207041|FG000|Overall Study|given steroids|1|||
147012504|NCT02416934|530207042|FG001|Overall Study|given steroids|2|||
147012505|NCT02416934|530207041|FG000|Overall Study|Lost to Follow-up|0|||
147012506|NCT02416934|530207042|FG001|Overall Study|Lost to Follow-up|2|||
147012507|NCT02416934|530207041|FG000|Overall Study|Withdrawal by Subject|1|||
147012508|NCT02416934|530207042|FG001|Overall Study|Withdrawal by Subject|0|||
147012509|NCT02416934|530207041|FG000|Overall Study|recruited during continuing renewal proc|0|||
147012510|NCT02416934|530207042|FG001|Overall Study|recruited during continuing renewal proc|1|||
147012511|NCT02416934|530207041|FG000|Overall Study|Protocol Violation|0|||
147012512|NCT02416934|530207042|FG001|Overall Study|Protocol Violation|1|||
147012513|NCT02416934|530207041|FG000|Overall Study|surgery started late|0|||
147012514|NCT02416934|530207042|FG001|Overall Study|surgery started late|1|||
147012515|NCT02416934|530207041|FG000|Overall Study|re-operation|1|||
147012516|NCT02416934|530207042|FG001|Overall Study|re-operation|0|||
147012517|NCT01337596|530207054|FG000|Overall Study|Withdrawal by Subject|0|||
147012518|NCT01337596|530207055|FG001|Overall Study|Withdrawal by Subject|0|||
147012519|NCT01337596|530207056|FG002|Overall Study|Withdrawal by Subject|0|||
147012520|NCT01337596|530207057|FG003|Overall Study|Withdrawal by Subject|0|||
147012521|NCT01337596|530207058|FG004|Overall Study|Withdrawal by Subject|2|||
147012522|NCT01337596|530207059|FG005|Overall Study|Withdrawal by Subject|0|||
147012523|NCT01337596|530207060|FG006|Overall Study|Withdrawal by Subject|0|||
146848133|NCT02535091|529614018|FG000|Overall Study|Lost to Follow-up|0|||
147012524|NCT01337596|530207061|FG007|Overall Study|Withdrawal by Subject|0|||
147012525|NCT01337596|530207062|FG008|Overall Study|Withdrawal by Subject|0|||
147012526|NCT03201003|530207066|FG000|Overall Study|Adverse Event|14|||
147012527|NCT03201003|530207067|FG001|Overall Study|Adverse Event|1|||
147012528|NCT03201003|530207066|FG000|Overall Study|Other reasons|5|||
147012529|NCT03201003|530207067|FG001|Overall Study|Other reasons|1|||
147012530|NCT03201003|530207066|FG000|Overall Study|Withdrawal by Subject|4|||
147012531|NCT03201003|530207067|FG001|Overall Study|Withdrawal by Subject|1|||
147012532|NCT03201003|530207066|FG000|Overall Study|Lost to Follow-up|2|||
147012533|NCT03201003|530207067|FG001|Overall Study|Lost to Follow-up|0|||
147012534|NCT03201003|530207066|FG000|Overall Study|Protocol Violation|1|||
147012535|NCT03201003|530207067|FG001|Overall Study|Protocol Violation|0|||
147012536|NCT00834613|530207068|FG000|First Intervention|Protocol Violation|1|||
147012537|NCT00834613|530207069|FG001|First Intervention|Protocol Violation|0|||
147012538|NCT00697619|530207075|FG000|Overall Study|Lack of Efficacy|2|||
147012539|NCT00697619|530207076|FG001|Overall Study|Lack of Efficacy|2|||
147012540|NCT00697619|530207075|FG000|Overall Study|Adverse Event|4|||
147012541|NCT00697619|530207076|FG001|Overall Study|Adverse Event|6|||
147012542|NCT01188226|530208732|FG000|Overall Study|Withdrawal by Subject|4|||
147012543|NCT04980456|530208733|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
147012544|NCT04980456|530208734|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
147012545|NCT04980456|530208733|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
147012546|NCT04980456|530208734|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
147012547|NCT04980456|530208733|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
147012548|NCT04980456|530208734|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
147012549|NCT04980456|530208733|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
147012550|NCT04980456|530208734|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
147012551|NCT02293460|530208735|FG000|Overall Study|Protocol Violation|1|||
147012552|NCT02293460|530208735|FG000|Overall Study|Lack of Efficacy|2|||
147012553|NCT02293460|530208735|FG000|Overall Study|Adverse Event|2|||
147012554|NCT02293460|530208735|FG000|Overall Study|Withdrawal by Subject|1|||
147012555|NCT00224484|530208736|FG000|Overall Study|Serious Adverse Event|1|||
147012556|NCT00224484|530208737|FG001|Overall Study|Serious Adverse Event|1|||
147012557|NCT00224484|530208738|FG002|Overall Study|Serious Adverse Event|0|||
147012558|NCT00224484|530208736|FG000|Overall Study|Non-Serious Adverse Event|5|||
147012559|NCT00224484|530208737|FG001|Overall Study|Non-Serious Adverse Event|7|||
147012560|NCT00224484|530208738|FG002|Overall Study|Non-Serious Adverse Event|3|||
147012561|NCT00224484|530208736|FG000|Overall Study|Protocol Violation|2|||
147012562|NCT00224484|530208737|FG001|Overall Study|Protocol Violation|2|||
147012563|NCT00224484|530208738|FG002|Overall Study|Protocol Violation|0|||
147012564|NCT00224484|530208736|FG000|Overall Study|Withdrawal by Subject|49|||
147012565|NCT00224484|530208737|FG001|Overall Study|Withdrawal by Subject|18|||
147012566|NCT00224484|530208738|FG002|Overall Study|Withdrawal by Subject|16|||
147012567|NCT00224484|530208736|FG000|Overall Study|Migrated/moved from study area|18|||
147012568|NCT00224484|530208737|FG001|Overall Study|Migrated/moved from study area|5|||
147012569|NCT00224484|530208738|FG002|Overall Study|Migrated/moved from study area|5|||
147012570|NCT00224484|530208736|FG000|Overall Study|Lost to Follow-up|66|||
147012571|NCT00224484|530208737|FG001|Overall Study|Lost to Follow-up|28|||
147012572|NCT00224484|530208738|FG002|Overall Study|Lost to Follow-up|36|||
147012573|NCT00224484|530208736|FG000|Overall Study|Reason not specified|5|||
147012574|NCT00224484|530208737|FG001|Overall Study|Reason not specified|4|||
147012575|NCT00224484|530208738|FG002|Overall Study|Reason not specified|2|||
147012576|NCT01074008|530208741|FG000|Overall Study|Adverse Event|0|||
147012577|NCT01074008|530208742|FG001|Overall Study|Adverse Event|1|||
147012578|NCT01074008|530208743|FG002|Overall Study|Adverse Event|0|||
147012579|NCT01074008|530208744|FG003|Overall Study|Adverse Event|0|||
147012580|NCT01074008|530208745|FG004|Overall Study|Adverse Event|0|||
147012581|NCT01074008|530208746|FG005|Overall Study|Adverse Event|0|||
147012582|NCT01074008|530208747|FG006|Overall Study|Adverse Event|0|||
147012583|NCT01074008|530208748|FG007|Overall Study|Adverse Event|0|||
147012584|NCT01074008|530208749|FG008|Overall Study|Adverse Event|0|||
147012585|NCT01074008|530208741|FG000|Overall Study|Withdrawal by Subject|1|||
147012586|NCT01074008|530208742|FG001|Overall Study|Withdrawal by Subject|1|||
147012587|NCT01074008|530208743|FG002|Overall Study|Withdrawal by Subject|1|||
147012588|NCT01074008|530208744|FG003|Overall Study|Withdrawal by Subject|0|||
147012589|NCT01074008|530208745|FG004|Overall Study|Withdrawal by Subject|1|||
147012590|NCT01074008|530208746|FG005|Overall Study|Withdrawal by Subject|0|||
147012591|NCT01074008|530208747|FG006|Overall Study|Withdrawal by Subject|0|||
147012592|NCT01074008|530208748|FG007|Overall Study|Withdrawal by Subject|0|||
147012593|NCT01074008|530208749|FG008|Overall Study|Withdrawal by Subject|0|||
147012594|NCT01074008|530208741|FG000|Overall Study|Lost to Follow-up|0|||
147012595|NCT01074008|530208742|FG001|Overall Study|Lost to Follow-up|1|||
147012596|NCT01074008|530208743|FG002|Overall Study|Lost to Follow-up|1|||
147012597|NCT01074008|530208744|FG003|Overall Study|Lost to Follow-up|1|||
146848134|NCT02535091|529614019|FG001|Overall Study|Lost to Follow-up|1|||
147012598|NCT01074008|530208745|FG004|Overall Study|Lost to Follow-up|1|||
147012599|NCT01074008|530208746|FG005|Overall Study|Lost to Follow-up|0|||
147012600|NCT01074008|530208747|FG006|Overall Study|Lost to Follow-up|1|||
147012601|NCT01074008|530208748|FG007|Overall Study|Lost to Follow-up|0|||
147012602|NCT01074008|530208749|FG008|Overall Study|Lost to Follow-up|4|||
147012603|NCT02805309|530208750|FG000|Overall Study|Lost to Follow-up|2|||
147012604|NCT02805309|530208751|FG001|Overall Study|Lost to Follow-up|2|||
147012605|NCT02805309|530208752|FG002|Overall Study|Lost to Follow-up|2|||
147012606|NCT02805309|530208750|FG000|Overall Study|Post-Randomization Exclusion|0|||
147012607|NCT02805309|530208751|FG001|Overall Study|Post-Randomization Exclusion|2|||
147012608|NCT02805309|530208752|FG002|Overall Study|Post-Randomization Exclusion|1|||
147012609|NCT01636934|530208755|FG000|Overall Study|Withdrawal by Subject|3|||
147012610|NCT01636934|530208756|FG001|Overall Study|Withdrawal by Subject|2|||
147012611|NCT01636934|530208755|FG000|Overall Study|Chemo cancel|1|||
147012612|NCT01636934|530208756|FG001|Overall Study|Chemo cancel|0|||
147012613|NCT01636934|530208755|FG000|Overall Study|Too ill to continue|1|||
147012614|NCT01636934|530208756|FG001|Overall Study|Too ill to continue|0|||
147012615|NCT01636934|530208755|FG000|Overall Study|Never started study medication|1|||
147012616|NCT01636934|530208756|FG001|Overall Study|Never started study medication|1|||
147012617|NCT03687242|530208759|FG000|Overall Study|Adverse Event|1|||
147012618|NCT00377156|530208762|FG000|Overall Study|Death|23|||
147012619|NCT00377156|530208763|FG001|Overall Study|Death|19|||
147012620|NCT00377156|530208762|FG000|Overall Study|Withdrawal by Subject|16|||
147012621|NCT00377156|530208763|FG001|Overall Study|Withdrawal by Subject|24|||
147012622|NCT00377156|530208762|FG000|Overall Study|Had follow-up <90 d|3|||
147012623|NCT00377156|530208763|FG001|Overall Study|Had follow-up <90 d|6|||
147012624|NCT00377156|530208762|FG000|Overall Study|Cancellation|1|||
147012625|NCT00377156|530208763|FG001|Overall Study|Cancellation|0|||
147012626|NCT00377156|530208762|FG000|Overall Study|Refused testing|0|||
147012627|NCT00377156|530208763|FG001|Overall Study|Refused testing|1|||
147012628|NCT00377156|530208762|FG000|Overall Study|Ineligible|0|||
147012629|NCT00377156|530208763|FG001|Overall Study|Ineligible|1|||
147012630|NCT00377156|530208762|FG000|Overall Study|Disability or language problem|0|||
147012631|NCT00377156|530208763|FG001|Overall Study|Disability or language problem|1|||
147012632|NCT00377156|530208762|FG000|Overall Study|Other|5|||
147012633|NCT00377156|530208763|FG001|Overall Study|Other|2|||
147012634|NCT00288704|530208764|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
147012635|NCT00288704|530208765|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
147012636|NCT00288704|530208766|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
147012637|NCT00288704|530208764|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
147012638|NCT00288704|530208765|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
147012639|NCT00288704|530208766|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
147012640|NCT00288704|530208764|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
147012641|NCT00288704|530208765|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
147012642|NCT00288704|530208766|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
147012643|NCT00288704|530208764|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
147012644|NCT00288704|530208765|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
147012645|NCT00288704|530208766|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
147012646|NCT00288704|530208764|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
147012647|NCT00288704|530208765|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
147012648|NCT00288704|530208766|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
147012649|NCT00288704|530208764|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
147012650|NCT00288704|530208765|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
147012651|NCT00288704|530208766|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
147012652|NCT00288704|530208764|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
147012653|NCT00288704|530208765|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
147012654|NCT00288704|530208766|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
147012655|NCT01579006|530208767|FG000|Overall Study|Lack of Efficacy|10|||
147012656|NCT01579006|530208767|FG000|Overall Study|Adverse Event|13|||
147012657|NCT01579006|530208767|FG000|Overall Study|Withdrawal by Subject|5|||
147012658|NCT01579006|530208767|FG000|Overall Study|Non-compliance|3|||
147012659|NCT01579006|530208767|FG000|Overall Study|Due to participant's health fund|1|||
147012660|NCT01579006|530208767|FG000|Overall Study|Scheduled surgery|1|||
147012661|NCT01802216|530208770|FG000|4 Month Visit|Participant did not show to visit|3|||
147012662|NCT01802216|530208771|FG001|4 Month Visit|Participant did not show to visit|4|||
147012663|NCT01802216|530208770|FG000|8 Month Visit|Participant did not show to visit|3|||
147012664|NCT01802216|530208771|FG001|8 Month Visit|Participant did not show to visit|5|||
147012665|NCT01802216|530208770|FG000|12 Month Visit|Participant did not show to visit|3|||
147012666|NCT01802216|530208771|FG001|12 Month Visit|Participant did not show to visit|4|||
147012667|NCT04675775|530208772|FG000|Overall Study|Withdrawal by Subject|7|||
147012668|NCT02340780|530208774|FG000|Overall Study|Ineligible|1|||
147012669|NCT01957150|530208775|FG000|Overall Study|Adverse Event|23|||
147012670|NCT01957150|530208776|FG001|Overall Study|Adverse Event|20|||
146848135|NCT02535091|529614020|FG002|Overall Study|Lost to Follow-up|19|||
147012671|NCT01957150|530208775|FG000|Overall Study|Withdrawal by Subject|13|||
147012672|NCT01957150|530208776|FG001|Overall Study|Withdrawal by Subject|17|||
147012673|NCT01957150|530208775|FG000|Overall Study|Physician Decision|3|||
147012674|NCT01957150|530208776|FG001|Overall Study|Physician Decision|6|||
147012675|NCT01957150|530208775|FG000|Overall Study|Lost to Follow-up|4|||
147012676|NCT01957150|530208776|FG001|Overall Study|Lost to Follow-up|4|||
147012677|NCT01957150|530208775|FG000|Overall Study|Protocol Violation|1|||
147012678|NCT01957150|530208776|FG001|Overall Study|Protocol Violation|0|||
147012679|NCT01957150|530208775|FG000|Overall Study|Lack of Efficacy|11|||
147012680|NCT01957150|530208776|FG001|Overall Study|Lack of Efficacy|11|||
147012681|NCT03223909|530208777|FG000|Overall Study|Protocol Violation|48|||
147012682|NCT03223909|530208778|FG001|Overall Study|Protocol Violation|45|||
147012683|NCT03223909|530208779|FG002|Overall Study|Protocol Violation|16|||
147012684|NCT01698554|530208782|FG000|Overall Study|Adverse Event|2|||
147012685|NCT01698554|530208783|FG001|Overall Study|Adverse Event|5|||
147012686|NCT01698554|530208784|FG002|Overall Study|Adverse Event|0|||
147012687|NCT01698554|530208785|FG003|Overall Study|Adverse Event|1|||
147012688|NCT01698554|530208782|FG000|Overall Study|Lost to Follow-up|1|||
147012689|NCT01698554|530208783|FG001|Overall Study|Lost to Follow-up|0|||
147012690|NCT01698554|530208784|FG002|Overall Study|Lost to Follow-up|0|||
147012691|NCT01698554|530208785|FG003|Overall Study|Lost to Follow-up|0|||
147012692|NCT01698554|530208782|FG000|Overall Study|Personal Reasons|0|||
147012693|NCT01698554|530208783|FG001|Overall Study|Personal Reasons|5|||
147012694|NCT01698554|530208784|FG002|Overall Study|Personal Reasons|1|||
147012695|NCT01698554|530208785|FG003|Overall Study|Personal Reasons|1|||
147012696|NCT01698554|530208782|FG000|Overall Study|Protocol Violation|2|||
147012697|NCT01698554|530208783|FG001|Overall Study|Protocol Violation|0|||
147012698|NCT01698554|530208784|FG002|Overall Study|Protocol Violation|1|||
147012699|NCT01698554|530208785|FG003|Overall Study|Protocol Violation|0|||
147012700|NCT01698554|530208782|FG000|Overall Study|Other Miscellaneous Reasons|1|||
147012701|NCT01698554|530208783|FG001|Overall Study|Other Miscellaneous Reasons|0|||
147012702|NCT01698554|530208784|FG002|Overall Study|Other Miscellaneous Reasons|0|||
147012703|NCT01698554|530208785|FG003|Overall Study|Other Miscellaneous Reasons|0|||
147012704|NCT00252564|530208786|FG000|Overall Study|Adverse Event|17|||
147012705|NCT00252564|530208787|FG001|Overall Study|Adverse Event|13|||
147012706|NCT00252564|530208786|FG000|Overall Study|Unrelated Complication|2|||
147012707|NCT00252564|530208787|FG001|Overall Study|Unrelated Complication|1|||
147012708|NCT00252564|530208786|FG000|Overall Study|Disease Progression|14|||
147012709|NCT00252564|530208787|FG001|Overall Study|Disease Progression|20|||
147012710|NCT00252564|530208786|FG000|Overall Study|Death|0|||
147012711|NCT00252564|530208787|FG001|Overall Study|Death|3|||
147012712|NCT00252564|530208786|FG000|Overall Study|Physician Decision|1|||
147012713|NCT00252564|530208787|FG001|Overall Study|Physician Decision|0|||
147012714|NCT00252564|530208786|FG000|Overall Study|Lost to Follow-up|1|||
147012715|NCT00252564|530208787|FG001|Overall Study|Lost to Follow-up|0|||
147012716|NCT00252564|530208786|FG000|Overall Study|Patient Request|4|||
147012717|NCT00252564|530208787|FG001|Overall Study|Patient Request|5|||
147012718|NCT00252564|530208786|FG000|Overall Study|Withdrawal by Subject|0|||
147012719|NCT00252564|530208787|FG001|Overall Study|Withdrawal by Subject|2|||
147012720|NCT01583530|530208788|FG000|Overall Study|Adverse Event|0|||
147012721|NCT01583530|530208789|FG001|Overall Study|Adverse Event|0|||
147012722|NCT01583530|530208790|FG002|Overall Study|Adverse Event|0|||
147012723|NCT01583530|530208791|FG003|Overall Study|Adverse Event|0|||
147012724|NCT01583530|530208792|FG004|Overall Study|Adverse Event|0|||
147012725|NCT01583530|530208793|FG005|Overall Study|Adverse Event|1|||
147012726|NCT01583530|530208788|FG000|Overall Study|Withdrawal by Subject|0|||
147012727|NCT01583530|530208789|FG001|Overall Study|Withdrawal by Subject|3|||
147012728|NCT01583530|530208790|FG002|Overall Study|Withdrawal by Subject|0|||
147012729|NCT01583530|530208791|FG003|Overall Study|Withdrawal by Subject|1|||
147012730|NCT01583530|530208792|FG004|Overall Study|Withdrawal by Subject|1|||
147012731|NCT01583530|530208793|FG005|Overall Study|Withdrawal by Subject|2|||
147012732|NCT01583530|530208788|FG000|Overall Study|Lost to Follow-up|0|||
147012733|NCT01583530|530208789|FG001|Overall Study|Lost to Follow-up|0|||
147012734|NCT01583530|530208790|FG002|Overall Study|Lost to Follow-up|0|||
147012735|NCT01583530|530208791|FG003|Overall Study|Lost to Follow-up|0|||
147012736|NCT01583530|530208792|FG004|Overall Study|Lost to Follow-up|3|||
147012737|NCT01583530|530208793|FG005|Overall Study|Lost to Follow-up|0|||
147012738|NCT01583530|530208788|FG000|Overall Study|Lack of compliance|0|||
147012739|NCT01583530|530208789|FG001|Overall Study|Lack of compliance|0|||
147012740|NCT01583530|530208790|FG002|Overall Study|Lack of compliance|0|||
147012741|NCT01583530|530208791|FG003|Overall Study|Lack of compliance|0|||
147012742|NCT01583530|530208792|FG004|Overall Study|Lack of compliance|1|||
147012743|NCT01583530|530208793|FG005|Overall Study|Lack of compliance|0|||
147012744|NCT02416180|530208794|FG000|Overall Study|Withdrawal by Subject|1|||
147012745|NCT00640926|530208795|FG000|Overall Study|Adverse Event|2|||
147012746|NCT00640926|530208796|FG001|Overall Study|Adverse Event|3|||
147012747|NCT00640926|530208797|FG002|Overall Study|Adverse Event|2|||
147012748|NCT00640926|530208795|FG000|Overall Study|Lack of Efficacy|0|||
147012749|NCT00640926|530208796|FG001|Overall Study|Lack of Efficacy|2|||
147012750|NCT00640926|530208797|FG002|Overall Study|Lack of Efficacy|1|||
147012751|NCT00640926|530208795|FG000|Overall Study|Protocol Violation|2|||
147012752|NCT00640926|530208796|FG001|Overall Study|Protocol Violation|0|||
147012753|NCT00640926|530208797|FG002|Overall Study|Protocol Violation|2|||
147012754|NCT00640926|530208795|FG000|Overall Study|Lost to Follow-up|3|||
147012755|NCT00640926|530208796|FG001|Overall Study|Lost to Follow-up|1|||
147012756|NCT00640926|530208797|FG002|Overall Study|Lost to Follow-up|2|||
147012757|NCT00640926|530208795|FG000|Overall Study|Withdrawal by Subject|1|||
147012758|NCT00640926|530208796|FG001|Overall Study|Withdrawal by Subject|0|||
147012759|NCT00640926|530208797|FG002|Overall Study|Withdrawal by Subject|1|||
147012760|NCT01841073|530208800|FG000|Overall Study|Adverse Event|1|||
147012761|NCT01841073|530208801|FG001|Overall Study|Adverse Event|1|||
147012762|NCT01841073|530208800|FG000|Overall Study|Physician Decision|1|||
147012763|NCT01841073|530208801|FG001|Overall Study|Physician Decision|0|||
147012764|NCT01841073|530208800|FG000|Overall Study|Lost to Follow-up|0|||
147012765|NCT01841073|530208801|FG001|Overall Study|Lost to Follow-up|2|||
147012766|NCT02858037|530208804|FG000|Overall Study|Death|1|||
147012767|NCT02858037|530208804|FG000|Overall Study|Withdrawal by Subject|18|||
147012768|NCT02858037|530208804|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
147012769|NCT02858037|530208804|FG000|Overall Study|Lost to Follow-up|3|||
147012770|NCT02858037|530208804|FG000|Overall Study|Other|4|||
147012771|NCT00550147|530208805|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
147012772|NCT00550147|530208805|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
147012773|NCT00550147|530208805|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
147012774|NCT00550147|530208805|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
147012775|NCT00550147|530208805|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
147012776|NCT04320745|530208806|FG000|Overall Study|Adverse Event|26|||
147012777|NCT04320745|530208806|FG000|Overall Study|Withdrawal by Subject|4|||
147012778|NCT04320745|530208806|FG000|Overall Study|Lost to Follow-up|12|||
147012779|NCT04320745|530208806|FG000|Overall Study|Protocol Deviation|2|||
147012780|NCT04320745|530208806|FG000|Overall Study|Non-compliance With Study Drug|2|||
147012781|NCT04320745|530208806|FG000|Overall Study|Reason Not Specified|1|||
147012782|NCT00046839|530208808|FG000|Overall Study|Ineligible / No protocol treatment|0|||
147012783|NCT00046839|530208809|FG001|Overall Study|Ineligible / No protocol treatment|2|||
147012784|NCT00046839|530208808|FG000|Overall Study|Withdrawal of consent|1|||
147012785|NCT00046839|530208809|FG001|Overall Study|Withdrawal of consent|0|||
147012786|NCT02050321|530208811|FG000|Overall Study|Withdrawal by Subject|1|||
147012787|NCT02050321|530208811|FG000|Overall Study|Adverse Event|1|||
147012788|NCT00715676|530208816|FG000|Overall Study|Adverse Event|3|||
147012789|NCT00715676|530208817|FG001|Overall Study|Adverse Event|5|||
147012790|NCT00715676|530208818|FG002|Overall Study|Adverse Event|21|||
147012791|NCT00715676|530208816|FG000|Overall Study|Withdrawal by Subject|1|||
147012792|NCT00715676|530208817|FG001|Overall Study|Withdrawal by Subject|3|||
147012793|NCT00715676|530208818|FG002|Overall Study|Withdrawal by Subject|8|||
147012794|NCT00715676|530208816|FG000|Overall Study|Lost to Follow-up|1|||
147012795|NCT00715676|530208817|FG001|Overall Study|Lost to Follow-up|2|||
147012796|NCT00715676|530208818|FG002|Overall Study|Lost to Follow-up|1|||
147012797|NCT00715676|530208816|FG000|Overall Study|Terminated by Sponsor|1|||
147012798|NCT00715676|530208817|FG001|Overall Study|Terminated by Sponsor|0|||
147012799|NCT00715676|530208818|FG002|Overall Study|Terminated by Sponsor|0|||
147012800|NCT00715676|530208816|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
147012801|NCT00715676|530208817|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
147012802|NCT00715676|530208818|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
147012803|NCT00715676|530208816|FG000|Overall Study|Use of Exclusionary Medication|0|||
147012804|NCT00715676|530208817|FG001|Overall Study|Use of Exclusionary Medication|0|||
147012805|NCT00715676|530208818|FG002|Overall Study|Use of Exclusionary Medication|1|||
147012806|NCT00715676|530208816|FG000|Overall Study|Elevated Blood Glucose|0|||
147012807|NCT00715676|530208817|FG001|Overall Study|Elevated Blood Glucose|1|||
147012808|NCT00715676|530208818|FG002|Overall Study|Elevated Blood Glucose|0|||
147012809|NCT04994431|530208819|FG000|Overall Study|Adverse Event|1|||
147012810|NCT04994431|530208820|FG001|Overall Study|Adverse Event|0|||
147012811|NCT01067521|530208822|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
147012812|NCT01067521|530208823|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
147012813|NCT01067521|530208822|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
147012814|NCT01067521|530208823|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
147012815|NCT01067521|530208822|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
147012816|NCT01067521|530208823|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
147012817|NCT01067521|530208822|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
147012818|NCT01067521|530208823|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
147012819|NCT01067521|530208822|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
147012820|NCT01067521|530208823|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
147012821|NCT01067521|530208822|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
147012822|NCT01067521|530208823|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
147012823|NCT01067521|530208822|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
147012824|NCT01067521|530208823|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
147012825|NCT01067521|530208822|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
147012826|NCT01067521|530208823|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
147012827|NCT01067521|530208822|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
147012828|NCT01067521|530208823|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
147012829|NCT01067521|530208822|FG000|Open-Label Period|Death|3|||
147012830|NCT01067521|530208823|FG001|Open-Label Period|Death|1|||
147012831|NCT01067521|530208822|FG000|Open-Label Period|Adverse Event|30|||
147012832|NCT01067521|530208823|FG001|Open-Label Period|Adverse Event|28|||
147012833|NCT01067521|530208822|FG000|Open-Label Period|Withdrawal by Subject|160|||
147012834|NCT01067521|530208823|FG001|Open-Label Period|Withdrawal by Subject|88|||
147012835|NCT01067521|530208822|FG000|Open-Label Period|Physician Decision|13|||
147012836|NCT01067521|530208823|FG001|Open-Label Period|Physician Decision|11|||
147012837|NCT01067521|530208822|FG000|Open-Label Period|Non-compliance with study drug|5|||
147012838|NCT01067521|530208823|FG001|Open-Label Period|Non-compliance with study drug|0|||
147012839|NCT01067521|530208822|FG000|Open-Label Period|Protocol Violation|3|||
147012840|NCT01067521|530208823|FG001|Open-Label Period|Protocol Violation|0|||
147012841|NCT01067521|530208822|FG000|Open-Label Period|Pregnancy|14|||
147012842|NCT01067521|530208823|FG001|Open-Label Period|Pregnancy|8|||
147012843|NCT01067521|530208822|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
147012844|NCT01067521|530208823|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
147012845|NCT01067521|530208822|FG000|Open-Label Period|Lost to Follow-up|21|||
147012846|NCT01067521|530208823|FG001|Open-Label Period|Lost to Follow-up|20|||
147012847|NCT01547728|530208824|FG000|Overall Study|Change in procedure and equipment|1|||
147012848|NCT01547728|530208824|FG000|Overall Study|Drug not ready for subject|1|||
147012849|NCT01547728|530208824|FG000|Overall Study|Screen failure|39|||
147012850|NCT02151149|530208825|FG000|Treatment Period|Death|2|||
147012851|NCT02151149|530208826|FG001|Treatment Period|Death|3|||
147012852|NCT02151149|530208825|FG000|Treatment Period|Adverse Event|17|||
147012853|NCT02151149|530208826|FG001|Treatment Period|Adverse Event|14|||
147012854|NCT02151149|530208825|FG000|Treatment Period|Progressive Disease|25|||
147012855|NCT02151149|530208826|FG001|Treatment Period|Progressive Disease|24|||
147012856|NCT02151149|530208825|FG000|Treatment Period|Symptomatic Deterioration|2|||
147012857|NCT02151149|530208826|FG001|Treatment Period|Symptomatic Deterioration|10|||
147012858|NCT02151149|530208825|FG000|Treatment Period|Withdrawal by Subject|13|||
147012859|NCT02151149|530208826|FG001|Treatment Period|Withdrawal by Subject|11|||
147012860|NCT02151149|530208825|FG000|Treatment Period|Miscellaneous|8|||
147012861|NCT02151149|530208826|FG001|Treatment Period|Miscellaneous|7|||
147012862|NCT02151149|530208825|FG000|Treatment Period|Participants randomized but not treated|3|||
147012863|NCT02151149|530208826|FG001|Treatment Period|Participants randomized but not treated|2|||
147012864|NCT02151149|530208825|FG000|Follow-Up Period|Lost to Follow-up|2|||
147012865|NCT02151149|530208826|FG001|Follow-Up Period|Lost to Follow-up|3|||
147012866|NCT02151149|530208825|FG000|Follow-Up Period|Death|37|||
147012867|NCT02151149|530208826|FG001|Follow-Up Period|Death|34|||
147012868|NCT03419962|530208827|FG000|Overall Study|Change to other medication|1|||
147012869|NCT03419962|530208827|FG000|Overall Study|Refusal of continuing with trial drug|1|||
147012870|NCT03419962|530208827|FG000|Overall Study|Lost to Follow-up|3|||
147012871|NCT03419962|530208827|FG000|Overall Study|Difficulty in inhaling the doses|1|||
147012872|NCT03419962|530208827|FG000|Overall Study|Missing completion data|31|||
147012873|NCT04142658|530208830|FG000|Overall Study|Death|2|||
147012874|NCT04142658|530208831|FG001|Overall Study|Death|1|||
147012875|NCT04142658|530208830|FG000|Overall Study|Lost to Follow-up|4|||
147012876|NCT04142658|530208831|FG001|Overall Study|Lost to Follow-up|13|||
147012877|NCT04142658|530208830|FG000|Overall Study|Withdrawal by Subject|9|||
147012878|NCT04142658|530208831|FG001|Overall Study|Withdrawal by Subject|16|||
147012879|NCT01781234|530208832|FG000|Overall Study|Adverse Event|2|||
147012880|NCT01781234|530208833|FG001|Overall Study|Adverse Event|0|||
147012881|NCT01781234|530208832|FG000|Overall Study|Protocol Violation|3|||
147012882|NCT01781234|530208833|FG001|Overall Study|Protocol Violation|0|||
147012883|NCT01781234|530208832|FG000|Overall Study|Withdrawal by Subject|4|||
147012884|NCT01781234|530208833|FG001|Overall Study|Withdrawal by Subject|3|||
147012885|NCT00830167|530208836|FG000|Overall Study|Lack of Efficacy|26|||
147012886|NCT00830167|530208837|FG001|Overall Study|Lack of Efficacy|10|||
147012887|NCT00830167|530208836|FG000|Overall Study|Adverse Event|8|||
147012888|NCT00830167|530208837|FG001|Overall Study|Adverse Event|24|||
147012889|NCT00830167|530208836|FG000|Overall Study|Not meeting entrance criteria|2|||
147012890|NCT00830167|530208837|FG001|Overall Study|Not meeting entrance criteria|5|||
147012891|NCT00830167|530208836|FG000|Overall Study|Withdrawal by Subject|2|||
147012892|NCT00830167|530208837|FG001|Overall Study|Withdrawal by Subject|0|||
147012893|NCT00830167|530208836|FG000|Overall Study|Lost to Follow-up|0|||
147012894|NCT00830167|530208837|FG001|Overall Study|Lost to Follow-up|1|||
147012895|NCT00830167|530208836|FG000|Overall Study|Protocol Violation|0|||
147012896|NCT00830167|530208837|FG001|Overall Study|Protocol Violation|1|||
147012897|NCT00830167|530208836|FG000|Overall Study|Other|2|||
147012898|NCT00830167|530208837|FG001|Overall Study|Other|2|||
147012899|NCT01499160|530208841|FG000|Overall Study|Adverse Event|1|||
147012900|NCT01499160|530208841|FG000|Overall Study|Withdrawal by Subject|1|||
147012901|NCT01438476|530208842|FG000|Overall Study|Protocol Violation|1|||
147012902|NCT01438476|530208843|FG001|Overall Study|Protocol Violation|0|||
147012903|NCT01438476|530208842|FG000|Overall Study|Withdrawal by Subject|1|||
147012904|NCT01438476|530208843|FG001|Overall Study|Withdrawal by Subject|0|||
147012905|NCT01438476|530208842|FG000|Overall Study|No Surgery- Disease|8|||
147012906|NCT01438476|530208843|FG001|Overall Study|No Surgery- Disease|10|||
147012907|NCT01438476|530208842|FG000|Overall Study|Communication barrier|0|||
147012908|NCT01438476|530208843|FG001|Overall Study|Communication barrier|1|||
147012909|NCT02289820|530208844|FG000|Overall Study|Withdrawal by Subject|2|||
147012910|NCT02289820|530208845|FG001|Overall Study|Withdrawal by Subject|1|||
147012911|NCT02289820|530208846|FG002|Overall Study|Withdrawal by Subject|2|||
147012912|NCT02289820|530208847|FG003|Overall Study|Withdrawal by Subject|1|||
147012913|NCT02289820|530208848|FG004|Overall Study|Withdrawal by Subject|0|||
147012914|NCT02289820|530208849|FG005|Overall Study|Withdrawal by Subject|0|||
147012915|NCT02289820|530208850|FG006|Overall Study|Withdrawal by Subject|1|||
147012916|NCT02289820|530208844|FG000|Overall Study|Death|0|||
147012917|NCT02289820|530208845|FG001|Overall Study|Death|0|||
147012918|NCT02289820|530208846|FG002|Overall Study|Death|1|||
147012919|NCT02289820|530208847|FG003|Overall Study|Death|0|||
147012920|NCT02289820|530208848|FG004|Overall Study|Death|0|||
147012921|NCT02289820|530208849|FG005|Overall Study|Death|0|||
147012922|NCT02289820|530208850|FG006|Overall Study|Death|0|||
147012923|NCT02289820|530208844|FG000|Overall Study|Lost to Follow-up|0|||
147012924|NCT02289820|530208845|FG001|Overall Study|Lost to Follow-up|0|||
147012925|NCT02289820|530208846|FG002|Overall Study|Lost to Follow-up|3|||
147012926|NCT02289820|530208847|FG003|Overall Study|Lost to Follow-up|1|||
147012927|NCT02289820|530208848|FG004|Overall Study|Lost to Follow-up|0|||
147012928|NCT02289820|530208849|FG005|Overall Study|Lost to Follow-up|1|||
147012929|NCT02289820|530208850|FG006|Overall Study|Lost to Follow-up|1|||
147012930|NCT02289820|530208844|FG000|Overall Study|withdrawal of consent|0|||
147012931|NCT02289820|530208845|FG001|Overall Study|withdrawal of consent|1|||
147012932|NCT02289820|530208846|FG002|Overall Study|withdrawal of consent|0|||
147012933|NCT02289820|530208847|FG003|Overall Study|withdrawal of consent|0|||
147012934|NCT02289820|530208848|FG004|Overall Study|withdrawal of consent|0|||
147012935|NCT02289820|530208849|FG005|Overall Study|withdrawal of consent|0|||
147012936|NCT02289820|530208850|FG006|Overall Study|withdrawal of consent|0|||
147012937|NCT01924364|530208857|FG000|Overall Study|Physician Decision|3|||
147012938|NCT00265785|530208858|FG000|Overall Study|Adverse Event|4|||
147012939|NCT00265785|530208858|FG000|Overall Study|Withdrawal by Subject|3|||
147012940|NCT00265785|530208858|FG000|Overall Study|Progression/Relapse|15|||
147012941|NCT00265785|530208858|FG000|Overall Study|Not protocol specified|2|||
147012942|NCT00265785|530208858|FG000|Overall Study|Ineligible|1|||
147012943|NCT00265785|530208858|FG000|Overall Study|Did not receive protocol treatment|2|||
147012944|NCT00603512|530208859|FG000|Overall Study|Adverse Event|0|||
147012945|NCT00603512|530208860|FG001|Overall Study|Adverse Event|2|||
147012946|NCT00603512|530208861|FG002|Overall Study|Adverse Event|4|||
147012947|NCT00603512|530208862|FG003|Overall Study|Adverse Event|4|||
147012948|NCT00603512|530208863|FG004|Overall Study|Adverse Event|2|||
147012949|NCT00603512|530208859|FG000|Overall Study|Lack of Efficacy|0|||
147012950|NCT00603512|530208860|FG001|Overall Study|Lack of Efficacy|1|||
147012951|NCT00603512|530208861|FG002|Overall Study|Lack of Efficacy|0|||
147012952|NCT00603512|530208862|FG003|Overall Study|Lack of Efficacy|0|||
147012953|NCT00603512|530208863|FG004|Overall Study|Lack of Efficacy|1|||
147012954|NCT00603512|530208859|FG000|Overall Study|Other|2|||
147012955|NCT00603512|530208860|FG001|Overall Study|Other|1|||
147012956|NCT00603512|530208861|FG002|Overall Study|Other|0|||
147012957|NCT00603512|530208862|FG003|Overall Study|Other|1|||
147012958|NCT00603512|530208863|FG004|Overall Study|Other|1|||
147012959|NCT00603512|530208859|FG000|Overall Study|Withdrawal by Subject|0|||
147012960|NCT00603512|530208860|FG001|Overall Study|Withdrawal by Subject|0|||
147012961|NCT00603512|530208861|FG002|Overall Study|Withdrawal by Subject|0|||
147012962|NCT00603512|530208862|FG003|Overall Study|Withdrawal by Subject|0|||
147012963|NCT00603512|530208863|FG004|Overall Study|Withdrawal by Subject|1|||
147012964|NCT00603512|530208859|FG000|Overall Study|Randomized but not treated|0|||
147012965|NCT00603512|530208860|FG001|Overall Study|Randomized but not treated|1|||
147012966|NCT00603512|530208861|FG002|Overall Study|Randomized but not treated|1|||
147012967|NCT00603512|530208862|FG003|Overall Study|Randomized but not treated|2|||
147012968|NCT00603512|530208863|FG004|Overall Study|Randomized but not treated|0|||
147012969|NCT04979858|530208864|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
147012970|NCT04979858|530208865|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
147012971|NCT04253236|530208866|FG000|Overall Study|Adverse Event|1|||
147012972|NCT04253236|530208867|FG001|Overall Study|Adverse Event|0|||
147012973|NCT04253236|530208866|FG000|Overall Study|Safety Concerns|1|||
147012974|NCT04253236|530208867|FG001|Overall Study|Safety Concerns|0|||
147012975|NCT04253236|530208866|FG000|Overall Study|Study Terminated by Sponsor|1|||
147012976|NCT04253236|530208867|FG001|Overall Study|Study Terminated by Sponsor|0|||
147012977|NCT01688882|530208868|FG000|Overall Study|Adverse Event|1|||
147012978|NCT01688882|530208869|FG001|Overall Study|Adverse Event|0|||
147012979|NCT01688882|530208868|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147012980|NCT01688882|530208869|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147012981|NCT01688882|530208868|FG000|Overall Study|Administrative problems|1|||
147012982|NCT01688882|530208869|FG001|Overall Study|Administrative problems|0|||
147012983|NCT00860262|530208873|FG000|Overall Study|Adverse Event|9|||
147012984|NCT00860262|530208874|FG001|Overall Study|Adverse Event|6|||
147012985|NCT00860262|530208875|FG002|Overall Study|Adverse Event|7|||
147012986|NCT00860262|530208873|FG000|Overall Study|Protocol Violation|0|||
147012987|NCT00860262|530208874|FG001|Overall Study|Protocol Violation|1|||
147012988|NCT00860262|530208875|FG002|Overall Study|Protocol Violation|0|||
147012989|NCT00860262|530208873|FG000|Overall Study|Lost to Follow-up|2|||
147012990|NCT00860262|530208874|FG001|Overall Study|Lost to Follow-up|0|||
147012991|NCT00860262|530208875|FG002|Overall Study|Lost to Follow-up|1|||
147012992|NCT00860262|530208873|FG000|Overall Study|Withdrawal by Subject|4|||
147012993|NCT00860262|530208874|FG001|Overall Study|Withdrawal by Subject|8|||
147012994|NCT00860262|530208875|FG002|Overall Study|Withdrawal by Subject|6|||
147012995|NCT00860262|530208873|FG000|Overall Study|Lack of Efficacy|0|||
147012996|NCT00860262|530208874|FG001|Overall Study|Lack of Efficacy|4|||
147012997|NCT00860262|530208875|FG002|Overall Study|Lack of Efficacy|3|||
147012998|NCT00860262|530208873|FG000|Overall Study|Other|5|||
147012999|NCT00860262|530208874|FG001|Overall Study|Other|3|||
147013000|NCT00860262|530208875|FG002|Overall Study|Other|1|||
147013001|NCT00124618|530208876|FG000|Overall Study|Ineligible|1|||
147013002|NCT04640194|530208882|FG000|Overall Study|Adverse Event|3|||
147013003|NCT04640194|530208883|FG001|Overall Study|Adverse Event|7|||
147013004|NCT04640194|530208884|FG002|Overall Study|Adverse Event|0|||
147013005|NCT04640194|530208885|FG003|Overall Study|Adverse Event|5|||
147013006|NCT04640194|530208886|FG004|Overall Study|Adverse Event|0|||
147013007|NCT04640194|530208887|FG005|Overall Study|Adverse Event|4|||
147013008|NCT04640194|530208888|FG006|Overall Study|Adverse Event|0|||
147013009|NCT04640194|530208882|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
147013010|NCT04640194|530208883|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
147013011|NCT04640194|530208884|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
147013012|NCT04640194|530208885|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
147013013|NCT04640194|530208886|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
147013014|NCT04640194|530208887|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
147013015|NCT04640194|530208888|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
147013016|NCT04640194|530208882|FG000|Overall Study|fibrinogen level too low|0|||
147013017|NCT04640194|530208883|FG001|Overall Study|fibrinogen level too low|0|||
147013018|NCT04640194|530208884|FG002|Overall Study|fibrinogen level too low|0|||
147013019|NCT04640194|530208885|FG003|Overall Study|fibrinogen level too low|1|||
147013020|NCT04640194|530208886|FG004|Overall Study|fibrinogen level too low|0|||
147013021|NCT04640194|530208887|FG005|Overall Study|fibrinogen level too low|0|||
147013022|NCT04640194|530208888|FG006|Overall Study|fibrinogen level too low|0|||
147013023|NCT04640194|530208882|FG000|Overall Study|mild bleeding|0|||
147013024|NCT04640194|530208883|FG001|Overall Study|mild bleeding|0|||
147013025|NCT04640194|530208884|FG002|Overall Study|mild bleeding|0|||
147013026|NCT04640194|530208885|FG003|Overall Study|mild bleeding|1|||
147013027|NCT04640194|530208886|FG004|Overall Study|mild bleeding|0|||
147013028|NCT04640194|530208887|FG005|Overall Study|mild bleeding|0|||
147013029|NCT04640194|530208888|FG006|Overall Study|mild bleeding|0|||
147013030|NCT04640194|530208882|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
147013031|NCT04640194|530208883|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
147013032|NCT04640194|530208884|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
147013033|NCT04640194|530208885|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
147013034|NCT04640194|530208886|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
147013035|NCT04640194|530208887|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
147013036|NCT04640194|530208888|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
147013037|NCT01709903|530208889|FG000|Overall Study|administrative problems|2|||
147013038|NCT01709903|530208890|FG001|Overall Study|administrative problems|6|||
147013039|NCT01709903|530208889|FG000|Overall Study|Abnormal test procedure results|1|||
147013040|NCT01709903|530208890|FG001|Overall Study|Abnormal test procedure results|0|||
147013041|NCT01709903|530208889|FG000|Overall Study|In ability to use device|1|||
147013042|NCT01709903|530208890|FG001|Overall Study|In ability to use device|1|||
147013043|NCT01709903|530208889|FG000|Overall Study|no longer needed study drug|0|||
147013044|NCT01709903|530208890|FG001|Overall Study|no longer needed study drug|1|||
147013045|NCT01709903|530208889|FG000|Overall Study|Lost to Follow-up|0|||
147013046|NCT01709903|530208890|FG001|Overall Study|Lost to Follow-up|2|||
147013047|NCT01709903|530208889|FG000|Overall Study|Death|2|||
147013048|NCT01709903|530208890|FG001|Overall Study|Death|0|||
147013049|NCT01709903|530208889|FG000|Overall Study|Protocol Violation|3|||
147013050|NCT01709903|530208890|FG001|Overall Study|Protocol Violation|2|||
147013051|NCT01709903|530208889|FG000|Overall Study|Lack of Efficacy|3|||
147013052|NCT01709903|530208890|FG001|Overall Study|Lack of Efficacy|3|||
147013053|NCT01709903|530208889|FG000|Overall Study|Withdrawal by Subject|6|||
147013054|NCT01709903|530208890|FG001|Overall Study|Withdrawal by Subject|6|||
147013055|NCT01709903|530208889|FG000|Overall Study|Adverse Event|11|||
147013056|NCT01709903|530208890|FG001|Overall Study|Adverse Event|18|||
147013057|NCT02061280|530208891|FG000|Overall Study|Protocol Violation|12|||
147013058|NCT02061280|530208892|FG001|Overall Study|Protocol Violation|8|||
147013059|NCT02061280|530208891|FG000|Overall Study|moved out of state|0|||
147013060|NCT02061280|530208892|FG001|Overall Study|moved out of state|1|||
147013061|NCT02061280|530208891|FG000|Overall Study|Withdrawal by Subject|1|||
147013062|NCT02061280|530208892|FG001|Overall Study|Withdrawal by Subject|2|||
147013063|NCT02061280|530208891|FG000|Overall Study|Lost to Follow-up|5|||
146848136|NCT02535091|529614018|FG000|Overall Study|Protocol Violation|0|||
147013064|NCT02061280|530208892|FG001|Overall Study|Lost to Follow-up|1|||
147013065|NCT04662710|530210010|FG000|Overall Study|Death|14|||
147013066|NCT04662710|530210011|FG001|Overall Study|Death|331|||
147013067|NCT04662710|530210012|FG002|Overall Study|Death|367|||
147013068|NCT04662710|530210010|FG000|Overall Study|Ongoing|1|||
147013069|NCT04662710|530210011|FG001|Overall Study|Ongoing|109|||
147013070|NCT04662710|530210012|FG002|Overall Study|Ongoing|56|||
147013071|NCT04662710|530210010|FG000|Overall Study|Withdrawal by Subject|0|||
147013072|NCT04662710|530210011|FG001|Overall Study|Withdrawal by Subject|3|||
147013073|NCT04662710|530210012|FG002|Overall Study|Withdrawal by Subject|14|||
147013074|NCT05480800|530210018|FG000|Overall Study|Withdrawal by Subject|0|||
147013075|NCT05480800|530210019|FG001|Overall Study|Withdrawal by Subject|0|||
147013076|NCT05480800|530210020|FG002|Overall Study|Withdrawal by Subject|2|||
147013077|NCT05480800|530210021|FG003|Overall Study|Withdrawal by Subject|1|||
147013078|NCT05480800|530210022|FG004|Overall Study|Withdrawal by Subject|0|||
147013079|NCT05480800|530210023|FG005|Overall Study|Withdrawal by Subject|0|||
147013080|NCT05480800|530210024|FG006|Overall Study|Withdrawal by Subject|1|||
147013081|NCT05480800|530210025|FG007|Overall Study|Withdrawal by Subject|0|||
147013082|NCT05480800|530210018|FG000|Overall Study|Other|0|||
147013083|NCT05480800|530210019|FG001|Overall Study|Other|0|||
147013084|NCT05480800|530210020|FG002|Overall Study|Other|0|||
147013085|NCT05480800|530210021|FG003|Overall Study|Other|0|||
147013086|NCT05480800|530210022|FG004|Overall Study|Other|0|||
147013087|NCT05480800|530210023|FG005|Overall Study|Other|0|||
147013088|NCT05480800|530210024|FG006|Overall Study|Other|1|||
147013089|NCT05480800|530210025|FG007|Overall Study|Other|0|||
147013090|NCT05693805|530210028|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
147013091|NCT05693805|530210029|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
147013092|NCT02152982|530210034|FG000|Overall Study|Withdrawal by Subject|17|||
147013093|NCT02152982|530210035|FG001|Overall Study|Withdrawal by Subject|16|||
147013094|NCT02152982|530210034|FG000|Overall Study|Did not start treatment|11|||
147013095|NCT02152982|530210035|FG001|Overall Study|Did not start treatment|5|||
147013096|NCT02152982|530210034|FG000|Overall Study|Disease progression|41|||
147013097|NCT02152982|530210035|FG001|Overall Study|Disease progression|52|||
147013098|NCT02152982|530210034|FG000|Overall Study|Adverse Event|7|||
147013099|NCT02152982|530210035|FG001|Overall Study|Adverse Event|12|||
147013100|NCT02152982|530210034|FG000|Overall Study|Complicating disease|1|||
147013101|NCT02152982|530210035|FG001|Overall Study|Complicating disease|1|||
147013102|NCT02152982|530210034|FG000|Overall Study|Death|0|||
147013103|NCT02152982|530210035|FG001|Overall Study|Death|3|||
147013104|NCT02152982|530210034|FG000|Overall Study|Physician Decision|3|||
147013105|NCT02152982|530210035|FG001|Overall Study|Physician Decision|0|||
147013106|NCT03230487|530210041|FG000|Overall Study|Adverse Event|0|||
147013107|NCT03230487|530210042|FG001|Overall Study|Adverse Event|0|||
147013108|NCT03230487|530210043|FG002|Overall Study|Adverse Event|0|||
147013109|NCT03230487|530210044|FG003|Overall Study|Adverse Event|1|||
147013110|NCT03230487|530210045|FG004|Overall Study|Adverse Event|0|||
147013111|NCT03230487|530210046|FG005|Overall Study|Adverse Event|0|||
147013112|NCT05212948|530210047|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
147013113|NCT05212948|530210048|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
147013114|NCT05212948|530210047|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
147013115|NCT05212948|530210048|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
147013116|NCT05212948|530210047|FG000|Initial Vaccination Period|Pregnancy|20|||
147013117|NCT05212948|530210048|FG001|Initial Vaccination Period|Pregnancy|14|||
147013118|NCT05212948|530210047|FG000|Initial Vaccination Period|Physician Decision|686|||
147013119|NCT05212948|530210048|FG001|Initial Vaccination Period|Physician Decision|401|||
147013120|NCT05212948|530210047|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
147013121|NCT05212948|530210048|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
147013122|NCT05212948|530210047|FG000|Initial Vaccination Period|Death|23|||
147013123|NCT05212948|530210048|FG001|Initial Vaccination Period|Death|18|||
147013124|NCT05212948|530210047|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
147013125|NCT05212948|530210048|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
146848137|NCT02535091|529614019|FG001|Overall Study|Protocol Violation|1|||
146848138|NCT02535091|529614020|FG002|Overall Study|Protocol Violation|11|||
146848139|NCT02535091|529614018|FG000|Overall Study|Pregnancy|0|||
146848140|NCT02535091|529614019|FG001|Overall Study|Pregnancy|0|||
147013126|NCT05212948|530210047|FG000|Initial Vaccination Period|Adverse Event|36|||
147013127|NCT05212948|530210048|FG001|Initial Vaccination Period|Adverse Event|23|||
147013128|NCT05212948|530210047|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
147013129|NCT05212948|530210048|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
147013130|NCT05212948|530210047|FG000|Crossover Vaccination Period|Pregnancy|6|||
147013131|NCT05212948|530210048|FG001|Crossover Vaccination Period|Pregnancy|1|||
147013132|NCT05212948|530210047|FG000|Crossover Vaccination Period|Physician Decision|49|||
147013133|NCT05212948|530210048|FG001|Crossover Vaccination Period|Physician Decision|24|||
147013134|NCT05212948|530210047|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
147013135|NCT05212948|530210048|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
147013136|NCT05212948|530210047|FG000|Crossover Vaccination Period|Death|10|||
147013137|NCT05212948|530210048|FG001|Crossover Vaccination Period|Death|5|||
147013138|NCT05212948|530210047|FG000|Crossover Vaccination Period|Adverse Event|9|||
147013139|NCT05212948|530210048|FG001|Crossover Vaccination Period|Adverse Event|4|||
147013140|NCT05347693|530210049|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
147013141|NCT05347693|530210050|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
147013142|NCT05347693|530210051|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
147013143|NCT05347693|530210049|FG000|Inpatient Period|Withdrawal of consent|10|||
147013144|NCT05347693|530210050|FG001|Inpatient Period|Withdrawal of consent|0|||
147013145|NCT05347693|530210051|FG002|Inpatient Period|Withdrawal of consent|0|||
147013146|NCT05347693|530210049|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
147013147|NCT05347693|530210050|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
147013148|NCT05347693|530210051|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
147013149|NCT05347693|530210049|FG000|Inpatient Period|Screening Failure|8|||
147013150|NCT05347693|530210050|FG001|Inpatient Period|Screening Failure|0|||
147013151|NCT05347693|530210051|FG002|Inpatient Period|Screening Failure|0|||
147013152|NCT05347693|530210049|FG000|Inpatient Period|Death|2|||
147013153|NCT05347693|530210050|FG001|Inpatient Period|Death|0|||
147013154|NCT05347693|530210051|FG002|Inpatient Period|Death|0|||
147013155|NCT05347693|530210049|FG000|Inpatient Period|Physician Decision|5|||
147013156|NCT05347693|530210050|FG001|Inpatient Period|Physician Decision|0|||
147013157|NCT05347693|530210051|FG002|Inpatient Period|Physician Decision|0|||
147013158|NCT05347693|530210049|FG000|Inpatient Period|Adverse Event|3|||
147013159|NCT05347693|530210050|FG001|Inpatient Period|Adverse Event|0|||
147013160|NCT05347693|530210051|FG002|Inpatient Period|Adverse Event|0|||
147013161|NCT05347693|530210049|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
147013162|NCT05347693|530210050|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
147013163|NCT05347693|530210051|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
147013164|NCT05347693|530210049|FG000|Outpatient Period|Adverse Event|0|||
147013165|NCT05347693|530210050|FG001|Outpatient Period|Adverse Event|9|||
147013166|NCT05347693|530210051|FG002|Outpatient Period|Adverse Event|0|||
147013167|NCT05347693|530210049|FG000|Outpatient Period|Death|0|||
147013168|NCT05347693|530210050|FG001|Outpatient Period|Death|6|||
147013169|NCT05347693|530210051|FG002|Outpatient Period|Death|2|||
147013170|NCT05347693|530210049|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
147013171|NCT05347693|530210050|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
147013172|NCT05347693|530210051|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
147013173|NCT05347693|530210049|FG000|Outpatient Period|Lost to Follow-up|0|||
147013174|NCT05347693|530210050|FG001|Outpatient Period|Lost to Follow-up|0|||
147013175|NCT05347693|530210051|FG002|Outpatient Period|Lost to Follow-up|1|||
147013176|NCT05347693|530210049|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
147013177|NCT05347693|530210050|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
147013178|NCT05347693|530210051|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
147013179|NCT05347693|530210049|FG000|Outpatient Period|Scheduled hemodialysis|0|||
147013180|NCT05347693|530210050|FG001|Outpatient Period|Scheduled hemodialysis|1|||
147013181|NCT05347693|530210051|FG002|Outpatient Period|Scheduled hemodialysis|0|||
147013182|NCT05347693|530210049|FG000|Outpatient Period|Severe HK|0|||
147013183|NCT05347693|530210050|FG001|Outpatient Period|Severe HK|0|||
147013184|NCT05347693|530210051|FG002|Outpatient Period|Severe HK|1|||
147013185|NCT05347693|530210049|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
147013186|NCT05347693|530210050|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
147013187|NCT05347693|530210051|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
147013188|NCT05347693|530210049|FG000|Outpatient Period|Start of dialysis|0|||
147013189|NCT05347693|530210050|FG001|Outpatient Period|Start of dialysis|0|||
147013190|NCT05347693|530210051|FG002|Outpatient Period|Start of dialysis|1|||
147013191|NCT05347693|530210049|FG000|Outpatient Period|The participant entered hemodialysis|0|||
147013192|NCT05347693|530210050|FG001|Outpatient Period|The participant entered hemodialysis|0|||
147013193|NCT05347693|530210051|FG002|Outpatient Period|The participant entered hemodialysis|1|||
147013194|NCT05347693|530210049|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
147013195|NCT05347693|530210050|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
147013196|NCT05347693|530210051|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
147013197|NCT05347693|530210049|FG000|Outpatient Period|Withdrawal by Subject|0|||
147013198|NCT05347693|530210050|FG001|Outpatient Period|Withdrawal by Subject|8|||
147013199|NCT05347693|530210051|FG002|Outpatient Period|Withdrawal by Subject|5|||
147013200|NCT02048813|530210052|FG000|Overall Study|Still on treatment|279|||
147013201|NCT02048813|530210053|FG001|Overall Study|Still on treatment|0|||
147013202|NCT02048813|530210052|FG000|Overall Study|Adverse Event|40|||
147013203|NCT02048813|530210053|FG001|Overall Study|Adverse Event|38|||
147013204|NCT02048813|530210052|FG000|Overall Study|Disease progression|13|||
147013245|NCT01708954|530210054|FG000|Step 1|Off-treatment reason not submitted|1|||
147013246|NCT01708954|530210055|FG001|Step 1|Off-treatment reason not submitted|1|||
147013247|NCT01708954|530210056|FG002|Step 1|Off-treatment reason not submitted|1|||
147013248|NCT01708954|530210054|FG000|Step 1|Ineligible or never received treatment|4|||
147013249|NCT01708954|530210055|FG001|Step 1|Ineligible or never received treatment|2|||
147013250|NCT01708954|530210056|FG002|Step 1|Ineligible or never received treatment|8|||
147013251|NCT01708954|530210054|FG000|Step 2|Disease progression|9|||
147013252|NCT01708954|530210055|FG001|Step 2|Disease progression|4|||
147013253|NCT01708954|530210056|FG002|Step 2|Disease progression|0|||
147013254|NCT01708954|530210054|FG000|Step 2|Adverse Event|3|||
147013255|NCT01708954|530210055|FG001|Step 2|Adverse Event|2|||
147013256|NCT01708954|530210056|FG002|Step 2|Adverse Event|0|||
147013257|NCT01708954|530210054|FG000|Step 2|Withdrawal by Subject|1|||
147013258|NCT01708954|530210055|FG001|Step 2|Withdrawal by Subject|1|||
147013259|NCT01708954|530210056|FG002|Step 2|Withdrawal by Subject|0|||
147013260|NCT01192776|530210057|FG000|Overall Study|Death|8|||
147013261|NCT01192776|530210058|FG001|Overall Study|Death|15|||
147013262|NCT01192776|530210059|FG002|Overall Study|Death|18|||
147013263|NCT01192776|530210060|FG003|Overall Study|Death|15|||
147013264|NCT01192776|530210057|FG000|Overall Study|Lost to Follow-up|3|||
147013265|NCT01192776|530210058|FG001|Overall Study|Lost to Follow-up|6|||
147013266|NCT01192776|530210059|FG002|Overall Study|Lost to Follow-up|3|||
147013267|NCT01192776|530210060|FG003|Overall Study|Lost to Follow-up|5|||
147013268|NCT05552261|530210064|FG000|Overall Study|Withdrawal by Subject|1|||
147013269|NCT05552261|530210064|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
147013270|NCT04941768|530210069|FG000|Overall Study|Lost to Follow-up|10|||
147013271|NCT04941768|530210069|FG000|Overall Study|Death|24|||
147013272|NCT04941768|530210069|FG000|Overall Study|Progressive Disease|4|||
147013273|NCT04941768|530210069|FG000|Overall Study|Withdrawal by Subject|4|||
147013274|NCT04941768|530210069|FG000|Overall Study|Other|3|||
147013275|NCT04941768|530210069|FG000|Overall Study|Treatment ongoing|21|||
147013276|NCT04941768|530210069|FG000|Overall Study|Off treatment and in follow-up|21|||
147013277|NCT03302078|530210071|FG000|Washout Period|Adverse Event|0|||
147013278|NCT03302078|530210072|FG001|Washout Period|Adverse Event|1|||
147013279|NCT01886872|530210073|FG000|Overall Study|Ineligible|7|||
147013280|NCT01886872|530210074|FG001|Overall Study|Ineligible|4|||
147013281|NCT01886872|530210075|FG002|Overall Study|Ineligible|12|||
147013282|NCT01856192|530210076|FG000|Overall Study|Adverse Event|12|||
147013283|NCT01856192|530210077|FG001|Overall Study|Adverse Event|4|||
147013284|NCT01856192|530210076|FG000|Overall Study|Alternative therapy|0|||
147013285|NCT01856192|530210077|FG001|Overall Study|Alternative therapy|3|||
147013286|NCT01856192|530210076|FG000|Overall Study|Death|3|||
147013287|NCT01856192|530210077|FG001|Overall Study|Death|5|||
147013288|NCT01856192|530210076|FG000|Overall Study|Lack of Efficacy|0|||
147013289|NCT01856192|530210077|FG001|Overall Study|Lack of Efficacy|5|||
147013290|NCT01856192|530210076|FG000|Overall Study|Withdrawal by Subject|1|||
147013291|NCT01856192|530210077|FG001|Overall Study|Withdrawal by Subject|1|||
147013292|NCT01856192|530210076|FG000|Overall Study|Other diseases|1|||
147013293|NCT01856192|530210077|FG001|Overall Study|Other diseases|0|||
147013294|NCT01856192|530210076|FG000|Overall Study|Never started treatment|7|||
147013295|NCT01856192|530210077|FG001|Overall Study|Never started treatment|5|||
147013296|NCT01856192|530210076|FG000|Overall Study|Path ineligible|20|||
147013297|NCT01856192|530210077|FG001|Overall Study|Path ineligible|34|||
147013298|NCT01856192|530210076|FG000|Overall Study|Non-path ineligible|2|||
147013299|NCT01856192|530210077|FG001|Overall Study|Non-path ineligible|2|||
147013300|NCT01856192|530210076|FG000|Overall Study|Physician Decision|1|||
147013301|NCT01856192|530210077|FG001|Overall Study|Physician Decision|1|||
147013302|NCT01856192|530210076|FG000|Overall Study|Suspicion of progressive disease|1|||
147013303|NCT01856192|530210077|FG001|Overall Study|Suspicion of progressive disease|0|||
147013304|NCT01856192|530210076|FG000|Overall Study|Non-compliance|1|||
147013305|NCT01856192|530210077|FG001|Overall Study|Non-compliance|0|||
147013306|NCT00098475|530210078|FG000|Step 1|Progressive disease|33|||
147013307|NCT00098475|530210079|FG001|Step 1|Progressive disease|35|||
147013308|NCT00098475|530210080|FG002|Step 1|Progressive disease|2|||
147013309|NCT00098475|530210081|FG003|Step 1|Progressive disease|1|||
147013310|NCT00098475|530210078|FG000|Step 1|Adverse Event|56|||
147013311|NCT00098475|530210079|FG001|Step 1|Adverse Event|37|||
147013312|NCT00098475|530210080|FG002|Step 1|Adverse Event|0|||
147013313|NCT00098475|530210081|FG003|Step 1|Adverse Event|1|||
147013314|NCT00098475|530210078|FG000|Step 1|Death|8|||
147013315|NCT00098475|530210079|FG001|Step 1|Death|5|||
147013316|NCT00098475|530210080|FG002|Step 1|Death|0|||
147013317|NCT00098475|530210081|FG003|Step 1|Death|1|||
147013318|NCT00098475|530210078|FG000|Step 1|Withdrawal by Subject|14|||
147013319|NCT00098475|530210079|FG001|Step 1|Withdrawal by Subject|11|||
147013320|NCT00098475|530210080|FG002|Step 1|Withdrawal by Subject|0|||
147013321|NCT00098475|530210081|FG003|Step 1|Withdrawal by Subject|0|||
147013322|NCT00098475|530210078|FG000|Step 1|Physician Decision|5|||
147013323|NCT00098475|530210079|FG001|Step 1|Physician Decision|2|||
147013324|NCT00098475|530210080|FG002|Step 1|Physician Decision|0|||
147013325|NCT00098475|530210081|FG003|Step 1|Physician Decision|0|||
146848558|NCT04828837|529615737|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
146848559|NCT04828837|529615736|FG000|Overall Study|Lost to Follow-up|2|||
146848560|NCT04828837|529615737|FG001|Overall Study|Lost to Follow-up|6|||
146848561|NCT04828837|529615736|FG000|Overall Study|Lack of Efficacy|1|||
146848562|NCT04828837|529615737|FG001|Overall Study|Lack of Efficacy|0|||
147013326|NCT00098475|530210078|FG000|Step 1|Alternative therapy|31|||
147013327|NCT00098475|530210079|FG001|Step 1|Alternative therapy|43|||
147013328|NCT00098475|530210080|FG002|Step 1|Alternative therapy|1|||
147013329|NCT00098475|530210081|FG003|Step 1|Alternative therapy|0|||
147013330|NCT00098475|530210078|FG000|Step 1|Other disease|2|||
147013331|NCT00098475|530210079|FG001|Step 1|Other disease|1|||
147013332|NCT00098475|530210080|FG002|Step 1|Other disease|1|||
147013333|NCT00098475|530210081|FG003|Step 1|Other disease|0|||
147013334|NCT00098475|530210078|FG000|Step 1|Never started treatment|0|||
147013335|NCT00098475|530210079|FG001|Step 1|Never started treatment|2|||
147013336|NCT00098475|530210080|FG002|Step 1|Never started treatment|0|||
147013337|NCT00098475|530210081|FG003|Step 1|Never started treatment|0|||
147013338|NCT00098475|530210078|FG000|Step 1|Still on treatment as of this analysis|14|||
147013339|NCT00098475|530210079|FG001|Step 1|Still on treatment as of this analysis|27|||
147013340|NCT00098475|530210080|FG002|Step 1|Still on treatment as of this analysis|0|||
147013341|NCT00098475|530210081|FG003|Step 1|Still on treatment as of this analysis|0|||
147013342|NCT00098475|530210078|FG000|Step 1|Knee surgery|1|||
147013343|NCT00098475|530210079|FG001|Step 1|Knee surgery|0|||
147013344|NCT00098475|530210080|FG002|Step 1|Knee surgery|0|||
147013345|NCT00098475|530210081|FG003|Step 1|Knee surgery|0|||
147013346|NCT00098475|530210078|FG000|Step 1|Complications|1|||
147013347|NCT00098475|530210079|FG001|Step 1|Complications|0|||
147013348|NCT00098475|530210080|FG002|Step 1|Complications|0|||
147013349|NCT00098475|530210081|FG003|Step 1|Complications|0|||
147013350|NCT00098475|530210078|FG000|Step 1|Cannot comply due to other tx|0|||
147013351|NCT00098475|530210079|FG001|Step 1|Cannot comply due to other tx|1|||
147013352|NCT00098475|530210080|FG002|Step 1|Cannot comply due to other tx|0|||
147013353|NCT00098475|530210081|FG003|Step 1|Cannot comply due to other tx|0|||
147013354|NCT00098475|530210078|FG000|Step 1|Both patient and physician's decision|2|||
147013355|NCT00098475|530210079|FG001|Step 1|Both patient and physician's decision|1|||
147013356|NCT00098475|530210080|FG002|Step 1|Both patient and physician's decision|0|||
147013357|NCT00098475|530210081|FG003|Step 1|Both patient and physician's decision|0|||
147013358|NCT00098475|530210078|FG000|Step 1|Incorrect disease assessment|2|||
147013359|NCT00098475|530210079|FG001|Step 1|Incorrect disease assessment|0|||
147013360|NCT00098475|530210080|FG002|Step 1|Incorrect disease assessment|0|||
147013361|NCT00098475|530210081|FG003|Step 1|Incorrect disease assessment|0|||
147013362|NCT00098475|530210078|FG000|Step 1|Off treatment for > specified timeframe|1|||
147013363|NCT00098475|530210079|FG001|Step 1|Off treatment for > specified timeframe|1|||
147013364|NCT00098475|530210080|FG002|Step 1|Off treatment for > specified timeframe|0|||
147013365|NCT00098475|530210081|FG003|Step 1|Off treatment for > specified timeframe|0|||
147013366|NCT00098475|530210078|FG000|Step 1|Declining performance status|0|||
147013367|NCT00098475|530210079|FG001|Step 1|Declining performance status|1|||
147013368|NCT00098475|530210080|FG002|Step 1|Declining performance status|0|||
147013369|NCT00098475|530210081|FG003|Step 1|Declining performance status|0|||
147013370|NCT00098475|530210078|FG000|Step 1|Insurance issue|0|||
147013371|NCT00098475|530210079|FG001|Step 1|Insurance issue|1|||
147013372|NCT00098475|530210080|FG002|Step 1|Insurance issue|0|||
147013373|NCT00098475|530210081|FG003|Step 1|Insurance issue|0|||
147013374|NCT00098475|530210078|FG000|Step 1|Rising paraprotein|0|||
147013375|NCT00098475|530210079|FG001|Step 1|Rising paraprotein|1|||
147013376|NCT00098475|530210080|FG002|Step 1|Rising paraprotein|0|||
147013377|NCT00098475|530210081|FG003|Step 1|Rising paraprotein|0|||
147013378|NCT00098475|530210078|FG000|Step 1|Referred to other physicians|0|||
147013379|NCT00098475|530210079|FG001|Step 1|Referred to other physicians|1|||
147013380|NCT00098475|530210080|FG002|Step 1|Referred to other physicians|0|||
147013381|NCT00098475|530210081|FG003|Step 1|Referred to other physicians|0|||
147013382|NCT00098475|530210078|FG000|Step 1|Criteria to continue treatment not met|0|||
147013383|NCT00098475|530210079|FG001|Step 1|Criteria to continue treatment not met|1|||
147013384|NCT00098475|530210080|FG002|Step 1|Criteria to continue treatment not met|0|||
147013385|NCT00098475|530210081|FG003|Step 1|Criteria to continue treatment not met|0|||
147013386|NCT00098475|530210078|FG000|Step 1|Misinterpretation of lab data|0|||
147013387|NCT00098475|530210079|FG001|Step 1|Misinterpretation of lab data|1|||
146848563|NCT04828837|529615736|FG000|Overall Study|Admitted due to pneumothorax.|1|||
146848564|NCT04828837|529615737|FG001|Overall Study|Admitted due to pneumothorax.|0|||
147013388|NCT00098475|530210080|FG002|Step 1|Misinterpretation of lab data|0|||
147013389|NCT00098475|530210081|FG003|Step 1|Misinterpretation of lab data|0|||
147013390|NCT00098475|530210078|FG000|Step 1|Patient fell with fracture|1|||
147013391|NCT00098475|530210079|FG001|Step 1|Patient fell with fracture|0|||
147013392|NCT00098475|530210080|FG002|Step 1|Patient fell with fracture|0|||
147013393|NCT00098475|530210081|FG003|Step 1|Patient fell with fracture|0|||
147013394|NCT00098475|530210078|FG000|Step 1|Not documented|0|||
147013395|NCT00098475|530210079|FG001|Step 1|Not documented|1|||
147013396|NCT00098475|530210080|FG002|Step 1|Not documented|0|||
147013397|NCT00098475|530210081|FG003|Step 1|Not documented|0|||
147013398|NCT00098475|530210078|FG000|Step 2|Disease progression|1|||
147013399|NCT00098475|530210079|FG001|Step 2|Disease progression|4|||
147013400|NCT00098475|530210080|FG002|Step 2|Disease progression|0|||
147013401|NCT00098475|530210081|FG003|Step 2|Disease progression|0|||
147013402|NCT00098475|530210078|FG000|Step 2|Adverse Event|2|||
147013403|NCT00098475|530210079|FG001|Step 2|Adverse Event|0|||
147013404|NCT00098475|530210080|FG002|Step 2|Adverse Event|0|||
147013405|NCT00098475|530210081|FG003|Step 2|Adverse Event|0|||
147013406|NCT00098475|530210078|FG000|Step 2|Withdrawal by Subject|0|||
147013407|NCT00098475|530210079|FG001|Step 2|Withdrawal by Subject|2|||
147013408|NCT00098475|530210080|FG002|Step 2|Withdrawal by Subject|0|||
147013409|NCT00098475|530210081|FG003|Step 2|Withdrawal by Subject|0|||
147013410|NCT00098475|530210078|FG000|Step 2|Physician Decision|0|||
147013411|NCT00098475|530210079|FG001|Step 2|Physician Decision|1|||
147013412|NCT00098475|530210080|FG002|Step 2|Physician Decision|0|||
147013413|NCT00098475|530210081|FG003|Step 2|Physician Decision|0|||
147013414|NCT00098475|530210078|FG000|Step 2|Alternative therapy|1|||
147013415|NCT00098475|530210079|FG001|Step 2|Alternative therapy|2|||
147013416|NCT00098475|530210080|FG002|Step 2|Alternative therapy|0|||
147013417|NCT00098475|530210081|FG003|Step 2|Alternative therapy|0|||
147013418|NCT00098475|530210078|FG000|Step 2|Never started treatment|1|||
147013419|NCT00098475|530210079|FG001|Step 2|Never started treatment|1|||
147013420|NCT00098475|530210080|FG002|Step 2|Never started treatment|0|||
147013421|NCT00098475|530210081|FG003|Step 2|Never started treatment|0|||
147013422|NCT03422068|530210082|FG000|Overall Study|Adverse Event|0|||
147013423|NCT03422068|530210083|FG001|Overall Study|Adverse Event|1|||
147013424|NCT03422068|530210082|FG000|Overall Study|Inconvenience to frequent study visits|0|||
147013425|NCT03422068|530210083|FG001|Overall Study|Inconvenience to frequent study visits|1|||
147013426|NCT06128525|530210091|FG000|Overall Study|Patient withdrew consent|1|||
147013427|NCT03566238|530210092|FG000|Overall Study|Adverse Event|0|||
147013428|NCT03566238|530210093|FG001|Overall Study|Adverse Event|0|||
147013429|NCT03566238|530210094|FG002|Overall Study|Adverse Event|1|||
147013430|NCT03566238|530210092|FG000|Overall Study|Lack of Efficacy|5|||
147013431|NCT03566238|530210093|FG001|Overall Study|Lack of Efficacy|4|||
147013432|NCT03566238|530210094|FG002|Overall Study|Lack of Efficacy|2|||
147013433|NCT03566238|530210092|FG000|Overall Study|Other|0|||
147013434|NCT03566238|530210093|FG001|Overall Study|Other|1|||
147013435|NCT03566238|530210094|FG002|Overall Study|Other|0|||
147013436|NCT02722616|530210766|FG000|Overall Study|Sponsor closed study after one month|2|||
147013437|NCT02722616|530210767|FG001|Overall Study|Sponsor closed study after one month|0|||
147013438|NCT02722616|530210768|FG002|Overall Study|Sponsor closed study after one month|0|||
147013439|NCT02031237|530210769|FG000|Overall Study|Death|1|||
147013440|NCT02031237|530210770|FG001|Overall Study|Death|5|||
147013441|NCT02031237|530210771|FG002|Overall Study|Death|0|||
147013442|NCT02031237|530210769|FG000|Overall Study|Physician Decision|0|||
147013443|NCT02031237|530210770|FG001|Overall Study|Physician Decision|1|||
147013444|NCT02031237|530210771|FG002|Overall Study|Physician Decision|0|||
147013445|NCT02031237|530210769|FG000|Overall Study|Withdrawal by Subject|2|||
147013446|NCT02031237|530210770|FG001|Overall Study|Withdrawal by Subject|2|||
147013447|NCT02031237|530210771|FG002|Overall Study|Withdrawal by Subject|0|||
147013448|NCT02031237|530210769|FG000|Overall Study|Protocol Violation|2|||
147013449|NCT02031237|530210770|FG001|Overall Study|Protocol Violation|6|||
147013450|NCT02031237|530210771|FG002|Overall Study|Protocol Violation|0|||
147013451|NCT02031237|530210769|FG000|Overall Study|Alternate Treatment Given|0|||
147013452|NCT02031237|530210770|FG001|Overall Study|Alternate Treatment Given|0|||
147013453|NCT02031237|530210771|FG002|Overall Study|Alternate Treatment Given|3|||
147013454|NCT00676650|530210774|FG000|Overall Study|Death|45|||
147013455|NCT00676650|530210775|FG001|Overall Study|Death|14|||
147013456|NCT00676650|530210774|FG000|Overall Study|Adverse Event|159|||
147013457|NCT00676650|530210775|FG001|Overall Study|Adverse Event|21|||
147013458|NCT00676650|530210774|FG000|Overall Study|Global deterioration of health status|66|||
147013459|NCT00676650|530210775|FG001|Overall Study|Global deterioration of health status|31|||
147013460|NCT00676650|530210774|FG000|Overall Study|Lost to Follow-up|0|||
147013461|NCT00676650|530210775|FG001|Overall Study|Lost to Follow-up|1|||
147013462|NCT00676650|530210774|FG000|Overall Study|Objective progression or relapse|189|||
147013463|NCT00676650|530210775|FG001|Overall Study|Objective progression or relapse|140|||
147013464|NCT00676650|530210774|FG000|Overall Study|Other|14|||
147013465|NCT00676650|530210775|FG001|Overall Study|Other|10|||
147013466|NCT00676650|530210774|FG000|Overall Study|Protocol Violation|3|||
147013467|NCT00676650|530210775|FG001|Overall Study|Protocol Violation|1|||
147013468|NCT00676650|530210774|FG000|Overall Study|Study terminated by sponsor|57|||
147013469|NCT00676650|530210775|FG001|Overall Study|Study terminated by sponsor|43|||
147013470|NCT00676650|530210774|FG000|Overall Study|Withdrawal by Subject|48|||
147013471|NCT00676650|530210775|FG001|Overall Study|Withdrawal by Subject|24|||
147013472|NCT00676650|530210774|FG000|Overall Study|Randomized but not treated|3|||
147013473|NCT00676650|530210775|FG001|Overall Study|Randomized but not treated|4|||
147013474|NCT02297841|530210779|FG000|Overall Study|Withdrawal by Subject|1|||
147013475|NCT02297841|530210779|FG000|Overall Study|Protocol Violation|7|||
147013476|NCT05061992|530210780|FG000|Overall Study|Excess bowel movements|1|||
147013477|NCT05061992|530210781|FG001|Overall Study|Excess bowel movements|0|||
147013478|NCT05061992|530210780|FG000|Overall Study|Complications of Medical Care|1|||
147013479|NCT05061992|530210781|FG001|Overall Study|Complications of Medical Care|0|||
147013480|NCT05061992|530210780|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
147013481|NCT05061992|530210781|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
147013482|NCT05061992|530210780|FG000|Overall Study|Withdrawal by Subject|0|||
147013483|NCT05061992|530210781|FG001|Overall Study|Withdrawal by Subject|1|||
147013484|NCT05996198|530210782|FG000|Overall Study|Withdrawal by Subject|1|||
147013485|NCT05996198|530210783|FG001|Overall Study|Withdrawal by Subject|0|||
147013486|NCT01358877|530210784|FG000|Overall Study|Withdrawal by Subject|475|||
147013487|NCT01358877|530210785|FG001|Overall Study|Withdrawal by Subject|466|||
147013488|NCT01358877|530210784|FG000|Overall Study|Recurrence of disease|181|||
147013489|NCT01358877|530210785|FG001|Overall Study|Recurrence of disease|269|||
147013490|NCT01358877|530210784|FG000|Overall Study|Lost to Follow-up|181|||
147013491|NCT01358877|530210785|FG001|Overall Study|Lost to Follow-up|176|||
147013492|NCT01358877|530210784|FG000|Overall Study|Death|41|||
147013493|NCT01358877|530210785|FG001|Overall Study|Death|46|||
147013494|NCT01358877|530210784|FG000|Overall Study|Adverse Event|39|||
147013495|NCT01358877|530210785|FG001|Overall Study|Adverse Event|42|||
146848565|NCT04828837|529615736|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
146848566|NCT04828837|529615737|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
146848567|NCT01397422|529615738|FG000|Overall Study|Adverse Event|0|||
146848568|NCT01397422|529615739|FG001|Overall Study|Adverse Event|3|||
146848569|NCT01397422|529615740|FG002|Overall Study|Adverse Event|3|||
146848570|NCT01397422|529615741|FG003|Overall Study|Adverse Event|8|||
146848571|NCT01397422|529615738|FG000|Overall Study|Withdrawal by Subject|1|||
146848572|NCT01397422|529615739|FG001|Overall Study|Withdrawal by Subject|0|||
146848573|NCT01397422|529615740|FG002|Overall Study|Withdrawal by Subject|0|||
146848574|NCT01397422|529615741|FG003|Overall Study|Withdrawal by Subject|0|||
146848575|NCT01397422|529615738|FG000|Overall Study|Increased bradykinesia related to PD|1|||
146848576|NCT01397422|529615739|FG001|Overall Study|Increased bradykinesia related to PD|0|||
146848577|NCT01397422|529615740|FG002|Overall Study|Increased bradykinesia related to PD|0|||
146848578|NCT01397422|529615741|FG003|Overall Study|Increased bradykinesia related to PD|0|||
146848579|NCT00545753|529615742|FG000|Overall Study|Withdrawal by Subject|0|||
146848580|NCT00545753|529615743|FG001|Overall Study|Withdrawal by Subject|1|||
146848581|NCT00545753|529615744|FG002|Overall Study|Withdrawal by Subject|10|||
146848582|NCT00545753|529615742|FG000|Overall Study|Lost to Follow-up|13|||
146848583|NCT00545753|529615743|FG001|Overall Study|Lost to Follow-up|3|||
146848584|NCT00545753|529615744|FG002|Overall Study|Lost to Follow-up|12|||
146848585|NCT00545753|529615742|FG000|Overall Study|Protocol Violation|3|||
146848586|NCT00545753|529615743|FG001|Overall Study|Protocol Violation|1|||
146848587|NCT00545753|529615744|FG002|Overall Study|Protocol Violation|4|||
146848588|NCT02489968|529615755|FG000|Open-label Treatment Period|Adverse Event|14|||
146848589|NCT02489968|529615756|FG001|Open-label Treatment Period|Adverse Event|7|||
146848590|NCT02489968|529615757|FG002|Open-label Treatment Period|Adverse Event|0|||
146848591|NCT02489968|529615758|FG003|Open-label Treatment Period|Adverse Event|0|||
146848592|NCT02489968|529615759|FG004|Open-label Treatment Period|Adverse Event|0|||
146848593|NCT02489968|529615760|FG005|Open-label Treatment Period|Adverse Event|0|||
146848594|NCT02489968|529615755|FG000|Open-label Treatment Period|Protocol Violation|2|||
146848595|NCT02489968|529615756|FG001|Open-label Treatment Period|Protocol Violation|2|||
146848596|NCT02489968|529615757|FG002|Open-label Treatment Period|Protocol Violation|0|||
146848597|NCT02489968|529615758|FG003|Open-label Treatment Period|Protocol Violation|0|||
146848598|NCT02489968|529615759|FG004|Open-label Treatment Period|Protocol Violation|0|||
146848599|NCT02489968|529615760|FG005|Open-label Treatment Period|Protocol Violation|0|||
146848600|NCT02489968|529615755|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
146848601|NCT02489968|529615756|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
146848602|NCT02489968|529615757|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
146848603|NCT02489968|529615758|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
146848604|NCT02489968|529615759|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
146848605|NCT02489968|529615760|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
146848606|NCT02489968|529615755|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
146848607|NCT02489968|529615756|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
146848608|NCT02489968|529615757|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
146848609|NCT02489968|529615758|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
146848610|NCT02489968|529615759|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
146848611|NCT02489968|529615760|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
146848612|NCT02489968|529615755|FG000|Open-label Treatment Period|Other than specified above|204|||
146848613|NCT02489968|529615756|FG001|Open-label Treatment Period|Other than specified above|189|||
146848614|NCT02489968|529615757|FG002|Open-label Treatment Period|Other than specified above|0|||
146848615|NCT02489968|529615758|FG003|Open-label Treatment Period|Other than specified above|0|||
147013496|NCT01358877|530210784|FG000|Overall Study|Physician Decision|43|||
147013497|NCT01358877|530210785|FG001|Overall Study|Physician Decision|32|||
147013498|NCT01358877|530210784|FG000|Overall Study|Contralateral breast cancer|42|||
147013499|NCT01358877|530210785|FG001|Overall Study|Contralateral breast cancer|28|||
146848616|NCT02489968|529615759|FG004|Open-label Treatment Period|Other than specified above|0|||
146848617|NCT02489968|529615760|FG005|Open-label Treatment Period|Other than specified above|0|||
146848618|NCT02489968|529615755|FG000|Double-blind Treatment Period|Adverse Event|0|||
146848619|NCT02489968|529615756|FG001|Double-blind Treatment Period|Adverse Event|0|||
146848620|NCT02489968|529615757|FG002|Double-blind Treatment Period|Adverse Event|2|||
146848621|NCT02489968|529615758|FG003|Double-blind Treatment Period|Adverse Event|6|||
146848622|NCT02489968|529615759|FG004|Double-blind Treatment Period|Adverse Event|4|||
146848623|NCT02489968|529615760|FG005|Double-blind Treatment Period|Adverse Event|5|||
146848624|NCT02489968|529615755|FG000|Double-blind Treatment Period|Protocol Violation|0|||
146848625|NCT02489968|529615756|FG001|Double-blind Treatment Period|Protocol Violation|0|||
146848626|NCT02489968|529615757|FG002|Double-blind Treatment Period|Protocol Violation|0|||
146848627|NCT02489968|529615758|FG003|Double-blind Treatment Period|Protocol Violation|0|||
146848628|NCT02489968|529615759|FG004|Double-blind Treatment Period|Protocol Violation|1|||
146848629|NCT02489968|529615760|FG005|Double-blind Treatment Period|Protocol Violation|1|||
146848630|NCT02489968|529615755|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
146848631|NCT02489968|529615756|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
146848632|NCT02489968|529615757|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146848633|NCT02489968|529615758|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
146848634|NCT02489968|529615759|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
146848635|NCT02489968|529615760|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
146848636|NCT02489968|529615755|FG000|Double-blind Treatment Period|Other than specified above|0|||
146848637|NCT02489968|529615756|FG001|Double-blind Treatment Period|Other than specified above|0|||
146848638|NCT02489968|529615757|FG002|Double-blind Treatment Period|Other than specified above|0|||
146848639|NCT02489968|529615758|FG003|Double-blind Treatment Period|Other than specified above|0|||
146848640|NCT02489968|529615759|FG004|Double-blind Treatment Period|Other than specified above|1|||
146848641|NCT02489968|529615760|FG005|Double-blind Treatment Period|Other than specified above|0|||
146848642|NCT04577001|529615761|FG000|Overall Study|Subject became ineligible|0|||
146848643|NCT04577001|529615762|FG001|Overall Study|Subject became ineligible|1|||
146848644|NCT01593787|529615763|FG000|Overall Study|Adverse Event|1|||
146848645|NCT01593787|529615764|FG001|Overall Study|Adverse Event|0|||
146848646|NCT01593787|529615765|FG002|Overall Study|Adverse Event|0|||
146848647|NCT01022112|529615771|FG000|Overall Study|Adverse Event|1|||
146848648|NCT01022112|529615772|FG001|Overall Study|Adverse Event|2|||
146848649|NCT01022112|529615773|FG002|Overall Study|Adverse Event|0|||
146848650|NCT01022112|529615774|FG003|Overall Study|Adverse Event|1|||
146848651|NCT01022112|529615775|FG004|Overall Study|Adverse Event|0|||
146848652|NCT01022112|529615771|FG000|Overall Study|Lack of Efficacy|1|||
146848653|NCT01022112|529615772|FG001|Overall Study|Lack of Efficacy|0|||
146848654|NCT01022112|529615773|FG002|Overall Study|Lack of Efficacy|0|||
146848655|NCT01022112|529615774|FG003|Overall Study|Lack of Efficacy|0|||
146848656|NCT01022112|529615775|FG004|Overall Study|Lack of Efficacy|1|||
146848657|NCT01022112|529615771|FG000|Overall Study|Physician Decision|0|||
146848658|NCT01022112|529615772|FG001|Overall Study|Physician Decision|0|||
146848659|NCT01022112|529615773|FG002|Overall Study|Physician Decision|1|||
146848660|NCT01022112|529615774|FG003|Overall Study|Physician Decision|0|||
146848661|NCT01022112|529615775|FG004|Overall Study|Physician Decision|1|||
146848662|NCT01022112|529615771|FG000|Overall Study|Withdrawal by Subject|0|||
146848663|NCT01022112|529615772|FG001|Overall Study|Withdrawal by Subject|1|||
146848664|NCT01022112|529615773|FG002|Overall Study|Withdrawal by Subject|2|||
146848665|NCT01022112|529615774|FG003|Overall Study|Withdrawal by Subject|2|||
146848666|NCT01022112|529615775|FG004|Overall Study|Withdrawal by Subject|1|||
146848667|NCT01022112|529615771|FG000|Overall Study|Fasting plasma glucose level increased|1|||
146848668|NCT01022112|529615772|FG001|Overall Study|Fasting plasma glucose level increased|0|||
146848669|NCT01022112|529615773|FG002|Overall Study|Fasting plasma glucose level increased|0|||
146848670|NCT01022112|529615774|FG003|Overall Study|Fasting plasma glucose level increased|0|||
146848671|NCT01022112|529615775|FG004|Overall Study|Fasting plasma glucose level increased|7|||
146848672|NCT01982448|529615776|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
146848673|NCT01982448|529615777|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
146848674|NCT01982448|529615776|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
146848675|NCT01982448|529615777|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
146848676|NCT01982448|529615776|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
146848677|NCT01982448|529615777|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
146848678|NCT01982448|529615776|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
146848679|NCT01982448|529615777|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
146848680|NCT01789567|529616942|FG000|Overall Study|Death|6|||
146848681|NCT02914275|529616943|FG000|Overall Study|Lost to Follow-up|84|||
146848682|NCT02914275|529616944|FG001|Overall Study|Lost to Follow-up|29|||
146848683|NCT02914275|529616943|FG000|Overall Study|Withdrawal by Subject|26|||
147013500|NCT01358877|530210784|FG000|Overall Study|Reason not specified|37|||
147013501|NCT01358877|530210785|FG001|Overall Study|Reason not specified|29|||
146848684|NCT02914275|529616944|FG001|Overall Study|Withdrawal by Subject|10|||
146848685|NCT02914275|529616943|FG000|Overall Study|Protocol Violation|1|||
147013502|NCT02003222|530210789|FG000|Induction|Never started treatment|0|||
147013503|NCT02003222|530210790|FG001|Induction|Never started treatment|0|||
147013504|NCT02003222|530210791|FG002|Induction|Never started treatment|0|||
147013505|NCT02003222|530210792|FG003|Induction|Never started treatment|0|||
147013506|NCT02003222|530210793|FG004|Induction|Never started treatment|8|||
147013507|NCT02003222|530210789|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
147013508|NCT02003222|530210790|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
147013509|NCT02003222|530210791|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
147013510|NCT02003222|530210792|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
147013511|NCT02003222|530210793|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
147013512|NCT02003222|530210789|FG000|Induction|Adverse Event|0|||
147013513|NCT02003222|530210790|FG001|Induction|Adverse Event|0|||
147013514|NCT02003222|530210791|FG002|Induction|Adverse Event|0|||
147013515|NCT02003222|530210792|FG003|Induction|Adverse Event|0|||
147013516|NCT02003222|530210793|FG004|Induction|Adverse Event|13|||
147013517|NCT02003222|530210789|FG000|Induction|Alternative therapy|0|||
147013518|NCT02003222|530210790|FG001|Induction|Alternative therapy|0|||
147013519|NCT02003222|530210791|FG002|Induction|Alternative therapy|0|||
147013520|NCT02003222|530210792|FG003|Induction|Alternative therapy|0|||
147013521|NCT02003222|530210793|FG004|Induction|Alternative therapy|12|||
147013522|NCT02003222|530210789|FG000|Induction|Disease progression|0|||
147013523|NCT02003222|530210790|FG001|Induction|Disease progression|0|||
147013524|NCT02003222|530210791|FG002|Induction|Disease progression|0|||
147013525|NCT02003222|530210792|FG003|Induction|Disease progression|0|||
147013526|NCT02003222|530210793|FG004|Induction|Disease progression|22|||
147013527|NCT02003222|530210789|FG000|Induction|Death|0|||
147013528|NCT02003222|530210790|FG001|Induction|Death|0|||
147013529|NCT02003222|530210791|FG002|Induction|Death|0|||
147013530|NCT02003222|530210792|FG003|Induction|Death|0|||
147013531|NCT02003222|530210793|FG004|Induction|Death|3|||
147013532|NCT02003222|530210789|FG000|Induction|Withdrawal by Subject|0|||
147013533|NCT02003222|530210790|FG001|Induction|Withdrawal by Subject|0|||
147013534|NCT02003222|530210791|FG002|Induction|Withdrawal by Subject|0|||
147013535|NCT02003222|530210792|FG003|Induction|Withdrawal by Subject|0|||
147013536|NCT02003222|530210793|FG004|Induction|Withdrawal by Subject|8|||
147013537|NCT02003222|530210789|FG000|Induction|Other reasons|0|||
147013538|NCT02003222|530210790|FG001|Induction|Other reasons|0|||
147013539|NCT02003222|530210791|FG002|Induction|Other reasons|0|||
147013540|NCT02003222|530210792|FG003|Induction|Other reasons|0|||
147013541|NCT02003222|530210793|FG004|Induction|Other reasons|22|||
147013542|NCT02003222|530210789|FG000|Intensification|Never started treatment|0|||
147013543|NCT02003222|530210790|FG001|Intensification|Never started treatment|0|||
147013544|NCT02003222|530210791|FG002|Intensification|Never started treatment|0|||
147013545|NCT02003222|530210792|FG003|Intensification|Never started treatment|0|||
147013546|NCT02003222|530210793|FG004|Intensification|Never started treatment|2|||
147013547|NCT02003222|530210789|FG000|Intensification|Adverse Event|0|||
147013548|NCT02003222|530210790|FG001|Intensification|Adverse Event|0|||
147013549|NCT02003222|530210791|FG002|Intensification|Adverse Event|0|||
147013550|NCT02003222|530210792|FG003|Intensification|Adverse Event|0|||
147013551|NCT02003222|530210793|FG004|Intensification|Adverse Event|6|||
147013552|NCT02003222|530210789|FG000|Intensification|Alternative therapy|0|||
147013553|NCT02003222|530210790|FG001|Intensification|Alternative therapy|0|||
147013554|NCT02003222|530210791|FG002|Intensification|Alternative therapy|0|||
147013555|NCT02003222|530210792|FG003|Intensification|Alternative therapy|0|||
147013556|NCT02003222|530210793|FG004|Intensification|Alternative therapy|8|||
147013557|NCT02003222|530210789|FG000|Intensification|Disease progression|0|||
147013558|NCT02003222|530210790|FG001|Intensification|Disease progression|0|||
147013559|NCT02003222|530210791|FG002|Intensification|Disease progression|0|||
147013560|NCT02003222|530210792|FG003|Intensification|Disease progression|0|||
147013561|NCT02003222|530210793|FG004|Intensification|Disease progression|18|||
147013562|NCT02003222|530210789|FG000|Intensification|Withdrawal by Subject|0|||
147013563|NCT02003222|530210790|FG001|Intensification|Withdrawal by Subject|0|||
147013564|NCT02003222|530210791|FG002|Intensification|Withdrawal by Subject|0|||
147013565|NCT02003222|530210792|FG003|Intensification|Withdrawal by Subject|0|||
147013566|NCT02003222|530210793|FG004|Intensification|Withdrawal by Subject|5|||
147013567|NCT02003222|530210789|FG000|Intensification|Other reasons|0|||
147013568|NCT02003222|530210790|FG001|Intensification|Other reasons|0|||
147013569|NCT02003222|530210791|FG002|Intensification|Other reasons|0|||
147013570|NCT02003222|530210792|FG003|Intensification|Other reasons|0|||
147013571|NCT02003222|530210793|FG004|Intensification|Other reasons|8|||
147013572|NCT05148299|530210794|FG000|Treatment Period|Adverse Event|1|||
147013573|NCT05148299|530210794|FG000|Treatment Period|Physician Decision|1|||
147013574|NCT05148299|530210794|FG000|Treatment Period|Death|1|||
147013575|NCT05148299|530210794|FG000|Follow-up Period|Death|3|||
147013576|NCT03294317|530210801|FG000|Overall Study|Physician Decision|1|||
147013577|NCT03294317|530210801|FG000|Overall Study|Withdrawal by Subject|6|||
147013578|NCT03294317|530210801|FG000|Overall Study|Lost to Follow-up|1|||
147013579|NCT03294317|530210801|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
147013580|NCT03294317|530210801|FG000|Overall Study|Failed HB lead implant|8|||
147013581|NCT03294317|530210801|FG000|Overall Study|Received CRT instead|1|||
146848686|NCT02914275|529616944|FG001|Overall Study|Protocol Violation|1|||
146848687|NCT02914275|529616943|FG000|Overall Study|Physician Decision|3|||
146848688|NCT02914275|529616944|FG001|Overall Study|Physician Decision|1|||
146848689|NCT02914275|529616943|FG000|Overall Study|Other|4|||
146848690|NCT02914275|529616944|FG001|Overall Study|Other|1|||
146848691|NCT02914275|529616943|FG000|Overall Study|Excluded due to invalid informed consent|3|||
146848692|NCT02914275|529616944|FG001|Overall Study|Excluded due to invalid informed consent|0|||
146848693|NCT01238900|529616945|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
146848694|NCT01238900|529616945|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
146848695|NCT02738203|529616949|FG000|Overall Study|Failed IUD Insertion|2|||
146848696|NCT02738203|529616950|FG001|Overall Study|Failed IUD Insertion|2|||
146848697|NCT02738203|529616949|FG000|Overall Study|Protocol Violation|0|||
146848698|NCT02738203|529616950|FG001|Overall Study|Protocol Violation|1|||
146848699|NCT03241927|529616951|FG000|Overall Study|study terminated|1|||
146848700|NCT03241927|529616952|FG001|Overall Study|study terminated|0|||
146848701|NCT01198756|529616953|FG000|Overall Study|Adverse Event|0|||
147013582|NCT03294317|530210801|FG000|Overall Study|Exited after lead revision|2|||
147013583|NCT05317195|530210802|FG000|Randomization|Withdrawal by Subject|1|||
147013584|NCT05317195|530210802|FG000|Randomization|Discontinued|6|||
147013585|NCT05317195|530210802|FG000|Admission|Withdrawal by Subject|2|||
147013586|NCT05467540|530210803|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
147013587|NCT05467540|530210803|FG000|3-Month Follow-up|Lost to Follow-up|4|||
147013588|NCT05467540|530210803|FG000|3-Month Follow-up|Death|5|||
147013589|NCT05467540|530210803|FG000|12-Month Follow-up|Lost to Follow-up|6|||
147013590|NCT05467540|530210803|FG000|12-Month Follow-up|Death|8|||
147013591|NCT05467540|530210803|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
147013592|NCT03370510|530210806|FG000|Overall Study|COVID-19|2|||
147013593|NCT03370510|530210807|FG001|Overall Study|COVID-19|0|||
147013594|NCT03382041|530210808|FG000|Overall Study|Consent Form Lost|2|||
147013595|NCT03382041|530210809|FG001|Overall Study|Consent Form Lost|1|||
147013596|NCT03382041|530210808|FG000|Overall Study|Withdrawal by Subject|1|||
147013597|NCT03382041|530210809|FG001|Overall Study|Withdrawal by Subject|4|||
147013598|NCT03382041|530210808|FG000|Overall Study|Lost to Follow-up|1|||
147013599|NCT03382041|530210809|FG001|Overall Study|Lost to Follow-up|4|||
147013600|NCT01374451|530210810|FG000|Overall Study|Administrative problems|1|||
147013601|NCT01374451|530210811|FG001|Overall Study|Administrative problems|0|||
147013602|NCT01977456|530210812|FG000|Overall Study|Death|5|||
147013603|NCT04490057|530210813|FG000|Stage 1|Death|1|||
147013604|NCT04490057|530210814|FG001|Stage 1|Death|2|||
147013605|NCT04490057|530210815|FG002|Stage 1|Death|0|||
147013606|NCT04490057|530210816|FG003|Stage 1|Death|0|||
147013607|NCT04490057|530210817|FG004|Stage 1|Death|0|||
147013608|NCT04490057|530210818|FG005|Stage 1|Death|0|||
147013609|NCT04490057|530210819|FG006|Stage 1|Death|0|||
147013610|NCT04490057|530210820|FG007|Stage 1|Death|0|||
147013611|NCT04490057|530210813|FG000|Stage 1|Withdrawal by Subject|2|||
147013612|NCT04490057|530210814|FG001|Stage 1|Withdrawal by Subject|0|||
147013613|NCT04490057|530210815|FG002|Stage 1|Withdrawal by Subject|0|||
147013614|NCT04490057|530210816|FG003|Stage 1|Withdrawal by Subject|0|||
147013615|NCT04490057|530210817|FG004|Stage 1|Withdrawal by Subject|0|||
147013616|NCT04490057|530210818|FG005|Stage 1|Withdrawal by Subject|0|||
147013617|NCT04490057|530210819|FG006|Stage 1|Withdrawal by Subject|0|||
147013618|NCT04490057|530210820|FG007|Stage 1|Withdrawal by Subject|0|||
147013619|NCT04490057|530210813|FG000|Stage 2|Death|0|||
147013620|NCT04490057|530210814|FG001|Stage 2|Death|0|||
147013621|NCT04490057|530210815|FG002|Stage 2|Death|0|||
147013622|NCT04490057|530210816|FG003|Stage 2|Death|0|||
146848702|NCT01198756|529616954|FG001|Overall Study|Adverse Event|0|||
147013623|NCT04490057|530210817|FG004|Stage 2|Death|1|||
147013624|NCT04490057|530210818|FG005|Stage 2|Death|0|||
147013625|NCT04490057|530210819|FG006|Stage 2|Death|0|||
147013626|NCT04490057|530210820|FG007|Stage 2|Death|0|||
147013627|NCT04490057|530210813|FG000|Stage 2|Lost to Follow-up|0|||
147013628|NCT04490057|530210814|FG001|Stage 2|Lost to Follow-up|0|||
147013629|NCT04490057|530210815|FG002|Stage 2|Lost to Follow-up|0|||
146848703|NCT01198756|529616955|FG002|Overall Study|Adverse Event|0|||
146848704|NCT01198756|529616956|FG003|Overall Study|Adverse Event|1|||
146848705|NCT01198756|529616953|FG000|Overall Study|Protocol Violation|0|||
146848706|NCT01198756|529616954|FG001|Overall Study|Protocol Violation|0|||
147013630|NCT04490057|530210816|FG003|Stage 2|Lost to Follow-up|11|||
147013631|NCT04490057|530210817|FG004|Stage 2|Lost to Follow-up|17|||
147013632|NCT04490057|530210818|FG005|Stage 2|Lost to Follow-up|4|||
147013633|NCT04490057|530210819|FG006|Stage 2|Lost to Follow-up|21|||
147013634|NCT04490057|530210820|FG007|Stage 2|Lost to Follow-up|14|||
147013635|NCT04584983|530210825|FG000|Overall Study|Parental request for withdraw|2|||
146848707|NCT01198756|529616955|FG002|Overall Study|Protocol Violation|0|||
146848708|NCT01198756|529616956|FG003|Overall Study|Protocol Violation|2|||
147013636|NCT04584983|530210826|FG001|Overall Study|Parental request for withdraw|0|||
147013637|NCT05377489|530210827|FG000|Overall Study|Withdrawal by Subject|122|||
147013638|NCT05377489|530210827|FG000|Overall Study|Lost to Follow-up|21|||
146848709|NCT01198756|529616953|FG000|Overall Study|Withdrawal by Subject|9|||
146848710|NCT01198756|529616954|FG001|Overall Study|Withdrawal by Subject|4|||
146848711|NCT01198756|529616955|FG002|Overall Study|Withdrawal by Subject|7|||
146848712|NCT01198756|529616956|FG003|Overall Study|Withdrawal by Subject|5|||
146848713|NCT01198756|529616953|FG000|Overall Study|Lost to Follow-up|29|||
146848714|NCT01198756|529616954|FG001|Overall Study|Lost to Follow-up|36|||
146848715|NCT01198756|529616955|FG002|Overall Study|Lost to Follow-up|23|||
146848716|NCT01198756|529616956|FG003|Overall Study|Lost to Follow-up|18|||
146848717|NCT02915302|529616959|FG000|Overall Study|Adverse Event|3|||
146848718|NCT02915302|529616960|FG001|Overall Study|Adverse Event|0|||
146848719|NCT02915302|529616959|FG000|Overall Study|Protocol Violation|20|||
146848720|NCT02915302|529616960|FG001|Overall Study|Protocol Violation|27|||
146848721|NCT02915302|529616959|FG000|Overall Study|Lost to Follow-up|19|||
146848722|NCT02915302|529616960|FG001|Overall Study|Lost to Follow-up|22|||
146848723|NCT02915302|529616959|FG000|Overall Study|Withdrawal by Subject|22|||
146848724|NCT02915302|529616960|FG001|Overall Study|Withdrawal by Subject|29|||
146848725|NCT02915302|529616959|FG000|Overall Study|Other|1|||
146848726|NCT02915302|529616960|FG001|Overall Study|Other|0|||
146848727|NCT03725085|529616961|FG000|Overall Study|Lost to Follow-up|2|||
146848728|NCT02704754|529616962|FG000|Overall Study|Lost to Follow-up|1|||
146848729|NCT02704754|529616963|FG001|Overall Study|Lost to Follow-up|1|||
146848730|NCT02704754|529616962|FG000|Overall Study|Lack of Efficacy|1|||
146848731|NCT02704754|529616963|FG001|Overall Study|Lack of Efficacy|0|||
146848732|NCT02704754|529616962|FG000|Overall Study|Withdrawal by Subject|1|||
146848733|NCT02704754|529616963|FG001|Overall Study|Withdrawal by Subject|0|||
146848734|NCT00423943|529616964|FG000|Overall Study|Withdrawal by Subject|3|||
146848735|NCT00423943|529616965|FG001|Overall Study|Withdrawal by Subject|1|||
146848736|NCT02134977|529616966|FG000|Overall Study|Protocol Deviation|102|||
146848737|NCT04187989|529616973|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
146848738|NCT04187989|529616974|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
146848739|NCT04187989|529616973|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
146848740|NCT04187989|529616974|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
146848741|NCT03646656|529616975|FG000|Overall Study|Lost to Follow-up|1|||
146848742|NCT03646656|529616976|FG001|Overall Study|Lost to Follow-up|0|||
146848743|NCT03646656|529616975|FG000|Overall Study|Withdrawal by Subject|2|||
146848744|NCT03646656|529616976|FG001|Overall Study|Withdrawal by Subject|0|||
146848745|NCT04988867|529616979|FG000|Overall Study|Study terminated by Sponsor|12|||
146848746|NCT04988867|529616979|FG000|Overall Study|Adverse Event|2|||
146848747|NCT04988867|529616979|FG000|Overall Study|Study drug noncompliance|1|||
146848748|NCT01327495|529616980|FG000|Overall Study|Adverse Event|2|||
146848749|NCT01327495|529616981|FG001|Overall Study|Adverse Event|1|||
146848750|NCT01327495|529616982|FG002|Overall Study|Adverse Event|1|||
146848751|NCT01327495|529616983|FG003|Overall Study|Adverse Event|0|||
146848752|NCT01327495|529616984|FG004|Overall Study|Adverse Event|0|||
146848753|NCT01327495|529616985|FG005|Overall Study|Adverse Event|2|||
146848754|NCT01327495|529616980|FG000|Overall Study|Withdrawal by Subject|0|||
146848755|NCT01327495|529616981|FG001|Overall Study|Withdrawal by Subject|1|||
146848756|NCT01327495|529616982|FG002|Overall Study|Withdrawal by Subject|1|||
146848757|NCT01327495|529616983|FG003|Overall Study|Withdrawal by Subject|0|||
146848758|NCT01327495|529616984|FG004|Overall Study|Withdrawal by Subject|1|||
146848759|NCT01327495|529616985|FG005|Overall Study|Withdrawal by Subject|0|||
146848760|NCT01327495|529616980|FG000|Overall Study|Physician Decision|0|||
146848761|NCT01327495|529616981|FG001|Overall Study|Physician Decision|0|||
146848762|NCT01327495|529616982|FG002|Overall Study|Physician Decision|0|||
146848763|NCT01327495|529616983|FG003|Overall Study|Physician Decision|0|||
146848764|NCT01327495|529616984|FG004|Overall Study|Physician Decision|2|||
147013639|NCT05377489|530210827|FG000|Overall Study|Lack of Efficacy|10|||
147013640|NCT05377489|530210827|FG000|Overall Study|Adverse Event|5|||
147013641|NCT05377489|530210827|FG000|Overall Study|Death|4|||
147013642|NCT05377489|530210827|FG000|Overall Study|Physician Decision|3|||
147013643|NCT05377489|530210827|FG000|Overall Study|Protocol Violation|1|||
146848765|NCT01327495|529616985|FG005|Overall Study|Physician Decision|0|||
147013644|NCT05377489|530210827|FG000|Overall Study|Other|9|||
146848766|NCT03020576|529616988|FG000|Overall Study|Withdrawal by Subject|1|||
146848767|NCT03020576|529616989|FG001|Overall Study|Withdrawal by Subject|2|||
146848768|NCT00700427|529616992|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
146848769|NCT00700427|529616993|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
146848770|NCT00700427|529616994|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
146848771|NCT00700427|529616995|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
146848772|NCT00700427|529616996|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
146848773|NCT00700427|529616992|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
146848774|NCT00700427|529616993|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
146848775|NCT00700427|529616994|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
147013645|NCT02459418|530212508|FG000|Overall Study|Exclusion Criteria|4|||
146848776|NCT00700427|529616995|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
146848777|NCT00700427|529616996|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
146848778|NCT00700427|529616992|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
146848779|NCT00700427|529616993|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
146848780|NCT00700427|529616994|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
146848781|NCT00700427|529616995|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
146848782|NCT00700427|529616996|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
146848783|NCT00700427|529616992|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
146848784|NCT00700427|529616993|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
146848785|NCT00700427|529616994|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
146848786|NCT00700427|529616995|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
146848787|NCT00700427|529616996|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
146848788|NCT00700427|529616992|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
146848789|NCT00700427|529616993|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
146848790|NCT00700427|529616994|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
146848791|NCT00700427|529616995|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
146848792|NCT00700427|529616996|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
146848793|NCT00700427|529616992|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
146848794|NCT00700427|529616993|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
146848795|NCT00700427|529616994|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
146848796|NCT00700427|529616995|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
146848797|NCT00700427|529616996|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
146848798|NCT00700427|529616992|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
146848799|NCT00700427|529616993|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
146848800|NCT00700427|529616994|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
146848801|NCT00700427|529616995|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
146848802|NCT00700427|529616996|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
146848803|NCT00700427|529616992|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
146848804|NCT00700427|529616993|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
146848805|NCT00700427|529616994|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
146848806|NCT00700427|529616995|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
146848807|NCT00700427|529616996|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
146848808|NCT00700427|529616992|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
146848809|NCT00700427|529616993|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
146848810|NCT00700427|529616994|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
146848811|NCT00700427|529616995|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
146848812|NCT00700427|529616996|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
146848813|NCT00700427|529616992|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
146848814|NCT00700427|529616993|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
146848815|NCT00700427|529616994|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
146848816|NCT00700427|529616995|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
146848817|NCT00700427|529616996|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
146848818|NCT00700427|529616992|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
146848819|NCT00700427|529616993|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
146848820|NCT00700427|529616994|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
146848821|NCT00700427|529616995|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
146848822|NCT00700427|529616996|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
146848823|NCT00700427|529616992|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
146848824|NCT00700427|529616993|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
146848825|NCT00700427|529616994|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
146848826|NCT00700427|529616995|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
146848827|NCT00700427|529616996|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
146848828|NCT00700427|529616992|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
146848829|NCT00700427|529616993|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
146848830|NCT00700427|529616994|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
146848831|NCT00700427|529616995|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
146848832|NCT00700427|529616996|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
146848833|NCT00700427|529616992|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
146848834|NCT00700427|529616993|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
146848835|NCT00700427|529616994|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
146848836|NCT00700427|529616995|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
146848837|NCT00700427|529616996|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
146848838|NCT00700427|529616992|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
146848839|NCT00700427|529616993|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
147013646|NCT02459418|530212509|FG001|Overall Study|Exclusion Criteria|0|||
147013647|NCT02459418|530212508|FG000|Overall Study|Protocol Violation|0|||
147013648|NCT02459418|530212509|FG001|Overall Study|Protocol Violation|2|||
147013649|NCT02459418|530212508|FG000|Overall Study|Physician Decision|0|||
147013650|NCT02459418|530212509|FG001|Overall Study|Physician Decision|2|||
147013651|NCT02459418|530212508|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
147013652|NCT02459418|530212509|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
147013653|NCT02459418|530212508|FG000|Overall Study|Adverse Event|0|||
147013654|NCT02459418|530212509|FG001|Overall Study|Adverse Event|1|||
147013655|NCT02459418|530212508|FG000|Overall Study|Withdrawal by Subject|1|||
147013656|NCT02459418|530212509|FG001|Overall Study|Withdrawal by Subject|1|||
147013657|NCT02459418|530212508|FG000|Overall Study|Elevated Creatine Kinase|1|||
147013658|NCT02459418|530212509|FG001|Overall Study|Elevated Creatine Kinase|0|||
147013659|NCT02459418|530212508|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
147013660|NCT02459418|530212509|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
147013661|NCT00653159|530212510|FG000|Overall Study|Adverse Event|4|||
147013662|NCT00653159|530212511|FG001|Overall Study|Adverse Event|1|||
147013663|NCT00653159|530212510|FG000|Overall Study|Lost to Follow-up|1|||
147013664|NCT00653159|530212511|FG001|Overall Study|Lost to Follow-up|2|||
147013665|NCT01872715|530212512|FG000|Overall Study|Adverse Event|1|||
147013666|NCT01872715|530212512|FG000|Overall Study|Protocol Violation|1|||
147013667|NCT01872715|530212512|FG000|Overall Study|Withdrawal by Subject|2|||
147013668|NCT00683592|530212513|FG000|Overall Study|Adverse Event|12|||
147013669|NCT00683592|530212514|FG001|Overall Study|Adverse Event|4|||
147013670|NCT00683592|530212513|FG000|Overall Study|Withdrawal by Subject|11|||
147013671|NCT00683592|530212514|FG001|Overall Study|Withdrawal by Subject|11|||
147013672|NCT00683592|530212513|FG000|Overall Study|Lost to Follow-up|17|||
147013673|NCT00683592|530212514|FG001|Overall Study|Lost to Follow-up|17|||
147013674|NCT00683592|530212513|FG000|Overall Study|Lack of Efficacy|3|||
147013675|NCT00683592|530212514|FG001|Overall Study|Lack of Efficacy|7|||
147013676|NCT00683592|530212513|FG000|Overall Study|Physician Decision|0|||
147013677|NCT00683592|530212514|FG001|Overall Study|Physician Decision|1|||
147013678|NCT00683592|530212513|FG000|Overall Study|Non-compliance|3|||
147013679|NCT00683592|530212514|FG001|Overall Study|Non-compliance|5|||
147013680|NCT00683592|530212513|FG000|Overall Study|Other|1|||
147013681|NCT00683592|530212514|FG001|Overall Study|Other|1|||
147013682|NCT03303417|530212522|FG000|Overall Study|Withdrawal by Subject|1|||
147013683|NCT03303417|530212523|FG001|Overall Study|Withdrawal by Subject|1|||
147013684|NCT02697617|530212524|FG000|Overall Study|Withdrawal by Subject|0|||
147013685|NCT02697617|530212525|FG001|Overall Study|Withdrawal by Subject|2|||
147013686|NCT02697617|530212524|FG000|Overall Study|Pregnancy|1|||
147013687|NCT02697617|530212525|FG001|Overall Study|Pregnancy|0|||
147013688|NCT00381849|530212528|FG000|Wash Out|Withdrawal by Subject|0|||
147013689|NCT00381849|530212529|FG001|Wash Out|Withdrawal by Subject|1|||
147013690|NCT00329160|530212533|FG000|Overall Study|Adverse Event|27|||
147013691|NCT00329160|530212533|FG000|Overall Study|Withdrawal by Subject|13|||
147013692|NCT00329160|530212533|FG000|Overall Study|Protocol Violation|2|||
147013693|NCT00329160|530212533|FG000|Overall Study|Did not Receive Study Drug|1|||
147013694|NCT00329160|530212533|FG000|Overall Study|Incomplete IVUS|45|||
147013695|NCT00493792|530212534|FG000|Overall Study|Death|55|||
147013696|NCT00493792|530212535|FG001|Overall Study|Death|50|||
147013697|NCT00493792|530212534|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
147013698|NCT00493792|530212535|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
147013699|NCT04167618|530212539|FG000|Overall Study|Trial terminated by sponsor|1|||
147013700|NCT04167618|530212540|FG001|Overall Study|Trial terminated by sponsor|1|||
147013701|NCT02943993|530212543|FG000|Overall Study|Withdrawal by Subject|52|||
147013702|NCT02943993|530212543|FG000|Overall Study|Transfer to another institution|6|||
147013703|NCT02943993|530212543|FG000|Overall Study|Lost to Follow-up|135|||
147013704|NCT02943993|530212543|FG000|Overall Study|Death|98|||
147013705|NCT02943993|530212543|FG000|Overall Study|Other reason for premature termination|32|||
147013706|NCT02943993|530212543|FG000|Overall Study|Missing reason for termination|7|||
147013707|NCT00876265|530212547|FG000|Overall Study|Miscellaneous reasons|4|||
147013708|NCT00876265|530212547|FG000|Overall Study|Lost to Follow-up|6|||
147013709|NCT00876265|530212547|FG000|Overall Study|Withdrawal by Subject|2|||
147013710|NCT00996437|530212552|FG000|Overall Study|Death|1|||
147013711|NCT00996437|530212553|FG001|Overall Study|Death|0|||
147013712|NCT00996437|530212552|FG000|Overall Study|Dropped|2|||
147013713|NCT00996437|530212553|FG001|Overall Study|Dropped|2|||
147013714|NCT00996437|530212552|FG000|Overall Study|Missed|2|||
147013715|NCT00996437|530212553|FG001|Overall Study|Missed|5|||
147013716|NCT01755975|530212556|FG000|Overall Study|Adverse Event|0|||
147013717|NCT01755975|530212557|FG001|Overall Study|Adverse Event|0|||
147013718|NCT01755975|530212558|FG002|Overall Study|Adverse Event|1|||
147013719|NCT01755975|530212559|FG003|Overall Study|Adverse Event|0|||
147013720|NCT01755975|530212560|FG004|Overall Study|Adverse Event|2|||
147013721|NCT03653026|530212561|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
147013722|NCT03653026|530212562|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
147013723|NCT03653026|530212563|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
147013724|NCT03653026|530212564|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
147013725|NCT03653026|530212561|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
147013726|NCT03653026|530212562|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
147013727|NCT03653026|530212563|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
147013728|NCT03653026|530212564|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
147013729|NCT03653026|530212561|FG000|Part 1: Placebo-controlled Period|Other|0|||
147013730|NCT03653026|530212562|FG001|Part 1: Placebo-controlled Period|Other|3|||
147013731|NCT03653026|530212563|FG002|Part 1: Placebo-controlled Period|Other|0|||
147013732|NCT03653026|530212564|FG003|Part 1: Placebo-controlled Period|Other|0|||
147013733|NCT03653026|530212561|FG000|Part 2: Open-label Extension|Adverse Event|0|||
147013734|NCT03653026|530212562|FG001|Part 2: Open-label Extension|Adverse Event|0|||
147013735|NCT03653026|530212563|FG002|Part 2: Open-label Extension|Adverse Event|1|||
147013736|NCT03653026|530212564|FG003|Part 2: Open-label Extension|Adverse Event|1|||
147013737|NCT03653026|530212561|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
147013738|NCT03653026|530212562|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
147013739|NCT03653026|530212563|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
147013740|NCT03653026|530212564|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
147013741|NCT03653026|530212561|FG000|Part 2: Open-label Extension|Other|0|||
147013742|NCT03653026|530212562|FG001|Part 2: Open-label Extension|Other|0|||
147013743|NCT03653026|530212563|FG002|Part 2: Open-label Extension|Other|1|||
147013744|NCT03653026|530212564|FG003|Part 2: Open-label Extension|Other|2|||
147013745|NCT00852917|530212567|FG000|Overall Study|Adverse Event|13|||
147013746|NCT00852917|530212568|FG001|Overall Study|Adverse Event|20|||
147013747|NCT00852917|530212569|FG002|Overall Study|Adverse Event|35|||
147013748|NCT00852917|530212570|FG003|Overall Study|Adverse Event|17|||
147013749|NCT00852917|530212567|FG000|Overall Study|Lack of Efficacy|21|||
147013750|NCT00852917|530212568|FG001|Overall Study|Lack of Efficacy|11|||
147013751|NCT00852917|530212569|FG002|Overall Study|Lack of Efficacy|11|||
147013752|NCT00852917|530212570|FG003|Overall Study|Lack of Efficacy|47|||
147013753|NCT00852917|530212567|FG000|Overall Study|Withdrawal by Subject|4|||
147013754|NCT00852917|530212568|FG001|Overall Study|Withdrawal by Subject|8|||
147013755|NCT00852917|530212569|FG002|Overall Study|Withdrawal by Subject|10|||
147013756|NCT00852917|530212570|FG003|Overall Study|Withdrawal by Subject|9|||
147013757|NCT00852917|530212567|FG000|Overall Study|Physician Decision|6|||
147013758|NCT00852917|530212568|FG001|Overall Study|Physician Decision|7|||
147013759|NCT00852917|530212569|FG002|Overall Study|Physician Decision|2|||
147013760|NCT00852917|530212570|FG003|Overall Study|Physician Decision|19|||
147013761|NCT00852917|530212567|FG000|Overall Study|Death|0|||
147013762|NCT00852917|530212568|FG001|Overall Study|Death|0|||
147013763|NCT00852917|530212569|FG002|Overall Study|Death|0|||
147013764|NCT00852917|530212570|FG003|Overall Study|Death|1|||
147013765|NCT02510261|530212571|FG000|Overall Study|Adverse Event|5|||
147013766|NCT02510261|530212572|FG001|Overall Study|Adverse Event|8|||
147013767|NCT02510261|530212573|FG002|Overall Study|Adverse Event|0|||
147013768|NCT02510261|530212571|FG000|Overall Study|Physician Decision|1|||
147013769|NCT02510261|530212572|FG001|Overall Study|Physician Decision|5|||
147013770|NCT02510261|530212573|FG002|Overall Study|Physician Decision|0|||
147013771|NCT02510261|530212571|FG000|Overall Study|Death|19|||
147013772|NCT02510261|530212572|FG001|Overall Study|Death|19|||
147013773|NCT02510261|530212573|FG002|Overall Study|Death|0|||
147013774|NCT02510261|530212571|FG000|Overall Study|Withdrawal by Subject|3|||
147013775|NCT02510261|530212572|FG001|Overall Study|Withdrawal by Subject|10|||
147013776|NCT02510261|530212573|FG002|Overall Study|Withdrawal by Subject|3|||
147013777|NCT02161549|530212574|FG000|Overall Study|Physician Decision|6|||
147013778|NCT02161549|530212575|FG001|Overall Study|Physician Decision|2|||
147013779|NCT00979212|530212576|FG000|Overall Study|Protocol Violation|1|||
147013780|NCT00979212|530212577|FG001|Overall Study|Protocol Violation|8|||
147013781|NCT00979212|530212576|FG000|Overall Study|No protocol therapy received|1|||
147013782|NCT00979212|530212577|FG001|Overall Study|No protocol therapy received|0|||
147013783|NCT04886063|530212580|FG000|Overall Study|Adverse Event|50|||
147013784|NCT04886063|530212580|FG000|Overall Study|Lack of Efficacy|31|||
147013785|NCT04886063|530212580|FG000|Overall Study|Withdrawal by Subject|45|||
147013786|NCT04886063|530212580|FG000|Overall Study|Physician Decision|3|||
147013787|NCT04886063|530212580|FG000|Overall Study|Protocol Violation|3|||
147013788|NCT04886063|530212580|FG000|Overall Study|Site closure|4|||
147013789|NCT04886063|530212580|FG000|Overall Study|Nursing home replacement|3|||
147013790|NCT04886063|530212580|FG000|Overall Study|Lost to Follow-up|5|||
147013791|NCT04886063|530212580|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
147013792|NCT04886063|530212580|FG000|Overall Study|>1 reason|20|||
147013793|NCT00965757|530212586|FG000|Double-blind Phase|Progression of concomitant disease|1|||
147013794|NCT00965757|530212587|FG001|Double-blind Phase|Progression of concomitant disease|2|||
147013795|NCT00965757|530212588|FG002|Double-blind Phase|Progression of concomitant disease|0|||
147013796|NCT00965757|530212589|FG003|Double-blind Phase|Progression of concomitant disease|0|||
147013797|NCT00965757|530212586|FG000|Double-blind Phase|Adverse drug reaction|2|||
147013798|NCT00965757|530212587|FG001|Double-blind Phase|Adverse drug reaction|1|||
147013799|NCT00965757|530212588|FG002|Double-blind Phase|Adverse drug reaction|0|||
147013800|NCT00965757|530212589|FG003|Double-blind Phase|Adverse drug reaction|0|||
147013801|NCT00965757|530212586|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
147013802|NCT00965757|530212587|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
147013803|NCT00965757|530212588|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
147013804|NCT00965757|530212589|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
147013805|NCT00965757|530212586|FG000|Double-blind Phase|Lack of Efficacy|7|||
147013806|NCT00965757|530212587|FG001|Double-blind Phase|Lack of Efficacy|11|||
147013807|NCT00965757|530212588|FG002|Double-blind Phase|Lack of Efficacy|0|||
147013808|NCT00965757|530212589|FG003|Double-blind Phase|Lack of Efficacy|0|||
147013809|NCT00965757|530212586|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
147013810|NCT00965757|530212587|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
147013811|NCT00965757|530212588|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
147013812|NCT00965757|530212589|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
147013813|NCT00965757|530212586|FG000|Double-blind Phase|Lost to Follow-up|0|||
147013814|NCT00965757|530212587|FG001|Double-blind Phase|Lost to Follow-up|1|||
147013815|NCT00965757|530212588|FG002|Double-blind Phase|Lost to Follow-up|0|||
147013816|NCT00965757|530212589|FG003|Double-blind Phase|Lost to Follow-up|0|||
147013817|NCT00965757|530212586|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
147013818|NCT00965757|530212587|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
147013819|NCT00965757|530212588|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
147013820|NCT00965757|530212589|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
147013821|NCT00965757|530212586|FG000|Double-blind Phase|Other|1|||
147013822|NCT00965757|530212587|FG001|Double-blind Phase|Other|0|||
147013823|NCT00965757|530212588|FG002|Double-blind Phase|Other|0|||
147013824|NCT00965757|530212589|FG003|Double-blind Phase|Other|0|||
147013825|NCT00965757|530212586|FG000|Extension Phase|Progression of concomitant disease|0|||
147013826|NCT00965757|530212587|FG001|Extension Phase|Progression of concomitant disease|0|||
147013827|NCT00965757|530212588|FG002|Extension Phase|Progression of concomitant disease|4|||
147013828|NCT00965757|530212589|FG003|Extension Phase|Progression of concomitant disease|2|||
147013829|NCT00965757|530212586|FG000|Extension Phase|Adverse drug reaction|0|||
147013830|NCT00965757|530212587|FG001|Extension Phase|Adverse drug reaction|0|||
147013831|NCT00965757|530212588|FG002|Extension Phase|Adverse drug reaction|6|||
147013832|NCT00965757|530212589|FG003|Extension Phase|Adverse drug reaction|3|||
147013833|NCT00965757|530212586|FG000|Extension Phase|Abnormal Laboratory Value|0|||
147013834|NCT00965757|530212587|FG001|Extension Phase|Abnormal Laboratory Value|0|||
147013835|NCT00965757|530212588|FG002|Extension Phase|Abnormal Laboratory Value|6|||
147013836|NCT00965757|530212589|FG003|Extension Phase|Abnormal Laboratory Value|1|||
147013837|NCT00965757|530212586|FG000|Extension Phase|Lack of Efficacy|0|||
147013838|NCT00965757|530212587|FG001|Extension Phase|Lack of Efficacy|0|||
147013839|NCT00965757|530212588|FG002|Extension Phase|Lack of Efficacy|8|||
147013840|NCT00965757|530212589|FG003|Extension Phase|Lack of Efficacy|12|||
147013841|NCT00965757|530212586|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
147013842|NCT00965757|530212587|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
147013843|NCT00965757|530212588|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
147013844|NCT00965757|530212589|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
147013845|NCT00965757|530212586|FG000|Extension Phase|Lost to Follow-up|0|||
147013846|NCT00965757|530212587|FG001|Extension Phase|Lost to Follow-up|0|||
147013847|NCT00965757|530212588|FG002|Extension Phase|Lost to Follow-up|0|||
147013848|NCT00965757|530212589|FG003|Extension Phase|Lost to Follow-up|1|||
147013849|NCT00965757|530212586|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
147013850|NCT00965757|530212587|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
147013851|NCT00965757|530212588|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
147013852|NCT00965757|530212589|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
146848840|NCT00700427|529616994|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
147013853|NCT00965757|530212586|FG000|Extension Phase|Protocol Violation|0|||
147013854|NCT00965757|530212587|FG001|Extension Phase|Protocol Violation|0|||
147013855|NCT00965757|530212588|FG002|Extension Phase|Protocol Violation|0|||
147013856|NCT00965757|530212589|FG003|Extension Phase|Protocol Violation|1|||
146848841|NCT00700427|529616995|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
147013857|NCT00965757|530212586|FG000|Extension Phase|Other|0|||
146848842|NCT00700427|529616996|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
146848843|NCT00700427|529616992|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
146848844|NCT00700427|529616993|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
146848845|NCT00700427|529616994|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
146848846|NCT00700427|529616995|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
146848847|NCT00700427|529616996|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
146848848|NCT00700427|529616992|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
146848849|NCT00700427|529616993|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
146848850|NCT00700427|529616994|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
147013858|NCT00965757|530212587|FG001|Extension Phase|Other|0|||
147013859|NCT00965757|530212588|FG002|Extension Phase|Other|2|||
147013860|NCT00965757|530212589|FG003|Extension Phase|Other|1|||
147013861|NCT03807440|530212590|FG000|Overall Study|No documentation of index date 2|320|||
147013862|NCT03807440|530212590|FG000|Overall Study|No informed consent for index date 2|117|||
147013863|NCT02451358|530212591|FG000|Overall Study|Withdrawal by Subject|1|||
147013864|NCT02451358|530212592|FG001|Overall Study|Withdrawal by Subject|1|||
147013865|NCT02451358|530212593|FG002|Overall Study|Withdrawal by Subject|0|||
147013866|NCT02451358|530212594|FG003|Overall Study|Withdrawal by Subject|0|||
147013867|NCT02451358|530212591|FG000|Overall Study|Protocol Violation|0|||
147013868|NCT02451358|530212592|FG001|Overall Study|Protocol Violation|1|||
147013869|NCT02451358|530212593|FG002|Overall Study|Protocol Violation|1|||
147013870|NCT02451358|530212594|FG003|Overall Study|Protocol Violation|0|||
147013871|NCT01398787|530212597|FG000|Overall Study|Adverse Event|1|||
147013872|NCT03414034|530212598|FG000|Overall Study|Adverse Event|6|||
147013873|NCT03414034|530212599|FG001|Overall Study|Adverse Event|1|||
147013874|NCT03414034|530212600|FG002|Overall Study|Adverse Event|1|||
147013875|NCT03414034|530212598|FG000|Overall Study|Death|0|||
147013876|NCT03414034|530212599|FG001|Overall Study|Death|0|||
147013877|NCT03414034|530212600|FG002|Overall Study|Death|1|||
147013878|NCT03414034|530212598|FG000|Overall Study|Non-compliance With Study Drug|0|||
147013879|NCT03414034|530212599|FG001|Overall Study|Non-compliance With Study Drug|0|||
147013880|NCT03414034|530212600|FG002|Overall Study|Non-compliance With Study Drug|1|||
147013881|NCT03414034|530212598|FG000|Overall Study|Physician Decision|1|||
147013882|NCT03414034|530212599|FG001|Overall Study|Physician Decision|3|||
147013883|NCT03414034|530212600|FG002|Overall Study|Physician Decision|2|||
147013884|NCT03414034|530212598|FG000|Overall Study|Withdrawal of Informed Consent|2|||
147013885|NCT03414034|530212599|FG001|Overall Study|Withdrawal of Informed Consent|1|||
147013886|NCT03414034|530212600|FG002|Overall Study|Withdrawal of Informed Consent|4|||
147013887|NCT03414034|530212598|FG000|Overall Study|Progressive Disease|15|||
147013888|NCT03414034|530212599|FG001|Overall Study|Progressive Disease|15|||
147013889|NCT03414034|530212600|FG002|Overall Study|Progressive Disease|17|||
147013890|NCT03414034|530212598|FG000|Overall Study|Miscellaneous|0|||
147013891|NCT03414034|530212599|FG001|Overall Study|Miscellaneous|0|||
147013892|NCT03414034|530212600|FG002|Overall Study|Miscellaneous|2|||
147013893|NCT04010227|530212602|FG000|Overall Study|Death|1|||
147013894|NCT04010227|530212603|FG001|Overall Study|Death|2|||
147013895|NCT04010227|530212602|FG000|Overall Study|Medical Reasons|4|||
147013896|NCT04010227|530212603|FG001|Overall Study|Medical Reasons|3|||
147013897|NCT04010227|530212602|FG000|Overall Study|Withdrawal by Subject|2|||
147013898|NCT04010227|530212603|FG001|Overall Study|Withdrawal by Subject|0|||
147013899|NCT04010227|530212602|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
147013900|NCT04010227|530212603|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
147013901|NCT02351167|530212604|FG000|Overall Study|Withdrawal by Subject|19|||
147013902|NCT02351167|530212605|FG001|Overall Study|Withdrawal by Subject|18|||
147013903|NCT02351167|530212606|FG002|Overall Study|Withdrawal by Subject|21|||
147013904|NCT01332968|530212607|FG000|Induction Period|Adverse Event|23|||
147013905|NCT01332968|530212608|FG001|Induction Period|Adverse Event|26|||
147013906|NCT01332968|530212609|FG002|Induction Period|Adverse Event|0|||
147013907|NCT01332968|530212610|FG003|Induction Period|Adverse Event|0|||
147013908|NCT01332968|530212611|FG004|Induction Period|Adverse Event|0|||
147013909|NCT01332968|530212612|FG005|Induction Period|Adverse Event|0|||
147013910|NCT01332968|530212613|FG006|Induction Period|Adverse Event|0|||
147013911|NCT01332968|530212614|FG007|Induction Period|Adverse Event|0|||
147013912|NCT01332968|530212607|FG000|Induction Period|Death|1|||
147013913|NCT01332968|530212608|FG001|Induction Period|Death|4|||
147013914|NCT01332968|530212609|FG002|Induction Period|Death|0|||
147013915|NCT01332968|530212610|FG003|Induction Period|Death|0|||
147013916|NCT01332968|530212611|FG004|Induction Period|Death|0|||
147013917|NCT01332968|530212612|FG005|Induction Period|Death|0|||
147013918|NCT01332968|530212613|FG006|Induction Period|Death|0|||
147013919|NCT01332968|530212614|FG007|Induction Period|Death|0|||
147013920|NCT01332968|530212607|FG000|Induction Period|Non-compliance|1|||
147013921|NCT01332968|530212608|FG001|Induction Period|Non-compliance|0|||
147013922|NCT01332968|530212609|FG002|Induction Period|Non-compliance|0|||
147013923|NCT01332968|530212610|FG003|Induction Period|Non-compliance|0|||
147013924|NCT01332968|530212611|FG004|Induction Period|Non-compliance|0|||
147013925|NCT01332968|530212612|FG005|Induction Period|Non-compliance|0|||
147013926|NCT01332968|530212613|FG006|Induction Period|Non-compliance|0|||
147013927|NCT01332968|530212614|FG007|Induction Period|Non-compliance|0|||
147013928|NCT01332968|530212607|FG000|Induction Period|Other|2|||
147013929|NCT01332968|530212608|FG001|Induction Period|Other|2|||
147013930|NCT01332968|530212609|FG002|Induction Period|Other|0|||
147013931|NCT01332968|530212610|FG003|Induction Period|Other|0|||
147013932|NCT01332968|530212611|FG004|Induction Period|Other|0|||
147013933|NCT01332968|530212612|FG005|Induction Period|Other|0|||
147013934|NCT01332968|530212613|FG006|Induction Period|Other|0|||
147013935|NCT01332968|530212614|FG007|Induction Period|Other|0|||
147013936|NCT01332968|530212607|FG000|Induction Period|Physician Decision|6|||
147013937|NCT01332968|530212608|FG001|Induction Period|Physician Decision|1|||
147013938|NCT01332968|530212609|FG002|Induction Period|Physician Decision|0|||
147013939|NCT01332968|530212610|FG003|Induction Period|Physician Decision|0|||
147013940|NCT01332968|530212611|FG004|Induction Period|Physician Decision|0|||
147013941|NCT01332968|530212612|FG005|Induction Period|Physician Decision|0|||
147013942|NCT01332968|530212613|FG006|Induction Period|Physician Decision|0|||
147013943|NCT01332968|530212614|FG007|Induction Period|Physician Decision|0|||
147013944|NCT01332968|530212607|FG000|Induction Period|Progressive Disease|15|||
147013945|NCT01332968|530212608|FG001|Induction Period|Progressive Disease|7|||
147013946|NCT01332968|530212609|FG002|Induction Period|Progressive Disease|0|||
147013947|NCT01332968|530212610|FG003|Induction Period|Progressive Disease|0|||
146848851|NCT00700427|529616995|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
146848852|NCT00700427|529616996|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
146848853|NCT00700427|529616992|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
146848854|NCT00700427|529616993|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
146848855|NCT00700427|529616994|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
146848856|NCT00700427|529616995|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
146848857|NCT00700427|529616996|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
146848858|NCT00700427|529616992|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
146848859|NCT00700427|529616993|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
146848860|NCT00700427|529616994|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
146848861|NCT00700427|529616995|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
146848862|NCT00700427|529616996|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
146848863|NCT00700427|529616992|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
146848864|NCT00700427|529616993|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
146848865|NCT00700427|529616994|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
146848866|NCT00700427|529616995|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
146848867|NCT00700427|529616996|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
146848868|NCT00700427|529616992|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
146848869|NCT00700427|529616993|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
147013948|NCT01332968|530212611|FG004|Induction Period|Progressive Disease|0|||
147013949|NCT01332968|530212612|FG005|Induction Period|Progressive Disease|0|||
147013950|NCT01332968|530212613|FG006|Induction Period|Progressive Disease|0|||
146736473|NCT05375955|529206891|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
146736474|NCT05375955|529206892|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
146736475|NCT05375955|529206893|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
146736476|NCT05375955|529206894|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
146736477|NCT05375955|529206888|FG000|Treatment (12 Weeks)|Physician Decision|4|||
146736478|NCT05375955|529206889|FG001|Treatment (12 Weeks)|Physician Decision|1|||
146736479|NCT05375955|529206890|FG002|Treatment (12 Weeks)|Physician Decision|3|||
146736480|NCT05375955|529206891|FG003|Treatment (12 Weeks)|Physician Decision|0|||
146736481|NCT05375955|529206892|FG004|Treatment (12 Weeks)|Physician Decision|0|||
146736482|NCT05375955|529206893|FG005|Treatment (12 Weeks)|Physician Decision|1|||
146736483|NCT05375955|529206894|FG006|Treatment (12 Weeks)|Physician Decision|0|||
146736484|NCT05375955|529206888|FG000|Treatment (12 Weeks)|Other|0|||
146736485|NCT05375955|529206889|FG001|Treatment (12 Weeks)|Other|1|||
146736486|NCT05375955|529206890|FG002|Treatment (12 Weeks)|Other|0|||
146736487|NCT05375955|529206891|FG003|Treatment (12 Weeks)|Other|0|||
146736488|NCT05375955|529206892|FG004|Treatment (12 Weeks)|Other|0|||
146736489|NCT05375955|529206893|FG005|Treatment (12 Weeks)|Other|0|||
146736490|NCT05375955|529206894|FG006|Treatment (12 Weeks)|Other|0|||
146736491|NCT05375955|529206888|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
146736492|NCT05375955|529206889|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
146736493|NCT05375955|529206890|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
146736494|NCT05375955|529206891|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
146736495|NCT05375955|529206892|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
146736496|NCT05375955|529206893|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
146736497|NCT05375955|529206894|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
146736498|NCT05375955|529206888|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
146736499|NCT05375955|529206889|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
146736500|NCT05375955|529206890|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
146736501|NCT05375955|529206891|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
146736502|NCT05375955|529206892|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
146736503|NCT05375955|529206893|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
146736504|NCT05375955|529206894|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
146736505|NCT05375955|529206888|FG000|Treatment (12 Weeks)|Pregnancy|0|||
146736506|NCT05375955|529206889|FG001|Treatment (12 Weeks)|Pregnancy|0|||
146736507|NCT05375955|529206890|FG002|Treatment (12 Weeks)|Pregnancy|1|||
146736508|NCT05375955|529206891|FG003|Treatment (12 Weeks)|Pregnancy|0|||
146736509|NCT05375955|529206892|FG004|Treatment (12 Weeks)|Pregnancy|0|||
146736510|NCT05375955|529206893|FG005|Treatment (12 Weeks)|Pregnancy|0|||
146736511|NCT05375955|529206894|FG006|Treatment (12 Weeks)|Pregnancy|0|||
146736512|NCT05375955|529206888|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
146736513|NCT05375955|529206889|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
146736514|NCT05375955|529206890|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
147013951|NCT01332968|530212614|FG007|Induction Period|Progressive Disease|0|||
147013952|NCT01332968|530212607|FG000|Induction Period|Protocol Violation|3|||
147013953|NCT01332968|530212608|FG001|Induction Period|Protocol Violation|4|||
147013954|NCT01332968|530212609|FG002|Induction Period|Protocol Violation|0|||
147013955|NCT01332968|530212610|FG003|Induction Period|Protocol Violation|0|||
147013956|NCT01332968|530212611|FG004|Induction Period|Protocol Violation|0|||
147013957|NCT01332968|530212612|FG005|Induction Period|Protocol Violation|0|||
147013958|NCT01332968|530212613|FG006|Induction Period|Protocol Violation|0|||
147013959|NCT01332968|530212614|FG007|Induction Period|Protocol Violation|0|||
147013960|NCT01332968|530212607|FG000|Induction Period|Withdrawal by Subject|3|||
147013961|NCT01332968|530212608|FG001|Induction Period|Withdrawal by Subject|5|||
147013962|NCT01332968|530212609|FG002|Induction Period|Withdrawal by Subject|0|||
147013963|NCT01332968|530212610|FG003|Induction Period|Withdrawal by Subject|0|||
147013964|NCT01332968|530212611|FG004|Induction Period|Withdrawal by Subject|0|||
147013965|NCT01332968|530212612|FG005|Induction Period|Withdrawal by Subject|0|||
147013966|NCT01332968|530212613|FG006|Induction Period|Withdrawal by Subject|0|||
147013967|NCT01332968|530212614|FG007|Induction Period|Withdrawal by Subject|0|||
147013968|NCT01332968|530212607|FG000|Induction Period|Randomised but not treated|4|||
147013969|NCT01332968|530212608|FG001|Induction Period|Randomised but not treated|7|||
147013970|NCT01332968|530212609|FG002|Induction Period|Randomised but not treated|0|||
147013971|NCT01332968|530212610|FG003|Induction Period|Randomised but not treated|0|||
147013972|NCT01332968|530212611|FG004|Induction Period|Randomised but not treated|0|||
147013973|NCT01332968|530212612|FG005|Induction Period|Randomised but not treated|0|||
147013974|NCT01332968|530212613|FG006|Induction Period|Randomised but not treated|0|||
147013975|NCT01332968|530212614|FG007|Induction Period|Randomised but not treated|0|||
147013976|NCT01332968|530212607|FG000|Maintenance/Observation Period|Adverse Event|0|||
147013977|NCT01332968|530212608|FG001|Maintenance/Observation Period|Adverse Event|0|||
147013978|NCT01332968|530212609|FG002|Maintenance/Observation Period|Adverse Event|53|||
147013979|NCT01332968|530212610|FG003|Maintenance/Observation Period|Adverse Event|66|||
147013980|NCT01332968|530212611|FG004|Maintenance/Observation Period|Adverse Event|0|||
147013981|NCT01332968|530212612|FG005|Maintenance/Observation Period|Adverse Event|0|||
147013982|NCT01332968|530212613|FG006|Maintenance/Observation Period|Adverse Event|0|||
147013983|NCT01332968|530212614|FG007|Maintenance/Observation Period|Adverse Event|0|||
147013984|NCT01332968|530212607|FG000|Maintenance/Observation Period|Death|0|||
147013985|NCT01332968|530212608|FG001|Maintenance/Observation Period|Death|0|||
147013986|NCT01332968|530212609|FG002|Maintenance/Observation Period|Death|5|||
147013987|NCT01332968|530212610|FG003|Maintenance/Observation Period|Death|6|||
147013988|NCT01332968|530212611|FG004|Maintenance/Observation Period|Death|0|||
147013989|NCT01332968|530212612|FG005|Maintenance/Observation Period|Death|0|||
147013990|NCT01332968|530212613|FG006|Maintenance/Observation Period|Death|0|||
147013991|NCT01332968|530212614|FG007|Maintenance/Observation Period|Death|0|||
147013992|NCT01332968|530212607|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
147013993|NCT01332968|530212608|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
147013994|NCT01332968|530212609|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
147013995|NCT01332968|530212610|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
147013996|NCT01332968|530212611|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
147013997|NCT01332968|530212612|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
147013998|NCT01332968|530212613|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
147013999|NCT01332968|530212614|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
147014000|NCT01332968|530212607|FG000|Maintenance/Observation Period|Non-compliance|0|||
147014001|NCT01332968|530212608|FG001|Maintenance/Observation Period|Non-compliance|0|||
147014002|NCT01332968|530212609|FG002|Maintenance/Observation Period|Non-compliance|4|||
147014003|NCT01332968|530212610|FG003|Maintenance/Observation Period|Non-compliance|3|||
147014004|NCT01332968|530212611|FG004|Maintenance/Observation Period|Non-compliance|0|||
147014005|NCT01332968|530212612|FG005|Maintenance/Observation Period|Non-compliance|0|||
147014006|NCT01332968|530212613|FG006|Maintenance/Observation Period|Non-compliance|0|||
147014007|NCT01332968|530212614|FG007|Maintenance/Observation Period|Non-compliance|0|||
147014008|NCT01332968|530212607|FG000|Maintenance/Observation Period|Other|0|||
147014009|NCT01332968|530212608|FG001|Maintenance/Observation Period|Other|0|||
147014010|NCT01332968|530212609|FG002|Maintenance/Observation Period|Other|4|||
147014011|NCT01332968|530212610|FG003|Maintenance/Observation Period|Other|7|||
147014012|NCT01332968|530212611|FG004|Maintenance/Observation Period|Other|0|||
147014013|NCT01332968|530212612|FG005|Maintenance/Observation Period|Other|0|||
147014014|NCT01332968|530212613|FG006|Maintenance/Observation Period|Other|0|||
147014015|NCT01332968|530212614|FG007|Maintenance/Observation Period|Other|0|||
147014016|NCT01332968|530212607|FG000|Maintenance/Observation Period|Physician Decision|0|||
147014017|NCT01332968|530212608|FG001|Maintenance/Observation Period|Physician Decision|0|||
147014018|NCT01332968|530212609|FG002|Maintenance/Observation Period|Physician Decision|14|||
147014019|NCT01332968|530212610|FG003|Maintenance/Observation Period|Physician Decision|19|||
147014020|NCT01332968|530212611|FG004|Maintenance/Observation Period|Physician Decision|0|||
147014021|NCT01332968|530212612|FG005|Maintenance/Observation Period|Physician Decision|1|||
147014022|NCT01332968|530212613|FG006|Maintenance/Observation Period|Physician Decision|0|||
147014023|NCT01332968|530212614|FG007|Maintenance/Observation Period|Physician Decision|0|||
147014024|NCT01332968|530212607|FG000|Maintenance/Observation Period|Progressive Disease|0|||
147014025|NCT01332968|530212608|FG001|Maintenance/Observation Period|Progressive Disease|0|||
147014026|NCT01332968|530212609|FG002|Maintenance/Observation Period|Progressive Disease|72|||
147014027|NCT01332968|530212610|FG003|Maintenance/Observation Period|Progressive Disease|40|||
147014028|NCT01332968|530212611|FG004|Maintenance/Observation Period|Progressive Disease|0|||
147014029|NCT01332968|530212612|FG005|Maintenance/Observation Period|Progressive Disease|0|||
147014030|NCT01332968|530212613|FG006|Maintenance/Observation Period|Progressive Disease|0|||
147014031|NCT01332968|530212614|FG007|Maintenance/Observation Period|Progressive Disease|0|||
147014032|NCT01332968|530212607|FG000|Maintenance/Observation Period|Protocol Violation|0|||
147014033|NCT01332968|530212608|FG001|Maintenance/Observation Period|Protocol Violation|0|||
147014034|NCT01332968|530212609|FG002|Maintenance/Observation Period|Protocol Violation|1|||
147014035|NCT01332968|530212610|FG003|Maintenance/Observation Period|Protocol Violation|1|||
147014036|NCT01332968|530212611|FG004|Maintenance/Observation Period|Protocol Violation|0|||
147014037|NCT01332968|530212612|FG005|Maintenance/Observation Period|Protocol Violation|0|||
147014038|NCT01332968|530212613|FG006|Maintenance/Observation Period|Protocol Violation|0|||
147014039|NCT01332968|530212614|FG007|Maintenance/Observation Period|Protocol Violation|0|||
147014040|NCT01332968|530212607|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
147014041|NCT01332968|530212608|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
147014042|NCT01332968|530212609|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
147014043|NCT01332968|530212610|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
147014044|NCT01332968|530212611|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
147014045|NCT01332968|530212612|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
147014046|NCT01332968|530212613|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
147014047|NCT01332968|530212614|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
147014048|NCT01332968|530212607|FG000|Follow-Up Period|Adverse Event|0|||
147014049|NCT01332968|530212608|FG001|Follow-Up Period|Adverse Event|0|||
147014050|NCT01332968|530212609|FG002|Follow-Up Period|Adverse Event|0|||
147014051|NCT01332968|530212610|FG003|Follow-Up Period|Adverse Event|0|||
147014052|NCT01332968|530212611|FG004|Follow-Up Period|Adverse Event|0|||
147014053|NCT01332968|530212612|FG005|Follow-Up Period|Adverse Event|0|||
147014054|NCT01332968|530212613|FG006|Follow-Up Period|Adverse Event|0|||
147014055|NCT01332968|530212614|FG007|Follow-Up Period|Adverse Event|4|||
147014056|NCT01332968|530212607|FG000|Follow-Up Period|Death|0|||
147014057|NCT01332968|530212608|FG001|Follow-Up Period|Death|0|||
147014058|NCT01332968|530212609|FG002|Follow-Up Period|Death|0|||
147014059|NCT01332968|530212610|FG003|Follow-Up Period|Death|0|||
147014060|NCT01332968|530212611|FG004|Follow-Up Period|Death|0|||
147014061|NCT01332968|530212612|FG005|Follow-Up Period|Death|0|||
147014062|NCT01332968|530212613|FG006|Follow-Up Period|Death|27|||
147014063|NCT01332968|530212614|FG007|Follow-Up Period|Death|30|||
147014064|NCT01332968|530212607|FG000|Follow-Up Period|Lost to Follow-up|0|||
147014065|NCT01332968|530212608|FG001|Follow-Up Period|Lost to Follow-up|0|||
147014066|NCT01332968|530212609|FG002|Follow-Up Period|Lost to Follow-up|0|||
147014067|NCT01332968|530212610|FG003|Follow-Up Period|Lost to Follow-up|0|||
147014068|NCT01332968|530212611|FG004|Follow-Up Period|Lost to Follow-up|0|||
147014069|NCT01332968|530212612|FG005|Follow-Up Period|Lost to Follow-up|0|||
147014070|NCT01332968|530212613|FG006|Follow-Up Period|Lost to Follow-up|11|||
147014071|NCT01332968|530212614|FG007|Follow-Up Period|Lost to Follow-up|15|||
147014072|NCT01332968|530212607|FG000|Follow-Up Period|Non-compliance|0|||
147014073|NCT01332968|530212608|FG001|Follow-Up Period|Non-compliance|0|||
147014074|NCT01332968|530212609|FG002|Follow-Up Period|Non-compliance|0|||
147014075|NCT01332968|530212610|FG003|Follow-Up Period|Non-compliance|0|||
147014076|NCT01332968|530212611|FG004|Follow-Up Period|Non-compliance|0|||
147014077|NCT01332968|530212612|FG005|Follow-Up Period|Non-compliance|0|||
147014078|NCT01332968|530212613|FG006|Follow-Up Period|Non-compliance|4|||
147014079|NCT01332968|530212614|FG007|Follow-Up Period|Non-compliance|9|||
147014080|NCT01332968|530212607|FG000|Follow-Up Period|Other|0|||
147014081|NCT01332968|530212608|FG001|Follow-Up Period|Other|0|||
147014082|NCT01332968|530212609|FG002|Follow-Up Period|Other|0|||
147014083|NCT01332968|530212610|FG003|Follow-Up Period|Other|0|||
147014084|NCT01332968|530212611|FG004|Follow-Up Period|Other|0|||
147014085|NCT01332968|530212612|FG005|Follow-Up Period|Other|0|||
147014086|NCT01332968|530212613|FG006|Follow-Up Period|Other|18|||
147014087|NCT01332968|530212614|FG007|Follow-Up Period|Other|21|||
147014088|NCT01332968|530212607|FG000|Follow-Up Period|Physician Decision|0|||
147014089|NCT01332968|530212608|FG001|Follow-Up Period|Physician Decision|0|||
147014090|NCT01332968|530212609|FG002|Follow-Up Period|Physician Decision|0|||
146848870|NCT00700427|529616994|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
147014091|NCT01332968|530212610|FG003|Follow-Up Period|Physician Decision|0|||
147014092|NCT01332968|530212611|FG004|Follow-Up Period|Physician Decision|0|||
147014093|NCT01332968|530212612|FG005|Follow-Up Period|Physician Decision|0|||
147014094|NCT01332968|530212613|FG006|Follow-Up Period|Physician Decision|12|||
147014095|NCT01332968|530212614|FG007|Follow-Up Period|Physician Decision|15|||
147014096|NCT01332968|530212607|FG000|Follow-Up Period|Progressive Disease|0|||
147014097|NCT01332968|530212608|FG001|Follow-Up Period|Progressive Disease|0|||
147014098|NCT01332968|530212609|FG002|Follow-Up Period|Progressive Disease|0|||
147014099|NCT01332968|530212610|FG003|Follow-Up Period|Progressive Disease|0|||
147014100|NCT01332968|530212611|FG004|Follow-Up Period|Progressive Disease|0|||
147014101|NCT01332968|530212612|FG005|Follow-Up Period|Progressive Disease|0|||
147014102|NCT01332968|530212613|FG006|Follow-Up Period|Progressive Disease|126|||
147014103|NCT01332968|530212614|FG007|Follow-Up Period|Progressive Disease|106|||
147014104|NCT01332968|530212607|FG000|Follow-Up Period|Protocol Violation|0|||
147014105|NCT01332968|530212608|FG001|Follow-Up Period|Protocol Violation|0|||
147014106|NCT01332968|530212609|FG002|Follow-Up Period|Protocol Violation|0|||
147014107|NCT01332968|530212610|FG003|Follow-Up Period|Protocol Violation|0|||
147014108|NCT01332968|530212611|FG004|Follow-Up Period|Protocol Violation|0|||
147014109|NCT01332968|530212612|FG005|Follow-Up Period|Protocol Violation|0|||
147014110|NCT01332968|530212613|FG006|Follow-Up Period|Protocol Violation|1|||
147014111|NCT01332968|530212614|FG007|Follow-Up Period|Protocol Violation|0|||
147014112|NCT01332968|530212607|FG000|Follow-Up Period|Withdrawal by Subject|0|||
147014113|NCT01332968|530212608|FG001|Follow-Up Period|Withdrawal by Subject|0|||
147014114|NCT01332968|530212609|FG002|Follow-Up Period|Withdrawal by Subject|0|||
147014115|NCT01332968|530212610|FG003|Follow-Up Period|Withdrawal by Subject|0|||
147014116|NCT01332968|530212611|FG004|Follow-Up Period|Withdrawal by Subject|0|||
147014117|NCT01332968|530212612|FG005|Follow-Up Period|Withdrawal by Subject|0|||
147014118|NCT01332968|530212613|FG006|Follow-Up Period|Withdrawal by Subject|29|||
147014119|NCT01332968|530212614|FG007|Follow-Up Period|Withdrawal by Subject|32|||
147014120|NCT01332968|530212607|FG000|Follow-Up Period|No reason provided|0|||
147014121|NCT01332968|530212608|FG001|Follow-Up Period|No reason provided|0|||
147014122|NCT01332968|530212609|FG002|Follow-Up Period|No reason provided|0|||
147014123|NCT01332968|530212610|FG003|Follow-Up Period|No reason provided|0|||
147014124|NCT01332968|530212611|FG004|Follow-Up Period|No reason provided|0|||
147014125|NCT01332968|530212612|FG005|Follow-Up Period|No reason provided|0|||
147014126|NCT01332968|530212613|FG006|Follow-Up Period|No reason provided|2|||
147014127|NCT01332968|530212614|FG007|Follow-Up Period|No reason provided|3|||
147014128|NCT00702507|530212615|FG000|Initial Treatment Phase|Adverse Event|2|||
147014129|NCT00702507|530212615|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
147014130|NCT00702507|530212615|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
147014131|NCT00702507|530212615|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
147014132|NCT00702507|530212615|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
147014133|NCT00702507|530212615|FG000|Follow-up Phase|Protocol Violation|2|||
147014134|NCT00702507|530212615|FG000|Follow-up Phase|Lost to Follow-up|23|||
147014135|NCT00702507|530212615|FG000|Follow-up Phase|Late Enrollment|1|||
147014136|NCT02308696|530212617|FG000|Overall Study|Lost to Follow-up|28|||
147014137|NCT02308696|530212618|FG001|Overall Study|Lost to Follow-up|21|||
147014138|NCT02308696|530212617|FG000|Overall Study|Death|8|||
147014139|NCT02308696|530212618|FG001|Overall Study|Death|4|||
147014140|NCT02308696|530212617|FG000|Overall Study|Moved to a Higher Level of Care|17|||
147014141|NCT02308696|530212618|FG001|Overall Study|Moved to a Higher Level of Care|6|||
147014142|NCT01055886|530212624|FG000|Overall Study|Withdrawal by Subject|4|||
147014143|NCT01055886|530212625|FG001|Overall Study|Withdrawal by Subject|9|||
147014144|NCT01055886|530212624|FG000|Overall Study|Lost to Follow-up|1|||
147014145|NCT01055886|530212625|FG001|Overall Study|Lost to Follow-up|1|||
147014146|NCT01055886|530212624|FG000|Overall Study|Withdrawal by PI|0|||
147014147|NCT01055886|530212625|FG001|Overall Study|Withdrawal by PI|1|||
147014148|NCT04194008|530212626|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
147014149|NCT04194008|530212626|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
147014150|NCT04194008|530212626|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
147014151|NCT04194008|530212626|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
147014152|NCT04194008|530212626|FG000|Treatment Phase With Nerivio|Missing data|4|||
147014153|NCT04194008|530212626|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
147014154|NCT02522780|530212630|FG000|Overall Study|Consent withdrawn by subject|5|||
147014155|NCT02522780|530212631|FG001|Overall Study|Consent withdrawn by subject|7|||
147014156|NCT02522780|530212630|FG000|Overall Study|Protocol deviation|1|||
147014157|NCT02522780|530212631|FG001|Overall Study|Protocol deviation|3|||
147014158|NCT02522780|530212630|FG000|Overall Study|Subject refused endoscopic procedure|0|||
147014159|NCT02522780|530212631|FG001|Overall Study|Subject refused endoscopic procedure|1|||
147014160|NCT02522780|530212630|FG000|Overall Study|Adverse event, non-fatal|11|||
147014161|NCT02522780|530212631|FG001|Overall Study|Adverse event, non-fatal|16|||
147014162|NCT02260635|530212632|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
147014163|NCT02260635|530212633|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
147014164|NCT02260635|530212632|FG000|Open-Label Extension|Study Termination|25|||
146848871|NCT00700427|529616995|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
147014165|NCT02260635|530212633|FG001|Open-Label Extension|Study Termination|25|||
146848872|NCT00700427|529616996|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
147014166|NCT02260635|530212632|FG000|Open-Label Extension|Withdrawal by Subject|1|||
147014167|NCT02260635|530212633|FG001|Open-Label Extension|Withdrawal by Subject|0|||
147014168|NCT00926367|530212634|FG000|Overall Study|Withdrawal by Subject|0|||
147014169|NCT00926367|530212635|FG001|Overall Study|Withdrawal by Subject|1|||
147014170|NCT00926367|530212634|FG000|Overall Study|Lost to Follow-up|1|||
147014171|NCT00926367|530212635|FG001|Overall Study|Lost to Follow-up|0|||
147014172|NCT00926367|530212634|FG000|Overall Study|Skin Irritation|1|||
147014173|NCT00926367|530212635|FG001|Overall Study|Skin Irritation|2|||
147014174|NCT01517867|530212636|FG000|Overall Study|never started treatment|29|||
147014175|NCT01517867|530212637|FG001|Overall Study|never started treatment|32|||
147014176|NCT01517867|530212636|FG000|Overall Study|Withdrawal by Subject|34|||
147014177|NCT01517867|530212637|FG001|Overall Study|Withdrawal by Subject|30|||
147014178|NCT01517867|530212636|FG000|Overall Study|Still in treatment at study end|0|||
147014179|NCT01517867|530212637|FG001|Overall Study|Still in treatment at study end|3|||
147014180|NCT04307849|530212639|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
147014181|NCT04307849|530212640|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
147014182|NCT04307849|530212641|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
147014183|NCT04307849|530212642|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
147014184|NCT04307849|530212643|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
147014185|NCT04307849|530212644|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
147014186|NCT04307849|530212639|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
147014187|NCT04307849|530212640|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
147014188|NCT04307849|530212641|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
147014189|NCT04307849|530212642|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
147014190|NCT04307849|530212643|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
147014191|NCT04307849|530212644|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
147014192|NCT04307849|530212639|FG000|Overall Study|Family member did not want them to continue|0|||
147014193|NCT04307849|530212640|FG001|Overall Study|Family member did not want them to continue|0|||
147014194|NCT04307849|530212641|FG002|Overall Study|Family member did not want them to continue|1|||
147014195|NCT04307849|530212642|FG003|Overall Study|Family member did not want them to continue|0|||
147014196|NCT04307849|530212643|FG004|Overall Study|Family member did not want them to continue|0|||
147014197|NCT04307849|530212644|FG005|Overall Study|Family member did not want them to continue|0|||
147014198|NCT04307849|530212639|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
147014199|NCT04307849|530212640|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
147014200|NCT04307849|530212641|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
147014201|NCT04307849|530212642|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
147014202|NCT04307849|530212643|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
147014203|NCT04307849|530212644|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
147014204|NCT01294449|530212645|FG000|Overall Study|Death|11|||
147014205|NCT01294449|530212646|FG001|Overall Study|Death|12|||
147014206|NCT01294449|530212645|FG000|Overall Study|Withdrawal by Subject|1|||
147014207|NCT01294449|530212646|FG001|Overall Study|Withdrawal by Subject|3|||
147014208|NCT02911935|530212647|FG000|Overall Study|Lost to Follow-up|5|||
147014209|NCT02911935|530212648|FG001|Overall Study|Lost to Follow-up|7|||
147014210|NCT01685216|530212649|FG000|Overall Study|Did not receive study drug|1|||
147014211|NCT02466386|530212652|FG000|Overall Study|Adverse Event|5|||
147014212|NCT02466386|530212652|FG000|Overall Study|Protocol Violation|2|||
147014213|NCT02466386|530212652|FG000|Overall Study|Withdrawal by Subject|14|||
147014214|NCT02466386|530212652|FG000|Overall Study|Lost to Follow-up|5|||
147014215|NCT02466386|530212652|FG000|Overall Study|Lack of Efficacy|8|||
147014216|NCT02466386|530212652|FG000|Overall Study|Other|10|||
147014217|NCT02387762|530212653|FG000|Overall Study|Withdrawal by Subject|1|||
147014218|NCT02387762|530212654|FG001|Overall Study|Withdrawal by Subject|0|||
147014219|NCT00593827|530212655|FG000|Overall Study|On Active Treatment/Pending|0|||
147014220|NCT00593827|530212656|FG001|Overall Study|On Active Treatment/Pending|2|||
147014221|NCT01160640|530212657|FG000|Overall Study|Physician Decision|3|||
147014222|NCT01160640|530212658|FG001|Overall Study|Physician Decision|3|||
146848873|NCT00700427|529616992|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
146848874|NCT00700427|529616993|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
146848875|NCT00700427|529616994|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
146848876|NCT00700427|529616995|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
147014223|NCT01160640|530212657|FG000|Overall Study|Incarceration|1|||
147014224|NCT01160640|530212658|FG001|Overall Study|Incarceration|0|||
147014225|NCT01160640|530212657|FG000|Overall Study|Withdrawal by Subject|0|||
147014226|NCT01160640|530212658|FG001|Overall Study|Withdrawal by Subject|3|||
147014227|NCT02169336|530212659|FG000|Overall Study|Lack of Efficacy|1|||
147014228|NCT02169336|530212660|FG001|Overall Study|Lack of Efficacy|1|||
146848877|NCT00700427|529616996|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
147014229|NCT02169336|530212661|FG002|Overall Study|Lack of Efficacy|0|||
147014230|NCT02169336|530212659|FG000|Overall Study|Adverse Event|2|||
147014231|NCT02169336|530212660|FG001|Overall Study|Adverse Event|3|||
147014232|NCT02169336|530212661|FG002|Overall Study|Adverse Event|1|||
147014233|NCT02169336|530212659|FG000|Overall Study|Withdrawal by Subject|1|||
147014234|NCT02169336|530212660|FG001|Overall Study|Withdrawal by Subject|0|||
147014235|NCT02169336|530212661|FG002|Overall Study|Withdrawal by Subject|0|||
147014236|NCT02169336|530212659|FG000|Overall Study|Physician Decision|0|||
147014237|NCT02169336|530212660|FG001|Overall Study|Physician Decision|0|||
147014238|NCT02169336|530212661|FG002|Overall Study|Physician Decision|1|||
147014239|NCT02169336|530212659|FG000|Overall Study|Subject declined to continue dosing|0|||
147014240|NCT02169336|530212660|FG001|Overall Study|Subject declined to continue dosing|0|||
147014241|NCT02169336|530212661|FG002|Overall Study|Subject declined to continue dosing|1|||
147014242|NCT01598896|530212662|FG000|Overall Study|Withdrawal by Subject|0|||
147014243|NCT01598896|530212663|FG001|Overall Study|Withdrawal by Subject|1|||
147014244|NCT01598896|530212662|FG000|Overall Study|Lack of Efficacy|0|||
147014245|NCT01598896|530212663|FG001|Overall Study|Lack of Efficacy|1|||
147014246|NCT00239005|530212665|FG000|Overall Study|Adverse Event|6|||
147014247|NCT00239005|530212666|FG001|Overall Study|Adverse Event|6|||
147014248|NCT00239005|530212665|FG000|Overall Study|Withdrawal by Subject|3|||
147014249|NCT00239005|530212666|FG001|Overall Study|Withdrawal by Subject|4|||
147014250|NCT00239005|530212665|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
147014251|NCT00239005|530212666|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
147014252|NCT00239005|530212665|FG000|Overall Study|Protocol Violation|1|||
147014253|NCT00239005|530212666|FG001|Overall Study|Protocol Violation|0|||
147014254|NCT00239005|530212665|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
147014255|NCT00239005|530212666|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
146848878|NCT00700427|529616992|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
146848879|NCT00700427|529616993|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
146848880|NCT00700427|529616994|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
146848881|NCT00700427|529616995|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
146848882|NCT00700427|529616996|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
146848883|NCT00700427|529616992|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
146848884|NCT00700427|529616993|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
146848885|NCT00700427|529616994|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
146848886|NCT00700427|529616995|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
146848887|NCT00700427|529616996|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
146848888|NCT00700427|529616992|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
146848889|NCT00700427|529616993|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
146848890|NCT00700427|529616994|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
146848891|NCT00700427|529616995|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
146848892|NCT00700427|529616996|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
146848893|NCT00700427|529616992|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
146848894|NCT00700427|529616993|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
146848895|NCT00700427|529616994|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
146848896|NCT00700427|529616995|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
146848897|NCT00700427|529616996|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
146848898|NCT00700427|529616992|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
146848899|NCT00700427|529616993|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
146848900|NCT00700427|529616994|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
146848901|NCT00700427|529616995|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
146848902|NCT00700427|529616996|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
147014256|NCT00239005|530212665|FG000|Overall Study|Lost to Follow-up|0|||
147014257|NCT00239005|530212666|FG001|Overall Study|Lost to Follow-up|1|||
147014258|NCT02614898|530212667|FG000|Overall Study|Participated until study termination|10|||
147014259|NCT02614898|530212668|FG001|Overall Study|Participated until study termination|26|||
147014260|NCT02614898|530212667|FG000|Overall Study|Lost to Follow-up|0|||
147014261|NCT02614898|530212668|FG001|Overall Study|Lost to Follow-up|2|||
147014262|NCT02614898|530212667|FG000|Overall Study|Physician Decision|1|||
147014263|NCT02614898|530212668|FG001|Overall Study|Physician Decision|8|||
147014264|NCT02614898|530212667|FG000|Overall Study|Study Terminated by Sponsor|3|||
147014265|NCT02614898|530212668|FG001|Overall Study|Study Terminated by Sponsor|0|||
147014266|NCT02614898|530212667|FG000|Overall Study|Withdrawal by Subject|0|||
147014267|NCT02614898|530212668|FG001|Overall Study|Withdrawal by Subject|2|||
147014268|NCT02614898|530212667|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
147014269|NCT02614898|530212668|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
147014270|NCT02614898|530212667|FG000|Overall Study|Other-Additional Information Unavailable|0|||
147014271|NCT02614898|530212668|FG001|Overall Study|Other-Additional Information Unavailable|11|||
147014272|NCT02614898|530212667|FG000|Overall Study|Missing|0|||
147014273|NCT02614898|530212668|FG001|Overall Study|Missing|1|||
147014274|NCT00688844|530212669|FG000|Overall Study|Lost to Follow-up|10|||
147014275|NCT03493919|530212671|FG000|Overall Study|Other|2|||
147014276|NCT03493919|530212672|FG001|Overall Study|Other|0|||
147014277|NCT03493919|530212673|FG002|Overall Study|Other|1|||
147014278|NCT03493919|530212674|FG003|Overall Study|Other|0|||
147014279|NCT03493919|530212671|FG000|Overall Study|Withdrawal by Subject|9|||
147014280|NCT03493919|530212672|FG001|Overall Study|Withdrawal by Subject|3|||
147014281|NCT03493919|530212673|FG002|Overall Study|Withdrawal by Subject|1|||
147014282|NCT03493919|530212674|FG003|Overall Study|Withdrawal by Subject|1|||
147014283|NCT03493919|530212671|FG000|Overall Study|Lost to Follow-up|5|||
147014284|NCT03493919|530212672|FG001|Overall Study|Lost to Follow-up|0|||
147014285|NCT03493919|530212673|FG002|Overall Study|Lost to Follow-up|0|||
147014286|NCT03493919|530212674|FG003|Overall Study|Lost to Follow-up|3|||
147014287|NCT03493919|530212671|FG000|Overall Study|Adverse Event|0|||
147014288|NCT03493919|530212672|FG001|Overall Study|Adverse Event|1|||
147014289|NCT03493919|530212673|FG002|Overall Study|Adverse Event|0|||
147014290|NCT03493919|530212674|FG003|Overall Study|Adverse Event|0|||
147014291|NCT00724958|530212675|FG000|Overall Study|Adverse Event|28|||
147014292|NCT00724958|530212675|FG000|Overall Study|Loss of Response|40|||
147014293|NCT00724958|530212675|FG000|Overall Study|No Response|18|||
147014294|NCT00724958|530212675|FG000|Overall Study|Remission|7|||
147014295|NCT00724958|530212675|FG000|Overall Study|Other Reason|76|||
147014296|NCT00724958|530212675|FG000|Overall Study|No documentation for end of therapy|13|||
147014297|NCT00965731|530212676|FG000|Overall Study|Death|0|||
147014298|NCT00965731|530212677|FG001|Overall Study|Death|4|||
147014299|NCT00965731|530212676|FG000|Overall Study|Withdrawal by Subject|0|||
147014300|NCT00965731|530212677|FG001|Overall Study|Withdrawal by Subject|1|||
147014301|NCT00965731|530212676|FG000|Overall Study|Other|7|||
147014302|NCT00965731|530212677|FG001|Overall Study|Other|15|||
147014303|NCT04773600|530212678|FG000|Overall Study|Withdrawal by Subject|15|||
147014304|NCT04773600|530212679|FG001|Overall Study|Withdrawal by Subject|9|||
147014305|NCT04773600|530212678|FG000|Overall Study|Lost to Follow-up|10|||
147014306|NCT04773600|530212679|FG001|Overall Study|Lost to Follow-up|6|||
147014307|NCT04773600|530212678|FG000|Overall Study|Adverse Event|8|||
147014308|NCT04773600|530212679|FG001|Overall Study|Adverse Event|2|||
147014309|NCT04773600|530212678|FG000|Overall Study|Lack of Efficacy|2|||
147014310|NCT04773600|530212679|FG001|Overall Study|Lack of Efficacy|3|||
147014311|NCT04773600|530212678|FG000|Overall Study|Noncompliance|2|||
147014312|NCT04773600|530212679|FG001|Overall Study|Noncompliance|0|||
147014313|NCT04773600|530212678|FG000|Overall Study|Protocol Violation|2|||
147014314|NCT04773600|530212679|FG001|Overall Study|Protocol Violation|0|||
147014315|NCT04773600|530212678|FG000|Overall Study|Physician Decision|0|||
147014316|NCT04773600|530212679|FG001|Overall Study|Physician Decision|1|||
147014317|NCT04773600|530212678|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
147014318|NCT04773600|530212679|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
147014319|NCT04773600|530212678|FG000|Overall Study|Emergency Travel Out of Country|1|||
147014320|NCT04773600|530212679|FG001|Overall Study|Emergency Travel Out of Country|0|||
147014321|NCT02129062|530214554|FG000|Overall Study|Death|1|||
147014322|NCT02129062|530214554|FG000|Overall Study|Disease Progression|2|||
147014323|NCT01841060|530214558|FG000|Overall Study|Protocol Violation|10|||
147014324|NCT01848210|530214559|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
147014325|NCT01848210|530214560|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
147014326|NCT01848210|530214559|FG000|Overall Study|Lost to Follow-up|24|||
147014327|NCT01848210|530214560|FG001|Overall Study|Lost to Follow-up|12|||
147014328|NCT01848210|530214559|FG000|Overall Study|Protocol Violation|3|||
147014329|NCT01848210|530214560|FG001|Overall Study|Protocol Violation|5|||
147014330|NCT01848210|530214559|FG000|Overall Study|Use of Forbidden Drugs|9|||
147014331|NCT01848210|530214560|FG001|Overall Study|Use of Forbidden Drugs|10|||
147014332|NCT01848210|530214559|FG000|Overall Study|Impedition Condition|5|||
147014333|NCT01848210|530214560|FG001|Overall Study|Impedition Condition|9|||
147014334|NCT01848210|530214559|FG000|Overall Study|Adverse Event|7|||
147014335|NCT01848210|530214560|FG001|Overall Study|Adverse Event|9|||
147014336|NCT01848210|530214559|FG000|Overall Study|Discontinuation Criterion|5|||
147014337|NCT01848210|530214560|FG001|Overall Study|Discontinuation Criterion|7|||
147014338|NCT01848210|530214559|FG000|Overall Study|Hypesensitivity|1|||
147014339|NCT01848210|530214560|FG001|Overall Study|Hypesensitivity|0|||
147014340|NCT01848210|530214559|FG000|Overall Study|Hepatic Function Alteration|4|||
147014341|NCT01848210|530214560|FG001|Overall Study|Hepatic Function Alteration|0|||
147014342|NCT01848210|530214559|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
147014343|NCT01848210|530214560|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
146736515|NCT05375955|529206891|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
147014344|NCT01848210|530214559|FG000|Overall Study|Administrative|1|||
147014345|NCT01848210|530214560|FG001|Overall Study|Administrative|0|||
147014346|NCT04592419|530214561|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
147014347|NCT04592419|530214562|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
147014348|NCT04592419|530214561|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
147014349|NCT04592419|530214562|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
147014350|NCT04592419|530214561|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
147014351|NCT04592419|530214562|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
147014352|NCT04592419|530214561|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
147014353|NCT04592419|530214562|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
147014354|NCT04592419|530214561|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
147014355|NCT04592419|530214562|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
147014356|NCT04592419|530214561|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
147014357|NCT04592419|530214562|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
147014358|NCT04592419|530214561|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
147014359|NCT04592419|530214562|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
147014360|NCT04592419|530214561|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
147014361|NCT04592419|530214562|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
147014362|NCT04592419|530214561|FG000|Open-Label Extension Period|Adverse Event|1|||
147014363|NCT04592419|530214562|FG001|Open-Label Extension Period|Adverse Event|2|||
147014364|NCT04592419|530214561|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
147014365|NCT04592419|530214562|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
147014366|NCT04592419|530214561|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
147014367|NCT04592419|530214562|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
147014368|NCT04592419|530214561|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
147014369|NCT04592419|530214562|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
147014370|NCT04592419|530214561|FG000|Open-Label Extension Period|Sponsor Request|73|||
147014371|NCT04592419|530214562|FG001|Open-Label Extension Period|Sponsor Request|84|||
147014372|NCT01765270|530214563|FG000|Overall Study|Physician Decision|1|||
147014373|NCT01765270|530214564|FG001|Overall Study|Physician Decision|0|||
147014374|NCT01765270|530214563|FG000|Overall Study|Withdrawal by Subject|0|||
147014375|NCT01765270|530214564|FG001|Overall Study|Withdrawal by Subject|1|||
147014376|NCT02419573|530214565|FG000|Overall Study|Lost to Follow-up|3|||
147014377|NCT02419573|530214566|FG001|Overall Study|Lost to Follow-up|0|||
147014378|NCT02419573|530214565|FG000|Overall Study|Withdrawal by Subject|1|||
147014379|NCT02419573|530214566|FG001|Overall Study|Withdrawal by Subject|0|||
147014380|NCT04501094|530214567|FG000|Overall Study|Death (unrelated to research)|1|||
147014381|NCT04501094|530214568|FG001|Overall Study|Death (unrelated to research)|0|||
147014382|NCT00685035|530214573|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
147014383|NCT00685035|530214574|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
147014384|NCT02426541|530214577|FG000|Overall Study|Protocol Violation|1|||
147014385|NCT02426541|530214578|FG001|Overall Study|Protocol Violation|0|||
147014386|NCT00784979|530214579|FG000|Overall Study|incomplete data|6|||
147014387|NCT00894933|530214580|FG000|Overall Study|Lost to Follow-up|2|||
147014388|NCT00894933|530214580|FG000|Overall Study|Cancelled Procedure|1|||
147014389|NCT00894933|530214580|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
147014390|NCT00631007|530214585|FG000|Overall Study|Adverse Event|0|||
147014391|NCT00631007|530214586|FG001|Overall Study|Adverse Event|2|||
147014392|NCT00631007|530214587|FG002|Overall Study|Adverse Event|0|||
147014393|NCT00631007|530214588|FG003|Overall Study|Adverse Event|2|||
147014394|NCT00631007|530214589|FG004|Overall Study|Adverse Event|3|||
147014395|NCT00631007|530214590|FG005|Overall Study|Adverse Event|2|||
147014396|NCT00631007|530214585|FG000|Overall Study|Lost to Follow-up|2|||
147014397|NCT00631007|530214586|FG001|Overall Study|Lost to Follow-up|1|||
147014398|NCT00631007|530214587|FG002|Overall Study|Lost to Follow-up|2|||
147014399|NCT00631007|530214588|FG003|Overall Study|Lost to Follow-up|4|||
147014400|NCT00631007|530214589|FG004|Overall Study|Lost to Follow-up|5|||
147014401|NCT00631007|530214590|FG005|Overall Study|Lost to Follow-up|3|||
147014402|NCT00631007|530214585|FG000|Overall Study|Physician Decision|1|||
147014403|NCT00631007|530214586|FG001|Overall Study|Physician Decision|0|||
147014404|NCT00631007|530214587|FG002|Overall Study|Physician Decision|1|||
147014405|NCT00631007|530214588|FG003|Overall Study|Physician Decision|0|||
147014406|NCT00631007|530214589|FG004|Overall Study|Physician Decision|0|||
147014407|NCT00631007|530214590|FG005|Overall Study|Physician Decision|2|||
147014408|NCT00631007|530214585|FG000|Overall Study|Persistent Hyperglycemia|2|||
147014409|NCT00631007|530214586|FG001|Overall Study|Persistent Hyperglycemia|2|||
147014410|NCT00631007|530214587|FG002|Overall Study|Persistent Hyperglycemia|5|||
147014411|NCT00631007|530214588|FG003|Overall Study|Persistent Hyperglycemia|1|||
147014412|NCT00631007|530214589|FG004|Overall Study|Persistent Hyperglycemia|2|||
147014413|NCT00631007|530214590|FG005|Overall Study|Persistent Hyperglycemia|5|||
147014414|NCT00631007|530214585|FG000|Overall Study|Withdrawal by Subject|4|||
147014415|NCT00631007|530214586|FG001|Overall Study|Withdrawal by Subject|5|||
147014416|NCT00631007|530214587|FG002|Overall Study|Withdrawal by Subject|2|||
147014417|NCT00631007|530214588|FG003|Overall Study|Withdrawal by Subject|2|||
147014418|NCT00631007|530214589|FG004|Overall Study|Withdrawal by Subject|1|||
147014419|NCT00631007|530214590|FG005|Overall Study|Withdrawal by Subject|3|||
147014420|NCT00631007|530214585|FG000|Overall Study|Other|2|||
147014421|NCT00631007|530214586|FG001|Overall Study|Other|1|||
147014422|NCT00631007|530214587|FG002|Overall Study|Other|0|||
147014423|NCT00631007|530214588|FG003|Overall Study|Other|0|||
147014424|NCT00631007|530214589|FG004|Overall Study|Other|1|||
147014425|NCT00631007|530214590|FG005|Overall Study|Other|0|||
147014426|NCT02674633|530214591|FG000|Overall Study|Lost to Follow-up|3|||
147014427|NCT02674633|530214592|FG001|Overall Study|Lost to Follow-up|2|||
147014428|NCT02674633|530214591|FG000|Overall Study|Physician Decision|1|||
147014429|NCT02674633|530214592|FG001|Overall Study|Physician Decision|0|||
147014430|NCT02674633|530214591|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
147014431|NCT02674633|530214592|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
147014432|NCT00683787|530214593|FG000|Overall Study|Progression|3|||
147014433|NCT00683787|530214594|FG001|Overall Study|Progression|3|||
147014434|NCT00683787|530214595|FG002|Overall Study|Progression|0|||
147014435|NCT00683787|530214593|FG000|Overall Study|Adverse Event|0|||
147014436|NCT00683787|530214594|FG001|Overall Study|Adverse Event|0|||
147014437|NCT00683787|530214595|FG002|Overall Study|Adverse Event|2|||
147014438|NCT00460109|530214596|FG000|Overall Study|Death|1|||
147014439|NCT01235715|530214597|FG000|Overall Study|Physician Decision|0|||
147014440|NCT01235715|530214598|FG001|Overall Study|Physician Decision|2|||
147014441|NCT03619876|530214599|FG000|Overall Study|Withdrawal by Subject|1|||
147014442|NCT03619876|530214600|FG001|Overall Study|Withdrawal by Subject|2|||
147014443|NCT03619876|530214599|FG000|Overall Study|Withdrawal due to incidental finding|0|||
147014444|NCT03619876|530214600|FG001|Overall Study|Withdrawal due to incidental finding|2|||
147014445|NCT02344745|530214601|FG000|Overall Study|Data collection sheets were lost|2|||
147014446|NCT02344745|530214602|FG001|Overall Study|Data collection sheets were lost|0|||
147014447|NCT02788513|530214603|FG000|Overall Study|Withdrawal by Subject|3|||
147014448|NCT02788513|530214604|FG001|Overall Study|Withdrawal by Subject|0|||
147014449|NCT02788513|530214605|FG002|Overall Study|Withdrawal by Subject|2|||
147014450|NCT02788513|530214606|FG003|Overall Study|Withdrawal by Subject|3|||
147014451|NCT02788513|530214607|FG004|Overall Study|Withdrawal by Subject|1|||
147014452|NCT02788513|530214603|FG000|Overall Study|Lost to Follow-up|1|||
147014453|NCT02788513|530214604|FG001|Overall Study|Lost to Follow-up|0|||
147014454|NCT02788513|530214605|FG002|Overall Study|Lost to Follow-up|0|||
147014455|NCT02788513|530214606|FG003|Overall Study|Lost to Follow-up|0|||
147014456|NCT02788513|530214607|FG004|Overall Study|Lost to Follow-up|1|||
147014457|NCT02788513|530214603|FG000|Overall Study|Adverse Event|5|||
147014458|NCT02788513|530214604|FG001|Overall Study|Adverse Event|8|||
147014459|NCT02788513|530214605|FG002|Overall Study|Adverse Event|4|||
147014460|NCT02788513|530214606|FG003|Overall Study|Adverse Event|2|||
147014461|NCT02788513|530214607|FG004|Overall Study|Adverse Event|2|||
147014462|NCT02788513|530214603|FG000|Overall Study|Protocol Violation|0|||
147014463|NCT02788513|530214604|FG001|Overall Study|Protocol Violation|0|||
147014464|NCT02788513|530214605|FG002|Overall Study|Protocol Violation|1|||
147014465|NCT02788513|530214606|FG003|Overall Study|Protocol Violation|1|||
147014466|NCT02788513|530214607|FG004|Overall Study|Protocol Violation|0|||
147014467|NCT02788513|530214603|FG000|Overall Study|Subject decided to stop taking treatment|0|||
147014468|NCT02788513|530214604|FG001|Overall Study|Subject decided to stop taking treatment|0|||
147014469|NCT02788513|530214605|FG002|Overall Study|Subject decided to stop taking treatment|1|||
147014470|NCT02788513|530214606|FG003|Overall Study|Subject decided to stop taking treatment|0|||
147014471|NCT02788513|530214607|FG004|Overall Study|Subject decided to stop taking treatment|0|||
147014472|NCT02788513|530214603|FG000|Overall Study|Decision by the study team|0|||
147014473|NCT02788513|530214604|FG001|Overall Study|Decision by the study team|0|||
147014474|NCT02788513|530214605|FG002|Overall Study|Decision by the study team|0|||
147014475|NCT02788513|530214606|FG003|Overall Study|Decision by the study team|0|||
147014476|NCT02788513|530214607|FG004|Overall Study|Decision by the study team|1|||
147014477|NCT04982445|530214608|FG000|Overall Study|Protocol Violation|1|||
147014478|NCT04982445|530214608|FG000|Overall Study|Withdrawal by Subject|4|||
147014479|NCT04982445|530214608|FG000|Overall Study|Lost to Follow-up|1|||
147014480|NCT04968925|530214611|FG000|Phase I- Period 1|COVID-19 related|0|||
147014481|NCT04968925|530214612|FG001|Phase I- Period 1|COVID-19 related|1|||
147014482|NCT04968925|530214613|FG002|Phase I- Period 1|COVID-19 related|0|||
147014483|NCT04968925|530214614|FG003|Phase I- Period 1|COVID-19 related|0|||
147014484|NCT04968925|530214611|FG000|Phase I- Period 1|Subject enrolled in error|1|||
147014485|NCT04968925|530214612|FG001|Phase I- Period 1|Subject enrolled in error|1|||
147014486|NCT04968925|530214613|FG002|Phase I- Period 1|Subject enrolled in error|0|||
147014487|NCT04968925|530214614|FG003|Phase I- Period 1|Subject enrolled in error|0|||
147014488|NCT04968925|530214611|FG000|Phase II- Period 1|COVID-19 Related|0|||
147014489|NCT04968925|530214612|FG001|Phase II- Period 1|COVID-19 Related|0|||
147014490|NCT04968925|530214613|FG002|Phase II- Period 1|COVID-19 Related|6|||
147014491|NCT04968925|530214614|FG003|Phase II- Period 1|COVID-19 Related|6|||
147014492|NCT04968925|530214611|FG000|Phase II- Period 1|Subject enrolled in error|0|||
147014493|NCT04968925|530214612|FG001|Phase II- Period 1|Subject enrolled in error|0|||
147014494|NCT04968925|530214613|FG002|Phase II- Period 1|Subject enrolled in error|1|||
147014495|NCT04968925|530214614|FG003|Phase II- Period 1|Subject enrolled in error|0|||
147014496|NCT04968925|530214611|FG000|Phase II -Period 2|COVID-19 related|0|||
147014497|NCT04968925|530214612|FG001|Phase II -Period 2|COVID-19 related|0|||
147014498|NCT04968925|530214613|FG002|Phase II -Period 2|COVID-19 related|4|||
147014499|NCT04968925|530214614|FG003|Phase II -Period 2|COVID-19 related|3|||
147014500|NCT04968925|530214611|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
147014501|NCT04968925|530214612|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
147014502|NCT04968925|530214613|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
147014503|NCT04968925|530214614|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
147014504|NCT00835796|530214616|FG000|First Intervention|Withdrawal by Subject|0|||
147014505|NCT00835796|530214617|FG001|First Intervention|Withdrawal by Subject|1|||
147014506|NCT02327325|530214618|FG000|Overall Study|Withdrawal by Subject|1|||
147014507|NCT02327325|530214619|FG001|Overall Study|Withdrawal by Subject|4|||
147014508|NCT02327325|530214620|FG002|Overall Study|Withdrawal by Subject|4|||
147014509|NCT02327325|530214618|FG000|Overall Study|Excluded by Study Team|0|||
147014510|NCT02327325|530214619|FG001|Overall Study|Excluded by Study Team|0|||
147014511|NCT02327325|530214620|FG002|Overall Study|Excluded by Study Team|1|||
147014512|NCT02457819|530214621|FG000|Overall Study|reason not given|8|||
147014513|NCT02457819|530214621|FG000|Overall Study|Withdrawal by Subject|24|||
147014514|NCT02457819|530214621|FG000|Overall Study|Protocol Violation|1|||
147014515|NCT02457819|530214621|FG000|Overall Study|non compliance with study drug|4|||
147014516|NCT02457819|530214621|FG000|Overall Study|Lost to Follow-up|10|||
147014517|NCT02457819|530214621|FG000|Overall Study|Lack of Efficacy|19|||
147014518|NCT02457819|530214621|FG000|Overall Study|Adverse Event|33|||
147014519|NCT01933919|530214622|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
147014520|NCT01933919|530214623|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
147014521|NCT01933919|530214622|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
147014522|NCT01933919|530214623|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
147014523|NCT01933919|530214622|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
147014524|NCT01933919|530214623|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
147014525|NCT01933919|530214622|FG000|Open-label Long-term Phase|Adverse Event|2|||
147014526|NCT01933919|530214623|FG001|Open-label Long-term Phase|Adverse Event|0|||
147014527|NCT01933919|530214622|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
147014528|NCT01933919|530214623|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
147014529|NCT01933919|530214622|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
147014530|NCT01933919|530214623|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
147014531|NCT01933919|530214622|FG000|Open-label Long-term Phase|Other|1|||
147014532|NCT01933919|530214623|FG001|Open-label Long-term Phase|Other|2|||
147014533|NCT00763555|530214624|FG000|Overall Study|Adverse Event|2|||
147014534|NCT00763555|530214625|FG001|Overall Study|Adverse Event|1|||
147014535|NCT00763555|530214624|FG000|Overall Study|Withdrawal by Subject|2|||
147014536|NCT00763555|530214625|FG001|Overall Study|Withdrawal by Subject|6|||
147014537|NCT00763555|530214624|FG000|Overall Study|Lost to Follow-up|0|||
147014538|NCT00763555|530214625|FG001|Overall Study|Lost to Follow-up|3|||
147014539|NCT00177164|530214626|FG000|Overall Study|Protocol Violation|0|||
147014540|NCT00177164|530214627|FG001|Overall Study|Protocol Violation|7|||
147014541|NCT00177164|530214626|FG000|Overall Study|Lost to Follow-up|4|||
147014542|NCT00177164|530214627|FG001|Overall Study|Lost to Follow-up|5|||
147014543|NCT00177164|530214626|FG000|Overall Study|increase in alcohol and drug use|1|||
147014544|NCT00177164|530214627|FG001|Overall Study|increase in alcohol and drug use|2|||
147014545|NCT00177164|530214626|FG000|Overall Study|Adverse Event|1|||
147014546|NCT00177164|530214627|FG001|Overall Study|Adverse Event|0|||
147014547|NCT00177164|530214626|FG000|Overall Study|discharge from hospital|1|||
147014548|NCT00177164|530214627|FG001|Overall Study|discharge from hospital|0|||
147014549|NCT00177164|530214626|FG000|Overall Study|Lack of Efficacy|2|||
147014550|NCT00177164|530214627|FG001|Overall Study|Lack of Efficacy|1|||
147014551|NCT00177164|530214626|FG000|Overall Study|Pregnancy|0|||
147014552|NCT00177164|530214627|FG001|Overall Study|Pregnancy|1|||
147014553|NCT01344018|530214633|FG000|Overall Study|Death|22|||
147014554|NCT01344018|530214634|FG001|Overall Study|Death|25|||
147014555|NCT01344018|530214633|FG000|Overall Study|Lost to Follow-up|4|||
147014556|NCT01344018|530214634|FG001|Overall Study|Lost to Follow-up|7|||
147014557|NCT05070754|530214635|FG000|Overall Study|Withdrawal by Subject|0|||
147014558|NCT05070754|530214636|FG001|Overall Study|Withdrawal by Subject|0|||
147014559|NCT05070754|530214637|FG002|Overall Study|Withdrawal by Subject|0|||
147014560|NCT05070754|530214638|FG003|Overall Study|Withdrawal by Subject|1|||
147014561|NCT05070754|530214635|FG000|Overall Study|Protocol Violation|0|||
147014562|NCT05070754|530214636|FG001|Overall Study|Protocol Violation|0|||
147014563|NCT05070754|530214637|FG002|Overall Study|Protocol Violation|0|||
147014564|NCT05070754|530214638|FG003|Overall Study|Protocol Violation|1|||
147014565|NCT02725411|530214642|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
147014566|NCT02725411|530214643|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
147014567|NCT02725411|530214644|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
147014568|NCT02725411|530214642|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
147014569|NCT02725411|530214643|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
147014570|NCT02725411|530214644|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
147014571|NCT02725411|530214642|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
147014572|NCT02725411|530214643|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
147014573|NCT02725411|530214644|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
147014574|NCT02725411|530214642|FG000|Treatment Period (56 Weeks)|Other|1|||
147014575|NCT02725411|530214643|FG001|Treatment Period (56 Weeks)|Other|4|||
147014576|NCT02725411|530214644|FG002|Treatment Period (56 Weeks)|Other|5|||
147014577|NCT02725411|530214642|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
147014578|NCT02725411|530214643|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
147014579|NCT02725411|530214644|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
147014580|NCT02725411|530214642|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
147014581|NCT02725411|530214643|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
147014582|NCT02725411|530214644|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
147014583|NCT02725411|530214642|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
147014584|NCT02725411|530214643|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
147014585|NCT02725411|530214644|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
147014586|NCT02725411|530214642|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
147014587|NCT02725411|530214643|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
147014588|NCT02725411|530214644|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
147014589|NCT02725411|530214642|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
147014590|NCT02725411|530214643|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
147014591|NCT02725411|530214644|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
147014592|NCT02725411|530214642|FG000|Follow-up Period (24 Weeks)|Other|1|||
147014593|NCT02725411|530214643|FG001|Follow-up Period (24 Weeks)|Other|4|||
147014594|NCT02725411|530214644|FG002|Follow-up Period (24 Weeks)|Other|2|||
147014595|NCT02725411|530214642|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
147014596|NCT02725411|530214643|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
147014597|NCT02725411|530214644|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
147014598|NCT03847974|530214645|FG000|Overall Study|relocated out of region|3|||
147014599|NCT03847974|530214645|FG000|Overall Study|Withdrawal by Subject|2|||
147014600|NCT03847974|530214645|FG000|Overall Study|Adverse Event|1|||
147014601|NCT00756717|530214648|FG000|Overall Study|Withdrawal by Subject|2|||
147014602|NCT02654015|530214649|FG000|Overall Study|Death|12|||
147014603|NCT02654015|530214649|FG000|Overall Study|Lost to Follow-up|3|||
147014604|NCT01896505|530214650|FG000|Overall Study|Adverse Event|1|||
147014605|NCT01896505|530214651|FG001|Overall Study|Adverse Event|0|||
147014606|NCT01896505|530214652|FG002|Overall Study|Adverse Event|2|||
147014607|NCT01896505|530214653|FG003|Overall Study|Adverse Event|1|||
147014608|NCT01896505|530214654|FG004|Overall Study|Adverse Event|1|||
147014609|NCT01896505|530214655|FG005|Overall Study|Adverse Event|0|||
147014610|NCT01896505|530214650|FG000|Overall Study|Physician Decision|1|||
147014611|NCT01896505|530214651|FG001|Overall Study|Physician Decision|3|||
147014612|NCT01896505|530214652|FG002|Overall Study|Physician Decision|2|||
147014613|NCT01896505|530214653|FG003|Overall Study|Physician Decision|0|||
147014614|NCT01896505|530214654|FG004|Overall Study|Physician Decision|0|||
147014615|NCT01896505|530214655|FG005|Overall Study|Physician Decision|1|||
147014616|NCT01896505|530214650|FG000|Overall Study|Withdrawal by Subject|1|||
147014617|NCT01896505|530214651|FG001|Overall Study|Withdrawal by Subject|0|||
147014618|NCT01896505|530214652|FG002|Overall Study|Withdrawal by Subject|3|||
147014619|NCT01896505|530214653|FG003|Overall Study|Withdrawal by Subject|1|||
147014620|NCT01896505|530214654|FG004|Overall Study|Withdrawal by Subject|0|||
147014621|NCT01896505|530214655|FG005|Overall Study|Withdrawal by Subject|0|||
147014622|NCT01896505|530214650|FG000|Overall Study|Disease Progression|7|||
147014623|NCT01896505|530214651|FG001|Overall Study|Disease Progression|5|||
147014624|NCT01896505|530214652|FG002|Overall Study|Disease Progression|8|||
147014625|NCT01896505|530214653|FG003|Overall Study|Disease Progression|4|||
147014626|NCT01896505|530214654|FG004|Overall Study|Disease Progression|4|||
147014627|NCT01896505|530214655|FG005|Overall Study|Disease Progression|4|||
147014628|NCT01896505|530214650|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
147014629|NCT01896505|530214651|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
147014630|NCT01896505|530214652|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
147014631|NCT01896505|530214653|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
147014632|NCT01896505|530214654|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
147014633|NCT01896505|530214655|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
147014634|NCT01896505|530214650|FG000|Overall Study|Intercurrent illness|0|||
147014635|NCT01896505|530214651|FG001|Overall Study|Intercurrent illness|1|||
147014636|NCT01896505|530214652|FG002|Overall Study|Intercurrent illness|0|||
147014637|NCT01896505|530214653|FG003|Overall Study|Intercurrent illness|0|||
146848903|NCT00700427|529616992|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
147014638|NCT01896505|530214654|FG004|Overall Study|Intercurrent illness|0|||
147014639|NCT01896505|530214655|FG005|Overall Study|Intercurrent illness|0|||
147014640|NCT01896505|530214650|FG000|Overall Study|Death|0|||
147014641|NCT01896505|530214651|FG001|Overall Study|Death|0|||
147014642|NCT01896505|530214652|FG002|Overall Study|Death|1|||
147014643|NCT01896505|530214653|FG003|Overall Study|Death|1|||
147014644|NCT01896505|530214654|FG004|Overall Study|Death|0|||
147014645|NCT01896505|530214655|FG005|Overall Study|Death|1|||
147014646|NCT02063217|530214656|FG000|Overall Study|Withdrawal by Subject|1|||
147014647|NCT02063217|530214657|FG001|Overall Study|Withdrawal by Subject|0|||
147014648|NCT02063217|530214658|FG002|Overall Study|Withdrawal by Subject|0|||
147014649|NCT00889252|530214659|FG000|Overall Study|Adverse Event|2|||
147014650|NCT00889252|530214660|FG001|Overall Study|Adverse Event|4|||
147014651|NCT00889252|530214659|FG000|Overall Study|Withdrawal by Subject|3|||
147014652|NCT00889252|530214660|FG001|Overall Study|Withdrawal by Subject|0|||
147014653|NCT00889252|530214659|FG000|Overall Study|Protocol Violation|2|||
147014654|NCT00889252|530214660|FG001|Overall Study|Protocol Violation|0|||
147014655|NCT04203667|530214667|FG000|Overall Study|Withdrawal by Subject|1|||
147014656|NCT04203667|530214667|FG000|Overall Study|Lost to Follow-up|1|||
147014657|NCT04203667|530214667|FG000|Overall Study|Death|1|||
147014658|NCT04203667|530214667|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
147014659|NCT01833169|530214671|FG000|Overall Study|Disease Progression|99|||
147014660|NCT01833169|530214671|FG000|Overall Study|Adverse Event|33|||
147014661|NCT01833169|530214671|FG000|Overall Study|Withdrawal by Subject|9|||
147014662|NCT01833169|530214671|FG000|Overall Study|Death|3|||
147014663|NCT01833169|530214671|FG000|Overall Study|Physician Decision|2|||
147014664|NCT01183884|530214672|FG000|Overall Study|Progressive Disease|26|||
147014665|NCT01183884|530214672|FG000|Overall Study|Adverse Event|3|||
147014666|NCT01183884|530214672|FG000|Overall Study|Withdrawal by Subject|1|||
147014667|NCT01183884|530214672|FG000|Overall Study|Other Complicating Disease|3|||
147014668|NCT01183884|530214672|FG000|Overall Study|Not Treated|1|||
147014669|NCT01183884|530214672|FG000|Overall Study|Other|4|||
147014670|NCT04718129|530214677|FG000|Overall Study|Lost to Follow-up|6|||
147014671|NCT04718129|530214678|FG001|Overall Study|Lost to Follow-up|7|||
147014672|NCT02212457|530214679|FG000|Overall Study|Adverse Event|1|||
147014673|NCT02212457|530214680|FG001|Overall Study|Adverse Event|2|||
147014674|NCT02212457|530214681|FG002|Overall Study|Adverse Event|2|||
147014675|NCT02212457|530214682|FG003|Overall Study|Adverse Event|2|||
147014676|NCT02212457|530214683|FG004|Overall Study|Adverse Event|0|||
147014677|NCT02212457|530214684|FG005|Overall Study|Adverse Event|1|||
147014678|NCT02212457|530214679|FG000|Overall Study|Withdrawal by Subject|8|||
147014679|NCT02212457|530214680|FG001|Overall Study|Withdrawal by Subject|10|||
147014680|NCT02212457|530214681|FG002|Overall Study|Withdrawal by Subject|8|||
147014681|NCT02212457|530214682|FG003|Overall Study|Withdrawal by Subject|6|||
147014682|NCT02212457|530214683|FG004|Overall Study|Withdrawal by Subject|5|||
147014683|NCT02212457|530214684|FG005|Overall Study|Withdrawal by Subject|4|||
147014684|NCT02212457|530214679|FG000|Overall Study|Lost to Follow-up|6|||
147014685|NCT02212457|530214680|FG001|Overall Study|Lost to Follow-up|7|||
147014686|NCT02212457|530214681|FG002|Overall Study|Lost to Follow-up|4|||
147014687|NCT02212457|530214682|FG003|Overall Study|Lost to Follow-up|1|||
147014688|NCT02212457|530214683|FG004|Overall Study|Lost to Follow-up|8|||
147014689|NCT02212457|530214684|FG005|Overall Study|Lost to Follow-up|4|||
146848904|NCT00700427|529616993|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
146848905|NCT00700427|529616994|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
146848906|NCT00700427|529616995|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
146848907|NCT00700427|529616996|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
146848908|NCT00700427|529616992|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
146848909|NCT00700427|529616993|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
146848910|NCT00700427|529616994|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
146848911|NCT00700427|529616995|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
146848912|NCT00700427|529616996|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
146848913|NCT00700427|529616992|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
146848914|NCT00700427|529616993|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
146848915|NCT00700427|529616994|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
146848916|NCT00700427|529616995|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
146848917|NCT00700427|529616996|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
146848918|NCT00700427|529616992|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
146848919|NCT00700427|529616993|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
146848920|NCT00700427|529616994|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
146848921|NCT00700427|529616995|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
146848922|NCT00700427|529616996|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
146848923|NCT00700427|529616992|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
146848924|NCT00700427|529616993|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
146848925|NCT00700427|529616994|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
146848926|NCT00700427|529616995|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
146848927|NCT00700427|529616996|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
146848928|NCT00700427|529616992|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
146848929|NCT00700427|529616993|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
146848930|NCT00700427|529616994|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
146848931|NCT00700427|529616995|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
146848932|NCT00700427|529616996|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
146848933|NCT00700427|529616992|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
146848934|NCT00700427|529616993|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
146848935|NCT00700427|529616994|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
147014690|NCT02212457|530214679|FG000|Overall Study|Protocol Violation|2|||
147014691|NCT02212457|530214680|FG001|Overall Study|Protocol Violation|1|||
147014692|NCT02212457|530214681|FG002|Overall Study|Protocol Violation|0|||
147014693|NCT02212457|530214682|FG003|Overall Study|Protocol Violation|1|||
147014694|NCT02212457|530214683|FG004|Overall Study|Protocol Violation|2|||
147014695|NCT02212457|530214684|FG005|Overall Study|Protocol Violation|3|||
147014696|NCT02212457|530214679|FG000|Overall Study|Other|2|||
147014697|NCT02212457|530214680|FG001|Overall Study|Other|1|||
147014698|NCT02212457|530214681|FG002|Overall Study|Other|2|||
147014699|NCT02212457|530214682|FG003|Overall Study|Other|1|||
147014700|NCT02212457|530214683|FG004|Overall Study|Other|0|||
147014701|NCT02212457|530214684|FG005|Overall Study|Other|1|||
147014702|NCT00420095|530214686|FG000|Overall Study|Adverse Event|1|||
147014703|NCT00420095|530214687|FG001|Overall Study|Adverse Event|0|||
147014704|NCT00420095|530214686|FG000|Overall Study|Protocol Violation|1|||
147014705|NCT00420095|530214687|FG001|Overall Study|Protocol Violation|1|||
147014706|NCT00420095|530214686|FG000|Overall Study|Lost to Follow-up|1|||
147014707|NCT00420095|530214687|FG001|Overall Study|Lost to Follow-up|0|||
147014708|NCT00393705|530214688|FG000|Overall Study|Adverse Event|0|||
147014709|NCT00393705|530214689|FG001|Overall Study|Adverse Event|2|||
147014710|NCT00393705|530214688|FG000|Overall Study|Death|0|||
147014711|NCT00393705|530214689|FG001|Overall Study|Death|1|||
147014712|NCT00393705|530214688|FG000|Overall Study|Lost to Follow-up|2|||
147014713|NCT00393705|530214689|FG001|Overall Study|Lost to Follow-up|2|||
147014714|NCT00393705|530214688|FG000|Overall Study|Entry Criteria Not Met|10|||
147014715|NCT00393705|530214689|FG001|Overall Study|Entry Criteria Not Met|10|||
147014716|NCT00393705|530214688|FG000|Overall Study|Protocol Violation|4|||
147014717|NCT00393705|530214689|FG001|Overall Study|Protocol Violation|3|||
147014718|NCT00393705|530214688|FG000|Overall Study|Withdrawal by Subject|5|||
147014719|NCT00393705|530214689|FG001|Overall Study|Withdrawal by Subject|3|||
147014720|NCT00393705|530214688|FG000|Overall Study|Physician Decision|2|||
147014721|NCT00393705|530214689|FG001|Overall Study|Physician Decision|2|||
147014722|NCT00642811|530214692|FG000|Overall Study|Adverse Event|2|||
147014723|NCT00642811|530214693|FG001|Overall Study|Adverse Event|3|||
147014724|NCT00642811|530214694|FG002|Overall Study|Adverse Event|0|||
147014725|NCT00642811|530214695|FG003|Overall Study|Adverse Event|0|||
147014726|NCT00642811|530214696|FG004|Overall Study|Adverse Event|0|||
147014727|NCT00642811|530214697|FG005|Overall Study|Adverse Event|1|||
147014728|NCT00642811|530214692|FG000|Overall Study|Developement of discontinuation criteria|0|||
147014729|NCT00642811|530214693|FG001|Overall Study|Developement of discontinuation criteria|0|||
147014730|NCT00642811|530214694|FG002|Overall Study|Developement of discontinuation criteria|0|||
147014731|NCT00642811|530214695|FG003|Overall Study|Developement of discontinuation criteria|0|||
147014732|NCT00642811|530214696|FG004|Overall Study|Developement of discontinuation criteria|1|||
147014733|NCT00642811|530214697|FG005|Overall Study|Developement of discontinuation criteria|0|||
147014734|NCT00642811|530214692|FG000|Overall Study|Severe Non-compliance to protocol|1|||
147014735|NCT00642811|530214693|FG001|Overall Study|Severe Non-compliance to protocol|0|||
147014736|NCT00642811|530214694|FG002|Overall Study|Severe Non-compliance to protocol|0|||
147014737|NCT00642811|530214695|FG003|Overall Study|Severe Non-compliance to protocol|0|||
147014738|NCT00642811|530214696|FG004|Overall Study|Severe Non-compliance to protocol|0|||
147014739|NCT00642811|530214697|FG005|Overall Study|Severe Non-compliance to protocol|0|||
147014740|NCT00642811|530214692|FG000|Overall Study|Other|0|||
147014741|NCT00642811|530214693|FG001|Overall Study|Other|1|||
147014742|NCT00642811|530214694|FG002|Overall Study|Other|0|||
147014743|NCT00642811|530214695|FG003|Overall Study|Other|1|||
147014744|NCT00642811|530214696|FG004|Overall Study|Other|0|||
147014745|NCT00642811|530214697|FG005|Overall Study|Other|0|||
147014746|NCT01120691|530214698|FG000|Overall Study|Adverse Event|59|||
147014747|NCT01120691|530214699|FG001|Overall Study|Adverse Event|67|||
147014748|NCT01120691|530214700|FG002|Overall Study|Adverse Event|47|||
147014749|NCT01120691|530214698|FG000|Overall Study|Subject withdrew consent|33|||
147014750|NCT01120691|530214699|FG001|Overall Study|Subject withdrew consent|50|||
147014751|NCT01120691|530214700|FG002|Overall Study|Subject withdrew consent|44|||
147014752|NCT01120691|530214698|FG000|Overall Study|Death|21|||
147014753|NCT01120691|530214699|FG001|Overall Study|Death|22|||
147014754|NCT01120691|530214700|FG002|Overall Study|Death|24|||
147014755|NCT01120691|530214698|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
147014756|NCT01120691|530214699|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
147014757|NCT01120691|530214700|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
147014758|NCT01120691|530214698|FG000|Overall Study|Administrative problems|15|||
147014759|NCT01120691|530214699|FG001|Overall Study|Administrative problems|8|||
147014760|NCT01120691|530214700|FG002|Overall Study|Administrative problems|9|||
147014761|NCT01120691|530214698|FG000|Overall Study|Protocol deviation|13|||
147014762|NCT01120691|530214699|FG001|Overall Study|Protocol deviation|12|||
147014763|NCT01120691|530214700|FG002|Overall Study|Protocol deviation|12|||
147014764|NCT01120691|530214698|FG000|Overall Study|Lost to Follow-up|5|||
147014765|NCT01120691|530214699|FG001|Overall Study|Lost to Follow-up|6|||
147014766|NCT01120691|530214700|FG002|Overall Study|Lost to Follow-up|4|||
147014767|NCT01120691|530214698|FG000|Overall Study|Abnormal test procedure result(s)|3|||
147014768|NCT01120691|530214699|FG001|Overall Study|Abnormal test procedure result(s)|2|||
147014769|NCT01120691|530214700|FG002|Overall Study|Abnormal test procedure result(s)|1|||
147014770|NCT01120691|530214698|FG000|Overall Study|Patient's inability to use the device|3|||
147014771|NCT01120691|530214699|FG001|Overall Study|Patient's inability to use the device|1|||
147014772|NCT01120691|530214700|FG002|Overall Study|Patient's inability to use the device|0|||
147014773|NCT01120691|530214698|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147014774|NCT01120691|530214699|FG001|Overall Study|Abnormal laboratory value(s)|3|||
147014775|NCT01120691|530214700|FG002|Overall Study|Abnormal laboratory value(s)|4|||
147014776|NCT04553406|530214703|FG000|Overall Study|Study Discontinuation|0|||
147014777|NCT04553406|530214704|FG001|Overall Study|Study Discontinuation|1|||
147014778|NCT00772148|530214705|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
147014779|NCT00772148|530214706|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
147014780|NCT00772148|530214705|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
147014781|NCT00772148|530214706|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
147014782|NCT00772148|530214705|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
147014783|NCT00772148|530214706|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
147014784|NCT00772148|530214705|FG000|Maintenance Phase (Week 52)|Death|2|||
147014785|NCT00772148|530214706|FG001|Maintenance Phase (Week 52)|Death|2|||
147014786|NCT00772148|530214705|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
147014787|NCT00772148|530214706|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
147014788|NCT00772148|530214705|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
147014789|NCT00772148|530214706|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
147014790|NCT00772148|530214705|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
147014791|NCT00772148|530214706|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
147014792|NCT01525628|530214709|FG000|Overall Study|Adverse Event|1|||
147014793|NCT01525628|530214710|FG001|Overall Study|Adverse Event|1|||
147014794|NCT01525628|530214711|FG002|Overall Study|Adverse Event|2|||
147014795|NCT01525628|530214712|FG003|Overall Study|Adverse Event|0|||
147014796|NCT01525628|530214713|FG004|Overall Study|Adverse Event|1|||
147014797|NCT01525628|530214709|FG000|Overall Study|Lack of Efficacy|0|||
147014798|NCT01525628|530214710|FG001|Overall Study|Lack of Efficacy|2|||
147014799|NCT01525628|530214711|FG002|Overall Study|Lack of Efficacy|2|||
147014800|NCT01525628|530214712|FG003|Overall Study|Lack of Efficacy|1|||
147014801|NCT01525628|530214713|FG004|Overall Study|Lack of Efficacy|2|||
147014802|NCT01525628|530214709|FG000|Overall Study|Protocol Violation|0|||
147014803|NCT01525628|530214710|FG001|Overall Study|Protocol Violation|0|||
147014804|NCT01525628|530214711|FG002|Overall Study|Protocol Violation|1|||
147014805|NCT01525628|530214712|FG003|Overall Study|Protocol Violation|0|||
147014806|NCT01525628|530214713|FG004|Overall Study|Protocol Violation|0|||
147014807|NCT01525628|530214709|FG000|Overall Study|Lost to Follow-up|1|||
147014808|NCT01525628|530214710|FG001|Overall Study|Lost to Follow-up|1|||
147014809|NCT01525628|530214711|FG002|Overall Study|Lost to Follow-up|0|||
147014810|NCT01525628|530214712|FG003|Overall Study|Lost to Follow-up|0|||
147014811|NCT01525628|530214713|FG004|Overall Study|Lost to Follow-up|0|||
147014812|NCT01525628|530214709|FG000|Overall Study|Withdrawal by Subject|0|||
147014813|NCT01525628|530214710|FG001|Overall Study|Withdrawal by Subject|1|||
147014814|NCT01525628|530214711|FG002|Overall Study|Withdrawal by Subject|0|||
147014815|NCT01525628|530214712|FG003|Overall Study|Withdrawal by Subject|0|||
147014816|NCT01525628|530214713|FG004|Overall Study|Withdrawal by Subject|0|||
147014817|NCT01525628|530214709|FG000|Overall Study|Other reason not defined above|0|||
147014818|NCT01525628|530214710|FG001|Overall Study|Other reason not defined above|0|||
147014819|NCT01525628|530214711|FG002|Overall Study|Other reason not defined above|0|||
147014820|NCT01525628|530214712|FG003|Overall Study|Other reason not defined above|3|||
147014821|NCT01525628|530214713|FG004|Overall Study|Other reason not defined above|0|||
147014822|NCT03573336|530214714|FG000|Overall Study|Study terminated|2|||
147014823|NCT03573336|530214715|FG001|Overall Study|Study terminated|4|||
147014824|NCT03573336|530214716|FG002|Overall Study|Study terminated|2|||
147014825|NCT03108820|530214717|FG000|Overall Study|Lost to Follow-up|30|||
147014826|NCT03108820|530214718|FG001|Overall Study|Lost to Follow-up|28|||
147014827|NCT03108820|530214717|FG000|Overall Study|Withdrawal by Subject|32|||
147014828|NCT03108820|530214718|FG001|Overall Study|Withdrawal by Subject|24|||
147014829|NCT03108820|530214717|FG000|Overall Study|Death|6|||
147014830|NCT03108820|530214718|FG001|Overall Study|Death|11|||
147014831|NCT00787605|530214719|FG000|Overall Study|Administrative Problems|3|||
147014832|NCT00787605|530214720|FG001|Overall Study|Administrative Problems|0|||
147014833|NCT00787605|530214719|FG000|Overall Study|Adverse Event|14|||
147014834|NCT00787605|530214720|FG001|Overall Study|Adverse Event|25|||
147014835|NCT00787605|530214719|FG000|Overall Study|Lost to Follow-up|3|||
147014836|NCT00787605|530214720|FG001|Overall Study|Lost to Follow-up|6|||
147014837|NCT00787605|530214719|FG000|Overall Study|Protocol Violation|7|||
147014838|NCT00787605|530214720|FG001|Overall Study|Protocol Violation|3|||
147014839|NCT00787605|530214719|FG000|Overall Study|Withdrawal by Subject|6|||
147014840|NCT00787605|530214720|FG001|Overall Study|Withdrawal by Subject|13|||
147014841|NCT00787605|530214719|FG000|Overall Study|Lack of Efficacy|13|||
147014842|NCT00787605|530214720|FG001|Overall Study|Lack of Efficacy|9|||
147014843|NCT00089973|530214728|FG000|Overall Study|Adverse Event|3|||
147014844|NCT00089973|530214728|FG000|Overall Study|Withdrawal by Subject|1|||
147014845|NCT00089973|530214728|FG000|Overall Study|Disease progression|45|||
147014846|NCT00089973|530214728|FG000|Overall Study|Death|1|||
147014847|NCT01223027|530214729|FG000|Overall Study|Adverse Event|20|||
147014848|NCT01223027|530214730|FG001|Overall Study|Adverse Event|10|||
146736516|NCT05375955|529206892|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
147014849|NCT01223027|530214729|FG000|Overall Study|Death|42|||
147014850|NCT01223027|530214730|FG001|Overall Study|Death|42|||
147014851|NCT01223027|530214729|FG000|Overall Study|Lost to Follow-up|2|||
147014852|NCT01223027|530214730|FG001|Overall Study|Lost to Follow-up|1|||
147014853|NCT01223027|530214729|FG000|Overall Study|Physician Decision|4|||
147014854|NCT01223027|530214730|FG001|Overall Study|Physician Decision|8|||
147014855|NCT01223027|530214729|FG000|Overall Study|Progressive Disease|167|||
147014856|NCT01223027|530214730|FG001|Overall Study|Progressive Disease|183|||
147014857|NCT01223027|530214729|FG000|Overall Study|Protocol Violation|2|||
147014858|NCT01223027|530214730|FG001|Overall Study|Protocol Violation|1|||
147014859|NCT01223027|530214729|FG000|Overall Study|Subject/guardian decicion|18|||
147014860|NCT01223027|530214730|FG001|Overall Study|Subject/guardian decicion|16|||
147014861|NCT01223027|530214729|FG000|Overall Study|New therapy for study indication|17|||
147014862|NCT01223027|530214730|FG001|Overall Study|New therapy for study indication|8|||
147014863|NCT01223027|530214729|FG000|Overall Study|Study terminated by sponsor|2|||
147014864|NCT01223027|530214730|FG001|Overall Study|Study terminated by sponsor|8|||
147014865|NCT00651183|530216691|FG000|Overall Study|Lack of Efficacy|1|||
147014866|NCT00651183|530216692|FG001|Overall Study|Lack of Efficacy|0|||
147014867|NCT00651183|530216691|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
147014868|NCT00651183|530216692|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
147014869|NCT00651183|530216691|FG000|Overall Study|Tolerability insufficient|5|||
147014870|NCT00651183|530216692|FG001|Overall Study|Tolerability insufficient|2|||
147014871|NCT00651183|530216691|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
147014872|NCT00651183|530216692|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
147014873|NCT00651183|530216691|FG000|Overall Study|Withdrawal by Subject|6|||
147014874|NCT00651183|530216692|FG001|Overall Study|Withdrawal by Subject|3|||
147014875|NCT00651183|530216691|FG000|Overall Study|Lost to Follow-up|3|||
147014876|NCT00651183|530216692|FG001|Overall Study|Lost to Follow-up|1|||
147014877|NCT00651183|530216691|FG000|Overall Study|Other reasons|4|||
147014878|NCT00651183|530216692|FG001|Overall Study|Other reasons|2|||
147014879|NCT00651183|530216691|FG000|Overall Study|missing|1|||
147014880|NCT00651183|530216692|FG001|Overall Study|missing|0|||
147014881|NCT01190930|530216705|FG000|Induction|Adverse Event|17|||
147014882|NCT01190930|530216706|FG001|Induction|Adverse Event|0|||
147014883|NCT01190930|530216707|FG002|Induction|Adverse Event|0|||
147014884|NCT01190930|530216708|FG003|Induction|Adverse Event|0|||
147014885|NCT01190930|530216709|FG004|Induction|Adverse Event|0|||
147014886|NCT01190930|530216710|FG005|Induction|Adverse Event|0|||
147014887|NCT01190930|530216711|FG006|Induction|Adverse Event|0|||
147014888|NCT01190930|530216712|FG007|Induction|Adverse Event|0|||
147014889|NCT01190930|530216713|FG008|Induction|Adverse Event|0|||
147014890|NCT01190930|530216714|FG009|Induction|Adverse Event|0|||
147014891|NCT01190930|530216705|FG000|Induction|Death|34|||
147014892|NCT01190930|530216706|FG001|Induction|Death|0|||
147014893|NCT01190930|530216707|FG002|Induction|Death|0|||
147014894|NCT01190930|530216708|FG003|Induction|Death|0|||
147014895|NCT01190930|530216709|FG004|Induction|Death|0|||
147014896|NCT01190930|530216710|FG005|Induction|Death|0|||
147014897|NCT01190930|530216711|FG006|Induction|Death|0|||
147014898|NCT01190930|530216712|FG007|Induction|Death|0|||
147014899|NCT01190930|530216713|FG008|Induction|Death|0|||
147014900|NCT01190930|530216714|FG009|Induction|Death|0|||
147014901|NCT01190930|530216705|FG000|Induction|Lost to Follow-up|1|||
147014902|NCT01190930|530216706|FG001|Induction|Lost to Follow-up|0|||
147014903|NCT01190930|530216707|FG002|Induction|Lost to Follow-up|0|||
147014904|NCT01190930|530216708|FG003|Induction|Lost to Follow-up|0|||
147014905|NCT01190930|530216709|FG004|Induction|Lost to Follow-up|0|||
147014906|NCT01190930|530216710|FG005|Induction|Lost to Follow-up|0|||
147014907|NCT01190930|530216711|FG006|Induction|Lost to Follow-up|0|||
147014908|NCT01190930|530216712|FG007|Induction|Lost to Follow-up|0|||
147014909|NCT01190930|530216713|FG008|Induction|Lost to Follow-up|0|||
146848936|NCT00700427|529616995|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
146848937|NCT00700427|529616996|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
147014910|NCT01190930|530216714|FG009|Induction|Lost to Follow-up|0|||
147014911|NCT01190930|530216705|FG000|Induction|Physician Decision|125|||
147014912|NCT01190930|530216706|FG001|Induction|Physician Decision|3|||
147014913|NCT01190930|530216707|FG002|Induction|Physician Decision|0|||
147014914|NCT01190930|530216708|FG003|Induction|Physician Decision|0|||
147014915|NCT01190930|530216709|FG004|Induction|Physician Decision|0|||
147014916|NCT01190930|530216710|FG005|Induction|Physician Decision|0|||
147014917|NCT01190930|530216711|FG006|Induction|Physician Decision|0|||
147014918|NCT01190930|530216712|FG007|Induction|Physician Decision|0|||
147014919|NCT01190930|530216713|FG008|Induction|Physician Decision|0|||
147014920|NCT01190930|530216714|FG009|Induction|Physician Decision|0|||
147014921|NCT01190930|530216705|FG000|Induction|Withdrawal by Subject|9|||
147014922|NCT01190930|530216706|FG001|Induction|Withdrawal by Subject|0|||
147014923|NCT01190930|530216707|FG002|Induction|Withdrawal by Subject|0|||
147014924|NCT01190930|530216708|FG003|Induction|Withdrawal by Subject|0|||
147014925|NCT01190930|530216709|FG004|Induction|Withdrawal by Subject|0|||
147014926|NCT01190930|530216710|FG005|Induction|Withdrawal by Subject|0|||
147014927|NCT01190930|530216711|FG006|Induction|Withdrawal by Subject|0|||
147014928|NCT01190930|530216712|FG007|Induction|Withdrawal by Subject|0|||
147014929|NCT01190930|530216713|FG008|Induction|Withdrawal by Subject|0|||
147014930|NCT01190930|530216714|FG009|Induction|Withdrawal by Subject|0|||
147014931|NCT01190930|530216705|FG000|Induction|Refusal|235|||
147014932|NCT01190930|530216706|FG001|Induction|Refusal|0|||
147014933|NCT01190930|530216707|FG002|Induction|Refusal|0|||
147014934|NCT01190930|530216708|FG003|Induction|Refusal|0|||
147014935|NCT01190930|530216709|FG004|Induction|Refusal|0|||
147014936|NCT01190930|530216710|FG005|Induction|Refusal|0|||
147014937|NCT01190930|530216711|FG006|Induction|Refusal|0|||
147014938|NCT01190930|530216712|FG007|Induction|Refusal|0|||
147014939|NCT01190930|530216713|FG008|Induction|Refusal|0|||
147014940|NCT01190930|530216714|FG009|Induction|Refusal|0|||
147014941|NCT01190930|530216705|FG000|Induction|Inevaluable|23|||
147014942|NCT01190930|530216706|FG001|Induction|Inevaluable|1|||
147014943|NCT01190930|530216707|FG002|Induction|Inevaluable|0|||
147014944|NCT01190930|530216708|FG003|Induction|Inevaluable|0|||
147014945|NCT01190930|530216709|FG004|Induction|Inevaluable|0|||
147014946|NCT01190930|530216710|FG005|Induction|Inevaluable|0|||
147014947|NCT01190930|530216711|FG006|Induction|Inevaluable|0|||
147014948|NCT01190930|530216712|FG007|Induction|Inevaluable|0|||
147014949|NCT01190930|530216713|FG008|Induction|Inevaluable|0|||
147014950|NCT01190930|530216714|FG009|Induction|Inevaluable|0|||
147014951|NCT01190930|530216705|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
147014952|NCT01190930|530216706|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147014953|NCT01190930|530216707|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147014954|NCT01190930|530216708|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147014955|NCT01190930|530216709|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147014956|NCT01190930|530216710|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147014957|NCT01190930|530216711|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147014958|NCT01190930|530216712|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147014959|NCT01190930|530216713|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147014960|NCT01190930|530216714|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147014961|NCT01190930|530216705|FG000|Induction|High Risk Downs|80|||
147014962|NCT01190930|530216706|FG001|Induction|High Risk Downs|0|||
147014963|NCT01190930|530216707|FG002|Induction|High Risk Downs|0|||
147014964|NCT01190930|530216708|FG003|Induction|High Risk Downs|0|||
147014965|NCT01190930|530216709|FG004|Induction|High Risk Downs|0|||
147014966|NCT01190930|530216710|FG005|Induction|High Risk Downs|0|||
147014967|NCT01190930|530216711|FG006|Induction|High Risk Downs|0|||
147014968|NCT01190930|530216712|FG007|Induction|High Risk Downs|0|||
147014969|NCT01190930|530216713|FG008|Induction|High Risk Downs|0|||
147014970|NCT01190930|530216714|FG009|Induction|High Risk Downs|0|||
147014971|NCT01190930|530216705|FG000|Induction|Enrollment onto another COG Protocol|1|||
147014972|NCT01190930|530216706|FG001|Induction|Enrollment onto another COG Protocol|0|||
147014973|NCT01190930|530216707|FG002|Induction|Enrollment onto another COG Protocol|0|||
147014974|NCT01190930|530216708|FG003|Induction|Enrollment onto another COG Protocol|0|||
147014975|NCT01190930|530216709|FG004|Induction|Enrollment onto another COG Protocol|0|||
147014976|NCT01190930|530216710|FG005|Induction|Enrollment onto another COG Protocol|0|||
147014977|NCT01190930|530216711|FG006|Induction|Enrollment onto another COG Protocol|0|||
147014978|NCT01190930|530216712|FG007|Induction|Enrollment onto another COG Protocol|0|||
147014979|NCT01190930|530216713|FG008|Induction|Enrollment onto another COG Protocol|0|||
147014980|NCT01190930|530216714|FG009|Induction|Enrollment onto another COG Protocol|0|||
147014981|NCT01190930|530216705|FG000|Induction|Average Risk|1847|||
147014982|NCT01190930|530216706|FG001|Induction|Average Risk|0|||
147014983|NCT01190930|530216707|FG002|Induction|Average Risk|0|||
147014984|NCT01190930|530216708|FG003|Induction|Average Risk|0|||
147014985|NCT01190930|530216709|FG004|Induction|Average Risk|0|||
147014986|NCT01190930|530216710|FG005|Induction|Average Risk|0|||
147014987|NCT01190930|530216711|FG006|Induction|Average Risk|0|||
147014988|NCT01190930|530216712|FG007|Induction|Average Risk|0|||
147014989|NCT01190930|530216713|FG008|Induction|Average Risk|0|||
147014990|NCT01190930|530216714|FG009|Induction|Average Risk|0|||
147014991|NCT01190930|530216705|FG000|Induction|High Risk|1227|||
147014992|NCT01190930|530216706|FG001|Induction|High Risk|0|||
147014993|NCT01190930|530216707|FG002|Induction|High Risk|0|||
147014994|NCT01190930|530216708|FG003|Induction|High Risk|0|||
147014995|NCT01190930|530216709|FG004|Induction|High Risk|0|||
147014996|NCT01190930|530216710|FG005|Induction|High Risk|0|||
147014997|NCT01190930|530216711|FG006|Induction|High Risk|0|||
147014998|NCT01190930|530216712|FG007|Induction|High Risk|0|||
147014999|NCT01190930|530216713|FG008|Induction|High Risk|0|||
147015000|NCT01190930|530216714|FG009|Induction|High Risk|0|||
147015001|NCT01190930|530216705|FG000|Induction|Low Risk|443|||
147015002|NCT01190930|530216706|FG001|Induction|Low Risk|0|||
147015003|NCT01190930|530216707|FG002|Induction|Low Risk|0|||
147015004|NCT01190930|530216708|FG003|Induction|Low Risk|0|||
147015005|NCT01190930|530216709|FG004|Induction|Low Risk|0|||
147015006|NCT01190930|530216710|FG005|Induction|Low Risk|0|||
147015007|NCT01190930|530216711|FG006|Induction|Low Risk|0|||
147015008|NCT01190930|530216712|FG007|Induction|Low Risk|0|||
147015009|NCT01190930|530216713|FG008|Induction|Low Risk|0|||
147015010|NCT01190930|530216714|FG009|Induction|Low Risk|0|||
147015011|NCT01190930|530216705|FG000|Induction|Very High Risk|1012|||
147015012|NCT01190930|530216706|FG001|Induction|Very High Risk|0|||
147015013|NCT01190930|530216707|FG002|Induction|Very High Risk|0|||
147015014|NCT01190930|530216708|FG003|Induction|Very High Risk|0|||
147015015|NCT01190930|530216709|FG004|Induction|Very High Risk|0|||
147015016|NCT01190930|530216710|FG005|Induction|Very High Risk|0|||
147015017|NCT01190930|530216711|FG006|Induction|Very High Risk|0|||
147015018|NCT01190930|530216712|FG007|Induction|Very High Risk|0|||
147015019|NCT01190930|530216713|FG008|Induction|Very High Risk|0|||
147015020|NCT01190930|530216714|FG009|Induction|Very High Risk|0|||
147015021|NCT01190930|530216705|FG000|Induction|Philadelphia chromosome-positive|99|||
147015022|NCT01190930|530216706|FG001|Induction|Philadelphia chromosome-positive|0|||
147015023|NCT01190930|530216707|FG002|Induction|Philadelphia chromosome-positive|0|||
147015024|NCT01190930|530216708|FG003|Induction|Philadelphia chromosome-positive|0|||
147015025|NCT01190930|530216709|FG004|Induction|Philadelphia chromosome-positive|0|||
147015026|NCT01190930|530216710|FG005|Induction|Philadelphia chromosome-positive|0|||
147015027|NCT01190930|530216711|FG006|Induction|Philadelphia chromosome-positive|0|||
147015028|NCT01190930|530216712|FG007|Induction|Philadelphia chromosome-positive|0|||
147015029|NCT01190930|530216713|FG008|Induction|Philadelphia chromosome-positive|0|||
147015030|NCT01190930|530216714|FG009|Induction|Philadelphia chromosome-positive|0|||
147015031|NCT01190930|530216705|FG000|Induction|Incomplete Induction data|63|||
147015032|NCT01190930|530216706|FG001|Induction|Incomplete Induction data|0|||
147015033|NCT01190930|530216707|FG002|Induction|Incomplete Induction data|0|||
147015034|NCT01190930|530216708|FG003|Induction|Incomplete Induction data|0|||
147015035|NCT01190930|530216709|FG004|Induction|Incomplete Induction data|0|||
147015036|NCT01190930|530216710|FG005|Induction|Incomplete Induction data|0|||
147015037|NCT01190930|530216711|FG006|Induction|Incomplete Induction data|0|||
147015038|NCT01190930|530216712|FG007|Induction|Incomplete Induction data|0|||
147015039|NCT01190930|530216713|FG008|Induction|Incomplete Induction data|0|||
147015040|NCT01190930|530216714|FG009|Induction|Incomplete Induction data|0|||
147015041|NCT01190930|530216705|FG000|Induction|Progressive disease|0|||
147015042|NCT01190930|530216706|FG001|Induction|Progressive disease|1|||
147015043|NCT01190930|530216707|FG002|Induction|Progressive disease|0|||
147015044|NCT01190930|530216708|FG003|Induction|Progressive disease|0|||
147015045|NCT01190930|530216709|FG004|Induction|Progressive disease|0|||
147015046|NCT01190930|530216710|FG005|Induction|Progressive disease|0|||
147015047|NCT01190930|530216711|FG006|Induction|Progressive disease|0|||
147015048|NCT01190930|530216712|FG007|Induction|Progressive disease|0|||
147015049|NCT01190930|530216713|FG008|Induction|Progressive disease|0|||
147015050|NCT01190930|530216714|FG009|Induction|Progressive disease|0|||
147015051|NCT01190930|530216705|FG000|Induction|No treatment|3|||
147015052|NCT01190930|530216706|FG001|Induction|No treatment|0|||
147015053|NCT01190930|530216707|FG002|Induction|No treatment|0|||
147015054|NCT01190930|530216708|FG003|Induction|No treatment|0|||
147015055|NCT01190930|530216709|FG004|Induction|No treatment|0|||
147015056|NCT01190930|530216710|FG005|Induction|No treatment|0|||
147015057|NCT01190930|530216711|FG006|Induction|No treatment|0|||
147015058|NCT01190930|530216712|FG007|Induction|No treatment|0|||
147015059|NCT01190930|530216713|FG008|Induction|No treatment|0|||
147015060|NCT01190930|530216714|FG009|Induction|No treatment|0|||
147015061|NCT01190930|530216705|FG000|Induction|Ineligible|69|||
147015062|NCT01190930|530216706|FG001|Induction|Ineligible|4|||
147015063|NCT01190930|530216707|FG002|Induction|Ineligible|0|||
147015064|NCT01190930|530216708|FG003|Induction|Ineligible|0|||
147015065|NCT01190930|530216709|FG004|Induction|Ineligible|0|||
147015066|NCT01190930|530216710|FG005|Induction|Ineligible|0|||
147015067|NCT01190930|530216711|FG006|Induction|Ineligible|0|||
147015068|NCT01190930|530216712|FG007|Induction|Ineligible|0|||
147015069|NCT01190930|530216713|FG008|Induction|Ineligible|0|||
147015070|NCT01190930|530216714|FG009|Induction|Ineligible|0|||
147015071|NCT01190930|530216705|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
147015072|NCT01190930|530216706|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
147015073|NCT01190930|530216707|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
147015074|NCT01190930|530216708|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
147015075|NCT01190930|530216709|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
146736517|NCT05375955|529206893|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
146736518|NCT05375955|529206894|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
146736519|NCT05375955|529206888|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
146736520|NCT05375955|529206889|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
146736521|NCT05375955|529206890|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
146736522|NCT05375955|529206891|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
146736523|NCT05375955|529206892|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
146736524|NCT05375955|529206893|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
146736525|NCT05375955|529206894|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
146736526|NCT05375955|529206888|FG000|Follow-up (up to 5 Weeks)|Other|0|||
146736527|NCT05375955|529206889|FG001|Follow-up (up to 5 Weeks)|Other|1|||
146736528|NCT05375955|529206890|FG002|Follow-up (up to 5 Weeks)|Other|0|||
146736529|NCT05375955|529206891|FG003|Follow-up (up to 5 Weeks)|Other|0|||
146736530|NCT05375955|529206892|FG004|Follow-up (up to 5 Weeks)|Other|0|||
146736531|NCT05375955|529206893|FG005|Follow-up (up to 5 Weeks)|Other|0|||
146736532|NCT05375955|529206894|FG006|Follow-up (up to 5 Weeks)|Other|0|||
147015076|NCT01190930|530216710|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
147015077|NCT01190930|530216711|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
147015078|NCT01190930|530216712|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
147015079|NCT01190930|530216713|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
147015080|NCT01190930|530216714|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
147015081|NCT01190930|530216705|FG000|Post Induction Pre-Maintenance|Death|0|||
147015082|NCT01190930|530216706|FG001|Post Induction Pre-Maintenance|Death|0|||
147015083|NCT01190930|530216707|FG002|Post Induction Pre-Maintenance|Death|8|||
147015084|NCT01190930|530216708|FG003|Post Induction Pre-Maintenance|Death|4|||
147015085|NCT01190930|530216709|FG004|Post Induction Pre-Maintenance|Death|0|||
147015086|NCT01190930|530216710|FG005|Post Induction Pre-Maintenance|Death|0|||
147015087|NCT01190930|530216711|FG006|Post Induction Pre-Maintenance|Death|0|||
147015088|NCT01190930|530216712|FG007|Post Induction Pre-Maintenance|Death|0|||
147015089|NCT01190930|530216713|FG008|Post Induction Pre-Maintenance|Death|0|||
147015090|NCT01190930|530216714|FG009|Post Induction Pre-Maintenance|Death|0|||
147015091|NCT01190930|530216705|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
147015092|NCT01190930|530216706|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
147015093|NCT01190930|530216707|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
147015094|NCT01190930|530216708|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
147015095|NCT01190930|530216709|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
147015096|NCT01190930|530216710|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
147015097|NCT01190930|530216711|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
147015098|NCT01190930|530216712|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
147015099|NCT01190930|530216713|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
147015100|NCT01190930|530216714|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
147015101|NCT01190930|530216705|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
147015102|NCT01190930|530216706|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
147015103|NCT01190930|530216707|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
147015104|NCT01190930|530216708|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
147015105|NCT01190930|530216709|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
147015106|NCT01190930|530216710|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
147015107|NCT01190930|530216711|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
147015108|NCT01190930|530216712|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
147015109|NCT01190930|530216713|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
147015110|NCT01190930|530216714|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
147015111|NCT01190930|530216705|FG000|Post Induction Pre-Maintenance|Refusal|0|||
147015112|NCT01190930|530216706|FG001|Post Induction Pre-Maintenance|Refusal|2|||
147015113|NCT01190930|530216707|FG002|Post Induction Pre-Maintenance|Refusal|694|||
147015114|NCT01190930|530216708|FG003|Post Induction Pre-Maintenance|Refusal|4|||
147015115|NCT01190930|530216709|FG004|Post Induction Pre-Maintenance|Refusal|0|||
147015116|NCT01190930|530216710|FG005|Post Induction Pre-Maintenance|Refusal|3|||
147015117|NCT01190930|530216711|FG006|Post Induction Pre-Maintenance|Refusal|0|||
147015118|NCT01190930|530216712|FG007|Post Induction Pre-Maintenance|Refusal|0|||
147015119|NCT01190930|530216713|FG008|Post Induction Pre-Maintenance|Refusal|0|||
147015120|NCT01190930|530216714|FG009|Post Induction Pre-Maintenance|Refusal|0|||
147015121|NCT01190930|530216705|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
147015122|NCT01190930|530216706|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
147015123|NCT01190930|530216707|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
147015124|NCT01190930|530216708|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
147015125|NCT01190930|530216709|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
147015126|NCT01190930|530216710|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
147015127|NCT01190930|530216711|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
147015128|NCT01190930|530216712|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
147015129|NCT01190930|530216713|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
147015130|NCT01190930|530216714|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
147015131|NCT01190930|530216705|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147015132|NCT01190930|530216706|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
147015133|NCT01190930|530216707|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147015134|NCT01190930|530216708|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147015135|NCT01190930|530216709|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147015136|NCT01190930|530216710|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147015137|NCT01190930|530216711|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147015138|NCT01190930|530216712|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147015139|NCT01190930|530216713|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147015140|NCT01190930|530216714|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147015141|NCT01190930|530216705|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
147015142|NCT01190930|530216706|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
147015143|NCT01190930|530216707|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
146848938|NCT00700427|529616992|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
146848939|NCT00700427|529616993|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
146848940|NCT00700427|529616994|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
146848941|NCT00700427|529616995|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
146848942|NCT00700427|529616996|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
146848943|NCT00700427|529616992|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
146848944|NCT00700427|529616993|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
146848945|NCT00700427|529616994|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
146848946|NCT00700427|529616995|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
146848947|NCT00700427|529616996|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
146848948|NCT00700427|529616992|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
146848949|NCT00700427|529616993|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
146848950|NCT00700427|529616994|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
146848951|NCT00700427|529616995|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
146848952|NCT00700427|529616996|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
146848953|NCT00700427|529616992|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
146848954|NCT00700427|529616993|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
146848955|NCT00700427|529616994|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
146848956|NCT00700427|529616995|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
146848957|NCT00700427|529616996|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
146848958|NCT00506441|529617001|FG000|Period 1; Open-label Period|Adverse Event|21|||
146848959|NCT00506441|529617002|FG001|Period 1; Open-label Period|Adverse Event|0|||
146848960|NCT00506441|529617001|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
146848961|NCT00506441|529617002|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
146848962|NCT00506441|529617001|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
146848963|NCT00506441|529617002|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
146848964|NCT00506441|529617001|FG000|Period 1; Open-label Period|Physician Decision|5|||
146848965|NCT00506441|529617002|FG001|Period 1; Open-label Period|Physician Decision|0|||
146848966|NCT00506441|529617001|FG000|Period 1; Open-label Period|Protocol Violation|9|||
146848967|NCT00506441|529617002|FG001|Period 1; Open-label Period|Protocol Violation|0|||
146848968|NCT00506441|529617001|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
146848969|NCT00506441|529617002|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
146848970|NCT00506441|529617001|FG000|Period 1; Open-label Period|Other Reasons|13|||
146848971|NCT00506441|529617002|FG001|Period 1; Open-label Period|Other Reasons|0|||
146848972|NCT00506441|529617001|FG000|Period 2; Double-blind Period|Adverse Event|0|||
146848973|NCT00506441|529617002|FG001|Period 2; Double-blind Period|Adverse Event|1|||
146848974|NCT00506441|529617001|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
146848975|NCT00506441|529617002|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
147015144|NCT01190930|530216708|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
147015145|NCT01190930|530216709|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
147015146|NCT01190930|530216710|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
147015147|NCT01190930|530216711|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
147015148|NCT01190930|530216712|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
147015149|NCT01190930|530216713|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
147015150|NCT01190930|530216714|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
147015151|NCT01190930|530216705|FG000|Post Induction Pre-Maintenance|Relapse|0|||
147015152|NCT01190930|530216706|FG001|Post Induction Pre-Maintenance|Relapse|0|||
147015153|NCT01190930|530216707|FG002|Post Induction Pre-Maintenance|Relapse|1|||
147015154|NCT01190930|530216708|FG003|Post Induction Pre-Maintenance|Relapse|0|||
147015155|NCT01190930|530216709|FG004|Post Induction Pre-Maintenance|Relapse|0|||
147015156|NCT01190930|530216710|FG005|Post Induction Pre-Maintenance|Relapse|0|||
147015157|NCT01190930|530216711|FG006|Post Induction Pre-Maintenance|Relapse|0|||
147015158|NCT01190930|530216712|FG007|Post Induction Pre-Maintenance|Relapse|0|||
147015159|NCT01190930|530216713|FG008|Post Induction Pre-Maintenance|Relapse|0|||
147015160|NCT01190930|530216714|FG009|Post Induction Pre-Maintenance|Relapse|0|||
147015161|NCT01190930|530216705|FG000|Maintenance|Adverse Event|0|||
147015162|NCT01190930|530216706|FG001|Maintenance|Adverse Event|0|||
147015163|NCT01190930|530216707|FG002|Maintenance|Adverse Event|0|||
147015164|NCT01190930|530216708|FG003|Maintenance|Adverse Event|0|||
147015165|NCT01190930|530216709|FG004|Maintenance|Adverse Event|0|||
147015166|NCT01190930|530216710|FG005|Maintenance|Adverse Event|1|||
147015167|NCT01190930|530216711|FG006|Maintenance|Adverse Event|1|||
147015168|NCT01190930|530216712|FG007|Maintenance|Adverse Event|3|||
147015169|NCT01190930|530216713|FG008|Maintenance|Adverse Event|3|||
147015170|NCT01190930|530216714|FG009|Maintenance|Adverse Event|0|||
147015171|NCT01190930|530216705|FG000|Maintenance|Death|0|||
147015172|NCT01190930|530216706|FG001|Maintenance|Death|0|||
147015173|NCT01190930|530216707|FG002|Maintenance|Death|0|||
147015174|NCT01190930|530216708|FG003|Maintenance|Death|1|||
147015175|NCT01190930|530216709|FG004|Maintenance|Death|0|||
147015176|NCT01190930|530216710|FG005|Maintenance|Death|0|||
147015177|NCT01190930|530216711|FG006|Maintenance|Death|2|||
147015178|NCT01190930|530216712|FG007|Maintenance|Death|2|||
147015179|NCT01190930|530216713|FG008|Maintenance|Death|2|||
147015180|NCT01190930|530216714|FG009|Maintenance|Death|2|||
147015181|NCT01190930|530216705|FG000|Maintenance|Lost to Follow-up|0|||
147015182|NCT01190930|530216706|FG001|Maintenance|Lost to Follow-up|0|||
147015183|NCT01190930|530216707|FG002|Maintenance|Lost to Follow-up|0|||
147015184|NCT01190930|530216708|FG003|Maintenance|Lost to Follow-up|0|||
147015185|NCT01190930|530216709|FG004|Maintenance|Lost to Follow-up|0|||
147015186|NCT01190930|530216710|FG005|Maintenance|Lost to Follow-up|0|||
147015187|NCT01190930|530216711|FG006|Maintenance|Lost to Follow-up|1|||
147015188|NCT01190930|530216712|FG007|Maintenance|Lost to Follow-up|1|||
147015189|NCT01190930|530216713|FG008|Maintenance|Lost to Follow-up|1|||
147015190|NCT01190930|530216714|FG009|Maintenance|Lost to Follow-up|0|||
147015191|NCT01190930|530216705|FG000|Maintenance|Physician Decision|0|||
147015192|NCT01190930|530216706|FG001|Maintenance|Physician Decision|1|||
147015193|NCT01190930|530216707|FG002|Maintenance|Physician Decision|0|||
147015194|NCT01190930|530216708|FG003|Maintenance|Physician Decision|5|||
147015195|NCT01190930|530216709|FG004|Maintenance|Physician Decision|9|||
147015196|NCT01190930|530216710|FG005|Maintenance|Physician Decision|4|||
147015197|NCT01190930|530216711|FG006|Maintenance|Physician Decision|8|||
147015198|NCT01190930|530216712|FG007|Maintenance|Physician Decision|8|||
147015199|NCT01190930|530216713|FG008|Maintenance|Physician Decision|10|||
147015200|NCT01190930|530216714|FG009|Maintenance|Physician Decision|17|||
147015201|NCT01190930|530216705|FG000|Maintenance|Withdrawal by Subject|0|||
147015202|NCT01190930|530216706|FG001|Maintenance|Withdrawal by Subject|0|||
147015203|NCT01190930|530216707|FG002|Maintenance|Withdrawal by Subject|0|||
147015204|NCT01190930|530216708|FG003|Maintenance|Withdrawal by Subject|0|||
147015205|NCT01190930|530216709|FG004|Maintenance|Withdrawal by Subject|0|||
147015206|NCT01190930|530216710|FG005|Maintenance|Withdrawal by Subject|0|||
147015207|NCT01190930|530216711|FG006|Maintenance|Withdrawal by Subject|2|||
147015208|NCT01190930|530216712|FG007|Maintenance|Withdrawal by Subject|1|||
147015209|NCT01190930|530216713|FG008|Maintenance|Withdrawal by Subject|4|||
147015210|NCT01190930|530216714|FG009|Maintenance|Withdrawal by Subject|1|||
147015211|NCT01190930|530216705|FG000|Maintenance|Refusal|0|||
147015212|NCT01190930|530216706|FG001|Maintenance|Refusal|1|||
147015213|NCT01190930|530216707|FG002|Maintenance|Refusal|0|||
147015214|NCT01190930|530216708|FG003|Maintenance|Refusal|2|||
147015215|NCT01190930|530216709|FG004|Maintenance|Refusal|0|||
147015216|NCT01190930|530216710|FG005|Maintenance|Refusal|4|||
147015217|NCT01190930|530216711|FG006|Maintenance|Refusal|5|||
147015218|NCT01190930|530216712|FG007|Maintenance|Refusal|17|||
147015219|NCT01190930|530216713|FG008|Maintenance|Refusal|13|||
147015220|NCT01190930|530216714|FG009|Maintenance|Refusal|6|||
147015221|NCT01190930|530216705|FG000|Maintenance|second malignant neoplasm|0|||
147015222|NCT01190930|530216706|FG001|Maintenance|second malignant neoplasm|0|||
147015223|NCT01190930|530216707|FG002|Maintenance|second malignant neoplasm|0|||
147015224|NCT01190930|530216708|FG003|Maintenance|second malignant neoplasm|1|||
147015225|NCT01190930|530216709|FG004|Maintenance|second malignant neoplasm|0|||
147015226|NCT01190930|530216710|FG005|Maintenance|second malignant neoplasm|1|||
147015227|NCT01190930|530216711|FG006|Maintenance|second malignant neoplasm|0|||
147015228|NCT01190930|530216712|FG007|Maintenance|second malignant neoplasm|0|||
146848976|NCT00506441|529617001|FG000|Period 2; Double-blind Period|Physician Decision|1|||
146848977|NCT00506441|529617002|FG001|Period 2; Double-blind Period|Physician Decision|1|||
146848978|NCT00506441|529617001|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
146848979|NCT00506441|529617002|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
146848980|NCT00506441|529617001|FG000|Period 2; Double-blind Period|Other Reason|1|||
146848981|NCT00506441|529617002|FG001|Period 2; Double-blind Period|Other Reason|1|||
147015229|NCT01190930|530216713|FG008|Maintenance|second malignant neoplasm|1|||
147015230|NCT01190930|530216714|FG009|Maintenance|second malignant neoplasm|0|||
147015231|NCT01190930|530216705|FG000|Maintenance|Inevaluable|0|||
147015232|NCT01190930|530216706|FG001|Maintenance|Inevaluable|0|||
147015233|NCT01190930|530216707|FG002|Maintenance|Inevaluable|0|||
147015234|NCT01190930|530216708|FG003|Maintenance|Inevaluable|0|||
147015235|NCT01190930|530216709|FG004|Maintenance|Inevaluable|0|||
147015236|NCT01190930|530216710|FG005|Maintenance|Inevaluable|1|||
147015237|NCT01190930|530216711|FG006|Maintenance|Inevaluable|1|||
147015238|NCT01190930|530216712|FG007|Maintenance|Inevaluable|1|||
147015239|NCT01190930|530216713|FG008|Maintenance|Inevaluable|0|||
147015240|NCT01190930|530216714|FG009|Maintenance|Inevaluable|0|||
146848982|NCT01151410|529617004|FG000|Overall Study|Withdrawal by Subject|3|||
146848983|NCT01151410|529617005|FG001|Overall Study|Withdrawal by Subject|5|||
147015241|NCT01190930|530216705|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
147015242|NCT01190930|530216706|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
147015243|NCT01190930|530216707|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
147015244|NCT01190930|530216708|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
147015245|NCT01190930|530216709|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
147015246|NCT01190930|530216710|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
147015247|NCT01190930|530216711|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
147015248|NCT01190930|530216712|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
147015249|NCT01190930|530216713|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
147015250|NCT01190930|530216714|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
147015251|NCT01190930|530216705|FG000|Maintenance|Relapse|0|||
147015252|NCT01190930|530216706|FG001|Maintenance|Relapse|0|||
147015253|NCT01190930|530216707|FG002|Maintenance|Relapse|0|||
147015254|NCT01190930|530216708|FG003|Maintenance|Relapse|2|||
147015255|NCT01190930|530216709|FG004|Maintenance|Relapse|0|||
147015256|NCT01190930|530216710|FG005|Maintenance|Relapse|1|||
147015257|NCT01190930|530216711|FG006|Maintenance|Relapse|6|||
147015258|NCT01190930|530216712|FG007|Maintenance|Relapse|13|||
147015259|NCT01190930|530216713|FG008|Maintenance|Relapse|11|||
147015260|NCT01190930|530216714|FG009|Maintenance|Relapse|11|||
147015261|NCT01190930|530216705|FG000|Maintenance|Still on therapy|0|||
147015262|NCT01190930|530216706|FG001|Maintenance|Still on therapy|8|||
147015263|NCT01190930|530216707|FG002|Maintenance|Still on therapy|0|||
147015264|NCT01190930|530216708|FG003|Maintenance|Still on therapy|29|||
147015265|NCT01190930|530216709|FG004|Maintenance|Still on therapy|0|||
147015266|NCT01190930|530216710|FG005|Maintenance|Still on therapy|0|||
147015267|NCT01190930|530216711|FG006|Maintenance|Still on therapy|0|||
147015268|NCT01190930|530216712|FG007|Maintenance|Still on therapy|0|||
147015269|NCT01190930|530216713|FG008|Maintenance|Still on therapy|0|||
147015270|NCT01190930|530216714|FG009|Maintenance|Still on therapy|0|||
147015271|NCT00194792|530216717|FG000|Overall Study|Withdrawal by Subject|1|||
147015272|NCT00113919|530216719|FG000|Overall Study|Physician Decision|8|||
147015273|NCT00113919|530216719|FG000|Overall Study|Death|6|||
147015274|NCT02340962|530216720|FG000|Overall Study|Lost to Follow-up|1|||
147015275|NCT02340962|530216721|FG001|Overall Study|Lost to Follow-up|0|||
147015276|NCT02914457|530216724|FG000|Overall Study|Withdrawal by Subject|1|||
147015277|NCT02914457|530216724|FG000|Overall Study|Physician Decision|1|||
147015278|NCT02914457|530216724|FG000|Overall Study|No veins available for lead placement|1|||
147015279|NCT02914457|530216724|FG000|Overall Study|Electrical instability of patient|1|||
147015280|NCT02914457|530216724|FG000|Overall Study|ECG acquisition error due to sweating|1|||
147015281|NCT02914457|530216724|FG000|Overall Study|Protocol Violation|1|||
147015282|NCT01292837|530216730|FG000|Overall Study|Adverse Event|1|||
147015283|NCT01292837|530216730|FG000|Overall Study|Further treatment determined|1|||
147015284|NCT02174276|530216733|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
147015285|NCT02174276|530216734|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
147015286|NCT02174276|530216735|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
147015287|NCT02174276|530216736|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
147015288|NCT02174276|530216733|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
147015289|NCT02174276|530216734|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
147015290|NCT02174276|530216735|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
147015291|NCT02174276|530216736|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
147015292|NCT02174276|530216733|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
147015293|NCT02174276|530216734|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
147015294|NCT02174276|530216735|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
147015295|NCT02174276|530216736|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
147015296|NCT02174276|530216733|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
147015297|NCT02174276|530216734|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
147015298|NCT02174276|530216735|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
147015299|NCT02174276|530216736|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
147015300|NCT02174276|530216733|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
147015301|NCT02174276|530216734|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
147015302|NCT02174276|530216735|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
147015303|NCT02174276|530216736|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
147015304|NCT02174276|530216733|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
147015305|NCT02174276|530216734|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
147015306|NCT02174276|530216735|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
147015307|NCT02174276|530216736|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
147015308|NCT01206439|530216737|FG000|Overall Study|subject did not meet inclusion criteria|1|||
147015309|NCT02661022|530216738|FG000|Overall Study|Withdrawal by Subject|3|||
147015310|NCT02661022|530216739|FG001|Overall Study|Withdrawal by Subject|0|||
147015311|NCT02661022|530216738|FG000|Overall Study|Adverse Event|1|||
147015312|NCT02661022|530216739|FG001|Overall Study|Adverse Event|1|||
147015313|NCT02661022|530216738|FG000|Overall Study|Physician Decision|1|||
147015314|NCT02661022|530216739|FG001|Overall Study|Physician Decision|0|||
147015315|NCT02661022|530216738|FG000|Overall Study|Progressive Disease|2|||
147015316|NCT02661022|530216739|FG001|Overall Study|Progressive Disease|1|||
147015317|NCT05889039|530216740|FG000|Overall Study|error in completing survey|0|||
147015318|NCT05889039|530216741|FG001|Overall Study|error in completing survey|2|||
147015319|NCT05889039|530216742|FG002|Overall Study|error in completing survey|0|||
147015320|NCT05889039|530216743|FG003|Overall Study|error in completing survey|0|||
147015321|NCT05889039|530216740|FG000|Overall Study|Lost to Follow-up|4|||
147015322|NCT05889039|530216741|FG001|Overall Study|Lost to Follow-up|0|||
147015323|NCT05889039|530216742|FG002|Overall Study|Lost to Follow-up|0|||
147015324|NCT05889039|530216743|FG003|Overall Study|Lost to Follow-up|0|||
147015325|NCT00609154|530216747|FG000|Overall Study|Protocol Violation|1|||
147015326|NCT00609154|530216748|FG001|Overall Study|Protocol Violation|2|||
147015327|NCT00609154|530216747|FG000|Overall Study|Unable to establish IV access|0|||
147015328|NCT00609154|530216748|FG001|Overall Study|Unable to establish IV access|4|||
147015329|NCT00609154|530216747|FG000|Overall Study|Adverse Event|0|||
147015330|NCT00609154|530216748|FG001|Overall Study|Adverse Event|2|||
147015331|NCT04531527|530216749|FG000|Overall Study|Found to be Ineligible|3|||
147015332|NCT00434837|530216755|FG000|Overall Study|Lost to Follow-up|20|||
147015333|NCT00434837|530216756|FG001|Overall Study|Lost to Follow-up|23|||
147015334|NCT00434837|530216757|FG002|Overall Study|Lost to Follow-up|30|||
147015335|NCT00726895|530216758|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
147015336|NCT00726895|530216759|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
147015337|NCT01785615|530216765|FG000|Dietary Phase|Lost to Follow-up|0|||
147015338|NCT01785615|530216766|FG001|Dietary Phase|Lost to Follow-up|0|||
147015339|NCT01785615|530216767|FG002|Dietary Phase|Lost to Follow-up|0|||
147015340|NCT01785615|530216768|FG003|Dietary Phase|Lost to Follow-up|24|||
147015341|NCT01881737|530216769|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
147015342|NCT01881737|530216769|FG000|Overall Study|Withdrawal by Subject|1|||
147015343|NCT01881737|530216769|FG000|Overall Study|Worsening of baseline behavior|1|||
147015344|NCT01450800|530216772|FG000|Overall Study|Protocol Violation|1|||
147015345|NCT01450800|530216773|FG001|Overall Study|Protocol Violation|3|||
147015346|NCT03496298|530216784|FG000|Overall Study|Adverse Event|49|||
147015347|NCT03496298|530216785|FG001|Overall Study|Adverse Event|68|||
147015348|NCT03496298|530216786|FG002|Overall Study|Adverse Event|79|||
147015349|NCT03496298|530216784|FG000|Overall Study|Study terminated by Sponsor|1050|||
147015350|NCT03496298|530216785|FG001|Overall Study|Study terminated by Sponsor|1063|||
147015351|NCT03496298|530216786|FG002|Overall Study|Study terminated by Sponsor|1071|||
147015352|NCT03496298|530216784|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
147015353|NCT03496298|530216785|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
147015354|NCT03496298|530216786|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
147015355|NCT03496298|530216784|FG000|Overall Study|Withdrawal by Subject|176|||
147015356|NCT03496298|530216785|FG001|Overall Study|Withdrawal by Subject|154|||
147015357|NCT03496298|530216786|FG002|Overall Study|Withdrawal by Subject|151|||
147015358|NCT03496298|530216784|FG000|Overall Study|Other|29|||
147015359|NCT03496298|530216785|FG001|Overall Study|Other|20|||
147015360|NCT03496298|530216786|FG002|Overall Study|Other|23|||
147015361|NCT03496298|530216784|FG000|Overall Study|Randomized and not treated|1|||
147015362|NCT03496298|530216785|FG001|Overall Study|Randomized and not treated|1|||
147015363|NCT03496298|530216786|FG002|Overall Study|Randomized and not treated|1|||
147015364|NCT02608476|530216791|FG000|Overall Study|Withdrawal by Subject|30|||
147015365|NCT02608476|530216792|FG001|Overall Study|Withdrawal by Subject|37|||
147015366|NCT02608476|530216791|FG000|Overall Study|Lost to Follow-up|24|||
147015367|NCT02608476|530216792|FG001|Overall Study|Lost to Follow-up|24|||
147015368|NCT02608476|530216791|FG000|Overall Study|Adverse Event|2|||
147015369|NCT02608476|530216792|FG001|Overall Study|Adverse Event|8|||
147015370|NCT02608476|530216791|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
147015371|NCT02608476|530216792|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
147015372|NCT02608476|530216791|FG000|Overall Study|Noncompliance with treatment|1|||
147015373|NCT02608476|530216792|FG001|Overall Study|Noncompliance with treatment|5|||
147015374|NCT02608476|530216791|FG000|Overall Study|Lack of Efficacy|3|||
147015375|NCT02608476|530216792|FG001|Overall Study|Lack of Efficacy|1|||
147015376|NCT02608476|530216791|FG000|Overall Study|Other|0|||
147015377|NCT02608476|530216792|FG001|Overall Study|Other|1|||
147015378|NCT02608476|530216791|FG000|Overall Study|Physician Decision|1|||
147015379|NCT02608476|530216792|FG001|Overall Study|Physician Decision|0|||
146848984|NCT01151410|529617004|FG000|Overall Study|Lost to Follow-up|3|||
146848985|NCT01151410|529617005|FG001|Overall Study|Lost to Follow-up|4|||
146848986|NCT01151410|529617004|FG000|Overall Study|Adverse Event|1|||
146848987|NCT01151410|529617005|FG001|Overall Study|Adverse Event|2|||
146848988|NCT01151410|529617004|FG000|Overall Study|Protocol deviation|2|||
146848989|NCT01151410|529617005|FG001|Overall Study|Protocol deviation|1|||
146848990|NCT01151410|529617004|FG000|Overall Study|Administrative problems|1|||
146848991|NCT01151410|529617005|FG001|Overall Study|Administrative problems|1|||
146848992|NCT01151410|529617004|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146848993|NCT01151410|529617005|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146848994|NCT01151410|529617004|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146848995|NCT01151410|529617005|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146848996|NCT01820585|529617007|FG000|Overall Study|Adverse Event|9|||
146848997|NCT01820585|529617008|FG001|Overall Study|Adverse Event|13|||
146848998|NCT01820585|529617009|FG002|Overall Study|Adverse Event|23|||
147015380|NCT02608476|530216791|FG000|Overall Study|Pregnancy|0|||
147015381|NCT02608476|530216792|FG001|Overall Study|Pregnancy|1|||
147015382|NCT02608476|530216791|FG000|Overall Study|Progressive disease|1|||
147015383|NCT02608476|530216792|FG001|Overall Study|Progressive disease|0|||
147015384|NCT02058160|530216795|FG000|Overall Study|Randomized but not treated|2|||
147015385|NCT02058160|530216796|FG001|Overall Study|Randomized but not treated|4|||
147015386|NCT02058160|530216795|FG000|Overall Study|Poor compliance to protocol|4|||
147015387|NCT02058160|530216796|FG001|Overall Study|Poor compliance to protocol|1|||
147015388|NCT02058160|530216795|FG000|Overall Study|Adverse Event|12|||
147015389|NCT02058160|530216796|FG001|Overall Study|Adverse Event|3|||
147015390|NCT02058160|530216795|FG000|Overall Study|Lost to Follow-up|1|||
147015391|NCT02058160|530216796|FG001|Overall Study|Lost to Follow-up|0|||
147015392|NCT02058160|530216795|FG000|Overall Study|Other than specified above|12|||
147015393|NCT02058160|530216796|FG001|Overall Study|Other than specified above|6|||
147015394|NCT04106817|530216797|FG000|Overall Study|Lost to Follow-up|1|||
147015395|NCT04106817|530216798|FG001|Overall Study|Lost to Follow-up|0|||
147015396|NCT04106817|530216799|FG002|Overall Study|Lost to Follow-up|0|||
147015397|NCT03310619|530216800|FG000|Pre-Treatment Period|Death|1|||
147015398|NCT03310619|530216801|FG001|Pre-Treatment Period|Death|0|||
147015399|NCT03310619|530216802|FG002|Pre-Treatment Period|Death|0|||
147015400|NCT03310619|530216803|FG003|Pre-Treatment Period|Death|0|||
147015401|NCT03310619|530216804|FG004|Pre-Treatment Period|Death|1|||
147015402|NCT03310619|530216805|FG005|Pre-Treatment Period|Death|0|||
147015403|NCT03310619|530216806|FG006|Pre-Treatment Period|Death|0|||
147015404|NCT03310619|530216807|FG007|Pre-Treatment Period|Death|0|||
147015405|NCT03310619|530216800|FG000|Pre-Treatment Period|Other reasons|2|||
147015406|NCT03310619|530216801|FG001|Pre-Treatment Period|Other reasons|1|||
147015407|NCT03310619|530216802|FG002|Pre-Treatment Period|Other reasons|2|||
147015408|NCT03310619|530216803|FG003|Pre-Treatment Period|Other reasons|0|||
147015409|NCT03310619|530216804|FG004|Pre-Treatment Period|Other reasons|0|||
147015410|NCT03310619|530216805|FG005|Pre-Treatment Period|Other reasons|0|||
147015411|NCT03310619|530216806|FG006|Pre-Treatment Period|Other reasons|2|||
147015412|NCT03310619|530216807|FG007|Pre-Treatment Period|Other reasons|0|||
147015413|NCT03310619|530216800|FG000|Treatment Period|Death|1|||
147015414|NCT03310619|530216801|FG001|Treatment Period|Death|2|||
147015415|NCT03310619|530216802|FG002|Treatment Period|Death|0|||
147015416|NCT03310619|530216803|FG003|Treatment Period|Death|0|||
147015417|NCT03310619|530216804|FG004|Treatment Period|Death|1|||
147015418|NCT03310619|530216805|FG005|Treatment Period|Death|0|||
147015419|NCT03310619|530216806|FG006|Treatment Period|Death|2|||
147015420|NCT03310619|530216807|FG007|Treatment Period|Death|0|||
147015421|NCT03310619|530216800|FG000|Treatment Period|Adverse Event|0|||
147015422|NCT03310619|530216801|FG001|Treatment Period|Adverse Event|1|||
147015423|NCT03310619|530216802|FG002|Treatment Period|Adverse Event|4|||
147015424|NCT03310619|530216803|FG003|Treatment Period|Adverse Event|1|||
147015425|NCT03310619|530216804|FG004|Treatment Period|Adverse Event|0|||
147015426|NCT03310619|530216805|FG005|Treatment Period|Adverse Event|0|||
147015427|NCT03310619|530216806|FG006|Treatment Period|Adverse Event|0|||
147015428|NCT03310619|530216807|FG007|Treatment Period|Adverse Event|0|||
147015429|NCT03310619|530216800|FG000|Treatment Period|Withdrawal by participant|0|||
147015430|NCT03310619|530216801|FG001|Treatment Period|Withdrawal by participant|0|||
147015431|NCT03310619|530216802|FG002|Treatment Period|Withdrawal by participant|1|||
147015432|NCT03310619|530216803|FG003|Treatment Period|Withdrawal by participant|0|||
147015433|NCT03310619|530216804|FG004|Treatment Period|Withdrawal by participant|0|||
147015434|NCT03310619|530216805|FG005|Treatment Period|Withdrawal by participant|0|||
147015435|NCT03310619|530216806|FG006|Treatment Period|Withdrawal by participant|0|||
147015436|NCT03310619|530216807|FG007|Treatment Period|Withdrawal by participant|0|||
147015437|NCT03310619|530216800|FG000|Treatment Period|Lost to Follow-up|0|||
147015438|NCT03310619|530216801|FG001|Treatment Period|Lost to Follow-up|0|||
147015439|NCT03310619|530216802|FG002|Treatment Period|Lost to Follow-up|0|||
147015440|NCT03310619|530216803|FG003|Treatment Period|Lost to Follow-up|0|||
147015441|NCT03310619|530216804|FG004|Treatment Period|Lost to Follow-up|0|||
147015442|NCT03310619|530216805|FG005|Treatment Period|Lost to Follow-up|0|||
147015443|NCT03310619|530216806|FG006|Treatment Period|Lost to Follow-up|0|||
147015444|NCT03310619|530216807|FG007|Treatment Period|Lost to Follow-up|1|||
147015445|NCT03310619|530216800|FG000|Treatment Period|Study terminated by sponsor|0|||
147015446|NCT03310619|530216801|FG001|Treatment Period|Study terminated by sponsor|0|||
147015447|NCT03310619|530216802|FG002|Treatment Period|Study terminated by sponsor|0|||
147015448|NCT03310619|530216803|FG003|Treatment Period|Study terminated by sponsor|0|||
147015449|NCT03310619|530216804|FG004|Treatment Period|Study terminated by sponsor|0|||
147015450|NCT03310619|530216805|FG005|Treatment Period|Study terminated by sponsor|0|||
146848999|NCT01820585|529617010|FG003|Overall Study|Adverse Event|34|||
147015451|NCT03310619|530216806|FG006|Treatment Period|Study terminated by sponsor|0|||
147015452|NCT03310619|530216807|FG007|Treatment Period|Study terminated by sponsor|1|||
147015453|NCT03310619|530216800|FG000|Treatment Period|Physician Decision|0|||
147015454|NCT03310619|530216801|FG001|Treatment Period|Physician Decision|0|||
147015455|NCT03310619|530216802|FG002|Treatment Period|Physician Decision|0|||
147015456|NCT03310619|530216803|FG003|Treatment Period|Physician Decision|0|||
147015457|NCT03310619|530216804|FG004|Treatment Period|Physician Decision|3|||
147015458|NCT03310619|530216805|FG005|Treatment Period|Physician Decision|0|||
147015459|NCT03310619|530216806|FG006|Treatment Period|Physician Decision|0|||
146849000|NCT01820585|529617007|FG000|Overall Study|Lack of Efficacy|9|||
147015460|NCT03310619|530216807|FG007|Treatment Period|Physician Decision|0|||
147015461|NCT03310619|530216800|FG000|Treatment Period|Other reasons|1|||
147015462|NCT03310619|530216801|FG001|Treatment Period|Other reasons|0|||
147015463|NCT03310619|530216802|FG002|Treatment Period|Other reasons|2|||
147015464|NCT03310619|530216803|FG003|Treatment Period|Other reasons|0|||
147015465|NCT03310619|530216804|FG004|Treatment Period|Other reasons|0|||
147015466|NCT03310619|530216805|FG005|Treatment Period|Other reasons|0|||
147015467|NCT03310619|530216806|FG006|Treatment Period|Other reasons|0|||
147015468|NCT03310619|530216807|FG007|Treatment Period|Other reasons|0|||
147015469|NCT00152516|530216808|FG000|Overall Study|Adverse Event|18|||
147015470|NCT00152516|530216808|FG000|Overall Study|Lack and Loss of Efficacy|30|||
147015471|NCT00152516|530216808|FG000|Overall Study|Lost to Follow-up|5|||
147015472|NCT00152516|530216808|FG000|Overall Study|Withdrawal by Subject|8|||
147015473|NCT00152516|530216808|FG000|Overall Study|Protocol Violation|3|||
147015474|NCT00152516|530216808|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
147015475|NCT00152516|530216808|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
147015476|NCT00152516|530216808|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
147015477|NCT00152516|530216808|FG000|Overall Study|Other: Non-Compliance|2|||
147015478|NCT00152516|530216808|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
147015479|NCT00152516|530216808|FG000|Overall Study|Other: Moved Out Of State|1|||
147015480|NCT00152516|530216808|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
147015481|NCT00152516|530216808|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
147015482|NCT01266603|530216811|FG000|Overall Study|Adverse Event|1|||
147015483|NCT01266603|530216811|FG000|Overall Study|Lack of Efficacy|14|||
147015484|NCT01266603|530216811|FG000|Overall Study|Withdrawal by Subject|1|||
147015485|NCT01266603|530216811|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
147015486|NCT02418754|530216812|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
147015487|NCT02418754|530216813|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
147015488|NCT02418754|530216814|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
147015489|NCT02418754|530216815|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
147015490|NCT02418754|530216816|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
147015491|NCT02418754|530216812|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
147015492|NCT02418754|530216813|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
147015493|NCT02418754|530216814|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
147015494|NCT02418754|530216815|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
147015495|NCT02418754|530216816|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
147015496|NCT02418754|530216812|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
147015497|NCT02418754|530216813|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
147015498|NCT02418754|530216814|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
147015499|NCT02418754|530216815|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
147015500|NCT02418754|530216816|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
147015501|NCT02418754|530216812|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
147015502|NCT02418754|530216813|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
147015503|NCT02418754|530216814|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
147015504|NCT02418754|530216815|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
147015505|NCT02418754|530216816|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
147015506|NCT02418754|530216812|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
147015507|NCT02418754|530216813|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
147015508|NCT02418754|530216814|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
147015509|NCT02418754|530216815|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
147015510|NCT02418754|530216816|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
147015511|NCT02418754|530216812|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
147015512|NCT02418754|530216813|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
147015513|NCT02418754|530216814|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
147015514|NCT02418754|530216815|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
147015515|NCT02418754|530216816|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
147015516|NCT02418754|530216812|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
147015517|NCT02418754|530216813|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
147015518|NCT02418754|530216814|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
147015519|NCT02418754|530216815|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
147015520|NCT02418754|530216816|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
147015521|NCT02418754|530216812|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
147015522|NCT02418754|530216813|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
147015523|NCT02418754|530216814|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
147015524|NCT02418754|530216815|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
147015525|NCT02418754|530216816|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
147015526|NCT02418754|530216812|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
147015527|NCT02418754|530216813|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
147015528|NCT02418754|530216814|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
147015529|NCT02418754|530216815|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
147015530|NCT02418754|530216816|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
147015531|NCT02418754|530216812|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
147015532|NCT02418754|530216813|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
147015533|NCT02418754|530216814|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
147015534|NCT02418754|530216815|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
147015535|NCT02418754|530216816|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
147015536|NCT02418754|530216812|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
147015537|NCT02418754|530216813|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
147015538|NCT02418754|530216814|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
147015539|NCT02418754|530216815|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
147015540|NCT02418754|530216816|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
147015541|NCT03259789|530216819|FG000|Overall Study|Adverse Event|3|||
147015542|NCT03259789|530216820|FG001|Overall Study|Adverse Event|2|||
147015543|NCT03259789|530216821|FG002|Overall Study|Adverse Event|1|||
147015544|NCT03259789|530216819|FG000|Overall Study|Withdrawal by Subject|9|||
147015545|NCT03259789|530216820|FG001|Overall Study|Withdrawal by Subject|5|||
147015546|NCT03259789|530216821|FG002|Overall Study|Withdrawal by Subject|1|||
147015547|NCT03259789|530216819|FG000|Overall Study|Lost to Follow-up|5|||
147015548|NCT03259789|530216820|FG001|Overall Study|Lost to Follow-up|9|||
147015549|NCT03259789|530216821|FG002|Overall Study|Lost to Follow-up|4|||
147015550|NCT03259789|530216819|FG000|Overall Study|Physician Decision|0|||
147015551|NCT03259789|530216820|FG001|Overall Study|Physician Decision|1|||
147015552|NCT03259789|530216821|FG002|Overall Study|Physician Decision|0|||
147015553|NCT04291508|530216822|FG000|Overall Study|Withdrawal by Subject|1|||
147015554|NCT04291508|530216823|FG001|Overall Study|Withdrawal by Subject|0|||
147015555|NCT04291508|530216824|FG002|Overall Study|Withdrawal by Subject|1|||
147015556|NCT04291508|530216825|FG003|Overall Study|Withdrawal by Subject|0|||
147015557|NCT04291508|530216822|FG000|Overall Study|lost to follow up|4|||
147015558|NCT04291508|530216823|FG001|Overall Study|lost to follow up|0|||
147015559|NCT04291508|530216824|FG002|Overall Study|lost to follow up|1|||
147015560|NCT04291508|530216825|FG003|Overall Study|lost to follow up|0|||
147015561|NCT00398073|530216826|FG000|Overall Study|Withdrawal by Subject|1|||
147015562|NCT00398073|530216827|FG001|Overall Study|Withdrawal by Subject|0|||
147015563|NCT01263561|530216828|FG000|Overall Study|Death|1|||
147015564|NCT01263561|530216829|FG001|Overall Study|Death|2|||
147015565|NCT03185741|530216832|FG000|Baseline|Withdrawal by Subject|1|||
147015566|NCT03185741|530216833|FG001|Baseline|Withdrawal by Subject|3|||
147015567|NCT03185741|530216834|FG002|Baseline|Withdrawal by Subject|2|||
147015568|NCT03185741|530216832|FG000|Baseline|Lost to Follow-up|1|||
147015569|NCT03185741|530216833|FG001|Baseline|Lost to Follow-up|2|||
147015570|NCT03185741|530216834|FG002|Baseline|Lost to Follow-up|3|||
147015571|NCT03185741|530216832|FG000|3Month|Death|1|||
147015572|NCT03185741|530216833|FG001|3Month|Death|1|||
147015573|NCT03185741|530216834|FG002|3Month|Death|2|||
147015574|NCT03185741|530216832|FG000|3Month|Withdrawal by Subject|1|||
147015575|NCT03185741|530216833|FG001|3Month|Withdrawal by Subject|5|||
147015576|NCT03185741|530216834|FG002|3Month|Withdrawal by Subject|1|||
147015577|NCT03185741|530216832|FG000|3Month|Lost to Follow-up|7|||
147015578|NCT03185741|530216833|FG001|3Month|Lost to Follow-up|9|||
147015579|NCT03185741|530216834|FG002|3Month|Lost to Follow-up|8|||
147015580|NCT03185741|530216832|FG000|3Month|Unavailable for 3Month|11|||
147015581|NCT03185741|530216833|FG001|3Month|Unavailable for 3Month|10|||
147015582|NCT03185741|530216834|FG002|3Month|Unavailable for 3Month|11|||
147015583|NCT03185741|530216832|FG000|3Month|Protocol Violation|0|||
147015584|NCT03185741|530216833|FG001|3Month|Protocol Violation|0|||
147015585|NCT03185741|530216834|FG002|3Month|Protocol Violation|3|||
147015586|NCT03185741|530216832|FG000|6Month|Death|1|||
147015587|NCT03185741|530216833|FG001|6Month|Death|1|||
147015588|NCT03185741|530216834|FG002|6Month|Death|2|||
147015589|NCT03185741|530216832|FG000|6Month|Withdrawal by Subject|2|||
147015590|NCT03185741|530216833|FG001|6Month|Withdrawal by Subject|3|||
147015591|NCT03185741|530216834|FG002|6Month|Withdrawal by Subject|1|||
147015592|NCT03185741|530216832|FG000|6Month|Lost to Follow-up|16|||
147015593|NCT03185741|530216833|FG001|6Month|Lost to Follow-up|15|||
147015594|NCT03185741|530216834|FG002|6Month|Lost to Follow-up|16|||
147015595|NCT01488448|530216835|FG000|Overall Study|Withdrawal by Subject|3|||
147015596|NCT01488448|530216836|FG001|Overall Study|Withdrawal by Subject|1|||
147015597|NCT01488448|530216835|FG000|Overall Study|Adverse Event|9|||
147015598|NCT01488448|530216836|FG001|Overall Study|Adverse Event|4|||
147015599|NCT01488448|530216835|FG000|Overall Study|Physician Decision|4|||
147015600|NCT01488448|530216836|FG001|Overall Study|Physician Decision|9|||
147015601|NCT01488448|530216835|FG000|Overall Study|Protocol Violation|4|||
147015602|NCT01488448|530216836|FG001|Overall Study|Protocol Violation|3|||
147015603|NCT00654641|530216837|FG000|Overall Study|Lost to Follow-up|2|||
147015604|NCT00654641|530216838|FG001|Overall Study|Lost to Follow-up|3|||
147015605|NCT01992094|530216839|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
147015606|NCT01992094|530216840|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
147015607|NCT01992094|530216841|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
147015608|NCT01992094|530216839|FG000|Overall Study|Adverse Event|1|||
147015609|NCT01992094|530216840|FG001|Overall Study|Adverse Event|0|||
147015610|NCT01992094|530216841|FG002|Overall Study|Adverse Event|0|||
147015611|NCT01992094|530216839|FG000|Overall Study|Death|5|||
147015612|NCT01992094|530216840|FG001|Overall Study|Death|5|||
147015613|NCT01992094|530216841|FG002|Overall Study|Death|2|||
147015614|NCT01992094|530216839|FG000|Overall Study|Lost to Follow-up|26|||
147015615|NCT01992094|530216840|FG001|Overall Study|Lost to Follow-up|9|||
147015616|NCT01992094|530216841|FG002|Overall Study|Lost to Follow-up|13|||
147015617|NCT01992094|530216839|FG000|Overall Study|OTHER|4|||
147015618|NCT01992094|530216840|FG001|Overall Study|OTHER|0|||
147015619|NCT01992094|530216841|FG002|Overall Study|OTHER|0|||
147015620|NCT01992094|530216839|FG000|Overall Study|Protocol Violation|1|||
147015621|NCT01992094|530216840|FG001|Overall Study|Protocol Violation|0|||
147015622|NCT01992094|530216841|FG002|Overall Study|Protocol Violation|1|||
147015623|NCT01992094|530216839|FG000|Overall Study|Withdrawal by Subject|7|||
147015624|NCT01992094|530216840|FG001|Overall Study|Withdrawal by Subject|3|||
147015625|NCT01992094|530216841|FG002|Overall Study|Withdrawal by Subject|4|||
147015626|NCT01475487|530216842|FG000|Overall Study|had to leave early for personal reasons|2|||
147015627|NCT01475487|530216843|FG001|Overall Study|had to leave early for personal reasons|1|||
147015628|NCT04428645|530216848|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
147015629|NCT03168906|530216849|FG000|Overall Study|Lack of Efficacy|6|||
147015630|NCT03168906|530216850|FG001|Overall Study|Lack of Efficacy|6|||
147015631|NCT01214239|530216851|FG000|Overall Study|Adverse Event|3|||
147015632|NCT01214239|530216852|FG001|Overall Study|Adverse Event|4|||
147015633|NCT01214239|530216851|FG000|Overall Study|Protocol Violation|2|||
147015634|NCT01214239|530216852|FG001|Overall Study|Protocol Violation|1|||
147015635|NCT01214239|530216851|FG000|Overall Study|Lost to Follow-up|1|||
147015636|NCT01214239|530216852|FG001|Overall Study|Lost to Follow-up|1|||
147015637|NCT01214239|530216851|FG000|Overall Study|Withdrawal by Subject|4|||
147015638|NCT01214239|530216852|FG001|Overall Study|Withdrawal by Subject|9|||
147015639|NCT01214239|530216851|FG000|Overall Study|Lack of Efficacy|1|||
147015640|NCT01214239|530216852|FG001|Overall Study|Lack of Efficacy|2|||
147015641|NCT01214239|530216851|FG000|Overall Study|patient's private reason|1|||
147015642|NCT01214239|530216852|FG001|Overall Study|patient's private reason|1|||
147015643|NCT01321697|530216853|FG000|Overall Study|Study Terminated|7|||
147015644|NCT00857818|530216856|FG000|Overall Study|Lack of Efficacy|1|||
147015645|NCT00857818|530216857|FG001|Overall Study|Lack of Efficacy|0|||
147015646|NCT00857818|530216856|FG000|Overall Study|Adverse Event|3|||
147015647|NCT00857818|530216857|FG001|Overall Study|Adverse Event|0|||
147015648|NCT00857818|530216856|FG000|Overall Study|Withdrawal by Subject|0|||
147015649|NCT00857818|530216857|FG001|Overall Study|Withdrawal by Subject|4|||
147015650|NCT00857818|530216856|FG000|Overall Study|Sponsor terminated study|6|||
147015651|NCT00857818|530216857|FG001|Overall Study|Sponsor terminated study|4|||
147015652|NCT00857818|530216856|FG000|Overall Study|Investigator decision|1|||
147015653|NCT00857818|530216857|FG001|Overall Study|Investigator decision|0|||
147015654|NCT01049581|530216858|FG000|Overall Study|Lost to Follow-up|2|||
147015655|NCT01049581|530216859|FG001|Overall Study|Lost to Follow-up|1|||
147015656|NCT00810602|530216860|FG000|Overall Study|Withdrawal by Subject|8|||
147015657|NCT00810602|530216861|FG001|Overall Study|Withdrawal by Subject|3|||
147015658|NCT03840382|530216865|FG000|Overall Study|Lost to Follow-up|11|||
147015659|NCT02625974|530216866|FG000|Part 1|Lost to Follow-up|9|||
147015660|NCT02625974|530216867|FG001|Part 1|Lost to Follow-up|3|||
147015661|NCT02625974|530216866|FG000|Part 2|Lost to Follow-up|4|||
147015662|NCT02625974|530216867|FG001|Part 2|Lost to Follow-up|6|||
147015663|NCT02625974|530216866|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
147015664|NCT02625974|530216867|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
147015665|NCT01142661|530216868|FG000|Overall Study|Adverse Event|2|||
147015666|NCT01142661|530216868|FG000|Overall Study|Withdrawal by Subject|1|||
147015667|NCT01142661|530216868|FG000|Overall Study|Physician Decision|1|||
147015668|NCT00559637|530218501|FG000|Overall Study|Adverse Event|22|||
147015669|NCT00559637|530218501|FG000|Overall Study|Withdrawal by Subject|4|||
147015670|NCT00559637|530218501|FG000|Overall Study|Protocol Violation|6|||
147015671|NCT00559637|530218501|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
147015672|NCT00559637|530218501|FG000|Overall Study|Failure to return|6|||
147015673|NCT00559637|530218501|FG000|Overall Study|Insufficient response|3|||
147015674|NCT00559637|530218501|FG000|Overall Study|Started requiring dialysis after month 7|2|||
147015675|NCT00559637|530218501|FG000|Overall Study|Suspected lung cancer|1|||
147015676|NCT00559637|530218501|FG000|Overall Study|Participation in another study|1|||
147015677|NCT00559637|530218501|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
147015678|NCT00559637|530218501|FG000|Overall Study|Change of center|1|||
147015679|NCT00559637|530218501|FG000|Overall Study|Change of home|1|||
147015680|NCT00559637|530218501|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
147015681|NCT01923311|530218502|FG000|Overall Study|Pregnancy|1|||
147015682|NCT01923311|530218503|FG001|Overall Study|Pregnancy|0|||
147015683|NCT01923311|530218502|FG000|Overall Study|Investigator's Discretion|1|||
147015684|NCT01923311|530218503|FG001|Overall Study|Investigator's Discretion|0|||
147015685|NCT01923311|530218502|FG000|Overall Study|Non-Compliance with Study Drug|2|||
147015686|NCT01923311|530218503|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147015687|NCT01923311|530218502|FG000|Overall Study|Withdrew Consent|1|||
147015688|NCT01923311|530218503|FG001|Overall Study|Withdrew Consent|0|||
147015689|NCT01923311|530218502|FG000|Overall Study|Study Terminated by Sponsor|12|||
147015690|NCT01923311|530218503|FG001|Overall Study|Study Terminated by Sponsor|0|||
147015691|NCT03429049|530218506|FG000|Overall Study|Adverse Event|2|||
147015692|NCT03429049|530218507|FG001|Overall Study|Adverse Event|3|||
147015693|NCT03429049|530218506|FG000|Overall Study|Death|0|||
147015694|NCT03429049|530218507|FG001|Overall Study|Death|1|||
147015695|NCT03429049|530218506|FG000|Overall Study|Lack of Efficacy|4|||
147015696|NCT03429049|530218507|FG001|Overall Study|Lack of Efficacy|2|||
147015697|NCT03429049|530218506|FG000|Overall Study|Lost to Follow-up|9|||
147015698|NCT03429049|530218507|FG001|Overall Study|Lost to Follow-up|8|||
147015699|NCT03429049|530218506|FG000|Overall Study|Physician Decision|1|||
147015700|NCT03429049|530218507|FG001|Overall Study|Physician Decision|0|||
147015701|NCT03429049|530218506|FG000|Overall Study|Protocol Violation|3|||
147015702|NCT03429049|530218507|FG001|Overall Study|Protocol Violation|0|||
147015703|NCT03429049|530218506|FG000|Overall Study|Sponsor Decision|2|||
147015704|NCT03429049|530218507|FG001|Overall Study|Sponsor Decision|0|||
147015705|NCT03429049|530218506|FG000|Overall Study|Withdrawal by Subject|4|||
147015706|NCT03429049|530218507|FG001|Overall Study|Withdrawal by Subject|20|||
147015707|NCT03429049|530218506|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
147015708|NCT03429049|530218507|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
147015709|NCT04129944|530218509|FG000|Overall Study|Death|0|||
147015710|NCT04129944|530218510|FG001|Overall Study|Death|0|||
147015711|NCT04129944|530218511|FG002|Overall Study|Death|0|||
147015712|NCT04129944|530218512|FG003|Overall Study|Death|1|||
147015713|NCT04129944|530218509|FG000|Overall Study|Lost to Follow-up|1|||
147015714|NCT04129944|530218510|FG001|Overall Study|Lost to Follow-up|0|||
147015715|NCT04129944|530218511|FG002|Overall Study|Lost to Follow-up|0|||
147015716|NCT04129944|530218512|FG003|Overall Study|Lost to Follow-up|0|||
147015717|NCT04129944|530218509|FG000|Overall Study|Withdrawal by Subject|1|||
147015718|NCT04129944|530218510|FG001|Overall Study|Withdrawal by Subject|0|||
147015719|NCT04129944|530218511|FG002|Overall Study|Withdrawal by Subject|1|||
147015720|NCT04129944|530218512|FG003|Overall Study|Withdrawal by Subject|2|||
147015721|NCT04241133|530218518|FG000|Overall Study|COVID19 Precautions|14|||
147015722|NCT04241133|530218519|FG001|Overall Study|COVID19 Precautions|34|||
147015723|NCT02994394|530218520|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
147015724|NCT02994394|530218521|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
147015725|NCT02994394|530218522|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
147015726|NCT02994394|530218523|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
147015727|NCT02994394|530218524|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
147015728|NCT02994394|530218525|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
147015729|NCT02994394|530218520|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
147015730|NCT02994394|530218521|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
147015731|NCT02994394|530218522|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
147015732|NCT02994394|530218523|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
147015733|NCT02994394|530218524|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
147015734|NCT02994394|530218525|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
147015735|NCT00396630|530218526|FG000|Overall Study|Lost to Follow-up|1|||
147015736|NCT00396630|530218527|FG001|Overall Study|Lost to Follow-up|1|||
147015737|NCT00396630|530218526|FG000|Overall Study|Withdrawal by Subject|1|||
147015738|NCT00396630|530218527|FG001|Overall Study|Withdrawal by Subject|1|||
147015739|NCT00396630|530218526|FG000|Overall Study|Not vaccinated at Visit 3|3|||
147015740|NCT00396630|530218527|FG001|Overall Study|Not vaccinated at Visit 3|3|||
147015741|NCT02576717|530218528|FG000|Overall Study|Other Reasons|16|||
147015742|NCT02576717|530218529|FG001|Overall Study|Other Reasons|18|||
147015743|NCT02576717|530218530|FG002|Overall Study|Other Reasons|15|||
147015744|NCT02576717|530218528|FG000|Overall Study|Covid-19 Pandemic|0|||
147015745|NCT02576717|530218529|FG001|Overall Study|Covid-19 Pandemic|1|||
147015746|NCT02576717|530218530|FG002|Overall Study|Covid-19 Pandemic|1|||
147015747|NCT02576717|530218528|FG000|Overall Study|Sponsor Decision|0|||
147015748|NCT02576717|530218529|FG001|Overall Study|Sponsor Decision|0|||
147015749|NCT02576717|530218530|FG002|Overall Study|Sponsor Decision|1|||
147015750|NCT02576717|530218528|FG000|Overall Study|Physician Decision|3|||
147015751|NCT02576717|530218529|FG001|Overall Study|Physician Decision|8|||
147015752|NCT02576717|530218530|FG002|Overall Study|Physician Decision|9|||
147015753|NCT02576717|530218528|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
147015754|NCT02576717|530218529|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
147015755|NCT02576717|530218530|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
147015756|NCT02576717|530218528|FG000|Overall Study|Death|3|||
147015757|NCT02576717|530218529|FG001|Overall Study|Death|5|||
147015758|NCT02576717|530218530|FG002|Overall Study|Death|3|||
147015759|NCT02576717|530218528|FG000|Overall Study|Lost to Follow-up|9|||
147015760|NCT02576717|530218529|FG001|Overall Study|Lost to Follow-up|10|||
147015761|NCT02576717|530218530|FG002|Overall Study|Lost to Follow-up|19|||
147015762|NCT02576717|530218528|FG000|Overall Study|Protocol Violation|4|||
147015763|NCT02576717|530218529|FG001|Overall Study|Protocol Violation|0|||
147015764|NCT02576717|530218530|FG002|Overall Study|Protocol Violation|5|||
147015765|NCT02576717|530218528|FG000|Overall Study|Lack of Efficacy|24|||
147015766|NCT02576717|530218529|FG001|Overall Study|Lack of Efficacy|28|||
146736533|NCT05375955|529206888|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
147015767|NCT02576717|530218530|FG002|Overall Study|Lack of Efficacy|20|||
146736534|NCT05375955|529206889|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
147015768|NCT02576717|530218528|FG000|Overall Study|Adverse Event|26|||
147015769|NCT02576717|530218529|FG001|Overall Study|Adverse Event|32|||
147015770|NCT02576717|530218530|FG002|Overall Study|Adverse Event|26|||
147015771|NCT00399893|530218531|FG000|Overall Study|Withdrawal by Subject|1|||
147015772|NCT00399893|530218532|FG001|Overall Study|Withdrawal by Subject|0|||
147015773|NCT04412057|530218533|FG000|Overall Study|Death|3|||
147015774|NCT04412057|530218534|FG001|Overall Study|Death|7|||
147015775|NCT04412057|530218533|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
147015776|NCT04412057|530218534|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
147015777|NCT03330236|530218537|FG000|Overall Study|Death|2|||
147015778|NCT03330236|530218538|FG001|Overall Study|Death|1|||
147015779|NCT03330236|530218537|FG000|Overall Study|Withdrawal by Subject|2|||
147015780|NCT03330236|530218538|FG001|Overall Study|Withdrawal by Subject|4|||
147015781|NCT03330236|530218537|FG000|Overall Study|Lost to Follow-up|0|||
147015782|NCT03330236|530218538|FG001|Overall Study|Lost to Follow-up|2|||
147015783|NCT03330236|530218537|FG000|Overall Study|Physician Decision|2|||
147015784|NCT03330236|530218538|FG001|Overall Study|Physician Decision|0|||
147015785|NCT03330236|530218537|FG000|Overall Study|Protocol Violation|4|||
147015786|NCT03330236|530218538|FG001|Overall Study|Protocol Violation|3|||
147015787|NCT03330236|530218537|FG000|Overall Study|SedLine malfunction/blinding|19|||
147015788|NCT03330236|530218538|FG001|Overall Study|SedLine malfunction/blinding|14|||
147015789|NCT03330236|530218537|FG000|Overall Study|Volatile anesthetics used|11|||
147015790|NCT03330236|530218538|FG001|Overall Study|Volatile anesthetics used|8|||
147015791|NCT03330236|530218537|FG000|Overall Study|Surgery aborted/converted to open|60|||
147015792|NCT03330236|530218538|FG001|Overall Study|Surgery aborted/converted to open|52|||
147015793|NCT03710590|530218545|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
147015794|NCT03710590|530218546|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
147015795|NCT00407745|530218547|FG000|Overall Study|Lack of Efficacy|1|||
147015796|NCT00407745|530218548|FG001|Overall Study|Lack of Efficacy|2|||
147015797|NCT00407745|530218547|FG000|Overall Study|Withdrawal by Subject|3|||
147015798|NCT00407745|530218548|FG001|Overall Study|Withdrawal by Subject|3|||
147015799|NCT00407745|530218547|FG000|Overall Study|Protocol Violation|5|||
147015800|NCT00407745|530218548|FG001|Overall Study|Protocol Violation|3|||
147015801|NCT00407745|530218547|FG000|Overall Study|Adverse Event|8|||
147015802|NCT00407745|530218548|FG001|Overall Study|Adverse Event|8|||
147015803|NCT00407745|530218547|FG000|Overall Study|Other|2|||
147015804|NCT00407745|530218548|FG001|Overall Study|Other|0|||
147015805|NCT00407745|530218547|FG000|Overall Study|Randomized, unknown if treated|0|||
147015806|NCT00407745|530218548|FG001|Overall Study|Randomized, unknown if treated|1|||
147015807|NCT00108082|530218549|FG000|Overall Study|Adverse Event|14|||
147015808|NCT00108082|530218550|FG001|Overall Study|Adverse Event|12|||
147015809|NCT00108082|530218551|FG002|Overall Study|Adverse Event|17|||
147015810|NCT00108082|530218549|FG000|Overall Study|Lost to Follow-up|6|||
147015811|NCT00108082|530218550|FG001|Overall Study|Lost to Follow-up|3|||
147015812|NCT00108082|530218551|FG002|Overall Study|Lost to Follow-up|7|||
147015813|NCT00108082|530218549|FG000|Overall Study|Consent Withdrawn|3|||
147015814|NCT00108082|530218550|FG001|Overall Study|Consent Withdrawn|3|||
147015815|NCT00108082|530218551|FG002|Overall Study|Consent Withdrawn|5|||
147015816|NCT00108082|530218549|FG000|Overall Study|Protocol Violation|1|||
147015817|NCT00108082|530218550|FG001|Overall Study|Protocol Violation|2|||
147015818|NCT00108082|530218551|FG002|Overall Study|Protocol Violation|0|||
147015819|NCT00108082|530218549|FG000|Overall Study|Lack of Efficacy|3|||
147015820|NCT00108082|530218550|FG001|Overall Study|Lack of Efficacy|1|||
147015821|NCT00108082|530218551|FG002|Overall Study|Lack of Efficacy|2|||
147015822|NCT00108082|530218549|FG000|Overall Study|Amendment 4: > Month 12|5|||
147015823|NCT00108082|530218550|FG001|Overall Study|Amendment 4: > Month 12|7|||
147015824|NCT00108082|530218551|FG002|Overall Study|Amendment 4: > Month 12|5|||
147015825|NCT00108082|530218549|FG000|Overall Study|Woman of Child-bearing Potential|2|||
147015826|NCT00108082|530218550|FG001|Overall Study|Woman of Child-bearing Potential|0|||
147015827|NCT00108082|530218551|FG002|Overall Study|Woman of Child-bearing Potential|2|||
147015828|NCT00108082|530218549|FG000|Overall Study|Incorrectly Randomized|0|||
147015829|NCT00108082|530218550|FG001|Overall Study|Incorrectly Randomized|0|||
147015830|NCT00108082|530218551|FG002|Overall Study|Incorrectly Randomized|2|||
147015831|NCT00108082|530218549|FG000|Overall Study|Non-compliance|1|||
147015832|NCT00108082|530218550|FG001|Overall Study|Non-compliance|0|||
147015833|NCT00108082|530218551|FG002|Overall Study|Non-compliance|2|||
147015834|NCT00108082|530218549|FG000|Overall Study|Stopped Study Medication|0|||
147015835|NCT00108082|530218550|FG001|Overall Study|Stopped Study Medication|0|||
147015836|NCT00108082|530218551|FG002|Overall Study|Stopped Study Medication|1|||
147015837|NCT00108082|530218549|FG000|Overall Study|Site Closed Study|0|||
147015838|NCT00108082|530218550|FG001|Overall Study|Site Closed Study|2|||
147015839|NCT00108082|530218551|FG002|Overall Study|Site Closed Study|0|||
147015840|NCT00108082|530218549|FG000|Overall Study|Protocol Amendment|0|||
147015841|NCT00108082|530218550|FG001|Overall Study|Protocol Amendment|1|||
147015842|NCT00108082|530218551|FG002|Overall Study|Protocol Amendment|0|||
147015843|NCT00108082|530218549|FG000|Overall Study|Study Medication Not Tapered|0|||
147015844|NCT00108082|530218550|FG001|Overall Study|Study Medication Not Tapered|1|||
147015845|NCT00108082|530218551|FG002|Overall Study|Study Medication Not Tapered|0|||
147015846|NCT00108082|530218549|FG000|Overall Study|Subject Left Site Location|1|||
147015847|NCT00108082|530218550|FG001|Overall Study|Subject Left Site Location|0|||
147015848|NCT00108082|530218551|FG002|Overall Study|Subject Left Site Location|0|||
147015849|NCT00108082|530218549|FG000|Overall Study|Investigator Not at Site|1|||
147015850|NCT00108082|530218550|FG001|Overall Study|Investigator Not at Site|0|||
147015851|NCT00108082|530218551|FG002|Overall Study|Investigator Not at Site|0|||
147015852|NCT00108082|530218549|FG000|Overall Study|Blood Pressure Not Controlled|1|||
147015853|NCT00108082|530218550|FG001|Overall Study|Blood Pressure Not Controlled|0|||
147015854|NCT00108082|530218551|FG002|Overall Study|Blood Pressure Not Controlled|0|||
147015855|NCT02940730|530218555|FG000|Intervention 2|Physician Decision|7|||
147015856|NCT02940730|530218556|FG001|Intervention 2|Physician Decision|0|||
147015857|NCT01522950|530218557|FG000|Overall Study|Withdrawal by Subject|3|||
147015858|NCT01522950|530218558|FG001|Overall Study|Withdrawal by Subject|2|||
147015859|NCT01522950|530218559|FG002|Overall Study|Withdrawal by Subject|1|||
147015860|NCT01522950|530218557|FG000|Overall Study|Adverse Event|3|||
147015861|NCT01522950|530218558|FG001|Overall Study|Adverse Event|1|||
147015862|NCT01522950|530218559|FG002|Overall Study|Adverse Event|1|||
147015863|NCT01522950|530218557|FG000|Overall Study|Protocol Violation|0|||
147015864|NCT01522950|530218558|FG001|Overall Study|Protocol Violation|0|||
147015865|NCT01522950|530218559|FG002|Overall Study|Protocol Violation|2|||
147015866|NCT01522950|530218557|FG000|Overall Study|Death|0|||
147015867|NCT01522950|530218558|FG001|Overall Study|Death|1|||
147015868|NCT01522950|530218559|FG002|Overall Study|Death|1|||
147015869|NCT01522950|530218557|FG000|Overall Study|Study Medication Sensitivity|0|||
147015870|NCT01522950|530218558|FG001|Overall Study|Study Medication Sensitivity|1|||
147015871|NCT01522950|530218559|FG002|Overall Study|Study Medication Sensitivity|0|||
147015872|NCT01091103|530218563|FG000|Overall Study|Adverse Event|1|||
147015873|NCT01091103|530218563|FG000|Overall Study|Progressive Disease|3|||
147015874|NCT03449199|530218564|FG000|Overall Study|Lost to Follow-up|1|||
147015875|NCT03449199|530218565|FG001|Overall Study|Lost to Follow-up|1|||
147015876|NCT03449199|530218566|FG002|Overall Study|Lost to Follow-up|0|||
147015877|NCT03449199|530218564|FG000|Overall Study|Protocol Deviation|0|||
147015878|NCT03449199|530218565|FG001|Overall Study|Protocol Deviation|0|||
147015879|NCT03449199|530218566|FG002|Overall Study|Protocol Deviation|1|||
147015880|NCT03449199|530218564|FG000|Overall Study|Withdrawal by Subject|0|||
147015881|NCT03449199|530218565|FG001|Overall Study|Withdrawal by Subject|0|||
147015882|NCT03449199|530218566|FG002|Overall Study|Withdrawal by Subject|1|||
147015883|NCT03136406|530218567|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
147015884|NCT01045707|530218568|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
147015885|NCT01045707|530218569|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
147015886|NCT01045707|530218568|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
147015887|NCT01045707|530218569|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
147015888|NCT01045707|530218568|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
147015889|NCT01045707|530218569|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
147015890|NCT01045707|530218568|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
147015891|NCT01045707|530218569|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
147015892|NCT01045707|530218568|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
147015893|NCT01045707|530218569|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
147015894|NCT01045707|530218568|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
147015895|NCT01045707|530218569|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
147015896|NCT01045707|530218568|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
147015897|NCT01045707|530218569|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
147015898|NCT01045707|530218568|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
147015899|NCT01045707|530218569|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
147015900|NCT01045707|530218568|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
147015901|NCT01045707|530218569|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
147015902|NCT00348816|530218570|FG000|Overall Study|Noncompliance with radiation treatment|1|||
147015903|NCT00848042|530218571|FG000|Overall Study|Death|1|||
147015904|NCT00848042|530218572|FG001|Overall Study|Death|2|||
147015905|NCT00848042|530218573|FG002|Overall Study|Death|0|||
147015906|NCT00848042|530218571|FG000|Overall Study|Other Therapy|3|||
147015907|NCT00848042|530218572|FG001|Overall Study|Other Therapy|0|||
147015908|NCT00848042|530218573|FG002|Overall Study|Other Therapy|0|||
147015909|NCT02448563|530218576|FG000|Overall Study|Lost to Follow-up|16|||
147015910|NCT02448563|530218577|FG001|Overall Study|Lost to Follow-up|10|||
147015911|NCT02448563|530218576|FG000|Overall Study|Withdrawal by Subject|0|||
147015912|NCT02448563|530218577|FG001|Overall Study|Withdrawal by Subject|1|||
147015913|NCT00721955|530218578|FG000|Overall Study|Adverse Event|0|||
147015914|NCT00721955|530218579|FG001|Overall Study|Adverse Event|0|||
147015915|NCT00721955|530218580|FG002|Overall Study|Adverse Event|2|||
147015916|NCT01077258|530218583|FG000|Overall Study|Lost to Follow-up|1390|||
147015917|NCT01077258|530218583|FG000|Overall Study|Adverse drug reaction|218|||
147015918|NCT01077258|530218583|FG000|Overall Study|Lack of Efficacy|663|||
147015919|NCT01077258|530218583|FG000|Overall Study|Clinical remission|37|||
147015920|NCT01077258|530218583|FG000|Overall Study|Other reasons|260|||
147015921|NCT00515216|530218584|FG000|Overall Study|Withdrawal by Subject|1|||
147015922|NCT01115933|530218587|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
147015923|NCT01086969|530218596|FG000|Overall Study|Withdrawal by Subject|1|||
147015924|NCT01086969|530218597|FG001|Overall Study|Withdrawal by Subject|2|||
147015925|NCT01086969|530218598|FG002|Overall Study|Withdrawal by Subject|0|||
147015926|NCT00250705|530218605|FG000|Overall Study|Lack of Efficacy|2|||
147015927|NCT00129116|530218614|FG000|Primary Phase|Lost to Follow-up|1|||
147015928|NCT00129116|530218615|FG001|Primary Phase|Lost to Follow-up|1|||
147015929|NCT00129116|530218616|FG002|Primary Phase|Lost to Follow-up|0|||
147015930|NCT00129116|530218617|FG003|Primary Phase|Lost to Follow-up|1|||
147015931|NCT00129116|530218618|FG004|Primary Phase|Lost to Follow-up|1|||
147015932|NCT00129116|530218614|FG000|Primary Phase|Protocol Violation|0|||
147015933|NCT00129116|530218615|FG001|Primary Phase|Protocol Violation|1|||
147015934|NCT00129116|530218616|FG002|Primary Phase|Protocol Violation|0|||
147015935|NCT00129116|530218617|FG003|Primary Phase|Protocol Violation|0|||
147015936|NCT00129116|530218618|FG004|Primary Phase|Protocol Violation|0|||
147015937|NCT00129116|530218614|FG000|Primary Phase|Adverse Event|1|||
147015938|NCT00129116|530218615|FG001|Primary Phase|Adverse Event|1|||
147015939|NCT00129116|530218616|FG002|Primary Phase|Adverse Event|0|||
147015940|NCT00129116|530218617|FG003|Primary Phase|Adverse Event|0|||
147015941|NCT00129116|530218618|FG004|Primary Phase|Adverse Event|0|||
147015942|NCT00129116|530218614|FG000|Primary Phase|Withdrawal by Subject|0|||
147015943|NCT00129116|530218615|FG001|Primary Phase|Withdrawal by Subject|1|||
147015944|NCT00129116|530218616|FG002|Primary Phase|Withdrawal by Subject|0|||
147015945|NCT00129116|530218617|FG003|Primary Phase|Withdrawal by Subject|0|||
147015946|NCT00129116|530218618|FG004|Primary Phase|Withdrawal by Subject|0|||
147015947|NCT00129116|530218614|FG000|Primary Phase|Other|0|||
147015948|NCT00129116|530218615|FG001|Primary Phase|Other|0|||
147015949|NCT00129116|530218616|FG002|Primary Phase|Other|1|||
147015950|NCT00129116|530218617|FG003|Primary Phase|Other|0|||
147015951|NCT00129116|530218618|FG004|Primary Phase|Other|0|||
147015952|NCT00129116|530218614|FG000|Booster Phase|Lost to Follow-up|2|||
147015953|NCT00129116|530218615|FG001|Booster Phase|Lost to Follow-up|0|||
147015954|NCT00129116|530218616|FG002|Booster Phase|Lost to Follow-up|0|||
147015955|NCT00129116|530218617|FG003|Booster Phase|Lost to Follow-up|0|||
147015956|NCT00129116|530218618|FG004|Booster Phase|Lost to Follow-up|1|||
147015957|NCT00879684|530218619|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
147015958|NCT00879684|530218620|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
147015959|NCT00879684|530218621|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
147015960|NCT00879684|530218622|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
147015961|NCT00879684|530218623|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
147015962|NCT00879684|530218624|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
147015963|NCT00879684|530218625|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
147015964|NCT00879684|530218619|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
147015965|NCT00879684|530218620|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
147015966|NCT00879684|530218621|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
147015967|NCT00879684|530218622|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
147015968|NCT00879684|530218623|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
147015969|NCT00879684|530218624|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
147015970|NCT00879684|530218625|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
147015971|NCT00879684|530218619|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
147015972|NCT00879684|530218620|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
147015973|NCT00879684|530218621|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
147015974|NCT00879684|530218622|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
147015975|NCT00879684|530218623|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
147015976|NCT00879684|530218624|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
147015977|NCT00879684|530218625|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
147015978|NCT00879684|530218619|FG000|Stage 1: Dose Escalation|Death|0|||
147015979|NCT00879684|530218620|FG001|Stage 1: Dose Escalation|Death|0|||
147015980|NCT00879684|530218621|FG002|Stage 1: Dose Escalation|Death|1|||
147015981|NCT00879684|530218622|FG003|Stage 1: Dose Escalation|Death|0|||
147015982|NCT00879684|530218623|FG004|Stage 1: Dose Escalation|Death|0|||
147015983|NCT00879684|530218624|FG005|Stage 1: Dose Escalation|Death|0|||
147015984|NCT00879684|530218625|FG006|Stage 1: Dose Escalation|Death|0|||
147015985|NCT00879684|530218619|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
147015986|NCT00879684|530218620|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
147015987|NCT00879684|530218621|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
147015988|NCT00879684|530218622|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
147015989|NCT00879684|530218623|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
147015990|NCT00879684|530218624|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
147015991|NCT00879684|530218625|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
147015992|NCT00879684|530218619|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
147015993|NCT00879684|530218620|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
147015994|NCT00879684|530218621|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
147015995|NCT00879684|530218622|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
147015996|NCT00879684|530218623|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
147015997|NCT00879684|530218624|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
147015998|NCT00879684|530218625|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
147015999|NCT00879684|530218619|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
147016000|NCT00879684|530218620|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
147016001|NCT00879684|530218621|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
147016002|NCT00879684|530218622|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
147016003|NCT00879684|530218623|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
147016004|NCT00879684|530218624|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
147016005|NCT00879684|530218625|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
147016006|NCT00708682|530218626|FG000|Infant Series|Adverse Event|1|||
147016007|NCT00708682|530218626|FG000|Infant Series|Lost to Follow-up|4|||
147016008|NCT00708682|530218626|FG000|Infant Series|Protocol Violation|1|||
147016009|NCT00708682|530218626|FG000|Infant Series|Parent/legal guardian request|6|||
147016010|NCT00708682|530218626|FG000|Infant Series|Failed to return|2|||
147016011|NCT00708682|530218626|FG000|Infant Series|Other|19|||
147016012|NCT00708682|530218626|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
147016013|NCT00708682|530218626|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
147016014|NCT00708682|530218626|FG000|Toddler Dose|Lost to Follow-up|3|||
147016015|NCT00708682|530218626|FG000|Toddler Dose|Failed to Return|4|||
147016016|NCT01148225|530218629|FG000|Overall Study|Other|185|||
147016017|NCT03689894|530218630|FG000|Overall Study|Adverse Event|1|||
147016018|NCT02839798|530219883|FG000|Overall Study|Withdrawal by Subject|2|||
147016019|NCT04703855|530219884|FG000|Overall Study|Heart Transplant|1|||
147016020|NCT05258630|530219886|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
147016021|NCT05258630|530219887|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
147016022|NCT05258630|530219886|FG000|Overall Study|Lost to Follow-up|0|||
147016023|NCT05258630|530219887|FG001|Overall Study|Lost to Follow-up|2|||
147016024|NCT03431337|530219888|FG000|Overall Study|Lost to Follow-up|21|||
147016025|NCT03431337|530219889|FG001|Overall Study|Lost to Follow-up|19|||
147016026|NCT03431337|530219888|FG000|Overall Study|Withdrawal by Subject|8|||
147016027|NCT03431337|530219889|FG001|Overall Study|Withdrawal by Subject|3|||
147016028|NCT00401245|530219890|FG000|Double Blind Titration Phase|Adverse Event|3|||
147016029|NCT00401245|530219891|FG001|Double Blind Titration Phase|Adverse Event|2|||
147016030|NCT00401245|530219892|FG002|Double Blind Titration Phase|Adverse Event|5|||
147016031|NCT00401245|530219893|FG003|Double Blind Titration Phase|Adverse Event|12|||
147016032|NCT00401245|530219894|FG004|Double Blind Titration Phase|Adverse Event|0|||
147016033|NCT00401245|530219895|FG005|Double Blind Titration Phase|Adverse Event|0|||
147016034|NCT00401245|530219896|FG006|Double Blind Titration Phase|Adverse Event|0|||
147016035|NCT00401245|530219897|FG007|Double Blind Titration Phase|Adverse Event|0|||
147016036|NCT00401245|530219890|FG000|Double Blind Titration Phase|Other|0|||
147016037|NCT00401245|530219891|FG001|Double Blind Titration Phase|Other|0|||
147016038|NCT00401245|530219892|FG002|Double Blind Titration Phase|Other|1|||
147016039|NCT00401245|530219893|FG003|Double Blind Titration Phase|Other|0|||
147016040|NCT00401245|530219894|FG004|Double Blind Titration Phase|Other|0|||
147016041|NCT00401245|530219895|FG005|Double Blind Titration Phase|Other|0|||
147016042|NCT00401245|530219896|FG006|Double Blind Titration Phase|Other|0|||
147016043|NCT00401245|530219897|FG007|Double Blind Titration Phase|Other|0|||
147016044|NCT00401245|530219890|FG000|Double Blind Titration Phase|Protocol Violation|0|||
147016045|NCT00401245|530219891|FG001|Double Blind Titration Phase|Protocol Violation|0|||
147016046|NCT00401245|530219892|FG002|Double Blind Titration Phase|Protocol Violation|0|||
147016047|NCT00401245|530219893|FG003|Double Blind Titration Phase|Protocol Violation|1|||
147016048|NCT00401245|530219894|FG004|Double Blind Titration Phase|Protocol Violation|0|||
147016049|NCT00401245|530219895|FG005|Double Blind Titration Phase|Protocol Violation|0|||
147016050|NCT00401245|530219896|FG006|Double Blind Titration Phase|Protocol Violation|0|||
147016051|NCT00401245|530219897|FG007|Double Blind Titration Phase|Protocol Violation|0|||
147016052|NCT00401245|530219890|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
147016053|NCT00401245|530219891|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
147016054|NCT00401245|530219892|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
147016055|NCT00401245|530219893|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
147016056|NCT00401245|530219894|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
147016057|NCT00401245|530219895|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
147016058|NCT00401245|530219896|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
147016059|NCT00401245|530219897|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
147016060|NCT00401245|530219890|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
147016061|NCT00401245|530219891|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
147016062|NCT00401245|530219892|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
147016063|NCT00401245|530219893|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
146736535|NCT05375955|529206890|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
147016064|NCT00401245|530219894|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
147016065|NCT00401245|530219895|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
147016066|NCT00401245|530219896|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
147016067|NCT00401245|530219897|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
147016068|NCT00401245|530219890|FG000|Open Label Phase|Adverse Event|5|||
147016069|NCT00401245|530219891|FG001|Open Label Phase|Adverse Event|14|||
147016070|NCT00401245|530219892|FG002|Open Label Phase|Adverse Event|6|||
147016071|NCT00401245|530219893|FG003|Open Label Phase|Adverse Event|7|||
147016072|NCT00401245|530219894|FG004|Open Label Phase|Adverse Event|0|||
147016073|NCT00401245|530219895|FG005|Open Label Phase|Adverse Event|0|||
147016074|NCT00401245|530219896|FG006|Open Label Phase|Adverse Event|0|||
147016075|NCT00401245|530219897|FG007|Open Label Phase|Adverse Event|0|||
147016076|NCT00401245|530219890|FG000|Open Label Phase|Lost to Follow-up|5|||
147016077|NCT00401245|530219891|FG001|Open Label Phase|Lost to Follow-up|7|||
147016078|NCT00401245|530219892|FG002|Open Label Phase|Lost to Follow-up|5|||
147016079|NCT00401245|530219893|FG003|Open Label Phase|Lost to Follow-up|4|||
147016080|NCT00401245|530219894|FG004|Open Label Phase|Lost to Follow-up|0|||
147016081|NCT00401245|530219895|FG005|Open Label Phase|Lost to Follow-up|0|||
147016082|NCT00401245|530219896|FG006|Open Label Phase|Lost to Follow-up|0|||
147016083|NCT00401245|530219897|FG007|Open Label Phase|Lost to Follow-up|0|||
147016084|NCT00401245|530219890|FG000|Open Label Phase|Other|4|||
147016085|NCT00401245|530219891|FG001|Open Label Phase|Other|8|||
147016086|NCT00401245|530219892|FG002|Open Label Phase|Other|7|||
147016087|NCT00401245|530219893|FG003|Open Label Phase|Other|8|||
147016088|NCT00401245|530219894|FG004|Open Label Phase|Other|0|||
147016089|NCT00401245|530219895|FG005|Open Label Phase|Other|0|||
147016090|NCT00401245|530219896|FG006|Open Label Phase|Other|0|||
147016091|NCT00401245|530219897|FG007|Open Label Phase|Other|0|||
147016092|NCT00401245|530219890|FG000|Open Label Phase|Protocol Violation|0|||
147016093|NCT00401245|530219891|FG001|Open Label Phase|Protocol Violation|1|||
147016094|NCT00401245|530219892|FG002|Open Label Phase|Protocol Violation|0|||
147016095|NCT00401245|530219893|FG003|Open Label Phase|Protocol Violation|1|||
147016096|NCT00401245|530219894|FG004|Open Label Phase|Protocol Violation|0|||
147016097|NCT00401245|530219895|FG005|Open Label Phase|Protocol Violation|0|||
147016098|NCT00401245|530219896|FG006|Open Label Phase|Protocol Violation|0|||
147016099|NCT00401245|530219897|FG007|Open Label Phase|Protocol Violation|0|||
147016100|NCT00401245|530219890|FG000|Open Label Phase|Withdrawal by Subject|3|||
147016101|NCT00401245|530219891|FG001|Open Label Phase|Withdrawal by Subject|3|||
147016102|NCT00401245|530219892|FG002|Open Label Phase|Withdrawal by Subject|2|||
147016103|NCT00401245|530219893|FG003|Open Label Phase|Withdrawal by Subject|1|||
147016104|NCT00401245|530219894|FG004|Open Label Phase|Withdrawal by Subject|0|||
147016105|NCT00401245|530219895|FG005|Open Label Phase|Withdrawal by Subject|0|||
147016106|NCT00401245|530219896|FG006|Open Label Phase|Withdrawal by Subject|0|||
147016107|NCT00401245|530219897|FG007|Open Label Phase|Withdrawal by Subject|0|||
147016108|NCT00401245|530219890|FG000|Open Label Phase|Lack of Efficacy|4|||
147016109|NCT00401245|530219891|FG001|Open Label Phase|Lack of Efficacy|2|||
147016110|NCT00401245|530219892|FG002|Open Label Phase|Lack of Efficacy|3|||
147016111|NCT00401245|530219893|FG003|Open Label Phase|Lack of Efficacy|0|||
147016112|NCT00401245|530219894|FG004|Open Label Phase|Lack of Efficacy|0|||
147016113|NCT00401245|530219895|FG005|Open Label Phase|Lack of Efficacy|0|||
147016114|NCT00401245|530219896|FG006|Open Label Phase|Lack of Efficacy|0|||
147016115|NCT00401245|530219897|FG007|Open Label Phase|Lack of Efficacy|0|||
147016116|NCT00401245|530219890|FG000|Double Blind Tapering Phase|Adverse Event|0|||
147016117|NCT00401245|530219891|FG001|Double Blind Tapering Phase|Adverse Event|0|||
147016118|NCT00401245|530219892|FG002|Double Blind Tapering Phase|Adverse Event|0|||
147016119|NCT00401245|530219893|FG003|Double Blind Tapering Phase|Adverse Event|0|||
147016120|NCT00401245|530219894|FG004|Double Blind Tapering Phase|Adverse Event|1|||
147016121|NCT00401245|530219895|FG005|Double Blind Tapering Phase|Adverse Event|1|||
147016122|NCT00401245|530219896|FG006|Double Blind Tapering Phase|Adverse Event|2|||
147016123|NCT00401245|530219897|FG007|Double Blind Tapering Phase|Adverse Event|4|||
147016124|NCT00401245|530219890|FG000|Double Blind Tapering Phase|Investigator request|0|||
147016125|NCT00401245|530219891|FG001|Double Blind Tapering Phase|Investigator request|0|||
147016126|NCT00401245|530219892|FG002|Double Blind Tapering Phase|Investigator request|0|||
147016127|NCT00401245|530219893|FG003|Double Blind Tapering Phase|Investigator request|0|||
147016128|NCT00401245|530219894|FG004|Double Blind Tapering Phase|Investigator request|0|||
147016129|NCT00401245|530219895|FG005|Double Blind Tapering Phase|Investigator request|0|||
147016130|NCT00401245|530219896|FG006|Double Blind Tapering Phase|Investigator request|0|||
147016131|NCT00401245|530219897|FG007|Double Blind Tapering Phase|Investigator request|1|||
147016132|NCT00401245|530219890|FG000|Double Blind Tapering Phase|Other|0|||
147016133|NCT00401245|530219891|FG001|Double Blind Tapering Phase|Other|0|||
147016134|NCT00401245|530219892|FG002|Double Blind Tapering Phase|Other|0|||
147016135|NCT00401245|530219893|FG003|Double Blind Tapering Phase|Other|0|||
147016136|NCT00401245|530219894|FG004|Double Blind Tapering Phase|Other|1|||
147016137|NCT00401245|530219895|FG005|Double Blind Tapering Phase|Other|0|||
147016138|NCT00401245|530219896|FG006|Double Blind Tapering Phase|Other|2|||
147016139|NCT00401245|530219897|FG007|Double Blind Tapering Phase|Other|2|||
147016140|NCT00401245|530219890|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
147016141|NCT00401245|530219891|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
147016142|NCT00401245|530219892|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
147016143|NCT00401245|530219893|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
147016144|NCT00401245|530219894|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
147016145|NCT00401245|530219895|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
147016146|NCT00401245|530219896|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
147016147|NCT00401245|530219897|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
147016148|NCT00401245|530219890|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
147016149|NCT00401245|530219891|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
147016150|NCT00401245|530219892|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
147016151|NCT00401245|530219893|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
147016152|NCT00401245|530219894|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
147016153|NCT00401245|530219895|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
147016154|NCT00401245|530219896|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
147016155|NCT00401245|530219897|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
147016156|NCT01560819|530219901|FG000|Overall Study|Physician Decision|1|||
147016157|NCT01560819|530219902|FG001|Overall Study|Physician Decision|0|||
147016158|NCT02014441|530219903|FG000|Overall Study|Withdrawal by Subject|12|||
147016159|NCT01363011|530219904|FG000|Main Study|Adverse Event|2|||
147016160|NCT01363011|530219905|FG001|Main Study|Adverse Event|3|||
147016161|NCT01363011|530219904|FG000|Main Study|Investigator's Discretion|1|||
147016162|NCT01363011|530219905|FG001|Main Study|Investigator's Discretion|1|||
147016163|NCT01363011|530219904|FG000|Main Study|Withdrew Consent|1|||
147016164|NCT01363011|530219905|FG001|Main Study|Withdrew Consent|4|||
147016165|NCT01363011|530219904|FG000|Main Study|Protocol Violation|0|||
147016166|NCT01363011|530219905|FG001|Main Study|Protocol Violation|1|||
147016167|NCT01363011|530219904|FG000|Extension Phase|Adverse Event|1|||
147016168|NCT01363011|530219905|FG001|Extension Phase|Adverse Event|1|||
147016169|NCT01363011|530219904|FG000|Extension Phase|Lack of Efficacy|0|||
147016170|NCT01363011|530219905|FG001|Extension Phase|Lack of Efficacy|1|||
147016171|NCT01363011|530219904|FG000|Extension Phase|Investigator's Discretion|2|||
147016172|NCT01363011|530219905|FG001|Extension Phase|Investigator's Discretion|2|||
147016173|NCT01363011|530219904|FG000|Extension Phase|Withdrew Consent|0|||
147016174|NCT01363011|530219905|FG001|Extension Phase|Withdrew Consent|1|||
147016175|NCT01363011|530219904|FG000|Extension Phase|Lost to Follow-up|0|||
147016176|NCT01363011|530219905|FG001|Extension Phase|Lost to Follow-up|2|||
147016177|NCT01363011|530219904|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
147016178|NCT01363011|530219905|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
147016179|NCT00114231|530219906|FG000|Overall Study|No consent|2|||
147016180|NCT00114231|530219907|FG001|Overall Study|No consent|0|||
147016181|NCT00114231|530219906|FG000|Overall Study|QARC requirement not met|1|||
147016182|NCT00114231|530219907|FG001|Overall Study|QARC requirement not met|0|||
147016183|NCT00114231|530219906|FG000|Overall Study|Suspected metastatic disease|1|||
147016184|NCT00114231|530219907|FG001|Overall Study|Suspected metastatic disease|0|||
147016185|NCT00114231|530219906|FG000|Overall Study|No adenocarcinoma|1|||
147016186|NCT00114231|530219907|FG001|Overall Study|No adenocarcinoma|0|||
147016187|NCT00114231|530219906|FG000|Overall Study|Low creatinine clearance|0|||
147016188|NCT00114231|530219907|FG001|Overall Study|Low creatinine clearance|1|||
147016189|NCT00114231|530219906|FG000|Overall Study|Tumor size > 4cm|1|||
147016190|NCT00114231|530219907|FG001|Overall Study|Tumor size > 4cm|0|||
147016191|NCT00114231|530219906|FG000|Overall Study|Tumor fixed on digital exam|0|||
147016192|NCT00114231|530219907|FG001|Overall Study|Tumor fixed on digital exam|1|||
147016193|NCT00114231|530219906|FG000|Overall Study|No Absolute Neutrophil Count|2|||
147016194|NCT00114231|530219907|FG001|Overall Study|No Absolute Neutrophil Count|0|||
147016195|NCT00114231|530219906|FG000|Overall Study|Biopsy done after registration|1|||
147016196|NCT00114231|530219907|FG001|Overall Study|Biopsy done after registration|0|||
147016197|NCT01961882|530219912|FG000|Overall Study|Adverse Event|3|||
147016198|NCT01961882|530219913|FG001|Overall Study|Adverse Event|2|||
147016199|NCT01961882|530219912|FG000|Overall Study|Physician Decision|1|||
147016200|NCT01961882|530219913|FG001|Overall Study|Physician Decision|0|||
147016201|NCT01961882|530219912|FG000|Overall Study|Withdrawal by Subject|4|||
146849001|NCT01820585|529617008|FG001|Overall Study|Lack of Efficacy|7|||
146849002|NCT01820585|529617009|FG002|Overall Study|Lack of Efficacy|5|||
146849003|NCT01820585|529617010|FG003|Overall Study|Lack of Efficacy|1|||
146849004|NCT01820585|529617007|FG000|Overall Study|Withdrawal by Subject|3|||
146849005|NCT01820585|529617008|FG001|Overall Study|Withdrawal by Subject|7|||
146849006|NCT01820585|529617009|FG002|Overall Study|Withdrawal by Subject|3|||
146849007|NCT01820585|529617010|FG003|Overall Study|Withdrawal by Subject|8|||
146849008|NCT01820585|529617007|FG000|Overall Study|Lost to Follow-up|3|||
147016202|NCT01961882|530219913|FG001|Overall Study|Withdrawal by Subject|1|||
147016203|NCT01961882|530219912|FG000|Overall Study|Relapse of AML|39|||
147016204|NCT01961882|530219913|FG001|Overall Study|Relapse of AML|37|||
147016205|NCT01961882|530219912|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
147016206|NCT01961882|530219913|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
147016207|NCT01961882|530219912|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
147016208|NCT01961882|530219913|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
147016209|NCT01901848|530219914|FG000|Randomized and Treated|Lost to Follow-up|3|||
147016210|NCT01901848|530219915|FG001|Randomized and Treated|Lost to Follow-up|6|||
147016211|NCT01901848|530219914|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
147016212|NCT01901848|530219915|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
147016213|NCT01729026|530219916|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
147016214|NCT01729026|530219917|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
147016215|NCT01729026|530219916|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
147016216|NCT01729026|530219917|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
147016217|NCT02488824|530219918|FG000|Overall Study|Adverse Event|1|||
147016218|NCT02488824|530219919|FG001|Overall Study|Adverse Event|1|||
147016219|NCT02668822|530219924|FG000|Overall Study|Protocol Violation|2|||
147016220|NCT02668822|530219925|FG001|Overall Study|Protocol Violation|0|||
147016221|NCT02668822|530219924|FG000|Overall Study|Study Terminated by Sponsor|7|||
147016222|NCT02668822|530219925|FG001|Overall Study|Study Terminated by Sponsor|9|||
147016223|NCT03036839|530219926|FG000|Overall Study|Adverse Event|0|||
147016224|NCT03036839|530219927|FG001|Overall Study|Adverse Event|0|||
147016225|NCT03036839|530219928|FG002|Overall Study|Adverse Event|1|||
147016226|NCT03036839|530219926|FG000|Overall Study|Death|3|||
147016227|NCT03036839|530219927|FG001|Overall Study|Death|0|||
147016228|NCT03036839|530219928|FG002|Overall Study|Death|3|||
147016229|NCT03036839|530219926|FG000|Overall Study|Withdrew Consent|0|||
147016230|NCT03036839|530219927|FG001|Overall Study|Withdrew Consent|0|||
147016231|NCT03036839|530219928|FG002|Overall Study|Withdrew Consent|1|||
147016232|NCT00412737|530219929|FG000|Overall Study|Death|1|||
147016233|NCT00412737|530219930|FG001|Overall Study|Death|0|||
147016234|NCT00412737|530219929|FG000|Overall Study|Adverse Event|3|||
147016235|NCT00412737|530219930|FG001|Overall Study|Adverse Event|2|||
147016236|NCT00412737|530219929|FG000|Overall Study|Refused Treatment|6|||
147016237|NCT00412737|530219930|FG001|Overall Study|Refused Treatment|2|||
147016238|NCT00412737|530219929|FG000|Overall Study|Failure to Return|6|||
147016239|NCT00412737|530219930|FG001|Overall Study|Failure to Return|2|||
147016240|NCT01064531|530219931|FG000|Overall Study|Lost to Follow-up|0|||
147016241|NCT01064531|530219932|FG001|Overall Study|Lost to Follow-up|2|||
147016242|NCT01064531|530219931|FG000|Overall Study|Physician Decision|0|||
147016243|NCT01064531|530219932|FG001|Overall Study|Physician Decision|1|||
147016244|NCT01064531|530219931|FG000|Overall Study|Withdrawal by Subject|2|||
147016245|NCT01064531|530219932|FG001|Overall Study|Withdrawal by Subject|2|||
147016246|NCT01064531|530219931|FG000|Overall Study|Revision due to femoral stem loosening|1|||
147016247|NCT01064531|530219932|FG001|Overall Study|Revision due to femoral stem loosening|0|||
147016248|NCT01064531|530219931|FG000|Overall Study|Revision due to dislocation|0|||
147016249|NCT01064531|530219932|FG001|Overall Study|Revision due to dislocation|1|||
147016250|NCT01064531|530219931|FG000|Overall Study|Death|0|||
147016251|NCT01064531|530219932|FG001|Overall Study|Death|1|||
147016252|NCT00298740|530219933|FG000|Overall Study|Lack of Efficacy|6|||
147016253|NCT00298740|530219933|FG000|Overall Study|Withdrawal by Subject|3|||
147016254|NCT01270620|530219937|FG000|Overall Study|Withdrawal by Subject|1|||
147016255|NCT01270620|530219938|FG001|Overall Study|Withdrawal by Subject|3|||
147016256|NCT00684567|530219939|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
147016257|NCT00684567|530219939|FG000|Monotherapy Period|Adverse Event|2|||
147016258|NCT00684567|530219939|FG000|Monotherapy Period|Death|1|||
147016259|NCT00684567|530219939|FG000|Monotherapy Period|Progression of primary disease|11|||
147016260|NCT00906373|530219940|FG000|Overall Study|Withdrawal by Subject|0|||
147016261|NCT00906373|530219941|FG001|Overall Study|Withdrawal by Subject|5|||
147016262|NCT00906373|530219940|FG000|Overall Study|Other|0|||
147016263|NCT00906373|530219941|FG001|Overall Study|Other|1|||
147016264|NCT00906373|530219940|FG000|Overall Study|Still on treatment at cutoff date|0|||
147016265|NCT00906373|530219941|FG001|Overall Study|Still on treatment at cutoff date|2|||
147016266|NCT01597479|530219942|FG000|Overall Study|Protocol Violation|1|||
147016267|NCT01597479|530219943|FG001|Overall Study|Protocol Violation|0|||
147016268|NCT01597479|530219942|FG000|Overall Study|Lost to Follow-up|1|||
147016269|NCT01597479|530219943|FG001|Overall Study|Lost to Follow-up|0|||
147016270|NCT04317599|530219944|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
147016271|NCT04317599|530219944|FG000|Overall Study|treatment outside standard of care|4|||
147016272|NCT00809965|530219945|FG000|Overall Study|Death|194|||
147016273|NCT00809965|530219946|FG001|Overall Study|Death|147|||
147016274|NCT00809965|530219947|FG002|Overall Study|Death|196|||
147016275|NCT00809965|530219945|FG000|Overall Study|Lost to Follow-up|17|||
147016276|NCT00809965|530219946|FG001|Overall Study|Lost to Follow-up|10|||
147016277|NCT00809965|530219947|FG002|Overall Study|Lost to Follow-up|18|||
147016278|NCT00809965|530219945|FG000|Overall Study|Withdrawal by Subject|405|||
147016279|NCT00809965|530219946|FG001|Overall Study|Withdrawal by Subject|448|||
147016280|NCT00809965|530219947|FG002|Overall Study|Withdrawal by Subject|441|||
147016281|NCT00809965|530219945|FG000|Overall Study|Other Reason|167|||
147016282|NCT00809965|530219946|FG001|Overall Study|Other Reason|170|||
147016283|NCT00809965|530219947|FG002|Overall Study|Other Reason|189|||
147016284|NCT01628549|530219950|FG000|Overall Study|Adverse Event|1|||
147016285|NCT01628549|530219951|FG001|Overall Study|Adverse Event|1|||
147016286|NCT01628549|530219952|FG002|Overall Study|Adverse Event|0|||
147016287|NCT01628549|530219953|FG003|Overall Study|Adverse Event|4|||
147016288|NCT01628549|530219950|FG000|Overall Study|Lost to Follow-up|3|||
147016289|NCT01628549|530219951|FG001|Overall Study|Lost to Follow-up|4|||
147016290|NCT01628549|530219952|FG002|Overall Study|Lost to Follow-up|3|||
147016291|NCT01628549|530219953|FG003|Overall Study|Lost to Follow-up|3|||
147016292|NCT01628549|530219950|FG000|Overall Study|Withdrawal by Subject|3|||
147016293|NCT01628549|530219951|FG001|Overall Study|Withdrawal by Subject|4|||
147016294|NCT01628549|530219952|FG002|Overall Study|Withdrawal by Subject|4|||
147016295|NCT01628549|530219953|FG003|Overall Study|Withdrawal by Subject|1|||
147016296|NCT01628549|530219950|FG000|Overall Study|Protocol Violation|2|||
147016297|NCT01628549|530219951|FG001|Overall Study|Protocol Violation|1|||
147016298|NCT01628549|530219952|FG002|Overall Study|Protocol Violation|1|||
147016299|NCT01628549|530219953|FG003|Overall Study|Protocol Violation|0|||
147016300|NCT01628549|530219950|FG000|Overall Study|withdrawn for noncompliance|0|||
147016301|NCT01628549|530219951|FG001|Overall Study|withdrawn for noncompliance|2|||
147016302|NCT01628549|530219952|FG002|Overall Study|withdrawn for noncompliance|1|||
147016303|NCT01628549|530219953|FG003|Overall Study|withdrawn for noncompliance|0|||
147016304|NCT01628549|530219950|FG000|Overall Study|abnormal laboratory test results|0|||
147016305|NCT01628549|530219951|FG001|Overall Study|abnormal laboratory test results|0|||
147016306|NCT01628549|530219952|FG002|Overall Study|abnormal laboratory test results|1|||
147016307|NCT01628549|530219953|FG003|Overall Study|abnormal laboratory test results|0|||
147016308|NCT01628549|530219950|FG000|Overall Study|positive pregnancy test|0|||
147016309|NCT01628549|530219951|FG001|Overall Study|positive pregnancy test|0|||
147016310|NCT01628549|530219952|FG002|Overall Study|positive pregnancy test|0|||
147016311|NCT01628549|530219953|FG003|Overall Study|positive pregnancy test|1|||
147016312|NCT01999894|530219954|FG000|Overall Study|Adverse Event|9|||
147016313|NCT01999894|530219954|FG000|Overall Study|Lack of Efficacy|5|||
147016314|NCT01999894|530219954|FG000|Overall Study|Protocol Violation|1|||
147016315|NCT01999894|530219954|FG000|Overall Study|Withdrawal by Subject|7|||
147016316|NCT01999894|530219954|FG000|Overall Study|Lost to Follow-up|10|||
147016317|NCT01999894|530219954|FG000|Overall Study|Other Reason|3|||
147016318|NCT01999894|530219954|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
147016319|NCT01519947|530219957|FG000|Overall Study|Death|0|||
147016320|NCT01519947|530219958|FG001|Overall Study|Death|0|||
147016321|NCT01519947|530219959|FG002|Overall Study|Death|0|||
147016322|NCT01519947|530219960|FG003|Overall Study|Death|1|||
147016323|NCT01519947|530219957|FG000|Overall Study|Protocol Violation|0|||
147016324|NCT01519947|530219958|FG001|Overall Study|Protocol Violation|0|||
147016325|NCT01519947|530219959|FG002|Overall Study|Protocol Violation|2|||
147016326|NCT01519947|530219960|FG003|Overall Study|Protocol Violation|1|||
147016327|NCT01519947|530219957|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
147016328|NCT01519947|530219958|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
147016329|NCT01519947|530219959|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
147016330|NCT01519947|530219960|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
147016331|NCT01519947|530219957|FG000|Overall Study|Development of Anemia|0|||
147016332|NCT01519947|530219958|FG001|Overall Study|Development of Anemia|1|||
147016333|NCT01519947|530219959|FG002|Overall Study|Development of Anemia|0|||
147016334|NCT01519947|530219960|FG003|Overall Study|Development of Anemia|1|||
147016335|NCT01519947|530219957|FG000|Overall Study|Blood Transfusion|0|||
147016336|NCT01519947|530219958|FG001|Overall Study|Blood Transfusion|1|||
147016337|NCT01519947|530219959|FG002|Overall Study|Blood Transfusion|1|||
147016338|NCT01519947|530219960|FG003|Overall Study|Blood Transfusion|0|||
147016339|NCT01519947|530219957|FG000|Overall Study|Withdrawal by Subject|0|||
147016340|NCT01519947|530219958|FG001|Overall Study|Withdrawal by Subject|1|||
147016341|NCT01519947|530219959|FG002|Overall Study|Withdrawal by Subject|0|||
147016342|NCT01519947|530219960|FG003|Overall Study|Withdrawal by Subject|1|||
147016343|NCT01519947|530219957|FG000|Overall Study|Lost to Follow-up|0|||
147016344|NCT01519947|530219958|FG001|Overall Study|Lost to Follow-up|0|||
147016345|NCT01519947|530219959|FG002|Overall Study|Lost to Follow-up|3|||
147016346|NCT01519947|530219960|FG003|Overall Study|Lost to Follow-up|2|||
147016347|NCT01519947|530219957|FG000|Overall Study|Poor Response|1|||
147016348|NCT01519947|530219958|FG001|Overall Study|Poor Response|0|||
147016349|NCT01519947|530219959|FG002|Overall Study|Poor Response|0|||
147016350|NCT01519947|530219960|FG003|Overall Study|Poor Response|1|||
147016351|NCT01519947|530219957|FG000|Overall Study|Adverse Event|1|||
147016352|NCT01519947|530219958|FG001|Overall Study|Adverse Event|0|||
147016353|NCT01519947|530219959|FG002|Overall Study|Adverse Event|1|||
147016354|NCT01519947|530219960|FG003|Overall Study|Adverse Event|1|||
147016355|NCT00693225|530219961|FG000|Overall Study|Lost to Follow-up|1|||
147016356|NCT00693225|530219962|FG001|Overall Study|Lost to Follow-up|2|||
147016357|NCT00693225|530219961|FG000|Overall Study|Adverse Event|1|||
147016358|NCT00693225|530219962|FG001|Overall Study|Adverse Event|3|||
147016359|NCT00372996|530219964|FG000|Overall Study|Death|11|||
147016360|NCT00372996|530219965|FG001|Overall Study|Death|4|||
147016361|NCT00372996|530219966|FG002|Overall Study|Death|8|||
147016362|NCT00372996|530219967|FG003|Overall Study|Death|7|||
147016363|NCT00372996|530219964|FG000|Overall Study|Lost to Follow-up|0|||
146849009|NCT01820585|529617008|FG001|Overall Study|Lost to Follow-up|3|||
146849010|NCT01820585|529617009|FG002|Overall Study|Lost to Follow-up|0|||
146849011|NCT01820585|529617010|FG003|Overall Study|Lost to Follow-up|3|||
146849012|NCT01820585|529617007|FG000|Overall Study|Protocol Violation|3|||
146849013|NCT01820585|529617008|FG001|Overall Study|Protocol Violation|1|||
146849014|NCT01820585|529617009|FG002|Overall Study|Protocol Violation|1|||
146849015|NCT01820585|529617010|FG003|Overall Study|Protocol Violation|1|||
146849016|NCT01820585|529617007|FG000|Overall Study|Subject non-compliance|0|||
146849017|NCT01820585|529617008|FG001|Overall Study|Subject non-compliance|0|||
146849018|NCT01820585|529617009|FG002|Overall Study|Subject non-compliance|1|||
146849019|NCT01820585|529617010|FG003|Overall Study|Subject non-compliance|2|||
146849020|NCT01820585|529617007|FG000|Overall Study|at sponsor request|0|||
146849021|NCT01820585|529617008|FG001|Overall Study|at sponsor request|0|||
146849022|NCT01820585|529617009|FG002|Overall Study|at sponsor request|1|||
146849023|NCT01820585|529617010|FG003|Overall Study|at sponsor request|0|||
146849024|NCT01820585|529617007|FG000|Overall Study|Pregnancy|0|||
146849025|NCT01820585|529617008|FG001|Overall Study|Pregnancy|1|||
146849026|NCT01820585|529617009|FG002|Overall Study|Pregnancy|0|||
146849027|NCT01820585|529617010|FG003|Overall Study|Pregnancy|0|||
146849028|NCT02544451|529617011|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
146849029|NCT02544451|529617012|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
146849030|NCT02544451|529617013|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
146849031|NCT02544451|529617014|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
146849032|NCT02544451|529617011|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
146849033|NCT02544451|529617012|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
146849034|NCT02544451|529617013|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
146849035|NCT02544451|529617014|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
146849036|NCT02544451|529617011|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
146849037|NCT02544451|529617012|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
146849038|NCT02544451|529617013|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
146849039|NCT02544451|529617014|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
146849040|NCT02544451|529617011|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
146849041|NCT02544451|529617012|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
146849042|NCT02544451|529617013|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
146849043|NCT02544451|529617014|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
146849044|NCT02544451|529617011|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
146849045|NCT02544451|529617012|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
146849046|NCT02544451|529617013|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
146849047|NCT02544451|529617014|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
146849048|NCT02544451|529617011|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
146849049|NCT02544451|529617012|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
146849050|NCT02544451|529617013|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
146849051|NCT02544451|529617014|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
146849052|NCT05086276|529617015|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
146849053|NCT05086276|529617016|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
146849054|NCT03590366|529617017|FG000|Overall Study|Adverse Event|0|||
146849055|NCT03590366|529617018|FG001|Overall Study|Adverse Event|3|||
146849056|NCT03590366|529617017|FG000|Overall Study|Lost to Follow-up|3|||
146849057|NCT03590366|529617018|FG001|Overall Study|Lost to Follow-up|3|||
146849058|NCT03590366|529617017|FG000|Overall Study|Withdrawal by Subject|0|||
146849059|NCT03590366|529617018|FG001|Overall Study|Withdrawal by Subject|2|||
146849060|NCT00738894|529617020|FG000|Overall Study|Lost to Follow-up|23|||
146849061|NCT00738894|529617021|FG001|Overall Study|Lost to Follow-up|13|||
146849062|NCT00738894|529617020|FG000|Overall Study|Withdrawal by Subject|10|||
146849063|NCT00738894|529617021|FG001|Overall Study|Withdrawal by Subject|15|||
147016364|NCT00372996|530219965|FG001|Overall Study|Lost to Follow-up|2|||
147016365|NCT00372996|530219966|FG002|Overall Study|Lost to Follow-up|0|||
147016366|NCT00372996|530219967|FG003|Overall Study|Lost to Follow-up|1|||
147016367|NCT00372996|530219964|FG000|Overall Study|Withdrawal by Subject|12|||
147016368|NCT00372996|530219965|FG001|Overall Study|Withdrawal by Subject|6|||
147016369|NCT00372996|530219966|FG002|Overall Study|Withdrawal by Subject|9|||
147016370|NCT00372996|530219967|FG003|Overall Study|Withdrawal by Subject|5|||
147016371|NCT00372996|530219964|FG000|Overall Study|Study Terminated by Sponsor|4|||
147016372|NCT00372996|530219965|FG001|Overall Study|Study Terminated by Sponsor|0|||
147016373|NCT00372996|530219966|FG002|Overall Study|Study Terminated by Sponsor|4|||
147016374|NCT00372996|530219967|FG003|Overall Study|Study Terminated by Sponsor|0|||
147016375|NCT00372996|530219964|FG000|Overall Study|Other|10|||
147016376|NCT00372996|530219965|FG001|Overall Study|Other|2|||
147016377|NCT00372996|530219966|FG002|Overall Study|Other|7|||
147016378|NCT00372996|530219967|FG003|Overall Study|Other|7|||
146849064|NCT00738894|529617020|FG000|Overall Study|Physician Decision|4|||
146849065|NCT00738894|529617021|FG001|Overall Study|Physician Decision|5|||
146849066|NCT00738894|529617020|FG000|Overall Study|Death|2|||
146849067|NCT00738894|529617021|FG001|Overall Study|Death|0|||
147016379|NCT01186016|530219968|FG000|Overall Study|Withdrawal by Subject|46|||
147016380|NCT01186016|530219969|FG001|Overall Study|Withdrawal by Subject|29|||
147016381|NCT02250651|530219974|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
147016382|NCT02250651|530219975|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
147016383|NCT02250651|530219976|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
147016384|NCT02250651|530219974|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
147016385|NCT02250651|530219975|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
147016386|NCT02250651|530219976|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
147016387|NCT02250651|530219974|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
147016388|NCT02250651|530219975|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
147016389|NCT02250651|530219976|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
147016390|NCT02250651|530219974|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
147016391|NCT02250651|530219975|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
147016392|NCT02250651|530219976|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
147016393|NCT02250651|530219974|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
147016394|NCT02250651|530219975|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
147016395|NCT02250651|530219976|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
147016396|NCT02250651|530219974|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
147016397|NCT02250651|530219975|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
147016398|NCT02250651|530219976|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
147016399|NCT02250651|530219974|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
147016400|NCT02250651|530219975|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
147016401|NCT02250651|530219976|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
147016402|NCT02250651|530219974|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
147016403|NCT02250651|530219975|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
147016404|NCT02250651|530219976|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
147016405|NCT02250651|530219974|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
147016406|NCT02250651|530219975|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
147016407|NCT02250651|530219976|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
147016408|NCT02250651|530219974|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
147016409|NCT02250651|530219975|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
147016410|NCT02250651|530219976|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
147016411|NCT02250651|530219974|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
147016412|NCT02250651|530219975|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
147016413|NCT02250651|530219976|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
147016414|NCT02250651|530219974|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
147016415|NCT02250651|530219975|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
147016416|NCT02250651|530219976|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
147016417|NCT02250651|530219974|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
147016418|NCT02250651|530219975|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
147016419|NCT02250651|530219976|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
147016420|NCT02250651|530219974|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
147016421|NCT02250651|530219975|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
147016422|NCT02250651|530219976|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
147016423|NCT02250651|530219974|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
147016424|NCT02250651|530219975|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
147016425|NCT02250651|530219976|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
147016426|NCT00676494|530219980|FG000|Overall Study|Missed Visit|8|||
147016427|NCT00676494|530219980|FG000|Overall Study|Withdrawal by Subject|6|||
147016428|NCT00732160|530219981|FG000|Overall Study|Adverse Event|1|||
147016429|NCT00732160|530219982|FG001|Overall Study|Adverse Event|0|||
147016430|NCT00732160|530219983|FG002|Overall Study|Adverse Event|1|||
147016431|NCT00732160|530219984|FG003|Overall Study|Adverse Event|1|||
147016432|NCT00732160|530219981|FG000|Overall Study|scheduling|4|||
147016433|NCT00732160|530219982|FG001|Overall Study|scheduling|4|||
147016434|NCT00732160|530219983|FG002|Overall Study|scheduling|2|||
147016435|NCT00732160|530219984|FG003|Overall Study|scheduling|1|||
147016436|NCT02795676|530219985|FG000|Overall Study|Adverse Event|2|||
147016437|NCT02795676|530219986|FG001|Overall Study|Adverse Event|0|||
147016438|NCT02795676|530219985|FG000|Overall Study|Withdrawal by Subject|3|||
147016439|NCT02795676|530219986|FG001|Overall Study|Withdrawal by Subject|1|||
147016440|NCT01203917|530219987|FG000|Overall Study|Death|29|||
147016441|NCT01203917|530219987|FG000|Overall Study|Lost to Follow-up|2|||
147016442|NCT01203917|530219987|FG000|Overall Study|Withdrawal by Subject|3|||
147016443|NCT01203917|530219987|FG000|Overall Study|Due to objective disease progression|1|||
147016444|NCT01203917|530219987|FG000|Overall Study|Due to EGFR M+I patient|1|||
147016445|NCT01264835|530219988|FG000|Overall Study|Lost to Follow-up|1|||
147016446|NCT02427399|530219996|FG000|Overall Study|Protocol Violation|14|||
147016447|NCT02427399|530219997|FG001|Overall Study|Protocol Violation|16|||
147016448|NCT02427399|530219998|FG002|Overall Study|Protocol Violation|12|||
147016449|NCT02427399|530219999|FG003|Overall Study|Protocol Violation|18|||
147016450|NCT02427399|530220000|FG004|Overall Study|Protocol Violation|15|||
147016451|NCT04660032|530220001|FG000|Overall Study|Protocol Violation|1|||
147016452|NCT04660032|530220002|FG001|Overall Study|Protocol Violation|1|||
147016453|NCT00090753|530220003|FG000|First Treatment Period|Adverse Event|20|||
147016454|NCT00090753|530220004|FG001|First Treatment Period|Adverse Event|8|||
147016455|NCT00090753|530220003|FG000|First Treatment Period|Death|88|||
147016456|NCT00090753|530220004|FG001|First Treatment Period|Death|62|||
147016457|NCT00090753|530220003|FG000|First Treatment Period|Lack of Efficacy|2|||
147016458|NCT00090753|530220004|FG001|First Treatment Period|Lack of Efficacy|1|||
147016459|NCT00090753|530220003|FG000|First Treatment Period|Refused Treatment|32|||
147016460|NCT00090753|530220004|FG001|First Treatment Period|Refused Treatment|25|||
147016461|NCT00090753|530220003|FG000|First Treatment Period|Lost to Follow-up|4|||
147016462|NCT00090753|530220004|FG001|First Treatment Period|Lost to Follow-up|4|||
147016463|NCT00090753|530220003|FG000|First Treatment Period|Renal Transplant|70|||
147016464|NCT00090753|530220004|FG001|First Treatment Period|Renal Transplant|50|||
147016465|NCT00090753|530220003|FG000|First Treatment Period|Mircera Commercialization|1|||
147016466|NCT00090753|530220004|FG001|First Treatment Period|Mircera Commercialization|0|||
147016467|NCT00090753|530220003|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
147016468|NCT00090753|530220004|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
147016469|NCT00090753|530220003|FG000|Extended Treatment Period|Adverse Event|11|||
147016470|NCT00090753|530220004|FG001|Extended Treatment Period|Adverse Event|0|||
147016471|NCT00090753|530220003|FG000|Extended Treatment Period|Death|58|||
147016472|NCT00090753|530220004|FG001|Extended Treatment Period|Death|30|||
147016473|NCT00090753|530220003|FG000|Extended Treatment Period|Lack of Efficacy|1|||
147016474|NCT00090753|530220004|FG001|Extended Treatment Period|Lack of Efficacy|0|||
147016475|NCT00090753|530220003|FG000|Extended Treatment Period|Refused Treatment|18|||
147016476|NCT00090753|530220004|FG001|Extended Treatment Period|Refused Treatment|12|||
147016477|NCT00090753|530220003|FG000|Extended Treatment Period|Lost to Follow-up|3|||
147016478|NCT00090753|530220004|FG001|Extended Treatment Period|Lost to Follow-up|1|||
147016479|NCT00090753|530220003|FG000|Extended Treatment Period|Renal Transplant|15|||
147016480|NCT00090753|530220004|FG001|Extended Treatment Period|Renal Transplant|12|||
147016481|NCT00090753|530220003|FG000|Extended Treatment Period|Mircera Commercialization|188|||
147016482|NCT00090753|530220004|FG001|Extended Treatment Period|Mircera Commercialization|93|||
147016483|NCT00090753|530220003|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
147016484|NCT00090753|530220004|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
147016485|NCT01466036|530220007|FG000|Overall Study|Death|1|||
147016486|NCT01466036|530220008|FG001|Overall Study|Death|1|||
147016487|NCT01466036|530220007|FG000|Overall Study|Physician Decision|0|||
147016488|NCT01466036|530220008|FG001|Overall Study|Physician Decision|4|||
147016489|NCT01466036|530220007|FG000|Overall Study|Adverse Event|2|||
147016490|NCT01466036|530220008|FG001|Overall Study|Adverse Event|6|||
147016491|NCT01466036|530220007|FG000|Overall Study|Withdrawal by Subject|2|||
147016492|NCT01466036|530220008|FG001|Overall Study|Withdrawal by Subject|8|||
147016493|NCT01466036|530220007|FG000|Overall Study|progression/relapse|14|||
147016494|NCT01466036|530220008|FG001|Overall Study|progression/relapse|21|||
147016495|NCT01466036|530220007|FG000|Overall Study|prolonged treatment delay|1|||
147016496|NCT01466036|530220008|FG001|Overall Study|prolonged treatment delay|1|||
147016497|NCT01609582|530220009|FG000|Overall Study|Adverse Event|20|||
147016498|NCT01609582|530220010|FG001|Overall Study|Adverse Event|18|||
147016499|NCT01609582|530220009|FG000|Overall Study|Lost to Follow-up|10|||
147016500|NCT01609582|530220010|FG001|Overall Study|Lost to Follow-up|10|||
147016501|NCT01609582|530220009|FG000|Overall Study|Withdrawal by Subject|21|||
147016502|NCT01609582|530220010|FG001|Overall Study|Withdrawal by Subject|15|||
147016503|NCT01609582|530220009|FG000|Overall Study|Study Terminated by Sponsor|1543|||
147016504|NCT01609582|530220010|FG001|Overall Study|Study Terminated by Sponsor|1548|||
147016505|NCT01609582|530220009|FG000|Overall Study|Other|9|||
147016506|NCT01609582|530220010|FG001|Overall Study|Other|10|||
147016507|NCT01609582|530220009|FG000|Overall Study|Randomized, but not treated|0|||
147016508|NCT01609582|530220010|FG001|Overall Study|Randomized, but not treated|3|||
147016509|NCT00819767|530220011|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147016510|NCT00819767|530220012|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147016511|NCT01169038|530220017|FG000|Overall Study|Death|1|||
147016512|NCT01169038|530220017|FG000|Overall Study|Adverse Event|5|||
147016513|NCT01169038|530220017|FG000|Overall Study|Required antibiotic administration|1|||
147016514|NCT03257254|530220018|FG000|Overall Study|Withdrawal by Subject|7|||
147016515|NCT03257254|530220018|FG000|Overall Study|Lost to Follow-up|9|||
147016516|NCT03257254|530220018|FG000|Overall Study|Study discontinued by sponsor|5|||
147016517|NCT03203642|530220019|FG000|Overall Study|Adverse Event|3|||
147016518|NCT03203642|530220020|FG001|Overall Study|Adverse Event|1|||
147016519|NCT03203642|530220019|FG000|Overall Study|Withdrawal by Subject|6|||
147016520|NCT03203642|530220020|FG001|Overall Study|Withdrawal by Subject|6|||
147016521|NCT03203642|530220019|FG000|Overall Study|Lost to Follow-up|2|||
147016522|NCT03203642|530220020|FG001|Overall Study|Lost to Follow-up|1|||
147016523|NCT03203642|530220019|FG000|Overall Study|Termination of the study by sponsor|1|||
147016524|NCT03203642|530220020|FG001|Overall Study|Termination of the study by sponsor|1|||
147016525|NCT03203642|530220019|FG000|Overall Study|Participant moved|0|||
147016526|NCT03203642|530220020|FG001|Overall Study|Participant moved|1|||
147016527|NCT03203642|530220019|FG000|Overall Study|Investigator's decision|3|||
147016528|NCT03203642|530220020|FG001|Overall Study|Investigator's decision|0|||
147016529|NCT03203642|530220019|FG000|Overall Study|Other than above specified|0|||
147016530|NCT03203642|530220020|FG001|Overall Study|Other than above specified|1|||
147016531|NCT02413294|530220021|FG000|Overall Study|Withdrawal by Subject|1|||
147016532|NCT00434590|530220022|FG000|Overall Study|Administrative problems|5|||
147016533|NCT00434590|530220023|FG001|Overall Study|Administrative problems|5|||
147016534|NCT01201759|530222263|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
147016535|NCT01201759|530222264|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
147016536|NCT01201759|530222263|FG000|Visit 3 - Washout|Adverse Event|0|||
147016537|NCT01201759|530222264|FG001|Visit 3 - Washout|Adverse Event|3|||
147016538|NCT01201759|530222263|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
147016539|NCT01201759|530222264|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
147016540|NCT01201759|530222263|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
147016541|NCT01201759|530222264|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
147016542|NCT02744755|530222265|FG000|Study Period 1|Protocol Violation|2|||
147016543|NCT02744755|530222266|FG001|Study Period 1|Protocol Violation|1|||
147016544|NCT02744755|530222265|FG000|Study Period 1|not defined|0|||
147016545|NCT02744755|530222266|FG001|Study Period 1|not defined|1|||
147016546|NCT02744755|530222265|FG000|Study Period 1|Pregnancy|1|||
147016547|NCT02744755|530222266|FG001|Study Period 1|Pregnancy|0|||
147016548|NCT02744755|530222265|FG000|Study Period 1|Adverse Event|1|||
147016549|NCT02744755|530222266|FG001|Study Period 1|Adverse Event|1|||
147016550|NCT02744755|530222265|FG000|Study Period 1|Lost to Follow-up|1|||
147016551|NCT02744755|530222266|FG001|Study Period 1|Lost to Follow-up|1|||
147016552|NCT02744755|530222265|FG000|Study Period 1|Lack of Efficacy|1|||
147016553|NCT02744755|530222266|FG001|Study Period 1|Lack of Efficacy|0|||
147016554|NCT02744755|530222265|FG000|Study Period 1|Withdrawal by Subject|8|||
147016555|NCT02744755|530222266|FG001|Study Period 1|Withdrawal by Subject|4|||
147016556|NCT02744755|530222265|FG000|Study Period 2|Adverse Event|5|||
147016557|NCT02744755|530222266|FG001|Study Period 2|Adverse Event|0|||
147016558|NCT02744755|530222265|FG000|Study Period 2|Protocol Violation|1|||
147016559|NCT02744755|530222266|FG001|Study Period 2|Protocol Violation|0|||
147016560|NCT02744755|530222265|FG000|Study Period 2|not defined|3|||
147016561|NCT02744755|530222266|FG001|Study Period 2|not defined|2|||
147016562|NCT02744755|530222265|FG000|Study Period 2|Lost to Follow-up|0|||
147016563|NCT02744755|530222266|FG001|Study Period 2|Lost to Follow-up|2|||
147016564|NCT02744755|530222265|FG000|Study Period 2|Withdrawal by Subject|2|||
147016565|NCT02744755|530222266|FG001|Study Period 2|Withdrawal by Subject|2|||
147016566|NCT02744755|530222265|FG000|Study Period 2|Lack of Efficacy|3|||
147016567|NCT02744755|530222266|FG001|Study Period 2|Lack of Efficacy|2|||
147016568|NCT02780167|530222267|FG000|Overall Study|Adverse Event|9|||
147016569|NCT02780167|530222268|FG001|Overall Study|Adverse Event|8|||
147016570|NCT02780167|530222269|FG002|Overall Study|Adverse Event|8|||
147016571|NCT02780167|530222270|FG003|Overall Study|Adverse Event|12|||
147016572|NCT02780167|530222271|FG004|Overall Study|Adverse Event|8|||
147016573|NCT02780167|530222267|FG000|Overall Study|Lack of Efficacy|6|||
147016574|NCT02780167|530222268|FG001|Overall Study|Lack of Efficacy|5|||
147016575|NCT02780167|530222269|FG002|Overall Study|Lack of Efficacy|6|||
147016576|NCT02780167|530222270|FG003|Overall Study|Lack of Efficacy|1|||
147016577|NCT02780167|530222271|FG004|Overall Study|Lack of Efficacy|0|||
147016578|NCT02780167|530222267|FG000|Overall Study|Lost to Follow-up|2|||
147016579|NCT02780167|530222268|FG001|Overall Study|Lost to Follow-up|0|||
147016580|NCT02780167|530222269|FG002|Overall Study|Lost to Follow-up|1|||
147016581|NCT02780167|530222270|FG003|Overall Study|Lost to Follow-up|0|||
147016582|NCT02780167|530222271|FG004|Overall Study|Lost to Follow-up|0|||
147016583|NCT02780167|530222267|FG000|Overall Study|Does not meet entrance criteria|0|||
147016584|NCT02780167|530222268|FG001|Overall Study|Does not meet entrance criteria|0|||
147016585|NCT02780167|530222269|FG002|Overall Study|Does not meet entrance criteria|1|||
147016586|NCT02780167|530222270|FG003|Overall Study|Does not meet entrance criteria|0|||
147016587|NCT02780167|530222271|FG004|Overall Study|Does not meet entrance criteria|0|||
147016588|NCT02780167|530222267|FG000|Overall Study|No longer meets eligibility criteria|0|||
147016589|NCT02780167|530222268|FG001|Overall Study|No longer meets eligibility criteria|0|||
147016590|NCT02780167|530222269|FG002|Overall Study|No longer meets eligibility criteria|0|||
147016591|NCT02780167|530222270|FG003|Overall Study|No longer meets eligibility criteria|1|||
147016592|NCT02780167|530222271|FG004|Overall Study|No longer meets eligibility criteria|1|||
147016593|NCT02780167|530222267|FG000|Overall Study|Protocol Violation|5|||
147016594|NCT02780167|530222268|FG001|Overall Study|Protocol Violation|5|||
147016595|NCT02780167|530222269|FG002|Overall Study|Protocol Violation|1|||
147016596|NCT02780167|530222270|FG003|Overall Study|Protocol Violation|1|||
147016597|NCT02780167|530222271|FG004|Overall Study|Protocol Violation|2|||
147016598|NCT02780167|530222267|FG000|Overall Study|Withdrawal by Subject|6|||
147016599|NCT02780167|530222268|FG001|Overall Study|Withdrawal by Subject|4|||
147016600|NCT02780167|530222269|FG002|Overall Study|Withdrawal by Subject|4|||
147016601|NCT02780167|530222270|FG003|Overall Study|Withdrawal by Subject|3|||
147016602|NCT02780167|530222271|FG004|Overall Study|Withdrawal by Subject|4|||
147016603|NCT02780167|530222267|FG000|Overall Study|Other|0|||
147016604|NCT02780167|530222268|FG001|Overall Study|Other|0|||
147016605|NCT02780167|530222269|FG002|Overall Study|Other|3|||
147016606|NCT02780167|530222270|FG003|Overall Study|Other|1|||
147016607|NCT02780167|530222271|FG004|Overall Study|Other|2|||
147016608|NCT02315066|530222272|FG000|Overall Study|Lost to Follow-up|0|||
147016609|NCT02315066|530222273|FG001|Overall Study|Lost to Follow-up|1|||
147016610|NCT02315066|530222274|FG002|Overall Study|Lost to Follow-up|1|||
147016611|NCT02315066|530222275|FG003|Overall Study|Lost to Follow-up|0|||
147016612|NCT02315066|530222276|FG004|Overall Study|Lost to Follow-up|1|||
147016613|NCT02315066|530222277|FG005|Overall Study|Lost to Follow-up|0|||
147016614|NCT02315066|530222278|FG006|Overall Study|Lost to Follow-up|2|||
147016615|NCT02315066|530222279|FG007|Overall Study|Lost to Follow-up|1|||
147016616|NCT02315066|530222280|FG008|Overall Study|Lost to Follow-up|0|||
147016617|NCT02315066|530222281|FG009|Overall Study|Lost to Follow-up|0|||
147016618|NCT02315066|530222282|FG010|Overall Study|Lost to Follow-up|1|||
147016619|NCT02315066|530222283|FG011|Overall Study|Lost to Follow-up|2|||
147016620|NCT02315066|530222284|FG012|Overall Study|Lost to Follow-up|0|||
147016621|NCT02315066|530222285|FG013|Overall Study|Lost to Follow-up|4|||
147016622|NCT02315066|530222272|FG000|Overall Study|Death|2|||
147016623|NCT02315066|530222273|FG001|Overall Study|Death|7|||
147016624|NCT02315066|530222274|FG002|Overall Study|Death|6|||
147016625|NCT02315066|530222275|FG003|Overall Study|Death|11|||
147016626|NCT02315066|530222276|FG004|Overall Study|Death|10|||
147016627|NCT02315066|530222277|FG005|Overall Study|Death|3|||
147016628|NCT02315066|530222278|FG006|Overall Study|Death|9|||
147016629|NCT02315066|530222279|FG007|Overall Study|Death|9|||
147016630|NCT02315066|530222280|FG008|Overall Study|Death|10|||
147016631|NCT02315066|530222281|FG009|Overall Study|Death|8|||
147016632|NCT02315066|530222282|FG010|Overall Study|Death|10|||
147016633|NCT02315066|530222283|FG011|Overall Study|Death|7|||
147016634|NCT02315066|530222284|FG012|Overall Study|Death|8|||
147016635|NCT02315066|530222285|FG013|Overall Study|Death|21|||
147016636|NCT02315066|530222272|FG000|Overall Study|Other|0|||
147016637|NCT02315066|530222273|FG001|Overall Study|Other|0|||
147016638|NCT02315066|530222274|FG002|Overall Study|Other|0|||
147016639|NCT02315066|530222275|FG003|Overall Study|Other|0|||
147016640|NCT02315066|530222276|FG004|Overall Study|Other|0|||
147016641|NCT02315066|530222277|FG005|Overall Study|Other|0|||
147016642|NCT02315066|530222278|FG006|Overall Study|Other|0|||
147016643|NCT02315066|530222279|FG007|Overall Study|Other|1|||
147016644|NCT02315066|530222280|FG008|Overall Study|Other|1|||
147016645|NCT02315066|530222281|FG009|Overall Study|Other|2|||
147016646|NCT02315066|530222282|FG010|Overall Study|Other|0|||
147016647|NCT02315066|530222283|FG011|Overall Study|Other|0|||
147016648|NCT02315066|530222284|FG012|Overall Study|Other|0|||
147016649|NCT02315066|530222285|FG013|Overall Study|Other|0|||
147016650|NCT02315066|530222272|FG000|Overall Study|Subject refused further follow-up|0|||
147016651|NCT02315066|530222273|FG001|Overall Study|Subject refused further follow-up|2|||
147016652|NCT02315066|530222274|FG002|Overall Study|Subject refused further follow-up|2|||
147016653|NCT02315066|530222275|FG003|Overall Study|Subject refused further follow-up|0|||
147016654|NCT02315066|530222276|FG004|Overall Study|Subject refused further follow-up|0|||
147016655|NCT02315066|530222277|FG005|Overall Study|Subject refused further follow-up|0|||
147016656|NCT02315066|530222278|FG006|Overall Study|Subject refused further follow-up|2|||
147016657|NCT02315066|530222279|FG007|Overall Study|Subject refused further follow-up|3|||
146849068|NCT02656329|529617022|FG000|Overall Study|Lost to Follow-up|2|||
146849069|NCT02656329|529617023|FG001|Overall Study|Lost to Follow-up|3|||
146849070|NCT02656329|529617022|FG000|Overall Study|Withdrawal by Subject|7|||
146849071|NCT02656329|529617023|FG001|Overall Study|Withdrawal by Subject|6|||
146849072|NCT02656329|529617022|FG000|Overall Study|Study termination by Sponsor|150|||
147016658|NCT02315066|530222280|FG008|Overall Study|Subject refused further follow-up|0|||
147016659|NCT02315066|530222281|FG009|Overall Study|Subject refused further follow-up|1|||
147016660|NCT02315066|530222282|FG010|Overall Study|Subject refused further follow-up|1|||
147016661|NCT02315066|530222283|FG011|Overall Study|Subject refused further follow-up|2|||
147016662|NCT02315066|530222284|FG012|Overall Study|Subject refused further follow-up|2|||
147016663|NCT02315066|530222285|FG013|Overall Study|Subject refused further follow-up|4|||
147016664|NCT02315066|530222272|FG000|Overall Study|Study ongoing at date of cut-off|0|||
147016665|NCT02315066|530222273|FG001|Overall Study|Study ongoing at date of cut-off|0|||
147016666|NCT02315066|530222274|FG002|Overall Study|Study ongoing at date of cut-off|0|||
147016667|NCT02315066|530222275|FG003|Overall Study|Study ongoing at date of cut-off|0|||
147016668|NCT02315066|530222276|FG004|Overall Study|Study ongoing at date of cut-off|0|||
147016669|NCT02315066|530222277|FG005|Overall Study|Study ongoing at date of cut-off|0|||
147016670|NCT02315066|530222278|FG006|Overall Study|Study ongoing at date of cut-off|0|||
147016671|NCT02315066|530222279|FG007|Overall Study|Study ongoing at date of cut-off|0|||
147016672|NCT02315066|530222280|FG008|Overall Study|Study ongoing at date of cut-off|0|||
147016673|NCT02315066|530222281|FG009|Overall Study|Study ongoing at date of cut-off|0|||
147016674|NCT02315066|530222282|FG010|Overall Study|Study ongoing at date of cut-off|0|||
147016675|NCT02315066|530222283|FG011|Overall Study|Study ongoing at date of cut-off|0|||
147016676|NCT02315066|530222284|FG012|Overall Study|Study ongoing at date of cut-off|0|||
147016677|NCT02315066|530222285|FG013|Overall Study|Study ongoing at date of cut-off|1|||
147016678|NCT02916693|530222286|FG000|Overall Study|Lost to Follow-up|7|||
147016679|NCT03180801|530222287|FG000|Overall Study|Physician Decision|3|||
147016680|NCT03180801|530222288|FG001|Overall Study|Physician Decision|3|||
147016681|NCT03180801|530222289|FG002|Overall Study|Physician Decision|1|||
147016682|NCT03180801|530222287|FG000|Overall Study|Non-compliance|1|||
147016683|NCT03180801|530222288|FG001|Overall Study|Non-compliance|4|||
147016684|NCT03180801|530222289|FG002|Overall Study|Non-compliance|0|||
147016685|NCT03180801|530222287|FG000|Overall Study|Inoculation Target Reached|1|||
147016686|NCT03180801|530222288|FG001|Overall Study|Inoculation Target Reached|1|||
147016687|NCT03180801|530222289|FG002|Overall Study|Inoculation Target Reached|3|||
147016688|NCT03180801|530222287|FG000|Overall Study|Adverse Event|1|||
147016689|NCT03180801|530222288|FG001|Overall Study|Adverse Event|0|||
147016690|NCT03180801|530222289|FG002|Overall Study|Adverse Event|2|||
147016691|NCT03180801|530222287|FG000|Overall Study|Withdrawal by Subject|2|||
147016692|NCT03180801|530222288|FG001|Overall Study|Withdrawal by Subject|2|||
147016693|NCT03180801|530222289|FG002|Overall Study|Withdrawal by Subject|1|||
147016694|NCT03180801|530222287|FG000|Overall Study|Lost to Follow-up|0|||
147016695|NCT03180801|530222288|FG001|Overall Study|Lost to Follow-up|2|||
147016696|NCT03180801|530222289|FG002|Overall Study|Lost to Follow-up|3|||
147016697|NCT01142908|530222290|FG000|Overall Study|Lost to Follow-up|19|||
147016698|NCT01142908|530222291|FG001|Overall Study|Lost to Follow-up|13|||
147016699|NCT01142908|530222290|FG000|Overall Study|Death|1|||
147016700|NCT01142908|530222291|FG001|Overall Study|Death|4|||
147016701|NCT01142908|530222290|FG000|Overall Study|Excluded - did not meet criteria|9|||
147016702|NCT01142908|530222291|FG001|Overall Study|Excluded - did not meet criteria|5|||
147016703|NCT01142908|530222290|FG000|Overall Study|Withdrawal by Subject|3|||
146849073|NCT02656329|529617023|FG001|Overall Study|Study termination by Sponsor|142|||
146849074|NCT02656329|529617022|FG000|Overall Study|Other than specified above|5|||
146849075|NCT02656329|529617023|FG001|Overall Study|Other than specified above|6|||
147016704|NCT01142908|530222291|FG001|Overall Study|Withdrawal by Subject|0|||
147016705|NCT00035555|530222293|FG000|Overall Study|Adverse Event|5|||
147016706|NCT00035555|530222294|FG001|Overall Study|Adverse Event|8|||
147016707|NCT00035555|530222295|FG002|Overall Study|Adverse Event|9|||
147016708|NCT00035555|530222293|FG000|Overall Study|Allograft loss|1|||
147016709|NCT00035555|530222294|FG001|Overall Study|Allograft loss|1|||
147016710|NCT00035555|530222295|FG002|Overall Study|Allograft loss|2|||
147016711|NCT00035555|530222293|FG000|Overall Study|Death|0|||
147016712|NCT00035555|530222294|FG001|Overall Study|Death|0|||
147016713|NCT00035555|530222295|FG002|Overall Study|Death|2|||
147016714|NCT00035555|530222293|FG000|Overall Study|Lost to Follow-up|0|||
147016715|NCT00035555|530222294|FG001|Overall Study|Lost to Follow-up|0|||
147016716|NCT00035555|530222295|FG002|Overall Study|Lost to Follow-up|1|||
147016717|NCT00035555|530222293|FG000|Overall Study|Noncompliance|0|||
147016718|NCT00035555|530222294|FG001|Overall Study|Noncompliance|1|||
147016719|NCT00035555|530222295|FG002|Overall Study|Noncompliance|1|||
147016720|NCT00035555|530222293|FG000|Overall Study|Prohibited medication|1|||
147016721|NCT00035555|530222294|FG001|Overall Study|Prohibited medication|1|||
147016722|NCT00035555|530222295|FG002|Overall Study|Prohibited medication|0|||
147016723|NCT00035555|530222293|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
147016724|NCT00035555|530222294|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
147016725|NCT00035555|530222295|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
147016726|NCT00035555|530222293|FG000|Overall Study|Withdrawal by Subject|2|||
147016727|NCT00035555|530222294|FG001|Overall Study|Withdrawal by Subject|0|||
147016728|NCT00035555|530222295|FG002|Overall Study|Withdrawal by Subject|2|||
147016729|NCT00035555|530222293|FG000|Overall Study|Investigator deemed not a good candidate|0|||
147016730|NCT00035555|530222294|FG001|Overall Study|Investigator deemed not a good candidate|0|||
147016731|NCT00035555|530222295|FG002|Overall Study|Investigator deemed not a good candidate|1|||
147016732|NCT00035555|530222293|FG000|Overall Study|Received cyclosporin in error|0|||
147016733|NCT00035555|530222294|FG001|Overall Study|Received cyclosporin in error|0|||
147016734|NCT00035555|530222295|FG002|Overall Study|Received cyclosporin in error|1|||
147016735|NCT00337428|530222296|FG000|Overall Study|Withdrawal by Subject|1|||
147016736|NCT00337428|530222297|FG001|Overall Study|Withdrawal by Subject|2|||
147016737|NCT00337428|530222296|FG000|Overall Study|Lack of Time|1|||
147016738|NCT00337428|530222297|FG001|Overall Study|Lack of Time|1|||
147016739|NCT00337428|530222296|FG000|Overall Study|Unwilling to Continue|1|||
147016740|NCT00337428|530222297|FG001|Overall Study|Unwilling to Continue|0|||
147016741|NCT00337428|530222296|FG000|Overall Study|Anorexia|1|||
147016742|NCT00337428|530222297|FG001|Overall Study|Anorexia|0|||
147016743|NCT02618382|530222298|FG000|Overall Study|Physician Decision|1|||
147016744|NCT02618382|530222298|FG000|Overall Study|Withdrawal by Subject|1|||
147016745|NCT02618382|530222298|FG000|Overall Study|Protocol Violation|1|||
147016746|NCT04205162|530222303|FG000|Overall Study|Lost to Follow-up|1|||
147016747|NCT04205162|530222304|FG001|Overall Study|Lost to Follow-up|0|||
146849076|NCT01081665|529617025|FG000|Overall Study|Death|41|||
147016748|NCT04205162|530222303|FG000|Overall Study|Withdrawal by Subject|2|||
147016749|NCT04205162|530222304|FG001|Overall Study|Withdrawal by Subject|0|||
147016750|NCT04205162|530222303|FG000|Overall Study|University closure due to COVID-19|1|||
147016751|NCT04205162|530222304|FG001|Overall Study|University closure due to COVID-19|0|||
147016752|NCT00529217|530222305|FG000|Overall Study|Lack of Efficacy|2|||
147016753|NCT00529217|530222305|FG000|Overall Study|Unable to adhere to study schedule|2|||
147016754|NCT00779402|530222307|FG000|Treatment Phase 1|Disease Progression|1|||
147016755|NCT00779402|530222308|FG001|Treatment Phase 1|Disease Progression|0|||
147016756|NCT00779402|530222307|FG000|Treatment Phase 1|Adverse Event|2|||
147016757|NCT00779402|530222308|FG001|Treatment Phase 1|Adverse Event|0|||
147016758|NCT00779402|530222307|FG000|Treatment Phase 1|Protocol Violation|1|||
147016759|NCT00779402|530222308|FG001|Treatment Phase 1|Protocol Violation|0|||
147016760|NCT00779402|530222307|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
147016761|NCT00779402|530222308|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
147016762|NCT00779402|530222307|FG000|Treatment Phase 1|Lost to Follow-up|0|||
147016763|NCT00779402|530222308|FG001|Treatment Phase 1|Lost to Follow-up|1|||
147016764|NCT00779402|530222307|FG000|Treatment Phase 1|Death|0|||
147016765|NCT00779402|530222308|FG001|Treatment Phase 1|Death|1|||
147016766|NCT00779402|530222307|FG000|Treatment Phase 1|Intercurrent Illness|1|||
147016767|NCT00779402|530222308|FG001|Treatment Phase 1|Intercurrent Illness|1|||
147016768|NCT00779402|530222307|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
147016769|NCT00779402|530222308|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
147016770|NCT00779402|530222307|FG000|Treatment Phase 1|Other|4|||
147016771|NCT00779402|530222308|FG001|Treatment Phase 1|Other|2|||
147016772|NCT00779402|530222307|FG000|Treatment Phase 1|Closure of Study|3|||
147016773|NCT00779402|530222308|FG001|Treatment Phase 1|Closure of Study|2|||
147016774|NCT00779402|530222307|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
147016775|NCT00779402|530222308|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
147016776|NCT00779402|530222307|FG000|Surveillance Phase|Protocol Violation|0|||
147016777|NCT00779402|530222308|FG001|Surveillance Phase|Protocol Violation|1|||
147016778|NCT00779402|530222307|FG000|Surveillance Phase|Patient refused to continue|22|||
147016779|NCT00779402|530222308|FG001|Surveillance Phase|Patient refused to continue|14|||
147016780|NCT00779402|530222307|FG000|Surveillance Phase|Lost to Follow-up|2|||
147016781|NCT00779402|530222308|FG001|Surveillance Phase|Lost to Follow-up|1|||
147016782|NCT00779402|530222307|FG000|Surveillance Phase|Death|0|||
147016783|NCT00779402|530222308|FG001|Surveillance Phase|Death|1|||
147016784|NCT00779402|530222307|FG000|Surveillance Phase|Intercurrent Illness|2|||
147016785|NCT00779402|530222308|FG001|Surveillance Phase|Intercurrent Illness|0|||
147016786|NCT00779402|530222307|FG000|Surveillance Phase|Other|5|||
147016787|NCT00779402|530222308|FG001|Surveillance Phase|Other|5|||
147016788|NCT00779402|530222307|FG000|Surveillance Phase|Withdrawal by Subject|4|||
147016789|NCT00779402|530222308|FG001|Surveillance Phase|Withdrawal by Subject|1|||
147016790|NCT00779402|530222307|FG000|Surveillance Phase|Closure of study|5|||
147016791|NCT00779402|530222308|FG001|Surveillance Phase|Closure of study|6|||
147016792|NCT00779402|530222307|FG000|Surveillance Phase|Completed Protocol Visits|3|||
147016793|NCT00779402|530222308|FG001|Surveillance Phase|Completed Protocol Visits|2|||
147016794|NCT00779402|530222307|FG000|Long-term Follow-up|Patient refused to continue|2|||
147016795|NCT00779402|530222308|FG001|Long-term Follow-up|Patient refused to continue|0|||
147016796|NCT00779402|530222307|FG000|Long-term Follow-up|Other|5|||
147016797|NCT00779402|530222308|FG001|Long-term Follow-up|Other|0|||
147016798|NCT00779402|530222307|FG000|Long-term Follow-up|Closure of Study|8|||
147016799|NCT00779402|530222308|FG001|Long-term Follow-up|Closure of Study|4|||
147016800|NCT00779402|530222307|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
147016801|NCT00779402|530222308|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
147016802|NCT01315028|530222313|FG000|Overall Study|Lost to Follow-up|1|||
147016803|NCT01315028|530222314|FG001|Overall Study|Lost to Follow-up|0|||
147016804|NCT01315028|530222313|FG000|Overall Study|Death|0|||
147016805|NCT01315028|530222314|FG001|Overall Study|Death|1|||
147016806|NCT02274948|530222319|FG000|Overall Study|Lost to Follow-up|28|||
147016807|NCT02274948|530222320|FG001|Overall Study|Lost to Follow-up|25|||
147016808|NCT02274948|530222319|FG000|Overall Study|Withdrawal by Subject|64|||
147016809|NCT02274948|530222320|FG001|Overall Study|Withdrawal by Subject|58|||
147016810|NCT02274948|530222319|FG000|Overall Study|Stopped on family Practitioner advice|2|||
147016811|NCT02274948|530222320|FG001|Overall Study|Stopped on family Practitioner advice|5|||
147016812|NCT02274948|530222319|FG000|Overall Study|Left the area|4|||
147016813|NCT02274948|530222320|FG001|Overall Study|Left the area|3|||
147016814|NCT01098539|530222323|FG000|Overall Study|Adverse Event|26|||
147016815|NCT01098539|530222324|FG001|Overall Study|Adverse Event|26|||
147016816|NCT01098539|530222323|FG000|Overall Study|Protocol Violation|1|||
147016817|NCT01098539|530222324|FG001|Overall Study|Protocol Violation|4|||
147016818|NCT01098539|530222323|FG000|Overall Study|Noncompliance|3|||
147016819|NCT01098539|530222324|FG001|Overall Study|Noncompliance|5|||
147016820|NCT01098539|530222323|FG000|Overall Study|Lost to Follow-up|4|||
147016821|NCT01098539|530222324|FG001|Overall Study|Lost to Follow-up|4|||
147016822|NCT01098539|530222323|FG000|Overall Study|Withdrawal by Subject|12|||
147016823|NCT01098539|530222324|FG001|Overall Study|Withdrawal by Subject|26|||
147016824|NCT01098539|530222323|FG000|Overall Study|Physician Decision|5|||
147016825|NCT01098539|530222324|FG001|Overall Study|Physician Decision|3|||
147016826|NCT01386125|530222325|FG000|Overall Study|Lost to Follow-up|3|||
147016827|NCT01386125|530222326|FG001|Overall Study|Lost to Follow-up|9|||
147016828|NCT01386125|530222325|FG000|Overall Study|Physician Decision|0|||
147016829|NCT01386125|530222326|FG001|Overall Study|Physician Decision|1|||
147016830|NCT01386125|530222325|FG000|Overall Study|Protocol Violation|5|||
147016831|NCT01386125|530222326|FG001|Overall Study|Protocol Violation|7|||
147016832|NCT01386125|530222325|FG000|Overall Study|Disease Progress|1|||
147016833|NCT01386125|530222326|FG001|Overall Study|Disease Progress|2|||
147016834|NCT01386125|530222325|FG000|Overall Study|Withdrawal by Subject|13|||
147016835|NCT01386125|530222326|FG001|Overall Study|Withdrawal by Subject|12|||
147016836|NCT01386125|530222325|FG000|Overall Study|Adverse Event|2|||
147016837|NCT01386125|530222326|FG001|Overall Study|Adverse Event|5|||
147016838|NCT01386125|530222325|FG000|Overall Study|Lack of Efficacy|0|||
147016839|NCT01386125|530222326|FG001|Overall Study|Lack of Efficacy|1|||
147016840|NCT01386125|530222325|FG000|Overall Study|Participant Leaving Country|1|||
147016841|NCT01386125|530222326|FG001|Overall Study|Participant Leaving Country|0|||
147016842|NCT03843125|530222327|FG000|Overall Study|Adverse Event|17|||
147016843|NCT03843125|530222328|FG001|Overall Study|Adverse Event|13|||
147016844|NCT03843125|530222329|FG002|Overall Study|Adverse Event|5|||
147016845|NCT03843125|530222330|FG003|Overall Study|Adverse Event|9|||
147016846|NCT03843125|530222327|FG000|Overall Study|Death|0|||
147016847|NCT03843125|530222328|FG001|Overall Study|Death|6|||
147016848|NCT03843125|530222329|FG002|Overall Study|Death|2|||
147016849|NCT03843125|530222330|FG003|Overall Study|Death|0|||
147016850|NCT03843125|530222327|FG000|Overall Study|Lack of Efficacy|14|||
147016851|NCT03843125|530222328|FG001|Overall Study|Lack of Efficacy|11|||
147016852|NCT03843125|530222329|FG002|Overall Study|Lack of Efficacy|9|||
147016853|NCT03843125|530222330|FG003|Overall Study|Lack of Efficacy|4|||
147016854|NCT03843125|530222327|FG000|Overall Study|Lost to Follow-up|3|||
147016855|NCT03843125|530222328|FG001|Overall Study|Lost to Follow-up|4|||
147016856|NCT03843125|530222329|FG002|Overall Study|Lost to Follow-up|0|||
147016857|NCT03843125|530222330|FG003|Overall Study|Lost to Follow-up|2|||
147016858|NCT03843125|530222327|FG000|Overall Study|Other|12|||
147016859|NCT03843125|530222328|FG001|Overall Study|Other|14|||
147016860|NCT03843125|530222329|FG002|Overall Study|Other|3|||
147016861|NCT03843125|530222330|FG003|Overall Study|Other|4|||
147016862|NCT03843125|530222327|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
147016863|NCT03843125|530222328|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
147016864|NCT03843125|530222329|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
147016865|NCT03843125|530222330|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
147016866|NCT03843125|530222327|FG000|Overall Study|Study Terminated by Sponsor|318|||
147016867|NCT03843125|530222328|FG001|Overall Study|Study Terminated by Sponsor|318|||
147016868|NCT03843125|530222329|FG002|Overall Study|Study Terminated by Sponsor|163|||
147016869|NCT03843125|530222330|FG003|Overall Study|Study Terminated by Sponsor|163|||
147016870|NCT03843125|530222327|FG000|Overall Study|Withdrawal by Subject|23|||
147016871|NCT03843125|530222328|FG001|Overall Study|Withdrawal by Subject|12|||
147016872|NCT03843125|530222329|FG002|Overall Study|Withdrawal by Subject|6|||
147016873|NCT03843125|530222330|FG003|Overall Study|Withdrawal by Subject|9|||
147016874|NCT03843125|530222327|FG000|Overall Study|Missing data|0|||
147016875|NCT03843125|530222328|FG001|Overall Study|Missing data|1|||
147016876|NCT03843125|530222329|FG002|Overall Study|Missing data|1|||
147016877|NCT03843125|530222330|FG003|Overall Study|Missing data|0|||
147016878|NCT03173560|530222331|FG000|Overall Study|Death|70|||
147016879|NCT03173560|530222332|FG001|Overall Study|Death|60|||
147016880|NCT03173560|530222331|FG000|Overall Study|Lost to Follow-up|1|||
147016881|NCT03173560|530222332|FG001|Overall Study|Lost to Follow-up|4|||
147016882|NCT03173560|530222331|FG000|Overall Study|Withdrawal by Subject|10|||
147016883|NCT03173560|530222332|FG001|Overall Study|Withdrawal by Subject|5|||
147016884|NCT03173560|530222331|FG000|Overall Study|Other|0|||
147016885|NCT03173560|530222332|FG001|Overall Study|Other|1|||
147016886|NCT04254809|530222334|FG000|Overall Study|Lost to Follow-up|5|||
147016887|NCT04254809|530222335|FG001|Overall Study|Lost to Follow-up|10|||
147016888|NCT01928615|530222336|FG000|Overall Study|Study Terminated by Sponsor|2|||
147016889|NCT02972515|530222337|FG000|Overall Study|Lost to Follow-up|78|||
147016890|NCT03023137|530222342|FG000|Overall Study|Multiple pregnancy|2|||
147016891|NCT03023137|530222343|FG001|Overall Study|Multiple pregnancy|4|||
147016892|NCT03023137|530222342|FG000|Overall Study|Lost to Follow-up|1|||
147016893|NCT03023137|530222343|FG001|Overall Study|Lost to Follow-up|1|||
147016894|NCT03023137|530222342|FG000|Overall Study|Protocol Violation|0|||
147016895|NCT03023137|530222343|FG001|Overall Study|Protocol Violation|4|||
147016896|NCT03023137|530222342|FG000|Overall Study|Lost the baby in a car accident|1|||
147016897|NCT03023137|530222343|FG001|Overall Study|Lost the baby in a car accident|0|||
147016898|NCT01808248|530222345|FG000|Overall Study|Lack of Efficacy|3|||
147016899|NCT01808248|530222345|FG000|Overall Study|Withdrawal by Subject|1|||
147016900|NCT01808248|530222345|FG000|Overall Study|Lost to Follow-up|1|||
147016901|NCT00685750|530222346|FG000|Overall Study|Tumor sampling failure|0|||
147016902|NCT00685750|530222347|FG001|Overall Study|Tumor sampling failure|0|||
147016903|NCT00685750|530222348|FG002|Overall Study|Tumor sampling failure|1|||
147016904|NCT00685750|530222349|FG003|Overall Study|Tumor sampling failure|0|||
147016905|NCT00685750|530222350|FG004|Overall Study|Tumor sampling failure|0|||
147016906|NCT00685750|530222351|FG005|Overall Study|Tumor sampling failure|0|||
147016907|NCT00685750|530222352|FG006|Overall Study|Tumor sampling failure|0|||
147016908|NCT00685750|530222346|FG000|Overall Study|Patient didn't receive the treatment|0|||
147016909|NCT00685750|530222347|FG001|Overall Study|Patient didn't receive the treatment|0|||
147016910|NCT00685750|530222348|FG002|Overall Study|Patient didn't receive the treatment|0|||
147016911|NCT00685750|530222349|FG003|Overall Study|Patient didn't receive the treatment|0|||
147016912|NCT00685750|530222350|FG004|Overall Study|Patient didn't receive the treatment|0|||
147016913|NCT00685750|530222351|FG005|Overall Study|Patient didn't receive the treatment|0|||
147016914|NCT00685750|530222352|FG006|Overall Study|Patient didn't receive the treatment|1|||
147016915|NCT00685750|530222346|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147016916|NCT00685750|530222347|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147016917|NCT00685750|530222348|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
147016918|NCT00685750|530222349|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
147016919|NCT00685750|530222350|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
147016920|NCT00685750|530222351|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
147016921|NCT00685750|530222352|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
147016922|NCT04974580|530222353|FG000|Overall Study|Lost to Follow-up|33|||
147016923|NCT04974580|530222354|FG001|Overall Study|Lost to Follow-up|39|||
147016924|NCT04974580|530222355|FG002|Overall Study|Lost to Follow-up|30|||
147016925|NCT04974580|530222356|FG003|Overall Study|Lost to Follow-up|29|||
147016926|NCT00587431|530222357|FG000|Overall Study|Adverse Event|1|||
147016927|NCT00587431|530222358|FG001|Overall Study|Adverse Event|0|||
147016928|NCT00587431|530222357|FG000|Overall Study|Withdrawal by Subject|0|||
147016929|NCT00587431|530222358|FG001|Overall Study|Withdrawal by Subject|1|||
147016930|NCT05467982|530222359|FG000|Overall Study|Death|0|||
147016931|NCT05467982|530222360|FG001|Overall Study|Death|1|||
147016932|NCT05467982|530222359|FG000|Overall Study|Lost to Follow-up|3|||
147016933|NCT05467982|530222360|FG001|Overall Study|Lost to Follow-up|1|||
147016934|NCT00761176|530222386|FG000|Overall Study|Death|1|||
147016935|NCT00761176|530222387|FG001|Overall Study|Death|0|||
147016936|NCT00761176|530222386|FG000|Overall Study|Withdrawal by Subject|1|||
147016937|NCT00761176|530222387|FG001|Overall Study|Withdrawal by Subject|1|||
147016938|NCT02762994|530222390|FG000|Overall Study|Withdrawal by Subject|0|||
147016939|NCT02762994|530222391|FG001|Overall Study|Withdrawal by Subject|1|||
147016940|NCT02762994|530222392|FG002|Overall Study|Withdrawal by Subject|2|||
147016941|NCT02762994|530222393|FG003|Overall Study|Withdrawal by Subject|0|||
147016942|NCT02762994|530222390|FG000|Overall Study|Protocol Violation|1|||
147016943|NCT02762994|530222391|FG001|Overall Study|Protocol Violation|0|||
147016944|NCT02762994|530222392|FG002|Overall Study|Protocol Violation|0|||
147016945|NCT02762994|530222393|FG003|Overall Study|Protocol Violation|2|||
147016946|NCT05103657|530222394|FG000|Overall Study|Other reasons than listed|9|||
147016947|NCT05103657|530222395|FG001|Overall Study|Other reasons than listed|8|||
147016948|NCT05103657|530222394|FG000|Overall Study|Protocol deviation|2|||
147016949|NCT05103657|530222395|FG001|Overall Study|Protocol deviation|2|||
147016950|NCT05103657|530222394|FG000|Overall Study|No reason available|5|||
147016951|NCT05103657|530222395|FG001|Overall Study|No reason available|4|||
147016952|NCT05103657|530222394|FG000|Overall Study|Burden of study procedures|3|||
147016953|NCT05103657|530222395|FG001|Overall Study|Burden of study procedures|1|||
147016954|NCT05103657|530222394|FG000|Overall Study|Perceived lack of efficacy|1|||
147016955|NCT05103657|530222395|FG001|Overall Study|Perceived lack of efficacy|1|||
147016956|NCT05103657|530222394|FG000|Overall Study|Adverse Event|6|||
147016957|NCT05103657|530222395|FG001|Overall Study|Adverse Event|14|||
147016958|NCT05103657|530222394|FG000|Overall Study|Not Treated|1|||
147016959|NCT05103657|530222395|FG001|Overall Study|Not Treated|1|||
147016960|NCT02020967|530222396|FG000|Overall Study|Withdrawal by Subject|51|||
147016961|NCT03507686|530222397|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
147016962|NCT03507686|530222398|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
147016963|NCT03507686|530222397|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
147016964|NCT03507686|530222398|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
147016965|NCT03507686|530222397|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
147016966|NCT03507686|530222398|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
147016967|NCT03507686|530222397|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
147016968|NCT03507686|530222398|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
146849077|NCT01081665|529617025|FG000|Overall Study|Lost to Follow-up|18|||
146849078|NCT01081665|529617025|FG000|Overall Study|Withdrawal by Subject|17|||
146849079|NCT01081665|529617025|FG000|Overall Study|Change of dialysis unit|10|||
147016969|NCT03507686|530222397|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
147016970|NCT03507686|530222398|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
147016971|NCT03507686|530222397|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
147016972|NCT03507686|530222398|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
147016973|NCT00585312|530222399|FG000|Overall Study|Adverse Event|3|||
147016974|NCT00585312|530222400|FG001|Overall Study|Adverse Event|0|||
147016975|NCT00585312|530222399|FG000|Overall Study|Lack of Efficacy|6|||
147016976|NCT00585312|530222400|FG001|Overall Study|Lack of Efficacy|11|||
147016977|NCT00585312|530222399|FG000|Overall Study|Lost to Follow-up|1|||
147016978|NCT00585312|530222400|FG001|Overall Study|Lost to Follow-up|1|||
147016979|NCT00585312|530222399|FG000|Overall Study|Reason not specified|2|||
147016980|NCT00585312|530222400|FG001|Overall Study|Reason not specified|0|||
147016981|NCT00585312|530222399|FG000|Overall Study|Withdrawal by Subject|5|||
147016982|NCT00585312|530222400|FG001|Overall Study|Withdrawal by Subject|1|||
147016983|NCT00585312|530222399|FG000|Overall Study|Study terminated by the sponsor|34|||
147016984|NCT00585312|530222400|FG001|Overall Study|Study terminated by the sponsor|31|||
147016985|NCT04234464|530222401|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
147016986|NCT04234464|530222402|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
147016987|NCT00983528|530222403|FG000|Overall Study|Death|4|||
147016988|NCT00983528|530222403|FG000|Overall Study|Lost to Follow-up|1|||
147016989|NCT00983528|530222403|FG000|Overall Study|Study Terminated|1|||
147016990|NCT00330460|530222408|FG000|Overall Study|Physician Decision|1|||
147016991|NCT00330460|530222409|FG001|Overall Study|Physician Decision|0|||
147016992|NCT00330460|530222408|FG000|Overall Study|Adverse Event|10|||
147016993|NCT00330460|530222409|FG001|Overall Study|Adverse Event|8|||
147016994|NCT00330460|530222408|FG000|Overall Study|Withdrawal by Subject|18|||
147016995|NCT00330460|530222409|FG001|Overall Study|Withdrawal by Subject|17|||
147016996|NCT00330460|530222408|FG000|Overall Study|Death|1|||
147016997|NCT00330460|530222409|FG001|Overall Study|Death|1|||
147016998|NCT00330460|530222408|FG000|Overall Study|Ineligibility determined|1|||
147016999|NCT00330460|530222409|FG001|Overall Study|Ineligibility determined|3|||
147017000|NCT00330460|530222408|FG000|Overall Study|Lost to Follow-up|8|||
147017001|NCT00330460|530222409|FG001|Overall Study|Lost to Follow-up|3|||
147017002|NCT00330460|530222408|FG000|Overall Study|Noncompliance|2|||
147017003|NCT00330460|530222409|FG001|Overall Study|Noncompliance|1|||
147017004|NCT00330460|530222408|FG000|Overall Study|Other|1|||
147017005|NCT00330460|530222409|FG001|Overall Study|Other|0|||
147017006|NCT03712124|530222410|FG000|Overall Study|Protocol Violation|1|||
147017007|NCT03712124|530222411|FG001|Overall Study|Protocol Violation|0|||
147017008|NCT02941523|530222415|FG000|Monotherapy|Withdrawal by Subject|0|||
147017009|NCT02941523|530222416|FG001|Monotherapy|Withdrawal by Subject|1|||
147017010|NCT02941523|530222415|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
147017011|NCT02941523|530222416|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
147017012|NCT02941523|530222415|FG000|Carboplatin Combination Therapy|Death|1|||
147017013|NCT02941523|530222416|FG001|Carboplatin Combination Therapy|Death|2|||
147017014|NCT02941523|530222415|FG000|Carboplatin Combination Therapy|Disease progression|2|||
147017015|NCT02941523|530222416|FG001|Carboplatin Combination Therapy|Disease progression|0|||
147017016|NCT02941523|530222415|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
147017017|NCT02941523|530222416|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
147017018|NCT02539368|530222417|FG000|Overall Study|Death|4|||
147017019|NCT02539368|530222418|FG001|Overall Study|Death|2|||
147017020|NCT02539368|530222419|FG002|Overall Study|Death|1|||
147017021|NCT02539368|530222420|FG003|Overall Study|Death|0|||
147017022|NCT02539368|530222421|FG004|Overall Study|Death|0|||
147017023|NCT02539368|530222417|FG000|Overall Study|Withdrawal by Subject|44|||
147017024|NCT02539368|530222418|FG001|Overall Study|Withdrawal by Subject|35|||
147017025|NCT02539368|530222419|FG002|Overall Study|Withdrawal by Subject|9|||
147017026|NCT02539368|530222420|FG003|Overall Study|Withdrawal by Subject|1|||
147017027|NCT02539368|530222421|FG004|Overall Study|Withdrawal by Subject|3|||
147017028|NCT02539368|530222417|FG000|Overall Study|Physician Decision|49|||
147017029|NCT02539368|530222418|FG001|Overall Study|Physician Decision|15|||
147017030|NCT02539368|530222419|FG002|Overall Study|Physician Decision|7|||
147017031|NCT02539368|530222420|FG003|Overall Study|Physician Decision|0|||
147017032|NCT02539368|530222421|FG004|Overall Study|Physician Decision|2|||
147017033|NCT02539368|530222417|FG000|Overall Study|Lost to Follow-up|96|||
147017034|NCT02539368|530222418|FG001|Overall Study|Lost to Follow-up|21|||
147017035|NCT02539368|530222419|FG002|Overall Study|Lost to Follow-up|16|||
147017036|NCT02539368|530222420|FG003|Overall Study|Lost to Follow-up|4|||
147017037|NCT02539368|530222421|FG004|Overall Study|Lost to Follow-up|3|||
147017038|NCT02539368|530222417|FG000|Overall Study|Adverse Event|44|||
146849080|NCT01081665|529617025|FG000|Overall Study|Regulation of iPTH|5|||
146849081|NCT01081665|529617025|FG000|Overall Study|Change in renal replacement therapy|2|||
146849082|NCT01081665|529617025|FG000|Overall Study|Adverse Event|1|||
147017039|NCT02539368|530222418|FG001|Overall Study|Adverse Event|5|||
147017040|NCT02539368|530222419|FG002|Overall Study|Adverse Event|9|||
147017041|NCT02539368|530222420|FG003|Overall Study|Adverse Event|0|||
147017042|NCT02539368|530222421|FG004|Overall Study|Adverse Event|3|||
147017043|NCT02539368|530222417|FG000|Overall Study|Participant Non-compliant|13|||
147017044|NCT02539368|530222418|FG001|Overall Study|Participant Non-compliant|2|||
147017045|NCT02539368|530222419|FG002|Overall Study|Participant Non-compliant|1|||
147017046|NCT02539368|530222420|FG003|Overall Study|Participant Non-compliant|1|||
147017047|NCT02539368|530222421|FG004|Overall Study|Participant Non-compliant|0|||
147017048|NCT02539368|530222417|FG000|Overall Study|Other|145|||
147017049|NCT02539368|530222418|FG001|Overall Study|Other|18|||
147017050|NCT02539368|530222419|FG002|Overall Study|Other|24|||
147017051|NCT02539368|530222420|FG003|Overall Study|Other|1|||
147017052|NCT02539368|530222421|FG004|Overall Study|Other|3|||
147017053|NCT02539368|530222417|FG000|Overall Study|Missing|10|||
147017054|NCT02539368|530222418|FG001|Overall Study|Missing|3|||
147017055|NCT02539368|530222419|FG002|Overall Study|Missing|0|||
147017056|NCT02539368|530222420|FG003|Overall Study|Missing|0|||
147017057|NCT02539368|530222421|FG004|Overall Study|Missing|0|||
147017058|NCT00105157|530222422|FG000|Double-Blind (DB)|Never Treated|1|||
147017059|NCT00105157|530222423|FG001|Double-Blind (DB)|Never Treated|0|||
147017060|NCT00105157|530222424|FG002|Double-Blind (DB)|Never Treated|0|||
147017061|NCT00105157|530222425|FG003|Double-Blind (DB)|Never Treated|0|||
147017062|NCT00105157|530222422|FG000|Double-Blind (DB)|Adverse Event|2|||
147017063|NCT00105157|530222423|FG001|Double-Blind (DB)|Adverse Event|0|||
147017064|NCT00105157|530222424|FG002|Double-Blind (DB)|Adverse Event|1|||
147017065|NCT00105157|530222425|FG003|Double-Blind (DB)|Adverse Event|1|||
147017066|NCT00105157|530222422|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
147017067|NCT00105157|530222423|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
147017068|NCT00105157|530222424|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
147017069|NCT00105157|530222425|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
147017070|NCT00105157|530222422|FG000|Open-Label Continuation of DB|Adverse Event|3|||
147017071|NCT00105157|530222423|FG001|Open-Label Continuation of DB|Adverse Event|1|||
147017072|NCT00105157|530222424|FG002|Open-Label Continuation of DB|Adverse Event|0|||
147017073|NCT00105157|530222425|FG003|Open-Label Continuation of DB|Adverse Event|0|||
147017074|NCT00105157|530222422|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
147017075|NCT00105157|530222423|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
147017076|NCT00105157|530222424|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
147017077|NCT00105157|530222425|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
147017078|NCT00105157|530222422|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
147017079|NCT00105157|530222423|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
147017080|NCT00105157|530222424|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
147017081|NCT00105157|530222425|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
147017082|NCT00105157|530222422|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
147017083|NCT00105157|530222423|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
147017084|NCT00105157|530222424|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
147017085|NCT00105157|530222425|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
147017086|NCT00105157|530222422|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
147017087|NCT00105157|530222423|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
147017088|NCT00105157|530222424|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
147017089|NCT00105157|530222425|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
147017090|NCT00105157|530222422|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
147017091|NCT00105157|530222423|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
147017092|NCT00105157|530222424|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
147017093|NCT00105157|530222425|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
147017094|NCT00105157|530222422|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
147017095|NCT00105157|530222423|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
147017096|NCT00105157|530222424|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
147017097|NCT00105157|530222425|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
147017098|NCT00105157|530222422|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
147017099|NCT00105157|530222423|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
147017100|NCT00105157|530222424|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
147017101|NCT00105157|530222425|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
147017102|NCT00105157|530222422|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
147017103|NCT00105157|530222423|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
147017104|NCT00105157|530222424|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
147017105|NCT00105157|530222425|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
147017106|NCT00105157|530222422|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
147017107|NCT00105157|530222423|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
147017108|NCT00105157|530222424|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
147017109|NCT00105157|530222425|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
147017110|NCT00105157|530222422|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
147017111|NCT00105157|530222423|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
147017112|NCT00105157|530222424|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
147017113|NCT00105157|530222425|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
147017114|NCT00127166|530222426|FG000|Period I|Protocol Violation|0|||
147017115|NCT00127166|530222427|FG001|Period I|Protocol Violation|2|||
147017116|NCT00127166|530222426|FG000|Period I|Withdrawal by Subject|2|||
147017117|NCT00127166|530222427|FG001|Period I|Withdrawal by Subject|0|||
146736536|NCT05375955|529206891|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
147017118|NCT00127166|530222426|FG000|Period I|Patient did not meet inclusion criteria|1|||
147017119|NCT00127166|530222427|FG001|Period I|Patient did not meet inclusion criteria|0|||
147017120|NCT00127166|530222426|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
147017121|NCT00127166|530222427|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
147017122|NCT00127166|530222426|FG000|Period II|Withdrawal by Subject|2|||
147017123|NCT00127166|530222427|FG001|Period II|Withdrawal by Subject|0|||
147017124|NCT00127166|530222426|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
147017125|NCT00127166|530222427|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
147017126|NCT02030535|530222431|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
147017127|NCT02329431|530222433|FG000|Overall Study|Lost to Follow-up|20|||
147017128|NCT02329431|530222434|FG001|Overall Study|Lost to Follow-up|13|||
147017129|NCT01557582|530222435|FG000|Overall Study|Protocol Violation|4|||
147017130|NCT01557582|530222435|FG000|Overall Study|Operator error|2|||
147017131|NCT02843659|530222436|FG000|Overall Study|Subject Withdrew Consent|0|||
147017132|NCT02843659|530222437|FG001|Overall Study|Subject Withdrew Consent|0|||
147017133|NCT02843659|530222438|FG002|Overall Study|Subject Withdrew Consent|1|||
147017134|NCT02843659|530222436|FG000|Overall Study|Administrative Reason by Sponsor|4|||
147017135|NCT02843659|530222437|FG001|Overall Study|Administrative Reason by Sponsor|5|||
147017136|NCT02843659|530222438|FG002|Overall Study|Administrative Reason by Sponsor|4|||
147017137|NCT02843659|530222436|FG000|Overall Study|Adverse Event|0|||
147017138|NCT02843659|530222437|FG001|Overall Study|Adverse Event|1|||
147017139|NCT02843659|530222438|FG002|Overall Study|Adverse Event|0|||
147017140|NCT03180528|530224075|FG000|Overall Study|Adverse Event|1|||
147017141|NCT03180528|530224075|FG000|Overall Study|Withdrawal by Subject|1|||
147017142|NCT03180528|530224075|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
147017143|NCT02447887|530224076|FG000|Overall Study|Study was terminated|3|||
147017144|NCT00109837|530224077|FG000|Overall Study|Adverse Event|2|||
147017145|NCT00109837|530224077|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
147017146|NCT00109837|530224077|FG000|Overall Study|Death|1|||
147017147|NCT00109837|530224077|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
147017148|NCT00109837|530224077|FG000|Overall Study|Not treated|1|||
147017149|NCT00109837|530224077|FG000|Overall Study|Ineligible|1|||
147017150|NCT01563237|530224079|FG000|Overall Study|Lost to Follow-up|6|||
147017151|NCT01563237|530224080|FG001|Overall Study|Lost to Follow-up|0|||
147017152|NCT01563237|530224079|FG000|Overall Study|Withdrawal by Subject|1|||
147017153|NCT01563237|530224080|FG001|Overall Study|Withdrawal by Subject|0|||
147017154|NCT01563237|530224079|FG000|Overall Study|Adverse Event|1|||
147017155|NCT01563237|530224080|FG001|Overall Study|Adverse Event|0|||
147017156|NCT01563237|530224079|FG000|Overall Study|Medical Reasons|1|||
147017157|NCT01563237|530224080|FG001|Overall Study|Medical Reasons|0|||
147017158|NCT01563237|530224079|FG000|Overall Study|Death|1|||
147017159|NCT01563237|530224080|FG001|Overall Study|Death|0|||
147017160|NCT00988208|530224082|FG000|Overall Study|Adverse Event|71|||
147017161|NCT00988208|530224083|FG001|Overall Study|Adverse Event|122|||
147017162|NCT00988208|530224082|FG000|Overall Study|Disease Progression|103|||
147017163|NCT00988208|530224083|FG001|Overall Study|Disease Progression|89|||
147017164|NCT00988208|530224082|FG000|Overall Study|Withdrawal by Subject|50|||
147017165|NCT00988208|530224083|FG001|Overall Study|Withdrawal by Subject|57|||
147017166|NCT00988208|530224082|FG000|Overall Study|Death|9|||
147017167|NCT00988208|530224083|FG001|Overall Study|Death|15|||
147017168|NCT00988208|530224082|FG000|Overall Study|Lost to Follow-up|2|||
147017169|NCT00988208|530224083|FG001|Overall Study|Lost to Follow-up|3|||
147017170|NCT00988208|530224082|FG000|Overall Study|Protocol Violation|9|||
147017171|NCT00988208|530224083|FG001|Overall Study|Protocol Violation|2|||
147017172|NCT00988208|530224082|FG000|Overall Study|Sponsor Decision|102|||
147017173|NCT00988208|530224083|FG001|Overall Study|Sponsor Decision|78|||
147017174|NCT00988208|530224082|FG000|Overall Study|Clinical Progression|17|||
147017175|NCT00988208|530224083|FG001|Overall Study|Clinical Progression|16|||
147017176|NCT00988208|530224082|FG000|Overall Study|Biochemical Progression|21|||
147017177|NCT00988208|530224083|FG001|Overall Study|Biochemical Progression|7|||
147017178|NCT00988208|530224082|FG000|Overall Study|Clinical Deterioration|7|||
147017179|NCT00988208|530224083|FG001|Overall Study|Clinical Deterioration|14|||
147017180|NCT00988208|530224082|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
147017181|NCT00988208|530224083|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
147017182|NCT00988208|530224082|FG000|Overall Study|Other|8|||
147017183|NCT00988208|530224083|FG001|Overall Study|Other|3|||
147017184|NCT00317642|530224086|FG000|Overall Study|Not Received Either Study Drug|1|||
147017185|NCT00317642|530224087|FG001|Overall Study|Not Received Either Study Drug|3|||
147017186|NCT00317642|530224086|FG000|Overall Study|Physician Decision|15|||
147017187|NCT00317642|530224087|FG001|Overall Study|Physician Decision|7|||
147017188|NCT00317642|530224086|FG000|Overall Study|Participant declined treatment|14|||
147017189|NCT00317642|530224087|FG001|Overall Study|Participant declined treatment|3|||
147017190|NCT00317642|530224086|FG000|Overall Study|Adverse Event|17|||
147017191|NCT00317642|530224087|FG001|Overall Study|Adverse Event|5|||
147017192|NCT00317642|530224086|FG000|Overall Study|Treatment Failure|56|||
147017193|NCT00317642|530224087|FG001|Overall Study|Treatment Failure|102|||
146849083|NCT01081665|529617025|FG000|Overall Study|Lack of Efficacy|1|||
147017194|NCT00317642|530224086|FG000|Overall Study|Disease Recurrence|1|||
147017195|NCT00317642|530224087|FG001|Overall Study|Disease Recurrence|2|||
147017196|NCT00317642|530224086|FG000|Overall Study|Death|14|||
147017197|NCT00317642|530224087|FG001|Overall Study|Death|7|||
147017198|NCT00317642|530224086|FG000|Overall Study|Not Continue to Consolidation|2|||
147017199|NCT00317642|530224087|FG001|Overall Study|Not Continue to Consolidation|0|||
147017200|NCT00317642|530224086|FG000|Overall Study|Withdrawal by Subject|0|||
147017201|NCT00317642|530224087|FG001|Overall Study|Withdrawal by Subject|1|||
147017202|NCT00317642|530224086|FG000|Overall Study|Referred For Transplantation|1|||
147017203|NCT00317642|530224087|FG001|Overall Study|Referred For Transplantation|0|||
147017204|NCT00317642|530224086|FG000|Overall Study|AML Not Centrally Confirmed|1|||
147017205|NCT00317642|530224087|FG001|Overall Study|AML Not Centrally Confirmed|5|||
147017206|NCT04364737|530224089|FG000|Overall Study|Withdrawal by Subject|4|||
147017207|NCT04364737|530224090|FG001|Overall Study|Withdrawal by Subject|9|||
147017208|NCT04364737|530224089|FG000|Overall Study|Lost to Follow-up|1|||
147017209|NCT04364737|530224090|FG001|Overall Study|Lost to Follow-up|1|||
147017210|NCT01220609|530224091|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
147017211|NCT01220609|530224091|FG000|Overall Study|Ineligible- Wrong cell type|1|||
147017212|NCT01220609|530224091|FG000|Overall Study|Ineligible-Never treated|1|||
147017213|NCT00868296|530224094|FG000|Overall Study|Adverse Event|0|||
147017214|NCT00868296|530224095|FG001|Overall Study|Adverse Event|2|||
147017215|NCT00868296|530224094|FG000|Overall Study|Withdrawal by Subject|0|||
147017216|NCT00868296|530224095|FG001|Overall Study|Withdrawal by Subject|1|||
147017217|NCT00112294|530224096|FG000|Overall Study|Still on study|5|||
147017218|NCT00112294|530224097|FG001|Overall Study|Still on study|0|||
147017219|NCT00605176|530224098|FG000|Overall Study|Adverse Event|2|||
147017220|NCT00605176|530224099|FG001|Overall Study|Adverse Event|1|||
147017221|NCT00605176|530224100|FG002|Overall Study|Adverse Event|3|||
147017222|NCT00605176|530224098|FG000|Overall Study|Withdrawal by Subject|4|||
147017223|NCT00605176|530224099|FG001|Overall Study|Withdrawal by Subject|2|||
147017224|NCT00605176|530224100|FG002|Overall Study|Withdrawal by Subject|4|||
147017225|NCT00605176|530224098|FG000|Overall Study|Lost to Follow-up|2|||
147017226|NCT00605176|530224099|FG001|Overall Study|Lost to Follow-up|2|||
147017227|NCT00605176|530224100|FG002|Overall Study|Lost to Follow-up|1|||
147017228|NCT00605176|530224098|FG000|Overall Study|Non-complicance with study procedures|1|||
147017229|NCT00605176|530224099|FG001|Overall Study|Non-complicance with study procedures|0|||
147017230|NCT00605176|530224100|FG002|Overall Study|Non-complicance with study procedures|0|||
147017231|NCT00605176|530224098|FG000|Overall Study|Use of concomitant therapy|1|||
147017232|NCT00605176|530224099|FG001|Overall Study|Use of concomitant therapy|0|||
147017233|NCT00605176|530224100|FG002|Overall Study|Use of concomitant therapy|1|||
147017234|NCT00605176|530224098|FG000|Overall Study|Other (not due to AE)|1|||
147017235|NCT00605176|530224099|FG001|Overall Study|Other (not due to AE)|1|||
147017236|NCT00605176|530224100|FG002|Overall Study|Other (not due to AE)|0|||
147017237|NCT00109850|530224103|FG000|Overall Study|Adverse Event|1|||
147017238|NCT00109850|530224103|FG000|Overall Study|Death|2|||
147017239|NCT00109850|530224103|FG000|Overall Study|Ineligible|1|||
147017240|NCT00476593|530224104|FG000|Overall Study|Lost to Follow-up|10|||
147017241|NCT00476593|530224105|FG001|Overall Study|Lost to Follow-up|2|||
147017242|NCT00476593|530224106|FG002|Overall Study|Lost to Follow-up|8|||
147017243|NCT00476593|530224107|FG003|Overall Study|Lost to Follow-up|22|||
147017244|NCT03635983|530224108|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
147017245|NCT03635983|530224109|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
147017246|NCT03635983|530224108|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
147017247|NCT03635983|530224109|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147017248|NCT03635983|530224108|FG000|Pre-Treatment Period|Other reasons|0|||
147017249|NCT03635983|530224109|FG001|Pre-Treatment Period|Other reasons|1|||
147017250|NCT03635983|530224108|FG000|Pre-Treatment Period|Disease Progression|0|||
147017251|NCT03635983|530224109|FG001|Pre-Treatment Period|Disease Progression|1|||
147017252|NCT03635983|530224108|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
147017253|NCT03635983|530224109|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
147017254|NCT03635983|530224108|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
146736537|NCT05375955|529206892|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
146736538|NCT05375955|529206893|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
146736539|NCT05375955|529206894|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
146736540|NCT05375955|529206888|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
146736541|NCT05375955|529206889|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
146736542|NCT05375955|529206890|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
146736543|NCT05375955|529206891|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
146736544|NCT05375955|529206892|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
146736545|NCT05375955|529206893|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
146736546|NCT05375955|529206894|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
146736547|NCT05454410|529206895|FG000|Overall Study|Withdrawal by Subject|0|||
146736548|NCT05454410|529206896|FG001|Overall Study|Withdrawal by Subject|0|||
147017255|NCT03635983|530224109|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
147017256|NCT03635983|530224108|FG000|Treatment Period|Withdrawal by Subject|3|||
147017257|NCT03635983|530224109|FG001|Treatment Period|Withdrawal by Subject|5|||
147017258|NCT03635983|530224108|FG000|Treatment Period|Death|3|||
147017259|NCT03635983|530224109|FG001|Treatment Period|Death|5|||
147017260|NCT03635983|530224108|FG000|Treatment Period|Poor/Non-compliance|2|||
147017261|NCT03635983|530224109|FG001|Treatment Period|Poor/Non-compliance|1|||
147017262|NCT03635983|530224108|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
147017263|NCT03635983|530224109|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
147017264|NCT03635983|530224108|FG000|Treatment Period|Other reasons|7|||
147017265|NCT03635983|530224109|FG001|Treatment Period|Other reasons|4|||
147017266|NCT03635983|530224108|FG000|Treatment Period|Disease progression|230|||
147017267|NCT03635983|530224109|FG001|Treatment Period|Disease progression|201|||
147017268|NCT03635983|530224108|FG000|Treatment Period|Study drug toxicity|35|||
147017269|NCT03635983|530224109|FG001|Treatment Period|Study drug toxicity|36|||
147017270|NCT03635983|530224108|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
147017271|NCT03635983|530224109|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
147017272|NCT03635983|530224108|FG000|Treatment Period|Maximum clinical benefit|3|||
147017273|NCT03635983|530224109|FG001|Treatment Period|Maximum clinical benefit|5|||
146849084|NCT01747551|529617028|FG000|Overall Study|Progressive Disease|24|||
147017274|NCT03635983|530224108|FG000|Treatment Period|Administrative reason by the sponsor|1|||
147017275|NCT03635983|530224109|FG001|Treatment Period|Administrative reason by the sponsor|2|||
147017276|NCT03635983|530224108|FG000|Treatment Period|Lost to Follow-up|0|||
147017277|NCT03635983|530224109|FG001|Treatment Period|Lost to Follow-up|1|||
147017278|NCT03430011|530224110|FG000|Pre-Treatment|Death|1|||
147017279|NCT03430011|530224111|FG001|Pre-Treatment|Death|0|||
147017280|NCT03430011|530224112|FG002|Pre-Treatment|Death|0|||
147017281|NCT03430011|530224113|FG003|Pre-Treatment|Death|0|||
147017282|NCT03430011|530224114|FG004|Pre-Treatment|Death|1|||
147017283|NCT03430011|530224115|FG005|Pre-Treatment|Death|0|||
147017284|NCT03430011|530224116|FG006|Pre-Treatment|Death|1|||
147017285|NCT03430011|530224117|FG007|Pre-Treatment|Death|0|||
147017286|NCT03430011|530224110|FG000|Pre-Treatment|Screen Fail|0|||
147017287|NCT03430011|530224111|FG001|Pre-Treatment|Screen Fail|0|||
147017288|NCT03430011|530224112|FG002|Pre-Treatment|Screen Fail|0|||
147017289|NCT03430011|530224113|FG003|Pre-Treatment|Screen Fail|0|||
147017290|NCT03430011|530224114|FG004|Pre-Treatment|Screen Fail|1|||
147017291|NCT03430011|530224115|FG005|Pre-Treatment|Screen Fail|0|||
147017292|NCT03430011|530224116|FG006|Pre-Treatment|Screen Fail|0|||
147017293|NCT03430011|530224117|FG007|Pre-Treatment|Screen Fail|0|||
147017294|NCT03430011|530224110|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
147017295|NCT03430011|530224111|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
147017296|NCT03430011|530224112|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
147017297|NCT03430011|530224113|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
147017298|NCT03430011|530224114|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
147017299|NCT03430011|530224115|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
147017300|NCT03430011|530224116|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
147017301|NCT03430011|530224117|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
147017302|NCT03430011|530224110|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
147017303|NCT03430011|530224111|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
147017304|NCT03430011|530224112|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
147017305|NCT03430011|530224113|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
147017306|NCT03430011|530224114|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
147017307|NCT03430011|530224115|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
147017308|NCT03430011|530224116|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
147017309|NCT03430011|530224117|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
147017310|NCT03430011|530224110|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
147017311|NCT03430011|530224111|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
147017312|NCT03430011|530224112|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
147017313|NCT03430011|530224113|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
146849085|NCT01747551|529617029|FG001|Overall Study|Progressive Disease|17|||
146849086|NCT01747551|529617028|FG000|Overall Study|Death|3|||
146849087|NCT01747551|529617029|FG001|Overall Study|Death|1|||
146849088|NCT01747551|529617028|FG000|Overall Study|Adverse Event|7|||
147017314|NCT03430011|530224114|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
147017315|NCT03430011|530224115|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
147017316|NCT03430011|530224116|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
147017317|NCT03430011|530224117|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
147017318|NCT03430011|530224110|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
147017319|NCT03430011|530224111|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
147017320|NCT03430011|530224112|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
147017321|NCT03430011|530224113|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
146849089|NCT01747551|529617029|FG001|Overall Study|Adverse Event|1|||
147017322|NCT03430011|530224114|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
147017323|NCT03430011|530224115|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
147017324|NCT03430011|530224116|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
147017325|NCT03430011|530224117|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
147017326|NCT03430011|530224110|FG000|JCARH125 Treatment|Death|4|||
147017327|NCT03430011|530224111|FG001|JCARH125 Treatment|Death|19|||
147017328|NCT03430011|530224112|FG002|JCARH125 Treatment|Death|10|||
147017329|NCT03430011|530224113|FG003|JCARH125 Treatment|Death|8|||
147017330|NCT03430011|530224114|FG004|JCARH125 Treatment|Death|5|||
147017331|NCT03430011|530224115|FG005|JCARH125 Treatment|Death|3|||
147017332|NCT03430011|530224116|FG006|JCARH125 Treatment|Death|4|||
147017333|NCT03430011|530224117|FG007|JCARH125 Treatment|Death|2|||
147017334|NCT03430011|530224110|FG000|JCARH125 Treatment|Other reasons|1|||
147017335|NCT03430011|530224111|FG001|JCARH125 Treatment|Other reasons|0|||
147017336|NCT03430011|530224112|FG002|JCARH125 Treatment|Other reasons|4|||
147017337|NCT03430011|530224113|FG003|JCARH125 Treatment|Other reasons|2|||
147017338|NCT03430011|530224114|FG004|JCARH125 Treatment|Other reasons|2|||
147017339|NCT03430011|530224115|FG005|JCARH125 Treatment|Other reasons|1|||
147017340|NCT03430011|530224116|FG006|JCARH125 Treatment|Other reasons|3|||
147017341|NCT03430011|530224117|FG007|JCARH125 Treatment|Other reasons|2|||
147017342|NCT04126343|530224119|FG000|Overall Study|Adverse Event|0|||
147017343|NCT04126343|530224120|FG001|Overall Study|Adverse Event|0|||
147017344|NCT04126343|530224121|FG002|Overall Study|Adverse Event|0|||
147017345|NCT04126343|530224122|FG003|Overall Study|Adverse Event|0|||
147017346|NCT04126343|530224123|FG004|Overall Study|Adverse Event|0|||
147017347|NCT04126343|530224124|FG005|Overall Study|Adverse Event|1|||
147017348|NCT04126343|530224119|FG000|Overall Study|Withdrawal by Subject|0|||
147017349|NCT04126343|530224120|FG001|Overall Study|Withdrawal by Subject|0|||
147017350|NCT04126343|530224121|FG002|Overall Study|Withdrawal by Subject|0|||
147017351|NCT04126343|530224122|FG003|Overall Study|Withdrawal by Subject|1|||
147017352|NCT04126343|530224123|FG004|Overall Study|Withdrawal by Subject|0|||
147017353|NCT04126343|530224124|FG005|Overall Study|Withdrawal by Subject|0|||
147017354|NCT04126343|530224119|FG000|Overall Study|Related to COVID-19 pandemic|3|||
147017355|NCT04126343|530224120|FG001|Overall Study|Related to COVID-19 pandemic|4|||
147017356|NCT04126343|530224121|FG002|Overall Study|Related to COVID-19 pandemic|3|||
147017357|NCT04126343|530224122|FG003|Overall Study|Related to COVID-19 pandemic|3|||
147017358|NCT04126343|530224123|FG004|Overall Study|Related to COVID-19 pandemic|3|||
147017359|NCT04126343|530224124|FG005|Overall Study|Related to COVID-19 pandemic|3|||
147017360|NCT00388037|530224133|FG000|Overall Study|Protocol Violation|1|||
147017361|NCT00602537|530224134|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
147017362|NCT00602537|530224135|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
147017363|NCT00602537|530224134|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
147017364|NCT00602537|530224135|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
147017365|NCT00602537|530224134|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
147017366|NCT00602537|530224135|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
147017367|NCT00602537|530224134|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
147017368|NCT00602537|530224135|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
147017369|NCT00602537|530224134|FG000|Follow Up Study Comparison|Adverse Event|1|||
147017370|NCT00602537|530224135|FG001|Follow Up Study Comparison|Adverse Event|0|||
147017371|NCT00602537|530224134|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
147017372|NCT00602537|530224135|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
147017373|NCT00602537|530224134|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
147017374|NCT00602537|530224135|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
147017375|NCT04330157|530224136|FG000|Overall Study|Protocol Violation|4|||
147017376|NCT04330157|530224136|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
147017377|NCT04314843|530224138|FG000|Overall Study|Death|2|||
147017378|NCT04314843|530224139|FG001|Overall Study|Death|2|||
147017379|NCT04314843|530224138|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
147017380|NCT04314843|530224139|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
147017381|NCT01899326|530224141|FG000|Overall Study|Withdrawal by Subject|1|||
147017382|NCT01899326|530224141|FG000|Overall Study|Adverse Event|2|||
147017383|NCT01899326|530224141|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
147017384|NCT01020526|530224142|FG000|Overall Study|Withdrawal by Subject|5|||
147017385|NCT01020526|530224142|FG000|Overall Study|Other reasons|3|||
147017386|NCT01020526|530224142|FG000|Overall Study|Insufficient clinical response|3|||
147017387|NCT01020526|530224142|FG000|Overall Study|Lost to Follow-up|1|||
147017388|NCT01020526|530224142|FG000|Overall Study|Adverse Event|2|||
147017389|NCT00373425|530224143|FG000|Overall Study|Relapse of NSCLC|116|||
147017390|NCT00373425|530224144|FG001|Overall Study|Relapse of NSCLC|104|||
147017391|NCT00373425|530224145|FG002|Overall Study|Relapse of NSCLC|19|||
147017392|NCT00373425|530224146|FG003|Overall Study|Relapse of NSCLC|2|||
147017393|NCT00373425|530224147|FG004|Overall Study|Relapse of NSCLC|26|||
147017394|NCT00373425|530224143|FG000|Overall Study|Adverse Event|191|||
147017395|NCT00373425|530224144|FG001|Overall Study|Adverse Event|22|||
147017396|NCT00373425|530224145|FG002|Overall Study|Adverse Event|59|||
147017397|NCT00373425|530224146|FG003|Overall Study|Adverse Event|0|||
147017398|NCT00373425|530224147|FG004|Overall Study|Adverse Event|34|||
147017399|NCT00373425|530224143|FG000|Overall Study|Patient request|35|||
147017400|NCT00373425|530224144|FG001|Overall Study|Patient request|18|||
147017401|NCT00373425|530224145|FG002|Overall Study|Patient request|43|||
147017402|NCT00373425|530224146|FG003|Overall Study|Patient request|6|||
147017403|NCT00373425|530224147|FG004|Overall Study|Patient request|7|||
147017404|NCT00373425|530224143|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
147017405|NCT00373425|530224144|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
147017406|NCT00373425|530224145|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
147017407|NCT00373425|530224146|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
147017408|NCT00373425|530224147|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
147017409|NCT00373425|530224143|FG000|Overall Study|Death|7|||
147017410|NCT00373425|530224144|FG001|Overall Study|Death|0|||
147017411|NCT00373425|530224145|FG002|Overall Study|Death|3|||
147017412|NCT00373425|530224146|FG003|Overall Study|Death|1|||
147017413|NCT00373425|530224147|FG004|Overall Study|Death|0|||
147017414|NCT03558139|530224148|FG000|Overall Study|Consent Withdrawn|1|||
147017415|NCT03558139|530224149|FG001|Overall Study|Consent Withdrawn|1|||
147017416|NCT03558139|530224150|FG002|Overall Study|Consent Withdrawn|4|||
147017417|NCT03558139|530224148|FG000|Overall Study|Death|5|||
147017418|NCT03558139|530224149|FG001|Overall Study|Death|3|||
147017419|NCT03558139|530224150|FG002|Overall Study|Death|8|||
147017420|NCT03558139|530224148|FG000|Overall Study|Lost to Follow-up|0|||
147017421|NCT03558139|530224149|FG001|Overall Study|Lost to Follow-up|0|||
147017422|NCT03558139|530224150|FG002|Overall Study|Lost to Follow-up|3|||
147017423|NCT03558139|530224148|FG000|Overall Study|Study Ended Per Protocol|0|||
147017424|NCT03558139|530224149|FG001|Overall Study|Study Ended Per Protocol|3|||
147017425|NCT03558139|530224150|FG002|Overall Study|Study Ended Per Protocol|6|||
147017426|NCT00551616|530224153|FG000|Overall Study|Lost to Follow-up|48|||
147017427|NCT00551616|530224154|FG001|Overall Study|Lost to Follow-up|40|||
147017428|NCT02752802|530224155|FG000|Overall Study|Contrast Volume Not Collected|1|||
147017429|NCT02752802|530224156|FG001|Overall Study|Contrast Volume Not Collected|0|||
147017430|NCT02808819|530224157|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
147017431|NCT02808819|530224158|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
147017432|NCT02808819|530224157|FG000|Overall Study|Withdrawal by Subject|10|||
147017433|NCT02808819|530224158|FG001|Overall Study|Withdrawal by Subject|13|||
147017434|NCT02808819|530224157|FG000|Overall Study|Site terminated by sponsor|2|||
147017435|NCT02808819|530224158|FG001|Overall Study|Site terminated by sponsor|0|||
147017436|NCT02808819|530224157|FG000|Overall Study|Pregnancy|1|||
147017437|NCT02808819|530224158|FG001|Overall Study|Pregnancy|0|||
147017438|NCT02808819|530224157|FG000|Overall Study|Lost to Follow-up|1|||
147017439|NCT02808819|530224158|FG001|Overall Study|Lost to Follow-up|6|||
147017440|NCT02808819|530224157|FG000|Overall Study|Protocol Violation|0|||
147017441|NCT02808819|530224158|FG001|Overall Study|Protocol Violation|1|||
147017442|NCT02808819|530224157|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
147017443|NCT02808819|530224158|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
147017444|NCT02808819|530224157|FG000|Overall Study|Death|1|||
147017445|NCT02808819|530224158|FG001|Overall Study|Death|0|||
147017446|NCT02808819|530224157|FG000|Overall Study|Adverse Event|3|||
147017447|NCT02808819|530224158|FG001|Overall Study|Adverse Event|4|||
147017448|NCT00251316|530224159|FG000|Overall Study|Physician Decision|2|||
147017449|NCT00251316|530224160|FG001|Overall Study|Physician Decision|3|||
147017450|NCT03139240|530224161|FG000|Overall Study|Lost to Follow-up|0|||
147017451|NCT03139240|530224162|FG001|Overall Study|Lost to Follow-up|1|||
147017452|NCT03139240|530224163|FG002|Overall Study|Lost to Follow-up|1|||
147017453|NCT03139240|530224164|FG003|Overall Study|Lost to Follow-up|0|||
147017454|NCT01396421|530224171|FG000|Overall Study|Lost to Follow-up|0|||
147017455|NCT01396421|530224172|FG001|Overall Study|Lost to Follow-up|0|||
147017456|NCT01396421|530224173|FG002|Overall Study|Lost to Follow-up|0|||
147017457|NCT01396421|530224174|FG003|Overall Study|Lost to Follow-up|1|||
147017458|NCT01396421|530224171|FG000|Overall Study|Adverse Event|17|||
147017459|NCT01396421|530224172|FG001|Overall Study|Adverse Event|15|||
147017460|NCT01396421|530224173|FG002|Overall Study|Adverse Event|12|||
147017461|NCT01396421|530224174|FG003|Overall Study|Adverse Event|32|||
147017462|NCT01396421|530224171|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
147017463|NCT01396421|530224172|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
147017464|NCT01396421|530224173|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
147017465|NCT01396421|530224174|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
147017466|NCT01396421|530224171|FG000|Overall Study|Physician Decision|1|||
147017467|NCT01396421|530224172|FG001|Overall Study|Physician Decision|1|||
147017468|NCT01396421|530224173|FG002|Overall Study|Physician Decision|0|||
147017469|NCT01396421|530224174|FG003|Overall Study|Physician Decision|3|||
147017470|NCT01396421|530224171|FG000|Overall Study|Withdrawal by Subject|31|||
147017471|NCT01396421|530224172|FG001|Overall Study|Withdrawal by Subject|24|||
147017472|NCT01396421|530224173|FG002|Overall Study|Withdrawal by Subject|13|||
147017473|NCT01396421|530224174|FG003|Overall Study|Withdrawal by Subject|21|||
147017474|NCT01396421|530224171|FG000|Overall Study|Protocol Deviation|2|||
147017475|NCT01396421|530224172|FG001|Overall Study|Protocol Deviation|1|||
147017476|NCT01396421|530224173|FG002|Overall Study|Protocol Deviation|1|||
147017477|NCT01396421|530224174|FG003|Overall Study|Protocol Deviation|0|||
147017478|NCT01396421|530224171|FG000|Overall Study|Lack of Efficacy|7|||
147017479|NCT01396421|530224172|FG001|Overall Study|Lack of Efficacy|17|||
147017480|NCT01396421|530224173|FG002|Overall Study|Lack of Efficacy|7|||
147017481|NCT01396421|530224174|FG003|Overall Study|Lack of Efficacy|18|||
147017482|NCT00569777|530224175|FG000|Overall Study|Withdrawal by Subject|4|||
147017483|NCT00569777|530224176|FG001|Overall Study|Withdrawal by Subject|0|||
147017484|NCT00569777|530224175|FG000|Overall Study|Adverse Event|3|||
147017485|NCT00569777|530224176|FG001|Overall Study|Adverse Event|0|||
147017486|NCT00569777|530224175|FG000|Overall Study|Lost to Follow-up|1|||
147017487|NCT00569777|530224176|FG001|Overall Study|Lost to Follow-up|0|||
147017488|NCT00569777|530224175|FG000|Overall Study|scheduled eye surgery|0|||
147017489|NCT00569777|530224176|FG001|Overall Study|scheduled eye surgery|1|||
147017490|NCT00569777|530224175|FG000|Overall Study|did not meet exclusion criteria|1|||
147017491|NCT00569777|530224176|FG001|Overall Study|did not meet exclusion criteria|2|||
147017492|NCT00569777|530224175|FG000|Overall Study|pregnant|1|||
147017493|NCT00569777|530224176|FG001|Overall Study|pregnant|0|||
147017494|NCT01610063|530224181|FG000|Overall Study|Lost to Follow-up|42|||
147017495|NCT01610063|530224182|FG001|Overall Study|Lost to Follow-up|20|||
147017496|NCT03314662|530224183|FG000|Overall Study|Withdrawal by Subject|1|||
147017497|NCT03314662|530224184|FG001|Overall Study|Withdrawal by Subject|1|||
147017498|NCT03314662|530224185|FG002|Overall Study|Withdrawal by Subject|1|||
147017499|NCT03314662|530224183|FG000|Overall Study|Lost to Follow-up|5|||
147017500|NCT03314662|530224184|FG001|Overall Study|Lost to Follow-up|4|||
147017501|NCT03314662|530224185|FG002|Overall Study|Lost to Follow-up|4|||
147017502|NCT03314662|530224183|FG000|Overall Study|Death|2|||
147017503|NCT03314662|530224184|FG001|Overall Study|Death|0|||
147017504|NCT03314662|530224185|FG002|Overall Study|Death|0|||
147017505|NCT01867606|530224188|FG000|Overall Study|Withdrawal by Subject|10|||
147017506|NCT01867606|530224189|FG001|Overall Study|Withdrawal by Subject|14|||
147017507|NCT01867606|530224188|FG000|Overall Study|Protocol Violation|0|||
147017508|NCT01867606|530224189|FG001|Overall Study|Protocol Violation|1|||
147017509|NCT01378962|530224190|FG000|Overall Study|Death|14|||
147017510|NCT01378962|530224190|FG000|Overall Study|Lost to Follow-up|1|||
147017511|NCT01378962|530224190|FG000|Overall Study|Other|2|||
147017512|NCT01835548|530224195|FG000|Dose Optimization Period|Adverse Event|0|||
147017513|NCT01835548|530224196|FG001|Dose Optimization Period|Adverse Event|0|||
147017514|NCT01835548|530224197|FG002|Dose Optimization Period|Adverse Event|1|||
147017515|NCT01835548|530224195|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
147017516|NCT01835548|530224196|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
147017517|NCT01835548|530224197|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
147017518|NCT01835548|530224195|FG000|Double-Blind Treatment Period|Adverse Event|0|||
147017519|NCT01835548|530224196|FG001|Double-Blind Treatment Period|Adverse Event|1|||
147017520|NCT01835548|530224197|FG002|Double-Blind Treatment Period|Adverse Event|0|||
147017521|NCT01835548|530224195|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147017522|NCT01835548|530224196|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
147017523|NCT01835548|530224197|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147017524|NCT02490800|530224198|FG000|Overall Study|Adverse Event|0|||
147017525|NCT02490800|530224199|FG001|Overall Study|Adverse Event|0|||
147017526|NCT02490800|530224200|FG002|Overall Study|Adverse Event|0|||
147017527|NCT02490800|530224201|FG003|Overall Study|Adverse Event|2|||
147017528|NCT02490800|530224202|FG004|Overall Study|Adverse Event|3|||
147017529|NCT02490800|530224203|FG005|Overall Study|Adverse Event|2|||
147017530|NCT02490800|530224204|FG006|Overall Study|Adverse Event|0|||
147017531|NCT02490800|530224205|FG007|Overall Study|Adverse Event|0|||
147017532|NCT02490800|530224206|FG008|Overall Study|Adverse Event|0|||
147017533|NCT02490800|530224207|FG009|Overall Study|Adverse Event|0|||
147017534|NCT02490800|530224208|FG010|Overall Study|Adverse Event|0|||
147017535|NCT02490800|530224209|FG011|Overall Study|Adverse Event|2|||
147017536|NCT02490800|530224210|FG012|Overall Study|Adverse Event|2|||
147017537|NCT02490800|530224198|FG000|Overall Study|Withdrawal by Subject|0|||
147017538|NCT02490800|530224199|FG001|Overall Study|Withdrawal by Subject|0|||
147017539|NCT02490800|530224200|FG002|Overall Study|Withdrawal by Subject|0|||
147017540|NCT02490800|530224201|FG003|Overall Study|Withdrawal by Subject|1|||
147017541|NCT02490800|530224202|FG004|Overall Study|Withdrawal by Subject|0|||
147017542|NCT02490800|530224203|FG005|Overall Study|Withdrawal by Subject|0|||
147017543|NCT02490800|530224204|FG006|Overall Study|Withdrawal by Subject|0|||
147017544|NCT02490800|530224205|FG007|Overall Study|Withdrawal by Subject|0|||
147017545|NCT02490800|530224206|FG008|Overall Study|Withdrawal by Subject|1|||
147017546|NCT02490800|530224207|FG009|Overall Study|Withdrawal by Subject|0|||
147017547|NCT02490800|530224208|FG010|Overall Study|Withdrawal by Subject|0|||
147017548|NCT02490800|530224209|FG011|Overall Study|Withdrawal by Subject|0|||
147017549|NCT02490800|530224210|FG012|Overall Study|Withdrawal by Subject|0|||
147017550|NCT02490800|530224198|FG000|Overall Study|Progressive disease|3|||
147017551|NCT02490800|530224199|FG001|Overall Study|Progressive disease|3|||
147017552|NCT02490800|530224200|FG002|Overall Study|Progressive disease|3|||
147017553|NCT02490800|530224201|FG003|Overall Study|Progressive disease|4|||
147017554|NCT02490800|530224202|FG004|Overall Study|Progressive disease|4|||
147017555|NCT02490800|530224203|FG005|Overall Study|Progressive disease|1|||
147017556|NCT02490800|530224204|FG006|Overall Study|Progressive disease|4|||
147017557|NCT02490800|530224205|FG007|Overall Study|Progressive disease|3|||
147017558|NCT02490800|530224206|FG008|Overall Study|Progressive disease|6|||
147017559|NCT02490800|530224207|FG009|Overall Study|Progressive disease|2|||
147017560|NCT02490800|530224208|FG010|Overall Study|Progressive disease|7|||
147017561|NCT02490800|530224209|FG011|Overall Study|Progressive disease|1|||
147017562|NCT02490800|530224210|FG012|Overall Study|Progressive disease|10|||
147017563|NCT02490800|530224198|FG000|Overall Study|Patient enrolled in post-trial access|0|||
147017564|NCT02490800|530224199|FG001|Overall Study|Patient enrolled in post-trial access|0|||
147017565|NCT02490800|530224200|FG002|Overall Study|Patient enrolled in post-trial access|0|||
147017566|NCT02490800|530224201|FG003|Overall Study|Patient enrolled in post-trial access|0|||
147017567|NCT02490800|530224202|FG004|Overall Study|Patient enrolled in post-trial access|0|||
147017568|NCT02490800|530224203|FG005|Overall Study|Patient enrolled in post-trial access|0|||
147017569|NCT02490800|530224204|FG006|Overall Study|Patient enrolled in post-trial access|0|||
147017570|NCT02490800|530224205|FG007|Overall Study|Patient enrolled in post-trial access|0|||
147017571|NCT02490800|530224206|FG008|Overall Study|Patient enrolled in post-trial access|0|||
147017572|NCT02490800|530224207|FG009|Overall Study|Patient enrolled in post-trial access|1|||
147017573|NCT02490800|530224208|FG010|Overall Study|Patient enrolled in post-trial access|1|||
147017574|NCT02490800|530224209|FG011|Overall Study|Patient enrolled in post-trial access|0|||
147017575|NCT02490800|530224210|FG012|Overall Study|Patient enrolled in post-trial access|6|||
147017576|NCT01634854|530224211|FG000|Overall Study|Cesarean delivery|2|||
147017577|NCT01634854|530224212|FG001|Overall Study|Cesarean delivery|7|||
147017578|NCT00537017|530224213|FG000|Treatment Phase|Adverse Event|19|||
147017579|NCT00537017|530224213|FG000|Treatment Phase|Withdrawal by Subject|13|||
147017580|NCT00537017|530224213|FG000|Treatment Phase|Protocol Violation|2|||
147017581|NCT00537017|530224213|FG000|Follow-up Phase|Withdrawal by Subject|9|||
147017582|NCT03365791|530224215|FG000|Overall Study|Adverse Event|5|||
147017583|NCT03365791|530224215|FG000|Overall Study|Death|1|||
147017584|NCT03365791|530224215|FG000|Overall Study|Lost to Follow-up|1|||
147017585|NCT03365791|530224215|FG000|Overall Study|Physician Decision|9|||
147017586|NCT03365791|530224215|FG000|Overall Study|Progressive disease|51|||
147017587|NCT03365791|530224215|FG000|Overall Study|Subject/guardian decision|5|||
147017588|NCT00739973|530224216|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
147017589|NCT00739973|530224217|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
147017590|NCT00739973|530224218|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
147017591|NCT00739973|530224219|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
147017592|NCT00739973|530224220|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
147017593|NCT00739973|530224221|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
147017594|NCT00739973|530224222|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
147017595|NCT00739973|530224223|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
147017596|NCT00739973|530224224|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
147017597|NCT00739973|530224216|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
147017598|NCT00739973|530224217|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
147017599|NCT00739973|530224218|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
147017600|NCT00739973|530224219|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
147017601|NCT00739973|530224220|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
147017602|NCT00739973|530224221|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
147017603|NCT00739973|530224222|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
147017604|NCT00739973|530224223|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
147017605|NCT00739973|530224224|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
147017606|NCT00739973|530224216|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
147017607|NCT00739973|530224217|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
146849090|NCT01747551|529617028|FG000|Overall Study|Prolonged Treatment Delay|2|||
146849091|NCT01747551|529617029|FG001|Overall Study|Prolonged Treatment Delay|0|||
146849092|NCT01747551|529617028|FG000|Overall Study|Withdrawal by Subject|3|||
146849093|NCT01747551|529617029|FG001|Overall Study|Withdrawal by Subject|1|||
146849094|NCT01747551|529617028|FG000|Overall Study|Physician Decision|2|||
146849095|NCT01747551|529617029|FG001|Overall Study|Physician Decision|1|||
146849096|NCT01747551|529617028|FG000|Overall Study|Other|2|||
146849097|NCT01747551|529617029|FG001|Overall Study|Other|0|||
146849098|NCT03117998|529617033|FG000|Overall Study|Adverse Event|1|||
146849099|NCT03117998|529617034|FG001|Overall Study|Adverse Event|0|||
146849100|NCT03117998|529617035|FG002|Overall Study|Adverse Event|0|||
146849101|NCT03117998|529617036|FG003|Overall Study|Adverse Event|0|||
147017608|NCT00739973|530224218|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
147017609|NCT00739973|530224219|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
147017610|NCT00739973|530224220|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
147017611|NCT00739973|530224221|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
146849102|NCT03117998|529617037|FG004|Overall Study|Adverse Event|0|||
146849103|NCT03117998|529617038|FG005|Overall Study|Adverse Event|0|||
147017612|NCT00739973|530224222|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
147017613|NCT00739973|530224223|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
147017614|NCT00739973|530224224|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
147017615|NCT00739973|530224216|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
147017616|NCT00739973|530224217|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
147017617|NCT00739973|530224218|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
147017618|NCT00739973|530224219|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
147017619|NCT00739973|530224220|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
147017620|NCT00739973|530224221|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
147017621|NCT00739973|530224222|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
147017622|NCT00739973|530224223|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
147017623|NCT00739973|530224224|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
147017624|NCT00739973|530224216|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
147017625|NCT00739973|530224217|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
147017626|NCT00739973|530224218|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
147017627|NCT00739973|530224219|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
147017628|NCT00739973|530224220|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
147017629|NCT00739973|530224221|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
147017630|NCT00739973|530224222|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
147017631|NCT00739973|530224223|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
147017632|NCT00739973|530224224|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
147017633|NCT00739973|530224216|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
147017634|NCT00739973|530224217|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
147017635|NCT00739973|530224218|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
147017636|NCT00739973|530224219|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
147017637|NCT00739973|530224220|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
147017638|NCT00739973|530224221|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
147017639|NCT00739973|530224222|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
147017640|NCT00739973|530224223|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
147017641|NCT00739973|530224224|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
147017642|NCT00739973|530224216|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
147017643|NCT00739973|530224217|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
147017644|NCT00739973|530224218|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
147017645|NCT00739973|530224219|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
147017646|NCT00739973|530224220|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
147017647|NCT00739973|530224221|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
147017648|NCT00739973|530224222|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
147017649|NCT00739973|530224223|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
147017650|NCT00739973|530224224|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
147017651|NCT00739973|530224216|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
147017652|NCT00739973|530224217|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
147017653|NCT00739973|530224218|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
147017654|NCT00739973|530224219|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
147017655|NCT00739973|530224220|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
147017656|NCT00739973|530224221|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
147017657|NCT00739973|530224222|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
147017658|NCT00739973|530224223|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
147017659|NCT00739973|530224224|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
147017660|NCT00739973|530224216|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
147017661|NCT00739973|530224217|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
147017662|NCT00739973|530224218|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
147017663|NCT00739973|530224219|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
147017664|NCT00739973|530224220|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
147017665|NCT00739973|530224221|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
147017666|NCT00739973|530224222|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
147017667|NCT00739973|530224223|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
147017668|NCT00739973|530224224|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
147017669|NCT00739973|530224216|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
147017670|NCT00739973|530224217|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
147017671|NCT00739973|530224218|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
147017672|NCT00739973|530224219|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
147017673|NCT00739973|530224220|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
147017674|NCT00739973|530224221|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
147017675|NCT00739973|530224222|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
147017676|NCT00739973|530224223|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
147017677|NCT00739973|530224224|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
147017678|NCT00739973|530224216|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
147017679|NCT00739973|530224217|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
147017680|NCT00739973|530224218|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
147017681|NCT00739973|530224219|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
147017682|NCT00739973|530224220|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
147017683|NCT00739973|530224221|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
147017684|NCT00739973|530224222|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
147017685|NCT00739973|530224223|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
147017686|NCT00739973|530224224|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
147017687|NCT00739973|530224216|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
147017688|NCT00739973|530224217|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
147017689|NCT00739973|530224218|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
147017690|NCT00739973|530224219|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
147017691|NCT00739973|530224220|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
147017692|NCT00739973|530224221|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
147017693|NCT00739973|530224222|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
147017694|NCT00739973|530224223|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
147017695|NCT00739973|530224224|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
147017696|NCT00739973|530224216|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
147017697|NCT00739973|530224217|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
147017698|NCT00739973|530224218|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
147017699|NCT00739973|530224219|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
147017700|NCT00739973|530224220|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
147017701|NCT00739973|530224221|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
147017702|NCT00739973|530224222|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
147017703|NCT00739973|530224223|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
147017704|NCT00739973|530224224|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
147017705|NCT00739973|530224216|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
147017706|NCT00739973|530224217|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
147017707|NCT00739973|530224218|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
147017708|NCT00739973|530224219|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
147017709|NCT00739973|530224220|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
147017710|NCT00739973|530224221|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
147017711|NCT00739973|530224222|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
147017712|NCT00739973|530224223|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
147017713|NCT00739973|530224224|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
147017714|NCT00739973|530224216|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
147017715|NCT00739973|530224217|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
147017716|NCT00739973|530224218|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
147017717|NCT00739973|530224219|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
147017718|NCT00739973|530224220|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
147017719|NCT00739973|530224221|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
147017720|NCT00739973|530224222|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
147017721|NCT00739973|530224223|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
147017722|NCT00739973|530224224|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
147017723|NCT00739973|530224216|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
147017724|NCT00739973|530224217|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
147017725|NCT00739973|530224218|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
147017726|NCT00739973|530224219|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
147017727|NCT00739973|530224220|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
147017728|NCT00739973|530224221|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
147017729|NCT00739973|530224222|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
147017730|NCT00739973|530224223|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
147017731|NCT00739973|530224224|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
146849104|NCT03117998|529617033|FG000|Overall Study|Withdrawal by Subject|0|||
147017732|NCT00739973|530224216|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
147017733|NCT00739973|530224217|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
147017734|NCT00739973|530224218|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
147017735|NCT00739973|530224219|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
147017736|NCT00739973|530224220|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
147017737|NCT00739973|530224221|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
147017738|NCT00739973|530224222|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
147017739|NCT00739973|530224223|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
147017740|NCT00739973|530224224|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
147017741|NCT00987831|530224225|FG000|Overall Study|Never flared in 12 months|1|||
147017742|NCT00987831|530224226|FG001|Overall Study|Never flared in 12 months|0|||
147017743|NCT00987831|530224227|FG002|Overall Study|Never flared in 12 months|0|||
147017744|NCT00987831|530224225|FG000|Overall Study|Lost to Follow-up|0|||
147017745|NCT00987831|530224226|FG001|Overall Study|Lost to Follow-up|3|||
147017746|NCT00987831|530224227|FG002|Overall Study|Lost to Follow-up|0|||
147017747|NCT02219308|530224228|FG000|Overall Study|Withdrawal by Subject|1|||
147017748|NCT02219308|530224229|FG001|Overall Study|Withdrawal by Subject|2|||
147017749|NCT04149535|530224232|FG000|Overall Study|Death|11|||
147017750|NCT04149535|530224233|FG001|Overall Study|Death|7|||
147017751|NCT04149535|530224232|FG000|Overall Study|Physician Decision|10|||
147017752|NCT04149535|530224233|FG001|Overall Study|Physician Decision|4|||
147017753|NCT04149535|530224232|FG000|Overall Study|Withdrawal by Subject|6|||
147017754|NCT04149535|530224233|FG001|Overall Study|Withdrawal by Subject|7|||
147017755|NCT04149535|530224232|FG000|Overall Study|Not described|2|||
147017756|NCT04149535|530224233|FG001|Overall Study|Not described|0|||
147017757|NCT02175368|530224234|FG000|Overall Study|Lost to Follow-up|1|||
147017758|NCT02875028|530224235|FG000|Washout Period|Withdrawal by Subject|0|||
147017759|NCT02875028|530224236|FG001|Washout Period|Withdrawal by Subject|1|||
147017760|NCT05068284|530224237|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
147017761|NCT05068284|530224238|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
147017762|NCT05068284|530224239|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
147017763|NCT05068284|530224240|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
147017764|NCT05068284|530224241|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
147017765|NCT05068284|530224242|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
147017766|NCT05068284|530224243|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
147017767|NCT05068284|530224244|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
147017768|NCT05068284|530224237|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
147017769|NCT05068284|530224238|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
147017770|NCT05068284|530224239|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
147017771|NCT05068284|530224240|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
147017772|NCT05068284|530224241|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
147017773|NCT05068284|530224242|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
147017774|NCT05068284|530224243|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
147017775|NCT05068284|530224244|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
147017776|NCT05068284|530224237|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
147017777|NCT05068284|530224238|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
147017778|NCT05068284|530224239|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
147017779|NCT05068284|530224240|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
147017780|NCT05068284|530224241|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
147017781|NCT05068284|530224242|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
147017782|NCT05068284|530224243|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
147017783|NCT05068284|530224244|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
147017784|NCT05068284|530224237|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
147017785|NCT05068284|530224238|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
147017786|NCT05068284|530224239|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
147017787|NCT05068284|530224240|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
147017788|NCT05068284|530224241|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
147017789|NCT05068284|530224242|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
147017790|NCT05068284|530224243|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
147017791|NCT05068284|530224244|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
147017792|NCT05068284|530224237|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
147017793|NCT05068284|530224238|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
147017794|NCT05068284|530224239|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
147017795|NCT05068284|530224240|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
147017796|NCT05068284|530224241|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
147017797|NCT05068284|530224242|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
147017798|NCT05068284|530224243|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
147017799|NCT05068284|530224244|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
147017800|NCT05068284|530224237|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
147017801|NCT05068284|530224238|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
147017802|NCT05068284|530224239|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
147017803|NCT05068284|530224240|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
147017804|NCT05068284|530224241|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
147017805|NCT05068284|530224242|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
147017806|NCT05068284|530224243|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
147017807|NCT05068284|530224244|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
147017808|NCT05068284|530224237|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
147017809|NCT05068284|530224238|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
147017810|NCT05068284|530224239|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
147017811|NCT05068284|530224240|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
147017812|NCT05068284|530224241|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
147017813|NCT05068284|530224242|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
147017814|NCT05068284|530224243|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
147017815|NCT05068284|530224244|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
147017816|NCT05068284|530224237|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
147017817|NCT05068284|530224238|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
147017818|NCT05068284|530224239|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
147017819|NCT05068284|530224240|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
147017820|NCT05068284|530224241|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
147017821|NCT05068284|530224242|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
147017822|NCT05068284|530224243|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
147017823|NCT05068284|530224244|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
147017824|NCT05068284|530224237|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
147017825|NCT05068284|530224238|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
147017826|NCT05068284|530224239|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
147017827|NCT05068284|530224240|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
147017828|NCT05068284|530224241|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
147017829|NCT05068284|530224242|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
147017830|NCT05068284|530224243|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
147017831|NCT05068284|530224244|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
147017832|NCT05068284|530224237|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
147017833|NCT05068284|530224238|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
147017834|NCT05068284|530224239|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
147017835|NCT05068284|530224240|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
147017836|NCT05068284|530224241|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
147017837|NCT05068284|530224242|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
147017838|NCT05068284|530224243|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
147017839|NCT05068284|530224244|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
147017840|NCT05068284|530224237|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
147017841|NCT05068284|530224238|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
147017842|NCT05068284|530224239|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
147017843|NCT05068284|530224240|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
147017844|NCT05068284|530224241|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
147017845|NCT05068284|530224242|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
147017846|NCT05068284|530224243|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
147017847|NCT05068284|530224244|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
147017848|NCT05068284|530224237|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
147017849|NCT05068284|530224238|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
147017850|NCT05068284|530224239|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
147017851|NCT05068284|530224240|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
147017852|NCT05068284|530224241|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
147017853|NCT05068284|530224242|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
147017854|NCT05068284|530224243|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
146736549|NCT05454410|529206897|FG002|Overall Study|Withdrawal by Subject|1|||
147017855|NCT05068284|530224244|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
147017856|NCT05068284|530224237|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
147017857|NCT05068284|530224238|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
147017858|NCT05068284|530224239|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
147017859|NCT05068284|530224240|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
147017860|NCT05068284|530224241|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
147017861|NCT05068284|530224242|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
147017862|NCT05068284|530224243|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
147017863|NCT05068284|530224244|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
147017864|NCT05068284|530224237|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
147017865|NCT05068284|530224238|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
147017866|NCT05068284|530224239|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
147017867|NCT05068284|530224240|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
147017868|NCT05068284|530224241|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
147017869|NCT05068284|530224242|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
147017870|NCT05068284|530224243|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
147017871|NCT05068284|530224244|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
147017872|NCT01989676|530226222|FG000|Overall Study|Death|52|||
147017873|NCT01989676|530226223|FG001|Overall Study|Death|60|||
147017874|NCT01989676|530226222|FG000|Overall Study|Protocol Violation|2|||
147017875|NCT01989676|530226223|FG001|Overall Study|Protocol Violation|1|||
147017876|NCT01989676|530226222|FG000|Overall Study|Lost to Follow-up|8|||
147017877|NCT01989676|530226223|FG001|Overall Study|Lost to Follow-up|18|||
147017878|NCT01989676|530226222|FG000|Overall Study|No longer willing to participate in study|26|||
147017879|NCT01989676|530226223|FG001|Overall Study|No longer willing to participate in study|26|||
147017880|NCT01989676|530226222|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
147017881|NCT01989676|530226223|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
147017882|NCT01989676|530226222|FG000|Overall Study|Other|4|||
147017883|NCT01989676|530226223|FG001|Overall Study|Other|3|||
147017884|NCT03941834|530226224|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
147017885|NCT03941834|530226225|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
147017886|NCT03941834|530226226|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
147017887|NCT03941834|530226224|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
147017888|NCT03941834|530226225|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
147017889|NCT03941834|530226226|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
147017890|NCT03941834|530226224|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
147017891|NCT03941834|530226225|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
147017892|NCT03941834|530226226|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
147017893|NCT03941834|530226224|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
147017894|NCT03941834|530226225|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
147017895|NCT03941834|530226226|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
147017896|NCT03941834|530226224|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
147017897|NCT03941834|530226225|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
147017898|NCT03941834|530226226|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
147017899|NCT03941834|530226224|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
147017900|NCT03941834|530226225|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
147017901|NCT03941834|530226226|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
147017902|NCT02688387|530226229|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017903|NCT02688387|530226230|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017904|NCT02688387|530226231|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
147017905|NCT02688387|530226232|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017906|NCT02688387|530226233|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017907|NCT02688387|530226234|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017908|NCT02688387|530226235|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017909|NCT02688387|530226236|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017910|NCT02688387|530226237|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017911|NCT02688387|530226238|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017912|NCT02688387|530226239|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017913|NCT02688387|530226240|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017914|NCT02688387|530226241|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017915|NCT02688387|530226242|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017916|NCT02688387|530226243|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017917|NCT02688387|530226244|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017918|NCT02688387|530226245|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017919|NCT02688387|530226246|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017920|NCT02688387|530226247|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017921|NCT02688387|530226248|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017922|NCT02688387|530226249|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017923|NCT02688387|530226250|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147017924|NCT02688387|530226229|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017925|NCT02688387|530226230|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017926|NCT02688387|530226231|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017927|NCT02688387|530226232|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
147017928|NCT02688387|530226233|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017929|NCT02688387|530226234|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017930|NCT02688387|530226235|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017931|NCT02688387|530226236|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017932|NCT02688387|530226237|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017933|NCT02688387|530226238|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017934|NCT02688387|530226239|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017935|NCT02688387|530226240|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017936|NCT02688387|530226241|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017937|NCT02688387|530226242|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017938|NCT02688387|530226243|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017939|NCT02688387|530226244|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017940|NCT02688387|530226245|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017941|NCT02688387|530226246|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017942|NCT02688387|530226247|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017943|NCT02688387|530226248|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017944|NCT02688387|530226249|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017945|NCT02688387|530226250|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147017946|NCT02688387|530226229|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017947|NCT02688387|530226230|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
147017948|NCT02688387|530226231|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017949|NCT02688387|530226232|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017950|NCT02688387|530226233|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017951|NCT02688387|530226234|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017952|NCT02688387|530226235|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017953|NCT02688387|530226236|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017954|NCT02688387|530226237|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017955|NCT02688387|530226238|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017956|NCT02688387|530226239|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017957|NCT02688387|530226240|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017958|NCT02688387|530226241|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017959|NCT02688387|530226242|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017960|NCT02688387|530226243|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017961|NCT02688387|530226244|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017962|NCT02688387|530226245|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017963|NCT02688387|530226246|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017964|NCT02688387|530226247|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017965|NCT02688387|530226248|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017966|NCT02688387|530226249|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017967|NCT02688387|530226250|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147017968|NCT02688387|530226229|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017969|NCT02688387|530226230|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017970|NCT02688387|530226231|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
147017971|NCT02688387|530226232|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017972|NCT02688387|530226233|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
147017973|NCT02688387|530226234|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017974|NCT02688387|530226235|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017975|NCT02688387|530226236|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017976|NCT02688387|530226237|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017977|NCT02688387|530226238|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017978|NCT02688387|530226239|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017979|NCT02688387|530226240|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017980|NCT02688387|530226241|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
146849105|NCT03117998|529617034|FG001|Overall Study|Withdrawal by Subject|0|||
146849106|NCT03117998|529617035|FG002|Overall Study|Withdrawal by Subject|2|||
147017981|NCT02688387|530226242|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017982|NCT02688387|530226243|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017983|NCT02688387|530226244|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017984|NCT02688387|530226245|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017985|NCT02688387|530226246|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017986|NCT02688387|530226247|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017987|NCT02688387|530226248|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017988|NCT02688387|530226249|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017989|NCT02688387|530226250|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147017990|NCT02688387|530226229|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
147017991|NCT02688387|530226230|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147017992|NCT02688387|530226231|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147017993|NCT02688387|530226232|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147017994|NCT02688387|530226233|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147017995|NCT02688387|530226234|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147017996|NCT02688387|530226235|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147017997|NCT02688387|530226236|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147017998|NCT02688387|530226237|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147017999|NCT02688387|530226238|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147018000|NCT02688387|530226239|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147018001|NCT02688387|530226240|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147018002|NCT02688387|530226241|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147018003|NCT02688387|530226242|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147018004|NCT02688387|530226243|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147018005|NCT02688387|530226244|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147018006|NCT02688387|530226245|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147018007|NCT02688387|530226246|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147018008|NCT02688387|530226247|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147018009|NCT02688387|530226248|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147018010|NCT02688387|530226249|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147018011|NCT02688387|530226250|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147018012|NCT02688387|530226229|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018013|NCT02688387|530226230|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018014|NCT02688387|530226231|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018015|NCT02688387|530226232|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018016|NCT02688387|530226233|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018017|NCT02688387|530226234|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018018|NCT02688387|530226235|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018019|NCT02688387|530226236|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018020|NCT02688387|530226237|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018021|NCT02688387|530226238|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018022|NCT02688387|530226239|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
147018023|NCT02688387|530226240|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018024|NCT02688387|530226241|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018025|NCT02688387|530226242|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018026|NCT02688387|530226243|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018027|NCT02688387|530226244|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018028|NCT02688387|530226245|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018029|NCT02688387|530226246|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018030|NCT02688387|530226247|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018031|NCT02688387|530226248|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018032|NCT02688387|530226249|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018033|NCT02688387|530226250|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147018034|NCT02688387|530226229|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018035|NCT02688387|530226230|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018036|NCT02688387|530226231|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018037|NCT02688387|530226232|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018038|NCT02688387|530226233|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018039|NCT02688387|530226234|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018040|NCT02688387|530226235|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018041|NCT02688387|530226236|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018042|NCT02688387|530226237|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018043|NCT02688387|530226238|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018044|NCT02688387|530226239|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
146736550|NCT05454410|529206898|FG003|Overall Study|Withdrawal by Subject|1|||
146736551|NCT05004688|529206908|FG000|Overall Study|Protocol Violation|7|||
147018045|NCT02688387|530226240|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018046|NCT02688387|530226241|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018047|NCT02688387|530226242|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018048|NCT02688387|530226243|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
147018049|NCT02688387|530226244|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018050|NCT02688387|530226245|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018051|NCT02688387|530226246|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018052|NCT02688387|530226247|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018053|NCT02688387|530226248|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018054|NCT02688387|530226249|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018055|NCT02688387|530226250|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147018056|NCT02688387|530226229|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018057|NCT02688387|530226230|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018058|NCT02688387|530226231|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018059|NCT02688387|530226232|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018060|NCT02688387|530226233|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018061|NCT02688387|530226234|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018062|NCT02688387|530226235|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018063|NCT02688387|530226236|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018064|NCT02688387|530226237|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018065|NCT02688387|530226238|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018066|NCT02688387|530226239|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018067|NCT02688387|530226240|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018068|NCT02688387|530226241|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018069|NCT02688387|530226242|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018070|NCT02688387|530226243|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018071|NCT02688387|530226244|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018072|NCT02688387|530226245|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018073|NCT02688387|530226246|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018074|NCT02688387|530226247|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018075|NCT02688387|530226248|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018076|NCT02688387|530226249|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
147018077|NCT02688387|530226250|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147018078|NCT02688387|530226229|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018079|NCT02688387|530226230|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018080|NCT02688387|530226231|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018081|NCT02688387|530226232|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018082|NCT02688387|530226233|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018083|NCT02688387|530226234|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018084|NCT02688387|530226235|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018085|NCT02688387|530226236|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018086|NCT02688387|530226237|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018087|NCT02688387|530226238|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018088|NCT02688387|530226239|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018089|NCT02688387|530226240|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018090|NCT02688387|530226241|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018091|NCT02688387|530226242|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018092|NCT02688387|530226243|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018093|NCT02688387|530226244|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018094|NCT02688387|530226245|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018095|NCT02688387|530226246|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018096|NCT02688387|530226247|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
147018097|NCT02688387|530226248|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018098|NCT02688387|530226249|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
147018099|NCT02688387|530226250|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147018100|NCT02688387|530226229|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018101|NCT02688387|530226230|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018102|NCT02688387|530226231|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018103|NCT02688387|530226232|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018104|NCT02688387|530226233|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018105|NCT02688387|530226234|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018106|NCT02688387|530226235|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018107|NCT02688387|530226236|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018108|NCT02688387|530226237|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018109|NCT02688387|530226238|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018110|NCT02688387|530226239|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018111|NCT02688387|530226240|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018112|NCT02688387|530226241|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018113|NCT02688387|530226242|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018114|NCT02688387|530226243|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018115|NCT02688387|530226244|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018116|NCT02688387|530226245|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018117|NCT02688387|530226246|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018118|NCT02688387|530226247|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018119|NCT02688387|530226248|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
147018120|NCT02688387|530226249|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018121|NCT02688387|530226250|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147018122|NCT00802178|530226253|FG000|Overall Study|Lack of Efficacy|36|||
147018123|NCT00802178|530226253|FG000|Overall Study|Insufficient tolerability (IT)|17|||
147018124|NCT00802178|530226253|FG000|Overall Study|Withdrawal by Subject|18|||
147018125|NCT00802178|530226253|FG000|Overall Study|Other|32|||
147018126|NCT00802178|530226253|FG000|Overall Study|Lack of efficacy and patient wish|1|||
147018127|NCT00802178|530226253|FG000|Overall Study|IT and patient wish|8|||
147018128|NCT00802178|530226253|FG000|Overall Study|Patients wish and other reason|1|||
147018129|NCT01606228|530226254|FG000|Overall Study|Lost to Follow-up|20|||
147018130|NCT01606228|530226254|FG000|Overall Study|Withdrawal by Subject|3|||
147018131|NCT01606228|530226254|FG000|Overall Study|Non-compliant|3|||
147018132|NCT01606228|530226254|FG000|Overall Study|Lack of Efficacy|2|||
147018133|NCT01606228|530226254|FG000|Overall Study|Adverse Event|1|||
147018134|NCT04100096|530226255|FG000|Overall Study|Adverse Event|19|||
147018135|NCT04100096|530226256|FG001|Overall Study|Adverse Event|7|||
147018136|NCT04100096|530226255|FG000|Overall Study|Lack of Efficacy|0|||
147018137|NCT04100096|530226256|FG001|Overall Study|Lack of Efficacy|1|||
147018138|NCT04100096|530226255|FG000|Overall Study|Lost to Follow-up|13|||
147018139|NCT04100096|530226256|FG001|Overall Study|Lost to Follow-up|11|||
147018140|NCT04100096|530226255|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147018141|NCT04100096|530226256|FG001|Overall Study|Non-Compliance With Study Drug|3|||
147018142|NCT04100096|530226255|FG000|Overall Study|Protocol Deviation|1|||
147018143|NCT04100096|530226256|FG001|Overall Study|Protocol Deviation|1|||
147018144|NCT04100096|530226255|FG000|Overall Study|Withdrawal by Participant|13|||
147018145|NCT04100096|530226256|FG001|Overall Study|Withdrawal by Participant|15|||
147018146|NCT00991510|530226259|FG000|Period I (Days 1-14)|Adverse Event|1|||
147018147|NCT00991510|530226260|FG001|Period I (Days 1-14)|Adverse Event|0|||
147018148|NCT00991510|530226259|FG000|Period III (Days 29-112)|Adverse Event|1|||
147018149|NCT00991510|530226260|FG001|Period III (Days 29-112)|Adverse Event|1|||
147018150|NCT01976728|530226261|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
147018151|NCT01976728|530226262|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
147018152|NCT01976728|530226263|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
147018153|NCT01976728|530226264|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
147018154|NCT02356211|530226265|FG000|Overall Study|Withdrawal by Subject|2|||
147018155|NCT02356211|530226266|FG001|Overall Study|Withdrawal by Subject|2|||
147018156|NCT02356211|530226265|FG000|Overall Study|ineligible|1|||
147018157|NCT02356211|530226266|FG001|Overall Study|ineligible|8|||
147018158|NCT02211014|530226267|FG000|Overall Study|Adverse Event|0|||
147018159|NCT02211014|530226268|FG001|Overall Study|Adverse Event|2|||
147018160|NCT02211014|530226267|FG000|Overall Study|Physician Decision|1|||
147018161|NCT02211014|530226268|FG001|Overall Study|Physician Decision|2|||
147018162|NCT02211014|530226267|FG000|Overall Study|Started another cancer therapy|1|||
147018163|NCT02211014|530226268|FG001|Overall Study|Started another cancer therapy|0|||
147018164|NCT02211014|530226267|FG000|Overall Study|Withdrawal by Subject|0|||
147018165|NCT02211014|530226268|FG001|Overall Study|Withdrawal by Subject|1|||
147018166|NCT02211014|530226267|FG000|Overall Study|In agreement with patient, no benefit|0|||
147018167|NCT02211014|530226268|FG001|Overall Study|In agreement with patient, no benefit|1|||
147018168|NCT00966381|530226269|FG000|Overall Study|Withdrawal by Subject|2|||
147018169|NCT00966381|530226270|FG001|Overall Study|Withdrawal by Subject|2|||
147018170|NCT01124695|530226271|FG000|Overall Study|Disease progression|77|||
147018171|NCT01124695|530226271|FG000|Overall Study|Adverse Event|11|||
147018172|NCT01124695|530226271|FG000|Overall Study|Death|1|||
147018173|NCT01124695|530226271|FG000|Overall Study|Withdrawal by Subject|7|||
147018174|NCT01124695|530226271|FG000|Overall Study|Physician Decision|3|||
147018175|NCT01124695|530226271|FG000|Overall Study|Alternative therapy|9|||
147018176|NCT01124695|530226271|FG000|Overall Study|No documentation that patient went off treatment|4|||
147018177|NCT01124695|530226271|FG000|Overall Study|Ineligible|9|||
147018178|NCT01124695|530226271|FG000|Overall Study|Ineligible and never start treatment|2|||
147018179|NCT01796964|530226276|FG000|Overall Study|Adverse Event|1|||
147018180|NCT01796964|530226277|FG001|Overall Study|Adverse Event|1|||
147018181|NCT01796964|530226276|FG000|Overall Study|Death|1|||
147018182|NCT01796964|530226277|FG001|Overall Study|Death|0|||
147018183|NCT01796964|530226276|FG000|Overall Study|Protocol Violation|0|||
147018184|NCT01796964|530226277|FG001|Overall Study|Protocol Violation|1|||
147018185|NCT01796964|530226276|FG000|Overall Study|Withdrawal by Subject|1|||
147018186|NCT01796964|530226277|FG001|Overall Study|Withdrawal by Subject|1|||
147018187|NCT04025684|530226278|FG000|Overall Study|Withdrawal by Subject|1|||
147018188|NCT04025684|530226279|FG001|Overall Study|Withdrawal by Subject|1|||
147018189|NCT04025684|530226280|FG002|Overall Study|Withdrawal by Subject|0|||
147018190|NCT04025684|530226281|FG003|Overall Study|Withdrawal by Subject|0|||
147018191|NCT04025684|530226278|FG000|Overall Study|Multiple reasons|1|||
147018192|NCT04025684|530226279|FG001|Overall Study|Multiple reasons|3|||
147018193|NCT04025684|530226280|FG002|Overall Study|Multiple reasons|0|||
147018194|NCT04025684|530226281|FG003|Overall Study|Multiple reasons|1|||
147018195|NCT01613378|530226289|FG000|Overall Study|Lack of Efficacy|13|||
147018196|NCT01613378|530226289|FG000|Overall Study|Adverse Event|11|||
147018197|NCT01613378|530226289|FG000|Overall Study|Withdrawal by Subject|8|||
147018198|NCT01613378|530226289|FG000|Overall Study|Death|2|||
147018199|NCT01613378|530226289|FG000|Overall Study|Lost to Follow-up|1|||
147018200|NCT01613378|530226289|FG000|Overall Study|Other Reason|4|||
147018201|NCT02000531|530226295|FG000|Overall Study|Lost to Follow-up|1|||
147018202|NCT02000531|530226296|FG001|Overall Study|Lost to Follow-up|0|||
147018203|NCT02000531|530226295|FG000|Overall Study|Discontinued due to data cut-off|3|||
147018204|NCT02000531|530226296|FG001|Overall Study|Discontinued due to data cut-off|8|||
147018205|NCT00794417|530226297|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
147018206|NCT00794417|530226298|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
147018207|NCT00794417|530226299|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
147018208|NCT00794417|530226300|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
147018209|NCT00794417|530226297|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
147018210|NCT00794417|530226298|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
147018211|NCT00794417|530226299|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
147018212|NCT00794417|530226300|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
147018213|NCT00794417|530226297|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
147018214|NCT00794417|530226298|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
147018215|NCT00794417|530226299|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
147018216|NCT00794417|530226300|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
147018217|NCT00794417|530226297|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
147018218|NCT00794417|530226298|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
147018219|NCT00794417|530226299|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
147018220|NCT00794417|530226300|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
147018221|NCT00794417|530226297|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
147018222|NCT00794417|530226298|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
147018223|NCT00794417|530226299|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
147018224|NCT00794417|530226300|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
147018225|NCT00794417|530226297|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
147018226|NCT00794417|530226298|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
147018227|NCT00794417|530226299|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
147018228|NCT00794417|530226300|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
147018229|NCT01345318|530226310|FG000|Overall Study|Adverse Event|16|||
147018230|NCT01345318|530226310|FG000|Overall Study|Lack of Efficacy|17|||
147018231|NCT01345318|530226310|FG000|Overall Study|Lost to Follow-up|2|||
147018232|NCT01345318|530226310|FG000|Overall Study|Protocol Violation|1|||
147018233|NCT01345318|530226310|FG000|Overall Study|Withdrawal by Subject|41|||
147018234|NCT01345318|530226310|FG000|Overall Study|Other|3|||
147018235|NCT01239472|530226314|FG000|Overall Study|Withdrawal by Subject|5|||
147018236|NCT01239472|530226315|FG001|Overall Study|Withdrawal by Subject|1|||
146849107|NCT03117998|529617036|FG003|Overall Study|Withdrawal by Subject|3|||
146849108|NCT03117998|529617037|FG004|Overall Study|Withdrawal by Subject|3|||
146849109|NCT03117998|529617038|FG005|Overall Study|Withdrawal by Subject|0|||
146849110|NCT03117998|529617033|FG000|Overall Study|Physician Decision|0|||
146849111|NCT03117998|529617034|FG001|Overall Study|Physician Decision|1|||
146849112|NCT03117998|529617035|FG002|Overall Study|Physician Decision|1|||
146849113|NCT03117998|529617036|FG003|Overall Study|Physician Decision|0|||
146849114|NCT03117998|529617037|FG004|Overall Study|Physician Decision|0|||
146849115|NCT03117998|529617038|FG005|Overall Study|Physician Decision|0|||
146849116|NCT03117998|529617033|FG000|Overall Study|Lost to Follow-up|0|||
146849117|NCT03117998|529617034|FG001|Overall Study|Lost to Follow-up|0|||
146849118|NCT03117998|529617035|FG002|Overall Study|Lost to Follow-up|0|||
146849119|NCT03117998|529617036|FG003|Overall Study|Lost to Follow-up|1|||
146849120|NCT03117998|529617037|FG004|Overall Study|Lost to Follow-up|4|||
146849121|NCT03117998|529617038|FG005|Overall Study|Lost to Follow-up|0|||
146849122|NCT03117998|529617033|FG000|Overall Study|Subject noncompliance|0|||
146849123|NCT03117998|529617034|FG001|Overall Study|Subject noncompliance|0|||
146849124|NCT03117998|529617035|FG002|Overall Study|Subject noncompliance|1|||
147018237|NCT01239472|530226314|FG000|Overall Study|Adverse Event|0|||
147018238|NCT01239472|530226315|FG001|Overall Study|Adverse Event|1|||
147018239|NCT01239472|530226314|FG000|Overall Study|Lack of Efficacy|0|||
146849125|NCT03117998|529617036|FG003|Overall Study|Subject noncompliance|0|||
146849126|NCT03117998|529617037|FG004|Overall Study|Subject noncompliance|0|||
146849127|NCT03117998|529617038|FG005|Overall Study|Subject noncompliance|2|||
147018240|NCT01239472|530226315|FG001|Overall Study|Lack of Efficacy|1|||
147018241|NCT02695719|530226316|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
147018242|NCT02695719|530226317|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
147018243|NCT02695719|530226316|FG000|Overall Study|Significant Protocol Deviation|0|||
147018244|NCT02695719|530226317|FG001|Overall Study|Significant Protocol Deviation|1|||
147018245|NCT02695719|530226316|FG000|Overall Study|Voluntary Withdrawal|1|||
147018246|NCT02695719|530226317|FG001|Overall Study|Voluntary Withdrawal|0|||
147018247|NCT01534078|530226320|FG000|Overall Study|Death|1|||
147018248|NCT01534078|530226320|FG000|Overall Study|Withdrawal by Subject|1|||
147018249|NCT01049412|530226321|FG000|Period I|Withdrawal by Subject|4|||
147018250|NCT01049412|530226322|FG001|Period I|Withdrawal by Subject|6|||
147018251|NCT01049412|530226321|FG000|Period I|Lost to Follow-up|2|||
147018252|NCT01049412|530226322|FG001|Period I|Lost to Follow-up|2|||
147018253|NCT01049412|530226321|FG000|Period I|Physician Decision|0|||
147018254|NCT01049412|530226322|FG001|Period I|Physician Decision|3|||
147018255|NCT01049412|530226321|FG000|Period I|Protocol Violation|1|||
147018256|NCT01049412|530226322|FG001|Period I|Protocol Violation|2|||
147018257|NCT01049412|530226321|FG000|Period I|Adverse Event|1|||
147018258|NCT01049412|530226322|FG001|Period I|Adverse Event|0|||
147018259|NCT01049412|530226321|FG000|Period II|Withdrawal by Subject|2|||
147018260|NCT01049412|530226322|FG001|Period II|Withdrawal by Subject|3|||
147018261|NCT01049412|530226321|FG000|Period II|Adverse Event|1|||
147018262|NCT01049412|530226322|FG001|Period II|Adverse Event|0|||
147018263|NCT01049412|530226321|FG000|Period II|Lost to Follow-up|1|||
147018264|NCT01049412|530226322|FG001|Period II|Lost to Follow-up|0|||
147018265|NCT05966090|530226326|FG000|Overall Study|Lost to Follow-up|6|||
147018266|NCT05966090|530226327|FG001|Overall Study|Lost to Follow-up|6|||
147018267|NCT05966090|530226326|FG000|Overall Study|Adverse Event|1|||
147018268|NCT05966090|530226327|FG001|Overall Study|Adverse Event|1|||
147018269|NCT05966090|530226326|FG000|Overall Study|Withdrawal by Subject|1|||
147018270|NCT05966090|530226327|FG001|Overall Study|Withdrawal by Subject|1|||
147018271|NCT05966090|530226326|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
147018272|NCT05966090|530226327|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
147018273|NCT05966090|530226326|FG000|Overall Study|Other|1|||
147018274|NCT05966090|530226327|FG001|Overall Study|Other|1|||
147018275|NCT00804141|530226328|FG000|Overall Study|Adverse Event|157|||
147018276|NCT00804141|530226328|FG000|Overall Study|Death|4|||
147018277|NCT00804141|530226328|FG000|Overall Study|Failed to return|96|||
147018278|NCT00804141|530226328|FG000|Overall Study|Investigator request|8|||
147018279|NCT00804141|530226328|FG000|Overall Study|Protocol Violation|85|||
147018280|NCT00804141|530226328|FG000|Overall Study|Withdrawal by Subject|131|||
147018281|NCT00804141|530226328|FG000|Overall Study|Lack of Efficacy|46|||
147018282|NCT00804141|530226328|FG000|Overall Study|Other than specified|30|||
147018283|NCT00804141|530226328|FG000|Overall Study|Enrolled but not treated|6|||
147018284|NCT02418455|530226329|FG000|48-Week Treatment Period|Other- Not Specified|1|||
147018285|NCT02418455|530226329|FG000|Continuation Period|Sponsor Decision|7|||
147018286|NCT03235479|530226332|FG000|Overall Study|Lost to Follow-up|8|||
147018287|NCT03235479|530226333|FG001|Overall Study|Lost to Follow-up|11|||
147018288|NCT03235479|530226332|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
147018289|NCT03235479|530226333|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
147018290|NCT03235479|530226332|FG000|Overall Study|Pregnancy|1|||
147018291|NCT03235479|530226333|FG001|Overall Study|Pregnancy|0|||
147018292|NCT03235479|530226332|FG000|Overall Study|Protocol Deviation|1|||
147018293|NCT03235479|530226333|FG001|Overall Study|Protocol Deviation|3|||
147018294|NCT03235479|530226332|FG000|Overall Study|Technical Problems|3|||
147018295|NCT03235479|530226333|FG001|Overall Study|Technical Problems|2|||
147018296|NCT03235479|530226332|FG000|Overall Study|Withdrawal by Subject|2|||
147018297|NCT03235479|530226333|FG001|Overall Study|Withdrawal by Subject|2|||
147018298|NCT03235479|530226332|FG000|Overall Study|Other Reasons|3|||
147018299|NCT03235479|530226333|FG001|Overall Study|Other Reasons|5|||
147018300|NCT02001051|530226336|FG000|Overall Study|Deemed not eligible following enrollment|0|||
147018301|NCT02001051|530226337|FG001|Overall Study|Deemed not eligible following enrollment|1|||
147018302|NCT00309985|530226344|FG000|Overall Study|Disease progression|12|||
147018303|NCT00309985|530226345|FG001|Overall Study|Disease progression|0|||
147018304|NCT00309985|530226344|FG000|Overall Study|Adverse Event|30|||
147018305|NCT00309985|530226345|FG001|Overall Study|Adverse Event|0|||
147018306|NCT00309985|530226344|FG000|Overall Study|Death|2|||
147018307|NCT00309985|530226345|FG001|Overall Study|Death|0|||
147018308|NCT00309985|530226344|FG000|Overall Study|Withdrawal by Subject|5|||
147018309|NCT00309985|530226345|FG001|Overall Study|Withdrawal by Subject|1|||
147018310|NCT00309985|530226344|FG000|Overall Study|Physician Decision|3|||
147018311|NCT00309985|530226345|FG001|Overall Study|Physician Decision|0|||
147018312|NCT00309985|530226344|FG000|Overall Study|Never started treatment|7|||
147018313|NCT00309985|530226345|FG001|Overall Study|Never started treatment|0|||
147018314|NCT00309985|530226344|FG000|Overall Study|Complicating disease|1|||
147018315|NCT00309985|530226345|FG001|Overall Study|Complicating disease|0|||
147018316|NCT00309985|530226344|FG000|Overall Study|Non-compliance|1|||
147018317|NCT00309985|530226345|FG001|Overall Study|Non-compliance|0|||
147018318|NCT00309985|530226344|FG000|Overall Study|Chemotherapy discontinued only|1|||
147018319|NCT00309985|530226345|FG001|Overall Study|Chemotherapy discontinued only|0|||
147018320|NCT03110380|530226356|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
147018321|NCT03110380|530226357|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
147018322|NCT03110380|530226358|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
147018323|NCT03110380|530226359|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
147018324|NCT03110380|530226356|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
147018325|NCT03110380|530226357|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
147018326|NCT03110380|530226358|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
147018327|NCT03110380|530226359|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
147018328|NCT03110380|530226356|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
147018329|NCT03110380|530226357|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
147018330|NCT03110380|530226358|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
147018331|NCT03110380|530226359|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
147018332|NCT03110380|530226356|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
147018333|NCT03110380|530226357|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
147018334|NCT03110380|530226358|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
147018335|NCT03110380|530226359|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
147018336|NCT03110380|530226356|FG000|Double-Blind Treatment Phase|Death|2|||
147018337|NCT03110380|530226357|FG001|Double-Blind Treatment Phase|Death|1|||
147018338|NCT03110380|530226358|FG002|Double-Blind Treatment Phase|Death|0|||
147018339|NCT03110380|530226359|FG003|Double-Blind Treatment Phase|Death|0|||
147018340|NCT03110380|530226356|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
147018341|NCT03110380|530226357|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
147018342|NCT03110380|530226358|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
147018343|NCT03110380|530226359|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
147018344|NCT03110380|530226356|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
147018345|NCT03110380|530226357|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
147018346|NCT03110380|530226358|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
147018347|NCT03110380|530226359|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
147018348|NCT03110380|530226356|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
147018349|NCT03110380|530226357|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
147018350|NCT03110380|530226358|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
147018351|NCT03110380|530226359|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
147018352|NCT03110380|530226356|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
147018353|NCT03110380|530226357|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
147018354|NCT03110380|530226358|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
147018355|NCT03110380|530226359|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
147018356|NCT03110380|530226356|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
147018357|NCT03110380|530226357|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
147018358|NCT03110380|530226358|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
147018359|NCT03110380|530226359|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
147018360|NCT03110380|530226356|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
147018361|NCT03110380|530226357|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
147018362|NCT03110380|530226358|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
147018363|NCT03110380|530226359|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
147018364|NCT01546519|530226362|FG000|Overall Study|Adverse Event|0|||
147018365|NCT01546519|530226363|FG001|Overall Study|Adverse Event|0|||
147018366|NCT01546519|530226364|FG002|Overall Study|Adverse Event|1|||
147018367|NCT01546519|530226365|FG003|Overall Study|Adverse Event|1|||
147018368|NCT01546519|530226362|FG000|Overall Study|Death|0|||
147018369|NCT01546519|530226363|FG001|Overall Study|Death|1|||
147018370|NCT01546519|530226364|FG002|Overall Study|Death|3|||
147018371|NCT01546519|530226365|FG003|Overall Study|Death|1|||
147018372|NCT01546519|530226362|FG000|Overall Study|related to disease progression|2|||
147018373|NCT01546519|530226363|FG001|Overall Study|related to disease progression|2|||
147018374|NCT01546519|530226364|FG002|Overall Study|related to disease progression|2|||
147018375|NCT01546519|530226365|FG003|Overall Study|related to disease progression|1|||
147018376|NCT01546519|530226362|FG000|Overall Study|Physician Decision|6|||
147018377|NCT01546519|530226363|FG001|Overall Study|Physician Decision|5|||
147018378|NCT01546519|530226364|FG002|Overall Study|Physician Decision|2|||
147018379|NCT01546519|530226365|FG003|Overall Study|Physician Decision|3|||
147018380|NCT01546519|530226362|FG000|Overall Study|Withdrawal by Subject|1|||
147018381|NCT01546519|530226363|FG001|Overall Study|Withdrawal by Subject|0|||
147018382|NCT01546519|530226364|FG002|Overall Study|Withdrawal by Subject|0|||
147018383|NCT01546519|530226365|FG003|Overall Study|Withdrawal by Subject|0|||
147018384|NCT01714739|530226366|FG000|Overall Study|Disease progression|3|||
147018385|NCT01714739|530226367|FG001|Overall Study|Disease progression|5|||
147018386|NCT01714739|530226368|FG002|Overall Study|Disease progression|5|||
147018387|NCT01714739|530226369|FG003|Overall Study|Disease progression|204|||
147018388|NCT01714739|530226370|FG004|Overall Study|Disease progression|1|||
147018389|NCT01714739|530226371|FG005|Overall Study|Disease progression|3|||
147018390|NCT01714739|530226372|FG006|Overall Study|Disease progression|5|||
147018391|NCT01714739|530226366|FG000|Overall Study|Study drug toxicity|1|||
147018392|NCT01714739|530226367|FG001|Overall Study|Study drug toxicity|1|||
147018393|NCT01714739|530226368|FG002|Overall Study|Study drug toxicity|1|||
147018394|NCT01714739|530226369|FG003|Overall Study|Study drug toxicity|15|||
147018395|NCT01714739|530226370|FG004|Overall Study|Study drug toxicity|0|||
147018396|NCT01714739|530226371|FG005|Overall Study|Study drug toxicity|0|||
147018397|NCT01714739|530226372|FG006|Overall Study|Study drug toxicity|5|||
147018398|NCT01714739|530226366|FG000|Overall Study|Death|0|||
147018399|NCT01714739|530226367|FG001|Overall Study|Death|0|||
147018400|NCT01714739|530226368|FG002|Overall Study|Death|0|||
147018401|NCT01714739|530226369|FG003|Overall Study|Death|1|||
147018402|NCT01714739|530226370|FG004|Overall Study|Death|0|||
147018403|NCT01714739|530226371|FG005|Overall Study|Death|0|||
147018404|NCT01714739|530226372|FG006|Overall Study|Death|0|||
147018405|NCT01714739|530226366|FG000|Overall Study|Adverse Event unrelated to drug|0|||
147018406|NCT01714739|530226367|FG001|Overall Study|Adverse Event unrelated to drug|0|||
147018407|NCT01714739|530226368|FG002|Overall Study|Adverse Event unrelated to drug|3|||
147018408|NCT01714739|530226369|FG003|Overall Study|Adverse Event unrelated to drug|21|||
147018409|NCT01714739|530226370|FG004|Overall Study|Adverse Event unrelated to drug|0|||
147018410|NCT01714739|530226371|FG005|Overall Study|Adverse Event unrelated to drug|0|||
147018411|NCT01714739|530226372|FG006|Overall Study|Adverse Event unrelated to drug|0|||
147018412|NCT01714739|530226366|FG000|Overall Study|Participant request to stop therapy|0|||
147018413|NCT01714739|530226367|FG001|Overall Study|Participant request to stop therapy|1|||
147018414|NCT01714739|530226368|FG002|Overall Study|Participant request to stop therapy|0|||
147018415|NCT01714739|530226369|FG003|Overall Study|Participant request to stop therapy|6|||
147018416|NCT01714739|530226370|FG004|Overall Study|Participant request to stop therapy|0|||
147018417|NCT01714739|530226371|FG005|Overall Study|Participant request to stop therapy|0|||
147018418|NCT01714739|530226372|FG006|Overall Study|Participant request to stop therapy|0|||
147018419|NCT01714739|530226366|FG000|Overall Study|Participant withdrew consent|0|||
147018420|NCT01714739|530226367|FG001|Overall Study|Participant withdrew consent|1|||
147018421|NCT01714739|530226368|FG002|Overall Study|Participant withdrew consent|0|||
147018422|NCT01714739|530226369|FG003|Overall Study|Participant withdrew consent|8|||
147018423|NCT01714739|530226370|FG004|Overall Study|Participant withdrew consent|0|||
147018424|NCT01714739|530226371|FG005|Overall Study|Participant withdrew consent|0|||
147018425|NCT01714739|530226372|FG006|Overall Study|Participant withdrew consent|0|||
147018426|NCT01714739|530226366|FG000|Overall Study|Lost to Follow-up|0|||
147018427|NCT01714739|530226367|FG001|Overall Study|Lost to Follow-up|0|||
147018428|NCT01714739|530226368|FG002|Overall Study|Lost to Follow-up|0|||
147018429|NCT01714739|530226369|FG003|Overall Study|Lost to Follow-up|1|||
147018430|NCT01714739|530226370|FG004|Overall Study|Lost to Follow-up|0|||
147018431|NCT01714739|530226371|FG005|Overall Study|Lost to Follow-up|0|||
147018432|NCT01714739|530226372|FG006|Overall Study|Lost to Follow-up|0|||
147018433|NCT01714739|530226366|FG000|Overall Study|Maximum clinical benefit|0|||
147018434|NCT01714739|530226367|FG001|Overall Study|Maximum clinical benefit|1|||
147018435|NCT01714739|530226368|FG002|Overall Study|Maximum clinical benefit|1|||
147018436|NCT01714739|530226369|FG003|Overall Study|Maximum clinical benefit|3|||
147018437|NCT01714739|530226370|FG004|Overall Study|Maximum clinical benefit|0|||
147018438|NCT01714739|530226371|FG005|Overall Study|Maximum clinical benefit|0|||
147018439|NCT01714739|530226372|FG006|Overall Study|Maximum clinical benefit|0|||
147018440|NCT01714739|530226366|FG000|Overall Study|Poor/non-comliance|0|||
147018441|NCT01714739|530226367|FG001|Overall Study|Poor/non-comliance|1|||
147018442|NCT01714739|530226368|FG002|Overall Study|Poor/non-comliance|0|||
147018443|NCT01714739|530226369|FG003|Overall Study|Poor/non-comliance|1|||
147018444|NCT01714739|530226370|FG004|Overall Study|Poor/non-comliance|0|||
147018445|NCT01714739|530226371|FG005|Overall Study|Poor/non-comliance|0|||
147018446|NCT01714739|530226372|FG006|Overall Study|Poor/non-comliance|0|||
147018447|NCT01714739|530226366|FG000|Overall Study|No longer meets study criteria|0|||
147018448|NCT01714739|530226367|FG001|Overall Study|No longer meets study criteria|0|||
147018449|NCT01714739|530226368|FG002|Overall Study|No longer meets study criteria|0|||
147018450|NCT01714739|530226369|FG003|Overall Study|No longer meets study criteria|1|||
147018451|NCT01714739|530226370|FG004|Overall Study|No longer meets study criteria|0|||
147018452|NCT01714739|530226371|FG005|Overall Study|No longer meets study criteria|0|||
147018453|NCT01714739|530226372|FG006|Overall Study|No longer meets study criteria|0|||
147018454|NCT01714739|530226366|FG000|Overall Study|Other reason|0|||
147018455|NCT01714739|530226367|FG001|Overall Study|Other reason|0|||
147018456|NCT01714739|530226368|FG002|Overall Study|Other reason|0|||
147018457|NCT01714739|530226369|FG003|Overall Study|Other reason|3|||
147018458|NCT01714739|530226370|FG004|Overall Study|Other reason|1|||
147018459|NCT01714739|530226371|FG005|Overall Study|Other reason|0|||
147018460|NCT01714739|530226372|FG006|Overall Study|Other reason|0|||
147018461|NCT00707434|530226375|FG000|Overall Study|Adverse Event|1|||
147018462|NCT03585959|530226376|FG000|Overall Study|Physician Decision|1|||
147018463|NCT03585959|530226376|FG000|Overall Study|Unsuccessful Procedure|2|||
147018464|NCT02531594|530226377|FG000|Overall Study|Withdrawal by Subject|7|||
147018465|NCT02531594|530226378|FG001|Overall Study|Withdrawal by Subject|8|||
147018466|NCT00614822|530226379|FG000|Overall Study|Adverse Event|3|||
147018467|NCT03750695|530226380|FG000|Overall Study|Lost to Follow-up|0|||
147018468|NCT03750695|530226381|FG001|Overall Study|Lost to Follow-up|1|||
147018469|NCT04480307|530226382|FG000|Overall Study|Withdrawal by Subject|0|||
147018470|NCT04480307|530226383|FG001|Overall Study|Withdrawal by Subject|1|||
147018471|NCT04480307|530226384|FG002|Overall Study|Withdrawal by Subject|0|||
147018472|NCT04480307|530226385|FG003|Overall Study|Withdrawal by Subject|0|||
147018473|NCT04480307|530226382|FG000|Overall Study|Adverse Event|0|||
147018474|NCT04480307|530226383|FG001|Overall Study|Adverse Event|0|||
147018475|NCT04480307|530226384|FG002|Overall Study|Adverse Event|0|||
147018476|NCT04480307|530226385|FG003|Overall Study|Adverse Event|1|||
147018477|NCT01256060|530226388|FG000|Overall Study|Lost to Follow-up|0|||
147018478|NCT01256060|530226389|FG001|Overall Study|Lost to Follow-up|1|||
147018479|NCT01256060|530226390|FG002|Overall Study|Lost to Follow-up|0|||
147018480|NCT01256060|530226391|FG003|Overall Study|Lost to Follow-up|0|||
147018481|NCT00220727|530226392|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
147018482|NCT00220727|530226393|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
147018483|NCT02508116|530226394|FG000|Overall Study|Lost to Follow-up|2|||
147018484|NCT02508116|530226395|FG001|Overall Study|Lost to Follow-up|3|||
147018485|NCT02508116|530226394|FG000|Overall Study|Withdrawal by Subject|3|||
147018486|NCT02508116|530226395|FG001|Overall Study|Withdrawal by Subject|2|||
147018487|NCT02508116|530226394|FG000|Overall Study|Protocol Violation|1|||
147018488|NCT02508116|530226395|FG001|Overall Study|Protocol Violation|2|||
147018489|NCT02508116|530226394|FG000|Overall Study|Physician Decision|2|||
147018490|NCT02508116|530226395|FG001|Overall Study|Physician Decision|0|||
147018491|NCT01857206|530226396|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
147018492|NCT01857206|530226397|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
147018493|NCT01857206|530226396|FG000|Overall Study|Lost to Follow-up|9|||
147018494|NCT01857206|530226397|FG001|Overall Study|Lost to Follow-up|6|||
147018495|NCT01857206|530226396|FG000|Overall Study|Unclassified|3|||
147018496|NCT01857206|530226397|FG001|Overall Study|Unclassified|3|||
147018497|NCT01857206|530226396|FG000|Overall Study|Withdrawal by Subject|1|||
147018498|NCT01857206|530226397|FG001|Overall Study|Withdrawal by Subject|0|||
147018499|NCT00575380|530226402|FG000|Overall Study|Withdrawal by Subject|1|||
147018500|NCT00575380|530226403|FG001|Overall Study|Withdrawal by Subject|0|||
147018501|NCT00575380|530226402|FG000|Overall Study|Adverse Event|0|||
147018502|NCT00575380|530226403|FG001|Overall Study|Adverse Event|1|||
147018503|NCT00575380|530226402|FG000|Overall Study|Various|0|||
147018504|NCT00575380|530226403|FG001|Overall Study|Various|2|||
147018505|NCT00559364|530226405|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
147018506|NCT00559364|530226406|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
147018507|NCT01235442|530226407|FG000|Overall Study|Lost to Follow-up|12|||
147018508|NCT01235442|530226408|FG001|Overall Study|Lost to Follow-up|10|||
147018509|NCT01235442|530226407|FG000|Overall Study|Death|0|||
147018510|NCT01235442|530226408|FG001|Overall Study|Death|2|||
147018511|NCT01235442|530226407|FG000|Overall Study|Pregnancy|1|||
147018512|NCT01235442|530226408|FG001|Overall Study|Pregnancy|1|||
147018513|NCT01235442|530226407|FG000|Overall Study|Ineligibility determined|5|||
147018514|NCT01235442|530226408|FG001|Overall Study|Ineligibility determined|4|||
147018515|NCT01235442|530226407|FG000|Overall Study|Protocol Violation|3|||
147018516|NCT01235442|530226408|FG001|Overall Study|Protocol Violation|3|||
147018517|NCT01235442|530226407|FG000|Overall Study|Adverse Event|4|||
147018518|NCT01235442|530226408|FG001|Overall Study|Adverse Event|6|||
147018519|NCT01235442|530226407|FG000|Overall Study|Withdrawal by Subject|15|||
147018520|NCT01235442|530226408|FG001|Overall Study|Withdrawal by Subject|9|||
147018521|NCT01235442|530226407|FG000|Overall Study|Lack of Efficacy|1|||
147018522|NCT01235442|530226408|FG001|Overall Study|Lack of Efficacy|3|||
147018523|NCT01235442|530226407|FG000|Overall Study|Noncompliance|1|||
147018524|NCT01235442|530226408|FG001|Overall Study|Noncompliance|2|||
147018525|NCT01235442|530226407|FG000|Overall Study|Administrative decision|1|||
147018526|NCT01235442|530226408|FG001|Overall Study|Administrative decision|2|||
147018527|NCT01235442|530226407|FG000|Overall Study|Other unspecified|1|||
147018528|NCT01235442|530226408|FG001|Overall Study|Other unspecified|2|||
147018529|NCT01857973|530226409|FG000|Overall Study|Subject did not meet required BG range|3|||
147018530|NCT01857973|530226409|FG000|Overall Study|drop out after 3 failed attempts|1|||
147018531|NCT01857973|530226409|FG000|Overall Study|Physician Decision|1|||
147018532|NCT01701973|530226410|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
147018533|NCT01701973|530226411|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
147018534|NCT01701973|530226412|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
147018535|NCT01701973|530226413|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
147018536|NCT01701973|530226414|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
147018537|NCT01701973|530226415|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
147018538|NCT01701973|530226416|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
147018539|NCT01701973|530226417|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
147018540|NCT04499482|530226422|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
147018541|NCT01588548|530226424|FG000|Overall Study|Withdrawal by Subject|0|||
147018542|NCT01588548|530226425|FG001|Overall Study|Withdrawal by Subject|1|||
147018543|NCT01588548|530226426|FG002|Overall Study|Withdrawal by Subject|1|||
147018544|NCT01588548|530226427|FG003|Overall Study|Withdrawal by Subject|1|||
147018545|NCT01588548|530226428|FG004|Overall Study|Withdrawal by Subject|2|||
147018546|NCT01588548|530226429|FG005|Overall Study|Withdrawal by Subject|3|||
147018547|NCT01588548|530226424|FG000|Overall Study|Adverse Event|0|||
147018548|NCT01588548|530226425|FG001|Overall Study|Adverse Event|0|||
147018549|NCT01588548|530226426|FG002|Overall Study|Adverse Event|1|||
147018550|NCT01588548|530226427|FG003|Overall Study|Adverse Event|2|||
147018551|NCT01588548|530226428|FG004|Overall Study|Adverse Event|1|||
147018552|NCT01588548|530226429|FG005|Overall Study|Adverse Event|0|||
147018553|NCT01588548|530226424|FG000|Overall Study|Condition Under Investigation Worsened|3|||
147018554|NCT01588548|530226425|FG001|Overall Study|Condition Under Investigation Worsened|6|||
147018555|NCT01588548|530226426|FG002|Overall Study|Condition Under Investigation Worsened|4|||
147018556|NCT01588548|530226427|FG003|Overall Study|Condition Under Investigation Worsened|4|||
147018557|NCT01588548|530226428|FG004|Overall Study|Condition Under Investigation Worsened|3|||
147018558|NCT01588548|530226429|FG005|Overall Study|Condition Under Investigation Worsened|3|||
147018559|NCT01115855|530228453|FG000|Overall Study|Adverse Event|16|||
147018560|NCT01115855|530228454|FG001|Overall Study|Adverse Event|18|||
147018561|NCT01115855|530228453|FG000|Overall Study|Death|6|||
147018562|NCT01115855|530228454|FG001|Overall Study|Death|5|||
147018563|NCT01115855|530228453|FG000|Overall Study|Lab Abnormality|1|||
147018564|NCT01115855|530228454|FG001|Overall Study|Lab Abnormality|1|||
147018565|NCT01115855|530228453|FG000|Overall Study|Protocol Violation|0|||
147018566|NCT01115855|530228454|FG001|Overall Study|Protocol Violation|1|||
147018567|NCT01115855|530228453|FG000|Overall Study|Withdrawal by Subject|5|||
147018568|NCT01115855|530228454|FG001|Overall Study|Withdrawal by Subject|5|||
147018569|NCT01115855|530228453|FG000|Overall Study|Other|8|||
147018570|NCT01115855|530228454|FG001|Overall Study|Other|6|||
147018571|NCT00831233|530228455|FG000|Overall Study|Adverse Event|0|||
147018572|NCT00831233|530228456|FG001|Overall Study|Adverse Event|1|||
147018573|NCT00831233|530228455|FG000|Overall Study|Protocol Violation|1|||
147018574|NCT00831233|530228456|FG001|Overall Study|Protocol Violation|0|||
147018575|NCT00831233|530228455|FG000|Overall Study|Selection Criteria Not Met|2|||
147018576|NCT00831233|530228456|FG001|Overall Study|Selection Criteria Not Met|0|||
147018577|NCT00480324|530228457|FG000|Overall Study|Adverse Event|1|||
147018578|NCT00480324|530228458|FG001|Overall Study|Adverse Event|1|||
147018579|NCT00480324|530228457|FG000|Overall Study|Protocol Violation|0|||
147018580|NCT00480324|530228458|FG001|Overall Study|Protocol Violation|1|||
147018581|NCT00480324|530228457|FG000|Overall Study|Withdrawal by Subject|14|||
147018582|NCT00480324|530228458|FG001|Overall Study|Withdrawal by Subject|5|||
147018583|NCT00480324|530228457|FG000|Overall Study|Lost to Follow-up|17|||
147018584|NCT00480324|530228458|FG001|Overall Study|Lost to Follow-up|8|||
147018585|NCT00480324|530228457|FG000|Overall Study|Subject's mother pregnant|0|||
147018586|NCT00480324|530228458|FG001|Overall Study|Subject's mother pregnant|1|||
147018587|NCT00784134|530228459|FG000|Overall Study|Lost to Follow-up|3|||
147018588|NCT00784134|530228460|FG001|Overall Study|Lost to Follow-up|6|||
147018589|NCT03785145|530228461|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
147018590|NCT03785145|530228462|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
147018591|NCT03785145|530228461|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
147018592|NCT03785145|530228462|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
147018593|NCT03785145|530228461|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
147018594|NCT03785145|530228462|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
147018595|NCT03785145|530228461|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
147018596|NCT03785145|530228462|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
147018597|NCT03785145|530228461|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
147018598|NCT03785145|530228462|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
147018599|NCT03785145|530228461|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
147018600|NCT03785145|530228462|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
147018601|NCT03785145|530228461|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
147018602|NCT03785145|530228462|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
147018603|NCT03785145|530228461|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
147018604|NCT03785145|530228462|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
147018605|NCT03785145|530228461|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
147018606|NCT03785145|530228462|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
147018607|NCT03785145|530228461|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
147018608|NCT03785145|530228462|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
147018609|NCT03785145|530228461|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
147018610|NCT03785145|530228462|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
147018611|NCT00097786|530228463|FG000|Overall Study|lost to follow-up for all-cause death|296|||
147018612|NCT00097786|530228464|FG001|Overall Study|lost to follow-up for all-cause death|292|||
147018613|NCT00097786|530228465|FG002|Overall Study|lost to follow-up for all-cause death|313|||
147018614|NCT00097786|530228466|FG003|Overall Study|lost to follow-up for all-cause death|310|||
147018615|NCT02960438|530228467|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
147018616|NCT02960438|530228468|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
147018617|NCT02960438|530228469|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
147018618|NCT02960438|530228470|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
147018619|NCT02960438|530228467|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
147018620|NCT02960438|530228468|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
147018621|NCT02960438|530228469|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
147018622|NCT02960438|530228470|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
147018623|NCT02960438|530228467|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
147018624|NCT02960438|530228468|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
147018625|NCT02960438|530228469|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
147018626|NCT02960438|530228470|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
147018627|NCT02960438|530228467|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
147018628|NCT02960438|530228468|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
147018629|NCT02960438|530228469|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
147018630|NCT02960438|530228470|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
147018631|NCT02960438|530228467|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
147018632|NCT02960438|530228468|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
147018633|NCT02960438|530228469|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
147018634|NCT02960438|530228470|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
147018635|NCT02960438|530228467|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
147018636|NCT02960438|530228468|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
147018637|NCT02960438|530228469|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
147018638|NCT02960438|530228470|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
147018639|NCT02960438|530228467|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
147018640|NCT02960438|530228468|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
147018641|NCT02960438|530228469|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
147018642|NCT02960438|530228470|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
147018643|NCT02960438|530228467|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
147018644|NCT02960438|530228468|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
147018645|NCT02960438|530228469|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
147018646|NCT02960438|530228470|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
147018647|NCT02960438|530228467|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
147018648|NCT02960438|530228468|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
147018649|NCT02960438|530228469|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
147018650|NCT02960438|530228470|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
147018651|NCT02960438|530228467|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
147018652|NCT02960438|530228468|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
147018653|NCT02960438|530228469|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
147018654|NCT02960438|530228470|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
147018655|NCT02960438|530228467|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
147018656|NCT02960438|530228468|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
147018657|NCT02960438|530228469|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
147018658|NCT02960438|530228470|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
147018659|NCT02960438|530228467|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
147018660|NCT02960438|530228468|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
147018661|NCT02960438|530228469|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
147018662|NCT02960438|530228470|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
147018663|NCT03686150|530228471|FG000|Overall Study|Withdrawal by Subject|1|||
147018664|NCT03686150|530228472|FG001|Overall Study|Withdrawal by Subject|1|||
147018665|NCT03686150|530228473|FG002|Overall Study|Withdrawal by Subject|1|||
147018666|NCT03686150|530228474|FG003|Overall Study|Withdrawal by Subject|0|||
147018667|NCT03686150|530228475|FG004|Overall Study|Withdrawal by Subject|1|||
147018668|NCT03686150|530228476|FG005|Overall Study|Withdrawal by Subject|2|||
147018669|NCT03686150|530228471|FG000|Overall Study|Physician Decision|1|||
147018670|NCT03686150|530228472|FG001|Overall Study|Physician Decision|0|||
147018671|NCT03686150|530228473|FG002|Overall Study|Physician Decision|0|||
147018672|NCT03686150|530228474|FG003|Overall Study|Physician Decision|0|||
147018673|NCT03686150|530228475|FG004|Overall Study|Physician Decision|0|||
147018674|NCT03686150|530228476|FG005|Overall Study|Physician Decision|1|||
147018675|NCT03686150|530228471|FG000|Overall Study|Lost to Follow-up|0|||
147018676|NCT03686150|530228472|FG001|Overall Study|Lost to Follow-up|1|||
147018677|NCT03686150|530228473|FG002|Overall Study|Lost to Follow-up|0|||
147018678|NCT03686150|530228474|FG003|Overall Study|Lost to Follow-up|0|||
147018679|NCT03686150|530228475|FG004|Overall Study|Lost to Follow-up|0|||
147018680|NCT03686150|530228476|FG005|Overall Study|Lost to Follow-up|0|||
147018681|NCT02443324|530228478|FG000|Overall Study|Death|4|||
147018682|NCT02443324|530228479|FG001|Overall Study|Death|1|||
147018683|NCT02443324|530228480|FG002|Overall Study|Death|0|||
147018684|NCT02443324|530228481|FG003|Overall Study|Death|3|||
147018685|NCT02443324|530228482|FG004|Overall Study|Death|1|||
147018686|NCT02443324|530228483|FG005|Overall Study|Death|3|||
147018687|NCT02443324|530228484|FG006|Overall Study|Death|2|||
147018688|NCT02443324|530228478|FG000|Overall Study|Lost to Follow-up|0|||
147018689|NCT02443324|530228479|FG001|Overall Study|Lost to Follow-up|0|||
147018690|NCT02443324|530228480|FG002|Overall Study|Lost to Follow-up|0|||
147018691|NCT02443324|530228481|FG003|Overall Study|Lost to Follow-up|1|||
147018692|NCT02443324|530228482|FG004|Overall Study|Lost to Follow-up|0|||
147018693|NCT02443324|530228483|FG005|Overall Study|Lost to Follow-up|1|||
147018694|NCT02443324|530228484|FG006|Overall Study|Lost to Follow-up|0|||
147018695|NCT02443324|530228478|FG000|Overall Study|Physician Decision|0|||
147018696|NCT02443324|530228479|FG001|Overall Study|Physician Decision|3|||
147018697|NCT02443324|530228480|FG002|Overall Study|Physician Decision|5|||
147018698|NCT02443324|530228481|FG003|Overall Study|Physician Decision|1|||
147018699|NCT02443324|530228482|FG004|Overall Study|Physician Decision|1|||
147018700|NCT02443324|530228483|FG005|Overall Study|Physician Decision|0|||
147018701|NCT02443324|530228484|FG006|Overall Study|Physician Decision|2|||
147018702|NCT02443324|530228478|FG000|Overall Study|Progressive Disease|20|||
147018703|NCT02443324|530228479|FG001|Overall Study|Progressive Disease|20|||
147018704|NCT02443324|530228480|FG002|Overall Study|Progressive Disease|13|||
147018705|NCT02443324|530228481|FG003|Overall Study|Progressive Disease|10|||
147018706|NCT02443324|530228482|FG004|Overall Study|Progressive Disease|13|||
147018707|NCT02443324|530228483|FG005|Overall Study|Progressive Disease|17|||
147018708|NCT02443324|530228484|FG006|Overall Study|Progressive Disease|10|||
147018709|NCT02443324|530228478|FG000|Overall Study|Withdrawal by Subject|0|||
147018710|NCT02443324|530228479|FG001|Overall Study|Withdrawal by Subject|0|||
147018711|NCT02443324|530228480|FG002|Overall Study|Withdrawal by Subject|3|||
147018712|NCT02443324|530228481|FG003|Overall Study|Withdrawal by Subject|1|||
147018713|NCT02443324|530228482|FG004|Overall Study|Withdrawal by Subject|1|||
147018714|NCT02443324|530228483|FG005|Overall Study|Withdrawal by Subject|0|||
147018715|NCT02443324|530228484|FG006|Overall Study|Withdrawal by Subject|1|||
147018716|NCT02443324|530228478|FG000|Overall Study|Adverse Event|0|||
147018717|NCT02443324|530228479|FG001|Overall Study|Adverse Event|1|||
147018718|NCT02443324|530228480|FG002|Overall Study|Adverse Event|3|||
147018719|NCT02443324|530228481|FG003|Overall Study|Adverse Event|0|||
147018720|NCT02443324|530228482|FG004|Overall Study|Adverse Event|4|||
147018721|NCT02443324|530228483|FG005|Overall Study|Adverse Event|3|||
147018722|NCT02443324|530228484|FG006|Overall Study|Adverse Event|3|||
147018723|NCT02443324|530228478|FG000|Overall Study|Enrolled but Never Treated|0|||
147018724|NCT02443324|530228479|FG001|Overall Study|Enrolled but Never Treated|0|||
147018725|NCT02443324|530228480|FG002|Overall Study|Enrolled but Never Treated|1|||
147018726|NCT02443324|530228481|FG003|Overall Study|Enrolled but Never Treated|0|||
147018727|NCT02443324|530228482|FG004|Overall Study|Enrolled but Never Treated|1|||
147018728|NCT02443324|530228483|FG005|Overall Study|Enrolled but Never Treated|0|||
147018729|NCT02443324|530228484|FG006|Overall Study|Enrolled but Never Treated|1|||
147018730|NCT01647711|530228485|FG000|Overall Study|Progressive disease|6|||
147018731|NCT01647711|530228486|FG001|Overall Study|Progressive disease|2|||
147018732|NCT01647711|530228487|FG002|Overall Study|Progressive disease|6|||
147018733|NCT01647711|530228488|FG003|Overall Study|Progressive disease|8|||
147018734|NCT01647711|530228489|FG004|Overall Study|Progressive disease|2|||
147018735|NCT01647711|530228485|FG000|Overall Study|Other adverse event|0|||
147018736|NCT01647711|530228486|FG001|Overall Study|Other adverse event|0|||
147018737|NCT01647711|530228487|FG002|Overall Study|Other adverse event|2|||
147018738|NCT01647711|530228488|FG003|Overall Study|Other adverse event|0|||
147018739|NCT01647711|530228489|FG004|Overall Study|Other adverse event|2|||
147018740|NCT01647711|530228485|FG000|Overall Study|Protocol Violation|0|||
147018741|NCT01647711|530228486|FG001|Overall Study|Protocol Violation|0|||
147018742|NCT01647711|530228487|FG002|Overall Study|Protocol Violation|0|||
147018743|NCT01647711|530228488|FG003|Overall Study|Protocol Violation|0|||
147018744|NCT01647711|530228489|FG004|Overall Study|Protocol Violation|1|||
147018745|NCT01647711|530228485|FG000|Overall Study|Refused to continue taking medication|0|||
147018746|NCT01647711|530228486|FG001|Overall Study|Refused to continue taking medication|0|||
147018747|NCT01647711|530228487|FG002|Overall Study|Refused to continue taking medication|0|||
146849128|NCT03117998|529617033|FG000|Overall Study|Protocol Violation|0|||
147018748|NCT01647711|530228488|FG003|Overall Study|Refused to continue taking medication|2|||
147018749|NCT01647711|530228489|FG004|Overall Study|Refused to continue taking medication|1|||
147018750|NCT01647711|530228485|FG000|Overall Study|Other reason not defined|0|||
147018751|NCT01647711|530228486|FG001|Overall Study|Other reason not defined|1|||
147018752|NCT01647711|530228487|FG002|Overall Study|Other reason not defined|1|||
147018753|NCT01647711|530228488|FG003|Overall Study|Other reason not defined|1|||
147018754|NCT01647711|530228489|FG004|Overall Study|Other reason not defined|0|||
147018755|NCT01844531|530228496|FG000|Overall Study|Withdrawal by Subject|0|||
147018756|NCT01844531|530228497|FG001|Overall Study|Withdrawal by Subject|1|||
147018757|NCT01844531|530228498|FG002|Overall Study|Withdrawal by Subject|0|||
147018758|NCT01844531|530228499|FG003|Overall Study|Withdrawal by Subject|0|||
147018759|NCT02070757|530228500|FG000|Overall Study|Adverse Event|107|||
147018760|NCT02070757|530228501|FG001|Overall Study|Adverse Event|99|||
147018761|NCT02070757|530228500|FG000|Overall Study|Lost to Follow-up|7|||
147018762|NCT02070757|530228501|FG001|Overall Study|Lost to Follow-up|4|||
147018763|NCT02070757|530228500|FG000|Overall Study|Protocol Violation|0|||
147018764|NCT02070757|530228501|FG001|Overall Study|Protocol Violation|4|||
147018765|NCT02070757|530228500|FG000|Overall Study|Withdrawal by Subject|1|||
147018766|NCT02070757|530228501|FG001|Overall Study|Withdrawal by Subject|3|||
147018767|NCT02070757|530228500|FG000|Overall Study|Investigator Decision|0|||
147018768|NCT02070757|530228501|FG001|Overall Study|Investigator Decision|2|||
147018769|NCT02070757|530228500|FG000|Overall Study|Discharged from Study Hospital|2|||
147018770|NCT02070757|530228501|FG001|Overall Study|Discharged from Study Hospital|2|||
147018771|NCT01546922|530228502|FG000|First Period of 10 Weeks|Protocol Violation|3|||
147018772|NCT01546922|530228503|FG001|First Period of 10 Weeks|Protocol Violation|1|||
147018773|NCT01546922|530228502|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
147018774|NCT01546922|530228503|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
147018775|NCT01546922|530228502|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
147018776|NCT01546922|530228503|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
147018777|NCT01546922|530228502|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
147018778|NCT01546922|530228503|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
147018779|NCT01546922|530228502|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
147018780|NCT01546922|530228503|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
147018781|NCT00743509|530228505|FG000|Overall Study|Withdrawal by Subject|2|||
147018782|NCT00418522|530228506|FG000|Overall Study|Adverse Event|7|||
147018783|NCT00418522|530228507|FG001|Overall Study|Adverse Event|1|||
147018784|NCT00418522|530228506|FG000|Overall Study|Lack of Efficacy|1|||
147018785|NCT00418522|530228507|FG001|Overall Study|Lack of Efficacy|3|||
147018786|NCT00418522|530228506|FG000|Overall Study|Lost to Follow-up|10|||
147018787|NCT00418522|530228507|FG001|Overall Study|Lost to Follow-up|4|||
147018788|NCT00418522|530228506|FG000|Overall Study|Withdrawal by Subject|31|||
147018789|NCT00418522|530228507|FG001|Overall Study|Withdrawal by Subject|7|||
147018790|NCT00418522|530228506|FG000|Overall Study|Other|27|||
147018791|NCT00418522|530228507|FG001|Overall Study|Other|23|||
147018792|NCT00418522|530228506|FG000|Overall Study|Randomized but did not receive treatment|7|||
147018793|NCT00418522|530228507|FG001|Overall Study|Randomized but did not receive treatment|4|||
147018794|NCT01652729|530228508|FG000|Overall Study|Withdrawal by Subject|14|||
147018795|NCT01652729|530228509|FG001|Overall Study|Withdrawal by Subject|7|||
147018796|NCT01652729|530228510|FG002|Overall Study|Withdrawal by Subject|7|||
147018797|NCT01652729|530228508|FG000|Overall Study|Adverse Event|4|||
147018798|NCT01652729|530228509|FG001|Overall Study|Adverse Event|0|||
147018799|NCT01652729|530228510|FG002|Overall Study|Adverse Event|3|||
147018800|NCT01652729|530228508|FG000|Overall Study|Physician Decision|1|||
147018801|NCT01652729|530228509|FG001|Overall Study|Physician Decision|0|||
147018802|NCT01652729|530228510|FG002|Overall Study|Physician Decision|1|||
147018803|NCT01652729|530228508|FG000|Overall Study|Protocol Violation|1|||
147018804|NCT01652729|530228509|FG001|Overall Study|Protocol Violation|0|||
147018805|NCT01652729|530228510|FG002|Overall Study|Protocol Violation|0|||
147018806|NCT01652729|530228508|FG000|Overall Study|Lost to Follow-up|6|||
147018807|NCT01652729|530228509|FG001|Overall Study|Lost to Follow-up|6|||
147018808|NCT01652729|530228510|FG002|Overall Study|Lost to Follow-up|3|||
147018809|NCT01652729|530228508|FG000|Overall Study|Administrative|1|||
147018810|NCT01652729|530228509|FG001|Overall Study|Administrative|0|||
147018811|NCT01652729|530228510|FG002|Overall Study|Administrative|0|||
147018812|NCT00483548|530228511|FG000|Overall Study|Randomized; not treated with study drug|1|||
147018813|NCT00483548|530228512|FG001|Overall Study|Randomized; not treated with study drug|3|||
147018814|NCT00483548|530228511|FG000|Overall Study|Adverse Event|25|||
147018815|NCT00483548|530228512|FG001|Overall Study|Adverse Event|14|||
147018816|NCT00483548|530228511|FG000|Overall Study|Laboratory abnormality|1|||
147018817|NCT00483548|530228512|FG001|Overall Study|Laboratory abnormality|2|||
147018818|NCT00483548|530228511|FG000|Overall Study|Lack of Efficacy|4|||
147018819|NCT00483548|530228512|FG001|Overall Study|Lack of Efficacy|8|||
147018820|NCT00483548|530228511|FG000|Overall Study|Protocol Violation|11|||
147018821|NCT00483548|530228512|FG001|Overall Study|Protocol Violation|7|||
147018822|NCT00483548|530228511|FG000|Overall Study|Pregnancy|1|||
147018823|NCT00483548|530228512|FG001|Overall Study|Pregnancy|0|||
147018824|NCT00483548|530228511|FG000|Overall Study|Protocol required discontinuation|6|||
147018825|NCT00483548|530228512|FG001|Overall Study|Protocol required discontinuation|6|||
147018826|NCT00483548|530228511|FG000|Overall Study|Unable to comply with protocol schedule|1|||
147018827|NCT00483548|530228512|FG001|Overall Study|Unable to comply with protocol schedule|0|||
147018828|NCT00483548|530228511|FG000|Overall Study|Non-compliance with medication|2|||
147018829|NCT00483548|530228512|FG001|Overall Study|Non-compliance with medication|0|||
147018830|NCT00483548|530228511|FG000|Overall Study|Lost to Follow-up|3|||
147018831|NCT00483548|530228512|FG001|Overall Study|Lost to Follow-up|4|||
147018832|NCT00483548|530228511|FG000|Overall Study|Withdrawal by Subject|5|||
147018833|NCT00483548|530228512|FG001|Overall Study|Withdrawal by Subject|2|||
147018834|NCT01280617|530228515|FG000|Overall Study|Adverse Event|0|||
147018835|NCT01280617|530228516|FG001|Overall Study|Adverse Event|1|||
147018836|NCT00573170|530228517|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
147018837|NCT00573170|530228518|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
147018838|NCT00573170|530228519|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
147018839|NCT00573170|530228520|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
147018840|NCT00573170|530228521|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
147018841|NCT00573170|530228522|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
147018842|NCT00573170|530228517|FG000|First Washout Period|Adverse Event|1|||
147018843|NCT00573170|530228518|FG001|First Washout Period|Adverse Event|1|||
147018844|NCT00573170|530228519|FG002|First Washout Period|Adverse Event|0|||
147018845|NCT00573170|530228520|FG003|First Washout Period|Adverse Event|0|||
147018846|NCT00573170|530228521|FG004|First Washout Period|Adverse Event|0|||
147018847|NCT00573170|530228522|FG005|First Washout Period|Adverse Event|1|||
147018848|NCT00573170|530228517|FG000|First Washout Period|Lack of Efficacy|0|||
147018849|NCT00573170|530228518|FG001|First Washout Period|Lack of Efficacy|0|||
147018850|NCT00573170|530228519|FG002|First Washout Period|Lack of Efficacy|0|||
147018851|NCT00573170|530228520|FG003|First Washout Period|Lack of Efficacy|0|||
147018852|NCT00573170|530228521|FG004|First Washout Period|Lack of Efficacy|0|||
147018853|NCT00573170|530228522|FG005|First Washout Period|Lack of Efficacy|1|||
147018854|NCT00573170|530228517|FG000|First Washout Period|Lost to Follow-up|1|||
147018855|NCT00573170|530228518|FG001|First Washout Period|Lost to Follow-up|1|||
147018856|NCT00573170|530228519|FG002|First Washout Period|Lost to Follow-up|0|||
147018857|NCT00573170|530228520|FG003|First Washout Period|Lost to Follow-up|2|||
147018858|NCT00573170|530228521|FG004|First Washout Period|Lost to Follow-up|0|||
147018859|NCT00573170|530228522|FG005|First Washout Period|Lost to Follow-up|2|||
147018860|NCT00573170|530228517|FG000|First Washout Period|Withdrawal by Subject|2|||
147018861|NCT00573170|530228518|FG001|First Washout Period|Withdrawal by Subject|0|||
147018862|NCT00573170|530228519|FG002|First Washout Period|Withdrawal by Subject|0|||
147018863|NCT00573170|530228520|FG003|First Washout Period|Withdrawal by Subject|2|||
147018864|NCT00573170|530228521|FG004|First Washout Period|Withdrawal by Subject|3|||
147018865|NCT00573170|530228522|FG005|First Washout Period|Withdrawal by Subject|3|||
147018866|NCT00573170|530228517|FG000|First Washout Period|Other|4|||
147018867|NCT00573170|530228518|FG001|First Washout Period|Other|0|||
147018868|NCT00573170|530228519|FG002|First Washout Period|Other|1|||
147018869|NCT00573170|530228520|FG003|First Washout Period|Other|1|||
147018870|NCT00573170|530228521|FG004|First Washout Period|Other|0|||
147018871|NCT00573170|530228522|FG005|First Washout Period|Other|0|||
147018872|NCT00573170|530228517|FG000|Second Washout Period|Adverse Event|1|||
147018873|NCT00573170|530228518|FG001|Second Washout Period|Adverse Event|0|||
147018874|NCT00573170|530228519|FG002|Second Washout Period|Adverse Event|0|||
147018875|NCT00573170|530228520|FG003|Second Washout Period|Adverse Event|0|||
147018876|NCT00573170|530228521|FG004|Second Washout Period|Adverse Event|1|||
147018877|NCT00573170|530228522|FG005|Second Washout Period|Adverse Event|0|||
147018878|NCT00573170|530228517|FG000|Second Washout Period|Protocol Violation|2|||
147018879|NCT00573170|530228518|FG001|Second Washout Period|Protocol Violation|1|||
147018880|NCT00573170|530228519|FG002|Second Washout Period|Protocol Violation|1|||
147018881|NCT00573170|530228520|FG003|Second Washout Period|Protocol Violation|0|||
147018882|NCT00573170|530228521|FG004|Second Washout Period|Protocol Violation|0|||
147018883|NCT00573170|530228522|FG005|Second Washout Period|Protocol Violation|0|||
147018884|NCT00573170|530228517|FG000|Second Washout Period|Withdrawal by Subject|1|||
147018885|NCT00573170|530228518|FG001|Second Washout Period|Withdrawal by Subject|1|||
147018886|NCT00573170|530228519|FG002|Second Washout Period|Withdrawal by Subject|2|||
147018887|NCT00573170|530228520|FG003|Second Washout Period|Withdrawal by Subject|0|||
147018888|NCT00573170|530228521|FG004|Second Washout Period|Withdrawal by Subject|1|||
147018889|NCT00573170|530228522|FG005|Second Washout Period|Withdrawal by Subject|0|||
147018890|NCT00573170|530228517|FG000|Second Washout Period|Lost to Follow-up|0|||
147018891|NCT00573170|530228518|FG001|Second Washout Period|Lost to Follow-up|0|||
147018892|NCT00573170|530228519|FG002|Second Washout Period|Lost to Follow-up|0|||
147018893|NCT00573170|530228520|FG003|Second Washout Period|Lost to Follow-up|1|||
147018894|NCT00573170|530228521|FG004|Second Washout Period|Lost to Follow-up|0|||
147018895|NCT00573170|530228522|FG005|Second Washout Period|Lost to Follow-up|0|||
147018896|NCT00573170|530228517|FG000|Second Washout Period|Other|1|||
147018897|NCT00573170|530228518|FG001|Second Washout Period|Other|2|||
147018898|NCT00573170|530228519|FG002|Second Washout Period|Other|1|||
147018899|NCT00573170|530228520|FG003|Second Washout Period|Other|4|||
147018900|NCT00573170|530228521|FG004|Second Washout Period|Other|6|||
147018901|NCT00573170|530228522|FG005|Second Washout Period|Other|2|||
147018902|NCT00573170|530228517|FG000|Third Treatment Period|Withdrawal by Subject|1|||
147018903|NCT00573170|530228518|FG001|Third Treatment Period|Withdrawal by Subject|0|||
147018904|NCT00573170|530228519|FG002|Third Treatment Period|Withdrawal by Subject|0|||
147018905|NCT00573170|530228520|FG003|Third Treatment Period|Withdrawal by Subject|0|||
147018906|NCT00573170|530228521|FG004|Third Treatment Period|Withdrawal by Subject|0|||
147018907|NCT00573170|530228522|FG005|Third Treatment Period|Withdrawal by Subject|0|||
147018908|NCT00573170|530228517|FG000|Third Treatment Period|Lost to Follow-up|0|||
147018909|NCT00573170|530228518|FG001|Third Treatment Period|Lost to Follow-up|0|||
147018910|NCT00573170|530228519|FG002|Third Treatment Period|Lost to Follow-up|0|||
147018911|NCT00573170|530228520|FG003|Third Treatment Period|Lost to Follow-up|0|||
147018912|NCT00573170|530228521|FG004|Third Treatment Period|Lost to Follow-up|0|||
147018913|NCT00573170|530228522|FG005|Third Treatment Period|Lost to Follow-up|2|||
147018914|NCT00263887|530228523|FG000|Overall Study|Withdrawal by Subject|1|||
147018915|NCT00263887|530228524|FG001|Overall Study|Withdrawal by Subject|1|||
147018916|NCT00263887|530228523|FG000|Overall Study|Lung transplantation|1|||
147018917|NCT00263887|530228524|FG001|Overall Study|Lung transplantation|2|||
147018918|NCT00263887|530228523|FG000|Overall Study|Too ill to attend visit|1|||
147018919|NCT00263887|530228524|FG001|Overall Study|Too ill to attend visit|0|||
147018920|NCT00263887|530228523|FG000|Overall Study|Adverse Event|0|||
147018921|NCT00263887|530228524|FG001|Overall Study|Adverse Event|2|||
147018922|NCT00263887|530228523|FG000|Overall Study|Disease progression|0|||
147018923|NCT00263887|530228524|FG001|Overall Study|Disease progression|1|||
147018924|NCT00263887|530228523|FG000|Overall Study|Lack of Efficacy|0|||
147018925|NCT00263887|530228524|FG001|Overall Study|Lack of Efficacy|1|||
147018926|NCT04364763|530228525|FG000|Overall Study|Death|1|||
147018927|NCT04364763|530228526|FG001|Overall Study|Death|2|||
147018928|NCT04364763|530228525|FG000|Overall Study|Lost to Follow-up|1|||
147018929|NCT04364763|530228526|FG001|Overall Study|Lost to Follow-up|0|||
147018930|NCT02359864|530228528|FG000|Overall Study|Withdrawal by Subject|1|||
147018931|NCT02359864|530228529|FG001|Overall Study|Withdrawal by Subject|0|||
147018932|NCT00725764|530228530|FG000|Overall Study|Withdrawal by Subject|2|||
147018933|NCT00725764|530228530|FG000|Overall Study|Physician Decision|1|||
147018934|NCT00725764|530228530|FG000|Overall Study|Progressive Disease|7|||
147018935|NCT00725764|530228530|FG000|Overall Study|Lost to Follow-up|1|||
147018936|NCT00725764|530228530|FG000|Overall Study|Death|1|||
147018937|NCT00725764|530228530|FG000|Overall Study|Participant non compliant with protocol|1|||
147018938|NCT00725764|530228530|FG000|Overall Study|Decline in performance status|1|||
147018939|NCT00985231|530228543|FG000|Overall Study|ineligible|1|||
147018940|NCT00985231|530228544|FG001|Overall Study|ineligible|0|||
147018941|NCT00985231|530228543|FG000|Overall Study|Protocol Violation|1|||
147018942|NCT00985231|530228544|FG001|Overall Study|Protocol Violation|0|||
147018943|NCT00985231|530228543|FG000|Overall Study|Withdrawal by Subject|1|||
147018944|NCT00985231|530228544|FG001|Overall Study|Withdrawal by Subject|0|||
147018945|NCT00985231|530228543|FG000|Overall Study|Lost to Follow-up|0|||
147018946|NCT00985231|530228544|FG001|Overall Study|Lost to Follow-up|1|||
147018947|NCT00985231|530228543|FG000|Overall Study|Study related symptoms & complaints|0|||
147018948|NCT00985231|530228544|FG001|Overall Study|Study related symptoms & complaints|2|||
147018949|NCT00983476|530228550|FG000|Overall Study|Did not receive intervention|17|||
147018950|NCT00983476|530228551|FG001|Overall Study|Did not receive intervention|22|||
147018951|NCT00983476|530228552|FG002|Overall Study|Did not receive intervention|0|||
147018952|NCT00084799|530228558|FG000|Overall Study|Disease Progression|1|||
147018953|NCT00084799|530228559|FG001|Overall Study|Disease Progression|0|||
147018954|NCT02663882|530228560|FG000|Overall Study|Lost to Follow-up|4|||
147018955|NCT02663882|530228561|FG001|Overall Study|Lost to Follow-up|2|||
147018956|NCT02412722|530228562|FG000|Overall Study|Adverse Event|0|||
147018957|NCT02412722|530228563|FG001|Overall Study|Adverse Event|2|||
147018958|NCT02412722|530228564|FG002|Overall Study|Adverse Event|0|||
147018959|NCT02412722|530228565|FG003|Overall Study|Adverse Event|3|||
147018960|NCT02412722|530228566|FG004|Overall Study|Adverse Event|0|||
147018961|NCT02412722|530228567|FG005|Overall Study|Adverse Event|3|||
147018962|NCT02412722|530228562|FG000|Overall Study|Progressive Disease|6|||
147018963|NCT02412722|530228563|FG001|Overall Study|Progressive Disease|4|||
147018964|NCT02412722|530228564|FG002|Overall Study|Progressive Disease|4|||
147018965|NCT02412722|530228565|FG003|Overall Study|Progressive Disease|9|||
147018966|NCT02412722|530228566|FG004|Overall Study|Progressive Disease|3|||
147018967|NCT02412722|530228567|FG005|Overall Study|Progressive Disease|3|||
147018968|NCT02412722|530228562|FG000|Overall Study|Withdrawal by Subject|2|||
147018969|NCT02412722|530228563|FG001|Overall Study|Withdrawal by Subject|0|||
147018970|NCT02412722|530228564|FG002|Overall Study|Withdrawal by Subject|1|||
147018971|NCT02412722|530228565|FG003|Overall Study|Withdrawal by Subject|2|||
147018972|NCT02412722|530228566|FG004|Overall Study|Withdrawal by Subject|1|||
147018973|NCT02412722|530228567|FG005|Overall Study|Withdrawal by Subject|1|||
147018974|NCT02412722|530228562|FG000|Overall Study|Lost to Follow-up|0|||
147018975|NCT02412722|530228563|FG001|Overall Study|Lost to Follow-up|0|||
147018976|NCT02412722|530228564|FG002|Overall Study|Lost to Follow-up|0|||
147018977|NCT02412722|530228565|FG003|Overall Study|Lost to Follow-up|0|||
147018978|NCT02412722|530228566|FG004|Overall Study|Lost to Follow-up|1|||
147018979|NCT02412722|530228567|FG005|Overall Study|Lost to Follow-up|0|||
147018980|NCT02412722|530228562|FG000|Overall Study|Received drug in run-in and discontinued|0|||
147018981|NCT02412722|530228563|FG001|Overall Study|Received drug in run-in and discontinued|2|||
147018982|NCT02412722|530228564|FG002|Overall Study|Received drug in run-in and discontinued|0|||
147018983|NCT02412722|530228565|FG003|Overall Study|Received drug in run-in and discontinued|0|||
147018984|NCT02412722|530228566|FG004|Overall Study|Received drug in run-in and discontinued|0|||
147018985|NCT02412722|530228567|FG005|Overall Study|Received drug in run-in and discontinued|0|||
147018986|NCT02412722|530228562|FG000|Overall Study|Reason not Specified|3|||
147018987|NCT02412722|530228563|FG001|Overall Study|Reason not Specified|0|||
147018988|NCT02412722|530228564|FG002|Overall Study|Reason not Specified|2|||
147018989|NCT02412722|530228565|FG003|Overall Study|Reason not Specified|1|||
147018990|NCT02412722|530228566|FG004|Overall Study|Reason not Specified|2|||
147018991|NCT02412722|530228567|FG005|Overall Study|Reason not Specified|6|||
147018992|NCT04449341|530228570|FG000|Overall Study|Protocol Violation|1|||
147018993|NCT04449341|530228571|FG001|Overall Study|Protocol Violation|0|||
147018994|NCT00869440|530228572|FG000|Overall Study|Withdrawal by Subject|1|||
147018995|NCT00869440|530228573|FG001|Overall Study|Withdrawal by Subject|0|||
147018996|NCT00869440|530228574|FG002|Overall Study|Withdrawal by Subject|0|||
147018997|NCT00869440|530228575|FG003|Overall Study|Withdrawal by Subject|0|||
147018998|NCT00869440|530228572|FG000|Overall Study|Physician Decision|1|||
147018999|NCT00869440|530228573|FG001|Overall Study|Physician Decision|1|||
147019000|NCT00869440|530228574|FG002|Overall Study|Physician Decision|0|||
147019001|NCT00869440|530228575|FG003|Overall Study|Physician Decision|0|||
147019002|NCT01083680|530228577|FG000|Overall Study|Lost to Follow-up|2758|||
147019003|NCT01083680|530228577|FG000|Overall Study|Withdrawal by Subject|1086|||
147019004|NCT03546647|530228578|FG000|Overall Study|Adverse Event|1|||
147019005|NCT03546647|530228579|FG001|Overall Study|Adverse Event|0|||
147019006|NCT00124462|530228582|FG000|Overall Study|Lost to Follow-up|3|||
147019007|NCT00124462|530228583|FG001|Overall Study|Lost to Follow-up|3|||
147019008|NCT00124462|530228582|FG000|Overall Study|Physician Decision|3|||
147019009|NCT00124462|530228583|FG001|Overall Study|Physician Decision|4|||
147019010|NCT00124462|530228582|FG000|Overall Study|Withdrawal by Subject|4|||
147019011|NCT00124462|530228583|FG001|Overall Study|Withdrawal by Subject|5|||
147019012|NCT00124462|530228582|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
147019013|NCT00124462|530228583|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
147019014|NCT02400476|530228584|FG000|Overall Study|Adverse Event|57|||
147019015|NCT02400476|530228585|FG001|Overall Study|Adverse Event|10|||
147019016|NCT02400476|530228586|FG002|Overall Study|Adverse Event|22|||
147019017|NCT02400476|530228587|FG003|Overall Study|Adverse Event|19|||
147019018|NCT02400476|530228588|FG004|Overall Study|Adverse Event|5|||
147019019|NCT02400476|530228589|FG005|Overall Study|Adverse Event|8|||
147019020|NCT02400476|530228584|FG000|Overall Study|Withdrawal by Subject|4|||
147019021|NCT02400476|530228585|FG001|Overall Study|Withdrawal by Subject|1|||
147019022|NCT02400476|530228586|FG002|Overall Study|Withdrawal by Subject|12|||
147019023|NCT02400476|530228587|FG003|Overall Study|Withdrawal by Subject|7|||
147019024|NCT02400476|530228588|FG004|Overall Study|Withdrawal by Subject|5|||
147019025|NCT02400476|530228589|FG005|Overall Study|Withdrawal by Subject|5|||
147019026|NCT02400476|530228584|FG000|Overall Study|Lost to Follow-up|0|||
147019027|NCT02400476|530228585|FG001|Overall Study|Lost to Follow-up|0|||
147019028|NCT02400476|530228586|FG002|Overall Study|Lost to Follow-up|0|||
147019029|NCT02400476|530228587|FG003|Overall Study|Lost to Follow-up|1|||
147019030|NCT02400476|530228588|FG004|Overall Study|Lost to Follow-up|3|||
147019031|NCT02400476|530228589|FG005|Overall Study|Lost to Follow-up|1|||
147019032|NCT02400476|530228584|FG000|Overall Study|Physician Decision|0|||
147019033|NCT02400476|530228585|FG001|Overall Study|Physician Decision|0|||
146849129|NCT03117998|529617034|FG001|Overall Study|Protocol Violation|0|||
146849130|NCT03117998|529617035|FG002|Overall Study|Protocol Violation|0|||
146849131|NCT03117998|529617036|FG003|Overall Study|Protocol Violation|0|||
146849132|NCT03117998|529617037|FG004|Overall Study|Protocol Violation|0|||
146849133|NCT03117998|529617038|FG005|Overall Study|Protocol Violation|1|||
146849134|NCT01468181|529617039|FG000|Overall Study|Adverse Event|8|||
146849135|NCT01468181|529617040|FG001|Overall Study|Adverse Event|1|||
146849136|NCT01468181|529617041|FG002|Overall Study|Adverse Event|6|||
146849137|NCT01468181|529617042|FG003|Overall Study|Adverse Event|2|||
146849138|NCT01468181|529617043|FG004|Overall Study|Adverse Event|2|||
146849139|NCT01468181|529617039|FG000|Overall Study|Protocol Violation|2|||
146849140|NCT01468181|529617040|FG001|Overall Study|Protocol Violation|0|||
146849141|NCT01468181|529617041|FG002|Overall Study|Protocol Violation|1|||
146849142|NCT01468181|529617042|FG003|Overall Study|Protocol Violation|0|||
146849143|NCT01468181|529617043|FG004|Overall Study|Protocol Violation|1|||
146849144|NCT01468181|529617039|FG000|Overall Study|Physician Decision|0|||
146849145|NCT01468181|529617040|FG001|Overall Study|Physician Decision|0|||
146849146|NCT01468181|529617041|FG002|Overall Study|Physician Decision|0|||
146849147|NCT01468181|529617042|FG003|Overall Study|Physician Decision|1|||
146849148|NCT01468181|529617043|FG004|Overall Study|Physician Decision|1|||
146849149|NCT01468181|529617039|FG000|Overall Study|Lost to Follow-up|0|||
146849150|NCT01468181|529617040|FG001|Overall Study|Lost to Follow-up|0|||
146849151|NCT01468181|529617041|FG002|Overall Study|Lost to Follow-up|1|||
147019034|NCT02400476|530228586|FG002|Overall Study|Physician Decision|1|||
146849152|NCT01468181|529617042|FG003|Overall Study|Lost to Follow-up|0|||
146849153|NCT01468181|529617043|FG004|Overall Study|Lost to Follow-up|1|||
146849154|NCT01468181|529617039|FG000|Overall Study|Withdrawal by Subject|0|||
147019035|NCT02400476|530228587|FG003|Overall Study|Physician Decision|1|||
146849155|NCT01468181|529617040|FG001|Overall Study|Withdrawal by Subject|1|||
147019036|NCT02400476|530228588|FG004|Overall Study|Physician Decision|0|||
147019037|NCT02400476|530228589|FG005|Overall Study|Physician Decision|1|||
147019038|NCT02400476|530228584|FG000|Overall Study|Other, Disease Progression|0|||
147019039|NCT02400476|530228585|FG001|Overall Study|Other, Disease Progression|1|||
147019040|NCT02400476|530228586|FG002|Overall Study|Other, Disease Progression|2|||
147019041|NCT02400476|530228587|FG003|Overall Study|Other, Disease Progression|1|||
147019042|NCT02400476|530228588|FG004|Overall Study|Other, Disease Progression|2|||
147019043|NCT02400476|530228589|FG005|Overall Study|Other, Disease Progression|1|||
147019044|NCT02400476|530228584|FG000|Overall Study|Other, Decreased Quality of Life|0|||
147019045|NCT02400476|530228585|FG001|Overall Study|Other, Decreased Quality of Life|0|||
147019046|NCT02400476|530228586|FG002|Overall Study|Other, Decreased Quality of Life|2|||
147019047|NCT02400476|530228587|FG003|Overall Study|Other, Decreased Quality of Life|0|||
147019048|NCT02400476|530228588|FG004|Overall Study|Other, Decreased Quality of Life|0|||
147019049|NCT02400476|530228589|FG005|Overall Study|Other, Decreased Quality of Life|0|||
147019050|NCT02400476|530228584|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
147019051|NCT02400476|530228585|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
147019052|NCT02400476|530228586|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
147019053|NCT02400476|530228587|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
147019054|NCT02400476|530228588|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
147019055|NCT02400476|530228589|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
147019056|NCT02487082|530228590|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
147019057|NCT02487082|530228591|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
147019058|NCT02487082|530228590|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
147019059|NCT02487082|530228591|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
147019060|NCT00003531|530228592|FG000|Overall Study|Not evaluable|10|||
147019061|NCT00588731|530228593|FG000|Overall Study|Withdrawal by Subject|3|||
147019062|NCT00588731|530228594|FG001|Overall Study|Withdrawal by Subject|2|||
147019063|NCT00346164|530228595|FG000|Overall Study|Adverse Event|0|||
147019064|NCT00346164|530228596|FG001|Overall Study|Adverse Event|0|||
147019065|NCT00346164|530228597|FG002|Overall Study|Adverse Event|0|||
147019066|NCT00346164|530228598|FG003|Overall Study|Adverse Event|1|||
147019067|NCT00346164|530228595|FG000|Overall Study|Lack of Efficacy|0|||
147019068|NCT00346164|530228596|FG001|Overall Study|Lack of Efficacy|1|||
147019069|NCT00346164|530228597|FG002|Overall Study|Lack of Efficacy|7|||
147019070|NCT00346164|530228598|FG003|Overall Study|Lack of Efficacy|25|||
147019071|NCT00346164|530228595|FG000|Overall Study|Physician Decision|0|||
147019072|NCT00346164|530228596|FG001|Overall Study|Physician Decision|1|||
147019073|NCT00346164|530228597|FG002|Overall Study|Physician Decision|2|||
147019074|NCT00346164|530228598|FG003|Overall Study|Physician Decision|27|||
147019075|NCT00346164|530228595|FG000|Overall Study|Protocol Violation|6|||
147019076|NCT00346164|530228596|FG001|Overall Study|Protocol Violation|2|||
147019077|NCT00346164|530228597|FG002|Overall Study|Protocol Violation|10|||
147019078|NCT00346164|530228598|FG003|Overall Study|Protocol Violation|4|||
147019079|NCT00346164|530228595|FG000|Overall Study|Withdrawal by Subject|0|||
147019080|NCT00346164|530228596|FG001|Overall Study|Withdrawal by Subject|0|||
147019081|NCT00346164|530228597|FG002|Overall Study|Withdrawal by Subject|2|||
147019082|NCT00346164|530228598|FG003|Overall Study|Withdrawal by Subject|0|||
147019083|NCT00346164|530228595|FG000|Overall Study|Ineligible|11|||
147019084|NCT00346164|530228596|FG001|Overall Study|Ineligible|2|||
147019085|NCT00346164|530228597|FG002|Overall Study|Ineligible|2|||
147019086|NCT00346164|530228598|FG003|Overall Study|Ineligible|23|||
147019087|NCT00346164|530228595|FG000|Overall Study|Refusal of further protocol therapy|0|||
147019088|NCT00346164|530228596|FG001|Overall Study|Refusal of further protocol therapy|1|||
147019089|NCT00346164|530228597|FG002|Overall Study|Refusal of further protocol therapy|3|||
147019090|NCT00346164|530228598|FG003|Overall Study|Refusal of further protocol therapy|15|||
147019091|NCT00346164|530228595|FG000|Overall Study|Inability to start week 16 tx on time|0|||
147019092|NCT00346164|530228596|FG001|Overall Study|Inability to start week 16 tx on time|0|||
147019093|NCT00346164|530228597|FG002|Overall Study|Inability to start week 16 tx on time|0|||
147019094|NCT00346164|530228598|FG003|Overall Study|Inability to start week 16 tx on time|11|||
147019095|NCT03297294|530228599|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
146849156|NCT01468181|529617041|FG002|Overall Study|Withdrawal by Subject|0|||
146849157|NCT01468181|529617042|FG003|Overall Study|Withdrawal by Subject|0|||
146849158|NCT01468181|529617043|FG004|Overall Study|Withdrawal by Subject|0|||
146849159|NCT04664400|529617044|FG000|Overall Study|Withdrawal by Subject|2|||
146849160|NCT01011153|529617047|FG000|Overall Study|Less than 78 cases completed|8|||
146849161|NCT01011153|529617048|FG001|Overall Study|Less than 78 cases completed|11|||
147019096|NCT03297294|530228600|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
147019097|NCT03297294|530228601|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
147019098|NCT03297294|530228602|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
146849162|NCT01011153|529617049|FG002|Overall Study|Less than 78 cases completed|9|||
146849163|NCT01081132|529617052|FG000|Overall Study|Lack of Efficacy|25|||
147019099|NCT03297294|530228603|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
147019100|NCT03297294|530228599|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
147019101|NCT03297294|530228600|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
147019102|NCT03297294|530228601|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
147019103|NCT03297294|530228602|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
147019104|NCT03297294|530228603|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
147019105|NCT03297294|530228599|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
147019106|NCT03297294|530228600|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
147019107|NCT03297294|530228601|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
147019108|NCT03297294|530228602|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
147019109|NCT03297294|530228603|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
147019110|NCT03297294|530228599|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
147019111|NCT03297294|530228600|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
147019112|NCT03297294|530228601|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
147019113|NCT03297294|530228602|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
147019114|NCT03297294|530228603|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
147019115|NCT03297294|530228599|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
147019116|NCT03297294|530228600|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
147019117|NCT03297294|530228601|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
147019118|NCT03297294|530228602|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
147019119|NCT03297294|530228603|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
147019120|NCT01198873|530228604|FG000|Overall Study|Adverse Event|4|||
147019121|NCT01198873|530228605|FG001|Overall Study|Adverse Event|7|||
147019122|NCT01198873|530228604|FG000|Overall Study|Study closure|29|||
147019123|NCT01198873|530228605|FG001|Overall Study|Study closure|23|||
147019124|NCT01198873|530228604|FG000|Overall Study|Other than above|4|||
147019125|NCT01198873|530228605|FG001|Overall Study|Other than above|2|||
147019126|NCT04569786|530228606|FG000|Overall Study|Lost to Follow-up|1|||
147019127|NCT04569786|530228607|FG001|Overall Study|Lost to Follow-up|0|||
147019128|NCT04569786|530228608|FG002|Overall Study|Lost to Follow-up|4|||
147019129|NCT04569786|530228609|FG003|Overall Study|Lost to Follow-up|1|||
147019130|NCT04569786|530228610|FG004|Overall Study|Lost to Follow-up|0|||
147019131|NCT04569786|530228606|FG000|Overall Study|Withdrawal by Subject|0|||
147019132|NCT04569786|530228607|FG001|Overall Study|Withdrawal by Subject|0|||
147019133|NCT04569786|530228608|FG002|Overall Study|Withdrawal by Subject|0|||
147019134|NCT04569786|530228609|FG003|Overall Study|Withdrawal by Subject|5|||
147019135|NCT04569786|530228610|FG004|Overall Study|Withdrawal by Subject|1|||
147019136|NCT04569786|530228606|FG000|Overall Study|Physician Decision|0|||
147019137|NCT04569786|530228607|FG001|Overall Study|Physician Decision|0|||
147019138|NCT04569786|530228608|FG002|Overall Study|Physician Decision|0|||
147019139|NCT04569786|530228609|FG003|Overall Study|Physician Decision|1|||
147019140|NCT04569786|530228610|FG004|Overall Study|Physician Decision|0|||
147019141|NCT02692482|530228611|FG000|Overall Study|Death|2|||
147019142|NCT02692482|530228612|FG001|Overall Study|Death|2|||
147019143|NCT02692482|530228611|FG000|Overall Study|Withdrawal by Subject|1|||
147019144|NCT02692482|530228612|FG001|Overall Study|Withdrawal by Subject|2|||
147019145|NCT00292227|530228617|FG000|Patch Period|Adverse Event|1|||
147019146|NCT00292227|530228618|FG001|Patch Period|Adverse Event|0|||
147019147|NCT00292227|530228619|FG002|Patch Period|Adverse Event|2|||
147019148|NCT00292227|530228617|FG000|Patch Period|Withdrawal by Subject|0|||
147019149|NCT00292227|530228618|FG001|Patch Period|Withdrawal by Subject|0|||
147019150|NCT00292227|530228619|FG002|Patch Period|Withdrawal by Subject|1|||
147019151|NCT03253094|530228622|FG000|Overall Study|Adverse Event|2|||
147019152|NCT03253094|530228623|FG001|Overall Study|Adverse Event|0|||
147019153|NCT03253094|530228624|FG002|Overall Study|Adverse Event|0|||
147019154|NCT03253094|530228625|FG003|Overall Study|Adverse Event|0|||
147019155|NCT03253094|530228626|FG004|Overall Study|Adverse Event|0|||
147019156|NCT03253094|530228627|FG005|Overall Study|Adverse Event|0|||
147019157|NCT03253094|530228622|FG000|Overall Study|Lack of Efficacy|0|||
147019158|NCT03253094|530228623|FG001|Overall Study|Lack of Efficacy|0|||
147019159|NCT03253094|530228624|FG002|Overall Study|Lack of Efficacy|2|||
147019160|NCT03253094|530228625|FG003|Overall Study|Lack of Efficacy|1|||
147019161|NCT03253094|530228626|FG004|Overall Study|Lack of Efficacy|2|||
147019162|NCT03253094|530228627|FG005|Overall Study|Lack of Efficacy|1|||
147019163|NCT03253094|530228622|FG000|Overall Study|Lost to Follow-up|0|||
147019164|NCT03253094|530228623|FG001|Overall Study|Lost to Follow-up|0|||
147019165|NCT03253094|530228624|FG002|Overall Study|Lost to Follow-up|1|||
147019166|NCT03253094|530228625|FG003|Overall Study|Lost to Follow-up|1|||
147019167|NCT03253094|530228626|FG004|Overall Study|Lost to Follow-up|0|||
147019168|NCT03253094|530228627|FG005|Overall Study|Lost to Follow-up|1|||
147019169|NCT03253094|530228622|FG000|Overall Study|Physician Decision|1|||
147019170|NCT03253094|530228623|FG001|Overall Study|Physician Decision|0|||
147019171|NCT03253094|530228624|FG002|Overall Study|Physician Decision|0|||
147019172|NCT03253094|530228625|FG003|Overall Study|Physician Decision|1|||
147019173|NCT03253094|530228626|FG004|Overall Study|Physician Decision|0|||
147019174|NCT03253094|530228627|FG005|Overall Study|Physician Decision|2|||
147019175|NCT03253094|530228622|FG000|Overall Study|Withdrawal by Subject|1|||
146849164|NCT01081132|529617053|FG001|Overall Study|Lack of Efficacy|9|||
147019176|NCT03253094|530228623|FG001|Overall Study|Withdrawal by Subject|2|||
147019177|NCT03253094|530228624|FG002|Overall Study|Withdrawal by Subject|1|||
147019178|NCT03253094|530228625|FG003|Overall Study|Withdrawal by Subject|0|||
147019179|NCT03253094|530228626|FG004|Overall Study|Withdrawal by Subject|3|||
147019180|NCT03253094|530228627|FG005|Overall Study|Withdrawal by Subject|0|||
147019181|NCT03253094|530228622|FG000|Overall Study|Other|0|||
147019182|NCT03253094|530228623|FG001|Overall Study|Other|1|||
147019183|NCT03253094|530228624|FG002|Overall Study|Other|2|||
147019184|NCT03253094|530228625|FG003|Overall Study|Other|1|||
147019185|NCT03253094|530228626|FG004|Overall Study|Other|0|||
147019186|NCT03253094|530228627|FG005|Overall Study|Other|0|||
147019187|NCT00576303|530228628|FG000|Dose Titration Period|Early withdrawal|17|||
147019188|NCT00576303|530228628|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
147019189|NCT00576303|530228628|FG000|Long Term Safety Period|Early withdrawal|16|||
147019190|NCT00824369|530228629|FG000|Overall Study|Nolonger willing to participate in study|1|||
147019191|NCT00824369|530228630|FG001|Overall Study|Nolonger willing to participate in study|0|||
147019192|NCT00824369|530228631|FG002|Overall Study|Nolonger willing to participate in study|1|||
147019193|NCT00824369|530228632|FG003|Overall Study|Nolonger willing to participate in study|2|||
147019194|NCT00824369|530228633|FG004|Overall Study|Nolonger willing to participate in study|0|||
147019195|NCT00824369|530228634|FG005|Overall Study|Nolonger willing to participate in study|1|||
147019196|NCT00824369|530228629|FG000|Overall Study|Lost to Follow-up|0|||
147019197|NCT00824369|530228630|FG001|Overall Study|Lost to Follow-up|0|||
147019198|NCT00824369|530228631|FG002|Overall Study|Lost to Follow-up|0|||
147019199|NCT00824369|530228632|FG003|Overall Study|Lost to Follow-up|0|||
147019200|NCT00824369|530228633|FG004|Overall Study|Lost to Follow-up|1|||
147019201|NCT00824369|530228634|FG005|Overall Study|Lost to Follow-up|0|||
147019202|NCT00442546|530228635|FG000|Overall Study|Adverse Event|11|||
147019203|NCT00442546|530228636|FG001|Overall Study|Adverse Event|17|||
147019204|NCT00442546|530228637|FG002|Overall Study|Adverse Event|13|||
147019205|NCT00442546|530228635|FG000|Overall Study|Lost to Follow-up|1|||
147019206|NCT00442546|530228636|FG001|Overall Study|Lost to Follow-up|2|||
147019207|NCT00442546|530228637|FG002|Overall Study|Lost to Follow-up|1|||
147019208|NCT00442546|530228635|FG000|Overall Study|Other|4|||
147019209|NCT00442546|530228636|FG001|Overall Study|Other|9|||
147019210|NCT00442546|530228637|FG002|Overall Study|Other|6|||
147019211|NCT00442546|530228635|FG000|Overall Study|Withdrawal by Subject|5|||
147019212|NCT00442546|530228636|FG001|Overall Study|Withdrawal by Subject|5|||
147019213|NCT00442546|530228637|FG002|Overall Study|Withdrawal by Subject|7|||
147019214|NCT00442546|530228635|FG000|Overall Study|Randomized But Not Treated|5|||
147019215|NCT00442546|530228636|FG001|Overall Study|Randomized But Not Treated|4|||
147019216|NCT00442546|530228637|FG002|Overall Study|Randomized But Not Treated|6|||
147019217|NCT03581188|530230389|FG000|Overall Study|Inclusion criteria not met|3|||
147019218|NCT03581188|530230390|FG001|Overall Study|Inclusion criteria not met|2|||
147019219|NCT03581188|530230389|FG000|Overall Study|Lost to Follow-up|5|||
147019220|NCT03581188|530230390|FG001|Overall Study|Lost to Follow-up|5|||
147019221|NCT03581188|530230389|FG000|Overall Study|Discontinued intervention|11|||
147019222|NCT03581188|530230390|FG001|Overall Study|Discontinued intervention|8|||
147019223|NCT01619579|530230391|FG000|Overall Study|Withdrawal by Subject|0|||
147019224|NCT01619579|530230392|FG001|Overall Study|Withdrawal by Subject|3|||
147019225|NCT02012452|530230394|FG000|Overall Study|Lost to Follow-up|2|||
147019226|NCT02012452|530230395|FG001|Overall Study|Lost to Follow-up|1|||
147019227|NCT02012452|530230394|FG000|Overall Study|Withdrawal by Subject|4|||
147019228|NCT02012452|530230395|FG001|Overall Study|Withdrawal by Subject|0|||
147019229|NCT02190279|530230396|FG000|Overall Study|Withdrawal consent|1|||
147019230|NCT02190279|530230397|FG001|Overall Study|Withdrawal consent|0|||
147019231|NCT02190279|530230398|FG002|Overall Study|Withdrawal consent|1|||
147019232|NCT02190279|530230396|FG000|Overall Study|Lost to Follow-up|2|||
147019233|NCT02190279|530230397|FG001|Overall Study|Lost to Follow-up|0|||
147019234|NCT02190279|530230398|FG002|Overall Study|Lost to Follow-up|0|||
147019235|NCT02190279|530230396|FG000|Overall Study|Refused further treatment|0|||
147019236|NCT02190279|530230397|FG001|Overall Study|Refused further treatment|0|||
147019237|NCT02190279|530230398|FG002|Overall Study|Refused further treatment|1|||
147019238|NCT02190279|530230396|FG000|Overall Study|Screening failure|0|||
147019239|NCT02190279|530230397|FG001|Overall Study|Screening failure|0|||
147019240|NCT02190279|530230398|FG002|Overall Study|Screening failure|1|||
147019241|NCT02938442|530230399|FG000|Overall Study|Death|0|||
147019242|NCT02938442|530230400|FG001|Overall Study|Death|1|||
147019243|NCT02938442|530230399|FG000|Overall Study|Lost to Follow-up|0|||
147019244|NCT02938442|530230400|FG001|Overall Study|Lost to Follow-up|1|||
147019245|NCT02938442|530230399|FG000|Overall Study|Physician Decision|0|||
147019246|NCT02938442|530230400|FG001|Overall Study|Physician Decision|1|||
147019247|NCT02938442|530230399|FG000|Overall Study|Withdrawal by Subject|2|||
147019248|NCT02938442|530230400|FG001|Overall Study|Withdrawal by Subject|0|||
147019249|NCT04403399|530230401|FG000|Period 2|Physician Decision|0|||
147019250|NCT04403399|530230402|FG001|Period 2|Physician Decision|1|||
147019251|NCT01316419|530230404|FG000|Overall Study|Not treated|103|||
147019252|NCT01316419|530230404|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
147019253|NCT01316419|530230404|FG000|Overall Study|Lost to Follow-up|19|||
147019254|NCT00983918|530230413|FG000|Overall Study|conversion to open cholecystectomy|0|||
147019255|NCT00983918|530230414|FG001|Overall Study|conversion to open cholecystectomy|2|||
147019256|NCT00983918|530230415|FG002|Overall Study|conversion to open cholecystectomy|2|||
147019257|NCT00983918|530230416|FG003|Overall Study|conversion to open cholecystectomy|2|||
147019258|NCT03346070|530230426|FG000|Overall Study|Death|0|||
147019259|NCT03346070|530230427|FG001|Overall Study|Death|0|||
147019260|NCT03346070|530230428|FG002|Overall Study|Death|0|||
147019261|NCT03346070|530230429|FG003|Overall Study|Death|0|||
147019262|NCT03346070|530230430|FG004|Overall Study|Death|1|||
147019263|NCT03346070|530230426|FG000|Overall Study|Lost to Follow-up|0|||
147019264|NCT03346070|530230427|FG001|Overall Study|Lost to Follow-up|1|||
147019265|NCT03346070|530230428|FG002|Overall Study|Lost to Follow-up|2|||
147019266|NCT03346070|530230429|FG003|Overall Study|Lost to Follow-up|0|||
147019267|NCT03346070|530230430|FG004|Overall Study|Lost to Follow-up|0|||
147019268|NCT03346070|530230426|FG000|Overall Study|Physician Decision|0|||
147019269|NCT03346070|530230427|FG001|Overall Study|Physician Decision|0|||
147019270|NCT03346070|530230428|FG002|Overall Study|Physician Decision|0|||
147019271|NCT03346070|530230429|FG003|Overall Study|Physician Decision|1|||
147019272|NCT03346070|530230430|FG004|Overall Study|Physician Decision|1|||
147019273|NCT03346070|530230426|FG000|Overall Study|Withdrawal by Subject|1|||
147019274|NCT03346070|530230427|FG001|Overall Study|Withdrawal by Subject|0|||
147019275|NCT03346070|530230428|FG002|Overall Study|Withdrawal by Subject|0|||
146962314|NCT01049360|530021586|FG012|Period 1|Did not meet inc/exc criteria|0|||
146962315|NCT01049360|530021587|FG013|Period 1|Did not meet inc/exc criteria|0|||
147019276|NCT03346070|530230429|FG003|Overall Study|Withdrawal by Subject|1|||
147019277|NCT03346070|530230430|FG004|Overall Study|Withdrawal by Subject|0|||
147019278|NCT03346070|530230426|FG000|Overall Study|Study medication not received as planned|2|||
147019279|NCT03346070|530230427|FG001|Overall Study|Study medication not received as planned|3|||
147019280|NCT03346070|530230428|FG002|Overall Study|Study medication not received as planned|2|||
147019281|NCT03346070|530230429|FG003|Overall Study|Study medication not received as planned|3|||
147019282|NCT03346070|530230430|FG004|Overall Study|Study medication not received as planned|2|||
147019283|NCT03346070|530230426|FG000|Overall Study|Screen Failure|0|||
147019284|NCT03346070|530230427|FG001|Overall Study|Screen Failure|0|||
147019285|NCT03346070|530230428|FG002|Overall Study|Screen Failure|0|||
147019286|NCT03346070|530230429|FG003|Overall Study|Screen Failure|1|||
147019287|NCT03346070|530230430|FG004|Overall Study|Screen Failure|1|||
147019288|NCT04086641|530230433|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
147019289|NCT04086641|530230434|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
147019290|NCT00255151|530230435|FG000|Overall Study|Adverse Event|10|||
147019291|NCT00255151|530230436|FG001|Overall Study|Adverse Event|6|||
147019292|NCT00255151|530230437|FG002|Overall Study|Adverse Event|9|||
147019293|NCT00255151|530230435|FG000|Overall Study|Lost to Follow-up|4|||
147019294|NCT00255151|530230436|FG001|Overall Study|Lost to Follow-up|3|||
147019295|NCT00255151|530230437|FG002|Overall Study|Lost to Follow-up|4|||
147019296|NCT00255151|530230435|FG000|Overall Study|Withdrawal by Subject|18|||
147019297|NCT00255151|530230436|FG001|Overall Study|Withdrawal by Subject|17|||
147019298|NCT00255151|530230437|FG002|Overall Study|Withdrawal by Subject|8|||
147019299|NCT00255151|530230435|FG000|Overall Study|Noncompliance|0|||
147019300|NCT00255151|530230436|FG001|Overall Study|Noncompliance|1|||
147019301|NCT00255151|530230437|FG002|Overall Study|Noncompliance|2|||
147019302|NCT00255151|530230435|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
147019303|NCT00255151|530230436|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
147019304|NCT00255151|530230437|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
147019305|NCT00255151|530230435|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
147019306|NCT00255151|530230436|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
147019307|NCT00255151|530230437|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
147019308|NCT00255151|530230435|FG000|Overall Study|Possible Barrett's Esophagus|1|||
147019309|NCT00255151|530230436|FG001|Overall Study|Possible Barrett's Esophagus|3|||
147019310|NCT00255151|530230437|FG002|Overall Study|Possible Barrett's Esophagus|8|||
147019311|NCT00255151|530230435|FG000|Overall Study|Esophageal Stricture|0|||
147019312|NCT00255151|530230436|FG001|Overall Study|Esophageal Stricture|0|||
147019313|NCT00255151|530230437|FG002|Overall Study|Esophageal Stricture|1|||
147019314|NCT00255151|530230435|FG000|Overall Study|Therapeutic Failure|11|||
147019315|NCT00255151|530230436|FG001|Overall Study|Therapeutic Failure|2|||
147019316|NCT00255151|530230437|FG002|Overall Study|Therapeutic Failure|3|||
147019317|NCT00792623|530230438|FG000|Overall Study|Adverse Event|2|||
146962316|NCT01049360|530021588|FG014|Period 1|Did not meet inc/exc criteria|0|||
146962317|NCT01049360|530021589|FG015|Period 1|Did not meet inc/exc criteria|0|||
146962318|NCT01049360|530021590|FG016|Period 1|Did not meet inc/exc criteria|0|||
146962319|NCT01049360|530021591|FG017|Period 1|Did not meet inc/exc criteria|0|||
146962320|NCT01049360|530021592|FG018|Period 1|Did not meet inc/exc criteria|0|||
146962321|NCT01049360|530021593|FG019|Period 1|Did not meet inc/exc criteria|0|||
146962322|NCT01049360|530021574|FG000|Period 1|Withdrawal by Subject|0|||
146962323|NCT01049360|530021575|FG001|Period 1|Withdrawal by Subject|0|||
146962324|NCT01049360|530021576|FG002|Period 1|Withdrawal by Subject|0|||
146962325|NCT01049360|530021577|FG003|Period 1|Withdrawal by Subject|0|||
146962326|NCT01049360|530021578|FG004|Period 1|Withdrawal by Subject|0|||
147019318|NCT00792623|530230438|FG000|Overall Study|Withdrawal by Subject|5|||
147019319|NCT01685073|530230439|FG000|Overall Study|Lost to Follow-up|6|||
147019320|NCT01685073|530230440|FG001|Overall Study|Lost to Follow-up|8|||
147019321|NCT01685073|530230439|FG000|Overall Study|Withdrawal by Subject|24|||
147019322|NCT01685073|530230440|FG001|Overall Study|Withdrawal by Subject|24|||
147019323|NCT00572039|530230443|FG000|Overall Study|Withdrawal by Subject|9|||
147019324|NCT00572039|530230444|FG001|Overall Study|Withdrawal by Subject|6|||
147019325|NCT00572039|530230443|FG000|Overall Study|Death|2|||
147019326|NCT00572039|530230444|FG001|Overall Study|Death|3|||
147019327|NCT00572039|530230443|FG000|Overall Study|Ill|5|||
147019328|NCT00572039|530230444|FG001|Overall Study|Ill|1|||
147019329|NCT03756883|530230445|FG000|Overall Study|Adverse Event|2|||
147019330|NCT03756883|530230446|FG001|Overall Study|Adverse Event|2|||
147019331|NCT03756883|530230447|FG002|Overall Study|Adverse Event|2|||
147019332|NCT03756883|530230445|FG000|Overall Study|Lack of Efficacy|0|||
147019333|NCT03756883|530230446|FG001|Overall Study|Lack of Efficacy|1|||
147019334|NCT03756883|530230447|FG002|Overall Study|Lack of Efficacy|2|||
147019335|NCT03756883|530230445|FG000|Overall Study|Lost to Follow-up|3|||
147019336|NCT03756883|530230446|FG001|Overall Study|Lost to Follow-up|3|||
147019337|NCT03756883|530230447|FG002|Overall Study|Lost to Follow-up|0|||
147019338|NCT03756883|530230445|FG000|Overall Study|Protocol Violation|2|||
147019339|NCT03756883|530230446|FG001|Overall Study|Protocol Violation|0|||
147019340|NCT03756883|530230447|FG002|Overall Study|Protocol Violation|1|||
147019341|NCT03756883|530230445|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
147019342|NCT03756883|530230446|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
147019343|NCT03756883|530230447|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
147019344|NCT03756883|530230445|FG000|Overall Study|Withdrawal by Subject|4|||
147019345|NCT03756883|530230446|FG001|Overall Study|Withdrawal by Subject|1|||
147019346|NCT03756883|530230447|FG002|Overall Study|Withdrawal by Subject|0|||
147019347|NCT03756883|530230445|FG000|Overall Study|Other Reasons|2|||
147019348|NCT03756883|530230446|FG001|Overall Study|Other Reasons|4|||
147019349|NCT03756883|530230447|FG002|Overall Study|Other Reasons|0|||
147019350|NCT01011556|530230454|FG000|Overall Study|Adverse Event|1|||
147019351|NCT01011556|530230455|FG001|Overall Study|Adverse Event|3|||
147019352|NCT01011556|530230456|FG002|Overall Study|Adverse Event|2|||
147019353|NCT01011556|530230457|FG003|Overall Study|Adverse Event|1|||
147019354|NCT01011556|530230454|FG000|Overall Study|Lost to Follow-up|1|||
147019355|NCT01011556|530230455|FG001|Overall Study|Lost to Follow-up|0|||
147019356|NCT01011556|530230456|FG002|Overall Study|Lost to Follow-up|0|||
147019357|NCT01011556|530230457|FG003|Overall Study|Lost to Follow-up|0|||
147019358|NCT01011556|530230454|FG000|Overall Study|Physician Decision|1|||
147019359|NCT01011556|530230455|FG001|Overall Study|Physician Decision|0|||
147019360|NCT01011556|530230456|FG002|Overall Study|Physician Decision|0|||
147019361|NCT01011556|530230457|FG003|Overall Study|Physician Decision|1|||
147019362|NCT01011556|530230454|FG000|Overall Study|Protocol Violation|0|||
147019363|NCT01011556|530230455|FG001|Overall Study|Protocol Violation|1|||
147019364|NCT01011556|530230456|FG002|Overall Study|Protocol Violation|0|||
147019365|NCT01011556|530230457|FG003|Overall Study|Protocol Violation|0|||
147019366|NCT01011556|530230454|FG000|Overall Study|Withdrawal by Subject|1|||
147019367|NCT01011556|530230455|FG001|Overall Study|Withdrawal by Subject|2|||
147019368|NCT01011556|530230456|FG002|Overall Study|Withdrawal by Subject|4|||
147019369|NCT01011556|530230457|FG003|Overall Study|Withdrawal by Subject|4|||
147019370|NCT01011556|530230454|FG000|Overall Study|Sponsor decision|0|||
147019371|NCT01011556|530230455|FG001|Overall Study|Sponsor decision|1|||
147019372|NCT01011556|530230456|FG002|Overall Study|Sponsor decision|1|||
147019373|NCT01011556|530230457|FG003|Overall Study|Sponsor decision|2|||
147019374|NCT01011556|530230454|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
147019375|NCT01011556|530230455|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
147019376|NCT01011556|530230456|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
147019377|NCT01011556|530230457|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
147019378|NCT02147587|530230458|FG000|Overall Study|Adverse Event|9|||
147019379|NCT02147587|530230459|FG001|Overall Study|Adverse Event|4|||
147019380|NCT02147587|530230458|FG000|Overall Study|Lack of Efficacy|2|||
147019381|NCT02147587|530230459|FG001|Overall Study|Lack of Efficacy|1|||
147019382|NCT01355302|530230460|FG000|Phase 1b|Death|4|||
147019383|NCT01355302|530230461|FG001|Phase 1b|Death|0|||
147019384|NCT01355302|530230462|FG002|Phase 1b|Death|0|||
147019385|NCT01355302|530230460|FG000|Phase 1b|Study terminated by sponsor|2|||
147019386|NCT01355302|530230461|FG001|Phase 1b|Study terminated by sponsor|0|||
147019387|NCT01355302|530230462|FG002|Phase 1b|Study terminated by sponsor|0|||
147019388|NCT01557920|530230469|FG000|Overall Study|Withdrawal by Subject|2|||
147019389|NCT01557920|530230470|FG001|Overall Study|Withdrawal by Subject|3|||
147019390|NCT01557920|530230469|FG000|Overall Study|Lack of Efficacy|1|||
147019391|NCT01557920|530230470|FG001|Overall Study|Lack of Efficacy|0|||
147019392|NCT04220775|530230477|FG000|Overall Study|Adverse Event|1|||
147019393|NCT04220775|530230478|FG001|Overall Study|Adverse Event|0|||
147019394|NCT04220775|530230477|FG000|Overall Study|Disease Progression|1|||
147019395|NCT04220775|530230478|FG001|Overall Study|Disease Progression|0|||
147019396|NCT00089076|530230479|FG000|Overall Study|Alternate Therapy|1|||
147019397|NCT00089076|530230479|FG000|Overall Study|Withdrawal by Subject|2|||
147019398|NCT00089076|530230479|FG000|Overall Study|Progression|7|||
147019399|NCT00436917|530230480|FG000|Overall Study|Withdrawal by Subject|13|||
147019400|NCT00436917|530230480|FG000|Overall Study|Adverse Event|2|||
147019401|NCT00436917|530230480|FG000|Overall Study|Physician Decision|1|||
147019402|NCT00436917|530230480|FG000|Overall Study|Death|1|||
147019403|NCT00436917|530230480|FG000|Overall Study|Lost to Follow-up|1|||
147019404|NCT00436917|530230480|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
147019405|NCT00436917|530230480|FG000|Overall Study|Increased creatinine|1|||
147019406|NCT00436917|530230480|FG000|Overall Study|Personal conflicts of patient|1|||
147019407|NCT00808509|530230481|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
147019408|NCT00808509|530230482|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
147019409|NCT00808509|530230481|FG000|Randomized Phase|Reduced methotrexate dose|1|||
147019410|NCT00808509|530230482|FG001|Randomized Phase|Reduced methotrexate dose|2|||
147019411|NCT00808509|530230481|FG000|Randomized Phase|Patient refused rescue therapy|0|||
147019412|NCT00808509|530230482|FG001|Randomized Phase|Patient refused rescue therapy|3|||
147019413|NCT00931463|530230483|FG000|Overall Study|Death|8|||
147019414|NCT00931463|530230484|FG001|Overall Study|Death|4|||
147019415|NCT00931463|530230483|FG000|Overall Study|Withdrawal by Subject|5|||
147019416|NCT00931463|530230484|FG001|Overall Study|Withdrawal by Subject|0|||
147019417|NCT00931463|530230483|FG000|Overall Study|Lost to Follow-up|4|||
147019418|NCT00931463|530230484|FG001|Overall Study|Lost to Follow-up|1|||
147019419|NCT02169791|530230487|FG000|Overall Study|Death|6|||
147019420|NCT02169791|530230487|FG000|Overall Study|patient withdrew consent|1|||
147019421|NCT03170869|530230488|FG000|Overall Study|Protocol Violation|5|||
147019422|NCT03170869|530230488|FG000|Overall Study|Early study termination|3|||
147019423|NCT01175473|530230490|FG000|Overall Study|Adverse Event|2|||
147019424|NCT01175473|530230491|FG001|Overall Study|Adverse Event|2|||
147019425|NCT03942211|530230496|FG000|Overall Study|Death|1|||
147019426|NCT03942211|530230497|FG001|Overall Study|Death|0|||
147019427|NCT03942211|530230496|FG000|Overall Study|Study terminated by sponsor|5|||
147019428|NCT03942211|530230497|FG001|Overall Study|Study terminated by sponsor|3|||
147019429|NCT03942211|530230496|FG000|Overall Study|Adverse Event|0|||
147019430|NCT03942211|530230497|FG001|Overall Study|Adverse Event|1|||
147019431|NCT01955044|530230498|FG000|Overall Study|Death|1|||
147019432|NCT01955044|530230499|FG001|Overall Study|Death|1|||
147019433|NCT01955044|530230500|FG002|Overall Study|Death|0|||
147019434|NCT02260258|530230504|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
147019435|NCT02260258|530230505|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
147019436|NCT00690482|530230506|FG000|Overall Study|Adverse Event|2|||
147019437|NCT00690482|530230507|FG001|Overall Study|Adverse Event|1|||
147019438|NCT00690482|530230506|FG000|Overall Study|Incorrect enrolment|0|||
147019439|NCT00690482|530230507|FG001|Overall Study|Incorrect enrolment|1|||
147019440|NCT00690482|530230506|FG000|Overall Study|Study-specific discontinuation criteria|1|||
147019441|NCT00690482|530230507|FG001|Overall Study|Study-specific discontinuation criteria|0|||
147019442|NCT00690482|530230506|FG000|Overall Study|Intake of prohibited medicine|1|||
147019443|NCT00690482|530230507|FG001|Overall Study|Intake of prohibited medicine|0|||
147019444|NCT00690482|530230506|FG000|Overall Study|withdrew consent at rand.day|0|||
147019445|NCT00690482|530230507|FG001|Overall Study|withdrew consent at rand.day|1|||
147019446|NCT00724373|530230508|FG000|Overall Study|Adverse Event|41|||
147019447|NCT00724373|530230508|FG000|Overall Study|Lack of Efficacy|82|||
147019448|NCT00724373|530230508|FG000|Overall Study|Lost to Follow-up|7|||
147019449|NCT00724373|530230508|FG000|Overall Study|Non-compliance|2|||
147019450|NCT00724373|530230508|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
147019451|NCT00724373|530230508|FG000|Overall Study|Participant moved away|1|||
147019452|NCT00724373|530230508|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
147019453|NCT00724373|530230508|FG000|Overall Study|Only to have 24 week regimen|1|||
147019454|NCT00724373|530230508|FG000|Overall Study|Viral Relapse|1|||
147019455|NCT00724373|530230508|FG000|Overall Study|Acute HCV infection|1|||
147019456|NCT00724373|530230508|FG000|Overall Study|Drug Relapse|1|||
147019457|NCT00724373|530230508|FG000|Overall Study|Tolerability|23|||
147019458|NCT01506908|530230509|FG000|Overall Study|Adverse Event|1|||
147019459|NCT01506908|530230510|FG001|Overall Study|Adverse Event|0|||
147019460|NCT00925301|530230521|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
147019461|NCT00925301|530230522|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
147019462|NCT00925301|530230523|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
147019463|NCT00925301|530230524|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
147019464|NCT00925301|530230521|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
147019465|NCT00925301|530230522|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
147019466|NCT00925301|530230523|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
146736552|NCT05004688|529206908|FG000|Overall Study|Physician Decision|2|||
146736553|NCT05004688|529206908|FG000|Overall Study|Withdrawal by Subject|2|||
147019467|NCT00925301|530230524|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
147019468|NCT00925301|530230521|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
147019469|NCT00925301|530230522|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
147019470|NCT00925301|530230523|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
147019471|NCT00925301|530230524|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
147019472|NCT00925301|530230521|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
147019473|NCT00925301|530230522|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
147019474|NCT00925301|530230523|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
147019475|NCT00925301|530230524|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
147019476|NCT00925301|530230521|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
147019477|NCT00925301|530230522|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
147019478|NCT00925301|530230523|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
147019479|NCT00925301|530230524|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
147019480|NCT00925301|530230521|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
147019481|NCT00925301|530230522|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
147019482|NCT00925301|530230523|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
147019483|NCT00925301|530230524|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
146962327|NCT01049360|530021579|FG005|Period 1|Withdrawal by Subject|0|||
146962328|NCT01049360|530021580|FG006|Period 1|Withdrawal by Subject|0|||
146962329|NCT01049360|530021581|FG007|Period 1|Withdrawal by Subject|0|||
146962330|NCT01049360|530021582|FG008|Period 1|Withdrawal by Subject|1|||
146962331|NCT01049360|530021583|FG009|Period 1|Withdrawal by Subject|0|||
146962332|NCT01049360|530021584|FG010|Period 1|Withdrawal by Subject|1|||
146962333|NCT01049360|530021585|FG011|Period 1|Withdrawal by Subject|0|||
146962334|NCT01049360|530021586|FG012|Period 1|Withdrawal by Subject|1|||
146962335|NCT01049360|530021587|FG013|Period 1|Withdrawal by Subject|0|||
146962336|NCT01049360|530021588|FG014|Period 1|Withdrawal by Subject|0|||
146962337|NCT01049360|530021589|FG015|Period 1|Withdrawal by Subject|0|||
146962338|NCT01049360|530021590|FG016|Period 1|Withdrawal by Subject|0|||
146962339|NCT01049360|530021591|FG017|Period 1|Withdrawal by Subject|0|||
146962340|NCT01049360|530021592|FG018|Period 1|Withdrawal by Subject|0|||
146962341|NCT01049360|530021593|FG019|Period 1|Withdrawal by Subject|0|||
146962342|NCT01049360|530021574|FG000|Period 2|Protocol Violation|0|||
146962343|NCT01049360|530021575|FG001|Period 2|Protocol Violation|0|||
146962344|NCT01049360|530021576|FG002|Period 2|Protocol Violation|0|||
146962345|NCT01049360|530021577|FG003|Period 2|Protocol Violation|1|||
146962346|NCT01049360|530021578|FG004|Period 2|Protocol Violation|0|||
146962347|NCT01049360|530021579|FG005|Period 2|Protocol Violation|0|||
146962348|NCT01049360|530021580|FG006|Period 2|Protocol Violation|0|||
146962349|NCT01049360|530021581|FG007|Period 2|Protocol Violation|0|||
146962350|NCT01049360|530021582|FG008|Period 2|Protocol Violation|0|||
146962351|NCT01049360|530021583|FG009|Period 2|Protocol Violation|0|||
146962352|NCT01049360|530021584|FG010|Period 2|Protocol Violation|0|||
146962353|NCT01049360|530021585|FG011|Period 2|Protocol Violation|0|||
146962354|NCT01049360|530021586|FG012|Period 2|Protocol Violation|0|||
146962355|NCT01049360|530021587|FG013|Period 2|Protocol Violation|0|||
146962356|NCT01049360|530021588|FG014|Period 2|Protocol Violation|1|||
146962357|NCT01049360|530021589|FG015|Period 2|Protocol Violation|1|||
146962358|NCT01049360|530021590|FG016|Period 2|Protocol Violation|0|||
146962359|NCT01049360|530021591|FG017|Period 2|Protocol Violation|0|||
146962360|NCT01049360|530021592|FG018|Period 2|Protocol Violation|0|||
146962361|NCT01049360|530021593|FG019|Period 2|Protocol Violation|0|||
146962362|NCT01049360|530021574|FG000|Period 2|Adverse Event|0|||
146962363|NCT01049360|530021575|FG001|Period 2|Adverse Event|1|||
146962364|NCT01049360|530021576|FG002|Period 2|Adverse Event|0|||
146962365|NCT01049360|530021577|FG003|Period 2|Adverse Event|0|||
146962366|NCT01049360|530021578|FG004|Period 2|Adverse Event|0|||
146962367|NCT01049360|530021579|FG005|Period 2|Adverse Event|0|||
146962368|NCT01049360|530021580|FG006|Period 2|Adverse Event|0|||
146962369|NCT01049360|530021581|FG007|Period 2|Adverse Event|0|||
146962370|NCT01049360|530021582|FG008|Period 2|Adverse Event|1|||
146962371|NCT01049360|530021583|FG009|Period 2|Adverse Event|0|||
146962372|NCT01049360|530021584|FG010|Period 2|Adverse Event|0|||
146962373|NCT01049360|530021585|FG011|Period 2|Adverse Event|0|||
146962374|NCT01049360|530021586|FG012|Period 2|Adverse Event|0|||
146962375|NCT01049360|530021587|FG013|Period 2|Adverse Event|0|||
146962376|NCT01049360|530021588|FG014|Period 2|Adverse Event|0|||
146962377|NCT01049360|530021589|FG015|Period 2|Adverse Event|0|||
146962378|NCT01049360|530021590|FG016|Period 2|Adverse Event|0|||
146962379|NCT01049360|530021591|FG017|Period 2|Adverse Event|0|||
146962380|NCT01049360|530021592|FG018|Period 2|Adverse Event|0|||
146962381|NCT01049360|530021593|FG019|Period 2|Adverse Event|1|||
146962382|NCT01049360|530021574|FG000|Period 2|Withdrawal by Subject|0|||
146962383|NCT01049360|530021575|FG001|Period 2|Withdrawal by Subject|0|||
146962384|NCT01049360|530021576|FG002|Period 2|Withdrawal by Subject|0|||
146962385|NCT01049360|530021577|FG003|Period 2|Withdrawal by Subject|1|||
146962386|NCT01049360|530021578|FG004|Period 2|Withdrawal by Subject|0|||
146962387|NCT01049360|530021579|FG005|Period 2|Withdrawal by Subject|0|||
146962388|NCT01049360|530021580|FG006|Period 2|Withdrawal by Subject|0|||
146962389|NCT01049360|530021581|FG007|Period 2|Withdrawal by Subject|0|||
147019484|NCT00925301|530230521|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
147019485|NCT00925301|530230522|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
147019486|NCT00925301|530230523|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
147019487|NCT00925301|530230524|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
147019488|NCT03043560|530230525|FG000|Overall Study|Discontinued Intervention|1|||
147019489|NCT03043560|530230526|FG001|Overall Study|Discontinued Intervention|2|||
147019490|NCT03043560|530230525|FG000|Overall Study|Lost to Follow-up|0|||
147019491|NCT03043560|530230526|FG001|Overall Study|Lost to Follow-up|1|||
147019492|NCT01117766|530230527|FG000|First Intervention|Adverse Event|0|||
147019493|NCT01117766|530230528|FG001|First Intervention|Adverse Event|1|||
147019494|NCT01117766|530230527|FG000|First Intervention|Protocol Violation|1|||
147019495|NCT01117766|530230528|FG001|First Intervention|Protocol Violation|0|||
147019496|NCT01117766|530230527|FG000|Washout Period|Protocol Violation|0|||
147019497|NCT01117766|530230528|FG001|Washout Period|Protocol Violation|2|||
147019498|NCT01117766|530230527|FG000|Second Intervention|Lost to Follow-up|1|||
147019499|NCT01117766|530230528|FG001|Second Intervention|Lost to Follow-up|0|||
147019500|NCT01117766|530230527|FG000|Second Intervention|Other|1|||
147019501|NCT01117766|530230528|FG001|Second Intervention|Other|2|||
147019502|NCT01117766|530230527|FG000|Second Intervention|Adverse Event|0|||
147019503|NCT01117766|530230528|FG001|Second Intervention|Adverse Event|2|||
147019504|NCT01117766|530230527|FG000|Second Intervention|Withdrawal by Subject|0|||
147019505|NCT01117766|530230528|FG001|Second Intervention|Withdrawal by Subject|1|||
147019506|NCT04405739|530230529|FG000|Overall Study|Adverse Event|0|||
147019507|NCT04405739|530230530|FG001|Overall Study|Adverse Event|1|||
147019508|NCT04405739|530230531|FG002|Overall Study|Adverse Event|0|||
147019509|NCT04405739|530230532|FG003|Overall Study|Adverse Event|0|||
147019510|NCT04405739|530230529|FG000|Overall Study|Lost to Follow-up|0|||
147019511|NCT04405739|530230530|FG001|Overall Study|Lost to Follow-up|2|||
147019512|NCT04405739|530230531|FG002|Overall Study|Lost to Follow-up|1|||
147019513|NCT04405739|530230532|FG003|Overall Study|Lost to Follow-up|3|||
147019514|NCT04405739|530230529|FG000|Overall Study|Withdrawal by Subject|0|||
147019515|NCT04405739|530230530|FG001|Overall Study|Withdrawal by Subject|2|||
147019516|NCT04405739|530230531|FG002|Overall Study|Withdrawal by Subject|1|||
147019517|NCT04405739|530230532|FG003|Overall Study|Withdrawal by Subject|1|||
147019518|NCT04405739|530230529|FG000|Overall Study|Death|0|||
147019519|NCT04405739|530230530|FG001|Overall Study|Death|0|||
147019520|NCT04405739|530230531|FG002|Overall Study|Death|1|||
147019521|NCT04405739|530230532|FG003|Overall Study|Death|0|||
147019522|NCT04405739|530230529|FG000|Overall Study|Transferred to rehab|0|||
147019523|NCT04405739|530230530|FG001|Overall Study|Transferred to rehab|0|||
147019524|NCT04405739|530230531|FG002|Overall Study|Transferred to rehab|0|||
147019525|NCT04405739|530230532|FG003|Overall Study|Transferred to rehab|1|||
147019526|NCT04405739|530230529|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
147019527|NCT04405739|530230530|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
147019528|NCT04405739|530230531|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
147019529|NCT04405739|530230532|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
147019530|NCT00438659|530230533|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
147019531|NCT00438659|530230534|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
147019532|NCT00438659|530230533|FG000|Overall Study|Cancel|5|||
147019533|NCT00438659|530230534|FG001|Overall Study|Cancel|2|||
147019534|NCT01436643|530230535|FG000|2-week Pre-treatment|Abnormal test result|0|||
147019535|NCT01436643|530230536|FG001|2-week Pre-treatment|Abnormal test result|0|||
147019536|NCT01436643|530230537|FG002|2-week Pre-treatment|Abnormal test result|0|||
147019537|NCT01436643|530230538|FG003|2-week Pre-treatment|Abnormal test result|1|||
147019538|NCT01436643|530230535|FG000|2-week Pre-treatment|Adverse Event|0|||
147019539|NCT01436643|530230536|FG001|2-week Pre-treatment|Adverse Event|0|||
147019540|NCT01436643|530230537|FG002|2-week Pre-treatment|Adverse Event|0|||
147019541|NCT01436643|530230538|FG003|2-week Pre-treatment|Adverse Event|5|||
147019542|NCT01436643|530230535|FG000|2-week Pre-treatment|Protocol Violation|0|||
147019543|NCT01436643|530230536|FG001|2-week Pre-treatment|Protocol Violation|0|||
147019544|NCT01436643|530230537|FG002|2-week Pre-treatment|Protocol Violation|0|||
147019545|NCT01436643|530230538|FG003|2-week Pre-treatment|Protocol Violation|4|||
147019546|NCT01436643|530230535|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
147019547|NCT01436643|530230536|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
147019548|NCT01436643|530230537|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
147019549|NCT01436643|530230538|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
147019550|NCT01436643|530230535|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
147019551|NCT01436643|530230536|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
147019552|NCT01436643|530230537|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
146736554|NCT00895622|529206909|FG000|Overall Study|Protocol Violation|5|||
147019553|NCT01436643|530230538|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
147019554|NCT01436643|530230535|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
147019555|NCT01436643|530230536|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
147019556|NCT01436643|530230537|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
147019557|NCT01436643|530230538|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
147019558|NCT05766787|530230539|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
147019559|NCT05766787|530230540|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
147019560|NCT05766787|530230539|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
147019561|NCT05766787|530230540|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
147019562|NCT05766787|530230539|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
147019563|NCT05766787|530230540|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
147019564|NCT02056652|530230541|FG000|Overall Study|Withdrawal by Subject|1|||
147019565|NCT02056652|530230542|FG001|Overall Study|Withdrawal by Subject|0|||
147019566|NCT02056652|530230541|FG000|Overall Study|Lost to Follow-up|0|||
147019567|NCT02056652|530230542|FG001|Overall Study|Lost to Follow-up|3|||
147019568|NCT01917968|530230543|FG000|Overall Study|Death|3|||
147019569|NCT01917968|530230544|FG001|Overall Study|Death|2|||
147019570|NCT01917968|530230543|FG000|Overall Study|Lost to Follow-up|21|||
147019571|NCT01917968|530230544|FG001|Overall Study|Lost to Follow-up|39|||
147019572|NCT01917968|530230543|FG000|Overall Study|Physician Decision|1|||
147019573|NCT01917968|530230544|FG001|Overall Study|Physician Decision|2|||
147019574|NCT01917968|530230543|FG000|Overall Study|Withdrawal by Subject|20|||
147019575|NCT01917968|530230544|FG001|Overall Study|Withdrawal by Subject|35|||
147019576|NCT01917968|530230543|FG000|Overall Study|Subject Relocation|5|||
147019577|NCT01917968|530230544|FG001|Overall Study|Subject Relocation|1|||
147019578|NCT01917968|530230543|FG000|Overall Study|36M Missed Visit|3|||
147019579|NCT01917968|530230544|FG001|Overall Study|36M Missed Visit|2|||
147019580|NCT01917968|530230543|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
147019581|NCT01917968|530230544|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
147019582|NCT01917968|530230543|FG000|Overall Study|Change in Family Circumstances|0|||
147019583|NCT01917968|530230544|FG001|Overall Study|Change in Family Circumstances|1|||
147019584|NCT01917968|530230543|FG000|Overall Study|No Data Available|0|||
147019585|NCT01917968|530230544|FG001|Overall Study|No Data Available|2|||
147019586|NCT01435928|530230545|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
147019587|NCT01435928|530230546|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
147019588|NCT01435928|530230547|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
147019589|NCT01435928|530230545|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
147019590|NCT01435928|530230546|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
147019591|NCT01435928|530230547|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
147019592|NCT01435928|530230545|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
147019593|NCT01435928|530230546|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
147019594|NCT01435928|530230547|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
147019595|NCT01435928|530230545|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
147019596|NCT01435928|530230546|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
147019597|NCT01435928|530230547|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
147019598|NCT01435928|530230545|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
147019599|NCT01435928|530230546|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
147019600|NCT01435928|530230547|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
147019601|NCT01435928|530230545|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
147019602|NCT01435928|530230546|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
147019603|NCT01435928|530230547|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
147019604|NCT01435928|530230545|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
147019605|NCT01435928|530230546|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
147019606|NCT01435928|530230547|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
147019607|NCT01435928|530230545|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
147019608|NCT01435928|530230546|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
147019609|NCT01435928|530230547|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
147019610|NCT01435928|530230545|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
147019611|NCT01435928|530230546|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
147019612|NCT01435928|530230547|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
147019613|NCT01435928|530230545|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
147019614|NCT01435928|530230546|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
147019615|NCT01435928|530230547|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
147019616|NCT01435928|530230545|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
147019617|NCT01435928|530230546|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
147019618|NCT01435928|530230547|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
147019619|NCT01435928|530230545|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
147019620|NCT01435928|530230546|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
147019621|NCT01435928|530230547|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
147019622|NCT01435928|530230545|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
147019623|NCT01435928|530230546|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
147019624|NCT01435928|530230547|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
147019625|NCT01435928|530230545|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
147019626|NCT01435928|530230546|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
147019627|NCT01435928|530230547|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
147019628|NCT01435928|530230545|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
147019629|NCT01435928|530230546|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
147019630|NCT01435928|530230547|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
147019631|NCT01435928|530230545|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
147019632|NCT01435928|530230546|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
147019633|NCT01435928|530230547|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
147019634|NCT02105701|530230549|FG000|Overall Study|Lost to Follow-up|1|||
147019635|NCT02105701|530230550|FG001|Overall Study|Lost to Follow-up|0|||
147019636|NCT02105701|530230551|FG002|Overall Study|Lost to Follow-up|2|||
147019637|NCT02105701|530230552|FG003|Overall Study|Lost to Follow-up|1|||
147019638|NCT02105701|530230549|FG000|Overall Study|Protocol Violation|0|||
147019639|NCT02105701|530230550|FG001|Overall Study|Protocol Violation|0|||
147019640|NCT02105701|530230551|FG002|Overall Study|Protocol Violation|1|||
147019641|NCT02105701|530230552|FG003|Overall Study|Protocol Violation|0|||
147019642|NCT02105701|530230549|FG000|Overall Study|Withdrawal by Subject|2|||
147019643|NCT02105701|530230550|FG001|Overall Study|Withdrawal by Subject|1|||
147019644|NCT02105701|530230551|FG002|Overall Study|Withdrawal by Subject|0|||
147019645|NCT02105701|530230552|FG003|Overall Study|Withdrawal by Subject|1|||
147019646|NCT02105701|530230549|FG000|Overall Study|Death|1|||
147019647|NCT02105701|530230550|FG001|Overall Study|Death|0|||
147019648|NCT02105701|530230551|FG002|Overall Study|Death|0|||
147019649|NCT02105701|530230552|FG003|Overall Study|Death|0|||
147019650|NCT03234608|530230553|FG000|Overall Study|Lost to Follow-up|23|||
147019651|NCT03234608|530230554|FG001|Overall Study|Lost to Follow-up|21|||
147019652|NCT01362296|530230555|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
147019653|NCT01362296|530230556|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
147019654|NCT01362296|530230557|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
147019655|NCT01362296|530230558|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
147019656|NCT01362296|530230555|FG000|Randomized Phase (RP)|Physician Decision|1|||
147019657|NCT01362296|530230556|FG001|Randomized Phase (RP)|Physician Decision|9|||
147019658|NCT01362296|530230557|FG002|Randomized Phase (RP)|Physician Decision|0|||
147019659|NCT01362296|530230558|FG003|Randomized Phase (RP)|Physician Decision|0|||
147019660|NCT01362296|530230555|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
147019661|NCT01362296|530230556|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
147019662|NCT01362296|530230557|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
147019663|NCT01362296|530230558|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
147019664|NCT01362296|530230555|FG000|Randomized Phase (RP)|Adverse Event|20|||
147019665|NCT01362296|530230556|FG001|Randomized Phase (RP)|Adverse Event|4|||
147019666|NCT01362296|530230557|FG002|Randomized Phase (RP)|Adverse Event|0|||
147019667|NCT01362296|530230558|FG003|Randomized Phase (RP)|Adverse Event|0|||
147019668|NCT01362296|530230555|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
147019669|NCT01362296|530230556|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
147019670|NCT01362296|530230557|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
147019671|NCT01362296|530230558|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
147019672|NCT01362296|530230555|FG000|Crossover Phase|PD including Death due to PD|0|||
147019673|NCT01362296|530230556|FG001|Crossover Phase|PD including Death due to PD|0|||
147019674|NCT01362296|530230557|FG002|Crossover Phase|PD including Death due to PD|16|||
147019675|NCT01362296|530230558|FG003|Crossover Phase|PD including Death due to PD|1|||
147019676|NCT01362296|530230555|FG000|Crossover Phase|Withdrawal by Subject|0|||
147019677|NCT01362296|530230556|FG001|Crossover Phase|Withdrawal by Subject|0|||
147019678|NCT01362296|530230557|FG002|Crossover Phase|Withdrawal by Subject|2|||
147019679|NCT01362296|530230558|FG003|Crossover Phase|Withdrawal by Subject|1|||
147019680|NCT01362296|530230555|FG000|Crossover Phase|Adverse Event|0|||
147019681|NCT01362296|530230556|FG001|Crossover Phase|Adverse Event|0|||
147019682|NCT01362296|530230557|FG002|Crossover Phase|Adverse Event|4|||
147019683|NCT01362296|530230558|FG003|Crossover Phase|Adverse Event|0|||
147019684|NCT01362296|530230555|FG000|Crossover Phase|Study Closed/Terminated|0|||
147019685|NCT01362296|530230556|FG001|Crossover Phase|Study Closed/Terminated|0|||
147019686|NCT01362296|530230557|FG002|Crossover Phase|Study Closed/Terminated|1|||
147019687|NCT01362296|530230558|FG003|Crossover Phase|Study Closed/Terminated|0|||
147019688|NCT03693950|530230559|FG000|Overall Study|Withdrawal by Subject|1|||
147019689|NCT03693950|530230560|FG001|Overall Study|Withdrawal by Subject|0|||
147019690|NCT00248170|530230561|FG000|Overall Study|Withdrawal by Subject|71|||
147019691|NCT00248170|530230562|FG001|Overall Study|Withdrawal by Subject|79|||
147019692|NCT00248170|530230561|FG000|Overall Study|Protocol Violation|35|||
146736555|NCT00895622|529206910|FG001|Overall Study|Protocol Violation|4|||
146736556|NCT00895622|529206911|FG002|Overall Study|Protocol Violation|4|||
147019693|NCT00248170|530230562|FG001|Overall Study|Protocol Violation|30|||
147019694|NCT00248170|530230561|FG000|Overall Study|Lost to Follow-up|28|||
147019695|NCT00248170|530230562|FG001|Overall Study|Lost to Follow-up|35|||
147019696|NCT00248170|530230561|FG000|Overall Study|Disease progression|196|||
147019697|NCT00248170|530230562|FG001|Overall Study|Disease progression|216|||
147019698|NCT00248170|530230561|FG000|Overall Study|Death|28|||
147019699|NCT00248170|530230562|FG001|Overall Study|Death|47|||
147019700|NCT00248170|530230561|FG000|Overall Study|Adverse Event|311|||
147019701|NCT00248170|530230562|FG001|Overall Study|Adverse Event|296|||
147019702|NCT00248170|530230561|FG000|Overall Study|Administrative problems|22|||
147019703|NCT00248170|530230562|FG001|Overall Study|Administrative problems|25|||
147019704|NCT00248170|530230561|FG000|Overall Study|Abnormal test procedure(s) result|49|||
147019705|NCT00248170|530230562|FG001|Overall Study|Abnormal test procedure(s) result|61|||
147019706|NCT00248170|530230561|FG000|Overall Study|Abnormal laboratory values|4|||
147019707|NCT00248170|530230562|FG001|Overall Study|Abnormal laboratory values|0|||
147019708|NCT00248170|530230561|FG000|Overall Study|Protocol deviation|17|||
147019709|NCT00248170|530230562|FG001|Overall Study|Protocol deviation|19|||
147019710|NCT03123783|530230563|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
147019711|NCT03123783|530230564|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
147019712|NCT03123783|530230565|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
147019713|NCT03123783|530230566|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
147019714|NCT03123783|530230567|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
147019715|NCT03123783|530230568|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
147019716|NCT03123783|530230569|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
147019717|NCT03123783|530230563|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
147019718|NCT03123783|530230564|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
147019719|NCT03123783|530230565|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
147019720|NCT03123783|530230566|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
147019721|NCT03123783|530230567|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
147019722|NCT03123783|530230568|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
147019723|NCT03123783|530230569|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
147019724|NCT03123783|530230563|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
147019725|NCT03123783|530230564|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
147019726|NCT03123783|530230565|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
147019727|NCT03123783|530230566|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
147019728|NCT03123783|530230567|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
147019729|NCT03123783|530230568|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
147019730|NCT03123783|530230569|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
147019731|NCT03123783|530230563|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
146962390|NCT01049360|530021582|FG008|Period 2|Withdrawal by Subject|0|||
146962391|NCT01049360|530021583|FG009|Period 2|Withdrawal by Subject|0|||
146962392|NCT01049360|530021584|FG010|Period 2|Withdrawal by Subject|0|||
146962393|NCT01049360|530021585|FG011|Period 2|Withdrawal by Subject|0|||
146962394|NCT01049360|530021586|FG012|Period 2|Withdrawal by Subject|0|||
146962395|NCT01049360|530021587|FG013|Period 2|Withdrawal by Subject|0|||
146962396|NCT01049360|530021588|FG014|Period 2|Withdrawal by Subject|1|||
146962397|NCT01049360|530021589|FG015|Period 2|Withdrawal by Subject|0|||
146962398|NCT01049360|530021590|FG016|Period 2|Withdrawal by Subject|0|||
146962399|NCT01049360|530021591|FG017|Period 2|Withdrawal by Subject|0|||
146962400|NCT01049360|530021592|FG018|Period 2|Withdrawal by Subject|0|||
146962401|NCT01049360|530021593|FG019|Period 2|Withdrawal by Subject|1|||
146962402|NCT01049360|530021574|FG000|Period 2|Lack of Efficacy|0|||
146962403|NCT01049360|530021575|FG001|Period 2|Lack of Efficacy|0|||
146962404|NCT01049360|530021576|FG002|Period 2|Lack of Efficacy|0|||
146962405|NCT01049360|530021577|FG003|Period 2|Lack of Efficacy|0|||
146962406|NCT01049360|530021578|FG004|Period 2|Lack of Efficacy|0|||
146962407|NCT01049360|530021579|FG005|Period 2|Lack of Efficacy|1|||
146962408|NCT01049360|530021580|FG006|Period 2|Lack of Efficacy|0|||
146962409|NCT01049360|530021581|FG007|Period 2|Lack of Efficacy|0|||
146962410|NCT01049360|530021582|FG008|Period 2|Lack of Efficacy|0|||
146962411|NCT01049360|530021583|FG009|Period 2|Lack of Efficacy|0|||
146962412|NCT01049360|530021584|FG010|Period 2|Lack of Efficacy|0|||
146962413|NCT01049360|530021585|FG011|Period 2|Lack of Efficacy|0|||
146962414|NCT01049360|530021586|FG012|Period 2|Lack of Efficacy|0|||
146962415|NCT01049360|530021587|FG013|Period 2|Lack of Efficacy|0|||
146962416|NCT01049360|530021588|FG014|Period 2|Lack of Efficacy|0|||
146962417|NCT01049360|530021589|FG015|Period 2|Lack of Efficacy|0|||
146962418|NCT01049360|530021590|FG016|Period 2|Lack of Efficacy|0|||
146962419|NCT01049360|530021591|FG017|Period 2|Lack of Efficacy|0|||
147019732|NCT03123783|530230564|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
147019733|NCT03123783|530230565|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
147019734|NCT03123783|530230566|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
147019735|NCT03123783|530230567|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
147019736|NCT03123783|530230568|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
147019737|NCT03123783|530230569|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
147019738|NCT00749411|530230570|FG000|Overall Study|Adverse Event|0|||
147019739|NCT00749411|530230571|FG001|Overall Study|Adverse Event|2|||
146962420|NCT01049360|530021592|FG018|Period 2|Lack of Efficacy|0|||
146962421|NCT01049360|530021593|FG019|Period 2|Lack of Efficacy|0|||
146962422|NCT01049360|530021574|FG000|Period 4|Protocol Violation|0|||
147019740|NCT00749411|530230570|FG000|Overall Study|Lack of Efficacy|0|||
147019741|NCT00749411|530230571|FG001|Overall Study|Lack of Efficacy|1|||
147019742|NCT00749411|530230570|FG000|Overall Study|Protocol Violation|1|||
147019743|NCT00749411|530230571|FG001|Overall Study|Protocol Violation|1|||
147019744|NCT00749411|530230570|FG000|Overall Study|Protocol-defined stopping criteria|0|||
147019745|NCT00749411|530230571|FG001|Overall Study|Protocol-defined stopping criteria|1|||
147019746|NCT00880087|530232974|FG000|Overall Study|Lost to Follow-up|0|||
147019747|NCT00880087|530232975|FG001|Overall Study|Lost to Follow-up|2|||
147019748|NCT01005329|530232979|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
147019749|NCT00126126|530232982|FG000|Overall Study|Lost to Follow-up|0|||
147019750|NCT00126126|530232983|FG001|Overall Study|Lost to Follow-up|2|||
147019751|NCT00986570|530232987|FG000|Overall Study|Lost to Follow-up|6|||
147019752|NCT00986570|530232987|FG000|Overall Study|Potential bias for objective assessment|1|||
147019753|NCT02225665|530232988|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
147019754|NCT02225665|530232989|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
147019755|NCT02225665|530232988|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
147019756|NCT02225665|530232989|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
147019757|NCT01470417|530232992|FG000|Overall Study|Disease progression|0|||
147019758|NCT01470417|530232993|FG001|Overall Study|Disease progression|2|||
147019759|NCT02973321|530232996|FG000|Overall Study|Other than specified|0|||
147019760|NCT02973321|530232997|FG001|Overall Study|Other than specified|5|||
147019761|NCT02973321|530232998|FG002|Overall Study|Other than specified|3|||
147019762|NCT02973321|530232999|FG003|Overall Study|Other than specified|3|||
147019763|NCT02973321|530233000|FG004|Overall Study|Other than specified|1|||
147019764|NCT02973321|530232996|FG000|Overall Study|Lack of Efficacy|0|||
147019765|NCT02973321|530232997|FG001|Overall Study|Lack of Efficacy|0|||
147019766|NCT02973321|530232998|FG002|Overall Study|Lack of Efficacy|0|||
147019767|NCT02973321|530232999|FG003|Overall Study|Lack of Efficacy|0|||
147019768|NCT02973321|530233000|FG004|Overall Study|Lack of Efficacy|1|||
147019769|NCT02973321|530232996|FG000|Overall Study|Adverse Event|1|||
147019770|NCT02973321|530232997|FG001|Overall Study|Adverse Event|10|||
147019771|NCT02973321|530232998|FG002|Overall Study|Adverse Event|11|||
147019772|NCT02973321|530232999|FG003|Overall Study|Adverse Event|13|||
147019773|NCT02973321|530233000|FG004|Overall Study|Adverse Event|3|||
147019774|NCT01098110|530233002|FG000|Overall Study|Withdrawal by Subject|14|||
147019775|NCT01098110|530233003|FG001|Overall Study|Withdrawal by Subject|24|||
147019776|NCT01098110|530233004|FG002|Overall Study|Withdrawal by Subject|19|||
147019777|NCT01098110|530233002|FG000|Overall Study|Adverse Event|30|||
147019778|NCT01098110|530233003|FG001|Overall Study|Adverse Event|32|||
147019779|NCT01098110|530233004|FG002|Overall Study|Adverse Event|43|||
147019780|NCT01098110|530233002|FG000|Overall Study|Lack of Efficacy|13|||
147019781|NCT01098110|530233003|FG001|Overall Study|Lack of Efficacy|9|||
147019782|NCT01098110|530233004|FG002|Overall Study|Lack of Efficacy|27|||
147019783|NCT01098110|530233002|FG000|Overall Study|Other|4|||
147019784|NCT01098110|530233003|FG001|Overall Study|Other|7|||
147019785|NCT01098110|530233004|FG002|Overall Study|Other|5|||
147019786|NCT01098110|530233002|FG000|Overall Study|Untreated|1|||
147019787|NCT01098110|530233003|FG001|Overall Study|Untreated|1|||
147019788|NCT01098110|530233004|FG002|Overall Study|Untreated|0|||
147019789|NCT00865514|530233005|FG000|Overall Study|Infusion cost exceeded funding|2|||
147019790|NCT03649412|530233006|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
147019791|NCT03649412|530233007|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
147019792|NCT03649412|530233006|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
147019793|NCT03649412|530233007|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
147019794|NCT03649412|530233006|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
147019795|NCT03649412|530233007|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
147019796|NCT03649412|530233006|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
147019797|NCT03649412|530233007|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
147019798|NCT03649412|530233006|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
147019799|NCT03649412|530233007|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
147019800|NCT03649412|530233006|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
147019801|NCT03649412|530233007|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
147019802|NCT02865395|530233008|FG000|Overall Study|Physician Decision|6|||
147019803|NCT02865395|530233009|FG001|Overall Study|Physician Decision|10|||
147019804|NCT02865395|530233010|FG002|Overall Study|Physician Decision|7|||
147019805|NCT00530348|530233011|FG000|Overall Study|Adverse Event|5|||
147019806|NCT00530348|530233012|FG001|Overall Study|Adverse Event|1|||
147019807|NCT00530348|530233011|FG000|Overall Study|Death|0|||
147019808|NCT00530348|530233012|FG001|Overall Study|Death|1|||
147019809|NCT00530348|530233011|FG000|Overall Study|Lack of Efficacy|2|||
147019810|NCT00530348|530233012|FG001|Overall Study|Lack of Efficacy|0|||
147019811|NCT00530348|530233011|FG000|Overall Study|Lost to Follow-up|0|||
147019812|NCT00530348|530233012|FG001|Overall Study|Lost to Follow-up|2|||
147019813|NCT00530348|530233011|FG000|Overall Study|Physician Decision|1|||
147019814|NCT00530348|530233012|FG001|Overall Study|Physician Decision|2|||
147019815|NCT00530348|530233011|FG000|Overall Study|Pregnancy|1|||
147019816|NCT00530348|530233012|FG001|Overall Study|Pregnancy|0|||
147019817|NCT00530348|530233011|FG000|Overall Study|Withdrawal by Subject|12|||
147019818|NCT00530348|530233012|FG001|Overall Study|Withdrawal by Subject|12|||
147019819|NCT00530348|530233011|FG000|Overall Study|Randomised in error|1|||
147019820|NCT00530348|530233012|FG001|Overall Study|Randomised in error|0|||
147019821|NCT00530348|530233011|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
147019822|NCT00530348|530233012|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
147019823|NCT03920280|530233013|FG000|Overall Study|Adverse Event|2|||
147019824|NCT03920280|530233014|FG001|Overall Study|Adverse Event|3|||
147019825|NCT03920280|530233013|FG000|Overall Study|Lost to Follow-up|0|||
147019826|NCT03920280|530233014|FG001|Overall Study|Lost to Follow-up|1|||
147019827|NCT03920280|530233013|FG000|Overall Study|Withdrawal by Subject|1|||
147019828|NCT03920280|530233014|FG001|Overall Study|Withdrawal by Subject|1|||
147019829|NCT03920280|530233013|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
147019830|NCT03920280|530233014|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
147019831|NCT01009515|530233022|FG000|Overall Study|Withdrawal by Subject|3|||
147019832|NCT01501110|530233024|FG000|Overall Study|Death|0|||
147019833|NCT01501110|530233025|FG001|Overall Study|Death|1|||
147019834|NCT01040793|530233034|FG000|Overall Study|Adverse Event|5|||
147019835|NCT01040793|530233035|FG001|Overall Study|Adverse Event|3|||
147019836|NCT01040793|530233036|FG002|Overall Study|Adverse Event|0|||
147019837|NCT01040793|530233037|FG003|Overall Study|Adverse Event|2|||
147019838|NCT01040793|530233038|FG004|Overall Study|Adverse Event|2|||
147019839|NCT01040793|530233039|FG005|Overall Study|Adverse Event|1|||
147019840|NCT01040793|530233034|FG000|Overall Study|Protocol Violation|1|||
147019841|NCT01040793|530233035|FG001|Overall Study|Protocol Violation|1|||
147019842|NCT01040793|530233036|FG002|Overall Study|Protocol Violation|1|||
147019843|NCT01040793|530233037|FG003|Overall Study|Protocol Violation|0|||
147019844|NCT01040793|530233038|FG004|Overall Study|Protocol Violation|1|||
147019845|NCT01040793|530233039|FG005|Overall Study|Protocol Violation|0|||
147019846|NCT01040793|530233034|FG000|Overall Study|Lost to Follow-up|0|||
147019847|NCT01040793|530233035|FG001|Overall Study|Lost to Follow-up|1|||
147019848|NCT01040793|530233036|FG002|Overall Study|Lost to Follow-up|1|||
147019849|NCT01040793|530233037|FG003|Overall Study|Lost to Follow-up|0|||
147019850|NCT01040793|530233038|FG004|Overall Study|Lost to Follow-up|0|||
147019851|NCT01040793|530233039|FG005|Overall Study|Lost to Follow-up|0|||
147019852|NCT01040793|530233034|FG000|Overall Study|Withdrawal by Subject|0|||
147019853|NCT01040793|530233035|FG001|Overall Study|Withdrawal by Subject|0|||
147019854|NCT01040793|530233036|FG002|Overall Study|Withdrawal by Subject|0|||
147019855|NCT01040793|530233037|FG003|Overall Study|Withdrawal by Subject|2|||
147019856|NCT01040793|530233038|FG004|Overall Study|Withdrawal by Subject|0|||
147019857|NCT01040793|530233039|FG005|Overall Study|Withdrawal by Subject|0|||
147019858|NCT01040793|530233034|FG000|Overall Study|Other reasons not listed above|0|||
147019859|NCT01040793|530233035|FG001|Overall Study|Other reasons not listed above|0|||
147019860|NCT01040793|530233036|FG002|Overall Study|Other reasons not listed above|1|||
147019861|NCT01040793|530233037|FG003|Overall Study|Other reasons not listed above|0|||
147019862|NCT01040793|530233038|FG004|Overall Study|Other reasons not listed above|1|||
147019863|NCT01040793|530233039|FG005|Overall Study|Other reasons not listed above|0|||
147019864|NCT03573817|530233041|FG000|Overall Study|Adverse Event|0|||
147019865|NCT03573817|530233042|FG001|Overall Study|Adverse Event|2|||
147019866|NCT03573817|530233041|FG000|Overall Study|Protocol Violation|0|||
147019867|NCT03573817|530233042|FG001|Overall Study|Protocol Violation|1|||
147019868|NCT03573817|530233041|FG000|Overall Study|Withdrawal by Subject|1|||
147019869|NCT03573817|530233042|FG001|Overall Study|Withdrawal by Subject|1|||
147019870|NCT03554317|530233043|FG000|Overall Study|Withdrawal by Subject|1|||
147019871|NCT03554317|530233043|FG000|Overall Study|PSA Progression|3|||
147019872|NCT03554317|530233043|FG000|Overall Study|Radiographic Progression|4|||
147019873|NCT00612677|530233046|FG000|Overall Study|study closed before treatment started|1|||
147019874|NCT00860743|530233047|FG000|Overall Study|Withdrawal by Subject|3|||
147019875|NCT00860743|530233048|FG001|Overall Study|Withdrawal by Subject|0|||
147019876|NCT00823199|530233049|FG000|Overall Study|Withdrawal by Subject|2|||
147019877|NCT01640184|530233054|FG000|Overall Study|Death|1|||
147019878|NCT01640184|530233055|FG001|Overall Study|Death|0|||
147019879|NCT01640184|530233056|FG002|Overall Study|Death|0|||
147019880|NCT01640184|530233054|FG000|Overall Study|Lost to Follow-up|4|||
147019881|NCT01640184|530233055|FG001|Overall Study|Lost to Follow-up|1|||
147019882|NCT01640184|530233056|FG002|Overall Study|Lost to Follow-up|0|||
146849165|NCT01081132|529617052|FG000|Overall Study|Withdrawal by Subject|13|||
147019883|NCT01640184|530233054|FG000|Overall Study|Physician Decision|3|||
147019884|NCT01640184|530233055|FG001|Overall Study|Physician Decision|0|||
147019885|NCT01640184|530233056|FG002|Overall Study|Physician Decision|0|||
147019886|NCT01640184|530233054|FG000|Overall Study|Withdrawal by Subject|0|||
147019887|NCT01640184|530233055|FG001|Overall Study|Withdrawal by Subject|1|||
147019888|NCT01640184|530233056|FG002|Overall Study|Withdrawal by Subject|1|||
147019889|NCT01640184|530233054|FG000|Overall Study|Protocol Violation|0|||
147019890|NCT01640184|530233055|FG001|Overall Study|Protocol Violation|0|||
147019891|NCT01640184|530233056|FG002|Overall Study|Protocol Violation|1|||
147019892|NCT01684878|530233060|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
146962423|NCT01049360|530021575|FG001|Period 4|Protocol Violation|0|||
146962424|NCT01049360|530021576|FG002|Period 4|Protocol Violation|0|||
146962425|NCT01049360|530021577|FG003|Period 4|Protocol Violation|0|||
146962426|NCT01049360|530021578|FG004|Period 4|Protocol Violation|0|||
146962427|NCT01049360|530021579|FG005|Period 4|Protocol Violation|0|||
146962428|NCT01049360|530021580|FG006|Period 4|Protocol Violation|0|||
146962429|NCT01049360|530021581|FG007|Period 4|Protocol Violation|0|||
146962430|NCT01049360|530021582|FG008|Period 4|Protocol Violation|0|||
146962431|NCT01049360|530021583|FG009|Period 4|Protocol Violation|0|||
146962432|NCT01049360|530021584|FG010|Period 4|Protocol Violation|0|||
146962433|NCT01049360|530021585|FG011|Period 4|Protocol Violation|0|||
146962434|NCT01049360|530021586|FG012|Period 4|Protocol Violation|0|||
146962435|NCT01049360|530021587|FG013|Period 4|Protocol Violation|0|||
146962436|NCT01049360|530021588|FG014|Period 4|Protocol Violation|0|||
146962437|NCT01049360|530021589|FG015|Period 4|Protocol Violation|0|||
146962438|NCT01049360|530021590|FG016|Period 4|Protocol Violation|0|||
146962439|NCT01049360|530021591|FG017|Period 4|Protocol Violation|1|||
146962440|NCT01049360|530021592|FG018|Period 4|Protocol Violation|0|||
146962441|NCT01049360|530021593|FG019|Period 4|Protocol Violation|0|||
146962442|NCT01049360|530021574|FG000|Period 4|Withdrawal by Subject|0|||
146962443|NCT01049360|530021575|FG001|Period 4|Withdrawal by Subject|0|||
146962444|NCT01049360|530021576|FG002|Period 4|Withdrawal by Subject|0|||
146962445|NCT01049360|530021577|FG003|Period 4|Withdrawal by Subject|1|||
146962446|NCT01049360|530021578|FG004|Period 4|Withdrawal by Subject|0|||
146962447|NCT01049360|530021579|FG005|Period 4|Withdrawal by Subject|0|||
146962448|NCT01049360|530021580|FG006|Period 4|Withdrawal by Subject|0|||
146962449|NCT01049360|530021581|FG007|Period 4|Withdrawal by Subject|0|||
146962450|NCT01049360|530021582|FG008|Period 4|Withdrawal by Subject|0|||
146962451|NCT01049360|530021583|FG009|Period 4|Withdrawal by Subject|0|||
146962452|NCT01049360|530021584|FG010|Period 4|Withdrawal by Subject|0|||
146962453|NCT01049360|530021585|FG011|Period 4|Withdrawal by Subject|0|||
146962454|NCT01049360|530021586|FG012|Period 4|Withdrawal by Subject|0|||
146962455|NCT01049360|530021587|FG013|Period 4|Withdrawal by Subject|0|||
146962456|NCT01049360|530021588|FG014|Period 4|Withdrawal by Subject|0|||
146962457|NCT01049360|530021589|FG015|Period 4|Withdrawal by Subject|0|||
146962458|NCT01049360|530021590|FG016|Period 4|Withdrawal by Subject|0|||
146962459|NCT01049360|530021591|FG017|Period 4|Withdrawal by Subject|0|||
146962460|NCT01049360|530021592|FG018|Period 4|Withdrawal by Subject|0|||
146962461|NCT01049360|530021593|FG019|Period 4|Withdrawal by Subject|0|||
146962462|NCT00429026|530021594|FG000|Overall Study|Inevaluable for response.|40|||
146962463|NCT00903357|530021597|FG000|First Intervention|Withdrawal by Subject|5|||
146962464|NCT00903357|530021598|FG001|First Intervention|Withdrawal by Subject|3|||
146962465|NCT00903357|530021597|FG000|First Intervention|Flu|0|||
146962466|NCT00903357|530021598|FG001|First Intervention|Flu|1|||
146962467|NCT00903357|530021597|FG000|Wash Out Period of 2 Weeks|Flu|0|||
146962468|NCT00903357|530021598|FG001|Wash Out Period of 2 Weeks|Flu|1|||
146962469|NCT00903357|530021597|FG000|Second Intervention|Lost to Follow-up|1|||
146962470|NCT00903357|530021598|FG001|Second Intervention|Lost to Follow-up|0|||
146962471|NCT00678652|530021601|FG000|Overall Study|Protocol Violation|2|||
146962472|NCT00678652|530021602|FG001|Overall Study|Protocol Violation|0|||
146962473|NCT00678652|530021603|FG002|Overall Study|Protocol Violation|0|||
146962474|NCT00678652|530021604|FG003|Overall Study|Protocol Violation|0|||
146962475|NCT00678652|530021601|FG000|Overall Study|Pregnancy|0|||
146962476|NCT00678652|530021602|FG001|Overall Study|Pregnancy|0|||
146962477|NCT00678652|530021603|FG002|Overall Study|Pregnancy|1|||
146962478|NCT00678652|530021604|FG003|Overall Study|Pregnancy|0|||
146962479|NCT00678652|530021601|FG000|Overall Study|Relocation|1|||
146962480|NCT00678652|530021602|FG001|Overall Study|Relocation|0|||
146962481|NCT00678652|530021603|FG002|Overall Study|Relocation|0|||
146962482|NCT00678652|530021604|FG003|Overall Study|Relocation|0|||
146962483|NCT03958045|530021607|FG000|Overall Study|Withdrawal by Subject|1|||
146962484|NCT00674440|530021608|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
146962485|NCT00674440|530021608|FG000|Overall Study|did not have surgery, so unevaluable|7|||
146962486|NCT00674440|530021608|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
146962487|NCT04095039|530021609|FG000|Overall Study|Withdrawal by Subject|2|||
146962488|NCT04095039|530021610|FG001|Overall Study|Withdrawal by Subject|16|||
146962489|NCT04095039|530021609|FG000|Overall Study|Transplanted|21|||
146962490|NCT04095039|530021610|FG001|Overall Study|Transplanted|24|||
146962491|NCT04095039|530021609|FG000|Overall Study|Transferred to Non-study Facility|47|||
146962492|NCT04095039|530021610|FG001|Overall Study|Transferred to Non-study Facility|44|||
146962493|NCT04095039|530021609|FG000|Overall Study|Withdrawal from internvention target|0|||
146962494|NCT04095039|530021610|FG001|Overall Study|Withdrawal from internvention target|2|||
146962495|NCT04095039|530021609|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
146962496|NCT04095039|530021610|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
146962497|NCT04095039|530021609|FG000|Overall Study|Cacliphylaxis|0|||
147019893|NCT01684878|530233061|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
147019894|NCT01684878|530233062|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
147019895|NCT01684878|530233063|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
147019896|NCT01684878|530233060|FG000|Part 1: Safety Run in Phase|Death|15|||
147019897|NCT01684878|530233061|FG001|Part 1: Safety Run in Phase|Death|20|||
147019898|NCT01684878|530233062|FG002|Part 1: Safety Run in Phase|Death|0|||
147019899|NCT01684878|530233063|FG003|Part 1: Safety Run in Phase|Death|0|||
147019900|NCT01684878|530233060|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
147019901|NCT01684878|530233061|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
147019902|NCT01684878|530233062|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
147019903|NCT01684878|530233063|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
147019904|NCT01684878|530233060|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
147019905|NCT01684878|530233061|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
147019906|NCT01684878|530233062|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
147019907|NCT01684878|530233063|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
147019908|NCT01684878|530233060|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
147019909|NCT01684878|530233061|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
147019910|NCT01684878|530233062|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
147019911|NCT01684878|530233063|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
147019912|NCT01684878|530233060|FG000|Part 2: Randomized Phase|Death|0|||
147019913|NCT01684878|530233061|FG001|Part 2: Randomized Phase|Death|0|||
147019914|NCT01684878|530233062|FG002|Part 2: Randomized Phase|Death|62|||
147019915|NCT01684878|530233063|FG003|Part 2: Randomized Phase|Death|68|||
147019916|NCT01684878|530233060|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
147019917|NCT01684878|530233061|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
147019918|NCT01684878|530233062|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
147019919|NCT01684878|530233063|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
147019920|NCT01684878|530233060|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
147019921|NCT01684878|530233061|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
147019922|NCT01684878|530233062|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
147019923|NCT01684878|530233063|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
147019924|NCT01435031|530233064|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
147019925|NCT01435031|530233064|FG000|ITT at 1 Month|Death|1|||
147019926|NCT01435031|530233064|FG000|ITT at 1 Month|Lost to Follow-up|4|||
147019927|NCT01435031|530233064|FG000|ITT at 6 Months|Death|2|||
147019928|NCT01435031|530233064|FG000|ITT at 6 Months|Lost to Follow-up|3|||
147019929|NCT01435031|530233064|FG000|ITT at 1 Year|Death|1|||
147019930|NCT01435031|530233064|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
147019931|NCT01435031|530233064|FG000|ITT at 1 Year|Lost to Follow-up|6|||
147019932|NCT01435031|530233064|FG000|ITT at 2 Years|Death|7|||
147019933|NCT01435031|530233064|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
147019934|NCT01435031|530233064|FG000|ITT at 2 Years|Lost to Follow-up|4|||
147019935|NCT01435031|530233064|FG000|ITT at 3 Years|Death|5|||
147019936|NCT01435031|530233064|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
147019937|NCT01435031|530233064|FG000|ITT at 3 Years|Lost to Follow-up|4|||
147019938|NCT01435031|530233064|FG000|ITT at 4 Years|Death|4|||
147019939|NCT01435031|530233064|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
147019940|NCT01435031|530233064|FG000|ITT at 4 Years|Lost to Follow-up|1|||
147019941|NCT02927834|530233065|FG000|Overall Study|Lost to Follow-up|1|||
147019942|NCT02927834|530233066|FG001|Overall Study|Lost to Follow-up|2|||
147019943|NCT02927834|530233067|FG002|Overall Study|Lost to Follow-up|2|||
147019944|NCT00613730|530233071|FG000|Overall Study|Disease progression|2|||
146849166|NCT01081132|529617053|FG001|Overall Study|Withdrawal by Subject|16|||
146849167|NCT01081132|529617052|FG000|Overall Study|Lost to Follow-up|4|||
146849168|NCT01081132|529617053|FG001|Overall Study|Lost to Follow-up|11|||
146849169|NCT01081132|529617052|FG000|Overall Study|Adverse Event|3|||
146849170|NCT01081132|529617053|FG001|Overall Study|Adverse Event|9|||
146849171|NCT01081132|529617052|FG000|Overall Study|Non Compliance|4|||
146849172|NCT01081132|529617053|FG001|Overall Study|Non Compliance|2|||
146849173|NCT01081132|529617052|FG000|Overall Study|Lack Of Compliance|0|||
146849174|NCT01081132|529617053|FG001|Overall Study|Lack Of Compliance|1|||
146849175|NCT01081132|529617052|FG000|Overall Study|Missed Visits|1|||
146849176|NCT01081132|529617053|FG001|Overall Study|Missed Visits|1|||
146849177|NCT01081132|529617052|FG000|Overall Study|Stopped Taking Meds|2|||
146849178|NCT01081132|529617053|FG001|Overall Study|Stopped Taking Meds|0|||
146849179|NCT01081132|529617052|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
146849180|NCT01081132|529617053|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
146849181|NCT01081132|529617052|FG000|Overall Study|Declined Taper Phase|0|||
146849182|NCT01081132|529617053|FG001|Overall Study|Declined Taper Phase|1|||
146849183|NCT01081132|529617052|FG000|Overall Study|Protocol Violation|3|||
146849184|NCT01081132|529617053|FG001|Overall Study|Protocol Violation|1|||
147019945|NCT00613730|530233071|FG000|Overall Study|Administrative decision|1|||
147019946|NCT00479388|530233072|FG000|Overall Study|Adverse Event|90|||
147019947|NCT00479388|530233073|FG001|Overall Study|Adverse Event|45|||
147019948|NCT00479388|530233072|FG000|Overall Study|Lost to Follow-up|0|||
147019949|NCT00479388|530233073|FG001|Overall Study|Lost to Follow-up|2|||
147019950|NCT00479388|530233072|FG000|Overall Study|Protocol Violation|10|||
147019951|NCT00479388|530233073|FG001|Overall Study|Protocol Violation|9|||
147019952|NCT00479388|530233072|FG000|Overall Study|Withdrawal by Subject|32|||
147019953|NCT00479388|530233073|FG001|Overall Study|Withdrawal by Subject|17|||
147019954|NCT01876368|530233076|FG000|Overall Study|Adverse Event|2|||
147019955|NCT01876368|530233077|FG001|Overall Study|Adverse Event|5|||
146849185|NCT02297139|529617054|FG000|Overall Study|Disease progression|0|||
146849186|NCT02297139|529617055|FG001|Overall Study|Disease progression|1|||
146849187|NCT02297139|529617054|FG000|Overall Study|Study drug toxicity|0|||
146849188|NCT02297139|529617055|FG001|Overall Study|Study drug toxicity|4|||
146849189|NCT02297139|529617054|FG000|Overall Study|Participant request to discontinue study treatment|0|||
147019956|NCT01876368|530233076|FG000|Overall Study|Lack of Efficacy|1|||
147019957|NCT01876368|530233077|FG001|Overall Study|Lack of Efficacy|0|||
147019958|NCT01876368|530233076|FG000|Overall Study|Lost to Follow-up|0|||
147019959|NCT01876368|530233077|FG001|Overall Study|Lost to Follow-up|1|||
147019960|NCT01876368|530233076|FG000|Overall Study|Non-compliance with study treatment|0|||
147019961|NCT01876368|530233077|FG001|Overall Study|Non-compliance with study treatment|1|||
147019962|NCT01876368|530233076|FG000|Overall Study|Physician Decision|0|||
147019963|NCT01876368|530233077|FG001|Overall Study|Physician Decision|2|||
147019964|NCT01876368|530233076|FG000|Overall Study|Protocol deviation|3|||
147019965|NCT01876368|530233077|FG001|Overall Study|Protocol deviation|3|||
147019966|NCT01876368|530233076|FG000|Overall Study|Subject/guardian decision|3|||
147019967|NCT01876368|530233077|FG001|Overall Study|Subject/guardian decision|1|||
147019968|NCT02563769|530233078|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
147019969|NCT02563769|530233079|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
147019970|NCT02563769|530233080|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
147019971|NCT01644149|530233085|FG000|Overall Study|Withdrawal by Subject|1|||
147019972|NCT01644149|530233086|FG001|Overall Study|Withdrawal by Subject|0|||
147019973|NCT01644149|530233085|FG000|Overall Study|Lost to Follow-up|3|||
147019974|NCT01644149|530233086|FG001|Overall Study|Lost to Follow-up|1|||
147019975|NCT00104247|530233087|FG000|Overall Study|Withdrawal by Subject|1|||
147019976|NCT00104247|530233088|FG001|Overall Study|Withdrawal by Subject|0|||
147019977|NCT00104247|530233087|FG000|Overall Study|Noncompliant with dosing|0|||
147019978|NCT00104247|530233088|FG001|Overall Study|Noncompliant with dosing|1|||
147019979|NCT04798482|530233089|FG000|Overall Study|Physician Decision|1|||
147019980|NCT04798482|530233089|FG000|Overall Study|Lost eligibility|1|||
147019981|NCT01930175|530233097|FG000|Core Study|Lost to Follow-up|0|||
147019982|NCT01930175|530233098|FG001|Core Study|Lost to Follow-up|1|||
147019983|NCT01930175|530233099|FG002|Core Study|Lost to Follow-up|0|||
147019984|NCT01930175|530233097|FG000|Core Study|Adverse Event|0|||
147019985|NCT01930175|530233098|FG001|Core Study|Adverse Event|0|||
147019986|NCT01930175|530233099|FG002|Core Study|Adverse Event|1|||
147019987|NCT00605917|530233100|FG000|Overall Study|Protocol Violation|79|||
147019988|NCT00890552|530233101|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
147019989|NCT00890552|530233101|FG000|On-treatment|Early prog disease/ death|10|||
147019990|NCT03718117|530233104|FG000|Overall Study|Death|12|||
147019991|NCT03718117|530233105|FG001|Overall Study|Death|11|||
147019992|NCT03718117|530233106|FG002|Overall Study|Death|0|||
147019993|NCT03718117|530233104|FG000|Overall Study|Other|0|||
147019994|NCT03718117|530233105|FG001|Overall Study|Other|1|||
147019995|NCT03718117|530233106|FG002|Overall Study|Other|0|||
147019996|NCT03718117|530233104|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
147019997|NCT03718117|530233105|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
147019998|NCT03718117|530233106|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
147019999|NCT03718117|530233104|FG000|Overall Study|Participant not met eligibility criteria|0|||
147020000|NCT03718117|530233105|FG001|Overall Study|Participant not met eligibility criteria|0|||
147020001|NCT03718117|530233106|FG002|Overall Study|Participant not met eligibility criteria|2|||
147020002|NCT01382251|530233107|FG000|Overall Study|Surgeries cancelled or delayed|16|||
147020003|NCT01382251|530233108|FG001|Overall Study|Surgeries cancelled or delayed|16|||
147020004|NCT01382251|530233107|FG000|Overall Study|Lost to Follow-up|4|||
147020005|NCT01382251|530233108|FG001|Overall Study|Lost to Follow-up|4|||
147020006|NCT01382251|530233107|FG000|Overall Study|Contacted after study closed|1|||
147020007|NCT01382251|530233108|FG001|Overall Study|Contacted after study closed|1|||
147020008|NCT01117987|530233109|FG000|Overall Study|Protocol deviation|0|||
147020009|NCT01117987|530233110|FG001|Overall Study|Protocol deviation|1|||
147020010|NCT01117987|530233109|FG000|Overall Study|Subject no longer requires study drug|1|||
147020011|NCT01117987|530233110|FG001|Overall Study|Subject no longer requires study drug|0|||
147020012|NCT01117987|530233109|FG000|Overall Study|Lost to Follow-up|1|||
147020013|NCT01117987|530233110|FG001|Overall Study|Lost to Follow-up|1|||
147020014|NCT01117987|530233109|FG000|Overall Study|Abnormal test procedure result|2|||
147020015|NCT01117987|530233110|FG001|Overall Study|Abnormal test procedure result|0|||
147020016|NCT01117987|530233109|FG000|Overall Study|Lack of Efficacy|3|||
146849190|NCT02297139|529617055|FG001|Overall Study|Participant request to discontinue study treatment|1|||
146849191|NCT02297139|529617054|FG000|Overall Study|Maximum clinical benefit|1|||
146849192|NCT02297139|529617055|FG001|Overall Study|Maximum clinical benefit|0|||
147020017|NCT01117987|530233110|FG001|Overall Study|Lack of Efficacy|4|||
147020018|NCT01117987|530233109|FG000|Overall Study|Death|5|||
147020019|NCT01117987|530233110|FG001|Overall Study|Death|10|||
147020020|NCT01117987|530233109|FG000|Overall Study|Withdrawal by Subject|5|||
147020021|NCT01117987|530233110|FG001|Overall Study|Withdrawal by Subject|10|||
147020022|NCT01117987|530233109|FG000|Overall Study|Adverse Event|19|||
147020023|NCT01117987|530233110|FG001|Overall Study|Adverse Event|26|||
147020024|NCT01117987|530233109|FG000|Overall Study|Administrative problems|25|||
147020025|NCT01117987|530233110|FG001|Overall Study|Administrative problems|22|||
147020026|NCT04232540|530233114|FG000|Overall Study|Lost to Follow-up|1|||
147020027|NCT04232540|530233115|FG001|Overall Study|Lost to Follow-up|0|||
147020028|NCT04230876|530233116|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
147020029|NCT04230876|530233117|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
147020030|NCT02093923|530233119|FG000|Overall Study|Lost to Follow-up|0|||
147020031|NCT02093923|530233120|FG001|Overall Study|Lost to Follow-up|0|||
147020032|NCT02093923|530233121|FG002|Overall Study|Lost to Follow-up|0|||
147020033|NCT02093923|530233122|FG003|Overall Study|Lost to Follow-up|1|||
147020034|NCT02093923|530233123|FG004|Overall Study|Lost to Follow-up|0|||
147020035|NCT02093923|530233119|FG000|Overall Study|Screen failure after randomization|0|||
147020036|NCT02093923|530233120|FG001|Overall Study|Screen failure after randomization|0|||
147020037|NCT02093923|530233121|FG002|Overall Study|Screen failure after randomization|0|||
147020038|NCT02093923|530233122|FG003|Overall Study|Screen failure after randomization|1|||
147020039|NCT02093923|530233123|FG004|Overall Study|Screen failure after randomization|0|||
147020040|NCT01662362|530233128|FG000|Overall Study|Lost to Follow-up|38|||
147020041|NCT02339090|530233134|FG000|Overall Study|Adverse Event|1|||
147020042|NCT02339090|530233135|FG001|Overall Study|Adverse Event|0|||
147020043|NCT02339090|530233134|FG000|Overall Study|Lost to Follow-up|0|||
147020044|NCT02339090|530233135|FG001|Overall Study|Lost to Follow-up|1|||
147020045|NCT02339090|530233134|FG000|Overall Study|Non-compliance With Study Drug|0|||
147020046|NCT02339090|530233135|FG001|Overall Study|Non-compliance With Study Drug|1|||
147020047|NCT02339090|530233134|FG000|Overall Study|Withdrawal by Subject|2|||
147020048|NCT02339090|530233135|FG001|Overall Study|Withdrawal by Subject|1|||
147020049|NCT02339090|530233134|FG000|Overall Study|Poor Growth|3|||
147020050|NCT02339090|530233135|FG001|Overall Study|Poor Growth|0|||
147020051|NCT02339090|530233134|FG000|Overall Study|Randomized but not treated|0|||
147020052|NCT02339090|530233135|FG001|Overall Study|Randomized but not treated|2|||
147020053|NCT02737592|530233137|FG000|Overall Study|Withdrawal by Subject|1|||
147020054|NCT04678817|530234664|FG000|Overall Study|Lost to Follow-up|28|||
147020055|NCT04678817|530234665|FG001|Overall Study|Lost to Follow-up|0|||
147020056|NCT04678817|530234666|FG002|Overall Study|Lost to Follow-up|0|||
147020057|NCT02124902|530234672|FG000|Overall Study|Adverse Event|7|||
147020058|NCT02124902|530234673|FG001|Overall Study|Adverse Event|2|||
147020059|NCT02124902|530234672|FG000|Overall Study|Went to alternative treatment|4|||
147020060|NCT02124902|530234673|FG001|Overall Study|Went to alternative treatment|0|||
147020061|NCT02124902|530234672|FG000|Overall Study|Withdrawal by Subject|2|||
147020062|NCT02124902|530234673|FG001|Overall Study|Withdrawal by Subject|1|||
147020063|NCT02124902|530234672|FG000|Overall Study|Physician Decision|2|||
147020064|NCT02124902|530234673|FG001|Overall Study|Physician Decision|0|||
147020065|NCT02124902|530234672|FG000|Overall Study|Not eligible|1|||
147020066|NCT02124902|530234673|FG001|Overall Study|Not eligible|0|||
147020067|NCT02124902|530234672|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
147020068|NCT02124902|530234673|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
147020069|NCT00546910|530234677|FG000|Overall Study|Adverse Event|2|||
147020070|NCT00546910|530234678|FG001|Overall Study|Adverse Event|3|||
147020071|NCT00546910|530234677|FG000|Overall Study|Lack of Efficacy|5|||
147020072|NCT00546910|530234678|FG001|Overall Study|Lack of Efficacy|7|||
147020073|NCT00546910|530234677|FG000|Overall Study|Physician Decision|0|||
147020074|NCT00546910|530234678|FG001|Overall Study|Physician Decision|1|||
147020075|NCT00546910|530234677|FG000|Overall Study|Withdrawal by Subject|2|||
147020076|NCT00546910|530234678|FG001|Overall Study|Withdrawal by Subject|0|||
147020077|NCT01467479|530234679|FG000|Overall Study|No Study Medication|1|||
147020078|NCT01467479|530234680|FG001|Overall Study|No Study Medication|0|||
147020079|NCT01467479|530234681|FG002|Overall Study|No Study Medication|2|||
147020080|NCT01467479|530234679|FG000|Overall Study|Adverse Event|1|||
147020081|NCT01467479|530234680|FG001|Overall Study|Adverse Event|2|||
147020082|NCT01467479|530234681|FG002|Overall Study|Adverse Event|0|||
147020083|NCT01467479|530234679|FG000|Overall Study|Death|0|||
147020084|NCT01467479|530234680|FG001|Overall Study|Death|0|||
147020085|NCT01467479|530234681|FG002|Overall Study|Death|1|||
147020086|NCT01467479|530234679|FG000|Overall Study|Lost to Follow-up|2|||
147020087|NCT01467479|530234680|FG001|Overall Study|Lost to Follow-up|5|||
147020088|NCT01467479|530234681|FG002|Overall Study|Lost to Follow-up|3|||
147020089|NCT01467479|530234679|FG000|Overall Study|Withdrawal of Consent|3|||
147020090|NCT01467479|530234680|FG001|Overall Study|Withdrawal of Consent|7|||
147020091|NCT01467479|530234681|FG002|Overall Study|Withdrawal of Consent|7|||
147020092|NCT01467479|530234679|FG000|Overall Study|Study Terminated by Sponsor|1|||
147020093|NCT01467479|530234680|FG001|Overall Study|Study Terminated by Sponsor|3|||
147020094|NCT01467479|530234681|FG002|Overall Study|Study Terminated by Sponsor|3|||
147020095|NCT01467479|530234679|FG000|Overall Study|Other|1|||
147020096|NCT01467479|530234680|FG001|Overall Study|Other|0|||
147020097|NCT01467479|530234681|FG002|Overall Study|Other|0|||
147020098|NCT02284347|530234691|FG000|Overall Study|Lost to Follow-up|2|||
147020099|NCT02284347|530234691|FG000|Overall Study|Withdrawn prior to treatment|1|||
147020100|NCT01684215|530234695|FG000|Phase 1, Part 1|Adverse Event|1|||
147020101|NCT01684215|530234696|FG001|Phase 1, Part 1|Adverse Event|0|||
147020102|NCT01684215|530234697|FG002|Phase 1, Part 1|Adverse Event|0|||
147020103|NCT01684215|530234698|FG003|Phase 1, Part 1|Adverse Event|0|||
147020104|NCT01684215|530234695|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
147020105|NCT01684215|530234696|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
147020106|NCT01684215|530234697|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
147020107|NCT01684215|530234698|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
147020108|NCT01684215|530234695|FG000|Phase 1, Part 2|Adverse Event|0|||
147020109|NCT01684215|530234696|FG001|Phase 1, Part 2|Adverse Event|0|||
147020110|NCT01684215|530234697|FG002|Phase 1, Part 2|Adverse Event|1|||
147020111|NCT01684215|530234698|FG003|Phase 1, Part 2|Adverse Event|0|||
147020112|NCT01684215|530234695|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
147020113|NCT01684215|530234696|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
147020114|NCT01684215|530234697|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
147020115|NCT01684215|530234698|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
147020116|NCT01684215|530234695|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
147020117|NCT01684215|530234696|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
147020118|NCT01684215|530234697|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
147020119|NCT01684215|530234698|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
147020120|NCT01684215|530234695|FG000|Phase 2|Death|0|||
147020121|NCT01684215|530234696|FG001|Phase 2|Death|0|||
147020122|NCT01684215|530234697|FG002|Phase 2|Death|0|||
147020123|NCT01684215|530234698|FG003|Phase 2|Death|8|||
147020124|NCT01684215|530234695|FG000|Phase 2|Study terminated by sponsor|0|||
147020125|NCT01684215|530234696|FG001|Phase 2|Study terminated by sponsor|0|||
147020126|NCT01684215|530234697|FG002|Phase 2|Study terminated by sponsor|0|||
147020127|NCT01684215|530234698|FG003|Phase 2|Study terminated by sponsor|30|||
147020128|NCT01684215|530234695|FG000|Phase 2|Enrolled but not treated|0|||
147020129|NCT01684215|530234696|FG001|Phase 2|Enrolled but not treated|0|||
147020130|NCT01684215|530234697|FG002|Phase 2|Enrolled but not treated|0|||
147020131|NCT01684215|530234698|FG003|Phase 2|Enrolled but not treated|1|||
147020132|NCT01684215|530234695|FG000|Phase 2|Lost to Follow-up|0|||
147020133|NCT01684215|530234696|FG001|Phase 2|Lost to Follow-up|0|||
147020134|NCT01684215|530234697|FG002|Phase 2|Lost to Follow-up|0|||
147020135|NCT01684215|530234698|FG003|Phase 2|Lost to Follow-up|4|||
147020136|NCT01301482|530234699|FG000|Overall Study|Withdrawal by Subject|1|||
147020137|NCT01915940|530234703|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
147020138|NCT01915940|530234704|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
147020139|NCT01915940|530234705|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
147020140|NCT01915940|530234703|FG000|Treatment Period|Decision of Participant|0|||
147020141|NCT01915940|530234704|FG001|Treatment Period|Decision of Participant|1|||
147020142|NCT01915940|530234705|FG002|Treatment Period|Decision of Participant|3|||
147020143|NCT01915940|530234703|FG000|Treatment Period|Adverse Event|0|||
147020144|NCT01915940|530234704|FG001|Treatment Period|Adverse Event|9|||
147020145|NCT01915940|530234705|FG002|Treatment Period|Adverse Event|1|||
147020146|NCT01915940|530234703|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
147020147|NCT01915940|530234704|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
147020148|NCT01915940|530234705|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
147020149|NCT00614926|530234706|FG000|Overall Study|Burden of travel|1|||
147020150|NCT00614926|530234707|FG001|Overall Study|Burden of travel|0|||
147020151|NCT00614926|530234706|FG000|Overall Study|Adverse Event|3|||
147020152|NCT00614926|530234707|FG001|Overall Study|Adverse Event|0|||
147020153|NCT02075606|530234710|FG000|Overall Study|Adverse Event|5|||
147020154|NCT02075606|530234710|FG000|Overall Study|Withdrawal by Subject|1|||
147020155|NCT02075606|530234710|FG000|Overall Study|Death|1|||
147020156|NCT02075606|530234710|FG000|Overall Study|Investigator's decision|1|||
147020157|NCT02075606|530234710|FG000|Overall Study|Symptom management|1|||
147020158|NCT02075606|530234710|FG000|Overall Study|Increasing Symptoms|1|||
147020159|NCT01439724|530234713|FG000|Overall Study|missing consultation|9|||
147020160|NCT01439724|530234714|FG001|Overall Study|missing consultation|8|||
147020161|NCT04019054|530234715|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
147020162|NCT04019054|530234716|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
147020163|NCT04019054|530234715|FG000|Overall Study|Withdrawal by Subject|3|||
147020164|NCT04019054|530234716|FG001|Overall Study|Withdrawal by Subject|1|||
147020165|NCT00271024|530234722|FG000|Overall Study|Lost Interest|3|||
147020166|NCT00271024|530234723|FG001|Overall Study|Lost Interest|4|||
147020167|NCT00271024|530234724|FG002|Overall Study|Lost Interest|2|||
147020168|NCT00271024|530234725|FG003|Overall Study|Lost Interest|3|||
147020169|NCT00271024|530234722|FG000|Overall Study|Unknown/Unspecified|11|||
147020170|NCT00271024|530234723|FG001|Overall Study|Unknown/Unspecified|11|||
147020171|NCT00271024|530234724|FG002|Overall Study|Unknown/Unspecified|8|||
147020172|NCT00271024|530234725|FG003|Overall Study|Unknown/Unspecified|4|||
147020173|NCT00271024|530234722|FG000|Overall Study|Protocol Violation|1|||
147020174|NCT00271024|530234723|FG001|Overall Study|Protocol Violation|6|||
147020175|NCT00271024|530234724|FG002|Overall Study|Protocol Violation|5|||
147020176|NCT00271024|530234725|FG003|Overall Study|Protocol Violation|11|||
147020177|NCT00271024|530234722|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
147020178|NCT00271024|530234723|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
147020179|NCT00271024|530234724|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
147020180|NCT00271024|530234725|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
147020181|NCT00271024|530234722|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
147020182|NCT00271024|530234723|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
147020183|NCT00271024|530234724|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
147020184|NCT00271024|530234725|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
147020185|NCT01261624|530234726|FG000|Week 0 to Week 12|Disease Progression|1|||
147020186|NCT01261624|530234727|FG001|Week 0 to Week 12|Disease Progression|1|||
147020187|NCT01261624|530234726|FG000|Week 0 to Week 12|Insufficient Response|0|||
147020188|NCT01261624|530234727|FG001|Week 0 to Week 12|Insufficient Response|2|||
147020189|NCT01261624|530234726|FG000|Week 13 to Week 24|Insufficient Response|0|||
147020190|NCT01261624|530234727|FG001|Week 13 to Week 24|Insufficient Response|1|||
147020191|NCT01719562|530234738|FG000|Overall Study|Lost to Follow-up|1|||
147020192|NCT01719562|530234739|FG001|Overall Study|Lost to Follow-up|0|||
147020193|NCT01719562|530234738|FG000|Overall Study|Death|1|||
147020194|NCT01719562|530234739|FG001|Overall Study|Death|0|||
147020195|NCT01719562|530234738|FG000|Overall Study|New cancer diagnosis|1|||
147020196|NCT01719562|530234739|FG001|Overall Study|New cancer diagnosis|0|||
147020197|NCT00508027|530234740|FG000|Dose Level 1|Lost to Follow-up|4|||
147020198|NCT00508027|530234740|FG000|Dose Level 1|Withdrawal by Subject|2|||
147020199|NCT00508027|530234740|FG000|Dose Level 1|Physician Decision|2|||
147020200|NCT00508027|530234740|FG000|Dose Level 2|Lost to Follow-up|2|||
147020201|NCT00508027|530234740|FG000|Dose Level 2|Withdrawal by Subject|2|||
147020202|NCT03877926|530234743|FG000|Overall Study|Adverse Event|1|||
147020203|NCT03877926|530234744|FG001|Overall Study|Adverse Event|0|||
147020204|NCT03877926|530234745|FG002|Overall Study|Adverse Event|0|||
147020205|NCT03877926|530234746|FG003|Overall Study|Adverse Event|0|||
147020206|NCT03877926|530234743|FG000|Overall Study|Death|2|||
147020207|NCT03877926|530234744|FG001|Overall Study|Death|2|||
147020208|NCT03877926|530234745|FG002|Overall Study|Death|2|||
147020209|NCT03877926|530234746|FG003|Overall Study|Death|0|||
147020210|NCT03877926|530234743|FG000|Overall Study|Lost to Follow-up|41|||
147020211|NCT03877926|530234744|FG001|Overall Study|Lost to Follow-up|52|||
147020212|NCT03877926|530234745|FG002|Overall Study|Lost to Follow-up|45|||
147020213|NCT03877926|530234746|FG003|Overall Study|Lost to Follow-up|17|||
147020214|NCT03877926|530234743|FG000|Overall Study|Physician Decision|2|||
147020215|NCT03877926|530234744|FG001|Overall Study|Physician Decision|0|||
147020216|NCT03877926|530234745|FG002|Overall Study|Physician Decision|2|||
147020217|NCT03877926|530234746|FG003|Overall Study|Physician Decision|0|||
147020218|NCT03877926|530234743|FG000|Overall Study|Withdrawal by Subject|18|||
147020219|NCT03877926|530234744|FG001|Overall Study|Withdrawal by Subject|21|||
147020220|NCT03877926|530234745|FG002|Overall Study|Withdrawal by Subject|12|||
147020221|NCT03877926|530234746|FG003|Overall Study|Withdrawal by Subject|4|||
147020222|NCT03877926|530234743|FG000|Overall Study|Other - Various|4|||
147020223|NCT03877926|530234744|FG001|Overall Study|Other - Various|1|||
147020224|NCT03877926|530234745|FG002|Overall Study|Other - Various|1|||
147020225|NCT03877926|530234746|FG003|Overall Study|Other - Various|0|||
147020226|NCT03877926|530234743|FG000|Overall Study|Not Treated|3|||
147020227|NCT03877926|530234744|FG001|Overall Study|Not Treated|1|||
147020228|NCT03877926|530234745|FG002|Overall Study|Not Treated|1|||
147020229|NCT03877926|530234746|FG003|Overall Study|Not Treated|0|||
147020230|NCT02013531|530234747|FG000|Overall Study|Lost to Follow-up|3|||
147020231|NCT02013531|530234747|FG000|Overall Study|Met Withdrawal Criteria|1|||
147020232|NCT02013531|530234747|FG000|Overall Study|Withdrawal by Subject|1|||
147020233|NCT00939627|530234749|FG000|Overall Study|Disease Progression|16|||
147020234|NCT00939627|530234750|FG001|Overall Study|Disease Progression|12|||
147020235|NCT00939627|530234751|FG002|Overall Study|Disease Progression|0|||
147020236|NCT00939627|530234749|FG000|Overall Study|Adverse Event|6|||
147020237|NCT00939627|530234750|FG001|Overall Study|Adverse Event|7|||
147020238|NCT00939627|530234751|FG002|Overall Study|Adverse Event|0|||
147020239|NCT00939627|530234749|FG000|Overall Study|Death|0|||
147020240|NCT00939627|530234750|FG001|Overall Study|Death|2|||
147020241|NCT00939627|530234751|FG002|Overall Study|Death|0|||
147020242|NCT00939627|530234749|FG000|Overall Study|Withdrawal by Subject|2|||
147020243|NCT00939627|530234750|FG001|Overall Study|Withdrawal by Subject|4|||
147020244|NCT00939627|530234751|FG002|Overall Study|Withdrawal by Subject|0|||
147020245|NCT00939627|530234749|FG000|Overall Study|Other complicating disease|1|||
147020246|NCT00939627|530234750|FG001|Overall Study|Other complicating disease|1|||
147020247|NCT00939627|530234751|FG002|Overall Study|Other complicating disease|0|||
146849193|NCT02297139|529617054|FG000|Overall Study|Administrative reason by sponsor|0|||
147020248|NCT00939627|530234749|FG000|Overall Study|Not compliant|2|||
147020249|NCT00939627|530234750|FG001|Overall Study|Not compliant|0|||
146962498|NCT04095039|530021610|FG001|Overall Study|Cacliphylaxis|1|||
146962499|NCT04095039|530021609|FG000|Overall Study|Pregnancy|1|||
146962500|NCT04095039|530021610|FG001|Overall Study|Pregnancy|0|||
146962501|NCT01326481|530021613|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
146962502|NCT01990339|530021618|FG000|Overall Study|Data Not Available|49|||
146962503|NCT01990339|530021618|FG000|Overall Study|Voluntary Withdrawal|1402|||
146962504|NCT01990339|530021618|FG000|Overall Study|Lost to Follow-up|861|||
146962505|NCT01314261|530021619|FG000|Overall Study|Adverse Event|1|||
146962506|NCT01314261|530021620|FG001|Overall Study|Adverse Event|0|||
146962507|NCT01314261|530021621|FG002|Overall Study|Adverse Event|0|||
146962508|NCT01314261|530021622|FG003|Overall Study|Adverse Event|0|||
146962509|NCT01314261|530021619|FG000|Overall Study|Withdrawal by Subject|0|||
146962510|NCT01314261|530021620|FG001|Overall Study|Withdrawal by Subject|3|||
146962511|NCT01314261|530021621|FG002|Overall Study|Withdrawal by Subject|1|||
146962512|NCT01314261|530021622|FG003|Overall Study|Withdrawal by Subject|0|||
146962513|NCT01314261|530021619|FG000|Overall Study|Lost to Follow-up|1|||
146962514|NCT01314261|530021620|FG001|Overall Study|Lost to Follow-up|0|||
146962515|NCT01314261|530021621|FG002|Overall Study|Lost to Follow-up|2|||
146962516|NCT01314261|530021622|FG003|Overall Study|Lost to Follow-up|2|||
146962517|NCT01314261|530021619|FG000|Overall Study|Virologic Failure|0|||
146962518|NCT01314261|530021620|FG001|Overall Study|Virologic Failure|1|||
146962519|NCT01314261|530021621|FG002|Overall Study|Virologic Failure|0|||
146962520|NCT01314261|530021622|FG003|Overall Study|Virologic Failure|1|||
146962521|NCT02129192|530021623|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
146962522|NCT02129192|530021624|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
146962523|NCT01231620|530021625|FG000|Overall Study|Physician Decision|3|||
146962524|NCT01231620|530021626|FG001|Overall Study|Physician Decision|5|||
146962525|NCT01231620|530021627|FG002|Overall Study|Physician Decision|10|||
146962526|NCT01231620|530021625|FG000|Overall Study|Death|12|||
146962527|NCT01231620|530021626|FG001|Overall Study|Death|14|||
146962528|NCT01231620|530021627|FG002|Overall Study|Death|11|||
146962529|NCT01231620|530021625|FG000|Overall Study|Adverse Event|2|||
146962530|NCT01231620|530021626|FG001|Overall Study|Adverse Event|2|||
146962531|NCT01231620|530021627|FG002|Overall Study|Adverse Event|1|||
146962532|NCT01231620|530021625|FG000|Overall Study|Withdrawal by Subject|6|||
146962533|NCT01231620|530021626|FG001|Overall Study|Withdrawal by Subject|6|||
146962534|NCT01231620|530021627|FG002|Overall Study|Withdrawal by Subject|8|||
146962535|NCT01231620|530021625|FG000|Overall Study|Lost to Follow-up|3|||
146962536|NCT01231620|530021626|FG001|Overall Study|Lost to Follow-up|4|||
146962537|NCT01231620|530021627|FG002|Overall Study|Lost to Follow-up|9|||
146962538|NCT04524507|530021628|FG000|Overall Study|Lost to Follow-up|2|||
146962539|NCT04524507|530021629|FG001|Overall Study|Lost to Follow-up|4|||
146962540|NCT04524507|530021628|FG000|Overall Study|Withdrawal by Subject|2|||
146962541|NCT04524507|530021629|FG001|Overall Study|Withdrawal by Subject|9|||
146962542|NCT04524507|530021628|FG000|Overall Study|Death|2|||
146962543|NCT04524507|530021629|FG001|Overall Study|Death|10|||
146962544|NCT02441517|530021635|FG000|Overall Study|Lost to Follow-up|1|||
146962545|NCT02441517|530021635|FG000|Overall Study|Withdrawal by Subject|2|||
146962546|NCT02441517|530021635|FG000|Overall Study|Study Terminated by Sponsor|1|||
146962547|NCT01393444|530021636|FG000|Overall Study|Withdrawal by Subject|1|||
146962548|NCT01393444|530021636|FG000|Overall Study|Determined ineligible during screening.|2|||
146962549|NCT03039699|530021637|FG000|Overall Study|Incorrect inclusion|5|||
146962550|NCT03039699|530021638|FG001|Overall Study|Incorrect inclusion|4|||
146962551|NCT03039699|530021637|FG000|Overall Study|Lack of data to assess study endpoint|5|||
146962552|NCT03039699|530021638|FG001|Overall Study|Lack of data to assess study endpoint|3|||
146962553|NCT03039699|530021637|FG000|Overall Study|Bacterial infection|12|||
146962554|NCT03039699|530021638|FG001|Overall Study|Bacterial infection|28|||
146962555|NCT01302366|530023235|FG000|Overall Study|patient choice or noncompliance|5|||
146962556|NCT00467051|530023236|FG000|Overall Study|Adverse Event|2|||
146962557|NCT00503035|530023239|FG000|Overall Study|Lost to Follow-up|2|||
146962558|NCT00503035|530023239|FG000|Overall Study|Physician Decision|3|||
146962559|NCT00503035|530023239|FG000|Overall Study|Ineligible|15|||
146962560|NCT04579666|530023241|FG000|RTP (Up to Week 52)|Adverse Event|4|||
146962561|NCT04579666|530023242|FG001|RTP (Up to Week 52)|Adverse Event|3|||
146962562|NCT04579666|530023243|FG002|RTP (Up to Week 52)|Adverse Event|0|||
146962563|NCT04579666|530023244|FG003|RTP (Up to Week 52)|Adverse Event|0|||
146962564|NCT04579666|530023241|FG000|RTP (Up to Week 52)|Death|24|||
146962565|NCT04579666|530023242|FG001|RTP (Up to Week 52)|Death|9|||
146962566|NCT04579666|530023243|FG002|RTP (Up to Week 52)|Death|0|||
146962567|NCT04579666|530023244|FG003|RTP (Up to Week 52)|Death|0|||
146962568|NCT04579666|530023241|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
146962569|NCT04579666|530023242|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
146962570|NCT04579666|530023243|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
146962571|NCT04579666|530023244|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
146962572|NCT04579666|530023241|FG000|RTP (Up to Week 52)|Physician Decision|4|||
146962573|NCT04579666|530023242|FG001|RTP (Up to Week 52)|Physician Decision|1|||
147020250|NCT00939627|530234751|FG002|Overall Study|Not compliant|0|||
147020251|NCT00939627|530234749|FG000|Overall Study|No off-tx reason given|0|||
147020252|NCT00939627|530234750|FG001|Overall Study|No off-tx reason given|2|||
147020253|NCT00939627|530234751|FG002|Overall Study|No off-tx reason given|0|||
147020254|NCT00537199|530234754|FG000|Overall Study|Study Terminated|1|||
147020255|NCT02039063|530234757|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
147020256|NCT02039063|530234758|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
147020257|NCT02039063|530234759|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
147020258|NCT02039063|530234760|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
147020259|NCT02039063|530234757|FG000|Treatment Phase|Progression of disease|0|||
147020260|NCT02039063|530234758|FG001|Treatment Phase|Progression of disease|0|||
147020261|NCT02039063|530234759|FG002|Treatment Phase|Progression of disease|1|||
147020262|NCT02039063|530234760|FG003|Treatment Phase|Progression of disease|1|||
147020263|NCT02039063|530234757|FG000|Extension Phase|Inadequate therapeutic effect|0|||
147020264|NCT02039063|530234758|FG001|Extension Phase|Inadequate therapeutic effect|1|||
147020265|NCT02039063|530234759|FG002|Extension Phase|Inadequate therapeutic effect|2|||
147020266|NCT02039063|530234760|FG003|Extension Phase|Inadequate therapeutic effect|0|||
147020267|NCT02039063|530234757|FG000|Extension Phase|Progression of disease|0|||
147020268|NCT02039063|530234758|FG001|Extension Phase|Progression of disease|0|||
147020269|NCT02039063|530234759|FG002|Extension Phase|Progression of disease|0|||
147020270|NCT02039063|530234760|FG003|Extension Phase|Progression of disease|1|||
147020271|NCT02039063|530234757|FG000|Extension Phase|Adverse Event|0|||
147020272|NCT02039063|530234758|FG001|Extension Phase|Adverse Event|0|||
147020273|NCT02039063|530234759|FG002|Extension Phase|Adverse Event|1|||
147020274|NCT02039063|530234760|FG003|Extension Phase|Adverse Event|0|||
147020275|NCT00467831|530234763|FG000|Overall Study|Death|2|||
147020276|NCT00467831|530234763|FG000|Overall Study|Withdrawal by Subject|1|||
147020277|NCT01832402|530234766|FG000|Overall Study|Lost to Follow-up|2|||
147020278|NCT01832402|530234767|FG001|Overall Study|Lost to Follow-up|0|||
147020279|NCT01832402|530234766|FG000|Overall Study|Withdrawal by Subject|3|||
147020280|NCT01832402|530234767|FG001|Overall Study|Withdrawal by Subject|3|||
147020281|NCT01832402|530234766|FG000|Overall Study|Declining Performance status|2|||
147020282|NCT01832402|530234767|FG001|Overall Study|Declining Performance status|1|||
147020283|NCT02776553|530234769|FG000|Overall Study|Lost to Follow-up|1|||
147020284|NCT02776553|530234770|FG001|Overall Study|Lost to Follow-up|0|||
147020285|NCT02776553|530234769|FG000|Overall Study|got liver transplant|1|||
147020286|NCT02776553|530234770|FG001|Overall Study|got liver transplant|2|||
147020287|NCT02776553|530234769|FG000|Overall Study|had other surgery|1|||
147020288|NCT02776553|530234770|FG001|Overall Study|had other surgery|0|||
147020289|NCT02776553|530234769|FG000|Overall Study|Protocol Violation|0|||
147020290|NCT02776553|530234770|FG001|Overall Study|Protocol Violation|1|||
147020291|NCT01998243|530234771|FG000|Overall Study|Pregnancy|0|||
147020292|NCT01998243|530234772|FG001|Overall Study|Pregnancy|1|||
147020293|NCT01998243|530234771|FG000|Overall Study|Protocol Violation|5|||
147020294|NCT01998243|530234772|FG001|Overall Study|Protocol Violation|2|||
147020295|NCT01998243|530234771|FG000|Overall Study|Withdrawal by Subject|3|||
147020296|NCT01998243|530234772|FG001|Overall Study|Withdrawal by Subject|4|||
147020297|NCT02492841|530234773|FG000|Overall Study|Lost to Follow-up|34|||
147020298|NCT02492841|530234774|FG001|Overall Study|Lost to Follow-up|31|||
147020299|NCT02492841|530234775|FG002|Overall Study|Lost to Follow-up|35|||
147020300|NCT02820740|530234776|FG000|Overall Study|Did not have procedure|2|||
147020301|NCT04965389|530234777|FG000|Overall Study|Other reasons|1|||
147020302|NCT04965389|530234778|FG001|Overall Study|Other reasons|0|||
147020303|NCT04965389|530234779|FG002|Overall Study|Other reasons|0|||
147020304|NCT04965389|530234780|FG003|Overall Study|Other reasons|0|||
147020305|NCT04965389|530234777|FG000|Overall Study|Participant withdrew consent|0|||
147020306|NCT04965389|530234778|FG001|Overall Study|Participant withdrew consent|1|||
147020307|NCT04965389|530234779|FG002|Overall Study|Participant withdrew consent|0|||
147020308|NCT04965389|530234780|FG003|Overall Study|Participant withdrew consent|0|||
147020309|NCT04965389|530234777|FG000|Overall Study|Poor/Non-compliance|0|||
147020310|NCT04965389|530234778|FG001|Overall Study|Poor/Non-compliance|1|||
147020311|NCT04965389|530234779|FG002|Overall Study|Poor/Non-compliance|0|||
147020312|NCT04965389|530234780|FG003|Overall Study|Poor/Non-compliance|0|||
147020313|NCT03903159|530234781|FG000|Overall Study|Discharged with Staff Approval|2|||
147020314|NCT03903159|530234781|FG000|Overall Study|Discharged at Staff Request|2|||
147020315|NCT03903159|530234781|FG000|Overall Study|Discharged Against Staff Advice|1|||
147020316|NCT00206102|530234787|FG000|Overall Study|Adverse Event|119|||
147020317|NCT00206102|530234788|FG001|Overall Study|Adverse Event|82|||
146849194|NCT02297139|529617055|FG001|Overall Study|Administrative reason by sponsor|2|||
146849195|NCT02297139|529617054|FG000|Overall Study|Other reasons|0|||
147020318|NCT00206102|530234787|FG000|Overall Study|Protocol Violation|0|||
147020319|NCT00206102|530234788|FG001|Overall Study|Protocol Violation|2|||
147020320|NCT00206102|530234787|FG000|Overall Study|Lack of therapeutic response|16|||
146849196|NCT02297139|529617055|FG001|Overall Study|Other reasons|8|||
146849197|NCT01865747|529617056|FG000|Overall Study (ITT)|Adverse Event|32|||
147020321|NCT00206102|530234788|FG001|Overall Study|Lack of therapeutic response|11|||
147020322|NCT00206102|530234787|FG000|Overall Study|Lost to Follow-up|95|||
147020323|NCT00206102|530234788|FG001|Overall Study|Lost to Follow-up|66|||
147020324|NCT00206102|530234787|FG000|Overall Study|Withdrawal by Subject|118|||
147020325|NCT00206102|530234788|FG001|Overall Study|Withdrawal by Subject|101|||
147020326|NCT00206102|530234787|FG000|Overall Study|Study-specific discontinuation criteria|18|||
147020327|NCT00206102|530234788|FG001|Overall Study|Study-specific discontinuation criteria|17|||
147020328|NCT00206102|530234787|FG000|Overall Study|None of those categories|42|||
147020329|NCT00206102|530234788|FG001|Overall Study|None of those categories|36|||
147020330|NCT04117945|530234789|FG000|Overall Study|Death|1|||
147020331|NCT04117945|530234790|FG001|Overall Study|Death|0|||
147020332|NCT04117945|530234789|FG000|Overall Study|Withdrawal by Subject|3|||
147020333|NCT04117945|530234790|FG001|Overall Study|Withdrawal by Subject|1|||
147020334|NCT04117945|530234789|FG000|Overall Study|Disease Progression|0|||
147020335|NCT04117945|530234790|FG001|Overall Study|Disease Progression|2|||
147020336|NCT04117945|530234789|FG000|Overall Study|Ineligible|8|||
147020337|NCT04117945|530234790|FG001|Overall Study|Ineligible|7|||
147020338|NCT00562120|530234796|FG000|First Intervention Period|Adverse Event|1|||
147020339|NCT00562120|530234797|FG001|First Intervention Period|Adverse Event|0|||
147020340|NCT00562120|530234798|FG002|First Intervention Period|Adverse Event|0|||
147020341|NCT00562120|530234799|FG003|First Intervention Period|Adverse Event|0|||
147020342|NCT00562120|530234796|FG000|First Intervention Period|Randomized but not Treated|1|||
147020343|NCT00562120|530234797|FG001|First Intervention Period|Randomized but not Treated|0|||
147020344|NCT00562120|530234798|FG002|First Intervention Period|Randomized but not Treated|0|||
147020345|NCT00562120|530234799|FG003|First Intervention Period|Randomized but not Treated|0|||
147020346|NCT02148445|530234800|FG000|Overall Study|Death|1|||
147020347|NCT02148445|530234801|FG001|Overall Study|Death|3|||
147020348|NCT03450629|530234802|FG000|Overall Study|Adverse Event|15|||
147020349|NCT03450629|530234803|FG001|Overall Study|Adverse Event|14|||
147020350|NCT03450629|530234802|FG000|Overall Study|Physician Decision|2|||
147020351|NCT03450629|530234803|FG001|Overall Study|Physician Decision|2|||
147020352|NCT03450629|530234802|FG000|Overall Study|Lack of Efficacy|2|||
147020353|NCT03450629|530234803|FG001|Overall Study|Lack of Efficacy|0|||
147020354|NCT03450629|530234802|FG000|Overall Study|Lost to Follow-up|4|||
147020355|NCT03450629|530234803|FG001|Overall Study|Lost to Follow-up|2|||
147020356|NCT03450629|530234802|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
147020357|NCT03450629|530234803|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
147020358|NCT03450629|530234802|FG000|Overall Study|Non-Compliance With Study Drug|2|||
147020359|NCT03450629|530234803|FG001|Overall Study|Non-Compliance With Study Drug|1|||
147020360|NCT03450629|530234802|FG000|Overall Study|Protocol Violation|11|||
147020361|NCT03450629|530234803|FG001|Overall Study|Protocol Violation|8|||
147020362|NCT03450629|530234802|FG000|Overall Study|Withdrawal by Subject|12|||
147020363|NCT03450629|530234803|FG001|Overall Study|Withdrawal by Subject|6|||
147020364|NCT03438006|530234804|FG000|Overall Study|Adverse Event|1|||
147020365|NCT03438006|530234804|FG000|Overall Study|Lost to Follow-up|67|||
147020366|NCT03438006|530234804|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
147020367|NCT03438006|530234804|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
147020368|NCT01181531|530234815|FG000|Overall Study|Other|17|||
147020369|NCT01181531|530234816|FG001|Overall Study|Other|12|||
147020370|NCT01181531|530234815|FG000|Overall Study|Partial consent by subject withdrawn|0|||
147020371|NCT01181531|530234816|FG001|Overall Study|Partial consent by subject withdrawn|1|||
147020372|NCT01181531|530234815|FG000|Overall Study|Physician Decision|3|||
147020373|NCT01181531|530234816|FG001|Overall Study|Physician Decision|1|||
147020374|NCT01181531|530234815|FG000|Overall Study|Noncompliance|2|||
147020375|NCT01181531|530234816|FG001|Overall Study|Noncompliance|2|||
147020376|NCT01181531|530234815|FG000|Overall Study|Ineligibility determined|1|||
147020377|NCT01181531|530234816|FG001|Overall Study|Ineligibility determined|2|||
147020378|NCT01181531|530234815|FG000|Overall Study|Protocol Specified Criteria|15|||
147020379|NCT01181531|530234816|FG001|Overall Study|Protocol Specified Criteria|8|||
147020380|NCT01181531|530234815|FG000|Overall Study|Pregnancy|0|||
147020381|NCT01181531|530234816|FG001|Overall Study|Pregnancy|1|||
147020382|NCT01181531|530234815|FG000|Overall Study|Withdrawal by Subject|8|||
147020383|NCT01181531|530234816|FG001|Overall Study|Withdrawal by Subject|7|||
147020384|NCT01181531|530234815|FG000|Overall Study|Protocol Violation|6|||
147020385|NCT01181531|530234816|FG001|Overall Study|Protocol Violation|6|||
147020386|NCT01181531|530234815|FG000|Overall Study|Death|9|||
147020387|NCT01181531|530234816|FG001|Overall Study|Death|12|||
147020388|NCT01181531|530234815|FG000|Overall Study|Adverse Event|0|||
147020389|NCT01181531|530234816|FG001|Overall Study|Adverse Event|1|||
147020390|NCT03183141|530234822|FG000|Overall Study|Withdrawal by Subject|2|||
147020391|NCT03183141|530234823|FG001|Overall Study|Withdrawal by Subject|4|||
147020392|NCT03183141|530234822|FG000|Overall Study|Death|0|||
147020393|NCT03183141|530234823|FG001|Overall Study|Death|8|||
147020394|NCT02756637|530234824|FG000|Overall Study|Not eligible for initial SWOG study|10|||
147020395|NCT02756637|530234825|FG001|Overall Study|Not eligible for initial SWOG study|10|||
147020396|NCT02756637|530234824|FG000|Overall Study|No available NLR value|44|||
147020397|NCT02756637|530234825|FG001|Overall Study|No available NLR value|44|||
147020398|NCT02756637|530234824|FG000|Overall Study|Did not complete curative therapy|33|||
147020399|NCT02756637|530234825|FG001|Overall Study|Did not complete curative therapy|0|||
147020400|NCT01507090|530234826|FG000|Overall Study|incomplete dataset|18|||
147020401|NCT04034355|530234829|FG000|Overall Study|Study terminated by Sponsor|10|||
147020402|NCT04034355|530234830|FG001|Overall Study|Study terminated by Sponsor|17|||
147020403|NCT04034355|530234829|FG000|Overall Study|Withdrawal by Subject|12|||
147020404|NCT04034355|530234830|FG001|Overall Study|Withdrawal by Subject|11|||
147020405|NCT04034355|530234829|FG000|Overall Study|Site terminated by Sponsor|4|||
147020406|NCT04034355|530234830|FG001|Overall Study|Site terminated by Sponsor|5|||
147020407|NCT04034355|530234829|FG000|Overall Study|Adverse Event|2|||
146736557|NCT03879408|529206912|FG000|Overall Study|Lost to Follow-up|0|||
146736558|NCT03879408|529206913|FG001|Overall Study|Lost to Follow-up|3|||
146736559|NCT03879408|529206914|FG002|Overall Study|Lost to Follow-up|2|||
146736560|NCT03879408|529206915|FG003|Overall Study|Lost to Follow-up|1|||
146736561|NCT03879408|529206916|FG004|Overall Study|Lost to Follow-up|0|||
146736562|NCT03879408|529206912|FG000|Overall Study|Withdrawal by Subject|2|||
146736563|NCT03879408|529206913|FG001|Overall Study|Withdrawal by Subject|1|||
146736564|NCT03879408|529206914|FG002|Overall Study|Withdrawal by Subject|1|||
146736565|NCT03879408|529206915|FG003|Overall Study|Withdrawal by Subject|0|||
146736566|NCT03879408|529206916|FG004|Overall Study|Withdrawal by Subject|1|||
146736567|NCT01320943|529206917|FG000|Overall Study|Lost to Follow-up|1|||
146736568|NCT01320943|529206918|FG001|Overall Study|Lost to Follow-up|0|||
146736569|NCT01320943|529206917|FG000|Overall Study|Physician Decision|0|||
146736570|NCT01320943|529206918|FG001|Overall Study|Physician Decision|1|||
146736571|NCT01320943|529206917|FG000|Overall Study|Randomized but not Treated|0|||
146736572|NCT01320943|529206918|FG001|Overall Study|Randomized but not Treated|1|||
146736573|NCT00652938|529206927|FG000|Overall Study|Adverse Event|1|||
146736574|NCT00652938|529206928|FG001|Overall Study|Adverse Event|0|||
146736575|NCT00652938|529206929|FG002|Overall Study|Adverse Event|2|||
146736576|NCT00652938|529206927|FG000|Overall Study|Withdrawal by Subject|0|||
146736577|NCT00652938|529206928|FG001|Overall Study|Withdrawal by Subject|6|||
146736578|NCT00652938|529206929|FG002|Overall Study|Withdrawal by Subject|1|||
146736579|NCT00652938|529206927|FG000|Overall Study|Lost to Follow-up|0|||
146736580|NCT00652938|529206928|FG001|Overall Study|Lost to Follow-up|0|||
146736581|NCT00652938|529206929|FG002|Overall Study|Lost to Follow-up|2|||
146736582|NCT00652938|529206927|FG000|Overall Study|fear of blood sampling|0|||
146736583|NCT00652938|529206928|FG001|Overall Study|fear of blood sampling|1|||
146736584|NCT00652938|529206929|FG002|Overall Study|fear of blood sampling|0|||
146736585|NCT02272725|529206937|FG000|Overall Study|equipment malfunction|2|||
146736586|NCT02272725|529206938|FG001|Overall Study|equipment malfunction|0|||
146736587|NCT04739761|529206939|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
146736588|NCT04739761|529206940|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
146736589|NCT04739761|529206939|FG000|Overall Study|By complete response from the participant|1|||
146736590|NCT04739761|529206940|FG001|Overall Study|By complete response from the participant|0|||
146736591|NCT04739761|529206939|FG000|Overall Study|Lost to Follow-up|3|||
146736592|NCT04739761|529206940|FG001|Overall Study|Lost to Follow-up|3|||
146736593|NCT04739761|529206939|FG000|Overall Study|Death|13|||
146736594|NCT04739761|529206940|FG001|Overall Study|Death|13|||
146736595|NCT04739761|529206939|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
146736596|NCT04739761|529206940|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
146736597|NCT04739761|529206939|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
146849198|NCT01865747|529617057|FG001|Overall Study (ITT)|Adverse Event|31|||
147020408|NCT04034355|530234830|FG001|Overall Study|Adverse Event|0|||
147020409|NCT04034355|530234829|FG000|Overall Study|Death|1|||
147020410|NCT04034355|530234830|FG001|Overall Study|Death|1|||
147020411|NCT04034355|530234829|FG000|Overall Study|Not reported|2|||
147020412|NCT04034355|530234830|FG001|Overall Study|Not reported|0|||
147020413|NCT04034355|530234829|FG000|Overall Study|Lost to Follow-up|1|||
147020414|NCT04034355|530234830|FG001|Overall Study|Lost to Follow-up|0|||
147020415|NCT04034355|530234829|FG000|Overall Study|Physician Decision|1|||
147020416|NCT04034355|530234830|FG001|Overall Study|Physician Decision|0|||
147020417|NCT04034355|530234829|FG000|Overall Study|Protocol Violation|0|||
147020418|NCT04034355|530234830|FG001|Overall Study|Protocol Violation|1|||
147020419|NCT04034355|530234829|FG000|Overall Study|Progressive disease|1|||
147020420|NCT04034355|530234830|FG001|Overall Study|Progressive disease|0|||
147020421|NCT01552369|530236455|FG000|Overall Study|Did not consent to extended follow up|8|||
147020422|NCT01552369|530236456|FG001|Overall Study|Did not consent to extended follow up|9|||
146736598|NCT04739761|529206940|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
146736599|NCT04739761|529206939|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
146736600|NCT04739761|529206940|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
146736601|NCT04739761|529206939|FG000|Overall Study|Adverse Event|0|||
146736602|NCT04739761|529206940|FG001|Overall Study|Adverse Event|3|||
146736603|NCT04739761|529206939|FG000|Overall Study|Participant decision|1|||
146736604|NCT04739761|529206940|FG001|Overall Study|Participant decision|0|||
147020423|NCT02999984|530236464|FG000|Overall Study|Treatment Failure|1|||
147020424|NCT04039919|530236467|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147020425|NCT04039919|530236468|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147020426|NCT04039919|530236469|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147020427|NCT04039919|530236470|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147020428|NCT04039919|530236471|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147020429|NCT04039919|530236467|FG000|Treatment Period 1|Sponsor's decision|0|||
147020430|NCT04039919|530236468|FG001|Treatment Period 1|Sponsor's decision|0|||
147020431|NCT04039919|530236469|FG002|Treatment Period 1|Sponsor's decision|0|||
147020432|NCT04039919|530236470|FG003|Treatment Period 1|Sponsor's decision|0|||
147020433|NCT04039919|530236471|FG004|Treatment Period 1|Sponsor's decision|16|||
147020434|NCT04039919|530236467|FG000|Treatment Period 5|Withdrawal by Subject|1|||
147020435|NCT04039919|530236468|FG001|Treatment Period 5|Withdrawal by Subject|0|||
147020436|NCT04039919|530236469|FG002|Treatment Period 5|Withdrawal by Subject|0|||
147020437|NCT04039919|530236470|FG003|Treatment Period 5|Withdrawal by Subject|0|||
147020438|NCT04039919|530236471|FG004|Treatment Period 5|Withdrawal by Subject|0|||
147020439|NCT00754013|530236472|FG000|Overall Study|Lost to Follow-up|1|||
147020440|NCT00754013|530236473|FG001|Overall Study|Lost to Follow-up|1|||
147020441|NCT00754013|530236472|FG000|Overall Study|didn't return after study termed|3|||
147020442|NCT00754013|530236473|FG001|Overall Study|didn't return after study termed|4|||
147020443|NCT02310789|530236474|FG000|Overall Study|Adverse Event|1|||
147020444|NCT01197417|530236475|FG000|Overall Study|Physician Decision|3|||
147020445|NCT01197417|530236476|FG001|Overall Study|Physician Decision|2|||
147020446|NCT01197417|530236475|FG000|Overall Study|Withdrawal by Subject|2|||
147020447|NCT01197417|530236476|FG001|Overall Study|Withdrawal by Subject|4|||
147020448|NCT01197417|530236475|FG000|Overall Study|Site miscommunication|0|||
147020449|NCT01197417|530236476|FG001|Overall Study|Site miscommunication|1|||
147020450|NCT01197417|530236475|FG000|Overall Study|Subject transferred to intensive care|0|||
147020451|NCT01197417|530236476|FG001|Overall Study|Subject transferred to intensive care|1|||
147020452|NCT01197417|530236475|FG000|Overall Study|Not consented in time to receive drug|0|||
147020453|NCT01197417|530236476|FG001|Overall Study|Not consented in time to receive drug|1|||
147020454|NCT01197417|530236475|FG000|Overall Study|Hypotension|1|||
147020455|NCT01197417|530236476|FG001|Overall Study|Hypotension|2|||
147020456|NCT01197417|530236475|FG000|Overall Study|Found to be ineligible|2|||
147020457|NCT01197417|530236476|FG001|Overall Study|Found to be ineligible|5|||
147020458|NCT01197417|530236475|FG000|Overall Study|No 25-hour magnesium level|0|||
147020459|NCT01197417|530236476|FG001|Overall Study|No 25-hour magnesium level|2|||
147020460|NCT03250299|530236477|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
147020461|NCT03250299|530236478|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
147020462|NCT03250299|530236479|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
147020463|NCT03250299|530236480|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
147020464|NCT03250299|530236481|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
147020465|NCT03250299|530236477|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
147020466|NCT03250299|530236478|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
147020467|NCT03250299|530236479|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
147020468|NCT03250299|530236480|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
147020469|NCT03250299|530236481|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
147020470|NCT03250299|530236477|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
147020471|NCT03250299|530236478|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
147020472|NCT03250299|530236479|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
147020473|NCT03250299|530236480|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
147020474|NCT03250299|530236481|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
147020475|NCT03250299|530236477|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
147020476|NCT03250299|530236478|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
147020477|NCT03250299|530236479|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
147020478|NCT03250299|530236480|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
147020479|NCT03250299|530236481|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
147020480|NCT01546142|530236496|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
147020481|NCT01546142|530236497|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
147020482|NCT01546142|530236496|FG000|Overall Study|Subject Noncompliance|1|||
147020483|NCT01546142|530236497|FG001|Overall Study|Subject Noncompliance|1|||
147020484|NCT01546142|530236496|FG000|Overall Study|Adverse Event|6|||
147020485|NCT01546142|530236497|FG001|Overall Study|Adverse Event|3|||
147020486|NCT01546142|530236496|FG000|Overall Study|Lost to Follow-up|20|||
147020487|NCT01546142|530236497|FG001|Overall Study|Lost to Follow-up|15|||
147020488|NCT01546142|530236496|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
147020489|NCT01546142|530236497|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
147020490|NCT01546142|530236496|FG000|Overall Study|Subject Randomized but Not Treated|1|||
147020491|NCT01546142|530236497|FG001|Overall Study|Subject Randomized but Not Treated|0|||
147020492|NCT01213836|530236498|FG000|Period 1, First Intervention|Adverse Event|2|||
147020493|NCT01213836|530236499|FG001|Period 1, First Intervention|Adverse Event|1|||
147020494|NCT01213836|530236498|FG000|Period 1, First Intervention|Protocol Violation|0|||
147020495|NCT01213836|530236499|FG001|Period 1, First Intervention|Protocol Violation|1|||
147020496|NCT01213836|530236498|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
147020497|NCT01213836|530236499|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
147020498|NCT00706095|530236506|FG000|Overall Study|Progressive Disease|4|||
147020499|NCT00706095|530236507|FG001|Overall Study|Progressive Disease|5|||
147020500|NCT00706095|530236508|FG002|Overall Study|Progressive Disease|3|||
147020501|NCT00706095|530236506|FG000|Overall Study|Clinical Progression|1|||
147020502|NCT00706095|530236507|FG001|Overall Study|Clinical Progression|2|||
147020503|NCT00706095|530236508|FG002|Overall Study|Clinical Progression|2|||
147020504|NCT00706095|530236506|FG000|Overall Study|Withdrawal by Subject|1|||
147020505|NCT00706095|530236507|FG001|Overall Study|Withdrawal by Subject|0|||
147020506|NCT00706095|530236508|FG002|Overall Study|Withdrawal by Subject|0|||
147020507|NCT04213209|530236514|FG000|Overall Study|Protocol Violation|1|||
147020508|NCT04213209|530236515|FG001|Overall Study|Protocol Violation|0|||
147020509|NCT04213209|530236516|FG002|Overall Study|Protocol Violation|0|||
147020510|NCT04213209|530236517|FG003|Overall Study|Protocol Violation|0|||
147020511|NCT04213209|530236518|FG004|Overall Study|Protocol Violation|0|||
147020512|NCT04213209|530236519|FG005|Overall Study|Protocol Violation|0|||
147020513|NCT02129647|530236529|FG000|Overall Study|Adverse Event|2|||
147020514|NCT02129647|530236529|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
147020515|NCT01311557|530236530|FG000|Overall Study|Serious adverse event|0|||
147020516|NCT01311557|530236531|FG001|Overall Study|Serious adverse event|1|||
147020517|NCT01311557|530236530|FG000|Overall Study|Protocol Violation|4|||
147020518|NCT01311557|530236531|FG001|Overall Study|Protocol Violation|2|||
147020519|NCT01311557|530236530|FG000|Overall Study|Lost to Follow-up|0|||
147020520|NCT01311557|530236531|FG001|Overall Study|Lost to Follow-up|1|||
147020521|NCT01311557|530236530|FG000|Overall Study|Withdrawal by Subject|1|||
147020522|NCT01311557|530236531|FG001|Overall Study|Withdrawal by Subject|2|||
147020523|NCT00608517|530236532|FG000|Overall Study|Death|1|||
147020524|NCT00608517|530236533|FG001|Overall Study|Death|0|||
147020525|NCT00608517|530236534|FG002|Overall Study|Death|0|||
147020526|NCT01833533|530236535|FG000|Overall Study|Adverse Event|0|||
147020527|NCT01833533|530236536|FG001|Overall Study|Adverse Event|1|||
147020528|NCT01833533|530236535|FG000|Overall Study|Lost to Follow-up|4|||
147020529|NCT01833533|530236536|FG001|Overall Study|Lost to Follow-up|9|||
147020530|NCT01833533|530236535|FG000|Overall Study|To Enter an Extension Study|0|||
147020531|NCT01833533|530236536|FG001|Overall Study|To Enter an Extension Study|4|||
147020532|NCT01833533|530236535|FG000|Overall Study|Other|2|||
147020533|NCT01833533|530236536|FG001|Overall Study|Other|7|||
147020534|NCT05212883|530236539|FG000|Overall Study|Invalid test result|125|||
147020535|NCT02502734|530236540|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
147020536|NCT02502734|530236541|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
147020537|NCT02502734|530236540|FG000|Washout Period|Adverse Event|1|||
147020538|NCT02502734|530236541|FG001|Washout Period|Adverse Event|0|||
147020539|NCT01740791|530236545|FG000|Overall Study|Randomized but never treated|5|||
147020540|NCT01740791|530236546|FG001|Overall Study|Randomized but never treated|3|||
147020541|NCT01740791|530236547|FG002|Overall Study|Randomized but never treated|2|||
147020542|NCT01740791|530236548|FG003|Overall Study|Randomized but never treated|2|||
147020543|NCT01740791|530236549|FG004|Overall Study|Randomized but never treated|1|||
147020544|NCT01740791|530236550|FG005|Overall Study|Randomized but never treated|3|||
147020545|NCT01740791|530236545|FG000|Overall Study|Lost to Follow-up|2|||
147020546|NCT01740791|530236546|FG001|Overall Study|Lost to Follow-up|0|||
147020547|NCT01740791|530236547|FG002|Overall Study|Lost to Follow-up|2|||
147020548|NCT01740791|530236548|FG003|Overall Study|Lost to Follow-up|3|||
147020549|NCT01740791|530236549|FG004|Overall Study|Lost to Follow-up|2|||
147020550|NCT01740791|530236550|FG005|Overall Study|Lost to Follow-up|3|||
147020551|NCT01740791|530236545|FG000|Overall Study|Withdrew Consent|4|||
147020552|NCT01740791|530236546|FG001|Overall Study|Withdrew Consent|0|||
147020553|NCT01740791|530236547|FG002|Overall Study|Withdrew Consent|1|||
147020554|NCT01740791|530236548|FG003|Overall Study|Withdrew Consent|2|||
147020555|NCT01740791|530236549|FG004|Overall Study|Withdrew Consent|0|||
147020556|NCT01740791|530236550|FG005|Overall Study|Withdrew Consent|3|||
147020557|NCT01740791|530236545|FG000|Overall Study|Investigator's discretion|1|||
147020558|NCT01740791|530236546|FG001|Overall Study|Investigator's discretion|0|||
147020559|NCT01740791|530236547|FG002|Overall Study|Investigator's discretion|1|||
147020560|NCT01740791|530236548|FG003|Overall Study|Investigator's discretion|0|||
147020561|NCT01740791|530236549|FG004|Overall Study|Investigator's discretion|0|||
147020562|NCT01740791|530236550|FG005|Overall Study|Investigator's discretion|1|||
147020563|NCT01740791|530236545|FG000|Overall Study|Adverse Event|0|||
147020564|NCT01740791|530236546|FG001|Overall Study|Adverse Event|0|||
147020565|NCT01740791|530236547|FG002|Overall Study|Adverse Event|0|||
147020566|NCT01740791|530236548|FG003|Overall Study|Adverse Event|0|||
147020567|NCT01740791|530236549|FG004|Overall Study|Adverse Event|0|||
147020568|NCT01740791|530236550|FG005|Overall Study|Adverse Event|1|||
147020569|NCT01463982|530236551|FG000|Overall Study|Withdrawal by Subject|0|||
147020570|NCT01463982|530236552|FG001|Overall Study|Withdrawal by Subject|1|||
147020571|NCT01463982|530236553|FG002|Overall Study|Withdrawal by Subject|1|||
147020572|NCT01463982|530236554|FG003|Overall Study|Withdrawal by Subject|0|||
147020573|NCT01463982|530236551|FG000|Overall Study|Treatment delay over 5 week|0|||
147020574|NCT01463982|530236552|FG001|Overall Study|Treatment delay over 5 week|0|||
147020575|NCT01463982|530236553|FG002|Overall Study|Treatment delay over 5 week|1|||
147020576|NCT01463982|530236554|FG003|Overall Study|Treatment delay over 5 week|0|||
147020577|NCT03417830|530236557|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
147020578|NCT03417830|530236558|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
147020579|NCT00941720|530236563|FG000|Overall Study|Withdrawal by Subject|1|||
147020580|NCT00941720|530236563|FG000|Overall Study|Insurance denied participation|11|||
147020581|NCT00941720|530236563|FG000|Overall Study|ineligible|2|||
147020582|NCT03827018|530236566|FG000|Overall Study|Adverse Event|1|||
147020583|NCT03827018|530236567|FG001|Overall Study|Adverse Event|0|||
147020584|NCT03827018|530236566|FG000|Overall Study|Withdrawal by Subject|2|||
147020585|NCT03827018|530236567|FG001|Overall Study|Withdrawal by Subject|2|||
147020586|NCT03827018|530236566|FG000|Overall Study|Lack of Efficacy|0|||
147020587|NCT03827018|530236567|FG001|Overall Study|Lack of Efficacy|1|||
147020588|NCT00268892|530236569|FG000|Overall Study|Adverse Event|14|||
147020589|NCT00268892|530236570|FG001|Overall Study|Adverse Event|17|||
147020590|NCT00268892|530236571|FG002|Overall Study|Adverse Event|20|||
147020591|NCT00268892|530236569|FG000|Overall Study|Lack of Efficacy|1|||
147020592|NCT00268892|530236570|FG001|Overall Study|Lack of Efficacy|3|||
147020593|NCT00268892|530236571|FG002|Overall Study|Lack of Efficacy|0|||
147020594|NCT00268892|530236569|FG000|Overall Study|Withdrawal by Subject|14|||
147020595|NCT00268892|530236570|FG001|Overall Study|Withdrawal by Subject|15|||
147020596|NCT00268892|530236571|FG002|Overall Study|Withdrawal by Subject|13|||
147020597|NCT00268892|530236569|FG000|Overall Study|Physician Decision|0|||
147020598|NCT00268892|530236570|FG001|Overall Study|Physician Decision|1|||
147020599|NCT00268892|530236571|FG002|Overall Study|Physician Decision|0|||
147020600|NCT00268892|530236569|FG000|Overall Study|Lost to Follow-up|5|||
147020601|NCT00268892|530236570|FG001|Overall Study|Lost to Follow-up|2|||
147020602|NCT00268892|530236571|FG002|Overall Study|Lost to Follow-up|4|||
147020603|NCT00268892|530236569|FG000|Overall Study|Protocol Violation|0|||
147020604|NCT00268892|530236570|FG001|Overall Study|Protocol Violation|1|||
147020605|NCT00268892|530236571|FG002|Overall Study|Protocol Violation|0|||
147020606|NCT00268892|530236569|FG000|Overall Study|Disease Progression|1|||
147020607|NCT00268892|530236570|FG001|Overall Study|Disease Progression|1|||
147020608|NCT00268892|530236571|FG002|Overall Study|Disease Progression|0|||
147020609|NCT00268892|530236569|FG000|Overall Study|Trial Site Closed|4|||
147020610|NCT00268892|530236570|FG001|Overall Study|Trial Site Closed|2|||
147020611|NCT00268892|530236571|FG002|Overall Study|Trial Site Closed|2|||
147020612|NCT03366194|530236572|FG000|Overall Study|Lost to Follow-up|2|||
147020613|NCT03078478|530236573|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
147020614|NCT03078478|530236574|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
147020615|NCT03078478|530236573|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
147020616|NCT03078478|530236574|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
147020617|NCT03078478|530236573|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
147020618|NCT03078478|530236574|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
147020619|NCT03078478|530236573|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
147020620|NCT03078478|530236574|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
147020621|NCT03078478|530236573|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
147020622|NCT03078478|530236574|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
147020623|NCT03078478|530236573|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
147020624|NCT03078478|530236574|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
147020625|NCT03078478|530236573|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
147020626|NCT03078478|530236574|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
147020627|NCT03078478|530236573|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
147020628|NCT03078478|530236574|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
147020629|NCT00545688|530236575|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
147020630|NCT00545688|530236576|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
147020631|NCT00545688|530236577|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
147020632|NCT00545688|530236578|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
147020633|NCT00545688|530236575|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
147020634|NCT00545688|530236576|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
147020635|NCT00545688|530236577|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
147020636|NCT00545688|530236578|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
147020637|NCT00545688|530236575|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
147020638|NCT00545688|530236576|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
147020639|NCT00545688|530236577|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
147020640|NCT00545688|530236578|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
147020641|NCT00545688|530236575|FG000|Neo-Adjuvant Treatment Period|Death|0|||
147020642|NCT00545688|530236576|FG001|Neo-Adjuvant Treatment Period|Death|1|||
147020643|NCT00545688|530236577|FG002|Neo-Adjuvant Treatment Period|Death|0|||
147020644|NCT00545688|530236578|FG003|Neo-Adjuvant Treatment Period|Death|0|||
147020645|NCT00545688|530236575|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
147020646|NCT00545688|530236576|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
147020647|NCT00545688|530236577|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
147020648|NCT00545688|530236578|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
147020649|NCT00545688|530236575|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
147020650|NCT00545688|530236576|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
147020651|NCT00545688|530236577|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
147020652|NCT00545688|530236578|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
147020653|NCT00545688|530236575|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
147020654|NCT00545688|530236576|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
147020655|NCT00545688|530236577|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
147020656|NCT00545688|530236578|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
147020657|NCT00545688|530236575|FG000|Adjuvant Treatment Period|Disease Progression|3|||
147020658|NCT00545688|530236576|FG001|Adjuvant Treatment Period|Disease Progression|3|||
147020659|NCT00545688|530236577|FG002|Adjuvant Treatment Period|Disease Progression|0|||
147020660|NCT00545688|530236578|FG003|Adjuvant Treatment Period|Disease Progression|7|||
147020661|NCT00545688|530236575|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
147020662|NCT00545688|530236576|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
147020663|NCT00545688|530236577|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
147020664|NCT00545688|530236578|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
147020665|NCT00545688|530236575|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
147020666|NCT00545688|530236576|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
147020667|NCT00545688|530236577|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
147020668|NCT00545688|530236578|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
147020669|NCT00545688|530236575|FG000|Adjuvant Treatment Period|Adverse Event|0|||
147020670|NCT00545688|530236576|FG001|Adjuvant Treatment Period|Adverse Event|3|||
147020671|NCT00545688|530236577|FG002|Adjuvant Treatment Period|Adverse Event|2|||
147020672|NCT00545688|530236578|FG003|Adjuvant Treatment Period|Adverse Event|2|||
147020673|NCT00545688|530236575|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
147020674|NCT00545688|530236576|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
147020675|NCT00545688|530236577|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
147020676|NCT00545688|530236578|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
147020677|NCT00545688|530236575|FG000|Follow-Up Period|Death|4|||
147020678|NCT00545688|530236576|FG001|Follow-Up Period|Death|2|||
147020679|NCT00545688|530236577|FG002|Follow-Up Period|Death|2|||
147020680|NCT00545688|530236578|FG003|Follow-Up Period|Death|6|||
147020681|NCT00545688|530236575|FG000|Follow-Up Period|Disease Progression|6|||
147020682|NCT00545688|530236576|FG001|Follow-Up Period|Disease Progression|5|||
147020683|NCT00545688|530236577|FG002|Follow-Up Period|Disease Progression|9|||
147020684|NCT00545688|530236578|FG003|Follow-Up Period|Disease Progression|9|||
147020685|NCT00545688|530236575|FG000|Follow-Up Period|Refused Treatment|6|||
147020686|NCT00545688|530236576|FG001|Follow-Up Period|Refused Treatment|2|||
147020687|NCT00545688|530236577|FG002|Follow-Up Period|Refused Treatment|0|||
147020688|NCT00545688|530236578|FG003|Follow-Up Period|Refused Treatment|2|||
147020689|NCT00545688|530236575|FG000|Follow-Up Period|Lost to Follow-up|3|||
147020690|NCT00545688|530236576|FG001|Follow-Up Period|Lost to Follow-up|3|||
147020691|NCT00545688|530236577|FG002|Follow-Up Period|Lost to Follow-up|3|||
147020692|NCT00545688|530236578|FG003|Follow-Up Period|Lost to Follow-up|1|||
147020693|NCT00545688|530236575|FG000|Follow-Up Period|Unspecified Reason|2|||
147020694|NCT00545688|530236576|FG001|Follow-Up Period|Unspecified Reason|5|||
147020695|NCT00545688|530236577|FG002|Follow-Up Period|Unspecified Reason|6|||
147020696|NCT00545688|530236578|FG003|Follow-Up Period|Unspecified Reason|8|||
147020697|NCT00545688|530236575|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
147020698|NCT00545688|530236576|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
147020699|NCT00545688|530236577|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
147020700|NCT00545688|530236578|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
147020701|NCT02792218|530236579|FG000|Overall Study|Patient/guardian decision|15|||
147020702|NCT02792218|530236580|FG001|Overall Study|Patient/guardian decision|42|||
147020703|NCT02792218|530236579|FG000|Overall Study|Adverse Event|15|||
147020704|NCT02792218|530236580|FG001|Overall Study|Adverse Event|14|||
147020705|NCT02792218|530236579|FG000|Overall Study|Lost to Follow-up|10|||
147020706|NCT02792218|530236580|FG001|Overall Study|Lost to Follow-up|5|||
147020707|NCT02792218|530236579|FG000|Overall Study|Lack of Efficacy|1|||
147020708|NCT02792218|530236580|FG001|Overall Study|Lack of Efficacy|12|||
147020709|NCT02792218|530236579|FG000|Overall Study|Physician Decision|4|||
147020710|NCT02792218|530236580|FG001|Overall Study|Physician Decision|4|||
147020711|NCT02792218|530236579|FG000|Overall Study|Protocol deviation|3|||
147020712|NCT02792218|530236580|FG001|Overall Study|Protocol deviation|2|||
147020713|NCT02792218|530236579|FG000|Overall Study|New therapy for study indication|0|||
147020714|NCT02792218|530236580|FG001|Overall Study|New therapy for study indication|1|||
147020715|NCT02792218|530236579|FG000|Overall Study|Non-compliance with study treatment|0|||
147020716|NCT02792218|530236580|FG001|Overall Study|Non-compliance with study treatment|1|||
147020717|NCT02792218|530236579|FG000|Overall Study|Pregnancy|1|||
146849199|NCT01865747|529617056|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
147020718|NCT02792218|530236580|FG001|Overall Study|Pregnancy|0|||
147020719|NCT00955721|530236581|FG000|Overall Study|Physician Decision|1|||
147020720|NCT00955721|530236582|FG001|Overall Study|Physician Decision|0|||
147020721|NCT00955721|530236581|FG000|Overall Study|Death|1|||
147020722|NCT00955721|530236582|FG001|Overall Study|Death|0|||
147020723|NCT00955721|530236581|FG000|Overall Study|Withdrawal by Subject|1|||
147020724|NCT00955721|530236582|FG001|Overall Study|Withdrawal by Subject|0|||
147020725|NCT01253317|530236587|FG000|Overall Study|Adverse Event|2|||
147020726|NCT02065713|530237455|FG000|Overall Study|Adverse Event|0|||
147020727|NCT02065713|530237456|FG001|Overall Study|Adverse Event|1|||
147020728|NCT02065713|530237455|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147020729|NCT02065713|530237456|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147020730|NCT00892281|530237459|FG000|Overall Study|Adverse Event|65|||
147020731|NCT00892281|530237460|FG001|Overall Study|Adverse Event|8|||
147020732|NCT00892281|530237459|FG000|Overall Study|Lost to Follow-up|81|||
147020733|NCT00892281|530237460|FG001|Overall Study|Lost to Follow-up|8|||
147020734|NCT00892281|530237459|FG000|Overall Study|Pregnancy|1|||
147020735|NCT00892281|530237460|FG001|Overall Study|Pregnancy|0|||
147020736|NCT00892281|530237459|FG000|Overall Study|Protocol Violation|7|||
147020737|NCT00892281|530237460|FG001|Overall Study|Protocol Violation|2|||
147020738|NCT00892281|530237459|FG000|Overall Study|Withdrawal by Subject|86|||
147020739|NCT00892281|530237460|FG001|Overall Study|Withdrawal by Subject|14|||
147020740|NCT00892281|530237459|FG000|Overall Study|Subject failed to return for final visit|2|||
147020741|NCT00892281|530237460|FG001|Overall Study|Subject failed to return for final visit|0|||
147020742|NCT00892281|530237459|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
147020743|NCT00892281|530237460|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
147020744|NCT00892281|530237459|FG000|Overall Study|Final visit completed 4 weeks late|0|||
147020745|NCT00892281|530237460|FG001|Overall Study|Final visit completed 4 weeks late|1|||
147020746|NCT00892281|530237459|FG000|Overall Study|Subject completed day after study closed|1|||
147020747|NCT00892281|530237460|FG001|Overall Study|Subject completed day after study closed|0|||
147020748|NCT00892281|530237459|FG000|Overall Study|Family emergency|1|||
147020749|NCT00892281|530237460|FG001|Overall Study|Family emergency|0|||
147020750|NCT00892281|530237459|FG000|Overall Study|Last visit not done - death in family|1|||
147020751|NCT00892281|530237460|FG001|Overall Study|Last visit not done - death in family|0|||
147020752|NCT00892281|530237459|FG000|Overall Study|Did not meet incl/excl criteria|1|||
147020753|NCT00892281|530237460|FG001|Overall Study|Did not meet incl/excl criteria|0|||
147020754|NCT00892281|530237459|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
147020755|NCT00892281|530237460|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
147020756|NCT00892281|530237459|FG000|Overall Study|Unable to redeem the drug voucher|1|||
147020757|NCT00892281|530237460|FG001|Overall Study|Unable to redeem the drug voucher|0|||
147020758|NCT00892281|530237459|FG000|Overall Study|Subject not good candidate for study|1|||
147020759|NCT00892281|530237460|FG001|Overall Study|Subject not good candidate for study|0|||
147020760|NCT00892281|530237459|FG000|Overall Study|Subject did not return for any visits|1|||
147020761|NCT00892281|530237460|FG001|Overall Study|Subject did not return for any visits|0|||
147020762|NCT00892281|530237459|FG000|Overall Study|Subject missed several visits/lost meds|1|||
147020763|NCT00892281|530237460|FG001|Overall Study|Subject missed several visits/lost meds|0|||
147020764|NCT00892281|530237459|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
147020765|NCT00892281|530237460|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
147020766|NCT00892281|530237459|FG000|Overall Study|Scheduled for knee replacement|0|||
147020767|NCT00892281|530237460|FG001|Overall Study|Scheduled for knee replacement|1|||
147020768|NCT00892281|530237459|FG000|Overall Study|PI complained of inadequate compensation|3|||
147020769|NCT00892281|530237460|FG001|Overall Study|PI complained of inadequate compensation|0|||
147020770|NCT00892281|530237459|FG000|Overall Study|Subject lost interest in program|0|||
147020771|NCT00892281|530237460|FG001|Overall Study|Subject lost interest in program|1|||
147020772|NCT00892281|530237459|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
147020773|NCT00892281|530237460|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
147020774|NCT00892281|530237459|FG000|Overall Study|Death in family|1|||
147020775|NCT00892281|530237460|FG001|Overall Study|Death in family|0|||
147020776|NCT00892281|530237459|FG000|Overall Study|Lack of efficacy of study product|2|||
147020777|NCT00892281|530237460|FG001|Overall Study|Lack of efficacy of study product|0|||
147020778|NCT00892281|530237459|FG000|Overall Study|Subject not seen by PI at final visit|1|||
147020779|NCT00892281|530237460|FG001|Overall Study|Subject not seen by PI at final visit|0|||
147020780|NCT00892281|530237459|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
147020781|NCT00892281|530237460|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
147020782|NCT00892281|530237459|FG000|Overall Study|Missed multiple visits|1|||
147020783|NCT00892281|530237460|FG001|Overall Study|Missed multiple visits|0|||
147020784|NCT00892281|530237459|FG000|Overall Study|Missed visits rescheduled out of window|1|||
147020785|NCT00892281|530237460|FG001|Overall Study|Missed visits rescheduled out of window|0|||
147020786|NCT00892281|530237459|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
147020787|NCT00892281|530237460|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
147020788|NCT00892281|530237459|FG000|Overall Study|Subject had history of drug abuse|1|||
147020789|NCT00892281|530237460|FG001|Overall Study|Subject had history of drug abuse|0|||
147020790|NCT00892281|530237459|FG000|Overall Study|Rash on hand|1|||
147020791|NCT00892281|530237460|FG001|Overall Study|Rash on hand|0|||
147020792|NCT00892281|530237459|FG000|Overall Study|Visit 4 date out of window|1|||
147020793|NCT00892281|530237460|FG001|Overall Study|Visit 4 date out of window|0|||
147020794|NCT00685802|530237465|FG000|Washout Period of 7 Days|Protocol Violation|2|||
147020795|NCT00685802|530237466|FG001|Washout Period of 7 Days|Protocol Violation|0|||
147020796|NCT00685802|530237465|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
147020797|NCT00685802|530237466|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
147020798|NCT00619359|530237467|FG000|Overall Study|Adverse Event|32|||
147020799|NCT00619359|530237468|FG001|Overall Study|Adverse Event|36|||
147020800|NCT00619359|530237467|FG000|Overall Study|Lost to Follow-up|12|||
147020801|NCT00619359|530237468|FG001|Overall Study|Lost to Follow-up|16|||
147020802|NCT00619359|530237467|FG000|Overall Study|Physician Decision|0|||
147020803|NCT00619359|530237468|FG001|Overall Study|Physician Decision|7|||
147020804|NCT00619359|530237467|FG000|Overall Study|Protocol Violation|1|||
147020805|NCT00619359|530237468|FG001|Overall Study|Protocol Violation|1|||
147020806|NCT00619359|530237467|FG000|Overall Study|Withdrawal by Subject|19|||
147020807|NCT00619359|530237468|FG001|Overall Study|Withdrawal by Subject|20|||
147020808|NCT00619359|530237467|FG000|Overall Study|Progressive Disease|3|||
147020809|NCT00619359|530237468|FG001|Overall Study|Progressive Disease|1|||
147020810|NCT00103038|530237469|FG000|Overall Study|Withdrawal by Subject|8|||
147020811|NCT00103038|530237469|FG000|Overall Study|Screen failure|3|||
147020812|NCT00103038|530237469|FG000|Overall Study|Death|1|||
147020813|NCT00103038|530237469|FG000|Overall Study|Physician Decision|1|||
147020814|NCT01731886|530237470|FG000|Overall Study|Death|1|||
147020815|NCT01731886|530237471|FG001|Overall Study|Death|0|||
147020816|NCT01731886|530237470|FG000|Overall Study|Never started treatment|0|||
147020817|NCT01731886|530237471|FG001|Overall Study|Never started treatment|1|||
147020818|NCT01731886|530237470|FG000|Overall Study|Non-compliant|1|||
147020819|NCT01731886|530237471|FG001|Overall Study|Non-compliant|0|||
147020820|NCT02280187|530237472|FG000|Overall Study|Lost to Follow-up|218|||
147020821|NCT02087176|530237479|FG000|Overall Study|Withdrawal by Subject|1|||
147020822|NCT02087176|530237479|FG000|Overall Study|Death|10|||
147020823|NCT02087176|530237479|FG000|Overall Study|Censored|19|||
147020824|NCT02087176|530237479|FG000|Overall Study|Study Terminated by Sponsor|2|||
147020825|NCT04099641|530237483|FG000|Overall Study|Death|46|||
147020826|NCT04099641|530237484|FG001|Overall Study|Death|12|||
147020827|NCT04099641|530237483|FG000|Overall Study|Lost to Follow-up|1|||
147020828|NCT04099641|530237484|FG001|Overall Study|Lost to Follow-up|0|||
147020829|NCT04099641|530237483|FG000|Overall Study|Withdrawal by Subject|2|||
147020830|NCT04099641|530237484|FG001|Overall Study|Withdrawal by Subject|0|||
147020831|NCT00895037|530237485|FG000|Overall Study|Death|0|||
147020832|NCT00895037|530237486|FG001|Overall Study|Death|2|||
147020833|NCT00895037|530237487|FG002|Overall Study|Death|1|||
147020834|NCT02470091|530237500|FG000|Overall Study|Withdrawal by Subject|1|||
147020835|NCT02470091|530237501|FG001|Overall Study|Withdrawal by Subject|0|||
147020836|NCT02470091|530237500|FG000|Overall Study|Ineligible|0|||
147020837|NCT02470091|530237501|FG001|Overall Study|Ineligible|2|||
147020838|NCT00303667|530237513|FG000|Overall Study|Death|0|||
147020839|NCT00303667|530237514|FG001|Overall Study|Death|4|||
147020840|NCT01192399|530237515|FG000|Overall Study|Lack of Efficacy|2|||
147020841|NCT01029392|530237516|FG000|Overall Study|Withdrawal by Subject|18|||
147020842|NCT01029392|530237517|FG001|Overall Study|Withdrawal by Subject|11|||
147020843|NCT01029392|530237516|FG000|Overall Study|Physician Decision|2|||
147020844|NCT01029392|530237517|FG001|Overall Study|Physician Decision|0|||
147020845|NCT01103479|530237518|FG000|Overall Study|Up to date with CRC screening|1|||
147020846|NCT01103479|530237519|FG001|Overall Study|Up to date with CRC screening|9|||
147020847|NCT01103479|530237520|FG002|Overall Study|Up to date with CRC screening|12|||
147020848|NCT01103479|530237518|FG000|Overall Study|Family history of CRC|1|||
147020849|NCT01103479|530237519|FG001|Overall Study|Family history of CRC|0|||
147020850|NCT01103479|530237520|FG002|Overall Study|Family history of CRC|2|||
147020851|NCT01103479|530237518|FG000|Overall Study|Active cancer|1|||
147020852|NCT01103479|530237519|FG001|Overall Study|Active cancer|0|||
147020853|NCT01103479|530237520|FG002|Overall Study|Active cancer|0|||
147020854|NCT01103479|530237518|FG000|Overall Study|Saw non-study physician|2|||
147020855|NCT01103479|530237519|FG001|Overall Study|Saw non-study physician|0|||
147020856|NCT01103479|530237520|FG002|Overall Study|Saw non-study physician|0|||
147020857|NCT01523587|530237521|FG000|Overall Study|Other than listed|5|||
147020858|NCT01523587|530237522|FG001|Overall Study|Other than listed|5|||
147020859|NCT01523587|530237521|FG000|Overall Study|Worsening of underlying cancer disease|19|||
147020860|NCT01523587|530237522|FG001|Overall Study|Worsening of underlying cancer disease|34|||
146849200|NCT01865747|529617057|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
147020861|NCT01523587|530237521|FG000|Overall Study|Adverse Event|68|||
147020862|NCT01523587|530237522|FG001|Overall Study|Adverse Event|52|||
147020863|NCT01523587|530237521|FG000|Overall Study|Protocol Violation|5|||
147020864|NCT01523587|530237522|FG001|Overall Study|Protocol Violation|3|||
147020865|NCT01523587|530237521|FG000|Overall Study|Lost to Follow-up|2|||
147020866|NCT01523587|530237522|FG001|Overall Study|Lost to Follow-up|2|||
147020867|NCT01523587|530237521|FG000|Overall Study|Withdrawal by Subject|28|||
147020868|NCT01523587|530237522|FG001|Overall Study|Withdrawal by Subject|20|||
147020869|NCT01523587|530237521|FG000|Overall Study|Withdrew due to Progressive disease|265|||
147020870|NCT01523587|530237522|FG001|Overall Study|Withdrew due to Progressive disease|279|||
147020871|NCT01523587|530237521|FG000|Overall Study|Randomised but bot treated|6|||
147020872|NCT01523587|530237522|FG001|Overall Study|Randomised but bot treated|2|||
147020873|NCT01298778|530237523|FG000|Overall Study|Lost to Follow-up|2|||
147020874|NCT01298778|530237524|FG001|Overall Study|Lost to Follow-up|3|||
147020875|NCT01298778|530237523|FG000|Overall Study|Incorrect use of VAS|1|||
147020876|NCT01298778|530237524|FG001|Overall Study|Incorrect use of VAS|0|||
147020877|NCT01298778|530237523|FG000|Overall Study|Withdrawal by Subject|0|||
147020878|NCT01298778|530237524|FG001|Overall Study|Withdrawal by Subject|1|||
147020879|NCT01298778|530237523|FG000|Overall Study|Protocol Violation|0|||
147020880|NCT01298778|530237524|FG001|Overall Study|Protocol Violation|1|||
147020881|NCT01298778|530237523|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
147020882|NCT01298778|530237524|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
147020883|NCT00536484|530237525|FG000|Overall Study|Adverse Event|21|||
147020884|NCT00536484|530237526|FG001|Overall Study|Adverse Event|34|||
147020885|NCT00536484|530237525|FG000|Overall Study|Withdrawal by Subject|11|||
147020886|NCT00536484|530237526|FG001|Overall Study|Withdrawal by Subject|11|||
147020887|NCT00536484|530237525|FG000|Overall Study|Lost to Follow-up|8|||
147020888|NCT00536484|530237526|FG001|Overall Study|Lost to Follow-up|6|||
147020889|NCT00536484|530237525|FG000|Overall Study|Lack of Efficacy|16|||
147020890|NCT00536484|530237526|FG001|Overall Study|Lack of Efficacy|5|||
147020891|NCT00536484|530237525|FG000|Overall Study|Other|4|||
147020892|NCT00536484|530237526|FG001|Overall Study|Other|0|||
147020893|NCT02083926|530237527|FG000|Overall Study|Withdrawal by Subject|1|||
147020894|NCT02083926|530237528|FG001|Overall Study|Withdrawal by Subject|0|||
147020895|NCT00384176|530237530|FG000|Overall Study|Death|239|||
147020896|NCT00384176|530237531|FG001|Overall Study|Death|247|||
147020897|NCT00384176|530237532|FG002|Overall Study|Death|105|||
147020898|NCT00384176|530237530|FG000|Overall Study|Withdrawal by Subject|52|||
147020899|NCT00384176|530237531|FG001|Overall Study|Withdrawal by Subject|48|||
147020900|NCT00384176|530237532|FG002|Overall Study|Withdrawal by Subject|22|||
147020901|NCT00384176|530237530|FG000|Overall Study|Lost to Follow-up|16|||
147020902|NCT00384176|530237531|FG001|Overall Study|Lost to Follow-up|18|||
147020903|NCT00384176|530237532|FG002|Overall Study|Lost to Follow-up|4|||
147020904|NCT00384176|530237530|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
147020905|NCT00384176|530237531|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
147020906|NCT00384176|530237532|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
147020907|NCT00384176|530237530|FG000|Overall Study|Longer QTC as Visit 1|1|||
147020908|NCT00384176|530237531|FG001|Overall Study|Longer QTC as Visit 1|0|||
147020909|NCT00384176|530237532|FG002|Overall Study|Longer QTC as Visit 1|0|||
147020910|NCT00384176|530237530|FG000|Overall Study|Toxicity of treatment|1|||
147020911|NCT00384176|530237531|FG001|Overall Study|Toxicity of treatment|0|||
147020912|NCT00384176|530237532|FG002|Overall Study|Toxicity of treatment|0|||
147020913|NCT00384176|530237530|FG000|Overall Study|Did not receive study treatment|0|||
147020914|NCT00384176|530237531|FG001|Overall Study|Did not receive study treatment|1|||
147020915|NCT00384176|530237532|FG002|Overall Study|Did not receive study treatment|1|||
147020916|NCT00384176|530237530|FG000|Overall Study|Physician Decision|0|||
147020917|NCT00384176|530237531|FG001|Overall Study|Physician Decision|2|||
147020918|NCT00384176|530237532|FG002|Overall Study|Physician Decision|0|||
147020919|NCT00384176|530237530|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
147020920|NCT00384176|530237531|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
147020921|NCT00384176|530237532|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
147020922|NCT02691741|530237533|FG000|Overall Study|Adverse Event|0|||
147020923|NCT02691741|530237534|FG001|Overall Study|Adverse Event|2|||
147020924|NCT02691741|530237533|FG000|Overall Study|Lost to Follow-up|1|||
147020925|NCT02691741|530237534|FG001|Overall Study|Lost to Follow-up|0|||
147020926|NCT02691741|530237533|FG000|Overall Study|Physician Decision|0|||
147020927|NCT02691741|530237534|FG001|Overall Study|Physician Decision|1|||
147020928|NCT02691741|530237533|FG000|Overall Study|Withdrawal by Subject|0|||
147020929|NCT02691741|530237534|FG001|Overall Study|Withdrawal by Subject|4|||
147020930|NCT02139124|530237535|FG000|Overall Study|Adverse Event|2|||
147020931|NCT02139124|530237536|FG001|Overall Study|Adverse Event|0|||
147020932|NCT02139124|530237537|FG002|Overall Study|Adverse Event|1|||
147020933|NCT02139124|530237538|FG003|Overall Study|Adverse Event|2|||
147020934|NCT02139124|530237539|FG004|Overall Study|Adverse Event|5|||
147020935|NCT02139124|530237535|FG000|Overall Study|Withdrawal by Subject|2|||
147020936|NCT02139124|530237536|FG001|Overall Study|Withdrawal by Subject|2|||
147020937|NCT02139124|530237537|FG002|Overall Study|Withdrawal by Subject|2|||
147020938|NCT02139124|530237538|FG003|Overall Study|Withdrawal by Subject|2|||
147020939|NCT02139124|530237539|FG004|Overall Study|Withdrawal by Subject|3|||
147020940|NCT02139124|530237535|FG000|Overall Study|Protocol Violation|0|||
147020941|NCT02139124|530237536|FG001|Overall Study|Protocol Violation|0|||
147020942|NCT02139124|530237537|FG002|Overall Study|Protocol Violation|0|||
147020943|NCT02139124|530237538|FG003|Overall Study|Protocol Violation|1|||
147020944|NCT02139124|530237539|FG004|Overall Study|Protocol Violation|1|||
147020945|NCT02139124|530237535|FG000|Overall Study|non-compliant|1|||
147020946|NCT02139124|530237536|FG001|Overall Study|non-compliant|0|||
147020947|NCT02139124|530237537|FG002|Overall Study|non-compliant|0|||
147020948|NCT02139124|530237538|FG003|Overall Study|non-compliant|2|||
147020949|NCT02139124|530237539|FG004|Overall Study|non-compliant|0|||
147020950|NCT02139124|530237535|FG000|Overall Study|incarceration|0|||
147020951|NCT02139124|530237536|FG001|Overall Study|incarceration|0|||
147020952|NCT02139124|530237537|FG002|Overall Study|incarceration|1|||
147020953|NCT02139124|530237538|FG003|Overall Study|incarceration|0|||
147020954|NCT02139124|530237539|FG004|Overall Study|incarceration|0|||
147020955|NCT02139124|530237535|FG000|Overall Study|subject moved|1|||
147020956|NCT02139124|530237536|FG001|Overall Study|subject moved|0|||
147020957|NCT02139124|530237537|FG002|Overall Study|subject moved|0|||
147020958|NCT02139124|530237538|FG003|Overall Study|subject moved|0|||
147020959|NCT02139124|530237539|FG004|Overall Study|subject moved|0|||
147020960|NCT02139124|530237535|FG000|Overall Study|Lost to Follow-up|3|||
147020961|NCT02139124|530237536|FG001|Overall Study|Lost to Follow-up|2|||
147020962|NCT02139124|530237537|FG002|Overall Study|Lost to Follow-up|0|||
147020963|NCT02139124|530237538|FG003|Overall Study|Lost to Follow-up|5|||
147020964|NCT02139124|530237539|FG004|Overall Study|Lost to Follow-up|4|||
147020965|NCT01425528|530237540|FG000|Overall Study|Withdrawal by Subject|1|||
147020966|NCT01425528|530237541|FG001|Overall Study|Withdrawal by Subject|1|||
147020967|NCT00307931|530237542|FG000|Overall Study|Adverse Event|1|||
147020968|NCT02244424|530237543|FG000|Overall Study|Lost to Follow-up|20|||
147020969|NCT02244424|530237544|FG001|Overall Study|Lost to Follow-up|10|||
147020970|NCT00402025|530237546|FG000|Overall Study|Adverse Event|0|||
147020971|NCT00402025|530237547|FG001|Overall Study|Adverse Event|0|||
147020972|NCT00402025|530237548|FG002|Overall Study|Adverse Event|2|||
147020973|NCT00402025|530237546|FG000|Overall Study|Death|0|||
147020974|NCT00402025|530237547|FG001|Overall Study|Death|1|||
147020975|NCT00402025|530237548|FG002|Overall Study|Death|5|||
147020976|NCT00402025|530237546|FG000|Overall Study|Disease Progression|1|||
147020977|NCT00402025|530237547|FG001|Overall Study|Disease Progression|1|||
147020978|NCT00402025|530237548|FG002|Overall Study|Disease Progression|2|||
147020979|NCT00402025|530237546|FG000|Overall Study|Physician Decision|1|||
147020980|NCT00402025|530237547|FG001|Overall Study|Physician Decision|1|||
147020981|NCT00402025|530237548|FG002|Overall Study|Physician Decision|0|||
147020982|NCT00402025|530237546|FG000|Overall Study|Participant Decision|0|||
147020983|NCT00402025|530237547|FG001|Overall Study|Participant Decision|0|||
147020984|NCT00402025|530237548|FG002|Overall Study|Participant Decision|1|||
147020985|NCT01961687|530238915|FG000|Overall Study|Lost to Follow-up|19|||
147020986|NCT01961687|530238915|FG000|Overall Study|Re-operation|17|||
147020987|NCT01961687|530238915|FG000|Overall Study|Death|7|||
147020988|NCT01961687|530238915|FG000|Overall Study|Withdrawal by Subject|6|||
147020989|NCT01961687|530238915|FG000|Overall Study|Adverse Event|6|||
147020990|NCT01961687|530238915|FG000|Overall Study|Moved to area without study site|2|||
147020991|NCT01961687|530238915|FG000|Overall Study|Sponsor decision|2|||
147020992|NCT01961687|530238915|FG000|Overall Study|Physician Decision|1|||
147020993|NCT01961687|530238915|FG000|Overall Study|Unable to meet follow-up requirements|1|||
147020994|NCT01730040|530238916|FG000|Overall Study|Randomized but not treated|0|||
147020995|NCT01730040|530238917|FG001|Overall Study|Randomized but not treated|0|||
147020996|NCT01730040|530238918|FG002|Overall Study|Randomized but not treated|0|||
147020997|NCT01730040|530238919|FG003|Overall Study|Randomized but not treated|0|||
147020998|NCT01730040|530238920|FG004|Overall Study|Randomized but not treated|0|||
147020999|NCT01730040|530238921|FG005|Overall Study|Randomized but not treated|1|||
147021000|NCT01730040|530238922|FG006|Overall Study|Randomized but not treated|0|||
147021001|NCT01730040|530238916|FG000|Overall Study|Subject moved|0|||
147021002|NCT01730040|530238917|FG001|Overall Study|Subject moved|0|||
147021003|NCT01730040|530238918|FG002|Overall Study|Subject moved|1|||
147021004|NCT01730040|530238919|FG003|Overall Study|Subject moved|0|||
147021005|NCT01730040|530238920|FG004|Overall Study|Subject moved|0|||
147021006|NCT01730040|530238921|FG005|Overall Study|Subject moved|0|||
147021007|NCT01730040|530238922|FG006|Overall Study|Subject moved|1|||
147021008|NCT01730040|530238916|FG000|Overall Study|Physician Decision|0|||
147021009|NCT01730040|530238917|FG001|Overall Study|Physician Decision|0|||
147021010|NCT01730040|530238918|FG002|Overall Study|Physician Decision|0|||
147021011|NCT01730040|530238919|FG003|Overall Study|Physician Decision|0|||
147021012|NCT01730040|530238920|FG004|Overall Study|Physician Decision|0|||
147021013|NCT01730040|530238921|FG005|Overall Study|Physician Decision|1|||
147021014|NCT01730040|530238922|FG006|Overall Study|Physician Decision|1|||
147021015|NCT01730040|530238916|FG000|Overall Study|Other than specified|7|||
147021016|NCT01730040|530238917|FG001|Overall Study|Other than specified|8|||
147021017|NCT01730040|530238918|FG002|Overall Study|Other than specified|5|||
147021018|NCT01730040|530238919|FG003|Overall Study|Other than specified|5|||
147021019|NCT01730040|530238920|FG004|Overall Study|Other than specified|5|||
147021020|NCT01730040|530238921|FG005|Overall Study|Other than specified|4|||
147021021|NCT01730040|530238922|FG006|Overall Study|Other than specified|4|||
147021022|NCT01730040|530238916|FG000|Overall Study|Adverse Event|4|||
147021023|NCT01730040|530238917|FG001|Overall Study|Adverse Event|3|||
147021024|NCT01730040|530238918|FG002|Overall Study|Adverse Event|5|||
147021025|NCT01730040|530238919|FG003|Overall Study|Adverse Event|3|||
147021026|NCT01730040|530238920|FG004|Overall Study|Adverse Event|1|||
147021027|NCT01730040|530238921|FG005|Overall Study|Adverse Event|1|||
147021028|NCT01730040|530238922|FG006|Overall Study|Adverse Event|2|||
147021029|NCT01730040|530238916|FG000|Overall Study|Poor compliance to protocol|2|||
147021030|NCT01730040|530238917|FG001|Overall Study|Poor compliance to protocol|4|||
147021031|NCT01730040|530238918|FG002|Overall Study|Poor compliance to protocol|0|||
147021032|NCT01730040|530238919|FG003|Overall Study|Poor compliance to protocol|0|||
147021033|NCT01730040|530238920|FG004|Overall Study|Poor compliance to protocol|0|||
147021034|NCT01730040|530238921|FG005|Overall Study|Poor compliance to protocol|0|||
147021035|NCT01730040|530238922|FG006|Overall Study|Poor compliance to protocol|1|||
147021036|NCT00544817|530238923|FG000|Combined Modality|Lack of Efficacy|2|||
147021037|NCT00544817|530238923|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
147021038|NCT00544817|530238923|FG000|Combined Modality|Adverse Event|2|||
147021039|NCT00544817|530238923|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
147021040|NCT00544817|530238923|FG000|No Treatment Interval|Lack of Efficacy|8|||
147021041|NCT00544817|530238923|FG000|No Treatment Interval|Physician Decision|3|||
147021042|NCT00544817|530238923|FG000|No Treatment Interval|Adverse Event|1|||
147021043|NCT00544817|530238923|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
147021044|NCT00544817|530238923|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
147021045|NCT00544817|530238923|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
147021046|NCT02813421|530238924|FG000|Overall Study|Withdrawal by Subject|1|||
147021047|NCT02813421|530238925|FG001|Overall Study|Withdrawal by Subject|2|||
147021048|NCT02813421|530238924|FG000|Overall Study|Lost to Follow-up|1|||
147021049|NCT02813421|530238925|FG001|Overall Study|Lost to Follow-up|1|||
146849201|NCT01865747|529617056|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
146849202|NCT01865747|529617057|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
147021050|NCT00977548|530238926|FG000|Overall Study|Ineligible|4|||
147021051|NCT00977548|530238926|FG000|Overall Study|Adverse Event|8|||
147021052|NCT00977548|530238926|FG000|Overall Study|Withdrawal by Subject|1|||
147021053|NCT01042535|530238927|FG000|Overall Study|disease progression prior to treatment|3|||
147021054|NCT01042535|530238927|FG000|Overall Study|disease progression during treatment|3|||
147021055|NCT01042535|530238927|FG000|Overall Study|complications from other disease|2|||
147021056|NCT00107042|530238930|FG000|Overall Study|Lost to Follow-up|9|||
147021057|NCT00107042|530238931|FG001|Overall Study|Lost to Follow-up|7|||
147021058|NCT00107042|530238930|FG000|Overall Study|Withdrawal by Subject|6|||
147021059|NCT00107042|530238931|FG001|Overall Study|Withdrawal by Subject|1|||
147021060|NCT00107042|530238930|FG000|Overall Study|Moved out of area|5|||
147021061|NCT00107042|530238931|FG001|Overall Study|Moved out of area|3|||
147021062|NCT00107042|530238930|FG000|Overall Study|Pregnancy|1|||
147021063|NCT00107042|530238931|FG001|Overall Study|Pregnancy|1|||
147021064|NCT00107042|530238930|FG000|Overall Study|Inadvertent enrollment|0|||
147021065|NCT00107042|530238931|FG001|Overall Study|Inadvertent enrollment|1|||
147021066|NCT00107042|530238930|FG000|Overall Study|vaccinated outside window|1|||
147021067|NCT00107042|530238931|FG001|Overall Study|vaccinated outside window|1|||
147021068|NCT00107042|530238930|FG000|Overall Study|Disallowed medications|0|||
147021069|NCT00107042|530238931|FG001|Overall Study|Disallowed medications|2|||
147021070|NCT03919448|530238932|FG000|Overall Study|Withdrawal by Subject|1|||
147021071|NCT03919448|530238933|FG001|Overall Study|Withdrawal by Subject|0|||
147021072|NCT03919448|530238934|FG002|Overall Study|Withdrawal by Subject|0|||
147021073|NCT03438539|530238936|FG000|Overall Study|Lost to Follow-up|8|||
147021074|NCT03438539|530238937|FG001|Overall Study|Lost to Follow-up|4|||
147021075|NCT03438539|530238938|FG002|Overall Study|Lost to Follow-up|10|||
147021076|NCT03438539|530238939|FG003|Overall Study|Lost to Follow-up|9|||
147021077|NCT03438539|530238940|FG004|Overall Study|Lost to Follow-up|3|||
147021078|NCT03438539|530238941|FG005|Overall Study|Lost to Follow-up|8|||
147021079|NCT01221090|530238942|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
147021080|NCT01221090|530238943|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
147021081|NCT01221090|530238944|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
147021082|NCT01221090|530238945|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
147021083|NCT01221090|530238942|FG000|Overall Study|Withdrawal by Subject|0|||
147021084|NCT01221090|530238943|FG001|Overall Study|Withdrawal by Subject|22|||
147021085|NCT01221090|530238944|FG002|Overall Study|Withdrawal by Subject|27|||
146849203|NCT01865747|529617056|FG000|Overall Study (ITT)|Protocol Violation|1|||
146849204|NCT01865747|529617057|FG001|Overall Study (ITT)|Protocol Violation|1|||
147021086|NCT01221090|530238945|FG003|Overall Study|Withdrawal by Subject|2|||
147021087|NCT04776746|530238946|FG000|Overall Study|Study terminated by sponsor|61|||
147021088|NCT04776746|530238946|FG000|Overall Study|Adverse Event|5|||
147021089|NCT04776746|530238946|FG000|Overall Study|Death|4|||
147021090|NCT04776746|530238946|FG000|Overall Study|Lack of Efficacy|3|||
147021091|NCT04776746|530238946|FG000|Overall Study|Noncompliance with study drug|2|||
147021092|NCT04776746|530238946|FG000|Overall Study|Not related to COVID-19|2|||
147021093|NCT00440466|530238947|FG000|Overall Study|Death|3|||
147021094|NCT00440466|530238948|FG001|Overall Study|Death|2|||
147021095|NCT00440466|530238949|FG002|Overall Study|Death|9|||
147021096|NCT00440466|530238947|FG000|Overall Study|Adverse Event|3|||
147021097|NCT00440466|530238948|FG001|Overall Study|Adverse Event|4|||
147021098|NCT00440466|530238949|FG002|Overall Study|Adverse Event|11|||
147021099|NCT00440466|530238947|FG000|Overall Study|Lost to Follow-up|1|||
147021100|NCT00440466|530238948|FG001|Overall Study|Lost to Follow-up|0|||
147021101|NCT00440466|530238949|FG002|Overall Study|Lost to Follow-up|2|||
147021102|NCT00440466|530238947|FG000|Overall Study|Physician Decision|2|||
147021103|NCT00440466|530238948|FG001|Overall Study|Physician Decision|0|||
147021104|NCT00440466|530238949|FG002|Overall Study|Physician Decision|1|||
147021105|NCT00440466|530238947|FG000|Overall Study|Protocol Violation|2|||
147021106|NCT00440466|530238948|FG001|Overall Study|Protocol Violation|0|||
147021107|NCT00440466|530238949|FG002|Overall Study|Protocol Violation|4|||
147021108|NCT00440466|530238947|FG000|Overall Study|Withdrawal by Subject|2|||
147021109|NCT00440466|530238948|FG001|Overall Study|Withdrawal by Subject|5|||
147021110|NCT00440466|530238949|FG002|Overall Study|Withdrawal by Subject|9|||
147021111|NCT00440466|530238947|FG000|Overall Study|Began Dialysis|0|||
147021112|NCT00440466|530238948|FG001|Overall Study|Began Dialysis|0|||
147021113|NCT00440466|530238949|FG002|Overall Study|Began Dialysis|1|||
147021114|NCT00440466|530238947|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
147021115|NCT00440466|530238948|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
147021116|NCT00440466|530238949|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
147021117|NCT00655850|530238954|FG000|Overall Study|Death|2|||
146849205|NCT01865747|529617056|FG000|Overall Study (ITT)|Physician Decision|5|||
147021118|NCT00655850|530238954|FG000|Overall Study|Withdrawal by Subject|1|||
147021119|NCT02459665|530238955|FG000|Overall Study|Withdrawal by Subject|0|||
147021120|NCT02459665|530238956|FG001|Overall Study|Withdrawal by Subject|1|||
147021121|NCT02459665|530238957|FG002|Overall Study|Withdrawal by Subject|1|||
147021122|NCT02459665|530238958|FG003|Overall Study|Withdrawal by Subject|2|||
147021123|NCT00099268|530238959|FG000|Overall Study|Withdrawal by Subject|46|||
147021124|NCT00099268|530238960|FG001|Overall Study|Withdrawal by Subject|28|||
147021125|NCT00099268|530238959|FG000|Overall Study|Adverse Event|19|||
147021126|NCT00099268|530238960|FG001|Overall Study|Adverse Event|19|||
147021127|NCT00099268|530238959|FG000|Overall Study|Protocol Violation|9|||
147021128|NCT00099268|530238960|FG001|Overall Study|Protocol Violation|8|||
147021129|NCT00099268|530238959|FG000|Overall Study|Lost to Follow-up|6|||
147021130|NCT00099268|530238960|FG001|Overall Study|Lost to Follow-up|4|||
147021131|NCT00099268|530238959|FG000|Overall Study|Lack of Efficacy|5|||
147021132|NCT00099268|530238960|FG001|Overall Study|Lack of Efficacy|18|||
147021133|NCT00099268|530238959|FG000|Overall Study|Administrative problems|4|||
147021134|NCT00099268|530238960|FG001|Overall Study|Administrative problems|4|||
147021135|NCT00099268|530238959|FG000|Overall Study|Death|3|||
147021136|NCT00099268|530238960|FG001|Overall Study|Death|1|||
147021137|NCT01360866|530238961|FG000|Overall Study|Lost to Follow-up|11|||
147021138|NCT01360866|530238962|FG001|Overall Study|Lost to Follow-up|28|||
147021139|NCT01360866|530238963|FG002|Overall Study|Lost to Follow-up|41|||
147021140|NCT01360866|530238964|FG003|Overall Study|Lost to Follow-up|0|||
147021141|NCT01360866|530238961|FG000|Overall Study|Adverse Event|56|||
147021142|NCT01360866|530238962|FG001|Overall Study|Adverse Event|61|||
147021143|NCT01360866|530238963|FG002|Overall Study|Adverse Event|134|||
147021144|NCT01360866|530238964|FG003|Overall Study|Adverse Event|6|||
147021145|NCT01360866|530238961|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
147021146|NCT01360866|530238962|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
147021147|NCT01360866|530238963|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
147021148|NCT01360866|530238964|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
147021149|NCT01360866|530238961|FG000|Overall Study|Withdrawn by Investigator|9|||
147021150|NCT01360866|530238962|FG001|Overall Study|Withdrawn by Investigator|8|||
147021151|NCT01360866|530238963|FG002|Overall Study|Withdrawn by Investigator|31|||
147021152|NCT01360866|530238964|FG003|Overall Study|Withdrawn by Investigator|2|||
147021153|NCT01360866|530238961|FG000|Overall Study|Withdrawal by participant|79|||
147021154|NCT01360866|530238962|FG001|Overall Study|Withdrawal by participant|89|||
147021155|NCT01360866|530238963|FG002|Overall Study|Withdrawal by participant|168|||
147021156|NCT01360866|530238964|FG003|Overall Study|Withdrawal by participant|8|||
147021157|NCT01360866|530238961|FG000|Overall Study|Protocol Deviation|25|||
147021158|NCT01360866|530238962|FG001|Overall Study|Protocol Deviation|33|||
147021159|NCT01360866|530238963|FG002|Overall Study|Protocol Deviation|61|||
147021160|NCT01360866|530238964|FG003|Overall Study|Protocol Deviation|2|||
147021161|NCT01360866|530238961|FG000|Overall Study|Lack of Efficacy|30|||
147021162|NCT01360866|530238962|FG001|Overall Study|Lack of Efficacy|40|||
147021163|NCT01360866|530238963|FG002|Overall Study|Lack of Efficacy|30|||
147021164|NCT01360866|530238964|FG003|Overall Study|Lack of Efficacy|4|||
147021165|NCT03702049|530238965|FG000|Overall Study|Lost to Follow-up|4|||
147021166|NCT03702049|530238965|FG000|Overall Study|Physician Decision|1|||
147021167|NCT00918463|530238973|FG000|Overall Study|Death|1|||
147021168|NCT00918463|530238973|FG000|Overall Study|Lack of Efficacy|1|||
147021169|NCT01014624|530238977|FG000|Overall Study|Adverse Event|0|||
147021170|NCT01014624|530238978|FG001|Overall Study|Adverse Event|1|||
147021171|NCT01014624|530238977|FG000|Overall Study|Protocol Violation|1|||
147021172|NCT01014624|530238978|FG001|Overall Study|Protocol Violation|0|||
147021173|NCT01014624|530238977|FG000|Overall Study|Withdrawal by Subject|1|||
147021174|NCT01014624|530238978|FG001|Overall Study|Withdrawal by Subject|0|||
147021175|NCT01117337|530238986|FG000|Overall Study|Lost to Follow-up|4|||
147021176|NCT01117337|530238987|FG001|Overall Study|Lost to Follow-up|0|||
147021177|NCT01045993|530238988|FG000|Overall Study|Treated-later found eligibility not met|0|||
147021178|NCT01045993|530238989|FG001|Overall Study|Treated-later found eligibility not met|1|||
147021179|NCT01045993|530238990|FG002|Overall Study|Treated-later found eligibility not met|0|||
147021180|NCT01045993|530238991|FG003|Overall Study|Treated-later found eligibility not met|0|||
147021181|NCT01659736|530238992|FG000|Treatment Period|Adverse Event|1|||
147021182|NCT01659736|530238993|FG001|Treatment Period|Adverse Event|1|||
147021183|NCT01659736|530238992|FG000|Treatment Period|Protocol Violation|3|||
147021184|NCT01659736|530238993|FG001|Treatment Period|Protocol Violation|1|||
147021185|NCT01659736|530238992|FG000|Treatment Period|Withdrawal by Subject|1|||
147021186|NCT01659736|530238993|FG001|Treatment Period|Withdrawal by Subject|0|||
147021187|NCT01659736|530238992|FG000|3-month Follow-up|Lost to Follow-up|0|||
147021188|NCT01659736|530238993|FG001|3-month Follow-up|Lost to Follow-up|1|||
147021189|NCT02791893|530239003|FG000|Blinded Phase|Lost to Follow-up|2|||
147021190|NCT02791893|530239004|FG001|Blinded Phase|Lost to Follow-up|2|||
147021191|NCT02791893|530239003|FG000|Blinded Phase|Withdrawal by Subject|1|||
147021192|NCT02791893|530239004|FG001|Blinded Phase|Withdrawal by Subject|2|||
147021193|NCT02791893|530239003|FG000|Open Label Phase|Lost to Follow-up|3|||
147021194|NCT02791893|530239004|FG001|Open Label Phase|Lost to Follow-up|0|||
147021195|NCT02791893|530239003|FG000|Open Label Phase|Withdrawal by Subject|0|||
147021196|NCT02791893|530239004|FG001|Open Label Phase|Withdrawal by Subject|2|||
147021197|NCT01570283|530239005|FG000|Cohort 1: Dose Level 1|Death|0|||
147021198|NCT01570283|530239006|FG001|Cohort 1: Dose Level 1|Death|1|||
147021199|NCT01570283|530239007|FG002|Cohort 1: Dose Level 1|Death|0|||
147021200|NCT01570283|530239008|FG003|Cohort 1: Dose Level 1|Death|0|||
147021201|NCT01570283|530239009|FG004|Cohort 1: Dose Level 1|Death|0|||
147021202|NCT01570283|530239010|FG005|Cohort 1: Dose Level 1|Death|0|||
146849206|NCT01865747|529617057|FG001|Overall Study (ITT)|Physician Decision|2|||
147021203|NCT01570283|530239005|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
147021204|NCT01570283|530239006|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
147021205|NCT01570283|530239007|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
147021206|NCT01570283|530239008|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
147021207|NCT01570283|530239009|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
147021208|NCT01570283|530239010|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
147021209|NCT01570283|530239005|FG000|Cohort 2: Dose Level 2|Death|0|||
147021210|NCT01570283|530239006|FG001|Cohort 2: Dose Level 2|Death|0|||
147021211|NCT01570283|530239007|FG002|Cohort 2: Dose Level 2|Death|1|||
147021212|NCT01570283|530239008|FG003|Cohort 2: Dose Level 2|Death|0|||
147021213|NCT01570283|530239009|FG004|Cohort 2: Dose Level 2|Death|0|||
147021214|NCT01570283|530239010|FG005|Cohort 2: Dose Level 2|Death|0|||
147021215|NCT01570283|530239005|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
147021216|NCT01570283|530239006|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
147021217|NCT01570283|530239007|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
147021218|NCT01570283|530239008|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
147021219|NCT01570283|530239009|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
147021220|NCT01570283|530239010|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
147021221|NCT01570283|530239005|FG000|Cohort 3: Dose Level 3|Death|0|||
147021222|NCT01570283|530239006|FG001|Cohort 3: Dose Level 3|Death|0|||
147021223|NCT01570283|530239007|FG002|Cohort 3: Dose Level 3|Death|0|||
147021224|NCT01570283|530239008|FG003|Cohort 3: Dose Level 3|Death|0|||
147021225|NCT01570283|530239009|FG004|Cohort 3: Dose Level 3|Death|0|||
147021226|NCT01570283|530239010|FG005|Cohort 3: Dose Level 3|Death|1|||
147021227|NCT01570283|530239005|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
147021228|NCT01570283|530239006|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
147021229|NCT01570283|530239007|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
147021230|NCT01570283|530239008|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
147021231|NCT01570283|530239009|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
147021232|NCT01570283|530239010|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
147021233|NCT01048502|530239014|FG000|Overall Study|Lost to Follow-up|2|||
147021234|NCT01048502|530239015|FG001|Overall Study|Lost to Follow-up|0|||
147021235|NCT01048502|530239016|FG002|Overall Study|Lost to Follow-up|0|||
147021236|NCT01048502|530239017|FG003|Overall Study|Lost to Follow-up|0|||
147021237|NCT01048502|530239014|FG000|Overall Study|Adverse Event|1|||
147021238|NCT01048502|530239015|FG001|Overall Study|Adverse Event|0|||
147021239|NCT01048502|530239016|FG002|Overall Study|Adverse Event|0|||
147021240|NCT01048502|530239017|FG003|Overall Study|Adverse Event|0|||
147021241|NCT01048502|530239014|FG000|Overall Study|Withdrawal by Subject|1|||
147021242|NCT01048502|530239015|FG001|Overall Study|Withdrawal by Subject|4|||
147021243|NCT01048502|530239016|FG002|Overall Study|Withdrawal by Subject|5|||
147021244|NCT01048502|530239017|FG003|Overall Study|Withdrawal by Subject|3|||
147021245|NCT01048502|530239014|FG000|Overall Study|Physician Decision|0|||
147021246|NCT01048502|530239015|FG001|Overall Study|Physician Decision|3|||
147021247|NCT01048502|530239016|FG002|Overall Study|Physician Decision|0|||
147021248|NCT01048502|530239017|FG003|Overall Study|Physician Decision|1|||
147021249|NCT01333072|530239018|FG000|Overall Study|Lost to Follow-up|3|||
147021250|NCT01333072|530239019|FG001|Overall Study|Lost to Follow-up|0|||
147021251|NCT01333072|530239018|FG000|Overall Study|Adverse Event|2|||
147021252|NCT01333072|530239019|FG001|Overall Study|Adverse Event|4|||
147021253|NCT01333072|530239018|FG000|Overall Study|Physician Decision|1|||
147021254|NCT01333072|530239019|FG001|Overall Study|Physician Decision|0|||
147021255|NCT00493454|530239021|FG000|Overall Study|Withdrawal by Subject|1|||
147021256|NCT03095118|530239030|FG000|Overall Study|Adverse Event|1|||
147021257|NCT03095118|530239030|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
147021258|NCT01483625|530239031|FG000|Overall Study|Adverse Event|1|||
147021259|NCT01483625|530239032|FG001|Overall Study|Adverse Event|1|||
147021260|NCT01483625|530239031|FG000|Overall Study|Refused to continue medication|2|||
147021261|NCT01483625|530239032|FG001|Overall Study|Refused to continue medication|1|||
147021262|NCT01483625|530239031|FG000|Overall Study|Due to other reason|1|||
147021263|NCT01483625|530239032|FG001|Overall Study|Due to other reason|0|||
147021264|NCT02094261|530239033|FG000|Overall Study|Death|24|||
147021265|NCT02094261|530239033|FG000|Overall Study|Lost to Follow-up|1|||
147021266|NCT02094261|530239033|FG000|Overall Study|Withdrawal by Subject|4|||
147021267|NCT02094261|530239033|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
147021268|NCT04668274|530239034|FG000|Part 1 Study Period 1|Adverse Event|3|||
147021269|NCT04668274|530239035|FG001|Part 1 Study Period 1|Adverse Event|0|||
147021270|NCT04668274|530239036|FG002|Part 1 Study Period 1|Adverse Event|0|||
147021271|NCT04668274|530239037|FG003|Part 1 Study Period 1|Adverse Event|0|||
147021272|NCT04668274|530239034|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
147021273|NCT04668274|530239035|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
147021274|NCT04668274|530239036|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
147021275|NCT04668274|530239037|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
146849207|NCT01865747|529617056|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
146849208|NCT01865747|529617057|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
147021276|NCT04668274|530239034|FG000|Part 1 Study Period 2|Other|0|||
147021277|NCT04668274|530239035|FG001|Part 1 Study Period 2|Other|1|||
147021278|NCT04668274|530239036|FG002|Part 1 Study Period 2|Other|0|||
147021279|NCT04668274|530239037|FG003|Part 1 Study Period 2|Other|0|||
147021280|NCT04668274|530239034|FG000|Part 1 Study Period 3|Adverse Event|0|||
147021281|NCT04668274|530239035|FG001|Part 1 Study Period 3|Adverse Event|0|||
147021282|NCT04668274|530239036|FG002|Part 1 Study Period 3|Adverse Event|1|||
147021283|NCT04668274|530239037|FG003|Part 1 Study Period 3|Adverse Event|0|||
147021284|NCT04668274|530239034|FG000|Part 1 Study Period 3|Other|0|||
147021285|NCT04668274|530239035|FG001|Part 1 Study Period 3|Other|0|||
147021286|NCT04668274|530239036|FG002|Part 1 Study Period 3|Other|2|||
147021287|NCT04668274|530239037|FG003|Part 1 Study Period 3|Other|0|||
147021288|NCT04668274|530239034|FG000|Part 2 Study Period 4|Other|0|||
147021289|NCT04668274|530239035|FG001|Part 2 Study Period 4|Other|0|||
147021290|NCT04668274|530239036|FG002|Part 2 Study Period 4|Other|0|||
147021291|NCT04668274|530239037|FG003|Part 2 Study Period 4|Other|1|||
147021292|NCT02363439|530239038|FG000|Overall Study|Lack of Efficacy|4|||
147021293|NCT01682148|530239040|FG000|Overall Study|Withdrawal by Subject|2|||
147021294|NCT01682148|530239041|FG001|Overall Study|Withdrawal by Subject|0|||
147021295|NCT01682148|530239040|FG000|Overall Study|Lost to Follow-up|1|||
147021296|NCT01682148|530239041|FG001|Overall Study|Lost to Follow-up|2|||
147021297|NCT01682148|530239040|FG000|Overall Study|Protocol Violation|1|||
147021298|NCT01682148|530239041|FG001|Overall Study|Protocol Violation|1|||
147021299|NCT00171340|530239042|FG000|Overall Study|Adverse Event|46|||
147021300|NCT00171340|530239043|FG001|Overall Study|Adverse Event|42|||
147021301|NCT00171340|530239042|FG000|Overall Study|Lack of Efficacy|29|||
147021302|NCT00171340|530239043|FG001|Overall Study|Lack of Efficacy|41|||
147021303|NCT00171340|530239042|FG000|Overall Study|Protocol Violation|7|||
147021304|NCT00171340|530239043|FG001|Overall Study|Protocol Violation|8|||
147021305|NCT00171340|530239042|FG000|Overall Study|Withdrawal by Subject|22|||
147021306|NCT00171340|530239043|FG001|Overall Study|Withdrawal by Subject|19|||
147021307|NCT00171340|530239042|FG000|Overall Study|Lost to Follow-up|0|||
147021308|NCT00171340|530239043|FG001|Overall Study|Lost to Follow-up|5|||
147021309|NCT00171340|530239042|FG000|Overall Study|Abnormal Laboratory Results|2|||
147021310|NCT00171340|530239043|FG001|Overall Study|Abnormal Laboratory Results|0|||
147021311|NCT00171340|530239042|FG000|Overall Study|Abnormal Test Procedure Results|6|||
147021312|NCT00171340|530239043|FG001|Overall Study|Abnormal Test Procedure Results|11|||
147021313|NCT00171340|530239042|FG000|Overall Study|No Longer Required Study Drug|1|||
147021314|NCT00171340|530239043|FG001|Overall Study|No Longer Required Study Drug|1|||
147021315|NCT00171340|530239042|FG000|Overall Study|Administrative Problems|5|||
147021316|NCT00171340|530239043|FG001|Overall Study|Administrative Problems|2|||
147021317|NCT00171340|530239042|FG000|Overall Study|Death|6|||
147021318|NCT00171340|530239043|FG001|Overall Study|Death|6|||
147021319|NCT01056640|530239044|FG000|Overall Study|Withdrawal by Subject|11|||
147021320|NCT01056640|530239045|FG001|Overall Study|Withdrawal by Subject|8|||
147021321|NCT01056640|530239044|FG000|Overall Study|Death|15|||
147021322|NCT01056640|530239045|FG001|Overall Study|Death|4|||
147021323|NCT01803269|530239046|FG000|Overall Study|Withdrawal by Subject|3|||
147021324|NCT01803269|530239047|FG001|Overall Study|Withdrawal by Subject|0|||
147021325|NCT01803269|530239048|FG002|Overall Study|Withdrawal by Subject|0|||
147021326|NCT00285584|530239055|FG000|Month 3|Lost to Follow-up|3|||
147021327|NCT00285584|530239056|FG001|Month 3|Lost to Follow-up|3|||
147021328|NCT00285584|530239055|FG000|Month 3|Withdrawal by Subject|1|||
147021329|NCT00285584|530239056|FG001|Month 3|Withdrawal by Subject|0|||
147021330|NCT00285584|530239055|FG000|Month 6|Lost to Follow-up|0|||
147021331|NCT00285584|530239056|FG001|Month 6|Lost to Follow-up|1|||
147021332|NCT03812991|530239057|FG000|Overall Study|Lost to Follow-up|3|||
147021333|NCT03812991|530239058|FG001|Overall Study|Lost to Follow-up|1|||
147021334|NCT01884688|530239063|FG000|Overall Study|Screen Failure|2|||
147021335|NCT02243293|530239064|FG000|Overall Study|Adverse Event|1|||
147021336|NCT02243293|530239065|FG001|Overall Study|Adverse Event|0|||
147021337|NCT02243293|530239066|FG002|Overall Study|Adverse Event|0|||
147021338|NCT02243293|530239067|FG003|Overall Study|Adverse Event|0|||
147021339|NCT02243293|530239068|FG004|Overall Study|Adverse Event|0|||
147021340|NCT02243293|530239069|FG005|Overall Study|Adverse Event|0|||
147021341|NCT02243293|530239070|FG006|Overall Study|Adverse Event|0|||
147021342|NCT02243293|530239071|FG007|Overall Study|Adverse Event|0|||
147021343|NCT02243293|530239072|FG008|Overall Study|Adverse Event|0|||
147021344|NCT02243293|530239073|FG009|Overall Study|Adverse Event|0|||
147021345|NCT02243293|530239074|FG010|Overall Study|Adverse Event|0|||
147021346|NCT02243293|530239075|FG011|Overall Study|Adverse Event|0|||
147021347|NCT02243293|530239076|FG012|Overall Study|Adverse Event|0|||
147021348|NCT02243293|530239077|FG013|Overall Study|Adverse Event|0|||
146849209|NCT01865747|529617056|FG000|Overall Study (ITT)|Sponsor Decision|0|||
147021349|NCT02243293|530239078|FG014|Overall Study|Adverse Event|0|||
147021350|NCT02243293|530239079|FG015|Overall Study|Adverse Event|1|||
147021351|NCT02243293|530239080|FG016|Overall Study|Adverse Event|0|||
147021352|NCT02243293|530239081|FG017|Overall Study|Adverse Event|0|||
147021353|NCT02243293|530239082|FG018|Overall Study|Adverse Event|0|||
147021354|NCT02243293|530239083|FG019|Overall Study|Adverse Event|0|||
147021355|NCT02243293|530239084|FG020|Overall Study|Adverse Event|1|||
147021356|NCT02243293|530239085|FG021|Overall Study|Adverse Event|0|||
147021357|NCT02243293|530239064|FG000|Overall Study|Withdrawal by Subject|1|||
147021358|NCT02243293|530239065|FG001|Overall Study|Withdrawal by Subject|0|||
147021359|NCT02243293|530239066|FG002|Overall Study|Withdrawal by Subject|0|||
147021360|NCT02243293|530239067|FG003|Overall Study|Withdrawal by Subject|0|||
147021361|NCT02243293|530239068|FG004|Overall Study|Withdrawal by Subject|0|||
147021362|NCT02243293|530239069|FG005|Overall Study|Withdrawal by Subject|0|||
147021363|NCT02243293|530239070|FG006|Overall Study|Withdrawal by Subject|0|||
147021364|NCT02243293|530239071|FG007|Overall Study|Withdrawal by Subject|0|||
147021365|NCT02243293|530239072|FG008|Overall Study|Withdrawal by Subject|0|||
147021366|NCT02243293|530239073|FG009|Overall Study|Withdrawal by Subject|1|||
147021367|NCT02243293|530239074|FG010|Overall Study|Withdrawal by Subject|0|||
147021368|NCT02243293|530239075|FG011|Overall Study|Withdrawal by Subject|1|||
147021369|NCT02243293|530239076|FG012|Overall Study|Withdrawal by Subject|0|||
147021370|NCT02243293|530239077|FG013|Overall Study|Withdrawal by Subject|0|||
147021371|NCT02243293|530239078|FG014|Overall Study|Withdrawal by Subject|0|||
147021372|NCT02243293|530239079|FG015|Overall Study|Withdrawal by Subject|0|||
147021373|NCT02243293|530239080|FG016|Overall Study|Withdrawal by Subject|0|||
147021374|NCT02243293|530239081|FG017|Overall Study|Withdrawal by Subject|0|||
147021375|NCT02243293|530239082|FG018|Overall Study|Withdrawal by Subject|0|||
147021376|NCT02243293|530239083|FG019|Overall Study|Withdrawal by Subject|0|||
147021377|NCT02243293|530239084|FG020|Overall Study|Withdrawal by Subject|0|||
147021378|NCT02243293|530239085|FG021|Overall Study|Withdrawal by Subject|1|||
147021379|NCT02243293|530239064|FG000|Overall Study|Lost to Follow-up|0|||
147021380|NCT02243293|530239065|FG001|Overall Study|Lost to Follow-up|1|||
147021381|NCT02243293|530239066|FG002|Overall Study|Lost to Follow-up|1|||
147021382|NCT02243293|530239067|FG003|Overall Study|Lost to Follow-up|1|||
147021383|NCT02243293|530239068|FG004|Overall Study|Lost to Follow-up|0|||
147021384|NCT02243293|530239069|FG005|Overall Study|Lost to Follow-up|0|||
147021385|NCT02243293|530239070|FG006|Overall Study|Lost to Follow-up|3|||
147021386|NCT02243293|530239071|FG007|Overall Study|Lost to Follow-up|0|||
147021387|NCT02243293|530239072|FG008|Overall Study|Lost to Follow-up|0|||
147021388|NCT02243293|530239073|FG009|Overall Study|Lost to Follow-up|0|||
147021389|NCT02243293|530239074|FG010|Overall Study|Lost to Follow-up|0|||
147021390|NCT02243293|530239075|FG011|Overall Study|Lost to Follow-up|2|||
147021391|NCT02243293|530239076|FG012|Overall Study|Lost to Follow-up|0|||
147021392|NCT02243293|530239077|FG013|Overall Study|Lost to Follow-up|0|||
147021393|NCT02243293|530239078|FG014|Overall Study|Lost to Follow-up|0|||
147021394|NCT02243293|530239079|FG015|Overall Study|Lost to Follow-up|0|||
147021395|NCT02243293|530239080|FG016|Overall Study|Lost to Follow-up|3|||
147021396|NCT02243293|530239081|FG017|Overall Study|Lost to Follow-up|1|||
147021397|NCT02243293|530239082|FG018|Overall Study|Lost to Follow-up|0|||
147021398|NCT02243293|530239083|FG019|Overall Study|Lost to Follow-up|0|||
147021399|NCT02243293|530239084|FG020|Overall Study|Lost to Follow-up|1|||
147021400|NCT02243293|530239085|FG021|Overall Study|Lost to Follow-up|2|||
147021401|NCT02243293|530239064|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
147021402|NCT02243293|530239065|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
147021403|NCT02243293|530239066|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
147021404|NCT02243293|530239067|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
147021405|NCT02243293|530239068|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
147021406|NCT02243293|530239069|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
147021407|NCT02243293|530239070|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
147021408|NCT02243293|530239071|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
147021409|NCT02243293|530239072|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
147021410|NCT02243293|530239073|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
147021411|NCT02243293|530239074|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
147021412|NCT02243293|530239075|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
147021413|NCT02243293|530239076|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
147021414|NCT02243293|530239077|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
147021415|NCT02243293|530239078|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
147021416|NCT02243293|530239079|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
147021417|NCT02243293|530239080|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
147021418|NCT02243293|530239081|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
147021419|NCT02243293|530239082|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
147021420|NCT02243293|530239083|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
147021421|NCT02243293|530239084|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
147021422|NCT02243293|530239085|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
147021423|NCT02243293|530239064|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
147021424|NCT02243293|530239065|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
147021425|NCT02243293|530239066|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
147021426|NCT02243293|530239067|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
147021427|NCT02243293|530239068|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
147021428|NCT02243293|530239069|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
147021429|NCT02243293|530239070|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
146849210|NCT01865747|529617057|FG001|Overall Study (ITT)|Sponsor Decision|1|||
147021430|NCT02243293|530239071|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
147021431|NCT02243293|530239072|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
147021432|NCT02243293|530239073|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
147021433|NCT02243293|530239074|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
147021434|NCT02243293|530239075|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
147021435|NCT02243293|530239076|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
147021436|NCT02243293|530239077|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
147021437|NCT02243293|530239078|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
147021438|NCT02243293|530239079|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
147021439|NCT02243293|530239080|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
147021440|NCT02243293|530239081|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
147021441|NCT02243293|530239082|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
147021442|NCT02243293|530239083|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
147021443|NCT02243293|530239084|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
147021444|NCT02243293|530239085|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
147021445|NCT03069417|530239086|FG000|Overall Study|Lost to Follow-up|2|||
147021446|NCT03069417|530239087|FG001|Overall Study|Lost to Follow-up|0|||
147021447|NCT03069417|530239086|FG000|Overall Study|Reason Unknown|4|||
147021448|NCT03069417|530239087|FG001|Overall Study|Reason Unknown|7|||
147021449|NCT02953678|530239091|FG000|Overall Study|Adverse Event|20|||
147021450|NCT02953678|530239091|FG000|Overall Study|Death|7|||
147021451|NCT02953678|530239091|FG000|Overall Study|Physician Decision|23|||
147021452|NCT02953678|530239091|FG000|Overall Study|Progressive Disease of GVHD|7|||
147021453|NCT02953678|530239091|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
147021454|NCT02953678|530239091|FG000|Overall Study|Withdrawal by participant|3|||
147021455|NCT02953678|530239091|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
147021456|NCT02953678|530239091|FG000|Overall Study|Participants were transferred to commercial product.|3|||
147021457|NCT03064438|530241859|FG000|Overall Study|Lost to Follow-up|1|||
147021458|NCT03064438|530241860|FG001|Overall Study|Lost to Follow-up|0|||
147021459|NCT03064438|530241859|FG000|Overall Study|Withdrawal by Subject|0|||
147021460|NCT03064438|530241860|FG001|Overall Study|Withdrawal by Subject|1|||
147021461|NCT01937351|530241861|FG000|Overall Study|Withdrawal by Subject|4|||
147021462|NCT01937351|530241862|FG001|Overall Study|Withdrawal by Subject|2|||
147021463|NCT01937351|530241861|FG000|Overall Study|Death|1|||
147021464|NCT01937351|530241862|FG001|Overall Study|Death|0|||
147021465|NCT01937351|530241861|FG000|Overall Study|Not treated w device, per protocol fail|4|||
147021466|NCT01937351|530241862|FG001|Overall Study|Not treated w device, per protocol fail|0|||
147021467|NCT01223235|530241863|FG000|Overall Study|Withdrawal by Subject|1|||
147021468|NCT05506358|530241867|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
147021469|NCT05506358|530241868|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
147021470|NCT05506358|530241869|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
147021471|NCT05506358|530241870|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
147021472|NCT05506358|530241871|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
147021473|NCT05506358|530241867|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
147021474|NCT05506358|530241868|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
147021475|NCT05506358|530241869|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
147021476|NCT05506358|530241870|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
147021477|NCT05506358|530241871|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
147021478|NCT05506358|530241867|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
147021479|NCT05506358|530241868|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
147021480|NCT05506358|530241869|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
147021481|NCT05506358|530241870|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
147021482|NCT05506358|530241871|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
147021483|NCT05506358|530241867|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
147021484|NCT05506358|530241868|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
147021485|NCT05506358|530241869|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
147021486|NCT05506358|530241870|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
147021487|NCT05506358|530241871|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
147021488|NCT05506358|530241867|FG000|Overall Study|HbE trait|0|||
147021489|NCT05506358|530241868|FG001|Overall Study|HbE trait|0|||
147021490|NCT05506358|530241869|FG002|Overall Study|HbE trait|0|||
147021491|NCT05506358|530241870|FG003|Overall Study|HbE trait|1|||
147021492|NCT05506358|530241871|FG004|Overall Study|HbE trait|0|||
147021493|NCT03336242|530241877|FG000|Overall Study|Adverse Event|0|||
147021494|NCT03336242|530241878|FG001|Overall Study|Adverse Event|1|||
147021495|NCT02457611|530241882|FG000|Overall Study|Lost to Follow-up|3|||
147021496|NCT00384293|530241883|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
147021497|NCT00384293|530241884|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
147021498|NCT00384293|530241885|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
147021499|NCT00384293|530241883|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
147021500|NCT00384293|530241884|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
147021501|NCT00384293|530241885|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
147021502|NCT00384293|530241883|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
147021503|NCT00384293|530241884|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
147021504|NCT00384293|530241885|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
147021505|NCT00384293|530241883|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
147021506|NCT00384293|530241884|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
146736605|NCT04739761|529206939|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
146736606|NCT04739761|529206940|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
146736607|NCT04739761|529206939|FG000|Overall Study|Participant immediately started next line of treatment|1|||
146736608|NCT04739761|529206940|FG001|Overall Study|Participant immediately started next line of treatment|0|||
146736609|NCT04739761|529206939|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
146736610|NCT04739761|529206940|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
146736611|NCT04739761|529206939|FG000|Overall Study|Lack of clinical benefit|1|||
146736612|NCT04739761|529206940|FG001|Overall Study|Lack of clinical benefit|0|||
146736613|NCT04739761|529206939|FG000|Overall Study|Disease progression|5|||
146736614|NCT04739761|529206940|FG001|Overall Study|Disease progression|5|||
146736615|NCT04739761|529206939|FG000|Overall Study|Withdrawal by Subject|14|||
146736616|NCT04739761|529206940|FG001|Overall Study|Withdrawal by Subject|13|||
146736617|NCT04739761|529206939|FG000|Overall Study|Protocol Violation|1|||
146736618|NCT04739761|529206940|FG001|Overall Study|Protocol Violation|0|||
146736619|NCT04739761|529206939|FG000|Overall Study|Physician Decision|2|||
146736620|NCT04739761|529206940|FG001|Overall Study|Physician Decision|0|||
146849211|NCT01865747|529617056|FG000|Overall Study (ITT)|Progressive Disease|122|||
146849212|NCT01865747|529617057|FG001|Overall Study (ITT)|Progressive Disease|158|||
146849213|NCT01865747|529617056|FG000|Overall Study (ITT)|Reason Not Provided|0|||
146849214|NCT01865747|529617057|FG001|Overall Study (ITT)|Reason Not Provided|1|||
146849215|NCT01865747|529617056|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
146849216|NCT01865747|529617057|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
146849217|NCT01865747|529617056|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
146849218|NCT01865747|529617057|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
146849219|NCT01865747|529617056|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
146849220|NCT01865747|529617057|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
146849221|NCT01865747|529617056|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
146849222|NCT01865747|529617057|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
146849223|NCT01865747|529617056|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
146849224|NCT01865747|529617057|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
146849225|NCT01865747|529617056|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
146849226|NCT01865747|529617057|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
146849227|NCT01865747|529617056|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
146849228|NCT01865747|529617057|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
146849229|NCT01865747|529617056|FG000|Primary Intent to Treat (PITT)|Other|0|||
146849230|NCT01865747|529617057|FG001|Primary Intent to Treat (PITT)|Other|1|||
146849231|NCT05618912|529617058|FG000|Overall Study|Lost to Follow-up|14|||
146849232|NCT05618912|529617059|FG001|Overall Study|Lost to Follow-up|19|||
146849233|NCT03973931|529617060|FG000|Overall Study|Lost to Follow-up|47|||
146849234|NCT03973931|529617061|FG001|Overall Study|Lost to Follow-up|63|||
146849235|NCT03973931|529617062|FG002|Overall Study|Lost to Follow-up|51|||
146849236|NCT03973931|529617063|FG003|Overall Study|Lost to Follow-up|54|||
146849237|NCT03973931|529617060|FG000|Overall Study|opted out|6|||
146849238|NCT03973931|529617061|FG001|Overall Study|opted out|5|||
146849239|NCT03973931|529617062|FG002|Overall Study|opted out|5|||
146849240|NCT03973931|529617063|FG003|Overall Study|opted out|1|||
146849241|NCT00925353|529617064|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
146849242|NCT03695237|529618788|FG000|Overall Study|Withdrawal by Subject|1|||
146849243|NCT03695237|529618789|FG001|Overall Study|Withdrawal by Subject|3|||
146849244|NCT03695237|529618788|FG000|Overall Study|Lost to Follow-up|1|||
146849245|NCT03695237|529618789|FG001|Overall Study|Lost to Follow-up|2|||
146849246|NCT03695237|529618788|FG000|Overall Study|Other, Not Specified|8|||
146849247|NCT03695237|529618789|FG001|Overall Study|Other, Not Specified|2|||
146849248|NCT02516332|529618790|FG000|Overall Study|Withdrawal by Subject|2|||
146849249|NCT02516332|529618791|FG001|Overall Study|Withdrawal by Subject|1|||
146849250|NCT02516332|529618792|FG002|Overall Study|Withdrawal by Subject|2|||
146849251|NCT00055601|529618793|FG000|Overall Study|Protocol Violation|1|||
146849252|NCT00055601|529618794|FG001|Overall Study|Protocol Violation|1|||
146849253|NCT00055601|529618793|FG000|Overall Study|No protocol treatment received|1|||
146849254|NCT00055601|529618794|FG001|Overall Study|No protocol treatment received|1|||
146849255|NCT03541174|529618797|FG000|Part 1 Double-Blind|Adverse Event|6|||
146849256|NCT03541174|529618798|FG001|Part 1 Double-Blind|Adverse Event|5|||
146849257|NCT03541174|529618799|FG002|Part 1 Double-Blind|Adverse Event|2|||
146849258|NCT03541174|529618800|FG003|Part 1 Double-Blind|Adverse Event|0|||
146849259|NCT03541174|529618801|FG004|Part 1 Double-Blind|Adverse Event|0|||
146849260|NCT03541174|529618802|FG005|Part 1 Double-Blind|Adverse Event|0|||
146849261|NCT03541174|529618797|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
146849262|NCT03541174|529618798|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
147021507|NCT00384293|530241885|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
147021508|NCT00384293|530241883|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
147021509|NCT00384293|530241884|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
147021510|NCT00384293|530241885|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
147021511|NCT00384293|530241883|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
147021512|NCT00384293|530241884|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
147021513|NCT00384293|530241885|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
147021514|NCT00384293|530241883|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
147021515|NCT00384293|530241884|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
147021516|NCT00384293|530241885|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
147021517|NCT00384293|530241883|FG000|Post-randomization Period|Adverse Event|0|||
147021518|NCT00384293|530241884|FG001|Post-randomization Period|Adverse Event|23|||
147021519|NCT00384293|530241885|FG002|Post-randomization Period|Adverse Event|7|||
147021520|NCT00384293|530241883|FG000|Post-randomization Period|Lost to Follow-up|0|||
147021521|NCT00384293|530241884|FG001|Post-randomization Period|Lost to Follow-up|2|||
147021522|NCT00384293|530241885|FG002|Post-randomization Period|Lost to Follow-up|1|||
147021523|NCT00384293|530241883|FG000|Post-randomization Period|Protocol Violation|0|||
147021524|NCT00384293|530241884|FG001|Post-randomization Period|Protocol Violation|1|||
147021525|NCT00384293|530241885|FG002|Post-randomization Period|Protocol Violation|0|||
147021526|NCT00384293|530241883|FG000|Post-randomization Period|Withdrawal by Subject|0|||
147021527|NCT00384293|530241884|FG001|Post-randomization Period|Withdrawal by Subject|8|||
147021528|NCT00384293|530241885|FG002|Post-randomization Period|Withdrawal by Subject|6|||
147021529|NCT00384293|530241883|FG000|Post-randomization Period|Trial Termination|0|||
147021530|NCT00384293|530241884|FG001|Post-randomization Period|Trial Termination|180|||
147021531|NCT00384293|530241885|FG002|Post-randomization Period|Trial Termination|204|||
147021532|NCT00384293|530241883|FG000|Post-randomization Period|Patient Randomized in Error|0|||
147021533|NCT00384293|530241884|FG001|Post-randomization Period|Patient Randomized in Error|0|||
147021534|NCT00384293|530241885|FG002|Post-randomization Period|Patient Randomized in Error|1|||
147021535|NCT03005067|530241886|FG000|Overall Study|Withdrawal by Subject|3|||
147021536|NCT03005067|530241887|FG001|Overall Study|Withdrawal by Subject|2|||
147021537|NCT03005067|530241886|FG000|Overall Study|Adverse Event|4|||
147021538|NCT03005067|530241887|FG001|Overall Study|Adverse Event|3|||
147021539|NCT03005067|530241886|FG000|Overall Study|Other (reason not specified)|3|||
147021540|NCT03005067|530241887|FG001|Overall Study|Other (reason not specified)|1|||
147021541|NCT03005067|530241886|FG000|Overall Study|Protocol Violation|0|||
147021542|NCT03005067|530241887|FG001|Overall Study|Protocol Violation|1|||
147021543|NCT01790113|530241892|FG000|Overall Study|Adverse Event|2|||
147021544|NCT01790113|530241893|FG001|Overall Study|Adverse Event|7|||
147021545|NCT01790113|530241892|FG000|Overall Study|Study ended due to FDA clearance|1|||
147021546|NCT01790113|530241893|FG001|Overall Study|Study ended due to FDA clearance|68|||
147021547|NCT02674386|530241896|FG000|Overall Study|Lost to Follow-up|0|||
147021548|NCT02674386|530241897|FG001|Overall Study|Lost to Follow-up|1|||
147021549|NCT02674386|530241898|FG002|Overall Study|Lost to Follow-up|1|||
147021550|NCT02674386|530241896|FG000|Overall Study|Withdrawal by Subject|0|||
147021551|NCT02674386|530241897|FG001|Overall Study|Withdrawal by Subject|4|||
147021552|NCT02674386|530241898|FG002|Overall Study|Withdrawal by Subject|0|||
147021553|NCT02674386|530241896|FG000|Overall Study|Other|0|||
147021554|NCT02674386|530241897|FG001|Overall Study|Other|1|||
147021555|NCT02674386|530241898|FG002|Overall Study|Other|0|||
147021556|NCT02674386|530241896|FG000|Overall Study|Enrolled but not evaluated|0|||
147021557|NCT02674386|530241897|FG001|Overall Study|Enrolled but not evaluated|4|||
147021558|NCT02674386|530241898|FG002|Overall Study|Enrolled but not evaluated|0|||
147021559|NCT02462486|530241899|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
147021560|NCT02462486|530241900|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
147021561|NCT02462486|530241901|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
147021562|NCT02462486|530241899|FG000|Overall Study|Adverse Event|53|||
147021563|NCT02462486|530241900|FG001|Overall Study|Adverse Event|48|||
147021564|NCT02462486|530241901|FG002|Overall Study|Adverse Event|21|||
147021565|NCT02462486|530241899|FG000|Overall Study|Lack of Efficacy|6|||
147021566|NCT02462486|530241900|FG001|Overall Study|Lack of Efficacy|12|||
147021567|NCT02462486|530241901|FG002|Overall Study|Lack of Efficacy|3|||
147021568|NCT02462486|530241899|FG000|Overall Study|Lost to Follow-up|3|||
147021569|NCT02462486|530241900|FG001|Overall Study|Lost to Follow-up|4|||
147021570|NCT02462486|530241901|FG002|Overall Study|Lost to Follow-up|2|||
147021571|NCT02462486|530241899|FG000|Overall Study|Withdrawal by Subject|25|||
146849263|NCT03541174|529618799|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
146849264|NCT03541174|529618800|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
146849265|NCT03541174|529618801|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
146849266|NCT03541174|529618802|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
146849267|NCT03541174|529618797|FG000|Part 1 Double-Blind|Other reasons|3|||
147021572|NCT02462486|530241900|FG001|Overall Study|Withdrawal by Subject|22|||
147021573|NCT02462486|530241901|FG002|Overall Study|Withdrawal by Subject|19|||
147021574|NCT02462486|530241899|FG000|Overall Study|Protocol Violation|3|||
147021575|NCT02462486|530241900|FG001|Overall Study|Protocol Violation|1|||
147021576|NCT02462486|530241901|FG002|Overall Study|Protocol Violation|1|||
147021577|NCT02462486|530241899|FG000|Overall Study|Reason not Specified|3|||
147021578|NCT02462486|530241900|FG001|Overall Study|Reason not Specified|4|||
147021579|NCT02462486|530241901|FG002|Overall Study|Reason not Specified|3|||
147021580|NCT02310763|530241909|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
147021581|NCT02310763|530241910|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
147021582|NCT02310763|530241911|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
147021583|NCT02310763|530241909|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
147021584|NCT02310763|530241910|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
147021585|NCT02310763|530241911|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
147021586|NCT02310763|530241909|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
147021587|NCT02310763|530241910|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
147021588|NCT02310763|530241911|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
147021589|NCT02310763|530241909|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
147021590|NCT02310763|530241910|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
147021591|NCT02310763|530241911|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
147021592|NCT02310763|530241909|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
147021593|NCT02310763|530241910|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
147021594|NCT02310763|530241911|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
147021595|NCT02010255|530241914|FG000|Overall Study|Death|0|||
147021596|NCT02010255|530241915|FG001|Overall Study|Death|1|||
147021597|NCT02010255|530241916|FG002|Overall Study|Death|4|||
147021598|NCT02010255|530241917|FG003|Overall Study|Death|4|||
147021599|NCT02010255|530241918|FG004|Overall Study|Death|2|||
147021600|NCT02010255|530241919|FG005|Overall Study|Death|0|||
147021601|NCT02010255|530241920|FG006|Overall Study|Death|1|||
147021602|NCT02010255|530241921|FG007|Overall Study|Death|1|||
147021603|NCT02010255|530241922|FG008|Overall Study|Death|1|||
147021604|NCT02010255|530241923|FG009|Overall Study|Death|0|||
147021605|NCT02010255|530241924|FG010|Overall Study|Death|1|||
147021606|NCT02010255|530241925|FG011|Overall Study|Death|1|||
147021607|NCT02010255|530241926|FG012|Overall Study|Death|0|||
147021608|NCT02010255|530241927|FG013|Overall Study|Death|0|||
147021609|NCT02010255|530241914|FG000|Overall Study|Lack of Efficacy|4|||
147021610|NCT02010255|530241915|FG001|Overall Study|Lack of Efficacy|1|||
147021611|NCT02010255|530241916|FG002|Overall Study|Lack of Efficacy|2|||
147021612|NCT02010255|530241917|FG003|Overall Study|Lack of Efficacy|1|||
147021613|NCT02010255|530241918|FG004|Overall Study|Lack of Efficacy|1|||
147021614|NCT02010255|530241919|FG005|Overall Study|Lack of Efficacy|0|||
147021615|NCT02010255|530241920|FG006|Overall Study|Lack of Efficacy|0|||
147021616|NCT02010255|530241921|FG007|Overall Study|Lack of Efficacy|0|||
147021617|NCT02010255|530241922|FG008|Overall Study|Lack of Efficacy|0|||
147021618|NCT02010255|530241923|FG009|Overall Study|Lack of Efficacy|0|||
147021619|NCT02010255|530241924|FG010|Overall Study|Lack of Efficacy|1|||
147021620|NCT02010255|530241925|FG011|Overall Study|Lack of Efficacy|0|||
147021621|NCT02010255|530241926|FG012|Overall Study|Lack of Efficacy|0|||
147021622|NCT02010255|530241927|FG013|Overall Study|Lack of Efficacy|0|||
147021623|NCT02010255|530241914|FG000|Overall Study|Withdrew Consent|1|||
147021624|NCT02010255|530241915|FG001|Overall Study|Withdrew Consent|0|||
147021625|NCT02010255|530241916|FG002|Overall Study|Withdrew Consent|0|||
147021626|NCT02010255|530241917|FG003|Overall Study|Withdrew Consent|1|||
147021627|NCT02010255|530241918|FG004|Overall Study|Withdrew Consent|0|||
147021628|NCT02010255|530241919|FG005|Overall Study|Withdrew Consent|0|||
147021629|NCT02010255|530241920|FG006|Overall Study|Withdrew Consent|0|||
147021630|NCT02010255|530241921|FG007|Overall Study|Withdrew Consent|0|||
147021631|NCT02010255|530241922|FG008|Overall Study|Withdrew Consent|0|||
147021632|NCT02010255|530241923|FG009|Overall Study|Withdrew Consent|0|||
147021633|NCT02010255|530241924|FG010|Overall Study|Withdrew Consent|0|||
147021634|NCT02010255|530241925|FG011|Overall Study|Withdrew Consent|0|||
147021635|NCT02010255|530241926|FG012|Overall Study|Withdrew Consent|0|||
146849268|NCT03541174|529618798|FG001|Part 1 Double-Blind|Other reasons|2|||
147021636|NCT02010255|530241927|FG013|Overall Study|Withdrew Consent|0|||
146849269|NCT03541174|529618799|FG002|Part 1 Double-Blind|Other reasons|3|||
146849270|NCT03541174|529618800|FG003|Part 1 Double-Blind|Other reasons|0|||
147021637|NCT02010255|530241914|FG000|Overall Study|Adverse Event|1|||
147021638|NCT02010255|530241915|FG001|Overall Study|Adverse Event|0|||
147021639|NCT02010255|530241916|FG002|Overall Study|Adverse Event|0|||
147021640|NCT02010255|530241917|FG003|Overall Study|Adverse Event|0|||
147021641|NCT02010255|530241918|FG004|Overall Study|Adverse Event|0|||
147021642|NCT02010255|530241919|FG005|Overall Study|Adverse Event|0|||
147021643|NCT02010255|530241920|FG006|Overall Study|Adverse Event|0|||
147021644|NCT02010255|530241921|FG007|Overall Study|Adverse Event|0|||
147021645|NCT02010255|530241922|FG008|Overall Study|Adverse Event|0|||
147021646|NCT02010255|530241923|FG009|Overall Study|Adverse Event|0|||
147021647|NCT02010255|530241924|FG010|Overall Study|Adverse Event|0|||
147021648|NCT02010255|530241925|FG011|Overall Study|Adverse Event|0|||
147021649|NCT02010255|530241926|FG012|Overall Study|Adverse Event|0|||
147021650|NCT02010255|530241927|FG013|Overall Study|Adverse Event|0|||
147021651|NCT02010255|530241914|FG000|Overall Study|Lost to Follow-up|0|||
147021652|NCT02010255|530241915|FG001|Overall Study|Lost to Follow-up|0|||
147021653|NCT02010255|530241916|FG002|Overall Study|Lost to Follow-up|1|||
147021654|NCT02010255|530241917|FG003|Overall Study|Lost to Follow-up|0|||
147021655|NCT02010255|530241918|FG004|Overall Study|Lost to Follow-up|1|||
147021656|NCT02010255|530241919|FG005|Overall Study|Lost to Follow-up|0|||
147021657|NCT02010255|530241920|FG006|Overall Study|Lost to Follow-up|0|||
147021658|NCT02010255|530241921|FG007|Overall Study|Lost to Follow-up|0|||
147021659|NCT02010255|530241922|FG008|Overall Study|Lost to Follow-up|0|||
147021660|NCT02010255|530241923|FG009|Overall Study|Lost to Follow-up|0|||
147021661|NCT02010255|530241924|FG010|Overall Study|Lost to Follow-up|0|||
147021662|NCT02010255|530241925|FG011|Overall Study|Lost to Follow-up|0|||
147021663|NCT02010255|530241926|FG012|Overall Study|Lost to Follow-up|0|||
147021664|NCT02010255|530241927|FG013|Overall Study|Lost to Follow-up|0|||
147021665|NCT02010255|530241914|FG000|Overall Study|Randomized but Not Treated|0|||
147021666|NCT02010255|530241915|FG001|Overall Study|Randomized but Not Treated|0|||
147021667|NCT02010255|530241916|FG002|Overall Study|Randomized but Not Treated|0|||
147021668|NCT02010255|530241917|FG003|Overall Study|Randomized but Not Treated|0|||
147021669|NCT02010255|530241918|FG004|Overall Study|Randomized but Not Treated|0|||
147021670|NCT02010255|530241919|FG005|Overall Study|Randomized but Not Treated|0|||
147021671|NCT02010255|530241920|FG006|Overall Study|Randomized but Not Treated|0|||
147021672|NCT02010255|530241921|FG007|Overall Study|Randomized but Not Treated|0|||
147021673|NCT02010255|530241922|FG008|Overall Study|Randomized but Not Treated|0|||
147021674|NCT02010255|530241923|FG009|Overall Study|Randomized but Not Treated|0|||
147021675|NCT02010255|530241924|FG010|Overall Study|Randomized but Not Treated|0|||
147021676|NCT02010255|530241925|FG011|Overall Study|Randomized but Not Treated|0|||
147021677|NCT02010255|530241926|FG012|Overall Study|Randomized but Not Treated|0|||
147021678|NCT02010255|530241927|FG013|Overall Study|Randomized but Not Treated|1|||
147021679|NCT01202877|530241930|FG000|Overall Study|Disease Progression|0|||
147021680|NCT01202877|530241931|FG001|Overall Study|Disease Progression|1|||
147021681|NCT01202877|530241932|FG002|Overall Study|Disease Progression|2|||
147021682|NCT01202877|530241930|FG000|Overall Study|Adverse Event|0|||
147021683|NCT01202877|530241931|FG001|Overall Study|Adverse Event|0|||
147021684|NCT01202877|530241932|FG002|Overall Study|Adverse Event|2|||
147021685|NCT01202877|530241930|FG000|Overall Study|Withdrawal by Subject|0|||
147021686|NCT01202877|530241931|FG001|Overall Study|Withdrawal by Subject|0|||
147021687|NCT01202877|530241932|FG002|Overall Study|Withdrawal by Subject|1|||
147021688|NCT01202877|530241930|FG000|Overall Study|Death|0|||
147021689|NCT01202877|530241931|FG001|Overall Study|Death|0|||
147021690|NCT01202877|530241932|FG002|Overall Study|Death|1|||
147021691|NCT00396331|530241933|FG000|Overall Study|Failed to mobilize - no transplant|8|||
147021692|NCT00396331|530241933|FG000|Overall Study|Did not go on to transplant|5|||
147021693|NCT00396331|530241933|FG000|Overall Study|Lost to Follow-up|3|||
147021694|NCT00396331|530241933|FG000|Overall Study|Death|16|||
147021695|NCT00680186|530241934|FG000|Overall Study|Adverse Event|47|||
147021696|NCT00680186|530241935|FG001|Overall Study|Adverse Event|44|||
147021697|NCT00680186|530241934|FG000|Overall Study|Protocol Violation|31|||
147021698|NCT00680186|530241935|FG001|Overall Study|Protocol Violation|26|||
147021699|NCT00680186|530241934|FG000|Overall Study|Lost to Follow-up|11|||
147021700|NCT00680186|530241935|FG001|Overall Study|Lost to Follow-up|6|||
147021701|NCT00680186|530241934|FG000|Overall Study|Withdrawal by Subject|32|||
147021702|NCT00680186|530241935|FG001|Overall Study|Withdrawal by Subject|39|||
147021703|NCT00680186|530241934|FG000|Overall Study|Other|4|||
147021704|NCT00680186|530241935|FG001|Overall Study|Other|1|||
147021705|NCT01351350|530241936|FG000|Overall Study|Disease Progression|5|||
147021706|NCT01351350|530241937|FG001|Overall Study|Disease Progression|13|||
147021707|NCT01351350|530241938|FG002|Overall Study|Disease Progression|6|||
147021708|NCT01351350|530241939|FG003|Overall Study|Disease Progression|8|||
147021709|NCT01351350|530241940|FG004|Overall Study|Disease Progression|5|||
147021710|NCT01351350|530241936|FG000|Overall Study|Adverse Event|1|||
147021711|NCT01351350|530241937|FG001|Overall Study|Adverse Event|10|||
147021712|NCT01351350|530241938|FG002|Overall Study|Adverse Event|1|||
147021713|NCT01351350|530241939|FG003|Overall Study|Adverse Event|2|||
147021714|NCT01351350|530241940|FG004|Overall Study|Adverse Event|0|||
147021715|NCT01351350|530241936|FG000|Overall Study|Participant Decision|2|||
147021716|NCT01351350|530241937|FG001|Overall Study|Participant Decision|6|||
147021717|NCT01351350|530241938|FG002|Overall Study|Participant Decision|3|||
147021718|NCT01351350|530241939|FG003|Overall Study|Participant Decision|3|||
147021719|NCT01351350|530241940|FG004|Overall Study|Participant Decision|2|||
147021720|NCT01351350|530241936|FG000|Overall Study|Enrolled but not Treated|0|||
146849271|NCT03541174|529618801|FG004|Part 1 Double-Blind|Other reasons|0|||
146849272|NCT03541174|529618802|FG005|Part 1 Double-Blind|Other reasons|0|||
147021721|NCT01351350|530241937|FG001|Overall Study|Enrolled but not Treated|0|||
147021722|NCT01351350|530241938|FG002|Overall Study|Enrolled but not Treated|1|||
147021723|NCT01351350|530241939|FG003|Overall Study|Enrolled but not Treated|0|||
147021724|NCT01351350|530241940|FG004|Overall Study|Enrolled but not Treated|0|||
147021725|NCT00775528|530241945|FG000|Overall Study|Protocol Violation|1|||
147021726|NCT04647383|530241946|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
147021727|NCT04647383|530241947|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
147021728|NCT04647383|530241948|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
147021729|NCT04647383|530241949|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
147021730|NCT00466726|530241952|FG000|Overall Study|Not evaluable for response|14|||
147021731|NCT04403763|530241953|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
147021732|NCT04403763|530241954|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
147021733|NCT04403763|530241955|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
147021734|NCT04403763|530241956|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
147021735|NCT04403763|530241957|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
147021736|NCT04403763|530241958|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
147021737|NCT04403763|530241959|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
147021738|NCT04403763|530241953|FG000|Stage 1|Early termination due to PK tube failure|0|||
147021739|NCT04403763|530241954|FG001|Stage 1|Early termination due to PK tube failure|0|||
147021740|NCT04403763|530241955|FG002|Stage 1|Early termination due to PK tube failure|1|||
147021741|NCT04403763|530241956|FG003|Stage 1|Early termination due to PK tube failure|0|||
147021742|NCT04403763|530241957|FG004|Stage 1|Early termination due to PK tube failure|0|||
147021743|NCT04403763|530241958|FG005|Stage 1|Early termination due to PK tube failure|0|||
147021744|NCT04403763|530241959|FG006|Stage 1|Early termination due to PK tube failure|0|||
147021745|NCT04403763|530241953|FG000|Stage 2A|Adverse Event|0|||
147021746|NCT04403763|530241954|FG001|Stage 2A|Adverse Event|0|||
147021747|NCT04403763|530241955|FG002|Stage 2A|Adverse Event|0|||
147021748|NCT04403763|530241956|FG003|Stage 2A|Adverse Event|0|||
147021749|NCT04403763|530241957|FG004|Stage 2A|Adverse Event|0|||
147021750|NCT04403763|530241958|FG005|Stage 2A|Adverse Event|0|||
147021751|NCT04403763|530241959|FG006|Stage 2A|Adverse Event|1|||
147021752|NCT00350402|530241960|FG000|Overall Study|Lost to Follow-up|1|||
147021753|NCT00350402|530241961|FG001|Overall Study|Lost to Follow-up|1|||
147021754|NCT00834899|530241965|FG000|Overall Study|Withdrawal by Subject|1|||
147021755|NCT00834899|530241966|FG001|Overall Study|Withdrawal by Subject|1|||
147021756|NCT02709486|530241972|FG000|Overall Study|Adverse Event|2|||
147021757|NCT02709486|530241973|FG001|Overall Study|Adverse Event|5|||
147021758|NCT02709486|530241974|FG002|Overall Study|Adverse Event|3|||
147021759|NCT02709486|530241972|FG000|Overall Study|Death|0|||
147021760|NCT02709486|530241973|FG001|Overall Study|Death|0|||
147021761|NCT02709486|530241974|FG002|Overall Study|Death|2|||
147021762|NCT02709486|530241972|FG000|Overall Study|Insufficient clinical response|7|||
147021763|NCT02709486|530241973|FG001|Overall Study|Insufficient clinical response|3|||
147021764|NCT02709486|530241974|FG002|Overall Study|Insufficient clinical response|3|||
147021765|NCT02709486|530241972|FG000|Overall Study|Lost to Follow-up|3|||
147021766|NCT02709486|530241973|FG001|Overall Study|Lost to Follow-up|2|||
147021767|NCT02709486|530241974|FG002|Overall Study|Lost to Follow-up|2|||
147021768|NCT02709486|530241972|FG000|Overall Study|Other|0|||
147021769|NCT02709486|530241973|FG001|Overall Study|Other|2|||
147021770|NCT02709486|530241974|FG002|Overall Study|Other|3|||
147021771|NCT02709486|530241972|FG000|Overall Study|Withdrawal by Subject|32|||
147021772|NCT02709486|530241973|FG001|Overall Study|Withdrawal by Subject|22|||
147021773|NCT02709486|530241974|FG002|Overall Study|Withdrawal by Subject|32|||
147021774|NCT00606502|530241977|FG000|Randomization|Randomized but not treated|3|||
147021775|NCT00606502|530241978|FG001|Randomization|Randomized but not treated|0|||
147021776|NCT00606502|530241977|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
147021777|NCT00606502|530241978|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
147021778|NCT02443545|530241983|FG000|Overall Study|Adverse Event|1|||
147021779|NCT02443545|530241984|FG001|Overall Study|Adverse Event|1|||
147021780|NCT02443545|530241983|FG000|Overall Study|Lost to Follow-up|0|||
147021781|NCT02443545|530241984|FG001|Overall Study|Lost to Follow-up|2|||
147021782|NCT02443545|530241983|FG000|Overall Study|Physician Decision|3|||
147021783|NCT02443545|530241984|FG001|Overall Study|Physician Decision|0|||
147021784|NCT02443545|530241983|FG000|Overall Study|Protocol Violation|8|||
147021785|NCT02443545|530241984|FG001|Overall Study|Protocol Violation|1|||
147021786|NCT02443545|530241983|FG000|Overall Study|Pregnancy|1|||
147021787|NCT02443545|530241984|FG001|Overall Study|Pregnancy|1|||
147021788|NCT02443545|530241983|FG000|Overall Study|Withdrawal by Subject|6|||
147021789|NCT02443545|530241984|FG001|Overall Study|Withdrawal by Subject|3|||
147021790|NCT02443545|530241983|FG000|Overall Study|Termination of study|20|||
147021791|NCT02443545|530241984|FG001|Overall Study|Termination of study|11|||
147021792|NCT02549573|530241990|FG000|Overall Study|Withdrawal by Subject|0|||
147021793|NCT02549573|530241991|FG001|Overall Study|Withdrawal by Subject|2|||
147021794|NCT02549573|530241990|FG000|Overall Study|Protocol Violation|0|||
147021795|NCT02549573|530241991|FG001|Overall Study|Protocol Violation|1|||
146849273|NCT03541174|529618797|FG000|Part 2 Single-Blind|Adverse Event|0|||
147021796|NCT02610816|530241994|FG000|Phase 1|Withdrawal by Subject|2|||
147021797|NCT02610816|530241995|FG001|Phase 1|Withdrawal by Subject|6|||
147021798|NCT02610816|530241996|FG002|Phase 1|Withdrawal by Subject|0|||
147021799|NCT02610816|530241997|FG003|Phase 1|Withdrawal by Subject|0|||
147021800|NCT02610816|530241994|FG000|Phase 1|Lost to Follow-up|2|||
147021801|NCT02610816|530241995|FG001|Phase 1|Lost to Follow-up|1|||
147021802|NCT02610816|530241996|FG002|Phase 1|Lost to Follow-up|0|||
147021803|NCT02610816|530241997|FG003|Phase 1|Lost to Follow-up|0|||
147021804|NCT02610816|530241994|FG000|Phase 1|Physician Decision|0|||
147021805|NCT02610816|530241995|FG001|Phase 1|Physician Decision|1|||
147021806|NCT02610816|530241996|FG002|Phase 1|Physician Decision|0|||
147021807|NCT02610816|530241997|FG003|Phase 1|Physician Decision|0|||
147021808|NCT02610816|530241994|FG000|Phase 2|Withdrawal by Subject|0|||
147021809|NCT02610816|530241995|FG001|Phase 2|Withdrawal by Subject|0|||
147021810|NCT02610816|530241996|FG002|Phase 2|Withdrawal by Subject|9|||
147021811|NCT02610816|530241997|FG003|Phase 2|Withdrawal by Subject|3|||
147021812|NCT02610816|530241994|FG000|Phase 2|Lost to Follow-up|0|||
147021813|NCT02610816|530241995|FG001|Phase 2|Lost to Follow-up|0|||
147021814|NCT02610816|530241996|FG002|Phase 2|Lost to Follow-up|2|||
147021815|NCT02610816|530241997|FG003|Phase 2|Lost to Follow-up|0|||
147021816|NCT02610816|530241994|FG000|Phase 2|Physician Decision|0|||
147021817|NCT02610816|530241995|FG001|Phase 2|Physician Decision|0|||
147021818|NCT02610816|530241996|FG002|Phase 2|Physician Decision|0|||
147021819|NCT02610816|530241997|FG003|Phase 2|Physician Decision|2|||
147021820|NCT02610816|530241994|FG000|Phase 2|Pregnancy|0|||
147021821|NCT02610816|530241995|FG001|Phase 2|Pregnancy|0|||
147021822|NCT02610816|530241996|FG002|Phase 2|Pregnancy|0|||
147021823|NCT02610816|530241997|FG003|Phase 2|Pregnancy|1|||
147021824|NCT01855048|530242000|FG000|Overall Study|Withdrawal by Subject|0|||
147021825|NCT01855048|530242001|FG001|Overall Study|Withdrawal by Subject|1|||
147021826|NCT01855048|530242002|FG002|Overall Study|Withdrawal by Subject|0|||
147021827|NCT01855048|530242003|FG003|Overall Study|Withdrawal by Subject|0|||
147021828|NCT01855048|530242004|FG004|Overall Study|Withdrawal by Subject|1|||
147021829|NCT01855048|530242005|FG005|Overall Study|Withdrawal by Subject|0|||
147021830|NCT03465436|530242006|FG000|Period 1|Protocol Violation|0|||
147021831|NCT03465436|530242007|FG001|Period 1|Protocol Violation|0|||
147021832|NCT03465436|530242008|FG002|Period 1|Protocol Violation|1|||
147021833|NCT03465436|530242009|FG003|Period 1|Protocol Violation|0|||
147021834|NCT03465436|530242006|FG000|Period 2|Protocol Violation|0|||
147021835|NCT03465436|530242007|FG001|Period 2|Protocol Violation|1|||
147021836|NCT03465436|530242008|FG002|Period 2|Protocol Violation|0|||
147021837|NCT03465436|530242009|FG003|Period 2|Protocol Violation|0|||
147021838|NCT03465436|530242006|FG000|Period 3|Protocol Violation|1|||
147021839|NCT03465436|530242007|FG001|Period 3|Protocol Violation|1|||
147021840|NCT03465436|530242008|FG002|Period 3|Protocol Violation|0|||
147021841|NCT03465436|530242009|FG003|Period 3|Protocol Violation|0|||
147021842|NCT03465436|530242006|FG000|Period 4|Protocol Violation|0|||
147021843|NCT03465436|530242007|FG001|Period 4|Protocol Violation|0|||
147021844|NCT03465436|530242008|FG002|Period 4|Protocol Violation|1|||
147021845|NCT03465436|530242009|FG003|Period 4|Protocol Violation|0|||
147021846|NCT01813071|530242010|FG000|Overall Study|Protocol Violation|0|||
147021847|NCT01813071|530242011|FG001|Overall Study|Protocol Violation|0|||
147021848|NCT01813071|530242012|FG002|Overall Study|Protocol Violation|0|||
147021849|NCT01813071|530242013|FG003|Overall Study|Protocol Violation|0|||
147021850|NCT01813071|530242014|FG004|Overall Study|Protocol Violation|1|||
147021851|NCT01813071|530242015|FG005|Overall Study|Protocol Violation|4|||
147021852|NCT01813071|530242016|FG006|Overall Study|Protocol Violation|2|||
147021853|NCT01813071|530242017|FG007|Overall Study|Protocol Violation|4|||
147021854|NCT01813071|530242018|FG008|Overall Study|Protocol Violation|2|||
147021855|NCT01813071|530242010|FG000|Overall Study|Withdrawal by Subject|0|||
147021856|NCT01813071|530242011|FG001|Overall Study|Withdrawal by Subject|0|||
147021857|NCT01813071|530242012|FG002|Overall Study|Withdrawal by Subject|0|||
147021858|NCT01813071|530242013|FG003|Overall Study|Withdrawal by Subject|0|||
147021859|NCT01813071|530242014|FG004|Overall Study|Withdrawal by Subject|0|||
147021860|NCT01813071|530242015|FG005|Overall Study|Withdrawal by Subject|1|||
147021861|NCT01813071|530242016|FG006|Overall Study|Withdrawal by Subject|0|||
147021862|NCT01813071|530242017|FG007|Overall Study|Withdrawal by Subject|0|||
147021863|NCT01813071|530242018|FG008|Overall Study|Withdrawal by Subject|0|||
147021864|NCT01813071|530242010|FG000|Overall Study|Adverse Event|0|||
147021865|NCT01813071|530242011|FG001|Overall Study|Adverse Event|0|||
147021866|NCT01813071|530242012|FG002|Overall Study|Adverse Event|0|||
147021867|NCT01813071|530242013|FG003|Overall Study|Adverse Event|0|||
147021868|NCT01813071|530242014|FG004|Overall Study|Adverse Event|0|||
147021869|NCT01813071|530242015|FG005|Overall Study|Adverse Event|1|||
147021870|NCT01813071|530242016|FG006|Overall Study|Adverse Event|0|||
147021871|NCT01813071|530242017|FG007|Overall Study|Adverse Event|0|||
146849274|NCT03541174|529618798|FG001|Part 2 Single-Blind|Adverse Event|0|||
147021872|NCT01813071|530242018|FG008|Overall Study|Adverse Event|0|||
147021873|NCT01813071|530242010|FG000|Overall Study|Physician Decision|0|||
147021874|NCT01813071|530242011|FG001|Overall Study|Physician Decision|0|||
147021875|NCT01813071|530242012|FG002|Overall Study|Physician Decision|0|||
147021876|NCT01813071|530242013|FG003|Overall Study|Physician Decision|0|||
147021877|NCT01813071|530242014|FG004|Overall Study|Physician Decision|0|||
147021878|NCT01813071|530242015|FG005|Overall Study|Physician Decision|0|||
147021879|NCT01813071|530242016|FG006|Overall Study|Physician Decision|1|||
147021880|NCT01813071|530242017|FG007|Overall Study|Physician Decision|0|||
147021881|NCT01813071|530242018|FG008|Overall Study|Physician Decision|0|||
147021882|NCT01813071|530242010|FG000|Overall Study|Met inc/exc criteria|0|||
147021883|NCT01813071|530242011|FG001|Overall Study|Met inc/exc criteria|0|||
147021884|NCT01813071|530242012|FG002|Overall Study|Met inc/exc criteria|0|||
147021885|NCT01813071|530242013|FG003|Overall Study|Met inc/exc criteria|0|||
147021886|NCT01813071|530242014|FG004|Overall Study|Met inc/exc criteria|0|||
147021887|NCT01813071|530242015|FG005|Overall Study|Met inc/exc criteria|1|||
147021888|NCT01813071|530242016|FG006|Overall Study|Met inc/exc criteria|0|||
147021889|NCT01813071|530242017|FG007|Overall Study|Met inc/exc criteria|1|||
147021890|NCT01813071|530242018|FG008|Overall Study|Met inc/exc criteria|1|||
147021891|NCT00854373|530242019|FG000|Overall Study|Withdrawal by Subject|1|||
147021892|NCT00854373|530242020|FG001|Overall Study|Withdrawal by Subject|3|||
147021893|NCT00854373|530242019|FG000|Overall Study|Forgot to take study drug|1|||
147021894|NCT00854373|530242020|FG001|Overall Study|Forgot to take study drug|1|||
147021895|NCT02697773|530242021|FG000|Overall Study|Adverse Event|2|||
147021896|NCT02697773|530242022|FG001|Overall Study|Adverse Event|1|||
147021897|NCT02697773|530242023|FG002|Overall Study|Adverse Event|2|||
146849275|NCT03541174|529618799|FG002|Part 2 Single-Blind|Adverse Event|0|||
146849276|NCT03541174|529618800|FG003|Part 2 Single-Blind|Adverse Event|25|||
146849277|NCT03541174|529618801|FG004|Part 2 Single-Blind|Adverse Event|0|||
146849278|NCT03541174|529618802|FG005|Part 2 Single-Blind|Adverse Event|0|||
147021898|NCT02697773|530242021|FG000|Overall Study|Death|0|||
147021899|NCT02697773|530242022|FG001|Overall Study|Death|0|||
147021900|NCT02697773|530242023|FG002|Overall Study|Death|2|||
147021901|NCT02697773|530242021|FG000|Overall Study|Lack of Efficacy|4|||
147021902|NCT02697773|530242022|FG001|Overall Study|Lack of Efficacy|6|||
147021903|NCT02697773|530242023|FG002|Overall Study|Lack of Efficacy|6|||
147021904|NCT02697773|530242021|FG000|Overall Study|Lost to Follow-up|5|||
147021905|NCT02697773|530242022|FG001|Overall Study|Lost to Follow-up|5|||
147021906|NCT02697773|530242023|FG002|Overall Study|Lost to Follow-up|7|||
147021907|NCT02697773|530242021|FG000|Overall Study|Other|15|||
147021908|NCT02697773|530242022|FG001|Overall Study|Other|11|||
147021909|NCT02697773|530242023|FG002|Overall Study|Other|10|||
147021910|NCT02697773|530242021|FG000|Overall Study|Protocol Violation|1|||
147021911|NCT02697773|530242022|FG001|Overall Study|Protocol Violation|1|||
147021912|NCT02697773|530242023|FG002|Overall Study|Protocol Violation|0|||
147021913|NCT02697773|530242021|FG000|Overall Study|Withdrawal by Subject|10|||
147021914|NCT02697773|530242022|FG001|Overall Study|Withdrawal by Subject|13|||
147021915|NCT02697773|530242023|FG002|Overall Study|Withdrawal by Subject|13|||
147021916|NCT02697773|530242021|FG000|Overall Study|Randomized but not treated|1|||
147021917|NCT02697773|530242022|FG001|Overall Study|Randomized but not treated|1|||
147021918|NCT02697773|530242023|FG002|Overall Study|Randomized but not treated|0|||
147021919|NCT00613834|530242024|FG000|Overall Study|Withdrawal by Subject|0|||
147021920|NCT00613834|530242025|FG001|Overall Study|Withdrawal by Subject|3|||
147021921|NCT00842530|530242026|FG000|Overall Study|Serious adverse event|0|||
147021922|NCT00842530|530242027|FG001|Overall Study|Serious adverse event|6|||
147021923|NCT00842530|530242026|FG000|Overall Study|Other adverse event|6|||
147021924|NCT00842530|530242027|FG001|Overall Study|Other adverse event|1|||
147021925|NCT00842530|530242026|FG000|Overall Study|Protocol Violation|32|||
147021926|NCT00842530|530242027|FG001|Overall Study|Protocol Violation|14|||
147021927|NCT00842530|530242026|FG000|Overall Study|Lost to Follow-up|6|||
147021928|NCT00842530|530242027|FG001|Overall Study|Lost to Follow-up|8|||
147021929|NCT00842530|530242026|FG000|Overall Study|Withdrawal by Subject|73|||
147021930|NCT00842530|530242027|FG001|Overall Study|Withdrawal by Subject|28|||
147021931|NCT02939950|530242028|FG000|Overall Study|Lost to Follow-up|13|||
147021932|NCT02939950|530242029|FG001|Overall Study|Lost to Follow-up|16|||
147021933|NCT02939950|530242028|FG000|Overall Study|Positive slit lamp findings|0|||
147021934|NCT02939950|530242029|FG001|Overall Study|Positive slit lamp findings|1|||
147021935|NCT02939950|530242028|FG000|Overall Study|Chalazion upper lid|0|||
147021936|NCT02939950|530242029|FG001|Overall Study|Chalazion upper lid|1|||
147021937|NCT02939950|530242028|FG000|Overall Study|Lack of motivation|0|||
147021938|NCT02939950|530242029|FG001|Overall Study|Lack of motivation|2|||
146849279|NCT03541174|529618797|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
146849280|NCT03541174|529618798|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
147021939|NCT02939950|530242028|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
147021940|NCT02939950|530242029|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
147021941|NCT02939950|530242028|FG000|Overall Study|Military orders|1|||
147021942|NCT02939950|530242029|FG001|Overall Study|Military orders|0|||
147021943|NCT02939950|530242028|FG000|Overall Study|Participant Relocated|5|||
147021944|NCT02939950|530242029|FG001|Overall Study|Participant Relocated|3|||
147021945|NCT02939950|530242028|FG000|Overall Study|Study related symptoms|8|||
147021946|NCT02939950|530242029|FG001|Overall Study|Study related symptoms|8|||
147021947|NCT02939950|530242028|FG000|Overall Study|Unacceptable lens movement|2|||
146849281|NCT03541174|529618799|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
146849282|NCT03541174|529618800|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
146849283|NCT03541174|529618801|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
147021948|NCT02939950|530242029|FG001|Overall Study|Unacceptable lens movement|0|||
147021949|NCT02939950|530242028|FG000|Overall Study|Protocol Violation|6|||
147021950|NCT02939950|530242029|FG001|Overall Study|Protocol Violation|3|||
147021951|NCT02939950|530242028|FG000|Overall Study|Physician Decision|2|||
147021952|NCT02939950|530242029|FG001|Overall Study|Physician Decision|0|||
147021953|NCT02939950|530242028|FG000|Overall Study|Pregnancy|6|||
147021954|NCT02939950|530242029|FG001|Overall Study|Pregnancy|7|||
147021955|NCT02939950|530242028|FG000|Overall Study|Withdrawal by Subject|12|||
147021956|NCT02939950|530242029|FG001|Overall Study|Withdrawal by Subject|28|||
147021957|NCT02939950|530242028|FG000|Overall Study|Adverse Event|7|||
147021958|NCT02939950|530242029|FG001|Overall Study|Adverse Event|3|||
147021959|NCT02939950|530242028|FG000|Overall Study|Randomized, not dispensed|1|||
147021960|NCT02939950|530242029|FG001|Overall Study|Randomized, not dispensed|0|||
147021961|NCT02939950|530242028|FG000|Overall Study|Ineligible at Baseline|2|||
147021962|NCT02939950|530242029|FG001|Overall Study|Ineligible at Baseline|8|||
147021963|NCT00440115|530242030|FG000|Overall Study|Death|7|||
147021964|NCT00440115|530242031|FG001|Overall Study|Death|9|||
147021965|NCT00440115|530242032|FG002|Overall Study|Death|5|||
147021966|NCT00440115|530242030|FG000|Overall Study|Incarceration|0|||
147021967|NCT00440115|530242031|FG001|Overall Study|Incarceration|2|||
147021968|NCT00440115|530242032|FG002|Overall Study|Incarceration|1|||
147021969|NCT02377063|530242036|FG000|Overall Study|Non-compliance|5|||
147021970|NCT01524913|530242037|FG000|Overall Study|Lost to Follow-up|4|||
147021971|NCT01524913|530242038|FG001|Overall Study|Lost to Follow-up|0|||
147021972|NCT01524913|530242039|FG002|Overall Study|Lost to Follow-up|0|||
147021973|NCT00702208|530242040|FG000|Overall Study|Lost to Follow-up|28|||
147021974|NCT00702208|530242040|FG000|Overall Study|Did not self-lavage|1|||
147021975|NCT00702208|530242040|FG000|Overall Study|Unsatisfactory colposcopy|2|||
147021976|NCT01688726|530242041|FG000|Overall Study|Adverse Event|1|||
147021977|NCT01688726|530242042|FG001|Overall Study|Adverse Event|0|||
147021978|NCT01688726|530242041|FG000|Overall Study|Relocated abroad|0|||
147021979|NCT01688726|530242042|FG001|Overall Study|Relocated abroad|1|||
147021980|NCT04553913|530242043|FG000|Overall Study|patient's block resolved prior to PACU|1|||
147021981|NCT04553913|530242043|FG000|Overall Study|did not use the device properly|5|||
147021982|NCT01172821|530242044|FG000|Overall Study|Adverse Event|5|||
147021983|NCT01172821|530242045|FG001|Overall Study|Adverse Event|2|||
147021984|NCT01172821|530242046|FG002|Overall Study|Adverse Event|2|||
147021985|NCT01172821|530242047|FG003|Overall Study|Adverse Event|7|||
147021986|NCT01172821|530242044|FG000|Overall Study|Protocol Violation|0|||
147021987|NCT01172821|530242045|FG001|Overall Study|Protocol Violation|2|||
147021988|NCT01172821|530242046|FG002|Overall Study|Protocol Violation|1|||
147021989|NCT01172821|530242047|FG003|Overall Study|Protocol Violation|2|||
147021990|NCT01172821|530242044|FG000|Overall Study|Lost to Follow-up|4|||
147021991|NCT01172821|530242045|FG001|Overall Study|Lost to Follow-up|1|||
147021992|NCT01172821|530242046|FG002|Overall Study|Lost to Follow-up|2|||
147021993|NCT01172821|530242047|FG003|Overall Study|Lost to Follow-up|2|||
147021994|NCT01172821|530242044|FG000|Overall Study|Withdrawal by Subject|2|||
147021995|NCT01172821|530242045|FG001|Overall Study|Withdrawal by Subject|3|||
147021996|NCT01172821|530242046|FG002|Overall Study|Withdrawal by Subject|3|||
147021997|NCT01172821|530242047|FG003|Overall Study|Withdrawal by Subject|3|||
147021998|NCT01172821|530242044|FG000|Overall Study|Other|3|||
147021999|NCT01172821|530242045|FG001|Overall Study|Other|4|||
147022000|NCT01172821|530242046|FG002|Overall Study|Other|5|||
147022001|NCT01172821|530242047|FG003|Overall Study|Other|3|||
147022002|NCT00710749|530242049|FG000|First Intervention|Withdrawal by Subject|1|||
147022003|NCT00710749|530242050|FG001|First Intervention|Withdrawal by Subject|0|||
147022004|NCT02985879|530242053|FG000|Overall Study|Adverse Event|7|||
147022005|NCT02985879|530242054|FG001|Overall Study|Adverse Event|9|||
147022006|NCT02985879|530242055|FG002|Overall Study|Adverse Event|7|||
147022007|NCT02985879|530242053|FG000|Overall Study|Withdrew consent|6|||
147022008|NCT02985879|530242054|FG001|Overall Study|Withdrew consent|8|||
147022009|NCT02985879|530242055|FG002|Overall Study|Withdrew consent|10|||
147022010|NCT02985879|530242053|FG000|Overall Study|Lost to Follow-up|1|||
147022011|NCT02985879|530242054|FG001|Overall Study|Lost to Follow-up|0|||
147022012|NCT02985879|530242055|FG002|Overall Study|Lost to Follow-up|2|||
147022013|NCT02985879|530242053|FG000|Overall Study|Other, not specified|62|||
147022014|NCT02985879|530242054|FG001|Overall Study|Other, not specified|58|||
147022015|NCT02985879|530242055|FG002|Overall Study|Other, not specified|58|||
146849284|NCT03541174|529618802|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
147022016|NCT02658487|530243862|FG000|Overall Study|Death|2|||
147022017|NCT02658487|530243862|FG000|Overall Study|Disease progression|10|||
147022018|NCT02658487|530243862|FG000|Overall Study|Alternative therapy|1|||
147022019|NCT02658487|530243862|FG000|Overall Study|Adverse Event|1|||
147022020|NCT02658487|530243862|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
147022021|NCT02658487|530243862|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
147022022|NCT01647958|530243863|FG000|Initial Study|Lost to Follow-up|2|||
147022023|NCT01647958|530243864|FG001|Initial Study|Lost to Follow-up|3|||
147022024|NCT01647958|530243863|FG000|Continuation Phase|treatment received during Overall Study|39|||
147022025|NCT01647958|530243864|FG001|Continuation Phase|treatment received during Overall Study|0|||
147022026|NCT01647958|530243863|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
146849285|NCT03541174|529618797|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
147022027|NCT01647958|530243864|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
147022028|NCT01432574|530243866|FG000|Overall Study|Moved|2|||
147022029|NCT01432574|530243866|FG000|Overall Study|Not interested|1|||
147022030|NCT02516410|530243867|FG000|Overall Study|Adverse Event|0|||
147022031|NCT02516410|530243868|FG001|Overall Study|Adverse Event|1|||
147022032|NCT02516410|530243867|FG000|Overall Study|Withdrawal by Subject|0|||
147022033|NCT02516410|530243868|FG001|Overall Study|Withdrawal by Subject|1|||
147022034|NCT01475253|530243871|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
147022035|NCT01475253|530243872|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
147022036|NCT01475253|530243873|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
147022037|NCT01475253|530243874|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
147022038|NCT01475253|530243871|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
147022039|NCT01475253|530243872|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
147022040|NCT01475253|530243873|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
147022041|NCT01475253|530243874|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
147022042|NCT03135899|530243875|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
147022043|NCT03135899|530243876|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
147022044|NCT03135899|530243877|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
147022045|NCT03135899|530243878|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
147022046|NCT03135899|530243879|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
147022047|NCT03135899|530243880|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
147022048|NCT03135899|530243881|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
147022049|NCT03135899|530243882|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
147022050|NCT03135899|530243875|FG000|Overall Study|Withdrawal by Subject|0|||
147022051|NCT03135899|530243876|FG001|Overall Study|Withdrawal by Subject|0|||
147022052|NCT03135899|530243877|FG002|Overall Study|Withdrawal by Subject|0|||
147022053|NCT03135899|530243878|FG003|Overall Study|Withdrawal by Subject|0|||
147022054|NCT03135899|530243879|FG004|Overall Study|Withdrawal by Subject|0|||
147022055|NCT03135899|530243880|FG005|Overall Study|Withdrawal by Subject|2|||
147022056|NCT03135899|530243881|FG006|Overall Study|Withdrawal by Subject|0|||
147022057|NCT03135899|530243882|FG007|Overall Study|Withdrawal by Subject|0|||
147022058|NCT04146363|530243883|FG000|Induction Period|Adverse Event|1|||
147022059|NCT04146363|530243884|FG001|Induction Period|Adverse Event|2|||
147022060|NCT04146363|530243885|FG002|Induction Period|Adverse Event|0|||
147022061|NCT04146363|530243886|FG003|Induction Period|Adverse Event|0|||
147022062|NCT04146363|530243887|FG004|Induction Period|Adverse Event|0|||
147022063|NCT04146363|530243888|FG005|Induction Period|Adverse Event|0|||
147022064|NCT04146363|530243889|FG006|Induction Period|Adverse Event|0|||
147022065|NCT04146363|530243890|FG007|Induction Period|Adverse Event|0|||
147022066|NCT04146363|530243891|FG008|Induction Period|Adverse Event|0|||
147022067|NCT04146363|530243892|FG009|Induction Period|Adverse Event|0|||
147022068|NCT04146363|530243893|FG010|Induction Period|Adverse Event|0|||
147022069|NCT04146363|530243883|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
147022070|NCT04146363|530243884|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
147022071|NCT04146363|530243885|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
147022072|NCT04146363|530243886|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
147022073|NCT04146363|530243887|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
147022074|NCT04146363|530243888|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
147022075|NCT04146363|530243889|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
147022076|NCT04146363|530243890|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
147022077|NCT04146363|530243891|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
147022078|NCT04146363|530243892|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
147022079|NCT04146363|530243893|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
147022080|NCT04146363|530243883|FG000|Induction Period|Lack of Efficacy|7|||
147022081|NCT04146363|530243884|FG001|Induction Period|Lack of Efficacy|2|||
147022082|NCT04146363|530243885|FG002|Induction Period|Lack of Efficacy|0|||
147022083|NCT04146363|530243886|FG003|Induction Period|Lack of Efficacy|0|||
147022084|NCT04146363|530243887|FG004|Induction Period|Lack of Efficacy|0|||
147022085|NCT04146363|530243888|FG005|Induction Period|Lack of Efficacy|0|||
147022086|NCT04146363|530243889|FG006|Induction Period|Lack of Efficacy|0|||
147022087|NCT04146363|530243890|FG007|Induction Period|Lack of Efficacy|0|||
147022088|NCT04146363|530243891|FG008|Induction Period|Lack of Efficacy|0|||
147022089|NCT04146363|530243892|FG009|Induction Period|Lack of Efficacy|0|||
147022090|NCT04146363|530243893|FG010|Induction Period|Lack of Efficacy|0|||
147022091|NCT04146363|530243883|FG000|Induction Period|Lost to Follow-up|1|||
147022092|NCT04146363|530243884|FG001|Induction Period|Lost to Follow-up|4|||
147022093|NCT04146363|530243885|FG002|Induction Period|Lost to Follow-up|0|||
147022094|NCT04146363|530243886|FG003|Induction Period|Lost to Follow-up|0|||
147022095|NCT04146363|530243887|FG004|Induction Period|Lost to Follow-up|0|||
147022096|NCT04146363|530243888|FG005|Induction Period|Lost to Follow-up|0|||
147022097|NCT04146363|530243889|FG006|Induction Period|Lost to Follow-up|0|||
147022098|NCT04146363|530243890|FG007|Induction Period|Lost to Follow-up|0|||
147022099|NCT04146363|530243891|FG008|Induction Period|Lost to Follow-up|0|||
147022100|NCT04146363|530243892|FG009|Induction Period|Lost to Follow-up|0|||
147022101|NCT04146363|530243893|FG010|Induction Period|Lost to Follow-up|0|||
147022102|NCT04146363|530243883|FG000|Induction Period|Positive quantiferon test|0|||
147022103|NCT04146363|530243884|FG001|Induction Period|Positive quantiferon test|1|||
147022104|NCT04146363|530243885|FG002|Induction Period|Positive quantiferon test|0|||
147022105|NCT04146363|530243886|FG003|Induction Period|Positive quantiferon test|0|||
147022106|NCT04146363|530243887|FG004|Induction Period|Positive quantiferon test|0|||
147022107|NCT04146363|530243888|FG005|Induction Period|Positive quantiferon test|0|||
147022108|NCT04146363|530243889|FG006|Induction Period|Positive quantiferon test|0|||
147022109|NCT04146363|530243890|FG007|Induction Period|Positive quantiferon test|0|||
147022110|NCT04146363|530243891|FG008|Induction Period|Positive quantiferon test|0|||
147022111|NCT04146363|530243892|FG009|Induction Period|Positive quantiferon test|0|||
147022112|NCT04146363|530243893|FG010|Induction Period|Positive quantiferon test|0|||
147022113|NCT04146363|530243883|FG000|Induction Period|Protocol Deviation|5|||
147022114|NCT04146363|530243884|FG001|Induction Period|Protocol Deviation|6|||
147022115|NCT04146363|530243885|FG002|Induction Period|Protocol Deviation|0|||
147022116|NCT04146363|530243886|FG003|Induction Period|Protocol Deviation|0|||
147022117|NCT04146363|530243887|FG004|Induction Period|Protocol Deviation|0|||
147022118|NCT04146363|530243888|FG005|Induction Period|Protocol Deviation|0|||
147022119|NCT04146363|530243889|FG006|Induction Period|Protocol Deviation|0|||
147022120|NCT04146363|530243890|FG007|Induction Period|Protocol Deviation|0|||
147022121|NCT04146363|530243891|FG008|Induction Period|Protocol Deviation|0|||
147022122|NCT04146363|530243892|FG009|Induction Period|Protocol Deviation|0|||
147022123|NCT04146363|530243893|FG010|Induction Period|Protocol Deviation|0|||
147022124|NCT04146363|530243883|FG000|Induction Period|Withdrawal by Subject|6|||
147022125|NCT04146363|530243884|FG001|Induction Period|Withdrawal by Subject|3|||
147022126|NCT04146363|530243885|FG002|Induction Period|Withdrawal by Subject|0|||
147022127|NCT04146363|530243886|FG003|Induction Period|Withdrawal by Subject|0|||
147022128|NCT04146363|530243887|FG004|Induction Period|Withdrawal by Subject|0|||
147022129|NCT04146363|530243888|FG005|Induction Period|Withdrawal by Subject|0|||
147022130|NCT04146363|530243889|FG006|Induction Period|Withdrawal by Subject|0|||
147022131|NCT04146363|530243890|FG007|Induction Period|Withdrawal by Subject|0|||
147022132|NCT04146363|530243891|FG008|Induction Period|Withdrawal by Subject|0|||
147022133|NCT04146363|530243892|FG009|Induction Period|Withdrawal by Subject|0|||
147022134|NCT04146363|530243893|FG010|Induction Period|Withdrawal by Subject|0|||
147022135|NCT04146363|530243883|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
147022136|NCT04146363|530243884|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
147022137|NCT04146363|530243885|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
147022138|NCT04146363|530243886|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
147022139|NCT04146363|530243887|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
147022140|NCT04146363|530243888|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
147022141|NCT04146363|530243889|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
147022142|NCT04146363|530243890|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
147022143|NCT04146363|530243891|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
147022144|NCT04146363|530243892|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
147022145|NCT04146363|530243893|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
147022146|NCT04146363|530243883|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147022147|NCT04146363|530243884|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147022148|NCT04146363|530243885|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147022149|NCT04146363|530243886|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147022150|NCT04146363|530243887|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147022151|NCT04146363|530243888|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147022152|NCT04146363|530243889|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147022153|NCT04146363|530243890|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
147022154|NCT04146363|530243891|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147022155|NCT04146363|530243892|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147022156|NCT04146363|530243893|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147022157|NCT04146363|530243883|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147022158|NCT04146363|530243884|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147022159|NCT04146363|530243885|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147022160|NCT04146363|530243886|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147022161|NCT04146363|530243887|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147022162|NCT04146363|530243888|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147022163|NCT04146363|530243889|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
147022164|NCT04146363|530243890|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
147022165|NCT04146363|530243891|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147022166|NCT04146363|530243892|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146849286|NCT03541174|529618798|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
146849287|NCT03541174|529618799|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
146849288|NCT03541174|529618800|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
147022167|NCT04146363|530243893|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147022168|NCT04146363|530243883|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
147022169|NCT04146363|530243884|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
146849289|NCT03541174|529618801|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
147022170|NCT04146363|530243885|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
147022171|NCT04146363|530243886|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
147022172|NCT04146363|530243887|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
147022173|NCT04146363|530243888|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
147022174|NCT04146363|530243889|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
147022175|NCT04146363|530243890|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
147022176|NCT04146363|530243891|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
147022177|NCT04146363|530243892|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
147022178|NCT04146363|530243893|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
147022179|NCT04146363|530243883|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147022180|NCT04146363|530243884|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147022181|NCT04146363|530243885|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147022182|NCT04146363|530243886|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147022183|NCT04146363|530243887|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
147022184|NCT04146363|530243888|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
147022185|NCT04146363|530243889|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
147022186|NCT04146363|530243890|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
147022187|NCT04146363|530243891|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147022188|NCT04146363|530243892|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147022189|NCT04146363|530243893|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147022190|NCT04146363|530243883|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147022191|NCT04146363|530243884|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147022192|NCT04146363|530243885|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
147022193|NCT04146363|530243886|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147022194|NCT04146363|530243887|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147022195|NCT04146363|530243888|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
147022196|NCT04146363|530243889|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
147022197|NCT04146363|530243890|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
147022198|NCT04146363|530243891|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147022199|NCT04146363|530243892|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147022200|NCT04146363|530243893|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147022201|NCT04146363|530243883|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
147022202|NCT04146363|530243884|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
147022203|NCT04146363|530243885|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
147022204|NCT04146363|530243886|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
147022205|NCT04146363|530243887|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
147022206|NCT04146363|530243888|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
147022207|NCT04146363|530243889|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
147022208|NCT04146363|530243890|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
147022209|NCT04146363|530243891|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
147022210|NCT04146363|530243892|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
147022211|NCT04146363|530243893|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
147022212|NCT04146363|530243883|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147022213|NCT04146363|530243884|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147022214|NCT04146363|530243885|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147022215|NCT04146363|530243886|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147022216|NCT04146363|530243887|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147022217|NCT04146363|530243888|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147022218|NCT04146363|530243889|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147022219|NCT04146363|530243890|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147022220|NCT04146363|530243891|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
147022221|NCT04146363|530243892|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
147022222|NCT04146363|530243893|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
147022223|NCT04146363|530243883|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147022224|NCT04146363|530243884|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147022225|NCT04146363|530243885|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147022226|NCT04146363|530243886|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147022227|NCT04146363|530243887|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147022228|NCT04146363|530243888|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147022229|NCT04146363|530243889|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147022230|NCT04146363|530243890|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147022231|NCT04146363|530243891|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
147022232|NCT04146363|530243892|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
147022233|NCT04146363|530243893|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147022234|NCT04146363|530243883|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
147022235|NCT04146363|530243884|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
147022236|NCT04146363|530243885|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
147022237|NCT04146363|530243886|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
147022238|NCT04146363|530243887|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
147022239|NCT04146363|530243888|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
147022240|NCT04146363|530243889|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
147022241|NCT04146363|530243890|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
147022242|NCT04146363|530243891|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
147022243|NCT04146363|530243892|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
147022244|NCT04146363|530243893|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
147022245|NCT04146363|530243883|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147022246|NCT04146363|530243884|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147022247|NCT04146363|530243885|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147022248|NCT04146363|530243886|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147022249|NCT04146363|530243887|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147022250|NCT04146363|530243888|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147022251|NCT04146363|530243889|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147022252|NCT04146363|530243890|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147022253|NCT04146363|530243891|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
147022254|NCT04146363|530243892|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
147022255|NCT04146363|530243893|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
147022256|NCT04146363|530243883|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
147022257|NCT04146363|530243884|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
147022258|NCT04146363|530243885|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
147022259|NCT04146363|530243886|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
147022260|NCT04146363|530243887|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
147022261|NCT04146363|530243888|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
147022262|NCT04146363|530243889|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
147022263|NCT04146363|530243890|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
147022264|NCT04146363|530243891|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
147022265|NCT04146363|530243892|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
147022266|NCT04146363|530243893|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
147022267|NCT04146363|530243883|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147022268|NCT04146363|530243884|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147022269|NCT04146363|530243885|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147022270|NCT04146363|530243886|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147022271|NCT04146363|530243887|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147022272|NCT04146363|530243888|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147022273|NCT04146363|530243889|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147022274|NCT04146363|530243890|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147022275|NCT04146363|530243891|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147022276|NCT04146363|530243892|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
147022277|NCT04146363|530243893|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147022278|NCT02914236|530243898|FG000|Overall Study|Lost to Follow-up|1|||
147022279|NCT02676284|530243899|FG000|Overall Study|Withdrawal by Subject|1|||
147022280|NCT00708708|530243901|FG000|Overall Study|Another therapy instead of Enbrel|141|||
147022281|NCT00708708|530243901|FG000|Overall Study|Lost to Follow-up|52|||
147022282|NCT00708708|530243901|FG000|Overall Study|Withdrawal by Subject|51|||
147022283|NCT00708708|530243901|FG000|Overall Study|Intolerance|42|||
147022284|NCT00708708|530243901|FG000|Overall Study|Another therapy along with Enbrel|15|||
147022285|NCT00708708|530243901|FG000|Overall Study|Other unspecified|11|||
147022286|NCT00708708|530243901|FG000|Overall Study|Good effectiveness|9|||
147022287|NCT00708708|530243901|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
147022288|NCT00708708|530243901|FG000|Overall Study|Administrative reasons|7|||
147022289|NCT00708708|530243901|FG000|Overall Study|Lack of effectiveness|4|||
147022290|NCT00708708|530243901|FG000|Overall Study|Lack of compliance|3|||
147022291|NCT00708708|530243901|FG000|Overall Study|Pregnancy|3|||
147022292|NCT00708708|530243901|FG000|Overall Study|Adverse Event|3|||
147022293|NCT00708708|530243901|FG000|Overall Study|Missing values|392|||
147022294|NCT00856830|530243902|FG000|Irinotecan & Bendamustine|Death|0|||
147022295|NCT00856830|530243903|FG001|Irinotecan & Bendamustine|Death|0|||
147022296|NCT00856830|530243904|FG002|Irinotecan & Bendamustine|Death|0|||
147022297|NCT00856830|530243905|FG003|Irinotecan & Bendamustine|Death|2|||
147022298|NCT00856830|530243902|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
147022299|NCT00856830|530243903|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
147022300|NCT00856830|530243904|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
147022301|NCT00856830|530243905|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
147022302|NCT03768726|530243908|FG000|Treatment Phase|Adverse Event|2|||
147022303|NCT03768726|530243909|FG001|Treatment Phase|Adverse Event|2|||
147022304|NCT03768726|530243908|FG000|Treatment Phase|Lost to Follow-up|1|||
147022305|NCT03768726|530243909|FG001|Treatment Phase|Lost to Follow-up|0|||
147022306|NCT03768726|530243908|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
147022307|NCT03768726|530243909|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
147022308|NCT03768726|530243908|FG000|Treatment Phase|Withdrawal by Subject|3|||
147022309|NCT03768726|530243909|FG001|Treatment Phase|Withdrawal by Subject|1|||
147022310|NCT03768726|530243908|FG000|Follow-Up|Adverse Event|2|||
147022311|NCT03768726|530243909|FG001|Follow-Up|Adverse Event|2|||
147022312|NCT03768726|530243908|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
147022313|NCT03768726|530243909|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
147022314|NCT03768726|530243908|FG000|Follow-Up|Withdrawal by Subject|2|||
147022315|NCT03768726|530243909|FG001|Follow-Up|Withdrawal by Subject|0|||
147022316|NCT03768726|530243908|FG000|Follow-Up|Other|1|||
147022317|NCT03768726|530243909|FG001|Follow-Up|Other|0|||
147022318|NCT01286558|530243910|FG000|Overall Study|Adverse Event|1|||
147022319|NCT01286558|530243911|FG001|Overall Study|Adverse Event|1|||
147022320|NCT01286558|530243910|FG000|Overall Study|Withdrawal by Subject|0|||
147022321|NCT01286558|530243911|FG001|Overall Study|Withdrawal by Subject|1|||
147022322|NCT01787279|530243913|FG000|Overall Study|Lost to Follow-up|2|||
147022323|NCT01787279|530243913|FG000|Overall Study|Lack of Efficacy|1|||
147022324|NCT00140413|530243916|FG000|Overall Study|Lost to Follow-up|1|||
147022325|NCT00140413|530243917|FG001|Overall Study|Lost to Follow-up|0|||
147022326|NCT00140413|530243916|FG000|Overall Study|Withdrawal by Subject|2|||
147022327|NCT00140413|530243917|FG001|Overall Study|Withdrawal by Subject|0|||
147022328|NCT02694549|530243920|FG000|Overall Study|screen failures|2|||
147022329|NCT01567826|530243921|FG000|Overall Study|Lost to Follow-up|3|||
147022330|NCT01567826|530243922|FG001|Overall Study|Lost to Follow-up|2|||
147022331|NCT00865098|530243928|FG000|Overall Study|Progressive disease|1|||
147022332|NCT03265288|530243931|FG000|Overall Study|Adverse Event|0|||
147022333|NCT03265288|530243932|FG001|Overall Study|Adverse Event|1|||
147022334|NCT03265288|530243931|FG000|Overall Study|Withdrawal by Subject|13|||
147022335|NCT03265288|530243932|FG001|Overall Study|Withdrawal by Subject|5|||
147022336|NCT03265288|530243931|FG000|Overall Study|Drug Withdrawn|3|||
147022337|NCT03265288|530243932|FG001|Overall Study|Drug Withdrawn|3|||
147022338|NCT03265288|530243931|FG000|Overall Study|Any Other Reason|7|||
147022339|NCT03265288|530243932|FG001|Overall Study|Any Other Reason|3|||
147022340|NCT01715896|530243936|FG000|Overall Study|Lost to Follow-up|0|||
147022341|NCT01715896|530243937|FG001|Overall Study|Lost to Follow-up|2|||
147022342|NCT01715896|530243936|FG000|Overall Study|Withdrawal by Subject|1|||
147022343|NCT01715896|530243937|FG001|Overall Study|Withdrawal by Subject|4|||
147022344|NCT01715896|530243936|FG000|Overall Study|Other|2|||
147022345|NCT01715896|530243937|FG001|Overall Study|Other|5|||
147022346|NCT03575871|530243942|FG000|Overall Study|Adverse Event|5|||
146849290|NCT03541174|529618802|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
146849291|NCT03541174|529618797|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
146849292|NCT03541174|529618798|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
146849293|NCT03541174|529618799|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
146849294|NCT03541174|529618800|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
146849295|NCT03541174|529618801|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
146849296|NCT03541174|529618802|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
146849297|NCT03541174|529618797|FG000|Part 2 Single-Blind|Death|0|||
146849298|NCT03541174|529618798|FG001|Part 2 Single-Blind|Death|0|||
146849299|NCT03541174|529618799|FG002|Part 2 Single-Blind|Death|0|||
146849300|NCT03541174|529618800|FG003|Part 2 Single-Blind|Death|5|||
146849301|NCT03541174|529618801|FG004|Part 2 Single-Blind|Death|0|||
146849302|NCT03541174|529618802|FG005|Part 2 Single-Blind|Death|0|||
146849303|NCT03541174|529618797|FG000|Part 2 Single-Blind|Pregnancy|0|||
146849304|NCT03541174|529618798|FG001|Part 2 Single-Blind|Pregnancy|0|||
146849305|NCT03541174|529618799|FG002|Part 2 Single-Blind|Pregnancy|0|||
146849306|NCT03541174|529618800|FG003|Part 2 Single-Blind|Pregnancy|1|||
146849307|NCT03541174|529618801|FG004|Part 2 Single-Blind|Pregnancy|0|||
146849308|NCT03541174|529618802|FG005|Part 2 Single-Blind|Pregnancy|0|||
146849309|NCT03541174|529618797|FG000|Part 2 Single-Blind|Other reasons|0|||
146849310|NCT03541174|529618798|FG001|Part 2 Single-Blind|Other reasons|0|||
146849311|NCT03541174|529618799|FG002|Part 2 Single-Blind|Other reasons|0|||
146849312|NCT03541174|529618800|FG003|Part 2 Single-Blind|Other reasons|32|||
146849313|NCT03541174|529618801|FG004|Part 2 Single-Blind|Other reasons|0|||
146849314|NCT03541174|529618802|FG005|Part 2 Single-Blind|Other reasons|0|||
146849315|NCT03541174|529618797|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
146849316|NCT03541174|529618798|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
146849317|NCT03541174|529618799|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
146849318|NCT03541174|529618800|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
146849319|NCT03541174|529618801|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
147022347|NCT03575871|530243943|FG001|Overall Study|Adverse Event|5|||
147022348|NCT03575871|530243944|FG002|Overall Study|Adverse Event|8|||
147022349|NCT03575871|530243942|FG000|Overall Study|Death|1|||
147022350|NCT03575871|530243943|FG001|Overall Study|Death|0|||
147022351|NCT03575871|530243944|FG002|Overall Study|Death|0|||
147022352|NCT03575871|530243942|FG000|Overall Study|Lack of Efficacy|5|||
147022353|NCT03575871|530243943|FG001|Overall Study|Lack of Efficacy|4|||
146849320|NCT03541174|529618802|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
147022354|NCT03575871|530243944|FG002|Overall Study|Lack of Efficacy|7|||
147022355|NCT03575871|530243942|FG000|Overall Study|Lost to Follow-up|1|||
147022356|NCT03575871|530243943|FG001|Overall Study|Lost to Follow-up|1|||
147022357|NCT03575871|530243944|FG002|Overall Study|Lost to Follow-up|1|||
147022358|NCT03575871|530243942|FG000|Overall Study|Protocol Deviation|1|||
147022359|NCT03575871|530243943|FG001|Overall Study|Protocol Deviation|1|||
147022360|NCT03575871|530243944|FG002|Overall Study|Protocol Deviation|1|||
147022361|NCT03575871|530243942|FG000|Overall Study|Withdrawal by Subject|6|||
147022362|NCT03575871|530243943|FG001|Overall Study|Withdrawal by Subject|1|||
147022363|NCT03575871|530243944|FG002|Overall Study|Withdrawal by Subject|9|||
147022364|NCT03575871|530243942|FG000|Overall Study|Other than specified|2|||
147022365|NCT03575871|530243943|FG001|Overall Study|Other than specified|2|||
147022366|NCT03575871|530243944|FG002|Overall Study|Other than specified|0|||
147022367|NCT02017860|530243945|FG000|Overall Study|Adverse Event|1|||
147022368|NCT02017860|530243945|FG000|Overall Study|Withdrawal by Subject|1|||
147022369|NCT06005597|530243946|FG000|Overall Study|Lost to Follow-up|1|||
147022370|NCT06005597|530243947|FG001|Overall Study|Lost to Follow-up|2|||
147022371|NCT06005597|530243948|FG002|Overall Study|Lost to Follow-up|1|||
147022372|NCT06005597|530243949|FG003|Overall Study|Lost to Follow-up|2|||
147022373|NCT06005597|530243946|FG000|Overall Study|Death|1|||
147022374|NCT06005597|530243947|FG001|Overall Study|Death|1|||
147022375|NCT06005597|530243948|FG002|Overall Study|Death|1|||
147022376|NCT06005597|530243949|FG003|Overall Study|Death|0|||
147022377|NCT02224573|530243956|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
147022378|NCT02224573|530243957|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
147022379|NCT02224573|530243956|FG000|Treatment Phase|Started on Other IMP|1|||
147022380|NCT02224573|530243957|FG001|Treatment Phase|Started on Other IMP|0|||
147022381|NCT02224573|530243956|FG000|Treatment Phase|Participant Discontinued IMP|0|||
147022382|NCT02224573|530243957|FG001|Treatment Phase|Participant Discontinued IMP|1|||
147022383|NCT02224573|530243956|FG000|Treatment Phase|Lack of Efficacy|15|||
147022384|NCT02224573|530243957|FG001|Treatment Phase|Lack of Efficacy|8|||
147022385|NCT02224573|530243956|FG000|Treatment Phase|Began Commercial Product|1|||
147022386|NCT02224573|530243957|FG001|Treatment Phase|Began Commercial Product|0|||
147022387|NCT02224573|530243956|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
147022388|NCT02224573|530243957|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
147022389|NCT02224573|530243956|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
147022390|NCT02224573|530243957|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
147022391|NCT02224573|530243956|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
147022392|NCT02224573|530243957|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
147022393|NCT02224573|530243956|FG000|Treatment Phase|Continued Compassionate Use|1|||
147022394|NCT02224573|530243957|FG001|Treatment Phase|Continued Compassionate Use|0|||
147022395|NCT02224573|530243956|FG000|Treatment Phase|Lack of Efficiency|2|||
147022396|NCT02224573|530243957|FG001|Treatment Phase|Lack of Efficiency|1|||
147022397|NCT02224573|530243956|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
147022398|NCT02224573|530243957|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
147022399|NCT02224573|530243956|FG000|Treatment Phase|Participant Moved|2|||
147022400|NCT02224573|530243957|FG001|Treatment Phase|Participant Moved|0|||
147022401|NCT02224573|530243956|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
147022402|NCT02224573|530243957|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
147022403|NCT02224573|530243956|FG000|Treatment Phase|Refused Medication|1|||
147022404|NCT02224573|530243957|FG001|Treatment Phase|Refused Medication|1|||
147022405|NCT02224573|530243956|FG000|Treatment Phase|Adverse Event|26|||
147022406|NCT02224573|530243957|FG001|Treatment Phase|Adverse Event|38|||
147022407|NCT02224573|530243956|FG000|Treatment Phase|Placed in Group Home|0|||
147022408|NCT02224573|530243957|FG001|Treatment Phase|Placed in Group Home|1|||
147022409|NCT02224573|530243956|FG000|Treatment Phase|Pursued Other Trials|1|||
147022410|NCT02224573|530243957|FG001|Treatment Phase|Pursued Other Trials|0|||
147022411|NCT02224573|530243956|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
147022412|NCT02224573|530243957|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
147022413|NCT02224573|530243956|FG000|Treatment Phase|Lost to Follow-up|2|||
147022414|NCT02224573|530243957|FG001|Treatment Phase|Lost to Follow-up|1|||
147022415|NCT02224573|530243956|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
147022416|NCT02224573|530243957|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
147022417|NCT02224573|530243956|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
147022418|NCT02224573|530243957|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
147022419|NCT02224573|530243956|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
147022420|NCT02224573|530243957|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
147022421|NCT02224573|530243956|FG000|Taper Phase|Adverse Event|1|||
147022422|NCT02224573|530243957|FG001|Taper Phase|Adverse Event|1|||
147022423|NCT00252174|530243958|FG000|Overall Study|Withdrawal by Subject|0|||
147022424|NCT00252174|530243959|FG001|Overall Study|Withdrawal by Subject|1|||
147022425|NCT00252174|530243960|FG002|Overall Study|Withdrawal by Subject|0|||
147022426|NCT02546362|530243961|FG000|4-week Treatment Period|Lost to Follow-up|1|||
147022427|NCT02546362|530243961|FG000|4-week Treatment Period|Change in medication|2|||
147022428|NCT02546362|530243961|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
147022429|NCT02546362|530243961|FG000|12-week Treatment Period|Lost to Follow-up|2|||
147022430|NCT02546362|530243961|FG000|12-week Treatment Period|Change in medication|1|||
147022431|NCT01138826|530243962|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
147022432|NCT01138826|530243963|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
147022433|NCT01138826|530243964|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
147022434|NCT01138826|530243965|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
147022435|NCT01138826|530243966|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
147022436|NCT01138826|530243967|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
147022437|NCT05206448|530243968|FG000|Overall Study|Lost to Follow-up|2|||
147022438|NCT05206448|530243969|FG001|Overall Study|Lost to Follow-up|2|||
147022439|NCT05206448|530243968|FG000|Overall Study|Withdrawal by Subject|2|||
147022440|NCT05206448|530243969|FG001|Overall Study|Withdrawal by Subject|0|||
147022441|NCT05206448|530243968|FG000|Overall Study|found ineligible after randomization|1|||
147022442|NCT05206448|530243969|FG001|Overall Study|found ineligible after randomization|1|||
147022443|NCT05206448|530243968|FG000|Overall Study|unable to complete study due to personal constraints|1|||
147022444|NCT05206448|530243969|FG001|Overall Study|unable to complete study due to personal constraints|0|||
147022445|NCT05206448|530243968|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
147022446|NCT05206448|530243969|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
147022447|NCT00754442|530243973|FG000|Overall Study|Withdrawal by Subject|5|||
147022448|NCT00754442|530243974|FG001|Overall Study|Withdrawal by Subject|3|||
147022449|NCT01557842|530243975|FG000|Overall Study|Lost to Follow-up|0|||
147022450|NCT01557842|530243976|FG001|Overall Study|Lost to Follow-up|1|||
147022451|NCT01557842|530243975|FG000|Overall Study|Death|1|||
147022452|NCT01557842|530243976|FG001|Overall Study|Death|0|||
147022453|NCT01557842|530243975|FG000|Overall Study|Lack of Efficacy|0|||
147022454|NCT01557842|530243976|FG001|Overall Study|Lack of Efficacy|1|||
147022455|NCT01557842|530243975|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
147022456|NCT01557842|530243976|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
147022457|NCT01557842|530243975|FG000|Overall Study|Study Terminated by Sponsor|3|||
147022458|NCT01557842|530243976|FG001|Overall Study|Study Terminated by Sponsor|4|||
147022459|NCT01557842|530243975|FG000|Overall Study|Not Ablated|2|||
147022460|NCT01557842|530243976|FG001|Overall Study|Not Ablated|0|||
147022461|NCT05560763|530243977|FG000|Overall Study|Withdrawal by Subject|4|||
147022462|NCT06972251|530243980|FG000|Overall Study|Withdrawal by Subject|1|||
147022463|NCT06972251|530243981|FG001|Overall Study|Withdrawal by Subject|0|||
147022464|NCT06972251|530243980|FG000|Overall Study|Lost to Follow-up|10|||
147022465|NCT06972251|530243981|FG001|Overall Study|Lost to Follow-up|2|||
147022466|NCT00949988|530243982|FG000|Overall Study|Withdrawal by Subject|3|||
147022467|NCT01929395|530243983|FG000|Overall Study|Did not complete - non-related toxicity|1|||
147022468|NCT01929395|530243984|FG001|Overall Study|Did not complete - non-related toxicity|0|||
147022469|NCT01929395|530243985|FG002|Overall Study|Did not complete - non-related toxicity|0|||
147022470|NCT01929395|530243983|FG000|Overall Study|Withdrawal by Subject|0|||
147022471|NCT01929395|530243984|FG001|Overall Study|Withdrawal by Subject|1|||
147022472|NCT01929395|530243985|FG002|Overall Study|Withdrawal by Subject|0|||
147022473|NCT01929395|530243983|FG000|Overall Study|Screen Fail|0|||
147022474|NCT01929395|530243984|FG001|Overall Study|Screen Fail|0|||
147022475|NCT01929395|530243985|FG002|Overall Study|Screen Fail|1|||
147022476|NCT00484419|530243987|FG000|Overall Study|Adverse Event|3|||
147022477|NCT00484419|530243988|FG001|Overall Study|Adverse Event|0|||
147022478|NCT00484419|530243989|FG002|Overall Study|Adverse Event|0|||
147022479|NCT00484419|530243987|FG000|Overall Study|Lost to Follow-up|1|||
147022480|NCT00484419|530243988|FG001|Overall Study|Lost to Follow-up|0|||
147022481|NCT00484419|530243989|FG002|Overall Study|Lost to Follow-up|2|||
147022482|NCT00484419|530243987|FG000|Overall Study|Withdrawal by Subject|3|||
147022483|NCT00484419|530243988|FG001|Overall Study|Withdrawal by Subject|1|||
147022484|NCT00484419|530243989|FG002|Overall Study|Withdrawal by Subject|1|||
147022485|NCT00484419|530243987|FG000|Overall Study|subject met discontinuation criteria|2|||
147022486|NCT00484419|530243988|FG001|Overall Study|subject met discontinuation criteria|2|||
147022487|NCT00484419|530243989|FG002|Overall Study|subject met discontinuation criteria|4|||
147022488|NCT00484419|530243987|FG000|Overall Study|required restricted medication|1|||
147022489|NCT00484419|530243988|FG001|Overall Study|required restricted medication|0|||
147022490|NCT00484419|530243989|FG002|Overall Study|required restricted medication|1|||
147022491|NCT00484419|530243987|FG000|Overall Study|Physician Decision|1|||
147022492|NCT00484419|530243988|FG001|Overall Study|Physician Decision|1|||
147022493|NCT00484419|530243989|FG002|Overall Study|Physician Decision|1|||
147022494|NCT00484419|530243987|FG000|Overall Study|subject unable to receive medication|1|||
147022495|NCT00484419|530243988|FG001|Overall Study|subject unable to receive medication|0|||
147022496|NCT00484419|530243989|FG002|Overall Study|subject unable to receive medication|0|||
147022497|NCT00484419|530243987|FG000|Overall Study|subject relocated|0|||
147022498|NCT00484419|530243988|FG001|Overall Study|subject relocated|1|||
147022499|NCT00484419|530243989|FG002|Overall Study|subject relocated|0|||
147022500|NCT00484419|530243987|FG000|Overall Study|sponsor decision, randomized in error|0|||
147022501|NCT00484419|530243988|FG001|Overall Study|sponsor decision, randomized in error|0|||
147022502|NCT00484419|530243989|FG002|Overall Study|sponsor decision, randomized in error|2|||
147022503|NCT03604341|530243990|FG000|Overall Study|Withdrawal by Subject|1|||
147022504|NCT03604341|530243991|FG001|Overall Study|Withdrawal by Subject|1|||
147022505|NCT03604341|530243990|FG000|Overall Study|Adverse Event|1|||
147022506|NCT03604341|530243991|FG001|Overall Study|Adverse Event|0|||
147022507|NCT03604341|530243990|FG000|Overall Study|Protocol Violation|0|||
147022508|NCT03604341|530243991|FG001|Overall Study|Protocol Violation|1|||
147022509|NCT00355472|530243992|FG000|Overall Study|Physician Decision|1|||
147022510|NCT01341587|530243993|FG000|Overall Study|Lost to Follow-up|2|||
147022511|NCT01341587|530243994|FG001|Overall Study|Lost to Follow-up|0|||
147022512|NCT01341587|530243993|FG000|Overall Study|stopped using the meters|2|||
147022513|NCT01341587|530243994|FG001|Overall Study|stopped using the meters|10|||
147022514|NCT00351351|530243995|FG000|Overall Study|surgical access pbs; device issues|9|||
147022515|NCT00351351|530243996|FG001|Overall Study|surgical access pbs; device issues|4|||
147022516|NCT03176784|530243997|FG000|Overall Study|Lost to Follow-up|77|||
147022517|NCT03176784|530243998|FG001|Overall Study|Lost to Follow-up|79|||
147022518|NCT03176784|530243999|FG002|Overall Study|Lost to Follow-up|79|||
147022519|NCT03176784|530244000|FG003|Overall Study|Lost to Follow-up|49|||
147022520|NCT03176784|530243997|FG000|Overall Study|Withdrawal by Subject|28|||
147022521|NCT03176784|530243998|FG001|Overall Study|Withdrawal by Subject|34|||
147022522|NCT03176784|530243999|FG002|Overall Study|Withdrawal by Subject|34|||
147022523|NCT03176784|530244000|FG003|Overall Study|Withdrawal by Subject|21|||
147022524|NCT02990806|530244001|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
147022525|NCT02990806|530244002|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
147022526|NCT02990806|530244003|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
147022527|NCT02990806|530244004|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
147022528|NCT02990806|530244001|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
147022529|NCT02990806|530244002|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
147022530|NCT02990806|530244003|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
147022531|NCT02990806|530244004|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
147022532|NCT02990806|530244001|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
147022533|NCT02990806|530244002|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
147022534|NCT02990806|530244003|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
147022535|NCT02990806|530244004|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
147022536|NCT02990806|530244001|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
147022537|NCT02990806|530244002|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
147022538|NCT02990806|530244003|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
147022539|NCT02990806|530244004|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
147022540|NCT02990806|530244001|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
147022541|NCT02990806|530244002|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
147022542|NCT02990806|530244003|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
147022543|NCT02990806|530244004|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
147022544|NCT02990806|530244001|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
147022545|NCT02990806|530244002|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
147022546|NCT02990806|530244003|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
147022547|NCT02990806|530244004|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
147022548|NCT02990806|530244001|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
147022549|NCT02990806|530244002|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
147022550|NCT02990806|530244003|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
147022551|NCT02990806|530244004|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
147022552|NCT02990806|530244001|FG000|Stage 1 (22 Weeks)|Death|0|||
147022553|NCT02990806|530244002|FG001|Stage 1 (22 Weeks)|Death|1|||
147022554|NCT02990806|530244003|FG002|Stage 1 (22 Weeks)|Death|0|||
147022555|NCT02990806|530244004|FG003|Stage 1 (22 Weeks)|Death|0|||
147022556|NCT02990806|530244001|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
147022557|NCT02990806|530244002|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
147022558|NCT02990806|530244003|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
147022559|NCT02990806|530244004|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
147022560|NCT02990806|530244001|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
147022561|NCT02990806|530244002|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
147022562|NCT02990806|530244003|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
147022563|NCT02990806|530244004|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
147022564|NCT02990806|530244001|FG000|Stage 1 (22 Weeks)|Other|1|||
147022565|NCT02990806|530244002|FG001|Stage 1 (22 Weeks)|Other|3|||
147022566|NCT02990806|530244003|FG002|Stage 1 (22 Weeks)|Other|0|||
147022567|NCT02990806|530244004|FG003|Stage 1 (22 Weeks)|Other|0|||
147022568|NCT02990806|530244001|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
147022569|NCT02990806|530244002|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
147022570|NCT02990806|530244003|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
147022571|NCT02990806|530244004|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
147022572|NCT02990806|530244001|FG000|Stage 2 (32 Weeks)|Death|1|||
147022573|NCT02990806|530244002|FG001|Stage 2 (32 Weeks)|Death|0|||
147022574|NCT02990806|530244003|FG002|Stage 2 (32 Weeks)|Death|0|||
147022575|NCT02990806|530244004|FG003|Stage 2 (32 Weeks)|Death|0|||
147022576|NCT02990806|530244001|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
147022577|NCT02990806|530244002|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
147022578|NCT02990806|530244003|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
147022579|NCT02990806|530244004|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
147022580|NCT02990806|530244001|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
147022581|NCT02990806|530244002|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
147022582|NCT02990806|530244003|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
147022583|NCT02990806|530244004|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
147022584|NCT02990806|530244001|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
147022585|NCT02990806|530244002|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
147022586|NCT02990806|530244003|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
147022587|NCT02990806|530244004|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
147022588|NCT02990806|530244001|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
147022589|NCT02990806|530244002|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
147022590|NCT02990806|530244003|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
147022591|NCT02990806|530244004|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
147022592|NCT02990806|530244001|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
147022593|NCT02990806|530244002|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
147022594|NCT02990806|530244003|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
147022595|NCT02990806|530244004|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
147022596|NCT02990806|530244001|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
147022597|NCT02990806|530244002|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
147022598|NCT02990806|530244003|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
147022599|NCT02990806|530244004|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
147022600|NCT02990806|530244001|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
147022601|NCT02990806|530244002|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
147022602|NCT02990806|530244003|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
147022603|NCT02990806|530244004|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
147022604|NCT02990806|530244001|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
147022605|NCT02990806|530244002|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
147022606|NCT02990806|530244003|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
147022607|NCT02990806|530244004|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
147022608|NCT02990806|530244001|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
147022609|NCT02990806|530244002|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
147022610|NCT02990806|530244003|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
147022611|NCT02990806|530244004|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
147022612|NCT02990806|530244001|FG000|Stage 2 (32 Weeks)|Other|3|||
147022613|NCT02990806|530244002|FG001|Stage 2 (32 Weeks)|Other|0|||
147022614|NCT02990806|530244003|FG002|Stage 2 (32 Weeks)|Other|4|||
147022615|NCT02990806|530244004|FG003|Stage 2 (32 Weeks)|Other|1|||
147022616|NCT02990806|530244001|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
147022617|NCT02990806|530244002|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
147022618|NCT02990806|530244003|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
147022619|NCT02990806|530244004|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
147022620|NCT02990806|530244001|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
147022621|NCT02990806|530244002|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
147022622|NCT02990806|530244003|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
147022623|NCT02990806|530244004|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
147022624|NCT02990806|530244001|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
147022625|NCT02990806|530244002|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
147022626|NCT02990806|530244003|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
147022627|NCT02990806|530244004|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
147022628|NCT02990806|530244001|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
147022629|NCT02990806|530244002|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
147022630|NCT02990806|530244003|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
147022631|NCT02990806|530244004|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
147022632|NCT02990806|530244001|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
147022633|NCT02990806|530244002|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
147022634|NCT02990806|530244003|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
147022635|NCT02990806|530244004|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
147022636|NCT02990806|530244001|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
147022637|NCT02990806|530244002|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
147022638|NCT02990806|530244003|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
147022639|NCT02990806|530244004|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
147022640|NCT02990806|530244001|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
147022641|NCT02990806|530244002|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
147022642|NCT02990806|530244003|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
147022643|NCT02990806|530244004|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
147022644|NCT02990806|530244001|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
147022645|NCT02990806|530244002|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
147022646|NCT02990806|530244003|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
147022647|NCT02990806|530244004|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
147022648|NCT02990806|530244001|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
147022649|NCT02990806|530244002|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
147022650|NCT02990806|530244003|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
147022651|NCT02990806|530244004|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
147022652|NCT01010750|530244005|FG000|Second Intervention|Adverse Event|0|||
147022653|NCT01010750|530244006|FG001|Second Intervention|Adverse Event|1|||
147022654|NCT01010750|530244007|FG002|Second Intervention|Adverse Event|0|||
147022655|NCT01010750|530244008|FG003|Second Intervention|Adverse Event|0|||
147022656|NCT01010750|530244009|FG004|Second Intervention|Adverse Event|0|||
147022657|NCT01010750|530244010|FG005|Second Intervention|Adverse Event|0|||
147022658|NCT00873119|530244016|FG000|Overall Study|Patient request|4|||
147022659|NCT00873119|530244017|FG001|Overall Study|Patient request|2|||
147022660|NCT00873119|530244016|FG000|Overall Study|Adverse Event|8|||
147022661|NCT00873119|530244017|FG001|Overall Study|Adverse Event|0|||
147022662|NCT00873119|530244016|FG000|Overall Study|Progressive disease|26|||
147022663|NCT00873119|530244017|FG001|Overall Study|Progressive disease|18|||
147022664|NCT00873119|530244016|FG000|Overall Study|Death|2|||
147022665|NCT00873119|530244017|FG001|Overall Study|Death|1|||
147022666|NCT00873119|530244016|FG000|Overall Study|Other|2|||
147022667|NCT00873119|530244017|FG001|Overall Study|Other|5|||
147022668|NCT00873119|530244016|FG000|Overall Study|Not treated|2|||
147022669|NCT00873119|530244017|FG001|Overall Study|Not treated|0|||
147022670|NCT03648879|530244018|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
147022671|NCT01376310|530244019|FG000|Overall Study|Study closed/terminated|1|||
147022672|NCT01376310|530244020|FG001|Overall Study|Study closed/terminated|2|||
147022673|NCT01376310|530244019|FG000|Overall Study|Withdrawal by Subject|8|||
147022674|NCT01376310|530244020|FG001|Overall Study|Withdrawal by Subject|2|||
147022675|NCT01376310|530244019|FG000|Overall Study|Physician Decision|26|||
147022676|NCT01376310|530244020|FG001|Overall Study|Physician Decision|7|||
147022677|NCT01376310|530244019|FG000|Overall Study|Lost to Follow-up|1|||
147022678|NCT01376310|530244020|FG001|Overall Study|Lost to Follow-up|0|||
147022679|NCT02339740|530244021|FG000|Overall Study|Death|1|||
147022680|NCT02339740|530244022|FG001|Overall Study|Death|0|||
147022681|NCT02339740|530244021|FG000|Overall Study|Physician Decision|0|||
147022682|NCT02339740|530244022|FG001|Overall Study|Physician Decision|2|||
147022683|NCT02339740|530244021|FG000|Overall Study|Withdrawal by Subject|5|||
147022684|NCT02339740|530244022|FG001|Overall Study|Withdrawal by Subject|1|||
147022685|NCT02339740|530244021|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
147022686|NCT02339740|530244022|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
147022687|NCT00645944|530244023|FG000|Randomized|Withdrawal by Subject|1|||
147022688|NCT00645944|530244024|FG001|Randomized|Withdrawal by Subject|2|||
146849321|NCT03541174|529618797|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
146849322|NCT03541174|529618798|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
146849323|NCT03541174|529618799|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
146849324|NCT03541174|529618800|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
146849325|NCT03541174|529618801|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
146849326|NCT03541174|529618802|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
146849327|NCT03541174|529618797|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
146849328|NCT03541174|529618798|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
146849329|NCT03541174|529618799|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
146849330|NCT03541174|529618800|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
146849331|NCT03541174|529618801|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
146849332|NCT03541174|529618802|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
147022689|NCT00645944|530244023|FG000|Received Medication|Adverse Event|2|||
147022690|NCT00645944|530244024|FG001|Received Medication|Adverse Event|1|||
147022691|NCT00645944|530244023|FG000|Received Medication|Withdrawal by Subject|1|||
147022692|NCT00645944|530244024|FG001|Received Medication|Withdrawal by Subject|1|||
147022693|NCT00645944|530244023|FG000|Received Medication|Lost to Follow-up|1|||
147022694|NCT00645944|530244024|FG001|Received Medication|Lost to Follow-up|0|||
147022695|NCT00645944|530244023|FG000|Received Medication|Protocol Violation|2|||
146849333|NCT03541174|529618797|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
146849334|NCT03541174|529618798|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
147022696|NCT00645944|530244024|FG001|Received Medication|Protocol Violation|1|||
147022697|NCT01807117|530244025|FG000|Overall Study|Physician Decision|2|||
147022698|NCT01807117|530244025|FG000|Overall Study|Disease diagnosis not a study disease|1|||
147022699|NCT02377921|530244028|FG000|Overall Study|Subject non-compliance|1|||
147022700|NCT02377921|530244029|FG001|Overall Study|Subject non-compliance|1|||
147022701|NCT00706355|530244032|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
147022702|NCT00706355|530244033|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
147022703|NCT00706355|530244034|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
147022704|NCT00706355|530244035|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
147022705|NCT00706355|530244032|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
147022706|NCT00706355|530244033|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
147022707|NCT00706355|530244034|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
147022708|NCT00706355|530244035|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
147022709|NCT00706355|530244032|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
147022710|NCT00706355|530244033|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
147022711|NCT00706355|530244034|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
147022712|NCT00706355|530244035|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
147022713|NCT00706355|530244032|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
147022714|NCT00706355|530244033|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
147022715|NCT00706355|530244034|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
147022716|NCT00706355|530244035|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
147022717|NCT00706355|530244032|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
147022718|NCT00706355|530244033|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
147022719|NCT00706355|530244034|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
147022720|NCT00706355|530244035|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
147022721|NCT00706355|530244032|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
147022722|NCT00706355|530244033|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
147022723|NCT00706355|530244034|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
147022724|NCT00706355|530244035|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
147022725|NCT00706355|530244032|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
147022726|NCT00706355|530244033|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
147022727|NCT00706355|530244034|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
147022728|NCT00706355|530244035|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
147022729|NCT00706355|530244032|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
147022730|NCT00706355|530244033|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
147022731|NCT00706355|530244034|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
147022732|NCT00706355|530244035|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
147022733|NCT00706355|530244032|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
147022734|NCT00706355|530244033|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
147022735|NCT00706355|530244034|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
147022736|NCT00706355|530244035|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
147022737|NCT02510014|530244036|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
147022738|NCT02510014|530244037|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
147022739|NCT02510014|530244036|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
147022740|NCT02510014|530244037|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
147022741|NCT02510014|530244036|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
147022742|NCT02510014|530244037|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
147022743|NCT02510014|530244036|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
147022744|NCT02510014|530244037|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
147022745|NCT02510014|530244036|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
147022746|NCT02510014|530244037|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
147022747|NCT02510014|530244036|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
147022748|NCT02510014|530244037|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
147022749|NCT02510014|530244036|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
147022750|NCT02510014|530244037|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
147022751|NCT02510014|530244036|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
147022752|NCT02510014|530244037|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
147022753|NCT02510014|530244036|FG000|Treatment Period|Adverse Event|11|||
147022754|NCT02510014|530244037|FG001|Treatment Period|Adverse Event|4|||
147022755|NCT02510014|530244036|FG000|Treatment Period|Withdrawal symptoms|3|||
147022756|NCT02510014|530244037|FG001|Treatment Period|Withdrawal symptoms|0|||
147022757|NCT02510014|530244036|FG000|Treatment Period|Lost to Follow-up|80|||
147022758|NCT02510014|530244037|FG001|Treatment Period|Lost to Follow-up|19|||
147022759|NCT02510014|530244036|FG000|Treatment Period|Physician Decision|5|||
147022760|NCT02510014|530244037|FG001|Treatment Period|Physician Decision|0|||
147022761|NCT02510014|530244036|FG000|Treatment Period|Withdrawal by Subject|67|||
147022762|NCT02510014|530244037|FG001|Treatment Period|Withdrawal by Subject|24|||
147022763|NCT02510014|530244036|FG000|Treatment Period|Withdrawn by the investigator|7|||
147022764|NCT02510014|530244037|FG001|Treatment Period|Withdrawn by the investigator|1|||
147022765|NCT02510014|530244036|FG000|Treatment Period|Protocol Violation|4|||
147022766|NCT02510014|530244037|FG001|Treatment Period|Protocol Violation|4|||
147022767|NCT02510014|530244036|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
147022768|NCT02510014|530244037|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
147022769|NCT04179019|530244040|FG000|Overall Study|Lost to Follow-up|2|||
147022770|NCT04179019|530244040|FG000|Overall Study|Physician Decision|2|||
147022771|NCT04179019|530244040|FG000|Overall Study|Withdrawal by Subject|5|||
147022772|NCT04179019|530244040|FG000|Overall Study|Adverse Event|4|||
147022773|NCT04974619|530245592|FG000|Overall Study|Lost to Follow-up|0|||
147022774|NCT04974619|530245593|FG001|Overall Study|Lost to Follow-up|0|||
147022775|NCT04974619|530245594|FG002|Overall Study|Lost to Follow-up|1|||
147022776|NCT04974619|530245592|FG000|Overall Study|Withdrawal by Subject|0|||
147022777|NCT04974619|530245593|FG001|Overall Study|Withdrawal by Subject|0|||
147022778|NCT04974619|530245594|FG002|Overall Study|Withdrawal by Subject|1|||
147022779|NCT04974619|530245592|FG000|Overall Study|Protocol Violation|0|||
147022780|NCT04974619|530245593|FG001|Overall Study|Protocol Violation|1|||
147022781|NCT04974619|530245594|FG002|Overall Study|Protocol Violation|0|||
147022782|NCT03959527|530245601|FG000|Overall Study|Withdrawal by Subject|8|||
147022783|NCT03959527|530245602|FG001|Overall Study|Withdrawal by Subject|3|||
147022784|NCT03959527|530245601|FG000|Overall Study|Lost to Follow-up|31|||
147022785|NCT03959527|530245602|FG001|Overall Study|Lost to Follow-up|15|||
147022786|NCT03959527|530245601|FG000|Overall Study|Did not meet eligibility criteria|1|||
147022787|NCT03959527|530245602|FG001|Overall Study|Did not meet eligibility criteria|1|||
147022788|NCT03959527|530245601|FG000|Overall Study|Protocol Violation|10|||
147022789|NCT03959527|530245602|FG001|Overall Study|Protocol Violation|5|||
147022790|NCT01688466|530245603|FG000|Overall Study|Withdrawal by Subject|2|||
147022791|NCT01688466|530245604|FG001|Overall Study|Withdrawal by Subject|1|||
147022792|NCT01688466|530245603|FG000|Overall Study|Death|0|||
147022793|NCT01688466|530245604|FG001|Overall Study|Death|1|||
147022794|NCT01688466|530245603|FG000|Overall Study|Adverse Event|0|||
147022795|NCT01688466|530245604|FG001|Overall Study|Adverse Event|4|||
147022796|NCT01688466|530245603|FG000|Overall Study|Not evaluable|0|||
147022797|NCT01688466|530245604|FG001|Overall Study|Not evaluable|1|||
147022798|NCT01000610|530245609|FG000|Overall Study|Adverse Event|1|||
147022799|NCT01000610|530245609|FG000|Overall Study|Lost to Follow-up|4|||
147022800|NCT01000610|530245609|FG000|Overall Study|Treatment failure|1|||
147022801|NCT00595335|530245614|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
147022802|NCT00595335|530245615|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
147022803|NCT00595335|530245614|FG000|Baseline to Six Months|Disease Progression|1|||
147022804|NCT00595335|530245615|FG001|Baseline to Six Months|Disease Progression|1|||
147022805|NCT00595335|530245614|FG000|Baseline to Six Months|Adverse Event|1|||
147022806|NCT00595335|530245615|FG001|Baseline to Six Months|Adverse Event|0|||
147022807|NCT00595335|530245614|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
147022808|NCT00595335|530245615|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
147022809|NCT00595335|530245614|FG000|Six Months to Twelve Months|Disease Progression|1|||
147022810|NCT00595335|530245615|FG001|Six Months to Twelve Months|Disease Progression|0|||
147022811|NCT00493779|530245627|FG000|Overall Study|Logistical issue at site|1|||
147022812|NCT01131299|530245628|FG000|Overall Study|Withdrawal by Subject|4|||
147022813|NCT01131299|530245629|FG001|Overall Study|Withdrawal by Subject|7|||
147022814|NCT01885182|530245637|FG000|Overall Study|Adverse Event|11|||
147022815|NCT01885182|530245638|FG001|Overall Study|Adverse Event|13|||
147022816|NCT01885182|530245637|FG000|Overall Study|Withdrawal by Subject|13|||
147022817|NCT01885182|530245638|FG001|Overall Study|Withdrawal by Subject|6|||
147022818|NCT01885182|530245637|FG000|Overall Study|Lost to Follow-up|2|||
147022819|NCT01885182|530245638|FG001|Overall Study|Lost to Follow-up|2|||
147022820|NCT01885182|530245637|FG000|Overall Study|Lack of Efficacy|8|||
147022821|NCT01885182|530245638|FG001|Overall Study|Lack of Efficacy|1|||
147022822|NCT02148913|530245651|FG000|Overall Study|Death|0|||
147022823|NCT02148913|530245652|FG001|Overall Study|Death|1|||
147022824|NCT02148913|530245653|FG002|Overall Study|Death|0|||
147022825|NCT02148913|530245654|FG003|Overall Study|Death|0|||
147022826|NCT01287039|530245655|FG000|Overall Study|Noncompliance with study procedures|0|||
147022827|NCT01287039|530245656|FG001|Overall Study|Noncompliance with study procedures|1|||
147022828|NCT01287039|530245655|FG000|Overall Study|Change of location/residence|0|||
147022829|NCT01287039|530245656|FG001|Overall Study|Change of location/residence|3|||
147022830|NCT01287039|530245655|FG000|Overall Study|Elective surgery|0|||
147022831|NCT01287039|530245656|FG001|Overall Study|Elective surgery|1|||
147022832|NCT01287039|530245655|FG000|Overall Study|Protocol Violation|2|||
147022833|NCT01287039|530245656|FG001|Overall Study|Protocol Violation|3|||
147022834|NCT01287039|530245655|FG000|Overall Study|Excluded medication taken|1|||
147022835|NCT01287039|530245656|FG001|Overall Study|Excluded medication taken|0|||
147022836|NCT01287039|530245655|FG000|Overall Study|Noncompliance with study medication|0|||
147022837|NCT01287039|530245656|FG001|Overall Study|Noncompliance with study medication|1|||
147022838|NCT01287039|530245655|FG000|Overall Study|Problem with travel|0|||
147022839|NCT01287039|530245656|FG001|Overall Study|Problem with travel|1|||
147022840|NCT01287039|530245655|FG000|Overall Study|Death|1|||
147022841|NCT01287039|530245656|FG001|Overall Study|Death|0|||
147022842|NCT01287039|530245655|FG000|Overall Study|Change of residence|1|||
147022843|NCT01287039|530245656|FG001|Overall Study|Change of residence|0|||
147022844|NCT01287039|530245655|FG000|Overall Study|Adverse Event|7|||
147022845|NCT01287039|530245656|FG001|Overall Study|Adverse Event|4|||
147022846|NCT01287039|530245655|FG000|Overall Study|Withdrawal by Subject|14|||
147022847|NCT01287039|530245656|FG001|Overall Study|Withdrawal by Subject|11|||
147022848|NCT01287039|530245655|FG000|Overall Study|Lost to Follow-up|3|||
147022849|NCT01287039|530245656|FG001|Overall Study|Lost to Follow-up|2|||
147022850|NCT02370914|530245657|FG000|Overall Study|Protocol Violation|2|||
147022851|NCT01478828|530245658|FG000|Overall Study|Adverse Event|1|||
147022852|NCT05611996|530245659|FG000|Overall Study|Ineligible|1|||
147022853|NCT05611996|530245659|FG000|Overall Study|Withdrawal by Subject|9|||
147022854|NCT04479475|530245660|FG000|Overall Study|Withdrawal by Subject|7|||
147022855|NCT00296491|530245662|FG000|Overall Study|Low Pollen Counts|18|||
147022856|NCT00296491|530245663|FG001|Overall Study|Low Pollen Counts|26|||
147022857|NCT00296491|530245664|FG002|Overall Study|Low Pollen Counts|25|||
147022858|NCT00296491|530245665|FG003|Overall Study|Low Pollen Counts|16|||
147022859|NCT00296491|530245662|FG000|Overall Study|Protocol Violation|4|||
147022860|NCT00296491|530245663|FG001|Overall Study|Protocol Violation|6|||
147022861|NCT00296491|530245664|FG002|Overall Study|Protocol Violation|2|||
147022862|NCT00296491|530245665|FG003|Overall Study|Protocol Violation|3|||
147022863|NCT00296491|530245662|FG000|Overall Study|Adverse Event|1|||
147022864|NCT00296491|530245663|FG001|Overall Study|Adverse Event|3|||
147022865|NCT00296491|530245664|FG002|Overall Study|Adverse Event|1|||
147022866|NCT00296491|530245665|FG003|Overall Study|Adverse Event|4|||
147022867|NCT00296491|530245662|FG000|Overall Study|Withdrawn due to Asthma|0|||
147022868|NCT00296491|530245663|FG001|Overall Study|Withdrawn due to Asthma|0|||
147022869|NCT00296491|530245664|FG002|Overall Study|Withdrawn due to Asthma|0|||
147022870|NCT00296491|530245665|FG003|Overall Study|Withdrawn due to Asthma|4|||
147022871|NCT00296491|530245662|FG000|Overall Study|Withdrawal by Subject|7|||
147022872|NCT00296491|530245663|FG001|Overall Study|Withdrawal by Subject|3|||
147022873|NCT00296491|530245664|FG002|Overall Study|Withdrawal by Subject|3|||
147022874|NCT00296491|530245665|FG003|Overall Study|Withdrawal by Subject|2|||
147022875|NCT00296491|530245662|FG000|Overall Study|Non-Compliance|12|||
147022876|NCT00296491|530245663|FG001|Overall Study|Non-Compliance|13|||
147022877|NCT00296491|530245664|FG002|Overall Study|Non-Compliance|10|||
147022878|NCT00296491|530245665|FG003|Overall Study|Non-Compliance|14|||
147022879|NCT00296491|530245662|FG000|Overall Study|Lost to Follow-up|0|||
147022880|NCT00296491|530245663|FG001|Overall Study|Lost to Follow-up|2|||
147022881|NCT00296491|530245664|FG002|Overall Study|Lost to Follow-up|2|||
147022882|NCT00296491|530245665|FG003|Overall Study|Lost to Follow-up|0|||
147022883|NCT03451006|530245666|FG000|Overall Study|Withdrawal by Subject|2|||
147022884|NCT03451006|530245667|FG001|Overall Study|Withdrawal by Subject|2|||
147022885|NCT02547766|530245668|FG000|Overall Study|Withdrawal by Subject|1|||
147022886|NCT01829113|530245672|FG000|Overall Study|Disease Progression|37|||
147022887|NCT01829113|530245673|FG001|Overall Study|Disease Progression|48|||
147022888|NCT01829113|530245672|FG000|Overall Study|Adverse Event|14|||
147022889|NCT01829113|530245673|FG001|Overall Study|Adverse Event|10|||
147022890|NCT01829113|530245672|FG000|Overall Study|Withdrawal by Subject|17|||
147022891|NCT01829113|530245673|FG001|Overall Study|Withdrawal by Subject|10|||
147022892|NCT01829113|530245672|FG000|Overall Study|Death|4|||
147022893|NCT01829113|530245673|FG001|Overall Study|Death|6|||
147022894|NCT01829113|530245672|FG000|Overall Study|Sponsor Decision|1|||
147022895|NCT01829113|530245673|FG001|Overall Study|Sponsor Decision|1|||
147022896|NCT01829113|530245672|FG000|Overall Study|No Study Treatment Received|3|||
147022897|NCT01829113|530245673|FG001|Overall Study|No Study Treatment Received|2|||
147022898|NCT01829113|530245672|FG000|Overall Study|Physician Decision|1|||
147022899|NCT01829113|530245673|FG001|Overall Study|Physician Decision|1|||
147022900|NCT02654587|530245680|FG000|Overall Study|patient alive at end of study|22|||
147022901|NCT02654587|530245681|FG001|Overall Study|patient alive at end of study|8|||
147022902|NCT02654587|530245680|FG000|Overall Study|Withdrawal by Subject|1|||
147022903|NCT02654587|530245681|FG001|Overall Study|Withdrawal by Subject|7|||
147022904|NCT01825837|530245682|FG000|PART I|Withdrawal by Subject|0|||
147022905|NCT01825837|530245683|FG001|PART I|Withdrawal by Subject|0|||
147022906|NCT01825837|530245684|FG002|PART I|Withdrawal by Subject|0|||
147022907|NCT01825837|530245685|FG003|PART I|Withdrawal by Subject|6|||
147022908|NCT01825837|530245682|FG000|PART I|Patient non-compliance|0|||
147022909|NCT01825837|530245683|FG001|PART I|Patient non-compliance|0|||
147022910|NCT01825837|530245684|FG002|PART I|Patient non-compliance|0|||
147022911|NCT01825837|530245685|FG003|PART I|Patient non-compliance|1|||
147022912|NCT01825837|530245682|FG000|PART I|Treatment failure|0|||
147022913|NCT01825837|530245683|FG001|PART I|Treatment failure|0|||
147022914|NCT01825837|530245684|FG002|PART I|Treatment failure|0|||
147022915|NCT01825837|530245685|FG003|PART I|Treatment failure|7|||
147022916|NCT01825837|530245682|FG000|PART I|reason unspecified|0|||
147022917|NCT01825837|530245683|FG001|PART I|reason unspecified|0|||
147022918|NCT01825837|530245684|FG002|PART I|reason unspecified|0|||
147022919|NCT01825837|530245685|FG003|PART I|reason unspecified|3|||
147022920|NCT01825837|530245682|FG000|PART II|Withdrawal by Subject|3|||
147022921|NCT01825837|530245683|FG001|PART II|Withdrawal by Subject|3|||
147022922|NCT01825837|530245684|FG002|PART II|Withdrawal by Subject|7|||
147022923|NCT01825837|530245685|FG003|PART II|Withdrawal by Subject|0|||
147022924|NCT01825837|530245682|FG000|PART II|Patient non-compliance|5|||
147022925|NCT01825837|530245683|FG001|PART II|Patient non-compliance|2|||
147022926|NCT01825837|530245684|FG002|PART II|Patient non-compliance|4|||
147022927|NCT01825837|530245685|FG003|PART II|Patient non-compliance|0|||
147022928|NCT01825837|530245682|FG000|PART II|Adverse Event|3|||
147022929|NCT01825837|530245683|FG001|PART II|Adverse Event|3|||
147022930|NCT01825837|530245684|FG002|PART II|Adverse Event|1|||
147022931|NCT01825837|530245685|FG003|PART II|Adverse Event|0|||
147022932|NCT01825837|530245682|FG000|PART II|Treatment failure|6|||
147022933|NCT01825837|530245683|FG001|PART II|Treatment failure|4|||
147022934|NCT01825837|530245684|FG002|PART II|Treatment failure|5|||
147022935|NCT01825837|530245685|FG003|PART II|Treatment failure|0|||
147022936|NCT01825837|530245682|FG000|PART II|reason unspecified|2|||
147022937|NCT01825837|530245683|FG001|PART II|reason unspecified|2|||
147022938|NCT01825837|530245684|FG002|PART II|reason unspecified|2|||
147022939|NCT01825837|530245685|FG003|PART II|reason unspecified|0|||
147022940|NCT00904748|530245686|FG000|Overall Study|Withdrawal by Subject|1|||
147022941|NCT00904748|530245687|FG001|Overall Study|Withdrawal by Subject|1|||
147022942|NCT00904748|530245688|FG002|Overall Study|Withdrawal by Subject|1|||
147022943|NCT00904748|530245689|FG003|Overall Study|Withdrawal by Subject|2|||
147022944|NCT00904748|530245690|FG004|Overall Study|Withdrawal by Subject|0|||
147022945|NCT00904748|530245691|FG005|Overall Study|Withdrawal by Subject|0|||
147022946|NCT00904748|530245686|FG000|Overall Study|Adverse Event|0|||
147022947|NCT00904748|530245687|FG001|Overall Study|Adverse Event|0|||
147022948|NCT00904748|530245688|FG002|Overall Study|Adverse Event|0|||
147022949|NCT00904748|530245689|FG003|Overall Study|Adverse Event|0|||
147022950|NCT00904748|530245690|FG004|Overall Study|Adverse Event|1|||
147022951|NCT00904748|530245691|FG005|Overall Study|Adverse Event|0|||
147022952|NCT04740931|530245693|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
147022953|NCT04740931|530245694|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
147022954|NCT04740931|530245693|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
147022955|NCT04740931|530245694|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
147022956|NCT04740931|530245693|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
147022957|NCT04740931|530245694|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
147022958|NCT04740931|530245693|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
147022959|NCT04740931|530245694|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
147022960|NCT04740931|530245693|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
147022961|NCT04740931|530245694|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
147022962|NCT04740931|530245693|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
147022963|NCT04740931|530245694|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
147022964|NCT04740931|530245693|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
147022965|NCT04740931|530245694|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
147022966|NCT04740931|530245693|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
147022967|NCT04740931|530245694|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
147022968|NCT04740931|530245693|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
147022969|NCT04740931|530245694|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
147022970|NCT04740931|530245693|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
147022971|NCT04740931|530245694|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
147022972|NCT04740931|530245693|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
147022973|NCT04740931|530245694|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
147022974|NCT04740931|530245693|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
147022975|NCT04740931|530245694|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
147022976|NCT04740931|530245693|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
147022977|NCT04740931|530245694|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
147022978|NCT04740931|530245693|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
147022979|NCT04740931|530245694|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
147022980|NCT04740931|530245693|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
147022981|NCT04740931|530245694|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
147022982|NCT01534637|530245695|FG000|Overall Study|Physician Decision|3|||
147022983|NCT01534637|530245695|FG000|Overall Study|Lack of Efficacy|3|||
147022984|NCT01534637|530245695|FG000|Overall Study|Withdrawal by Subject|1|||
147022985|NCT01534637|530245695|FG000|Overall Study|Adverse Event|1|||
147022986|NCT01534637|530245695|FG000|Overall Study|Liver Mets before treatment|1|||
147022987|NCT01020799|530245699|FG000|Overall Study|Adverse Event|4|||
147022988|NCT01020799|530245700|FG001|Overall Study|Adverse Event|3|||
147022989|NCT01020799|530245701|FG002|Overall Study|Adverse Event|2|||
147022990|NCT01020799|530245699|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
147022991|NCT01020799|530245700|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
147022992|NCT01020799|530245701|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
147022993|NCT01020799|530245699|FG000|Overall Study|Protocol Violation|3|||
147022994|NCT01020799|530245700|FG001|Overall Study|Protocol Violation|2|||
147022995|NCT01020799|530245701|FG002|Overall Study|Protocol Violation|0|||
147022996|NCT01020799|530245699|FG000|Overall Study|Withdrawal by Subject|2|||
147022997|NCT01020799|530245700|FG001|Overall Study|Withdrawal by Subject|2|||
147022998|NCT01020799|530245701|FG002|Overall Study|Withdrawal by Subject|3|||
147022999|NCT01020799|530245699|FG000|Overall Study|Lost to Follow-up|6|||
147023000|NCT01020799|530245700|FG001|Overall Study|Lost to Follow-up|4|||
147023001|NCT01020799|530245701|FG002|Overall Study|Lost to Follow-up|2|||
147023002|NCT01560507|530245707|FG000|Overall Study|Lost to Follow-up|3|||
147023003|NCT01560507|530245708|FG001|Overall Study|Lost to Follow-up|1|||
147023004|NCT01560507|530245709|FG002|Overall Study|Lost to Follow-up|2|||
147023005|NCT01560507|530245707|FG000|Overall Study|Withdrawal by Subject|1|||
147023006|NCT01560507|530245708|FG001|Overall Study|Withdrawal by Subject|1|||
147023007|NCT01560507|530245709|FG002|Overall Study|Withdrawal by Subject|0|||
147023008|NCT00560937|530245710|FG000|Overall Study|Withdrawal by Subject|0|||
147023009|NCT00560937|530245711|FG001|Overall Study|Withdrawal by Subject|1|||
147023010|NCT00560937|530245710|FG000|Overall Study|Physician Decision|1|||
147023011|NCT00560937|530245711|FG001|Overall Study|Physician Decision|1|||
147023012|NCT01138111|530245712|FG000|Overall Study|Withdrawal by Subject|5|||
147023013|NCT01138111|530245712|FG000|Overall Study|Adverse Event|1|||
147023014|NCT01138111|530245712|FG000|Overall Study|Death|1|||
147023015|NCT01138111|530245712|FG000|Overall Study|Lost to Follow-up|2|||
147023016|NCT01118117|530245713|FG000|Overall Study|Death|8|||
147023017|NCT01118117|530245714|FG001|Overall Study|Death|0|||
147023018|NCT01118117|530245713|FG000|Overall Study|Lost to Follow-up|6|||
147023019|NCT01118117|530245714|FG001|Overall Study|Lost to Follow-up|0|||
147023020|NCT01118117|530245713|FG000|Overall Study|Missed 12 Month Visit|7|||
147023021|NCT01118117|530245714|FG001|Overall Study|Missed 12 Month Visit|0|||
147023022|NCT01660022|530245715|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
147023023|NCT01660022|530245716|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
147023024|NCT01660022|530245717|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
147023025|NCT01660022|530245718|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
147023026|NCT01660022|530245719|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
147023027|NCT01660022|530245720|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
147023028|NCT01660022|530245715|FG000|First Sequence (7 Days)|Adverse Event|0|||
147023029|NCT01660022|530245716|FG001|First Sequence (7 Days)|Adverse Event|0|||
147023030|NCT01660022|530245717|FG002|First Sequence (7 Days)|Adverse Event|0|||
147023031|NCT01660022|530245718|FG003|First Sequence (7 Days)|Adverse Event|0|||
147023032|NCT01660022|530245719|FG004|First Sequence (7 Days)|Adverse Event|1|||
147023033|NCT01660022|530245720|FG005|First Sequence (7 Days)|Adverse Event|3|||
147023034|NCT01660022|530245715|FG000|First Sequence (7 Days)|Protocol Violation|0|||
147023035|NCT01660022|530245716|FG001|First Sequence (7 Days)|Protocol Violation|0|||
147023036|NCT01660022|530245717|FG002|First Sequence (7 Days)|Protocol Violation|0|||
147023037|NCT01660022|530245718|FG003|First Sequence (7 Days)|Protocol Violation|0|||
147023038|NCT01660022|530245719|FG004|First Sequence (7 Days)|Protocol Violation|0|||
147023039|NCT01660022|530245720|FG005|First Sequence (7 Days)|Protocol Violation|1|||
147023040|NCT02149121|530245726|FG000|Main Study Period|Lack of Efficacy|2|||
147023041|NCT02149121|530245727|FG001|Main Study Period|Lack of Efficacy|2|||
147023042|NCT02149121|530245728|FG002|Main Study Period|Lack of Efficacy|1|||
147023043|NCT02149121|530245729|FG003|Main Study Period|Lack of Efficacy|0|||
147023044|NCT02149121|530245730|FG004|Main Study Period|Lack of Efficacy|0|||
147023045|NCT02149121|530245731|FG005|Main Study Period|Lack of Efficacy|0|||
147023046|NCT02149121|530245732|FG006|Main Study Period|Lack of Efficacy|0|||
147023047|NCT02149121|530245726|FG000|Main Study Period|Withdrawal by Subject|9|||
147023048|NCT02149121|530245727|FG001|Main Study Period|Withdrawal by Subject|5|||
147023049|NCT02149121|530245728|FG002|Main Study Period|Withdrawal by Subject|1|||
147023050|NCT02149121|530245729|FG003|Main Study Period|Withdrawal by Subject|0|||
147023051|NCT02149121|530245730|FG004|Main Study Period|Withdrawal by Subject|0|||
147023052|NCT02149121|530245731|FG005|Main Study Period|Withdrawal by Subject|0|||
147023053|NCT02149121|530245732|FG006|Main Study Period|Withdrawal by Subject|0|||
147023054|NCT02149121|530245726|FG000|Main Study Period|Adverse Event|2|||
147023055|NCT02149121|530245727|FG001|Main Study Period|Adverse Event|5|||
147023056|NCT02149121|530245728|FG002|Main Study Period|Adverse Event|1|||
147023057|NCT02149121|530245729|FG003|Main Study Period|Adverse Event|0|||
147023058|NCT02149121|530245730|FG004|Main Study Period|Adverse Event|0|||
147023059|NCT02149121|530245731|FG005|Main Study Period|Adverse Event|0|||
147023060|NCT02149121|530245732|FG006|Main Study Period|Adverse Event|0|||
147023061|NCT02149121|530245726|FG000|Main Study Period|Protocol Violation|2|||
147023062|NCT02149121|530245727|FG001|Main Study Period|Protocol Violation|0|||
147023063|NCT02149121|530245728|FG002|Main Study Period|Protocol Violation|0|||
147023064|NCT02149121|530245729|FG003|Main Study Period|Protocol Violation|0|||
147023065|NCT02149121|530245730|FG004|Main Study Period|Protocol Violation|0|||
147023066|NCT02149121|530245731|FG005|Main Study Period|Protocol Violation|0|||
147023067|NCT02149121|530245732|FG006|Main Study Period|Protocol Violation|0|||
147023068|NCT02149121|530245726|FG000|Main Study Period|Lost to Follow-up|2|||
147023069|NCT02149121|530245727|FG001|Main Study Period|Lost to Follow-up|1|||
147023070|NCT02149121|530245728|FG002|Main Study Period|Lost to Follow-up|0|||
147023071|NCT02149121|530245729|FG003|Main Study Period|Lost to Follow-up|0|||
147023072|NCT02149121|530245730|FG004|Main Study Period|Lost to Follow-up|0|||
147023073|NCT02149121|530245731|FG005|Main Study Period|Lost to Follow-up|0|||
147023074|NCT02149121|530245732|FG006|Main Study Period|Lost to Follow-up|0|||
147023075|NCT02149121|530245726|FG000|Main Study Period|Death|1|||
147023076|NCT02149121|530245727|FG001|Main Study Period|Death|0|||
147023077|NCT02149121|530245728|FG002|Main Study Period|Death|0|||
147023078|NCT02149121|530245729|FG003|Main Study Period|Death|0|||
147023079|NCT02149121|530245730|FG004|Main Study Period|Death|0|||
147023080|NCT02149121|530245731|FG005|Main Study Period|Death|0|||
147023081|NCT02149121|530245732|FG006|Main Study Period|Death|0|||
147023082|NCT02149121|530245726|FG000|Main Study Period|Physician Decision|1|||
147023083|NCT02149121|530245727|FG001|Main Study Period|Physician Decision|0|||
147023084|NCT02149121|530245728|FG002|Main Study Period|Physician Decision|0|||
147023085|NCT02149121|530245729|FG003|Main Study Period|Physician Decision|0|||
147023086|NCT02149121|530245730|FG004|Main Study Period|Physician Decision|0|||
147023087|NCT02149121|530245731|FG005|Main Study Period|Physician Decision|0|||
147023088|NCT02149121|530245732|FG006|Main Study Period|Physician Decision|0|||
147023089|NCT02149121|530245726|FG000|Main Study Period|Developed any malignancy|0|||
147023090|NCT02149121|530245727|FG001|Main Study Period|Developed any malignancy|1|||
147023091|NCT02149121|530245728|FG002|Main Study Period|Developed any malignancy|1|||
147023092|NCT02149121|530245729|FG003|Main Study Period|Developed any malignancy|0|||
147023093|NCT02149121|530245730|FG004|Main Study Period|Developed any malignancy|0|||
147023094|NCT02149121|530245731|FG005|Main Study Period|Developed any malignancy|0|||
147023095|NCT02149121|530245732|FG006|Main Study Period|Developed any malignancy|0|||
147023096|NCT02149121|530245726|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
147023097|NCT02149121|530245727|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
147023098|NCT02149121|530245728|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
147023099|NCT02149121|530245729|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
147023100|NCT02149121|530245730|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
147023101|NCT02149121|530245731|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
147023102|NCT02149121|530245732|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
147023103|NCT02149121|530245726|FG000|Main Study Period|Disease progression|0|||
147023104|NCT02149121|530245727|FG001|Main Study Period|Disease progression|1|||
147023105|NCT02149121|530245728|FG002|Main Study Period|Disease progression|0|||
147023106|NCT02149121|530245729|FG003|Main Study Period|Disease progression|0|||
147023107|NCT02149121|530245730|FG004|Main Study Period|Disease progression|0|||
147023108|NCT02149121|530245731|FG005|Main Study Period|Disease progression|0|||
147023109|NCT02149121|530245732|FG006|Main Study Period|Disease progression|0|||
147023110|NCT02149121|530245726|FG000|Extension Study Period|Withdrawal by Subject|0|||
147023111|NCT02149121|530245727|FG001|Extension Study Period|Withdrawal by Subject|0|||
147023112|NCT02149121|530245728|FG002|Extension Study Period|Withdrawal by Subject|0|||
147023113|NCT02149121|530245729|FG003|Extension Study Period|Withdrawal by Subject|1|||
147023114|NCT02149121|530245730|FG004|Extension Study Period|Withdrawal by Subject|0|||
147023115|NCT02149121|530245731|FG005|Extension Study Period|Withdrawal by Subject|2|||
147023116|NCT02149121|530245732|FG006|Extension Study Period|Withdrawal by Subject|0|||
147023117|NCT03166124|530245733|FG000|Treatment Period 1|Adverse Event|0|||
147023118|NCT03166124|530245734|FG001|Treatment Period 1|Adverse Event|0|||
147023119|NCT03166124|530245735|FG002|Treatment Period 1|Adverse Event|1|||
147023120|NCT03166124|530245736|FG003|Treatment Period 1|Adverse Event|0|||
147023121|NCT03166124|530245733|FG000|Wash-out Period|Withdrawal by Subject|0|||
147023122|NCT03166124|530245734|FG001|Wash-out Period|Withdrawal by Subject|1|||
147023123|NCT03166124|530245735|FG002|Wash-out Period|Withdrawal by Subject|0|||
147023124|NCT03166124|530245736|FG003|Wash-out Period|Withdrawal by Subject|1|||
147023125|NCT03166124|530245733|FG000|Wash-out Period|Adverse Event|0|||
147023126|NCT03166124|530245734|FG001|Wash-out Period|Adverse Event|1|||
147023127|NCT03166124|530245735|FG002|Wash-out Period|Adverse Event|1|||
147023128|NCT03166124|530245736|FG003|Wash-out Period|Adverse Event|0|||
147023129|NCT00788593|530245739|FG000|Placebo Run-in Phase|Adverse Event|2|||
147023130|NCT00788593|530245740|FG001|Placebo Run-in Phase|Adverse Event|0|||
147023131|NCT00788593|530245741|FG002|Placebo Run-in Phase|Adverse Event|0|||
147023132|NCT00788593|530245739|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
147023133|NCT00788593|530245740|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
147023134|NCT00788593|530245741|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
147023135|NCT00788593|530245739|FG000|Placebo Run-in Phase|Protocol Violation|2|||
147023136|NCT00788593|530245740|FG001|Placebo Run-in Phase|Protocol Violation|0|||
147023137|NCT00788593|530245741|FG002|Placebo Run-in Phase|Protocol Violation|0|||
147023138|NCT00788593|530245739|FG000|First Intervention Period|Adverse Event|0|||
147023139|NCT00788593|530245740|FG001|First Intervention Period|Adverse Event|1|||
147023140|NCT00788593|530245741|FG002|First Intervention Period|Adverse Event|0|||
147023141|NCT00788593|530245739|FG000|Second Intervention Period|Lost to Follow-up|0|||
147023142|NCT00788593|530245740|FG001|Second Intervention Period|Lost to Follow-up|1|||
147023143|NCT00788593|530245741|FG002|Second Intervention Period|Lost to Follow-up|0|||
147023144|NCT00788593|530245739|FG000|Second Intervention Period|Other|0|||
147023145|NCT00788593|530245740|FG001|Second Intervention Period|Other|0|||
147023146|NCT00788593|530245741|FG002|Second Intervention Period|Other|1|||
147023147|NCT00515034|530245742|FG000|Overall Study|Adverse Event|2|||
147023148|NCT00515034|530245743|FG001|Overall Study|Adverse Event|0|||
147023149|NCT00515034|530245744|FG002|Overall Study|Adverse Event|1|||
147023150|NCT00515034|530245745|FG003|Overall Study|Adverse Event|0|||
147023151|NCT00515034|530245742|FG000|Overall Study|Death|4|||
147023152|NCT00515034|530245743|FG001|Overall Study|Death|2|||
147023153|NCT00515034|530245744|FG002|Overall Study|Death|1|||
147023154|NCT00515034|530245745|FG003|Overall Study|Death|3|||
147023155|NCT00515034|530245742|FG000|Overall Study|Withdrawal by Subject|1|||
147023156|NCT00515034|530245743|FG001|Overall Study|Withdrawal by Subject|0|||
147023157|NCT00515034|530245744|FG002|Overall Study|Withdrawal by Subject|3|||
147023158|NCT00515034|530245745|FG003|Overall Study|Withdrawal by Subject|0|||
147023159|NCT00515034|530245742|FG000|Overall Study|Physician Decision|0|||
147023160|NCT00515034|530245743|FG001|Overall Study|Physician Decision|0|||
147023161|NCT00515034|530245744|FG002|Overall Study|Physician Decision|1|||
147023162|NCT00515034|530245745|FG003|Overall Study|Physician Decision|1|||
147023163|NCT00515034|530245742|FG000|Overall Study|Other|1|||
147023164|NCT00515034|530245743|FG001|Overall Study|Other|0|||
147023165|NCT00515034|530245744|FG002|Overall Study|Other|2|||
147023166|NCT00515034|530245745|FG003|Overall Study|Other|1|||
147023167|NCT02858726|530245746|FG000|Overall Study|Adverse Event|4|||
147023168|NCT02858726|530245747|FG001|Overall Study|Adverse Event|4|||
147023169|NCT02858726|530245748|FG002|Overall Study|Adverse Event|9|||
147023170|NCT02858726|530245749|FG003|Overall Study|Adverse Event|1|||
147023171|NCT02858726|530245746|FG000|Overall Study|Physician Decision|0|||
147023172|NCT02858726|530245747|FG001|Overall Study|Physician Decision|0|||
147023173|NCT02858726|530245748|FG002|Overall Study|Physician Decision|1|||
147023174|NCT02858726|530245749|FG003|Overall Study|Physician Decision|0|||
147023175|NCT02858726|530245746|FG000|Overall Study|Protocol Violation|0|||
147023176|NCT02858726|530245747|FG001|Overall Study|Protocol Violation|0|||
147023177|NCT02858726|530245748|FG002|Overall Study|Protocol Violation|0|||
147023178|NCT02858726|530245749|FG003|Overall Study|Protocol Violation|1|||
147023179|NCT02858726|530245746|FG000|Overall Study|Study Terminated by Sponsor|0|||
147023180|NCT02858726|530245747|FG001|Overall Study|Study Terminated by Sponsor|0|||
147023181|NCT02858726|530245748|FG002|Overall Study|Study Terminated by Sponsor|0|||
147023182|NCT02858726|530245749|FG003|Overall Study|Study Terminated by Sponsor|1|||
147023183|NCT02858726|530245746|FG000|Overall Study|Withdrawal by Subject|1|||
147023184|NCT02858726|530245747|FG001|Overall Study|Withdrawal by Subject|2|||
147023185|NCT02858726|530245748|FG002|Overall Study|Withdrawal by Subject|1|||
147023186|NCT02858726|530245749|FG003|Overall Study|Withdrawal by Subject|0|||
147023187|NCT02858726|530245746|FG000|Overall Study|Noncompliance|0|||
147023188|NCT02858726|530245747|FG001|Overall Study|Noncompliance|1|||
147023189|NCT02858726|530245748|FG002|Overall Study|Noncompliance|0|||
147023190|NCT02858726|530245749|FG003|Overall Study|Noncompliance|0|||
147023191|NCT00233987|530245756|FG000|Overall Study|Withdrawal by Subject|1|||
147023192|NCT00233987|530245756|FG000|Overall Study|Lack of Efficacy|2|||
147023193|NCT00233987|530245756|FG000|Overall Study|Reason Under Review|1|||
147023194|NCT00233987|530245756|FG000|Overall Study|Other - Not Protocol Specified|5|||
147023195|NCT00233987|530245756|FG000|Overall Study|Eligible but No Treatment Received|2|||
147023196|NCT00233987|530245756|FG000|Overall Study|Ineligible|4|||
147023197|NCT01481324|530245759|FG000|Overall Study|Missing Data|0|||
147023198|NCT01481324|530245760|FG001|Overall Study|Missing Data|2|||
147023199|NCT01481324|530245761|FG002|Overall Study|Missing Data|2|||
147023200|NCT00952276|530245768|FG000|Overall Study|Withdrawal by Subject|1|||
147023201|NCT00952276|530245769|FG001|Overall Study|Withdrawal by Subject|0|||
147023202|NCT00952276|530245770|FG002|Overall Study|Withdrawal by Subject|0|||
147023203|NCT00952276|530245771|FG003|Overall Study|Withdrawal by Subject|1|||
147023204|NCT00952276|530245772|FG004|Overall Study|Withdrawal by Subject|0|||
147023205|NCT02427984|530245773|FG000|Overall Study|Lost to Follow-up|13|||
147023206|NCT02427984|530245774|FG001|Overall Study|Lost to Follow-up|5|||
147023207|NCT02427984|530245775|FG002|Overall Study|Lost to Follow-up|18|||
147023208|NCT03821272|530247975|FG000|Overall Study|Death|1|||
147023209|NCT03821272|530247976|FG001|Overall Study|Death|0|||
147023210|NCT03821272|530247975|FG000|Overall Study|Physician Decision|1|||
147023211|NCT03821272|530247976|FG001|Overall Study|Physician Decision|0|||
147023212|NCT03821272|530247975|FG000|Overall Study|Withdrawal by Subject|1|||
147023213|NCT03821272|530247976|FG001|Overall Study|Withdrawal by Subject|0|||
147023214|NCT05904769|530247977|FG000|Overall Study|Physician Decision|0|||
147023215|NCT05904769|530247978|FG001|Overall Study|Physician Decision|6|||
147023216|NCT05626803|530247979|FG000|Overall Study|Lost to Follow-up|0|||
147023217|NCT05626803|530247980|FG001|Overall Study|Lost to Follow-up|1|||
147023218|NCT05626803|530247981|FG002|Overall Study|Lost to Follow-up|0|||
147023219|NCT05626803|530247982|FG003|Overall Study|Lost to Follow-up|0|||
147023220|NCT01010126|530247987|FG000|Overall Study|Withdrawal by Subject|1|||
147023221|NCT01010126|530247988|FG001|Overall Study|Withdrawal by Subject|0|||
147023222|NCT01010126|530247989|FG002|Overall Study|Withdrawal by Subject|1|||
147023223|NCT01010126|530247990|FG003|Overall Study|Withdrawal by Subject|0|||
147023224|NCT01010126|530247991|FG004|Overall Study|Withdrawal by Subject|3|||
147023225|NCT01010126|530247992|FG005|Overall Study|Withdrawal by Subject|0|||
146849335|NCT03541174|529618799|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
147023226|NCT00493246|530247995|FG000|Overall Study|Withdrawal by Subject|0|||
147023227|NCT00493246|530247996|FG001|Overall Study|Withdrawal by Subject|0|||
147023228|NCT00493246|530247997|FG002|Overall Study|Withdrawal by Subject|0|||
147023229|NCT00493246|530247998|FG003|Overall Study|Withdrawal by Subject|0|||
147023230|NCT00493246|530247999|FG004|Overall Study|Withdrawal by Subject|1|||
147023231|NCT00493246|530248000|FG005|Overall Study|Withdrawal by Subject|0|||
147023232|NCT00493246|530248001|FG006|Overall Study|Withdrawal by Subject|0|||
147023233|NCT00493246|530248002|FG007|Overall Study|Withdrawal by Subject|0|||
147023234|NCT00493246|530247995|FG000|Overall Study|No access to draw blood|0|||
147023235|NCT00493246|530247996|FG001|Overall Study|No access to draw blood|0|||
147023236|NCT00493246|530247997|FG002|Overall Study|No access to draw blood|0|||
147023237|NCT00493246|530247998|FG003|Overall Study|No access to draw blood|0|||
147023238|NCT00493246|530247999|FG004|Overall Study|No access to draw blood|0|||
147023239|NCT00493246|530248000|FG005|Overall Study|No access to draw blood|1|||
147023240|NCT00493246|530248001|FG006|Overall Study|No access to draw blood|0|||
147023241|NCT00493246|530248002|FG007|Overall Study|No access to draw blood|0|||
147023242|NCT00493246|530247995|FG000|Overall Study|Lost to Follow-up|0|||
147023243|NCT00493246|530247996|FG001|Overall Study|Lost to Follow-up|0|||
147023244|NCT00493246|530247997|FG002|Overall Study|Lost to Follow-up|0|||
147023245|NCT00493246|530247998|FG003|Overall Study|Lost to Follow-up|0|||
147023246|NCT00493246|530247999|FG004|Overall Study|Lost to Follow-up|0|||
147023247|NCT00493246|530248000|FG005|Overall Study|Lost to Follow-up|0|||
147023248|NCT00493246|530248001|FG006|Overall Study|Lost to Follow-up|1|||
147023249|NCT00493246|530248002|FG007|Overall Study|Lost to Follow-up|0|||
147023250|NCT01207440|530248005|FG000|Overall Study|Adverse Event|46|||
147023251|NCT01207440|530248006|FG001|Overall Study|Adverse Event|11|||
147023252|NCT01207440|530248007|FG002|Overall Study|Adverse Event|7|||
147023253|NCT01207440|530248008|FG003|Overall Study|Adverse Event|2|||
147023254|NCT01207440|530248009|FG004|Overall Study|Adverse Event|6|||
147023255|NCT01207440|530248010|FG005|Overall Study|Adverse Event|6|||
147023256|NCT01207440|530248011|FG006|Overall Study|Adverse Event|2|||
147023257|NCT01207440|530248005|FG000|Overall Study|Death|6|||
147023258|NCT01207440|530248006|FG001|Overall Study|Death|3|||
147023259|NCT01207440|530248007|FG002|Overall Study|Death|2|||
147023260|NCT01207440|530248008|FG003|Overall Study|Death|2|||
147023261|NCT01207440|530248009|FG004|Overall Study|Death|7|||
147023262|NCT01207440|530248010|FG005|Overall Study|Death|5|||
147023263|NCT01207440|530248011|FG006|Overall Study|Death|1|||
147023264|NCT01207440|530248005|FG000|Overall Study|Lack of Efficacy|13|||
147023265|NCT01207440|530248006|FG001|Overall Study|Lack of Efficacy|2|||
147023266|NCT01207440|530248007|FG002|Overall Study|Lack of Efficacy|5|||
147023267|NCT01207440|530248008|FG003|Overall Study|Lack of Efficacy|1|||
147023268|NCT01207440|530248009|FG004|Overall Study|Lack of Efficacy|2|||
147023269|NCT01207440|530248010|FG005|Overall Study|Lack of Efficacy|3|||
147023270|NCT01207440|530248011|FG006|Overall Study|Lack of Efficacy|0|||
147023271|NCT01207440|530248005|FG000|Overall Study|Lost to Follow-up|0|||
147023272|NCT01207440|530248006|FG001|Overall Study|Lost to Follow-up|0|||
147023273|NCT01207440|530248007|FG002|Overall Study|Lost to Follow-up|2|||
147023274|NCT01207440|530248008|FG003|Overall Study|Lost to Follow-up|1|||
147023275|NCT01207440|530248009|FG004|Overall Study|Lost to Follow-up|0|||
147023276|NCT01207440|530248010|FG005|Overall Study|Lost to Follow-up|0|||
147023277|NCT01207440|530248011|FG006|Overall Study|Lost to Follow-up|0|||
147023278|NCT01207440|530248005|FG000|Overall Study|Non-compliance with Study Drug|3|||
147023279|NCT01207440|530248006|FG001|Overall Study|Non-compliance with Study Drug|0|||
147023280|NCT01207440|530248007|FG002|Overall Study|Non-compliance with Study Drug|1|||
147023281|NCT01207440|530248008|FG003|Overall Study|Non-compliance with Study Drug|0|||
147023282|NCT01207440|530248009|FG004|Overall Study|Non-compliance with Study Drug|0|||
147023283|NCT01207440|530248010|FG005|Overall Study|Non-compliance with Study Drug|0|||
147023284|NCT01207440|530248011|FG006|Overall Study|Non-compliance with Study Drug|0|||
147023285|NCT01207440|530248005|FG000|Overall Study|Physician Decision|6|||
147023286|NCT01207440|530248006|FG001|Overall Study|Physician Decision|5|||
147023287|NCT01207440|530248007|FG002|Overall Study|Physician Decision|5|||
147023288|NCT01207440|530248008|FG003|Overall Study|Physician Decision|0|||
147023289|NCT01207440|530248009|FG004|Overall Study|Physician Decision|1|||
147023290|NCT01207440|530248010|FG005|Overall Study|Physician Decision|0|||
147023291|NCT01207440|530248011|FG006|Overall Study|Physician Decision|0|||
147023292|NCT01207440|530248005|FG000|Overall Study|Progressive Disease|19|||
147023293|NCT01207440|530248006|FG001|Overall Study|Progressive Disease|10|||
146849336|NCT03541174|529618800|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
147023294|NCT01207440|530248007|FG002|Overall Study|Progressive Disease|19|||
147023295|NCT01207440|530248008|FG003|Overall Study|Progressive Disease|7|||
146849337|NCT03541174|529618801|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
146849338|NCT03541174|529618802|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
147023296|NCT01207440|530248009|FG004|Overall Study|Progressive Disease|23|||
147023297|NCT01207440|530248010|FG005|Overall Study|Progressive Disease|27|||
147023298|NCT01207440|530248011|FG006|Overall Study|Progressive Disease|0|||
147023299|NCT01207440|530248005|FG000|Overall Study|Protocol Violation|2|||
147023300|NCT01207440|530248006|FG001|Overall Study|Protocol Violation|0|||
147023301|NCT01207440|530248007|FG002|Overall Study|Protocol Violation|0|||
147023302|NCT01207440|530248008|FG003|Overall Study|Protocol Violation|0|||
147023303|NCT01207440|530248009|FG004|Overall Study|Protocol Violation|0|||
147023304|NCT01207440|530248010|FG005|Overall Study|Protocol Violation|0|||
147023305|NCT01207440|530248011|FG006|Overall Study|Protocol Violation|0|||
147023306|NCT01207440|530248005|FG000|Overall Study|Site Terminated by Sponsor|69|||
147023307|NCT01207440|530248006|FG001|Overall Study|Site Terminated by Sponsor|19|||
147023308|NCT01207440|530248007|FG002|Overall Study|Site Terminated by Sponsor|12|||
147023309|NCT01207440|530248008|FG003|Overall Study|Site Terminated by Sponsor|2|||
147023310|NCT01207440|530248009|FG004|Overall Study|Site Terminated by Sponsor|3|||
147023311|NCT01207440|530248010|FG005|Overall Study|Site Terminated by Sponsor|0|||
147023312|NCT01207440|530248011|FG006|Overall Study|Site Terminated by Sponsor|2|||
147023313|NCT01207440|530248005|FG000|Overall Study|Withdrawal by Subject|29|||
147023314|NCT01207440|530248006|FG001|Overall Study|Withdrawal by Subject|4|||
147023315|NCT01207440|530248007|FG002|Overall Study|Withdrawal by Subject|5|||
147023316|NCT01207440|530248008|FG003|Overall Study|Withdrawal by Subject|3|||
147023317|NCT01207440|530248009|FG004|Overall Study|Withdrawal by Subject|2|||
147023318|NCT01207440|530248010|FG005|Overall Study|Withdrawal by Subject|2|||
147023319|NCT01207440|530248011|FG006|Overall Study|Withdrawal by Subject|0|||
147023320|NCT01207440|530248005|FG000|Overall Study|Reason Not Specified|10|||
147023321|NCT01207440|530248006|FG001|Overall Study|Reason Not Specified|10|||
147023322|NCT01207440|530248007|FG002|Overall Study|Reason Not Specified|7|||
147023323|NCT01207440|530248008|FG003|Overall Study|Reason Not Specified|0|||
147023324|NCT01207440|530248009|FG004|Overall Study|Reason Not Specified|4|||
147023325|NCT01207440|530248010|FG005|Overall Study|Reason Not Specified|3|||
147023326|NCT01207440|530248011|FG006|Overall Study|Reason Not Specified|0|||
147023327|NCT03341000|530248012|FG000|Overall Study|Adverse Event|1|||
147023328|NCT01592721|530248013|FG000|Long-term Follow-up|Death|1|||
147023329|NCT00380692|530248017|FG000|Study Period II - Double Blind|Adverse Event|1|||
147023330|NCT00380692|530248018|FG001|Study Period II - Double Blind|Adverse Event|0|||
147023331|NCT00380692|530248017|FG000|Study Period II - Double Blind|Protocol Violation|2|||
147023332|NCT00380692|530248018|FG001|Study Period II - Double Blind|Protocol Violation|2|||
147023333|NCT00380692|530248017|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
147023334|NCT00380692|530248018|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
147023335|NCT00380692|530248017|FG000|Study Period II - Double Blind|Physician Decision|0|||
147023336|NCT00380692|530248018|FG001|Study Period II - Double Blind|Physician Decision|1|||
147023337|NCT00380692|530248017|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
147023338|NCT00380692|530248018|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
147023339|NCT00380692|530248017|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
147023340|NCT00380692|530248018|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
147023341|NCT00380692|530248017|FG000|Study Period III - Open Label|Adverse Event|5|||
147023342|NCT00380692|530248018|FG001|Study Period III - Open Label|Adverse Event|3|||
147023343|NCT00380692|530248017|FG000|Study Period III - Open Label|Protocol Violation|0|||
147023344|NCT00380692|530248018|FG001|Study Period III - Open Label|Protocol Violation|0|||
147023345|NCT00380692|530248017|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
147023346|NCT00380692|530248018|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
147023347|NCT00380692|530248017|FG000|Study Period III - Open Label|Physician Decision|0|||
147023348|NCT00380692|530248018|FG001|Study Period III - Open Label|Physician Decision|3|||
147023349|NCT00380692|530248017|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
147023350|NCT00380692|530248018|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
147023351|NCT00380692|530248017|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
147023352|NCT00380692|530248018|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
147023353|NCT02698865|530248021|FG000|Overall Study|Other|11|||
147023354|NCT02698865|530248022|FG001|Overall Study|Other|11|||
147023355|NCT02698865|530248021|FG000|Overall Study|Withdrawal by Subject|20|||
147023356|NCT02698865|530248022|FG001|Overall Study|Withdrawal by Subject|16|||
147023357|NCT02698865|530248021|FG000|Overall Study|Physician Decision|0|||
147023358|NCT02698865|530248022|FG001|Overall Study|Physician Decision|4|||
147023359|NCT02698865|530248021|FG000|Overall Study|Lost to Follow-up|4|||
147023360|NCT02698865|530248022|FG001|Overall Study|Lost to Follow-up|2|||
147023361|NCT03861481|530248023|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
147023362|NCT03861481|530248024|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
147023363|NCT03861481|530248023|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
147023364|NCT03861481|530248024|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
147023365|NCT03861481|530248023|FG000|Overall Study|Relapse|1|||
147023366|NCT03861481|530248024|FG001|Overall Study|Relapse|0|||
147023367|NCT03861481|530248023|FG000|Overall Study|Withdrawal by Subject|0|||
147023368|NCT03861481|530248024|FG001|Overall Study|Withdrawal by Subject|1|||
147023369|NCT03861481|530248023|FG000|Overall Study|Lack of Efficacy|4|||
147023370|NCT03861481|530248024|FG001|Overall Study|Lack of Efficacy|5|||
147023371|NCT00773734|530248025|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
147023372|NCT00773734|530248026|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
147023373|NCT00773734|530248027|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
147023374|NCT00773734|530248028|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
147023375|NCT00773734|530248029|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
147023376|NCT00773734|530248030|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
147023377|NCT00773734|530248025|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
147023378|NCT00773734|530248026|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
147023379|NCT00773734|530248027|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
147023380|NCT00773734|530248028|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
147023381|NCT00773734|530248029|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
147023382|NCT00773734|530248030|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
147023383|NCT00773734|530248025|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
147023384|NCT00773734|530248026|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
147023385|NCT00773734|530248027|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
147023386|NCT00773734|530248028|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
147023387|NCT00773734|530248029|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
147023388|NCT00773734|530248030|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
147023389|NCT00773734|530248025|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
147023390|NCT00773734|530248026|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
147023391|NCT00773734|530248027|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
147023392|NCT00773734|530248028|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
147023393|NCT00773734|530248029|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
147023394|NCT00773734|530248030|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
147023395|NCT00773734|530248025|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
147023396|NCT00773734|530248026|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
147023397|NCT00773734|530248027|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
147023398|NCT00773734|530248028|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
147023399|NCT00773734|530248029|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
147023400|NCT00773734|530248030|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
147023401|NCT00773734|530248025|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
147023402|NCT00773734|530248026|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
147023403|NCT00773734|530248027|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
147023404|NCT00773734|530248028|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
147023405|NCT00773734|530248029|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
147023406|NCT00773734|530248030|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
147023407|NCT00773734|530248025|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
147023408|NCT00773734|530248026|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
147023409|NCT00773734|530248027|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
147023410|NCT00773734|530248028|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
147023411|NCT00773734|530248029|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
147023412|NCT00773734|530248030|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
147023413|NCT00773734|530248025|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
147023414|NCT00773734|530248026|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
147023415|NCT00773734|530248027|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
147023416|NCT00773734|530248028|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
147023417|NCT00773734|530248029|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
147023418|NCT00773734|530248030|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
147023419|NCT00773734|530248025|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
147023420|NCT00773734|530248026|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
147023421|NCT00773734|530248027|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
147023422|NCT00773734|530248028|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
147023423|NCT00773734|530248029|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
147023424|NCT00773734|530248030|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
147023425|NCT00773734|530248025|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
147023426|NCT00773734|530248026|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
147023427|NCT00773734|530248027|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
147023428|NCT00773734|530248028|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
147023429|NCT00773734|530248029|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
147023430|NCT00773734|530248030|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
147023431|NCT00773734|530248025|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
147023432|NCT00773734|530248026|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
147023433|NCT00773734|530248027|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
147023434|NCT00773734|530248028|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
147023435|NCT00773734|530248029|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
147023436|NCT00773734|530248030|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
147023437|NCT00773734|530248025|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
147023438|NCT00773734|530248026|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
147023439|NCT00773734|530248027|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
147023440|NCT00773734|530248028|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
147023441|NCT00773734|530248029|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
147023442|NCT00773734|530248030|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
147023443|NCT00773734|530248025|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
147023444|NCT00773734|530248026|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
147023445|NCT00773734|530248027|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
147023446|NCT00773734|530248028|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
147023447|NCT00773734|530248029|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
147023448|NCT00773734|530248030|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
147023449|NCT00773734|530248025|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
147023450|NCT00773734|530248026|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
147023451|NCT00773734|530248027|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
147023452|NCT00773734|530248028|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
147023453|NCT00773734|530248029|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
147023454|NCT00773734|530248030|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
147023455|NCT00773734|530248025|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
147023456|NCT00773734|530248026|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
147023457|NCT00773734|530248027|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
147023458|NCT00773734|530248028|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
147023459|NCT00773734|530248029|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
147023460|NCT00773734|530248030|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
147023461|NCT00773734|530248025|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
147023462|NCT00773734|530248026|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
147023463|NCT00773734|530248027|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
147023464|NCT00773734|530248028|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
147023465|NCT00773734|530248029|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
147023466|NCT00773734|530248030|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
147023467|NCT00773734|530248025|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
147023468|NCT00773734|530248026|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
147023469|NCT00773734|530248027|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
147023470|NCT00773734|530248028|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
147023471|NCT00773734|530248029|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
147023472|NCT00773734|530248030|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
147023473|NCT00773734|530248025|FG000|Extension: Active Treatment Week 24-52|Other|0|||
147023474|NCT00773734|530248026|FG001|Extension: Active Treatment Week 24-52|Other|0|||
147023475|NCT00773734|530248027|FG002|Extension: Active Treatment Week 24-52|Other|1|||
147023476|NCT00773734|530248028|FG003|Extension: Active Treatment Week 24-52|Other|2|||
147023477|NCT00773734|530248029|FG004|Extension: Active Treatment Week 24-52|Other|0|||
147023478|NCT00773734|530248030|FG005|Extension: Active Treatment Week 24-52|Other|1|||
147023479|NCT00773734|530248025|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
147023480|NCT00773734|530248026|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
147023481|NCT00773734|530248027|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
147023482|NCT00773734|530248028|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
147023483|NCT00773734|530248029|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
147023484|NCT00773734|530248030|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
147023485|NCT00773734|530248025|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
147023486|NCT00773734|530248026|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
147023487|NCT00773734|530248027|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
147023488|NCT00773734|530248028|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
147023489|NCT00773734|530248029|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
147023490|NCT00773734|530248030|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
147023491|NCT00773734|530248025|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
147023492|NCT00773734|530248026|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
147023493|NCT00773734|530248027|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
147023494|NCT00773734|530248028|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
147023495|NCT00773734|530248029|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
147023496|NCT00773734|530248030|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
147023497|NCT00773734|530248025|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
147023498|NCT00773734|530248026|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
147023499|NCT00773734|530248027|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
147023500|NCT00773734|530248028|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
147023501|NCT00773734|530248029|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
147023502|NCT00773734|530248030|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
147023503|NCT01220297|530248037|FG000|Overall Study|Death|2|||
147023504|NCT01220297|530248037|FG000|Overall Study|Lost to Follow-up|1|||
147023505|NCT02119286|530248039|FG000|Overall Study|Adverse Event|9|||
147023506|NCT02119286|530248040|FG001|Overall Study|Adverse Event|7|||
147023507|NCT02119286|530248041|FG002|Overall Study|Adverse Event|2|||
147023508|NCT02119286|530248039|FG000|Overall Study|Lack of Efficacy|11|||
147023509|NCT02119286|530248040|FG001|Overall Study|Lack of Efficacy|3|||
147023510|NCT02119286|530248041|FG002|Overall Study|Lack of Efficacy|4|||
147023511|NCT02119286|530248039|FG000|Overall Study|Lost to Follow-up|2|||
147023512|NCT02119286|530248040|FG001|Overall Study|Lost to Follow-up|0|||
147023513|NCT02119286|530248041|FG002|Overall Study|Lost to Follow-up|1|||
147023514|NCT02119286|530248039|FG000|Overall Study|Withdrawal by Subject|4|||
147023515|NCT02119286|530248040|FG001|Overall Study|Withdrawal by Subject|1|||
147023516|NCT02119286|530248041|FG002|Overall Study|Withdrawal by Subject|0|||
147023517|NCT04109313|530248042|FG000|Overall Study|Pregnancy|1|||
147023518|NCT04109313|530248042|FG000|Overall Study|Adverse Event|11|||
147023519|NCT04109313|530248042|FG000|Overall Study|Lack of Efficacy|11|||
147023520|NCT04109313|530248042|FG000|Overall Study|Lost to Follow-up|1|||
147023521|NCT04109313|530248042|FG000|Overall Study|Physician Decision|2|||
147023522|NCT04109313|530248042|FG000|Overall Study|Subject Decision|13|||
147023523|NCT04109313|530248042|FG000|Overall Study|Covid-19 situation|2|||
147023524|NCT01272921|530248043|FG000|Overall Study|Protocol Violation|2|||
147023525|NCT01272921|530248044|FG001|Overall Study|Protocol Violation|1|||
147023526|NCT01132664|530248045|FG000|Phase lb|Adverse Event|0|||
147023527|NCT01132664|530248046|FG001|Phase lb|Adverse Event|1|||
146849339|NCT03541174|529618797|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
146849340|NCT03541174|529618798|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
146849341|NCT03541174|529618799|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
146849342|NCT03541174|529618800|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
146849343|NCT03541174|529618801|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
146849344|NCT03541174|529618802|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
146849345|NCT00605215|529618803|FG000|Overall Study|Death|0|||
146849346|NCT00605215|529618804|FG001|Overall Study|Death|0|||
146849347|NCT00605215|529618805|FG002|Overall Study|Death|1|||
146849348|NCT00605215|529618803|FG000|Overall Study|Adverse Event|19|||
146849349|NCT00605215|529618804|FG001|Overall Study|Adverse Event|21|||
146849350|NCT00605215|529618805|FG002|Overall Study|Adverse Event|26|||
146849351|NCT00605215|529618803|FG000|Overall Study|Refusal to sign the re-consent form|8|||
146849352|NCT00605215|529618804|FG001|Overall Study|Refusal to sign the re-consent form|3|||
146849353|NCT00605215|529618805|FG002|Overall Study|Refusal to sign the re-consent form|3|||
146849354|NCT00605215|529618803|FG000|Overall Study|Withdrawal by Subject|39|||
146849355|NCT00605215|529618804|FG001|Overall Study|Withdrawal by Subject|37|||
146849356|NCT00605215|529618805|FG002|Overall Study|Withdrawal by Subject|27|||
146849357|NCT00605215|529618803|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
146849358|NCT00605215|529618804|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
146849359|NCT00605215|529618805|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
146849360|NCT00605215|529618803|FG000|Overall Study|Protocol Violation|3|||
146849361|NCT00605215|529618804|FG001|Overall Study|Protocol Violation|4|||
146849362|NCT00605215|529618805|FG002|Overall Study|Protocol Violation|1|||
146849363|NCT00605215|529618803|FG000|Overall Study|Pregnancy|8|||
146849364|NCT00605215|529618804|FG001|Overall Study|Pregnancy|5|||
146849365|NCT00605215|529618805|FG002|Overall Study|Pregnancy|4|||
146849366|NCT00605215|529618803|FG000|Overall Study|Lost to Follow-up|8|||
146849367|NCT00605215|529618804|FG001|Overall Study|Lost to Follow-up|5|||
147023528|NCT01132664|530248047|FG002|Phase lb|Adverse Event|0|||
147023529|NCT01132664|530248048|FG003|Phase lb|Adverse Event|0|||
147023530|NCT01132664|530248049|FG004|Phase lb|Adverse Event|0|||
147023531|NCT01132664|530248045|FG000|Phase lb|Withdrawal by Subject|1|||
147023532|NCT01132664|530248046|FG001|Phase lb|Withdrawal by Subject|2|||
147023533|NCT01132664|530248047|FG002|Phase lb|Withdrawal by Subject|0|||
147023534|NCT01132664|530248048|FG003|Phase lb|Withdrawal by Subject|0|||
147023535|NCT01132664|530248049|FG004|Phase lb|Withdrawal by Subject|0|||
147023536|NCT01132664|530248045|FG000|Phase lb|Disease Progression|4|||
147023537|NCT01132664|530248046|FG001|Phase lb|Disease Progression|9|||
147023538|NCT01132664|530248047|FG002|Phase lb|Disease Progression|0|||
147023539|NCT01132664|530248048|FG003|Phase lb|Disease Progression|0|||
147023540|NCT01132664|530248049|FG004|Phase lb|Disease Progression|0|||
147023541|NCT01132664|530248045|FG000|Phase ll|Death|0|||
147023542|NCT01132664|530248046|FG001|Phase ll|Death|0|||
147023543|NCT01132664|530248047|FG002|Phase ll|Death|2|||
147023544|NCT01132664|530248048|FG003|Phase ll|Death|0|||
147023545|NCT01132664|530248049|FG004|Phase ll|Death|0|||
147023546|NCT01132664|530248045|FG000|Phase ll|Adverse Event|0|||
147023547|NCT01132664|530248046|FG001|Phase ll|Adverse Event|0|||
147023548|NCT01132664|530248047|FG002|Phase ll|Adverse Event|10|||
147023549|NCT01132664|530248048|FG003|Phase ll|Adverse Event|0|||
147023550|NCT01132664|530248049|FG004|Phase ll|Adverse Event|0|||
147023551|NCT01132664|530248045|FG000|Phase ll|Withdrawal by Subject|0|||
147023552|NCT01132664|530248046|FG001|Phase ll|Withdrawal by Subject|0|||
147023553|NCT01132664|530248047|FG002|Phase ll|Withdrawal by Subject|3|||
147023554|NCT01132664|530248048|FG003|Phase ll|Withdrawal by Subject|0|||
147023555|NCT01132664|530248049|FG004|Phase ll|Withdrawal by Subject|0|||
147023556|NCT01132664|530248045|FG000|Phase ll|Disease progression|0|||
147023557|NCT01132664|530248046|FG001|Phase ll|Disease progression|0|||
147023558|NCT01132664|530248047|FG002|Phase ll|Disease progression|35|||
147023559|NCT01132664|530248048|FG003|Phase ll|Disease progression|0|||
147023560|NCT01132664|530248049|FG004|Phase ll|Disease progression|0|||
147023561|NCT01132664|530248045|FG000|BM Cohort|Disease progression|0|||
147023562|NCT01132664|530248046|FG001|BM Cohort|Disease progression|0|||
147023563|NCT01132664|530248047|FG002|BM Cohort|Disease progression|0|||
147023564|NCT01132664|530248048|FG003|BM Cohort|Disease progression|3|||
147023565|NCT01132664|530248049|FG004|BM Cohort|Disease progression|4|||
147023566|NCT01132664|530248045|FG000|BM Cohort|Adverse Event|0|||
147023567|NCT01132664|530248046|FG001|BM Cohort|Adverse Event|0|||
147023568|NCT01132664|530248047|FG002|BM Cohort|Adverse Event|0|||
147023569|NCT01132664|530248048|FG003|BM Cohort|Adverse Event|0|||
147023570|NCT01132664|530248049|FG004|BM Cohort|Adverse Event|1|||
147023571|NCT01132664|530248045|FG000|BM Cohort|Withdrawal by Subject|0|||
147023572|NCT01132664|530248046|FG001|BM Cohort|Withdrawal by Subject|0|||
147023573|NCT01132664|530248047|FG002|BM Cohort|Withdrawal by Subject|0|||
147023574|NCT01132664|530248048|FG003|BM Cohort|Withdrawal by Subject|0|||
147023575|NCT01132664|530248049|FG004|BM Cohort|Withdrawal by Subject|1|||
147023576|NCT01996332|530248051|FG000|Overall Study|Adverse Event|117|||
147023577|NCT01996332|530248051|FG000|Overall Study|Lack of Efficacy|1245|||
147023578|NCT01996332|530248051|FG000|Overall Study|Death|264|||
147023579|NCT01996332|530248051|FG000|Overall Study|Protocol Violation|9|||
147023580|NCT01996332|530248051|FG000|Overall Study|Withdrawal by Subject|71|||
147023581|NCT01996332|530248051|FG000|Overall Study|Other|20|||
147023582|NCT01996332|530248051|FG000|Overall Study|Clinical Deterioration|28|||
147023583|NCT01996332|530248051|FG000|Overall Study|Physician Decision|17|||
147023584|NCT01996332|530248051|FG000|Overall Study|Lost to Follow-up|34|||
147023585|NCT02113189|530248052|FG000|Overall Study|Lost to follow up|2|||
147023586|NCT02113189|530248053|FG001|Overall Study|Lost to follow up|1|||
147023587|NCT02113189|530248054|FG002|Overall Study|Lost to follow up|3|||
147023588|NCT05016622|530248055|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
147023589|NCT05016622|530248055|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
147023590|NCT01304693|530248056|FG000|Overall Study|Adverse Event|0|||
147023591|NCT01304693|530248057|FG001|Overall Study|Adverse Event|0|||
147023592|NCT01304693|530248058|FG002|Overall Study|Adverse Event|0|||
147023593|NCT01304693|530248059|FG003|Overall Study|Adverse Event|0|||
147023594|NCT01304693|530248060|FG004|Overall Study|Adverse Event|1|||
147023595|NCT01304693|530248056|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
147023596|NCT01304693|530248057|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
147023597|NCT01304693|530248058|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
147023598|NCT01304693|530248059|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
147023599|NCT01304693|530248060|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
147023600|NCT02954159|530248061|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
147023601|NCT02954159|530248062|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
147023602|NCT02954159|530248061|FG000|Overall Study|Withdrawal by Subject|0|||
147023603|NCT02954159|530248062|FG001|Overall Study|Withdrawal by Subject|1|||
147023604|NCT02581163|530248065|FG000|Overall Study|Failure to return|15|||
147023605|NCT02581163|530248065|FG000|Overall Study|Insufficient virological response|3|||
147023606|NCT02581163|530248065|FG000|Overall Study|Withdrew consent|1|||
147023607|NCT02581163|530248065|FG000|Overall Study|Death|1|||
147023608|NCT02581163|530248065|FG000|Overall Study|Other, not specified|9|||
147023609|NCT03438396|530248066|FG000|Overall Study|Reason Not Specified|9|||
147023610|NCT03438396|530248066|FG000|Overall Study|Withdrawal by Subject|5|||
147023611|NCT03438396|530248066|FG000|Overall Study|Lost to Follow-up|2|||
147023612|NCT03438396|530248066|FG000|Overall Study|Death|85|||
147023613|NCT03438396|530248066|FG000|Overall Study|Not treated|1|||
147023614|NCT00262041|530248070|FG000|Overall Study|Withdrawal by Subject|0|||
147023615|NCT00262041|530248071|FG001|Overall Study|Withdrawal by Subject|3|||
147023616|NCT00262041|530248072|FG002|Overall Study|Withdrawal by Subject|1|||
147023617|NCT00262041|530248070|FG000|Overall Study|Lost to Follow-up|1|||
147023618|NCT00262041|530248071|FG001|Overall Study|Lost to Follow-up|1|||
147023619|NCT00262041|530248072|FG002|Overall Study|Lost to Follow-up|5|||
147023620|NCT00262041|530248070|FG000|Overall Study|Unable to classify|1|||
147023621|NCT00262041|530248071|FG001|Overall Study|Unable to classify|0|||
147023622|NCT00262041|530248072|FG002|Overall Study|Unable to classify|0|||
147023623|NCT03578237|530248075|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
147023624|NCT03578237|530248076|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
147023625|NCT01173471|530248077|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147023626|NCT01173471|530248078|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147023627|NCT01173471|530248079|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
147023628|NCT01173471|530248080|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
147023629|NCT01173471|530248077|FG000|Overall Study|Condition under investigation worsened|2|||
147023630|NCT01173471|530248078|FG001|Overall Study|Condition under investigation worsened|0|||
147023631|NCT01173471|530248079|FG002|Overall Study|Condition under investigation worsened|0|||
147023632|NCT01173471|530248080|FG003|Overall Study|Condition under investigation worsened|0|||
147023633|NCT01173471|530248077|FG000|Overall Study|Lost to Follow-up|0|||
147023634|NCT01173471|530248078|FG001|Overall Study|Lost to Follow-up|0|||
147023635|NCT01173471|530248079|FG002|Overall Study|Lost to Follow-up|1|||
147023636|NCT01173471|530248080|FG003|Overall Study|Lost to Follow-up|0|||
147023637|NCT01173471|530248077|FG000|Overall Study|Reason given as Other|0|||
147023638|NCT01173471|530248078|FG001|Overall Study|Reason given as Other|0|||
147023639|NCT01173471|530248079|FG002|Overall Study|Reason given as Other|1|||
147023640|NCT01173471|530248080|FG003|Overall Study|Reason given as Other|0|||
147023641|NCT04132336|530248081|FG000|Overall Study|Investigator Decision|0|||
147023642|NCT04132336|530248082|FG001|Overall Study|Investigator Decision|1|||
147023643|NCT04132336|530248083|FG002|Overall Study|Investigator Decision|0|||
147023644|NCT04132336|530248084|FG003|Overall Study|Investigator Decision|0|||
147023645|NCT04132336|530248085|FG004|Overall Study|Investigator Decision|0|||
147023646|NCT04132336|530248086|FG005|Overall Study|Investigator Decision|0|||
147023647|NCT04132336|530248087|FG006|Overall Study|Investigator Decision|0|||
147023648|NCT00584844|530248089|FG000|Overall Study|Withdrawal by Subject|59|||
147023649|NCT00584844|530248089|FG000|Overall Study|Screen Failure|20|||
147023650|NCT02488330|530248090|FG000|Overall Study|Adverse Event|1|||
147023651|NCT02488330|530248090|FG000|Overall Study|Physician Decision|2|||
147023652|NCT02488330|530248090|FG000|Overall Study|Death|2|||
147023653|NCT02488330|530248090|FG000|Overall Study|Disease Progression|3|||
147023654|NCT02488330|530248090|FG000|Overall Study|Study Termination by Sponsor|4|||
147023655|NCT01206816|530248093|FG000|Overall Study|Protocol Violation|0|||
147023656|NCT01206816|530248094|FG001|Overall Study|Protocol Violation|0|||
147023657|NCT01206816|530248095|FG002|Overall Study|Protocol Violation|1|||
147023658|NCT01206816|530248096|FG003|Overall Study|Protocol Violation|0|||
147023659|NCT01206816|530248097|FG004|Overall Study|Protocol Violation|0|||
147023660|NCT01206816|530248098|FG005|Overall Study|Protocol Violation|0|||
147023661|NCT01206816|530248099|FG006|Overall Study|Protocol Violation|0|||
147023662|NCT01206816|530248093|FG000|Overall Study|Withdrawal by Subject|0|||
147023663|NCT01206816|530248094|FG001|Overall Study|Withdrawal by Subject|0|||
147023664|NCT01206816|530248095|FG002|Overall Study|Withdrawal by Subject|1|||
147023665|NCT01206816|530248096|FG003|Overall Study|Withdrawal by Subject|0|||
147023666|NCT01206816|530248097|FG004|Overall Study|Withdrawal by Subject|0|||
147023667|NCT01206816|530248098|FG005|Overall Study|Withdrawal by Subject|0|||
147023668|NCT01206816|530248099|FG006|Overall Study|Withdrawal by Subject|0|||
147023669|NCT01206816|530248093|FG000|Overall Study|Progressive disease|3|||
147023670|NCT01206816|530248094|FG001|Overall Study|Progressive disease|3|||
147023671|NCT01206816|530248095|FG002|Overall Study|Progressive disease|13|||
147023672|NCT01206816|530248096|FG003|Overall Study|Progressive disease|3|||
147023673|NCT01206816|530248097|FG004|Overall Study|Progressive disease|3|||
147023674|NCT01206816|530248098|FG005|Overall Study|Progressive disease|16|||
147023675|NCT01206816|530248099|FG006|Overall Study|Progressive disease|3|||
147023676|NCT01206816|530248093|FG000|Overall Study|Other AE|0|||
147023677|NCT01206816|530248094|FG001|Overall Study|Other AE|0|||
147023678|NCT01206816|530248095|FG002|Overall Study|Other AE|4|||
147023679|NCT01206816|530248096|FG003|Overall Study|Other AE|0|||
147023680|NCT01206816|530248097|FG004|Overall Study|Other AE|0|||
147023681|NCT01206816|530248098|FG005|Overall Study|Other AE|3|||
147023682|NCT01206816|530248099|FG006|Overall Study|Other AE|2|||
147023683|NCT01206816|530248093|FG000|Overall Study|other than stated above|0|||
147023684|NCT01206816|530248094|FG001|Overall Study|other than stated above|0|||
147023685|NCT01206816|530248095|FG002|Overall Study|other than stated above|1|||
147023686|NCT01206816|530248096|FG003|Overall Study|other than stated above|0|||
147023687|NCT01206816|530248097|FG004|Overall Study|other than stated above|0|||
147023688|NCT01206816|530248098|FG005|Overall Study|other than stated above|0|||
147023689|NCT01206816|530248099|FG006|Overall Study|other than stated above|1|||
147023690|NCT01939496|530248100|FG000|Overall Study|Adverse Event|2|||
147023691|NCT01939496|530248101|FG001|Overall Study|Adverse Event|0|||
147023692|NCT01939496|530248102|FG002|Overall Study|Adverse Event|0|||
147023693|NCT01939496|530248100|FG000|Overall Study|Lost to Follow-up|1|||
147023694|NCT01939496|530248101|FG001|Overall Study|Lost to Follow-up|1|||
147023695|NCT01939496|530248102|FG002|Overall Study|Lost to Follow-up|0|||
147023696|NCT01939496|530248100|FG000|Overall Study|Physician Decision|1|||
147023697|NCT01939496|530248101|FG001|Overall Study|Physician Decision|0|||
147023698|NCT01939496|530248102|FG002|Overall Study|Physician Decision|0|||
147023699|NCT01939496|530248100|FG000|Overall Study|Protocol Violation|3|||
147023700|NCT01939496|530248101|FG001|Overall Study|Protocol Violation|0|||
147023701|NCT01939496|530248102|FG002|Overall Study|Protocol Violation|0|||
147023702|NCT01939496|530248100|FG000|Overall Study|Withdrawal by Subject|0|||
147023703|NCT01939496|530248101|FG001|Overall Study|Withdrawal by Subject|1|||
147023704|NCT01939496|530248102|FG002|Overall Study|Withdrawal by Subject|1|||
147023705|NCT01939496|530248100|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
147023706|NCT01939496|530248101|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
147023707|NCT01939496|530248102|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
147023708|NCT01939496|530248100|FG000|Overall Study|Other|2|||
147023709|NCT01939496|530248101|FG001|Overall Study|Other|0|||
147023710|NCT01939496|530248102|FG002|Overall Study|Other|1|||
147023711|NCT01642914|530248103|FG000|Overall Study|Adverse Event|11|||
147023712|NCT01642914|530248104|FG001|Overall Study|Adverse Event|7|||
147023713|NCT01642914|530248105|FG002|Overall Study|Adverse Event|15|||
147023714|NCT01642914|530248103|FG000|Overall Study|Lack of Efficacy|9|||
147023715|NCT01642914|530248104|FG001|Overall Study|Lack of Efficacy|4|||
147023716|NCT01642914|530248105|FG002|Overall Study|Lack of Efficacy|2|||
147023717|NCT01642914|530248103|FG000|Overall Study|Protocol Violation|15|||
147023718|NCT01642914|530248104|FG001|Overall Study|Protocol Violation|13|||
147023719|NCT01642914|530248105|FG002|Overall Study|Protocol Violation|6|||
147023720|NCT01642914|530248103|FG000|Overall Study|Withdrawal by Subject|5|||
147023721|NCT01642914|530248104|FG001|Overall Study|Withdrawal by Subject|5|||
147023722|NCT01642914|530248105|FG002|Overall Study|Withdrawal by Subject|10|||
147023723|NCT01642914|530248103|FG000|Overall Study|Lost to Follow-up|5|||
147023724|NCT01642914|530248104|FG001|Overall Study|Lost to Follow-up|3|||
147023725|NCT01642914|530248105|FG002|Overall Study|Lost to Follow-up|7|||
147023726|NCT01642914|530248103|FG000|Overall Study|Other Reason|1|||
147023727|NCT01642914|530248104|FG001|Overall Study|Other Reason|0|||
147023728|NCT01642914|530248105|FG002|Overall Study|Other Reason|0|||
147023729|NCT03028740|530248106|FG000|Overall Study|Did not Receive Study Drug|4|||
147023730|NCT03028740|530248107|FG001|Overall Study|Did not Receive Study Drug|5|||
147023731|NCT03028740|530248106|FG000|Overall Study|Adverse Event|8|||
147023732|NCT03028740|530248107|FG001|Overall Study|Adverse Event|26|||
147023733|NCT03028740|530248106|FG000|Overall Study|Lack of Efficacy|0|||
147023734|NCT03028740|530248107|FG001|Overall Study|Lack of Efficacy|1|||
147023735|NCT03028740|530248106|FG000|Overall Study|Withdrawal by Subject|48|||
147023736|NCT03028740|530248107|FG001|Overall Study|Withdrawal by Subject|101|||
147023737|NCT03028740|530248106|FG000|Overall Study|Lost to Follow-up|30|||
147023738|NCT03028740|530248107|FG001|Overall Study|Lost to Follow-up|54|||
147023739|NCT03028740|530248106|FG000|Overall Study|Physician Decision|4|||
147023740|NCT03028740|530248107|FG001|Overall Study|Physician Decision|11|||
147023741|NCT03028740|530248106|FG000|Overall Study|Protocol Violation|4|||
147023742|NCT03028740|530248107|FG001|Overall Study|Protocol Violation|8|||
147023743|NCT03028740|530248106|FG000|Overall Study|Non-compliance with Study Drug|0|||
147023744|NCT03028740|530248107|FG001|Overall Study|Non-compliance with Study Drug|2|||
147023745|NCT03028740|530248106|FG000|Overall Study|Study Terminated by Sponsor|467|||
147023746|NCT03028740|530248107|FG001|Overall Study|Study Terminated by Sponsor|917|||
147023747|NCT03028740|530248106|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
147023748|NCT03028740|530248107|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
147023749|NCT03028740|530248106|FG000|Overall Study|Reason not Specified|1|||
147023750|NCT03028740|530248107|FG001|Overall Study|Reason not Specified|5|||
147023751|NCT00171301|530248108|FG000|Overall Study|Death|1|||
147023752|NCT00171301|530248109|FG001|Overall Study|Death|2|||
147023753|NCT00171301|530248108|FG000|Overall Study|Adverse Event|1|||
147023754|NCT00171301|530248109|FG001|Overall Study|Adverse Event|2|||
147023755|NCT00171301|530248108|FG000|Overall Study|Lost to Follow-up|6|||
147023756|NCT00171301|530248109|FG001|Overall Study|Lost to Follow-up|2|||
147023757|NCT00171301|530248108|FG000|Overall Study|Protocol Violation|0|||
147023758|NCT00171301|530248109|FG001|Overall Study|Protocol Violation|2|||
147023759|NCT00171301|530248108|FG000|Overall Study|Withdrawal by Subject|0|||
147023760|NCT00171301|530248109|FG001|Overall Study|Withdrawal by Subject|1|||
147023761|NCT04319159|530248111|FG000|Overall Study|Screening failure|13|||
147023762|NCT04319159|530248111|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
147023763|NCT04319159|530248111|FG000|Overall Study|Withdrawal by Subject|1|||
147023764|NCT02100319|530248114|FG000|Overall Study|Case Report Forms Uncollected|11|||
147023765|NCT02100319|530248114|FG000|Overall Study|Protocol Deviation|5|||
147023766|NCT02589522|530248117|FG000|Overall Study|Physician Decision|1|||
147023767|NCT02589522|530248118|FG001|Overall Study|Physician Decision|2|||
147023768|NCT02589522|530248119|FG002|Overall Study|Physician Decision|0|||
147023769|NCT02589522|530248117|FG000|Overall Study|Did not start treatment|1|||
147023770|NCT02589522|530248118|FG001|Overall Study|Did not start treatment|0|||
147023771|NCT02589522|530248119|FG002|Overall Study|Did not start treatment|0|||
147023772|NCT02025010|530248120|FG000|Overall Study|Symptomatic or radiographic progression|36|||
147023773|NCT02025010|530248120|FG000|Overall Study|Adverse Event|6|||
147023774|NCT02025010|530248120|FG000|Overall Study|Physician Decision|7|||
147023775|NCT02025010|530248120|FG000|Overall Study|Withdrawal by Subject|3|||
147023776|NCT02025010|530248120|FG000|Overall Study|Intercurrent illness|3|||
147023777|NCT02025010|530248120|FG000|Overall Study|Patients still on treatment|3|||
147023778|NCT02025010|530248120|FG000|Overall Study|Never initiate the treatment|2|||
147023779|NCT01300052|530248121|FG000|Overall Study|Adverse Event|3|||
147023780|NCT01300052|530248122|FG001|Overall Study|Adverse Event|0|||
147023781|NCT01300052|530248121|FG000|Overall Study|Withdrawal by Subject|2|||
147023782|NCT01300052|530248122|FG001|Overall Study|Withdrawal by Subject|2|||
147023783|NCT01300052|530248121|FG000|Overall Study|Protocol Violation|1|||
147023784|NCT01300052|530248122|FG001|Overall Study|Protocol Violation|1|||
147023785|NCT01661881|530248123|FG000|Overall Study|Disease Progression|1|||
147023786|NCT05444543|530248124|FG000|Overall Study|Withdrawal by Subject|1|||
147023787|NCT05444543|530248125|FG001|Overall Study|Withdrawal by Subject|0|||
147023788|NCT05444543|530248124|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
147023789|NCT05444543|530248125|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
147023790|NCT05444543|530248124|FG000|Overall Study|Adverse Event|0|||
147023791|NCT05444543|530248125|FG001|Overall Study|Adverse Event|1|||
147023792|NCT05444543|530248124|FG000|Overall Study|Family relocating at a distance from study site|0|||
147023793|NCT05444543|530248125|FG001|Overall Study|Family relocating at a distance from study site|1|||
147023794|NCT03847194|530248126|FG000|Overall Study|Lost to Follow-up|2|||
147023795|NCT03847194|530248127|FG001|Overall Study|Lost to Follow-up|5|||
147023796|NCT03847194|530248126|FG000|Overall Study|Withdrawal by Subject|1|||
147023797|NCT03847194|530248127|FG001|Overall Study|Withdrawal by Subject|2|||
147023798|NCT03847194|530248126|FG000|Overall Study|Death|0|||
147023799|NCT03847194|530248127|FG001|Overall Study|Death|1|||
147023800|NCT01144403|530248129|FG000|Overall Study|Lost to Follow-up|3|||
147023801|NCT01144403|530248129|FG000|Overall Study|Death|1|||
147023802|NCT01144403|530248129|FG000|Overall Study|Adverse Event|1|||
147023803|NCT03891329|530248130|FG000|Overall Study|Death|5|||
147023804|NCT03891329|530248130|FG000|Overall Study|Lost to Follow-up|4|||
147023805|NCT03891329|530248130|FG000|Overall Study|Physician Decision|4|||
147023806|NCT03891329|530248130|FG000|Overall Study|Device explanted|3|||
147023807|NCT03891329|530248130|FG000|Overall Study|No study device implanted|3|||
147023808|NCT02096588|530248131|FG000|Overall Study|Lack of Efficacy|2|||
147023809|NCT02096588|530248132|FG001|Overall Study|Lack of Efficacy|0|||
147023810|NCT02096588|530248131|FG000|Overall Study|Withdrawal by Subject|0|||
147023811|NCT02096588|530248132|FG001|Overall Study|Withdrawal by Subject|1|||
147023812|NCT01258101|530248134|FG000|Overall Study|Adverse Event|5|||
147023813|NCT01258101|530248135|FG001|Overall Study|Adverse Event|6|||
147023814|NCT01258101|530248136|FG002|Overall Study|Adverse Event|0|||
147023815|NCT01258101|530248137|FG003|Overall Study|Adverse Event|0|||
147023816|NCT01258101|530248134|FG000|Overall Study|Extra exclusion criterion amended|2|||
147023817|NCT01258101|530248135|FG001|Overall Study|Extra exclusion criterion amended|1|||
147023818|NCT01258101|530248136|FG002|Overall Study|Extra exclusion criterion amended|1|||
147023819|NCT01258101|530248137|FG003|Overall Study|Extra exclusion criterion amended|1|||
147023820|NCT01258101|530248134|FG000|Overall Study|Informed consent has been withdrawn|2|||
147023821|NCT01258101|530248135|FG001|Overall Study|Informed consent has been withdrawn|2|||
147023822|NCT01258101|530248136|FG002|Overall Study|Informed consent has been withdrawn|1|||
147023823|NCT01258101|530248137|FG003|Overall Study|Informed consent has been withdrawn|1|||
147023824|NCT01258101|530248134|FG000|Overall Study|Patient is not able to attend visits|8|||
147023825|NCT01258101|530248135|FG001|Overall Study|Patient is not able to attend visits|9|||
147023826|NCT01258101|530248136|FG002|Overall Study|Patient is not able to attend visits|7|||
147023827|NCT01258101|530248137|FG003|Overall Study|Patient is not able to attend visits|6|||
147023828|NCT01258101|530248134|FG000|Overall Study|Patient´s compliance|4|||
147023829|NCT01258101|530248135|FG001|Overall Study|Patient´s compliance|3|||
147023830|NCT01258101|530248136|FG002|Overall Study|Patient´s compliance|1|||
147023831|NCT01258101|530248137|FG003|Overall Study|Patient´s compliance|2|||
147023832|NCT01258101|530248134|FG000|Overall Study|Lost to Follow-up|5|||
147023833|NCT01258101|530248135|FG001|Overall Study|Lost to Follow-up|5|||
147023834|NCT01258101|530248136|FG002|Overall Study|Lost to Follow-up|0|||
147023835|NCT01258101|530248137|FG003|Overall Study|Lost to Follow-up|6|||
147023836|NCT01258101|530248134|FG000|Overall Study|PCR positive at week 24|0|||
147023837|NCT01258101|530248135|FG001|Overall Study|PCR positive at week 24|0|||
147023838|NCT01258101|530248136|FG002|Overall Study|PCR positive at week 24|0|||
147023839|NCT01258101|530248137|FG003|Overall Study|PCR positive at week 24|1|||
147023840|NCT01258101|530248134|FG000|Overall Study|Other reason|7|||
147023841|NCT01258101|530248135|FG001|Overall Study|Other reason|8|||
147023842|NCT01258101|530248136|FG002|Overall Study|Other reason|1|||
147023843|NCT01258101|530248137|FG003|Overall Study|Other reason|8|||
147023844|NCT00063882|530248138|FG000|Overall Study|Protocol Violation|3|||
147023845|NCT00063882|530248139|FG001|Overall Study|Protocol Violation|3|||
147023846|NCT00063882|530248138|FG000|Overall Study|Withdrawal by Subject|2|||
147023847|NCT00063882|530248139|FG001|Overall Study|Withdrawal by Subject|1|||
147023848|NCT03438227|530248143|FG000|Overall Study|Withdrawal by Subject|10|||
147023849|NCT03438227|530248144|FG001|Overall Study|Withdrawal by Subject|5|||
147023850|NCT00293202|530248147|FG000|Overall Study|Withdrawal by Subject|1|||
147023851|NCT00293202|530248148|FG001|Overall Study|Withdrawal by Subject|2|||
147023852|NCT00293202|530248147|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
147023853|NCT00293202|530248148|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
147023854|NCT00293202|530248147|FG000|Overall Study|on-hold due to fistula maturation time|1|||
147023855|NCT00293202|530248148|FG001|Overall Study|on-hold due to fistula maturation time|0|||
147023856|NCT01744093|530249705|FG000|Overall Study|Withdrawal by Subject|6|||
147023857|NCT01744093|530249706|FG001|Overall Study|Withdrawal by Subject|1|||
147023858|NCT02006628|530249707|FG000|Overall Study|Adverse Event|1|||
147023859|NCT02006628|530249708|FG001|Overall Study|Adverse Event|1|||
147023860|NCT02006628|530249707|FG000|Overall Study|Withdrawal by Subject|2|||
147023861|NCT02006628|530249708|FG001|Overall Study|Withdrawal by Subject|1|||
146849368|NCT00605215|529618805|FG002|Overall Study|Lost to Follow-up|2|||
147023862|NCT02384941|530249711|FG000|Overall Study|Adverse Event|11|||
147023863|NCT02384941|530249712|FG001|Overall Study|Adverse Event|13|||
147023864|NCT02384941|530249713|FG002|Overall Study|Adverse Event|17|||
147023865|NCT02384941|530249711|FG000|Overall Study|Lost to Follow-up|3|||
147023866|NCT02384941|530249712|FG001|Overall Study|Lost to Follow-up|2|||
147023867|NCT02384941|530249713|FG002|Overall Study|Lost to Follow-up|1|||
147023868|NCT02384941|530249711|FG000|Overall Study|Non-Compliance With Study Drug|2|||
147023869|NCT02384941|530249712|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147023870|NCT02384941|530249713|FG002|Overall Study|Non-Compliance With Study Drug|1|||
147023871|NCT02384941|530249711|FG000|Overall Study|Physician Decision|1|||
147023872|NCT02384941|530249712|FG001|Overall Study|Physician Decision|1|||
147023873|NCT02384941|530249713|FG002|Overall Study|Physician Decision|0|||
147023874|NCT02384941|530249711|FG000|Overall Study|Protocol Violation|3|||
147023875|NCT02384941|530249712|FG001|Overall Study|Protocol Violation|0|||
147023876|NCT02384941|530249713|FG002|Overall Study|Protocol Violation|0|||
147023877|NCT02384941|530249711|FG000|Overall Study|Withdrawal by Subject|26|||
147023878|NCT02384941|530249712|FG001|Overall Study|Withdrawal by Subject|19|||
147023879|NCT02384941|530249713|FG002|Overall Study|Withdrawal by Subject|20|||
147023880|NCT02384941|530249711|FG000|Overall Study|Pregnancy|0|||
147023881|NCT02384941|530249712|FG001|Overall Study|Pregnancy|0|||
147023882|NCT02384941|530249713|FG002|Overall Study|Pregnancy|1|||
147023883|NCT02384941|530249711|FG000|Overall Study|Other than specified above|4|||
147023884|NCT02384941|530249712|FG001|Overall Study|Other than specified above|0|||
147023885|NCT02384941|530249713|FG002|Overall Study|Other than specified above|1|||
147023886|NCT02493777|530249714|FG000|Overall Study|Lost to Follow-up|0|||
147023887|NCT02493777|530249715|FG001|Overall Study|Lost to Follow-up|1|||
147023888|NCT00468728|530249716|FG000|Treatment|criteria for mITT population|4|||
147023889|NCT00468728|530249717|FG001|Treatment|criteria for mITT population|11|||
147023890|NCT00468728|530249716|FG000|Follow-up|mITT failure|34|||
147023891|NCT00468728|530249717|FG001|Follow-up|mITT failure|31|||
147023892|NCT01705236|530249718|FG000|Overall Study|Lost to Follow-up|1|||
147023893|NCT01705236|530249718|FG000|Overall Study|Administrative problems|2|||
147023894|NCT01705236|530249718|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
147023895|NCT01705236|530249718|FG000|Overall Study|Protocol Violation|3|||
147023896|NCT01705236|530249718|FG000|Overall Study|Abnormal test procedure result(s)|4|||
147023897|NCT01705236|530249718|FG000|Overall Study|Abnormal laboratory value(s)|4|||
147023898|NCT01705236|530249718|FG000|Overall Study|Withdrawal by Subject|5|||
147023899|NCT01705236|530249718|FG000|Overall Study|Adverse Event|5|||
147023900|NCT04572243|530249719|FG000|Core Study: 14 Weeks|Adverse Event|1|||
147023901|NCT04572243|530249720|FG001|Core Study: 14 Weeks|Adverse Event|2|||
147023902|NCT04572243|530249721|FG002|Core Study: 14 Weeks|Adverse Event|0|||
147023903|NCT04572243|530249722|FG003|Core Study: 14 Weeks|Adverse Event|0|||
147023904|NCT04572243|530249719|FG000|Core Study: 14 Weeks|Subject choice|0|||
147023905|NCT04572243|530249720|FG001|Core Study: 14 Weeks|Subject choice|2|||
147023906|NCT04572243|530249721|FG002|Core Study: 14 Weeks|Subject choice|0|||
147023907|NCT04572243|530249722|FG003|Core Study: 14 Weeks|Subject choice|0|||
147023908|NCT04572243|530249719|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
147023909|NCT04572243|530249720|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
147023910|NCT04572243|530249721|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
147023911|NCT04572243|530249722|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
147023912|NCT04572243|530249719|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
147023913|NCT04572243|530249720|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
147023914|NCT04572243|530249721|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
147023915|NCT04572243|530249722|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
147023916|NCT01231373|530249723|FG000|Overall Study|Withdrew consent prior to randomization|2|||
147023917|NCT01231373|530249724|FG001|Overall Study|Withdrew consent prior to randomization|1|||
147023918|NCT01231373|530249725|FG002|Overall Study|Withdrew consent prior to randomization|0|||
147023919|NCT01231373|530249726|FG003|Overall Study|Withdrew consent prior to randomization|0|||
147023920|NCT01231373|530249723|FG000|Overall Study|Lost to Follow-up|0|||
147023921|NCT01231373|530249724|FG001|Overall Study|Lost to Follow-up|0|||
147023922|NCT01231373|530249725|FG002|Overall Study|Lost to Follow-up|0|||
147023923|NCT01231373|530249726|FG003|Overall Study|Lost to Follow-up|1|||
147023924|NCT01231373|530249723|FG000|Overall Study|Withdrew Consent|1|||
147023925|NCT01231373|530249724|FG001|Overall Study|Withdrew Consent|0|||
147023926|NCT01231373|530249725|FG002|Overall Study|Withdrew Consent|0|||
147023927|NCT01231373|530249726|FG003|Overall Study|Withdrew Consent|0|||
147023928|NCT00775606|530249731|FG000|Overall Study|Study sponsor terminated funding|3|||
147023929|NCT00775606|530249732|FG001|Overall Study|Study sponsor terminated funding|0|||
147023930|NCT00102687|530249733|FG000|Initial Period|Withdrawal by Subject|6|||
147023931|NCT00102687|530249734|FG001|Initial Period|Withdrawal by Subject|3|||
147023932|NCT00102687|530249735|FG002|Initial Period|Withdrawal by Subject|5|||
147023933|NCT00102687|530249736|FG003|Initial Period|Withdrawal by Subject|0|||
147023934|NCT00102687|530249737|FG004|Initial Period|Withdrawal by Subject|0|||
147023935|NCT00102687|530249733|FG000|Initial Period|Adverse Event|4|||
147023936|NCT00102687|530249734|FG001|Initial Period|Adverse Event|7|||
147023937|NCT00102687|530249735|FG002|Initial Period|Adverse Event|9|||
147023938|NCT00102687|530249736|FG003|Initial Period|Adverse Event|0|||
147023939|NCT00102687|530249737|FG004|Initial Period|Adverse Event|0|||
147023940|NCT00102687|530249733|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
147023941|NCT00102687|530249734|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
147023942|NCT00102687|530249735|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
147023943|NCT00102687|530249736|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
147023944|NCT00102687|530249737|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
147023945|NCT00102687|530249733|FG000|Initial Period|Protocol Violation|0|||
147023946|NCT00102687|530249734|FG001|Initial Period|Protocol Violation|0|||
147023947|NCT00102687|530249735|FG002|Initial Period|Protocol Violation|2|||
147023948|NCT00102687|530249736|FG003|Initial Period|Protocol Violation|0|||
147023949|NCT00102687|530249737|FG004|Initial Period|Protocol Violation|0|||
147023950|NCT00102687|530249733|FG000|Initial Period|Physician Decision|2|||
147023951|NCT00102687|530249734|FG001|Initial Period|Physician Decision|9|||
147023952|NCT00102687|530249735|FG002|Initial Period|Physician Decision|6|||
147023953|NCT00102687|530249736|FG003|Initial Period|Physician Decision|0|||
147023954|NCT00102687|530249737|FG004|Initial Period|Physician Decision|0|||
147023955|NCT00102687|530249733|FG000|Initial Period|Sponsor's decision|0|||
147023956|NCT00102687|530249734|FG001|Initial Period|Sponsor's decision|1|||
147023957|NCT00102687|530249735|FG002|Initial Period|Sponsor's decision|1|||
147023958|NCT00102687|530249736|FG003|Initial Period|Sponsor's decision|0|||
147023959|NCT00102687|530249737|FG004|Initial Period|Sponsor's decision|0|||
147023960|NCT00102687|530249733|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
147023961|NCT00102687|530249734|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
147023962|NCT00102687|530249735|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
147023963|NCT00102687|530249736|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
147023964|NCT00102687|530249737|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
147023965|NCT00102687|530249733|FG000|Initial Period|Death|1|||
147023966|NCT00102687|530249734|FG001|Initial Period|Death|1|||
147023967|NCT00102687|530249735|FG002|Initial Period|Death|1|||
147023968|NCT00102687|530249736|FG003|Initial Period|Death|0|||
147023969|NCT00102687|530249737|FG004|Initial Period|Death|0|||
147023970|NCT00102687|530249733|FG000|Maintenance Period|Withdrawal by Subject|4|||
147023971|NCT00102687|530249734|FG001|Maintenance Period|Withdrawal by Subject|0|||
147023972|NCT00102687|530249735|FG002|Maintenance Period|Withdrawal by Subject|2|||
147023973|NCT00102687|530249736|FG003|Maintenance Period|Withdrawal by Subject|3|||
147023974|NCT00102687|530249737|FG004|Maintenance Period|Withdrawal by Subject|1|||
147023975|NCT00102687|530249733|FG000|Maintenance Period|Adverse Event|1|||
147023976|NCT00102687|530249734|FG001|Maintenance Period|Adverse Event|0|||
147023977|NCT00102687|530249735|FG002|Maintenance Period|Adverse Event|0|||
147023978|NCT00102687|530249736|FG003|Maintenance Period|Adverse Event|1|||
147023979|NCT00102687|530249737|FG004|Maintenance Period|Adverse Event|3|||
147023980|NCT00102687|530249733|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
147023981|NCT00102687|530249734|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
147023982|NCT00102687|530249735|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
147023983|NCT00102687|530249736|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
147023984|NCT00102687|530249737|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
147023985|NCT00102687|530249733|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
147023986|NCT00102687|530249734|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
147023987|NCT00102687|530249735|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
147023988|NCT00102687|530249736|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
147023989|NCT00102687|530249737|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
147023990|NCT00102687|530249733|FG000|Maintenance Period|Death|0|||
147023991|NCT00102687|530249734|FG001|Maintenance Period|Death|0|||
147023992|NCT00102687|530249735|FG002|Maintenance Period|Death|0|||
147023993|NCT00102687|530249736|FG003|Maintenance Period|Death|1|||
147023994|NCT00102687|530249737|FG004|Maintenance Period|Death|1|||
147023995|NCT00102687|530249733|FG000|Maintenance Period|Physician Decision|1|||
147023996|NCT00102687|530249734|FG001|Maintenance Period|Physician Decision|2|||
147023997|NCT00102687|530249735|FG002|Maintenance Period|Physician Decision|3|||
147023998|NCT00102687|530249736|FG003|Maintenance Period|Physician Decision|0|||
147023999|NCT00102687|530249737|FG004|Maintenance Period|Physician Decision|4|||
147024000|NCT00767520|530249742|FG000|Overall Study|Participants still on treatment|11|||
147024001|NCT00767520|530249743|FG001|Overall Study|Participants still on treatment|15|||
147024002|NCT00767520|530249742|FG000|Overall Study|Randomized in error and Never treated|0|||
147024003|NCT00767520|530249743|FG001|Overall Study|Randomized in error and Never treated|2|||
147024004|NCT00757848|530249744|FG000|Overall Study|Voluntary discontinuation|1|||
147024005|NCT00757848|530249745|FG001|Overall Study|Voluntary discontinuation|0|||
147024006|NCT00757848|530249744|FG000|Overall Study|Adverse Event|1|||
147024007|NCT00757848|530249745|FG001|Overall Study|Adverse Event|2|||
147024008|NCT00757848|530249744|FG000|Overall Study|Incorrect enrolment|1|||
147024009|NCT00757848|530249745|FG001|Overall Study|Incorrect enrolment|0|||
147024010|NCT01338987|530249746|FG000|Overall Study|enrolled on new protocol|0|||
147024011|NCT01338987|530249747|FG001|Overall Study|enrolled on new protocol|0|||
147024012|NCT01338987|530249748|FG002|Overall Study|enrolled on new protocol|1|||
147024013|NCT01338987|530249749|FG003|Overall Study|enrolled on new protocol|0|||
147024014|NCT01338987|530249750|FG004|Overall Study|enrolled on new protocol|0|||
147024015|NCT01338987|530249746|FG000|Overall Study|Disease progression on study|2|||
147024016|NCT01338987|530249747|FG001|Overall Study|Disease progression on study|1|||
147024017|NCT01338987|530249748|FG002|Overall Study|Disease progression on study|1|||
147024018|NCT01338987|530249749|FG003|Overall Study|Disease progression on study|0|||
147024019|NCT01338987|530249750|FG004|Overall Study|Disease progression on study|0|||
147024020|NCT00720226|530249758|FG000|Overall Study|Withdrawal by Subject|7|||
147024021|NCT00720226|530249759|FG001|Overall Study|Withdrawal by Subject|4|||
147024022|NCT00958126|530249760|FG000|Overall Study|Serious Adverse Event|0|||
147024023|NCT00958126|530249761|FG001|Overall Study|Serious Adverse Event|2|||
147024024|NCT00958126|530249762|FG002|Overall Study|Serious Adverse Event|0|||
147024025|NCT00958126|530249763|FG003|Overall Study|Serious Adverse Event|0|||
147024026|NCT00958126|530249764|FG004|Overall Study|Serious Adverse Event|0|||
147024027|NCT00958126|530249765|FG005|Overall Study|Serious Adverse Event|0|||
147024028|NCT00958126|530249766|FG006|Overall Study|Serious Adverse Event|1|||
147024029|NCT00958126|530249767|FG007|Overall Study|Serious Adverse Event|0|||
147024030|NCT00958126|530249760|FG000|Overall Study|Withdrawal by Subject|0|||
147024031|NCT00958126|530249761|FG001|Overall Study|Withdrawal by Subject|2|||
147024032|NCT00958126|530249762|FG002|Overall Study|Withdrawal by Subject|0|||
147024033|NCT00958126|530249763|FG003|Overall Study|Withdrawal by Subject|0|||
147024034|NCT00958126|530249764|FG004|Overall Study|Withdrawal by Subject|0|||
147024035|NCT00958126|530249765|FG005|Overall Study|Withdrawal by Subject|0|||
147024036|NCT00958126|530249766|FG006|Overall Study|Withdrawal by Subject|0|||
147024037|NCT00958126|530249767|FG007|Overall Study|Withdrawal by Subject|0|||
147024038|NCT00958126|530249760|FG000|Overall Study|Moved away from study area|0|||
147024039|NCT00958126|530249761|FG001|Overall Study|Moved away from study area|0|||
147024040|NCT00958126|530249762|FG002|Overall Study|Moved away from study area|1|||
147024041|NCT00958126|530249763|FG003|Overall Study|Moved away from study area|1|||
147024042|NCT00958126|530249764|FG004|Overall Study|Moved away from study area|0|||
147024043|NCT00958126|530249765|FG005|Overall Study|Moved away from study area|0|||
147024044|NCT00958126|530249766|FG006|Overall Study|Moved away from study area|0|||
147024045|NCT00958126|530249767|FG007|Overall Study|Moved away from study area|0|||
147024046|NCT00958126|530249760|FG000|Overall Study|Lost to Follow-up|1|||
147024047|NCT00958126|530249761|FG001|Overall Study|Lost to Follow-up|5|||
147024048|NCT00958126|530249762|FG002|Overall Study|Lost to Follow-up|9|||
147024049|NCT00958126|530249763|FG003|Overall Study|Lost to Follow-up|8|||
147024050|NCT00958126|530249764|FG004|Overall Study|Lost to Follow-up|0|||
147024051|NCT00958126|530249765|FG005|Overall Study|Lost to Follow-up|0|||
147024052|NCT00958126|530249766|FG006|Overall Study|Lost to Follow-up|0|||
147024053|NCT00958126|530249767|FG007|Overall Study|Lost to Follow-up|0|||
147024054|NCT00958126|530249760|FG000|Overall Study|Sponsor/Investigator decision|0|||
147024055|NCT00958126|530249761|FG001|Overall Study|Sponsor/Investigator decision|0|||
147024056|NCT00958126|530249762|FG002|Overall Study|Sponsor/Investigator decision|0|||
147024057|NCT00958126|530249763|FG003|Overall Study|Sponsor/Investigator decision|1|||
147024058|NCT00958126|530249764|FG004|Overall Study|Sponsor/Investigator decision|0|||
147024059|NCT00958126|530249765|FG005|Overall Study|Sponsor/Investigator decision|0|||
147024060|NCT00958126|530249766|FG006|Overall Study|Sponsor/Investigator decision|0|||
147024061|NCT00958126|530249767|FG007|Overall Study|Sponsor/Investigator decision|0|||
147024062|NCT00958126|530249760|FG000|Overall Study|Other Reason|0|||
147024063|NCT00958126|530249761|FG001|Overall Study|Other Reason|0|||
147024064|NCT00958126|530249762|FG002|Overall Study|Other Reason|0|||
147024065|NCT00958126|530249763|FG003|Overall Study|Other Reason|1|||
147024066|NCT00958126|530249764|FG004|Overall Study|Other Reason|0|||
147024067|NCT00958126|530249765|FG005|Overall Study|Other Reason|1|||
147024068|NCT00958126|530249766|FG006|Overall Study|Other Reason|0|||
147024069|NCT00958126|530249767|FG007|Overall Study|Other Reason|0|||
147024070|NCT03401073|530249768|FG000|Overall Study|Lost to Follow-up|1|||
147024071|NCT03401073|530249769|FG001|Overall Study|Lost to Follow-up|2|||
147024072|NCT00733369|530249770|FG000|Overall Study|Lost to Follow-up|2|||
147024073|NCT00733369|530249771|FG001|Overall Study|Lost to Follow-up|1|||
147024074|NCT00733369|530249770|FG000|Overall Study|Adverse Event|4|||
147024075|NCT00733369|530249771|FG001|Overall Study|Adverse Event|4|||
147024076|NCT00733369|530249770|FG000|Overall Study|Protocol Violation|4|||
147024077|NCT00733369|530249771|FG001|Overall Study|Protocol Violation|4|||
147024078|NCT01470612|530249772|FG000|Overall Study|Adverse Event|20|||
147024079|NCT01470612|530249773|FG001|Overall Study|Adverse Event|80|||
147024080|NCT01470612|530249772|FG000|Overall Study|Death|0|||
146849369|NCT00605215|529618803|FG000|Overall Study|Other than specified|0|||
147024081|NCT01470612|530249773|FG001|Overall Study|Death|1|||
147024082|NCT01470612|530249772|FG000|Overall Study|Lack of Efficacy|20|||
147024083|NCT01470612|530249773|FG001|Overall Study|Lack of Efficacy|326|||
147024084|NCT01470612|530249772|FG000|Overall Study|Lost to Follow-up|2|||
147024085|NCT01470612|530249773|FG001|Overall Study|Lost to Follow-up|5|||
147024086|NCT01470612|530249772|FG000|Overall Study|Did not meet entrance criteria|0|||
147024087|NCT01470612|530249773|FG001|Overall Study|Did not meet entrance criteria|1|||
147024088|NCT01470612|530249772|FG000|Overall Study|Pregnancy|2|||
147024089|NCT01470612|530249773|FG001|Overall Study|Pregnancy|10|||
147024090|NCT01470612|530249772|FG000|Overall Study|Protocol Violation|2|||
147024091|NCT01470612|530249773|FG001|Overall Study|Protocol Violation|7|||
147024092|NCT01470612|530249772|FG000|Overall Study|Withdrawal by Subject|24|||
147024093|NCT01470612|530249773|FG001|Overall Study|Withdrawal by Subject|79|||
147024094|NCT01470612|530249772|FG000|Overall Study|Other|14|||
147024095|NCT01470612|530249773|FG001|Overall Study|Other|156|||
147024096|NCT01949116|530249783|FG000|Overall Study|Death|2|||
147024097|NCT01949116|530249784|FG001|Overall Study|Death|0|||
147024098|NCT01949116|530249783|FG000|Overall Study|Lost to Follow-up|1|||
147024099|NCT01949116|530249784|FG001|Overall Study|Lost to Follow-up|3|||
147024100|NCT01949116|530249783|FG000|Overall Study|Withdrawal by Subject|5|||
147024101|NCT01949116|530249784|FG001|Overall Study|Withdrawal by Subject|3|||
147024102|NCT02556307|530249789|FG000|Overall Study|Premature treatment interruption|11|||
147024103|NCT02556307|530249789|FG000|Overall Study|Lost to Follow-up|36|||
147024104|NCT02556307|530249789|FG000|Overall Study|Change to triple therapy|4|||
147024105|NCT02556307|530249789|FG000|Overall Study|Enrolled but not treated|2|||
147024106|NCT03078582|530249790|FG000|Overall Study|Adverse Event|0|||
147024107|NCT03078582|530249791|FG001|Overall Study|Adverse Event|8|||
147024108|NCT02039414|530249802|FG000|Overall Study|Delivered|1|||
147024109|NCT02039414|530249803|FG001|Overall Study|Delivered|1|||
147024110|NCT02039414|530249802|FG000|Overall Study|Lost to Follow-up|2|||
147024111|NCT02039414|530249803|FG001|Overall Study|Lost to Follow-up|0|||
147024112|NCT02039414|530249802|FG000|Overall Study|Protocol Violation|3|||
147024113|NCT02039414|530249803|FG001|Overall Study|Protocol Violation|1|||
147024114|NCT02972502|530249806|FG000|Overall Study|Lost to Follow-up|3|||
147024115|NCT02972502|530249807|FG001|Overall Study|Lost to Follow-up|1|||
147024116|NCT02972502|530249806|FG000|Overall Study|Withdrawal by Subject|1|||
147024117|NCT02972502|530249807|FG001|Overall Study|Withdrawal by Subject|1|||
147024118|NCT03832738|530249808|FG000|Overall Study|Withdrawal by Subject|6|||
147024119|NCT03832738|530249809|FG001|Overall Study|Withdrawal by Subject|7|||
147024120|NCT03832738|530249810|FG002|Overall Study|Withdrawal by Subject|16|||
147024121|NCT03832738|530249808|FG000|Overall Study|Physician Decision|0|||
147024122|NCT03832738|530249809|FG001|Overall Study|Physician Decision|1|||
147024123|NCT03832738|530249810|FG002|Overall Study|Physician Decision|2|||
147024124|NCT03832738|530249808|FG000|Overall Study|Adverse Event|2|||
147024125|NCT03832738|530249809|FG001|Overall Study|Adverse Event|3|||
147024126|NCT03832738|530249810|FG002|Overall Study|Adverse Event|1|||
147024127|NCT03832738|530249808|FG000|Overall Study|Pregnancy|0|||
147024128|NCT03832738|530249809|FG001|Overall Study|Pregnancy|1|||
147024129|NCT03832738|530249810|FG002|Overall Study|Pregnancy|0|||
147024130|NCT03852459|530249811|FG000|Overall Study|Adverse Event|2|||
147024131|NCT03852459|530249812|FG001|Overall Study|Adverse Event|2|||
147024132|NCT03852459|530249811|FG000|Overall Study|Withdrawal by Subject|1|||
147024133|NCT03852459|530249812|FG001|Overall Study|Withdrawal by Subject|1|||
147024134|NCT00430950|530249813|FG000|Overall Study|Adverse Event|7|||
147024135|NCT00430950|530249814|FG001|Overall Study|Adverse Event|6|||
147024136|NCT00430950|530249813|FG000|Overall Study|Withdrawal by Subject|1|||
147024137|NCT00430950|530249814|FG001|Overall Study|Withdrawal by Subject|0|||
147024138|NCT00430950|530249813|FG000|Overall Study|concomitant medication,etc.|5|||
147024139|NCT00430950|530249814|FG001|Overall Study|concomitant medication,etc.|7|||
147024140|NCT02442271|530249817|FG000|Overall Study|Adverse Event|1|||
147024141|NCT02442271|530249817|FG000|Overall Study|Withdrew Consent|1|||
147024142|NCT02442271|530249817|FG000|Overall Study|Lost to Follow-up|1|||
147024143|NCT02442271|530249817|FG000|Overall Study|Other|1|||
147024144|NCT00831623|530249821|FG000|Overall Study|Withdrawal by Subject|9|||
147024145|NCT00831623|530249821|FG000|Overall Study|Lost to Follow-up|1|||
147024146|NCT00831623|530249821|FG000|Overall Study|Not 2 years post-treatment|12|||
147024147|NCT01564459|530249824|FG000|Run-In|Adverse Event|7|||
147024148|NCT01564459|530249825|FG001|Run-In|Adverse Event|0|||
147024149|NCT01564459|530249826|FG002|Run-In|Adverse Event|0|||
147024150|NCT01564459|530249824|FG000|Run-In|Lost to Follow-up|1|||
147024151|NCT01564459|530249825|FG001|Run-In|Lost to Follow-up|0|||
147024152|NCT01564459|530249826|FG002|Run-In|Lost to Follow-up|0|||
147024153|NCT01564459|530249824|FG000|Run-In|Non-compliance with study drug|2|||
147024154|NCT01564459|530249825|FG001|Run-In|Non-compliance with study drug|0|||
147024155|NCT01564459|530249826|FG002|Run-In|Non-compliance with study drug|0|||
147024156|NCT01564459|530249824|FG000|Run-In|Protocol Violation|1|||
147024157|NCT01564459|530249825|FG001|Run-In|Protocol Violation|0|||
147024158|NCT01564459|530249826|FG002|Run-In|Protocol Violation|0|||
147024159|NCT01564459|530249824|FG000|Run-In|Withdrawal by Subject|1|||
147024160|NCT01564459|530249825|FG001|Run-In|Withdrawal by Subject|0|||
147024161|NCT01564459|530249826|FG002|Run-In|Withdrawal by Subject|0|||
146849370|NCT00605215|529618804|FG001|Overall Study|Other than specified|2|||
147024162|NCT01564459|530249824|FG000|Double-blind Treatment|Adverse Event|0|||
147024163|NCT01564459|530249825|FG001|Double-blind Treatment|Adverse Event|0|||
147024164|NCT01564459|530249826|FG002|Double-blind Treatment|Adverse Event|1|||
147024165|NCT02080832|530249831|FG000|Overall Study|Excluded from analysis by MRI|9|||
147024166|NCT02080832|530249832|FG001|Overall Study|Excluded from analysis by MRI|10|||
147024167|NCT02080832|530249833|FG002|Overall Study|Excluded from analysis by MRI|14|||
147024168|NCT02080832|530249831|FG000|Overall Study|Lost to Follow-up|0|||
147024169|NCT02080832|530249832|FG001|Overall Study|Lost to Follow-up|2|||
147024170|NCT02080832|530249833|FG002|Overall Study|Lost to Follow-up|2|||
147024171|NCT00706992|530249838|FG000|Overall Study|Study termination|5|||
147024172|NCT00706992|530249839|FG001|Overall Study|Study termination|5|||
147024173|NCT00706992|530249840|FG002|Overall Study|Study termination|6|||
147024174|NCT00706992|530249841|FG003|Overall Study|Study termination|2|||
147024175|NCT00706992|530249842|FG004|Overall Study|Study termination|3|||
147024176|NCT00706992|530249843|FG005|Overall Study|Study termination|2|||
147024177|NCT00706992|530249844|FG006|Overall Study|Study termination|3|||
147024178|NCT00706992|530249838|FG000|Overall Study|Disease progression before treatment|0|||
147024179|NCT00706992|530249839|FG001|Overall Study|Disease progression before treatment|0|||
147024180|NCT00706992|530249840|FG002|Overall Study|Disease progression before treatment|0|||
147024181|NCT00706992|530249841|FG003|Overall Study|Disease progression before treatment|0|||
147024182|NCT00706992|530249842|FG004|Overall Study|Disease progression before treatment|1|||
147024183|NCT00706992|530249843|FG005|Overall Study|Disease progression before treatment|0|||
147024184|NCT00706992|530249844|FG006|Overall Study|Disease progression before treatment|0|||
147024185|NCT01277718|530249845|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
147024186|NCT01277718|530249846|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
147024187|NCT01277718|530249845|FG000|Period 2 - Second Intervention|Physician Decision|0|||
147024188|NCT01277718|530249846|FG001|Period 2 - Second Intervention|Physician Decision|2|||
147024189|NCT02746627|530249848|FG000|Overall Study|Withdrawal by Subject|1|||
147024190|NCT02746627|530249849|FG001|Overall Study|Withdrawal by Subject|1|||
147024191|NCT02746627|530249850|FG002|Overall Study|Withdrawal by Subject|1|||
147024192|NCT00766831|530249859|FG000|Overall Study|Withdrawal by Subject|4|||
147024193|NCT00766831|530249859|FG000|Overall Study|Lost to Follow-up|3|||
147024194|NCT00766831|530249859|FG000|Overall Study|Adverse Event|20|||
147024195|NCT00766831|530249859|FG000|Overall Study|Protocol Violation|15|||
147024196|NCT00766831|530249859|FG000|Overall Study|Physician Decision|5|||
147024197|NCT00766831|530249859|FG000|Overall Study|Withdrawal of consent|26|||
147024198|NCT00766831|530249859|FG000|Overall Study|Non cooperation by participants|14|||
147024199|NCT00766831|530249859|FG000|Overall Study|Other|28|||
147024200|NCT01392326|530249860|FG000|Overall Study|Death|2|||
147024201|NCT01392326|530249861|FG001|Overall Study|Death|0|||
147024202|NCT01392326|530249862|FG002|Overall Study|Death|0|||
147024203|NCT01392326|530249860|FG000|Overall Study|Withdrawal by Subject|12|||
147024204|NCT01392326|530249861|FG001|Overall Study|Withdrawal by Subject|11|||
147024205|NCT01392326|530249862|FG002|Overall Study|Withdrawal by Subject|15|||
147024206|NCT01392326|530249860|FG000|Overall Study|Protocol Violation|2|||
147024207|NCT01392326|530249861|FG001|Overall Study|Protocol Violation|0|||
147024208|NCT01392326|530249862|FG002|Overall Study|Protocol Violation|0|||
147024209|NCT01392326|530249860|FG000|Overall Study|Pregnancy|0|||
147024210|NCT01392326|530249861|FG001|Overall Study|Pregnancy|0|||
147024211|NCT01392326|530249862|FG002|Overall Study|Pregnancy|1|||
147024212|NCT01392326|530249860|FG000|Overall Study|Physician Decision|7|||
147024213|NCT01392326|530249861|FG001|Overall Study|Physician Decision|5|||
147024214|NCT01392326|530249862|FG002|Overall Study|Physician Decision|2|||
147024215|NCT01392326|530249860|FG000|Overall Study|Lost to Follow-up|1|||
147024216|NCT01392326|530249861|FG001|Overall Study|Lost to Follow-up|3|||
147024217|NCT01392326|530249862|FG002|Overall Study|Lost to Follow-up|4|||
147024218|NCT01392326|530249860|FG000|Overall Study|Lack of Efficacy|14|||
147024219|NCT01392326|530249861|FG001|Overall Study|Lack of Efficacy|10|||
147024220|NCT01392326|530249862|FG002|Overall Study|Lack of Efficacy|15|||
147024221|NCT01392326|530249860|FG000|Overall Study|Adverse Event|9|||
147024222|NCT01392326|530249861|FG001|Overall Study|Adverse Event|6|||
147024223|NCT01392326|530249862|FG002|Overall Study|Adverse Event|11|||
147024224|NCT00094094|530249865|FG000|Overall Study|Death|2|||
147024225|NCT00094094|530249865|FG000|Overall Study|Lack of Efficacy|23|||
147024226|NCT00094094|530249865|FG000|Overall Study|Adverse Event|7|||
147024227|NCT02655016|530249866|FG000|Overall Study|Disease progression|6|||
146849371|NCT00605215|529618805|FG002|Overall Study|Other than specified|1|||
146849372|NCT00275262|529618812|FG000|Overall Study|Adverse Event|2|||
146849373|NCT00275262|529618813|FG001|Overall Study|Adverse Event|0|||
146849374|NCT00275262|529618812|FG000|Overall Study|Disease progression|2|||
146849375|NCT00275262|529618813|FG001|Overall Study|Disease progression|5|||
146849376|NCT00275262|529618812|FG000|Overall Study|Lost to Follow-up|0|||
146849377|NCT00275262|529618813|FG001|Overall Study|Lost to Follow-up|2|||
146849378|NCT00275262|529618812|FG000|Overall Study|Protocol Violation|0|||
146849379|NCT00275262|529618813|FG001|Overall Study|Protocol Violation|2|||
146849380|NCT00275262|529618812|FG000|Overall Study|Death|1|||
146849381|NCT00275262|529618813|FG001|Overall Study|Death|0|||
146849382|NCT00275262|529618812|FG000|Overall Study|Started Chemotherapy|1|||
146849383|NCT00275262|529618813|FG001|Overall Study|Started Chemotherapy|0|||
146849384|NCT01342341|529618814|FG000|Overall Study|Lost to Follow-up|4|||
146849385|NCT01342341|529618815|FG001|Overall Study|Lost to Follow-up|4|||
146849386|NCT01302067|529618818|FG000|Overall Study|Death|0|||
146849387|NCT01302067|529618819|FG001|Overall Study|Death|0|||
146849388|NCT01302067|529618820|FG002|Overall Study|Death|1|||
146849389|NCT01302067|529618818|FG000|Overall Study|Physician Decision|9|||
146849390|NCT01302067|529618819|FG001|Overall Study|Physician Decision|5|||
146849391|NCT01302067|529618820|FG002|Overall Study|Physician Decision|14|||
147024228|NCT02655016|530249867|FG001|Overall Study|Disease progression|4|||
146849392|NCT01302067|529618818|FG000|Overall Study|Lack of Efficacy|8|||
146849393|NCT01302067|529618819|FG001|Overall Study|Lack of Efficacy|4|||
146849394|NCT01302067|529618820|FG002|Overall Study|Lack of Efficacy|2|||
146849395|NCT01302067|529618818|FG000|Overall Study|Lost to Follow-up|9|||
146849396|NCT01302067|529618819|FG001|Overall Study|Lost to Follow-up|4|||
146849397|NCT01302067|529618820|FG002|Overall Study|Lost to Follow-up|15|||
146849398|NCT01302067|529618818|FG000|Overall Study|Withdrawal by Subject|13|||
146849399|NCT01302067|529618819|FG001|Overall Study|Withdrawal by Subject|6|||
146849400|NCT01302067|529618820|FG002|Overall Study|Withdrawal by Subject|10|||
146849401|NCT01302067|529618818|FG000|Overall Study|Other|1|||
146849402|NCT01302067|529618819|FG001|Overall Study|Other|1|||
146849403|NCT01302067|529618820|FG002|Overall Study|Other|3|||
146849404|NCT01302067|529618818|FG000|Overall Study|Protocol Violation|11|||
146849405|NCT01302067|529618819|FG001|Overall Study|Protocol Violation|0|||
146849406|NCT01302067|529618820|FG002|Overall Study|Protocol Violation|8|||
146849407|NCT01302067|529618818|FG000|Overall Study|Adverse Event|27|||
146849408|NCT01302067|529618819|FG001|Overall Study|Adverse Event|14|||
146849409|NCT01302067|529618820|FG002|Overall Study|Adverse Event|45|||
146849410|NCT00266227|529618821|FG000|Initial Treatment|Adverse Event|0|||
147024229|NCT02655016|530249866|FG000|Overall Study|Site closed|0|||
147024230|NCT02655016|530249867|FG001|Overall Study|Site closed|1|||
147024231|NCT02655016|530249866|FG000|Overall Study|Death|30|||
147024232|NCT02655016|530249867|FG001|Overall Study|Death|48|||
147024233|NCT02655016|530249866|FG000|Overall Study|Lost to Follow-up|1|||
147024234|NCT02655016|530249867|FG001|Overall Study|Lost to Follow-up|1|||
147024235|NCT02655016|530249866|FG000|Overall Study|Withdrawal by Subject|18|||
147024236|NCT02655016|530249867|FG001|Overall Study|Withdrawal by Subject|36|||
147024237|NCT04459715|530249868|FG000|Overall Study|Adverse Event|3|||
147024238|NCT04459715|530249869|FG001|Overall Study|Adverse Event|3|||
147024239|NCT04459715|530249868|FG000|Overall Study|Death|111|||
147024240|NCT04459715|530249869|FG001|Overall Study|Death|93|||
147024241|NCT04459715|530249868|FG000|Overall Study|Lost to Follow-up|10|||
147024242|NCT04459715|530249869|FG001|Overall Study|Lost to Follow-up|9|||
147024243|NCT04459715|530249868|FG000|Overall Study|Other Reasons|4|||
147024244|NCT04459715|530249869|FG001|Overall Study|Other Reasons|5|||
147024245|NCT04459715|530249868|FG000|Overall Study|PROTOCOL DEVIATION|0|||
147024246|NCT04459715|530249869|FG001|Overall Study|PROTOCOL DEVIATION|1|||
147024247|NCT04459715|530249868|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
147024248|NCT04459715|530249869|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
147024249|NCT04459715|530249868|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
147024250|NCT04459715|530249869|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
147024251|NCT04459715|530249868|FG000|Overall Study|Withdrawal by Subject|22|||
147024252|NCT04459715|530249869|FG001|Overall Study|Withdrawal by Subject|22|||
147024253|NCT06029959|530251644|FG000|Overall Study|Physician Decision|6|||
147024254|NCT00003138|530251645|FG000|Step 1|Reasons off treatment not documented|60|||
147024255|NCT00003138|530251646|FG001|Step 1|Reasons off treatment not documented|57|||
147024256|NCT00003138|530251645|FG000|Step 1|Never started treatment|1|||
147024257|NCT00003138|530251646|FG001|Step 1|Never started treatment|0|||
147024258|NCT00003138|530251645|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
147024259|NCT00003138|530251646|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
147024260|NCT00003138|530251645|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
147024261|NCT00003138|530251646|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
147024262|NCT00003138|530251645|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
147024263|NCT00003138|530251646|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
147024264|NCT00003138|530251645|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
147024265|NCT00003138|530251646|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
147024266|NCT04495283|530251647|FG000|Overall Study|Physician Decision|0|||
147024267|NCT04495283|530251648|FG001|Overall Study|Physician Decision|0|||
147024268|NCT04495283|530251649|FG002|Overall Study|Physician Decision|1|||
147024269|NCT04495283|530251647|FG000|Overall Study|Withdrawal by Subject|0|||
147024270|NCT04495283|530251648|FG001|Overall Study|Withdrawal by Subject|1|||
147024271|NCT04495283|530251649|FG002|Overall Study|Withdrawal by Subject|1|||
147024272|NCT04495283|530251647|FG000|Overall Study|Other|1|||
147024273|NCT04495283|530251648|FG001|Overall Study|Other|0|||
147024274|NCT04495283|530251649|FG002|Overall Study|Other|1|||
147024275|NCT02091141|530251650|FG000|Overall Study|Death|280|||
147024276|NCT02091141|530251651|FG001|Overall Study|Death|118|||
147024277|NCT02091141|530251652|FG002|Overall Study|Death|46|||
147024278|NCT02091141|530251653|FG003|Overall Study|Death|13|||
147024279|NCT02091141|530251654|FG004|Overall Study|Death|31|||
147024280|NCT02091141|530251655|FG005|Overall Study|Death|16|||
147024281|NCT02091141|530251656|FG006|Overall Study|Death|12|||
146849411|NCT00266227|529618822|FG001|Initial Treatment|Adverse Event|0|||
146849412|NCT00266227|529618823|FG002|Initial Treatment|Adverse Event|13|||
146849413|NCT00266227|529618821|FG000|Initial Treatment|Lost to Follow-up|0|||
146849414|NCT00266227|529618822|FG001|Initial Treatment|Lost to Follow-up|0|||
146849415|NCT00266227|529618823|FG002|Initial Treatment|Lost to Follow-up|6|||
146849416|NCT00266227|529618821|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
147024282|NCT02091141|530251650|FG000|Overall Study|Withdrawal by Subject|21|||
147024283|NCT02091141|530251651|FG001|Overall Study|Withdrawal by Subject|13|||
147024284|NCT02091141|530251652|FG002|Overall Study|Withdrawal by Subject|3|||
147024285|NCT02091141|530251653|FG003|Overall Study|Withdrawal by Subject|2|||
147024286|NCT02091141|530251654|FG004|Overall Study|Withdrawal by Subject|2|||
147024287|NCT02091141|530251655|FG005|Overall Study|Withdrawal by Subject|3|||
147024288|NCT02091141|530251656|FG006|Overall Study|Withdrawal by Subject|0|||
147024289|NCT02091141|530251650|FG000|Overall Study|Lost to Follow-up|21|||
147024290|NCT02091141|530251651|FG001|Overall Study|Lost to Follow-up|5|||
147024291|NCT02091141|530251652|FG002|Overall Study|Lost to Follow-up|1|||
147024292|NCT02091141|530251653|FG003|Overall Study|Lost to Follow-up|0|||
147024293|NCT02091141|530251654|FG004|Overall Study|Lost to Follow-up|1|||
147024294|NCT02091141|530251655|FG005|Overall Study|Lost to Follow-up|2|||
147024295|NCT02091141|530251656|FG006|Overall Study|Lost to Follow-up|0|||
147024296|NCT02091141|530251650|FG000|Overall Study|Reason Not Specified|6|||
147024297|NCT02091141|530251651|FG001|Overall Study|Reason Not Specified|5|||
147024298|NCT02091141|530251652|FG002|Overall Study|Reason Not Specified|2|||
147024299|NCT02091141|530251653|FG003|Overall Study|Reason Not Specified|0|||
147024300|NCT02091141|530251654|FG004|Overall Study|Reason Not Specified|0|||
147024301|NCT02091141|530251655|FG005|Overall Study|Reason Not Specified|0|||
147024302|NCT02091141|530251656|FG006|Overall Study|Reason Not Specified|1|||
147024303|NCT02091141|530251650|FG000|Overall Study|Study Ended by Sponsor|1|||
147024304|NCT02091141|530251651|FG001|Overall Study|Study Ended by Sponsor|9|||
147024305|NCT02091141|530251652|FG002|Overall Study|Study Ended by Sponsor|0|||
147024306|NCT02091141|530251653|FG003|Overall Study|Study Ended by Sponsor|0|||
147024307|NCT02091141|530251654|FG004|Overall Study|Study Ended by Sponsor|0|||
147024308|NCT02091141|530251655|FG005|Overall Study|Study Ended by Sponsor|0|||
147024309|NCT02091141|530251656|FG006|Overall Study|Study Ended by Sponsor|0|||
147024310|NCT02091141|530251650|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
147024311|NCT02091141|530251651|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
147024312|NCT02091141|530251652|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
147024313|NCT02091141|530251653|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
147024314|NCT02091141|530251654|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
147024315|NCT02091141|530251655|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
147024316|NCT02091141|530251656|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
147024317|NCT02712333|530251661|FG000|First Period|Withdrawal by Subject|3|||
147024318|NCT02712333|530251662|FG001|First Period|Withdrawal by Subject|2|||
147024319|NCT02278718|530251663|FG000|Overall Study|Adverse Event|1|||
147024320|NCT02278718|530251664|FG001|Overall Study|Adverse Event|0|||
147024321|NCT02278718|530251663|FG000|Overall Study|Lost to Follow-up|2|||
147024322|NCT02278718|530251664|FG001|Overall Study|Lost to Follow-up|4|||
147024323|NCT02278718|530251663|FG000|Overall Study|Withdrawal by Subject|1|||
147024324|NCT02278718|530251664|FG001|Overall Study|Withdrawal by Subject|4|||
147024325|NCT02278718|530251663|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
147024326|NCT02278718|530251664|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
147024327|NCT02278718|530251663|FG000|Overall Study|Missing|0|||
147024328|NCT02278718|530251664|FG001|Overall Study|Missing|1|||
147024329|NCT03212794|530251665|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
147024330|NCT03212794|530251666|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
147024331|NCT03212794|530251665|FG000|Overall Study|Lost to Follow-up|5|||
147024332|NCT03212794|530251666|FG001|Overall Study|Lost to Follow-up|6|||
147024333|NCT03212794|530251665|FG000|Overall Study|Incarcerated; unable to participate|2|||
147024334|NCT03212794|530251666|FG001|Overall Study|Incarcerated; unable to participate|0|||
147024335|NCT03212794|530251665|FG000|Overall Study|Withdrawal by Subject|1|||
147024336|NCT03212794|530251666|FG001|Overall Study|Withdrawal by Subject|0|||
147024337|NCT03212794|530251665|FG000|Overall Study|Death|0|||
147024338|NCT03212794|530251666|FG001|Overall Study|Death|1|||
147024339|NCT03212794|530251665|FG000|Overall Study|Found to be ineligible after allocation|0|||
147024340|NCT03212794|530251666|FG001|Overall Study|Found to be ineligible after allocation|1|||
147024341|NCT03212794|530251665|FG000|Overall Study|Relocated out of area|2|||
147024342|NCT03212794|530251666|FG001|Overall Study|Relocated out of area|0|||
147024343|NCT00897949|530251667|FG000|Overall Study|Adverse Event|1|||
147024344|NCT00897949|530251668|FG001|Overall Study|Adverse Event|1|||
147024345|NCT00897949|530251669|FG002|Overall Study|Adverse Event|0|||
147024346|NCT00897949|530251667|FG000|Overall Study|Lost to Follow-up|0|||
147024347|NCT00897949|530251668|FG001|Overall Study|Lost to Follow-up|2|||
147024348|NCT00897949|530251669|FG002|Overall Study|Lost to Follow-up|1|||
147024349|NCT00897949|530251667|FG000|Overall Study|Protocol Violation|6|||
146849417|NCT00266227|529618822|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
147024350|NCT00897949|530251668|FG001|Overall Study|Protocol Violation|3|||
147024351|NCT00897949|530251669|FG002|Overall Study|Protocol Violation|1|||
147024352|NCT00897949|530251667|FG000|Overall Study|Withdrawal by Subject|1|||
147024353|NCT00897949|530251668|FG001|Overall Study|Withdrawal by Subject|2|||
147024354|NCT00897949|530251669|FG002|Overall Study|Withdrawal by Subject|0|||
147024355|NCT00897949|530251667|FG000|Overall Study|Patient Uncoorperative|0|||
147024356|NCT00897949|530251668|FG001|Overall Study|Patient Uncoorperative|2|||
147024357|NCT00897949|530251669|FG002|Overall Study|Patient Uncoorperative|1|||
147024358|NCT00897949|530251667|FG000|Overall Study|Lost to Follow-up|30|||
147024359|NCT00897949|530251668|FG001|Overall Study|Lost to Follow-up|23|||
147024360|NCT00897949|530251669|FG002|Overall Study|Lost to Follow-up|17|||
147024361|NCT00897949|530251667|FG000|Overall Study|Withdrawal by Subject|24|||
147024362|NCT00897949|530251668|FG001|Overall Study|Withdrawal by Subject|31|||
147024363|NCT00897949|530251669|FG002|Overall Study|Withdrawal by Subject|17|||
147024364|NCT00897949|530251667|FG000|Overall Study|Abnormal Prestudy Labs|2|||
147024365|NCT00897949|530251668|FG001|Overall Study|Abnormal Prestudy Labs|3|||
147024366|NCT00897949|530251669|FG002|Overall Study|Abnormal Prestudy Labs|4|||
147024367|NCT00897949|530251667|FG000|Overall Study|Abnormal Baseline ECG|2|||
147024368|NCT00897949|530251668|FG001|Overall Study|Abnormal Baseline ECG|2|||
147024369|NCT00897949|530251669|FG002|Overall Study|Abnormal Baseline ECG|4|||
147024370|NCT00897949|530251667|FG000|Overall Study|Need for Concom. Med.|0|||
147024371|NCT00897949|530251668|FG001|Overall Study|Need for Concom. Med.|1|||
147024372|NCT00897949|530251669|FG002|Overall Study|Need for Concom. Med.|1|||
147024373|NCT00897949|530251667|FG000|Overall Study|Lack of Migraine Attack|29|||
147024374|NCT00897949|530251668|FG001|Overall Study|Lack of Migraine Attack|30|||
147024375|NCT00897949|530251669|FG002|Overall Study|Lack of Migraine Attack|19|||
147024376|NCT00897949|530251667|FG000|Overall Study|Did not take study drug|9|||
147024377|NCT00897949|530251668|FG001|Overall Study|Did not take study drug|3|||
147024378|NCT00897949|530251669|FG002|Overall Study|Did not take study drug|4|||
147024379|NCT01763918|530251670|FG000|Overall Study|Withdrawal by Subject|2|||
147024380|NCT01763918|530251671|FG001|Overall Study|Withdrawal by Subject|1|||
147024381|NCT01763918|530251672|FG002|Overall Study|Withdrawal by Subject|1|||
147024382|NCT01763918|530251673|FG003|Overall Study|Withdrawal by Subject|2|||
147024383|NCT01763918|530251670|FG000|Overall Study|Sponsor Decision|4|||
147024384|NCT01763918|530251671|FG001|Overall Study|Sponsor Decision|0|||
147024385|NCT01763918|530251672|FG002|Overall Study|Sponsor Decision|9|||
147024386|NCT01763918|530251673|FG003|Overall Study|Sponsor Decision|0|||
147024387|NCT01553747|530251674|FG000|Overall Study|Protocol Violation|0|||
147024388|NCT01553747|530251675|FG001|Overall Study|Protocol Violation|2|||
147024389|NCT01553747|530251676|FG002|Overall Study|Protocol Violation|0|||
147024390|NCT01553747|530251674|FG000|Overall Study|Voluntarily withdrew|70|||
147024391|NCT01553747|530251675|FG001|Overall Study|Voluntarily withdrew|66|||
147024392|NCT01553747|530251676|FG002|Overall Study|Voluntarily withdrew|74|||
147024393|NCT01553747|530251674|FG000|Overall Study|Adverse event or SAE|32|||
147024394|NCT01553747|530251675|FG001|Overall Study|Adverse event or SAE|28|||
147024395|NCT01553747|530251676|FG002|Overall Study|Adverse event or SAE|19|||
147024396|NCT01553747|530251674|FG000|Overall Study|Physician decision: other|10|||
147024397|NCT01553747|530251675|FG001|Overall Study|Physician decision: other|8|||
147024398|NCT01553747|530251676|FG002|Overall Study|Physician decision: other|7|||
147024399|NCT01553747|530251674|FG000|Overall Study|Lost to Follow-up|11|||
147024400|NCT01553747|530251675|FG001|Overall Study|Lost to Follow-up|5|||
147024401|NCT01553747|530251676|FG002|Overall Study|Lost to Follow-up|6|||
147024402|NCT01553747|530251674|FG000|Overall Study|Sponsor decision, specify|7|||
147024403|NCT01553747|530251675|FG001|Overall Study|Sponsor decision, specify|5|||
147024404|NCT01553747|530251676|FG002|Overall Study|Sponsor decision, specify|0|||
147024405|NCT01553747|530251674|FG000|Overall Study|Physician decision: lack of efficacy|1|||
147024406|NCT01553747|530251675|FG001|Overall Study|Physician decision: lack of efficacy|5|||
147024407|NCT01553747|530251676|FG002|Overall Study|Physician decision: lack of efficacy|3|||
147024408|NCT03253744|530251678|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
147024409|NCT03253744|530251679|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
147024410|NCT03253744|530251680|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
146849418|NCT00266227|529618823|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
146849419|NCT00266227|529618821|FG000|Initial Treatment|Physician decision to withdraw|0|||
146849420|NCT00266227|529618822|FG001|Initial Treatment|Physician decision to withdraw|0|||
146849421|NCT00266227|529618823|FG002|Initial Treatment|Physician decision to withdraw|12|||
146849422|NCT00266227|529618821|FG000|Initial Treatment|Pregnancy|0|||
146849423|NCT00266227|529618822|FG001|Initial Treatment|Pregnancy|0|||
147024411|NCT03253744|530251681|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
147024412|NCT02408120|530251682|FG000|Overall Study|Withdrawal by Subject|0|||
147024413|NCT02408120|530251683|FG001|Overall Study|Withdrawal by Subject|1|||
147024414|NCT02408120|530251682|FG000|Overall Study|Treatment Refusal|1|||
147024415|NCT02408120|530251683|FG001|Overall Study|Treatment Refusal|0|||
147024416|NCT02408120|530251682|FG000|Overall Study|Received Steroids|1|||
147024417|NCT02408120|530251683|FG001|Overall Study|Received Steroids|1|||
146849424|NCT00266227|529618823|FG002|Initial Treatment|Pregnancy|1|||
147024418|NCT02408120|530251682|FG000|Overall Study|Discharged same day|1|||
147024419|NCT02408120|530251683|FG001|Overall Study|Discharged same day|1|||
147024420|NCT02408120|530251682|FG000|Overall Study|Did not receive insulin|1|||
147024421|NCT02408120|530251683|FG001|Overall Study|Did not receive insulin|2|||
147024422|NCT01134627|530251684|FG000|Overall Study|Adverse Event|47|||
146849425|NCT00266227|529618821|FG000|Retreatment: Up to Week 48|Death|1|||
147024423|NCT01134627|530251685|FG001|Overall Study|Adverse Event|31|||
147024424|NCT01134627|530251684|FG000|Overall Study|Lost to Follow-up|1|||
147024425|NCT01134627|530251685|FG001|Overall Study|Lost to Follow-up|2|||
147024426|NCT01134627|530251684|FG000|Overall Study|Protocol Violation|3|||
147024427|NCT01134627|530251685|FG001|Overall Study|Protocol Violation|5|||
147024428|NCT01134627|530251684|FG000|Overall Study|Lack of Efficacy|2|||
147024429|NCT01134627|530251685|FG001|Overall Study|Lack of Efficacy|12|||
147024430|NCT01134627|530251684|FG000|Overall Study|Withdrawal by Subject|4|||
147024431|NCT01134627|530251685|FG001|Overall Study|Withdrawal by Subject|3|||
147024432|NCT01134627|530251684|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
147024433|NCT01134627|530251685|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
147024434|NCT01134627|530251684|FG000|Overall Study|Other|11|||
147024435|NCT01134627|530251685|FG001|Overall Study|Other|14|||
147024436|NCT00977431|530251691|FG000|Overall Study|Other than listed|1|||
147024437|NCT00977431|530251692|FG001|Overall Study|Other than listed|0|||
147024438|NCT00977431|530251693|FG002|Overall Study|Other than listed|0|||
147024439|NCT00977431|530251694|FG003|Overall Study|Other than listed|0|||
147024440|NCT00977431|530251695|FG004|Overall Study|Other than listed|2|||
147024441|NCT00977431|530251691|FG000|Overall Study|Protocol Violation|0|||
147024442|NCT00977431|530251692|FG001|Overall Study|Protocol Violation|0|||
147024443|NCT00977431|530251693|FG002|Overall Study|Protocol Violation|1|||
147024444|NCT00977431|530251694|FG003|Overall Study|Protocol Violation|0|||
147024445|NCT00977431|530251695|FG004|Overall Study|Protocol Violation|0|||
147024446|NCT00977431|530251691|FG000|Overall Study|Adverse Event|3|||
147024447|NCT00977431|530251692|FG001|Overall Study|Adverse Event|0|||
147024448|NCT00977431|530251693|FG002|Overall Study|Adverse Event|4|||
147024449|NCT00977431|530251694|FG003|Overall Study|Adverse Event|0|||
147024450|NCT00977431|530251695|FG004|Overall Study|Adverse Event|6|||
147024451|NCT00977431|530251691|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
147024452|NCT00977431|530251692|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
147024453|NCT00977431|530251693|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
147024454|NCT00977431|530251694|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
147024455|NCT00977431|530251695|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
147024456|NCT00977431|530251691|FG000|Overall Study|Progressive disease|2|||
147024457|NCT00977431|530251692|FG001|Overall Study|Progressive disease|6|||
147024458|NCT00977431|530251693|FG002|Overall Study|Progressive disease|1|||
147024459|NCT00977431|530251694|FG003|Overall Study|Progressive disease|3|||
147024460|NCT00977431|530251695|FG004|Overall Study|Progressive disease|5|||
147024461|NCT03739138|530251702|FG000|Overall Study|Death|0|||
147024462|NCT03739138|530251703|FG001|Overall Study|Death|7|||
147024463|NCT03739138|530251704|FG002|Overall Study|Death|4|||
147024464|NCT03739138|530251705|FG003|Overall Study|Death|13|||
147024465|NCT03739138|530251706|FG004|Overall Study|Death|0|||
147024466|NCT03739138|530251702|FG000|Overall Study|Lost to Follow-up|0|||
147024467|NCT03739138|530251703|FG001|Overall Study|Lost to Follow-up|0|||
147024468|NCT03739138|530251704|FG002|Overall Study|Lost to Follow-up|1|||
147024469|NCT03739138|530251705|FG003|Overall Study|Lost to Follow-up|0|||
147024470|NCT03739138|530251706|FG004|Overall Study|Lost to Follow-up|0|||
147024471|NCT03739138|530251702|FG000|Overall Study|Study Terminated By Sponsor|0|||
147024472|NCT03739138|530251703|FG001|Overall Study|Study Terminated By Sponsor|0|||
147024473|NCT03739138|530251704|FG002|Overall Study|Study Terminated By Sponsor|0|||
147024474|NCT03739138|530251705|FG003|Overall Study|Study Terminated By Sponsor|4|||
147024475|NCT03739138|530251706|FG004|Overall Study|Study Terminated By Sponsor|0|||
147024476|NCT03739138|530251702|FG000|Overall Study|Withdrawal by Subject|0|||
147024477|NCT03739138|530251703|FG001|Overall Study|Withdrawal by Subject|0|||
147024478|NCT03739138|530251704|FG002|Overall Study|Withdrawal by Subject|0|||
147024479|NCT03739138|530251705|FG003|Overall Study|Withdrawal by Subject|1|||
147024480|NCT03739138|530251706|FG004|Overall Study|Withdrawal by Subject|0|||
147024481|NCT00518882|530251709|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
147024482|NCT00518882|530251710|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
147024483|NCT00518882|530251709|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
147024484|NCT00518882|530251710|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
147024485|NCT00518882|530251709|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
147024486|NCT00518882|530251710|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
147024487|NCT00518882|530251709|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
147024488|NCT00518882|530251710|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
147024489|NCT00518882|530251709|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
147024490|NCT00518882|530251710|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
146849426|NCT00266227|529618822|FG001|Retreatment: Up to Week 48|Death|0|||
146849427|NCT00266227|529618823|FG002|Retreatment: Up to Week 48|Death|0|||
146849428|NCT00266227|529618821|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
147024491|NCT00518882|530251709|FG000|Double-Blind, Week 0-26|Subject decision|1|||
147024492|NCT00518882|530251710|FG001|Double-Blind, Week 0-26|Subject decision|1|||
147024493|NCT00518882|530251709|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
147024494|NCT00518882|530251710|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
147024495|NCT00518882|530251709|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
147024496|NCT00518882|530251710|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
147024497|NCT00518882|530251709|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
147024498|NCT00518882|530251710|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
147024499|NCT00518882|530251709|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
147024500|NCT00518882|530251710|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
147024501|NCT00518882|530251709|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
147024502|NCT00518882|530251710|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
147024503|NCT00518882|530251709|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
147024504|NCT00518882|530251710|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
147024505|NCT00518882|530251709|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
147024506|NCT00518882|530251710|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
147024507|NCT00518882|530251709|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
147024508|NCT00518882|530251710|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
147024509|NCT00518882|530251709|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
147024510|NCT00518882|530251710|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
147024511|NCT00518882|530251709|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
147024512|NCT00518882|530251710|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
147024513|NCT00518882|530251709|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
147024514|NCT00518882|530251710|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
147024515|NCT00518882|530251709|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
147024516|NCT00518882|530251710|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
147024517|NCT00518882|530251709|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
147024518|NCT00518882|530251710|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
147024519|NCT00518882|530251709|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
147024520|NCT00518882|530251710|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
147024521|NCT00518882|530251709|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
147024522|NCT00518882|530251710|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
147024523|NCT00518882|530251709|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
147024524|NCT00518882|530251710|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
147024525|NCT00518882|530251709|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
147024526|NCT00518882|530251710|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
147024527|NCT00518882|530251709|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
147024528|NCT00518882|530251710|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
147024529|NCT02696031|530251712|FG000|Up to Week 24|Adverse Event|2|||
147024530|NCT02696031|530251713|FG001|Up to Week 24|Adverse Event|4|||
147024531|NCT02696031|530251714|FG002|Up to Week 24|Adverse Event|2|||
147024532|NCT02696031|530251715|FG003|Up to Week 24|Adverse Event|0|||
147024533|NCT02696031|530251716|FG004|Up to Week 24|Adverse Event|0|||
147024534|NCT02696031|530251717|FG005|Up to Week 24|Adverse Event|0|||
147024535|NCT02696031|530251712|FG000|Up to Week 24|Lack of Efficacy|2|||
147024536|NCT02696031|530251713|FG001|Up to Week 24|Lack of Efficacy|1|||
147024537|NCT02696031|530251714|FG002|Up to Week 24|Lack of Efficacy|2|||
147024538|NCT02696031|530251715|FG003|Up to Week 24|Lack of Efficacy|0|||
147024539|NCT02696031|530251716|FG004|Up to Week 24|Lack of Efficacy|0|||
147024540|NCT02696031|530251717|FG005|Up to Week 24|Lack of Efficacy|0|||
147024541|NCT02696031|530251712|FG000|Up to Week 24|Lost to Follow-up|0|||
147024542|NCT02696031|530251713|FG001|Up to Week 24|Lost to Follow-up|1|||
147024543|NCT02696031|530251714|FG002|Up to Week 24|Lost to Follow-up|1|||
147024544|NCT02696031|530251715|FG003|Up to Week 24|Lost to Follow-up|0|||
147024545|NCT02696031|530251716|FG004|Up to Week 24|Lost to Follow-up|0|||
147024546|NCT02696031|530251717|FG005|Up to Week 24|Lost to Follow-up|0|||
147024547|NCT02696031|530251712|FG000|Up to Week 24|Physician Decision|1|||
147024548|NCT02696031|530251713|FG001|Up to Week 24|Physician Decision|0|||
147024549|NCT02696031|530251714|FG002|Up to Week 24|Physician Decision|1|||
147024550|NCT02696031|530251715|FG003|Up to Week 24|Physician Decision|0|||
147024551|NCT02696031|530251716|FG004|Up to Week 24|Physician Decision|0|||
147024552|NCT02696031|530251717|FG005|Up to Week 24|Physician Decision|0|||
147024553|NCT02696031|530251712|FG000|Up to Week 24|Protocol Violation|1|||
147024554|NCT02696031|530251713|FG001|Up to Week 24|Protocol Violation|0|||
147024555|NCT02696031|530251714|FG002|Up to Week 24|Protocol Violation|0|||
147024556|NCT02696031|530251715|FG003|Up to Week 24|Protocol Violation|0|||
147024557|NCT02696031|530251716|FG004|Up to Week 24|Protocol Violation|0|||
147024558|NCT02696031|530251717|FG005|Up to Week 24|Protocol Violation|0|||
147024559|NCT02696031|530251712|FG000|Up to Week 24|Withdrawal by Subject|4|||
147024560|NCT02696031|530251713|FG001|Up to Week 24|Withdrawal by Subject|1|||
147024561|NCT02696031|530251714|FG002|Up to Week 24|Withdrawal by Subject|5|||
147024562|NCT02696031|530251715|FG003|Up to Week 24|Withdrawal by Subject|0|||
147024563|NCT02696031|530251716|FG004|Up to Week 24|Withdrawal by Subject|0|||
147024564|NCT02696031|530251717|FG005|Up to Week 24|Withdrawal by Subject|0|||
147024565|NCT02696031|530251712|FG000|Up to Week 52|Adverse Event|4|||
147024566|NCT02696031|530251713|FG001|Up to Week 52|Adverse Event|5|||
147024567|NCT02696031|530251714|FG002|Up to Week 52|Adverse Event|3|||
147024568|NCT02696031|530251715|FG003|Up to Week 52|Adverse Event|0|||
147024569|NCT02696031|530251716|FG004|Up to Week 52|Adverse Event|0|||
147024570|NCT02696031|530251717|FG005|Up to Week 52|Adverse Event|0|||
147024571|NCT02696031|530251712|FG000|Up to Week 52|Lack of Efficacy|10|||
147024572|NCT02696031|530251713|FG001|Up to Week 52|Lack of Efficacy|7|||
147024573|NCT02696031|530251714|FG002|Up to Week 52|Lack of Efficacy|11|||
147024574|NCT02696031|530251715|FG003|Up to Week 52|Lack of Efficacy|0|||
147024575|NCT02696031|530251716|FG004|Up to Week 52|Lack of Efficacy|0|||
147024576|NCT02696031|530251717|FG005|Up to Week 52|Lack of Efficacy|0|||
147024577|NCT02696031|530251712|FG000|Up to Week 52|Lost to Follow-up|1|||
147024578|NCT02696031|530251713|FG001|Up to Week 52|Lost to Follow-up|1|||
147024579|NCT02696031|530251714|FG002|Up to Week 52|Lost to Follow-up|1|||
147024580|NCT02696031|530251715|FG003|Up to Week 52|Lost to Follow-up|0|||
147024581|NCT02696031|530251716|FG004|Up to Week 52|Lost to Follow-up|0|||
147024582|NCT02696031|530251717|FG005|Up to Week 52|Lost to Follow-up|0|||
147024583|NCT02696031|530251712|FG000|Up to Week 52|Physician Decision|1|||
147024584|NCT02696031|530251713|FG001|Up to Week 52|Physician Decision|1|||
147024585|NCT02696031|530251714|FG002|Up to Week 52|Physician Decision|2|||
147024586|NCT02696031|530251715|FG003|Up to Week 52|Physician Decision|0|||
147024587|NCT02696031|530251716|FG004|Up to Week 52|Physician Decision|0|||
147024588|NCT02696031|530251717|FG005|Up to Week 52|Physician Decision|0|||
147024589|NCT02696031|530251712|FG000|Up to Week 52|Pregnancy|0|||
147024590|NCT02696031|530251713|FG001|Up to Week 52|Pregnancy|2|||
147024591|NCT02696031|530251714|FG002|Up to Week 52|Pregnancy|0|||
147024592|NCT02696031|530251715|FG003|Up to Week 52|Pregnancy|0|||
147024593|NCT02696031|530251716|FG004|Up to Week 52|Pregnancy|0|||
147024594|NCT02696031|530251717|FG005|Up to Week 52|Pregnancy|0|||
147024595|NCT02696031|530251712|FG000|Up to Week 52|Protocol Violation|1|||
147024596|NCT02696031|530251713|FG001|Up to Week 52|Protocol Violation|0|||
147024597|NCT02696031|530251714|FG002|Up to Week 52|Protocol Violation|0|||
147024598|NCT02696031|530251715|FG003|Up to Week 52|Protocol Violation|0|||
147024599|NCT02696031|530251716|FG004|Up to Week 52|Protocol Violation|0|||
147024600|NCT02696031|530251717|FG005|Up to Week 52|Protocol Violation|0|||
147024601|NCT02696031|530251712|FG000|Up to Week 52|Withdrawal by Subject|12|||
147024602|NCT02696031|530251713|FG001|Up to Week 52|Withdrawal by Subject|3|||
147024603|NCT02696031|530251714|FG002|Up to Week 52|Withdrawal by Subject|9|||
147024604|NCT02696031|530251715|FG003|Up to Week 52|Withdrawal by Subject|0|||
147024605|NCT02696031|530251716|FG004|Up to Week 52|Withdrawal by Subject|0|||
147024606|NCT02696031|530251717|FG005|Up to Week 52|Withdrawal by Subject|0|||
147024607|NCT02696031|530251712|FG000|Up to Week 104|Pregnancy|0|||
147024608|NCT02696031|530251713|FG001|Up to Week 104|Pregnancy|2|||
147024609|NCT02696031|530251714|FG002|Up to Week 104|Pregnancy|1|||
147024610|NCT02696031|530251715|FG003|Up to Week 104|Pregnancy|0|||
147024611|NCT02696031|530251716|FG004|Up to Week 104|Pregnancy|0|||
147024612|NCT02696031|530251717|FG005|Up to Week 104|Pregnancy|0|||
147024613|NCT02696031|530251712|FG000|Up to Week 104|Withdrawal by Subject|15|||
147024614|NCT02696031|530251713|FG001|Up to Week 104|Withdrawal by Subject|10|||
147024615|NCT02696031|530251714|FG002|Up to Week 104|Withdrawal by Subject|16|||
147024616|NCT02696031|530251715|FG003|Up to Week 104|Withdrawal by Subject|0|||
147024617|NCT02696031|530251716|FG004|Up to Week 104|Withdrawal by Subject|0|||
147024618|NCT02696031|530251717|FG005|Up to Week 104|Withdrawal by Subject|0|||
147024619|NCT02696031|530251712|FG000|Up to Week 104|Protocol Violation|1|||
147024620|NCT02696031|530251713|FG001|Up to Week 104|Protocol Violation|0|||
147024621|NCT02696031|530251714|FG002|Up to Week 104|Protocol Violation|0|||
147024622|NCT02696031|530251715|FG003|Up to Week 104|Protocol Violation|0|||
147024623|NCT02696031|530251716|FG004|Up to Week 104|Protocol Violation|0|||
147024624|NCT02696031|530251717|FG005|Up to Week 104|Protocol Violation|0|||
147024625|NCT02696031|530251712|FG000|Up to Week 104|Physician Decision|1|||
147024626|NCT02696031|530251713|FG001|Up to Week 104|Physician Decision|2|||
147024627|NCT02696031|530251714|FG002|Up to Week 104|Physician Decision|3|||
147024628|NCT02696031|530251715|FG003|Up to Week 104|Physician Decision|0|||
147024629|NCT02696031|530251716|FG004|Up to Week 104|Physician Decision|0|||
147024630|NCT02696031|530251717|FG005|Up to Week 104|Physician Decision|0|||
147024631|NCT02696031|530251712|FG000|Up to Week 104|Lost to Follow-up|2|||
147024632|NCT02696031|530251713|FG001|Up to Week 104|Lost to Follow-up|3|||
147024633|NCT02696031|530251714|FG002|Up to Week 104|Lost to Follow-up|1|||
147024634|NCT02696031|530251715|FG003|Up to Week 104|Lost to Follow-up|0|||
147024635|NCT02696031|530251716|FG004|Up to Week 104|Lost to Follow-up|0|||
147024636|NCT02696031|530251717|FG005|Up to Week 104|Lost to Follow-up|0|||
147024637|NCT02696031|530251712|FG000|Up to Week 104|Lack of Efficacy|13|||
147024638|NCT02696031|530251713|FG001|Up to Week 104|Lack of Efficacy|12|||
147024639|NCT02696031|530251714|FG002|Up to Week 104|Lack of Efficacy|11|||
147024640|NCT02696031|530251715|FG003|Up to Week 104|Lack of Efficacy|0|||
147024641|NCT02696031|530251716|FG004|Up to Week 104|Lack of Efficacy|0|||
147024642|NCT02696031|530251717|FG005|Up to Week 104|Lack of Efficacy|0|||
147024643|NCT02696031|530251712|FG000|Up to Week 104|Adverse Event|7|||
147024644|NCT02696031|530251713|FG001|Up to Week 104|Adverse Event|11|||
147024645|NCT02696031|530251714|FG002|Up to Week 104|Adverse Event|5|||
147024646|NCT02696031|530251715|FG003|Up to Week 104|Adverse Event|0|||
147024647|NCT02696031|530251716|FG004|Up to Week 104|Adverse Event|0|||
147024648|NCT02696031|530251717|FG005|Up to Week 104|Adverse Event|0|||
147024649|NCT02696031|530251712|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
147024650|NCT02696031|530251713|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
147024651|NCT02696031|530251714|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
147024652|NCT02696031|530251715|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
147024653|NCT02696031|530251716|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
147024654|NCT02696031|530251717|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
147024655|NCT02696031|530251712|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
147024656|NCT02696031|530251713|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
147024657|NCT02696031|530251714|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
147024658|NCT02696031|530251715|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
147024659|NCT02696031|530251716|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
147024660|NCT02696031|530251717|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
147024661|NCT02696031|530251712|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
147024662|NCT02696031|530251713|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
147024663|NCT02696031|530251714|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
147024664|NCT02696031|530251715|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
147024665|NCT02696031|530251716|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
147024666|NCT02696031|530251717|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
147024667|NCT02696031|530251712|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
147024668|NCT02696031|530251713|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
147024669|NCT02696031|530251714|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
147024670|NCT02696031|530251715|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
147024671|NCT02696031|530251716|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
147024672|NCT02696031|530251717|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
147024673|NCT02696031|530251712|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
147024674|NCT02696031|530251713|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
147024675|NCT02696031|530251714|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
147024676|NCT02696031|530251715|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
147024677|NCT02696031|530251716|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
147024678|NCT02696031|530251717|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
147024679|NCT02696031|530251712|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
147024680|NCT02696031|530251713|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
147024681|NCT02696031|530251714|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
147024682|NCT02696031|530251715|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
147024683|NCT02696031|530251716|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
147024684|NCT02696031|530251717|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
147024685|NCT02696031|530251712|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
147024686|NCT02696031|530251713|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
147024687|NCT02696031|530251714|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
147024688|NCT02696031|530251715|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
147024689|NCT02696031|530251716|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
147024690|NCT02696031|530251717|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
147024691|NCT00597116|530251718|FG000|Overall Study|Adverse Event|2|||
147024692|NCT00597116|530251719|FG001|Overall Study|Adverse Event|1|||
147024693|NCT00597116|530251718|FG000|Overall Study|Withdrawal by Subject|0|||
147024694|NCT00597116|530251719|FG001|Overall Study|Withdrawal by Subject|2|||
147024695|NCT00597116|530251718|FG000|Overall Study|Physician Decision|0|||
147024696|NCT00597116|530251719|FG001|Overall Study|Physician Decision|1|||
147024697|NCT00597116|530251718|FG000|Overall Study|Death|0|||
147024698|NCT00597116|530251719|FG001|Overall Study|Death|1|||
147024699|NCT00597116|530251718|FG000|Overall Study|Lost to Follow-up|1|||
147024700|NCT00597116|530251719|FG001|Overall Study|Lost to Follow-up|0|||
147024701|NCT00597116|530251718|FG000|Overall Study|Progressive disease|11|||
147024702|NCT00597116|530251719|FG001|Overall Study|Progressive disease|6|||
147024703|NCT02903238|530251723|FG000|Overall Study|Lost to Follow-up|4|||
147024704|NCT00700817|530251728|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
147024705|NCT00700817|530251729|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
147024706|NCT00700817|530251730|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
147024707|NCT00700817|530251731|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
147024708|NCT00700817|530251732|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
147024709|NCT00700817|530251728|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
147024710|NCT00700817|530251729|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
147024711|NCT00700817|530251730|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
147024712|NCT00700817|530251731|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
147024713|NCT00700817|530251732|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
147024714|NCT00700817|530251728|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
147024715|NCT00700817|530251729|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
147024716|NCT00700817|530251730|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
147024717|NCT00700817|530251731|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
147024718|NCT00700817|530251732|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
147024719|NCT00700817|530251728|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
147024720|NCT00700817|530251729|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
147024721|NCT00700817|530251730|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
147024722|NCT00700817|530251731|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
147024723|NCT00700817|530251732|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
147024724|NCT00700817|530251728|FG000|Week 0-26 (Main Period)|Unclassified|14|||
147024725|NCT00700817|530251729|FG001|Week 0-26 (Main Period)|Unclassified|4|||
147024726|NCT00700817|530251730|FG002|Week 0-26 (Main Period)|Unclassified|8|||
147024727|NCT00700817|530251731|FG003|Week 0-26 (Main Period)|Unclassified|0|||
147024728|NCT00700817|530251732|FG004|Week 0-26 (Main Period)|Unclassified|0|||
147024729|NCT00700817|530251728|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
147024730|NCT00700817|530251729|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
147024731|NCT00700817|530251730|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
147024732|NCT00700817|530251731|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
147024733|NCT00700817|530251732|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
147024734|NCT00700817|530251728|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
147024735|NCT00700817|530251729|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
147024736|NCT00700817|530251730|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
147024737|NCT00700817|530251731|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
147024738|NCT00700817|530251732|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
147024739|NCT00700817|530251728|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
147024740|NCT00700817|530251729|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
147024741|NCT00700817|530251730|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
147024742|NCT00700817|530251731|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
147024743|NCT00700817|530251732|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
147024744|NCT00700817|530251728|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
146849429|NCT00266227|529618822|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
146849430|NCT00266227|529618823|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
146849431|NCT00266227|529618821|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
147024745|NCT00700817|530251729|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
147024746|NCT00700817|530251730|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
147024747|NCT00700817|530251731|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
147024748|NCT00700817|530251732|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
147024749|NCT00700817|530251728|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
147024750|NCT00700817|530251729|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
147024751|NCT00700817|530251730|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
147024752|NCT00700817|530251731|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
147024753|NCT00700817|530251732|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
147024754|NCT00700817|530251728|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
147024755|NCT00700817|530251729|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
147024756|NCT00700817|530251730|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
147024757|NCT00700817|530251731|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
147024758|NCT00700817|530251732|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
147024759|NCT00700817|530251728|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
147024760|NCT00700817|530251729|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
147024761|NCT00700817|530251730|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
147024762|NCT00700817|530251731|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
147024763|NCT00700817|530251732|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
147024764|NCT00700817|530251728|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
147024765|NCT00700817|530251729|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
147024766|NCT00700817|530251730|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
147024767|NCT00700817|530251731|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
147024768|NCT00700817|530251732|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
147024769|NCT00700817|530251728|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
147024770|NCT00700817|530251729|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
147024771|NCT00700817|530251730|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
147024772|NCT00700817|530251731|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
147024773|NCT00700817|530251732|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
147024774|NCT00700817|530251728|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
147024775|NCT00700817|530251729|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
147024776|NCT00700817|530251730|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
147024777|NCT00700817|530251731|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
147024778|NCT00700817|530251732|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
147024779|NCT02777918|530251735|FG000|Overall Study|Medical reasons|1|||
147024780|NCT02777918|530251736|FG001|Overall Study|Medical reasons|2|||
146849432|NCT00266227|529618822|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
147024781|NCT02777918|530251735|FG000|Overall Study|Too busy / stressed|1|||
147024782|NCT02777918|530251736|FG001|Overall Study|Too busy / stressed|1|||
147024783|NCT02777918|530251735|FG000|Overall Study|Withdrawal by Subject|1|||
147024784|NCT02777918|530251736|FG001|Overall Study|Withdrawal by Subject|1|||
147024785|NCT00058214|530251739|FG000|Overall Study|Adverse Event|1|||
147024786|NCT03856593|530251740|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
147024787|NCT03856593|530251741|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
147024788|NCT00049842|530251745|FG000|Treatment Phase|Adverse Event|47|||
147024789|NCT00049842|530251746|FG001|Treatment Phase|Adverse Event|12|||
147024790|NCT00049842|530251745|FG000|Treatment Phase|Withdrawal by Subject|35|||
147024791|NCT00049842|530251746|FG001|Treatment Phase|Withdrawal by Subject|46|||
147024792|NCT00049842|530251745|FG000|Treatment Phase|Non-compliance with protocol|7|||
147024793|NCT00049842|530251746|FG001|Treatment Phase|Non-compliance with protocol|8|||
147024794|NCT00049842|530251745|FG000|Treatment Phase|Lost to Follow-up|4|||
147024795|NCT00049842|530251746|FG001|Treatment Phase|Lost to Follow-up|8|||
147024796|NCT00049842|530251745|FG000|Treatment Phase|Administrative|0|||
147024797|NCT00049842|530251746|FG001|Treatment Phase|Administrative|3|||
147024798|NCT00049842|530251745|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
147024799|NCT00049842|530251746|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
147024800|NCT00049842|530251745|FG000|Follow-up Phase|Adverse Event|6|||
147024801|NCT00049842|530251746|FG001|Follow-up Phase|Adverse Event|1|||
147024802|NCT00049842|530251745|FG000|Follow-up Phase|Other|1|||
147024803|NCT00049842|530251746|FG001|Follow-up Phase|Other|4|||
147024804|NCT03977701|530251747|FG000|Overall Study|COVID-19 pandemic|0|||
147024805|NCT03977701|530251748|FG001|Overall Study|COVID-19 pandemic|0|||
147024806|NCT03977701|530251749|FG002|Overall Study|COVID-19 pandemic|0|||
147024807|NCT03977701|530251750|FG003|Overall Study|COVID-19 pandemic|0|||
147024808|NCT03977701|530251751|FG004|Overall Study|COVID-19 pandemic|0|||
147024809|NCT03977701|530251752|FG005|Overall Study|COVID-19 pandemic|1|||
147024810|NCT03977701|530251753|FG006|Overall Study|COVID-19 pandemic|0|||
147024811|NCT03977701|530251754|FG007|Overall Study|COVID-19 pandemic|1|||
147024812|NCT03977701|530251755|FG008|Overall Study|COVID-19 pandemic|0|||
147024813|NCT03977701|530251756|FG009|Overall Study|COVID-19 pandemic|0|||
147024814|NCT03545191|530251761|FG000|Overall Study|Death|1|||
147024815|NCT03545191|530251762|FG001|Overall Study|Death|0|||
147024816|NCT03545191|530251763|FG002|Overall Study|Death|0|||
147024817|NCT03545191|530251761|FG000|Overall Study|Adverse Event|4|||
147024818|NCT03545191|530251762|FG001|Overall Study|Adverse Event|2|||
147024819|NCT03545191|530251763|FG002|Overall Study|Adverse Event|7|||
147024820|NCT03545191|530251761|FG000|Overall Study|Other reasons|3|||
147024821|NCT03545191|530251762|FG001|Overall Study|Other reasons|11|||
147024822|NCT03545191|530251763|FG002|Overall Study|Other reasons|8|||
147024823|NCT03545191|530251761|FG000|Overall Study|Withdrawal by Subject|13|||
147024824|NCT03545191|530251762|FG001|Overall Study|Withdrawal by Subject|10|||
147024825|NCT03545191|530251763|FG002|Overall Study|Withdrawal by Subject|12|||
147024826|NCT03545191|530251761|FG000|Overall Study|Lost to Follow-up|1|||
147024827|NCT03545191|530251762|FG001|Overall Study|Lost to Follow-up|2|||
147024828|NCT03545191|530251763|FG002|Overall Study|Lost to Follow-up|3|||
147024829|NCT02025751|530251764|FG000|Overall Study|Lost to Follow-up|1|||
147024830|NCT02025751|530251765|FG001|Overall Study|Lost to Follow-up|0|||
147024831|NCT02025751|530251764|FG000|Overall Study|Adverse Event|0|||
147024832|NCT02025751|530251765|FG001|Overall Study|Adverse Event|1|||
147024833|NCT02025751|530251764|FG000|Overall Study|Physician Decision|0|||
147024834|NCT02025751|530251765|FG001|Overall Study|Physician Decision|1|||
147024835|NCT02025751|530251764|FG000|Overall Study|Withdrawal by Subject|0|||
147024836|NCT02025751|530251765|FG001|Overall Study|Withdrawal by Subject|1|||
147024837|NCT00653991|530251766|FG000|3 Month Follow-up|Participant would not respond|150|||
147024838|NCT00653991|530251767|FG001|3 Month Follow-up|Participant would not respond|157|||
147024839|NCT00653991|530251766|FG000|6 Month Follow-up|Participant would not respond|133|||
147024840|NCT00653991|530251767|FG001|6 Month Follow-up|Participant would not respond|141|||
147024841|NCT02340221|530251768|FG000|Overall Study|Death|100|||
147024842|NCT02340221|530251769|FG001|Overall Study|Death|197|||
147024843|NCT02340221|530251768|FG000|Overall Study|Withdrawal by Participant|24|||
147024844|NCT02340221|530251769|FG001|Overall Study|Withdrawal by Participant|37|||
147024845|NCT02340221|530251768|FG000|Overall Study|Lost to Follow-up|4|||
147024846|NCT02340221|530251769|FG001|Overall Study|Lost to Follow-up|15|||
147024847|NCT02340221|530251768|FG000|Overall Study|Reason Not Specified|85|||
147024848|NCT02340221|530251769|FG001|Overall Study|Reason Not Specified|165|||
147024849|NCT02340221|530251768|FG000|Overall Study|Study Terminated by Sponsor|1|||
147024850|NCT02340221|530251769|FG001|Overall Study|Study Terminated by Sponsor|3|||
147024851|NCT00518622|530251770|FG000|Overall Study|Lost to Follow-up|0|||
147024852|NCT00518622|530251771|FG001|Overall Study|Lost to Follow-up|0|||
147024853|NCT00518622|530251772|FG002|Overall Study|Lost to Follow-up|1|||
147024854|NCT00518622|530251773|FG003|Overall Study|Lost to Follow-up|0|||
147024855|NCT00518622|530251774|FG004|Overall Study|Lost to Follow-up|0|||
147024856|NCT00518622|530251775|FG005|Overall Study|Lost to Follow-up|0|||
147024857|NCT00518622|530251776|FG006|Overall Study|Lost to Follow-up|0|||
147024858|NCT00518622|530251777|FG007|Overall Study|Lost to Follow-up|0|||
147024859|NCT00518622|530251770|FG000|Overall Study|Study medication taken incorrectly|0|||
147024860|NCT00518622|530251771|FG001|Overall Study|Study medication taken incorrectly|1|||
147024861|NCT00518622|530251772|FG002|Overall Study|Study medication taken incorrectly|0|||
147024862|NCT00518622|530251773|FG003|Overall Study|Study medication taken incorrectly|0|||
147024863|NCT00518622|530251774|FG004|Overall Study|Study medication taken incorrectly|0|||
147024864|NCT00518622|530251775|FG005|Overall Study|Study medication taken incorrectly|0|||
147024865|NCT00518622|530251776|FG006|Overall Study|Study medication taken incorrectly|0|||
147024866|NCT00518622|530251777|FG007|Overall Study|Study medication taken incorrectly|0|||
147024867|NCT03487848|530251778|FG000|Overall Study|Lost to Follow-up|1|||
147024868|NCT02631876|530253436|FG000|Overall Study|Death|96|||
147024869|NCT02631876|530253437|FG001|Overall Study|Death|50|||
147024870|NCT02631876|530253436|FG000|Overall Study|Investigator's discretion|1|||
147024871|NCT02631876|530253437|FG001|Overall Study|Investigator's discretion|0|||
147024872|NCT02631876|530253436|FG000|Overall Study|Lost to Follow-up|2|||
147024873|NCT02631876|530253437|FG001|Overall Study|Lost to Follow-up|0|||
147024874|NCT02631876|530253436|FG000|Overall Study|Withdrawal by Subject|16|||
147024875|NCT02631876|530253437|FG001|Overall Study|Withdrawal by Subject|9|||
147024876|NCT02631876|530253436|FG000|Overall Study|Other than specified|4|||
147024877|NCT02631876|530253437|FG001|Overall Study|Other than specified|4|||
147024878|NCT01013649|530253440|FG000|First Step|Withdrawal by Subject|36|||
147024879|NCT01013649|530253441|FG001|First Step|Withdrawal by Subject|19|||
147024880|NCT01013649|530253442|FG002|First Step|Withdrawal by Subject|0|||
147024881|NCT01013649|530253443|FG003|First Step|Withdrawal by Subject|0|||
147024882|NCT01013649|530253440|FG000|First Step|Progression|58|||
147024883|NCT01013649|530253441|FG001|First Step|Progression|23|||
147024884|NCT01013649|530253442|FG002|First Step|Progression|0|||
147024885|NCT01013649|530253443|FG003|First Step|Progression|0|||
147024886|NCT01013649|530253440|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
147024887|NCT01013649|530253441|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
147024888|NCT01013649|530253442|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
147024889|NCT01013649|530253443|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
147024890|NCT01013649|530253440|FG000|First Step|Death|3|||
147024891|NCT01013649|530253441|FG001|First Step|Death|4|||
147024892|NCT01013649|530253442|FG002|First Step|Death|0|||
147024893|NCT01013649|530253443|FG003|First Step|Death|0|||
147024894|NCT01013649|530253440|FG000|First Step|Adverse Event|9|||
147024895|NCT01013649|530253441|FG001|First Step|Adverse Event|5|||
147024896|NCT01013649|530253442|FG002|First Step|Adverse Event|0|||
147024897|NCT01013649|530253443|FG003|First Step|Adverse Event|0|||
147024898|NCT01013649|530253440|FG000|First Step|Other|4|||
147024899|NCT01013649|530253441|FG001|First Step|Other|6|||
147024900|NCT01013649|530253442|FG002|First Step|Other|0|||
147024901|NCT01013649|530253443|FG003|First Step|Other|0|||
147024902|NCT04285567|530253444|FG000|Overall Study|Death|3|||
147024903|NCT04285567|530253445|FG001|Overall Study|Death|3|||
147024904|NCT04285567|530253444|FG000|Overall Study|Lost to Follow-up|1|||
147024905|NCT04285567|530253445|FG001|Overall Study|Lost to Follow-up|1|||
147024906|NCT04285567|530253444|FG000|Overall Study|Reason Not Specified|1|||
147024907|NCT04285567|530253445|FG001|Overall Study|Reason Not Specified|1|||
147024908|NCT04285567|530253444|FG000|Overall Study|Physician Decision|2|||
147024909|NCT04285567|530253445|FG001|Overall Study|Physician Decision|1|||
147024910|NCT04285567|530253444|FG000|Overall Study|Withdrawal by Subject|2|||
147024911|NCT04285567|530253445|FG001|Overall Study|Withdrawal by Subject|6|||
147024912|NCT04285567|530253444|FG000|Overall Study|Adverse Event|1|||
147024913|NCT04285567|530253445|FG001|Overall Study|Adverse Event|0|||
147024914|NCT04285567|530253444|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
147024915|NCT04285567|530253445|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
147024916|NCT04271735|530253446|FG000|Overall Study|Physician Decision|2|||
147024917|NCT04271735|530253447|FG001|Overall Study|Physician Decision|0|||
146849433|NCT00266227|529618823|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
146849434|NCT00266227|529618821|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
146849435|NCT00266227|529618822|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
146849436|NCT00266227|529618823|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
146849437|NCT00266227|529618821|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
146849438|NCT00266227|529618822|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
146849439|NCT00266227|529618823|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
146849440|NCT00266227|529618821|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
146849441|NCT00266227|529618822|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
146849442|NCT00266227|529618823|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
146849443|NCT00266227|529618821|FG000|Retreatment: Week 48 to Week 72|Death|1|||
147024918|NCT00515541|530253448|FG000|Overall Study|Physician Decision|0|||
147024919|NCT00515541|530253449|FG001|Overall Study|Physician Decision|2|||
146849444|NCT00266227|529618822|FG001|Retreatment: Week 48 to Week 72|Death|1|||
147024920|NCT00515541|530253450|FG002|Overall Study|Physician Decision|0|||
147024921|NCT00515541|530253451|FG003|Overall Study|Physician Decision|1|||
147024922|NCT00515541|530253448|FG000|Overall Study|No show for appointments|0|||
147024923|NCT00515541|530253449|FG001|Overall Study|No show for appointments|1|||
147024924|NCT00515541|530253450|FG002|Overall Study|No show for appointments|0|||
147024925|NCT00515541|530253451|FG003|Overall Study|No show for appointments|2|||
147024926|NCT00515541|530253448|FG000|Overall Study|Withdrawal by Subject|0|||
146849445|NCT00266227|529618823|FG002|Retreatment: Week 48 to Week 72|Death|0|||
146849446|NCT00266227|529618821|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
146849447|NCT00266227|529618822|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
146849448|NCT00266227|529618823|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
146849449|NCT00266227|529618821|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
146849450|NCT00266227|529618822|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
146849451|NCT00266227|529618823|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
146849452|NCT00266227|529618821|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
146849453|NCT00266227|529618822|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
146849454|NCT00266227|529618823|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
146849455|NCT00266227|529618821|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
146849456|NCT00266227|529618822|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
146849457|NCT00266227|529618823|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
146849458|NCT04343872|529618827|FG000|Overall Study|Lost to Follow-up|6|||
146849459|NCT04343872|529618828|FG001|Overall Study|Lost to Follow-up|3|||
146849460|NCT01850446|529618829|FG000|Overall Study|Lack of Efficacy|1|||
146849461|NCT01850446|529618830|FG001|Overall Study|Lack of Efficacy|0|||
146849462|NCT01850446|529618829|FG000|Overall Study|Withdrawal by Subject|4|||
146849463|NCT01850446|529618830|FG001|Overall Study|Withdrawal by Subject|0|||
146849464|NCT01850446|529618829|FG000|Overall Study|Protocol Violation|0|||
146849465|NCT01850446|529618830|FG001|Overall Study|Protocol Violation|2|||
146849466|NCT01290315|529618831|FG000|Overall Study|Adverse Event|0|||
146849467|NCT01290315|529618832|FG001|Overall Study|Adverse Event|0|||
146849468|NCT01290315|529618833|FG002|Overall Study|Adverse Event|0|||
146849469|NCT01290315|529618834|FG003|Overall Study|Adverse Event|3|||
146849470|NCT01290315|529618831|FG000|Overall Study|Selection criteria/compliance|2|||
146849471|NCT01290315|529618832|FG001|Overall Study|Selection criteria/compliance|1|||
146849472|NCT01290315|529618833|FG002|Overall Study|Selection criteria/compliance|0|||
146849473|NCT01290315|529618834|FG003|Overall Study|Selection criteria/compliance|2|||
146849474|NCT01290315|529618831|FG000|Overall Study|Lost to Follow-up|0|||
146849475|NCT01290315|529618832|FG001|Overall Study|Lost to Follow-up|1|||
146849476|NCT01290315|529618833|FG002|Overall Study|Lost to Follow-up|0|||
146849477|NCT01290315|529618834|FG003|Overall Study|Lost to Follow-up|0|||
146849478|NCT01290315|529618831|FG000|Overall Study|Withdrawal by Subject|1|||
146849479|NCT01290315|529618832|FG001|Overall Study|Withdrawal by Subject|1|||
146849480|NCT01290315|529618833|FG002|Overall Study|Withdrawal by Subject|0|||
146849481|NCT01290315|529618834|FG003|Overall Study|Withdrawal by Subject|0|||
146849482|NCT01658150|529618835|FG000|Overall Study|Withdrawal by Subject|1|||
146849483|NCT00621777|529618837|FG000|Open Phase|Adverse Event|20|||
146849484|NCT00621777|529618838|FG001|Open Phase|Adverse Event|0|||
146849485|NCT00621777|529618837|FG000|Open Phase|Did not abstain during open phase|56|||
146849486|NCT00621777|529618838|FG001|Open Phase|Did not abstain during open phase|0|||
146849487|NCT00621777|529618837|FG000|Open Phase|Withdrawal by Subject|17|||
146849488|NCT00621777|529618838|FG001|Open Phase|Withdrawal by Subject|0|||
147024927|NCT00515541|530253449|FG001|Overall Study|Withdrawal by Subject|2|||
147024928|NCT00515541|530253450|FG002|Overall Study|Withdrawal by Subject|0|||
147024929|NCT00515541|530253451|FG003|Overall Study|Withdrawal by Subject|2|||
147024930|NCT04268316|530253452|FG000|Overall Study|Withdrawal by Subject|2|||
147024931|NCT04268316|530253453|FG001|Overall Study|Withdrawal by Subject|1|||
147024932|NCT04268316|530253454|FG002|Overall Study|Withdrawal by Subject|0|||
147024933|NCT00931268|530253468|FG000|Overall Study|Lost to Follow-up|6|||
147024934|NCT02072148|530253470|FG000|Overall Study|withdrew prior to surgery|23|||
147024935|NCT02072148|530253471|FG001|Overall Study|withdrew prior to surgery|0|||
147024936|NCT02072148|530253472|FG002|Overall Study|withdrew prior to surgery|0|||
147024937|NCT02072148|530253470|FG000|Overall Study|Death|0|||
147024938|NCT02072148|530253471|FG001|Overall Study|Death|0|||
147024939|NCT02072148|530253472|FG002|Overall Study|Death|1|||
147024940|NCT02072148|530253470|FG000|Overall Study|Withdrawal by Subject|0|||
147024941|NCT02072148|530253471|FG001|Overall Study|Withdrawal by Subject|13|||
147024942|NCT02072148|530253472|FG002|Overall Study|Withdrawal by Subject|12|||
147024943|NCT00430495|530253473|FG000|Overall Study|Adverse Event|2|||
147024944|NCT00430495|530253474|FG001|Overall Study|Adverse Event|3|||
147024945|NCT00430495|530253475|FG002|Overall Study|Adverse Event|2|||
147024946|NCT00430495|530253476|FG003|Overall Study|Adverse Event|0|||
147024947|NCT00430495|530253473|FG000|Overall Study|Death|0|||
147024948|NCT00430495|530253474|FG001|Overall Study|Death|0|||
147024949|NCT00430495|530253475|FG002|Overall Study|Death|1|||
147024950|NCT00430495|530253476|FG003|Overall Study|Death|0|||
147024951|NCT00430495|530253473|FG000|Overall Study|Lost to Follow-up|0|||
146849489|NCT00621777|529618837|FG000|Open Phase|administrative|13|||
147024952|NCT00430495|530253474|FG001|Overall Study|Lost to Follow-up|1|||
147024953|NCT00430495|530253475|FG002|Overall Study|Lost to Follow-up|4|||
147024954|NCT00430495|530253476|FG003|Overall Study|Lost to Follow-up|0|||
147024955|NCT00430495|530253473|FG000|Overall Study|Protocol Violation|1|||
147024956|NCT00430495|530253474|FG001|Overall Study|Protocol Violation|0|||
147024957|NCT00430495|530253475|FG002|Overall Study|Protocol Violation|1|||
147024958|NCT00430495|530253476|FG003|Overall Study|Protocol Violation|0|||
147024959|NCT00430495|530253473|FG000|Overall Study|Disease Progression|1|||
147024960|NCT00430495|530253474|FG001|Overall Study|Disease Progression|1|||
147024961|NCT00430495|530253475|FG002|Overall Study|Disease Progression|0|||
147024962|NCT00430495|530253476|FG003|Overall Study|Disease Progression|0|||
147024963|NCT00430495|530253473|FG000|Overall Study|Other|8|||
147024964|NCT00430495|530253474|FG001|Overall Study|Other|2|||
147024965|NCT00430495|530253475|FG002|Overall Study|Other|5|||
147024966|NCT00430495|530253476|FG003|Overall Study|Other|4|||
147024967|NCT00430495|530253473|FG000|Overall Study|Randomized but not Treated|2|||
147024968|NCT00430495|530253474|FG001|Overall Study|Randomized but not Treated|0|||
147024969|NCT00430495|530253475|FG002|Overall Study|Randomized but not Treated|0|||
147024970|NCT00430495|530253476|FG003|Overall Study|Randomized but not Treated|0|||
147024971|NCT00158756|530253477|FG000|Overall Study|Withdrawal by Subject|5|||
147024972|NCT00158756|530253478|FG001|Overall Study|Withdrawal by Subject|0|||
147024973|NCT00158756|530253479|FG002|Overall Study|Withdrawal by Subject|6|||
147024974|NCT00158756|530253480|FG003|Overall Study|Withdrawal by Subject|1|||
147024975|NCT00158756|530253481|FG004|Overall Study|Withdrawal by Subject|3|||
147024976|NCT00158756|530253477|FG000|Overall Study|Adverse Event|0|||
147024977|NCT00158756|530253478|FG001|Overall Study|Adverse Event|0|||
147024978|NCT00158756|530253479|FG002|Overall Study|Adverse Event|1|||
147024979|NCT00158756|530253480|FG003|Overall Study|Adverse Event|0|||
147024980|NCT00158756|530253481|FG004|Overall Study|Adverse Event|0|||
147024981|NCT00158756|530253477|FG000|Overall Study|Serious adverse event|0|||
147024982|NCT00158756|530253478|FG001|Overall Study|Serious adverse event|0|||
147024983|NCT00158756|530253479|FG002|Overall Study|Serious adverse event|1|||
147024984|NCT00158756|530253480|FG003|Overall Study|Serious adverse event|0|||
147024985|NCT00158756|530253481|FG004|Overall Study|Serious adverse event|0|||
147024986|NCT02400671|530253482|FG000|Overall Study|Death|5|||
147024987|NCT02400671|530253483|FG001|Overall Study|Death|3|||
147024988|NCT02400671|530253484|FG002|Overall Study|Death|4|||
147024989|NCT02400671|530253482|FG000|Overall Study|Lost to Follow-up|20|||
147024990|NCT02400671|530253483|FG001|Overall Study|Lost to Follow-up|27|||
147024991|NCT02400671|530253484|FG002|Overall Study|Lost to Follow-up|24|||
147024992|NCT02400671|530253482|FG000|Overall Study|Withdrawal by Subject|2|||
147024993|NCT02400671|530253483|FG001|Overall Study|Withdrawal by Subject|2|||
147024994|NCT02400671|530253484|FG002|Overall Study|Withdrawal by Subject|0|||
147024995|NCT01421342|530253485|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
147024996|NCT01421342|530253486|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
147024997|NCT01421342|530253487|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
147024998|NCT01421342|530253485|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
147024999|NCT01421342|530253486|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
147025000|NCT01421342|530253487|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
147025001|NCT01421342|530253485|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
147025002|NCT01421342|530253486|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
147025003|NCT01421342|530253487|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
147025004|NCT01421342|530253485|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
147025005|NCT01421342|530253486|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
147025006|NCT01421342|530253487|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
147025007|NCT01421342|530253485|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
147025008|NCT01421342|530253486|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
147025009|NCT01421342|530253487|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
147025010|NCT01421342|530253485|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
147025011|NCT01421342|530253486|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
147025012|NCT01421342|530253487|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
147025013|NCT01421342|530253485|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
147025014|NCT01421342|530253486|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
147025015|NCT01421342|530253487|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
147025016|NCT01421342|530253485|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
147025017|NCT01421342|530253486|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
147025018|NCT01421342|530253487|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
147025019|NCT01421342|530253485|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
147025020|NCT01421342|530253486|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
146849490|NCT00621777|529618838|FG001|Open Phase|administrative|0|||
146849491|NCT00621777|529618837|FG000|Open Phase|Lost to Follow-up|10|||
146849492|NCT00621777|529618838|FG001|Open Phase|Lost to Follow-up|0|||
147025021|NCT01421342|530253487|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
147025022|NCT01421342|530253485|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
147025023|NCT01421342|530253486|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
147025024|NCT01421342|530253487|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
147025025|NCT01421342|530253485|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
147025026|NCT01421342|530253486|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
147025027|NCT01421342|530253487|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
147025028|NCT01421342|530253485|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
147025029|NCT01421342|530253486|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
147025030|NCT01421342|530253487|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
147025031|NCT01421342|530253485|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
147025032|NCT01421342|530253486|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
147025033|NCT01421342|530253487|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
147025034|NCT01421342|530253485|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
147025035|NCT01421342|530253486|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
147025036|NCT01421342|530253487|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
147025037|NCT01421342|530253485|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
147025038|NCT01421342|530253486|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
147025039|NCT01421342|530253487|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
147025040|NCT01421342|530253485|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
147025041|NCT01421342|530253486|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
147025042|NCT01421342|530253487|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
147025043|NCT01421342|530253485|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
147025044|NCT01421342|530253486|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
147025045|NCT01421342|530253487|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
147025046|NCT01421342|530253485|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
147025047|NCT01421342|530253486|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
147025048|NCT01421342|530253487|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
147025049|NCT01421342|530253485|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
147025050|NCT01421342|530253486|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
147025051|NCT01421342|530253487|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
147025052|NCT01421342|530253485|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
147025053|NCT01421342|530253486|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
147025054|NCT01421342|530253487|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
147025055|NCT01421342|530253485|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
147025056|NCT01421342|530253486|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
147025057|NCT01421342|530253487|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
147025058|NCT01421342|530253485|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
147025059|NCT01421342|530253486|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
147025060|NCT01421342|530253487|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
147025061|NCT01421342|530253485|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
147025062|NCT01421342|530253486|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
147025063|NCT01421342|530253487|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
147025064|NCT01421342|530253485|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
147025065|NCT01421342|530253486|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
147025066|NCT01421342|530253487|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
147025067|NCT01421342|530253485|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
147025068|NCT01421342|530253486|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
147025069|NCT01421342|530253487|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
147025070|NCT01421342|530253485|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
147025071|NCT01421342|530253486|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
147025072|NCT01421342|530253487|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
147025073|NCT01421342|530253485|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
147025074|NCT01421342|530253486|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
147025075|NCT01421342|530253487|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
147025076|NCT01421342|530253485|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
147025077|NCT01421342|530253486|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
147025078|NCT01421342|530253487|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
147025079|NCT03656874|530253490|FG000|Overall Study|Lost to Follow-up|3|||
147025080|NCT03656874|530253491|FG001|Overall Study|Lost to Follow-up|17|||
147025081|NCT03052322|530253493|FG000|Overall Study|Other un-specified|1|||
147025082|NCT03052322|530253494|FG001|Overall Study|Other un-specified|2|||
147025083|NCT03052322|530253493|FG000|Overall Study|Withdrawal by Subject|10|||
147025084|NCT03052322|530253494|FG001|Overall Study|Withdrawal by Subject|9|||
147025085|NCT03052322|530253493|FG000|Overall Study|Death|0|||
147025086|NCT03052322|530253494|FG001|Overall Study|Death|2|||
147025087|NCT03052322|530253493|FG000|Overall Study|Lack of Efficacy|1|||
147025088|NCT03052322|530253494|FG001|Overall Study|Lack of Efficacy|2|||
147025089|NCT03052322|530253493|FG000|Overall Study|Protocol Violation|1|||
147025090|NCT03052322|530253494|FG001|Overall Study|Protocol Violation|0|||
147025091|NCT03052322|530253493|FG000|Overall Study|Lost to Follow-up|2|||
147025092|NCT03052322|530253494|FG001|Overall Study|Lost to Follow-up|4|||
147025093|NCT03052322|530253493|FG000|Overall Study|Adverse Event|6|||
147025094|NCT03052322|530253494|FG001|Overall Study|Adverse Event|13|||
147025095|NCT04920916|530253495|FG000|Phase IIa 60 Day Study|Death|2|||
147025096|NCT04920916|530253496|FG001|Phase IIa 60 Day Study|Death|5|||
147025097|NCT04920916|530253495|FG000|1 Year Follow up (Phone Call)|Death|1|||
147025098|NCT04920916|530253496|FG001|1 Year Follow up (Phone Call)|Death|3|||
147025099|NCT04920916|530253495|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
147025100|NCT04920916|530253496|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
147025101|NCT00973765|530253497|FG000|Overall Study|Lost to Follow-up|8|||
147025102|NCT00973765|530253498|FG001|Overall Study|Lost to Follow-up|14|||
147025103|NCT01892657|530253499|FG000|Overall Study|Withdrawal by Subject|6|||
147025104|NCT01892657|530253499|FG000|Overall Study|Protocol Violation|12|||
147025105|NCT00076804|530253500|FG000|Overall Study|Death|9|||
147025106|NCT00076804|530253501|FG001|Overall Study|Death|20|||
147025107|NCT00076804|530253500|FG000|Overall Study|Lost to Follow-up|9|||
147025108|NCT00076804|530253501|FG001|Overall Study|Lost to Follow-up|9|||
147025109|NCT00076804|530253500|FG000|Overall Study|Withdrawal by Subject|10|||
147025110|NCT00076804|530253501|FG001|Overall Study|Withdrawal by Subject|8|||
147025111|NCT00076804|530253500|FG000|Overall Study|Early study Closure|32|||
147025112|NCT00076804|530253501|FG001|Overall Study|Early study Closure|32|||
147025113|NCT00354341|530253502|FG000|Overall Study|Adverse Event|1|||
147025114|NCT00354341|530253503|FG001|Overall Study|Adverse Event|0|||
147025115|NCT00354341|530253502|FG000|Overall Study|Death|0|||
147025116|NCT00354341|530253503|FG001|Overall Study|Death|2|||
147025117|NCT00354341|530253502|FG000|Overall Study|Refused treatment|1|||
147025118|NCT00354341|530253503|FG001|Overall Study|Refused treatment|2|||
147025119|NCT00354341|530253502|FG000|Overall Study|Failure to return|0|||
147025120|NCT00354341|530253503|FG001|Overall Study|Failure to return|1|||
147025121|NCT00354341|530253502|FG000|Overall Study|Other|1|||
147025122|NCT00354341|530253503|FG001|Overall Study|Other|2|||
147025123|NCT04295135|530253504|FG000|Overall Study|Withdrawal by Subject|2|||
147025124|NCT04295135|530253505|FG001|Overall Study|Withdrawal by Subject|1|||
147025125|NCT04295135|530253504|FG000|Overall Study|Subject left organization|8|||
147025126|NCT04295135|530253505|FG001|Overall Study|Subject left organization|4|||
147025127|NCT03463993|530253508|FG000|Overall Study|Lost to Follow-up|7|||
147025128|NCT03463993|530253509|FG001|Overall Study|Lost to Follow-up|8|||
147025129|NCT03463993|530253508|FG000|Overall Study|Withdrawal by Subject|2|||
147025130|NCT03463993|530253509|FG001|Overall Study|Withdrawal by Subject|0|||
147025131|NCT03463993|530253508|FG000|Overall Study|Protocol Violation|4|||
147025132|NCT03463993|530253509|FG001|Overall Study|Protocol Violation|1|||
147025133|NCT03463993|530253508|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
147025134|NCT03463993|530253509|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
147025135|NCT03463993|530253508|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
147025136|NCT03463993|530253509|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
147025137|NCT02566993|530253510|FG000|Overall Study|Randomized but not treated|5|||
147025138|NCT02566993|530253511|FG001|Overall Study|Randomized but not treated|16|||
147025139|NCT02566993|530253510|FG000|Overall Study|Progressive disease|213|||
147025140|NCT02566993|530253511|FG001|Overall Study|Progressive disease|152|||
147025141|NCT02566993|530253510|FG000|Overall Study|Withdrawal by Subject|12|||
147025142|NCT02566993|530253511|FG001|Overall Study|Withdrawal by Subject|28|||
147025143|NCT02566993|530253510|FG000|Overall Study|Death|17|||
147025144|NCT02566993|530253511|FG001|Overall Study|Death|23|||
147025145|NCT02566993|530253510|FG000|Overall Study|Physician Decision|10|||
147025146|NCT02566993|530253511|FG001|Overall Study|Physician Decision|17|||
147025147|NCT02566993|530253510|FG000|Overall Study|Study drug-related adverse event|20|||
147025148|NCT02566993|530253511|FG001|Overall Study|Study drug-related adverse event|41|||
147025149|NCT02566993|530253510|FG000|Overall Study|Non study drug-related adverse event|9|||
147025150|NCT02566993|530253511|FG001|Overall Study|Non study drug-related adverse event|9|||
147025151|NCT02566993|530253510|FG000|Overall Study|Symptomatic deterioration|9|||
147025152|NCT02566993|530253511|FG001|Overall Study|Symptomatic deterioration|16|||
147025153|NCT02566993|530253510|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
147025154|NCT02566993|530253511|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
147025155|NCT02566993|530253510|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
147025156|NCT02566993|530253511|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
147025157|NCT02566993|530253510|FG000|Overall Study|Screening failure|2|||
147025158|NCT02566993|530253511|FG001|Overall Study|Screening failure|0|||
147025159|NCT02566993|530253510|FG000|Overall Study|Lost to Follow-up|0|||
147025160|NCT02566993|530253511|FG001|Overall Study|Lost to Follow-up|1|||
147025161|NCT02566993|530253510|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
147025162|NCT02566993|530253511|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
147025163|NCT04440449|530253512|FG000|Overall Study|Lost to Follow-up|2|||
147025164|NCT04440449|530253513|FG001|Overall Study|Lost to Follow-up|0|||
147025165|NCT05420012|530253517|FG000|Overall Study|Lost to Follow-up|0|||
147025166|NCT05420012|530253518|FG001|Overall Study|Lost to Follow-up|1|||
147025167|NCT01901874|530253522|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
147025168|NCT01901874|530253522|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
147025169|NCT01901874|530253522|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
147025170|NCT01901874|530253522|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
147025171|NCT01901874|530253522|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
147025172|NCT01901874|530253522|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
147025173|NCT01347866|530253525|FG000|Overall Study|Death|0|||
147025174|NCT01347866|530253526|FG001|Overall Study|Death|0|||
147025175|NCT01347866|530253527|FG002|Overall Study|Death|0|||
147025176|NCT01347866|530253528|FG003|Overall Study|Death|1|||
147025177|NCT01347866|530253529|FG004|Overall Study|Death|2|||
147025178|NCT01347866|530253530|FG005|Overall Study|Death|2|||
147025179|NCT01347866|530253531|FG006|Overall Study|Death|1|||
147025180|NCT01347866|530253532|FG007|Overall Study|Death|0|||
147025181|NCT01347866|530253533|FG008|Overall Study|Death|4|||
147025182|NCT01347866|530253534|FG009|Overall Study|Death|1|||
147025183|NCT01347866|530253535|FG010|Overall Study|Death|3|||
147025184|NCT01347866|530253536|FG011|Overall Study|Death|1|||
147025185|NCT01347866|530253537|FG012|Overall Study|Death|2|||
147025186|NCT01347866|530253538|FG013|Overall Study|Death|0|||
147025187|NCT01347866|530253539|FG014|Overall Study|Death|0|||
147025188|NCT01347866|530253540|FG015|Overall Study|Death|1|||
147025189|NCT01347866|530253541|FG016|Overall Study|Death|0|||
147025190|NCT01347866|530253525|FG000|Overall Study|Lost to Follow-up|0|||
147025191|NCT01347866|530253526|FG001|Overall Study|Lost to Follow-up|0|||
147025192|NCT01347866|530253527|FG002|Overall Study|Lost to Follow-up|0|||
147025193|NCT01347866|530253528|FG003|Overall Study|Lost to Follow-up|0|||
147025194|NCT01347866|530253529|FG004|Overall Study|Lost to Follow-up|0|||
147025195|NCT01347866|530253530|FG005|Overall Study|Lost to Follow-up|0|||
147025196|NCT01347866|530253531|FG006|Overall Study|Lost to Follow-up|0|||
147025197|NCT01347866|530253532|FG007|Overall Study|Lost to Follow-up|1|||
147025198|NCT01347866|530253533|FG008|Overall Study|Lost to Follow-up|1|||
147025199|NCT01347866|530253534|FG009|Overall Study|Lost to Follow-up|0|||
147025200|NCT01347866|530253535|FG010|Overall Study|Lost to Follow-up|0|||
147025201|NCT01347866|530253536|FG011|Overall Study|Lost to Follow-up|0|||
147025202|NCT01347866|530253537|FG012|Overall Study|Lost to Follow-up|0|||
147025203|NCT01347866|530253538|FG013|Overall Study|Lost to Follow-up|0|||
147025204|NCT01347866|530253539|FG014|Overall Study|Lost to Follow-up|0|||
147025205|NCT01347866|530253540|FG015|Overall Study|Lost to Follow-up|0|||
147025206|NCT01347866|530253541|FG016|Overall Study|Lost to Follow-up|0|||
147025207|NCT01347866|530253525|FG000|Overall Study|Other|3|||
147025208|NCT01347866|530253526|FG001|Overall Study|Other|1|||
147025209|NCT01347866|530253527|FG002|Overall Study|Other|1|||
147025210|NCT01347866|530253528|FG003|Overall Study|Other|4|||
147025211|NCT01347866|530253529|FG004|Overall Study|Other|5|||
147025212|NCT01347866|530253530|FG005|Overall Study|Other|0|||
147025213|NCT01347866|530253531|FG006|Overall Study|Other|5|||
147025214|NCT01347866|530253532|FG007|Overall Study|Other|3|||
147025215|NCT01347866|530253533|FG008|Overall Study|Other|22|||
147025216|NCT01347866|530253534|FG009|Overall Study|Other|5|||
147025217|NCT01347866|530253535|FG010|Overall Study|Other|0|||
147025218|NCT01347866|530253536|FG011|Overall Study|Other|3|||
147025219|NCT01347866|530253537|FG012|Overall Study|Other|4|||
147025220|NCT01347866|530253538|FG013|Overall Study|Other|4|||
147025221|NCT01347866|530253539|FG014|Overall Study|Other|2|||
147025222|NCT01347866|530253540|FG015|Overall Study|Other|3|||
147025223|NCT01347866|530253541|FG016|Overall Study|Other|0|||
147025224|NCT01347866|530253525|FG000|Overall Study|Subject refused further follow-up|2|||
147025225|NCT01347866|530253526|FG001|Overall Study|Subject refused further follow-up|0|||
147025226|NCT01347866|530253527|FG002|Overall Study|Subject refused further follow-up|0|||
147025227|NCT01347866|530253528|FG003|Overall Study|Subject refused further follow-up|2|||
147025228|NCT01347866|530253529|FG004|Overall Study|Subject refused further follow-up|0|||
147025229|NCT01347866|530253530|FG005|Overall Study|Subject refused further follow-up|1|||
147025230|NCT01347866|530253531|FG006|Overall Study|Subject refused further follow-up|0|||
147025231|NCT01347866|530253532|FG007|Overall Study|Subject refused further follow-up|0|||
147025232|NCT01347866|530253533|FG008|Overall Study|Subject refused further follow-up|4|||
147025233|NCT01347866|530253534|FG009|Overall Study|Subject refused further follow-up|1|||
147025234|NCT01347866|530253535|FG010|Overall Study|Subject refused further follow-up|0|||
147025235|NCT01347866|530253536|FG011|Overall Study|Subject refused further follow-up|0|||
147025236|NCT01347866|530253537|FG012|Overall Study|Subject refused further follow-up|1|||
147025237|NCT01347866|530253538|FG013|Overall Study|Subject refused further follow-up|3|||
147025238|NCT01347866|530253539|FG014|Overall Study|Subject refused further follow-up|1|||
147025239|NCT01347866|530253540|FG015|Overall Study|Subject refused further follow-up|0|||
147025240|NCT01347866|530253541|FG016|Overall Study|Subject refused further follow-up|2|||
147025241|NCT02429934|530253542|FG000|Overall Study|Withdrawal by Subject|0|||
147025242|NCT02429934|530253543|FG001|Overall Study|Withdrawal by Subject|2|||
147025243|NCT02429934|530253542|FG000|Overall Study|Adverse Event|2|||
147025244|NCT02429934|530253543|FG001|Overall Study|Adverse Event|0|||
147025245|NCT02429934|530253542|FG000|Overall Study|Lost to Follow-up|1|||
147025246|NCT02429934|530253543|FG001|Overall Study|Lost to Follow-up|1|||
147025247|NCT02429934|530253542|FG000|Overall Study|Physician Decision|1|||
147025248|NCT02429934|530253543|FG001|Overall Study|Physician Decision|0|||
147025249|NCT00869024|530253544|FG000|Overall Study|Death|2|||
147025250|NCT00869024|530253545|FG001|Overall Study|Death|3|||
147025251|NCT00869024|530253544|FG000|Overall Study|Lost to Follow-up|0|||
147025252|NCT00869024|530253545|FG001|Overall Study|Lost to Follow-up|1|||
147025253|NCT00869024|530253544|FG000|Overall Study|Protocol Violation|0|||
147025254|NCT00869024|530253545|FG001|Overall Study|Protocol Violation|1|||
147025255|NCT02181296|530253552|FG000|Overall Study|Lost to Follow-up|7|||
147025256|NCT02181296|530253553|FG001|Overall Study|Lost to Follow-up|6|||
147025257|NCT02939014|530253554|FG000|Overall Study|Lost to Follow-up|1|||
147025258|NCT02939014|530253555|FG001|Overall Study|Lost to Follow-up|0|||
147025259|NCT02939014|530253554|FG000|Overall Study|Death|4|||
147025260|NCT02939014|530253555|FG001|Overall Study|Death|3|||
147025261|NCT01244061|530253558|FG000|Overall Study|Death|1|||
147025262|NCT01244061|530253559|FG001|Overall Study|Death|0|||
147025263|NCT01244061|530253558|FG000|Overall Study|Did not meet entrance criteria|1|||
147025264|NCT01244061|530253559|FG001|Overall Study|Did not meet entrance criteria|0|||
147025265|NCT01244061|530253558|FG000|Overall Study|Lack of Efficacy|1|||
147025266|NCT01244061|530253559|FG001|Overall Study|Lack of Efficacy|3|||
147025267|NCT01244061|530253558|FG000|Overall Study|Lost to Follow-up|34|||
147025268|NCT01244061|530253559|FG001|Overall Study|Lost to Follow-up|30|||
147025269|NCT01244061|530253558|FG000|Overall Study|Withdrawal by Subject|29|||
147025270|NCT01244061|530253559|FG001|Overall Study|Withdrawal by Subject|46|||
147025271|NCT01244061|530253558|FG000|Overall Study|Other|8|||
147025272|NCT01244061|530253559|FG001|Overall Study|Other|19|||
147025273|NCT01244061|530253558|FG000|Overall Study|Protocol Violation|1|||
147025274|NCT01244061|530253559|FG001|Overall Study|Protocol Violation|1|||
147025275|NCT01244061|530253558|FG000|Overall Study|Adverse Event|5|||
147025276|NCT01244061|530253559|FG001|Overall Study|Adverse Event|2|||
147025277|NCT01244061|530253558|FG000|Overall Study|Randomized but not treated|2|||
147025278|NCT01244061|530253559|FG001|Overall Study|Randomized but not treated|2|||
147025279|NCT03351231|530253564|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
147025280|NCT03351231|530253564|FG000|Combination Therapy Period|Disease progression|2|||
147025281|NCT03351231|530253564|FG000|Combination Therapy Period|Study drug toxicity|1|||
147025282|NCT03351231|530253564|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
147025283|NCT03351231|530253564|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
147025284|NCT03351231|530253564|FG000|Safety Follow-Up Period|Other reason|2|||
147025285|NCT03499119|530253567|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
147025286|NCT03499119|530253568|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
147025287|NCT03499119|530253569|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
147025288|NCT03499119|530253570|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
147025289|NCT03499119|530253567|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
147025290|NCT03499119|530253568|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
147025291|NCT03499119|530253569|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
147025292|NCT03499119|530253570|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
147025293|NCT03499119|530253567|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
147025294|NCT03499119|530253568|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
147025295|NCT03499119|530253569|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
147025296|NCT03499119|530253570|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
147025297|NCT03499119|530253567|FG000|Optional Extension Phase|Lost to Follow-up|0|||
147025298|NCT03499119|530253568|FG001|Optional Extension Phase|Lost to Follow-up|0|||
147025299|NCT03499119|530253569|FG002|Optional Extension Phase|Lost to Follow-up|0|||
147025300|NCT03499119|530253570|FG003|Optional Extension Phase|Lost to Follow-up|1|||
147025301|NCT03499119|530253567|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
147025302|NCT03499119|530253568|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
147025303|NCT03499119|530253569|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
147025304|NCT03499119|530253570|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
147025305|NCT03499119|530253567|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
147025306|NCT03499119|530253568|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
147025307|NCT03499119|530253569|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
147025308|NCT03499119|530253570|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
146849493|NCT00621777|529618837|FG000|Randomized Phase|Adverse Event|3|||
146849494|NCT00621777|529618838|FG001|Randomized Phase|Adverse Event|3|||
146849495|NCT00621777|529618837|FG000|Randomized Phase|Lost to Follow-up|3|||
147025309|NCT02333487|530253571|FG000|Overall Study|Adverse Event|0|||
147025310|NCT02333487|530253572|FG001|Overall Study|Adverse Event|2|||
147025311|NCT02333487|530253573|FG002|Overall Study|Adverse Event|0|||
147025312|NCT00123955|530253574|FG000|Overall Study|Adverse Event|1|||
147025313|NCT00123955|530253575|FG001|Overall Study|Adverse Event|0|||
147025314|NCT00123955|530253574|FG000|Overall Study|Withdrawal by Subject|4|||
147025315|NCT00123955|530253575|FG001|Overall Study|Withdrawal by Subject|3|||
147025316|NCT00123955|530253574|FG000|Overall Study|Death|0|||
147025317|NCT00123955|530253575|FG001|Overall Study|Death|1|||
147025318|NCT01558297|530253576|FG000|Overall Study|Withdrawal by Subject|2|||
147025319|NCT01558297|530253577|FG001|Overall Study|Withdrawal by Subject|2|||
147025320|NCT01558297|530253578|FG002|Overall Study|Withdrawal by Subject|1|||
147025321|NCT01408563|530255325|FG000|Overall Study|Ineligible after consent/ registration|2|||
147025322|NCT02246439|530255331|FG000|Overall Study|Adverse Event|3|||
147025323|NCT02246439|530255332|FG001|Overall Study|Adverse Event|0|||
147025324|NCT02246439|530255331|FG000|Overall Study|Lost to Follow-up|7|||
147025325|NCT02246439|530255332|FG001|Overall Study|Lost to Follow-up|5|||
147025326|NCT02246439|530255331|FG000|Overall Study|Protocol Violation|0|||
147025327|NCT02246439|530255332|FG001|Overall Study|Protocol Violation|2|||
147025328|NCT02246439|530255331|FG000|Overall Study|Physician Decision|0|||
147025329|NCT02246439|530255332|FG001|Overall Study|Physician Decision|1|||
147025330|NCT02246439|530255331|FG000|Overall Study|Unkonwn|1|||
147025331|NCT02246439|530255332|FG001|Overall Study|Unkonwn|3|||
147025332|NCT02246439|530255331|FG000|Overall Study|Withdrawal by Subject|1|||
147025333|NCT02246439|530255332|FG001|Overall Study|Withdrawal by Subject|0|||
147025334|NCT03439852|530255333|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
147025335|NCT03439852|530255334|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
147025336|NCT03439852|530255333|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
147025337|NCT03439852|530255334|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
147025338|NCT03439852|530255333|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
147025339|NCT03439852|530255334|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
147025340|NCT02177136|530255339|FG000|DB Phase|Withdrawal by Subject|2|||
147025341|NCT02177136|530255340|FG001|DB Phase|Withdrawal by Subject|0|||
147025342|NCT02177136|530255341|FG002|DB Phase|Withdrawal by Subject|0|||
147025343|NCT02177136|530255342|FG003|DB Phase|Withdrawal by Subject|0|||
147025344|NCT02177136|530255339|FG000|DB Phase|Discontinued Due to Pruritus|1|||
147025345|NCT02177136|530255340|FG001|DB Phase|Discontinued Due to Pruritus|3|||
147025346|NCT02177136|530255341|FG002|DB Phase|Discontinued Due to Pruritus|0|||
147025347|NCT02177136|530255342|FG003|DB Phase|Discontinued Due to Pruritus|0|||
147025348|NCT02177136|530255339|FG000|DB Phase|Adverse Event|3|||
147025349|NCT02177136|530255340|FG001|DB Phase|Adverse Event|2|||
147025350|NCT02177136|530255341|FG002|DB Phase|Adverse Event|3|||
147025351|NCT02177136|530255342|FG003|DB Phase|Adverse Event|0|||
147025352|NCT02177136|530255339|FG000|DB Phase|Protocol Violation|0|||
147025353|NCT02177136|530255340|FG001|DB Phase|Protocol Violation|0|||
147025354|NCT02177136|530255341|FG002|DB Phase|Protocol Violation|1|||
147025355|NCT02177136|530255342|FG003|DB Phase|Protocol Violation|0|||
147025356|NCT02177136|530255339|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
147025357|NCT02177136|530255340|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
147025358|NCT02177136|530255341|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
147025359|NCT02177136|530255342|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
147025360|NCT02177136|530255339|FG000|LTSE Phase|Withdrawal by Subject|0|||
147025361|NCT02177136|530255340|FG001|LTSE Phase|Withdrawal by Subject|0|||
147025362|NCT02177136|530255341|FG002|LTSE Phase|Withdrawal by Subject|0|||
147025363|NCT02177136|530255342|FG003|LTSE Phase|Withdrawal by Subject|6|||
147025364|NCT02177136|530255339|FG000|LTSE Phase|Adverse Event|0|||
147025365|NCT02177136|530255340|FG001|LTSE Phase|Adverse Event|0|||
147025366|NCT02177136|530255341|FG002|LTSE Phase|Adverse Event|0|||
147025367|NCT02177136|530255342|FG003|LTSE Phase|Adverse Event|10|||
147025368|NCT02177136|530255339|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
147025369|NCT02177136|530255340|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
147025370|NCT02177136|530255341|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
147025371|NCT02177136|530255342|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
147025372|NCT02177136|530255339|FG000|LTSE Phase|Physician Decision|0|||
147025373|NCT02177136|530255340|FG001|LTSE Phase|Physician Decision|0|||
147025374|NCT02177136|530255341|FG002|LTSE Phase|Physician Decision|0|||
147025375|NCT02177136|530255342|FG003|LTSE Phase|Physician Decision|2|||
147025376|NCT02177136|530255339|FG000|LTSE Phase|Lost to Follow-up|0|||
147025377|NCT02177136|530255340|FG001|LTSE Phase|Lost to Follow-up|0|||
147025378|NCT02177136|530255341|FG002|LTSE Phase|Lost to Follow-up|0|||
147025379|NCT02177136|530255342|FG003|LTSE Phase|Lost to Follow-up|1|||
147025380|NCT02177136|530255339|FG000|LTSE Phase|Participant Moved|0|||
147025381|NCT02177136|530255340|FG001|LTSE Phase|Participant Moved|0|||
147025382|NCT02177136|530255341|FG002|LTSE Phase|Participant Moved|0|||
147025383|NCT02177136|530255342|FG003|LTSE Phase|Participant Moved|1|||
147025384|NCT02054130|530255343|FG000|Overall Study|Withdrawal by Subject|4|||
147025385|NCT02054130|530255344|FG001|Overall Study|Withdrawal by Subject|4|||
147025386|NCT02054130|530255345|FG002|Overall Study|Withdrawal by Subject|7|||
147025387|NCT02054130|530255346|FG003|Overall Study|Withdrawal by Subject|10|||
147025388|NCT02054130|530255343|FG000|Overall Study|Death|0|||
147025389|NCT02054130|530255344|FG001|Overall Study|Death|1|||
147025390|NCT02054130|530255345|FG002|Overall Study|Death|0|||
147025391|NCT02054130|530255346|FG003|Overall Study|Death|0|||
147025392|NCT02054130|530255343|FG000|Overall Study|Lost to Follow-up|0|||
147025393|NCT02054130|530255344|FG001|Overall Study|Lost to Follow-up|0|||
147025394|NCT02054130|530255345|FG002|Overall Study|Lost to Follow-up|1|||
147025395|NCT02054130|530255346|FG003|Overall Study|Lost to Follow-up|2|||
147025396|NCT02054130|530255343|FG000|Overall Study|Missed dose|4|||
147025397|NCT02054130|530255344|FG001|Overall Study|Missed dose|6|||
147025398|NCT02054130|530255345|FG002|Overall Study|Missed dose|7|||
147025399|NCT02054130|530255346|FG003|Overall Study|Missed dose|10|||
147025400|NCT01386684|530255347|FG000|Overall Study|Lost to Follow-up|51|||
147025401|NCT01386684|530255347|FG000|Overall Study|Other|51|||
147025402|NCT01386684|530255347|FG000|Overall Study|Death|47|||
147025403|NCT01386684|530255347|FG000|Overall Study|Withdrawal of Consent|44|||
147025404|NCT01386684|530255347|FG000|Overall Study|Alternative Therapy Required|37|||
147025405|NCT01386684|530255347|FG000|Overall Study|Disease Progression|28|||
147025406|NCT01386684|530255347|FG000|Overall Study|Adverse Event|20|||
147025407|NCT01386684|530255347|FG000|Overall Study|Noncompliance|8|||
147025408|NCT01386684|530255347|FG000|Overall Study|Protocol Violation|4|||
147025409|NCT01386684|530255347|FG000|Overall Study|Missing|3|||
147025410|NCT00094458|530255348|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
147025411|NCT00094458|530255349|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
147025412|NCT00094458|530255350|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
147025413|NCT00094458|530255351|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
147025414|NCT00094458|530255352|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
147025415|NCT00094458|530255353|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
147025416|NCT00094458|530255348|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
147025417|NCT00094458|530255349|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
147025418|NCT00094458|530255350|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
147025419|NCT00094458|530255351|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
147025420|NCT00094458|530255352|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
147025421|NCT00094458|530255353|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
147025422|NCT00094458|530255348|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
147025423|NCT00094458|530255349|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
147025424|NCT00094458|530255350|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
147025425|NCT00094458|530255351|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
147025426|NCT00094458|530255352|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
147025427|NCT00094458|530255353|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
147025428|NCT00094458|530255348|FG000|Main Study: Through Week 30|Adverse Event|38|||
147025429|NCT00094458|530255349|FG001|Main Study: Through Week 30|Adverse Event|20|||
147025430|NCT00094458|530255350|FG002|Main Study: Through Week 30|Adverse Event|28|||
147025431|NCT00094458|530255351|FG003|Main Study: Through Week 30|Adverse Event|0|||
147025432|NCT00094458|530255352|FG004|Main Study: Through Week 30|Adverse Event|0|||
147025433|NCT00094458|530255353|FG005|Main Study: Through Week 30|Adverse Event|0|||
147025434|NCT00094458|530255348|FG000|Main Study: Through Week 30|Death|1|||
147025435|NCT00094458|530255349|FG001|Main Study: Through Week 30|Death|0|||
147025436|NCT00094458|530255350|FG002|Main Study: Through Week 30|Death|0|||
147025437|NCT00094458|530255351|FG003|Main Study: Through Week 30|Death|0|||
147025438|NCT00094458|530255352|FG004|Main Study: Through Week 30|Death|0|||
147025439|NCT00094458|530255353|FG005|Main Study: Through Week 30|Death|0|||
147025440|NCT00094458|530255348|FG000|Main Study: Through Week 30|Other|19|||
147025441|NCT00094458|530255349|FG001|Main Study: Through Week 30|Other|16|||
147025442|NCT00094458|530255350|FG002|Main Study: Through Week 30|Other|9|||
147025443|NCT00094458|530255351|FG003|Main Study: Through Week 30|Other|0|||
147025444|NCT00094458|530255352|FG004|Main Study: Through Week 30|Other|0|||
147025445|NCT00094458|530255353|FG005|Main Study: Through Week 30|Other|0|||
147025446|NCT00094458|530255348|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
147025447|NCT00094458|530255349|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
147025448|NCT00094458|530255350|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
147025449|NCT00094458|530255351|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
147025450|NCT00094458|530255352|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
147025451|NCT00094458|530255353|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
147025452|NCT00094458|530255348|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
147025453|NCT00094458|530255349|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
147025454|NCT00094458|530255350|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
147025455|NCT00094458|530255351|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
147025456|NCT00094458|530255352|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
147025457|NCT00094458|530255353|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
147025458|NCT00094458|530255348|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
147025459|NCT00094458|530255349|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
147025460|NCT00094458|530255350|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
147025461|NCT00094458|530255351|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
147025462|NCT00094458|530255352|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
147025463|NCT00094458|530255353|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
147025464|NCT00094458|530255348|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
147025465|NCT00094458|530255349|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
147025466|NCT00094458|530255350|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
146849496|NCT00621777|529618838|FG001|Randomized Phase|Lost to Follow-up|3|||
147025467|NCT00094458|530255351|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
147025468|NCT00094458|530255352|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
147025469|NCT00094458|530255353|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
147025470|NCT00094458|530255348|FG000|OLE: Open-Label Extension|Adverse Event|0|||
147025471|NCT00094458|530255349|FG001|OLE: Open-Label Extension|Adverse Event|0|||
147025472|NCT00094458|530255350|FG002|OLE: Open-Label Extension|Adverse Event|0|||
147025473|NCT00094458|530255351|FG003|OLE: Open-Label Extension|Adverse Event|0|||
147025474|NCT00094458|530255352|FG004|OLE: Open-Label Extension|Adverse Event|3|||
147025475|NCT00094458|530255353|FG005|OLE: Open-Label Extension|Adverse Event|4|||
147025476|NCT00094458|530255348|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
147025477|NCT00094458|530255349|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
147025478|NCT00094458|530255350|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
147025479|NCT00094458|530255351|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
147025480|NCT00094458|530255352|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
147025481|NCT00094458|530255353|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
147025482|NCT00094458|530255348|FG000|OLE: Open-Label Extension|Patient decision|0|||
147025483|NCT00094458|530255349|FG001|OLE: Open-Label Extension|Patient decision|0|||
147025484|NCT00094458|530255350|FG002|OLE: Open-Label Extension|Patient decision|0|||
147025485|NCT00094458|530255351|FG003|OLE: Open-Label Extension|Patient decision|0|||
147025486|NCT00094458|530255352|FG004|OLE: Open-Label Extension|Patient decision|1|||
147025487|NCT00094458|530255353|FG005|OLE: Open-Label Extension|Patient decision|0|||
147025488|NCT03247517|530255360|FG000|Overall Study|Adverse Event|0|||
147025489|NCT03247517|530255361|FG001|Overall Study|Adverse Event|4|||
147025490|NCT03247517|530255362|FG002|Overall Study|Adverse Event|2|||
147025491|NCT03247517|530255360|FG000|Overall Study|Lost to Follow-up|2|||
147025492|NCT03247517|530255361|FG001|Overall Study|Lost to Follow-up|6|||
147025493|NCT03247517|530255362|FG002|Overall Study|Lost to Follow-up|4|||
147025494|NCT03247517|530255360|FG000|Overall Study|Consent withdrawn by caregiver|1|||
147025495|NCT03247517|530255361|FG001|Overall Study|Consent withdrawn by caregiver|4|||
147025496|NCT03247517|530255362|FG002|Overall Study|Consent withdrawn by caregiver|7|||
147025497|NCT03247517|530255360|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
147025498|NCT03247517|530255361|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
147025499|NCT03247517|530255362|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
147025500|NCT03247517|530255360|FG000|Overall Study|Protocol Violation|0|||
147025501|NCT03247517|530255361|FG001|Overall Study|Protocol Violation|2|||
147025502|NCT03247517|530255362|FG002|Overall Study|Protocol Violation|0|||
147025503|NCT03247517|530255360|FG000|Overall Study|Multiple reasons|3|||
147025504|NCT03247517|530255361|FG001|Overall Study|Multiple reasons|1|||
147025505|NCT03247517|530255362|FG002|Overall Study|Multiple reasons|0|||
147025506|NCT03623386|530255363|FG000|Overall Study|Protocol Violation|3|||
147025507|NCT03623386|530255364|FG001|Overall Study|Protocol Violation|2|||
147025508|NCT03623386|530255365|FG002|Overall Study|Protocol Violation|0|||
147025509|NCT03623386|530255363|FG000|Overall Study|Physician Decision|1|||
147025510|NCT03623386|530255364|FG001|Overall Study|Physician Decision|1|||
147025511|NCT03623386|530255365|FG002|Overall Study|Physician Decision|0|||
147025512|NCT03623386|530255363|FG000|Overall Study|Lost to Follow-up|0|||
147025513|NCT03623386|530255364|FG001|Overall Study|Lost to Follow-up|2|||
147025514|NCT03623386|530255365|FG002|Overall Study|Lost to Follow-up|0|||
147025515|NCT03623386|530255363|FG000|Overall Study|COVID-19|0|||
147025516|NCT03623386|530255364|FG001|Overall Study|COVID-19|1|||
147025517|NCT03623386|530255365|FG002|Overall Study|COVID-19|0|||
147025518|NCT02132637|530255368|FG000|Study Period 1|Withdrawal by Subject|0|||
147025519|NCT02132637|530255369|FG001|Study Period 1|Withdrawal by Subject|4|||
147025520|NCT02132637|530255368|FG000|Study Period 1|Physician Decision|1|||
147025521|NCT02132637|530255369|FG001|Study Period 1|Physician Decision|0|||
147025522|NCT02132637|530255368|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
147025523|NCT02132637|530255369|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
147025524|NCT02132637|530255368|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
147025525|NCT02132637|530255369|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
147025526|NCT03197558|530255370|FG000|Overall Study|Tubes not placed|1|||
147025527|NCT02145026|530255375|FG000|Overall Study|Adverse Event|2|||
147025528|NCT02145026|530255375|FG000|Overall Study|Death|4|||
147025529|NCT02145026|530255375|FG000|Overall Study|Withdrawal by Subject|2|||
147025530|NCT02145026|530255375|FG000|Overall Study|Physician Decision|4|||
147025531|NCT01546649|530255378|FG000|Overall Study|Adverse Event|4|||
147025532|NCT01546649|530255379|FG001|Overall Study|Adverse Event|5|||
147025533|NCT01546649|530255378|FG000|Overall Study|Protocol Violation|1|||
147025534|NCT01546649|530255379|FG001|Overall Study|Protocol Violation|0|||
147025535|NCT01546649|530255378|FG000|Overall Study|Lack of Efficacy|1|||
147025536|NCT01546649|530255379|FG001|Overall Study|Lack of Efficacy|0|||
147025537|NCT01546649|530255378|FG000|Overall Study|Recurrence|1|||
147025538|NCT01546649|530255379|FG001|Overall Study|Recurrence|1|||
147025539|NCT01546649|530255378|FG000|Overall Study|Discovery of secondary cancer|0|||
147025540|NCT01546649|530255379|FG001|Overall Study|Discovery of secondary cancer|1|||
147025541|NCT01546649|530255378|FG000|Overall Study|Withdrawal by Subject|1|||
147025542|NCT01546649|530255379|FG001|Overall Study|Withdrawal by Subject|2|||
147025543|NCT01621191|530255381|FG000|Overall Study|Adverse Event|9|||
147025544|NCT01621191|530255381|FG000|Overall Study|Withdrawal by Subject|8|||
147025545|NCT01621191|530255381|FG000|Overall Study|Lack of Efficacy|6|||
147025546|NCT01621191|530255381|FG000|Overall Study|Lost to Follow-up|1|||
147025547|NCT01621191|530255381|FG000|Overall Study|Site Removed From Study|1|||
147025548|NCT00038649|530255387|FG000|Overall Study|Adverse Event|9|||
147025549|NCT00942331|530255388|FG000|Overall Study|Did not start treatment|15|||
147025550|NCT00942331|530255389|FG001|Overall Study|Did not start treatment|22|||
147025551|NCT00567476|530255391|FG000|Overall Study|Adverse Event|2|||
147025552|NCT00567476|530255392|FG001|Overall Study|Adverse Event|0|||
147025553|NCT00567476|530255391|FG000|Overall Study|Pregnancy|1|||
147025554|NCT00567476|530255392|FG001|Overall Study|Pregnancy|0|||
147025555|NCT00567476|530255391|FG000|Overall Study|Protocol Violation|4|||
147025556|NCT00567476|530255392|FG001|Overall Study|Protocol Violation|1|||
147025557|NCT00567476|530255391|FG000|Overall Study|Lost to Follow-up|0|||
147025558|NCT00567476|530255392|FG001|Overall Study|Lost to Follow-up|1|||
147025559|NCT00567476|530255391|FG000|Overall Study|Administrative issues|1|||
147025560|NCT00567476|530255392|FG001|Overall Study|Administrative issues|0|||
147025561|NCT00567476|530255391|FG000|Overall Study|Medical Decision|0|||
147025562|NCT00567476|530255392|FG001|Overall Study|Medical Decision|1|||
147025563|NCT00567476|530255391|FG000|Overall Study|Non-adherence to protocol|0|||
147025564|NCT00567476|530255392|FG001|Overall Study|Non-adherence to protocol|1|||
147025565|NCT01491035|530255398|FG000|Overall Study|Lost to Follow-up|0|||
147025566|NCT01491035|530255399|FG001|Overall Study|Lost to Follow-up|0|||
147025567|NCT01491035|530255400|FG002|Overall Study|Lost to Follow-up|0|||
147025568|NCT01491035|530255401|FG003|Overall Study|Lost to Follow-up|0|||
147025569|NCT01491035|530255402|FG004|Overall Study|Lost to Follow-up|1|||
147025570|NCT01491035|530255403|FG005|Overall Study|Lost to Follow-up|0|||
147025571|NCT01491035|530255404|FG006|Overall Study|Lost to Follow-up|0|||
147025572|NCT01491035|530255405|FG007|Overall Study|Lost to Follow-up|0|||
147025573|NCT00891839|530255407|FG000|Overall Study|Adverse Event|2|||
147025574|NCT00891839|530255407|FG000|Overall Study|Withdrawal by Subject|2|||
147025575|NCT00891839|530255407|FG000|Overall Study|Disease progression|3|||
147025576|NCT00851643|530255411|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
147025577|NCT00851643|530255412|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
147025578|NCT00851643|530255413|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
147025579|NCT00851643|530255414|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
147025580|NCT00851643|530255415|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
147025581|NCT00851643|530255416|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
147025582|NCT00851643|530255411|FG000|Base Study (Up to 12 Months)|Other|0|||
147025583|NCT00851643|530255412|FG001|Base Study (Up to 12 Months)|Other|0|||
147025584|NCT00851643|530255413|FG002|Base Study (Up to 12 Months)|Other|0|||
147025585|NCT00851643|530255414|FG003|Base Study (Up to 12 Months)|Other|0|||
147025586|NCT00851643|530255415|FG004|Base Study (Up to 12 Months)|Other|0|||
147025587|NCT00851643|530255416|FG005|Base Study (Up to 12 Months)|Other|1|||
147025588|NCT00851643|530255411|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
147025589|NCT00851643|530255412|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
147025590|NCT00851643|530255413|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
147025591|NCT00851643|530255414|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
147025592|NCT00851643|530255415|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
147025593|NCT00851643|530255416|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
147025594|NCT00851643|530255411|FG000|Extension Study (Up to 36 Months)|Moved|0|||
147025595|NCT00851643|530255412|FG001|Extension Study (Up to 36 Months)|Moved|2|||
147025596|NCT00851643|530255413|FG002|Extension Study (Up to 36 Months)|Moved|1|||
147025597|NCT00851643|530255414|FG003|Extension Study (Up to 36 Months)|Moved|1|||
147025598|NCT00851643|530255415|FG004|Extension Study (Up to 36 Months)|Moved|0|||
147025599|NCT00851643|530255416|FG005|Extension Study (Up to 36 Months)|Moved|1|||
147025600|NCT01568866|530255417|FG000|Overall Study|Disease Progression|208|||
147025601|NCT01568866|530255418|FG001|Overall Study|Disease Progression|183|||
147025602|NCT01568866|530255417|FG000|Overall Study|Adverse Event|94|||
147025603|NCT01568866|530255418|FG001|Overall Study|Adverse Event|96|||
147025604|NCT01568866|530255417|FG000|Overall Study|Patient Request|55|||
147025605|NCT01568866|530255418|FG001|Overall Study|Patient Request|71|||
147025606|NCT01568866|530255417|FG000|Overall Study|Physician Decision|40|||
147025607|NCT01568866|530255418|FG001|Overall Study|Physician Decision|32|||
147025608|NCT01568866|530255417|FG000|Overall Study|Withdrawal by Subject|19|||
147025609|NCT01568866|530255418|FG001|Overall Study|Withdrawal by Subject|11|||
147025610|NCT01568866|530255417|FG000|Overall Study|Death|10|||
147025611|NCT01568866|530255418|FG001|Overall Study|Death|18|||
147025612|NCT01568866|530255417|FG000|Overall Study|Protocol Non-compliance|2|||
147025613|NCT01568866|530255418|FG001|Overall Study|Protocol Non-compliance|4|||
147025614|NCT01568866|530255417|FG000|Overall Study|Lost to Follow-up|1|||
147025615|NCT01568866|530255418|FG001|Overall Study|Lost to Follow-up|0|||
147025616|NCT01568866|530255417|FG000|Overall Study|Randomized but Not Dosed|9|||
147025617|NCT01568866|530255418|FG001|Overall Study|Randomized but Not Dosed|1|||
147025618|NCT03864042|530255419|FG000|DDI Phase|Adverse Event|2|||
147025619|NCT03864042|530255420|FG001|DDI Phase|Adverse Event|0|||
146849497|NCT00621777|529618837|FG000|Randomized Phase|Withdrawal by Subject|1|||
147025620|NCT03864042|530255421|FG002|DDI Phase|Adverse Event|0|||
147025621|NCT03864042|530255419|FG000|DDI Phase|Physician Decision|1|||
147025622|NCT03864042|530255420|FG001|DDI Phase|Physician Decision|0|||
147025623|NCT03864042|530255421|FG002|DDI Phase|Physician Decision|0|||
147025624|NCT03864042|530255419|FG000|DDI Phase|Progressive Disease|1|||
147025625|NCT03864042|530255420|FG001|DDI Phase|Progressive Disease|0|||
147025626|NCT03864042|530255421|FG002|DDI Phase|Progressive Disease|0|||
147025627|NCT03864042|530255419|FG000|Post-DDI Phase|Adverse Event|5|||
147025628|NCT03864042|530255420|FG001|Post-DDI Phase|Adverse Event|3|||
147025629|NCT03864042|530255421|FG002|Post-DDI Phase|Adverse Event|2|||
147025630|NCT03864042|530255419|FG000|Post-DDI Phase|Progressive Disease|11|||
147025631|NCT03864042|530255420|FG001|Post-DDI Phase|Progressive Disease|6|||
147025632|NCT03864042|530255421|FG002|Post-DDI Phase|Progressive Disease|13|||
147025633|NCT03864042|530255419|FG000|Post-DDI Phase|Discretion of investigator|1|||
147025634|NCT03864042|530255420|FG001|Post-DDI Phase|Discretion of investigator|1|||
147025635|NCT03864042|530255421|FG002|Post-DDI Phase|Discretion of investigator|0|||
147025636|NCT03864042|530255419|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
147025637|NCT03864042|530255420|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
147025638|NCT03864042|530255421|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
147025639|NCT03864042|530255419|FG000|Post-DDI Phase|Withdrawal of consent|1|||
147025640|NCT03864042|530255420|FG001|Post-DDI Phase|Withdrawal of consent|2|||
147025641|NCT03864042|530255421|FG002|Post-DDI Phase|Withdrawal of consent|0|||
147025642|NCT01698775|530255422|FG000|Phase A|Adverse Event|2|||
147025643|NCT01698775|530255423|FG001|Phase A|Adverse Event|1|||
147025644|NCT01698775|530255422|FG000|Phase A|Death|1|||
147025645|NCT01698775|530255423|FG001|Phase A|Death|1|||
147025646|NCT01698775|530255422|FG000|Phase A|Lack of Efficacy|1|||
147025647|NCT01698775|530255423|FG001|Phase A|Lack of Efficacy|0|||
147025648|NCT01698775|530255422|FG000|Phase A|Lost to Follow-up|1|||
147025649|NCT01698775|530255423|FG001|Phase A|Lost to Follow-up|2|||
147025650|NCT01698775|530255422|FG000|Phase A|Protocol Violation|1|||
147025651|NCT01698775|530255423|FG001|Phase A|Protocol Violation|0|||
147025652|NCT01698775|530255422|FG000|Phase A|Withdrawal by Subject|3|||
147025653|NCT01698775|530255423|FG001|Phase A|Withdrawal by Subject|4|||
147025654|NCT01698775|530255422|FG000|Phase A|Kidney [transplant]|0|||
147025655|NCT01698775|530255423|FG001|Phase A|Kidney [transplant]|1|||
147025656|NCT01698775|530255422|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
147025657|NCT01698775|530255423|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
147025658|NCT01698775|530255422|FG000|Phase B|Adverse Event|6|||
147025659|NCT01698775|530255423|FG001|Phase B|Adverse Event|3|||
147025660|NCT01698775|530255422|FG000|Phase B|Death|0|||
147025661|NCT01698775|530255423|FG001|Phase B|Death|1|||
147025662|NCT01698775|530255422|FG000|Phase B|Lack of Efficacy|0|||
147025663|NCT01698775|530255423|FG001|Phase B|Lack of Efficacy|1|||
147025664|NCT01698775|530255422|FG000|Phase B|Lost to Follow-up|0|||
147025665|NCT01698775|530255423|FG001|Phase B|Lost to Follow-up|1|||
147025666|NCT01698775|530255422|FG000|Phase B|Physician Decision|1|||
147025667|NCT01698775|530255423|FG001|Phase B|Physician Decision|1|||
147025668|NCT01698775|530255422|FG000|Phase B|Protocol Violation|1|||
147025669|NCT01698775|530255423|FG001|Phase B|Protocol Violation|1|||
147025670|NCT01698775|530255422|FG000|Phase B|Withdrawal by Subject|6|||
147025671|NCT01698775|530255423|FG001|Phase B|Withdrawal by Subject|2|||
147025672|NCT00359788|530255424|FG000|Overall Study|Adverse Event|11|||
147025673|NCT00359788|530255425|FG001|Overall Study|Adverse Event|10|||
147025674|NCT00359788|530255424|FG000|Overall Study|Lack of Efficacy|1|||
147025675|NCT00359788|530255425|FG001|Overall Study|Lack of Efficacy|2|||
147025676|NCT00359788|530255424|FG000|Overall Study|Lost to Follow-up|3|||
147025677|NCT00359788|530255425|FG001|Overall Study|Lost to Follow-up|2|||
147025678|NCT00359788|530255424|FG000|Overall Study|Withdrawal by Subject|4|||
147025679|NCT00359788|530255425|FG001|Overall Study|Withdrawal by Subject|1|||
147025680|NCT00359788|530255424|FG000|Overall Study|Protocol Violation|4|||
147025681|NCT00359788|530255425|FG001|Overall Study|Protocol Violation|2|||
147025682|NCT02143583|530255428|FG000|Overall Study|Withdrawal by Subject|1|||
147025683|NCT02143583|530255429|FG001|Overall Study|Withdrawal by Subject|0|||
147025684|NCT02143583|530255430|FG002|Overall Study|Withdrawal by Subject|1|||
147025685|NCT02143583|530255428|FG000|Overall Study|husband illness|0|||
147025686|NCT02143583|530255429|FG001|Overall Study|husband illness|0|||
147025687|NCT02143583|530255430|FG002|Overall Study|husband illness|1|||
147025688|NCT01641133|530255431|FG000|Overall Study|Protocol Violation|0|||
147025689|NCT01641133|530255432|FG001|Overall Study|Protocol Violation|1|||
147025690|NCT01641133|530255433|FG002|Overall Study|Protocol Violation|1|||
147025691|NCT01641133|530255431|FG000|Overall Study|Migrated/moved from study area|5|||
147025692|NCT01641133|530255432|FG001|Overall Study|Migrated/moved from study area|3|||
147025693|NCT01641133|530255433|FG002|Overall Study|Migrated/moved from study area|1|||
147025694|NCT01641133|530255431|FG000|Overall Study|Adverse Event|0|||
147025695|NCT01641133|530255432|FG001|Overall Study|Adverse Event|0|||
147025696|NCT01641133|530255433|FG002|Overall Study|Adverse Event|1|||
147025697|NCT01641133|530255431|FG000|Overall Study|Withdrawal by Subject|5|||
147025698|NCT01641133|530255432|FG001|Overall Study|Withdrawal by Subject|3|||
147025699|NCT01641133|530255433|FG002|Overall Study|Withdrawal by Subject|3|||
147025700|NCT01641133|530255431|FG000|Overall Study|Lost to Follow-up|0|||
147025701|NCT01641133|530255432|FG001|Overall Study|Lost to Follow-up|2|||
147025702|NCT01641133|530255433|FG002|Overall Study|Lost to Follow-up|2|||
147025703|NCT00103402|530255434|FG000|Overall Study|Adverse Event|3|||
147025704|NCT00103402|530255435|FG001|Overall Study|Adverse Event|4|||
147025705|NCT00103402|530255434|FG000|Overall Study|Lost to Follow-up|8|||
147025706|NCT00103402|530255435|FG001|Overall Study|Lost to Follow-up|7|||
147025707|NCT00103402|530255434|FG000|Overall Study|Dissatisfied/No longer interested|6|||
147025708|NCT00103402|530255435|FG001|Overall Study|Dissatisfied/No longer interested|6|||
147025709|NCT00103402|530255434|FG000|Overall Study|Personal constraints/Other|5|||
147025710|NCT00103402|530255435|FG001|Overall Study|Personal constraints/Other|0|||
147025711|NCT01393730|530255436|FG000|Overall Study|Withdrawal by Subject|3|||
147025712|NCT01393730|530255436|FG000|Overall Study|Other|2|||
147025713|NCT01393730|530255436|FG000|Overall Study|Adverse Event|1|||
147025714|NCT02674061|530255437|FG000|Overall Study|Death|229|||
147025715|NCT02674061|530255438|FG001|Overall Study|Death|77|||
147025716|NCT02674061|530255437|FG000|Overall Study|Lost to Follow-up|3|||
147025717|NCT02674061|530255438|FG001|Overall Study|Lost to Follow-up|3|||
147025718|NCT02674061|530255437|FG000|Overall Study|Withdrawal by Subject|9|||
147025719|NCT02674061|530255438|FG001|Overall Study|Withdrawal by Subject|1|||
147025720|NCT02674061|530255437|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
147025721|NCT02674061|530255438|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
147025722|NCT03334721|530255441|FG000|Overall Study|Withdrawal by Subject|1|||
147025723|NCT03334721|530255442|FG001|Overall Study|Withdrawal by Subject|0|||
147025724|NCT03334721|530255441|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
147025725|NCT03334721|530255442|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
147025726|NCT02932228|530255445|FG000|Overall Study|Death|8|||
147025727|NCT02932228|530255446|FG001|Overall Study|Death|23|||
147025728|NCT02932228|530255445|FG000|Overall Study|not eligible upon chart review|2|||
147025729|NCT02932228|530255446|FG001|Overall Study|not eligible upon chart review|5|||
147025730|NCT04189445|530256959|FG000|Overall Study|Withdrawal of consent|8|||
147025731|NCT04189445|530256960|FG001|Overall Study|Withdrawal of consent|1|||
147025732|NCT04189445|530256961|FG002|Overall Study|Withdrawal of consent|0|||
147025733|NCT04189445|530256959|FG000|Overall Study|Study Terminated by Sponsor|25|||
147025734|NCT04189445|530256960|FG001|Overall Study|Study Terminated by Sponsor|3|||
147025735|NCT04189445|530256961|FG002|Overall Study|Study Terminated by Sponsor|0|||
147025736|NCT04189445|530256959|FG000|Overall Study|Death|54|||
147025737|NCT04189445|530256960|FG001|Overall Study|Death|24|||
147025738|NCT04189445|530256961|FG002|Overall Study|Death|0|||
147025739|NCT02960893|530256963|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
147025740|NCT02960893|530256964|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
147025741|NCT02960893|530256965|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
147025742|NCT02960893|530256966|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
147025743|NCT02960893|530256963|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
147025744|NCT02960893|530256964|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
147025745|NCT02960893|530256965|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
147025746|NCT02960893|530256966|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
147025747|NCT02960893|530256963|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
147025748|NCT02960893|530256964|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
147025749|NCT02960893|530256965|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
147025750|NCT02960893|530256966|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
147025751|NCT02960893|530256963|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
147025752|NCT02960893|530256964|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
147025753|NCT02960893|530256965|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
147025754|NCT02960893|530256966|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
147025755|NCT02960893|530256963|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
147025756|NCT02960893|530256964|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
147025757|NCT02960893|530256965|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
147025758|NCT02960893|530256966|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
147025759|NCT02960893|530256963|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
147025760|NCT02960893|530256964|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
147025761|NCT02960893|530256965|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
147025762|NCT02960893|530256966|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
147025763|NCT02960893|530256963|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
147025764|NCT02960893|530256964|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
147025765|NCT02960893|530256965|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
147025766|NCT02960893|530256966|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
147025767|NCT02960893|530256963|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
147025768|NCT02960893|530256964|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
147025769|NCT02960893|530256965|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
147025770|NCT02960893|530256966|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
147025771|NCT02960893|530256963|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
147025772|NCT02960893|530256964|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
147025773|NCT02960893|530256965|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
147025774|NCT02960893|530256966|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
147025775|NCT02960893|530256963|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
147025776|NCT02960893|530256964|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
147025777|NCT02960893|530256965|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
147025778|NCT02960893|530256966|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
147025779|NCT04551911|530256969|FG000|Overall Study|Lost to Follow-up|2|||
147025780|NCT04551911|530256970|FG001|Overall Study|Lost to Follow-up|1|||
147025781|NCT04551911|530256969|FG000|Overall Study|Withdrawal by Subject|10|||
147025782|NCT04551911|530256970|FG001|Overall Study|Withdrawal by Subject|10|||
147025783|NCT04551911|530256969|FG000|Overall Study|Did not receive the study drug|3|||
147025784|NCT04551911|530256970|FG001|Overall Study|Did not receive the study drug|4|||
147025785|NCT01215513|530256971|FG000|Overall Study|Not completed CS42|9|||
147025786|NCT01215513|530256971|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
147025787|NCT01215513|530256971|FG000|Overall Study|Adverse event (CS42A)|2|||
147025788|NCT01215513|530256971|FG000|Overall Study|Physician decision (CS42A)|6|||
147025789|NCT01215513|530256971|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
147025790|NCT01215513|530256971|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
147025791|NCT00821873|530256973|FG000|Overall Study|Lost to Follow-up|4|||
147025792|NCT01995266|530256981|FG000|Overall Study|Death|1|||
147025793|NCT01995266|530256981|FG000|Overall Study|Lack of Efficacy|6|||
147025794|NCT01995266|530256981|FG000|Overall Study|Adverse Event|2|||
147025795|NCT03310411|530256982|FG000|Period 1|Adverse Event|0|||
147025796|NCT03310411|530256983|FG001|Period 1|Adverse Event|0|||
147025797|NCT03310411|530256984|FG002|Period 1|Adverse Event|0|||
147025798|NCT03310411|530256985|FG003|Period 1|Adverse Event|1|||
147025799|NCT00619112|530256986|FG000|Overall Study|Adverse Event|1|||
147025800|NCT00619112|530256987|FG001|Overall Study|Adverse Event|2|||
147025801|NCT00729248|530256990|FG000|Overall Study|Physician Decision|2|||
147025802|NCT03573505|530256993|FG000|Overall Study|Adverse Event|1|||
147025803|NCT03573505|530256994|FG001|Overall Study|Adverse Event|1|||
147025804|NCT03573505|530256993|FG000|Overall Study|Consent withdrawn|0|||
147025805|NCT03573505|530256994|FG001|Overall Study|Consent withdrawn|1|||
147025806|NCT03573505|530256993|FG000|Overall Study|Disease progression|0|||
147025807|NCT03573505|530256994|FG001|Overall Study|Disease progression|1|||
147025808|NCT03573505|530256993|FG000|Overall Study|Site Terminated by Sponsor|1|||
147025809|NCT03573505|530256994|FG001|Overall Study|Site Terminated by Sponsor|1|||
147025810|NCT03573505|530256993|FG000|Overall Study|Study terminated by sponsor|50|||
147025811|NCT03573505|530256994|FG001|Overall Study|Study terminated by sponsor|45|||
147025812|NCT03573505|530256993|FG000|Overall Study|Reason not specified|0|||
147025813|NCT03573505|530256994|FG001|Overall Study|Reason not specified|1|||
147025814|NCT03573505|530256993|FG000|Overall Study|Death|0|||
147025815|NCT03573505|530256994|FG001|Overall Study|Death|4|||
147025816|NCT02040779|530256995|FG000|Overall Study|Adverse Event|1|||
147025817|NCT02040779|530256996|FG001|Overall Study|Adverse Event|0|||
147025818|NCT02040779|530256997|FG002|Overall Study|Adverse Event|0|||
147025819|NCT02040779|530256995|FG000|Overall Study|Withdrawal by Subject|4|||
147025820|NCT02040779|530256996|FG001|Overall Study|Withdrawal by Subject|1|||
147025821|NCT02040779|530256997|FG002|Overall Study|Withdrawal by Subject|3|||
147025822|NCT02040779|530256995|FG000|Overall Study|Non-compliance|0|||
147025823|NCT02040779|530256996|FG001|Overall Study|Non-compliance|1|||
147025824|NCT02040779|530256997|FG002|Overall Study|Non-compliance|0|||
147025825|NCT02040779|530256995|FG000|Overall Study|Protocol Violation|2|||
147025826|NCT02040779|530256996|FG001|Overall Study|Protocol Violation|1|||
147025827|NCT02040779|530256997|FG002|Overall Study|Protocol Violation|0|||
147025828|NCT02040779|530256995|FG000|Overall Study|Lost to Follow-up|1|||
147025829|NCT02040779|530256996|FG001|Overall Study|Lost to Follow-up|2|||
147025830|NCT02040779|530256997|FG002|Overall Study|Lost to Follow-up|1|||
147025831|NCT02040779|530256995|FG000|Overall Study|Lack of Efficacy|4|||
147025832|NCT02040779|530256996|FG001|Overall Study|Lack of Efficacy|2|||
147025833|NCT02040779|530256997|FG002|Overall Study|Lack of Efficacy|0|||
147025834|NCT00922272|530256998|FG000|Open-label Phase|Adverse Event|5|||
147025835|NCT00922272|530256999|FG001|Open-label Phase|Adverse Event|0|||
147025836|NCT00922272|530256998|FG000|Open-label Phase|Protocol Violation|1|||
147025837|NCT00922272|530256999|FG001|Open-label Phase|Protocol Violation|0|||
147025838|NCT00922272|530256998|FG000|Open-label Phase|Withdrawal by Subject|11|||
147025839|NCT00922272|530256999|FG001|Open-label Phase|Withdrawal by Subject|0|||
147025840|NCT00922272|530256998|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
147025841|NCT00922272|530256999|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
147025842|NCT00922272|530256998|FG000|Open-label Phase|Withdrawal criteria met|5|||
147025843|NCT00922272|530256999|FG001|Open-label Phase|Withdrawal criteria met|0|||
147025844|NCT00922272|530256998|FG000|Double-blind Phase|Adverse Event|1|||
147025845|NCT00922272|530256999|FG001|Double-blind Phase|Adverse Event|1|||
147025846|NCT00922272|530256998|FG000|Double-blind Phase|Withdrawal by Subject|1|||
147025847|NCT00922272|530256999|FG001|Double-blind Phase|Withdrawal by Subject|1|||
147025848|NCT00922272|530256998|FG000|Double-blind Phase|Lost to Follow-up|2|||
147025849|NCT00922272|530256999|FG001|Double-blind Phase|Lost to Follow-up|1|||
147025850|NCT00922272|530256998|FG000|Double-blind Phase|Withdrawal criteria met|1|||
147025851|NCT00922272|530256999|FG001|Double-blind Phase|Withdrawal criteria met|1|||
147025852|NCT00922272|530256998|FG000|Double-blind Phase|Noncompliance|1|||
147025853|NCT00922272|530256999|FG001|Double-blind Phase|Noncompliance|1|||
147025854|NCT00922272|530256998|FG000|Double-blind Phase|Positive urine drug screen|1|||
147025855|NCT00922272|530256999|FG001|Double-blind Phase|Positive urine drug screen|1|||
147025856|NCT02588950|530257006|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
147025857|NCT02588950|530257007|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
147025858|NCT02588950|530257008|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
147025859|NCT02588950|530257009|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
147025860|NCT02588950|530257006|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
147025861|NCT02588950|530257007|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
147025862|NCT02588950|530257008|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
147025863|NCT02588950|530257009|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
147025864|NCT00866658|530257010|FG000|Overall Study|Adverse Event|5|||
147025865|NCT00866658|530257011|FG001|Overall Study|Adverse Event|14|||
147025866|NCT00866658|530257010|FG000|Overall Study|Lack of Efficacy|2|||
147025867|NCT00866658|530257011|FG001|Overall Study|Lack of Efficacy|1|||
147025868|NCT00866658|530257010|FG000|Overall Study|Withdrawal by Subject|1|||
147025869|NCT00866658|530257011|FG001|Overall Study|Withdrawal by Subject|0|||
147025870|NCT00866658|530257010|FG000|Overall Study|Protocol Violation|1|||
147025871|NCT00866658|530257011|FG001|Overall Study|Protocol Violation|1|||
147025872|NCT00866658|530257010|FG000|Overall Study|Familial and Personal Reasons|4|||
147025873|NCT00866658|530257011|FG001|Overall Study|Familial and Personal Reasons|5|||
147025874|NCT00652028|530257012|FG000|Overall Study|Adverse Event|1|||
147025875|NCT00652028|530257013|FG001|Overall Study|Adverse Event|0|||
147025876|NCT00652028|530257014|FG002|Overall Study|Adverse Event|0|||
147025877|NCT00652028|530257015|FG003|Overall Study|Adverse Event|0|||
147025878|NCT00652028|530257012|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
147025879|NCT00652028|530257013|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
147025880|NCT00652028|530257014|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
147025881|NCT00652028|530257015|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
147025882|NCT00652028|530257012|FG000|Overall Study|Physician Decision|0|||
147025883|NCT00652028|530257013|FG001|Overall Study|Physician Decision|0|||
147025884|NCT00652028|530257014|FG002|Overall Study|Physician Decision|1|||
147025885|NCT00652028|530257015|FG003|Overall Study|Physician Decision|0|||
147025886|NCT02072824|530257016|FG000|Overall Study|Insufficient clinical response|1|||
147025887|NCT02072824|530257017|FG001|Overall Study|Insufficient clinical response|0|||
147025888|NCT02072824|530257018|FG002|Overall Study|Insufficient clinical response|1|||
147025889|NCT02072824|530257016|FG000|Overall Study|No longer willing to participate|1|||
147025890|NCT02072824|530257017|FG001|Overall Study|No longer willing to participate|0|||
147025891|NCT02072824|530257018|FG002|Overall Study|No longer willing to participate|1|||
147025892|NCT02072824|530257016|FG000|Overall Study|Medication error|0|||
147025893|NCT02072824|530257017|FG001|Overall Study|Medication error|1|||
147025894|NCT02072824|530257018|FG002|Overall Study|Medication error|0|||
147025895|NCT02072824|530257016|FG000|Overall Study|Adverse Event|0|||
147025896|NCT02072824|530257017|FG001|Overall Study|Adverse Event|0|||
147025897|NCT02072824|530257018|FG002|Overall Study|Adverse Event|1|||
147025898|NCT02751359|530257019|FG000|Overall Study|Lost to Follow-up|1|||
147025899|NCT02011113|530257020|FG000|Overall Study|Adverse Event|4|||
147025900|NCT02011113|530257020|FG000|Overall Study|Disease Progression (DP)|16|||
147025901|NCT02011113|530257020|FG000|Overall Study|Death|1|||
147025902|NCT02011113|530257020|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
147025903|NCT02011113|530257020|FG000|Overall Study|Investigator's judgement- DP|3|||
147025904|NCT02011113|530257020|FG000|Overall Study|Study terminated by sponsor|11|||
147025905|NCT02669940|530257023|FG000|Overall Study|Failure to return|0|||
147025906|NCT02669940|530257024|FG001|Overall Study|Failure to return|3|||
147025907|NCT02669940|530257023|FG000|Overall Study|Insufficient follow-up data|1|||
147025908|NCT02669940|530257024|FG001|Overall Study|Insufficient follow-up data|0|||
147025909|NCT05065983|530257033|FG000|Overall Study|Lost to Follow-up|2|||
147025910|NCT01765582|530257034|FG000|Overall Study|Other|3|||
147025911|NCT01765582|530257035|FG001|Overall Study|Other|6|||
147025912|NCT01765582|530257036|FG002|Overall Study|Other|9|||
146849498|NCT00621777|529618838|FG001|Randomized Phase|Withdrawal by Subject|9|||
146849499|NCT00621777|529618837|FG000|Randomized Phase|administrative|0|||
147025913|NCT01765582|530257034|FG000|Overall Study|Lost to Follow-up|2|||
147025914|NCT01765582|530257035|FG001|Overall Study|Lost to Follow-up|2|||
147025915|NCT01765582|530257036|FG002|Overall Study|Lost to Follow-up|1|||
147025916|NCT01765582|530257034|FG000|Overall Study|Death|31|||
147025917|NCT01765582|530257035|FG001|Overall Study|Death|36|||
147025918|NCT01765582|530257036|FG002|Overall Study|Death|33|||
147025919|NCT01765582|530257034|FG000|Overall Study|Sponsor Decision|46|||
147025920|NCT01765582|530257035|FG001|Overall Study|Sponsor Decision|42|||
147025921|NCT01765582|530257036|FG002|Overall Study|Sponsor Decision|42|||
147025922|NCT01765582|530257034|FG000|Overall Study|Withdrawal of Consent|11|||
147025923|NCT01765582|530257035|FG001|Overall Study|Withdrawal of Consent|6|||
147025924|NCT01765582|530257036|FG002|Overall Study|Withdrawal of Consent|10|||
147025925|NCT00986180|530257037|FG000|Overall Study|Adverse Event|21|||
147025926|NCT00986180|530257038|FG001|Overall Study|Adverse Event|23|||
147025927|NCT00986180|530257037|FG000|Overall Study|Lack of Efficacy|4|||
147025928|NCT00986180|530257038|FG001|Overall Study|Lack of Efficacy|3|||
147025929|NCT00986180|530257037|FG000|Overall Study|Lost to Follow-up|5|||
147025930|NCT00986180|530257038|FG001|Overall Study|Lost to Follow-up|7|||
147025931|NCT00986180|530257037|FG000|Overall Study|Physician Decision|1|||
147025932|NCT00986180|530257038|FG001|Overall Study|Physician Decision|3|||
147025933|NCT00986180|530257037|FG000|Overall Study|Protocol Violation|2|||
147025934|NCT00986180|530257038|FG001|Overall Study|Protocol Violation|0|||
147025935|NCT00986180|530257037|FG000|Overall Study|Withdrawal by Subject|1|||
147025936|NCT00986180|530257038|FG001|Overall Study|Withdrawal by Subject|9|||
147025937|NCT00986180|530257037|FG000|Overall Study|Miscellanies|10|||
147025938|NCT00986180|530257038|FG001|Overall Study|Miscellanies|11|||
147025939|NCT03251963|530257043|FG000|Overall Study|inappropriate Xa level timing|6|||
147025940|NCT03251963|530257044|FG001|Overall Study|inappropriate Xa level timing|3|||
147025941|NCT03251963|530257043|FG000|Overall Study|no peak Xa level drawn|2|||
147025942|NCT03251963|530257044|FG001|Overall Study|no peak Xa level drawn|0|||
147025943|NCT03251963|530257043|FG000|Overall Study|bled prior to Xa level|1|||
147025944|NCT03251963|530257044|FG001|Overall Study|bled prior to Xa level|2|||
147025945|NCT00616941|530257045|FG000|Overall Study|Progressive Disease|1|||
147025946|NCT00616941|530257046|FG001|Overall Study|Progressive Disease|2|||
147025947|NCT00616941|530257047|FG002|Overall Study|Progressive Disease|1|||
147025948|NCT00616941|530257045|FG000|Overall Study|Adverse Event|0|||
147025949|NCT00616941|530257046|FG001|Overall Study|Adverse Event|1|||
147025950|NCT00616941|530257047|FG002|Overall Study|Adverse Event|1|||
147025951|NCT00616941|530257045|FG000|Overall Study|Subject Non-compliance|0|||
147025952|NCT00616941|530257046|FG001|Overall Study|Subject Non-compliance|0|||
147025953|NCT00616941|530257047|FG002|Overall Study|Subject Non-compliance|1|||
147025954|NCT00616941|530257045|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
147025955|NCT00616941|530257046|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
147025956|NCT00616941|530257047|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
147025957|NCT00616941|530257045|FG000|Overall Study|Vaccination Suspended|0|||
147025958|NCT00616941|530257046|FG001|Overall Study|Vaccination Suspended|0|||
147025959|NCT00616941|530257047|FG002|Overall Study|Vaccination Suspended|3|||
147025960|NCT04392583|530257049|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
147025961|NCT03484117|530257050|FG000|Overall Study|Lost to Follow-up|1|||
147025962|NCT03484117|530257051|FG001|Overall Study|Lost to Follow-up|3|||
147025963|NCT03484117|530257050|FG000|Overall Study|Declined participation in exit assess|1|||
147025964|NCT03484117|530257051|FG001|Overall Study|Declined participation in exit assess|1|||
147025965|NCT00289874|530257052|FG000|Overall Study|Adverse Event|1|||
147025966|NCT00289874|530257053|FG001|Overall Study|Adverse Event|5|||
147025967|NCT00289874|530257052|FG000|Overall Study|Lost to Follow-up|1|||
147025968|NCT00289874|530257053|FG001|Overall Study|Lost to Follow-up|1|||
147025969|NCT00289874|530257052|FG000|Overall Study|Protocol Violation|3|||
147025970|NCT00289874|530257053|FG001|Overall Study|Protocol Violation|2|||
147025971|NCT00289874|530257052|FG000|Overall Study|Did not meet eligibility|1|||
147025972|NCT00289874|530257053|FG001|Overall Study|Did not meet eligibility|0|||
147025973|NCT00136318|530257054|FG000|Overall Study|Adverse Event|5|||
147025974|NCT00136318|530257055|FG001|Overall Study|Adverse Event|5|||
147025975|NCT00136318|530257054|FG000|Overall Study|Withdrawal by Subject|2|||
147025976|NCT00136318|530257055|FG001|Overall Study|Withdrawal by Subject|2|||
147025977|NCT03835325|530257056|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
147025978|NCT03835325|530257056|FG000|Overall Study|Selection failure|1|||
147025979|NCT01370213|530257057|FG000|Overall Study|Early Death|1|||
147025980|NCT01370213|530257058|FG001|Overall Study|Early Death|0|||
147025981|NCT01370213|530257059|FG002|Overall Study|Early Death|0|||
147025982|NCT01370213|530257057|FG000|Overall Study|Not evaluable|0|||
147025983|NCT01370213|530257058|FG001|Overall Study|Not evaluable|2|||
147025984|NCT01370213|530257059|FG002|Overall Study|Not evaluable|0|||
147025985|NCT01550744|530257060|FG000|Open-Label|Lost to Follow-up|7|||
147025986|NCT01550744|530257061|FG001|Open-Label|Lost to Follow-up|0|||
146849500|NCT00621777|529618838|FG001|Randomized Phase|administrative|3|||
146849501|NCT00621777|529618837|FG000|Randomized Phase|Death|0|||
146849502|NCT00621777|529618838|FG001|Randomized Phase|Death|1|||
147025987|NCT01550744|530257062|FG002|Open-Label|Lost to Follow-up|0|||
147025988|NCT01550744|530257060|FG000|Open-Label|Withdrawal by Subject|13|||
147025989|NCT01550744|530257061|FG001|Open-Label|Withdrawal by Subject|0|||
147025990|NCT01550744|530257062|FG002|Open-Label|Withdrawal by Subject|0|||
147025991|NCT01550744|530257060|FG000|Open-Label|Adverse Event|11|||
147025992|NCT01550744|530257061|FG001|Open-Label|Adverse Event|0|||
147025993|NCT01550744|530257062|FG002|Open-Label|Adverse Event|0|||
147025994|NCT01550744|530257060|FG000|Open-Label|Lack of Efficacy|4|||
147025995|NCT01550744|530257061|FG001|Open-Label|Lack of Efficacy|0|||
147025996|NCT01550744|530257062|FG002|Open-Label|Lack of Efficacy|0|||
147025997|NCT01550744|530257060|FG000|Open-Label|Protocol Violation|4|||
147025998|NCT01550744|530257061|FG001|Open-Label|Protocol Violation|0|||
147025999|NCT01550744|530257062|FG002|Open-Label|Protocol Violation|0|||
147026000|NCT01550744|530257060|FG000|Open-Label|Not all 3 study drug injections received|2|||
147026001|NCT01550744|530257061|FG001|Open-Label|Not all 3 study drug injections received|0|||
147026002|NCT01550744|530257062|FG002|Open-Label|Not all 3 study drug injections received|0|||
147026003|NCT01550744|530257060|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
147026004|NCT01550744|530257061|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
147026005|NCT01550744|530257062|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
147026006|NCT01550744|530257060|FG000|Open-Label|Other|1|||
147026007|NCT01550744|530257061|FG001|Open-Label|Other|0|||
147026008|NCT01550744|530257062|FG002|Open-Label|Other|0|||
147026009|NCT01550744|530257060|FG000|Double-Blind|Lost to Follow-up|0|||
147026010|NCT01550744|530257061|FG001|Double-Blind|Lost to Follow-up|6|||
147026011|NCT01550744|530257062|FG002|Double-Blind|Lost to Follow-up|12|||
147026012|NCT01550744|530257060|FG000|Double-Blind|Withdrawal by Subject|0|||
147026013|NCT01550744|530257061|FG001|Double-Blind|Withdrawal by Subject|2|||
147026014|NCT01550744|530257062|FG002|Double-Blind|Withdrawal by Subject|15|||
147026015|NCT01550744|530257060|FG000|Double-Blind|Adverse Event|0|||
147026016|NCT01550744|530257061|FG001|Double-Blind|Adverse Event|4|||
147026017|NCT01550744|530257062|FG002|Double-Blind|Adverse Event|15|||
147026018|NCT01550744|530257060|FG000|Double-Blind|Death|0|||
147026019|NCT01550744|530257061|FG001|Double-Blind|Death|1|||
147026020|NCT01550744|530257062|FG002|Double-Blind|Death|0|||
147026021|NCT01550744|530257060|FG000|Double-Blind|Lack of Efficacy|0|||
147026022|NCT01550744|530257061|FG001|Double-Blind|Lack of Efficacy|2|||
147026023|NCT01550744|530257062|FG002|Double-Blind|Lack of Efficacy|8|||
147026024|NCT01550744|530257060|FG000|Double-Blind|Protocol Violation|0|||
147026025|NCT01550744|530257061|FG001|Double-Blind|Protocol Violation|0|||
147026026|NCT01550744|530257062|FG002|Double-Blind|Protocol Violation|4|||
147026027|NCT01550744|530257060|FG000|Double-Blind|Pregnancy|0|||
147026028|NCT01550744|530257061|FG001|Double-Blind|Pregnancy|0|||
147026029|NCT01550744|530257062|FG002|Double-Blind|Pregnancy|3|||
147026030|NCT01550744|530257060|FG000|Double-Blind|Other|0|||
147026031|NCT01550744|530257061|FG001|Double-Blind|Other|2|||
147026032|NCT01550744|530257062|FG002|Double-Blind|Other|10|||
147026033|NCT00706381|530257064|FG000|Overall Study|Lost to Follow-up|0|||
147026034|NCT00706381|530257065|FG001|Overall Study|Lost to Follow-up|1|||
147026035|NCT00706381|530257066|FG002|Overall Study|Lost to Follow-up|1|||
147026036|NCT00706381|530257067|FG003|Overall Study|Lost to Follow-up|0|||
147026037|NCT04355663|530257068|FG000|Overall Study|Physician Decision|2|||
147026038|NCT04355663|530257069|FG001|Overall Study|Physician Decision|7|||
147026039|NCT04355663|530257070|FG002|Overall Study|Physician Decision|0|||
147026040|NCT04355663|530257068|FG000|Overall Study|Adverse Event|0|||
147026041|NCT04355663|530257069|FG001|Overall Study|Adverse Event|0|||
147026042|NCT04355663|530257070|FG002|Overall Study|Adverse Event|1|||
147026043|NCT04355663|530257068|FG000|Overall Study|Withdrawal by Subject|0|||
147026044|NCT04355663|530257069|FG001|Overall Study|Withdrawal by Subject|8|||
147026045|NCT04355663|530257070|FG002|Overall Study|Withdrawal by Subject|3|||
147026046|NCT03395639|530257076|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
147026047|NCT03395639|530257077|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
147026048|NCT03395639|530257078|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
147026049|NCT03395639|530257076|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
147026050|NCT03395639|530257077|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
147026051|NCT03395639|530257078|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
147026052|NCT03395639|530257076|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
147026053|NCT03395639|530257077|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
147026054|NCT03395639|530257078|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
147026055|NCT03395639|530257076|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
147026056|NCT03395639|530257077|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
147026057|NCT03395639|530257078|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
147026058|NCT03395639|530257076|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
147026059|NCT03395639|530257077|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
147026060|NCT03395639|530257078|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
147026061|NCT00995085|530257082|FG000|Overall Study|Withdrawal by Subject|5|||
147026062|NCT02595008|530257086|FG000|Overall Study|Enrolled In Error|1|||
147026063|NCT02595008|530257087|FG001|Overall Study|Enrolled In Error|0|||
147026064|NCT03407118|530257088|FG000|Period 2|Withdrawal by Subject|1|||
147026065|NCT03407118|530257089|FG001|Period 2|Withdrawal by Subject|0|||
147026066|NCT02999477|530257092|FG000|Overall Study|found ineligible after first dose|0|||
147026067|NCT02999477|530257093|FG001|Overall Study|found ineligible after first dose|1|||
147026068|NCT02999477|530257092|FG000|Overall Study|Withdrawal by Subject|1|||
147026069|NCT02999477|530257093|FG001|Overall Study|Withdrawal by Subject|1|||
147026070|NCT01846273|530257094|FG000|Overall Study|Adverse Event|9|||
147026071|NCT01846273|530257095|FG001|Overall Study|Adverse Event|7|||
147026072|NCT01846273|530257096|FG002|Overall Study|Adverse Event|0|||
147026073|NCT01846273|530257094|FG000|Overall Study|Subject withdrew consent|5|||
147026074|NCT01846273|530257095|FG001|Overall Study|Subject withdrew consent|8|||
147026075|NCT01846273|530257096|FG002|Overall Study|Subject withdrew consent|0|||
147026076|NCT01846273|530257094|FG000|Overall Study|Lost to Follow-up|2|||
147026077|NCT01846273|530257095|FG001|Overall Study|Lost to Follow-up|1|||
147026078|NCT01846273|530257096|FG002|Overall Study|Lost to Follow-up|0|||
147026079|NCT01846273|530257094|FG000|Overall Study|Administrative problems|1|||
147026080|NCT01846273|530257095|FG001|Overall Study|Administrative problems|0|||
147026081|NCT01846273|530257096|FG002|Overall Study|Administrative problems|0|||
147026082|NCT01846273|530257094|FG000|Overall Study|Death|2|||
147026083|NCT01846273|530257095|FG001|Overall Study|Death|1|||
147026084|NCT01846273|530257096|FG002|Overall Study|Death|0|||
147026085|NCT01846273|530257094|FG000|Overall Study|Disease Progression|0|||
147026086|NCT01846273|530257095|FG001|Overall Study|Disease Progression|4|||
147026087|NCT01846273|530257096|FG002|Overall Study|Disease Progression|0|||
147026088|NCT01846273|530257094|FG000|Overall Study|Protocol Deviation|2|||
147026089|NCT01846273|530257095|FG001|Overall Study|Protocol Deviation|3|||
147026090|NCT01846273|530257096|FG002|Overall Study|Protocol Deviation|0|||
147026091|NCT01846273|530257094|FG000|Overall Study|Physician Decision|1|||
147026092|NCT01846273|530257095|FG001|Overall Study|Physician Decision|2|||
147026093|NCT01846273|530257096|FG002|Overall Study|Physician Decision|0|||
147026094|NCT02037165|530257099|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
147026095|NCT02037165|530257100|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
147026096|NCT02037165|530257101|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
147026097|NCT02037165|530257102|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
147026098|NCT02037165|530257103|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
147026099|NCT02220725|530257104|FG000|Overall Study|Lost to Follow-up|0|||
147026100|NCT02220725|530257105|FG001|Overall Study|Lost to Follow-up|0|||
147026101|NCT02220725|530257106|FG002|Overall Study|Lost to Follow-up|0|||
147026102|NCT02220725|530257107|FG003|Overall Study|Lost to Follow-up|1|||
147026103|NCT02220725|530257104|FG000|Overall Study|Withdrawal by Subject|0|||
147026104|NCT02220725|530257105|FG001|Overall Study|Withdrawal by Subject|0|||
147026105|NCT02220725|530257106|FG002|Overall Study|Withdrawal by Subject|0|||
147026106|NCT02220725|530257107|FG003|Overall Study|Withdrawal by Subject|1|||
147026107|NCT01673698|530257108|FG000|Overall Study|Lost to Follow-up|51|||
147026108|NCT01673698|530257109|FG001|Overall Study|Lost to Follow-up|13|||
147026109|NCT01232491|530257110|FG000|Overall Study|Adverse Event|13|||
147026110|NCT01232491|530257111|FG001|Overall Study|Adverse Event|8|||
147026111|NCT01232491|530257110|FG000|Overall Study|Lack of Efficacy|1|||
147026112|NCT01232491|530257111|FG001|Overall Study|Lack of Efficacy|5|||
147026113|NCT01232491|530257110|FG000|Overall Study|Protocol Violation|13|||
147026114|NCT01232491|530257111|FG001|Overall Study|Protocol Violation|11|||
147026115|NCT01232491|530257110|FG000|Overall Study|Withdrawal Criteria|12|||
147026116|NCT01232491|530257111|FG001|Overall Study|Withdrawal Criteria|21|||
147026117|NCT01232491|530257110|FG000|Overall Study|Other|21|||
147026118|NCT01232491|530257111|FG001|Overall Study|Other|18|||
147026119|NCT06204887|530258710|FG000|Overall Study|Lost to Follow-up|3|||
147026120|NCT06204887|530258711|FG001|Overall Study|Lost to Follow-up|4|||
147026121|NCT06204887|530258712|FG002|Overall Study|Lost to Follow-up|1|||
147026122|NCT06204887|530258713|FG003|Overall Study|Lost to Follow-up|6|||
147026123|NCT02522403|530258714|FG000|Overall Study|Lost to Follow-up|2|||
147026124|NCT02522403|530258715|FG001|Overall Study|Lost to Follow-up|2|||
147026125|NCT02522403|530258714|FG000|Overall Study|Withdrawal by Subject|2|||
147026126|NCT02522403|530258715|FG001|Overall Study|Withdrawal by Subject|4|||
147026127|NCT05142566|530258716|FG000|Overall Study|Protocol Violation|1|||
147026128|NCT04718194|530258719|FG000|Overall Study|Withdrawal by Subject|3|||
147026129|NCT04718194|530258720|FG001|Overall Study|Withdrawal by Subject|0|||
147026130|NCT04718194|530258719|FG000|Overall Study|Lost to Follow-up|3|||
147026131|NCT04718194|530258720|FG001|Overall Study|Lost to Follow-up|0|||
147026132|NCT00856973|530258721|FG000|Overall Study|Adverse Event|5|||
147026133|NCT00856973|530258722|FG001|Overall Study|Adverse Event|5|||
147026134|NCT00856973|530258723|FG002|Overall Study|Adverse Event|3|||
147026135|NCT00856973|530258721|FG000|Overall Study|Lost to Follow-up|6|||
147026136|NCT00856973|530258722|FG001|Overall Study|Lost to Follow-up|3|||
147026137|NCT00856973|530258723|FG002|Overall Study|Lost to Follow-up|5|||
147026138|NCT00856973|530258721|FG000|Overall Study|Physician Decision|0|||
147026139|NCT00856973|530258722|FG001|Overall Study|Physician Decision|3|||
147026140|NCT00856973|530258723|FG002|Overall Study|Physician Decision|1|||
147026141|NCT00856973|530258721|FG000|Overall Study|Protocol Violation|1|||
147026142|NCT00856973|530258722|FG001|Overall Study|Protocol Violation|2|||
147026143|NCT00856973|530258723|FG002|Overall Study|Protocol Violation|1|||
147026144|NCT00856973|530258721|FG000|Overall Study|Withdrawal by Subject|13|||
147026145|NCT00856973|530258722|FG001|Overall Study|Withdrawal by Subject|16|||
147026146|NCT00856973|530258723|FG002|Overall Study|Withdrawal by Subject|15|||
147026147|NCT00856973|530258721|FG000|Overall Study|Other|11|||
147026148|NCT00856973|530258722|FG001|Overall Study|Other|12|||
147026149|NCT00856973|530258723|FG002|Overall Study|Other|13|||
147026150|NCT04556552|530258726|FG000|Overall Study|Lost to Follow-up|1|||
147026151|NCT04556552|530258727|FG001|Overall Study|Lost to Follow-up|0|||
147026152|NCT04556552|530258726|FG000|Overall Study|Claustrophobia|0|||
147026153|NCT04556552|530258727|FG001|Overall Study|Claustrophobia|1|||
147026154|NCT04556552|530258726|FG000|Overall Study|Inability to continue|0|||
147026155|NCT04556552|530258727|FG001|Overall Study|Inability to continue|1|||
147026156|NCT01553279|530258730|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
147026157|NCT01553279|530258731|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
147026158|NCT01553279|530258730|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
147026159|NCT01553279|530258731|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
147026160|NCT01553279|530258730|FG000|Interim Period|Withdrawal by Subject|2|||
147026161|NCT01553279|530258731|FG001|Interim Period|Withdrawal by Subject|2|||
147026162|NCT01553279|530258730|FG000|Interim Period|Lost to Follow-up|1|||
147026163|NCT01553279|530258731|FG001|Interim Period|Lost to Follow-up|0|||
147026164|NCT01553279|530258730|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
147026165|NCT01553279|530258731|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
147026166|NCT01553279|530258730|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
147026167|NCT01553279|530258731|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
147026168|NCT00605865|530258732|FG000|Overall Study|Protocol Violation|115|||
147026169|NCT03955471|530258733|FG000|Overall Study|Death|22|||
147026170|NCT03955471|530258733|FG000|Overall Study|Lost to Follow-up|1|||
147026171|NCT03955471|530258733|FG000|Overall Study|Withdrawal by Subject|6|||
147026172|NCT03955471|530258733|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
147026173|NCT01030341|530258736|FG000|Overall Study|Withdrawal by Subject|1|||
147026174|NCT01030341|530258736|FG000|Overall Study|Lost to Follow-up|2|||
147026175|NCT01884311|530258739|FG000|Overall Study|Withdrawal by Subject|3|||
147026176|NCT01884311|530258739|FG000|Overall Study|withdrew consent due to AEs|1|||
147026177|NCT01884311|530258739|FG000|Overall Study|Precautionary measure|1|||
147026178|NCT02856880|530258740|FG000|Overall Study|Withdrawal of consent|1|||
147026179|NCT00793780|530258741|FG000|Overall Study|Withdrawal by Subject|2|||
147026180|NCT00793780|530258742|FG001|Overall Study|Withdrawal by Subject|1|||
147026181|NCT02858492|530258743|FG000|Overall Study|Withdrawal by Subject|0|||
147026182|NCT02858492|530258744|FG001|Overall Study|Withdrawal by Subject|1|||
147026183|NCT02858492|530258745|FG002|Overall Study|Withdrawal by Subject|0|||
147026184|NCT02858492|530258746|FG003|Overall Study|Withdrawal by Subject|1|||
147026185|NCT02858492|530258743|FG000|Overall Study|Adverse Event|0|||
147026186|NCT02858492|530258744|FG001|Overall Study|Adverse Event|0|||
147026187|NCT02858492|530258745|FG002|Overall Study|Adverse Event|0|||
147026188|NCT02858492|530258746|FG003|Overall Study|Adverse Event|3|||
147026189|NCT02858492|530258743|FG000|Overall Study|Lack of Efficacy|0|||
147026190|NCT02858492|530258744|FG001|Overall Study|Lack of Efficacy|0|||
147026191|NCT02858492|530258745|FG002|Overall Study|Lack of Efficacy|0|||
147026192|NCT02858492|530258746|FG003|Overall Study|Lack of Efficacy|1|||
147026193|NCT02858492|530258743|FG000|Overall Study|Protocol defined stopping criteria|0|||
147026194|NCT02858492|530258744|FG001|Overall Study|Protocol defined stopping criteria|0|||
147026195|NCT02858492|530258745|FG002|Overall Study|Protocol defined stopping criteria|0|||
147026196|NCT02858492|530258746|FG003|Overall Study|Protocol defined stopping criteria|1|||
147026197|NCT00573157|530258747|FG000|Overall Study|Adverse Event|3|||
147026198|NCT00573157|530258748|FG001|Overall Study|Adverse Event|1|||
147026199|NCT00573157|530258747|FG000|Overall Study|Other|1|||
147026200|NCT00573157|530258748|FG001|Overall Study|Other|1|||
147026201|NCT01032018|530258749|FG000|Overall Study|Lost to Follow-up|6|||
147026202|NCT01032018|530258750|FG001|Overall Study|Lost to Follow-up|5|||
147026203|NCT01032018|530258749|FG000|Overall Study|Death|0|||
147026204|NCT01032018|530258750|FG001|Overall Study|Death|1|||
147026205|NCT01388166|530258756|FG000|Overall Study|Adverse Event|16|||
147026206|NCT01388166|530258756|FG000|Overall Study|Lost to Follow-up|30|||
147026207|NCT01388166|530258756|FG000|Overall Study|Others than specified above|13|||
147026208|NCT00841906|530258757|FG000|Overall Study|Withdrawal by Subject|2|||
147026209|NCT00841906|530258758|FG001|Overall Study|Withdrawal by Subject|0|||
147026210|NCT01196078|530258759|FG000|Overall Study|Withdrawal by Subject|3|||
147026211|NCT01196078|530258760|FG001|Overall Study|Withdrawal by Subject|5|||
147026212|NCT01196078|530258759|FG000|Overall Study|Adverse Event|4|||
147026213|NCT01196078|530258760|FG001|Overall Study|Adverse Event|4|||
147026214|NCT01196078|530258759|FG000|Overall Study|Protocol Violation|2|||
147026215|NCT01196078|530258760|FG001|Overall Study|Protocol Violation|1|||
147026216|NCT01196078|530258759|FG000|Overall Study|Lack of Efficacy|17|||
147026217|NCT01196078|530258760|FG001|Overall Study|Lack of Efficacy|23|||
147026218|NCT01196078|530258759|FG000|Overall Study|Lost to Follow-up|1|||
147026219|NCT01196078|530258760|FG001|Overall Study|Lost to Follow-up|0|||
147026220|NCT01196078|530258759|FG000|Overall Study|Death|6|||
147026221|NCT01196078|530258760|FG001|Overall Study|Death|4|||
147026222|NCT00127036|530258761|FG000|Overall Study|Insufficient Data for Analysis|6|||
147026223|NCT00127036|530258762|FG001|Overall Study|Insufficient Data for Analysis|11|||
147026224|NCT00127036|530258761|FG000|Overall Study|Screen Failure|2|||
147026225|NCT00127036|530258762|FG001|Overall Study|Screen Failure|0|||
147026226|NCT03001219|530258772|FG000|Proof of Concept|Study Termination by Sponsor|0|||
147026227|NCT03001219|530258773|FG001|Proof of Concept|Study Termination by Sponsor|1|||
147026228|NCT03001219|530258772|FG000|Proof of Concept|Withdrawal by Subject|0|||
147026229|NCT03001219|530258773|FG001|Proof of Concept|Withdrawal by Subject|4|||
147026230|NCT03001219|530258772|FG000|Proof of Concept|Protocol Deviation|0|||
147026231|NCT03001219|530258773|FG001|Proof of Concept|Protocol Deviation|1|||
147026232|NCT03001219|530258772|FG000|Proof of Concept|Adverse Event|1|||
147026233|NCT03001219|530258773|FG001|Proof of Concept|Adverse Event|1|||
147026234|NCT03001219|530258772|FG000|Proof of Concept|Physician Decision|1|||
147026235|NCT03001219|530258773|FG001|Proof of Concept|Physician Decision|0|||
147026236|NCT03001219|530258772|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
147026237|NCT03001219|530258773|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
147026238|NCT03001219|530258772|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
147026239|NCT03001219|530258773|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
147026240|NCT03001219|530258772|FG000|Extension Period Analysis|Physician Decision|0|||
147026241|NCT03001219|530258773|FG001|Extension Period Analysis|Physician Decision|1|||
147026242|NCT03001219|530258772|FG000|Extension Period Analysis|Adverse Event|1|||
147026243|NCT03001219|530258773|FG001|Extension Period Analysis|Adverse Event|1|||
147026244|NCT03001219|530258772|FG000|Extension Period Analysis|Protocol Deviation|0|||
147026245|NCT03001219|530258773|FG001|Extension Period Analysis|Protocol Deviation|1|||
147026246|NCT03001219|530258772|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
147026247|NCT03001219|530258773|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
147026248|NCT01797835|530258774|FG000|Overall Study|Lost to Follow-up|31|||
147026249|NCT01797835|530258775|FG001|Overall Study|Lost to Follow-up|27|||
147026250|NCT01403064|530258776|FG000|Overall Study|Death|0|||
147026251|NCT01403064|530258777|FG001|Overall Study|Death|0|||
147026252|NCT01403064|530258778|FG002|Overall Study|Death|1|||
147026253|NCT01403064|530258779|FG003|Overall Study|Death|1|||
147026254|NCT01403064|530258776|FG000|Overall Study|Withdrawal by Subject|0|||
147026255|NCT01403064|530258777|FG001|Overall Study|Withdrawal by Subject|0|||
147026256|NCT01403064|530258778|FG002|Overall Study|Withdrawal by Subject|1|||
147026257|NCT01403064|530258779|FG003|Overall Study|Withdrawal by Subject|1|||
147026258|NCT01403064|530258776|FG000|Overall Study|Other|1|||
147026259|NCT01403064|530258777|FG001|Overall Study|Other|0|||
147026260|NCT01403064|530258778|FG002|Overall Study|Other|2|||
147026261|NCT01403064|530258779|FG003|Overall Study|Other|1|||
147026262|NCT02528123|530258780|FG000|Overall Study|Lost to Follow-up|1|||
147026263|NCT03760250|530258781|FG000|Overall Study|Withdrawal by Subject|1|||
147026264|NCT03760250|530258781|FG000|Overall Study|Physician Decision|1|||
147026265|NCT02963441|530258782|FG000|Overall Study|Protocol violation or withdrawn|8|||
147026266|NCT02963441|530258782|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
147026267|NCT02963441|530258782|FG000|Overall Study|IDx-DR insufficient quality|33|||
147026268|NCT04688931|530258783|FG000|Overall Study|Adverse Event|4|||
147026269|NCT04688931|530258784|FG001|Overall Study|Adverse Event|1|||
147026270|NCT04688931|530258783|FG000|Overall Study|Withdrawal by Subject|5|||
147026271|NCT04688931|530258784|FG001|Overall Study|Withdrawal by Subject|16|||
147026272|NCT04688931|530258783|FG000|Overall Study|Physician Decision|3|||
147026273|NCT04688931|530258784|FG001|Overall Study|Physician Decision|5|||
147026274|NCT04688931|530258783|FG000|Overall Study|Noncompliance|0|||
147026275|NCT04688931|530258784|FG001|Overall Study|Noncompliance|1|||
147026276|NCT04688931|530258783|FG000|Overall Study|Lost to Follow-up|1|||
147026277|NCT04688931|530258784|FG001|Overall Study|Lost to Follow-up|3|||
147026278|NCT04688931|530258783|FG000|Overall Study|Randomization Error|3|||
147026279|NCT04688931|530258784|FG001|Overall Study|Randomization Error|0|||
147026280|NCT04688931|530258783|FG000|Overall Study|Not Eligible|1|||
147026281|NCT04688931|530258784|FG001|Overall Study|Not Eligible|3|||
147026282|NCT04688931|530258783|FG000|Overall Study|Disease Progression|0|||
147026283|NCT04688931|530258784|FG001|Overall Study|Disease Progression|2|||
147026284|NCT04688931|530258783|FG000|Overall Study|Sponsor Requirement|1|||
147026285|NCT04688931|530258784|FG001|Overall Study|Sponsor Requirement|1|||
147026286|NCT04688931|530258783|FG000|Overall Study|Other Reason|1|||
147026287|NCT04688931|530258784|FG001|Overall Study|Other Reason|2|||
147026288|NCT00361335|530258785|FG000|IV Period: Baseline to E0|Adverse Event|9|||
147026289|NCT00361335|530258786|FG001|IV Period: Baseline to E0|Adverse Event|4|||
147026290|NCT00361335|530258787|FG002|IV Period: Baseline to E0|Adverse Event|5|||
147026291|NCT00361335|530258788|FG003|IV Period: Baseline to E0|Adverse Event|9|||
147026292|NCT00361335|530258789|FG004|IV Period: Baseline to E0|Adverse Event|8|||
147026293|NCT00361335|530258790|FG005|IV Period: Baseline to E0|Adverse Event|0|||
146849503|NCT00446043|529618839|FG000|Overall Study|Adverse Event|9|||
147026294|NCT00361335|530258791|FG006|IV Period: Baseline to E0|Adverse Event|0|||
147026295|NCT00361335|530258785|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
147026296|NCT00361335|530258786|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
147026297|NCT00361335|530258787|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
147026298|NCT00361335|530258788|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
147026299|NCT00361335|530258789|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
147026300|NCT00361335|530258790|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
147026301|NCT00361335|530258791|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
147026302|NCT00361335|530258785|FG000|IV Period: Baseline to E0|Death|1|||
147026303|NCT00361335|530258786|FG001|IV Period: Baseline to E0|Death|1|||
147026304|NCT00361335|530258787|FG002|IV Period: Baseline to E0|Death|1|||
147026305|NCT00361335|530258788|FG003|IV Period: Baseline to E0|Death|1|||
147026306|NCT00361335|530258789|FG004|IV Period: Baseline to E0|Death|0|||
147026307|NCT00361335|530258790|FG005|IV Period: Baseline to E0|Death|0|||
147026308|NCT00361335|530258791|FG006|IV Period: Baseline to E0|Death|0|||
147026309|NCT00361335|530258785|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
147026310|NCT00361335|530258786|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
147026311|NCT00361335|530258787|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
147026312|NCT00361335|530258788|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
147026313|NCT00361335|530258789|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
147026314|NCT00361335|530258790|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
147026315|NCT00361335|530258791|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
147026316|NCT00361335|530258785|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
147026317|NCT00361335|530258786|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
147026318|NCT00361335|530258787|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
147026319|NCT00361335|530258788|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
147026320|NCT00361335|530258789|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
147026321|NCT00361335|530258790|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
147026322|NCT00361335|530258791|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
147026323|NCT00361335|530258785|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
147026324|NCT00361335|530258786|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
147026325|NCT00361335|530258787|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
147026326|NCT00361335|530258788|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
147026327|NCT00361335|530258789|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
147026328|NCT00361335|530258790|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
147026329|NCT00361335|530258791|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
147026330|NCT00361335|530258785|FG000|IV Period: Baseline to E0|Other|2|||
147026331|NCT00361335|530258786|FG001|IV Period: Baseline to E0|Other|9|||
147026332|NCT00361335|530258787|FG002|IV Period: Baseline to E0|Other|9|||
147026333|NCT00361335|530258788|FG003|IV Period: Baseline to E0|Other|3|||
147026334|NCT00361335|530258789|FG004|IV Period: Baseline to E0|Other|2|||
147026335|NCT00361335|530258790|FG005|IV Period: Baseline to E0|Other|0|||
147026336|NCT00361335|530258791|FG006|IV Period: Baseline to E0|Other|0|||
147026337|NCT00361335|530258785|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
147026338|NCT00361335|530258786|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
147026339|NCT00361335|530258787|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
147026340|NCT00361335|530258788|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
147026341|NCT00361335|530258789|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
147026342|NCT00361335|530258790|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
147026343|NCT00361335|530258791|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
147026344|NCT00361335|530258785|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
147026345|NCT00361335|530258786|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
147026346|NCT00361335|530258787|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
147026347|NCT00361335|530258788|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
147026348|NCT00361335|530258789|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
147026349|NCT00361335|530258790|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
147026350|NCT00361335|530258791|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
147026351|NCT00361335|530258785|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
147026352|NCT00361335|530258786|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
147026353|NCT00361335|530258787|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
147026354|NCT00361335|530258788|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
147026355|NCT00361335|530258789|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
147026356|NCT00361335|530258790|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
147026357|NCT00361335|530258791|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
147026358|NCT00361335|530258785|FG000|SC Period: Week E0 to Week E24|Death|0|||
147026359|NCT00361335|530258786|FG001|SC Period: Week E0 to Week E24|Death|0|||
147026360|NCT00361335|530258787|FG002|SC Period: Week E0 to Week E24|Death|0|||
147026361|NCT00361335|530258788|FG003|SC Period: Week E0 to Week E24|Death|0|||
147026362|NCT00361335|530258789|FG004|SC Period: Week E0 to Week E24|Death|0|||
147026363|NCT00361335|530258790|FG005|SC Period: Week E0 to Week E24|Death|0|||
147026364|NCT00361335|530258791|FG006|SC Period: Week E0 to Week E24|Death|1|||
147026365|NCT00361335|530258785|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
147026366|NCT00361335|530258786|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
146849504|NCT00446043|529618839|FG000|Overall Study|Withdrawal by Subject|70|||
146849505|NCT00446043|529618839|FG000|Overall Study|Protocol Violation|2|||
147026367|NCT00361335|530258787|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
147026368|NCT00361335|530258788|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
147026369|NCT00361335|530258789|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
147026370|NCT00361335|530258790|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
147026371|NCT00361335|530258791|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
147026372|NCT00361335|530258785|FG000|SC Period: Week E0 to Week E24|Other|1|||
147026373|NCT00361335|530258786|FG001|SC Period: Week E0 to Week E24|Other|0|||
146849506|NCT00446043|529618839|FG000|Overall Study|Lost to Follow-up|42|||
146849507|NCT00446043|529618839|FG000|Overall Study|Pregnancy|2|||
147026374|NCT00361335|530258787|FG002|SC Period: Week E0 to Week E24|Other|0|||
147026375|NCT00361335|530258788|FG003|SC Period: Week E0 to Week E24|Other|1|||
147026376|NCT00361335|530258789|FG004|SC Period: Week E0 to Week E24|Other|0|||
147026377|NCT00361335|530258790|FG005|SC Period: Week E0 to Week E24|Other|1|||
147026378|NCT00361335|530258791|FG006|SC Period: Week E0 to Week E24|Other|2|||
147026379|NCT00361335|530258785|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
147026380|NCT00361335|530258786|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
147026381|NCT00361335|530258787|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
147026382|NCT00361335|530258788|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
147026383|NCT00361335|530258789|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
147026384|NCT00361335|530258790|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
147026385|NCT00361335|530258791|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
147026386|NCT00714493|530258799|FG000|Overall Study|Adverse Event|11|||
147026387|NCT00714493|530258799|FG000|Overall Study|Death|3|||
147026388|NCT00714493|530258799|FG000|Overall Study|Lack of Efficacy|10|||
147026389|NCT00714493|530258799|FG000|Overall Study|Lost to Follow-up|3|||
147026390|NCT00714493|530258799|FG000|Overall Study|Protocol Violation|12|||
147026391|NCT00714493|530258799|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
147026392|NCT00714493|530258799|FG000|Overall Study|OTHER|2|||
147026393|NCT04505293|530258800|FG000|Overall Study|Lost to Follow-up|2|||
147026394|NCT04505293|530258800|FG000|Overall Study|Withdrawal by Subject|6|||
147026395|NCT04505293|530258800|FG000|Overall Study|CT scan unreadable|277|||
147026396|NCT00506129|530258801|FG000|Overall Study|Disease Progression/Relapse|15|||
147026397|NCT00506129|530258801|FG000|Overall Study|Death|7|||
147026398|NCT01400919|530258805|FG000|Overall Study|Withdrawal by Subject|4|||
147026399|NCT01400919|530258805|FG000|Overall Study|Lost to Follow-up|2|||
147026400|NCT01400919|530258805|FG000|Overall Study|Missed visit|2|||
147026401|NCT00251719|530258806|FG000|Overall Study|Adverse Event|14|||
147026402|NCT00251719|530258807|FG001|Overall Study|Adverse Event|8|||
147026403|NCT00251719|530258808|FG002|Overall Study|Adverse Event|7|||
147026404|NCT00251719|530258806|FG000|Overall Study|Protocol Violation|1|||
147026405|NCT00251719|530258807|FG001|Overall Study|Protocol Violation|1|||
147026406|NCT00251719|530258808|FG002|Overall Study|Protocol Violation|1|||
147026407|NCT00251719|530258806|FG000|Overall Study|Lost to Follow-up|5|||
147026408|NCT00251719|530258807|FG001|Overall Study|Lost to Follow-up|11|||
147026409|NCT00251719|530258808|FG002|Overall Study|Lost to Follow-up|8|||
147026410|NCT00251719|530258806|FG000|Overall Study|Withdrawal by Subject|14|||
147026411|NCT00251719|530258807|FG001|Overall Study|Withdrawal by Subject|12|||
147026412|NCT00251719|530258808|FG002|Overall Study|Withdrawal by Subject|11|||
147026413|NCT00251719|530258806|FG000|Overall Study|Lack of Efficacy|2|||
147026414|NCT00251719|530258807|FG001|Overall Study|Lack of Efficacy|1|||
147026415|NCT00251719|530258808|FG002|Overall Study|Lack of Efficacy|0|||
147026416|NCT00251719|530258806|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
147026417|NCT00251719|530258807|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
147026418|NCT00251719|530258808|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
147026419|NCT00251719|530258806|FG000|Overall Study|Investigator decision|1|||
147026420|NCT00251719|530258807|FG001|Overall Study|Investigator decision|1|||
147026421|NCT00251719|530258808|FG002|Overall Study|Investigator decision|0|||
147026422|NCT00251719|530258806|FG000|Overall Study|Noncompliance|2|||
147026423|NCT00251719|530258807|FG001|Overall Study|Noncompliance|3|||
147026424|NCT00251719|530258808|FG002|Overall Study|Noncompliance|1|||
147026425|NCT00251719|530258806|FG000|Overall Study|Barrett's esophagus|2|||
147026426|NCT00251719|530258807|FG001|Overall Study|Barrett's esophagus|2|||
147026427|NCT00251719|530258808|FG002|Overall Study|Barrett's esophagus|0|||
147026428|NCT01732874|530258811|FG000|Overall Study|Withdrawal by Subject|5|||
147026429|NCT01732874|530258812|FG001|Overall Study|Withdrawal by Subject|1|||
147026430|NCT01732874|530258811|FG000|Overall Study|Death of Infant|3|||
147026431|NCT01732874|530258812|FG001|Overall Study|Death of Infant|2|||
147026432|NCT02923674|530258813|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
147026433|NCT02923674|530258814|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
147026434|NCT02923674|530258815|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
147026435|NCT02923674|530258813|FG000|Overall Study|Lost to Follow-up|7|||
147026436|NCT02923674|530258814|FG001|Overall Study|Lost to Follow-up|12|||
147026437|NCT02923674|530258815|FG002|Overall Study|Lost to Follow-up|7|||
147026438|NCT02923674|530258813|FG000|Overall Study|Problem with intervention|2|||
147026439|NCT02923674|530258814|FG001|Overall Study|Problem with intervention|2|||
147026440|NCT02923674|530258815|FG002|Overall Study|Problem with intervention|1|||
147026441|NCT02923674|530258813|FG000|Overall Study|Adverse Event|3|||
147026442|NCT02923674|530258814|FG001|Overall Study|Adverse Event|1|||
146849508|NCT01239043|529618840|FG000|Overall Study|Protocol Violation|2|||
146849509|NCT01239043|529618841|FG001|Overall Study|Protocol Violation|1|||
147026443|NCT02923674|530258815|FG002|Overall Study|Adverse Event|1|||
147026444|NCT02923674|530258813|FG000|Overall Study|Withdrawal by Subject|2|||
147026445|NCT02923674|530258814|FG001|Overall Study|Withdrawal by Subject|2|||
147026446|NCT02923674|530258815|FG002|Overall Study|Withdrawal by Subject|2|||
147026447|NCT00688376|530258818|FG000|Double-Blind Phase|Adverse Event|4|||
147026448|NCT00688376|530258819|FG001|Double-Blind Phase|Adverse Event|4|||
147026449|NCT00688376|530258818|FG000|Double-Blind Phase|Protocol Violation|1|||
147026450|NCT00688376|530258819|FG001|Double-Blind Phase|Protocol Violation|2|||
147026451|NCT00688376|530258818|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
147026452|NCT00688376|530258819|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
147026453|NCT00688376|530258818|FG000|Double-Blind Phase|Not treated|0|||
147026454|NCT00688376|530258819|FG001|Double-Blind Phase|Not treated|1|||
147026455|NCT00688376|530258818|FG000|Blinded Extension Phase|Adverse Event|3|||
147026456|NCT00688376|530258819|FG001|Blinded Extension Phase|Adverse Event|4|||
147026457|NCT00688376|530258818|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
147026458|NCT00688376|530258819|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
147026459|NCT00688376|530258818|FG000|Blinded Extension Phase|Physician Decision|1|||
147026460|NCT00688376|530258819|FG001|Blinded Extension Phase|Physician Decision|0|||
147026461|NCT00688376|530258818|FG000|Blinded Extension Phase|Other|1|||
147026462|NCT00688376|530258819|FG001|Blinded Extension Phase|Other|0|||
147026463|NCT00557076|530258820|FG000|Overall Study|Unblinding|0|||
147026464|NCT00557076|530258821|FG001|Overall Study|Unblinding|1|||
147026465|NCT00003875|530258825|FG000|Overall Study|Screen Failed|1|||
147026466|NCT02303041|530258826|FG000|Overall Study|Adverse Event|1|||
147026467|NCT02303041|530258827|FG001|Overall Study|Adverse Event|2|||
147026468|NCT00886288|530258828|FG000|Overall Study|no respect of the 12 weeks period|657|||
147026469|NCT00886288|530258829|FG001|Overall Study|no respect of the 12 weeks period|227|||
147026470|NCT00886288|530258828|FG000|Overall Study|Lost to Follow-up|86|||
147026471|NCT00886288|530258829|FG001|Overall Study|Lost to Follow-up|0|||
147026472|NCT02335983|530258830|FG000|Overall Study|Sponsor Decision|0|||
147026473|NCT02335983|530258831|FG001|Overall Study|Sponsor Decision|0|||
147026474|NCT02335983|530258832|FG002|Overall Study|Sponsor Decision|1|||
147026475|NCT02335983|530258833|FG003|Overall Study|Sponsor Decision|1|||
147026476|NCT02335983|530258834|FG004|Overall Study|Sponsor Decision|0|||
147026477|NCT02335983|530258835|FG005|Overall Study|Sponsor Decision|1|||
147026478|NCT02335983|530258830|FG000|Overall Study|Withdrawal by Subject|3|||
147026479|NCT02335983|530258831|FG001|Overall Study|Withdrawal by Subject|2|||
147026480|NCT02335983|530258832|FG002|Overall Study|Withdrawal by Subject|2|||
147026481|NCT02335983|530258833|FG003|Overall Study|Withdrawal by Subject|1|||
147026482|NCT02335983|530258834|FG004|Overall Study|Withdrawal by Subject|3|||
147026483|NCT02335983|530258835|FG005|Overall Study|Withdrawal by Subject|9|||
147026484|NCT02335983|530258830|FG000|Overall Study|Death|0|||
147026485|NCT02335983|530258831|FG001|Overall Study|Death|0|||
147026486|NCT02335983|530258832|FG002|Overall Study|Death|2|||
147026487|NCT02335983|530258833|FG003|Overall Study|Death|0|||
147026488|NCT02335983|530258834|FG004|Overall Study|Death|0|||
147026489|NCT02335983|530258835|FG005|Overall Study|Death|0|||
147026490|NCT02335983|530258830|FG000|Overall Study|Lost to Follow-up|0|||
147026491|NCT02335983|530258831|FG001|Overall Study|Lost to Follow-up|0|||
147026492|NCT02335983|530258832|FG002|Overall Study|Lost to Follow-up|0|||
147026493|NCT02335983|530258833|FG003|Overall Study|Lost to Follow-up|0|||
147026494|NCT02335983|530258834|FG004|Overall Study|Lost to Follow-up|0|||
147026495|NCT02335983|530258835|FG005|Overall Study|Lost to Follow-up|1|||
147026496|NCT02335983|530258830|FG000|Overall Study|Protocol Specified Criteria|5|||
147026497|NCT02335983|530258831|FG001|Overall Study|Protocol Specified Criteria|7|||
147026498|NCT02335983|530258832|FG002|Overall Study|Protocol Specified Criteria|27|||
147026499|NCT02335983|530258833|FG003|Overall Study|Protocol Specified Criteria|7|||
147026500|NCT02335983|530258834|FG004|Overall Study|Protocol Specified Criteria|5|||
147026501|NCT02335983|530258835|FG005|Overall Study|Protocol Specified Criteria|21|||
147026502|NCT01070771|530258836|FG000|Overall Study|Adverse Event|2|||
147026503|NCT01070771|530258836|FG000|Overall Study|Protocol Violation|1|||
147026504|NCT03127644|530258837|FG000|Overall Study|Study-specific withdrawal criteria|0|||
147026505|NCT03127644|530258838|FG001|Overall Study|Study-specific withdrawal criteria|0|||
147026506|NCT03127644|530258839|FG002|Overall Study|Study-specific withdrawal criteria|2|||
147026507|NCT04700280|530258847|FG000|Overall Study|Adverse Event|4|||
147026508|NCT04700280|530258848|FG001|Overall Study|Adverse Event|0|||
147026509|NCT04700280|530258847|FG000|Overall Study|Lack of Efficacy|1|||
147026510|NCT04700280|530258848|FG001|Overall Study|Lack of Efficacy|0|||
147026511|NCT04700280|530258847|FG000|Overall Study|Study terminated by sponsor|5|||
147026512|NCT04700280|530258848|FG001|Overall Study|Study terminated by sponsor|3|||
147026513|NCT04700280|530258847|FG000|Overall Study|Other than specified|1|||
147026514|NCT04700280|530258848|FG001|Overall Study|Other than specified|0|||
147026515|NCT02093221|530258851|FG000|Overall Study|Adverse Event|1|||
147026516|NCT02093221|530258852|FG001|Overall Study|Adverse Event|0|||
147026517|NCT02093221|530258853|FG002|Overall Study|Adverse Event|0|||
147026518|NCT02093221|530258854|FG003|Overall Study|Adverse Event|0|||
147026519|NCT02093221|530258855|FG004|Overall Study|Adverse Event|0|||
147026520|NCT02093221|530258851|FG000|Overall Study|Withdrawal by Subject|1|||
147026521|NCT02093221|530258852|FG001|Overall Study|Withdrawal by Subject|1|||
147026522|NCT02093221|530258853|FG002|Overall Study|Withdrawal by Subject|4|||
147026523|NCT02093221|530258854|FG003|Overall Study|Withdrawal by Subject|1|||
147026524|NCT02093221|530258855|FG004|Overall Study|Withdrawal by Subject|1|||
147026525|NCT02093221|530258851|FG000|Overall Study|Lost to Follow-up|2|||
147026526|NCT02093221|530258852|FG001|Overall Study|Lost to Follow-up|0|||
147026527|NCT02093221|530258853|FG002|Overall Study|Lost to Follow-up|1|||
147026528|NCT02093221|530258854|FG003|Overall Study|Lost to Follow-up|1|||
147026529|NCT02093221|530258855|FG004|Overall Study|Lost to Follow-up|0|||
147026530|NCT02093221|530258851|FG000|Overall Study|Death|0|||
147026531|NCT02093221|530258852|FG001|Overall Study|Death|1|||
147026532|NCT02093221|530258853|FG002|Overall Study|Death|0|||
147026533|NCT02093221|530258854|FG003|Overall Study|Death|0|||
147026534|NCT02093221|530258855|FG004|Overall Study|Death|0|||
147026535|NCT02093221|530258851|FG000|Overall Study|Protocol Violation|0|||
147026536|NCT02093221|530258852|FG001|Overall Study|Protocol Violation|1|||
147026537|NCT02093221|530258853|FG002|Overall Study|Protocol Violation|0|||
147026538|NCT02093221|530258854|FG003|Overall Study|Protocol Violation|0|||
147026539|NCT02093221|530258855|FG004|Overall Study|Protocol Violation|0|||
147026540|NCT02093221|530258851|FG000|Overall Study|Study termination|6|||
147026541|NCT02093221|530258852|FG001|Overall Study|Study termination|5|||
147026542|NCT02093221|530258853|FG002|Overall Study|Study termination|4|||
147026543|NCT02093221|530258854|FG003|Overall Study|Study termination|6|||
147026544|NCT02093221|530258855|FG004|Overall Study|Study termination|7|||
147026545|NCT01297322|530258856|FG000|Overall Study|Lost to Follow-up|1|||
147026546|NCT01297322|530258857|FG001|Overall Study|Lost to Follow-up|0|||
147026547|NCT01297322|530258856|FG000|Overall Study|Withdrawal by Subject|0|||
147026548|NCT01297322|530258857|FG001|Overall Study|Withdrawal by Subject|1|||
147026549|NCT01297322|530258856|FG000|Overall Study|Protocol Violation|0|||
147026550|NCT01297322|530258857|FG001|Overall Study|Protocol Violation|3|||
147026551|NCT01583218|530258858|FG000|Overall Study|Withdrawal by Subject|43|||
147026552|NCT01583218|530258859|FG001|Overall Study|Withdrawal by Subject|29|||
147026553|NCT01583218|530258858|FG000|Overall Study|Death|206|||
147026554|NCT01583218|530258859|FG001|Overall Study|Death|211|||
147026555|NCT01583218|530258858|FG000|Overall Study|Lost to Follow-up|11|||
147026556|NCT01583218|530258859|FG001|Overall Study|Lost to Follow-up|17|||
147026557|NCT01583218|530258858|FG000|Overall Study|Adverse event or serious adverse event|3|||
147026558|NCT01583218|530258859|FG001|Overall Study|Adverse event or serious adverse event|3|||
147026559|NCT01583218|530258858|FG000|Overall Study|Patient /Family decision|3|||
147026560|NCT01583218|530258859|FG001|Overall Study|Patient /Family decision|0|||
147026561|NCT01583218|530258858|FG000|Overall Study|Cannot contact patient directly|1|||
147026562|NCT01583218|530258859|FG001|Overall Study|Cannot contact patient directly|2|||
147026563|NCT01583218|530258858|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
147026564|NCT01583218|530258859|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
147026565|NCT01583218|530258858|FG000|Overall Study|Patient did not wish to attend visits|0|||
147026566|NCT01583218|530258859|FG001|Overall Study|Patient did not wish to attend visits|1|||
147026567|NCT01583218|530258858|FG000|Overall Study|Patient randomized but not dosed|17|||
147026568|NCT01583218|530258859|FG001|Overall Study|Patient randomized but not dosed|16|||
147026569|NCT01583218|530258858|FG000|Overall Study|Patient was assessed via phone in person|1|||
147026570|NCT01583218|530258859|FG001|Overall Study|Patient was assessed via phone in person|0|||
147026571|NCT01583218|530258858|FG000|Overall Study|Patient deemed ineligible after random|2|||
147026572|NCT01583218|530258859|FG001|Overall Study|Patient deemed ineligible after random|0|||
147026573|NCT01583218|530258858|FG000|Overall Study|Patient was early terminated from study|0|||
147026574|NCT01583218|530258859|FG001|Overall Study|Patient was early terminated from study|1|||
147026575|NCT01583218|530258858|FG000|Overall Study|Patient was randomized due to mistake|1|||
147026576|NCT01583218|530258859|FG001|Overall Study|Patient was randomized due to mistake|0|||
147026577|NCT01583218|530258858|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
147026578|NCT01583218|530258859|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
147026579|NCT01583218|530258858|FG000|Overall Study|Withdraw of consent on day of random|1|||
147026580|NCT01583218|530258859|FG001|Overall Study|Withdraw of consent on day of random|0|||
147026581|NCT02013375|530258862|FG000|Overall Study|Did not engraft|1|||
147026582|NCT02013375|530258862|FG000|Overall Study|Did not engraft|1|||
147026583|NCT00712985|530258863|FG000|Overall Study|1 withdrew prior to start of drug|1|||
147026584|NCT00712985|530258863|FG000|Overall Study|1 patient moved out of state|1|||
147026585|NCT00712985|530258863|FG000|Overall Study|Lack of Efficacy|3|||
147026586|NCT01663727|530258866|FG000|Overall Study|Death|161|||
147026587|NCT01663727|530258867|FG001|Overall Study|Death|155|||
147026588|NCT01663727|530258866|FG000|Overall Study|Lost to Follow-up|10|||
147026589|NCT01663727|530258867|FG001|Overall Study|Lost to Follow-up|8|||
147026590|NCT01663727|530258866|FG000|Overall Study|Withdrawal by Subject|18|||
147026591|NCT01663727|530258867|FG001|Overall Study|Withdrawal by Subject|25|||
147026592|NCT01663727|530258866|FG000|Overall Study|Study Terminated|51|||
147026593|NCT01663727|530258867|FG001|Overall Study|Study Terminated|50|||
147026594|NCT01663727|530258866|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
147026595|NCT01663727|530258867|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
147026596|NCT01663727|530258866|FG000|Overall Study|Withdrawal prior to dosing.|1|||
147026597|NCT01663727|530258867|FG001|Overall Study|Withdrawal prior to dosing.|0|||
147026598|NCT01902628|530258868|FG000|Overall Study|Withdrawal of participant's consent|7|||
147026599|NCT01902628|530258868|FG000|Overall Study|Adverse Event|41|||
147026600|NCT01902628|530258868|FG000|Overall Study|Lost to Follow-up|35|||
147026601|NCT00321828|530260264|FG000|Overall Study|Ineligible|3|||
147026602|NCT00321828|530260264|FG000|Overall Study|No follow up data|1|||
147026603|NCT02307266|530260265|FG000|Overall Study|Adverse Event|3|||
147026604|NCT02307266|530260266|FG001|Overall Study|Adverse Event|1|||
147026605|NCT02307266|530260267|FG002|Overall Study|Adverse Event|5|||
147026606|NCT02307266|530260265|FG000|Overall Study|Withdrawal by Subject|2|||
147026607|NCT02307266|530260266|FG001|Overall Study|Withdrawal by Subject|0|||
147026608|NCT02307266|530260267|FG002|Overall Study|Withdrawal by Subject|1|||
147026609|NCT02307266|530260265|FG000|Overall Study|Lost to Follow-up|3|||
147026610|NCT02307266|530260266|FG001|Overall Study|Lost to Follow-up|0|||
147026611|NCT02307266|530260267|FG002|Overall Study|Lost to Follow-up|0|||
147026612|NCT00858143|530260272|FG000|Overall Study|Adverse Event|16|||
147026613|NCT00858143|530260272|FG000|Overall Study|Lack of Efficacy|4|||
147026614|NCT00858143|530260272|FG000|Overall Study|Death|7|||
147026615|NCT00858143|530260272|FG000|Overall Study|Other|23|||
147026616|NCT03853148|530260273|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
147026617|NCT03853148|530260274|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
147026618|NCT03853148|530260275|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
147026619|NCT03853148|530260276|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
147026620|NCT00059787|530260277|FG000|Overall Study|Adverse Event|13|||
147026621|NCT00059787|530260277|FG000|Overall Study|disease progression|2|||
147026622|NCT00059787|530260277|FG000|Overall Study|ineligible|1|||
147026623|NCT00059787|530260277|FG000|Overall Study|Other|4|||
147026624|NCT01248013|530260278|FG000|Overall Study|Withdrawal by Subject|14|||
147026625|NCT02667288|530260285|FG000|Overall Study|Protocol Violation|5|||
147026626|NCT02667288|530260285|FG000|Overall Study|Lost to Follow-up|3|||
147026627|NCT02667288|530260285|FG000|Overall Study|Withdrawal by Subject|5|||
147026628|NCT04397445|530260286|FG000|Overall Study|Withdrawal by Subject|1|||
147026629|NCT04397445|530260287|FG001|Overall Study|Withdrawal by Subject|0|||
147026630|NCT04397445|530260288|FG002|Overall Study|Withdrawal by Subject|0|||
147026631|NCT04397445|530260289|FG003|Overall Study|Withdrawal by Subject|0|||
147026632|NCT03921151|530260290|FG000|Overall Study|Withdrawal by Subject|11|||
147026633|NCT03921151|530260291|FG001|Overall Study|Withdrawal by Subject|16|||
147026634|NCT01429051|530260292|FG000|Titration Phase|Death|1|||
147026635|NCT01429051|530260292|FG000|Titration Phase|Withdrawal by Subject|7|||
147026636|NCT01429051|530260292|FG000|Titration Phase|Physician Decision|1|||
147026637|NCT01429051|530260292|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
147026638|NCT01429051|530260292|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
147026639|NCT01429051|530260292|FG000|Efficacy Phase|Adverse Event|1|||
147026640|NCT01429051|530260292|FG000|Efficacy Phase|Death|1|||
147026641|NCT01429051|530260292|FG000|Tolerability Phase|Death|5|||
147026642|NCT01429051|530260292|FG000|Tolerability Phase|Adverse Event|2|||
147026643|NCT01429051|530260292|FG000|Tolerability Phase|Withdrawal by Subject|5|||
147026644|NCT01429051|530260292|FG000|Tolerability Phase|Physician Decision|1|||
147026645|NCT01429051|530260292|FG000|Tolerability Phase|Other|2|||
147026646|NCT00857792|530260294|FG000|Overall Study|inadequate image quality for analysis|12|||
147026647|NCT03733210|530260296|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
147026648|NCT03733210|530260297|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
147026649|NCT04421586|530260307|FG000|Overall Study|Death|0|||
147026650|NCT04421586|530260308|FG001|Overall Study|Death|1|||
147026651|NCT04421586|530260307|FG000|Overall Study|Lost to Follow-up|2|||
147026652|NCT04421586|530260308|FG001|Overall Study|Lost to Follow-up|2|||
147026653|NCT04421586|530260307|FG000|Overall Study|Withdrawn by PI|1|||
147026654|NCT04421586|530260308|FG001|Overall Study|Withdrawn by PI|0|||
147026655|NCT04421586|530260307|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
147026656|NCT04421586|530260308|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
147026657|NCT01968694|530260309|FG000|Washout (1 Month)|Lost to Follow-up|0|||
147026658|NCT01968694|530260310|FG001|Washout (1 Month)|Lost to Follow-up|1|||
147026659|NCT00846521|530260311|FG000|Overall Study|Withdrawal by Subject|5|||
147026660|NCT00846521|530260311|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
147026661|NCT00846521|530260311|FG000|Overall Study|Protocol Violation|1|||
147026662|NCT02792959|530260312|FG000|Overall Study|Protocol Violation|1|||
147026663|NCT02408068|530260313|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
147026664|NCT02408068|530260314|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
147026665|NCT02408068|530260315|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
147026666|NCT02408068|530260316|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
147026667|NCT02408068|530260317|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
147026668|NCT02408068|530260318|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
147026669|NCT01780987|530260319|FG000|Overall Study|Adverse Event|0|||
147026670|NCT01780987|530260320|FG001|Overall Study|Adverse Event|4|||
147026671|NCT01780987|530260319|FG000|Overall Study|Withdrawal by Subject|2|||
147026672|NCT01780987|530260320|FG001|Overall Study|Withdrawal by Subject|0|||
147026673|NCT01780987|530260319|FG000|Overall Study|Request of Changing Hospital|0|||
147026674|NCT01780987|530260320|FG001|Overall Study|Request of Changing Hospital|1|||
147026675|NCT01780987|530260319|FG000|Overall Study|Changing Residence|1|||
147026676|NCT01780987|530260320|FG001|Overall Study|Changing Residence|0|||
147026677|NCT01780987|530260319|FG000|Overall Study|Not Receiving any Study Medication|0|||
147026678|NCT01780987|530260320|FG001|Overall Study|Not Receiving any Study Medication|1|||
147026679|NCT04168190|530260321|FG000|Overall Study|Lost to Follow-up|0|||
147026680|NCT04168190|530260322|FG001|Overall Study|Lost to Follow-up|1|||
147026681|NCT04168190|530260323|FG002|Overall Study|Lost to Follow-up|0|||
147026682|NCT04168190|530260324|FG003|Overall Study|Lost to Follow-up|7|||
147026683|NCT04168190|530260325|FG004|Overall Study|Lost to Follow-up|5|||
147026684|NCT04168190|530260321|FG000|Overall Study|Withdrawal by Subject|1|||
147026685|NCT04168190|530260322|FG001|Overall Study|Withdrawal by Subject|0|||
147026686|NCT04168190|530260323|FG002|Overall Study|Withdrawal by Subject|0|||
147026687|NCT04168190|530260324|FG003|Overall Study|Withdrawal by Subject|2|||
147026688|NCT04168190|530260325|FG004|Overall Study|Withdrawal by Subject|4|||
147026689|NCT04168190|530260321|FG000|Overall Study|Death|0|||
147026690|NCT04168190|530260322|FG001|Overall Study|Death|0|||
147026691|NCT04168190|530260323|FG002|Overall Study|Death|0|||
147026692|NCT04168190|530260324|FG003|Overall Study|Death|1|||
147026693|NCT04168190|530260325|FG004|Overall Study|Death|0|||
147026694|NCT01640873|530260326|FG000|Overall Study|Protocol Violation|2|||
147026695|NCT01640873|530260327|FG001|Overall Study|Protocol Violation|1|||
147026696|NCT03978091|530260332|FG000|Overall Study|Lost to Follow-up|0|||
147026697|NCT03978091|530260333|FG001|Overall Study|Lost to Follow-up|0|||
147026698|NCT03978091|530260334|FG002|Overall Study|Lost to Follow-up|1|||
147026699|NCT03978091|530260335|FG003|Overall Study|Lost to Follow-up|0|||
147026700|NCT03978091|530260336|FG004|Overall Study|Lost to Follow-up|0|||
147026701|NCT03978091|530260337|FG005|Overall Study|Lost to Follow-up|0|||
147026702|NCT03978091|530260332|FG000|Overall Study|Withdrawal by Subject|0|||
147026703|NCT03978091|530260333|FG001|Overall Study|Withdrawal by Subject|0|||
147026704|NCT03978091|530260334|FG002|Overall Study|Withdrawal by Subject|0|||
147026705|NCT03978091|530260335|FG003|Overall Study|Withdrawal by Subject|1|||
147026706|NCT03978091|530260336|FG004|Overall Study|Withdrawal by Subject|1|||
147026707|NCT03978091|530260337|FG005|Overall Study|Withdrawal by Subject|0|||
147026708|NCT00257920|530260340|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
147026709|NCT00257920|530260341|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
147026710|NCT00257920|530260340|FG000|Period: Second Intervention|Other|2|||
147026711|NCT00257920|530260341|FG001|Period: Second Intervention|Other|1|||
147026712|NCT00770692|530260342|FG000|Overall Study|Withdrawal by Subject|7|||
147026713|NCT00770692|530260343|FG001|Overall Study|Withdrawal by Subject|9|||
147026714|NCT00770692|530260344|FG002|Overall Study|Withdrawal by Subject|9|||
147026715|NCT00770692|530260345|FG003|Overall Study|Withdrawal by Subject|6|||
147026716|NCT00770692|530260342|FG000|Overall Study|Adverse Event|3|||
147026717|NCT00770692|530260343|FG001|Overall Study|Adverse Event|0|||
147026718|NCT00770692|530260344|FG002|Overall Study|Adverse Event|4|||
147026719|NCT00770692|530260345|FG003|Overall Study|Adverse Event|4|||
147026720|NCT00770692|530260342|FG000|Overall Study|Investigator judgment|2|||
147026721|NCT00770692|530260343|FG001|Overall Study|Investigator judgment|0|||
147026722|NCT00770692|530260344|FG002|Overall Study|Investigator judgment|1|||
147026723|NCT00770692|530260345|FG003|Overall Study|Investigator judgment|1|||
147026724|NCT00062751|530260346|FG000|Overall Study|Disease progression|24|||
147026725|NCT00062751|530260347|FG001|Overall Study|Disease progression|17|||
147026726|NCT00062751|530260348|FG002|Overall Study|Disease progression|24|||
147026727|NCT00062751|530260349|FG003|Overall Study|Disease progression|2|||
147026728|NCT00062751|530260350|FG004|Overall Study|Disease progression|2|||
147026729|NCT00062751|530260346|FG000|Overall Study|Adverse Event|4|||
147026730|NCT00062751|530260347|FG001|Overall Study|Adverse Event|7|||
147026731|NCT00062751|530260348|FG002|Overall Study|Adverse Event|2|||
147026732|NCT00062751|530260349|FG003|Overall Study|Adverse Event|2|||
147026733|NCT00062751|530260350|FG004|Overall Study|Adverse Event|2|||
147026734|NCT00062751|530260346|FG000|Overall Study|Other|2|||
147026735|NCT00062751|530260347|FG001|Overall Study|Other|3|||
147026736|NCT00062751|530260348|FG002|Overall Study|Other|1|||
147026737|NCT00062751|530260349|FG003|Overall Study|Other|0|||
147026738|NCT00062751|530260350|FG004|Overall Study|Other|1|||
147026739|NCT00062751|530260346|FG000|Overall Study|Withdrawal by Subject|1|||
147026740|NCT00062751|530260347|FG001|Overall Study|Withdrawal by Subject|2|||
147026741|NCT00062751|530260348|FG002|Overall Study|Withdrawal by Subject|2|||
147026742|NCT00062751|530260349|FG003|Overall Study|Withdrawal by Subject|1|||
147026743|NCT00062751|530260350|FG004|Overall Study|Withdrawal by Subject|0|||
147026744|NCT00062751|530260346|FG000|Overall Study|Symptomatic deterioration|1|||
147026745|NCT00062751|530260347|FG001|Overall Study|Symptomatic deterioration|1|||
147026746|NCT00062751|530260348|FG002|Overall Study|Symptomatic deterioration|0|||
147026747|NCT00062751|530260349|FG003|Overall Study|Symptomatic deterioration|0|||
146849510|NCT02929329|529618844|FG000|Overall Study|Withdrawal by Subject|24|||
147026748|NCT00062751|530260350|FG004|Overall Study|Symptomatic deterioration|1|||
147026749|NCT00062751|530260346|FG000|Overall Study|Death|1|||
147026750|NCT00062751|530260347|FG001|Overall Study|Death|0|||
147026751|NCT00062751|530260348|FG002|Overall Study|Death|1|||
147026752|NCT00062751|530260349|FG003|Overall Study|Death|0|||
147026753|NCT00062751|530260350|FG004|Overall Study|Death|0|||
147026754|NCT03629028|530260351|FG000|Overall Study|Lost to Follow-up|26|||
147026755|NCT03629028|530260352|FG001|Overall Study|Lost to Follow-up|23|||
147026756|NCT03629028|530260351|FG000|Overall Study|Pregnancy|4|||
147026757|NCT03629028|530260352|FG001|Overall Study|Pregnancy|2|||
147026758|NCT03629028|530260351|FG000|Overall Study|intolerance to examination|2|||
147026759|NCT03629028|530260352|FG001|Overall Study|intolerance to examination|0|||
147026760|NCT03097588|530260359|FG000|Overall Study|Adverse Event|1|||
147026761|NCT02687360|530260362|FG000|Overall Study|Withdrawal by Subject|3|||
147026762|NCT02687360|530260363|FG001|Overall Study|Withdrawal by Subject|0|||
147026763|NCT03828448|530260366|FG000|Overall Study|Sponsor's Discretion|34|||
147026764|NCT02192164|530260367|FG000|Overall Study|Other|8|||
147026765|NCT02192164|530260367|FG000|Overall Study|Withdrawal by Subject|1|||
147026766|NCT02192164|530260367|FG000|Overall Study|Physician Decision|4|||
147026767|NCT02192164|530260367|FG000|Overall Study|Did not meet the exclusion criteria|1|||
147026768|NCT00673933|530260368|FG000|Overall Study|Withdrawal by Subject|2|||
147026769|NCT00673933|530260368|FG000|Overall Study|Lost to Follow-up|1|||
147026770|NCT04932941|530260369|FG000|Overall Study|Lost to Follow-up|3|||
147026771|NCT04932941|530260370|FG001|Overall Study|Lost to Follow-up|1|||
147026772|NCT04932941|530260369|FG000|Overall Study|Withdrawal by Subject|7|||
147026773|NCT04932941|530260370|FG001|Overall Study|Withdrawal by Subject|4|||
147026774|NCT04932941|530260369|FG000|Overall Study|Other|4|||
147026775|NCT04932941|530260370|FG001|Overall Study|Other|2|||
147026776|NCT05069155|530260371|FG000|Overall Study|Withdrawal by Subject|1|||
147026777|NCT05069155|530260372|FG001|Overall Study|Withdrawal by Subject|3|||
147026778|NCT02206620|530260373|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
147026779|NCT02206620|530260374|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
147026780|NCT02206620|530260373|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
147026781|NCT02206620|530260374|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
147026782|NCT01366443|530260375|FG000|Overall Study|Lost to Follow-up|2|||
147026783|NCT01366443|530260375|FG000|Overall Study|Under 18 yo|1|||
147026784|NCT00731549|530260376|FG000|Overall Study|Lost to Follow-up|19|||
147026785|NCT00731549|530260376|FG000|Overall Study|Met withdrawal criteria|24|||
147026786|NCT00731549|530260376|FG000|Overall Study|Physician Decision|16|||
147026787|NCT00731549|530260376|FG000|Overall Study|Withdrawal by Subject|89|||
147026788|NCT00731549|530260376|FG000|Overall Study|Protocol deviation|1|||
147026789|NCT00731549|530260376|FG000|Overall Study|Adverse Event|31|||
147026790|NCT00731549|530260376|FG000|Overall Study|Lack of efficacy with AE|37|||
147026791|NCT00731549|530260376|FG000|Overall Study|Lack of efficacy without AE|6|||
147026792|NCT00588640|530260377|FG000|Overall Study|Physician Decision|1|||
147026793|NCT00588640|530260377|FG000|Overall Study|Ineligible Patient|1|||
147026794|NCT00507546|530260378|FG000|Overall Study|Withdrawal by Subject|1|||
147026795|NCT00507546|530260379|FG001|Overall Study|Withdrawal by Subject|0|||
147026796|NCT00507546|530260378|FG000|Overall Study|Protocol Violation|1|||
147026797|NCT00507546|530260379|FG001|Overall Study|Protocol Violation|0|||
147026798|NCT00507546|530260378|FG000|Overall Study|Physician Decision|0|||
147026799|NCT00507546|530260379|FG001|Overall Study|Physician Decision|1|||
147026800|NCT01111019|530260380|FG000|Overall Study|Withdrew Prematurely|2|||
147026801|NCT01111019|530260380|FG000|Overall Study|Other|1|||
147026802|NCT04062448|530261282|FG000|Overall Study|Lost to Follow-up|1|||
147026803|NCT04062448|530261282|FG000|Overall Study|Withdrawal by Subject|2|||
147026804|NCT04319718|530261283|FG000|Overall Study|Adverse Event|0|||
147026805|NCT04319718|530261284|FG001|Overall Study|Adverse Event|2|||
147026806|NCT04319718|530261283|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
147026807|NCT04319718|530261284|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
147026808|NCT01045421|530261285|FG000|Phase 1|Progressive Disease|0|||
147026809|NCT01045421|530261286|FG001|Phase 1|Progressive Disease|0|||
147026810|NCT01045421|530261287|FG002|Phase 1|Progressive Disease|0|||
147026811|NCT01045421|530261288|FG003|Phase 1|Progressive Disease|0|||
147026812|NCT01045421|530261289|FG004|Phase 1|Progressive Disease|1|||
147026813|NCT01045421|530261290|FG005|Phase 1|Progressive Disease|0|||
147026814|NCT01045421|530261291|FG006|Phase 1|Progressive Disease|0|||
147026815|NCT01045421|530261292|FG007|Phase 1|Progressive Disease|0|||
147026816|NCT01045421|530261293|FG008|Phase 1|Progressive Disease|0|||
147026817|NCT01045421|530261294|FG009|Phase 1|Progressive Disease|0|||
147026818|NCT01045421|530261295|FG010|Phase 1|Progressive Disease|0|||
147026819|NCT01045421|530261285|FG000|Phase 1|Withdrawal by Subject|0|||
147026820|NCT01045421|530261286|FG001|Phase 1|Withdrawal by Subject|0|||
146849511|NCT02929329|529618845|FG001|Overall Study|Withdrawal by Subject|21|||
146849512|NCT02929329|529618844|FG000|Overall Study|Lost to Follow-up|26|||
147026821|NCT01045421|530261287|FG002|Phase 1|Withdrawal by Subject|0|||
147026822|NCT01045421|530261288|FG003|Phase 1|Withdrawal by Subject|1|||
147026823|NCT01045421|530261289|FG004|Phase 1|Withdrawal by Subject|0|||
147026824|NCT01045421|530261290|FG005|Phase 1|Withdrawal by Subject|0|||
147026825|NCT01045421|530261291|FG006|Phase 1|Withdrawal by Subject|0|||
147026826|NCT01045421|530261292|FG007|Phase 1|Withdrawal by Subject|0|||
147026827|NCT01045421|530261293|FG008|Phase 1|Withdrawal by Subject|0|||
147026828|NCT01045421|530261294|FG009|Phase 1|Withdrawal by Subject|0|||
147026829|NCT01045421|530261295|FG010|Phase 1|Withdrawal by Subject|0|||
147026830|NCT01045421|530261285|FG000|Phase 2|Progressive Disease|0|||
147026831|NCT01045421|530261286|FG001|Phase 2|Progressive Disease|0|||
147026832|NCT01045421|530261287|FG002|Phase 2|Progressive Disease|0|||
147026833|NCT01045421|530261288|FG003|Phase 2|Progressive Disease|0|||
147026834|NCT01045421|530261289|FG004|Phase 2|Progressive Disease|0|||
147026835|NCT01045421|530261290|FG005|Phase 2|Progressive Disease|0|||
147026836|NCT01045421|530261291|FG006|Phase 2|Progressive Disease|0|||
147026837|NCT01045421|530261292|FG007|Phase 2|Progressive Disease|1|||
147026838|NCT01045421|530261293|FG008|Phase 2|Progressive Disease|1|||
147026839|NCT01045421|530261294|FG009|Phase 2|Progressive Disease|1|||
147026840|NCT01045421|530261295|FG010|Phase 2|Progressive Disease|1|||
147026841|NCT01045421|530261285|FG000|Phase 2|Death|0|||
147026842|NCT01045421|530261286|FG001|Phase 2|Death|0|||
147026843|NCT01045421|530261287|FG002|Phase 2|Death|0|||
147026844|NCT01045421|530261288|FG003|Phase 2|Death|0|||
147026845|NCT01045421|530261289|FG004|Phase 2|Death|0|||
147026846|NCT01045421|530261290|FG005|Phase 2|Death|0|||
147026847|NCT01045421|530261291|FG006|Phase 2|Death|0|||
147026848|NCT01045421|530261292|FG007|Phase 2|Death|1|||
147026849|NCT01045421|530261293|FG008|Phase 2|Death|1|||
147026850|NCT01045421|530261294|FG009|Phase 2|Death|2|||
147026851|NCT01045421|530261295|FG010|Phase 2|Death|0|||
147026852|NCT01045421|530261285|FG000|Phase 2|Other|0|||
147026853|NCT01045421|530261286|FG001|Phase 2|Other|0|||
147026854|NCT01045421|530261287|FG002|Phase 2|Other|0|||
147026855|NCT01045421|530261288|FG003|Phase 2|Other|0|||
147026856|NCT01045421|530261289|FG004|Phase 2|Other|0|||
147026857|NCT01045421|530261290|FG005|Phase 2|Other|0|||
147026858|NCT01045421|530261291|FG006|Phase 2|Other|0|||
147026859|NCT01045421|530261292|FG007|Phase 2|Other|3|||
147026860|NCT01045421|530261293|FG008|Phase 2|Other|0|||
147026861|NCT01045421|530261294|FG009|Phase 2|Other|0|||
147026862|NCT01045421|530261295|FG010|Phase 2|Other|1|||
147026863|NCT00090610|530261296|FG000|Overall Study|Withdrawal by Subject|1|||
147026864|NCT00090610|530261297|FG001|Overall Study|Withdrawal by Subject|1|||
147026865|NCT00599521|530261300|FG000|Overall Study|Lack of Efficacy|4|||
147026866|NCT00599521|530261301|FG001|Overall Study|Lack of Efficacy|8|||
147026867|NCT00599521|530261300|FG000|Overall Study|Adverse Event|4|||
147026868|NCT00599521|530261301|FG001|Overall Study|Adverse Event|1|||
147026869|NCT00599521|530261300|FG000|Overall Study|Withdrawal by Subject|28|||
147026870|NCT00599521|530261301|FG001|Overall Study|Withdrawal by Subject|34|||
147026871|NCT00599521|530261300|FG000|Overall Study|Protocol Violation|1|||
147026872|NCT00599521|530261301|FG001|Overall Study|Protocol Violation|1|||
147026873|NCT00599521|530261300|FG000|Overall Study|Lost to Follow-up|23|||
147026874|NCT00599521|530261301|FG001|Overall Study|Lost to Follow-up|23|||
147026875|NCT00599521|530261300|FG000|Overall Study|Pregnancy|0|||
147026876|NCT00599521|530261301|FG001|Overall Study|Pregnancy|2|||
147026877|NCT01293539|530261303|FG000|Overall Study|Physician Decision|1|||
147026878|NCT00912093|530261305|FG000|The Controlled Phase|Death|0|||
147026879|NCT00912093|530261306|FG001|The Controlled Phase|Death|1|||
147026880|NCT00912093|530261307|FG002|The Controlled Phase|Death|0|||
147026881|NCT00912093|530261308|FG003|The Controlled Phase|Death|0|||
147026882|NCT00912093|530261309|FG004|The Controlled Phase|Death|0|||
147026883|NCT00912093|530261305|FG000|The Controlled Phase|Medical Condition|0|||
147026884|NCT00912093|530261306|FG001|The Controlled Phase|Medical Condition|1|||
147026885|NCT00912093|530261307|FG002|The Controlled Phase|Medical Condition|0|||
147026886|NCT00912093|530261308|FG003|The Controlled Phase|Medical Condition|0|||
147026887|NCT00912093|530261309|FG004|The Controlled Phase|Medical Condition|0|||
147026888|NCT00912093|530261305|FG000|The Controlled Phase|Lost to Follow-up|0|||
147026889|NCT00912093|530261306|FG001|The Controlled Phase|Lost to Follow-up|0|||
147026890|NCT00912093|530261307|FG002|The Controlled Phase|Lost to Follow-up|0|||
147026891|NCT00912093|530261308|FG003|The Controlled Phase|Lost to Follow-up|0|||
147026892|NCT00912093|530261309|FG004|The Controlled Phase|Lost to Follow-up|1|||
147026893|NCT00891371|530261314|FG000|Pre-assignment|Inclusion/exclusion|5|||
147026894|NCT00891371|530261314|FG000|Pre-assignment|Consent withdrawal|1|||
146849513|NCT02929329|529618845|FG001|Overall Study|Lost to Follow-up|20|||
147026895|NCT00891371|530261314|FG000|Treatment|Lack of Efficacy|5|||
147026896|NCT00891371|530261314|FG000|Treatment|Adverse Event|2|||
147026897|NCT00891371|530261314|FG000|Treatment|Death|1|||
147026898|NCT00891371|530261314|FG000|Treatment|Lost to Follow-up|1|||
147026899|NCT00450619|530261315|FG000|Overall Study|refused treatment after randomization|2|||
147026900|NCT00450619|530261316|FG001|Overall Study|refused treatment after randomization|0|||
147026901|NCT00450619|530261315|FG000|Overall Study|did not progress; refused further trmt|1|||
147026902|NCT00450619|530261316|FG001|Overall Study|did not progress; refused further trmt|1|||
147026903|NCT00450619|530261315|FG000|Overall Study|Adverse Event|1|||
146849514|NCT02929329|529618844|FG000|Overall Study|Death|1054|||
147026904|NCT00450619|530261316|FG001|Overall Study|Adverse Event|0|||
147026905|NCT02034058|530261317|FG000|Overall Study|Death|3|||
147026906|NCT02836496|530261318|FG000|Overall Study|Adverse Event|2|||
147026907|NCT02836496|530261319|FG001|Overall Study|Adverse Event|1|||
147026908|NCT02836496|530261318|FG000|Overall Study|Withdrawal by Subject|0|||
147026909|NCT02836496|530261319|FG001|Overall Study|Withdrawal by Subject|1|||
147026910|NCT03914950|530261320|FG000|Overall Study|Physician Decision|54|||
147026911|NCT03201250|530261327|FG000|Overall Study|screen failures|3|||
147026912|NCT03201250|530261328|FG001|Overall Study|screen failures|0|||
147026913|NCT03201250|530261329|FG002|Overall Study|screen failures|0|||
147026914|NCT03052959|530261330|FG000|Overall Study|Lost to Follow-up|4|||
147026915|NCT03052959|530261331|FG001|Overall Study|Lost to Follow-up|5|||
147026916|NCT00629265|530261332|FG000|Overall Study|Lost to Follow-up|4|||
147026917|NCT00629265|530261333|FG001|Overall Study|Lost to Follow-up|5|||
147026918|NCT00629265|530261332|FG000|Overall Study|Withdrawal by Subject|11|||
147026919|NCT00629265|530261333|FG001|Overall Study|Withdrawal by Subject|8|||
147026920|NCT00629265|530261332|FG000|Overall Study|Death|1|||
147026921|NCT00629265|530261333|FG001|Overall Study|Death|0|||
147026922|NCT00629265|530261332|FG000|Overall Study|Adverse Event|2|||
147026923|NCT00629265|530261333|FG001|Overall Study|Adverse Event|0|||
147026924|NCT00629265|530261332|FG000|Overall Study|HNC Recurrence|4|||
147026925|NCT00629265|530261333|FG001|Overall Study|HNC Recurrence|0|||
147026926|NCT00629265|530261332|FG000|Overall Study|Other CA Requiring Treatment|1|||
147026927|NCT00629265|530261333|FG001|Overall Study|Other CA Requiring Treatment|3|||
147026928|NCT00629265|530261332|FG000|Overall Study|Needed Esophageal Dilation|4|||
147026929|NCT00629265|530261333|FG001|Overall Study|Needed Esophageal Dilation|1|||
147026930|NCT00629265|530261332|FG000|Overall Study|Unrelated Medical Complications|3|||
147026931|NCT00629265|530261333|FG001|Overall Study|Unrelated Medical Complications|1|||
147026932|NCT00629265|530261332|FG000|Overall Study|Unknown Reason|2|||
147026933|NCT00629265|530261333|FG001|Overall Study|Unknown Reason|2|||
147026934|NCT01782482|530261339|FG000|Overall Study|Adverse Event|2|||
147026935|NCT01782482|530261340|FG001|Overall Study|Adverse Event|1|||
147026936|NCT01782482|530261339|FG000|Overall Study|Lost to Follow-up|2|||
147026937|NCT01782482|530261340|FG001|Overall Study|Lost to Follow-up|3|||
147026938|NCT01782482|530261339|FG000|Overall Study|Physician Decision|1|||
147026939|NCT01782482|530261340|FG001|Overall Study|Physician Decision|0|||
147026940|NCT01782482|530261339|FG000|Overall Study|Protocol Violation|1|||
147026941|NCT01782482|530261340|FG001|Overall Study|Protocol Violation|0|||
147026942|NCT01782482|530261339|FG000|Overall Study|Withdrawal by Subject|2|||
147026943|NCT01782482|530261340|FG001|Overall Study|Withdrawal by Subject|3|||
147026944|NCT01782482|530261339|FG000|Overall Study|Randomized in Error|2|||
147026945|NCT01782482|530261340|FG001|Overall Study|Randomized in Error|2|||
147026946|NCT01782482|530261339|FG000|Overall Study|Habitually wearing toric lens OS|0|||
147026947|NCT01782482|530261340|FG001|Overall Study|Habitually wearing toric lens OS|1|||
147026948|NCT01194973|530261346|FG000|Screening Period|Screen Failure|3|||
147026949|NCT01194973|530261346|FG000|26 Week Treatment Period|Adverse Event|1|||
147026950|NCT01194973|530261346|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
147026951|NCT01194973|530261346|FG000|26 Week Treatment Period|Pregnancy|1|||
147026952|NCT01875471|530261347|FG000|Overall Study|Adverse Event|0|||
147026953|NCT01875471|530261348|FG001|Overall Study|Adverse Event|1|||
147026954|NCT01875471|530261347|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
147026955|NCT01875471|530261348|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
147026956|NCT01321008|530261349|FG000|Overall Study|Early Study Termination|1|||
147026957|NCT02749292|530261350|FG000|Overall Study|Physician Decision|1|||
147026958|NCT02749292|530261351|FG001|Overall Study|Physician Decision|0|||
147026959|NCT02749292|530261350|FG000|Overall Study|Withdrawal by Subject|5|||
147026960|NCT02749292|530261351|FG001|Overall Study|Withdrawal by Subject|7|||
147026961|NCT02749292|530261350|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
147026962|NCT02749292|530261351|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
147026963|NCT02749292|530261350|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
147026964|NCT02749292|530261351|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
147026965|NCT02749292|530261350|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
147026966|NCT02749292|530261351|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
147026967|NCT02749292|530261350|FG000|Overall Study|Adverse Event|4|||
147026968|NCT02749292|530261351|FG001|Overall Study|Adverse Event|1|||
147026969|NCT02749292|530261350|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
147026970|NCT02749292|530261351|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
147026971|NCT02749292|530261350|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
147026972|NCT02749292|530261351|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
147026973|NCT02749292|530261350|FG000|Overall Study|Requiring glucocorticoids|0|||
147026974|NCT02749292|530261351|FG001|Overall Study|Requiring glucocorticoids|3|||
147026975|NCT02749292|530261350|FG000|Overall Study|Cancer|1|||
147026976|NCT02749292|530261351|FG001|Overall Study|Cancer|0|||
147026977|NCT01843348|530261352|FG000|Overall Study|Withdrawal by Subject|4|||
147026978|NCT01843348|530261353|FG001|Overall Study|Withdrawal by Subject|16|||
147026979|NCT01843348|530261354|FG002|Overall Study|Withdrawal by Subject|18|||
147026980|NCT01843348|530261352|FG000|Overall Study|Lost to Follow-up|5|||
147026981|NCT01843348|530261353|FG001|Overall Study|Lost to Follow-up|4|||
147026982|NCT01843348|530261354|FG002|Overall Study|Lost to Follow-up|2|||
147026983|NCT01843348|530261352|FG000|Overall Study|Death|5|||
147026984|NCT01843348|530261353|FG001|Overall Study|Death|3|||
147026985|NCT01843348|530261354|FG002|Overall Study|Death|4|||
147026986|NCT01843348|530261352|FG000|Overall Study|Graft loss/retransplantation|5|||
147026987|NCT01843348|530261353|FG001|Overall Study|Graft loss/retransplantation|8|||
147026988|NCT01843348|530261354|FG002|Overall Study|Graft loss/retransplantation|11|||
147026989|NCT01843348|530261352|FG000|Overall Study|Various reasons|4|||
147026990|NCT01843348|530261353|FG001|Overall Study|Various reasons|9|||
147026991|NCT01843348|530261354|FG002|Overall Study|Various reasons|6|||
147026992|NCT00876018|530261355|FG000|Overall Study|Lost to Follow-up|0|||
147026993|NCT00876018|530261356|FG001|Overall Study|Lost to Follow-up|1|||
147026994|NCT00876018|530261357|FG002|Overall Study|Lost to Follow-up|1|||
147026995|NCT00876018|530261355|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
147026996|NCT00876018|530261356|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
147026997|NCT00876018|530261357|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
147026998|NCT00679913|530261358|FG000|Overall Study|Protocol Violation|18|||
147026999|NCT00679913|530261359|FG001|Overall Study|Protocol Violation|13|||
147027000|NCT00456495|530261360|FG000|Overall Study|Physician Decision|2|||
147027001|NCT01346774|530261361|FG000|Overall Study|Did not take a single dose|6|||
147027002|NCT01346774|530261362|FG001|Overall Study|Did not take a single dose|4|||
147027003|NCT01346774|530261361|FG000|Overall Study|Lost to Follow-up|3|||
147027004|NCT01346774|530261362|FG001|Overall Study|Lost to Follow-up|4|||
147027005|NCT01346774|530261361|FG000|Overall Study|Withdrawal by Subject|1|||
147027006|NCT01346774|530261362|FG001|Overall Study|Withdrawal by Subject|4|||
147027007|NCT01346774|530261361|FG000|Overall Study|Protocol Violation|2|||
147027008|NCT01346774|530261362|FG001|Overall Study|Protocol Violation|3|||
147027009|NCT01346774|530261361|FG000|Overall Study|Adverse Event|1|||
147027010|NCT01346774|530261362|FG001|Overall Study|Adverse Event|2|||
147027011|NCT01929031|530261365|FG000|Overall Study|Adverse Event|3|||
147027012|NCT01929031|530261366|FG001|Overall Study|Adverse Event|1|||
147027013|NCT01929031|530261367|FG002|Overall Study|Adverse Event|1|||
147027014|NCT01929031|530261368|FG003|Overall Study|Adverse Event|0|||
147027015|NCT01929031|530261369|FG004|Overall Study|Adverse Event|0|||
147027016|NCT01929031|530261370|FG005|Overall Study|Adverse Event|0|||
147027017|NCT01929031|530261365|FG000|Overall Study|Protocol Violation|1|||
147027018|NCT01929031|530261366|FG001|Overall Study|Protocol Violation|0|||
147027019|NCT01929031|530261367|FG002|Overall Study|Protocol Violation|0|||
147027020|NCT01929031|530261368|FG003|Overall Study|Protocol Violation|0|||
147027021|NCT01929031|530261369|FG004|Overall Study|Protocol Violation|0|||
147027022|NCT01929031|530261370|FG005|Overall Study|Protocol Violation|1|||
147027023|NCT01929031|530261365|FG000|Overall Study|Reason other than specified above|0|||
147027024|NCT01929031|530261366|FG001|Overall Study|Reason other than specified above|1|||
147027025|NCT01929031|530261367|FG002|Overall Study|Reason other than specified above|0|||
147027026|NCT01929031|530261368|FG003|Overall Study|Reason other than specified above|0|||
147027027|NCT01929031|530261369|FG004|Overall Study|Reason other than specified above|1|||
147027028|NCT01929031|530261370|FG005|Overall Study|Reason other than specified above|0|||
147027029|NCT05816200|530261371|FG000|Overall Study|Lost to Follow-up|2|||
147027030|NCT05816200|530261372|FG001|Overall Study|Lost to Follow-up|1|||
147027031|NCT02394730|530261378|FG000|Overall Study|Lost to Follow-up|1|||
147027032|NCT02394730|530261379|FG001|Overall Study|Lost to Follow-up|0|||
147027033|NCT02394730|530261378|FG000|Overall Study|Withdrawal by Subject|0|||
147027034|NCT02394730|530261379|FG001|Overall Study|Withdrawal by Subject|1|||
147027035|NCT02384850|530261380|FG000|Overall Study|Withdrawal by Subject|2|||
147027036|NCT02384850|530261381|FG001|Overall Study|Withdrawal by Subject|2|||
147027037|NCT00609466|530261385|FG000|Overall Study|Withdrawal by Subject|0|||
147027038|NCT00609466|530261386|FG001|Overall Study|Withdrawal by Subject|1|||
147027039|NCT00609466|530261387|FG002|Overall Study|Withdrawal by Subject|1|||
147027040|NCT00609466|530261385|FG000|Overall Study|Adverse Event|2|||
147027041|NCT00609466|530261386|FG001|Overall Study|Adverse Event|3|||
147027042|NCT00609466|530261387|FG002|Overall Study|Adverse Event|1|||
147027043|NCT00609466|530261385|FG000|Overall Study|Lack of Efficacy|0|||
147027044|NCT00609466|530261386|FG001|Overall Study|Lack of Efficacy|2|||
147027045|NCT00609466|530261387|FG002|Overall Study|Lack of Efficacy|2|||
147027046|NCT03512262|530261388|FG000|Overall Study|Adverse Event|8|||
147027047|NCT03512262|530261389|FG001|Overall Study|Adverse Event|3|||
147027048|NCT03512262|530261388|FG000|Overall Study|Death (non-treatment emergent)|1|||
147027049|NCT03512262|530261389|FG001|Overall Study|Death (non-treatment emergent)|0|||
147027050|NCT03512262|530261388|FG000|Overall Study|Withdrawal by Subject|17|||
147027051|NCT03512262|530261389|FG001|Overall Study|Withdrawal by Subject|9|||
147027052|NCT03512262|530261388|FG000|Overall Study|Lost to Follow-up|7|||
147027053|NCT03512262|530261389|FG001|Overall Study|Lost to Follow-up|1|||
147027054|NCT03512262|530261388|FG000|Overall Study|Other than Specified|2|||
147027055|NCT03512262|530261389|FG001|Overall Study|Other than Specified|2|||
147027056|NCT01299805|530261390|FG000|Overall Study|Adverse Event|2|||
147027057|NCT01299805|530261391|FG001|Overall Study|Adverse Event|0|||
147027058|NCT03510182|530261392|FG000|Overall Study|Withdrawal by Subject|2|||
147027059|NCT01334710|530261399|FG000|Overall Study|Trial was terminated|3|||
147027060|NCT00375492|530261400|FG000|Overall Study|Adverse Event|4|||
147027061|NCT00375492|530261401|FG001|Overall Study|Adverse Event|5|||
147027062|NCT00375492|530261400|FG000|Overall Study|Entry Criteria Not Met|0|||
147027063|NCT00375492|530261401|FG001|Overall Study|Entry Criteria Not Met|1|||
147027064|NCT00375492|530261400|FG000|Overall Study|Loss of Glucose Control|0|||
147027065|NCT00375492|530261401|FG001|Overall Study|Loss of Glucose Control|1|||
147027066|NCT00375492|530261400|FG000|Overall Study|Lost to Follow-up|10|||
147027067|NCT00375492|530261401|FG001|Overall Study|Lost to Follow-up|5|||
147027068|NCT00375492|530261400|FG000|Overall Study|Physician Decision|0|||
147027069|NCT00375492|530261401|FG001|Overall Study|Physician Decision|4|||
147027070|NCT00375492|530261400|FG000|Overall Study|Protocol Violation|6|||
147027071|NCT00375492|530261401|FG001|Overall Study|Protocol Violation|3|||
147027072|NCT00375492|530261400|FG000|Overall Study|Sponsor Decision|0|||
147027073|NCT00375492|530261401|FG001|Overall Study|Sponsor Decision|1|||
147027074|NCT00375492|530261400|FG000|Overall Study|Withdrawal by Subject|6|||
147027075|NCT00375492|530261401|FG001|Overall Study|Withdrawal by Subject|6|||
147027076|NCT00290251|530261405|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
147027077|NCT00290251|530261406|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
147027078|NCT00290251|530261407|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
147027079|NCT00290251|530261408|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
147027080|NCT00290251|530261409|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
147027081|NCT00290251|530261410|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
147027082|NCT00290251|530261405|FG000|Treatment 1 (Months 2-4)|headache|0|||
147027083|NCT00290251|530261406|FG001|Treatment 1 (Months 2-4)|headache|0|||
147027084|NCT00290251|530261407|FG002|Treatment 1 (Months 2-4)|headache|0|||
147027085|NCT00290251|530261408|FG003|Treatment 1 (Months 2-4)|headache|0|||
147027086|NCT00290251|530261409|FG004|Treatment 1 (Months 2-4)|headache|1|||
147027087|NCT00290251|530261410|FG005|Treatment 1 (Months 2-4)|headache|0|||
147027088|NCT00290251|530261405|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
147027089|NCT00290251|530261406|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
147027090|NCT00290251|530261407|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
147027091|NCT00290251|530261408|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
147027092|NCT00290251|530261409|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
147027093|NCT00290251|530261410|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
147027094|NCT03340064|530263512|FG000|First Period|Adverse Event, non-fatal|2|||
147027095|NCT03340064|530263513|FG001|First Period|Adverse Event, non-fatal|0|||
147027096|NCT03340064|530263512|FG000|First Period|Lack of Efficacy|3|||
147027097|NCT03340064|530263513|FG001|First Period|Lack of Efficacy|0|||
147027098|NCT03340064|530263512|FG000|Second Period|Adverse Event, non-fatal|1|||
147027099|NCT03340064|530263513|FG001|Second Period|Adverse Event, non-fatal|1|||
147027100|NCT03340064|530263512|FG000|Second Period|Lack of Efficacy|11|||
147027101|NCT03340064|530263513|FG001|Second Period|Lack of Efficacy|0|||
147027102|NCT03340064|530263512|FG000|Second Period|Physician Decision|3|||
147027103|NCT03340064|530263513|FG001|Second Period|Physician Decision|0|||
147027104|NCT03340064|530263512|FG000|Second Period|Withdrawal by Subject|2|||
147027105|NCT03340064|530263513|FG001|Second Period|Withdrawal by Subject|1|||
147027106|NCT03340064|530263512|FG000|Second Period|Approved Drug Available For Indication|1|||
147027107|NCT03340064|530263513|FG001|Second Period|Approved Drug Available For Indication|0|||
147027108|NCT03340064|530263512|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
147027109|NCT03340064|530263513|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
147027110|NCT02221037|530263514|FG000|Overall Study|Physician Decision|0|||
147027111|NCT02221037|530263515|FG001|Overall Study|Physician Decision|0|||
147027112|NCT02221037|530263516|FG002|Overall Study|Physician Decision|1|||
147027113|NCT02221037|530263517|FG003|Overall Study|Physician Decision|0|||
147027114|NCT02944383|530263520|FG000|Overall Study|Lost to Follow-up|0|||
147027115|NCT02944383|530263521|FG001|Overall Study|Lost to Follow-up|0|||
147027116|NCT02944383|530263522|FG002|Overall Study|Lost to Follow-up|1|||
147027117|NCT02944383|530263520|FG000|Overall Study|Withdrawal by Subject|1|||
147027118|NCT02944383|530263521|FG001|Overall Study|Withdrawal by Subject|0|||
147027119|NCT02944383|530263522|FG002|Overall Study|Withdrawal by Subject|0|||
147027120|NCT00852969|530263527|FG000|Overall Study|Adverse Event|0|||
147027121|NCT00852969|530263528|FG001|Overall Study|Adverse Event|1|||
147027122|NCT00852969|530263527|FG000|Overall Study|Lost to Follow-up|0|||
147027123|NCT00852969|530263528|FG001|Overall Study|Lost to Follow-up|1|||
147027124|NCT02358343|530263531|FG000|Screening Intervention|Death|0|||
147027125|NCT02358343|530263532|FG001|Screening Intervention|Death|2|||
147027126|NCT02358343|530263533|FG002|Screening Intervention|Death|0|||
147027127|NCT02358343|530263534|FG003|Screening Intervention|Death|0|||
147027128|NCT02358343|530263535|FG004|Screening Intervention|Death|0|||
147027129|NCT02358343|530263531|FG000|Screening Intervention|Withdrawal by Subject|1|||
147027130|NCT02358343|530263532|FG001|Screening Intervention|Withdrawal by Subject|0|||
147027131|NCT02358343|530263533|FG002|Screening Intervention|Withdrawal by Subject|0|||
146849515|NCT02929329|529618845|FG001|Overall Study|Death|1051|||
146849516|NCT02121301|529618846|FG000|Overall Study|Protocol Violation|1|||
147027132|NCT02358343|530263534|FG003|Screening Intervention|Withdrawal by Subject|0|||
147027133|NCT02358343|530263535|FG004|Screening Intervention|Withdrawal by Subject|0|||
146849517|NCT02121301|529618847|FG001|Overall Study|Protocol Violation|4|||
147027134|NCT02358343|530263531|FG000|Screening Intervention|Determined Ineligible|5|||
147027135|NCT02358343|530263532|FG001|Screening Intervention|Determined Ineligible|6|||
147027136|NCT02358343|530263533|FG002|Screening Intervention|Determined Ineligible|0|||
147027137|NCT02358343|530263534|FG003|Screening Intervention|Determined Ineligible|0|||
147027138|NCT02358343|530263535|FG004|Screening Intervention|Determined Ineligible|0|||
147027139|NCT02358343|530263531|FG000|Comparative Efficacy Trial / Observation|Death|0|||
147027140|NCT02358343|530263532|FG001|Comparative Efficacy Trial / Observation|Death|0|||
147027141|NCT02358343|530263533|FG002|Comparative Efficacy Trial / Observation|Death|2|||
147027142|NCT02358343|530263534|FG003|Comparative Efficacy Trial / Observation|Death|0|||
147027143|NCT02358343|530263535|FG004|Comparative Efficacy Trial / Observation|Death|0|||
147027144|NCT02358343|530263531|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
147027145|NCT02358343|530263532|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
147027146|NCT02358343|530263533|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
147027147|NCT02358343|530263534|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
147027148|NCT02358343|530263535|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
147027149|NCT02358343|530263531|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
147027150|NCT02358343|530263532|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
147027151|NCT02358343|530263533|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
147027152|NCT02358343|530263534|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
147027153|NCT02358343|530263535|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
147027154|NCT00609518|530263538|FG000|Overall Study|Death from Study Disease|32|||
147027155|NCT00609518|530263539|FG001|Overall Study|Death from Study Disease|32|||
147027156|NCT00609518|530263538|FG000|Overall Study|Withdrawal by Subject|5|||
147027157|NCT00609518|530263539|FG001|Overall Study|Withdrawal by Subject|3|||
147027158|NCT00609518|530263538|FG000|Overall Study|Lost to Follow-up|3|||
147027159|NCT00609518|530263539|FG001|Overall Study|Lost to Follow-up|0|||
147027160|NCT00609518|530263538|FG000|Overall Study|Physician Decision|1|||
147027161|NCT00609518|530263539|FG001|Overall Study|Physician Decision|3|||
147027162|NCT00609518|530263538|FG000|Overall Study|Death from Adverse Event|2|||
147027163|NCT00609518|530263539|FG001|Overall Study|Death from Adverse Event|2|||
147027164|NCT05855616|530263540|FG000|Overall Study|Lost to Follow-up|1|||
147027165|NCT05855616|530263541|FG001|Overall Study|Lost to Follow-up|2|||
147027166|NCT04032158|530263542|FG000|Overall Study|Study Termination|2|||
147027167|NCT04032158|530263543|FG001|Overall Study|Study Termination|1|||
147027168|NCT04322149|530263544|FG000|Overall Study|Adverse Event|1|||
147027169|NCT04322149|530263545|FG001|Overall Study|Adverse Event|1|||
147027170|NCT04322149|530263546|FG002|Overall Study|Adverse Event|0|||
147027171|NCT04322149|530263547|FG003|Overall Study|Adverse Event|0|||
147027172|NCT04322149|530263544|FG000|Overall Study|Withdrawal by Subject|0|||
147027173|NCT04322149|530263545|FG001|Overall Study|Withdrawal by Subject|0|||
147027174|NCT04322149|530263546|FG002|Overall Study|Withdrawal by Subject|0|||
147027175|NCT04322149|530263547|FG003|Overall Study|Withdrawal by Subject|2|||
147027176|NCT04322149|530263544|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
147027177|NCT04322149|530263545|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
147027178|NCT04322149|530263546|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
147027179|NCT04322149|530263547|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
147027180|NCT01700049|530263554|FG000|Overall Study|Withdrawal by Subject|1|||
147027181|NCT03084367|530263557|FG000|Overall Study|Lost to Follow-up|32|||
147027182|NCT03084367|530263557|FG000|Overall Study|Withdrawal by Subject|4|||
147027183|NCT03084367|530263557|FG000|Overall Study|Other|1|||
147027184|NCT04325204|530263558|FG000|Overall Study|Death|0|||
147027185|NCT04325204|530263559|FG001|Overall Study|Death|1|||
147027186|NCT04325204|530263558|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
147027187|NCT04325204|530263559|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
147027188|NCT04325204|530263558|FG000|Overall Study|Lost to Follow-up|8|||
147027189|NCT04325204|530263559|FG001|Overall Study|Lost to Follow-up|8|||
147027190|NCT04325204|530263558|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
147027191|NCT04325204|530263559|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
147027192|NCT04710979|530263561|FG000|Overall Study|Lost to Follow-up|2|||
147027193|NCT04710979|530263562|FG001|Overall Study|Lost to Follow-up|4|||
147027194|NCT04710979|530263561|FG000|Overall Study|Withdrawal by Subject|1|||
147027195|NCT04710979|530263562|FG001|Overall Study|Withdrawal by Subject|0|||
147027196|NCT00307034|530263567|FG000|Overall Study|Adverse Event|1|||
147027197|NCT00307034|530263568|FG001|Overall Study|Adverse Event|2|||
147027198|NCT00307034|530263567|FG000|Overall Study|Withdrawal by Subject|1|||
147027199|NCT00307034|530263568|FG001|Overall Study|Withdrawal by Subject|2|||
147027200|NCT00307034|530263567|FG000|Overall Study|Lost to Follow-up|0|||
147027201|NCT00307034|530263568|FG001|Overall Study|Lost to Follow-up|3|||
147027202|NCT03254602|530263574|FG000|Overall Study|Lost to Follow-up|4|||
147027203|NCT02963311|530263577|FG000|Overall Study|Withdrawal by Subject|1|||
147027204|NCT02963311|530263577|FG000|Overall Study|Screen Failure|4|||
147027205|NCT01691820|530263578|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
147027206|NCT01691820|530263579|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
147027207|NCT01691820|530263578|FG000|Overall Study|Migrated/moved from study area|7|||
147027208|NCT01691820|530263579|FG001|Overall Study|Migrated/moved from study area|4|||
147027209|NCT01691820|530263578|FG000|Overall Study|Lost to Follow-up|6|||
147027210|NCT01691820|530263579|FG001|Overall Study|Lost to Follow-up|17|||
147027211|NCT01691820|530263578|FG000|Overall Study|Other (unspecified)|4|||
147027212|NCT01691820|530263579|FG001|Overall Study|Other (unspecified)|1|||
147027213|NCT04442490|530263581|FG000|Overall Study|Withdrawal by Subject|18|||
147027214|NCT04442490|530263582|FG001|Overall Study|Withdrawal by Subject|10|||
147027215|NCT04442490|530263581|FG000|Overall Study|Lost to Follow-up|7|||
147027216|NCT04442490|530263582|FG001|Overall Study|Lost to Follow-up|7|||
147027217|NCT04442490|530263581|FG000|Overall Study|Adverse Event|2|||
147027218|NCT04442490|530263582|FG001|Overall Study|Adverse Event|6|||
147027219|NCT04442490|530263581|FG000|Overall Study|Noncompliance|3|||
147027220|NCT04442490|530263582|FG001|Overall Study|Noncompliance|1|||
147027221|NCT04442490|530263581|FG000|Overall Study|Physician Decision|2|||
147027222|NCT04442490|530263582|FG001|Overall Study|Physician Decision|1|||
147027223|NCT04442490|530263581|FG000|Overall Study|Reason not Specified|2|||
147027224|NCT04442490|530263582|FG001|Overall Study|Reason not Specified|1|||
147027225|NCT04442490|530263581|FG000|Overall Study|Randomized but not Treated|3|||
147027226|NCT04442490|530263582|FG001|Overall Study|Randomized but not Treated|3|||
147027227|NCT02372071|530263594|FG000|Overall Study|Protocol Violation|18|||
147027228|NCT01449279|530263595|FG000|Overall Study|Lack of Efficacy|5|||
147027229|NCT01449279|530263595|FG000|Overall Study|Toxicity|2|||
147027230|NCT02618408|530263596|FG000|Overall Study|Withdrawal by Subject|1|||
147027231|NCT02618408|530263597|FG001|Overall Study|Withdrawal by Subject|0|||
147027232|NCT02618408|530263598|FG002|Overall Study|Withdrawal by Subject|4|||
147027233|NCT02618408|530263596|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
147027234|NCT02618408|530263597|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
147027235|NCT02618408|530263598|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
147027236|NCT02618408|530263596|FG000|Overall Study|Lost to Follow-up|4|||
147027237|NCT02618408|530263597|FG001|Overall Study|Lost to Follow-up|2|||
147027238|NCT02618408|530263598|FG002|Overall Study|Lost to Follow-up|6|||
147027239|NCT02618408|530263596|FG000|Overall Study|Adverse Event|4|||
147027240|NCT02618408|530263597|FG001|Overall Study|Adverse Event|0|||
147027241|NCT02618408|530263598|FG002|Overall Study|Adverse Event|10|||
147027242|NCT02618408|530263596|FG000|Overall Study|Physician Decision|1|||
147027243|NCT02618408|530263597|FG001|Overall Study|Physician Decision|1|||
147027244|NCT02618408|530263598|FG002|Overall Study|Physician Decision|2|||
147027245|NCT02618408|530263596|FG000|Overall Study|Protocol Violation|1|||
147027246|NCT02618408|530263597|FG001|Overall Study|Protocol Violation|1|||
147027247|NCT02618408|530263598|FG002|Overall Study|Protocol Violation|2|||
147027248|NCT02618408|530263596|FG000|Overall Study|Other, Multiple Categories|0|||
147027249|NCT02618408|530263597|FG001|Overall Study|Other, Multiple Categories|0|||
147027250|NCT02618408|530263598|FG002|Overall Study|Other, Multiple Categories|4|||
147027251|NCT01524679|530263612|FG000|Overall Study|Lost to Follow-up|1|||
147027252|NCT01524679|530263613|FG001|Overall Study|Lost to Follow-up|4|||
147027253|NCT01524679|530263612|FG000|Overall Study|Withdrawal by Subject|4|||
147027254|NCT01524679|530263613|FG001|Overall Study|Withdrawal by Subject|4|||
147027255|NCT01524679|530263612|FG000|Overall Study|Adverse Event|9|||
147027256|NCT01524679|530263613|FG001|Overall Study|Adverse Event|0|||
147027257|NCT01524679|530263612|FG000|Overall Study|Protocol Violation|1|||
147027258|NCT01524679|530263613|FG001|Overall Study|Protocol Violation|0|||
147027259|NCT01524679|530263612|FG000|Overall Study|Lack of Efficacy|2|||
147027260|NCT01524679|530263613|FG001|Overall Study|Lack of Efficacy|0|||
147027261|NCT01524679|530263612|FG000|Overall Study|e.g.wish for children, relocation|6|||
147027262|NCT01524679|530263613|FG001|Overall Study|e.g.wish for children, relocation|1|||
147027263|NCT03321630|530263616|FG000|Overall Study|Adverse Event|1|||
147027264|NCT03321630|530263616|FG000|Overall Study|Investigator Discretion|2|||
147027265|NCT03321630|530263616|FG000|Overall Study|Withdrawal by Subject|1|||
147027266|NCT00140426|530263617|FG000|Overall Study|Withdrawal by Subject|0|||
147027267|NCT00140426|530263618|FG001|Overall Study|Withdrawal by Subject|3|||
147027268|NCT04765384|530263619|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
147027269|NCT04765384|530263620|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
147027270|NCT04765384|530263621|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
147027271|NCT04765384|530263622|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
147027272|NCT04765384|530263623|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
147027273|NCT04765384|530263624|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
147027274|NCT04765384|530263619|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
147027275|NCT04765384|530263620|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
147027276|NCT04765384|530263621|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
147027277|NCT04765384|530263622|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
147027278|NCT04765384|530263623|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
147027279|NCT04765384|530263624|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
147027280|NCT04765384|530263619|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
147027281|NCT04765384|530263620|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
147027282|NCT04765384|530263621|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
147027283|NCT04765384|530263622|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
147027284|NCT04765384|530263623|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
147027285|NCT04765384|530263624|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
147027286|NCT04765384|530263619|FG000|Post-natal: Neonates and Infants|Death|0|||
147027287|NCT04765384|530263620|FG001|Post-natal: Neonates and Infants|Death|0|||
147027288|NCT04765384|530263621|FG002|Post-natal: Neonates and Infants|Death|0|||
147027289|NCT04765384|530263622|FG003|Post-natal: Neonates and Infants|Death|1|||
147027290|NCT04765384|530263623|FG004|Post-natal: Neonates and Infants|Death|0|||
147027291|NCT04765384|530263624|FG005|Post-natal: Neonates and Infants|Death|0|||
147027292|NCT04765384|530263619|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
147027293|NCT04765384|530263620|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
147027294|NCT04765384|530263621|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
147027295|NCT04765384|530263622|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
147027296|NCT04765384|530263623|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
147027297|NCT04765384|530263624|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
147027298|NCT01169532|530263629|FG000|Overall Study|Withdrawal by Subject|1|||
147027299|NCT02032706|530263633|FG000|Overall Study|Did not qualify|5|||
147027300|NCT02032706|530263633|FG000|Overall Study|Protocol Violation|1|||
147027301|NCT05070546|530263638|FG000|Overall Study|Death|0|||
147027302|NCT05070546|530263639|FG001|Overall Study|Death|0|||
147027303|NCT05070546|530263640|FG002|Overall Study|Death|0|||
147027304|NCT05070546|530263641|FG003|Overall Study|Death|0|||
147027305|NCT05070546|530263642|FG004|Overall Study|Death|0|||
147027306|NCT05070546|530263643|FG005|Overall Study|Death|1|||
147027307|NCT05070546|530263638|FG000|Overall Study|Lost to Follow-up|8|||
147027308|NCT05070546|530263639|FG001|Overall Study|Lost to Follow-up|2|||
147027309|NCT05070546|530263640|FG002|Overall Study|Lost to Follow-up|7|||
147027310|NCT05070546|530263641|FG003|Overall Study|Lost to Follow-up|1|||
147027311|NCT05070546|530263642|FG004|Overall Study|Lost to Follow-up|2|||
147027312|NCT05070546|530263643|FG005|Overall Study|Lost to Follow-up|0|||
147027313|NCT05070546|530263638|FG000|Overall Study|Withdrawal by Subject|1|||
147027314|NCT05070546|530263639|FG001|Overall Study|Withdrawal by Subject|1|||
147027315|NCT05070546|530263640|FG002|Overall Study|Withdrawal by Subject|3|||
147027316|NCT05070546|530263641|FG003|Overall Study|Withdrawal by Subject|0|||
147027317|NCT05070546|530263642|FG004|Overall Study|Withdrawal by Subject|0|||
147027318|NCT05070546|530263643|FG005|Overall Study|Withdrawal by Subject|0|||
147027319|NCT05070546|530263638|FG000|Overall Study|Other|0|||
147027320|NCT05070546|530263639|FG001|Overall Study|Other|0|||
147027321|NCT05070546|530263640|FG002|Overall Study|Other|0|||
147027322|NCT05070546|530263641|FG003|Overall Study|Other|0|||
147027323|NCT05070546|530263642|FG004|Overall Study|Other|3|||
147027324|NCT05070546|530263643|FG005|Overall Study|Other|0|||
147027325|NCT05070546|530263638|FG000|Overall Study|Randomized but not vaccinated|1|||
147027326|NCT05070546|530263639|FG001|Overall Study|Randomized but not vaccinated|0|||
147027327|NCT05070546|530263640|FG002|Overall Study|Randomized but not vaccinated|1|||
147027328|NCT05070546|530263641|FG003|Overall Study|Randomized but not vaccinated|1|||
147027329|NCT05070546|530263642|FG004|Overall Study|Randomized but not vaccinated|3|||
147027330|NCT05070546|530263643|FG005|Overall Study|Randomized but not vaccinated|0|||
147027331|NCT00160641|530263644|FG000|Overall Study|Adverse Event|102|||
147027332|NCT00160641|530263644|FG000|Overall Study|Withdrawal by Subject|87|||
147027333|NCT00160641|530263644|FG000|Overall Study|Lost to Follow-up|8|||
147027334|NCT00160641|530263644|FG000|Overall Study|Lack of Efficacy|12|||
147027335|NCT00160641|530263644|FG000|Overall Study|Protocol Violation|3|||
147027336|NCT00160641|530263644|FG000|Overall Study|Other|9|||
147027337|NCT02787408|530263645|FG000|Overall Study|Death|16|||
147027338|NCT02787408|530263645|FG000|Overall Study|Withdrawal by Subject|1|||
147027339|NCT02787408|530263645|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
147027340|NCT00985712|530263647|FG000|Overall Study|Adverse Event|0|||
147027341|NCT00985712|530263648|FG001|Overall Study|Adverse Event|1|||
147027342|NCT00985712|530263647|FG000|Overall Study|Lost to Follow-up|2|||
147027343|NCT00985712|530263648|FG001|Overall Study|Lost to Follow-up|2|||
147027344|NCT00985712|530263647|FG000|Overall Study|Protocol Violation|0|||
147027345|NCT00985712|530263648|FG001|Overall Study|Protocol Violation|1|||
147027346|NCT00985712|530263647|FG000|Overall Study|Withdrawal by Subject|4|||
147027347|NCT00985712|530263648|FG001|Overall Study|Withdrawal by Subject|1|||
147027348|NCT00985712|530263647|FG000|Overall Study|Sponsor decision|0|||
147027349|NCT00985712|530263648|FG001|Overall Study|Sponsor decision|2|||
147027350|NCT03096847|530263649|FG000|Overall Study|Other|2|||
147027351|NCT03096847|530263650|FG001|Overall Study|Other|1|||
147027352|NCT03096847|530263651|FG002|Overall Study|Other|2|||
147027353|NCT03096847|530263649|FG000|Overall Study|Lost to Follow-up|1|||
147027354|NCT03096847|530263650|FG001|Overall Study|Lost to Follow-up|0|||
147027355|NCT03096847|530263651|FG002|Overall Study|Lost to Follow-up|1|||
147027356|NCT03096847|530263649|FG000|Overall Study|Death|6|||
147027357|NCT03096847|530263650|FG001|Overall Study|Death|0|||
147027358|NCT03096847|530263651|FG002|Overall Study|Death|2|||
147027359|NCT03096847|530263649|FG000|Overall Study|Protocol Violation|3|||
147027360|NCT03096847|530263650|FG001|Overall Study|Protocol Violation|0|||
147027361|NCT03096847|530263651|FG002|Overall Study|Protocol Violation|6|||
147027362|NCT03096847|530263649|FG000|Overall Study|Physician Decision|12|||
147027363|NCT03096847|530263650|FG001|Overall Study|Physician Decision|2|||
147027364|NCT03096847|530263651|FG002|Overall Study|Physician Decision|8|||
147027365|NCT03096847|530263649|FG000|Overall Study|Withdrawal by Subject|24|||
147027366|NCT03096847|530263650|FG001|Overall Study|Withdrawal by Subject|1|||
147027367|NCT03096847|530263651|FG002|Overall Study|Withdrawal by Subject|12|||
147027368|NCT03096847|530263649|FG000|Overall Study|Adverse Event|72|||
147027369|NCT03096847|530263650|FG001|Overall Study|Adverse Event|6|||
147027370|NCT03096847|530263651|FG002|Overall Study|Adverse Event|28|||
147027371|NCT03096847|530263649|FG000|Overall Study|Progressive disease|97|||
147027372|NCT03096847|530263650|FG001|Overall Study|Progressive disease|10|||
147027373|NCT03096847|530263651|FG002|Overall Study|Progressive disease|78|||
147027374|NCT03096847|530263649|FG000|Overall Study|Non-compliance with study medication|1|||
147027375|NCT03096847|530263650|FG001|Overall Study|Non-compliance with study medication|0|||
147027376|NCT03096847|530263651|FG002|Overall Study|Non-compliance with study medication|0|||
147027377|NCT03096847|530263649|FG000|Overall Study|New therapy for study indication|1|||
147027378|NCT03096847|530263650|FG001|Overall Study|New therapy for study indication|0|||
147027379|NCT03096847|530263651|FG002|Overall Study|New therapy for study indication|1|||
147027380|NCT00359632|530263652|FG000|Overall Study|Death|2|||
147027381|NCT00359632|530263653|FG001|Overall Study|Death|0|||
147027382|NCT00359632|530263652|FG000|Overall Study|Adverse Event|1|||
147027383|NCT00359632|530263653|FG001|Overall Study|Adverse Event|0|||
147027384|NCT00359632|530263652|FG000|Overall Study|Non-compliance with visit schedule|1|||
147027385|NCT00359632|530263653|FG001|Overall Study|Non-compliance with visit schedule|0|||
147027386|NCT02458092|530263657|FG000|Overall Study|Withdrawal by Subject|1|||
147027387|NCT02458092|530263658|FG001|Overall Study|Withdrawal by Subject|0|||
147027388|NCT00251641|530263659|FG000|Overall Study|Adverse Event|80|||
147027389|NCT00251641|530263660|FG001|Overall Study|Adverse Event|8|||
147027390|NCT00251641|530263659|FG000|Overall Study|Lack of Efficacy|2|||
147027391|NCT00251641|530263660|FG001|Overall Study|Lack of Efficacy|1|||
147027392|NCT00251641|530263659|FG000|Overall Study|Progression of Disease|0|||
147027393|NCT00251641|530263660|FG001|Overall Study|Progression of Disease|2|||
147027394|NCT00251641|530263659|FG000|Overall Study|Lost to Follow-up|3|||
147027395|NCT00251641|530263660|FG001|Overall Study|Lost to Follow-up|3|||
147027396|NCT00251641|530263659|FG000|Overall Study|Withdrawal by Subject|6|||
147027397|NCT00251641|530263660|FG001|Overall Study|Withdrawal by Subject|8|||
147027398|NCT00251641|530263659|FG000|Overall Study|Protocol Violation|10|||
147027399|NCT00251641|530263660|FG001|Overall Study|Protocol Violation|2|||
147027400|NCT00251641|530263659|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
147027401|NCT00251641|530263660|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
147027402|NCT00251641|530263659|FG000|Overall Study|Switched Treatment|9|||
147027403|NCT00251641|530263660|FG001|Overall Study|Switched Treatment|63|||
147027404|NCT01230892|530263661|FG000|Overall Study|Withdrawal by Subject|1|||
147027405|NCT01230892|530263662|FG001|Overall Study|Withdrawal by Subject|1|||
147027406|NCT01230892|530263661|FG000|Overall Study|Lost to Follow-up|2|||
147027407|NCT01230892|530263662|FG001|Overall Study|Lost to Follow-up|0|||
147027408|NCT00725621|530263665|FG000|Overall Study|Adverse Event|25|||
147027409|NCT00725621|530263665|FG000|Overall Study|Lack of Efficacy|46|||
147027410|NCT00725621|530263665|FG000|Overall Study|Withdrawal by Subject|57|||
147027411|NCT00725621|530263665|FG000|Overall Study|Physician Decision|19|||
147027412|NCT00725621|530263665|FG000|Overall Study|Lost to Follow-up|52|||
147027413|NCT00725621|530263665|FG000|Overall Study|Non-compliance|8|||
147027414|NCT00725621|530263665|FG000|Overall Study|Continued treatment by other physician|6|||
147027415|NCT00725621|530263665|FG000|Overall Study|Switched to other study|1|||
147027416|NCT00725621|530263665|FG000|Overall Study|Switched to other drug|1|||
147027417|NCT00725621|530263665|FG000|Overall Study|Prepared for elective surgery|1|||
147027418|NCT00725621|530263665|FG000|Overall Study|Reason not specified|55|||
147027419|NCT01189500|530263666|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
147027420|NCT01189500|530263666|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
147027421|NCT01000493|530263667|FG000|Overall Study|Adverse Event|3|||
147027422|NCT01000493|530263668|FG001|Overall Study|Adverse Event|6|||
147027423|NCT01000493|530263667|FG000|Overall Study|Lack of Efficacy|1|||
147027424|NCT01000493|530263668|FG001|Overall Study|Lack of Efficacy|1|||
147027425|NCT01000493|530263667|FG000|Overall Study|Protocol Violation|1|||
147027426|NCT01000493|530263668|FG001|Overall Study|Protocol Violation|8|||
147027427|NCT01000493|530263667|FG000|Overall Study|Study closed/terminated|25|||
146849518|NCT02121301|529618848|FG002|Overall Study|Protocol Violation|1|||
146849519|NCT02663518|529618851|FG000|Part 1: Phase 1a Escalation|Death|0|||
147027428|NCT01000493|530263668|FG001|Overall Study|Study closed/terminated|23|||
147027429|NCT01000493|530263667|FG000|Overall Study|Lost to Follow-up|5|||
147027430|NCT01000493|530263668|FG001|Overall Study|Lost to Follow-up|9|||
147027431|NCT01000493|530263667|FG000|Overall Study|Physician Decision|1|||
147027432|NCT01000493|530263668|FG001|Overall Study|Physician Decision|1|||
147027433|NCT01000493|530263667|FG000|Overall Study|Withdrawal by Subject|3|||
147027434|NCT01000493|530263668|FG001|Overall Study|Withdrawal by Subject|7|||
147027435|NCT01144364|530263674|FG000|Induction Phase|Disease progression|14|||
147027436|NCT01144364|530263675|FG001|Induction Phase|Disease progression|0|||
147027437|NCT01144364|530263676|FG002|Induction Phase|Disease progression|0|||
147027438|NCT01144364|530263674|FG000|Induction Phase|Adverse Event|9|||
147027439|NCT01144364|530263675|FG001|Induction Phase|Adverse Event|0|||
147027440|NCT01144364|530263676|FG002|Induction Phase|Adverse Event|0|||
147027441|NCT01144364|530263674|FG000|Induction Phase|Death|1|||
147027442|NCT01144364|530263675|FG001|Induction Phase|Death|0|||
147027443|NCT01144364|530263676|FG002|Induction Phase|Death|0|||
147027444|NCT01144364|530263674|FG000|Induction Phase|Withdrawal by Subject|1|||
147027445|NCT01144364|530263675|FG001|Induction Phase|Withdrawal by Subject|0|||
147027446|NCT01144364|530263676|FG002|Induction Phase|Withdrawal by Subject|0|||
147027447|NCT01144364|530263674|FG000|Induction Phase|Lost to Follow-up|2|||
147027448|NCT01144364|530263675|FG001|Induction Phase|Lost to Follow-up|0|||
147027449|NCT01144364|530263676|FG002|Induction Phase|Lost to Follow-up|0|||
147027450|NCT01144364|530263674|FG000|Induction Phase|Physician Decision|1|||
147027451|NCT01144364|530263675|FG001|Induction Phase|Physician Decision|0|||
147027452|NCT01144364|530263676|FG002|Induction Phase|Physician Decision|0|||
147027453|NCT01144364|530263674|FG000|Induction Phase|Stable disease|2|||
147027454|NCT01144364|530263675|FG001|Induction Phase|Stable disease|0|||
147027455|NCT01144364|530263676|FG002|Induction Phase|Stable disease|0|||
147027456|NCT01144364|530263674|FG000|Induction Phase|Secondary neoplasia|1|||
147027457|NCT01144364|530263675|FG001|Induction Phase|Secondary neoplasia|0|||
147027458|NCT01144364|530263676|FG002|Induction Phase|Secondary neoplasia|0|||
147027459|NCT01144364|530263674|FG000|Induction Phase|Protocol Violation|1|||
147027460|NCT01144364|530263675|FG001|Induction Phase|Protocol Violation|0|||
147027461|NCT01144364|530263676|FG002|Induction Phase|Protocol Violation|0|||
147027462|NCT01144364|530263674|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
147027463|NCT01144364|530263675|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
147027464|NCT01144364|530263676|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
147027465|NCT01144364|530263674|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
147027466|NCT01144364|530263675|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
147027467|NCT01144364|530263676|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
147027468|NCT01144364|530263674|FG000|Follow-Up/Maintenance Phase|Death|0|||
147027469|NCT01144364|530263675|FG001|Follow-Up/Maintenance Phase|Death|2|||
147027470|NCT01144364|530263676|FG002|Follow-Up/Maintenance Phase|Death|0|||
147027471|NCT01144364|530263674|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
147027472|NCT01144364|530263675|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
147027473|NCT01144364|530263676|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
147027474|NCT01144364|530263674|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
147027475|NCT01144364|530263675|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
147027476|NCT01144364|530263676|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
147027477|NCT01144364|530263674|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
147027478|NCT01144364|530263675|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
147027479|NCT01144364|530263676|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
147027480|NCT01144364|530263674|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
147027481|NCT01144364|530263675|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
147027482|NCT01144364|530263676|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
147027483|NCT02989168|530263677|FG000|Overall Study|Withdrawal by Subject|2|||
147027484|NCT02989168|530263678|FG001|Overall Study|Withdrawal by Subject|0|||
147027485|NCT02989168|530263677|FG000|Overall Study|Physician Decision|0|||
147027486|NCT02989168|530263678|FG001|Overall Study|Physician Decision|1|||
147027487|NCT02989168|530263677|FG000|Overall Study|Adverse Event|1|||
147027488|NCT02989168|530263678|FG001|Overall Study|Adverse Event|2|||
147027489|NCT02989168|530263677|FG000|Overall Study|Sponsor stopped study.|1|||
147027490|NCT02989168|530263678|FG001|Overall Study|Sponsor stopped study.|0|||
147027491|NCT03456960|530263679|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
147027492|NCT03456960|530263680|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
147027493|NCT03456960|530263681|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
147027494|NCT03456960|530263682|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
147027495|NCT03456960|530263683|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
147027496|NCT03456960|530263684|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
147027497|NCT03456960|530263679|FG000|Period 2 (1 Day)|Adverse Event|1|||
147027498|NCT03456960|530263680|FG001|Period 2 (1 Day)|Adverse Event|0|||
147027499|NCT03456960|530263681|FG002|Period 2 (1 Day)|Adverse Event|0|||
147027500|NCT03456960|530263682|FG003|Period 2 (1 Day)|Adverse Event|1|||
147027501|NCT03456960|530263683|FG004|Period 2 (1 Day)|Adverse Event|0|||
147027502|NCT03456960|530263684|FG005|Period 2 (1 Day)|Adverse Event|0|||
147027503|NCT00532935|530263685|FG000|Overall Study|Adverse Event|11|||
147027504|NCT00532935|530263686|FG001|Overall Study|Adverse Event|12|||
147027505|NCT00532935|530263685|FG000|Overall Study|Lack of Efficacy|0|||
147027506|NCT00532935|530263686|FG001|Overall Study|Lack of Efficacy|3|||
147027507|NCT00532935|530263685|FG000|Overall Study|Lost to Follow-up|10|||
147027508|NCT00532935|530263686|FG001|Overall Study|Lost to Follow-up|6|||
147027509|NCT00532935|530263685|FG000|Overall Study|Physician Decision|4|||
147027510|NCT00532935|530263686|FG001|Overall Study|Physician Decision|5|||
147027511|NCT00532935|530263685|FG000|Overall Study|Pregnancy|1|||
147027512|NCT00532935|530263686|FG001|Overall Study|Pregnancy|0|||
147027513|NCT00532935|530263685|FG000|Overall Study|Protocol Violation|4|||
147027514|NCT00532935|530263686|FG001|Overall Study|Protocol Violation|2|||
147027515|NCT00532935|530263685|FG000|Overall Study|Withdrawal by Subject|10|||
147027516|NCT00532935|530263686|FG001|Overall Study|Withdrawal by Subject|9|||
147027517|NCT00532935|530263685|FG000|Overall Study|Protocol Specific Criteria|11|||
147027518|NCT00532935|530263686|FG001|Overall Study|Protocol Specific Criteria|15|||
147027519|NCT01301508|530263687|FG000|Overall Study|Withdrawal by Subject|1|||
147027520|NCT01301508|530263688|FG001|Overall Study|Withdrawal by Subject|2|||
147027521|NCT01301508|530263687|FG000|Overall Study|Lost to Follow-up|0|||
147027522|NCT01301508|530263688|FG001|Overall Study|Lost to Follow-up|1|||
147027523|NCT01300923|530263689|FG000|Overall Study|Physician Decision|0|||
147027524|NCT01300923|530263690|FG001|Overall Study|Physician Decision|2|||
147027525|NCT01940497|530263693|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
147027526|NCT01940497|530263694|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
147027527|NCT01940497|530263693|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
147027528|NCT01940497|530263694|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
147027529|NCT01940497|530263693|FG000|Overall Study|Violation of Entry Criteria|1|||
147027530|NCT01940497|530263694|FG001|Overall Study|Violation of Entry Criteria|1|||
147027531|NCT01940497|530263693|FG000|Overall Study|Refused Treatment|1|||
147027532|NCT01940497|530263694|FG001|Overall Study|Refused Treatment|3|||
147027533|NCT01940497|530263693|FG000|Overall Study|Withdrew Consent|6|||
147027534|NCT01940497|530263694|FG001|Overall Study|Withdrew Consent|2|||
147027535|NCT01940497|530263693|FG000|Overall Study|Administrative/Other|1|||
147027536|NCT01940497|530263694|FG001|Overall Study|Administrative/Other|1|||
147027537|NCT02707861|530263695|FG000|Overall Study|Went onto commercial drug|30|||
147027538|NCT02707861|530263696|FG001|Overall Study|Went onto commercial drug|23|||
147027539|NCT02707861|530263695|FG000|Overall Study|Adverse Event|2|||
147027540|NCT02707861|530263696|FG001|Overall Study|Adverse Event|3|||
147027541|NCT02707861|530263695|FG000|Overall Study|Death|5|||
147027542|NCT02707861|530263696|FG001|Overall Study|Death|2|||
147027543|NCT02707861|530263695|FG000|Overall Study|Lack of Efficacy|0|||
147027544|NCT02707861|530263696|FG001|Overall Study|Lack of Efficacy|2|||
147027545|NCT02707861|530263695|FG000|Overall Study|Physician Decision|1|||
147027546|NCT02707861|530263696|FG001|Overall Study|Physician Decision|4|||
147027547|NCT02707861|530263695|FG000|Overall Study|Withdrawal by Subject|2|||
147027548|NCT02707861|530263696|FG001|Overall Study|Withdrawal by Subject|1|||
147027549|NCT02707861|530263695|FG000|Overall Study|Lost to Follow-up|1|||
147027550|NCT02707861|530263696|FG001|Overall Study|Lost to Follow-up|3|||
147027551|NCT03123861|530263697|FG000|Overall Study|Protocol Violation|1|||
147027552|NCT03123861|530263698|FG001|Overall Study|Protocol Violation|1|||
147027553|NCT03123861|530263697|FG000|Overall Study|Withdrawal by Subject|2|||
147027554|NCT03123861|530263698|FG001|Overall Study|Withdrawal by Subject|2|||
147027555|NCT00448136|530263703|FG000|Overall Study|Death|3|||
147027556|NCT00448136|530263704|FG001|Overall Study|Death|8|||
147027557|NCT00448136|530263703|FG000|Overall Study|Investigator's decision (progression)|1|||
147027558|NCT00448136|530263704|FG001|Overall Study|Investigator's decision (progression)|0|||
147027559|NCT03407430|530263707|FG000|Washout|Protocol Violation|1|||
147027560|NCT03407430|530263708|FG001|Washout|Protocol Violation|0|||
147027561|NCT00922987|530263710|FG000|Overall Study|Insufficient clinical response|1|||
147027562|NCT00922987|530263710|FG000|Overall Study|Protocol Violation|2|||
147027563|NCT00922987|530263710|FG000|Overall Study|Adverse Event|1|||
147027564|NCT04969861|530263713|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
147027565|NCT04969861|530263714|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
147027566|NCT03303625|530265917|FG000|Overall Study|Withdrawal by Subject|2|||
147027567|NCT03303625|530265918|FG001|Overall Study|Withdrawal by Subject|0|||
147027568|NCT03303625|530265919|FG002|Overall Study|Withdrawal by Subject|0|||
147027569|NCT03303625|530265920|FG003|Overall Study|Withdrawal by Subject|0|||
147027570|NCT01288053|530265921|FG000|Overall Study|Death|1|||
147027571|NCT03188666|530265922|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
146849520|NCT02663518|529618852|FG001|Part 1: Phase 1a Escalation|Death|0|||
147027572|NCT03188666|530265923|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
147027573|NCT03188666|530265924|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
147027574|NCT03188666|530265925|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
147027575|NCT03188666|530265922|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
147027576|NCT03188666|530265923|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
147027577|NCT03188666|530265924|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
147027578|NCT03188666|530265925|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
147027579|NCT03188666|530265922|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
147027580|NCT03188666|530265923|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
147027581|NCT03188666|530265924|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
147027582|NCT03188666|530265925|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
147027583|NCT03188666|530265922|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
147027584|NCT03188666|530265923|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
147027585|NCT03188666|530265924|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
147027586|NCT03188666|530265925|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
147027587|NCT00144781|530265926|FG000|Overall Study|Adverse Event|0|||
147027588|NCT00144781|530265927|FG001|Overall Study|Adverse Event|1|||
147027589|NCT00144781|530265928|FG002|Overall Study|Adverse Event|0|||
147027590|NCT00144781|530265929|FG003|Overall Study|Adverse Event|0|||
147027591|NCT00144781|530265926|FG000|Overall Study|Non-compliant|0|||
147027592|NCT00144781|530265927|FG001|Overall Study|Non-compliant|1|||
147027593|NCT00144781|530265928|FG002|Overall Study|Non-compliant|0|||
147027594|NCT00144781|530265929|FG003|Overall Study|Non-compliant|0|||
147027595|NCT02068092|530265930|FG000|Overall Study|Physician Decision|2|||
147027596|NCT02068092|530265930|FG000|Overall Study|Adverse Event|2|||
147027597|NCT02068092|530265930|FG000|Overall Study|Lost to Follow-up|4|||
147027598|NCT02068092|530265930|FG000|Overall Study|Withdrawal by Subject|2|||
147027599|NCT03502707|530265931|FG000|Overall Study|Adverse Event|0|||
147027600|NCT03502707|530265932|FG001|Overall Study|Adverse Event|0|||
147027601|NCT03502707|530265933|FG002|Overall Study|Adverse Event|0|||
147027602|NCT03502707|530265934|FG003|Overall Study|Adverse Event|0|||
147027603|NCT03502707|530265935|FG004|Overall Study|Adverse Event|0|||
147027604|NCT03502707|530265936|FG005|Overall Study|Adverse Event|0|||
147027605|NCT03502707|530265937|FG006|Overall Study|Adverse Event|0|||
147027606|NCT03502707|530265938|FG007|Overall Study|Adverse Event|0|||
147027607|NCT03502707|530265939|FG008|Overall Study|Adverse Event|0|||
147027608|NCT03502707|530265940|FG009|Overall Study|Adverse Event|0|||
147027609|NCT03502707|530265941|FG010|Overall Study|Adverse Event|0|||
147027610|NCT03502707|530265942|FG011|Overall Study|Adverse Event|0|||
147027611|NCT03502707|530265943|FG012|Overall Study|Adverse Event|0|||
147027612|NCT03502707|530265944|FG013|Overall Study|Adverse Event|0|||
147027613|NCT03502707|530265945|FG014|Overall Study|Adverse Event|0|||
147027614|NCT03502707|530265946|FG015|Overall Study|Adverse Event|1|||
147027615|NCT03502707|530265947|FG016|Overall Study|Adverse Event|5|||
147027616|NCT03502707|530265948|FG017|Overall Study|Adverse Event|0|||
147027617|NCT03502707|530265931|FG000|Overall Study|Death|0|||
147027618|NCT03502707|530265932|FG001|Overall Study|Death|0|||
147027619|NCT03502707|530265933|FG002|Overall Study|Death|0|||
147027620|NCT03502707|530265934|FG003|Overall Study|Death|1|||
147027621|NCT03502707|530265935|FG004|Overall Study|Death|0|||
147027622|NCT03502707|530265936|FG005|Overall Study|Death|0|||
147027623|NCT03502707|530265937|FG006|Overall Study|Death|0|||
147027624|NCT03502707|530265938|FG007|Overall Study|Death|0|||
147027625|NCT03502707|530265939|FG008|Overall Study|Death|1|||
147027626|NCT03502707|530265940|FG009|Overall Study|Death|1|||
147027627|NCT03502707|530265941|FG010|Overall Study|Death|0|||
147027628|NCT03502707|530265942|FG011|Overall Study|Death|0|||
147027629|NCT03502707|530265943|FG012|Overall Study|Death|1|||
147027630|NCT03502707|530265944|FG013|Overall Study|Death|0|||
147027631|NCT03502707|530265945|FG014|Overall Study|Death|0|||
147027632|NCT03502707|530265946|FG015|Overall Study|Death|1|||
147027633|NCT03502707|530265947|FG016|Overall Study|Death|0|||
147027634|NCT03502707|530265948|FG017|Overall Study|Death|0|||
147027635|NCT03502707|530265931|FG000|Overall Study|Lost to Follow-up|0|||
147027636|NCT03502707|530265932|FG001|Overall Study|Lost to Follow-up|0|||
147027637|NCT03502707|530265933|FG002|Overall Study|Lost to Follow-up|0|||
147027638|NCT03502707|530265934|FG003|Overall Study|Lost to Follow-up|0|||
147027639|NCT03502707|530265935|FG004|Overall Study|Lost to Follow-up|0|||
147027640|NCT03502707|530265936|FG005|Overall Study|Lost to Follow-up|0|||
147027641|NCT03502707|530265937|FG006|Overall Study|Lost to Follow-up|0|||
147027642|NCT03502707|530265938|FG007|Overall Study|Lost to Follow-up|5|||
147027643|NCT03502707|530265939|FG008|Overall Study|Lost to Follow-up|0|||
147027644|NCT03502707|530265940|FG009|Overall Study|Lost to Follow-up|2|||
147027645|NCT03502707|530265941|FG010|Overall Study|Lost to Follow-up|1|||
147027646|NCT03502707|530265942|FG011|Overall Study|Lost to Follow-up|2|||
147027647|NCT03502707|530265943|FG012|Overall Study|Lost to Follow-up|1|||
147027648|NCT03502707|530265944|FG013|Overall Study|Lost to Follow-up|1|||
147027649|NCT03502707|530265945|FG014|Overall Study|Lost to Follow-up|0|||
147027650|NCT03502707|530265946|FG015|Overall Study|Lost to Follow-up|4|||
147027651|NCT03502707|530265947|FG016|Overall Study|Lost to Follow-up|9|||
147027652|NCT03502707|530265948|FG017|Overall Study|Lost to Follow-up|2|||
147027653|NCT03502707|530265931|FG000|Overall Study|Physician Decision|0|||
147027654|NCT03502707|530265932|FG001|Overall Study|Physician Decision|0|||
147027655|NCT03502707|530265933|FG002|Overall Study|Physician Decision|0|||
147027656|NCT03502707|530265934|FG003|Overall Study|Physician Decision|0|||
147027657|NCT03502707|530265935|FG004|Overall Study|Physician Decision|0|||
147027658|NCT03502707|530265936|FG005|Overall Study|Physician Decision|0|||
147027659|NCT03502707|530265937|FG006|Overall Study|Physician Decision|0|||
147027660|NCT03502707|530265938|FG007|Overall Study|Physician Decision|0|||
147027661|NCT03502707|530265939|FG008|Overall Study|Physician Decision|2|||
147027662|NCT03502707|530265940|FG009|Overall Study|Physician Decision|1|||
147027663|NCT03502707|530265941|FG010|Overall Study|Physician Decision|0|||
147027664|NCT03502707|530265942|FG011|Overall Study|Physician Decision|0|||
147027665|NCT03502707|530265943|FG012|Overall Study|Physician Decision|0|||
147027666|NCT03502707|530265944|FG013|Overall Study|Physician Decision|0|||
147027667|NCT03502707|530265945|FG014|Overall Study|Physician Decision|1|||
147027668|NCT03502707|530265946|FG015|Overall Study|Physician Decision|3|||
147027669|NCT03502707|530265947|FG016|Overall Study|Physician Decision|0|||
147027670|NCT03502707|530265948|FG017|Overall Study|Physician Decision|0|||
147027671|NCT03502707|530265931|FG000|Overall Study|Protocol Violation|0|||
147027672|NCT03502707|530265932|FG001|Overall Study|Protocol Violation|0|||
147027673|NCT03502707|530265933|FG002|Overall Study|Protocol Violation|0|||
147027674|NCT03502707|530265934|FG003|Overall Study|Protocol Violation|0|||
147027675|NCT03502707|530265935|FG004|Overall Study|Protocol Violation|0|||
147027676|NCT03502707|530265936|FG005|Overall Study|Protocol Violation|0|||
147027677|NCT03502707|530265937|FG006|Overall Study|Protocol Violation|0|||
147027678|NCT03502707|530265938|FG007|Overall Study|Protocol Violation|0|||
147027679|NCT03502707|530265939|FG008|Overall Study|Protocol Violation|0|||
147027680|NCT03502707|530265940|FG009|Overall Study|Protocol Violation|0|||
147027681|NCT03502707|530265941|FG010|Overall Study|Protocol Violation|0|||
147027682|NCT03502707|530265942|FG011|Overall Study|Protocol Violation|0|||
147027683|NCT03502707|530265943|FG012|Overall Study|Protocol Violation|0|||
147027684|NCT03502707|530265944|FG013|Overall Study|Protocol Violation|0|||
147027685|NCT03502707|530265945|FG014|Overall Study|Protocol Violation|0|||
147027686|NCT03502707|530265946|FG015|Overall Study|Protocol Violation|1|||
147027687|NCT03502707|530265947|FG016|Overall Study|Protocol Violation|0|||
147027688|NCT03502707|530265948|FG017|Overall Study|Protocol Violation|0|||
147027689|NCT03502707|530265931|FG000|Overall Study|Withdrawal by Subject|1|||
147027690|NCT03502707|530265932|FG001|Overall Study|Withdrawal by Subject|1|||
147027691|NCT03502707|530265933|FG002|Overall Study|Withdrawal by Subject|0|||
147027692|NCT03502707|530265934|FG003|Overall Study|Withdrawal by Subject|0|||
147027693|NCT03502707|530265935|FG004|Overall Study|Withdrawal by Subject|0|||
147027694|NCT03502707|530265936|FG005|Overall Study|Withdrawal by Subject|2|||
147027695|NCT03502707|530265937|FG006|Overall Study|Withdrawal by Subject|0|||
147027696|NCT03502707|530265938|FG007|Overall Study|Withdrawal by Subject|3|||
147027697|NCT03502707|530265939|FG008|Overall Study|Withdrawal by Subject|1|||
147027698|NCT03502707|530265940|FG009|Overall Study|Withdrawal by Subject|2|||
147027699|NCT03502707|530265941|FG010|Overall Study|Withdrawal by Subject|12|||
147027700|NCT03502707|530265942|FG011|Overall Study|Withdrawal by Subject|23|||
147027701|NCT03502707|530265943|FG012|Overall Study|Withdrawal by Subject|5|||
147027702|NCT03502707|530265944|FG013|Overall Study|Withdrawal by Subject|3|||
147027703|NCT03502707|530265945|FG014|Overall Study|Withdrawal by Subject|3|||
147027704|NCT03502707|530265946|FG015|Overall Study|Withdrawal by Subject|43|||
147027705|NCT03502707|530265947|FG016|Overall Study|Withdrawal by Subject|44|||
147027706|NCT03502707|530265948|FG017|Overall Study|Withdrawal by Subject|18|||
147027707|NCT03502707|530265931|FG000|Overall Study|Sponsor's Decision|1|||
147027708|NCT03502707|530265932|FG001|Overall Study|Sponsor's Decision|0|||
147027709|NCT03502707|530265933|FG002|Overall Study|Sponsor's Decision|0|||
147027710|NCT03502707|530265934|FG003|Overall Study|Sponsor's Decision|0|||
147027711|NCT03502707|530265935|FG004|Overall Study|Sponsor's Decision|0|||
147027712|NCT03502707|530265936|FG005|Overall Study|Sponsor's Decision|0|||
147027713|NCT03502707|530265937|FG006|Overall Study|Sponsor's Decision|0|||
147027714|NCT03502707|530265938|FG007|Overall Study|Sponsor's Decision|0|||
147027715|NCT03502707|530265939|FG008|Overall Study|Sponsor's Decision|0|||
147027716|NCT03502707|530265940|FG009|Overall Study|Sponsor's Decision|1|||
147027717|NCT03502707|530265941|FG010|Overall Study|Sponsor's Decision|0|||
147027718|NCT03502707|530265942|FG011|Overall Study|Sponsor's Decision|0|||
147027719|NCT03502707|530265943|FG012|Overall Study|Sponsor's Decision|0|||
147027720|NCT03502707|530265944|FG013|Overall Study|Sponsor's Decision|0|||
147027721|NCT03502707|530265945|FG014|Overall Study|Sponsor's Decision|0|||
147027722|NCT03502707|530265946|FG015|Overall Study|Sponsor's Decision|2|||
147027723|NCT03502707|530265947|FG016|Overall Study|Sponsor's Decision|1|||
147027724|NCT03502707|530265948|FG017|Overall Study|Sponsor's Decision|0|||
147027725|NCT03502707|530265931|FG000|Overall Study|Initiated Prohibited Medication|0|||
147027726|NCT03502707|530265932|FG001|Overall Study|Initiated Prohibited Medication|0|||
147027727|NCT03502707|530265933|FG002|Overall Study|Initiated Prohibited Medication|0|||
147027728|NCT03502707|530265934|FG003|Overall Study|Initiated Prohibited Medication|0|||
147027729|NCT03502707|530265935|FG004|Overall Study|Initiated Prohibited Medication|0|||
147027730|NCT03502707|530265936|FG005|Overall Study|Initiated Prohibited Medication|0|||
147027731|NCT03502707|530265937|FG006|Overall Study|Initiated Prohibited Medication|0|||
147027732|NCT03502707|530265938|FG007|Overall Study|Initiated Prohibited Medication|0|||
147027733|NCT03502707|530265939|FG008|Overall Study|Initiated Prohibited Medication|0|||
147027734|NCT03502707|530265940|FG009|Overall Study|Initiated Prohibited Medication|0|||
147027735|NCT03502707|530265941|FG010|Overall Study|Initiated Prohibited Medication|0|||
147027736|NCT03502707|530265942|FG011|Overall Study|Initiated Prohibited Medication|0|||
147027737|NCT03502707|530265943|FG012|Overall Study|Initiated Prohibited Medication|0|||
147027738|NCT03502707|530265944|FG013|Overall Study|Initiated Prohibited Medication|0|||
147027739|NCT03502707|530265945|FG014|Overall Study|Initiated Prohibited Medication|0|||
147027740|NCT03502707|530265946|FG015|Overall Study|Initiated Prohibited Medication|0|||
147027741|NCT03502707|530265947|FG016|Overall Study|Initiated Prohibited Medication|1|||
147027742|NCT03502707|530265948|FG017|Overall Study|Initiated Prohibited Medication|0|||
147027743|NCT03502707|530265931|FG000|Overall Study|Other|0|||
147027744|NCT03502707|530265932|FG001|Overall Study|Other|0|||
147027745|NCT03502707|530265933|FG002|Overall Study|Other|0|||
147027746|NCT03502707|530265934|FG003|Overall Study|Other|0|||
147027747|NCT03502707|530265935|FG004|Overall Study|Other|0|||
147027748|NCT03502707|530265936|FG005|Overall Study|Other|0|||
147027749|NCT03502707|530265937|FG006|Overall Study|Other|0|||
147027750|NCT03502707|530265938|FG007|Overall Study|Other|0|||
147027751|NCT03502707|530265939|FG008|Overall Study|Other|1|||
147027752|NCT03502707|530265940|FG009|Overall Study|Other|1|||
147027753|NCT03502707|530265941|FG010|Overall Study|Other|2|||
147027754|NCT03502707|530265942|FG011|Overall Study|Other|0|||
147027755|NCT03502707|530265943|FG012|Overall Study|Other|0|||
147027756|NCT03502707|530265944|FG013|Overall Study|Other|0|||
147027757|NCT03502707|530265945|FG014|Overall Study|Other|0|||
147027758|NCT03502707|530265946|FG015|Overall Study|Other|4|||
147027759|NCT03502707|530265947|FG016|Overall Study|Other|1|||
147027760|NCT03502707|530265948|FG017|Overall Study|Other|0|||
147027761|NCT03502707|530265931|FG000|Overall Study|Randomized but not vaccinated|0|||
147027762|NCT03502707|530265932|FG001|Overall Study|Randomized but not vaccinated|0|||
147027763|NCT03502707|530265933|FG002|Overall Study|Randomized but not vaccinated|0|||
147027764|NCT03502707|530265934|FG003|Overall Study|Randomized but not vaccinated|0|||
147027765|NCT03502707|530265935|FG004|Overall Study|Randomized but not vaccinated|0|||
147027766|NCT03502707|530265936|FG005|Overall Study|Randomized but not vaccinated|0|||
147027767|NCT03502707|530265937|FG006|Overall Study|Randomized but not vaccinated|0|||
147027768|NCT03502707|530265938|FG007|Overall Study|Randomized but not vaccinated|0|||
147027769|NCT03502707|530265939|FG008|Overall Study|Randomized but not vaccinated|0|||
147027770|NCT03502707|530265940|FG009|Overall Study|Randomized but not vaccinated|0|||
147027771|NCT03502707|530265941|FG010|Overall Study|Randomized but not vaccinated|0|||
147027772|NCT03502707|530265942|FG011|Overall Study|Randomized but not vaccinated|1|||
147027773|NCT03502707|530265943|FG012|Overall Study|Randomized but not vaccinated|0|||
147027774|NCT03502707|530265944|FG013|Overall Study|Randomized but not vaccinated|0|||
147027775|NCT03502707|530265945|FG014|Overall Study|Randomized but not vaccinated|0|||
147027776|NCT03502707|530265946|FG015|Overall Study|Randomized but not vaccinated|0|||
147027777|NCT03502707|530265947|FG016|Overall Study|Randomized but not vaccinated|0|||
147027778|NCT03502707|530265948|FG017|Overall Study|Randomized but not vaccinated|1|||
147027779|NCT00062010|530265949|FG000|Overall Study|Ineligible|3|||
147027780|NCT01687478|530265950|FG000|Overall Study|Adverse Event|3|||
147027781|NCT01687478|530265951|FG001|Overall Study|Adverse Event|10|||
147027782|NCT01687478|530265950|FG000|Overall Study|Lost to Follow-up|1|||
147027783|NCT01687478|530265951|FG001|Overall Study|Lost to Follow-up|3|||
147027784|NCT01687478|530265950|FG000|Overall Study|Protocol Violation|0|||
147027785|NCT01687478|530265951|FG001|Overall Study|Protocol Violation|2|||
147027786|NCT01687478|530265950|FG000|Overall Study|Withdrawal by Subject|21|||
147027787|NCT01687478|530265951|FG001|Overall Study|Withdrawal by Subject|19|||
147027788|NCT01687478|530265950|FG000|Overall Study|Physician Decision|1|||
147027789|NCT01687478|530265951|FG001|Overall Study|Physician Decision|3|||
147027790|NCT01687478|530265950|FG000|Overall Study|Entry Criteria Not Met|6|||
147027791|NCT01687478|530265951|FG001|Overall Study|Entry Criteria Not Met|2|||
147027792|NCT00292188|530265952|FG000|Single-Blind|Adverse Event|14|||
147027793|NCT00292188|530265953|FG001|Single-Blind|Adverse Event|0|||
147027794|NCT00292188|530265954|FG002|Single-Blind|Adverse Event|0|||
147027795|NCT00292188|530265952|FG000|Single-Blind|Lack of Efficacy|2|||
147027796|NCT00292188|530265953|FG001|Single-Blind|Lack of Efficacy|0|||
147027797|NCT00292188|530265954|FG002|Single-Blind|Lack of Efficacy|0|||
147027798|NCT00292188|530265952|FG000|Single-Blind|Laboratory Abnormality|5|||
147027799|NCT00292188|530265953|FG001|Single-Blind|Laboratory Abnormality|0|||
147027800|NCT00292188|530265954|FG002|Single-Blind|Laboratory Abnormality|0|||
147027801|NCT00292188|530265952|FG000|Single-Blind|Lost to Follow-up|3|||
146849521|NCT02663518|529618853|FG002|Part 1: Phase 1a Escalation|Death|1|||
146849522|NCT02663518|529618854|FG003|Part 1: Phase 1a Escalation|Death|0|||
146849523|NCT02663518|529618855|FG004|Part 1: Phase 1a Escalation|Death|0|||
147027802|NCT00292188|530265953|FG001|Single-Blind|Lost to Follow-up|0|||
147027803|NCT00292188|530265954|FG002|Single-Blind|Lost to Follow-up|0|||
147027804|NCT00292188|530265952|FG000|Single-Blind|Other|77|||
147027805|NCT00292188|530265953|FG001|Single-Blind|Other|0|||
147027806|NCT00292188|530265954|FG002|Single-Blind|Other|0|||
147027807|NCT00292188|530265952|FG000|Single-Blind|Withdrawal by Subject|12|||
147027808|NCT00292188|530265953|FG001|Single-Blind|Withdrawal by Subject|0|||
146849524|NCT02663518|529618856|FG005|Part 1: Phase 1a Escalation|Death|0|||
147027809|NCT00292188|530265954|FG002|Single-Blind|Withdrawal by Subject|0|||
147027810|NCT00292188|530265952|FG000|Single-Blind|Did not receive treatment|1|||
147027811|NCT00292188|530265953|FG001|Single-Blind|Did not receive treatment|0|||
147027812|NCT00292188|530265954|FG002|Single-Blind|Did not receive treatment|0|||
147027813|NCT00292188|530265952|FG000|Double-Blind|Adverse Event|0|||
147027814|NCT00292188|530265953|FG001|Double-Blind|Adverse Event|25|||
147027815|NCT00292188|530265954|FG002|Double-Blind|Adverse Event|9|||
147027816|NCT00292188|530265952|FG000|Double-Blind|Lack of Efficacy|0|||
147027817|NCT00292188|530265953|FG001|Double-Blind|Lack of Efficacy|2|||
147027818|NCT00292188|530265954|FG002|Double-Blind|Lack of Efficacy|12|||
147027819|NCT00292188|530265952|FG000|Double-Blind|Lost to Follow-up|0|||
147027820|NCT00292188|530265953|FG001|Double-Blind|Lost to Follow-up|1|||
147027821|NCT00292188|530265954|FG002|Double-Blind|Lost to Follow-up|0|||
147027822|NCT00292188|530265952|FG000|Double-Blind|Other|0|||
147027823|NCT00292188|530265953|FG001|Double-Blind|Other|3|||
147027824|NCT00292188|530265954|FG002|Double-Blind|Other|4|||
147027825|NCT00292188|530265952|FG000|Double-Blind|Withdrawal by Subject|0|||
147027826|NCT00292188|530265953|FG001|Double-Blind|Withdrawal by Subject|0|||
147027827|NCT00292188|530265954|FG002|Double-Blind|Withdrawal by Subject|3|||
147027828|NCT00292188|530265952|FG000|Double-Blind|Laboratory Abnormality|0|||
147027829|NCT00292188|530265953|FG001|Double-Blind|Laboratory Abnormality|0|||
147027830|NCT00292188|530265954|FG002|Double-Blind|Laboratory Abnormality|1|||
147027831|NCT00577395|530265955|FG000|Overall Study|Study was terminated early by Sponsor|7|||
147027832|NCT00577395|530265956|FG001|Overall Study|Study was terminated early by Sponsor|6|||
147027833|NCT01206101|530265957|FG000|Overall Study|Adverse Event|1|||
147027834|NCT01206101|530265958|FG001|Overall Study|Adverse Event|0|||
147027835|NCT01206101|530265957|FG000|Overall Study|Physician Decision|0|||
147027836|NCT01206101|530265958|FG001|Overall Study|Physician Decision|1|||
147027837|NCT01206101|530265957|FG000|Overall Study|Unclassified|1|||
147027838|NCT01206101|530265958|FG001|Overall Study|Unclassified|0|||
147027839|NCT04709835|530265961|FG000|Overall Study|Withdrawal by Subject|0|||
147027840|NCT04709835|530265962|FG001|Overall Study|Withdrawal by Subject|1|||
147027841|NCT04709835|530265963|FG002|Overall Study|Withdrawal by Subject|0|||
147027842|NCT01859130|530265964|FG000|Overall Study|Death|4|||
147027843|NCT01859130|530265964|FG000|Overall Study|Lost to Follow-up|16|||
147027844|NCT01859130|530265964|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
147027845|NCT01859130|530265964|FG000|Overall Study|Physician Decision|6|||
147027846|NCT01859130|530265964|FG000|Overall Study|Withdrawal by Subject|17|||
147027847|NCT01859130|530265964|FG000|Overall Study|Adverse Event|11|||
147027848|NCT00103311|530265970|FG000|Overall Study|Lost to Follow-up|1|||
147027849|NCT00103311|530265971|FG001|Overall Study|Lost to Follow-up|0|||
147027850|NCT00103311|530265970|FG000|Overall Study|Withdrawal by Subject|2|||
147027851|NCT00103311|530265971|FG001|Overall Study|Withdrawal by Subject|1|||
147027852|NCT00103311|530265970|FG000|Overall Study|Adverse Event|1|||
147027853|NCT00103311|530265971|FG001|Overall Study|Adverse Event|0|||
147027854|NCT03827564|530265972|FG000|Overall Study|Discontinued due to Study Termination|1|||
147027855|NCT03827564|530265973|FG001|Overall Study|Discontinued due to Study Termination|0|||
147027856|NCT00270257|530265974|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
147027857|NCT00270257|530265975|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
147027858|NCT01195103|530265976|FG000|Overall Study|Withdrawal by Subject|1|||
147027859|NCT01195103|530265977|FG001|Overall Study|Withdrawal by Subject|0|||
147027860|NCT01195103|530265978|FG002|Overall Study|Withdrawal by Subject|0|||
147027861|NCT02621034|530265979|FG000|Overall Study|Lost to Follow-up|3|||
147027862|NCT02621034|530265980|FG001|Overall Study|Lost to Follow-up|2|||
147027863|NCT02621034|530265981|FG002|Overall Study|Lost to Follow-up|5|||
147027864|NCT00974974|530265991|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
147027865|NCT00974974|530265992|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
147027866|NCT00974974|530265991|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
147027867|NCT00974974|530265992|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
147027868|NCT00974974|530265991|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
147027869|NCT00974974|530265992|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
147027870|NCT00974974|530265991|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
147027871|NCT00974974|530265992|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
147027872|NCT00974974|530265991|FG000|IR CD-LD Dose Adjustment|Various|0|||
147027873|NCT00974974|530265992|FG001|IR CD-LD Dose Adjustment|Various|9|||
147027874|NCT00974974|530265991|FG000|IPX066 Dose Conversion|Adverse Event|23|||
147027875|NCT00974974|530265992|FG001|IPX066 Dose Conversion|Adverse Event|0|||
147027876|NCT00974974|530265991|FG000|IPX066 Dose Conversion|Death|2|||
147027877|NCT00974974|530265992|FG001|IPX066 Dose Conversion|Death|0|||
147027878|NCT00974974|530265991|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
147027879|NCT00974974|530265992|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
147027880|NCT00974974|530265991|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
147027881|NCT00974974|530265992|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
147027882|NCT00974974|530265991|FG000|IPX066 Dose Conversion|Various|3|||
147027883|NCT00974974|530265992|FG001|IPX066 Dose Conversion|Various|0|||
147027884|NCT00974974|530265991|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
147027885|NCT00974974|530265992|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
147027886|NCT00974974|530265991|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
146849525|NCT02663518|529618857|FG006|Part 1: Phase 1a Escalation|Death|0|||
146849526|NCT02663518|529618858|FG007|Part 1: Phase 1a Escalation|Death|0|||
146849527|NCT02663518|529618859|FG008|Part 1: Phase 1a Escalation|Death|0|||
147027887|NCT00974974|530265992|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
147027888|NCT00974974|530265991|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
147027889|NCT00974974|530265992|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
147027890|NCT00974974|530265991|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
147027891|NCT00974974|530265992|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
147027892|NCT00974974|530265991|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
147027893|NCT00974974|530265992|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
147027894|NCT00974974|530265991|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
147027895|NCT00974974|530265992|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
147027896|NCT00974974|530265991|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
147027897|NCT00974974|530265992|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
147027898|NCT00974974|530265991|FG000|Maintenance - Double Blind Treatment|Various|4|||
147027899|NCT00974974|530265992|FG001|Maintenance - Double Blind Treatment|Various|0|||
147027900|NCT01959035|530265993|FG000|Overall Study|Adverse Event|5|||
147027901|NCT01959035|530265993|FG000|Overall Study|Withdrawal by Subject|4|||
147027902|NCT01959035|530265993|FG000|Overall Study|Lost to Follow-up|1|||
147027903|NCT01959035|530265993|FG000|Overall Study|Other (no primary reason given)|1|||
147027904|NCT02227147|530265994|FG000|Controlled Treatment Period|Adverse Event|4|||
147027905|NCT02227147|530265995|FG001|Controlled Treatment Period|Adverse Event|3|||
147027906|NCT02227147|530265994|FG000|Controlled Treatment Period|Other|2|||
147027907|NCT02227147|530265995|FG001|Controlled Treatment Period|Other|0|||
147027908|NCT02227147|530265994|FG000|Follow-up Period|Other|3|||
147027909|NCT02227147|530265995|FG001|Follow-up Period|Other|5|||
147027910|NCT03347422|530265998|FG000|Part A (26 Weeks)|Adverse Event|3|||
147027911|NCT03347422|530265999|FG001|Part A (26 Weeks)|Adverse Event|0|||
147027912|NCT03347422|530265998|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
147027913|NCT03347422|530265999|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
147027914|NCT03347422|530265998|FG000|Part B (149 Weeks)|Adverse Event|0|||
147027915|NCT03347422|530265999|FG001|Part B (149 Weeks)|Adverse Event|1|||
147027916|NCT03347422|530265998|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
147027917|NCT03347422|530265999|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
147027918|NCT03347422|530265998|FG000|Part B (149 Weeks)|Other|1|||
147027919|NCT03347422|530265999|FG001|Part B (149 Weeks)|Other|0|||
147027920|NCT03709823|530266000|FG000|Overall Study|Adverse Event|0|||
147027921|NCT03709823|530266001|FG001|Overall Study|Adverse Event|0|||
147027922|NCT03709823|530266002|FG002|Overall Study|Adverse Event|1|||
147027923|NCT03709823|530266003|FG003|Overall Study|Adverse Event|0|||
147027924|NCT03709823|530266004|FG004|Overall Study|Adverse Event|0|||
147027925|NCT03709823|530266005|FG005|Overall Study|Adverse Event|0|||
147027926|NCT03709823|530266000|FG000|Overall Study|Lost to Follow-up|2|||
147027927|NCT03709823|530266001|FG001|Overall Study|Lost to Follow-up|2|||
147027928|NCT03709823|530266002|FG002|Overall Study|Lost to Follow-up|2|||
147027929|NCT03709823|530266003|FG003|Overall Study|Lost to Follow-up|1|||
147027930|NCT03709823|530266004|FG004|Overall Study|Lost to Follow-up|1|||
147027931|NCT03709823|530266005|FG005|Overall Study|Lost to Follow-up|0|||
147027932|NCT03709823|530266000|FG000|Overall Study|Withdrawal by Subject|1|||
147027933|NCT03709823|530266001|FG001|Overall Study|Withdrawal by Subject|3|||
147027934|NCT03709823|530266002|FG002|Overall Study|Withdrawal by Subject|0|||
147027935|NCT03709823|530266003|FG003|Overall Study|Withdrawal by Subject|0|||
147027936|NCT03709823|530266004|FG004|Overall Study|Withdrawal by Subject|0|||
147027937|NCT03709823|530266005|FG005|Overall Study|Withdrawal by Subject|0|||
147027938|NCT03709823|530266000|FG000|Overall Study|Other, Not Specified|0|||
147027939|NCT03709823|530266001|FG001|Overall Study|Other, Not Specified|0|||
147027940|NCT03709823|530266002|FG002|Overall Study|Other, Not Specified|0|||
147027941|NCT03709823|530266003|FG003|Overall Study|Other, Not Specified|1|||
147027942|NCT03709823|530266004|FG004|Overall Study|Other, Not Specified|0|||
147027943|NCT03709823|530266005|FG005|Overall Study|Other, Not Specified|0|||
147027944|NCT00158600|530266008|FG000|Overall Study|unable to commit time to study|0|||
147027945|NCT00158600|530266009|FG001|Overall Study|unable to commit time to study|1|||
147027946|NCT00158600|530266008|FG000|Overall Study|Adverse Event|2|||
147027947|NCT00158600|530266009|FG001|Overall Study|Adverse Event|1|||
147027948|NCT00158600|530266008|FG000|Overall Study|Death|1|||
147027949|NCT00158600|530266009|FG001|Overall Study|Death|0|||
147027950|NCT00158600|530266008|FG000|Overall Study|Withdrawal by Subject|2|||
147027951|NCT00158600|530266009|FG001|Overall Study|Withdrawal by Subject|2|||
147027952|NCT02038907|530266010|FG000|Overall Study|Protocol Violation|0|||
147027953|NCT02038907|530266011|FG001|Overall Study|Protocol Violation|0|||
147027954|NCT02038907|530266012|FG002|Overall Study|Protocol Violation|0|||
147027955|NCT02038907|530266013|FG003|Overall Study|Protocol Violation|0|||
146849528|NCT02663518|529618860|FG009|Part 1: Phase 1a Escalation|Death|0|||
147027956|NCT02038907|530266014|FG004|Overall Study|Protocol Violation|0|||
147027957|NCT02038907|530266015|FG005|Overall Study|Protocol Violation|0|||
147027958|NCT02038907|530266016|FG006|Overall Study|Protocol Violation|0|||
147027959|NCT02038907|530266017|FG007|Overall Study|Protocol Violation|0|||
147027960|NCT02038907|530266018|FG008|Overall Study|Protocol Violation|0|||
147027961|NCT02038907|530266019|FG009|Overall Study|Protocol Violation|0|||
147027962|NCT02038907|530266020|FG010|Overall Study|Protocol Violation|1|||
147027963|NCT02038907|530266021|FG011|Overall Study|Protocol Violation|0|||
147027964|NCT02038907|530266022|FG012|Overall Study|Protocol Violation|0|||
147027965|NCT02038907|530266023|FG013|Overall Study|Protocol Violation|0|||
147027966|NCT02038907|530266010|FG000|Overall Study|Withdrawal by Subject|0|||
147027967|NCT02038907|530266011|FG001|Overall Study|Withdrawal by Subject|0|||
147027968|NCT02038907|530266012|FG002|Overall Study|Withdrawal by Subject|0|||
147027969|NCT02038907|530266013|FG003|Overall Study|Withdrawal by Subject|0|||
147027970|NCT02038907|530266014|FG004|Overall Study|Withdrawal by Subject|0|||
147027971|NCT02038907|530266015|FG005|Overall Study|Withdrawal by Subject|0|||
147027972|NCT02038907|530266016|FG006|Overall Study|Withdrawal by Subject|0|||
147027973|NCT02038907|530266017|FG007|Overall Study|Withdrawal by Subject|0|||
147027974|NCT02038907|530266018|FG008|Overall Study|Withdrawal by Subject|0|||
147027975|NCT02038907|530266019|FG009|Overall Study|Withdrawal by Subject|0|||
147027976|NCT02038907|530266020|FG010|Overall Study|Withdrawal by Subject|1|||
147027977|NCT02038907|530266021|FG011|Overall Study|Withdrawal by Subject|0|||
147027978|NCT02038907|530266022|FG012|Overall Study|Withdrawal by Subject|0|||
147027979|NCT02038907|530266023|FG013|Overall Study|Withdrawal by Subject|0|||
147027980|NCT01246011|530266027|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
147027981|NCT01246011|530266028|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
147027982|NCT01246011|530266029|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
147027983|NCT01246011|530266027|FG000|Overall Study|Withdrawal by Subject|0|||
147027984|NCT01246011|530266028|FG001|Overall Study|Withdrawal by Subject|0|||
147027985|NCT01246011|530266029|FG002|Overall Study|Withdrawal by Subject|1|||
147027986|NCT01155024|530266031|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
147027987|NCT01155024|530266032|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
147027988|NCT01155024|530266031|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
147027989|NCT01155024|530266032|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
147027990|NCT01155024|530266031|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
147027991|NCT01155024|530266032|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
147027992|NCT01593696|530266033|FG000|Dose Escalation|Progressive Disease|2|||
147027993|NCT01593696|530266034|FG001|Dose Escalation|Progressive Disease|0|||
147027994|NCT01593696|530266035|FG002|Dose Escalation|Progressive Disease|0|||
147027995|NCT01593696|530266036|FG003|Dose Escalation|Progressive Disease|0|||
147027996|NCT01593696|530266033|FG000|Dose Expansion|Fungal infection|0|||
147027997|NCT01593696|530266034|FG001|Dose Expansion|Fungal infection|0|||
147027998|NCT01593696|530266035|FG002|Dose Expansion|Fungal infection|1|||
147027999|NCT01593696|530266036|FG003|Dose Expansion|Fungal infection|0|||
147028000|NCT01936623|530266037|FG000|Overall Study|Lost to Follow-up|0|||
147028001|NCT01936623|530266038|FG001|Overall Study|Lost to Follow-up|5|||
147028002|NCT02575911|530266039|FG000|Overall Study|Lost to Follow-up|1|||
147028003|NCT03579966|530266040|FG000|Overall Study|Adverse Event|6|||
147028004|NCT03579966|530266040|FG000|Overall Study|Lost to Follow-up|4|||
147028005|NCT03579966|530266040|FG000|Overall Study|Physician Decision|10|||
147028006|NCT03579966|530266040|FG000|Overall Study|Pregnancy|1|||
147028007|NCT03579966|530266040|FG000|Overall Study|Withdrawal by Subject|16|||
147028008|NCT03579966|530266040|FG000|Overall Study|Study terminated by Sponsor|22|||
147028009|NCT03579966|530266040|FG000|Overall Study|Protocol Violation|1|||
147028010|NCT01249365|530266041|FG000|Overall Study|Lost to Follow-up|1|||
147028011|NCT01340768|530266042|FG000|Overall Study|Lost to Follow-up|10|||
147028012|NCT01340768|530266043|FG001|Overall Study|Lost to Follow-up|4|||
147028013|NCT01340768|530266042|FG000|Overall Study|Withdrawal by Subject|5|||
147028014|NCT01340768|530266043|FG001|Overall Study|Withdrawal by Subject|1|||
147028015|NCT01340768|530266042|FG000|Overall Study|Other|2|||
147028016|NCT01340768|530266043|FG001|Overall Study|Other|0|||
147028017|NCT04049617|530266044|FG000|Overall Study|Adverse Event|0|||
147028018|NCT04049617|530266045|FG001|Overall Study|Adverse Event|0|||
147028019|NCT04049617|530266046|FG002|Overall Study|Adverse Event|0|||
147028020|NCT04049617|530266047|FG003|Overall Study|Adverse Event|1|||
147028021|NCT04049617|530266048|FG004|Overall Study|Adverse Event|0|||
147028022|NCT04049617|530266049|FG005|Overall Study|Adverse Event|0|||
147028023|NCT04049617|530266044|FG000|Overall Study|Death|0|||
147028024|NCT04049617|530266045|FG001|Overall Study|Death|0|||
147028025|NCT04049617|530266046|FG002|Overall Study|Death|0|||
147028026|NCT04049617|530266047|FG003|Overall Study|Death|0|||
147028027|NCT04049617|530266048|FG004|Overall Study|Death|0|||
147028028|NCT04049617|530266049|FG005|Overall Study|Death|1|||
147028029|NCT04049617|530266044|FG000|Overall Study|Lost to Follow-up|0|||
147028030|NCT04049617|530266045|FG001|Overall Study|Lost to Follow-up|0|||
147028031|NCT04049617|530266046|FG002|Overall Study|Lost to Follow-up|0|||
147028032|NCT04049617|530266047|FG003|Overall Study|Lost to Follow-up|1|||
147028033|NCT04049617|530266048|FG004|Overall Study|Lost to Follow-up|0|||
147028034|NCT04049617|530266049|FG005|Overall Study|Lost to Follow-up|0|||
147028035|NCT04049617|530266044|FG000|Overall Study|Withdrew consent|0|||
147028036|NCT04049617|530266045|FG001|Overall Study|Withdrew consent|0|||
147028037|NCT04049617|530266046|FG002|Overall Study|Withdrew consent|1|||
147028038|NCT04049617|530266047|FG003|Overall Study|Withdrew consent|0|||
147028039|NCT04049617|530266048|FG004|Overall Study|Withdrew consent|0|||
147028040|NCT04049617|530266049|FG005|Overall Study|Withdrew consent|0|||
147028041|NCT03551496|530266050|FG000|Overall Study|Death|11|||
147028042|NCT03551496|530266051|FG001|Overall Study|Death|7|||
147028043|NCT03551496|530266050|FG000|Overall Study|Withdrawal by Subject|4|||
147028044|NCT03551496|530266051|FG001|Overall Study|Withdrawal by Subject|3|||
147028045|NCT03551496|530266050|FG000|Overall Study|Other Reasons|1|||
147028046|NCT03551496|530266051|FG001|Overall Study|Other Reasons|0|||
147028047|NCT00801099|530266052|FG000|Overall Study|Lost to Follow-up|101|||
147028048|NCT00950963|530266057|FG000|Overall Study|Lost to Follow-up|29|||
147028049|NCT00950963|530266058|FG001|Overall Study|Lost to Follow-up|24|||
147028050|NCT01675661|530266059|FG000|Overall Study|Lost to Follow-up|22|||
147028051|NCT01675661|530266060|FG001|Overall Study|Lost to Follow-up|23|||
147028052|NCT01675661|530266059|FG000|Overall Study|Practical problems|9|||
147028053|NCT01675661|530266060|FG001|Overall Study|Practical problems|5|||
147028054|NCT01675661|530266059|FG000|Overall Study|Moved away|5|||
147028055|NCT01675661|530266060|FG001|Overall Study|Moved away|6|||
147028056|NCT01675661|530266059|FG000|Overall Study|Withdrawal by Subject|3|||
147028057|NCT01675661|530266060|FG001|Overall Study|Withdrawal by Subject|7|||
147028058|NCT01675661|530266059|FG000|Overall Study|Physician Decision|0|||
147028059|NCT01675661|530266060|FG001|Overall Study|Physician Decision|2|||
147028060|NCT01675661|530266059|FG000|Overall Study|Death|0|||
147028061|NCT01675661|530266060|FG001|Overall Study|Death|1|||
147028062|NCT01675661|530266059|FG000|Overall Study|Other reason|1|||
147028063|NCT01675661|530266060|FG001|Overall Study|Other reason|2|||
147028064|NCT00987389|530266061|FG000|Overall Study|Ineligible|0|||
147028065|NCT00987389|530266062|FG001|Overall Study|Ineligible|3|||
147028066|NCT00987389|530266063|FG002|Overall Study|Ineligible|0|||
147028067|NCT00987389|530266064|FG003|Overall Study|Ineligible|0|||
147028068|NCT00987389|530266061|FG000|Overall Study|Lost to Follow-up|4|||
147028069|NCT00987389|530266062|FG001|Overall Study|Lost to Follow-up|1|||
147028070|NCT00987389|530266063|FG002|Overall Study|Lost to Follow-up|3|||
147028071|NCT00987389|530266064|FG003|Overall Study|Lost to Follow-up|1|||
147028072|NCT00987389|530266061|FG000|Overall Study|Withdrawal by Subject|4|||
147028073|NCT00987389|530266062|FG001|Overall Study|Withdrawal by Subject|3|||
147028074|NCT00987389|530266063|FG002|Overall Study|Withdrawal by Subject|2|||
147028075|NCT00987389|530266064|FG003|Overall Study|Withdrawal by Subject|1|||
147028076|NCT00987389|530266061|FG000|Overall Study|Withdrawn from Treatment|0|||
147028077|NCT00987389|530266062|FG001|Overall Study|Withdrawn from Treatment|1|||
147028078|NCT00987389|530266063|FG002|Overall Study|Withdrawn from Treatment|0|||
147028079|NCT00987389|530266064|FG003|Overall Study|Withdrawn from Treatment|0|||
147028080|NCT00987389|530266061|FG000|Overall Study|Multiple different reasons|1|||
147028081|NCT00987389|530266062|FG001|Overall Study|Multiple different reasons|0|||
147028082|NCT00987389|530266063|FG002|Overall Study|Multiple different reasons|3|||
147028083|NCT00987389|530266064|FG003|Overall Study|Multiple different reasons|1|||
147028084|NCT02992418|530266065|FG000|Overall Study|Withdrawal by Subject|11|||
147028085|NCT02992418|530266066|FG001|Overall Study|Withdrawal by Subject|12|||
147028086|NCT02992418|530266065|FG000|Overall Study|Non-compliance with the protocol|308|||
147028087|NCT02992418|530266066|FG001|Overall Study|Non-compliance with the protocol|308|||
147028088|NCT02992418|530266065|FG000|Overall Study|Lost to Follow-up|27|||
147028089|NCT02992418|530266066|FG001|Overall Study|Lost to Follow-up|22|||
147028090|NCT00289536|530266067|FG000|Period 3|Lost to Follow-up|0|||
147028091|NCT00289536|530266068|FG001|Period 3|Lost to Follow-up|0|||
147028092|NCT00289536|530266069|FG002|Period 3|Lost to Follow-up|1|||
147028093|NCT03246126|530266070|FG000|Overall Study|Withdrawal by Subject|0|||
147028094|NCT03246126|530266071|FG001|Overall Study|Withdrawal by Subject|1|||
147028095|NCT04465630|530266074|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
147028096|NCT04465630|530266074|FG000|Overall Study|Screen failure|8|||
147028097|NCT04465630|530266074|FG000|Overall Study|Baseline failure|16|||
147028098|NCT01006135|530266075|FG000|Overall Study|Adverse Event|22|||
147028099|NCT01006135|530266075|FG000|Overall Study|Protocol Violation|14|||
147028100|NCT01006135|530266075|FG000|Overall Study|Lost to Follow-up|32|||
147028101|NCT01006135|530266075|FG000|Overall Study|Other|72|||
147028102|NCT01732484|530266077|FG000|Overall Study|Death|7|||
147028103|NCT01732484|530266077|FG000|Overall Study|Lost to Follow-up|14|||
147028104|NCT01732484|530266077|FG000|Overall Study|chronical illness|5|||
147028105|NCT01087489|530266078|FG000|Overall Study|enrolled in another VA study|0|||
147028106|NCT01087489|530266079|FG001|Overall Study|enrolled in another VA study|1|||
147028107|NCT01087489|530266078|FG000|Overall Study|Death|0|||
147028108|NCT01087489|530266079|FG001|Overall Study|Death|1|||
147028109|NCT01087489|530266078|FG000|Overall Study|unable to survey by telephone|0|||
147028110|NCT01087489|530266079|FG001|Overall Study|unable to survey by telephone|1|||
147028111|NCT00928707|530266087|FG000|Overall Study|Protocol Violation|1|||
147028112|NCT00928707|530266088|FG001|Overall Study|Protocol Violation|0|||
147028113|NCT00132028|530266089|FG000|Overall Study|Adverse Event|7|||
147028114|NCT00132028|530266089|FG000|Overall Study|Death|2|||
147028115|NCT00132028|530266089|FG000|Overall Study|Lack of Efficacy|11|||
147028116|NCT00132028|530266089|FG000|Overall Study|Withdrawal by Subject|2|||
147028117|NCT00132028|530266089|FG000|Overall Study|not eligible|2|||
147028118|NCT00132028|530266089|FG000|Overall Study|Physician Decision|3|||
147028119|NCT02140411|530266090|FG000|Overall Study|Adverse Event|1|||
147028120|NCT02005887|530266093|FG000|Overall Study|Protocol Violation|0|||
147028121|NCT02005887|530266094|FG001|Overall Study|Protocol Violation|2|||
147028122|NCT04771403|530266103|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
147028123|NCT04771403|530266104|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
147028124|NCT04771403|530266103|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
147028125|NCT04771403|530266104|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
147028126|NCT04771403|530266103|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
147028127|NCT04771403|530266104|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
147028128|NCT04771403|530266103|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
147028129|NCT04771403|530266104|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
147028130|NCT04771403|530266103|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
147028131|NCT04771403|530266104|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
147028132|NCT04771403|530266103|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
147028133|NCT04771403|530266104|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
147028134|NCT04771403|530266103|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
147028135|NCT04771403|530266104|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
147028136|NCT04771403|530266103|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
147028137|NCT04771403|530266104|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
147028138|NCT01615263|530266105|FG000|Overall Study|Post-randomization exclusion|0|||
147028139|NCT01615263|530266106|FG001|Overall Study|Post-randomization exclusion|2|||
147028140|NCT03176459|530266113|FG000|Overall Study|Lost to Follow-up|5|||
147028141|NCT03176459|530266114|FG001|Overall Study|Lost to Follow-up|7|||
147028142|NCT04221789|530268442|FG000|Overall Study|deviation from protoco|22|||
147028143|NCT04221789|530268443|FG001|Overall Study|deviation from protoco|8|||
147028144|NCT06077487|530268444|FG000|Overall Study|Withdrawal by Subject|0|||
147028145|NCT06077487|530268445|FG001|Overall Study|Withdrawal by Subject|1|||
147028146|NCT04385277|530268446|FG000|Overall Study|Physician Decision|2|||
147028147|NCT04385277|530268446|FG000|Overall Study|Ineligible|1|||
147028148|NCT04385277|530268446|FG000|Overall Study|Patient/Parent Refusal|2|||
147028149|NCT04905290|530268447|FG000|Overall Study|Adverse Event|4|||
147028150|NCT04905290|530268447|FG000|Overall Study|Death|2|||
147028151|NCT04905290|530268447|FG000|Overall Study|Withdrawal by Subject|4|||
147028152|NCT04905290|530268447|FG000|Overall Study|Physician Decision|2|||
147028153|NCT04905290|530268447|FG000|Overall Study|Lost to Follow-up|2|||
147028154|NCT04905290|530268447|FG000|Overall Study|Screen Failure|2|||
147028155|NCT04905290|530268447|FG000|Overall Study|Unsuccessful Procedure|2|||
147028156|NCT05101486|530268448|FG000|Overall Study|Death|1|||
147028157|NCT05101486|530268449|FG001|Overall Study|Death|0|||
147028158|NCT05101486|530268450|FG002|Overall Study|Death|1|||
147028159|NCT05101486|530268448|FG000|Overall Study|Lost to Follow-up|12|||
147028160|NCT05101486|530268449|FG001|Overall Study|Lost to Follow-up|8|||
147028161|NCT05101486|530268450|FG002|Overall Study|Lost to Follow-up|17|||
147028162|NCT05101486|530268448|FG000|Overall Study|Physician Decision|1|||
147028163|NCT05101486|530268449|FG001|Overall Study|Physician Decision|0|||
147028164|NCT05101486|530268450|FG002|Overall Study|Physician Decision|0|||
147028165|NCT05101486|530268448|FG000|Overall Study|Protocol Violation|0|||
147028166|NCT05101486|530268449|FG001|Overall Study|Protocol Violation|0|||
147028167|NCT05101486|530268450|FG002|Overall Study|Protocol Violation|1|||
147028168|NCT05101486|530268448|FG000|Overall Study|Withdrawal by Subject|5|||
147028169|NCT05101486|530268449|FG001|Overall Study|Withdrawal by Subject|2|||
147028170|NCT05101486|530268450|FG002|Overall Study|Withdrawal by Subject|4|||
147028171|NCT05101486|530268448|FG000|Overall Study|Randomized but not vaccinated|1|||
147028172|NCT05101486|530268449|FG001|Overall Study|Randomized but not vaccinated|1|||
147028173|NCT05101486|530268450|FG002|Overall Study|Randomized but not vaccinated|1|||
147028174|NCT03295318|530268451|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
147028175|NCT03295318|530268452|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
147028176|NCT03295318|530268453|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
147028177|NCT03295318|530268451|FG000|Overall Study|Death|1|||
147028178|NCT03295318|530268452|FG001|Overall Study|Death|1|||
147028179|NCT03295318|530268453|FG002|Overall Study|Death|1|||
147028180|NCT03295318|530268451|FG000|Overall Study|Protocol Violation|4|||
147028181|NCT03295318|530268452|FG001|Overall Study|Protocol Violation|3|||
147028182|NCT03295318|530268453|FG002|Overall Study|Protocol Violation|3|||
147028183|NCT03295318|530268451|FG000|Overall Study|Withdrawal by Subject|0|||
146849529|NCT02663518|529618861|FG010|Part 1: Phase 1a Escalation|Death|0|||
146849530|NCT02663518|529618862|FG011|Part 1: Phase 1a Escalation|Death|0|||
146849531|NCT02663518|529618863|FG012|Part 1: Phase 1a Escalation|Death|0|||
147028184|NCT03295318|530268452|FG001|Overall Study|Withdrawal by Subject|0|||
147028185|NCT03295318|530268453|FG002|Overall Study|Withdrawal by Subject|1|||
147028186|NCT03295318|530268451|FG000|Overall Study|Subject discontinued due to travel|0|||
147028187|NCT03295318|530268452|FG001|Overall Study|Subject discontinued due to travel|1|||
147028188|NCT03295318|530268453|FG002|Overall Study|Subject discontinued due to travel|0|||
146849532|NCT02663518|529618864|FG013|Part 1: Phase 1a Escalation|Death|0|||
146849533|NCT02663518|529618851|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146849534|NCT02663518|529618852|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146849535|NCT02663518|529618853|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
146849536|NCT02663518|529618854|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146849537|NCT02663518|529618855|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146849538|NCT02663518|529618856|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146849539|NCT02663518|529618857|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146849540|NCT02663518|529618858|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146849541|NCT02663518|529618859|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146849542|NCT02663518|529618860|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146849543|NCT02663518|529618861|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146849544|NCT02663518|529618862|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146849545|NCT02663518|529618863|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146849546|NCT02663518|529618864|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146849547|NCT02663518|529618851|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
146849548|NCT02663518|529618852|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
146849549|NCT02663518|529618853|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
146849550|NCT02663518|529618854|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
147028189|NCT03747601|530268454|FG000|Overall Study|COVID halt to visits|4|||
146849551|NCT02663518|529618855|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
147028190|NCT02788045|530268455|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
147028191|NCT02788045|530268456|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
147028192|NCT02788045|530268457|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
147028193|NCT02788045|530268455|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
147028194|NCT02788045|530268456|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
147028195|NCT02788045|530268457|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
147028196|NCT02788045|530268455|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
147028197|NCT02788045|530268456|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
147028198|NCT02788045|530268457|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
147028199|NCT02788045|530268455|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
147028200|NCT02788045|530268456|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
147028201|NCT02788045|530268457|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
147028202|NCT02788045|530268455|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
147028203|NCT02788045|530268456|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
147028204|NCT02788045|530268457|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
147028205|NCT02788045|530268455|FG000|Main Study (Up to Week 72)|Other|3|||
147028206|NCT02788045|530268456|FG001|Main Study (Up to Week 72)|Other|0|||
147028207|NCT02788045|530268457|FG002|Main Study (Up to Week 72)|Other|0|||
147028208|NCT02788045|530268455|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
147028209|NCT02788045|530268456|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
147028210|NCT02788045|530268457|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
147028211|NCT02788045|530268455|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
147028212|NCT02788045|530268456|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
147028213|NCT02788045|530268457|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
147028214|NCT02788045|530268455|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
147028215|NCT02788045|530268456|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
147028216|NCT02788045|530268457|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
147028217|NCT03696953|530268461|FG000|Overall Study|Withdrawal by Subject|6|||
147028218|NCT03696953|530268462|FG001|Overall Study|Withdrawal by Subject|1|||
147028219|NCT03696953|530268461|FG000|Overall Study|missed GBS swabs|2|||
147028220|NCT03696953|530268462|FG001|Overall Study|missed GBS swabs|2|||
147028221|NCT03696953|530268461|FG000|Overall Study|lost study bottle containing capsules|2|||
147028222|NCT03696953|530268462|FG001|Overall Study|lost study bottle containing capsules|0|||
147028223|NCT03696953|530268461|FG000|Overall Study|Premature birth|1|||
147028224|NCT03696953|530268462|FG001|Overall Study|Premature birth|4|||
146849552|NCT02663518|529618856|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146849553|NCT02663518|529618857|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146849554|NCT02663518|529618858|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146849555|NCT02663518|529618859|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146849556|NCT02663518|529618860|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
147028225|NCT03696953|530268461|FG000|Overall Study|Gestational hypertension|1|||
147028226|NCT03696953|530268462|FG001|Overall Study|Gestational hypertension|1|||
147028227|NCT03696953|530268461|FG000|Overall Study|Gestational diabetes|2|||
147028228|NCT03696953|530268462|FG001|Overall Study|Gestational diabetes|1|||
147028229|NCT03696953|530268461|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
147028230|NCT03696953|530268462|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
146849557|NCT02663518|529618861|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146849558|NCT02663518|529618862|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
147028231|NCT03696953|530268461|FG000|Overall Study|Changed prenatal provider|1|||
147028232|NCT03696953|530268462|FG001|Overall Study|Changed prenatal provider|1|||
147028233|NCT00461253|530268463|FG000|Overall Study|Death|985|||
147028234|NCT00461253|530268464|FG001|Overall Study|Death|0|||
147028235|NCT00461253|530268463|FG000|Overall Study|Protocol Violation|613|||
147028236|NCT00461253|530268464|FG001|Overall Study|Protocol Violation|236|||
147028237|NCT00461253|530268463|FG000|Overall Study|no response|2609|||
147028238|NCT00461253|530268464|FG001|Overall Study|no response|11789|||
147028239|NCT00461253|530268463|FG000|Overall Study|administrative|773|||
147028240|NCT00461253|530268464|FG001|Overall Study|administrative|7773|||
147028241|NCT02935686|530268466|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
147028242|NCT02935686|530268467|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
147028243|NCT02935686|530268468|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
147028244|NCT02935686|530268469|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
147028245|NCT02935686|530268470|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
147028246|NCT02935686|530268466|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
147028247|NCT02935686|530268467|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
147028248|NCT02935686|530268468|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
147028249|NCT02935686|530268469|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
147028250|NCT02935686|530268470|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
147028251|NCT02935686|530268466|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
147028252|NCT02935686|530268467|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
147028253|NCT02935686|530268468|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
147028254|NCT02935686|530268469|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
147028255|NCT02935686|530268470|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
147028256|NCT02935686|530268466|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
147028257|NCT02935686|530268467|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
147028258|NCT02935686|530268468|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
147028259|NCT02935686|530268469|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
147028260|NCT02935686|530268470|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
147028261|NCT02935686|530268466|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
147028262|NCT02935686|530268467|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
147028263|NCT02935686|530268468|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
147028264|NCT02935686|530268469|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
147028265|NCT02935686|530268470|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
147028266|NCT02935686|530268466|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
147028267|NCT02935686|530268467|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
147028268|NCT02935686|530268468|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
147028269|NCT02935686|530268469|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
147028270|NCT02935686|530268470|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
147028271|NCT02935686|530268466|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
147028272|NCT02935686|530268467|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
147028273|NCT02935686|530268468|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
147028274|NCT02935686|530268469|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
147028275|NCT02935686|530268470|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
147028276|NCT02935686|530268466|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
147028277|NCT02935686|530268467|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
147028278|NCT02935686|530268468|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
147028279|NCT02935686|530268469|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
147028280|NCT02935686|530268470|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
147028281|NCT02935686|530268466|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
147028282|NCT02935686|530268467|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
147028283|NCT02935686|530268468|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
147028284|NCT02935686|530268469|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
147028285|NCT02935686|530268470|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
147028286|NCT02935686|530268466|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
147028287|NCT02935686|530268467|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
146849559|NCT02663518|529618863|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146849560|NCT02663518|529618864|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146849561|NCT02663518|529618851|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
147028288|NCT02935686|530268468|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
147028289|NCT02935686|530268469|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
147028290|NCT02935686|530268470|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
147028291|NCT02935686|530268466|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
147028292|NCT02935686|530268467|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
147028293|NCT02935686|530268468|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
147028294|NCT02935686|530268469|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
147028295|NCT02935686|530268470|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
147028296|NCT00541970|530268471|FG000|Month 7|Protocol Violation|9|||
147028297|NCT00541970|530268472|FG001|Month 7|Protocol Violation|13|||
147028298|NCT00541970|530268473|FG002|Month 7|Protocol Violation|11|||
147028299|NCT00541970|530268474|FG003|Month 7|Protocol Violation|5|||
147028300|NCT00541970|530268471|FG000|Month 12|Adverse Event|0|||
147028301|NCT00541970|530268472|FG001|Month 12|Adverse Event|1|||
147028302|NCT00541970|530268473|FG002|Month 12|Adverse Event|1|||
147028303|NCT00541970|530268474|FG003|Month 12|Adverse Event|1|||
147028304|NCT00541970|530268471|FG000|Month 12|Protocol Violation|12|||
147028305|NCT00541970|530268472|FG001|Month 12|Protocol Violation|21|||
147028306|NCT00541970|530268473|FG002|Month 12|Protocol Violation|20|||
147028307|NCT00541970|530268474|FG003|Month 12|Protocol Violation|15|||
147028308|NCT00541970|530268471|FG000|Month 18|Adverse Event|0|||
147028309|NCT00541970|530268472|FG001|Month 18|Adverse Event|1|||
147028310|NCT00541970|530268473|FG002|Month 18|Adverse Event|1|||
147028311|NCT00541970|530268474|FG003|Month 18|Adverse Event|1|||
147028312|NCT00541970|530268471|FG000|Month 18|Protocol Violation|14|||
147028313|NCT00541970|530268472|FG001|Month 18|Protocol Violation|23|||
147028314|NCT00541970|530268473|FG002|Month 18|Protocol Violation|24|||
147028315|NCT00541970|530268474|FG003|Month 18|Protocol Violation|16|||
147028316|NCT00541970|530268471|FG000|Month 24|Adverse Event|0|||
147028317|NCT00541970|530268472|FG001|Month 24|Adverse Event|1|||
147028318|NCT00541970|530268473|FG002|Month 24|Adverse Event|1|||
147028319|NCT00541970|530268474|FG003|Month 24|Adverse Event|1|||
147028320|NCT00541970|530268471|FG000|Month 24|Protocol Violation|29|||
147028321|NCT00541970|530268472|FG001|Month 24|Protocol Violation|31|||
147028322|NCT00541970|530268473|FG002|Month 24|Protocol Violation|31|||
147028323|NCT00541970|530268474|FG003|Month 24|Protocol Violation|21|||
147028324|NCT00541970|530268471|FG000|Month 36|Protocol Violation|61|||
147028325|NCT00541970|530268472|FG001|Month 36|Protocol Violation|66|||
147028326|NCT00541970|530268473|FG002|Month 36|Protocol Violation|66|||
147028327|NCT00541970|530268474|FG003|Month 36|Protocol Violation|60|||
147028328|NCT00541970|530268471|FG000|Month 48|Withdrawal by Subject|2|||
147028329|NCT00541970|530268472|FG001|Month 48|Withdrawal by Subject|4|||
147028330|NCT00541970|530268473|FG002|Month 48|Withdrawal by Subject|4|||
147028331|NCT00541970|530268474|FG003|Month 48|Withdrawal by Subject|2|||
147028332|NCT00541970|530268471|FG000|Month 48|Other|3|||
147028333|NCT00541970|530268472|FG001|Month 48|Other|1|||
147028334|NCT00541970|530268473|FG002|Month 48|Other|1|||
147028335|NCT00541970|530268474|FG003|Month 48|Other|0|||
147028336|NCT00541970|530268471|FG000|Month 48|Lost to Follow-up|66|||
147028337|NCT00541970|530268472|FG001|Month 48|Lost to Follow-up|68|||
147028338|NCT00541970|530268473|FG002|Month 48|Lost to Follow-up|68|||
147028339|NCT00541970|530268474|FG003|Month 48|Lost to Follow-up|73|||
147028340|NCT00541970|530268471|FG000|Month 60|Protocol Violation|78|||
147028341|NCT00541970|530268472|FG001|Month 60|Protocol Violation|77|||
147028342|NCT00541970|530268473|FG002|Month 60|Protocol Violation|82|||
147028343|NCT00541970|530268474|FG003|Month 60|Protocol Violation|72|||
147028344|NCT01183221|530268475|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
147028345|NCT01183221|530268476|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
147028346|NCT00678041|530268480|FG000|Overall Study|Physician Decision|5|||
147028347|NCT00678041|530268481|FG001|Overall Study|Physician Decision|5|||
147028348|NCT00807248|530268483|FG000|Overall Study|Adverse Event|1|||
147028349|NCT00807248|530268484|FG001|Overall Study|Adverse Event|2|||
147028350|NCT00807248|530268485|FG002|Overall Study|Adverse Event|2|||
147028351|NCT00807248|530268486|FG003|Overall Study|Adverse Event|6|||
147028352|NCT00807248|530268483|FG000|Overall Study|Lack of Efficacy|14|||
147028353|NCT00807248|530268484|FG001|Overall Study|Lack of Efficacy|4|||
147028354|NCT00807248|530268485|FG002|Overall Study|Lack of Efficacy|8|||
147028355|NCT00807248|530268486|FG003|Overall Study|Lack of Efficacy|3|||
147028356|NCT00807248|530268483|FG000|Overall Study|Protocol Violation|0|||
147028357|NCT00807248|530268484|FG001|Overall Study|Protocol Violation|1|||
147028358|NCT00807248|530268485|FG002|Overall Study|Protocol Violation|1|||
147028359|NCT00807248|530268486|FG003|Overall Study|Protocol Violation|0|||
147028360|NCT00807248|530268483|FG000|Overall Study|Withdrawal of Consent|5|||
147028361|NCT00807248|530268484|FG001|Overall Study|Withdrawal of Consent|5|||
147028362|NCT00807248|530268485|FG002|Overall Study|Withdrawal of Consent|5|||
147028363|NCT00807248|530268486|FG003|Overall Study|Withdrawal of Consent|5|||
147028364|NCT00807248|530268483|FG000|Overall Study|Lost to Follow-up|1|||
147028365|NCT00807248|530268484|FG001|Overall Study|Lost to Follow-up|0|||
147028366|NCT00807248|530268485|FG002|Overall Study|Lost to Follow-up|0|||
147028367|NCT00807248|530268486|FG003|Overall Study|Lost to Follow-up|0|||
147028368|NCT00807248|530268483|FG000|Overall Study|Other Reason|0|||
147028369|NCT00807248|530268484|FG001|Overall Study|Other Reason|0|||
147028370|NCT00807248|530268485|FG002|Overall Study|Other Reason|2|||
147028371|NCT00807248|530268486|FG003|Overall Study|Other Reason|0|||
147028372|NCT02444793|530268487|FG000|Overall Study|Lost to Follow-up|2|||
147028373|NCT02444793|530268488|FG001|Overall Study|Lost to Follow-up|2|||
147028374|NCT02444793|530268489|FG002|Overall Study|Lost to Follow-up|0|||
147028375|NCT02444793|530268490|FG003|Overall Study|Lost to Follow-up|0|||
147028376|NCT02444793|530268487|FG000|Overall Study|Death|0|||
147028377|NCT02444793|530268488|FG001|Overall Study|Death|3|||
147028378|NCT02444793|530268489|FG002|Overall Study|Death|0|||
147028379|NCT02444793|530268490|FG003|Overall Study|Death|0|||
147028380|NCT02444793|530268487|FG000|Overall Study|Other|0|||
147028381|NCT02444793|530268488|FG001|Overall Study|Other|0|||
147028382|NCT02444793|530268489|FG002|Overall Study|Other|2|||
147028383|NCT02444793|530268490|FG003|Overall Study|Other|0|||
147028384|NCT02444793|530268487|FG000|Overall Study|Objective progression or relapse|9|||
147028385|NCT02444793|530268488|FG001|Overall Study|Objective progression or relapse|1|||
147028386|NCT02444793|530268489|FG002|Overall Study|Objective progression or relapse|2|||
147028387|NCT02444793|530268490|FG003|Overall Study|Objective progression or relapse|3|||
147028388|NCT02504671|530268495|FG000|Overall Study|Withdrawal by Subject|1|||
147028389|NCT02504671|530268496|FG001|Overall Study|Withdrawal by Subject|5|||
147028390|NCT02504671|530268497|FG002|Overall Study|Withdrawal by Subject|4|||
147028391|NCT02504671|530268498|FG003|Overall Study|Withdrawal by Subject|4|||
147028392|NCT02504671|530268499|FG004|Overall Study|Withdrawal by Subject|5|||
147028393|NCT02504671|530268500|FG005|Overall Study|Withdrawal by Subject|3|||
147028394|NCT02504671|530268495|FG000|Overall Study|Lack of Efficacy|1|||
147028395|NCT02504671|530268496|FG001|Overall Study|Lack of Efficacy|3|||
147028396|NCT02504671|530268497|FG002|Overall Study|Lack of Efficacy|1|||
147028397|NCT02504671|530268498|FG003|Overall Study|Lack of Efficacy|0|||
147028398|NCT02504671|530268499|FG004|Overall Study|Lack of Efficacy|4|||
147028399|NCT02504671|530268500|FG005|Overall Study|Lack of Efficacy|4|||
147028400|NCT02504671|530268495|FG000|Overall Study|Adverse Event|1|||
147028401|NCT02504671|530268496|FG001|Overall Study|Adverse Event|1|||
147028402|NCT02504671|530268497|FG002|Overall Study|Adverse Event|0|||
147028403|NCT02504671|530268498|FG003|Overall Study|Adverse Event|1|||
147028404|NCT02504671|530268499|FG004|Overall Study|Adverse Event|0|||
147028405|NCT02504671|530268500|FG005|Overall Study|Adverse Event|2|||
147028406|NCT02504671|530268495|FG000|Overall Study|Protocol Violation|2|||
147028407|NCT02504671|530268496|FG001|Overall Study|Protocol Violation|1|||
147028408|NCT02504671|530268497|FG002|Overall Study|Protocol Violation|0|||
147028409|NCT02504671|530268498|FG003|Overall Study|Protocol Violation|0|||
147028410|NCT02504671|530268499|FG004|Overall Study|Protocol Violation|0|||
147028411|NCT02504671|530268500|FG005|Overall Study|Protocol Violation|1|||
147028412|NCT02504671|530268495|FG000|Overall Study|Lost to Follow-up|0|||
147028413|NCT02504671|530268496|FG001|Overall Study|Lost to Follow-up|0|||
147028414|NCT02504671|530268497|FG002|Overall Study|Lost to Follow-up|2|||
147028415|NCT02504671|530268498|FG003|Overall Study|Lost to Follow-up|0|||
147028416|NCT02504671|530268499|FG004|Overall Study|Lost to Follow-up|0|||
147028417|NCT02504671|530268500|FG005|Overall Study|Lost to Follow-up|1|||
147028418|NCT02504671|530268495|FG000|Overall Study|Protocol defined stopping criteria|7|||
147028419|NCT02504671|530268496|FG001|Overall Study|Protocol defined stopping criteria|4|||
147028420|NCT02504671|530268497|FG002|Overall Study|Protocol defined stopping criteria|3|||
147028421|NCT02504671|530268498|FG003|Overall Study|Protocol defined stopping criteria|5|||
147028422|NCT02504671|530268499|FG004|Overall Study|Protocol defined stopping criteria|3|||
147028423|NCT02504671|530268500|FG005|Overall Study|Protocol defined stopping criteria|3|||
147028424|NCT00210249|530268501|FG000|Overall Study|Lost to Follow-up|5|||
147028425|NCT00210249|530268501|FG000|Overall Study|Protocol Violation|11|||
147028426|NCT04280705|530268502|FG000|Overall Study|Enrolled but not treated|4|||
147028427|NCT04280705|530268503|FG001|Overall Study|Enrolled but not treated|10|||
147028428|NCT04280705|530268502|FG000|Overall Study|Physician Decision|1|||
147028429|NCT04280705|530268503|FG001|Overall Study|Physician Decision|0|||
147028430|NCT04280705|530268502|FG000|Overall Study|Withdrawal by Subject|7|||
147028431|NCT04280705|530268503|FG001|Overall Study|Withdrawal by Subject|9|||
147028432|NCT04280705|530268502|FG000|Overall Study|Adverse Event|0|||
147028433|NCT04280705|530268503|FG001|Overall Study|Adverse Event|4|||
147028434|NCT04280705|530268502|FG000|Overall Study|Transferred to another hospital|1|||
147028435|NCT04280705|530268503|FG001|Overall Study|Transferred to another hospital|1|||
147028436|NCT03222583|530268504|FG000|Overall Study|Withdrawal by Subject|3|||
147028437|NCT03222583|530268505|FG001|Overall Study|Withdrawal by Subject|3|||
147028438|NCT03222583|530268504|FG000|Overall Study|Lost to Follow-up|1|||
147028439|NCT03222583|530268505|FG001|Overall Study|Lost to Follow-up|0|||
147028440|NCT03222583|530268504|FG000|Overall Study|Other|1|||
147028441|NCT03222583|530268505|FG001|Overall Study|Other|3|||
147028442|NCT02518919|530268508|FG000|Overall Study|Protocol Violation|1|||
147028443|NCT02518919|530268509|FG001|Overall Study|Protocol Violation|1|||
147028444|NCT02518919|530268510|FG002|Overall Study|Protocol Violation|2|||
147028445|NCT04498403|530268511|FG000|Overall Study|Adverse Event|1|||
147028446|NCT04498403|530268512|FG001|Overall Study|Adverse Event|0|||
147028447|NCT04498403|530268511|FG000|Overall Study|Study Terminated By Sponsor|29|||
147028448|NCT04498403|530268512|FG001|Overall Study|Study Terminated By Sponsor|10|||
147028449|NCT02031458|530268513|FG000|May 8, 2015 to January 11, 2019|Death|89|||
147028450|NCT02031458|530268514|FG001|May 8, 2015 to January 11, 2019|Death|193|||
147028451|NCT02031458|530268515|FG002|May 8, 2015 to January 11, 2019|Death|198|||
147028452|NCT02031458|530268513|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
147028453|NCT02031458|530268514|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
147028454|NCT02031458|530268515|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
147028455|NCT02031458|530268513|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
147028456|NCT02031458|530268514|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
147028457|NCT02031458|530268515|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
147028458|NCT02031458|530268513|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
147028459|NCT02031458|530268514|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
147028460|NCT02031458|530268515|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
147028461|NCT02031458|530268513|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
147028462|NCT02031458|530268514|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
147028463|NCT02031458|530268515|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
147028464|NCT02031458|530268513|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
147028465|NCT02031458|530268514|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
147028466|NCT02031458|530268515|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
147028467|NCT02031458|530268513|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
147028468|NCT02031458|530268514|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
147028469|NCT02031458|530268515|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
147028470|NCT02031458|530268513|FG000|Baseline to May 8, 2015|Death|36|||
147028471|NCT02031458|530268514|FG001|Baseline to May 8, 2015|Death|87|||
147028472|NCT02031458|530268515|FG002|Baseline to May 8, 2015|Death|100|||
147028473|NCT02031458|530268513|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
147028474|NCT02031458|530268514|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
147028475|NCT02031458|530268515|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
147028476|NCT02031458|530268513|FG000|Baseline to May 8, 2015|Physician Decision|0|||
147028477|NCT02031458|530268514|FG001|Baseline to May 8, 2015|Physician Decision|1|||
147028478|NCT02031458|530268515|FG002|Baseline to May 8, 2015|Physician Decision|0|||
147028479|NCT02031458|530268513|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
147028480|NCT02031458|530268514|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
147028481|NCT02031458|530268515|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
147028482|NCT02031458|530268513|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
147028483|NCT02031458|530268514|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
147028484|NCT02031458|530268515|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
147028485|NCT02031458|530268513|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
147028486|NCT02031458|530268514|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
147028487|NCT02031458|530268515|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
147028488|NCT02031458|530268513|FG000|Baseline to May 8, 2015|On Treatment|43|||
147028489|NCT02031458|530268514|FG001|Baseline to May 8, 2015|On Treatment|81|||
147028490|NCT02031458|530268515|FG002|Baseline to May 8, 2015|On Treatment|73|||
147028491|NCT02031458|530268513|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
147028492|NCT02031458|530268514|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
147028493|NCT02031458|530268515|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
147028494|NCT03188718|530268518|FG000|Overall Study|Participant noncompliance|4|||
147028495|NCT03188718|530268518|FG000|Overall Study|Withdrawal by Subject|1|||
147028496|NCT03188718|530268518|FG000|Overall Study|Device failure|3|||
147028497|NCT02049450|530268519|FG000|Overall Study|Adverse Event|2|||
147028498|NCT02049450|530268519|FG000|Overall Study|Withdrawal by Subject|1|||
147028499|NCT02049450|530268519|FG000|Overall Study|Patients/guardian decision|1|||
147028500|NCT00394524|530268523|FG000|Overall Study|Protocol Violation|2|||
147028501|NCT00394524|530268524|FG001|Overall Study|Protocol Violation|3|||
147028502|NCT00394524|530268523|FG000|Overall Study|Death|1|||
147028503|NCT00394524|530268524|FG001|Overall Study|Death|0|||
147028504|NCT00394524|530268523|FG000|Overall Study|Withdrawal by Subject|0|||
147028505|NCT00394524|530268524|FG001|Overall Study|Withdrawal by Subject|1|||
147028506|NCT01462318|530268525|FG000|Main Study / TP-DI Study|Other|2|||
147028507|NCT01462318|530268526|FG001|Main Study / TP-DI Study|Other|0|||
147028508|NCT01462318|530268527|FG002|Main Study / TP-DI Study|Other|0|||
147028509|NCT01462318|530268525|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
147028510|NCT01462318|530268526|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
147028511|NCT01462318|530268527|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
147028512|NCT01462318|530268525|FG000|Main Study / TP-DI Study|Adverse Event|4|||
147028513|NCT01462318|530268526|FG001|Main Study / TP-DI Study|Adverse Event|0|||
147028514|NCT01462318|530268527|FG002|Main Study / TP-DI Study|Adverse Event|0|||
147028515|NCT01462318|530268525|FG000|Extension Phase|Lost to Follow-up|0|||
146849562|NCT02663518|529618852|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
146849563|NCT02663518|529618853|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
146849564|NCT02663518|529618854|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
147028516|NCT01462318|530268526|FG001|Extension Phase|Lost to Follow-up|0|||
146849565|NCT02663518|529618855|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147028517|NCT01462318|530268527|FG002|Extension Phase|Lost to Follow-up|1|||
147028518|NCT01462318|530268525|FG000|Extension Phase|Other|0|||
147028519|NCT01462318|530268526|FG001|Extension Phase|Other|0|||
147028520|NCT01462318|530268527|FG002|Extension Phase|Other|1|||
147028521|NCT01462318|530268525|FG000|Extension Phase|Disease Progression|0|||
147028522|NCT01462318|530268526|FG001|Extension Phase|Disease Progression|0|||
147028523|NCT01462318|530268527|FG002|Extension Phase|Disease Progression|1|||
147028524|NCT01462318|530268525|FG000|Extension Phase|Withdrawal by Subject|0|||
147028525|NCT01462318|530268526|FG001|Extension Phase|Withdrawal by Subject|0|||
147028526|NCT01462318|530268527|FG002|Extension Phase|Withdrawal by Subject|15|||
147028527|NCT01462318|530268525|FG000|Extension Phase|Investigator Decision|0|||
147028528|NCT01462318|530268526|FG001|Extension Phase|Investigator Decision|0|||
147028529|NCT01462318|530268527|FG002|Extension Phase|Investigator Decision|5|||
147028530|NCT01462318|530268525|FG000|Extension Phase|Adverse Event|0|||
147028531|NCT01462318|530268526|FG001|Extension Phase|Adverse Event|0|||
147028532|NCT01462318|530268527|FG002|Extension Phase|Adverse Event|22|||
147028533|NCT00893737|530268533|FG000|Overall Study|Adverse Event|4|||
147028534|NCT00893737|530268533|FG000|Overall Study|Withdrawal by Subject|2|||
147028535|NCT00893737|530268533|FG000|Overall Study|Lost to Follow-up|6|||
147028536|NCT01156142|530268534|FG000|Overall Study|Withdrawal by Subject|8|||
147028537|NCT01156142|530268535|FG001|Overall Study|Withdrawal by Subject|6|||
147028538|NCT01156142|530268534|FG000|Overall Study|Ineligible|0|||
147028539|NCT01156142|530268535|FG001|Overall Study|Ineligible|1|||
147028540|NCT03981419|530268536|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
147028541|NCT03981419|530268537|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
147028542|NCT01330459|530268538|FG000|Overall Study|Physician Decision|0|||
147028543|NCT01330459|530268539|FG001|Overall Study|Physician Decision|2|||
147028544|NCT00895947|530268541|FG000|Overall Study|Adverse Event|3|||
147028545|NCT00895947|530268542|FG001|Overall Study|Adverse Event|4|||
147028546|NCT00895947|530268541|FG000|Overall Study|Lost to Follow-up|3|||
147028547|NCT00895947|530268542|FG001|Overall Study|Lost to Follow-up|4|||
147028548|NCT00895947|530268541|FG000|Overall Study|Protocol Violation|4|||
147028549|NCT00895947|530268542|FG001|Overall Study|Protocol Violation|2|||
147028550|NCT00895947|530268541|FG000|Overall Study|Withdrawal by Subject|2|||
147028551|NCT00895947|530268542|FG001|Overall Study|Withdrawal by Subject|0|||
147028552|NCT04620135|530268547|FG000|Study Completion|Adverse Event|2|||
147028553|NCT04620135|530268548|FG001|Study Completion|Adverse Event|3|||
147028554|NCT04620135|530268547|FG000|Study Completion|Withdrawal by Subject|2|||
147028555|NCT04620135|530268548|FG001|Study Completion|Withdrawal by Subject|0|||
147028556|NCT02272634|530268550|FG000|Overall Study|Adverse Event|1|||
147028557|NCT02272634|530268551|FG001|Overall Study|Adverse Event|0|||
147028558|NCT02272634|530268552|FG002|Overall Study|Adverse Event|0|||
147028559|NCT02272634|530268550|FG000|Overall Study|Protocol Violation|0|||
147028560|NCT02272634|530268551|FG001|Overall Study|Protocol Violation|0|||
147028561|NCT02272634|530268552|FG002|Overall Study|Protocol Violation|1|||
147028562|NCT02272634|530268550|FG000|Overall Study|Withdrawal by Subject|0|||
147028563|NCT02272634|530268551|FG001|Overall Study|Withdrawal by Subject|1|||
147028564|NCT02272634|530268552|FG002|Overall Study|Withdrawal by Subject|0|||
147028565|NCT01437943|530268553|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
147028566|NCT01437943|530268554|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
147028567|NCT01437943|530268553|FG000|Overall Study|Subject expressed pregnancy plans|1|||
147028568|NCT01437943|530268554|FG001|Overall Study|Subject expressed pregnancy plans|0|||
147028569|NCT01437943|530268553|FG000|Overall Study|Adverse Event|2|||
147028570|NCT01437943|530268554|FG001|Overall Study|Adverse Event|0|||
147028571|NCT04647721|530268555|FG000|Overall Study|Withdrawal by Subject|0|||
147028572|NCT04647721|530268556|FG001|Overall Study|Withdrawal by Subject|2|||
147028573|NCT04647721|530268555|FG000|Overall Study|Lost to Follow-up|2|||
147028574|NCT04647721|530268556|FG001|Overall Study|Lost to Follow-up|0|||
147028575|NCT01974440|530268558|FG000|Overall Study|Lost to Follow-up|7|||
147028576|NCT01974440|530268559|FG001|Overall Study|Lost to Follow-up|7|||
147028577|NCT01974440|530268558|FG000|Overall Study|Withdrawal by Subject|24|||
147028578|NCT01974440|530268559|FG001|Overall Study|Withdrawal by Subject|20|||
147028579|NCT01974440|530268558|FG000|Overall Study|Sponsor decision|109|||
147028580|NCT01974440|530268559|FG001|Overall Study|Sponsor decision|110|||
147028581|NCT00857259|530268563|FG000|Overall Study|Protocol Violation|1|||
147028582|NCT00857259|530268564|FG001|Overall Study|Protocol Violation|0|||
147028583|NCT00857259|530268565|FG002|Overall Study|Protocol Violation|1|||
147028584|NCT02701413|530268566|FG000|Overall Study|Withdrawal by Subject|7|||
146849566|NCT02663518|529618856|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147028585|NCT02701413|530268567|FG001|Overall Study|Withdrawal by Subject|11|||
146849567|NCT02663518|529618857|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147028586|NCT02138136|530268568|FG000|Overall Study|Protocol Violation|4|||
147028587|NCT02138136|530268568|FG000|Overall Study|Physician Decision|7|||
147028588|NCT02138136|530268568|FG000|Overall Study|Lack of Efficacy|35|||
147028589|NCT02138136|530268568|FG000|Overall Study|Pregnancy|2|||
147028590|NCT02138136|530268568|FG000|Overall Study|Adverse Event|18|||
147028591|NCT02138136|530268568|FG000|Overall Study|Withdrawal by Subject|36|||
147028592|NCT02138136|530268568|FG000|Overall Study|Lost to Follow-up|32|||
147028593|NCT02138136|530268568|FG000|Overall Study|Withdrawn by Sponsor|5|||
147028594|NCT01359644|530268573|FG000|Treatment Period|Lack of Efficacy|0|||
147028595|NCT01359644|530268574|FG001|Treatment Period|Lack of Efficacy|1|||
147028596|NCT01359644|530268575|FG002|Treatment Period|Lack of Efficacy|0|||
147028597|NCT01359644|530268576|FG003|Treatment Period|Lack of Efficacy|0|||
147028598|NCT01359644|530268577|FG004|Treatment Period|Lack of Efficacy|0|||
147028599|NCT01359644|530268578|FG005|Treatment Period|Lack of Efficacy|0|||
147028600|NCT01359644|530268579|FG006|Treatment Period|Lack of Efficacy|0|||
147028601|NCT01359644|530268580|FG007|Treatment Period|Lack of Efficacy|0|||
147028602|NCT01359644|530268581|FG008|Treatment Period|Lack of Efficacy|0|||
147028603|NCT01359644|530268582|FG009|Treatment Period|Lack of Efficacy|0|||
147028604|NCT01359644|530268573|FG000|Treatment Period|Adverse Event|0|||
147028605|NCT01359644|530268574|FG001|Treatment Period|Adverse Event|0|||
147028606|NCT01359644|530268575|FG002|Treatment Period|Adverse Event|1|||
147028607|NCT01359644|530268576|FG003|Treatment Period|Adverse Event|0|||
147028608|NCT01359644|530268577|FG004|Treatment Period|Adverse Event|0|||
147028609|NCT01359644|530268578|FG005|Treatment Period|Adverse Event|1|||
147028610|NCT01359644|530268579|FG006|Treatment Period|Adverse Event|0|||
147028611|NCT01359644|530268580|FG007|Treatment Period|Adverse Event|0|||
147028612|NCT01359644|530268581|FG008|Treatment Period|Adverse Event|0|||
147028613|NCT01359644|530268582|FG009|Treatment Period|Adverse Event|0|||
147028614|NCT01359644|530268573|FG000|Treatment Period|Lost to Follow-up|0|||
147028615|NCT01359644|530268574|FG001|Treatment Period|Lost to Follow-up|0|||
147028616|NCT01359644|530268575|FG002|Treatment Period|Lost to Follow-up|0|||
147028617|NCT01359644|530268576|FG003|Treatment Period|Lost to Follow-up|0|||
147028618|NCT01359644|530268577|FG004|Treatment Period|Lost to Follow-up|0|||
147028619|NCT01359644|530268578|FG005|Treatment Period|Lost to Follow-up|1|||
147028620|NCT01359644|530268579|FG006|Treatment Period|Lost to Follow-up|0|||
147028621|NCT01359644|530268580|FG007|Treatment Period|Lost to Follow-up|0|||
147028622|NCT01359644|530268581|FG008|Treatment Period|Lost to Follow-up|0|||
147028623|NCT01359644|530268582|FG009|Treatment Period|Lost to Follow-up|0|||
147028624|NCT01359644|530268573|FG000|Follow-up Period|Withdrawal by Subject|0|||
147028625|NCT01359644|530268574|FG001|Follow-up Period|Withdrawal by Subject|0|||
147028626|NCT01359644|530268575|FG002|Follow-up Period|Withdrawal by Subject|0|||
147028627|NCT01359644|530268576|FG003|Follow-up Period|Withdrawal by Subject|0|||
147028628|NCT01359644|530268577|FG004|Follow-up Period|Withdrawal by Subject|0|||
147028629|NCT01359644|530268578|FG005|Follow-up Period|Withdrawal by Subject|1|||
147028630|NCT01359644|530268579|FG006|Follow-up Period|Withdrawal by Subject|0|||
147028631|NCT01359644|530268580|FG007|Follow-up Period|Withdrawal by Subject|0|||
147028632|NCT01359644|530268581|FG008|Follow-up Period|Withdrawal by Subject|0|||
147028633|NCT01359644|530268582|FG009|Follow-up Period|Withdrawal by Subject|0|||
147028634|NCT01359644|530268573|FG000|Follow-up Period|Lost to Follow-up|0|||
147028635|NCT01359644|530268574|FG001|Follow-up Period|Lost to Follow-up|0|||
147028636|NCT01359644|530268575|FG002|Follow-up Period|Lost to Follow-up|0|||
147028637|NCT01359644|530268576|FG003|Follow-up Period|Lost to Follow-up|0|||
147028638|NCT01359644|530268577|FG004|Follow-up Period|Lost to Follow-up|0|||
147028639|NCT01359644|530268578|FG005|Follow-up Period|Lost to Follow-up|0|||
147028640|NCT01359644|530268579|FG006|Follow-up Period|Lost to Follow-up|1|||
147028641|NCT01359644|530268580|FG007|Follow-up Period|Lost to Follow-up|2|||
147028642|NCT01359644|530268581|FG008|Follow-up Period|Lost to Follow-up|0|||
147028643|NCT01359644|530268582|FG009|Follow-up Period|Lost to Follow-up|0|||
147028644|NCT01660334|530268584|FG000|Overall Study|Lost to Follow-up|1|||
147028645|NCT00311311|530268585|FG000|Overall Study|Adverse Event|3|||
147028646|NCT00311311|530268586|FG001|Overall Study|Adverse Event|2|||
147028647|NCT00311311|530268585|FG000|Overall Study|Withdrawal by Subject|1|||
147028648|NCT00311311|530268586|FG001|Overall Study|Withdrawal by Subject|1|||
147028649|NCT00311311|530268585|FG000|Overall Study|Noncompliance|0|||
147028650|NCT00311311|530268586|FG001|Overall Study|Noncompliance|1|||
147028651|NCT00311311|530268585|FG000|Overall Study|Study Termination by Sponsor|3|||
147028652|NCT00311311|530268586|FG001|Overall Study|Study Termination by Sponsor|4|||
147028653|NCT00311311|530268585|FG000|Overall Study|Death|1|||
147028654|NCT00311311|530268586|FG001|Overall Study|Death|0|||
147028655|NCT00311311|530268585|FG000|Overall Study|Lack of ancillary assistance|0|||
147028656|NCT00311311|530268586|FG001|Overall Study|Lack of ancillary assistance|1|||
147028657|NCT00546572|530268587|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
147028658|NCT00546572|530268588|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
147028659|NCT00546572|530268587|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
147028660|NCT00546572|530268588|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
147028661|NCT00546572|530268587|FG000|Vax 1 / Year 0|Protocol Violation|3|||
147028662|NCT00546572|530268588|FG001|Vax 1 / Year 0|Protocol Violation|4|||
147028663|NCT00546572|530268587|FG000|Vax 1 / Year 0|Death|2|||
147028664|NCT00546572|530268588|FG001|Vax 1 / Year 0|Death|2|||
147028665|NCT00546572|530268587|FG000|Vax 1 / Year 0|Adverse Event|0|||
147028666|NCT00546572|530268588|FG001|Vax 1 / Year 0|Adverse Event|1|||
147028667|NCT00546572|530268587|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
147028668|NCT00546572|530268588|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
147028669|NCT00546572|530268587|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
147028670|NCT00546572|530268588|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
147028671|NCT00546572|530268587|FG000|Vax 2 / Year 1|Other|1|||
147028672|NCT00546572|530268588|FG001|Vax 2 / Year 1|Other|1|||
147028673|NCT00546572|530268587|FG000|Vax 2 / Year 1|Adverse Event|1|||
147028674|NCT00546572|530268588|FG001|Vax 2 / Year 1|Adverse Event|0|||
147028675|NCT00546572|530268587|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
147028676|NCT00546572|530268588|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
147028677|NCT03979820|530268589|FG000|Overall Study|Protocol Violation|1|||
147028678|NCT03979820|530268590|FG001|Overall Study|Protocol Violation|0|||
147028679|NCT03979820|530268591|FG002|Overall Study|Protocol Violation|0|||
147028680|NCT03979820|530268592|FG003|Overall Study|Protocol Violation|0|||
147028681|NCT03979820|530268589|FG000|Overall Study|Withdrawal by Subject|0|||
147028682|NCT03979820|530268590|FG001|Overall Study|Withdrawal by Subject|0|||
147028683|NCT03979820|530268591|FG002|Overall Study|Withdrawal by Subject|1|||
147028684|NCT03979820|530268592|FG003|Overall Study|Withdrawal by Subject|0|||
147028685|NCT03979820|530268589|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
147028686|NCT03979820|530268590|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
147028687|NCT03979820|530268591|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
147028688|NCT03979820|530268592|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
147028689|NCT00988065|530268593|FG000|Overall Study|Adverse Event|4|||
147028690|NCT00988065|530268594|FG001|Overall Study|Adverse Event|10|||
147028691|NCT00988065|530268595|FG002|Overall Study|Adverse Event|2|||
147028692|NCT00988065|530268593|FG000|Overall Study|Lost to Follow-up|1|||
147028693|NCT00988065|530268594|FG001|Overall Study|Lost to Follow-up|2|||
147028694|NCT00988065|530268595|FG002|Overall Study|Lost to Follow-up|2|||
147028695|NCT00988065|530268593|FG000|Overall Study|Subject withdrew consent|3|||
147028696|NCT00988065|530268594|FG001|Overall Study|Subject withdrew consent|5|||
147028697|NCT00988065|530268595|FG002|Overall Study|Subject withdrew consent|2|||
147028698|NCT00988065|530268593|FG000|Overall Study|Noncompliance with protocol|5|||
147028699|NCT00988065|530268594|FG001|Overall Study|Noncompliance with protocol|6|||
147028700|NCT00988065|530268595|FG002|Overall Study|Noncompliance with protocol|9|||
147028701|NCT02685202|530268596|FG000|Overall Study|Lost to Follow-up|9|||
147028702|NCT01229735|530268597|FG000|Overall Study|Lack of Efficacy|8|||
147028703|NCT01229735|530268598|FG001|Overall Study|Lack of Efficacy|8|||
147028704|NCT01229735|530268597|FG000|Overall Study|Protocol Violation|13|||
147028705|NCT01229735|530268598|FG001|Overall Study|Protocol Violation|8|||
147028706|NCT01229735|530268597|FG000|Overall Study|Lost to Follow-up|0|||
147028707|NCT01229735|530268598|FG001|Overall Study|Lost to Follow-up|2|||
147028708|NCT01229735|530268597|FG000|Overall Study|Withdrawal by Subject|18|||
147028709|NCT01229735|530268598|FG001|Overall Study|Withdrawal by Subject|17|||
147028710|NCT01229735|530268597|FG000|Overall Study|Other Reason|13|||
147028711|NCT01229735|530268598|FG001|Overall Study|Other Reason|10|||
147028712|NCT01229735|530268597|FG000|Overall Study|SAE, non-fatal|0|||
147028713|NCT01229735|530268598|FG001|Overall Study|SAE, non-fatal|4|||
147028714|NCT01229735|530268597|FG000|Overall Study|AE, non-serious non-fatal|13|||
147028715|NCT01229735|530268598|FG001|Overall Study|AE, non-serious non-fatal|17|||
147028716|NCT01229735|530268597|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
147028717|NCT01229735|530268598|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
147028718|NCT02130882|530268599|FG000|Overall Study|Withdrawal by Subject|0|||
147028719|NCT02130882|530268600|FG001|Overall Study|Withdrawal by Subject|1|||
147028720|NCT02615171|530268614|FG000|Overall Study|Lost to Follow-up|2|||
147028721|NCT02615171|530268615|FG001|Overall Study|Lost to Follow-up|1|||
147028722|NCT00741936|530268623|FG000|Overall Study|Lost to Follow-up|1|||
147028723|NCT00741936|530268624|FG001|Overall Study|Lost to Follow-up|1|||
147028724|NCT00741936|530268623|FG000|Overall Study|Adverse Event|3|||
147028725|NCT00741936|530268624|FG001|Overall Study|Adverse Event|4|||
147028726|NCT00741936|530268623|FG000|Overall Study|Pregnancy|0|||
147028727|NCT00741936|530268624|FG001|Overall Study|Pregnancy|1|||
147028728|NCT00741936|530268623|FG000|Overall Study|Protocol Violation|2|||
147028729|NCT00741936|530268624|FG001|Overall Study|Protocol Violation|0|||
147028730|NCT00741936|530268623|FG000|Overall Study|Lack of Efficacy|0|||
147028731|NCT00741936|530268624|FG001|Overall Study|Lack of Efficacy|2|||
147028732|NCT00741936|530268623|FG000|Overall Study|Low compliance|3|||
147028733|NCT00741936|530268624|FG001|Overall Study|Low compliance|0|||
147028734|NCT00369382|530268625|FG000|Overall Study|Death|0|||
147028735|NCT00369382|530268626|FG001|Overall Study|Death|2|||
147028736|NCT00369382|530268625|FG000|Overall Study|Physician Decision|2|||
147028737|NCT00369382|530268626|FG001|Overall Study|Physician Decision|1|||
147028738|NCT00369382|530268625|FG000|Overall Study|Withdrawal by Subject|5|||
146849568|NCT02663518|529618858|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
146849569|NCT02663518|529618859|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147028739|NCT00369382|530268626|FG001|Overall Study|Withdrawal by Subject|0|||
147028740|NCT00369382|530268625|FG000|Overall Study|Randomized, not treated|2|||
147028741|NCT00369382|530268626|FG001|Overall Study|Randomized, not treated|0|||
147028742|NCT00369382|530268625|FG000|Overall Study|Other|1|||
147028743|NCT00369382|530268626|FG001|Overall Study|Other|0|||
147028744|NCT00502801|530268627|FG000|Treatment Period|Withdrawal by Subject|3|||
147028745|NCT00502801|530268627|FG000|Treatment Period|Adverse Event|7|||
147028746|NCT00502801|530268627|FG000|Treatment Period|Death|14|||
147028747|NCT00502801|530268627|FG000|Treatment Period|OTHER|30|||
147028748|NCT00502801|530268627|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
147028749|NCT00502801|530268627|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
147028750|NCT00502801|530268627|FG000|End of Therapy to Test of Cure|Death|3|||
147028751|NCT00502801|530268627|FG000|End of Therapy to Test of Cure|OTHER|2|||
147028752|NCT00446199|530268630|FG000|Overall Study|Adverse Event|7|||
147028753|NCT00446199|530268631|FG001|Overall Study|Adverse Event|4|||
147028754|NCT00446199|530268632|FG002|Overall Study|Adverse Event|6|||
147028755|NCT00446199|530268633|FG003|Overall Study|Adverse Event|4|||
147028756|NCT00446199|530268630|FG000|Overall Study|Lost to Follow-up|4|||
147028757|NCT00446199|530268631|FG001|Overall Study|Lost to Follow-up|5|||
147028758|NCT00446199|530268632|FG002|Overall Study|Lost to Follow-up|2|||
147028759|NCT00446199|530268633|FG003|Overall Study|Lost to Follow-up|6|||
147028760|NCT00446199|530268630|FG000|Overall Study|Protocol Violation|1|||
147028761|NCT00446199|530268631|FG001|Overall Study|Protocol Violation|2|||
147028762|NCT00446199|530268632|FG002|Overall Study|Protocol Violation|1|||
147028763|NCT00446199|530268633|FG003|Overall Study|Protocol Violation|3|||
147028764|NCT00446199|530268630|FG000|Overall Study|Withdrawal by Subject|2|||
147028765|NCT00446199|530268631|FG001|Overall Study|Withdrawal by Subject|5|||
147028766|NCT00446199|530268632|FG002|Overall Study|Withdrawal by Subject|9|||
147028767|NCT00446199|530268633|FG003|Overall Study|Withdrawal by Subject|10|||
147028768|NCT00446199|530268630|FG000|Overall Study|Site termination|2|||
147028769|NCT00446199|530268631|FG001|Overall Study|Site termination|0|||
147028770|NCT00446199|530268632|FG002|Overall Study|Site termination|0|||
147028771|NCT00446199|530268633|FG003|Overall Study|Site termination|1|||
147028772|NCT00446199|530268630|FG000|Overall Study|Randomization in Error|2|||
147028773|NCT00446199|530268631|FG001|Overall Study|Randomization in Error|0|||
147028774|NCT00446199|530268632|FG002|Overall Study|Randomization in Error|1|||
147028775|NCT00446199|530268633|FG003|Overall Study|Randomization in Error|1|||
147028776|NCT00446199|530268630|FG000|Overall Study|Lack of Efficacy|1|||
147028777|NCT00446199|530268631|FG001|Overall Study|Lack of Efficacy|0|||
147028778|NCT00446199|530268632|FG002|Overall Study|Lack of Efficacy|0|||
147028779|NCT00446199|530268633|FG003|Overall Study|Lack of Efficacy|1|||
147028780|NCT00446199|530268630|FG000|Overall Study|Non-compliant with study drug|1|||
147028781|NCT00446199|530268631|FG001|Overall Study|Non-compliant with study drug|0|||
147028782|NCT00446199|530268632|FG002|Overall Study|Non-compliant with study drug|5|||
147028783|NCT00446199|530268633|FG003|Overall Study|Non-compliant with study drug|0|||
147028784|NCT00446199|530268630|FG000|Overall Study|Non-compliant with visit schedule|1|||
147028785|NCT00446199|530268631|FG001|Overall Study|Non-compliant with visit schedule|1|||
147028786|NCT00446199|530268632|FG002|Overall Study|Non-compliant with visit schedule|1|||
147028787|NCT00446199|530268633|FG003|Overall Study|Non-compliant with visit schedule|2|||
147028788|NCT00446199|530268630|FG000|Overall Study|Hormone fear|0|||
147028789|NCT00446199|530268631|FG001|Overall Study|Hormone fear|0|||
147028790|NCT00446199|530268632|FG002|Overall Study|Hormone fear|0|||
147028791|NCT00446199|530268633|FG003|Overall Study|Hormone fear|1|||
147028792|NCT00446199|530268630|FG000|Overall Study|Lost interest in study participation|0|||
147028793|NCT00446199|530268631|FG001|Overall Study|Lost interest in study participation|1|||
147028794|NCT00446199|530268632|FG002|Overall Study|Lost interest in study participation|0|||
147028795|NCT00446199|530268633|FG003|Overall Study|Lost interest in study participation|0|||
147028796|NCT00446199|530268630|FG000|Overall Study|In-/Exclusion criterion violated|2|||
147028797|NCT00446199|530268631|FG001|Overall Study|In-/Exclusion criterion violated|1|||
147028798|NCT00446199|530268632|FG002|Overall Study|In-/Exclusion criterion violated|2|||
147028799|NCT00446199|530268633|FG003|Overall Study|In-/Exclusion criterion violated|1|||
147028800|NCT00446199|530268630|FG000|Overall Study|Move|0|||
147028801|NCT00446199|530268631|FG001|Overall Study|Move|1|||
147028802|NCT00446199|530268632|FG002|Overall Study|Move|0|||
147028803|NCT00446199|530268633|FG003|Overall Study|Move|0|||
147028804|NCT05011123|530270586|FG000|Overall Study|Withdrawal by Subject|4|||
147028805|NCT05011123|530270587|FG001|Overall Study|Withdrawal by Subject|2|||
147028806|NCT05011123|530270586|FG000|Overall Study|Lost to Follow-up|7|||
147028807|NCT05011123|530270587|FG001|Overall Study|Lost to Follow-up|6|||
147028808|NCT05011123|530270586|FG000|Overall Study|Ongoing at the time of DBL date|36|||
147028809|NCT05011123|530270587|FG001|Overall Study|Ongoing at the time of DBL date|10|||
147028810|NCT05011123|530270586|FG000|Overall Study|Randomized but did not receive vaccination|1|||
147028811|NCT05011123|530270587|FG001|Overall Study|Randomized but did not receive vaccination|0|||
147028812|NCT03845296|530270591|FG000|Overall Study|On Treatment|2|||
147028813|NCT03845296|530270592|FG001|Overall Study|On Treatment|1|||
146849570|NCT02663518|529618860|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147028814|NCT03845296|530270591|FG000|Overall Study|Adverse Event|4|||
147028815|NCT03845296|530270592|FG001|Overall Study|Adverse Event|11|||
147028816|NCT03845296|530270591|FG000|Overall Study|Refusal unrelated to adverse event|0|||
147028817|NCT03845296|530270592|FG001|Overall Study|Refusal unrelated to adverse event|1|||
147028818|NCT03845296|530270591|FG000|Overall Study|Progression/relapse|14|||
147028819|NCT03845296|530270592|FG001|Overall Study|Progression/relapse|18|||
147028820|NCT03845296|530270591|FG000|Overall Study|Death|4|||
147028821|NCT03845296|530270592|FG001|Overall Study|Death|0|||
147028822|NCT03845296|530270591|FG000|Overall Study|Other - not protocol specified|1|||
147028823|NCT03845296|530270592|FG001|Overall Study|Other - not protocol specified|3|||
147028824|NCT06218823|530270595|FG000|Overall Study|Death|3|||
147028825|NCT06218823|530270596|FG001|Overall Study|Death|0|||
147028826|NCT06218823|530270595|FG000|Overall Study|Lost to Follow-up|0|||
147028827|NCT06218823|530270596|FG001|Overall Study|Lost to Follow-up|2|||
147028828|NCT04732221|530270597|FG000|Base Period|Death|2|||
147028829|NCT04732221|530270598|FG001|Base Period|Death|0|||
147028830|NCT04732221|530270599|FG002|Base Period|Death|0|||
147028831|NCT04732221|530270600|FG003|Base Period|Death|0|||
147028832|NCT04732221|530270601|FG004|Base Period|Death|0|||
147028833|NCT04732221|530270602|FG005|Base Period|Death|0|||
147028834|NCT04732221|530270603|FG006|Base Period|Death|0|||
147028835|NCT04732221|530270597|FG000|Base Period|Withdrawal by Subject|0|||
147028836|NCT04732221|530270598|FG001|Base Period|Withdrawal by Subject|1|||
147028837|NCT04732221|530270599|FG002|Base Period|Withdrawal by Subject|1|||
147028838|NCT04732221|530270600|FG003|Base Period|Withdrawal by Subject|0|||
147028839|NCT04732221|530270601|FG004|Base Period|Withdrawal by Subject|0|||
147028840|NCT04732221|530270602|FG005|Base Period|Withdrawal by Subject|0|||
147028841|NCT04732221|530270603|FG006|Base Period|Withdrawal by Subject|0|||
147028842|NCT04732221|530270597|FG000|Extension Period|Adverse Event|0|||
147028843|NCT04732221|530270598|FG001|Extension Period|Adverse Event|0|||
147028844|NCT04732221|530270599|FG002|Extension Period|Adverse Event|0|||
147028845|NCT04732221|530270600|FG003|Extension Period|Adverse Event|0|||
147028846|NCT04732221|530270601|FG004|Extension Period|Adverse Event|0|||
147028847|NCT04732221|530270602|FG005|Extension Period|Adverse Event|1|||
147028848|NCT04732221|530270603|FG006|Extension Period|Adverse Event|0|||
147028849|NCT04732221|530270597|FG000|Extension Period|Death|0|||
147028850|NCT04732221|530270598|FG001|Extension Period|Death|0|||
147028851|NCT04732221|530270599|FG002|Extension Period|Death|0|||
147028852|NCT04732221|530270600|FG003|Extension Period|Death|0|||
147028853|NCT04732221|530270601|FG004|Extension Period|Death|1|||
147028854|NCT04732221|530270602|FG005|Extension Period|Death|0|||
147028855|NCT04732221|530270603|FG006|Extension Period|Death|2|||
147028856|NCT04732221|530270597|FG000|Extension Period|Pregnancy|0|||
147028857|NCT04732221|530270598|FG001|Extension Period|Pregnancy|0|||
147028858|NCT04732221|530270599|FG002|Extension Period|Pregnancy|0|||
147028859|NCT04732221|530270600|FG003|Extension Period|Pregnancy|0|||
147028860|NCT04732221|530270601|FG004|Extension Period|Pregnancy|1|||
147028861|NCT04732221|530270602|FG005|Extension Period|Pregnancy|0|||
147028862|NCT04732221|530270603|FG006|Extension Period|Pregnancy|0|||
147028863|NCT04732221|530270597|FG000|Extension Period|Sponsors Decision|0|||
147028864|NCT04732221|530270598|FG001|Extension Period|Sponsors Decision|0|||
147028865|NCT04732221|530270599|FG002|Extension Period|Sponsors Decision|0|||
147028866|NCT04732221|530270600|FG003|Extension Period|Sponsors Decision|0|||
147028867|NCT04732221|530270601|FG004|Extension Period|Sponsors Decision|41|||
147028868|NCT04732221|530270602|FG005|Extension Period|Sponsors Decision|40|||
147028869|NCT04732221|530270603|FG006|Extension Period|Sponsors Decision|40|||
147028870|NCT04732221|530270597|FG000|Extension Period|Withdrawal by Subject|0|||
147028871|NCT04732221|530270598|FG001|Extension Period|Withdrawal by Subject|0|||
147028872|NCT04732221|530270599|FG002|Extension Period|Withdrawal by Subject|0|||
147028873|NCT04732221|530270600|FG003|Extension Period|Withdrawal by Subject|0|||
147028874|NCT04732221|530270601|FG004|Extension Period|Withdrawal by Subject|1|||
147028875|NCT04732221|530270602|FG005|Extension Period|Withdrawal by Subject|5|||
147028876|NCT04732221|530270603|FG006|Extension Period|Withdrawal by Subject|2|||
147028877|NCT02799095|530270604|FG000|Part A|Adverse Event|1|||
147028878|NCT02799095|530270605|FG001|Part A|Adverse Event|0|||
147028879|NCT02799095|530270606|FG002|Part A|Adverse Event|1|||
147028880|NCT02799095|530270607|FG003|Part A|Adverse Event|4|||
147028881|NCT02799095|530270608|FG004|Part A|Adverse Event|1|||
147028882|NCT02799095|530270609|FG005|Part A|Adverse Event|0|||
147028883|NCT02799095|530270610|FG006|Part A|Adverse Event|0|||
147028884|NCT02799095|530270611|FG007|Part A|Adverse Event|0|||
147028885|NCT02799095|530270612|FG008|Part A|Adverse Event|0|||
147028886|NCT02799095|530270613|FG009|Part A|Adverse Event|0|||
147028887|NCT02799095|530270614|FG010|Part A|Adverse Event|0|||
147028888|NCT02799095|530270615|FG011|Part A|Adverse Event|0|||
147028889|NCT02799095|530270616|FG012|Part A|Adverse Event|0|||
147028890|NCT02799095|530270617|FG013|Part A|Adverse Event|0|||
147028891|NCT02799095|530270618|FG014|Part A|Adverse Event|0|||
147028892|NCT02799095|530270619|FG015|Part A|Adverse Event|0|||
147028893|NCT02799095|530270620|FG016|Part A|Adverse Event|0|||
147028894|NCT02799095|530270604|FG000|Part A|Death|0|||
147028895|NCT02799095|530270605|FG001|Part A|Death|0|||
147028896|NCT02799095|530270606|FG002|Part A|Death|0|||
147028897|NCT02799095|530270607|FG003|Part A|Death|0|||
147028898|NCT02799095|530270608|FG004|Part A|Death|0|||
147028899|NCT02799095|530270609|FG005|Part A|Death|0|||
147028900|NCT02799095|530270610|FG006|Part A|Death|3|||
147028901|NCT02799095|530270611|FG007|Part A|Death|0|||
147028902|NCT02799095|530270612|FG008|Part A|Death|0|||
147028903|NCT02799095|530270613|FG009|Part A|Death|0|||
147028904|NCT02799095|530270614|FG010|Part A|Death|0|||
147028905|NCT02799095|530270615|FG011|Part A|Death|0|||
147028906|NCT02799095|530270616|FG012|Part A|Death|0|||
147028907|NCT02799095|530270617|FG013|Part A|Death|0|||
147028908|NCT02799095|530270618|FG014|Part A|Death|0|||
147028909|NCT02799095|530270619|FG015|Part A|Death|0|||
147028910|NCT02799095|530270620|FG016|Part A|Death|0|||
147028911|NCT02799095|530270604|FG000|Part A|Lost to Follow-up|0|||
147028912|NCT02799095|530270605|FG001|Part A|Lost to Follow-up|1|||
147028913|NCT02799095|530270606|FG002|Part A|Lost to Follow-up|0|||
147028914|NCT02799095|530270607|FG003|Part A|Lost to Follow-up|0|||
147028915|NCT02799095|530270608|FG004|Part A|Lost to Follow-up|0|||
147028916|NCT02799095|530270609|FG005|Part A|Lost to Follow-up|0|||
147028917|NCT02799095|530270610|FG006|Part A|Lost to Follow-up|1|||
147028918|NCT02799095|530270611|FG007|Part A|Lost to Follow-up|0|||
147028919|NCT02799095|530270612|FG008|Part A|Lost to Follow-up|0|||
147028920|NCT02799095|530270613|FG009|Part A|Lost to Follow-up|0|||
147028921|NCT02799095|530270614|FG010|Part A|Lost to Follow-up|0|||
147028922|NCT02799095|530270615|FG011|Part A|Lost to Follow-up|0|||
147028923|NCT02799095|530270616|FG012|Part A|Lost to Follow-up|0|||
147028924|NCT02799095|530270617|FG013|Part A|Lost to Follow-up|0|||
147028925|NCT02799095|530270618|FG014|Part A|Lost to Follow-up|0|||
147028926|NCT02799095|530270619|FG015|Part A|Lost to Follow-up|0|||
147028927|NCT02799095|530270620|FG016|Part A|Lost to Follow-up|0|||
147028928|NCT02799095|530270604|FG000|Part A|Progressive Disease|3|||
147028929|NCT02799095|530270605|FG001|Part A|Progressive Disease|3|||
147028930|NCT02799095|530270606|FG002|Part A|Progressive Disease|3|||
147028931|NCT02799095|530270607|FG003|Part A|Progressive Disease|2|||
147028932|NCT02799095|530270608|FG004|Part A|Progressive Disease|2|||
147028933|NCT02799095|530270609|FG005|Part A|Progressive Disease|0|||
147028934|NCT02799095|530270610|FG006|Part A|Progressive Disease|0|||
147028935|NCT02799095|530270611|FG007|Part A|Progressive Disease|0|||
147028936|NCT02799095|530270612|FG008|Part A|Progressive Disease|0|||
147028937|NCT02799095|530270613|FG009|Part A|Progressive Disease|0|||
147028938|NCT02799095|530270614|FG010|Part A|Progressive Disease|0|||
147028939|NCT02799095|530270615|FG011|Part A|Progressive Disease|0|||
147028940|NCT02799095|530270616|FG012|Part A|Progressive Disease|0|||
147028941|NCT02799095|530270617|FG013|Part A|Progressive Disease|0|||
147028942|NCT02799095|530270618|FG014|Part A|Progressive Disease|0|||
147028943|NCT02799095|530270619|FG015|Part A|Progressive Disease|0|||
147028944|NCT02799095|530270620|FG016|Part A|Progressive Disease|0|||
147028945|NCT02799095|530270604|FG000|Part A|Clinical Progression|1|||
147028946|NCT02799095|530270605|FG001|Part A|Clinical Progression|0|||
147028947|NCT02799095|530270606|FG002|Part A|Clinical Progression|2|||
147028948|NCT02799095|530270607|FG003|Part A|Clinical Progression|1|||
147028949|NCT02799095|530270608|FG004|Part A|Clinical Progression|5|||
147028950|NCT02799095|530270609|FG005|Part A|Clinical Progression|0|||
147028951|NCT02799095|530270610|FG006|Part A|Clinical Progression|0|||
147028952|NCT02799095|530270611|FG007|Part A|Clinical Progression|0|||
147028953|NCT02799095|530270612|FG008|Part A|Clinical Progression|0|||
147028954|NCT02799095|530270613|FG009|Part A|Clinical Progression|0|||
147028955|NCT02799095|530270614|FG010|Part A|Clinical Progression|0|||
147028956|NCT02799095|530270615|FG011|Part A|Clinical Progression|0|||
147028957|NCT02799095|530270616|FG012|Part A|Clinical Progression|0|||
147028958|NCT02799095|530270617|FG013|Part A|Clinical Progression|0|||
147028959|NCT02799095|530270618|FG014|Part A|Clinical Progression|0|||
147028960|NCT02799095|530270619|FG015|Part A|Clinical Progression|0|||
147028961|NCT02799095|530270620|FG016|Part A|Clinical Progression|0|||
147028962|NCT02799095|530270604|FG000|Part A|Protocol Deviation|0|||
147028963|NCT02799095|530270605|FG001|Part A|Protocol Deviation|0|||
147028964|NCT02799095|530270606|FG002|Part A|Protocol Deviation|1|||
147028965|NCT02799095|530270607|FG003|Part A|Protocol Deviation|0|||
147028966|NCT02799095|530270608|FG004|Part A|Protocol Deviation|0|||
147028967|NCT02799095|530270609|FG005|Part A|Protocol Deviation|0|||
147028968|NCT02799095|530270610|FG006|Part A|Protocol Deviation|0|||
147028969|NCT02799095|530270611|FG007|Part A|Protocol Deviation|0|||
147028970|NCT02799095|530270612|FG008|Part A|Protocol Deviation|0|||
147028971|NCT02799095|530270613|FG009|Part A|Protocol Deviation|0|||
147028972|NCT02799095|530270614|FG010|Part A|Protocol Deviation|0|||
146849571|NCT02663518|529618861|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147028973|NCT02799095|530270615|FG011|Part A|Protocol Deviation|0|||
147028974|NCT02799095|530270616|FG012|Part A|Protocol Deviation|0|||
147028975|NCT02799095|530270617|FG013|Part A|Protocol Deviation|0|||
146849572|NCT02663518|529618862|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
146849573|NCT02663518|529618863|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147028976|NCT02799095|530270618|FG014|Part A|Protocol Deviation|0|||
147028977|NCT02799095|530270619|FG015|Part A|Protocol Deviation|0|||
147028978|NCT02799095|530270620|FG016|Part A|Protocol Deviation|0|||
147028979|NCT02799095|530270604|FG000|Part A|Withdrawal by Subject|0|||
147028980|NCT02799095|530270605|FG001|Part A|Withdrawal by Subject|0|||
147028981|NCT02799095|530270606|FG002|Part A|Withdrawal by Subject|0|||
146849574|NCT02663518|529618864|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147028982|NCT02799095|530270607|FG003|Part A|Withdrawal by Subject|1|||
147028983|NCT02799095|530270608|FG004|Part A|Withdrawal by Subject|3|||
147028984|NCT02799095|530270609|FG005|Part A|Withdrawal by Subject|1|||
147028985|NCT02799095|530270610|FG006|Part A|Withdrawal by Subject|1|||
147028986|NCT02799095|530270611|FG007|Part A|Withdrawal by Subject|0|||
147028987|NCT02799095|530270612|FG008|Part A|Withdrawal by Subject|0|||
147028988|NCT02799095|530270613|FG009|Part A|Withdrawal by Subject|0|||
147028989|NCT02799095|530270614|FG010|Part A|Withdrawal by Subject|0|||
147028990|NCT02799095|530270615|FG011|Part A|Withdrawal by Subject|0|||
147028991|NCT02799095|530270616|FG012|Part A|Withdrawal by Subject|0|||
147028992|NCT02799095|530270617|FG013|Part A|Withdrawal by Subject|0|||
147028993|NCT02799095|530270618|FG014|Part A|Withdrawal by Subject|0|||
147028994|NCT02799095|530270619|FG015|Part A|Withdrawal by Subject|0|||
147028995|NCT02799095|530270620|FG016|Part A|Withdrawal by Subject|0|||
147028996|NCT02799095|530270604|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
147028997|NCT02799095|530270605|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
147028998|NCT02799095|530270606|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
147028999|NCT02799095|530270607|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
147029000|NCT02799095|530270608|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
147029001|NCT02799095|530270609|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
147029002|NCT02799095|530270610|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
147029003|NCT02799095|530270611|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
147029004|NCT02799095|530270612|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
147029005|NCT02799095|530270613|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
147029006|NCT02799095|530270614|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
147029007|NCT02799095|530270615|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
147029008|NCT02799095|530270616|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
147029009|NCT02799095|530270617|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
147029010|NCT02799095|530270618|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
147029011|NCT02799095|530270619|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
147029012|NCT02799095|530270620|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
147029013|NCT02799095|530270604|FG000|Part B|Death|0|||
147029014|NCT02799095|530270605|FG001|Part B|Death|0|||
147029015|NCT02799095|530270606|FG002|Part B|Death|0|||
147029016|NCT02799095|530270607|FG003|Part B|Death|0|||
147029017|NCT02799095|530270608|FG004|Part B|Death|0|||
147029018|NCT02799095|530270609|FG005|Part B|Death|0|||
147029019|NCT02799095|530270610|FG006|Part B|Death|0|||
147029020|NCT02799095|530270611|FG007|Part B|Death|7|||
147029021|NCT02799095|530270612|FG008|Part B|Death|7|||
147029022|NCT02799095|530270613|FG009|Part B|Death|0|||
147029023|NCT02799095|530270614|FG010|Part B|Death|0|||
147029024|NCT02799095|530270615|FG011|Part B|Death|0|||
147029025|NCT02799095|530270616|FG012|Part B|Death|0|||
147029026|NCT02799095|530270617|FG013|Part B|Death|0|||
147029027|NCT02799095|530270618|FG014|Part B|Death|0|||
147029028|NCT02799095|530270619|FG015|Part B|Death|0|||
147029029|NCT02799095|530270620|FG016|Part B|Death|0|||
147029030|NCT02799095|530270604|FG000|Part B|Progressive Disease|0|||
147029031|NCT02799095|530270605|FG001|Part B|Progressive Disease|0|||
147029032|NCT02799095|530270606|FG002|Part B|Progressive Disease|0|||
147029033|NCT02799095|530270607|FG003|Part B|Progressive Disease|0|||
147029034|NCT02799095|530270608|FG004|Part B|Progressive Disease|0|||
147029035|NCT02799095|530270609|FG005|Part B|Progressive Disease|0|||
147029036|NCT02799095|530270610|FG006|Part B|Progressive Disease|0|||
147029037|NCT02799095|530270611|FG007|Part B|Progressive Disease|1|||
147029038|NCT02799095|530270612|FG008|Part B|Progressive Disease|0|||
147029039|NCT02799095|530270613|FG009|Part B|Progressive Disease|0|||
147029040|NCT02799095|530270614|FG010|Part B|Progressive Disease|0|||
147029041|NCT02799095|530270615|FG011|Part B|Progressive Disease|0|||
147029042|NCT02799095|530270616|FG012|Part B|Progressive Disease|0|||
147029043|NCT02799095|530270617|FG013|Part B|Progressive Disease|0|||
147029044|NCT02799095|530270618|FG014|Part B|Progressive Disease|0|||
147029045|NCT02799095|530270619|FG015|Part B|Progressive Disease|0|||
147029046|NCT02799095|530270620|FG016|Part B|Progressive Disease|0|||
147029047|NCT02799095|530270604|FG000|Part B|Withdrawal by Subject|0|||
147029048|NCT02799095|530270605|FG001|Part B|Withdrawal by Subject|0|||
147029049|NCT02799095|530270606|FG002|Part B|Withdrawal by Subject|0|||
147029050|NCT02799095|530270607|FG003|Part B|Withdrawal by Subject|0|||
147029051|NCT02799095|530270608|FG004|Part B|Withdrawal by Subject|0|||
147029052|NCT02799095|530270609|FG005|Part B|Withdrawal by Subject|0|||
147029053|NCT02799095|530270610|FG006|Part B|Withdrawal by Subject|0|||
147029054|NCT02799095|530270611|FG007|Part B|Withdrawal by Subject|10|||
147029055|NCT02799095|530270612|FG008|Part B|Withdrawal by Subject|7|||
147029056|NCT02799095|530270613|FG009|Part B|Withdrawal by Subject|0|||
147029057|NCT02799095|530270614|FG010|Part B|Withdrawal by Subject|0|||
147029058|NCT02799095|530270615|FG011|Part B|Withdrawal by Subject|0|||
147029059|NCT02799095|530270616|FG012|Part B|Withdrawal by Subject|0|||
147029060|NCT02799095|530270617|FG013|Part B|Withdrawal by Subject|0|||
147029061|NCT02799095|530270618|FG014|Part B|Withdrawal by Subject|0|||
147029062|NCT02799095|530270619|FG015|Part B|Withdrawal by Subject|0|||
147029063|NCT02799095|530270620|FG016|Part B|Withdrawal by Subject|0|||
146849575|NCT02663518|529618851|FG000|Part 1: Phase 1a Escalation|Other|0|||
147029064|NCT02799095|530270604|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
147029065|NCT02799095|530270605|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
147029066|NCT02799095|530270606|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
147029067|NCT02799095|530270607|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
147029068|NCT02799095|530270608|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
147029069|NCT02799095|530270609|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
147029070|NCT02799095|530270610|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
147029071|NCT02799095|530270611|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
147029072|NCT02799095|530270612|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
147029073|NCT02799095|530270613|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
147029074|NCT02799095|530270614|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
147029075|NCT02799095|530270615|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
147029076|NCT02799095|530270616|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
147029077|NCT02799095|530270617|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
147029078|NCT02799095|530270618|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
147029079|NCT02799095|530270619|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
147029080|NCT02799095|530270620|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
147029081|NCT02799095|530270604|FG000|Part C|Adverse Event|0|||
147029082|NCT02799095|530270605|FG001|Part C|Adverse Event|0|||
147029083|NCT02799095|530270606|FG002|Part C|Adverse Event|0|||
147029084|NCT02799095|530270607|FG003|Part C|Adverse Event|0|||
147029085|NCT02799095|530270608|FG004|Part C|Adverse Event|0|||
147029086|NCT02799095|530270609|FG005|Part C|Adverse Event|0|||
147029087|NCT02799095|530270610|FG006|Part C|Adverse Event|0|||
147029088|NCT02799095|530270611|FG007|Part C|Adverse Event|0|||
147029089|NCT02799095|530270612|FG008|Part C|Adverse Event|0|||
147029090|NCT02799095|530270613|FG009|Part C|Adverse Event|0|||
147029091|NCT02799095|530270614|FG010|Part C|Adverse Event|3|||
147029092|NCT02799095|530270615|FG011|Part C|Adverse Event|1|||
147029093|NCT02799095|530270616|FG012|Part C|Adverse Event|0|||
147029094|NCT02799095|530270617|FG013|Part C|Adverse Event|1|||
147029095|NCT02799095|530270618|FG014|Part C|Adverse Event|0|||
147029096|NCT02799095|530270619|FG015|Part C|Adverse Event|0|||
147029097|NCT02799095|530270620|FG016|Part C|Adverse Event|0|||
147029098|NCT02799095|530270604|FG000|Part C|Death|0|||
147029099|NCT02799095|530270605|FG001|Part C|Death|0|||
147029100|NCT02799095|530270606|FG002|Part C|Death|0|||
147029101|NCT02799095|530270607|FG003|Part C|Death|0|||
147029102|NCT02799095|530270608|FG004|Part C|Death|0|||
147029103|NCT02799095|530270609|FG005|Part C|Death|0|||
147029104|NCT02799095|530270610|FG006|Part C|Death|0|||
147029105|NCT02799095|530270611|FG007|Part C|Death|0|||
147029106|NCT02799095|530270612|FG008|Part C|Death|0|||
147029107|NCT02799095|530270613|FG009|Part C|Death|0|||
147029108|NCT02799095|530270614|FG010|Part C|Death|7|||
147029109|NCT02799095|530270615|FG011|Part C|Death|5|||
147029110|NCT02799095|530270616|FG012|Part C|Death|6|||
147029111|NCT02799095|530270617|FG013|Part C|Death|8|||
147029112|NCT02799095|530270618|FG014|Part C|Death|1|||
147029113|NCT02799095|530270619|FG015|Part C|Death|8|||
147029114|NCT02799095|530270620|FG016|Part C|Death|1|||
147029115|NCT02799095|530270604|FG000|Part C|Lost to Follow-up|0|||
147029116|NCT02799095|530270605|FG001|Part C|Lost to Follow-up|0|||
147029117|NCT02799095|530270606|FG002|Part C|Lost to Follow-up|0|||
147029118|NCT02799095|530270607|FG003|Part C|Lost to Follow-up|0|||
147029119|NCT02799095|530270608|FG004|Part C|Lost to Follow-up|0|||
147029120|NCT02799095|530270609|FG005|Part C|Lost to Follow-up|0|||
147029121|NCT02799095|530270610|FG006|Part C|Lost to Follow-up|0|||
147029122|NCT02799095|530270611|FG007|Part C|Lost to Follow-up|0|||
147029123|NCT02799095|530270612|FG008|Part C|Lost to Follow-up|0|||
147029124|NCT02799095|530270613|FG009|Part C|Lost to Follow-up|0|||
147029125|NCT02799095|530270614|FG010|Part C|Lost to Follow-up|1|||
147029126|NCT02799095|530270615|FG011|Part C|Lost to Follow-up|1|||
147029127|NCT02799095|530270616|FG012|Part C|Lost to Follow-up|1|||
147029128|NCT02799095|530270617|FG013|Part C|Lost to Follow-up|3|||
147029129|NCT02799095|530270618|FG014|Part C|Lost to Follow-up|0|||
147029130|NCT02799095|530270619|FG015|Part C|Lost to Follow-up|0|||
147029131|NCT02799095|530270620|FG016|Part C|Lost to Follow-up|0|||
147029132|NCT02799095|530270604|FG000|Part C|Progressive Disease|0|||
147029133|NCT02799095|530270605|FG001|Part C|Progressive Disease|0|||
147029134|NCT02799095|530270606|FG002|Part C|Progressive Disease|0|||
147029135|NCT02799095|530270607|FG003|Part C|Progressive Disease|0|||
147029136|NCT02799095|530270608|FG004|Part C|Progressive Disease|0|||
147029137|NCT02799095|530270609|FG005|Part C|Progressive Disease|0|||
147029138|NCT02799095|530270610|FG006|Part C|Progressive Disease|0|||
147029139|NCT02799095|530270611|FG007|Part C|Progressive Disease|0|||
147029140|NCT02799095|530270612|FG008|Part C|Progressive Disease|0|||
147029141|NCT02799095|530270613|FG009|Part C|Progressive Disease|2|||
147029142|NCT02799095|530270614|FG010|Part C|Progressive Disease|13|||
147029143|NCT02799095|530270615|FG011|Part C|Progressive Disease|2|||
147029144|NCT02799095|530270616|FG012|Part C|Progressive Disease|0|||
147029145|NCT02799095|530270617|FG013|Part C|Progressive Disease|1|||
147029146|NCT02799095|530270618|FG014|Part C|Progressive Disease|0|||
147029147|NCT02799095|530270619|FG015|Part C|Progressive Disease|0|||
147029148|NCT02799095|530270620|FG016|Part C|Progressive Disease|0|||
147029149|NCT02799095|530270604|FG000|Part C|Clinical Progression|0|||
147029150|NCT02799095|530270605|FG001|Part C|Clinical Progression|0|||
147029151|NCT02799095|530270606|FG002|Part C|Clinical Progression|0|||
147029152|NCT02799095|530270607|FG003|Part C|Clinical Progression|0|||
147029153|NCT02799095|530270608|FG004|Part C|Clinical Progression|0|||
147029154|NCT02799095|530270609|FG005|Part C|Clinical Progression|0|||
147029155|NCT02799095|530270610|FG006|Part C|Clinical Progression|0|||
147029156|NCT02799095|530270611|FG007|Part C|Clinical Progression|0|||
147029157|NCT02799095|530270612|FG008|Part C|Clinical Progression|0|||
147029158|NCT02799095|530270613|FG009|Part C|Clinical Progression|1|||
147029159|NCT02799095|530270614|FG010|Part C|Clinical Progression|3|||
147029160|NCT02799095|530270615|FG011|Part C|Clinical Progression|0|||
147029161|NCT02799095|530270616|FG012|Part C|Clinical Progression|0|||
147029162|NCT02799095|530270617|FG013|Part C|Clinical Progression|1|||
147029163|NCT02799095|530270618|FG014|Part C|Clinical Progression|0|||
147029164|NCT02799095|530270619|FG015|Part C|Clinical Progression|0|||
147029165|NCT02799095|530270620|FG016|Part C|Clinical Progression|0|||
147029166|NCT02799095|530270604|FG000|Part C|Withdrawal by Subject|0|||
147029167|NCT02799095|530270605|FG001|Part C|Withdrawal by Subject|0|||
147029168|NCT02799095|530270606|FG002|Part C|Withdrawal by Subject|0|||
147029169|NCT02799095|530270607|FG003|Part C|Withdrawal by Subject|0|||
147029170|NCT02799095|530270608|FG004|Part C|Withdrawal by Subject|0|||
147029171|NCT02799095|530270609|FG005|Part C|Withdrawal by Subject|0|||
147029172|NCT02799095|530270610|FG006|Part C|Withdrawal by Subject|0|||
147029173|NCT02799095|530270611|FG007|Part C|Withdrawal by Subject|0|||
147029174|NCT02799095|530270612|FG008|Part C|Withdrawal by Subject|0|||
147029175|NCT02799095|530270613|FG009|Part C|Withdrawal by Subject|0|||
147029176|NCT02799095|530270614|FG010|Part C|Withdrawal by Subject|13|||
147029177|NCT02799095|530270615|FG011|Part C|Withdrawal by Subject|15|||
147029178|NCT02799095|530270616|FG012|Part C|Withdrawal by Subject|13|||
147029179|NCT02799095|530270617|FG013|Part C|Withdrawal by Subject|21|||
147029180|NCT02799095|530270618|FG014|Part C|Withdrawal by Subject|0|||
147029181|NCT02799095|530270619|FG015|Part C|Withdrawal by Subject|12|||
147029182|NCT02799095|530270620|FG016|Part C|Withdrawal by Subject|1|||
147029183|NCT02799095|530270604|FG000|Part C|Physician Decision|0|||
147029184|NCT02799095|530270605|FG001|Part C|Physician Decision|0|||
147029185|NCT02799095|530270606|FG002|Part C|Physician Decision|0|||
147029186|NCT02799095|530270607|FG003|Part C|Physician Decision|0|||
147029187|NCT02799095|530270608|FG004|Part C|Physician Decision|0|||
147029188|NCT02799095|530270609|FG005|Part C|Physician Decision|0|||
147029189|NCT02799095|530270610|FG006|Part C|Physician Decision|0|||
147029190|NCT02799095|530270611|FG007|Part C|Physician Decision|0|||
147029191|NCT02799095|530270612|FG008|Part C|Physician Decision|0|||
147029192|NCT02799095|530270613|FG009|Part C|Physician Decision|0|||
147029193|NCT02799095|530270614|FG010|Part C|Physician Decision|1|||
147029194|NCT02799095|530270615|FG011|Part C|Physician Decision|0|||
147029195|NCT02799095|530270616|FG012|Part C|Physician Decision|0|||
147029196|NCT02799095|530270617|FG013|Part C|Physician Decision|0|||
147029197|NCT02799095|530270618|FG014|Part C|Physician Decision|0|||
147029198|NCT02799095|530270619|FG015|Part C|Physician Decision|0|||
147029199|NCT02799095|530270620|FG016|Part C|Physician Decision|0|||
147029200|NCT02799095|530270604|FG000|Part C|Other|0|||
147029201|NCT02799095|530270605|FG001|Part C|Other|0|||
147029202|NCT02799095|530270606|FG002|Part C|Other|0|||
147029203|NCT02799095|530270607|FG003|Part C|Other|0|||
147029204|NCT02799095|530270608|FG004|Part C|Other|0|||
147029205|NCT02799095|530270609|FG005|Part C|Other|0|||
147029206|NCT02799095|530270610|FG006|Part C|Other|0|||
147029207|NCT02799095|530270611|FG007|Part C|Other|0|||
147029208|NCT02799095|530270612|FG008|Part C|Other|0|||
147029209|NCT02799095|530270613|FG009|Part C|Other|0|||
147029210|NCT02799095|530270614|FG010|Part C|Other|0|||
147029211|NCT02799095|530270615|FG011|Part C|Other|2|||
147029212|NCT02799095|530270616|FG012|Part C|Other|2|||
147029213|NCT02799095|530270617|FG013|Part C|Other|0|||
147029214|NCT02799095|530270618|FG014|Part C|Other|0|||
147029215|NCT02799095|530270619|FG015|Part C|Other|0|||
147029216|NCT02799095|530270620|FG016|Part C|Other|0|||
147029217|NCT01933113|530270621|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
147029218|NCT02297438|530270622|FG000|Overall Study|Death|79|||
147029219|NCT02297438|530270623|FG001|Overall Study|Death|86|||
147029220|NCT02297438|530270622|FG000|Overall Study|Lost to Follow-up|9|||
147029221|NCT02297438|530270623|FG001|Overall Study|Lost to Follow-up|7|||
147029222|NCT02297438|530270622|FG000|Overall Study|Withdrawal by Subject|7|||
147029223|NCT02297438|530270623|FG001|Overall Study|Withdrawal by Subject|0|||
147029224|NCT02297438|530270622|FG000|Overall Study|Other|9|||
147029225|NCT02297438|530270623|FG001|Overall Study|Other|5|||
147029226|NCT02297438|530270622|FG000|Overall Study|Ongoing|65|||
147029227|NCT02297438|530270623|FG001|Overall Study|Ongoing|73|||
147029228|NCT04092894|530270626|FG000|Overall Study|Withdrawal by Subject|2|||
147029229|NCT04092894|530270627|FG001|Overall Study|Withdrawal by Subject|4|||
147029230|NCT04092894|530270626|FG000|Overall Study|Discontinued EEG after randomization|10|||
147029231|NCT04092894|530270627|FG001|Overall Study|Discontinued EEG after randomization|6|||
147029232|NCT00759902|530270630|FG000|Overall Study|Adverse Event|0|||
147029233|NCT00759902|530270631|FG001|Overall Study|Adverse Event|1|||
147029234|NCT02128217|530270634|FG000|Overall Study|Lost to Follow-up|0|||
147029235|NCT02128217|530270635|FG001|Overall Study|Lost to Follow-up|1|||
147029236|NCT05071313|530270636|FG000|Overall Study|Lost to Follow-up|17|||
147029237|NCT05071313|530270637|FG001|Overall Study|Lost to Follow-up|10|||
147029238|NCT05071313|530270636|FG000|Overall Study|Physician Decision|1|||
147029239|NCT05071313|530270637|FG001|Overall Study|Physician Decision|6|||
147029240|NCT05071313|530270636|FG000|Overall Study|Death|1|||
147029241|NCT05071313|530270637|FG001|Overall Study|Death|0|||
147029242|NCT05071313|530270636|FG000|Overall Study|Withdrawal by Subject|10|||
147029243|NCT05071313|530270637|FG001|Overall Study|Withdrawal by Subject|15|||
147029244|NCT05071313|530270636|FG000|Overall Study|Other|1|||
147029245|NCT05071313|530270637|FG001|Overall Study|Other|0|||
147029246|NCT05071313|530270636|FG000|Overall Study|Randomized but not vaccinated|4|||
147029247|NCT05071313|530270637|FG001|Overall Study|Randomized but not vaccinated|2|||
147029248|NCT03107026|530270638|FG000|Overall Study|Adverse Event|2|||
147029249|NCT03107026|530270639|FG001|Overall Study|Adverse Event|14|||
147029250|NCT03107026|530270640|FG002|Overall Study|Adverse Event|23|||
147029251|NCT03107026|530270638|FG000|Overall Study|Lost to Follow-up|12|||
147029252|NCT03107026|530270639|FG001|Overall Study|Lost to Follow-up|12|||
147029253|NCT03107026|530270640|FG002|Overall Study|Lost to Follow-up|13|||
147029254|NCT03107026|530270638|FG000|Overall Study|Protocol Violation|1|||
147029255|NCT03107026|530270639|FG001|Overall Study|Protocol Violation|2|||
147029256|NCT03107026|530270640|FG002|Overall Study|Protocol Violation|0|||
147029257|NCT03107026|530270638|FG000|Overall Study|Pregnancy|1|||
147029258|NCT03107026|530270639|FG001|Overall Study|Pregnancy|0|||
147029259|NCT03107026|530270640|FG002|Overall Study|Pregnancy|0|||
147029260|NCT03107026|530270638|FG000|Overall Study|Withdrawal by Subject|13|||
147029261|NCT03107026|530270639|FG001|Overall Study|Withdrawal by Subject|5|||
147029262|NCT03107026|530270640|FG002|Overall Study|Withdrawal by Subject|17|||
147029263|NCT03107026|530270638|FG000|Overall Study|non compliance with study visits|1|||
147029264|NCT03107026|530270639|FG001|Overall Study|non compliance with study visits|2|||
147029265|NCT03107026|530270640|FG002|Overall Study|non compliance with study visits|0|||
147029266|NCT03107026|530270638|FG000|Overall Study|non-compliance with study drug|2|||
147029267|NCT03107026|530270639|FG001|Overall Study|non-compliance with study drug|2|||
147029268|NCT03107026|530270640|FG002|Overall Study|non-compliance with study drug|3|||
147029269|NCT03107026|530270638|FG000|Overall Study|Physician Decision|0|||
147029270|NCT03107026|530270639|FG001|Overall Study|Physician Decision|1|||
147029271|NCT03107026|530270640|FG002|Overall Study|Physician Decision|0|||
147029272|NCT03596151|530270643|FG000|Overall Study|Withdrawal by Subject|1|||
147029273|NCT01951885|530270645|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
147029274|NCT01951885|530270646|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
147029275|NCT01951885|530270645|FG000|Overall Study|Adverse Event|1|||
147029276|NCT01951885|530270646|FG001|Overall Study|Adverse Event|0|||
147029277|NCT01951885|530270645|FG000|Overall Study|Withdrawal by Subject|0|||
147029278|NCT01951885|530270646|FG001|Overall Study|Withdrawal by Subject|1|||
147029279|NCT01951885|530270645|FG000|Overall Study|ineligible due to a change in donor|0|||
147029280|NCT01951885|530270646|FG001|Overall Study|ineligible due to a change in donor|1|||
147029281|NCT01951885|530270645|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
147029282|NCT01951885|530270646|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
147029283|NCT00824616|530270647|FG000|Overall Study|Adverse Event|2|||
147029284|NCT00824616|530270648|FG001|Overall Study|Adverse Event|1|||
147029285|NCT00824616|530270647|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
147029286|NCT00824616|530270648|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
147029287|NCT00824616|530270647|FG000|Overall Study|Hyperglycemia|1|||
147029288|NCT00824616|530270648|FG001|Overall Study|Hyperglycemia|1|||
147029289|NCT00824616|530270647|FG000|Overall Study|Lack of Efficacy|2|||
147029290|NCT00824616|530270648|FG001|Overall Study|Lack of Efficacy|1|||
147029291|NCT00824616|530270647|FG000|Overall Study|Lost to Follow-up|0|||
147029292|NCT00824616|530270648|FG001|Overall Study|Lost to Follow-up|1|||
147029293|NCT00824616|530270647|FG000|Overall Study|Withdrawal by Subject|1|||
147029294|NCT00824616|530270648|FG001|Overall Study|Withdrawal by Subject|1|||
147029295|NCT04711902|530270649|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
147029296|NCT04711902|530270650|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
147029297|NCT04711902|530270651|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
147029298|NCT04711902|530270652|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
147029299|NCT04711902|530270653|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
147029300|NCT04711902|530270654|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
147029301|NCT00368979|530270658|FG000|Overall Study|Adverse Event|9|||
147029302|NCT00368979|530270659|FG001|Overall Study|Adverse Event|16|||
147029303|NCT00368979|530270658|FG000|Overall Study|Lack of Efficacy|5|||
147029304|NCT00368979|530270659|FG001|Overall Study|Lack of Efficacy|3|||
147029305|NCT00368979|530270658|FG000|Overall Study|Other|3|||
147029306|NCT00368979|530270659|FG001|Overall Study|Other|1|||
147029307|NCT00368979|530270658|FG000|Overall Study|Lost to Follow-up|1|||
147029308|NCT00368979|530270659|FG001|Overall Study|Lost to Follow-up|0|||
147029309|NCT00368979|530270658|FG000|Overall Study|Protocol Violation|2|||
147029310|NCT00368979|530270659|FG001|Overall Study|Protocol Violation|1|||
147029311|NCT00368979|530270658|FG000|Overall Study|Withdrawal by Subject|5|||
147029312|NCT00368979|530270659|FG001|Overall Study|Withdrawal by Subject|9|||
147029313|NCT02238626|530270660|FG000|Overall Study|Adverse Event|3|||
147029314|NCT02238626|530270661|FG001|Overall Study|Adverse Event|5|||
147029315|NCT02238626|530270662|FG002|Overall Study|Adverse Event|0|||
147029316|NCT02238626|530270663|FG003|Overall Study|Adverse Event|3|||
147029317|NCT02238626|530270660|FG000|Overall Study|Lost to Follow-up|2|||
147029318|NCT02238626|530270661|FG001|Overall Study|Lost to Follow-up|4|||
147029319|NCT02238626|530270662|FG002|Overall Study|Lost to Follow-up|2|||
147029320|NCT02238626|530270663|FG003|Overall Study|Lost to Follow-up|2|||
147029321|NCT02238626|530270660|FG000|Overall Study|Withdrawal by Subject|0|||
147029322|NCT02238626|530270661|FG001|Overall Study|Withdrawal by Subject|3|||
147029323|NCT02238626|530270662|FG002|Overall Study|Withdrawal by Subject|0|||
147029324|NCT02238626|530270663|FG003|Overall Study|Withdrawal by Subject|1|||
147029325|NCT02238626|530270660|FG000|Overall Study|Death|0|||
147029326|NCT02238626|530270661|FG001|Overall Study|Death|0|||
147029327|NCT02238626|530270662|FG002|Overall Study|Death|1|||
147029328|NCT02238626|530270663|FG003|Overall Study|Death|1|||
147029329|NCT02238626|530270660|FG000|Overall Study|Other|0|||
147029330|NCT02238626|530270661|FG001|Overall Study|Other|2|||
147029331|NCT02238626|530270662|FG002|Overall Study|Other|0|||
147029332|NCT02238626|530270663|FG003|Overall Study|Other|0|||
147029333|NCT03412396|530270670|FG000|Overall Study|Withdrawal by Subject|2|||
147029334|NCT03412396|530270670|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
147029335|NCT03412396|530270670|FG000|Overall Study|Did not undergo RP|2|||
147029336|NCT01383135|530270671|FG000|Overall Study|Not Scanned / Imaged|1|||
147029337|NCT01383135|530270672|FG001|Overall Study|Not Scanned / Imaged|0|||
147029338|NCT01383135|530270673|FG002|Overall Study|Not Scanned / Imaged|1|||
147029339|NCT01383135|530270674|FG003|Overall Study|Not Scanned / Imaged|0|||
147029340|NCT03167723|530270678|FG000|Overall Study|Protocol Violation|4|||
147029341|NCT03167723|530270679|FG001|Overall Study|Protocol Violation|6|||
147029342|NCT02397408|530270680|FG000|Overall Study|Physician Decision|4|||
147029343|NCT02397408|530270680|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
147029344|NCT00369655|530270681|FG000|Overall Study|Refusal of further treatment|2|||
147029345|NCT01683838|530270682|FG000|Overall Study|Adverse Event|12|||
147029346|NCT01683838|530270683|FG001|Overall Study|Adverse Event|2|||
147029347|NCT01683838|530270682|FG000|Overall Study|Protocol Violation|3|||
147029348|NCT01683838|530270683|FG001|Overall Study|Protocol Violation|1|||
147029349|NCT01683838|530270682|FG000|Overall Study|Withdrawal by Subject|6|||
147029350|NCT01683838|530270683|FG001|Overall Study|Withdrawal by Subject|5|||
147029351|NCT01683838|530270682|FG000|Overall Study|Lost to Follow-up|1|||
147029352|NCT01683838|530270683|FG001|Overall Study|Lost to Follow-up|1|||
147029353|NCT01683838|530270682|FG000|Overall Study|Other|4|||
147029354|NCT01683838|530270683|FG001|Overall Study|Other|3|||
147029355|NCT01646138|530270684|FG000|Overall Study|Lost to Follow-up|0|||
147029356|NCT01646138|530270685|FG001|Overall Study|Lost to Follow-up|0|||
147029357|NCT01646138|530270686|FG002|Overall Study|Lost to Follow-up|0|||
147029358|NCT01646138|530270687|FG003|Overall Study|Lost to Follow-up|0|||
147029359|NCT01646138|530270688|FG004|Overall Study|Lost to Follow-up|2|||
147029360|NCT03397771|530270689|FG000|Overall Study|2 erroneously randomized, never treated|3|||
147029361|NCT03397771|530270690|FG001|Overall Study|2 erroneously randomized, never treated|1|||
147029362|NCT03397771|530270689|FG000|Overall Study|Withdrawal by Subject|1|||
147029363|NCT03397771|530270690|FG001|Overall Study|Withdrawal by Subject|3|||
147029364|NCT03397771|530270689|FG000|Overall Study|Protocol Violation|2|||
147029365|NCT03397771|530270690|FG001|Overall Study|Protocol Violation|2|||
147029366|NCT03397771|530270689|FG000|Overall Study|Adverse Event|2|||
147029367|NCT03397771|530270690|FG001|Overall Study|Adverse Event|1|||
147029368|NCT04078126|530270694|FG000|Washout|Study put on hold due to COVID-19|0|||
147029369|NCT04078126|530270695|FG001|Washout|Study put on hold due to COVID-19|2|||
147029370|NCT04078126|530270694|FG000|Period 2|Study put on hold due to COVID-19|1|||
147029371|NCT04078126|530270695|FG001|Period 2|Study put on hold due to COVID-19|1|||
147029372|NCT02669758|530270696|FG000|Overall Study|Withdrawal by Subject|43|||
147029373|NCT02669758|530270696|FG000|Overall Study|Lost to Follow-up|19|||
147029374|NCT02669758|530270696|FG000|Overall Study|Adverse Event|16|||
147029375|NCT02669758|530270696|FG000|Overall Study|Non-Compliance with Study Drug|8|||
147029376|NCT02669758|530270696|FG000|Overall Study|Lack of Efficacy|5|||
147029377|NCT02669758|530270696|FG000|Overall Study|Pregnancy|1|||
147029378|NCT02669758|530270696|FG000|Overall Study|Study noncompliance|1|||
147029379|NCT02669758|530270696|FG000|Overall Study|Protocol Violation|1|||
147029380|NCT02149108|530270697|FG000|Overall Study|Not treated|1|||
147029381|NCT02149108|530270698|FG001|Overall Study|Not treated|2|||
147029382|NCT02149108|530270697|FG000|Overall Study|Progressive Disease (PD)|324|||
147029383|NCT02149108|530270698|FG001|Overall Study|Progressive Disease (PD)|318|||
147029384|NCT02149108|530270697|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
147029385|NCT02149108|530270698|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
147029386|NCT02149108|530270697|FG000|Overall Study|Other Adverse Event (AE)|8|||
147029387|NCT02149108|530270698|FG001|Overall Study|Other Adverse Event (AE)|18|||
146849576|NCT02663518|529618852|FG001|Part 1: Phase 1a Escalation|Other|0|||
147029388|NCT02149108|530270697|FG000|Overall Study|Other not defined above|0|||
147029389|NCT02149108|530270698|FG001|Overall Study|Other not defined above|2|||
147029390|NCT02149108|530270697|FG000|Overall Study|Refusal to continue trial medication|15|||
147029391|NCT02149108|530270698|FG001|Overall Study|Refusal to continue trial medication|11|||
147029392|NCT02149108|530270697|FG000|Overall Study|Lost to Follow-up|1|||
147029393|NCT02149108|530270698|FG001|Overall Study|Lost to Follow-up|0|||
147029394|NCT02455050|530270699|FG000|Treatment Period 1|Lost to Follow-up|1|||
147029395|NCT02455050|530270700|FG001|Treatment Period 1|Lost to Follow-up|1|||
147029396|NCT02455050|530270701|FG002|Treatment Period 1|Lost to Follow-up|1|||
147029397|NCT02455050|530270702|FG003|Treatment Period 1|Lost to Follow-up|2|||
147029398|NCT02455050|530270699|FG000|Treatment Period 2|Lost to Follow-up|1|||
147029399|NCT02455050|530270700|FG001|Treatment Period 2|Lost to Follow-up|0|||
147029400|NCT02455050|530270701|FG002|Treatment Period 2|Lost to Follow-up|2|||
147029401|NCT02455050|530270702|FG003|Treatment Period 2|Lost to Follow-up|1|||
147029402|NCT03402750|530270703|FG000|Overall Study|Lost to Follow-up|2|||
147029403|NCT03402750|530270704|FG001|Overall Study|Lost to Follow-up|1|||
147029404|NCT02981303|530270705|FG000|Overall Study|Progressive Disease|17|||
147029405|NCT02981303|530270706|FG001|Overall Study|Progressive Disease|37|||
147029406|NCT02981303|530270705|FG000|Overall Study|Adverse Event|1|||
147029407|NCT02981303|530270706|FG001|Overall Study|Adverse Event|4|||
147029408|NCT02981303|530270705|FG000|Overall Study|Withdrawal by Subject|0|||
147029409|NCT02981303|530270706|FG001|Overall Study|Withdrawal by Subject|1|||
147029410|NCT02325518|530270707|FG000|Overall Study|Adverse Event|4|||
147029411|NCT02325518|530270708|FG001|Overall Study|Adverse Event|1|||
147029412|NCT02325518|530270707|FG000|Overall Study|Physician Decision|0|||
147029413|NCT02325518|530270708|FG001|Overall Study|Physician Decision|1|||
147029414|NCT02325518|530270707|FG000|Overall Study|Withdrawal by Subject|0|||
147029415|NCT02325518|530270708|FG001|Overall Study|Withdrawal by Subject|1|||
147029416|NCT03393806|530270711|FG000|Overall Study|Physician Decision|1|||
147029417|NCT03393806|530270712|FG001|Overall Study|Physician Decision|0|||
147029418|NCT01259115|530270713|FG000|Period 1|Adverse Event|1|||
147029419|NCT01259115|530270714|FG001|Period 1|Adverse Event|0|||
147029420|NCT01259115|530270713|FG000|Period 1|Protocol Violation|2|||
147029421|NCT01259115|530270714|FG001|Period 1|Protocol Violation|0|||
147029422|NCT01259115|530270713|FG000|Period 1|Lost to Follow-up|0|||
147029423|NCT01259115|530270714|FG001|Period 1|Lost to Follow-up|1|||
147029424|NCT01259115|530270713|FG000|Period 2|Adverse Event|1|||
147029425|NCT01259115|530270714|FG001|Period 2|Adverse Event|0|||
147029426|NCT01971970|530270715|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
147029427|NCT01971970|530270716|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
147029428|NCT01971970|530270715|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
147029429|NCT01971970|530270716|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
147029430|NCT01971970|530270715|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
147029431|NCT01971970|530270716|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
147029432|NCT01971970|530270715|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
147029433|NCT01971970|530270716|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
147029434|NCT01971970|530270715|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
147029435|NCT01971970|530270716|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
147029436|NCT01971970|530270715|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
147029437|NCT01971970|530270716|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
147029438|NCT01971970|530270715|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
147029439|NCT01971970|530270716|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
147029440|NCT00848107|530270717|FG000|Overall Study|Lost to Follow-up|2|||
147029441|NCT00848107|530270717|FG000|Overall Study|Withdrawal by Subject|8|||
147029442|NCT00848107|530270717|FG000|Overall Study|Adverse Event|9|||
147029443|NCT00848107|530270717|FG000|Overall Study|Death|1|||
147029444|NCT00848107|530270717|FG000|Overall Study|Pregnancy|1|||
147029445|NCT01831765|530270718|FG000|Overall Study|Lack of Efficacy|1|||
147029446|NCT01831765|530270719|FG001|Overall Study|Lack of Efficacy|0|||
147029447|NCT01831765|530270720|FG002|Overall Study|Lack of Efficacy|0|||
147029448|NCT01831765|530270718|FG000|Overall Study|Other, sponsor withdrew subject|0|||
147029449|NCT01831765|530270719|FG001|Overall Study|Other, sponsor withdrew subject|1|||
147029450|NCT01831765|530270720|FG002|Overall Study|Other, sponsor withdrew subject|0|||
147029451|NCT01831765|530270718|FG000|Overall Study|Pregnancy|1|||
147029452|NCT01831765|530270719|FG001|Overall Study|Pregnancy|1|||
147029453|NCT01831765|530270720|FG002|Overall Study|Pregnancy|2|||
147029454|NCT01831765|530270718|FG000|Overall Study|Death|0|||
147029455|NCT01831765|530270719|FG001|Overall Study|Death|1|||
147029456|NCT01831765|530270720|FG002|Overall Study|Death|1|||
147029457|NCT01831765|530270718|FG000|Overall Study|Other, site closed|1|||
147029458|NCT01831765|530270719|FG001|Overall Study|Other, site closed|1|||
147029459|NCT01831765|530270720|FG002|Overall Study|Other, site closed|0|||
147029460|NCT01831765|530270718|FG000|Overall Study|Adverse Event|5|||
147029461|NCT01831765|530270719|FG001|Overall Study|Adverse Event|3|||
147029462|NCT01831765|530270720|FG002|Overall Study|Adverse Event|3|||
147029463|NCT01831765|530270718|FG000|Overall Study|Withdrawal by Subject|22|||
147029464|NCT01831765|530270719|FG001|Overall Study|Withdrawal by Subject|7|||
147029465|NCT01831765|530270720|FG002|Overall Study|Withdrawal by Subject|17|||
147029466|NCT01831765|530270718|FG000|Overall Study|Withdrawal criteria|12|||
147029467|NCT01831765|530270719|FG001|Overall Study|Withdrawal criteria|10|||
147029468|NCT01831765|530270720|FG002|Overall Study|Withdrawal criteria|16|||
147029469|NCT01831765|530270718|FG000|Overall Study|Lost to Follow-up|2|||
147029470|NCT01831765|530270719|FG001|Overall Study|Lost to Follow-up|3|||
147029471|NCT01831765|530270720|FG002|Overall Study|Lost to Follow-up|3|||
147029472|NCT00507130|530270721|FG000|Overall Study|Lost to Follow-up|0|||
147029473|NCT00507130|530270722|FG001|Overall Study|Lost to Follow-up|0|||
147029474|NCT00507130|530270723|FG002|Overall Study|Lost to Follow-up|1|||
147029475|NCT00507130|530270724|FG003|Overall Study|Lost to Follow-up|1|||
147029476|NCT00507130|530270721|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
147029477|NCT00507130|530270722|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
147029478|NCT00507130|530270723|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
147029479|NCT00507130|530270724|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
147029480|NCT02524730|530270725|FG000|Overall Study|Lost to Follow-up|5|||
147029481|NCT02524730|530270725|FG000|Overall Study|Withdrawal by Subject|18|||
147029482|NCT02524730|530270725|FG000|Overall Study|Death|10|||
147029483|NCT02524730|530270725|FG000|Overall Study|Adverse Event|8|||
147029484|NCT02524730|530270725|FG000|Overall Study|Protocol Violation|1|||
147029485|NCT02524730|530270725|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
147029486|NCT00859586|530270726|FG000|Overall Study|Donors|4|||
147029487|NCT00080938|530270731|FG000|Overall Study|Adverse Event|3|||
147029488|NCT00080938|530270731|FG000|Overall Study|Withdrawal by Subject|6|||
147029489|NCT00080938|530270731|FG000|Overall Study|Death|2|||
147029490|NCT00080938|530270731|FG000|Overall Study|Lack of Efficacy|7|||
147029491|NCT00080938|530270731|FG000|Overall Study|other disease|1|||
147029492|NCT00080938|530270731|FG000|Overall Study|Not started protocol therapy|1|||
147029493|NCT00080938|530270731|FG000|Overall Study|Ineligible|4|||
147029494|NCT00706511|530270738|FG000|Overall Study|Withdrawal by Subject|1|||
147029495|NCT00706511|530270739|FG001|Overall Study|Withdrawal by Subject|0|||
147029496|NCT00706511|530270740|FG002|Overall Study|Withdrawal by Subject|0|||
147029497|NCT00706511|530270741|FG003|Overall Study|Withdrawal by Subject|0|||
147029498|NCT02605993|530270742|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
147029499|NCT02605993|530270743|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
147029500|NCT02605993|530270744|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
147029501|NCT02605993|530270745|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
147029502|NCT03493386|530270750|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
147029503|NCT03493386|530270751|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
147029504|NCT03493386|530270752|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
147029505|NCT03493386|530270753|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
147029506|NCT04645966|530270754|FG000|Vaccination Phase|Adverse Event|1|||
147029507|NCT04645966|530270755|FG001|Vaccination Phase|Adverse Event|0|||
147029508|NCT04645966|530270756|FG002|Vaccination Phase|Adverse Event|0|||
147029509|NCT04645966|530270757|FG003|Vaccination Phase|Adverse Event|0|||
147029510|NCT04645966|530270758|FG004|Vaccination Phase|Adverse Event|0|||
147029511|NCT04645966|530270759|FG005|Vaccination Phase|Adverse Event|0|||
147029512|NCT04645966|530270760|FG006|Vaccination Phase|Adverse Event|1|||
147029513|NCT04645966|530270761|FG007|Vaccination Phase|Adverse Event|0|||
147029514|NCT04645966|530270762|FG008|Vaccination Phase|Adverse Event|0|||
147029515|NCT04645966|530270754|FG000|Vaccination Phase|Death|0|||
147029516|NCT04645966|530270755|FG001|Vaccination Phase|Death|0|||
147029517|NCT04645966|530270756|FG002|Vaccination Phase|Death|0|||
147029518|NCT04645966|530270757|FG003|Vaccination Phase|Death|0|||
147029519|NCT04645966|530270758|FG004|Vaccination Phase|Death|0|||
147029520|NCT04645966|530270759|FG005|Vaccination Phase|Death|1|||
147029521|NCT04645966|530270760|FG006|Vaccination Phase|Death|0|||
147029522|NCT04645966|530270761|FG007|Vaccination Phase|Death|0|||
147029523|NCT04645966|530270762|FG008|Vaccination Phase|Death|0|||
147029524|NCT04645966|530270754|FG000|Vaccination Phase|Protocol Violation|0|||
147029525|NCT04645966|530270755|FG001|Vaccination Phase|Protocol Violation|0|||
147029526|NCT04645966|530270756|FG002|Vaccination Phase|Protocol Violation|0|||
147029527|NCT04645966|530270757|FG003|Vaccination Phase|Protocol Violation|0|||
147029528|NCT04645966|530270758|FG004|Vaccination Phase|Protocol Violation|1|||
147029529|NCT04645966|530270759|FG005|Vaccination Phase|Protocol Violation|0|||
147029530|NCT04645966|530270760|FG006|Vaccination Phase|Protocol Violation|0|||
147029531|NCT04645966|530270761|FG007|Vaccination Phase|Protocol Violation|0|||
147029532|NCT04645966|530270762|FG008|Vaccination Phase|Protocol Violation|0|||
147029533|NCT04645966|530270754|FG000|Vaccination Phase|Study terminated by sponsor|0|||
147029534|NCT04645966|530270755|FG001|Vaccination Phase|Study terminated by sponsor|0|||
147029535|NCT04645966|530270756|FG002|Vaccination Phase|Study terminated by sponsor|14|||
147029536|NCT04645966|530270757|FG003|Vaccination Phase|Study terminated by sponsor|15|||
147029537|NCT04645966|530270758|FG004|Vaccination Phase|Study terminated by sponsor|47|||
147029538|NCT04645966|530270759|FG005|Vaccination Phase|Study terminated by sponsor|43|||
147029539|NCT04645966|530270760|FG006|Vaccination Phase|Study terminated by sponsor|29|||
147029540|NCT04645966|530270761|FG007|Vaccination Phase|Study terminated by sponsor|29|||
147029541|NCT04645966|530270762|FG008|Vaccination Phase|Study terminated by sponsor|12|||
147029542|NCT04645966|530270754|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
147029543|NCT04645966|530270755|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
147029544|NCT04645966|530270756|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
147029545|NCT04645966|530270757|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
147029546|NCT04645966|530270758|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
147029547|NCT04645966|530270759|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
147029548|NCT04645966|530270760|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
147029549|NCT04645966|530270761|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
147029550|NCT04645966|530270762|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
147029551|NCT04645966|530270754|FG000|Vaccination Phase|Other|0|||
147029552|NCT04645966|530270755|FG001|Vaccination Phase|Other|0|||
147029553|NCT04645966|530270756|FG002|Vaccination Phase|Other|0|||
147029554|NCT04645966|530270757|FG003|Vaccination Phase|Other|0|||
147029555|NCT04645966|530270758|FG004|Vaccination Phase|Other|0|||
147029556|NCT04645966|530270759|FG005|Vaccination Phase|Other|2|||
147029557|NCT04645966|530270760|FG006|Vaccination Phase|Other|0|||
147029558|NCT04645966|530270761|FG007|Vaccination Phase|Other|0|||
147029559|NCT04645966|530270762|FG008|Vaccination Phase|Other|0|||
147029560|NCT04645966|530270754|FG000|Vaccination Phase|Lost to Follow-up|0|||
147029561|NCT04645966|530270755|FG001|Vaccination Phase|Lost to Follow-up|0|||
147029562|NCT04645966|530270756|FG002|Vaccination Phase|Lost to Follow-up|0|||
147029563|NCT04645966|530270757|FG003|Vaccination Phase|Lost to Follow-up|0|||
147029564|NCT04645966|530270758|FG004|Vaccination Phase|Lost to Follow-up|0|||
147029565|NCT04645966|530270759|FG005|Vaccination Phase|Lost to Follow-up|0|||
147029566|NCT04645966|530270760|FG006|Vaccination Phase|Lost to Follow-up|0|||
147029567|NCT04645966|530270761|FG007|Vaccination Phase|Lost to Follow-up|1|||
147029568|NCT04645966|530270762|FG008|Vaccination Phase|Lost to Follow-up|0|||
147029569|NCT04645966|530270754|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
147029570|NCT04645966|530270755|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
147029571|NCT04645966|530270756|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
147029572|NCT04645966|530270757|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
147029573|NCT04645966|530270758|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
147029574|NCT04645966|530270759|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
147029575|NCT04645966|530270760|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
147029576|NCT04645966|530270761|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
147029577|NCT04645966|530270762|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
147029578|NCT04645966|530270754|FG000|Follow-up Phase|Lost to Follow-up|0|||
147029579|NCT04645966|530270755|FG001|Follow-up Phase|Lost to Follow-up|0|||
147029580|NCT04645966|530270756|FG002|Follow-up Phase|Lost to Follow-up|0|||
147029581|NCT04645966|530270757|FG003|Follow-up Phase|Lost to Follow-up|0|||
147029582|NCT04645966|530270758|FG004|Follow-up Phase|Lost to Follow-up|0|||
147029583|NCT04645966|530270759|FG005|Follow-up Phase|Lost to Follow-up|0|||
147029584|NCT04645966|530270760|FG006|Follow-up Phase|Lost to Follow-up|0|||
147029585|NCT04645966|530270761|FG007|Follow-up Phase|Lost to Follow-up|1|||
147029586|NCT04645966|530270762|FG008|Follow-up Phase|Lost to Follow-up|0|||
147029587|NCT01460901|530270763|FG000|Overall Study|Withdrawal by Subject|2|||
147029588|NCT00117325|530270764|FG000|Overall Study|Adverse Event|3|||
147029589|NCT00117325|530270765|FG001|Overall Study|Adverse Event|3|||
147029590|NCT00117325|530270764|FG000|Overall Study|Lost to Follow-up|1|||
147029591|NCT00117325|530270765|FG001|Overall Study|Lost to Follow-up|1|||
147029592|NCT00117325|530270764|FG000|Overall Study|Protocol Violation|2|||
147029593|NCT00117325|530270765|FG001|Overall Study|Protocol Violation|3|||
147029594|NCT00117325|530270764|FG000|Overall Study|Withdrawal by Subject|3|||
147029595|NCT00117325|530270765|FG001|Overall Study|Withdrawal by Subject|2|||
147029596|NCT00117325|530270764|FG000|Overall Study|Lack of Efficacy|1|||
147029597|NCT00117325|530270765|FG001|Overall Study|Lack of Efficacy|0|||
147029598|NCT00117325|530270764|FG000|Overall Study|Use of prohibited medicine|1|||
147029599|NCT00117325|530270765|FG001|Overall Study|Use of prohibited medicine|2|||
147029600|NCT00117325|530270764|FG000|Overall Study|Early termination|1|||
147029601|NCT00117325|530270765|FG001|Overall Study|Early termination|1|||
147029602|NCT00117325|530270764|FG000|Overall Study|Admisnitrative|1|||
147029603|NCT00117325|530270765|FG001|Overall Study|Admisnitrative|0|||
147029604|NCT04394351|530272703|FG000|Part A (16 Weeks)|Adverse Event|1|||
147029605|NCT04394351|530272704|FG001|Part A (16 Weeks)|Adverse Event|0|||
147029606|NCT04394351|530272705|FG002|Part A (16 Weeks)|Adverse Event|0|||
147029607|NCT04394351|530272706|FG003|Part A (16 Weeks)|Adverse Event|0|||
147029608|NCT04394351|530272707|FG004|Part A (16 Weeks)|Adverse Event|0|||
147029609|NCT04394351|530272708|FG005|Part A (16 Weeks)|Adverse Event|0|||
147029610|NCT04394351|530272709|FG006|Part A (16 Weeks)|Adverse Event|0|||
147029611|NCT04394351|530272710|FG007|Part A (16 Weeks)|Adverse Event|0|||
147029612|NCT04394351|530272703|FG000|Part A (16 Weeks)|Physician Decision|0|||
147029613|NCT04394351|530272704|FG001|Part A (16 Weeks)|Physician Decision|1|||
147029614|NCT04394351|530272705|FG002|Part A (16 Weeks)|Physician Decision|0|||
147029615|NCT04394351|530272706|FG003|Part A (16 Weeks)|Physician Decision|0|||
147029616|NCT04394351|530272707|FG004|Part A (16 Weeks)|Physician Decision|0|||
147029617|NCT04394351|530272708|FG005|Part A (16 Weeks)|Physician Decision|0|||
147029618|NCT04394351|530272709|FG006|Part A (16 Weeks)|Physician Decision|0|||
147029619|NCT04394351|530272710|FG007|Part A (16 Weeks)|Physician Decision|0|||
147029620|NCT04394351|530272703|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
146849577|NCT02663518|529618853|FG002|Part 1: Phase 1a Escalation|Other|2|||
146849578|NCT02663518|529618854|FG003|Part 1: Phase 1a Escalation|Other|0|||
146849579|NCT02663518|529618855|FG004|Part 1: Phase 1a Escalation|Other|0|||
146849580|NCT02663518|529618856|FG005|Part 1: Phase 1a Escalation|Other|0|||
146849581|NCT02663518|529618857|FG006|Part 1: Phase 1a Escalation|Other|0|||
146849582|NCT02663518|529618858|FG007|Part 1: Phase 1a Escalation|Other|0|||
147029621|NCT04394351|530272704|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
147029622|NCT04394351|530272705|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
147029623|NCT04394351|530272706|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
147029624|NCT04394351|530272707|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
147029625|NCT04394351|530272708|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
147029626|NCT04394351|530272709|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
147029627|NCT04394351|530272710|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
147029628|NCT04394351|530272703|FG000|Part B (36 Weeks)|Adverse Event|0|||
147029629|NCT04394351|530272704|FG001|Part B (36 Weeks)|Adverse Event|0|||
147029630|NCT04394351|530272705|FG002|Part B (36 Weeks)|Adverse Event|0|||
147029631|NCT04394351|530272706|FG003|Part B (36 Weeks)|Adverse Event|0|||
147029632|NCT04394351|530272707|FG004|Part B (36 Weeks)|Adverse Event|0|||
147029633|NCT04394351|530272708|FG005|Part B (36 Weeks)|Adverse Event|0|||
147029634|NCT04394351|530272709|FG006|Part B (36 Weeks)|Adverse Event|1|||
147029635|NCT04394351|530272710|FG007|Part B (36 Weeks)|Adverse Event|0|||
147029636|NCT04394351|530272703|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
147029637|NCT04394351|530272704|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
147029638|NCT04394351|530272705|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
147029639|NCT04394351|530272706|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
147029640|NCT04394351|530272707|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
147029641|NCT04394351|530272708|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
147029642|NCT04394351|530272709|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
147029643|NCT04394351|530272710|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
147029644|NCT04394351|530272703|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
147029645|NCT04394351|530272704|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
147029646|NCT04394351|530272705|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
147029647|NCT04394351|530272706|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
147029648|NCT04394351|530272707|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
147029649|NCT04394351|530272708|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
147029650|NCT04394351|530272709|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
147029651|NCT04394351|530272710|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
147029652|NCT04394351|530272703|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
146849583|NCT02663518|529618859|FG008|Part 1: Phase 1a Escalation|Other|0|||
146849584|NCT02663518|529618860|FG009|Part 1: Phase 1a Escalation|Other|0|||
146849585|NCT02663518|529618861|FG010|Part 1: Phase 1a Escalation|Other|0|||
146849586|NCT02663518|529618862|FG011|Part 1: Phase 1a Escalation|Other|0|||
146849587|NCT02663518|529618863|FG012|Part 1: Phase 1a Escalation|Other|0|||
146849588|NCT02663518|529618864|FG013|Part 1: Phase 1a Escalation|Other|0|||
146849589|NCT02663518|529618851|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
146849590|NCT02663518|529618852|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
146849591|NCT02663518|529618853|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
146849592|NCT02663518|529618854|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
146849593|NCT02663518|529618855|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
146849594|NCT02663518|529618856|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
146849595|NCT02663518|529618857|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
146849596|NCT02663518|529618858|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
146849597|NCT02663518|529618859|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
146849598|NCT02663518|529618860|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
146849599|NCT02663518|529618861|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
146849600|NCT02663518|529618862|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
146849601|NCT02663518|529618863|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
146849602|NCT02663518|529618864|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
146849603|NCT02663518|529618851|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
147029653|NCT04394351|530272704|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
147029654|NCT04394351|530272705|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
147029655|NCT04394351|530272706|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
147029656|NCT04394351|530272707|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
147029657|NCT04394351|530272708|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
147029658|NCT04394351|530272709|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
146849604|NCT02663518|529618852|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146849605|NCT02663518|529618853|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146849606|NCT02663518|529618854|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146849607|NCT02663518|529618855|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
146849608|NCT02663518|529618856|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146849609|NCT02663518|529618857|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
147029659|NCT04394351|530272710|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
147029660|NCT04394351|530272703|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
147029661|NCT04394351|530272704|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
147029662|NCT04394351|530272705|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
147029663|NCT04394351|530272706|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
147029664|NCT04394351|530272707|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
147029665|NCT04394351|530272708|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
147029666|NCT04394351|530272709|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
147029667|NCT04394351|530272710|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
147029668|NCT05327816|530272713|FG000|Overall Study|Lost to Follow-up|1|||
147029669|NCT05327816|530272714|FG001|Overall Study|Lost to Follow-up|0|||
147029670|NCT05327816|530272715|FG002|Overall Study|Lost to Follow-up|0|||
147029671|NCT05327816|530272716|FG003|Overall Study|Lost to Follow-up|0|||
147029672|NCT05327816|530272717|FG004|Overall Study|Lost to Follow-up|0|||
147029673|NCT05327816|530272718|FG005|Overall Study|Lost to Follow-up|0|||
147029674|NCT05327816|530272719|FG006|Overall Study|Lost to Follow-up|0|||
147029675|NCT05327816|530272720|FG007|Overall Study|Lost to Follow-up|0|||
147029676|NCT05327816|530272721|FG008|Overall Study|Lost to Follow-up|0|||
147029677|NCT05327816|530272722|FG009|Overall Study|Lost to Follow-up|1|||
147029678|NCT05327816|530272723|FG010|Overall Study|Lost to Follow-up|0|||
147029679|NCT05327816|530272713|FG000|Overall Study|Withdrawal by Subject|0|||
147029680|NCT05327816|530272714|FG001|Overall Study|Withdrawal by Subject|0|||
147029681|NCT05327816|530272715|FG002|Overall Study|Withdrawal by Subject|0|||
147029682|NCT05327816|530272716|FG003|Overall Study|Withdrawal by Subject|0|||
147029683|NCT05327816|530272717|FG004|Overall Study|Withdrawal by Subject|1|||
147029684|NCT05327816|530272718|FG005|Overall Study|Withdrawal by Subject|1|||
147029685|NCT05327816|530272719|FG006|Overall Study|Withdrawal by Subject|0|||
147029686|NCT05327816|530272720|FG007|Overall Study|Withdrawal by Subject|0|||
147029687|NCT05327816|530272721|FG008|Overall Study|Withdrawal by Subject|0|||
147029688|NCT05327816|530272722|FG009|Overall Study|Withdrawal by Subject|0|||
147029689|NCT05327816|530272723|FG010|Overall Study|Withdrawal by Subject|0|||
147029690|NCT05327816|530272713|FG000|Overall Study|Study Terminated by Sponsor|11|||
147029691|NCT05327816|530272714|FG001|Overall Study|Study Terminated by Sponsor|12|||
147029692|NCT05327816|530272715|FG002|Overall Study|Study Terminated by Sponsor|12|||
147029693|NCT05327816|530272716|FG003|Overall Study|Study Terminated by Sponsor|12|||
147029694|NCT05327816|530272717|FG004|Overall Study|Study Terminated by Sponsor|11|||
147029695|NCT05327816|530272718|FG005|Overall Study|Study Terminated by Sponsor|11|||
147029696|NCT05327816|530272719|FG006|Overall Study|Study Terminated by Sponsor|11|||
147029697|NCT05327816|530272720|FG007|Overall Study|Study Terminated by Sponsor|11|||
147029698|NCT05327816|530272721|FG008|Overall Study|Study Terminated by Sponsor|11|||
147029699|NCT05327816|530272722|FG009|Overall Study|Study Terminated by Sponsor|11|||
147029700|NCT05327816|530272723|FG010|Overall Study|Study Terminated by Sponsor|12|||
147029701|NCT05327816|530272713|FG000|Overall Study|Randomized but not treated|0|||
147029702|NCT05327816|530272714|FG001|Overall Study|Randomized but not treated|0|||
147029703|NCT05327816|530272715|FG002|Overall Study|Randomized but not treated|0|||
147029704|NCT05327816|530272716|FG003|Overall Study|Randomized but not treated|0|||
147029705|NCT05327816|530272717|FG004|Overall Study|Randomized but not treated|0|||
147029706|NCT05327816|530272718|FG005|Overall Study|Randomized but not treated|0|||
147029707|NCT05327816|530272719|FG006|Overall Study|Randomized but not treated|1|||
147029708|NCT05327816|530272720|FG007|Overall Study|Randomized but not treated|1|||
147029709|NCT05327816|530272721|FG008|Overall Study|Randomized but not treated|1|||
147029710|NCT05327816|530272722|FG009|Overall Study|Randomized but not treated|0|||
147029711|NCT05327816|530272723|FG010|Overall Study|Randomized but not treated|0|||
147029712|NCT01106014|530272724|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
147029713|NCT01106014|530272725|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
147029714|NCT01106014|530272724|FG000|Overall Study|Adverse Event|78|||
147029715|NCT01106014|530272725|FG001|Overall Study|Adverse Event|42|||
147029716|NCT01106014|530272724|FG000|Overall Study|Withdrawal by Subject|43|||
147029717|NCT01106014|530272725|FG001|Overall Study|Withdrawal by Subject|37|||
147029718|NCT01106014|530272724|FG000|Overall Study|Administrative reason|7|||
147029719|NCT01106014|530272725|FG001|Overall Study|Administrative reason|6|||
147029720|NCT01106014|530272724|FG000|Overall Study|Lost to Follow-up|2|||
147029721|NCT01106014|530272725|FG001|Overall Study|Lost to Follow-up|3|||
147029722|NCT00658658|530272732|FG000|Overall Study|Withdrawal by Subject|0|||
147029723|NCT00658658|530272733|FG001|Overall Study|Withdrawal by Subject|1|||
147029724|NCT00658658|530272734|FG002|Overall Study|Withdrawal by Subject|0|||
147029725|NCT00658658|530272735|FG003|Overall Study|Withdrawal by Subject|0|||
147029726|NCT00658658|530272736|FG004|Overall Study|Withdrawal by Subject|0|||
147029727|NCT00658658|530272732|FG000|Overall Study|Death|4|||
147029728|NCT00658658|530272733|FG001|Overall Study|Death|0|||
147029729|NCT00658658|530272734|FG002|Overall Study|Death|0|||
147029730|NCT00658658|530272735|FG003|Overall Study|Death|1|||
147029731|NCT00658658|530272736|FG004|Overall Study|Death|1|||
147029732|NCT00658658|530272732|FG000|Overall Study|Disease Progression|0|||
147029733|NCT00658658|530272733|FG001|Overall Study|Disease Progression|1|||
147029734|NCT00658658|530272734|FG002|Overall Study|Disease Progression|0|||
147029735|NCT00658658|530272735|FG003|Overall Study|Disease Progression|1|||
147029736|NCT00658658|530272736|FG004|Overall Study|Disease Progression|3|||
147029737|NCT00658658|530272732|FG000|Overall Study|Protocol-specified Criteria|1|||
147029738|NCT00658658|530272733|FG001|Overall Study|Protocol-specified Criteria|0|||
147029739|NCT00658658|530272734|FG002|Overall Study|Protocol-specified Criteria|0|||
147029740|NCT00658658|530272735|FG003|Overall Study|Protocol-specified Criteria|0|||
147029741|NCT00658658|530272736|FG004|Overall Study|Protocol-specified Criteria|0|||
147029742|NCT00658658|530272732|FG000|Overall Study|Other|0|||
147029743|NCT00658658|530272733|FG001|Overall Study|Other|0|||
147029744|NCT00658658|530272734|FG002|Overall Study|Other|0|||
147029745|NCT00658658|530272735|FG003|Overall Study|Other|0|||
147029746|NCT00658658|530272736|FG004|Overall Study|Other|1|||
147029747|NCT03186781|530272738|FG000|Overall Study|Lost to Follow-up|0|||
147029748|NCT03186781|530272739|FG001|Overall Study|Lost to Follow-up|0|||
147029749|NCT03186781|530272740|FG002|Overall Study|Lost to Follow-up|1|||
147029750|NCT03186781|530272741|FG003|Overall Study|Lost to Follow-up|0|||
147029751|NCT03186781|530272742|FG004|Overall Study|Lost to Follow-up|1|||
147029752|NCT03186781|530272743|FG005|Overall Study|Lost to Follow-up|0|||
147029753|NCT03186781|530272738|FG000|Overall Study|Moved from Area|0|||
147029754|NCT03186781|530272739|FG001|Overall Study|Moved from Area|0|||
147029755|NCT03186781|530272740|FG002|Overall Study|Moved from Area|0|||
147029756|NCT03186781|530272741|FG003|Overall Study|Moved from Area|0|||
147029757|NCT03186781|530272742|FG004|Overall Study|Moved from Area|1|||
147029758|NCT03186781|530272743|FG005|Overall Study|Moved from Area|0|||
147029759|NCT03186781|530272738|FG000|Overall Study|Withdrawal by Subject|0|||
147029760|NCT03186781|530272739|FG001|Overall Study|Withdrawal by Subject|0|||
147029761|NCT03186781|530272740|FG002|Overall Study|Withdrawal by Subject|0|||
147029762|NCT03186781|530272741|FG003|Overall Study|Withdrawal by Subject|0|||
147029763|NCT03186781|530272742|FG004|Overall Study|Withdrawal by Subject|1|||
147029764|NCT03186781|530272743|FG005|Overall Study|Withdrawal by Subject|0|||
147029765|NCT00667810|530272744|FG000|Overall Study|Adverse Event|13|||
147029766|NCT00667810|530272745|FG001|Overall Study|Adverse Event|14|||
147029767|NCT00667810|530272746|FG002|Overall Study|Adverse Event|19|||
147029768|NCT00667810|530272747|FG003|Overall Study|Adverse Event|1|||
147029769|NCT00667810|530272744|FG000|Overall Study|Death|1|||
147029770|NCT00667810|530272745|FG001|Overall Study|Death|1|||
147029771|NCT00667810|530272746|FG002|Overall Study|Death|3|||
147029772|NCT00667810|530272747|FG003|Overall Study|Death|0|||
147029773|NCT00667810|530272744|FG000|Overall Study|Lack of Efficacy|1|||
147029774|NCT00667810|530272745|FG001|Overall Study|Lack of Efficacy|0|||
147029775|NCT00667810|530272746|FG002|Overall Study|Lack of Efficacy|2|||
147029776|NCT00667810|530272747|FG003|Overall Study|Lack of Efficacy|0|||
147029777|NCT00667810|530272744|FG000|Overall Study|Lost to Follow-up|1|||
147029778|NCT00667810|530272745|FG001|Overall Study|Lost to Follow-up|4|||
147029779|NCT00667810|530272746|FG002|Overall Study|Lost to Follow-up|2|||
147029780|NCT00667810|530272747|FG003|Overall Study|Lost to Follow-up|0|||
147029781|NCT00667810|530272744|FG000|Overall Study|Physician Decision|1|||
147029782|NCT00667810|530272745|FG001|Overall Study|Physician Decision|1|||
147029783|NCT00667810|530272746|FG002|Overall Study|Physician Decision|2|||
147029784|NCT00667810|530272747|FG003|Overall Study|Physician Decision|0|||
147029785|NCT00667810|530272744|FG000|Overall Study|Protocol Violation|0|||
147029786|NCT00667810|530272745|FG001|Overall Study|Protocol Violation|2|||
147029787|NCT00667810|530272746|FG002|Overall Study|Protocol Violation|0|||
147029788|NCT00667810|530272747|FG003|Overall Study|Protocol Violation|0|||
147029789|NCT00667810|530272744|FG000|Overall Study|Withdrawal by Subject|14|||
147029790|NCT00667810|530272745|FG001|Overall Study|Withdrawal by Subject|20|||
147029791|NCT00667810|530272746|FG002|Overall Study|Withdrawal by Subject|29|||
147029792|NCT00667810|530272747|FG003|Overall Study|Withdrawal by Subject|1|||
147029793|NCT00667810|530272744|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
147029794|NCT00667810|530272745|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
147029795|NCT00667810|530272746|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
147029796|NCT00667810|530272747|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
147029797|NCT00667810|530272744|FG000|Overall Study|Failed to Return|0|||
147029798|NCT00667810|530272745|FG001|Overall Study|Failed to Return|0|||
147029799|NCT00667810|530272746|FG002|Overall Study|Failed to Return|2|||
147029800|NCT00667810|530272747|FG003|Overall Study|Failed to Return|0|||
147029801|NCT00667810|530272744|FG000|Overall Study|Loss of Caregiver|0|||
147029802|NCT00667810|530272745|FG001|Overall Study|Loss of Caregiver|1|||
147029803|NCT00667810|530272746|FG002|Overall Study|Loss of Caregiver|3|||
147029804|NCT00667810|530272747|FG003|Overall Study|Loss of Caregiver|0|||
147029805|NCT00667810|530272744|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
147029806|NCT00667810|530272745|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
147029807|NCT00667810|530272746|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
147029808|NCT00667810|530272747|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
147029809|NCT00667810|530272744|FG000|Overall Study|Other|6|||
147029810|NCT00667810|530272745|FG001|Overall Study|Other|6|||
147029811|NCT00667810|530272746|FG002|Overall Study|Other|5|||
147029812|NCT00667810|530272747|FG003|Overall Study|Other|0|||
147029813|NCT01561430|530272748|FG000|Overall Study|Adverse Event|0|||
147029814|NCT01561430|530272749|FG001|Overall Study|Adverse Event|0|||
147029815|NCT01561430|530272750|FG002|Overall Study|Adverse Event|3|||
147029816|NCT01561430|530272751|FG003|Overall Study|Adverse Event|1|||
147029817|NCT01561430|530272748|FG000|Overall Study|Withdrawal by Subject|0|||
147029818|NCT01561430|530272749|FG001|Overall Study|Withdrawal by Subject|0|||
147029819|NCT01561430|530272750|FG002|Overall Study|Withdrawal by Subject|1|||
147029820|NCT01561430|530272751|FG003|Overall Study|Withdrawal by Subject|0|||
147029821|NCT01561430|530272748|FG000|Overall Study|Physician Decision|0|||
147029822|NCT01561430|530272749|FG001|Overall Study|Physician Decision|1|||
147029823|NCT01561430|530272750|FG002|Overall Study|Physician Decision|0|||
147029824|NCT01561430|530272751|FG003|Overall Study|Physician Decision|0|||
147029825|NCT01561430|530272748|FG000|Overall Study|Sponsor Decision|1|||
147029826|NCT01561430|530272749|FG001|Overall Study|Sponsor Decision|14|||
147029827|NCT01561430|530272750|FG002|Overall Study|Sponsor Decision|13|||
147029828|NCT01561430|530272751|FG003|Overall Study|Sponsor Decision|12|||
147029829|NCT04234984|530272759|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
147029830|NCT04234984|530272759|FG000|Follow-up at the Second Time Point|Death|1|||
147029831|NCT04234984|530272759|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
147029832|NCT01055132|530272760|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
147029833|NCT01055132|530272761|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
147029834|NCT01055132|530272760|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
147029835|NCT01055132|530272761|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
147029836|NCT05183217|530272764|FG000|Overall Study|Withdrawal by Subject|1|||
147029837|NCT05183217|530272765|FG001|Overall Study|Withdrawal by Subject|1|||
147029838|NCT00415194|530272773|FG000|Overall Study|Adverse Event|37|||
147029839|NCT00415194|530272774|FG001|Overall Study|Adverse Event|32|||
147029840|NCT00415194|530272773|FG000|Overall Study|Entry Criteria Not Met|4|||
147029841|NCT00415194|530272774|FG001|Overall Study|Entry Criteria Not Met|8|||
147029842|NCT00415194|530272773|FG000|Overall Study|Lost to Follow-up|1|||
147029843|NCT00415194|530272774|FG001|Overall Study|Lost to Follow-up|0|||
147029844|NCT00415194|530272773|FG000|Overall Study|Physician Decision|10|||
147029845|NCT00415194|530272774|FG001|Overall Study|Physician Decision|16|||
147029846|NCT00415194|530272773|FG000|Overall Study|Progressive Disease|180|||
147029847|NCT00415194|530272774|FG001|Overall Study|Progressive Disease|217|||
147029848|NCT00415194|530272773|FG000|Overall Study|Protocol Violation|4|||
147029849|NCT00415194|530272774|FG001|Overall Study|Protocol Violation|2|||
147029850|NCT00415194|530272773|FG000|Overall Study|Withdrawal by Subject|28|||
147029851|NCT00415194|530272774|FG001|Overall Study|Withdrawal by Subject|21|||
147029852|NCT00415194|530272773|FG000|Overall Study|Death Due to Study Disease|26|||
147029853|NCT00415194|530272774|FG001|Overall Study|Death Due to Study Disease|29|||
147029854|NCT00415194|530272773|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
147029855|NCT00415194|530272774|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
147029856|NCT00415194|530272773|FG000|Overall Study|Death Due to Procedural Related AE|0|||
147029857|NCT00415194|530272774|FG001|Overall Study|Death Due to Procedural Related AE|1|||
147029858|NCT00415194|530272773|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
147029859|NCT00415194|530272774|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
147029860|NCT01297465|530272775|FG000|Overall Study|Lack of Ovarian Response|1|||
147029861|NCT01297465|530272776|FG001|Overall Study|Lack of Ovarian Response|1|||
147029862|NCT01297465|530272775|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
147029863|NCT01297465|530272776|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
147029864|NCT01297465|530272775|FG000|Overall Study|No Oocytes Retrieved|1|||
147029865|NCT01297465|530272776|FG001|Overall Study|No Oocytes Retrieved|1|||
147029866|NCT01297465|530272775|FG000|Overall Study|Poor oocyte quality|0|||
147029867|NCT01297465|530272776|FG001|Overall Study|Poor oocyte quality|1|||
147029868|NCT01297465|530272775|FG000|Overall Study|No Fertilization|6|||
147029869|NCT01297465|530272776|FG001|Overall Study|No Fertilization|4|||
147029870|NCT01297465|530272775|FG000|Overall Study|All Embryos Discarded|0|||
147029871|NCT01297465|530272776|FG001|Overall Study|All Embryos Discarded|1|||
147029872|NCT01297465|530272775|FG000|Overall Study|Intention to Freeze all Embryos|0|||
147029873|NCT01297465|530272776|FG001|Overall Study|Intention to Freeze all Embryos|1|||
147029874|NCT02116608|530272782|FG000|Overall Study|Lost to Follow-up|0|||
146849610|NCT02663518|529618858|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
147029875|NCT02116608|530272783|FG001|Overall Study|Lost to Follow-up|0|||
147029876|NCT02116608|530272784|FG002|Overall Study|Lost to Follow-up|1|||
147029877|NCT02116608|530272782|FG000|Overall Study|Physician Decision|0|||
147029878|NCT02116608|530272783|FG001|Overall Study|Physician Decision|1|||
147029879|NCT02116608|530272784|FG002|Overall Study|Physician Decision|0|||
147029880|NCT02116608|530272782|FG000|Overall Study|Death|0|||
147029881|NCT02116608|530272783|FG001|Overall Study|Death|1|||
147029882|NCT02116608|530272784|FG002|Overall Study|Death|0|||
147029883|NCT00988442|530272786|FG000|Overall Study|Death|1|||
147029884|NCT00988442|530272787|FG001|Overall Study|Death|2|||
147029885|NCT00988442|530272786|FG000|Overall Study|Lost to Follow-up|0|||
147029886|NCT00988442|530272787|FG001|Overall Study|Lost to Follow-up|1|||
147029887|NCT00988442|530272786|FG000|Overall Study|Early Study Closure|29|||
147029888|NCT00988442|530272787|FG001|Overall Study|Early Study Closure|25|||
147029889|NCT05297578|530272800|FG000|Overall Study|Lost to Follow-up|1|||
147029890|NCT05297578|530272801|FG001|Overall Study|Lost to Follow-up|1|||
147029891|NCT05297578|530272802|FG002|Overall Study|Lost to Follow-up|2|||
147029892|NCT05297578|530272803|FG003|Overall Study|Lost to Follow-up|1|||
147029893|NCT05297578|530272800|FG000|Overall Study|Death|0|||
147029894|NCT05297578|530272801|FG001|Overall Study|Death|1|||
147029895|NCT05297578|530272802|FG002|Overall Study|Death|0|||
147029896|NCT05297578|530272803|FG003|Overall Study|Death|0|||
147029897|NCT05297578|530272800|FG000|Overall Study|Withdrawal by Subject|0|||
147029898|NCT05297578|530272801|FG001|Overall Study|Withdrawal by Subject|0|||
147029899|NCT05297578|530272802|FG002|Overall Study|Withdrawal by Subject|1|||
147029900|NCT05297578|530272803|FG003|Overall Study|Withdrawal by Subject|0|||
147029901|NCT00762437|530272809|FG000|Overall Study|Lost to Follow-up|7|||
147029902|NCT00762437|530272809|FG000|Overall Study|Missed final study visit|11|||
147029903|NCT00762437|530272809|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
147029904|NCT00302081|530272810|FG000|Overall Study|Adverse Event|6|||
147029905|NCT00302081|530272811|FG001|Overall Study|Adverse Event|5|||
147029906|NCT00302081|530272812|FG002|Overall Study|Adverse Event|4|||
147029907|NCT00302081|530272810|FG000|Overall Study|Lost to Follow-up|21|||
147029908|NCT00302081|530272811|FG001|Overall Study|Lost to Follow-up|18|||
147029909|NCT00302081|530272812|FG002|Overall Study|Lost to Follow-up|28|||
147029910|NCT00302081|530272810|FG000|Overall Study|Withdrawal by Subject|8|||
147029911|NCT00302081|530272811|FG001|Overall Study|Withdrawal by Subject|12|||
147029912|NCT00302081|530272812|FG002|Overall Study|Withdrawal by Subject|8|||
147029913|NCT00302081|530272810|FG000|Overall Study|Protocol Violation|5|||
147029914|NCT00302081|530272811|FG001|Overall Study|Protocol Violation|1|||
147029915|NCT00302081|530272812|FG002|Overall Study|Protocol Violation|2|||
147029916|NCT00302081|530272810|FG000|Overall Study|Lack of Efficacy|1|||
147029917|NCT00302081|530272811|FG001|Overall Study|Lack of Efficacy|0|||
147029918|NCT00302081|530272812|FG002|Overall Study|Lack of Efficacy|5|||
147029919|NCT00302081|530272810|FG000|Overall Study|Death|2|||
147029920|NCT00302081|530272811|FG001|Overall Study|Death|1|||
147029921|NCT00302081|530272812|FG002|Overall Study|Death|0|||
147029922|NCT00302081|530272810|FG000|Overall Study|Other|13|||
147029923|NCT00302081|530272811|FG001|Overall Study|Other|6|||
147029924|NCT00302081|530272812|FG002|Overall Study|Other|5|||
147029925|NCT04480710|530272813|FG000|Overall Study|Adverse Event|0|||
147029926|NCT04480710|530272814|FG001|Overall Study|Adverse Event|2|||
147029927|NCT04480710|530272815|FG002|Overall Study|Adverse Event|0|||
147029928|NCT04480710|530272816|FG003|Overall Study|Adverse Event|0|||
147029929|NCT04480710|530272813|FG000|Overall Study|Withdrawal by Subject|0|||
147029930|NCT04480710|530272814|FG001|Overall Study|Withdrawal by Subject|1|||
147029931|NCT04480710|530272815|FG002|Overall Study|Withdrawal by Subject|0|||
147029932|NCT04480710|530272816|FG003|Overall Study|Withdrawal by Subject|0|||
147029933|NCT04480710|530272813|FG000|Overall Study|Physician Decision|0|||
147029934|NCT04480710|530272814|FG001|Overall Study|Physician Decision|0|||
147029935|NCT04480710|530272815|FG002|Overall Study|Physician Decision|1|||
147029936|NCT04480710|530272816|FG003|Overall Study|Physician Decision|0|||
147029937|NCT05084963|530272818|FG000|Overall Study|Withdrawal by Subject|0|||
147029938|NCT05084963|530272819|FG001|Overall Study|Withdrawal by Subject|0|||
147029939|NCT05084963|530272820|FG002|Overall Study|Withdrawal by Subject|1|||
147029940|NCT05442866|530272821|FG000|Overall Study|Death|1|||
147029941|NCT05442866|530272821|FG000|Overall Study|Lost to Follow-up|9|||
147029942|NCT05442866|530272821|FG000|Overall Study|Protocol Violation|1|||
147029943|NCT01986010|530272822|FG000|Overall Study|Adverse Event|0|||
147029944|NCT01986010|530272823|FG001|Overall Study|Adverse Event|1|||
147029945|NCT01986010|530272824|FG002|Overall Study|Adverse Event|0|||
147029946|NCT01986010|530272825|FG003|Overall Study|Adverse Event|0|||
147029947|NCT01986010|530272826|FG004|Overall Study|Adverse Event|0|||
147029948|NCT01986010|530272827|FG005|Overall Study|Adverse Event|0|||
147029949|NCT01986010|530272828|FG006|Overall Study|Adverse Event|0|||
147029950|NCT01986010|530272829|FG007|Overall Study|Adverse Event|0|||
147029951|NCT01986010|530272830|FG008|Overall Study|Adverse Event|0|||
147029952|NCT01986010|530272831|FG009|Overall Study|Adverse Event|0|||
147029953|NCT01986010|530272832|FG010|Overall Study|Adverse Event|0|||
147029954|NCT01986010|530272833|FG011|Overall Study|Adverse Event|0|||
147029955|NCT01986010|530272834|FG012|Overall Study|Adverse Event|0|||
147029956|NCT01986010|530272835|FG013|Overall Study|Adverse Event|0|||
147029957|NCT01986010|530272836|FG014|Overall Study|Adverse Event|0|||
147029958|NCT01986010|530272837|FG015|Overall Study|Adverse Event|1|||
147029959|NCT01986010|530272838|FG016|Overall Study|Adverse Event|0|||
147029960|NCT01986010|530272822|FG000|Overall Study|Lost to Follow-up|2|||
147029961|NCT01986010|530272823|FG001|Overall Study|Lost to Follow-up|1|||
147029962|NCT01986010|530272824|FG002|Overall Study|Lost to Follow-up|2|||
147029963|NCT01986010|530272825|FG003|Overall Study|Lost to Follow-up|2|||
147029964|NCT01986010|530272826|FG004|Overall Study|Lost to Follow-up|2|||
147029965|NCT01986010|530272827|FG005|Overall Study|Lost to Follow-up|2|||
147029966|NCT01986010|530272828|FG006|Overall Study|Lost to Follow-up|0|||
147029967|NCT01986010|530272829|FG007|Overall Study|Lost to Follow-up|0|||
147029968|NCT01986010|530272830|FG008|Overall Study|Lost to Follow-up|4|||
147029969|NCT01986010|530272831|FG009|Overall Study|Lost to Follow-up|2|||
147029970|NCT01986010|530272832|FG010|Overall Study|Lost to Follow-up|0|||
147029971|NCT01986010|530272833|FG011|Overall Study|Lost to Follow-up|1|||
147029972|NCT01986010|530272834|FG012|Overall Study|Lost to Follow-up|1|||
147029973|NCT01986010|530272835|FG013|Overall Study|Lost to Follow-up|1|||
147029974|NCT01986010|530272836|FG014|Overall Study|Lost to Follow-up|2|||
147029975|NCT01986010|530272837|FG015|Overall Study|Lost to Follow-up|0|||
147029976|NCT01986010|530272838|FG016|Overall Study|Lost to Follow-up|0|||
147029977|NCT01986010|530272822|FG000|Overall Study|Physician Decision|0|||
147029978|NCT01986010|530272823|FG001|Overall Study|Physician Decision|0|||
147029979|NCT01986010|530272824|FG002|Overall Study|Physician Decision|0|||
147029980|NCT01986010|530272825|FG003|Overall Study|Physician Decision|0|||
147029981|NCT01986010|530272826|FG004|Overall Study|Physician Decision|0|||
147029982|NCT01986010|530272827|FG005|Overall Study|Physician Decision|0|||
147029983|NCT01986010|530272828|FG006|Overall Study|Physician Decision|0|||
147029984|NCT01986010|530272829|FG007|Overall Study|Physician Decision|0|||
147029985|NCT01986010|530272830|FG008|Overall Study|Physician Decision|0|||
147029986|NCT01986010|530272831|FG009|Overall Study|Physician Decision|0|||
147029987|NCT01986010|530272832|FG010|Overall Study|Physician Decision|0|||
147029988|NCT01986010|530272833|FG011|Overall Study|Physician Decision|0|||
147029989|NCT01986010|530272834|FG012|Overall Study|Physician Decision|0|||
147029990|NCT01986010|530272835|FG013|Overall Study|Physician Decision|0|||
147029991|NCT01986010|530272836|FG014|Overall Study|Physician Decision|1|||
147029992|NCT01986010|530272837|FG015|Overall Study|Physician Decision|0|||
147029993|NCT01986010|530272838|FG016|Overall Study|Physician Decision|0|||
147029994|NCT01986010|530272822|FG000|Overall Study|Withdrawal by Subject|2|||
147029995|NCT01986010|530272823|FG001|Overall Study|Withdrawal by Subject|2|||
147029996|NCT01986010|530272824|FG002|Overall Study|Withdrawal by Subject|3|||
147029997|NCT01986010|530272825|FG003|Overall Study|Withdrawal by Subject|0|||
147029998|NCT01986010|530272826|FG004|Overall Study|Withdrawal by Subject|2|||
147029999|NCT01986010|530272827|FG005|Overall Study|Withdrawal by Subject|4|||
147030000|NCT01986010|530272828|FG006|Overall Study|Withdrawal by Subject|0|||
147030001|NCT01986010|530272829|FG007|Overall Study|Withdrawal by Subject|0|||
147030002|NCT01986010|530272830|FG008|Overall Study|Withdrawal by Subject|0|||
147030003|NCT01986010|530272831|FG009|Overall Study|Withdrawal by Subject|0|||
147030004|NCT01986010|530272832|FG010|Overall Study|Withdrawal by Subject|0|||
147030005|NCT01986010|530272833|FG011|Overall Study|Withdrawal by Subject|2|||
147030006|NCT01986010|530272834|FG012|Overall Study|Withdrawal by Subject|0|||
147030007|NCT01986010|530272835|FG013|Overall Study|Withdrawal by Subject|1|||
147030008|NCT01986010|530272836|FG014|Overall Study|Withdrawal by Subject|2|||
147030009|NCT01986010|530272837|FG015|Overall Study|Withdrawal by Subject|0|||
147030010|NCT01986010|530272838|FG016|Overall Study|Withdrawal by Subject|0|||
147030011|NCT01986010|530272822|FG000|Overall Study|Status Not Recorded|2|||
147030012|NCT01986010|530272823|FG001|Overall Study|Status Not Recorded|4|||
147030013|NCT01986010|530272824|FG002|Overall Study|Status Not Recorded|2|||
147030014|NCT01986010|530272825|FG003|Overall Study|Status Not Recorded|0|||
147030015|NCT01986010|530272826|FG004|Overall Study|Status Not Recorded|1|||
147030016|NCT01986010|530272827|FG005|Overall Study|Status Not Recorded|2|||
147030017|NCT01986010|530272828|FG006|Overall Study|Status Not Recorded|0|||
147030018|NCT01986010|530272829|FG007|Overall Study|Status Not Recorded|0|||
147030019|NCT01986010|530272830|FG008|Overall Study|Status Not Recorded|2|||
147030020|NCT01986010|530272831|FG009|Overall Study|Status Not Recorded|1|||
147030021|NCT01986010|530272832|FG010|Overall Study|Status Not Recorded|7|||
147030022|NCT01986010|530272833|FG011|Overall Study|Status Not Recorded|7|||
147030023|NCT01986010|530272834|FG012|Overall Study|Status Not Recorded|9|||
147030024|NCT01986010|530272835|FG013|Overall Study|Status Not Recorded|9|||
147030025|NCT01986010|530272836|FG014|Overall Study|Status Not Recorded|5|||
147030026|NCT01986010|530272837|FG015|Overall Study|Status Not Recorded|10|||
147030027|NCT01986010|530272838|FG016|Overall Study|Status Not Recorded|4|||
147030028|NCT01335997|530272841|FG000|Period I and II|Adverse Event|63|||
147030029|NCT01335997|530272842|FG001|Period I and II|Adverse Event|43|||
147030030|NCT01335997|530272841|FG000|Period I and II|Noncompliance with Study Drug|1|||
147030031|NCT01335997|530272842|FG001|Period I and II|Noncompliance with Study Drug|1|||
147030032|NCT01335997|530272841|FG000|Period I and II|Lost to Follow-up|3|||
147030033|NCT01335997|530272842|FG001|Period I and II|Lost to Follow-up|5|||
147030034|NCT01335997|530272841|FG000|Period I and II|Withdrawal by Subject|9|||
147030035|NCT01335997|530272842|FG001|Period I and II|Withdrawal by Subject|4|||
147030036|NCT01335997|530272841|FG000|Period I and II|Study Terminated by Sponsor|406|||
147030037|NCT01335997|530272842|FG001|Period I and II|Study Terminated by Sponsor|415|||
147030038|NCT01335997|530272841|FG000|Period I and II|Protocol Violation|9|||
147030039|NCT01335997|530272842|FG001|Period I and II|Protocol Violation|10|||
147030040|NCT01335997|530272841|FG000|Period I and II|Physician Decision|2|||
147030041|NCT01335997|530272842|FG001|Period I and II|Physician Decision|1|||
147030042|NCT01335997|530272841|FG000|Period III|Adverse Event|0|||
147030043|NCT01335997|530272842|FG001|Period III|Adverse Event|2|||
147030044|NCT01335997|530272841|FG000|Period III|Study Terminated by Sponsor|77|||
147030045|NCT01335997|530272842|FG001|Period III|Study Terminated by Sponsor|76|||
147030046|NCT01335997|530272841|FG000|Period III|Protocol Violation|0|||
147030047|NCT01335997|530272842|FG001|Period III|Protocol Violation|1|||
147030048|NCT01335997|530272841|FG000|Period III|Lost to Follow-up|1|||
147030049|NCT01335997|530272842|FG001|Period III|Lost to Follow-up|0|||
147030050|NCT01355159|530272854|FG000|Overall Study|Withdrew consent|39|||
147030051|NCT01355159|530272855|FG001|Overall Study|Withdrew consent|47|||
147030052|NCT01355159|530272854|FG000|Overall Study|No primary outcome data|17|||
147030053|NCT01355159|530272855|FG001|Overall Study|No primary outcome data|11|||
147030054|NCT01355159|530272854|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
147030055|NCT01355159|530272855|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
147030056|NCT01355159|530272854|FG000|Overall Study|Early intrauterine fetal death|6|||
147030057|NCT01355159|530272855|FG001|Overall Study|Early intrauterine fetal death|6|||
147030058|NCT01941940|530272856|FG000|Overall Study|Adverse Event|11|||
147030059|NCT01941940|530272856|FG000|Overall Study|Lost to Follow-up|2|||
147030060|NCT01941940|530272856|FG000|Overall Study|Physician Decision|2|||
147030061|NCT01941940|530272856|FG000|Overall Study|Withdrawal by Subject|15|||
147030062|NCT01941940|530272856|FG000|Overall Study|Death|1|||
147030063|NCT01941940|530272856|FG000|Overall Study|Other|1|||
147030064|NCT01941940|530272856|FG000|Overall Study|Other|1|||
147030065|NCT03212521|530272860|FG000|Overall Study|Adverse Event|1|||
147030066|NCT03212521|530272860|FG000|Overall Study|Lost to Follow-up|4|||
147030067|NCT03212521|530272860|FG000|Overall Study|Withdrawal by Subject|1|||
147030068|NCT03212521|530272860|FG000|Overall Study|Other|1|||
147030069|NCT00444457|530272861|FG000|Infant Series|Other|0|||
147030070|NCT00444457|530272862|FG001|Infant Series|Other|1|||
147030071|NCT00444457|530272863|FG002|Infant Series|Other|0|||
147030072|NCT00444457|530272864|FG003|Infant Series|Other|0|||
147030073|NCT00444457|530272861|FG000|Infant Series|Parent or legal guardian request|18|||
147030074|NCT00444457|530272862|FG001|Infant Series|Parent or legal guardian request|29|||
147030075|NCT00444457|530272863|FG002|Infant Series|Parent or legal guardian request|34|||
147030076|NCT00444457|530272864|FG003|Infant Series|Parent or legal guardian request|14|||
147030077|NCT00444457|530272861|FG000|Infant Series|Lost to Follow-up|10|||
147030078|NCT00444457|530272862|FG001|Infant Series|Lost to Follow-up|11|||
147030079|NCT00444457|530272863|FG002|Infant Series|Lost to Follow-up|7|||
147030080|NCT00444457|530272864|FG003|Infant Series|Lost to Follow-up|6|||
147030081|NCT00444457|530272861|FG000|Infant Series|Protocol Violation|16|||
147030082|NCT00444457|530272862|FG001|Infant Series|Protocol Violation|8|||
147030083|NCT00444457|530272863|FG002|Infant Series|Protocol Violation|6|||
147030084|NCT00444457|530272864|FG003|Infant Series|Protocol Violation|3|||
147030085|NCT00444457|530272861|FG000|Infant Series|Failed to return|5|||
147030086|NCT00444457|530272862|FG001|Infant Series|Failed to return|4|||
147030087|NCT00444457|530272863|FG002|Infant Series|Failed to return|4|||
147030088|NCT00444457|530272864|FG003|Infant Series|Failed to return|2|||
147030089|NCT00444457|530272861|FG000|Infant Series|Investigator request|4|||
147030090|NCT00444457|530272862|FG001|Infant Series|Investigator request|3|||
147030091|NCT00444457|530272863|FG002|Infant Series|Investigator request|3|||
147030092|NCT00444457|530272864|FG003|Infant Series|Investigator request|2|||
147030093|NCT00444457|530272861|FG000|Infant Series|Other|0|||
147030094|NCT00444457|530272862|FG001|Infant Series|Other|2|||
147030095|NCT00444457|530272863|FG002|Infant Series|Other|4|||
147030096|NCT00444457|530272864|FG003|Infant Series|Other|0|||
147030097|NCT00444457|530272861|FG000|Infant Series|Adverse Event|1|||
147030098|NCT00444457|530272862|FG001|Infant Series|Adverse Event|2|||
147030099|NCT00444457|530272863|FG002|Infant Series|Adverse Event|2|||
147030100|NCT00444457|530272864|FG003|Infant Series|Adverse Event|0|||
147030101|NCT00444457|530272861|FG000|Infant Series|Death|0|||
147030102|NCT00444457|530272862|FG001|Infant Series|Death|1|||
147030103|NCT00444457|530272863|FG002|Infant Series|Death|1|||
147030104|NCT00444457|530272864|FG003|Infant Series|Death|1|||
147030105|NCT00444457|530272861|FG000|After Infant Series|Other|0|||
147030106|NCT00444457|530272862|FG001|After Infant Series|Other|1|||
147030107|NCT00444457|530272863|FG002|After Infant Series|Other|1|||
147030108|NCT00444457|530272864|FG003|After Infant Series|Other|1|||
146849611|NCT02663518|529618859|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146849612|NCT02663518|529618860|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146849613|NCT02663518|529618861|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
147030109|NCT00444457|530272861|FG000|After Infant Series|Parent or legal guardian request|4|||
147030110|NCT00444457|530272862|FG001|After Infant Series|Parent or legal guardian request|11|||
147030111|NCT00444457|530272863|FG002|After Infant Series|Parent or legal guardian request|6|||
147030112|NCT00444457|530272864|FG003|After Infant Series|Parent or legal guardian request|3|||
147030113|NCT00444457|530272861|FG000|After Infant Series|Failed to return|7|||
147030114|NCT00444457|530272862|FG001|After Infant Series|Failed to return|6|||
147030115|NCT00444457|530272863|FG002|After Infant Series|Failed to return|5|||
147030116|NCT00444457|530272864|FG003|After Infant Series|Failed to return|1|||
147030117|NCT00444457|530272861|FG000|After Infant Series|Lost to Follow-up|5|||
147030118|NCT00444457|530272862|FG001|After Infant Series|Lost to Follow-up|5|||
147030119|NCT00444457|530272863|FG002|After Infant Series|Lost to Follow-up|5|||
147030120|NCT00444457|530272864|FG003|After Infant Series|Lost to Follow-up|2|||
147030121|NCT00444457|530272861|FG000|After Infant Series|Protocol Violation|2|||
147030122|NCT00444457|530272862|FG001|After Infant Series|Protocol Violation|4|||
147030123|NCT00444457|530272863|FG002|After Infant Series|Protocol Violation|2|||
147030124|NCT00444457|530272864|FG003|After Infant Series|Protocol Violation|2|||
147030125|NCT00444457|530272861|FG000|After Infant Series|Adverse Event|2|||
147030126|NCT00444457|530272862|FG001|After Infant Series|Adverse Event|2|||
147030127|NCT00444457|530272863|FG002|After Infant Series|Adverse Event|0|||
147030128|NCT00444457|530272864|FG003|After Infant Series|Adverse Event|0|||
147030129|NCT00444457|530272861|FG000|After Infant Series|Investigator request|0|||
147030130|NCT00444457|530272862|FG001|After Infant Series|Investigator request|0|||
147030131|NCT00444457|530272863|FG002|After Infant Series|Investigator request|0|||
147030132|NCT00444457|530272864|FG003|After Infant Series|Investigator request|1|||
147030133|NCT00444457|530272861|FG000|After Infant Series|Other|0|||
147030134|NCT00444457|530272862|FG001|After Infant Series|Other|1|||
147030135|NCT00444457|530272863|FG002|After Infant Series|Other|0|||
147030136|NCT00444457|530272864|FG003|After Infant Series|Other|0|||
147030137|NCT00444457|530272861|FG000|Toddler Dose|Lost to Follow-up|4|||
147030138|NCT00444457|530272862|FG001|Toddler Dose|Lost to Follow-up|1|||
147030139|NCT00444457|530272863|FG002|Toddler Dose|Lost to Follow-up|1|||
147030140|NCT00444457|530272864|FG003|Toddler Dose|Lost to Follow-up|3|||
147030141|NCT00444457|530272861|FG000|Toddler Dose|Failed to return|2|||
147030142|NCT00444457|530272862|FG001|Toddler Dose|Failed to return|2|||
147030143|NCT00444457|530272863|FG002|Toddler Dose|Failed to return|1|||
147030144|NCT00444457|530272864|FG003|Toddler Dose|Failed to return|3|||
147030145|NCT00444457|530272861|FG000|Toddler Dose|Parent or legal guardian request|0|||
147030146|NCT00444457|530272862|FG001|Toddler Dose|Parent or legal guardian request|3|||
147030147|NCT00444457|530272863|FG002|Toddler Dose|Parent or legal guardian request|2|||
147030148|NCT00444457|530272864|FG003|Toddler Dose|Parent or legal guardian request|1|||
147030149|NCT00444457|530272861|FG000|Toddler Dose|Protocol Violation|1|||
147030150|NCT00444457|530272862|FG001|Toddler Dose|Protocol Violation|0|||
147030151|NCT00444457|530272863|FG002|Toddler Dose|Protocol Violation|0|||
147030152|NCT00444457|530272864|FG003|Toddler Dose|Protocol Violation|1|||
147030153|NCT00914459|530272867|FG000|Overall Study|Protocol Violation|0|||
147030154|NCT00914459|530272868|FG001|Overall Study|Protocol Violation|1|||
147030155|NCT00914459|530272867|FG000|Overall Study|Parent/Legal guardian request|1|||
147030156|NCT00914459|530272868|FG001|Overall Study|Parent/Legal guardian request|0|||
147030157|NCT01661179|530272869|FG000|Overall Study|Death|1|||
147030158|NCT01661179|530272869|FG000|Overall Study|Withdrawal by Subject|1|||
147030159|NCT01661179|530272869|FG000|Overall Study|Other Eligibility criteria|4|||
147030160|NCT01602965|530272870|FG000|Overall Study|Lost to Follow-up|4|||
147030161|NCT01602965|530272871|FG001|Overall Study|Lost to Follow-up|2|||
147030162|NCT03118570|530272872|FG000|Overall Study|Adverse Event|2|||
147030163|NCT03118570|530272873|FG001|Overall Study|Adverse Event|0|||
147030164|NCT03118570|530272874|FG002|Overall Study|Adverse Event|0|||
147030165|NCT03118570|530272875|FG003|Overall Study|Adverse Event|0|||
147030166|NCT03118570|530272876|FG004|Overall Study|Adverse Event|3|||
147030167|NCT03118570|530272872|FG000|Overall Study|Withdrawal by Subject|0|||
147030168|NCT03118570|530272873|FG001|Overall Study|Withdrawal by Subject|1|||
147030169|NCT03118570|530272874|FG002|Overall Study|Withdrawal by Subject|4|||
147030170|NCT03118570|530272875|FG003|Overall Study|Withdrawal by Subject|0|||
147030171|NCT03118570|530272876|FG004|Overall Study|Withdrawal by Subject|1|||
147030172|NCT03118570|530272872|FG000|Overall Study|Lost to Follow-up|2|||
147030173|NCT03118570|530272873|FG001|Overall Study|Lost to Follow-up|3|||
147030174|NCT03118570|530272874|FG002|Overall Study|Lost to Follow-up|1|||
147030175|NCT03118570|530272875|FG003|Overall Study|Lost to Follow-up|0|||
147030176|NCT03118570|530272876|FG004|Overall Study|Lost to Follow-up|1|||
147030177|NCT03118570|530272872|FG000|Overall Study|Other, Not Specified|1|||
147030178|NCT03118570|530272873|FG001|Overall Study|Other, Not Specified|3|||
147030179|NCT03118570|530272874|FG002|Overall Study|Other, Not Specified|0|||
147030180|NCT03118570|530272875|FG003|Overall Study|Other, Not Specified|0|||
147030181|NCT03118570|530272876|FG004|Overall Study|Other, Not Specified|0|||
147030182|NCT03071094|530272880|FG000|Overall Study|Death|1|||
147030183|NCT03071094|530272881|FG001|Overall Study|Death|1|||
147030184|NCT03071094|530272880|FG000|Overall Study|Adverse Event|1|||
147030185|NCT03071094|530272881|FG001|Overall Study|Adverse Event|0|||
147030186|NCT02312063|530272882|FG000|Overall Study|Withdrawal by Subject|0|||
147030187|NCT02312063|530272883|FG001|Overall Study|Withdrawal by Subject|1|||
147030188|NCT00321737|530272889|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
147030189|NCT00321737|530272890|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
147030190|NCT00321737|530272891|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
147030191|NCT00321737|530272889|FG000|Overall Study|Adverse Event|11|||
147030192|NCT00321737|530272890|FG001|Overall Study|Adverse Event|3|||
147030193|NCT00321737|530272891|FG002|Overall Study|Adverse Event|6|||
147030194|NCT00321737|530272889|FG000|Overall Study|Lost to Follow-up|5|||
147030195|NCT00321737|530272890|FG001|Overall Study|Lost to Follow-up|5|||
147030196|NCT00321737|530272891|FG002|Overall Study|Lost to Follow-up|6|||
147030197|NCT00321737|530272889|FG000|Overall Study|Withdrawal by Subject|19|||
147030198|NCT00321737|530272890|FG001|Overall Study|Withdrawal by Subject|12|||
147030199|NCT00321737|530272891|FG002|Overall Study|Withdrawal by Subject|17|||
147030200|NCT00321737|530272889|FG000|Overall Study|Protocol Violation|0|||
147030201|NCT00321737|530272890|FG001|Overall Study|Protocol Violation|0|||
147030202|NCT00321737|530272891|FG002|Overall Study|Protocol Violation|1|||
147030203|NCT00321737|530272889|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
147030204|NCT00321737|530272890|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
147030205|NCT00321737|530272891|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
147030206|NCT00321737|530272889|FG000|Overall Study|Possible Barrett's Esophagus|2|||
147030207|NCT00321737|530272890|FG001|Overall Study|Possible Barrett's Esophagus|1|||
147030208|NCT00321737|530272891|FG002|Overall Study|Possible Barrett's Esophagus|1|||
147030209|NCT00321737|530272889|FG000|Overall Study|Therapeutic Failure|6|||
147030210|NCT00321737|530272890|FG001|Overall Study|Therapeutic Failure|0|||
147030211|NCT00321737|530272891|FG002|Overall Study|Therapeutic Failure|2|||
147030212|NCT00321737|530272889|FG000|Overall Study|Pregnancy|0|||
147030213|NCT00321737|530272890|FG001|Overall Study|Pregnancy|2|||
147030214|NCT00321737|530272891|FG002|Overall Study|Pregnancy|0|||
147030215|NCT00321737|530272889|FG000|Overall Study|Noncompliance|2|||
147030216|NCT00321737|530272890|FG001|Overall Study|Noncompliance|0|||
147030217|NCT00321737|530272891|FG002|Overall Study|Noncompliance|0|||
147030218|NCT00321737|530272889|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
147030219|NCT00321737|530272890|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
147030220|NCT00321737|530272891|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
147030221|NCT01079832|530272892|FG000|Overall Study|Withdrawal by Subject|1|||
147030222|NCT02283294|530272893|FG000|Overall Study|Lost to Follow-up|1|||
147030223|NCT02283294|530272894|FG001|Overall Study|Lost to Follow-up|1|||
147030224|NCT02283294|530272893|FG000|Overall Study|Withdrawal by Subject|1|||
147030225|NCT02283294|530272894|FG001|Overall Study|Withdrawal by Subject|6|||
147030226|NCT02283294|530272893|FG000|Overall Study|Protocol Violation|1|||
147030227|NCT02283294|530272894|FG001|Overall Study|Protocol Violation|0|||
147030228|NCT02283294|530272893|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
147030229|NCT02283294|530272894|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
147030230|NCT00594646|530272895|FG000|Overall Study|Withdrawal by Subject|1|||
147030231|NCT00594646|530272895|FG000|Overall Study|Lost to Follow-up|15|||
147030232|NCT01769339|530272896|FG000|Overall Study|Lost to Follow-up|42|||
147030233|NCT01769339|530272896|FG000|Overall Study|Adverse Event|1|||
147030234|NCT01195272|530272897|FG000|Overall Study|Adverse Event|1|||
147030235|NCT01195272|530272897|FG000|Overall Study|Lack of Efficacy|3|||
147030236|NCT03548064|530275146|FG000|Overall Study|Withdrawal by Subject|0|||
147030237|NCT03548064|530275147|FG001|Overall Study|Withdrawal by Subject|0|||
147030238|NCT03548064|530275148|FG002|Overall Study|Withdrawal by Subject|0|||
147030239|NCT03548064|530275149|FG003|Overall Study|Withdrawal by Subject|1|||
147030240|NCT03548064|530275150|FG004|Overall Study|Withdrawal by Subject|0|||
147030241|NCT03548064|530275151|FG005|Overall Study|Withdrawal by Subject|0|||
147030242|NCT03548064|530275152|FG006|Overall Study|Withdrawal by Subject|0|||
147030243|NCT03548064|530275153|FG007|Overall Study|Withdrawal by Subject|0|||
147030244|NCT03548064|530275146|FG000|Overall Study|Lost to Follow-up|0|||
147030245|NCT03548064|530275147|FG001|Overall Study|Lost to Follow-up|0|||
147030246|NCT03548064|530275148|FG002|Overall Study|Lost to Follow-up|0|||
147030247|NCT03548064|530275149|FG003|Overall Study|Lost to Follow-up|0|||
147030248|NCT03548064|530275150|FG004|Overall Study|Lost to Follow-up|2|||
147030249|NCT03548064|530275151|FG005|Overall Study|Lost to Follow-up|0|||
147030250|NCT03548064|530275152|FG006|Overall Study|Lost to Follow-up|0|||
147030251|NCT03548064|530275153|FG007|Overall Study|Lost to Follow-up|0|||
147030252|NCT03548064|530275146|FG000|Overall Study|Covid-19 Pandemic|0|||
147030253|NCT03548064|530275147|FG001|Overall Study|Covid-19 Pandemic|0|||
147030254|NCT03548064|530275148|FG002|Overall Study|Covid-19 Pandemic|0|||
147030255|NCT03548064|530275149|FG003|Overall Study|Covid-19 Pandemic|0|||
147030256|NCT03548064|530275150|FG004|Overall Study|Covid-19 Pandemic|10|||
147030257|NCT03548064|530275151|FG005|Overall Study|Covid-19 Pandemic|3|||
147030258|NCT03548064|530275152|FG006|Overall Study|Covid-19 Pandemic|0|||
147030259|NCT03548064|530275153|FG007|Overall Study|Covid-19 Pandemic|0|||
147030260|NCT04941729|530275154|FG000|Overall Study|Death|0|||
147030261|NCT04941729|530275155|FG001|Overall Study|Death|1|||
147030262|NCT04941729|530275154|FG000|Overall Study|Study terminated by sponsor|11|||
147030263|NCT04941729|530275155|FG001|Overall Study|Study terminated by sponsor|10|||
147030264|NCT00006721|530275156|FG000|Overall Study|Adverse Event|0|||
147030265|NCT00006721|530275157|FG001|Overall Study|Adverse Event|4|||
147030266|NCT00006721|530275158|FG002|Overall Study|Adverse Event|4|||
147030267|NCT00006721|530275156|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
147030268|NCT00006721|530275157|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
147030269|NCT00006721|530275158|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
147030270|NCT00006721|530275156|FG000|Overall Study|Progression/Relapse|0|||
147030271|NCT00006721|530275157|FG001|Overall Study|Progression/Relapse|1|||
147030272|NCT00006721|530275158|FG002|Overall Study|Progression/Relapse|2|||
147030273|NCT00006721|530275156|FG000|Overall Study|Death|0|||
147030274|NCT00006721|530275157|FG001|Overall Study|Death|1|||
147030275|NCT00006721|530275158|FG002|Overall Study|Death|2|||
147030276|NCT00006721|530275156|FG000|Overall Study|Other - Not Protocol Specified|0|||
147030277|NCT00006721|530275157|FG001|Overall Study|Other - Not Protocol Specified|7|||
147030278|NCT00006721|530275158|FG002|Overall Study|Other - Not Protocol Specified|7|||
147030279|NCT00006721|530275156|FG000|Overall Study|Ineligible|2|||
147030280|NCT00006721|530275157|FG001|Overall Study|Ineligible|12|||
147030281|NCT00006721|530275158|FG002|Overall Study|Ineligible|10|||
147030282|NCT00006721|530275156|FG000|Overall Study|Eligible but no Treatment Received|1|||
147030283|NCT00006721|530275157|FG001|Overall Study|Eligible but no Treatment Received|0|||
147030284|NCT00006721|530275158|FG002|Overall Study|Eligible but no Treatment Received|0|||
147030285|NCT03653507|530275159|FG000|Overall Study|Miscellaneous|28|||
147030286|NCT03653507|530275160|FG001|Overall Study|Miscellaneous|19|||
147030287|NCT03653507|530275159|FG000|Overall Study|Withdrawal by Subject|37|||
147030288|NCT03653507|530275160|FG001|Overall Study|Withdrawal by Subject|22|||
147030289|NCT03653507|530275159|FG000|Overall Study|Protocol Deviation|2|||
147030290|NCT03653507|530275160|FG001|Overall Study|Protocol Deviation|1|||
147030291|NCT03653507|530275159|FG000|Overall Study|Progressive disease|117|||
147030292|NCT03653507|530275160|FG001|Overall Study|Progressive disease|168|||
147030293|NCT03653507|530275159|FG000|Overall Study|Lost to Follow-up|1|||
147030294|NCT03653507|530275160|FG001|Overall Study|Lost to Follow-up|1|||
147030295|NCT03653507|530275159|FG000|Overall Study|Death|25|||
147030296|NCT03653507|530275160|FG001|Overall Study|Death|22|||
147030297|NCT03653507|530275159|FG000|Overall Study|Adverse Event|35|||
147030298|NCT03653507|530275160|FG001|Overall Study|Adverse Event|14|||
147030299|NCT03986138|530275165|FG000|First MRI Examination|Physician Decision|0|||
147030300|NCT03986138|530275166|FG001|First MRI Examination|Physician Decision|1|||
147030301|NCT03986138|530275165|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
147030302|NCT03986138|530275166|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
147030303|NCT03986138|530275165|FG000|Washout|Withdrawal by Subject|4|||
147030304|NCT03986138|530275166|FG001|Washout|Withdrawal by Subject|5|||
147030305|NCT03986138|530275165|FG000|Washout|Lost to Follow-up|0|||
147030306|NCT03986138|530275166|FG001|Washout|Lost to Follow-up|2|||
147030307|NCT03986138|530275165|FG000|Washout|Adverse Event|1|||
147030308|NCT03986138|530275166|FG001|Washout|Adverse Event|1|||
147030309|NCT03986138|530275165|FG000|Washout|Other reason|5|||
147030310|NCT03986138|530275166|FG001|Washout|Other reason|5|||
147030311|NCT03986138|530275165|FG000|Second MRI Examination|Withdrawal by Subject|0|||
147030312|NCT03986138|530275166|FG001|Second MRI Examination|Withdrawal by Subject|2|||
147030313|NCT04305587|530275167|FG000|Overall Study|Withdrawal by Subject|0|||
147030314|NCT04305587|530275168|FG001|Overall Study|Withdrawal by Subject|0|||
147030315|NCT04305587|530275169|FG002|Overall Study|Withdrawal by Subject|0|||
147030316|NCT04305587|530275170|FG003|Overall Study|Withdrawal by Subject|1|||
147030317|NCT04305587|530275171|FG004|Overall Study|Withdrawal by Subject|0|||
147030318|NCT04305587|530275172|FG005|Overall Study|Withdrawal by Subject|0|||
147030319|NCT04305587|530275173|FG006|Overall Study|Withdrawal by Subject|0|||
147030320|NCT04305587|530275174|FG007|Overall Study|Withdrawal by Subject|0|||
147030321|NCT04305587|530275175|FG008|Overall Study|Withdrawal by Subject|0|||
147030322|NCT01523457|530275176|FG000|Overall Study|Withdrawal by Subject|7|||
147030323|NCT01523457|530275177|FG001|Overall Study|Withdrawal by Subject|2|||
147030324|NCT01367665|530275178|FG000|Overall Study|Death|102|||
147030325|NCT01367665|530275179|FG001|Overall Study|Death|19|||
147030326|NCT01367665|530275178|FG000|Overall Study|Lost to Follow-up|222|||
147030327|NCT01367665|530275179|FG001|Overall Study|Lost to Follow-up|22|||
147030328|NCT01367665|530275178|FG000|Overall Study|Not Done|118|||
147030329|NCT01367665|530275179|FG001|Overall Study|Not Done|14|||
147030330|NCT03182244|530275180|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
147030331|NCT03182244|530275181|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
147030332|NCT03182244|530275180|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
147030333|NCT03182244|530275181|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
147030334|NCT03182244|530275180|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
147030335|NCT03182244|530275181|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
147030336|NCT03182244|530275180|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
147030337|NCT03182244|530275181|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
147030338|NCT03182244|530275180|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
147030339|NCT03182244|530275181|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
147030340|NCT03182244|530275180|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
147030341|NCT03182244|530275181|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
147030342|NCT03182244|530275180|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
147030343|NCT03182244|530275181|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
147030344|NCT03182244|530275180|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
147030345|NCT03182244|530275181|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
147030346|NCT03182244|530275180|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
147030347|NCT03182244|530275181|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
147030348|NCT03182244|530275180|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
147030349|NCT03182244|530275181|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
147030350|NCT03182244|530275180|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
147030351|NCT03182244|530275181|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
147030352|NCT03182244|530275180|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
147030353|NCT03182244|530275181|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
147030354|NCT03182244|530275180|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
147030355|NCT03182244|530275181|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
147030356|NCT02752906|530275182|FG000|Overall Study|Protocol Violation|2|||
147030357|NCT02752906|530275183|FG001|Overall Study|Protocol Violation|1|||
147030358|NCT02752906|530275182|FG000|Overall Study|Withdrawal by Subject|2|||
147030359|NCT02752906|530275183|FG001|Overall Study|Withdrawal by Subject|2|||
147030360|NCT02752906|530275182|FG000|Overall Study|Lost to Follow-up|3|||
147030361|NCT02752906|530275183|FG001|Overall Study|Lost to Follow-up|2|||
147030362|NCT02492880|530275184|FG000|Overall Study|Lost to Follow-up|1|||
147030363|NCT02492880|530275184|FG000|Overall Study|Protocol Violation|1|||
147030364|NCT01200992|530275185|FG000|Overall Study|Study terminated early|35|||
147030365|NCT01200992|530275186|FG001|Overall Study|Study terminated early|41|||
147030366|NCT01200992|530275185|FG000|Overall Study|Randomized but not treated|2|||
147030367|NCT01200992|530275186|FG001|Overall Study|Randomized but not treated|0|||
147030368|NCT00792935|530275187|FG000|Overall Study|Adverse Event|2|||
147030369|NCT00792935|530275188|FG001|Overall Study|Adverse Event|1|||
147030370|NCT00792935|530275187|FG000|Overall Study|Lost to Follow-up|0|||
147030371|NCT00792935|530275188|FG001|Overall Study|Lost to Follow-up|1|||
147030372|NCT00792935|530275187|FG000|Overall Study|Protocol Violation|2|||
147030373|NCT00792935|530275188|FG001|Overall Study|Protocol Violation|0|||
147030374|NCT00792935|530275187|FG000|Overall Study|Withdrawal by Subject|0|||
147030375|NCT00792935|530275188|FG001|Overall Study|Withdrawal by Subject|1|||
147030376|NCT02622113|530275193|FG000|Overall Study|Adverse Event|4|||
147030377|NCT02622113|530275194|FG001|Overall Study|Adverse Event|4|||
147030378|NCT02622113|530275193|FG000|Overall Study|Physician Decision|0|||
147030379|NCT02622113|530275194|FG001|Overall Study|Physician Decision|1|||
147030380|NCT02622113|530275193|FG000|Overall Study|Withdrawal by Subject|0|||
147030381|NCT02622113|530275194|FG001|Overall Study|Withdrawal by Subject|2|||
147030382|NCT02622113|530275193|FG000|Overall Study|Stopping Criteria|1|||
147030383|NCT02622113|530275194|FG001|Overall Study|Stopping Criteria|3|||
147030384|NCT03514641|530275206|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
147030385|NCT03514641|530275207|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
147030386|NCT03514641|530275208|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
147030387|NCT03514641|530275209|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
147030388|NCT03514641|530275206|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
147030389|NCT03514641|530275207|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
147030390|NCT03514641|530275208|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
147030391|NCT03514641|530275209|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
147030392|NCT03514641|530275206|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
147030393|NCT03514641|530275207|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
147030394|NCT03514641|530275208|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
147030395|NCT03514641|530275209|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
147030396|NCT03514641|530275206|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
147030397|NCT03514641|530275207|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
147030398|NCT03514641|530275208|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
147030399|NCT03514641|530275209|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
147030400|NCT03514641|530275206|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
147030401|NCT03514641|530275207|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
147030402|NCT03514641|530275208|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
147030403|NCT03514641|530275209|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
147030404|NCT03514641|530275206|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
146849614|NCT02663518|529618862|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146849615|NCT02663518|529618863|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146849616|NCT02663518|529618864|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146849617|NCT02663518|529618851|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146849618|NCT02663518|529618852|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146849619|NCT02663518|529618853|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147030405|NCT03514641|530275207|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
147030406|NCT03514641|530275208|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
147030407|NCT03514641|530275209|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
147030408|NCT03514641|530275206|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
147030409|NCT03514641|530275207|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
147030410|NCT03514641|530275208|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
147030411|NCT03514641|530275209|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
147030412|NCT03514641|530275206|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
147030413|NCT03514641|530275207|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
147030414|NCT03514641|530275208|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
147030415|NCT03514641|530275209|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
147030416|NCT03514641|530275206|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
147030417|NCT03514641|530275207|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
147030418|NCT03514641|530275208|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
147030419|NCT03514641|530275209|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
147030420|NCT03514641|530275206|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
147030421|NCT03514641|530275207|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
147030422|NCT03514641|530275208|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
147030423|NCT03514641|530275209|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
147030424|NCT03514641|530275206|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
147030425|NCT03514641|530275207|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
147030426|NCT03514641|530275208|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
147030427|NCT03514641|530275209|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
147030428|NCT03514641|530275206|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
147030429|NCT03514641|530275207|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
147030430|NCT03514641|530275208|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
147030431|NCT03514641|530275209|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
147030432|NCT00505375|530275210|FG000|Overall Study|Death|1|||
147030433|NCT00505375|530275211|FG001|Overall Study|Death|0|||
147030434|NCT00505375|530275210|FG000|Overall Study|Withdrawal by Subject|2|||
147030435|NCT00505375|530275211|FG001|Overall Study|Withdrawal by Subject|2|||
147030436|NCT00505375|530275210|FG000|Overall Study|Lost to Follow-up|0|||
147030437|NCT00505375|530275211|FG001|Overall Study|Lost to Follow-up|2|||
147030438|NCT00505375|530275210|FG000|Overall Study|Pregnancy|1|||
147030439|NCT00505375|530275211|FG001|Overall Study|Pregnancy|0|||
147030440|NCT00505375|530275210|FG000|Overall Study|Travel issues|0|||
147030441|NCT00505375|530275211|FG001|Overall Study|Travel issues|1|||
147030442|NCT01345175|530275212|FG000|Overall Study|Physician Decision|0|||
147030443|NCT01345175|530275213|FG001|Overall Study|Physician Decision|1|||
147030444|NCT01345175|530275212|FG000|Overall Study|Withdrawal by Subject|1|||
147030445|NCT01345175|530275213|FG001|Overall Study|Withdrawal by Subject|1|||
147030446|NCT01345175|530275212|FG000|Overall Study|Failed to complete BFI|3|||
147030447|NCT01345175|530275213|FG001|Overall Study|Failed to complete BFI|2|||
147030448|NCT01345175|530275212|FG000|Overall Study|Stopped taking medication|2|||
147030449|NCT01345175|530275213|FG001|Overall Study|Stopped taking medication|2|||
147030450|NCT04112173|530275214|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
147030451|NCT02570113|530275215|FG000|Overall Study|Withdrawal by Subject|3|||
147030452|NCT02746471|530275216|FG000|Overall Study|Death|43|||
147030453|NCT02746471|530275216|FG000|Overall Study|Exited before 36 months|1119|||
147030454|NCT02564211|530275217|FG000|Overall Study|Adverse Event|4|||
147030455|NCT04492020|530275220|FG000|Overall Study|Adverse Event|1|||
147030456|NCT04492020|530275221|FG001|Overall Study|Adverse Event|3|||
147030457|NCT04492020|530275220|FG000|Overall Study|Withdrawal by Subject|4|||
147030458|NCT04492020|530275221|FG001|Overall Study|Withdrawal by Subject|3|||
147030459|NCT04492020|530275220|FG000|Overall Study|Lost to Follow-up|4|||
147030460|NCT04492020|530275221|FG001|Overall Study|Lost to Follow-up|3|||
147030461|NCT04492020|530275220|FG000|Overall Study|Protocol Violation|5|||
147030462|NCT04492020|530275221|FG001|Overall Study|Protocol Violation|2|||
147030463|NCT04492020|530275220|FG000|Overall Study|Lack of Qualifying Event|25|||
147030464|NCT04492020|530275221|FG001|Overall Study|Lack of Qualifying Event|27|||
147030465|NCT04492020|530275220|FG000|Overall Study|Non-compliance with Study Drug|2|||
147030466|NCT04492020|530275221|FG001|Overall Study|Non-compliance with Study Drug|1|||
147030467|NCT04594707|530275222|FG000|Overall Study|Adverse Event|0|||
147030468|NCT04594707|530275223|FG001|Overall Study|Adverse Event|0|||
147030469|NCT04594707|530275224|FG002|Overall Study|Adverse Event|1|||
147030470|NCT04594707|530275222|FG000|Overall Study|Death|0|||
147030471|NCT04594707|530275223|FG001|Overall Study|Death|2|||
147030472|NCT04594707|530275224|FG002|Overall Study|Death|2|||
147030473|NCT04594707|530275222|FG000|Overall Study|Lung Transplant|0|||
147030474|NCT04594707|530275223|FG001|Overall Study|Lung Transplant|0|||
147030475|NCT04594707|530275224|FG002|Overall Study|Lung Transplant|1|||
147030476|NCT04594707|530275222|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
147030477|NCT04594707|530275223|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
147030478|NCT04594707|530275224|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
147030479|NCT04594707|530275222|FG000|Overall Study|Study Terminated By Sponsor|19|||
147030480|NCT04594707|530275223|FG001|Overall Study|Study Terminated By Sponsor|47|||
147030481|NCT04594707|530275224|FG002|Overall Study|Study Terminated By Sponsor|41|||
147030482|NCT04594707|530275222|FG000|Overall Study|Withdrawal by Subject|1|||
147030483|NCT04594707|530275223|FG001|Overall Study|Withdrawal by Subject|0|||
147030484|NCT04594707|530275224|FG002|Overall Study|Withdrawal by Subject|2|||
147030485|NCT00969540|530275225|FG000|Overall Study|Lost to Follow-up|1|||
147030486|NCT00969540|530275226|FG001|Overall Study|Lost to Follow-up|1|||
147030487|NCT02266134|530275227|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
147030488|NCT02266134|530275228|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
147030489|NCT02266134|530275229|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
147030490|NCT02266134|530275230|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
147030491|NCT02266134|530275227|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
147030492|NCT02266134|530275228|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
147030493|NCT02266134|530275229|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
147030494|NCT02266134|530275230|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
147030495|NCT02266134|530275227|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
147030496|NCT02266134|530275228|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
147030497|NCT02266134|530275229|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
147030498|NCT02266134|530275230|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
147030499|NCT02266134|530275227|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
147030500|NCT02266134|530275228|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
147030501|NCT02266134|530275229|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
147030502|NCT02266134|530275230|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
147030503|NCT02266134|530275227|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
147030504|NCT02266134|530275228|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
147030505|NCT02266134|530275229|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
147030506|NCT02266134|530275230|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
147030507|NCT02266134|530275227|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
147030508|NCT02266134|530275228|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
147030509|NCT02266134|530275229|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
147030510|NCT02266134|530275230|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
147030511|NCT02731326|530275233|FG000|Overall Study|Withdrawal by Subject|4|||
147030512|NCT02731326|530275234|FG001|Overall Study|Withdrawal by Subject|1|||
147030513|NCT02731326|530275233|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
147030514|NCT02731326|530275234|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
147030515|NCT02731326|530275233|FG000|Overall Study|Discharged without AliveCor|10|||
147030516|NCT02731326|530275234|FG001|Overall Study|Discharged without AliveCor|0|||
147030517|NCT02731326|530275233|FG000|Overall Study|Duplicate Participant|1|||
147030518|NCT02731326|530275234|FG001|Overall Study|Duplicate Participant|1|||
147030519|NCT03569228|530275236|FG000|Overall Study|Withdrawal by PI|0|||
147030520|NCT03569228|530275237|FG001|Overall Study|Withdrawal by PI|0|||
147030521|NCT03569228|530275238|FG002|Overall Study|Withdrawal by PI|2|||
147030522|NCT03569228|530275239|FG003|Overall Study|Withdrawal by PI|2|||
147030523|NCT03569228|530275240|FG004|Overall Study|Withdrawal by PI|1|||
147030524|NCT03569228|530275241|FG005|Overall Study|Withdrawal by PI|0|||
147030525|NCT03569228|530275242|FG006|Overall Study|Withdrawal by PI|0|||
147030526|NCT03569228|530275243|FG007|Overall Study|Withdrawal by PI|0|||
147030527|NCT03569228|530275244|FG008|Overall Study|Withdrawal by PI|0|||
147030528|NCT03569228|530275236|FG000|Overall Study|Lost to Follow-up|0|||
147030529|NCT03569228|530275237|FG001|Overall Study|Lost to Follow-up|0|||
147030530|NCT03569228|530275238|FG002|Overall Study|Lost to Follow-up|0|||
147030531|NCT03569228|530275239|FG003|Overall Study|Lost to Follow-up|0|||
147030532|NCT03569228|530275240|FG004|Overall Study|Lost to Follow-up|0|||
147030533|NCT03569228|530275241|FG005|Overall Study|Lost to Follow-up|0|||
147030534|NCT03569228|530275242|FG006|Overall Study|Lost to Follow-up|0|||
147030535|NCT03569228|530275243|FG007|Overall Study|Lost to Follow-up|0|||
147030536|NCT03569228|530275244|FG008|Overall Study|Lost to Follow-up|1|||
147030537|NCT03569228|530275236|FG000|Overall Study|Screen Fail|2|||
147030538|NCT03569228|530275237|FG001|Overall Study|Screen Fail|2|||
147030539|NCT03569228|530275238|FG002|Overall Study|Screen Fail|1|||
147030540|NCT03569228|530275239|FG003|Overall Study|Screen Fail|1|||
147030541|NCT03569228|530275240|FG004|Overall Study|Screen Fail|1|||
147030542|NCT03569228|530275241|FG005|Overall Study|Screen Fail|3|||
147030543|NCT03569228|530275242|FG006|Overall Study|Screen Fail|1|||
147030544|NCT03569228|530275243|FG007|Overall Study|Screen Fail|5|||
147030545|NCT03569228|530275244|FG008|Overall Study|Screen Fail|2|||
147030546|NCT03819049|530275245|FG000|Overall Study|Lost to Follow-up|1|||
147030547|NCT03819049|530275246|FG001|Overall Study|Lost to Follow-up|2|||
147030548|NCT03819049|530275247|FG002|Overall Study|Lost to Follow-up|9|||
147030549|NCT03819049|530275248|FG003|Overall Study|Lost to Follow-up|0|||
147030550|NCT03819049|530275249|FG004|Overall Study|Lost to Follow-up|3|||
147030551|NCT03819049|530275250|FG005|Overall Study|Lost to Follow-up|1|||
147030552|NCT03819049|530275251|FG006|Overall Study|Lost to Follow-up|0|||
147030553|NCT03819049|530275245|FG000|Overall Study|Withdrawal by Subject|0|||
147030554|NCT03819049|530275246|FG001|Overall Study|Withdrawal by Subject|0|||
147030555|NCT03819049|530275247|FG002|Overall Study|Withdrawal by Subject|18|||
147030556|NCT03819049|530275248|FG003|Overall Study|Withdrawal by Subject|0|||
147030557|NCT03819049|530275249|FG004|Overall Study|Withdrawal by Subject|10|||
147030558|NCT03819049|530275250|FG005|Overall Study|Withdrawal by Subject|9|||
147030559|NCT03819049|530275251|FG006|Overall Study|Withdrawal by Subject|1|||
147030560|NCT03819049|530275245|FG000|Overall Study|Ongoing|0|||
147030561|NCT03819049|530275246|FG001|Overall Study|Ongoing|0|||
147030562|NCT03819049|530275247|FG002|Overall Study|Ongoing|75|||
147030563|NCT03819049|530275248|FG003|Overall Study|Ongoing|0|||
147030564|NCT03819049|530275249|FG004|Overall Study|Ongoing|41|||
147030565|NCT03819049|530275250|FG005|Overall Study|Ongoing|0|||
147030566|NCT03819049|530275251|FG006|Overall Study|Ongoing|0|||
147030567|NCT03819049|530275245|FG000|Overall Study|Other|0|||
147030568|NCT03819049|530275246|FG001|Overall Study|Other|0|||
147030569|NCT03819049|530275247|FG002|Overall Study|Other|2|||
147030570|NCT03819049|530275248|FG003|Overall Study|Other|0|||
147030571|NCT03819049|530275249|FG004|Overall Study|Other|0|||
147030572|NCT03819049|530275250|FG005|Overall Study|Other|0|||
147030573|NCT03819049|530275251|FG006|Overall Study|Other|0|||
147030574|NCT03819049|530275245|FG000|Overall Study|Randomized but not vaccinated|0|||
147030575|NCT03819049|530275246|FG001|Overall Study|Randomized but not vaccinated|0|||
147030576|NCT03819049|530275247|FG002|Overall Study|Randomized but not vaccinated|0|||
147030577|NCT03819049|530275248|FG003|Overall Study|Randomized but not vaccinated|1|||
147030578|NCT03819049|530275249|FG004|Overall Study|Randomized but not vaccinated|0|||
147030579|NCT03819049|530275250|FG005|Overall Study|Randomized but not vaccinated|2|||
147030580|NCT03819049|530275251|FG006|Overall Study|Randomized but not vaccinated|1|||
147030581|NCT03819049|530275245|FG000|Overall Study|Physician Decision|0|||
147030582|NCT03819049|530275246|FG001|Overall Study|Physician Decision|0|||
147030583|NCT03819049|530275247|FG002|Overall Study|Physician Decision|0|||
147030584|NCT03819049|530275248|FG003|Overall Study|Physician Decision|0|||
147030585|NCT03819049|530275249|FG004|Overall Study|Physician Decision|0|||
147030586|NCT03819049|530275250|FG005|Overall Study|Physician Decision|0|||
147030587|NCT03819049|530275251|FG006|Overall Study|Physician Decision|1|||
147030588|NCT01616953|530275252|FG000|Overall Study|Lost to Follow-up|1|||
147030589|NCT01616953|530275253|FG001|Overall Study|Lost to Follow-up|0|||
147030590|NCT01616953|530275252|FG000|Overall Study|lack of bone and soft tissue|1|||
147030591|NCT01616953|530275253|FG001|Overall Study|lack of bone and soft tissue|0|||
147030592|NCT01568320|530275254|FG000|Overall Study|Death|20|||
147030593|NCT01568320|530275254|FG000|Overall Study|Lost to Follow-up|9|||
147030594|NCT01568320|530275254|FG000|Overall Study|Withdrawal by Subject|10|||
147030595|NCT01568320|530275254|FG000|Overall Study|Conversion to open repair|1|||
147030596|NCT01568320|530275254|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
147030597|NCT00816361|530275256|FG000|Overall Study|Withdrawal by Subject|0|||
147030598|NCT00816361|530275257|FG001|Overall Study|Withdrawal by Subject|0|||
147030599|NCT00816361|530275258|FG002|Overall Study|Withdrawal by Subject|0|||
147030600|NCT00816361|530275259|FG003|Overall Study|Withdrawal by Subject|0|||
147030601|NCT00816361|530275260|FG004|Overall Study|Withdrawal by Subject|1|||
147030602|NCT00816361|530275261|FG005|Overall Study|Withdrawal by Subject|2|||
147030603|NCT00816361|530275262|FG006|Overall Study|Withdrawal by Subject|0|||
147030604|NCT00816361|530275263|FG007|Overall Study|Withdrawal by Subject|2|||
147030605|NCT00816361|530275264|FG008|Overall Study|Withdrawal by Subject|1|||
147030606|NCT00816361|530275256|FG000|Overall Study|Death|4|||
147030607|NCT00816361|530275257|FG001|Overall Study|Death|3|||
147030608|NCT00816361|530275258|FG002|Overall Study|Death|3|||
147030609|NCT00816361|530275259|FG003|Overall Study|Death|3|||
147030610|NCT00816361|530275260|FG004|Overall Study|Death|1|||
147030611|NCT00816361|530275261|FG005|Overall Study|Death|1|||
147030612|NCT00816361|530275262|FG006|Overall Study|Death|3|||
147030613|NCT00816361|530275263|FG007|Overall Study|Death|7|||
147030614|NCT00816361|530275264|FG008|Overall Study|Death|8|||
147030615|NCT00816361|530275256|FG000|Overall Study|Other|0|||
147030616|NCT00816361|530275257|FG001|Overall Study|Other|0|||
147030617|NCT00816361|530275258|FG002|Overall Study|Other|0|||
147030618|NCT00816361|530275259|FG003|Overall Study|Other|0|||
147030619|NCT00816361|530275260|FG004|Overall Study|Other|0|||
147030620|NCT00816361|530275261|FG005|Overall Study|Other|0|||
147030621|NCT00816361|530275262|FG006|Overall Study|Other|0|||
147030622|NCT00816361|530275263|FG007|Overall Study|Other|0|||
147030623|NCT00816361|530275264|FG008|Overall Study|Other|1|||
147030624|NCT01394952|530275265|FG000|Overall Study|Lost to Follow-up|0|||
147030625|NCT01394952|530275266|FG001|Overall Study|Lost to Follow-up|5|||
147030626|NCT01394952|530275265|FG000|Overall Study|Withdrawal by Subject|10|||
147030627|NCT01394952|530275266|FG001|Overall Study|Withdrawal by Subject|5|||
147030628|NCT01394952|530275265|FG000|Overall Study|Physician Decision|2|||
147030629|NCT01394952|530275266|FG001|Overall Study|Physician Decision|0|||
147030630|NCT01394952|530275265|FG000|Overall Study|Sponsor Decision|5|||
147030631|NCT01394952|530275266|FG001|Overall Study|Sponsor Decision|7|||
147030632|NCT02440568|530275267|FG000|Overall Study|Death|1|||
147030633|NCT02440568|530275268|FG001|Overall Study|Death|3|||
147030634|NCT02440568|530275269|FG002|Overall Study|Death|4|||
147030635|NCT02440568|530275270|FG003|Overall Study|Death|2|||
147030636|NCT02440568|530275267|FG000|Overall Study|Lack of Efficacy|2|||
147030637|NCT02440568|530275268|FG001|Overall Study|Lack of Efficacy|0|||
147030638|NCT02440568|530275269|FG002|Overall Study|Lack of Efficacy|1|||
147030639|NCT02440568|530275270|FG003|Overall Study|Lack of Efficacy|0|||
147030640|NCT02440568|530275267|FG000|Overall Study|Lost to Follow-up|1|||
147030641|NCT02440568|530275268|FG001|Overall Study|Lost to Follow-up|0|||
147030642|NCT02440568|530275269|FG002|Overall Study|Lost to Follow-up|0|||
147030643|NCT02440568|530275270|FG003|Overall Study|Lost to Follow-up|0|||
147030644|NCT00536263|530275271|FG000|Overall Study|Adverse Event|5|||
147030645|NCT00536263|530275272|FG001|Overall Study|Adverse Event|5|||
147030646|NCT00536263|530275273|FG002|Overall Study|Adverse Event|7|||
147030647|NCT00536263|530275271|FG000|Overall Study|Lost to Follow-up|3|||
147030648|NCT00536263|530275272|FG001|Overall Study|Lost to Follow-up|4|||
147030649|NCT00536263|530275273|FG002|Overall Study|Lost to Follow-up|4|||
147030650|NCT00536263|530275271|FG000|Overall Study|Subject withdrew - not treatment related|2|||
147030651|NCT00536263|530275272|FG001|Overall Study|Subject withdrew - not treatment related|0|||
147030652|NCT00536263|530275273|FG002|Overall Study|Subject withdrew - not treatment related|5|||
147030653|NCT00536263|530275271|FG000|Overall Study|Subject withdrew - treatment related|0|||
147030654|NCT00536263|530275272|FG001|Overall Study|Subject withdrew - treatment related|3|||
147030655|NCT00536263|530275273|FG002|Overall Study|Subject withdrew - treatment related|2|||
147030656|NCT00536263|530275271|FG000|Overall Study|Noncompliance with protocol|0|||
147030657|NCT00536263|530275272|FG001|Overall Study|Noncompliance with protocol|0|||
147030658|NCT00536263|530275273|FG002|Overall Study|Noncompliance with protocol|1|||
147030659|NCT00536263|530275271|FG000|Overall Study|Did not meet protocol eligibility|1|||
147030660|NCT00536263|530275272|FG001|Overall Study|Did not meet protocol eligibility|2|||
147030661|NCT00536263|530275273|FG002|Overall Study|Did not meet protocol eligibility|2|||
147030662|NCT00826449|530275274|FG000|Overall Study|Disease Progression|4|||
147030663|NCT00826449|530275274|FG000|Overall Study|Withdrawal by Subject|1|||
147030664|NCT02994940|530275275|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
147030665|NCT02994940|530275276|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
147030666|NCT02994940|530275275|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
147030667|NCT02994940|530275276|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
147030668|NCT02994940|530275275|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
147030669|NCT02994940|530275276|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
147030670|NCT01103466|530275279|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
147030671|NCT01103466|530275280|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
147030672|NCT01103466|530275281|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
147030673|NCT01103466|530275279|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
147030674|NCT01103466|530275280|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
147030675|NCT01103466|530275281|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
147030676|NCT01103466|530275279|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
147030677|NCT01103466|530275280|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
147030678|NCT01103466|530275281|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
147030679|NCT01103466|530275279|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
147030680|NCT01103466|530275280|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
147030681|NCT01103466|530275281|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
147030682|NCT01103466|530275279|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
147030683|NCT01103466|530275280|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
147030684|NCT01103466|530275281|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
147030685|NCT01103466|530275279|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
147030686|NCT01103466|530275280|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
147030687|NCT01103466|530275281|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
147030688|NCT02331368|530275286|FG000|Overall Study|Withdrawal by Subject|3|||
147030689|NCT02302859|530275287|FG000|Overall Study|Lost Phone|1|||
147030690|NCT02302859|530275288|FG001|Overall Study|Lost Phone|1|||
147030691|NCT02302859|530275287|FG000|Overall Study|Withdrawal by Subject|0|||
147030692|NCT02302859|530275288|FG001|Overall Study|Withdrawal by Subject|1|||
147030693|NCT02562482|530275289|FG000|Overall Study|Enrolled, but did not receive product|4|||
147030694|NCT02562482|530275290|FG001|Overall Study|Enrolled, but did not receive product|0|||
147030695|NCT02562482|530275289|FG000|Overall Study|Lost to Follow-up|9|||
147030696|NCT02562482|530275290|FG001|Overall Study|Lost to Follow-up|6|||
147030697|NCT02562482|530275289|FG000|Overall Study|Moved from area|2|||
147030698|NCT02562482|530275290|FG001|Overall Study|Moved from area|3|||
147030699|NCT02562482|530275289|FG000|Overall Study|Withdrawal by Subject|5|||
147030700|NCT02562482|530275290|FG001|Overall Study|Withdrawal by Subject|3|||
147030701|NCT02562482|530275289|FG000|Overall Study|Physician Decision|1|||
147030702|NCT02562482|530275290|FG001|Overall Study|Physician Decision|3|||
147030703|NCT02562482|530275289|FG000|Overall Study|Illness/Injury unrelated to product|0|||
147030704|NCT02562482|530275290|FG001|Overall Study|Illness/Injury unrelated to product|1|||
147030705|NCT00975286|530275294|FG000|Overall Study|Adverse Event|9|||
147030706|NCT00975286|530275295|FG001|Overall Study|Adverse Event|19|||
147030707|NCT00975286|530275294|FG000|Overall Study|Protocol Violation|1|||
147030708|NCT00975286|530275295|FG001|Overall Study|Protocol Violation|2|||
147030709|NCT00975286|530275294|FG000|Overall Study|Withdrawal by Subject|0|||
147030710|NCT00975286|530275295|FG001|Overall Study|Withdrawal by Subject|2|||
147030711|NCT00975286|530275294|FG000|Overall Study|Familial and Personal Reasons|2|||
147030712|NCT00975286|530275295|FG001|Overall Study|Familial and Personal Reasons|2|||
147030713|NCT00975286|530275294|FG000|Overall Study|Poor Compliance to Protocol|0|||
147030714|NCT00975286|530275295|FG001|Overall Study|Poor Compliance to Protocol|2|||
147030715|NCT00975286|530275294|FG000|Overall Study|Sponsor Decision|0|||
147030716|NCT00975286|530275295|FG001|Overall Study|Sponsor Decision|2|||
147030717|NCT02357342|530275296|FG000|First 6 Months|Death|2|||
147030718|NCT02357342|530275297|FG001|First 6 Months|Death|0|||
147030719|NCT01674647|530275298|FG000|Treatment Period|Death|4|||
147030720|NCT01674647|530275299|FG001|Treatment Period|Death|1|||
147030721|NCT01674647|530275298|FG000|Treatment Period|Efficacy outcome reached|0|||
147030722|NCT01674647|530275299|FG001|Treatment Period|Efficacy outcome reached|1|||
147030723|NCT01674647|530275298|FG000|Treatment Period|Physician Decision|3|||
147030724|NCT01674647|530275299|FG001|Treatment Period|Physician Decision|1|||
147030725|NCT01674647|530275298|FG000|Treatment Period|Adverse Event|60|||
147030726|NCT01674647|530275299|FG001|Treatment Period|Adverse Event|22|||
147030727|NCT01674647|530275298|FG000|Treatment Period|Non-compliance with study drug|3|||
147030728|NCT01674647|530275299|FG001|Treatment Period|Non-compliance with study drug|0|||
147030729|NCT01674647|530275298|FG000|Treatment Period|Lost to Follow-up|1|||
147030730|NCT01674647|530275299|FG001|Treatment Period|Lost to Follow-up|1|||
147030731|NCT01674647|530275298|FG000|Treatment Period|Withdrawal by Subject|19|||
147030732|NCT01674647|530275299|FG001|Treatment Period|Withdrawal by Subject|16|||
147030733|NCT01674647|530275298|FG000|Treatment Period|Switching to other therapy|5|||
147030734|NCT01674647|530275299|FG001|Treatment Period|Switching to other therapy|2|||
147030735|NCT01674647|530275298|FG000|Treatment Period|Logistical difficulties|5|||
147030736|NCT01674647|530275299|FG001|Treatment Period|Logistical difficulties|8|||
147030737|NCT01674647|530275298|FG000|Treatment Period|Treatment failure|0|||
147030738|NCT01674647|530275299|FG001|Treatment Period|Treatment failure|14|||
147030739|NCT01674647|530275298|FG000|Treatment Period|Protocol Violation|56|||
147030740|NCT01674647|530275299|FG001|Treatment Period|Protocol Violation|36|||
147030741|NCT01674647|530275298|FG000|30-day Safety Follow-up Period|Death|3|||
147030742|NCT01674647|530275299|FG001|30-day Safety Follow-up Period|Death|2|||
147030743|NCT01674647|530275298|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
147030744|NCT01674647|530275299|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
147030745|NCT01674647|530275298|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
147030746|NCT01674647|530275299|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
147030747|NCT01674647|530275298|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
147030748|NCT01674647|530275299|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
147030749|NCT01674647|530275298|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
147030750|NCT01674647|530275299|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
147030751|NCT01674647|530275298|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
147030752|NCT01674647|530275299|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
147030753|NCT01490866|530275301|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
147030754|NCT01490866|530275301|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
147030755|NCT01490866|530275301|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
147030756|NCT01490866|530275301|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
147030757|NCT01490866|530275301|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
147030758|NCT01490866|530275301|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
147030759|NCT01490866|530275301|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
147030760|NCT01490866|530275301|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
147030761|NCT01490866|530275301|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
147030762|NCT01490866|530275301|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
147030763|NCT01490866|530275301|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
147030764|NCT04135196|530275302|FG000|Overall Study|Lost to Follow-up|8|||
147030765|NCT04135196|530275303|FG001|Overall Study|Lost to Follow-up|7|||
147030766|NCT04135196|530275304|FG002|Overall Study|Lost to Follow-up|8|||
147030767|NCT04135196|530275305|FG003|Overall Study|Lost to Follow-up|9|||
147030768|NCT04135196|530275306|FG004|Overall Study|Lost to Follow-up|1|||
147030769|NCT04135196|530275302|FG000|Overall Study|Pregnancy|0|||
147030770|NCT04135196|530275303|FG001|Overall Study|Pregnancy|0|||
147030771|NCT04135196|530275304|FG002|Overall Study|Pregnancy|1|||
147030772|NCT04135196|530275305|FG003|Overall Study|Pregnancy|0|||
147030773|NCT04135196|530275306|FG004|Overall Study|Pregnancy|0|||
147030774|NCT04135196|530275302|FG000|Overall Study|Withdrawal by Subject|0|||
147030775|NCT04135196|530275303|FG001|Overall Study|Withdrawal by Subject|0|||
147030776|NCT04135196|530275304|FG002|Overall Study|Withdrawal by Subject|0|||
147030777|NCT04135196|530275305|FG003|Overall Study|Withdrawal by Subject|0|||
147030778|NCT04135196|530275306|FG004|Overall Study|Withdrawal by Subject|1|||
147030779|NCT03201211|530275307|FG000|Overall Study|Adverse Event|1|||
147030780|NCT03201211|530275308|FG001|Overall Study|Adverse Event|0|||
147030781|NCT03201211|530275309|FG002|Overall Study|Adverse Event|0|||
147030782|NCT03201211|530275307|FG000|Overall Study|Protocol Violation|1|||
147030783|NCT03201211|530275308|FG001|Overall Study|Protocol Violation|0|||
147030784|NCT03201211|530275309|FG002|Overall Study|Protocol Violation|0|||
147030785|NCT03201211|530275307|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
147030786|NCT03201211|530275308|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
147030787|NCT03201211|530275309|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
147030788|NCT03201211|530275307|FG000|Overall Study|OTHER unknown reasons|0|||
147030789|NCT03201211|530275308|FG001|Overall Study|OTHER unknown reasons|1|||
147030790|NCT03201211|530275309|FG002|Overall Study|OTHER unknown reasons|0|||
147030791|NCT01970865|530275310|FG000|Overall Study|Death|3|||
147030792|NCT01970865|530275311|FG001|Overall Study|Death|2|||
147030793|NCT01970865|530275312|FG002|Overall Study|Death|3|||
147030794|NCT01970865|530275313|FG003|Overall Study|Death|6|||
147030795|NCT01970865|530275314|FG004|Overall Study|Death|9|||
147030796|NCT01970865|530275315|FG005|Overall Study|Death|3|||
147030797|NCT01970865|530275316|FG006|Overall Study|Death|2|||
147030798|NCT01970865|530275317|FG007|Overall Study|Death|3|||
147030799|NCT01970865|530275318|FG008|Overall Study|Death|2|||
147030800|NCT01970865|530275319|FG009|Overall Study|Death|2|||
147030801|NCT01970865|530275320|FG010|Overall Study|Death|8|||
147030802|NCT01970865|530275321|FG011|Overall Study|Death|13|||
147030803|NCT01970865|530275322|FG012|Overall Study|Death|25|||
147030804|NCT01970865|530275323|FG013|Overall Study|Death|46|||
147030805|NCT01970865|530275324|FG014|Overall Study|Death|37|||
147030806|NCT01970865|530275325|FG015|Overall Study|Death|22|||
147030807|NCT01970865|530275326|FG016|Overall Study|Death|1|||
147030808|NCT01970865|530275327|FG017|Overall Study|Death|17|||
147030809|NCT01970865|530275310|FG000|Overall Study|Lost to Follow-up|0|||
147030810|NCT01970865|530275311|FG001|Overall Study|Lost to Follow-up|0|||
147030811|NCT01970865|530275312|FG002|Overall Study|Lost to Follow-up|0|||
147030812|NCT01970865|530275313|FG003|Overall Study|Lost to Follow-up|1|||
147030813|NCT01970865|530275314|FG004|Overall Study|Lost to Follow-up|1|||
147030814|NCT01970865|530275315|FG005|Overall Study|Lost to Follow-up|0|||
147030815|NCT01970865|530275316|FG006|Overall Study|Lost to Follow-up|0|||
147030816|NCT01970865|530275317|FG007|Overall Study|Lost to Follow-up|0|||
147030817|NCT01970865|530275318|FG008|Overall Study|Lost to Follow-up|0|||
147030818|NCT01970865|530275319|FG009|Overall Study|Lost to Follow-up|0|||
147030819|NCT01970865|530275320|FG010|Overall Study|Lost to Follow-up|1|||
147030820|NCT01970865|530275321|FG011|Overall Study|Lost to Follow-up|0|||
147030821|NCT01970865|530275322|FG012|Overall Study|Lost to Follow-up|2|||
147030822|NCT01970865|530275323|FG013|Overall Study|Lost to Follow-up|0|||
147030823|NCT01970865|530275324|FG014|Overall Study|Lost to Follow-up|1|||
147030824|NCT01970865|530275325|FG015|Overall Study|Lost to Follow-up|4|||
147030825|NCT01970865|530275326|FG016|Overall Study|Lost to Follow-up|0|||
147030826|NCT01970865|530275327|FG017|Overall Study|Lost to Follow-up|1|||
147030827|NCT01970865|530275310|FG000|Overall Study|Other|0|||
147030828|NCT01970865|530275311|FG001|Overall Study|Other|1|||
147030829|NCT01970865|530275312|FG002|Overall Study|Other|0|||
147030830|NCT01970865|530275313|FG003|Overall Study|Other|1|||
147030831|NCT01970865|530275314|FG004|Overall Study|Other|1|||
147030832|NCT01970865|530275315|FG005|Overall Study|Other|0|||
147030833|NCT01970865|530275316|FG006|Overall Study|Other|1|||
147030834|NCT01970865|530275317|FG007|Overall Study|Other|0|||
147030835|NCT01970865|530275318|FG008|Overall Study|Other|0|||
147030836|NCT01970865|530275319|FG009|Overall Study|Other|0|||
147030837|NCT01970865|530275320|FG010|Overall Study|Other|2|||
147030838|NCT01970865|530275321|FG011|Overall Study|Other|3|||
147030839|NCT01970865|530275322|FG012|Overall Study|Other|8|||
147030840|NCT01970865|530275323|FG013|Overall Study|Other|3|||
147030841|NCT01970865|530275324|FG014|Overall Study|Other|2|||
147030842|NCT01970865|530275325|FG015|Overall Study|Other|3|||
147030843|NCT01970865|530275326|FG016|Overall Study|Other|0|||
147030844|NCT01970865|530275327|FG017|Overall Study|Other|2|||
147030845|NCT01970865|530275310|FG000|Overall Study|Participant refused further follow-up|0|||
147030846|NCT01970865|530275311|FG001|Overall Study|Participant refused further follow-up|0|||
147030847|NCT01970865|530275312|FG002|Overall Study|Participant refused further follow-up|0|||
147030848|NCT01970865|530275313|FG003|Overall Study|Participant refused further follow-up|2|||
147030849|NCT01970865|530275314|FG004|Overall Study|Participant refused further follow-up|3|||
147030850|NCT01970865|530275315|FG005|Overall Study|Participant refused further follow-up|0|||
147030851|NCT01970865|530275316|FG006|Overall Study|Participant refused further follow-up|0|||
147030852|NCT01970865|530275317|FG007|Overall Study|Participant refused further follow-up|0|||
147030853|NCT01970865|530275318|FG008|Overall Study|Participant refused further follow-up|0|||
147030854|NCT01970865|530275319|FG009|Overall Study|Participant refused further follow-up|0|||
147030855|NCT01970865|530275320|FG010|Overall Study|Participant refused further follow-up|1|||
147030856|NCT01970865|530275321|FG011|Overall Study|Participant refused further follow-up|4|||
147030857|NCT01970865|530275322|FG012|Overall Study|Participant refused further follow-up|7|||
147030858|NCT01970865|530275323|FG013|Overall Study|Participant refused further follow-up|8|||
147030859|NCT01970865|530275324|FG014|Overall Study|Participant refused further follow-up|3|||
147030860|NCT01970865|530275325|FG015|Overall Study|Participant refused further follow-up|11|||
147030861|NCT01970865|530275326|FG016|Overall Study|Participant refused further follow-up|0|||
147030862|NCT01970865|530275327|FG017|Overall Study|Participant refused further follow-up|6|||
147030863|NCT01946191|530275328|FG000|Allocation|Did not complete orientation|1|||
147030864|NCT01946191|530275329|FG001|Allocation|Did not complete orientation|1|||
147030865|NCT01946191|530275328|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
147030866|NCT01946191|530275329|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
147030867|NCT01946191|530275328|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
147030868|NCT01946191|530275329|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
147030869|NCT01946191|530275328|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
146849620|NCT02663518|529618854|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147030870|NCT01946191|530275329|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
147030871|NCT01083810|530275330|FG000|Overall Study|Lost to Follow-up|23|||
147030872|NCT01083810|530275331|FG001|Overall Study|Lost to Follow-up|11|||
147030873|NCT01083810|530275332|FG002|Overall Study|Lost to Follow-up|4|||
147030874|NCT01083810|530275330|FG000|Overall Study|Adverse Event|15|||
147030875|NCT01083810|530275331|FG001|Overall Study|Adverse Event|11|||
147030876|NCT01083810|530275332|FG002|Overall Study|Adverse Event|4|||
147030877|NCT01083810|530275330|FG000|Overall Study|Withdrawal by Subject|7|||
147030878|NCT01083810|530275331|FG001|Overall Study|Withdrawal by Subject|2|||
147030879|NCT01083810|530275332|FG002|Overall Study|Withdrawal by Subject|4|||
147030880|NCT01083810|530275330|FG000|Overall Study|Reason not reported|6|||
147030881|NCT01083810|530275331|FG001|Overall Study|Reason not reported|1|||
147030882|NCT01083810|530275332|FG002|Overall Study|Reason not reported|1|||
147030883|NCT01083810|530275330|FG000|Overall Study|Non-compliance|4|||
147030884|NCT01083810|530275331|FG001|Overall Study|Non-compliance|7|||
147030885|NCT01083810|530275332|FG002|Overall Study|Non-compliance|2|||
147030886|NCT01083810|530275330|FG000|Overall Study|Simplification|4|||
147030887|NCT01083810|530275331|FG001|Overall Study|Simplification|1|||
147030888|NCT01083810|530275332|FG002|Overall Study|Simplification|0|||
147030889|NCT01083810|530275330|FG000|Overall Study|Death|2|||
147030890|NCT01083810|530275331|FG001|Overall Study|Death|2|||
147030891|NCT01083810|530275332|FG002|Overall Study|Death|3|||
147030892|NCT01083810|530275330|FG000|Overall Study|Co-morbidities|1|||
147030893|NCT01083810|530275331|FG001|Overall Study|Co-morbidities|0|||
147030894|NCT01083810|530275332|FG002|Overall Study|Co-morbidities|0|||
147030895|NCT01083810|530275330|FG000|Overall Study|Participation in study|1|||
147030896|NCT01083810|530275331|FG001|Overall Study|Participation in study|0|||
147030897|NCT01083810|530275332|FG002|Overall Study|Participation in study|0|||
147030898|NCT01083810|530275330|FG000|Overall Study|Therapy break|1|||
147030899|NCT01083810|530275331|FG001|Overall Study|Therapy break|2|||
147030900|NCT01083810|530275332|FG002|Overall Study|Therapy break|2|||
147030901|NCT01083810|530275330|FG000|Overall Study|Virologic failure|1|||
147030902|NCT01083810|530275331|FG001|Overall Study|Virologic failure|8|||
147030903|NCT01083810|530275332|FG002|Overall Study|Virologic failure|0|||
147030904|NCT02041091|530275333|FG000|Treatment|Adverse Event|3|||
147030905|NCT02041091|530275334|FG001|Treatment|Adverse Event|3|||
147030906|NCT02041091|530275333|FG000|Treatment|Withdrawal by Subject|2|||
147030907|NCT02041091|530275334|FG001|Treatment|Withdrawal by Subject|4|||
147030908|NCT02041091|530275333|FG000|Treatment|Physician Decision|1|||
147030909|NCT02041091|530275334|FG001|Treatment|Physician Decision|0|||
147030910|NCT02041091|530275333|FG000|Treatment|Sponsor Decision|15|||
147030911|NCT02041091|530275334|FG001|Treatment|Sponsor Decision|16|||
147030912|NCT02041091|530275333|FG000|Treatment|Lost to Follow-up|1|||
147030913|NCT02041091|530275334|FG001|Treatment|Lost to Follow-up|0|||
147030914|NCT02041091|530275333|FG000|Optional Safety Extension Period|Adverse Event|4|||
147030915|NCT02041091|530275334|FG001|Optional Safety Extension Period|Adverse Event|2|||
147030916|NCT02041091|530275333|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
147030917|NCT02041091|530275334|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
147030918|NCT02041091|530275333|FG000|Optional Safety Extension Period|Protocol Violation|2|||
147030919|NCT02041091|530275334|FG001|Optional Safety Extension Period|Protocol Violation|0|||
147030920|NCT02041091|530275333|FG000|Optional Safety Extension Period|Physician Decision|2|||
147030921|NCT02041091|530275334|FG001|Optional Safety Extension Period|Physician Decision|1|||
147030922|NCT02041091|530275333|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
147030923|NCT02041091|530275334|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
147030924|NCT02041091|530275333|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
147030925|NCT02041091|530275334|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
147030926|NCT01855074|530275335|FG000|Overall Study|Adverse Event|1|||
147030927|NCT01855074|530275335|FG000|Overall Study|Lost to Follow-up|4|||
147030928|NCT01855074|530275335|FG000|Overall Study|Withdrawal by Subject|8|||
147030929|NCT01855074|530275335|FG000|Overall Study|Started but not treated|1|||
147030930|NCT01150890|530275336|FG000|Overall Study|Other|0|||
147030931|NCT01150890|530275337|FG001|Overall Study|Other|1|||
147030932|NCT01150890|530275338|FG002|Overall Study|Other|0|||
147030933|NCT01150890|530275339|FG003|Overall Study|Other|2|||
147030934|NCT01150890|530275336|FG000|Overall Study|Pregnancy|0|||
147030935|NCT01150890|530275337|FG001|Overall Study|Pregnancy|0|||
147030936|NCT01150890|530275338|FG002|Overall Study|Pregnancy|0|||
147030937|NCT01150890|530275339|FG003|Overall Study|Pregnancy|1|||
147030938|NCT01150890|530275336|FG000|Overall Study|Administrative Decision|4|||
147030939|NCT01150890|530275337|FG001|Overall Study|Administrative Decision|4|||
147030940|NCT01150890|530275338|FG002|Overall Study|Administrative Decision|5|||
147030941|NCT01150890|530275339|FG003|Overall Study|Administrative Decision|6|||
147030942|NCT01150890|530275336|FG000|Overall Study|Ineligibility determined|0|||
147030943|NCT01150890|530275337|FG001|Overall Study|Ineligibility determined|1|||
147030944|NCT01150890|530275338|FG002|Overall Study|Ineligibility determined|0|||
147030945|NCT01150890|530275339|FG003|Overall Study|Ineligibility determined|0|||
147030946|NCT01150890|530275336|FG000|Overall Study|Adverse Event|0|||
146849621|NCT02663518|529618855|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
146849622|NCT02663518|529618856|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147030947|NCT01150890|530275337|FG001|Overall Study|Adverse Event|0|||
147030948|NCT01150890|530275338|FG002|Overall Study|Adverse Event|2|||
147030949|NCT01150890|530275339|FG003|Overall Study|Adverse Event|0|||
147030950|NCT01150890|530275336|FG000|Overall Study|Withdrawal by Subject|0|||
147030951|NCT01150890|530275337|FG001|Overall Study|Withdrawal by Subject|0|||
147030952|NCT01150890|530275338|FG002|Overall Study|Withdrawal by Subject|2|||
147030953|NCT01150890|530275339|FG003|Overall Study|Withdrawal by Subject|1|||
147030954|NCT01150890|530275336|FG000|Overall Study|Disease progression|0|||
147030955|NCT01150890|530275337|FG001|Overall Study|Disease progression|7|||
147030956|NCT01150890|530275338|FG002|Overall Study|Disease progression|3|||
147030957|NCT01150890|530275339|FG003|Overall Study|Disease progression|7|||
147030958|NCT05424042|530278467|FG000|Overall Study|Withdrawal by Subject|2|||
147030959|NCT05424042|530278468|FG001|Overall Study|Withdrawal by Subject|0|||
147030960|NCT05424042|530278469|FG002|Overall Study|Withdrawal by Subject|4|||
147030961|NCT05424042|530278467|FG000|Overall Study|Lost to Follow-up|0|||
147030962|NCT05424042|530278468|FG001|Overall Study|Lost to Follow-up|0|||
147030963|NCT05424042|530278469|FG002|Overall Study|Lost to Follow-up|1|||
147030964|NCT05091307|530278470|FG000|Overall Study|Death|0|||
147030965|NCT05091307|530278471|FG001|Overall Study|Death|0|||
147030966|NCT05091307|530278472|FG002|Overall Study|Death|1|||
147030967|NCT05091307|530278473|FG003|Overall Study|Death|0|||
147030968|NCT05091307|530278470|FG000|Overall Study|Lost to Follow-up|33|||
147030969|NCT05091307|530278471|FG001|Overall Study|Lost to Follow-up|33|||
147030970|NCT05091307|530278472|FG002|Overall Study|Lost to Follow-up|2|||
147030971|NCT05091307|530278473|FG003|Overall Study|Lost to Follow-up|0|||
147030972|NCT05091307|530278470|FG000|Overall Study|Physician Decision|1|||
147030973|NCT05091307|530278471|FG001|Overall Study|Physician Decision|0|||
147030974|NCT05091307|530278472|FG002|Overall Study|Physician Decision|0|||
147030975|NCT05091307|530278473|FG003|Overall Study|Physician Decision|0|||
147030976|NCT05091307|530278470|FG000|Overall Study|Protocol Violation|1|||
147030977|NCT05091307|530278471|FG001|Overall Study|Protocol Violation|0|||
147030978|NCT05091307|530278472|FG002|Overall Study|Protocol Violation|0|||
147030979|NCT05091307|530278473|FG003|Overall Study|Protocol Violation|0|||
147030980|NCT05091307|530278470|FG000|Overall Study|Withdrawal by Subject|16|||
147030981|NCT05091307|530278471|FG001|Overall Study|Withdrawal by Subject|16|||
147030982|NCT05091307|530278472|FG002|Overall Study|Withdrawal by Subject|0|||
147030983|NCT05091307|530278473|FG003|Overall Study|Withdrawal by Subject|1|||
147030984|NCT05091307|530278470|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
147030985|NCT05091307|530278471|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
147030986|NCT05091307|530278472|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
147030987|NCT05091307|530278473|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
147030988|NCT05091307|530278470|FG000|Overall Study|Initiated Prohibited Medication|1|||
147030989|NCT05091307|530278471|FG001|Overall Study|Initiated Prohibited Medication|0|||
147030990|NCT05091307|530278472|FG002|Overall Study|Initiated Prohibited Medication|0|||
147030991|NCT05091307|530278473|FG003|Overall Study|Initiated Prohibited Medication|0|||
147030992|NCT05091307|530278470|FG000|Overall Study|Other|4|||
147030993|NCT05091307|530278471|FG001|Overall Study|Other|4|||
147030994|NCT05091307|530278472|FG002|Overall Study|Other|0|||
147030995|NCT05091307|530278473|FG003|Overall Study|Other|0|||
147030996|NCT05091307|530278470|FG000|Overall Study|Randomized but not vaccinated|0|||
147030997|NCT05091307|530278471|FG001|Overall Study|Randomized but not vaccinated|2|||
147030998|NCT05091307|530278472|FG002|Overall Study|Randomized but not vaccinated|0|||
147030999|NCT05091307|530278473|FG003|Overall Study|Randomized but not vaccinated|0|||
147031000|NCT03611543|530278474|FG000|Overall Study|Withdrawal by Subject|4|||
147031001|NCT03611543|530278475|FG001|Overall Study|Withdrawal by Subject|4|||
147031002|NCT03611543|530278474|FG000|Overall Study|Physician Decision|1|||
147031003|NCT03611543|530278475|FG001|Overall Study|Physician Decision|1|||
147031004|NCT03611543|530278474|FG000|Overall Study|Protocol Violation|2|||
147031005|NCT03611543|530278475|FG001|Overall Study|Protocol Violation|2|||
147031006|NCT03611543|530278474|FG000|Overall Study|Device failure|2|||
147031007|NCT03611543|530278475|FG001|Overall Study|Device failure|2|||
147031008|NCT03611543|530278474|FG000|Overall Study|Missing information|5|||
147031009|NCT03611543|530278475|FG001|Overall Study|Missing information|5|||
147031010|NCT03047473|530278482|FG000|Overall Study|Lost to Follow-up|2|||
147031011|NCT01167257|530278483|FG000|Overall Study|Lost to Follow-up|2|||
147031012|NCT01167257|530278484|FG001|Overall Study|Lost to Follow-up|2|||
147031013|NCT01167257|530278483|FG000|Overall Study|Withdrew consent|1|||
147031014|NCT01167257|530278484|FG001|Overall Study|Withdrew consent|1|||
147031015|NCT03283319|530278486|FG000|Overall Study|Lost to Follow-up|5|||
147031016|NCT03283319|530278487|FG001|Overall Study|Lost to Follow-up|4|||
147031017|NCT03283319|530278488|FG002|Overall Study|Lost to Follow-up|5|||
147031018|NCT03283319|530278489|FG003|Overall Study|Lost to Follow-up|5|||
147031019|NCT03283319|530278490|FG004|Overall Study|Lost to Follow-up|4|||
147031020|NCT03283319|530278491|FG005|Overall Study|Lost to Follow-up|3|||
147031021|NCT03283319|530278486|FG000|Overall Study|Withdrawal by Subject|2|||
147031022|NCT03283319|530278487|FG001|Overall Study|Withdrawal by Subject|2|||
147031023|NCT03283319|530278488|FG002|Overall Study|Withdrawal by Subject|2|||
147031024|NCT03283319|530278489|FG003|Overall Study|Withdrawal by Subject|1|||
147031025|NCT03283319|530278490|FG004|Overall Study|Withdrawal by Subject|0|||
147031026|NCT03283319|530278491|FG005|Overall Study|Withdrawal by Subject|1|||
147031027|NCT03283319|530278486|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
147031028|NCT03283319|530278487|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
147031029|NCT03283319|530278488|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
147031030|NCT03283319|530278489|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
147031031|NCT03283319|530278490|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
147031032|NCT03283319|530278491|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
147031033|NCT00721630|530278492|FG000|Overall Study|Participant found to be ineligible|1|||
147031034|NCT02213510|530278494|FG000|Overall Study|Death|0|||
147031035|NCT02213510|530278495|FG001|Overall Study|Death|1|||
147031036|NCT02213510|530278494|FG000|Overall Study|Lost to Follow-up|1|||
147031037|NCT02213510|530278495|FG001|Overall Study|Lost to Follow-up|0|||
147031038|NCT03954834|530278496|FG000|Overall Study|Adverse Event|1|||
147031039|NCT03954834|530278497|FG001|Overall Study|Adverse Event|3|||
147031040|NCT03954834|530278498|FG002|Overall Study|Adverse Event|1|||
147031041|NCT03954834|530278499|FG003|Overall Study|Adverse Event|1|||
147031042|NCT03954834|530278496|FG000|Overall Study|Death|0|||
147031043|NCT03954834|530278497|FG001|Overall Study|Death|0|||
147031044|NCT03954834|530278498|FG002|Overall Study|Death|0|||
147031045|NCT03954834|530278499|FG003|Overall Study|Death|1|||
147031046|NCT03954834|530278496|FG000|Overall Study|Physician Decision|0|||
147031047|NCT03954834|530278497|FG001|Overall Study|Physician Decision|1|||
147031048|NCT03954834|530278498|FG002|Overall Study|Physician Decision|0|||
147031049|NCT03954834|530278499|FG003|Overall Study|Physician Decision|2|||
147031050|NCT03954834|530278496|FG000|Overall Study|Protocol Violation|1|||
147031051|NCT03954834|530278497|FG001|Overall Study|Protocol Violation|0|||
147031052|NCT03954834|530278498|FG002|Overall Study|Protocol Violation|0|||
147031053|NCT03954834|530278499|FG003|Overall Study|Protocol Violation|1|||
147031054|NCT03954834|530278496|FG000|Overall Study|Withdrawal by Subject|2|||
147031055|NCT03954834|530278497|FG001|Overall Study|Withdrawal by Subject|3|||
147031056|NCT03954834|530278498|FG002|Overall Study|Withdrawal by Subject|13|||
147031057|NCT03954834|530278499|FG003|Overall Study|Withdrawal by Subject|6|||
147031058|NCT03954834|530278496|FG000|Overall Study|Participant left the country|0|||
147031059|NCT03954834|530278497|FG001|Overall Study|Participant left the country|0|||
147031060|NCT03954834|530278498|FG002|Overall Study|Participant left the country|1|||
147031061|NCT03954834|530278499|FG003|Overall Study|Participant left the country|0|||
147031062|NCT03954834|530278496|FG000|Overall Study|Lost to Follow-up|3|||
147031063|NCT03954834|530278497|FG001|Overall Study|Lost to Follow-up|2|||
147031064|NCT03954834|530278498|FG002|Overall Study|Lost to Follow-up|3|||
147031065|NCT03954834|530278499|FG003|Overall Study|Lost to Follow-up|5|||
147031066|NCT03786718|530278502|FG000|Overall Study|Lost to Follow-up|3|||
147031067|NCT03786718|530278502|FG000|Overall Study|Withdrawal by Subject|1|||
147031068|NCT03786718|530278502|FG000|Overall Study|Did not use the intervention|2|||
147031069|NCT03786718|530278502|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
147031070|NCT00372411|530278507|FG000|Overall Study|Withdrawal by Subject|3|||
147031071|NCT00372411|530278508|FG001|Overall Study|Withdrawal by Subject|4|||
147031072|NCT00372411|530278509|FG002|Overall Study|Withdrawal by Subject|1|||
147031073|NCT00372411|530278507|FG000|Overall Study|Death|0|||
147031074|NCT00372411|530278508|FG001|Overall Study|Death|2|||
147031075|NCT00372411|530278509|FG002|Overall Study|Death|1|||
147031076|NCT00372411|530278507|FG000|Overall Study|Lost to Follow-up|1|||
147031077|NCT00372411|530278508|FG001|Overall Study|Lost to Follow-up|1|||
147031078|NCT00372411|530278509|FG002|Overall Study|Lost to Follow-up|1|||
147031079|NCT00372411|530278507|FG000|Overall Study|Adverse Event|1|||
147031080|NCT00372411|530278508|FG001|Overall Study|Adverse Event|1|||
147031081|NCT00372411|530278509|FG002|Overall Study|Adverse Event|0|||
147031082|NCT01398514|530278510|FG000|Overall Study|Adverse Event|1|||
147031083|NCT01398514|530278511|FG001|Overall Study|Adverse Event|0|||
147031084|NCT01398514|530278510|FG000|Overall Study|Non-compliance with study procedures|2|||
147031085|NCT01398514|530278511|FG001|Overall Study|Non-compliance with study procedures|0|||
147031086|NCT01398514|530278510|FG000|Overall Study|Physiologic non-responsiveness|1|||
147031087|NCT01398514|530278511|FG001|Overall Study|Physiologic non-responsiveness|3|||
147031088|NCT01398514|530278510|FG000|Overall Study|Failure to show a conditioned response|4|||
147031089|NCT01398514|530278511|FG001|Overall Study|Failure to show a conditioned response|3|||
147031090|NCT01570686|530278515|FG000|Overall Study|Abnormal test procedure result(s)|1|||
147031091|NCT01570686|530278516|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147031092|NCT01570686|530278515|FG000|Overall Study|Administrative problems|0|||
147031093|NCT01570686|530278516|FG001|Overall Study|Administrative problems|1|||
147031094|NCT01570686|530278515|FG000|Overall Study|Adverse Event|8|||
147031095|NCT01570686|530278516|FG001|Overall Study|Adverse Event|6|||
147031096|NCT01570686|530278515|FG000|Overall Study|Lost to Follow-up|4|||
147031097|NCT01570686|530278516|FG001|Overall Study|Lost to Follow-up|3|||
147031098|NCT01570686|530278515|FG000|Overall Study|Protocol Deviation|3|||
147031099|NCT01570686|530278516|FG001|Overall Study|Protocol Deviation|0|||
147031100|NCT01570686|530278515|FG000|Overall Study|Withdrawal by Subject|4|||
147031101|NCT01570686|530278516|FG001|Overall Study|Withdrawal by Subject|4|||
147031102|NCT01570686|530278515|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147031103|NCT01570686|530278516|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147031104|NCT02906930|530278520|FG000|Overall Study|Withdrawal by Subject|0|||
147031105|NCT02906930|530278521|FG001|Overall Study|Withdrawal by Subject|5|||
147031106|NCT02906930|530278522|FG002|Overall Study|Withdrawal by Subject|5|||
147031107|NCT02906930|530278523|FG003|Overall Study|Withdrawal by Subject|4|||
147031108|NCT02906930|530278520|FG000|Overall Study|Lost to Follow-up|5|||
147031109|NCT02906930|530278521|FG001|Overall Study|Lost to Follow-up|7|||
147031110|NCT02906930|530278522|FG002|Overall Study|Lost to Follow-up|5|||
147031111|NCT02906930|530278523|FG003|Overall Study|Lost to Follow-up|2|||
147031112|NCT02906930|530278520|FG000|Overall Study|Death|0|||
147031113|NCT02906930|530278521|FG001|Overall Study|Death|0|||
147031114|NCT02906930|530278522|FG002|Overall Study|Death|1|||
147031115|NCT02906930|530278523|FG003|Overall Study|Death|0|||
147031116|NCT02906930|530278520|FG000|Overall Study|Other|1|||
147031117|NCT02906930|530278521|FG001|Overall Study|Other|2|||
147031118|NCT02906930|530278522|FG002|Overall Study|Other|1|||
147031119|NCT02906930|530278523|FG003|Overall Study|Other|2|||
147031120|NCT00910091|530278526|FG000|Pre-assignment|Withdrawal by Subject|0|||
147031121|NCT00910091|530278527|FG001|Pre-assignment|Withdrawal by Subject|2|||
147031122|NCT00910091|530278526|FG000|Treatment and Survival|Withdrawal by Subject|3|||
147031123|NCT00910091|530278527|FG001|Treatment and Survival|Withdrawal by Subject|4|||
147031124|NCT00910091|530278526|FG000|Treatment and Survival|Adverse Event|1|||
147031125|NCT00910091|530278527|FG001|Treatment and Survival|Adverse Event|0|||
147031126|NCT00622466|530278528|FG000|Overall Study|Death|1|||
147031127|NCT00622466|530278528|FG000|Overall Study|Adverse Event|1|||
147031128|NCT00622466|530278528|FG000|Overall Study|Withdrawal by Subject|2|||
147031129|NCT01908816|530278529|FG000|Overall Study|Subject's no longer requires study drug|0|||
147031130|NCT01908816|530278530|FG001|Overall Study|Subject's no longer requires study drug|0|||
147031131|NCT01908816|530278531|FG002|Overall Study|Subject's no longer requires study drug|0|||
147031132|NCT01908816|530278532|FG003|Overall Study|Subject's no longer requires study drug|1|||
147031133|NCT01908816|530278529|FG000|Overall Study|Protocol deviation|1|||
147031134|NCT01908816|530278530|FG001|Overall Study|Protocol deviation|2|||
147031135|NCT01908816|530278531|FG002|Overall Study|Protocol deviation|1|||
147031136|NCT01908816|530278532|FG003|Overall Study|Protocol deviation|1|||
147031137|NCT01908816|530278529|FG000|Overall Study|Withdrawal by Subject|0|||
147031138|NCT01908816|530278530|FG001|Overall Study|Withdrawal by Subject|4|||
147031139|NCT01908816|530278531|FG002|Overall Study|Withdrawal by Subject|2|||
147031140|NCT01908816|530278532|FG003|Overall Study|Withdrawal by Subject|2|||
147031141|NCT01908816|530278529|FG000|Overall Study|Lost to Follow-up|3|||
147031142|NCT01908816|530278530|FG001|Overall Study|Lost to Follow-up|5|||
147031143|NCT01908816|530278531|FG002|Overall Study|Lost to Follow-up|4|||
147031144|NCT01908816|530278532|FG003|Overall Study|Lost to Follow-up|2|||
147031145|NCT01908816|530278529|FG000|Overall Study|Death|1|||
147031146|NCT01908816|530278530|FG001|Overall Study|Death|0|||
147031147|NCT01908816|530278531|FG002|Overall Study|Death|7|||
147031148|NCT01908816|530278532|FG003|Overall Study|Death|1|||
147031149|NCT01908816|530278529|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147031150|NCT01908816|530278530|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
147031151|NCT01908816|530278531|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
147031152|NCT01908816|530278532|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
147031153|NCT01908816|530278529|FG000|Overall Study|Early termination|87|||
147031154|NCT01908816|530278530|FG001|Overall Study|Early termination|60|||
147031155|NCT01908816|530278531|FG002|Overall Study|Early termination|43|||
147031156|NCT01908816|530278532|FG003|Overall Study|Early termination|28|||
147031157|NCT04585789|530278533|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
147031158|NCT04585789|530278534|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
147031159|NCT04585789|530278535|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
147031160|NCT04585789|530278533|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
147031161|NCT04585789|530278534|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
147031162|NCT04585789|530278535|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
147031163|NCT01175811|530278536|FG000|Overall Study|Adverse Event|1|||
147031164|NCT01175811|530278537|FG001|Overall Study|Adverse Event|1|||
147031165|NCT01175811|530278536|FG000|Overall Study|Entry criteria not met|3|||
147031166|NCT01175811|530278537|FG001|Overall Study|Entry criteria not met|1|||
147031167|NCT01175811|530278536|FG000|Overall Study|Lack of Efficacy|1|||
147031168|NCT01175811|530278537|FG001|Overall Study|Lack of Efficacy|0|||
147031169|NCT01175811|530278536|FG000|Overall Study|Lost to Follow-up|3|||
147031170|NCT01175811|530278537|FG001|Overall Study|Lost to Follow-up|2|||
147031171|NCT01175811|530278536|FG000|Overall Study|Physician Decision|1|||
147031172|NCT01175811|530278537|FG001|Overall Study|Physician Decision|1|||
147031173|NCT01175811|530278536|FG000|Overall Study|Protocol Violation|1|||
147031174|NCT01175811|530278537|FG001|Overall Study|Protocol Violation|2|||
147031175|NCT01175811|530278536|FG000|Overall Study|Withdrawal by Subject|6|||
147031176|NCT01175811|530278537|FG001|Overall Study|Withdrawal by Subject|7|||
147031177|NCT02628743|530278539|FG000|Overall Study|Other|3|||
147031178|NCT02628743|530278539|FG000|Overall Study|Withdrawal by Subject|50|||
147031179|NCT02628743|530278539|FG000|Overall Study|Study Terminated by Sponsor|76|||
147031180|NCT02628743|530278539|FG000|Overall Study|Physician Decision|2|||
147031181|NCT02534844|530278540|FG000|Part B|Withdrawal by Subject|0|||
146849623|NCT02663518|529618857|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147031182|NCT02534844|530278541|FG001|Part B|Withdrawal by Subject|0|||
147031183|NCT02534844|530278542|FG002|Part B|Withdrawal by Subject|0|||
147031184|NCT02534844|530278543|FG003|Part B|Withdrawal by Subject|0|||
147031185|NCT02534844|530278544|FG004|Part B|Withdrawal by Subject|2|||
147031186|NCT02534844|530278545|FG005|Part B|Withdrawal by Subject|1|||
147031187|NCT00655876|530278546|FG000|Overall Study|Protocol Violation|9|||
147031188|NCT00655876|530278547|FG001|Overall Study|Protocol Violation|7|||
147031189|NCT00326963|530278548|FG000|Overall Study|Adverse Event|2|||
147031190|NCT00326963|530278548|FG000|Overall Study|Injection site reaction|1|||
147031191|NCT00326963|530278548|FG000|Overall Study|Death|1|||
147031192|NCT00326963|530278548|FG000|Overall Study|Failure to return|10|||
147031193|NCT00326963|530278548|FG000|Overall Study|Withdrawal by Subject|10|||
147031194|NCT00326963|530278548|FG000|Overall Study|Refused treatment / did not cooperate|5|||
147031195|NCT00326963|530278548|FG000|Overall Study|Violation of selection criteria at entry|2|||
147031196|NCT00326963|530278548|FG000|Overall Study|Other protocol violation|1|||
147031197|NCT00326963|530278548|FG000|Overall Study|Administrative / other|1|||
147031198|NCT01468818|530278554|FG000|Overall Study|Death during treatment|2|||
147031199|NCT00338455|530278559|FG000|Overall Study|Death|2|||
147031200|NCT00338455|530278560|FG001|Overall Study|Death|1|||
147031201|NCT00338455|530278559|FG000|Overall Study|Physician Decision|1|||
147031202|NCT00338455|530278560|FG001|Overall Study|Physician Decision|0|||
147031203|NCT01059344|530278561|FG000|Overall Study|Adverse Event|12|||
147031204|NCT01059344|530278562|FG001|Overall Study|Adverse Event|30|||
147031205|NCT01059344|530278561|FG000|Overall Study|Withdrawal by Subject|6|||
147031206|NCT01059344|530278562|FG001|Overall Study|Withdrawal by Subject|9|||
147031207|NCT01059344|530278561|FG000|Overall Study|Lost to Follow-up|1|||
147031208|NCT01059344|530278562|FG001|Overall Study|Lost to Follow-up|1|||
147031209|NCT01059344|530278561|FG000|Overall Study|Other|3|||
147031210|NCT01059344|530278562|FG001|Overall Study|Other|6|||
147031211|NCT01739348|530278563|FG000|Part I (Base Study)|Adverse Event|41|||
147031212|NCT01739348|530278564|FG001|Part I (Base Study)|Adverse Event|52|||
147031213|NCT01739348|530278565|FG002|Part I (Base Study)|Adverse Event|8|||
147031214|NCT01739348|530278566|FG003|Part I (Base Study)|Adverse Event|33|||
147031215|NCT01739348|530278563|FG000|Part I (Base Study)|Death|10|||
147031216|NCT01739348|530278564|FG001|Part I (Base Study)|Death|7|||
147031217|NCT01739348|530278565|FG002|Part I (Base Study)|Death|2|||
147031218|NCT01739348|530278566|FG003|Part I (Base Study)|Death|8|||
147031219|NCT01739348|530278563|FG000|Part I (Base Study)|Lack of Efficacy|3|||
147031220|NCT01739348|530278564|FG001|Part I (Base Study)|Lack of Efficacy|8|||
147031221|NCT01739348|530278565|FG002|Part I (Base Study)|Lack of Efficacy|0|||
147031222|NCT01739348|530278566|FG003|Part I (Base Study)|Lack of Efficacy|7|||
147031223|NCT01739348|530278563|FG000|Part I (Base Study)|Lost to Follow-up|4|||
147031224|NCT01739348|530278564|FG001|Part I (Base Study)|Lost to Follow-up|2|||
147031225|NCT01739348|530278565|FG002|Part I (Base Study)|Lost to Follow-up|4|||
147031226|NCT01739348|530278566|FG003|Part I (Base Study)|Lost to Follow-up|4|||
147031227|NCT01739348|530278563|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
147031228|NCT01739348|530278564|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
147031229|NCT01739348|530278565|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
147031230|NCT01739348|530278566|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
147031231|NCT01739348|530278563|FG000|Part I (Base Study)|Physician Decision|10|||
147031232|NCT01739348|530278564|FG001|Part I (Base Study)|Physician Decision|7|||
147031233|NCT01739348|530278565|FG002|Part I (Base Study)|Physician Decision|1|||
147031234|NCT01739348|530278566|FG003|Part I (Base Study)|Physician Decision|4|||
147031235|NCT01739348|530278563|FG000|Part I (Base Study)|Protocol Violation|2|||
147031236|NCT01739348|530278564|FG001|Part I (Base Study)|Protocol Violation|0|||
147031237|NCT01739348|530278565|FG002|Part I (Base Study)|Protocol Violation|1|||
147031238|NCT01739348|530278566|FG003|Part I (Base Study)|Protocol Violation|2|||
147031239|NCT01739348|530278563|FG000|Part I (Base Study)|Screen Failure|2|||
147031240|NCT01739348|530278564|FG001|Part I (Base Study)|Screen Failure|0|||
147031241|NCT01739348|530278565|FG002|Part I (Base Study)|Screen Failure|0|||
147031242|NCT01739348|530278566|FG003|Part I (Base Study)|Screen Failure|0|||
147031243|NCT01739348|530278563|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
147031244|NCT01739348|530278564|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
147031245|NCT01739348|530278565|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
147031246|NCT01739348|530278566|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
147031247|NCT01739348|530278563|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
147031248|NCT01739348|530278564|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
147031249|NCT01739348|530278565|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
147031250|NCT01739348|530278566|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
147031251|NCT01739348|530278563|FG000|Part I (Base Study)|Participant Moved|4|||
147031252|NCT01739348|530278564|FG001|Part I (Base Study)|Participant Moved|3|||
147031253|NCT01739348|530278565|FG002|Part I (Base Study)|Participant Moved|1|||
147031254|NCT01739348|530278566|FG003|Part I (Base Study)|Participant Moved|7|||
147031255|NCT01739348|530278563|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
147031256|NCT01739348|530278564|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
146849624|NCT02663518|529618858|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147031257|NCT01739348|530278565|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
147031258|NCT01739348|530278566|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
147031259|NCT01739348|530278563|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
147031260|NCT01739348|530278564|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
147031261|NCT01739348|530278565|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
147031262|NCT01739348|530278566|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
147031263|NCT01739348|530278563|FG000|Part II (Extension Study)|Adverse Event|10|||
147031264|NCT01739348|530278564|FG001|Part II (Extension Study)|Adverse Event|11|||
147031265|NCT01739348|530278565|FG002|Part II (Extension Study)|Adverse Event|7|||
147031266|NCT01739348|530278566|FG003|Part II (Extension Study)|Adverse Event|26|||
147031267|NCT01739348|530278563|FG000|Part II (Extension Study)|Death|3|||
147031268|NCT01739348|530278564|FG001|Part II (Extension Study)|Death|3|||
147031269|NCT01739348|530278565|FG002|Part II (Extension Study)|Death|2|||
147031270|NCT01739348|530278566|FG003|Part II (Extension Study)|Death|6|||
147031271|NCT01739348|530278563|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
147031272|NCT01739348|530278564|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
147031273|NCT01739348|530278565|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
147031274|NCT01739348|530278566|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
147031275|NCT01739348|530278563|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
147031276|NCT01739348|530278564|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
147031277|NCT01739348|530278565|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
147031278|NCT01739348|530278566|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
147031279|NCT01739348|530278563|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
147031280|NCT01739348|530278564|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
147031281|NCT01739348|530278565|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
147031282|NCT01739348|530278566|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
147031283|NCT01739348|530278563|FG000|Part II (Extension Study)|Physician Decision|7|||
147031284|NCT01739348|530278564|FG001|Part II (Extension Study)|Physician Decision|11|||
147031285|NCT01739348|530278565|FG002|Part II (Extension Study)|Physician Decision|6|||
147031286|NCT01739348|530278566|FG003|Part II (Extension Study)|Physician Decision|12|||
147031287|NCT01739348|530278563|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
147031288|NCT01739348|530278564|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
147031289|NCT01739348|530278565|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
147031290|NCT01739348|530278566|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
147031291|NCT01739348|530278563|FG000|Part II (Extension Study)|Participant Moved|3|||
147031292|NCT01739348|530278564|FG001|Part II (Extension Study)|Participant Moved|3|||
147031293|NCT01739348|530278565|FG002|Part II (Extension Study)|Participant Moved|0|||
147031294|NCT01739348|530278566|FG003|Part II (Extension Study)|Participant Moved|3|||
147031295|NCT01739348|530278563|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
147031296|NCT01739348|530278564|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
147031297|NCT01739348|530278565|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
147031298|NCT01739348|530278566|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
147031299|NCT01739348|530278563|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
147031300|NCT01739348|530278564|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
147031301|NCT01739348|530278565|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
147031302|NCT01739348|530278566|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
147031303|NCT01447420|530278569|FG000|Overall Study|Adverse Event|2|||
147031304|NCT01447420|530278570|FG001|Overall Study|Adverse Event|4|||
147031305|NCT01447420|530278571|FG002|Overall Study|Adverse Event|2|||
147031306|NCT01447420|530278569|FG000|Overall Study|Protocol Violation|3|||
147031307|NCT01447420|530278570|FG001|Overall Study|Protocol Violation|3|||
147031308|NCT01447420|530278571|FG002|Overall Study|Protocol Violation|0|||
147031309|NCT01447420|530278569|FG000|Overall Study|Withdrawal by Subject|4|||
147031310|NCT01447420|530278570|FG001|Overall Study|Withdrawal by Subject|1|||
147031311|NCT01447420|530278571|FG002|Overall Study|Withdrawal by Subject|0|||
147031312|NCT01447420|530278569|FG000|Overall Study|Lack of Efficacy|1|||
147031313|NCT01447420|530278570|FG001|Overall Study|Lack of Efficacy|19|||
147031314|NCT01447420|530278571|FG002|Overall Study|Lack of Efficacy|8|||
147031315|NCT04562155|530278573|FG000|Overall Study|COVID-19 pandemic|0|||
147031316|NCT04562155|530278574|FG001|Overall Study|COVID-19 pandemic|0|||
147031317|NCT04562155|530278575|FG002|Overall Study|COVID-19 pandemic|0|||
147031318|NCT04562155|530278576|FG003|Overall Study|COVID-19 pandemic|1|||
147031319|NCT04562155|530278573|FG000|Overall Study|Adverse Event|7|||
147031320|NCT04562155|530278574|FG001|Overall Study|Adverse Event|3|||
147031321|NCT04562155|530278575|FG002|Overall Study|Adverse Event|8|||
146849625|NCT02663518|529618859|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147031322|NCT04562155|530278576|FG003|Overall Study|Adverse Event|1|||
147031323|NCT04562155|530278573|FG000|Overall Study|Withdrawal by Subject|3|||
146849626|NCT02663518|529618860|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147031324|NCT04562155|530278574|FG001|Overall Study|Withdrawal by Subject|6|||
147031325|NCT04562155|530278575|FG002|Overall Study|Withdrawal by Subject|3|||
147031326|NCT04562155|530278576|FG003|Overall Study|Withdrawal by Subject|3|||
147031327|NCT04562155|530278573|FG000|Overall Study|Participant personal reason|1|||
147031328|NCT04562155|530278574|FG001|Overall Study|Participant personal reason|0|||
147031329|NCT04562155|530278575|FG002|Overall Study|Participant personal reason|2|||
147031330|NCT04562155|530278576|FG003|Overall Study|Participant personal reason|1|||
147031331|NCT01085201|530278577|FG000|Overall Study|Scheduling conflict|1|||
147031332|NCT01085201|530278578|FG001|Overall Study|Scheduling conflict|0|||
147031333|NCT01085201|530278579|FG002|Overall Study|Scheduling conflict|1|||
147031334|NCT01085201|530278580|FG003|Overall Study|Scheduling conflict|0|||
147031335|NCT01085201|530278581|FG004|Overall Study|Scheduling conflict|0|||
147031336|NCT01085201|530278577|FG000|Overall Study|Unknown- no study drug|2|||
147031337|NCT01085201|530278578|FG001|Overall Study|Unknown- no study drug|0|||
147031338|NCT01085201|530278579|FG002|Overall Study|Unknown- no study drug|0|||
147031339|NCT01085201|530278580|FG003|Overall Study|Unknown- no study drug|0|||
147031340|NCT01085201|530278581|FG004|Overall Study|Unknown- no study drug|0|||
147031341|NCT01085201|530278577|FG000|Overall Study|Fond ineligible after consent|0|||
147031342|NCT01085201|530278578|FG001|Overall Study|Fond ineligible after consent|1|||
147031343|NCT01085201|530278579|FG002|Overall Study|Fond ineligible after consent|1|||
147031344|NCT01085201|530278580|FG003|Overall Study|Fond ineligible after consent|0|||
147031345|NCT01085201|530278581|FG004|Overall Study|Fond ineligible after consent|0|||
147031346|NCT00528411|530278583|FG000|Overall Study|Adverse Event|4|||
147031347|NCT00528411|530278584|FG001|Overall Study|Adverse Event|0|||
147031348|NCT00528411|530278585|FG002|Overall Study|Adverse Event|1|||
147031349|NCT00528411|530278583|FG000|Overall Study|Incorrect Enrolment|1|||
147031350|NCT00528411|530278584|FG001|Overall Study|Incorrect Enrolment|1|||
147031351|NCT00528411|530278585|FG002|Overall Study|Incorrect Enrolment|0|||
147031352|NCT00528411|530278583|FG000|Overall Study|Severe non-compliance to protocol|0|||
147031353|NCT00528411|530278584|FG001|Overall Study|Severe non-compliance to protocol|1|||
147031354|NCT00528411|530278585|FG002|Overall Study|Severe non-compliance to protocol|0|||
147031355|NCT00528411|530278583|FG000|Overall Study|Prior commitment medication|0|||
147031356|NCT00528411|530278584|FG001|Overall Study|Prior commitment medication|1|||
147031357|NCT00528411|530278585|FG002|Overall Study|Prior commitment medication|0|||
147031358|NCT03893565|530278586|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
147031359|NCT03893565|530278587|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
147031360|NCT03893565|530278588|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
147031361|NCT03893565|530278589|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
147031362|NCT03893565|530278590|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
147031363|NCT03893565|530278591|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
147031364|NCT03893565|530278592|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
147031365|NCT03893565|530278593|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
147031366|NCT03893565|530278594|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
147031367|NCT03893565|530278586|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
147031368|NCT03893565|530278587|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
147031369|NCT03893565|530278588|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
147031370|NCT03893565|530278589|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
147031371|NCT03893565|530278590|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
147031372|NCT03893565|530278591|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
147031373|NCT03893565|530278592|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
147031374|NCT03893565|530278593|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
147031375|NCT03893565|530278594|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
147031376|NCT03893565|530278586|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147031377|NCT03893565|530278587|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
147031378|NCT03893565|530278588|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147031379|NCT03893565|530278589|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
147031380|NCT03893565|530278590|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147031381|NCT03893565|530278591|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147031382|NCT03893565|530278592|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147031383|NCT03893565|530278593|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147031384|NCT03893565|530278594|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147031385|NCT03893565|530278586|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
147031386|NCT03893565|530278587|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
147031387|NCT03893565|530278588|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
147031388|NCT03893565|530278589|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
147031389|NCT03893565|530278590|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
147031390|NCT03893565|530278591|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
147031391|NCT03893565|530278592|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
146849627|NCT02663518|529618861|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147031392|NCT03893565|530278593|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
147031393|NCT03893565|530278594|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
147031394|NCT03893565|530278586|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
147031395|NCT03893565|530278587|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
147031396|NCT03893565|530278588|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
147031397|NCT03893565|530278589|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147031398|NCT03893565|530278590|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
147031399|NCT03893565|530278591|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147031400|NCT03893565|530278592|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147031401|NCT03893565|530278593|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147031402|NCT03893565|530278594|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147031403|NCT03893565|530278586|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
147031404|NCT03893565|530278587|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
147031405|NCT03893565|530278588|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
147031406|NCT03893565|530278589|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
147031407|NCT03893565|530278590|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
147031408|NCT03893565|530278591|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
147031409|NCT03893565|530278592|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
147031410|NCT03893565|530278593|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
147031411|NCT03893565|530278594|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
147031412|NCT03893565|530278586|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147031413|NCT03893565|530278587|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147031414|NCT03893565|530278588|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147031415|NCT03893565|530278589|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
147031416|NCT03893565|530278590|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147031417|NCT03893565|530278591|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147031418|NCT03893565|530278592|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147031419|NCT03893565|530278593|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147031420|NCT03893565|530278594|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147031421|NCT03893565|530278586|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
147031422|NCT03893565|530278587|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
147031423|NCT03893565|530278588|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
147031424|NCT03893565|530278589|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
147031425|NCT03893565|530278590|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
147031426|NCT03893565|530278591|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
147031427|NCT03893565|530278592|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
147031428|NCT03893565|530278593|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
147031429|NCT03893565|530278594|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
147031430|NCT03893565|530278586|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
147031431|NCT03893565|530278587|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
147031432|NCT03893565|530278588|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
147031433|NCT03893565|530278589|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
147031434|NCT03893565|530278590|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
147031435|NCT03893565|530278591|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
147031436|NCT03893565|530278592|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
147031437|NCT03893565|530278593|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
147031438|NCT03893565|530278594|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
147031439|NCT03893565|530278586|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
147031440|NCT03893565|530278587|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
147031441|NCT03893565|530278588|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
147031442|NCT03893565|530278589|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
147031443|NCT03893565|530278590|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
147031444|NCT03893565|530278591|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
147031445|NCT03893565|530278592|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
147031446|NCT03893565|530278593|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
147031447|NCT03893565|530278594|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
147031448|NCT03893565|530278586|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
147031449|NCT03893565|530278587|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
147031450|NCT03893565|530278588|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
147031451|NCT03893565|530278589|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
147031452|NCT03893565|530278590|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
147031453|NCT03893565|530278591|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
147031454|NCT03893565|530278592|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
147031455|NCT03893565|530278593|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
147031456|NCT03893565|530278594|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
147031457|NCT03893565|530278586|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
147031458|NCT03893565|530278587|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
147031459|NCT03893565|530278588|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
147031460|NCT03893565|530278589|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
147031461|NCT03893565|530278590|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
147031462|NCT03893565|530278591|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
147031463|NCT03893565|530278592|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
147031464|NCT03893565|530278593|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
147031465|NCT03893565|530278594|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
147031466|NCT03893565|530278586|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147031467|NCT03893565|530278587|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147031468|NCT03893565|530278588|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147031469|NCT03893565|530278589|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147031470|NCT03893565|530278590|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147031471|NCT03893565|530278591|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147031472|NCT03893565|530278592|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147031473|NCT03893565|530278593|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
147031474|NCT03893565|530278594|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147031475|NCT03893565|530278586|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147031476|NCT03893565|530278587|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147031477|NCT03893565|530278588|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147031478|NCT03893565|530278589|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147031479|NCT03893565|530278590|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147031480|NCT03893565|530278591|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147031481|NCT03893565|530278592|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147031482|NCT03893565|530278593|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
147031483|NCT03893565|530278594|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147031484|NCT03893565|530278586|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147031485|NCT03893565|530278587|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147031486|NCT03893565|530278588|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147031487|NCT03893565|530278589|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147031488|NCT03893565|530278590|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147031489|NCT03893565|530278591|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147031490|NCT03893565|530278592|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147031491|NCT03893565|530278593|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
147031492|NCT03893565|530278594|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147031493|NCT03893565|530278586|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
147031494|NCT03893565|530278587|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
147031495|NCT03893565|530278588|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
147031496|NCT03893565|530278589|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
147031497|NCT03893565|530278590|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
147031498|NCT03893565|530278591|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
147031499|NCT03893565|530278592|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
147031500|NCT03893565|530278593|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
147031501|NCT03893565|530278594|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
147031502|NCT00851318|530278595|FG000|Overall Study|Withdrawal by Subject|7|||
147031503|NCT00851318|530278596|FG001|Overall Study|Withdrawal by Subject|1|||
146849628|NCT02663518|529618862|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146849629|NCT02663518|529618863|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146849630|NCT02663518|529618864|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146849631|NCT02663518|529618851|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146849632|NCT02663518|529618852|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146849633|NCT02663518|529618853|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146849634|NCT02663518|529618854|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146849635|NCT02663518|529618855|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
146849636|NCT02663518|529618856|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
146849637|NCT02663518|529618857|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
146849638|NCT02663518|529618858|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
146849639|NCT02663518|529618859|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146849640|NCT02663518|529618860|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146849641|NCT02663518|529618861|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146849642|NCT02663518|529618862|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146849643|NCT02663518|529618863|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146849644|NCT02663518|529618864|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146849645|NCT02663518|529618851|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
146849646|NCT02663518|529618852|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
147031504|NCT00851318|530278597|FG002|Overall Study|Withdrawal by Subject|5|||
147031505|NCT00851318|530278598|FG003|Overall Study|Withdrawal by Subject|3|||
147031506|NCT00851318|530278595|FG000|Overall Study|Adverse Event|13|||
147031507|NCT00851318|530278596|FG001|Overall Study|Adverse Event|2|||
147031508|NCT00851318|530278597|FG002|Overall Study|Adverse Event|9|||
147031509|NCT00851318|530278598|FG003|Overall Study|Adverse Event|12|||
147031510|NCT00851318|530278595|FG000|Overall Study|Pregnancy|0|||
147031511|NCT00851318|530278596|FG001|Overall Study|Pregnancy|0|||
147031512|NCT00851318|530278597|FG002|Overall Study|Pregnancy|1|||
147031513|NCT00851318|530278598|FG003|Overall Study|Pregnancy|1|||
147031514|NCT00851318|530278595|FG000|Overall Study|Lack of Efficacy|8|||
147031515|NCT00851318|530278596|FG001|Overall Study|Lack of Efficacy|2|||
147031516|NCT00851318|530278597|FG002|Overall Study|Lack of Efficacy|4|||
147031517|NCT00851318|530278598|FG003|Overall Study|Lack of Efficacy|2|||
147031518|NCT00851318|530278595|FG000|Overall Study|Non-compliance with Study Procedures|2|||
147031519|NCT00851318|530278596|FG001|Overall Study|Non-compliance with Study Procedures|0|||
147031520|NCT00851318|530278597|FG002|Overall Study|Non-compliance with Study Procedures|1|||
147031521|NCT00851318|530278598|FG003|Overall Study|Non-compliance with Study Procedures|0|||
147031522|NCT00851318|530278595|FG000|Overall Study|Physician Decision|0|||
147031523|NCT00851318|530278596|FG001|Overall Study|Physician Decision|0|||
147031524|NCT00851318|530278597|FG002|Overall Study|Physician Decision|1|||
147031525|NCT00851318|530278598|FG003|Overall Study|Physician Decision|1|||
147031526|NCT01442688|530278599|FG000|First Intervention|Withdrawal by Subject|1|||
147031527|NCT01442688|530278600|FG001|First Intervention|Withdrawal by Subject|0|||
147031528|NCT01442688|530278599|FG000|First Intervention|subject incarcerated|1|||
147031529|NCT01442688|530278600|FG001|First Intervention|subject incarcerated|0|||
147031530|NCT01442688|530278599|FG000|Second Intervention|Adverse Event|1|||
147031531|NCT01442688|530278600|FG001|Second Intervention|Adverse Event|0|||
147031532|NCT02643355|530278601|FG000|Overall Study|Withdrawal by Subject|1|||
147031533|NCT02643355|530278602|FG001|Overall Study|Withdrawal by Subject|3|||
147031534|NCT02643355|530278601|FG000|Overall Study|Protocol Violation|0|||
147031535|NCT02643355|530278602|FG001|Overall Study|Protocol Violation|2|||
147031536|NCT01715571|530278603|FG000|Overall Study|Lost to Follow-up|8|||
147031537|NCT04658095|530278608|FG000|Overall Study|Study terminated|5|||
147031538|NCT04658095|530278609|FG001|Overall Study|Study terminated|1|||
147031539|NCT04658095|530278610|FG002|Overall Study|Study terminated|4|||
147031540|NCT05961215|530278611|FG000|Overall Study|Withdrawal by Subject|1|||
147031541|NCT05187013|530278612|FG000|Overall Study|Withdrawal by Subject|1|||
147031542|NCT05187013|530278613|FG001|Overall Study|Withdrawal by Subject|1|||
147031543|NCT05187013|530278614|FG002|Overall Study|Withdrawal by Subject|0|||
147031544|NCT05187013|530278612|FG000|Overall Study|Death|0|||
147031545|NCT05187013|530278613|FG001|Overall Study|Death|1|||
147031546|NCT05187013|530278614|FG002|Overall Study|Death|0|||
147031547|NCT05187013|530278612|FG000|Overall Study|Lost to Follow-up|20|||
147031548|NCT05187013|530278613|FG001|Overall Study|Lost to Follow-up|17|||
147031549|NCT05187013|530278614|FG002|Overall Study|Lost to Follow-up|0|||
147031550|NCT05187013|530278612|FG000|Overall Study|Ongoing Participants|3|||
147031551|NCT05187013|530278613|FG001|Overall Study|Ongoing Participants|5|||
147031552|NCT05187013|530278614|FG002|Overall Study|Ongoing Participants|0|||
147031553|NCT02387983|530278615|FG000|Overall Study|Adverse Event|4|||
147031554|NCT02387983|530278615|FG000|Overall Study|Protocol Violation|1|||
147031555|NCT02387983|530278615|FG000|Overall Study|Withdrawal by Subject|2|||
147031556|NCT00077857|530278616|FG000|Overall Study|Adverse Event|30|||
147031557|NCT00077857|530278617|FG001|Overall Study|Adverse Event|32|||
147031558|NCT00077857|530278616|FG000|Overall Study|Death|7|||
147031559|NCT00077857|530278617|FG001|Overall Study|Death|3|||
147031560|NCT00077857|530278616|FG000|Overall Study|Insufficient therapeutic response|112|||
147031561|NCT00077857|530278617|FG001|Overall Study|Insufficient therapeutic response|128|||
147031562|NCT00077857|530278616|FG000|Overall Study|Violation of selection criteria at entry|3|||
147031563|NCT00077857|530278617|FG001|Overall Study|Violation of selection criteria at entry|1|||
147031564|NCT00077857|530278616|FG000|Overall Study|Other protocol violation|0|||
146849647|NCT02663518|529618853|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
146849648|NCT02663518|529618854|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
147031565|NCT00077857|530278617|FG001|Overall Study|Other protocol violation|1|||
147031566|NCT00077857|530278616|FG000|Overall Study|Refused treatment|29|||
147031567|NCT00077857|530278617|FG001|Overall Study|Refused treatment|21|||
147031568|NCT00077857|530278616|FG000|Overall Study|Failure to return|5|||
147031569|NCT00077857|530278617|FG001|Overall Study|Failure to return|5|||
147031570|NCT00077857|530278616|FG000|Overall Study|Other|15|||
147031571|NCT00077857|530278617|FG001|Overall Study|Other|13|||
147031572|NCT04480021|530278618|FG000|Overall Study|Lost to Follow-up|3|||
147031573|NCT04480021|530278619|FG001|Overall Study|Lost to Follow-up|4|||
147031574|NCT01096368|530278622|FG000|Overall Study|Death|0|||
147031575|NCT01096368|530278623|FG001|Overall Study|Death|1|||
147031576|NCT01096368|530278624|FG002|Overall Study|Death|0|||
147031577|NCT01096368|530278625|FG003|Overall Study|Death|0|||
147031578|NCT01096368|530278626|FG004|Overall Study|Death|0|||
147031579|NCT01096368|530278622|FG000|Overall Study|Physician Decision|0|||
147031580|NCT01096368|530278623|FG001|Overall Study|Physician Decision|13|||
147031581|NCT01096368|530278624|FG002|Overall Study|Physician Decision|2|||
147031582|NCT01096368|530278625|FG003|Overall Study|Physician Decision|4|||
147031583|NCT01096368|530278626|FG004|Overall Study|Physician Decision|6|||
147031584|NCT01096368|530278622|FG000|Overall Study|Withdrawal by Subject|0|||
147031585|NCT01096368|530278623|FG001|Overall Study|Withdrawal by Subject|52|||
147031586|NCT01096368|530278624|FG002|Overall Study|Withdrawal by Subject|0|||
147031587|NCT01096368|530278625|FG003|Overall Study|Withdrawal by Subject|10|||
147031588|NCT01096368|530278626|FG004|Overall Study|Withdrawal by Subject|14|||
147031589|NCT01096368|530278622|FG000|Overall Study|Ineligible|0|||
147031590|NCT01096368|530278623|FG001|Overall Study|Ineligible|3|||
147031591|NCT01096368|530278624|FG002|Overall Study|Ineligible|2|||
147031592|NCT01096368|530278625|FG003|Overall Study|Ineligible|0|||
147031593|NCT01096368|530278626|FG004|Overall Study|Ineligible|25|||
147031594|NCT01096368|530278622|FG000|Overall Study|Did not start treatment|0|||
147031595|NCT01096368|530278623|FG001|Overall Study|Did not start treatment|4|||
147031596|NCT01096368|530278624|FG002|Overall Study|Did not start treatment|4|||
147031597|NCT01096368|530278625|FG003|Overall Study|Did not start treatment|0|||
147031598|NCT01096368|530278626|FG004|Overall Study|Did not start treatment|0|||
147031599|NCT01096368|530278622|FG000|Overall Study|Progressive disease|0|||
147031600|NCT01096368|530278623|FG001|Overall Study|Progressive disease|6|||
147031601|NCT01096368|530278624|FG002|Overall Study|Progressive disease|0|||
147031602|NCT01096368|530278625|FG003|Overall Study|Progressive disease|10|||
147031603|NCT01096368|530278626|FG004|Overall Study|Progressive disease|3|||
147031604|NCT01096368|530278622|FG000|Overall Study|Other|0|||
147031605|NCT01096368|530278623|FG001|Overall Study|Other|0|||
147031606|NCT01096368|530278624|FG002|Overall Study|Other|1|||
147031607|NCT01096368|530278625|FG003|Overall Study|Other|0|||
147031608|NCT01096368|530278626|FG004|Overall Study|Other|0|||
147031609|NCT01096368|530278622|FG000|Overall Study|Treated with institutional review|0|||
147031610|NCT01096368|530278623|FG001|Overall Study|Treated with institutional review|0|||
147031611|NCT01096368|530278624|FG002|Overall Study|Treated with institutional review|0|||
147031612|NCT01096368|530278625|FG003|Overall Study|Treated with institutional review|0|||
147031613|NCT01096368|530278626|FG004|Overall Study|Treated with institutional review|1|||
147031614|NCT06187909|530278627|FG000|Overall Study|Withdrawal by Subject|2|||
147031615|NCT06187909|530278628|FG001|Overall Study|Withdrawal by Subject|2|||
147031616|NCT06354998|530278629|FG000|Overall Study|Withdrawal by Subject|3|||
147031617|NCT06354998|530278630|FG001|Overall Study|Withdrawal by Subject|0|||
147031618|NCT01763684|530278633|FG000|Overall Study|Study terminated early due to low enrollment|126|||
147031619|NCT01763684|530278634|FG001|Overall Study|Study terminated early due to low enrollment|127|||
147031620|NCT01763684|530278633|FG000|Overall Study|Study surgery not performed|7|||
147031621|NCT01763684|530278634|FG001|Overall Study|Study surgery not performed|6|||
147031622|NCT02987959|530278635|FG000|Overall Study|Grantor stopped supply of drugs|6|||
147031623|NCT00643565|530278638|FG000|Overall Study|Death|12|||
147031624|NCT00643565|530278639|FG001|Overall Study|Death|11|||
147031625|NCT00643565|530278638|FG000|Overall Study|Withdrawal by Subject|4|||
147031626|NCT00643565|530278639|FG001|Overall Study|Withdrawal by Subject|1|||
147031627|NCT00643565|530278638|FG000|Overall Study|Lost to Follow-up|0|||
147031628|NCT00643565|530278639|FG001|Overall Study|Lost to Follow-up|6|||
147031629|NCT00643565|530278638|FG000|Overall Study|Other|7|||
147031630|NCT00643565|530278639|FG001|Overall Study|Other|8|||
147031631|NCT00643565|530278638|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
147031632|NCT00643565|530278639|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
147031633|NCT00643565|530278638|FG000|Overall Study|Recurrence of Disease|2|||
147031634|NCT00643565|530278639|FG001|Overall Study|Recurrence of Disease|1|||
147031635|NCT00643565|530278638|FG000|Overall Study|Progression of Disease|18|||
147031636|NCT00643565|530278639|FG001|Overall Study|Progression of Disease|14|||
147031637|NCT00643565|530278638|FG000|Overall Study|Protocol Violation|3|||
147031638|NCT00643565|530278639|FG001|Overall Study|Protocol Violation|0|||
147031639|NCT00643565|530278638|FG000|Overall Study|Did Not Cooperate|0|||
147031640|NCT00643565|530278639|FG001|Overall Study|Did Not Cooperate|1|||
147031641|NCT00643565|530278638|FG000|Overall Study|Administrative|22|||
147031642|NCT00643565|530278639|FG001|Overall Study|Administrative|16|||
147031643|NCT00643565|530278638|FG000|Overall Study|Adverse Event|5|||
147031644|NCT00643565|530278639|FG001|Overall Study|Adverse Event|8|||
147031645|NCT04305496|530278644|FG000|Global Cohort|Withdrawal by Subject|13|||
147031646|NCT04305496|530278645|FG001|Global Cohort|Withdrawal by Subject|6|||
147031647|NCT04305496|530278644|FG000|Global Cohort|Physician Decision|1|||
147031648|NCT04305496|530278645|FG001|Global Cohort|Physician Decision|1|||
147031649|NCT04305496|530278644|FG000|Global Cohort|Subjective disease progression|16|||
147031650|NCT04305496|530278645|FG001|Global Cohort|Subjective disease progression|17|||
147031651|NCT04305496|530278644|FG000|Global Cohort|Condition under investigation worsened|209|||
147031652|NCT04305496|530278645|FG001|Global Cohort|Condition under investigation worsened|273|||
147031653|NCT04305496|530278644|FG000|Global Cohort|Protocol Violation|2|||
147031654|NCT04305496|530278645|FG001|Global Cohort|Protocol Violation|0|||
147031655|NCT04305496|530278644|FG000|Global Cohort|Adverse Event|44|||
147031656|NCT04305496|530278645|FG001|Global Cohort|Adverse Event|6|||
147031657|NCT04305496|530278644|FG000|Global Cohort|Death|3|||
147031658|NCT04305496|530278645|FG001|Global Cohort|Death|2|||
147031659|NCT04305496|530278644|FG000|Global Cohort|Any reason not specifically recorded|4|||
147031660|NCT04305496|530278645|FG001|Global Cohort|Any reason not specifically recorded|5|||
147031661|NCT04305496|530278644|FG000|China Cohort|Any reason not specifically recorded|1|||
147031662|NCT04305496|530278645|FG001|China Cohort|Any reason not specifically recorded|1|||
147031663|NCT04305496|530278644|FG000|China Cohort|Adverse Event|8|||
147031664|NCT04305496|530278645|FG001|China Cohort|Adverse Event|2|||
147031665|NCT04305496|530278644|FG000|China Cohort|Condition under investigation worsened|40|||
147031666|NCT04305496|530278645|FG001|China Cohort|Condition under investigation worsened|47|||
147031667|NCT04305496|530278644|FG000|China Cohort|Subjective disease progression|2|||
147031668|NCT04305496|530278645|FG001|China Cohort|Subjective disease progression|2|||
147031669|NCT04305496|530278644|FG000|China Cohort|Withdrawal by Subject|2|||
147031670|NCT04305496|530278645|FG001|China Cohort|Withdrawal by Subject|1|||
147031671|NCT01157897|530278646|FG000|Overall Study|Lost to Follow-up|2|||
147031672|NCT01157897|530278647|FG001|Overall Study|Lost to Follow-up|0|||
147031673|NCT01157897|530278648|FG002|Overall Study|Lost to Follow-up|0|||
147031674|NCT01157897|530278649|FG003|Overall Study|Lost to Follow-up|1|||
147031675|NCT01157897|530278646|FG000|Overall Study|Relocated|0|||
147031676|NCT01157897|530278647|FG001|Overall Study|Relocated|2|||
147031677|NCT01157897|530278648|FG002|Overall Study|Relocated|0|||
147031678|NCT01157897|530278649|FG003|Overall Study|Relocated|0|||
147031679|NCT00681590|530278650|FG000|Overall Study|Withdrawal by Subject|2|||
147031680|NCT00681590|530278651|FG001|Overall Study|Withdrawal by Subject|12|||
147031681|NCT02912650|530278652|FG000|Overall Study|Withdrawal by Subject|1|||
147031682|NCT02912650|530278653|FG001|Overall Study|Withdrawal by Subject|0|||
147031683|NCT02912650|530278654|FG002|Overall Study|Withdrawal by Subject|1|||
147031684|NCT02912650|530278655|FG003|Overall Study|Withdrawal by Subject|5|||
147031685|NCT02912650|530278652|FG000|Overall Study|Adverse Event|0|||
147031686|NCT02912650|530278653|FG001|Overall Study|Adverse Event|0|||
147031687|NCT02912650|530278654|FG002|Overall Study|Adverse Event|1|||
147031688|NCT02912650|530278655|FG003|Overall Study|Adverse Event|0|||
147031689|NCT01791153|530278657|FG000|Part 1: Blinded Period|Adverse Event|7|||
147031690|NCT01791153|530278658|FG001|Part 1: Blinded Period|Adverse Event|3|||
147031691|NCT01791153|530278659|FG002|Part 1: Blinded Period|Adverse Event|2|||
147031692|NCT01791153|530278660|FG003|Part 1: Blinded Period|Adverse Event|0|||
147031693|NCT01791153|530278661|FG004|Part 1: Blinded Period|Adverse Event|0|||
147031694|NCT01791153|530278662|FG005|Part 1: Blinded Period|Adverse Event|0|||
147031695|NCT01791153|530278663|FG006|Part 1: Blinded Period|Adverse Event|0|||
147031696|NCT01791153|530278664|FG007|Part 1: Blinded Period|Adverse Event|0|||
147031697|NCT01791153|530278657|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
147031698|NCT01791153|530278658|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
147031699|NCT01791153|530278659|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
147031700|NCT01791153|530278660|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
147031701|NCT01791153|530278661|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
147031702|NCT01791153|530278662|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
147031703|NCT01791153|530278663|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
147031704|NCT01791153|530278664|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
147031705|NCT01791153|530278657|FG000|Part 1: Blinded Period|Non-Compliance|1|||
147031706|NCT01791153|530278658|FG001|Part 1: Blinded Period|Non-Compliance|0|||
147031707|NCT01791153|530278659|FG002|Part 1: Blinded Period|Non-Compliance|0|||
147031708|NCT01791153|530278660|FG003|Part 1: Blinded Period|Non-Compliance|0|||
147031709|NCT01791153|530278661|FG004|Part 1: Blinded Period|Non-Compliance|0|||
147031710|NCT01791153|530278662|FG005|Part 1: Blinded Period|Non-Compliance|0|||
147031711|NCT01791153|530278663|FG006|Part 1: Blinded Period|Non-Compliance|0|||
147031712|NCT01791153|530278664|FG007|Part 1: Blinded Period|Non-Compliance|0|||
147031713|NCT01791153|530278657|FG000|Part 1: Blinded Period|Physician Decision|0|||
147031714|NCT01791153|530278658|FG001|Part 1: Blinded Period|Physician Decision|0|||
147031715|NCT01791153|530278659|FG002|Part 1: Blinded Period|Physician Decision|0|||
147031716|NCT01791153|530278660|FG003|Part 1: Blinded Period|Physician Decision|1|||
147031717|NCT01791153|530278661|FG004|Part 1: Blinded Period|Physician Decision|0|||
147031718|NCT01791153|530278662|FG005|Part 1: Blinded Period|Physician Decision|0|||
147031719|NCT01791153|530278663|FG006|Part 1: Blinded Period|Physician Decision|0|||
147031720|NCT01791153|530278664|FG007|Part 1: Blinded Period|Physician Decision|0|||
147031721|NCT01791153|530278657|FG000|Part 1: Blinded Period|Protocol Violation|0|||
146849649|NCT02663518|529618855|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
147031722|NCT01791153|530278658|FG001|Part 1: Blinded Period|Protocol Violation|0|||
147031723|NCT01791153|530278659|FG002|Part 1: Blinded Period|Protocol Violation|0|||
147031724|NCT01791153|530278660|FG003|Part 1: Blinded Period|Protocol Violation|1|||
147031725|NCT01791153|530278661|FG004|Part 1: Blinded Period|Protocol Violation|0|||
147031726|NCT01791153|530278662|FG005|Part 1: Blinded Period|Protocol Violation|0|||
146849650|NCT02663518|529618856|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
147031727|NCT01791153|530278663|FG006|Part 1: Blinded Period|Protocol Violation|0|||
147031728|NCT01791153|530278664|FG007|Part 1: Blinded Period|Protocol Violation|0|||
147031729|NCT01791153|530278657|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
147031730|NCT01791153|530278658|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
147031731|NCT01791153|530278659|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
147031732|NCT01791153|530278660|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
147031733|NCT01791153|530278661|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
147031734|NCT01791153|530278662|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
147031735|NCT01791153|530278663|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
147031736|NCT01791153|530278664|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
147031737|NCT01791153|530278657|FG000|Part 2: Open-label Period|Adverse Event|0|||
147031738|NCT01791153|530278658|FG001|Part 2: Open-label Period|Adverse Event|0|||
147031739|NCT01791153|530278659|FG002|Part 2: Open-label Period|Adverse Event|0|||
147031740|NCT01791153|530278660|FG003|Part 2: Open-label Period|Adverse Event|0|||
147031741|NCT01791153|530278661|FG004|Part 2: Open-label Period|Adverse Event|0|||
147031742|NCT01791153|530278662|FG005|Part 2: Open-label Period|Adverse Event|1|||
147031743|NCT01791153|530278663|FG006|Part 2: Open-label Period|Adverse Event|1|||
147031744|NCT01791153|530278664|FG007|Part 2: Open-label Period|Adverse Event|2|||
147031745|NCT01791153|530278657|FG000|Part 2: Open-label Period|Death|0|||
147031746|NCT01791153|530278658|FG001|Part 2: Open-label Period|Death|0|||
147031747|NCT01791153|530278659|FG002|Part 2: Open-label Period|Death|0|||
147031748|NCT01791153|530278660|FG003|Part 2: Open-label Period|Death|0|||
147031749|NCT01791153|530278661|FG004|Part 2: Open-label Period|Death|0|||
147031750|NCT01791153|530278662|FG005|Part 2: Open-label Period|Death|1|||
147031751|NCT01791153|530278663|FG006|Part 2: Open-label Period|Death|1|||
147031752|NCT01791153|530278664|FG007|Part 2: Open-label Period|Death|1|||
147031753|NCT01791153|530278657|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
147031754|NCT01791153|530278658|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
147031755|NCT01791153|530278659|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
147031756|NCT01791153|530278660|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
147031757|NCT01791153|530278661|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
147031758|NCT01791153|530278662|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
147031759|NCT01791153|530278663|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
147031760|NCT01791153|530278664|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
147031761|NCT01791153|530278657|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
147031762|NCT01791153|530278658|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
147031763|NCT01791153|530278659|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
147031764|NCT01791153|530278660|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
147031765|NCT01791153|530278661|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
147031766|NCT01791153|530278662|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
147031767|NCT01791153|530278663|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
147031768|NCT01791153|530278664|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
147031769|NCT01791153|530278657|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
147031770|NCT01791153|530278658|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
147031771|NCT01791153|530278659|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
147031772|NCT01791153|530278660|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
147031773|NCT01791153|530278661|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
147031774|NCT01791153|530278662|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
147031775|NCT01791153|530278663|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
147031776|NCT01791153|530278664|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
147031777|NCT01791153|530278657|FG000|Part 2: Open-label Period|Physician Decision|0|||
147031778|NCT01791153|530278658|FG001|Part 2: Open-label Period|Physician Decision|0|||
147031779|NCT01791153|530278659|FG002|Part 2: Open-label Period|Physician Decision|0|||
147031780|NCT01791153|530278660|FG003|Part 2: Open-label Period|Physician Decision|0|||
147031781|NCT01791153|530278661|FG004|Part 2: Open-label Period|Physician Decision|1|||
147031782|NCT01791153|530278662|FG005|Part 2: Open-label Period|Physician Decision|1|||
147031783|NCT01791153|530278663|FG006|Part 2: Open-label Period|Physician Decision|0|||
147031784|NCT01791153|530278664|FG007|Part 2: Open-label Period|Physician Decision|0|||
147031785|NCT01121666|530278672|FG000|Overall Study|Protocol Violation|29|||
147031786|NCT01121666|530278673|FG001|Overall Study|Protocol Violation|10|||
147031787|NCT02132754|530278676|FG000|Overall Study|Adverse Event|0|||
147031788|NCT02132754|530278677|FG001|Overall Study|Adverse Event|0|||
147031789|NCT02132754|530278678|FG002|Overall Study|Adverse Event|0|||
147031790|NCT02132754|530278679|FG003|Overall Study|Adverse Event|0|||
147031791|NCT02132754|530278680|FG004|Overall Study|Adverse Event|0|||
147031792|NCT02132754|530278681|FG005|Overall Study|Adverse Event|0|||
147031793|NCT02132754|530278682|FG006|Overall Study|Adverse Event|0|||
147031794|NCT02132754|530278683|FG007|Overall Study|Adverse Event|0|||
147031795|NCT02132754|530278684|FG008|Overall Study|Adverse Event|0|||
147031796|NCT02132754|530278685|FG009|Overall Study|Adverse Event|0|||
147031797|NCT02132754|530278686|FG010|Overall Study|Adverse Event|0|||
147031798|NCT02132754|530278687|FG011|Overall Study|Adverse Event|0|||
147031799|NCT02132754|530278688|FG012|Overall Study|Adverse Event|0|||
147031800|NCT02132754|530278689|FG013|Overall Study|Adverse Event|0|||
147031801|NCT02132754|530278690|FG014|Overall Study|Adverse Event|0|||
147031802|NCT02132754|530278691|FG015|Overall Study|Adverse Event|0|||
147031803|NCT02132754|530278692|FG016|Overall Study|Adverse Event|0|||
147031804|NCT02132754|530278693|FG017|Overall Study|Adverse Event|1|||
147031805|NCT02132754|530278694|FG018|Overall Study|Adverse Event|0|||
147031806|NCT02132754|530278695|FG019|Overall Study|Adverse Event|0|||
147031807|NCT02132754|530278696|FG020|Overall Study|Adverse Event|0|||
147031808|NCT02132754|530278697|FG021|Overall Study|Adverse Event|0|||
147031809|NCT02132754|530278698|FG022|Overall Study|Adverse Event|0|||
147031810|NCT02132754|530278699|FG023|Overall Study|Adverse Event|0|||
147031811|NCT02132754|530278700|FG024|Overall Study|Adverse Event|0|||
147031812|NCT02132754|530278701|FG025|Overall Study|Adverse Event|1|||
147031813|NCT02132754|530278702|FG026|Overall Study|Adverse Event|1|||
147031814|NCT02132754|530278703|FG027|Overall Study|Adverse Event|0|||
147031815|NCT02132754|530278704|FG028|Overall Study|Adverse Event|0|||
147031816|NCT02132754|530278705|FG029|Overall Study|Adverse Event|0|||
147031817|NCT02132754|530278706|FG030|Overall Study|Adverse Event|1|||
147031818|NCT02132754|530278707|FG031|Overall Study|Adverse Event|0|||
147031819|NCT02132754|530278708|FG032|Overall Study|Adverse Event|1|||
147031820|NCT02132754|530278709|FG033|Overall Study|Adverse Event|1|||
147031821|NCT02132754|530278676|FG000|Overall Study|Clinical Progression|0|||
147031822|NCT02132754|530278677|FG001|Overall Study|Clinical Progression|0|||
147031823|NCT02132754|530278678|FG002|Overall Study|Clinical Progression|0|||
147031824|NCT02132754|530278679|FG003|Overall Study|Clinical Progression|0|||
147031825|NCT02132754|530278680|FG004|Overall Study|Clinical Progression|0|||
147031826|NCT02132754|530278681|FG005|Overall Study|Clinical Progression|0|||
147031827|NCT02132754|530278682|FG006|Overall Study|Clinical Progression|0|||
147031828|NCT02132754|530278683|FG007|Overall Study|Clinical Progression|0|||
147031829|NCT02132754|530278684|FG008|Overall Study|Clinical Progression|0|||
147031830|NCT02132754|530278685|FG009|Overall Study|Clinical Progression|1|||
147031831|NCT02132754|530278686|FG010|Overall Study|Clinical Progression|0|||
147031832|NCT02132754|530278687|FG011|Overall Study|Clinical Progression|0|||
147031833|NCT02132754|530278688|FG012|Overall Study|Clinical Progression|0|||
147031834|NCT02132754|530278689|FG013|Overall Study|Clinical Progression|0|||
147031835|NCT02132754|530278690|FG014|Overall Study|Clinical Progression|0|||
147031836|NCT02132754|530278691|FG015|Overall Study|Clinical Progression|0|||
147031837|NCT02132754|530278692|FG016|Overall Study|Clinical Progression|1|||
147031838|NCT02132754|530278693|FG017|Overall Study|Clinical Progression|1|||
147031839|NCT02132754|530278694|FG018|Overall Study|Clinical Progression|0|||
147031840|NCT02132754|530278695|FG019|Overall Study|Clinical Progression|1|||
147031841|NCT02132754|530278696|FG020|Overall Study|Clinical Progression|0|||
147031842|NCT02132754|530278697|FG021|Overall Study|Clinical Progression|0|||
147031843|NCT02132754|530278698|FG022|Overall Study|Clinical Progression|1|||
147031844|NCT02132754|530278699|FG023|Overall Study|Clinical Progression|0|||
147031845|NCT02132754|530278700|FG024|Overall Study|Clinical Progression|1|||
147031846|NCT02132754|530278701|FG025|Overall Study|Clinical Progression|1|||
147031847|NCT02132754|530278702|FG026|Overall Study|Clinical Progression|0|||
147031848|NCT02132754|530278703|FG027|Overall Study|Clinical Progression|1|||
147031849|NCT02132754|530278704|FG028|Overall Study|Clinical Progression|1|||
147031850|NCT02132754|530278705|FG029|Overall Study|Clinical Progression|0|||
147031851|NCT02132754|530278706|FG030|Overall Study|Clinical Progression|1|||
147031852|NCT02132754|530278707|FG031|Overall Study|Clinical Progression|0|||
147031853|NCT02132754|530278708|FG032|Overall Study|Clinical Progression|0|||
147031854|NCT02132754|530278709|FG033|Overall Study|Clinical Progression|2|||
147031855|NCT02132754|530278676|FG000|Overall Study|Death|0|||
147031856|NCT02132754|530278677|FG001|Overall Study|Death|0|||
147031857|NCT02132754|530278678|FG002|Overall Study|Death|0|||
147031858|NCT02132754|530278679|FG003|Overall Study|Death|0|||
147031859|NCT02132754|530278680|FG004|Overall Study|Death|0|||
147031860|NCT02132754|530278681|FG005|Overall Study|Death|0|||
147031861|NCT02132754|530278682|FG006|Overall Study|Death|0|||
147031862|NCT02132754|530278683|FG007|Overall Study|Death|0|||
147031863|NCT02132754|530278684|FG008|Overall Study|Death|0|||
147031864|NCT02132754|530278685|FG009|Overall Study|Death|0|||
147031865|NCT02132754|530278686|FG010|Overall Study|Death|0|||
147031866|NCT02132754|530278687|FG011|Overall Study|Death|0|||
147031867|NCT02132754|530278688|FG012|Overall Study|Death|0|||
147031868|NCT02132754|530278689|FG013|Overall Study|Death|0|||
147031869|NCT02132754|530278690|FG014|Overall Study|Death|0|||
147031870|NCT02132754|530278691|FG015|Overall Study|Death|1|||
147031871|NCT02132754|530278692|FG016|Overall Study|Death|0|||
147031872|NCT02132754|530278693|FG017|Overall Study|Death|0|||
147031873|NCT02132754|530278694|FG018|Overall Study|Death|0|||
147031874|NCT02132754|530278695|FG019|Overall Study|Death|1|||
147031875|NCT02132754|530278696|FG020|Overall Study|Death|0|||
147031876|NCT02132754|530278697|FG021|Overall Study|Death|1|||
147031877|NCT02132754|530278698|FG022|Overall Study|Death|0|||
147031878|NCT02132754|530278699|FG023|Overall Study|Death|0|||
147031879|NCT02132754|530278700|FG024|Overall Study|Death|0|||
147031880|NCT02132754|530278701|FG025|Overall Study|Death|0|||
147031881|NCT02132754|530278702|FG026|Overall Study|Death|1|||
147031882|NCT02132754|530278703|FG027|Overall Study|Death|0|||
147031883|NCT02132754|530278704|FG028|Overall Study|Death|0|||
147031884|NCT02132754|530278705|FG029|Overall Study|Death|0|||
147031885|NCT02132754|530278706|FG030|Overall Study|Death|0|||
147031886|NCT02132754|530278707|FG031|Overall Study|Death|0|||
147031887|NCT02132754|530278708|FG032|Overall Study|Death|0|||
147031888|NCT02132754|530278709|FG033|Overall Study|Death|2|||
147031889|NCT02132754|530278676|FG000|Overall Study|Excluded Medication|0|||
147031890|NCT02132754|530278677|FG001|Overall Study|Excluded Medication|0|||
147031891|NCT02132754|530278678|FG002|Overall Study|Excluded Medication|0|||
147031892|NCT02132754|530278679|FG003|Overall Study|Excluded Medication|0|||
147031893|NCT02132754|530278680|FG004|Overall Study|Excluded Medication|0|||
147031894|NCT02132754|530278681|FG005|Overall Study|Excluded Medication|0|||
147031895|NCT02132754|530278682|FG006|Overall Study|Excluded Medication|0|||
147031896|NCT02132754|530278683|FG007|Overall Study|Excluded Medication|0|||
147031897|NCT02132754|530278684|FG008|Overall Study|Excluded Medication|0|||
147031898|NCT02132754|530278685|FG009|Overall Study|Excluded Medication|0|||
147031899|NCT02132754|530278686|FG010|Overall Study|Excluded Medication|0|||
147031900|NCT02132754|530278687|FG011|Overall Study|Excluded Medication|0|||
147031901|NCT02132754|530278688|FG012|Overall Study|Excluded Medication|0|||
147031902|NCT02132754|530278689|FG013|Overall Study|Excluded Medication|0|||
147031903|NCT02132754|530278690|FG014|Overall Study|Excluded Medication|0|||
147031904|NCT02132754|530278691|FG015|Overall Study|Excluded Medication|0|||
147031905|NCT02132754|530278692|FG016|Overall Study|Excluded Medication|0|||
147031906|NCT02132754|530278693|FG017|Overall Study|Excluded Medication|0|||
147031907|NCT02132754|530278694|FG018|Overall Study|Excluded Medication|0|||
147031908|NCT02132754|530278695|FG019|Overall Study|Excluded Medication|0|||
147031909|NCT02132754|530278696|FG020|Overall Study|Excluded Medication|1|||
147031910|NCT02132754|530278697|FG021|Overall Study|Excluded Medication|0|||
147031911|NCT02132754|530278698|FG022|Overall Study|Excluded Medication|0|||
147031912|NCT02132754|530278699|FG023|Overall Study|Excluded Medication|0|||
147031913|NCT02132754|530278700|FG024|Overall Study|Excluded Medication|0|||
147031914|NCT02132754|530278701|FG025|Overall Study|Excluded Medication|0|||
147031915|NCT02132754|530278702|FG026|Overall Study|Excluded Medication|0|||
147031916|NCT02132754|530278703|FG027|Overall Study|Excluded Medication|0|||
147031917|NCT02132754|530278704|FG028|Overall Study|Excluded Medication|0|||
147031918|NCT02132754|530278705|FG029|Overall Study|Excluded Medication|0|||
147031919|NCT02132754|530278706|FG030|Overall Study|Excluded Medication|0|||
147031920|NCT02132754|530278707|FG031|Overall Study|Excluded Medication|0|||
147031921|NCT02132754|530278708|FG032|Overall Study|Excluded Medication|0|||
147031922|NCT02132754|530278709|FG033|Overall Study|Excluded Medication|1|||
147031923|NCT02132754|530278676|FG000|Overall Study|Physician Decision|0|||
147031924|NCT02132754|530278677|FG001|Overall Study|Physician Decision|0|||
147031925|NCT02132754|530278678|FG002|Overall Study|Physician Decision|0|||
147031926|NCT02132754|530278679|FG003|Overall Study|Physician Decision|0|||
147031927|NCT02132754|530278680|FG004|Overall Study|Physician Decision|0|||
147031928|NCT02132754|530278681|FG005|Overall Study|Physician Decision|0|||
147031929|NCT02132754|530278682|FG006|Overall Study|Physician Decision|0|||
147031930|NCT02132754|530278683|FG007|Overall Study|Physician Decision|0|||
147031931|NCT02132754|530278684|FG008|Overall Study|Physician Decision|0|||
147031932|NCT02132754|530278685|FG009|Overall Study|Physician Decision|1|||
147031933|NCT02132754|530278686|FG010|Overall Study|Physician Decision|0|||
147031934|NCT02132754|530278687|FG011|Overall Study|Physician Decision|1|||
147031935|NCT02132754|530278688|FG012|Overall Study|Physician Decision|1|||
147031936|NCT02132754|530278689|FG013|Overall Study|Physician Decision|0|||
147031937|NCT02132754|530278690|FG014|Overall Study|Physician Decision|0|||
147031938|NCT02132754|530278691|FG015|Overall Study|Physician Decision|1|||
147031939|NCT02132754|530278692|FG016|Overall Study|Physician Decision|0|||
147031940|NCT02132754|530278693|FG017|Overall Study|Physician Decision|0|||
147031941|NCT02132754|530278694|FG018|Overall Study|Physician Decision|0|||
147031942|NCT02132754|530278695|FG019|Overall Study|Physician Decision|0|||
147031943|NCT02132754|530278696|FG020|Overall Study|Physician Decision|0|||
147031944|NCT02132754|530278697|FG021|Overall Study|Physician Decision|0|||
147031945|NCT02132754|530278698|FG022|Overall Study|Physician Decision|0|||
147031946|NCT02132754|530278699|FG023|Overall Study|Physician Decision|0|||
147031947|NCT02132754|530278700|FG024|Overall Study|Physician Decision|1|||
147031948|NCT02132754|530278701|FG025|Overall Study|Physician Decision|0|||
147031949|NCT02132754|530278702|FG026|Overall Study|Physician Decision|0|||
147031950|NCT02132754|530278703|FG027|Overall Study|Physician Decision|0|||
147031951|NCT02132754|530278704|FG028|Overall Study|Physician Decision|0|||
147031952|NCT02132754|530278705|FG029|Overall Study|Physician Decision|0|||
147031953|NCT02132754|530278706|FG030|Overall Study|Physician Decision|0|||
147031954|NCT02132754|530278707|FG031|Overall Study|Physician Decision|1|||
147031955|NCT02132754|530278708|FG032|Overall Study|Physician Decision|0|||
147031956|NCT02132754|530278709|FG033|Overall Study|Physician Decision|3|||
147031957|NCT02132754|530278676|FG000|Overall Study|Progressive Disease|1|||
147031958|NCT02132754|530278677|FG001|Overall Study|Progressive Disease|1|||
147031959|NCT02132754|530278678|FG002|Overall Study|Progressive Disease|1|||
147031960|NCT02132754|530278679|FG003|Overall Study|Progressive Disease|1|||
147031961|NCT02132754|530278680|FG004|Overall Study|Progressive Disease|1|||
147031962|NCT02132754|530278681|FG005|Overall Study|Progressive Disease|1|||
147031963|NCT02132754|530278682|FG006|Overall Study|Progressive Disease|1|||
147031964|NCT02132754|530278683|FG007|Overall Study|Progressive Disease|1|||
147031965|NCT02132754|530278684|FG008|Overall Study|Progressive Disease|1|||
147031966|NCT02132754|530278685|FG009|Overall Study|Progressive Disease|3|||
147031967|NCT02132754|530278686|FG010|Overall Study|Progressive Disease|3|||
147031968|NCT02132754|530278687|FG011|Overall Study|Progressive Disease|2|||
147031969|NCT02132754|530278688|FG012|Overall Study|Progressive Disease|2|||
147031970|NCT02132754|530278689|FG013|Overall Study|Progressive Disease|3|||
147031971|NCT02132754|530278690|FG014|Overall Study|Progressive Disease|2|||
147031972|NCT02132754|530278691|FG015|Overall Study|Progressive Disease|1|||
147031973|NCT02132754|530278692|FG016|Overall Study|Progressive Disease|2|||
147031974|NCT02132754|530278693|FG017|Overall Study|Progressive Disease|1|||
147031975|NCT02132754|530278694|FG018|Overall Study|Progressive Disease|3|||
147031976|NCT02132754|530278695|FG019|Overall Study|Progressive Disease|1|||
147031977|NCT02132754|530278696|FG020|Overall Study|Progressive Disease|1|||
147031978|NCT02132754|530278697|FG021|Overall Study|Progressive Disease|3|||
147031979|NCT02132754|530278698|FG022|Overall Study|Progressive Disease|2|||
147031980|NCT02132754|530278699|FG023|Overall Study|Progressive Disease|3|||
147031981|NCT02132754|530278700|FG024|Overall Study|Progressive Disease|0|||
147031982|NCT02132754|530278701|FG025|Overall Study|Progressive Disease|1|||
147031983|NCT02132754|530278702|FG026|Overall Study|Progressive Disease|2|||
147031984|NCT02132754|530278703|FG027|Overall Study|Progressive Disease|1|||
147031985|NCT02132754|530278704|FG028|Overall Study|Progressive Disease|2|||
147031986|NCT02132754|530278705|FG029|Overall Study|Progressive Disease|3|||
147031987|NCT02132754|530278706|FG030|Overall Study|Progressive Disease|1|||
147031988|NCT02132754|530278707|FG031|Overall Study|Progressive Disease|1|||
147031989|NCT02132754|530278708|FG032|Overall Study|Progressive Disease|3|||
147031990|NCT02132754|530278709|FG033|Overall Study|Progressive Disease|6|||
147031991|NCT02132754|530278676|FG000|Overall Study|Screen Failure|0|||
147031992|NCT02132754|530278677|FG001|Overall Study|Screen Failure|0|||
147031993|NCT02132754|530278678|FG002|Overall Study|Screen Failure|0|||
147031994|NCT02132754|530278679|FG003|Overall Study|Screen Failure|0|||
147031995|NCT02132754|530278680|FG004|Overall Study|Screen Failure|0|||
147031996|NCT02132754|530278681|FG005|Overall Study|Screen Failure|0|||
147031997|NCT02132754|530278682|FG006|Overall Study|Screen Failure|0|||
147031998|NCT02132754|530278683|FG007|Overall Study|Screen Failure|0|||
147031999|NCT02132754|530278684|FG008|Overall Study|Screen Failure|0|||
147032000|NCT02132754|530278685|FG009|Overall Study|Screen Failure|0|||
147032001|NCT02132754|530278686|FG010|Overall Study|Screen Failure|0|||
147032002|NCT02132754|530278687|FG011|Overall Study|Screen Failure|0|||
147032003|NCT02132754|530278688|FG012|Overall Study|Screen Failure|0|||
147032004|NCT02132754|530278689|FG013|Overall Study|Screen Failure|0|||
147032005|NCT02132754|530278690|FG014|Overall Study|Screen Failure|0|||
147032006|NCT02132754|530278691|FG015|Overall Study|Screen Failure|0|||
147032007|NCT02132754|530278692|FG016|Overall Study|Screen Failure|0|||
147032008|NCT02132754|530278693|FG017|Overall Study|Screen Failure|0|||
147032009|NCT02132754|530278694|FG018|Overall Study|Screen Failure|0|||
147032010|NCT02132754|530278695|FG019|Overall Study|Screen Failure|1|||
147032011|NCT02132754|530278696|FG020|Overall Study|Screen Failure|0|||
147032012|NCT02132754|530278697|FG021|Overall Study|Screen Failure|1|||
147032013|NCT02132754|530278698|FG022|Overall Study|Screen Failure|0|||
147032014|NCT02132754|530278699|FG023|Overall Study|Screen Failure|0|||
147032015|NCT02132754|530278700|FG024|Overall Study|Screen Failure|0|||
147032016|NCT02132754|530278701|FG025|Overall Study|Screen Failure|0|||
147032017|NCT02132754|530278702|FG026|Overall Study|Screen Failure|0|||
147032018|NCT02132754|530278703|FG027|Overall Study|Screen Failure|0|||
147032019|NCT02132754|530278704|FG028|Overall Study|Screen Failure|0|||
147032020|NCT02132754|530278705|FG029|Overall Study|Screen Failure|0|||
147032021|NCT02132754|530278706|FG030|Overall Study|Screen Failure|0|||
147032022|NCT02132754|530278707|FG031|Overall Study|Screen Failure|0|||
147032023|NCT02132754|530278708|FG032|Overall Study|Screen Failure|0|||
147032024|NCT02132754|530278709|FG033|Overall Study|Screen Failure|0|||
147032025|NCT02132754|530278676|FG000|Overall Study|Transferred to Extension Study|0|||
147032026|NCT02132754|530278677|FG001|Overall Study|Transferred to Extension Study|0|||
147032027|NCT02132754|530278678|FG002|Overall Study|Transferred to Extension Study|0|||
147032028|NCT02132754|530278679|FG003|Overall Study|Transferred to Extension Study|0|||
147032029|NCT02132754|530278680|FG004|Overall Study|Transferred to Extension Study|0|||
147032030|NCT02132754|530278681|FG005|Overall Study|Transferred to Extension Study|0|||
147032031|NCT02132754|530278682|FG006|Overall Study|Transferred to Extension Study|0|||
147032032|NCT02132754|530278683|FG007|Overall Study|Transferred to Extension Study|0|||
147032033|NCT02132754|530278684|FG008|Overall Study|Transferred to Extension Study|0|||
147032034|NCT02132754|530278685|FG009|Overall Study|Transferred to Extension Study|0|||
147032035|NCT02132754|530278686|FG010|Overall Study|Transferred to Extension Study|0|||
147032036|NCT02132754|530278687|FG011|Overall Study|Transferred to Extension Study|0|||
147032037|NCT02132754|530278688|FG012|Overall Study|Transferred to Extension Study|0|||
147032038|NCT02132754|530278689|FG013|Overall Study|Transferred to Extension Study|0|||
147032039|NCT02132754|530278690|FG014|Overall Study|Transferred to Extension Study|0|||
146849651|NCT02663518|529618857|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
146849652|NCT02663518|529618858|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
147032040|NCT02132754|530278691|FG015|Overall Study|Transferred to Extension Study|0|||
147032041|NCT02132754|530278692|FG016|Overall Study|Transferred to Extension Study|0|||
147032042|NCT02132754|530278693|FG017|Overall Study|Transferred to Extension Study|0|||
147032043|NCT02132754|530278694|FG018|Overall Study|Transferred to Extension Study|0|||
147032044|NCT02132754|530278695|FG019|Overall Study|Transferred to Extension Study|0|||
147032045|NCT02132754|530278696|FG020|Overall Study|Transferred to Extension Study|0|||
147032046|NCT02132754|530278697|FG021|Overall Study|Transferred to Extension Study|0|||
147032047|NCT02132754|530278698|FG022|Overall Study|Transferred to Extension Study|0|||
147032048|NCT02132754|530278699|FG023|Overall Study|Transferred to Extension Study|0|||
147032049|NCT02132754|530278700|FG024|Overall Study|Transferred to Extension Study|0|||
147032050|NCT02132754|530278701|FG025|Overall Study|Transferred to Extension Study|0|||
147032051|NCT02132754|530278702|FG026|Overall Study|Transferred to Extension Study|0|||
147032052|NCT02132754|530278703|FG027|Overall Study|Transferred to Extension Study|0|||
147032053|NCT02132754|530278704|FG028|Overall Study|Transferred to Extension Study|0|||
147032054|NCT02132754|530278705|FG029|Overall Study|Transferred to Extension Study|0|||
147032055|NCT02132754|530278706|FG030|Overall Study|Transferred to Extension Study|0|||
147032056|NCT02132754|530278707|FG031|Overall Study|Transferred to Extension Study|0|||
147032057|NCT02132754|530278708|FG032|Overall Study|Transferred to Extension Study|0|||
147032058|NCT02132754|530278709|FG033|Overall Study|Transferred to Extension Study|6|||
147032059|NCT02132754|530278676|FG000|Overall Study|Withdrawal by Subject|0|||
147032060|NCT02132754|530278677|FG001|Overall Study|Withdrawal by Subject|0|||
147032061|NCT02132754|530278678|FG002|Overall Study|Withdrawal by Subject|0|||
147032062|NCT02132754|530278679|FG003|Overall Study|Withdrawal by Subject|0|||
147032063|NCT02132754|530278680|FG004|Overall Study|Withdrawal by Subject|0|||
147032064|NCT02132754|530278681|FG005|Overall Study|Withdrawal by Subject|0|||
147032065|NCT02132754|530278682|FG006|Overall Study|Withdrawal by Subject|0|||
147032066|NCT02132754|530278683|FG007|Overall Study|Withdrawal by Subject|0|||
147032067|NCT02132754|530278684|FG008|Overall Study|Withdrawal by Subject|0|||
147032068|NCT02132754|530278685|FG009|Overall Study|Withdrawal by Subject|1|||
147032069|NCT02132754|530278686|FG010|Overall Study|Withdrawal by Subject|0|||
147032070|NCT02132754|530278687|FG011|Overall Study|Withdrawal by Subject|0|||
147032071|NCT02132754|530278688|FG012|Overall Study|Withdrawal by Subject|1|||
147032072|NCT02132754|530278689|FG013|Overall Study|Withdrawal by Subject|0|||
147032073|NCT02132754|530278690|FG014|Overall Study|Withdrawal by Subject|1|||
147032074|NCT02132754|530278691|FG015|Overall Study|Withdrawal by Subject|2|||
147032075|NCT02132754|530278692|FG016|Overall Study|Withdrawal by Subject|1|||
147032076|NCT02132754|530278693|FG017|Overall Study|Withdrawal by Subject|0|||
147032077|NCT02132754|530278694|FG018|Overall Study|Withdrawal by Subject|0|||
147032078|NCT02132754|530278695|FG019|Overall Study|Withdrawal by Subject|0|||
147032079|NCT02132754|530278696|FG020|Overall Study|Withdrawal by Subject|1|||
147032080|NCT02132754|530278697|FG021|Overall Study|Withdrawal by Subject|0|||
147032081|NCT02132754|530278698|FG022|Overall Study|Withdrawal by Subject|0|||
147032082|NCT02132754|530278699|FG023|Overall Study|Withdrawal by Subject|0|||
147032083|NCT02132754|530278700|FG024|Overall Study|Withdrawal by Subject|1|||
147032084|NCT02132754|530278701|FG025|Overall Study|Withdrawal by Subject|0|||
147032085|NCT02132754|530278702|FG026|Overall Study|Withdrawal by Subject|0|||
147032086|NCT02132754|530278703|FG027|Overall Study|Withdrawal by Subject|1|||
147032087|NCT02132754|530278704|FG028|Overall Study|Withdrawal by Subject|0|||
147032088|NCT02132754|530278705|FG029|Overall Study|Withdrawal by Subject|0|||
147032089|NCT02132754|530278706|FG030|Overall Study|Withdrawal by Subject|0|||
147032090|NCT02132754|530278707|FG031|Overall Study|Withdrawal by Subject|1|||
147032091|NCT02132754|530278708|FG032|Overall Study|Withdrawal by Subject|0|||
147032092|NCT02132754|530278709|FG033|Overall Study|Withdrawal by Subject|2|||
147032093|NCT03825341|530281056|FG000|Overall Study|Withdrawal by Subject|0|||
147032094|NCT03825341|530281057|FG001|Overall Study|Withdrawal by Subject|1|||
147032095|NCT00552578|530281061|FG000|Overall Study|Lost to Follow-up|1|||
147032096|NCT00552578|530281062|FG001|Overall Study|Lost to Follow-up|1|||
147032097|NCT00470067|530281063|FG000|Overall Study|Death|1|||
147032098|NCT00470067|530281063|FG000|Overall Study|Disease Progression|6|||
147032099|NCT03678285|530281075|FG000|Overall Study|Adverse Event|2|||
147032100|NCT03678285|530281075|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
147032101|NCT03678285|530281075|FG000|Overall Study|Dehydrated prior to start of workout|1|||
147032102|NCT00123474|530281076|FG000|Randomized to Treatment|Randomized, never treated|1|||
147032103|NCT00123474|530281077|FG001|Randomized to Treatment|Randomized, never treated|4|||
147032104|NCT00123474|530281078|FG002|Randomized to Treatment|Randomized, never treated|2|||
147032105|NCT00123474|530281079|FG003|Randomized to Treatment|Randomized, never treated|1|||
147032106|NCT00123474|530281076|FG000|As Treated at Study Closure|not reported when site closed|1|||
147032107|NCT00123474|530281077|FG001|As Treated at Study Closure|not reported when site closed|0|||
147032108|NCT00123474|530281078|FG002|As Treated at Study Closure|not reported when site closed|1|||
147032109|NCT00123474|530281079|FG003|As Treated at Study Closure|not reported when site closed|0|||
147032110|NCT00123474|530281076|FG000|As Treated at Study Closure|Adverse Event|10|||
147032111|NCT00123474|530281077|FG001|As Treated at Study Closure|Adverse Event|4|||
147032112|NCT00123474|530281078|FG002|As Treated at Study Closure|Adverse Event|10|||
147032113|NCT00123474|530281079|FG003|As Treated at Study Closure|Adverse Event|8|||
147032114|NCT00123474|530281076|FG000|As Treated at Study Closure|Disease Progression|35|||
147032115|NCT00123474|530281077|FG001|As Treated at Study Closure|Disease Progression|42|||
147032116|NCT00123474|530281078|FG002|As Treated at Study Closure|Disease Progression|29|||
147032117|NCT00123474|530281079|FG003|As Treated at Study Closure|Disease Progression|27|||
147032118|NCT00123474|530281076|FG000|As Treated at Study Closure|Investigator Request|12|||
147032119|NCT00123474|530281077|FG001|As Treated at Study Closure|Investigator Request|6|||
147032120|NCT00123474|530281078|FG002|As Treated at Study Closure|Investigator Request|7|||
147032121|NCT00123474|530281079|FG003|As Treated at Study Closure|Investigator Request|5|||
147032122|NCT00123474|530281076|FG000|As Treated at Study Closure|non-specified|54|||
147032123|NCT00123474|530281077|FG001|As Treated at Study Closure|non-specified|47|||
147032124|NCT00123474|530281078|FG002|As Treated at Study Closure|non-specified|57|||
147032125|NCT00123474|530281079|FG003|As Treated at Study Closure|non-specified|60|||
147032126|NCT00123474|530281076|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
147032127|NCT00123474|530281077|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
147032128|NCT00123474|530281078|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
147032129|NCT00123474|530281079|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
147032130|NCT00123474|530281076|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
147032131|NCT00123474|530281077|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
147032132|NCT00123474|530281078|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
147032133|NCT00123474|530281079|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
147032134|NCT00616629|530281080|FG000|Overall Study|Protocol Violation|1|||
147032135|NCT00616629|530281081|FG001|Overall Study|Protocol Violation|2|||
147032136|NCT00616629|530281082|FG002|Overall Study|Protocol Violation|1|||
147032137|NCT00616629|530281083|FG003|Overall Study|Protocol Violation|0|||
147032138|NCT00616629|530281084|FG004|Overall Study|Protocol Violation|0|||
147032139|NCT00616629|530281080|FG000|Overall Study|AV-block|1|||
147032140|NCT00616629|530281081|FG001|Overall Study|AV-block|0|||
147032141|NCT00616629|530281082|FG002|Overall Study|AV-block|0|||
147032142|NCT00616629|530281083|FG003|Overall Study|AV-block|0|||
147032143|NCT00616629|530281084|FG004|Overall Study|AV-block|0|||
147032144|NCT00660400|530281088|FG000|Overall Study|Lack of insurance approval|1|||
147032145|NCT00660400|530281088|FG000|Overall Study|Suboptimal organ function|1|||
147032146|NCT00660400|530281088|FG000|Overall Study|Intracranial hemorrhage|1|||
147032147|NCT00660400|530281088|FG000|Overall Study|Withdrawal by Subject|1|||
147032148|NCT00085423|530281091|FG000|Overall Study|Withdrawal by Subject|1|||
147032149|NCT00085423|530281091|FG000|Overall Study|screen failure|1|||
147032150|NCT04740814|530281092|FG000|Overall Study|Adverse Event|3|||
147032151|NCT04740814|530281092|FG000|Overall Study|Protocol Violation|2|||
147032152|NCT04740814|530281092|FG000|Overall Study|Lost to Follow-up|2|||
147032153|NCT04740814|530281092|FG000|Overall Study|Withdrawal by Subject|3|||
147032154|NCT02500641|530281095|FG000|Overall Study|Adverse Event|0|||
147032155|NCT02500641|530281096|FG001|Overall Study|Adverse Event|2|||
147032156|NCT02500641|530281095|FG000|Overall Study|Withdrawal by Subject|4|||
147032157|NCT02500641|530281096|FG001|Overall Study|Withdrawal by Subject|5|||
147032158|NCT02500641|530281095|FG000|Overall Study|Unable to follow study procedures|3|||
147032159|NCT02500641|530281096|FG001|Overall Study|Unable to follow study procedures|2|||
147032160|NCT02500641|530281095|FG000|Overall Study|Protocol Violation|1|||
147032161|NCT02500641|530281096|FG001|Overall Study|Protocol Violation|2|||
147032162|NCT02500641|530281095|FG000|Overall Study|Lost to Follow-up|1|||
147032163|NCT02500641|530281096|FG001|Overall Study|Lost to Follow-up|0|||
147032164|NCT02500641|530281095|FG000|Overall Study|Sponsor decision|1|||
147032165|NCT02500641|530281096|FG001|Overall Study|Sponsor decision|0|||
147032166|NCT02500641|530281095|FG000|Overall Study|Non compliance to study drug|0|||
147032167|NCT02500641|530281096|FG001|Overall Study|Non compliance to study drug|1|||
147032168|NCT02317614|530281104|FG000|Overall Study|Lost to Follow-up|1|||
147032169|NCT02317614|530281105|FG001|Overall Study|Lost to Follow-up|1|||
147032170|NCT02317614|530281104|FG000|Overall Study|Withdrawal by Subject|1|||
147032171|NCT02317614|530281105|FG001|Overall Study|Withdrawal by Subject|0|||
147032172|NCT02317614|530281104|FG000|Overall Study|Death|1|||
147032173|NCT02317614|530281105|FG001|Overall Study|Death|1|||
147032174|NCT03285308|530281110|FG000|Overall Study|Adverse Event|3|||
147032175|NCT03285308|530281111|FG001|Overall Study|Adverse Event|7|||
147032176|NCT03285308|530281110|FG000|Overall Study|Withdrawal by Subject|8|||
147032177|NCT03285308|530281111|FG001|Overall Study|Withdrawal by Subject|9|||
147032178|NCT03285308|530281110|FG000|Overall Study|Lost to Follow-up|3|||
147032179|NCT03285308|530281111|FG001|Overall Study|Lost to Follow-up|1|||
147032180|NCT03285308|530281110|FG000|Overall Study|Protocol Deviation|6|||
147032181|NCT03285308|530281111|FG001|Overall Study|Protocol Deviation|5|||
147032182|NCT03285308|530281110|FG000|Overall Study|Reason not Specified|0|||
147032183|NCT03285308|530281111|FG001|Overall Study|Reason not Specified|1|||
147032184|NCT03283761|530281112|FG000|Study Treatment|Patient Non-Compliance|1|||
147032185|NCT03283761|530281112|FG000|Study Treatment|Alternative Cancer Therapy|7|||
147032186|NCT03283761|530281112|FG000|Study Treatment|Disease progression|21|||
147032187|NCT03283761|530281112|FG000|Study Treatment|Adverse Event|3|||
147032188|NCT03283761|530281112|FG000|Study Treatment|Withdrawal by Subject|4|||
147032189|NCT03283761|530281112|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
147032190|NCT03283761|530281112|FG000|Study Treatment|Symptomatic Deterioration|1|||
147032191|NCT03283761|530281112|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
147032192|NCT03283761|530281112|FG000|Follow up|Lost to Follow-up|1|||
147032193|NCT03283761|530281112|FG000|Follow up|Symptomatic Deterioration|1|||
147032194|NCT03283761|530281112|FG000|Follow up|Death|29|||
147032195|NCT03283761|530281112|FG000|Follow up|study terminated|4|||
147032196|NCT03283761|530281112|FG000|Follow up|Primary Investigator Withdrawal|1|||
147032197|NCT03283761|530281112|FG000|Follow up|Switched to alternative therapy|1|||
147032198|NCT03283761|530281112|FG000|Follow up|Subject is now in Hospice|1|||
147032199|NCT02283983|530281113|FG000|Overall Study|Inclusion criteria not met|0|||
147032200|NCT02283983|530281114|FG001|Overall Study|Inclusion criteria not met|1|||
147032201|NCT02283983|530281113|FG000|Overall Study|Withdrawal by Subject|4|||
147032202|NCT02283983|530281114|FG001|Overall Study|Withdrawal by Subject|2|||
147032203|NCT02283983|530281113|FG000|Overall Study|Protocol Violation|0|||
147032204|NCT02283983|530281114|FG001|Overall Study|Protocol Violation|4|||
147032205|NCT02283983|530281113|FG000|Overall Study|Physician Decision|2|||
147032206|NCT02283983|530281114|FG001|Overall Study|Physician Decision|4|||
147032207|NCT02283983|530281113|FG000|Overall Study|Death|1|||
147032208|NCT02283983|530281114|FG001|Overall Study|Death|0|||
147032209|NCT02283983|530281113|FG000|Overall Study|Adverse Event|1|||
147032210|NCT02283983|530281114|FG001|Overall Study|Adverse Event|0|||
147032211|NCT02283983|530281113|FG000|Overall Study|Lost to Follow-up|9|||
147032212|NCT02283983|530281114|FG001|Overall Study|Lost to Follow-up|8|||
147032213|NCT02283983|530281113|FG000|Overall Study|Relapse|1|||
147032214|NCT02283983|530281114|FG001|Overall Study|Relapse|0|||
147032215|NCT04453202|530281120|FG000|Overall Study|Adverse Event|0|||
147032216|NCT04453202|530281121|FG001|Overall Study|Adverse Event|0|||
147032217|NCT04453202|530281122|FG002|Overall Study|Adverse Event|0|||
147032218|NCT04453202|530281123|FG003|Overall Study|Adverse Event|0|||
147032219|NCT04453202|530281124|FG004|Overall Study|Adverse Event|0|||
147032220|NCT04453202|530281125|FG005|Overall Study|Adverse Event|0|||
147032221|NCT04453202|530281126|FG006|Overall Study|Adverse Event|1|||
147032222|NCT04453202|530281127|FG007|Overall Study|Adverse Event|0|||
147032223|NCT04453202|530281128|FG008|Overall Study|Adverse Event|0|||
147032224|NCT04453202|530281129|FG009|Overall Study|Adverse Event|0|||
147032225|NCT04453202|530281130|FG010|Overall Study|Adverse Event|0|||
147032226|NCT04453202|530281120|FG000|Overall Study|Death|0|||
147032227|NCT04453202|530281121|FG001|Overall Study|Death|0|||
147032228|NCT04453202|530281122|FG002|Overall Study|Death|0|||
147032229|NCT04453202|530281123|FG003|Overall Study|Death|0|||
147032230|NCT04453202|530281124|FG004|Overall Study|Death|0|||
147032231|NCT04453202|530281125|FG005|Overall Study|Death|0|||
147032232|NCT04453202|530281126|FG006|Overall Study|Death|0|||
147032233|NCT04453202|530281127|FG007|Overall Study|Death|0|||
147032234|NCT04453202|530281128|FG008|Overall Study|Death|0|||
147032235|NCT04453202|530281129|FG009|Overall Study|Death|1|||
147032236|NCT04453202|530281130|FG010|Overall Study|Death|0|||
147032237|NCT04453202|530281120|FG000|Overall Study|Lost to Follow-up|0|||
147032238|NCT04453202|530281121|FG001|Overall Study|Lost to Follow-up|1|||
147032239|NCT04453202|530281122|FG002|Overall Study|Lost to Follow-up|0|||
147032240|NCT04453202|530281123|FG003|Overall Study|Lost to Follow-up|1|||
147032241|NCT04453202|530281124|FG004|Overall Study|Lost to Follow-up|0|||
147032242|NCT04453202|530281125|FG005|Overall Study|Lost to Follow-up|0|||
147032243|NCT04453202|530281126|FG006|Overall Study|Lost to Follow-up|0|||
147032244|NCT04453202|530281127|FG007|Overall Study|Lost to Follow-up|0|||
147032245|NCT04453202|530281128|FG008|Overall Study|Lost to Follow-up|0|||
147032246|NCT04453202|530281129|FG009|Overall Study|Lost to Follow-up|1|||
147032247|NCT04453202|530281130|FG010|Overall Study|Lost to Follow-up|1|||
147032248|NCT04453202|530281120|FG000|Overall Study|Withdrawal by Subject|1|||
147032249|NCT04453202|530281121|FG001|Overall Study|Withdrawal by Subject|2|||
147032250|NCT04453202|530281122|FG002|Overall Study|Withdrawal by Subject|1|||
147032251|NCT04453202|530281123|FG003|Overall Study|Withdrawal by Subject|2|||
147032252|NCT04453202|530281124|FG004|Overall Study|Withdrawal by Subject|1|||
147032253|NCT04453202|530281125|FG005|Overall Study|Withdrawal by Subject|1|||
147032254|NCT04453202|530281126|FG006|Overall Study|Withdrawal by Subject|0|||
146849653|NCT02663518|529618859|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
146849654|NCT02663518|529618860|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
147032255|NCT04453202|530281127|FG007|Overall Study|Withdrawal by Subject|0|||
147032256|NCT04453202|530281128|FG008|Overall Study|Withdrawal by Subject|0|||
146849655|NCT02663518|529618861|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
147032257|NCT04453202|530281129|FG009|Overall Study|Withdrawal by Subject|1|||
147032258|NCT04453202|530281130|FG010|Overall Study|Withdrawal by Subject|0|||
146849656|NCT02663518|529618862|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
147032259|NCT04453202|530281120|FG000|Overall Study|Adverse Event|0|||
147032260|NCT04453202|530281121|FG001|Overall Study|Adverse Event|0|||
147032261|NCT04453202|530281122|FG002|Overall Study|Adverse Event|0|||
147032262|NCT04453202|530281123|FG003|Overall Study|Adverse Event|0|||
147032263|NCT04453202|530281124|FG004|Overall Study|Adverse Event|0|||
147032264|NCT04453202|530281125|FG005|Overall Study|Adverse Event|1|||
147032265|NCT04453202|530281126|FG006|Overall Study|Adverse Event|0|||
147032266|NCT04453202|530281127|FG007|Overall Study|Adverse Event|0|||
147032267|NCT04453202|530281128|FG008|Overall Study|Adverse Event|0|||
147032268|NCT04453202|530281129|FG009|Overall Study|Adverse Event|0|||
147032269|NCT04453202|530281130|FG010|Overall Study|Adverse Event|0|||
147032270|NCT00669071|530281134|FG000|Overall Study|Lost to Follow-up|3|||
147032271|NCT00669071|530281134|FG000|Overall Study|Final visit 40 days out of window|1|||
147032272|NCT03276221|530281135|FG000|Overall Study|Lost to Follow-up|6|||
147032273|NCT03276221|530281136|FG001|Overall Study|Lost to Follow-up|2|||
147032274|NCT03276221|530281137|FG002|Overall Study|Lost to Follow-up|0|||
147032275|NCT03276221|530281135|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
147032276|NCT03276221|530281136|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
147032277|NCT03276221|530281137|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
147032278|NCT00424775|530281138|FG000|Overall Study|Adverse Event|2|||
147032279|NCT00424775|530281139|FG001|Overall Study|Adverse Event|0|||
147032280|NCT00424775|530281138|FG000|Overall Study|Lack of Efficacy|1|||
147032281|NCT00424775|530281139|FG001|Overall Study|Lack of Efficacy|0|||
147032282|NCT02900976|530281141|FG000|Overall Study|Adverse Event|0|||
147032283|NCT02900976|530281142|FG001|Overall Study|Adverse Event|1|||
147032284|NCT02900976|530281141|FG000|Overall Study|Physician Decision|0|||
147032285|NCT02900976|530281142|FG001|Overall Study|Physician Decision|2|||
147032286|NCT02900976|530281141|FG000|Overall Study|Progressive disease|0|||
147032287|NCT02900976|530281142|FG001|Overall Study|Progressive disease|6|||
147032288|NCT01181271|530281143|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
147032289|NCT01181271|530281143|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
147032290|NCT01181271|530281143|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
147032291|NCT01181271|530281143|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
147032292|NCT01408628|530281144|FG000|Consented|Withdrawal by Subject|12|||
147032293|NCT01408628|530281144|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
147032294|NCT01408628|530281144|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
147032295|NCT01408628|530281144|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
147032296|NCT00750308|530281145|FG000|First Treatment|Adverse Event|0|||
147032297|NCT00750308|530281146|FG001|First Treatment|Adverse Event|1|||
147032298|NCT00750308|530281147|FG002|First Treatment|Adverse Event|0|||
147032299|NCT00750308|530281148|FG003|First Treatment|Adverse Event|0|||
147032300|NCT00750308|530281149|FG004|First Treatment|Adverse Event|0|||
147032301|NCT00750308|530281150|FG005|First Treatment|Adverse Event|0|||
147032302|NCT00750308|530281151|FG006|First Treatment|Adverse Event|0|||
147032303|NCT00750308|530281152|FG007|First Treatment|Adverse Event|0|||
147032304|NCT00750308|530281153|FG008|First Treatment|Adverse Event|0|||
147032305|NCT00750308|530281154|FG009|First Treatment|Adverse Event|0|||
147032306|NCT00750308|530281155|FG010|First Treatment|Adverse Event|1|||
147032307|NCT00750308|530281156|FG011|First Treatment|Adverse Event|1|||
147032308|NCT00750308|530281145|FG000|First Treatment|Withdrawal by Subject|0|||
147032309|NCT00750308|530281146|FG001|First Treatment|Withdrawal by Subject|0|||
147032310|NCT00750308|530281147|FG002|First Treatment|Withdrawal by Subject|0|||
147032311|NCT00750308|530281148|FG003|First Treatment|Withdrawal by Subject|1|||
147032312|NCT00750308|530281149|FG004|First Treatment|Withdrawal by Subject|0|||
147032313|NCT00750308|530281150|FG005|First Treatment|Withdrawal by Subject|0|||
147032314|NCT00750308|530281151|FG006|First Treatment|Withdrawal by Subject|0|||
147032315|NCT00750308|530281152|FG007|First Treatment|Withdrawal by Subject|1|||
147032316|NCT00750308|530281153|FG008|First Treatment|Withdrawal by Subject|0|||
147032317|NCT00750308|530281154|FG009|First Treatment|Withdrawal by Subject|0|||
147032318|NCT00750308|530281155|FG010|First Treatment|Withdrawal by Subject|0|||
147032319|NCT00750308|530281156|FG011|First Treatment|Withdrawal by Subject|0|||
147032320|NCT00750308|530281145|FG000|Second Treatment|Adverse Event|0|||
147032321|NCT00750308|530281146|FG001|Second Treatment|Adverse Event|0|||
147032322|NCT00750308|530281147|FG002|Second Treatment|Adverse Event|0|||
147032323|NCT00750308|530281148|FG003|Second Treatment|Adverse Event|0|||
147032324|NCT00750308|530281149|FG004|Second Treatment|Adverse Event|0|||
147032325|NCT00750308|530281150|FG005|Second Treatment|Adverse Event|1|||
147032326|NCT00750308|530281151|FG006|Second Treatment|Adverse Event|0|||
147032327|NCT00750308|530281152|FG007|Second Treatment|Adverse Event|0|||
147032328|NCT00750308|530281153|FG008|Second Treatment|Adverse Event|1|||
147032329|NCT00750308|530281154|FG009|Second Treatment|Adverse Event|0|||
147032330|NCT00750308|530281155|FG010|Second Treatment|Adverse Event|0|||
147032331|NCT00750308|530281156|FG011|Second Treatment|Adverse Event|0|||
147032332|NCT00750308|530281145|FG000|Second Treatment|Withdrawal by Subject|0|||
147032333|NCT00750308|530281146|FG001|Second Treatment|Withdrawal by Subject|0|||
147032334|NCT00750308|530281147|FG002|Second Treatment|Withdrawal by Subject|0|||
147032335|NCT00750308|530281148|FG003|Second Treatment|Withdrawal by Subject|0|||
146849657|NCT02663518|529618863|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
147032336|NCT00750308|530281149|FG004|Second Treatment|Withdrawal by Subject|1|||
147032337|NCT00750308|530281150|FG005|Second Treatment|Withdrawal by Subject|0|||
147032338|NCT00750308|530281151|FG006|Second Treatment|Withdrawal by Subject|0|||
147032339|NCT00750308|530281152|FG007|Second Treatment|Withdrawal by Subject|0|||
147032340|NCT00750308|530281153|FG008|Second Treatment|Withdrawal by Subject|0|||
147032341|NCT00750308|530281154|FG009|Second Treatment|Withdrawal by Subject|0|||
147032342|NCT00750308|530281155|FG010|Second Treatment|Withdrawal by Subject|0|||
147032343|NCT00750308|530281156|FG011|Second Treatment|Withdrawal by Subject|0|||
147032344|NCT00750308|530281145|FG000|Third Treatment|Withdrawal by Subject|0|||
147032345|NCT00750308|530281146|FG001|Third Treatment|Withdrawal by Subject|1|||
147032346|NCT00750308|530281147|FG002|Third Treatment|Withdrawal by Subject|0|||
147032347|NCT00750308|530281148|FG003|Third Treatment|Withdrawal by Subject|0|||
147032348|NCT00750308|530281149|FG004|Third Treatment|Withdrawal by Subject|0|||
147032349|NCT00750308|530281150|FG005|Third Treatment|Withdrawal by Subject|0|||
147032350|NCT00750308|530281151|FG006|Third Treatment|Withdrawal by Subject|0|||
147032351|NCT00750308|530281152|FG007|Third Treatment|Withdrawal by Subject|0|||
147032352|NCT00750308|530281153|FG008|Third Treatment|Withdrawal by Subject|0|||
147032353|NCT00750308|530281154|FG009|Third Treatment|Withdrawal by Subject|0|||
147032354|NCT00750308|530281155|FG010|Third Treatment|Withdrawal by Subject|0|||
147032355|NCT00750308|530281156|FG011|Third Treatment|Withdrawal by Subject|0|||
147032356|NCT00513682|530281157|FG000|Washout Phase|Adverse Event|2|||
147032357|NCT02980874|530281158|FG000|Overall Study|Adverse Event|2|||
147032358|NCT02980874|530281159|FG001|Overall Study|Adverse Event|7|||
147032359|NCT02980874|530281158|FG000|Overall Study|Withdrawal by Subject|7|||
147032360|NCT02980874|530281159|FG001|Overall Study|Withdrawal by Subject|2|||
147032361|NCT02980874|530281158|FG000|Overall Study|Lost to Follow-up|5|||
147032362|NCT02980874|530281159|FG001|Overall Study|Lost to Follow-up|5|||
147032363|NCT02980874|530281158|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
147032364|NCT02980874|530281159|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
147032365|NCT02980874|530281158|FG000|Overall Study|Unknown study completion status|1|||
147032366|NCT02980874|530281159|FG001|Overall Study|Unknown study completion status|0|||
147032367|NCT04156620|530281160|FG000|Overall Study|Adverse event - TP 1|5|||
147032368|NCT04156620|530281161|FG001|Overall Study|Adverse event - TP 1|2|||
147032369|NCT04156620|530281160|FG000|Overall Study|Lost to follow-up TP 1|1|||
147032370|NCT04156620|530281161|FG001|Overall Study|Lost to follow-up TP 1|1|||
147032371|NCT04156620|530281160|FG000|Overall Study|Progressive disease - TP 1|0|||
147032372|NCT04156620|530281161|FG001|Overall Study|Progressive disease - TP 1|1|||
147032373|NCT04156620|530281160|FG000|Overall Study|Subject decision - TP 1|3|||
147032374|NCT04156620|530281161|FG001|Overall Study|Subject decision - TP 1|5|||
147032375|NCT04156620|530281160|FG000|Overall Study|Adverse event - TP 2|5|||
147032376|NCT04156620|530281161|FG001|Overall Study|Adverse event - TP 2|6|||
147032377|NCT04156620|530281160|FG000|Overall Study|Death - TP 2|1|||
147032378|NCT04156620|530281161|FG001|Overall Study|Death - TP 2|0|||
147032379|NCT04156620|530281160|FG000|Overall Study|Lost to follow-up - TP 2|5|||
147032380|NCT04156620|530281161|FG001|Overall Study|Lost to follow-up - TP 2|2|||
147032381|NCT04156620|530281160|FG000|Overall Study|Physician decision - TP 2|4|||
147032382|NCT04156620|530281161|FG001|Overall Study|Physician decision - TP 2|2|||
147032383|NCT04156620|530281160|FG000|Overall Study|Pregnancy - TP 2|1|||
147032384|NCT04156620|530281161|FG001|Overall Study|Pregnancy - TP 2|1|||
147032385|NCT04156620|530281160|FG000|Overall Study|Subject decision - TP 2|11|||
147032386|NCT04156620|530281161|FG001|Overall Study|Subject decision - TP 2|9|||
147032387|NCT04156620|530281160|FG000|Overall Study|New therapy for study indication - TP 2|1|||
147032388|NCT04156620|530281161|FG001|Overall Study|New therapy for study indication - TP 2|0|||
147032389|NCT02450526|530281162|FG000|DB Period (Cycle 1)|Adverse Event|0|||
147032390|NCT02450526|530281163|FG001|DB Period (Cycle 1)|Adverse Event|0|||
147032391|NCT02450526|530281164|FG002|DB Period (Cycle 1)|Adverse Event|2|||
147032392|NCT02450526|530281165|FG003|DB Period (Cycle 1)|Adverse Event|0|||
147032393|NCT02450526|530281166|FG004|DB Period (Cycle 1)|Adverse Event|0|||
147032394|NCT02450526|530281162|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
147032395|NCT02450526|530281163|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
147032396|NCT02450526|530281164|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
147032397|NCT02450526|530281165|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
147032398|NCT02450526|530281166|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
147032399|NCT02450526|530281162|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
147032400|NCT02450526|530281163|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
147032401|NCT02450526|530281164|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
147032402|NCT02450526|530281165|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
147032403|NCT02450526|530281166|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
147032404|NCT02450526|530281162|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
147032405|NCT02450526|530281163|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
147032406|NCT02450526|530281164|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
147032407|NCT02450526|530281165|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
147032408|NCT02450526|530281166|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
147032409|NCT02450526|530281162|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
147032410|NCT02450526|530281163|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
147032411|NCT02450526|530281164|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
147032412|NCT02450526|530281165|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
147032413|NCT02450526|530281166|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
147032414|NCT02450526|530281162|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
147032415|NCT02450526|530281163|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
147032416|NCT02450526|530281164|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
147032417|NCT02450526|530281165|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
147032418|NCT02450526|530281166|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
147032419|NCT02450526|530281162|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
147032420|NCT02450526|530281163|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
147032421|NCT02450526|530281164|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
147032422|NCT02450526|530281165|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
147032423|NCT02450526|530281166|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
147032424|NCT02450526|530281162|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
147032425|NCT02450526|530281163|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
147032426|NCT02450526|530281164|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
147032427|NCT02450526|530281165|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
147032428|NCT02450526|530281166|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
147032429|NCT01753336|530281167|FG000|Overall Study|Patient decision|12|||
147032430|NCT01753336|530281167|FG000|Overall Study|Lost to Follow-up|3|||
147032431|NCT01753336|530281167|FG000|Overall Study|Physician Decision|2|||
147032432|NCT01753336|530281167|FG000|Overall Study|Sponsor's decision|2|||
147032433|NCT01753336|530281167|FG000|Overall Study|Withdrawal by Subject|1|||
147032434|NCT02435836|530281168|FG000|Overall Study|Lost to Follow-up|21|||
147032435|NCT02435836|530281168|FG000|Overall Study|Lack of Efficacy|1|||
147032436|NCT02435836|530281168|FG000|Overall Study|Withdrawal by Subject|236|||
147032437|NCT02435836|530281168|FG000|Overall Study|Insufficient Clinical Response|26|||
147032438|NCT02435836|530281168|FG000|Overall Study|Adverse Event|44|||
147032439|NCT02435836|530281168|FG000|Overall Study|Sponsor discontinued trial|167|||
147032440|NCT02435836|530281168|FG000|Overall Study|Noncompliance|27|||
147032441|NCT02435836|530281168|FG000|Overall Study|Protocol Violation|6|||
147032442|NCT02435836|530281168|FG000|Overall Study|Met Withdrawal Criteria|7|||
147032443|NCT02435836|530281168|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
147032444|NCT01629966|530281169|FG000|Overall Study|Pregnancy|0|||
147032445|NCT01629966|530281170|FG001|Overall Study|Pregnancy|1|||
147032446|NCT01629966|530281171|FG002|Overall Study|Pregnancy|0|||
147032447|NCT01629966|530281169|FG000|Overall Study|Lost to Follow-up|10|||
147032448|NCT01629966|530281170|FG001|Overall Study|Lost to Follow-up|13|||
147032449|NCT01629966|530281171|FG002|Overall Study|Lost to Follow-up|9|||
147032450|NCT01629966|530281169|FG000|Overall Study|Withdrawal by Subject|8|||
147032451|NCT01629966|530281170|FG001|Overall Study|Withdrawal by Subject|9|||
147032452|NCT01629966|530281171|FG002|Overall Study|Withdrawal by Subject|16|||
147032453|NCT01629966|530281169|FG000|Overall Study|Protocol Violation|7|||
147032454|NCT01629966|530281170|FG001|Overall Study|Protocol Violation|9|||
147032455|NCT01629966|530281171|FG002|Overall Study|Protocol Violation|7|||
147032456|NCT01629966|530281169|FG000|Overall Study|Lack of Efficacy|5|||
147032457|NCT01629966|530281170|FG001|Overall Study|Lack of Efficacy|2|||
147032458|NCT01629966|530281171|FG002|Overall Study|Lack of Efficacy|4|||
147032459|NCT01629966|530281169|FG000|Overall Study|Adverse Event|11|||
147032460|NCT01629966|530281170|FG001|Overall Study|Adverse Event|18|||
147032461|NCT01629966|530281171|FG002|Overall Study|Adverse Event|30|||
147032462|NCT02991430|530281174|FG000|Treatment Period 1|Adverse Event|1|||
147032463|NCT02991430|530281175|FG001|Treatment Period 1|Adverse Event|0|||
147032464|NCT02991430|530281176|FG002|Treatment Period 1|Adverse Event|2|||
147032465|NCT02991430|530281174|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147032466|NCT02991430|530281175|FG001|Treatment Period 1|Withdrawal by Subject|4|||
147032467|NCT02991430|530281176|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147032468|NCT02991430|530281174|FG000|Treatment Period 2|Study Termination|6|||
147032469|NCT02991430|530281175|FG001|Treatment Period 2|Study Termination|3|||
147032470|NCT02991430|530281176|FG002|Treatment Period 2|Study Termination|3|||
147032471|NCT02991430|530281174|FG000|Treatment Period 2|Lost to Follow-up|0|||
147032472|NCT02991430|530281175|FG001|Treatment Period 2|Lost to Follow-up|0|||
147032473|NCT02991430|530281176|FG002|Treatment Period 2|Lost to Follow-up|1|||
147032474|NCT02991430|530281174|FG000|Post-treatment Observation Period|Study Termination|3|||
147032475|NCT02991430|530281175|FG001|Post-treatment Observation Period|Study Termination|6|||
147032476|NCT02991430|530281176|FG002|Post-treatment Observation Period|Study Termination|5|||
147032477|NCT03970837|530281177|FG000|Overall Study|Adverse Event|23|||
147032478|NCT03970837|530281178|FG001|Overall Study|Adverse Event|20|||
147032479|NCT03970837|530281179|FG002|Overall Study|Adverse Event|16|||
147032480|NCT03970837|530281180|FG003|Overall Study|Adverse Event|6|||
147032481|NCT03970837|530281181|FG004|Overall Study|Adverse Event|4|||
147032482|NCT03970837|530281182|FG005|Overall Study|Adverse Event|5|||
147032483|NCT03970837|530281183|FG006|Overall Study|Adverse Event|1|||
147032484|NCT03970837|530281184|FG007|Overall Study|Adverse Event|5|||
147032485|NCT03970837|530281185|FG008|Overall Study|Adverse Event|0|||
147032486|NCT03970837|530281186|FG009|Overall Study|Adverse Event|0|||
147032487|NCT03970837|530281187|FG010|Overall Study|Adverse Event|1|||
147032488|NCT03970837|530281188|FG011|Overall Study|Adverse Event|1|||
147032489|NCT03970837|530281177|FG000|Overall Study|Lack of Efficacy|14|||
147032490|NCT03970837|530281178|FG001|Overall Study|Lack of Efficacy|12|||
146849658|NCT02663518|529618864|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
147032491|NCT03970837|530281179|FG002|Overall Study|Lack of Efficacy|1|||
147032492|NCT03970837|530281180|FG003|Overall Study|Lack of Efficacy|2|||
147032493|NCT03970837|530281181|FG004|Overall Study|Lack of Efficacy|3|||
147032494|NCT03970837|530281182|FG005|Overall Study|Lack of Efficacy|4|||
147032495|NCT03970837|530281183|FG006|Overall Study|Lack of Efficacy|6|||
147032496|NCT03970837|530281184|FG007|Overall Study|Lack of Efficacy|1|||
147032497|NCT03970837|530281185|FG008|Overall Study|Lack of Efficacy|1|||
147032498|NCT03970837|530281186|FG009|Overall Study|Lack of Efficacy|0|||
147032499|NCT03970837|530281187|FG010|Overall Study|Lack of Efficacy|0|||
147032500|NCT03970837|530281188|FG011|Overall Study|Lack of Efficacy|0|||
147032501|NCT03970837|530281177|FG000|Overall Study|Lost to Follow-up|6|||
147032502|NCT03970837|530281178|FG001|Overall Study|Lost to Follow-up|5|||
147032503|NCT03970837|530281179|FG002|Overall Study|Lost to Follow-up|5|||
147032504|NCT03970837|530281180|FG003|Overall Study|Lost to Follow-up|1|||
147032505|NCT03970837|530281181|FG004|Overall Study|Lost to Follow-up|0|||
147032506|NCT03970837|530281182|FG005|Overall Study|Lost to Follow-up|2|||
147032507|NCT03970837|530281183|FG006|Overall Study|Lost to Follow-up|0|||
147032508|NCT03970837|530281184|FG007|Overall Study|Lost to Follow-up|0|||
147032509|NCT03970837|530281185|FG008|Overall Study|Lost to Follow-up|0|||
147032510|NCT03970837|530281186|FG009|Overall Study|Lost to Follow-up|0|||
147032511|NCT03970837|530281187|FG010|Overall Study|Lost to Follow-up|0|||
147032512|NCT03970837|530281188|FG011|Overall Study|Lost to Follow-up|0|||
147032513|NCT03970837|530281177|FG000|Overall Study|Protocol Violation|1|||
147032514|NCT03970837|530281178|FG001|Overall Study|Protocol Violation|0|||
147032515|NCT03970837|530281179|FG002|Overall Study|Protocol Violation|0|||
147032516|NCT03970837|530281180|FG003|Overall Study|Protocol Violation|0|||
147032517|NCT03970837|530281181|FG004|Overall Study|Protocol Violation|0|||
147032518|NCT03970837|530281182|FG005|Overall Study|Protocol Violation|0|||
147032519|NCT03970837|530281183|FG006|Overall Study|Protocol Violation|0|||
147032520|NCT03970837|530281184|FG007|Overall Study|Protocol Violation|0|||
147032521|NCT03970837|530281185|FG008|Overall Study|Protocol Violation|0|||
147032522|NCT03970837|530281186|FG009|Overall Study|Protocol Violation|0|||
147032523|NCT03970837|530281187|FG010|Overall Study|Protocol Violation|0|||
147032524|NCT03970837|530281188|FG011|Overall Study|Protocol Violation|0|||
147032525|NCT03970837|530281177|FG000|Overall Study|Physician Decision|5|||
147032526|NCT03970837|530281178|FG001|Overall Study|Physician Decision|8|||
147032527|NCT03970837|530281179|FG002|Overall Study|Physician Decision|4|||
147032528|NCT03970837|530281180|FG003|Overall Study|Physician Decision|1|||
147032529|NCT03970837|530281181|FG004|Overall Study|Physician Decision|5|||
147032530|NCT03970837|530281182|FG005|Overall Study|Physician Decision|2|||
147032531|NCT03970837|530281183|FG006|Overall Study|Physician Decision|4|||
147032532|NCT03970837|530281184|FG007|Overall Study|Physician Decision|5|||
147032533|NCT03970837|530281185|FG008|Overall Study|Physician Decision|0|||
147032534|NCT03970837|530281186|FG009|Overall Study|Physician Decision|1|||
147032535|NCT03970837|530281187|FG010|Overall Study|Physician Decision|0|||
147032536|NCT03970837|530281188|FG011|Overall Study|Physician Decision|0|||
147032537|NCT03970837|530281177|FG000|Overall Study|Withdrawal by Subject|32|||
147032538|NCT03970837|530281178|FG001|Overall Study|Withdrawal by Subject|35|||
147032539|NCT03970837|530281179|FG002|Overall Study|Withdrawal by Subject|12|||
147032540|NCT03970837|530281180|FG003|Overall Study|Withdrawal by Subject|8|||
147032541|NCT03970837|530281181|FG004|Overall Study|Withdrawal by Subject|6|||
147032542|NCT03970837|530281182|FG005|Overall Study|Withdrawal by Subject|8|||
147032543|NCT03970837|530281183|FG006|Overall Study|Withdrawal by Subject|2|||
147032544|NCT03970837|530281184|FG007|Overall Study|Withdrawal by Subject|3|||
147032545|NCT03970837|530281185|FG008|Overall Study|Withdrawal by Subject|0|||
147032546|NCT03970837|530281186|FG009|Overall Study|Withdrawal by Subject|0|||
147032547|NCT03970837|530281187|FG010|Overall Study|Withdrawal by Subject|0|||
147032548|NCT03970837|530281188|FG011|Overall Study|Withdrawal by Subject|1|||
147032549|NCT03970837|530281177|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
147032550|NCT03970837|530281178|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
147032551|NCT03970837|530281179|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
147032552|NCT03970837|530281180|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
147032553|NCT03970837|530281181|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
147032554|NCT03970837|530281182|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
147032555|NCT03970837|530281183|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
147032556|NCT03970837|530281184|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
147032557|NCT03970837|530281185|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
147032558|NCT03970837|530281186|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
147032559|NCT03970837|530281187|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
147032560|NCT03970837|530281188|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
147032561|NCT03970837|530281177|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
147032562|NCT03970837|530281178|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
147032563|NCT03970837|530281179|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
146849659|NCT02663518|529618851|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
147032564|NCT03970837|530281180|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
147032565|NCT03970837|530281181|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
147032566|NCT03970837|530281182|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
147032567|NCT03970837|530281183|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
147032568|NCT03970837|530281184|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
147032569|NCT03970837|530281185|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
147032570|NCT03970837|530281186|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
147032571|NCT03970837|530281187|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
147032572|NCT03970837|530281188|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
147032573|NCT04568031|530281189|FG000|Overall Study|Lost to Follow-up|1|||
147032574|NCT04568031|530281190|FG001|Overall Study|Lost to Follow-up|0|||
147032575|NCT04568031|530281191|FG002|Overall Study|Lost to Follow-up|0|||
147032576|NCT04568031|530281192|FG003|Overall Study|Lost to Follow-up|0|||
147032577|NCT04568031|530281189|FG000|Overall Study|Physician Decision|1|||
147032578|NCT04568031|530281190|FG001|Overall Study|Physician Decision|0|||
147032579|NCT04568031|530281191|FG002|Overall Study|Physician Decision|1|||
147032580|NCT04568031|530281192|FG003|Overall Study|Physician Decision|0|||
147032581|NCT04568031|530281189|FG000|Overall Study|Withdrawal by Subject|1|||
147032582|NCT04568031|530281190|FG001|Overall Study|Withdrawal by Subject|0|||
147032583|NCT04568031|530281191|FG002|Overall Study|Withdrawal by Subject|4|||
147032584|NCT04568031|530281192|FG003|Overall Study|Withdrawal by Subject|1|||
147032585|NCT00228423|530281195|FG000|Overall Study|Adverse Event|2|||
147032586|NCT00228423|530281196|FG001|Overall Study|Adverse Event|5|||
147032587|NCT00228423|530281195|FG000|Overall Study|Withdrawal by Subject|7|||
147032588|NCT00228423|530281196|FG001|Overall Study|Withdrawal by Subject|3|||
147032589|NCT00228423|530281195|FG000|Overall Study|Protocol Violation|1|||
147032590|NCT00228423|530281196|FG001|Overall Study|Protocol Violation|3|||
147032591|NCT00228423|530281195|FG000|Overall Study|Physician Decision|0|||
147032592|NCT00228423|530281196|FG001|Overall Study|Physician Decision|1|||
147032593|NCT03870477|530281205|FG000|Overall Study|Early Study Termination|1|||
147032594|NCT04555720|530281210|FG000|Overall Study|Lost to Follow-up|2|||
147032595|NCT04555720|530281211|FG001|Overall Study|Lost to Follow-up|0|||
147032596|NCT04555720|530281212|FG002|Overall Study|Lost to Follow-up|0|||
147032597|NCT04555720|530281213|FG003|Overall Study|Lost to Follow-up|0|||
147032598|NCT04555720|530281210|FG000|Overall Study|Withdrawal by Subject|4|||
147032599|NCT04555720|530281211|FG001|Overall Study|Withdrawal by Subject|6|||
147032600|NCT04555720|530281212|FG002|Overall Study|Withdrawal by Subject|0|||
147032601|NCT04555720|530281213|FG003|Overall Study|Withdrawal by Subject|0|||
147032602|NCT00719849|530281214|FG000|Overall Study|Death|0|||
147032603|NCT00719849|530281215|FG001|Overall Study|Death|1|||
147032604|NCT02201290|530281217|FG000|Overall Study|Withdrawal by Subject|2|||
147032605|NCT02201290|530281217|FG000|Overall Study|Lack of Efficacy|2|||
147032606|NCT02201290|530281217|FG000|Overall Study|Adverse Event|1|||
147032607|NCT03907462|530281218|FG000|Overall Study|Physician Decision|1|||
147032608|NCT03907462|530281219|FG001|Overall Study|Physician Decision|3|||
147032609|NCT03907462|530281220|FG002|Overall Study|Physician Decision|1|||
147032610|NCT03907462|530281218|FG000|Overall Study|Withdrawal by Subject|6|||
147032611|NCT03907462|530281219|FG001|Overall Study|Withdrawal by Subject|3|||
147032612|NCT03907462|530281220|FG002|Overall Study|Withdrawal by Subject|3|||
147032613|NCT03907462|530281218|FG000|Overall Study|Pregnancy|4|||
147032614|NCT03907462|530281219|FG001|Overall Study|Pregnancy|2|||
147032615|NCT03907462|530281220|FG002|Overall Study|Pregnancy|6|||
147032616|NCT03907462|530281218|FG000|Overall Study|Lost to Follow-up|16|||
147032617|NCT03907462|530281219|FG001|Overall Study|Lost to Follow-up|18|||
147032618|NCT03907462|530281220|FG002|Overall Study|Lost to Follow-up|22|||
147032619|NCT02370329|530283216|FG000|Overall Study|Alternate treatment|1|||
147032620|NCT02370329|530283216|FG000|Overall Study|Adverse Event|1|||
147032621|NCT02370329|530283216|FG000|Overall Study|Disease progression|3|||
147032622|NCT02370329|530283216|FG000|Overall Study|Physician Decision|2|||
147032623|NCT02370329|530283216|FG000|Overall Study|Study closure|4|||
147032624|NCT00699283|530283225|FG000|Overall Study|Lack of Efficacy|15|||
147032625|NCT00699283|530283226|FG001|Overall Study|Lack of Efficacy|5|||
147032626|NCT00699283|530283225|FG000|Overall Study|Lost to Follow-up|2|||
147032627|NCT00699283|530283226|FG001|Overall Study|Lost to Follow-up|0|||
147032628|NCT00699283|530283225|FG000|Overall Study|Withdrawal by Subject|1|||
147032629|NCT00699283|530283226|FG001|Overall Study|Withdrawal by Subject|0|||
147032630|NCT00699283|530283225|FG000|Overall Study|Other Reason|5|||
146849660|NCT02663518|529618852|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146849661|NCT02663518|529618853|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
147032631|NCT00699283|530283226|FG001|Overall Study|Other Reason|1|||
147032632|NCT00699283|530283225|FG000|Overall Study|SAE, non-fatal|1|||
147032633|NCT00699283|530283226|FG001|Overall Study|SAE, non-fatal|1|||
147032634|NCT00699283|530283225|FG000|Overall Study|AE, non-serious non-fatal|8|||
147032635|NCT00699283|530283226|FG001|Overall Study|AE, non-serious non-fatal|1|||
147032636|NCT00699283|530283225|FG000|Overall Study|AE of unknown type|1|||
147032637|NCT00699283|530283226|FG001|Overall Study|AE of unknown type|0|||
147032638|NCT00754650|530283227|FG000|Overall Study|Disease Progression|2|||
147032639|NCT00805675|530283228|FG000|Overall Study|Adverse Event|0|||
147032640|NCT00805675|530283229|FG001|Overall Study|Adverse Event|0|||
147032641|NCT00805675|530283230|FG002|Overall Study|Adverse Event|1|||
147032642|NCT02771795|530283231|FG000|Overall Study|Withdrawal by Subject|47|||
147032643|NCT02771795|530283232|FG001|Overall Study|Withdrawal by Subject|37|||
147032644|NCT02771795|530283231|FG000|Overall Study|Termination by premature discontinuation of study|168|||
147032645|NCT02771795|530283232|FG001|Overall Study|Termination by premature discontinuation of study|185|||
147032646|NCT01007942|530283233|FG000|Overall Study|Adverse Event|29|||
146849662|NCT02663518|529618854|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146849663|NCT02663518|529618855|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146849664|NCT02663518|529618856|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146849665|NCT02663518|529618857|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
147032647|NCT01007942|530283234|FG001|Overall Study|Adverse Event|14|||
147032648|NCT01007942|530283233|FG000|Overall Study|Abnormal test procedure|0|||
147032649|NCT01007942|530283234|FG001|Overall Study|Abnormal test procedure|1|||
147032650|NCT01007942|530283233|FG000|Overall Study|Disease progression|217|||
147032651|NCT01007942|530283234|FG001|Overall Study|Disease progression|242|||
147032652|NCT01007942|530283233|FG000|Overall Study|New cancer therapy|5|||
147032653|NCT01007942|530283234|FG001|Overall Study|New cancer therapy|1|||
147032654|NCT01007942|530283233|FG000|Overall Study|Protocol Violation|1|||
147032655|NCT01007942|530283234|FG001|Overall Study|Protocol Violation|1|||
147032656|NCT01007942|530283233|FG000|Overall Study|Withdrawal by Subject|19|||
147032657|NCT01007942|530283234|FG001|Overall Study|Withdrawal by Subject|14|||
147032658|NCT01007942|530283233|FG000|Overall Study|Lost to Follow-up|1|||
147032659|NCT01007942|530283234|FG001|Overall Study|Lost to Follow-up|0|||
147032660|NCT01007942|530283233|FG000|Overall Study|Administrative problems|2|||
147032661|NCT01007942|530283234|FG001|Overall Study|Administrative problems|0|||
147032662|NCT01007942|530283233|FG000|Overall Study|Death|3|||
147032663|NCT01007942|530283234|FG001|Overall Study|Death|2|||
147032664|NCT01007942|530283233|FG000|Overall Study|Patients untreated|4|||
147032665|NCT01007942|530283234|FG001|Overall Study|Patients untreated|3|||
147032666|NCT03929757|530283235|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
147032667|NCT03929757|530283236|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
147032668|NCT03929757|530283237|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
147032669|NCT03929757|530283235|FG000|Main Study: Up to Day 365|Other|1|||
147032670|NCT03929757|530283236|FG001|Main Study: Up to Day 365|Other|0|||
147032671|NCT03929757|530283237|FG002|Main Study: Up to Day 365|Other|0|||
147032672|NCT03929757|530283235|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
147032673|NCT03929757|530283236|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
147032674|NCT03929757|530283237|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
147032675|NCT00114166|530283238|FG000|Overall Study|Wrong primary|0|||
147032676|NCT00114166|530283239|FG001|Overall Study|Wrong primary|1|||
147032677|NCT01154816|530283240|FG000|Overall Study|Withdrawal by Subject|1|||
147032678|NCT01154816|530283241|FG001|Overall Study|Withdrawal by Subject|0|||
147032679|NCT01154816|530283242|FG002|Overall Study|Withdrawal by Subject|0|||
147032680|NCT01154816|530283243|FG003|Overall Study|Withdrawal by Subject|1|||
147032681|NCT01154816|530283244|FG004|Overall Study|Withdrawal by Subject|0|||
147032682|NCT01154816|530283245|FG005|Overall Study|Withdrawal by Subject|0|||
147032683|NCT01154816|530283246|FG006|Overall Study|Withdrawal by Subject|0|||
147032684|NCT01154816|530283247|FG007|Overall Study|Withdrawal by Subject|0|||
147032685|NCT01154816|530283248|FG008|Overall Study|Withdrawal by Subject|1|||
147032686|NCT01154816|530283249|FG009|Overall Study|Withdrawal by Subject|3|||
147032687|NCT01154816|530283250|FG010|Overall Study|Withdrawal by Subject|0|||
147032688|NCT01154816|530283251|FG011|Overall Study|Withdrawal by Subject|0|||
147032689|NCT01154816|530283240|FG000|Overall Study|Progressive Disease|13|||
147032690|NCT01154816|530283241|FG001|Overall Study|Progressive Disease|8|||
147032691|NCT01154816|530283242|FG002|Overall Study|Progressive Disease|9|||
147032692|NCT01154816|530283243|FG003|Overall Study|Progressive Disease|9|||
147032693|NCT01154816|530283244|FG004|Overall Study|Progressive Disease|8|||
147032694|NCT01154816|530283245|FG005|Overall Study|Progressive Disease|8|||
147032695|NCT01154816|530283246|FG006|Overall Study|Progressive Disease|5|||
147032696|NCT01154816|530283247|FG007|Overall Study|Progressive Disease|6|||
147032697|NCT01154816|530283248|FG008|Overall Study|Progressive Disease|8|||
147032698|NCT01154816|530283249|FG009|Overall Study|Progressive Disease|6|||
147032699|NCT01154816|530283250|FG010|Overall Study|Progressive Disease|10|||
147032700|NCT01154816|530283251|FG011|Overall Study|Progressive Disease|3|||
147032701|NCT01154816|530283240|FG000|Overall Study|Physician Decision|1|||
147032702|NCT01154816|530283241|FG001|Overall Study|Physician Decision|0|||
147032703|NCT01154816|530283242|FG002|Overall Study|Physician Decision|1|||
147032704|NCT01154816|530283243|FG003|Overall Study|Physician Decision|0|||
146849666|NCT02663518|529618858|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
147032705|NCT01154816|530283244|FG004|Overall Study|Physician Decision|2|||
147032706|NCT01154816|530283245|FG005|Overall Study|Physician Decision|0|||
147032707|NCT01154816|530283246|FG006|Overall Study|Physician Decision|0|||
147032708|NCT01154816|530283247|FG007|Overall Study|Physician Decision|0|||
147032709|NCT01154816|530283248|FG008|Overall Study|Physician Decision|0|||
147032710|NCT01154816|530283249|FG009|Overall Study|Physician Decision|1|||
147032711|NCT01154816|530283250|FG010|Overall Study|Physician Decision|1|||
147032712|NCT01154816|530283251|FG011|Overall Study|Physician Decision|1|||
147032713|NCT01154816|530283240|FG000|Overall Study|Adverse Event|5|||
147032714|NCT01154816|530283241|FG001|Overall Study|Adverse Event|2|||
147032715|NCT01154816|530283242|FG002|Overall Study|Adverse Event|0|||
147032716|NCT01154816|530283243|FG003|Overall Study|Adverse Event|0|||
147032717|NCT01154816|530283244|FG004|Overall Study|Adverse Event|0|||
147032718|NCT01154816|530283245|FG005|Overall Study|Adverse Event|0|||
147032719|NCT01154816|530283246|FG006|Overall Study|Adverse Event|1|||
147032720|NCT01154816|530283247|FG007|Overall Study|Adverse Event|1|||
147032721|NCT01154816|530283248|FG008|Overall Study|Adverse Event|0|||
147032722|NCT01154816|530283249|FG009|Overall Study|Adverse Event|0|||
147032723|NCT01154816|530283250|FG010|Overall Study|Adverse Event|0|||
147032724|NCT01154816|530283251|FG011|Overall Study|Adverse Event|0|||
147032725|NCT04715932|530283252|FG000|Overall Study|Lost to Follow-up|1|||
147032726|NCT04715932|530283253|FG001|Overall Study|Lost to Follow-up|0|||
147032727|NCT02393248|530283254|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032728|NCT02393248|530283255|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
146849667|NCT02663518|529618859|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146849668|NCT02663518|529618860|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146849669|NCT02663518|529618861|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146849670|NCT02663518|529618862|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146849671|NCT02663518|529618863|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146849672|NCT02663518|529618864|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146849673|NCT02663518|529618851|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
146849674|NCT02663518|529618852|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
146849675|NCT02663518|529618853|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
146849676|NCT02663518|529618854|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
146849677|NCT02663518|529618855|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
146849678|NCT02663518|529618856|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
146849679|NCT02663518|529618857|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
146849680|NCT02663518|529618858|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
146849681|NCT02663518|529618859|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
146849682|NCT02663518|529618860|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
146849683|NCT02663518|529618861|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
146849684|NCT02663518|529618862|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
146849685|NCT02663518|529618863|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
146849686|NCT02663518|529618864|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
146849687|NCT02663518|529618851|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146849688|NCT02663518|529618852|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146849689|NCT02663518|529618853|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146849690|NCT02663518|529618854|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146849691|NCT02663518|529618855|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146849692|NCT02663518|529618856|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146849693|NCT02663518|529618857|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146849694|NCT02663518|529618858|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146849695|NCT02663518|529618859|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146849696|NCT02663518|529618860|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146849697|NCT02663518|529618861|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146849698|NCT02663518|529618862|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
147032729|NCT02393248|530283256|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032730|NCT02393248|530283257|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032731|NCT02393248|530283258|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032732|NCT02393248|530283259|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
147032733|NCT02393248|530283260|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
147032734|NCT02393248|530283261|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032735|NCT02393248|530283262|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032736|NCT02393248|530283263|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032737|NCT02393248|530283264|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032738|NCT02393248|530283265|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032739|NCT02393248|530283266|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032740|NCT02393248|530283267|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032741|NCT02393248|530283268|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032742|NCT02393248|530283269|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032743|NCT02393248|530283270|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032744|NCT02393248|530283271|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032745|NCT02393248|530283272|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032746|NCT02393248|530283273|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032747|NCT02393248|530283274|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032748|NCT02393248|530283275|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032749|NCT02393248|530283276|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032750|NCT02393248|530283277|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
146849699|NCT02663518|529618863|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
147032751|NCT02393248|530283278|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147032752|NCT02393248|530283254|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032753|NCT02393248|530283255|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
147032754|NCT02393248|530283256|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032755|NCT02393248|530283257|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032756|NCT02393248|530283258|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032757|NCT02393248|530283259|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032758|NCT02393248|530283260|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032759|NCT02393248|530283261|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032760|NCT02393248|530283262|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032761|NCT02393248|530283263|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032762|NCT02393248|530283264|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032763|NCT02393248|530283265|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032764|NCT02393248|530283266|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032765|NCT02393248|530283267|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032766|NCT02393248|530283268|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032767|NCT02393248|530283269|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032768|NCT02393248|530283270|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032769|NCT02393248|530283271|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032770|NCT02393248|530283272|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032771|NCT02393248|530283273|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032772|NCT02393248|530283274|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032773|NCT02393248|530283275|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032774|NCT02393248|530283276|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032775|NCT02393248|530283277|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032776|NCT02393248|530283278|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147032777|NCT02393248|530283254|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
147032778|NCT02393248|530283255|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
147032779|NCT02393248|530283256|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
147032780|NCT02393248|530283257|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
147032781|NCT02393248|530283258|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
147032782|NCT02393248|530283259|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
147032783|NCT02393248|530283260|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
147032784|NCT02393248|530283261|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
147032785|NCT02393248|530283262|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
147032786|NCT02393248|530283263|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
147032787|NCT02393248|530283264|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
147032788|NCT02393248|530283265|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
147032789|NCT02393248|530283266|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
147032790|NCT02393248|530283267|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
147032791|NCT02393248|530283268|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
147032792|NCT02393248|530283269|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
147032793|NCT02393248|530283270|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
147032794|NCT02393248|530283271|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
147032795|NCT02393248|530283272|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
147032796|NCT02393248|530283273|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
147032797|NCT02393248|530283274|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
147032798|NCT02393248|530283275|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
147032799|NCT02393248|530283276|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
147032800|NCT02393248|530283277|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
147032801|NCT02393248|530283278|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
147032802|NCT02393248|530283254|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
147032803|NCT02393248|530283255|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032804|NCT02393248|530283256|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032805|NCT02393248|530283257|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032806|NCT02393248|530283258|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032807|NCT02393248|530283259|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032808|NCT02393248|530283260|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032809|NCT02393248|530283261|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032810|NCT02393248|530283262|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032811|NCT02393248|530283263|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
146849700|NCT02663518|529618864|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146849701|NCT02663518|529618851|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146849702|NCT02663518|529618852|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147032812|NCT02393248|530283264|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032813|NCT02393248|530283265|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032814|NCT02393248|530283266|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032815|NCT02393248|530283267|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032816|NCT02393248|530283268|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032817|NCT02393248|530283269|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032818|NCT02393248|530283270|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032819|NCT02393248|530283271|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032820|NCT02393248|530283272|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032821|NCT02393248|530283273|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032822|NCT02393248|530283274|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032823|NCT02393248|530283275|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032824|NCT02393248|530283276|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032825|NCT02393248|530283277|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032826|NCT02393248|530283278|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147032827|NCT02393248|530283254|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032828|NCT02393248|530283255|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032829|NCT02393248|530283256|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032830|NCT02393248|530283257|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032831|NCT02393248|530283258|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032832|NCT02393248|530283259|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
147032833|NCT02393248|530283260|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
147032834|NCT02393248|530283261|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032835|NCT02393248|530283262|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032836|NCT02393248|530283263|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
147032837|NCT02393248|530283264|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032838|NCT02393248|530283265|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032839|NCT02393248|530283266|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032840|NCT02393248|530283267|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032841|NCT02393248|530283268|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032842|NCT02393248|530283269|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032843|NCT02393248|530283270|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032844|NCT02393248|530283271|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032845|NCT02393248|530283272|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032846|NCT02393248|530283273|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032847|NCT02393248|530283274|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032848|NCT02393248|530283275|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032849|NCT02393248|530283276|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032850|NCT02393248|530283277|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032851|NCT02393248|530283278|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147032852|NCT02393248|530283254|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032853|NCT02393248|530283255|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032854|NCT02393248|530283256|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032855|NCT02393248|530283257|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032856|NCT02393248|530283258|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032857|NCT02393248|530283259|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032858|NCT02393248|530283260|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
147032859|NCT02393248|530283261|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032860|NCT02393248|530283262|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032861|NCT02393248|530283263|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032862|NCT02393248|530283264|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032863|NCT02393248|530283265|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032864|NCT02393248|530283266|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032865|NCT02393248|530283267|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032866|NCT02393248|530283268|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032867|NCT02393248|530283269|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032868|NCT02393248|530283270|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032869|NCT02393248|530283271|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032870|NCT02393248|530283272|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032871|NCT02393248|530283273|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032872|NCT02393248|530283274|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032873|NCT02393248|530283275|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032874|NCT02393248|530283276|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032875|NCT02393248|530283277|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147032876|NCT02393248|530283278|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
146849703|NCT02663518|529618853|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146849704|NCT02663518|529618854|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147032877|NCT02393248|530283254|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032878|NCT02393248|530283255|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032879|NCT02393248|530283256|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032880|NCT02393248|530283257|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032881|NCT02393248|530283258|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032882|NCT02393248|530283259|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032883|NCT02393248|530283260|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032884|NCT02393248|530283261|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032885|NCT02393248|530283262|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032886|NCT02393248|530283263|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032887|NCT02393248|530283264|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032888|NCT02393248|530283265|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
147032889|NCT02393248|530283266|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
147032890|NCT02393248|530283267|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
147032891|NCT02393248|530283268|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
147032892|NCT02393248|530283269|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032893|NCT02393248|530283270|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032894|NCT02393248|530283271|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032895|NCT02393248|530283272|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032896|NCT02393248|530283273|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032897|NCT02393248|530283274|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032898|NCT02393248|530283275|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032899|NCT02393248|530283276|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032900|NCT02393248|530283277|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032901|NCT02393248|530283278|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147032902|NCT02393248|530283254|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032903|NCT02393248|530283255|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032904|NCT02393248|530283256|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032905|NCT02393248|530283257|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032906|NCT02393248|530283258|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032907|NCT02393248|530283259|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032908|NCT02393248|530283260|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032909|NCT02393248|530283261|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032910|NCT02393248|530283262|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032911|NCT02393248|530283263|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032912|NCT02393248|530283264|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
147032913|NCT02393248|530283265|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
147032914|NCT02393248|530283266|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032915|NCT02393248|530283267|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032916|NCT02393248|530283268|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032917|NCT02393248|530283269|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032918|NCT02393248|530283270|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032919|NCT02393248|530283271|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032920|NCT02393248|530283272|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032921|NCT02393248|530283273|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032922|NCT02393248|530283274|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032923|NCT02393248|530283275|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032924|NCT02393248|530283276|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032925|NCT02393248|530283277|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032926|NCT02393248|530283278|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147032927|NCT02393248|530283254|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
147032928|NCT02393248|530283255|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
147032929|NCT02393248|530283256|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
147032930|NCT02393248|530283257|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
147032931|NCT02393248|530283258|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
147032932|NCT02393248|530283259|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
147032933|NCT02393248|530283260|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
147032934|NCT02393248|530283261|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
147032935|NCT02393248|530283262|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
147032936|NCT02393248|530283263|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
147032937|NCT02393248|530283264|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
147032938|NCT02393248|530283265|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
147032939|NCT02393248|530283266|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
147032940|NCT02393248|530283267|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
147032941|NCT02393248|530283268|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
147032942|NCT02393248|530283269|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
147032943|NCT02393248|530283270|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
147032944|NCT02393248|530283271|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
147032945|NCT02393248|530283272|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
147032946|NCT02393248|530283273|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
147032947|NCT02393248|530283274|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
147032948|NCT02393248|530283275|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
147032949|NCT02393248|530283276|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
147032950|NCT02393248|530283277|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
147032951|NCT02393248|530283278|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
147032952|NCT02393248|530283254|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032953|NCT02393248|530283255|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032954|NCT02393248|530283256|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032955|NCT02393248|530283257|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032956|NCT02393248|530283258|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032957|NCT02393248|530283259|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032958|NCT02393248|530283260|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032959|NCT02393248|530283261|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032960|NCT02393248|530283262|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032961|NCT02393248|530283263|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032962|NCT02393248|530283264|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032963|NCT02393248|530283265|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
147032964|NCT02393248|530283266|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032965|NCT02393248|530283267|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
147032966|NCT02393248|530283268|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032967|NCT02393248|530283269|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032968|NCT02393248|530283270|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032969|NCT02393248|530283271|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032970|NCT02393248|530283272|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032971|NCT02393248|530283273|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032972|NCT02393248|530283274|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032973|NCT02393248|530283275|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032974|NCT02393248|530283276|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032975|NCT02393248|530283277|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032976|NCT02393248|530283278|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147032977|NCT02393248|530283254|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032978|NCT02393248|530283255|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032979|NCT02393248|530283256|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032980|NCT02393248|530283257|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032981|NCT02393248|530283258|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032982|NCT02393248|530283259|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032983|NCT02393248|530283260|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032984|NCT02393248|530283261|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032985|NCT02393248|530283262|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032986|NCT02393248|530283263|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032987|NCT02393248|530283264|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032988|NCT02393248|530283265|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032989|NCT02393248|530283266|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032990|NCT02393248|530283267|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032991|NCT02393248|530283268|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032992|NCT02393248|530283269|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032993|NCT02393248|530283270|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032994|NCT02393248|530283271|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032995|NCT02393248|530283272|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
147032996|NCT02393248|530283273|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147032997|NCT02393248|530283274|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
147032998|NCT02393248|530283275|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
147032999|NCT02393248|530283276|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147033000|NCT02393248|530283277|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
147033001|NCT02393248|530283278|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147033002|NCT02393248|530283254|FG000|Part 3: Combination Therapy|Death|0|||
147033003|NCT02393248|530283255|FG001|Part 3: Combination Therapy|Death|0|||
147033004|NCT02393248|530283256|FG002|Part 3: Combination Therapy|Death|0|||
147033005|NCT02393248|530283257|FG003|Part 3: Combination Therapy|Death|0|||
147033006|NCT02393248|530283258|FG004|Part 3: Combination Therapy|Death|0|||
147033007|NCT02393248|530283259|FG005|Part 3: Combination Therapy|Death|0|||
147033008|NCT02393248|530283260|FG006|Part 3: Combination Therapy|Death|0|||
147033009|NCT02393248|530283261|FG007|Part 3: Combination Therapy|Death|0|||
147033010|NCT02393248|530283262|FG008|Part 3: Combination Therapy|Death|0|||
147033011|NCT02393248|530283263|FG009|Part 3: Combination Therapy|Death|0|||
147033012|NCT02393248|530283264|FG010|Part 3: Combination Therapy|Death|0|||
147033013|NCT02393248|530283265|FG011|Part 3: Combination Therapy|Death|0|||
147033014|NCT02393248|530283266|FG012|Part 3: Combination Therapy|Death|0|||
147033015|NCT02393248|530283267|FG013|Part 3: Combination Therapy|Death|0|||
147033016|NCT02393248|530283268|FG014|Part 3: Combination Therapy|Death|0|||
147033017|NCT02393248|530283269|FG015|Part 3: Combination Therapy|Death|1|||
147033018|NCT02393248|530283270|FG016|Part 3: Combination Therapy|Death|7|||
147033019|NCT02393248|530283271|FG017|Part 3: Combination Therapy|Death|5|||
147033020|NCT02393248|530283272|FG018|Part 3: Combination Therapy|Death|5|||
147033021|NCT02393248|530283273|FG019|Part 3: Combination Therapy|Death|3|||
147033022|NCT02393248|530283274|FG020|Part 3: Combination Therapy|Death|7|||
147033023|NCT02393248|530283275|FG021|Part 3: Combination Therapy|Death|5|||
147033024|NCT02393248|530283276|FG022|Part 3: Combination Therapy|Death|6|||
147033025|NCT02393248|530283277|FG023|Part 3: Combination Therapy|Death|3|||
147033026|NCT02393248|530283278|FG024|Part 3: Combination Therapy|Death|0|||
147033027|NCT02393248|530283254|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033028|NCT02393248|530283255|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033029|NCT02393248|530283256|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033030|NCT02393248|530283257|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033031|NCT02393248|530283258|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033032|NCT02393248|530283259|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033033|NCT02393248|530283260|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033034|NCT02393248|530283261|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033035|NCT02393248|530283262|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033036|NCT02393248|530283263|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033037|NCT02393248|530283264|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033038|NCT02393248|530283265|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033039|NCT02393248|530283266|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033040|NCT02393248|530283267|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033041|NCT02393248|530283268|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033042|NCT02393248|530283269|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033043|NCT02393248|530283270|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033044|NCT02393248|530283271|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
147033045|NCT02393248|530283272|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
147033046|NCT02393248|530283273|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147033047|NCT02393248|530283274|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
147033048|NCT02393248|530283275|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
147033049|NCT02393248|530283276|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
147033050|NCT02393248|530283277|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
147033051|NCT02393248|530283278|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
147033052|NCT02393248|530283254|FG000|Part 3: Combination Therapy|Disease Progression|0|||
147033053|NCT02393248|530283255|FG001|Part 3: Combination Therapy|Disease Progression|0|||
147033054|NCT02393248|530283256|FG002|Part 3: Combination Therapy|Disease Progression|0|||
147033055|NCT02393248|530283257|FG003|Part 3: Combination Therapy|Disease Progression|0|||
147033056|NCT02393248|530283258|FG004|Part 3: Combination Therapy|Disease Progression|0|||
147033057|NCT02393248|530283259|FG005|Part 3: Combination Therapy|Disease Progression|0|||
147033058|NCT02393248|530283260|FG006|Part 3: Combination Therapy|Disease Progression|0|||
147033059|NCT02393248|530283261|FG007|Part 3: Combination Therapy|Disease Progression|0|||
147033060|NCT02393248|530283262|FG008|Part 3: Combination Therapy|Disease Progression|0|||
147033061|NCT02393248|530283263|FG009|Part 3: Combination Therapy|Disease Progression|0|||
147033062|NCT02393248|530283264|FG010|Part 3: Combination Therapy|Disease Progression|0|||
147033063|NCT02393248|530283265|FG011|Part 3: Combination Therapy|Disease Progression|0|||
147033064|NCT02393248|530283266|FG012|Part 3: Combination Therapy|Disease Progression|0|||
147033065|NCT02393248|530283267|FG013|Part 3: Combination Therapy|Disease Progression|0|||
147033066|NCT02393248|530283268|FG014|Part 3: Combination Therapy|Disease Progression|0|||
147033067|NCT02393248|530283269|FG015|Part 3: Combination Therapy|Disease Progression|0|||
147033068|NCT02393248|530283270|FG016|Part 3: Combination Therapy|Disease Progression|0|||
147033069|NCT02393248|530283271|FG017|Part 3: Combination Therapy|Disease Progression|0|||
147033070|NCT02393248|530283272|FG018|Part 3: Combination Therapy|Disease Progression|0|||
147033071|NCT02393248|530283273|FG019|Part 3: Combination Therapy|Disease Progression|0|||
147033072|NCT02393248|530283274|FG020|Part 3: Combination Therapy|Disease Progression|2|||
147033073|NCT02393248|530283275|FG021|Part 3: Combination Therapy|Disease Progression|1|||
147033074|NCT02393248|530283276|FG022|Part 3: Combination Therapy|Disease Progression|0|||
147033075|NCT02393248|530283277|FG023|Part 3: Combination Therapy|Disease Progression|0|||
147033076|NCT02393248|530283278|FG024|Part 3: Combination Therapy|Disease Progression|0|||
147033077|NCT02393248|530283254|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033078|NCT02393248|530283255|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033079|NCT02393248|530283256|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033080|NCT02393248|530283257|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033081|NCT02393248|530283258|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033082|NCT02393248|530283259|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033083|NCT02393248|530283260|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033084|NCT02393248|530283261|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033085|NCT02393248|530283262|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033086|NCT02393248|530283263|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033087|NCT02393248|530283264|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033088|NCT02393248|530283265|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033089|NCT02393248|530283266|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033090|NCT02393248|530283267|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033091|NCT02393248|530283268|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033092|NCT02393248|530283269|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033093|NCT02393248|530283270|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033094|NCT02393248|530283271|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033095|NCT02393248|530283272|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033096|NCT02393248|530283273|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033097|NCT02393248|530283274|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
147033098|NCT02393248|530283275|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
147033099|NCT02393248|530283276|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033100|NCT02393248|530283277|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033101|NCT02393248|530283278|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
147033102|NCT02393248|530283254|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033103|NCT02393248|530283255|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033104|NCT02393248|530283256|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033105|NCT02393248|530283257|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033106|NCT02393248|530283258|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033107|NCT02393248|530283259|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033108|NCT02393248|530283260|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033109|NCT02393248|530283261|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033110|NCT02393248|530283262|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033111|NCT02393248|530283263|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033112|NCT02393248|530283264|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033113|NCT02393248|530283265|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033114|NCT02393248|530283266|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033115|NCT02393248|530283267|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033116|NCT02393248|530283268|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033117|NCT02393248|530283269|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033118|NCT02393248|530283270|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033119|NCT02393248|530283271|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033120|NCT02393248|530283272|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033121|NCT02393248|530283273|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033122|NCT02393248|530283274|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
147033123|NCT02393248|530283275|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033124|NCT02393248|530283276|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033125|NCT02393248|530283277|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033126|NCT02393248|530283278|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147033127|NCT02393248|530283254|FG000|Part 3: Combination Therapy|Adverse Event|0|||
147033128|NCT02393248|530283255|FG001|Part 3: Combination Therapy|Adverse Event|0|||
147033129|NCT02393248|530283256|FG002|Part 3: Combination Therapy|Adverse Event|0|||
147033130|NCT02393248|530283257|FG003|Part 3: Combination Therapy|Adverse Event|0|||
147033131|NCT02393248|530283258|FG004|Part 3: Combination Therapy|Adverse Event|0|||
147033132|NCT02393248|530283259|FG005|Part 3: Combination Therapy|Adverse Event|0|||
147033133|NCT02393248|530283260|FG006|Part 3: Combination Therapy|Adverse Event|0|||
147033134|NCT02393248|530283261|FG007|Part 3: Combination Therapy|Adverse Event|0|||
147033135|NCT02393248|530283262|FG008|Part 3: Combination Therapy|Adverse Event|0|||
147033136|NCT02393248|530283263|FG009|Part 3: Combination Therapy|Adverse Event|0|||
147033137|NCT02393248|530283264|FG010|Part 3: Combination Therapy|Adverse Event|0|||
147033138|NCT02393248|530283265|FG011|Part 3: Combination Therapy|Adverse Event|0|||
147033139|NCT02393248|530283266|FG012|Part 3: Combination Therapy|Adverse Event|0|||
147033140|NCT02393248|530283267|FG013|Part 3: Combination Therapy|Adverse Event|0|||
147033141|NCT02393248|530283268|FG014|Part 3: Combination Therapy|Adverse Event|0|||
147033142|NCT02393248|530283269|FG015|Part 3: Combination Therapy|Adverse Event|0|||
147033143|NCT02393248|530283270|FG016|Part 3: Combination Therapy|Adverse Event|0|||
147033144|NCT02393248|530283271|FG017|Part 3: Combination Therapy|Adverse Event|0|||
147033145|NCT02393248|530283272|FG018|Part 3: Combination Therapy|Adverse Event|0|||
147033146|NCT02393248|530283273|FG019|Part 3: Combination Therapy|Adverse Event|0|||
147033147|NCT02393248|530283274|FG020|Part 3: Combination Therapy|Adverse Event|0|||
147033148|NCT02393248|530283275|FG021|Part 3: Combination Therapy|Adverse Event|0|||
147033149|NCT02393248|530283276|FG022|Part 3: Combination Therapy|Adverse Event|0|||
147033150|NCT02393248|530283277|FG023|Part 3: Combination Therapy|Adverse Event|1|||
147033151|NCT02393248|530283278|FG024|Part 3: Combination Therapy|Adverse Event|0|||
147033152|NCT02393248|530283254|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033153|NCT02393248|530283255|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033154|NCT02393248|530283256|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033155|NCT02393248|530283257|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033156|NCT02393248|530283258|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033157|NCT02393248|530283259|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033158|NCT02393248|530283260|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033159|NCT02393248|530283261|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033160|NCT02393248|530283262|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033161|NCT02393248|530283263|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033162|NCT02393248|530283264|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033163|NCT02393248|530283265|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033164|NCT02393248|530283266|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033165|NCT02393248|530283267|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033166|NCT02393248|530283268|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033167|NCT02393248|530283269|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033168|NCT02393248|530283270|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033169|NCT02393248|530283271|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033170|NCT02393248|530283272|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033171|NCT02393248|530283273|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033172|NCT02393248|530283274|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033173|NCT02393248|530283275|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033174|NCT02393248|530283276|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033175|NCT02393248|530283277|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
147033176|NCT02393248|530283278|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147033177|NCT03560986|530283279|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
147033178|NCT03560986|530283280|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
147033179|NCT03560986|530283279|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
147033180|NCT03560986|530283280|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
147033181|NCT03560986|530283279|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
147033182|NCT03560986|530283280|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
147033183|NCT03560986|530283279|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
147033184|NCT03560986|530283280|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
147033185|NCT03560986|530283279|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
147033186|NCT03560986|530283280|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
147033187|NCT03560986|530283279|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
147033188|NCT03560986|530283280|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
147033189|NCT03560986|530283279|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
147033190|NCT03560986|530283280|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
147033191|NCT01783548|530283293|FG000|Overall Study|Adverse Event|8|||
147033192|NCT01783548|530283294|FG001|Overall Study|Adverse Event|4|||
147033193|NCT01783548|530283293|FG000|Overall Study|Withdrawal by Subject|11|||
147033194|NCT01783548|530283294|FG001|Overall Study|Withdrawal by Subject|8|||
147033195|NCT01783548|530283293|FG000|Overall Study|Non-compliance|4|||
147033196|NCT01783548|530283294|FG001|Overall Study|Non-compliance|0|||
147033197|NCT01783548|530283293|FG000|Overall Study|Protocol Violation|2|||
147033198|NCT01783548|530283294|FG001|Overall Study|Protocol Violation|2|||
147033199|NCT01783548|530283293|FG000|Overall Study|Lost to Follow-up|8|||
147033200|NCT01783548|530283294|FG001|Overall Study|Lost to Follow-up|3|||
147033201|NCT01783548|530283293|FG000|Overall Study|Lack of Efficacy|1|||
147033202|NCT01783548|530283294|FG001|Overall Study|Lack of Efficacy|1|||
147033203|NCT04053465|530283298|FG000|Overall Study|Withdrawal by Subject|4|||
147033204|NCT04053465|530283299|FG001|Overall Study|Withdrawal by Subject|4|||
147033205|NCT04091659|530283302|FG000|Overall Study|Protocol Violation|3|||
147033206|NCT04091659|530283303|FG001|Overall Study|Protocol Violation|0|||
147033207|NCT04091659|530283302|FG000|Overall Study|Lost to Follow-up|0|||
146849705|NCT02663518|529618855|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146849706|NCT02663518|529618856|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147033208|NCT04091659|530283303|FG001|Overall Study|Lost to Follow-up|1|||
147033209|NCT01085734|530283304|FG000|Overall Study|Adverse Event|0|||
147033210|NCT01085734|530283305|FG001|Overall Study|Adverse Event|2|||
147033211|NCT01085734|530283304|FG000|Overall Study|Death|1|||
147033212|NCT01085734|530283305|FG001|Overall Study|Death|0|||
147033213|NCT01085734|530283304|FG000|Overall Study|Lost to Follow-up|0|||
147033214|NCT01085734|530283305|FG001|Overall Study|Lost to Follow-up|1|||
147033215|NCT01085734|530283304|FG000|Overall Study|Withdrawal by Subject|0|||
147033216|NCT01085734|530283305|FG001|Overall Study|Withdrawal by Subject|1|||
147033217|NCT04005352|530283306|FG000|Overall Study|Adverse Event|4|||
147033218|NCT04005352|530283307|FG001|Overall Study|Adverse Event|5|||
147033219|NCT04005352|530283306|FG000|Overall Study|Death|4|||
147033220|NCT04005352|530283307|FG001|Overall Study|Death|2|||
147033221|NCT04005352|530283306|FG000|Overall Study|Lost to Follow-up|6|||
147033222|NCT04005352|530283307|FG001|Overall Study|Lost to Follow-up|2|||
147033223|NCT04005352|530283306|FG000|Overall Study|Physician Decision|7|||
147033224|NCT04005352|530283307|FG001|Overall Study|Physician Decision|13|||
147033225|NCT04005352|530283306|FG000|Overall Study|Protocol Violation|0|||
147033226|NCT04005352|530283307|FG001|Overall Study|Protocol Violation|1|||
147033227|NCT04005352|530283306|FG000|Overall Study|Withdrawal by Subject|28|||
147033228|NCT04005352|530283307|FG001|Overall Study|Withdrawal by Subject|38|||
147033229|NCT02695537|530283317|FG000|Overall Study|Adverse Event|3|||
147033230|NCT02695537|530283317|FG000|Overall Study|Lack of Efficacy|28|||
147033231|NCT02695537|530283317|FG000|Overall Study|Withdrawal by Subject|4|||
147033232|NCT02695537|530283317|FG000|Overall Study|Protocol Violation|3|||
147033233|NCT05788289|530283322|FG000|Overall Study|Death|3|||
147033234|NCT02970318|530283325|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
147033235|NCT02970318|530283326|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
147033236|NCT02970318|530283327|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
147033237|NCT02970318|530283328|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
147033238|NCT02970318|530283325|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
147033239|NCT02970318|530283326|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
147033240|NCT02970318|530283327|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
147033241|NCT02970318|530283328|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
147033242|NCT02970318|530283325|FG000|Overall for Arm A & Main for Arm B|Death|41|||
147033243|NCT02970318|530283326|FG001|Overall for Arm A & Main for Arm B|Death|33|||
147033244|NCT02970318|530283327|FG002|Overall for Arm A & Main for Arm B|Death|0|||
147033245|NCT02970318|530283328|FG003|Overall for Arm A & Main for Arm B|Death|0|||
147033246|NCT02970318|530283325|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
147033247|NCT02970318|530283326|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
147033248|NCT02970318|530283327|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
147033249|NCT02970318|530283328|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
147033250|NCT02970318|530283325|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
147033251|NCT02970318|530283326|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
147033252|NCT02970318|530283327|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
147033253|NCT02970318|530283328|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
147033254|NCT02970318|530283325|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
147033255|NCT02970318|530283326|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
147033256|NCT02970318|530283327|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
147033257|NCT02970318|530283328|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
147033258|NCT02970318|530283325|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
147033259|NCT02970318|530283326|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
147033260|NCT02970318|530283327|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
147033261|NCT02970318|530283328|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
147033262|NCT00827632|530283329|FG000|Overall Study|Lost to Follow-up|8|||
147033263|NCT00827632|530283330|FG001|Overall Study|Lost to Follow-up|12|||
147033264|NCT00827632|530283329|FG000|Overall Study|Early withdrawal|14|||
147033265|NCT00827632|530283330|FG001|Overall Study|Early withdrawal|11|||
147033266|NCT01898650|530283332|FG000|Overall Study|the subject would not lie still for imaging|1|||
147033267|NCT03923530|530283334|FG000|Overall Study|Withdrawal by Subject|1|||
147033268|NCT03923530|530283334|FG000|Overall Study|screen failure|3|||
147033269|NCT00407758|530283335|FG000|Overall Study|ineligible -improper prior treatment|1|||
147033270|NCT02722148|530283346|FG000|Overall Study|Lost to Follow-up|2|||
147033271|NCT02722148|530283346|FG000|Overall Study|Non compliant with treatment regimen|3|||
147033272|NCT00855803|530283348|FG000|Overall Study|Death|2|||
147033273|NCT00855803|530283348|FG000|Overall Study|Lost to Follow-up|2|||
147033274|NCT00855803|530283348|FG000|Overall Study|Technical inability to undergo procedure|2|||
146849707|NCT02663518|529618857|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146849708|NCT02663518|529618858|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147033275|NCT00855803|530283348|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
147033276|NCT00855803|530283348|FG000|Overall Study|Withdrawal by Subject|3|||
147033277|NCT00855803|530283348|FG000|Overall Study|Physician Decision|3|||
147033278|NCT00809159|530283349|FG000|Part 1|Adverse Event|1|||
147033279|NCT00809159|530283350|FG001|Part 1|Adverse Event|1|||
147033280|NCT00809159|530283351|FG002|Part 1|Adverse Event|0|||
147033281|NCT00809159|530283352|FG003|Part 1|Adverse Event|0|||
147033282|NCT00809159|530283353|FG004|Part 1|Adverse Event|0|||
147033283|NCT00809159|530283354|FG005|Part 1|Adverse Event|0|||
147033284|NCT00809159|530283349|FG000|Part 1|Lost to Follow-up|1|||
147033285|NCT00809159|530283350|FG001|Part 1|Lost to Follow-up|0|||
147033286|NCT00809159|530283351|FG002|Part 1|Lost to Follow-up|0|||
147033287|NCT00809159|530283352|FG003|Part 1|Lost to Follow-up|0|||
147033288|NCT00809159|530283353|FG004|Part 1|Lost to Follow-up|0|||
147033289|NCT00809159|530283354|FG005|Part 1|Lost to Follow-up|0|||
147033290|NCT00809159|530283349|FG000|Part 1|Withdrawal by Subject|3|||
147033291|NCT00809159|530283350|FG001|Part 1|Withdrawal by Subject|1|||
147033292|NCT00809159|530283351|FG002|Part 1|Withdrawal by Subject|0|||
147033293|NCT00809159|530283352|FG003|Part 1|Withdrawal by Subject|0|||
147033294|NCT00809159|530283353|FG004|Part 1|Withdrawal by Subject|0|||
147033295|NCT00809159|530283354|FG005|Part 1|Withdrawal by Subject|0|||
147033296|NCT00809159|530283349|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
147033297|NCT00809159|530283350|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
147033298|NCT00809159|530283351|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
147033299|NCT00809159|530283352|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
147033300|NCT00809159|530283353|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
147033301|NCT00809159|530283354|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
147033302|NCT00809159|530283349|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
147033303|NCT00809159|530283350|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
147033304|NCT00809159|530283351|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
147033305|NCT00809159|530283352|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
147033306|NCT00809159|530283353|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
147033307|NCT00809159|530283354|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
147033308|NCT00809159|530283349|FG000|Part 1 and 2|Administrative problems|0|||
147033309|NCT00809159|530283350|FG001|Part 1 and 2|Administrative problems|0|||
147033310|NCT00809159|530283351|FG002|Part 1 and 2|Administrative problems|0|||
147033311|NCT00809159|530283352|FG003|Part 1 and 2|Administrative problems|1|||
147033312|NCT00809159|530283353|FG004|Part 1 and 2|Administrative problems|0|||
147033313|NCT00809159|530283354|FG005|Part 1 and 2|Administrative problems|0|||
147033314|NCT00809159|530283349|FG000|Part 1 and 2|Adverse Event|0|||
147033315|NCT00809159|530283350|FG001|Part 1 and 2|Adverse Event|0|||
147033316|NCT00809159|530283351|FG002|Part 1 and 2|Adverse Event|1|||
147033317|NCT00809159|530283352|FG003|Part 1 and 2|Adverse Event|0|||
147033318|NCT00809159|530283353|FG004|Part 1 and 2|Adverse Event|1|||
147033319|NCT00809159|530283354|FG005|Part 1 and 2|Adverse Event|1|||
147033320|NCT00809159|530283349|FG000|Part 1 and 2|Lost to Follow-up|0|||
147033321|NCT00809159|530283350|FG001|Part 1 and 2|Lost to Follow-up|0|||
147033322|NCT00809159|530283351|FG002|Part 1 and 2|Lost to Follow-up|1|||
147033323|NCT00809159|530283352|FG003|Part 1 and 2|Lost to Follow-up|1|||
147033324|NCT00809159|530283353|FG004|Part 1 and 2|Lost to Follow-up|0|||
147033325|NCT00809159|530283354|FG005|Part 1 and 2|Lost to Follow-up|0|||
147033326|NCT00809159|530283349|FG000|Part 1 and 2|Withdrawal by Subject|0|||
147033327|NCT00809159|530283350|FG001|Part 1 and 2|Withdrawal by Subject|0|||
147033328|NCT00809159|530283351|FG002|Part 1 and 2|Withdrawal by Subject|4|||
147033329|NCT00809159|530283352|FG003|Part 1 and 2|Withdrawal by Subject|0|||
147033330|NCT00809159|530283353|FG004|Part 1 and 2|Withdrawal by Subject|0|||
147033331|NCT00809159|530283354|FG005|Part 1 and 2|Withdrawal by Subject|1|||
147033332|NCT01672970|530283358|FG000|Overall Study|Lack of Efficacy|12|||
147033333|NCT01672970|530283358|FG000|Overall Study|Adverse Event|18|||
147033334|NCT01672970|530283358|FG000|Overall Study|Withdrawal by Subject|2|||
147033335|NCT01672970|530283358|FG000|Overall Study|Lost to Follow-up|5|||
147033336|NCT01672970|530283358|FG000|Overall Study|Other|9|||
147033337|NCT01672970|530283358|FG000|Overall Study|Enrolled but not treated|1|||
147033338|NCT04874636|530283359|FG000|Overall Study|Adverse Event|17|||
147033339|NCT04874636|530283360|FG001|Overall Study|Adverse Event|7|||
147033340|NCT04874636|530283359|FG000|Overall Study|Lost to Follow-up|1|||
147033341|NCT04874636|530283360|FG001|Overall Study|Lost to Follow-up|0|||
147033342|NCT04874636|530283359|FG000|Overall Study|Non-Compliance with Study Drug|2|||
147033343|NCT04874636|530283360|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147033344|NCT04874636|530283359|FG000|Overall Study|Physician Decision|1|||
147033345|NCT04874636|530283360|FG001|Overall Study|Physician Decision|0|||
147033346|NCT04874636|530283359|FG000|Overall Study|Withdrawal by Subject|6|||
147033347|NCT04874636|530283360|FG001|Overall Study|Withdrawal by Subject|5|||
147033348|NCT01770392|530283361|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
147033349|NCT04188301|530283362|FG000|Month 3|Lost to Follow-up|0|||
147033350|NCT04188301|530283363|FG001|Month 3|Lost to Follow-up|0|||
147033351|NCT04188301|530283364|FG002|Month 3|Lost to Follow-up|1|||
147033352|NCT04188301|530283362|FG000|Month 12|Lost to Follow-up|0|||
147033353|NCT04188301|530283363|FG001|Month 12|Lost to Follow-up|0|||
147033354|NCT04188301|530283364|FG002|Month 12|Lost to Follow-up|2|||
147033355|NCT04188301|530283362|FG000|Month 12|Death|1|||
147033356|NCT04188301|530283363|FG001|Month 12|Death|1|||
147033357|NCT04188301|530283364|FG002|Month 12|Death|0|||
147033358|NCT04188301|530283362|FG000|Month 18|Lost to Follow-up|6|||
147033359|NCT04188301|530283363|FG001|Month 18|Lost to Follow-up|0|||
147033360|NCT04188301|530283364|FG002|Month 18|Lost to Follow-up|0|||
147033361|NCT03401450|530283365|FG000|Overall Study|Lost to Follow-up|4|||
147033362|NCT03401450|530283366|FG001|Overall Study|Lost to Follow-up|6|||
147033363|NCT03401450|530283365|FG000|Overall Study|Anesthesia plan changed|2|||
147033364|NCT03401450|530283366|FG001|Overall Study|Anesthesia plan changed|2|||
147033365|NCT03401450|530283365|FG000|Overall Study|Did not complete medication diary|4|||
147033366|NCT03401450|530283366|FG001|Overall Study|Did not complete medication diary|2|||
147033367|NCT03401450|530283365|FG000|Overall Study|post surgery medication change|2|||
147033368|NCT03401450|530283366|FG001|Overall Study|post surgery medication change|1|||
147033369|NCT03401450|530283365|FG000|Overall Study|Cancelled surgery|0|||
147033370|NCT03401450|530283366|FG001|Overall Study|Cancelled surgery|2|||
147033371|NCT03258853|530283380|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
147033372|NCT03258853|530283381|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
147033373|NCT02582866|530283382|FG000|Overall Study|Death|1|||
147033374|NCT02582866|530283382|FG000|Overall Study|Lack of Efficacy|2|||
147033375|NCT02582866|530283382|FG000|Overall Study|Lost to Follow-up|2|||
147033376|NCT02582866|530283382|FG000|Overall Study|Withdrawal by Subject|7|||
147033377|NCT02582866|530283382|FG000|Overall Study|Investigator decision|5|||
147033378|NCT02582866|530283382|FG000|Overall Study|Participant wants to get pregnant|1|||
147033379|NCT02582866|530283382|FG000|Overall Study|Pregnancy|2|||
147033380|NCT02582866|530283382|FG000|Overall Study|Sponsor decision|1|||
147033381|NCT02582866|530283382|FG000|Overall Study|Withdrawal due to personal reasons|1|||
147033382|NCT03567382|530283389|FG000|Overall Study|Lost to Follow-up|1|||
147033383|NCT03567382|530283390|FG001|Overall Study|Lost to Follow-up|21|||
147033384|NCT03567382|530283391|FG002|Overall Study|Lost to Follow-up|1|||
147033385|NCT03567382|530283392|FG003|Overall Study|Lost to Follow-up|21|||
147033386|NCT03567382|530283389|FG000|Overall Study|Withdrawal by Subject|2|||
147033387|NCT03567382|530283390|FG001|Overall Study|Withdrawal by Subject|14|||
147033388|NCT03567382|530283391|FG002|Overall Study|Withdrawal by Subject|1|||
147033389|NCT03567382|530283392|FG003|Overall Study|Withdrawal by Subject|12|||
147033390|NCT02011386|530283393|FG000|Overall Study|Non-compliance|2|||
147033391|NCT02011386|530283393|FG000|Overall Study|Lack of Efficacy|3|||
147033392|NCT01709838|530283394|FG000|Overall Study|Withdrawal by Subject|21|||
147033393|NCT01709838|530283394|FG000|Overall Study|Lost to Follow-up|16|||
147033394|NCT01709838|530283394|FG000|Overall Study|Pregnancy|10|||
147033395|NCT01709838|530283394|FG000|Overall Study|Subject/guardian decision|8|||
147033396|NCT01709838|530283394|FG000|Overall Study|Adverse Event|4|||
147033397|NCT01709838|530283394|FG000|Overall Study|Physician Decision|4|||
147033398|NCT01709838|530283394|FG000|Overall Study|Death|3|||
147033399|NCT01709838|530283394|FG000|Overall Study|Protocol Violation|1|||
147033400|NCT00620659|530283395|FG000|Treatment Period 1|Adverse Event|1|||
147033401|NCT00620659|530283396|FG001|Treatment Period 1|Adverse Event|0|||
147033402|NCT00620659|530283397|FG002|Treatment Period 1|Adverse Event|0|||
147033403|NCT00620659|530283398|FG003|Treatment Period 1|Adverse Event|3|||
147033404|NCT00620659|530283399|FG004|Treatment Period 1|Adverse Event|0|||
147033405|NCT00620659|530283400|FG005|Treatment Period 1|Adverse Event|0|||
147033406|NCT00620659|530283395|FG000|Treatment Period 1|Protocol Violation|1|||
147033407|NCT00620659|530283396|FG001|Treatment Period 1|Protocol Violation|0|||
147033408|NCT00620659|530283397|FG002|Treatment Period 1|Protocol Violation|0|||
147033409|NCT00620659|530283398|FG003|Treatment Period 1|Protocol Violation|0|||
147033410|NCT00620659|530283399|FG004|Treatment Period 1|Protocol Violation|0|||
147033411|NCT00620659|530283400|FG005|Treatment Period 1|Protocol Violation|0|||
147033412|NCT00620659|530283395|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147033413|NCT00620659|530283396|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147033414|NCT00620659|530283397|FG002|Treatment Period 1|Withdrawal by Subject|1|||
147033415|NCT00620659|530283398|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147033416|NCT00620659|530283399|FG004|Treatment Period 1|Withdrawal by Subject|1|||
147033417|NCT00620659|530283400|FG005|Treatment Period 1|Withdrawal by Subject|0|||
147033418|NCT00620659|530283395|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
147033419|NCT00620659|530283396|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
147033420|NCT00620659|530283397|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
147033421|NCT00620659|530283398|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
147033422|NCT00620659|530283399|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
147033423|NCT00620659|530283400|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
147033424|NCT00620659|530283395|FG000|Treatment Period 2|Adverse Event|0|||
147033425|NCT00620659|530283396|FG001|Treatment Period 2|Adverse Event|3|||
147033426|NCT00620659|530283397|FG002|Treatment Period 2|Adverse Event|0|||
146849709|NCT02663518|529618859|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147033427|NCT00620659|530283398|FG003|Treatment Period 2|Adverse Event|0|||
147033428|NCT00620659|530283399|FG004|Treatment Period 2|Adverse Event|2|||
147033429|NCT00620659|530283400|FG005|Treatment Period 2|Adverse Event|0|||
147033430|NCT00620659|530283395|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147033431|NCT00620659|530283396|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147033432|NCT00620659|530283397|FG002|Treatment Period 2|Withdrawal by Subject|1|||
147033433|NCT00620659|530283398|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147033434|NCT00620659|530283399|FG004|Treatment Period 2|Withdrawal by Subject|3|||
147033435|NCT00620659|530283400|FG005|Treatment Period 2|Withdrawal by Subject|0|||
147033436|NCT00620659|530283395|FG000|Placebo Washout Period 2|Adverse Event|2|||
147033437|NCT00620659|530283396|FG001|Placebo Washout Period 2|Adverse Event|0|||
147033438|NCT00620659|530283397|FG002|Placebo Washout Period 2|Adverse Event|0|||
147033439|NCT00620659|530283398|FG003|Placebo Washout Period 2|Adverse Event|0|||
147033440|NCT00620659|530283399|FG004|Placebo Washout Period 2|Adverse Event|0|||
147033441|NCT00620659|530283400|FG005|Placebo Washout Period 2|Adverse Event|0|||
147033442|NCT00620659|530283395|FG000|Treatment Period 3|Adverse Event|0|||
147033443|NCT00620659|530283396|FG001|Treatment Period 3|Adverse Event|2|||
147033444|NCT00620659|530283397|FG002|Treatment Period 3|Adverse Event|0|||
147033445|NCT00620659|530283398|FG003|Treatment Period 3|Adverse Event|0|||
147033446|NCT00620659|530283399|FG004|Treatment Period 3|Adverse Event|0|||
147033447|NCT00620659|530283400|FG005|Treatment Period 3|Adverse Event|0|||
147033448|NCT00620659|530283395|FG000|Treatment Period 3|Withdrawal by Subject|0|||
147033449|NCT00620659|530283396|FG001|Treatment Period 3|Withdrawal by Subject|0|||
147033450|NCT00620659|530283397|FG002|Treatment Period 3|Withdrawal by Subject|0|||
147033451|NCT00620659|530283398|FG003|Treatment Period 3|Withdrawal by Subject|1|||
147033452|NCT00620659|530283399|FG004|Treatment Period 3|Withdrawal by Subject|0|||
147033453|NCT00620659|530283400|FG005|Treatment Period 3|Withdrawal by Subject|0|||
147033454|NCT01193127|530283403|FG000|Randomized|Surgery Cancelled|0|||
147033455|NCT01193127|530283404|FG001|Randomized|Surgery Cancelled|0|||
147033456|NCT01193127|530283405|FG002|Randomized|Surgery Cancelled|0|||
147033457|NCT01193127|530283406|FG003|Randomized|Surgery Cancelled|1|||
147033458|NCT01193127|530283403|FG000|Treated|Withdrawal by Subject|0|||
147033459|NCT01193127|530283404|FG001|Treated|Withdrawal by Subject|0|||
147033460|NCT01193127|530283405|FG002|Treated|Withdrawal by Subject|0|||
147033461|NCT01193127|530283406|FG003|Treated|Withdrawal by Subject|1|||
147033462|NCT03246646|530283409|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
147033463|NCT03246646|530283410|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
147033464|NCT03246646|530283409|FG000|Overall Study|Withdrawal by Subject|3|||
147033465|NCT03246646|530283410|FG001|Overall Study|Withdrawal by Subject|0|||
147033466|NCT03246646|530283409|FG000|Overall Study|Lost to Follow-up|7|||
147033467|NCT03246646|530283410|FG001|Overall Study|Lost to Follow-up|0|||
147033468|NCT02352779|530283411|FG000|Overall Study|Personal Issues|1|||
147033469|NCT02352779|530283412|FG001|Overall Study|Personal Issues|1|||
147033470|NCT02352779|530283413|FG002|Overall Study|Personal Issues|0|||
147033471|NCT02352779|530283411|FG000|Overall Study|Too Many Forms|2|||
147033472|NCT02352779|530283412|FG001|Overall Study|Too Many Forms|0|||
147033473|NCT02352779|530283413|FG002|Overall Study|Too Many Forms|0|||
147033474|NCT02352779|530283411|FG000|Overall Study|Feeling Overwhelmed|1|||
147033475|NCT02352779|530283412|FG001|Overall Study|Feeling Overwhelmed|0|||
147033476|NCT02352779|530283413|FG002|Overall Study|Feeling Overwhelmed|0|||
147033477|NCT02352779|530283411|FG000|Overall Study|Disliked Intervention|1|||
147033478|NCT02352779|530283412|FG001|Overall Study|Disliked Intervention|0|||
147033479|NCT02352779|530283413|FG002|Overall Study|Disliked Intervention|0|||
147033480|NCT02352779|530283411|FG000|Overall Study|Changed Mind|1|||
147033481|NCT02352779|530283412|FG001|Overall Study|Changed Mind|0|||
147033482|NCT02352779|530283413|FG002|Overall Study|Changed Mind|0|||
147033483|NCT02352779|530283411|FG000|Overall Study|Study Related Symptoms|1|||
147033484|NCT02352779|530283412|FG001|Overall Study|Study Related Symptoms|0|||
147033485|NCT02352779|530283413|FG002|Overall Study|Study Related Symptoms|0|||
147033486|NCT02352779|530283411|FG000|Overall Study|Absence of Symptoms|1|||
147033487|NCT02352779|530283412|FG001|Overall Study|Absence of Symptoms|0|||
147033488|NCT02352779|530283413|FG002|Overall Study|Absence of Symptoms|0|||
147033489|NCT02352779|530283411|FG000|Overall Study|Other Medical Reason|0|||
147033490|NCT02352779|530283412|FG001|Overall Study|Other Medical Reason|0|||
147033491|NCT02352779|530283413|FG002|Overall Study|Other Medical Reason|1|||
147033492|NCT02352779|530283411|FG000|Overall Study|No Reason|0|||
147033493|NCT02352779|530283412|FG001|Overall Study|No Reason|0|||
147033494|NCT02352779|530283413|FG002|Overall Study|No Reason|1|||
147033495|NCT00968799|530283418|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
147033496|NCT01104779|530283421|FG000|Overall Study|Protocol Violation|1|||
147033497|NCT01104779|530283422|FG001|Overall Study|Protocol Violation|2|||
147033498|NCT01104779|530283423|FG002|Overall Study|Protocol Violation|2|||
147033499|NCT01104779|530283421|FG000|Overall Study|Lack of Efficacy|26|||
147033500|NCT01104779|530283422|FG001|Overall Study|Lack of Efficacy|12|||
147033501|NCT01104779|530283423|FG002|Overall Study|Lack of Efficacy|13|||
147033502|NCT01104779|530283421|FG000|Overall Study|Adverse Event|13|||
147033503|NCT01104779|530283422|FG001|Overall Study|Adverse Event|14|||
147033504|NCT01104779|530283423|FG002|Overall Study|Adverse Event|13|||
147033505|NCT01104779|530283421|FG000|Overall Study|Did not meet inc/exc criteria|1|||
147033506|NCT01104779|530283422|FG001|Overall Study|Did not meet inc/exc criteria|1|||
147033507|NCT01104779|530283423|FG002|Overall Study|Did not meet inc/exc criteria|1|||
147033508|NCT01104779|530283421|FG000|Overall Study|Other reasons|0|||
147033509|NCT01104779|530283422|FG001|Overall Study|Other reasons|1|||
147033510|NCT01104779|530283423|FG002|Overall Study|Other reasons|0|||
147033511|NCT01104779|530283421|FG000|Overall Study|Lost to Follow-up|2|||
147033512|NCT01104779|530283422|FG001|Overall Study|Lost to Follow-up|0|||
147033513|NCT01104779|530283423|FG002|Overall Study|Lost to Follow-up|1|||
147033514|NCT01104779|530283421|FG000|Overall Study|Withdrawal by Subject|16|||
147033515|NCT01104779|530283422|FG001|Overall Study|Withdrawal by Subject|25|||
147033516|NCT01104779|530283423|FG002|Overall Study|Withdrawal by Subject|32|||
147033517|NCT03753763|530283424|FG000|Overall Study|Adverse Event|2|||
147033518|NCT03753763|530283425|FG001|Overall Study|Adverse Event|0|||
147033519|NCT03753763|530283424|FG000|Overall Study|Withdrawal by Subject|3|||
147033520|NCT03753763|530283425|FG001|Overall Study|Withdrawal by Subject|1|||
147033521|NCT03753763|530283424|FG000|Overall Study|clinical deterioration|1|||
147033522|NCT03753763|530283425|FG001|Overall Study|clinical deterioration|0|||
147033523|NCT01372774|530283428|FG000|Overall Study|Withdrawal prior to treatment|4|||
147033524|NCT01372774|530283429|FG001|Overall Study|Withdrawal prior to treatment|5|||
147033525|NCT00389831|530283430|FG000|Overall Study|Lack of Efficacy|0|||
147033526|NCT00389831|530283431|FG001|Overall Study|Lack of Efficacy|2|||
147033527|NCT00389831|530283430|FG000|Overall Study|Did not receive treatment.|0|||
147033528|NCT00389831|530283431|FG001|Overall Study|Did not receive treatment.|2|||
147033529|NCT00389831|530283430|FG000|Overall Study|Other reasons|0|||
147033530|NCT00389831|530283431|FG001|Overall Study|Other reasons|2|||
147033531|NCT00389831|530283430|FG000|Overall Study|Lost to Follow-up|0|||
147033532|NCT00389831|530283431|FG001|Overall Study|Lost to Follow-up|1|||
147033533|NCT04639713|530283436|FG000|Overall Study|Protocol Noncompliance|2|||
147033534|NCT04639713|530283436|FG000|Overall Study|Withdrawal by Subject|1|||
147033535|NCT02081209|530285923|FG000|Overall Study|Withdrawal by Subject|1|||
147033536|NCT02022748|530285927|FG000|Overall Study|Adverse Event|1|||
147033537|NCT02022748|530285928|FG001|Overall Study|Adverse Event|1|||
147033538|NCT02022748|530285929|FG002|Overall Study|Adverse Event|0|||
147033539|NCT02022748|530285927|FG000|Overall Study|Withdrawal by Subject|0|||
147033540|NCT02022748|530285928|FG001|Overall Study|Withdrawal by Subject|1|||
147033541|NCT02022748|530285929|FG002|Overall Study|Withdrawal by Subject|0|||
147033542|NCT00554190|530285930|FG000|Overall Study|Termination forms not completed|10|||
147033543|NCT01502410|530285931|FG000|Overall Study|Adverse Event|1|||
147033544|NCT01502410|530285932|FG001|Overall Study|Adverse Event|2|||
147033545|NCT01502410|530285933|FG002|Overall Study|Adverse Event|0|||
147033546|NCT01502410|530285934|FG003|Overall Study|Adverse Event|0|||
147033547|NCT01502410|530285931|FG000|Overall Study|Lack of Efficacy|7|||
147033548|NCT01502410|530285932|FG001|Overall Study|Lack of Efficacy|7|||
147033549|NCT01502410|530285933|FG002|Overall Study|Lack of Efficacy|0|||
147033550|NCT01502410|530285934|FG003|Overall Study|Lack of Efficacy|0|||
147033551|NCT01502410|530285931|FG000|Overall Study|Physician Decision|0|||
147033552|NCT01502410|530285932|FG001|Overall Study|Physician Decision|1|||
147033553|NCT01502410|530285933|FG002|Overall Study|Physician Decision|0|||
147033554|NCT01502410|530285934|FG003|Overall Study|Physician Decision|0|||
147033555|NCT01502410|530285931|FG000|Overall Study|Withdrawal by Subject|2|||
147033556|NCT01502410|530285932|FG001|Overall Study|Withdrawal by Subject|0|||
147033557|NCT01502410|530285933|FG002|Overall Study|Withdrawal by Subject|0|||
147033558|NCT01502410|530285934|FG003|Overall Study|Withdrawal by Subject|0|||
147033559|NCT04345601|530285935|FG000|Overall Study|Death|0|||
147033560|NCT04345601|530285936|FG001|Overall Study|Death|3|||
147033561|NCT04345601|530285937|FG002|Overall Study|Death|2|||
147033562|NCT04345601|530285935|FG000|Overall Study|Lost to Follow-up|0|||
147033563|NCT04345601|530285936|FG001|Overall Study|Lost to Follow-up|0|||
147033564|NCT04345601|530285937|FG002|Overall Study|Lost to Follow-up|2|||
147033565|NCT00977379|530285938|FG000|Overall Study|Withdrawal by Subject|1|||
147033566|NCT00977379|530285939|FG001|Overall Study|Withdrawal by Subject|1|||
147033567|NCT00977379|530285938|FG000|Overall Study|Death|7|||
147033568|NCT00977379|530285939|FG001|Overall Study|Death|9|||
147033569|NCT00977379|530285938|FG000|Overall Study|Premature Study Termination|4|||
147033570|NCT00977379|530285939|FG001|Overall Study|Premature Study Termination|0|||
147033571|NCT00977379|530285938|FG000|Overall Study|Participant Moving House|0|||
147033572|NCT00977379|530285939|FG001|Overall Study|Participant Moving House|1|||
147033573|NCT00977379|530285938|FG000|Overall Study|Randomization Error|0|||
147033574|NCT00977379|530285939|FG001|Overall Study|Randomization Error|1|||
146849710|NCT02663518|529618860|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147033575|NCT02603393|530285940|FG000|Overall Study|Patient/guardian decision|32|||
147033576|NCT02603393|530285941|FG001|Overall Study|Patient/guardian decision|18|||
147033577|NCT02603393|530285940|FG000|Overall Study|Adverse Event|17|||
147033578|NCT02603393|530285941|FG001|Overall Study|Adverse Event|15|||
147033579|NCT02603393|530285940|FG000|Overall Study|Technical problems|4|||
147033580|NCT02603393|530285941|FG001|Overall Study|Technical problems|7|||
147033581|NCT02603393|530285940|FG000|Overall Study|Lack of Efficacy|7|||
147033582|NCT02603393|530285941|FG001|Overall Study|Lack of Efficacy|2|||
147033583|NCT02603393|530285940|FG000|Overall Study|Death|3|||
147033584|NCT02603393|530285941|FG001|Overall Study|Death|4|||
147033585|NCT02603393|530285940|FG000|Overall Study|Physician Decision|3|||
147033586|NCT02603393|530285941|FG001|Overall Study|Physician Decision|3|||
147033587|NCT02603393|530285940|FG000|Overall Study|Protocol deviation|2|||
147033588|NCT02603393|530285941|FG001|Overall Study|Protocol deviation|3|||
147033589|NCT02603393|530285940|FG000|Overall Study|Lost to Follow-up|1|||
147033590|NCT02603393|530285941|FG001|Overall Study|Lost to Follow-up|2|||
147033591|NCT02603393|530285940|FG000|Overall Study|Non-compliance with study treatment|1|||
147033592|NCT02603393|530285941|FG001|Overall Study|Non-compliance with study treatment|0|||
147033593|NCT02603393|530285940|FG000|Overall Study|Sponsor decision|1|||
147033594|NCT02603393|530285941|FG001|Overall Study|Sponsor decision|0|||
147033595|NCT00699374|530285942|FG000|Overall Study|Death|93|||
147033596|NCT00699374|530285943|FG001|Overall Study|Death|83|||
147033597|NCT00699374|530285942|FG000|Overall Study|Adverse Event|70|||
147033598|NCT00699374|530285943|FG001|Overall Study|Adverse Event|67|||
147033599|NCT00699374|530285942|FG000|Overall Study|Global deterioration of health status|7|||
147033600|NCT00699374|530285943|FG001|Overall Study|Global deterioration of health status|8|||
147033601|NCT00699374|530285942|FG000|Overall Study|Lost to Follow-up|3|||
147033602|NCT00699374|530285943|FG001|Overall Study|Lost to Follow-up|5|||
147033603|NCT00699374|530285942|FG000|Overall Study|Withdrawal by Subject|34|||
147033604|NCT00699374|530285943|FG001|Overall Study|Withdrawal by Subject|44|||
147033605|NCT00699374|530285942|FG000|Overall Study|Objective progression or relapse|281|||
147033606|NCT00699374|530285943|FG001|Overall Study|Objective progression or relapse|277|||
147033607|NCT00699374|530285942|FG000|Overall Study|Other|18|||
147033608|NCT00699374|530285943|FG001|Overall Study|Other|15|||
147033609|NCT00699374|530285942|FG000|Overall Study|Protocol Violation|2|||
147033610|NCT00699374|530285943|FG001|Overall Study|Protocol Violation|6|||
147033611|NCT00699374|530285942|FG000|Overall Study|Study terminated by sponsor|13|||
147033612|NCT00699374|530285943|FG001|Overall Study|Study terminated by sponsor|28|||
147033613|NCT00699374|530285942|FG000|Overall Study|Randomized but not treated|4|||
147033614|NCT00699374|530285943|FG001|Overall Study|Randomized but not treated|2|||
147033615|NCT00699374|530285942|FG000|Overall Study|Died 28 days after last dose|5|||
147033616|NCT00699374|530285943|FG001|Overall Study|Died 28 days after last dose|9|||
147033617|NCT01359969|530285944|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
147033618|NCT00593736|530285951|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
147033619|NCT00593736|530285952|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
147033620|NCT00593736|530285953|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
147033621|NCT00593736|530285954|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
147033622|NCT00593736|530285951|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
147033623|NCT00593736|530285952|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
147033624|NCT00593736|530285953|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
147033625|NCT00593736|530285954|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
147033626|NCT00593736|530285951|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
147033627|NCT00593736|530285952|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
147033628|NCT00593736|530285953|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
147033629|NCT00593736|530285954|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
147033630|NCT00593736|530285951|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
147033631|NCT00593736|530285952|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
147033632|NCT00593736|530285953|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
147033633|NCT00593736|530285954|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
147033634|NCT00593736|530285951|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
147033635|NCT00593736|530285952|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
147033636|NCT00593736|530285953|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
147033637|NCT00593736|530285954|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
147033638|NCT00593736|530285951|FG000|Screening Period and Placebo Run-in|Various|0|||
147033639|NCT00593736|530285952|FG001|Screening Period and Placebo Run-in|Various|0|||
147033640|NCT00593736|530285953|FG002|Screening Period and Placebo Run-in|Various|0|||
147033641|NCT00593736|530285954|FG003|Screening Period and Placebo Run-in|Various|25|||
147033642|NCT00593736|530285951|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
147033643|NCT00593736|530285952|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
147033644|NCT00593736|530285953|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
147033645|NCT00593736|530285954|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
147033646|NCT00593736|530285951|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
147033647|NCT00593736|530285952|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
147033648|NCT00593736|530285953|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
147033649|NCT00593736|530285954|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
147033650|NCT00593736|530285951|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
147033651|NCT00593736|530285952|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
147033652|NCT00593736|530285953|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
147033653|NCT00593736|530285954|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
147033654|NCT00593736|530285951|FG000|Treatment Period and Placebo Run-out|Various|1|||
147033655|NCT00593736|530285952|FG001|Treatment Period and Placebo Run-out|Various|1|||
147033656|NCT00593736|530285953|FG002|Treatment Period and Placebo Run-out|Various|1|||
147033657|NCT00593736|530285954|FG003|Treatment Period and Placebo Run-out|Various|0|||
147033658|NCT01868893|530285955|FG000|Overall Study|Adverse Event|2|||
147033659|NCT01868893|530285955|FG000|Overall Study|Commercial availability of study drug|17|||
147033660|NCT01868893|530285955|FG000|Overall Study|Neutropenia|1|||
147033661|NCT01857271|530285956|FG000|Overall Study|Lost to Follow-up|1|||
147033662|NCT04283500|530285961|FG000|Overall Study|Lost to Follow-up|8|||
147033663|NCT04283500|530285961|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
147033664|NCT02006693|530285965|FG000|Overall Study|No Reason Specified|6|||
147033665|NCT02006693|530285966|FG001|Overall Study|No Reason Specified|8|||
147033666|NCT02006693|530285965|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
147033667|NCT02006693|530285966|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
147033668|NCT02006693|530285965|FG000|Overall Study|XEN Implant Explantation|0|||
147033669|NCT02006693|530285966|FG001|Overall Study|XEN Implant Explantation|1|||
147033670|NCT02006693|530285965|FG000|Overall Study|Death|2|||
147033671|NCT02006693|530285966|FG001|Overall Study|Death|2|||
147033672|NCT02006693|530285965|FG000|Overall Study|Lost to Follow-up|4|||
147033673|NCT02006693|530285966|FG001|Overall Study|Lost to Follow-up|1|||
147033674|NCT02006693|530285965|FG000|Overall Study|Patient Decision|4|||
147033675|NCT02006693|530285966|FG001|Overall Study|Patient Decision|0|||
147033676|NCT01119508|530285969|FG000|Overall Study|Adverse Event|56|||
147033677|NCT01119508|530285969|FG000|Overall Study|Withdrawal by Subject|2|||
147033678|NCT01119508|530285969|FG000|Overall Study|Died before tumor response evaluation|1|||
147033679|NCT00265395|530285970|FG000|Overall Study|Adverse Event|3|||
147033680|NCT00265395|530285971|FG001|Overall Study|Adverse Event|6|||
147033681|NCT00265395|530285970|FG000|Overall Study|Lost to Follow-up|2|||
147033682|NCT00265395|530285971|FG001|Overall Study|Lost to Follow-up|1|||
147033683|NCT00265395|530285970|FG000|Overall Study|Withdrawal by Subject|1|||
147033684|NCT00265395|530285971|FG001|Overall Study|Withdrawal by Subject|6|||
147033685|NCT00265395|530285970|FG000|Overall Study|Protocol Violation|2|||
147033686|NCT00265395|530285971|FG001|Overall Study|Protocol Violation|2|||
147033687|NCT00265395|530285970|FG000|Overall Study|Lack of Efficacy|0|||
147033688|NCT00265395|530285971|FG001|Overall Study|Lack of Efficacy|1|||
147033689|NCT00265395|530285970|FG000|Overall Study|Administrative|0|||
147033690|NCT00265395|530285971|FG001|Overall Study|Administrative|1|||
147033691|NCT02563106|530285976|FG000|Overall Study|Withdrawal by Subject|7|||
147033692|NCT02563106|530285977|FG001|Overall Study|Withdrawal by Subject|8|||
147033693|NCT02563106|530285976|FG000|Overall Study|Adverse Event|17|||
147033694|NCT02563106|530285977|FG001|Overall Study|Adverse Event|15|||
147033695|NCT02563106|530285976|FG000|Overall Study|Protocol Violation|1|||
147033696|NCT02563106|530285977|FG001|Overall Study|Protocol Violation|0|||
147033697|NCT02563106|530285976|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
147033698|NCT02563106|530285977|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
147033699|NCT02563106|530285976|FG000|Overall Study|Lost to Follow-up|3|||
147033700|NCT02563106|530285977|FG001|Overall Study|Lost to Follow-up|2|||
147033701|NCT02563106|530285976|FG000|Overall Study|Physician Decision|3|||
147033702|NCT02563106|530285977|FG001|Overall Study|Physician Decision|1|||
147033703|NCT02563106|530285976|FG000|Overall Study|Other reason - not specified|2|||
147033704|NCT02563106|530285977|FG001|Overall Study|Other reason - not specified|1|||
147033705|NCT04729309|530285978|FG000|Period 1|Subject unable to return for Period 2|3|||
147033706|NCT04729309|530285979|FG001|Period 1|Subject unable to return for Period 2|0|||
147033707|NCT04729309|530285978|FG000|Period 1|Lost to Follow-up|1|||
147033708|NCT04729309|530285979|FG001|Period 1|Lost to Follow-up|0|||
147033709|NCT01059539|530285980|FG000|Overall Study|Adverse Event|66|||
147033710|NCT01059539|530285980|FG000|Overall Study|Insufficient Therapeutic Response|26|||
147033711|NCT01059539|530285980|FG000|Overall Study|Protocol Violation|55|||
147033712|NCT01059539|530285980|FG000|Overall Study|Withdrawal of Consent|80|||
147033713|NCT01059539|530285980|FG000|Overall Study|Lost to Follow-up|42|||
147033714|NCT01059539|530285980|FG000|Overall Study|Reason Not Specified|2|||
147033715|NCT02085135|530285981|FG000|Overall Study|Adverse Event|4|||
147033716|NCT02085135|530285982|FG001|Overall Study|Adverse Event|7|||
147033717|NCT02085135|530285981|FG000|Overall Study|Lost to Follow-up|2|||
147033718|NCT02085135|530285982|FG001|Overall Study|Lost to Follow-up|2|||
147033719|NCT02085135|530285981|FG000|Overall Study|Withdrawal by Subject|3|||
147033720|NCT02085135|530285982|FG001|Overall Study|Withdrawal by Subject|0|||
147033721|NCT02085135|530285981|FG000|Overall Study|Lack of Efficacy|2|||
147033722|NCT02085135|530285982|FG001|Overall Study|Lack of Efficacy|0|||
147033723|NCT01212588|530285983|FG000|Overall Study|Physician Decision|0|||
147033724|NCT01212588|530285984|FG001|Overall Study|Physician Decision|1|||
147033725|NCT01212588|530285983|FG000|Overall Study|Protocol Violation|1|||
147033726|NCT01212588|530285984|FG001|Overall Study|Protocol Violation|1|||
147033727|NCT02338193|530285985|FG000|Overall Study|Withdrawal by Subject|0|||
147033728|NCT02338193|530285986|FG001|Overall Study|Withdrawal by Subject|0|||
147033729|NCT02338193|530285987|FG002|Overall Study|Withdrawal by Subject|2|||
147033730|NCT02338193|530285985|FG000|Overall Study|Pregnancy|0|||
147033731|NCT02338193|530285986|FG001|Overall Study|Pregnancy|1|||
147033732|NCT02338193|530285987|FG002|Overall Study|Pregnancy|1|||
147033733|NCT02338193|530285985|FG000|Overall Study|Noncompliant with visits|2|||
147033734|NCT02338193|530285986|FG001|Overall Study|Noncompliant with visits|2|||
147033735|NCT02338193|530285987|FG002|Overall Study|Noncompliant with visits|7|||
147033736|NCT02338193|530285985|FG000|Overall Study|moved out of state|0|||
147033737|NCT02338193|530285986|FG001|Overall Study|moved out of state|1|||
147033738|NCT02338193|530285987|FG002|Overall Study|moved out of state|0|||
147033739|NCT02338193|530285985|FG000|Overall Study|intolerant of side effects|1|||
147033740|NCT02338193|530285986|FG001|Overall Study|intolerant of side effects|0|||
147033741|NCT02338193|530285987|FG002|Overall Study|intolerant of side effects|0|||
147033742|NCT01136967|530285988|FG000|Overall Study|Adverse Event|9|||
147033743|NCT01136967|530285989|FG001|Overall Study|Adverse Event|12|||
147033744|NCT01136967|530285988|FG000|Overall Study|Participant Choice|8|||
147033745|NCT01136967|530285989|FG001|Overall Study|Participant Choice|3|||
147033746|NCT01136967|530285988|FG000|Overall Study|Lost to Follow-up|0|||
147033747|NCT01136967|530285989|FG001|Overall Study|Lost to Follow-up|1|||
147033748|NCT01136967|530285988|FG000|Overall Study|Withdrawal by Subject|1|||
147033749|NCT01136967|530285989|FG001|Overall Study|Withdrawal by Subject|2|||
147033750|NCT01136967|530285988|FG000|Overall Study|Clinical Progression|3|||
147033751|NCT01136967|530285989|FG001|Overall Study|Clinical Progression|5|||
147033752|NCT01136967|530285988|FG000|Overall Study|Radiation|1|||
147033753|NCT01136967|530285989|FG001|Overall Study|Radiation|0|||
147033754|NCT01136967|530285988|FG000|Overall Study|Non-compliance|1|||
147033755|NCT01136967|530285989|FG001|Overall Study|Non-compliance|0|||
147033756|NCT01136967|530285988|FG000|Overall Study|Investigator's Choice|1|||
147033757|NCT01136967|530285989|FG001|Overall Study|Investigator's Choice|1|||
147033758|NCT01136967|530285988|FG000|Overall Study|Increase in Lesion Size|0|||
147033759|NCT01136967|530285989|FG001|Overall Study|Increase in Lesion Size|2|||
147033760|NCT01136967|530285988|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
147033761|NCT01136967|530285989|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
147033762|NCT01735955|530285991|FG000|Overall Study|Administrative problems|1|||
147033763|NCT01735955|530285991|FG000|Overall Study|Patient/guardian decision|1|||
147033764|NCT01735955|530285991|FG000|Overall Study|Patient withdrew consent|2|||
147033765|NCT01735955|530285991|FG000|Overall Study|Physician Decision|4|||
147033766|NCT01735955|530285991|FG000|Overall Study|Disease progression|24|||
147033767|NCT01735955|530285991|FG000|Overall Study|Adverse Event|5|||
147033768|NCT02885181|530285992|FG000|Overall Study|Investigator's Discretion|0|||
147033769|NCT02885181|530285993|FG001|Overall Study|Investigator's Discretion|1|||
147033770|NCT02885181|530285994|FG002|Overall Study|Investigator's Discretion|0|||
147033771|NCT02885181|530285995|FG003|Overall Study|Investigator's Discretion|1|||
147033772|NCT02885181|530285992|FG000|Overall Study|Adverse Event|0|||
147033773|NCT02885181|530285993|FG001|Overall Study|Adverse Event|0|||
147033774|NCT02885181|530285994|FG002|Overall Study|Adverse Event|0|||
147033775|NCT02885181|530285995|FG003|Overall Study|Adverse Event|1|||
147033776|NCT02885181|530285992|FG000|Overall Study|Withdrawal by Subject|0|||
147033777|NCT02885181|530285993|FG001|Overall Study|Withdrawal by Subject|0|||
147033778|NCT02885181|530285994|FG002|Overall Study|Withdrawal by Subject|0|||
147033779|NCT02885181|530285995|FG003|Overall Study|Withdrawal by Subject|1|||
147033780|NCT03317834|530285996|FG000|Overall Study|Death|2|||
147033781|NCT03317834|530285996|FG000|Overall Study|Device Revision|5|||
147033782|NCT03317834|530285996|FG000|Overall Study|Withdrawal by Subject|13|||
147033783|NCT03317834|530285996|FG000|Overall Study|Lost to Follow-up|13|||
147033784|NCT04228783|530286000|FG000|Overall Study|Adverse Event|1|||
147033785|NCT04228783|530286001|FG001|Overall Study|Adverse Event|0|||
147033786|NCT04228783|530286002|FG002|Overall Study|Adverse Event|2|||
147033787|NCT04228783|530286003|FG003|Overall Study|Adverse Event|0|||
147033788|NCT04228783|530286004|FG004|Overall Study|Adverse Event|0|||
147033789|NCT04228783|530286005|FG005|Overall Study|Adverse Event|1|||
147033790|NCT04228783|530286000|FG000|Overall Study|Death|0|||
147033791|NCT04228783|530286001|FG001|Overall Study|Death|0|||
147033792|NCT04228783|530286002|FG002|Overall Study|Death|0|||
147033793|NCT04228783|530286003|FG003|Overall Study|Death|0|||
147033794|NCT04228783|530286004|FG004|Overall Study|Death|1|||
147033795|NCT04228783|530286005|FG005|Overall Study|Death|0|||
147033796|NCT04228783|530286000|FG000|Overall Study|Lost to Follow-up|36|||
147033797|NCT04228783|530286001|FG001|Overall Study|Lost to Follow-up|36|||
147033798|NCT04228783|530286002|FG002|Overall Study|Lost to Follow-up|28|||
147033799|NCT04228783|530286003|FG003|Overall Study|Lost to Follow-up|6|||
147033800|NCT04228783|530286004|FG004|Overall Study|Lost to Follow-up|14|||
147033801|NCT04228783|530286005|FG005|Overall Study|Lost to Follow-up|3|||
147033802|NCT04228783|530286000|FG000|Overall Study|Physician Decision|1|||
147033803|NCT04228783|530286001|FG001|Overall Study|Physician Decision|2|||
147033804|NCT04228783|530286002|FG002|Overall Study|Physician Decision|0|||
147033805|NCT04228783|530286003|FG003|Overall Study|Physician Decision|0|||
147033806|NCT04228783|530286004|FG004|Overall Study|Physician Decision|0|||
146849711|NCT02663518|529618861|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146849712|NCT02663518|529618862|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
147033807|NCT04228783|530286005|FG005|Overall Study|Physician Decision|0|||
147033808|NCT04228783|530286000|FG000|Overall Study|Protocol Violation|0|||
147033809|NCT04228783|530286001|FG001|Overall Study|Protocol Violation|0|||
147033810|NCT04228783|530286002|FG002|Overall Study|Protocol Violation|0|||
147033811|NCT04228783|530286003|FG003|Overall Study|Protocol Violation|1|||
147033812|NCT04228783|530286004|FG004|Overall Study|Protocol Violation|0|||
147033813|NCT04228783|530286005|FG005|Overall Study|Protocol Violation|0|||
147033814|NCT04228783|530286000|FG000|Overall Study|Withdrawal by Subject|6|||
147033815|NCT04228783|530286001|FG001|Overall Study|Withdrawal by Subject|10|||
147033816|NCT04228783|530286002|FG002|Overall Study|Withdrawal by Subject|19|||
147033817|NCT04228783|530286003|FG003|Overall Study|Withdrawal by Subject|1|||
147033818|NCT04228783|530286004|FG004|Overall Study|Withdrawal by Subject|2|||
147033819|NCT04228783|530286005|FG005|Overall Study|Withdrawal by Subject|0|||
147033820|NCT04228783|530286000|FG000|Overall Study|Other|4|||
147033821|NCT04228783|530286001|FG001|Overall Study|Other|3|||
147033822|NCT04228783|530286002|FG002|Overall Study|Other|2|||
147033823|NCT04228783|530286003|FG003|Overall Study|Other|1|||
147033824|NCT04228783|530286004|FG004|Overall Study|Other|0|||
147033825|NCT04228783|530286005|FG005|Overall Study|Other|0|||
147033826|NCT00626392|530286006|FG000|Run-in Period|Adverse Event|0|||
147033827|NCT00626392|530286007|FG001|Run-in Period|Adverse Event|0|||
147033828|NCT00626392|530286008|FG002|Run-in Period|Adverse Event|1|||
147033829|NCT00626392|530286009|FG003|Run-in Period|Adverse Event|0|||
147033830|NCT00626392|530286010|FG004|Run-in Period|Adverse Event|1|||
147033831|NCT00626392|530286011|FG005|Run-in Period|Adverse Event|0|||
147033832|NCT00626392|530286006|FG000|Run-in Period|Withdrawal by Subject|0|||
147033833|NCT00626392|530286007|FG001|Run-in Period|Withdrawal by Subject|1|||
147033834|NCT00626392|530286008|FG002|Run-in Period|Withdrawal by Subject|1|||
147033835|NCT00626392|530286009|FG003|Run-in Period|Withdrawal by Subject|1|||
147033836|NCT00626392|530286010|FG004|Run-in Period|Withdrawal by Subject|3|||
147033837|NCT00626392|530286011|FG005|Run-in Period|Withdrawal by Subject|1|||
147033838|NCT00626392|530286006|FG000|Run-in Period|Noncompliance|1|||
147033839|NCT00626392|530286007|FG001|Run-in Period|Noncompliance|0|||
147033840|NCT00626392|530286008|FG002|Run-in Period|Noncompliance|1|||
147033841|NCT00626392|530286009|FG003|Run-in Period|Noncompliance|0|||
147033842|NCT00626392|530286010|FG004|Run-in Period|Noncompliance|0|||
147033843|NCT00626392|530286011|FG005|Run-in Period|Noncompliance|0|||
147033844|NCT00626392|530286006|FG000|Coadministration Period|Adverse Event|3|||
147033845|NCT00626392|530286007|FG001|Coadministration Period|Adverse Event|1|||
147033846|NCT00626392|530286008|FG002|Coadministration Period|Adverse Event|7|||
147033847|NCT00626392|530286009|FG003|Coadministration Period|Adverse Event|4|||
147033848|NCT00626392|530286010|FG004|Coadministration Period|Adverse Event|3|||
147033849|NCT00626392|530286011|FG005|Coadministration Period|Adverse Event|4|||
147033850|NCT00626392|530286006|FG000|Coadministration Period|Withdrawal by Subject|1|||
147033851|NCT00626392|530286007|FG001|Coadministration Period|Withdrawal by Subject|1|||
147033852|NCT00626392|530286008|FG002|Coadministration Period|Withdrawal by Subject|0|||
147033853|NCT00626392|530286009|FG003|Coadministration Period|Withdrawal by Subject|1|||
147033854|NCT00626392|530286010|FG004|Coadministration Period|Withdrawal by Subject|0|||
147033855|NCT00626392|530286011|FG005|Coadministration Period|Withdrawal by Subject|1|||
147033856|NCT00626392|530286006|FG000|Coadministration Period|Protocol Violation|0|||
147033857|NCT00626392|530286007|FG001|Coadministration Period|Protocol Violation|1|||
147033858|NCT00626392|530286008|FG002|Coadministration Period|Protocol Violation|0|||
147033859|NCT00626392|530286009|FG003|Coadministration Period|Protocol Violation|1|||
147033860|NCT00626392|530286010|FG004|Coadministration Period|Protocol Violation|1|||
147033861|NCT00626392|530286011|FG005|Coadministration Period|Protocol Violation|0|||
147033862|NCT00626392|530286006|FG000|Coadministration Period|Other|0|||
147033863|NCT00626392|530286007|FG001|Coadministration Period|Other|2|||
147033864|NCT00626392|530286008|FG002|Coadministration Period|Other|3|||
147033865|NCT00626392|530286009|FG003|Coadministration Period|Other|1|||
147033866|NCT00626392|530286010|FG004|Coadministration Period|Other|1|||
147033867|NCT00626392|530286011|FG005|Coadministration Period|Other|1|||
147033868|NCT03151811|530286013|FG000|Overall Study|Randomized But Not Treated|18|||
147033869|NCT03151811|530286014|FG001|Overall Study|Randomized But Not Treated|3|||
147033870|NCT03151811|530286013|FG000|Overall Study|Progressive Disease|130|||
147033871|NCT03151811|530286014|FG001|Overall Study|Progressive Disease|170|||
147033872|NCT03151811|530286013|FG000|Overall Study|Adverse Event|49|||
147033873|NCT03151811|530286014|FG001|Overall Study|Adverse Event|40|||
147033874|NCT03151811|530286013|FG000|Overall Study|Lack of Efficacy|6|||
147033875|NCT03151811|530286014|FG001|Overall Study|Lack of Efficacy|8|||
147033876|NCT03151811|530286013|FG000|Overall Study|Physician Decision|21|||
147033877|NCT03151811|530286014|FG001|Overall Study|Physician Decision|9|||
147033878|NCT03151811|530286013|FG000|Overall Study|Withdrawal by Subject|17|||
147033879|NCT03151811|530286014|FG001|Overall Study|Withdrawal by Subject|7|||
147033880|NCT03151811|530286013|FG000|Overall Study|Lost to Follow-up|0|||
147033881|NCT03151811|530286014|FG001|Overall Study|Lost to Follow-up|1|||
147033882|NCT03151811|530286013|FG000|Overall Study|Study Terminated by Sponsor|5|||
147033883|NCT03151811|530286014|FG001|Overall Study|Study Terminated by Sponsor|11|||
147033884|NCT01517373|530286015|FG000|Run-in Period|Death|1|||
147033885|NCT01517373|530286016|FG001|Run-in Period|Death|0|||
147033886|NCT01517373|530286017|FG002|Run-in Period|Death|0|||
147033887|NCT01517373|530286018|FG003|Run-in Period|Death|0|||
147033888|NCT01517373|530286019|FG004|Run-in Period|Death|0|||
147033889|NCT01517373|530286020|FG005|Run-in Period|Death|0|||
147033890|NCT01517373|530286015|FG000|Run-in Period|Adverse Event|5|||
147033891|NCT01517373|530286016|FG001|Run-in Period|Adverse Event|0|||
147033892|NCT01517373|530286017|FG002|Run-in Period|Adverse Event|0|||
147033893|NCT01517373|530286018|FG003|Run-in Period|Adverse Event|0|||
147033894|NCT01517373|530286019|FG004|Run-in Period|Adverse Event|0|||
147033895|NCT01517373|530286020|FG005|Run-in Period|Adverse Event|0|||
147033896|NCT01517373|530286015|FG000|Run-in Period|Did not meet eligibility criteria|34|||
147033897|NCT01517373|530286016|FG001|Run-in Period|Did not meet eligibility criteria|0|||
147033898|NCT01517373|530286017|FG002|Run-in Period|Did not meet eligibility criteria|0|||
147033899|NCT01517373|530286018|FG003|Run-in Period|Did not meet eligibility criteria|0|||
147033900|NCT01517373|530286019|FG004|Run-in Period|Did not meet eligibility criteria|0|||
147033901|NCT01517373|530286020|FG005|Run-in Period|Did not meet eligibility criteria|0|||
147033902|NCT01517373|530286015|FG000|Run-in Period|Lost to Follow-up|1|||
147033903|NCT01517373|530286016|FG001|Run-in Period|Lost to Follow-up|0|||
147033904|NCT01517373|530286017|FG002|Run-in Period|Lost to Follow-up|0|||
147033905|NCT01517373|530286018|FG003|Run-in Period|Lost to Follow-up|0|||
147033906|NCT01517373|530286019|FG004|Run-in Period|Lost to Follow-up|0|||
147033907|NCT01517373|530286020|FG005|Run-in Period|Lost to Follow-up|0|||
147033908|NCT01517373|530286015|FG000|Run-in Period|Withdrawal by Subject|12|||
147033909|NCT01517373|530286016|FG001|Run-in Period|Withdrawal by Subject|0|||
147033910|NCT01517373|530286017|FG002|Run-in Period|Withdrawal by Subject|0|||
147033911|NCT01517373|530286018|FG003|Run-in Period|Withdrawal by Subject|0|||
147033912|NCT01517373|530286019|FG004|Run-in Period|Withdrawal by Subject|0|||
147033913|NCT01517373|530286020|FG005|Run-in Period|Withdrawal by Subject|0|||
147033914|NCT01517373|530286015|FG000|Run-in Period|Sponsor Decision|3|||
147033915|NCT01517373|530286016|FG001|Run-in Period|Sponsor Decision|0|||
147033916|NCT01517373|530286017|FG002|Run-in Period|Sponsor Decision|0|||
147033917|NCT01517373|530286018|FG003|Run-in Period|Sponsor Decision|0|||
147033918|NCT01517373|530286019|FG004|Run-in Period|Sponsor Decision|0|||
147033919|NCT01517373|530286020|FG005|Run-in Period|Sponsor Decision|0|||
147033920|NCT01517373|530286015|FG000|Run-in Period|Other|1|||
147033921|NCT01517373|530286016|FG001|Run-in Period|Other|0|||
147033922|NCT01517373|530286017|FG002|Run-in Period|Other|0|||
147033923|NCT01517373|530286018|FG003|Run-in Period|Other|0|||
147033924|NCT01517373|530286019|FG004|Run-in Period|Other|0|||
147033925|NCT01517373|530286020|FG005|Run-in Period|Other|0|||
147033926|NCT01517373|530286015|FG000|Treatment Period|Adverse Event|0|||
147033927|NCT01517373|530286016|FG001|Treatment Period|Adverse Event|0|||
147033928|NCT01517373|530286017|FG002|Treatment Period|Adverse Event|0|||
147033929|NCT01517373|530286018|FG003|Treatment Period|Adverse Event|0|||
147033930|NCT01517373|530286019|FG004|Treatment Period|Adverse Event|0|||
147033931|NCT01517373|530286020|FG005|Treatment Period|Adverse Event|2|||
147033932|NCT01517373|530286015|FG000|Treatment Period|Lost to Follow-up|0|||
147033933|NCT01517373|530286016|FG001|Treatment Period|Lost to Follow-up|0|||
147033934|NCT01517373|530286017|FG002|Treatment Period|Lost to Follow-up|1|||
147033935|NCT01517373|530286018|FG003|Treatment Period|Lost to Follow-up|1|||
147033936|NCT01517373|530286019|FG004|Treatment Period|Lost to Follow-up|0|||
147033937|NCT01517373|530286020|FG005|Treatment Period|Lost to Follow-up|0|||
147033938|NCT01517373|530286015|FG000|Treatment Period|Withdrawal by Subject|0|||
147033939|NCT01517373|530286016|FG001|Treatment Period|Withdrawal by Subject|3|||
147033940|NCT01517373|530286017|FG002|Treatment Period|Withdrawal by Subject|2|||
147033941|NCT01517373|530286018|FG003|Treatment Period|Withdrawal by Subject|2|||
147033942|NCT01517373|530286019|FG004|Treatment Period|Withdrawal by Subject|2|||
147033943|NCT01517373|530286020|FG005|Treatment Period|Withdrawal by Subject|3|||
147033944|NCT01517373|530286015|FG000|Treatment Period|Other|0|||
147033945|NCT01517373|530286016|FG001|Treatment Period|Other|0|||
147033946|NCT01517373|530286017|FG002|Treatment Period|Other|0|||
147033947|NCT01517373|530286018|FG003|Treatment Period|Other|0|||
147033948|NCT01517373|530286019|FG004|Treatment Period|Other|1|||
147033949|NCT01517373|530286020|FG005|Treatment Period|Other|0|||
147033950|NCT01517373|530286015|FG000|Treatment Period|Protocol Violation|0|||
147033951|NCT01517373|530286016|FG001|Treatment Period|Protocol Violation|0|||
147033952|NCT01517373|530286017|FG002|Treatment Period|Protocol Violation|0|||
147033953|NCT01517373|530286018|FG003|Treatment Period|Protocol Violation|0|||
147033954|NCT01517373|530286019|FG004|Treatment Period|Protocol Violation|1|||
147033955|NCT01517373|530286020|FG005|Treatment Period|Protocol Violation|0|||
147033956|NCT01517373|530286015|FG000|Treatment Period|Lack of Efficacy|0|||
147033957|NCT01517373|530286016|FG001|Treatment Period|Lack of Efficacy|1|||
147033958|NCT01517373|530286017|FG002|Treatment Period|Lack of Efficacy|1|||
147033959|NCT01517373|530286018|FG003|Treatment Period|Lack of Efficacy|3|||
147033960|NCT01517373|530286019|FG004|Treatment Period|Lack of Efficacy|2|||
147033961|NCT01517373|530286020|FG005|Treatment Period|Lack of Efficacy|0|||
147033962|NCT01517373|530286015|FG000|Treatment Period|Medication error without AEs|0|||
147033963|NCT01517373|530286016|FG001|Treatment Period|Medication error without AEs|0|||
147033964|NCT01517373|530286017|FG002|Treatment Period|Medication error without AEs|2|||
147033965|NCT01517373|530286018|FG003|Treatment Period|Medication error without AEs|1|||
147033966|NCT01517373|530286019|FG004|Treatment Period|Medication error without AEs|0|||
147033967|NCT01517373|530286020|FG005|Treatment Period|Medication error without AEs|2|||
147033968|NCT00742924|530286025|FG000|Overall Study|Adverse Event|0|||
147033969|NCT00742924|530286026|FG001|Overall Study|Adverse Event|0|||
147033970|NCT00742924|530286027|FG002|Overall Study|Adverse Event|1|||
147033971|NCT00742924|530286028|FG003|Overall Study|Adverse Event|1|||
147033972|NCT00742924|530286025|FG000|Overall Study|Lack of Efficacy|5|||
147033973|NCT00742924|530286026|FG001|Overall Study|Lack of Efficacy|1|||
147033974|NCT00742924|530286027|FG002|Overall Study|Lack of Efficacy|2|||
147033975|NCT00742924|530286028|FG003|Overall Study|Lack of Efficacy|4|||
147033976|NCT00742924|530286025|FG000|Overall Study|Physician Decision|0|||
147033977|NCT00742924|530286026|FG001|Overall Study|Physician Decision|0|||
147033978|NCT00742924|530286027|FG002|Overall Study|Physician Decision|0|||
147033979|NCT00742924|530286028|FG003|Overall Study|Physician Decision|1|||
147033980|NCT00742924|530286025|FG000|Overall Study|Withdrawal by Subject|0|||
147033981|NCT00742924|530286026|FG001|Overall Study|Withdrawal by Subject|1|||
147033982|NCT00742924|530286027|FG002|Overall Study|Withdrawal by Subject|1|||
147033983|NCT00742924|530286028|FG003|Overall Study|Withdrawal by Subject|0|||
147033984|NCT02792699|530286044|FG000|Overall Study|Adverse Event|1|||
147033985|NCT02792699|530286045|FG001|Overall Study|Adverse Event|2|||
147033986|NCT02792699|530286046|FG002|Overall Study|Adverse Event|4|||
147033987|NCT02792699|530286044|FG000|Overall Study|Withdrawal by Subject|4|||
147033988|NCT02792699|530286045|FG001|Overall Study|Withdrawal by Subject|4|||
147033989|NCT02792699|530286046|FG002|Overall Study|Withdrawal by Subject|3|||
147033990|NCT02792699|530286044|FG000|Overall Study|Lost to Follow-up|0|||
147033991|NCT02792699|530286045|FG001|Overall Study|Lost to Follow-up|1|||
147033992|NCT02792699|530286046|FG002|Overall Study|Lost to Follow-up|2|||
147033993|NCT02792699|530286044|FG000|Overall Study|Physician Decision|2|||
147033994|NCT02792699|530286045|FG001|Overall Study|Physician Decision|0|||
147033995|NCT02792699|530286046|FG002|Overall Study|Physician Decision|0|||
147033996|NCT02792699|530286044|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
147033997|NCT02792699|530286045|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
147033998|NCT02792699|530286046|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
147033999|NCT02792699|530286044|FG000|Overall Study|Other|1|||
147034000|NCT02792699|530286045|FG001|Overall Study|Other|0|||
147034001|NCT02792699|530286046|FG002|Overall Study|Other|0|||
147034002|NCT04524364|530286047|FG000|Overall Study|Physician Decision|3|||
147034003|NCT04524364|530286048|FG001|Overall Study|Physician Decision|6|||
147034004|NCT04524364|530286047|FG000|Overall Study|Adverse Event|0|||
147034005|NCT04524364|530286048|FG001|Overall Study|Adverse Event|1|||
147034006|NCT04524364|530286047|FG000|Overall Study|Investigational device deficiency|0|||
147034007|NCT04524364|530286048|FG001|Overall Study|Investigational device deficiency|1|||
147034008|NCT04524364|530286047|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
147034009|NCT04524364|530286048|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
147034010|NCT04524364|530286047|FG000|Overall Study|Device unavailability|0|||
147034011|NCT04524364|530286048|FG001|Overall Study|Device unavailability|2|||
147034012|NCT04524364|530286047|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
147034013|NCT04524364|530286048|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
147034014|NCT04524364|530286047|FG000|Overall Study|Low International normalized ratio (INR)|1|||
147034015|NCT04524364|530286048|FG001|Overall Study|Low International normalized ratio (INR)|0|||
147034016|NCT02865460|530286049|FG000|Overall Study|Adverse Event|1|||
147034017|NCT02865460|530286050|FG001|Overall Study|Adverse Event|0|||
147034018|NCT02865460|530286049|FG000|Overall Study|Withdrawal by Subject|1|||
147034019|NCT02865460|530286050|FG001|Overall Study|Withdrawal by Subject|1|||
147034020|NCT02865460|530286049|FG000|Overall Study|Lost to Follow-up|7|||
147034021|NCT02865460|530286050|FG001|Overall Study|Lost to Follow-up|4|||
147034022|NCT02865460|530286049|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
147034023|NCT02865460|530286050|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
147034024|NCT00380744|530286051|FG000|Overall Study|Death|0|||
147034025|NCT00380744|530286052|FG001|Overall Study|Death|0|||
147034026|NCT00380744|530286053|FG002|Overall Study|Death|0|||
147034027|NCT00380744|530286054|FG003|Overall Study|Death|0|||
147034028|NCT00380744|530286055|FG004|Overall Study|Death|0|||
147034029|NCT00380744|530286056|FG005|Overall Study|Death|0|||
147034030|NCT00380744|530286057|FG006|Overall Study|Death|1|||
147034031|NCT00380744|530286051|FG000|Overall Study|Withdrawal by Subject|1|||
147034032|NCT00380744|530286052|FG001|Overall Study|Withdrawal by Subject|0|||
147034033|NCT00380744|530286053|FG002|Overall Study|Withdrawal by Subject|0|||
147034034|NCT00380744|530286054|FG003|Overall Study|Withdrawal by Subject|0|||
147034035|NCT00380744|530286055|FG004|Overall Study|Withdrawal by Subject|0|||
147034036|NCT00380744|530286056|FG005|Overall Study|Withdrawal by Subject|0|||
147034037|NCT00380744|530286057|FG006|Overall Study|Withdrawal by Subject|0|||
147034038|NCT02256436|530286064|FG000|Overall Study|Adverse Event|9|||
147034039|NCT02256436|530286065|FG001|Overall Study|Adverse Event|14|||
147034040|NCT02256436|530286064|FG000|Overall Study|Death|216|||
147034041|NCT02256436|530286065|FG001|Overall Study|Death|208|||
147034042|NCT02256436|530286064|FG000|Overall Study|Lost to Follow-up|1|||
147034043|NCT02256436|530286065|FG001|Overall Study|Lost to Follow-up|2|||
147034044|NCT02256436|530286064|FG000|Overall Study|Physician Decision|1|||
147034045|NCT02256436|530286065|FG001|Overall Study|Physician Decision|0|||
147034046|NCT02256436|530286064|FG000|Overall Study|Protocol Violation|0|||
147034047|NCT02256436|530286065|FG001|Overall Study|Protocol Violation|1|||
147034048|NCT02256436|530286064|FG000|Overall Study|Withdrawal by Subject|26|||
147034049|NCT02256436|530286065|FG001|Overall Study|Withdrawal by Subject|10|||
147034050|NCT02256436|530286064|FG000|Overall Study|Transferred to Extension Study|11|||
147034051|NCT02256436|530286065|FG001|Overall Study|Transferred to Extension Study|23|||
147034052|NCT02256436|530286064|FG000|Overall Study|Did Not Continue on Extension Study|8|||
147034053|NCT02256436|530286065|FG001|Overall Study|Did Not Continue on Extension Study|12|||
147034054|NCT01696279|530286066|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
147034055|NCT01696279|530286067|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
147034056|NCT01696279|530286068|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
147034057|NCT01696279|530286069|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
147034058|NCT01696279|530286066|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
147034059|NCT01696279|530286067|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
147034060|NCT01696279|530286068|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
147034061|NCT01696279|530286069|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
147034062|NCT01696279|530286066|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
147034063|NCT01696279|530286067|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
147034064|NCT01696279|530286068|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
147034065|NCT01696279|530286069|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
147034066|NCT01696279|530286066|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
147034067|NCT01696279|530286067|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
147034068|NCT01696279|530286068|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
147034069|NCT01696279|530286069|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
147034070|NCT01696279|530286066|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
147034071|NCT01696279|530286067|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
147034072|NCT01696279|530286068|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
147034073|NCT01696279|530286069|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
147034074|NCT01696279|530286066|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
147034075|NCT01696279|530286067|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
147034076|NCT01696279|530286068|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
147034077|NCT01696279|530286069|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
147034078|NCT01696279|530286066|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
147034079|NCT01696279|530286067|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
147034080|NCT01696279|530286068|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
147034081|NCT01696279|530286069|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
147034082|NCT01696279|530286066|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
147034083|NCT01696279|530286067|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
147034084|NCT01696279|530286068|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
147034085|NCT01696279|530286069|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
147034086|NCT01696279|530286066|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
147034087|NCT01696279|530286067|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
147034088|NCT01696279|530286068|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
147034089|NCT01696279|530286069|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
147034090|NCT01696279|530286066|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
147034091|NCT01696279|530286067|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
147034092|NCT01696279|530286068|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
147034093|NCT01696279|530286069|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
147034094|NCT01696279|530286066|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
147034095|NCT01696279|530286067|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
147034096|NCT01696279|530286068|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
147034097|NCT01696279|530286069|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
147034098|NCT03233230|530286072|FG000|Overall Study|Adverse Event|6|||
147034099|NCT03233230|530286073|FG001|Overall Study|Adverse Event|3|||
147034100|NCT03233230|530286074|FG002|Overall Study|Adverse Event|6|||
147034101|NCT03233230|530286075|FG003|Overall Study|Adverse Event|3|||
147034102|NCT03233230|530286072|FG000|Overall Study|Protocol Violation|1|||
147034103|NCT03233230|530286073|FG001|Overall Study|Protocol Violation|2|||
147034104|NCT03233230|530286074|FG002|Overall Study|Protocol Violation|1|||
147034105|NCT03233230|530286075|FG003|Overall Study|Protocol Violation|1|||
147034106|NCT03233230|530286072|FG000|Overall Study|Lack of Efficacy|1|||
147034107|NCT03233230|530286073|FG001|Overall Study|Lack of Efficacy|0|||
147034108|NCT03233230|530286074|FG002|Overall Study|Lack of Efficacy|0|||
147034109|NCT03233230|530286075|FG003|Overall Study|Lack of Efficacy|0|||
147034110|NCT03233230|530286072|FG000|Overall Study|Other|5|||
147034111|NCT03233230|530286073|FG001|Overall Study|Other|5|||
147034112|NCT03233230|530286074|FG002|Overall Study|Other|5|||
147034113|NCT03233230|530286075|FG003|Overall Study|Other|3|||
147034114|NCT03233230|530286072|FG000|Overall Study|Withdrawal by Subject|2|||
147034115|NCT03233230|530286073|FG001|Overall Study|Withdrawal by Subject|2|||
147034116|NCT03233230|530286074|FG002|Overall Study|Withdrawal by Subject|0|||
147034117|NCT03233230|530286075|FG003|Overall Study|Withdrawal by Subject|1|||
147034118|NCT03233230|530286072|FG000|Overall Study|Lost to Follow-up|0|||
147034119|NCT03233230|530286073|FG001|Overall Study|Lost to Follow-up|3|||
147034120|NCT03233230|530286074|FG002|Overall Study|Lost to Follow-up|0|||
147034121|NCT03233230|530286075|FG003|Overall Study|Lost to Follow-up|0|||
147034122|NCT01584843|530286076|FG000|First Treatment Period|Adverse Event|0|||
147034123|NCT01584843|530286077|FG001|First Treatment Period|Adverse Event|0|||
147034124|NCT01584843|530286078|FG002|First Treatment Period|Adverse Event|1|||
147034125|NCT01584843|530286079|FG003|First Treatment Period|Adverse Event|0|||
147034126|NCT01584843|530286080|FG004|First Treatment Period|Adverse Event|0|||
147034127|NCT01584843|530286081|FG005|First Treatment Period|Adverse Event|0|||
147034128|NCT01584843|530286076|FG000|First Treatment Period|Protocol Violation|0|||
147034129|NCT01584843|530286077|FG001|First Treatment Period|Protocol Violation|0|||
147034130|NCT01584843|530286078|FG002|First Treatment Period|Protocol Violation|0|||
147034131|NCT01584843|530286079|FG003|First Treatment Period|Protocol Violation|0|||
147034132|NCT01584843|530286080|FG004|First Treatment Period|Protocol Violation|0|||
147034133|NCT01584843|530286081|FG005|First Treatment Period|Protocol Violation|1|||
147034134|NCT01584843|530286076|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
147034135|NCT01584843|530286077|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
147034136|NCT01584843|530286078|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
147034137|NCT01584843|530286079|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
147034138|NCT01584843|530286080|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
147034139|NCT01584843|530286081|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
147034140|NCT01584843|530286076|FG000|Second Treatment Period|Withdrawal by Subject|0|||
147034141|NCT01584843|530286077|FG001|Second Treatment Period|Withdrawal by Subject|0|||
147034142|NCT01584843|530286078|FG002|Second Treatment Period|Withdrawal by Subject|0|||
147034143|NCT01584843|530286079|FG003|Second Treatment Period|Withdrawal by Subject|0|||
147034144|NCT01584843|530286080|FG004|Second Treatment Period|Withdrawal by Subject|0|||
147034145|NCT01584843|530286081|FG005|Second Treatment Period|Withdrawal by Subject|1|||
147034146|NCT04126213|530286084|FG000|Overall Study|Lost to Follow-up|9|||
147034147|NCT04126213|530286085|FG001|Overall Study|Lost to Follow-up|1|||
147034148|NCT04126213|530286086|FG002|Overall Study|Lost to Follow-up|5|||
147034149|NCT04126213|530286087|FG003|Overall Study|Lost to Follow-up|10|||
147034150|NCT04126213|530286088|FG004|Overall Study|Lost to Follow-up|4|||
147034151|NCT04126213|530286089|FG005|Overall Study|Lost to Follow-up|7|||
147034152|NCT04126213|530286084|FG000|Overall Study|Withdrawal by Subject|3|||
147034153|NCT04126213|530286085|FG001|Overall Study|Withdrawal by Subject|2|||
147034154|NCT04126213|530286086|FG002|Overall Study|Withdrawal by Subject|1|||
147034155|NCT04126213|530286087|FG003|Overall Study|Withdrawal by Subject|1|||
147034156|NCT04126213|530286088|FG004|Overall Study|Withdrawal by Subject|1|||
147034157|NCT04126213|530286089|FG005|Overall Study|Withdrawal by Subject|1|||
147034158|NCT04126213|530286084|FG000|Overall Study|Other|0|||
147034159|NCT04126213|530286085|FG001|Overall Study|Other|0|||
147034160|NCT04126213|530286086|FG002|Overall Study|Other|2|||
147034161|NCT04126213|530286087|FG003|Overall Study|Other|2|||
147034162|NCT04126213|530286088|FG004|Overall Study|Other|0|||
147034163|NCT04126213|530286089|FG005|Overall Study|Other|1|||
147034164|NCT04126213|530286084|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147034165|NCT04126213|530286085|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
147034166|NCT04126213|530286086|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147034167|NCT04126213|530286087|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147034168|NCT04126213|530286088|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147034169|NCT04126213|530286089|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
147034170|NCT02853370|530286090|FG000|Overall Study|Physician Decision|1|||
147034171|NCT02853370|530286090|FG000|Overall Study|Lack of Efficacy|2|||
147034172|NCT02853370|530286090|FG000|Overall Study|Death|1|||
147034173|NCT02853370|530286090|FG000|Overall Study|Adverse Event|4|||
147034174|NCT02853370|530286090|FG000|Overall Study|Withdrawal by Subject|3|||
147034175|NCT02196701|530286091|FG000|Overall Study|Adverse Event|1|||
147034176|NCT02196701|530286091|FG000|Overall Study|Lost to Follow-up|1|||
147034177|NCT02196701|530286091|FG000|Overall Study|Non-adherence to Protocol|1|||
147034178|NCT03275064|530286092|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
147034179|NCT03275064|530286093|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
147034180|NCT03275064|530286094|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
147034181|NCT03275064|530286095|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
147034182|NCT03275064|530286096|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
147034183|NCT03275064|530286092|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
147034184|NCT03275064|530286093|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
147034185|NCT03275064|530286094|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
147034186|NCT03275064|530286095|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
147034187|NCT03275064|530286096|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
147034188|NCT03275064|530286092|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
147034189|NCT03275064|530286093|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
147034190|NCT03275064|530286094|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
147034191|NCT03275064|530286095|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
147034192|NCT03275064|530286096|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
147034193|NCT03275064|530286092|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
147034194|NCT03275064|530286093|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
147034195|NCT03275064|530286094|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
147034196|NCT03275064|530286095|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
147034197|NCT03275064|530286096|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
147034198|NCT03275064|530286092|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
147034199|NCT03275064|530286093|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
147034200|NCT03275064|530286094|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
147034201|NCT03275064|530286095|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
147034202|NCT03275064|530286096|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
147034203|NCT03734666|530286098|FG000|Overall Study|Other|7|||
147034204|NCT03734666|530286099|FG001|Overall Study|Other|4|||
147034205|NCT03734666|530286098|FG000|Overall Study|Lost to Follow-up|12|||
147034206|NCT03734666|530286099|FG001|Overall Study|Lost to Follow-up|12|||
147034207|NCT01910389|530286101|FG000|Overall Study|Withdrawal by Subject|2|||
147034208|NCT01910389|530286102|FG001|Overall Study|Withdrawal by Subject|0|||
147034209|NCT01910389|530286101|FG000|Overall Study|Study Closed|13|||
147034210|NCT01910389|530286102|FG001|Overall Study|Study Closed|8|||
147034211|NCT05896202|530286103|FG000|Overall Study|Lost to Follow-up|2|||
147034212|NCT05896202|530286104|FG001|Overall Study|Lost to Follow-up|2|||
147034213|NCT04669691|530286105|FG000|Overall Study|Death|0|||
147034214|NCT04669691|530286106|FG001|Overall Study|Death|1|||
147034215|NCT04669691|530286107|FG002|Overall Study|Death|0|||
147034216|NCT04669691|530286108|FG003|Overall Study|Death|0|||
147034217|NCT04669691|530286109|FG004|Overall Study|Death|0|||
147034218|NCT04669691|530286110|FG005|Overall Study|Death|0|||
147034219|NCT01822275|530286111|FG000|Overall Study|Withdrawal by Subject|3|||
147034220|NCT01822275|530286111|FG000|Overall Study|Adverse Event|3|||
147034221|NCT01822275|530286111|FG000|Overall Study|Progression|14|||
147034222|NCT01822275|530286111|FG000|Overall Study|Physician Decision|2|||
147034223|NCT04430855|530286115|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
147034224|NCT04430855|530286116|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
147034225|NCT04430855|530286115|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
147034226|NCT04430855|530286116|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
147034227|NCT04430855|530286115|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
147034228|NCT04430855|530286116|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
147034229|NCT04430855|530286115|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
147034230|NCT04430855|530286116|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
147034231|NCT04430855|530286115|FG000|Period 1 (Weeks 1-12)|Other|0|||
147034232|NCT04430855|530286116|FG001|Period 1 (Weeks 1-12)|Other|1|||
147034233|NCT04430855|530286115|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
147034234|NCT04430855|530286116|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
147034235|NCT04430855|530286115|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
147034236|NCT04430855|530286116|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
147034237|NCT04430855|530286115|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
147034238|NCT04430855|530286116|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
147034239|NCT01425723|530286117|FG000|Overall Study|Lack of Efficacy|0|||
147034240|NCT01425723|530286118|FG001|Overall Study|Lack of Efficacy|1|||
147034241|NCT01425723|530286117|FG000|Overall Study|Withdrawal by Subject|1|||
147034242|NCT01425723|530286118|FG001|Overall Study|Withdrawal by Subject|4|||
147034243|NCT01425723|530286117|FG000|Overall Study|Lost to Follow-up|0|||
147034244|NCT01425723|530286118|FG001|Overall Study|Lost to Follow-up|3|||
147034245|NCT01425723|530286117|FG000|Overall Study|Physician Decision|2|||
147034246|NCT01425723|530286118|FG001|Overall Study|Physician Decision|0|||
147034247|NCT01425723|530286117|FG000|Overall Study|Other|1|||
147034248|NCT01425723|530286118|FG001|Overall Study|Other|10|||
147034249|NCT00186043|530286119|FG000|Overall Study|Lack of Efficacy|1|||
147034250|NCT00186043|530286120|FG001|Overall Study|Lack of Efficacy|3|||
147034251|NCT00186043|530286119|FG000|Overall Study|Lost to Follow-up|4|||
147034252|NCT00186043|530286120|FG001|Overall Study|Lost to Follow-up|6|||
147034253|NCT00186043|530286119|FG000|Overall Study|Withdrawal by Subject|1|||
147034254|NCT00186043|530286120|FG001|Overall Study|Withdrawal by Subject|0|||
147034255|NCT00186043|530286119|FG000|Overall Study|Adverse Event|7|||
147034256|NCT00186043|530286120|FG001|Overall Study|Adverse Event|3|||
147034257|NCT00186043|530286119|FG000|Overall Study|Protocol Violation|2|||
147034258|NCT00186043|530286120|FG001|Overall Study|Protocol Violation|1|||
147034259|NCT00871741|530286123|FG000|Overall Study|Premature study termination|9|||
147034260|NCT00871741|530286124|FG001|Overall Study|Premature study termination|7|||
147034261|NCT03190330|530288403|FG000|Overall Study|Adverse Event|2|||
147034262|NCT03190330|530288403|FG000|Overall Study|Death|10|||
147034263|NCT03190330|530288403|FG000|Overall Study|Lost to Follow-up|1|||
147034264|NCT03190330|530288403|FG000|Overall Study|Withdrawal by Subject|6|||
147034265|NCT03190330|530288403|FG000|Overall Study|Progressive Disease|1|||
147034266|NCT00633243|530288404|FG000|Overall Study|Withdrawal by Subject|0|||
147034267|NCT00633243|530288405|FG001|Overall Study|Withdrawal by Subject|1|||
147034268|NCT00633243|530288404|FG000|Overall Study|incarceration|0|||
147034269|NCT00633243|530288405|FG001|Overall Study|incarceration|2|||
147034270|NCT00633243|530288404|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
147034271|NCT00633243|530288405|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
147034272|NCT00633243|530288404|FG000|Overall Study|Not comfortable with self-injecting|0|||
147034273|NCT00633243|530288405|FG001|Overall Study|Not comfortable with self-injecting|1|||
147034274|NCT00633243|530288404|FG000|Overall Study|Mental Health--Depression|0|||
147034275|NCT00633243|530288405|FG001|Overall Study|Mental Health--Depression|1|||
147034276|NCT00633243|530288404|FG000|Overall Study|Couldn't tolerate side-effects|1|||
147034277|NCT00633243|530288405|FG001|Overall Study|Couldn't tolerate side-effects|1|||
147034278|NCT00379340|530288407|FG000|Overall Study|Death|0|||
147034279|NCT00379340|530288408|FG001|Overall Study|Death|0|||
147034280|NCT00379340|530288409|FG002|Overall Study|Death|0|||
147034281|NCT00379340|530288410|FG003|Overall Study|Death|2|||
147034282|NCT00379340|530288411|FG004|Overall Study|Death|0|||
147034283|NCT00379340|530288407|FG000|Overall Study|Lack of Efficacy|6|||
147034284|NCT00379340|530288408|FG001|Overall Study|Lack of Efficacy|1|||
147034285|NCT00379340|530288409|FG002|Overall Study|Lack of Efficacy|0|||
147034286|NCT00379340|530288410|FG003|Overall Study|Lack of Efficacy|4|||
147034287|NCT00379340|530288411|FG004|Overall Study|Lack of Efficacy|3|||
147034288|NCT00379340|530288407|FG000|Overall Study|Physician Decision|6|||
147034289|NCT00379340|530288408|FG001|Overall Study|Physician Decision|2|||
147034290|NCT00379340|530288409|FG002|Overall Study|Physician Decision|1|||
147034291|NCT00379340|530288410|FG003|Overall Study|Physician Decision|2|||
147034292|NCT00379340|530288411|FG004|Overall Study|Physician Decision|3|||
147034293|NCT00379340|530288407|FG000|Overall Study|Withdrawal by Subject|0|||
147034294|NCT00379340|530288408|FG001|Overall Study|Withdrawal by Subject|0|||
147034295|NCT00379340|530288409|FG002|Overall Study|Withdrawal by Subject|0|||
147034296|NCT00379340|530288410|FG003|Overall Study|Withdrawal by Subject|1|||
147034297|NCT00379340|530288411|FG004|Overall Study|Withdrawal by Subject|0|||
147034298|NCT00379340|530288407|FG000|Overall Study|Refusal of further protocol therapy|1|||
147034299|NCT00379340|530288408|FG001|Overall Study|Refusal of further protocol therapy|0|||
147034300|NCT00379340|530288409|FG002|Overall Study|Refusal of further protocol therapy|1|||
147034301|NCT00379340|530288410|FG003|Overall Study|Refusal of further protocol therapy|1|||
147034302|NCT00379340|530288411|FG004|Overall Study|Refusal of further protocol therapy|7|||
147034303|NCT00379340|530288407|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
147034304|NCT00379340|530288408|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
147034305|NCT00379340|530288409|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
147034306|NCT00379340|530288410|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
147034307|NCT00379340|530288411|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
147034308|NCT00379340|530288407|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
147034309|NCT00379340|530288408|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
147034310|NCT00379340|530288409|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
147034311|NCT00379340|530288410|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
147034312|NCT00379340|530288411|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
147034313|NCT04347122|530288412|FG000|Overall Study|Physician Decision|0|||
147034314|NCT04347122|530288413|FG001|Overall Study|Physician Decision|3|||
147034315|NCT04347122|530288414|FG002|Overall Study|Physician Decision|3|||
147034316|NCT04347122|530288415|FG003|Overall Study|Physician Decision|6|||
147034317|NCT04994483|530288419|FG000|Overall Study|Adverse Event|26|||
147034318|NCT04994483|530288420|FG001|Overall Study|Adverse Event|17|||
147034319|NCT04994483|530288419|FG000|Overall Study|Lost to Follow-up|6|||
147034320|NCT04994483|530288420|FG001|Overall Study|Lost to Follow-up|10|||
147034321|NCT04994483|530288419|FG000|Overall Study|Noncompliance with study drug|8|||
147034322|NCT04994483|530288420|FG001|Overall Study|Noncompliance with study drug|5|||
147034323|NCT04994483|530288419|FG000|Overall Study|Physician Decision|5|||
147034324|NCT04994483|530288420|FG001|Overall Study|Physician Decision|0|||
147034325|NCT04994483|530288419|FG000|Overall Study|Withdrawal by Subject|41|||
147034326|NCT04994483|530288420|FG001|Overall Study|Withdrawal by Subject|38|||
147034327|NCT04994483|530288419|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
147034328|NCT04994483|530288420|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
147034329|NCT04994483|530288419|FG000|Overall Study|Met stopping criteria|1|||
147034330|NCT04994483|530288420|FG001|Overall Study|Met stopping criteria|0|||
147034331|NCT04994483|530288419|FG000|Overall Study|Randomized in error, not treated|4|||
147034332|NCT04994483|530288420|FG001|Overall Study|Randomized in error, not treated|3|||
147034333|NCT04994483|530288419|FG000|Overall Study|Lack of a reliable study partner|0|||
147034334|NCT04994483|530288420|FG001|Overall Study|Lack of a reliable study partner|1|||
147034335|NCT04994483|530288419|FG000|Overall Study|Met MRI exclusion criteria|0|||
147034336|NCT04994483|530288420|FG001|Overall Study|Met MRI exclusion criteria|1|||
147034337|NCT00112866|530288421|FG000|Overall Study|Protocol Violation|1|||
147034338|NCT00112866|530288422|FG001|Overall Study|Protocol Violation|0|||
147034339|NCT00112866|530288421|FG000|Overall Study|did not start treatment post-op|1|||
147034340|NCT00112866|530288422|FG001|Overall Study|did not start treatment post-op|2|||
147034341|NCT02903030|530288423|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
147034342|NCT02903030|530288424|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
147034343|NCT03700385|530288425|FG000|Overall Study|Lost to Follow-up|1|||
147034344|NCT01555671|530288427|FG000|Overall Study|Physician Decision|20|||
147034345|NCT01555671|530288428|FG001|Overall Study|Physician Decision|25|||
147034346|NCT04590040|530288432|FG000|Treatment Period|Lost to Follow-up|2|||
147034347|NCT04590040|530288433|FG001|Treatment Period|Lost to Follow-up|5|||
147034348|NCT04590040|530288434|FG002|Treatment Period|Lost to Follow-up|0|||
147034349|NCT04590040|530288432|FG000|Treatment Period|Physician Decision|0|||
147034350|NCT04590040|530288433|FG001|Treatment Period|Physician Decision|0|||
147034351|NCT04590040|530288434|FG002|Treatment Period|Physician Decision|2|||
147034352|NCT00631657|530288439|FG000|6-Month Treatment Period|Adverse Event|47|||
147034353|NCT00631657|530288440|FG001|6-Month Treatment Period|Adverse Event|0|||
147034354|NCT00631657|530288441|FG002|6-Month Treatment Period|Adverse Event|7|||
147034355|NCT00631657|530288439|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
147034356|NCT00631657|530288440|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
147034357|NCT00631657|530288441|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
147034358|NCT00631657|530288439|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
147034359|NCT00631657|530288440|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
147034360|NCT00631657|530288441|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
147034361|NCT00631657|530288439|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
147034362|NCT00631657|530288440|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
147034363|NCT00631657|530288441|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
147034364|NCT00631657|530288439|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
147034365|NCT00631657|530288440|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
147034366|NCT00631657|530288441|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
147034367|NCT00631657|530288439|FG000|6-Month Treatment Period|Other|16|||
147034368|NCT00631657|530288440|FG001|6-Month Treatment Period|Other|0|||
147034369|NCT00631657|530288441|FG002|6-Month Treatment Period|Other|4|||
147034370|NCT00631657|530288439|FG000|6-Month Treatment Period|Not Treated|2|||
147034371|NCT00631657|530288440|FG001|6-Month Treatment Period|Not Treated|0|||
147034372|NCT00631657|530288441|FG002|6-Month Treatment Period|Not Treated|1|||
147034373|NCT00631657|530288439|FG000|7-Day Discontinuation Period|Not Treated|1|||
147034374|NCT00631657|530288440|FG001|7-Day Discontinuation Period|Not Treated|1|||
147034375|NCT00631657|530288441|FG002|7-Day Discontinuation Period|Not Treated|1|||
147034376|NCT00631657|530288439|FG000|7-Day Discontinuation Period|Other|1|||
147034377|NCT00631657|530288440|FG001|7-Day Discontinuation Period|Other|0|||
147034378|NCT00631657|530288441|FG002|7-Day Discontinuation Period|Other|0|||
147034379|NCT01284361|530288447|FG000|Overall Study|Withdrawal by Subject|1|||
147034380|NCT01284361|530288447|FG000|Overall Study|Protocol Violation|5|||
147034381|NCT01284361|530288447|FG000|Overall Study|Adverse Event|1|||
147034382|NCT01284361|530288447|FG000|Overall Study|Lost to Follow-up|2|||
147034383|NCT01957397|530288454|FG000|Test Period 1|sudden leakage/small bag|1|||
147034384|NCT01957397|530288455|FG001|Test Period 1|sudden leakage/small bag|1|||
147034385|NCT01957397|530288454|FG000|Test Period 1|Withdrawal by Subject|1|||
147034386|NCT01957397|530288455|FG001|Test Period 1|Withdrawal by Subject|0|||
147034387|NCT01957397|530288454|FG000|Test Period 2|Adverse Event|0|||
147034388|NCT01957397|530288455|FG001|Test Period 2|Adverse Event|1|||
147034389|NCT01957397|530288454|FG000|Test Period 3|Adverse Event|1|||
147034390|NCT01957397|530288455|FG001|Test Period 3|Adverse Event|2|||
147034391|NCT01957397|530288454|FG000|Test Period 3|the adhesive did not work|1|||
147034392|NCT01957397|530288455|FG001|Test Period 3|the adhesive did not work|0|||
147034393|NCT00540293|530288456|FG000|Overall Study|Adverse event related to study drug|10|||
147034394|NCT00540293|530288456|FG000|Overall Study|Adverse event not related to study drug|7|||
147034395|NCT00540293|530288456|FG000|Overall Study|Withdrawal by Subject|6|||
147034396|NCT00540293|530288456|FG000|Overall Study|Protocol violation, & subject schedule|12|||
147034397|NCT03537599|530288457|FG000|Overall Study|Disease Progression|2|||
147034398|NCT03537599|530288458|FG001|Overall Study|Disease Progression|1|||
147034399|NCT03537599|530288457|FG000|Overall Study|Death|0|||
147034400|NCT03537599|530288458|FG001|Overall Study|Death|1|||
147034401|NCT00325195|530288461|FG000|Randomized|Not dosed|5|||
147034402|NCT00325195|530288462|FG001|Randomized|Not dosed|5|||
147034403|NCT00325195|530288463|FG002|Randomized|Not dosed|3|||
147034404|NCT00325195|530288461|FG000|Received Intervention: ITT Population|Adverse Event|15|||
146849713|NCT02663518|529618863|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146849714|NCT02663518|529618864|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147034405|NCT00325195|530288462|FG001|Received Intervention: ITT Population|Adverse Event|17|||
147034406|NCT00325195|530288463|FG002|Received Intervention: ITT Population|Adverse Event|1|||
147034407|NCT00325195|530288461|FG000|Received Intervention: ITT Population|Death|3|||
147034408|NCT00325195|530288462|FG001|Received Intervention: ITT Population|Death|1|||
147034409|NCT00325195|530288463|FG002|Received Intervention: ITT Population|Death|0|||
147034410|NCT00325195|530288461|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
147034411|NCT00325195|530288462|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
147034412|NCT00325195|530288463|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
147034413|NCT00325195|530288461|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
147034414|NCT00325195|530288462|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
147034415|NCT00325195|530288463|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
147034416|NCT00325195|530288461|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
147034417|NCT00325195|530288462|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
147034418|NCT00325195|530288463|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
147034419|NCT05083585|530288464|FG000|Overall Study|Death|1|||
147034420|NCT05083585|530288465|FG001|Overall Study|Death|1|||
147034421|NCT05083585|530288464|FG000|Overall Study|Lost to Follow-up|1|||
147034422|NCT05083585|530288465|FG001|Overall Study|Lost to Follow-up|1|||
147034423|NCT05083585|530288464|FG000|Overall Study|Withdrawal by Subject|2|||
147034424|NCT05083585|530288465|FG001|Overall Study|Withdrawal by Subject|0|||
147034425|NCT05083585|530288464|FG000|Overall Study|Randomized but not vaccinated|2|||
147034426|NCT05083585|530288465|FG001|Overall Study|Randomized but not vaccinated|0|||
147034427|NCT00806286|530288466|FG000|Overall Study|Adverse Event|5|||
147034428|NCT00806286|530288467|FG001|Overall Study|Adverse Event|2|||
147034429|NCT00806286|530288468|FG002|Overall Study|Adverse Event|0|||
147034430|NCT00806286|530288466|FG000|Overall Study|Disease progression|31|||
147034431|NCT00806286|530288467|FG001|Overall Study|Disease progression|38|||
147034432|NCT00806286|530288468|FG002|Overall Study|Disease progression|1|||
147034433|NCT00806286|530288466|FG000|Overall Study|Death|1|||
147034434|NCT00806286|530288467|FG001|Overall Study|Death|6|||
147034435|NCT00806286|530288468|FG002|Overall Study|Death|0|||
147034436|NCT00806286|530288466|FG000|Overall Study|Lost to Follow-up|0|||
147034437|NCT00806286|530288467|FG001|Overall Study|Lost to Follow-up|1|||
147034438|NCT00806286|530288468|FG002|Overall Study|Lost to Follow-up|0|||
147034439|NCT00806286|530288466|FG000|Overall Study|Withdrawal by Subject|8|||
147034440|NCT00806286|530288467|FG001|Overall Study|Withdrawal by Subject|3|||
147034441|NCT00806286|530288468|FG002|Overall Study|Withdrawal by Subject|1|||
147034442|NCT00806286|530288466|FG000|Overall Study|Physician Decision|2|||
147034443|NCT00806286|530288467|FG001|Overall Study|Physician Decision|2|||
147034444|NCT00806286|530288468|FG002|Overall Study|Physician Decision|0|||
147034445|NCT00806286|530288466|FG000|Overall Study|Due to a variety of reasons|7|||
147034446|NCT00806286|530288467|FG001|Overall Study|Due to a variety of reasons|2|||
147034447|NCT00806286|530288468|FG002|Overall Study|Due to a variety of reasons|1|||
147034448|NCT03469336|530288469|FG000|Overall Study|Adverse Event|1|||
147034449|NCT00686075|530288471|FG000|Overall Study|Withdrawal by Subject|4|||
147034450|NCT00686075|530288472|FG001|Overall Study|Withdrawal by Subject|3|||
147034451|NCT00686075|530288473|FG002|Overall Study|Withdrawal by Subject|3|||
147034452|NCT00686075|530288474|FG003|Overall Study|Withdrawal by Subject|7|||
147034453|NCT00686075|530288475|FG004|Overall Study|Withdrawal by Subject|1|||
147034454|NCT00686075|530288476|FG005|Overall Study|Withdrawal by Subject|0|||
147034455|NCT00686075|530288477|FG006|Overall Study|Withdrawal by Subject|0|||
147034456|NCT00686075|530288478|FG007|Overall Study|Withdrawal by Subject|2|||
147034457|NCT00686075|530288479|FG008|Overall Study|Withdrawal by Subject|4|||
147034458|NCT00686075|530288480|FG009|Overall Study|Withdrawal by Subject|6|||
147034459|NCT00686075|530288471|FG000|Overall Study|Lost to Follow-up|3|||
147034460|NCT00686075|530288472|FG001|Overall Study|Lost to Follow-up|6|||
147034461|NCT00686075|530288473|FG002|Overall Study|Lost to Follow-up|3|||
147034462|NCT00686075|530288474|FG003|Overall Study|Lost to Follow-up|2|||
147034463|NCT00686075|530288475|FG004|Overall Study|Lost to Follow-up|3|||
147034464|NCT00686075|530288476|FG005|Overall Study|Lost to Follow-up|3|||
147034465|NCT00686075|530288477|FG006|Overall Study|Lost to Follow-up|0|||
147034466|NCT00686075|530288478|FG007|Overall Study|Lost to Follow-up|0|||
147034467|NCT00686075|530288479|FG008|Overall Study|Lost to Follow-up|2|||
147034468|NCT00686075|530288480|FG009|Overall Study|Lost to Follow-up|3|||
147034469|NCT00686075|530288471|FG000|Overall Study|Other|1|||
147034470|NCT00686075|530288472|FG001|Overall Study|Other|1|||
147034471|NCT00686075|530288473|FG002|Overall Study|Other|0|||
147034472|NCT00686075|530288474|FG003|Overall Study|Other|0|||
147034473|NCT00686075|530288475|FG004|Overall Study|Other|0|||
147034474|NCT00686075|530288476|FG005|Overall Study|Other|0|||
147034475|NCT00686075|530288477|FG006|Overall Study|Other|0|||
147034476|NCT00686075|530288478|FG007|Overall Study|Other|0|||
147034477|NCT00686075|530288479|FG008|Overall Study|Other|0|||
147034478|NCT00686075|530288480|FG009|Overall Study|Other|1|||
147034479|NCT02740699|530288481|FG000|Overall Study|Lost to Follow-up|5|||
147034480|NCT02740699|530288481|FG000|Overall Study|Withdrawal by Subject|14|||
147034481|NCT02740699|530288481|FG000|Overall Study|Physician Decision|5|||
147034482|NCT02585934|530288483|FG000|Overall Study|Lost to Follow-up|2|||
147034483|NCT02585934|530288484|FG001|Overall Study|Lost to Follow-up|2|||
147034484|NCT02585934|530288483|FG000|Overall Study|Protocol Violation|14|||
147034485|NCT02585934|530288484|FG001|Overall Study|Protocol Violation|11|||
147034486|NCT02585934|530288483|FG000|Overall Study|Adverse Event|21|||
147034487|NCT02585934|530288484|FG001|Overall Study|Adverse Event|22|||
147034488|NCT02585934|530288483|FG000|Overall Study|Physician Decision|3|||
147034489|NCT02585934|530288484|FG001|Overall Study|Physician Decision|2|||
147034490|NCT02585934|530288483|FG000|Overall Study|Withdrawal by Subject|7|||
147034491|NCT02585934|530288484|FG001|Overall Study|Withdrawal by Subject|21|||
147034492|NCT02585934|530288483|FG000|Overall Study|Lack of Efficacy|2|||
147034493|NCT02585934|530288484|FG001|Overall Study|Lack of Efficacy|1|||
147034494|NCT02585934|530288483|FG000|Overall Study|Death|2|||
147034495|NCT02585934|530288484|FG001|Overall Study|Death|0|||
147034496|NCT02585934|530288483|FG000|Overall Study|Caregiver Withdrew Consent|7|||
147034497|NCT02585934|530288484|FG001|Overall Study|Caregiver Withdrew Consent|7|||
147034498|NCT02585934|530288483|FG000|Overall Study|Sponsor Termination|1|||
147034499|NCT02585934|530288484|FG001|Overall Study|Sponsor Termination|2|||
147034500|NCT02585934|530288483|FG000|Overall Study|Another Reason|10|||
147034501|NCT02585934|530288484|FG001|Overall Study|Another Reason|5|||
147034502|NCT04713553|530288485|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
147034503|NCT04713553|530288486|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
147034504|NCT04713553|530288487|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
147034505|NCT04713553|530288488|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
147034506|NCT04713553|530288489|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
147034507|NCT04713553|530288490|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
147034508|NCT04713553|530288491|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
147034509|NCT04713553|530288485|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
147034510|NCT04713553|530288486|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
147034511|NCT04713553|530288487|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
147034512|NCT04713553|530288488|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
147034513|NCT04713553|530288489|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
147034514|NCT04713553|530288490|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
147034515|NCT04713553|530288491|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
147034516|NCT04713553|530288485|FG000|Primary Study (2 Months)|Other|1|||
147034517|NCT04713553|530288486|FG001|Primary Study (2 Months)|Other|2|||
147034518|NCT04713553|530288487|FG002|Primary Study (2 Months)|Other|0|||
147034519|NCT04713553|530288488|FG003|Primary Study (2 Months)|Other|0|||
147034520|NCT04713553|530288489|FG004|Primary Study (2 Months)|Other|1|||
147034521|NCT04713553|530288490|FG005|Primary Study (2 Months)|Other|0|||
147034522|NCT04713553|530288491|FG006|Primary Study (2 Months)|Other|0|||
147034523|NCT04713553|530288485|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
147034524|NCT04713553|530288486|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
147034525|NCT04713553|530288487|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
147034526|NCT04713553|530288488|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
147034527|NCT04713553|530288489|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
147034528|NCT04713553|530288490|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
147034529|NCT04713553|530288491|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
147034530|NCT04713553|530288485|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
147034531|NCT04713553|530288486|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
147034532|NCT04713553|530288487|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
147034533|NCT04713553|530288488|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
147034534|NCT04713553|530288489|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
147034535|NCT04713553|530288490|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
147034536|NCT04713553|530288491|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
147034537|NCT01716715|530288496|FG000|Overall Study|Never Treated|2|||
147034538|NCT01716715|530288497|FG001|Overall Study|Never Treated|4|||
147034539|NCT01081834|530288500|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
147034540|NCT01081834|530288501|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
147034541|NCT01081834|530288502|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
147034542|NCT01081834|530288503|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
147034543|NCT01081834|530288504|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
147034544|NCT01081834|530288500|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
147034545|NCT01081834|530288501|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
147034546|NCT01081834|530288502|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
147034547|NCT01081834|530288503|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
147034548|NCT01081834|530288504|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
147034549|NCT01081834|530288500|FG000|Core Period: Baseline to Week 26|Death|1|||
147034550|NCT01081834|530288501|FG001|Core Period: Baseline to Week 26|Death|0|||
147034551|NCT01081834|530288502|FG002|Core Period: Baseline to Week 26|Death|0|||
147034552|NCT01081834|530288503|FG003|Core Period: Baseline to Week 26|Death|0|||
147034553|NCT01081834|530288504|FG004|Core Period: Baseline to Week 26|Death|0|||
147034554|NCT01081834|530288500|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
147034555|NCT01081834|530288501|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
147034556|NCT01081834|530288502|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
147034557|NCT01081834|530288503|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
147034558|NCT01081834|530288504|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
147034559|NCT01081834|530288500|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
147034560|NCT01081834|530288501|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
147034561|NCT01081834|530288502|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
147034562|NCT01081834|530288503|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
147034563|NCT01081834|530288504|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
147034564|NCT01081834|530288500|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
147034565|NCT01081834|530288501|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
147034566|NCT01081834|530288502|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
147034567|NCT01081834|530288503|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
147034568|NCT01081834|530288504|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
147034569|NCT01081834|530288500|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
147034570|NCT01081834|530288501|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
147034571|NCT01081834|530288502|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
147034572|NCT01081834|530288503|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
147034573|NCT01081834|530288504|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
147034574|NCT01081834|530288500|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
147034575|NCT01081834|530288501|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
147034576|NCT01081834|530288502|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
147034577|NCT01081834|530288503|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
147034578|NCT01081834|530288504|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
147034579|NCT01081834|530288500|FG000|Core Period: Baseline to Week 26|Other|4|||
147034580|NCT01081834|530288501|FG001|Core Period: Baseline to Week 26|Other|4|||
147034581|NCT01081834|530288502|FG002|Core Period: Baseline to Week 26|Other|3|||
147034582|NCT01081834|530288503|FG003|Core Period: Baseline to Week 26|Other|1|||
147034583|NCT01081834|530288504|FG004|Core Period: Baseline to Week 26|Other|0|||
147034584|NCT01081834|530288500|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
147034585|NCT01081834|530288501|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
147034586|NCT01081834|530288502|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
147034587|NCT01081834|530288503|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
147034588|NCT01081834|530288504|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
147034589|NCT01081834|530288500|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
147034590|NCT01081834|530288501|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
147034591|NCT01081834|530288502|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
147034592|NCT01081834|530288503|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
147034593|NCT01081834|530288504|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
147034594|NCT01081834|530288500|FG000|Extension Period: Week 26 to Week 52|Death|1|||
147034595|NCT01081834|530288501|FG001|Extension Period: Week 26 to Week 52|Death|0|||
147034596|NCT01081834|530288502|FG002|Extension Period: Week 26 to Week 52|Death|0|||
147034597|NCT01081834|530288503|FG003|Extension Period: Week 26 to Week 52|Death|0|||
147034598|NCT01081834|530288504|FG004|Extension Period: Week 26 to Week 52|Death|0|||
147034599|NCT01081834|530288500|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
147034600|NCT01081834|530288501|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
147034601|NCT01081834|530288502|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
147034602|NCT01081834|530288503|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
147034603|NCT01081834|530288504|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
147034604|NCT01081834|530288500|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
147034605|NCT01081834|530288501|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
147034606|NCT01081834|530288502|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
147034607|NCT01081834|530288503|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
147034608|NCT01081834|530288504|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
147034609|NCT01081834|530288500|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
147034610|NCT01081834|530288501|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
147034611|NCT01081834|530288502|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
147034612|NCT01081834|530288503|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
147034613|NCT01081834|530288504|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
147034614|NCT01081834|530288500|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
147034615|NCT01081834|530288501|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
147034616|NCT01081834|530288502|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
147034617|NCT01081834|530288503|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
147034618|NCT01081834|530288504|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
147034619|NCT01081834|530288500|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
147034620|NCT01081834|530288501|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
146849715|NCT02663518|529618851|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147034621|NCT01081834|530288502|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
147034622|NCT01081834|530288503|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
147034623|NCT01081834|530288504|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
147034624|NCT01081834|530288500|FG000|Extension Period: Week 26 to Week 52|Other|4|||
147034625|NCT01081834|530288501|FG001|Extension Period: Week 26 to Week 52|Other|5|||
147034626|NCT01081834|530288502|FG002|Extension Period: Week 26 to Week 52|Other|4|||
147034627|NCT01081834|530288503|FG003|Extension Period: Week 26 to Week 52|Other|0|||
147034628|NCT01081834|530288504|FG004|Extension Period: Week 26 to Week 52|Other|0|||
147034629|NCT01081834|530288500|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
147034630|NCT01081834|530288501|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
147034631|NCT01081834|530288502|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
147034632|NCT01081834|530288503|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
147034633|NCT01081834|530288504|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
147034634|NCT01081834|530288500|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
147034635|NCT01081834|530288501|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
147034636|NCT01081834|530288502|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
147034637|NCT01081834|530288503|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
147034638|NCT01081834|530288504|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
147034639|NCT01777620|530288505|FG000|Overall Study|Subject Withdrawal|1|||
147034640|NCT01777620|530288506|FG001|Overall Study|Subject Withdrawal|0|||
147034641|NCT00936897|530288517|FG000|Overall Study|Withdrawal by Subject|9|||
147034642|NCT00936897|530288518|FG001|Overall Study|Withdrawal by Subject|19|||
147034643|NCT00936897|530288517|FG000|Overall Study|Adverse Event|4|||
147034644|NCT00936897|530288518|FG001|Overall Study|Adverse Event|13|||
147034645|NCT00936897|530288517|FG000|Overall Study|Other|3|||
147034646|NCT00936897|530288518|FG001|Overall Study|Other|9|||
147034647|NCT00936897|530288517|FG000|Overall Study|Lost to Follow-up|1|||
147034648|NCT00936897|530288518|FG001|Overall Study|Lost to Follow-up|10|||
147034649|NCT00936897|530288517|FG000|Overall Study|Administrative Decision|1|||
147034650|NCT00936897|530288518|FG001|Overall Study|Administrative Decision|2|||
147034651|NCT00936897|530288517|FG000|Overall Study|Protocol Violation|1|||
147034652|NCT00936897|530288518|FG001|Overall Study|Protocol Violation|1|||
147034653|NCT00936897|530288517|FG000|Overall Study|Ineligibility Determined|0|||
147034654|NCT00936897|530288518|FG001|Overall Study|Ineligibility Determined|3|||
147034655|NCT00936897|530288517|FG000|Overall Study|Noncompliance|0|||
147034656|NCT00936897|530288518|FG001|Overall Study|Noncompliance|2|||
147034657|NCT00936897|530288517|FG000|Overall Study|Death|0|||
147034658|NCT00936897|530288518|FG001|Overall Study|Death|1|||
147034659|NCT04058067|530288519|FG000|Overall Study|Adverse Event|2|||
147034660|NCT04058067|530288520|FG001|Overall Study|Adverse Event|0|||
147034661|NCT04058067|530288519|FG000|Overall Study|Death|0|||
147034662|NCT04058067|530288520|FG001|Overall Study|Death|1|||
147034663|NCT04058067|530288519|FG000|Overall Study|Physician Decision|3|||
147034664|NCT04058067|530288520|FG001|Overall Study|Physician Decision|1|||
147034665|NCT04058067|530288519|FG000|Overall Study|Protocol Violation|0|||
147034666|NCT04058067|530288520|FG001|Overall Study|Protocol Violation|1|||
147034667|NCT04058067|530288519|FG000|Overall Study|Withdrawal by Subject|7|||
147034668|NCT04058067|530288520|FG001|Overall Study|Withdrawal by Subject|8|||
147034669|NCT00417170|530288521|FG000|Overall Study|Adverse Event|1|||
147034670|NCT00417170|530288522|FG001|Overall Study|Adverse Event|1|||
147034671|NCT00417170|530288521|FG000|Overall Study|Withdrawal by Subject|1|||
147034672|NCT00417170|530288522|FG001|Overall Study|Withdrawal by Subject|1|||
147034673|NCT00417170|530288521|FG000|Overall Study|Lost to Follow-up|0|||
147034674|NCT00417170|530288522|FG001|Overall Study|Lost to Follow-up|1|||
147034675|NCT05005312|530288523|FG000|Overall Study|Enrolled, but not treated|0|||
147034676|NCT05005312|530288524|FG001|Overall Study|Enrolled, but not treated|1|||
147034677|NCT01283035|530288526|FG000|Overall Study|Subject later found ineligible|1|||
147034678|NCT03597529|530288527|FG000|Overall Study|Lost to Follow-up|10|||
147034679|NCT03597529|530288528|FG001|Overall Study|Lost to Follow-up|12|||
147034680|NCT03597529|530288527|FG000|Overall Study|Physician Decision|3|||
147034681|NCT03597529|530288528|FG001|Overall Study|Physician Decision|1|||
147034682|NCT03597529|530288527|FG000|Overall Study|Withdrawal by Subject|6|||
147034683|NCT03597529|530288528|FG001|Overall Study|Withdrawal by Subject|3|||
147034684|NCT03597529|530288527|FG000|Overall Study|Non-compliant with study activities|1|||
147034685|NCT03597529|530288528|FG001|Overall Study|Non-compliant with study activities|2|||
147034686|NCT03464630|530288531|FG000|Overall Study|Lost to Follow-up|62|||
147034687|NCT03464630|530288532|FG001|Overall Study|Lost to Follow-up|52|||
147034688|NCT03464630|530288531|FG000|Overall Study|Withdrawal by Subject|16|||
147034689|NCT03464630|530288532|FG001|Overall Study|Withdrawal by Subject|10|||
147034690|NCT03464630|530288531|FG000|Overall Study|Passive Disengagement|8|||
147034691|NCT03464630|530288532|FG001|Overall Study|Passive Disengagement|4|||
147034692|NCT00998309|530288537|FG000|Overall Study|Protocol Violation|4|||
147034693|NCT00735397|530288539|FG000|Overall Study|Adverse Event|194|||
147034694|NCT00735397|530288539|FG000|Overall Study|Lost to Follow-up|33|||
147034695|NCT00735397|530288539|FG000|Overall Study|Participant choice|252|||
147034696|NCT00735397|530288539|FG000|Overall Study|Inadequate therapeutic effect|202|||
147034697|NCT00735397|530288539|FG000|Overall Study|Administrative/Other|502|||
147034698|NCT06077149|530288540|FG000|Overall Study|Death|1|||
147034699|NCT06077149|530288541|FG001|Overall Study|Death|0|||
147034700|NCT06077149|530288540|FG000|Overall Study|Withdrawal by Subject|2|||
147034701|NCT06077149|530288541|FG001|Overall Study|Withdrawal by Subject|0|||
147034702|NCT06077149|530288540|FG000|Overall Study|RSV infection before vaccination|3|||
147034703|NCT06077149|530288541|FG001|Overall Study|RSV infection before vaccination|0|||
147034704|NCT04154631|530288543|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
147034705|NCT04154631|530288544|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
147034706|NCT01441947|530288545|FG000|Overall Study|Withdrawal by Subject|3|||
147034707|NCT01441947|530288546|FG001|Overall Study|Withdrawal by Subject|0|||
147034708|NCT02238795|530288547|FG000|Overall Study|Patient without purpura fulminans|1|||
147034709|NCT03384654|530288549|FG000|Overall Study|Withdrawal by Subject|0|||
147034710|NCT03384654|530288550|FG001|Overall Study|Withdrawal by Subject|0|||
147034711|NCT03384654|530288551|FG002|Overall Study|Withdrawal by Subject|1|||
147034712|NCT03384654|530288552|FG003|Overall Study|Withdrawal by Subject|0|||
147034713|NCT04159935|530288555|FG000|Overall Study|Study terminated due to COVID-19|1|||
147034714|NCT04159935|530288556|FG001|Overall Study|Study terminated due to COVID-19|3|||
147034715|NCT01341782|530288557|FG000|Overall Study|Adverse Event|1|||
147034716|NCT01341782|530288558|FG001|Overall Study|Adverse Event|1|||
147034717|NCT01341782|530288557|FG000|Overall Study|Withdrawal by Subject|6|||
147034718|NCT01341782|530288558|FG001|Overall Study|Withdrawal by Subject|5|||
147034719|NCT01341782|530288557|FG000|Overall Study|Missed 3 consecutive doses|0|||
147034720|NCT01341782|530288558|FG001|Overall Study|Missed 3 consecutive doses|4|||
147034721|NCT01341782|530288557|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
147034722|NCT01341782|530288558|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
147034723|NCT01341782|530288557|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
147034724|NCT01341782|530288558|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
147034725|NCT01341782|530288557|FG000|Overall Study|Other|5|||
147034726|NCT01341782|530288558|FG001|Overall Study|Other|0|||
147034727|NCT00620555|530288560|FG000|Overall Study|Adverse Event|4|||
147034728|NCT00620555|530288560|FG000|Overall Study|Protocol Violation|2|||
147034729|NCT00620555|530288560|FG000|Overall Study|Lack of Efficacy|12|||
147034730|NCT00620555|530288560|FG000|Overall Study|Withdrawal by Subject|1|||
147034731|NCT00620555|530288560|FG000|Overall Study|Choice of other treatment|1|||
147034732|NCT00620555|530288560|FG000|Overall Study|Visit failure against planned|1|||
147034733|NCT02036775|530288561|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
147034734|NCT02036775|530288562|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
147034735|NCT02036775|530288563|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
147034736|NCT02036775|530288564|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
147034737|NCT02036775|530288565|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
147034738|NCT02036775|530288566|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
147034739|NCT03796039|530288567|FG000|Overall Study|Death|2|||
147034740|NCT03796039|530288568|FG001|Overall Study|Death|1|||
147034741|NCT03796039|530288567|FG000|Overall Study|Withdrawal by Subject|7|||
147034742|NCT03796039|530288568|FG001|Overall Study|Withdrawal by Subject|4|||
147034743|NCT01140503|530288569|FG000|Overall Study|Withdrawal by Subject|1|||
147034744|NCT02927366|530288570|FG000|Overall Study|Adverse Event|1|||
147034745|NCT02927366|530288571|FG001|Overall Study|Adverse Event|0|||
147034746|NCT02927366|530288570|FG000|Overall Study|Patient schedule|1|||
147034747|NCT02927366|530288571|FG001|Overall Study|Patient schedule|0|||
147034748|NCT00587990|530288572|FG000|Overall Study|Death|0|||
147034749|NCT00587990|530288573|FG001|Overall Study|Death|0|||
147034750|NCT00587990|530288574|FG002|Overall Study|Death|1|||
147034751|NCT00206323|530288577|FG000|Overall Study|Lack of Efficacy|4|||
147034752|NCT00206323|530288578|FG001|Overall Study|Lack of Efficacy|1|||
147034753|NCT00206323|530288577|FG000|Overall Study|Adverse Event|1|||
147034754|NCT00206323|530288578|FG001|Overall Study|Adverse Event|1|||
147034755|NCT00206323|530288577|FG000|Overall Study|Lost to Follow-up|1|||
147034756|NCT00206323|530288578|FG001|Overall Study|Lost to Follow-up|1|||
147034757|NCT03334617|530288579|FG000|Overall Study|Adverse Event|0|||
147034758|NCT03334617|530288580|FG001|Overall Study|Adverse Event|0|||
147034759|NCT03334617|530288581|FG002|Overall Study|Adverse Event|0|||
147034760|NCT03334617|530288582|FG003|Overall Study|Adverse Event|0|||
147034761|NCT03334617|530288583|FG004|Overall Study|Adverse Event|0|||
147034762|NCT03334617|530288584|FG005|Overall Study|Adverse Event|0|||
147034763|NCT03334617|530288585|FG006|Overall Study|Adverse Event|0|||
147034764|NCT03334617|530288586|FG007|Overall Study|Adverse Event|0|||
147034765|NCT03334617|530288587|FG008|Overall Study|Adverse Event|1|||
147034766|NCT03334617|530288588|FG009|Overall Study|Adverse Event|0|||
147034767|NCT03334617|530288589|FG010|Overall Study|Adverse Event|0|||
147034768|NCT03334617|530288590|FG011|Overall Study|Adverse Event|0|||
147034769|NCT03334617|530288591|FG012|Overall Study|Adverse Event|1|||
147034770|NCT03334617|530288592|FG013|Overall Study|Adverse Event|0|||
146849716|NCT02663518|529618852|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147034771|NCT03334617|530288593|FG014|Overall Study|Adverse Event|0|||
147034772|NCT03334617|530288594|FG015|Overall Study|Adverse Event|0|||
147034773|NCT03334617|530288595|FG016|Overall Study|Adverse Event|0|||
147034774|NCT03334617|530288596|FG017|Overall Study|Adverse Event|0|||
147034775|NCT03334617|530288597|FG018|Overall Study|Adverse Event|0|||
147034776|NCT03334617|530288598|FG019|Overall Study|Adverse Event|0|||
147034777|NCT03334617|530288599|FG020|Overall Study|Adverse Event|0|||
147034778|NCT03334617|530288600|FG021|Overall Study|Adverse Event|0|||
147034779|NCT03334617|530288579|FG000|Overall Study|Death|18|||
147034780|NCT03334617|530288580|FG001|Overall Study|Death|18|||
147034781|NCT03334617|530288581|FG002|Overall Study|Death|20|||
147034782|NCT03334617|530288582|FG003|Overall Study|Death|21|||
147034783|NCT03334617|530288583|FG004|Overall Study|Death|20|||
147034784|NCT03334617|530288584|FG005|Overall Study|Death|16|||
147034785|NCT03334617|530288585|FG006|Overall Study|Death|28|||
147034786|NCT03334617|530288586|FG007|Overall Study|Death|35|||
147034787|NCT03334617|530288587|FG008|Overall Study|Death|47|||
147034788|NCT03334617|530288588|FG009|Overall Study|Death|0|||
147034789|NCT03334617|530288589|FG010|Overall Study|Death|19|||
147034790|NCT03334617|530288590|FG011|Overall Study|Death|6|||
147034791|NCT03334617|530288591|FG012|Overall Study|Death|20|||
147034792|NCT03334617|530288592|FG013|Overall Study|Death|22|||
147034793|NCT03334617|530288593|FG014|Overall Study|Death|17|||
147034794|NCT03334617|530288594|FG015|Overall Study|Death|18|||
147034795|NCT03334617|530288595|FG016|Overall Study|Death|12|||
147034796|NCT03334617|530288596|FG017|Overall Study|Death|15|||
147034797|NCT03334617|530288597|FG018|Overall Study|Death|16|||
147034798|NCT03334617|530288598|FG019|Overall Study|Death|27|||
147034799|NCT03334617|530288599|FG020|Overall Study|Death|14|||
147034800|NCT03334617|530288600|FG021|Overall Study|Death|27|||
147034801|NCT03334617|530288579|FG000|Overall Study|Lost to Follow-up|0|||
147034802|NCT03334617|530288580|FG001|Overall Study|Lost to Follow-up|0|||
147034803|NCT03334617|530288581|FG002|Overall Study|Lost to Follow-up|0|||
147034804|NCT03334617|530288582|FG003|Overall Study|Lost to Follow-up|1|||
147034805|NCT03334617|530288583|FG004|Overall Study|Lost to Follow-up|0|||
147034806|NCT03334617|530288584|FG005|Overall Study|Lost to Follow-up|1|||
147034807|NCT03334617|530288585|FG006|Overall Study|Lost to Follow-up|0|||
147034808|NCT03334617|530288586|FG007|Overall Study|Lost to Follow-up|0|||
147034809|NCT03334617|530288587|FG008|Overall Study|Lost to Follow-up|1|||
147034810|NCT03334617|530288588|FG009|Overall Study|Lost to Follow-up|0|||
147034811|NCT03334617|530288589|FG010|Overall Study|Lost to Follow-up|0|||
147034812|NCT03334617|530288590|FG011|Overall Study|Lost to Follow-up|0|||
147034813|NCT03334617|530288591|FG012|Overall Study|Lost to Follow-up|0|||
147034814|NCT03334617|530288592|FG013|Overall Study|Lost to Follow-up|0|||
147034815|NCT03334617|530288593|FG014|Overall Study|Lost to Follow-up|0|||
147034816|NCT03334617|530288594|FG015|Overall Study|Lost to Follow-up|0|||
147034817|NCT03334617|530288595|FG016|Overall Study|Lost to Follow-up|0|||
147034818|NCT03334617|530288596|FG017|Overall Study|Lost to Follow-up|0|||
147034819|NCT03334617|530288597|FG018|Overall Study|Lost to Follow-up|0|||
147034820|NCT03334617|530288598|FG019|Overall Study|Lost to Follow-up|0|||
147034821|NCT03334617|530288599|FG020|Overall Study|Lost to Follow-up|0|||
147034822|NCT03334617|530288600|FG021|Overall Study|Lost to Follow-up|0|||
147034823|NCT03334617|530288579|FG000|Overall Study|Withdrawal by Subject|0|||
147034824|NCT03334617|530288580|FG001|Overall Study|Withdrawal by Subject|1|||
147034825|NCT03334617|530288581|FG002|Overall Study|Withdrawal by Subject|0|||
147034826|NCT03334617|530288582|FG003|Overall Study|Withdrawal by Subject|0|||
147034827|NCT03334617|530288583|FG004|Overall Study|Withdrawal by Subject|1|||
147034828|NCT03334617|530288584|FG005|Overall Study|Withdrawal by Subject|1|||
147034829|NCT03334617|530288585|FG006|Overall Study|Withdrawal by Subject|1|||
147034830|NCT03334617|530288586|FG007|Overall Study|Withdrawal by Subject|2|||
147034831|NCT03334617|530288587|FG008|Overall Study|Withdrawal by Subject|0|||
147034832|NCT03334617|530288588|FG009|Overall Study|Withdrawal by Subject|0|||
147034833|NCT03334617|530288589|FG010|Overall Study|Withdrawal by Subject|0|||
147034834|NCT03334617|530288590|FG011|Overall Study|Withdrawal by Subject|1|||
147034835|NCT03334617|530288591|FG012|Overall Study|Withdrawal by Subject|1|||
147034836|NCT03334617|530288592|FG013|Overall Study|Withdrawal by Subject|0|||
147034837|NCT03334617|530288593|FG014|Overall Study|Withdrawal by Subject|2|||
147034838|NCT03334617|530288594|FG015|Overall Study|Withdrawal by Subject|1|||
147034839|NCT03334617|530288595|FG016|Overall Study|Withdrawal by Subject|0|||
147034840|NCT03334617|530288596|FG017|Overall Study|Withdrawal by Subject|1|||
147034841|NCT03334617|530288597|FG018|Overall Study|Withdrawal by Subject|1|||
147034842|NCT03334617|530288598|FG019|Overall Study|Withdrawal by Subject|1|||
147034843|NCT03334617|530288599|FG020|Overall Study|Withdrawal by Subject|0|||
147034844|NCT03334617|530288600|FG021|Overall Study|Withdrawal by Subject|1|||
147034845|NCT03334617|530288579|FG000|Overall Study|Other|1|||
147034846|NCT03334617|530288580|FG001|Overall Study|Other|2|||
147034847|NCT03334617|530288581|FG002|Overall Study|Other|0|||
147034848|NCT03334617|530288582|FG003|Overall Study|Other|1|||
147034849|NCT03334617|530288583|FG004|Overall Study|Other|1|||
147034850|NCT03334617|530288584|FG005|Overall Study|Other|0|||
147034851|NCT03334617|530288585|FG006|Overall Study|Other|2|||
147034852|NCT03334617|530288586|FG007|Overall Study|Other|1|||
147034853|NCT03334617|530288587|FG008|Overall Study|Other|8|||
147034854|NCT03334617|530288588|FG009|Overall Study|Other|0|||
147034855|NCT03334617|530288589|FG010|Overall Study|Other|3|||
147034856|NCT03334617|530288590|FG011|Overall Study|Other|1|||
147034857|NCT03334617|530288591|FG012|Overall Study|Other|3|||
147034858|NCT03334617|530288592|FG013|Overall Study|Other|1|||
147034859|NCT03334617|530288593|FG014|Overall Study|Other|1|||
147034860|NCT03334617|530288594|FG015|Overall Study|Other|3|||
147034861|NCT03334617|530288595|FG016|Overall Study|Other|3|||
147034862|NCT03334617|530288596|FG017|Overall Study|Other|3|||
147034863|NCT03334617|530288597|FG018|Overall Study|Other|7|||
147034864|NCT03334617|530288598|FG019|Overall Study|Other|4|||
147034865|NCT03334617|530288599|FG020|Overall Study|Other|1|||
147034866|NCT03334617|530288600|FG021|Overall Study|Other|4|||
147034867|NCT03334617|530288579|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
147034868|NCT03334617|530288580|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
147034869|NCT03334617|530288581|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
147034870|NCT03334617|530288582|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
147034871|NCT03334617|530288583|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
147034872|NCT03334617|530288584|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
147034873|NCT03334617|530288585|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
147034874|NCT03334617|530288586|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
147034875|NCT03334617|530288587|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
147034876|NCT03334617|530288588|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
147034877|NCT03334617|530288589|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
147034878|NCT03334617|530288590|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
147034879|NCT03334617|530288591|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
147034880|NCT03334617|530288592|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
147034881|NCT03334617|530288593|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
147034882|NCT03334617|530288594|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
147034883|NCT03334617|530288595|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
147034884|NCT03334617|530288596|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
147034885|NCT03334617|530288597|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
147034886|NCT03334617|530288598|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
147034887|NCT03334617|530288599|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
147034888|NCT03334617|530288600|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
147034889|NCT03657342|530288601|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
147034890|NCT03657342|530288602|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
147034891|NCT03657342|530288601|FG000|Overall Study|Withdrawal by Subject|4|||
147034892|NCT03657342|530288602|FG001|Overall Study|Withdrawal by Subject|4|||
147034893|NCT03657342|530288601|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
147034894|NCT03657342|530288602|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
147034895|NCT03657342|530288601|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
147034896|NCT03657342|530288602|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
147034897|NCT00911807|530288603|FG000|Overall Study|Adverse Event|2|||
147034898|NCT00911807|530288604|FG001|Overall Study|Adverse Event|1|||
147034899|NCT00911807|530288605|FG002|Overall Study|Adverse Event|5|||
147034900|NCT00911807|530288603|FG000|Overall Study|Death|0|||
147034901|NCT00911807|530288604|FG001|Overall Study|Death|0|||
147034902|NCT00911807|530288605|FG002|Overall Study|Death|1|||
147034903|NCT00911807|530288603|FG000|Overall Study|Protocol Violation|6|||
147034904|NCT00911807|530288604|FG001|Overall Study|Protocol Violation|4|||
147034905|NCT00911807|530288605|FG002|Overall Study|Protocol Violation|9|||
147034906|NCT00911807|530288603|FG000|Overall Study|Withdrawal by Subject|8|||
147034907|NCT00911807|530288604|FG001|Overall Study|Withdrawal by Subject|10|||
147034908|NCT00911807|530288605|FG002|Overall Study|Withdrawal by Subject|7|||
147034909|NCT00911807|530288603|FG000|Overall Study|Organizational reasons|1|||
147034910|NCT00911807|530288604|FG001|Overall Study|Organizational reasons|3|||
147034911|NCT00911807|530288605|FG002|Overall Study|Organizational reasons|1|||
147034912|NCT03918109|530288606|FG000|Overall Study|Withdrawal by Subject|0|||
147034913|NCT03918109|530288607|FG001|Overall Study|Withdrawal by Subject|0|||
147034914|NCT03918109|530288608|FG002|Overall Study|Withdrawal by Subject|2|||
147034915|NCT03918109|530288609|FG003|Overall Study|Withdrawal by Subject|1|||
147034916|NCT03918109|530288606|FG000|Overall Study|Lost to Follow-up|0|||
147034917|NCT03918109|530288607|FG001|Overall Study|Lost to Follow-up|0|||
147034918|NCT03918109|530288608|FG002|Overall Study|Lost to Follow-up|0|||
147034919|NCT03918109|530288609|FG003|Overall Study|Lost to Follow-up|1|||
147034920|NCT01565850|530288612|FG000|Overall Study|Adverse Event|0|||
147034921|NCT01565850|530288613|FG001|Overall Study|Adverse Event|1|||
147034922|NCT01565850|530288612|FG000|Overall Study|Lost to Follow-up|12|||
147034923|NCT01565850|530288613|FG001|Overall Study|Lost to Follow-up|4|||
147034924|NCT01565850|530288612|FG000|Overall Study|Investigator's Discretion|2|||
147034925|NCT01565850|530288613|FG001|Overall Study|Investigator's Discretion|1|||
147034926|NCT01565850|530288612|FG000|Overall Study|Participant noncompliance|2|||
147034927|NCT01565850|530288613|FG001|Overall Study|Participant noncompliance|0|||
147034928|NCT01565850|530288612|FG000|Overall Study|Withdrew Consent|4|||
147034929|NCT01565850|530288613|FG001|Overall Study|Withdrew Consent|2|||
147034930|NCT05323123|530288614|FG000|Overall Study|Withdrawal by Subject|2|||
147034931|NCT05323123|530288615|FG001|Overall Study|Withdrawal by Subject|1|||
147034932|NCT05323123|530288614|FG000|Overall Study|Lost to Follow-up|4|||
147034933|NCT05323123|530288615|FG001|Overall Study|Lost to Follow-up|2|||
147034934|NCT05323123|530288614|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
147034935|NCT05323123|530288615|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
147034936|NCT05529472|530288616|FG000|Overall Study|Withdrawal by Subject|1|||
147034937|NCT05529472|530288617|FG001|Overall Study|Withdrawal by Subject|1|||
147034938|NCT03589768|530290800|FG000|Overall Study|Death|1|||
147034939|NCT03589768|530290801|FG001|Overall Study|Death|0|||
147034940|NCT03589768|530290802|FG002|Overall Study|Death|8|||
147034941|NCT03589768|530290803|FG003|Overall Study|Death|3|||
147034942|NCT03589768|530290800|FG000|Overall Study|Withdrawal by Subject|2|||
147034943|NCT03589768|530290801|FG001|Overall Study|Withdrawal by Subject|0|||
147034944|NCT03589768|530290802|FG002|Overall Study|Withdrawal by Subject|0|||
147034945|NCT03589768|530290803|FG003|Overall Study|Withdrawal by Subject|0|||
147034946|NCT03589768|530290800|FG000|Overall Study|Protocol Violation|1|||
147034947|NCT03589768|530290801|FG001|Overall Study|Protocol Violation|0|||
147034948|NCT03589768|530290802|FG002|Overall Study|Protocol Violation|0|||
147034949|NCT03589768|530290803|FG003|Overall Study|Protocol Violation|0|||
147034950|NCT04663295|530290804|FG000|Run-in Period|Withdrawal by Subject|3|||
147034951|NCT04663295|530290804|FG000|Overall Study Period|Pregnancy|1|||
147034952|NCT04663295|530290804|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
147034953|NCT03610516|530290805|FG000|Treatment Epoch|Adverse Event|3|||
147034954|NCT03610516|530290806|FG001|Treatment Epoch|Adverse Event|1|||
147034955|NCT03610516|530290805|FG000|Treatment Epoch|Death|1|||
147034956|NCT03610516|530290806|FG001|Treatment Epoch|Death|0|||
147034957|NCT03610516|530290805|FG000|Treatment Epoch|Lack of Efficacy|0|||
147034958|NCT03610516|530290806|FG001|Treatment Epoch|Lack of Efficacy|1|||
147034959|NCT03610516|530290805|FG000|Treatment Epoch|No longer requires treatment|1|||
147034960|NCT03610516|530290806|FG001|Treatment Epoch|No longer requires treatment|0|||
147034961|NCT03610516|530290805|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
147034962|NCT03610516|530290806|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
147034963|NCT03610516|530290805|FG000|Treatment Epoch|Physician Decision|8|||
147034964|NCT03610516|530290806|FG001|Treatment Epoch|Physician Decision|5|||
147034965|NCT03610516|530290805|FG000|Treatment Epoch|Protocol Deviation|1|||
147034966|NCT03610516|530290806|FG001|Treatment Epoch|Protocol Deviation|0|||
147034967|NCT03610516|530290805|FG000|Treatment Epoch|Withdrawal by Subject|3|||
147034968|NCT03610516|530290806|FG001|Treatment Epoch|Withdrawal by Subject|1|||
147034969|NCT03610516|530290805|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
147034970|NCT03610516|530290806|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
147034971|NCT03610516|530290805|FG000|Post-Treatment Follow-up|Death|1|||
147034972|NCT03610516|530290806|FG001|Post-Treatment Follow-up|Death|0|||
147034973|NCT04241315|530290808|FG000|Overall Study|Withdrawal by Subject|0|||
147034974|NCT04241315|530290809|FG001|Overall Study|Withdrawal by Subject|1|||
147034975|NCT03047330|530290812|FG000|Sleep Block 1|Withdrawal by Subject|3|||
147034976|NCT00000378|530290813|FG000|Overall Study|Lack of Efficacy|16|||
147034977|NCT00000378|530290814|FG001|Overall Study|Lack of Efficacy|14|||
147034978|NCT00663026|530290829|FG000|Overall Study|Lost to Follow-up|1|||
147034979|NCT00663026|530290830|FG001|Overall Study|Lost to Follow-up|0|||
147034980|NCT00663026|530290831|FG002|Overall Study|Lost to Follow-up|0|||
147034981|NCT00663026|530290829|FG000|Overall Study|Other|1|||
147034982|NCT00663026|530290830|FG001|Overall Study|Other|2|||
147034983|NCT00663026|530290831|FG002|Overall Study|Other|0|||
147034984|NCT00663026|530290829|FG000|Overall Study|Adverse Event|0|||
147034985|NCT00663026|530290830|FG001|Overall Study|Adverse Event|2|||
147034986|NCT00663026|530290831|FG002|Overall Study|Adverse Event|3|||
147034987|NCT00663026|530290829|FG000|Overall Study|Caregiver Request|0|||
147034988|NCT00663026|530290830|FG001|Overall Study|Caregiver Request|2|||
147034989|NCT00663026|530290831|FG002|Overall Study|Caregiver Request|0|||
147034990|NCT00663026|530290829|FG000|Overall Study|Withdrawal by Subject|0|||
147034991|NCT00663026|530290830|FG001|Overall Study|Withdrawal by Subject|0|||
147034992|NCT00663026|530290831|FG002|Overall Study|Withdrawal by Subject|1|||
147034993|NCT03783039|530290842|FG000|Overall Study|Death|2|||
147034994|NCT03783039|530290843|FG001|Overall Study|Death|1|||
147034995|NCT00918138|530290844|FG000|Overall Study|Subject withdrew consent|1|||
147034996|NCT00918138|530290845|FG001|Overall Study|Subject withdrew consent|1|||
147034997|NCT00918138|530290844|FG000|Overall Study|Death|1|||
147034998|NCT00918138|530290845|FG001|Overall Study|Death|0|||
147034999|NCT03972163|530290846|FG000|Overall Study|Death|0|||
147035000|NCT03972163|530290847|FG001|Overall Study|Death|1|||
147035001|NCT02315196|530290848|FG000|Overall Study|Withdrew consent|9|||
147035002|NCT03400943|530290849|FG000|Treatment Period 1|Adverse Event|0|||
147035003|NCT03400943|530290850|FG001|Treatment Period 1|Adverse Event|0|||
147035004|NCT03400943|530290851|FG002|Treatment Period 1|Adverse Event|0|||
147035005|NCT03400943|530290852|FG003|Treatment Period 1|Adverse Event|1|||
147035006|NCT03400943|530290849|FG000|Treatment Period 1|Lost to Follow-up|1|||
147035007|NCT03400943|530290850|FG001|Treatment Period 1|Lost to Follow-up|0|||
147035008|NCT03400943|530290851|FG002|Treatment Period 1|Lost to Follow-up|0|||
147035009|NCT03400943|530290852|FG003|Treatment Period 1|Lost to Follow-up|0|||
147035010|NCT03400943|530290849|FG000|Treatment Period 1|Protocol Violation|0|||
147035011|NCT03400943|530290850|FG001|Treatment Period 1|Protocol Violation|1|||
147035012|NCT03400943|530290851|FG002|Treatment Period 1|Protocol Violation|1|||
147035013|NCT03400943|530290852|FG003|Treatment Period 1|Protocol Violation|0|||
147035014|NCT03400943|530290849|FG000|Treatment Period 1|Study terminated by sponsor|2|||
147035015|NCT03400943|530290850|FG001|Treatment Period 1|Study terminated by sponsor|0|||
147035016|NCT03400943|530290851|FG002|Treatment Period 1|Study terminated by sponsor|0|||
147035017|NCT03400943|530290852|FG003|Treatment Period 1|Study terminated by sponsor|1|||
147035018|NCT03400943|530290849|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147035019|NCT03400943|530290850|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147035020|NCT03400943|530290851|FG002|Treatment Period 1|Withdrawal by Subject|3|||
147035021|NCT03400943|530290852|FG003|Treatment Period 1|Withdrawal by Subject|1|||
147035022|NCT03400943|530290849|FG000|Treatment Period 1|Other|2|||
147035023|NCT03400943|530290850|FG001|Treatment Period 1|Other|1|||
147035024|NCT03400943|530290851|FG002|Treatment Period 1|Other|2|||
147035025|NCT03400943|530290852|FG003|Treatment Period 1|Other|2|||
147035026|NCT03400943|530290849|FG000|Post-treatment Period 1|Adverse Event|2|||
147035027|NCT03400943|530290850|FG001|Post-treatment Period 1|Adverse Event|0|||
147035028|NCT03400943|530290851|FG002|Post-treatment Period 1|Adverse Event|0|||
147035029|NCT03400943|530290852|FG003|Post-treatment Period 1|Adverse Event|0|||
147035030|NCT03400943|530290849|FG000|Post-treatment Period 1|Protocol Violation|1|||
147035031|NCT03400943|530290850|FG001|Post-treatment Period 1|Protocol Violation|0|||
147035032|NCT03400943|530290851|FG002|Post-treatment Period 1|Protocol Violation|0|||
147035033|NCT03400943|530290852|FG003|Post-treatment Period 1|Protocol Violation|0|||
147035034|NCT03400943|530290849|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
147035035|NCT03400943|530290850|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
147035036|NCT03400943|530290851|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
147035037|NCT03400943|530290852|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
147035038|NCT03400943|530290849|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
147035039|NCT03400943|530290850|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
147035040|NCT03400943|530290851|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
147035041|NCT03400943|530290852|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
147035042|NCT03400943|530290849|FG000|Post-treatment Period 1|Other|2|||
147035043|NCT03400943|530290850|FG001|Post-treatment Period 1|Other|0|||
147035044|NCT03400943|530290851|FG002|Post-treatment Period 1|Other|4|||
147035045|NCT03400943|530290852|FG003|Post-treatment Period 1|Other|5|||
147035046|NCT03400943|530290849|FG000|Treatment Period 2|Study terminated by sponsor|0|||
147035047|NCT03400943|530290850|FG001|Treatment Period 2|Study terminated by sponsor|1|||
147035048|NCT03400943|530290851|FG002|Treatment Period 2|Study terminated by sponsor|0|||
147035049|NCT03400943|530290852|FG003|Treatment Period 2|Study terminated by sponsor|0|||
147035050|NCT03400943|530290849|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147035051|NCT03400943|530290850|FG001|Treatment Period 2|Withdrawal by Subject|1|||
147035052|NCT03400943|530290851|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147035053|NCT03400943|530290852|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147035054|NCT03400943|530290849|FG000|Treatment Period 2|Other|1|||
147035055|NCT03400943|530290850|FG001|Treatment Period 2|Other|6|||
147035056|NCT03400943|530290851|FG002|Treatment Period 2|Other|0|||
147035057|NCT03400943|530290852|FG003|Treatment Period 2|Other|0|||
147035058|NCT03400943|530290849|FG000|Follow-up Period|Withdrawal by Subject|1|||
147035059|NCT03400943|530290850|FG001|Follow-up Period|Withdrawal by Subject|0|||
147035060|NCT03400943|530290851|FG002|Follow-up Period|Withdrawal by Subject|0|||
147035061|NCT03400943|530290852|FG003|Follow-up Period|Withdrawal by Subject|0|||
147035062|NCT00537303|530290853|FG000|Overall Study|Adverse Event|1|||
147035063|NCT00537303|530290854|FG001|Overall Study|Adverse Event|4|||
147035064|NCT00537303|530290853|FG000|Overall Study|Lack of Efficacy|6|||
147035065|NCT00537303|530290854|FG001|Overall Study|Lack of Efficacy|7|||
147035066|NCT00537303|530290853|FG000|Overall Study|Protocol Violation|8|||
147035067|NCT00537303|530290854|FG001|Overall Study|Protocol Violation|4|||
147035068|NCT00537303|530290853|FG000|Overall Study|Withdrawal criteria|3|||
147035069|NCT00537303|530290854|FG001|Overall Study|Withdrawal criteria|3|||
147035070|NCT00537303|530290853|FG000|Overall Study|Unclassified|8|||
147035071|NCT00537303|530290854|FG001|Overall Study|Unclassified|7|||
146849717|NCT02663518|529618853|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147035072|NCT03839823|530290855|FG000|Overall Study|Adverse Event|8|||
147035073|NCT03839823|530290856|FG001|Overall Study|Adverse Event|4|||
147035074|NCT03839823|530290855|FG000|Overall Study|Death|1|||
147035075|NCT03839823|530290856|FG001|Overall Study|Death|0|||
147035076|NCT03839823|530290855|FG000|Overall Study|Physician Decision|1|||
147035077|NCT03839823|530290856|FG001|Overall Study|Physician Decision|5|||
147035078|NCT03839823|530290855|FG000|Overall Study|Progressive Disease (PD)|65|||
147035079|NCT03839823|530290856|FG001|Overall Study|Progressive Disease (PD)|65|||
147035080|NCT03839823|530290855|FG000|Overall Study|Subject Decision|2|||
147035081|NCT03839823|530290856|FG001|Overall Study|Subject Decision|9|||
147035082|NCT03839823|530290855|FG000|Overall Study|Not Treated|0|||
147035083|NCT03839823|530290856|FG001|Overall Study|Not Treated|10|||
147035084|NCT03327792|530290857|FG000|Overall Study|Adverse Event|4|||
147035085|NCT03327792|530290858|FG001|Overall Study|Adverse Event|0|||
147035086|NCT03327792|530290857|FG000|Overall Study|Family/Personal issues|3|||
147035087|NCT03327792|530290858|FG001|Overall Study|Family/Personal issues|2|||
147035088|NCT03327792|530290857|FG000|Overall Study|Lost to Follow-up|0|||
147035089|NCT03327792|530290858|FG001|Overall Study|Lost to Follow-up|1|||
147035090|NCT01475097|530290864|FG000|Overall Study|Protocol Violation|1|||
147035091|NCT01475097|530290865|FG001|Overall Study|Protocol Violation|1|||
147035092|NCT04516759|530290867|FG000|Overall Study|Withdrawal by Subject|1|||
147035093|NCT04516759|530290868|FG001|Overall Study|Withdrawal by Subject|1|||
147035094|NCT04516759|530290867|FG000|Overall Study|Other|0|||
147035095|NCT04516759|530290868|FG001|Overall Study|Other|1|||
147035096|NCT03511326|530290869|FG000|Overall Study|Withdrawal by Subject|1|||
147035097|NCT00849186|530290870|FG000|Overall Study|Adverse Event|2|||
147035098|NCT00849186|530290870|FG000|Overall Study|Withdrawal by Subject|1|||
147035099|NCT00849186|530290870|FG000|Overall Study|not treated|6|||
147035100|NCT00849186|530290870|FG000|Overall Study|Other|1|||
147035101|NCT00867503|530290873|FG000|Overall Study|Withdrawal by Subject|1|||
147035102|NCT02704403|530290874|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
147035103|NCT02704403|530290875|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
147035104|NCT02704403|530290874|FG000|Overall Study|Administrative reasons by sponsor|1251|||
147035105|NCT02704403|530290875|FG001|Overall Study|Administrative reasons by sponsor|616|||
147035106|NCT02704403|530290874|FG000|Overall Study|Death|4|||
147035107|NCT02704403|530290875|FG001|Overall Study|Death|3|||
147035108|NCT02704403|530290874|FG000|Overall Study|Endpoint event|52|||
147035109|NCT02704403|530290875|FG001|Overall Study|Endpoint event|24|||
147035110|NCT02704403|530290874|FG000|Overall Study|Lost to Follow-up|22|||
147035111|NCT02704403|530290875|FG001|Overall Study|Lost to Follow-up|11|||
147035112|NCT02704403|530290874|FG000|Overall Study|Protocol Violation|15|||
147035113|NCT02704403|530290875|FG001|Overall Study|Protocol Violation|15|||
147035114|NCT02704403|530290874|FG000|Overall Study|Adverse Event|2|||
147035115|NCT02704403|530290875|FG001|Overall Study|Adverse Event|0|||
147035116|NCT02704403|530290874|FG000|Overall Study|Withdrawal by Subject|85|||
147035117|NCT02704403|530290875|FG001|Overall Study|Withdrawal by Subject|45|||
147035118|NCT02704403|530290874|FG000|Overall Study|Investigator decision|1|||
147035119|NCT02704403|530290875|FG001|Overall Study|Investigator decision|1|||
147035120|NCT02704403|530290874|FG000|Overall Study|Follow-up not possible|1|||
147035121|NCT02704403|530290875|FG001|Overall Study|Follow-up not possible|2|||
147035122|NCT01844856|530290878|FG000|Overall Study|Lost to Follow-up|15|||
147035123|NCT01844856|530290879|FG001|Overall Study|Lost to Follow-up|3|||
147035124|NCT01844856|530290878|FG000|Overall Study|Adverse Event|3|||
147035125|NCT01844856|530290879|FG001|Overall Study|Adverse Event|6|||
147035126|NCT01844856|530290878|FG000|Overall Study|Withdrawal by Subject|3|||
147035127|NCT01844856|530290879|FG001|Overall Study|Withdrawal by Subject|2|||
147035128|NCT01844856|530290878|FG000|Overall Study|Noncompliance|2|||
147035129|NCT01844856|530290879|FG001|Overall Study|Noncompliance|3|||
147035130|NCT01844856|530290878|FG000|Overall Study|Enterococcus Resistant|0|||
147035131|NCT01844856|530290879|FG001|Overall Study|Enterococcus Resistant|1|||
147035132|NCT01844856|530290878|FG000|Overall Study|Inadvertently Not Scheduled|1|||
147035133|NCT01844856|530290879|FG001|Overall Study|Inadvertently Not Scheduled|0|||
147035134|NCT01844856|530290878|FG000|Overall Study|Randomized but was a Screen Failure|0|||
147035135|NCT01844856|530290879|FG001|Overall Study|Randomized but was a Screen Failure|1|||
147035136|NCT01001988|530290880|FG000|Overall Study|Protocol Violation|84|||
147035137|NCT01001988|530290880|FG000|Overall Study|Withdrawal by Subject|18|||
147035138|NCT01001988|530290880|FG000|Overall Study|Lost to Follow-up|15|||
147035139|NCT00927394|530290883|FG000|Overall Study|Adverse Event|14|||
147035140|NCT00927394|530290884|FG001|Overall Study|Adverse Event|9|||
147035141|NCT00927394|530290883|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
147035142|NCT00927394|530290884|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
147035143|NCT00927394|530290883|FG000|Overall Study|Withdrawal by Subject|20|||
147035144|NCT00927394|530290884|FG001|Overall Study|Withdrawal by Subject|24|||
147035145|NCT00927394|530290883|FG000|Overall Study|Lost to Follow-up|8|||
147035146|NCT00927394|530290884|FG001|Overall Study|Lost to Follow-up|14|||
147035147|NCT00927394|530290883|FG000|Overall Study|Administrative Problem|1|||
146849718|NCT02663518|529618854|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147035148|NCT00927394|530290884|FG001|Overall Study|Administrative Problem|0|||
147035149|NCT00927394|530290883|FG000|Overall Study|Death|1|||
147035150|NCT00927394|530290884|FG001|Overall Study|Death|1|||
147035151|NCT00927394|530290883|FG000|Overall Study|Protocol deviation|16|||
147035152|NCT00927394|530290884|FG001|Overall Study|Protocol deviation|13|||
147035153|NCT00927394|530290883|FG000|Overall Study|Randomized in error|0|||
147035154|NCT00927394|530290884|FG001|Overall Study|Randomized in error|1|||
147035155|NCT01221363|530290885|FG000|Overall Study|Pregnancy|1|||
147035156|NCT01221363|530290886|FG001|Overall Study|Pregnancy|0|||
147035157|NCT01221363|530290885|FG000|Overall Study|Withdrawal by Subject|11|||
147035158|NCT01221363|530290886|FG001|Overall Study|Withdrawal by Subject|5|||
147035159|NCT01329549|530290889|FG000|Overall Study|Withdrawal by Subject|1|||
147035160|NCT01329549|530290889|FG000|Overall Study|Adverse Event|1|||
147035161|NCT01756079|530290892|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
147035162|NCT01756079|530290892|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
147035163|NCT01756079|530290892|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
147035164|NCT01756079|530290892|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
147035165|NCT01756079|530290892|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
147035166|NCT04015908|530290893|FG000|Overall Study|Lost to Follow-up|0|||
147035167|NCT04015908|530290894|FG001|Overall Study|Lost to Follow-up|1|||
147035168|NCT01775189|530290895|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147035169|NCT01775189|530290896|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
147035170|NCT01775189|530290897|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147035171|NCT01775189|530290898|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147035172|NCT01775189|530290899|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147035173|NCT01775189|530290900|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147035174|NCT01775189|530290901|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147035175|NCT01775189|530290895|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147035176|NCT01775189|530290896|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
147035177|NCT01775189|530290897|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147035178|NCT01775189|530290898|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147035179|NCT01775189|530290899|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147035180|NCT01775189|530290900|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147035181|NCT01775189|530290901|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147035182|NCT01775189|530290895|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
147035183|NCT01775189|530290896|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
147035184|NCT01775189|530290897|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
147035185|NCT01775189|530290898|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
147035186|NCT01775189|530290899|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
147035187|NCT01775189|530290900|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
147035188|NCT01775189|530290901|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
147035189|NCT01775189|530290895|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
147035190|NCT01775189|530290896|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
147035191|NCT01775189|530290897|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
147035192|NCT01775189|530290898|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
147035193|NCT01775189|530290899|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
147035194|NCT01775189|530290900|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
147035195|NCT01775189|530290901|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
147035196|NCT01775189|530290895|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
147035197|NCT01775189|530290896|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
147035198|NCT01775189|530290897|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
147035199|NCT01775189|530290898|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
147035200|NCT01775189|530290899|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
147035201|NCT01775189|530290900|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
147035202|NCT01775189|530290901|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
147035203|NCT01775189|530290895|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
147035204|NCT01775189|530290896|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
147035205|NCT01775189|530290897|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
147035206|NCT01775189|530290898|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
147035207|NCT01775189|530290899|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
147035208|NCT01775189|530290900|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
147035209|NCT01775189|530290901|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
147035210|NCT04623086|530290902|FG000|Overall Study|Withdrawal by Subject|0|||
147035211|NCT04623086|530290903|FG001|Overall Study|Withdrawal by Subject|0|||
147035212|NCT04623086|530290904|FG002|Overall Study|Withdrawal by Subject|10|||
147035213|NCT01755767|530290905|FG000|Overall Study|Progressive Disease|8|||
147035214|NCT01755767|530290906|FG001|Overall Study|Progressive Disease|7|||
147035215|NCT01755767|530290907|FG002|Overall Study|Progressive Disease|91|||
147035216|NCT01755767|530290908|FG003|Overall Study|Progressive Disease|43|||
147035217|NCT01755767|530290905|FG000|Overall Study|Clinical Disease Progression|4|||
147035218|NCT01755767|530290906|FG001|Overall Study|Clinical Disease Progression|2|||
147035219|NCT01755767|530290907|FG002|Overall Study|Clinical Disease Progression|29|||
147035220|NCT01755767|530290908|FG003|Overall Study|Clinical Disease Progression|20|||
147035221|NCT01755767|530290905|FG000|Overall Study|Radiographic Disease Progression|9|||
147035222|NCT01755767|530290906|FG001|Overall Study|Radiographic Disease Progression|4|||
147035223|NCT01755767|530290907|FG002|Overall Study|Radiographic Disease Progression|44|||
147035224|NCT01755767|530290908|FG003|Overall Study|Radiographic Disease Progression|27|||
147035225|NCT01755767|530290905|FG000|Overall Study|Adverse Event|6|||
147035226|NCT01755767|530290906|FG001|Overall Study|Adverse Event|0|||
147035227|NCT01755767|530290907|FG002|Overall Study|Adverse Event|28|||
147035228|NCT01755767|530290908|FG003|Overall Study|Adverse Event|11|||
147035229|NCT01755767|530290905|FG000|Overall Study|Death|1|||
147035230|NCT01755767|530290906|FG001|Overall Study|Death|2|||
147035231|NCT01755767|530290907|FG002|Overall Study|Death|15|||
147035232|NCT01755767|530290908|FG003|Overall Study|Death|4|||
147035233|NCT01755767|530290905|FG000|Overall Study|Subject Decision|0|||
147035234|NCT01755767|530290906|FG001|Overall Study|Subject Decision|0|||
147035235|NCT01755767|530290907|FG002|Overall Study|Subject Decision|10|||
147035236|NCT01755767|530290908|FG003|Overall Study|Subject Decision|3|||
147035237|NCT01755767|530290905|FG000|Overall Study|Withdrawal by Subject|0|||
147035238|NCT01755767|530290906|FG001|Overall Study|Withdrawal by Subject|0|||
147035239|NCT01755767|530290907|FG002|Overall Study|Withdrawal by Subject|2|||
147035240|NCT01755767|530290908|FG003|Overall Study|Withdrawal by Subject|1|||
147035241|NCT01755767|530290905|FG000|Overall Study|Other|0|||
147035242|NCT01755767|530290906|FG001|Overall Study|Other|0|||
147035243|NCT01755767|530290907|FG002|Overall Study|Other|2|||
147035244|NCT01755767|530290908|FG003|Overall Study|Other|3|||
147035245|NCT01755767|530290905|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
147035246|NCT01755767|530290906|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
147035247|NCT01755767|530290907|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
147035248|NCT01755767|530290908|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
147035249|NCT00191165|530290909|FG000|Overall Study|Adverse Event|2|||
147035250|NCT00191165|530290910|FG001|Overall Study|Adverse Event|0|||
147035251|NCT00191165|530290909|FG000|Overall Study|Protocol Violation|0|||
147035252|NCT00191165|530290910|FG001|Overall Study|Protocol Violation|1|||
147035253|NCT00191165|530290909|FG000|Overall Study|Participant Moved Away|0|||
147035254|NCT00191165|530290910|FG001|Overall Study|Participant Moved Away|1|||
147035255|NCT00715624|530290911|FG000|Overall Study|Adverse Event|12|||
147035256|NCT00715624|530290912|FG001|Overall Study|Adverse Event|37|||
147035257|NCT00715624|530290911|FG000|Overall Study|Lack of Efficacy|11|||
147035258|NCT00715624|530290912|FG001|Overall Study|Lack of Efficacy|11|||
147035259|NCT00715624|530290911|FG000|Overall Study|Lost to Follow-up|1|||
147035260|NCT00715624|530290912|FG001|Overall Study|Lost to Follow-up|2|||
147035261|NCT00715624|530290911|FG000|Overall Study|Protocol Violation|1|||
147035262|NCT00715624|530290912|FG001|Overall Study|Protocol Violation|0|||
147035263|NCT00715624|530290911|FG000|Overall Study|Withdrawal by Subject|11|||
147035264|NCT00715624|530290912|FG001|Overall Study|Withdrawal by Subject|25|||
147035265|NCT00715624|530290911|FG000|Overall Study|Familial and personal reasons|10|||
147035266|NCT00715624|530290912|FG001|Overall Study|Familial and personal reasons|22|||
147035267|NCT00715624|530290911|FG000|Overall Study|Poor compliance|6|||
147035268|NCT00715624|530290912|FG001|Overall Study|Poor compliance|13|||
147035269|NCT00715624|530290911|FG000|Overall Study|Sponsor decision|0|||
147035270|NCT00715624|530290912|FG001|Overall Study|Sponsor decision|4|||
147035271|NCT00715624|530290911|FG000|Overall Study|Incorrect randomization (not treated)|0|||
147035272|NCT00715624|530290912|FG001|Overall Study|Incorrect randomization (not treated)|1|||
147035273|NCT00715624|530290911|FG000|Overall Study|Other|0|||
147035274|NCT00715624|530290912|FG001|Overall Study|Other|1|||
147035275|NCT03200912|530290913|FG000|Overall Study|Adverse Event|3|||
147035276|NCT03200912|530290914|FG001|Overall Study|Adverse Event|0|||
147035277|NCT03200912|530290915|FG002|Overall Study|Adverse Event|0|||
147035278|NCT03200912|530290913|FG000|Overall Study|Withdrawal by Subject|1|||
147035279|NCT03200912|530290914|FG001|Overall Study|Withdrawal by Subject|2|||
147035280|NCT03200912|530290915|FG002|Overall Study|Withdrawal by Subject|4|||
147035281|NCT03200912|530290913|FG000|Overall Study|Non-compliance with study drug|0|||
147035282|NCT03200912|530290914|FG001|Overall Study|Non-compliance with study drug|1|||
147035283|NCT03200912|530290915|FG002|Overall Study|Non-compliance with study drug|0|||
147035284|NCT03196635|530290918|FG000|Overall Study|Withdrawal by Subject|1|||
147035285|NCT00901576|530290921|FG000|Second Intervention|Withdrawal by Subject|0|||
147035286|NCT00901576|530290922|FG001|Second Intervention|Withdrawal by Subject|0|||
147035287|NCT00901576|530290923|FG002|Second Intervention|Withdrawal by Subject|0|||
147035288|NCT00901576|530290924|FG003|Second Intervention|Withdrawal by Subject|1|||
147035289|NCT00901576|530290925|FG004|Second Intervention|Withdrawal by Subject|0|||
147035290|NCT00901576|530290926|FG005|Second Intervention|Withdrawal by Subject|1|||
147035291|NCT00901576|530290921|FG000|Second Intervention|Physician Decision|1|||
147035292|NCT00901576|530290922|FG001|Second Intervention|Physician Decision|0|||
147035293|NCT00901576|530290923|FG002|Second Intervention|Physician Decision|0|||
147035294|NCT00901576|530290924|FG003|Second Intervention|Physician Decision|0|||
147035295|NCT00901576|530290925|FG004|Second Intervention|Physician Decision|0|||
147035296|NCT00901576|530290926|FG005|Second Intervention|Physician Decision|0|||
147035297|NCT00171951|530290929|FG000|Overall Study|Adverse Event|1|||
147035298|NCT00171951|530290929|FG000|Overall Study|Abnormal Laboratory Values|2|||
147035299|NCT00171951|530290929|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
147035300|NCT00171951|530290929|FG000|Overall Study|Participants Withdrew Consent|3|||
147035301|NCT00171951|530290929|FG000|Overall Study|New Cancer Therapy|5|||
147035302|NCT00171951|530290929|FG000|Overall Study|Reason not Specified|2|||
147035303|NCT00724048|530290930|FG000|Overall Study|Adverse Event|1|||
147035304|NCT00724048|530290931|FG001|Overall Study|Adverse Event|1|||
147035305|NCT00724048|530290932|FG002|Overall Study|Adverse Event|1|||
147035306|NCT00724048|530290933|FG003|Overall Study|Adverse Event|0|||
147035307|NCT00724048|530290930|FG000|Overall Study|Lost to Follow-up|0|||
147035308|NCT00724048|530290931|FG001|Overall Study|Lost to Follow-up|1|||
147035309|NCT00724048|530290932|FG002|Overall Study|Lost to Follow-up|0|||
147035310|NCT00724048|530290933|FG003|Overall Study|Lost to Follow-up|0|||
147035311|NCT00724048|530290930|FG000|Overall Study|Withdrawal by Subject|1|||
147035312|NCT00724048|530290931|FG001|Overall Study|Withdrawal by Subject|2|||
147035313|NCT00724048|530290932|FG002|Overall Study|Withdrawal by Subject|1|||
147035314|NCT00724048|530290933|FG003|Overall Study|Withdrawal by Subject|2|||
147035315|NCT00724048|530290930|FG000|Overall Study|Investigator decision|0|||
147035316|NCT00724048|530290931|FG001|Overall Study|Investigator decision|0|||
147035317|NCT00724048|530290932|FG002|Overall Study|Investigator decision|1|||
147035318|NCT00724048|530290933|FG003|Overall Study|Investigator decision|0|||
147035319|NCT00724048|530290930|FG000|Overall Study|Did not tolerate study drug|0|||
147035320|NCT00724048|530290931|FG001|Overall Study|Did not tolerate study drug|0|||
147035321|NCT00724048|530290932|FG002|Overall Study|Did not tolerate study drug|0|||
147035322|NCT00724048|530290933|FG003|Overall Study|Did not tolerate study drug|1|||
147035323|NCT00724048|530290930|FG000|Overall Study|Other than specified|1|||
147035324|NCT00724048|530290931|FG001|Overall Study|Other than specified|1|||
147035325|NCT00724048|530290932|FG002|Overall Study|Other than specified|0|||
147035326|NCT00724048|530290933|FG003|Overall Study|Other than specified|0|||
147035327|NCT02329847|530290934|FG000|Overall Study|Death|4|||
147035328|NCT02329847|530290935|FG001|Overall Study|Death|4|||
147035329|NCT02329847|530290936|FG002|Overall Study|Death|22|||
147035330|NCT02329847|530290937|FG003|Overall Study|Death|12|||
147035331|NCT02329847|530290938|FG004|Overall Study|Death|20|||
147035332|NCT02329847|530290939|FG005|Overall Study|Death|13|||
147035333|NCT02329847|530290934|FG000|Overall Study|Lost to Follow-up|0|||
147035334|NCT02329847|530290935|FG001|Overall Study|Lost to Follow-up|0|||
147035335|NCT02329847|530290936|FG002|Overall Study|Lost to Follow-up|2|||
147035336|NCT02329847|530290937|FG003|Overall Study|Lost to Follow-up|3|||
147035337|NCT02329847|530290938|FG004|Overall Study|Lost to Follow-up|0|||
147035338|NCT02329847|530290939|FG005|Overall Study|Lost to Follow-up|1|||
147035339|NCT02329847|530290934|FG000|Overall Study|Physician Decision|0|||
147035340|NCT02329847|530290935|FG001|Overall Study|Physician Decision|0|||
147035341|NCT02329847|530290936|FG002|Overall Study|Physician Decision|0|||
147035342|NCT02329847|530290937|FG003|Overall Study|Physician Decision|0|||
147035343|NCT02329847|530290938|FG004|Overall Study|Physician Decision|1|||
147035344|NCT02329847|530290939|FG005|Overall Study|Physician Decision|0|||
147035345|NCT02329847|530290934|FG000|Overall Study|Withdrawal by Subject|2|||
147035346|NCT02329847|530290935|FG001|Overall Study|Withdrawal by Subject|1|||
147035347|NCT02329847|530290936|FG002|Overall Study|Withdrawal by Subject|5|||
147035348|NCT02329847|530290937|FG003|Overall Study|Withdrawal by Subject|7|||
147035349|NCT02329847|530290938|FG004|Overall Study|Withdrawal by Subject|8|||
147035350|NCT02329847|530290939|FG005|Overall Study|Withdrawal by Subject|3|||
147035351|NCT02329847|530290934|FG000|Overall Study|Other|1|||
147035352|NCT02329847|530290935|FG001|Overall Study|Other|2|||
147035353|NCT02329847|530290936|FG002|Overall Study|Other|6|||
147035354|NCT02329847|530290937|FG003|Overall Study|Other|13|||
147035355|NCT02329847|530290938|FG004|Overall Study|Other|10|||
147035356|NCT02329847|530290939|FG005|Overall Study|Other|3|||
147035357|NCT00477295|530290943|FG000|Overall Study|Adverse Event|31|||
147035358|NCT00477295|530290944|FG001|Overall Study|Adverse Event|35|||
147035359|NCT00477295|530290943|FG000|Overall Study|Withdrawal by Subject|35|||
147035360|NCT00477295|530290944|FG001|Overall Study|Withdrawal by Subject|24|||
147035361|NCT00477295|530290943|FG000|Overall Study|Lack of Efficacy|23|||
147035362|NCT00477295|530290944|FG001|Overall Study|Lack of Efficacy|23|||
147035363|NCT00477295|530290943|FG000|Overall Study|Protocol Violation|3|||
147035364|NCT00477295|530290944|FG001|Overall Study|Protocol Violation|8|||
147035365|NCT00477295|530290943|FG000|Overall Study|Physician Decision|4|||
147035366|NCT00477295|530290944|FG001|Overall Study|Physician Decision|5|||
147035367|NCT00477295|530290943|FG000|Overall Study|Lost to Follow-up|21|||
147035368|NCT00477295|530290944|FG001|Overall Study|Lost to Follow-up|11|||
147035369|NCT00477295|530290943|FG000|Overall Study|Other|4|||
147035370|NCT00477295|530290944|FG001|Overall Study|Other|3|||
147035371|NCT03276780|530290947|FG000|Overall Study|Withdrawal by Subject|5|||
147035372|NCT03276780|530290948|FG001|Overall Study|Withdrawal by Subject|3|||
147035373|NCT03276780|530290947|FG000|Overall Study|Lost to Follow-up|3|||
147035374|NCT03276780|530290948|FG001|Overall Study|Lost to Follow-up|5|||
147035375|NCT03276780|530290947|FG000|Overall Study|Moved out of state|1|||
147035376|NCT03276780|530290948|FG001|Overall Study|Moved out of state|1|||
147035377|NCT03276780|530290947|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
147035378|NCT03276780|530290948|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
147035379|NCT03276780|530290947|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
147035380|NCT03276780|530290948|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
147035381|NCT02304458|530290949|FG000|Overall Study|Adverse Event|0|||
147035382|NCT02304458|530290950|FG001|Overall Study|Adverse Event|0|||
147035383|NCT02304458|530290951|FG002|Overall Study|Adverse Event|7|||
147035384|NCT02304458|530290952|FG003|Overall Study|Adverse Event|0|||
147035385|NCT02304458|530290953|FG004|Overall Study|Adverse Event|0|||
147035386|NCT02304458|530290954|FG005|Overall Study|Adverse Event|0|||
147035387|NCT02304458|530290955|FG006|Overall Study|Adverse Event|3|||
147035388|NCT02304458|530290956|FG007|Overall Study|Adverse Event|4|||
147035389|NCT02304458|530290949|FG000|Overall Study|Death|0|||
147035390|NCT02304458|530290950|FG001|Overall Study|Death|0|||
147035391|NCT02304458|530290951|FG002|Overall Study|Death|2|||
147035392|NCT02304458|530290952|FG003|Overall Study|Death|0|||
147035393|NCT02304458|530290953|FG004|Overall Study|Death|0|||
147035394|NCT02304458|530290954|FG005|Overall Study|Death|0|||
147035395|NCT02304458|530290955|FG006|Overall Study|Death|1|||
147035396|NCT02304458|530290956|FG007|Overall Study|Death|0|||
147035397|NCT02304458|530290949|FG000|Overall Study|Lack of Efficacy|4|||
147035398|NCT02304458|530290950|FG001|Overall Study|Lack of Efficacy|6|||
147035399|NCT02304458|530290951|FG002|Overall Study|Lack of Efficacy|38|||
147035400|NCT02304458|530290952|FG003|Overall Study|Lack of Efficacy|5|||
147035401|NCT02304458|530290953|FG004|Overall Study|Lack of Efficacy|6|||
147035402|NCT02304458|530290954|FG005|Overall Study|Lack of Efficacy|6|||
147035403|NCT02304458|530290955|FG006|Overall Study|Lack of Efficacy|21|||
147035404|NCT02304458|530290956|FG007|Overall Study|Lack of Efficacy|4|||
147035405|NCT02304458|530290949|FG000|Overall Study|Physician Decision|2|||
147035406|NCT02304458|530290950|FG001|Overall Study|Physician Decision|0|||
147035407|NCT02304458|530290951|FG002|Overall Study|Physician Decision|16|||
147035408|NCT02304458|530290952|FG003|Overall Study|Physician Decision|1|||
147035409|NCT02304458|530290953|FG004|Overall Study|Physician Decision|0|||
147035410|NCT02304458|530290954|FG005|Overall Study|Physician Decision|0|||
147035411|NCT02304458|530290955|FG006|Overall Study|Physician Decision|3|||
147035412|NCT02304458|530290956|FG007|Overall Study|Physician Decision|0|||
147035413|NCT02304458|530290949|FG000|Overall Study|Protocol Violation|0|||
147035414|NCT02304458|530290950|FG001|Overall Study|Protocol Violation|0|||
147035415|NCT02304458|530290951|FG002|Overall Study|Protocol Violation|1|||
147035416|NCT02304458|530290952|FG003|Overall Study|Protocol Violation|0|||
147035417|NCT02304458|530290953|FG004|Overall Study|Protocol Violation|0|||
147035418|NCT02304458|530290954|FG005|Overall Study|Protocol Violation|0|||
147035419|NCT02304458|530290955|FG006|Overall Study|Protocol Violation|0|||
147035420|NCT02304458|530290956|FG007|Overall Study|Protocol Violation|0|||
147035421|NCT02304458|530290949|FG000|Overall Study|Withdrawal by Subject|1|||
147035422|NCT02304458|530290950|FG001|Overall Study|Withdrawal by Subject|0|||
147035423|NCT02304458|530290951|FG002|Overall Study|Withdrawal by Subject|7|||
147035424|NCT02304458|530290952|FG003|Overall Study|Withdrawal by Subject|0|||
147035425|NCT02304458|530290953|FG004|Overall Study|Withdrawal by Subject|0|||
147035426|NCT02304458|530290954|FG005|Overall Study|Withdrawal by Subject|0|||
147035427|NCT02304458|530290955|FG006|Overall Study|Withdrawal by Subject|1|||
147035428|NCT02304458|530290956|FG007|Overall Study|Withdrawal by Subject|0|||
147035429|NCT00390221|530290957|FG000|Overall Study|Lost to Follow-up|0|||
147035430|NCT00390221|530290958|FG001|Overall Study|Lost to Follow-up|3|||
147035431|NCT00390221|530290959|FG002|Overall Study|Lost to Follow-up|0|||
147035432|NCT00390221|530290957|FG000|Overall Study|Adverse Event|1|||
147035433|NCT00390221|530290958|FG001|Overall Study|Adverse Event|4|||
147035434|NCT00390221|530290959|FG002|Overall Study|Adverse Event|3|||
147035435|NCT00390221|530290957|FG000|Overall Study|Investigator Decision|0|||
147035436|NCT00390221|530290958|FG001|Overall Study|Investigator Decision|0|||
147035437|NCT00390221|530290959|FG002|Overall Study|Investigator Decision|1|||
147035438|NCT00390221|530290957|FG000|Overall Study|Withdrawal by Subject|13|||
147035439|NCT00390221|530290958|FG001|Overall Study|Withdrawal by Subject|9|||
147035440|NCT00390221|530290959|FG002|Overall Study|Withdrawal by Subject|7|||
147035441|NCT00390221|530290957|FG000|Overall Study|Subject Non-compliance|1|||
147035442|NCT00390221|530290958|FG001|Overall Study|Subject Non-compliance|0|||
147035443|NCT00390221|530290959|FG002|Overall Study|Subject Non-compliance|2|||
147035444|NCT00390221|530290957|FG000|Overall Study|Other|3|||
147035445|NCT00390221|530290958|FG001|Overall Study|Other|4|||
147035446|NCT00390221|530290959|FG002|Overall Study|Other|2|||
147035447|NCT03582826|530290964|FG000|Overall Study|Lost to Follow-up|39|||
147035448|NCT03582826|530290965|FG001|Overall Study|Lost to Follow-up|0|||
147035449|NCT03582826|530290964|FG000|Overall Study|Withdrawal by Subject|2|||
147035450|NCT03582826|530290965|FG001|Overall Study|Withdrawal by Subject|0|||
147035451|NCT02013674|530290968|FG000|Overall Study|Death|0|||
147035452|NCT02013674|530290969|FG001|Overall Study|Death|1|||
147035453|NCT02013674|530290968|FG000|Overall Study|Lost to Follow-up|1|||
147035454|NCT02013674|530290969|FG001|Overall Study|Lost to Follow-up|0|||
147035455|NCT03433755|530290973|FG000|Overall Study|Lost to Follow-up|1|||
147035456|NCT03433755|530290974|FG001|Overall Study|Lost to Follow-up|0|||
147035457|NCT03433755|530290975|FG002|Overall Study|Lost to Follow-up|0|||
147035458|NCT03433755|530290976|FG003|Overall Study|Lost to Follow-up|0|||
147035459|NCT03433755|530290973|FG000|Overall Study|Decision by Sponsor|1|||
147035460|NCT03433755|530290974|FG001|Overall Study|Decision by Sponsor|0|||
147035461|NCT03433755|530290975|FG002|Overall Study|Decision by Sponsor|0|||
147035462|NCT03433755|530290976|FG003|Overall Study|Decision by Sponsor|0|||
147035463|NCT05065567|530290980|FG000|Overall Study|Lost to Follow-up|10|||
147035464|NCT05065567|530290981|FG001|Overall Study|Lost to Follow-up|9|||
147035465|NCT05065567|530290982|FG002|Overall Study|Lost to Follow-up|6|||
147035466|NCT01161407|530292616|FG000|Overall Study|Protocol Violation|3|||
147035467|NCT01161407|530292617|FG001|Overall Study|Protocol Violation|1|||
147035468|NCT01635283|530292618|FG000|Overall Study|Tumor Progression|3|||
147035469|NCT01635283|530292618|FG000|Overall Study|Lost to Follow-up|1|||
147035470|NCT01305044|530292621|FG000|Overall Study|Withdrawal by Subject|3|||
147035471|NCT01305044|530292622|FG001|Overall Study|Withdrawal by Subject|6|||
147035472|NCT00492024|530292625|FG000|Treatment|Adverse Event|3|||
147035473|NCT00492024|530292626|FG001|Treatment|Adverse Event|1|||
147035474|NCT00492024|530292625|FG000|Treatment|Lack of Efficacy|21|||
147035475|NCT00492024|530292626|FG001|Treatment|Lack of Efficacy|20|||
147035476|NCT00492024|530292625|FG000|Treatment|Lost to Follow-up|3|||
147035477|NCT00492024|530292626|FG001|Treatment|Lost to Follow-up|1|||
147035478|NCT00492024|530292625|FG000|Treatment|Withdrawal by Subject|2|||
147035479|NCT00492024|530292626|FG001|Treatment|Withdrawal by Subject|0|||
147035480|NCT00492024|530292625|FG000|Follow up|Lack of Efficacy|0|||
147035481|NCT00492024|530292626|FG001|Follow up|Lack of Efficacy|1|||
147035482|NCT00492024|530292625|FG000|Follow up|Lost to Follow-up|1|||
147035483|NCT00492024|530292626|FG001|Follow up|Lost to Follow-up|1|||
147035484|NCT02677714|530292639|FG000|Overall Study|Withdrawal by Subject|2|||
147035485|NCT02677714|530292640|FG001|Overall Study|Withdrawal by Subject|0|||
147035486|NCT04628793|530292641|FG000|Overall Study|Study terminated by sponsor|0|||
147035487|NCT04628793|530292642|FG001|Overall Study|Study terminated by sponsor|0|||
147035488|NCT04628793|530292643|FG002|Overall Study|Study terminated by sponsor|8|||
147035489|NCT04628793|530292641|FG000|Overall Study|Withdrawal by Subject|2|||
147035490|NCT04628793|530292642|FG001|Overall Study|Withdrawal by Subject|3|||
147035491|NCT04628793|530292643|FG002|Overall Study|Withdrawal by Subject|0|||
147035492|NCT04628793|530292641|FG000|Overall Study|Lost to Follow-up|0|||
147035493|NCT04628793|530292642|FG001|Overall Study|Lost to Follow-up|1|||
147035494|NCT04628793|530292643|FG002|Overall Study|Lost to Follow-up|0|||
147035495|NCT00229723|530292647|FG000|Concomitant Phase|Adverse Event|4|||
147035496|NCT00229723|530292648|FG001|Concomitant Phase|Adverse Event|2|||
147035497|NCT00229723|530292649|FG002|Concomitant Phase|Adverse Event|5|||
147035498|NCT00229723|530292650|FG003|Concomitant Phase|Adverse Event|2|||
147035499|NCT00229723|530292651|FG004|Concomitant Phase|Adverse Event|0|||
147035500|NCT00229723|530292652|FG005|Concomitant Phase|Adverse Event|1|||
147035501|NCT00229723|530292653|FG006|Concomitant Phase|Adverse Event|2|||
147035502|NCT00229723|530292647|FG000|Concomitant Phase|Objective disease progression|0|||
147035503|NCT00229723|530292648|FG001|Concomitant Phase|Objective disease progression|0|||
147035504|NCT00229723|530292649|FG002|Concomitant Phase|Objective disease progression|0|||
147035505|NCT00229723|530292650|FG003|Concomitant Phase|Objective disease progression|0|||
147035506|NCT00229723|530292651|FG004|Concomitant Phase|Objective disease progression|0|||
147035507|NCT00229723|530292652|FG005|Concomitant Phase|Objective disease progression|0|||
147035508|NCT00229723|530292653|FG006|Concomitant Phase|Objective disease progression|0|||
147035509|NCT00229723|530292647|FG000|Concomitant Phase|Clinical progression|0|||
147035510|NCT00229723|530292648|FG001|Concomitant Phase|Clinical progression|0|||
147035511|NCT00229723|530292649|FG002|Concomitant Phase|Clinical progression|0|||
147035512|NCT00229723|530292650|FG003|Concomitant Phase|Clinical progression|0|||
147035513|NCT00229723|530292651|FG004|Concomitant Phase|Clinical progression|0|||
147035514|NCT00229723|530292652|FG005|Concomitant Phase|Clinical progression|0|||
147035515|NCT00229723|530292653|FG006|Concomitant Phase|Clinical progression|1|||
147035516|NCT00229723|530292647|FG000|Concomitant Phase|Lost to Follow-up|0|||
147035517|NCT00229723|530292648|FG001|Concomitant Phase|Lost to Follow-up|0|||
147035518|NCT00229723|530292649|FG002|Concomitant Phase|Lost to Follow-up|0|||
147035519|NCT00229723|530292650|FG003|Concomitant Phase|Lost to Follow-up|0|||
147035520|NCT00229723|530292651|FG004|Concomitant Phase|Lost to Follow-up|1|||
147035521|NCT00229723|530292652|FG005|Concomitant Phase|Lost to Follow-up|0|||
147035522|NCT00229723|530292653|FG006|Concomitant Phase|Lost to Follow-up|0|||
147035523|NCT00229723|530292647|FG000|Concomitant Phase|Informed consent withdrawn|3|||
147035524|NCT00229723|530292648|FG001|Concomitant Phase|Informed consent withdrawn|2|||
147035525|NCT00229723|530292649|FG002|Concomitant Phase|Informed consent withdrawn|0|||
147035526|NCT00229723|530292650|FG003|Concomitant Phase|Informed consent withdrawn|2|||
147035527|NCT00229723|530292651|FG004|Concomitant Phase|Informed consent withdrawn|0|||
147035528|NCT00229723|530292652|FG005|Concomitant Phase|Informed consent withdrawn|0|||
147035529|NCT00229723|530292653|FG006|Concomitant Phase|Informed consent withdrawn|0|||
146849719|NCT02663518|529618855|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147035530|NCT00229723|530292647|FG000|Concomitant Phase|Severe non-compliance|0|||
147035531|NCT00229723|530292648|FG001|Concomitant Phase|Severe non-compliance|1|||
147035532|NCT00229723|530292649|FG002|Concomitant Phase|Severe non-compliance|0|||
147035533|NCT00229723|530292650|FG003|Concomitant Phase|Severe non-compliance|0|||
147035534|NCT00229723|530292651|FG004|Concomitant Phase|Severe non-compliance|1|||
147035535|NCT00229723|530292652|FG005|Concomitant Phase|Severe non-compliance|0|||
147035536|NCT00229723|530292653|FG006|Concomitant Phase|Severe non-compliance|0|||
147035537|NCT00229723|530292647|FG000|Concomitant Phase|Other|3|||
147035538|NCT00229723|530292648|FG001|Concomitant Phase|Other|0|||
147035539|NCT00229723|530292649|FG002|Concomitant Phase|Other|1|||
147035540|NCT00229723|530292650|FG003|Concomitant Phase|Other|1|||
147035541|NCT00229723|530292651|FG004|Concomitant Phase|Other|0|||
147035542|NCT00229723|530292652|FG005|Concomitant Phase|Other|2|||
147035543|NCT00229723|530292653|FG006|Concomitant Phase|Other|0|||
147035544|NCT00229723|530292647|FG000|Maintenance Phase|Adverse Event|7|||
147035545|NCT00229723|530292648|FG001|Maintenance Phase|Adverse Event|2|||
147035546|NCT00229723|530292649|FG002|Maintenance Phase|Adverse Event|1|||
147035547|NCT00229723|530292650|FG003|Maintenance Phase|Adverse Event|4|||
147035548|NCT00229723|530292651|FG004|Maintenance Phase|Adverse Event|7|||
147035549|NCT00229723|530292652|FG005|Maintenance Phase|Adverse Event|5|||
147035550|NCT00229723|530292653|FG006|Maintenance Phase|Adverse Event|2|||
147035551|NCT00229723|530292647|FG000|Maintenance Phase|Objective disease progression|5|||
147035552|NCT00229723|530292648|FG001|Maintenance Phase|Objective disease progression|5|||
147035553|NCT00229723|530292649|FG002|Maintenance Phase|Objective disease progression|3|||
147035554|NCT00229723|530292650|FG003|Maintenance Phase|Objective disease progression|6|||
147035555|NCT00229723|530292651|FG004|Maintenance Phase|Objective disease progression|2|||
147035556|NCT00229723|530292652|FG005|Maintenance Phase|Objective disease progression|9|||
147035557|NCT00229723|530292653|FG006|Maintenance Phase|Objective disease progression|5|||
147035558|NCT00229723|530292647|FG000|Maintenance Phase|Clinical progression|4|||
147035559|NCT00229723|530292648|FG001|Maintenance Phase|Clinical progression|1|||
147035560|NCT00229723|530292649|FG002|Maintenance Phase|Clinical progression|2|||
147035561|NCT00229723|530292650|FG003|Maintenance Phase|Clinical progression|2|||
147035562|NCT00229723|530292651|FG004|Maintenance Phase|Clinical progression|1|||
147035563|NCT00229723|530292652|FG005|Maintenance Phase|Clinical progression|1|||
147035564|NCT00229723|530292653|FG006|Maintenance Phase|Clinical progression|1|||
147035565|NCT00229723|530292647|FG000|Maintenance Phase|Lost to Follow-up|0|||
147035566|NCT00229723|530292648|FG001|Maintenance Phase|Lost to Follow-up|1|||
147035567|NCT00229723|530292649|FG002|Maintenance Phase|Lost to Follow-up|2|||
147035568|NCT00229723|530292650|FG003|Maintenance Phase|Lost to Follow-up|2|||
147035569|NCT00229723|530292651|FG004|Maintenance Phase|Lost to Follow-up|0|||
147035570|NCT00229723|530292652|FG005|Maintenance Phase|Lost to Follow-up|0|||
147035571|NCT00229723|530292653|FG006|Maintenance Phase|Lost to Follow-up|1|||
147035572|NCT00229723|530292647|FG000|Maintenance Phase|Informed consent withdrawn|1|||
147035573|NCT00229723|530292648|FG001|Maintenance Phase|Informed consent withdrawn|0|||
147035574|NCT00229723|530292649|FG002|Maintenance Phase|Informed consent withdrawn|0|||
147035575|NCT00229723|530292650|FG003|Maintenance Phase|Informed consent withdrawn|1|||
147035576|NCT00229723|530292651|FG004|Maintenance Phase|Informed consent withdrawn|1|||
147035577|NCT00229723|530292652|FG005|Maintenance Phase|Informed consent withdrawn|1|||
147035578|NCT00229723|530292653|FG006|Maintenance Phase|Informed consent withdrawn|0|||
147035579|NCT00229723|530292647|FG000|Maintenance Phase|Severe non-compliance|3|||
147035580|NCT00229723|530292648|FG001|Maintenance Phase|Severe non-compliance|1|||
147035581|NCT00229723|530292649|FG002|Maintenance Phase|Severe non-compliance|0|||
147035582|NCT00229723|530292650|FG003|Maintenance Phase|Severe non-compliance|0|||
147035583|NCT00229723|530292651|FG004|Maintenance Phase|Severe non-compliance|1|||
147035584|NCT00229723|530292652|FG005|Maintenance Phase|Severe non-compliance|0|||
147035585|NCT00229723|530292653|FG006|Maintenance Phase|Severe non-compliance|0|||
147035586|NCT00229723|530292647|FG000|Maintenance Phase|Other|5|||
147035587|NCT00229723|530292648|FG001|Maintenance Phase|Other|4|||
147035588|NCT00229723|530292649|FG002|Maintenance Phase|Other|1|||
147035589|NCT00229723|530292650|FG003|Maintenance Phase|Other|2|||
147035590|NCT00229723|530292651|FG004|Maintenance Phase|Other|3|||
147035591|NCT00229723|530292652|FG005|Maintenance Phase|Other|3|||
147035592|NCT00229723|530292653|FG006|Maintenance Phase|Other|1|||
147035593|NCT02309138|530292654|FG000|Overall Study|Withdrawal by Subject|44|||
147035594|NCT02309138|530292655|FG001|Overall Study|Withdrawal by Subject|15|||
147035595|NCT02309138|530292654|FG000|Overall Study|Protocol Violation|4|||
147035596|NCT02309138|530292655|FG001|Overall Study|Protocol Violation|2|||
147035597|NCT02309138|530292654|FG000|Overall Study|delivered before visit 2|0|||
147035598|NCT02309138|530292655|FG001|Overall Study|delivered before visit 2|1|||
147035599|NCT03421730|530292659|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147035600|NCT03421730|530292660|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
147035601|NCT03421730|530292661|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147035602|NCT03421730|530292662|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147035603|NCT03421730|530292663|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147035604|NCT03421730|530292664|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147035605|NCT03421730|530292665|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147035606|NCT03421730|530292666|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147035607|NCT03421730|530292667|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147035608|NCT03421730|530292668|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147035609|NCT03421730|530292669|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147035610|NCT03421730|530292670|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147035611|NCT03421730|530292659|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147035612|NCT03421730|530292660|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147035613|NCT03421730|530292661|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147035614|NCT03421730|530292662|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147035615|NCT03421730|530292663|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
147035616|NCT03421730|530292664|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147035617|NCT03421730|530292665|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147035618|NCT03421730|530292666|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147035619|NCT03421730|530292667|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147035620|NCT03421730|530292668|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147035621|NCT03421730|530292669|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147035622|NCT03421730|530292670|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147035623|NCT01338870|530292673|FG000|Overall Study|Lost to Follow-up|0|||
147035624|NCT01338870|530292674|FG001|Overall Study|Lost to Follow-up|0|||
147035625|NCT01338870|530292675|FG002|Overall Study|Lost to Follow-up|1|||
147035626|NCT01338870|530292676|FG003|Overall Study|Lost to Follow-up|0|||
147035627|NCT01338870|530292677|FG004|Overall Study|Lost to Follow-up|1|||
147035628|NCT01338870|530292678|FG005|Overall Study|Lost to Follow-up|0|||
147035629|NCT01338870|530292673|FG000|Overall Study|Withdrawal by Subject|2|||
147035630|NCT01338870|530292674|FG001|Overall Study|Withdrawal by Subject|3|||
147035631|NCT01338870|530292675|FG002|Overall Study|Withdrawal by Subject|4|||
147035632|NCT01338870|530292676|FG003|Overall Study|Withdrawal by Subject|0|||
147035633|NCT01338870|530292677|FG004|Overall Study|Withdrawal by Subject|0|||
147035634|NCT01338870|530292678|FG005|Overall Study|Withdrawal by Subject|2|||
147035635|NCT01338870|530292673|FG000|Overall Study|Other|3|||
147035636|NCT01338870|530292674|FG001|Overall Study|Other|3|||
147035637|NCT01338870|530292675|FG002|Overall Study|Other|3|||
147035638|NCT01338870|530292676|FG003|Overall Study|Other|2|||
147035639|NCT01338870|530292677|FG004|Overall Study|Other|0|||
147035640|NCT01338870|530292678|FG005|Overall Study|Other|2|||
147035641|NCT01338870|530292673|FG000|Overall Study|Protocol Violation|0|||
147035642|NCT01338870|530292674|FG001|Overall Study|Protocol Violation|2|||
147035643|NCT01338870|530292675|FG002|Overall Study|Protocol Violation|2|||
147035644|NCT01338870|530292676|FG003|Overall Study|Protocol Violation|2|||
147035645|NCT01338870|530292677|FG004|Overall Study|Protocol Violation|1|||
147035646|NCT01338870|530292678|FG005|Overall Study|Protocol Violation|1|||
147035647|NCT01338870|530292673|FG000|Overall Study|Adverse Event|4|||
147035648|NCT01338870|530292674|FG001|Overall Study|Adverse Event|4|||
147035649|NCT01338870|530292675|FG002|Overall Study|Adverse Event|1|||
147035650|NCT01338870|530292676|FG003|Overall Study|Adverse Event|5|||
147035651|NCT01338870|530292677|FG004|Overall Study|Adverse Event|4|||
147035652|NCT01338870|530292678|FG005|Overall Study|Adverse Event|1|||
147035653|NCT01955083|530292679|FG000|Overall Study|Lost to Follow-up|1|||
147035654|NCT01955083|530292680|FG001|Overall Study|Lost to Follow-up|1|||
147035655|NCT01559389|530292689|FG000|Overall Study|Withdrawal by Subject|20|||
147035656|NCT01559389|530292690|FG001|Overall Study|Withdrawal by Subject|20|||
147035657|NCT02871492|530292691|FG000|Overall Study|Lost to Follow-up|6|||
147035658|NCT02871492|530292692|FG001|Overall Study|Lost to Follow-up|3|||
147035659|NCT02871492|530292693|FG002|Overall Study|Lost to Follow-up|5|||
147035660|NCT02871492|530292691|FG000|Overall Study|Withdrawal by Subject|0|||
147035661|NCT02871492|530292692|FG001|Overall Study|Withdrawal by Subject|0|||
147035662|NCT02871492|530292693|FG002|Overall Study|Withdrawal by Subject|1|||
147035663|NCT04546724|530292694|FG000|Overall Study|Withdrawal by Subject|145|||
147035664|NCT04546724|530292695|FG001|Overall Study|Withdrawal by Subject|41|||
147035665|NCT04546724|530292694|FG000|Overall Study|Adverse Event|1|||
147035666|NCT04546724|530292695|FG001|Overall Study|Adverse Event|1|||
147035667|NCT04546724|530292694|FG000|Overall Study|Lost to Follow-up|186|||
147035668|NCT04546724|530292695|FG001|Overall Study|Lost to Follow-up|63|||
147035669|NCT04546724|530292694|FG000|Overall Study|Physician Decision|8|||
147035670|NCT04546724|530292695|FG001|Overall Study|Physician Decision|2|||
147035671|NCT04546724|530292694|FG000|Overall Study|Death|2|||
147035672|NCT04546724|530292695|FG001|Overall Study|Death|1|||
147035673|NCT04546724|530292694|FG000|Overall Study|subject has been out of town|1|||
147035674|NCT04546724|530292695|FG001|Overall Study|subject has been out of town|0|||
147035675|NCT04546724|530292694|FG000|Overall Study|subject is incarcerated|2|||
147035676|NCT04546724|530292695|FG001|Overall Study|subject is incarcerated|0|||
147035677|NCT04546724|530292694|FG000|Overall Study|subject is relocating|12|||
147035678|NCT04546724|530292695|FG001|Overall Study|subject is relocating|4|||
147035679|NCT04546724|530292694|FG000|Overall Study|Subject in another study|1|||
147035680|NCT04546724|530292695|FG001|Overall Study|Subject in another study|1|||
147035681|NCT03583086|530292696|FG000|Overall Study|Death|2|||
147035682|NCT03583086|530292697|FG001|Overall Study|Death|6|||
147035683|NCT03583086|530292698|FG002|Overall Study|Death|12|||
147035684|NCT03583086|530292699|FG003|Overall Study|Death|10|||
147035685|NCT03583086|530292700|FG004|Overall Study|Death|14|||
147035686|NCT03583086|530292701|FG005|Overall Study|Death|14|||
147035687|NCT03583086|530292702|FG006|Overall Study|Death|4|||
147035688|NCT03583086|530292696|FG000|Overall Study|Withdrawal by Subject|0|||
147035689|NCT03583086|530292697|FG001|Overall Study|Withdrawal by Subject|0|||
147035690|NCT03583086|530292698|FG002|Overall Study|Withdrawal by Subject|1|||
147035691|NCT03583086|530292699|FG003|Overall Study|Withdrawal by Subject|0|||
147035692|NCT03583086|530292700|FG004|Overall Study|Withdrawal by Subject|0|||
147035693|NCT03583086|530292701|FG005|Overall Study|Withdrawal by Subject|0|||
147035694|NCT03583086|530292702|FG006|Overall Study|Withdrawal by Subject|1|||
147035695|NCT03583086|530292696|FG000|Overall Study|Refused follow-up|0|||
147035696|NCT03583086|530292697|FG001|Overall Study|Refused follow-up|0|||
147035697|NCT03583086|530292698|FG002|Overall Study|Refused follow-up|1|||
147035698|NCT03583086|530292699|FG003|Overall Study|Refused follow-up|0|||
147035699|NCT03583086|530292700|FG004|Overall Study|Refused follow-up|1|||
147035700|NCT03583086|530292701|FG005|Overall Study|Refused follow-up|0|||
147035701|NCT03583086|530292702|FG006|Overall Study|Refused follow-up|0|||
147035702|NCT03583086|530292696|FG000|Overall Study|Declining Performance Status|0|||
147035703|NCT03583086|530292697|FG001|Overall Study|Declining Performance Status|0|||
147035704|NCT03583086|530292698|FG002|Overall Study|Declining Performance Status|1|||
147035705|NCT03583086|530292699|FG003|Overall Study|Declining Performance Status|0|||
147035706|NCT03583086|530292700|FG004|Overall Study|Declining Performance Status|0|||
147035707|NCT03583086|530292701|FG005|Overall Study|Declining Performance Status|0|||
147035708|NCT03583086|530292702|FG006|Overall Study|Declining Performance Status|0|||
147035709|NCT03583086|530292696|FG000|Overall Study|Still on study|0|||
147035710|NCT03583086|530292697|FG001|Overall Study|Still on study|0|||
147035711|NCT03583086|530292698|FG002|Overall Study|Still on study|0|||
147035712|NCT03583086|530292699|FG003|Overall Study|Still on study|1|||
147035713|NCT03583086|530292700|FG004|Overall Study|Still on study|0|||
147035714|NCT03583086|530292701|FG005|Overall Study|Still on study|0|||
147035715|NCT03583086|530292702|FG006|Overall Study|Still on study|1|||
147035716|NCT03583086|530292696|FG000|Overall Study|Disease progression|0|||
147035717|NCT03583086|530292697|FG001|Overall Study|Disease progression|0|||
147035718|NCT03583086|530292698|FG002|Overall Study|Disease progression|0|||
147035719|NCT03583086|530292699|FG003|Overall Study|Disease progression|0|||
147035720|NCT03583086|530292700|FG004|Overall Study|Disease progression|0|||
147035721|NCT03583086|530292701|FG005|Overall Study|Disease progression|0|||
147035722|NCT03583086|530292702|FG006|Overall Study|Disease progression|1|||
147035723|NCT03583086|530292696|FG000|Overall Study|Undergoing radiation therapy|0|||
147035724|NCT03583086|530292697|FG001|Overall Study|Undergoing radiation therapy|0|||
147035725|NCT03583086|530292698|FG002|Overall Study|Undergoing radiation therapy|0|||
147035726|NCT03583086|530292699|FG003|Overall Study|Undergoing radiation therapy|0|||
147035727|NCT03583086|530292700|FG004|Overall Study|Undergoing radiation therapy|0|||
147035728|NCT03583086|530292701|FG005|Overall Study|Undergoing radiation therapy|0|||
147035729|NCT03583086|530292702|FG006|Overall Study|Undergoing radiation therapy|1|||
147035730|NCT03583086|530292696|FG000|Overall Study|Lost to Follow-up|0|||
147035731|NCT03583086|530292697|FG001|Overall Study|Lost to Follow-up|0|||
147035732|NCT03583086|530292698|FG002|Overall Study|Lost to Follow-up|0|||
147035733|NCT03583086|530292699|FG003|Overall Study|Lost to Follow-up|0|||
147035734|NCT03583086|530292700|FG004|Overall Study|Lost to Follow-up|0|||
147035735|NCT03583086|530292701|FG005|Overall Study|Lost to Follow-up|1|||
147035736|NCT03583086|530292702|FG006|Overall Study|Lost to Follow-up|0|||
147035737|NCT03583086|530292696|FG000|Overall Study|Adverse Event|0|||
147035738|NCT03583086|530292697|FG001|Overall Study|Adverse Event|0|||
147035739|NCT03583086|530292698|FG002|Overall Study|Adverse Event|0|||
147035740|NCT03583086|530292699|FG003|Overall Study|Adverse Event|0|||
147035741|NCT03583086|530292700|FG004|Overall Study|Adverse Event|0|||
147035742|NCT03583086|530292701|FG005|Overall Study|Adverse Event|1|||
147035743|NCT03583086|530292702|FG006|Overall Study|Adverse Event|0|||
147035744|NCT00396812|530292706|FG000|Overall Study|Physician Decision|1|||
147035745|NCT03201445|530292708|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
147035746|NCT03201445|530292709|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
147035747|NCT03201445|530292708|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
147035748|NCT03201445|530292709|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
147035749|NCT03201445|530292708|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
147035750|NCT03201445|530292709|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
147035751|NCT03201445|530292708|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
147035752|NCT03201445|530292709|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
147035753|NCT03201445|530292708|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
147035754|NCT03201445|530292709|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
147035755|NCT03201445|530292708|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
147035756|NCT03201445|530292709|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
147035757|NCT03201445|530292708|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
147035758|NCT03201445|530292709|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
147035759|NCT03201445|530292708|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
147035760|NCT03201445|530292709|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
147035761|NCT03201445|530292708|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
147035762|NCT03201445|530292709|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
147035763|NCT03201445|530292708|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
147035764|NCT03201445|530292709|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
147035765|NCT03201445|530292708|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
147035766|NCT03201445|530292709|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
147035767|NCT03201445|530292708|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
147035768|NCT03201445|530292709|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
147035769|NCT03201445|530292708|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
147035770|NCT03201445|530292709|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
147035771|NCT03201445|530292708|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
147035772|NCT03201445|530292709|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
147035773|NCT03201445|530292708|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
147035774|NCT03201445|530292709|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
147035775|NCT03201445|530292708|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
147035776|NCT03201445|530292709|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
147035777|NCT03201445|530292708|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
147035778|NCT03201445|530292709|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
147035779|NCT03201445|530292708|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
147035780|NCT03201445|530292709|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
147035781|NCT03201445|530292708|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
147035782|NCT03201445|530292709|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
147035783|NCT03201445|530292708|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
147035784|NCT03201445|530292709|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
147035785|NCT03201445|530292708|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
147035786|NCT03201445|530292709|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
147035787|NCT01346293|530292712|FG000|Overall Study|Protocol Violation|30|||
147035788|NCT01346293|530292713|FG001|Overall Study|Protocol Violation|9|||
147035789|NCT01346293|530292712|FG000|Overall Study|Lost to Follow-up|21|||
147035790|NCT01346293|530292713|FG001|Overall Study|Lost to Follow-up|8|||
147035791|NCT01346293|530292712|FG000|Overall Study|Withdrawal by Subject|15|||
147035792|NCT01346293|530292713|FG001|Overall Study|Withdrawal by Subject|4|||
147035793|NCT01346293|530292712|FG000|Overall Study|Other|1|||
147035794|NCT01346293|530292713|FG001|Overall Study|Other|0|||
147035795|NCT01844505|530292716|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
147035796|NCT01844505|530292717|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
147035797|NCT01844505|530292718|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
147035798|NCT01844505|530292716|FG000|Treatment Period|Other Reasons|120|||
147035799|NCT01844505|530292717|FG001|Treatment Period|Other Reasons|136|||
147035800|NCT01844505|530292718|FG002|Treatment Period|Other Reasons|58|||
147035801|NCT01844505|530292716|FG000|Treatment Period|Lost to Follow-up|9|||
147035802|NCT01844505|530292717|FG001|Treatment Period|Lost to Follow-up|11|||
147035803|NCT01844505|530292718|FG002|Treatment Period|Lost to Follow-up|6|||
147035804|NCT01844505|530292716|FG000|Treatment Period|Death|175|||
147035805|NCT01844505|530292717|FG001|Treatment Period|Death|154|||
147035806|NCT01844505|530292718|FG002|Treatment Period|Death|228|||
147035807|NCT02730351|530292719|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
147035808|NCT02730351|530292720|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
147035809|NCT02730351|530292719|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
147035810|NCT02730351|530292720|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
147035811|NCT02730351|530292719|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
147035812|NCT02730351|530292720|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
147035813|NCT02730351|530292719|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
147035814|NCT02730351|530292720|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
147035815|NCT02730351|530292719|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
147035816|NCT02730351|530292720|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
147035817|NCT00128830|530292721|FG000|Overall Study|Adverse Event|10|||
147035818|NCT00128830|530292721|FG000|Overall Study|Withdrawal by Subject|14|||
147035819|NCT00128830|530292721|FG000|Overall Study|Lost to Follow-up|4|||
147035820|NCT00128830|530292721|FG000|Overall Study|Reached a virologic endpoint|29|||
147035821|NCT00128830|530292721|FG000|Overall Study|Non-compliant|4|||
147035822|NCT00128830|530292721|FG000|Overall Study|Discontinued or ineligible for study|2|||
147035823|NCT00128830|530292721|FG000|Overall Study|Other|9|||
147035824|NCT00311402|530292722|FG000|Overall Study|Adverse Event|118|||
147035825|NCT00311402|530292723|FG001|Overall Study|Adverse Event|105|||
147035826|NCT00311402|530292722|FG000|Overall Study|Lost to Follow-up|0|||
147035827|NCT00311402|530292723|FG001|Overall Study|Lost to Follow-up|3|||
147035828|NCT00311402|530292722|FG000|Overall Study|Withdrawal by Subject|17|||
147035829|NCT00311402|530292723|FG001|Overall Study|Withdrawal by Subject|18|||
147035830|NCT00311402|530292722|FG000|Overall Study|Lack of Efficacy|58|||
147035831|NCT00311402|530292723|FG001|Overall Study|Lack of Efficacy|42|||
147035832|NCT00311402|530292722|FG000|Overall Study|Protocol Violation|7|||
147035833|NCT00311402|530292723|FG001|Overall Study|Protocol Violation|6|||
147035834|NCT00311402|530292722|FG000|Overall Study|IRB's rejection etc.|10|||
147035835|NCT00311402|530292723|FG001|Overall Study|IRB's rejection etc.|3|||
147035836|NCT00838435|530292724|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
147035837|NCT00838435|530292724|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
147035838|NCT00838435|530292724|FG000|Part 2 (7 Years)|Adverse Event|2|||
147035839|NCT00838435|530292724|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
147035840|NCT00838435|530292724|FG000|Part 2 (7 Years)|Physician Decision|1|||
147035841|NCT00838435|530292724|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
147035842|NCT00838435|530292724|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
147035843|NCT02754856|530292730|FG000|Overall Study|Withdrawal by Subject|1|||
147035844|NCT04874155|530292733|FG000|Overall Study|Lost to Follow-up|1|||
147035845|NCT04874155|530292734|FG001|Overall Study|Lost to Follow-up|1|||
147035846|NCT04874155|530292733|FG000|Overall Study|Withdrawal by Subject|2|||
147035847|NCT04874155|530292734|FG001|Overall Study|Withdrawal by Subject|2|||
147035848|NCT00530218|530292735|FG000|Overall Study|CMV Not Detected|13|||
147035849|NCT00530218|530292735|FG000|Overall Study|Death|12|||
147035850|NCT00678886|530292738|FG000|Overall Study|Withdrawal by Subject|0|||
147035851|NCT00678886|530292739|FG001|Overall Study|Withdrawal by Subject|0|||
147035852|NCT00678886|530292740|FG002|Overall Study|Withdrawal by Subject|4|||
147035853|NCT00678886|530292741|FG003|Overall Study|Withdrawal by Subject|6|||
147035854|NCT00678886|530292738|FG000|Overall Study|Physician Decision|0|||
147035855|NCT00678886|530292739|FG001|Overall Study|Physician Decision|0|||
147035856|NCT00678886|530292740|FG002|Overall Study|Physician Decision|1|||
147035857|NCT00678886|530292741|FG003|Overall Study|Physician Decision|1|||
147035858|NCT00678886|530292738|FG000|Overall Study|Lost to Follow-up|0|||
147035859|NCT00678886|530292739|FG001|Overall Study|Lost to Follow-up|0|||
147035860|NCT00678886|530292740|FG002|Overall Study|Lost to Follow-up|3|||
147035861|NCT00678886|530292741|FG003|Overall Study|Lost to Follow-up|2|||
147035862|NCT00678886|530292738|FG000|Overall Study|Other|0|||
147035863|NCT00678886|530292739|FG001|Overall Study|Other|0|||
147035864|NCT00678886|530292740|FG002|Overall Study|Other|1|||
147035865|NCT00678886|530292741|FG003|Overall Study|Other|0|||
147035866|NCT03477903|530292742|FG000|Overall Study|Study Terminated by Sponsor|1|||
147035867|NCT01147107|530292743|FG000|Overall Study|Lack of Efficacy|5|||
147035868|NCT01147107|530292744|FG001|Overall Study|Lack of Efficacy|0|||
147035869|NCT01147107|530292743|FG000|Overall Study|Withdrawal by Subject|1|||
147035870|NCT01147107|530292744|FG001|Overall Study|Withdrawal by Subject|1|||
147035871|NCT03496610|530292745|FG000|Overall Study|Lost to Follow-up|3|||
147035872|NCT03496610|530292746|FG001|Overall Study|Lost to Follow-up|2|||
147035873|NCT03496610|530292745|FG000|Overall Study|Physician Decision|1|||
147035874|NCT03496610|530292746|FG001|Overall Study|Physician Decision|0|||
147035875|NCT03496610|530292745|FG000|Overall Study|Withdrawal by Subject|1|||
147035876|NCT03496610|530292746|FG001|Overall Study|Withdrawal by Subject|0|||
147035877|NCT05330468|530292747|FG000|Overall Study|Death|6|||
147035878|NCT05330468|530292747|FG000|Overall Study|Withdrawal by Subject|4|||
147035879|NCT05330468|530292747|FG000|Overall Study|Lost to Follow-up|4|||
147035880|NCT03835221|530292749|FG000|Methafilcon A|Withdrawal by Subject|1|||
147035881|NCT01197755|530292753|FG000|Overall Study|Adverse Event|8|||
147035882|NCT01197755|530292754|FG001|Overall Study|Adverse Event|10|||
147035883|NCT01197755|530292755|FG002|Overall Study|Adverse Event|10|||
147035884|NCT01197755|530292753|FG000|Overall Study|Study-specific discontinuation criteria|2|||
147035885|NCT01197755|530292754|FG001|Overall Study|Study-specific discontinuation criteria|1|||
147035886|NCT01197755|530292755|FG002|Overall Study|Study-specific discontinuation criteria|0|||
147035887|NCT01197755|530292753|FG000|Overall Study|Entered the long-term extension study|18|||
147035888|NCT01197755|530292754|FG001|Overall Study|Entered the long-term extension study|21|||
147035889|NCT01197755|530292755|FG002|Overall Study|Entered the long-term extension study|35|||
147035890|NCT01197755|530292753|FG000|Overall Study|Lack of therapeutic response|0|||
147035891|NCT01197755|530292754|FG001|Overall Study|Lack of therapeutic response|7|||
147035892|NCT01197755|530292755|FG002|Overall Study|Lack of therapeutic response|4|||
147035893|NCT01197755|530292753|FG000|Overall Study|Severe non-compliance to the protocol|2|||
147035894|NCT01197755|530292754|FG001|Overall Study|Severe non-compliance to the protocol|1|||
147035895|NCT01197755|530292755|FG002|Overall Study|Severe non-compliance to the protocol|2|||
147035896|NCT01197755|530292753|FG000|Overall Study|Withdrawal by Subject|1|||
147035897|NCT01197755|530292754|FG001|Overall Study|Withdrawal by Subject|0|||
147035898|NCT01197755|530292755|FG002|Overall Study|Withdrawal by Subject|0|||
147035899|NCT01197755|530292753|FG000|Overall Study|Lost to Follow-up|0|||
147035900|NCT01197755|530292754|FG001|Overall Study|Lost to Follow-up|0|||
147035901|NCT01197755|530292755|FG002|Overall Study|Lost to Follow-up|1|||
147035902|NCT01197755|530292753|FG000|Overall Study|eg, change in circumstances|7|||
147035903|NCT01197755|530292754|FG001|Overall Study|eg, change in circumstances|3|||
147035904|NCT01197755|530292755|FG002|Overall Study|eg, change in circumstances|2|||
147035905|NCT03365011|530292756|FG000|Overall Study|Withdrawal by Subject|1|||
147035906|NCT03365011|530292757|FG001|Overall Study|Withdrawal by Subject|2|||
147035907|NCT00499174|530292758|FG000|Overall Study|Physician Decision|78|||
147035908|NCT00499174|530292759|FG001|Overall Study|Physician Decision|9|||
147035909|NCT01214915|530292760|FG000|Overall Study|Adverse Event|8|||
147035910|NCT01214915|530292760|FG000|Overall Study|Lack of Efficacy|3|||
147035911|NCT03866902|530292761|FG000|Overall Study|Lost to Follow-up|98|||
147035912|NCT03866902|530292762|FG001|Overall Study|Lost to Follow-up|82|||
147035913|NCT03866902|530292761|FG000|Overall Study|Pregnancy|18|||
147035914|NCT03866902|530292762|FG001|Overall Study|Pregnancy|24|||
147035915|NCT04730349|530292767|FG000|Overall Study|Participant withdrew consent|1|||
147035916|NCT04730349|530292768|FG001|Overall Study|Participant withdrew consent|0|||
147035917|NCT04730349|530292767|FG000|Overall Study|Disease progression|6|||
147035918|NCT04730349|530292768|FG001|Overall Study|Disease progression|4|||
147035919|NCT04730349|530292767|FG000|Overall Study|Study drug toxicity|0|||
147035920|NCT04730349|530292768|FG001|Overall Study|Study drug toxicity|1|||
147035921|NCT03155945|530292778|FG000|Overall Study|Lost to Follow-up|0|||
147035922|NCT03155945|530292779|FG001|Overall Study|Lost to Follow-up|1|||
147035923|NCT03155945|530292778|FG000|Overall Study|Withdrawal by Subject|0|||
147035924|NCT03155945|530292779|FG001|Overall Study|Withdrawal by Subject|1|||
147035925|NCT03155945|530292778|FG000|Overall Study|Other Reason|0|||
147035926|NCT03155945|530292779|FG001|Overall Study|Other Reason|1|||
147035927|NCT03982199|530292781|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
147035928|NCT03982199|530292782|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
147035929|NCT03982199|530292783|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147035930|NCT03982199|530292784|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147035931|NCT03982199|530292785|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147035932|NCT03982199|530292786|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147035933|NCT03982199|530292787|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147035934|NCT03982199|530292788|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147035935|NCT03982199|530292789|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147035936|NCT03982199|530292790|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147035937|NCT03982199|530292791|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147035938|NCT03982199|530292792|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147035939|NCT03982199|530292793|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147035940|NCT03982199|530292794|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147035941|NCT03982199|530292781|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
147035942|NCT03982199|530292782|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
147035943|NCT03982199|530292783|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147035944|NCT03982199|530292784|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147035945|NCT03982199|530292785|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147035946|NCT03982199|530292786|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147035947|NCT03982199|530292787|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147035948|NCT03982199|530292788|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147035949|NCT03982199|530292789|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147035950|NCT03982199|530292790|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147035951|NCT03982199|530292791|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147035952|NCT03982199|530292792|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147035953|NCT03982199|530292793|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147035954|NCT03982199|530292794|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147035955|NCT03982199|530292781|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
147035956|NCT03982199|530292782|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
147035957|NCT03982199|530292783|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147035958|NCT03982199|530292784|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147035959|NCT03982199|530292785|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147035960|NCT03982199|530292786|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147035961|NCT03982199|530292787|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147035962|NCT03982199|530292788|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147035963|NCT03982199|530292789|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147035964|NCT03982199|530292790|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147035965|NCT03982199|530292791|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147035966|NCT03982199|530292792|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147035967|NCT03982199|530292793|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147035968|NCT03982199|530292794|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147035969|NCT03982199|530292781|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
147035970|NCT03982199|530292782|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
147035971|NCT03982199|530292783|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147035972|NCT03982199|530292784|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147035973|NCT03982199|530292785|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147035974|NCT03982199|530292786|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147035975|NCT03982199|530292787|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147035976|NCT03982199|530292788|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147035977|NCT03982199|530292789|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147035978|NCT03982199|530292790|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147035979|NCT03982199|530292791|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147035980|NCT03982199|530292792|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147035981|NCT03982199|530292793|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147035982|NCT03982199|530292794|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147035983|NCT03982199|530292781|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
147035984|NCT03982199|530292782|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
147035985|NCT03982199|530292783|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147035986|NCT03982199|530292784|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147035987|NCT03982199|530292785|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147035988|NCT03982199|530292786|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147035989|NCT03982199|530292787|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147035990|NCT03982199|530292788|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147035991|NCT03982199|530292789|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147035992|NCT03982199|530292790|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147035993|NCT03982199|530292791|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147035994|NCT03982199|530292792|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147035995|NCT03982199|530292793|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147035996|NCT03982199|530292794|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147035997|NCT03982199|530292781|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
147035998|NCT03982199|530292782|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
147035999|NCT03982199|530292783|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147036000|NCT03982199|530292784|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147036001|NCT03982199|530292785|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147036002|NCT03982199|530292786|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147036003|NCT03982199|530292787|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147036004|NCT03982199|530292788|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147036005|NCT03982199|530292789|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147036006|NCT03982199|530292790|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147036007|NCT03982199|530292791|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147036008|NCT03982199|530292792|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147036009|NCT03982199|530292793|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147036010|NCT03982199|530292794|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147036011|NCT03982199|530292781|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
147036012|NCT03982199|530292782|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
147036013|NCT03982199|530292783|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147036014|NCT03982199|530292784|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147036015|NCT03982199|530292785|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147036016|NCT03982199|530292786|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147036017|NCT03982199|530292787|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147036018|NCT03982199|530292788|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147036019|NCT03982199|530292789|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147036020|NCT03982199|530292790|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147036021|NCT03982199|530292791|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147036022|NCT03982199|530292792|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147036023|NCT03982199|530292793|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147036024|NCT03982199|530292794|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147036025|NCT03982199|530292781|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
147036026|NCT03982199|530292782|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
147036027|NCT03982199|530292783|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147036028|NCT03982199|530292784|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147036029|NCT03982199|530292785|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147036030|NCT03982199|530292786|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147036031|NCT03982199|530292787|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147036032|NCT03982199|530292788|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147036033|NCT03982199|530292789|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147036034|NCT03982199|530292790|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147036035|NCT03982199|530292791|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147036036|NCT03982199|530292792|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147036037|NCT03982199|530292793|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147036038|NCT03982199|530292794|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147036039|NCT03982199|530292781|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
146849720|NCT02663518|529618856|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147036040|NCT03982199|530292782|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
147036041|NCT03982199|530292783|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147036042|NCT03982199|530292784|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147036043|NCT03982199|530292785|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147036044|NCT03982199|530292786|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147036045|NCT03982199|530292787|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147036046|NCT03982199|530292788|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147036047|NCT03982199|530292789|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147036048|NCT03982199|530292790|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147036049|NCT03982199|530292791|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147036050|NCT03982199|530292792|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147036051|NCT03982199|530292793|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147036052|NCT03982199|530292794|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147036053|NCT03982199|530292781|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
147036054|NCT03982199|530292782|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
147036055|NCT03982199|530292783|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147036056|NCT03982199|530292784|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147036057|NCT03982199|530292785|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147036058|NCT03982199|530292786|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147036059|NCT03982199|530292787|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147036060|NCT03982199|530292788|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147036061|NCT03982199|530292789|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147036062|NCT03982199|530292790|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147036063|NCT03982199|530292791|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147036064|NCT03982199|530292792|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147036065|NCT03982199|530292793|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147036066|NCT03982199|530292794|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147036067|NCT03982199|530292781|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
147036068|NCT03982199|530292782|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
147036069|NCT03982199|530292783|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147036070|NCT03982199|530292784|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147036071|NCT03982199|530292785|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147036072|NCT03982199|530292786|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147036073|NCT03982199|530292787|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147036074|NCT03982199|530292788|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147036075|NCT03982199|530292789|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147036076|NCT03982199|530292790|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147036077|NCT03982199|530292791|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147036078|NCT03982199|530292792|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147036079|NCT03982199|530292793|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147036080|NCT03982199|530292794|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147036081|NCT03982199|530292781|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
147036082|NCT03982199|530292782|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
147036083|NCT03982199|530292783|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147036084|NCT03982199|530292784|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147036085|NCT03982199|530292785|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147036086|NCT03982199|530292786|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147036087|NCT03982199|530292787|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147036088|NCT03982199|530292788|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147036089|NCT03982199|530292789|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147036090|NCT03982199|530292790|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147036091|NCT03982199|530292791|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147036092|NCT03982199|530292792|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147036093|NCT03982199|530292793|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147036094|NCT03982199|530292794|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147036095|NCT03982199|530292781|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147036096|NCT03982199|530292782|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147036097|NCT03982199|530292783|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147036098|NCT03982199|530292784|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
147036099|NCT03982199|530292785|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147036100|NCT03982199|530292786|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147036101|NCT03982199|530292787|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147036102|NCT03982199|530292788|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147036103|NCT03982199|530292789|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147036104|NCT03982199|530292790|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147036105|NCT03982199|530292791|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147036106|NCT03982199|530292792|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147036107|NCT03982199|530292793|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147036108|NCT03982199|530292794|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147036109|NCT03982199|530292781|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147036110|NCT03982199|530292782|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147036111|NCT03982199|530292783|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
147036112|NCT03982199|530292784|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147036113|NCT03982199|530292785|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147036114|NCT03982199|530292786|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147036115|NCT03982199|530292787|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147036116|NCT03982199|530292788|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147036117|NCT03982199|530292789|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147036118|NCT03982199|530292790|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147036119|NCT03982199|530292791|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147036120|NCT03982199|530292792|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147036121|NCT03982199|530292793|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147036122|NCT03982199|530292794|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147036123|NCT03982199|530292781|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147036124|NCT03982199|530292782|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147036125|NCT03982199|530292783|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
147036126|NCT03982199|530292784|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147036127|NCT03982199|530292785|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147036128|NCT03982199|530292786|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147036129|NCT03982199|530292787|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147036130|NCT03982199|530292788|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147036131|NCT03982199|530292789|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147036132|NCT03982199|530292790|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147036133|NCT03982199|530292791|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147036134|NCT03982199|530292792|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147036135|NCT03982199|530292793|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147036136|NCT03982199|530292794|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147036137|NCT03982199|530292781|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147036138|NCT03982199|530292782|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147036139|NCT03982199|530292783|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
147036140|NCT03982199|530292784|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
147036141|NCT03982199|530292785|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147036142|NCT03982199|530292786|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147036143|NCT03982199|530292787|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147036144|NCT03982199|530292788|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147036145|NCT03982199|530292789|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147036146|NCT03982199|530292790|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147036147|NCT03982199|530292791|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147036148|NCT03982199|530292792|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147036149|NCT03982199|530292793|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147036150|NCT03982199|530292794|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147036151|NCT03982199|530292781|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147036152|NCT03982199|530292782|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147036153|NCT03982199|530292783|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147036154|NCT03982199|530292784|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
147036155|NCT03982199|530292785|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147036156|NCT03982199|530292786|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147036157|NCT03982199|530292787|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147036158|NCT03982199|530292788|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147036159|NCT03982199|530292789|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147036160|NCT03982199|530292790|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147036161|NCT03982199|530292791|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147036162|NCT03982199|530292792|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147036163|NCT03982199|530292793|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147036164|NCT03982199|530292794|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147036165|NCT03982199|530292781|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147036166|NCT03982199|530292782|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147036167|NCT03982199|530292783|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
147036168|NCT03982199|530292784|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
147036169|NCT03982199|530292785|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147036170|NCT03982199|530292786|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147036171|NCT03982199|530292787|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147036172|NCT03982199|530292788|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147036173|NCT03982199|530292789|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147036174|NCT03982199|530292790|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147036175|NCT03982199|530292791|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147036176|NCT03982199|530292792|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147036177|NCT03982199|530292793|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147036178|NCT03982199|530292794|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147036179|NCT03982199|530292781|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147036180|NCT03982199|530292782|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147036181|NCT03982199|530292783|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147036182|NCT03982199|530292784|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147036183|NCT03982199|530292785|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147036184|NCT03982199|530292786|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147036185|NCT03982199|530292787|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147036186|NCT03982199|530292788|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147036187|NCT03982199|530292789|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
147036188|NCT03982199|530292790|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147036189|NCT03982199|530292791|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147036190|NCT03982199|530292792|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147036191|NCT03982199|530292793|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147036192|NCT03982199|530292794|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147036193|NCT03982199|530292781|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147036194|NCT03982199|530292782|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147036195|NCT03982199|530292783|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147036196|NCT03982199|530292784|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147036197|NCT03982199|530292785|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147036198|NCT03982199|530292786|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147036199|NCT03982199|530292787|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147036200|NCT03982199|530292788|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147036201|NCT03982199|530292789|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
147036202|NCT03982199|530292790|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147036203|NCT03982199|530292791|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147036204|NCT03982199|530292792|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147036205|NCT03982199|530292793|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147036206|NCT03982199|530292794|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147036207|NCT03982199|530292781|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147036208|NCT03982199|530292782|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147036209|NCT03982199|530292783|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147036210|NCT03982199|530292784|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147036211|NCT03982199|530292785|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147036212|NCT03982199|530292786|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147036213|NCT03982199|530292787|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147036214|NCT03982199|530292788|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147036215|NCT03982199|530292789|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
147036216|NCT03982199|530292790|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147036217|NCT03982199|530292791|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147036218|NCT03982199|530292792|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147036219|NCT03982199|530292793|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147036220|NCT03982199|530292794|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147036221|NCT03982199|530292781|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147036222|NCT03982199|530292782|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147036223|NCT03982199|530292783|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147036224|NCT03982199|530292784|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147036225|NCT03982199|530292785|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147036226|NCT03982199|530292786|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147036227|NCT03982199|530292787|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147036228|NCT03982199|530292788|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147036229|NCT03982199|530292789|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
146849721|NCT02663518|529618857|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147036230|NCT03982199|530292790|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147036231|NCT03982199|530292791|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147036232|NCT03982199|530292792|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147036233|NCT03982199|530292793|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147036234|NCT03982199|530292794|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147036235|NCT03982199|530292781|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147036236|NCT03982199|530292782|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147036237|NCT03982199|530292783|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147036238|NCT03982199|530292784|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147036239|NCT03982199|530292785|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147036240|NCT03982199|530292786|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147036241|NCT03982199|530292787|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147036242|NCT03982199|530292788|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147036243|NCT03982199|530292789|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
147036244|NCT03982199|530292790|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147036245|NCT03982199|530292791|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147036246|NCT03982199|530292792|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147036247|NCT03982199|530292793|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147036248|NCT03982199|530292794|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147036249|NCT03982199|530292781|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147036250|NCT03982199|530292782|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147036251|NCT03982199|530292783|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147036252|NCT03982199|530292784|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147036253|NCT03982199|530292785|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147036254|NCT03982199|530292786|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
147036255|NCT03982199|530292787|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147036256|NCT03982199|530292788|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
147036257|NCT03982199|530292789|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
147036258|NCT03982199|530292790|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147036259|NCT03982199|530292791|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147036260|NCT03982199|530292792|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147036261|NCT03982199|530292793|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147036262|NCT03982199|530292794|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147036263|NCT03982199|530292781|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147036264|NCT03982199|530292782|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147036265|NCT03982199|530292783|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147036266|NCT03982199|530292784|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147036267|NCT03982199|530292785|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147036268|NCT03982199|530292786|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147036269|NCT03982199|530292787|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147036270|NCT03982199|530292788|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147036271|NCT03982199|530292789|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
147036272|NCT03982199|530292790|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147036273|NCT03982199|530292791|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147036274|NCT03982199|530292792|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147036275|NCT03982199|530292793|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147036276|NCT03982199|530292794|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147036277|NCT03982199|530292781|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147036278|NCT03982199|530292782|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147036279|NCT03982199|530292783|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147036280|NCT03982199|530292784|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147036281|NCT03982199|530292785|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147036282|NCT03982199|530292786|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
147036283|NCT03982199|530292787|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147036284|NCT03982199|530292788|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
147036285|NCT03982199|530292789|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
147036286|NCT03982199|530292790|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147036287|NCT03982199|530292791|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147036288|NCT03982199|530292792|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147036289|NCT03982199|530292793|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147036290|NCT03982199|530292794|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147036291|NCT03982199|530292781|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147036292|NCT03982199|530292782|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147036293|NCT03982199|530292783|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147036294|NCT03982199|530292784|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147036295|NCT03982199|530292785|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147036296|NCT03982199|530292786|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147036297|NCT03982199|530292787|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147036298|NCT03982199|530292788|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147036299|NCT03982199|530292789|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147036300|NCT03982199|530292790|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
147036301|NCT03982199|530292791|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
147036302|NCT03982199|530292792|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
147036303|NCT03982199|530292793|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
147036304|NCT03982199|530292794|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
147036305|NCT03982199|530292781|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147036306|NCT03982199|530292782|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147036307|NCT03982199|530292783|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147036308|NCT03982199|530292784|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147036309|NCT03982199|530292785|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147036310|NCT03982199|530292786|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147036311|NCT03982199|530292787|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147036312|NCT03982199|530292788|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147036313|NCT03982199|530292789|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147036314|NCT03982199|530292790|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
147036315|NCT03982199|530292791|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147036316|NCT03982199|530292792|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147036317|NCT03982199|530292793|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147036318|NCT03982199|530292794|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147036319|NCT03982199|530292781|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147036320|NCT03982199|530292782|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147036321|NCT03982199|530292783|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147036322|NCT03982199|530292784|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147036323|NCT03982199|530292785|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147036324|NCT03982199|530292786|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147036325|NCT03982199|530292787|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147036326|NCT03982199|530292788|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147036327|NCT03982199|530292789|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147036328|NCT03982199|530292790|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147036329|NCT03982199|530292791|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147036330|NCT03982199|530292792|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147036331|NCT03982199|530292793|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147036332|NCT03982199|530292794|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
147036333|NCT03982199|530292781|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147036334|NCT03982199|530292782|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147036335|NCT03982199|530292783|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147036336|NCT03982199|530292784|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147036337|NCT03982199|530292785|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147036338|NCT03982199|530292786|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147036339|NCT03982199|530292787|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147036340|NCT03982199|530292788|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147036341|NCT03982199|530292789|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147036342|NCT03982199|530292790|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147036343|NCT03982199|530292791|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
147036344|NCT03982199|530292792|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
147036345|NCT03982199|530292793|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
147036346|NCT03982199|530292794|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147036347|NCT03982199|530292781|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147036348|NCT03982199|530292782|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147036349|NCT03982199|530292783|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147036350|NCT03982199|530292784|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147036351|NCT03982199|530292785|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147036352|NCT03982199|530292786|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147036353|NCT03982199|530292787|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147036354|NCT03982199|530292788|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147036355|NCT03982199|530292789|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147036356|NCT03982199|530292790|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147036357|NCT03982199|530292791|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147036358|NCT03982199|530292792|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147036359|NCT03982199|530292793|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147036360|NCT03982199|530292794|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
147036361|NCT03982199|530292781|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147036362|NCT03982199|530292782|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147036363|NCT03982199|530292783|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147036364|NCT03982199|530292784|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147036365|NCT03982199|530292785|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147036366|NCT03982199|530292786|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147036367|NCT03982199|530292787|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147036368|NCT03982199|530292788|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147036369|NCT03982199|530292789|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147036370|NCT03982199|530292790|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147036371|NCT03982199|530292791|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147036372|NCT03982199|530292792|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147036373|NCT03982199|530292793|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
147036374|NCT03982199|530292794|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
147036375|NCT03982199|530292781|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147036376|NCT03982199|530292782|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147036377|NCT03982199|530292783|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147036378|NCT03982199|530292784|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147036379|NCT03982199|530292785|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147036380|NCT03982199|530292786|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147036381|NCT03982199|530292787|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147036382|NCT03982199|530292788|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147036383|NCT03982199|530292789|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147036384|NCT03982199|530292790|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147036385|NCT03982199|530292791|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147036386|NCT03982199|530292792|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147036387|NCT03982199|530292793|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
147036388|NCT03982199|530292794|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147036389|NCT03510598|530294447|FG000|Overall Study|Withdrawal by Subject|1|||
147036390|NCT04240392|530294448|FG000|Overall Study|Withdrawal by Subject|13|||
147036391|NCT04240392|530294449|FG001|Overall Study|Withdrawal by Subject|4|||
147036392|NCT04240392|530294448|FG000|Overall Study|Lost to Follow-up|11|||
147036393|NCT04240392|530294449|FG001|Overall Study|Lost to Follow-up|12|||
147036394|NCT03665441|530294457|FG000|Overall Study|survival follow up ongoing|23|||
147036395|NCT03665441|530294458|FG001|Overall Study|survival follow up ongoing|0|||
147036396|NCT03665441|530294457|FG000|Overall Study|Patients ongoing on treatment|9|||
147036397|NCT03665441|530294458|FG001|Overall Study|Patients ongoing on treatment|6|||
147036398|NCT03665441|530294457|FG000|Overall Study|Randomized but not treated|7|||
147036399|NCT03665441|530294458|FG001|Overall Study|Randomized but not treated|11|||
147036400|NCT00191113|530294459|FG000|Core Study|Withdrawal by Subject|25|||
147036401|NCT00191113|530294460|FG001|Core Study|Withdrawal by Subject|9|||
147036402|NCT00191113|530294459|FG000|Core Study|Protocol Violation|6|||
147036403|NCT00191113|530294460|FG001|Core Study|Protocol Violation|2|||
147036404|NCT00191113|530294459|FG000|Core Study|Lost to Follow-up|3|||
147036405|NCT00191113|530294460|FG001|Core Study|Lost to Follow-up|0|||
147036406|NCT00191113|530294459|FG000|Core Study|Adverse Event|0|||
147036407|NCT00191113|530294460|FG001|Core Study|Adverse Event|2|||
147036408|NCT00191113|530294459|FG000|Core Study|Lack of Efficacy|0|||
147036409|NCT00191113|530294460|FG001|Core Study|Lack of Efficacy|2|||
147036410|NCT00191113|530294459|FG000|Core Study|Death|1|||
147036411|NCT00191113|530294460|FG001|Core Study|Death|0|||
147036412|NCT05307510|530294461|FG000|Overall Study|Lost to Follow-up|3|||
147036413|NCT05307510|530294462|FG001|Overall Study|Lost to Follow-up|6|||
147036414|NCT05307510|530294461|FG000|Overall Study|Withdrawal by Subject|0|||
147036415|NCT05307510|530294462|FG001|Overall Study|Withdrawal by Subject|1|||
147036416|NCT04003896|530294466|FG000|Overall Study|Withdrawal by Subject|3|||
147036417|NCT04003896|530294466|FG000|Overall Study|Physician Decision|1|||
147036418|NCT01682863|530294467|FG000|Overall Study|Subject/guardian decision|19|||
147036419|NCT01682863|530294468|FG001|Overall Study|Subject/guardian decision|12|||
147036420|NCT01682863|530294469|FG002|Overall Study|Subject/guardian decision|10|||
147036421|NCT01682863|530294467|FG000|Overall Study|Lost to Follow-up|5|||
147036422|NCT01682863|530294468|FG001|Overall Study|Lost to Follow-up|1|||
147036423|NCT01682863|530294469|FG002|Overall Study|Lost to Follow-up|6|||
147036424|NCT01682863|530294467|FG000|Overall Study|Death|1|||
147036425|NCT01682863|530294468|FG001|Overall Study|Death|3|||
147036426|NCT01682863|530294469|FG002|Overall Study|Death|4|||
147036427|NCT01682863|530294467|FG000|Overall Study|Protocol deviation|1|||
147036428|NCT01682863|530294468|FG001|Overall Study|Protocol deviation|0|||
147036429|NCT01682863|530294469|FG002|Overall Study|Protocol deviation|1|||
147036430|NCT01682863|530294467|FG000|Overall Study|Technical problems|1|||
147036431|NCT01682863|530294468|FG001|Overall Study|Technical problems|0|||
147036432|NCT01682863|530294469|FG002|Overall Study|Technical problems|0|||
147036433|NCT01682863|530294467|FG000|Overall Study|Adverse Event|0|||
147036434|NCT01682863|530294468|FG001|Overall Study|Adverse Event|1|||
147036435|NCT01682863|530294469|FG002|Overall Study|Adverse Event|2|||
147036436|NCT01682863|530294467|FG000|Overall Study|Physician Decision|0|||
147036437|NCT01682863|530294468|FG001|Overall Study|Physician Decision|0|||
147036438|NCT01682863|530294469|FG002|Overall Study|Physician Decision|1|||
147036439|NCT00837473|530294470|FG000|Overall Study|Lost to Follow-up|1|||
147036440|NCT00837473|530294470|FG000|Overall Study|Withdrawal by Subject|2|||
147036441|NCT01635218|530294471|FG000|Overall Study|Lost to Follow-up|3|||
147036442|NCT01635218|530294472|FG001|Overall Study|Lost to Follow-up|7|||
147036443|NCT01635218|530294473|FG002|Overall Study|Lost to Follow-up|6|||
147036444|NCT04576923|530294474|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
147036445|NCT02278055|530294477|FG000|Overall Study|Adverse Event|1|||
147036446|NCT02278055|530294477|FG000|Overall Study|Lost to Follow-up|1|||
147036447|NCT02278055|530294477|FG000|Overall Study|Withdrawal by Subject|2|||
147036448|NCT02278055|530294477|FG000|Overall Study|Progressive Disease|4|||
147036449|NCT04040192|530294478|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
147036450|NCT04040192|530294479|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
147036451|NCT04040192|530294480|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
147036452|NCT04040192|530294478|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
147036453|NCT04040192|530294479|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
147036454|NCT04040192|530294480|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
147036455|NCT04040192|530294478|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
147036456|NCT04040192|530294479|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
147036457|NCT04040192|530294480|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
147036458|NCT04040192|530294478|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
147036459|NCT04040192|530294479|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
147036460|NCT04040192|530294480|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
147036461|NCT04040192|530294478|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
147036462|NCT04040192|530294479|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
147036463|NCT04040192|530294480|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
147036464|NCT04040192|530294478|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
147036465|NCT04040192|530294479|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
147036466|NCT04040192|530294480|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
147036467|NCT04040192|530294478|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
147036468|NCT04040192|530294479|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
147036469|NCT04040192|530294480|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
147036470|NCT04040192|530294478|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
147036471|NCT04040192|530294479|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
147036472|NCT04040192|530294480|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
147036473|NCT04040192|530294478|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
147036474|NCT04040192|530294479|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
147036475|NCT04040192|530294480|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
147036476|NCT04040192|530294478|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
147036477|NCT04040192|530294479|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
147036478|NCT04040192|530294480|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
147036479|NCT04040192|530294478|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
147036480|NCT04040192|530294479|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
147036481|NCT04040192|530294480|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
147036482|NCT04040192|530294478|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
147036483|NCT04040192|530294479|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
147036484|NCT04040192|530294480|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
147036485|NCT04040192|530294478|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
147036486|NCT04040192|530294479|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
147036487|NCT04040192|530294480|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
147036488|NCT04040192|530294478|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
147036489|NCT04040192|530294479|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
147036490|NCT04040192|530294480|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
147036491|NCT04040192|530294478|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
147036492|NCT04040192|530294479|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
147036493|NCT04040192|530294480|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
147036494|NCT04040192|530294478|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
147036495|NCT04040192|530294479|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
147036496|NCT04040192|530294480|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
147036497|NCT04040192|530294478|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
147036498|NCT04040192|530294479|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
147036499|NCT04040192|530294480|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
147036500|NCT00469144|530294481|FG000|Overall Study|Death|0|||
147036501|NCT00469144|530294482|FG001|Overall Study|Death|1|||
147036502|NCT00469144|530294481|FG000|Overall Study|No Response|5|||
147036503|NCT00469144|530294482|FG001|Overall Study|No Response|5|||
147036504|NCT00469144|530294481|FG000|Overall Study|Progressive Disease|1|||
147036505|NCT00469144|530294482|FG001|Overall Study|Progressive Disease|0|||
147036506|NCT01994291|530294483|FG000|Overall Study|Adverse Event|4|||
147036507|NCT01994291|530294484|FG001|Overall Study|Adverse Event|1|||
147036508|NCT01994291|530294485|FG002|Overall Study|Adverse Event|3|||
147036509|NCT01994291|530294483|FG000|Overall Study|Lost to Follow-up|1|||
147036510|NCT01994291|530294484|FG001|Overall Study|Lost to Follow-up|1|||
147036511|NCT01994291|530294485|FG002|Overall Study|Lost to Follow-up|0|||
147036512|NCT01994291|530294483|FG000|Overall Study|Does not meet entrance criteria|1|||
147036513|NCT01994291|530294484|FG001|Overall Study|Does not meet entrance criteria|0|||
147036514|NCT01994291|530294485|FG002|Overall Study|Does not meet entrance criteria|0|||
147036515|NCT01994291|530294483|FG000|Overall Study|Medication error without associated AE|1|||
147036516|NCT01994291|530294484|FG001|Overall Study|Medication error without associated AE|0|||
147036517|NCT01994291|530294485|FG002|Overall Study|Medication error without associated AE|1|||
147036518|NCT01994291|530294483|FG000|Overall Study|Protocol Violation|1|||
147036519|NCT01994291|530294484|FG001|Overall Study|Protocol Violation|0|||
147036520|NCT01994291|530294485|FG002|Overall Study|Protocol Violation|0|||
147036521|NCT01994291|530294483|FG000|Overall Study|Withdrawal by Subject|6|||
147036522|NCT01994291|530294484|FG001|Overall Study|Withdrawal by Subject|3|||
147036523|NCT01994291|530294485|FG002|Overall Study|Withdrawal by Subject|5|||
147036524|NCT01994291|530294483|FG000|Overall Study|Other|1|||
147036525|NCT01994291|530294484|FG001|Overall Study|Other|2|||
147036526|NCT01994291|530294485|FG002|Overall Study|Other|0|||
147036527|NCT00856375|530294486|FG000|Overall Study|Other|0|||
147036528|NCT00856375|530294487|FG001|Overall Study|Other|1|||
147036529|NCT00856375|530294486|FG000|Overall Study|Death|32|||
147036530|NCT00856375|530294487|FG001|Overall Study|Death|30|||
147036531|NCT00856375|530294486|FG000|Overall Study|Sponsor Terminated Study|7|||
147036532|NCT00856375|530294487|FG001|Overall Study|Sponsor Terminated Study|7|||
147036533|NCT00856375|530294486|FG000|Overall Study|Withdrawal by Subject|2|||
147036534|NCT00856375|530294487|FG001|Overall Study|Withdrawal by Subject|1|||
147036535|NCT00856375|530294486|FG000|Overall Study|Lost to Follow-up|1|||
147036536|NCT00856375|530294487|FG001|Overall Study|Lost to Follow-up|2|||
147036537|NCT02227446|530294488|FG000|Overall Study|not eligible post randomization|18|||
147036538|NCT02227446|530294489|FG001|Overall Study|not eligible post randomization|29|||
147036539|NCT02227446|530294488|FG000|Overall Study|Withdrawal by Subject|4|||
147036540|NCT02227446|530294489|FG001|Overall Study|Withdrawal by Subject|5|||
147036541|NCT02121392|530294490|FG000|Prior to Intervention|Protocol Violation|40|||
147036542|NCT02121392|530294491|FG001|Prior to Intervention|Protocol Violation|35|||
147036543|NCT02121392|530294490|FG000|Prior to Intervention|Withdrawal by Subject|8|||
147036544|NCT02121392|530294491|FG001|Prior to Intervention|Withdrawal by Subject|6|||
147036545|NCT02121392|530294490|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
147036546|NCT02121392|530294491|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
147036547|NCT02121392|530294490|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
147036548|NCT02121392|530294491|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
147036549|NCT01352416|530294492|FG000|Overall Study|Physician Decision|1|||
147036550|NCT01352416|530294493|FG001|Overall Study|Physician Decision|2|||
147036551|NCT01352416|530294494|FG002|Overall Study|Physician Decision|2|||
147036552|NCT01352416|530294495|FG003|Overall Study|Physician Decision|1|||
147036553|NCT03016975|530294504|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
147036554|NCT03016975|530294505|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
147036555|NCT03016975|530294506|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
147036556|NCT03016975|530294504|FG000|At 6 Months Follow-up|Death|2|||
147036557|NCT03016975|530294505|FG001|At 6 Months Follow-up|Death|0|||
147036558|NCT03016975|530294506|FG002|At 6 Months Follow-up|Death|0|||
147036559|NCT03016975|530294504|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
147036560|NCT03016975|530294505|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
147036561|NCT03016975|530294506|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
147036562|NCT03016975|530294504|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
147036563|NCT03016975|530294505|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
147036564|NCT03016975|530294506|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
146849722|NCT02663518|529618858|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147036565|NCT03016975|530294504|FG000|At 6 Months Follow-up|Aborted implant|1|||
147036566|NCT03016975|530294505|FG001|At 6 Months Follow-up|Aborted implant|0|||
147036567|NCT03016975|530294506|FG002|At 6 Months Follow-up|Aborted implant|0|||
147036568|NCT03016975|530294504|FG000|At 2 Year Follow-up|Death|1|||
147036569|NCT03016975|530294505|FG001|At 2 Year Follow-up|Death|0|||
147036570|NCT03016975|530294506|FG002|At 2 Year Follow-up|Death|0|||
147036571|NCT03016975|530294504|FG000|At 3 Year Follow-up|Death|1|||
147036572|NCT03016975|530294505|FG001|At 3 Year Follow-up|Death|0|||
147036573|NCT03016975|530294506|FG002|At 3 Year Follow-up|Death|0|||
147036574|NCT03016975|530294504|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
147036575|NCT03016975|530294505|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
147036576|NCT03016975|530294506|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
147036577|NCT03016975|530294504|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
147036578|NCT03016975|530294505|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
147036579|NCT03016975|530294506|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
147036580|NCT02901548|530294507|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
147036581|NCT01228019|530294519|FG000|Overall Study|Dose Violation|70|||
147036582|NCT01228019|530294519|FG000|Overall Study|Duplicate enrollment|1|||
147036583|NCT01228019|530294519|FG000|Overall Study|Missing pre-treatment data|72|||
147036584|NCT01228019|530294519|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
147036585|NCT01228019|530294519|FG000|Overall Study|Violation of Entry Criterion|9|||
147036586|NCT02640053|530294521|FG000|Overall Study|Withdrawal by Subject|2|||
147036587|NCT02640053|530294522|FG001|Overall Study|Withdrawal by Subject|1|||
147036588|NCT02640053|530294521|FG000|Overall Study|Adverse Event|1|||
147036589|NCT02640053|530294522|FG001|Overall Study|Adverse Event|1|||
147036590|NCT02640053|530294521|FG000|Overall Study|Alternative Therapy|1|||
147036591|NCT02640053|530294522|FG001|Overall Study|Alternative Therapy|1|||
147036592|NCT02640053|530294521|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
147036593|NCT02640053|530294522|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
147036594|NCT02348723|530294524|FG000|Overall Study|No ablation|21|||
147036595|NCT02348723|530294525|FG001|Overall Study|No ablation|20|||
147036596|NCT02348723|530294524|FG000|Overall Study|Non-compliant with Protocol|1|||
147036597|NCT02348723|530294525|FG001|Overall Study|Non-compliant with Protocol|0|||
147036598|NCT02348723|530294524|FG000|Overall Study|Lost to Follow-up|1|||
147036599|NCT02348723|530294525|FG001|Overall Study|Lost to Follow-up|1|||
147036600|NCT02348723|530294524|FG000|Overall Study|Consent withdrawn|1|||
147036601|NCT02348723|530294525|FG001|Overall Study|Consent withdrawn|3|||
147036602|NCT02348723|530294524|FG000|Overall Study|Reason other than specified|1|||
147036603|NCT02348723|530294525|FG001|Overall Study|Reason other than specified|1|||
147036604|NCT02348723|530294524|FG000|Overall Study|Adverse Event|3|||
147036605|NCT02348723|530294525|FG001|Overall Study|Adverse Event|1|||
147036606|NCT01268501|530294526|FG000|Overall Study|Lost to Follow-up|1|||
147036607|NCT01268501|530294526|FG000|Overall Study|Withdrawal by Subject|3|||
147036608|NCT01268501|530294526|FG000|Overall Study|Unacceptable Subjective Vision|3|||
147036609|NCT01268501|530294526|FG000|Overall Study|Handling Difficulties|2|||
147036610|NCT02910063|530294527|FG000|Phase 2|Withdrawal by Subject|3|||
147036611|NCT02910063|530294528|FG001|Phase 2|Withdrawal by Subject|0|||
147036612|NCT02910063|530294529|FG002|Phase 2|Withdrawal by Subject|0|||
147036613|NCT02910063|530294527|FG000|Phase 2|Lost to Follow-up|1|||
147036614|NCT02910063|530294528|FG001|Phase 2|Lost to Follow-up|0|||
147036615|NCT02910063|530294529|FG002|Phase 2|Lost to Follow-up|0|||
147036616|NCT02910063|530294527|FG000|Phase 2|Death|24|||
147036617|NCT02910063|530294528|FG001|Phase 2|Death|0|||
147036618|NCT02910063|530294529|FG002|Phase 2|Death|0|||
147036619|NCT04435184|530294530|FG000|Overall Study|follow-up blood draws missing|3|||
147036620|NCT04435184|530294531|FG001|Overall Study|follow-up blood draws missing|5|||
147036621|NCT04693416|530294532|FG000|Overall Study|Lost to Follow-up|13|||
147036622|NCT04693416|530294533|FG001|Overall Study|Lost to Follow-up|0|||
147036623|NCT00474266|530294534|FG000|Overall Study|Withdrawal by Subject|7|||
147036624|NCT00474266|530294535|FG001|Overall Study|Withdrawal by Subject|20|||
147036625|NCT00474266|530294536|FG002|Overall Study|Withdrawal by Subject|4|||
147036626|NCT00474266|530294537|FG003|Overall Study|Withdrawal by Subject|7|||
147036627|NCT02774642|530294541|FG000|Overall Study|Lost to Follow-up|9|||
147036628|NCT02774642|530294542|FG001|Overall Study|Lost to Follow-up|7|||
147036629|NCT00369317|530294546|FG000|Overall Study|Adverse Event|3|||
147036630|NCT00369317|530294546|FG000|Overall Study|Death|1|||
147036631|NCT00369317|530294546|FG000|Overall Study|Lack of Efficacy|5|||
147036632|NCT00369317|530294546|FG000|Overall Study|Physician Decision|2|||
147036633|NCT00369317|530294546|FG000|Overall Study|Withdrawal by Subject|8|||
147036634|NCT00369317|530294546|FG000|Overall Study|Ineligible|1|||
147036635|NCT02365558|530294547|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
147036636|NCT02365558|530294548|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
147036637|NCT02365558|530294547|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
147036638|NCT02365558|530294548|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
147036639|NCT00426361|530294555|FG000|Overall Study|Lost to Follow-up|3|||
147036640|NCT00426361|530294556|FG001|Overall Study|Lost to Follow-up|2|||
147036641|NCT00426361|530294557|FG002|Overall Study|Lost to Follow-up|5|||
147036642|NCT00426361|530294555|FG000|Overall Study|Withdrawal by Subject|1|||
147036643|NCT00426361|530294556|FG001|Overall Study|Withdrawal by Subject|3|||
147036644|NCT00426361|530294557|FG002|Overall Study|Withdrawal by Subject|0|||
147036645|NCT02828241|530294561|FG000|Overall Study|Adverse Event|7|||
147036646|NCT02828241|530294562|FG001|Overall Study|Adverse Event|2|||
147036647|NCT02828241|530294561|FG000|Overall Study|Protocol Violation|1|||
147036648|NCT02828241|530294562|FG001|Overall Study|Protocol Violation|0|||
147036649|NCT06281171|530294576|FG000|Timepoint 2|Lost to Follow-up|6|||
147036650|NCT06281171|530294577|FG001|Timepoint 2|Lost to Follow-up|4|||
147036651|NCT06281171|530294576|FG000|Timepoint 3|Lost to Follow-up|0|||
147036652|NCT06281171|530294577|FG001|Timepoint 3|Lost to Follow-up|5|||
147036653|NCT01458106|530294582|FG000|Overall Study|Withdrawal by Subject|2|||
147036654|NCT01458106|530294583|FG001|Overall Study|Withdrawal by Subject|0|||
147036655|NCT01458106|530294582|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
147036656|NCT01458106|530294583|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
147036657|NCT01458106|530294582|FG000|Overall Study|Withdrawn Per Protocol|0|||
147036658|NCT01458106|530294583|FG001|Overall Study|Withdrawn Per Protocol|1|||
147036659|NCT00073021|530294584|FG000|Overall Study|Protocol Violation|2|||
147036660|NCT00073021|530294585|FG001|Overall Study|Protocol Violation|1|||
147036661|NCT00073021|530294584|FG000|Overall Study|Adverse Event|4|||
147036662|NCT00073021|530294585|FG001|Overall Study|Adverse Event|4|||
147036663|NCT00073021|530294584|FG000|Overall Study|Withdrawal by Subject|6|||
147036664|NCT00073021|530294585|FG001|Overall Study|Withdrawal by Subject|5|||
147036665|NCT00073021|530294584|FG000|Overall Study|Physician Decision|3|||
147036666|NCT00073021|530294585|FG001|Overall Study|Physician Decision|1|||
147036667|NCT00073021|530294584|FG000|Overall Study|Lack of Efficacy|11|||
147036668|NCT00073021|530294585|FG001|Overall Study|Lack of Efficacy|5|||
147036669|NCT03050060|530294586|FG000|Overall Study|Adverse Event|7|||
147036670|NCT03050060|530294586|FG000|Overall Study|Withdrawal by Subject|1|||
147036671|NCT03050060|530294586|FG000|Overall Study|Progression|7|||
147036672|NCT00510289|530294587|FG000|Overall Study|Withdrawal by Subject|7|||
147036673|NCT00510289|530294587|FG000|Overall Study|Refused bone marrow biopsy|2|||
147036674|NCT00510289|530294587|FG000|Overall Study|Lost to Follow-up|1|||
147036675|NCT00510289|530294587|FG000|Overall Study|Progressed prior to starting drug|2|||
147036676|NCT00861198|530294591|FG000|Overall Study|SpyGlass Failed|5|||
147036677|NCT00761865|530294593|FG000|Overall Study|Lost to Follow-up|8|||
147036678|NCT00761865|530294594|FG001|Overall Study|Lost to Follow-up|7|||
147036679|NCT01094886|530294595|FG000|Overall Study|Adverse Event|2|||
147036680|NCT01094886|530294595|FG000|Overall Study|Withdrawal by Subject|5|||
147036681|NCT00371397|530294597|FG000|Session 1|Withdrawal by Subject|1|||
147036682|NCT00371397|530294598|FG001|Session 1|Withdrawal by Subject|0|||
147036683|NCT00371397|530294599|FG002|Session 1|Withdrawal by Subject|0|||
147036684|NCT00371397|530294600|FG003|Session 1|Withdrawal by Subject|0|||
147036685|NCT00371397|530294601|FG004|Session 1|Withdrawal by Subject|0|||
147036686|NCT00371397|530294602|FG005|Session 1|Withdrawal by Subject|0|||
147036687|NCT00371397|530294603|FG006|Session 1|Withdrawal by Subject|0|||
147036688|NCT00371397|530294604|FG007|Session 1|Withdrawal by Subject|1|||
147036689|NCT00371397|530294605|FG008|Session 1|Withdrawal by Subject|0|||
147036690|NCT00371397|530294606|FG009|Session 1|Withdrawal by Subject|0|||
147036691|NCT00371397|530294607|FG010|Session 1|Withdrawal by Subject|0|||
147036692|NCT00371397|530294608|FG011|Session 1|Withdrawal by Subject|0|||
147036693|NCT02886624|530296148|FG000|12-week Post Treatment Follow-up|Death|1|||
147036694|NCT02886624|530296148|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
147036695|NCT00402116|530296149|FG000|Overall Study|Jaw infection after surgery-other|1|||
147036696|NCT00402116|530296150|FG001|Overall Study|Jaw infection after surgery-other|0|||
147036697|NCT00402116|530296151|FG002|Overall Study|Jaw infection after surgery-other|0|||
147036698|NCT00402116|530296149|FG000|Overall Study|Withdrawal by Subject|1|||
147036699|NCT00402116|530296150|FG001|Overall Study|Withdrawal by Subject|0|||
147036700|NCT00402116|530296151|FG002|Overall Study|Withdrawal by Subject|5|||
147036701|NCT00402116|530296149|FG000|Overall Study|Treatment completed per protocol|1|||
147036702|NCT00402116|530296150|FG001|Overall Study|Treatment completed per protocol|1|||
147036703|NCT00402116|530296151|FG002|Overall Study|Treatment completed per protocol|2|||
147036704|NCT00402116|530296149|FG000|Overall Study|other complicating disease|0|||
147036705|NCT00402116|530296150|FG001|Overall Study|other complicating disease|0|||
147036706|NCT00402116|530296151|FG002|Overall Study|other complicating disease|2|||
147036707|NCT00402116|530296149|FG000|Overall Study|Disease Progression|0|||
147036708|NCT00402116|530296150|FG001|Overall Study|Disease Progression|4|||
147036709|NCT00402116|530296151|FG002|Overall Study|Disease Progression|38|||
147036710|NCT00402116|530296149|FG000|Overall Study|mistaken thrombocytopenia|0|||
147036711|NCT00402116|530296150|FG001|Overall Study|mistaken thrombocytopenia|0|||
147036712|NCT00402116|530296151|FG002|Overall Study|mistaken thrombocytopenia|1|||
147036713|NCT00402116|530296149|FG000|Overall Study|decline related hyponatremia/tumor|0|||
147036714|NCT00402116|530296150|FG001|Overall Study|decline related hyponatremia/tumor|0|||
147036715|NCT00402116|530296151|FG002|Overall Study|decline related hyponatremia/tumor|1|||
147036716|NCT00402116|530296149|FG000|Overall Study|Adverse Event|0|||
147036717|NCT00402116|530296150|FG001|Overall Study|Adverse Event|1|||
147036718|NCT00402116|530296151|FG002|Overall Study|Adverse Event|6|||
147036719|NCT05048329|530296152|FG000|Overall Study|Withdrawal by Subject|1|||
147036720|NCT05048329|530296152|FG000|Overall Study|Screenfail|1|||
147036721|NCT00324649|530296153|FG000|Overall Study|Adverse Event|1|||
147036722|NCT00324649|530296154|FG001|Overall Study|Adverse Event|4|||
147036723|NCT00324649|530296153|FG000|Overall Study|Withdrawal by Subject|0|||
147036724|NCT00324649|530296154|FG001|Overall Study|Withdrawal by Subject|1|||
147036725|NCT00324649|530296153|FG000|Overall Study|Noncompliance|1|||
147036726|NCT00324649|530296154|FG001|Overall Study|Noncompliance|0|||
147036727|NCT01564537|530296155|FG000|Overall Study|Site Terminated by Sponsor|1|||
147036728|NCT01564537|530296156|FG001|Overall Study|Site Terminated by Sponsor|0|||
147036729|NCT01564537|530296155|FG000|Overall Study|Withdrawal by Subject|12|||
147036730|NCT01564537|530296156|FG001|Overall Study|Withdrawal by Subject|14|||
147036731|NCT01564537|530296155|FG000|Overall Study|Lost to Follow-up|7|||
147036732|NCT01564537|530296156|FG001|Overall Study|Lost to Follow-up|3|||
147036733|NCT01564537|530296155|FG000|Overall Study|Reason not specified|81|||
147036734|NCT01564537|530296156|FG001|Overall Study|Reason not specified|82|||
147036735|NCT05776862|530296157|FG000|Overall Study|Adverse Event|0|||
147036736|NCT05776862|530296158|FG001|Overall Study|Adverse Event|1|||
147036737|NCT05776862|530296157|FG000|Overall Study|non-compliance|1|||
147036738|NCT05776862|530296158|FG001|Overall Study|non-compliance|0|||
147036739|NCT02448706|530296159|FG000|Overall Study|Withdrawal by Subject|4|||
147036740|NCT02448706|530296160|FG001|Overall Study|Withdrawal by Subject|3|||
147036741|NCT02448706|530296159|FG000|Overall Study|Protocol Violation|1|||
147036742|NCT02448706|530296160|FG001|Overall Study|Protocol Violation|1|||
147036743|NCT01199471|530296161|FG000|Overall Study|Protocol Violation|4|||
147036744|NCT01199471|530296161|FG000|Overall Study|Withdrawal by Subject|1|||
147036745|NCT01199471|530296161|FG000|Overall Study|Physician Decision|1|||
147036746|NCT02065700|530296162|FG000|Overall Study|Adverse Event|165|||
147036747|NCT02065700|530296163|FG001|Overall Study|Adverse Event|101|||
147036748|NCT02065700|530296162|FG000|Overall Study|Withdrawal by Subject|90|||
147036749|NCT02065700|530296163|FG001|Overall Study|Withdrawal by Subject|29|||
147036750|NCT02065700|530296162|FG000|Overall Study|Lost to Follow-up|12|||
147036751|NCT02065700|530296163|FG001|Overall Study|Lost to Follow-up|9|||
147036752|NCT02065700|530296162|FG000|Overall Study|Physician Decision|2|||
147036753|NCT02065700|530296163|FG001|Overall Study|Physician Decision|0|||
147036754|NCT02065700|530296162|FG000|Overall Study|Sponsor Request|38|||
147036755|NCT02065700|530296163|FG001|Overall Study|Sponsor Request|15|||
147036756|NCT02065700|530296162|FG000|Overall Study|Treatment Failure|3|||
147036757|NCT02065700|530296163|FG001|Overall Study|Treatment Failure|2|||
147036758|NCT02065700|530296162|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
147036759|NCT02065700|530296163|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
147036760|NCT02065700|530296162|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
147036761|NCT02065700|530296163|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
147036762|NCT02065700|530296162|FG000|Overall Study|Non-compliance with Study Procedures|2|||
147036763|NCT02065700|530296163|FG001|Overall Study|Non-compliance with Study Procedures|0|||
147036764|NCT02065700|530296162|FG000|Overall Study|Not Defined|21|||
147036765|NCT02065700|530296163|FG001|Overall Study|Not Defined|3|||
147036766|NCT03151408|530296164|FG000|Overall Study|Adverse Event|24|||
147036767|NCT03151408|530296165|FG001|Overall Study|Adverse Event|23|||
147036768|NCT03151408|530296164|FG000|Overall Study|Death|46|||
147036769|NCT03151408|530296165|FG001|Overall Study|Death|26|||
147036770|NCT03151408|530296164|FG000|Overall Study|Physician Decision|13|||
147036771|NCT03151408|530296165|FG001|Overall Study|Physician Decision|19|||
147036772|NCT03151408|530296164|FG000|Overall Study|Withdrawal by Subject|16|||
147036773|NCT03151408|530296165|FG001|Overall Study|Withdrawal by Subject|20|||
147036774|NCT03151408|530296164|FG000|Overall Study|Progressive disease|45|||
147036775|NCT03151408|530296165|FG001|Overall Study|Progressive disease|61|||
147036776|NCT03151408|530296164|FG000|Overall Study|non-compliance by patient|1|||
147036777|NCT03151408|530296165|FG001|Overall Study|non-compliance by patient|0|||
147036778|NCT03151408|530296164|FG000|Overall Study|other reasons|56|||
147036779|NCT03151408|530296165|FG001|Overall Study|other reasons|52|||
147036780|NCT03151408|530296164|FG000|Overall Study|randomized and not treated|2|||
147036781|NCT03151408|530296165|FG001|Overall Study|randomized and not treated|2|||
147036782|NCT03262038|530296170|FG000|Overall Study|Withdrawal by Subject|0|||
147036783|NCT03262038|530296171|FG001|Overall Study|Withdrawal by Subject|1|||
147036784|NCT04933968|530296172|FG000|Overall Study|Adverse Event|0|||
147036785|NCT04933968|530296173|FG001|Overall Study|Adverse Event|0|||
147036786|NCT04933968|530296174|FG002|Overall Study|Adverse Event|1|||
147036787|NCT04933968|530296175|FG003|Overall Study|Adverse Event|1|||
147036788|NCT04933968|530296176|FG004|Overall Study|Adverse Event|0|||
147036789|NCT04933968|530296177|FG005|Overall Study|Adverse Event|0|||
147036790|NCT04933968|530296172|FG000|Overall Study|Lost to Follow-up|1|||
147036791|NCT04933968|530296173|FG001|Overall Study|Lost to Follow-up|0|||
147036792|NCT04933968|530296174|FG002|Overall Study|Lost to Follow-up|1|||
147036793|NCT04933968|530296175|FG003|Overall Study|Lost to Follow-up|0|||
147036794|NCT04933968|530296176|FG004|Overall Study|Lost to Follow-up|0|||
147036795|NCT04933968|530296177|FG005|Overall Study|Lost to Follow-up|0|||
147036796|NCT04933968|530296172|FG000|Overall Study|Randomized not treated|1|||
147036797|NCT04933968|530296173|FG001|Overall Study|Randomized not treated|0|||
147036798|NCT04933968|530296174|FG002|Overall Study|Randomized not treated|0|||
147036799|NCT04933968|530296175|FG003|Overall Study|Randomized not treated|0|||
147036800|NCT04933968|530296176|FG004|Overall Study|Randomized not treated|0|||
147036801|NCT04933968|530296177|FG005|Overall Study|Randomized not treated|0|||
147036802|NCT04933968|530296172|FG000|Overall Study|Sponsor terminated study|0|||
147036803|NCT04933968|530296173|FG001|Overall Study|Sponsor terminated study|0|||
147036804|NCT04933968|530296174|FG002|Overall Study|Sponsor terminated study|0|||
147036805|NCT04933968|530296175|FG003|Overall Study|Sponsor terminated study|1|||
147036806|NCT04933968|530296176|FG004|Overall Study|Sponsor terminated study|2|||
147036807|NCT04933968|530296177|FG005|Overall Study|Sponsor terminated study|0|||
147036808|NCT04933968|530296172|FG000|Overall Study|Other|0|||
147036809|NCT04933968|530296173|FG001|Overall Study|Other|0|||
147036810|NCT04933968|530296174|FG002|Overall Study|Other|0|||
147036811|NCT04933968|530296175|FG003|Overall Study|Other|1|||
147036812|NCT04933968|530296176|FG004|Overall Study|Other|0|||
147036813|NCT04933968|530296177|FG005|Overall Study|Other|0|||
147036814|NCT04933968|530296172|FG000|Overall Study|Missing|1|||
147036815|NCT04933968|530296173|FG001|Overall Study|Missing|3|||
147036816|NCT04933968|530296174|FG002|Overall Study|Missing|2|||
147036817|NCT04933968|530296175|FG003|Overall Study|Missing|1|||
147036818|NCT04933968|530296176|FG004|Overall Study|Missing|1|||
147036819|NCT04933968|530296177|FG005|Overall Study|Missing|0|||
147036820|NCT01724489|530296178|FG000|Overall Study|Adverse Event|8|||
147036821|NCT01724489|530296179|FG001|Overall Study|Adverse Event|3|||
147036822|NCT01724489|530296178|FG000|Overall Study|Surgery, medication|1|||
147036823|NCT01724489|530296179|FG001|Overall Study|Surgery, medication|1|||
147036824|NCT01724489|530296178|FG000|Overall Study|Lost to Follow-up|1|||
147036825|NCT01724489|530296179|FG001|Overall Study|Lost to Follow-up|2|||
147036826|NCT01724489|530296178|FG000|Overall Study|Withdrawal by Subject|6|||
147036827|NCT01724489|530296179|FG001|Overall Study|Withdrawal by Subject|6|||
147036828|NCT01664130|530296182|FG000|Overall Study|competing secondary disease|2|||
147036829|NCT00554606|530296185|FG000|Overall Study|Adverse Event|3|||
147036830|NCT00554606|530296185|FG000|Overall Study|Abnormal laboratory values|1|||
147036831|NCT00554606|530296185|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
147036832|NCT00554606|530296185|FG000|Overall Study|Subject withdrew consent|2|||
147036833|NCT00554606|530296185|FG000|Overall Study|Lost to Follow-up|2|||
147036834|NCT00554606|530296185|FG000|Overall Study|Administrative problems|60|||
147036835|NCT00554606|530296185|FG000|Overall Study|Death|1|||
147036836|NCT00554606|530296185|FG000|Overall Study|Protocol deviation|2|||
147036837|NCT03323437|530296187|FG000|Overall Study|Withdrawal by Subject|0|||
147036838|NCT03323437|530296188|FG001|Overall Study|Withdrawal by Subject|4|||
147036839|NCT02119819|530296193|FG000|Overall Study|Adverse Event|3|||
147036840|NCT02119819|530296194|FG001|Overall Study|Adverse Event|1|||
147036841|NCT02119819|530296195|FG002|Overall Study|Adverse Event|2|||
147036842|NCT02119819|530296196|FG003|Overall Study|Adverse Event|3|||
147036843|NCT02119819|530296197|FG004|Overall Study|Adverse Event|0|||
147036844|NCT02119819|530296198|FG005|Overall Study|Adverse Event|1|||
147036845|NCT02119819|530296193|FG000|Overall Study|Lack of Efficacy|0|||
147036846|NCT02119819|530296194|FG001|Overall Study|Lack of Efficacy|0|||
147036847|NCT02119819|530296195|FG002|Overall Study|Lack of Efficacy|0|||
147036848|NCT02119819|530296196|FG003|Overall Study|Lack of Efficacy|0|||
147036849|NCT02119819|530296197|FG004|Overall Study|Lack of Efficacy|0|||
147036850|NCT02119819|530296198|FG005|Overall Study|Lack of Efficacy|1|||
147036851|NCT02119819|530296193|FG000|Overall Study|Lost to Follow-up|0|||
147036852|NCT02119819|530296194|FG001|Overall Study|Lost to Follow-up|0|||
147036853|NCT02119819|530296195|FG002|Overall Study|Lost to Follow-up|1|||
147036854|NCT02119819|530296196|FG003|Overall Study|Lost to Follow-up|2|||
147036855|NCT02119819|530296197|FG004|Overall Study|Lost to Follow-up|1|||
147036856|NCT02119819|530296198|FG005|Overall Study|Lost to Follow-up|2|||
147036857|NCT02119819|530296193|FG000|Overall Study|Physician Decision|1|||
147036858|NCT02119819|530296194|FG001|Overall Study|Physician Decision|1|||
147036859|NCT02119819|530296195|FG002|Overall Study|Physician Decision|0|||
147036860|NCT02119819|530296196|FG003|Overall Study|Physician Decision|0|||
147036861|NCT02119819|530296197|FG004|Overall Study|Physician Decision|0|||
147036862|NCT02119819|530296198|FG005|Overall Study|Physician Decision|1|||
147036863|NCT02119819|530296193|FG000|Overall Study|Withdrawal by Subject|5|||
147036864|NCT02119819|530296194|FG001|Overall Study|Withdrawal by Subject|3|||
147036865|NCT02119819|530296195|FG002|Overall Study|Withdrawal by Subject|0|||
147036866|NCT02119819|530296196|FG003|Overall Study|Withdrawal by Subject|0|||
146849723|NCT02663518|529618859|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147036867|NCT02119819|530296197|FG004|Overall Study|Withdrawal by Subject|6|||
147036868|NCT02119819|530296198|FG005|Overall Study|Withdrawal by Subject|10|||
147036869|NCT02119819|530296193|FG000|Overall Study|Jury Duty|0|||
147036870|NCT02119819|530296194|FG001|Overall Study|Jury Duty|0|||
147036871|NCT02119819|530296195|FG002|Overall Study|Jury Duty|1|||
147036872|NCT02119819|530296196|FG003|Overall Study|Jury Duty|0|||
147036873|NCT02119819|530296197|FG004|Overall Study|Jury Duty|0|||
147036874|NCT02119819|530296198|FG005|Overall Study|Jury Duty|0|||
147036875|NCT02119819|530296193|FG000|Overall Study|Protocol Violation|0|||
147036876|NCT02119819|530296194|FG001|Overall Study|Protocol Violation|0|||
147036877|NCT02119819|530296195|FG002|Overall Study|Protocol Violation|0|||
147036878|NCT02119819|530296196|FG003|Overall Study|Protocol Violation|1|||
147036879|NCT02119819|530296197|FG004|Overall Study|Protocol Violation|0|||
147036880|NCT02119819|530296198|FG005|Overall Study|Protocol Violation|0|||
147036881|NCT02119819|530296193|FG000|Overall Study|Left the city to get a job|0|||
147036882|NCT02119819|530296194|FG001|Overall Study|Left the city to get a job|0|||
147036883|NCT02119819|530296195|FG002|Overall Study|Left the city to get a job|0|||
147036884|NCT02119819|530296196|FG003|Overall Study|Left the city to get a job|1|||
147036885|NCT02119819|530296197|FG004|Overall Study|Left the city to get a job|0|||
147036886|NCT02119819|530296198|FG005|Overall Study|Left the city to get a job|0|||
147036887|NCT02045147|530296199|FG000|Overall Study|Withdrawal by Subject|2|||
147036888|NCT02045147|530296200|FG001|Overall Study|Withdrawal by Subject|0|||
147036889|NCT02045147|530296201|FG002|Overall Study|Withdrawal by Subject|0|||
147036890|NCT02045147|530296202|FG003|Overall Study|Withdrawal by Subject|0|||
147036891|NCT02045147|530296203|FG004|Overall Study|Withdrawal by Subject|0|||
147036892|NCT02045147|530296204|FG005|Overall Study|Withdrawal by Subject|0|||
147036893|NCT02045147|530296205|FG006|Overall Study|Withdrawal by Subject|0|||
147036894|NCT02045147|530296206|FG007|Overall Study|Withdrawal by Subject|1|||
147036895|NCT02045147|530296199|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
147036896|NCT02045147|530296200|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
147036897|NCT02045147|530296201|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
147036898|NCT02045147|530296202|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
147036899|NCT02045147|530296203|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
147036900|NCT02045147|530296204|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
147036901|NCT02045147|530296205|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
147036902|NCT02045147|530296206|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
147036903|NCT04839692|530296207|FG000|Overall Study|Withdrawal by Subject|0|||
147036904|NCT04839692|530296208|FG001|Overall Study|Withdrawal by Subject|3|||
147036905|NCT04839692|530296207|FG000|Overall Study|Physician Decision|1|||
147036906|NCT04839692|530296208|FG001|Overall Study|Physician Decision|0|||
147036907|NCT02383810|530296209|FG000|Overall Study|Physician Decision|1|||
147036908|NCT02383810|530296210|FG001|Overall Study|Physician Decision|1|||
147036909|NCT02383810|530296211|FG002|Overall Study|Physician Decision|0|||
147036910|NCT02383810|530296212|FG003|Overall Study|Physician Decision|0|||
147036911|NCT02383810|530296213|FG004|Overall Study|Physician Decision|0|||
147036912|NCT02383810|530296214|FG005|Overall Study|Physician Decision|0|||
147036913|NCT02383810|530296215|FG006|Overall Study|Physician Decision|0|||
147036914|NCT02383810|530296216|FG007|Overall Study|Physician Decision|0|||
147036915|NCT02383810|530296209|FG000|Overall Study|Withdrawal by Subject|2|||
147036916|NCT02383810|530296210|FG001|Overall Study|Withdrawal by Subject|3|||
147036917|NCT02383810|530296211|FG002|Overall Study|Withdrawal by Subject|3|||
147036918|NCT02383810|530296212|FG003|Overall Study|Withdrawal by Subject|3|||
147036919|NCT02383810|530296213|FG004|Overall Study|Withdrawal by Subject|0|||
147036920|NCT02383810|530296214|FG005|Overall Study|Withdrawal by Subject|0|||
147036921|NCT02383810|530296215|FG006|Overall Study|Withdrawal by Subject|0|||
147036922|NCT02383810|530296216|FG007|Overall Study|Withdrawal by Subject|0|||
147036923|NCT02383810|530296209|FG000|Overall Study|Adverse Event|0|||
147036924|NCT02383810|530296210|FG001|Overall Study|Adverse Event|2|||
147036925|NCT02383810|530296211|FG002|Overall Study|Adverse Event|4|||
147036926|NCT02383810|530296212|FG003|Overall Study|Adverse Event|5|||
147036927|NCT02383810|530296213|FG004|Overall Study|Adverse Event|0|||
147036928|NCT02383810|530296214|FG005|Overall Study|Adverse Event|1|||
147036929|NCT02383810|530296215|FG006|Overall Study|Adverse Event|1|||
147036930|NCT02383810|530296216|FG007|Overall Study|Adverse Event|0|||
147036931|NCT02383810|530296209|FG000|Overall Study|Lost to Follow-up|0|||
147036932|NCT02383810|530296210|FG001|Overall Study|Lost to Follow-up|1|||
147036933|NCT02383810|530296211|FG002|Overall Study|Lost to Follow-up|0|||
147036934|NCT02383810|530296212|FG003|Overall Study|Lost to Follow-up|1|||
147036935|NCT02383810|530296213|FG004|Overall Study|Lost to Follow-up|0|||
147036936|NCT02383810|530296214|FG005|Overall Study|Lost to Follow-up|0|||
147036937|NCT02383810|530296215|FG006|Overall Study|Lost to Follow-up|0|||
147036938|NCT02383810|530296216|FG007|Overall Study|Lost to Follow-up|0|||
147036939|NCT02383810|530296209|FG000|Overall Study|other|0|||
147036940|NCT02383810|530296210|FG001|Overall Study|other|0|||
147036941|NCT02383810|530296211|FG002|Overall Study|other|0|||
147036942|NCT02383810|530296212|FG003|Overall Study|other|2|||
147036943|NCT02383810|530296213|FG004|Overall Study|other|0|||
147036944|NCT02383810|530296214|FG005|Overall Study|other|0|||
147036945|NCT02383810|530296215|FG006|Overall Study|other|0|||
147036946|NCT02383810|530296216|FG007|Overall Study|other|0|||
147036947|NCT02383810|530296209|FG000|Overall Study|subject did not receive study treatment|0|||
147036948|NCT02383810|530296210|FG001|Overall Study|subject did not receive study treatment|1|||
147036949|NCT02383810|530296211|FG002|Overall Study|subject did not receive study treatment|0|||
147036950|NCT02383810|530296212|FG003|Overall Study|subject did not receive study treatment|0|||
146849724|NCT02663518|529618860|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
147036951|NCT02383810|530296213|FG004|Overall Study|subject did not receive study treatment|0|||
147036952|NCT02383810|530296214|FG005|Overall Study|subject did not receive study treatment|0|||
147036953|NCT02383810|530296215|FG006|Overall Study|subject did not receive study treatment|0|||
147036954|NCT02383810|530296216|FG007|Overall Study|subject did not receive study treatment|0|||
147036955|NCT02861014|530296219|FG000|Primary Analysis|Adverse Event|7|||
147036956|NCT02861014|530296219|FG000|Primary Analysis|Death|1|||
147036957|NCT02861014|530296219|FG000|Primary Analysis|Lack of Efficacy|3|||
147036958|NCT02861014|530296219|FG000|Primary Analysis|Physician Decision|2|||
147036959|NCT02861014|530296219|FG000|Primary Analysis|Pregnancy|4|||
147036960|NCT02861014|530296219|FG000|Primary Analysis|Protocol Violation|2|||
147036961|NCT02861014|530296219|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
147036962|NCT02861014|530296219|FG000|Primary Analysis|Withdrawal by Subject|14|||
147036963|NCT02861014|530296219|FG000|Primary Analysis|Commercial ocrelizumab|3|||
147036964|NCT02861014|530296219|FG000|Safety Follow-up|Adverse Event|1|||
147036965|NCT02861014|530296219|FG000|Safety Follow-up|Pregnancy|1|||
147036966|NCT02861014|530296219|FG000|Safety Follow-up|Withdrawal by Subject|9|||
147036967|NCT02861014|530296219|FG000|Safety Follow-up|Study terminated by sponsor|1|||
147036968|NCT02861014|530296219|FG000|Safety Follow-up|Physician Decision|1|||
147036969|NCT02861014|530296219|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
147036970|NCT02861014|530296219|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
147036971|NCT03247816|530296220|FG000|Overall Study|Adverse Event|12|||
147036972|NCT03247816|530296220|FG000|Overall Study|Physician Decision|3|||
147036973|NCT03247816|530296220|FG000|Overall Study|Lack of Efficacy|1|||
147036974|NCT03247816|530296220|FG000|Overall Study|Lost to Follow-up|10|||
147036975|NCT03247816|530296220|FG000|Overall Study|Missing Feraccru stop date|3|||
147036976|NCT00926783|530296222|FG000|Overall Study|Incomplete CFAE Procedures|3|||
147036977|NCT00926783|530296223|FG001|Overall Study|Incomplete CFAE Procedures|3|||
147036978|NCT01439009|530296224|FG000|Overall Study|Physician Decision|5|||
147036979|NCT01439009|530296225|FG001|Overall Study|Physician Decision|3|||
147036980|NCT01439009|530296224|FG000|Overall Study|Protocol Violation|2|||
147036981|NCT01439009|530296225|FG001|Overall Study|Protocol Violation|0|||
147036982|NCT01439009|530296224|FG000|Overall Study|Deviation of exclusion criteria|1|||
147036983|NCT01439009|530296225|FG001|Overall Study|Deviation of exclusion criteria|0|||
147036984|NCT03257865|530296226|FG000|Overall Study|Adverse Event|4|||
147036985|NCT03257865|530296227|FG001|Overall Study|Adverse Event|8|||
147036986|NCT03257865|530296226|FG000|Overall Study|Lack of Efficacy|1|||
147036987|NCT03257865|530296227|FG001|Overall Study|Lack of Efficacy|2|||
147036988|NCT03257865|530296226|FG000|Overall Study|Non-compliance with Study Drug|0|||
147036989|NCT03257865|530296227|FG001|Overall Study|Non-compliance with Study Drug|2|||
147036990|NCT03257865|530296226|FG000|Overall Study|Withdrawal by Subject|23|||
147036991|NCT03257865|530296227|FG001|Overall Study|Withdrawal by Subject|17|||
147036992|NCT03257865|530296226|FG000|Overall Study|Physician Decision|3|||
147036993|NCT03257865|530296227|FG001|Overall Study|Physician Decision|1|||
147036994|NCT03257865|530296226|FG000|Overall Study|Other|0|||
147036995|NCT03257865|530296227|FG001|Overall Study|Other|1|||
147036996|NCT03257865|530296226|FG000|Overall Study|Lost to Follow-up|4|||
147036997|NCT03257865|530296227|FG001|Overall Study|Lost to Follow-up|4|||
147036998|NCT01292226|530296229|FG000|Overall Study|Adverse Event|5|||
147036999|NCT01292226|530296229|FG000|Overall Study|Death|1|||
147037000|NCT01292226|530296229|FG000|Overall Study|Graft loss|1|||
147037001|NCT01292226|530296229|FG000|Overall Study|Protocol Violation|3|||
147037002|NCT01292226|530296229|FG000|Overall Study|Withdrawal by Subject|1|||
147037003|NCT01292226|530296229|FG000|Overall Study|Other|2|||
147037004|NCT02288182|530296233|FG000|Overall Study|Adverse Event|0|||
147037005|NCT02288182|530296234|FG001|Overall Study|Adverse Event|1|||
147037006|NCT02288182|530296233|FG000|Overall Study|Lost to Follow-up|0|||
147037007|NCT02288182|530296234|FG001|Overall Study|Lost to Follow-up|1|||
147037008|NCT02823652|530296235|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
147037009|NCT02823652|530296236|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
147037010|NCT02823652|530296237|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
147037011|NCT02823652|530296235|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
147037012|NCT02823652|530296236|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
147037013|NCT02823652|530296237|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
147037014|NCT02823652|530296235|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
147037015|NCT02823652|530296236|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
147037016|NCT02823652|530296237|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
147037017|NCT02823652|530296235|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
147037018|NCT02823652|530296236|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
147037019|NCT02823652|530296237|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
147037020|NCT04619992|530296238|FG000|Overall Study|Withdrawal by Subject|1|||
147037021|NCT04619992|530296239|FG001|Overall Study|Withdrawal by Subject|0|||
147037022|NCT04428333|530296240|FG000|Overall Study|Physician Decision|5|||
147037023|NCT04428333|530296241|FG001|Overall Study|Physician Decision|6|||
147037024|NCT04428333|530296240|FG000|Overall Study|Withdrawal by Subject|1|||
147037025|NCT04428333|530296241|FG001|Overall Study|Withdrawal by Subject|3|||
147037026|NCT04428333|530296240|FG000|Overall Study|Study Terminated By Sponsor|14|||
147037027|NCT04428333|530296241|FG001|Overall Study|Study Terminated By Sponsor|16|||
146849725|NCT02663518|529618861|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147037028|NCT02269163|530296242|FG000|Overall Study|Lost to Follow-up|1|||
147037029|NCT02269163|530296243|FG001|Overall Study|Lost to Follow-up|0|||
147037030|NCT02269163|530296242|FG000|Overall Study|Major protocol violation|0|||
147037031|NCT02269163|530296243|FG001|Overall Study|Major protocol violation|1|||
147037032|NCT02269163|530296242|FG000|Overall Study|Other|2|||
147037033|NCT02269163|530296243|FG001|Overall Study|Other|2|||
147037034|NCT02269163|530296242|FG000|Overall Study|Withdrawal by Subject|0|||
147037035|NCT02269163|530296243|FG001|Overall Study|Withdrawal by Subject|3|||
147037036|NCT02269163|530296242|FG000|Overall Study|Physician Decision|0|||
147037037|NCT02269163|530296243|FG001|Overall Study|Physician Decision|1|||
147037038|NCT00758680|530296244|FG000|Overall Study|Adverse Event|0|||
147037039|NCT00758680|530296245|FG001|Overall Study|Adverse Event|0|||
147037040|NCT00758680|530296246|FG002|Overall Study|Adverse Event|0|||
147037041|NCT00758680|530296247|FG003|Overall Study|Adverse Event|0|||
147037042|NCT00758680|530296248|FG004|Overall Study|Adverse Event|0|||
147037043|NCT00758680|530296249|FG005|Overall Study|Adverse Event|0|||
147037044|NCT00758680|530296250|FG006|Overall Study|Adverse Event|0|||
147037045|NCT00758680|530296251|FG007|Overall Study|Adverse Event|1|||
147037046|NCT00758680|530296252|FG008|Overall Study|Adverse Event|0|||
147037047|NCT00758680|530296253|FG009|Overall Study|Adverse Event|1|||
147037048|NCT00758680|530296244|FG000|Overall Study|Laboratory Adverse Event|0|||
147037049|NCT00758680|530296245|FG001|Overall Study|Laboratory Adverse Event|0|||
147037050|NCT00758680|530296246|FG002|Overall Study|Laboratory Adverse Event|0|||
147037051|NCT00758680|530296247|FG003|Overall Study|Laboratory Adverse Event|0|||
147037052|NCT00758680|530296248|FG004|Overall Study|Laboratory Adverse Event|0|||
147037053|NCT00758680|530296249|FG005|Overall Study|Laboratory Adverse Event|0|||
147037054|NCT00758680|530296250|FG006|Overall Study|Laboratory Adverse Event|0|||
147037055|NCT00758680|530296251|FG007|Overall Study|Laboratory Adverse Event|0|||
147037056|NCT00758680|530296252|FG008|Overall Study|Laboratory Adverse Event|1|||
147037057|NCT00758680|530296253|FG009|Overall Study|Laboratory Adverse Event|0|||
147037058|NCT00758680|530296244|FG000|Overall Study|Withdrawal by Subject|0|||
147037059|NCT00758680|530296245|FG001|Overall Study|Withdrawal by Subject|0|||
147037060|NCT00758680|530296246|FG002|Overall Study|Withdrawal by Subject|0|||
147037061|NCT00758680|530296247|FG003|Overall Study|Withdrawal by Subject|0|||
147037062|NCT00758680|530296248|FG004|Overall Study|Withdrawal by Subject|0|||
147037063|NCT00758680|530296249|FG005|Overall Study|Withdrawal by Subject|0|||
147037064|NCT00758680|530296250|FG006|Overall Study|Withdrawal by Subject|1|||
147037065|NCT00758680|530296251|FG007|Overall Study|Withdrawal by Subject|0|||
147037066|NCT00758680|530296252|FG008|Overall Study|Withdrawal by Subject|1|||
147037067|NCT00758680|530296253|FG009|Overall Study|Withdrawal by Subject|0|||
147037068|NCT00319982|530296256|FG000|Overall Study|Withdrawal by Subject|1|||
147037069|NCT00319982|530296257|FG001|Overall Study|Withdrawal by Subject|0|||
147037070|NCT02351960|530296258|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
147037071|NCT02351960|530296259|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
147037072|NCT02351960|530296258|FG000|Overall Study|Voluntary Withdrawal|5|||
147037073|NCT02351960|530296259|FG001|Overall Study|Voluntary Withdrawal|4|||
147037074|NCT02351960|530296258|FG000|Overall Study|Significant Protocol Deviation|0|||
147037075|NCT02351960|530296259|FG001|Overall Study|Significant Protocol Deviation|5|||
147037076|NCT03480386|530296260|FG000|Overall Study|Did not complete measures at 3-months|17|||
147037077|NCT03480386|530296261|FG001|Overall Study|Did not complete measures at 3-months|14|||
147037078|NCT03480386|530296260|FG000|Overall Study|No baseline measures|11|||
147037079|NCT03480386|530296261|FG001|Overall Study|No baseline measures|14|||
147037080|NCT03480386|530296260|FG000|Overall Study|Death|0|||
147037081|NCT03480386|530296261|FG001|Overall Study|Death|5|||
147037082|NCT03480386|530296260|FG000|Overall Study|Withdrawal by Subject|12|||
146849726|NCT02663518|529618862|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
146849727|NCT02663518|529618863|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
146849728|NCT02663518|529618864|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
146849729|NCT02663518|529618851|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
146849730|NCT02663518|529618852|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
147037083|NCT03480386|530296261|FG001|Overall Study|Withdrawal by Subject|8|||
147037084|NCT03480386|530296260|FG000|Overall Study|Lost to Follow-up|2|||
147037085|NCT03480386|530296261|FG001|Overall Study|Lost to Follow-up|1|||
147037086|NCT03480386|530296260|FG000|Overall Study|Complicating disease|0|||
146849731|NCT02663518|529618853|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
147037087|NCT03480386|530296261|FG001|Overall Study|Complicating disease|1|||
147037088|NCT03480386|530296260|FG000|Overall Study|Disease progression|3|||
147037089|NCT03480386|530296261|FG001|Overall Study|Disease progression|0|||
147037090|NCT03480386|530296260|FG000|Overall Study|Became ineligible|0|||
147037091|NCT03480386|530296261|FG001|Overall Study|Became ineligible|2|||
146849732|NCT02663518|529618854|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
147037092|NCT00574912|530296262|FG000|Overall Study|Could not place IV lines.|3|||
147037093|NCT00574912|530296262|FG000|Overall Study|scheduling conflicts|3|||
147037094|NCT00574912|530296262|FG000|Overall Study|Physician Decision|2|||
147037095|NCT00638027|530296266|FG000|Overall Study|Adverse Event|0|||
147037096|NCT00638027|530296267|FG001|Overall Study|Adverse Event|2|||
147037097|NCT03014180|530296268|FG000|Overall Study|Protocol Violation|2|||
147037098|NCT01284621|530296269|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
147037099|NCT01284621|530296270|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
147037100|NCT01284621|530296271|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
147037101|NCT01284621|530296272|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
147037102|NCT01284621|530296273|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
147037103|NCT01284621|530296274|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
147037104|NCT02099682|530296277|FG000|Overall Study|Data Not Available|51|||
147037105|NCT02099682|530296277|FG000|Overall Study|Lost to Follow-up|31|||
147037106|NCT02099682|530296277|FG000|Overall Study|Other|29|||
147037107|NCT02802631|530296278|FG000|Overall Study|Withdrawal by Subject|1|||
147037108|NCT02802631|530296279|FG001|Overall Study|Withdrawal by Subject|0|||
147037109|NCT02802631|530296280|FG002|Overall Study|Withdrawal by Subject|0|||
147037110|NCT02802631|530296281|FG003|Overall Study|Withdrawal by Subject|0|||
147037111|NCT02802631|530296282|FG004|Overall Study|Withdrawal by Subject|0|||
147037112|NCT02802631|530296283|FG005|Overall Study|Withdrawal by Subject|0|||
147037113|NCT02802631|530296284|FG006|Overall Study|Withdrawal by Subject|0|||
147037114|NCT02802631|530296285|FG007|Overall Study|Withdrawal by Subject|0|||
147037115|NCT02802631|530296278|FG000|Overall Study|Physician Decision|1|||
147037116|NCT02802631|530296279|FG001|Overall Study|Physician Decision|0|||
147037117|NCT02802631|530296280|FG002|Overall Study|Physician Decision|0|||
147037118|NCT02802631|530296281|FG003|Overall Study|Physician Decision|0|||
147037119|NCT02802631|530296282|FG004|Overall Study|Physician Decision|0|||
147037120|NCT02802631|530296283|FG005|Overall Study|Physician Decision|0|||
147037121|NCT02802631|530296284|FG006|Overall Study|Physician Decision|1|||
147037122|NCT02802631|530296285|FG007|Overall Study|Physician Decision|0|||
147037123|NCT02802631|530296278|FG000|Overall Study|Adverse Event|0|||
147037124|NCT02802631|530296279|FG001|Overall Study|Adverse Event|2|||
147037125|NCT02802631|530296280|FG002|Overall Study|Adverse Event|0|||
147037126|NCT02802631|530296281|FG003|Overall Study|Adverse Event|1|||
147037127|NCT02802631|530296282|FG004|Overall Study|Adverse Event|6|||
147037128|NCT02802631|530296283|FG005|Overall Study|Adverse Event|1|||
147037129|NCT02802631|530296284|FG006|Overall Study|Adverse Event|4|||
147037130|NCT02802631|530296285|FG007|Overall Study|Adverse Event|0|||
147037131|NCT02802631|530296278|FG000|Overall Study|Sponsor Decision|0|||
147037132|NCT02802631|530296279|FG001|Overall Study|Sponsor Decision|0|||
147037133|NCT02802631|530296280|FG002|Overall Study|Sponsor Decision|6|||
147037134|NCT02802631|530296281|FG003|Overall Study|Sponsor Decision|0|||
147037135|NCT02802631|530296282|FG004|Overall Study|Sponsor Decision|2|||
147037136|NCT02802631|530296283|FG005|Overall Study|Sponsor Decision|0|||
147037137|NCT02802631|530296284|FG006|Overall Study|Sponsor Decision|0|||
147037138|NCT02802631|530296285|FG007|Overall Study|Sponsor Decision|4|||
147037139|NCT02377427|530296286|FG000|Part A (Up to Week 20)|Physician Decision|1|||
147037140|NCT02377427|530296287|FG001|Part A (Up to Week 20)|Physician Decision|0|||
147037141|NCT02377427|530296288|FG002|Part A (Up to Week 20)|Physician Decision|0|||
147037142|NCT02377427|530296289|FG003|Part A (Up to Week 20)|Physician Decision|0|||
147037143|NCT02377427|530296290|FG004|Part A (Up to Week 20)|Physician Decision|0|||
147037144|NCT02377427|530296286|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
147037145|NCT02377427|530296287|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
147037146|NCT02377427|530296288|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
147037147|NCT02377427|530296289|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
147037148|NCT02377427|530296290|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
147037149|NCT02377427|530296286|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
147037150|NCT02377427|530296287|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
147037151|NCT02377427|530296288|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
147037152|NCT02377427|530296289|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
147037153|NCT02377427|530296290|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
147037154|NCT02377427|530296286|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
147037155|NCT02377427|530296287|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
147037156|NCT02377427|530296288|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
147037157|NCT02377427|530296289|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
147037158|NCT02377427|530296290|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
147037159|NCT02293863|530296291|FG000|Overall Study|Death|4|||
147037160|NCT02293863|530296292|FG001|Overall Study|Death|6|||
147037161|NCT02293863|530296293|FG002|Overall Study|Death|4|||
147037162|NCT02293863|530296291|FG000|Overall Study|Lost to Follow-up|2|||
147037163|NCT02293863|530296292|FG001|Overall Study|Lost to Follow-up|2|||
147037164|NCT02293863|530296293|FG002|Overall Study|Lost to Follow-up|2|||
147037165|NCT02293863|530296291|FG000|Overall Study|Withdrawal by Subject|3|||
147037166|NCT02293863|530296292|FG001|Overall Study|Withdrawal by Subject|3|||
147037167|NCT02293863|530296293|FG002|Overall Study|Withdrawal by Subject|1|||
147037168|NCT02293863|530296291|FG000|Overall Study|Reason Not Specified|0|||
146849733|NCT02663518|529618855|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
147037169|NCT02293863|530296292|FG001|Overall Study|Reason Not Specified|2|||
147037170|NCT02293863|530296293|FG002|Overall Study|Reason Not Specified|2|||
147037171|NCT02342639|530296294|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
147037172|NCT02342639|530296295|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
147037173|NCT02342639|530296294|FG000|Overall Study|Protocol Violation|0|||
147037174|NCT02342639|530296295|FG001|Overall Study|Protocol Violation|2|||
147037175|NCT00416884|530296298|FG000|Overall Study|Study terminated due to low accrual|1|||
147037176|NCT00704730|530296299|FG000|Overall Study|Adverse Event|35|||
147037177|NCT00704730|530296300|FG001|Overall Study|Adverse Event|9|||
147037178|NCT00704730|530296299|FG000|Overall Study|Death|11|||
147037179|NCT00704730|530296300|FG001|Overall Study|Death|5|||
147037180|NCT00704730|530296299|FG000|Overall Study|Physician Decision|2|||
147037181|NCT00704730|530296300|FG001|Overall Study|Physician Decision|0|||
147037182|NCT00704730|530296299|FG000|Overall Study|Did not receive drug|5|||
147037183|NCT00704730|530296300|FG001|Overall Study|Did not receive drug|2|||
147037184|NCT00704730|530296299|FG000|Overall Study|Disease progression per PI|58|||
147037185|NCT00704730|530296300|FG001|Overall Study|Disease progression per PI|67|||
147037186|NCT00704730|530296299|FG000|Overall Study|data unavailable|1|||
147037187|NCT00704730|530296300|FG001|Overall Study|data unavailable|0|||
147037188|NCT00704730|530296299|FG000|Overall Study|Withdrawal by Subject|9|||
147037189|NCT00704730|530296300|FG001|Overall Study|Withdrawal by Subject|13|||
147037190|NCT03395405|530297921|FG000|Overall Study|Death|0|||
147037191|NCT03395405|530297922|FG001|Overall Study|Death|2|||
147037192|NCT03395405|530297921|FG000|Overall Study|Lost to Follow-up|0|||
147037193|NCT03395405|530297922|FG001|Overall Study|Lost to Follow-up|1|||
147037194|NCT03395405|530297921|FG000|Overall Study|Protocol Violation|0|||
147037195|NCT03395405|530297922|FG001|Overall Study|Protocol Violation|1|||
147037196|NCT03395405|530297921|FG000|Overall Study|Withdrawal by Subject|3|||
147037197|NCT03395405|530297922|FG001|Overall Study|Withdrawal by Subject|1|||
147037198|NCT03395405|530297921|FG000|Overall Study|COVID-19 Pandemic|1|||
147037199|NCT03395405|530297922|FG001|Overall Study|COVID-19 Pandemic|0|||
147037200|NCT00213135|530297927|FG000|Overall Study|Adverse Event|9|||
147037201|NCT00213135|530297928|FG001|Overall Study|Adverse Event|5|||
147037202|NCT00213135|530297929|FG002|Overall Study|Adverse Event|5|||
147037203|NCT00213135|530297927|FG000|Overall Study|Lost to Follow-up|11|||
147037204|NCT00213135|530297928|FG001|Overall Study|Lost to Follow-up|8|||
147037205|NCT00213135|530297929|FG002|Overall Study|Lost to Follow-up|4|||
147037206|NCT00213135|530297927|FG000|Overall Study|Protocol Violation|4|||
147037207|NCT00213135|530297928|FG001|Overall Study|Protocol Violation|4|||
147037208|NCT00213135|530297929|FG002|Overall Study|Protocol Violation|10|||
147037209|NCT00213135|530297927|FG000|Overall Study|Death|1|||
147037210|NCT00213135|530297928|FG001|Overall Study|Death|1|||
147037211|NCT00213135|530297929|FG002|Overall Study|Death|2|||
147037212|NCT00213135|530297927|FG000|Overall Study|Disease progression|4|||
147037213|NCT00213135|530297928|FG001|Overall Study|Disease progression|5|||
147037214|NCT00213135|530297929|FG002|Overall Study|Disease progression|21|||
147037215|NCT00213135|530297927|FG000|Overall Study|Other|21|||
147037216|NCT00213135|530297928|FG001|Overall Study|Other|12|||
147037217|NCT00213135|530297929|FG002|Overall Study|Other|15|||
147037218|NCT01908907|530297933|FG000|Overall Study|Physician Decision|1|||
147037219|NCT01908907|530297934|FG001|Overall Study|Physician Decision|0|||
147037220|NCT01908907|530297933|FG000|Overall Study|Protocol Violation|1|||
147037221|NCT01908907|530297934|FG001|Overall Study|Protocol Violation|0|||
147037222|NCT00660907|530297935|FG000|Overall Study|Incorrect Enrollment|1|||
147037223|NCT00660907|530297936|FG001|Overall Study|Incorrect Enrollment|1|||
147037224|NCT00660907|530297935|FG000|Overall Study|Adverse Event|33|||
147037225|NCT00660907|530297936|FG001|Overall Study|Adverse Event|19|||
147037226|NCT00660907|530297935|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
147037227|NCT00660907|530297936|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
147037228|NCT00660907|530297935|FG000|Overall Study|Withdrawal by Subject|23|||
147037229|NCT00660907|530297936|FG001|Overall Study|Withdrawal by Subject|32|||
147037230|NCT00660907|530297935|FG000|Overall Study|Lost to Follow-up|3|||
147037231|NCT00660907|530297936|FG001|Overall Study|Lost to Follow-up|3|||
147037232|NCT00660907|530297935|FG000|Overall Study|Poor/Non-Compliance|5|||
147037233|NCT00660907|530297936|FG001|Overall Study|Poor/Non-Compliance|1|||
147037234|NCT00660907|530297935|FG000|Overall Study|Safety|1|||
147037235|NCT00660907|530297936|FG001|Overall Study|Safety|0|||
147037236|NCT00660907|530297935|FG000|Overall Study|Death|1|||
147037237|NCT00660907|530297936|FG001|Overall Study|Death|3|||
147037238|NCT00660907|530297935|FG000|Overall Study|Various|11|||
147037239|NCT00660907|530297936|FG001|Overall Study|Various|8|||
147037240|NCT04975191|530297937|FG000|Overall Study|Protocol Violation|1|||
147037241|NCT04975191|530297938|FG001|Overall Study|Protocol Violation|2|||
147037242|NCT04975191|530297939|FG002|Overall Study|Protocol Violation|2|||
147037243|NCT04975191|530297940|FG003|Overall Study|Protocol Violation|2|||
147037244|NCT04975191|530297937|FG000|Overall Study|Lost to Follow-up|13|||
147037245|NCT04975191|530297938|FG001|Overall Study|Lost to Follow-up|3|||
147037246|NCT04975191|530297939|FG002|Overall Study|Lost to Follow-up|8|||
147037247|NCT04975191|530297940|FG003|Overall Study|Lost to Follow-up|8|||
147037248|NCT00761657|530297943|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
147037249|NCT00761657|530297944|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
147037250|NCT00761657|530297945|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
147037251|NCT00761657|530297946|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
147037252|NCT00761657|530297947|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
147037253|NCT00761657|530297948|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
147037254|NCT00761657|530297949|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
147037255|NCT00761657|530297950|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
147037256|NCT00761657|530297951|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
147037257|NCT00761657|530297943|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
147037258|NCT00761657|530297944|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
147037259|NCT00761657|530297945|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
147037260|NCT00761657|530297946|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
147037261|NCT00761657|530297947|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
147037262|NCT00761657|530297948|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
147037263|NCT00761657|530297949|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
147037264|NCT00761657|530297950|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
147037265|NCT00761657|530297951|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
147037266|NCT00761657|530297943|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
147037267|NCT00761657|530297944|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
147037268|NCT00761657|530297945|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
147037269|NCT00761657|530297946|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
147037270|NCT00761657|530297947|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
147037271|NCT00761657|530297948|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
147037272|NCT00761657|530297949|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
147037273|NCT00761657|530297950|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
147037274|NCT00761657|530297951|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
147037275|NCT00761657|530297943|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
147037276|NCT00761657|530297944|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
147037277|NCT00761657|530297945|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
147037278|NCT00761657|530297946|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
147037279|NCT00761657|530297947|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
147037280|NCT00761657|530297948|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
147037281|NCT00761657|530297949|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
147037282|NCT00761657|530297950|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
147037283|NCT00761657|530297951|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
147037284|NCT00359801|530297959|FG000|Overall Study|Lost to Follow-up|72|||
147037285|NCT00359801|530297960|FG001|Overall Study|Lost to Follow-up|58|||
147037286|NCT00359801|530297959|FG000|Overall Study|Withdrawal by Subject|143|||
147037287|NCT00359801|530297960|FG001|Overall Study|Withdrawal by Subject|96|||
147037288|NCT00359801|530297959|FG000|Overall Study|Other|66|||
147037289|NCT00359801|530297960|FG001|Overall Study|Other|46|||
147037290|NCT00359801|530297959|FG000|Overall Study|Final Status Unknown: missing data|7|||
147037291|NCT00359801|530297960|FG001|Overall Study|Final Status Unknown: missing data|4|||
147037292|NCT00359801|530297959|FG000|Overall Study|Sponsor Decision|17|||
147037293|NCT00359801|530297960|FG001|Overall Study|Sponsor Decision|16|||
147037294|NCT02929056|530297966|FG000|Overall Study|Lost to Follow-up|0|||
147037295|NCT02929056|530297967|FG001|Overall Study|Lost to Follow-up|1|||
147037296|NCT02245412|530297968|FG000|Treatment Period|Death|1|||
147037297|NCT02245412|530297969|FG001|Treatment Period|Death|1|||
147037298|NCT02245412|530297970|FG002|Treatment Period|Death|0|||
147037299|NCT02245412|530297968|FG000|Treatment Period|Physician Decision|1|||
147037300|NCT02245412|530297969|FG001|Treatment Period|Physician Decision|1|||
147037301|NCT02245412|530297970|FG002|Treatment Period|Physician Decision|0|||
147037302|NCT02245412|530297968|FG000|Treatment Period|Withdrawal by Subject|2|||
147037303|NCT02245412|530297969|FG001|Treatment Period|Withdrawal by Subject|1|||
147037304|NCT02245412|530297970|FG002|Treatment Period|Withdrawal by Subject|0|||
147037305|NCT02245412|530297968|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
147037306|NCT02245412|530297969|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
147037307|NCT02245412|530297970|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
147037308|NCT02245412|530297968|FG000|Follow-Up Period|Death|4|||
147037309|NCT02245412|530297969|FG001|Follow-Up Period|Death|2|||
147037310|NCT02245412|530297970|FG002|Follow-Up Period|Death|1|||
147037311|NCT02245412|530297968|FG000|Follow-Up Period|Physician Decision|1|||
147037312|NCT02245412|530297969|FG001|Follow-Up Period|Physician Decision|0|||
147037313|NCT02245412|530297970|FG002|Follow-Up Period|Physician Decision|0|||
147037314|NCT02245412|530297968|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
147037315|NCT02245412|530297969|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
147037316|NCT02245412|530297970|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
147037317|NCT01056289|530297974|FG000|Open-label Phase|Adverse Event|29|||
147037318|NCT01056289|530297975|FG001|Open-label Phase|Adverse Event|0|||
147037319|NCT01056289|530297976|FG002|Open-label Phase|Adverse Event|0|||
147037320|NCT01056289|530297977|FG003|Open-label Phase|Adverse Event|0|||
147037321|NCT01056289|530297974|FG000|Open-label Phase|Lost to Follow-up|30|||
147037322|NCT01056289|530297975|FG001|Open-label Phase|Lost to Follow-up|0|||
147037323|NCT01056289|530297976|FG002|Open-label Phase|Lost to Follow-up|0|||
147037324|NCT01056289|530297977|FG003|Open-label Phase|Lost to Follow-up|0|||
147037325|NCT01056289|530297974|FG000|Open-label Phase|Other|9|||
147037326|NCT01056289|530297975|FG001|Open-label Phase|Other|0|||
147037327|NCT01056289|530297976|FG002|Open-label Phase|Other|0|||
147037328|NCT01056289|530297977|FG003|Open-label Phase|Other|0|||
147037329|NCT01056289|530297974|FG000|Open-label Phase|Protocol Violation|6|||
147037330|NCT01056289|530297975|FG001|Open-label Phase|Protocol Violation|0|||
147037331|NCT01056289|530297976|FG002|Open-label Phase|Protocol Violation|0|||
147037332|NCT01056289|530297977|FG003|Open-label Phase|Protocol Violation|0|||
147037333|NCT01056289|530297974|FG000|Open-label Phase|Withdrawal by Subject|26|||
147037334|NCT01056289|530297975|FG001|Open-label Phase|Withdrawal by Subject|0|||
147037335|NCT01056289|530297976|FG002|Open-label Phase|Withdrawal by Subject|0|||
147037336|NCT01056289|530297977|FG003|Open-label Phase|Withdrawal by Subject|0|||
147037337|NCT01056289|530297974|FG000|Open-label Phase|Lack of Efficacy|18|||
147037338|NCT01056289|530297975|FG001|Open-label Phase|Lack of Efficacy|0|||
147037339|NCT01056289|530297976|FG002|Open-label Phase|Lack of Efficacy|0|||
147037340|NCT01056289|530297977|FG003|Open-label Phase|Lack of Efficacy|0|||
147037341|NCT01056289|530297974|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
147037342|NCT01056289|530297975|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
147037343|NCT01056289|530297976|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
147037344|NCT01056289|530297977|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
147037345|NCT01056289|530297974|FG000|Double-blind Phase|Adverse Event|0|||
147037346|NCT01056289|530297975|FG001|Double-blind Phase|Adverse Event|1|||
147037347|NCT01056289|530297976|FG002|Double-blind Phase|Adverse Event|2|||
147037348|NCT01056289|530297977|FG003|Double-blind Phase|Adverse Event|1|||
147037349|NCT01056289|530297974|FG000|Double-blind Phase|Lost to Follow-up|0|||
147037350|NCT01056289|530297975|FG001|Double-blind Phase|Lost to Follow-up|2|||
147037351|NCT01056289|530297976|FG002|Double-blind Phase|Lost to Follow-up|2|||
147037352|NCT01056289|530297977|FG003|Double-blind Phase|Lost to Follow-up|2|||
147037353|NCT01056289|530297974|FG000|Double-blind Phase|Other|0|||
147037354|NCT01056289|530297975|FG001|Double-blind Phase|Other|0|||
147037355|NCT01056289|530297976|FG002|Double-blind Phase|Other|1|||
147037356|NCT01056289|530297977|FG003|Double-blind Phase|Other|2|||
147037357|NCT01056289|530297974|FG000|Double-blind Phase|Protocol Violation|0|||
147037358|NCT01056289|530297975|FG001|Double-blind Phase|Protocol Violation|0|||
147037359|NCT01056289|530297976|FG002|Double-blind Phase|Protocol Violation|1|||
147037360|NCT01056289|530297977|FG003|Double-blind Phase|Protocol Violation|1|||
147037361|NCT01056289|530297974|FG000|Double-blind Phase|Withdrawal by Subject|0|||
147037362|NCT01056289|530297975|FG001|Double-blind Phase|Withdrawal by Subject|0|||
147037363|NCT01056289|530297976|FG002|Double-blind Phase|Withdrawal by Subject|4|||
147037364|NCT01056289|530297977|FG003|Double-blind Phase|Withdrawal by Subject|2|||
147037365|NCT01056289|530297974|FG000|Double-blind Phase|Discontinuation symptom|0|||
147037366|NCT01056289|530297975|FG001|Double-blind Phase|Discontinuation symptom|1|||
147037367|NCT01056289|530297976|FG002|Double-blind Phase|Discontinuation symptom|2|||
147037368|NCT01056289|530297977|FG003|Double-blind Phase|Discontinuation symptom|2|||
147037369|NCT01056289|530297974|FG000|Double-blind Phase|Physician Decision|0|||
147037370|NCT01056289|530297975|FG001|Double-blind Phase|Physician Decision|0|||
147037371|NCT01056289|530297976|FG002|Double-blind Phase|Physician Decision|1|||
147037372|NCT01056289|530297977|FG003|Double-blind Phase|Physician Decision|0|||
147037373|NCT00270855|530297986|FG000|Overall Study|Withdrawal by Subject|8|||
147037374|NCT00270855|530297987|FG001|Overall Study|Withdrawal by Subject|8|||
147037375|NCT00450801|530297990|FG000|Overall Study|Death|1|||
147037376|NCT01396512|530297993|FG000|Overall Study|Withdrawal by Subject|0|||
147037377|NCT01396512|530297994|FG001|Overall Study|Withdrawal by Subject|1|||
147037378|NCT02618759|530297997|FG000|Overall Study|Lost to Follow-up|0|||
147037379|NCT02618759|530297998|FG001|Overall Study|Lost to Follow-up|1|||
147037380|NCT02618759|530297997|FG000|Overall Study|Withdrawal by Subject|1|||
147037381|NCT02618759|530297998|FG001|Overall Study|Withdrawal by Subject|0|||
147037382|NCT02618759|530297997|FG000|Overall Study|Other Reasons|1|||
147037383|NCT02618759|530297998|FG001|Overall Study|Other Reasons|4|||
147037384|NCT02152605|530297999|FG000|Overall Study|Adverse Event|6|||
147037385|NCT02152605|530298000|FG001|Overall Study|Adverse Event|8|||
147037386|NCT02152605|530297999|FG000|Overall Study|Lack of Efficacy|7|||
147037387|NCT02152605|530298000|FG001|Overall Study|Lack of Efficacy|4|||
147037388|NCT02152605|530297999|FG000|Overall Study|Protocol deviation|1|||
147037389|NCT02152605|530298000|FG001|Overall Study|Protocol deviation|4|||
147037390|NCT02152605|530297999|FG000|Overall Study|Lost to Follow-up|1|||
147037391|NCT02152605|530298000|FG001|Overall Study|Lost to Follow-up|0|||
147037392|NCT02152605|530297999|FG000|Overall Study|Withdrew consent|4|||
147037393|NCT02152605|530298000|FG001|Overall Study|Withdrew consent|2|||
147037394|NCT02500043|530298007|FG000|Overall Study|Randomized, but not Treated|2|||
147037395|NCT02500043|530298008|FG001|Overall Study|Randomized, but not Treated|2|||
147037396|NCT02500043|530298007|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
147037397|NCT02500043|530298008|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
147037398|NCT02500043|530298007|FG000|Overall Study|Adverse Event|33|||
147037399|NCT02500043|530298008|FG001|Overall Study|Adverse Event|11|||
147037400|NCT02500043|530298007|FG000|Overall Study|Clinical Progression|54|||
147037401|NCT02500043|530298008|FG001|Overall Study|Clinical Progression|35|||
147037402|NCT02500043|530298007|FG000|Overall Study|Radiological Progression|192|||
147037403|NCT02500043|530298008|FG001|Overall Study|Radiological Progression|110|||
147037404|NCT02500043|530298007|FG000|Overall Study|Physician's Decision|11|||
147037405|NCT02500043|530298008|FG001|Overall Study|Physician's Decision|3|||
147037406|NCT02500043|530298007|FG000|Overall Study|Withdrawal by Subject|14|||
147037407|NCT02500043|530298008|FG001|Overall Study|Withdrawal by Subject|4|||
147037408|NCT02500043|530298007|FG000|Overall Study|Death|11|||
147037409|NCT02500043|530298008|FG001|Overall Study|Death|2|||
147037410|NCT02500043|530298007|FG000|Overall Study|Protocol Deviation|1|||
147037411|NCT02500043|530298008|FG001|Overall Study|Protocol Deviation|0|||
147037412|NCT01371747|530298009|FG000|Overall Study|Adverse Event|4|||
147037413|NCT01371747|530298010|FG001|Overall Study|Adverse Event|2|||
147037414|NCT01371747|530298011|FG002|Overall Study|Adverse Event|7|||
147037415|NCT01371747|530298012|FG003|Overall Study|Adverse Event|2|||
147037416|NCT01371747|530298013|FG004|Overall Study|Adverse Event|2|||
147037417|NCT01371747|530298014|FG005|Overall Study|Adverse Event|2|||
147037418|NCT01371747|530298009|FG000|Overall Study|Death|1|||
147037419|NCT01371747|530298010|FG001|Overall Study|Death|0|||
147037420|NCT01371747|530298011|FG002|Overall Study|Death|4|||
147037421|NCT01371747|530298012|FG003|Overall Study|Death|1|||
147037422|NCT01371747|530298013|FG004|Overall Study|Death|2|||
147037423|NCT01371747|530298014|FG005|Overall Study|Death|0|||
147037424|NCT01371747|530298009|FG000|Overall Study|Abnormal Renal Function|0|||
147037425|NCT01371747|530298010|FG001|Overall Study|Abnormal Renal Function|2|||
147037426|NCT01371747|530298011|FG002|Overall Study|Abnormal Renal Function|0|||
147037427|NCT01371747|530298012|FG003|Overall Study|Abnormal Renal Function|1|||
147037428|NCT01371747|530298013|FG004|Overall Study|Abnormal Renal Function|0|||
147037429|NCT01371747|530298014|FG005|Overall Study|Abnormal Renal Function|1|||
147037430|NCT01371747|530298009|FG000|Overall Study|High Serum Potassium Results|1|||
147037431|NCT01371747|530298010|FG001|Overall Study|High Serum Potassium Results|1|||
147037432|NCT01371747|530298011|FG002|Overall Study|High Serum Potassium Results|1|||
147037433|NCT01371747|530298012|FG003|Overall Study|High Serum Potassium Results|2|||
147037434|NCT01371747|530298013|FG004|Overall Study|High Serum Potassium Results|0|||
147037435|NCT01371747|530298014|FG005|Overall Study|High Serum Potassium Results|2|||
147037436|NCT01371747|530298009|FG000|Overall Study|Low Serum Potassium Results|1|||
147037437|NCT01371747|530298010|FG001|Overall Study|Low Serum Potassium Results|1|||
147037438|NCT01371747|530298011|FG002|Overall Study|Low Serum Potassium Results|1|||
147037439|NCT01371747|530298012|FG003|Overall Study|Low Serum Potassium Results|1|||
147037440|NCT01371747|530298013|FG004|Overall Study|Low Serum Potassium Results|0|||
147037441|NCT01371747|530298014|FG005|Overall Study|Low Serum Potassium Results|3|||
147037442|NCT01371747|530298009|FG000|Overall Study|Protocol Violation|0|||
147037443|NCT01371747|530298010|FG001|Overall Study|Protocol Violation|0|||
147037444|NCT01371747|530298011|FG002|Overall Study|Protocol Violation|1|||
147037445|NCT01371747|530298012|FG003|Overall Study|Protocol Violation|0|||
147037446|NCT01371747|530298013|FG004|Overall Study|Protocol Violation|0|||
147037447|NCT01371747|530298014|FG005|Overall Study|Protocol Violation|0|||
147037448|NCT01371747|530298009|FG000|Overall Study|Non-Compliance|3|||
147037449|NCT01371747|530298010|FG001|Overall Study|Non-Compliance|4|||
147037450|NCT01371747|530298011|FG002|Overall Study|Non-Compliance|3|||
147037451|NCT01371747|530298012|FG003|Overall Study|Non-Compliance|0|||
147037452|NCT01371747|530298013|FG004|Overall Study|Non-Compliance|0|||
147037453|NCT01371747|530298014|FG005|Overall Study|Non-Compliance|1|||
147037454|NCT01371747|530298009|FG000|Overall Study|Physician Decision|0|||
147037455|NCT01371747|530298010|FG001|Overall Study|Physician Decision|0|||
147037456|NCT01371747|530298011|FG002|Overall Study|Physician Decision|0|||
147037457|NCT01371747|530298012|FG003|Overall Study|Physician Decision|0|||
147037458|NCT01371747|530298013|FG004|Overall Study|Physician Decision|1|||
147037459|NCT01371747|530298014|FG005|Overall Study|Physician Decision|0|||
147037460|NCT01371747|530298009|FG000|Overall Study|Withdrawal by Subject|6|||
147037461|NCT01371747|530298010|FG001|Overall Study|Withdrawal by Subject|12|||
147037462|NCT01371747|530298011|FG002|Overall Study|Withdrawal by Subject|5|||
147037463|NCT01371747|530298012|FG003|Overall Study|Withdrawal by Subject|2|||
147037464|NCT01371747|530298013|FG004|Overall Study|Withdrawal by Subject|2|||
147037465|NCT01371747|530298014|FG005|Overall Study|Withdrawal by Subject|4|||
147037466|NCT01371747|530298009|FG000|Overall Study|Other Reasons|2|||
147037467|NCT01371747|530298010|FG001|Overall Study|Other Reasons|1|||
147037468|NCT01371747|530298011|FG002|Overall Study|Other Reasons|2|||
146849734|NCT02663518|529618856|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
146849735|NCT02663518|529618857|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
146849736|NCT02663518|529618858|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
147037469|NCT01371747|530298012|FG003|Overall Study|Other Reasons|0|||
147037470|NCT01371747|530298013|FG004|Overall Study|Other Reasons|0|||
147037471|NCT01371747|530298014|FG005|Overall Study|Other Reasons|1|||
147037472|NCT02856555|530298018|FG000|Overall Study|Adverse Event|1|||
147037473|NCT02856555|530298019|FG001|Overall Study|Adverse Event|0|||
147037474|NCT02856555|530298020|FG002|Overall Study|Adverse Event|0|||
147037475|NCT02856555|530298018|FG000|Overall Study|Lost to Follow-up|1|||
147037476|NCT02856555|530298019|FG001|Overall Study|Lost to Follow-up|3|||
147037477|NCT02856555|530298020|FG002|Overall Study|Lost to Follow-up|0|||
147037478|NCT02856555|530298018|FG000|Overall Study|Withdrawal by Subject|3|||
147037479|NCT02856555|530298019|FG001|Overall Study|Withdrawal by Subject|0|||
147037480|NCT02856555|530298020|FG002|Overall Study|Withdrawal by Subject|0|||
147037481|NCT02856555|530298018|FG000|Overall Study|Randomized but Never Treated|0|||
147037482|NCT02856555|530298019|FG001|Overall Study|Randomized but Never Treated|1|||
147037483|NCT02856555|530298020|FG002|Overall Study|Randomized but Never Treated|0|||
147037484|NCT02094417|530298021|FG000|Overall Study|Adverse Event|0|||
147037485|NCT02094417|530298022|FG001|Overall Study|Adverse Event|0|||
147037486|NCT02094417|530298023|FG002|Overall Study|Adverse Event|0|||
147037487|NCT02094417|530298024|FG003|Overall Study|Adverse Event|1|||
147037488|NCT02094417|530298021|FG000|Overall Study|Eligibility criteria|0|||
147037489|NCT02094417|530298022|FG001|Overall Study|Eligibility criteria|1|||
147037490|NCT02094417|530298023|FG002|Overall Study|Eligibility criteria|0|||
147037491|NCT02094417|530298024|FG003|Overall Study|Eligibility criteria|0|||
147037492|NCT02094417|530298021|FG000|Overall Study|No responder|4|||
147037493|NCT02094417|530298022|FG001|Overall Study|No responder|4|||
147037494|NCT02094417|530298023|FG002|Overall Study|No responder|4|||
147037495|NCT02094417|530298024|FG003|Overall Study|No responder|3|||
147037496|NCT02094417|530298021|FG000|Overall Study|Unable to conduct observations or assess|0|||
147037497|NCT02094417|530298022|FG001|Overall Study|Unable to conduct observations or assess|1|||
147037498|NCT02094417|530298023|FG002|Overall Study|Unable to conduct observations or assess|0|||
147037499|NCT02094417|530298024|FG003|Overall Study|Unable to conduct observations or assess|0|||
147037500|NCT02094417|530298021|FG000|Overall Study|Withdrawal by Subject|1|||
147037501|NCT02094417|530298022|FG001|Overall Study|Withdrawal by Subject|2|||
147037502|NCT02094417|530298023|FG002|Overall Study|Withdrawal by Subject|1|||
147037503|NCT02094417|530298024|FG003|Overall Study|Withdrawal by Subject|3|||
147037504|NCT01473524|530298025|FG000|DB Phase|Adverse Event|4|||
147037505|NCT01473524|530298026|FG001|DB Phase|Adverse Event|8|||
147037506|NCT01473524|530298027|FG002|DB Phase|Adverse Event|2|||
147037507|NCT01473524|530298028|FG003|DB Phase|Adverse Event|0|||
147037508|NCT01473524|530298029|FG004|DB Phase|Adverse Event|0|||
147037509|NCT01473524|530298030|FG005|DB Phase|Adverse Event|0|||
147037510|NCT01473524|530298025|FG000|DB Phase|Death|1|||
147037511|NCT01473524|530298026|FG001|DB Phase|Death|0|||
147037512|NCT01473524|530298027|FG002|DB Phase|Death|0|||
147037513|NCT01473524|530298028|FG003|DB Phase|Death|0|||
147037514|NCT01473524|530298029|FG004|DB Phase|Death|0|||
147037515|NCT01473524|530298030|FG005|DB Phase|Death|0|||
147037516|NCT01473524|530298025|FG000|DB Phase|Withdrawal by Subject|2|||
147037517|NCT01473524|530298026|FG001|DB Phase|Withdrawal by Subject|1|||
147037518|NCT01473524|530298027|FG002|DB Phase|Withdrawal by Subject|1|||
147037519|NCT01473524|530298028|FG003|DB Phase|Withdrawal by Subject|0|||
147037520|NCT01473524|530298029|FG004|DB Phase|Withdrawal by Subject|0|||
147037521|NCT01473524|530298030|FG005|DB Phase|Withdrawal by Subject|0|||
147037522|NCT01473524|530298025|FG000|LTSE Phase|Withdrawal by Subject|0|||
147037523|NCT01473524|530298026|FG001|LTSE Phase|Withdrawal by Subject|0|||
147037524|NCT01473524|530298027|FG002|LTSE Phase|Withdrawal by Subject|0|||
147037525|NCT01473524|530298028|FG003|LTSE Phase|Withdrawal by Subject|3|||
147037526|NCT01473524|530298029|FG004|LTSE Phase|Withdrawal by Subject|3|||
147037527|NCT01473524|530298030|FG005|LTSE Phase|Withdrawal by Subject|6|||
147037528|NCT01473524|530298025|FG000|LTSE Phase|Death|0|||
147037529|NCT01473524|530298026|FG001|LTSE Phase|Death|0|||
147037530|NCT01473524|530298027|FG002|LTSE Phase|Death|0|||
147037531|NCT01473524|530298028|FG003|LTSE Phase|Death|0|||
147037532|NCT01473524|530298029|FG004|LTSE Phase|Death|1|||
147037533|NCT01473524|530298030|FG005|LTSE Phase|Death|0|||
147037534|NCT01473524|530298025|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
147037535|NCT01473524|530298026|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
147037536|NCT01473524|530298027|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
147037537|NCT01473524|530298028|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
147037538|NCT01473524|530298029|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
147037539|NCT01473524|530298030|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
147037540|NCT01473524|530298025|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
147037541|NCT01473524|530298026|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
147037542|NCT01473524|530298027|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
147037543|NCT01473524|530298028|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
147037544|NCT01473524|530298029|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
147037545|NCT01473524|530298030|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
147037546|NCT01473524|530298025|FG000|LTSE Phase|Lost to Follow-up|0|||
147037547|NCT01473524|530298026|FG001|LTSE Phase|Lost to Follow-up|0|||
147037548|NCT01473524|530298027|FG002|LTSE Phase|Lost to Follow-up|0|||
147037549|NCT01473524|530298028|FG003|LTSE Phase|Lost to Follow-up|1|||
147037550|NCT01473524|530298029|FG004|LTSE Phase|Lost to Follow-up|3|||
147037551|NCT01473524|530298030|FG005|LTSE Phase|Lost to Follow-up|2|||
147037552|NCT01473524|530298025|FG000|LTSE Phase|Principal Investigator Decision|0|||
147037553|NCT01473524|530298026|FG001|LTSE Phase|Principal Investigator Decision|0|||
147037554|NCT01473524|530298027|FG002|LTSE Phase|Principal Investigator Decision|0|||
147037555|NCT01473524|530298028|FG003|LTSE Phase|Principal Investigator Decision|1|||
147037556|NCT01473524|530298029|FG004|LTSE Phase|Principal Investigator Decision|1|||
147037557|NCT01473524|530298030|FG005|LTSE Phase|Principal Investigator Decision|3|||
147037558|NCT01473524|530298025|FG000|LTSE Phase|Liver Transplantation|0|||
147037559|NCT01473524|530298026|FG001|LTSE Phase|Liver Transplantation|0|||
147037560|NCT01473524|530298027|FG002|LTSE Phase|Liver Transplantation|0|||
147037561|NCT01473524|530298028|FG003|LTSE Phase|Liver Transplantation|0|||
147037562|NCT01473524|530298029|FG004|LTSE Phase|Liver Transplantation|0|||
147037563|NCT01473524|530298030|FG005|LTSE Phase|Liver Transplantation|1|||
147037564|NCT01473524|530298025|FG000|LTSE Phase|Pregnancy|0|||
147037565|NCT01473524|530298026|FG001|LTSE Phase|Pregnancy|0|||
147037566|NCT01473524|530298027|FG002|LTSE Phase|Pregnancy|0|||
147037567|NCT01473524|530298028|FG003|LTSE Phase|Pregnancy|1|||
147037568|NCT01473524|530298029|FG004|LTSE Phase|Pregnancy|0|||
147037569|NCT01473524|530298030|FG005|LTSE Phase|Pregnancy|0|||
147037570|NCT01473524|530298025|FG000|LTSE Phase|Protocol Violation|0|||
147037571|NCT01473524|530298026|FG001|LTSE Phase|Protocol Violation|0|||
147037572|NCT01473524|530298027|FG002|LTSE Phase|Protocol Violation|0|||
147037573|NCT01473524|530298028|FG003|LTSE Phase|Protocol Violation|0|||
147037574|NCT01473524|530298029|FG004|LTSE Phase|Protocol Violation|0|||
147037575|NCT01473524|530298030|FG005|LTSE Phase|Protocol Violation|1|||
147037576|NCT01544179|530298032|FG000|Overall Study|Death|50|||
147037577|NCT01544179|530298033|FG001|Overall Study|Death|37|||
147037578|NCT01544179|530298032|FG000|Overall Study|Lost to Follow-up|0|||
147037579|NCT01544179|530298033|FG001|Overall Study|Lost to Follow-up|1|||
147037580|NCT01544179|530298032|FG000|Overall Study|Adverse Event|0|||
147037581|NCT01544179|530298033|FG001|Overall Study|Adverse Event|1|||
147037582|NCT01544179|530298032|FG000|Overall Study|Withdrawal by Subject|12|||
147037583|NCT01544179|530298033|FG001|Overall Study|Withdrawal by Subject|7|||
147037584|NCT01544179|530298032|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
147037585|NCT01544179|530298033|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147037586|NCT03146962|530298036|FG000|Overall Study|Lost to Follow-up|1|||
147037587|NCT03146962|530298037|FG001|Overall Study|Lost to Follow-up|1|||
147037588|NCT03146962|530298038|FG002|Overall Study|Lost to Follow-up|0|||
147037589|NCT03146962|530298039|FG003|Overall Study|Lost to Follow-up|0|||
147037590|NCT03146962|530298040|FG004|Overall Study|Lost to Follow-up|0|||
147037591|NCT03146962|530298041|FG005|Overall Study|Lost to Follow-up|0|||
147037592|NCT03146962|530298042|FG006|Overall Study|Lost to Follow-up|0|||
147037593|NCT03146962|530298043|FG007|Overall Study|Lost to Follow-up|0|||
147037594|NCT03146962|530298044|FG008|Overall Study|Lost to Follow-up|0|||
147037595|NCT03146962|530298045|FG009|Overall Study|Lost to Follow-up|0|||
147037596|NCT03146962|530298036|FG000|Overall Study|Adverse Event|0|||
147037597|NCT03146962|530298037|FG001|Overall Study|Adverse Event|3|||
147037598|NCT03146962|530298038|FG002|Overall Study|Adverse Event|0|||
147037599|NCT03146962|530298039|FG003|Overall Study|Adverse Event|0|||
147037600|NCT03146962|530298040|FG004|Overall Study|Adverse Event|0|||
147037601|NCT03146962|530298041|FG005|Overall Study|Adverse Event|0|||
147037602|NCT03146962|530298042|FG006|Overall Study|Adverse Event|0|||
147037603|NCT03146962|530298043|FG007|Overall Study|Adverse Event|1|||
147037604|NCT03146962|530298044|FG008|Overall Study|Adverse Event|0|||
147037605|NCT03146962|530298045|FG009|Overall Study|Adverse Event|0|||
147037606|NCT03146962|530298036|FG000|Overall Study|Withdrawal by Subject|0|||
147037607|NCT03146962|530298037|FG001|Overall Study|Withdrawal by Subject|0|||
147037608|NCT03146962|530298038|FG002|Overall Study|Withdrawal by Subject|0|||
147037609|NCT03146962|530298039|FG003|Overall Study|Withdrawal by Subject|0|||
147037610|NCT03146962|530298040|FG004|Overall Study|Withdrawal by Subject|1|||
147037611|NCT03146962|530298041|FG005|Overall Study|Withdrawal by Subject|0|||
147037612|NCT03146962|530298042|FG006|Overall Study|Withdrawal by Subject|0|||
147037613|NCT03146962|530298043|FG007|Overall Study|Withdrawal by Subject|0|||
147037614|NCT03146962|530298044|FG008|Overall Study|Withdrawal by Subject|0|||
147037615|NCT03146962|530298045|FG009|Overall Study|Withdrawal by Subject|0|||
147037616|NCT03146962|530298036|FG000|Overall Study|Death|0|||
147037617|NCT03146962|530298037|FG001|Overall Study|Death|1|||
147037618|NCT03146962|530298038|FG002|Overall Study|Death|0|||
147037619|NCT03146962|530298039|FG003|Overall Study|Death|0|||
147037620|NCT03146962|530298040|FG004|Overall Study|Death|0|||
147037621|NCT03146962|530298041|FG005|Overall Study|Death|0|||
147037622|NCT03146962|530298042|FG006|Overall Study|Death|0|||
147037623|NCT03146962|530298043|FG007|Overall Study|Death|0|||
147037624|NCT03146962|530298044|FG008|Overall Study|Death|0|||
147037625|NCT03146962|530298045|FG009|Overall Study|Death|0|||
146849737|NCT02663518|529618859|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
147037626|NCT03146962|530298036|FG000|Overall Study|COVID Precautions|1|||
147037627|NCT03146962|530298037|FG001|Overall Study|COVID Precautions|0|||
147037628|NCT03146962|530298038|FG002|Overall Study|COVID Precautions|0|||
147037629|NCT03146962|530298039|FG003|Overall Study|COVID Precautions|0|||
147037630|NCT03146962|530298040|FG004|Overall Study|COVID Precautions|0|||
147037631|NCT03146962|530298041|FG005|Overall Study|COVID Precautions|0|||
147037632|NCT03146962|530298042|FG006|Overall Study|COVID Precautions|0|||
147037633|NCT03146962|530298043|FG007|Overall Study|COVID Precautions|0|||
147037634|NCT03146962|530298044|FG008|Overall Study|COVID Precautions|0|||
147037635|NCT03146962|530298045|FG009|Overall Study|COVID Precautions|0|||
147037636|NCT03146962|530298036|FG000|Overall Study|Physician Decision|0|||
147037637|NCT03146962|530298037|FG001|Overall Study|Physician Decision|0|||
147037638|NCT03146962|530298038|FG002|Overall Study|Physician Decision|0|||
147037639|NCT03146962|530298039|FG003|Overall Study|Physician Decision|0|||
147037640|NCT03146962|530298040|FG004|Overall Study|Physician Decision|0|||
147037641|NCT03146962|530298041|FG005|Overall Study|Physician Decision|0|||
147037642|NCT03146962|530298042|FG006|Overall Study|Physician Decision|0|||
147037643|NCT03146962|530298043|FG007|Overall Study|Physician Decision|0|||
147037644|NCT03146962|530298044|FG008|Overall Study|Physician Decision|0|||
147037645|NCT03146962|530298045|FG009|Overall Study|Physician Decision|1|||
147037646|NCT03146962|530298036|FG000|Overall Study|Started New Treatment|0|||
147037647|NCT03146962|530298037|FG001|Overall Study|Started New Treatment|1|||
147037648|NCT03146962|530298038|FG002|Overall Study|Started New Treatment|0|||
147037649|NCT03146962|530298039|FG003|Overall Study|Started New Treatment|0|||
147037650|NCT03146962|530298040|FG004|Overall Study|Started New Treatment|0|||
147037651|NCT03146962|530298041|FG005|Overall Study|Started New Treatment|0|||
147037652|NCT03146962|530298042|FG006|Overall Study|Started New Treatment|0|||
147037653|NCT03146962|530298043|FG007|Overall Study|Started New Treatment|0|||
147037654|NCT03146962|530298044|FG008|Overall Study|Started New Treatment|0|||
147037655|NCT03146962|530298045|FG009|Overall Study|Started New Treatment|0|||
147037656|NCT00049530|530298046|FG000|Overall Study|Lack of Efficacy|25|||
147037657|NCT00049530|530298046|FG000|Overall Study|Adverse Event|2|||
147037658|NCT00049530|530298046|FG000|Overall Study|Death|1|||
147037659|NCT00049530|530298046|FG000|Overall Study|symptomatic deterioration|1|||
147037660|NCT00049530|530298046|FG000|Overall Study|ineligible|3|||
147037661|NCT01696058|530298051|FG000|Overall Study|Adverse Event|21|||
147037662|NCT01696058|530298052|FG001|Overall Study|Adverse Event|11|||
147037663|NCT01696058|530298051|FG000|Overall Study|Lack of Efficacy|2|||
147037664|NCT01696058|530298052|FG001|Overall Study|Lack of Efficacy|3|||
147037665|NCT01696058|530298051|FG000|Overall Study|Protocol Violation|9|||
147037666|NCT01696058|530298052|FG001|Overall Study|Protocol Violation|3|||
147037667|NCT01696058|530298051|FG000|Overall Study|Lost to Follow-up|2|||
147037668|NCT01696058|530298052|FG001|Overall Study|Lost to Follow-up|5|||
147037669|NCT01696058|530298051|FG000|Overall Study|Withdrawal by Subject|4|||
147037670|NCT01696058|530298052|FG001|Overall Study|Withdrawal by Subject|6|||
147037671|NCT01696058|530298051|FG000|Overall Study|Other reason prematurely discontinued|5|||
147037672|NCT01696058|530298052|FG001|Overall Study|Other reason prematurely discontinued|3|||
147037673|NCT01934335|530298053|FG000|Overall Study|Withdrawal by Subject|1|||
147037674|NCT01934335|530298054|FG001|Overall Study|Withdrawal by Subject|1|||
147037675|NCT01421511|530298055|FG000|Overall Study|Lost to Follow-up|11|||
147037676|NCT01421511|530298056|FG001|Overall Study|Lost to Follow-up|14|||
147037677|NCT01421511|530298055|FG000|Overall Study|Randomized but didn't receive study drug|1|||
147037678|NCT01421511|530298056|FG001|Overall Study|Randomized but didn't receive study drug|7|||
147037679|NCT01421511|530298055|FG000|Overall Study|Physician Decision|0|||
147037680|NCT01421511|530298056|FG001|Overall Study|Physician Decision|1|||
147037681|NCT01421511|530298055|FG000|Overall Study|Withdrawal by Subject|6|||
147037682|NCT01421511|530298056|FG001|Overall Study|Withdrawal by Subject|5|||
147037683|NCT01421511|530298055|FG000|Overall Study|Death|1|||
147037684|NCT01421511|530298056|FG001|Overall Study|Death|1|||
147037685|NCT01661062|530298059|FG000|Overall Study|Completed Treatment Off Study|3|||
147037686|NCT01661062|530298059|FG000|Overall Study|Withdrawal by Subject|2|||
147037687|NCT04106661|530298061|FG000|Overall Study|Protocol Violation|3|||
147037688|NCT04106661|530298062|FG001|Overall Study|Protocol Violation|0|||
147037689|NCT04106661|530298061|FG000|Overall Study|Scheduling difficulties|1|||
147037690|NCT04106661|530298062|FG001|Overall Study|Scheduling difficulties|1|||
147037691|NCT00233402|530298063|FG000|Overall Study|No pathology data|12|||
147037692|NCT00233402|530298064|FG001|Overall Study|No pathology data|9|||
147037693|NCT00233402|530298063|FG000|Overall Study|No Ta/T1|89|||
147037694|NCT00233402|530298064|FG001|Overall Study|No Ta/T1|94|||
147037695|NCT00233402|530298063|FG000|Overall Study|Lost to follow up etc|3|||
147037696|NCT00233402|530298064|FG001|Overall Study|Lost to follow up etc|21|||
147037697|NCT00423319|530298067|FG000|Overall Study|Death|2|||
147037698|NCT00423319|530298068|FG001|Overall Study|Death|0|||
147037699|NCT00423319|530298067|FG000|Overall Study|Adverse Event|93|||
147037700|NCT00423319|530298068|FG001|Overall Study|Adverse Event|112|||
147037701|NCT00423319|530298067|FG000|Overall Study|Withdrawal by Subject|86|||
147037702|NCT00423319|530298068|FG001|Overall Study|Withdrawal by Subject|99|||
147037703|NCT00423319|530298067|FG000|Overall Study|Lost to Follow-up|4|||
147037704|NCT00423319|530298068|FG001|Overall Study|Lost to Follow-up|3|||
147037705|NCT00423319|530298067|FG000|Overall Study|Poor compliance or noncompliance|1|||
147037706|NCT00423319|530298068|FG001|Overall Study|Poor compliance or noncompliance|1|||
147037707|NCT00423319|530298067|FG000|Overall Study|No longer meets study criteria|15|||
147037708|NCT00423319|530298068|FG001|Overall Study|No longer meets study criteria|15|||
147037709|NCT00423319|530298067|FG000|Overall Study|Other|23|||
147037710|NCT00423319|530298068|FG001|Overall Study|Other|22|||
147037711|NCT02639052|530298069|FG000|Overall Study|Lost to Follow-up|1|||
147037712|NCT04572893|530298075|FG000|Part A|Adverse Event|1|||
147037713|NCT04572893|530298076|FG001|Part A|Adverse Event|0|||
147037714|NCT04572893|530298077|FG002|Part A|Adverse Event|0|||
147037715|NCT04572893|530298078|FG003|Part A|Adverse Event|0|||
147037716|NCT04572893|530298079|FG004|Part A|Adverse Event|0|||
147037717|NCT04572893|530298080|FG005|Part A|Adverse Event|0|||
147037718|NCT04572893|530298081|FG006|Part A|Adverse Event|0|||
147037719|NCT04572893|530298075|FG000|Part B|Withdrawal by Subject|0|||
147037720|NCT04572893|530298076|FG001|Part B|Withdrawal by Subject|0|||
147037721|NCT04572893|530298077|FG002|Part B|Withdrawal by Subject|0|||
147037722|NCT04572893|530298078|FG003|Part B|Withdrawal by Subject|0|||
147037723|NCT04572893|530298079|FG004|Part B|Withdrawal by Subject|0|||
147037724|NCT04572893|530298080|FG005|Part B|Withdrawal by Subject|1|||
147037725|NCT04572893|530298081|FG006|Part B|Withdrawal by Subject|0|||
147037726|NCT04572893|530298075|FG000|Part B|Study terminated by sponsor|0|||
147037727|NCT04572893|530298076|FG001|Part B|Study terminated by sponsor|0|||
147037728|NCT04572893|530298077|FG002|Part B|Study terminated by sponsor|0|||
147037729|NCT04572893|530298078|FG003|Part B|Study terminated by sponsor|0|||
147037730|NCT04572893|530298079|FG004|Part B|Study terminated by sponsor|7|||
147037731|NCT04572893|530298080|FG005|Part B|Study terminated by sponsor|5|||
147037732|NCT04572893|530298081|FG006|Part B|Study terminated by sponsor|3|||
147037733|NCT04572893|530298075|FG000|Part B|Lost to Follow-up|0|||
147037734|NCT04572893|530298076|FG001|Part B|Lost to Follow-up|0|||
147037735|NCT04572893|530298077|FG002|Part B|Lost to Follow-up|0|||
147037736|NCT04572893|530298078|FG003|Part B|Lost to Follow-up|0|||
147037737|NCT04572893|530298079|FG004|Part B|Lost to Follow-up|0|||
147037738|NCT04572893|530298080|FG005|Part B|Lost to Follow-up|0|||
147037739|NCT04572893|530298081|FG006|Part B|Lost to Follow-up|1|||
147037740|NCT04572893|530298075|FG000|Part B|Adverse Event|0|||
147037741|NCT04572893|530298076|FG001|Part B|Adverse Event|0|||
147037742|NCT04572893|530298077|FG002|Part B|Adverse Event|0|||
147037743|NCT04572893|530298078|FG003|Part B|Adverse Event|0|||
147037744|NCT04572893|530298079|FG004|Part B|Adverse Event|1|||
147037745|NCT04572893|530298080|FG005|Part B|Adverse Event|1|||
147037746|NCT04572893|530298081|FG006|Part B|Adverse Event|0|||
147037747|NCT05038800|530298082|FG000|Overall Study|Death|1|||
147037748|NCT05038800|530298083|FG001|Overall Study|Death|1|||
147037749|NCT05038800|530298084|FG002|Overall Study|Death|5|||
147037750|NCT05038800|530298085|FG003|Overall Study|Death|3|||
147037751|NCT05038800|530298086|FG004|Overall Study|Death|1|||
147037752|NCT05038800|530298082|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147037753|NCT05038800|530298083|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147037754|NCT05038800|530298084|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147037755|NCT05038800|530298085|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147037756|NCT05038800|530298086|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
147037757|NCT05038800|530298082|FG000|Overall Study|Lack of Efficacy|0|||
147037758|NCT05038800|530298083|FG001|Overall Study|Lack of Efficacy|0|||
147037759|NCT05038800|530298084|FG002|Overall Study|Lack of Efficacy|0|||
147037760|NCT05038800|530298085|FG003|Overall Study|Lack of Efficacy|0|||
147037761|NCT05038800|530298086|FG004|Overall Study|Lack of Efficacy|1|||
147037762|NCT00121134|530298087|FG000|Overall Study|Progression of Disease|5|||
147037763|NCT00121134|530298088|FG001|Overall Study|Progression of Disease|3|||
147037764|NCT00121134|530298089|FG002|Overall Study|Progression of Disease|4|||
147037765|NCT00121134|530298090|FG003|Overall Study|Progression of Disease|2|||
147037766|NCT00121134|530298087|FG000|Overall Study|Toxicity|4|||
147037767|NCT00121134|530298088|FG001|Overall Study|Toxicity|7|||
147037768|NCT00121134|530298089|FG002|Overall Study|Toxicity|13|||
147037769|NCT00121134|530298090|FG003|Overall Study|Toxicity|5|||
147037770|NCT00121134|530298087|FG000|Overall Study|Physician Decision|6|||
147037771|NCT00121134|530298088|FG001|Overall Study|Physician Decision|4|||
147037772|NCT00121134|530298089|FG002|Overall Study|Physician Decision|4|||
147037773|NCT00121134|530298090|FG003|Overall Study|Physician Decision|1|||
147037774|NCT00121134|530298087|FG000|Overall Study|Treatment Delay|1|||
147037775|NCT00121134|530298088|FG001|Overall Study|Treatment Delay|0|||
147037776|NCT00121134|530298089|FG002|Overall Study|Treatment Delay|0|||
147037777|NCT00121134|530298090|FG003|Overall Study|Treatment Delay|0|||
147037778|NCT00121134|530298087|FG000|Overall Study|Intercurrent Illness|0|||
147037779|NCT00121134|530298088|FG001|Overall Study|Intercurrent Illness|0|||
147037780|NCT00121134|530298089|FG002|Overall Study|Intercurrent Illness|0|||
147037781|NCT00121134|530298090|FG003|Overall Study|Intercurrent Illness|1|||
147037782|NCT00121134|530298087|FG000|Overall Study|Patient Personal Reasons|0|||
147037783|NCT00121134|530298088|FG001|Overall Study|Patient Personal Reasons|1|||
147037784|NCT00121134|530298089|FG002|Overall Study|Patient Personal Reasons|0|||
147037785|NCT00121134|530298090|FG003|Overall Study|Patient Personal Reasons|0|||
147037786|NCT02478320|530298093|FG000|Overall Study|Adverse Event|2|||
147037787|NCT02478320|530298094|FG001|Overall Study|Adverse Event|0|||
147037788|NCT02478320|530298093|FG000|Overall Study|Death|1|||
147037789|NCT02478320|530298094|FG001|Overall Study|Death|0|||
147037790|NCT02478320|530298093|FG000|Overall Study|Lack of Efficacy|4|||
147037791|NCT02478320|530298094|FG001|Overall Study|Lack of Efficacy|0|||
147037792|NCT02478320|530298093|FG000|Overall Study|Withdrawal by Subject|2|||
147037793|NCT02478320|530298094|FG001|Overall Study|Withdrawal by Subject|0|||
147037794|NCT02478320|530298093|FG000|Overall Study|Screen Failure|3|||
147037795|NCT02478320|530298094|FG001|Overall Study|Screen Failure|0|||
147037796|NCT02533375|530298095|FG000|Overall Study|Lack of Efficacy|3|||
147037797|NCT02533375|530298095|FG000|Overall Study|Adverse Event|2|||
147037798|NCT00960115|530298096|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
147037799|NCT00960115|530298097|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
147037800|NCT04853992|530298098|FG000|Treatment Period A|Adverse Event|0|||
147037801|NCT04853992|530298099|FG001|Treatment Period A|Adverse Event|1|||
147037802|NCT04853992|530298098|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
147037803|NCT04853992|530298099|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
147037804|NCT02212379|530298100|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
147037805|NCT02212379|530298100|FG000|From Baseline to Week 48|Adverse Event|7|||
147037806|NCT02212379|530298100|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
147037807|NCT02212379|530298100|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
147037808|NCT02212379|530298100|FG000|From Week 48 to Week 96|Adverse Event|1|||
147037809|NCT02212379|530298100|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
147037810|NCT04497948|530299835|FG000|Overall Study|Death|2|||
147037811|NCT00696787|530299836|FG000|Overall Study|Adverse Event|1|||
147037812|NCT00696787|530299837|FG001|Overall Study|Adverse Event|0|||
147037813|NCT00696787|530299838|FG002|Overall Study|Adverse Event|6|||
147037814|NCT00696787|530299836|FG000|Overall Study|Discontinuation by Sponsor|9|||
147037815|NCT00696787|530299837|FG001|Overall Study|Discontinuation by Sponsor|13|||
147037816|NCT00696787|530299838|FG002|Overall Study|Discontinuation by Sponsor|14|||
147037817|NCT00696787|530299836|FG000|Overall Study|Lack of Efficacy|0|||
147037818|NCT00696787|530299837|FG001|Overall Study|Lack of Efficacy|1|||
147037819|NCT00696787|530299838|FG002|Overall Study|Lack of Efficacy|0|||
147037820|NCT00696787|530299836|FG000|Overall Study|Lost to Follow-up|4|||
147037821|NCT00696787|530299837|FG001|Overall Study|Lost to Follow-up|0|||
147037822|NCT00696787|530299838|FG002|Overall Study|Lost to Follow-up|3|||
147037823|NCT00696787|530299836|FG000|Overall Study|Withdrawal by Subject|0|||
147037824|NCT00696787|530299837|FG001|Overall Study|Withdrawal by Subject|3|||
147037825|NCT00696787|530299838|FG002|Overall Study|Withdrawal by Subject|2|||
147037826|NCT00696787|530299836|FG000|Overall Study|Failed to return|1|||
147037827|NCT00696787|530299837|FG001|Overall Study|Failed to return|3|||
147037828|NCT00696787|530299838|FG002|Overall Study|Failed to return|1|||
147037829|NCT02549027|530299840|FG000|Washout After Period 4|Withdrawal by Subject|0|||
147037830|NCT02549027|530299841|FG001|Washout After Period 4|Withdrawal by Subject|1|||
147037831|NCT02549027|530299842|FG002|Washout After Period 4|Withdrawal by Subject|1|||
147037832|NCT02549027|530299843|FG003|Washout After Period 4|Withdrawal by Subject|1|||
147037833|NCT02549027|530299844|FG004|Washout After Period 4|Withdrawal by Subject|0|||
147037834|NCT02549027|530299845|FG005|Washout After Period 4|Withdrawal by Subject|0|||
147037835|NCT02549027|530299840|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
147037836|NCT02549027|530299841|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
147037837|NCT02549027|530299842|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
147037838|NCT02549027|530299843|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
147037839|NCT02549027|530299844|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
147037840|NCT02549027|530299845|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
147037841|NCT02186834|530299846|FG000|Dose Escalation|Death|0|||
147037842|NCT02186834|530299847|FG001|Dose Escalation|Death|0|||
147037843|NCT02186834|530299848|FG002|Dose Escalation|Death|0|||
147037844|NCT02186834|530299849|FG003|Dose Escalation|Death|1|||
147037845|NCT02186834|530299850|FG004|Dose Escalation|Death|0|||
147037846|NCT02186834|530299851|FG005|Dose Escalation|Death|0|||
147037847|NCT02186834|530299846|FG000|Treatment at RP2D|Died prior to treatment|0|||
147037848|NCT02186834|530299847|FG001|Treatment at RP2D|Died prior to treatment|0|||
147037849|NCT02186834|530299848|FG002|Treatment at RP2D|Died prior to treatment|0|||
147037850|NCT02186834|530299849|FG003|Treatment at RP2D|Died prior to treatment|0|||
147037851|NCT02186834|530299850|FG004|Treatment at RP2D|Died prior to treatment|0|||
147037852|NCT02186834|530299851|FG005|Treatment at RP2D|Died prior to treatment|1|||
147037853|NCT05384171|530299855|FG000|Overall Study|Lost to Follow-up|9|||
147037854|NCT05384171|530299856|FG001|Overall Study|Lost to Follow-up|9|||
147037855|NCT05384171|530299855|FG000|Overall Study|Withdrawal by Subject|3|||
147037856|NCT05384171|530299856|FG001|Overall Study|Withdrawal by Subject|0|||
147037857|NCT00749892|530299857|FG000|Overall Study|Withdrawal by Subject|3|||
147037858|NCT04581369|530299858|FG000|Overall Study|Death|7|||
147037859|NCT04581369|530299859|FG001|Overall Study|Death|6|||
147037860|NCT04581369|530299860|FG002|Overall Study|Death|0|||
147037861|NCT04581369|530299858|FG000|Overall Study|Lost to Follow-up|7|||
147037862|NCT04581369|530299859|FG001|Overall Study|Lost to Follow-up|3|||
147037863|NCT04581369|530299860|FG002|Overall Study|Lost to Follow-up|0|||
147037864|NCT04581369|530299858|FG000|Overall Study|liver transplant|2|||
147037865|NCT04581369|530299859|FG001|Overall Study|liver transplant|2|||
147037866|NCT04581369|530299860|FG002|Overall Study|liver transplant|0|||
147037867|NCT04581369|530299858|FG000|Overall Study|transitioned to hospice care|0|||
147037868|NCT04581369|530299859|FG001|Overall Study|transitioned to hospice care|5|||
147037869|NCT04581369|530299860|FG002|Overall Study|transitioned to hospice care|0|||
147037870|NCT00780910|530299861|FG000|Overall Study|Adverse Event|2|||
147037871|NCT01111825|530299864|FG000|Overall Study|Withdrawal by Subject|0|||
147037872|NCT01111825|530299865|FG001|Overall Study|Withdrawal by Subject|0|||
147037873|NCT01111825|530299866|FG002|Overall Study|Withdrawal by Subject|1|||
147037874|NCT01111825|530299867|FG003|Overall Study|Withdrawal by Subject|0|||
147037875|NCT01111825|530299864|FG000|Overall Study|Lost to Follow-up|0|||
147037876|NCT01111825|530299865|FG001|Overall Study|Lost to Follow-up|0|||
147037877|NCT01111825|530299866|FG002|Overall Study|Lost to Follow-up|3|||
147037878|NCT01111825|530299867|FG003|Overall Study|Lost to Follow-up|1|||
147037879|NCT01111825|530299864|FG000|Overall Study|Adverse Event|2|||
147037880|NCT01111825|530299865|FG001|Overall Study|Adverse Event|1|||
147037881|NCT01111825|530299866|FG002|Overall Study|Adverse Event|4|||
147037882|NCT01111825|530299867|FG003|Overall Study|Adverse Event|0|||
147037883|NCT01111825|530299864|FG000|Overall Study|Disease Progression|1|||
147037884|NCT01111825|530299865|FG001|Overall Study|Disease Progression|0|||
147037885|NCT01111825|530299866|FG002|Overall Study|Disease Progression|0|||
147037886|NCT01111825|530299867|FG003|Overall Study|Disease Progression|0|||
147037887|NCT01111825|530299864|FG000|Overall Study|Discontinuation by Sponsor|0|||
147037888|NCT01111825|530299865|FG001|Overall Study|Discontinuation by Sponsor|0|||
147037889|NCT01111825|530299866|FG002|Overall Study|Discontinuation by Sponsor|0|||
147037890|NCT01111825|530299867|FG003|Overall Study|Discontinuation by Sponsor|20|||
147037891|NCT00106964|530299869|FG000|Overall Study|Lost to Follow-up|8|||
147037892|NCT00106964|530299870|FG001|Overall Study|Lost to Follow-up|6|||
147037893|NCT00106964|530299871|FG002|Overall Study|Lost to Follow-up|2|||
147037894|NCT00106964|530299869|FG000|Overall Study|Pregnancy|2|||
147037895|NCT00106964|530299870|FG001|Overall Study|Pregnancy|3|||
147037896|NCT00106964|530299871|FG002|Overall Study|Pregnancy|2|||
147037897|NCT00106964|530299869|FG000|Overall Study|Death|1|||
147037898|NCT00106964|530299870|FG001|Overall Study|Death|1|||
147037899|NCT00106964|530299871|FG002|Overall Study|Death|0|||
147037900|NCT00106964|530299869|FG000|Overall Study|Incarceration|0|||
147037901|NCT00106964|530299870|FG001|Overall Study|Incarceration|1|||
147037902|NCT00106964|530299871|FG002|Overall Study|Incarceration|0|||
147037903|NCT00106964|530299869|FG000|Overall Study|Site Funding Terminated|0|||
147037904|NCT00106964|530299870|FG001|Overall Study|Site Funding Terminated|1|||
147037905|NCT00106964|530299871|FG002|Overall Study|Site Funding Terminated|1|||
147037906|NCT00106964|530299869|FG000|Overall Study|Failure to adhere|2|||
147037907|NCT00106964|530299870|FG001|Overall Study|Failure to adhere|0|||
147037908|NCT00106964|530299871|FG002|Overall Study|Failure to adhere|0|||
147037909|NCT00106964|530299869|FG000|Overall Study|Did not meet eligibility criteria|0|||
147037910|NCT00106964|530299870|FG001|Overall Study|Did not meet eligibility criteria|2|||
147037911|NCT00106964|530299871|FG002|Overall Study|Did not meet eligibility criteria|2|||
147037912|NCT00106964|530299869|FG000|Overall Study|Required disallowed medication|0|||
147037913|NCT00106964|530299870|FG001|Overall Study|Required disallowed medication|1|||
147037914|NCT00106964|530299871|FG002|Overall Study|Required disallowed medication|0|||
147037915|NCT04746794|530299872|FG000|Overall Study|Did not complete any study assessment|50303|||
147037916|NCT04746794|530299873|FG001|Overall Study|Did not complete any study assessment|44997|||
147037917|NCT03207243|530299874|FG000|Overall Study|Adverse Event|2|||
147037918|NCT03207243|530299875|FG001|Overall Study|Adverse Event|2|||
147037919|NCT03207243|530299874|FG000|Overall Study|Loss of Asthma Control|47|||
147037920|NCT03207243|530299875|FG001|Overall Study|Loss of Asthma Control|31|||
147037921|NCT03207243|530299874|FG000|Overall Study|Withdrawal by Subject|2|||
147037922|NCT03207243|530299875|FG001|Overall Study|Withdrawal by Subject|4|||
147037923|NCT03207243|530299874|FG000|Overall Study|Physician Decision|1|||
147037924|NCT03207243|530299875|FG001|Overall Study|Physician Decision|1|||
147037925|NCT03207243|530299874|FG000|Overall Study|Lost to Follow-up|0|||
147037926|NCT03207243|530299875|FG001|Overall Study|Lost to Follow-up|1|||
147037927|NCT03207243|530299874|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
147037928|NCT03207243|530299875|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
147037929|NCT03207243|530299874|FG000|Overall Study|Protocol Violation|0|||
147037930|NCT03207243|530299875|FG001|Overall Study|Protocol Violation|3|||
147037931|NCT01377987|530299882|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
147037932|NCT01377987|530299883|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
147037933|NCT01422187|530299884|FG000|Overall Study|Personal reason|1|||
147037934|NCT01422187|530299885|FG001|Overall Study|Personal reason|0|||
147037935|NCT01422187|530299886|FG002|Overall Study|Personal reason|0|||
147037936|NCT01422187|530299884|FG000|Overall Study|Lost to Follow-up|0|||
147037937|NCT01422187|530299885|FG001|Overall Study|Lost to Follow-up|1|||
147037938|NCT01422187|530299886|FG002|Overall Study|Lost to Follow-up|0|||
147037939|NCT00168818|530299887|FG000|Overall Study|Adverse Event|23|||
147037940|NCT00168818|530299888|FG001|Overall Study|Adverse Event|29|||
147037941|NCT00168818|530299889|FG002|Overall Study|Adverse Event|31|||
147037942|NCT00168818|530299887|FG000|Overall Study|Protocol Violation|16|||
147037943|NCT00168818|530299888|FG001|Overall Study|Protocol Violation|11|||
147037944|NCT00168818|530299889|FG002|Overall Study|Protocol Violation|11|||
147037945|NCT00168818|530299887|FG000|Overall Study|Lost to Follow-up|13|||
147037946|NCT00168818|530299888|FG001|Overall Study|Lost to Follow-up|4|||
147037947|NCT00168818|530299889|FG002|Overall Study|Lost to Follow-up|15|||
147037948|NCT00168818|530299887|FG000|Overall Study|Withdrawal by Subject|43|||
147037949|NCT00168818|530299888|FG001|Overall Study|Withdrawal by Subject|41|||
147037950|NCT00168818|530299889|FG002|Overall Study|Withdrawal by Subject|37|||
147037951|NCT00168818|530299887|FG000|Overall Study|Other|22|||
147037952|NCT00168818|530299888|FG001|Overall Study|Other|24|||
147037953|NCT00168818|530299889|FG002|Overall Study|Other|30|||
147037954|NCT00168818|530299887|FG000|Treatment|Adverse Event|77|||
147037955|NCT00168818|530299888|FG001|Treatment|Adverse Event|89|||
147037956|NCT00168818|530299889|FG002|Treatment|Adverse Event|68|||
147037957|NCT00168818|530299887|FG000|Treatment|Protocol Violation|8|||
147037958|NCT00168818|530299888|FG001|Treatment|Protocol Violation|11|||
147037959|NCT00168818|530299889|FG002|Treatment|Protocol Violation|11|||
147037960|NCT00168818|530299887|FG000|Treatment|Lost to Follow-up|0|||
147037961|NCT00168818|530299888|FG001|Treatment|Lost to Follow-up|2|||
147037962|NCT00168818|530299889|FG002|Treatment|Lost to Follow-up|1|||
147037963|NCT00168818|530299887|FG000|Treatment|Withdrawal by Subject|25|||
147037964|NCT00168818|530299888|FG001|Treatment|Withdrawal by Subject|20|||
147037965|NCT00168818|530299889|FG002|Treatment|Withdrawal by Subject|22|||
147037966|NCT00168818|530299887|FG000|Treatment|Other|23|||
147037967|NCT00168818|530299888|FG001|Treatment|Other|29|||
147037968|NCT00168818|530299889|FG002|Treatment|Other|31|||
147037969|NCT02538965|530299897|FG000|Treatment Period|Other = Death due to disease progression|1|||
147037970|NCT02538965|530299897|FG000|Treatment Period|Adverse Event|2|||
147037971|NCT02538965|530299897|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
147037972|NCT02538965|530299897|FG000|Treatment Period|Treatment Failure|9|||
147037973|NCT02538965|530299897|FG000|Treatment Period|Disease Progression|1|||
147037974|NCT02538965|530299897|FG000|Treatment Period|Physician Decision|2|||
147037975|NCT02538965|530299897|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
147037976|NCT02538965|530299897|FG000|Follow-Up Period|Withdrawal by Parent|4|||
147037977|NCT00875797|530299898|FG000|Overall Study|Protocol Violation|6|||
147037978|NCT00875797|530299899|FG001|Overall Study|Protocol Violation|3|||
147037979|NCT01590797|530299904|FG000|Overall Study|Adverse Event|4|||
147037980|NCT01590797|530299905|FG001|Overall Study|Adverse Event|3|||
147037981|NCT01590797|530299904|FG000|Overall Study|Lack of Efficacy|0|||
147037982|NCT01590797|530299905|FG001|Overall Study|Lack of Efficacy|2|||
147037983|NCT01590797|530299904|FG000|Overall Study|Lost to Follow-up|0|||
147037984|NCT01590797|530299905|FG001|Overall Study|Lost to Follow-up|1|||
147037985|NCT01590797|530299904|FG000|Overall Study|Protocol Violation|4|||
147037986|NCT01590797|530299905|FG001|Overall Study|Protocol Violation|1|||
147037987|NCT01590797|530299904|FG000|Overall Study|Withdrawal by Subject|7|||
147037988|NCT01590797|530299905|FG001|Overall Study|Withdrawal by Subject|5|||
147037989|NCT01590797|530299904|FG000|Overall Study|Other Protocol Specified Criteria|2|||
147037990|NCT01590797|530299905|FG001|Overall Study|Other Protocol Specified Criteria|4|||
147037991|NCT04893018|530299908|FG000|Overall Study|Lost to Follow-up|1|||
147037992|NCT04893018|530299909|FG001|Overall Study|Lost to Follow-up|0|||
147037993|NCT04893018|530299908|FG000|Overall Study|Withdrawal by Subject|2|||
147037994|NCT04893018|530299909|FG001|Overall Study|Withdrawal by Subject|0|||
147037995|NCT04893018|530299908|FG000|Overall Study|Study Terminated|1|||
147037996|NCT04893018|530299909|FG001|Overall Study|Study Terminated|2|||
147037997|NCT00195338|530299915|FG000|Overall Study|Lost to Follow-up|2|||
147037998|NCT00195338|530299915|FG000|Overall Study|Adverse Event|5|||
147037999|NCT00195338|530299915|FG000|Overall Study|Lack of Efficacy|1|||
147038000|NCT00195338|530299915|FG000|Overall Study|Early closure of the site|4|||
147038001|NCT00811928|530299916|FG000|Overall Study|AEs and SAEs Including Death|7|||
147038002|NCT00811928|530299917|FG001|Overall Study|AEs and SAEs Including Death|11|||
147038003|NCT00811928|530299916|FG000|Overall Study|Withdrawal by Subject|18|||
147038004|NCT00811928|530299917|FG001|Overall Study|Withdrawal by Subject|12|||
147038005|NCT00811928|530299916|FG000|Overall Study|Did Not Take Study Drug|3|||
147038006|NCT00811928|530299917|FG001|Overall Study|Did Not Take Study Drug|0|||
147038007|NCT00811928|530299916|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
147038008|NCT00811928|530299917|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
147038009|NCT00811928|530299916|FG000|Overall Study|Investigator Decision|2|||
147038010|NCT00811928|530299917|FG001|Overall Study|Investigator Decision|1|||
147038011|NCT00811928|530299916|FG000|Overall Study|Poor Compliance|2|||
147038012|NCT00811928|530299917|FG001|Overall Study|Poor Compliance|5|||
147038013|NCT00314951|530299918|FG000|Treatment|Didn't meet criteria for mITT population|16|||
147038014|NCT00314951|530299919|FG001|Treatment|Didn't meet criteria for mITT population|11|||
147038015|NCT00314951|530299918|FG000|Follow-up|mITT failure|44|||
147038016|NCT00314951|530299919|FG001|Follow-up|mITT failure|34|||
147038017|NCT03503864|530299922|FG000|Overall Study|Protocol Violation|6|||
147038018|NCT03503864|530299922|FG000|Overall Study|Withdrawal by Subject|7|||
147038019|NCT00468650|530299923|FG000|Overall Study|Lost to Follow-up|4|||
147038020|NCT00468650|530299923|FG000|Overall Study|Withdrawal by Subject|2|||
147038021|NCT00468650|530299923|FG000|Overall Study|Protocol Violation|1|||
147038022|NCT02087189|530299924|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
147038023|NCT00642278|530299927|FG000|Overall Study|Adverse Event|2|||
147038024|NCT00642278|530299928|FG001|Overall Study|Adverse Event|1|||
147038025|NCT00642278|530299929|FG002|Overall Study|Adverse Event|3|||
147038026|NCT00642278|530299930|FG003|Overall Study|Adverse Event|1|||
147038027|NCT00642278|530299931|FG004|Overall Study|Adverse Event|2|||
147038028|NCT00642278|530299932|FG005|Overall Study|Adverse Event|2|||
147038029|NCT00642278|530299933|FG006|Overall Study|Adverse Event|0|||
147038030|NCT00642278|530299927|FG000|Overall Study|Lack of Efficacy|0|||
147038031|NCT00642278|530299928|FG001|Overall Study|Lack of Efficacy|1|||
147038032|NCT00642278|530299929|FG002|Overall Study|Lack of Efficacy|0|||
147038033|NCT00642278|530299930|FG003|Overall Study|Lack of Efficacy|0|||
147038034|NCT00642278|530299931|FG004|Overall Study|Lack of Efficacy|0|||
147038035|NCT00642278|530299932|FG005|Overall Study|Lack of Efficacy|0|||
147038036|NCT00642278|530299933|FG006|Overall Study|Lack of Efficacy|0|||
147038037|NCT00642278|530299927|FG000|Overall Study|Lost to Follow-up|5|||
147038038|NCT00642278|530299928|FG001|Overall Study|Lost to Follow-up|1|||
147038039|NCT00642278|530299929|FG002|Overall Study|Lost to Follow-up|0|||
147038040|NCT00642278|530299930|FG003|Overall Study|Lost to Follow-up|1|||
147038041|NCT00642278|530299931|FG004|Overall Study|Lost to Follow-up|0|||
147038042|NCT00642278|530299932|FG005|Overall Study|Lost to Follow-up|1|||
147038043|NCT00642278|530299933|FG006|Overall Study|Lost to Follow-up|1|||
147038044|NCT00642278|530299927|FG000|Overall Study|Physician Decision|0|||
147038045|NCT00642278|530299928|FG001|Overall Study|Physician Decision|0|||
147038046|NCT00642278|530299929|FG002|Overall Study|Physician Decision|0|||
147038047|NCT00642278|530299930|FG003|Overall Study|Physician Decision|1|||
147038048|NCT00642278|530299931|FG004|Overall Study|Physician Decision|0|||
147038049|NCT00642278|530299932|FG005|Overall Study|Physician Decision|0|||
147038050|NCT00642278|530299933|FG006|Overall Study|Physician Decision|0|||
147038051|NCT00642278|530299927|FG000|Overall Study|Protocol Violation|0|||
147038052|NCT00642278|530299928|FG001|Overall Study|Protocol Violation|0|||
147038053|NCT00642278|530299929|FG002|Overall Study|Protocol Violation|1|||
147038054|NCT00642278|530299930|FG003|Overall Study|Protocol Violation|1|||
147038055|NCT00642278|530299931|FG004|Overall Study|Protocol Violation|0|||
147038056|NCT00642278|530299932|FG005|Overall Study|Protocol Violation|1|||
147038057|NCT00642278|530299933|FG006|Overall Study|Protocol Violation|2|||
147038058|NCT00642278|530299927|FG000|Overall Study|Withdrawal by Subject|1|||
147038059|NCT00642278|530299928|FG001|Overall Study|Withdrawal by Subject|1|||
147038060|NCT00642278|530299929|FG002|Overall Study|Withdrawal by Subject|1|||
147038061|NCT00642278|530299930|FG003|Overall Study|Withdrawal by Subject|3|||
147038062|NCT00642278|530299931|FG004|Overall Study|Withdrawal by Subject|6|||
147038063|NCT00642278|530299932|FG005|Overall Study|Withdrawal by Subject|2|||
147038064|NCT00642278|530299933|FG006|Overall Study|Withdrawal by Subject|2|||
147038065|NCT00642278|530299927|FG000|Overall Study|Noncompliance with study drug regimen|0|||
147038066|NCT00642278|530299928|FG001|Overall Study|Noncompliance with study drug regimen|0|||
147038067|NCT00642278|530299929|FG002|Overall Study|Noncompliance with study drug regimen|0|||
147038068|NCT00642278|530299930|FG003|Overall Study|Noncompliance with study drug regimen|1|||
147038069|NCT00642278|530299931|FG004|Overall Study|Noncompliance with study drug regimen|0|||
147038070|NCT00642278|530299932|FG005|Overall Study|Noncompliance with study drug regimen|0|||
147038071|NCT00642278|530299933|FG006|Overall Study|Noncompliance with study drug regimen|0|||
147038072|NCT00642278|530299927|FG000|Overall Study|Other|2|||
147038073|NCT00642278|530299928|FG001|Overall Study|Other|1|||
147038074|NCT00642278|530299929|FG002|Overall Study|Other|0|||
147038075|NCT00642278|530299930|FG003|Overall Study|Other|1|||
147038076|NCT00642278|530299931|FG004|Overall Study|Other|0|||
147038077|NCT00642278|530299932|FG005|Overall Study|Other|1|||
147038078|NCT00642278|530299933|FG006|Overall Study|Other|0|||
147038079|NCT00090363|530299934|FG000|Overall Study|Lost to Follow-up|1|||
147038080|NCT00090363|530299935|FG001|Overall Study|Lost to Follow-up|2|||
147038081|NCT00090363|530299936|FG002|Overall Study|Lost to Follow-up|1|||
147038082|NCT00090363|530299934|FG000|Overall Study|Withdrawal by Subject|7|||
147038083|NCT00090363|530299935|FG001|Overall Study|Withdrawal by Subject|7|||
147038084|NCT00090363|530299936|FG002|Overall Study|Withdrawal by Subject|6|||
147038085|NCT00090363|530299934|FG000|Overall Study|Study-specific discontinuation criteria|75|||
147038086|NCT00090363|530299935|FG001|Overall Study|Study-specific discontinuation criteria|74|||
147038087|NCT00090363|530299936|FG002|Overall Study|Study-specific discontinuation criteria|62|||
147038088|NCT00090363|530299934|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147038089|NCT00090363|530299935|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147038090|NCT00090363|530299936|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
147038091|NCT00090363|530299934|FG000|Overall Study|Consent expired|7|||
147038092|NCT00090363|530299935|FG001|Overall Study|Consent expired|10|||
147038093|NCT00090363|530299936|FG002|Overall Study|Consent expired|9|||
147038094|NCT00090363|530299934|FG000|Overall Study|Reasons not specified|2|||
147038095|NCT00090363|530299935|FG001|Overall Study|Reasons not specified|1|||
147038096|NCT00090363|530299936|FG002|Overall Study|Reasons not specified|1|||
147038097|NCT00090363|530299934|FG000|Overall Study|Continuing on study off treatment|14|||
147038098|NCT00090363|530299935|FG001|Overall Study|Continuing on study off treatment|13|||
147038099|NCT00090363|530299936|FG002|Overall Study|Continuing on study off treatment|16|||
147038100|NCT03713619|530299937|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
147038101|NCT03713619|530299938|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
147038102|NCT03713619|530299939|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
147038103|NCT03713619|530299940|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
147038104|NCT03713619|530299941|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
147038105|NCT03713619|530299937|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
147038106|NCT03713619|530299938|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
147038107|NCT03713619|530299939|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
147038108|NCT03713619|530299940|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
147038109|NCT03713619|530299941|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
147038110|NCT03713619|530299937|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
147038111|NCT03713619|530299938|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
147038112|NCT03713619|530299939|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
147038113|NCT03713619|530299940|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
147038114|NCT03713619|530299941|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
147038115|NCT03713619|530299937|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
147038116|NCT03713619|530299938|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
147038117|NCT03713619|530299939|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
147038118|NCT03713619|530299940|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
147038119|NCT03713619|530299941|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
147038120|NCT03713619|530299937|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
147038121|NCT03713619|530299938|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
147038122|NCT03713619|530299939|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
147038123|NCT03713619|530299940|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
147038124|NCT03713619|530299941|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
147038125|NCT03713619|530299937|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
147038126|NCT03713619|530299938|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
147038127|NCT03713619|530299939|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
147038128|NCT03713619|530299940|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
147038129|NCT03713619|530299941|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
147038130|NCT03713619|530299937|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
147038131|NCT03713619|530299938|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
147038132|NCT03713619|530299939|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
147038133|NCT03713619|530299940|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
147038134|NCT03713619|530299941|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
147038135|NCT03713619|530299937|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
147038136|NCT03713619|530299938|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
147038137|NCT03713619|530299939|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
147038138|NCT03713619|530299940|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
147038139|NCT03713619|530299941|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
147038140|NCT03713619|530299937|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
147038141|NCT03713619|530299938|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
147038142|NCT03713619|530299939|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
147038143|NCT03713619|530299940|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
147038144|NCT03713619|530299941|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
147038145|NCT03713619|530299937|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
147038146|NCT03713619|530299938|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
147038147|NCT03713619|530299939|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
147038148|NCT03713619|530299940|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
147038149|NCT03713619|530299941|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
147038150|NCT03713619|530299937|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
147038151|NCT03713619|530299938|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
147038152|NCT03713619|530299939|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
147038153|NCT03713619|530299940|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
147038154|NCT03713619|530299941|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
147038155|NCT03713619|530299937|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
147038156|NCT03713619|530299938|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
147038157|NCT03713619|530299939|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
147038158|NCT03713619|530299940|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
147038159|NCT03713619|530299941|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
147038160|NCT03713619|530299937|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
147038161|NCT03713619|530299938|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
147038162|NCT03713619|530299939|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
147038163|NCT03713619|530299940|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
147038164|NCT03713619|530299941|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
147038165|NCT04642365|530299945|FG000|Overall Study|Death|3|||
147038166|NCT04642365|530299946|FG001|Overall Study|Death|2|||
147038167|NCT04642365|530299947|FG002|Overall Study|Death|4|||
147038168|NCT04642365|530299948|FG003|Overall Study|Death|5|||
147038169|NCT04642365|530299949|FG004|Overall Study|Death|5|||
147038170|NCT04642365|530299950|FG005|Overall Study|Death|3|||
147038171|NCT04642365|530299951|FG006|Overall Study|Death|2|||
147038172|NCT04642365|530299952|FG007|Overall Study|Death|1|||
147038173|NCT04642365|530299945|FG000|Overall Study|Physician Decision|1|||
147038174|NCT04642365|530299946|FG001|Overall Study|Physician Decision|0|||
147038175|NCT04642365|530299947|FG002|Overall Study|Physician Decision|0|||
147038176|NCT04642365|530299948|FG003|Overall Study|Physician Decision|0|||
147038177|NCT04642365|530299949|FG004|Overall Study|Physician Decision|0|||
146849738|NCT02663518|529618860|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
147038178|NCT04642365|530299950|FG005|Overall Study|Physician Decision|0|||
147038179|NCT04642365|530299951|FG006|Overall Study|Physician Decision|0|||
147038180|NCT04642365|530299952|FG007|Overall Study|Physician Decision|0|||
147038181|NCT04642365|530299945|FG000|Overall Study|Progressive Disease|1|||
147038182|NCT04642365|530299946|FG001|Overall Study|Progressive Disease|1|||
147038183|NCT04642365|530299947|FG002|Overall Study|Progressive Disease|1|||
147038184|NCT04642365|530299948|FG003|Overall Study|Progressive Disease|0|||
147038185|NCT04642365|530299949|FG004|Overall Study|Progressive Disease|0|||
147038186|NCT04642365|530299950|FG005|Overall Study|Progressive Disease|0|||
147038187|NCT04642365|530299951|FG006|Overall Study|Progressive Disease|1|||
147038188|NCT04642365|530299952|FG007|Overall Study|Progressive Disease|0|||
147038189|NCT04642365|530299945|FG000|Overall Study|Study Terminated By Sponsor|0|||
147038190|NCT04642365|530299946|FG001|Overall Study|Study Terminated By Sponsor|2|||
147038191|NCT04642365|530299947|FG002|Overall Study|Study Terminated By Sponsor|1|||
147038192|NCT04642365|530299948|FG003|Overall Study|Study Terminated By Sponsor|1|||
147038193|NCT04642365|530299949|FG004|Overall Study|Study Terminated By Sponsor|1|||
147038194|NCT04642365|530299950|FG005|Overall Study|Study Terminated By Sponsor|2|||
147038195|NCT04642365|530299951|FG006|Overall Study|Study Terminated By Sponsor|2|||
147038196|NCT04642365|530299952|FG007|Overall Study|Study Terminated By Sponsor|1|||
147038197|NCT04642365|530299945|FG000|Overall Study|Symptomatic Deterioration|1|||
147038198|NCT04642365|530299946|FG001|Overall Study|Symptomatic Deterioration|1|||
147038199|NCT04642365|530299947|FG002|Overall Study|Symptomatic Deterioration|0|||
147038200|NCT04642365|530299948|FG003|Overall Study|Symptomatic Deterioration|0|||
147038201|NCT04642365|530299949|FG004|Overall Study|Symptomatic Deterioration|0|||
147038202|NCT04642365|530299950|FG005|Overall Study|Symptomatic Deterioration|1|||
147038203|NCT04642365|530299951|FG006|Overall Study|Symptomatic Deterioration|0|||
147038204|NCT04642365|530299952|FG007|Overall Study|Symptomatic Deterioration|0|||
147038205|NCT04642365|530299945|FG000|Overall Study|Withdrawal by Subject|0|||
147038206|NCT04642365|530299946|FG001|Overall Study|Withdrawal by Subject|0|||
147038207|NCT04642365|530299947|FG002|Overall Study|Withdrawal by Subject|1|||
147038208|NCT04642365|530299948|FG003|Overall Study|Withdrawal by Subject|1|||
147038209|NCT04642365|530299949|FG004|Overall Study|Withdrawal by Subject|0|||
147038210|NCT04642365|530299950|FG005|Overall Study|Withdrawal by Subject|0|||
147038211|NCT04642365|530299951|FG006|Overall Study|Withdrawal by Subject|2|||
147038212|NCT04642365|530299952|FG007|Overall Study|Withdrawal by Subject|0|||
147038213|NCT04642365|530299945|FG000|Overall Study|Adverse Event|0|||
147038214|NCT04642365|530299946|FG001|Overall Study|Adverse Event|0|||
147038215|NCT04642365|530299947|FG002|Overall Study|Adverse Event|0|||
147038216|NCT04642365|530299948|FG003|Overall Study|Adverse Event|0|||
147038217|NCT04642365|530299949|FG004|Overall Study|Adverse Event|0|||
147038218|NCT04642365|530299950|FG005|Overall Study|Adverse Event|0|||
147038219|NCT04642365|530299951|FG006|Overall Study|Adverse Event|0|||
147038220|NCT04642365|530299952|FG007|Overall Study|Adverse Event|1|||
147038221|NCT02552212|530299953|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
147038222|NCT02552212|530299954|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
147038223|NCT02552212|530299955|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
147038224|NCT02552212|530299953|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
147038225|NCT02552212|530299954|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
147038226|NCT02552212|530299955|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
147038227|NCT02552212|530299953|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
147038228|NCT02552212|530299954|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
147038229|NCT02552212|530299955|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
147038230|NCT02552212|530299953|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
147038231|NCT02552212|530299954|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
147038232|NCT02552212|530299955|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
147038233|NCT02552212|530299953|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
147038234|NCT02552212|530299954|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
147038235|NCT02552212|530299955|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
147038236|NCT02552212|530299953|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
147038237|NCT02552212|530299954|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
147038238|NCT02552212|530299955|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
147038239|NCT02552212|530299953|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
147038240|NCT02552212|530299954|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
147038241|NCT02552212|530299955|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
146849739|NCT02663518|529618861|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
147038242|NCT02552212|530299953|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
147038243|NCT02552212|530299954|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
147038244|NCT02552212|530299955|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
147038245|NCT02552212|530299953|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
147038246|NCT02552212|530299954|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
147038247|NCT02552212|530299955|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
147038248|NCT02552212|530299953|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
147038249|NCT02552212|530299954|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
147038250|NCT02552212|530299955|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
147038251|NCT02552212|530299953|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
147038252|NCT02552212|530299954|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
147038253|NCT02552212|530299955|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
147038254|NCT02552212|530299953|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
147038255|NCT02552212|530299954|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
147038256|NCT02552212|530299955|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
147038257|NCT02552212|530299953|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
147038258|NCT02552212|530299954|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
147038259|NCT02552212|530299955|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
147038260|NCT02552212|530299953|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
147038261|NCT02552212|530299954|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
147038262|NCT02552212|530299955|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
147038263|NCT02552212|530299953|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
147038264|NCT02552212|530299954|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
147038265|NCT02552212|530299955|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
147038266|NCT02552212|530299953|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
147038267|NCT02552212|530299954|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
147038268|NCT02552212|530299955|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
147038269|NCT02552212|530299953|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
147038270|NCT02552212|530299954|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
147038271|NCT02552212|530299955|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
147038272|NCT02552212|530299953|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
147038273|NCT02552212|530299954|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
147038274|NCT02552212|530299955|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
147038275|NCT02552212|530299953|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
147038276|NCT02552212|530299954|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
147038277|NCT02552212|530299955|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
147038278|NCT02552212|530299953|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
147038279|NCT02552212|530299954|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
147038280|NCT02552212|530299955|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
147038281|NCT02552212|530299953|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
147038282|NCT02552212|530299954|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
147038283|NCT02552212|530299955|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
147038284|NCT02728843|530299956|FG000|Overall Study|Adverse Event|0|||
147038285|NCT02728843|530299957|FG001|Overall Study|Adverse Event|2|||
147038286|NCT02728843|530299958|FG002|Overall Study|Adverse Event|3|||
147038287|NCT02728843|530299959|FG003|Overall Study|Adverse Event|1|||
147038288|NCT02728843|530299960|FG004|Overall Study|Adverse Event|2|||
147038289|NCT02728843|530299956|FG000|Overall Study|Lack of Efficacy|0|||
147038290|NCT02728843|530299957|FG001|Overall Study|Lack of Efficacy|1|||
147038291|NCT02728843|530299958|FG002|Overall Study|Lack of Efficacy|1|||
147038292|NCT02728843|530299959|FG003|Overall Study|Lack of Efficacy|0|||
147038293|NCT02728843|530299960|FG004|Overall Study|Lack of Efficacy|0|||
147038294|NCT02728843|530299956|FG000|Overall Study|Protocol Violation|2|||
147038295|NCT02728843|530299957|FG001|Overall Study|Protocol Violation|0|||
147038296|NCT02728843|530299958|FG002|Overall Study|Protocol Violation|4|||
147038297|NCT02728843|530299959|FG003|Overall Study|Protocol Violation|2|||
147038298|NCT02728843|530299960|FG004|Overall Study|Protocol Violation|2|||
147038299|NCT02728843|530299956|FG000|Overall Study|Withdrawal by Subject|1|||
147038300|NCT02728843|530299957|FG001|Overall Study|Withdrawal by Subject|0|||
147038301|NCT02728843|530299958|FG002|Overall Study|Withdrawal by Subject|0|||
147038302|NCT02728843|530299959|FG003|Overall Study|Withdrawal by Subject|1|||
147038303|NCT02728843|530299960|FG004|Overall Study|Withdrawal by Subject|0|||
147038304|NCT02728843|530299956|FG000|Overall Study|Use of rescue medication|0|||
147038305|NCT02728843|530299957|FG001|Overall Study|Use of rescue medication|2|||
147038306|NCT02728843|530299958|FG002|Overall Study|Use of rescue medication|0|||
147038307|NCT02728843|530299959|FG003|Overall Study|Use of rescue medication|2|||
147038308|NCT02728843|530299960|FG004|Overall Study|Use of rescue medication|1|||
147038309|NCT01671332|530299961|FG000|Overall Study|Withdrawal by Subject|1|||
147038310|NCT01671332|530299962|FG001|Overall Study|Withdrawal by Subject|1|||
147038311|NCT00673387|530299970|FG000|Overall Study|Withdrawal by Subject|15|||
147038312|NCT00673387|530299971|FG001|Overall Study|Withdrawal by Subject|16|||
147038313|NCT00673387|530299972|FG002|Overall Study|Withdrawal by Subject|20|||
147038314|NCT00673387|530299973|FG003|Overall Study|Withdrawal by Subject|16|||
147038315|NCT00673387|530299974|FG004|Overall Study|Withdrawal by Subject|18|||
147038316|NCT00673387|530299975|FG005|Overall Study|Withdrawal by Subject|21|||
147038317|NCT00673387|530299976|FG006|Overall Study|Withdrawal by Subject|15|||
147038318|NCT00673387|530299977|FG007|Overall Study|Withdrawal by Subject|21|||
147038319|NCT00673387|530299970|FG000|Overall Study|Adverse Event|3|||
147038320|NCT00673387|530299971|FG001|Overall Study|Adverse Event|1|||
147038321|NCT00673387|530299972|FG002|Overall Study|Adverse Event|5|||
147038322|NCT00673387|530299973|FG003|Overall Study|Adverse Event|2|||
147038323|NCT00673387|530299974|FG004|Overall Study|Adverse Event|6|||
147038324|NCT00673387|530299975|FG005|Overall Study|Adverse Event|2|||
147038325|NCT00673387|530299976|FG006|Overall Study|Adverse Event|5|||
147038326|NCT00673387|530299977|FG007|Overall Study|Adverse Event|5|||
147038327|NCT00673387|530299970|FG000|Overall Study|Physician Decision|0|||
147038328|NCT00673387|530299971|FG001|Overall Study|Physician Decision|0|||
147038329|NCT00673387|530299972|FG002|Overall Study|Physician Decision|0|||
147038330|NCT00673387|530299973|FG003|Overall Study|Physician Decision|0|||
147038331|NCT00673387|530299974|FG004|Overall Study|Physician Decision|0|||
147038332|NCT00673387|530299975|FG005|Overall Study|Physician Decision|5|||
147038333|NCT00673387|530299976|FG006|Overall Study|Physician Decision|1|||
147038334|NCT00673387|530299977|FG007|Overall Study|Physician Decision|1|||
147038335|NCT00673387|530299970|FG000|Overall Study|Protocol Violation|3|||
147038336|NCT00673387|530299971|FG001|Overall Study|Protocol Violation|0|||
147038337|NCT00673387|530299972|FG002|Overall Study|Protocol Violation|1|||
147038338|NCT00673387|530299973|FG003|Overall Study|Protocol Violation|2|||
147038339|NCT00673387|530299974|FG004|Overall Study|Protocol Violation|0|||
147038340|NCT00673387|530299975|FG005|Overall Study|Protocol Violation|1|||
147038341|NCT00673387|530299976|FG006|Overall Study|Protocol Violation|1|||
147038342|NCT00673387|530299977|FG007|Overall Study|Protocol Violation|3|||
147038343|NCT00673387|530299970|FG000|Overall Study|Lost to Follow-up|8|||
147038344|NCT00673387|530299971|FG001|Overall Study|Lost to Follow-up|6|||
147038345|NCT00673387|530299972|FG002|Overall Study|Lost to Follow-up|5|||
147038346|NCT00673387|530299973|FG003|Overall Study|Lost to Follow-up|6|||
147038347|NCT00673387|530299974|FG004|Overall Study|Lost to Follow-up|6|||
147038348|NCT00673387|530299975|FG005|Overall Study|Lost to Follow-up|5|||
147038349|NCT00673387|530299976|FG006|Overall Study|Lost to Follow-up|8|||
147038350|NCT00673387|530299977|FG007|Overall Study|Lost to Follow-up|5|||
147038351|NCT00418821|530299978|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
147038352|NCT04400682|530299983|FG000|Period 1|Withdrawal by Subject|1|||
147038353|NCT04400682|530299984|FG001|Period 1|Withdrawal by Subject|4|||
147038354|NCT02105974|530299985|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
147038355|NCT02105974|530299986|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
147038356|NCT02105974|530299987|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
147038357|NCT02105974|530299985|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
147038358|NCT02105974|530299986|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
147038359|NCT02105974|530299987|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
147038360|NCT02105974|530299985|FG000|2 Week Run-in Period|Adverse Event|6|||
147038361|NCT02105974|530299986|FG001|2 Week Run-in Period|Adverse Event|0|||
147038362|NCT02105974|530299987|FG002|2 Week Run-in Period|Adverse Event|0|||
147038363|NCT02105974|530299985|FG000|2 Week Run-in Period|Study closed/terminated|1|||
147038364|NCT02105974|530299986|FG001|2 Week Run-in Period|Study closed/terminated|0|||
147038365|NCT02105974|530299987|FG002|2 Week Run-in Period|Study closed/terminated|0|||
147038366|NCT02105974|530299985|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
147038367|NCT02105974|530299986|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
147038368|NCT02105974|530299987|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
147038369|NCT02105974|530299985|FG000|2 Week Run-in Period|Withdrew consent|23|||
147038370|NCT02105974|530299986|FG001|2 Week Run-in Period|Withdrew consent|0|||
147038371|NCT02105974|530299987|FG002|2 Week Run-in Period|Withdrew consent|0|||
147038372|NCT02105974|530299985|FG000|2 Week Run-in Period|Investigator discretion|8|||
147038373|NCT02105974|530299986|FG001|2 Week Run-in Period|Investigator discretion|0|||
147038374|NCT02105974|530299987|FG002|2 Week Run-in Period|Investigator discretion|0|||
147038375|NCT02105974|530299985|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
147038376|NCT02105974|530299986|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
147038377|NCT02105974|530299987|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
147038378|NCT02105974|530299985|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
147038379|NCT02105974|530299986|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
147038380|NCT02105974|530299987|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
147038381|NCT02105974|530299985|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
147038382|NCT02105974|530299986|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
147038383|NCT02105974|530299987|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
147038384|NCT02105974|530299985|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
147038385|NCT02105974|530299986|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
147038386|NCT02105974|530299987|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
147038387|NCT02105974|530299985|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
147038388|NCT02105974|530299986|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
147038389|NCT02105974|530299987|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
147038390|NCT02105974|530299985|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
147038391|NCT02105974|530299986|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
147038392|NCT02105974|530299987|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
147038393|NCT02105974|530299985|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
147038394|NCT02105974|530299986|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
147038395|NCT02105974|530299987|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
147038396|NCT00477633|530299988|FG000|Overall Study|Did not receive treatment|23|||
147038397|NCT00477633|530299988|FG000|Overall Study|Adverse Event|143|||
147038398|NCT00477633|530299988|FG000|Overall Study|Pregnancy|23|||
147038399|NCT00477633|530299988|FG000|Overall Study|Lost to Follow-up|271|||
147038400|NCT00477633|530299988|FG000|Overall Study|Withdrawal by Subject|149|||
146849740|NCT02663518|529618862|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
146849741|NCT02663518|529618863|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
146849742|NCT02663518|529618864|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
146849743|NCT02663518|529618851|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146849744|NCT02663518|529618852|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146849745|NCT02663518|529618853|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146849746|NCT02663518|529618854|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146849747|NCT02663518|529618855|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146849748|NCT02663518|529618856|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
147038401|NCT00477633|530299988|FG000|Overall Study|Protocol Violation|25|||
147038402|NCT00477633|530299988|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
147038403|NCT02968849|530299989|FG000|Overall Study|Death|8|||
147038404|NCT02968849|530299990|FG001|Overall Study|Death|10|||
147038405|NCT02968849|530299989|FG000|Overall Study|Lost to Follow-up|31|||
147038406|NCT02968849|530299990|FG001|Overall Study|Lost to Follow-up|29|||
147038407|NCT02968849|530299989|FG000|Overall Study|Withdrawal by Subject|73|||
147038408|NCT02968849|530299990|FG001|Overall Study|Withdrawal by Subject|64|||
147038409|NCT02968849|530299989|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
147038410|NCT02968849|530299990|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
147038411|NCT02968849|530299989|FG000|Overall Study|Physician Decision|6|||
147038412|NCT02968849|530299990|FG001|Overall Study|Physician Decision|9|||
147038413|NCT02968849|530299989|FG000|Overall Study|Other|16|||
147038414|NCT02968849|530299990|FG001|Overall Study|Other|10|||
147038415|NCT00478244|530301588|FG000|Overall Study|Did not receive transplant|1|||
147038416|NCT00459043|530301589|FG000|Overall Study|Withdrawal by Subject|1|||
147038417|NCT00459043|530301590|FG001|Overall Study|Withdrawal by Subject|0|||
147038418|NCT01392963|530301591|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
147038419|NCT01392963|530301592|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
147038420|NCT01392963|530301591|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
147038421|NCT01392963|530301592|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
147038422|NCT01392963|530301591|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
147038423|NCT01392963|530301592|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
147038424|NCT03156504|530301596|FG000|Overall Study|Withdrawal by Subject|1|||
147038425|NCT03333941|530301597|FG000|Overall Study|Lost to Follow-up|10|||
147038426|NCT03333941|530301597|FG000|Overall Study|Death|2|||
147038427|NCT03333941|530301597|FG000|Overall Study|Adverse Event|1|||
147038428|NCT00580788|530301598|FG000|Overall Study|Adverse Event|0|||
147038429|NCT00580788|530301599|FG001|Overall Study|Adverse Event|0|||
147038430|NCT00580788|530301600|FG002|Overall Study|Adverse Event|0|||
147038431|NCT00580788|530301601|FG003|Overall Study|Adverse Event|1|||
147038432|NCT03301649|530301604|FG000|Overall Study|Need alternate therapy due to live lice|17|||
147038433|NCT03301649|530301605|FG001|Overall Study|Need alternate therapy due to live lice|25|||
147038434|NCT03301649|530301606|FG002|Overall Study|Need alternate therapy due to live lice|81|||
147038435|NCT03301649|530301604|FG000|Overall Study|Lost to Follow-up|11|||
147038436|NCT03301649|530301605|FG001|Overall Study|Lost to Follow-up|11|||
147038437|NCT03301649|530301606|FG002|Overall Study|Lost to Follow-up|3|||
147038438|NCT03301649|530301604|FG000|Overall Study|Protocol Violation|0|||
147038439|NCT03301649|530301605|FG001|Overall Study|Protocol Violation|1|||
147038440|NCT03301649|530301606|FG002|Overall Study|Protocol Violation|1|||
147038441|NCT03301649|530301604|FG000|Overall Study|Withdrawal by Subject|10|||
147038442|NCT03301649|530301605|FG001|Overall Study|Withdrawal by Subject|4|||
147038443|NCT03301649|530301606|FG002|Overall Study|Withdrawal by Subject|0|||
147038444|NCT03301649|530301604|FG000|Overall Study|Other than specified|5|||
147038445|NCT03301649|530301605|FG001|Overall Study|Other than specified|3|||
147038446|NCT03301649|530301606|FG002|Overall Study|Other than specified|0|||
147038447|NCT01403051|530301607|FG000|Overall Study|Protocol Violation|2|||
147038448|NCT01403051|530301608|FG001|Overall Study|Protocol Violation|0|||
147038449|NCT01403051|530301607|FG000|Overall Study|Death|1|||
147038450|NCT01403051|530301608|FG001|Overall Study|Death|0|||
147038451|NCT01403051|530301607|FG000|Overall Study|Withdrawal by Subject|2|||
147038452|NCT01403051|530301608|FG001|Overall Study|Withdrawal by Subject|1|||
147038453|NCT01403051|530301607|FG000|Overall Study|Lost to Follow-up|5|||
147038454|NCT01403051|530301608|FG001|Overall Study|Lost to Follow-up|5|||
147038455|NCT00887289|530301613|FG000|Overall Study|Lack of Efficacy|14|||
147038456|NCT00887289|530301613|FG000|Overall Study|Adverse Event|27|||
147038457|NCT00887289|530301613|FG000|Overall Study|Withdrawal by Subject|26|||
147038458|NCT00887289|530301613|FG000|Overall Study|Lost to Follow-up|8|||
147038459|NCT00887289|530301613|FG000|Overall Study|Other|20|||
147038460|NCT03022084|530301614|FG000|Overall Study|Lost to Follow-up|2|||
147038461|NCT03022084|530301615|FG001|Overall Study|Lost to Follow-up|3|||
147038462|NCT02932306|530301619|FG000|Overall Study|Withdrawal by Subject|16|||
147038463|NCT02932306|530301620|FG001|Overall Study|Withdrawal by Subject|25|||
147038464|NCT02932306|530301619|FG000|Overall Study|Adverse Event|3|||
147038465|NCT02932306|530301620|FG001|Overall Study|Adverse Event|0|||
147038466|NCT02932306|530301619|FG000|Overall Study|Pregnancy|2|||
147038467|NCT02932306|530301620|FG001|Overall Study|Pregnancy|0|||
147038468|NCT02932306|530301619|FG000|Overall Study|Protocol Violation|1|||
147038469|NCT02932306|530301620|FG001|Overall Study|Protocol Violation|1|||
147038470|NCT02932306|530301619|FG000|Overall Study|Noncompliance with Study Drug|1|||
147038471|NCT02932306|530301620|FG001|Overall Study|Noncompliance with Study Drug|1|||
147038472|NCT02932306|530301619|FG000|Overall Study|Lost to Follow-up|36|||
147038473|NCT02932306|530301620|FG001|Overall Study|Lost to Follow-up|40|||
147038474|NCT02932306|530301619|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
147038475|NCT02932306|530301620|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
147038476|NCT02932306|530301619|FG000|Overall Study|Lack of Efficacy|0|||
147038477|NCT02932306|530301620|FG001|Overall Study|Lack of Efficacy|2|||
147038478|NCT02932306|530301619|FG000|Overall Study|Worsening condition|2|||
147038479|NCT02932306|530301620|FG001|Overall Study|Worsening condition|0|||
147038480|NCT02932306|530301619|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
147038481|NCT02932306|530301620|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
147038482|NCT03559400|530301625|FG000|Overall Study|Lost to Follow-up|9|||
147038483|NCT03559400|530301626|FG001|Overall Study|Lost to Follow-up|7|||
147038484|NCT03559400|530301625|FG000|Overall Study|Death|0|||
147038485|NCT03559400|530301626|FG001|Overall Study|Death|2|||
147038486|NCT00509366|530301627|FG000|Overall Study|Not Treated (Screen Failure)|1|||
147038487|NCT00509366|530301628|FG001|Overall Study|Not Treated (Screen Failure)|1|||
147038488|NCT00509366|530301629|FG002|Overall Study|Not Treated (Screen Failure)|1|||
147038489|NCT00509366|530301630|FG003|Overall Study|Not Treated (Screen Failure)|0|||
147038490|NCT00509366|530301631|FG004|Overall Study|Not Treated (Screen Failure)|0|||
147038491|NCT00282919|530301634|FG000|Overall Study|Lack of Efficacy|4|||
147038492|NCT00282919|530301634|FG000|Overall Study|Withdrawal by Subject|1|||
147038493|NCT00282919|530301634|FG000|Overall Study|Asymptomatic Parasitemia|2|||
147038494|NCT01433549|530301635|FG000|Phase 2: Second Study Product|Adverse Event|0|||
147038495|NCT01433549|530301636|FG001|Phase 2: Second Study Product|Adverse Event|1|||
147038496|NCT01438996|530301637|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
147038497|NCT01438996|530301638|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
147038498|NCT01438996|530301639|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
147038499|NCT00603837|530301644|FG000|Overall Study|Physician Decision|3|||
147038500|NCT00603837|530301645|FG001|Overall Study|Physician Decision|0|||
147038501|NCT04611529|530301646|FG000|2-day Follow up|Lost to Follow-up|5|||
147038502|NCT04611529|530301647|FG001|2-day Follow up|Lost to Follow-up|6|||
147038503|NCT04611529|530301648|FG002|2-day Follow up|Lost to Follow-up|3|||
147038504|NCT00425373|530301649|FG000|Overall Study|Adverse Event|2|||
147038505|NCT00425373|530301650|FG001|Overall Study|Adverse Event|2|||
147038506|NCT00425373|530301651|FG002|Overall Study|Adverse Event|0|||
147038507|NCT00425373|530301652|FG003|Overall Study|Adverse Event|1|||
147038508|NCT00425373|530301653|FG004|Overall Study|Adverse Event|4|||
147038509|NCT00425373|530301654|FG005|Overall Study|Adverse Event|6|||
147038510|NCT00425373|530301655|FG006|Overall Study|Adverse Event|2|||
147038511|NCT00425373|530301656|FG007|Overall Study|Adverse Event|3|||
147038512|NCT00425373|530301657|FG008|Overall Study|Adverse Event|8|||
147038513|NCT00425373|530301649|FG000|Overall Study|Lost to Follow-up|0|||
147038514|NCT00425373|530301650|FG001|Overall Study|Lost to Follow-up|1|||
147038515|NCT00425373|530301651|FG002|Overall Study|Lost to Follow-up|0|||
147038516|NCT00425373|530301652|FG003|Overall Study|Lost to Follow-up|0|||
147038517|NCT00425373|530301653|FG004|Overall Study|Lost to Follow-up|1|||
147038518|NCT00425373|530301654|FG005|Overall Study|Lost to Follow-up|0|||
147038519|NCT00425373|530301655|FG006|Overall Study|Lost to Follow-up|0|||
147038520|NCT00425373|530301656|FG007|Overall Study|Lost to Follow-up|0|||
147038521|NCT00425373|530301657|FG008|Overall Study|Lost to Follow-up|0|||
147038522|NCT00425373|530301649|FG000|Overall Study|Protocol Violation|1|||
147038523|NCT00425373|530301650|FG001|Overall Study|Protocol Violation|0|||
147038524|NCT00425373|530301651|FG002|Overall Study|Protocol Violation|1|||
147038525|NCT00425373|530301652|FG003|Overall Study|Protocol Violation|0|||
147038526|NCT00425373|530301653|FG004|Overall Study|Protocol Violation|0|||
147038527|NCT00425373|530301654|FG005|Overall Study|Protocol Violation|0|||
147038528|NCT00425373|530301655|FG006|Overall Study|Protocol Violation|0|||
147038529|NCT00425373|530301656|FG007|Overall Study|Protocol Violation|5|||
147038530|NCT00425373|530301657|FG008|Overall Study|Protocol Violation|3|||
147038531|NCT00425373|530301649|FG000|Overall Study|Withdrawal by Subject|2|||
147038532|NCT00425373|530301650|FG001|Overall Study|Withdrawal by Subject|0|||
147038533|NCT00425373|530301651|FG002|Overall Study|Withdrawal by Subject|2|||
147038534|NCT00425373|530301652|FG003|Overall Study|Withdrawal by Subject|1|||
147038535|NCT00425373|530301653|FG004|Overall Study|Withdrawal by Subject|4|||
147038536|NCT00425373|530301654|FG005|Overall Study|Withdrawal by Subject|0|||
147038537|NCT00425373|530301655|FG006|Overall Study|Withdrawal by Subject|2|||
147038538|NCT00425373|530301656|FG007|Overall Study|Withdrawal by Subject|2|||
147038539|NCT00425373|530301657|FG008|Overall Study|Withdrawal by Subject|2|||
147038540|NCT00425373|530301649|FG000|Overall Study|Lack of Efficacy|0|||
147038541|NCT00425373|530301650|FG001|Overall Study|Lack of Efficacy|0|||
147038542|NCT00425373|530301651|FG002|Overall Study|Lack of Efficacy|0|||
147038543|NCT00425373|530301652|FG003|Overall Study|Lack of Efficacy|0|||
147038544|NCT00425373|530301653|FG004|Overall Study|Lack of Efficacy|1|||
147038545|NCT00425373|530301654|FG005|Overall Study|Lack of Efficacy|3|||
147038546|NCT00425373|530301655|FG006|Overall Study|Lack of Efficacy|3|||
147038547|NCT00425373|530301656|FG007|Overall Study|Lack of Efficacy|0|||
147038548|NCT00425373|530301657|FG008|Overall Study|Lack of Efficacy|5|||
147038549|NCT02960490|530301658|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
147038550|NCT02960490|530301659|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
147038551|NCT02960490|530301660|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
147038552|NCT02960490|530301661|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
147038553|NCT02960490|530301662|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
147038554|NCT02960490|530301663|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
147038555|NCT02960490|530301664|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
147038556|NCT02960490|530301665|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
147038557|NCT02960490|530301666|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
147038558|NCT02960490|530301667|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
147038559|NCT02960490|530301658|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147038560|NCT02960490|530301659|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
147038561|NCT02960490|530301660|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147038562|NCT02960490|530301661|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147038563|NCT02960490|530301662|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147038564|NCT02960490|530301663|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147038565|NCT02960490|530301664|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147038566|NCT02960490|530301665|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147038567|NCT02960490|530301666|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147038568|NCT02960490|530301667|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147038569|NCT02960490|530301658|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
147038570|NCT02960490|530301659|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
147038571|NCT02960490|530301660|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
147038572|NCT02960490|530301661|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
147038573|NCT02960490|530301662|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
147038574|NCT02960490|530301663|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
147038575|NCT02960490|530301664|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
147038576|NCT02960490|530301665|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
147038577|NCT02960490|530301666|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
147038578|NCT02960490|530301667|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
147038579|NCT02960490|530301658|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
147038580|NCT02960490|530301659|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
147038581|NCT02960490|530301660|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
147038582|NCT02960490|530301661|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
147038583|NCT02960490|530301662|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
147038584|NCT02960490|530301663|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
147038585|NCT02960490|530301664|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
147038586|NCT02960490|530301665|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
147038587|NCT02960490|530301666|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
147038588|NCT02960490|530301667|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
147038589|NCT02960490|530301658|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
147038590|NCT02960490|530301659|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
147038591|NCT02960490|530301660|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
147038592|NCT02960490|530301661|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
147038593|NCT02960490|530301662|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
147038594|NCT02960490|530301663|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
147038595|NCT02960490|530301664|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
147038596|NCT02960490|530301665|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
147038597|NCT02960490|530301666|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
147038598|NCT02960490|530301667|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
147038599|NCT02960490|530301658|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
147038600|NCT02960490|530301659|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
147038601|NCT02960490|530301660|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
147038602|NCT02960490|530301661|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
147038603|NCT02960490|530301662|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
147038604|NCT02960490|530301663|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
147038605|NCT02960490|530301664|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
147038606|NCT02960490|530301665|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
147038607|NCT02960490|530301666|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
147038608|NCT02960490|530301667|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
147038609|NCT02960490|530301658|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
147038610|NCT02960490|530301659|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
147038611|NCT02960490|530301660|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
147038612|NCT02960490|530301661|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
147038613|NCT02960490|530301662|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
147038614|NCT02960490|530301663|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
147038615|NCT02960490|530301664|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
147038616|NCT02960490|530301665|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
147038617|NCT02960490|530301666|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
147038618|NCT02960490|530301667|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
147038619|NCT02960490|530301658|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
147038620|NCT02960490|530301659|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
147038621|NCT02960490|530301660|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
147038622|NCT02960490|530301661|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
147038623|NCT02960490|530301662|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
147038624|NCT02960490|530301663|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
147038625|NCT02960490|530301664|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
147038626|NCT02960490|530301665|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
147038627|NCT02960490|530301666|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
147038628|NCT02960490|530301667|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
147038629|NCT02960490|530301658|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147038630|NCT02960490|530301659|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147038631|NCT02960490|530301660|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147038632|NCT02960490|530301661|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147038633|NCT02960490|530301662|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147038634|NCT02960490|530301663|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147038635|NCT02960490|530301664|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147038636|NCT02960490|530301665|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
147038637|NCT02960490|530301666|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147038638|NCT02960490|530301667|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147038639|NCT02960490|530301658|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
147038640|NCT02960490|530301659|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
147038641|NCT02960490|530301660|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
147038642|NCT02960490|530301661|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
147038643|NCT02960490|530301662|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
147038644|NCT02960490|530301663|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
147038645|NCT02960490|530301664|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
147038646|NCT02960490|530301665|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
147038647|NCT02960490|530301666|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
147038648|NCT02960490|530301667|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
147038649|NCT02960490|530301658|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147038650|NCT02960490|530301659|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147038651|NCT02960490|530301660|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147038652|NCT02960490|530301661|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147038653|NCT02960490|530301662|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147038654|NCT02960490|530301663|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147038655|NCT02960490|530301664|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
147038656|NCT02960490|530301665|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147038657|NCT02960490|530301666|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147038658|NCT02960490|530301667|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147038659|NCT02960490|530301658|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
147038660|NCT02960490|530301659|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
147038661|NCT02960490|530301660|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
147038662|NCT02960490|530301661|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
147038663|NCT02960490|530301662|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
147038664|NCT02960490|530301663|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
147038665|NCT02960490|530301664|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
147038666|NCT02960490|530301665|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
147038667|NCT02960490|530301666|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
147038668|NCT02960490|530301667|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
147038669|NCT02842073|530301671|FG000|Overall Study|Withdrawal by Subject|1|||
147038670|NCT01333397|530301672|FG000|Overall Study|Lost to Follow-up|1|||
147038671|NCT01333397|530301673|FG001|Overall Study|Lost to Follow-up|0|||
147038672|NCT01333397|530301674|FG002|Overall Study|Lost to Follow-up|0|||
147038673|NCT01333397|530301675|FG003|Overall Study|Lost to Follow-up|1|||
147038674|NCT01333397|530301676|FG004|Overall Study|Lost to Follow-up|0|||
147038675|NCT01085357|530301677|FG000|Overall Study|Adverse Event|1|||
147038676|NCT01085357|530301678|FG001|Overall Study|Adverse Event|1|||
147038677|NCT01085357|530301677|FG000|Overall Study|Subject Decision|4|||
147038678|NCT01085357|530301678|FG001|Overall Study|Subject Decision|3|||
147038679|NCT01085357|530301677|FG000|Overall Study|Investigator Decision|1|||
147038680|NCT01085357|530301678|FG001|Overall Study|Investigator Decision|1|||
147038681|NCT01085357|530301677|FG000|Overall Study|Death|11|||
147038682|NCT01085357|530301678|FG001|Overall Study|Death|1|||
147038683|NCT01085357|530301677|FG000|Overall Study|Lost to Follow-up|2|||
147038684|NCT01085357|530301678|FG001|Overall Study|Lost to Follow-up|0|||
147038685|NCT05320887|530301683|FG000|Overall Study|Lost to Follow-up|0|||
147038686|NCT05320887|530301684|FG001|Overall Study|Lost to Follow-up|3|||
147038687|NCT05320887|530301685|FG002|Overall Study|Lost to Follow-up|0|||
147038688|NCT05320887|530301686|FG003|Overall Study|Lost to Follow-up|0|||
147038689|NCT02910011|530301689|FG000|Overall Study|Physician Decision|2|||
147038690|NCT02460679|530301690|FG000|Overall Study|Investigator Decision|1|||
147038691|NCT02460679|530301690|FG000|Overall Study|Withdrawal by Subject|4|||
147038692|NCT00920790|530301691|FG000|Overall Study|aggravation of general condition|14|||
147038693|NCT04411914|530301692|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
147038694|NCT04411914|530301693|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
147038695|NCT02015065|530301700|FG000|Overall Study|Death on study|1|||
147038696|NCT02015065|530301701|FG001|Overall Study|Death on study|2|||
147038697|NCT02015065|530301702|FG002|Overall Study|Death on study|1|||
147038698|NCT00478426|530301703|FG000|Overall Study|Withdrawal by Subject|1|||
147038699|NCT00789737|530301708|FG000|Overall Study|Withdrawal by Subject|13|||
147038700|NCT00789737|530301709|FG001|Overall Study|Withdrawal by Subject|22|||
147038701|NCT00789737|530301708|FG000|Overall Study|Lost to Follow-up|10|||
147038702|NCT00789737|530301709|FG001|Overall Study|Lost to Follow-up|14|||
147038703|NCT00789737|530301708|FG000|Overall Study|Adverse Event|8|||
147038704|NCT00789737|530301709|FG001|Overall Study|Adverse Event|8|||
147038705|NCT00789737|530301708|FG000|Overall Study|Protocol Violation|3|||
147038706|NCT00789737|530301709|FG001|Overall Study|Protocol Violation|0|||
147038707|NCT00789737|530301708|FG000|Overall Study|Lack of Efficacy|3|||
147038708|NCT00789737|530301709|FG001|Overall Study|Lack of Efficacy|0|||
147038709|NCT00789737|530301708|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
147038710|NCT00789737|530301709|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
147038711|NCT00789737|530301708|FG000|Overall Study|Other|11|||
147038712|NCT00789737|530301709|FG001|Overall Study|Other|7|||
147038713|NCT01189487|530301710|FG000|Overall Study|Lack of Efficacy|2|||
147038714|NCT01189487|530301710|FG000|Overall Study|Adverse Event|1|||
147038715|NCT04630158|530301711|FG000|Overall Study|Adverse Event|1|||
147038716|NCT04630158|530301712|FG001|Overall Study|Adverse Event|1|||
147038717|NCT04630158|530301713|FG002|Overall Study|Adverse Event|1|||
147038718|NCT04630158|530301711|FG000|Overall Study|Physician Decision|0|||
147038719|NCT04630158|530301712|FG001|Overall Study|Physician Decision|2|||
147038720|NCT04630158|530301713|FG002|Overall Study|Physician Decision|0|||
147038721|NCT04630158|530301711|FG000|Overall Study|Protocol Violation|1|||
147038722|NCT04630158|530301712|FG001|Overall Study|Protocol Violation|0|||
147038723|NCT04630158|530301713|FG002|Overall Study|Protocol Violation|1|||
147038724|NCT04630158|530301711|FG000|Overall Study|Withdrawal by Subject|2|||
147038725|NCT04630158|530301712|FG001|Overall Study|Withdrawal by Subject|1|||
147038726|NCT04630158|530301713|FG002|Overall Study|Withdrawal by Subject|2|||
147038727|NCT03136965|530301717|FG000|Overall Study|Lost to Follow-up|0|||
147038728|NCT03136965|530301718|FG001|Overall Study|Lost to Follow-up|1|||
147038729|NCT03136965|530301719|FG002|Overall Study|Lost to Follow-up|0|||
147038730|NCT01210612|530301721|FG000|Overall Study|Withdrawal by Subject|0|||
147038731|NCT01210612|530301722|FG001|Overall Study|Withdrawal by Subject|2|||
147038732|NCT05293639|530301723|FG000|Overall Study|Withdrawal by Subject|1|||
147038733|NCT05293639|530301724|FG001|Overall Study|Withdrawal by Subject|1|||
147038734|NCT05293639|530301725|FG002|Overall Study|Withdrawal by Subject|2|||
147038735|NCT05293639|530301723|FG000|Overall Study|Death|0|||
147038736|NCT05293639|530301724|FG001|Overall Study|Death|1|||
147038737|NCT05293639|530301725|FG002|Overall Study|Death|0|||
147038738|NCT05293639|530301723|FG000|Overall Study|Lost to Follow-up|0|||
147038739|NCT05293639|530301724|FG001|Overall Study|Lost to Follow-up|0|||
147038740|NCT05293639|530301725|FG002|Overall Study|Lost to Follow-up|5|||
147038741|NCT05293639|530301723|FG000|Overall Study|Other|0|||
147038742|NCT05293639|530301724|FG001|Overall Study|Other|0|||
147038743|NCT05293639|530301725|FG002|Overall Study|Other|1|||
147038744|NCT00813800|530301731|FG000|Overall Study|Screen Failure after Consent|2|||
147038745|NCT00813800|530301731|FG000|Overall Study|Adverse Event|1|||
147038746|NCT00813800|530301731|FG000|Overall Study|Worsening of depression|2|||
147038747|NCT00813800|530301731|FG000|Overall Study|Physician Decision|1|||
147038748|NCT01860677|530301732|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
147038749|NCT01860677|530301733|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
147038750|NCT01144715|530301734|FG000|Overall Study|Lost to Follow-up|2|||
147038751|NCT01144715|530301735|FG001|Overall Study|Lost to Follow-up|1|||
147038752|NCT01144715|530301734|FG000|Overall Study|Withdrawal by Subject|2|||
147038753|NCT01144715|530301735|FG001|Overall Study|Withdrawal by Subject|1|||
147038754|NCT01144715|530301734|FG000|Overall Study|Adverse Event|0|||
147038755|NCT01144715|530301735|FG001|Overall Study|Adverse Event|1|||
147038756|NCT03553576|530301736|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
147038757|NCT03553576|530301737|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
147038758|NCT03553576|530301736|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
147038759|NCT03553576|530301737|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
147038760|NCT03553576|530301736|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
147038761|NCT03553576|530301737|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
147038762|NCT03553576|530301736|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
147038763|NCT03553576|530301737|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
147038764|NCT03553576|530301736|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
147038765|NCT03553576|530301737|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
147038766|NCT03553576|530301736|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
147038767|NCT03553576|530301737|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
147038768|NCT03553576|530301736|FG000|Overall Study|Physician Decision|2|||
147038769|NCT03553576|530301737|FG001|Overall Study|Physician Decision|5|||
147038770|NCT02056392|530301742|FG000|Overall Study|Lost to Follow-up|0|||
147038771|NCT02056392|530301743|FG001|Overall Study|Lost to Follow-up|1|||
147038772|NCT02056392|530301744|FG002|Overall Study|Lost to Follow-up|2|||
147038773|NCT02056392|530301745|FG003|Overall Study|Lost to Follow-up|0|||
147038774|NCT02056392|530301746|FG004|Overall Study|Lost to Follow-up|0|||
147038775|NCT02056392|530301747|FG005|Overall Study|Lost to Follow-up|0|||
147038776|NCT02056392|530301742|FG000|Overall Study|Protocol Violation|1|||
147038777|NCT02056392|530301743|FG001|Overall Study|Protocol Violation|0|||
147038778|NCT02056392|530301744|FG002|Overall Study|Protocol Violation|1|||
147038779|NCT02056392|530301745|FG003|Overall Study|Protocol Violation|0|||
147038780|NCT02056392|530301746|FG004|Overall Study|Protocol Violation|0|||
147038781|NCT02056392|530301747|FG005|Overall Study|Protocol Violation|0|||
147038782|NCT02056392|530301742|FG000|Overall Study|Withdrawal by Subject|1|||
147038783|NCT02056392|530301743|FG001|Overall Study|Withdrawal by Subject|0|||
147038784|NCT02056392|530301744|FG002|Overall Study|Withdrawal by Subject|0|||
147038785|NCT02056392|530301745|FG003|Overall Study|Withdrawal by Subject|0|||
147038786|NCT02056392|530301746|FG004|Overall Study|Withdrawal by Subject|1|||
147038787|NCT02056392|530301747|FG005|Overall Study|Withdrawal by Subject|0|||
147038788|NCT01806506|530301748|FG000|Overall Study|Lost to Follow-up|2|||
147038789|NCT01806506|530301749|FG001|Overall Study|Lost to Follow-up|1|||
147038790|NCT02092467|530301752|FG000|Overall Study|Death|49|||
147038791|NCT02092467|530301753|FG001|Overall Study|Death|66|||
147038792|NCT02092467|530301754|FG002|Overall Study|Death|38|||
147038793|NCT02092467|530301752|FG000|Overall Study|Lost to Follow-up|38|||
147038794|NCT02092467|530301753|FG001|Overall Study|Lost to Follow-up|35|||
147038795|NCT02092467|530301754|FG002|Overall Study|Lost to Follow-up|40|||
147038796|NCT02092467|530301752|FG000|Overall Study|Global Deterioration of Health Status|1|||
147038797|NCT02092467|530301753|FG001|Overall Study|Global Deterioration of Health Status|0|||
147038798|NCT02092467|530301754|FG002|Overall Study|Global Deterioration of Health Status|0|||
147038799|NCT02092467|530301752|FG000|Overall Study|Other|32|||
147038800|NCT02092467|530301753|FG001|Overall Study|Other|30|||
147038801|NCT02092467|530301754|FG002|Overall Study|Other|24|||
146849749|NCT02663518|529618857|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146849750|NCT02663518|529618858|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146849751|NCT02663518|529618859|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146849752|NCT02663518|529618860|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146849753|NCT02663518|529618861|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146849754|NCT02663518|529618862|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146849755|NCT02663518|529618863|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
146849756|NCT02663518|529618864|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146849757|NCT01144052|529618867|FG000|Overall Study|Withdrawal by Subject|1|||
146849758|NCT01144052|529618868|FG001|Overall Study|Withdrawal by Subject|1|||
146849759|NCT03836716|529618872|FG000|Overall Study|Adverse Event|3|||
146849760|NCT03836716|529618872|FG000|Overall Study|Death|22|||
146849761|NCT03836716|529618872|FG000|Overall Study|Withdrawal by Subject|8|||
146849762|NCT03836716|529618872|FG000|Overall Study|Study terminated by sponsor|87|||
146849763|NCT01879722|529618873|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
147038802|NCT02092467|530301752|FG000|Overall Study|Withdrawal by Subject|282|||
147038803|NCT02092467|530301753|FG001|Overall Study|Withdrawal by Subject|327|||
147038804|NCT02092467|530301754|FG002|Overall Study|Withdrawal by Subject|289|||
147038805|NCT02092467|530301752|FG000|Overall Study|Randomized but not treated|2|||
147038806|NCT02092467|530301753|FG001|Overall Study|Randomized but not treated|1|||
147038807|NCT02092467|530301754|FG002|Overall Study|Randomized but not treated|7|||
147038808|NCT02952898|530301757|FG000|Overall Study|Withdrawal by Subject|10|||
147038809|NCT02952898|530301758|FG001|Overall Study|Withdrawal by Subject|8|||
147038810|NCT02952898|530301759|FG002|Overall Study|Withdrawal by Subject|8|||
147038811|NCT02952898|530301757|FG000|Overall Study|Adverse Event|8|||
147038812|NCT02952898|530301758|FG001|Overall Study|Adverse Event|8|||
147038813|NCT02952898|530301759|FG002|Overall Study|Adverse Event|3|||
147038814|NCT02952898|530301757|FG000|Overall Study|Lost to Follow-up|3|||
147038815|NCT02952898|530301758|FG001|Overall Study|Lost to Follow-up|2|||
147038816|NCT02952898|530301759|FG002|Overall Study|Lost to Follow-up|2|||
147038817|NCT02952898|530301757|FG000|Overall Study|Non-compliance with study drug|1|||
147038818|NCT02952898|530301758|FG001|Overall Study|Non-compliance with study drug|1|||
147038819|NCT02952898|530301759|FG002|Overall Study|Non-compliance with study drug|2|||
147038820|NCT04844762|530301762|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147038821|NCT04844762|530301763|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147038822|NCT04844762|530301764|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
147038823|NCT04844762|530301765|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147038824|NCT04844762|530301766|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147038825|NCT04844762|530301767|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147038826|NCT04844762|530301762|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
147038827|NCT04844762|530301763|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
147038828|NCT04844762|530301764|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
147038829|NCT04844762|530301765|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
147038830|NCT04844762|530301766|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
147038831|NCT04844762|530301767|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
147038832|NCT04844762|530301762|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147038833|NCT04844762|530301763|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147038834|NCT04844762|530301764|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
147038835|NCT04844762|530301765|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
147038836|NCT04844762|530301766|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147038837|NCT04844762|530301767|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
147038838|NCT04844762|530301762|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147038839|NCT04844762|530301763|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147038840|NCT04844762|530301764|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
147038841|NCT04844762|530301765|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
147038842|NCT04844762|530301766|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
147038843|NCT04844762|530301767|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147038844|NCT04844762|530301762|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
147038845|NCT04844762|530301763|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
147038846|NCT04844762|530301764|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147038847|NCT04844762|530301765|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147038848|NCT04844762|530301766|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147038849|NCT04844762|530301767|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147038850|NCT04844762|530301762|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
147038851|NCT04844762|530301763|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147038852|NCT04844762|530301764|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147038853|NCT04844762|530301765|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147038854|NCT04844762|530301766|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147038855|NCT04844762|530301767|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147038856|NCT04844762|530301762|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147038857|NCT04844762|530301763|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147038858|NCT04844762|530301764|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147038859|NCT04844762|530301765|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147038860|NCT04844762|530301766|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
147038861|NCT04844762|530301767|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147038862|NCT04844762|530301762|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
147038863|NCT04844762|530301763|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147038864|NCT04844762|530301764|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147038865|NCT04844762|530301765|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147038866|NCT04844762|530301766|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147038867|NCT04844762|530301767|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147038868|NCT04844762|530301762|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
147038869|NCT04844762|530301763|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147038870|NCT04844762|530301764|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147038871|NCT04844762|530301765|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147038872|NCT04844762|530301766|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147038873|NCT04844762|530301767|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
147038874|NCT04844762|530301762|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
147038875|NCT04844762|530301763|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
147038876|NCT04844762|530301764|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
147038877|NCT04844762|530301765|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
147038878|NCT04844762|530301766|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
147038879|NCT04844762|530301767|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
147038880|NCT04844762|530301762|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
147038881|NCT04844762|530301763|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
147038882|NCT04844762|530301764|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
147038883|NCT04844762|530301765|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
147038884|NCT04844762|530301766|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
147038885|NCT04844762|530301767|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
147038886|NCT01200069|530303448|FG000|Overall Study|Withdrawal by Subject|0|||
147038887|NCT01200069|530303449|FG001|Overall Study|Withdrawal by Subject|1|||
147038888|NCT03408639|530303450|FG000|Overall Study|Death|5|||
147038889|NCT03408639|530303451|FG001|Overall Study|Death|5|||
147038890|NCT03408639|530303450|FG000|Overall Study|Lost to Follow-up|1|||
147038891|NCT03408639|530303451|FG001|Overall Study|Lost to Follow-up|4|||
147038892|NCT03408639|530303450|FG000|Overall Study|Withdrawal by Subject|2|||
147038893|NCT03408639|530303451|FG001|Overall Study|Withdrawal by Subject|7|||
147038894|NCT03408639|530303450|FG000|Overall Study|Physician Decision|3|||
147038895|NCT03408639|530303451|FG001|Overall Study|Physician Decision|6|||
147038896|NCT04998851|530303452|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
147038897|NCT04998851|530303453|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
147038898|NCT04998851|530303452|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
147038899|NCT04998851|530303453|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
147038900|NCT00070499|530303454|FG000|Overall Study|Adverse Event|6|||
147038901|NCT00070499|530303455|FG001|Overall Study|Adverse Event|6|||
147038902|NCT00070499|530303456|FG002|Overall Study|Adverse Event|19|||
147038903|NCT00070499|530303457|FG003|Overall Study|Adverse Event|15|||
147038904|NCT00070499|530303454|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
147038905|NCT00070499|530303455|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
147038906|NCT00070499|530303456|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
147038907|NCT00070499|530303457|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
147038908|NCT00070499|530303454|FG000|Overall Study|Progression/relapse|4|||
147038909|NCT00070499|530303455|FG001|Overall Study|Progression/relapse|2|||
147038910|NCT00070499|530303456|FG002|Overall Study|Progression/relapse|1|||
147038911|NCT00070499|530303457|FG003|Overall Study|Progression/relapse|4|||
147038912|NCT00070499|530303454|FG000|Overall Study|Death|1|||
147038913|NCT00070499|530303455|FG001|Overall Study|Death|1|||
147038914|NCT00070499|530303456|FG002|Overall Study|Death|1|||
147038915|NCT00070499|530303457|FG003|Overall Study|Death|2|||
147038916|NCT00070499|530303454|FG000|Overall Study|Other - not protocol specified|7|||
147038917|NCT00070499|530303455|FG001|Overall Study|Other - not protocol specified|3|||
147038918|NCT00070499|530303456|FG002|Overall Study|Other - not protocol specified|12|||
147038919|NCT00070499|530303457|FG003|Overall Study|Other - not protocol specified|20|||
147038920|NCT00070499|530303454|FG000|Overall Study|Still on protocol treatment|10|||
147038921|NCT00070499|530303455|FG001|Overall Study|Still on protocol treatment|4|||
147038922|NCT00070499|530303456|FG002|Overall Study|Still on protocol treatment|79|||
147038923|NCT00070499|530303457|FG003|Overall Study|Still on protocol treatment|57|||
147038924|NCT00070499|530303454|FG000|Overall Study|Did not start treatment|1|||
147038925|NCT00070499|530303455|FG001|Overall Study|Did not start treatment|0|||
147038926|NCT00070499|530303456|FG002|Overall Study|Did not start treatment|0|||
147038927|NCT00070499|530303457|FG003|Overall Study|Did not start treatment|2|||
147038928|NCT00070499|530303454|FG000|Overall Study|Not eligible|2|||
147038929|NCT00070499|530303455|FG001|Overall Study|Not eligible|5|||
147038930|NCT00070499|530303456|FG002|Overall Study|Not eligible|3|||
147038931|NCT00070499|530303457|FG003|Overall Study|Not eligible|2|||
147038932|NCT00805467|530303458|FG000|Overall Study|Lack of Efficacy|0|||
147038933|NCT00805467|530303459|FG001|Overall Study|Lack of Efficacy|8|||
147038934|NCT00805467|530303460|FG002|Overall Study|Lack of Efficacy|13|||
147038935|NCT00805467|530303461|FG003|Overall Study|Lack of Efficacy|86|||
147038936|NCT00805467|530303458|FG000|Overall Study|Lost to Follow-up|0|||
147038937|NCT00805467|530303459|FG001|Overall Study|Lost to Follow-up|1|||
147038938|NCT00805467|530303460|FG002|Overall Study|Lost to Follow-up|7|||
147038939|NCT00805467|530303461|FG003|Overall Study|Lost to Follow-up|21|||
147038940|NCT00805467|530303458|FG000|Overall Study|Withdrawal by Subject|0|||
147038941|NCT00805467|530303459|FG001|Overall Study|Withdrawal by Subject|6|||
147038942|NCT00805467|530303460|FG002|Overall Study|Withdrawal by Subject|45|||
147038943|NCT00805467|530303461|FG003|Overall Study|Withdrawal by Subject|50|||
147038944|NCT00805467|530303458|FG000|Overall Study|Protocol Violation|0|||
147038945|NCT00805467|530303459|FG001|Overall Study|Protocol Violation|3|||
147038946|NCT00805467|530303460|FG002|Overall Study|Protocol Violation|0|||
147038947|NCT00805467|530303461|FG003|Overall Study|Protocol Violation|5|||
147038948|NCT00805467|530303458|FG000|Overall Study|Adverse Event|0|||
147038949|NCT00805467|530303459|FG001|Overall Study|Adverse Event|13|||
147038950|NCT00805467|530303460|FG002|Overall Study|Adverse Event|26|||
147038951|NCT00805467|530303461|FG003|Overall Study|Adverse Event|57|||
147038952|NCT00805467|530303458|FG000|Overall Study|Death|0|||
147038953|NCT00805467|530303459|FG001|Overall Study|Death|2|||
147038954|NCT00805467|530303460|FG002|Overall Study|Death|7|||
147038955|NCT00805467|530303461|FG003|Overall Study|Death|5|||
147038956|NCT00805467|530303458|FG000|Overall Study|Physician Decision|0|||
147038957|NCT00805467|530303459|FG001|Overall Study|Physician Decision|1|||
147038958|NCT00805467|530303460|FG002|Overall Study|Physician Decision|2|||
147038959|NCT00805467|530303461|FG003|Overall Study|Physician Decision|6|||
147038960|NCT00805467|530303458|FG000|Overall Study|Not reported|0|||
147038961|NCT00805467|530303459|FG001|Overall Study|Not reported|0|||
147038962|NCT00805467|530303460|FG002|Overall Study|Not reported|3|||
147038963|NCT00805467|530303461|FG003|Overall Study|Not reported|7|||
147038964|NCT01924754|530303462|FG000|Overall Study|Lost to Follow-up|1|||
147038965|NCT01924754|530303463|FG001|Overall Study|Lost to Follow-up|2|||
147038966|NCT01924754|530303464|FG002|Overall Study|Lost to Follow-up|1|||
147038967|NCT01924754|530303462|FG000|Overall Study|Pregnancy|0|||
147038968|NCT01924754|530303463|FG001|Overall Study|Pregnancy|1|||
147038969|NCT01924754|530303464|FG002|Overall Study|Pregnancy|2|||
147038970|NCT02899195|530303467|FG000|Concurrent Durvalumab|Adverse Event|4|||
147038971|NCT02899195|530303467|FG000|Concurrent Durvalumab|Physician Decision|1|||
147038972|NCT02899195|530303467|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
147038973|NCT02899195|530303467|FG000|Concurrent Durvalumab|Progressive Disease|5|||
147038974|NCT02899195|530303467|FG000|Maintenance Durvalumab|Adverse Event|1|||
147038975|NCT02899195|530303467|FG000|Maintenance Durvalumab|Physician Decision|1|||
147038976|NCT02899195|530303467|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
147038977|NCT02899195|530303467|FG000|Maintenance Durvalumab|Progressive Disease|31|||
147038978|NCT02755649|530303468|FG000|Overall Study|Transitioned into OLE study|99|||
147038979|NCT02755649|530303469|FG001|Overall Study|Transitioned into OLE study|98|||
147038980|NCT02755649|530303470|FG002|Overall Study|Transitioned into OLE study|100|||
147038981|NCT02755649|530303468|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
147038982|NCT02755649|530303469|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
147038983|NCT02755649|530303470|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
147038984|NCT02755649|530303468|FG000|Overall Study|Physician Decision|0|||
147038985|NCT02755649|530303469|FG001|Overall Study|Physician Decision|0|||
147038986|NCT02755649|530303470|FG002|Overall Study|Physician Decision|2|||
147038987|NCT02755649|530303468|FG000|Overall Study|Withdrawal by Subject|0|||
147038988|NCT02755649|530303469|FG001|Overall Study|Withdrawal by Subject|1|||
147038989|NCT02755649|530303470|FG002|Overall Study|Withdrawal by Subject|0|||
147038990|NCT02755649|530303468|FG000|Overall Study|Undecided|1|||
147038991|NCT02755649|530303469|FG001|Overall Study|Undecided|0|||
147038992|NCT02755649|530303470|FG002|Overall Study|Undecided|0|||
147038993|NCT00923273|530303481|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
147038994|NCT00923273|530303482|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
147038995|NCT00923273|530303483|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
147038996|NCT00923273|530303484|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
147038997|NCT00923273|530303485|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
147038998|NCT00923273|530303481|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
147038999|NCT00923273|530303482|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
147039000|NCT00923273|530303483|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
147039001|NCT00923273|530303484|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
147039002|NCT00923273|530303485|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
147039003|NCT00605540|530303486|FG000|Overall Study|Death|15|||
147039004|NCT00605540|530303486|FG000|Overall Study|Lost to Follow-up|23|||
147039005|NCT00129389|530303487|FG000|Overall Study|Adverse Event|19|||
147039006|NCT00129389|530303488|FG001|Overall Study|Adverse Event|87|||
147039007|NCT00129389|530303487|FG000|Overall Study|Death|0|||
147039008|NCT00129389|530303488|FG001|Overall Study|Death|1|||
147039009|NCT00129389|530303487|FG000|Overall Study|Lost to Follow-up|2|||
147039010|NCT00129389|530303488|FG001|Overall Study|Lost to Follow-up|1|||
147039011|NCT00129389|530303487|FG000|Overall Study|Physician Decision|0|||
147039012|NCT00129389|530303488|FG001|Overall Study|Physician Decision|4|||
147039013|NCT00129389|530303487|FG000|Overall Study|Protocol Violation|0|||
147039014|NCT00129389|530303488|FG001|Overall Study|Protocol Violation|6|||
147039015|NCT00129389|530303487|FG000|Overall Study|Withdrawal by Subject|9|||
147039016|NCT00129389|530303488|FG001|Overall Study|Withdrawal by Subject|23|||
147039017|NCT00129389|530303487|FG000|Overall Study|Relapse|1|||
147039018|NCT00129389|530303488|FG001|Overall Study|Relapse|0|||
147039019|NCT00129389|530303487|FG000|Overall Study|Not eligible|1|||
147039020|NCT00129389|530303488|FG001|Overall Study|Not eligible|2|||
147039021|NCT00129389|530303487|FG000|Overall Study|Crossed to the other arm|1|||
147039022|NCT00129389|530303488|FG001|Overall Study|Crossed to the other arm|16|||
147039023|NCT00741286|530303496|FG000|Overall Study|Lost to Follow-up|15|||
147039024|NCT00741286|530303497|FG001|Overall Study|Lost to Follow-up|10|||
147039025|NCT00741286|530303496|FG000|Overall Study|Adverse Event|1|||
147039026|NCT00741286|530303497|FG001|Overall Study|Adverse Event|6|||
147039027|NCT00741286|530303496|FG000|Overall Study|Protocol Violation|3|||
147039028|NCT00741286|530303497|FG001|Overall Study|Protocol Violation|2|||
147039029|NCT00741286|530303496|FG000|Overall Study|Primary Outcome|1|||
147039030|NCT00741286|530303497|FG001|Overall Study|Primary Outcome|1|||
147039031|NCT00339144|530303505|FG000|Overall Study|Disease progression|5|||
147039032|NCT00339144|530303506|FG001|Overall Study|Disease progression|2|||
147039033|NCT00339144|530303507|FG002|Overall Study|Disease progression|2|||
147039034|NCT00339144|530303505|FG000|Overall Study|Study drug toxicity|3|||
147039035|NCT00339144|530303506|FG001|Overall Study|Study drug toxicity|1|||
147039036|NCT00339144|530303507|FG002|Overall Study|Study drug toxicity|1|||
147039037|NCT00339144|530303505|FG000|Overall Study|Participant's request to discontinuation|1|||
147039038|NCT00339144|530303506|FG001|Overall Study|Participant's request to discontinuation|0|||
147039039|NCT00339144|530303507|FG002|Overall Study|Participant's request to discontinuation|1|||
147039040|NCT05199090|530303513|FG000|Overall Study|Adverse Event|1|||
147039041|NCT05199090|530303514|FG001|Overall Study|Adverse Event|4|||
147039042|NCT05199090|530303515|FG002|Overall Study|Adverse Event|0|||
147039043|NCT05199090|530303516|FG003|Overall Study|Adverse Event|0|||
147039044|NCT05199090|530303517|FG004|Overall Study|Adverse Event|0|||
147039045|NCT05199090|530303518|FG005|Overall Study|Adverse Event|0|||
147039046|NCT05199090|530303513|FG000|Overall Study|Lost to Follow-up|1|||
147039047|NCT05199090|530303514|FG001|Overall Study|Lost to Follow-up|0|||
147039048|NCT05199090|530303515|FG002|Overall Study|Lost to Follow-up|1|||
147039049|NCT05199090|530303516|FG003|Overall Study|Lost to Follow-up|4|||
147039050|NCT05199090|530303517|FG004|Overall Study|Lost to Follow-up|0|||
147039051|NCT05199090|530303518|FG005|Overall Study|Lost to Follow-up|5|||
147039052|NCT05199090|530303513|FG000|Overall Study|Physician Decision|0|||
147039053|NCT05199090|530303514|FG001|Overall Study|Physician Decision|0|||
147039054|NCT05199090|530303515|FG002|Overall Study|Physician Decision|0|||
147039055|NCT05199090|530303516|FG003|Overall Study|Physician Decision|0|||
147039056|NCT05199090|530303517|FG004|Overall Study|Physician Decision|0|||
147039057|NCT05199090|530303518|FG005|Overall Study|Physician Decision|1|||
147039058|NCT05199090|530303513|FG000|Overall Study|Study terminated by sponsor|0|||
147039059|NCT05199090|530303514|FG001|Overall Study|Study terminated by sponsor|6|||
147039060|NCT05199090|530303515|FG002|Overall Study|Study terminated by sponsor|0|||
147039061|NCT05199090|530303516|FG003|Overall Study|Study terminated by sponsor|0|||
147039062|NCT05199090|530303517|FG004|Overall Study|Study terminated by sponsor|0|||
147039063|NCT05199090|530303518|FG005|Overall Study|Study terminated by sponsor|5|||
147039064|NCT05199090|530303513|FG000|Overall Study|Subject decision|0|||
147039065|NCT05199090|530303514|FG001|Overall Study|Subject decision|4|||
147039066|NCT05199090|530303515|FG002|Overall Study|Subject decision|0|||
147039067|NCT05199090|530303516|FG003|Overall Study|Subject decision|2|||
147039068|NCT05199090|530303517|FG004|Overall Study|Subject decision|5|||
147039069|NCT05199090|530303518|FG005|Overall Study|Subject decision|2|||
147039070|NCT03485365|530303519|FG000|Overall Study|Protocol Violation|0|||
147039071|NCT03485365|530303520|FG001|Overall Study|Protocol Violation|0|||
147039072|NCT03485365|530303521|FG002|Overall Study|Protocol Violation|0|||
147039073|NCT03485365|530303522|FG003|Overall Study|Protocol Violation|1|||
147039074|NCT03485365|530303523|FG004|Overall Study|Protocol Violation|0|||
147039075|NCT03485365|530303524|FG005|Overall Study|Protocol Violation|0|||
147039076|NCT03485365|530303525|FG006|Overall Study|Protocol Violation|1|||
147039077|NCT03485365|530303526|FG007|Overall Study|Protocol Violation|0|||
147039078|NCT03485365|530303527|FG008|Overall Study|Protocol Violation|0|||
147039079|NCT02181790|530303528|FG000|Overall Study|study terminated|2|||
147039080|NCT02181790|530303529|FG001|Overall Study|study terminated|0|||
147039081|NCT04988087|530303535|FG000|Overall Study|Adverse Event|4|||
147039082|NCT04988087|530303536|FG001|Overall Study|Adverse Event|0|||
147039083|NCT04988087|530303537|FG002|Overall Study|Adverse Event|0|||
147039084|NCT04988087|530303538|FG003|Overall Study|Adverse Event|0|||
147039085|NCT04988087|530303535|FG000|Overall Study|Withdrawal by Subject|1|||
147039086|NCT04988087|530303536|FG001|Overall Study|Withdrawal by Subject|1|||
147039087|NCT04988087|530303537|FG002|Overall Study|Withdrawal by Subject|0|||
147039088|NCT04988087|530303538|FG003|Overall Study|Withdrawal by Subject|0|||
147039089|NCT04988087|530303535|FG000|Overall Study|Technical problems|7|||
147039090|NCT04988087|530303536|FG001|Overall Study|Technical problems|9|||
147039091|NCT04988087|530303537|FG002|Overall Study|Technical problems|1|||
147039092|NCT04988087|530303538|FG003|Overall Study|Technical problems|2|||
147039093|NCT02458287|530303539|FG000|Overall Study|Adverse Event|0|||
147039094|NCT02458287|530303540|FG001|Overall Study|Adverse Event|0|||
147039095|NCT02458287|530303541|FG002|Overall Study|Adverse Event|0|||
147039096|NCT02458287|530303542|FG003|Overall Study|Adverse Event|1|||
147039097|NCT02458287|530303539|FG000|Overall Study|Lost to Follow-up|0|||
147039098|NCT02458287|530303540|FG001|Overall Study|Lost to Follow-up|1|||
147039099|NCT02458287|530303541|FG002|Overall Study|Lost to Follow-up|1|||
147039100|NCT02458287|530303542|FG003|Overall Study|Lost to Follow-up|0|||
147039101|NCT02458287|530303539|FG000|Overall Study|Protocol Violation|0|||
147039102|NCT02458287|530303540|FG001|Overall Study|Protocol Violation|1|||
147039103|NCT02458287|530303541|FG002|Overall Study|Protocol Violation|0|||
147039104|NCT02458287|530303542|FG003|Overall Study|Protocol Violation|0|||
147039105|NCT02458287|530303539|FG000|Overall Study|Withdrawal by Subject|0|||
147039106|NCT02458287|530303540|FG001|Overall Study|Withdrawal by Subject|2|||
147039107|NCT02458287|530303541|FG002|Overall Study|Withdrawal by Subject|2|||
147039108|NCT02458287|530303542|FG003|Overall Study|Withdrawal by Subject|1|||
147039109|NCT02458287|530303539|FG000|Overall Study|Relocated Out of State|0|||
147039110|NCT02458287|530303540|FG001|Overall Study|Relocated Out of State|0|||
147039111|NCT02458287|530303541|FG002|Overall Study|Relocated Out of State|0|||
147039112|NCT02458287|530303542|FG003|Overall Study|Relocated Out of State|1|||
147039113|NCT02752087|530303543|FG000|Washout|Physician Decision|1|||
147039114|NCT02752087|530303544|FG001|Washout|Physician Decision|0|||
147039115|NCT00843635|530303545|FG000|Overall Study|Adverse Event|2|||
147039116|NCT00843635|530303546|FG001|Overall Study|Adverse Event|2|||
147039117|NCT00843635|530303547|FG002|Overall Study|Adverse Event|0|||
147039118|NCT02290223|530303548|FG000|6 Months|Lost to Follow-up|9|||
147039119|NCT02290223|530303549|FG001|6 Months|Lost to Follow-up|6|||
147039120|NCT02290223|530303548|FG000|6 Months|Withdrawal by Subject|5|||
147039121|NCT02290223|530303549|FG001|6 Months|Withdrawal by Subject|0|||
147039122|NCT02290223|530303548|FG000|6 Months|deceased (not related to study)|2|||
147039123|NCT02290223|530303549|FG001|6 Months|deceased (not related to study)|0|||
147039124|NCT02290223|530303548|FG000|12 Months|Lost to Follow-up|16|||
147039125|NCT02290223|530303549|FG001|12 Months|Lost to Follow-up|10|||
147039126|NCT02290223|530303548|FG000|12 Months|Refusal|0|||
147039127|NCT02290223|530303549|FG001|12 Months|Refusal|1|||
147039128|NCT02785952|530303550|FG000|Overall Study|Adverse Event|31|||
147039129|NCT02785952|530303551|FG001|Overall Study|Adverse Event|19|||
147039130|NCT02785952|530303550|FG000|Overall Study|Refusal unrelated to adverse events|10|||
147039131|NCT02785952|530303551|FG001|Overall Study|Refusal unrelated to adverse events|5|||
147039132|NCT02785952|530303550|FG000|Overall Study|Disease progression/relapse|61|||
147039133|NCT02785952|530303551|FG001|Overall Study|Disease progression/relapse|89|||
147039134|NCT02785952|530303550|FG000|Overall Study|Death|11|||
147039135|NCT02785952|530303551|FG001|Overall Study|Death|7|||
147039136|NCT02785952|530303550|FG000|Overall Study|Other- not protocol specified|6|||
147039137|NCT02785952|530303551|FG001|Overall Study|Other- not protocol specified|4|||
147039138|NCT02785952|530303550|FG000|Overall Study|On protocol treatment|6|||
147039139|NCT02785952|530303551|FG001|Overall Study|On protocol treatment|3|||
147039140|NCT00351533|530303555|FG000|Overall Study|Extubated before first BAL|1|||
147039141|NCT00351533|530303556|FG001|Overall Study|Extubated before first BAL|0|||
147039142|NCT00351533|530303555|FG000|Overall Study|Lost to Follow-up|1|||
147039143|NCT00351533|530303556|FG001|Overall Study|Lost to Follow-up|3|||
147039144|NCT00351533|530303555|FG000|Overall Study|Physician Decision|0|||
147039145|NCT00351533|530303556|FG001|Overall Study|Physician Decision|1|||
147039146|NCT00351533|530303555|FG000|Overall Study|Withdrawal by Subject|0|||
147039147|NCT00351533|530303556|FG001|Overall Study|Withdrawal by Subject|1|||
147039148|NCT03185013|530303557|FG000|Overall Study|Withdrawal by Subject|5|||
147039149|NCT03185013|530303558|FG001|Overall Study|Withdrawal by Subject|3|||
147039150|NCT03185013|530303557|FG000|Overall Study|Adverse Event|1|||
147039151|NCT03185013|530303558|FG001|Overall Study|Adverse Event|0|||
147039152|NCT03185013|530303557|FG000|Overall Study|Progressive Disease|1|||
147039153|NCT03185013|530303558|FG001|Overall Study|Progressive Disease|0|||
147039154|NCT03185013|530303557|FG000|Overall Study|Lost to Follow-up|8|||
147039155|NCT03185013|530303558|FG001|Overall Study|Lost to Follow-up|2|||
147039156|NCT03185013|530303557|FG000|Overall Study|Physician Decision|1|||
147039157|NCT03185013|530303558|FG001|Overall Study|Physician Decision|0|||
147039158|NCT03185013|530303557|FG000|Overall Study|Protocol Deviation|2|||
147039159|NCT03185013|530303558|FG001|Overall Study|Protocol Deviation|0|||
147039160|NCT03185013|530303557|FG000|Overall Study|Reason not Specified|3|||
147039161|NCT03185013|530303558|FG001|Overall Study|Reason not Specified|2|||
147039162|NCT03185013|530303557|FG000|Overall Study|Death|1|||
147039163|NCT03185013|530303558|FG001|Overall Study|Death|0|||
147039164|NCT00197496|530303559|FG000|Baseline to Discharge|not interested|1|||
147039165|NCT00197496|530303560|FG001|Baseline to Discharge|not interested|0|||
147039166|NCT00197496|530303559|FG000|Baseline to Discharge|MRSA|1|||
147039167|NCT00197496|530303560|FG001|Baseline to Discharge|MRSA|0|||
147039168|NCT00197496|530303559|FG000|Baseline to Discharge|Physician Decision|0|||
147039169|NCT00197496|530303560|FG001|Baseline to Discharge|Physician Decision|1|||
147039170|NCT00197496|530303559|FG000|Baseline to Discharge|Protocol Violation|0|||
147039171|NCT00197496|530303560|FG001|Baseline to Discharge|Protocol Violation|1|||
147039172|NCT00197496|530303559|FG000|Follow-up|Lost to Follow-up|2|||
147039173|NCT00197496|530303560|FG001|Follow-up|Lost to Follow-up|1|||
147039174|NCT00857584|530303563|FG000|Overall Study|Lack of Efficacy|1|||
147039175|NCT00857584|530303564|FG001|Overall Study|Lack of Efficacy|2|||
147039176|NCT00857584|530303563|FG000|Overall Study|Adverse Event|2|||
147039177|NCT00857584|530303564|FG001|Overall Study|Adverse Event|2|||
146849764|NCT01879722|529618874|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
147039178|NCT00857584|530303563|FG000|Overall Study|Physician Decision|1|||
147039179|NCT00857584|530303564|FG001|Overall Study|Physician Decision|1|||
147039180|NCT01102374|530303565|FG000|Overall Study|Death|9|||
147039181|NCT01102374|530303566|FG001|Overall Study|Death|13|||
147039182|NCT01102374|530303565|FG000|Overall Study|Lost to Follow-up|7|||
147039183|NCT01102374|530303566|FG001|Overall Study|Lost to Follow-up|6|||
147039184|NCT01104792|530303567|FG000|Overall Study|Adverse Event|77|||
147039185|NCT01104792|530303567|FG000|Overall Study|Insufficient Therapeutic Response|22|||
147039186|NCT01104792|530303567|FG000|Overall Study|Protocol Violation|45|||
147039187|NCT01104792|530303567|FG000|Overall Study|Withdrawal of Consent|179|||
147039188|NCT01104792|530303567|FG000|Overall Study|Lost to Follow-up|43|||
147039189|NCT01104792|530303567|FG000|Overall Study|Reasons Not Specified|27|||
147039190|NCT01104792|530303567|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
147039191|NCT02203331|530303577|FG000|Overall Study|Pregnancy|1|||
147039192|NCT02203331|530303578|FG001|Overall Study|Pregnancy|0|||
147039193|NCT02203331|530303579|FG002|Overall Study|Pregnancy|0|||
147039194|NCT02203331|530303580|FG003|Overall Study|Pregnancy|0|||
147039195|NCT02203331|530303581|FG004|Overall Study|Pregnancy|2|||
147039196|NCT02203331|530303582|FG005|Overall Study|Pregnancy|0|||
147039197|NCT02203331|530303577|FG000|Overall Study|Withdrawal by Subject|1|||
147039198|NCT02203331|530303578|FG001|Overall Study|Withdrawal by Subject|0|||
147039199|NCT02203331|530303579|FG002|Overall Study|Withdrawal by Subject|1|||
147039200|NCT02203331|530303580|FG003|Overall Study|Withdrawal by Subject|0|||
147039201|NCT02203331|530303581|FG004|Overall Study|Withdrawal by Subject|0|||
147039202|NCT02203331|530303582|FG005|Overall Study|Withdrawal by Subject|3|||
147039203|NCT02203331|530303577|FG000|Overall Study|Adverse Event|4|||
147039204|NCT02203331|530303578|FG001|Overall Study|Adverse Event|8|||
147039205|NCT02203331|530303579|FG002|Overall Study|Adverse Event|3|||
147039206|NCT02203331|530303580|FG003|Overall Study|Adverse Event|4|||
147039207|NCT02203331|530303581|FG004|Overall Study|Adverse Event|3|||
147039208|NCT02203331|530303582|FG005|Overall Study|Adverse Event|3|||
147039209|NCT02203331|530303577|FG000|Overall Study|Other Reasons|1|||
147039210|NCT02203331|530303578|FG001|Overall Study|Other Reasons|2|||
147039211|NCT02203331|530303579|FG002|Overall Study|Other Reasons|0|||
147039212|NCT02203331|530303580|FG003|Overall Study|Other Reasons|2|||
147039213|NCT02203331|530303581|FG004|Overall Study|Other Reasons|0|||
147039214|NCT02203331|530303582|FG005|Overall Study|Other Reasons|0|||
147039215|NCT02203331|530303577|FG000|Overall Study|Lack of Efficacy|0|||
147039216|NCT02203331|530303578|FG001|Overall Study|Lack of Efficacy|2|||
147039217|NCT02203331|530303579|FG002|Overall Study|Lack of Efficacy|1|||
147039218|NCT02203331|530303580|FG003|Overall Study|Lack of Efficacy|0|||
147039219|NCT02203331|530303581|FG004|Overall Study|Lack of Efficacy|0|||
147039220|NCT02203331|530303582|FG005|Overall Study|Lack of Efficacy|1|||
147039221|NCT02203331|530303577|FG000|Overall Study|Protocol Violation|0|||
147039222|NCT02203331|530303578|FG001|Overall Study|Protocol Violation|2|||
147039223|NCT02203331|530303579|FG002|Overall Study|Protocol Violation|0|||
147039224|NCT02203331|530303580|FG003|Overall Study|Protocol Violation|1|||
147039225|NCT02203331|530303581|FG004|Overall Study|Protocol Violation|1|||
147039226|NCT02203331|530303582|FG005|Overall Study|Protocol Violation|0|||
147039227|NCT02203331|530303577|FG000|Overall Study|Lost to Follow-up|0|||
147039228|NCT02203331|530303578|FG001|Overall Study|Lost to Follow-up|0|||
147039229|NCT02203331|530303579|FG002|Overall Study|Lost to Follow-up|0|||
147039230|NCT02203331|530303580|FG003|Overall Study|Lost to Follow-up|0|||
147039231|NCT02203331|530303581|FG004|Overall Study|Lost to Follow-up|1|||
147039232|NCT02203331|530303582|FG005|Overall Study|Lost to Follow-up|0|||
147039233|NCT02542605|530303587|FG000|Part B: Challenge Phase|Sponsor decision|1|||
147039234|NCT02542605|530303588|FG001|Part B: Challenge Phase|Sponsor decision|0|||
147039235|NCT02542605|530303589|FG002|Part B: Challenge Phase|Sponsor decision|0|||
147039236|NCT02542605|530303587|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
147039237|NCT02542605|530303588|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
147039238|NCT02542605|530303589|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
147039239|NCT02682927|530303590|FG000|Overall Study|Adverse Event|0|||
147039240|NCT02682927|530303591|FG001|Overall Study|Adverse Event|0|||
147039241|NCT02682927|530303592|FG002|Overall Study|Adverse Event|5|||
147039242|NCT02682927|530303593|FG003|Overall Study|Adverse Event|1|||
147039243|NCT02682927|530303594|FG004|Overall Study|Adverse Event|0|||
147039244|NCT02682927|530303595|FG005|Overall Study|Adverse Event|2|||
147039245|NCT02682927|530303590|FG000|Overall Study|Death|0|||
147039246|NCT02682927|530303591|FG001|Overall Study|Death|0|||
147039247|NCT02682927|530303592|FG002|Overall Study|Death|0|||
147039248|NCT02682927|530303593|FG003|Overall Study|Death|1|||
147039249|NCT02682927|530303594|FG004|Overall Study|Death|0|||
147039250|NCT02682927|530303595|FG005|Overall Study|Death|0|||
147039251|NCT02682927|530303590|FG000|Overall Study|Lack of Efficacy|1|||
147039252|NCT02682927|530303591|FG001|Overall Study|Lack of Efficacy|0|||
147039253|NCT02682927|530303592|FG002|Overall Study|Lack of Efficacy|0|||
147039254|NCT02682927|530303593|FG003|Overall Study|Lack of Efficacy|1|||
147039255|NCT02682927|530303594|FG004|Overall Study|Lack of Efficacy|0|||
147039256|NCT02682927|530303595|FG005|Overall Study|Lack of Efficacy|0|||
147039257|NCT02682927|530303590|FG000|Overall Study|Other|0|||
147039258|NCT02682927|530303591|FG001|Overall Study|Other|0|||
147039259|NCT02682927|530303592|FG002|Overall Study|Other|0|||
147039260|NCT02682927|530303593|FG003|Overall Study|Other|2|||
147039261|NCT02682927|530303594|FG004|Overall Study|Other|0|||
147039262|NCT02682927|530303595|FG005|Overall Study|Other|0|||
147039263|NCT02682927|530303590|FG000|Overall Study|Withdrawal by Subject|2|||
147039264|NCT02682927|530303591|FG001|Overall Study|Withdrawal by Subject|0|||
147039265|NCT02682927|530303592|FG002|Overall Study|Withdrawal by Subject|1|||
147039266|NCT02682927|530303593|FG003|Overall Study|Withdrawal by Subject|0|||
147039267|NCT02682927|530303594|FG004|Overall Study|Withdrawal by Subject|1|||
147039268|NCT02682927|530303595|FG005|Overall Study|Withdrawal by Subject|1|||
147039269|NCT03462459|530303599|FG000|Overall Study|Death|1|||
147039270|NCT03462459|530303600|FG001|Overall Study|Death|0|||
147039271|NCT03462459|530303599|FG000|Overall Study|Lack of Efficacy|2|||
147039272|NCT03462459|530303600|FG001|Overall Study|Lack of Efficacy|4|||
147039273|NCT03462459|530303599|FG000|Overall Study|Lost to Follow-up|1|||
147039274|NCT03462459|530303600|FG001|Overall Study|Lost to Follow-up|3|||
147039275|NCT03462459|530303599|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
147039276|NCT03462459|530303600|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
147039277|NCT03462459|530303599|FG000|Overall Study|Withdrawal by Subject|3|||
147039278|NCT03462459|530303600|FG001|Overall Study|Withdrawal by Subject|2|||
147039279|NCT03462459|530303599|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
147039280|NCT03462459|530303600|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
147039281|NCT02551666|530303602|FG000|Overall Study|Withdrawal by Subject|1|||
147039282|NCT02551666|530303603|FG001|Overall Study|Withdrawal by Subject|3|||
147039283|NCT01177059|530303604|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
147039284|NCT01177059|530303604|FG000|Overall Study|Withdrew consent|2|||
147039285|NCT01177059|530303604|FG000|Overall Study|Lost to Follow-up|18|||
147039286|NCT04051619|530303605|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
147039287|NCT04051619|530303606|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
147039288|NCT04051619|530303605|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
147039289|NCT04051619|530303606|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
147039290|NCT03132155|530305412|FG000|Overall Study|Lack of Efficacy|6|||
147039291|NCT03132155|530305412|FG000|Overall Study|Lost to Follow-up|1|||
147039292|NCT03132155|530305412|FG000|Overall Study|Withdrawal by Subject|1|||
147039293|NCT04778904|530305416|FG000|Overall Study|Protocol Violation|1|||
147039294|NCT04778904|530305417|FG001|Overall Study|Protocol Violation|0|||
147039295|NCT04778904|530305418|FG002|Overall Study|Protocol Violation|0|||
147039296|NCT04778904|530305419|FG003|Overall Study|Protocol Violation|0|||
147039297|NCT04778904|530305416|FG000|Overall Study|Withdrawal by Subject|0|||
147039298|NCT04778904|530305417|FG001|Overall Study|Withdrawal by Subject|0|||
147039299|NCT04778904|530305418|FG002|Overall Study|Withdrawal by Subject|1|||
147039300|NCT04778904|530305419|FG003|Overall Study|Withdrawal by Subject|0|||
147039301|NCT03452137|530305420|FG000|Overall Study|Death|67|||
147039302|NCT03452137|530305421|FG001|Overall Study|Death|70|||
147039303|NCT03452137|530305420|FG000|Overall Study|Lost to Follow-up|4|||
147039304|NCT03452137|530305421|FG001|Overall Study|Lost to Follow-up|2|||
147039305|NCT03452137|530305420|FG000|Overall Study|Physician Decision|0|||
147039306|NCT03452137|530305421|FG001|Overall Study|Physician Decision|1|||
147039307|NCT03452137|530305420|FG000|Overall Study|Study Terminated by Sponsor|120|||
147039308|NCT03452137|530305421|FG001|Overall Study|Study Terminated by Sponsor|121|||
147039309|NCT03452137|530305420|FG000|Overall Study|Withdrawal by Subject|12|||
147039310|NCT03452137|530305421|FG001|Overall Study|Withdrawal by Subject|9|||
147039311|NCT02856802|530305422|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
147039312|NCT02856802|530305423|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
147039313|NCT02856802|530305422|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
147039314|NCT02856802|530305423|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
147039315|NCT02856802|530305422|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
147039316|NCT02856802|530305423|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
147039317|NCT02856802|530305422|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
147039318|NCT02856802|530305423|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
147039319|NCT02856802|530305422|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
147039320|NCT02856802|530305423|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
147039321|NCT02856802|530305422|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
147039322|NCT02856802|530305423|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
147039323|NCT04138043|530305424|FG000|Overall Study|Withdrawal by Subject|0|||
147039324|NCT04138043|530305425|FG001|Overall Study|Withdrawal by Subject|1|||
147039325|NCT03772717|530305426|FG000|Overall Study|Withdrawal by Subject|2|||
147039326|NCT00587860|530305427|FG000|Overall Study|Lost to Follow-up|2|||
147039327|NCT00587860|530305428|FG001|Overall Study|Lost to Follow-up|2|||
147039328|NCT00587860|530305427|FG000|Overall Study|Withdrawal by Subject|3|||
147039329|NCT00587860|530305428|FG001|Overall Study|Withdrawal by Subject|3|||
147039330|NCT00261443|530305429|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
147039331|NCT00261443|530305430|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
147039332|NCT00261443|530305431|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
147039333|NCT00261443|530305429|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
147039334|NCT00261443|530305430|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
147039335|NCT00261443|530305431|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
147039336|NCT00261443|530305429|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
147039337|NCT00261443|530305430|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
147039338|NCT00261443|530305431|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
147039339|NCT00261443|530305429|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
147039340|NCT00261443|530305430|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
147039341|NCT00261443|530305431|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
147039342|NCT00261443|530305429|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
147039343|NCT00261443|530305430|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
147039344|NCT00261443|530305431|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
147039345|NCT00261443|530305429|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
147039346|NCT00261443|530305430|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
147039347|NCT00261443|530305431|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
147039348|NCT00261443|530305429|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
147039349|NCT00261443|530305430|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
147039350|NCT00261443|530305431|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
147039351|NCT00261443|530305429|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
147039352|NCT00261443|530305430|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
147039353|NCT00261443|530305431|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
147039354|NCT00261443|530305429|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
147039355|NCT00261443|530305430|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
147039356|NCT00261443|530305431|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
147039357|NCT00261443|530305429|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
147039358|NCT00261443|530305430|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
147039359|NCT00261443|530305431|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
147039360|NCT00261443|530305429|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
147039361|NCT00261443|530305430|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
147039362|NCT00261443|530305431|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
147039363|NCT00261443|530305429|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
147039364|NCT00261443|530305430|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
147039365|NCT00261443|530305431|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
147039366|NCT00261443|530305429|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
147039367|NCT00261443|530305430|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
147039368|NCT00261443|530305431|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
147039369|NCT00261443|530305429|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
147039370|NCT00261443|530305430|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
147039371|NCT00261443|530305431|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
147039372|NCT00261443|530305429|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
147039373|NCT00261443|530305430|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
147039374|NCT00261443|530305431|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
147039375|NCT00261443|530305429|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
147039376|NCT00261443|530305430|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
147039377|NCT00261443|530305431|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
147039378|NCT00261443|530305429|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
147039379|NCT00261443|530305430|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
147039380|NCT00261443|530305431|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
147039381|NCT00261443|530305429|FG000|3: Assessment of Relapse|Adverse Event|0|||
147039382|NCT00261443|530305430|FG001|3: Assessment of Relapse|Adverse Event|15|||
147039383|NCT00261443|530305431|FG002|3: Assessment of Relapse|Adverse Event|19|||
147039384|NCT00261443|530305429|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
147039385|NCT00261443|530305430|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
147039386|NCT00261443|530305431|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
147039387|NCT00261443|530305429|FG000|3: Assessment of Relapse|Death|0|||
147039388|NCT00261443|530305430|FG001|3: Assessment of Relapse|Death|0|||
147039389|NCT00261443|530305431|FG002|3: Assessment of Relapse|Death|1|||
147039390|NCT00261443|530305429|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
147039391|NCT00261443|530305430|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
147039392|NCT00261443|530305431|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
147039393|NCT00261443|530305429|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
147039394|NCT00261443|530305430|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
147039395|NCT00261443|530305431|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
147039396|NCT00261443|530305429|FG000|3: Assessment of Relapse|Pregnancy|0|||
147039397|NCT00261443|530305430|FG001|3: Assessment of Relapse|Pregnancy|2|||
147039398|NCT00261443|530305431|FG002|3: Assessment of Relapse|Pregnancy|1|||
147039399|NCT00261443|530305429|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
146849765|NCT01879722|529618875|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
146849766|NCT01879722|529618876|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
147039400|NCT00261443|530305430|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
147039401|NCT00261443|530305431|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
147039402|NCT00261443|530305429|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
147039403|NCT00261443|530305430|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
147039404|NCT00261443|530305431|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
147039405|NCT00261443|530305429|FG000|3: Assessment of Relapse|Other Reasons|0|||
147039406|NCT00261443|530305430|FG001|3: Assessment of Relapse|Other Reasons|4|||
147039407|NCT00261443|530305431|FG002|3: Assessment of Relapse|Other Reasons|3|||
147039408|NCT00261443|530305429|FG000|4: Extension Phase|Adverse Event|0|||
147039409|NCT00261443|530305430|FG001|4: Extension Phase|Adverse Event|1|||
147039410|NCT00261443|530305431|FG002|4: Extension Phase|Adverse Event|0|||
147039411|NCT00261443|530305429|FG000|4: Extension Phase|Withdrawal by Subject|0|||
147039412|NCT00261443|530305430|FG001|4: Extension Phase|Withdrawal by Subject|1|||
147039413|NCT00261443|530305431|FG002|4: Extension Phase|Withdrawal by Subject|2|||
147039414|NCT00261443|530305429|FG000|4: Extension Phase|Lost to Follow-up|0|||
147039415|NCT00261443|530305430|FG001|4: Extension Phase|Lost to Follow-up|1|||
147039416|NCT00261443|530305431|FG002|4: Extension Phase|Lost to Follow-up|0|||
147039417|NCT01286753|530305432|FG000|Overall Study|Adverse Event|7|||
147039418|NCT01286753|530305433|FG001|Overall Study|Adverse Event|6|||
147039419|NCT01286753|530305432|FG000|Overall Study|Progression|11|||
147039420|NCT01286753|530305433|FG001|Overall Study|Progression|13|||
147039421|NCT01286753|530305432|FG000|Overall Study|Refused Treatment|1|||
147039422|NCT01286753|530305433|FG001|Overall Study|Refused Treatment|0|||
147039423|NCT01286753|530305432|FG000|Overall Study|Withdrawal of Consent|0|||
147039424|NCT01286753|530305433|FG001|Overall Study|Withdrawal of Consent|2|||
147039425|NCT01286753|530305432|FG000|Overall Study|Discontinued to Join Extension Study|6|||
147039426|NCT01286753|530305433|FG001|Overall Study|Discontinued to Join Extension Study|4|||
147039427|NCT01286753|530305432|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
147039428|NCT01286753|530305433|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
147039429|NCT02126826|530305434|FG000|Overall Study|Withdrawal by Subject|0|||
147039430|NCT02126826|530305435|FG001|Overall Study|Withdrawal by Subject|0|||
147039431|NCT02126826|530305436|FG002|Overall Study|Withdrawal by Subject|0|||
147039432|NCT02126826|530305437|FG003|Overall Study|Withdrawal by Subject|1|||
147039433|NCT02126826|530305438|FG004|Overall Study|Withdrawal by Subject|0|||
147039434|NCT02126826|530305439|FG005|Overall Study|Withdrawal by Subject|0|||
147039435|NCT02126826|530305440|FG006|Overall Study|Withdrawal by Subject|0|||
147039436|NCT04971187|530305441|FG000|Overall Study|Screen failures|2|||
147039437|NCT02135614|530305442|FG000|Overall Study|Randomized but Not Treated|2|||
147039438|NCT02135614|530305443|FG001|Overall Study|Randomized but Not Treated|1|||
147039439|NCT02135614|530305442|FG000|Overall Study|Adverse Event|0|||
147039440|NCT02135614|530305443|FG001|Overall Study|Adverse Event|1|||
147039441|NCT02135614|530305442|FG000|Overall Study|Death|1|||
147039442|NCT02135614|530305443|FG001|Overall Study|Death|0|||
147039443|NCT02135614|530305442|FG000|Overall Study|Investigator's Discretion|0|||
147039444|NCT02135614|530305443|FG001|Overall Study|Investigator's Discretion|1|||
147039445|NCT02135614|530305442|FG000|Overall Study|Withdrew Consent|2|||
147039446|NCT02135614|530305443|FG001|Overall Study|Withdrew Consent|2|||
147039447|NCT02135614|530305442|FG000|Overall Study|Lost to Follow-up|3|||
147039448|NCT02135614|530305443|FG001|Overall Study|Lost to Follow-up|0|||
147039449|NCT01207583|530305444|FG000|Overall Study|Withdrawal by Subject|0|||
147039450|NCT01207583|530305445|FG001|Overall Study|Withdrawal by Subject|3|||
147039451|NCT01207583|530305446|FG002|Overall Study|Withdrawal by Subject|1|||
147039452|NCT01207583|530305444|FG000|Overall Study|Participant failed to return|1|||
147039453|NCT01207583|530305445|FG001|Overall Study|Participant failed to return|0|||
147039454|NCT01207583|530305446|FG002|Overall Study|Participant failed to return|0|||
147039455|NCT01207583|530305444|FG000|Overall Study|Lost to Follow-up|0|||
147039456|NCT01207583|530305445|FG001|Overall Study|Lost to Follow-up|2|||
147039457|NCT01207583|530305446|FG002|Overall Study|Lost to Follow-up|0|||
146849767|NCT01879722|529618877|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
146849768|NCT01879722|529618878|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
147039458|NCT02679235|530305447|FG000|Overall Study|Withdrawal by Subject|3|||
147039459|NCT02679235|530305447|FG000|Overall Study|Adverse Event|1|||
147039460|NCT02540850|530305448|FG000|Overall Study|Lost to Follow-up|69|||
147039461|NCT02540850|530305449|FG001|Overall Study|Lost to Follow-up|66|||
147039462|NCT02540850|530305450|FG002|Overall Study|Lost to Follow-up|34|||
147039463|NCT00264550|530305451|FG000|Overall Study|Death|0|||
147039464|NCT00264550|530305452|FG001|Overall Study|Death|3|||
147039465|NCT00264550|530305453|FG002|Overall Study|Death|0|||
147039466|NCT00264550|530305454|FG003|Overall Study|Death|0|||
147039467|NCT00264550|530305451|FG000|Overall Study|Lost to Follow-up|3|||
147039468|NCT00264550|530305452|FG001|Overall Study|Lost to Follow-up|1|||
147039469|NCT00264550|530305453|FG002|Overall Study|Lost to Follow-up|1|||
147039470|NCT00264550|530305454|FG003|Overall Study|Lost to Follow-up|1|||
147039471|NCT00264550|530305451|FG000|Overall Study|Adverse Event|23|||
147039472|NCT00264550|530305452|FG001|Overall Study|Adverse Event|18|||
147039473|NCT00264550|530305453|FG002|Overall Study|Adverse Event|9|||
147039474|NCT00264550|530305454|FG003|Overall Study|Adverse Event|14|||
147039475|NCT00264550|530305451|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
147039476|NCT00264550|530305452|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
147039477|NCT00264550|530305453|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
147039478|NCT00264550|530305454|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
147039479|NCT00264550|530305451|FG000|Overall Study|Discontinued oral study agent|0|||
147039480|NCT00264550|530305452|FG001|Overall Study|Discontinued oral study agent|1|||
147039481|NCT00264550|530305453|FG002|Overall Study|Discontinued oral study agent|0|||
147039482|NCT00264550|530305454|FG003|Overall Study|Discontinued oral study agent|0|||
147039483|NCT00264550|530305451|FG000|Overall Study|Other|13|||
147039484|NCT00264550|530305452|FG001|Overall Study|Other|7|||
147039485|NCT00264550|530305453|FG002|Overall Study|Other|3|||
147039486|NCT00264550|530305454|FG003|Overall Study|Other|9|||
147039487|NCT02246114|530305457|FG000|Overall Study|miscarriage|1|||
147039488|NCT02246114|530305458|FG001|Overall Study|miscarriage|0|||
147039489|NCT02473523|530305462|FG000|Overall Study|Death|1|||
147039490|NCT02473523|530305462|FG000|Overall Study|Lost to Follow-up|1|||
147039491|NCT02794246|530305463|FG000|Overall Study|Withdrawal by Subject|2|||
147039492|NCT02794246|530305463|FG000|Overall Study|Physician Decision|4|||
147039493|NCT01831258|530305527|FG000|Overall Study|Withdrawal by Subject|2|||
147039494|NCT01831258|530305528|FG001|Overall Study|Withdrawal by Subject|1|||
147039495|NCT01831258|530305527|FG000|Overall Study|Lost to Follow-up|3|||
147039496|NCT01831258|530305528|FG001|Overall Study|Lost to Follow-up|2|||
147039497|NCT02564887|530305537|FG000|Overall Study|Lost to Follow-up|6|||
147039498|NCT02564887|530305538|FG001|Overall Study|Lost to Follow-up|0|||
147039499|NCT01199016|530305539|FG000|Overall Study|No longer meets eligibility criteria|4|||
147039500|NCT01199016|530305539|FG000|Overall Study|Entrance criteria|5|||
147039501|NCT01199016|530305539|FG000|Overall Study|Protocol Violation|9|||
147039502|NCT01199016|530305539|FG000|Overall Study|Other|13|||
147039503|NCT01199016|530305539|FG000|Overall Study|Withdrawal by Subject|21|||
147039504|NCT01199016|530305539|FG000|Overall Study|Lost to Follow-up|25|||
147039505|NCT02368314|530305548|FG000|Overall Study|Withdrawal by Subject|2|||
147039506|NCT02368314|530305549|FG001|Overall Study|Withdrawal by Subject|1|||
147039507|NCT02368314|530305548|FG000|Overall Study|Adverse Event|1|||
147039508|NCT02368314|530305549|FG001|Overall Study|Adverse Event|2|||
147039509|NCT00182325|530305550|FG000|Overall Study|Lost to Follow-up|7|||
147039510|NCT00182325|530305551|FG001|Overall Study|Lost to Follow-up|7|||
147039511|NCT00182325|530305550|FG000|Overall Study|Miscarriage|5|||
147039512|NCT00182325|530305551|FG001|Overall Study|Miscarriage|3|||
147039513|NCT00182325|530305550|FG000|Overall Study|Did not complete survey|22|||
147039514|NCT00182325|530305551|FG001|Overall Study|Did not complete survey|43|||
147039515|NCT01420965|530305554|FG000|Overall Study|Withdrawal by Subject|1|||
147039516|NCT01420965|530305555|FG001|Overall Study|Withdrawal by Subject|0|||
147039517|NCT01420965|530305556|FG002|Overall Study|Withdrawal by Subject|0|||
147039518|NCT01420965|530305554|FG000|Overall Study|Adverse Event|0|||
147039519|NCT01420965|530305555|FG001|Overall Study|Adverse Event|1|||
147039520|NCT01420965|530305556|FG002|Overall Study|Adverse Event|0|||
147039521|NCT01890434|530305593|FG000|Overall Study|Adverse Event|8|||
147039522|NCT01890434|530305593|FG000|Overall Study|PCI at external hospital|1|||
147039523|NCT01890434|530305593|FG000|Overall Study|Assessment discrepancy|1|||
147039524|NCT01890434|530305593|FG000|Overall Study|CRC didn't contact participant for FU|1|||
147039525|NCT01890434|530305593|FG000|Overall Study|Could not get whole set of images|1|||
147039526|NCT01890434|530305593|FG000|Overall Study|Decline to return for GSPECT|1|||
147039527|NCT01890434|530305593|FG000|Overall Study|GSPECT at rest was not done|1|||
147039528|NCT01890434|530305593|FG000|Overall Study|Participant didn't complete MRI|1|||
147039529|NCT01890434|530305593|FG000|Overall Study|Uncontactable by phone|1|||
147039530|NCT01890434|530305593|FG000|Overall Study|Moved out of position|1|||
147039531|NCT01890434|530305593|FG000|Overall Study|Unable to contact|1|||
147039532|NCT01890434|530305593|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
147039533|NCT03280381|530305594|FG000|Overall Study|Physician Decision|0|||
147039534|NCT03280381|530305595|FG001|Overall Study|Physician Decision|2|||
147039535|NCT01267994|530305598|FG000|Overall Study|Adverse Event|2|||
147039536|NCT02655666|530305599|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
147039537|NCT00895414|530305600|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
147039538|NCT00895414|530305601|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
147039539|NCT00895414|530305600|FG000|First Intervention (14 Days)|Physician Decision|0|||
147039540|NCT00895414|530305601|FG001|First Intervention (14 Days)|Physician Decision|1|||
147039541|NCT00863772|530305605|FG000|Overall Study|Adverse Event|1|||
147039542|NCT00863772|530305606|FG001|Overall Study|Adverse Event|4|||
147039543|NCT00863772|530305607|FG002|Overall Study|Adverse Event|0|||
147039544|NCT00863772|530305605|FG000|Overall Study|Lack of Efficacy|4|||
147039545|NCT00863772|530305606|FG001|Overall Study|Lack of Efficacy|2|||
147039546|NCT00863772|530305607|FG002|Overall Study|Lack of Efficacy|4|||
147039547|NCT00863772|530305605|FG000|Overall Study|Lost to Follow-up|5|||
147039548|NCT00863772|530305606|FG001|Overall Study|Lost to Follow-up|1|||
147039549|NCT00863772|530305607|FG002|Overall Study|Lost to Follow-up|1|||
147039550|NCT00863772|530305605|FG000|Overall Study|Protocol Violation|2|||
147039551|NCT00863772|530305606|FG001|Overall Study|Protocol Violation|0|||
147039552|NCT00863772|530305607|FG002|Overall Study|Protocol Violation|2|||
147039553|NCT00863772|530305605|FG000|Overall Study|Withdrawal by Subject|4|||
147039554|NCT00863772|530305606|FG001|Overall Study|Withdrawal by Subject|7|||
147039555|NCT00863772|530305607|FG002|Overall Study|Withdrawal by Subject|5|||
147039556|NCT00863772|530305605|FG000|Overall Study|Study terminated by sponsor|44|||
147039557|NCT00863772|530305606|FG001|Overall Study|Study terminated by sponsor|45|||
147039558|NCT00863772|530305607|FG002|Overall Study|Study terminated by sponsor|36|||
147039559|NCT00863772|530305605|FG000|Overall Study|Entered extension study|6|||
147039560|NCT00863772|530305606|FG001|Overall Study|Entered extension study|4|||
147039561|NCT00863772|530305607|FG002|Overall Study|Entered extension study|9|||
147039562|NCT00863772|530305605|FG000|Overall Study|Other|1|||
147039563|NCT00863772|530305606|FG001|Overall Study|Other|2|||
147039564|NCT00863772|530305607|FG002|Overall Study|Other|4|||
147039565|NCT00863772|530305605|FG000|Overall Study|Randomized but not Treated|1|||
147039566|NCT00863772|530305606|FG001|Overall Study|Randomized but not Treated|0|||
147039567|NCT00863772|530305607|FG002|Overall Study|Randomized but not Treated|0|||
147039568|NCT00086281|530305608|FG000|Phase 1|Adverse Event|0|||
147039569|NCT00086281|530305609|FG001|Phase 1|Adverse Event|0|||
147039570|NCT00086281|530305610|FG002|Phase 1|Adverse Event|0|||
147039571|NCT00086281|530305611|FG003|Phase 1|Adverse Event|0|||
147039572|NCT00086281|530305612|FG004|Phase 1|Adverse Event|0|||
147039573|NCT00086281|530305613|FG005|Phase 1|Adverse Event|0|||
147039574|NCT00086281|530305614|FG006|Phase 1|Adverse Event|0|||
147039575|NCT00086281|530305615|FG007|Phase 1|Adverse Event|0|||
147039576|NCT00086281|530305616|FG008|Phase 1|Adverse Event|0|||
147039577|NCT00086281|530305617|FG009|Phase 1|Adverse Event|1|||
147039578|NCT00086281|530305618|FG010|Phase 1|Adverse Event|2|||
147039579|NCT00086281|530305619|FG011|Phase 1|Adverse Event|1|||
147039580|NCT00086281|530305620|FG012|Phase 1|Adverse Event|1|||
147039581|NCT00086281|530305621|FG013|Phase 1|Adverse Event|1|||
147039582|NCT00086281|530305622|FG014|Phase 1|Adverse Event|2|||
147039583|NCT00086281|530305608|FG000|Phase 1|Protocol Violation|0|||
147039584|NCT00086281|530305609|FG001|Phase 1|Protocol Violation|0|||
147039585|NCT00086281|530305610|FG002|Phase 1|Protocol Violation|0|||
147039586|NCT00086281|530305611|FG003|Phase 1|Protocol Violation|0|||
147039587|NCT00086281|530305612|FG004|Phase 1|Protocol Violation|0|||
147039588|NCT00086281|530305613|FG005|Phase 1|Protocol Violation|0|||
147039589|NCT00086281|530305614|FG006|Phase 1|Protocol Violation|0|||
147039590|NCT00086281|530305615|FG007|Phase 1|Protocol Violation|0|||
147039591|NCT00086281|530305616|FG008|Phase 1|Protocol Violation|0|||
147039592|NCT00086281|530305617|FG009|Phase 1|Protocol Violation|0|||
147039593|NCT00086281|530305618|FG010|Phase 1|Protocol Violation|1|||
147039594|NCT00086281|530305619|FG011|Phase 1|Protocol Violation|0|||
147039595|NCT00086281|530305620|FG012|Phase 1|Protocol Violation|0|||
147039596|NCT00086281|530305621|FG013|Phase 1|Protocol Violation|0|||
147039597|NCT00086281|530305622|FG014|Phase 1|Protocol Violation|0|||
147039598|NCT00086281|530305608|FG000|Phase 1|Serious Adverse Event|0|||
147039599|NCT00086281|530305609|FG001|Phase 1|Serious Adverse Event|0|||
147039600|NCT00086281|530305610|FG002|Phase 1|Serious Adverse Event|0|||
147039601|NCT00086281|530305611|FG003|Phase 1|Serious Adverse Event|0|||
147039602|NCT00086281|530305612|FG004|Phase 1|Serious Adverse Event|0|||
147039603|NCT00086281|530305613|FG005|Phase 1|Serious Adverse Event|0|||
147039604|NCT00086281|530305614|FG006|Phase 1|Serious Adverse Event|0|||
147039605|NCT00086281|530305615|FG007|Phase 1|Serious Adverse Event|0|||
147039606|NCT00086281|530305616|FG008|Phase 1|Serious Adverse Event|0|||
147039607|NCT00086281|530305617|FG009|Phase 1|Serious Adverse Event|0|||
147039608|NCT00086281|530305618|FG010|Phase 1|Serious Adverse Event|0|||
147039609|NCT00086281|530305619|FG011|Phase 1|Serious Adverse Event|0|||
147039610|NCT00086281|530305620|FG012|Phase 1|Serious Adverse Event|0|||
147039611|NCT00086281|530305621|FG013|Phase 1|Serious Adverse Event|0|||
147039612|NCT00086281|530305622|FG014|Phase 1|Serious Adverse Event|1|||
147039613|NCT00086281|530305608|FG000|Phase 2|Adverse Event|0|||
147039614|NCT00086281|530305609|FG001|Phase 2|Adverse Event|0|||
147039615|NCT00086281|530305610|FG002|Phase 2|Adverse Event|0|||
147039616|NCT00086281|530305611|FG003|Phase 2|Adverse Event|0|||
147039617|NCT00086281|530305612|FG004|Phase 2|Adverse Event|0|||
147039618|NCT00086281|530305613|FG005|Phase 2|Adverse Event|0|||
147039619|NCT00086281|530305614|FG006|Phase 2|Adverse Event|0|||
147039620|NCT00086281|530305615|FG007|Phase 2|Adverse Event|0|||
147039621|NCT00086281|530305616|FG008|Phase 2|Adverse Event|0|||
147039622|NCT00086281|530305617|FG009|Phase 2|Adverse Event|0|||
147039623|NCT00086281|530305618|FG010|Phase 2|Adverse Event|0|||
147039624|NCT00086281|530305619|FG011|Phase 2|Adverse Event|0|||
147039625|NCT00086281|530305620|FG012|Phase 2|Adverse Event|1|||
147039626|NCT00086281|530305621|FG013|Phase 2|Adverse Event|1|||
147039627|NCT00086281|530305622|FG014|Phase 2|Adverse Event|0|||
147039628|NCT03456453|530305625|FG000|Overall Study|Withdrawal by Subject|2|||
147039629|NCT03456453|530305626|FG001|Overall Study|Withdrawal by Subject|0|||
147039630|NCT03456453|530305625|FG000|Overall Study|Not released to community|1|||
147039631|NCT03456453|530305626|FG001|Overall Study|Not released to community|5|||
147039632|NCT03456453|530305625|FG000|Overall Study|Lost to Follow-up|0|||
147039633|NCT03456453|530305626|FG001|Overall Study|Lost to Follow-up|2|||
147039634|NCT00896480|530305627|FG000|Overall Study|Disease progression/recurrence|21|||
147039635|NCT00205803|530305629|FG000|Infant Series|Lost to Follow-up|10|||
147039636|NCT00205803|530305630|FG001|Infant Series|Lost to Follow-up|4|||
147039637|NCT00205803|530305629|FG000|Infant Series|Withdrawal by Subject|2|||
147039638|NCT00205803|530305630|FG001|Infant Series|Withdrawal by Subject|5|||
147039639|NCT00205803|530305629|FG000|Infant Series|Physician Decision|3|||
147039640|NCT00205803|530305630|FG001|Infant Series|Physician Decision|1|||
147039641|NCT00205803|530305629|FG000|Infant Series|Protocol Violation|1|||
147039642|NCT00205803|530305630|FG001|Infant Series|Protocol Violation|0|||
147039643|NCT00205803|530305629|FG000|Infant Series|Lost Kaiser coverage|0|||
147039644|NCT00205803|530305630|FG001|Infant Series|Lost Kaiser coverage|1|||
147039645|NCT00205803|530305629|FG000|Infant Series|Non-compliant|1|||
147039646|NCT00205803|530305630|FG001|Infant Series|Non-compliant|0|||
147039647|NCT00205803|530305629|FG000|Infant Series|Sponsor request|1|||
147039648|NCT00205803|530305630|FG001|Infant Series|Sponsor request|0|||
147039649|NCT00205803|530305629|FG000|After Infant Series|Adverse Event|1|||
147039650|NCT00205803|530305630|FG001|After Infant Series|Adverse Event|1|||
147039651|NCT00205803|530305629|FG000|After Infant Series|Protocol Violation|1|||
147039652|NCT00205803|530305630|FG001|After Infant Series|Protocol Violation|1|||
147039653|NCT00205803|530305629|FG000|After Infant Series|Lost to Follow-up|2|||
147039654|NCT00205803|530305630|FG001|After Infant Series|Lost to Follow-up|1|||
147039655|NCT00205803|530305629|FG000|After Infant Series|Physician Decision|3|||
147039656|NCT00205803|530305630|FG001|After Infant Series|Physician Decision|2|||
147039657|NCT00205803|530305629|FG000|After Infant Series|Withdrawal by Subject|1|||
147039658|NCT00205803|530305630|FG001|After Infant Series|Withdrawal by Subject|4|||
147039659|NCT00205803|530305629|FG000|After Infant Series|Other|10|||
147039660|NCT00205803|530305630|FG001|After Infant Series|Other|4|||
147039661|NCT00205803|530305629|FG000|Toddler Dose|Lost to Follow-up|2|||
147039662|NCT00205803|530305630|FG001|Toddler Dose|Lost to Follow-up|3|||
147039663|NCT03255655|530305634|FG000|Overall Study|Lost to Follow-up|7|||
147039664|NCT03255655|530305635|FG001|Overall Study|Lost to Follow-up|4|||
147039665|NCT00658021|530305636|FG000|28-Week Treatment Period|Adverse Event|3|||
147039666|NCT00658021|530305637|FG001|28-Week Treatment Period|Adverse Event|1|||
147039667|NCT00658021|530305638|FG002|28-Week Treatment Period|Adverse Event|0|||
147039668|NCT00658021|530305636|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
147039669|NCT00658021|530305637|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
147039670|NCT00658021|530305638|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
147039671|NCT00658021|530305636|FG000|28-Week Treatment Period|Protocol Violation|0|||
147039672|NCT00658021|530305637|FG001|28-Week Treatment Period|Protocol Violation|2|||
147039673|NCT00658021|530305638|FG002|28-Week Treatment Period|Protocol Violation|1|||
147039674|NCT00658021|530305636|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
147039675|NCT00658021|530305637|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
147039676|NCT00658021|530305638|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
147039677|NCT00658021|530305636|FG000|28-Week Treatment Period|Physician Decision|1|||
147039678|NCT00658021|530305637|FG001|28-Week Treatment Period|Physician Decision|2|||
147039679|NCT00658021|530305638|FG002|28-Week Treatment Period|Physician Decision|1|||
147039680|NCT00658021|530305636|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
147039681|NCT00658021|530305637|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
147039682|NCT00658021|530305638|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
147039683|NCT00658021|530305636|FG000|28-Week Treatment Period|Loss of glucose control|1|||
147039684|NCT00658021|530305637|FG001|28-Week Treatment Period|Loss of glucose control|1|||
147039685|NCT00658021|530305638|FG002|28-Week Treatment Period|Loss of glucose control|10|||
147039686|NCT00658021|530305636|FG000|28-Week Treatment Period|Other|2|||
147039687|NCT00658021|530305637|FG001|28-Week Treatment Period|Other|3|||
147039688|NCT00658021|530305638|FG002|28-Week Treatment Period|Other|1|||
147039689|NCT00658021|530305636|FG000|28-Week Treatment Period|Did not receive treatment|2|||
147039690|NCT00658021|530305637|FG001|28-Week Treatment Period|Did not receive treatment|0|||
147039691|NCT00658021|530305638|FG002|28-Week Treatment Period|Did not receive treatment|0|||
147039692|NCT00658021|530305636|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
147039693|NCT00658021|530305637|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
147039694|NCT00658021|530305638|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
147039695|NCT00658021|530305636|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
147039696|NCT00658021|530305637|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
147039697|NCT00658021|530305638|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
147039698|NCT04784533|530305639|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
147039699|NCT04784533|530305640|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
147039700|NCT04784533|530305641|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
147039701|NCT04784533|530305642|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
147039702|NCT04784533|530305643|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
147039703|NCT04784533|530305644|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
147039704|NCT04784533|530305645|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
147039705|NCT04784533|530305646|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
147039706|NCT04784533|530305647|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
147039707|NCT04784533|530305648|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
147039708|NCT04784533|530305639|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
147039709|NCT04784533|530305640|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
147039710|NCT04784533|530305641|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
147039711|NCT04784533|530305642|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
147039712|NCT04784533|530305643|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
147039713|NCT04784533|530305644|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
147039714|NCT04784533|530305645|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
147039715|NCT04784533|530305646|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
147039716|NCT04784533|530305647|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
147039717|NCT04784533|530305648|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
147039718|NCT04784533|530305639|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147039719|NCT04784533|530305640|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
147039720|NCT04784533|530305641|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147039721|NCT04784533|530305642|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147039722|NCT04784533|530305643|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147039723|NCT04784533|530305644|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147039724|NCT04784533|530305645|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147039725|NCT04784533|530305646|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147039726|NCT04784533|530305647|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147039727|NCT04784533|530305648|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147039728|NCT04784533|530305639|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
147039729|NCT04784533|530305640|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147039730|NCT04784533|530305641|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147039731|NCT04784533|530305642|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147039732|NCT04784533|530305643|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147039733|NCT04784533|530305644|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147039734|NCT04784533|530305645|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147039735|NCT04784533|530305646|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147039736|NCT04784533|530305647|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147039737|NCT04784533|530305648|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147039738|NCT04784533|530305639|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
147039739|NCT04784533|530305640|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
147039740|NCT04784533|530305641|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
147039741|NCT04784533|530305642|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
147039742|NCT04784533|530305643|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
147039743|NCT04784533|530305644|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
147039744|NCT04784533|530305645|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
147039745|NCT04784533|530305646|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
147039746|NCT04784533|530305647|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
147039747|NCT04784533|530305648|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
147039748|NCT04784533|530305639|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
147039749|NCT04784533|530305640|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
147039750|NCT04784533|530305641|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
147039751|NCT04784533|530305642|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
147039752|NCT04784533|530305643|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
147039753|NCT04784533|530305644|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
147039754|NCT04784533|530305645|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
147039755|NCT04784533|530305646|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
147039756|NCT04784533|530305647|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
147039757|NCT04784533|530305648|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
147039758|NCT04784533|530305639|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
146849769|NCT01879722|529618879|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
146849770|NCT01879722|529618880|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
146849771|NCT01879722|529618881|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
146849772|NCT01879722|529618882|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
146849773|NCT01879722|529618873|FG000|Overall Study|Voluntary Withdrawal|0|||
146849774|NCT01879722|529618874|FG001|Overall Study|Voluntary Withdrawal|0|||
146849775|NCT01879722|529618875|FG002|Overall Study|Voluntary Withdrawal|0|||
146849776|NCT01879722|529618876|FG003|Overall Study|Voluntary Withdrawal|0|||
146849777|NCT01879722|529618877|FG004|Overall Study|Voluntary Withdrawal|0|||
146849778|NCT01879722|529618878|FG005|Overall Study|Voluntary Withdrawal|0|||
147039759|NCT04784533|530305640|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147039760|NCT04784533|530305641|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
147039761|NCT04784533|530305642|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147039762|NCT04784533|530305643|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147039763|NCT04784533|530305644|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147039764|NCT04784533|530305645|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147039765|NCT04784533|530305646|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147039766|NCT04784533|530305647|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147039767|NCT04784533|530305648|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147039768|NCT04784533|530305639|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147039769|NCT04784533|530305640|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147039770|NCT04784533|530305641|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147039771|NCT04784533|530305642|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147039772|NCT04784533|530305643|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147039773|NCT04784533|530305644|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147039774|NCT04784533|530305645|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147039775|NCT04784533|530305646|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147039776|NCT04784533|530305647|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
147039777|NCT04784533|530305648|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147039778|NCT04784533|530305639|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
147039779|NCT04784533|530305640|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
147039780|NCT04784533|530305641|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
147039781|NCT04784533|530305642|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
147039782|NCT04784533|530305643|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
147039783|NCT04784533|530305644|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
147039784|NCT04784533|530305645|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
147039785|NCT04784533|530305646|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
147039786|NCT04784533|530305647|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
147039787|NCT04784533|530305648|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
147039788|NCT02925403|530306957|FG000|Overall Study|Lost to Follow-up|0|||
147039789|NCT02925403|530306958|FG001|Overall Study|Lost to Follow-up|1|||
147039790|NCT03092219|530306959|FG000|Overall Study|Protocol Violation|7|||
147039791|NCT03092219|530306960|FG001|Overall Study|Protocol Violation|4|||
147039792|NCT03278626|530306961|FG000|Overall Study|Death|2|||
147039793|NCT03278626|530306961|FG000|Overall Study|Toxicity|1|||
147039794|NCT03278626|530306961|FG000|Overall Study|Disease Progression|2|||
147039795|NCT00591773|530306962|FG000|Overall Study|Adverse Event|9|||
147039796|NCT00591773|530306963|FG001|Overall Study|Adverse Event|9|||
147039797|NCT00591773|530306964|FG002|Overall Study|Adverse Event|6|||
147039798|NCT00591773|530306962|FG000|Overall Study|Protocol Violation|2|||
147039799|NCT00591773|530306963|FG001|Overall Study|Protocol Violation|3|||
147039800|NCT00591773|530306964|FG002|Overall Study|Protocol Violation|0|||
147039801|NCT00591773|530306962|FG000|Overall Study|Lost to Follow-up|1|||
147039802|NCT00591773|530306963|FG001|Overall Study|Lost to Follow-up|4|||
147039803|NCT00591773|530306964|FG002|Overall Study|Lost to Follow-up|1|||
147039804|NCT00591773|530306962|FG000|Overall Study|Withdrawal by Subject|2|||
147039805|NCT00591773|530306963|FG001|Overall Study|Withdrawal by Subject|5|||
147039806|NCT00591773|530306964|FG002|Overall Study|Withdrawal by Subject|3|||
147039807|NCT00591773|530306962|FG000|Overall Study|Lack of Efficacy|1|||
147039808|NCT00591773|530306963|FG001|Overall Study|Lack of Efficacy|2|||
147039809|NCT00591773|530306964|FG002|Overall Study|Lack of Efficacy|2|||
147039810|NCT00591773|530306962|FG000|Overall Study|Other|1|||
147039811|NCT00591773|530306963|FG001|Overall Study|Other|1|||
147039812|NCT00591773|530306964|FG002|Overall Study|Other|4|||
147039813|NCT03743415|530306972|FG000|Overall Study|Death|5|||
147039814|NCT03743415|530306973|FG001|Overall Study|Death|3|||
147039815|NCT03743415|530306974|FG002|Overall Study|Death|1|||
147039816|NCT03743415|530306975|FG003|Overall Study|Death|4|||
147039817|NCT03743415|530306976|FG004|Overall Study|Death|0|||
147039818|NCT03743415|530306977|FG005|Overall Study|Death|0|||
147039819|NCT03743415|530306978|FG006|Overall Study|Death|0|||
147039820|NCT03743415|530306979|FG007|Overall Study|Death|0|||
147039821|NCT03743415|530306980|FG008|Overall Study|Death|1|||
147039822|NCT03743415|530306981|FG009|Overall Study|Death|0|||
147039823|NCT03743415|530306972|FG000|Overall Study|Withdrawal by Subject|1|||
147039824|NCT03743415|530306973|FG001|Overall Study|Withdrawal by Subject|0|||
147039825|NCT03743415|530306974|FG002|Overall Study|Withdrawal by Subject|4|||
147039826|NCT03743415|530306975|FG003|Overall Study|Withdrawal by Subject|5|||
147039827|NCT03743415|530306976|FG004|Overall Study|Withdrawal by Subject|5|||
147039828|NCT03743415|530306977|FG005|Overall Study|Withdrawal by Subject|2|||
147039829|NCT03743415|530306978|FG006|Overall Study|Withdrawal by Subject|2|||
147039830|NCT03743415|530306979|FG007|Overall Study|Withdrawal by Subject|5|||
147039831|NCT03743415|530306980|FG008|Overall Study|Withdrawal by Subject|9|||
147039832|NCT03743415|530306981|FG009|Overall Study|Withdrawal by Subject|10|||
147039833|NCT03743415|530306972|FG000|Overall Study|Lost to Follow-up|2|||
147039834|NCT03743415|530306973|FG001|Overall Study|Lost to Follow-up|0|||
147039835|NCT03743415|530306974|FG002|Overall Study|Lost to Follow-up|2|||
147039836|NCT03743415|530306975|FG003|Overall Study|Lost to Follow-up|1|||
147039837|NCT03743415|530306976|FG004|Overall Study|Lost to Follow-up|1|||
147039838|NCT03743415|530306977|FG005|Overall Study|Lost to Follow-up|0|||
147039839|NCT03743415|530306978|FG006|Overall Study|Lost to Follow-up|1|||
147039840|NCT03743415|530306979|FG007|Overall Study|Lost to Follow-up|4|||
147039841|NCT03743415|530306980|FG008|Overall Study|Lost to Follow-up|13|||
147039842|NCT03743415|530306981|FG009|Overall Study|Lost to Follow-up|13|||
147039843|NCT00094861|530306982|FG000|Overall Study|Adverse Event|5|||
147039844|NCT00094861|530306983|FG001|Overall Study|Adverse Event|2|||
147039845|NCT00094861|530306982|FG000|Overall Study|Withdrawal by Subject|5|||
147039846|NCT00094861|530306983|FG001|Overall Study|Withdrawal by Subject|3|||
147039847|NCT00094861|530306982|FG000|Overall Study|Physician Decision|1|||
147039848|NCT00094861|530306983|FG001|Overall Study|Physician Decision|1|||
147039849|NCT00094861|530306982|FG000|Overall Study|Lost to Follow-up|0|||
147039850|NCT00094861|530306983|FG001|Overall Study|Lost to Follow-up|1|||
147039851|NCT00094861|530306982|FG000|Overall Study|Death|4|||
147039852|NCT00094861|530306983|FG001|Overall Study|Death|2|||
147039853|NCT00094861|530306982|FG000|Overall Study|Other|3|||
147039854|NCT00094861|530306983|FG001|Overall Study|Other|0|||
147039855|NCT00451204|530306986|FG000|Overall Study|Adverse Event|4|||
147039856|NCT00451204|530306987|FG001|Overall Study|Adverse Event|6|||
147039857|NCT00451204|530306986|FG000|Overall Study|Lack of Efficacy|4|||
147039858|NCT00451204|530306987|FG001|Overall Study|Lack of Efficacy|4|||
147039859|NCT00451204|530306986|FG000|Overall Study|Lost to Follow-up|4|||
147039860|NCT00451204|530306987|FG001|Overall Study|Lost to Follow-up|4|||
147039861|NCT00451204|530306986|FG000|Overall Study|Protocol Violation|1|||
147039862|NCT00451204|530306987|FG001|Overall Study|Protocol Violation|0|||
147039863|NCT00451204|530306986|FG000|Overall Study|Patient refusal|8|||
147039864|NCT00451204|530306987|FG001|Overall Study|Patient refusal|4|||
147039865|NCT00451204|530306986|FG000|Overall Study|Other|1|||
147039866|NCT00451204|530306987|FG001|Overall Study|Other|2|||
147039867|NCT03760185|530306988|FG000|Overall Study|Lost to Follow-up|1|||
147039868|NCT03760185|530306989|FG001|Overall Study|Lost to Follow-up|1|||
147039869|NCT00976911|530306992|FG000|Overall Study|Withdrawal by Subject|4|||
147039870|NCT00976911|530306993|FG001|Overall Study|Withdrawal by Subject|6|||
147039871|NCT00976911|530306992|FG000|Overall Study|Death|138|||
147039872|NCT00976911|530306993|FG001|Overall Study|Death|126|||
147039873|NCT00976911|530306992|FG000|Overall Study|Adverse Event|0|||
147039874|NCT00976911|530306993|FG001|Overall Study|Adverse Event|1|||
147039875|NCT00976911|530306992|FG000|Overall Study|Protocol Violation|2|||
147039876|NCT00976911|530306993|FG001|Overall Study|Protocol Violation|0|||
147039877|NCT00976911|530306992|FG000|Overall Study|Other|8|||
147039878|NCT00976911|530306993|FG001|Overall Study|Other|9|||
147039879|NCT00976911|530306992|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
147039880|NCT00976911|530306993|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
147039881|NCT01191944|530306994|FG000|Overall Study|Adverse Event|11|||
147039882|NCT01191944|530306995|FG001|Overall Study|Adverse Event|12|||
147039883|NCT01191944|530306994|FG000|Overall Study|Protocol Violation|1|||
147039884|NCT01191944|530306995|FG001|Overall Study|Protocol Violation|2|||
147039885|NCT01191944|530306994|FG000|Overall Study|Withdrawal by Subject|4|||
147039886|NCT01191944|530306995|FG001|Overall Study|Withdrawal by Subject|2|||
147039887|NCT01191944|530306994|FG000|Overall Study|Other|1|||
147039888|NCT01191944|530306995|FG001|Overall Study|Other|3|||
147039889|NCT02954991|530306998|FG000|Overall Study|Death|92|||
147039890|NCT02954991|530306999|FG001|Overall Study|Death|11|||
147039891|NCT02954991|530307000|FG002|Overall Study|Death|2|||
147039892|NCT02954991|530306998|FG000|Overall Study|Lost to Follow-up|3|||
147039893|NCT02954991|530306999|FG001|Overall Study|Lost to Follow-up|2|||
147039894|NCT02954991|530307000|FG002|Overall Study|Lost to Follow-up|0|||
147039895|NCT02954991|530306998|FG000|Overall Study|Withdrawal by Subject|9|||
147039896|NCT02954991|530306999|FG001|Overall Study|Withdrawal by Subject|8|||
147039897|NCT02954991|530307000|FG002|Overall Study|Withdrawal by Subject|1|||
147039898|NCT02954991|530306998|FG000|Overall Study|Study Terminated by Sponsor|18|||
146849779|NCT01879722|529618879|FG006|Overall Study|Voluntary Withdrawal|0|||
147039899|NCT02954991|530306999|FG001|Overall Study|Study Terminated by Sponsor|10|||
147039900|NCT02954991|530307000|FG002|Overall Study|Study Terminated by Sponsor|1|||
146849780|NCT01879722|529618880|FG007|Overall Study|Voluntary Withdrawal|0|||
146849781|NCT01879722|529618881|FG008|Overall Study|Voluntary Withdrawal|1|||
147039901|NCT02954991|530306998|FG000|Overall Study|Miscellaneous|2|||
146849782|NCT01879722|529618882|FG009|Overall Study|Voluntary Withdrawal|0|||
147039902|NCT02954991|530306999|FG001|Overall Study|Miscellaneous|1|||
147039903|NCT02954991|530307000|FG002|Overall Study|Miscellaneous|1|||
147039904|NCT00576316|530307001|FG000|Overall Study|Adverse Event|9|||
147039905|NCT00576316|530307001|FG000|Overall Study|Withdrawal by Subject|2|||
147039906|NCT00576316|530307001|FG000|Overall Study|Protocol Violation|9|||
147039907|NCT02552303|530307004|FG000|Allocation|Withdrawal by Subject|2|||
147039908|NCT02552303|530307005|FG001|Allocation|Withdrawal by Subject|1|||
147039909|NCT02552303|530307006|FG002|Allocation|Withdrawal by Subject|1|||
147039910|NCT02552303|530307007|FG003|Allocation|Withdrawal by Subject|1|||
147039911|NCT02552303|530307004|FG000|Allocation|ineligible|1|||
147039912|NCT02552303|530307005|FG001|Allocation|ineligible|1|||
147039913|NCT02552303|530307006|FG002|Allocation|ineligible|0|||
147039914|NCT02552303|530307007|FG003|Allocation|ineligible|0|||
147039915|NCT02552303|530307004|FG000|Follow-Up|Lost to Follow-up|0|||
147039916|NCT02552303|530307005|FG001|Follow-Up|Lost to Follow-up|0|||
147039917|NCT02552303|530307006|FG002|Follow-Up|Lost to Follow-up|1|||
147039918|NCT02552303|530307007|FG003|Follow-Up|Lost to Follow-up|0|||
147039919|NCT02552303|530307004|FG000|Follow-Up|ineligible|0|||
147039920|NCT02552303|530307005|FG001|Follow-Up|ineligible|2|||
147039921|NCT02552303|530307006|FG002|Follow-Up|ineligible|0|||
147039922|NCT02552303|530307007|FG003|Follow-Up|ineligible|0|||
147039923|NCT04602546|530307010|FG000|Overall Study|Training|2|||
147039924|NCT04602546|530307011|FG001|Overall Study|Training|2|||
147039925|NCT04602546|530307012|FG002|Overall Study|Training|1|||
147039926|NCT04602546|530307013|FG003|Overall Study|Training|2|||
147039927|NCT04602546|530307014|FG004|Overall Study|Training|0|||
147039928|NCT04602546|530307010|FG000|Overall Study|Randomized with disqualified data|2|||
147039929|NCT04602546|530307011|FG001|Overall Study|Randomized with disqualified data|0|||
147039930|NCT04602546|530307012|FG002|Overall Study|Randomized with disqualified data|2|||
147039931|NCT04602546|530307013|FG003|Overall Study|Randomized with disqualified data|5|||
147039932|NCT04602546|530307014|FG004|Overall Study|Randomized with disqualified data|3|||
147039933|NCT00253448|530307015|FG000|Overall Study|Withdrawal by Subject|1|||
147039934|NCT02052011|530307017|FG000|Overall Study|Lost to Follow-up|3|||
147039935|NCT02052011|530307018|FG001|Overall Study|Lost to Follow-up|0|||
147039936|NCT02052011|530307017|FG000|Overall Study|Withdrawal by Subject|1|||
147039937|NCT02052011|530307018|FG001|Overall Study|Withdrawal by Subject|2|||
147039938|NCT00000620|530307019|FG000|Overall Study|Death|86|||
147039939|NCT00000620|530307020|FG001|Overall Study|Death|67|||
147039940|NCT00000620|530307021|FG002|Overall Study|Death|112|||
147039941|NCT00000620|530307022|FG003|Overall Study|Death|126|||
147039942|NCT00000620|530307023|FG004|Overall Study|Death|64|||
147039943|NCT00000620|530307024|FG005|Overall Study|Death|77|||
147039944|NCT00000620|530307025|FG006|Overall Study|Death|91|||
147039945|NCT00000620|530307026|FG007|Overall Study|Death|95|||
147039946|NCT00000620|530307019|FG000|Overall Study|Lost to Follow-up|14|||
147039947|NCT00000620|530307020|FG001|Overall Study|Lost to Follow-up|14|||
147039948|NCT00000620|530307021|FG002|Overall Study|Lost to Follow-up|14|||
147039949|NCT00000620|530307022|FG003|Overall Study|Lost to Follow-up|14|||
147039950|NCT00000620|530307023|FG004|Overall Study|Lost to Follow-up|15|||
147039951|NCT00000620|530307024|FG005|Overall Study|Lost to Follow-up|15|||
147039952|NCT00000620|530307025|FG006|Overall Study|Lost to Follow-up|13|||
147039953|NCT00000620|530307026|FG007|Overall Study|Lost to Follow-up|14|||
147039954|NCT00000620|530307019|FG000|Overall Study|Withdrawal by Subject|40|||
147039955|NCT00000620|530307020|FG001|Overall Study|Withdrawal by Subject|27|||
147039956|NCT00000620|530307021|FG002|Overall Study|Withdrawal by Subject|28|||
147039957|NCT00000620|530307022|FG003|Overall Study|Withdrawal by Subject|27|||
147039958|NCT00000620|530307023|FG004|Overall Study|Withdrawal by Subject|30|||
147039959|NCT00000620|530307024|FG005|Overall Study|Withdrawal by Subject|32|||
147039960|NCT00000620|530307025|FG006|Overall Study|Withdrawal by Subject|32|||
147039961|NCT00000620|530307026|FG007|Overall Study|Withdrawal by Subject|21|||
147039962|NCT00000620|530307019|FG000|Overall Study|missed closeout visit|22|||
147039963|NCT00000620|530307020|FG001|Overall Study|missed closeout visit|28|||
147039964|NCT00000620|530307021|FG002|Overall Study|missed closeout visit|16|||
147039965|NCT00000620|530307022|FG003|Overall Study|missed closeout visit|11|||
147039966|NCT00000620|530307023|FG004|Overall Study|missed closeout visit|26|||
147039967|NCT00000620|530307024|FG005|Overall Study|missed closeout visit|28|||
147039968|NCT00000620|530307025|FG006|Overall Study|missed closeout visit|13|||
147039969|NCT00000620|530307026|FG007|Overall Study|missed closeout visit|16|||
147039970|NCT01851330|530307027|FG000|Overall Study|Lack of Efficacy|10|||
147039971|NCT01851330|530307028|FG001|Overall Study|Lack of Efficacy|9|||
147039972|NCT01851330|530307029|FG002|Overall Study|Lack of Efficacy|2|||
147039973|NCT01851330|530307027|FG000|Overall Study|Lost to Follow-up|1|||
147039974|NCT01851330|530307028|FG001|Overall Study|Lost to Follow-up|6|||
147039975|NCT01851330|530307029|FG002|Overall Study|Lost to Follow-up|9|||
147039976|NCT01851330|530307027|FG000|Overall Study|Withdrew Consent|2|||
147039977|NCT01851330|530307028|FG001|Overall Study|Withdrew Consent|1|||
147039978|NCT01851330|530307029|FG002|Overall Study|Withdrew Consent|0|||
147039979|NCT01851330|530307027|FG000|Overall Study|Investigator's Discretion|0|||
147039980|NCT01851330|530307028|FG001|Overall Study|Investigator's Discretion|0|||
147039981|NCT01851330|530307029|FG002|Overall Study|Investigator's Discretion|1|||
147039982|NCT02648932|530307030|FG000|Overall Study|No transplant|3|||
147039983|NCT02648932|530307031|FG001|Overall Study|No transplant|1|||
147039984|NCT01266031|530307032|FG000|Overall Study|Not treated|0|||
147039985|NCT01266031|530307033|FG001|Overall Study|Not treated|3|||
147039986|NCT01266031|530307034|FG002|Overall Study|Not treated|2|||
147039987|NCT01307111|530307037|FG000|IUD Insertion|Lost to Follow-up|2|||
147039988|NCT01307111|530307038|FG001|IUD Insertion|Lost to Follow-up|0|||
147039989|NCT01307111|530307037|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
147039990|NCT01307111|530307038|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
147039991|NCT01275729|530307042|FG000|Overall Study|Death|3|||
147039992|NCT01275729|530307042|FG000|Overall Study|Withdrawal by Subject|1|||
147039993|NCT02252406|530307043|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
147039994|NCT02252406|530307044|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
147039995|NCT02252406|530307043|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
147039996|NCT02252406|530307044|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
147039997|NCT02252406|530307043|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
147039998|NCT02252406|530307044|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
147039999|NCT02252406|530307043|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
147040000|NCT02252406|530307044|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
147040001|NCT02252406|530307043|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
147040002|NCT02252406|530307044|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
147040003|NCT00005957|530307049|FG000|Overall Study|No treated|3|||
147040004|NCT00005957|530307050|FG001|Overall Study|No treated|9|||
147040005|NCT00005957|530307049|FG000|Overall Study|Crossover to the other arm|5|||
147040006|NCT00005957|530307050|FG001|Overall Study|Crossover to the other arm|19|||
147040007|NCT01174043|530307051|FG000|Overall Study|Disease progression|5|||
147040008|NCT01174043|530307051|FG000|Overall Study|Adverse Event|3|||
147040009|NCT01174043|530307051|FG000|Overall Study|Death|1|||
147040010|NCT01174043|530307051|FG000|Overall Study|Withdrawal by Subject|2|||
147040011|NCT02047734|530307052|FG000|Overall Study|Adverse Event|18|||
147040012|NCT02047734|530307053|FG001|Overall Study|Adverse Event|13|||
147040013|NCT02047734|530307054|FG002|Overall Study|Adverse Event|13|||
147040014|NCT02047734|530307052|FG000|Overall Study|Lack of Efficacy|4|||
147040015|NCT02047734|530307053|FG001|Overall Study|Lack of Efficacy|5|||
147040016|NCT02047734|530307054|FG002|Overall Study|Lack of Efficacy|1|||
147040017|NCT02047734|530307052|FG000|Overall Study|Protocol Violation|3|||
147040018|NCT02047734|530307053|FG001|Overall Study|Protocol Violation|1|||
147040019|NCT02047734|530307054|FG002|Overall Study|Protocol Violation|1|||
147040020|NCT02047734|530307052|FG000|Overall Study|Lost to Follow-up|1|||
147040021|NCT02047734|530307053|FG001|Overall Study|Lost to Follow-up|4|||
147040022|NCT02047734|530307054|FG002|Overall Study|Lost to Follow-up|0|||
147040023|NCT02047734|530307052|FG000|Overall Study|Death|0|||
147040024|NCT02047734|530307053|FG001|Overall Study|Death|1|||
147040025|NCT02047734|530307054|FG002|Overall Study|Death|0|||
147040026|NCT02047734|530307052|FG000|Overall Study|Withdrawal by Subject|30|||
147040027|NCT02047734|530307053|FG001|Overall Study|Withdrawal by Subject|31|||
147040028|NCT02047734|530307054|FG002|Overall Study|Withdrawal by Subject|19|||
147040029|NCT02047734|530307052|FG000|Overall Study|Physician Decision|7|||
147040030|NCT02047734|530307053|FG001|Overall Study|Physician Decision|6|||
147040031|NCT02047734|530307054|FG002|Overall Study|Physician Decision|5|||
147040032|NCT02047734|530307052|FG000|Overall Study|Miscellaneous|2|||
147040033|NCT02047734|530307053|FG001|Overall Study|Miscellaneous|4|||
147040034|NCT02047734|530307054|FG002|Overall Study|Miscellaneous|6|||
147040035|NCT02047734|530307052|FG000|Overall Study|Did Not Receive Study Drug|2|||
147040036|NCT02047734|530307053|FG001|Overall Study|Did Not Receive Study Drug|4|||
147040037|NCT02047734|530307054|FG002|Overall Study|Did Not Receive Study Drug|1|||
147040038|NCT00582010|530307057|FG000|Overall Study|Death|0|||
147040039|NCT00582010|530307058|FG001|Overall Study|Death|1|||
147040040|NCT00958893|530307062|FG000|Overall Study|Study prematurely terminated|4|||
147040041|NCT02892149|530307063|FG000|Overall Study|Death|262|||
147040042|NCT02892149|530307064|FG001|Overall Study|Death|278|||
147040043|NCT02892149|530307063|FG000|Overall Study|Withdrawal by Subject|53|||
147040044|NCT02892149|530307064|FG001|Overall Study|Withdrawal by Subject|47|||
147040045|NCT02892149|530307063|FG000|Overall Study|Lost to Follow-up|37|||
147040046|NCT02892149|530307064|FG001|Overall Study|Lost to Follow-up|31|||
147040047|NCT01994850|530307066|FG000|Overall Study|Physician Decision|1|||
147040048|NCT01994850|530307066|FG000|Overall Study|Withdrawal by Subject|1|||
147040049|NCT03489109|530307074|FG000|Overall Study|Lost to Follow-up|1|||
147040050|NCT03489109|530307075|FG001|Overall Study|Lost to Follow-up|2|||
147040051|NCT04868968|530307076|FG000|Overall Study|Lost to Follow-up|1|||
147040052|NCT03276078|530307077|FG000|Overall Study|Adverse Event|1|||
147040053|NCT02552732|530307078|FG000|Overall Study|Lost to Follow-up|2|||
146849783|NCT01983254|529618883|FG000|Overall Study|Death|6|||
146849784|NCT01983254|529618884|FG001|Overall Study|Death|6|||
146849785|NCT01983254|529618883|FG000|Overall Study|Lost to Follow-up|17|||
147040054|NCT02552732|530307078|FG000|Overall Study|Physician Decision|1|||
147040055|NCT02552732|530307078|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
147040056|NCT02552732|530307078|FG000|Overall Study|Withdrawal by Subject|6|||
147040057|NCT01275430|530307080|FG000|Overall Study|Adverse Event|1|||
147040058|NCT01275430|530307080|FG000|Overall Study|No Contrast Injection|6|||
147040059|NCT01275430|530307080|FG000|Overall Study|Device Malfunction|1|||
147040060|NCT01275430|530307080|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
147040061|NCT02613182|530307081|FG000|Overall Study|Death|6|||
147040062|NCT02613182|530307081|FG000|Overall Study|Physician Decision|1|||
147040063|NCT02613182|530307081|FG000|Overall Study|Study Terminated by Sponsor|21|||
147040064|NCT02613182|530307081|FG000|Overall Study|Withdrawal by Subject|6|||
147040065|NCT01547130|530307082|FG000|Overall Study|Lost to Follow-up|9|||
147040066|NCT01547130|530307083|FG001|Overall Study|Lost to Follow-up|5|||
147040067|NCT03968978|530307084|FG000|Overall Study|Adverse Event|1|||
147040068|NCT03968978|530307085|FG001|Overall Study|Adverse Event|0|||
147040069|NCT02714426|530307086|FG000|Overall Study|Withdrawal by Subject|2|||
147040070|NCT02714426|530307087|FG001|Overall Study|Withdrawal by Subject|2|||
147040071|NCT00025259|530307089|FG000|Overall Study|Death|1|||
147040072|NCT00025259|530307090|FG001|Overall Study|Death|3|||
147040073|NCT00025259|530307091|FG002|Overall Study|Death|0|||
147040074|NCT00025259|530307092|FG003|Overall Study|Death|3|||
147040075|NCT00025259|530307093|FG004|Overall Study|Death|0|||
147040076|NCT00025259|530307094|FG005|Overall Study|Death|1|||
147040077|NCT00025259|530307095|FG006|Overall Study|Death|2|||
147040078|NCT00025259|530307089|FG000|Overall Study|Lack of Efficacy|2|||
147040079|NCT00025259|530307090|FG001|Overall Study|Lack of Efficacy|46|||
147040080|NCT00025259|530307091|FG002|Overall Study|Lack of Efficacy|60|||
147040081|NCT00025259|530307092|FG003|Overall Study|Lack of Efficacy|78|||
147040082|NCT00025259|530307093|FG004|Overall Study|Lack of Efficacy|11|||
147040083|NCT00025259|530307094|FG005|Overall Study|Lack of Efficacy|30|||
147040084|NCT00025259|530307095|FG006|Overall Study|Lack of Efficacy|38|||
147040085|NCT00025259|530307089|FG000|Overall Study|Lost to Follow-up|2|||
147040086|NCT00025259|530307090|FG001|Overall Study|Lost to Follow-up|9|||
147040087|NCT00025259|530307091|FG002|Overall Study|Lost to Follow-up|13|||
147040088|NCT00025259|530307092|FG003|Overall Study|Lost to Follow-up|13|||
147040089|NCT00025259|530307093|FG004|Overall Study|Lost to Follow-up|1|||
147040090|NCT00025259|530307094|FG005|Overall Study|Lost to Follow-up|3|||
147040091|NCT00025259|530307095|FG006|Overall Study|Lost to Follow-up|1|||
147040092|NCT00025259|530307089|FG000|Overall Study|Physician Decision|12|||
147040093|NCT00025259|530307090|FG001|Overall Study|Physician Decision|1|||
147040094|NCT00025259|530307091|FG002|Overall Study|Physician Decision|0|||
147040095|NCT00025259|530307092|FG003|Overall Study|Physician Decision|5|||
147040096|NCT00025259|530307093|FG004|Overall Study|Physician Decision|4|||
147040097|NCT00025259|530307094|FG005|Overall Study|Physician Decision|2|||
147040098|NCT00025259|530307095|FG006|Overall Study|Physician Decision|1|||
147040099|NCT00025259|530307089|FG000|Overall Study|Protocol Violation|3|||
147040100|NCT00025259|530307090|FG001|Overall Study|Protocol Violation|2|||
147040101|NCT00025259|530307091|FG002|Overall Study|Protocol Violation|2|||
147040102|NCT00025259|530307092|FG003|Overall Study|Protocol Violation|1|||
147040103|NCT00025259|530307093|FG004|Overall Study|Protocol Violation|2|||
147040104|NCT00025259|530307094|FG005|Overall Study|Protocol Violation|1|||
147040105|NCT00025259|530307095|FG006|Overall Study|Protocol Violation|3|||
147040106|NCT00025259|530307089|FG000|Overall Study|Withdrawal by Subject|9|||
147040107|NCT00025259|530307090|FG001|Overall Study|Withdrawal by Subject|27|||
147040108|NCT00025259|530307091|FG002|Overall Study|Withdrawal by Subject|6|||
147040109|NCT00025259|530307092|FG003|Overall Study|Withdrawal by Subject|14|||
147040110|NCT00025259|530307093|FG004|Overall Study|Withdrawal by Subject|11|||
147040111|NCT00025259|530307094|FG005|Overall Study|Withdrawal by Subject|8|||
147040112|NCT00025259|530307095|FG006|Overall Study|Withdrawal by Subject|3|||
147040113|NCT00025259|530307089|FG000|Overall Study|Ineligible|14|||
147040114|NCT00025259|530307090|FG001|Overall Study|Ineligible|1|||
147040115|NCT00025259|530307091|FG002|Overall Study|Ineligible|0|||
147040116|NCT00025259|530307092|FG003|Overall Study|Ineligible|0|||
147040117|NCT00025259|530307093|FG004|Overall Study|Ineligible|6|||
147040118|NCT00025259|530307094|FG005|Overall Study|Ineligible|0|||
147040119|NCT00025259|530307095|FG006|Overall Study|Ineligible|1|||
147040120|NCT00025259|530307089|FG000|Overall Study|Randomization error|1|||
147040121|NCT00025259|530307090|FG001|Overall Study|Randomization error|0|||
147040122|NCT00025259|530307091|FG002|Overall Study|Randomization error|0|||
147040123|NCT00025259|530307092|FG003|Overall Study|Randomization error|0|||
147040124|NCT00025259|530307093|FG004|Overall Study|Randomization error|1|||
147040125|NCT00025259|530307094|FG005|Overall Study|Randomization error|7|||
147040126|NCT00025259|530307095|FG006|Overall Study|Randomization error|2|||
147040127|NCT00025259|530307089|FG000|Overall Study|Adverse Event|1|||
147040128|NCT00025259|530307090|FG001|Overall Study|Adverse Event|0|||
147040129|NCT00025259|530307091|FG002|Overall Study|Adverse Event|0|||
147040130|NCT00025259|530307092|FG003|Overall Study|Adverse Event|0|||
146849786|NCT01983254|529618884|FG001|Overall Study|Lost to Follow-up|16|||
146849787|NCT01983254|529618883|FG000|Overall Study|too ill|11|||
147040131|NCT00025259|530307093|FG004|Overall Study|Adverse Event|0|||
147040132|NCT00025259|530307094|FG005|Overall Study|Adverse Event|0|||
147040133|NCT00025259|530307095|FG006|Overall Study|Adverse Event|0|||
147040134|NCT00908310|530307098|FG000|Overall Study|Death|37|||
147040135|NCT00908310|530307098|FG000|Overall Study|Withdrawal by Subject|7|||
147040136|NCT00908310|530307098|FG000|Overall Study|Lost to Follow-up|7|||
147040137|NCT00908310|530307098|FG000|Overall Study|Screening failure|5|||
147040138|NCT00908310|530307098|FG000|Overall Study|Other reasons|4|||
147040139|NCT02071849|530307101|FG000|6-month Primary Endpoint|Did not receive device|4|||
146849788|NCT01983254|529618884|FG001|Overall Study|too ill|8|||
147040140|NCT02071849|530307101|FG000|6-month Primary Endpoint|Adverse Event|1|||
147040141|NCT02071849|530307101|FG000|2-year Extended Follow-up|Adverse Event|1|||
147040142|NCT00103610|530307104|FG000|Overall Study|Entered Rescue Procedure|10|||
147040143|NCT00103610|530307105|FG001|Overall Study|Entered Rescue Procedure|52|||
147040144|NCT00103610|530307104|FG000|Overall Study|Death|16|||
147040145|NCT00103610|530307105|FG001|Overall Study|Death|12|||
147040146|NCT00103610|530307104|FG000|Overall Study|Elective Withdrawal|4|||
147040147|NCT00103610|530307105|FG001|Overall Study|Elective Withdrawal|0|||
147040148|NCT00103610|530307104|FG000|Overall Study|Lost to Follow-up|3|||
147040149|NCT00103610|530307105|FG001|Overall Study|Lost to Follow-up|1|||
147040150|NCT00103610|530307104|FG000|Overall Study|Adverse Event|2|||
147040151|NCT00103610|530307105|FG001|Overall Study|Adverse Event|2|||
147040152|NCT00103610|530307104|FG000|Overall Study|Other|2|||
147040153|NCT00103610|530307105|FG001|Overall Study|Other|7|||
147040154|NCT00103610|530307104|FG000|Overall Study|Failed mobilization|1|||
147040155|NCT00103610|530307105|FG001|Overall Study|Failed mobilization|5|||
147040156|NCT00103610|530307104|FG000|Overall Study|Noncompliance|0|||
147040157|NCT00103610|530307105|FG001|Overall Study|Noncompliance|1|||
147040158|NCT00725205|530307109|FG000|Overall Study|Adverse Event|22|||
147040159|NCT00725205|530307109|FG000|Overall Study|Investigator Discontinued|1|||
147040160|NCT00725205|530307109|FG000|Overall Study|Non-compliance With Protocol|14|||
147040161|NCT00725205|530307109|FG000|Overall Study|Other|8|||
147040162|NCT00725205|530307109|FG000|Overall Study|Protocol Defined Clinical Event|1|||
147040163|NCT00725205|530307109|FG000|Overall Study|Treatment Failure|41|||
147040164|NCT01680497|530307110|FG000|Overall Study|Lost to Follow-up|2|||
147040165|NCT05819203|530307111|FG000|Overall Study|Protocol Violation|1|||
147040166|NCT05819203|530307112|FG001|Overall Study|Protocol Violation|2|||
147040167|NCT05819203|530307111|FG000|Overall Study|Withdrawal by Subject|1|||
147040168|NCT05819203|530307112|FG001|Overall Study|Withdrawal by Subject|0|||
147040169|NCT04123561|530307115|FG000|Overall Study|Lost to Follow-up|20|||
147040170|NCT04123561|530307116|FG001|Overall Study|Lost to Follow-up|12|||
147040171|NCT04123561|530307117|FG002|Overall Study|Lost to Follow-up|5|||
147040172|NCT04123561|530307115|FG000|Overall Study|Withdrawal by Subject|9|||
147040173|NCT04123561|530307116|FG001|Overall Study|Withdrawal by Subject|7|||
147040174|NCT04123561|530307117|FG002|Overall Study|Withdrawal by Subject|9|||
147040175|NCT04123561|530307115|FG000|Overall Study|Lack of Efficacy|7|||
147040176|NCT04123561|530307116|FG001|Overall Study|Lack of Efficacy|8|||
147040177|NCT04123561|530307117|FG002|Overall Study|Lack of Efficacy|6|||
147040178|NCT04123561|530307115|FG000|Overall Study|Adverse Event|5|||
147040179|NCT04123561|530307116|FG001|Overall Study|Adverse Event|2|||
147040180|NCT04123561|530307117|FG002|Overall Study|Adverse Event|3|||
147040181|NCT04123561|530307115|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
147040182|NCT04123561|530307116|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
147040183|NCT04123561|530307117|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
147040184|NCT04123561|530307115|FG000|Overall Study|Death|0|||
147040185|NCT04123561|530307116|FG001|Overall Study|Death|0|||
147040186|NCT04123561|530307117|FG002|Overall Study|Death|1|||
147040187|NCT04123561|530307115|FG000|Overall Study|Protocol Violation|0|||
146849789|NCT00434213|529618887|FG000|Overall Study|Adverse Event|12|||
146849790|NCT00434213|529618887|FG000|Overall Study|Lack of Efficacy|9|||
146849791|NCT00434213|529618887|FG000|Overall Study|Lost to Follow-up|14|||
146849792|NCT00434213|529618887|FG000|Overall Study|Withdrawal by Subject|7|||
146849793|NCT00434213|529618887|FG000|Overall Study|Protocol Violation|3|||
146849794|NCT00434213|529618887|FG000|Overall Study|Unable to comply with study visit window|2|||
146849795|NCT00434213|529618887|FG000|Overall Study|Application site reaction|1|||
146849796|NCT00434213|529618887|FG000|Overall Study|Non-compliant to study schedule|1|||
146849797|NCT00037830|529618888|FG000|Overall Study|Adverse Event|2|||
146849798|NCT00037830|529618889|FG001|Overall Study|Adverse Event|0|||
146849799|NCT00037830|529618890|FG002|Overall Study|Adverse Event|0|||
146849800|NCT00037830|529618888|FG000|Overall Study|Withdrawal by Subject|4|||
146849801|NCT00037830|529618889|FG001|Overall Study|Withdrawal by Subject|5|||
146849802|NCT00037830|529618890|FG002|Overall Study|Withdrawal by Subject|1|||
146849803|NCT00037830|529618888|FG000|Overall Study|Protocol Violation|2|||
146849804|NCT00037830|529618889|FG001|Overall Study|Protocol Violation|2|||
147040188|NCT04123561|530307116|FG001|Overall Study|Protocol Violation|1|||
147040189|NCT04123561|530307117|FG002|Overall Study|Protocol Violation|0|||
147040190|NCT03654599|530307121|FG000|Overall Study|Lost to Follow-up|14|||
147040191|NCT03654599|530307122|FG001|Overall Study|Lost to Follow-up|12|||
147040192|NCT03654599|530307121|FG000|Overall Study|Death|8|||
147040193|NCT03654599|530307122|FG001|Overall Study|Death|6|||
147040194|NCT03654599|530307121|FG000|Overall Study|Withdrawal by Subject|6|||
146849805|NCT00037830|529618890|FG002|Overall Study|Protocol Violation|0|||
146849806|NCT00037830|529618888|FG000|Overall Study|Unrelated Medical Problem|2|||
146849807|NCT00037830|529618889|FG001|Overall Study|Unrelated Medical Problem|0|||
147040195|NCT03654599|530307122|FG001|Overall Study|Withdrawal by Subject|4|||
147040196|NCT04324073|530308459|FG000|Overall Study|withdrew consent|0|||
147040197|NCT04324073|530308460|FG001|Overall Study|withdrew consent|4|||
147040198|NCT04324073|530308461|FG002|Overall Study|withdrew consent|2|||
147040199|NCT04324073|530308462|FG003|Overall Study|withdrew consent|8|||
147040200|NCT00369486|530308464|FG000|4-Week Visit|Missed visit|2|||
147040201|NCT00369486|530308465|FG001|4-Week Visit|Missed visit|2|||
147040202|NCT00369486|530308466|FG002|4-Week Visit|Missed visit|0|||
146849808|NCT00037830|529618890|FG002|Overall Study|Unrelated Medical Problem|0|||
147040203|NCT00369486|530308467|FG003|4-Week Visit|Missed visit|2|||
147040204|NCT00369486|530308468|FG004|4-Week Visit|Missed visit|1|||
147040205|NCT00369486|530308464|FG000|4-Week Visit|Dropped|0|||
147040206|NCT00369486|530308465|FG001|4-Week Visit|Dropped|0|||
147040207|NCT00369486|530308466|FG002|4-Week Visit|Dropped|1|||
147040208|NCT00369486|530308467|FG003|4-Week Visit|Dropped|0|||
147040209|NCT00369486|530308468|FG004|4-Week Visit|Dropped|0|||
147040210|NCT00369486|530308464|FG000|8-Week Visit|Missed visit|0|||
147040211|NCT00369486|530308465|FG001|8-Week Visit|Missed visit|1|||
147040212|NCT00369486|530308466|FG002|8-Week Visit|Missed visit|0|||
147040213|NCT00369486|530308467|FG003|8-Week Visit|Missed visit|0|||
147040214|NCT00369486|530308468|FG004|8-Week Visit|Missed visit|1|||
147040215|NCT00369486|530308464|FG000|8-Week Visit|Dropped|0|||
147040216|NCT00369486|530308465|FG001|8-Week Visit|Dropped|0|||
147040217|NCT00369486|530308466|FG002|8-Week Visit|Dropped|0|||
147040218|NCT00369486|530308467|FG003|8-Week Visit|Dropped|1|||
147040219|NCT00369486|530308468|FG004|8-Week Visit|Dropped|0|||
147040220|NCT00369486|530308464|FG000|17-Week Visit|Missed visit|0|||
147040221|NCT00369486|530308465|FG001|17-Week Visit|Missed visit|0|||
147040222|NCT00369486|530308466|FG002|17-Week Visit|Missed visit|1|||
147040223|NCT00369486|530308467|FG003|17-Week Visit|Missed visit|1|||
147040224|NCT00369486|530308468|FG004|17-Week Visit|Missed visit|1|||
147040225|NCT00369486|530308464|FG000|34-Week Visit|Dropped|0|||
147040226|NCT00369486|530308465|FG001|34-Week Visit|Dropped|1|||
147040227|NCT00369486|530308466|FG002|34-Week Visit|Dropped|1|||
147040228|NCT00369486|530308467|FG003|34-Week Visit|Dropped|3|||
147040229|NCT00369486|530308468|FG004|34-Week Visit|Dropped|3|||
147040230|NCT01659125|530308469|FG000|Overall Study|Withdrawal by Subject|2|||
147040231|NCT01659125|530308469|FG000|Overall Study|Lost to Follow-up|7|||
147040232|NCT01659125|530308469|FG000|Overall Study|Technical Problem|1|||
147040233|NCT01659125|530308469|FG000|Overall Study|Time Constraints|2|||
147040234|NCT01659125|530308469|FG000|Overall Study|Failed to Start Treatment|2|||
147040235|NCT05013008|530308473|FG000|Overall Study|Exclusion from mBFAS|5|||
147040236|NCT05013008|530308474|FG001|Overall Study|Exclusion from mBFAS|25|||
147040237|NCT01443728|530308475|FG000|Overall Study|Lost to Follow-up|2|||
147040238|NCT01443728|530308476|FG001|Overall Study|Lost to Follow-up|0|||
147040239|NCT01443728|530308475|FG000|Overall Study|Withdrawal by Subject|1|||
147040240|NCT01443728|530308476|FG001|Overall Study|Withdrawal by Subject|1|||
147040241|NCT01443728|530308475|FG000|Overall Study|Adverse Event|0|||
147040242|NCT01443728|530308476|FG001|Overall Study|Adverse Event|2|||
147040243|NCT04981717|530308477|FG000|Overall Study|Protocol Violation|0|||
147040244|NCT04981717|530308478|FG001|Overall Study|Protocol Violation|3|||
147040245|NCT04981717|530308477|FG000|Overall Study|Adverse Event|1|||
147040246|NCT04981717|530308478|FG001|Overall Study|Adverse Event|3|||
147040247|NCT04981717|530308477|FG000|Overall Study|Pregnancy|1|||
147040248|NCT04981717|530308478|FG001|Overall Study|Pregnancy|0|||
147040249|NCT04981717|530308477|FG000|Overall Study|Physician Decision|1|||
147040250|NCT04981717|530308478|FG001|Overall Study|Physician Decision|0|||
147040251|NCT04981717|530308477|FG000|Overall Study|Sponsor Request|157|||
147040252|NCT04981717|530308478|FG001|Overall Study|Sponsor Request|172|||
147040253|NCT04981717|530308477|FG000|Overall Study|Lost to Follow-up|4|||
147040254|NCT04981717|530308478|FG001|Overall Study|Lost to Follow-up|5|||
147040255|NCT04981717|530308477|FG000|Overall Study|Withdrawal by Subject|50|||
147040256|NCT04981717|530308478|FG001|Overall Study|Withdrawal by Subject|37|||
147040257|NCT00974922|530308479|FG000|Overall Study|study terminated|24|||
147040258|NCT00287586|530308480|FG000|Overall Study|Withdrew Consent|19|||
147040259|NCT00287586|530308481|FG001|Overall Study|Withdrew Consent|30|||
147040260|NCT00287586|530308480|FG000|Overall Study|Lost to Follow-up|5|||
147040261|NCT00287586|530308481|FG001|Overall Study|Lost to Follow-up|4|||
147040262|NCT00287586|530308480|FG000|Overall Study|Death|2|||
147040263|NCT00287586|530308481|FG001|Overall Study|Death|3|||
147040264|NCT00287586|530308480|FG000|Overall Study|Elevated Hematocrit|3|||
147040265|NCT00287586|530308481|FG001|Overall Study|Elevated Hematocrit|0|||
147040266|NCT00287586|530308480|FG000|Overall Study|Rash|3|||
147040267|NCT00287586|530308481|FG001|Overall Study|Rash|0|||
147040268|NCT00287586|530308480|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
147040269|NCT00287586|530308481|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
147040270|NCT00287586|530308480|FG000|Overall Study|Stroke|2|||
147040271|NCT00287586|530308481|FG001|Overall Study|Stroke|0|||
147040272|NCT00287586|530308480|FG000|Overall Study|Myocardial Infarction|1|||
147040273|NCT00287586|530308481|FG001|Overall Study|Myocardial Infarction|0|||
147040274|NCT00287586|530308480|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
147040275|NCT00287586|530308481|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
147040276|NCT00287586|530308480|FG000|Overall Study|Cognitive Impairment|1|||
147040277|NCT00287586|530308481|FG001|Overall Study|Cognitive Impairment|0|||
147040278|NCT00287586|530308480|FG000|Overall Study|Pancreatic Cancer|1|||
147040279|NCT00287586|530308481|FG001|Overall Study|Pancreatic Cancer|3|||
147040280|NCT00287586|530308480|FG000|Overall Study|Sleep Apnea|1|||
147040281|NCT00287586|530308481|FG001|Overall Study|Sleep Apnea|0|||
147040282|NCT00287586|530308480|FG000|Overall Study|Shoulder Pain|1|||
147040283|NCT00287586|530308481|FG001|Overall Study|Shoulder Pain|0|||
147040284|NCT00287586|530308480|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
147040285|NCT00287586|530308481|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
147040286|NCT00287586|530308480|FG000|Overall Study|Nonadherence|1|||
147040287|NCT00287586|530308481|FG001|Overall Study|Nonadherence|1|||
147040288|NCT00287586|530308480|FG000|Overall Study|Enrolled in Another Study|1|||
147040289|NCT00287586|530308481|FG001|Overall Study|Enrolled in Another Study|0|||
147040290|NCT00287586|530308480|FG000|Overall Study|Major Depression|0|||
147040291|NCT00287586|530308481|FG001|Overall Study|Major Depression|2|||
147040292|NCT00287586|530308480|FG000|Overall Study|Lung Cancer|0|||
147040293|NCT00287586|530308481|FG001|Overall Study|Lung Cancer|2|||
147040294|NCT00287586|530308480|FG000|Overall Study|Elevated IPSS Score|0|||
147040295|NCT00287586|530308481|FG001|Overall Study|Elevated IPSS Score|1|||
147040296|NCT00287586|530308480|FG000|Overall Study|Retroperitoneal Cancer|0|||
147040297|NCT00287586|530308481|FG001|Overall Study|Retroperitoneal Cancer|1|||
147040298|NCT00287586|530308480|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
147040299|NCT00287586|530308481|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
147040300|NCT00287586|530308480|FG000|Overall Study|Mood Swings and Irritability|0|||
147040301|NCT00287586|530308481|FG001|Overall Study|Mood Swings and Irritability|1|||
147040302|NCT00287586|530308480|FG000|Overall Study|Bradycardia|0|||
147040303|NCT00287586|530308481|FG001|Overall Study|Bradycardia|1|||
147040304|NCT00287586|530308480|FG000|Overall Study|Itchy Swollen Eyes|0|||
147040305|NCT00287586|530308481|FG001|Overall Study|Itchy Swollen Eyes|1|||
147040306|NCT00287586|530308480|FG000|Overall Study|Recurrent Melanoma|0|||
147040307|NCT00287586|530308481|FG001|Overall Study|Recurrent Melanoma|1|||
147040308|NCT02640482|530308482|FG000|Overall Study|Lost to Follow-up|3|||
147040309|NCT02640482|530308483|FG001|Overall Study|Lost to Follow-up|0|||
147040310|NCT00113763|530308484|FG000|Overall Study|Adverse Event|5|||
147040311|NCT00113763|530308485|FG001|Overall Study|Adverse Event|2|||
147040312|NCT00113763|530308484|FG000|Overall Study|Disease Progression|28|||
147040313|NCT00113763|530308485|FG001|Overall Study|Disease Progression|14|||
147040314|NCT00113763|530308484|FG000|Overall Study|Lost to Follow-up|10|||
147040315|NCT00113763|530308485|FG001|Overall Study|Lost to Follow-up|0|||
147040316|NCT00113763|530308484|FG000|Overall Study|Withdrawal by Subject|1|||
147040317|NCT00113763|530308485|FG001|Overall Study|Withdrawal by Subject|4|||
147040318|NCT00113763|530308484|FG000|Overall Study|Other|27|||
147040319|NCT00113763|530308485|FG001|Overall Study|Other|6|||
147040320|NCT00113763|530308484|FG000|Overall Study|Non-compliance|1|||
147040321|NCT00113763|530308485|FG001|Overall Study|Non-compliance|0|||
147040322|NCT00113763|530308484|FG000|Overall Study|Ongoing|1|||
147040323|NCT00113763|530308485|FG001|Overall Study|Ongoing|0|||
147040324|NCT00517881|530308486|FG000|Overall Study|Protocol Violation|2|||
147040325|NCT00517881|530308486|FG000|Overall Study|Adverse Event|1|||
147040326|NCT00517881|530308486|FG000|Overall Study|Renal transplantation|2|||
147040327|NCT02129608|530308491|FG000|Overall Study|Lost to Follow-up|0|||
147040328|NCT02129608|530308492|FG001|Overall Study|Lost to Follow-up|1|||
147040329|NCT02129608|530308493|FG002|Overall Study|Lost to Follow-up|1|||
147040330|NCT02129608|530308491|FG000|Overall Study|Withdrawal by Subject|0|||
147040331|NCT02129608|530308492|FG001|Overall Study|Withdrawal by Subject|0|||
147040332|NCT02129608|530308493|FG002|Overall Study|Withdrawal by Subject|2|||
147040333|NCT02242045|530308494|FG000|Overall Study|Investigator's Discretion|1|||
147040334|NCT02242045|530308494|FG000|Overall Study|Progressive Disease|2|||
147040335|NCT02242045|530308494|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
147040336|NCT02242045|530308494|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
147040337|NCT03106987|530308498|FG000|Overall Study|Death|37|||
147040338|NCT03106987|530308499|FG001|Overall Study|Death|22|||
147040339|NCT03106987|530308500|FG002|Overall Study|Death|12|||
147040340|NCT03106987|530308501|FG003|Overall Study|Death|8|||
147040341|NCT03106987|530308498|FG000|Overall Study|Lost to Follow-up|2|||
147040342|NCT03106987|530308499|FG001|Overall Study|Lost to Follow-up|0|||
147040343|NCT03106987|530308500|FG002|Overall Study|Lost to Follow-up|2|||
147040344|NCT03106987|530308501|FG003|Overall Study|Lost to Follow-up|2|||
147040345|NCT03106987|530308498|FG000|Overall Study|Withdrawal by Subject|5|||
147040346|NCT03106987|530308499|FG001|Overall Study|Withdrawal by Subject|1|||
147040347|NCT03106987|530308500|FG002|Overall Study|Withdrawal by Subject|4|||
147040348|NCT03106987|530308501|FG003|Overall Study|Withdrawal by Subject|1|||
147040349|NCT03336528|530308502|FG000|Overall Study|Protocol Violation|1|||
147040350|NCT03336528|530308503|FG001|Overall Study|Protocol Violation|1|||
147040351|NCT03336528|530308502|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
147040352|NCT03336528|530308503|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
147040353|NCT03336528|530308502|FG000|Overall Study|Did not receive study medication|1|||
147040354|NCT03336528|530308503|FG001|Overall Study|Did not receive study medication|2|||
147040355|NCT02114385|530308506|FG000|Overall Study|Withdrawal by Subject|3|||
147040356|NCT02114385|530308507|FG001|Overall Study|Withdrawal by Subject|2|||
147040357|NCT02114385|530308506|FG000|Overall Study|Lost to Follow-up|0|||
147040358|NCT02114385|530308507|FG001|Overall Study|Lost to Follow-up|6|||
147040359|NCT01753297|530308511|FG000|Overall Study|Lost to Follow-up|7|||
147040360|NCT01753297|530308512|FG001|Overall Study|Lost to Follow-up|2|||
146849809|NCT01253304|529618891|FG000|Overall Study|Adverse Event|0|||
147040361|NCT01753297|530308511|FG000|Overall Study|Withdrawal by Subject|26|||
147040362|NCT01753297|530308512|FG001|Overall Study|Withdrawal by Subject|23|||
147040363|NCT01753297|530308511|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
147040364|NCT01753297|530308512|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
147040365|NCT01753297|530308511|FG000|Overall Study|Death|0|||
147040366|NCT01753297|530308512|FG001|Overall Study|Death|2|||
147040367|NCT01753297|530308511|FG000|Overall Study|Did not attend end of study visit|7|||
147040368|NCT01753297|530308512|FG001|Overall Study|Did not attend end of study visit|8|||
147040369|NCT00230178|530308513|FG000|Overall Study|Adverse Event|1|||
147040370|NCT00230178|530308514|FG001|Overall Study|Adverse Event|5|||
147040371|NCT00230178|530308515|FG002|Overall Study|Adverse Event|2|||
147040372|NCT00230178|530308513|FG000|Overall Study|Withdrawal by Subject|0|||
147040373|NCT00230178|530308514|FG001|Overall Study|Withdrawal by Subject|0|||
147040374|NCT00230178|530308515|FG002|Overall Study|Withdrawal by Subject|1|||
147040375|NCT00230178|530308513|FG000|Overall Study|Various other reasons|3|||
147040376|NCT00230178|530308514|FG001|Overall Study|Various other reasons|2|||
147040377|NCT00230178|530308515|FG002|Overall Study|Various other reasons|4|||
147040378|NCT02533180|530308516|FG000|Overall Study|Death|0|||
147040379|NCT02533180|530308517|FG001|Overall Study|Death|2|||
147040380|NCT02533180|530308516|FG000|Overall Study|Lost to Follow-up|0|||
147040381|NCT02533180|530308517|FG001|Overall Study|Lost to Follow-up|1|||
147040382|NCT02533180|530308516|FG000|Overall Study|Physician Decision|0|||
147040383|NCT02533180|530308517|FG001|Overall Study|Physician Decision|1|||
147040384|NCT02533180|530308516|FG000|Overall Study|Withdrawal by Subject|2|||
147040385|NCT02533180|530308517|FG001|Overall Study|Withdrawal by Subject|5|||
147040386|NCT02533180|530308516|FG000|Overall Study|Screen Failure|37|||
147040387|NCT02533180|530308517|FG001|Overall Study|Screen Failure|0|||
147040388|NCT02533180|530308516|FG000|Overall Study|Protocol Deviation|0|||
147040389|NCT02533180|530308517|FG001|Overall Study|Protocol Deviation|1|||
147040390|NCT02533180|530308516|FG000|Overall Study|Non-compliance|0|||
147040391|NCT02533180|530308517|FG001|Overall Study|Non-compliance|1|||
147040392|NCT00447876|530308518|FG000|Overall Study|Withdrawal by Subject|1|||
147040393|NCT00447876|530308519|FG001|Overall Study|Withdrawal by Subject|4|||
147040394|NCT00447876|530308518|FG000|Overall Study|Lost to Follow-up|1|||
147040395|NCT00447876|530308519|FG001|Overall Study|Lost to Follow-up|0|||
147040396|NCT00447876|530308518|FG000|Overall Study|Deterioration of symptomology|1|||
147040397|NCT00447876|530308519|FG001|Overall Study|Deterioration of symptomology|0|||
147040398|NCT02289456|530308525|FG000|Induction Period|Death|2|||
147040399|NCT02289456|530308525|FG000|Induction Period|Adverse Event|11|||
147040400|NCT02289456|530308525|FG000|Induction Period|Progressive Disease (PD)|4|||
147040401|NCT02289456|530308525|FG000|Induction Period|Symptomatic Deterioration|4|||
147040402|NCT02289456|530308525|FG000|Induction Period|Withdrawal by Subject|2|||
147040403|NCT02289456|530308525|FG000|Induction Period|Miscellaneous|1|||
147040404|NCT02289456|530308525|FG000|Monotherapy Period|Death|1|||
147040405|NCT02289456|530308525|FG000|Monotherapy Period|Adverse Event|1|||
147040406|NCT02289456|530308525|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
147040407|NCT02289456|530308525|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
147040408|NCT02289456|530308525|FG000|Monotherapy Period|Withdrawal by Subject|2|||
147040409|NCT02289456|530308525|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
147040410|NCT02289456|530308525|FG000|Monotherapy Period|Miscellaneous|1|||
147040411|NCT02463357|530308526|FG000|Overall Study|Withdrawal by Subject|1|||
147040412|NCT02463357|530308527|FG001|Overall Study|Withdrawal by Subject|0|||
147040413|NCT02463357|530308528|FG002|Overall Study|Withdrawal by Subject|0|||
147040414|NCT02463357|530308529|FG003|Overall Study|Withdrawal by Subject|0|||
147040415|NCT02463357|530308530|FG004|Overall Study|Withdrawal by Subject|0|||
147040416|NCT02463357|530308526|FG000|Overall Study|Withdrawal by Subject|0|||
147040417|NCT02463357|530308527|FG001|Overall Study|Withdrawal by Subject|0|||
147040418|NCT02463357|530308528|FG002|Overall Study|Withdrawal by Subject|0|||
146849810|NCT01253304|529618892|FG001|Overall Study|Adverse Event|0|||
146849811|NCT01253304|529618893|FG002|Overall Study|Adverse Event|0|||
146849812|NCT01253304|529618894|FG003|Overall Study|Adverse Event|1|||
146849813|NCT01699503|529618895|FG000|Overall Study|Death|31|||
146849814|NCT01699503|529618896|FG001|Overall Study|Death|40|||
146849815|NCT01699503|529618895|FG000|Overall Study|Withdrawal by Subject|65|||
146849816|NCT01699503|529618896|FG001|Overall Study|Withdrawal by Subject|57|||
146849817|NCT01699503|529618895|FG000|Overall Study|Lost to Follow-up|121|||
147040419|NCT02463357|530308529|FG003|Overall Study|Withdrawal by Subject|0|||
147040420|NCT02463357|530308530|FG004|Overall Study|Withdrawal by Subject|1|||
147040421|NCT01371539|530308533|FG000|Period One: One Week|Lost to Follow-up|0|||
147040422|NCT01371539|530308534|FG001|Period One: One Week|Lost to Follow-up|1|||
147040423|NCT01371539|530308533|FG000|Period Two: One Week|Lost to Follow-up|0|||
147040424|NCT01371539|530308534|FG001|Period Two: One Week|Lost to Follow-up|1|||
147040425|NCT01371539|530308533|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
147040426|NCT01371539|530308534|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
147040427|NCT01371539|530308533|FG000|Period Two: One Week|Time/job conflict|0|||
147040428|NCT01371539|530308534|FG001|Period Two: One Week|Time/job conflict|1|||
147040429|NCT01399658|530308535|FG000|Overall Study|Ineligible|1|||
147040430|NCT01399658|530308535|FG000|Overall Study|Machine Technical Issue|3|||
146849818|NCT01699503|529618896|FG001|Overall Study|Lost to Follow-up|117|||
147040431|NCT01399658|530308535|FG000|Overall Study|Alternative therapy|1|||
147040432|NCT01399658|530308535|FG000|Overall Study|No reason given|1|||
147040433|NCT02620579|530308536|FG000|Overall Study|Physician Decision|0|||
147040434|NCT02620579|530308537|FG001|Overall Study|Physician Decision|0|||
147040435|NCT02620579|530308538|FG002|Overall Study|Physician Decision|0|||
147040436|NCT02620579|530308539|FG003|Overall Study|Physician Decision|1|||
147040437|NCT02620579|530308536|FG000|Overall Study|Withdrawal by Subject|0|||
147040438|NCT02620579|530308537|FG001|Overall Study|Withdrawal by Subject|1|||
147040439|NCT02620579|530308538|FG002|Overall Study|Withdrawal by Subject|1|||
147040440|NCT02620579|530308539|FG003|Overall Study|Withdrawal by Subject|0|||
147040441|NCT00796107|530308540|FG000|Overall Study|Lack of Efficacy|1|||
147040442|NCT00796107|530308540|FG000|Overall Study|Progressive Disease|5|||
147040443|NCT02681510|530308541|FG000|Overall Study|Withdrawal by Subject|1|||
147040444|NCT02681510|530308541|FG000|Overall Study|Lost to Follow-up|9|||
147040445|NCT01721317|530308543|FG000|Overall Study|Study Closed / Terminated|2|||
147040446|NCT01721317|530308544|FG001|Overall Study|Study Closed / Terminated|2|||
147040447|NCT01721317|530308543|FG000|Overall Study|Physician Decision|0|||
147040448|NCT01721317|530308544|FG001|Overall Study|Physician Decision|1|||
147040449|NCT01721317|530308543|FG000|Overall Study|Withdrawal by Subject|0|||
147040450|NCT01721317|530308544|FG001|Overall Study|Withdrawal by Subject|1|||
147040451|NCT00378573|530308553|FG000|Treatment Period|Adverse Event|9|||
147040452|NCT00378573|530308553|FG000|Treatment Period|Physician Decision|1|||
147040453|NCT00378573|530308553|FG000|Treatment Period|Withdrawal by Subject|2|||
147040454|NCT00378573|530308553|FG000|Treatment Period|Disease Progression|4|||
147040455|NCT00378573|530308553|FG000|Treatment Period|Sponsor decision to close study|1|||
147040456|NCT00378573|530308553|FG000|Follow-up|Death|12|||
147040457|NCT00378573|530308553|FG000|Follow-up|Lost to Follow-up|1|||
147040458|NCT00378573|530308553|FG000|Follow-up|Withdrawal by Subject|1|||
147040459|NCT02806024|530308554|FG000|Overall Study|Night Delivery|1|||
147040460|NCT02806024|530308555|FG001|Overall Study|Night Delivery|1|||
147040461|NCT02806024|530308554|FG000|Overall Study|DVT during antepartum admission|0|||
147040462|NCT02806024|530308555|FG001|Overall Study|DVT during antepartum admission|1|||
147040463|NCT02996487|530308561|FG000|Overall Study|Lost to Follow-up|1|||
147040464|NCT02996487|530308562|FG001|Overall Study|Lost to Follow-up|1|||
147040465|NCT02996487|530308563|FG002|Overall Study|Lost to Follow-up|0|||
147040466|NCT02996487|530308561|FG000|Overall Study|Death|0|||
147040467|NCT02996487|530308562|FG001|Overall Study|Death|1|||
147040468|NCT02996487|530308563|FG002|Overall Study|Death|0|||
147040469|NCT02996487|530308561|FG000|Overall Study|Withdrawal by Subject|2|||
147040470|NCT02996487|530308562|FG001|Overall Study|Withdrawal by Subject|3|||
147040471|NCT02996487|530308563|FG002|Overall Study|Withdrawal by Subject|0|||
147040472|NCT01004003|530308564|FG000|Overall Study|Progressive disease|2|||
147040473|NCT01004003|530308565|FG001|Overall Study|Progressive disease|1|||
147040474|NCT01004003|530308566|FG002|Overall Study|Progressive disease|1|||
147040475|NCT01004003|530308567|FG003|Overall Study|Progressive disease|0|||
147040476|NCT01004003|530308568|FG004|Overall Study|Progressive disease|2|||
147040477|NCT01004003|530308569|FG005|Overall Study|Progressive disease|1|||
147040478|NCT01004003|530308570|FG006|Overall Study|Progressive disease|1|||
147040479|NCT01004003|530308571|FG007|Overall Study|Progressive disease|39|||
147040480|NCT01004003|530308572|FG008|Overall Study|Progressive disease|22|||
147040481|NCT01004003|530308564|FG000|Overall Study|Adverse Event|4|||
147040482|NCT01004003|530308565|FG001|Overall Study|Adverse Event|2|||
147040483|NCT01004003|530308566|FG002|Overall Study|Adverse Event|3|||
147040484|NCT01004003|530308567|FG003|Overall Study|Adverse Event|3|||
147040485|NCT01004003|530308568|FG004|Overall Study|Adverse Event|2|||
147040486|NCT01004003|530308569|FG005|Overall Study|Adverse Event|2|||
147040487|NCT01004003|530308570|FG006|Overall Study|Adverse Event|7|||
147040488|NCT01004003|530308571|FG007|Overall Study|Adverse Event|21|||
147040489|NCT01004003|530308572|FG008|Overall Study|Adverse Event|6|||
147040490|NCT01004003|530308564|FG000|Overall Study|Refused to continue taking trial med.|0|||
147040491|NCT01004003|530308565|FG001|Overall Study|Refused to continue taking trial med.|0|||
147040492|NCT01004003|530308566|FG002|Overall Study|Refused to continue taking trial med.|0|||
147040493|NCT01004003|530308567|FG003|Overall Study|Refused to continue taking trial med.|0|||
147040494|NCT01004003|530308568|FG004|Overall Study|Refused to continue taking trial med.|0|||
147040495|NCT01004003|530308569|FG005|Overall Study|Refused to continue taking trial med.|0|||
147040496|NCT01004003|530308570|FG006|Overall Study|Refused to continue taking trial med.|0|||
147040497|NCT01004003|530308571|FG007|Overall Study|Refused to continue taking trial med.|0|||
147040498|NCT01004003|530308572|FG008|Overall Study|Refused to continue taking trial med.|2|||
147040499|NCT01004003|530308564|FG000|Overall Study|Other|0|||
147040500|NCT01004003|530308565|FG001|Overall Study|Other|0|||
147040501|NCT01004003|530308566|FG002|Overall Study|Other|0|||
147040502|NCT01004003|530308567|FG003|Overall Study|Other|0|||
147040503|NCT01004003|530308568|FG004|Overall Study|Other|0|||
147040504|NCT01004003|530308569|FG005|Overall Study|Other|1|||
147040505|NCT01004003|530308570|FG006|Overall Study|Other|0|||
147040506|NCT01004003|530308571|FG007|Overall Study|Other|0|||
147040507|NCT01004003|530308572|FG008|Overall Study|Other|0|||
147040508|NCT00259272|530308573|FG000|Overall Study|Adverse Event|2|||
147040509|NCT00259272|530308574|FG001|Overall Study|Adverse Event|1|||
147040510|NCT00259272|530308575|FG002|Overall Study|Adverse Event|0|||
147040511|NCT00259272|530308576|FG003|Overall Study|Adverse Event|3|||
147040512|NCT00259272|530308573|FG000|Overall Study|Lack of Efficacy|5|||
147040513|NCT00259272|530308574|FG001|Overall Study|Lack of Efficacy|1|||
147040514|NCT00259272|530308575|FG002|Overall Study|Lack of Efficacy|2|||
147040515|NCT00259272|530308576|FG003|Overall Study|Lack of Efficacy|6|||
147040516|NCT00259272|530308573|FG000|Overall Study|Physician Decision|1|||
147040517|NCT00259272|530308574|FG001|Overall Study|Physician Decision|2|||
147040518|NCT00259272|530308575|FG002|Overall Study|Physician Decision|1|||
147040519|NCT00259272|530308576|FG003|Overall Study|Physician Decision|3|||
147040520|NCT00259272|530308573|FG000|Overall Study|Protocol Violation|2|||
147040521|NCT00259272|530308574|FG001|Overall Study|Protocol Violation|0|||
147040522|NCT00259272|530308575|FG002|Overall Study|Protocol Violation|0|||
147040523|NCT00259272|530308576|FG003|Overall Study|Protocol Violation|1|||
147040524|NCT00259272|530308573|FG000|Overall Study|Sponsor Decision|0|||
147040525|NCT00259272|530308574|FG001|Overall Study|Sponsor Decision|1|||
147040526|NCT00259272|530308575|FG002|Overall Study|Sponsor Decision|0|||
147040527|NCT00259272|530308576|FG003|Overall Study|Sponsor Decision|0|||
147040528|NCT00259272|530308573|FG000|Overall Study|Withdrawal by Subject|4|||
147040529|NCT00259272|530308574|FG001|Overall Study|Withdrawal by Subject|2|||
147040530|NCT00259272|530308575|FG002|Overall Study|Withdrawal by Subject|2|||
147040531|NCT00259272|530308576|FG003|Overall Study|Withdrawal by Subject|7|||
147040532|NCT00259272|530308573|FG000|Overall Study|Lost to Follow-up|1|||
147040533|NCT00259272|530308574|FG001|Overall Study|Lost to Follow-up|0|||
147040534|NCT00259272|530308575|FG002|Overall Study|Lost to Follow-up|0|||
147040535|NCT00259272|530308576|FG003|Overall Study|Lost to Follow-up|1|||
147040536|NCT00315731|530308579|FG000|Overall Study|Lost to Follow-up|1|||
147040537|NCT00315731|530308579|FG000|Overall Study|Death|5|||
147040538|NCT04614246|530308580|FG000|Overall Study|Adverse Event|0|||
147040539|NCT04614246|530308581|FG001|Overall Study|Adverse Event|1|||
147040540|NCT04614246|530308582|FG002|Overall Study|Adverse Event|1|||
147040541|NCT04614246|530308583|FG003|Overall Study|Adverse Event|2|||
147040542|NCT04614246|530308584|FG004|Overall Study|Adverse Event|1|||
147040543|NCT04614246|530308580|FG000|Overall Study|Lost to Follow-up|0|||
147040544|NCT04614246|530308581|FG001|Overall Study|Lost to Follow-up|1|||
147040545|NCT04614246|530308582|FG002|Overall Study|Lost to Follow-up|0|||
147040546|NCT04614246|530308583|FG003|Overall Study|Lost to Follow-up|1|||
147040547|NCT04614246|530308584|FG004|Overall Study|Lost to Follow-up|3|||
147040548|NCT04614246|530308580|FG000|Overall Study|Other reason|0|||
147040549|NCT04614246|530308581|FG001|Overall Study|Other reason|1|||
147040550|NCT04614246|530308582|FG002|Overall Study|Other reason|2|||
147040551|NCT04614246|530308583|FG003|Overall Study|Other reason|0|||
147040552|NCT04614246|530308584|FG004|Overall Study|Other reason|0|||
147040553|NCT04614246|530308580|FG000|Overall Study|Withdrawal by Subject|4|||
147040554|NCT04614246|530308581|FG001|Overall Study|Withdrawal by Subject|2|||
147040555|NCT04614246|530308582|FG002|Overall Study|Withdrawal by Subject|4|||
147040556|NCT04614246|530308583|FG003|Overall Study|Withdrawal by Subject|3|||
147040557|NCT04614246|530308584|FG004|Overall Study|Withdrawal by Subject|4|||
147040558|NCT04614246|530308580|FG000|Overall Study|Physician Decision|0|||
147040559|NCT04614246|530308581|FG001|Overall Study|Physician Decision|2|||
147040560|NCT04614246|530308582|FG002|Overall Study|Physician Decision|1|||
147040561|NCT04614246|530308583|FG003|Overall Study|Physician Decision|0|||
147040562|NCT04614246|530308584|FG004|Overall Study|Physician Decision|0|||
147040563|NCT04614246|530308580|FG000|Overall Study|Study terminated by sponsor|10|||
147040564|NCT04614246|530308581|FG001|Overall Study|Study terminated by sponsor|15|||
147040565|NCT04614246|530308582|FG002|Overall Study|Study terminated by sponsor|12|||
147040566|NCT04614246|530308583|FG003|Overall Study|Study terminated by sponsor|13|||
147040567|NCT04614246|530308584|FG004|Overall Study|Study terminated by sponsor|9|||
147040568|NCT04614246|530308580|FG000|Overall Study|Pregnancy|2|||
147040569|NCT04614246|530308581|FG001|Overall Study|Pregnancy|0|||
147040570|NCT04614246|530308582|FG002|Overall Study|Pregnancy|1|||
147040571|NCT04614246|530308583|FG003|Overall Study|Pregnancy|0|||
147040572|NCT04614246|530308584|FG004|Overall Study|Pregnancy|0|||
147040573|NCT03597464|530308587|FG000|Overall Study|Withdrawal by Subject|4|||
147040574|NCT03597464|530308588|FG001|Overall Study|Withdrawal by Subject|5|||
146849819|NCT01699503|529618895|FG000|Overall Study|Excluded due to quality|783|||
147040575|NCT03597464|530308587|FG000|Overall Study|Lost to Follow-up|3|||
147040576|NCT03597464|530308588|FG001|Overall Study|Lost to Follow-up|1|||
147040577|NCT03597464|530308587|FG000|Overall Study|Pregnancy|3|||
147040578|NCT03597464|530308588|FG001|Overall Study|Pregnancy|1|||
147040579|NCT03597464|530308587|FG000|Overall Study|Lack of Efficacy|2|||
147040580|NCT03597464|530308588|FG001|Overall Study|Lack of Efficacy|0|||
147040581|NCT03597464|530308587|FG000|Overall Study|Physician Decision|2|||
147040582|NCT03597464|530308588|FG001|Overall Study|Physician Decision|2|||
147040583|NCT03597464|530308587|FG000|Overall Study|Protocol Violation|1|||
147040584|NCT03597464|530308588|FG001|Overall Study|Protocol Violation|1|||
147040585|NCT03597464|530308587|FG000|Overall Study|Adverse Event|0|||
147040586|NCT03597464|530308588|FG001|Overall Study|Adverse Event|2|||
147040587|NCT03597464|530308587|FG000|Overall Study|Death|0|||
147040588|NCT03597464|530308588|FG001|Overall Study|Death|3|||
147040589|NCT00340678|530308595|FG000|Overall Study|Lost to Follow-up|1|||
147040590|NCT00340678|530308596|FG001|Overall Study|Lost to Follow-up|0|||
147040591|NCT00340678|530308597|FG002|Overall Study|Lost to Follow-up|0|||
147040592|NCT00340678|530308598|FG003|Overall Study|Lost to Follow-up|0|||
147040593|NCT00278889|530308599|FG000|Overall Study|Withdrawal by Subject|0|||
147040594|NCT00278889|530308600|FG001|Overall Study|Withdrawal by Subject|5|||
147040595|NCT00278889|530308601|FG002|Overall Study|Withdrawal by Subject|3|||
147040596|NCT00278889|530308599|FG000|Overall Study|Lost to Follow-up|1|||
147040597|NCT00278889|530308600|FG001|Overall Study|Lost to Follow-up|1|||
147040598|NCT00278889|530308601|FG002|Overall Study|Lost to Follow-up|0|||
147040599|NCT00278889|530308599|FG000|Overall Study|Death|24|||
147040600|NCT00278889|530308600|FG001|Overall Study|Death|21|||
147040601|NCT00278889|530308601|FG002|Overall Study|Death|17|||
147040602|NCT04042376|530308602|FG000|Overall Study|Withdrawal by Subject|1|||
147040603|NCT04042376|530308602|FG000|Overall Study|Death|3|||
147040604|NCT01243775|530308603|FG000|Overall Study|Withdrawal by Subject|2|||
147040605|NCT05833139|530311137|FG000|Study Period 2|Adverse Event|1|||
147040606|NCT02260570|530311142|FG000|Overall Study|Withdrawal by Subject|2|||
147040607|NCT02260570|530311143|FG001|Overall Study|Withdrawal by Subject|1|||
147040608|NCT02260570|530311142|FG000|Overall Study|Physician Decision|1|||
147040609|NCT02260570|530311143|FG001|Overall Study|Physician Decision|1|||
147040610|NCT03996447|530311144|FG000|First MRI Examination|Adverse Event|2|||
147040611|NCT03996447|530311145|FG001|First MRI Examination|Adverse Event|0|||
147040612|NCT03996447|530311144|FG000|First MRI Examination|Withdrawal by Subject|1|||
147040613|NCT03996447|530311145|FG001|First MRI Examination|Withdrawal by Subject|2|||
147040614|NCT03996447|530311144|FG000|First MRI Examination|Protocol Violation|0|||
147040615|NCT03996447|530311145|FG001|First MRI Examination|Protocol Violation|1|||
147040616|NCT03996447|530311144|FG000|Washout|Adverse Event|2|||
147040617|NCT03996447|530311145|FG001|Washout|Adverse Event|0|||
147040618|NCT03996447|530311144|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
147040619|NCT03996447|530311145|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
147040620|NCT03996447|530311144|FG000|Washout|Withdrawal by Subject|0|||
147040621|NCT03996447|530311145|FG001|Washout|Withdrawal by Subject|1|||
147040622|NCT03996447|530311144|FG000|Washout|Other reason|1|||
147040623|NCT03996447|530311145|FG001|Washout|Other reason|1|||
147040624|NCT01810302|530311153|FG000|Overall Study|Death|1|||
147040625|NCT01810302|530311154|FG001|Overall Study|Death|0|||
147040626|NCT01810302|530311153|FG000|Overall Study|Physician Decision|0|||
147040627|NCT01810302|530311154|FG001|Overall Study|Physician Decision|1|||
147040628|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criterion #1|24|||
147040629|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criterion #1|0|||
147040630|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
147040631|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
147040632|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
147040633|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147040634|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
147040635|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
147040636|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
147040637|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
147040638|NCT03888066|530311155|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
147040639|NCT03888066|530311156|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147040640|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
147040641|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147040642|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
147040643|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
147040644|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
147040645|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
146849820|NCT01699503|529618896|FG001|Overall Study|Excluded due to quality|791|||
146849821|NCT00766363|529618902|FG000|Overall Study|Withdrawal by Subject|1|||
146849822|NCT00766363|529618903|FG001|Overall Study|Withdrawal by Subject|0|||
146849823|NCT00766363|529618904|FG002|Overall Study|Withdrawal by Subject|0|||
146849824|NCT00766363|529618905|FG003|Overall Study|Withdrawal by Subject|0|||
146849825|NCT00766363|529618902|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
146849826|NCT00766363|529618903|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
147040646|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
147040647|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147040648|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criterion #2|5|||
147040649|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criterion #2|0|||
147040650|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
147040651|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
147040652|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
147040653|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
147040654|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
147040655|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
147040656|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criterion #3|11|||
147040657|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criterion #3|0|||
147040658|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
147040659|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
147040660|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
147040661|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
147040662|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
147040663|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147040664|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criterion #4|3|||
147040665|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criterion #4|0|||
147040666|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
147040667|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
147040668|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
147040669|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
147040670|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
147040671|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
147040672|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
147040673|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
147040674|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
147040675|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147040676|NCT03888066|530311155|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
147040677|NCT03888066|530311156|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
147040678|NCT03888066|530311155|FG000|Run-in Phase|AE (Adverse Event)|17|||
147040679|NCT03888066|530311156|FG001|Run-in Phase|AE (Adverse Event)|0|||
147040680|NCT03888066|530311155|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
147040681|NCT03888066|530311156|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
147040682|NCT03888066|530311155|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
147040683|NCT03888066|530311156|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147040684|NCT03888066|530311155|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
147040685|NCT03888066|530311156|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147040686|NCT03888066|530311155|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
147040687|NCT03888066|530311156|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
147040688|NCT03888066|530311155|FG000|Run-in Phase|Withdrawal by Subject|43|||
147040689|NCT03888066|530311156|FG001|Run-in Phase|Withdrawal by Subject|0|||
147040690|NCT03888066|530311155|FG000|Run-in Phase|AE; Physician Decision|1|||
147040691|NCT03888066|530311156|FG001|Run-in Phase|AE; Physician Decision|0|||
147040692|NCT03888066|530311155|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
147040693|NCT03888066|530311156|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147040694|NCT03888066|530311155|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
147040695|NCT03888066|530311156|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
147040696|NCT03888066|530311155|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
147040697|NCT03888066|530311156|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
147040698|NCT03888066|530311155|FG000|Run-in Phase|Death|1|||
147040699|NCT03888066|530311156|FG001|Run-in Phase|Death|0|||
147040700|NCT03888066|530311155|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
147040701|NCT03888066|530311156|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
147040702|NCT03888066|530311155|FG000|Run-in Phase|Physician Decision|1|||
147040703|NCT03888066|530311156|FG001|Run-in Phase|Physician Decision|0|||
147040704|NCT03888066|530311155|FG000|Run-in Phase|Protocol Violation|13|||
147040705|NCT03888066|530311156|FG001|Run-in Phase|Protocol Violation|0|||
147040706|NCT03888066|530311155|FG000|Run-in Phase|Sponsor Request|34|||
147040707|NCT03888066|530311156|FG001|Run-in Phase|Sponsor Request|0|||
147040708|NCT03888066|530311155|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
147040709|NCT03888066|530311156|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
147040710|NCT03888066|530311155|FG000|Run-in Phase|Withdrawal Of Consent|1|||
147040711|NCT03888066|530311156|FG001|Run-in Phase|Withdrawal Of Consent|0|||
147040712|NCT03888066|530311155|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
147040713|NCT03888066|530311156|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
147040714|NCT03888066|530311155|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
146849827|NCT00766363|529618904|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
147040715|NCT03888066|530311156|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
147040716|NCT03888066|530311155|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
147040717|NCT03888066|530311156|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
147040718|NCT03888066|530311155|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
147040719|NCT03888066|530311156|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
147040720|NCT03888066|530311155|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
147040721|NCT03888066|530311156|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
147040722|NCT03888066|530311155|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
147040723|NCT03888066|530311156|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
147040724|NCT03888066|530311155|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
147040725|NCT03888066|530311156|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
147040726|NCT03888066|530311155|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
147040727|NCT03888066|530311156|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
147040728|NCT03888066|530311155|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
147040729|NCT03888066|530311156|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
147040730|NCT03888066|530311155|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
147040731|NCT03888066|530311156|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
147040732|NCT03888066|530311155|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
147040733|NCT03888066|530311156|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
147040734|NCT03888066|530311155|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
147040735|NCT03888066|530311156|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
147040736|NCT02207634|530311157|FG000|Overall Study|Withdrawal by Subject|21|||
147040737|NCT02207634|530311158|FG001|Overall Study|Withdrawal by Subject|31|||
147040738|NCT02207634|530311157|FG000|Overall Study|Lost to Follow-up|1|||
147040739|NCT02207634|530311158|FG001|Overall Study|Lost to Follow-up|0|||
147040740|NCT02077140|530311159|FG000|Overall Study|Lost to Follow-up|4|||
147040741|NCT02077140|530311160|FG001|Overall Study|Lost to Follow-up|1|||
147040742|NCT02077140|530311161|FG002|Overall Study|Lost to Follow-up|2|||
147040743|NCT02077140|530311162|FG003|Overall Study|Lost to Follow-up|2|||
147040744|NCT02077140|530311163|FG004|Overall Study|Lost to Follow-up|3|||
147040745|NCT02077140|530311159|FG000|Overall Study|Withdrawal by Subject|0|||
147040746|NCT02077140|530311160|FG001|Overall Study|Withdrawal by Subject|1|||
147040747|NCT02077140|530311161|FG002|Overall Study|Withdrawal by Subject|0|||
147040748|NCT02077140|530311162|FG003|Overall Study|Withdrawal by Subject|2|||
147040749|NCT02077140|530311163|FG004|Overall Study|Withdrawal by Subject|2|||
147040750|NCT00459355|530311164|FG000|Overall Study|Subject no longer met inc criteria|20|||
147040751|NCT00459355|530311165|FG001|Overall Study|Subject no longer met inc criteria|18|||
147040752|NCT01762800|530311168|FG000|Overall Study|Adverse Event|8|||
147040753|NCT01762800|530311169|FG001|Overall Study|Adverse Event|13|||
147040754|NCT01762800|530311168|FG000|Overall Study|Lack of Efficacy|3|||
147040755|NCT01762800|530311169|FG001|Overall Study|Lack of Efficacy|2|||
147040756|NCT01762800|530311168|FG000|Overall Study|Study Closed/Terminated|0|||
147040757|NCT01762800|530311169|FG001|Overall Study|Study Closed/Terminated|1|||
147040758|NCT01762800|530311168|FG000|Overall Study|Physician Decision|1|||
147040759|NCT01762800|530311169|FG001|Overall Study|Physician Decision|1|||
147040760|NCT01762800|530311168|FG000|Overall Study|Withdrawal by Subject|7|||
147040761|NCT01762800|530311169|FG001|Overall Study|Withdrawal by Subject|4|||
147040762|NCT01173120|530311171|FG000|Overall Study|Lack of Efficacy|2|||
147040763|NCT01173120|530311171|FG000|Overall Study|Lost to Follow-up|1|||
147040764|NCT01173120|530311171|FG000|Overall Study|Participant Decision|2|||
147040765|NCT01173120|530311171|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
147040766|NCT01173120|530311171|FG000|Overall Study|Switch-Participant Decision|12|||
147040767|NCT01173120|530311171|FG000|Overall Study|Switch-Difficulty With Device|12|||
147040768|NCT02847260|530311172|FG000|Overall Study|Adverse Event|3|||
147040769|NCT02847260|530311172|FG000|Overall Study|Withdrawal by Subject|2|||
147040770|NCT02847260|530311172|FG000|Overall Study|Clinical Deterioration|1|||
147040771|NCT02847260|530311172|FG000|Overall Study|Physician Decision|1|||
147040772|NCT02906358|530311173|FG000|Overall Study|Withdrawal by Subject|10|||
147040773|NCT02906358|530311174|FG001|Overall Study|Withdrawal by Subject|7|||
147040774|NCT02906358|530311173|FG000|Overall Study|Lost to Follow-up|12|||
147040775|NCT02906358|530311174|FG001|Overall Study|Lost to Follow-up|15|||
147040776|NCT02699684|530311175|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
147040777|NCT02699684|530311176|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
147040778|NCT01145508|530311177|FG000|Overall Study|Adverse Event|1|||
147040779|NCT01145508|530311178|FG001|Overall Study|Adverse Event|0|||
147040780|NCT01145508|530311177|FG000|Overall Study|Death|1|||
147040781|NCT01145508|530311178|FG001|Overall Study|Death|0|||
147040782|NCT01145508|530311177|FG000|Overall Study|Physician Decision|2|||
146849828|NCT00766363|529618905|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
147040783|NCT01145508|530311178|FG001|Overall Study|Physician Decision|1|||
147040784|NCT01145508|530311177|FG000|Overall Study|Never started treatment|1|||
147040785|NCT01145508|530311178|FG001|Overall Study|Never started treatment|1|||
147040786|NCT02111603|530311187|FG000|Overall Study|Withdrawal by Subject|1|||
147040787|NCT01609023|530311190|FG000|Overall Study|Lack of Efficacy|3|||
147040788|NCT01609023|530311190|FG000|Overall Study|Withdrawal by Subject|4|||
147040789|NCT01609023|530311190|FG000|Overall Study|Lost to Follow-up|8|||
147040790|NCT01609023|530311190|FG000|Overall Study|Toxicity|3|||
147040791|NCT01609023|530311190|FG000|Overall Study|Disease progression|10|||
147040792|NCT01609023|530311190|FG000|Overall Study|Physician Decision|2|||
147040793|NCT01609023|530311190|FG000|Overall Study|Death|2|||
147040794|NCT01609023|530311190|FG000|Overall Study|Personal reasons|1|||
147040795|NCT04172597|530311191|FG000|Overall Study|Disease Progression|0|||
147040796|NCT04172597|530311192|FG001|Overall Study|Disease Progression|0|||
147040797|NCT04172597|530311193|FG002|Overall Study|Disease Progression|0|||
147040798|NCT04172597|530311194|FG003|Overall Study|Disease Progression|0|||
147040799|NCT04172597|530311195|FG004|Overall Study|Disease Progression|1|||
147040800|NCT00799825|530311198|FG000|Overall Study|Adverse Event|1|||
147040801|NCT00799825|530311198|FG000|Overall Study|Withdrawal by Subject|6|||
147040802|NCT00799825|530311198|FG000|Overall Study|Lost to Follow-up|38|||
147040803|NCT00799825|530311198|FG000|Overall Study|Pregnancy|3|||
147040804|NCT03717012|530311214|FG000|Overall Study|Due to trial termination|1|||
147040805|NCT03717012|530311215|FG001|Overall Study|Due to trial termination|2|||
147040806|NCT03717012|530311214|FG000|Overall Study|Protocol Violation|0|||
147040807|NCT03717012|530311215|FG001|Overall Study|Protocol Violation|2|||
147040808|NCT03717012|530311214|FG000|Overall Study|Adverse Event|0|||
147040809|NCT03717012|530311215|FG001|Overall Study|Adverse Event|1|||
147040810|NCT03717012|530311214|FG000|Overall Study|Lung transplant|0|||
147040811|NCT03717012|530311215|FG001|Overall Study|Lung transplant|1|||
147040812|NCT00789035|530311216|FG000|Overall Study|Adverse Event|0|||
147040813|NCT00789035|530311217|FG001|Overall Study|Adverse Event|2|||
147040814|NCT00789035|530311218|FG002|Overall Study|Adverse Event|0|||
147040815|NCT00789035|530311219|FG003|Overall Study|Adverse Event|1|||
147040816|NCT00789035|530311220|FG004|Overall Study|Adverse Event|3|||
147040817|NCT00789035|530311216|FG000|Overall Study|Lack of Efficacy|3|||
147040818|NCT00789035|530311217|FG001|Overall Study|Lack of Efficacy|0|||
147040819|NCT00789035|530311218|FG002|Overall Study|Lack of Efficacy|0|||
147040820|NCT00789035|530311219|FG003|Overall Study|Lack of Efficacy|0|||
147040821|NCT00789035|530311220|FG004|Overall Study|Lack of Efficacy|2|||
147040822|NCT00789035|530311216|FG000|Overall Study|Protocol Violation|1|||
147040823|NCT00789035|530311217|FG001|Overall Study|Protocol Violation|0|||
147040824|NCT00789035|530311218|FG002|Overall Study|Protocol Violation|0|||
147040825|NCT00789035|530311219|FG003|Overall Study|Protocol Violation|0|||
147040826|NCT00789035|530311220|FG004|Overall Study|Protocol Violation|0|||
147040827|NCT00789035|530311216|FG000|Overall Study|Withdrawal by Subject|0|||
147040828|NCT00789035|530311217|FG001|Overall Study|Withdrawal by Subject|2|||
147040829|NCT00789035|530311218|FG002|Overall Study|Withdrawal by Subject|0|||
147040830|NCT00789035|530311219|FG003|Overall Study|Withdrawal by Subject|0|||
147040831|NCT00789035|530311220|FG004|Overall Study|Withdrawal by Subject|0|||
147040832|NCT00789035|530311216|FG000|Overall Study|Other reason not defined above|2|||
147040833|NCT00789035|530311217|FG001|Overall Study|Other reason not defined above|3|||
147040834|NCT00789035|530311218|FG002|Overall Study|Other reason not defined above|1|||
147040835|NCT00789035|530311219|FG003|Overall Study|Other reason not defined above|0|||
147040836|NCT00789035|530311220|FG004|Overall Study|Other reason not defined above|1|||
147040837|NCT01520870|530311221|FG000|Overall Study|Withdrawal by Subject|2|||
147040838|NCT03682107|530311233|FG000|Overall Study|Withdrawal by Subject|0|||
147040839|NCT03682107|530311234|FG001|Overall Study|Withdrawal by Subject|1|||
147040840|NCT03682107|530311235|FG002|Overall Study|Withdrawal by Subject|0|||
147040841|NCT03682107|530311236|FG003|Overall Study|Withdrawal by Subject|0|||
147040842|NCT03682107|530311237|FG004|Overall Study|Withdrawal by Subject|0|||
147040843|NCT03837743|530311240|FG000|Overall Study|Adverse Event|1|||
147040844|NCT03837743|530311240|FG000|Overall Study|Withdrawal by Subject|2|||
147040845|NCT00252239|530311241|FG000|Overall Study|Withdrawal by Subject|1|||
147040846|NCT00252239|530311242|FG001|Overall Study|Withdrawal by Subject|0|||
147040847|NCT00252239|530311243|FG002|Overall Study|Withdrawal by Subject|0|||
147040848|NCT00252239|530311244|FG003|Overall Study|Withdrawal by Subject|1|||
147040849|NCT00252239|530311241|FG000|Overall Study|Lost to Follow-up|0|||
147040850|NCT00252239|530311242|FG001|Overall Study|Lost to Follow-up|0|||
147040851|NCT00252239|530311243|FG002|Overall Study|Lost to Follow-up|2|||
147040852|NCT00252239|530311244|FG003|Overall Study|Lost to Follow-up|0|||
147040853|NCT02257385|530311246|FG000|Overall Study|Adverse Event|12|||
147040854|NCT02257385|530311247|FG001|Overall Study|Adverse Event|8|||
147040855|NCT02257385|530311246|FG000|Overall Study|Lack of Efficacy|1|||
147040856|NCT02257385|530311247|FG001|Overall Study|Lack of Efficacy|2|||
146849829|NCT03292432|529618906|FG000|Overall Study|Lost to Follow-up|11|||
146849830|NCT03292432|529618907|FG001|Overall Study|Lost to Follow-up|8|||
147040857|NCT02257385|530311246|FG000|Overall Study|Protocol Violation|5|||
147040858|NCT02257385|530311247|FG001|Overall Study|Protocol Violation|7|||
147040859|NCT02257385|530311246|FG000|Overall Study|Lost to Follow-up|0|||
147040860|NCT02257385|530311247|FG001|Overall Study|Lost to Follow-up|1|||
147040861|NCT02257385|530311246|FG000|Overall Study|Withdrawal by Subject|4|||
147040862|NCT02257385|530311247|FG001|Overall Study|Withdrawal by Subject|4|||
147040863|NCT01822366|530311254|FG000|Overall Study|Lost to Follow-up|5|||
147040864|NCT01822366|530311255|FG001|Overall Study|Lost to Follow-up|1|||
147040865|NCT01822366|530311256|FG002|Overall Study|Lost to Follow-up|5|||
147040866|NCT01822366|530311257|FG003|Overall Study|Lost to Follow-up|1|||
147040867|NCT01822366|530311254|FG000|Overall Study|Withdrawal by Subject|0|||
147040868|NCT01822366|530311255|FG001|Overall Study|Withdrawal by Subject|6|||
147040869|NCT01822366|530311256|FG002|Overall Study|Withdrawal by Subject|0|||
147040870|NCT01822366|530311257|FG003|Overall Study|Withdrawal by Subject|6|||
147040871|NCT01822366|530311254|FG000|Overall Study|Partial Intervention Completion|0|||
147040872|NCT01822366|530311255|FG001|Overall Study|Partial Intervention Completion|15|||
147040873|NCT01822366|530311256|FG002|Overall Study|Partial Intervention Completion|0|||
147040874|NCT01822366|530311257|FG003|Overall Study|Partial Intervention Completion|15|||
147040875|NCT00384930|530311260|FG000|Overall Study|Adverse Event|5|||
147040876|NCT00384930|530311261|FG001|Overall Study|Adverse Event|4|||
147040877|NCT00384930|530311262|FG002|Overall Study|Adverse Event|12|||
147040878|NCT00384930|530311263|FG003|Overall Study|Adverse Event|11|||
147040879|NCT00384930|530311264|FG004|Overall Study|Adverse Event|14|||
147040880|NCT00384930|530311260|FG000|Overall Study|Entry Criteria Not Met|2|||
147040881|NCT00384930|530311261|FG001|Overall Study|Entry Criteria Not Met|6|||
147040882|NCT00384930|530311262|FG002|Overall Study|Entry Criteria Not Met|7|||
147040883|NCT00384930|530311263|FG003|Overall Study|Entry Criteria Not Met|8|||
147040884|NCT00384930|530311264|FG004|Overall Study|Entry Criteria Not Met|4|||
147040885|NCT00384930|530311260|FG000|Overall Study|Lack of Efficacy|1|||
147040886|NCT00384930|530311261|FG001|Overall Study|Lack of Efficacy|1|||
147040887|NCT00384930|530311262|FG002|Overall Study|Lack of Efficacy|2|||
147040888|NCT00384930|530311263|FG003|Overall Study|Lack of Efficacy|1|||
147040889|NCT00384930|530311264|FG004|Overall Study|Lack of Efficacy|2|||
147040890|NCT00384930|530311260|FG000|Overall Study|Lost to Follow-up|5|||
147040891|NCT00384930|530311261|FG001|Overall Study|Lost to Follow-up|3|||
147040892|NCT00384930|530311262|FG002|Overall Study|Lost to Follow-up|0|||
147040893|NCT00384930|530311263|FG003|Overall Study|Lost to Follow-up|4|||
147040894|NCT00384930|530311264|FG004|Overall Study|Lost to Follow-up|6|||
147040895|NCT00384930|530311260|FG000|Overall Study|Physician Decision|0|||
147040896|NCT00384930|530311261|FG001|Overall Study|Physician Decision|1|||
147040897|NCT00384930|530311262|FG002|Overall Study|Physician Decision|1|||
147040898|NCT00384930|530311263|FG003|Overall Study|Physician Decision|0|||
147040899|NCT00384930|530311264|FG004|Overall Study|Physician Decision|1|||
147040900|NCT00384930|530311260|FG000|Overall Study|Protocol Violation|1|||
147040901|NCT00384930|530311261|FG001|Overall Study|Protocol Violation|0|||
147040902|NCT00384930|530311262|FG002|Overall Study|Protocol Violation|1|||
147040903|NCT00384930|530311263|FG003|Overall Study|Protocol Violation|6|||
147040904|NCT00384930|530311264|FG004|Overall Study|Protocol Violation|4|||
147040905|NCT00384930|530311260|FG000|Overall Study|Sponsor Decision|3|||
147040906|NCT00384930|530311261|FG001|Overall Study|Sponsor Decision|4|||
147040907|NCT00384930|530311262|FG002|Overall Study|Sponsor Decision|0|||
147040908|NCT00384930|530311263|FG003|Overall Study|Sponsor Decision|5|||
147040909|NCT00384930|530311264|FG004|Overall Study|Sponsor Decision|0|||
147040910|NCT00384930|530311260|FG000|Overall Study|Withdrawal by Subject|9|||
147040911|NCT00384930|530311261|FG001|Overall Study|Withdrawal by Subject|7|||
147040912|NCT00384930|530311262|FG002|Overall Study|Withdrawal by Subject|7|||
147040913|NCT00384930|530311263|FG003|Overall Study|Withdrawal by Subject|6|||
147040914|NCT00384930|530311264|FG004|Overall Study|Withdrawal by Subject|16|||
147040915|NCT00384930|530311260|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
147040916|NCT00384930|530311261|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
147040917|NCT00384930|530311262|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
147040918|NCT00384930|530311263|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
147040919|NCT00384930|530311264|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
147040920|NCT01449370|530311267|FG000|Overall Study|Disease Progression|5|||
147040921|NCT01449370|530311268|FG001|Overall Study|Disease Progression|4|||
147040922|NCT01449370|530311269|FG002|Overall Study|Disease Progression|8|||
147040923|NCT01449370|530311270|FG003|Overall Study|Disease Progression|3|||
147040924|NCT01449370|530311271|FG004|Overall Study|Disease Progression|3|||
147040925|NCT01449370|530311272|FG005|Overall Study|Disease Progression|3|||
147040926|NCT01449370|530311273|FG006|Overall Study|Disease Progression|3|||
147040927|NCT01449370|530311274|FG007|Overall Study|Disease Progression|2|||
147040928|NCT01449370|530311275|FG008|Overall Study|Disease Progression|9|||
147040929|NCT01449370|530311276|FG009|Overall Study|Disease Progression|1|||
147040930|NCT01449370|530311277|FG010|Overall Study|Disease Progression|3|||
147040931|NCT01449370|530311278|FG011|Overall Study|Disease Progression|3|||
147040932|NCT01449370|530311279|FG012|Overall Study|Disease Progression|2|||
146849831|NCT03292432|529618906|FG000|Overall Study|Death|2|||
147040933|NCT01449370|530311280|FG013|Overall Study|Disease Progression|8|||
147040934|NCT01449370|530311281|FG014|Overall Study|Disease Progression|3|||
147040935|NCT01449370|530311282|FG015|Overall Study|Disease Progression|1|||
146849832|NCT03292432|529618907|FG001|Overall Study|Death|1|||
147040936|NCT01449370|530311283|FG016|Overall Study|Disease Progression|4|||
147040937|NCT01449370|530311284|FG017|Overall Study|Disease Progression|3|||
147040938|NCT01449370|530311285|FG018|Overall Study|Disease Progression|1|||
147040939|NCT01449370|530311286|FG019|Overall Study|Disease Progression|2|||
147040940|NCT01449370|530311287|FG020|Overall Study|Disease Progression|5|||
147040941|NCT01449370|530311288|FG021|Overall Study|Disease Progression|2|||
147040942|NCT01449370|530311289|FG022|Overall Study|Disease Progression|3|||
147040943|NCT01449370|530311290|FG023|Overall Study|Disease Progression|7|||
147040944|NCT01449370|530311291|FG024|Overall Study|Disease Progression|3|||
147040945|NCT01449370|530311267|FG000|Overall Study|Adverse Event|1|||
147040946|NCT01449370|530311268|FG001|Overall Study|Adverse Event|2|||
147040947|NCT01449370|530311269|FG002|Overall Study|Adverse Event|0|||
147040948|NCT01449370|530311270|FG003|Overall Study|Adverse Event|1|||
147040949|NCT01449370|530311271|FG004|Overall Study|Adverse Event|0|||
147040950|NCT01449370|530311272|FG005|Overall Study|Adverse Event|0|||
147040951|NCT01449370|530311273|FG006|Overall Study|Adverse Event|0|||
147040952|NCT01449370|530311274|FG007|Overall Study|Adverse Event|0|||
147040953|NCT01449370|530311275|FG008|Overall Study|Adverse Event|1|||
147040954|NCT01449370|530311276|FG009|Overall Study|Adverse Event|1|||
147040955|NCT01449370|530311277|FG010|Overall Study|Adverse Event|0|||
147040956|NCT01449370|530311278|FG011|Overall Study|Adverse Event|0|||
147040957|NCT01449370|530311279|FG012|Overall Study|Adverse Event|0|||
147040958|NCT01449370|530311280|FG013|Overall Study|Adverse Event|2|||
147040959|NCT01449370|530311281|FG014|Overall Study|Adverse Event|0|||
147040960|NCT01449370|530311282|FG015|Overall Study|Adverse Event|1|||
147040961|NCT01449370|530311283|FG016|Overall Study|Adverse Event|0|||
147040962|NCT01449370|530311284|FG017|Overall Study|Adverse Event|0|||
147040963|NCT01449370|530311285|FG018|Overall Study|Adverse Event|1|||
147040964|NCT01449370|530311286|FG019|Overall Study|Adverse Event|1|||
147040965|NCT01449370|530311287|FG020|Overall Study|Adverse Event|0|||
147040966|NCT01449370|530311288|FG021|Overall Study|Adverse Event|1|||
147040967|NCT01449370|530311289|FG022|Overall Study|Adverse Event|0|||
147040968|NCT01449370|530311290|FG023|Overall Study|Adverse Event|1|||
147040969|NCT01449370|530311291|FG024|Overall Study|Adverse Event|3|||
147040970|NCT01449370|530311267|FG000|Overall Study|Participant Decision|0|||
147040971|NCT01449370|530311268|FG001|Overall Study|Participant Decision|0|||
147040972|NCT01449370|530311269|FG002|Overall Study|Participant Decision|0|||
147040973|NCT01449370|530311270|FG003|Overall Study|Participant Decision|0|||
147040974|NCT01449370|530311271|FG004|Overall Study|Participant Decision|0|||
147040975|NCT01449370|530311272|FG005|Overall Study|Participant Decision|0|||
147040976|NCT01449370|530311273|FG006|Overall Study|Participant Decision|0|||
147040977|NCT01449370|530311274|FG007|Overall Study|Participant Decision|1|||
147040978|NCT01449370|530311275|FG008|Overall Study|Participant Decision|1|||
147040979|NCT01449370|530311276|FG009|Overall Study|Participant Decision|0|||
147040980|NCT01449370|530311277|FG010|Overall Study|Participant Decision|0|||
147040981|NCT01449370|530311278|FG011|Overall Study|Participant Decision|0|||
147040982|NCT01449370|530311279|FG012|Overall Study|Participant Decision|1|||
147040983|NCT01449370|530311280|FG013|Overall Study|Participant Decision|1|||
147040984|NCT01449370|530311281|FG014|Overall Study|Participant Decision|0|||
147040985|NCT01449370|530311282|FG015|Overall Study|Participant Decision|1|||
147040986|NCT01449370|530311283|FG016|Overall Study|Participant Decision|3|||
147040987|NCT01449370|530311284|FG017|Overall Study|Participant Decision|0|||
147040988|NCT01449370|530311285|FG018|Overall Study|Participant Decision|1|||
147040989|NCT01449370|530311286|FG019|Overall Study|Participant Decision|0|||
147040990|NCT01449370|530311287|FG020|Overall Study|Participant Decision|0|||
147040991|NCT01449370|530311288|FG021|Overall Study|Participant Decision|1|||
147040992|NCT01449370|530311289|FG022|Overall Study|Participant Decision|0|||
147040993|NCT01449370|530311290|FG023|Overall Study|Participant Decision|0|||
147040994|NCT01449370|530311291|FG024|Overall Study|Participant Decision|1|||
147040995|NCT01449370|530311267|FG000|Overall Study|Lost to Follow-up|0|||
147040996|NCT01449370|530311268|FG001|Overall Study|Lost to Follow-up|0|||
147040997|NCT01449370|530311269|FG002|Overall Study|Lost to Follow-up|0|||
147040998|NCT01449370|530311270|FG003|Overall Study|Lost to Follow-up|0|||
147040999|NCT01449370|530311271|FG004|Overall Study|Lost to Follow-up|0|||
147041000|NCT01449370|530311272|FG005|Overall Study|Lost to Follow-up|0|||
147041001|NCT01449370|530311273|FG006|Overall Study|Lost to Follow-up|0|||
147041002|NCT01449370|530311274|FG007|Overall Study|Lost to Follow-up|0|||
147041003|NCT01449370|530311275|FG008|Overall Study|Lost to Follow-up|0|||
147041004|NCT01449370|530311276|FG009|Overall Study|Lost to Follow-up|0|||
147041005|NCT01449370|530311277|FG010|Overall Study|Lost to Follow-up|0|||
147041006|NCT01449370|530311278|FG011|Overall Study|Lost to Follow-up|0|||
147041007|NCT01449370|530311279|FG012|Overall Study|Lost to Follow-up|0|||
147041008|NCT01449370|530311280|FG013|Overall Study|Lost to Follow-up|0|||
147041009|NCT01449370|530311281|FG014|Overall Study|Lost to Follow-up|0|||
147041010|NCT01449370|530311282|FG015|Overall Study|Lost to Follow-up|0|||
147041011|NCT01449370|530311283|FG016|Overall Study|Lost to Follow-up|0|||
147041012|NCT01449370|530311284|FG017|Overall Study|Lost to Follow-up|0|||
147041013|NCT01449370|530311285|FG018|Overall Study|Lost to Follow-up|0|||
147041014|NCT01449370|530311286|FG019|Overall Study|Lost to Follow-up|0|||
147041015|NCT01449370|530311287|FG020|Overall Study|Lost to Follow-up|1|||
147041016|NCT01449370|530311288|FG021|Overall Study|Lost to Follow-up|0|||
147041017|NCT01449370|530311289|FG022|Overall Study|Lost to Follow-up|0|||
147041018|NCT01449370|530311290|FG023|Overall Study|Lost to Follow-up|0|||
147041019|NCT01449370|530311291|FG024|Overall Study|Lost to Follow-up|0|||
147041020|NCT01449370|530311267|FG000|Overall Study|Other|0|||
147041021|NCT01449370|530311268|FG001|Overall Study|Other|0|||
147041022|NCT01449370|530311269|FG002|Overall Study|Other|0|||
147041023|NCT01449370|530311270|FG003|Overall Study|Other|0|||
147041024|NCT01449370|530311271|FG004|Overall Study|Other|0|||
147041025|NCT01449370|530311272|FG005|Overall Study|Other|0|||
147041026|NCT01449370|530311273|FG006|Overall Study|Other|0|||
147041027|NCT01449370|530311274|FG007|Overall Study|Other|0|||
147041028|NCT01449370|530311275|FG008|Overall Study|Other|1|||
147041029|NCT01449370|530311276|FG009|Overall Study|Other|1|||
147041030|NCT01449370|530311277|FG010|Overall Study|Other|0|||
147041031|NCT01449370|530311278|FG011|Overall Study|Other|0|||
147041032|NCT01449370|530311279|FG012|Overall Study|Other|0|||
147041033|NCT01449370|530311280|FG013|Overall Study|Other|0|||
147041034|NCT01449370|530311281|FG014|Overall Study|Other|0|||
147041035|NCT01449370|530311282|FG015|Overall Study|Other|0|||
147041036|NCT01449370|530311283|FG016|Overall Study|Other|0|||
147041037|NCT01449370|530311284|FG017|Overall Study|Other|0|||
147041038|NCT01449370|530311285|FG018|Overall Study|Other|0|||
147041039|NCT01449370|530311286|FG019|Overall Study|Other|0|||
147041040|NCT01449370|530311287|FG020|Overall Study|Other|0|||
147041041|NCT01449370|530311288|FG021|Overall Study|Other|0|||
147041042|NCT01449370|530311289|FG022|Overall Study|Other|1|||
147041043|NCT01449370|530311290|FG023|Overall Study|Other|1|||
147041044|NCT01449370|530311291|FG024|Overall Study|Other|0|||
147041045|NCT01449370|530311267|FG000|Overall Study|Medication Prohibited by Protocol|0|||
147041046|NCT01449370|530311268|FG001|Overall Study|Medication Prohibited by Protocol|0|||
147041047|NCT01449370|530311269|FG002|Overall Study|Medication Prohibited by Protocol|0|||
147041048|NCT01449370|530311270|FG003|Overall Study|Medication Prohibited by Protocol|0|||
147041049|NCT01449370|530311271|FG004|Overall Study|Medication Prohibited by Protocol|0|||
147041050|NCT01449370|530311272|FG005|Overall Study|Medication Prohibited by Protocol|0|||
147041051|NCT01449370|530311273|FG006|Overall Study|Medication Prohibited by Protocol|0|||
147041052|NCT01449370|530311274|FG007|Overall Study|Medication Prohibited by Protocol|0|||
147041053|NCT01449370|530311275|FG008|Overall Study|Medication Prohibited by Protocol|0|||
147041054|NCT01449370|530311276|FG009|Overall Study|Medication Prohibited by Protocol|0|||
147041055|NCT01449370|530311277|FG010|Overall Study|Medication Prohibited by Protocol|0|||
147041056|NCT01449370|530311278|FG011|Overall Study|Medication Prohibited by Protocol|0|||
147041057|NCT01449370|530311279|FG012|Overall Study|Medication Prohibited by Protocol|0|||
147041058|NCT01449370|530311280|FG013|Overall Study|Medication Prohibited by Protocol|0|||
147041059|NCT01449370|530311281|FG014|Overall Study|Medication Prohibited by Protocol|0|||
147041060|NCT01449370|530311282|FG015|Overall Study|Medication Prohibited by Protocol|0|||
147041061|NCT01449370|530311283|FG016|Overall Study|Medication Prohibited by Protocol|0|||
147041062|NCT01449370|530311284|FG017|Overall Study|Medication Prohibited by Protocol|0|||
147041063|NCT01449370|530311285|FG018|Overall Study|Medication Prohibited by Protocol|0|||
147041064|NCT01449370|530311286|FG019|Overall Study|Medication Prohibited by Protocol|0|||
147041065|NCT01449370|530311287|FG020|Overall Study|Medication Prohibited by Protocol|0|||
147041066|NCT01449370|530311288|FG021|Overall Study|Medication Prohibited by Protocol|0|||
147041067|NCT01449370|530311289|FG022|Overall Study|Medication Prohibited by Protocol|0|||
147041068|NCT01449370|530311290|FG023|Overall Study|Medication Prohibited by Protocol|1|||
147041069|NCT01449370|530311291|FG024|Overall Study|Medication Prohibited by Protocol|0|||
147041070|NCT01449370|530311267|FG000|Overall Study|Death|0|||
147041071|NCT01449370|530311268|FG001|Overall Study|Death|0|||
147041072|NCT01449370|530311269|FG002|Overall Study|Death|0|||
147041073|NCT01449370|530311270|FG003|Overall Study|Death|0|||
147041074|NCT01449370|530311271|FG004|Overall Study|Death|0|||
147041075|NCT01449370|530311272|FG005|Overall Study|Death|0|||
147041076|NCT01449370|530311273|FG006|Overall Study|Death|0|||
147041077|NCT01449370|530311274|FG007|Overall Study|Death|0|||
147041078|NCT01449370|530311275|FG008|Overall Study|Death|0|||
147041079|NCT01449370|530311276|FG009|Overall Study|Death|0|||
147041080|NCT01449370|530311277|FG010|Overall Study|Death|0|||
147041081|NCT01449370|530311278|FG011|Overall Study|Death|0|||
147041082|NCT01449370|530311279|FG012|Overall Study|Death|0|||
147041083|NCT01449370|530311280|FG013|Overall Study|Death|0|||
147041084|NCT01449370|530311281|FG014|Overall Study|Death|0|||
147041085|NCT01449370|530311282|FG015|Overall Study|Death|0|||
146849833|NCT03292432|529618906|FG000|Overall Study|Withdrawal by Subject|1|||
146849834|NCT03292432|529618907|FG001|Overall Study|Withdrawal by Subject|2|||
147041086|NCT01449370|530311283|FG016|Overall Study|Death|0|||
147041087|NCT01449370|530311284|FG017|Overall Study|Death|0|||
147041088|NCT01449370|530311285|FG018|Overall Study|Death|0|||
147041089|NCT01449370|530311286|FG019|Overall Study|Death|0|||
147041090|NCT01449370|530311287|FG020|Overall Study|Death|0|||
147041091|NCT01449370|530311288|FG021|Overall Study|Death|0|||
147041092|NCT01449370|530311289|FG022|Overall Study|Death|0|||
147041093|NCT01449370|530311290|FG023|Overall Study|Death|0|||
147041094|NCT01449370|530311291|FG024|Overall Study|Death|1|||
147041095|NCT00534404|530311292|FG000|Overall Study|Death|0|||
147041096|NCT00534404|530311293|FG001|Overall Study|Death|0|||
147041097|NCT00534404|530311294|FG002|Overall Study|Death|2|||
147041098|NCT00534404|530311292|FG000|Overall Study|Withdrawal by Subject|8|||
147041099|NCT00534404|530311293|FG001|Overall Study|Withdrawal by Subject|2|||
147041100|NCT00534404|530311294|FG002|Overall Study|Withdrawal by Subject|38|||
147041101|NCT00534404|530311292|FG000|Overall Study|Removed by study staff|2|||
147041102|NCT00534404|530311293|FG001|Overall Study|Removed by study staff|3|||
147041103|NCT00534404|530311294|FG002|Overall Study|Removed by study staff|1|||
147041104|NCT00534404|530311292|FG000|Overall Study|Lost to Follow-up|170|||
147041105|NCT00534404|530311293|FG001|Overall Study|Lost to Follow-up|138|||
147041106|NCT00534404|530311294|FG002|Overall Study|Lost to Follow-up|201|||
147041107|NCT02027428|530311295|FG000|Induction|Never treated|7|||
147041108|NCT02027428|530311296|FG001|Induction|Never treated|0|||
147041109|NCT02027428|530311297|FG002|Induction|Never treated|0|||
147041110|NCT02027428|530311295|FG000|Induction|Progressive disease|77|||
147041111|NCT02027428|530311296|FG001|Induction|Progressive disease|0|||
147041112|NCT02027428|530311297|FG002|Induction|Progressive disease|0|||
147041113|NCT02027428|530311295|FG000|Induction|Adverse Event|51|||
147041114|NCT02027428|530311296|FG001|Induction|Adverse Event|0|||
147041115|NCT02027428|530311297|FG002|Induction|Adverse Event|0|||
147041116|NCT02027428|530311295|FG000|Induction|Withdrawal by Subject|22|||
147041117|NCT02027428|530311296|FG001|Induction|Withdrawal by Subject|0|||
147041118|NCT02027428|530311297|FG002|Induction|Withdrawal by Subject|0|||
147041119|NCT02027428|530311295|FG000|Induction|Death|21|||
147041120|NCT02027428|530311296|FG001|Induction|Death|0|||
147041121|NCT02027428|530311297|FG002|Induction|Death|0|||
147041122|NCT02027428|530311295|FG000|Induction|Symptomatic deterioration|16|||
147041123|NCT02027428|530311296|FG001|Induction|Symptomatic deterioration|0|||
147041124|NCT02027428|530311297|FG002|Induction|Symptomatic deterioration|0|||
147041125|NCT02027428|530311295|FG000|Induction|Study terminated by sponsor|12|||
147041126|NCT02027428|530311296|FG001|Induction|Study terminated by sponsor|0|||
147041127|NCT02027428|530311297|FG002|Induction|Study terminated by sponsor|0|||
147041128|NCT02027428|530311295|FG000|Induction|Protocol Violation|1|||
147041129|NCT02027428|530311296|FG001|Induction|Protocol Violation|0|||
147041130|NCT02027428|530311297|FG002|Induction|Protocol Violation|0|||
147041131|NCT02027428|530311295|FG000|Induction|Miscellaneous|14|||
147041132|NCT02027428|530311296|FG001|Induction|Miscellaneous|0|||
147041133|NCT02027428|530311297|FG002|Induction|Miscellaneous|0|||
147041134|NCT02027428|530311295|FG000|Induction|Induction Treatment Ongoing|4|||
147041135|NCT02027428|530311296|FG001|Induction|Induction Treatment Ongoing|0|||
147041136|NCT02027428|530311297|FG002|Induction|Induction Treatment Ongoing|0|||
147041137|NCT02027428|530311295|FG000|Maintenance|Death|0|||
147041138|NCT02027428|530311296|FG001|Maintenance|Death|3|||
147041139|NCT02027428|530311297|FG002|Maintenance|Death|2|||
147041140|NCT02027428|530311295|FG000|Maintenance|Adverse Event|0|||
147041141|NCT02027428|530311296|FG001|Maintenance|Adverse Event|21|||
147041142|NCT02027428|530311297|FG002|Maintenance|Adverse Event|1|||
147041143|NCT02027428|530311295|FG000|Maintenance|Progressive disease|0|||
147041144|NCT02027428|530311296|FG001|Maintenance|Progressive disease|84|||
147041145|NCT02027428|530311297|FG002|Maintenance|Progressive disease|47|||
147041146|NCT02027428|530311295|FG000|Maintenance|Symptomatic deterioration|0|||
147041147|NCT02027428|530311296|FG001|Maintenance|Symptomatic deterioration|4|||
147041148|NCT02027428|530311297|FG002|Maintenance|Symptomatic deterioration|1|||
147041149|NCT02027428|530311295|FG000|Maintenance|Withdrawal by Subject|0|||
147041150|NCT02027428|530311296|FG001|Maintenance|Withdrawal by Subject|6|||
147041151|NCT02027428|530311297|FG002|Maintenance|Withdrawal by Subject|5|||
147041152|NCT02027428|530311295|FG000|Maintenance|Protocol Violation|0|||
147041153|NCT02027428|530311296|FG001|Maintenance|Protocol Violation|0|||
147041154|NCT02027428|530311297|FG002|Maintenance|Protocol Violation|1|||
147041155|NCT02027428|530311295|FG000|Maintenance|Other|0|||
147041156|NCT02027428|530311296|FG001|Maintenance|Other|6|||
147041157|NCT02027428|530311297|FG002|Maintenance|Other|3|||
147041158|NCT02027428|530311295|FG000|Survival Follow-up|Death|0|||
147041159|NCT02027428|530311296|FG001|Survival Follow-up|Death|78|||
147041160|NCT02027428|530311297|FG002|Survival Follow-up|Death|45|||
147041161|NCT02027428|530311295|FG000|Survival Follow-up|Lost to Follow-up|0|||
147041162|NCT02027428|530311296|FG001|Survival Follow-up|Lost to Follow-up|1|||
147041163|NCT02027428|530311297|FG002|Survival Follow-up|Lost to Follow-up|1|||
147041164|NCT03097991|530311301|FG000|Overall Study|Didn't meet study criteria|8|||
147041165|NCT03097991|530311302|FG001|Overall Study|Didn't meet study criteria|0|||
147041166|NCT03097991|530311301|FG000|Overall Study|Withdrawal by Subject|12|||
147041167|NCT03097991|530311302|FG001|Overall Study|Withdrawal by Subject|6|||
147041168|NCT03097991|530311301|FG000|Overall Study|Death of Baby|3|||
147041169|NCT03097991|530311302|FG001|Overall Study|Death of Baby|1|||
147041170|NCT03097991|530311301|FG000|Overall Study|Lost to Follow-up|24|||
147041171|NCT03097991|530311302|FG001|Overall Study|Lost to Follow-up|38|||
147041172|NCT03097991|530311301|FG000|Overall Study|Adverse Event|3|||
147041173|NCT03097991|530311302|FG001|Overall Study|Adverse Event|5|||
147041174|NCT01098487|530311304|FG000|Overall Study|Adverse Event|22|||
147041175|NCT01098487|530311304|FG000|Overall Study|Lack of Efficacy|11|||
147041176|NCT01098487|530311304|FG000|Overall Study|Withdrawal by Subject|7|||
147041177|NCT01098487|530311304|FG000|Overall Study|Lost to Follow-up|3|||
147041178|NCT01098487|530311304|FG000|Overall Study|Physician Decision|1|||
147041179|NCT03301623|530311309|FG000|Overall Study|Death|3|||
147041180|NCT03301623|530311310|FG001|Overall Study|Death|1|||
147041181|NCT03301623|530311309|FG000|Overall Study|Withdrawal by Subject|11|||
147041182|NCT03301623|530311310|FG001|Overall Study|Withdrawal by Subject|13|||
147041183|NCT03301623|530311309|FG000|Overall Study|Lost to Follow-up|3|||
147041184|NCT03301623|530311310|FG001|Overall Study|Lost to Follow-up|1|||
147041185|NCT01374269|530311312|FG000|Overall Study|Withdrawal by Subject|4|||
147041186|NCT01374269|530311313|FG001|Overall Study|Withdrawal by Subject|0|||
147041187|NCT01374269|530311312|FG000|Overall Study|Lost to Follow-up|1|||
147041188|NCT01374269|530311313|FG001|Overall Study|Lost to Follow-up|3|||
147041189|NCT01374269|530311312|FG000|Overall Study|closed research|1|||
147041190|NCT01374269|530311313|FG001|Overall Study|closed research|2|||
147041191|NCT03316547|530311316|FG000|Overall Study|Death|3|||
147041192|NCT03316547|530311317|FG001|Overall Study|Death|1|||
147041193|NCT03316547|530311316|FG000|Overall Study|Lost to Follow-up|6|||
147041194|NCT03316547|530311317|FG001|Overall Study|Lost to Follow-up|6|||
147041195|NCT03316547|530311316|FG000|Overall Study|Withdrawal by Subject|3|||
147041196|NCT03316547|530311317|FG001|Overall Study|Withdrawal by Subject|2|||
147041197|NCT03316547|530311316|FG000|Overall Study|Transfer to another hospital|6|||
147041198|NCT03316547|530311317|FG001|Overall Study|Transfer to another hospital|4|||
147041199|NCT00996892|530311318|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
147041200|NCT00996892|530311319|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
147041201|NCT00996892|530311320|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
147041202|NCT00996892|530311321|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
147041203|NCT00996892|530311322|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
147041204|NCT00996892|530311323|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
147041205|NCT00996892|530311324|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
147041206|NCT00996892|530311325|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
147041207|NCT00996892|530311326|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
147041208|NCT00996892|530311327|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
147041209|NCT00996892|530311328|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
147041210|NCT00996892|530311329|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
147041211|NCT00996892|530311330|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
147041212|NCT00996892|530311331|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
147041213|NCT00996892|530311332|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
147041214|NCT00996892|530311333|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
147041215|NCT00996892|530311334|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
147041216|NCT00996892|530311335|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
147041217|NCT00996892|530311336|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
147041218|NCT00996892|530311337|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
147041219|NCT00996892|530311318|FG000|Dose-Escalation Stage 1|Death|1|||
147041220|NCT00996892|530311319|FG001|Dose-Escalation Stage 1|Death|0|||
147041221|NCT00996892|530311320|FG002|Dose-Escalation Stage 1|Death|0|||
147041222|NCT00996892|530311321|FG003|Dose-Escalation Stage 1|Death|0|||
147041223|NCT00996892|530311322|FG004|Dose-Escalation Stage 1|Death|0|||
147041224|NCT00996892|530311323|FG005|Dose-Escalation Stage 1|Death|1|||
147041225|NCT00996892|530311324|FG006|Dose-Escalation Stage 1|Death|0|||
147041226|NCT00996892|530311325|FG007|Dose-Escalation Stage 1|Death|0|||
147041227|NCT00996892|530311326|FG008|Dose-Escalation Stage 1|Death|0|||
147041228|NCT00996892|530311327|FG009|Dose-Escalation Stage 1|Death|0|||
147041229|NCT00996892|530311328|FG010|Dose-Escalation Stage 1|Death|0|||
147041230|NCT00996892|530311329|FG011|Dose-Escalation Stage 1|Death|0|||
147041231|NCT00996892|530311330|FG012|Dose-Escalation Stage 1|Death|0|||
147041232|NCT00996892|530311331|FG013|Dose-Escalation Stage 1|Death|0|||
147041233|NCT00996892|530311332|FG014|Dose-Escalation Stage 1|Death|0|||
147041234|NCT00996892|530311333|FG015|Dose-Escalation Stage 1|Death|0|||
147041235|NCT00996892|530311334|FG016|Dose-Escalation Stage 1|Death|0|||
147041236|NCT00996892|530311335|FG017|Dose-Escalation Stage 1|Death|0|||
147041237|NCT00996892|530311336|FG018|Dose-Escalation Stage 1|Death|0|||
147041238|NCT00996892|530311337|FG019|Dose-Escalation Stage 1|Death|0|||
147041239|NCT00996892|530311318|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
147041240|NCT00996892|530311319|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
147041241|NCT00996892|530311320|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
147041242|NCT00996892|530311321|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
147041243|NCT00996892|530311322|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
147041244|NCT00996892|530311323|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
147041245|NCT00996892|530311324|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
147041246|NCT00996892|530311325|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
147041247|NCT00996892|530311326|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
147041248|NCT00996892|530311327|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
147041249|NCT00996892|530311328|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
147041250|NCT00996892|530311329|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
147041251|NCT00996892|530311330|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
147041252|NCT00996892|530311331|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
147041253|NCT00996892|530311332|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
147041254|NCT00996892|530311333|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
147041255|NCT00996892|530311334|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
147041256|NCT00996892|530311335|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
147041257|NCT00996892|530311336|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
147041258|NCT00996892|530311337|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
147041259|NCT00996892|530311318|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147041260|NCT00996892|530311319|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
147041261|NCT00996892|530311320|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147041262|NCT00996892|530311321|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
147041263|NCT00996892|530311322|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
147041264|NCT00996892|530311323|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
147041265|NCT00996892|530311324|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
147041266|NCT00996892|530311325|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147041267|NCT00996892|530311326|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147041268|NCT00996892|530311327|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147041269|NCT00996892|530311328|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147041270|NCT00996892|530311329|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147041271|NCT00996892|530311330|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147041272|NCT00996892|530311331|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147041273|NCT00996892|530311332|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147041274|NCT00996892|530311333|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147041275|NCT00996892|530311334|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147041276|NCT00996892|530311335|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147041277|NCT00996892|530311336|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147041278|NCT00996892|530311337|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147041279|NCT00996892|530311318|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
147041280|NCT00996892|530311319|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
147041281|NCT00996892|530311320|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
147041282|NCT00996892|530311321|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
147041283|NCT00996892|530311322|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
147041284|NCT00996892|530311323|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
147041285|NCT00996892|530311324|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
147041286|NCT00996892|530311325|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
147041287|NCT00996892|530311326|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
147041288|NCT00996892|530311327|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
147041289|NCT00996892|530311328|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
147041290|NCT00996892|530311329|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
147041291|NCT00996892|530311330|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
147041292|NCT00996892|530311331|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
147041293|NCT00996892|530311332|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
147041294|NCT00996892|530311333|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
147041295|NCT00996892|530311334|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
147041296|NCT00996892|530311335|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
147041297|NCT00996892|530311336|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
147041298|NCT00996892|530311337|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
147041299|NCT00996892|530311318|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
147041300|NCT00996892|530311319|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
147041301|NCT00996892|530311320|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
147041302|NCT00996892|530311321|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
147041303|NCT00996892|530311322|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
147041304|NCT00996892|530311323|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
147041305|NCT00996892|530311324|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
147041306|NCT00996892|530311325|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
147041307|NCT00996892|530311326|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
147041308|NCT00996892|530311327|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
147041309|NCT00996892|530311328|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
147041310|NCT00996892|530311329|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
147041311|NCT00996892|530311330|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
147041312|NCT00996892|530311331|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
147041313|NCT00996892|530311332|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
147041314|NCT00996892|530311333|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
147041315|NCT00996892|530311334|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
147041316|NCT00996892|530311335|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
147041317|NCT00996892|530311336|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
147041318|NCT00996892|530311337|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
147041319|NCT00996892|530311318|FG000|Dose-Escalation Stage 1A|Death|0|||
147041320|NCT00996892|530311319|FG001|Dose-Escalation Stage 1A|Death|0|||
147041321|NCT00996892|530311320|FG002|Dose-Escalation Stage 1A|Death|0|||
147041322|NCT00996892|530311321|FG003|Dose-Escalation Stage 1A|Death|0|||
147041323|NCT00996892|530311322|FG004|Dose-Escalation Stage 1A|Death|0|||
147041324|NCT00996892|530311323|FG005|Dose-Escalation Stage 1A|Death|0|||
147041325|NCT00996892|530311324|FG006|Dose-Escalation Stage 1A|Death|0|||
147041326|NCT00996892|530311325|FG007|Dose-Escalation Stage 1A|Death|0|||
147041327|NCT00996892|530311326|FG008|Dose-Escalation Stage 1A|Death|0|||
147041328|NCT00996892|530311327|FG009|Dose-Escalation Stage 1A|Death|2|||
147041329|NCT00996892|530311328|FG010|Dose-Escalation Stage 1A|Death|0|||
147041330|NCT00996892|530311329|FG011|Dose-Escalation Stage 1A|Death|1|||
147041331|NCT00996892|530311330|FG012|Dose-Escalation Stage 1A|Death|1|||
147041332|NCT00996892|530311331|FG013|Dose-Escalation Stage 1A|Death|0|||
147041333|NCT00996892|530311332|FG014|Dose-Escalation Stage 1A|Death|0|||
147041334|NCT00996892|530311333|FG015|Dose-Escalation Stage 1A|Death|0|||
147041335|NCT00996892|530311334|FG016|Dose-Escalation Stage 1A|Death|0|||
147041336|NCT00996892|530311335|FG017|Dose-Escalation Stage 1A|Death|0|||
147041337|NCT00996892|530311336|FG018|Dose-Escalation Stage 1A|Death|0|||
147041338|NCT00996892|530311337|FG019|Dose-Escalation Stage 1A|Death|0|||
147041339|NCT00996892|530311318|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
147041340|NCT00996892|530311319|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
147041341|NCT00996892|530311320|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
147041342|NCT00996892|530311321|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
147041343|NCT00996892|530311322|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
147041344|NCT00996892|530311323|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
147041345|NCT00996892|530311324|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
147041346|NCT00996892|530311325|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
147041347|NCT00996892|530311326|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
147041348|NCT00996892|530311327|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
147041349|NCT00996892|530311328|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
147041350|NCT00996892|530311329|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
147041351|NCT00996892|530311330|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
147041352|NCT00996892|530311331|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
147041353|NCT00996892|530311332|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
147041354|NCT00996892|530311333|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
147041355|NCT00996892|530311334|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
147041356|NCT00996892|530311335|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
147041357|NCT00996892|530311336|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
147041358|NCT00996892|530311337|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
147041359|NCT00996892|530311318|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147041360|NCT00996892|530311319|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147041361|NCT00996892|530311320|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147041362|NCT00996892|530311321|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147041363|NCT00996892|530311322|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147041364|NCT00996892|530311323|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147041365|NCT00996892|530311324|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147041366|NCT00996892|530311325|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147041367|NCT00996892|530311326|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147041368|NCT00996892|530311327|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
147041369|NCT00996892|530311328|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
147041370|NCT00996892|530311329|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
147041371|NCT00996892|530311330|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
147041372|NCT00996892|530311331|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147041373|NCT00996892|530311332|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147041374|NCT00996892|530311333|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147041375|NCT00996892|530311334|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147041376|NCT00996892|530311335|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147041377|NCT00996892|530311336|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147041378|NCT00996892|530311337|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147041379|NCT00996892|530311318|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
147041380|NCT00996892|530311319|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
147041381|NCT00996892|530311320|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
147041382|NCT00996892|530311321|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
147041383|NCT00996892|530311322|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
147041384|NCT00996892|530311323|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
147041385|NCT00996892|530311324|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
147041386|NCT00996892|530311325|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
147041387|NCT00996892|530311326|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
147041388|NCT00996892|530311327|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
147041389|NCT00996892|530311328|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
147041390|NCT00996892|530311329|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
147041391|NCT00996892|530311330|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
147041392|NCT00996892|530311331|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
147041393|NCT00996892|530311332|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
147041394|NCT00996892|530311333|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
147041395|NCT00996892|530311334|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
147041396|NCT00996892|530311335|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
147041397|NCT00996892|530311336|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
146849835|NCT03292432|529618906|FG000|Overall Study|Site closed before any data collected|1|||
147041398|NCT00996892|530311337|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
147041399|NCT00996892|530311318|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
147041400|NCT00996892|530311319|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
147041401|NCT00996892|530311320|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
147041402|NCT00996892|530311321|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
147041403|NCT00996892|530311322|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
147041404|NCT00996892|530311323|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
147041405|NCT00996892|530311324|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
147041406|NCT00996892|530311325|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
147041407|NCT00996892|530311326|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
147041408|NCT00996892|530311327|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
147041409|NCT00996892|530311328|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
147041410|NCT00996892|530311329|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
147041411|NCT00996892|530311330|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
147041412|NCT00996892|530311331|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
147041413|NCT00996892|530311332|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
147041414|NCT00996892|530311333|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
147041415|NCT00996892|530311334|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
147041416|NCT00996892|530311335|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
147041417|NCT00996892|530311336|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
147041418|NCT00996892|530311337|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
147041419|NCT00996892|530311318|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
147041420|NCT00996892|530311319|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
147041421|NCT00996892|530311320|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
147041422|NCT00996892|530311321|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
147041423|NCT00996892|530311322|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
147041424|NCT00996892|530311323|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
147041425|NCT00996892|530311324|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
147041426|NCT00996892|530311325|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
147041427|NCT00996892|530311326|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
147041428|NCT00996892|530311327|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
147041429|NCT00996892|530311328|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
147041430|NCT00996892|530311329|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
147041431|NCT00996892|530311330|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
147041432|NCT00996892|530311331|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
147041433|NCT00996892|530311332|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
147041434|NCT00996892|530311333|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
147041435|NCT00996892|530311334|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
147041436|NCT00996892|530311335|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
147041437|NCT00996892|530311336|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
147041438|NCT00996892|530311337|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
147041439|NCT00996892|530311318|FG000|Expansion Stage 2|Adverse Event|0|||
147041440|NCT00996892|530311319|FG001|Expansion Stage 2|Adverse Event|0|||
147041441|NCT00996892|530311320|FG002|Expansion Stage 2|Adverse Event|0|||
147041442|NCT00996892|530311321|FG003|Expansion Stage 2|Adverse Event|0|||
147041443|NCT00996892|530311322|FG004|Expansion Stage 2|Adverse Event|0|||
147041444|NCT00996892|530311323|FG005|Expansion Stage 2|Adverse Event|0|||
147041445|NCT00996892|530311324|FG006|Expansion Stage 2|Adverse Event|0|||
147041446|NCT00996892|530311325|FG007|Expansion Stage 2|Adverse Event|0|||
147041447|NCT00996892|530311326|FG008|Expansion Stage 2|Adverse Event|0|||
147041448|NCT00996892|530311327|FG009|Expansion Stage 2|Adverse Event|0|||
147041449|NCT00996892|530311328|FG010|Expansion Stage 2|Adverse Event|0|||
147041450|NCT00996892|530311329|FG011|Expansion Stage 2|Adverse Event|0|||
147041451|NCT00996892|530311330|FG012|Expansion Stage 2|Adverse Event|0|||
147041452|NCT00996892|530311331|FG013|Expansion Stage 2|Adverse Event|0|||
147041453|NCT00996892|530311332|FG014|Expansion Stage 2|Adverse Event|0|||
147041454|NCT00996892|530311333|FG015|Expansion Stage 2|Adverse Event|0|||
147041455|NCT00996892|530311334|FG016|Expansion Stage 2|Adverse Event|0|||
147041456|NCT00996892|530311335|FG017|Expansion Stage 2|Adverse Event|0|||
147041457|NCT00996892|530311336|FG018|Expansion Stage 2|Adverse Event|3|||
147041458|NCT00996892|530311337|FG019|Expansion Stage 2|Adverse Event|0|||
147041459|NCT00996892|530311318|FG000|Expansion Stage 2|Death|0|||
147041460|NCT00996892|530311319|FG001|Expansion Stage 2|Death|0|||
147041461|NCT00996892|530311320|FG002|Expansion Stage 2|Death|0|||
147041462|NCT00996892|530311321|FG003|Expansion Stage 2|Death|0|||
147041463|NCT00996892|530311322|FG004|Expansion Stage 2|Death|0|||
147041464|NCT00996892|530311323|FG005|Expansion Stage 2|Death|0|||
147041465|NCT00996892|530311324|FG006|Expansion Stage 2|Death|0|||
147041466|NCT00996892|530311325|FG007|Expansion Stage 2|Death|0|||
147041467|NCT00996892|530311326|FG008|Expansion Stage 2|Death|0|||
147041468|NCT00996892|530311327|FG009|Expansion Stage 2|Death|0|||
147041469|NCT00996892|530311328|FG010|Expansion Stage 2|Death|0|||
147041470|NCT00996892|530311329|FG011|Expansion Stage 2|Death|0|||
146849836|NCT03292432|529618907|FG001|Overall Study|Site closed before any data collected|0|||
147041471|NCT00996892|530311330|FG012|Expansion Stage 2|Death|0|||
147041472|NCT00996892|530311331|FG013|Expansion Stage 2|Death|0|||
147041473|NCT00996892|530311332|FG014|Expansion Stage 2|Death|0|||
147041474|NCT00996892|530311333|FG015|Expansion Stage 2|Death|0|||
147041475|NCT00996892|530311334|FG016|Expansion Stage 2|Death|0|||
147041476|NCT00996892|530311335|FG017|Expansion Stage 2|Death|0|||
147041477|NCT00996892|530311336|FG018|Expansion Stage 2|Death|2|||
147041478|NCT00996892|530311337|FG019|Expansion Stage 2|Death|0|||
147041479|NCT00996892|530311318|FG000|Expansion Stage 2|Physician Decision|0|||
147041480|NCT00996892|530311319|FG001|Expansion Stage 2|Physician Decision|0|||
147041481|NCT00996892|530311320|FG002|Expansion Stage 2|Physician Decision|0|||
147041482|NCT00996892|530311321|FG003|Expansion Stage 2|Physician Decision|0|||
147041483|NCT00996892|530311322|FG004|Expansion Stage 2|Physician Decision|0|||
147041484|NCT00996892|530311323|FG005|Expansion Stage 2|Physician Decision|0|||
147041485|NCT00996892|530311324|FG006|Expansion Stage 2|Physician Decision|0|||
147041486|NCT00996892|530311325|FG007|Expansion Stage 2|Physician Decision|0|||
147041487|NCT00996892|530311326|FG008|Expansion Stage 2|Physician Decision|0|||
147041488|NCT00996892|530311327|FG009|Expansion Stage 2|Physician Decision|0|||
147041489|NCT00996892|530311328|FG010|Expansion Stage 2|Physician Decision|0|||
147041490|NCT00996892|530311329|FG011|Expansion Stage 2|Physician Decision|0|||
147041491|NCT00996892|530311330|FG012|Expansion Stage 2|Physician Decision|0|||
147041492|NCT00996892|530311331|FG013|Expansion Stage 2|Physician Decision|0|||
147041493|NCT00996892|530311332|FG014|Expansion Stage 2|Physician Decision|0|||
147041494|NCT00996892|530311333|FG015|Expansion Stage 2|Physician Decision|0|||
147041495|NCT00996892|530311334|FG016|Expansion Stage 2|Physician Decision|0|||
147041496|NCT00996892|530311335|FG017|Expansion Stage 2|Physician Decision|0|||
147041497|NCT00996892|530311336|FG018|Expansion Stage 2|Physician Decision|1|||
147041498|NCT00996892|530311337|FG019|Expansion Stage 2|Physician Decision|0|||
147041499|NCT00996892|530311318|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
147041500|NCT00996892|530311319|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
147041501|NCT00996892|530311320|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
147041502|NCT00996892|530311321|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
147041503|NCT00996892|530311322|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
147041504|NCT00996892|530311323|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
147041505|NCT00996892|530311324|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
147041506|NCT00996892|530311325|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
147041507|NCT00996892|530311326|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
147041508|NCT00996892|530311327|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
147041509|NCT00996892|530311328|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
147041510|NCT00996892|530311329|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
147041511|NCT00996892|530311330|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
147041512|NCT00996892|530311331|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
147041513|NCT00996892|530311332|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
147041514|NCT00996892|530311333|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
147041515|NCT00996892|530311334|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
147041516|NCT00996892|530311335|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
147041517|NCT00996892|530311336|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
147041518|NCT00996892|530311337|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
147041519|NCT00996892|530311318|FG000|Expansion Stage 2|Disease Progression|0|||
147041520|NCT00996892|530311319|FG001|Expansion Stage 2|Disease Progression|0|||
147041521|NCT00996892|530311320|FG002|Expansion Stage 2|Disease Progression|0|||
147041522|NCT00996892|530311321|FG003|Expansion Stage 2|Disease Progression|0|||
147041523|NCT00996892|530311322|FG004|Expansion Stage 2|Disease Progression|0|||
147041524|NCT00996892|530311323|FG005|Expansion Stage 2|Disease Progression|0|||
147041525|NCT00996892|530311324|FG006|Expansion Stage 2|Disease Progression|0|||
147041526|NCT00996892|530311325|FG007|Expansion Stage 2|Disease Progression|0|||
147041527|NCT00996892|530311326|FG008|Expansion Stage 2|Disease Progression|0|||
147041528|NCT00996892|530311327|FG009|Expansion Stage 2|Disease Progression|0|||
147041529|NCT00996892|530311328|FG010|Expansion Stage 2|Disease Progression|0|||
147041530|NCT00996892|530311329|FG011|Expansion Stage 2|Disease Progression|0|||
147041531|NCT00996892|530311330|FG012|Expansion Stage 2|Disease Progression|0|||
147041532|NCT00996892|530311331|FG013|Expansion Stage 2|Disease Progression|0|||
147041533|NCT00996892|530311332|FG014|Expansion Stage 2|Disease Progression|0|||
147041534|NCT00996892|530311333|FG015|Expansion Stage 2|Disease Progression|0|||
147041535|NCT00996892|530311334|FG016|Expansion Stage 2|Disease Progression|0|||
147041536|NCT00996892|530311335|FG017|Expansion Stage 2|Disease Progression|0|||
147041537|NCT00996892|530311336|FG018|Expansion Stage 2|Disease Progression|28|||
147041538|NCT00996892|530311337|FG019|Expansion Stage 2|Disease Progression|0|||
147041539|NCT00996892|530311318|FG000|Expansion Stage 2A|Adverse Event|0|||
147041540|NCT00996892|530311319|FG001|Expansion Stage 2A|Adverse Event|0|||
147041541|NCT00996892|530311320|FG002|Expansion Stage 2A|Adverse Event|0|||
147041542|NCT00996892|530311321|FG003|Expansion Stage 2A|Adverse Event|0|||
147041543|NCT00996892|530311322|FG004|Expansion Stage 2A|Adverse Event|0|||
147041544|NCT00996892|530311323|FG005|Expansion Stage 2A|Adverse Event|0|||
147041545|NCT00996892|530311324|FG006|Expansion Stage 2A|Adverse Event|0|||
147041546|NCT00996892|530311325|FG007|Expansion Stage 2A|Adverse Event|0|||
147041547|NCT00996892|530311326|FG008|Expansion Stage 2A|Adverse Event|0|||
147041548|NCT00996892|530311327|FG009|Expansion Stage 2A|Adverse Event|0|||
147041549|NCT00996892|530311328|FG010|Expansion Stage 2A|Adverse Event|0|||
147041550|NCT00996892|530311329|FG011|Expansion Stage 2A|Adverse Event|0|||
147041551|NCT00996892|530311330|FG012|Expansion Stage 2A|Adverse Event|0|||
147041552|NCT00996892|530311331|FG013|Expansion Stage 2A|Adverse Event|0|||
147041553|NCT00996892|530311332|FG014|Expansion Stage 2A|Adverse Event|0|||
147041554|NCT00996892|530311333|FG015|Expansion Stage 2A|Adverse Event|0|||
147041555|NCT00996892|530311334|FG016|Expansion Stage 2A|Adverse Event|0|||
147041556|NCT00996892|530311335|FG017|Expansion Stage 2A|Adverse Event|0|||
147041557|NCT00996892|530311336|FG018|Expansion Stage 2A|Adverse Event|0|||
147041558|NCT00996892|530311337|FG019|Expansion Stage 2A|Adverse Event|8|||
147041559|NCT00996892|530311318|FG000|Expansion Stage 2A|Physician Decision|0|||
147041560|NCT00996892|530311319|FG001|Expansion Stage 2A|Physician Decision|0|||
147041561|NCT00996892|530311320|FG002|Expansion Stage 2A|Physician Decision|0|||
147041562|NCT00996892|530311321|FG003|Expansion Stage 2A|Physician Decision|0|||
147041563|NCT00996892|530311322|FG004|Expansion Stage 2A|Physician Decision|0|||
147041564|NCT00996892|530311323|FG005|Expansion Stage 2A|Physician Decision|0|||
147041565|NCT00996892|530311324|FG006|Expansion Stage 2A|Physician Decision|0|||
147041566|NCT00996892|530311325|FG007|Expansion Stage 2A|Physician Decision|0|||
147041567|NCT00996892|530311326|FG008|Expansion Stage 2A|Physician Decision|0|||
147041568|NCT00996892|530311327|FG009|Expansion Stage 2A|Physician Decision|0|||
147041569|NCT00996892|530311328|FG010|Expansion Stage 2A|Physician Decision|0|||
147041570|NCT00996892|530311329|FG011|Expansion Stage 2A|Physician Decision|0|||
147041571|NCT00996892|530311330|FG012|Expansion Stage 2A|Physician Decision|0|||
147041572|NCT00996892|530311331|FG013|Expansion Stage 2A|Physician Decision|0|||
147041573|NCT00996892|530311332|FG014|Expansion Stage 2A|Physician Decision|0|||
147041574|NCT00996892|530311333|FG015|Expansion Stage 2A|Physician Decision|0|||
147041575|NCT00996892|530311334|FG016|Expansion Stage 2A|Physician Decision|0|||
147041576|NCT00996892|530311335|FG017|Expansion Stage 2A|Physician Decision|0|||
147041577|NCT00996892|530311336|FG018|Expansion Stage 2A|Physician Decision|0|||
147041578|NCT00996892|530311337|FG019|Expansion Stage 2A|Physician Decision|2|||
147041579|NCT00996892|530311318|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
147041580|NCT00996892|530311319|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
147041581|NCT00996892|530311320|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
147041582|NCT00996892|530311321|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
147041583|NCT00996892|530311322|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
147041584|NCT00996892|530311323|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
147041585|NCT00996892|530311324|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
147041586|NCT00996892|530311325|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
147041587|NCT00996892|530311326|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
147041588|NCT00996892|530311327|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
147041589|NCT00996892|530311328|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
147041590|NCT00996892|530311329|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
147041591|NCT00996892|530311330|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
147041592|NCT00996892|530311331|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
147041593|NCT00996892|530311332|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
147041594|NCT00996892|530311333|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
147041595|NCT00996892|530311334|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
147041596|NCT00996892|530311335|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
147041597|NCT00996892|530311336|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
147041598|NCT00996892|530311337|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
147041599|NCT00996892|530311318|FG000|Expansion Stage 2A|Disease Progression|0|||
147041600|NCT00996892|530311319|FG001|Expansion Stage 2A|Disease Progression|0|||
147041601|NCT00996892|530311320|FG002|Expansion Stage 2A|Disease Progression|0|||
147041602|NCT00996892|530311321|FG003|Expansion Stage 2A|Disease Progression|0|||
147041603|NCT00996892|530311322|FG004|Expansion Stage 2A|Disease Progression|0|||
147041604|NCT00996892|530311323|FG005|Expansion Stage 2A|Disease Progression|0|||
147041605|NCT00996892|530311324|FG006|Expansion Stage 2A|Disease Progression|0|||
147041606|NCT00996892|530311325|FG007|Expansion Stage 2A|Disease Progression|0|||
147041607|NCT00996892|530311326|FG008|Expansion Stage 2A|Disease Progression|0|||
147041608|NCT00996892|530311327|FG009|Expansion Stage 2A|Disease Progression|0|||
147041609|NCT00996892|530311328|FG010|Expansion Stage 2A|Disease Progression|0|||
147041610|NCT00996892|530311329|FG011|Expansion Stage 2A|Disease Progression|0|||
147041611|NCT00996892|530311330|FG012|Expansion Stage 2A|Disease Progression|0|||
147041612|NCT00996892|530311331|FG013|Expansion Stage 2A|Disease Progression|0|||
147041613|NCT00996892|530311332|FG014|Expansion Stage 2A|Disease Progression|0|||
147041614|NCT00996892|530311333|FG015|Expansion Stage 2A|Disease Progression|0|||
147041615|NCT00996892|530311334|FG016|Expansion Stage 2A|Disease Progression|0|||
147041616|NCT00996892|530311335|FG017|Expansion Stage 2A|Disease Progression|0|||
147041617|NCT00996892|530311336|FG018|Expansion Stage 2A|Disease Progression|0|||
147041618|NCT00996892|530311337|FG019|Expansion Stage 2A|Disease Progression|31|||
147041619|NCT01653912|530311338|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
147041620|NCT01653912|530311339|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
147041621|NCT01653912|530311340|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
147041622|NCT01653912|530311341|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
147041623|NCT01653912|530311342|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
147041624|NCT01653912|530311343|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
147041625|NCT01653912|530311338|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
147041626|NCT01653912|530311339|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
147041627|NCT01653912|530311340|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
147041628|NCT01653912|530311341|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
147041629|NCT01653912|530311342|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
147041630|NCT01653912|530311343|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
147041631|NCT01653912|530311338|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
147041632|NCT01653912|530311339|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
147041633|NCT01653912|530311340|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
147041634|NCT01653912|530311341|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
147041635|NCT01653912|530311342|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
147041636|NCT01653912|530311343|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
147041637|NCT01653912|530311338|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
147041638|NCT01653912|530311339|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
147041639|NCT01653912|530311340|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
147041640|NCT01653912|530311341|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
147041641|NCT01653912|530311342|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
147041642|NCT01653912|530311343|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
147041643|NCT01653912|530311338|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
147041644|NCT01653912|530311339|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
147041645|NCT01653912|530311340|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
147041646|NCT01653912|530311341|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
147041647|NCT01653912|530311342|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
147041648|NCT01653912|530311343|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
147041649|NCT01653912|530311338|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
147041650|NCT01653912|530311339|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
147041651|NCT01653912|530311340|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
147041652|NCT01653912|530311341|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
147041653|NCT01653912|530311342|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
147041654|NCT01653912|530311343|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
147041655|NCT01653912|530311338|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
147041656|NCT01653912|530311339|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
147041657|NCT01653912|530311340|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
147041658|NCT01653912|530311341|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
147041659|NCT01653912|530311342|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
147041660|NCT01653912|530311343|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
147041661|NCT00708227|530311344|FG000|Overall Study|Physician Decision|0|||
147041662|NCT00708227|530311345|FG001|Overall Study|Physician Decision|3|||
147041663|NCT00708227|530311346|FG002|Overall Study|Physician Decision|1|||
147041664|NCT00708227|530311347|FG003|Overall Study|Physician Decision|2|||
147041665|NCT00708227|530311344|FG000|Overall Study|Withdrawal by Subject|1|||
147041666|NCT00708227|530311345|FG001|Overall Study|Withdrawal by Subject|2|||
147041667|NCT00708227|530311346|FG002|Overall Study|Withdrawal by Subject|0|||
147041668|NCT00708227|530311347|FG003|Overall Study|Withdrawal by Subject|1|||
147041669|NCT01987479|530311348|FG000|Overall Study|Protocol Violation|1|||
147041670|NCT01987479|530311348|FG000|Overall Study|Physician Decision|2|||
147041671|NCT01987479|530311348|FG000|Overall Study|Participant/legal guardian decision|1|||
147041672|NCT01987479|530311348|FG000|Overall Study|Other|5|||
147041673|NCT01987479|530311348|FG000|Overall Study|Lost to Follow-up|1|||
147041674|NCT01987479|530311348|FG000|Overall Study|Adverse Event|7|||
147041675|NCT04007991|530311349|FG000|Overall Study|Withdrawal by Subject|1|||
147041676|NCT04007991|530311350|FG001|Overall Study|Withdrawal by Subject|1|||
147041677|NCT04007991|530311349|FG000|Overall Study|Physician Decision|1|||
147041678|NCT04007991|530311350|FG001|Overall Study|Physician Decision|1|||
147041679|NCT04007991|530311349|FG000|Overall Study|Non-compliance with Study Drug|0|||
147041680|NCT04007991|530311350|FG001|Overall Study|Non-compliance with Study Drug|1|||
147041681|NCT04007991|530311349|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
147041682|NCT04007991|530311350|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
147041683|NCT04007991|530311349|FG000|Overall Study|Adverse event, non-fatal|5|||
147041684|NCT04007991|530311350|FG001|Overall Study|Adverse event, non-fatal|0|||
147041685|NCT04007991|530311349|FG000|Overall Study|Lost to Follow-up|2|||
147041686|NCT04007991|530311350|FG001|Overall Study|Lost to Follow-up|1|||
147041687|NCT05314816|530311351|FG000|Overall Study|Lost to Follow-up|5|||
147041688|NCT05314816|530311352|FG001|Overall Study|Lost to Follow-up|0|||
147041689|NCT05314816|530311353|FG002|Overall Study|Lost to Follow-up|1|||
147041690|NCT05314816|530311351|FG000|Overall Study|Protocol Violation|13|||
147041691|NCT05314816|530311352|FG001|Overall Study|Protocol Violation|8|||
147041692|NCT05314816|530311353|FG002|Overall Study|Protocol Violation|0|||
147041693|NCT00794339|530313751|FG000|Overall Study|Withdrawal by Subject|3|||
147041694|NCT00794339|530313751|FG000|Overall Study|Ineligible|4|||
147041695|NCT00794339|530313751|FG000|Overall Study|Tx prior to ATSM|3|||
147041696|NCT00794339|530313751|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
147041697|NCT00794339|530313751|FG000|Overall Study|Tx not per protocol|1|||
147041698|NCT01611857|530313752|FG000|Overall Study|Withdrawal by Subject|0|||
147041699|NCT01611857|530313753|FG001|Overall Study|Withdrawal by Subject|2|||
147041700|NCT02439970|530313754|FG000|Overall Study|Study Terminated|2|||
147041701|NCT02439970|530313755|FG001|Overall Study|Study Terminated|3|||
147041702|NCT02952586|530313758|FG000|Lead-In Phase (7 Days)|Death|0|||
147041703|NCT02952586|530313759|FG001|Lead-In Phase (7 Days)|Death|1|||
147041704|NCT02952586|530313758|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
147041705|NCT02952586|530313759|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
147041706|NCT02952586|530313758|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
147041707|NCT02952586|530313759|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
147041708|NCT02952586|530313758|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
147041709|NCT02952586|530313759|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
147041710|NCT02952586|530313758|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
147041711|NCT02952586|530313759|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
147041712|NCT02952586|530313758|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
147041713|NCT02952586|530313759|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
147041714|NCT02952586|530313758|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
147041715|NCT02952586|530313759|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
147041716|NCT02952586|530313758|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
147041717|NCT02952586|530313759|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
147041718|NCT02952586|530313758|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
147041719|NCT02952586|530313759|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
147041720|NCT02952586|530313758|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
147041721|NCT02952586|530313759|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
147041722|NCT02952586|530313758|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
147041723|NCT02952586|530313759|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
147041724|NCT02952586|530313758|FG000|CRT for Cisplatin (63 Days)|Death|3|||
147041725|NCT02952586|530313759|FG001|CRT for Cisplatin (63 Days)|Death|8|||
147041726|NCT02952586|530313758|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
147041727|NCT02952586|530313759|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
147041728|NCT02952586|530313758|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
147041729|NCT02952586|530313759|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
147041730|NCT02952586|530313758|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
147041731|NCT02952586|530313759|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
147041732|NCT02952586|530313758|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
147041733|NCT02952586|530313759|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
147041734|NCT02952586|530313758|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
147041735|NCT02952586|530313759|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
147041736|NCT02952586|530313758|FG000|CRT for Cisplatin (63 Days)|Other|1|||
147041737|NCT02952586|530313759|FG001|CRT for Cisplatin (63 Days)|Other|1|||
147041738|NCT02952586|530313758|FG000|CRT for IMRT (63 Days)|Death|5|||
147041739|NCT02952586|530313759|FG001|CRT for IMRT (63 Days)|Death|8|||
147041740|NCT02952586|530313758|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
147041741|NCT02952586|530313759|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
147041742|NCT02952586|530313758|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
147041743|NCT02952586|530313759|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
147041744|NCT02952586|530313758|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
147041745|NCT02952586|530313759|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
147041746|NCT02952586|530313758|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
147041747|NCT02952586|530313759|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
147041748|NCT02952586|530313758|FG000|CRT for IMRT (63 Days)|Other|1|||
147041749|NCT02952586|530313759|FG001|CRT for IMRT (63 Days)|Other|0|||
147041750|NCT02952586|530313758|FG000|Maintenance Phase (12 Months)|Death|17|||
147041751|NCT02952586|530313759|FG001|Maintenance Phase (12 Months)|Death|11|||
147041752|NCT02952586|530313758|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
147041753|NCT02952586|530313759|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
147041754|NCT02952586|530313758|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
147041755|NCT02952586|530313759|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
147041756|NCT02952586|530313758|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
147041757|NCT02952586|530313759|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
147041758|NCT02952586|530313758|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
147041759|NCT02952586|530313759|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
147041760|NCT02952586|530313758|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
147041761|NCT02952586|530313759|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
147041762|NCT02952586|530313758|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
147041763|NCT02952586|530313759|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
147041764|NCT02952586|530313758|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
147041765|NCT02952586|530313759|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
147041766|NCT02952586|530313758|FG000|Maintenance Phase (12 Months)|Other|2|||
147041767|NCT02952586|530313759|FG001|Maintenance Phase (12 Months)|Other|1|||
147041768|NCT02952586|530313758|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
147041769|NCT02952586|530313759|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
147041770|NCT02952586|530313758|FG000|Follow-Up Phase (90 Days)|Death|12|||
147041771|NCT02952586|530313759|FG001|Follow-Up Phase (90 Days)|Death|10|||
147041772|NCT02952586|530313758|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
147041773|NCT02952586|530313759|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
147041774|NCT02952586|530313758|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
147041775|NCT02952586|530313759|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
147041776|NCT02952586|530313758|FG000|Follow-Up Phase (90 Days)|Other|7|||
147041777|NCT02952586|530313759|FG001|Follow-Up Phase (90 Days)|Other|5|||
147041778|NCT02952586|530313758|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
147041779|NCT02952586|530313759|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
147041780|NCT02952586|530313758|FG000|LT Follow-up (up to 45 Months)|Death|51|||
147041781|NCT02952586|530313759|FG001|LT Follow-up (up to 45 Months)|Death|31|||
147041782|NCT02952586|530313758|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
147041783|NCT02952586|530313759|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
147041784|NCT02952586|530313758|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
147041785|NCT02952586|530313759|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
147041786|NCT02952586|530313758|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
147041787|NCT02952586|530313759|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
147041788|NCT00492778|530313762|FG000|Overall Study|Ineligible by Pathology Review|8|||
147041789|NCT00492778|530313763|FG001|Overall Study|Ineligible by Pathology Review|1|||
147041790|NCT04414618|530313766|FG000|Overall Study|Death|3|||
147041791|NCT04414618|530313767|FG001|Overall Study|Death|3|||
147041792|NCT04414618|530313766|FG000|Overall Study|Withdrawal by Subject|2|||
147041793|NCT04414618|530313767|FG001|Overall Study|Withdrawal by Subject|1|||
147041794|NCT04414618|530313766|FG000|Overall Study|Lost to Follow-up|2|||
147041795|NCT04414618|530313767|FG001|Overall Study|Lost to Follow-up|3|||
147041796|NCT04414618|530313766|FG000|Overall Study|Physician Decision|1|||
147041797|NCT04414618|530313767|FG001|Overall Study|Physician Decision|0|||
147041798|NCT00362336|530313768|FG000|Overall Study|Serious Adverse Event|1|||
147041799|NCT00362336|530313769|FG001|Overall Study|Serious Adverse Event|0|||
147041800|NCT00362336|530313770|FG002|Overall Study|Serious Adverse Event|1|||
147041801|NCT00362336|530313768|FG000|Overall Study|Protocol Violation|0|||
147041802|NCT00362336|530313769|FG001|Overall Study|Protocol Violation|0|||
147041803|NCT00362336|530313770|FG002|Overall Study|Protocol Violation|1|||
147041804|NCT00362336|530313768|FG000|Overall Study|Lost to Follow-up|6|||
147041805|NCT00362336|530313769|FG001|Overall Study|Lost to Follow-up|4|||
147041806|NCT00362336|530313770|FG002|Overall Study|Lost to Follow-up|0|||
147041807|NCT00362336|530313768|FG000|Overall Study|Withdrawal by Subject|3|||
147041808|NCT00362336|530313769|FG001|Overall Study|Withdrawal by Subject|3|||
147041809|NCT00362336|530313770|FG002|Overall Study|Withdrawal by Subject|1|||
147041810|NCT00658879|530313771|FG000|Overall Study|Protocol Violation|1|||
147041811|NCT02640690|530313772|FG000|Overall Study|Lost to Follow-up|7|||
147041812|NCT02640690|530313773|FG001|Overall Study|Lost to Follow-up|7|||
147041813|NCT02640690|530313772|FG000|Overall Study|Withdrawal by Subject|16|||
147041814|NCT02640690|530313773|FG001|Overall Study|Withdrawal by Subject|20|||
147041815|NCT02640690|530313772|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
147041816|NCT02640690|530313773|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
147041817|NCT01118975|530313774|FG000|Overall Study|Adverse Event|0|||
147041818|NCT01118975|530313775|FG001|Overall Study|Adverse Event|1|||
147041819|NCT01645787|530313776|FG000|Washout (2 Weeks)|Adverse Event|1|||
147041820|NCT01645787|530313777|FG001|Washout (2 Weeks)|Adverse Event|0|||
147041821|NCT04315506|530313782|FG000|Overall Study|Lost to Follow-up|74|||
147041822|NCT04315506|530313783|FG001|Overall Study|Lost to Follow-up|82|||
147041823|NCT04315506|530313782|FG000|Overall Study|Withdrawal by Subject|8|||
147041824|NCT04315506|530313783|FG001|Overall Study|Withdrawal by Subject|8|||
147041825|NCT04315506|530313782|FG000|Overall Study|Physician Decision|0|||
147041826|NCT04315506|530313783|FG001|Overall Study|Physician Decision|1|||
147041827|NCT02661217|530313784|FG000|Overall Study|Physician Decision|12|||
147041828|NCT02661217|530313785|FG001|Overall Study|Physician Decision|15|||
147041829|NCT02661217|530313784|FG000|Overall Study|Lost to Follow-up|1|||
147041830|NCT02661217|530313785|FG001|Overall Study|Lost to Follow-up|4|||
147041831|NCT02661217|530313784|FG000|Overall Study|Protocol Deviation|0|||
147041832|NCT02661217|530313785|FG001|Overall Study|Protocol Deviation|4|||
147041833|NCT02661217|530313784|FG000|Overall Study|Non-compliance with study treatment|5|||
147041834|NCT02661217|530313785|FG001|Overall Study|Non-compliance with study treatment|5|||
147041835|NCT02661217|530313784|FG000|Overall Study|Death|21|||
147041836|NCT02661217|530313785|FG001|Overall Study|Death|15|||
147041837|NCT02661217|530313784|FG000|Overall Study|Adverse Event|10|||
147041838|NCT02661217|530313785|FG001|Overall Study|Adverse Event|8|||
147041839|NCT02661217|530313784|FG000|Overall Study|Withdrawal by Subject|15|||
147041840|NCT02661217|530313785|FG001|Overall Study|Withdrawal by Subject|19|||
147041841|NCT02661217|530313784|FG000|Overall Study|Did not enter follow-up epoch|7|||
147041842|NCT02661217|530313785|FG001|Overall Study|Did not enter follow-up epoch|10|||
147041843|NCT02661217|530313784|FG000|Overall Study|Death - no study drug received|1|||
147041844|NCT02661217|530313785|FG001|Overall Study|Death - no study drug received|2|||
147041845|NCT02661217|530313784|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
147041846|NCT02661217|530313785|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
147041847|NCT01098474|530313803|FG000|Active Phase|Other|0|||
147041848|NCT01098474|530313804|FG001|Active Phase|Other|0|||
147041849|NCT01098474|530313805|FG002|Active Phase|Other|3|||
147041850|NCT01098474|530313806|FG003|Active Phase|Other|0|||
147041851|NCT01098474|530313807|FG004|Active Phase|Other|0|||
147041852|NCT01098474|530313808|FG005|Active Phase|Other|0|||
147041853|NCT01098474|530313803|FG000|Active Phase|Withdrawal by Subject|1|||
147041854|NCT01098474|530313804|FG001|Active Phase|Withdrawal by Subject|1|||
147041855|NCT01098474|530313805|FG002|Active Phase|Withdrawal by Subject|2|||
147041856|NCT01098474|530313806|FG003|Active Phase|Withdrawal by Subject|0|||
147041857|NCT01098474|530313807|FG004|Active Phase|Withdrawal by Subject|0|||
147041858|NCT01098474|530313808|FG005|Active Phase|Withdrawal by Subject|0|||
147041859|NCT01098474|530313803|FG000|Active Phase|Lost to Follow-up|1|||
147041860|NCT01098474|530313804|FG001|Active Phase|Lost to Follow-up|0|||
147041861|NCT01098474|530313805|FG002|Active Phase|Lost to Follow-up|0|||
147041862|NCT01098474|530313806|FG003|Active Phase|Lost to Follow-up|0|||
147041863|NCT01098474|530313807|FG004|Active Phase|Lost to Follow-up|0|||
147041864|NCT01098474|530313808|FG005|Active Phase|Lost to Follow-up|0|||
147041865|NCT01098474|530313803|FG000|Follow Up Phase|Travelled out of study area|0|||
147041866|NCT01098474|530313804|FG001|Follow Up Phase|Travelled out of study area|0|||
147041867|NCT01098474|530313805|FG002|Follow Up Phase|Travelled out of study area|0|||
147041868|NCT01098474|530313806|FG003|Follow Up Phase|Travelled out of study area|0|||
147041869|NCT01098474|530313807|FG004|Follow Up Phase|Travelled out of study area|1|||
147041870|NCT01098474|530313808|FG005|Follow Up Phase|Travelled out of study area|0|||
147041871|NCT01098474|530313803|FG000|Follow Up Phase|Other|0|||
147041872|NCT01098474|530313804|FG001|Follow Up Phase|Other|0|||
147041873|NCT01098474|530313805|FG002|Follow Up Phase|Other|0|||
147041874|NCT01098474|530313806|FG003|Follow Up Phase|Other|0|||
147041875|NCT01098474|530313807|FG004|Follow Up Phase|Other|0|||
147041876|NCT01098474|530313808|FG005|Follow Up Phase|Other|4|||
147041877|NCT01098474|530313803|FG000|Follow Up Phase|Withdrawal by Subject|0|||
147041878|NCT01098474|530313804|FG001|Follow Up Phase|Withdrawal by Subject|0|||
147041879|NCT01098474|530313805|FG002|Follow Up Phase|Withdrawal by Subject|0|||
147041880|NCT01098474|530313806|FG003|Follow Up Phase|Withdrawal by Subject|2|||
147041881|NCT01098474|530313807|FG004|Follow Up Phase|Withdrawal by Subject|0|||
147041882|NCT01098474|530313808|FG005|Follow Up Phase|Withdrawal by Subject|1|||
147041883|NCT01098474|530313803|FG000|Follow Up Phase|Lost to Follow-up|0|||
147041884|NCT01098474|530313804|FG001|Follow Up Phase|Lost to Follow-up|0|||
147041885|NCT01098474|530313805|FG002|Follow Up Phase|Lost to Follow-up|0|||
147041886|NCT01098474|530313806|FG003|Follow Up Phase|Lost to Follow-up|0|||
147041887|NCT01098474|530313807|FG004|Follow Up Phase|Lost to Follow-up|1|||
147041888|NCT01098474|530313808|FG005|Follow Up Phase|Lost to Follow-up|0|||
147041889|NCT00626561|530313811|FG000|Overall Study|Withdrawal by Subject|2|||
147041890|NCT00626561|530313811|FG000|Overall Study|Disease Progression|2|||
147041891|NCT03993379|530313812|FG000|Overall Study|The study was terminated early due to business decision.|0|||
147041892|NCT03993379|530313813|FG001|Overall Study|The study was terminated early due to business decision.|2|||
147041893|NCT03993379|530313814|FG002|Overall Study|The study was terminated early due to business decision.|0|||
147041894|NCT03993379|530313815|FG003|Overall Study|The study was terminated early due to business decision.|0|||
147041895|NCT03993379|530313812|FG000|Overall Study|Withdrawal by Subject|0|||
147041896|NCT03993379|530313813|FG001|Overall Study|Withdrawal by Subject|1|||
147041897|NCT03993379|530313814|FG002|Overall Study|Withdrawal by Subject|0|||
147041898|NCT03993379|530313815|FG003|Overall Study|Withdrawal by Subject|0|||
147041899|NCT02604407|530313816|FG000|Overall Study|Adverse Event|0|||
147041900|NCT02604407|530313817|FG001|Overall Study|Adverse Event|7|||
147041901|NCT02604407|530313818|FG002|Overall Study|Adverse Event|5|||
147041902|NCT02604407|530313816|FG000|Overall Study|Protocol Violation|2|||
147041903|NCT02604407|530313817|FG001|Overall Study|Protocol Violation|0|||
147041904|NCT02604407|530313818|FG002|Overall Study|Protocol Violation|0|||
147041905|NCT02604407|530313816|FG000|Overall Study|Withdrawal by Subject|3|||
147041906|NCT02604407|530313817|FG001|Overall Study|Withdrawal by Subject|3|||
147041907|NCT02604407|530313818|FG002|Overall Study|Withdrawal by Subject|5|||
147041908|NCT02604407|530313816|FG000|Overall Study|Lost to Follow-up|2|||
147041909|NCT02604407|530313817|FG001|Overall Study|Lost to Follow-up|1|||
147041910|NCT02604407|530313818|FG002|Overall Study|Lost to Follow-up|2|||
147041911|NCT02604407|530313816|FG000|Overall Study|Lack of Efficacy|1|||
147041912|NCT02604407|530313817|FG001|Overall Study|Lack of Efficacy|0|||
147041913|NCT02604407|530313818|FG002|Overall Study|Lack of Efficacy|0|||
146849837|NCT03412747|529618911|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
147041914|NCT02604407|530313816|FG000|Overall Study|Other|3|||
147041915|NCT02604407|530313817|FG001|Overall Study|Other|1|||
147041916|NCT02604407|530313818|FG002|Overall Study|Other|4|||
147041917|NCT00606632|530313819|FG000|Overall Study|Withdrawal by Subject|13|||
147041918|NCT00606632|530313819|FG000|Overall Study|Miscellaneous reasons|9|||
147041919|NCT00711880|530313824|FG000|Overall Study|Adverse Event|11|||
147041920|NCT00711880|530313825|FG001|Overall Study|Adverse Event|2|||
146849838|NCT03412747|529618912|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
147041921|NCT00711880|530313824|FG000|Overall Study|Patient non-compliance|1|||
147041922|NCT00711880|530313825|FG001|Overall Study|Patient non-compliance|0|||
147041923|NCT00711880|530313824|FG000|Overall Study|Lack of Efficacy|1|||
147041924|NCT00711880|530313825|FG001|Overall Study|Lack of Efficacy|5|||
147041925|NCT00704132|530313828|FG000|Overall Study|Clinical Adverse Experience|1|||
147041926|NCT00704132|530313829|FG001|Overall Study|Clinical Adverse Experience|0|||
146849839|NCT03412747|529618913|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
146849840|NCT03412747|529618911|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
146849841|NCT03412747|529618912|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
146849842|NCT03412747|529618913|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
147041927|NCT00704132|530313828|FG000|Overall Study|Lack of Efficacy|0|||
147041928|NCT00704132|530313829|FG001|Overall Study|Lack of Efficacy|1|||
147041929|NCT00704132|530313828|FG000|Overall Study|Withdrawal by Subject|0|||
147041930|NCT00704132|530313829|FG001|Overall Study|Withdrawal by Subject|1|||
147041931|NCT03908437|530313830|FG000|Overall Study|Death|0|||
147041932|NCT03908437|530313831|FG001|Overall Study|Death|1|||
147041933|NCT03908437|530313830|FG000|Overall Study|Lost to Follow-up|31|||
147041934|NCT03908437|530313831|FG001|Overall Study|Lost to Follow-up|24|||
147041935|NCT00442962|530313832|FG000|Overall Study|Pregnancy|1|||
147041936|NCT00442962|530313832|FG000|Overall Study|Lost to Follow-up|7|||
147041937|NCT04238650|530313833|FG000|Overall Study|Withdrawal by Subject|0|||
147041938|NCT04238650|530313834|FG001|Overall Study|Withdrawal by Subject|1|||
147041939|NCT03633825|530313835|FG000|Enrollment|Did not post on network|5066|||
147041940|NCT03633825|530313836|FG001|Enrollment|Did not post on network|5080|||
147041941|NCT03633825|530313835|FG000|Enrollment|Post not classified as crisis|13967|||
147041942|NCT03633825|530313836|FG001|Enrollment|Post not classified as crisis|13757|||
147041943|NCT03633825|530313835|FG000|Follow up|Lost to Follow-up|478|||
147041944|NCT03633825|530313836|FG001|Follow up|Lost to Follow-up|450|||
147041945|NCT03348163|530313837|FG000|Overall Study|Withdrawal by Subject|2|||
147041946|NCT03348163|530313838|FG001|Overall Study|Withdrawal by Subject|0|||
147041947|NCT02756208|530313839|FG000|Overall Study|Withdrawal by Subject|1|||
147041948|NCT02756208|530313840|FG001|Overall Study|Withdrawal by Subject|0|||
147041949|NCT02756208|530313841|FG002|Overall Study|Withdrawal by Subject|1|||
147041950|NCT02756208|530313842|FG003|Overall Study|Withdrawal by Subject|3|||
147041951|NCT02756208|530313839|FG000|Overall Study|Lost to Follow-up|3|||
147041952|NCT02756208|530313840|FG001|Overall Study|Lost to Follow-up|1|||
147041953|NCT02756208|530313841|FG002|Overall Study|Lost to Follow-up|1|||
147041954|NCT02756208|530313842|FG003|Overall Study|Lost to Follow-up|1|||
147041955|NCT02756208|530313839|FG000|Overall Study|Physician Decision|1|||
147041956|NCT02756208|530313840|FG001|Overall Study|Physician Decision|0|||
147041957|NCT02756208|530313841|FG002|Overall Study|Physician Decision|0|||
147041958|NCT02756208|530313842|FG003|Overall Study|Physician Decision|0|||
147041959|NCT02756208|530313839|FG000|Overall Study|Protocol Violation|0|||
147041960|NCT02756208|530313840|FG001|Overall Study|Protocol Violation|1|||
147041961|NCT02756208|530313841|FG002|Overall Study|Protocol Violation|0|||
147041962|NCT02756208|530313842|FG003|Overall Study|Protocol Violation|0|||
147041963|NCT02585778|530313843|FG000|Overall Study|Adverse Event|17|||
147041964|NCT02585778|530313844|FG001|Overall Study|Adverse Event|4|||
147041965|NCT02585778|530313843|FG000|Overall Study|Participant did not wish to continue|9|||
147041966|NCT02585778|530313844|FG001|Overall Study|Participant did not wish to continue|4|||
147041967|NCT02585778|530313843|FG000|Overall Study|Poor compliance to study protocol|0|||
147041968|NCT02585778|530313844|FG001|Overall Study|Poor compliance to study protocol|2|||
147041969|NCT02585778|530313843|FG000|Overall Study|Death|0|||
147041970|NCT02585778|530313844|FG001|Overall Study|Death|1|||
147041971|NCT02585778|530313843|FG000|Overall Study|Randomized but not treated|1|||
146849843|NCT03412747|529618911|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
146849844|NCT03412747|529618912|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
147041972|NCT02585778|530313844|FG001|Overall Study|Randomized but not treated|2|||
147041973|NCT02585778|530313843|FG000|Overall Study|Other than specified above|6|||
147041974|NCT02585778|530313844|FG001|Overall Study|Other than specified above|2|||
147041975|NCT04841577|530313845|FG000|Overall Study|Adverse Event|5|||
147041976|NCT04841577|530313846|FG001|Overall Study|Adverse Event|10|||
147041977|NCT04841577|530313845|FG000|Overall Study|Lost to Follow-up|8|||
147041978|NCT04841577|530313846|FG001|Overall Study|Lost to Follow-up|7|||
147041979|NCT04841577|530313845|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
147041980|NCT04841577|530313846|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
147041981|NCT04841577|530313845|FG000|Overall Study|Other|0|||
147041982|NCT04841577|530313846|FG001|Overall Study|Other|1|||
147041983|NCT00356525|530313852|FG000|Overall Study|Progressive Disease|8|||
147041984|NCT00356525|530313853|FG001|Overall Study|Progressive Disease|5|||
147041985|NCT00356525|530313854|FG002|Overall Study|Progressive Disease|4|||
147041986|NCT00356525|530313855|FG003|Overall Study|Progressive Disease|2|||
147041987|NCT00356525|530313852|FG000|Overall Study|Adverse Event|1|||
147041988|NCT00356525|530313853|FG001|Overall Study|Adverse Event|3|||
147041989|NCT00356525|530313854|FG002|Overall Study|Adverse Event|1|||
147041990|NCT00356525|530313855|FG003|Overall Study|Adverse Event|1|||
147041991|NCT00356525|530313852|FG000|Overall Study|Lost to Follow-up|1|||
147041992|NCT00356525|530313853|FG001|Overall Study|Lost to Follow-up|0|||
147041993|NCT00356525|530313854|FG002|Overall Study|Lost to Follow-up|0|||
147041994|NCT00356525|530313855|FG003|Overall Study|Lost to Follow-up|0|||
147041995|NCT00356525|530313852|FG000|Overall Study|Physician Decision|2|||
147041996|NCT00356525|530313853|FG001|Overall Study|Physician Decision|2|||
147041997|NCT00356525|530313854|FG002|Overall Study|Physician Decision|2|||
147041998|NCT00356525|530313855|FG003|Overall Study|Physician Decision|1|||
147041999|NCT00356525|530313852|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
147042000|NCT00356525|530313853|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
147042001|NCT00356525|530313854|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
147042002|NCT00356525|530313855|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
147042003|NCT00356525|530313852|FG000|Overall Study|Withdrawal by Subject|1|||
147042004|NCT00356525|530313853|FG001|Overall Study|Withdrawal by Subject|1|||
147042005|NCT00356525|530313854|FG002|Overall Study|Withdrawal by Subject|0|||
147042006|NCT00356525|530313855|FG003|Overall Study|Withdrawal by Subject|3|||
147042007|NCT00356525|530313852|FG000|Overall Study|Death|0|||
147042008|NCT00356525|530313853|FG001|Overall Study|Death|0|||
147042009|NCT00356525|530313854|FG002|Overall Study|Death|0|||
147042010|NCT00356525|530313855|FG003|Overall Study|Death|1|||
147042011|NCT00356525|530313852|FG000|Overall Study|Sponsor Decision|0|||
147042012|NCT00356525|530313853|FG001|Overall Study|Sponsor Decision|0|||
147042013|NCT00356525|530313854|FG002|Overall Study|Sponsor Decision|0|||
147042014|NCT00356525|530313855|FG003|Overall Study|Sponsor Decision|1|||
147042015|NCT00652340|530313856|FG000|Overall Study|Had not progressed.|4|||
147042016|NCT00652340|530313857|FG001|Overall Study|Had not progressed.|3|||
147042017|NCT00214383|530313860|FG000|Overall Study|Lost to Follow-up|16|||
147042018|NCT00214383|530313861|FG001|Overall Study|Lost to Follow-up|26|||
147042019|NCT00879411|530313862|FG000|Overall Study|lost to follow-up (non-AE)|162|||
147042020|NCT01038297|530313863|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
147042021|NCT01038297|530313864|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
147042022|NCT01038297|530313865|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
147042023|NCT01685840|530313874|FG000|Overall Study|Death|77|||
147042024|NCT01685840|530313875|FG001|Overall Study|Death|66|||
147042025|NCT01685840|530313874|FG000|Overall Study|Lost to Follow-up|27|||
147042026|NCT01685840|530313875|FG001|Overall Study|Lost to Follow-up|25|||
147042027|NCT01685840|530313874|FG000|Overall Study|Physician Decision|3|||
147042028|NCT01685840|530313875|FG001|Overall Study|Physician Decision|7|||
147042029|NCT01685840|530313874|FG000|Overall Study|Withdrawal by Subject|14|||
147042030|NCT01685840|530313875|FG001|Overall Study|Withdrawal by Subject|17|||
147042031|NCT01685840|530313874|FG000|Overall Study|Futility|197|||
147042032|NCT01685840|530313875|FG001|Overall Study|Futility|200|||
147042033|NCT01685840|530313874|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
147042034|NCT01685840|530313875|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
147042035|NCT00710866|530313876|FG000|Overall Study|Protocol Violation|5|||
147042036|NCT00710866|530313877|FG001|Overall Study|Protocol Violation|4|||
147042037|NCT00710866|530313876|FG000|Overall Study|Withdrawal by Subject|2|||
147042038|NCT00710866|530313877|FG001|Overall Study|Withdrawal by Subject|1|||
147042039|NCT00710866|530313876|FG000|Overall Study|Lost to Follow-up|1|||
147042040|NCT00710866|530313877|FG001|Overall Study|Lost to Follow-up|0|||
147042041|NCT00710866|530313876|FG000|Overall Study|Failed to meet eligibility|1|||
147042042|NCT00710866|530313877|FG001|Overall Study|Failed to meet eligibility|1|||
147042043|NCT01128543|530313884|FG000|Overall Study|Withdrawal by Subject|3|||
147042044|NCT01128543|530313884|FG000|Overall Study|Protocol Violation|1|||
147042045|NCT02676765|530313885|FG000|Overall Study|Lost to Follow-up|0|||
147042046|NCT02676765|530313886|FG001|Overall Study|Lost to Follow-up|1|||
147042047|NCT02374346|530313887|FG000|Overall Study|operated or discharged during weekend|48|||
147042048|NCT04487067|530313891|FG000|Overall Study|Adverse Event|3|||
147042049|NCT04487067|530313891|FG000|Overall Study|Death Other Than Progressive Disease|60|||
147042050|NCT04487067|530313891|FG000|Overall Study|Death Due To Progressive Disease|40|||
147042051|NCT04487067|530313891|FG000|Overall Study|Lost to Follow-up|3|||
147042052|NCT04487067|530313891|FG000|Overall Study|Progressive Disease|1|||
147042053|NCT04487067|530313891|FG000|Overall Study|Protocol Violation|3|||
147042054|NCT04487067|530313891|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
147042055|NCT04487067|530313891|FG000|Overall Study|Withdrawal by Subject|15|||
147042056|NCT00246324|530313892|FG000|Overall Study|Withdrawal by Subject|1|||
147042057|NCT00299130|530313893|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
147042058|NCT00299130|530313894|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
147042059|NCT00299130|530313895|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
147042060|NCT00299130|530313893|FG000|Treatment Period (up to 5 Years)|Death|1|||
147042061|NCT00299130|530313894|FG001|Treatment Period (up to 5 Years)|Death|3|||
147042062|NCT00299130|530313895|FG002|Treatment Period (up to 5 Years)|Death|1|||
147042063|NCT00299130|530313893|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
147042064|NCT00299130|530313894|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
147042065|NCT00299130|530313895|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
147042066|NCT00299130|530313893|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
147042067|NCT00299130|530313894|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
147042068|NCT00299130|530313895|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
147042069|NCT00299130|530313893|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
147042070|NCT00299130|530313894|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
147042071|NCT00299130|530313895|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
147042072|NCT00299130|530313893|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
147042073|NCT00299130|530313894|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
147042074|NCT00299130|530313895|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
147042075|NCT00299130|530313893|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
147042076|NCT00299130|530313894|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
147042077|NCT00299130|530313895|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
147042078|NCT00299130|530313893|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
147042079|NCT00299130|530313894|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
147042080|NCT00299130|530313895|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
147042081|NCT00299130|530313893|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
147042082|NCT00299130|530313894|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
147042083|NCT00299130|530313895|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
147042084|NCT00299130|530313893|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
147042085|NCT00299130|530313894|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
147042086|NCT00299130|530313895|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
147042087|NCT00299130|530313893|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
147042088|NCT00299130|530313894|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
147042089|NCT00299130|530313895|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
147042090|NCT00299130|530313893|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
147042091|NCT00299130|530313894|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
147042092|NCT00299130|530313895|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
147042093|NCT00299130|530313893|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
147042094|NCT00299130|530313894|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
147042095|NCT00299130|530313895|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
147042096|NCT00299130|530313893|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
147042097|NCT00299130|530313894|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
147042098|NCT00299130|530313895|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
147042099|NCT00299130|530313893|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
147042100|NCT00299130|530313894|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
147042101|NCT00299130|530313895|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
147042102|NCT00299130|530313893|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
147042103|NCT00299130|530313894|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
147042104|NCT00299130|530313895|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
147042105|NCT00299130|530313893|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
147042106|NCT00299130|530313894|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
147042107|NCT00299130|530313895|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
147042108|NCT00345631|530313896|FG000|Overall Study|Withdrawal by Subject|1|||
147042109|NCT00345631|530313897|FG001|Overall Study|Withdrawal by Subject|0|||
147042110|NCT00345631|530313898|FG002|Overall Study|Withdrawal by Subject|1|||
147042111|NCT00345631|530313896|FG000|Overall Study|Adverse Event|0|||
147042112|NCT00345631|530313897|FG001|Overall Study|Adverse Event|1|||
147042113|NCT00345631|530313898|FG002|Overall Study|Adverse Event|0|||
147042114|NCT00345631|530313896|FG000|Overall Study|Lost to Follow-up|3|||
147042115|NCT00345631|530313897|FG001|Overall Study|Lost to Follow-up|7|||
147042116|NCT00345631|530313898|FG002|Overall Study|Lost to Follow-up|4|||
147042117|NCT00345631|530313896|FG000|Overall Study|Other reasons|0|||
147042118|NCT00345631|530313897|FG001|Overall Study|Other reasons|0|||
147042119|NCT00345631|530313898|FG002|Overall Study|Other reasons|1|||
147042120|NCT01589497|530313901|FG000|Overall Study|Withdrawal by Subject|0|||
147042121|NCT01589497|530313902|FG001|Overall Study|Withdrawal by Subject|1|||
147042122|NCT01589497|530313903|FG002|Overall Study|Withdrawal by Subject|0|||
147042123|NCT01589497|530313904|FG003|Overall Study|Withdrawal by Subject|1|||
147042124|NCT01589497|530313901|FG000|Overall Study|Death|1|||
147042125|NCT01589497|530313902|FG001|Overall Study|Death|0|||
146849845|NCT03412747|529618913|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
147042126|NCT01589497|530313903|FG002|Overall Study|Death|0|||
147042127|NCT01589497|530313904|FG003|Overall Study|Death|0|||
147042128|NCT01589497|530313901|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
146849846|NCT03412747|529618911|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
146849847|NCT03412747|529618912|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
147042129|NCT01589497|530313902|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
147042130|NCT01589497|530313903|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
147042131|NCT01589497|530313904|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
147042132|NCT02516553|530313905|FG000|Overall Study|Progressive disease|2|||
147042133|NCT02516553|530313906|FG001|Overall Study|Progressive disease|2|||
147042134|NCT02516553|530313907|FG002|Overall Study|Progressive disease|3|||
147042135|NCT02516553|530313908|FG003|Overall Study|Progressive disease|5|||
147042136|NCT02516553|530313909|FG004|Overall Study|Progressive disease|3|||
147042137|NCT02516553|530313910|FG005|Overall Study|Progressive disease|0|||
147042138|NCT02516553|530313911|FG006|Overall Study|Progressive disease|5|||
147042139|NCT02516553|530313912|FG007|Overall Study|Progressive disease|5|||
147042140|NCT02516553|530313913|FG008|Overall Study|Progressive disease|11|||
147042141|NCT02516553|530313914|FG009|Overall Study|Progressive disease|3|||
147042142|NCT02516553|530313915|FG010|Overall Study|Progressive disease|10|||
147042143|NCT02516553|530313916|FG011|Overall Study|Progressive disease|8|||
147042144|NCT02516553|530313917|FG012|Overall Study|Progressive disease|8|||
147042145|NCT02516553|530313918|FG013|Overall Study|Progressive disease|2|||
147042146|NCT02516553|530313919|FG014|Overall Study|Progressive disease|2|||
147042147|NCT02516553|530313920|FG015|Overall Study|Progressive disease|2|||
147042148|NCT02516553|530313921|FG016|Overall Study|Progressive disease|1|||
147042149|NCT02516553|530313922|FG017|Overall Study|Progressive disease|9|||
147042150|NCT02516553|530313923|FG018|Overall Study|Progressive disease|12|||
147042151|NCT02516553|530313924|FG019|Overall Study|Progressive disease|7|||
147042152|NCT02516553|530313925|FG020|Overall Study|Progressive disease|16|||
147042153|NCT02516553|530313926|FG021|Overall Study|Progressive disease|18|||
147042154|NCT02516553|530313905|FG000|Overall Study|Dose limiting toxicity|0|||
147042155|NCT02516553|530313906|FG001|Overall Study|Dose limiting toxicity|0|||
147042156|NCT02516553|530313907|FG002|Overall Study|Dose limiting toxicity|0|||
147042157|NCT02516553|530313908|FG003|Overall Study|Dose limiting toxicity|0|||
147042158|NCT02516553|530313909|FG004|Overall Study|Dose limiting toxicity|3|||
147042159|NCT02516553|530313910|FG005|Overall Study|Dose limiting toxicity|1|||
147042160|NCT02516553|530313911|FG006|Overall Study|Dose limiting toxicity|1|||
147042161|NCT02516553|530313912|FG007|Overall Study|Dose limiting toxicity|0|||
147042162|NCT02516553|530313913|FG008|Overall Study|Dose limiting toxicity|1|||
147042163|NCT02516553|530313914|FG009|Overall Study|Dose limiting toxicity|0|||
147042164|NCT02516553|530313915|FG010|Overall Study|Dose limiting toxicity|0|||
147042165|NCT02516553|530313916|FG011|Overall Study|Dose limiting toxicity|1|||
147042166|NCT02516553|530313917|FG012|Overall Study|Dose limiting toxicity|0|||
147042167|NCT02516553|530313918|FG013|Overall Study|Dose limiting toxicity|1|||
147042168|NCT02516553|530313919|FG014|Overall Study|Dose limiting toxicity|0|||
147042169|NCT02516553|530313920|FG015|Overall Study|Dose limiting toxicity|0|||
147042170|NCT02516553|530313921|FG016|Overall Study|Dose limiting toxicity|1|||
147042171|NCT02516553|530313922|FG017|Overall Study|Dose limiting toxicity|1|||
147042172|NCT02516553|530313923|FG018|Overall Study|Dose limiting toxicity|0|||
147042173|NCT02516553|530313924|FG019|Overall Study|Dose limiting toxicity|2|||
147042174|NCT02516553|530313925|FG020|Overall Study|Dose limiting toxicity|0|||
147042175|NCT02516553|530313926|FG021|Overall Study|Dose limiting toxicity|0|||
147042176|NCT02516553|530313905|FG000|Overall Study|Other Adverse Events|0|||
147042177|NCT02516553|530313906|FG001|Overall Study|Other Adverse Events|0|||
147042178|NCT02516553|530313907|FG002|Overall Study|Other Adverse Events|0|||
147042179|NCT02516553|530313908|FG003|Overall Study|Other Adverse Events|1|||
147042180|NCT02516553|530313909|FG004|Overall Study|Other Adverse Events|0|||
147042181|NCT02516553|530313910|FG005|Overall Study|Other Adverse Events|1|||
147042182|NCT02516553|530313911|FG006|Overall Study|Other Adverse Events|0|||
147042183|NCT02516553|530313912|FG007|Overall Study|Other Adverse Events|0|||
147042184|NCT02516553|530313913|FG008|Overall Study|Other Adverse Events|0|||
147042185|NCT02516553|530313914|FG009|Overall Study|Other Adverse Events|1|||
147042186|NCT02516553|530313915|FG010|Overall Study|Other Adverse Events|3|||
147042187|NCT02516553|530313916|FG011|Overall Study|Other Adverse Events|2|||
147042188|NCT02516553|530313917|FG012|Overall Study|Other Adverse Events|0|||
147042189|NCT02516553|530313918|FG013|Overall Study|Other Adverse Events|1|||
147042190|NCT02516553|530313919|FG014|Overall Study|Other Adverse Events|0|||
146849848|NCT03412747|529618913|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
146849849|NCT03412747|529618911|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
147042191|NCT02516553|530313920|FG015|Overall Study|Other Adverse Events|0|||
147042192|NCT02516553|530313921|FG016|Overall Study|Other Adverse Events|0|||
147042193|NCT02516553|530313922|FG017|Overall Study|Other Adverse Events|2|||
147042194|NCT02516553|530313923|FG018|Overall Study|Other Adverse Events|1|||
147042195|NCT02516553|530313924|FG019|Overall Study|Other Adverse Events|2|||
147042196|NCT02516553|530313925|FG020|Overall Study|Other Adverse Events|2|||
147042197|NCT02516553|530313926|FG021|Overall Study|Other Adverse Events|1|||
147042198|NCT02516553|530313905|FG000|Overall Study|Refused to continue trial medication|0|||
147042199|NCT02516553|530313906|FG001|Overall Study|Refused to continue trial medication|0|||
147042200|NCT02516553|530313907|FG002|Overall Study|Refused to continue trial medication|0|||
147042201|NCT02516553|530313908|FG003|Overall Study|Refused to continue trial medication|0|||
147042202|NCT02516553|530313909|FG004|Overall Study|Refused to continue trial medication|0|||
147042203|NCT02516553|530313910|FG005|Overall Study|Refused to continue trial medication|0|||
147042204|NCT02516553|530313911|FG006|Overall Study|Refused to continue trial medication|0|||
147042205|NCT02516553|530313912|FG007|Overall Study|Refused to continue trial medication|0|||
147042206|NCT02516553|530313913|FG008|Overall Study|Refused to continue trial medication|0|||
147042207|NCT02516553|530313914|FG009|Overall Study|Refused to continue trial medication|0|||
147042208|NCT02516553|530313915|FG010|Overall Study|Refused to continue trial medication|1|||
147042209|NCT02516553|530313916|FG011|Overall Study|Refused to continue trial medication|0|||
147042210|NCT02516553|530313917|FG012|Overall Study|Refused to continue trial medication|0|||
147042211|NCT02516553|530313918|FG013|Overall Study|Refused to continue trial medication|0|||
147042212|NCT02516553|530313919|FG014|Overall Study|Refused to continue trial medication|0|||
147042213|NCT02516553|530313920|FG015|Overall Study|Refused to continue trial medication|0|||
147042214|NCT02516553|530313921|FG016|Overall Study|Refused to continue trial medication|0|||
147042215|NCT02516553|530313922|FG017|Overall Study|Refused to continue trial medication|0|||
147042216|NCT02516553|530313923|FG018|Overall Study|Refused to continue trial medication|1|||
147042217|NCT02516553|530313924|FG019|Overall Study|Refused to continue trial medication|0|||
147042218|NCT02516553|530313925|FG020|Overall Study|Refused to continue trial medication|0|||
147042219|NCT02516553|530313926|FG021|Overall Study|Refused to continue trial medication|1|||
147042220|NCT02516553|530313905|FG000|Overall Study|other reasons than listed|0|||
147042221|NCT02516553|530313906|FG001|Overall Study|other reasons than listed|0|||
147042222|NCT02516553|530313907|FG002|Overall Study|other reasons than listed|0|||
147042223|NCT02516553|530313908|FG003|Overall Study|other reasons than listed|0|||
147042224|NCT02516553|530313909|FG004|Overall Study|other reasons than listed|0|||
147042225|NCT02516553|530313910|FG005|Overall Study|other reasons than listed|0|||
147042226|NCT02516553|530313911|FG006|Overall Study|other reasons than listed|0|||
147042227|NCT02516553|530313912|FG007|Overall Study|other reasons than listed|1|||
147042228|NCT02516553|530313913|FG008|Overall Study|other reasons than listed|1|||
147042229|NCT02516553|530313914|FG009|Overall Study|other reasons than listed|0|||
147042230|NCT02516553|530313915|FG010|Overall Study|other reasons than listed|1|||
147042231|NCT02516553|530313916|FG011|Overall Study|other reasons than listed|1|||
147042232|NCT02516553|530313917|FG012|Overall Study|other reasons than listed|0|||
147042233|NCT02516553|530313918|FG013|Overall Study|other reasons than listed|0|||
147042234|NCT02516553|530313919|FG014|Overall Study|other reasons than listed|0|||
147042235|NCT02516553|530313920|FG015|Overall Study|other reasons than listed|0|||
147042236|NCT02516553|530313921|FG016|Overall Study|other reasons than listed|0|||
147042237|NCT02516553|530313922|FG017|Overall Study|other reasons than listed|0|||
147042238|NCT02516553|530313923|FG018|Overall Study|other reasons than listed|0|||
147042239|NCT02516553|530313924|FG019|Overall Study|other reasons than listed|0|||
147042240|NCT02516553|530313925|FG020|Overall Study|other reasons than listed|2|||
147042241|NCT02516553|530313926|FG021|Overall Study|other reasons than listed|2|||
147042242|NCT03052127|530313927|FG000|Overall Study|Withdrawal by Subject|0|||
147042243|NCT03052127|530313928|FG001|Overall Study|Withdrawal by Subject|0|||
147042244|NCT03052127|530313929|FG002|Overall Study|Withdrawal by Subject|0|||
147042245|NCT03052127|530313930|FG003|Overall Study|Withdrawal by Subject|0|||
147042246|NCT03052127|530313931|FG004|Overall Study|Withdrawal by Subject|0|||
147042247|NCT03052127|530313932|FG005|Overall Study|Withdrawal by Subject|0|||
147042248|NCT03052127|530313933|FG006|Overall Study|Withdrawal by Subject|0|||
147042249|NCT03052127|530313934|FG007|Overall Study|Withdrawal by Subject|1|||
147042250|NCT03052127|530313935|FG008|Overall Study|Withdrawal by Subject|1|||
147042251|NCT03052127|530313936|FG009|Overall Study|Withdrawal by Subject|1|||
147042252|NCT03052127|530313937|FG010|Overall Study|Withdrawal by Subject|0|||
147042253|NCT03052127|530313938|FG011|Overall Study|Withdrawal by Subject|0|||
147042254|NCT03052127|530313927|FG000|Overall Study|Discontinuation by Sponsor|0|||
147042255|NCT03052127|530313928|FG001|Overall Study|Discontinuation by Sponsor|0|||
147042256|NCT03052127|530313929|FG002|Overall Study|Discontinuation by Sponsor|0|||
147042257|NCT03052127|530313930|FG003|Overall Study|Discontinuation by Sponsor|0|||
147042258|NCT03052127|530313931|FG004|Overall Study|Discontinuation by Sponsor|0|||
147042259|NCT03052127|530313932|FG005|Overall Study|Discontinuation by Sponsor|0|||
147042260|NCT03052127|530313933|FG006|Overall Study|Discontinuation by Sponsor|0|||
147042261|NCT03052127|530313934|FG007|Overall Study|Discontinuation by Sponsor|0|||
147042262|NCT03052127|530313935|FG008|Overall Study|Discontinuation by Sponsor|4|||
147042263|NCT03052127|530313936|FG009|Overall Study|Discontinuation by Sponsor|2|||
147042264|NCT03052127|530313937|FG010|Overall Study|Discontinuation by Sponsor|5|||
146849850|NCT03412747|529618912|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
147042265|NCT03052127|530313938|FG011|Overall Study|Discontinuation by Sponsor|13|||
147042266|NCT03052127|530313927|FG000|Overall Study|Inability to comply with trial requirements|0|||
147042267|NCT03052127|530313928|FG001|Overall Study|Inability to comply with trial requirements|0|||
146849851|NCT03412747|529618913|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
147042268|NCT03052127|530313929|FG002|Overall Study|Inability to comply with trial requirements|1|||
147042269|NCT03052127|530313930|FG003|Overall Study|Inability to comply with trial requirements|0|||
147042270|NCT03052127|530313931|FG004|Overall Study|Inability to comply with trial requirements|0|||
147042271|NCT03052127|530313932|FG005|Overall Study|Inability to comply with trial requirements|0|||
147042272|NCT03052127|530313933|FG006|Overall Study|Inability to comply with trial requirements|0|||
147042273|NCT03052127|530313934|FG007|Overall Study|Inability to comply with trial requirements|0|||
147042274|NCT03052127|530313935|FG008|Overall Study|Inability to comply with trial requirements|0|||
147042275|NCT03052127|530313936|FG009|Overall Study|Inability to comply with trial requirements|0|||
147042276|NCT03052127|530313937|FG010|Overall Study|Inability to comply with trial requirements|0|||
147042277|NCT03052127|530313938|FG011|Overall Study|Inability to comply with trial requirements|0|||
147042278|NCT03052127|530313927|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
147042279|NCT03052127|530313928|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
147042280|NCT03052127|530313929|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
147042281|NCT03052127|530313930|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
147042282|NCT03052127|530313931|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
147042283|NCT03052127|530313932|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
147042284|NCT03052127|530313933|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
147042285|NCT03052127|530313934|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
147042286|NCT03052127|530313935|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
147042287|NCT03052127|530313936|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
147042288|NCT03052127|530313937|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
147042289|NCT03052127|530313938|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
147042290|NCT02017015|530316265|FG000|Overall Study|Adverse Event|9|||
147042291|NCT02017015|530316265|FG000|Overall Study|Withdrawal by Subject|21|||
147042292|NCT02017015|530316265|FG000|Overall Study|Death|4|||
147042293|NCT02017015|530316265|FG000|Overall Study|Progressive Disease|31|||
147042294|NCT02017015|530316265|FG000|Overall Study|Non-compliance with study drug|2|||
147042295|NCT02017015|530316265|FG000|Overall Study|Physician Decision|2|||
147042296|NCT02291510|530316268|FG000|Overall Study|Adverse Event|0|||
147042297|NCT02291510|530316269|FG001|Overall Study|Adverse Event|0|||
147042298|NCT02291510|530316270|FG002|Overall Study|Adverse Event|0|||
147042299|NCT02291510|530316271|FG003|Overall Study|Adverse Event|1|||
147042321|NCT04856930|530316278|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
147042322|NCT04856930|530316279|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
147042323|NCT04856930|530316280|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
147042324|NCT04856930|530316278|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
147042325|NCT04856930|530316279|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
147042326|NCT04856930|530316280|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
147042327|NCT04856930|530316278|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
147042328|NCT04856930|530316279|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
147042329|NCT04856930|530316280|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
147042330|NCT04856930|530316278|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
146849852|NCT03412747|529618911|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
146849853|NCT03412747|529618912|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
146849854|NCT03412747|529618913|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
147042331|NCT04856930|530316279|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
147042332|NCT04856930|530316280|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
147042333|NCT04856930|530316278|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
147042334|NCT04856930|530316279|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
147042335|NCT04856930|530316280|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
147042336|NCT04856930|530316278|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
147042337|NCT04856930|530316279|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
147042338|NCT04856930|530316280|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
147042339|NCT04856930|530316278|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
147042340|NCT04856930|530316279|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
147042341|NCT04856930|530316280|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
147042342|NCT04856930|530316278|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
147042343|NCT04856930|530316279|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
147042344|NCT04856930|530316280|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
147042345|NCT04856930|530316278|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
147042346|NCT04856930|530316279|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
147042347|NCT04856930|530316280|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
147042348|NCT04856930|530316278|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
147042349|NCT04856930|530316279|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
147042350|NCT04856930|530316280|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
147042351|NCT04856930|530316278|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
147042352|NCT04856930|530316279|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
147042353|NCT04856930|530316280|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
147042354|NCT04856930|530316278|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
147042355|NCT04856930|530316279|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
147042356|NCT04856930|530316280|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
147042357|NCT04856930|530316278|FG000|Extension Period (16 Weeks)|Other than specified|0|||
147042358|NCT04856930|530316279|FG001|Extension Period (16 Weeks)|Other than specified|0|||
147042359|NCT04856930|530316280|FG002|Extension Period (16 Weeks)|Other than specified|1|||
147042360|NCT04856930|530316278|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
147042361|NCT04856930|530316279|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
147042362|NCT04856930|530316280|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
147042363|NCT04856930|530316278|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
147042364|NCT04856930|530316279|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
147042365|NCT04856930|530316280|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
147042366|NCT04856930|530316278|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
147042367|NCT04856930|530316279|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
147042368|NCT04856930|530316280|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
147042369|NCT04856930|530316278|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
147042370|NCT04856930|530316279|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
147042371|NCT04856930|530316280|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
147042372|NCT01009814|530316283|FG000|Overall Study|No longer met study criteria|1|||
147042373|NCT01009814|530316284|FG001|Overall Study|No longer met study criteria|1|||
147042374|NCT01009814|530316285|FG002|Overall Study|No longer met study criteria|0|||
147042375|NCT01009814|530316286|FG003|Overall Study|No longer met study criteria|0|||
147042376|NCT01009814|530316287|FG004|Overall Study|No longer met study criteria|0|||
147042377|NCT00618371|530316288|FG000|Overall Study|Withdrawal by Subject|2|||
147042378|NCT03104400|530316289|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
147042379|NCT03104400|530316290|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
147042380|NCT03104400|530316291|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
147042381|NCT03104400|530316292|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
147042382|NCT03104400|530316293|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
147042383|NCT03104400|530316294|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
147042384|NCT03104400|530316295|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
147042385|NCT03104400|530316296|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
147042386|NCT03104400|530316297|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
147042387|NCT03104400|530316298|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
147042388|NCT03104400|530316289|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
147042389|NCT03104400|530316290|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
147042390|NCT03104400|530316291|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
147042391|NCT03104400|530316292|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
147042392|NCT03104400|530316293|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
147042393|NCT03104400|530316294|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
147042394|NCT03104400|530316295|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
147042395|NCT03104400|530316296|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
147042396|NCT03104400|530316297|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
147042397|NCT03104400|530316298|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
147042398|NCT03104400|530316289|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
147042399|NCT03104400|530316290|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
147042400|NCT03104400|530316291|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
147042401|NCT03104400|530316292|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
147042402|NCT03104400|530316293|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
147042403|NCT03104400|530316294|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
147042404|NCT03104400|530316295|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
147042405|NCT03104400|530316296|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
147042406|NCT03104400|530316297|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
147042407|NCT03104400|530316298|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
147042408|NCT03104400|530316289|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
147042409|NCT03104400|530316290|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
147042410|NCT03104400|530316291|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
147042411|NCT03104400|530316292|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
147042412|NCT03104400|530316293|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
147042413|NCT03104400|530316294|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
147042414|NCT03104400|530316295|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
147042415|NCT03104400|530316296|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
147042416|NCT03104400|530316297|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
147042417|NCT03104400|530316298|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
147042418|NCT03104400|530316289|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147042419|NCT03104400|530316290|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147042420|NCT03104400|530316291|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147042421|NCT03104400|530316292|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
147042422|NCT03104400|530316293|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147042423|NCT03104400|530316294|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147042424|NCT03104400|530316295|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147042425|NCT03104400|530316296|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147042426|NCT03104400|530316297|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147042427|NCT03104400|530316298|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147042428|NCT03104400|530316289|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
147042429|NCT03104400|530316290|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
147042430|NCT03104400|530316291|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
147042431|NCT03104400|530316292|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
147042432|NCT03104400|530316293|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
147042433|NCT03104400|530316294|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
147042434|NCT03104400|530316295|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
147042435|NCT03104400|530316296|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
147042436|NCT03104400|530316297|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
147042437|NCT03104400|530316298|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
147042438|NCT03104400|530316289|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147042439|NCT03104400|530316290|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147042440|NCT03104400|530316291|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147042441|NCT03104400|530316292|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
147042442|NCT03104400|530316293|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147042443|NCT03104400|530316294|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147042444|NCT03104400|530316295|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147042445|NCT03104400|530316296|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147042446|NCT03104400|530316297|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147042447|NCT03104400|530316298|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147042448|NCT03104400|530316289|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
147042449|NCT03104400|530316290|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
147042450|NCT03104400|530316291|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
147042451|NCT03104400|530316292|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
147042452|NCT03104400|530316293|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
147042453|NCT03104400|530316294|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
147042454|NCT03104400|530316295|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
147042455|NCT03104400|530316296|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
147042456|NCT03104400|530316297|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
147042457|NCT03104400|530316298|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
147042458|NCT03104400|530316289|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
147042459|NCT03104400|530316290|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
147042460|NCT03104400|530316291|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
147042461|NCT03104400|530316292|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
147042462|NCT03104400|530316293|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
147042463|NCT03104400|530316294|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
147042464|NCT03104400|530316295|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
147042465|NCT03104400|530316296|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
147042466|NCT03104400|530316297|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
147042467|NCT03104400|530316298|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
147042468|NCT03104400|530316289|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
147042469|NCT03104400|530316290|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
146849855|NCT03412747|529618911|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
146849856|NCT03412747|529618912|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
146849857|NCT03412747|529618913|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
147042470|NCT03104400|530316291|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
147042471|NCT03104400|530316292|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
147042472|NCT03104400|530316293|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
147042473|NCT03104400|530316294|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
147042474|NCT03104400|530316295|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
147042475|NCT03104400|530316296|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
147042476|NCT03104400|530316297|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
147042477|NCT03104400|530316298|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
147042478|NCT03104400|530316289|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
147042479|NCT03104400|530316290|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
147042480|NCT03104400|530316291|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
147042481|NCT03104400|530316292|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
147042482|NCT03104400|530316293|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
147042483|NCT03104400|530316294|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
147042484|NCT03104400|530316295|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
147042485|NCT03104400|530316296|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
147042486|NCT03104400|530316297|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
147042487|NCT03104400|530316298|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
147042488|NCT03104400|530316289|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
147042489|NCT03104400|530316290|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
147042490|NCT03104400|530316291|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
147042491|NCT03104400|530316292|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
147042492|NCT03104400|530316293|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
147042493|NCT03104400|530316294|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
147042494|NCT03104400|530316295|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
147042495|NCT03104400|530316296|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
147042496|NCT03104400|530316297|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
147042497|NCT03104400|530316298|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
147042498|NCT03104400|530316289|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
147042499|NCT03104400|530316290|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
147042500|NCT03104400|530316291|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
147042501|NCT03104400|530316292|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
147042502|NCT03104400|530316293|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
147042503|NCT03104400|530316294|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
147042504|NCT03104400|530316295|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
147042505|NCT03104400|530316296|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
147042506|NCT03104400|530316297|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
147042507|NCT03104400|530316298|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
147042508|NCT03104400|530316289|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
147042509|NCT03104400|530316290|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
147042510|NCT03104400|530316291|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
147042511|NCT03104400|530316292|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
147042512|NCT03104400|530316293|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
147042513|NCT03104400|530316294|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
147042514|NCT03104400|530316295|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
147042515|NCT03104400|530316296|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
147042516|NCT03104400|530316297|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
147042517|NCT03104400|530316298|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
147042518|NCT03104400|530316289|FG000|Period 2 Week 56 - 260)|Other|0|||
147042519|NCT03104400|530316290|FG001|Period 2 Week 56 - 260)|Other|0|||
147042520|NCT03104400|530316291|FG002|Period 2 Week 56 - 260)|Other|0|||
147042521|NCT03104400|530316292|FG003|Period 2 Week 56 - 260)|Other|0|||
147042522|NCT03104400|530316293|FG004|Period 2 Week 56 - 260)|Other|0|||
147042523|NCT03104400|530316294|FG005|Period 2 Week 56 - 260)|Other|0|||
147042524|NCT03104400|530316295|FG006|Period 2 Week 56 - 260)|Other|0|||
147042525|NCT03104400|530316296|FG007|Period 2 Week 56 - 260)|Other|0|||
147042526|NCT03104400|530316297|FG008|Period 2 Week 56 - 260)|Other|1|||
147042527|NCT03104400|530316298|FG009|Period 2 Week 56 - 260)|Other|1|||
147042528|NCT02013817|530316299|FG000|Overall Study|Adverse Event|12|||
147042529|NCT02013817|530316299|FG000|Overall Study|Withdrawal by Subject|4|||
147042530|NCT02013817|530316299|FG000|Overall Study|Death|2|||
147042531|NCT02013817|530316299|FG000|Overall Study|Other|9|||
147042532|NCT01582152|530316303|FG000|Overall Study|Disease Progression|4|||
147042533|NCT01582152|530316304|FG001|Overall Study|Disease Progression|5|||
147042534|NCT01582152|530316303|FG000|Overall Study|Adverse Event|2|||
147042535|NCT01582152|530316304|FG001|Overall Study|Adverse Event|1|||
147042536|NCT01434810|530316305|FG000|Overall Study|Did not receive treatment|11|||
146849858|NCT03412747|529618911|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
146849859|NCT03412747|529618912|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
146849860|NCT03412747|529618913|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
146849861|NCT03412747|529618911|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
146849862|NCT03412747|529618912|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
146849863|NCT03412747|529618913|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
146849864|NCT03412747|529618911|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
146849865|NCT03412747|529618912|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
146849866|NCT03412747|529618913|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
146849867|NCT03412747|529618911|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
146849868|NCT03412747|529618912|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
147042537|NCT01434810|530316306|FG001|Overall Study|Did not receive treatment|3|||
147042538|NCT01434810|530316305|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
147042539|NCT01434810|530316306|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
147042540|NCT04974749|530316311|FG000|Overall Study|Withdrawal by Subject|2|||
147042541|NCT04974749|530316311|FG000|Overall Study|Gestation|1|||
147042542|NCT02075515|530316318|FG000|Overall Study|Serious Adverse Event|1|||
147042543|NCT02075515|530316319|FG001|Overall Study|Serious Adverse Event|1|||
147042544|NCT02075515|530316320|FG002|Overall Study|Serious Adverse Event|1|||
147042545|NCT02075515|530316318|FG000|Overall Study|Non-Serious Adverse Event|0|||
147042546|NCT02075515|530316319|FG001|Overall Study|Non-Serious Adverse Event|1|||
147042547|NCT02075515|530316320|FG002|Overall Study|Non-Serious Adverse Event|0|||
147042548|NCT02075515|530316318|FG000|Overall Study|Withdrawal by Subject|2|||
147042549|NCT02075515|530316319|FG001|Overall Study|Withdrawal by Subject|0|||
147042550|NCT02075515|530316320|FG002|Overall Study|Withdrawal by Subject|1|||
147042551|NCT02075515|530316318|FG000|Overall Study|Lost to Follow-up|1|||
147042552|NCT02075515|530316319|FG001|Overall Study|Lost to Follow-up|3|||
147042553|NCT02075515|530316320|FG002|Overall Study|Lost to Follow-up|6|||
147042554|NCT03593395|530316323|FG000|Overall Study|Lost to Follow-up|48|||
147042555|NCT03593395|530316324|FG001|Overall Study|Lost to Follow-up|3|||
147042556|NCT03593395|530316323|FG000|Overall Study|Withdrawal by Subject|5|||
147042557|NCT03593395|530316324|FG001|Overall Study|Withdrawal by Subject|24|||
147042558|NCT03593395|530316323|FG000|Overall Study|Death|2|||
147042559|NCT03593395|530316324|FG001|Overall Study|Death|3|||
147042560|NCT03593395|530316323|FG000|Overall Study|Physician Decision|0|||
147042561|NCT03593395|530316324|FG001|Overall Study|Physician Decision|6|||
147042562|NCT03593395|530316323|FG000|Overall Study|Participant Relocated|19|||
147042563|NCT03593395|530316324|FG001|Overall Study|Participant Relocated|3|||
147042564|NCT03593395|530316323|FG000|Overall Study|No Information|1|||
147042565|NCT03593395|530316324|FG001|Overall Study|No Information|7|||
147042566|NCT00741338|530316325|FG000|Overall Study|Adverse Event|0|||
147042567|NCT00741338|530316326|FG001|Overall Study|Adverse Event|1|||
147042568|NCT03713632|530316327|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
147042569|NCT03713632|530316328|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
146849869|NCT03412747|529618913|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
146849870|NCT03412747|529618911|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
146849871|NCT03412747|529618912|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
146849872|NCT03412747|529618913|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
146849873|NCT03412747|529618911|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
146849874|NCT03412747|529618912|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
146849875|NCT03412747|529618913|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
146849876|NCT03412747|529618911|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
146849877|NCT03412747|529618912|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
146849878|NCT03412747|529618913|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
146849879|NCT03412747|529618911|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
146849880|NCT03412747|529618912|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
146849881|NCT03412747|529618913|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
146849882|NCT03412747|529618911|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
146849883|NCT03412747|529618912|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
146849884|NCT03412747|529618913|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
146849885|NCT00560066|529618916|FG000|Overall Study|Death|2|||
146849886|NCT00560066|529618917|FG001|Overall Study|Death|1|||
146849887|NCT00560066|529618916|FG000|Overall Study|Withdrawal by Subject|0|||
146849888|NCT00560066|529618917|FG001|Overall Study|Withdrawal by Subject|3|||
146849889|NCT00560066|529618916|FG000|Overall Study|Lost to Follow-up|4|||
146849890|NCT00560066|529618917|FG001|Overall Study|Lost to Follow-up|10|||
146849891|NCT00560066|529618916|FG000|Overall Study|Protocol Violation|0|||
146849892|NCT00560066|529618917|FG001|Overall Study|Protocol Violation|1|||
146849893|NCT00560066|529618916|FG000|Overall Study|Administrative reason|0|||
146849894|NCT00560066|529618917|FG001|Overall Study|Administrative reason|5|||
146849895|NCT00560066|529618916|FG000|Overall Study|Missing primary reason|0|||
146849896|NCT00560066|529618917|FG001|Overall Study|Missing primary reason|2|||
146849897|NCT02101385|529618926|FG000|Study Treatment|Disease Progression|9|||
146849898|NCT02101385|529618927|FG001|Study Treatment|Disease Progression|3|||
146849899|NCT02101385|529618926|FG000|Study Treatment|Alternative therapy|0|||
146849900|NCT02101385|529618927|FG001|Study Treatment|Alternative therapy|1|||
146849901|NCT02101385|529618926|FG000|Study Treatment|No treatment, per protocol criteria|0|||
146849902|NCT02101385|529618927|FG001|Study Treatment|No treatment, per protocol criteria|4|||
146849903|NCT02101385|529618926|FG000|Study Treatment|Patient Non compliance|0|||
146849904|NCT02101385|529618927|FG001|Study Treatment|Patient Non compliance|2|||
146849905|NCT02101385|529618926|FG000|Study Treatment|Withdrawal by Subject|5|||
146849906|NCT02101385|529618927|FG001|Study Treatment|Withdrawal by Subject|2|||
146849907|NCT02101385|529618926|FG000|Study Treatment|screen failure|1|||
146849908|NCT02101385|529618927|FG001|Study Treatment|screen failure|0|||
147042570|NCT03713632|530316329|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
147042571|NCT03713632|530316330|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
147042572|NCT03713632|530316331|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
147042573|NCT03713632|530316327|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
147042574|NCT03713632|530316328|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
147042575|NCT03713632|530316329|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
147042576|NCT03713632|530316330|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
147042577|NCT03713632|530316331|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
147042578|NCT03713632|530316327|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
147042579|NCT03713632|530316328|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
147042580|NCT03713632|530316329|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
147042581|NCT03713632|530316330|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
147042582|NCT03713632|530316331|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
147042583|NCT03713632|530316327|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
147042584|NCT03713632|530316328|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
147042585|NCT03713632|530316329|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
147042586|NCT03713632|530316330|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
147042587|NCT03713632|530316331|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
147042588|NCT03713632|530316327|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
147042589|NCT03713632|530316328|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
147042590|NCT03713632|530316329|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
147042591|NCT03713632|530316330|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
147042592|NCT03713632|530316331|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
147042593|NCT03713632|530316327|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
147042594|NCT03713632|530316328|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
147042595|NCT03713632|530316329|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
147042596|NCT03713632|530316330|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
147042597|NCT03713632|530316331|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
147042598|NCT03713632|530316327|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
147042599|NCT03713632|530316328|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
147042600|NCT03713632|530316329|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
147042601|NCT03713632|530316330|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
147042602|NCT03713632|530316331|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
147042603|NCT03713632|530316327|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
147042604|NCT03713632|530316328|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
147042605|NCT03713632|530316329|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
147042606|NCT03713632|530316330|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
147042607|NCT03713632|530316331|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
147042608|NCT03713632|530316327|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
147042609|NCT03713632|530316328|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
147042610|NCT03713632|530316329|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
147042611|NCT03713632|530316330|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
147042612|NCT03713632|530316331|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
147042613|NCT03713632|530316327|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
147042614|NCT03713632|530316328|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
147042615|NCT03713632|530316329|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
147042616|NCT03713632|530316330|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
147042617|NCT03713632|530316331|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
147042618|NCT03713632|530316327|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
147042619|NCT03713632|530316328|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
147042620|NCT03713632|530316329|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
147042621|NCT03713632|530316330|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
147042622|NCT03713632|530316331|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
147042623|NCT03713632|530316327|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
147042624|NCT03713632|530316328|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
147042625|NCT03713632|530316329|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
147042626|NCT03713632|530316330|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
147042627|NCT03713632|530316331|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
147042628|NCT03713632|530316327|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
147042629|NCT03713632|530316328|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
147042630|NCT03713632|530316329|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
147042631|NCT03713632|530316330|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
147042632|NCT03713632|530316331|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
147042633|NCT03713632|530316327|FG000|Treatment Period 2 (After Week 16)|Death|0|||
147042634|NCT03713632|530316328|FG001|Treatment Period 2 (After Week 16)|Death|1|||
147042635|NCT03713632|530316329|FG002|Treatment Period 2 (After Week 16)|Death|0|||
147042636|NCT03713632|530316330|FG003|Treatment Period 2 (After Week 16)|Death|0|||
147042637|NCT03713632|530316331|FG004|Treatment Period 2 (After Week 16)|Death|0|||
147042638|NCT03713632|530316327|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
147042639|NCT03713632|530316328|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
147042640|NCT03713632|530316329|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
147042641|NCT03713632|530316330|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
147042642|NCT03713632|530316331|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
147042643|NCT01524978|530316332|FG000|Overall Study|Other|16|||
147042644|NCT01524978|530316333|FG001|Overall Study|Other|2|||
147042645|NCT01524978|530316334|FG002|Overall Study|Other|1|||
147042646|NCT01524978|530316335|FG003|Overall Study|Other|2|||
147042647|NCT01524978|530316336|FG004|Overall Study|Other|1|||
147042648|NCT01524978|530316337|FG005|Overall Study|Other|3|||
147042649|NCT01524978|530316338|FG006|Overall Study|Other|17|||
147042650|NCT01524978|530316339|FG007|Overall Study|Other|1|||
147042651|NCT01524978|530316340|FG008|Overall Study|Other|2|||
147042652|NCT01524978|530316341|FG009|Overall Study|Other|2|||
147042653|NCT01524978|530316342|FG010|Overall Study|Other|5|||
147042654|NCT01524978|530316332|FG000|Overall Study|Withdrawal by Subject|12|||
147042655|NCT01524978|530316333|FG001|Overall Study|Withdrawal by Subject|0|||
147042656|NCT01524978|530316334|FG002|Overall Study|Withdrawal by Subject|1|||
147042657|NCT01524978|530316335|FG003|Overall Study|Withdrawal by Subject|1|||
147042658|NCT01524978|530316336|FG004|Overall Study|Withdrawal by Subject|3|||
147042659|NCT01524978|530316337|FG005|Overall Study|Withdrawal by Subject|1|||
147042660|NCT01524978|530316338|FG006|Overall Study|Withdrawal by Subject|6|||
147042661|NCT01524978|530316339|FG007|Overall Study|Withdrawal by Subject|2|||
147042662|NCT01524978|530316340|FG008|Overall Study|Withdrawal by Subject|4|||
147042663|NCT01524978|530316341|FG009|Overall Study|Withdrawal by Subject|0|||
147042664|NCT01524978|530316342|FG010|Overall Study|Withdrawal by Subject|5|||
147042665|NCT01524978|530316332|FG000|Overall Study|Lost to Follow-up|0|||
147042666|NCT01524978|530316333|FG001|Overall Study|Lost to Follow-up|0|||
147042667|NCT01524978|530316334|FG002|Overall Study|Lost to Follow-up|3|||
147042668|NCT01524978|530316335|FG003|Overall Study|Lost to Follow-up|0|||
147042669|NCT01524978|530316336|FG004|Overall Study|Lost to Follow-up|1|||
147042670|NCT01524978|530316337|FG005|Overall Study|Lost to Follow-up|1|||
147042671|NCT01524978|530316338|FG006|Overall Study|Lost to Follow-up|2|||
147042672|NCT01524978|530316339|FG007|Overall Study|Lost to Follow-up|0|||
147042673|NCT01524978|530316340|FG008|Overall Study|Lost to Follow-up|1|||
147042674|NCT01524978|530316341|FG009|Overall Study|Lost to Follow-up|1|||
147042675|NCT01524978|530316342|FG010|Overall Study|Lost to Follow-up|1|||
147042676|NCT01524978|530316332|FG000|Overall Study|Death|34|||
147042677|NCT01524978|530316333|FG001|Overall Study|Death|2|||
147042678|NCT01524978|530316334|FG002|Overall Study|Death|5|||
147042679|NCT01524978|530316335|FG003|Overall Study|Death|24|||
147042680|NCT01524978|530316336|FG004|Overall Study|Death|4|||
147042681|NCT01524978|530316337|FG005|Overall Study|Death|4|||
147042682|NCT01524978|530316338|FG006|Overall Study|Death|1|||
147042683|NCT01524978|530316339|FG007|Overall Study|Death|9|||
147042684|NCT01524978|530316340|FG008|Overall Study|Death|5|||
147042685|NCT01524978|530316341|FG009|Overall Study|Death|6|||
147042686|NCT01524978|530316342|FG010|Overall Study|Death|17|||
147042687|NCT02165735|530316348|FG000|Overall Study|Lost to Follow-up|12|||
147042688|NCT02165735|530316349|FG001|Overall Study|Lost to Follow-up|10|||
147042689|NCT02165735|530316348|FG000|Overall Study|Withdrawal by Subject|3|||
147042690|NCT02165735|530316349|FG001|Overall Study|Withdrawal by Subject|0|||
147042691|NCT02165735|530316348|FG000|Overall Study|Participant indicated lack of time|1|||
147042692|NCT02165735|530316349|FG001|Overall Study|Participant indicated lack of time|3|||
147042693|NCT02165735|530316348|FG000|Overall Study|Protocol Violation|0|||
147042694|NCT02165735|530316349|FG001|Overall Study|Protocol Violation|1|||
147042695|NCT03066258|530316350|FG000|Overall Study|Death|1|||
147042696|NCT03066258|530316351|FG001|Overall Study|Death|0|||
147042697|NCT03066258|530316352|FG002|Overall Study|Death|0|||
147042698|NCT03066258|530316353|FG003|Overall Study|Death|0|||
147042699|NCT03066258|530316354|FG004|Overall Study|Death|1|||
147042700|NCT02784795|530316355|FG000|Overall Study|Progressive Disease|2|||
147042701|NCT02784795|530316356|FG001|Overall Study|Progressive Disease|1|||
147042702|NCT02784795|530316357|FG002|Overall Study|Progressive Disease|1|||
147042703|NCT02784795|530316358|FG003|Overall Study|Progressive Disease|0|||
147042704|NCT02784795|530316359|FG004|Overall Study|Progressive Disease|2|||
147042705|NCT02784795|530316360|FG005|Overall Study|Progressive Disease|0|||
147042706|NCT02784795|530316361|FG006|Overall Study|Progressive Disease|2|||
147042707|NCT02784795|530316362|FG007|Overall Study|Progressive Disease|0|||
147042708|NCT02784795|530316363|FG008|Overall Study|Progressive Disease|0|||
147042709|NCT02784795|530316364|FG009|Overall Study|Progressive Disease|0|||
147042710|NCT02784795|530316365|FG010|Overall Study|Progressive Disease|1|||
147042711|NCT02784795|530316366|FG011|Overall Study|Progressive Disease|0|||
147042712|NCT02784795|530316355|FG000|Overall Study|Adverse Event|1|||
147042713|NCT02784795|530316356|FG001|Overall Study|Adverse Event|0|||
147042714|NCT02784795|530316357|FG002|Overall Study|Adverse Event|0|||
147042715|NCT02784795|530316358|FG003|Overall Study|Adverse Event|1|||
147042716|NCT02784795|530316359|FG004|Overall Study|Adverse Event|0|||
147042717|NCT02784795|530316360|FG005|Overall Study|Adverse Event|0|||
147042718|NCT02784795|530316361|FG006|Overall Study|Adverse Event|1|||
147042719|NCT02784795|530316362|FG007|Overall Study|Adverse Event|0|||
147042720|NCT02784795|530316363|FG008|Overall Study|Adverse Event|0|||
147042721|NCT02784795|530316364|FG009|Overall Study|Adverse Event|0|||
147042722|NCT02784795|530316365|FG010|Overall Study|Adverse Event|0|||
147042723|NCT02784795|530316366|FG011|Overall Study|Adverse Event|2|||
147042724|NCT02784795|530316355|FG000|Overall Study|Withdrawal by Subject|1|||
147042725|NCT02784795|530316356|FG001|Overall Study|Withdrawal by Subject|0|||
147042726|NCT02784795|530316357|FG002|Overall Study|Withdrawal by Subject|2|||
147042727|NCT02784795|530316358|FG003|Overall Study|Withdrawal by Subject|1|||
147042728|NCT02784795|530316359|FG004|Overall Study|Withdrawal by Subject|3|||
147042729|NCT02784795|530316360|FG005|Overall Study|Withdrawal by Subject|0|||
147042730|NCT02784795|530316361|FG006|Overall Study|Withdrawal by Subject|0|||
147042731|NCT02784795|530316362|FG007|Overall Study|Withdrawal by Subject|1|||
147042732|NCT02784795|530316363|FG008|Overall Study|Withdrawal by Subject|0|||
147042733|NCT02784795|530316364|FG009|Overall Study|Withdrawal by Subject|0|||
147042734|NCT02784795|530316365|FG010|Overall Study|Withdrawal by Subject|0|||
147042735|NCT02784795|530316366|FG011|Overall Study|Withdrawal by Subject|2|||
147042736|NCT02784795|530316355|FG000|Overall Study|Death|0|||
147042737|NCT02784795|530316356|FG001|Overall Study|Death|0|||
147042738|NCT02784795|530316357|FG002|Overall Study|Death|0|||
147042739|NCT02784795|530316358|FG003|Overall Study|Death|0|||
147042740|NCT02784795|530316359|FG004|Overall Study|Death|1|||
147042741|NCT02784795|530316360|FG005|Overall Study|Death|0|||
147042742|NCT02784795|530316361|FG006|Overall Study|Death|0|||
147042743|NCT02784795|530316362|FG007|Overall Study|Death|0|||
147042744|NCT02784795|530316363|FG008|Overall Study|Death|0|||
147042745|NCT02784795|530316364|FG009|Overall Study|Death|0|||
147042746|NCT02784795|530316365|FG010|Overall Study|Death|0|||
147042747|NCT02784795|530316366|FG011|Overall Study|Death|0|||
147042748|NCT02784795|530316355|FG000|Overall Study|Physician Decision|0|||
147042749|NCT02784795|530316356|FG001|Overall Study|Physician Decision|0|||
147042750|NCT02784795|530316357|FG002|Overall Study|Physician Decision|0|||
147042751|NCT02784795|530316358|FG003|Overall Study|Physician Decision|0|||
147042752|NCT02784795|530316359|FG004|Overall Study|Physician Decision|0|||
147042753|NCT02784795|530316360|FG005|Overall Study|Physician Decision|0|||
147042754|NCT02784795|530316361|FG006|Overall Study|Physician Decision|1|||
147042755|NCT02784795|530316362|FG007|Overall Study|Physician Decision|0|||
147042756|NCT02784795|530316363|FG008|Overall Study|Physician Decision|0|||
147042757|NCT02784795|530316364|FG009|Overall Study|Physician Decision|0|||
147042758|NCT02784795|530316365|FG010|Overall Study|Physician Decision|0|||
147042759|NCT02784795|530316366|FG011|Overall Study|Physician Decision|0|||
147042760|NCT02540083|530316367|FG000|Overall Study|Withdrawal by Subject|16|||
147042761|NCT00101283|530316368|FG000|Overall Study|Withdrawal by Subject|0|||
147042762|NCT00101283|530316369|FG001|Overall Study|Withdrawal by Subject|1|||
147042763|NCT00101283|530316368|FG000|Overall Study|Insurance Refusal|0|||
147042764|NCT00101283|530316369|FG001|Overall Study|Insurance Refusal|1|||
147042765|NCT00101283|530316368|FG000|Overall Study|Prostate Cancer Recurrence|0|||
147042766|NCT00101283|530316369|FG001|Overall Study|Prostate Cancer Recurrence|1|||
147042767|NCT00595309|530316370|FG000|Overall Study|Lost to Follow-up|1|||
147042768|NCT00595309|530316370|FG000|Overall Study|planned vaccination against yellow fever|1|||
147042769|NCT00595309|530316370|FG000|Overall Study|acute infection after V0|1|||
147042770|NCT00595309|530316370|FG000|Overall Study|personal reason|1|||
147042771|NCT02797171|530316371|FG000|Overall Study|Lost to Follow-up|2|||
147042772|NCT02797171|530316372|FG001|Overall Study|Lost to Follow-up|0|||
147042773|NCT02797171|530316373|FG002|Overall Study|Lost to Follow-up|2|||
147042774|NCT02797171|530316374|FG003|Overall Study|Lost to Follow-up|1|||
147042775|NCT02797171|530316375|FG004|Overall Study|Lost to Follow-up|2|||
147042776|NCT02797171|530316376|FG005|Overall Study|Lost to Follow-up|0|||
147042777|NCT02797171|530316371|FG000|Overall Study|Withdrawal by Subject|1|||
147042778|NCT02797171|530316372|FG001|Overall Study|Withdrawal by Subject|1|||
147042779|NCT02797171|530316373|FG002|Overall Study|Withdrawal by Subject|0|||
147042780|NCT02797171|530316374|FG003|Overall Study|Withdrawal by Subject|0|||
147042781|NCT02797171|530316375|FG004|Overall Study|Withdrawal by Subject|0|||
147042782|NCT02797171|530316376|FG005|Overall Study|Withdrawal by Subject|0|||
147042783|NCT02797171|530316371|FG000|Overall Study|Protocol Violation|1|||
147042784|NCT02797171|530316372|FG001|Overall Study|Protocol Violation|0|||
147042785|NCT02797171|530316373|FG002|Overall Study|Protocol Violation|0|||
147042786|NCT02797171|530316374|FG003|Overall Study|Protocol Violation|0|||
147042787|NCT02797171|530316375|FG004|Overall Study|Protocol Violation|0|||
147042788|NCT02797171|530316376|FG005|Overall Study|Protocol Violation|0|||
147042789|NCT02797171|530316371|FG000|Overall Study|Participant unable to adhere|0|||
147042790|NCT02797171|530316372|FG001|Overall Study|Participant unable to adhere|1|||
147042791|NCT02797171|530316373|FG002|Overall Study|Participant unable to adhere|0|||
147042792|NCT02797171|530316374|FG003|Overall Study|Participant unable to adhere|0|||
147042793|NCT02797171|530316375|FG004|Overall Study|Participant unable to adhere|0|||
147042794|NCT02797171|530316376|FG005|Overall Study|Participant unable to adhere|0|||
147042795|NCT02797171|530316371|FG000|Overall Study|Not Randomized|0|||
147042796|NCT02797171|530316372|FG001|Overall Study|Not Randomized|0|||
147042797|NCT02797171|530316373|FG002|Overall Study|Not Randomized|0|||
147042798|NCT02797171|530316374|FG003|Overall Study|Not Randomized|0|||
147042799|NCT02797171|530316375|FG004|Overall Study|Not Randomized|0|||
147042800|NCT02797171|530316376|FG005|Overall Study|Not Randomized|1|||
147042801|NCT01372748|530316381|FG000|Overall Study|Lost to Follow-up|16|||
147042802|NCT01372748|530316382|FG001|Overall Study|Lost to Follow-up|34|||
147042803|NCT01372748|530316381|FG000|Overall Study|Withdrawal by Subject|7|||
147042804|NCT01372748|530316382|FG001|Overall Study|Withdrawal by Subject|5|||
147042805|NCT00134901|530316383|FG000|Overall Study|Lost to Follow-up|5|||
147042806|NCT00134901|530316384|FG001|Overall Study|Lost to Follow-up|5|||
147042807|NCT00134901|530316383|FG000|Overall Study|discontinued intervention|12|||
147042808|NCT00134901|530316384|FG001|Overall Study|discontinued intervention|10|||
147042809|NCT02301390|530316387|FG000|Overall Study|Withdrawal by Subject|3|||
147042810|NCT02301390|530316388|FG001|Overall Study|Withdrawal by Subject|5|||
147042811|NCT02301390|530316387|FG000|Overall Study|Protocol Violation|1|||
147042812|NCT02301390|530316388|FG001|Overall Study|Protocol Violation|0|||
147042813|NCT02301390|530316387|FG000|Overall Study|Physician Decision|1|||
147042814|NCT02301390|530316388|FG001|Overall Study|Physician Decision|0|||
147042815|NCT02301390|530316387|FG000|Overall Study|Lost to Follow-up|0|||
147042816|NCT02301390|530316388|FG001|Overall Study|Lost to Follow-up|1|||
147042817|NCT02301390|530316387|FG000|Overall Study|Death|2|||
147042818|NCT02301390|530316388|FG001|Overall Study|Death|2|||
147042819|NCT02301390|530316387|FG000|Overall Study|Procedure not completed|0|||
147042820|NCT02301390|530316388|FG001|Overall Study|Procedure not completed|4|||
147042821|NCT02301390|530316387|FG000|Overall Study|Missed multiple visits|1|||
147042822|NCT02301390|530316388|FG001|Overall Study|Missed multiple visits|1|||
147042823|NCT02301390|530316387|FG000|Overall Study|study terminated|2|||
147042824|NCT02301390|530316388|FG001|Overall Study|study terminated|0|||
147042825|NCT00185588|530316389|FG000|Overall Study|Adverse Event|3|||
147042826|NCT00185588|530316390|FG001|Overall Study|Adverse Event|1|||
147042827|NCT00185588|530316391|FG002|Overall Study|Adverse Event|4|||
147042828|NCT00185588|530316392|FG003|Overall Study|Adverse Event|2|||
147042829|NCT00185588|530316389|FG000|Overall Study|Lost to Follow-up|0|||
147042830|NCT00185588|530316390|FG001|Overall Study|Lost to Follow-up|0|||
147042831|NCT00185588|530316391|FG002|Overall Study|Lost to Follow-up|1|||
147042832|NCT00185588|530316392|FG003|Overall Study|Lost to Follow-up|2|||
147042833|NCT00185588|530316389|FG000|Overall Study|Withdrawal by Subject|0|||
147042834|NCT00185588|530316390|FG001|Overall Study|Withdrawal by Subject|1|||
147042835|NCT00185588|530316391|FG002|Overall Study|Withdrawal by Subject|0|||
147042836|NCT00185588|530316392|FG003|Overall Study|Withdrawal by Subject|0|||
147042837|NCT00185588|530316389|FG000|Overall Study|Physician Decision|0|||
147042838|NCT00185588|530316390|FG001|Overall Study|Physician Decision|0|||
147042839|NCT00185588|530316391|FG002|Overall Study|Physician Decision|1|||
147042840|NCT00185588|530316392|FG003|Overall Study|Physician Decision|0|||
147042841|NCT00398866|530316393|FG000|Overall Study|Adverse Event|1|||
147042842|NCT00398866|530316394|FG001|Overall Study|Adverse Event|0|||
147042843|NCT00398866|530316395|FG002|Overall Study|Adverse Event|0|||
147042844|NCT00398866|530316393|FG000|Overall Study|Lack of Efficacy|0|||
147042845|NCT00398866|530316394|FG001|Overall Study|Lack of Efficacy|0|||
147042846|NCT00398866|530316395|FG002|Overall Study|Lack of Efficacy|1|||
147042847|NCT00398866|530316393|FG000|Overall Study|Lost to Follow-up|7|||
147042848|NCT00398866|530316394|FG001|Overall Study|Lost to Follow-up|6|||
147042849|NCT00398866|530316395|FG002|Overall Study|Lost to Follow-up|4|||
147042850|NCT00398866|530316393|FG000|Overall Study|Withdrawal by Subject|5|||
147042851|NCT00398866|530316394|FG001|Overall Study|Withdrawal by Subject|1|||
147042852|NCT00398866|530316395|FG002|Overall Study|Withdrawal by Subject|2|||
147042853|NCT00398866|530316393|FG000|Overall Study|Unable to complete requirements of study|1|||
147042854|NCT00398866|530316394|FG001|Overall Study|Unable to complete requirements of study|1|||
147042855|NCT00398866|530316395|FG002|Overall Study|Unable to complete requirements of study|1|||
147042856|NCT02481869|530316396|FG000|Overall Study|Lost to Follow-up|3|||
147042857|NCT02481869|530316397|FG001|Overall Study|Lost to Follow-up|4|||
147042858|NCT02481869|530316396|FG000|Overall Study|Withdrawal by Subject|2|||
147042859|NCT02481869|530316397|FG001|Overall Study|Withdrawal by Subject|0|||
147042860|NCT00191191|530316398|FG000|Overall Study|Entry Criteria Exclusion|2|||
147042861|NCT00191191|530316399|FG001|Overall Study|Entry Criteria Exclusion|0|||
147042862|NCT00191191|530316398|FG000|Overall Study|Treated with Another Systemic Agent|1|||
147042863|NCT00191191|530316399|FG001|Overall Study|Treated with Another Systemic Agent|1|||
147042864|NCT00191191|530316398|FG000|Overall Study|Adverse Event|11|||
147042865|NCT00191191|530316399|FG001|Overall Study|Adverse Event|21|||
147042866|NCT00191191|530316398|FG000|Overall Study|Progressive Disease|84|||
147042867|NCT00191191|530316399|FG001|Overall Study|Progressive Disease|72|||
147042868|NCT00191191|530316398|FG000|Overall Study|Toxicity After Dose Reduction|7|||
147042869|NCT00191191|530316399|FG001|Overall Study|Toxicity After Dose Reduction|8|||
147042870|NCT00191191|530316398|FG000|Overall Study|Family/Caregiver Decision|5|||
147042871|NCT00191191|530316399|FG001|Overall Study|Family/Caregiver Decision|7|||
147042872|NCT00191191|530316398|FG000|Overall Study|Lost to Follow-up|1|||
147042873|NCT00191191|530316399|FG001|Overall Study|Lost to Follow-up|0|||
147042874|NCT00191191|530316398|FG000|Overall Study|Physician Decision|3|||
147042875|NCT00191191|530316399|FG001|Overall Study|Physician Decision|2|||
147042876|NCT00191191|530316398|FG000|Overall Study|Good Clinical Practice Violation|0|||
147042877|NCT00191191|530316399|FG001|Overall Study|Good Clinical Practice Violation|1|||
147042878|NCT05246670|530316400|FG000|Overall Study|Withdrawal by Subject|2|||
147042879|NCT05246670|530316401|FG001|Overall Study|Withdrawal by Subject|3|||
147042880|NCT05246670|530316402|FG002|Overall Study|Withdrawal by Subject|0|||
147042881|NCT05246670|530316403|FG003|Overall Study|Withdrawal by Subject|1|||
147042882|NCT05246670|530316400|FG000|Overall Study|Adverse Event|0|||
147042883|NCT05246670|530316401|FG001|Overall Study|Adverse Event|0|||
147042884|NCT05246670|530316402|FG002|Overall Study|Adverse Event|1|||
147042885|NCT05246670|530316403|FG003|Overall Study|Adverse Event|0|||
147042886|NCT05246670|530316400|FG000|Overall Study|Physician Decision|1|||
147042887|NCT05246670|530316401|FG001|Overall Study|Physician Decision|0|||
147042888|NCT05246670|530316402|FG002|Overall Study|Physician Decision|0|||
147042889|NCT05246670|530316403|FG003|Overall Study|Physician Decision|0|||
147042890|NCT05246670|530316400|FG000|Overall Study|Protocol Violation|1|||
147042891|NCT05246670|530316401|FG001|Overall Study|Protocol Violation|0|||
147042892|NCT05246670|530316402|FG002|Overall Study|Protocol Violation|0|||
147042893|NCT05246670|530316403|FG003|Overall Study|Protocol Violation|0|||
147042894|NCT04152291|530316404|FG000|Overall Study|Covid-19 restrictions|27|||
147042895|NCT04152291|530316404|FG000|Overall Study|Withdrawal by Subject|3|||
147042896|NCT03597295|530316405|FG000|Overall Study|Death|70|||
147042897|NCT03597295|530316405|FG000|Overall Study|Lost to Follow-up|7|||
147042898|NCT05124691|530316406|FG000|Phase II|Eligibility criteria|0|||
147042899|NCT05124691|530316407|FG001|Phase II|Eligibility criteria|1|||
147042900|NCT05124691|530316408|FG002|Phase II|Eligibility criteria|0|||
147042901|NCT05124691|530316406|FG000|Phase II|Withdrawal by Subject|6|||
147042902|NCT05124691|530316407|FG001|Phase II|Withdrawal by Subject|2|||
147042903|NCT05124691|530316408|FG002|Phase II|Withdrawal by Subject|3|||
147042904|NCT05124691|530316406|FG000|Phase III|Withdrawal by Subject|6|||
147042905|NCT05124691|530316407|FG001|Phase III|Withdrawal by Subject|4|||
147042906|NCT05124691|530316408|FG002|Phase III|Withdrawal by Subject|4|||
147042907|NCT05124691|530316406|FG000|Phase III|Lost to Follow-up|1|||
147042908|NCT05124691|530316407|FG001|Phase III|Lost to Follow-up|0|||
147042909|NCT05124691|530316408|FG002|Phase III|Lost to Follow-up|0|||
147042910|NCT05211726|530316409|FG000|Overall Study|Withdrawal by Subject|2|||
147042911|NCT05211726|530316410|FG001|Overall Study|Withdrawal by Subject|3|||
147042912|NCT05211726|530316409|FG000|Overall Study|Protocol Violation|0|||
147042913|NCT05211726|530316410|FG001|Overall Study|Protocol Violation|1|||
147042914|NCT03509467|530316411|FG000|Overall Study|Withdrawal by Subject|5|||
147042915|NCT03509467|530316412|FG001|Overall Study|Withdrawal by Subject|1|||
147042916|NCT03509467|530316413|FG002|Overall Study|Withdrawal by Subject|6|||
147042917|NCT03509467|530316414|FG003|Overall Study|Withdrawal by Subject|7|||
147042918|NCT03509467|530316415|FG004|Overall Study|Withdrawal by Subject|10|||
147042919|NCT03509467|530316416|FG005|Overall Study|Withdrawal by Subject|10|||
147042920|NCT03509467|530316417|FG006|Overall Study|Withdrawal by Subject|10|||
147042921|NCT03509467|530316418|FG007|Overall Study|Withdrawal by Subject|10|||
147042922|NCT03509467|530316411|FG000|Overall Study|Death|0|||
147042923|NCT03509467|530316412|FG001|Overall Study|Death|0|||
147042924|NCT03509467|530316413|FG002|Overall Study|Death|2|||
147042925|NCT03509467|530316414|FG003|Overall Study|Death|2|||
147042926|NCT03509467|530316415|FG004|Overall Study|Death|1|||
147042927|NCT03509467|530316416|FG005|Overall Study|Death|0|||
147042928|NCT03509467|530316417|FG006|Overall Study|Death|1|||
147042929|NCT03509467|530316418|FG007|Overall Study|Death|0|||
147042930|NCT03509467|530316411|FG000|Overall Study|Proxy Withdrawal|0|||
147042931|NCT03509467|530316412|FG001|Overall Study|Proxy Withdrawal|0|||
147042932|NCT03509467|530316413|FG002|Overall Study|Proxy Withdrawal|0|||
147042933|NCT03509467|530316414|FG003|Overall Study|Proxy Withdrawal|0|||
147042934|NCT03509467|530316415|FG004|Overall Study|Proxy Withdrawal|0|||
147042935|NCT03509467|530316416|FG005|Overall Study|Proxy Withdrawal|0|||
147042936|NCT03509467|530316417|FG006|Overall Study|Proxy Withdrawal|0|||
147042937|NCT03509467|530316418|FG007|Overall Study|Proxy Withdrawal|1|||
147042938|NCT00428116|530316419|FG000|Overall Study|Death|1|||
147042939|NCT00428116|530316420|FG001|Overall Study|Death|0|||
147042940|NCT00428116|530316419|FG000|Overall Study|Withdrawal by Subject|1|||
147042941|NCT00428116|530316420|FG001|Overall Study|Withdrawal by Subject|0|||
147042942|NCT00428116|530316419|FG000|Overall Study|Lost to Follow-up|1|||
147042943|NCT00428116|530316420|FG001|Overall Study|Lost to Follow-up|0|||
147042944|NCT01141205|530316421|FG000|Overall Study|Physician Decision|1|||
147042945|NCT01141205|530316422|FG001|Overall Study|Physician Decision|1|||
147042946|NCT01141205|530316421|FG000|Overall Study|Lost to Follow-up|1|||
147042947|NCT01141205|530316422|FG001|Overall Study|Lost to Follow-up|0|||
147042948|NCT01141205|530316421|FG000|Overall Study|Withdrawal by Subject|1|||
147042949|NCT01141205|530316422|FG001|Overall Study|Withdrawal by Subject|1|||
147042950|NCT04759768|530316429|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
147042951|NCT04759768|530316430|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
147042952|NCT04759768|530316429|FG000|Washout (7 Days)|Physician Decision|0|||
147042953|NCT04759768|530316430|FG001|Washout (7 Days)|Physician Decision|1|||
147042954|NCT03340974|530316431|FG000|Completion of Study -Long Term Follow up|Death|8|||
147042955|NCT03340974|530316432|FG001|Completion of Study -Long Term Follow up|Death|5|||
147042956|NCT03340974|530316433|FG002|Completion of Study -Long Term Follow up|Death|5|||
147042957|NCT03340974|530316434|FG003|Completion of Study -Long Term Follow up|Death|7|||
147042958|NCT03340974|530316431|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
147042959|NCT03340974|530316432|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
147042960|NCT03340974|530316433|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
147042961|NCT03340974|530316434|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
147042962|NCT03340974|530316431|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
147042963|NCT03340974|530316432|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
147042964|NCT03340974|530316433|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
147042965|NCT03340974|530316434|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
147042966|NCT03340974|530316431|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
147042967|NCT03340974|530316432|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
147042968|NCT03340974|530316433|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
147042969|NCT03340974|530316434|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
147042970|NCT00396565|530316438|FG000|Overall Study|Physician Decision|3|||
147042971|NCT00396565|530316439|FG001|Overall Study|Physician Decision|1|||
147042972|NCT00396565|530316440|FG002|Overall Study|Physician Decision|2|||
147042973|NCT00396565|530316438|FG000|Overall Study|Adverse Event|5|||
147042974|NCT00396565|530316439|FG001|Overall Study|Adverse Event|13|||
147042975|NCT00396565|530316440|FG002|Overall Study|Adverse Event|3|||
147042976|NCT00396565|530316438|FG000|Overall Study|Withdrawal by Subject|8|||
147042977|NCT00396565|530316439|FG001|Overall Study|Withdrawal by Subject|13|||
147042978|NCT00396565|530316440|FG002|Overall Study|Withdrawal by Subject|1|||
147042979|NCT00396565|530316438|FG000|Overall Study|Lack of Efficacy|32|||
147042980|NCT00396565|530316439|FG001|Overall Study|Lack of Efficacy|64|||
147042981|NCT00396565|530316440|FG002|Overall Study|Lack of Efficacy|11|||
147042982|NCT04324021|530316444|FG000|Overall Study|Adverse Event|1|||
147042983|NCT04324021|530316445|FG001|Overall Study|Adverse Event|0|||
147042984|NCT04324021|530316446|FG002|Overall Study|Adverse Event|0|||
147042985|NCT04324021|530316444|FG000|Overall Study|Lack of Efficacy|0|||
147042986|NCT04324021|530316445|FG001|Overall Study|Lack of Efficacy|0|||
147042987|NCT04324021|530316446|FG002|Overall Study|Lack of Efficacy|1|||
147042988|NCT04324021|530316444|FG000|Overall Study|Death|1|||
147042989|NCT04324021|530316445|FG001|Overall Study|Death|1|||
147042990|NCT04324021|530316446|FG002|Overall Study|Death|0|||
147042991|NCT02006732|530316447|FG000|Overall Study|Adverse Event|10|||
147042992|NCT02006732|530316448|FG001|Overall Study|Adverse Event|7|||
147042993|NCT02006732|530316449|FG002|Overall Study|Adverse Event|4|||
147042994|NCT02006732|530316450|FG003|Overall Study|Adverse Event|2|||
147042995|NCT02006732|530316447|FG000|Overall Study|Lack of Efficacy|6|||
147042996|NCT02006732|530316448|FG001|Overall Study|Lack of Efficacy|3|||
147042997|NCT02006732|530316449|FG002|Overall Study|Lack of Efficacy|1|||
147042998|NCT02006732|530316450|FG003|Overall Study|Lack of Efficacy|1|||
147042999|NCT02006732|530316447|FG000|Overall Study|Protocol Violation|1|||
147043000|NCT02006732|530316448|FG001|Overall Study|Protocol Violation|1|||
147043001|NCT02006732|530316449|FG002|Overall Study|Protocol Violation|0|||
147043002|NCT02006732|530316450|FG003|Overall Study|Protocol Violation|0|||
147043003|NCT02006732|530316447|FG000|Overall Study|Lost to Follow-up|0|||
147043004|NCT02006732|530316448|FG001|Overall Study|Lost to Follow-up|1|||
147043005|NCT02006732|530316449|FG002|Overall Study|Lost to Follow-up|0|||
147043006|NCT02006732|530316450|FG003|Overall Study|Lost to Follow-up|0|||
147043007|NCT02006732|530316447|FG000|Overall Study|Withdrawal by Subject|3|||
147043008|NCT02006732|530316448|FG001|Overall Study|Withdrawal by Subject|0|||
147043009|NCT02006732|530316449|FG002|Overall Study|Withdrawal by Subject|4|||
147043010|NCT02006732|530316450|FG003|Overall Study|Withdrawal by Subject|1|||
147043011|NCT03516513|530316453|FG000|Overall Study|Withdrawal by Subject|2|||
147043012|NCT03516513|530316454|FG001|Overall Study|Withdrawal by Subject|2|||
147043013|NCT03516513|530316455|FG002|Overall Study|Withdrawal by Subject|0|||
147043014|NCT03516513|530316456|FG003|Overall Study|Withdrawal by Subject|0|||
147043015|NCT01130597|530316462|FG000|Overall Study|Protocol-specified (High K+)|1|||
147043016|NCT01130597|530316462|FG000|Overall Study|Adverse Event|4|||
147043017|NCT01130597|530316462|FG000|Overall Study|Death|1|||
147043018|NCT01130597|530316462|FG000|Overall Study|Protocol Violation|1|||
147043019|NCT03371459|530316463|FG000|Washout|Lost to Follow-up|0|||
147043020|NCT03371459|530316464|FG001|Washout|Lost to Follow-up|1|||
147043021|NCT01885195|530316465|FG000|Overall Study|Adverse Event|29|||
147043022|NCT01885195|530316465|FG000|Overall Study|Death|1|||
147043023|NCT01885195|530316465|FG000|Overall Study|Disease Progression|67|||
147043024|NCT01885195|530316465|FG000|Overall Study|Protocol Deviation|2|||
147043025|NCT01885195|530316465|FG000|Overall Study|Physician Decision|3|||
147043026|NCT01885195|530316465|FG000|Overall Study|Patient/guardian decision|8|||
147043027|NCT03390426|530316466|FG000|Overall Study|Protocol Violation|0|||
147043028|NCT03390426|530316467|FG001|Overall Study|Protocol Violation|1|||
147043029|NCT02521376|530316470|FG000|Overall Study|Enrolled, But Not Treated|1|||
147043030|NCT02521376|530316471|FG001|Overall Study|Enrolled, But Not Treated|0|||
147043031|NCT02521376|530316472|FG002|Overall Study|Enrolled, But Not Treated|0|||
147043032|NCT02521376|530316473|FG003|Overall Study|Enrolled, But Not Treated|0|||
147043033|NCT02759692|530316475|FG000|Period 1|Test article no longer available|1|||
147043034|NCT02759692|530316476|FG001|Period 1|Test article no longer available|1|||
147043035|NCT02759692|530316475|FG000|Period 1|No longer meets eligibility criteria.|1|||
147043036|NCT02759692|530316476|FG001|Period 1|No longer meets eligibility criteria.|0|||
147043037|NCT02759692|530316475|FG000|Period 1|Miss-Randomized|1|||
147043038|NCT02759692|530316476|FG001|Period 1|Miss-Randomized|1|||
147043039|NCT02759692|530316475|FG000|Period 2|Lost to Follow-up|1|||
147043040|NCT02759692|530316476|FG001|Period 2|Lost to Follow-up|0|||
147043041|NCT02759692|530316475|FG000|Period 2|Test article no longer available|0|||
147043042|NCT02759692|530316476|FG001|Period 2|Test article no longer available|1|||
147043043|NCT01954745|530316482|FG000|Overall Study|Radiological Progression|11|||
147043044|NCT01954745|530316482|FG000|Overall Study|Clinical Progression|5|||
147043045|NCT01954745|530316482|FG000|Overall Study|Adverse Event|2|||
147043046|NCT01954745|530316482|FG000|Overall Study|Death|1|||
147043047|NCT03922529|530318389|FG000|Overall Study|Withdrawal by Subject|13|||
147043048|NCT03922529|530318390|FG001|Overall Study|Withdrawal by Subject|12|||
147043049|NCT03922529|530318389|FG000|Overall Study|Death|7|||
147043050|NCT03922529|530318390|FG001|Overall Study|Death|12|||
147043051|NCT03922529|530318389|FG000|Overall Study|Lost to Follow-up|12|||
147043052|NCT03922529|530318390|FG001|Overall Study|Lost to Follow-up|19|||
147043053|NCT03922529|530318389|FG000|Overall Study|Adverse Event|1|||
147043054|NCT03922529|530318390|FG001|Overall Study|Adverse Event|0|||
147043055|NCT03922529|530318389|FG000|Overall Study|Death after withdrawal|1|||
147043056|NCT03922529|530318390|FG001|Overall Study|Death after withdrawal|0|||
147043057|NCT03922529|530318389|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
147043058|NCT03922529|530318390|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
147043059|NCT03922529|530318389|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
147043060|NCT03922529|530318390|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
147043061|NCT01277601|530318391|FG000|Overall Study|Adverse Event|5|||
147043062|NCT01277601|530318392|FG001|Overall Study|Adverse Event|3|||
147043063|NCT01277601|530318393|FG002|Overall Study|Adverse Event|0|||
147043064|NCT01277601|530318394|FG003|Overall Study|Adverse Event|7|||
147043065|NCT01277601|530318391|FG000|Overall Study|Withdrawal by Subject|18|||
147043066|NCT01277601|530318392|FG001|Overall Study|Withdrawal by Subject|21|||
147043067|NCT01277601|530318393|FG002|Overall Study|Withdrawal by Subject|8|||
147043068|NCT01277601|530318394|FG003|Overall Study|Withdrawal by Subject|17|||
147043069|NCT01277601|530318391|FG000|Overall Study|Lost to Follow-up|7|||
147043070|NCT01277601|530318392|FG001|Overall Study|Lost to Follow-up|9|||
147043071|NCT01277601|530318393|FG002|Overall Study|Lost to Follow-up|4|||
147043072|NCT01277601|530318394|FG003|Overall Study|Lost to Follow-up|2|||
147043073|NCT01277601|530318391|FG000|Overall Study|Physician Decision|3|||
147043074|NCT01277601|530318392|FG001|Overall Study|Physician Decision|5|||
147043075|NCT01277601|530318393|FG002|Overall Study|Physician Decision|1|||
147043076|NCT01277601|530318394|FG003|Overall Study|Physician Decision|6|||
147043077|NCT01277601|530318391|FG000|Overall Study|Pregnancy|2|||
147043078|NCT01277601|530318392|FG001|Overall Study|Pregnancy|2|||
147043079|NCT01277601|530318393|FG002|Overall Study|Pregnancy|4|||
147043080|NCT01277601|530318394|FG003|Overall Study|Pregnancy|1|||
147043081|NCT01277601|530318391|FG000|Overall Study|Noncompliance with Study Drug|1|||
147043082|NCT01277601|530318392|FG001|Overall Study|Noncompliance with Study Drug|3|||
147043083|NCT01277601|530318393|FG002|Overall Study|Noncompliance with Study Drug|2|||
147043084|NCT01277601|530318394|FG003|Overall Study|Noncompliance with Study Drug|0|||
147043085|NCT01277601|530318391|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
147043086|NCT01277601|530318392|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
147043087|NCT01277601|530318393|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
147043088|NCT01277601|530318394|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
147043089|NCT01277601|530318391|FG000|Overall Study|Protocol Violation|0|||
147043090|NCT01277601|530318392|FG001|Overall Study|Protocol Violation|2|||
147043091|NCT01277601|530318393|FG002|Overall Study|Protocol Violation|5|||
147043092|NCT01277601|530318394|FG003|Overall Study|Protocol Violation|0|||
147043093|NCT01277601|530318391|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
147043094|NCT01277601|530318392|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
147043095|NCT01277601|530318393|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
147043096|NCT01277601|530318394|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
147043097|NCT04034927|530318395|FG000|Overall Study|Adverse Event|4|||
147043098|NCT04034927|530318396|FG001|Overall Study|Adverse Event|9|||
147043099|NCT04034927|530318395|FG000|Overall Study|Death|0|||
147043100|NCT04034927|530318396|FG001|Overall Study|Death|1|||
147043101|NCT04034927|530318395|FG000|Overall Study|Withdrawal by Subject|0|||
147043102|NCT04034927|530318396|FG001|Overall Study|Withdrawal by Subject|3|||
147043103|NCT04034927|530318395|FG000|Overall Study|Still on Treatment|2|||
147043104|NCT04034927|530318396|FG001|Overall Study|Still on Treatment|1|||
147043105|NCT04034927|530318395|FG000|Overall Study|Other|1|||
147043106|NCT04034927|530318396|FG001|Overall Study|Other|1|||
147043107|NCT04158245|530318397|FG000|Overall Study|Lost to Follow-up|1|||
147043108|NCT01433055|530318401|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
147043109|NCT01433055|530318402|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
147043110|NCT01433055|530318401|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
147043111|NCT01433055|530318402|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
147043112|NCT00678210|530318407|FG000|Overall Study|Adverse Event|1|||
147043113|NCT00678210|530318408|FG001|Overall Study|Adverse Event|2|||
147043114|NCT00678210|530318409|FG002|Overall Study|Adverse Event|3|||
147043115|NCT00678210|530318410|FG003|Overall Study|Adverse Event|3|||
147043116|NCT00678210|530318407|FG000|Overall Study|Lack of Efficacy|2|||
147043117|NCT00678210|530318408|FG001|Overall Study|Lack of Efficacy|3|||
147043118|NCT00678210|530318409|FG002|Overall Study|Lack of Efficacy|1|||
147043119|NCT00678210|530318410|FG003|Overall Study|Lack of Efficacy|9|||
147043120|NCT00678210|530318407|FG000|Overall Study|Lost to Follow-up|4|||
147043121|NCT00678210|530318408|FG001|Overall Study|Lost to Follow-up|2|||
147043122|NCT00678210|530318409|FG002|Overall Study|Lost to Follow-up|0|||
147043123|NCT00678210|530318410|FG003|Overall Study|Lost to Follow-up|1|||
147043124|NCT00678210|530318407|FG000|Overall Study|Withdrawal by Subject|3|||
147043125|NCT00678210|530318408|FG001|Overall Study|Withdrawal by Subject|4|||
147043126|NCT00678210|530318409|FG002|Overall Study|Withdrawal by Subject|1|||
147043127|NCT00678210|530318410|FG003|Overall Study|Withdrawal by Subject|7|||
147043128|NCT00678210|530318407|FG000|Overall Study|Other|1|||
147043129|NCT00678210|530318408|FG001|Overall Study|Other|0|||
147043130|NCT00678210|530318409|FG002|Overall Study|Other|1|||
147043131|NCT00678210|530318410|FG003|Overall Study|Other|0|||
147043132|NCT04825912|530318411|FG000|Overall Study|Death|3|||
147043133|NCT04825912|530318411|FG000|Overall Study|Withdrawal by Subject|1|||
147043134|NCT03965689|530318412|FG000|Overall Study|Too sick to get study intervention|2|||
147043135|NCT01383707|530318417|FG000|Overall Study|Consent withdrawal|6|||
147043136|NCT01383707|530318417|FG000|Overall Study|Death|19|||
147043137|NCT01383707|530318417|FG000|Overall Study|Other|8|||
147043138|NCT01383707|530318417|FG000|Overall Study|Sponsor's decision|2|||
147043139|NCT01383707|530318417|FG000|Overall Study|Adverse Event|14|||
147043140|NCT01383707|530318417|FG000|Overall Study|Progressive disease|23|||
147043141|NCT00855894|530318418|FG000|Overall Study|Death|31|||
147043142|NCT00855894|530318418|FG000|Overall Study|Patient's decision|1|||
147043143|NCT00855894|530318418|FG000|Overall Study|Disease progression|1|||
147043144|NCT03055624|530318419|FG000|Overall Study|Study closed|9|||
147043145|NCT02437903|530318420|FG000|Overall Study|Adverse Event|1|||
147043146|NCT02437903|530318420|FG000|Overall Study|Withdrawal by Subject|1|||
147043147|NCT02437903|530318420|FG000|Overall Study|Lost to Follow-up|3|||
147043148|NCT01121562|530318423|FG000|Overall Study|Objective progression or relapse|8|||
147043149|NCT01121562|530318423|FG000|Overall Study|Withdrawal by Subject|1|||
147043150|NCT01121562|530318423|FG000|Overall Study|Adverse Event|1|||
147043151|NCT01121562|530318423|FG000|Overall Study|Sponsor Decision|1|||
147043152|NCT01121562|530318423|FG000|Overall Study|Met study discontinuation criteria|1|||
147043153|NCT04289363|530318424|FG000|Overall Study|Lost to Follow-up|14|||
147043154|NCT04289363|530318425|FG001|Overall Study|Lost to Follow-up|0|||
147043155|NCT03790657|530318426|FG000|Overall Study|Adverse Event|1|||
147043156|NCT03790657|530318427|FG001|Overall Study|Adverse Event|1|||
147043157|NCT03790657|530318426|FG000|Overall Study|Withdrawal by Subject|1|||
147043158|NCT03790657|530318427|FG001|Overall Study|Withdrawal by Subject|1|||
147043159|NCT03971474|530318428|FG000|Overall Study|Adverse Event|11|||
147043160|NCT03971474|530318429|FG001|Overall Study|Adverse Event|7|||
147043161|NCT03971474|530318428|FG000|Overall Study|Refusal unrelated to adverse event|5|||
147043162|NCT03971474|530318429|FG001|Overall Study|Refusal unrelated to adverse event|1|||
147043163|NCT03971474|530318428|FG000|Overall Study|Progression/relapse|40|||
147043164|NCT03971474|530318429|FG001|Overall Study|Progression/relapse|47|||
147043165|NCT03971474|530318428|FG000|Overall Study|Death|6|||
147043166|NCT03971474|530318429|FG001|Overall Study|Death|3|||
147043167|NCT03971474|530318428|FG000|Overall Study|Other - not protocol specified|5|||
147043168|NCT03971474|530318429|FG001|Overall Study|Other - not protocol specified|4|||
147043169|NCT03971474|530318428|FG000|Overall Study|On treatment|0|||
147043170|NCT03971474|530318429|FG001|Overall Study|On treatment|7|||
147043171|NCT02370238|530318430|FG000|Overall Study|Death|42|||
147043172|NCT02370238|530318431|FG001|Overall Study|Death|35|||
147043173|NCT02370238|530318430|FG000|Overall Study|Lost to Follow-up|1|||
147043174|NCT02370238|530318431|FG001|Overall Study|Lost to Follow-up|3|||
147043175|NCT02370238|530318430|FG000|Overall Study|Withdrawal by Subject|2|||
147043176|NCT02370238|530318431|FG001|Overall Study|Withdrawal by Subject|6|||
147043177|NCT02370238|530318430|FG000|Overall Study|Other|2|||
147043178|NCT02370238|530318431|FG001|Overall Study|Other|1|||
147043179|NCT01807065|530318432|FG000|Overall Study|Receive no sip-T due to IV access|1|||
147043180|NCT01807065|530318433|FG001|Overall Study|Receive no sip-T due to IV access|1|||
147043181|NCT01153425|530318434|FG000|Overall Study|Withdrawal by Subject|3|||
147043182|NCT01153425|530318435|FG001|Overall Study|Withdrawal by Subject|3|||
147043183|NCT01482312|530318436|FG000|Period 1, 90 Minutes of Wear|Other|1|||
147043184|NCT01482312|530318437|FG001|Period 1, 90 Minutes of Wear|Other|0|||
147043185|NCT01482312|530318438|FG002|Period 1, 90 Minutes of Wear|Other|0|||
147043186|NCT01482312|530318436|FG000|Period 2, 90 Minutes of Wear|Other|1|||
147043187|NCT01482312|530318437|FG001|Period 2, 90 Minutes of Wear|Other|0|||
147043188|NCT01482312|530318438|FG002|Period 2, 90 Minutes of Wear|Other|0|||
147043189|NCT01699815|530318439|FG000|Overall Study|Protocol Violation|4|||
147043190|NCT01699815|530318440|FG001|Overall Study|Protocol Violation|7|||
147043191|NCT01699815|530318439|FG000|Overall Study|record could not be located|1|||
147043192|NCT01699815|530318440|FG001|Overall Study|record could not be located|0|||
147043193|NCT01699815|530318439|FG000|Overall Study|Adverse Event|0|||
147043194|NCT01699815|530318440|FG001|Overall Study|Adverse Event|1|||
147043195|NCT01295320|530318441|FG000|Overall Study|Adverse Event|2|||
147043196|NCT01295320|530318441|FG000|Overall Study|Lost to Follow-up|4|||
147043197|NCT01295320|530318441|FG000|Overall Study|Withdrawal by Subject|2|||
147043198|NCT01295320|530318441|FG000|Overall Study|Subject was bedridden|1|||
147043199|NCT01295320|530318441|FG000|Overall Study|Unable to travel|1|||
147043200|NCT04877457|530318444|FG000|Overall Study|Early termination of study due to low enrollment|2|||
147043201|NCT04877457|530318445|FG001|Overall Study|Early termination of study due to low enrollment|1|||
147043202|NCT02211417|530318446|FG000|Overall Study|Withdrawal by Subject|11|||
147043203|NCT02211417|530318447|FG001|Overall Study|Withdrawal by Subject|8|||
147043204|NCT02211417|530318446|FG000|Overall Study|Protocol Violation|1|||
147043205|NCT02211417|530318447|FG001|Overall Study|Protocol Violation|0|||
147043206|NCT02211417|530318446|FG000|Overall Study|Pregnancy|0|||
147043207|NCT02211417|530318447|FG001|Overall Study|Pregnancy|1|||
147043208|NCT02211417|530318446|FG000|Overall Study|Lost to Follow-up|2|||
147043209|NCT02211417|530318447|FG001|Overall Study|Lost to Follow-up|3|||
147043210|NCT02211417|530318446|FG000|Overall Study|Adverse Event|1|||
147043211|NCT02211417|530318447|FG001|Overall Study|Adverse Event|4|||
147043212|NCT01198132|530318448|FG000|Overall Study|Withdrawal by Subject|4|||
147043213|NCT01198132|530318449|FG001|Overall Study|Withdrawal by Subject|5|||
147043214|NCT01198132|530318448|FG000|Overall Study|Physician Decision|5|||
147043215|NCT01198132|530318449|FG001|Overall Study|Physician Decision|4|||
147043216|NCT01198132|530318448|FG000|Overall Study|Other Unspecified|3|||
147043217|NCT01198132|530318449|FG001|Overall Study|Other Unspecified|6|||
147043218|NCT01198132|530318448|FG000|Overall Study|Lack of Efficacy|2|||
147043219|NCT01198132|530318449|FG001|Overall Study|Lack of Efficacy|3|||
147043220|NCT01198132|530318448|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
147043221|NCT01198132|530318449|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
147043222|NCT01198132|530318448|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
147043223|NCT01198132|530318449|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
147043224|NCT01198132|530318448|FG000|Overall Study|Adverse Event|0|||
147043225|NCT01198132|530318449|FG001|Overall Study|Adverse Event|1|||
147043226|NCT01198132|530318448|FG000|Overall Study|Protocol Violation|1|||
147043227|NCT01198132|530318449|FG001|Overall Study|Protocol Violation|0|||
147043228|NCT01755091|530318450|FG000|Overall Study|Withdrawal by Subject|6|||
147043229|NCT01755091|530318451|FG001|Overall Study|Withdrawal by Subject|1|||
147043230|NCT01755091|530318452|FG002|Overall Study|Withdrawal by Subject|3|||
147043231|NCT01755091|530318450|FG000|Overall Study|Adverse Event|1|||
147043232|NCT01755091|530318451|FG001|Overall Study|Adverse Event|1|||
147043233|NCT01755091|530318452|FG002|Overall Study|Adverse Event|1|||
147043234|NCT01755091|530318450|FG000|Overall Study|Lost to Follow-up|1|||
147043235|NCT01755091|530318451|FG001|Overall Study|Lost to Follow-up|0|||
147043236|NCT01755091|530318452|FG002|Overall Study|Lost to Follow-up|1|||
147043237|NCT01755091|530318450|FG000|Overall Study|Physician Decision|1|||
147043238|NCT01755091|530318451|FG001|Overall Study|Physician Decision|1|||
147043239|NCT01755091|530318452|FG002|Overall Study|Physician Decision|2|||
147043240|NCT03071276|530318453|FG000|Overall Study|Adverse Event|1|||
147043241|NCT03071276|530318453|FG000|Overall Study|Lack of Efficacy|14|||
147043242|NCT05794503|530318454|FG000|Overall Study|Operation Cancelled|2|||
147043243|NCT05794503|530318455|FG001|Overall Study|Operation Cancelled|0|||
147043244|NCT05794503|530318454|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
147043245|NCT05794503|530318455|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
147043246|NCT05794503|530318454|FG000|Overall Study|Protocol Violation|1|||
147043247|NCT05794503|530318455|FG001|Overall Study|Protocol Violation|0|||
147043248|NCT03694327|530318458|FG000|Overall Study|Lost to Follow-up|13|||
147043249|NCT03694327|530318459|FG001|Overall Study|Lost to Follow-up|23|||
147043250|NCT02185053|530318460|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
147043251|NCT02185053|530318461|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
147043252|NCT02185053|530318462|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
147043253|NCT02185053|530318460|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
147043254|NCT02185053|530318461|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
147043255|NCT02185053|530318462|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
147043256|NCT02185053|530318460|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
147043257|NCT02185053|530318461|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
147043258|NCT02185053|530318462|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
147043259|NCT02185053|530318460|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
147043260|NCT02185053|530318461|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
147043261|NCT02185053|530318462|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
147043262|NCT02185053|530318460|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
147043263|NCT02185053|530318461|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
147043264|NCT02185053|530318462|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
147043265|NCT02185053|530318460|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
147043266|NCT02185053|530318461|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
147043267|NCT02185053|530318462|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
147043268|NCT02185053|530318460|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
147043269|NCT02185053|530318461|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
147043270|NCT02185053|530318462|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
147043271|NCT02185053|530318460|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
147043272|NCT02185053|530318461|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
147043273|NCT02185053|530318462|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
147043274|NCT00307437|530318463|FG000|Controlled Period|Adverse Event|7|||
147043275|NCT00307437|530318464|FG001|Controlled Period|Adverse Event|2|||
147043276|NCT00307437|530318465|FG002|Controlled Period|Adverse Event|5|||
147043277|NCT00307437|530318466|FG003|Controlled Period|Adverse Event|0|||
147043278|NCT00307437|530318467|FG004|Controlled Period|Adverse Event|0|||
147043279|NCT00307437|530318468|FG005|Controlled Period|Adverse Event|0|||
147043280|NCT00307437|530318469|FG006|Controlled Period|Adverse Event|0|||
147043281|NCT00307437|530318463|FG000|Controlled Period|Death|0|||
147043282|NCT00307437|530318464|FG001|Controlled Period|Death|0|||
147043283|NCT00307437|530318465|FG002|Controlled Period|Death|1|||
147043284|NCT00307437|530318466|FG003|Controlled Period|Death|0|||
147043285|NCT00307437|530318467|FG004|Controlled Period|Death|0|||
147043286|NCT00307437|530318468|FG005|Controlled Period|Death|0|||
147043287|NCT00307437|530318469|FG006|Controlled Period|Death|0|||
147043288|NCT00307437|530318463|FG000|Controlled Period|Lack of Efficacy|2|||
147043289|NCT00307437|530318464|FG001|Controlled Period|Lack of Efficacy|0|||
147043290|NCT00307437|530318465|FG002|Controlled Period|Lack of Efficacy|0|||
147043291|NCT00307437|530318466|FG003|Controlled Period|Lack of Efficacy|0|||
147043292|NCT00307437|530318467|FG004|Controlled Period|Lack of Efficacy|0|||
147043293|NCT00307437|530318468|FG005|Controlled Period|Lack of Efficacy|0|||
147043294|NCT00307437|530318469|FG006|Controlled Period|Lack of Efficacy|0|||
147043295|NCT00307437|530318463|FG000|Controlled Period|Lost to Follow-up|2|||
147043296|NCT00307437|530318464|FG001|Controlled Period|Lost to Follow-up|3|||
147043297|NCT00307437|530318465|FG002|Controlled Period|Lost to Follow-up|0|||
147043298|NCT00307437|530318466|FG003|Controlled Period|Lost to Follow-up|0|||
147043299|NCT00307437|530318467|FG004|Controlled Period|Lost to Follow-up|0|||
147043300|NCT00307437|530318468|FG005|Controlled Period|Lost to Follow-up|0|||
147043301|NCT00307437|530318469|FG006|Controlled Period|Lost to Follow-up|0|||
147043302|NCT00307437|530318463|FG000|Controlled Period|Other|5|||
147043303|NCT00307437|530318464|FG001|Controlled Period|Other|1|||
147043304|NCT00307437|530318465|FG002|Controlled Period|Other|3|||
147043305|NCT00307437|530318466|FG003|Controlled Period|Other|0|||
147043306|NCT00307437|530318467|FG004|Controlled Period|Other|0|||
147043307|NCT00307437|530318468|FG005|Controlled Period|Other|0|||
147043308|NCT00307437|530318469|FG006|Controlled Period|Other|0|||
147043309|NCT00307437|530318463|FG000|After Controlled Period|Adverse Event|0|||
147043310|NCT00307437|530318464|FG001|After Controlled Period|Adverse Event|0|||
147043311|NCT00307437|530318465|FG002|After Controlled Period|Adverse Event|0|||
147043312|NCT00307437|530318466|FG003|After Controlled Period|Adverse Event|18|||
147043313|NCT00307437|530318467|FG004|After Controlled Period|Adverse Event|16|||
147043314|NCT00307437|530318468|FG005|After Controlled Period|Adverse Event|31|||
147043315|NCT00307437|530318469|FG006|After Controlled Period|Adverse Event|40|||
147043316|NCT00307437|530318463|FG000|After Controlled Period|Death|0|||
147043317|NCT00307437|530318464|FG001|After Controlled Period|Death|0|||
147043318|NCT00307437|530318465|FG002|After Controlled Period|Death|0|||
147043319|NCT00307437|530318466|FG003|After Controlled Period|Death|3|||
147043320|NCT00307437|530318467|FG004|After Controlled Period|Death|1|||
147043321|NCT00307437|530318468|FG005|After Controlled Period|Death|1|||
147043322|NCT00307437|530318469|FG006|After Controlled Period|Death|3|||
147043323|NCT00307437|530318463|FG000|After Controlled Period|Lack of Efficacy|0|||
147043324|NCT00307437|530318464|FG001|After Controlled Period|Lack of Efficacy|0|||
147043325|NCT00307437|530318465|FG002|After Controlled Period|Lack of Efficacy|0|||
147043326|NCT00307437|530318466|FG003|After Controlled Period|Lack of Efficacy|15|||
147043327|NCT00307437|530318467|FG004|After Controlled Period|Lack of Efficacy|17|||
147043328|NCT00307437|530318468|FG005|After Controlled Period|Lack of Efficacy|37|||
147043329|NCT00307437|530318469|FG006|After Controlled Period|Lack of Efficacy|24|||
147043330|NCT00307437|530318463|FG000|After Controlled Period|Lost to Follow-up|0|||
147043331|NCT00307437|530318464|FG001|After Controlled Period|Lost to Follow-up|0|||
147043332|NCT00307437|530318465|FG002|After Controlled Period|Lost to Follow-up|0|||
147043333|NCT00307437|530318466|FG003|After Controlled Period|Lost to Follow-up|7|||
147043334|NCT00307437|530318467|FG004|After Controlled Period|Lost to Follow-up|12|||
147043335|NCT00307437|530318468|FG005|After Controlled Period|Lost to Follow-up|13|||
147043336|NCT00307437|530318469|FG006|After Controlled Period|Lost to Follow-up|18|||
147043337|NCT00307437|530318463|FG000|After Controlled Period|Other|0|||
147043338|NCT00307437|530318464|FG001|After Controlled Period|Other|0|||
147043339|NCT00307437|530318465|FG002|After Controlled Period|Other|0|||
147043340|NCT00307437|530318466|FG003|After Controlled Period|Other|15|||
147043341|NCT00307437|530318467|FG004|After Controlled Period|Other|9|||
147043342|NCT00307437|530318468|FG005|After Controlled Period|Other|40|||
147043343|NCT00307437|530318469|FG006|After Controlled Period|Other|28|||
147043344|NCT00509795|530318475|FG000|Overall Study|Adverse Event|4|||
147043345|NCT00509795|530318476|FG001|Overall Study|Adverse Event|3|||
147043346|NCT00509795|530318477|FG002|Overall Study|Adverse Event|5|||
147043347|NCT00509795|530318478|FG003|Overall Study|Adverse Event|4|||
147043348|NCT00509795|530318475|FG000|Overall Study|Death|3|||
147043349|NCT00509795|530318476|FG001|Overall Study|Death|1|||
147043350|NCT00509795|530318477|FG002|Overall Study|Death|2|||
147043351|NCT00509795|530318478|FG003|Overall Study|Death|7|||
147043352|NCT00509795|530318475|FG000|Overall Study|Lack of Efficacy|0|||
147043353|NCT00509795|530318476|FG001|Overall Study|Lack of Efficacy|0|||
147043354|NCT00509795|530318477|FG002|Overall Study|Lack of Efficacy|2|||
147043355|NCT00509795|530318478|FG003|Overall Study|Lack of Efficacy|2|||
147043356|NCT00509795|530318475|FG000|Overall Study|Lost to Follow-up|1|||
147043357|NCT00509795|530318476|FG001|Overall Study|Lost to Follow-up|2|||
147043358|NCT00509795|530318477|FG002|Overall Study|Lost to Follow-up|4|||
147043359|NCT00509795|530318478|FG003|Overall Study|Lost to Follow-up|4|||
147043360|NCT00509795|530318475|FG000|Overall Study|OTHER|1|||
147043361|NCT00509795|530318476|FG001|Overall Study|OTHER|0|||
147043362|NCT00509795|530318477|FG002|Overall Study|OTHER|4|||
147043363|NCT00509795|530318478|FG003|Overall Study|OTHER|1|||
147043364|NCT00509795|530318475|FG000|Overall Study|Protocol Violation|3|||
147043365|NCT00509795|530318476|FG001|Overall Study|Protocol Violation|0|||
147043366|NCT00509795|530318477|FG002|Overall Study|Protocol Violation|3|||
147043367|NCT00509795|530318478|FG003|Overall Study|Protocol Violation|1|||
147043368|NCT00509795|530318475|FG000|Overall Study|Withdrawal by Subject|10|||
147043369|NCT00509795|530318476|FG001|Overall Study|Withdrawal by Subject|5|||
147043370|NCT00509795|530318477|FG002|Overall Study|Withdrawal by Subject|7|||
147043371|NCT00509795|530318478|FG003|Overall Study|Withdrawal by Subject|8|||
147043372|NCT00338728|530318479|FG000|Overall Study|Screen Failure|14|||
147043373|NCT00143247|530318485|FG000|Overall Study|Death|8|||
147043374|NCT00143247|530318485|FG000|Overall Study|Adverse Event|19|||
147043375|NCT00143247|530318485|FG000|Overall Study|Lack of Efficacy|3|||
147043376|NCT00143247|530318485|FG000|Overall Study|Withdrawal by Subject|55|||
147043377|NCT00143247|530318485|FG000|Overall Study|Study terminated by sponsor|31|||
147043378|NCT00143247|530318485|FG000|Overall Study|Protocol Violation|15|||
147043379|NCT00143247|530318485|FG000|Overall Study|Lost to Follow-up|12|||
147043380|NCT00143247|530318485|FG000|Overall Study|following inaccurate lab adverse event|1|||
147043381|NCT00143247|530318485|FG000|Overall Study|Other|12|||
147043382|NCT02933255|530318488|FG000|Overall Study|Discontinued due to study closure.|1|||
147043383|NCT02933255|530318489|FG001|Overall Study|Discontinued due to study closure.|0|||
147043384|NCT02766283|530318490|FG000|Overall Study|Lost to Follow-up|27|||
147043385|NCT00805961|530318491|FG000|Modality Therapy|Withdrawal by Subject|1|||
147043386|NCT00805961|530318491|FG000|Modality Therapy|Adverse Event|1|||
147043387|NCT00805961|530318491|FG000|Modality Therapy|Disease Progression|2|||
147043388|NCT00805961|530318491|FG000|Treatment-Free Interval|Adverse Event|3|||
147043389|NCT00805961|530318491|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
147043390|NCT00805961|530318491|FG000|Treatment-Free Interval|Physician Decision|1|||
147043391|NCT00805961|530318491|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
147043392|NCT00805961|530318491|FG000|Maintenance Treatment|Lack of Efficacy|13|||
147043393|NCT00805961|530318491|FG000|Maintenance Treatment|Intercurrent Illness|7|||
147043394|NCT00805961|530318491|FG000|Maintenance Treatment|Adverse Event|6|||
147043395|NCT00805961|530318491|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
147043396|NCT00805961|530318491|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
147043397|NCT00805961|530318491|FG000|Maintenance Treatment|Withdrawn Consent|1|||
147043398|NCT04380961|530318492|FG000|Overall Study|Lost to Follow-up|17|||
147043399|NCT04380961|530318493|FG001|Overall Study|Lost to Follow-up|11|||
147043400|NCT04380961|530318492|FG000|Overall Study|Withdrawal by Subject|3|||
147043401|NCT04380961|530318493|FG001|Overall Study|Withdrawal by Subject|0|||
147043402|NCT04380961|530318492|FG000|Overall Study|Death|22|||
147043403|NCT04380961|530318493|FG001|Overall Study|Death|16|||
147043404|NCT04380961|530318492|FG000|Overall Study|Other|1|||
147043405|NCT04380961|530318493|FG001|Overall Study|Other|0|||
147043406|NCT04380961|530318492|FG000|Overall Study|Randomized but Not Treated|1|||
147043407|NCT04380961|530318493|FG001|Overall Study|Randomized but Not Treated|2|||
147043408|NCT04803305|530318494|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
147043409|NCT04803305|530318495|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
147043410|NCT04803305|530318494|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
147043411|NCT04803305|530318495|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
147043412|NCT04803305|530318494|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
147043413|NCT04803305|530318495|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
147043414|NCT04803305|530318494|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
147043415|NCT04803305|530318495|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
147043416|NCT04803305|530318494|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
147043417|NCT04803305|530318495|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
147043418|NCT04803305|530318494|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
147043419|NCT04803305|530318495|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
147043420|NCT04803305|530318494|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
147043421|NCT04803305|530318495|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
147043422|NCT04803305|530318494|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
147043423|NCT04803305|530318495|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
147043424|NCT01862484|530318497|FG000|Overall Study|Lack of Efficacy|1|||
147043425|NCT01862484|530318498|FG001|Overall Study|Lack of Efficacy|1|||
147043426|NCT01862484|530318497|FG000|Overall Study|Lost to Follow-up|1|||
147043427|NCT01862484|530318498|FG001|Overall Study|Lost to Follow-up|2|||
147043428|NCT01862484|530318497|FG000|Overall Study|Protocol Violation|0|||
147043429|NCT01862484|530318498|FG001|Overall Study|Protocol Violation|2|||
147043430|NCT01862484|530318497|FG000|Overall Study|Withdrawal by Subject|0|||
147043431|NCT01862484|530318498|FG001|Overall Study|Withdrawal by Subject|3|||
147043432|NCT00721227|530318499|FG000|Overall Study|Lost to Follow-up|3|||
147043433|NCT00721227|530318500|FG001|Overall Study|Lost to Follow-up|0|||
147043434|NCT00721227|530318499|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
147043435|NCT00721227|530318500|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
147043436|NCT03207867|530318501|FG000|Overall Study|Adverse Event|1|||
147043437|NCT03207867|530318502|FG001|Overall Study|Adverse Event|0|||
147043438|NCT03207867|530318503|FG002|Overall Study|Adverse Event|1|||
147043439|NCT03207867|530318504|FG003|Overall Study|Adverse Event|0|||
147043440|NCT03207867|530318505|FG004|Overall Study|Adverse Event|0|||
147043441|NCT03207867|530318506|FG005|Overall Study|Adverse Event|2|||
147043442|NCT03207867|530318507|FG006|Overall Study|Adverse Event|1|||
147043443|NCT03207867|530318508|FG007|Overall Study|Adverse Event|1|||
147043444|NCT03207867|530318509|FG008|Overall Study|Adverse Event|2|||
147043445|NCT03207867|530318510|FG009|Overall Study|Adverse Event|2|||
147043446|NCT03207867|530318511|FG010|Overall Study|Adverse Event|0|||
147043447|NCT03207867|530318512|FG011|Overall Study|Adverse Event|0|||
147043448|NCT03207867|530318513|FG012|Overall Study|Adverse Event|0|||
147043449|NCT03207867|530318514|FG013|Overall Study|Adverse Event|0|||
147043450|NCT03207867|530318515|FG014|Overall Study|Adverse Event|0|||
147043451|NCT03207867|530318516|FG015|Overall Study|Adverse Event|0|||
147043452|NCT03207867|530318517|FG016|Overall Study|Adverse Event|3|||
147043453|NCT03207867|530318518|FG017|Overall Study|Adverse Event|1|||
147043454|NCT03207867|530318519|FG018|Overall Study|Adverse Event|2|||
147043455|NCT03207867|530318520|FG019|Overall Study|Adverse Event|1|||
147043456|NCT03207867|530318521|FG020|Overall Study|Adverse Event|0|||
147043457|NCT03207867|530318522|FG021|Overall Study|Adverse Event|0|||
147043458|NCT03207867|530318523|FG022|Overall Study|Adverse Event|0|||
147043459|NCT03207867|530318524|FG023|Overall Study|Adverse Event|0|||
147043460|NCT03207867|530318501|FG000|Overall Study|Death|0|||
147043461|NCT03207867|530318502|FG001|Overall Study|Death|0|||
147043462|NCT03207867|530318503|FG002|Overall Study|Death|0|||
147043463|NCT03207867|530318504|FG003|Overall Study|Death|0|||
147043464|NCT03207867|530318505|FG004|Overall Study|Death|0|||
147043465|NCT03207867|530318506|FG005|Overall Study|Death|1|||
147043466|NCT03207867|530318507|FG006|Overall Study|Death|0|||
147043467|NCT03207867|530318508|FG007|Overall Study|Death|3|||
147043468|NCT03207867|530318509|FG008|Overall Study|Death|1|||
147043469|NCT03207867|530318510|FG009|Overall Study|Death|2|||
147043470|NCT03207867|530318511|FG010|Overall Study|Death|0|||
147043471|NCT03207867|530318512|FG011|Overall Study|Death|1|||
147043472|NCT03207867|530318513|FG012|Overall Study|Death|0|||
147043473|NCT03207867|530318514|FG013|Overall Study|Death|1|||
147043474|NCT03207867|530318515|FG014|Overall Study|Death|0|||
147043475|NCT03207867|530318516|FG015|Overall Study|Death|0|||
147043476|NCT03207867|530318517|FG016|Overall Study|Death|0|||
147043477|NCT03207867|530318518|FG017|Overall Study|Death|2|||
147043478|NCT03207867|530318519|FG018|Overall Study|Death|0|||
147043479|NCT03207867|530318520|FG019|Overall Study|Death|1|||
147043480|NCT03207867|530318521|FG020|Overall Study|Death|0|||
147043481|NCT03207867|530318522|FG021|Overall Study|Death|0|||
147043482|NCT03207867|530318523|FG022|Overall Study|Death|0|||
147043483|NCT03207867|530318524|FG023|Overall Study|Death|0|||
147043484|NCT03207867|530318501|FG000|Overall Study|Physician Decision|3|||
147043485|NCT03207867|530318502|FG001|Overall Study|Physician Decision|5|||
147043486|NCT03207867|530318503|FG002|Overall Study|Physician Decision|0|||
147043487|NCT03207867|530318504|FG003|Overall Study|Physician Decision|3|||
147043488|NCT03207867|530318505|FG004|Overall Study|Physician Decision|2|||
147043489|NCT03207867|530318506|FG005|Overall Study|Physician Decision|0|||
147043490|NCT03207867|530318507|FG006|Overall Study|Physician Decision|0|||
147043491|NCT03207867|530318508|FG007|Overall Study|Physician Decision|0|||
147043492|NCT03207867|530318509|FG008|Overall Study|Physician Decision|4|||
147043493|NCT03207867|530318510|FG009|Overall Study|Physician Decision|2|||
147043494|NCT03207867|530318511|FG010|Overall Study|Physician Decision|0|||
147043495|NCT03207867|530318512|FG011|Overall Study|Physician Decision|4|||
147043496|NCT03207867|530318513|FG012|Overall Study|Physician Decision|0|||
147043497|NCT03207867|530318514|FG013|Overall Study|Physician Decision|0|||
147043498|NCT03207867|530318515|FG014|Overall Study|Physician Decision|2|||
147043499|NCT03207867|530318516|FG015|Overall Study|Physician Decision|1|||
147043500|NCT03207867|530318517|FG016|Overall Study|Physician Decision|1|||
147043501|NCT03207867|530318518|FG017|Overall Study|Physician Decision|2|||
147043502|NCT03207867|530318519|FG018|Overall Study|Physician Decision|1|||
147043503|NCT03207867|530318520|FG019|Overall Study|Physician Decision|3|||
147043504|NCT03207867|530318521|FG020|Overall Study|Physician Decision|0|||
147043505|NCT03207867|530318522|FG021|Overall Study|Physician Decision|0|||
147043506|NCT03207867|530318523|FG022|Overall Study|Physician Decision|0|||
147043507|NCT03207867|530318524|FG023|Overall Study|Physician Decision|0|||
147043508|NCT03207867|530318501|FG000|Overall Study|Progressive Disease|7|||
147043509|NCT03207867|530318502|FG001|Overall Study|Progressive Disease|7|||
147043510|NCT03207867|530318503|FG002|Overall Study|Progressive Disease|9|||
147043511|NCT03207867|530318504|FG003|Overall Study|Progressive Disease|10|||
147043512|NCT03207867|530318505|FG004|Overall Study|Progressive Disease|11|||
147043513|NCT03207867|530318506|FG005|Overall Study|Progressive Disease|10|||
147043514|NCT03207867|530318507|FG006|Overall Study|Progressive Disease|9|||
147043515|NCT03207867|530318508|FG007|Overall Study|Progressive Disease|8|||
147043516|NCT03207867|530318509|FG008|Overall Study|Progressive Disease|19|||
147043517|NCT03207867|530318510|FG009|Overall Study|Progressive Disease|23|||
147043518|NCT03207867|530318511|FG010|Overall Study|Progressive Disease|2|||
147043519|NCT03207867|530318512|FG011|Overall Study|Progressive Disease|24|||
147043520|NCT03207867|530318513|FG012|Overall Study|Progressive Disease|3|||
147043521|NCT03207867|530318514|FG013|Overall Study|Progressive Disease|11|||
147043522|NCT03207867|530318515|FG014|Overall Study|Progressive Disease|9|||
147043523|NCT03207867|530318516|FG015|Overall Study|Progressive Disease|5|||
147043524|NCT03207867|530318517|FG016|Overall Study|Progressive Disease|10|||
147043525|NCT03207867|530318518|FG017|Overall Study|Progressive Disease|14|||
147043526|NCT03207867|530318519|FG018|Overall Study|Progressive Disease|13|||
147043527|NCT03207867|530318520|FG019|Overall Study|Progressive Disease|14|||
147043528|NCT03207867|530318521|FG020|Overall Study|Progressive Disease|6|||
147043529|NCT03207867|530318522|FG021|Overall Study|Progressive Disease|3|||
147043530|NCT03207867|530318523|FG022|Overall Study|Progressive Disease|3|||
147043531|NCT03207867|530318524|FG023|Overall Study|Progressive Disease|3|||
147043532|NCT03207867|530318501|FG000|Overall Study|Patient/guardian Decision|0|||
147043533|NCT03207867|530318502|FG001|Overall Study|Patient/guardian Decision|0|||
147043534|NCT03207867|530318503|FG002|Overall Study|Patient/guardian Decision|1|||
147043535|NCT03207867|530318504|FG003|Overall Study|Patient/guardian Decision|1|||
147043536|NCT03207867|530318505|FG004|Overall Study|Patient/guardian Decision|1|||
147043537|NCT03207867|530318506|FG005|Overall Study|Patient/guardian Decision|2|||
147043538|NCT03207867|530318507|FG006|Overall Study|Patient/guardian Decision|1|||
147043539|NCT03207867|530318508|FG007|Overall Study|Patient/guardian Decision|0|||
147043540|NCT03207867|530318509|FG008|Overall Study|Patient/guardian Decision|1|||
147043541|NCT03207867|530318510|FG009|Overall Study|Patient/guardian Decision|0|||
147043542|NCT03207867|530318511|FG010|Overall Study|Patient/guardian Decision|0|||
147043543|NCT03207867|530318512|FG011|Overall Study|Patient/guardian Decision|1|||
147043544|NCT03207867|530318513|FG012|Overall Study|Patient/guardian Decision|0|||
147043545|NCT03207867|530318514|FG013|Overall Study|Patient/guardian Decision|1|||
147043546|NCT03207867|530318515|FG014|Overall Study|Patient/guardian Decision|2|||
147043547|NCT03207867|530318516|FG015|Overall Study|Patient/guardian Decision|0|||
147043548|NCT03207867|530318517|FG016|Overall Study|Patient/guardian Decision|1|||
147043549|NCT03207867|530318518|FG017|Overall Study|Patient/guardian Decision|3|||
147043550|NCT03207867|530318519|FG018|Overall Study|Patient/guardian Decision|4|||
147043551|NCT03207867|530318520|FG019|Overall Study|Patient/guardian Decision|1|||
147043552|NCT03207867|530318521|FG020|Overall Study|Patient/guardian Decision|0|||
147043553|NCT03207867|530318522|FG021|Overall Study|Patient/guardian Decision|0|||
147043554|NCT03207867|530318523|FG022|Overall Study|Patient/guardian Decision|0|||
147043555|NCT03207867|530318524|FG023|Overall Study|Patient/guardian Decision|0|||
147043556|NCT00306995|530318525|FG000|Study Part I|Withdrawal by Subject|0|||
147043557|NCT00306995|530318526|FG001|Study Part I|Withdrawal by Subject|0|||
147043558|NCT00306995|530318527|FG002|Study Part I|Withdrawal by Subject|0|||
147043559|NCT00306995|530318528|FG003|Study Part I|Withdrawal by Subject|0|||
147043560|NCT00306995|530318529|FG004|Study Part I|Withdrawal by Subject|0|||
147043561|NCT00306995|530318530|FG005|Study Part I|Withdrawal by Subject|0|||
147043562|NCT00306995|530318531|FG006|Study Part I|Withdrawal by Subject|1|||
147043563|NCT00306995|530318525|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
147043564|NCT00306995|530318526|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
147043565|NCT00306995|530318527|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
147043566|NCT00306995|530318528|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
147043567|NCT00306995|530318529|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
147043568|NCT00306995|530318530|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
147043569|NCT00306995|530318531|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
147043570|NCT01496976|530320030|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
147043571|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
147043572|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
147043573|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
147043574|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
147043575|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
147043576|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
147043577|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
147043578|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
147043579|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
147043580|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
147043581|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
147043582|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
147043583|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
147043584|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
147043585|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
147043586|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
147043587|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
147043588|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
147043589|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
147043590|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
147043591|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
147043592|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
147043593|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
147043594|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
147043595|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
147043596|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
147043597|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
147043598|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
147043599|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
147043600|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
147043601|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
147043602|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
147043603|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
147043604|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
147043605|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
147043606|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
147043607|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
147043608|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
147043609|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
147043610|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
147043611|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
147043612|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
147043613|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
147043614|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
147043615|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
147043616|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
147043617|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
147043618|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
147043619|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
147043620|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
147043621|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
147043622|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
147043623|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
147043624|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
147043625|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147043626|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
147043627|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147043628|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147043629|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147043630|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147043631|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147043632|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147043633|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147043634|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
147043635|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
147043636|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
147043637|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
147043638|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
147043639|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
147043640|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
147043641|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
147043642|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
147043643|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
147043644|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
147043645|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
147043646|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
147043647|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
147043648|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
147043649|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
147043650|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
147043651|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
147043652|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
147043653|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
147043654|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
147043655|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
147043656|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
147043657|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
147043658|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
147043659|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
147043660|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
147043661|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
147043662|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
147043663|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
147043664|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
147043665|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
147043666|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
147043667|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
147043668|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
147043669|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
147043670|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147043671|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
147043672|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
147043673|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147043674|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147043675|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147043676|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147043677|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147043678|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147043679|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
147043680|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
147043681|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
147043682|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
147043683|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
147043684|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
147043685|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
147043686|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
147043687|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
147043688|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
147043689|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
147043690|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
147043691|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
147043692|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
147043693|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
147043694|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
147043695|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
147043696|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
147043697|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
147043698|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
147043699|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
147043700|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
147043701|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
147043702|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
147043703|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
147043704|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
147043705|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
146849909|NCT02101385|529618926|FG000|Study Treatment|AE/Side Effects/Complications|8|||
147043706|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
147043707|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
147043708|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
147043709|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
147043710|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
147043711|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
147043712|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
147043713|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
147043714|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
147043715|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
147043716|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
147043717|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
147043718|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
147043719|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
147043720|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
147043721|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
147043722|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
147043723|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
147043724|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
147043725|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
147043726|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
147043727|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
147043728|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
147043729|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
147043730|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
147043731|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
147043732|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
147043733|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
147043734|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
147043735|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
147043736|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
147043737|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
147043738|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
147043739|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
147043740|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
147043741|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
147043742|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
147043743|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
147043744|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
147043745|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
147043746|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
147043747|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
147043748|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
147043749|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
147043750|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
147043751|NCT03598790|530320031|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
147043752|NCT03598790|530320032|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
147043753|NCT03598790|530320033|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
147043754|NCT03598790|530320034|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
147043755|NCT03598790|530320035|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
147043756|NCT03598790|530320036|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
147043757|NCT03598790|530320037|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
146849910|NCT02101385|529618927|FG001|Study Treatment|AE/Side Effects/Complications|0|||
146849911|NCT02101385|529618926|FG000|Study Treatment|Lost to Follow-up|1|||
146849912|NCT02101385|529618927|FG001|Study Treatment|Lost to Follow-up|0|||
147043758|NCT03598790|530320038|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
147043759|NCT03598790|530320039|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
147043760|NCT03598790|530320031|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147043761|NCT03598790|530320032|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147043762|NCT03598790|530320033|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147043763|NCT03598790|530320034|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
147043764|NCT03598790|530320035|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
147043765|NCT03598790|530320036|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
147043766|NCT03598790|530320037|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147043767|NCT03598790|530320038|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147043768|NCT03598790|530320039|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147043769|NCT03598790|530320031|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
147043770|NCT03598790|530320032|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
147043771|NCT03598790|530320033|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
147043772|NCT03598790|530320034|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
147043773|NCT03598790|530320035|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
147043774|NCT03598790|530320036|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
147043775|NCT03598790|530320037|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
147043776|NCT03598790|530320038|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
147043777|NCT03598790|530320039|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
147043778|NCT03598790|530320031|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147043779|NCT03598790|530320032|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147043780|NCT03598790|530320033|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147043781|NCT03598790|530320034|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
147043782|NCT03598790|530320035|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147043783|NCT03598790|530320036|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147043784|NCT03598790|530320037|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147043785|NCT03598790|530320038|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147043786|NCT03598790|530320039|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147043787|NCT03598790|530320031|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
147043788|NCT03598790|530320032|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
147043789|NCT03598790|530320033|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
147043790|NCT03598790|530320034|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
147043791|NCT03598790|530320035|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
147043792|NCT03598790|530320036|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
147043793|NCT03598790|530320037|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
147043794|NCT03598790|530320038|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
147043795|NCT03598790|530320039|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
147043796|NCT03598790|530320031|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
147043797|NCT03598790|530320032|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
147043798|NCT03598790|530320033|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
147043799|NCT03598790|530320034|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
147043800|NCT03598790|530320035|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
147043801|NCT03598790|530320036|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
147043802|NCT03598790|530320037|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
147043803|NCT03598790|530320038|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
147043804|NCT03598790|530320039|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
147043805|NCT05292183|530320040|FG000|Overall Study|Adverse Event|1|||
147043806|NCT01059786|530320041|FG000|Overall Study|Did not receive 6 cycles.|0|||
147043807|NCT01059786|530320042|FG001|Overall Study|Did not receive 6 cycles.|0|||
147043808|NCT01059786|530320043|FG002|Overall Study|Did not receive 6 cycles.|4|||
147043809|NCT01059786|530320044|FG003|Overall Study|Did not receive 6 cycles.|1|||
147043810|NCT01059786|530320045|FG004|Overall Study|Did not receive 6 cycles.|0|||
147043811|NCT05929651|530320054|FG000|Overall Study|Protocol Deviation|1|||
147043812|NCT05929651|530320054|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
147043813|NCT02731638|530320055|FG000|Overall Study|Lost to Follow-up|6|||
147043814|NCT02731638|530320056|FG001|Overall Study|Lost to Follow-up|9|||
147043815|NCT02454608|530320057|FG000|Double-Blind Period|Lack of Efficacy|0|||
147043816|NCT02454608|530320058|FG001|Double-Blind Period|Lack of Efficacy|2|||
147043817|NCT02454608|530320059|FG002|Double-Blind Period|Lack of Efficacy|0|||
147043818|NCT02454608|530320057|FG000|Open Label Period|Lost to Follow-up|0|||
147043819|NCT02454608|530320058|FG001|Open Label Period|Lost to Follow-up|0|||
147043820|NCT02454608|530320059|FG002|Open Label Period|Lost to Follow-up|11|||
147043821|NCT02454608|530320057|FG000|Open Label Period|Withdrawal by Subject|0|||
147043822|NCT02454608|530320058|FG001|Open Label Period|Withdrawal by Subject|0|||
147043823|NCT02454608|530320059|FG002|Open Label Period|Withdrawal by Subject|8|||
147043824|NCT01769456|530320064|FG000|Overall Study|Lost to Follow-up|19|||
147043825|NCT01769456|530320064|FG000|Overall Study|Withdrawal by Subject|3|||
147043826|NCT01769456|530320064|FG000|Overall Study|Did not receive PCC intervention|6|||
147043827|NCT01769456|530320064|FG000|Overall Study|Moved out of the area|3|||
147043828|NCT01769456|530320064|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
147043829|NCT01769456|530320064|FG000|Overall Study|Parental request to youth to withdraw|1|||
147043830|NCT02465398|530320071|FG000|Overall Study|Death|7|||
147043831|NCT02465398|530320071|FG000|Overall Study|Revision|7|||
147043832|NCT02465398|530320071|FG000|Overall Study|did not receive study device|1|||
147043833|NCT02465398|530320071|FG000|Overall Study|Withdrawal by Subject|1|||
147043834|NCT02465398|530320071|FG000|Overall Study|Lost to Follow-up|14|||
147043835|NCT05244122|530320072|FG000|Overall Study|Withdrawal by Subject|318|||
147043836|NCT02969382|530320077|FG000|Overall Study|Adverse Event|8|||
147043837|NCT02969382|530320078|FG001|Overall Study|Adverse Event|10|||
147043838|NCT02969382|530320077|FG000|Overall Study|Lack of Efficacy|4|||
147043839|NCT02969382|530320078|FG001|Overall Study|Lack of Efficacy|5|||
147043840|NCT02969382|530320077|FG000|Overall Study|Death|0|||
147043841|NCT02969382|530320078|FG001|Overall Study|Death|1|||
147043842|NCT02969382|530320077|FG000|Overall Study|PROTOCOL DEVIATION|0|||
147043843|NCT02969382|530320078|FG001|Overall Study|PROTOCOL DEVIATION|1|||
147043844|NCT02969382|530320077|FG000|Overall Study|Withdrawal by Subject|14|||
147043845|NCT02969382|530320078|FG001|Overall Study|Withdrawal by Subject|9|||
147043846|NCT01214655|530320079|FG000|Part A|Progressive Disease|7|||
147043847|NCT01214655|530320080|FG001|Part A|Progressive Disease|0|||
147043848|NCT01214655|530320081|FG002|Part A|Progressive Disease|0|||
147043849|NCT01214655|530320079|FG000|Part A|Physician Decision|1|||
147043850|NCT01214655|530320080|FG001|Part A|Physician Decision|0|||
147043851|NCT01214655|530320081|FG002|Part A|Physician Decision|0|||
147043852|NCT01214655|530320079|FG000|Part B|Progressive disease|0|||
147043853|NCT01214655|530320080|FG001|Part B|Progressive disease|10|||
147043854|NCT01214655|530320081|FG002|Part B|Progressive disease|0|||
147043855|NCT01214655|530320079|FG000|Part B|Death|0|||
147043856|NCT01214655|530320080|FG001|Part B|Death|1|||
147043857|NCT01214655|530320081|FG002|Part B|Death|0|||
147043858|NCT01214655|530320079|FG000|Part B|Withdrawal by Subject|0|||
147043859|NCT01214655|530320080|FG001|Part B|Withdrawal by Subject|2|||
147043860|NCT01214655|530320081|FG002|Part B|Withdrawal by Subject|0|||
147043861|NCT01214655|530320079|FG000|Part C|Progressive Disease|0|||
147043862|NCT01214655|530320080|FG001|Part C|Progressive Disease|0|||
147043863|NCT01214655|530320081|FG002|Part C|Progressive Disease|5|||
147043864|NCT01214655|530320079|FG000|Part C|Death|0|||
147043865|NCT01214655|530320080|FG001|Part C|Death|0|||
147043866|NCT01214655|530320081|FG002|Part C|Death|1|||
147043867|NCT01214655|530320079|FG000|Part C|Physician Decision|0|||
147043868|NCT01214655|530320080|FG001|Part C|Physician Decision|0|||
147043869|NCT01214655|530320081|FG002|Part C|Physician Decision|1|||
147043870|NCT01977417|530320089|FG000|Overall Study|Adverse Event|1|||
147043871|NCT01977417|530320090|FG001|Overall Study|Adverse Event|0|||
147043872|NCT01977417|530320089|FG000|Overall Study|Withdrawal by Subject|2|||
147043873|NCT01977417|530320090|FG001|Overall Study|Withdrawal by Subject|4|||
147043874|NCT01977417|530320089|FG000|Overall Study|Female enrollment goal met|0|||
147043875|NCT01977417|530320090|FG001|Overall Study|Female enrollment goal met|2|||
147043876|NCT01692626|530320091|FG000|Overall Study|Death|0|||
147043877|NCT01692626|530320092|FG001|Overall Study|Death|1|||
147043878|NCT01692626|530320091|FG000|Overall Study|Adverse Event|2|||
147043879|NCT01692626|530320092|FG001|Overall Study|Adverse Event|3|||
147043880|NCT01692626|530320091|FG000|Overall Study|Protocol Violation|1|||
147043881|NCT01692626|530320092|FG001|Overall Study|Protocol Violation|2|||
147043882|NCT01692626|530320091|FG000|Overall Study|Withdrawal by Subject|1|||
147043883|NCT01692626|530320092|FG001|Overall Study|Withdrawal by Subject|0|||
147043884|NCT02794870|530320099|FG000|Overall Study|Withdrawal by Subject|2|||
147043885|NCT02794870|530320100|FG001|Overall Study|Withdrawal by Subject|0|||
147043886|NCT00616421|530320101|FG000|Overall Study|Withdrawal by Subject|9|||
147043887|NCT00616421|530320102|FG001|Overall Study|Withdrawal by Subject|11|||
147043888|NCT00616421|530320103|FG002|Overall Study|Withdrawal by Subject|8|||
147043889|NCT00616421|530320101|FG000|Overall Study|Lost to Follow-up|12|||
147043890|NCT00616421|530320102|FG001|Overall Study|Lost to Follow-up|26|||
147043891|NCT00616421|530320103|FG002|Overall Study|Lost to Follow-up|30|||
147043892|NCT00616421|530320101|FG000|Overall Study|Inappropriate enrollment|3|||
147043893|NCT00616421|530320102|FG001|Overall Study|Inappropriate enrollment|0|||
147043894|NCT00616421|530320103|FG002|Overall Study|Inappropriate enrollment|1|||
147043895|NCT00616421|530320101|FG000|Overall Study|Administrative reason|1|||
147043896|NCT00616421|530320102|FG001|Overall Study|Administrative reason|0|||
147043897|NCT00616421|530320103|FG002|Overall Study|Administrative reason|0|||
147043898|NCT00616421|530320101|FG000|Overall Study|Protocol Violation|0|||
147043899|NCT00616421|530320102|FG001|Overall Study|Protocol Violation|1|||
147043900|NCT00616421|530320103|FG002|Overall Study|Protocol Violation|2|||
147043901|NCT00616421|530320101|FG000|Overall Study|Unable to classify|1|||
147043902|NCT00616421|530320102|FG001|Overall Study|Unable to classify|0|||
147043903|NCT00616421|530320103|FG002|Overall Study|Unable to classify|0|||
147043904|NCT01495702|530320104|FG000|Randomized Phase|Randomized But Not Treated|1|||
147043905|NCT01495702|530320105|FG001|Randomized Phase|Randomized But Not Treated|4|||
147043906|NCT01495702|530320104|FG000|Randomized Phase|Adverse Event|2|||
147043907|NCT01495702|530320105|FG001|Randomized Phase|Adverse Event|2|||
147043908|NCT01495702|530320104|FG000|Randomized Phase|Death|1|||
147043909|NCT01495702|530320105|FG001|Randomized Phase|Death|0|||
147043910|NCT01495702|530320104|FG000|Randomized Phase|Lack of Efficacy|2|||
147043911|NCT01495702|530320105|FG001|Randomized Phase|Lack of Efficacy|0|||
147043912|NCT01495702|530320104|FG000|Randomized Phase|Investigators Discretion|2|||
147043913|NCT01495702|530320105|FG001|Randomized Phase|Investigators Discretion|0|||
147043914|NCT01495702|530320104|FG000|Randomized Phase|Withdrew Consent|10|||
147043915|NCT01495702|530320105|FG001|Randomized Phase|Withdrew Consent|18|||
147043916|NCT01495702|530320104|FG000|Randomized Phase|Lost to Follow-up|4|||
147043917|NCT01495702|530320105|FG001|Randomized Phase|Lost to Follow-up|3|||
147043918|NCT01495702|530320104|FG000|Randomized Phase|Participant Noncompliance|1|||
147043919|NCT01495702|530320105|FG001|Randomized Phase|Participant Noncompliance|0|||
147043920|NCT01495702|530320104|FG000|Randomized Phase|Protocol Violation|3|||
147043921|NCT01495702|530320105|FG001|Randomized Phase|Protocol Violation|1|||
147043922|NCT01427608|530320106|FG000|Overall Study|Death|1|||
147043923|NCT01427608|530320107|FG001|Overall Study|Death|0|||
147043924|NCT01427608|530320106|FG000|Overall Study|Withdrawal by Subject|7|||
147043925|NCT01427608|530320107|FG001|Overall Study|Withdrawal by Subject|3|||
147043926|NCT01427608|530320106|FG000|Overall Study|Relapsed-all cause|13|||
147043927|NCT01427608|530320107|FG001|Overall Study|Relapsed-all cause|34|||
147043928|NCT01427608|530320106|FG000|Overall Study|Events not attributed to study meds|0|||
147043929|NCT01427608|530320107|FG001|Overall Study|Events not attributed to study meds|1|||
147043930|NCT04071405|530320108|FG000|Overall Study|Protocol Violation|3|||
147043931|NCT02422797|530320109|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
147043932|NCT02422797|530320110|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
147043933|NCT02422797|530320109|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
147043934|NCT02422797|530320110|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
147043935|NCT02422797|530320109|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
147043936|NCT02422797|530320110|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
147043937|NCT02422797|530320109|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
147043938|NCT02422797|530320110|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
147043939|NCT02422797|530320109|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
147043940|NCT02422797|530320110|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
147043941|NCT02422797|530320109|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
147043942|NCT02422797|530320110|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
147043943|NCT02422797|530320109|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
147043944|NCT02422797|530320110|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
147043945|NCT02422797|530320109|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
147043946|NCT02422797|530320110|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
147043947|NCT02422797|530320109|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
147043948|NCT02422797|530320110|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
147043949|NCT02422797|530320109|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
147043950|NCT02422797|530320110|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
147043951|NCT02422797|530320109|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
147043952|NCT02422797|530320110|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
147043953|NCT02422797|530320109|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
147043954|NCT02422797|530320110|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
147043955|NCT02422797|530320109|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
147043956|NCT02422797|530320110|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
147043957|NCT02422797|530320109|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
147043958|NCT02422797|530320110|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
147043959|NCT02422797|530320109|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
147043960|NCT02422797|530320110|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
147043961|NCT02422797|530320109|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
147043962|NCT02422797|530320110|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
147043963|NCT02422797|530320109|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
147043964|NCT02422797|530320110|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
147043965|NCT02422797|530320109|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
147043966|NCT02422797|530320110|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
147043967|NCT02422797|530320109|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
147043968|NCT02422797|530320110|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
147043969|NCT02422797|530320109|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
147043970|NCT02422797|530320110|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
147043971|NCT02422797|530320109|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
147043972|NCT02422797|530320110|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
147043973|NCT05445492|530320113|FG000|Overall Study|Physician Decision|1|||
147043974|NCT03126435|530320120|FG000|Overall Study|Death|90|||
147043975|NCT03126435|530320121|FG001|Overall Study|Death|84|||
147043976|NCT03126435|530320120|FG000|Overall Study|Lost to Follow-up|4|||
147043977|NCT03126435|530320121|FG001|Overall Study|Lost to Follow-up|3|||
147043978|NCT03126435|530320120|FG000|Overall Study|Physician Decision|0|||
147043979|NCT03126435|530320121|FG001|Overall Study|Physician Decision|1|||
147043980|NCT03126435|530320120|FG000|Overall Study|Withdrawal by Subject|6|||
147043981|NCT03126435|530320121|FG001|Overall Study|Withdrawal by Subject|12|||
147043982|NCT03126435|530320120|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
147043983|NCT03126435|530320121|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
147043984|NCT01937871|530320129|FG000|Overall Study|Adverse Event|6|||
147043985|NCT01937871|530320130|FG001|Overall Study|Adverse Event|6|||
147043986|NCT01937871|530320131|FG002|Overall Study|Adverse Event|2|||
147043987|NCT01937871|530320129|FG000|Overall Study|Lost to Follow-up|8|||
147043988|NCT01937871|530320130|FG001|Overall Study|Lost to Follow-up|2|||
147043989|NCT01937871|530320131|FG002|Overall Study|Lost to Follow-up|4|||
147043990|NCT01937871|530320129|FG000|Overall Study|Withdrawal by Subject|9|||
147043991|NCT01937871|530320130|FG001|Overall Study|Withdrawal by Subject|6|||
147043992|NCT01937871|530320131|FG002|Overall Study|Withdrawal by Subject|4|||
147043993|NCT01937871|530320129|FG000|Overall Study|Physician Decision|0|||
147043994|NCT01937871|530320130|FG001|Overall Study|Physician Decision|1|||
147043995|NCT01937871|530320131|FG002|Overall Study|Physician Decision|0|||
147043996|NCT01937871|530320129|FG000|Overall Study|Entry Criteria Not Met|1|||
147043997|NCT01937871|530320130|FG001|Overall Study|Entry Criteria Not Met|2|||
147043998|NCT01937871|530320131|FG002|Overall Study|Entry Criteria Not Met|1|||
147043999|NCT03154125|530320132|FG000|Overall Study|Lost to Follow-up|11|||
147044000|NCT03154125|530320133|FG001|Overall Study|Lost to Follow-up|11|||
147044001|NCT03154125|530320134|FG002|Overall Study|Lost to Follow-up|0|||
147044002|NCT03154125|530320132|FG000|Overall Study|Withdrawal by Subject|49|||
147044003|NCT03154125|530320133|FG001|Overall Study|Withdrawal by Subject|55|||
147044004|NCT03154125|530320134|FG002|Overall Study|Withdrawal by Subject|8|||
147044005|NCT03154125|530320132|FG000|Overall Study|Physician Decision|13|||
147044006|NCT03154125|530320133|FG001|Overall Study|Physician Decision|6|||
147044007|NCT03154125|530320134|FG002|Overall Study|Physician Decision|0|||
147044008|NCT03154125|530320132|FG000|Overall Study|Protocol Violation|3|||
147044009|NCT03154125|530320133|FG001|Overall Study|Protocol Violation|5|||
147044010|NCT03154125|530320134|FG002|Overall Study|Protocol Violation|0|||
147044011|NCT00799058|530320135|FG000|Overall Study|Withdrawal by Subject|2|||
147044012|NCT00799058|530320136|FG001|Overall Study|Withdrawal by Subject|2|||
147044013|NCT00799058|530320137|FG002|Overall Study|Withdrawal by Subject|2|||
147044014|NCT00799058|530320135|FG000|Overall Study|Lost to Follow-up|1|||
147044015|NCT00799058|530320136|FG001|Overall Study|Lost to Follow-up|2|||
147044016|NCT00799058|530320137|FG002|Overall Study|Lost to Follow-up|1|||
147044017|NCT00799058|530320135|FG000|Overall Study|Adverse Event|0|||
147044018|NCT00799058|530320136|FG001|Overall Study|Adverse Event|2|||
147044019|NCT00799058|530320137|FG002|Overall Study|Adverse Event|0|||
147044020|NCT00799058|530320135|FG000|Overall Study|Pregnancy|1|||
147044021|NCT00799058|530320136|FG001|Overall Study|Pregnancy|0|||
147044022|NCT00799058|530320137|FG002|Overall Study|Pregnancy|0|||
147044023|NCT00799058|530320135|FG000|Overall Study|Not adherent|3|||
147044024|NCT00799058|530320136|FG001|Overall Study|Not adherent|2|||
147044025|NCT00799058|530320137|FG002|Overall Study|Not adherent|1|||
147044026|NCT00799058|530320135|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
147044027|NCT00799058|530320136|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
147044028|NCT00799058|530320137|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
147044029|NCT00799058|530320135|FG000|Overall Study|IP dispensing error|1|||
147044030|NCT00799058|530320136|FG001|Overall Study|IP dispensing error|0|||
147044031|NCT00799058|530320137|FG002|Overall Study|IP dispensing error|0|||
147044032|NCT00799058|530320135|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
147044033|NCT00799058|530320136|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
147044034|NCT00799058|530320137|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
147044035|NCT00799058|530320135|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
147044036|NCT00799058|530320136|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
147044037|NCT00799058|530320137|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
147044038|NCT00799058|530320135|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
147044039|NCT00799058|530320136|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
147044040|NCT00799058|530320137|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
147044041|NCT00799058|530320135|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
147044042|NCT00799058|530320136|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
147044043|NCT00799058|530320137|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
147044044|NCT02088697|530320138|FG000|Period I|Physician Decision|1|||
147044045|NCT02088697|530320139|FG001|Period I|Physician Decision|4|||
147044046|NCT02088697|530320138|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
147044047|NCT02088697|530320139|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
147044048|NCT00810511|530320140|FG000|Overall Study|Protocol Violation|0|||
147044049|NCT00810511|530320141|FG001|Overall Study|Protocol Violation|1|||
147044050|NCT00810511|530320140|FG000|Overall Study|Lack of Efficacy|9|||
147044051|NCT00810511|530320141|FG001|Overall Study|Lack of Efficacy|1|||
147044052|NCT00810511|530320140|FG000|Overall Study|death in the family|0|||
147044053|NCT00810511|530320141|FG001|Overall Study|death in the family|1|||
147044054|NCT00810511|530320140|FG000|Overall Study|Lost to Follow-up|1|||
147044055|NCT00810511|530320141|FG001|Overall Study|Lost to Follow-up|0|||
147044056|NCT00810511|530320140|FG000|Overall Study|deposits on contact lens|0|||
147044057|NCT00810511|530320141|FG001|Overall Study|deposits on contact lens|1|||
147044058|NCT00462904|530320142|FG000|Overall Study|Lost to Follow-up|1|||
147044059|NCT02652949|530320143|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
147044060|NCT02652949|530320143|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
147044061|NCT02652949|530320143|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
147044062|NCT02652949|530320143|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
147044063|NCT02652949|530320143|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
147044064|NCT02652949|530320143|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
147044065|NCT02652949|530320143|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
147044066|NCT02652949|530320143|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
147044067|NCT02652949|530320143|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
147044068|NCT02652949|530320143|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
147044069|NCT02652949|530320143|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
147044070|NCT02652949|530320143|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
147044071|NCT02652949|530320143|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
147044072|NCT02652949|530320143|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
147044073|NCT02652949|530320143|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
147044074|NCT02652949|530320143|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
147044075|NCT02652949|530320143|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
147044076|NCT00699816|530320144|FG000|Overall Study|Protocol Violation|1|||
147044077|NCT00699816|530320145|FG001|Overall Study|Protocol Violation|3|||
147044078|NCT01569295|530320146|FG000|Overall Study|Progressive Disease|75|||
147044079|NCT01569295|530320147|FG001|Overall Study|Progressive Disease|139|||
147044080|NCT01569295|530320146|FG000|Overall Study|Adverse Event|39|||
147044081|NCT01569295|530320147|FG001|Overall Study|Adverse Event|14|||
147044082|NCT01569295|530320146|FG000|Overall Study|Withdrawal by Subject|25|||
147044083|NCT01569295|530320147|FG001|Overall Study|Withdrawal by Subject|12|||
147044084|NCT01569295|530320146|FG000|Overall Study|Death|19|||
147044085|NCT01569295|530320147|FG001|Overall Study|Death|15|||
147044086|NCT01569295|530320146|FG000|Overall Study|Physician Decision|13|||
147044087|NCT01569295|530320147|FG001|Overall Study|Physician Decision|18|||
147044088|NCT01569295|530320146|FG000|Overall Study|Study Terminated by Sponsor|24|||
147044089|NCT01569295|530320147|FG001|Overall Study|Study Terminated by Sponsor|2|||
147044090|NCT01569295|530320146|FG000|Overall Study|Other Reason not Specified|3|||
147044091|NCT01569295|530320147|FG001|Overall Study|Other Reason not Specified|5|||
147044092|NCT01569295|530320146|FG000|Overall Study|Non-Compliance with Study Drug|6|||
147044093|NCT01569295|530320147|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147044094|NCT01569295|530320146|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
147044095|NCT01569295|530320147|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
147044096|NCT01569295|530320146|FG000|Overall Study|Lost to Follow-up|1|||
147044097|NCT01569295|530320147|FG001|Overall Study|Lost to Follow-up|1|||
147044098|NCT01973595|530320148|FG000|Washout|Withdrawal by Subject|1|||
147044099|NCT01973595|530320149|FG001|Washout|Withdrawal by Subject|0|||
147044100|NCT01973595|530320150|FG002|Washout|Withdrawal by Subject|1|||
147044101|NCT01973595|530320151|FG003|Washout|Withdrawal by Subject|0|||
147044102|NCT02508935|530320152|FG000|Overall Study|Withdrawal by Subject|1|||
147044103|NCT02508935|530320152|FG000|Overall Study|Withdrawal by Caregiver|8|||
147044104|NCT02508935|530320152|FG000|Overall Study|Pain Score <4|1|||
147044105|NCT02508935|530320152|FG000|Overall Study|Emesis|3|||
147044106|NCT02508935|530320152|FG000|Overall Study|Adverse Event|3|||
147044107|NCT02508935|530320152|FG000|Overall Study|Protocol Violation|1|||
147044108|NCT02508935|530320152|FG000|Overall Study|Physician Decision|1|||
147044109|NCT02508935|530320152|FG000|Overall Study|Trial terminated by sponsor|5|||
147044110|NCT02125877|530320153|FG000|Overall Study|Physician Decision|1|||
147044111|NCT02125877|530320154|FG001|Overall Study|Physician Decision|0|||
147044112|NCT02125877|530320153|FG000|Overall Study|Death|0|||
147044113|NCT02125877|530320154|FG001|Overall Study|Death|1|||
147044114|NCT02125877|530320153|FG000|Overall Study|Administrative problems|0|||
147044115|NCT02125877|530320154|FG001|Overall Study|Administrative problems|1|||
147044116|NCT02125877|530320153|FG000|Overall Study|Participant/guardian decision|0|||
147044117|NCT02125877|530320154|FG001|Overall Study|Participant/guardian decision|2|||
147044118|NCT02125877|530320153|FG000|Overall Study|Withdrawal by Subject|2|||
147044119|NCT02125877|530320154|FG001|Overall Study|Withdrawal by Subject|1|||
147044120|NCT02125877|530320153|FG000|Overall Study|Protocol deviation|4|||
147044121|NCT02125877|530320154|FG001|Overall Study|Protocol deviation|1|||
147044122|NCT02125877|530320153|FG000|Overall Study|Adverse Event|6|||
147044123|NCT02125877|530320154|FG001|Overall Study|Adverse Event|4|||
147044124|NCT02800642|530320163|FG000|Overall Study|Death|3|||
147044125|NCT02800642|530320163|FG000|Overall Study|Other|10|||
147044126|NCT02800642|530320163|FG000|Overall Study|Physician Decision|2|||
147044127|NCT02800642|530320163|FG000|Overall Study|Adverse Event|6|||
147044128|NCT02800642|530320163|FG000|Overall Study|Withdrawal by Subject|3|||
147044129|NCT02800642|530320163|FG000|Overall Study|Lost to Follow-up|1|||
147044130|NCT04868500|530320164|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
147044131|NCT04868500|530320165|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
147044132|NCT04868500|530320164|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
147044133|NCT04868500|530320165|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
147044134|NCT01941498|530320169|FG000|Overall Study|Relocated out of state|1|||
147044135|NCT05299528|530320170|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
147044136|NCT05299528|530320171|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
147044137|NCT05299528|530320172|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
147044138|NCT05299528|530320173|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
147044139|NCT05299528|530320174|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
147044140|NCT05299528|530320175|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
147044141|NCT05299528|530320176|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
147044142|NCT05299528|530320170|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
147044143|NCT05299528|530320171|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
147044144|NCT05299528|530320172|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
147044145|NCT05299528|530320173|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
147044146|NCT05299528|530320174|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
147044147|NCT05299528|530320175|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
147044148|NCT05299528|530320176|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
147044149|NCT05299528|530320170|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
147044150|NCT05299528|530320171|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
147044151|NCT05299528|530320172|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
147044152|NCT05299528|530320173|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
147044153|NCT05299528|530320174|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
147044154|NCT05299528|530320175|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
147044155|NCT05299528|530320176|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
147044156|NCT00490841|530320177|FG000|Overall Study|Death|5|||
147044157|NCT00490841|530320177|FG000|Overall Study|Withdrawal by Subject|4|||
147044158|NCT00490841|530320177|FG000|Overall Study|Lost to Follow-up|1|||
147044159|NCT00490841|530320177|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
147044160|NCT04697069|530320178|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
147044161|NCT04697069|530320179|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
147044162|NCT04697069|530320178|FG000|Overall Study|Study termination|2|||
147044163|NCT04697069|530320179|FG001|Overall Study|Study termination|1|||
147044164|NCT02779855|530320180|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
147044165|NCT02779855|530320181|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
147044166|NCT02779855|530320182|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
147044167|NCT01301729|530320183|FG000|Overall Study|Withdrawal by Subject|2|||
147044168|NCT01301729|530320183|FG000|Overall Study|Participant did not Return for Treatment|1|||
147044169|NCT01301729|530320183|FG000|Overall Study|Violated Selection Criteria|1|||
147044170|NCT05422625|530320184|FG000|Overall Study|Withdrawal by Subject|1|||
147044171|NCT05422625|530320185|FG001|Overall Study|Withdrawal by Subject|0|||
147044172|NCT05938621|530322071|FG000|Overall Study|Lost to Follow-up|1|||
146849913|NCT02101385|529618926|FG000|Study Treatment|Disease Progression before treatment|1|||
147044173|NCT05938621|530322072|FG001|Overall Study|Lost to Follow-up|5|||
147044174|NCT05938621|530322073|FG002|Overall Study|Lost to Follow-up|2|||
147044175|NCT05938621|530322074|FG003|Overall Study|Lost to Follow-up|2|||
147044186|NCT04205812|530322078|FG000|Randomized Treatment Period|Ongoing|28|||
147044187|NCT04205812|530322079|FG001|Randomized Treatment Period|Ongoing|138|||
147044188|NCT04205812|530322078|FG000|Randomized Treatment Period|Death|94|||
147044189|NCT04205812|530322079|FG001|Randomized Treatment Period|Death|226|||
147044190|NCT04205812|530322078|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
147044191|NCT04205812|530322079|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
147044192|NCT04205812|530322078|FG000|Randomized Treatment Period|Physician Decision|1|||
147044193|NCT04205812|530322079|FG001|Randomized Treatment Period|Physician Decision|4|||
147044194|NCT04205812|530322078|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
147044195|NCT04205812|530322079|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
147044196|NCT04205812|530322078|FG000|Randomized Treatment Period|Progressive Disease|0|||
147044197|NCT04205812|530322079|FG001|Randomized Treatment Period|Progressive Disease|1|||
147044198|NCT04205812|530322078|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
147044199|NCT04205812|530322079|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
147044200|NCT04205812|530322078|FG000|Monotherapy Treatment Period|Ongoing|17|||
147044201|NCT04205812|530322079|FG001|Monotherapy Treatment Period|Ongoing|0|||
147044202|NCT04205812|530322078|FG000|Monotherapy Treatment Period|Death|39|||
147044203|NCT04205812|530322079|FG001|Monotherapy Treatment Period|Death|0|||
147044204|NCT04205812|530322078|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
147044205|NCT04205812|530322079|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
147044206|NCT04205812|530322078|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
147044207|NCT04205812|530322079|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
147044208|NCT04559347|530322080|FG000|Overall Study|Death|1|||
147044209|NCT04559347|530322081|FG001|Overall Study|Death|0|||
147044210|NCT04559347|530322080|FG000|Overall Study|Thoracotomy conversion|1|||
147044211|NCT04559347|530322081|FG001|Overall Study|Thoracotomy conversion|1|||
147044212|NCT04559347|530322080|FG000|Overall Study|Provider unavailable|2|||
147044213|NCT04559347|530322081|FG001|Overall Study|Provider unavailable|1|||
147044214|NCT04559347|530322080|FG000|Overall Study|Other|2|||
147044215|NCT04559347|530322081|FG001|Overall Study|Other|1|||
147044216|NCT00371033|530322082|FG000|Overall Study|Lost to Follow-up|3|||
147044217|NCT00371033|530322083|FG001|Overall Study|Lost to Follow-up|2|||
147044218|NCT00371033|530322082|FG000|Overall Study|No longer interested|2|||
147044219|NCT00371033|530322083|FG001|Overall Study|No longer interested|0|||
147044220|NCT00371033|530322082|FG000|Overall Study|Uknown|3|||
147044221|NCT00371033|530322083|FG001|Overall Study|Uknown|1|||
147044222|NCT05026177|530322087|FG000|Overall Study|Adverse Event|33|||
147044223|NCT05026177|530322088|FG001|Overall Study|Adverse Event|33|||
147044224|NCT05026177|530322089|FG002|Overall Study|Adverse Event|17|||
147044225|NCT05026177|530322087|FG000|Overall Study|Lost to Follow-up|7|||
147044226|NCT05026177|530322088|FG001|Overall Study|Lost to Follow-up|6|||
147044227|NCT05026177|530322089|FG002|Overall Study|Lost to Follow-up|8|||
147044228|NCT05026177|530322087|FG000|Overall Study|Noncompliance with study drug|6|||
147044229|NCT05026177|530322088|FG001|Overall Study|Noncompliance with study drug|2|||
147044230|NCT05026177|530322089|FG002|Overall Study|Noncompliance with study drug|1|||
147044231|NCT05026177|530322087|FG000|Overall Study|Physician Decision|4|||
147044232|NCT05026177|530322088|FG001|Overall Study|Physician Decision|1|||
147044233|NCT05026177|530322089|FG002|Overall Study|Physician Decision|0|||
147044234|NCT05026177|530322087|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
147044235|NCT05026177|530322088|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
147044236|NCT05026177|530322089|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
147044237|NCT05026177|530322087|FG000|Overall Study|Withdrawal by Subject|53|||
147044238|NCT05026177|530322088|FG001|Overall Study|Withdrawal by Subject|51|||
147044239|NCT05026177|530322089|FG002|Overall Study|Withdrawal by Subject|55|||
147044240|NCT05026177|530322087|FG000|Overall Study|Protocol Violation|0|||
147044241|NCT05026177|530322088|FG001|Overall Study|Protocol Violation|1|||
147044242|NCT05026177|530322089|FG002|Overall Study|Protocol Violation|0|||
147044243|NCT05026177|530322087|FG000|Overall Study|Study terminated by sponsor|70|||
147044244|NCT05026177|530322088|FG001|Overall Study|Study terminated by sponsor|74|||
147044245|NCT05026177|530322089|FG002|Overall Study|Study terminated by sponsor|67|||
147044246|NCT05026177|530322087|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
147044247|NCT05026177|530322088|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
147044248|NCT05026177|530322089|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
147044249|NCT05026177|530322087|FG000|Overall Study|Starting alternative treatment|0|||
147044250|NCT05026177|530322088|FG001|Overall Study|Starting alternative treatment|1|||
147044251|NCT05026177|530322089|FG002|Overall Study|Starting alternative treatment|1|||
147044252|NCT05026177|530322087|FG000|Overall Study|Noncompliance with study procedures|0|||
147044253|NCT05026177|530322088|FG001|Overall Study|Noncompliance with study procedures|1|||
147044254|NCT05026177|530322089|FG002|Overall Study|Noncompliance with study procedures|1|||
147044255|NCT05026177|530322087|FG000|Overall Study|Met stopping criteria|0|||
147044256|NCT05026177|530322088|FG001|Overall Study|Met stopping criteria|0|||
147044257|NCT05026177|530322089|FG002|Overall Study|Met stopping criteria|1|||
147044258|NCT05026177|530322087|FG000|Overall Study|Health issues preventing continuation|0|||
147044259|NCT05026177|530322088|FG001|Overall Study|Health issues preventing continuation|0|||
147044260|NCT05026177|530322089|FG002|Overall Study|Health issues preventing continuation|1|||
147044261|NCT05026177|530322087|FG000|Overall Study|Randomized in error, not treated|0|||
147044262|NCT05026177|530322088|FG001|Overall Study|Randomized in error, not treated|0|||
147044263|NCT05026177|530322089|FG002|Overall Study|Randomized in error, not treated|2|||
147044264|NCT03816878|530322096|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
147044265|NCT03816878|530322097|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
147044266|NCT03816878|530322096|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
147044267|NCT03816878|530322097|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
147044268|NCT03355469|530322098|FG000|Overall Study|COVID-19|3|||
147044269|NCT03355469|530322099|FG001|Overall Study|COVID-19|2|||
147044270|NCT03355469|530322100|FG002|Overall Study|COVID-19|3|||
147044271|NCT03355469|530322101|FG003|Overall Study|COVID-19|3|||
147044272|NCT03355469|530322098|FG000|Overall Study|Lost to Follow-up|1|||
147044273|NCT03355469|530322099|FG001|Overall Study|Lost to Follow-up|0|||
147044274|NCT03355469|530322100|FG002|Overall Study|Lost to Follow-up|1|||
147044275|NCT03355469|530322101|FG003|Overall Study|Lost to Follow-up|0|||
147044276|NCT03355469|530322098|FG000|Overall Study|Withdrawal by Subject|2|||
147044277|NCT03355469|530322099|FG001|Overall Study|Withdrawal by Subject|1|||
147044278|NCT03355469|530322100|FG002|Overall Study|Withdrawal by Subject|0|||
147044279|NCT03355469|530322101|FG003|Overall Study|Withdrawal by Subject|3|||
147044280|NCT05626231|530322102|FG000|Provider Enrollment|Worked part-time|4|||
147044281|NCT05626231|530322102|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
147044282|NCT05626231|530322102|FG000|Provider Enrollment|Non-clinical employee|1|||
147044283|NCT05626231|530322102|FG000|Provider Enrollment|Provider does not see clients|3|||
147044284|NCT05626231|530322102|FG000|Provider Enrollment|Other|5|||
147044285|NCT03765788|530322104|FG000|Overall Study|Subject decision|2|||
147044286|NCT03765788|530322105|FG001|Overall Study|Subject decision|3|||
147044287|NCT03765788|530322104|FG000|Overall Study|Physician Decision|2|||
147044288|NCT03765788|530322105|FG001|Overall Study|Physician Decision|4|||
147044289|NCT03765788|530322104|FG000|Overall Study|Death|0|||
147044290|NCT03765788|530322105|FG001|Overall Study|Death|1|||
147044291|NCT03765788|530322104|FG000|Overall Study|Lost to Follow-up|1|||
147044292|NCT03765788|530322105|FG001|Overall Study|Lost to Follow-up|0|||
147044293|NCT03203850|530322106|FG000|Overall Study|Subject/guardian decision|4|||
147044294|NCT03203850|530322107|FG001|Overall Study|Subject/guardian decision|3|||
147044295|NCT03203850|530322106|FG000|Overall Study|Adverse Event|3|||
147044296|NCT03203850|530322107|FG001|Overall Study|Adverse Event|0|||
147044297|NCT03203850|530322106|FG000|Overall Study|Death|1|||
147044298|NCT03203850|530322107|FG001|Overall Study|Death|0|||
147044299|NCT02717455|530322108|FG000|Overall Study|Adverse Event|1|||
147044300|NCT02717455|530322109|FG001|Overall Study|Adverse Event|0|||
147044301|NCT02717455|530322110|FG002|Overall Study|Adverse Event|0|||
147044302|NCT02717455|530322111|FG003|Overall Study|Adverse Event|2|||
147044303|NCT02717455|530322112|FG004|Overall Study|Adverse Event|2|||
147044304|NCT02717455|530322113|FG005|Overall Study|Adverse Event|2|||
147044305|NCT02717455|530322108|FG000|Overall Study|Withdrawal by Subject|1|||
147044306|NCT02717455|530322109|FG001|Overall Study|Withdrawal by Subject|1|||
147044307|NCT02717455|530322110|FG002|Overall Study|Withdrawal by Subject|0|||
147044308|NCT02717455|530322111|FG003|Overall Study|Withdrawal by Subject|2|||
147044309|NCT02717455|530322112|FG004|Overall Study|Withdrawal by Subject|2|||
147044310|NCT02717455|530322113|FG005|Overall Study|Withdrawal by Subject|1|||
147044311|NCT02717455|530322108|FG000|Overall Study|Death|1|||
147044312|NCT02717455|530322109|FG001|Overall Study|Death|0|||
147044313|NCT02717455|530322110|FG002|Overall Study|Death|0|||
147044314|NCT02717455|530322111|FG003|Overall Study|Death|0|||
147044315|NCT02717455|530322112|FG004|Overall Study|Death|1|||
147044316|NCT02717455|530322113|FG005|Overall Study|Death|0|||
147044317|NCT02717455|530322108|FG000|Overall Study|Did not receive study drug|0|||
147044318|NCT02717455|530322109|FG001|Overall Study|Did not receive study drug|0|||
147044319|NCT02717455|530322110|FG002|Overall Study|Did not receive study drug|0|||
147044320|NCT02717455|530322111|FG003|Overall Study|Did not receive study drug|1|||
147044321|NCT02717455|530322112|FG004|Overall Study|Did not receive study drug|0|||
147044322|NCT02717455|530322113|FG005|Overall Study|Did not receive study drug|1|||
147044323|NCT02717455|530322108|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
147044324|NCT02717455|530322109|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
147044325|NCT02717455|530322110|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
147044326|NCT02717455|530322111|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
147044327|NCT02717455|530322112|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
147044328|NCT02717455|530322113|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
147044329|NCT02717455|530322108|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
147044330|NCT02717455|530322109|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
147044331|NCT02717455|530322110|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
147044332|NCT02717455|530322111|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
147044333|NCT02717455|530322112|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
147044334|NCT02717455|530322113|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
147044335|NCT00733005|530322114|FG000|Overall Study|Adverse Event|0|||
147044336|NCT00733005|530322115|FG001|Overall Study|Adverse Event|1|||
147044337|NCT00733005|530322114|FG000|Overall Study|Treatment Failure|0|||
147044338|NCT00733005|530322115|FG001|Overall Study|Treatment Failure|1|||
147044339|NCT00733005|530322114|FG000|Overall Study|Withdrawal by Subject|0|||
147044340|NCT00733005|530322115|FG001|Overall Study|Withdrawal by Subject|1|||
147044341|NCT00733005|530322114|FG000|Overall Study|Protocol Violation|2|||
147044342|NCT00733005|530322115|FG001|Overall Study|Protocol Violation|0|||
147044343|NCT02090725|530322118|FG000|Overall Study|Withdrawal by Subject|1|||
147044344|NCT02090725|530322118|FG000|Overall Study|participants moved from area|3|||
147044345|NCT05256134|530322122|FG000|Overall Study|Study Terminated by Sponsor|11|||
147044346|NCT05256134|530322123|FG001|Overall Study|Study Terminated by Sponsor|10|||
147044347|NCT05256134|530322122|FG000|Overall Study|Withdrawal by Subject|1|||
147044348|NCT05256134|530322123|FG001|Overall Study|Withdrawal by Subject|3|||
147044349|NCT01625988|530322133|FG000|Overall Study|Lost to Follow-up|5|||
147044350|NCT01625988|530322134|FG001|Overall Study|Lost to Follow-up|6|||
147044351|NCT01625988|530322133|FG000|Overall Study|Withdrawal by Subject|8|||
147044352|NCT01625988|530322134|FG001|Overall Study|Withdrawal by Subject|3|||
147044353|NCT01625988|530322133|FG000|Overall Study|Adverse Event|0|||
147044354|NCT01625988|530322134|FG001|Overall Study|Adverse Event|1|||
147044355|NCT01625988|530322133|FG000|Overall Study|Lack of Efficacy|0|||
147044356|NCT01625988|530322134|FG001|Overall Study|Lack of Efficacy|1|||
147044357|NCT01625988|530322133|FG000|Overall Study|Randomized Inappropriately|1|||
147044358|NCT01625988|530322134|FG001|Overall Study|Randomized Inappropriately|0|||
147044359|NCT01625988|530322133|FG000|Overall Study|Protocol Violation|0|||
147044360|NCT01625988|530322134|FG001|Overall Study|Protocol Violation|2|||
147044361|NCT04152863|530322135|FG000|Overall Study|Death|13|||
147044362|NCT04152863|530322136|FG001|Overall Study|Death|12|||
147044363|NCT04152863|530322137|FG002|Overall Study|Death|7|||
147044364|NCT04152863|530322135|FG000|Overall Study|Physician Decision|1|||
147044365|NCT04152863|530322136|FG001|Overall Study|Physician Decision|1|||
147044366|NCT04152863|530322137|FG002|Overall Study|Physician Decision|1|||
147044367|NCT04152863|530322135|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
147044368|NCT04152863|530322136|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
147044369|NCT04152863|530322137|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
147044370|NCT04152863|530322135|FG000|Overall Study|Withdrawal by Subject|2|||
147044371|NCT04152863|530322136|FG001|Overall Study|Withdrawal by Subject|1|||
147044372|NCT04152863|530322137|FG002|Overall Study|Withdrawal by Subject|3|||
147044373|NCT01644617|530322138|FG000|Overall Study|Withdrawal by Subject|3|||
147044374|NCT01644617|530322139|FG001|Overall Study|Withdrawal by Subject|4|||
147044375|NCT01644617|530322140|FG002|Overall Study|Withdrawal by Subject|1|||
147044376|NCT01644617|530322138|FG000|Overall Study|Lost to Follow-up|0|||
147044377|NCT01644617|530322139|FG001|Overall Study|Lost to Follow-up|1|||
147044378|NCT01644617|530322140|FG002|Overall Study|Lost to Follow-up|0|||
147044379|NCT01644617|530322138|FG000|Overall Study|Adverse Event|3|||
147044380|NCT01644617|530322139|FG001|Overall Study|Adverse Event|0|||
147044381|NCT01644617|530322140|FG002|Overall Study|Adverse Event|6|||
147044382|NCT02276807|530322141|FG000|Overall Study|Withdrawal by Subject|8|||
147044383|NCT02276807|530322142|FG001|Overall Study|Withdrawal by Subject|7|||
147044384|NCT02276807|530322141|FG000|Overall Study|Lost to Follow-up|10|||
147044385|NCT02276807|530322142|FG001|Overall Study|Lost to Follow-up|10|||
147044386|NCT04342819|530322150|FG000|Overall Study|Declined|4|||
147044387|NCT04342819|530322150|FG000|Overall Study|Not meeeting selection criteria|1|||
147044388|NCT02287922|530322151|FG000|Overall Study|Adverse Event|1|||
147044389|NCT02287922|530322152|FG001|Overall Study|Adverse Event|1|||
147044390|NCT02287922|530322153|FG002|Overall Study|Adverse Event|3|||
147044391|NCT02287922|530322154|FG003|Overall Study|Adverse Event|4|||
147044392|NCT02287922|530322151|FG000|Overall Study|Withdrawal by Subject|1|||
147044393|NCT02287922|530322152|FG001|Overall Study|Withdrawal by Subject|1|||
147044394|NCT02287922|530322153|FG002|Overall Study|Withdrawal by Subject|1|||
147044395|NCT02287922|530322154|FG003|Overall Study|Withdrawal by Subject|2|||
147044396|NCT02287922|530322151|FG000|Overall Study|Lost to Follow-up|0|||
147044397|NCT02287922|530322152|FG001|Overall Study|Lost to Follow-up|0|||
147044398|NCT02287922|530322153|FG002|Overall Study|Lost to Follow-up|1|||
147044399|NCT02287922|530322154|FG003|Overall Study|Lost to Follow-up|0|||
147044400|NCT02287922|530322151|FG000|Overall Study|Sponsor's decision|0|||
147044401|NCT02287922|530322152|FG001|Overall Study|Sponsor's decision|0|||
147044402|NCT02287922|530322153|FG002|Overall Study|Sponsor's decision|0|||
147044403|NCT02287922|530322154|FG003|Overall Study|Sponsor's decision|1|||
147044404|NCT02287922|530322151|FG000|Overall Study|Other|1|||
147044405|NCT02287922|530322152|FG001|Overall Study|Other|0|||
147044406|NCT02287922|530322153|FG002|Overall Study|Other|2|||
147044407|NCT02287922|530322154|FG003|Overall Study|Other|0|||
147044408|NCT03607487|530322164|FG000|Overall Study|Withdrawal by Subject|2|||
147044409|NCT03607487|530322165|FG001|Overall Study|Withdrawal by Subject|0|||
147044410|NCT03607487|530322166|FG002|Overall Study|Withdrawal by Subject|0|||
147044411|NCT03607487|530322167|FG003|Overall Study|Withdrawal by Subject|1|||
147044412|NCT01884337|530322168|FG000|Treatment|Adverse Event|2|||
147044413|NCT01884337|530322169|FG001|Treatment|Adverse Event|2|||
147044414|NCT01884337|530322168|FG000|Treatment|Subj. request to discont. treatment|2|||
147044415|NCT01884337|530322169|FG001|Treatment|Subj. request to discont. treatment|0|||
147044416|NCT01884337|530322168|FG000|Follow-up Period|Lost to Follow-up|1|||
147044417|NCT01884337|530322169|FG001|Follow-up Period|Lost to Follow-up|1|||
147044418|NCT02455518|530322170|FG000|Overall Study|Protocol Violation|0|||
147044419|NCT02455518|530322171|FG001|Overall Study|Protocol Violation|1|||
147044420|NCT02455518|530322172|FG002|Overall Study|Protocol Violation|1|||
147044421|NCT02455518|530322173|FG003|Overall Study|Protocol Violation|3|||
147044422|NCT04223752|530322179|FG000|Overall Study|Participant enrolled in error|0|||
147044423|NCT04223752|530322180|FG001|Overall Study|Participant enrolled in error|0|||
147044424|NCT04223752|530322181|FG002|Overall Study|Participant enrolled in error|0|||
147044425|NCT04223752|530322182|FG003|Overall Study|Participant enrolled in error|0|||
147044426|NCT04223752|530322183|FG004|Overall Study|Participant enrolled in error|1|||
147044427|NCT04223752|530322179|FG000|Overall Study|Death|0|||
147044428|NCT04223752|530322180|FG001|Overall Study|Death|0|||
147044429|NCT04223752|530322181|FG002|Overall Study|Death|0|||
147044430|NCT04223752|530322182|FG003|Overall Study|Death|2|||
147044431|NCT04223752|530322183|FG004|Overall Study|Death|1|||
147044432|NCT04759703|530322184|FG000|Overall Study|Withdrawal by Subject|4|||
147044433|NCT04759703|530322185|FG001|Overall Study|Withdrawal by Subject|9|||
147044434|NCT04759703|530322184|FG000|Overall Study|Adverse Event|1|||
147044435|NCT04759703|530322185|FG001|Overall Study|Adverse Event|0|||
147044436|NCT04759703|530322184|FG000|Overall Study|Lost to Follow-up|2|||
147044437|NCT04759703|530322185|FG001|Overall Study|Lost to Follow-up|0|||
147044438|NCT04186845|530322197|FG000|Overall Study|Death|2|||
147044439|NCT04186845|530322197|FG000|Overall Study|Lost to Follow-up|1|||
147044440|NCT04186845|530322197|FG000|Overall Study|Physician Decision|1|||
147044441|NCT04186845|530322197|FG000|Overall Study|Protocol Violation|1|||
147044442|NCT04186845|530322197|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
147044443|NCT04186845|530322197|FG000|Overall Study|Biopsy ordered but not done|1|||
147044444|NCT04186845|530322197|FG000|Overall Study|It was previously confirmed|1|||
147044445|NCT04186845|530322197|FG000|Overall Study|Patient cancelled scheduled scans|2|||
147044446|NCT04186845|530322197|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
147044447|NCT04186845|530322197|FG000|Overall Study|Subject refused confirmatory imaging|1|||
147044448|NCT04186845|530322197|FG000|Overall Study|Too small to biopsy|1|||
147044449|NCT05061420|530322198|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
147044450|NCT05061420|530322199|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
147044451|NCT05061420|530322200|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
147044452|NCT05061420|530322198|FG000|Overall Study|Progressive disease|11|||
147044453|NCT05061420|530322199|FG001|Overall Study|Progressive disease|15|||
147044454|NCT05061420|530322200|FG002|Overall Study|Progressive disease|14|||
147044455|NCT05061420|530322198|FG000|Overall Study|Withdrawal by Subject|2|||
147044456|NCT05061420|530322199|FG001|Overall Study|Withdrawal by Subject|0|||
147044457|NCT05061420|530322200|FG002|Overall Study|Withdrawal by Subject|1|||
147044458|NCT05061420|530322198|FG000|Overall Study|Not related to COVID-19|2|||
147044459|NCT05061420|530322199|FG001|Overall Study|Not related to COVID-19|0|||
147044460|NCT05061420|530322200|FG002|Overall Study|Not related to COVID-19|0|||
147044461|NCT01814553|530322201|FG000|Overall Study|PD per clinical progression|6|||
147044462|NCT01814553|530322202|FG001|Overall Study|PD per clinical progression|8|||
147044463|NCT01814553|530322201|FG000|Overall Study|Other Adverse Event|4|||
147044464|NCT01814553|530322202|FG001|Overall Study|Other Adverse Event|5|||
147044465|NCT01814553|530322201|FG000|Overall Study|Withdrawal by Subject|1|||
147044466|NCT01814553|530322202|FG001|Overall Study|Withdrawal by Subject|1|||
147044467|NCT01814553|530322201|FG000|Overall Study|Other than stated|7|||
147044468|NCT01814553|530322202|FG001|Overall Study|Other than stated|8|||
147044469|NCT03138655|530322206|FG000|Overall Study|Adverse Event|2|||
147044470|NCT03138655|530322207|FG001|Overall Study|Adverse Event|1|||
147044471|NCT03138655|530322208|FG002|Overall Study|Adverse Event|2|||
147044472|NCT03138655|530322209|FG003|Overall Study|Adverse Event|1|||
147044473|NCT03138655|530322210|FG004|Overall Study|Adverse Event|1|||
147044474|NCT03138655|530322211|FG005|Overall Study|Adverse Event|4|||
147044475|NCT03138655|530322212|FG006|Overall Study|Adverse Event|2|||
147044476|NCT03138655|530322213|FG007|Overall Study|Adverse Event|2|||
147044477|NCT03138655|530322206|FG000|Overall Study|Withdrawal by Subject|0|||
147044478|NCT03138655|530322207|FG001|Overall Study|Withdrawal by Subject|1|||
147044479|NCT03138655|530322208|FG002|Overall Study|Withdrawal by Subject|0|||
147044480|NCT03138655|530322209|FG003|Overall Study|Withdrawal by Subject|0|||
147044481|NCT03138655|530322210|FG004|Overall Study|Withdrawal by Subject|0|||
147044482|NCT03138655|530322211|FG005|Overall Study|Withdrawal by Subject|0|||
147044483|NCT03138655|530322212|FG006|Overall Study|Withdrawal by Subject|1|||
147044484|NCT03138655|530322213|FG007|Overall Study|Withdrawal by Subject|0|||
147044485|NCT03138655|530322206|FG000|Overall Study|Reason not Specified|1|||
147044486|NCT03138655|530322207|FG001|Overall Study|Reason not Specified|0|||
147044487|NCT03138655|530322208|FG002|Overall Study|Reason not Specified|0|||
147044488|NCT03138655|530322209|FG003|Overall Study|Reason not Specified|2|||
147044489|NCT03138655|530322210|FG004|Overall Study|Reason not Specified|1|||
147044490|NCT03138655|530322211|FG005|Overall Study|Reason not Specified|1|||
147044491|NCT03138655|530322212|FG006|Overall Study|Reason not Specified|0|||
147044492|NCT03138655|530322213|FG007|Overall Study|Reason not Specified|0|||
147044493|NCT02859142|530322214|FG000|Overall Study|Adverse Event|1|||
147044494|NCT02859142|530322215|FG001|Overall Study|Adverse Event|2|||
147044495|NCT02859142|530322214|FG000|Overall Study|Lost to Follow-up|1|||
147044496|NCT02859142|530322215|FG001|Overall Study|Lost to Follow-up|4|||
147044497|NCT02859142|530322214|FG000|Overall Study|Withdrawal by Subject|2|||
147044498|NCT02859142|530322215|FG001|Overall Study|Withdrawal by Subject|0|||
147044499|NCT02859142|530322214|FG000|Overall Study|Scheduling difficulties|0|||
147044500|NCT02859142|530322215|FG001|Overall Study|Scheduling difficulties|3|||
147044501|NCT03290079|530322216|FG000|Overall Study|Death|2|||
147044502|NCT00447993|530322219|FG000|Overall Study|Lost to Follow-up|0|||
147044503|NCT00447993|530322220|FG001|Overall Study|Lost to Follow-up|0|||
147044504|NCT00447993|530322221|FG002|Overall Study|Lost to Follow-up|2|||
147044505|NCT00447993|530322222|FG003|Overall Study|Lost to Follow-up|2|||
147044506|NCT00447993|530322219|FG000|Overall Study|Withdrawal by Subject|0|||
147044507|NCT00447993|530322220|FG001|Overall Study|Withdrawal by Subject|0|||
147044508|NCT00447993|530322221|FG002|Overall Study|Withdrawal by Subject|2|||
147044509|NCT00447993|530322222|FG003|Overall Study|Withdrawal by Subject|2|||
147044510|NCT04700137|530322227|FG000|Overall Study|Lost to Follow-up|1|||
147044511|NCT04700137|530322228|FG001|Overall Study|Lost to Follow-up|6|||
147044512|NCT04700137|530322229|FG002|Overall Study|Lost to Follow-up|1|||
147044513|NCT04700137|530322230|FG003|Overall Study|Lost to Follow-up|1|||
147044514|NCT04700137|530322227|FG000|Overall Study|Withdrawal by Subject|0|||
147044515|NCT04700137|530322228|FG001|Overall Study|Withdrawal by Subject|0|||
147044516|NCT04700137|530322229|FG002|Overall Study|Withdrawal by Subject|1|||
147044517|NCT04700137|530322230|FG003|Overall Study|Withdrawal by Subject|0|||
147044518|NCT04700137|530322227|FG000|Overall Study|Death|0|||
147044519|NCT04700137|530322228|FG001|Overall Study|Death|0|||
147044520|NCT04700137|530322229|FG002|Overall Study|Death|1|||
147044521|NCT04700137|530322230|FG003|Overall Study|Death|0|||
147044522|NCT02503787|530322231|FG000|Enrollment|Withdrawal by Subject|6|||
147044523|NCT02503787|530322231|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
147044524|NCT02503787|530322231|FG000|Enrollment|Physician Decision|2|||
147044525|NCT02503787|530322231|FG000|Enrollment|Insurance issue|2|||
147044526|NCT02503787|530322231|FG000|Enrollment|Lost to Follow-up|1|||
147044527|NCT02503787|530322231|FG000|Enrollment|Study closure|1|||
147044528|NCT02503787|530322231|FG000|Enrollment|Adverse Event|1|||
147044529|NCT02503787|530322231|FG000|Enrollment|Protocol Violation|1|||
147044530|NCT02503787|530322231|FG000|Enrollment|Inability to implant system|1|||
147044531|NCT02503787|530322231|FG000|Enrollment|Unable to be programmed|1|||
147044532|NCT02503787|530322231|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
147044533|NCT02503787|530322231|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
147044534|NCT02503787|530322231|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
147044535|NCT02503787|530322231|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
147044536|NCT02503787|530322231|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
147044537|NCT02503787|530322231|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
147044538|NCT04787627|530322232|FG000|Overall Study|Withdrawal by Subject|3|||
147044539|NCT04787627|530322233|FG001|Overall Study|Withdrawal by Subject|0|||
147044540|NCT04787627|530322232|FG000|Overall Study|Physician Decision|2|||
147044541|NCT04787627|530322233|FG001|Overall Study|Physician Decision|0|||
147044542|NCT04787627|530322232|FG000|Overall Study|Excluded|0|||
147044543|NCT04787627|530322233|FG001|Overall Study|Excluded|1|||
147044544|NCT00548093|530322234|FG000|Overall Study|Death|33|||
147044545|NCT00548093|530322235|FG001|Overall Study|Death|13|||
147044546|NCT00548093|530322234|FG000|Overall Study|Lost to Follow-up|3|||
147044547|NCT00548093|530322235|FG001|Overall Study|Lost to Follow-up|1|||
147044548|NCT00548093|530322234|FG000|Overall Study|Objective progression or relapse|1|||
147044549|NCT00548093|530322235|FG001|Overall Study|Objective progression or relapse|1|||
147044550|NCT00548093|530322234|FG000|Overall Study|Other|11|||
147044551|NCT00548093|530322235|FG001|Overall Study|Other|1|||
147044552|NCT00548093|530322234|FG000|Overall Study|Withdrawal by Subject|1|||
147044553|NCT00548093|530322235|FG001|Overall Study|Withdrawal by Subject|0|||
147044554|NCT00548093|530322234|FG000|Overall Study|Completed post-treatment follow-up|1|||
147044555|NCT00548093|530322235|FG001|Overall Study|Completed post-treatment follow-up|0|||
147044556|NCT02924727|530322236|FG000|Overall Study|Withdrawal by Subject|2|||
147044557|NCT02924727|530322237|FG001|Overall Study|Withdrawal by Subject|4|||
147044558|NCT02924727|530322236|FG000|Overall Study|Lost to Follow-up|2|||
147044559|NCT02924727|530322237|FG001|Overall Study|Lost to Follow-up|5|||
147044560|NCT02924727|530322236|FG000|Overall Study|Death|221|||
147044561|NCT02924727|530322237|FG001|Overall Study|Death|247|||
147044562|NCT02924727|530322236|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
147044563|NCT02924727|530322237|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
147044564|NCT01464931|530322244|FG000|Overall Study|Withdrawal by Subject|1|||
147044565|NCT01464931|530322245|FG001|Overall Study|Withdrawal by Subject|0|||
147044566|NCT01982812|530322246|FG000|Overall Study|Death|1|||
147044567|NCT01982812|530322247|FG001|Overall Study|Death|5|||
147044568|NCT01982812|530322246|FG000|Overall Study|Adverse Event|0|||
147044569|NCT01982812|530322247|FG001|Overall Study|Adverse Event|5|||
147044570|NCT00174954|530322248|FG000|Overall Study|Adverse Event|2|||
147044571|NCT00174954|530322248|FG000|Overall Study|No tophi found in MRI|1|||
147044572|NCT00174954|530322248|FG000|Overall Study|Physician Decision|1|||
147044573|NCT00993421|530322249|FG000|Overall Study|Adverse Event|2|||
147044574|NCT00993421|530322250|FG001|Overall Study|Adverse Event|7|||
147044575|NCT00993421|530322251|FG002|Overall Study|Adverse Event|6|||
147044576|NCT00993421|530322252|FG003|Overall Study|Adverse Event|9|||
147044577|NCT00993421|530322253|FG004|Overall Study|Adverse Event|5|||
147044578|NCT00993421|530322254|FG005|Overall Study|Adverse Event|7|||
147044579|NCT00993421|530322255|FG006|Overall Study|Adverse Event|1|||
147044580|NCT00993421|530322249|FG000|Overall Study|Sponsor Decision|36|||
147044581|NCT00993421|530322250|FG001|Overall Study|Sponsor Decision|31|||
147044582|NCT00993421|530322251|FG002|Overall Study|Sponsor Decision|28|||
147044583|NCT00993421|530322252|FG003|Overall Study|Sponsor Decision|30|||
147044584|NCT00993421|530322253|FG004|Overall Study|Sponsor Decision|38|||
147044585|NCT00993421|530322254|FG005|Overall Study|Sponsor Decision|30|||
147044586|NCT00993421|530322255|FG006|Overall Study|Sponsor Decision|29|||
147044587|NCT00993421|530322249|FG000|Overall Study|Lost to Follow-up|3|||
147044588|NCT00993421|530322250|FG001|Overall Study|Lost to Follow-up|5|||
147044589|NCT00993421|530322251|FG002|Overall Study|Lost to Follow-up|5|||
147044590|NCT00993421|530322252|FG003|Overall Study|Lost to Follow-up|0|||
147044591|NCT00993421|530322253|FG004|Overall Study|Lost to Follow-up|0|||
147044592|NCT00993421|530322254|FG005|Overall Study|Lost to Follow-up|0|||
147044593|NCT00993421|530322255|FG006|Overall Study|Lost to Follow-up|6|||
147044594|NCT00993421|530322249|FG000|Overall Study|Withdrawal by Subject|3|||
147044595|NCT00993421|530322250|FG001|Overall Study|Withdrawal by Subject|2|||
147044596|NCT00993421|530322251|FG002|Overall Study|Withdrawal by Subject|3|||
147044597|NCT00993421|530322252|FG003|Overall Study|Withdrawal by Subject|3|||
147044598|NCT00993421|530322253|FG004|Overall Study|Withdrawal by Subject|3|||
147044599|NCT00993421|530322254|FG005|Overall Study|Withdrawal by Subject|5|||
147044600|NCT00993421|530322255|FG006|Overall Study|Withdrawal by Subject|3|||
147044601|NCT00993421|530322249|FG000|Overall Study|Death|0|||
147044602|NCT00993421|530322250|FG001|Overall Study|Death|0|||
147044603|NCT00993421|530322251|FG002|Overall Study|Death|0|||
147044604|NCT00993421|530322252|FG003|Overall Study|Death|0|||
147044605|NCT00993421|530322253|FG004|Overall Study|Death|0|||
147044606|NCT00993421|530322254|FG005|Overall Study|Death|0|||
147044607|NCT00993421|530322255|FG006|Overall Study|Death|1|||
147044608|NCT00993421|530322249|FG000|Overall Study|Entry Criteria Exclusion|0|||
147044609|NCT00993421|530322250|FG001|Overall Study|Entry Criteria Exclusion|0|||
147044610|NCT00993421|530322251|FG002|Overall Study|Entry Criteria Exclusion|1|||
147044611|NCT00993421|530322252|FG003|Overall Study|Entry Criteria Exclusion|3|||
147044612|NCT00993421|530322253|FG004|Overall Study|Entry Criteria Exclusion|0|||
147044613|NCT00993421|530322254|FG005|Overall Study|Entry Criteria Exclusion|1|||
147044614|NCT00993421|530322255|FG006|Overall Study|Entry Criteria Exclusion|0|||
147044615|NCT00993421|530322249|FG000|Overall Study|Physician Decision|0|||
147044616|NCT00993421|530322250|FG001|Overall Study|Physician Decision|0|||
147044617|NCT00993421|530322251|FG002|Overall Study|Physician Decision|0|||
147044618|NCT00993421|530322252|FG003|Overall Study|Physician Decision|0|||
147044619|NCT00993421|530322253|FG004|Overall Study|Physician Decision|0|||
147044620|NCT00993421|530322254|FG005|Overall Study|Physician Decision|1|||
147044621|NCT00993421|530322255|FG006|Overall Study|Physician Decision|1|||
147044622|NCT00993421|530322249|FG000|Overall Study|Protocol Violation|0|||
147044623|NCT00993421|530322250|FG001|Overall Study|Protocol Violation|0|||
147044624|NCT00993421|530322251|FG002|Overall Study|Protocol Violation|0|||
147044625|NCT00993421|530322252|FG003|Overall Study|Protocol Violation|0|||
147044626|NCT00993421|530322253|FG004|Overall Study|Protocol Violation|0|||
147044627|NCT00993421|530322254|FG005|Overall Study|Protocol Violation|2|||
147044628|NCT00993421|530322255|FG006|Overall Study|Protocol Violation|1|||
147044629|NCT03514017|530322256|FG000|Overall Study|Death|1|||
147044630|NCT03514017|530322256|FG000|Overall Study|Adverse Event|1|||
147044631|NCT02447744|530322260|FG000|Overall Study|Withdrawal by Subject|3|||
147044632|NCT02447744|530322261|FG001|Overall Study|Withdrawal by Subject|1|||
147044633|NCT02447744|530322260|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
147044634|NCT02447744|530322261|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
147044635|NCT00912912|530322262|FG000|Overall Study|Withdrawal by Subject|1|||
147044636|NCT00912912|530322262|FG000|Overall Study|Disease Progression|3|||
147044637|NCT00196326|530323813|FG000|Overall Study|Did not meet protocol requirements|64|||
147044638|NCT00196326|530323813|FG000|Overall Study|Non-compliance with the protocol|81|||
147044639|NCT00196326|530323813|FG000|Overall Study|Physician Decision|3|||
147044640|NCT00196326|530323813|FG000|Overall Study|Withdrawal by Subject|225|||
147044641|NCT00196326|530323813|FG000|Overall Study|Adverse Event|253|||
147044642|NCT00196326|530323813|FG000|Overall Study|Pregnancy|34|||
147044643|NCT00196326|530323813|FG000|Overall Study|Lost to Follow-up|304|||
147044644|NCT00196326|530323813|FG000|Overall Study|Other|22|||
147044645|NCT05223920|530323814|FG000|Overall Study|Adverse Event|6|||
147044646|NCT05223920|530323815|FG001|Overall Study|Adverse Event|3|||
147044647|NCT05223920|530323814|FG000|Overall Study|Death|2|||
147044648|NCT05223920|530323815|FG001|Overall Study|Death|0|||
147044649|NCT05223920|530323814|FG000|Overall Study|Disease Progression|1|||
147044650|NCT05223920|530323815|FG001|Overall Study|Disease Progression|2|||
147044651|NCT05223920|530323814|FG000|Overall Study|Physician Decision|1|||
147044652|NCT05223920|530323815|FG001|Overall Study|Physician Decision|2|||
147044653|NCT05223920|530323814|FG000|Overall Study|Sponsor decision|11|||
147044654|NCT05223920|530323815|FG001|Overall Study|Sponsor decision|9|||
147044655|NCT05223920|530323814|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
147044656|NCT05223920|530323815|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
147044657|NCT05223920|530323814|FG000|Overall Study|Subject decision|1|||
147044658|NCT05223920|530323815|FG001|Overall Study|Subject decision|0|||
147044659|NCT05223920|530323814|FG000|Overall Study|Withdrawal by Subject|1|||
147044660|NCT05223920|530323815|FG001|Overall Study|Withdrawal by Subject|6|||
147044661|NCT03685344|530323818|FG000|Overall Study|Withdrawal by Subject|1|||
147044662|NCT03685344|530323819|FG001|Overall Study|Withdrawal by Subject|1|||
147044663|NCT03685344|530323820|FG002|Overall Study|Withdrawal by Subject|2|||
147044664|NCT03685344|530323821|FG003|Overall Study|Withdrawal by Subject|0|||
147044665|NCT03685344|530323818|FG000|Overall Study|Physician Decision|1|||
147044666|NCT03685344|530323819|FG001|Overall Study|Physician Decision|1|||
147044667|NCT03685344|530323820|FG002|Overall Study|Physician Decision|5|||
147044668|NCT03685344|530323821|FG003|Overall Study|Physician Decision|0|||
147044669|NCT03685344|530323818|FG000|Overall Study|Death|1|||
147044670|NCT03685344|530323819|FG001|Overall Study|Death|1|||
147044671|NCT03685344|530323820|FG002|Overall Study|Death|0|||
147044672|NCT03685344|530323821|FG003|Overall Study|Death|0|||
147044673|NCT02121652|530323824|FG000|Overall Study|Lost to Follow-up|2|||
147044674|NCT02121652|530323825|FG001|Overall Study|Lost to Follow-up|1|||
147044675|NCT02121652|530323824|FG000|Overall Study|Death|1|||
147044676|NCT02121652|530323825|FG001|Overall Study|Death|0|||
147044677|NCT02121652|530323824|FG000|Overall Study|Withdrawal by Subject|3|||
147044678|NCT02121652|530323825|FG001|Overall Study|Withdrawal by Subject|3|||
147044679|NCT00261950|530323827|FG000|Overall Study|Lost to Follow-up|2|||
147044680|NCT00261950|530323827|FG000|Overall Study|Death|6|||
147044681|NCT00261950|530323827|FG000|Overall Study|Withdrawal by Subject|5|||
147044682|NCT00261950|530323827|FG000|Overall Study|Other|1|||
147044683|NCT00261950|530323827|FG000|Overall Study|Physician Decision|1|||
147044684|NCT00261950|530323827|FG000|Overall Study|Protocol specified Criteria|11|||
147044685|NCT01023035|530323828|FG000|Treatment Period|Adverse Event|27|||
147044686|NCT01023035|530323829|FG001|Treatment Period|Adverse Event|32|||
147044687|NCT01023035|530323830|FG002|Treatment Period|Adverse Event|50|||
147044688|NCT01023035|530323828|FG000|Treatment Period|Non-Medical Reasons|19|||
147044689|NCT01023035|530323829|FG001|Treatment Period|Non-Medical Reasons|22|||
147044690|NCT01023035|530323830|FG002|Treatment Period|Non-Medical Reasons|44|||
147044691|NCT01023035|530323828|FG000|Treatment Period|Treatment Failure|26|||
147044692|NCT01023035|530323829|FG001|Treatment Period|Treatment Failure|31|||
147044693|NCT01023035|530323830|FG002|Treatment Period|Treatment Failure|24|||
147044694|NCT01023035|530323828|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
147044695|NCT01023035|530323829|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
147044696|NCT01023035|530323830|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
147044697|NCT01023035|530323828|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
147044698|NCT01023035|530323829|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
147044699|NCT01023035|530323830|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
147044700|NCT00445432|530323835|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
147044701|NCT00445432|530323836|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
147044702|NCT00445432|530323837|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
147044703|NCT00445432|530323838|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
147044704|NCT00445432|530323835|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
147044705|NCT00445432|530323836|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
147044706|NCT00445432|530323837|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
147044707|NCT00445432|530323838|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
147044708|NCT00445432|530323835|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
147044709|NCT00445432|530323836|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
147044710|NCT00445432|530323837|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
147044711|NCT00445432|530323838|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
147044712|NCT00445432|530323835|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
147044713|NCT00445432|530323836|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
147044714|NCT00445432|530323837|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
147044715|NCT00445432|530323838|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
147044716|NCT00445432|530323835|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
147044717|NCT00445432|530323836|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
147044718|NCT00445432|530323837|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
147044719|NCT00445432|530323838|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
147044720|NCT00445432|530323835|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
147044721|NCT00445432|530323836|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
147044722|NCT00445432|530323837|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
147044723|NCT00445432|530323838|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
147044724|NCT00445432|530323835|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
147044725|NCT00445432|530323836|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
147044726|NCT00445432|530323837|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
147044727|NCT00445432|530323838|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
147044728|NCT02789137|530323839|FG000|Overall Study|Dropped out/Died|58|||
147044729|NCT01090414|530323840|FG000|Study 101-99|Progressive Disease|28|||
147044730|NCT01090414|530323841|FG001|Study 101-99|Progressive Disease|48|||
147044731|NCT01090414|530323842|FG002|Study 101-99|Progressive Disease|10|||
147044732|NCT01090414|530323843|FG003|Study 101-99|Progressive Disease|4|||
147044733|NCT01090414|530323840|FG000|Study 101-99|Adverse Event|10|||
147044734|NCT01090414|530323841|FG001|Study 101-99|Adverse Event|28|||
146849914|NCT02101385|529618927|FG001|Study Treatment|Disease Progression before treatment|0|||
147044735|NCT01090414|530323842|FG002|Study 101-99|Adverse Event|18|||
147044736|NCT01090414|530323843|FG003|Study 101-99|Adverse Event|0|||
147044737|NCT01090414|530323840|FG000|Study 101-99|Investigator Request|1|||
147044738|NCT01090414|530323841|FG001|Study 101-99|Investigator Request|11|||
147044739|NCT01090414|530323842|FG002|Study 101-99|Investigator Request|4|||
147044740|NCT01090414|530323843|FG003|Study 101-99|Investigator Request|0|||
147044741|NCT01090414|530323840|FG000|Study 101-99|Death|3|||
147044742|NCT01090414|530323841|FG001|Study 101-99|Death|8|||
147044743|NCT01090414|530323842|FG002|Study 101-99|Death|1|||
147044744|NCT01090414|530323843|FG003|Study 101-99|Death|0|||
147044745|NCT01090414|530323840|FG000|Study 101-99|Sponsor Discontinued Study|0|||
147044746|NCT01090414|530323841|FG001|Study 101-99|Sponsor Discontinued Study|7|||
146849915|NCT02101385|529618926|FG000|Study Treatment|Death|1|||
146849916|NCT02101385|529618927|FG001|Study Treatment|Death|0|||
146849917|NCT02101385|529618926|FG000|Follow up|Lost to Follow-up|4|||
146849918|NCT02101385|529618927|FG001|Follow up|Lost to Follow-up|9|||
146849919|NCT02101385|529618926|FG000|Follow up|Refused to follow up|5|||
146849920|NCT02101385|529618927|FG001|Follow up|Refused to follow up|4|||
146849921|NCT02101385|529618926|FG000|Follow up|Death|21|||
146849922|NCT02101385|529618927|FG001|Follow up|Death|39|||
146849923|NCT02101385|529618926|FG000|Follow up|study completed|33|||
146849924|NCT02101385|529618927|FG001|Follow up|study completed|52|||
146849925|NCT02101385|529618926|FG000|Follow up|screen failure|2|||
146849926|NCT02101385|529618927|FG001|Follow up|screen failure|0|||
146849927|NCT02101385|529618926|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
146849928|NCT02101385|529618927|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
147044747|NCT01090414|530323842|FG002|Study 101-99|Sponsor Discontinued Study|5|||
147044748|NCT01090414|530323843|FG003|Study 101-99|Sponsor Discontinued Study|0|||
147044749|NCT01090414|530323840|FG000|Study 101-99|Other (Unknown Reasons)|3|||
147044750|NCT01090414|530323841|FG001|Study 101-99|Other (Unknown Reasons)|3|||
147044751|NCT01090414|530323842|FG002|Study 101-99|Other (Unknown Reasons)|0|||
147044752|NCT01090414|530323843|FG003|Study 101-99|Other (Unknown Reasons)|0|||
147044753|NCT01090414|530323840|FG000|Study 101-99|Withdrew Consent|0|||
147044754|NCT01090414|530323841|FG001|Study 101-99|Withdrew Consent|2|||
147044755|NCT01090414|530323842|FG002|Study 101-99|Withdrew Consent|3|||
147044756|NCT01090414|530323843|FG003|Study 101-99|Withdrew Consent|1|||
147044757|NCT01090414|530323840|FG000|Study 101-99|Participant Request|3|||
147044758|NCT01090414|530323841|FG001|Study 101-99|Participant Request|1|||
147044759|NCT01090414|530323842|FG002|Study 101-99|Participant Request|0|||
147044760|NCT01090414|530323843|FG003|Study 101-99|Participant Request|0|||
147044761|NCT00247676|530323848|FG000|Overall Study|Death|5|||
147044762|NCT00247676|530323848|FG000|Overall Study|Adverse Event|11|||
147044763|NCT00247676|530323848|FG000|Overall Study|Lack of Efficacy|15|||
147044764|NCT00247676|530323848|FG000|Overall Study|Other|3|||
147044765|NCT00247676|530323848|FG000|Overall Study|Withdrawal by Subject|2|||
147044766|NCT03594071|530323849|FG000|Overall Study|Re-operation|3|||
147044767|NCT03594071|530323849|FG000|Overall Study|Missed visit|2|||
147044768|NCT05219448|530323850|FG000|Overall Study|Lost to Follow-up|9|||
147044769|NCT05219448|530323851|FG001|Overall Study|Lost to Follow-up|0|||
147044770|NCT00911300|530323853|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
147044771|NCT00911300|530323854|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
147044772|NCT00911300|530323853|FG000|Overall Study|Death|1|||
147044773|NCT00911300|530323854|FG001|Overall Study|Death|0|||
147044774|NCT00911300|530323853|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
146849929|NCT02101385|529618926|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
147044775|NCT00911300|530323854|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
147044776|NCT00911300|530323853|FG000|Overall Study|Adverse Event|14|||
147044777|NCT00911300|530323854|FG001|Overall Study|Adverse Event|6|||
147044778|NCT00911300|530323853|FG000|Overall Study|Protocol Violation|3|||
147044779|NCT00911300|530323854|FG001|Overall Study|Protocol Violation|2|||
147044780|NCT00911300|530323853|FG000|Overall Study|Consent Withdrawn|4|||
147044781|NCT00911300|530323854|FG001|Overall Study|Consent Withdrawn|12|||
147044782|NCT00911300|530323853|FG000|Overall Study|Coronary Angiography Performed|1|||
147044783|NCT00911300|530323854|FG001|Overall Study|Coronary Angiography Performed|0|||
147044784|NCT00911300|530323853|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
147044785|NCT00911300|530323854|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
147044786|NCT00911300|530323853|FG000|Overall Study|Received Commercial Treatment|1|||
147044787|NCT00911300|530323854|FG001|Overall Study|Received Commercial Treatment|0|||
147044788|NCT00911300|530323853|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
147044789|NCT00911300|530323854|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
147044790|NCT00911300|530323853|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
147044791|NCT00911300|530323854|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
147044792|NCT00911300|530323853|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
147044793|NCT00911300|530323854|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
147044794|NCT00911300|530323853|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
147044795|NCT00911300|530323854|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
147044796|NCT00911300|530323853|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
147044797|NCT00911300|530323854|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
147044798|NCT00911300|530323853|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
147044799|NCT00911300|530323854|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
147044800|NCT00911300|530323853|FG000|Overall Study|International Normalized Ratio Too High|0|||
147044801|NCT00911300|530323854|FG001|Overall Study|International Normalized Ratio Too High|1|||
147044802|NCT00911300|530323853|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
147044803|NCT00911300|530323854|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
147044804|NCT00911300|530323853|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
147044805|NCT00911300|530323854|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
147044806|NCT00911300|530323853|FG000|Overall Study|Physician Decision|0|||
147044807|NCT00911300|530323854|FG001|Overall Study|Physician Decision|1|||
147044808|NCT00911300|530323853|FG000|Overall Study|Treatment Stopped by Mistake|0|||
147044809|NCT00911300|530323854|FG001|Overall Study|Treatment Stopped by Mistake|1|||
147044810|NCT00911300|530323853|FG000|Overall Study|Randomized; No Study Medication Received|0|||
147044811|NCT00911300|530323854|FG001|Overall Study|Randomized; No Study Medication Received|2|||
147044812|NCT03022370|530323855|FG000|Overall Study|Death|6|||
147044813|NCT03022370|530323856|FG001|Overall Study|Death|12|||
147044814|NCT03022370|530323855|FG000|Overall Study|Lost to Follow-up|174|||
147044815|NCT03022370|530323856|FG001|Overall Study|Lost to Follow-up|109|||
147044816|NCT00668317|530323857|FG000|Overall Study|Adverse Event|2|||
147044817|NCT00560391|530323863|FG000|Overall Study|Still on treatment|0|||
147044818|NCT00560391|530323864|FG001|Overall Study|Still on treatment|0|||
147044819|NCT00560391|530323865|FG002|Overall Study|Still on treatment|0|||
147044820|NCT00560391|530323866|FG003|Overall Study|Still on treatment|1|||
147044821|NCT00560391|530323867|FG004|Overall Study|Still on treatment|2|||
147044822|NCT03668808|530323868|FG000|First Intervention|Withdrawal by Subject|2|||
147044823|NCT03668808|530323869|FG001|First Intervention|Withdrawal by Subject|2|||
147044824|NCT01526655|530323872|FG000|Overall Study|Withdrawal by Subject|0|||
147044825|NCT01526655|530323873|FG001|Overall Study|Withdrawal by Subject|1|||
147044826|NCT00280735|530323874|FG000|Overall Study|Adverse Event|5|||
147044827|NCT00280735|530323874|FG000|Overall Study|Lack of Efficacy|3|||
147044828|NCT00280735|530323874|FG000|Overall Study|Withdrawal by Subject|8|||
147044829|NCT00280735|530323874|FG000|Overall Study|Intercurrent Illness|2|||
147044830|NCT02001987|530323876|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
147044831|NCT02001987|530323876|FG000|Core Study Period (24 Weeks)|Death|1|||
147044832|NCT02001987|530323876|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
147044833|NCT02001987|530323876|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
147044834|NCT02001987|530323876|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
147044835|NCT02001987|530323876|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
147044836|NCT02001987|530323876|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
147044837|NCT02001987|530323876|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
147044838|NCT02001987|530323876|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
147044839|NCT02001987|530323876|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
147044840|NCT02001987|530323876|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
147044841|NCT02001987|530323876|FG000|LTE Period (52 Weeks)|Other|3|||
147044842|NCT01965860|530323877|FG000|Overall Study|Pregnancy|1|||
147044843|NCT01965860|530323878|FG001|Overall Study|Pregnancy|0|||
147044844|NCT01965860|530323879|FG002|Overall Study|Pregnancy|1|||
147044845|NCT01965860|530323877|FG000|Overall Study|Logistics|1|||
147044846|NCT01965860|530323878|FG001|Overall Study|Logistics|0|||
147044847|NCT01965860|530323879|FG002|Overall Study|Logistics|0|||
147044848|NCT02064296|530323883|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
147044849|NCT02064296|530323884|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
147044850|NCT02064296|530323885|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
147044851|NCT02064296|530323883|FG000|Intervention|Withdrawal by Subject|0|||
147044852|NCT02064296|530323884|FG001|Intervention|Withdrawal by Subject|1|||
147044853|NCT02064296|530323885|FG002|Intervention|Withdrawal by Subject|2|||
147044854|NCT02288325|530323891|FG000|Run-in Period|Adverse Event|48|||
147044855|NCT02288325|530323892|FG001|Run-in Period|Adverse Event|0|||
147044856|NCT02288325|530323893|FG002|Run-in Period|Adverse Event|0|||
147044857|NCT02288325|530323891|FG000|Run-in Period|Lack of Efficacy|16|||
147044858|NCT02288325|530323892|FG001|Run-in Period|Lack of Efficacy|0|||
147044859|NCT02288325|530323893|FG002|Run-in Period|Lack of Efficacy|0|||
147044860|NCT02288325|530323891|FG000|Run-in Period|Withdrawal of Consent|28|||
147044861|NCT02288325|530323892|FG001|Run-in Period|Withdrawal of Consent|0|||
147044862|NCT02288325|530323893|FG002|Run-in Period|Withdrawal of Consent|0|||
147044863|NCT02288325|530323891|FG000|Run-in Period|Lost to Follow-up|25|||
147044864|NCT02288325|530323892|FG001|Run-in Period|Lost to Follow-up|0|||
147044865|NCT02288325|530323893|FG002|Run-in Period|Lost to Follow-up|0|||
147044866|NCT02288325|530323891|FG000|Run-in Period|Protocol Violation|17|||
147044867|NCT02288325|530323892|FG001|Run-in Period|Protocol Violation|0|||
147044868|NCT02288325|530323893|FG002|Run-in Period|Protocol Violation|0|||
147044869|NCT02288325|530323891|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
147044870|NCT02288325|530323892|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
147044871|NCT02288325|530323893|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
147044872|NCT02288325|530323891|FG000|Run-in Period|Reason not Specified|8|||
147044873|NCT02288325|530323892|FG001|Run-in Period|Reason not Specified|0|||
147044874|NCT02288325|530323893|FG002|Run-in Period|Reason not Specified|0|||
147044875|NCT02288325|530323891|FG000|Stabilization Period|Adverse Event|13|||
147044876|NCT02288325|530323892|FG001|Stabilization Period|Adverse Event|0|||
147044877|NCT02288325|530323893|FG002|Stabilization Period|Adverse Event|0|||
147044878|NCT02288325|530323891|FG000|Stabilization Period|Lack of Efficacy|22|||
147044879|NCT02288325|530323892|FG001|Stabilization Period|Lack of Efficacy|0|||
147044880|NCT02288325|530323893|FG002|Stabilization Period|Lack of Efficacy|0|||
147044881|NCT02288325|530323891|FG000|Stabilization Period|Withdrawal of Consent|23|||
147044882|NCT02288325|530323892|FG001|Stabilization Period|Withdrawal of Consent|0|||
147044883|NCT02288325|530323893|FG002|Stabilization Period|Withdrawal of Consent|0|||
147044884|NCT02288325|530323891|FG000|Stabilization Period|Lost to Follow-up|12|||
147044885|NCT02288325|530323892|FG001|Stabilization Period|Lost to Follow-up|0|||
147044886|NCT02288325|530323893|FG002|Stabilization Period|Lost to Follow-up|0|||
147044887|NCT02288325|530323891|FG000|Stabilization Period|Protocol Violation|8|||
147044888|NCT02288325|530323892|FG001|Stabilization Period|Protocol Violation|0|||
147044889|NCT02288325|530323893|FG002|Stabilization Period|Protocol Violation|0|||
147044890|NCT02288325|530323891|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
147044891|NCT02288325|530323892|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
147044892|NCT02288325|530323893|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
147044893|NCT02288325|530323891|FG000|Stabilization Period|Reason not Specified|15|||
147044894|NCT02288325|530323892|FG001|Stabilization Period|Reason not Specified|0|||
147044895|NCT02288325|530323893|FG002|Stabilization Period|Reason not Specified|0|||
147044896|NCT02288325|530323891|FG000|Double-blind Treatment Period|Adverse Event|0|||
147044897|NCT02288325|530323892|FG001|Double-blind Treatment Period|Adverse Event|2|||
147044898|NCT02288325|530323893|FG002|Double-blind Treatment Period|Adverse Event|5|||
147044899|NCT02288325|530323891|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
147044900|NCT02288325|530323892|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
147044901|NCT02288325|530323893|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
147044902|NCT02288325|530323891|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
147044903|NCT02288325|530323892|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
147044904|NCT02288325|530323893|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
147044905|NCT02288325|530323891|FG000|Double-blind Treatment Period|Protocol Violation|0|||
147044906|NCT02288325|530323892|FG001|Double-blind Treatment Period|Protocol Violation|1|||
147044907|NCT02288325|530323893|FG002|Double-blind Treatment Period|Protocol Violation|2|||
147044908|NCT02288325|530323891|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
147044909|NCT02288325|530323892|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
147044910|NCT02288325|530323893|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
147044911|NCT02288325|530323891|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
147044912|NCT02288325|530323892|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
147044913|NCT02288325|530323893|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
147044914|NCT03735121|530323896|FG000|Overall Study|Death|3|||
147044915|NCT03735121|530323897|FG001|Overall Study|Death|6|||
147044916|NCT03735121|530323898|FG002|Overall Study|Death|8|||
147044917|NCT03735121|530323899|FG003|Overall Study|Death|37|||
146849930|NCT02101385|529618927|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
147044918|NCT03735121|530323900|FG004|Overall Study|Death|86|||
147044919|NCT03735121|530323896|FG000|Overall Study|Withdrawal by Subject|1|||
147044920|NCT03735121|530323897|FG001|Overall Study|Withdrawal by Subject|1|||
147044921|NCT03735121|530323898|FG002|Overall Study|Withdrawal by Subject|3|||
147044922|NCT03735121|530323899|FG003|Overall Study|Withdrawal by Subject|4|||
147044923|NCT03735121|530323900|FG004|Overall Study|Withdrawal by Subject|2|||
147044924|NCT03735121|530323896|FG000|Overall Study|Progressive Disease|0|||
147044925|NCT03735121|530323897|FG001|Overall Study|Progressive Disease|0|||
147044926|NCT03735121|530323898|FG002|Overall Study|Progressive Disease|1|||
147044927|NCT03735121|530323899|FG003|Overall Study|Progressive Disease|0|||
147044928|NCT03735121|530323900|FG004|Overall Study|Progressive Disease|0|||
147044929|NCT03735121|530323896|FG000|Overall Study|Lost to Follow-up|0|||
147044930|NCT03735121|530323897|FG001|Overall Study|Lost to Follow-up|0|||
147044931|NCT03735121|530323898|FG002|Overall Study|Lost to Follow-up|0|||
147044932|NCT03735121|530323899|FG003|Overall Study|Lost to Follow-up|0|||
147044933|NCT03735121|530323900|FG004|Overall Study|Lost to Follow-up|1|||
147044934|NCT03735121|530323896|FG000|Overall Study|Ongoing|3|||
147044935|NCT03735121|530323897|FG001|Overall Study|Ongoing|3|||
147044936|NCT03735121|530323898|FG002|Overall Study|Ongoing|26|||
147044937|NCT03735121|530323899|FG003|Overall Study|Ongoing|83|||
147044938|NCT03735121|530323900|FG004|Overall Study|Ongoing|158|||
147044939|NCT04138823|530323908|FG000|Overall Study|Clinical disease progression|0|||
147044940|NCT04138823|530323909|FG001|Overall Study|Clinical disease progression|0|||
147044941|NCT04138823|530323910|FG002|Overall Study|Clinical disease progression|1|||
147044942|NCT04138823|530323908|FG000|Overall Study|Objective disease progression|3|||
147044943|NCT04138823|530323909|FG001|Overall Study|Objective disease progression|2|||
147044944|NCT04138823|530323910|FG002|Overall Study|Objective disease progression|5|||
147044945|NCT04036110|530323911|FG000|Overall Study|Lost to Follow-up|3|||
147044946|NCT04036110|530323912|FG001|Overall Study|Lost to Follow-up|2|||
147044947|NCT04036110|530323913|FG002|Overall Study|Lost to Follow-up|1|||
147044948|NCT04036110|530323911|FG000|Overall Study|Study Suspended|4|||
147044949|NCT04036110|530323912|FG001|Overall Study|Study Suspended|5|||
147044950|NCT04036110|530323913|FG002|Overall Study|Study Suspended|1|||
147044951|NCT02466685|530323914|FG000|Overall Study|Adverse Event|5|||
147044952|NCT02466685|530323915|FG001|Overall Study|Adverse Event|2|||
147044953|NCT02466685|530323914|FG000|Overall Study|Lost to Follow-up|1|||
147044954|NCT02466685|530323915|FG001|Overall Study|Lost to Follow-up|1|||
147044955|NCT02466685|530323914|FG000|Overall Study|Withdrawal by Subject|1|||
147044956|NCT02466685|530323915|FG001|Overall Study|Withdrawal by Subject|0|||
147044957|NCT02466685|530323914|FG000|Overall Study|Physician Decision|1|||
147044958|NCT02466685|530323915|FG001|Overall Study|Physician Decision|1|||
147044959|NCT01277211|530323918|FG000|Overall Study|Adverse Event|60|||
147044960|NCT01277211|530323919|FG001|Overall Study|Adverse Event|22|||
147044961|NCT01277211|530323918|FG000|Overall Study|Pregnancy|9|||
147044962|NCT01277211|530323919|FG001|Overall Study|Pregnancy|4|||
147044963|NCT01277211|530323918|FG000|Overall Study|Lost to Follow-up|14|||
147044964|NCT01277211|530323919|FG001|Overall Study|Lost to Follow-up|9|||
147044965|NCT01277211|530323918|FG000|Overall Study|Did not wish to continue|17|||
147044966|NCT01277211|530323919|FG001|Overall Study|Did not wish to continue|0|||
147044967|NCT01277211|530323918|FG000|Overall Study|Withdrew Consent|9|||
147044968|NCT01277211|530323919|FG001|Overall Study|Withdrew Consent|9|||
147044969|NCT01277211|530323918|FG000|Overall Study|Non-compliance with protocol|13|||
147044970|NCT01277211|530323919|FG001|Overall Study|Non-compliance with protocol|4|||
147044971|NCT01277211|530323918|FG000|Overall Study|Did not meet protocol eligibility|1|||
147044972|NCT01277211|530323919|FG001|Overall Study|Did not meet protocol eligibility|0|||
147044973|NCT01277211|530323918|FG000|Overall Study|Administrative|3|||
147044974|NCT01277211|530323919|FG001|Overall Study|Administrative|0|||
147044975|NCT01277211|530323918|FG000|Overall Study|Pregnancy wish|0|||
147044976|NCT01277211|530323919|FG001|Overall Study|Pregnancy wish|2|||
147044977|NCT01277211|530323918|FG000|Overall Study|Discontinued prior to treatment|24|||
147044978|NCT01277211|530323919|FG001|Overall Study|Discontinued prior to treatment|13|||
147044979|NCT03452943|530323920|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
147044980|NCT03452943|530323921|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
147044981|NCT03452943|530323920|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
147044982|NCT03452943|530323921|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
147044983|NCT03452943|530323920|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
147044984|NCT03452943|530323921|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
147044985|NCT03452943|530323920|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
147044986|NCT03452943|530323921|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
147044987|NCT03452943|530323920|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
147044988|NCT03452943|530323921|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
147044989|NCT03452943|530323920|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
147044990|NCT03452943|530323921|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
147044991|NCT01107197|530323926|FG000|Overall Study|Death|12|||
147044992|NCT01107197|530323927|FG001|Overall Study|Death|10|||
147044993|NCT01107197|530323926|FG000|Overall Study|Lost to Follow-up|5|||
147044994|NCT01107197|530323927|FG001|Overall Study|Lost to Follow-up|8|||
147044995|NCT01107197|530323926|FG000|Overall Study|Withdrawal by Subject|3|||
147044996|NCT01107197|530323927|FG001|Overall Study|Withdrawal by Subject|5|||
146849931|NCT02101385|529618926|FG000|Follow up|Withdrawal by Subject|2|||
147044997|NCT05180227|530323928|FG000|Overall Study|Hypertension at screening|1|||
147044998|NCT05180227|530323928|FG000|Overall Study|Lost to Follow-up|1|||
147044999|NCT02593110|530323929|FG000|Overall Study|Withdrawal by Subject|0|||
147045000|NCT02593110|530323930|FG001|Overall Study|Withdrawal by Subject|3|||
147045001|NCT02593110|530323931|FG002|Overall Study|Withdrawal by Subject|3|||
147045002|NCT02593110|530323932|FG003|Overall Study|Withdrawal by Subject|2|||
147045003|NCT02593110|530323929|FG000|Overall Study|Death|0|||
147045004|NCT02593110|530323930|FG001|Overall Study|Death|0|||
147045005|NCT02593110|530323931|FG002|Overall Study|Death|1|||
147045006|NCT02593110|530323932|FG003|Overall Study|Death|0|||
147045007|NCT03548337|530323933|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
147045008|NCT03548337|530323934|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
147045009|NCT03548337|530323933|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
147045010|NCT03548337|530323934|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
147045011|NCT03548337|530323933|FG000|Infant Series|Lost to Follow-up|2|||
147045012|NCT03548337|530323934|FG001|Infant Series|Lost to Follow-up|1|||
147045013|NCT03548337|530323933|FG000|Infant Series|Adverse Event|0|||
147045014|NCT03548337|530323934|FG001|Infant Series|Adverse Event|2|||
147045015|NCT03548337|530323933|FG000|Infant Series|Randomized but Not Vaccinated|1|||
147045016|NCT03548337|530323934|FG001|Infant Series|Randomized but Not Vaccinated|0|||
147045017|NCT03548337|530323933|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
147045018|NCT03548337|530323934|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
147045019|NCT03017612|530323937|FG000|Overall Study|Adverse Event|2|||
147045020|NCT04895982|530323938|FG000|Overall Study|Withdrawal by Subject|0|||
147045021|NCT04895982|530323939|FG001|Overall Study|Withdrawal by Subject|0|||
147045022|NCT04895982|530323940|FG002|Overall Study|Withdrawal by Subject|0|||
147045023|NCT04895982|530323941|FG003|Overall Study|Withdrawal by Subject|0|||
147045024|NCT04895982|530323942|FG004|Overall Study|Withdrawal by Subject|0|||
147045025|NCT04895982|530323943|FG005|Overall Study|Withdrawal by Subject|1|||
147045026|NCT04895982|530323944|FG006|Overall Study|Withdrawal by Subject|1|||
147045027|NCT04895982|530323945|FG007|Overall Study|Withdrawal by Subject|0|||
147045028|NCT04895982|530323946|FG008|Overall Study|Withdrawal by Subject|0|||
147045029|NCT04895982|530323947|FG009|Overall Study|Withdrawal by Subject|1|||
147045030|NCT04895982|530323948|FG010|Overall Study|Withdrawal by Subject|0|||
147045031|NCT04895982|530323949|FG011|Overall Study|Withdrawal by Subject|1|||
147045032|NCT04895982|530323938|FG000|Overall Study|Withdrawal by parent/guardian|2|||
147045033|NCT04895982|530323939|FG001|Overall Study|Withdrawal by parent/guardian|3|||
147045034|NCT04895982|530323940|FG002|Overall Study|Withdrawal by parent/guardian|3|||
147045035|NCT04895982|530323941|FG003|Overall Study|Withdrawal by parent/guardian|1|||
147045036|NCT04895982|530323942|FG004|Overall Study|Withdrawal by parent/guardian|3|||
147045037|NCT04895982|530323943|FG005|Overall Study|Withdrawal by parent/guardian|2|||
147045038|NCT04895982|530323944|FG006|Overall Study|Withdrawal by parent/guardian|1|||
147045039|NCT04895982|530323945|FG007|Overall Study|Withdrawal by parent/guardian|0|||
147045040|NCT04895982|530323946|FG008|Overall Study|Withdrawal by parent/guardian|3|||
147045041|NCT04895982|530323947|FG009|Overall Study|Withdrawal by parent/guardian|0|||
147045042|NCT04895982|530323948|FG010|Overall Study|Withdrawal by parent/guardian|0|||
147045043|NCT04895982|530323949|FG011|Overall Study|Withdrawal by parent/guardian|0|||
147045044|NCT04895982|530323938|FG000|Overall Study|Other|0|||
147045045|NCT04895982|530323939|FG001|Overall Study|Other|0|||
147045046|NCT04895982|530323940|FG002|Overall Study|Other|1|||
147045047|NCT04895982|530323941|FG003|Overall Study|Other|1|||
147045048|NCT04895982|530323942|FG004|Overall Study|Other|0|||
147045049|NCT04895982|530323943|FG005|Overall Study|Other|0|||
147045050|NCT04895982|530323944|FG006|Overall Study|Other|0|||
147045051|NCT04895982|530323945|FG007|Overall Study|Other|0|||
147045052|NCT04895982|530323946|FG008|Overall Study|Other|0|||
147045053|NCT04895982|530323947|FG009|Overall Study|Other|1|||
147045054|NCT04895982|530323948|FG010|Overall Study|Other|0|||
147045055|NCT04895982|530323949|FG011|Overall Study|Other|0|||
147045056|NCT04895982|530323938|FG000|Overall Study|Protocol Violation|0|||
147045057|NCT04895982|530323939|FG001|Overall Study|Protocol Violation|0|||
147045058|NCT04895982|530323940|FG002|Overall Study|Protocol Violation|1|||
147045059|NCT04895982|530323941|FG003|Overall Study|Protocol Violation|1|||
147045060|NCT04895982|530323942|FG004|Overall Study|Protocol Violation|1|||
147045061|NCT04895982|530323943|FG005|Overall Study|Protocol Violation|0|||
147045062|NCT04895982|530323944|FG006|Overall Study|Protocol Violation|0|||
147045063|NCT04895982|530323945|FG007|Overall Study|Protocol Violation|1|||
147045064|NCT04895982|530323946|FG008|Overall Study|Protocol Violation|0|||
147045065|NCT04895982|530323947|FG009|Overall Study|Protocol Violation|0|||
147045066|NCT04895982|530323948|FG010|Overall Study|Protocol Violation|0|||
147045067|NCT04895982|530323949|FG011|Overall Study|Protocol Violation|0|||
147045068|NCT04895982|530323938|FG000|Overall Study|Lost to Follow-up|0|||
147045069|NCT04895982|530323939|FG001|Overall Study|Lost to Follow-up|0|||
147045070|NCT04895982|530323940|FG002|Overall Study|Lost to Follow-up|1|||
147045071|NCT04895982|530323941|FG003|Overall Study|Lost to Follow-up|0|||
147045072|NCT04895982|530323942|FG004|Overall Study|Lost to Follow-up|0|||
147045073|NCT04895982|530323943|FG005|Overall Study|Lost to Follow-up|1|||
147045074|NCT04895982|530323944|FG006|Overall Study|Lost to Follow-up|0|||
147045075|NCT04895982|530323945|FG007|Overall Study|Lost to Follow-up|0|||
147045076|NCT04895982|530323946|FG008|Overall Study|Lost to Follow-up|1|||
147045077|NCT04895982|530323947|FG009|Overall Study|Lost to Follow-up|0|||
147045078|NCT04895982|530323948|FG010|Overall Study|Lost to Follow-up|0|||
147045079|NCT04895982|530323949|FG011|Overall Study|Lost to Follow-up|0|||
147045080|NCT04895982|530323938|FG000|Overall Study|Refused further study procedures|0|||
147045081|NCT04895982|530323939|FG001|Overall Study|Refused further study procedures|0|||
147045082|NCT04895982|530323940|FG002|Overall Study|Refused further study procedures|1|||
147045083|NCT04895982|530323941|FG003|Overall Study|Refused further study procedures|0|||
147045084|NCT04895982|530323942|FG004|Overall Study|Refused further study procedures|0|||
147045085|NCT04895982|530323943|FG005|Overall Study|Refused further study procedures|0|||
147045086|NCT04895982|530323944|FG006|Overall Study|Refused further study procedures|0|||
147045087|NCT04895982|530323945|FG007|Overall Study|Refused further study procedures|0|||
147045088|NCT04895982|530323946|FG008|Overall Study|Refused further study procedures|0|||
147045089|NCT04895982|530323947|FG009|Overall Study|Refused further study procedures|0|||
147045090|NCT04895982|530323948|FG010|Overall Study|Refused further study procedures|0|||
147045091|NCT04895982|530323949|FG011|Overall Study|Refused further study procedures|0|||
147045092|NCT02215967|530323960|FG000|Overall Study|Patient became ineligible for treatment|0|||
147045093|NCT02215967|530323961|FG001|Overall Study|Patient became ineligible for treatment|0|||
147045094|NCT02215967|530323962|FG002|Overall Study|Patient became ineligible for treatment|0|||
147045095|NCT02215967|530323963|FG003|Overall Study|Patient became ineligible for treatment|3|||
147045096|NCT02215967|530323960|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
147045097|NCT02215967|530323961|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
147045098|NCT02215967|530323962|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
147045099|NCT02215967|530323963|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
147045100|NCT00352417|530323964|FG000|Overall Study|Adverse Event|1|||
147045101|NCT00352417|530323965|FG001|Overall Study|Adverse Event|0|||
147045102|NCT00352417|530323964|FG000|Overall Study|Protocol Violation|0|||
147045103|NCT00352417|530323965|FG001|Overall Study|Protocol Violation|2|||
147045104|NCT00352417|530323964|FG000|Overall Study|Withdrawal by Subject|1|||
147045105|NCT00352417|530323965|FG001|Overall Study|Withdrawal by Subject|2|||
147045106|NCT00352417|530323964|FG000|Overall Study|Lost to Follow-up|1|||
147045107|NCT00352417|530323965|FG001|Overall Study|Lost to Follow-up|0|||
147045108|NCT00352417|530323964|FG000|Overall Study|Schedule Change|2|||
147045109|NCT00352417|530323965|FG001|Overall Study|Schedule Change|1|||
147045110|NCT01290302|530326092|FG000|Overall Study|Adverse Event|2|||
147045111|NCT01290302|530326093|FG001|Overall Study|Adverse Event|0|||
147045112|NCT01290302|530326092|FG000|Overall Study|Withdrawal by Subject|1|||
147045113|NCT01290302|530326093|FG001|Overall Study|Withdrawal by Subject|0|||
147045114|NCT01290302|530326092|FG000|Overall Study|Physician Decision|0|||
147045115|NCT01290302|530326093|FG001|Overall Study|Physician Decision|2|||
147045116|NCT01290302|530326092|FG000|Overall Study|Expiration of time for screening window|1|||
147045117|NCT01290302|530326093|FG001|Overall Study|Expiration of time for screening window|0|||
147045118|NCT02498613|530326096|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
147045119|NCT02498613|530326097|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
147045120|NCT02498613|530326098|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
147045121|NCT02498613|530326099|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
147045122|NCT02498613|530326096|FG000|Overall Study|Withdrawal by Subject|3|||
147045123|NCT02498613|530326097|FG001|Overall Study|Withdrawal by Subject|1|||
147045124|NCT02498613|530326098|FG002|Overall Study|Withdrawal by Subject|0|||
147045125|NCT02498613|530326099|FG003|Overall Study|Withdrawal by Subject|0|||
147045126|NCT05109611|530326101|FG000|Overall Study|Adverse Event|13|||
147045127|NCT05109611|530326102|FG001|Overall Study|Adverse Event|10|||
147045128|NCT05109611|530326101|FG000|Overall Study|Withdrawal by Subject|1|||
147045129|NCT05109611|530326102|FG001|Overall Study|Withdrawal by Subject|0|||
147045130|NCT05109611|530326101|FG000|Overall Study|Lost to Follow-up|1|||
147045131|NCT05109611|530326102|FG001|Overall Study|Lost to Follow-up|2|||
147045132|NCT05109611|530326101|FG000|Overall Study|Protocol Violation|0|||
147045133|NCT05109611|530326102|FG001|Overall Study|Protocol Violation|4|||
147045134|NCT05109611|530326101|FG000|Overall Study|Information unavailable|1|||
147045135|NCT05109611|530326102|FG001|Overall Study|Information unavailable|1|||
147045136|NCT03573830|530326105|FG000|Overall Study|Dropped without completing treatment|0|||
147045137|NCT03573830|530326106|FG001|Overall Study|Dropped without completing treatment|7|||
147045138|NCT03573830|530326105|FG000|Overall Study|Lost to Follow-up|4|||
147045139|NCT03573830|530326106|FG001|Overall Study|Lost to Follow-up|0|||
147045140|NCT00233948|530326107|FG000|Overall Study|Adverse Event|1|||
147045141|NCT00233948|530326108|FG001|Overall Study|Adverse Event|0|||
147045142|NCT00233948|530326109|FG002|Overall Study|Adverse Event|0|||
147045143|NCT00233948|530326110|FG003|Overall Study|Adverse Event|0|||
147045144|NCT00233948|530326111|FG004|Overall Study|Adverse Event|0|||
147045145|NCT00233948|530326112|FG005|Overall Study|Adverse Event|0|||
147045146|NCT03284723|530326113|FG000|Overall Study|Death|0|||
147045147|NCT03284723|530326114|FG001|Overall Study|Death|0|||
147045148|NCT03284723|530326115|FG002|Overall Study|Death|0|||
147045149|NCT03284723|530326116|FG003|Overall Study|Death|1|||
147045150|NCT03284723|530326117|FG004|Overall Study|Death|0|||
147045151|NCT03284723|530326118|FG005|Overall Study|Death|0|||
147045152|NCT03284723|530326119|FG006|Overall Study|Death|1|||
147045153|NCT03284723|530326120|FG007|Overall Study|Death|0|||
147045154|NCT03284723|530326121|FG008|Overall Study|Death|0|||
147045155|NCT03284723|530326122|FG009|Overall Study|Death|2|||
147045156|NCT03284723|530326123|FG010|Overall Study|Death|1|||
147045157|NCT03284723|530326124|FG011|Overall Study|Death|0|||
147045158|NCT03284723|530326113|FG000|Overall Study|Lost to Follow-up|0|||
147045159|NCT03284723|530326114|FG001|Overall Study|Lost to Follow-up|0|||
147045160|NCT03284723|530326115|FG002|Overall Study|Lost to Follow-up|0|||
147045161|NCT03284723|530326116|FG003|Overall Study|Lost to Follow-up|0|||
147045162|NCT03284723|530326117|FG004|Overall Study|Lost to Follow-up|0|||
147045163|NCT03284723|530326118|FG005|Overall Study|Lost to Follow-up|2|||
147045164|NCT03284723|530326119|FG006|Overall Study|Lost to Follow-up|1|||
147045165|NCT03284723|530326120|FG007|Overall Study|Lost to Follow-up|0|||
147045166|NCT03284723|530326121|FG008|Overall Study|Lost to Follow-up|0|||
147045167|NCT03284723|530326122|FG009|Overall Study|Lost to Follow-up|2|||
147045168|NCT03284723|530326123|FG010|Overall Study|Lost to Follow-up|0|||
147045169|NCT03284723|530326124|FG011|Overall Study|Lost to Follow-up|0|||
147045170|NCT03284723|530326113|FG000|Overall Study|Study Terminated By Sponsor|0|||
147045171|NCT03284723|530326114|FG001|Overall Study|Study Terminated By Sponsor|0|||
147045172|NCT03284723|530326115|FG002|Overall Study|Study Terminated By Sponsor|0|||
147045173|NCT03284723|530326116|FG003|Overall Study|Study Terminated By Sponsor|0|||
147045174|NCT03284723|530326117|FG004|Overall Study|Study Terminated By Sponsor|1|||
147045175|NCT03284723|530326118|FG005|Overall Study|Study Terminated By Sponsor|0|||
147045176|NCT03284723|530326119|FG006|Overall Study|Study Terminated By Sponsor|0|||
147045177|NCT03284723|530326120|FG007|Overall Study|Study Terminated By Sponsor|0|||
147045178|NCT03284723|530326121|FG008|Overall Study|Study Terminated By Sponsor|1|||
147045179|NCT03284723|530326122|FG009|Overall Study|Study Terminated By Sponsor|1|||
147045180|NCT03284723|530326123|FG010|Overall Study|Study Terminated By Sponsor|1|||
147045181|NCT03284723|530326124|FG011|Overall Study|Study Terminated By Sponsor|1|||
147045182|NCT03284723|530326113|FG000|Overall Study|Withdrawal by Subject|0|||
147045183|NCT03284723|530326114|FG001|Overall Study|Withdrawal by Subject|0|||
147045184|NCT03284723|530326115|FG002|Overall Study|Withdrawal by Subject|0|||
147045185|NCT03284723|530326116|FG003|Overall Study|Withdrawal by Subject|0|||
147045186|NCT03284723|530326117|FG004|Overall Study|Withdrawal by Subject|5|||
147045187|NCT03284723|530326118|FG005|Overall Study|Withdrawal by Subject|3|||
147045188|NCT03284723|530326119|FG006|Overall Study|Withdrawal by Subject|1|||
147045189|NCT03284723|530326120|FG007|Overall Study|Withdrawal by Subject|0|||
147045190|NCT03284723|530326121|FG008|Overall Study|Withdrawal by Subject|6|||
147045191|NCT03284723|530326122|FG009|Overall Study|Withdrawal by Subject|0|||
147045192|NCT03284723|530326123|FG010|Overall Study|Withdrawal by Subject|3|||
147045193|NCT03284723|530326124|FG011|Overall Study|Withdrawal by Subject|1|||
147045194|NCT03284723|530326113|FG000|Overall Study|Other|1|||
147045195|NCT03284723|530326114|FG001|Overall Study|Other|0|||
147045196|NCT03284723|530326115|FG002|Overall Study|Other|1|||
147045197|NCT03284723|530326116|FG003|Overall Study|Other|0|||
147045198|NCT03284723|530326117|FG004|Overall Study|Other|1|||
147045199|NCT03284723|530326118|FG005|Overall Study|Other|0|||
147045200|NCT03284723|530326119|FG006|Overall Study|Other|0|||
147045201|NCT03284723|530326120|FG007|Overall Study|Other|0|||
147045202|NCT03284723|530326121|FG008|Overall Study|Other|0|||
147045203|NCT03284723|530326122|FG009|Overall Study|Other|0|||
147045204|NCT03284723|530326123|FG010|Overall Study|Other|1|||
147045205|NCT03284723|530326124|FG011|Overall Study|Other|0|||
147045206|NCT03284723|530326113|FG000|Overall Study|Adverse Event|0|||
147045207|NCT03284723|530326114|FG001|Overall Study|Adverse Event|0|||
147045208|NCT03284723|530326115|FG002|Overall Study|Adverse Event|0|||
147045209|NCT03284723|530326116|FG003|Overall Study|Adverse Event|0|||
147045210|NCT03284723|530326117|FG004|Overall Study|Adverse Event|0|||
147045211|NCT03284723|530326118|FG005|Overall Study|Adverse Event|0|||
147045212|NCT03284723|530326119|FG006|Overall Study|Adverse Event|0|||
147045213|NCT03284723|530326120|FG007|Overall Study|Adverse Event|0|||
147045214|NCT03284723|530326121|FG008|Overall Study|Adverse Event|1|||
147045215|NCT03284723|530326122|FG009|Overall Study|Adverse Event|0|||
147045216|NCT03284723|530326123|FG010|Overall Study|Adverse Event|0|||
147045217|NCT03284723|530326124|FG011|Overall Study|Adverse Event|0|||
147045218|NCT00615199|530326125|FG000|Overall Study|Adverse Event|3|||
147045219|NCT00615199|530326126|FG001|Overall Study|Adverse Event|1|||
147045220|NCT00615199|530326127|FG002|Overall Study|Adverse Event|1|||
147045221|NCT00615199|530326128|FG003|Overall Study|Adverse Event|0|||
147045222|NCT00615199|530326125|FG000|Overall Study|Lack of Efficacy|2|||
147045223|NCT00615199|530326126|FG001|Overall Study|Lack of Efficacy|0|||
147045224|NCT00615199|530326127|FG002|Overall Study|Lack of Efficacy|0|||
147045225|NCT00615199|530326128|FG003|Overall Study|Lack of Efficacy|1|||
147045226|NCT00615199|530326125|FG000|Overall Study|Lost to Follow-up|1|||
147045227|NCT00615199|530326126|FG001|Overall Study|Lost to Follow-up|0|||
147045228|NCT00615199|530326127|FG002|Overall Study|Lost to Follow-up|0|||
147045229|NCT00615199|530326128|FG003|Overall Study|Lost to Follow-up|0|||
147045230|NCT00615199|530326125|FG000|Overall Study|Other|0|||
147045231|NCT00615199|530326126|FG001|Overall Study|Other|0|||
147045232|NCT00615199|530326127|FG002|Overall Study|Other|0|||
147045233|NCT00615199|530326128|FG003|Overall Study|Other|1|||
147045234|NCT00615199|530326125|FG000|Overall Study|Withdrawal by Subject|2|||
147045235|NCT00615199|530326126|FG001|Overall Study|Withdrawal by Subject|1|||
147045236|NCT00615199|530326127|FG002|Overall Study|Withdrawal by Subject|0|||
147045237|NCT00615199|530326128|FG003|Overall Study|Withdrawal by Subject|0|||
147045238|NCT02653625|530326131|FG000|Overall Study|Adverse Event|1|||
147045239|NCT02653625|530326131|FG000|Overall Study|Non-compliance with Study Drug|1|||
147045240|NCT02653625|530326131|FG000|Overall Study|Protocol Violation|1|||
147045241|NCT02653625|530326131|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
147045242|NCT00064987|530326132|FG000|Overall Study|Physician Decision|3|||
147045243|NCT00064987|530326133|FG001|Overall Study|Physician Decision|0|||
147045244|NCT00764881|530326137|FG000|Overall Study|Adverse Event|5|||
147045245|NCT00764881|530326138|FG001|Overall Study|Adverse Event|1|||
147045246|NCT00764881|530326137|FG000|Overall Study|Withdrawal by Subject|1|||
147045247|NCT00764881|530326138|FG001|Overall Study|Withdrawal by Subject|3|||
147045248|NCT00764881|530326137|FG000|Overall Study|Protocol Violation|2|||
147045249|NCT00764881|530326138|FG001|Overall Study|Protocol Violation|2|||
147045250|NCT00764881|530326137|FG000|Overall Study|Lost to Follow-up|2|||
147045251|NCT00764881|530326138|FG001|Overall Study|Lost to Follow-up|0|||
147045252|NCT00764881|530326137|FG000|Overall Study|Noncompliant|1|||
147045253|NCT00764881|530326138|FG001|Overall Study|Noncompliant|0|||
147045254|NCT00764881|530326137|FG000|Overall Study|Accidentally discontinued study drug|1|||
147045255|NCT00764881|530326138|FG001|Overall Study|Accidentally discontinued study drug|0|||
147045256|NCT00764881|530326137|FG000|Overall Study|Wished to become pregnant|1|||
147045257|NCT00764881|530326138|FG001|Overall Study|Wished to become pregnant|0|||
147045258|NCT00764881|530326137|FG000|Overall Study|Carcinoma detected|1|||
147045259|NCT00764881|530326138|FG001|Overall Study|Carcinoma detected|0|||
147045260|NCT00764881|530326137|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
147045261|NCT00764881|530326138|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
147045262|NCT00764881|530326137|FG000|Overall Study|no treatment or no observation|2|||
147045263|NCT00764881|530326138|FG001|Overall Study|no treatment or no observation|2|||
147045264|NCT01567462|530326139|FG000|Overall Study|Withdrawal by Subject|4|||
147045265|NCT01567462|530326140|FG001|Overall Study|Withdrawal by Subject|7|||
147045266|NCT00886015|530326143|FG000|Overall Study|Death|0|||
147045267|NCT00886015|530326144|FG001|Overall Study|Death|2|||
147045268|NCT02548156|530326149|FG000|Washout Period 1|Lost to Follow-up|0|||
147045269|NCT02548156|530326150|FG001|Washout Period 1|Lost to Follow-up|0|||
147045270|NCT02548156|530326151|FG002|Washout Period 1|Lost to Follow-up|0|||
147045271|NCT02548156|530326152|FG003|Washout Period 1|Lost to Follow-up|0|||
147045272|NCT02548156|530326153|FG004|Washout Period 1|Lost to Follow-up|1|||
147045273|NCT02548156|530326154|FG005|Washout Period 1|Lost to Follow-up|0|||
147045274|NCT00444587|530326165|FG000|Overall Study|Death|2|||
147045275|NCT00444587|530326166|FG001|Overall Study|Death|1|||
147045276|NCT00444587|530326165|FG000|Overall Study|Progression of the disease|73|||
147045277|NCT00444587|530326166|FG001|Overall Study|Progression of the disease|8|||
147045278|NCT00444587|530326165|FG000|Overall Study|Refused treatment/did not cooperate|4|||
147045279|NCT00444587|530326166|FG001|Overall Study|Refused treatment/did not cooperate|1|||
147045280|NCT00444587|530326165|FG000|Overall Study|Investigator decision|3|||
147045281|NCT00444587|530326166|FG001|Overall Study|Investigator decision|0|||
147045282|NCT00444587|530326165|FG000|Overall Study|Protocol Violation|1|||
147045283|NCT00444587|530326166|FG001|Overall Study|Protocol Violation|0|||
147045284|NCT00444587|530326165|FG000|Overall Study|Missing|0|||
147045285|NCT00444587|530326166|FG001|Overall Study|Missing|5|||
147045286|NCT01473407|530326175|FG000|Overall Study|Physician Decision|1|||
147045287|NCT01473407|530326176|FG001|Overall Study|Physician Decision|4|||
147045288|NCT01473407|530326175|FG000|Overall Study|Lost to Follow-up|10|||
147045289|NCT01473407|530326176|FG001|Overall Study|Lost to Follow-up|4|||
147045290|NCT01473407|530326175|FG000|Overall Study|Adverse Event|8|||
147045291|NCT01473407|530326176|FG001|Overall Study|Adverse Event|8|||
147045292|NCT01473407|530326175|FG000|Overall Study|Randomization Error|3|||
147045293|NCT01473407|530326176|FG001|Overall Study|Randomization Error|1|||
147045294|NCT01473407|530326175|FG000|Overall Study|Withdrawal by Subject|4|||
147045295|NCT01473407|530326176|FG001|Overall Study|Withdrawal by Subject|7|||
147045296|NCT01473407|530326175|FG000|Overall Study|Kidney Transplant|7|||
147045297|NCT01473407|530326176|FG001|Overall Study|Kidney Transplant|6|||
147045298|NCT01473407|530326175|FG000|Overall Study|Vacation/Travel|1|||
147045299|NCT01473407|530326176|FG001|Overall Study|Vacation/Travel|1|||
147045300|NCT01473407|530326175|FG000|Overall Study|Elevated Hemoglobin|1|||
147045301|NCT01473407|530326176|FG001|Overall Study|Elevated Hemoglobin|0|||
147045302|NCT01473407|530326175|FG000|Overall Study|Patient Received Aranesp|1|||
147045303|NCT01473407|530326176|FG001|Overall Study|Patient Received Aranesp|0|||
147045304|NCT01473407|530326175|FG000|Overall Study|Patient Lost Green Card Status|1|||
147045305|NCT01473407|530326176|FG001|Overall Study|Patient Lost Green Card Status|0|||
147045306|NCT01473407|530326175|FG000|Overall Study|Temperature Excursion|2|||
147045307|NCT01473407|530326176|FG001|Overall Study|Temperature Excursion|3|||
147045308|NCT01473407|530326175|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
147045309|NCT01473407|530326176|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
147045310|NCT01473407|530326175|FG000|Overall Study|Sponsor's Decision|10|||
147045311|NCT01473407|530326176|FG001|Overall Study|Sponsor's Decision|10|||
147045312|NCT01473407|530326175|FG000|Overall Study|Site Closure|1|||
147045313|NCT01473407|530326176|FG001|Overall Study|Site Closure|0|||
147045314|NCT00369941|530326177|FG000|Overall Study|Never Treated|1|||
147045315|NCT00369941|530326178|FG001|Overall Study|Never Treated|2|||
147045316|NCT00369941|530326177|FG000|Overall Study|Adverse Event|14|||
147045317|NCT00369941|530326178|FG001|Overall Study|Adverse Event|28|||
147045318|NCT00369941|530326177|FG000|Overall Study|Lack of Efficacy|6|||
147045319|NCT00369941|530326178|FG001|Overall Study|Lack of Efficacy|10|||
147045320|NCT00369941|530326177|FG000|Overall Study|Lost to Follow-up|12|||
147045321|NCT00369941|530326178|FG001|Overall Study|Lost to Follow-up|22|||
147045322|NCT00369941|530326177|FG000|Overall Study|Protocol Violation|5|||
147045323|NCT00369941|530326178|FG001|Overall Study|Protocol Violation|3|||
147045324|NCT00369941|530326177|FG000|Overall Study|Withdrawal by Subject|5|||
147045325|NCT00369941|530326178|FG001|Overall Study|Withdrawal by Subject|18|||
147045326|NCT00369941|530326177|FG000|Overall Study|Pregnancy|4|||
147045327|NCT00369941|530326178|FG001|Overall Study|Pregnancy|2|||
147045328|NCT00369941|530326177|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
147045329|NCT00369941|530326178|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
147045330|NCT00369941|530326177|FG000|Overall Study|Moved|11|||
147045331|NCT00369941|530326178|FG001|Overall Study|Moved|5|||
147045332|NCT00369941|530326177|FG000|Overall Study|Treatment with Prohibited Medication|3|||
147045333|NCT00369941|530326178|FG001|Overall Study|Treatment with Prohibited Medication|1|||
147045334|NCT00369941|530326177|FG000|Overall Study|Employment Interfered with Study Visits|1|||
147045335|NCT00369941|530326178|FG001|Overall Study|Employment Interfered with Study Visits|0|||
147045336|NCT00369941|530326177|FG000|Overall Study|Study Site Terminated|2|||
147045337|NCT00369941|530326178|FG001|Overall Study|Study Site Terminated|0|||
147045338|NCT00369941|530326177|FG000|Overall Study|Miscellaneous|3|||
147045339|NCT00369941|530326178|FG001|Overall Study|Miscellaneous|3|||
147045340|NCT01027702|530326179|FG000|Overall Study|Received subsequent therapy|1|||
147045341|NCT01027702|530326180|FG001|Overall Study|Received subsequent therapy|2|||
147045342|NCT01027702|530326181|FG002|Overall Study|Received subsequent therapy|0|||
147045343|NCT01027702|530326182|FG003|Overall Study|Received subsequent therapy|4|||
147045344|NCT01027702|530326183|FG004|Overall Study|Received subsequent therapy|1|||
147045345|NCT01027702|530326184|FG005|Overall Study|Received subsequent therapy|0|||
147045346|NCT01027702|530326185|FG006|Overall Study|Received subsequent therapy|1|||
147045347|NCT01027702|530326179|FG000|Overall Study|Death|0|||
147045348|NCT01027702|530326180|FG001|Overall Study|Death|0|||
147045349|NCT01027702|530326181|FG002|Overall Study|Death|1|||
147045350|NCT01027702|530326182|FG003|Overall Study|Death|0|||
147045351|NCT01027702|530326183|FG004|Overall Study|Death|0|||
147045352|NCT01027702|530326184|FG005|Overall Study|Death|0|||
147045353|NCT01027702|530326185|FG006|Overall Study|Death|0|||
147045354|NCT00403585|530326186|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
147045355|NCT00403585|530326186|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
147045356|NCT00403585|530326186|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
147045357|NCT02964312|530326195|FG000|Overall Study|Lost to Follow-up|28|||
147045358|NCT02964312|530326195|FG000|Overall Study|Withdrawal by Subject|11|||
147045359|NCT02964312|530326195|FG000|Overall Study|Lack of Efficacy|10|||
147045360|NCT02964312|530326195|FG000|Overall Study|Did not consent to long-term FU|14|||
147045361|NCT02964312|530326195|FG000|Overall Study|Death|1|||
147045362|NCT02862730|530326196|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
147045363|NCT02862730|530326197|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
147045364|NCT02862730|530326198|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
147045365|NCT02862730|530326199|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
147045366|NCT02862730|530326200|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
147045367|NCT02862730|530326201|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
147045368|NCT02862730|530326202|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
147045369|NCT02862730|530326196|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
147045370|NCT02862730|530326197|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
147045371|NCT02862730|530326198|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
147045372|NCT02862730|530326199|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
147045373|NCT02862730|530326200|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
147045374|NCT02862730|530326201|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
147045375|NCT02862730|530326202|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
147045376|NCT02862730|530326196|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
147045377|NCT02862730|530326197|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
147045378|NCT02862730|530326198|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
147045379|NCT02862730|530326199|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
147045380|NCT02862730|530326200|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
147045381|NCT02862730|530326201|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
147045382|NCT02862730|530326202|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
147045383|NCT02862730|530326196|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
147045384|NCT02862730|530326197|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
147045385|NCT02862730|530326198|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
147045386|NCT02862730|530326199|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
147045387|NCT02862730|530326200|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
147045388|NCT02862730|530326201|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
147045389|NCT02862730|530326202|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
147045390|NCT02738138|530326211|FG000|Overall Study|Adverse Event|0|||
147045391|NCT02738138|530326212|FG001|Overall Study|Adverse Event|1|||
147045392|NCT02738138|530326211|FG000|Overall Study|Lost to Follow-up|2|||
147045393|NCT02738138|530326212|FG001|Overall Study|Lost to Follow-up|0|||
147045394|NCT02738138|530326211|FG000|Overall Study|Other - not further specified|1|||
147045395|NCT02738138|530326212|FG001|Overall Study|Other - not further specified|0|||
147045396|NCT03639779|530326218|FG000|Overall Study|Lost to Follow-up|1|||
147045397|NCT02932462|530326219|FG000|Overall Study|Adverse Event|1|||
147045398|NCT02932462|530326220|FG001|Overall Study|Adverse Event|2|||
147045399|NCT02932462|530326219|FG000|Overall Study|Lost to Follow-up|4|||
147045400|NCT02932462|530326220|FG001|Overall Study|Lost to Follow-up|1|||
147045401|NCT02932462|530326219|FG000|Overall Study|Protocol Violation|0|||
147045402|NCT02932462|530326220|FG001|Overall Study|Protocol Violation|5|||
147045403|NCT02932462|530326219|FG000|Overall Study|Withdrawal by Subject|1|||
147045404|NCT02932462|530326220|FG001|Overall Study|Withdrawal by Subject|4|||
147045405|NCT02932462|530326219|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147045406|NCT02932462|530326220|FG001|Overall Study|Non-Compliance With Study Drug|1|||
147045407|NCT02932462|530326219|FG000|Overall Study|Progressive Disease|1|||
147045408|NCT02932462|530326220|FG001|Overall Study|Progressive Disease|0|||
147045409|NCT02413229|530326221|FG000|Overall Study|Adverse Event|0|||
147045410|NCT02413229|530326222|FG001|Overall Study|Adverse Event|0|||
147045411|NCT02413229|530326223|FG002|Overall Study|Adverse Event|0|||
147045412|NCT02413229|530326224|FG003|Overall Study|Adverse Event|1|||
147045413|NCT02413229|530326225|FG004|Overall Study|Adverse Event|0|||
147045414|NCT02413229|530326226|FG005|Overall Study|Adverse Event|0|||
147045415|NCT02413229|530326227|FG006|Overall Study|Adverse Event|0|||
147045416|NCT02413229|530326228|FG007|Overall Study|Adverse Event|1|||
147045417|NCT02413229|530326221|FG000|Overall Study|Lost to Follow-up|0|||
147045418|NCT02413229|530326222|FG001|Overall Study|Lost to Follow-up|0|||
147045419|NCT02413229|530326223|FG002|Overall Study|Lost to Follow-up|1|||
147045420|NCT02413229|530326224|FG003|Overall Study|Lost to Follow-up|0|||
147045421|NCT02413229|530326225|FG004|Overall Study|Lost to Follow-up|2|||
147045422|NCT02413229|530326226|FG005|Overall Study|Lost to Follow-up|0|||
147045423|NCT02413229|530326227|FG006|Overall Study|Lost to Follow-up|0|||
147045424|NCT02413229|530326228|FG007|Overall Study|Lost to Follow-up|0|||
147045425|NCT02413229|530326221|FG000|Overall Study|Withdrawal by Subject|1|||
147045426|NCT02413229|530326222|FG001|Overall Study|Withdrawal by Subject|1|||
147045427|NCT02413229|530326223|FG002|Overall Study|Withdrawal by Subject|0|||
147045428|NCT02413229|530326224|FG003|Overall Study|Withdrawal by Subject|0|||
147045429|NCT02413229|530326225|FG004|Overall Study|Withdrawal by Subject|1|||
147045430|NCT02413229|530326226|FG005|Overall Study|Withdrawal by Subject|0|||
147045431|NCT02413229|530326227|FG006|Overall Study|Withdrawal by Subject|0|||
147045432|NCT02413229|530326228|FG007|Overall Study|Withdrawal by Subject|2|||
147045433|NCT02413229|530326221|FG000|Overall Study|Progressive Disease|0|||
147045434|NCT02413229|530326222|FG001|Overall Study|Progressive Disease|0|||
147045435|NCT02413229|530326223|FG002|Overall Study|Progressive Disease|0|||
147045436|NCT02413229|530326224|FG003|Overall Study|Progressive Disease|0|||
147045437|NCT02413229|530326225|FG004|Overall Study|Progressive Disease|0|||
147045438|NCT02413229|530326226|FG005|Overall Study|Progressive Disease|0|||
147045439|NCT02413229|530326227|FG006|Overall Study|Progressive Disease|0|||
147045440|NCT02413229|530326228|FG007|Overall Study|Progressive Disease|1|||
147045441|NCT01995513|530326229|FG000|Period 1: First Open Label Treatment|Other|34|||
147045442|NCT01995513|530326230|FG001|Period 1: First Open Label Treatment|Other|0|||
147045443|NCT01995513|530326231|FG002|Period 1: First Open Label Treatment|Other|0|||
147045444|NCT01995513|530326232|FG003|Period 1: First Open Label Treatment|Other|0|||
147045445|NCT01995513|530326229|FG000|Period 1: First Open Label Treatment|Death|14|||
147045446|NCT01995513|530326230|FG001|Period 1: First Open Label Treatment|Death|0|||
147045447|NCT01995513|530326231|FG002|Period 1: First Open Label Treatment|Death|0|||
147045448|NCT01995513|530326232|FG003|Period 1: First Open Label Treatment|Death|0|||
147045449|NCT01995513|530326229|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
147045450|NCT01995513|530326230|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
147045451|NCT01995513|530326231|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
147045452|NCT01995513|530326232|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
147045453|NCT01995513|530326229|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
147045454|NCT01995513|530326230|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
147045455|NCT01995513|530326231|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
147045456|NCT01995513|530326232|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
147045457|NCT01995513|530326229|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
147045458|NCT01995513|530326230|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
147045459|NCT01995513|530326231|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
147045460|NCT01995513|530326232|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
147045461|NCT01995513|530326229|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
147045462|NCT01995513|530326230|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
147045463|NCT01995513|530326231|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
147045464|NCT01995513|530326232|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
147045465|NCT01995513|530326229|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
147045466|NCT01995513|530326230|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
147045467|NCT01995513|530326231|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
147045468|NCT01995513|530326232|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
147045469|NCT01995513|530326229|FG000|Period 1: Second Open Label Treatment|Other|0|||
147045470|NCT01995513|530326230|FG001|Period 1: Second Open Label Treatment|Other|2|||
147045471|NCT01995513|530326231|FG002|Period 1: Second Open Label Treatment|Other|0|||
147045472|NCT01995513|530326232|FG003|Period 1: Second Open Label Treatment|Other|0|||
147045473|NCT01995513|530326229|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
147045474|NCT01995513|530326230|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
147045475|NCT01995513|530326231|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
147045476|NCT01995513|530326232|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
147045477|NCT01995513|530326229|FG000|Period 2: Double Blind Treatment|Death|0|||
147045478|NCT01995513|530326230|FG001|Period 2: Double Blind Treatment|Death|0|||
147045479|NCT01995513|530326231|FG002|Period 2: Double Blind Treatment|Death|0|||
147045480|NCT01995513|530326232|FG003|Period 2: Double Blind Treatment|Death|1|||
147045481|NCT01995513|530326229|FG000|Period 2: Double Blind Treatment|Other|0|||
147045482|NCT01995513|530326230|FG001|Period 2: Double Blind Treatment|Other|0|||
147045483|NCT01995513|530326231|FG002|Period 2: Double Blind Treatment|Other|3|||
147045484|NCT01995513|530326232|FG003|Period 2: Double Blind Treatment|Other|3|||
147045485|NCT01995513|530326229|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
147045486|NCT01995513|530326230|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
147045487|NCT01995513|530326231|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
147045488|NCT01995513|530326232|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
147045489|NCT01995513|530326229|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
147045490|NCT01995513|530326230|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
147045491|NCT01995513|530326231|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
147045492|NCT01995513|530326232|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
147045493|NCT01995513|530326229|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
147045494|NCT01995513|530326230|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
147045495|NCT01995513|530326231|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
147045496|NCT01995513|530326232|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
147045497|NCT01995513|530326229|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
147045498|NCT01995513|530326230|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
147045499|NCT01995513|530326231|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
147045500|NCT01995513|530326232|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
147045501|NCT01232452|530326233|FG000|Overall Study|Adverse Event|17|||
147045502|NCT01232452|530326234|FG001|Overall Study|Adverse Event|15|||
147045503|NCT01232452|530326233|FG000|Overall Study|Withdrawal by Subject|11|||
147045504|NCT01232452|530326234|FG001|Overall Study|Withdrawal by Subject|8|||
147045505|NCT01232452|530326233|FG000|Overall Study|Physician Decision|8|||
147045506|NCT01232452|530326234|FG001|Overall Study|Physician Decision|12|||
147045507|NCT01232452|530326233|FG000|Overall Study|Protocol entry criterion not met|0|||
147045508|NCT01232452|530326234|FG001|Overall Study|Protocol entry criterion not met|2|||
147045509|NCT01232452|530326233|FG000|Overall Study|Sponsor Decision|3|||
147045510|NCT01232452|530326234|FG001|Overall Study|Sponsor Decision|1|||
147045511|NCT01232452|530326233|FG000|Overall Study|Protocol Violation|0|||
147045512|NCT01232452|530326234|FG001|Overall Study|Protocol Violation|1|||
147045513|NCT01911273|530326235|FG000|Overall Study|Progression of Disease|1|||
147045514|NCT01911273|530326236|FG001|Overall Study|Progression of Disease|0|||
147045515|NCT01911273|530326235|FG000|Overall Study|Withdrawal by Subject|0|||
147045516|NCT01911273|530326236|FG001|Overall Study|Withdrawal by Subject|2|||
147045517|NCT02359994|530326241|FG000|Overall Population Study|Adverse Event|1|||
147045518|NCT02359994|530326242|FG001|Overall Population Study|Adverse Event|1|||
147045519|NCT02359994|530326241|FG000|Overall Population Study|Death|1|||
147045520|NCT02359994|530326242|FG001|Overall Population Study|Death|5|||
147045521|NCT02359994|530326241|FG000|Overall Population Study|Lost to Follow-up|1|||
147045522|NCT02359994|530326242|FG001|Overall Population Study|Lost to Follow-up|1|||
147045523|NCT02359994|530326241|FG000|Overall Population Study|Withdrawal by Subject|1|||
147045524|NCT02359994|530326242|FG001|Overall Population Study|Withdrawal by Subject|0|||
147045525|NCT02359994|530326241|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
147045526|NCT02359994|530326242|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
147045527|NCT02359994|530326241|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
147045528|NCT02359994|530326242|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
147045529|NCT02359994|530326241|FG000|Extended Oncology 24-Month Survival|Death|19|||
147045530|NCT02359994|530326242|FG001|Extended Oncology 24-Month Survival|Death|21|||
147045531|NCT02359994|530326241|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
147045532|NCT02359994|530326242|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
147045533|NCT04597632|530326243|FG000|Overall Study|Withdrawal by Subject|10|||
147045534|NCT04597632|530326243|FG000|Overall Study|Lost to Follow-up|1|||
147045535|NCT04597632|530326243|FG000|Overall Study|Death|1|||
147045536|NCT04597632|530326243|FG000|Overall Study|Adverse Event|5|||
147045537|NCT00919854|530326246|FG000|Overall Study|Adverse Event|1|||
147045538|NCT01893346|530326249|FG000|Overall Study|Lost to Follow-up|0|||
147045539|NCT01893346|530326250|FG001|Overall Study|Lost to Follow-up|1|||
147045540|NCT01893346|530326251|FG002|Overall Study|Lost to Follow-up|0|||
147045541|NCT01893346|530326252|FG003|Overall Study|Lost to Follow-up|0|||
147045542|NCT01893346|530326249|FG000|Overall Study|Protocol Violation|1|||
147045543|NCT01893346|530326250|FG001|Overall Study|Protocol Violation|0|||
147045544|NCT01893346|530326251|FG002|Overall Study|Protocol Violation|0|||
147045545|NCT01893346|530326252|FG003|Overall Study|Protocol Violation|0|||
147045546|NCT01893346|530326249|FG000|Overall Study|Withdrawal by Subject|2|||
147045547|NCT01893346|530326250|FG001|Overall Study|Withdrawal by Subject|0|||
147045548|NCT01893346|530326251|FG002|Overall Study|Withdrawal by Subject|0|||
147045549|NCT01893346|530326252|FG003|Overall Study|Withdrawal by Subject|0|||
147045550|NCT00985491|530326253|FG000|Overall Study|Adverse Event|8|||
147045551|NCT00985491|530326253|FG000|Overall Study|device migration|7|||
147045552|NCT00985491|530326253|FG000|Overall Study|Withdrawal by Subject|1|||
147045553|NCT00985491|530326253|FG000|Overall Study|implant failure|3|||
147045554|NCT02296931|530326256|FG000|Overall Study|Protocol Violation|0|||
147045555|NCT02296931|530326257|FG001|Overall Study|Protocol Violation|2|||
147045556|NCT01590277|530326258|FG000|Overall Study|Withdrawal by Subject|3|||
147045557|NCT01590277|530326258|FG000|Overall Study|Withdrawal by Subject|2|||
147045558|NCT01590277|530326258|FG000|Overall Study|Withdrawal by Subject|1|||
147045559|NCT01590277|530326258|FG000|Overall Study|Withdrawal by Subject|1|||
147045560|NCT04386616|530326259|FG000|Overall Study|Death|22|||
147045561|NCT04386616|530326260|FG001|Overall Study|Death|22|||
147045562|NCT04386616|530326261|FG002|Overall Study|Death|21|||
147045563|NCT04386616|530326259|FG000|Overall Study|Lost to Follow-up|5|||
147045564|NCT04386616|530326260|FG001|Overall Study|Lost to Follow-up|8|||
147045565|NCT04386616|530326261|FG002|Overall Study|Lost to Follow-up|6|||
147045566|NCT04386616|530326259|FG000|Overall Study|Withdrawal by Subject|2|||
147045567|NCT04386616|530326260|FG001|Overall Study|Withdrawal by Subject|4|||
147045568|NCT04386616|530326261|FG002|Overall Study|Withdrawal by Subject|1|||
147045569|NCT04386616|530326259|FG000|Overall Study|Adverse Event|1|||
147045570|NCT04386616|530326260|FG001|Overall Study|Adverse Event|1|||
147045571|NCT04386616|530326261|FG002|Overall Study|Adverse Event|0|||
147045572|NCT01377012|530326262|FG000|Core Study|Study terminated by Sponsor|47|||
147045573|NCT01377012|530326263|FG001|Core Study|Study terminated by Sponsor|54|||
147045574|NCT01377012|530326264|FG002|Core Study|Study terminated by Sponsor|46|||
147045575|NCT01377012|530326262|FG000|Core Study|Technical problems|1|||
147045576|NCT01377012|530326263|FG001|Core Study|Technical problems|0|||
147045577|NCT01377012|530326264|FG002|Core Study|Technical problems|0|||
147045578|NCT01377012|530326262|FG000|Core Study|Withdrawal by Subject|15|||
147045579|NCT01377012|530326263|FG001|Core Study|Withdrawal by Subject|23|||
147045580|NCT01377012|530326264|FG002|Core Study|Withdrawal by Subject|18|||
147045581|NCT01377012|530326262|FG000|Core Study|Protocol Violation|7|||
147045582|NCT01377012|530326263|FG001|Core Study|Protocol Violation|3|||
147045583|NCT01377012|530326264|FG002|Core Study|Protocol Violation|2|||
147045584|NCT01377012|530326262|FG000|Core Study|Pregnancy|0|||
147045585|NCT01377012|530326263|FG001|Core Study|Pregnancy|0|||
147045586|NCT01377012|530326264|FG002|Core Study|Pregnancy|1|||
147045587|NCT01377012|530326262|FG000|Core Study|Physician Decision|5|||
147045588|NCT01377012|530326263|FG001|Core Study|Physician Decision|4|||
147045589|NCT01377012|530326264|FG002|Core Study|Physician Decision|10|||
147045590|NCT01377012|530326262|FG000|Core Study|Non-Compliant with study treatment|0|||
147045591|NCT01377012|530326263|FG001|Core Study|Non-Compliant with study treatment|0|||
147045592|NCT01377012|530326264|FG002|Core Study|Non-Compliant with study treatment|1|||
147045593|NCT01377012|530326262|FG000|Core Study|No Longer require treatment|0|||
146849932|NCT02101385|529618927|FG001|Follow up|Withdrawal by Subject|2|||
147045594|NCT01377012|530326263|FG001|Core Study|No Longer require treatment|0|||
147045595|NCT01377012|530326264|FG002|Core Study|No Longer require treatment|1|||
147045596|NCT01377012|530326262|FG000|Core Study|Lost to Follow-up|7|||
147045597|NCT01377012|530326263|FG001|Core Study|Lost to Follow-up|5|||
147045598|NCT01377012|530326264|FG002|Core Study|Lost to Follow-up|4|||
147045599|NCT01377012|530326262|FG000|Core Study|Lack of Efficacy|41|||
147045600|NCT01377012|530326263|FG001|Core Study|Lack of Efficacy|28|||
147045601|NCT01377012|530326264|FG002|Core Study|Lack of Efficacy|37|||
147045602|NCT01377012|530326262|FG000|Core Study|Death|1|||
147045603|NCT01377012|530326263|FG001|Core Study|Death|1|||
147045604|NCT01377012|530326264|FG002|Core Study|Death|1|||
147045605|NCT01377012|530326262|FG000|Core Study|Adverse Event|10|||
147045606|NCT01377012|530326263|FG001|Core Study|Adverse Event|14|||
147045607|NCT01377012|530326264|FG002|Core Study|Adverse Event|13|||
147045608|NCT01377012|530326262|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
147045609|NCT01377012|530326263|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
147045610|NCT01377012|530326264|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
147045611|NCT01377012|530326262|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
147045612|NCT01377012|530326263|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
147045613|NCT01377012|530326264|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
147045614|NCT01377012|530326262|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
147045615|NCT01377012|530326263|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
147045616|NCT01377012|530326264|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
147045617|NCT01377012|530326262|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
147045618|NCT01377012|530326263|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
147045619|NCT01377012|530326264|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
147045620|NCT01377012|530326262|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
147045621|NCT01377012|530326263|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
147045622|NCT01377012|530326264|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
147045623|NCT01377012|530326262|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
147045624|NCT01377012|530326263|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
147045625|NCT01377012|530326264|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
147045626|NCT01632280|530326282|FG000|Overall Study|Withdrawal by Subject|1|||
147045627|NCT01632280|530326283|FG001|Overall Study|Withdrawal by Subject|0|||
147045628|NCT03086551|530326291|FG000|First Intervention|Failure to meet inclusion criterion|1|||
147045629|NCT03086551|530326292|FG001|First Intervention|Failure to meet inclusion criterion|0|||
147045630|NCT03086551|530326291|FG000|First Intervention|Lost to Follow-up|0|||
147045631|NCT03086551|530326292|FG001|First Intervention|Lost to Follow-up|1|||
147045632|NCT03086551|530326291|FG000|Washout|Lost to Follow-up|1|||
147045633|NCT03086551|530326292|FG001|Washout|Lost to Follow-up|2|||
147045634|NCT03086551|530326291|FG000|Washout|Withdrawal by Subject|2|||
147045635|NCT03086551|530326292|FG001|Washout|Withdrawal by Subject|1|||
147045636|NCT03736031|530326293|FG000|Overall Study|Death|2|||
147045637|NCT03736031|530326294|FG001|Overall Study|Death|4|||
147045638|NCT03736031|530326293|FG000|Overall Study|Lost to Follow-up|21|||
147045639|NCT03736031|530326294|FG001|Overall Study|Lost to Follow-up|2|||
147045640|NCT03736031|530326293|FG000|Overall Study|Withdrawal by Subject|9|||
147045641|NCT03736031|530326294|FG001|Overall Study|Withdrawal by Subject|0|||
147045642|NCT00451178|530326295|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
147045643|NCT00451178|530326296|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
147045644|NCT00451178|530326295|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
147045645|NCT00451178|530326296|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
147045646|NCT00451178|530326295|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
147045647|NCT00451178|530326296|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
147045648|NCT00451178|530326295|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
147045649|NCT00451178|530326296|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
147045650|NCT00451178|530326295|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
147045651|NCT00451178|530326296|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
147045652|NCT00451178|530326295|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
147045653|NCT00451178|530326296|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
147045654|NCT00451178|530326295|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
147045655|NCT00451178|530326296|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
147045656|NCT00451178|530326295|FG000|Prior to Maintenance Therapy|PD|2|||
147045657|NCT00451178|530326296|FG001|Prior to Maintenance Therapy|PD|0|||
147045658|NCT00451178|530326295|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
147045659|NCT00451178|530326296|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
147045660|NCT00451178|530326295|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
147045661|NCT00451178|530326296|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
147045662|NCT00451178|530326295|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
147045663|NCT00451178|530326296|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
147045664|NCT00451178|530326295|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
147045665|NCT00451178|530326296|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
147045666|NCT00451178|530326295|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
147045667|NCT00451178|530326296|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
147045668|NCT00451178|530326295|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
147045669|NCT00451178|530326296|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
147045670|NCT00451178|530326295|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
147045671|NCT00451178|530326296|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
147045672|NCT01260701|530326297|FG000|Overall Study|Adverse Event|9|||
147045673|NCT01260701|530326297|FG000|Overall Study|Withdrawal by Subject|2|||
147045674|NCT01260701|530326297|FG000|Overall Study|Progression|53|||
147045675|NCT01260701|530326297|FG000|Overall Study|Death|2|||
147045676|NCT01260701|530326297|FG000|Overall Study|Not protocol specified|3|||
147045677|NCT01260701|530326297|FG000|Overall Study|Under review|1|||
147045678|NCT01260701|530326297|FG000|Overall Study|Ineligible|4|||
147045679|NCT01260701|530326297|FG000|Overall Study|Did not begin protocol therapy|1|||
147045680|NCT03631199|530328049|FG000|Overall Study|Progressive disease|9|||
147045681|NCT03631199|530328050|FG001|Overall Study|Progressive disease|5|||
147045682|NCT03631199|530328051|FG002|Overall Study|Progressive disease|5|||
147045683|NCT03631199|530328052|FG003|Overall Study|Progressive disease|149|||
147045684|NCT03631199|530328053|FG004|Overall Study|Progressive disease|148|||
147045685|NCT03631199|530328049|FG000|Overall Study|Physician Decision|0|||
147045686|NCT03631199|530328050|FG001|Overall Study|Physician Decision|2|||
147045687|NCT03631199|530328051|FG002|Overall Study|Physician Decision|3|||
147045688|NCT03631199|530328052|FG003|Overall Study|Physician Decision|19|||
147045689|NCT03631199|530328053|FG004|Overall Study|Physician Decision|13|||
147045690|NCT03631199|530328049|FG000|Overall Study|Adverse Event|1|||
147045691|NCT03631199|530328050|FG001|Overall Study|Adverse Event|1|||
147045692|NCT03631199|530328051|FG002|Overall Study|Adverse Event|0|||
147045693|NCT03631199|530328052|FG003|Overall Study|Adverse Event|28|||
147045694|NCT03631199|530328053|FG004|Overall Study|Adverse Event|29|||
147045695|NCT03631199|530328049|FG000|Overall Study|Death|0|||
147045696|NCT03631199|530328050|FG001|Overall Study|Death|1|||
147045697|NCT03631199|530328051|FG002|Overall Study|Death|0|||
147045698|NCT03631199|530328052|FG003|Overall Study|Death|35|||
147045699|NCT03631199|530328053|FG004|Overall Study|Death|48|||
147045700|NCT03631199|530328049|FG000|Overall Study|Subject decision|0|||
147045701|NCT03631199|530328050|FG001|Overall Study|Subject decision|1|||
147045702|NCT03631199|530328051|FG002|Overall Study|Subject decision|0|||
147045703|NCT03631199|530328052|FG003|Overall Study|Subject decision|12|||
147045704|NCT03631199|530328053|FG004|Overall Study|Subject decision|12|||
147045705|NCT03631199|530328049|FG000|Overall Study|No treated|0|||
147045706|NCT03631199|530328050|FG001|Overall Study|No treated|0|||
147045707|NCT03631199|530328051|FG002|Overall Study|No treated|0|||
147045708|NCT03631199|530328052|FG003|Overall Study|No treated|0|||
147045709|NCT03631199|530328053|FG004|Overall Study|No treated|1|||
147045710|NCT03631199|530328049|FG000|Overall Study|Treatment ongoing|0|||
147045711|NCT03631199|530328050|FG001|Overall Study|Treatment ongoing|1|||
147045712|NCT03631199|530328051|FG002|Overall Study|Treatment ongoing|1|||
147045713|NCT03631199|530328052|FG003|Overall Study|Treatment ongoing|76|||
147045714|NCT03631199|530328053|FG004|Overall Study|Treatment ongoing|71|||
147045715|NCT03631199|530328049|FG000|Overall Study|Guardian decision|0|||
147045716|NCT03631199|530328050|FG001|Overall Study|Guardian decision|0|||
147045717|NCT03631199|530328051|FG002|Overall Study|Guardian decision|0|||
147045718|NCT03631199|530328052|FG003|Overall Study|Guardian decision|1|||
147045719|NCT03631199|530328053|FG004|Overall Study|Guardian decision|1|||
147045720|NCT00577863|530328054|FG000|Overall Study|Adverse Event|4|||
147045721|NCT00577863|530328055|FG001|Overall Study|Adverse Event|2|||
147045722|NCT00577863|530328054|FG000|Overall Study|Death|1|||
147045723|NCT00577863|530328055|FG001|Overall Study|Death|0|||
147045724|NCT00577863|530328054|FG000|Overall Study|Lost to Follow-up|2|||
147045725|NCT00577863|530328055|FG001|Overall Study|Lost to Follow-up|2|||
147045726|NCT00577863|530328054|FG000|Overall Study|Entry Criteria Exclusion|1|||
147045727|NCT00577863|530328055|FG001|Overall Study|Entry Criteria Exclusion|0|||
147045728|NCT00577863|530328054|FG000|Overall Study|Withdrawal by Subject|0|||
147045729|NCT00577863|530328055|FG001|Overall Study|Withdrawal by Subject|2|||
147045730|NCT00577863|530328054|FG000|Overall Study|Sponsor Decision|2|||
147045731|NCT00577863|530328055|FG001|Overall Study|Sponsor Decision|7|||
147045732|NCT00577863|530328054|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
147045733|NCT00577863|530328055|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
147045734|NCT01750190|530328056|FG000|Overall Study|Adverse Event|47|||
147045735|NCT01750190|530328057|FG001|Overall Study|Adverse Event|19|||
147045736|NCT01750190|530328056|FG000|Overall Study|Death|38|||
147045737|NCT01750190|530328057|FG001|Overall Study|Death|11|||
147045738|NCT01750190|530328056|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
147045739|NCT01750190|530328057|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
147045740|NCT01750190|530328056|FG000|Overall Study|Lost to Follow-up|28|||
147045741|NCT01750190|530328057|FG001|Overall Study|Lost to Follow-up|7|||
147045742|NCT01750190|530328056|FG000|Overall Study|Physician Decision|16|||
147045743|NCT01750190|530328057|FG001|Overall Study|Physician Decision|17|||
147045744|NCT01750190|530328056|FG000|Overall Study|Protocol Violation|6|||
147045745|NCT01750190|530328057|FG001|Overall Study|Protocol Violation|5|||
147045746|NCT01750190|530328056|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
147045747|NCT01750190|530328057|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
147045748|NCT01750190|530328056|FG000|Overall Study|Withdrawal by Subject|83|||
147045749|NCT01750190|530328057|FG001|Overall Study|Withdrawal by Subject|89|||
147045750|NCT01750190|530328056|FG000|Overall Study|Kidney Transplant|8|||
147045751|NCT01750190|530328057|FG001|Overall Study|Kidney Transplant|4|||
147045752|NCT01750190|530328056|FG000|Overall Study|Dialysis|22|||
147045753|NCT01750190|530328057|FG001|Overall Study|Dialysis|8|||
147045754|NCT01750190|530328056|FG000|Overall Study|Other than Specified|13|||
147045755|NCT01750190|530328057|FG001|Overall Study|Other than Specified|4|||
147045756|NCT02009722|530328064|FG000|Overall Study|Protocol Violation|1|||
147045757|NCT02009722|530328065|FG001|Overall Study|Protocol Violation|2|||
147045758|NCT02009722|530328064|FG000|Overall Study|Did not receive intervention|0|||
147045759|NCT02009722|530328065|FG001|Overall Study|Did not receive intervention|1|||
147045760|NCT02955212|530328066|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
147045761|NCT02955212|530328067|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
147045762|NCT02955212|530328066|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
147045763|NCT02955212|530328067|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
147045764|NCT02955212|530328066|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
147045765|NCT02955212|530328067|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
147045766|NCT02955212|530328066|FG000|Period 1: Double-blind Treatment Period|Other|3|||
147045767|NCT02955212|530328067|FG001|Period 1: Double-blind Treatment Period|Other|2|||
147045768|NCT02955212|530328066|FG000|Period 2: Open-label Extension|Adverse Event|11|||
147045769|NCT02955212|530328067|FG001|Period 2: Open-label Extension|Adverse Event|7|||
147045770|NCT02955212|530328066|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
147045771|NCT02955212|530328067|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
147045772|NCT02955212|530328066|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
147045773|NCT02955212|530328067|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
147045774|NCT02955212|530328066|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
147045775|NCT02955212|530328067|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
147045776|NCT02955212|530328066|FG000|Period 2: Open-label Extension|Other|2|||
147045777|NCT02955212|530328067|FG001|Period 2: Open-label Extension|Other|4|||
147045778|NCT02454933|530328076|FG000|Overall Study|Progressive disease|10|||
147045779|NCT02454933|530328077|FG001|Overall Study|Progressive disease|7|||
147045780|NCT02454933|530328076|FG000|Overall Study|Adverse Event|1|||
147045781|NCT02454933|530328077|FG001|Overall Study|Adverse Event|1|||
147045782|NCT02454933|530328076|FG000|Overall Study|Withdrawal by Subject|0|||
147045783|NCT02454933|530328077|FG001|Overall Study|Withdrawal by Subject|3|||
147045784|NCT02454933|530328076|FG000|Overall Study|Lost to Follow-up|1|||
147045785|NCT02454933|530328077|FG001|Overall Study|Lost to Follow-up|0|||
147045786|NCT02071225|530328083|FG000|Overall Study|Withdrawal of Consent|2|||
147045787|NCT02071225|530328083|FG000|Overall Study|Protocol Deviation|1|||
147045788|NCT02071225|530328083|FG000|Overall Study|Lost to Follow-up|2|||
147045789|NCT02071225|530328083|FG000|Overall Study|Death|25|||
147045790|NCT04753216|530328084|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
147045791|NCT04753216|530328084|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
147045792|NCT04753216|530328084|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
147045793|NCT01895777|530328085|FG000|Overall Study|Adverse Event|1|||
147045794|NCT01895777|530328086|FG001|Overall Study|Adverse Event|2|||
147045795|NCT01895777|530328085|FG000|Overall Study|Lost to Follow-up|2|||
147045796|NCT01895777|530328086|FG001|Overall Study|Lost to Follow-up|0|||
147045797|NCT01895777|530328085|FG000|Overall Study|Not treated|1|||
147045798|NCT01895777|530328086|FG001|Overall Study|Not treated|0|||
147045799|NCT01895777|530328085|FG000|Overall Study|Other reasons|3|||
147045800|NCT01895777|530328086|FG001|Overall Study|Other reasons|2|||
147045801|NCT01895777|530328085|FG000|Overall Study|Non-compliance with the CTP|2|||
147045802|NCT01895777|530328086|FG001|Overall Study|Non-compliance with the CTP|1|||
147045803|NCT01342081|530328087|FG000|Overall Study|Did not receive allocated intervention|0|||
147045804|NCT01342081|530328088|FG001|Overall Study|Did not receive allocated intervention|0|||
147045805|NCT01342081|530328089|FG002|Overall Study|Did not receive allocated intervention|1|||
147045806|NCT01342081|530328087|FG000|Overall Study|Adverse Event|1|||
147045807|NCT01342081|530328088|FG001|Overall Study|Adverse Event|0|||
147045808|NCT01342081|530328089|FG002|Overall Study|Adverse Event|0|||
147045809|NCT01342081|530328087|FG000|Overall Study|Physician Decision|0|||
147045810|NCT01342081|530328088|FG001|Overall Study|Physician Decision|1|||
147045811|NCT01342081|530328089|FG002|Overall Study|Physician Decision|0|||
147045812|NCT01342081|530328087|FG000|Overall Study|Withdrawal by Subject|1|||
147045813|NCT01342081|530328088|FG001|Overall Study|Withdrawal by Subject|1|||
147045814|NCT01342081|530328089|FG002|Overall Study|Withdrawal by Subject|0|||
147045815|NCT03571828|530328098|FG000|Overall Study|Withdrawal by Subject|1|||
147045816|NCT03571828|530328099|FG001|Overall Study|Withdrawal by Subject|0|||
147045817|NCT03571828|530328098|FG000|Overall Study|Decision by sponsor|5|||
147045818|NCT03571828|530328099|FG001|Overall Study|Decision by sponsor|1|||
147045819|NCT03571828|530328098|FG000|Overall Study|Death|2|||
147045820|NCT03571828|530328099|FG001|Overall Study|Death|0|||
147045821|NCT00666328|530328100|FG000|Overall Study|Death|2|||
147045822|NCT00666328|530328100|FG000|Overall Study|Lost to Follow-up|2|||
147045823|NCT00666328|530328100|FG000|Overall Study|No longer met eligibility criteria|1|||
147045824|NCT02829918|530328105|FG000|Overall Study|Death|2|||
147045825|NCT02829918|530328105|FG000|Overall Study|Withdrawal by Subject|4|||
147045826|NCT02829918|530328105|FG000|Overall Study|Adverse Event|1|||
147045827|NCT02829918|530328105|FG000|Overall Study|Progression|1|||
147045828|NCT02441686|530328109|FG000|Induction|Adverse Event|4|||
147045829|NCT02441686|530328109|FG000|Induction|Complicating disease|1|||
147045830|NCT02441686|530328109|FG000|Induction|Physician Decision|1|||
147045831|NCT02441686|530328109|FG000|Induction|Withdrawal by Subject|1|||
147045832|NCT02441686|530328109|FG000|Induction|Did not receive treatment|1|||
147045833|NCT02441686|530328109|FG000|Maintenance|Remaining on Treatment|23|||
147045834|NCT02441686|530328109|FG000|Maintenance|Physician Decision|1|||
147045835|NCT02441686|530328109|FG000|Maintenance|Adverse Event|3|||
147045836|NCT02441686|530328109|FG000|Maintenance|Progressive Disease|10|||
147045837|NCT02441686|530328109|FG000|Maintenance|Withdrawal by Subject|1|||
147045838|NCT03762239|530328110|FG000|Overall Study|Appointment to the doctor|1|||
147045839|NCT03762239|530328111|FG001|Overall Study|Appointment to the doctor|1|||
147045840|NCT04471428|530328112|FG000|Overall Study|Withdrawal by Subject|29|||
147045841|NCT04471428|530328113|FG001|Overall Study|Withdrawal by Subject|1|||
147045842|NCT04471428|530328112|FG000|Overall Study|Physician Decision|0|||
147045843|NCT04471428|530328113|FG001|Overall Study|Physician Decision|1|||
147045844|NCT04471428|530328112|FG000|Overall Study|Reason Not Specified|0|||
147045845|NCT04471428|530328113|FG001|Overall Study|Reason Not Specified|2|||
147045846|NCT04471428|530328112|FG000|Overall Study|Death|106|||
147045847|NCT04471428|530328113|FG001|Overall Study|Death|114|||
147045848|NCT04471428|530328112|FG000|Overall Study|Ongoing in the study|45|||
147045849|NCT04471428|530328113|FG001|Overall Study|Ongoing in the study|68|||
147045850|NCT03151304|530328114|FG000|Overall Study|Termination of study by Sponsor|23|||
147045851|NCT03151304|530328114|FG000|Overall Study|missing|3|||
147045852|NCT03151304|530328114|FG000|Overall Study|Withdrawal by Subject|8|||
147045853|NCT03151304|530328114|FG000|Overall Study|multiple reasons|30|||
147045854|NCT01137071|530328116|FG000|Overall Study|Disease Progression|11|||
147045855|NCT01137071|530328116|FG000|Overall Study|Withdrawal by Subject|2|||
147045856|NCT01137071|530328116|FG000|Overall Study|Wrongly Included|1|||
147045857|NCT02565511|530328117|FG000|Overall Study|Study terminated by Sponsor|35|||
147045858|NCT02565511|530328118|FG001|Overall Study|Study terminated by Sponsor|22|||
147045859|NCT02565511|530328119|FG002|Overall Study|Study terminated by Sponsor|235|||
147045860|NCT02565511|530328120|FG003|Overall Study|Study terminated by Sponsor|156|||
147045861|NCT02565511|530328117|FG000|Overall Study|Withdrawal by Subject|3|||
147045862|NCT02565511|530328118|FG001|Overall Study|Withdrawal by Subject|0|||
147045863|NCT02565511|530328119|FG002|Overall Study|Withdrawal by Subject|12|||
147045864|NCT02565511|530328120|FG003|Overall Study|Withdrawal by Subject|5|||
147045865|NCT02565511|530328117|FG000|Overall Study|Adverse Event|0|||
147045866|NCT02565511|530328118|FG001|Overall Study|Adverse Event|0|||
147045867|NCT02565511|530328119|FG002|Overall Study|Adverse Event|1|||
147045868|NCT02565511|530328120|FG003|Overall Study|Adverse Event|1|||
147045869|NCT02565511|530328117|FG000|Overall Study|Lost to Follow-up|4|||
147045870|NCT02565511|530328118|FG001|Overall Study|Lost to Follow-up|1|||
147045871|NCT02565511|530328119|FG002|Overall Study|Lost to Follow-up|0|||
147045872|NCT02565511|530328120|FG003|Overall Study|Lost to Follow-up|1|||
147045873|NCT02565511|530328117|FG000|Overall Study|Physician Decision|0|||
147045874|NCT02565511|530328118|FG001|Overall Study|Physician Decision|0|||
147045875|NCT02565511|530328119|FG002|Overall Study|Physician Decision|0|||
147045876|NCT02565511|530328120|FG003|Overall Study|Physician Decision|1|||
147045877|NCT02565511|530328117|FG000|Overall Study|Protocol deviation|0|||
147045878|NCT02565511|530328118|FG001|Overall Study|Protocol deviation|0|||
147045879|NCT02565511|530328119|FG002|Overall Study|Protocol deviation|3|||
147045880|NCT02565511|530328120|FG003|Overall Study|Protocol deviation|0|||
147045881|NCT04807400|530328121|FG000|Overall Study|Adverse Event|2|||
147045882|NCT04807400|530328122|FG001|Overall Study|Adverse Event|3|||
147045883|NCT04807400|530328123|FG002|Overall Study|Adverse Event|3|||
147045884|NCT04807400|530328121|FG000|Overall Study|Death|2|||
147045885|NCT04807400|530328122|FG001|Overall Study|Death|0|||
147045886|NCT04807400|530328123|FG002|Overall Study|Death|0|||
147045887|NCT04807400|530328121|FG000|Overall Study|Lost to Follow-up|8|||
147045888|NCT04807400|530328122|FG001|Overall Study|Lost to Follow-up|6|||
147045889|NCT04807400|530328123|FG002|Overall Study|Lost to Follow-up|6|||
147045890|NCT04807400|530328121|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147045891|NCT04807400|530328122|FG001|Overall Study|Non-Compliance With Study Drug|4|||
147045892|NCT04807400|530328123|FG002|Overall Study|Non-Compliance With Study Drug|1|||
147045893|NCT04807400|530328121|FG000|Overall Study|Participant Decision|20|||
147045894|NCT04807400|530328122|FG001|Overall Study|Participant Decision|19|||
147045895|NCT04807400|530328123|FG002|Overall Study|Participant Decision|26|||
147045896|NCT04807400|530328121|FG000|Overall Study|Physician Decision|0|||
147045897|NCT04807400|530328122|FG001|Overall Study|Physician Decision|1|||
147045898|NCT04807400|530328123|FG002|Overall Study|Physician Decision|0|||
147045899|NCT04807400|530328121|FG000|Overall Study|Protocol Violation|4|||
147045900|NCT04807400|530328122|FG001|Overall Study|Protocol Violation|3|||
147045901|NCT04807400|530328123|FG002|Overall Study|Protocol Violation|7|||
147045902|NCT04807400|530328121|FG000|Overall Study|Withdrawal by Subject|13|||
147045903|NCT04807400|530328122|FG001|Overall Study|Withdrawal by Subject|9|||
147045904|NCT04807400|530328123|FG002|Overall Study|Withdrawal by Subject|20|||
147045905|NCT04807400|530328121|FG000|Overall Study|Mis-randomized|1|||
147045906|NCT04807400|530328122|FG001|Overall Study|Mis-randomized|0|||
147045907|NCT04807400|530328123|FG002|Overall Study|Mis-randomized|0|||
147045908|NCT03656744|530328124|FG000|Overall Study|Adverse Event|1|||
147045909|NCT03656744|530328125|FG001|Overall Study|Adverse Event|4|||
147045910|NCT03656744|530328126|FG002|Overall Study|Adverse Event|1|||
147045911|NCT03656744|530328124|FG000|Overall Study|Protocol Violation|1|||
147045912|NCT03656744|530328125|FG001|Overall Study|Protocol Violation|0|||
147045913|NCT03656744|530328126|FG002|Overall Study|Protocol Violation|0|||
147045914|NCT03656744|530328124|FG000|Overall Study|Lost to Follow-up|2|||
147045915|NCT03656744|530328125|FG001|Overall Study|Lost to Follow-up|2|||
147045916|NCT03656744|530328126|FG002|Overall Study|Lost to Follow-up|0|||
147045917|NCT03656744|530328124|FG000|Overall Study|Withdrawal by Subject|0|||
147045918|NCT03656744|530328125|FG001|Overall Study|Withdrawal by Subject|1|||
147045919|NCT03656744|530328126|FG002|Overall Study|Withdrawal by Subject|0|||
147045920|NCT03656744|530328124|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
147045921|NCT03656744|530328125|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
147045922|NCT03656744|530328126|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
147045923|NCT01332292|530328129|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
147045924|NCT01332292|530328130|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
147045925|NCT01332292|530328129|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
147045926|NCT01332292|530328130|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
147045927|NCT01332292|530328129|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
147045928|NCT01332292|530328130|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
147045929|NCT03910673|530328132|FG000|Overall Study|Adverse Event|0|||
147045930|NCT03910673|530328133|FG001|Overall Study|Adverse Event|0|||
147045931|NCT03910673|530328134|FG002|Overall Study|Adverse Event|0|||
147045932|NCT03910673|530328135|FG003|Overall Study|Adverse Event|2|||
147045933|NCT03910673|530328136|FG004|Overall Study|Adverse Event|0|||
147045934|NCT00098774|530328137|FG000|Overall Study|Adverse Event|2|||
147045935|NCT00098774|530328137|FG000|Overall Study|Disease Progression|9|||
147045936|NCT00098774|530328137|FG000|Overall Study|Withdrawal by Subject|1|||
147045937|NCT00098774|530328137|FG000|Overall Study|Failed (to respond) during induction|4|||
147045938|NCT00098774|530328137|FG000|Overall Study|Physician Decision|2|||
147045939|NCT03142191|530328138|FG000|Placebo Controlled Period|Death|0|||
147045940|NCT03142191|530328139|FG001|Placebo Controlled Period|Death|1|||
147045941|NCT03142191|530328140|FG002|Placebo Controlled Period|Death|1|||
147045942|NCT03142191|530328141|FG003|Placebo Controlled Period|Death|0|||
147045943|NCT03142191|530328142|FG004|Placebo Controlled Period|Death|0|||
147045944|NCT03142191|530328138|FG000|Placebo Controlled Period|Adverse Event|4|||
147045945|NCT03142191|530328139|FG001|Placebo Controlled Period|Adverse Event|5|||
147045946|NCT03142191|530328140|FG002|Placebo Controlled Period|Adverse Event|1|||
147045947|NCT03142191|530328141|FG003|Placebo Controlled Period|Adverse Event|0|||
147045948|NCT03142191|530328142|FG004|Placebo Controlled Period|Adverse Event|0|||
147045949|NCT03142191|530328138|FG000|Placebo Controlled Period|Progressive Disease|1|||
147045950|NCT03142191|530328139|FG001|Placebo Controlled Period|Progressive Disease|0|||
147045951|NCT03142191|530328140|FG002|Placebo Controlled Period|Progressive Disease|1|||
147045952|NCT03142191|530328141|FG003|Placebo Controlled Period|Progressive Disease|0|||
147045953|NCT03142191|530328142|FG004|Placebo Controlled Period|Progressive Disease|0|||
147045954|NCT03142191|530328138|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
147045955|NCT03142191|530328139|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
147045956|NCT03142191|530328140|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
147045957|NCT03142191|530328141|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
147045958|NCT03142191|530328142|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
147045959|NCT03142191|530328138|FG000|Placebo Controlled Period|Other Reasons|1|||
147045960|NCT03142191|530328139|FG001|Placebo Controlled Period|Other Reasons|0|||
147045961|NCT03142191|530328140|FG002|Placebo Controlled Period|Other Reasons|0|||
147045962|NCT03142191|530328141|FG003|Placebo Controlled Period|Other Reasons|0|||
147045963|NCT03142191|530328142|FG004|Placebo Controlled Period|Other Reasons|0|||
147045964|NCT03142191|530328138|FG000|Active Treatment Extension Period|Death|2|||
147045965|NCT03142191|530328139|FG001|Active Treatment Extension Period|Death|1|||
147045966|NCT03142191|530328140|FG002|Active Treatment Extension Period|Death|1|||
147045967|NCT03142191|530328141|FG003|Active Treatment Extension Period|Death|1|||
147045968|NCT03142191|530328142|FG004|Active Treatment Extension Period|Death|0|||
147045969|NCT03142191|530328138|FG000|Active Treatment Extension Period|Adverse Event|6|||
147045970|NCT03142191|530328139|FG001|Active Treatment Extension Period|Adverse Event|5|||
147045971|NCT03142191|530328140|FG002|Active Treatment Extension Period|Adverse Event|4|||
147045972|NCT03142191|530328141|FG003|Active Treatment Extension Period|Adverse Event|1|||
147045973|NCT03142191|530328142|FG004|Active Treatment Extension Period|Adverse Event|0|||
147045974|NCT03142191|530328138|FG000|Active Treatment Extension Period|Progressive Disease|10|||
147045975|NCT03142191|530328139|FG001|Active Treatment Extension Period|Progressive Disease|5|||
147045976|NCT03142191|530328140|FG002|Active Treatment Extension Period|Progressive Disease|4|||
147045977|NCT03142191|530328141|FG003|Active Treatment Extension Period|Progressive Disease|1|||
147045978|NCT03142191|530328142|FG004|Active Treatment Extension Period|Progressive Disease|2|||
147045979|NCT03142191|530328138|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
147045980|NCT03142191|530328139|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
147045981|NCT03142191|530328140|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
147045982|NCT03142191|530328141|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
147045983|NCT03142191|530328142|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
147045984|NCT03142191|530328138|FG000|Active Treatment Extension Period|Physician Decision|2|||
147045985|NCT03142191|530328139|FG001|Active Treatment Extension Period|Physician Decision|0|||
147045986|NCT03142191|530328140|FG002|Active Treatment Extension Period|Physician Decision|0|||
147045987|NCT03142191|530328141|FG003|Active Treatment Extension Period|Physician Decision|0|||
147045988|NCT03142191|530328142|FG004|Active Treatment Extension Period|Physician Decision|0|||
147045989|NCT03142191|530328138|FG000|Active Treatment Extension Period|Other Reasons|3|||
147045990|NCT03142191|530328139|FG001|Active Treatment Extension Period|Other Reasons|3|||
147045991|NCT03142191|530328140|FG002|Active Treatment Extension Period|Other Reasons|3|||
147045992|NCT03142191|530328141|FG003|Active Treatment Extension Period|Other Reasons|8|||
147045993|NCT03142191|530328142|FG004|Active Treatment Extension Period|Other Reasons|3|||
147045994|NCT03142191|530328138|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
147045995|NCT03142191|530328139|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
147045996|NCT03142191|530328140|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
147045997|NCT03142191|530328141|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
147045998|NCT03142191|530328142|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
147045999|NCT01130493|530328145|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
147046000|NCT01130493|530328146|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
147046001|NCT01130493|530328147|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
147046002|NCT01130493|530328145|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
147046003|NCT01130493|530328146|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
147046004|NCT01130493|530328147|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
147046005|NCT01130493|530328145|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
147046006|NCT01130493|530328146|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
147046007|NCT01130493|530328147|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
147046008|NCT01130493|530328145|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
147046009|NCT01130493|530328146|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
147046010|NCT01130493|530328147|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
147046011|NCT01130493|530328145|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
147046012|NCT01130493|530328146|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
147046013|NCT01130493|530328147|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
147046014|NCT01130493|530328145|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
147046015|NCT01130493|530328146|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
147046016|NCT01130493|530328147|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
147046017|NCT01130493|530328145|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
147046018|NCT01130493|530328146|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
147046019|NCT01130493|530328147|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
147046020|NCT01130493|530328145|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
147046021|NCT01130493|530328146|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
147046022|NCT01130493|530328147|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
147046023|NCT01130493|530328145|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
147046024|NCT01130493|530328146|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
147046025|NCT01130493|530328147|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
147046026|NCT01130493|530328145|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
147046027|NCT01130493|530328146|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
147046028|NCT01130493|530328147|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
147046029|NCT01130493|530328145|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
147046030|NCT01130493|530328146|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
147046031|NCT01130493|530328147|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
147046032|NCT01130493|530328145|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
147046033|NCT01130493|530328146|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
147046034|NCT01130493|530328147|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
147046035|NCT01130493|530328145|FG000|Part 2: OLE|Adverse Event|0|||
147046036|NCT01130493|530328146|FG001|Part 2: OLE|Adverse Event|2|||
147046037|NCT01130493|530328147|FG002|Part 2: OLE|Adverse Event|1|||
147046038|NCT01130493|530328145|FG000|Part 2: OLE|Withdrawal by Subject|0|||
147046039|NCT01130493|530328146|FG001|Part 2: OLE|Withdrawal by Subject|1|||
147046040|NCT01130493|530328147|FG002|Part 2: OLE|Withdrawal by Subject|4|||
147046041|NCT02969044|530328148|FG000|Overall Study|Withdrawal by Subject|2|||
147046042|NCT02969044|530328149|FG001|Overall Study|Withdrawal by Subject|6|||
147046043|NCT02969044|530328148|FG000|Overall Study|Adverse Event|3|||
147046044|NCT02969044|530328149|FG001|Overall Study|Adverse Event|0|||
147046045|NCT04728802|530328150|FG000|Overall Study|Withdrawal by Subject|4|||
147046046|NCT04728802|530328151|FG001|Overall Study|Withdrawal by Subject|20|||
147046047|NCT04728802|530328150|FG000|Overall Study|Physician Decision|7|||
147046048|NCT04728802|530328151|FG001|Overall Study|Physician Decision|7|||
147046049|NCT04728802|530328150|FG000|Overall Study|Protocol Violation|10|||
147046050|NCT04728802|530328151|FG001|Overall Study|Protocol Violation|4|||
147046051|NCT04728802|530328150|FG000|Overall Study|Transfer|1|||
147046052|NCT04728802|530328151|FG001|Overall Study|Transfer|0|||
147046053|NCT04728802|530328150|FG000|Overall Study|Death|4|||
147046054|NCT04728802|530328151|FG001|Overall Study|Death|5|||
147046055|NCT04728802|530328150|FG000|Overall Study|Other|3|||
147046056|NCT04728802|530328151|FG001|Overall Study|Other|0|||
147046057|NCT04650204|530328152|FG000|Overall Study|Study was Terminated|2|||
147046058|NCT04650204|530328153|FG001|Overall Study|Study was Terminated|1|||
147046059|NCT02123446|530328154|FG000|Washout Period (1 Day)|Physician Decision|1|||
147046060|NCT02123446|530328155|FG001|Washout Period (1 Day)|Physician Decision|0|||
147046061|NCT04388553|530328156|FG000|Overall Study|Protocol Violation|1|||
147046062|NCT04388553|530328157|FG001|Overall Study|Protocol Violation|0|||
147046063|NCT01070953|530328162|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
147046064|NCT01070953|530328162|FG000|Participants for Safety Evaluation|Off-label use|283|||
147046065|NCT01070953|530328162|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
147046066|NCT01070953|530328162|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
147046067|NCT01070953|530328162|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
147046068|NCT01070953|530328162|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
147046069|NCT01070953|530328162|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
147046070|NCT01070953|530328162|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
147046071|NCT01070953|530328162|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
147046072|NCT01070953|530328162|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
147046073|NCT01957176|530328163|FG000|Overall Study|Adverse Event|2|||
147046074|NCT01957176|530328164|FG001|Overall Study|Adverse Event|0|||
147046075|NCT01957176|530328163|FG000|Overall Study|Physician Decision|2|||
147046076|NCT01957176|530328164|FG001|Overall Study|Physician Decision|1|||
147046077|NCT01957176|530328163|FG000|Overall Study|Withdrawal by Subject|1|||
147046078|NCT01957176|530328164|FG001|Overall Study|Withdrawal by Subject|0|||
147046079|NCT00839254|530328165|FG000|Overall Study|Protocol Violation|0|||
147046080|NCT00839254|530328166|FG001|Overall Study|Protocol Violation|1|||
147046081|NCT00839254|530328167|FG002|Overall Study|Protocol Violation|1|||
147046082|NCT00839254|530328168|FG003|Overall Study|Protocol Violation|1|||
147046083|NCT00839254|530328169|FG004|Overall Study|Protocol Violation|0|||
147046084|NCT00839254|530328170|FG005|Overall Study|Protocol Violation|0|||
147046085|NCT00839254|530328171|FG006|Overall Study|Protocol Violation|1|||
147046086|NCT00839254|530328172|FG007|Overall Study|Protocol Violation|2|||
147046087|NCT00839254|530328165|FG000|Overall Study|Physician Decision|0|||
147046088|NCT00839254|530328166|FG001|Overall Study|Physician Decision|1|||
147046089|NCT00839254|530328167|FG002|Overall Study|Physician Decision|0|||
147046090|NCT00839254|530328168|FG003|Overall Study|Physician Decision|0|||
147046091|NCT00839254|530328169|FG004|Overall Study|Physician Decision|0|||
147046092|NCT00839254|530328170|FG005|Overall Study|Physician Decision|0|||
147046093|NCT00839254|530328171|FG006|Overall Study|Physician Decision|0|||
147046094|NCT00839254|530328172|FG007|Overall Study|Physician Decision|1|||
147046095|NCT00839254|530328165|FG000|Overall Study|Wrong treatment number allocation|0|||
147046096|NCT00839254|530328166|FG001|Overall Study|Wrong treatment number allocation|1|||
147046097|NCT00839254|530328167|FG002|Overall Study|Wrong treatment number allocation|0|||
147046098|NCT00839254|530328168|FG003|Overall Study|Wrong treatment number allocation|0|||
147046099|NCT00839254|530328169|FG004|Overall Study|Wrong treatment number allocation|0|||
147046100|NCT00839254|530328170|FG005|Overall Study|Wrong treatment number allocation|1|||
147046101|NCT00839254|530328171|FG006|Overall Study|Wrong treatment number allocation|0|||
147046102|NCT00839254|530328172|FG007|Overall Study|Wrong treatment number allocation|0|||
147046103|NCT00839254|530328165|FG000|Overall Study|Adverse Event|12|||
147046104|NCT00839254|530328166|FG001|Overall Study|Adverse Event|6|||
147046105|NCT00839254|530328167|FG002|Overall Study|Adverse Event|3|||
147046106|NCT00839254|530328168|FG003|Overall Study|Adverse Event|5|||
147046107|NCT00839254|530328169|FG004|Overall Study|Adverse Event|2|||
147046108|NCT00839254|530328170|FG005|Overall Study|Adverse Event|1|||
147046109|NCT00839254|530328171|FG006|Overall Study|Adverse Event|0|||
147046110|NCT00839254|530328172|FG007|Overall Study|Adverse Event|1|||
147046111|NCT00839254|530328165|FG000|Overall Study|Withdrawal by Subject|87|||
147046112|NCT00839254|530328166|FG001|Overall Study|Withdrawal by Subject|53|||
147046113|NCT00839254|530328167|FG002|Overall Study|Withdrawal by Subject|54|||
147046114|NCT00839254|530328168|FG003|Overall Study|Withdrawal by Subject|32|||
147046115|NCT00839254|530328169|FG004|Overall Study|Withdrawal by Subject|27|||
147046116|NCT00839254|530328170|FG005|Overall Study|Withdrawal by Subject|15|||
147046117|NCT00839254|530328171|FG006|Overall Study|Withdrawal by Subject|22|||
147046118|NCT00839254|530328172|FG007|Overall Study|Withdrawal by Subject|9|||
147046119|NCT00839254|530328165|FG000|Overall Study|Wrong group allocation|0|||
147046120|NCT00839254|530328166|FG001|Overall Study|Wrong group allocation|0|||
147046121|NCT00839254|530328167|FG002|Overall Study|Wrong group allocation|0|||
147046122|NCT00839254|530328168|FG003|Overall Study|Wrong group allocation|0|||
147046123|NCT00839254|530328169|FG004|Overall Study|Wrong group allocation|0|||
147046124|NCT00839254|530328170|FG005|Overall Study|Wrong group allocation|0|||
147046125|NCT00839254|530328171|FG006|Overall Study|Wrong group allocation|1|||
147046126|NCT00839254|530328172|FG007|Overall Study|Wrong group allocation|0|||
147046127|NCT00839254|530328165|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
147046128|NCT00839254|530328166|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
147046129|NCT00839254|530328167|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
147046130|NCT00839254|530328168|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
147046131|NCT00839254|530328169|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
147046132|NCT00839254|530328170|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
147046133|NCT00839254|530328171|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
147046134|NCT00839254|530328172|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
147046135|NCT00839254|530328165|FG000|Overall Study|Withdrawn due to non-compliance|2|||
147046136|NCT00839254|530328166|FG001|Overall Study|Withdrawn due to non-compliance|0|||
147046137|NCT00839254|530328167|FG002|Overall Study|Withdrawn due to non-compliance|0|||
147046138|NCT00839254|530328168|FG003|Overall Study|Withdrawn due to non-compliance|0|||
147046139|NCT00839254|530328169|FG004|Overall Study|Withdrawn due to non-compliance|0|||
147046140|NCT00839254|530328170|FG005|Overall Study|Withdrawn due to non-compliance|0|||
147046141|NCT00839254|530328171|FG006|Overall Study|Withdrawn due to non-compliance|0|||
147046142|NCT00839254|530328172|FG007|Overall Study|Withdrawn due to non-compliance|0|||
147046143|NCT00839254|530328165|FG000|Overall Study|Lost to Follow-up|51|||
147046144|NCT00839254|530328166|FG001|Overall Study|Lost to Follow-up|30|||
147046145|NCT00839254|530328167|FG002|Overall Study|Lost to Follow-up|32|||
147046146|NCT00839254|530328168|FG003|Overall Study|Lost to Follow-up|24|||
147046147|NCT00839254|530328169|FG004|Overall Study|Lost to Follow-up|8|||
147046148|NCT00839254|530328170|FG005|Overall Study|Lost to Follow-up|8|||
147046149|NCT00839254|530328171|FG006|Overall Study|Lost to Follow-up|4|||
147046150|NCT00839254|530328172|FG007|Overall Study|Lost to Follow-up|2|||
147046151|NCT01823835|530328173|FG000|Overall Study|Adverse Event|0|||
147046152|NCT01823835|530328174|FG001|Overall Study|Adverse Event|0|||
147046153|NCT01823835|530328175|FG002|Overall Study|Adverse Event|0|||
147046154|NCT01823835|530328176|FG003|Overall Study|Adverse Event|0|||
147046155|NCT01823835|530328177|FG004|Overall Study|Adverse Event|1|||
147046156|NCT01823835|530328178|FG005|Overall Study|Adverse Event|0|||
147046157|NCT01823835|530328179|FG006|Overall Study|Adverse Event|1|||
147046158|NCT01823835|530328180|FG007|Overall Study|Adverse Event|0|||
147046159|NCT01823835|530328181|FG008|Overall Study|Adverse Event|0|||
147046160|NCT01823835|530328182|FG009|Overall Study|Adverse Event|0|||
147046161|NCT01823835|530328183|FG010|Overall Study|Adverse Event|1|||
147046162|NCT01823835|530328184|FG011|Overall Study|Adverse Event|2|||
147046163|NCT01823835|530328185|FG012|Overall Study|Adverse Event|0|||
147046164|NCT01823835|530328186|FG013|Overall Study|Adverse Event|0|||
147046165|NCT01823835|530328187|FG014|Overall Study|Adverse Event|0|||
147046166|NCT01823835|530328173|FG000|Overall Study|Physician Decision|0|||
147046167|NCT01823835|530328174|FG001|Overall Study|Physician Decision|0|||
147046168|NCT01823835|530328175|FG002|Overall Study|Physician Decision|0|||
147046169|NCT01823835|530328176|FG003|Overall Study|Physician Decision|0|||
147046170|NCT01823835|530328177|FG004|Overall Study|Physician Decision|0|||
147046171|NCT01823835|530328178|FG005|Overall Study|Physician Decision|0|||
147046172|NCT01823835|530328179|FG006|Overall Study|Physician Decision|0|||
147046173|NCT01823835|530328180|FG007|Overall Study|Physician Decision|0|||
147046174|NCT01823835|530328181|FG008|Overall Study|Physician Decision|0|||
147046175|NCT01823835|530328182|FG009|Overall Study|Physician Decision|0|||
147046176|NCT01823835|530328183|FG010|Overall Study|Physician Decision|0|||
147046177|NCT01823835|530328184|FG011|Overall Study|Physician Decision|2|||
147046178|NCT01823835|530328185|FG012|Overall Study|Physician Decision|0|||
147046179|NCT01823835|530328186|FG013|Overall Study|Physician Decision|0|||
147046180|NCT01823835|530328187|FG014|Overall Study|Physician Decision|0|||
147046181|NCT01823835|530328173|FG000|Overall Study|Progressive Disease|3|||
147046182|NCT01823835|530328174|FG001|Overall Study|Progressive Disease|4|||
147046183|NCT01823835|530328175|FG002|Overall Study|Progressive Disease|3|||
147046184|NCT01823835|530328176|FG003|Overall Study|Progressive Disease|6|||
147046185|NCT01823835|530328177|FG004|Overall Study|Progressive Disease|4|||
147046186|NCT01823835|530328178|FG005|Overall Study|Progressive Disease|6|||
147046187|NCT01823835|530328179|FG006|Overall Study|Progressive Disease|5|||
147046188|NCT01823835|530328180|FG007|Overall Study|Progressive Disease|3|||
147046189|NCT01823835|530328181|FG008|Overall Study|Progressive Disease|3|||
147046190|NCT01823835|530328182|FG009|Overall Study|Progressive Disease|18|||
146849933|NCT02101385|529618926|FG000|Follow up|PI requested closure of site|0|||
147046191|NCT01823835|530328183|FG010|Overall Study|Progressive Disease|8|||
147046192|NCT01823835|530328184|FG011|Overall Study|Progressive Disease|46|||
147046193|NCT01823835|530328185|FG012|Overall Study|Progressive Disease|18|||
147046194|NCT01823835|530328186|FG013|Overall Study|Progressive Disease|4|||
147046195|NCT01823835|530328187|FG014|Overall Study|Progressive Disease|6|||
147046196|NCT01823835|530328173|FG000|Overall Study|Study Termination|0|||
147046197|NCT01823835|530328174|FG001|Overall Study|Study Termination|0|||
147046198|NCT01823835|530328175|FG002|Overall Study|Study Termination|0|||
147046199|NCT01823835|530328176|FG003|Overall Study|Study Termination|0|||
147046200|NCT01823835|530328177|FG004|Overall Study|Study Termination|1|||
147046201|NCT01823835|530328178|FG005|Overall Study|Study Termination|0|||
147046202|NCT01823835|530328179|FG006|Overall Study|Study Termination|0|||
147046203|NCT01823835|530328180|FG007|Overall Study|Study Termination|0|||
147046204|NCT01823835|530328181|FG008|Overall Study|Study Termination|0|||
147046205|NCT01823835|530328182|FG009|Overall Study|Study Termination|0|||
147046206|NCT01823835|530328183|FG010|Overall Study|Study Termination|0|||
147046207|NCT01823835|530328184|FG011|Overall Study|Study Termination|1|||
147046208|NCT01823835|530328185|FG012|Overall Study|Study Termination|0|||
147046209|NCT01823835|530328186|FG013|Overall Study|Study Termination|0|||
147046210|NCT01823835|530328187|FG014|Overall Study|Study Termination|0|||
147046211|NCT01823835|530328173|FG000|Overall Study|Withdrawal by Subject|0|||
147046212|NCT01823835|530328174|FG001|Overall Study|Withdrawal by Subject|0|||
147046213|NCT01823835|530328175|FG002|Overall Study|Withdrawal by Subject|1|||
147046214|NCT01823835|530328176|FG003|Overall Study|Withdrawal by Subject|0|||
147046215|NCT01823835|530328177|FG004|Overall Study|Withdrawal by Subject|0|||
147046216|NCT01823835|530328178|FG005|Overall Study|Withdrawal by Subject|0|||
147046217|NCT01823835|530328179|FG006|Overall Study|Withdrawal by Subject|0|||
147046218|NCT01823835|530328180|FG007|Overall Study|Withdrawal by Subject|0|||
147046219|NCT01823835|530328181|FG008|Overall Study|Withdrawal by Subject|0|||
147046220|NCT01823835|530328182|FG009|Overall Study|Withdrawal by Subject|1|||
147046221|NCT01823835|530328183|FG010|Overall Study|Withdrawal by Subject|1|||
147046222|NCT01823835|530328184|FG011|Overall Study|Withdrawal by Subject|2|||
147046223|NCT01823835|530328185|FG012|Overall Study|Withdrawal by Subject|1|||
147046224|NCT01823835|530328186|FG013|Overall Study|Withdrawal by Subject|0|||
147046225|NCT01823835|530328187|FG014|Overall Study|Withdrawal by Subject|0|||
147046226|NCT01320150|530328188|FG000|Overall Study|Protocol Violation|15|||
147046227|NCT01320150|530328188|FG000|Overall Study|Withdrawal by Subject|5|||
147046228|NCT01320150|530328188|FG000|Overall Study|Death|2|||
147046229|NCT01320150|530328188|FG000|Overall Study|Lost to Follow-up|44|||
147046230|NCT06419907|530329543|FG000|Overall Study|Protocol Violation|0|||
147046231|NCT06419907|530329544|FG001|Overall Study|Protocol Violation|3|||
147046232|NCT06419907|530329545|FG002|Overall Study|Protocol Violation|0|||
147046233|NCT06419907|530329546|FG003|Overall Study|Protocol Violation|1|||
147046234|NCT06419907|530329543|FG000|Overall Study|Lost to Follow-up|0|||
147046235|NCT06419907|530329544|FG001|Overall Study|Lost to Follow-up|0|||
147046236|NCT06419907|530329545|FG002|Overall Study|Lost to Follow-up|2|||
147046237|NCT06419907|530329546|FG003|Overall Study|Lost to Follow-up|1|||
147046238|NCT03130777|530329547|FG000|Overall Study|Death|0|||
147046239|NCT03130777|530329548|FG001|Overall Study|Death|1|||
147046240|NCT03130777|530329547|FG000|Overall Study|Did not meet eligibility criteria|1|||
147046241|NCT03130777|530329548|FG001|Overall Study|Did not meet eligibility criteria|0|||
147046242|NCT02586688|530329549|FG000|Overall Study|Lost to Follow-up|2|||
147046243|NCT02586688|530329550|FG001|Overall Study|Lost to Follow-up|1|||
147046244|NCT02586688|530329549|FG000|Overall Study|Withdrawal by Subject|1|||
147046245|NCT02586688|530329550|FG001|Overall Study|Withdrawal by Subject|1|||
147046246|NCT02586688|530329549|FG000|Overall Study|Adverse Event|3|||
147046247|NCT02586688|530329550|FG001|Overall Study|Adverse Event|1|||
147046248|NCT04856917|530329551|FG000|Overall Study|Withdrawal by Subject|4|||
147046249|NCT04856917|530329552|FG001|Overall Study|Withdrawal by Subject|3|||
147046250|NCT04856917|530329553|FG002|Overall Study|Withdrawal by Subject|1|||
147046251|NCT04856917|530329551|FG000|Overall Study|Lost to Follow-up|3|||
147046252|NCT04856917|530329552|FG001|Overall Study|Lost to Follow-up|1|||
147046253|NCT04856917|530329553|FG002|Overall Study|Lost to Follow-up|1|||
147046254|NCT04856917|530329551|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
147046255|NCT04856917|530329552|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
147046256|NCT04856917|530329553|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
147046257|NCT04856917|530329551|FG000|Overall Study|Other|1|||
147046258|NCT04856917|530329552|FG001|Overall Study|Other|1|||
147046259|NCT04856917|530329553|FG002|Overall Study|Other|0|||
147046260|NCT06195930|530329559|FG000|Overall Study|Adverse Event|4|||
147046261|NCT03999996|530329560|FG000|Prior to Booster|Adverse Event|2|||
147046262|NCT03999996|530329561|FG001|Prior to Booster|Adverse Event|0|||
147046263|NCT03999996|530329562|FG002|Prior to Booster|Adverse Event|0|||
147046264|NCT03999996|530329563|FG003|Prior to Booster|Adverse Event|0|||
147046265|NCT03999996|530329560|FG000|Prior to Booster|Lost to Follow-up|17|||
147046266|NCT03999996|530329561|FG001|Prior to Booster|Lost to Follow-up|22|||
147046267|NCT03999996|530329562|FG002|Prior to Booster|Lost to Follow-up|0|||
147046268|NCT03999996|530329563|FG003|Prior to Booster|Lost to Follow-up|0|||
147046269|NCT03999996|530329560|FG000|Prior to Booster|Withdrawal of Consent|51|||
147046270|NCT03999996|530329561|FG001|Prior to Booster|Withdrawal of Consent|8|||
147046271|NCT03999996|530329562|FG002|Prior to Booster|Withdrawal of Consent|0|||
147046272|NCT03999996|530329563|FG003|Prior to Booster|Withdrawal of Consent|0|||
147046273|NCT03999996|530329560|FG000|Prior to Booster|Death|0|||
147046274|NCT03999996|530329561|FG001|Prior to Booster|Death|1|||
147046275|NCT03999996|530329562|FG002|Prior to Booster|Death|0|||
147046276|NCT03999996|530329563|FG003|Prior to Booster|Death|0|||
147046277|NCT03999996|530329560|FG000|Prior to Booster|Reason Not Specified|27|||
147046278|NCT03999996|530329561|FG001|Prior to Booster|Reason Not Specified|4|||
147046279|NCT03999996|530329562|FG002|Prior to Booster|Reason Not Specified|0|||
147046280|NCT03999996|530329563|FG003|Prior to Booster|Reason Not Specified|0|||
147046281|NCT03999996|530329560|FG000|Booster Phase|Lost to Follow-up|0|||
147046282|NCT03999996|530329561|FG001|Booster Phase|Lost to Follow-up|0|||
147046283|NCT03999996|530329562|FG002|Booster Phase|Lost to Follow-up|3|||
147046284|NCT03999996|530329563|FG003|Booster Phase|Lost to Follow-up|3|||
147046285|NCT03999996|530329560|FG000|Booster Phase|Withdrawal of Consent|0|||
147046286|NCT03999996|530329561|FG001|Booster Phase|Withdrawal of Consent|0|||
147046287|NCT03999996|530329562|FG002|Booster Phase|Withdrawal of Consent|0|||
147046288|NCT03999996|530329563|FG003|Booster Phase|Withdrawal of Consent|1|||
147046289|NCT03999996|530329560|FG000|Booster Phase|Reason Not Specified|0|||
147046290|NCT03999996|530329561|FG001|Booster Phase|Reason Not Specified|0|||
147046291|NCT03999996|530329562|FG002|Booster Phase|Reason Not Specified|0|||
147046292|NCT03999996|530329563|FG003|Booster Phase|Reason Not Specified|1|||
147046293|NCT03690388|530329564|FG000|Overall Study|Adverse Event|8|||
147046294|NCT03690388|530329565|FG001|Overall Study|Adverse Event|1|||
147046295|NCT03690388|530329564|FG000|Overall Study|Radiographic Progression|14|||
147046296|NCT03690388|530329565|FG001|Overall Study|Radiographic Progression|29|||
147046297|NCT03690388|530329564|FG000|Overall Study|Clinical deterioration|10|||
147046298|NCT03690388|530329565|FG001|Overall Study|Clinical deterioration|6|||
147046299|NCT03690388|530329564|FG000|Overall Study|Withdrawal by Subject|2|||
147046300|NCT03690388|530329565|FG001|Overall Study|Withdrawal by Subject|0|||
147046301|NCT03690388|530329564|FG000|Overall Study|Lack of Efficacy|1|||
147046302|NCT03690388|530329565|FG001|Overall Study|Lack of Efficacy|0|||
147046303|NCT03690388|530329564|FG000|Overall Study|Lost to Follow-up|1|||
147046304|NCT03690388|530329565|FG001|Overall Study|Lost to Follow-up|0|||
147046305|NCT00266630|530329570|FG000|Overall Study|Adverse Event|8|||
147046306|NCT00266630|530329571|FG001|Overall Study|Adverse Event|6|||
147046307|NCT00266630|530329570|FG000|Overall Study|Lack of Efficacy|1|||
147046308|NCT00266630|530329571|FG001|Overall Study|Lack of Efficacy|4|||
147046309|NCT00266630|530329570|FG000|Overall Study|Entry Criteria not met|1|||
147046310|NCT00266630|530329571|FG001|Overall Study|Entry Criteria not met|0|||
147046311|NCT00266630|530329570|FG000|Overall Study|Protocol Violation|1|||
147046312|NCT00266630|530329571|FG001|Overall Study|Protocol Violation|3|||
147046313|NCT00266630|530329570|FG000|Overall Study|Physician Decision|1|||
147046314|NCT00266630|530329571|FG001|Overall Study|Physician Decision|2|||
147046315|NCT00266630|530329570|FG000|Overall Study|Withdrawal by Subject|10|||
147046316|NCT00266630|530329571|FG001|Overall Study|Withdrawal by Subject|2|||
147046317|NCT00266630|530329570|FG000|Overall Study|Lost to Follow-up|1|||
147046318|NCT00266630|530329571|FG001|Overall Study|Lost to Follow-up|0|||
147046319|NCT00266630|530329570|FG000|Overall Study|Other|19|||
147046320|NCT00266630|530329571|FG001|Overall Study|Other|11|||
147046321|NCT05377749|530329576|FG000|3 Weeks|Lost to Follow-up|2|||
147046322|NCT05377749|530329577|FG001|3 Weeks|Lost to Follow-up|4|||
147046323|NCT05377749|530329576|FG000|3 Weeks|Withdrawal by Subject|1|||
147046324|NCT05377749|530329577|FG001|3 Weeks|Withdrawal by Subject|1|||
147046325|NCT01720225|530329580|FG000|Overall Study|Withdrawal by Subject|0|||
147046326|NCT01720225|530329581|FG001|Overall Study|Withdrawal by Subject|1|||
147046327|NCT01720225|530329580|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
147046328|NCT01720225|530329581|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
147046329|NCT00661193|530329585|FG000|Overall Study|Adverse Event|2|||
147046330|NCT00661193|530329586|FG001|Overall Study|Adverse Event|1|||
147046331|NCT00661193|530329585|FG000|Overall Study|Withdrawal by Subject|3|||
147046332|NCT00661193|530329586|FG001|Overall Study|Withdrawal by Subject|1|||
147046333|NCT00661193|530329585|FG000|Overall Study|Progression|27|||
147046334|NCT00661193|530329586|FG001|Overall Study|Progression|24|||
147046335|NCT00661193|530329585|FG000|Overall Study|Not protocol specified|1|||
147046336|NCT00661193|530329586|FG001|Overall Study|Not protocol specified|0|||
147046337|NCT03280264|530329587|FG000|Overall Study|Adverse Event|1|||
147046338|NCT03280264|530329587|FG000|Overall Study|Physician Decision|1|||
147046339|NCT03280264|530329587|FG000|Overall Study|Withdrawal by Subject|1|||
147046340|NCT00524420|530329589|FG000|Overall Study|Lack of Efficacy|1|||
147046341|NCT00524420|530329590|FG001|Overall Study|Lack of Efficacy|0|||
147046342|NCT03934541|530329603|FG000|Overall Study|Study Terminated by Sponsor|0|||
147046343|NCT03934541|530329604|FG001|Overall Study|Study Terminated by Sponsor|1|||
147046344|NCT03934541|530329605|FG002|Overall Study|Study Terminated by Sponsor|0|||
147046345|NCT03934541|530329606|FG003|Overall Study|Study Terminated by Sponsor|0|||
147046346|NCT02673775|530329607|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
147046347|NCT02673775|530329608|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
147046348|NCT02673775|530329607|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
147046349|NCT02673775|530329608|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
147046350|NCT02673775|530329607|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
147046351|NCT02673775|530329608|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
147046352|NCT02673775|530329607|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
147046353|NCT02673775|530329608|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
147046354|NCT00535405|530329609|FG000|Overall Study|Adverse Event|6|||
147046355|NCT00535405|530329610|FG001|Overall Study|Adverse Event|8|||
147046356|NCT00535405|530329611|FG002|Overall Study|Adverse Event|3|||
147046357|NCT00535405|530329612|FG003|Overall Study|Adverse Event|8|||
147046358|NCT00535405|530329613|FG004|Overall Study|Adverse Event|6|||
147046359|NCT00535405|530329609|FG000|Overall Study|Lost to Follow-up|1|||
147046360|NCT00535405|530329610|FG001|Overall Study|Lost to Follow-up|3|||
147046361|NCT00535405|530329611|FG002|Overall Study|Lost to Follow-up|3|||
147046362|NCT00535405|530329612|FG003|Overall Study|Lost to Follow-up|2|||
147046363|NCT00535405|530329613|FG004|Overall Study|Lost to Follow-up|1|||
147046364|NCT00535405|530329609|FG000|Overall Study|Physician Decision|3|||
147046365|NCT00535405|530329610|FG001|Overall Study|Physician Decision|2|||
147046366|NCT00535405|530329611|FG002|Overall Study|Physician Decision|0|||
147046367|NCT00535405|530329612|FG003|Overall Study|Physician Decision|1|||
147046368|NCT00535405|530329613|FG004|Overall Study|Physician Decision|1|||
147046369|NCT00535405|530329609|FG000|Overall Study|Protocol Violation|2|||
147046370|NCT00535405|530329610|FG001|Overall Study|Protocol Violation|2|||
147046371|NCT00535405|530329611|FG002|Overall Study|Protocol Violation|2|||
147046372|NCT00535405|530329612|FG003|Overall Study|Protocol Violation|1|||
147046373|NCT00535405|530329613|FG004|Overall Study|Protocol Violation|0|||
147046374|NCT00535405|530329609|FG000|Overall Study|Withdrawal by Subject|5|||
147046375|NCT00535405|530329610|FG001|Overall Study|Withdrawal by Subject|11|||
147046376|NCT00535405|530329611|FG002|Overall Study|Withdrawal by Subject|10|||
147046377|NCT00535405|530329612|FG003|Overall Study|Withdrawal by Subject|10|||
147046378|NCT00535405|530329613|FG004|Overall Study|Withdrawal by Subject|8|||
147046379|NCT03519087|530329614|FG000|Clinic Evaluation|Physician Decision|15|||
147046380|NCT03519087|530329615|FG001|Clinic Evaluation|Physician Decision|18|||
147046381|NCT03519087|530329616|FG002|Clinic Evaluation|Physician Decision|0|||
147046382|NCT03519087|530329617|FG003|Clinic Evaluation|Physician Decision|0|||
147046383|NCT03519087|530329618|FG004|Clinic Evaluation|Physician Decision|0|||
147046384|NCT03519087|530329614|FG000|Clinic Evaluation|Protocol Violation|1|||
147046385|NCT03519087|530329615|FG001|Clinic Evaluation|Protocol Violation|0|||
147046386|NCT03519087|530329616|FG002|Clinic Evaluation|Protocol Violation|0|||
147046387|NCT03519087|530329617|FG003|Clinic Evaluation|Protocol Violation|0|||
147046388|NCT03519087|530329618|FG004|Clinic Evaluation|Protocol Violation|0|||
147046389|NCT03519087|530329614|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
147046390|NCT03519087|530329615|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
147046391|NCT03519087|530329616|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
147046392|NCT03519087|530329617|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
147046393|NCT03519087|530329618|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
147046394|NCT03519087|530329614|FG000|Re-randomization for Treatment|Not appropriate|2|||
147046395|NCT03519087|530329615|FG001|Re-randomization for Treatment|Not appropriate|3|||
147046396|NCT03519087|530329616|FG002|Re-randomization for Treatment|Not appropriate|0|||
147046397|NCT03519087|530329617|FG003|Re-randomization for Treatment|Not appropriate|0|||
147046398|NCT03519087|530329618|FG004|Re-randomization for Treatment|Not appropriate|0|||
146849934|NCT02101385|529618927|FG001|Follow up|PI requested closure of site|5|||
146849935|NCT02432196|529618928|FG000|Overall Study|Exit - did not receive study device|1|||
146849936|NCT02432196|529618928|FG000|Overall Study|Death|2|||
146849937|NCT02432196|529618928|FG000|Overall Study|Reoperation|3|||
146849938|NCT01905150|529618930|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
146849939|NCT01905150|529618931|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
146849940|NCT03738423|529618936|FG000|Overall Study|Withdrawal by Subject|9|||
146849941|NCT03738423|529618937|FG001|Overall Study|Withdrawal by Subject|12|||
146849942|NCT03738423|529618938|FG002|Overall Study|Withdrawal by Subject|9|||
146962574|NCT04579666|530023243|FG002|RTP (Up to Week 52)|Physician Decision|0|||
146962575|NCT04579666|530023244|FG003|RTP (Up to Week 52)|Physician Decision|0|||
146962576|NCT04579666|530023241|FG000|RTP (Up to Week 52)|Progressive disease|1|||
146962577|NCT04579666|530023242|FG001|RTP (Up to Week 52)|Progressive disease|0|||
146962578|NCT04579666|530023243|FG002|RTP (Up to Week 52)|Progressive disease|0|||
146962579|NCT04579666|530023244|FG003|RTP (Up to Week 52)|Progressive disease|0|||
146962580|NCT04579666|530023241|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
146962581|NCT04579666|530023242|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
146962582|NCT04579666|530023243|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
146962583|NCT04579666|530023244|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
146962584|NCT04579666|530023241|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
146962585|NCT04579666|530023242|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
146962586|NCT04579666|530023243|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
147046399|NCT03519087|530329614|FG000|Laboratory Testing|Lost to Follow-up|0|||
146962587|NCT04579666|530023244|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
146962588|NCT04579666|530023241|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
146962589|NCT04579666|530023242|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
146962590|NCT04579666|530023243|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
146962591|NCT04579666|530023244|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
146962592|NCT04579666|530023241|FG000|RTP (Up to Week 52)|Other|2|||
147046400|NCT03519087|530329615|FG001|Laboratory Testing|Lost to Follow-up|0|||
147046401|NCT03519087|530329616|FG002|Laboratory Testing|Lost to Follow-up|2|||
147046402|NCT03519087|530329617|FG003|Laboratory Testing|Lost to Follow-up|3|||
147046403|NCT03519087|530329618|FG004|Laboratory Testing|Lost to Follow-up|6|||
147046404|NCT03519087|530329614|FG000|Laboratory Testing|Protocol Violation|0|||
147046405|NCT03519087|530329615|FG001|Laboratory Testing|Protocol Violation|0|||
147046406|NCT03519087|530329616|FG002|Laboratory Testing|Protocol Violation|0|||
147046407|NCT03519087|530329617|FG003|Laboratory Testing|Protocol Violation|1|||
147046408|NCT03519087|530329618|FG004|Laboratory Testing|Protocol Violation|0|||
147046409|NCT00796757|530329620|FG000|Overall Study|Withdrawal by Subject|14|||
147046410|NCT00796757|530329620|FG000|Overall Study|Death|61|||
147046411|NCT00796757|530329620|FG000|Overall Study|Protocol Violation|1|||
147046412|NCT00796757|530329620|FG000|Overall Study|Participant noncompliance|1|||
147046413|NCT00796757|530329620|FG000|Overall Study|Investigator's decision|2|||
147046414|NCT00796757|530329620|FG000|Overall Study|Other|7|||
147046415|NCT00879086|530329625|FG000|Overall Study|Adverse Event|3|||
147046416|NCT00879086|530329626|FG001|Overall Study|Adverse Event|15|||
147046417|NCT00879086|530329625|FG000|Overall Study|Participant choice|2|||
147046418|NCT00879086|530329626|FG001|Overall Study|Participant choice|2|||
147046419|NCT00879086|530329625|FG000|Overall Study|Progression of disease|40|||
147046420|NCT00879086|530329626|FG001|Overall Study|Progression of disease|26|||
147046421|NCT00879086|530329625|FG000|Overall Study|Withdrawal of consent|2|||
147046422|NCT00879086|530329626|FG001|Overall Study|Withdrawal of consent|1|||
147046423|NCT00879086|530329625|FG000|Overall Study|Other|4|||
147046424|NCT00879086|530329626|FG001|Overall Study|Other|6|||
147046425|NCT00879086|530329625|FG000|Overall Study|Death|1|||
147046426|NCT00879086|530329626|FG001|Overall Study|Death|2|||
147046427|NCT01330303|530329627|FG000|Period 1|Adverse Event|1|||
147046428|NCT01330303|530329628|FG001|Period 1|Adverse Event|0|||
147046429|NCT01330303|530329627|FG000|Period 1|Protocol Violation|0|||
147046430|NCT01330303|530329628|FG001|Period 1|Protocol Violation|1|||
147046431|NCT01330303|530329627|FG000|Period 1|Withdrawal by Subject|0|||
147046432|NCT01330303|530329628|FG001|Period 1|Withdrawal by Subject|1|||
147046433|NCT00489827|530329631|FG000|Overall Study|Intraoperative exclusion criteria|1|||
147046434|NCT00489827|530329632|FG001|Overall Study|Intraoperative exclusion criteria|1|||
147046435|NCT00489827|530329631|FG000|Overall Study|Intraoperative exclusion criteria|1|||
147046436|NCT00489827|530329632|FG001|Overall Study|Intraoperative exclusion criteria|1|||
147046437|NCT00625872|530329633|FG000|Overall Study|Withdrawal by Subject|1|||
147046438|NCT00625872|530329634|FG001|Overall Study|Withdrawal by Subject|0|||
147046439|NCT00625872|530329633|FG000|Overall Study|Does not meet inclusion criteria|1|||
147046440|NCT00625872|530329634|FG001|Overall Study|Does not meet inclusion criteria|0|||
147046441|NCT00625872|530329633|FG000|Overall Study|Terminated by sponsor|2|||
147046442|NCT00625872|530329634|FG001|Overall Study|Terminated by sponsor|5|||
147046443|NCT00625872|530329633|FG000|Overall Study|Randomized but not treated|0|||
147046444|NCT00625872|530329634|FG001|Overall Study|Randomized but not treated|1|||
147046445|NCT01512160|530329635|FG000|Overall Study|Lost to Follow-up|1|||
147046446|NCT01512160|530329636|FG001|Overall Study|Lost to Follow-up|0|||
147046447|NCT01512160|530329637|FG002|Overall Study|Lost to Follow-up|0|||
147046448|NCT01512160|530329638|FG003|Overall Study|Lost to Follow-up|0|||
147046449|NCT01512160|530329635|FG000|Overall Study|Withdrawal by Subject|1|||
147046450|NCT01512160|530329636|FG001|Overall Study|Withdrawal by Subject|0|||
147046451|NCT01512160|530329637|FG002|Overall Study|Withdrawal by Subject|0|||
147046452|NCT01512160|530329638|FG003|Overall Study|Withdrawal by Subject|1|||
147046453|NCT05022212|530329639|FG000|Overall Study|Lost to Follow-up|0|||
147046454|NCT05022212|530329640|FG001|Overall Study|Lost to Follow-up|2|||
147046455|NCT02729909|530329641|FG000|Overall Study|Lost to Follow-up|0|||
147046456|NCT02729909|530329642|FG001|Overall Study|Lost to Follow-up|1|||
147046457|NCT02729909|530329641|FG000|Overall Study|Lack of Efficacy|0|||
147046458|NCT02729909|530329642|FG001|Overall Study|Lack of Efficacy|2|||
147046459|NCT02729909|530329641|FG000|Overall Study|Significant Protocol Deviation|0|||
147046460|NCT02729909|530329642|FG001|Overall Study|Significant Protocol Deviation|2|||
147046461|NCT02729909|530329641|FG000|Overall Study|Voluntary Withdrawal|1|||
147046462|NCT02729909|530329642|FG001|Overall Study|Voluntary Withdrawal|0|||
147046463|NCT01625091|530329644|FG000|Intervention|Death|1|||
147046464|NCT01625091|530329645|FG001|Intervention|Death|1|||
147046465|NCT01625091|530329644|FG000|Intervention|Withdrawal by Subject|4|||
147046466|NCT01625091|530329645|FG001|Intervention|Withdrawal by Subject|1|||
147046467|NCT01625091|530329644|FG000|Intervention|Adverse Event|0|||
147046468|NCT01625091|530329645|FG001|Intervention|Adverse Event|2|||
147046469|NCT01625091|530329644|FG000|Intervention|Lost to Follow-up|4|||
147046470|NCT01625091|530329645|FG001|Intervention|Lost to Follow-up|4|||
147046471|NCT01625091|530329644|FG000|Intervention|Study termination|2|||
147046472|NCT01625091|530329645|FG001|Intervention|Study termination|3|||
147046473|NCT01625091|530329644|FG000|Post-intervention|Death|0|||
147046474|NCT01625091|530329645|FG001|Post-intervention|Death|1|||
147046475|NCT01625091|530329644|FG000|Post-intervention|Lost to Follow-up|2|||
147046476|NCT01625091|530329645|FG001|Post-intervention|Lost to Follow-up|0|||
147046477|NCT01625091|530329644|FG000|Post-intervention|Study termination|2|||
147046478|NCT01625091|530329645|FG001|Post-intervention|Study termination|1|||
147046479|NCT01547390|530329652|FG000|Overall Study|Withdrawal by Subject|10|||
147046480|NCT01547390|530329653|FG001|Overall Study|Withdrawal by Subject|7|||
147046481|NCT01547390|530329652|FG000|Overall Study|termination of pregnancy|0|||
147046482|NCT01547390|530329653|FG001|Overall Study|termination of pregnancy|1|||
147046483|NCT01547390|530329652|FG000|Overall Study|Lost to Follow-up|0|||
147046484|NCT01547390|530329653|FG001|Overall Study|Lost to Follow-up|2|||
147046485|NCT01547390|530329652|FG000|Overall Study|Adverse Event|3|||
147046486|NCT01547390|530329653|FG001|Overall Study|Adverse Event|0|||
147046487|NCT01959295|530329656|FG000|Overall Study|Adverse Event|2|||
147046488|NCT01959295|530329657|FG001|Overall Study|Adverse Event|0|||
147046489|NCT01959295|530329656|FG000|Overall Study|Lost to Follow-up|0|||
147046490|NCT01959295|530329657|FG001|Overall Study|Lost to Follow-up|2|||
147046491|NCT01959295|530329656|FG000|Overall Study|Physician Decision|2|||
147046492|NCT01959295|530329657|FG001|Overall Study|Physician Decision|3|||
147046493|NCT01959295|530329656|FG000|Overall Study|Protocol Violation|16|||
147046494|NCT01959295|530329657|FG001|Overall Study|Protocol Violation|5|||
147046495|NCT01959295|530329656|FG000|Overall Study|Withdrawal by Subject|3|||
147046496|NCT01959295|530329657|FG001|Overall Study|Withdrawal by Subject|1|||
147046497|NCT01959295|530329656|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
147046498|NCT01959295|530329657|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
147046499|NCT04917861|530329659|FG000|Main Study (196 Days)|Adverse Event|0|||
147046500|NCT04917861|530329660|FG001|Main Study (196 Days)|Adverse Event|1|||
147046501|NCT04917861|530329661|FG002|Main Study (196 Days)|Adverse Event|0|||
147046502|NCT04917861|530329662|FG003|Main Study (196 Days)|Adverse Event|0|||
147046503|NCT04917861|530329659|FG000|Main Study (196 Days)|Death|0|||
147046504|NCT04917861|530329660|FG001|Main Study (196 Days)|Death|0|||
147046505|NCT04917861|530329661|FG002|Main Study (196 Days)|Death|0|||
147046506|NCT04917861|530329662|FG003|Main Study (196 Days)|Death|1|||
147046507|NCT04917861|530329659|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
147046508|NCT04917861|530329660|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
147046509|NCT04917861|530329661|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
147046510|NCT04917861|530329662|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
147046511|NCT04917861|530329659|FG000|Main Study (196 Days)|Physician Decision|0|||
147046512|NCT04917861|530329660|FG001|Main Study (196 Days)|Physician Decision|0|||
147046513|NCT04917861|530329661|FG002|Main Study (196 Days)|Physician Decision|0|||
147046514|NCT04917861|530329662|FG003|Main Study (196 Days)|Physician Decision|1|||
147046515|NCT04917861|530329659|FG000|Main Study (196 Days)|Pregnancy|1|||
147046516|NCT04917861|530329660|FG001|Main Study (196 Days)|Pregnancy|1|||
147046517|NCT04917861|530329661|FG002|Main Study (196 Days)|Pregnancy|0|||
147046518|NCT04917861|530329662|FG003|Main Study (196 Days)|Pregnancy|0|||
147046519|NCT04917861|530329659|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
147046520|NCT04917861|530329660|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
147046521|NCT04917861|530329661|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
147046522|NCT04917861|530329662|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
147046523|NCT04917861|530329659|FG000|Main Study (196 Days)|Other Than Specified|1|||
147046524|NCT04917861|530329660|FG001|Main Study (196 Days)|Other Than Specified|0|||
147046525|NCT04917861|530329661|FG002|Main Study (196 Days)|Other Than Specified|1|||
147046526|NCT04917861|530329662|FG003|Main Study (196 Days)|Other Than Specified|2|||
147046527|NCT04917861|530329659|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
147046528|NCT04917861|530329660|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
147046529|NCT04917861|530329661|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
147046530|NCT04917861|530329662|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
147046531|NCT04917861|530329659|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
147046532|NCT04917861|530329660|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
147046533|NCT04917861|530329661|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
147046534|NCT04917861|530329662|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
147046535|NCT04917861|530329659|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
147046536|NCT04917861|530329660|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
147046537|NCT04917861|530329661|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
147046538|NCT04917861|530329662|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
147046539|NCT04917861|530329659|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
147046540|NCT04917861|530329660|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
147046541|NCT04917861|530329661|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
147046542|NCT04917861|530329662|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
147046543|NCT04917861|530329659|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
147046544|NCT04917861|530329660|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
147046545|NCT04917861|530329661|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
147046546|NCT04917861|530329662|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
147046547|NCT04917861|530329659|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
147046548|NCT04917861|530329660|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
147046549|NCT04917861|530329661|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
147046550|NCT04917861|530329662|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
147046551|NCT01128179|530329663|FG000|Overall Study|Death|1|||
147046552|NCT01128179|530329664|FG001|Overall Study|Death|0|||
147046553|NCT01128179|530329663|FG000|Overall Study|Protocol Violation|1|||
147046554|NCT01128179|530329664|FG001|Overall Study|Protocol Violation|0|||
147046555|NCT02694328|530329665|FG000|Overall Study|Adverse Event|27|||
147046556|NCT02694328|530329666|FG001|Overall Study|Adverse Event|33|||
147046557|NCT02694328|530329665|FG000|Overall Study|Withdrawal by Subject|27|||
147046558|NCT02694328|530329666|FG001|Overall Study|Withdrawal by Subject|23|||
147046559|NCT02694328|530329665|FG000|Overall Study|Lost to Follow-up|26|||
147046560|NCT02694328|530329666|FG001|Overall Study|Lost to Follow-up|22|||
147046561|NCT02694328|530329665|FG000|Overall Study|Noncompliant with study drug|11|||
147046562|NCT02694328|530329666|FG001|Overall Study|Noncompliant with study drug|8|||
147046563|NCT02694328|530329665|FG000|Overall Study|Incarceration|1|||
147046564|NCT02694328|530329666|FG001|Overall Study|Incarceration|1|||
147046565|NCT02694328|530329665|FG000|Overall Study|Lack of Efficacy|1|||
147046566|NCT02694328|530329666|FG001|Overall Study|Lack of Efficacy|2|||
147046567|NCT02694328|530329665|FG000|Overall Study|Pregnancy|1|||
147046568|NCT02694328|530329666|FG001|Overall Study|Pregnancy|1|||
147046569|NCT02694328|530329665|FG000|Overall Study|Protocol Violation|6|||
147046570|NCT02694328|530329666|FG001|Overall Study|Protocol Violation|5|||
147046571|NCT02694328|530329665|FG000|Overall Study|Abnormal Laboratory Value|0|||
147046572|NCT02694328|530329666|FG001|Overall Study|Abnormal Laboratory Value|3|||
147046573|NCT00720382|530329670|FG000|Overall Study|Adverse Event|54|||
147046574|NCT00720382|530329671|FG001|Overall Study|Adverse Event|17|||
147046575|NCT00720382|530329670|FG000|Overall Study|Lack of Efficacy|18|||
147046576|NCT00720382|530329671|FG001|Overall Study|Lack of Efficacy|7|||
147046577|NCT00720382|530329670|FG000|Overall Study|Non-Compliance|15|||
147046578|NCT00720382|530329671|FG001|Overall Study|Non-Compliance|5|||
147046579|NCT00720382|530329670|FG000|Overall Study|Withdrawal by Subject|47|||
147046580|NCT00720382|530329671|FG001|Overall Study|Withdrawal by Subject|11|||
147046581|NCT00720382|530329670|FG000|Overall Study|Lost to Follow-up|28|||
147046582|NCT00720382|530329671|FG001|Overall Study|Lost to Follow-up|14|||
147046583|NCT00720382|530329670|FG000|Overall Study|administrative|14|||
147046584|NCT00720382|530329671|FG001|Overall Study|administrative|5|||
147046585|NCT05192889|530329672|FG000|Block 1: All Eligible Patients|Death|2|||
147046586|NCT05192889|530329673|FG001|Block 1: All Eligible Patients|Death|0|||
147046587|NCT05192889|530329674|FG002|Block 1: All Eligible Patients|Death|0|||
147046588|NCT05192889|530329672|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
147046589|NCT05192889|530329673|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
147046590|NCT05192889|530329674|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
147046591|NCT05192889|530329672|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
147046592|NCT05192889|530329673|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
147046593|NCT05192889|530329674|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
147046594|NCT05221320|530331640|FG000|Overall Study|Lack of Efficacy|3|||
147046595|NCT05221320|530331641|FG001|Overall Study|Lack of Efficacy|7|||
147046596|NCT05221320|530331642|FG002|Overall Study|Lack of Efficacy|10|||
147046597|NCT05221320|530331643|FG003|Overall Study|Lack of Efficacy|1|||
147046598|NCT05221320|530331644|FG004|Overall Study|Lack of Efficacy|0|||
147046599|NCT05221320|530331645|FG005|Overall Study|Lack of Efficacy|0|||
147046600|NCT05221320|530331640|FG000|Overall Study|Physician Decision|1|||
147046601|NCT05221320|530331641|FG001|Overall Study|Physician Decision|0|||
147046602|NCT05221320|530331642|FG002|Overall Study|Physician Decision|3|||
147046603|NCT05221320|530331643|FG003|Overall Study|Physician Decision|1|||
147046604|NCT05221320|530331644|FG004|Overall Study|Physician Decision|0|||
147046605|NCT05221320|530331645|FG005|Overall Study|Physician Decision|0|||
147046606|NCT05221320|530331640|FG000|Overall Study|Withdrawal by Subject|0|||
147046607|NCT05221320|530331641|FG001|Overall Study|Withdrawal by Subject|3|||
147046608|NCT05221320|530331642|FG002|Overall Study|Withdrawal by Subject|1|||
147046609|NCT05221320|530331643|FG003|Overall Study|Withdrawal by Subject|0|||
147046610|NCT05221320|530331644|FG004|Overall Study|Withdrawal by Subject|0|||
147046611|NCT05221320|530331645|FG005|Overall Study|Withdrawal by Subject|0|||
147046612|NCT05221320|530331640|FG000|Overall Study|Death|0|||
147046613|NCT05221320|530331641|FG001|Overall Study|Death|5|||
147046614|NCT05221320|530331642|FG002|Overall Study|Death|6|||
147046615|NCT05221320|530331643|FG003|Overall Study|Death|0|||
147046616|NCT05221320|530331644|FG004|Overall Study|Death|1|||
147046617|NCT05221320|530331645|FG005|Overall Study|Death|0|||
147046618|NCT06473519|530331646|FG000|Overall Study|Lost to Follow-up|2|||
147046619|NCT06473519|530331647|FG001|Overall Study|Lost to Follow-up|5|||
147046620|NCT06473519|530331646|FG000|Overall Study|Withdrawal by Subject|1|||
147046621|NCT06473519|530331647|FG001|Overall Study|Withdrawal by Subject|4|||
147046622|NCT06473519|530331646|FG000|Overall Study|Randomized but not vaccinated|1|||
147046623|NCT06473519|530331647|FG001|Overall Study|Randomized but not vaccinated|2|||
147046624|NCT02514447|530331651|FG000|Overall Study|Withdrawal by Subject|3|||
147046625|NCT02514447|530331652|FG001|Overall Study|Withdrawal by Subject|1|||
147046626|NCT02514447|530331653|FG002|Overall Study|Withdrawal by Subject|1|||
147046627|NCT02514447|530331654|FG003|Overall Study|Withdrawal by Subject|0|||
147046628|NCT02514447|530331655|FG004|Overall Study|Withdrawal by Subject|0|||
147046629|NCT02514447|530331656|FG005|Overall Study|Withdrawal by Subject|0|||
147046630|NCT02514447|530331657|FG006|Overall Study|Withdrawal by Subject|0|||
147046631|NCT02514447|530331658|FG007|Overall Study|Withdrawal by Subject|1|||
146962593|NCT04579666|530023242|FG001|RTP (Up to Week 52)|Other|0|||
146962594|NCT04579666|530023243|FG002|RTP (Up to Week 52)|Other|0|||
146962595|NCT04579666|530023244|FG003|RTP (Up to Week 52)|Other|0|||
146962596|NCT04579666|530023241|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
146962597|NCT04579666|530023242|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
146962598|NCT04579666|530023243|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
146962599|NCT04579666|530023244|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
146962600|NCT04579666|530023241|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
146962601|NCT04579666|530023242|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
146962602|NCT04579666|530023243|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
146962603|NCT04579666|530023244|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
146962604|NCT04579666|530023241|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
146962605|NCT04579666|530023242|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
146962606|NCT04579666|530023243|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
146962607|NCT04579666|530023244|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
146962608|NCT04579666|530023241|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
146962609|NCT04579666|530023242|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
146962610|NCT04579666|530023243|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
146962611|NCT04579666|530023244|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
146962612|NCT04579666|530023241|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
146962613|NCT04579666|530023242|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
146962614|NCT04579666|530023243|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
146962615|NCT04579666|530023244|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
146962616|NCT01982942|530023245|FG000|Overall Study|Adverse Event|10|||
146962617|NCT01982942|530023246|FG001|Overall Study|Adverse Event|5|||
146962618|NCT01982942|530023245|FG000|Overall Study|Lost to Follow-up|4|||
146962619|NCT01982942|530023246|FG001|Overall Study|Lost to Follow-up|3|||
146962620|NCT01982942|530023245|FG000|Overall Study|Multiple sclerosis progression|3|||
146962621|NCT01982942|530023246|FG001|Overall Study|Multiple sclerosis progression|2|||
146962622|NCT01982942|530023245|FG000|Overall Study|Wanted to try therapy not permitted|1|||
146962623|NCT01982942|530023246|FG001|Overall Study|Wanted to try therapy not permitted|0|||
146962624|NCT01982942|530023245|FG000|Overall Study|Subject declined future visits|0|||
146962625|NCT01982942|530023246|FG001|Overall Study|Subject declined future visits|1|||
146962626|NCT01982942|530023245|FG000|Overall Study|Left geographical area|2|||
146962627|NCT01982942|530023246|FG001|Overall Study|Left geographical area|0|||
146962628|NCT01982942|530023245|FG000|Overall Study|Too many pills|1|||
146962629|NCT01982942|530023246|FG001|Overall Study|Too many pills|0|||
146962630|NCT01982942|530023245|FG000|Overall Study|MS Relapse|0|||
146962631|NCT01982942|530023246|FG001|Overall Study|MS Relapse|1|||
146962632|NCT01982942|530023245|FG000|Overall Study|Chose to join a stem cell trial|0|||
146962633|NCT01982942|530023246|FG001|Overall Study|Chose to join a stem cell trial|1|||
146962634|NCT01982942|530023245|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
146962635|NCT01982942|530023246|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
146962636|NCT00465101|530023249|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
146962637|NCT00465101|530023249|FG000|Overall Study|Change in health precluded follow up|4|||
146962638|NCT00465101|530023249|FG000|Overall Study|Did not meet study criteria|4|||
146962639|NCT00465101|530023249|FG000|Overall Study|Lost to Follow-up|5|||
146962640|NCT00465101|530023249|FG000|Overall Study|Other|6|||
146962641|NCT00465101|530023249|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
146962642|NCT00465101|530023249|FG000|Overall Study|Patient postponed procedure|1|||
146962643|NCT00465101|530023249|FG000|Overall Study|Site closed due to IRB expiration|1|||
146962644|NCT00465101|530023249|FG000|Overall Study|Unable to obtain IRB approval|1|||
146962645|NCT00465101|530023249|FG000|Overall Study|Death|3|||
146962646|NCT00465101|530023249|FG000|Overall Study|Withdrawal by Subject|25|||
146962647|NCT00465101|530023249|FG000|Overall Study|Physician Decision|1|||
146962648|NCT00465101|530023249|FG000|Overall Study|Withdrew consent prior to procedure|3|||
146962649|NCT03099096|530023250|FG000|Overall Study|Adverse Event|1|||
146962650|NCT03099096|530023250|FG000|Overall Study|Physician Decision|1|||
146962651|NCT03219372|530023253|FG000|Overall Study|Withdrawal by Subject|1|||
146962652|NCT03219372|530023254|FG001|Overall Study|Withdrawal by Subject|0|||
146962653|NCT01050998|530023255|FG000|Overall Study|Adverse Event|1|||
146962654|NCT01050998|530023256|FG001|Overall Study|Adverse Event|0|||
146962655|NCT01050998|530023257|FG002|Overall Study|Adverse Event|1|||
146962656|NCT01050998|530023258|FG003|Overall Study|Adverse Event|0|||
146962657|NCT01050998|530023259|FG004|Overall Study|Adverse Event|2|||
146962658|NCT01050998|530023255|FG000|Overall Study|Withdrawal by Subject|0|||
146962659|NCT01050998|530023256|FG001|Overall Study|Withdrawal by Subject|0|||
146962660|NCT01050998|530023257|FG002|Overall Study|Withdrawal by Subject|0|||
146962661|NCT01050998|530023258|FG003|Overall Study|Withdrawal by Subject|1|||
146962662|NCT01050998|530023259|FG004|Overall Study|Withdrawal by Subject|3|||
146962663|NCT01050998|530023255|FG000|Overall Study|Other|3|||
146962664|NCT01050998|530023256|FG001|Overall Study|Other|2|||
146962665|NCT01050998|530023257|FG002|Overall Study|Other|1|||
146962666|NCT01050998|530023258|FG003|Overall Study|Other|1|||
146962667|NCT01050998|530023259|FG004|Overall Study|Other|5|||
147046632|NCT02514447|530331659|FG008|Overall Study|Withdrawal by Subject|1|||
147046633|NCT02514447|530331651|FG000|Overall Study|Death|24|||
147046634|NCT02514447|530331652|FG001|Overall Study|Death|28|||
147046635|NCT02514447|530331653|FG002|Overall Study|Death|29|||
147046636|NCT02514447|530331654|FG003|Overall Study|Death|0|||
147046637|NCT02514447|530331655|FG004|Overall Study|Death|3|||
147046638|NCT02514447|530331656|FG005|Overall Study|Death|4|||
147046639|NCT02514447|530331657|FG006|Overall Study|Death|8|||
147046640|NCT02514447|530331658|FG007|Overall Study|Death|6|||
147046641|NCT02514447|530331659|FG008|Overall Study|Death|5|||
147046642|NCT02514447|530331651|FG000|Overall Study|Lost to Follow-up|1|||
147046643|NCT02514447|530331652|FG001|Overall Study|Lost to Follow-up|0|||
147046644|NCT02514447|530331653|FG002|Overall Study|Lost to Follow-up|0|||
147046645|NCT02514447|530331654|FG003|Overall Study|Lost to Follow-up|0|||
147046646|NCT02514447|530331655|FG004|Overall Study|Lost to Follow-up|0|||
147046647|NCT02514447|530331656|FG005|Overall Study|Lost to Follow-up|0|||
147046648|NCT02514447|530331657|FG006|Overall Study|Lost to Follow-up|0|||
147046649|NCT02514447|530331658|FG007|Overall Study|Lost to Follow-up|0|||
147046650|NCT02514447|530331659|FG008|Overall Study|Lost to Follow-up|1|||
147046651|NCT02514447|530331651|FG000|Overall Study|Sponsor Termination of Study|0|||
147046652|NCT02514447|530331652|FG001|Overall Study|Sponsor Termination of Study|1|||
147046653|NCT02514447|530331653|FG002|Overall Study|Sponsor Termination of Study|1|||
147046654|NCT02514447|530331654|FG003|Overall Study|Sponsor Termination of Study|0|||
147046655|NCT02514447|530331655|FG004|Overall Study|Sponsor Termination of Study|0|||
147046656|NCT02514447|530331656|FG005|Overall Study|Sponsor Termination of Study|0|||
147046657|NCT02514447|530331657|FG006|Overall Study|Sponsor Termination of Study|0|||
147046658|NCT02514447|530331658|FG007|Overall Study|Sponsor Termination of Study|0|||
147046659|NCT02514447|530331659|FG008|Overall Study|Sponsor Termination of Study|0|||
147046660|NCT02514447|530331651|FG000|Overall Study|Study completion per Investigator|1|||
147046661|NCT02514447|530331652|FG001|Overall Study|Study completion per Investigator|0|||
147046662|NCT02514447|530331653|FG002|Overall Study|Study completion per Investigator|1|||
147046663|NCT02514447|530331654|FG003|Overall Study|Study completion per Investigator|2|||
147046664|NCT02514447|530331655|FG004|Overall Study|Study completion per Investigator|0|||
147046665|NCT02514447|530331656|FG005|Overall Study|Study completion per Investigator|0|||
147046666|NCT02514447|530331657|FG006|Overall Study|Study completion per Investigator|0|||
147046667|NCT02514447|530331658|FG007|Overall Study|Study completion per Investigator|0|||
147046668|NCT02514447|530331659|FG008|Overall Study|Study completion per Investigator|1|||
147046669|NCT00265759|530331661|FG000|Overall Study|Withdrawal by Subject|0|||
147046670|NCT00265759|530331662|FG001|Overall Study|Withdrawal by Subject|1|||
147046671|NCT00265759|530331663|FG002|Overall Study|Withdrawal by Subject|2|||
147046672|NCT00265759|530331664|FG003|Overall Study|Withdrawal by Subject|2|||
147046673|NCT00265759|530331661|FG000|Overall Study|Cancel|0|||
147046674|NCT00265759|530331662|FG001|Overall Study|Cancel|0|||
147046675|NCT00265759|530331663|FG002|Overall Study|Cancel|0|||
147046676|NCT00265759|530331664|FG003|Overall Study|Cancel|3|||
147046677|NCT00265759|530331661|FG000|Overall Study|Ineligible|0|||
147046678|NCT00265759|530331662|FG001|Overall Study|Ineligible|0|||
147046679|NCT00265759|530331663|FG002|Overall Study|Ineligible|0|||
147046680|NCT00265759|530331664|FG003|Overall Study|Ineligible|1|||
147046681|NCT00265759|530331661|FG000|Overall Study|Bilateral disease|0|||
147046682|NCT00265759|530331662|FG001|Overall Study|Bilateral disease|0|||
147046683|NCT00265759|530331663|FG002|Overall Study|Bilateral disease|0|||
147046684|NCT00265759|530331664|FG003|Overall Study|Bilateral disease|2|||
147046685|NCT00265759|530331661|FG000|Overall Study|Discontinued due to intolerability|0|||
147046686|NCT00265759|530331662|FG001|Overall Study|Discontinued due to intolerability|0|||
147046687|NCT00265759|530331663|FG002|Overall Study|Discontinued due to intolerability|0|||
147046688|NCT00265759|530331664|FG003|Overall Study|Discontinued due to intolerability|1|||
147046689|NCT03729596|530331667|FG000|Overall Study|Death|3|||
147046690|NCT03729596|530331668|FG001|Overall Study|Death|5|||
147046691|NCT03729596|530331669|FG002|Overall Study|Death|4|||
147046692|NCT03729596|530331670|FG003|Overall Study|Death|1|||
147046693|NCT03729596|530331671|FG004|Overall Study|Death|0|||
147046694|NCT03729596|530331672|FG005|Overall Study|Death|34|||
147046695|NCT03729596|530331673|FG006|Overall Study|Death|18|||
147046696|NCT03729596|530331674|FG007|Overall Study|Death|14|||
147046697|NCT03729596|530331675|FG008|Overall Study|Death|19|||
147046698|NCT03729596|530331676|FG009|Overall Study|Death|9|||
147046699|NCT03729596|530331667|FG000|Overall Study|Lost to Follow-up|0|||
147046700|NCT03729596|530331668|FG001|Overall Study|Lost to Follow-up|0|||
147046701|NCT03729596|530331669|FG002|Overall Study|Lost to Follow-up|0|||
147046702|NCT03729596|530331670|FG003|Overall Study|Lost to Follow-up|0|||
147046703|NCT03729596|530331671|FG004|Overall Study|Lost to Follow-up|0|||
147046704|NCT03729596|530331672|FG005|Overall Study|Lost to Follow-up|0|||
147046705|NCT03729596|530331673|FG006|Overall Study|Lost to Follow-up|1|||
147046706|NCT03729596|530331674|FG007|Overall Study|Lost to Follow-up|0|||
147046707|NCT03729596|530331675|FG008|Overall Study|Lost to Follow-up|0|||
147046708|NCT03729596|530331676|FG009|Overall Study|Lost to Follow-up|1|||
147046709|NCT03729596|530331667|FG000|Overall Study|protocol amendment|0|||
147046710|NCT03729596|530331668|FG001|Overall Study|protocol amendment|1|||
147046711|NCT03729596|530331669|FG002|Overall Study|protocol amendment|3|||
147046712|NCT03729596|530331670|FG003|Overall Study|protocol amendment|6|||
147046713|NCT03729596|530331671|FG004|Overall Study|protocol amendment|5|||
147046714|NCT03729596|530331672|FG005|Overall Study|protocol amendment|0|||
147046715|NCT03729596|530331673|FG006|Overall Study|protocol amendment|0|||
147046716|NCT03729596|530331674|FG007|Overall Study|protocol amendment|0|||
147046717|NCT03729596|530331675|FG008|Overall Study|protocol amendment|0|||
147046718|NCT03729596|530331676|FG009|Overall Study|protocol amendment|0|||
147046719|NCT03729596|530331667|FG000|Overall Study|Withdrawal by Subject|0|||
147046720|NCT03729596|530331668|FG001|Overall Study|Withdrawal by Subject|0|||
147046721|NCT03729596|530331669|FG002|Overall Study|Withdrawal by Subject|0|||
147046722|NCT03729596|530331670|FG003|Overall Study|Withdrawal by Subject|0|||
147046723|NCT03729596|530331671|FG004|Overall Study|Withdrawal by Subject|0|||
147046724|NCT03729596|530331672|FG005|Overall Study|Withdrawal by Subject|4|||
147046725|NCT03729596|530331673|FG006|Overall Study|Withdrawal by Subject|2|||
147046726|NCT03729596|530331674|FG007|Overall Study|Withdrawal by Subject|3|||
147046727|NCT03729596|530331675|FG008|Overall Study|Withdrawal by Subject|2|||
147046728|NCT03729596|530331676|FG009|Overall Study|Withdrawal by Subject|3|||
147046729|NCT03729596|530331667|FG000|Overall Study|study terminated by sponsor|0|||
147046730|NCT03729596|530331668|FG001|Overall Study|study terminated by sponsor|0|||
147046731|NCT03729596|530331669|FG002|Overall Study|study terminated by sponsor|0|||
147046732|NCT03729596|530331670|FG003|Overall Study|study terminated by sponsor|0|||
147046733|NCT03729596|530331671|FG004|Overall Study|study terminated by sponsor|1|||
147046734|NCT03729596|530331672|FG005|Overall Study|study terminated by sponsor|3|||
147046735|NCT03729596|530331673|FG006|Overall Study|study terminated by sponsor|0|||
147046736|NCT03729596|530331674|FG007|Overall Study|study terminated by sponsor|1|||
147046737|NCT03729596|530331675|FG008|Overall Study|study terminated by sponsor|0|||
147046738|NCT03729596|530331676|FG009|Overall Study|study terminated by sponsor|0|||
147046739|NCT03713593|530331677|FG000|Overall Study|Sponsor Decision|73|||
147046740|NCT03713593|530331678|FG001|Overall Study|Sponsor Decision|41|||
147046741|NCT03713593|530331677|FG000|Overall Study|Lost to Follow-up|2|||
147046742|NCT03713593|530331678|FG001|Overall Study|Lost to Follow-up|1|||
147046743|NCT03713593|530331677|FG000|Overall Study|Death|314|||
147046744|NCT03713593|530331678|FG001|Overall Study|Death|349|||
147046745|NCT03713593|530331677|FG000|Overall Study|Withdrawal by Subject|6|||
147046746|NCT03713593|530331678|FG001|Overall Study|Withdrawal by Subject|8|||
147046747|NCT03560037|530331680|FG000|Overall Study|Protocol Violation|1|||
147046748|NCT03560037|530331681|FG001|Overall Study|Protocol Violation|0|||
147046749|NCT03560037|530331680|FG000|Overall Study|Physician Decision|0|||
147046750|NCT03560037|530331681|FG001|Overall Study|Physician Decision|1|||
147046751|NCT03620708|530331682|FG000|Overall Study|Lost to Follow-up|1|||
147046752|NCT03620708|530331683|FG001|Overall Study|Lost to Follow-up|1|||
147046753|NCT03620708|530331684|FG002|Overall Study|Lost to Follow-up|2|||
147046754|NCT03620708|530331682|FG000|Overall Study|Withdrawal by Subject|0|||
147046755|NCT03620708|530331683|FG001|Overall Study|Withdrawal by Subject|0|||
147046756|NCT03620708|530331684|FG002|Overall Study|Withdrawal by Subject|1|||
147046757|NCT04909853|530331690|FG000|Part 1|Assigned but not treated|0|||
147046758|NCT04909853|530331691|FG001|Part 1|Assigned but not treated|0|||
147046759|NCT04909853|530331692|FG002|Part 1|Assigned but not treated|1|||
147046760|NCT04909853|530331693|FG003|Part 1|Assigned but not treated|0|||
147046761|NCT04909853|530331690|FG000|Part 2|Adverse Event|0|||
147046762|NCT04909853|530331691|FG001|Part 2|Adverse Event|0|||
147046763|NCT04909853|530331692|FG002|Part 2|Adverse Event|0|||
147046764|NCT04909853|530331693|FG003|Part 2|Adverse Event|1|||
147046765|NCT00077207|530331694|FG000|Overall Study|Adverse Event|5|||
147046766|NCT00077207|530331694|FG000|Overall Study|Lack of Efficacy|12|||
147046767|NCT00077207|530331694|FG000|Overall Study|Physician Decision|6|||
147046768|NCT00077207|530331694|FG000|Overall Study|Withdrawal by Subject|6|||
147046769|NCT00077207|530331694|FG000|Overall Study|Ineligible|1|||
147046770|NCT03052751|530331696|FG000|Dosing Period 1|Adverse Event|0|||
147046771|NCT03052751|530331697|FG001|Dosing Period 1|Adverse Event|1|||
147046772|NCT03052751|530331698|FG002|Dosing Period 1|Adverse Event|0|||
147046773|NCT03052751|530331699|FG003|Dosing Period 1|Adverse Event|0|||
147046774|NCT03052751|530331700|FG004|Dosing Period 1|Adverse Event|0|||
147046775|NCT03052751|530331701|FG005|Dosing Period 1|Adverse Event|0|||
147046776|NCT03052751|530331696|FG000|Dosing Period 2|Adverse Event|0|||
147046777|NCT03052751|530331697|FG001|Dosing Period 2|Adverse Event|0|||
147046778|NCT03052751|530331698|FG002|Dosing Period 2|Adverse Event|3|||
147046779|NCT03052751|530331699|FG003|Dosing Period 2|Adverse Event|0|||
147046780|NCT03052751|530331700|FG004|Dosing Period 2|Adverse Event|0|||
147046781|NCT03052751|530331701|FG005|Dosing Period 2|Adverse Event|0|||
147046782|NCT03052751|530331696|FG000|Observation Period|Adverse Event|0|||
147046783|NCT03052751|530331697|FG001|Observation Period|Adverse Event|0|||
147046784|NCT03052751|530331698|FG002|Observation Period|Adverse Event|0|||
147046785|NCT03052751|530331699|FG003|Observation Period|Adverse Event|0|||
147046786|NCT03052751|530331700|FG004|Observation Period|Adverse Event|1|||
147046787|NCT03052751|530331701|FG005|Observation Period|Adverse Event|0|||
147046788|NCT01811472|530331702|FG000|Overall Study|Adverse Event|1|||
147046789|NCT01811472|530331703|FG001|Overall Study|Adverse Event|0|||
147046790|NCT01811472|530331704|FG002|Overall Study|Adverse Event|4|||
147046791|NCT01811472|530331702|FG000|Overall Study|Lost to Follow-up|0|||
147046792|NCT01811472|530331703|FG001|Overall Study|Lost to Follow-up|0|||
147046793|NCT01811472|530331704|FG002|Overall Study|Lost to Follow-up|1|||
147046794|NCT01811472|530331702|FG000|Overall Study|Subject/guardian decision|1|||
147046795|NCT01811472|530331703|FG001|Overall Study|Subject/guardian decision|0|||
147046796|NCT01811472|530331704|FG002|Overall Study|Subject/guardian decision|0|||
147046797|NCT03288714|530331705|FG000|Overall Study|Lost to Follow-up|2|||
147046798|NCT03288714|530331706|FG001|Overall Study|Lost to Follow-up|1|||
147046799|NCT03288714|530331705|FG000|Overall Study|Non-compliance with study schedule|2|||
147046800|NCT03288714|530331706|FG001|Overall Study|Non-compliance with study schedule|0|||
147046801|NCT03288714|530331705|FG000|Overall Study|Withdrawal by Subject|3|||
147046802|NCT03288714|530331706|FG001|Overall Study|Withdrawal by Subject|1|||
147046803|NCT03288714|530331705|FG000|Overall Study|Clinical Worsening|2|||
147046804|NCT03288714|530331706|FG001|Overall Study|Clinical Worsening|1|||
147046805|NCT03288714|530331705|FG000|Overall Study|Adverse Event|1|||
147046806|NCT03288714|530331706|FG001|Overall Study|Adverse Event|0|||
147046807|NCT04882241|530331707|FG000|Overall Study|Ongoing in study|46|||
147046808|NCT04882241|530331708|FG001|Overall Study|Ongoing in study|48|||
147046809|NCT04882241|530331709|FG002|Overall Study|Ongoing in study|0|||
147046810|NCT04882241|530331710|FG003|Overall Study|Ongoing in study|0|||
147046811|NCT04882241|530331707|FG000|Overall Study|Death|13|||
147046812|NCT04882241|530331708|FG001|Overall Study|Death|13|||
147046813|NCT04882241|530331709|FG002|Overall Study|Death|0|||
147046814|NCT04882241|530331710|FG003|Overall Study|Death|0|||
147046815|NCT00104572|530331722|FG000|Overall Study|Withdrawal by Subject|3|||
147046816|NCT00104572|530331723|FG001|Overall Study|Withdrawal by Subject|3|||
147046817|NCT00104572|530331724|FG002|Overall Study|Withdrawal by Subject|0|||
147046818|NCT02290405|530331726|FG000|Overall Study|Withdrawal by Subject|1|||
147046819|NCT02290405|530331727|FG001|Overall Study|Withdrawal by Subject|0|||
147046820|NCT02016183|530331728|FG000|Overall Study|Case Report Forms Uncollected|13|||
147046821|NCT02016183|530331728|FG000|Overall Study|Protocol Violation|52|||
147046822|NCT00129545|530331740|FG000|Overall Study|Death|5|||
147046823|NCT00129545|530331741|FG001|Overall Study|Death|60|||
147046824|NCT00129545|530331742|FG002|Overall Study|Death|44|||
147046825|NCT00129545|530331740|FG000|Overall Study|Withdrawal by Subject|3|||
147046826|NCT00129545|530331741|FG001|Overall Study|Withdrawal by Subject|18|||
147046827|NCT00129545|530331742|FG002|Overall Study|Withdrawal by Subject|44|||
147046828|NCT00129545|530331740|FG000|Overall Study|Lost to Follow-up|2|||
147046829|NCT00129545|530331741|FG001|Overall Study|Lost to Follow-up|22|||
147046830|NCT00129545|530331742|FG002|Overall Study|Lost to Follow-up|13|||
147046831|NCT00129545|530331740|FG000|Overall Study|Physician Decision|0|||
147046832|NCT00129545|530331741|FG001|Overall Study|Physician Decision|3|||
147046833|NCT00129545|530331742|FG002|Overall Study|Physician Decision|10|||
147046834|NCT00129545|530331740|FG000|Overall Study|Device not implanted|16|||
147046835|NCT00129545|530331741|FG001|Overall Study|Device not implanted|61|||
147046836|NCT00129545|530331742|FG002|Overall Study|Device not implanted|0|||
147046837|NCT00770328|530331743|FG000|Overall Study|Adverse Event|11|||
147046838|NCT00770328|530331744|FG001|Overall Study|Adverse Event|2|||
147046839|NCT00770328|530331743|FG000|Overall Study|Lost to Follow-up|2|||
147046840|NCT00770328|530331744|FG001|Overall Study|Lost to Follow-up|2|||
147046841|NCT03541317|530331746|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
147046842|NCT03541317|530331747|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
147046843|NCT03541317|530331748|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
147046844|NCT03541317|530331749|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
147046845|NCT03541317|530331750|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
147046846|NCT03541317|530331751|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
147046847|NCT02536846|530331756|FG000|Overall Study|Withdrawal by Subject|1|||
147046848|NCT03164616|530331757|FG000|Overall Study|Death|250|||
147046849|NCT03164616|530331758|FG001|Overall Study|Death|264|||
147046850|NCT03164616|530331759|FG002|Overall Study|Death|279|||
147046851|NCT03164616|530331757|FG000|Overall Study|Lost to Follow-up|2|||
147046852|NCT03164616|530331758|FG001|Overall Study|Lost to Follow-up|2|||
147046853|NCT03164616|530331759|FG002|Overall Study|Lost to Follow-up|2|||
147046854|NCT03164616|530331757|FG000|Overall Study|Withdrawal by Subject|6|||
147046855|NCT03164616|530331758|FG001|Overall Study|Withdrawal by Subject|7|||
147046856|NCT03164616|530331759|FG002|Overall Study|Withdrawal by Subject|16|||
147046857|NCT04604795|530331760|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
147046858|NCT04604795|530331761|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
147046859|NCT04604795|530331762|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
147046860|NCT04604795|530331763|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
147046861|NCT04604795|530331764|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
147046862|NCT04604795|530331765|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
147046863|NCT04604795|530331766|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
147046864|NCT04604795|530331767|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
147046865|NCT04604795|530331768|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
147046866|NCT04604795|530331769|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
147046867|NCT04604795|530331760|FG000|Part B: Up to Day 14|Adverse Event|0|||
147046868|NCT04604795|530331761|FG001|Part B: Up to Day 14|Adverse Event|0|||
147046869|NCT04604795|530331762|FG002|Part B: Up to Day 14|Adverse Event|0|||
147046870|NCT04604795|530331763|FG003|Part B: Up to Day 14|Adverse Event|0|||
147046871|NCT04604795|530331764|FG004|Part B: Up to Day 14|Adverse Event|2|||
147046872|NCT04604795|530331765|FG005|Part B: Up to Day 14|Adverse Event|1|||
147046873|NCT04604795|530331766|FG006|Part B: Up to Day 14|Adverse Event|0|||
147046874|NCT04604795|530331767|FG007|Part B: Up to Day 14|Adverse Event|0|||
147046875|NCT04604795|530331768|FG008|Part B: Up to Day 14|Adverse Event|0|||
147046876|NCT04604795|530331769|FG009|Part B: Up to Day 14|Adverse Event|0|||
147046877|NCT04604795|530331760|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147046878|NCT04604795|530331761|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147046879|NCT04604795|530331762|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147046880|NCT04604795|530331763|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147046881|NCT04604795|530331764|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147046882|NCT04604795|530331765|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147046883|NCT04604795|530331766|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147046884|NCT04604795|530331767|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147046885|NCT04604795|530331768|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147046886|NCT04604795|530331769|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
147046887|NCT04604795|530331760|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147046888|NCT04604795|530331761|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147046889|NCT04604795|530331762|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147046890|NCT04604795|530331763|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147046891|NCT04604795|530331764|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147046892|NCT04604795|530331765|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147046893|NCT04604795|530331766|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147046894|NCT04604795|530331767|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147046895|NCT04604795|530331768|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
147046896|NCT04604795|530331769|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147046897|NCT04604795|530331760|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147046898|NCT04604795|530331761|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147046899|NCT04604795|530331762|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147046900|NCT04604795|530331763|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147046901|NCT04604795|530331764|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147046902|NCT04604795|530331765|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147046903|NCT04604795|530331766|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147046904|NCT04604795|530331767|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147046905|NCT04604795|530331768|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
147046906|NCT04604795|530331769|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147046907|NCT04604795|530331760|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
147046908|NCT04604795|530331761|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
147046909|NCT04604795|530331762|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
147046910|NCT04604795|530331763|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
147046911|NCT04604795|530331764|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
147046912|NCT04604795|530331765|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
147046913|NCT04604795|530331766|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
147046914|NCT04604795|530331767|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
147046915|NCT04604795|530331768|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
147046916|NCT04604795|530331769|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
147046917|NCT00111241|530331775|FG000|Overall Study|Lost to Follow-up|1|||
147046918|NCT00111241|530331776|FG001|Overall Study|Lost to Follow-up|0|||
147046919|NCT00111241|530331775|FG000|Overall Study|Withdrawal by Subject|4|||
147046920|NCT00111241|530331776|FG001|Overall Study|Withdrawal by Subject|0|||
147046921|NCT00111241|530331775|FG000|Overall Study|Protocol Violation|9|||
147046922|NCT00111241|530331776|FG001|Overall Study|Protocol Violation|8|||
147046923|NCT00111241|530331775|FG000|Overall Study|Adverse Event|1|||
147046924|NCT00111241|530331776|FG001|Overall Study|Adverse Event|0|||
147046925|NCT04502212|530331777|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
147046926|NCT04502212|530331777|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
147046927|NCT02096744|530331788|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
147046928|NCT02096744|530331789|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
147046929|NCT02096744|530331788|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
147046930|NCT02096744|530331789|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
147046931|NCT02096744|530331788|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
147046932|NCT02096744|530331789|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
147046933|NCT02445963|530331792|FG000|Overall Study|Lost to Follow-up|1|||
146962668|NCT01050998|530023255|FG000|Overall Study|Data integrity issues|0|||
146962669|NCT01050998|530023256|FG001|Overall Study|Data integrity issues|0|||
146962670|NCT01050998|530023257|FG002|Overall Study|Data integrity issues|1|||
146962671|NCT01050998|530023258|FG003|Overall Study|Data integrity issues|1|||
146962672|NCT01050998|530023259|FG004|Overall Study|Data integrity issues|4|||
146962673|NCT01428882|530023260|FG000|Overall Study|Lack of Efficacy|2|||
146962674|NCT01428882|530023261|FG001|Overall Study|Lack of Efficacy|7|||
146962675|NCT01428882|530023260|FG000|Overall Study|Protocol Violation|4|||
146962676|NCT01428882|530023261|FG001|Overall Study|Protocol Violation|3|||
146962677|NCT02304484|530023264|FG000|Overall Study|Death|9|||
146962678|NCT02304484|530023264|FG000|Overall Study|Withdrawal by Subject|14|||
146962679|NCT02304484|530023264|FG000|Overall Study|Lost to Follow-up|2|||
146962680|NCT04338685|530023265|FG000|Overall Study|Death|3|||
146962681|NCT04338685|530023266|FG001|Overall Study|Death|4|||
146962682|NCT04338685|530023267|FG002|Overall Study|Death|2|||
146962683|NCT04338685|530023268|FG003|Overall Study|Death|4|||
146962684|NCT04338685|530023269|FG004|Overall Study|Death|4|||
146962685|NCT04338685|530023270|FG005|Overall Study|Death|8|||
146962686|NCT04338685|530023271|FG006|Overall Study|Death|1|||
146962687|NCT04338685|530023272|FG007|Overall Study|Death|0|||
146962688|NCT04338685|530023273|FG008|Overall Study|Death|0|||
146962689|NCT04338685|530023265|FG000|Overall Study|Study terminated by Sponsor|0|||
146962690|NCT04338685|530023266|FG001|Overall Study|Study terminated by Sponsor|0|||
146962691|NCT04338685|530023267|FG002|Overall Study|Study terminated by Sponsor|1|||
146962692|NCT04338685|530023268|FG003|Overall Study|Study terminated by Sponsor|4|||
146962693|NCT04338685|530023269|FG004|Overall Study|Study terminated by Sponsor|0|||
146962694|NCT04338685|530023270|FG005|Overall Study|Study terminated by Sponsor|5|||
146962695|NCT04338685|530023271|FG006|Overall Study|Study terminated by Sponsor|2|||
146962696|NCT04338685|530023272|FG007|Overall Study|Study terminated by Sponsor|4|||
146962697|NCT04338685|530023273|FG008|Overall Study|Study terminated by Sponsor|1|||
146962698|NCT04338685|530023265|FG000|Overall Study|Withdrawal by Subject|1|||
146962699|NCT04338685|530023266|FG001|Overall Study|Withdrawal by Subject|2|||
146962700|NCT04338685|530023267|FG002|Overall Study|Withdrawal by Subject|0|||
146962701|NCT04338685|530023268|FG003|Overall Study|Withdrawal by Subject|2|||
146962702|NCT04338685|530023269|FG004|Overall Study|Withdrawal by Subject|0|||
146962703|NCT04338685|530023270|FG005|Overall Study|Withdrawal by Subject|5|||
146962704|NCT04338685|530023271|FG006|Overall Study|Withdrawal by Subject|1|||
146962705|NCT04338685|530023272|FG007|Overall Study|Withdrawal by Subject|1|||
146962706|NCT04338685|530023273|FG008|Overall Study|Withdrawal by Subject|0|||
146962707|NCT00234533|530023274|FG000|Overall Study|Withdrawal by Subject|6|||
146962708|NCT00234533|530023274|FG000|Overall Study|Adverse Event|2|||
146962709|NCT00234533|530023274|FG000|Overall Study|Enrolled but not treated|3|||
146962710|NCT02967055|530023275|FG000|Overall Study|Excluded|40|||
146962711|NCT02967055|530023275|FG000|Overall Study|Screen fail|3|||
146962712|NCT02967055|530023275|FG000|Overall Study|Lost to Follow-up|2|||
146962713|NCT02967055|530023275|FG000|Overall Study|Stopped due to side effects|3|||
146962714|NCT02967055|530023275|FG000|Overall Study|Stopped due to drug cost|1|||
146962715|NCT00976989|530023276|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
146962716|NCT00976989|530023277|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
146962717|NCT00976989|530023278|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
146962718|NCT00976989|530023276|FG000|Overall Study|Death|5|||
146962719|NCT00976989|530023277|FG001|Overall Study|Death|7|||
146962720|NCT00976989|530023278|FG002|Overall Study|Death|10|||
146962721|NCT00976989|530023276|FG000|Overall Study|Refused Treatment|4|||
146962722|NCT00976989|530023277|FG001|Overall Study|Refused Treatment|3|||
146962723|NCT00976989|530023278|FG002|Overall Study|Refused Treatment|5|||
146962724|NCT00976989|530023276|FG000|Overall Study|Failure to Return|2|||
146962725|NCT00976989|530023277|FG001|Overall Study|Failure to Return|1|||
146962726|NCT00976989|530023278|FG002|Overall Study|Failure to Return|0|||
146962727|NCT00976989|530023276|FG000|Overall Study|Recurrence of Disease|0|||
146962728|NCT00976989|530023277|FG001|Overall Study|Recurrence of Disease|1|||
146962729|NCT00976989|530023278|FG002|Overall Study|Recurrence of Disease|0|||
146962730|NCT00976989|530023276|FG000|Overall Study|Other|1|||
146962731|NCT00976989|530023277|FG001|Overall Study|Other|0|||
146962732|NCT00976989|530023278|FG002|Overall Study|Other|1|||
146962733|NCT00570492|530023279|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
146962734|NCT00570492|530023280|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
146962735|NCT00570492|530023281|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
146962736|NCT00570492|530023279|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
146962737|NCT00570492|530023280|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
146962738|NCT00570492|530023281|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
146962739|NCT00570492|530023279|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
146962740|NCT00570492|530023280|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
146962741|NCT00570492|530023281|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
146962742|NCT00570492|530023279|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
147046934|NCT02445963|530331793|FG001|Overall Study|Lost to Follow-up|0|||
147046935|NCT02445963|530331794|FG002|Overall Study|Lost to Follow-up|0|||
147046936|NCT02445963|530331795|FG003|Overall Study|Lost to Follow-up|0|||
147046937|NCT02445963|530331792|FG000|Overall Study|Change in employment|1|||
147046938|NCT02445963|530331793|FG001|Overall Study|Change in employment|0|||
147046939|NCT02445963|530331794|FG002|Overall Study|Change in employment|0|||
147046940|NCT02445963|530331795|FG003|Overall Study|Change in employment|0|||
147046941|NCT02445963|530331792|FG000|Overall Study|Symptoms post-vaccination|0|||
147046942|NCT02445963|530331793|FG001|Overall Study|Symptoms post-vaccination|0|||
147046943|NCT02445963|530331794|FG002|Overall Study|Symptoms post-vaccination|1|||
147046944|NCT02445963|530331795|FG003|Overall Study|Symptoms post-vaccination|0|||
147046945|NCT01449812|530331799|FG000|Overall Study|Migrated/moved from study area|1|||
147046946|NCT01449812|530331800|FG001|Overall Study|Migrated/moved from study area|0|||
147046947|NCT01449812|530331801|FG002|Overall Study|Migrated/moved from study area|0|||
147046948|NCT01449812|530331799|FG000|Overall Study|Withdrawal by Subject|0|||
147046949|NCT01449812|530331800|FG001|Overall Study|Withdrawal by Subject|0|||
147046950|NCT01449812|530331801|FG002|Overall Study|Withdrawal by Subject|1|||
147046951|NCT01449812|530331799|FG000|Overall Study|Lost to Follow-up|1|||
147046952|NCT01449812|530331800|FG001|Overall Study|Lost to Follow-up|0|||
147046953|NCT01449812|530331801|FG002|Overall Study|Lost to Follow-up|0|||
147046954|NCT02517463|530331802|FG000|Overall Study|Lost to Follow-up|5|||
147046955|NCT02517463|530331803|FG001|Overall Study|Lost to Follow-up|2|||
147046956|NCT03449446|530331804|FG000|Overall Study|Randomized but Never Treated|0|||
147046957|NCT03449446|530331805|FG001|Overall Study|Randomized but Never Treated|0|||
147046958|NCT03449446|530331806|FG002|Overall Study|Randomized but Never Treated|1|||
147046959|NCT03449446|530331807|FG003|Overall Study|Randomized but Never Treated|1|||
147046960|NCT03449446|530331808|FG004|Overall Study|Randomized but Never Treated|1|||
147046961|NCT03449446|530331809|FG005|Overall Study|Randomized but Never Treated|0|||
147046962|NCT03449446|530331810|FG006|Overall Study|Randomized but Never Treated|0|||
147046963|NCT03449446|530331804|FG000|Overall Study|Unknown Reason|33|||
147046964|NCT03449446|530331805|FG001|Overall Study|Unknown Reason|1|||
147046965|NCT03449446|530331806|FG002|Overall Study|Unknown Reason|1|||
147046966|NCT03449446|530331807|FG003|Overall Study|Unknown Reason|1|||
147046967|NCT03449446|530331808|FG004|Overall Study|Unknown Reason|2|||
147046968|NCT03449446|530331809|FG005|Overall Study|Unknown Reason|2|||
147046969|NCT03449446|530331810|FG006|Overall Study|Unknown Reason|0|||
147046970|NCT03449446|530331804|FG000|Overall Study|Withdrew Consent|1|||
147046971|NCT03449446|530331805|FG001|Overall Study|Withdrew Consent|3|||
147046972|NCT03449446|530331806|FG002|Overall Study|Withdrew Consent|1|||
147046973|NCT03449446|530331807|FG003|Overall Study|Withdrew Consent|4|||
147046974|NCT03449446|530331808|FG004|Overall Study|Withdrew Consent|4|||
147046975|NCT03449446|530331809|FG005|Overall Study|Withdrew Consent|4|||
147046976|NCT03449446|530331810|FG006|Overall Study|Withdrew Consent|1|||
147046977|NCT03449446|530331804|FG000|Overall Study|Adverse Event|1|||
147046978|NCT03449446|530331805|FG001|Overall Study|Adverse Event|2|||
147046979|NCT03449446|530331806|FG002|Overall Study|Adverse Event|1|||
147046980|NCT03449446|530331807|FG003|Overall Study|Adverse Event|0|||
147046981|NCT03449446|530331808|FG004|Overall Study|Adverse Event|0|||
147046982|NCT03449446|530331809|FG005|Overall Study|Adverse Event|2|||
147046983|NCT03449446|530331810|FG006|Overall Study|Adverse Event|0|||
147046984|NCT03449446|530331804|FG000|Overall Study|Lost to Follow-up|0|||
147046985|NCT03449446|530331805|FG001|Overall Study|Lost to Follow-up|0|||
147046986|NCT03449446|530331806|FG002|Overall Study|Lost to Follow-up|2|||
147046987|NCT03449446|530331807|FG003|Overall Study|Lost to Follow-up|1|||
147046988|NCT03449446|530331808|FG004|Overall Study|Lost to Follow-up|3|||
147046989|NCT03449446|530331809|FG005|Overall Study|Lost to Follow-up|0|||
147046990|NCT03449446|530331810|FG006|Overall Study|Lost to Follow-up|0|||
147046991|NCT03449446|530331804|FG000|Overall Study|Investigator's Discretion|0|||
147046992|NCT03449446|530331805|FG001|Overall Study|Investigator's Discretion|1|||
147046993|NCT03449446|530331806|FG002|Overall Study|Investigator's Discretion|1|||
147046994|NCT03449446|530331807|FG003|Overall Study|Investigator's Discretion|2|||
147046995|NCT03449446|530331808|FG004|Overall Study|Investigator's Discretion|0|||
147046996|NCT03449446|530331809|FG005|Overall Study|Investigator's Discretion|0|||
147046997|NCT03449446|530331810|FG006|Overall Study|Investigator's Discretion|0|||
147046998|NCT03449446|530331804|FG000|Overall Study|Non Compliance with Study Drug|1|||
147046999|NCT03449446|530331805|FG001|Overall Study|Non Compliance with Study Drug|0|||
147047000|NCT03449446|530331806|FG002|Overall Study|Non Compliance with Study Drug|0|||
147047001|NCT03449446|530331807|FG003|Overall Study|Non Compliance with Study Drug|0|||
147047002|NCT03449446|530331808|FG004|Overall Study|Non Compliance with Study Drug|0|||
147047003|NCT03449446|530331809|FG005|Overall Study|Non Compliance with Study Drug|0|||
147047004|NCT03449446|530331810|FG006|Overall Study|Non Compliance with Study Drug|0|||
147047005|NCT03449446|530331804|FG000|Overall Study|Protocol Violation|0|||
147047006|NCT03449446|530331805|FG001|Overall Study|Protocol Violation|0|||
147047007|NCT03449446|530331806|FG002|Overall Study|Protocol Violation|0|||
147047008|NCT03449446|530331807|FG003|Overall Study|Protocol Violation|0|||
147047009|NCT03449446|530331808|FG004|Overall Study|Protocol Violation|1|||
147047010|NCT03449446|530331809|FG005|Overall Study|Protocol Violation|1|||
147047011|NCT03449446|530331810|FG006|Overall Study|Protocol Violation|0|||
146962743|NCT00570492|530023280|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
146962744|NCT00570492|530023281|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
146962745|NCT00570492|530023279|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
146962746|NCT00570492|530023280|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
146962747|NCT00570492|530023281|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
146962748|NCT00570492|530023279|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
146962749|NCT00570492|530023280|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
146962750|NCT00570492|530023281|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
146962751|NCT00570492|530023279|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
146962752|NCT00570492|530023280|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
146962753|NCT00570492|530023281|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
146962754|NCT00570492|530023279|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
146962755|NCT00570492|530023280|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
146962756|NCT00570492|530023281|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
146962757|NCT00570492|530023279|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
146962758|NCT00570492|530023280|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
146962759|NCT00570492|530023281|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
146962760|NCT00570492|530023279|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
146962761|NCT00570492|530023280|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
146962762|NCT00570492|530023281|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
146962763|NCT00570492|530023279|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
146962764|NCT00570492|530023280|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
146962765|NCT00570492|530023281|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
146962766|NCT00570492|530023279|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
146962767|NCT00570492|530023280|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
146962768|NCT00570492|530023281|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
146962769|NCT00570492|530023279|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
146962770|NCT00570492|530023280|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
146962771|NCT00570492|530023281|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
146962772|NCT00570492|530023279|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
146962773|NCT00570492|530023280|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
146962774|NCT00570492|530023281|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
146962775|NCT04419558|530023282|FG000|DB Period (48 Weeks)|Adverse Event|6|||
146962776|NCT04419558|530023283|FG001|DB Period (48 Weeks)|Adverse Event|6|||
146962777|NCT04419558|530023282|FG000|DB Period (48 Weeks)|Death|14|||
146962778|NCT04419558|530023283|FG001|DB Period (48 Weeks)|Death|11|||
146962779|NCT04419558|530023282|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
146962780|NCT04419558|530023283|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
146962781|NCT04419558|530023282|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
146962782|NCT04419558|530023283|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
146962783|NCT04419558|530023282|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
146962784|NCT04419558|530023283|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
146962785|NCT04419558|530023282|FG000|DB Period (48 Weeks)|Disease Progression|1|||
146962786|NCT04419558|530023283|FG001|DB Period (48 Weeks)|Disease Progression|0|||
146962787|NCT04419558|530023282|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
146962788|NCT04419558|530023283|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
146962789|NCT04419558|530023282|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
146962790|NCT04419558|530023283|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
146962791|NCT04419558|530023282|FG000|DB Period (48 Weeks)|Participant Decision|4|||
146962792|NCT04419558|530023283|FG001|DB Period (48 Weeks)|Participant Decision|3|||
146962793|NCT04419558|530023282|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
146962794|NCT04419558|530023283|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
146962795|NCT04419558|530023282|FG000|OLE Period (48 Weeks)|Death|4|||
146962796|NCT04419558|530023283|FG001|OLE Period (48 Weeks)|Death|6|||
146962797|NCT04419558|530023282|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
146962798|NCT04419558|530023283|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
146962799|NCT04419558|530023282|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
146962800|NCT04419558|530023283|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
146962801|NCT00908375|530023284|FG000|Overall Study|Withdrawal by Subject|2|||
146962802|NCT00908375|530023285|FG001|Overall Study|Withdrawal by Subject|4|||
146962803|NCT00908375|530023284|FG000|Overall Study|Lost to Follow-up|8|||
146962804|NCT00908375|530023285|FG001|Overall Study|Lost to Follow-up|6|||
146962805|NCT00752206|530023286|FG000|Overall Study|Disease progression|8|||
146962806|NCT00752206|530023287|FG001|Overall Study|Disease progression|11|||
146962807|NCT00752206|530023286|FG000|Overall Study|Pregnancy|1|||
146962808|NCT00752206|530023287|FG001|Overall Study|Pregnancy|0|||
146962809|NCT01539512|530023288|FG000|Overall Study|Adverse Event|9|||
146962810|NCT01539512|530023289|FG001|Overall Study|Adverse Event|7|||
146962811|NCT01539512|530023288|FG000|Overall Study|Physician Decision|1|||
147047012|NCT03449446|530331804|FG000|Overall Study|Death|0|||
147047013|NCT03449446|530331805|FG001|Overall Study|Death|0|||
147047014|NCT03449446|530331806|FG002|Overall Study|Death|0|||
147047015|NCT03449446|530331807|FG003|Overall Study|Death|0|||
147047016|NCT03449446|530331808|FG004|Overall Study|Death|1|||
147047017|NCT03449446|530331809|FG005|Overall Study|Death|0|||
147047018|NCT03449446|530331810|FG006|Overall Study|Death|0|||
147047019|NCT04208750|530331817|FG000|Overall Study|Lost to Follow-up|16|||
147047020|NCT04208750|530331818|FG001|Overall Study|Lost to Follow-up|15|||
147047021|NCT02201277|530331819|FG000|Overall Study|Death|3|||
147047022|NCT02201277|530331820|FG001|Overall Study|Death|4|||
147047023|NCT02201277|530331819|FG000|Overall Study|Lost to Follow-up|2|||
147047024|NCT02201277|530331820|FG001|Overall Study|Lost to Follow-up|1|||
147047025|NCT02201277|530331819|FG000|Overall Study|Failed retrieval|1|||
147047026|NCT02201277|530331820|FG001|Overall Study|Failed retrieval|0|||
147047027|NCT02201277|530331819|FG000|Overall Study|Physician Decision|1|||
147047028|NCT02201277|530331820|FG001|Overall Study|Physician Decision|0|||
147047029|NCT00866359|530331823|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
147047030|NCT00866359|530331824|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
147047031|NCT00866359|530331825|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
147047032|NCT00866359|530331826|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
147047033|NCT00866359|530331823|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
147047034|NCT00866359|530331824|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
147047035|NCT00866359|530331825|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
147047036|NCT00866359|530331826|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
147047037|NCT00866359|530331823|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
147047038|NCT00866359|530331824|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
147047039|NCT00866359|530331825|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
147047040|NCT00866359|530331826|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
147047041|NCT00866359|530331823|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
147047042|NCT00866359|530331824|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
147047043|NCT00866359|530331825|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
147047044|NCT00866359|530331826|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
147047045|NCT00866359|530331823|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
147047046|NCT00866359|530331824|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
147047047|NCT00866359|530331825|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
147047048|NCT00866359|530331826|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
147047049|NCT00866359|530331823|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
147047050|NCT00866359|530331824|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
147047051|NCT00866359|530331825|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
147047052|NCT00866359|530331826|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
147047053|NCT02163057|530331827|FG000|Overall Study|Participant Refusal to Continue|2|||
147047054|NCT02163057|530331828|FG001|Overall Study|Participant Refusal to Continue|2|||
147047055|NCT02163057|530331827|FG000|Overall Study|Participant Significant Noncompliance|0|||
147047056|NCT02163057|530331828|FG001|Overall Study|Participant Significant Noncompliance|1|||
147047057|NCT02163057|530331827|FG000|Overall Study|Progression of Disease|1|||
147047058|NCT02163057|530331828|FG001|Overall Study|Progression of Disease|2|||
147047059|NCT00768248|530331829|FG000|Overall Study|Research coordinator didn't collect data|1|||
147047060|NCT00768248|530331830|FG001|Overall Study|Research coordinator didn't collect data|1|||
147047061|NCT03300817|530333995|FG000|Overall Study|Withdrawal by Subject|1|||
147047062|NCT03300817|530333995|FG000|Overall Study|Adverse Event|1|||
147047063|NCT03300817|530333995|FG000|Overall Study|Subject Found to be Ineligible|2|||
147047064|NCT05168202|530333996|FG000|Overall Study|Progressive Disease|4|||
147047065|NCT05168202|530333997|FG001|Overall Study|Progressive Disease|4|||
147047066|NCT05168202|530333998|FG002|Overall Study|Progressive Disease|2|||
147047067|NCT05168202|530333999|FG003|Overall Study|Progressive Disease|3|||
147047068|NCT05168202|530334000|FG004|Overall Study|Progressive Disease|2|||
147047069|NCT05168202|530334001|FG005|Overall Study|Progressive Disease|3|||
147047070|NCT05168202|530334002|FG006|Overall Study|Progressive Disease|2|||
147047071|NCT05168202|530333996|FG000|Overall Study|Adverse Event|2|||
147047072|NCT05168202|530333997|FG001|Overall Study|Adverse Event|1|||
147047073|NCT05168202|530333998|FG002|Overall Study|Adverse Event|4|||
147047074|NCT05168202|530333999|FG003|Overall Study|Adverse Event|4|||
147047075|NCT05168202|530334000|FG004|Overall Study|Adverse Event|3|||
147047076|NCT05168202|530334001|FG005|Overall Study|Adverse Event|2|||
147047077|NCT05168202|530334002|FG006|Overall Study|Adverse Event|0|||
147047078|NCT05168202|530333996|FG000|Overall Study|Lack of Efficacy|0|||
147047079|NCT05168202|530333997|FG001|Overall Study|Lack of Efficacy|1|||
147047080|NCT05168202|530333998|FG002|Overall Study|Lack of Efficacy|1|||
147047081|NCT05168202|530333999|FG003|Overall Study|Lack of Efficacy|0|||
147047082|NCT05168202|530334000|FG004|Overall Study|Lack of Efficacy|1|||
147047083|NCT05168202|530334001|FG005|Overall Study|Lack of Efficacy|2|||
147047084|NCT05168202|530334002|FG006|Overall Study|Lack of Efficacy|2|||
147047085|NCT05168202|530333996|FG000|Overall Study|Withdrawal by Subject|0|||
147047086|NCT05168202|530333997|FG001|Overall Study|Withdrawal by Subject|0|||
147047087|NCT05168202|530333998|FG002|Overall Study|Withdrawal by Subject|1|||
147047088|NCT05168202|530333999|FG003|Overall Study|Withdrawal by Subject|1|||
147047089|NCT05168202|530334000|FG004|Overall Study|Withdrawal by Subject|1|||
147047090|NCT05168202|530334001|FG005|Overall Study|Withdrawal by Subject|1|||
147047091|NCT05168202|530334002|FG006|Overall Study|Withdrawal by Subject|0|||
147047092|NCT05168202|530333996|FG000|Overall Study|Disease Relapse|0|||
147047093|NCT05168202|530333997|FG001|Overall Study|Disease Relapse|1|||
147047094|NCT05168202|530333998|FG002|Overall Study|Disease Relapse|0|||
147047095|NCT05168202|530333999|FG003|Overall Study|Disease Relapse|1|||
147047096|NCT05168202|530334000|FG004|Overall Study|Disease Relapse|1|||
147047097|NCT05168202|530334001|FG005|Overall Study|Disease Relapse|0|||
147047098|NCT05168202|530334002|FG006|Overall Study|Disease Relapse|0|||
147047099|NCT05168202|530333996|FG000|Overall Study|Other Reasons|0|||
147047100|NCT05168202|530333997|FG001|Overall Study|Other Reasons|0|||
147047101|NCT05168202|530333998|FG002|Overall Study|Other Reasons|0|||
147047102|NCT05168202|530333999|FG003|Overall Study|Other Reasons|0|||
147047103|NCT05168202|530334000|FG004|Overall Study|Other Reasons|0|||
147047104|NCT05168202|530334001|FG005|Overall Study|Other Reasons|2|||
147047105|NCT05168202|530334002|FG006|Overall Study|Other Reasons|1|||
147047106|NCT05168202|530333996|FG000|Overall Study|Physician Decision|0|||
147047107|NCT05168202|530333997|FG001|Overall Study|Physician Decision|1|||
147047108|NCT05168202|530333998|FG002|Overall Study|Physician Decision|1|||
147047109|NCT05168202|530333999|FG003|Overall Study|Physician Decision|0|||
147047110|NCT05168202|530334000|FG004|Overall Study|Physician Decision|0|||
147047111|NCT05168202|530334001|FG005|Overall Study|Physician Decision|0|||
147047112|NCT05168202|530334002|FG006|Overall Study|Physician Decision|0|||
147047113|NCT05168202|530333996|FG000|Overall Study|Study Terminated by Sponsor|0|||
147047114|NCT05168202|530333997|FG001|Overall Study|Study Terminated by Sponsor|0|||
147047115|NCT05168202|530333998|FG002|Overall Study|Study Terminated by Sponsor|0|||
147047116|NCT05168202|530333999|FG003|Overall Study|Study Terminated by Sponsor|1|||
147047117|NCT05168202|530334000|FG004|Overall Study|Study Terminated by Sponsor|0|||
147047118|NCT05168202|530334001|FG005|Overall Study|Study Terminated by Sponsor|0|||
147047119|NCT05168202|530334002|FG006|Overall Study|Study Terminated by Sponsor|0|||
147047120|NCT04011722|530334003|FG000|30 Days|Death|5|||
147047121|NCT04011722|530334004|FG001|30 Days|Death|1|||
147047122|NCT04011722|530334003|FG000|1 Year|Death|13|||
147047123|NCT04011722|530334004|FG001|1 Year|Death|5|||
147047124|NCT04011722|530334003|FG000|1 Year|Withdrawal by Subject|8|||
147047125|NCT04011722|530334004|FG001|1 Year|Withdrawal by Subject|2|||
147047126|NCT04011722|530334003|FG000|1 Year|Missed Visit|6|||
147047127|NCT04011722|530334004|FG001|1 Year|Missed Visit|1|||
147047128|NCT04011722|530334003|FG000|1 Year|Pending Visit|0|||
147047129|NCT04011722|530334004|FG001|1 Year|Pending Visit|11|||
147047130|NCT04011722|530334003|FG000|1 Year|Not Yet Due|0|||
147047131|NCT04011722|530334004|FG001|1 Year|Not Yet Due|9|||
147047132|NCT04011722|530334003|FG000|2 Year|Death|16|||
147047133|NCT04011722|530334004|FG001|2 Year|Death|1|||
147047134|NCT04011722|530334003|FG000|2 Year|Withdrawal by Subject|10|||
147047135|NCT04011722|530334004|FG001|2 Year|Withdrawal by Subject|1|||
147047136|NCT04011722|530334003|FG000|2 Year|Missed Visit|9|||
147047137|NCT04011722|530334004|FG001|2 Year|Missed Visit|0|||
147047138|NCT04011722|530334003|FG000|2 Year|Visit Pending|1|||
147047139|NCT04011722|530334004|FG001|2 Year|Visit Pending|3|||
147047140|NCT04011722|530334003|FG000|2 Year|Not Yet Due|43|||
147047141|NCT04011722|530334004|FG001|2 Year|Not Yet Due|54|||
147047142|NCT04011722|530334003|FG000|3 Year|Death|10|||
147047143|NCT04011722|530334004|FG001|3 Year|Death|0|||
147047144|NCT04011722|530334003|FG000|3 Year|Withdrawal by Subject|2|||
147047145|NCT04011722|530334004|FG001|3 Year|Withdrawal by Subject|0|||
147047146|NCT04011722|530334003|FG000|3 Year|Missed Visit|2|||
147047147|NCT04011722|530334004|FG001|3 Year|Missed Visit|0|||
147047148|NCT04011722|530334003|FG000|3 Year|Pending Visit|34|||
147047149|NCT04011722|530334004|FG001|3 Year|Pending Visit|0|||
147047150|NCT04011722|530334003|FG000|3 Year|Not Yet Due|99|||
147047151|NCT04011722|530334004|FG001|3 Year|Not Yet Due|0|||
147047152|NCT05061134|530334005|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
147047153|NCT05061134|530334006|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
147047154|NCT05061134|530334007|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
147047155|NCT05061134|530334005|FG000|Overall Study|Subject not treated|0|||
147047156|NCT05061134|530334006|FG001|Overall Study|Subject not treated|0|||
147047157|NCT05061134|530334007|FG002|Overall Study|Subject not treated|2|||
147047158|NCT05061134|530334005|FG000|Overall Study|Other|0|||
147047159|NCT05061134|530334006|FG001|Overall Study|Other|0|||
147047160|NCT05061134|530334007|FG002|Overall Study|Other|9|||
147047161|NCT05061134|530334005|FG000|Overall Study|Withdrawal by Subject|9|||
147047162|NCT05061134|530334006|FG001|Overall Study|Withdrawal by Subject|8|||
147047163|NCT05061134|530334007|FG002|Overall Study|Withdrawal by Subject|5|||
147047164|NCT05061134|530334005|FG000|Overall Study|Study Terminated by Sponsor|22|||
147047165|NCT05061134|530334006|FG001|Overall Study|Study Terminated by Sponsor|14|||
147047166|NCT05061134|530334007|FG002|Overall Study|Study Terminated by Sponsor|7|||
147047167|NCT05061134|530334005|FG000|Overall Study|Progressive Disease|1|||
147047168|NCT05061134|530334006|FG001|Overall Study|Progressive Disease|2|||
147047169|NCT05061134|530334007|FG002|Overall Study|Progressive Disease|0|||
147047170|NCT05061134|530334005|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
147047171|NCT05061134|530334006|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
147047172|NCT05061134|530334007|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
147047173|NCT05061134|530334005|FG000|Overall Study|Lost to Follow-up|1|||
147047174|NCT05061134|530334006|FG001|Overall Study|Lost to Follow-up|0|||
147047175|NCT05061134|530334007|FG002|Overall Study|Lost to Follow-up|0|||
147047176|NCT05061134|530334005|FG000|Overall Study|Physician Decision|1|||
147047177|NCT05061134|530334006|FG001|Overall Study|Physician Decision|1|||
147047178|NCT05061134|530334007|FG002|Overall Study|Physician Decision|0|||
147047179|NCT05061134|530334005|FG000|Overall Study|Disease progression|1|||
147047180|NCT05061134|530334006|FG001|Overall Study|Disease progression|0|||
147047181|NCT05061134|530334007|FG002|Overall Study|Disease progression|0|||
147047182|NCT05061134|530334005|FG000|Overall Study|Death|43|||
147047183|NCT05061134|530334006|FG001|Overall Study|Death|23|||
147047184|NCT05061134|530334007|FG002|Overall Study|Death|14|||
147047185|NCT05061134|530334005|FG000|Overall Study|Database lock|2|||
147047186|NCT05061134|530334006|FG001|Overall Study|Database lock|0|||
147047187|NCT05061134|530334007|FG002|Overall Study|Database lock|0|||
147047188|NCT00001521|530334008|FG000|Overall Study|Withdrawal by Subject|3|||
147047189|NCT00001521|530334009|FG001|Overall Study|Withdrawal by Subject|3|||
147047190|NCT00001521|530334008|FG000|Overall Study|Physician Decision|1|||
147047191|NCT00001521|530334009|FG001|Overall Study|Physician Decision|1|||
147047192|NCT00001521|530334008|FG000|Overall Study|Noncompliant|6|||
147047193|NCT00001521|530334009|FG001|Overall Study|Noncompliant|3|||
147047206|NCT03176134|530334012|FG000|Overall Study|Lost to Follow-up|0|||
147047207|NCT03176134|530334013|FG001|Overall Study|Lost to Follow-up|2|||
147047208|NCT03176134|530334014|FG002|Overall Study|Lost to Follow-up|0|||
147047209|NCT03176134|530334015|FG003|Overall Study|Lost to Follow-up|0|||
147047210|NCT03176134|530334016|FG004|Overall Study|Lost to Follow-up|0|||
147047211|NCT03176134|530334017|FG005|Overall Study|Lost to Follow-up|0|||
147047212|NCT03176134|530334018|FG006|Overall Study|Lost to Follow-up|0|||
147047213|NCT03176134|530334019|FG007|Overall Study|Lost to Follow-up|0|||
147047214|NCT03176134|530334012|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
147047215|NCT03176134|530334013|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147047216|NCT03176134|530334014|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
147047217|NCT03176134|530334015|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
147047218|NCT03176134|530334016|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
147047219|NCT03176134|530334017|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
147047220|NCT03176134|530334018|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
147047221|NCT03176134|530334019|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
147047222|NCT03410056|530334022|FG000|Overall Study|Decision by Sponsor|0|||
147047223|NCT03410056|530334023|FG001|Overall Study|Decision by Sponsor|0|||
147047224|NCT03410056|530334024|FG002|Overall Study|Decision by Sponsor|3|||
147047225|NCT03410056|530334025|FG003|Overall Study|Decision by Sponsor|0|||
147047226|NCT03410056|530334026|FG004|Overall Study|Decision by Sponsor|0|||
147047227|NCT03410056|530334027|FG005|Overall Study|Decision by Sponsor|0|||
147047228|NCT03410056|530334028|FG006|Overall Study|Decision by Sponsor|0|||
147047229|NCT03410056|530334022|FG000|Overall Study|Withdrawal by Subject|0|||
147047230|NCT03410056|530334023|FG001|Overall Study|Withdrawal by Subject|2|||
147047231|NCT03410056|530334024|FG002|Overall Study|Withdrawal by Subject|5|||
147047232|NCT03410056|530334025|FG003|Overall Study|Withdrawal by Subject|5|||
147047233|NCT03410056|530334026|FG004|Overall Study|Withdrawal by Subject|0|||
147047234|NCT03410056|530334027|FG005|Overall Study|Withdrawal by Subject|0|||
147047235|NCT03410056|530334028|FG006|Overall Study|Withdrawal by Subject|0|||
147047236|NCT01499095|530334033|FG000|Overall Study|Randomized But Not Treated|1|||
147047237|NCT01499095|530334034|FG001|Overall Study|Randomized But Not Treated|1|||
147047238|NCT01499095|530334033|FG000|Overall Study|Adverse Event|12|||
147047239|NCT01499095|530334034|FG001|Overall Study|Adverse Event|7|||
147047240|NCT01499095|530334033|FG000|Overall Study|Lack of Efficacy|2|||
147047241|NCT01499095|530334034|FG001|Overall Study|Lack of Efficacy|1|||
147047242|NCT01499095|530334033|FG000|Overall Study|Protocol Violation|6|||
147047243|NCT01499095|530334034|FG001|Overall Study|Protocol Violation|7|||
147047244|NCT01499095|530334033|FG000|Overall Study|Received Rescue Therapy|32|||
147047245|NCT01499095|530334034|FG001|Overall Study|Received Rescue Therapy|40|||
147047246|NCT01499095|530334033|FG000|Overall Study|Diverse Reasons|22|||
147047247|NCT01499095|530334034|FG001|Overall Study|Diverse Reasons|25|||
147047248|NCT01499095|530334033|FG000|Overall Study|Lost to Follow-up|6|||
147047249|NCT01499095|530334034|FG001|Overall Study|Lost to Follow-up|4|||
147047250|NCT01499095|530334033|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
147047251|NCT01499095|530334034|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
147047252|NCT01499095|530334033|FG000|Overall Study|Hypoglycemia|3|||
147047253|NCT01499095|530334034|FG001|Overall Study|Hypoglycemia|1|||
147047254|NCT01499095|530334033|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
147047255|NCT01499095|530334034|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
147047256|NCT01499095|530334033|FG000|Overall Study|Change in Injection Schedule|2|||
147047257|NCT01499095|530334034|FG001|Overall Study|Change in Injection Schedule|0|||
147047258|NCT01499095|530334033|FG000|Overall Study|Perceived Lack of Efficacy|1|||
147047259|NCT01499095|530334034|FG001|Overall Study|Perceived Lack of Efficacy|1|||
147047260|NCT04358081|530334035|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
147047261|NCT04358081|530334036|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
147047262|NCT04358081|530334037|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
147047263|NCT04358081|530334035|FG000|Treatment Phase of Study|Adverse Event|1|||
147047264|NCT04358081|530334036|FG001|Treatment Phase of Study|Adverse Event|0|||
147047265|NCT04358081|530334037|FG002|Treatment Phase of Study|Adverse Event|1|||
147047266|NCT04358081|530334035|FG000|Treatment Phase of Study|Physician Decision|2|||
147047267|NCT04358081|530334036|FG001|Treatment Phase of Study|Physician Decision|0|||
147047268|NCT04358081|530334037|FG002|Treatment Phase of Study|Physician Decision|1|||
147047269|NCT04358081|530334035|FG000|Treatment Phase of Study|Protocol Violation|1|||
147047270|NCT04358081|530334036|FG001|Treatment Phase of Study|Protocol Violation|0|||
147047271|NCT04358081|530334037|FG002|Treatment Phase of Study|Protocol Violation|0|||
147047272|NCT04358081|530334035|FG000|Study Completion Phase|Death|0|||
147047273|NCT04358081|530334036|FG001|Study Completion Phase|Death|0|||
146962812|NCT01539512|530023289|FG001|Overall Study|Physician Decision|1|||
146962813|NCT01539512|530023288|FG000|Overall Study|Withdrawal by Subject|12|||
146962814|NCT01539512|530023289|FG001|Overall Study|Withdrawal by Subject|5|||
146962815|NCT01539512|530023288|FG000|Overall Study|Richter's Transformation|1|||
146962816|NCT01539512|530023289|FG001|Overall Study|Richter's Transformation|0|||
146962817|NCT01484691|530023290|FG000|Overall Study|Withdrawal by Subject|1|||
146962818|NCT01484691|530023291|FG001|Overall Study|Withdrawal by Subject|1|||
146962819|NCT01484691|530023292|FG002|Overall Study|Withdrawal by Subject|1|||
146962820|NCT01484691|530023290|FG000|Overall Study|Physician Decision|0|||
146962821|NCT01484691|530023291|FG001|Overall Study|Physician Decision|2|||
146962822|NCT01484691|530023292|FG002|Overall Study|Physician Decision|1|||
146962823|NCT04668157|530023295|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
146962824|NCT04668157|530023296|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
146962825|NCT04668157|530023295|FG000|Treatment Period (52 Weeks)|Other|0|||
146962826|NCT04668157|530023296|FG001|Treatment Period (52 Weeks)|Other|2|||
146962827|NCT03457701|530023305|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
146962828|NCT03457701|530023306|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
146962829|NCT03457701|530023305|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
146962830|NCT03457701|530023306|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
146962831|NCT03329404|530023307|FG000|Overall Study|The study was suspended.|1|||
146962832|NCT03329404|530023308|FG001|Overall Study|The study was suspended.|4|||
146962833|NCT05664672|530023312|FG000|Overall Study|Adverse Event|0|||
146962834|NCT05664672|530023313|FG001|Overall Study|Adverse Event|0|||
146962835|NCT05664672|530023314|FG002|Overall Study|Adverse Event|0|||
146962836|NCT05664672|530023315|FG003|Overall Study|Adverse Event|0|||
146962837|NCT05664672|530023316|FG004|Overall Study|Adverse Event|0|||
146962838|NCT05664672|530023317|FG005|Overall Study|Adverse Event|1|||
146962839|NCT05664672|530023312|FG000|Overall Study|Withdrawal by Subject|0|||
146962840|NCT05664672|530023313|FG001|Overall Study|Withdrawal by Subject|1|||
146962841|NCT05664672|530023314|FG002|Overall Study|Withdrawal by Subject|3|||
146962842|NCT05664672|530023315|FG003|Overall Study|Withdrawal by Subject|0|||
146962843|NCT05664672|530023316|FG004|Overall Study|Withdrawal by Subject|5|||
146962844|NCT05664672|530023317|FG005|Overall Study|Withdrawal by Subject|6|||
146962845|NCT05664672|530023312|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
146962846|NCT05664672|530023313|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
146962847|NCT05664672|530023314|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
146962848|NCT05664672|530023315|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
146962849|NCT05664672|530023316|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
146962850|NCT05664672|530023317|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
146962851|NCT05664672|530023312|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
147047274|NCT04358081|530334037|FG002|Study Completion Phase|Death|1|||
147047275|NCT04358081|530334035|FG000|Study Completion Phase|Lost to Follow-up|1|||
146962852|NCT05664672|530023313|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
146962853|NCT05664672|530023314|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
147047276|NCT04358081|530334036|FG001|Study Completion Phase|Lost to Follow-up|0|||
147047277|NCT04358081|530334037|FG002|Study Completion Phase|Lost to Follow-up|1|||
147047278|NCT00443729|530334038|FG000|Overall Study|Never Treated|0|||
147047279|NCT00443729|530334039|FG001|Overall Study|Never Treated|1|||
147047280|NCT00443729|530334038|FG000|Overall Study|Lack of Efficacy|4|||
147047281|NCT00443729|530334039|FG001|Overall Study|Lack of Efficacy|2|||
147047282|NCT00443729|530334038|FG000|Overall Study|Lost to Follow-up|0|||
147047283|NCT00443729|530334039|FG001|Overall Study|Lost to Follow-up|1|||
147047284|NCT00443729|530334038|FG000|Overall Study|Physician Decision|2|||
147047285|NCT00443729|530334039|FG001|Overall Study|Physician Decision|1|||
147047286|NCT00443729|530334038|FG000|Overall Study|Protocol Violation|1|||
147047287|NCT00443729|530334039|FG001|Overall Study|Protocol Violation|1|||
147047288|NCT00443729|530334038|FG000|Overall Study|Withdrawal by Subject|3|||
147047289|NCT00443729|530334039|FG001|Overall Study|Withdrawal by Subject|1|||
147047290|NCT01842438|530334040|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
147047291|NCT01842438|530334041|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
147047292|NCT01842438|530334040|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
147047293|NCT01842438|530334041|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
147047294|NCT01842438|530334040|FG000|T2: 6month Follow-up|Death|0|||
147047295|NCT01842438|530334041|FG001|T2: 6month Follow-up|Death|1|||
147047296|NCT00782626|530334045|FG000|Overall Study|Adverse Event|1|||
147047297|NCT00782626|530334045|FG000|Overall Study|Progressive Disease|5|||
147047298|NCT00782626|530334045|FG000|Overall Study|Other Complicating Disease|1|||
147047299|NCT04054765|530334046|FG000|Baseline|Withdrawal by Subject|5|||
147047300|NCT04054765|530334047|FG001|Baseline|Withdrawal by Subject|3|||
147047301|NCT04054765|530334046|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
147047302|NCT04054765|530334047|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
147047303|NCT04054765|530334046|FG000|3-month Follow up|Withdrawal by Subject|0|||
147047304|NCT04054765|530334047|FG001|3-month Follow up|Withdrawal by Subject|3|||
147047305|NCT04054765|530334046|FG000|6-month Follow up|Lost to Follow-up|32|||
147047306|NCT04054765|530334047|FG001|6-month Follow up|Lost to Follow-up|32|||
147047307|NCT03718832|530334052|FG000|Analysis Sample|Withdrawal by Subject|18|||
147047308|NCT03718832|530334053|FG001|Analysis Sample|Withdrawal by Subject|15|||
147047309|NCT03718832|530334052|FG000|Analysis Sample|Legal hold on data|1|||
147047310|NCT03718832|530334053|FG001|Analysis Sample|Legal hold on data|0|||
147047311|NCT03718832|530334052|FG000|Analysis Sample|Participant from treated household|0|||
147047312|NCT03718832|530334053|FG001|Analysis Sample|Participant from treated household|1|||
147047313|NCT03718832|530334052|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
147047314|NCT03718832|530334053|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
147047315|NCT01996241|530334054|FG000|Overall Study|Lost to Follow-up|252|||
147047316|NCT01996241|530334055|FG001|Overall Study|Lost to Follow-up|235|||
147047317|NCT01068262|530334058|FG000|Overall Study|Adverse Event|2|||
147047318|NCT01068262|530334059|FG001|Overall Study|Adverse Event|0|||
147047319|NCT01068262|530334060|FG002|Overall Study|Adverse Event|1|||
147047320|NCT01068262|530334061|FG003|Overall Study|Adverse Event|0|||
147047321|NCT01068262|530334058|FG000|Overall Study|Protocol Violation|1|||
147047322|NCT01068262|530334059|FG001|Overall Study|Protocol Violation|0|||
147047323|NCT01068262|530334060|FG002|Overall Study|Protocol Violation|0|||
147047324|NCT01068262|530334061|FG003|Overall Study|Protocol Violation|0|||
147047325|NCT01068262|530334058|FG000|Overall Study|Withdrawal by Subject|0|||
147047326|NCT01068262|530334059|FG001|Overall Study|Withdrawal by Subject|1|||
147047327|NCT01068262|530334060|FG002|Overall Study|Withdrawal by Subject|0|||
147047328|NCT01068262|530334061|FG003|Overall Study|Withdrawal by Subject|0|||
147047329|NCT04182490|530334062|FG000|Overall Study|Withdrawal by Subject|3|||
147047330|NCT04182490|530334063|FG001|Overall Study|Withdrawal by Subject|3|||
147047331|NCT04182490|530334062|FG000|Overall Study|Lost to Follow-up|0|||
147047332|NCT04182490|530334063|FG001|Overall Study|Lost to Follow-up|1|||
147047333|NCT04182490|530334062|FG000|Overall Study|Physician Decision|0|||
147047334|NCT04182490|530334063|FG001|Overall Study|Physician Decision|1|||
147047335|NCT05024747|530334064|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
147047336|NCT05024747|530334065|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
147047337|NCT05024747|530334064|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
147047338|NCT05024747|530334065|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
147047339|NCT05024747|530334064|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
147047340|NCT05024747|530334065|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
147047341|NCT04428034|530334066|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
147047342|NCT02556801|530334073|FG000|Overall Study|Lost to Follow-up|1|||
147047343|NCT02556801|530334074|FG001|Overall Study|Lost to Follow-up|0|||
147047344|NCT02556801|530334075|FG002|Overall Study|Lost to Follow-up|2|||
147047345|NCT02556801|530334076|FG003|Overall Study|Lost to Follow-up|0|||
147047346|NCT02556801|530334073|FG000|Overall Study|Withdrawal by Subject|1|||
147047347|NCT02556801|530334074|FG001|Overall Study|Withdrawal by Subject|1|||
147047348|NCT02556801|530334075|FG002|Overall Study|Withdrawal by Subject|1|||
147047349|NCT02556801|530334076|FG003|Overall Study|Withdrawal by Subject|0|||
147047350|NCT02556801|530334073|FG000|Overall Study|Protocol Violation|0|||
147047351|NCT02556801|530334074|FG001|Overall Study|Protocol Violation|3|||
147047352|NCT02556801|530334075|FG002|Overall Study|Protocol Violation|1|||
147047353|NCT02556801|530334076|FG003|Overall Study|Protocol Violation|1|||
147047354|NCT02556801|530334073|FG000|Overall Study|Adverse Event|0|||
147047355|NCT02556801|530334074|FG001|Overall Study|Adverse Event|2|||
147047356|NCT02556801|530334075|FG002|Overall Study|Adverse Event|0|||
147047357|NCT02556801|530334076|FG003|Overall Study|Adverse Event|3|||
147047358|NCT02556801|530334073|FG000|Overall Study|Pregnancy|0|||
147047359|NCT02556801|530334074|FG001|Overall Study|Pregnancy|1|||
147047360|NCT02556801|530334075|FG002|Overall Study|Pregnancy|0|||
147047361|NCT02556801|530334076|FG003|Overall Study|Pregnancy|0|||
147047362|NCT02556801|530334073|FG000|Overall Study|Personal reasons patient|0|||
147047363|NCT02556801|530334074|FG001|Overall Study|Personal reasons patient|0|||
147047364|NCT02556801|530334075|FG002|Overall Study|Personal reasons patient|0|||
147047365|NCT02556801|530334076|FG003|Overall Study|Personal reasons patient|1|||
147047366|NCT01942993|530334077|FG000|Overall Study|Lost to Follow-up|1|||
147047367|NCT01942993|530334077|FG000|Overall Study|Physician Decision|1|||
147047368|NCT01350271|530334081|FG000|Overall Study|Lost to Follow-up|21|||
147047369|NCT01350271|530334082|FG001|Overall Study|Lost to Follow-up|17|||
147047370|NCT01350271|530334083|FG002|Overall Study|Lost to Follow-up|26|||
147047371|NCT02906670|530334084|FG000|Cohort 1, QW|Radiological Progression|1|||
147047372|NCT02906670|530334085|FG001|Cohort 1, QW|Radiological Progression|0|||
147047373|NCT02906670|530334086|FG002|Cohort 1, QW|Radiological Progression|0|||
147047374|NCT02906670|530334087|FG003|Cohort 1, QW|Radiological Progression|0|||
147047375|NCT02906670|530334088|FG004|Cohort 1, QW|Radiological Progression|0|||
147047376|NCT02906670|530334089|FG005|Cohort 1, QW|Radiological Progression|0|||
147047377|NCT02906670|530334090|FG006|Cohort 1, QW|Radiological Progression|0|||
147047378|NCT02906670|530334091|FG007|Cohort 1, QW|Radiological Progression|0|||
147047379|NCT02906670|530334092|FG008|Cohort 1, QW|Radiological Progression|0|||
147047380|NCT02906670|530334093|FG009|Cohort 1, QW|Radiological Progression|0|||
147047381|NCT02906670|530334084|FG000|Cohort 2, QW|Radiological Progression|0|||
147047382|NCT02906670|530334085|FG001|Cohort 2, QW|Radiological Progression|1|||
147047383|NCT02906670|530334086|FG002|Cohort 2, QW|Radiological Progression|0|||
147047384|NCT02906670|530334087|FG003|Cohort 2, QW|Radiological Progression|0|||
147047385|NCT02906670|530334088|FG004|Cohort 2, QW|Radiological Progression|0|||
147047386|NCT02906670|530334089|FG005|Cohort 2, QW|Radiological Progression|0|||
147047387|NCT02906670|530334090|FG006|Cohort 2, QW|Radiological Progression|0|||
147047388|NCT02906670|530334091|FG007|Cohort 2, QW|Radiological Progression|0|||
147047389|NCT02906670|530334092|FG008|Cohort 2, QW|Radiological Progression|0|||
147047390|NCT02906670|530334093|FG009|Cohort 2, QW|Radiological Progression|0|||
147047391|NCT02906670|530334084|FG000|Cohort 3, QW|Radiological Progression|0|||
147047392|NCT02906670|530334085|FG001|Cohort 3, QW|Radiological Progression|0|||
147047393|NCT02906670|530334086|FG002|Cohort 3, QW|Radiological Progression|2|||
147047394|NCT02906670|530334087|FG003|Cohort 3, QW|Radiological Progression|0|||
147047395|NCT02906670|530334088|FG004|Cohort 3, QW|Radiological Progression|0|||
147047396|NCT02906670|530334089|FG005|Cohort 3, QW|Radiological Progression|0|||
147047397|NCT02906670|530334090|FG006|Cohort 3, QW|Radiological Progression|0|||
147047398|NCT02906670|530334091|FG007|Cohort 3, QW|Radiological Progression|0|||
147047399|NCT02906670|530334092|FG008|Cohort 3, QW|Radiological Progression|0|||
147047400|NCT02906670|530334093|FG009|Cohort 3, QW|Radiological Progression|0|||
147047401|NCT02906670|530334084|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
147047402|NCT02906670|530334085|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
147047403|NCT02906670|530334086|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
147047404|NCT02906670|530334087|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
147047405|NCT02906670|530334088|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
147047406|NCT02906670|530334089|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
147047407|NCT02906670|530334090|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
147047408|NCT02906670|530334091|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
147047409|NCT02906670|530334092|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
147047410|NCT02906670|530334093|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
147047411|NCT02906670|530334084|FG000|Cohort 4, Q2W|Radiological Progression|0|||
147047412|NCT02906670|530334085|FG001|Cohort 4, Q2W|Radiological Progression|0|||
147047413|NCT02906670|530334086|FG002|Cohort 4, Q2W|Radiological Progression|0|||
147047414|NCT02906670|530334087|FG003|Cohort 4, Q2W|Radiological Progression|0|||
147047415|NCT02906670|530334088|FG004|Cohort 4, Q2W|Radiological Progression|0|||
147047416|NCT02906670|530334089|FG005|Cohort 4, Q2W|Radiological Progression|1|||
147047417|NCT02906670|530334090|FG006|Cohort 4, Q2W|Radiological Progression|0|||
147047418|NCT02906670|530334091|FG007|Cohort 4, Q2W|Radiological Progression|0|||
147047419|NCT02906670|530334092|FG008|Cohort 4, Q2W|Radiological Progression|0|||
147047420|NCT02906670|530334093|FG009|Cohort 4, Q2W|Radiological Progression|0|||
147047421|NCT02906670|530334084|FG000|Cohort 4, Q2W|Clinical Progression|0|||
147047422|NCT02906670|530334085|FG001|Cohort 4, Q2W|Clinical Progression|0|||
147047423|NCT02906670|530334086|FG002|Cohort 4, Q2W|Clinical Progression|0|||
147047424|NCT02906670|530334087|FG003|Cohort 4, Q2W|Clinical Progression|0|||
147047425|NCT02906670|530334088|FG004|Cohort 4, Q2W|Clinical Progression|0|||
147047426|NCT02906670|530334089|FG005|Cohort 4, Q2W|Clinical Progression|2|||
147047427|NCT02906670|530334090|FG006|Cohort 4, Q2W|Clinical Progression|0|||
147047428|NCT02906670|530334091|FG007|Cohort 4, Q2W|Clinical Progression|0|||
147047429|NCT02906670|530334092|FG008|Cohort 4, Q2W|Clinical Progression|0|||
147047430|NCT02906670|530334093|FG009|Cohort 4, Q2W|Clinical Progression|0|||
147047431|NCT02906670|530334084|FG000|Cohort 5, Q2W|Radiological Progression|0|||
147047432|NCT02906670|530334085|FG001|Cohort 5, Q2W|Radiological Progression|0|||
147047433|NCT02906670|530334086|FG002|Cohort 5, Q2W|Radiological Progression|0|||
147047434|NCT02906670|530334087|FG003|Cohort 5, Q2W|Radiological Progression|0|||
147047435|NCT02906670|530334088|FG004|Cohort 5, Q2W|Radiological Progression|0|||
147047436|NCT02906670|530334089|FG005|Cohort 5, Q2W|Radiological Progression|0|||
147047437|NCT02906670|530334090|FG006|Cohort 5, Q2W|Radiological Progression|4|||
147047438|NCT02906670|530334091|FG007|Cohort 5, Q2W|Radiological Progression|0|||
147047439|NCT02906670|530334092|FG008|Cohort 5, Q2W|Radiological Progression|0|||
147047440|NCT02906670|530334093|FG009|Cohort 5, Q2W|Radiological Progression|0|||
147047441|NCT02906670|530334084|FG000|Cohort 5, Q2W|Clinical Progression|0|||
147047442|NCT02906670|530334085|FG001|Cohort 5, Q2W|Clinical Progression|0|||
147047443|NCT02906670|530334086|FG002|Cohort 5, Q2W|Clinical Progression|0|||
147047444|NCT02906670|530334087|FG003|Cohort 5, Q2W|Clinical Progression|0|||
147047445|NCT02906670|530334088|FG004|Cohort 5, Q2W|Clinical Progression|0|||
147047446|NCT02906670|530334089|FG005|Cohort 5, Q2W|Clinical Progression|0|||
147047447|NCT02906670|530334090|FG006|Cohort 5, Q2W|Clinical Progression|1|||
147047448|NCT02906670|530334091|FG007|Cohort 5, Q2W|Clinical Progression|0|||
147047449|NCT02906670|530334092|FG008|Cohort 5, Q2W|Clinical Progression|0|||
147047450|NCT02906670|530334093|FG009|Cohort 5, Q2W|Clinical Progression|0|||
147047451|NCT02906670|530334084|FG000|Cohort 5, Q2W|Adverse Event|0|||
147047452|NCT02906670|530334085|FG001|Cohort 5, Q2W|Adverse Event|0|||
147047453|NCT02906670|530334086|FG002|Cohort 5, Q2W|Adverse Event|0|||
147047454|NCT02906670|530334087|FG003|Cohort 5, Q2W|Adverse Event|0|||
147047455|NCT02906670|530334088|FG004|Cohort 5, Q2W|Adverse Event|0|||
147047456|NCT02906670|530334089|FG005|Cohort 5, Q2W|Adverse Event|0|||
147047457|NCT02906670|530334090|FG006|Cohort 5, Q2W|Adverse Event|1|||
147047458|NCT02906670|530334091|FG007|Cohort 5, Q2W|Adverse Event|0|||
147047459|NCT02906670|530334092|FG008|Cohort 5, Q2W|Adverse Event|0|||
147047460|NCT02906670|530334093|FG009|Cohort 5, Q2W|Adverse Event|0|||
147047461|NCT02906670|530334084|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147047462|NCT02906670|530334085|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147047463|NCT02906670|530334086|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147047464|NCT02906670|530334087|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147047465|NCT02906670|530334088|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147047466|NCT02906670|530334089|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147047467|NCT02906670|530334090|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
147047468|NCT02906670|530334091|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147047469|NCT02906670|530334092|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147047470|NCT02906670|530334093|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147047471|NCT02906670|530334084|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
147047472|NCT02906670|530334085|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
147047473|NCT02906670|530334086|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
147047474|NCT02906670|530334087|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
147047475|NCT02906670|530334088|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
147047476|NCT02906670|530334089|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
147047477|NCT02906670|530334090|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
147047478|NCT02906670|530334091|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
147047479|NCT02906670|530334092|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
147047480|NCT02906670|530334093|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
147047481|NCT02906670|530334084|FG000|Cohort 5P, Q2W|Adverse Event|0|||
147047482|NCT02906670|530334085|FG001|Cohort 5P, Q2W|Adverse Event|0|||
147047483|NCT02906670|530334086|FG002|Cohort 5P, Q2W|Adverse Event|0|||
147047484|NCT02906670|530334087|FG003|Cohort 5P, Q2W|Adverse Event|0|||
147047485|NCT02906670|530334088|FG004|Cohort 5P, Q2W|Adverse Event|0|||
147047486|NCT02906670|530334089|FG005|Cohort 5P, Q2W|Adverse Event|0|||
147047487|NCT02906670|530334090|FG006|Cohort 5P, Q2W|Adverse Event|0|||
147047488|NCT02906670|530334091|FG007|Cohort 5P, Q2W|Adverse Event|1|||
147047489|NCT02906670|530334092|FG008|Cohort 5P, Q2W|Adverse Event|0|||
147047490|NCT02906670|530334093|FG009|Cohort 5P, Q2W|Adverse Event|0|||
147047491|NCT02906670|530334084|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
147047492|NCT02906670|530334085|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
147047493|NCT02906670|530334086|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
147047494|NCT02906670|530334087|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
147047495|NCT02906670|530334088|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
147047496|NCT02906670|530334089|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
147047497|NCT02906670|530334090|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
147047498|NCT02906670|530334091|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
147047499|NCT02906670|530334092|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
147047500|NCT02906670|530334093|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
147047501|NCT02906670|530334084|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
147047502|NCT02906670|530334085|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
147047503|NCT02906670|530334086|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
147047504|NCT02906670|530334087|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
147047505|NCT02906670|530334088|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
146962854|NCT05664672|530023315|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
146962855|NCT05664672|530023316|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
146962856|NCT05664672|530023317|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
146962857|NCT04768881|530023320|FG000|Overall Study|Completed Study Follow-up|0|||
146962858|NCT04768881|530023321|FG001|Overall Study|Completed Study Follow-up|2|||
146962859|NCT04768881|530023320|FG000|Overall Study|Death|3|||
146962860|NCT04768881|530023321|FG001|Overall Study|Death|2|||
146962861|NCT04768881|530023320|FG000|Overall Study|Study Terminated by Sponsor|2|||
146962862|NCT04768881|530023321|FG001|Overall Study|Study Terminated by Sponsor|2|||
146962863|NCT04768881|530023320|FG000|Overall Study|Withdrawal by Subject|2|||
146962864|NCT04768881|530023321|FG001|Overall Study|Withdrawal by Subject|0|||
146962865|NCT04768881|530023320|FG000|Overall Study|Other|2|||
146962866|NCT04768881|530023321|FG001|Overall Study|Other|0|||
146962867|NCT04236986|530023322|FG000|Overall Study|Withdrawal by Subject|3|||
146962868|NCT04236986|530023323|FG001|Overall Study|Withdrawal by Subject|1|||
146962869|NCT01038609|530023326|FG000|Overall Study|Adverse Event|0|||
146962870|NCT01038609|530023327|FG001|Overall Study|Adverse Event|0|||
146962871|NCT01038609|530023328|FG002|Overall Study|Adverse Event|1|||
146962872|NCT01038609|530023329|FG003|Overall Study|Adverse Event|0|||
146962873|NCT01038609|530023330|FG004|Overall Study|Adverse Event|0|||
146962874|NCT01038609|530023326|FG000|Overall Study|Dosing Error|0|||
146962875|NCT01038609|530023327|FG001|Overall Study|Dosing Error|0|||
146962876|NCT01038609|530023328|FG002|Overall Study|Dosing Error|0|||
146962877|NCT01038609|530023329|FG003|Overall Study|Dosing Error|1|||
146962878|NCT01038609|530023330|FG004|Overall Study|Dosing Error|1|||
146962879|NCT01038609|530023326|FG000|Overall Study|Death in the Family|1|||
146962880|NCT01038609|530023327|FG001|Overall Study|Death in the Family|0|||
146962881|NCT01038609|530023328|FG002|Overall Study|Death in the Family|0|||
146962882|NCT01038609|530023329|FG003|Overall Study|Death in the Family|0|||
146962883|NCT01038609|530023330|FG004|Overall Study|Death in the Family|0|||
146962884|NCT01038609|530023326|FG000|Overall Study|Refusal of Blood Draws|0|||
146962885|NCT01038609|530023327|FG001|Overall Study|Refusal of Blood Draws|1|||
146962886|NCT01038609|530023328|FG002|Overall Study|Refusal of Blood Draws|0|||
146962887|NCT01038609|530023329|FG003|Overall Study|Refusal of Blood Draws|0|||
146962888|NCT01038609|530023330|FG004|Overall Study|Refusal of Blood Draws|0|||
146962889|NCT01078974|530023337|FG000|Overall Study|Adverse Event|3|||
146962890|NCT01349816|530023338|FG000|Overall Study|Withdrawal by Subject|4|||
146962891|NCT01349816|530023338|FG000|Overall Study|Physician Decision|1|||
146962892|NCT01349816|530023338|FG000|Overall Study|Adverse Event|14|||
146962893|NCT01349816|530023338|FG000|Overall Study|Lost to Follow-up|2|||
146962894|NCT01349816|530023338|FG000|Overall Study|Protocol Violation|1|||
146962895|NCT01349816|530023338|FG000|Overall Study|Protocol-specified criteria|8|||
146962896|NCT02569996|530023339|FG000|Overall Study|Adverse Event|6|||
146962897|NCT02569996|530023339|FG000|Overall Study|Physician Decision|3|||
146962898|NCT02569996|530023339|FG000|Overall Study|Progression of the disease|18|||
146962899|NCT02569996|530023339|FG000|Overall Study|New anti-lymphoma treatment|1|||
146962900|NCT02569996|530023339|FG000|Overall Study|Non-compliance|9|||
146962901|NCT02569996|530023339|FG000|Overall Study|Withdrawal by Subject|5|||
146962902|NCT02569996|530023339|FG000|Overall Study|Lost to Follow-up|5|||
146962903|NCT02569996|530023339|FG000|Overall Study|Complete remission|7|||
146962904|NCT02569996|530023339|FG000|Overall Study|Unknown reason|1|||
146962905|NCT01383317|530023340|FG000|Overall Study|Lost to Follow-up|2|||
146962906|NCT01383317|530023341|FG001|Overall Study|Lost to Follow-up|1|||
146962907|NCT01383317|530023340|FG000|Overall Study|Death|1|||
146962908|NCT01383317|530023341|FG001|Overall Study|Death|0|||
146962909|NCT01383317|530023340|FG000|Overall Study|Adverse Event|0|||
146962910|NCT01383317|530023341|FG001|Overall Study|Adverse Event|1|||
146962911|NCT01397409|530023343|FG000|Stage 2|Adverse Event|0|||
146962912|NCT01397409|530023344|FG001|Stage 2|Adverse Event|0|||
146962913|NCT01397409|530023345|FG002|Stage 2|Adverse Event|0|||
146962914|NCT01397409|530023346|FG003|Stage 2|Adverse Event|0|||
146962915|NCT01397409|530023347|FG004|Stage 2|Adverse Event|6|||
146962916|NCT01397409|530023348|FG005|Stage 2|Adverse Event|3|||
146962917|NCT01397409|530023349|FG006|Stage 2|Adverse Event|0|||
146962918|NCT01397409|530023350|FG007|Stage 2|Adverse Event|0|||
146962919|NCT01397409|530023351|FG008|Stage 2|Adverse Event|0|||
146962920|NCT01397409|530023352|FG009|Stage 2|Adverse Event|0|||
146962921|NCT01397409|530023343|FG000|Stage 2|Personal Reasons|0|||
146962922|NCT01397409|530023344|FG001|Stage 2|Personal Reasons|0|||
146962923|NCT01397409|530023345|FG002|Stage 2|Personal Reasons|0|||
146962924|NCT01397409|530023346|FG003|Stage 2|Personal Reasons|0|||
146962925|NCT01397409|530023347|FG004|Stage 2|Personal Reasons|1|||
146962926|NCT01397409|530023348|FG005|Stage 2|Personal Reasons|0|||
146962927|NCT01397409|530023349|FG006|Stage 2|Personal Reasons|0|||
146962928|NCT01397409|530023350|FG007|Stage 2|Personal Reasons|0|||
146962929|NCT01397409|530023351|FG008|Stage 2|Personal Reasons|0|||
146962930|NCT01397409|530023352|FG009|Stage 2|Personal Reasons|0|||
146962931|NCT01397409|530023343|FG000|Stage 2|Other Miscellaneous Reasons|0|||
146962932|NCT01397409|530023344|FG001|Stage 2|Other Miscellaneous Reasons|0|||
146962933|NCT01397409|530023345|FG002|Stage 2|Other Miscellaneous Reasons|0|||
146962934|NCT01397409|530023346|FG003|Stage 2|Other Miscellaneous Reasons|0|||
147047506|NCT02906670|530334089|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
147047507|NCT02906670|530334090|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
147047508|NCT02906670|530334091|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
147047509|NCT02906670|530334092|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
147047510|NCT02906670|530334093|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
147047511|NCT02906670|530334084|FG000|Cohort 4P, QW|Radiological Progression|0|||
147047512|NCT02906670|530334085|FG001|Cohort 4P, QW|Radiological Progression|0|||
147047513|NCT02906670|530334086|FG002|Cohort 4P, QW|Radiological Progression|0|||
147047514|NCT02906670|530334087|FG003|Cohort 4P, QW|Radiological Progression|3|||
147047515|NCT02906670|530334088|FG004|Cohort 4P, QW|Radiological Progression|0|||
147047516|NCT02906670|530334089|FG005|Cohort 4P, QW|Radiological Progression|0|||
147047517|NCT02906670|530334090|FG006|Cohort 4P, QW|Radiological Progression|0|||
147047518|NCT02906670|530334091|FG007|Cohort 4P, QW|Radiological Progression|0|||
147047519|NCT02906670|530334092|FG008|Cohort 4P, QW|Radiological Progression|0|||
147047520|NCT02906670|530334093|FG009|Cohort 4P, QW|Radiological Progression|0|||
147047521|NCT02906670|530334084|FG000|Cohort 7P, Q2W|Adverse Event|0|||
147047522|NCT02906670|530334085|FG001|Cohort 7P, Q2W|Adverse Event|0|||
147047523|NCT02906670|530334086|FG002|Cohort 7P, Q2W|Adverse Event|0|||
147047524|NCT02906670|530334087|FG003|Cohort 7P, Q2W|Adverse Event|0|||
147047525|NCT02906670|530334088|FG004|Cohort 7P, Q2W|Adverse Event|0|||
147047526|NCT02906670|530334089|FG005|Cohort 7P, Q2W|Adverse Event|0|||
147047527|NCT02906670|530334090|FG006|Cohort 7P, Q2W|Adverse Event|0|||
147047528|NCT02906670|530334091|FG007|Cohort 7P, Q2W|Adverse Event|0|||
147047529|NCT02906670|530334092|FG008|Cohort 7P, Q2W|Adverse Event|0|||
147047530|NCT02906670|530334093|FG009|Cohort 7P, Q2W|Adverse Event|1|||
147047531|NCT02906670|530334084|FG000|Cohort 7P, Q2W|Physician Decision|0|||
147047532|NCT02906670|530334085|FG001|Cohort 7P, Q2W|Physician Decision|0|||
147047533|NCT02906670|530334086|FG002|Cohort 7P, Q2W|Physician Decision|0|||
147047534|NCT02906670|530334087|FG003|Cohort 7P, Q2W|Physician Decision|0|||
147047535|NCT02906670|530334088|FG004|Cohort 7P, Q2W|Physician Decision|0|||
147047536|NCT02906670|530334089|FG005|Cohort 7P, Q2W|Physician Decision|0|||
147047537|NCT02906670|530334090|FG006|Cohort 7P, Q2W|Physician Decision|0|||
147047538|NCT02906670|530334091|FG007|Cohort 7P, Q2W|Physician Decision|0|||
147047539|NCT02906670|530334092|FG008|Cohort 7P, Q2W|Physician Decision|0|||
147047540|NCT02906670|530334093|FG009|Cohort 7P, Q2W|Physician Decision|1|||
147047541|NCT02906670|530334084|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147047542|NCT02906670|530334085|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147047543|NCT02906670|530334086|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147047544|NCT02906670|530334087|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147047545|NCT02906670|530334088|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147047546|NCT02906670|530334089|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147047547|NCT02906670|530334090|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147047548|NCT02906670|530334091|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147047549|NCT02906670|530334092|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147047550|NCT02906670|530334093|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
147047551|NCT02906670|530334084|FG000|Cohort 5P, QW|Radiological Progression|0|||
147047552|NCT02906670|530334085|FG001|Cohort 5P, QW|Radiological Progression|0|||
147047553|NCT02906670|530334086|FG002|Cohort 5P, QW|Radiological Progression|0|||
147047554|NCT02906670|530334087|FG003|Cohort 5P, QW|Radiological Progression|0|||
147047555|NCT02906670|530334088|FG004|Cohort 5P, QW|Radiological Progression|3|||
147047556|NCT02906670|530334089|FG005|Cohort 5P, QW|Radiological Progression|0|||
147047557|NCT02906670|530334090|FG006|Cohort 5P, QW|Radiological Progression|0|||
147047558|NCT02906670|530334091|FG007|Cohort 5P, QW|Radiological Progression|0|||
147047559|NCT02906670|530334092|FG008|Cohort 5P, QW|Radiological Progression|0|||
147047560|NCT02906670|530334093|FG009|Cohort 5P, QW|Radiological Progression|0|||
147047561|NCT01349192|530334094|FG000|Overall Study|Protocol Violation|0|||
147047562|NCT01349192|530334095|FG001|Overall Study|Protocol Violation|1|||
147047563|NCT01349192|530334094|FG000|Overall Study|Withdrawal by Subject|0|||
147047564|NCT01349192|530334095|FG001|Overall Study|Withdrawal by Subject|2|||
147047565|NCT01349192|530334094|FG000|Overall Study|Lost to Follow-up|1|||
147047566|NCT01349192|530334095|FG001|Overall Study|Lost to Follow-up|3|||
147047567|NCT01349192|530334094|FG000|Overall Study|Failure to adhere to Protocol|2|||
147047568|NCT01349192|530334095|FG001|Overall Study|Failure to adhere to Protocol|0|||
147047569|NCT01973439|530334096|FG000|Overall Study|Lost samples from one PK Day|2|||
147047570|NCT01973439|530334096|FG000|Overall Study|Vomiting after commencing once daily|1|||
147047571|NCT01973439|530334096|FG000|Overall Study|PK curve incomplete|2|||
147047572|NCT02038010|530334097|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
147047573|NCT02038010|530334098|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
147047574|NCT02038010|530334099|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
147047575|NCT02038010|530334100|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
147047576|NCT02038010|530334097|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
147047577|NCT02038010|530334098|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
147047578|NCT02038010|530334099|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
146962935|NCT01397409|530023347|FG004|Stage 2|Other Miscellaneous Reasons|1|||
146962936|NCT01397409|530023348|FG005|Stage 2|Other Miscellaneous Reasons|1|||
146962937|NCT01397409|530023349|FG006|Stage 2|Other Miscellaneous Reasons|0|||
146962938|NCT01397409|530023350|FG007|Stage 2|Other Miscellaneous Reasons|0|||
146962939|NCT01397409|530023351|FG008|Stage 2|Other Miscellaneous Reasons|0|||
146962940|NCT01397409|530023352|FG009|Stage 2|Other Miscellaneous Reasons|0|||
146962941|NCT01397409|530023343|FG000|Stage 3|Adverse Event|0|||
146962942|NCT01397409|530023344|FG001|Stage 3|Adverse Event|0|||
146962943|NCT01397409|530023345|FG002|Stage 3|Adverse Event|0|||
146962944|NCT01397409|530023346|FG003|Stage 3|Adverse Event|0|||
146962945|NCT01397409|530023347|FG004|Stage 3|Adverse Event|0|||
146962946|NCT01397409|530023348|FG005|Stage 3|Adverse Event|0|||
146962947|NCT01397409|530023349|FG006|Stage 3|Adverse Event|0|||
146962948|NCT01397409|530023350|FG007|Stage 3|Adverse Event|1|||
146962949|NCT01397409|530023351|FG008|Stage 3|Adverse Event|0|||
146962950|NCT01397409|530023352|FG009|Stage 3|Adverse Event|0|||
146962951|NCT01397409|530023343|FG000|Stage 3|Other Miscellaneous Reasons|0|||
146962952|NCT01397409|530023344|FG001|Stage 3|Other Miscellaneous Reasons|0|||
146962953|NCT01397409|530023345|FG002|Stage 3|Other Miscellaneous Reasons|0|||
146962954|NCT01397409|530023346|FG003|Stage 3|Other Miscellaneous Reasons|0|||
146962955|NCT01397409|530023347|FG004|Stage 3|Other Miscellaneous Reasons|0|||
146962956|NCT01397409|530023348|FG005|Stage 3|Other Miscellaneous Reasons|0|||
146962957|NCT01397409|530023349|FG006|Stage 3|Other Miscellaneous Reasons|0|||
146962958|NCT01397409|530023350|FG007|Stage 3|Other Miscellaneous Reasons|1|||
146962959|NCT01397409|530023351|FG008|Stage 3|Other Miscellaneous Reasons|0|||
146962960|NCT01397409|530023352|FG009|Stage 3|Other Miscellaneous Reasons|0|||
146962961|NCT02911285|530023353|FG000|Overall Study|Lost to Follow-up|8|||
146962962|NCT02911285|530023354|FG001|Overall Study|Lost to Follow-up|5|||
146962963|NCT02911285|530023353|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
146962964|NCT02911285|530023354|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
146962965|NCT01207427|530023355|FG000|Double-blind Treatment Period|Adverse Event|0|||
146962966|NCT01207427|530023356|FG001|Double-blind Treatment Period|Adverse Event|1|||
146962967|NCT01207427|530023357|FG002|Double-blind Treatment Period|Adverse Event|0|||
146962968|NCT01207427|530023355|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
146962969|NCT01207427|530023356|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
146962970|NCT01207427|530023357|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
146962971|NCT01207427|530023355|FG000|Double-blind Treatment Period|Protocol Violation|2|||
146962972|NCT01207427|530023356|FG001|Double-blind Treatment Period|Protocol Violation|1|||
146962973|NCT01207427|530023357|FG002|Double-blind Treatment Period|Protocol Violation|1|||
146962974|NCT01207427|530023355|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
146962975|NCT01207427|530023356|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
146962976|NCT01207427|530023357|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146962977|NCT03418727|530023358|FG000|Overall Study|Adverse Event|1|||
146962978|NCT03418727|530023359|FG001|Overall Study|Adverse Event|2|||
146962979|NCT03418727|530023360|FG002|Overall Study|Adverse Event|0|||
146962980|NCT03418727|530023358|FG000|Overall Study|Withdrawal by Subject|0|||
146962981|NCT03418727|530023359|FG001|Overall Study|Withdrawal by Subject|0|||
146962982|NCT03418727|530023360|FG002|Overall Study|Withdrawal by Subject|2|||
146962983|NCT00422227|530023361|FG000|Overall Study|Adverse Event|3|||
146962984|NCT00422227|530023362|FG001|Overall Study|Adverse Event|8|||
146962985|NCT00422227|530023361|FG000|Overall Study|Lost to Follow-up|1|||
146962986|NCT00422227|530023362|FG001|Overall Study|Lost to Follow-up|3|||
146962987|NCT00422227|530023361|FG000|Overall Study|Withdrawal by Subject|0|||
146962988|NCT00422227|530023362|FG001|Overall Study|Withdrawal by Subject|4|||
146962989|NCT00686894|530023364|FG000|Overall Study|Relapse|2|||
146962990|NCT00686894|530023364|FG000|Overall Study|Protocol Violation|4|||
146962991|NCT01791543|530023365|FG000|Overall Study|Lost to Follow-up|1|||
146962992|NCT01791543|530023365|FG000|Overall Study|Adverse Event|1|||
146962993|NCT01790633|530023370|FG000|Overall Study|Protocol Violation|1|||
146962994|NCT01790633|530023371|FG001|Overall Study|Protocol Violation|2|||
146962995|NCT01790633|530023370|FG000|Overall Study|Did not have serology performed|47|||
146962996|NCT01790633|530023371|FG001|Overall Study|Did not have serology performed|0|||
146962997|NCT01790633|530023370|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
146962998|NCT01790633|530023371|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
146962999|NCT01740297|530025363|FG000|Overall Study|Withdrawal by Subject|4|||
146963000|NCT01740297|530025364|FG001|Overall Study|Withdrawal by Subject|16|||
146963001|NCT01740297|530025365|FG002|Overall Study|Withdrawal by Subject|17|||
146963002|NCT01740297|530025363|FG000|Overall Study|Death|8|||
146963003|NCT01740297|530025364|FG001|Overall Study|Death|46|||
146963004|NCT01740297|530025365|FG002|Overall Study|Death|40|||
146963005|NCT01740297|530025363|FG000|Overall Study|Lost to Follow-up|1|||
146963006|NCT01740297|530025364|FG001|Overall Study|Lost to Follow-up|2|||
146963007|NCT01740297|530025365|FG002|Overall Study|Lost to Follow-up|4|||
146963008|NCT00761462|530025366|FG000|Treatment|Subjects never received study medication|23|||
146963009|NCT00761462|530025367|FG001|Treatment|Subjects never received study medication|12|||
146963010|NCT00761462|530025366|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
147047579|NCT02038010|530334100|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
147047580|NCT02038010|530334097|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
147047581|NCT02038010|530334098|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
147047582|NCT02038010|530334099|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
147047583|NCT02038010|530334100|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
147047584|NCT02038010|530334097|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
147047585|NCT02038010|530334098|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
147047586|NCT02038010|530334099|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
147047587|NCT02038010|530334100|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
147047588|NCT02038010|530334097|FG000|Follow Up|Death|4|||
147047589|NCT02038010|530334098|FG001|Follow Up|Death|3|||
147047590|NCT02038010|530334099|FG002|Follow Up|Death|0|||
147047591|NCT02038010|530334100|FG003|Follow Up|Death|0|||
147047592|NCT02038010|530334097|FG000|Follow Up|Other|3|||
147047593|NCT02038010|530334098|FG001|Follow Up|Other|0|||
147047594|NCT02038010|530334099|FG002|Follow Up|Other|0|||
147047595|NCT02038010|530334100|FG003|Follow Up|Other|0|||
147047596|NCT02262325|530334104|FG000|Overall Study|Death|16|||
147047597|NCT02262325|530334104|FG000|Overall Study|Lost to Follow-up|1|||
147047598|NCT02815995|530334105|FG000|Overall Study|Disease Progression|3|||
147047599|NCT02815995|530334106|FG001|Overall Study|Disease Progression|7|||
147047600|NCT02815995|530334107|FG002|Overall Study|Disease Progression|2|||
147047601|NCT02815995|530334108|FG003|Overall Study|Disease Progression|4|||
147047602|NCT02815995|530334109|FG004|Overall Study|Disease Progression|3|||
147047603|NCT02815995|530334110|FG005|Overall Study|Disease Progression|9|||
147047604|NCT02815995|530334111|FG006|Overall Study|Disease Progression|3|||
147047605|NCT02815995|530334112|FG007|Overall Study|Disease Progression|1|||
147047606|NCT02815995|530334105|FG000|Overall Study|Adverse Event|1|||
147047607|NCT02815995|530334106|FG001|Overall Study|Adverse Event|2|||
147047608|NCT02815995|530334107|FG002|Overall Study|Adverse Event|2|||
147047609|NCT02815995|530334108|FG003|Overall Study|Adverse Event|0|||
147047610|NCT02815995|530334109|FG004|Overall Study|Adverse Event|0|||
147047611|NCT02815995|530334110|FG005|Overall Study|Adverse Event|1|||
147047612|NCT02815995|530334111|FG006|Overall Study|Adverse Event|0|||
147047613|NCT02815995|530334112|FG007|Overall Study|Adverse Event|0|||
147047614|NCT02815995|530334105|FG000|Overall Study|Pregnancy|0|||
147047615|NCT02815995|530334106|FG001|Overall Study|Pregnancy|0|||
147047616|NCT02815995|530334107|FG002|Overall Study|Pregnancy|0|||
147047617|NCT02815995|530334108|FG003|Overall Study|Pregnancy|0|||
147047618|NCT02815995|530334109|FG004|Overall Study|Pregnancy|0|||
147047619|NCT02815995|530334110|FG005|Overall Study|Pregnancy|0|||
147047620|NCT02815995|530334111|FG006|Overall Study|Pregnancy|1|||
147047621|NCT02815995|530334112|FG007|Overall Study|Pregnancy|0|||
147047622|NCT01071915|530334113|FG000|Overall Study|Adverse Event|3|||
147047623|NCT01071915|530334113|FG000|Overall Study|Physician Decision|2|||
147047624|NCT01071915|530334113|FG000|Overall Study|Withdrawal by Subject|2|||
147047625|NCT01071915|530334113|FG000|Overall Study|Miscellaneous Reasons|2|||
147047626|NCT01125189|530334114|FG000|Treatment Period|Lack of Efficacy|15|||
147047627|NCT01125189|530334115|FG001|Treatment Period|Lack of Efficacy|18|||
147047628|NCT01125189|530334116|FG002|Treatment Period|Lack of Efficacy|25|||
147047629|NCT01125189|530334114|FG000|Treatment Period|Adverse Event|7|||
147047630|NCT01125189|530334115|FG001|Treatment Period|Adverse Event|8|||
146963011|NCT00761462|530025367|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
146963012|NCT00761462|530025366|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
146963013|NCT00761462|530025367|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
146963014|NCT00761462|530025366|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
146963015|NCT00761462|530025367|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
146963016|NCT02985541|530025371|FG000|Overall Study|Withdrawal by Subject|33|||
146963017|NCT02985541|530025371|FG000|Overall Study|Lost to Follow-up|26|||
146963018|NCT02985541|530025371|FG000|Overall Study|Adverse Event|27|||
146963019|NCT02985541|530025371|FG000|Overall Study|Physician Decision|2|||
146963020|NCT02985541|530025371|FG000|Overall Study|Pregnancy|2|||
146963021|NCT02985541|530025371|FG000|Overall Study|Wish for pregnancy|44|||
146963022|NCT02985541|530025371|FG000|Overall Study|Other reason|5|||
146963023|NCT02985541|530025371|FG000|Overall Study|Not valid for analysis|2|||
146963024|NCT02383966|530025372|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
146963025|NCT02383966|530025373|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
146963026|NCT02383966|530025372|FG000|Overall Study|Randomized, but not treated|1|||
146963027|NCT02383966|530025373|FG001|Overall Study|Randomized, but not treated|3|||
146963028|NCT02163759|530025374|FG000|Overall Study|Withdrawal by Subject|1|||
146963029|NCT02163759|530025375|FG001|Overall Study|Withdrawal by Subject|5|||
146963030|NCT02163759|530025376|FG002|Overall Study|Withdrawal by Subject|1|||
147047631|NCT01125189|530334116|FG002|Treatment Period|Adverse Event|8|||
147047632|NCT01125189|530334114|FG000|Treatment Period|Withdrawal by Subject|3|||
147047633|NCT01125189|530334115|FG001|Treatment Period|Withdrawal by Subject|1|||
147047634|NCT01125189|530334116|FG002|Treatment Period|Withdrawal by Subject|1|||
147047635|NCT01125189|530334114|FG000|Treatment Period|Death|1|||
147047636|NCT01125189|530334115|FG001|Treatment Period|Death|0|||
147047637|NCT01125189|530334116|FG002|Treatment Period|Death|0|||
146963031|NCT02163759|530025374|FG000|Overall Study|Adverse Event|0|||
146963032|NCT02163759|530025375|FG001|Overall Study|Adverse Event|0|||
146963033|NCT02163759|530025376|FG002|Overall Study|Adverse Event|1|||
146963034|NCT02163759|530025374|FG000|Overall Study|Death|0|||
146963035|NCT02163759|530025375|FG001|Overall Study|Death|0|||
146963036|NCT02163759|530025376|FG002|Overall Study|Death|1|||
146963037|NCT01479777|530025385|FG000|Overall Study|Physician Decision|2|||
146963038|NCT00451191|530025389|FG000|Overall Study|withdrawal or received alternate tx|15|||
146963039|NCT00451191|530025390|FG001|Overall Study|withdrawal or received alternate tx|11|||
146963040|NCT03575806|530025402|FG000|Overall Study|Withdrawal by Subject|0|||
146963041|NCT03575806|530025403|FG001|Overall Study|Withdrawal by Subject|2|||
146963042|NCT03575806|530025402|FG000|Overall Study|Protocol Violation|0|||
146963043|NCT03575806|530025403|FG001|Overall Study|Protocol Violation|2|||
146963044|NCT00219349|530025404|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
146963045|NCT00219349|530025404|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
146963046|NCT00219349|530025404|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
146963047|NCT00219349|530025404|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
146963048|NCT00270205|530025406|FG000|Overall Study|Lost to Follow-up|1|||
146963049|NCT00270205|530025407|FG001|Overall Study|Lost to Follow-up|0|||
146963050|NCT00270205|530025408|FG002|Overall Study|Lost to Follow-up|0|||
146963051|NCT00270205|530025409|FG003|Overall Study|Lost to Follow-up|1|||
146963052|NCT00869362|530025413|FG000|Overall Study|Death|0|||
146963053|NCT00869362|530025414|FG001|Overall Study|Death|2|||
146963054|NCT00869362|530025413|FG000|Overall Study|Lost to Follow-up|1|||
146963055|NCT00869362|530025414|FG001|Overall Study|Lost to Follow-up|3|||
146963056|NCT02646566|530025416|FG000|Overall Study|Lost to Follow-up|5|||
146963057|NCT02646566|530025417|FG001|Overall Study|Lost to Follow-up|4|||
146963058|NCT02646566|530025418|FG002|Overall Study|Lost to Follow-up|5|||
146963059|NCT02646566|530025416|FG000|Overall Study|Treatment failure|1|||
146963060|NCT02646566|530025417|FG001|Overall Study|Treatment failure|0|||
146963061|NCT02646566|530025418|FG002|Overall Study|Treatment failure|0|||
146963062|NCT02815540|530025423|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
146963063|NCT02222246|530025424|FG000|Overall Study|No Emergency Department Visits|27|||
146963064|NCT02222246|530025425|FG001|Overall Study|No Emergency Department Visits|26|||
146963065|NCT02222246|530025424|FG000|Overall Study|Physician Decision|0|||
146963066|NCT02222246|530025425|FG001|Overall Study|Physician Decision|1|||
146963067|NCT04887922|530025433|FG000|1st Randomization|Decided not to have surgery|0|||
146963068|NCT04887922|530025434|FG001|1st Randomization|Decided not to have surgery|1|||
146963069|NCT04887922|530025435|FG002|1st Randomization|Decided not to have surgery|0|||
146963070|NCT04887922|530025436|FG003|1st Randomization|Decided not to have surgery|0|||
146963071|NCT04887922|530025437|FG004|1st Randomization|Decided not to have surgery|0|||
146963072|NCT00953017|530025438|FG000|Overall Study|DId not show up for colonoscopy|4|||
146963073|NCT00953017|530025439|FG001|Overall Study|DId not show up for colonoscopy|4|||
146963074|NCT00953017|530025440|FG002|Overall Study|DId not show up for colonoscopy|5|||
146963075|NCT00953017|530025441|FG003|Overall Study|DId not show up for colonoscopy|4|||
146963076|NCT00953017|530025438|FG000|Overall Study|Incomplete data|1|||
146963077|NCT00953017|530025439|FG001|Overall Study|Incomplete data|1|||
146963078|NCT00953017|530025440|FG002|Overall Study|Incomplete data|0|||
146963079|NCT00953017|530025441|FG003|Overall Study|Incomplete data|0|||
146963080|NCT00953017|530025438|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
146963081|NCT00953017|530025439|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
146963082|NCT00953017|530025440|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
146963083|NCT00953017|530025441|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
146963084|NCT00953017|530025438|FG000|Overall Study|Brown stool prior to procedure|0|||
146963085|NCT00953017|530025439|FG001|Overall Study|Brown stool prior to procedure|0|||
146963086|NCT00953017|530025440|FG002|Overall Study|Brown stool prior to procedure|1|||
146963087|NCT00953017|530025441|FG003|Overall Study|Brown stool prior to procedure|0|||
146963088|NCT01300741|530025442|FG000|Overall Study|Lens deposits|1|||
146963089|NCT01300741|530025442|FG000|Overall Study|Lost to Follow-up|1|||
146963090|NCT01300741|530025442|FG000|Overall Study|Discomfort|1|||
146963091|NCT01548573|530025445|FG000|Overall Study|Death|3|||
146963092|NCT01548573|530025445|FG000|Overall Study|Withdrawal by Subject|2|||
146963093|NCT00290511|530025453|FG000|Overall Study|Adverse Event|1|||
146963094|NCT00290511|530025453|FG000|Overall Study|Death|1|||
146963095|NCT00290511|530025453|FG000|Overall Study|Physician Decision|1|||
146963096|NCT00290511|530025453|FG000|Overall Study|Withdrawal by Subject|1|||
146963097|NCT00558831|530025454|FG000|Overall Study|Lost to Follow-up|1|||
146963098|NCT00447265|530025455|FG000|Overall Study|Physician Decision|1|||
146963099|NCT00447265|530025456|FG001|Overall Study|Physician Decision|0|||
146963100|NCT02204449|530025457|FG000|Overall Study|Lost to Follow-up|7|||
146963101|NCT02204449|530025458|FG001|Overall Study|Lost to Follow-up|9|||
146963102|NCT02204449|530025457|FG000|Overall Study|Death|0|||
146963103|NCT02204449|530025458|FG001|Overall Study|Death|1|||
147047638|NCT01125189|530334114|FG000|Treatment Period|Lost to Follow-up|1|||
147047639|NCT01125189|530334115|FG001|Treatment Period|Lost to Follow-up|2|||
147047640|NCT01125189|530334116|FG002|Treatment Period|Lost to Follow-up|1|||
147047641|NCT01125189|530334114|FG000|Treatment Period|Poor compliance/noncompliance|0|||
147047642|NCT01125189|530334115|FG001|Treatment Period|Poor compliance/noncompliance|1|||
147047643|NCT01125189|530334116|FG002|Treatment Period|Poor compliance/noncompliance|0|||
147047644|NCT01125189|530334114|FG000|Treatment Period|Participants requested to discontinue|1|||
147047645|NCT01125189|530334115|FG001|Treatment Period|Participants requested to discontinue|3|||
147047646|NCT01125189|530334116|FG002|Treatment Period|Participants requested to discontinue|4|||
147047647|NCT01125189|530334114|FG000|Treatment Period|Other reasons|1|||
147047648|NCT01125189|530334115|FG001|Treatment Period|Other reasons|1|||
147047649|NCT01125189|530334116|FG002|Treatment Period|Other reasons|0|||
147047650|NCT01125189|530334114|FG000|Treatment Period|Completed 24 week treatment period only|2|||
147047651|NCT01125189|530334115|FG001|Treatment Period|Completed 24 week treatment period only|1|||
147047652|NCT01125189|530334116|FG002|Treatment Period|Completed 24 week treatment period only|2|||
147047653|NCT01125189|530334114|FG000|Follow up Period|Withdrawal by Subject|3|||
147047654|NCT01125189|530334115|FG001|Follow up Period|Withdrawal by Subject|2|||
147047655|NCT01125189|530334116|FG002|Follow up Period|Withdrawal by Subject|5|||
147047656|NCT01125189|530334114|FG000|Follow up Period|Death|1|||
147047657|NCT01125189|530334115|FG001|Follow up Period|Death|0|||
147047658|NCT01125189|530334116|FG002|Follow up Period|Death|0|||
147047659|NCT01125189|530334114|FG000|Follow up Period|Lost to Follow-up|12|||
147047660|NCT01125189|530334115|FG001|Follow up Period|Lost to Follow-up|9|||
147047661|NCT01125189|530334116|FG002|Follow up Period|Lost to Follow-up|6|||
147047662|NCT01125189|530334114|FG000|Follow up Period|Other reasons|4|||
147047663|NCT01125189|530334115|FG001|Follow up Period|Other reasons|4|||
147047664|NCT01125189|530334116|FG002|Follow up Period|Other reasons|5|||
147047665|NCT00114140|530334117|FG000|Overall Study|Protocol Violation|7|||
147047666|NCT00110396|530334118|FG000|Overall Study|Adverse Event|15|||
147047667|NCT00110396|530334118|FG000|Overall Study|Lost to Follow-up|1|||
147047668|NCT00110396|530334118|FG000|Overall Study|Administration of plasmapheresis|1|||
147047669|NCT00110396|530334118|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
147047670|NCT00110396|530334118|FG000|Overall Study|Lack of Efficacy|1|||
147047671|NCT00110396|530334118|FG000|Overall Study|Decided not to continue treatment|1|||
147047672|NCT00110396|530334118|FG000|Overall Study|Patient non-compliance|1|||
147047673|NCT00110396|530334118|FG000|Overall Study|Patient refused to continue|1|||
147047674|NCT00110396|530334118|FG000|Overall Study|Patient refused to participate|1|||
147047675|NCT00110396|530334118|FG000|Overall Study|Patient will|1|||
147047676|NCT00110396|530334118|FG000|Overall Study|Patient's decision|1|||
147047677|NCT00110396|530334118|FG000|Overall Study|Participation in MS vaccine study|1|||
147047678|NCT00110396|530334118|FG000|Overall Study|Pregnancy|1|||
147047679|NCT00110396|530334118|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
147047680|NCT00110396|530334118|FG000|Overall Study|Protocol Violation|2|||
147047681|NCT00110396|530334118|FG000|Overall Study|Patient refused to come back|1|||
147047682|NCT00110396|530334118|FG000|Overall Study|The patient has refused|2|||
147047683|NCT00110396|530334118|FG000|Overall Study|The patient has refused to visit site|1|||
147047684|NCT00110396|530334118|FG000|Overall Study|Patient is to be administered copaxone|1|||
147047685|NCT02414958|530334121|FG000|Overall Study|Adverse Event|6|||
147047686|NCT02414958|530334122|FG001|Overall Study|Adverse Event|6|||
147047687|NCT02414958|530334123|FG002|Overall Study|Adverse Event|3|||
147047688|NCT02414958|530334121|FG000|Overall Study|Protocol Violation|10|||
147047689|NCT02414958|530334122|FG001|Overall Study|Protocol Violation|3|||
147047690|NCT02414958|530334123|FG002|Overall Study|Protocol Violation|1|||
147047691|NCT02414958|530334121|FG000|Overall Study|Lost to Follow-up|7|||
147047692|NCT02414958|530334122|FG001|Overall Study|Lost to Follow-up|4|||
147047693|NCT02414958|530334123|FG002|Overall Study|Lost to Follow-up|0|||
147047694|NCT02414958|530334121|FG000|Overall Study|Withdrawal by Subject|5|||
147047695|NCT02414958|530334122|FG001|Overall Study|Withdrawal by Subject|3|||
147047696|NCT02414958|530334123|FG002|Overall Study|Withdrawal by Subject|5|||
147047697|NCT02414958|530334121|FG000|Overall Study|Other than specified|4|||
147047698|NCT02414958|530334122|FG001|Overall Study|Other than specified|4|||
147047699|NCT02414958|530334123|FG002|Overall Study|Other than specified|5|||
147047700|NCT00245466|530334125|FG000|Overall Study|Adverse Event|2|||
147047701|NCT00245466|530334126|FG001|Overall Study|Adverse Event|8|||
147047702|NCT00245466|530334127|FG002|Overall Study|Adverse Event|4|||
147047703|NCT00245466|530334125|FG000|Overall Study|Low prostate specific antigen suppr|16|||
147047704|NCT00245466|530334126|FG001|Overall Study|Low prostate specific antigen suppr|14|||
147047705|NCT00245466|530334127|FG002|Overall Study|Low prostate specific antigen suppr|5|||
147047706|NCT00245466|530334125|FG000|Overall Study|Insufficient testosterone suppr|12|||
147047707|NCT00245466|530334126|FG001|Overall Study|Insufficient testosterone suppr|12|||
147047708|NCT00245466|530334127|FG002|Overall Study|Insufficient testosterone suppr|21|||
147047709|NCT00245466|530334125|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
147047710|NCT00245466|530334126|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
147047711|NCT00245466|530334127|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
147047712|NCT00245466|530334125|FG000|Overall Study|Withdrawal by Subject|2|||
147047713|NCT00245466|530334126|FG001|Overall Study|Withdrawal by Subject|2|||
147047714|NCT00245466|530334127|FG002|Overall Study|Withdrawal by Subject|1|||
147047715|NCT00245466|530334125|FG000|Overall Study|Lost to Follow-up|3|||
147047716|NCT00245466|530334126|FG001|Overall Study|Lost to Follow-up|0|||
146963104|NCT02204449|530025457|FG000|Overall Study|Withdrawal by Subject|0|||
147047717|NCT00245466|530334127|FG002|Overall Study|Lost to Follow-up|0|||
147047718|NCT00245466|530334125|FG000|Overall Study|Disease progression|0|||
147047719|NCT00245466|530334126|FG001|Overall Study|Disease progression|3|||
147047720|NCT00245466|530334127|FG002|Overall Study|Disease progression|1|||
147047721|NCT00245466|530334125|FG000|Overall Study|Protocol Violation|1|||
147047722|NCT00245466|530334126|FG001|Overall Study|Protocol Violation|2|||
147047723|NCT00245466|530334127|FG002|Overall Study|Protocol Violation|2|||
147047724|NCT00245466|530334125|FG000|Overall Study|Death|0|||
147047725|NCT00245466|530334126|FG001|Overall Study|Death|2|||
147047726|NCT00245466|530334127|FG002|Overall Study|Death|0|||
147047727|NCT00245466|530334125|FG000|Overall Study|Administrative reasons|0|||
147047728|NCT00245466|530334126|FG001|Overall Study|Administrative reasons|1|||
147047729|NCT00245466|530334127|FG002|Overall Study|Administrative reasons|0|||
147047730|NCT03885661|530334128|FG000|Overall Study|Withdrawal by Subject|0|||
147047731|NCT03885661|530334129|FG001|Overall Study|Withdrawal by Subject|1|||
147047732|NCT03885661|530334128|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
147047733|NCT03885661|530334129|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
147047734|NCT05064397|530334130|FG000|Overall Study|Adverse Event|4|||
147047735|NCT05064397|530334130|FG000|Overall Study|Lack of Efficacy|12|||
147047736|NCT05064397|530334130|FG000|Overall Study|Withdrawal by Subject|3|||
147047737|NCT05064397|530334130|FG000|Overall Study|Lost to Follow-up|1|||
147047738|NCT05064397|530334130|FG000|Overall Study|Other reasons|3|||
147047739|NCT02232984|530334131|FG000|Overall Study|Withdrawal by Subject|5|||
147047740|NCT02232984|530334131|FG000|Overall Study|Death|1|||
147047741|NCT02232984|530334131|FG000|Overall Study|Investigator withdrawal|10|||
147047742|NCT02232984|530334131|FG000|Overall Study|Device implant unsuccessful|53|||
147047743|NCT02232984|530334131|FG000|Overall Study|not disclosed by site|7|||
147047744|NCT02232984|530334131|FG000|Overall Study|Protocol Violation|1|||
147047745|NCT00769379|530334134|FG000|Overall Study|No follow up data mapped to Other.|3|||
147047746|NCT00769379|530334135|FG001|Overall Study|No follow up data mapped to Other.|13|||
147047747|NCT00344448|530334138|FG000|Screening|Withdrawal by Subject|0|||
147047748|NCT00344448|530334139|FG001|Screening|Withdrawal by Subject|1|||
147047749|NCT00344448|530334138|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
147047750|NCT00344448|530334139|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
147047751|NCT00344448|530334138|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
147047752|NCT00344448|530334139|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
147047753|NCT00344448|530334138|FG000|Open Label|Withdrawal by Subject|1|||
147047754|NCT00344448|530334139|FG001|Open Label|Withdrawal by Subject|1|||
147047755|NCT00344448|530334138|FG000|Open Label|Study terminated|1|||
147047756|NCT00344448|530334139|FG001|Open Label|Study terminated|0|||
147047757|NCT04194645|530334142|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147047758|NCT04194645|530334143|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147047759|NCT04194645|530334144|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147047760|NCT04194645|530334145|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147047761|NCT04194645|530334146|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147047762|NCT04194645|530334147|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147047763|NCT04194645|530334148|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147047764|NCT04194645|530334149|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147047765|NCT04194645|530334150|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147047766|NCT04194645|530334151|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
147047767|NCT04194645|530334152|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147047768|NCT04194645|530334153|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147047769|NCT04194645|530334154|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147047770|NCT04194645|530334155|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147047771|NCT04194645|530334156|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147047772|NCT03076775|530334157|FG000|Overall Study|Lost to Follow-up|1|||
146963105|NCT02204449|530025458|FG001|Overall Study|Withdrawal by Subject|1|||
146963106|NCT04311411|530025461|FG000|Overall Study|Adverse Event|2|||
146963107|NCT04311411|530025462|FG001|Overall Study|Adverse Event|3|||
146963108|NCT04311411|530025463|FG002|Overall Study|Adverse Event|2|||
146963109|NCT04311411|530025461|FG000|Overall Study|Withdrawal by Subject|3|||
146963110|NCT04311411|530025462|FG001|Overall Study|Withdrawal by Subject|3|||
146963111|NCT04311411|530025463|FG002|Overall Study|Withdrawal by Subject|0|||
146963112|NCT01976663|530025467|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
146963113|NCT01976663|530025467|FG000|Overall Study|Personal Reasons|6|||
146963114|NCT01976663|530025467|FG000|Overall Study|Withdrawal by Subject|4|||
147047773|NCT03076775|530334158|FG001|Overall Study|Lost to Follow-up|0|||
147047774|NCT01783886|530334159|FG000|Overall Study|Lost to Follow-up|0|||
147047775|NCT01783886|530334160|FG001|Overall Study|Lost to Follow-up|3|||
147047776|NCT01783886|530334161|FG002|Overall Study|Lost to Follow-up|0|||
147047777|NCT01783886|530334159|FG000|Overall Study|Protocol deviation|0|||
147047778|NCT01783886|530334160|FG001|Overall Study|Protocol deviation|0|||
147047779|NCT01783886|530334161|FG002|Overall Study|Protocol deviation|2|||
147047780|NCT01783886|530334159|FG000|Overall Study|Withdrawal of consent by participant|1|||
147047781|NCT01783886|530334160|FG001|Overall Study|Withdrawal of consent by participant|3|||
147047782|NCT01783886|530334161|FG002|Overall Study|Withdrawal of consent by participant|4|||
147047783|NCT01783886|530334159|FG000|Overall Study|Adverse Event|4|||
147047784|NCT01783886|530334160|FG001|Overall Study|Adverse Event|5|||
147047785|NCT01783886|530334161|FG002|Overall Study|Adverse Event|4|||
147047786|NCT01855828|530334162|FG000|Overall Study|Adverse Event|1|||
147047787|NCT01855828|530334162|FG000|Overall Study|Withdrawal by Subject|1|||
147047788|NCT01866098|530334167|FG000|Overall Study|Lost to Follow-up|11|||
147047789|NCT01866098|530334168|FG001|Overall Study|Lost to Follow-up|18|||
147047790|NCT01866098|530334169|FG002|Overall Study|Lost to Follow-up|13|||
147047791|NCT01866098|530334167|FG000|Overall Study|Physician Decision|0|||
147047792|NCT01866098|530334168|FG001|Overall Study|Physician Decision|1|||
147047793|NCT01866098|530334169|FG002|Overall Study|Physician Decision|2|||
147047794|NCT01866098|530334167|FG000|Overall Study|Adverse Event|1|||
147047795|NCT01866098|530334168|FG001|Overall Study|Adverse Event|5|||
147047796|NCT01866098|530334169|FG002|Overall Study|Adverse Event|4|||
147047797|NCT01866098|530334167|FG000|Overall Study|Protocol Violation|1|||
147047798|NCT01866098|530334168|FG001|Overall Study|Protocol Violation|0|||
147047799|NCT01866098|530334169|FG002|Overall Study|Protocol Violation|0|||
147047800|NCT01866098|530334167|FG000|Overall Study|Withdrawal by Subject|1|||
147047801|NCT01866098|530334168|FG001|Overall Study|Withdrawal by Subject|2|||
147047802|NCT01866098|530334169|FG002|Overall Study|Withdrawal by Subject|0|||
147047803|NCT01866098|530334167|FG000|Overall Study|Unrelated Hospitalization|2|||
147047804|NCT01866098|530334168|FG001|Overall Study|Unrelated Hospitalization|0|||
147047805|NCT01866098|530334169|FG002|Overall Study|Unrelated Hospitalization|1|||
147047806|NCT01866098|530334167|FG000|Overall Study|Non-compliance|1|||
147047807|NCT01866098|530334168|FG001|Overall Study|Non-compliance|0|||
147047808|NCT01866098|530334169|FG002|Overall Study|Non-compliance|1|||
147047809|NCT01866098|530334167|FG000|Overall Study|Pregnancy|2|||
147047810|NCT01866098|530334168|FG001|Overall Study|Pregnancy|0|||
147047811|NCT01866098|530334169|FG002|Overall Study|Pregnancy|0|||
147047812|NCT01866098|530334167|FG000|Overall Study|Death|0|||
147047813|NCT01866098|530334168|FG001|Overall Study|Death|1|||
147047814|NCT01866098|530334169|FG002|Overall Study|Death|0|||
147047815|NCT04239027|530334170|FG000|Overall Study|Adverse Event|4|||
147047816|NCT04239027|530334170|FG000|Overall Study|Withdrawal by Subject|9|||
147047817|NCT04239027|530334170|FG000|Overall Study|Death|1|||
147047818|NCT04239027|530334170|FG000|Overall Study|Physician Decision|9|||
147047819|NCT04239027|530334170|FG000|Overall Study|Lost to Follow-up|2|||
147047820|NCT04239027|530334170|FG000|Overall Study|Lack of Efficacy|1|||
147047821|NCT03172494|530334177|FG000|Overall Study|Adverse Event|5|||
147047822|NCT03172494|530334178|FG001|Overall Study|Adverse Event|1|||
147047823|NCT03172494|530334179|FG002|Overall Study|Adverse Event|15|||
147047824|NCT03172494|530334177|FG000|Overall Study|Protocol Violation|3|||
147047825|NCT03172494|530334178|FG001|Overall Study|Protocol Violation|2|||
147047826|NCT03172494|530334179|FG002|Overall Study|Protocol Violation|1|||
147047827|NCT03172494|530334177|FG000|Overall Study|Lack of Efficacy|0|||
147047828|NCT03172494|530334178|FG001|Overall Study|Lack of Efficacy|0|||
147047829|NCT03172494|530334179|FG002|Overall Study|Lack of Efficacy|4|||
147047830|NCT03172494|530334177|FG000|Overall Study|Pregnancy|0|||
147047831|NCT03172494|530334178|FG001|Overall Study|Pregnancy|1|||
147047832|NCT03172494|530334179|FG002|Overall Study|Pregnancy|0|||
147047833|NCT03172494|530334177|FG000|Overall Study|Withdrawal by Subject|10|||
147047834|NCT03172494|530334178|FG001|Overall Study|Withdrawal by Subject|8|||
147047835|NCT03172494|530334179|FG002|Overall Study|Withdrawal by Subject|8|||
147047836|NCT03172494|530334177|FG000|Overall Study|Severe hypoglycaemic episode|0|||
147047837|NCT03172494|530334178|FG001|Overall Study|Severe hypoglycaemic episode|0|||
147047838|NCT03172494|530334179|FG002|Overall Study|Severe hypoglycaemic episode|1|||
147047839|NCT03172494|530334177|FG000|Overall Study|Non-compliance towards treatment|2|||
147047840|NCT03172494|530334178|FG001|Overall Study|Non-compliance towards treatment|0|||
147047841|NCT03172494|530334179|FG002|Overall Study|Non-compliance towards treatment|0|||
147047842|NCT00143390|530334180|FG000|Overall Study|Death|2|||
147047843|NCT00143390|530334181|FG001|Overall Study|Death|0|||
147047844|NCT00143390|530334180|FG000|Overall Study|Not meeting entry criteria|2|||
147047845|NCT00143390|530334181|FG001|Overall Study|Not meeting entry criteria|5|||
147047846|NCT00143390|530334180|FG000|Overall Study|Withdrawal by Subject|4|||
147047847|NCT00143390|530334181|FG001|Overall Study|Withdrawal by Subject|4|||
147047848|NCT00143390|530334180|FG000|Overall Study|Progressive disease|119|||
147047849|NCT00143390|530334181|FG001|Overall Study|Progressive disease|115|||
147047850|NCT00143390|530334180|FG000|Overall Study|Protocol Violation|2|||
147047851|NCT00143390|530334181|FG001|Overall Study|Protocol Violation|0|||
147047852|NCT00143390|530334180|FG000|Overall Study|Study termination|10|||
147047853|NCT00143390|530334181|FG001|Overall Study|Study termination|15|||
147047854|NCT00143390|530334180|FG000|Overall Study|Adverse Event|9|||
147047855|NCT00143390|530334181|FG001|Overall Study|Adverse Event|8|||
147047856|NCT00143390|530334180|FG000|Overall Study|Other|1|||
147047857|NCT00143390|530334181|FG001|Overall Study|Other|2|||
147047858|NCT02764151|530334184|FG000|Overall Study|Subject refused further follow-up|0|||
147047859|NCT02764151|530334185|FG001|Overall Study|Subject refused further follow-up|0|||
147047860|NCT02764151|530334186|FG002|Overall Study|Subject refused further follow-up|0|||
147047861|NCT02764151|530334187|FG003|Overall Study|Subject refused further follow-up|1|||
147047862|NCT02764151|530334184|FG000|Overall Study|Other|0|||
147047863|NCT02764151|530334185|FG001|Overall Study|Other|0|||
147047864|NCT02764151|530334186|FG002|Overall Study|Other|0|||
147047865|NCT02764151|530334187|FG003|Overall Study|Other|2|||
147047866|NCT01450683|530334188|FG000|Overall Study|Adverse Event|2|||
147047867|NCT02108912|530334190|FG000|Overall Study|Lost to Follow-up|1|||
147047868|NCT02108912|530334191|FG001|Overall Study|Lost to Follow-up|1|||
147047869|NCT02108912|530334190|FG000|Overall Study|lack of transportation|1|||
147047870|NCT02108912|530334191|FG001|Overall Study|lack of transportation|0|||
147047871|NCT02108912|530334190|FG000|Overall Study|high blood pressure|1|||
147047872|NCT02108912|530334191|FG001|Overall Study|high blood pressure|0|||
147047873|NCT03180645|530334192|FG000|Overall Study|Adverse Event|0|||
147047874|NCT03180645|530334193|FG001|Overall Study|Adverse Event|1|||
147047875|NCT03180645|530334194|FG002|Overall Study|Adverse Event|2|||
147047876|NCT00852202|530334199|FG000|Overall Study|Adverse Event|2|||
147047877|NCT00852202|530334200|FG001|Overall Study|Adverse Event|3|||
147047878|NCT00852202|530334201|FG002|Overall Study|Adverse Event|7|||
147047879|NCT00852202|530334199|FG000|Overall Study|Lack of Efficacy|4|||
147047880|NCT00852202|530334200|FG001|Overall Study|Lack of Efficacy|1|||
147047881|NCT00852202|530334201|FG002|Overall Study|Lack of Efficacy|2|||
147047882|NCT00852202|530334199|FG000|Overall Study|Protocol Violation|2|||
147047883|NCT00852202|530334200|FG001|Overall Study|Protocol Violation|2|||
147047884|NCT00852202|530334201|FG002|Overall Study|Protocol Violation|7|||
147047885|NCT00852202|530334199|FG000|Overall Study|Withdrawal by Subject|3|||
147047886|NCT00852202|530334200|FG001|Overall Study|Withdrawal by Subject|1|||
147047887|NCT00852202|530334201|FG002|Overall Study|Withdrawal by Subject|2|||
147047888|NCT00852202|530334199|FG000|Overall Study|Lost to Follow-up|5|||
147047889|NCT00852202|530334200|FG001|Overall Study|Lost to Follow-up|5|||
147047890|NCT00852202|530334201|FG002|Overall Study|Lost to Follow-up|6|||
147047891|NCT00852202|530334199|FG000|Overall Study|pregnancy,moving away and surgery|1|||
147047892|NCT00852202|530334200|FG001|Overall Study|pregnancy,moving away and surgery|0|||
147047893|NCT00852202|530334201|FG002|Overall Study|pregnancy,moving away and surgery|2|||
147047894|NCT02905032|530334204|FG000|Overall Study|Withdrawal by Subject|2|||
147047895|NCT02905032|530334205|FG001|Overall Study|Withdrawal by Subject|0|||
147047896|NCT02905032|530334206|FG002|Overall Study|Withdrawal by Subject|0|||
147047897|NCT02905032|530334204|FG000|Overall Study|Protocol Violation|6|||
147047898|NCT02905032|530334205|FG001|Overall Study|Protocol Violation|12|||
147047899|NCT02905032|530334206|FG002|Overall Study|Protocol Violation|0|||
147047900|NCT00739063|530334207|FG000|Overall Study|Screen failures|8|||
147047901|NCT06082843|530336319|FG000|Overall Study|Withdrawal by Subject|0|||
147047902|NCT06082843|530336320|FG001|Overall Study|Withdrawal by Subject|2|||
147047903|NCT06082843|530336319|FG000|Overall Study|Study terminated by sponsor|12|||
147047904|NCT06082843|530336320|FG001|Overall Study|Study terminated by sponsor|8|||
147047905|NCT01368497|530336321|FG000|Overall Study|Lost to Follow-up|2|||
147047906|NCT01130532|530336322|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
147047907|NCT01130532|530336323|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
147047908|NCT01130532|530336324|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
147047909|NCT01130532|530336325|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
147047910|NCT01130532|530336322|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
147047911|NCT01130532|530336323|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
147047912|NCT01130532|530336324|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
147047913|NCT01130532|530336325|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
147047914|NCT01130532|530336322|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
147047915|NCT01130532|530336323|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
147047916|NCT01130532|530336324|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
147047917|NCT01130532|530336325|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
147047918|NCT01130532|530336322|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
147047919|NCT01130532|530336323|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
147047920|NCT01130532|530336324|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
147047921|NCT01130532|530336325|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
147047922|NCT01130532|530336322|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
147047923|NCT01130532|530336323|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
147047924|NCT01130532|530336324|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
147047925|NCT01130532|530336325|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
147047926|NCT01130532|530336322|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
147047927|NCT01130532|530336323|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
147047928|NCT01130532|530336324|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
147047929|NCT01130532|530336325|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
147047930|NCT01130532|530336322|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
147047931|NCT01130532|530336323|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
147047932|NCT01130532|530336324|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
146963115|NCT01976663|530025467|FG000|Overall Study|Screen Failure|3|||
146963116|NCT01976663|530025467|FG000|Overall Study|Adverse Event|2|||
146963117|NCT01976663|530025467|FG000|Overall Study|Lost to Follow-up|3|||
146963118|NCT01151085|530025470|FG000|Overall Study|Lost to Follow-up|31|||
146963119|NCT01151085|530025470|FG000|Overall Study|Protocol Violation|25|||
146963120|NCT00489411|530025471|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
146963121|NCT00489411|530025472|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
146963122|NCT00489411|530025471|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
146963123|NCT00489411|530025472|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
146963124|NCT00489411|530025471|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
146963125|NCT00489411|530025472|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
146963126|NCT00489411|530025471|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
146963127|NCT00489411|530025472|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
146963128|NCT00489411|530025471|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
146963129|NCT00489411|530025472|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
146963130|NCT01748162|530025473|FG000|Overall Study|no additional croup episodes to evaluate|2|||
146963131|NCT01748162|530025474|FG001|Overall Study|no additional croup episodes to evaluate|2|||
146963132|NCT01748162|530025473|FG000|Overall Study|participant consented but did not begin|0|||
146963133|NCT01748162|530025474|FG001|Overall Study|participant consented but did not begin|1|||
146963134|NCT01748162|530025473|FG000|Overall Study|reasons not available|3|||
146963135|NCT01748162|530025474|FG001|Overall Study|reasons not available|2|||
146963136|NCT03841331|530025475|FG000|Overall Study|Withdrawal by Subject|4|||
146963137|NCT03841331|530025476|FG001|Overall Study|Withdrawal by Subject|9|||
146963138|NCT03841331|530025475|FG000|Overall Study|Lost to Follow-up|5|||
146963139|NCT03841331|530025476|FG001|Overall Study|Lost to Follow-up|1|||
146963140|NCT04640168|530025477|FG000|Overall Study|Withdrawal by Subject|8|||
146963141|NCT04640168|530025478|FG001|Overall Study|Withdrawal by Subject|7|||
146963142|NCT04640168|530025477|FG000|Overall Study|Lost to Follow-up|1|||
146963143|NCT04640168|530025478|FG001|Overall Study|Lost to Follow-up|0|||
146963144|NCT04640168|530025477|FG000|Overall Study|Enrolled but not treated|12|||
146963145|NCT04640168|530025478|FG001|Overall Study|Enrolled but not treated|12|||
146963146|NCT00779857|530025479|FG000|Overall Study|Death|1|||
146963147|NCT00779857|530025479|FG000|Overall Study|Withdrawal by Subject|3|||
146963148|NCT00779857|530025479|FG000|Overall Study|Missed Visit|2|||
146963149|NCT00442572|530025487|FG000|Overall Study|Relapse|8|||
146963150|NCT00442572|530025488|FG001|Overall Study|Relapse|1|||
146963151|NCT00442572|530025487|FG000|Overall Study|Lost to Follow-up|0|||
146963152|NCT00442572|530025488|FG001|Overall Study|Lost to Follow-up|1|||
146963153|NCT00442572|530025487|FG000|Overall Study|Withdrawal by Subject|0|||
146963154|NCT00442572|530025488|FG001|Overall Study|Withdrawal by Subject|1|||
146963155|NCT03557775|530025489|FG000|Overall Study|Withdrawal by Subject|1|||
146963156|NCT03557775|530025490|FG001|Overall Study|Withdrawal by Subject|2|||
146963157|NCT03557775|530025491|FG002|Overall Study|Withdrawal by Subject|4|||
146963158|NCT03557775|530025489|FG000|Overall Study|Physician Decision|0|||
146963159|NCT03557775|530025490|FG001|Overall Study|Physician Decision|1|||
146963160|NCT03557775|530025491|FG002|Overall Study|Physician Decision|0|||
146963161|NCT00276458|530025498|FG000|Overall Study|Adverse Event|0|||
146963162|NCT00276458|530025499|FG001|Overall Study|Adverse Event|2|||
146963163|NCT00276458|530025498|FG000|Overall Study|Lost to Follow-up|2|||
146963164|NCT00276458|530025499|FG001|Overall Study|Lost to Follow-up|2|||
146963165|NCT00276458|530025498|FG000|Overall Study|Protocol Violation|4|||
146963166|NCT00276458|530025499|FG001|Overall Study|Protocol Violation|3|||
146963167|NCT02283411|530025500|FG000|Overall Study|Withdrawal by Subject|3|||
146963168|NCT02283411|530025500|FG000|Overall Study|Screen Failed|28|||
146963169|NCT05437211|530025501|FG000|Overall Study|Patient's decision|1|||
146963170|NCT05437211|530025502|FG001|Overall Study|Patient's decision|1|||
146963171|NCT03282123|530025503|FG000|Overall Study|Withdrawal by Subject|5|||
146963172|NCT01463631|530025507|FG000|Overall Study|Withdrawal by Subject|0|||
146963173|NCT01463631|530025508|FG001|Overall Study|Withdrawal by Subject|0|||
146963174|NCT01463631|530025509|FG002|Overall Study|Withdrawal by Subject|0|||
146963175|NCT01463631|530025510|FG003|Overall Study|Withdrawal by Subject|1|||
146963176|NCT01463631|530025507|FG000|Overall Study|Death|0|||
146963177|NCT01463631|530025508|FG001|Overall Study|Death|0|||
146963178|NCT01463631|530025509|FG002|Overall Study|Death|1|||
146963179|NCT01463631|530025510|FG003|Overall Study|Death|0|||
146963180|NCT01463631|530025507|FG000|Overall Study|Progressive Disease|0|||
146963181|NCT01463631|530025508|FG001|Overall Study|Progressive Disease|0|||
146963182|NCT01463631|530025509|FG002|Overall Study|Progressive Disease|0|||
146963183|NCT01463631|530025510|FG003|Overall Study|Progressive Disease|5|||
146963184|NCT05966129|530025513|FG000|Overall Study|Death|1|||
146963185|NCT05966129|530025514|FG001|Overall Study|Death|2|||
146963186|NCT05966129|530025513|FG000|Overall Study|Lost to Follow-up|63|||
146963187|NCT05966129|530025514|FG001|Overall Study|Lost to Follow-up|66|||
146963188|NCT05966129|530025513|FG000|Overall Study|Protocol Violation|1|||
146963189|NCT05966129|530025514|FG001|Overall Study|Protocol Violation|0|||
146963190|NCT05966129|530025513|FG000|Overall Study|Withdrawal by Subject|26|||
147047933|NCT01130532|530336325|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
147047934|NCT01130532|530336322|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
147047935|NCT01130532|530336323|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
147047936|NCT01130532|530336324|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
147047937|NCT01130532|530336325|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
147047938|NCT01130532|530336322|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
147047939|NCT01130532|530336323|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
147047940|NCT01130532|530336324|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
147047941|NCT01130532|530336325|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
147047942|NCT01130532|530336322|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
147047943|NCT01130532|530336323|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
147047944|NCT01130532|530336324|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
147047945|NCT01130532|530336325|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
147047946|NCT01130532|530336322|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
147047947|NCT01130532|530336323|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
147047948|NCT01130532|530336324|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
147047949|NCT01130532|530336325|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
147047950|NCT02762929|530336326|FG000|Overall Study|Adverse Event|0|||
147047951|NCT02762929|530336327|FG001|Overall Study|Adverse Event|0|||
147047952|NCT02762929|530336328|FG002|Overall Study|Adverse Event|0|||
147047953|NCT02762929|530336329|FG003|Overall Study|Adverse Event|1|||
147047954|NCT02762929|530336330|FG004|Overall Study|Adverse Event|0|||
147047955|NCT02762929|530336331|FG005|Overall Study|Adverse Event|0|||
147047956|NCT02762929|530336326|FG000|Overall Study|Lost to Follow-up|1|||
147047957|NCT02762929|530336327|FG001|Overall Study|Lost to Follow-up|2|||
147047958|NCT02762929|530336328|FG002|Overall Study|Lost to Follow-up|0|||
147047959|NCT02762929|530336329|FG003|Overall Study|Lost to Follow-up|1|||
147047960|NCT02762929|530336330|FG004|Overall Study|Lost to Follow-up|0|||
147047961|NCT02762929|530336331|FG005|Overall Study|Lost to Follow-up|0|||
147047962|NCT02762929|530336326|FG000|Overall Study|Withdrawal by Subject|0|||
147047963|NCT02762929|530336327|FG001|Overall Study|Withdrawal by Subject|1|||
147047964|NCT02762929|530336328|FG002|Overall Study|Withdrawal by Subject|0|||
147047965|NCT02762929|530336329|FG003|Overall Study|Withdrawal by Subject|0|||
147047966|NCT02762929|530336330|FG004|Overall Study|Withdrawal by Subject|0|||
147047967|NCT02762929|530336331|FG005|Overall Study|Withdrawal by Subject|0|||
147047968|NCT02762929|530336326|FG000|Overall Study|exclusionary medication disclosed late|0|||
147047969|NCT02762929|530336327|FG001|Overall Study|exclusionary medication disclosed late|0|||
147047970|NCT02762929|530336328|FG002|Overall Study|exclusionary medication disclosed late|0|||
147047971|NCT02762929|530336329|FG003|Overall Study|exclusionary medication disclosed late|1|||
147047972|NCT02762929|530336330|FG004|Overall Study|exclusionary medication disclosed late|0|||
146849943|NCT03738423|529618939|FG003|Overall Study|Withdrawal by Subject|12|||
146849944|NCT03738423|529618940|FG004|Overall Study|Withdrawal by Subject|10|||
146849945|NCT03738423|529618936|FG000|Overall Study|Lack of Efficacy|3|||
146849946|NCT03738423|529618937|FG001|Overall Study|Lack of Efficacy|1|||
146849947|NCT03738423|529618938|FG002|Overall Study|Lack of Efficacy|1|||
146849948|NCT03738423|529618939|FG003|Overall Study|Lack of Efficacy|1|||
146849949|NCT03738423|529618940|FG004|Overall Study|Lack of Efficacy|2|||
146849950|NCT03738423|529618936|FG000|Overall Study|Lost to Follow-up|1|||
146849951|NCT03738423|529618937|FG001|Overall Study|Lost to Follow-up|0|||
146849952|NCT03738423|529618938|FG002|Overall Study|Lost to Follow-up|1|||
146849953|NCT03738423|529618939|FG003|Overall Study|Lost to Follow-up|1|||
146849954|NCT03738423|529618940|FG004|Overall Study|Lost to Follow-up|0|||
146849955|NCT03738423|529618936|FG000|Overall Study|Protocol Violation|1|||
146849956|NCT03738423|529618937|FG001|Overall Study|Protocol Violation|0|||
146849957|NCT03738423|529618938|FG002|Overall Study|Protocol Violation|0|||
146849958|NCT03738423|529618939|FG003|Overall Study|Protocol Violation|0|||
146849959|NCT03738423|529618940|FG004|Overall Study|Protocol Violation|1|||
146849960|NCT03738423|529618936|FG000|Overall Study|Physician Decision|0|||
146849961|NCT03738423|529618937|FG001|Overall Study|Physician Decision|0|||
146849962|NCT03738423|529618938|FG002|Overall Study|Physician Decision|1|||
147047973|NCT02762929|530336331|FG005|Overall Study|exclusionary medication disclosed late|0|||
147047974|NCT02656303|530336333|FG000|Overall Study|Adverse Event|3|||
147047975|NCT02656303|530336334|FG001|Overall Study|Adverse Event|2|||
147047976|NCT02656303|530336335|FG002|Overall Study|Adverse Event|0|||
147047977|NCT02656303|530336333|FG000|Overall Study|Death|12|||
147047978|NCT02656303|530336334|FG001|Overall Study|Death|4|||
147047979|NCT02656303|530336335|FG002|Overall Study|Death|1|||
147047980|NCT02656303|530336333|FG000|Overall Study|Lack of Efficacy|1|||
147047981|NCT02656303|530336334|FG001|Overall Study|Lack of Efficacy|0|||
146849963|NCT03738423|529618939|FG003|Overall Study|Physician Decision|0|||
146849964|NCT03738423|529618940|FG004|Overall Study|Physician Decision|1|||
146849965|NCT03738423|529618936|FG000|Overall Study|Death|0|||
146849966|NCT03738423|529618937|FG001|Overall Study|Death|0|||
146849967|NCT03738423|529618938|FG002|Overall Study|Death|0|||
146849968|NCT03738423|529618939|FG003|Overall Study|Death|0|||
146849969|NCT03738423|529618940|FG004|Overall Study|Death|1|||
146849970|NCT03738423|529618936|FG000|Overall Study|Randomized but never treated|0|||
147047982|NCT02656303|530336335|FG002|Overall Study|Lack of Efficacy|0|||
147047983|NCT02656303|530336333|FG000|Overall Study|Non-Compliance with Study|1|||
147047984|NCT02656303|530336334|FG001|Overall Study|Non-Compliance with Study|1|||
147047985|NCT02656303|530336335|FG002|Overall Study|Non-Compliance with Study|0|||
147047986|NCT02656303|530336333|FG000|Overall Study|Investigator Decision|2|||
147047987|NCT02656303|530336334|FG001|Overall Study|Investigator Decision|1|||
147047988|NCT02656303|530336335|FG002|Overall Study|Investigator Decision|0|||
147047989|NCT02656303|530336333|FG000|Overall Study|Progressive Disease|25|||
147047990|NCT02656303|530336334|FG001|Overall Study|Progressive Disease|14|||
147047991|NCT02656303|530336335|FG002|Overall Study|Progressive Disease|10|||
147047992|NCT02656303|530336333|FG000|Overall Study|Study Terminated by Sponsor|20|||
147047993|NCT02656303|530336334|FG001|Overall Study|Study Terminated by Sponsor|7|||
147047994|NCT02656303|530336335|FG002|Overall Study|Study Terminated by Sponsor|5|||
147047995|NCT02656303|530336333|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
147047996|NCT02656303|530336334|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
147047997|NCT02656303|530336335|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
147047998|NCT02656303|530336333|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
147047999|NCT02656303|530336334|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
147048000|NCT02656303|530336335|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
147048001|NCT02656303|530336333|FG000|Overall Study|Reason not Specified|1|||
147048002|NCT02656303|530336334|FG001|Overall Study|Reason not Specified|1|||
147048003|NCT02656303|530336335|FG002|Overall Study|Reason not Specified|2|||
147048004|NCT03041311|530336338|FG000|Overall Study|Death|39|||
147048005|NCT03041311|530336339|FG001|Overall Study|Death|42|||
147048006|NCT03041311|530336338|FG000|Overall Study|Lost to Follow-up|0|||
147048007|NCT03041311|530336339|FG001|Overall Study|Lost to Follow-up|1|||
147048008|NCT03041311|530336338|FG000|Overall Study|Withdrawal by Subject|8|||
147048009|NCT03041311|530336339|FG001|Overall Study|Withdrawal by Subject|5|||
147048010|NCT03041311|530336338|FG000|Overall Study|Sponsor Terminated Study|2|||
147048011|NCT03041311|530336339|FG001|Overall Study|Sponsor Terminated Study|4|||
147048012|NCT03041311|530336338|FG000|Overall Study|Disease Progression|3|||
147048013|NCT03041311|530336339|FG001|Overall Study|Disease Progression|1|||
147048014|NCT03041311|530336338|FG000|Overall Study|Randomized in error, did not receive drug|2|||
147048015|NCT03041311|530336339|FG001|Overall Study|Randomized in error, did not receive drug|0|||
147048016|NCT02366689|530336340|FG000|Overall Study|Withdrawal by Subject|1|||
147048017|NCT02366689|530336341|FG001|Overall Study|Withdrawal by Subject|0|||
147048018|NCT02366689|530336342|FG002|Overall Study|Withdrawal by Subject|1|||
147048019|NCT02366689|530336340|FG000|Overall Study|Lost to Follow-up|3|||
147048020|NCT02366689|530336341|FG001|Overall Study|Lost to Follow-up|2|||
147048021|NCT02366689|530336342|FG002|Overall Study|Lost to Follow-up|0|||
147048022|NCT02366689|530336340|FG000|Overall Study|Pregnancy|0|||
147048023|NCT02366689|530336341|FG001|Overall Study|Pregnancy|1|||
147048024|NCT02366689|530336342|FG002|Overall Study|Pregnancy|1|||
147048025|NCT01290068|530336343|FG000|Overall Study|Adverse Event|1|||
147048026|NCT01290068|530336344|FG001|Overall Study|Adverse Event|3|||
147048027|NCT01290068|530336343|FG000|Overall Study|Lost to Follow-up|3|||
147048028|NCT01290068|530336344|FG001|Overall Study|Lost to Follow-up|0|||
147048029|NCT01290068|530336343|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
147048030|NCT01290068|530336344|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
147048031|NCT01290068|530336343|FG000|Overall Study|Other|3|||
147048032|NCT01290068|530336344|FG001|Overall Study|Other|1|||
147048033|NCT03283566|530336345|FG000|Overall Study|Lost to Follow-up|1|||
147048034|NCT03283566|530336346|FG001|Overall Study|Lost to Follow-up|2|||
147048035|NCT00853099|530336347|FG000|Double-blind Period|Adverse Event|7|||
147048036|NCT00853099|530336348|FG001|Double-blind Period|Adverse Event|9|||
147048037|NCT00853099|530336349|FG002|Double-blind Period|Adverse Event|13|||
147048038|NCT00853099|530336350|FG003|Double-blind Period|Adverse Event|0|||
147048039|NCT00853099|530336347|FG000|Double-blind Period|Withdrawal by Subject|2|||
147048040|NCT00853099|530336348|FG001|Double-blind Period|Withdrawal by Subject|3|||
147048041|NCT00853099|530336349|FG002|Double-blind Period|Withdrawal by Subject|0|||
147048042|NCT00853099|530336350|FG003|Double-blind Period|Withdrawal by Subject|0|||
147048043|NCT00853099|530336347|FG000|Double-blind Period|Lack of Efficacy|14|||
147048044|NCT00853099|530336348|FG001|Double-blind Period|Lack of Efficacy|17|||
147048045|NCT00853099|530336349|FG002|Double-blind Period|Lack of Efficacy|16|||
147048046|NCT00853099|530336350|FG003|Double-blind Period|Lack of Efficacy|0|||
147048047|NCT00853099|530336347|FG000|Double-blind Period|Other|0|||
147048048|NCT00853099|530336348|FG001|Double-blind Period|Other|0|||
147048049|NCT00853099|530336349|FG002|Double-blind Period|Other|1|||
147048050|NCT00853099|530336350|FG003|Double-blind Period|Other|0|||
147048051|NCT00853099|530336347|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
147048052|NCT00853099|530336348|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
147048053|NCT00853099|530336349|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
147048054|NCT00853099|530336350|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
147048055|NCT00853099|530336347|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
147048056|NCT00853099|530336348|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
147048057|NCT00853099|530336349|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
147048058|NCT00853099|530336350|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
147048059|NCT00853099|530336347|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
147048060|NCT00853099|530336348|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
147048061|NCT00853099|530336349|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
147048062|NCT00853099|530336350|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
147048063|NCT00853099|530336347|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
147048064|NCT00853099|530336348|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
147048065|NCT00853099|530336349|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
147048066|NCT00853099|530336350|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
147048067|NCT00853099|530336347|FG000|Double-blind + Open-label Periods|Other|0|||
147048068|NCT00853099|530336348|FG001|Double-blind + Open-label Periods|Other|0|||
147048069|NCT00853099|530336349|FG002|Double-blind + Open-label Periods|Other|0|||
146963191|NCT05966129|530025514|FG001|Overall Study|Withdrawal by Subject|25|||
146963192|NCT05966129|530025513|FG000|Overall Study|Surgery not completed|63|||
146963193|NCT05966129|530025514|FG001|Overall Study|Surgery not completed|69|||
146963194|NCT05966129|530025513|FG000|Overall Study|Surgery logistics issue|2|||
146963195|NCT05966129|530025514|FG001|Overall Study|Surgery logistics issue|1|||
146963196|NCT01298323|530025515|FG000|Overall Study|Adverse Event|2|||
146963197|NCT01298323|530025516|FG001|Overall Study|Adverse Event|4|||
146963198|NCT01298323|530025515|FG000|Overall Study|Death|11|||
146963199|NCT01298323|530025516|FG001|Overall Study|Death|16|||
146963200|NCT01298323|530025515|FG000|Overall Study|Lost to Follow-up|1|||
146963201|NCT01298323|530025516|FG001|Overall Study|Lost to Follow-up|0|||
146963202|NCT01298323|530025515|FG000|Overall Study|Withdrawal by Subject|6|||
146963203|NCT01298323|530025516|FG001|Overall Study|Withdrawal by Subject|3|||
146963204|NCT01298323|530025515|FG000|Overall Study|Protocol Violation|1|||
146963205|NCT01298323|530025516|FG001|Overall Study|Protocol Violation|0|||
146963206|NCT01298323|530025515|FG000|Overall Study|Other|10|||
146963207|NCT01298323|530025516|FG001|Overall Study|Other|9|||
146963208|NCT01298323|530025515|FG000|Overall Study|Ongoing|55|||
146963209|NCT01298323|530025516|FG001|Overall Study|Ongoing|55|||
146963210|NCT01298323|530025515|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146963211|NCT01298323|530025516|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146963212|NCT00945815|530025527|FG000|Overall Study|Death|3|||
146963213|NCT00945815|530025527|FG000|Overall Study|Not protocol specified|1|||
146963214|NCT00945815|530025527|FG000|Overall Study|Ineligible|3|||
146963215|NCT00945815|530025527|FG000|Overall Study|Did not begin protocol therapy|1|||
146963216|NCT01590810|530025530|FG000|Overall Study|Physician Decision|0|||
146963217|NCT01590810|530025531|FG001|Overall Study|Physician Decision|1|||
146963218|NCT01590810|530025532|FG002|Overall Study|Physician Decision|1|||
146963219|NCT01590810|530025533|FG003|Overall Study|Physician Decision|0|||
146963220|NCT01590810|530025534|FG004|Overall Study|Physician Decision|0|||
146963221|NCT02400281|530025535|FG000|Overall Study|Adverse Event|0|||
146963222|NCT02400281|530025536|FG001|Overall Study|Adverse Event|0|||
146963223|NCT02400281|530025537|FG002|Overall Study|Adverse Event|1|||
146963224|NCT02400281|530025538|FG003|Overall Study|Adverse Event|0|||
146963225|NCT02400281|530025539|FG004|Overall Study|Adverse Event|1|||
146963226|NCT02400281|530025540|FG005|Overall Study|Adverse Event|0|||
146963227|NCT02400281|530025535|FG000|Overall Study|Physician Decision|0|||
146963228|NCT02400281|530025536|FG001|Overall Study|Physician Decision|0|||
146963229|NCT02400281|530025537|FG002|Overall Study|Physician Decision|1|||
146963230|NCT02400281|530025538|FG003|Overall Study|Physician Decision|0|||
146963231|NCT02400281|530025539|FG004|Overall Study|Physician Decision|0|||
146963232|NCT02400281|530025540|FG005|Overall Study|Physician Decision|0|||
146963233|NCT00412360|530025541|FG000|Overall Study|Lost to Follow-up|0|||
146963234|NCT00412360|530025542|FG001|Overall Study|Lost to Follow-up|1|||
146963235|NCT00412360|530025541|FG000|Overall Study|Not Transplanted|1|||
146963236|NCT00412360|530025542|FG001|Overall Study|Not Transplanted|2|||
146963237|NCT03655951|530025543|FG000|Overall Study|Lost to Follow-up|39|||
146963238|NCT03655951|530025544|FG001|Overall Study|Lost to Follow-up|20|||
146963239|NCT03655951|530025543|FG000|Overall Study|Withdrawal by Subject|0|||
146963240|NCT03655951|530025544|FG001|Overall Study|Withdrawal by Subject|1|||
146963241|NCT01241591|530027606|FG000|Overall Study|Lack of Efficacy|5|||
146963242|NCT01241591|530027607|FG001|Overall Study|Lack of Efficacy|2|||
146963243|NCT01241591|530027608|FG002|Overall Study|Lack of Efficacy|2|||
146963244|NCT01241591|530027609|FG003|Overall Study|Lack of Efficacy|3|||
146963245|NCT01241591|530027606|FG000|Overall Study|Protocol Violation|5|||
146963246|NCT01241591|530027607|FG001|Overall Study|Protocol Violation|2|||
146963247|NCT01241591|530027608|FG002|Overall Study|Protocol Violation|3|||
146963248|NCT01241591|530027609|FG003|Overall Study|Protocol Violation|0|||
146963249|NCT01241591|530027606|FG000|Overall Study|Lost to Follow-up|1|||
146963250|NCT01241591|530027607|FG001|Overall Study|Lost to Follow-up|2|||
146963251|NCT01241591|530027608|FG002|Overall Study|Lost to Follow-up|2|||
146963252|NCT01241591|530027609|FG003|Overall Study|Lost to Follow-up|2|||
146963253|NCT01241591|530027606|FG000|Overall Study|Screen Failure|3|||
146963254|NCT01241591|530027607|FG001|Overall Study|Screen Failure|2|||
146963255|NCT01241591|530027608|FG002|Overall Study|Screen Failure|1|||
146963256|NCT01241591|530027609|FG003|Overall Study|Screen Failure|0|||
146963257|NCT01241591|530027606|FG000|Overall Study|Withdrawal by Subject|6|||
146963258|NCT01241591|530027607|FG001|Overall Study|Withdrawal by Subject|4|||
147048070|NCT00853099|530336350|FG003|Double-blind + Open-label Periods|Other|6|||
147048071|NCT02719184|530336355|FG000|Overall Study|Other than listed|1|||
147048072|NCT02719184|530336356|FG001|Overall Study|Other than listed|12|||
147048073|NCT02719184|530336357|FG002|Overall Study|Other than listed|13|||
147048074|NCT02719184|530336358|FG003|Overall Study|Other than listed|22|||
147048075|NCT02719184|530336359|FG004|Overall Study|Other than listed|9|||
147048076|NCT02719184|530336355|FG000|Overall Study|Withdrawal by Subject|5|||
147048077|NCT02719184|530336356|FG001|Overall Study|Withdrawal by Subject|3|||
147048078|NCT02719184|530336357|FG002|Overall Study|Withdrawal by Subject|6|||
147048079|NCT02719184|530336358|FG003|Overall Study|Withdrawal by Subject|6|||
147048080|NCT02719184|530336359|FG004|Overall Study|Withdrawal by Subject|0|||
147048081|NCT02719184|530336355|FG000|Overall Study|Lost to Follow-up|0|||
147048082|NCT02719184|530336356|FG001|Overall Study|Lost to Follow-up|4|||
147048083|NCT02719184|530336357|FG002|Overall Study|Lost to Follow-up|1|||
147048084|NCT02719184|530336358|FG003|Overall Study|Lost to Follow-up|3|||
147048085|NCT02719184|530336359|FG004|Overall Study|Lost to Follow-up|0|||
147048086|NCT02719184|530336355|FG000|Overall Study|Protocol Violation|0|||
147048087|NCT02719184|530336356|FG001|Overall Study|Protocol Violation|3|||
147048088|NCT02719184|530336357|FG002|Overall Study|Protocol Violation|0|||
147048089|NCT02719184|530336358|FG003|Overall Study|Protocol Violation|2|||
147048090|NCT02719184|530336359|FG004|Overall Study|Protocol Violation|0|||
147048091|NCT02719184|530336355|FG000|Overall Study|Adverse Event|0|||
147048092|NCT02719184|530336356|FG001|Overall Study|Adverse Event|0|||
147048093|NCT02719184|530336357|FG002|Overall Study|Adverse Event|0|||
147048094|NCT02719184|530336358|FG003|Overall Study|Adverse Event|3|||
147048095|NCT02719184|530336359|FG004|Overall Study|Adverse Event|0|||
147048096|NCT00470535|530336364|FG000|Overall Study|Disease Progression|13|||
147048097|NCT00470535|530336364|FG000|Overall Study|Withdrawal by Subject|1|||
147048098|NCT00470535|530336364|FG000|Overall Study|Adverse Event|1|||
147048099|NCT00470535|530336364|FG000|Overall Study|Death|1|||
147048100|NCT00470535|530336364|FG000|Overall Study|Other|2|||
147048101|NCT04108299|530336365|FG000|Overall Study|Not interested in participating|2|||
147048102|NCT04108299|530336366|FG001|Overall Study|Not interested in participating|1|||
147048103|NCT04108299|530336367|FG002|Overall Study|Not interested in participating|2|||
147048104|NCT04108299|530336368|FG003|Overall Study|Not interested in participating|1|||
147048105|NCT04123405|530336372|FG000|Overall Study|Adverse Event|1|||
147048106|NCT04123405|530336373|FG001|Overall Study|Adverse Event|2|||
147048107|NCT04123405|530336374|FG002|Overall Study|Adverse Event|3|||
147048108|NCT04123405|530336375|FG003|Overall Study|Adverse Event|3|||
147048109|NCT04123405|530336372|FG000|Overall Study|Exclusion criteria met|1|||
147048110|NCT04123405|530336373|FG001|Overall Study|Exclusion criteria met|2|||
147048111|NCT04123405|530336374|FG002|Overall Study|Exclusion criteria met|0|||
147048112|NCT04123405|530336375|FG003|Overall Study|Exclusion criteria met|2|||
147048113|NCT04123405|530336372|FG000|Overall Study|Withdrawal by Subject|1|||
147048114|NCT04123405|530336373|FG001|Overall Study|Withdrawal by Subject|3|||
147048115|NCT04123405|530336374|FG002|Overall Study|Withdrawal by Subject|0|||
147048116|NCT04123405|530336375|FG003|Overall Study|Withdrawal by Subject|2|||
147048117|NCT04123405|530336372|FG000|Overall Study|Contact to subject lost|0|||
147048118|NCT04123405|530336373|FG001|Overall Study|Contact to subject lost|0|||
147048119|NCT04123405|530336374|FG002|Overall Study|Contact to subject lost|0|||
147048120|NCT04123405|530336375|FG003|Overall Study|Contact to subject lost|1|||
147048121|NCT04123405|530336372|FG000|Overall Study|screening failure|1|||
147048122|NCT04123405|530336373|FG001|Overall Study|screening failure|0|||
147048123|NCT04123405|530336374|FG002|Overall Study|screening failure|0|||
147048124|NCT04123405|530336375|FG003|Overall Study|screening failure|0|||
147048125|NCT00124748|530336378|FG000|Overall Study|Adverse Event|8|||
147048126|NCT00124748|530336379|FG001|Overall Study|Adverse Event|39|||
147048127|NCT00124748|530336378|FG000|Overall Study|Abnormal laboratory Value|2|||
147048128|NCT00124748|530336379|FG001|Overall Study|Abnormal laboratory Value|2|||
147048129|NCT00124748|530336378|FG000|Overall Study|Abnormal Procedure|0|||
147048130|NCT00124748|530336379|FG001|Overall Study|Abnormal Procedure|1|||
147048131|NCT00124748|530336378|FG000|Overall Study|Lack of Efficacy|20|||
147048132|NCT00124748|530336379|FG001|Overall Study|Lack of Efficacy|41|||
147048133|NCT00124748|530336378|FG000|Overall Study|No longer requires study drug|1|||
147048134|NCT00124748|530336379|FG001|Overall Study|No longer requires study drug|1|||
147048135|NCT00124748|530336378|FG000|Overall Study|Protocol Violation|3|||
147048136|NCT00124748|530336379|FG001|Overall Study|Protocol Violation|1|||
147048137|NCT00124748|530336378|FG000|Overall Study|Withdrawal by Subject|5|||
147048138|NCT00124748|530336379|FG001|Overall Study|Withdrawal by Subject|15|||
147048139|NCT00124748|530336378|FG000|Overall Study|Lost to Follow-up|2|||
147048140|NCT00124748|530336379|FG001|Overall Study|Lost to Follow-up|7|||
147048141|NCT00124748|530336378|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
147048142|NCT00124748|530336379|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
147048143|NCT00124748|530336378|FG000|Overall Study|Death|1|||
147048144|NCT00124748|530336379|FG001|Overall Study|Death|3|||
147048145|NCT00322712|530336380|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
147048146|NCT02790437|530336390|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
147048147|NCT02790437|530336391|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
147048148|NCT02790437|530336390|FG000|Overall Study|Adverse Event|1|||
147048149|NCT02790437|530336391|FG001|Overall Study|Adverse Event|0|||
147048150|NCT02790437|530336390|FG000|Overall Study|Withdrawal by Subject|1|||
147048151|NCT02790437|530336391|FG001|Overall Study|Withdrawal by Subject|0|||
147048152|NCT04747470|530336392|FG000|Overall Study|Death|0|||
147048153|NCT04747470|530336393|FG001|Overall Study|Death|3|||
147048154|NCT04747470|530336394|FG002|Overall Study|Death|2|||
147048155|NCT04747470|530336395|FG003|Overall Study|Death|2|||
147048156|NCT04747470|530336396|FG004|Overall Study|Death|2|||
147048157|NCT04747470|530336397|FG005|Overall Study|Death|0|||
147048158|NCT04747470|530336398|FG006|Overall Study|Death|0|||
147048159|NCT04747470|530336399|FG007|Overall Study|Death|0|||
147048160|NCT04747470|530336400|FG008|Overall Study|Death|0|||
147048161|NCT04747470|530336401|FG009|Overall Study|Death|0|||
147048162|NCT04747470|530336402|FG010|Overall Study|Death|0|||
147048163|NCT04747470|530336392|FG000|Overall Study|Withdrew Consent|0|||
147048164|NCT04747470|530336393|FG001|Overall Study|Withdrew Consent|0|||
147048165|NCT04747470|530336394|FG002|Overall Study|Withdrew Consent|0|||
147048166|NCT04747470|530336395|FG003|Overall Study|Withdrew Consent|1|||
147048167|NCT04747470|530336396|FG004|Overall Study|Withdrew Consent|0|||
147048168|NCT04747470|530336397|FG005|Overall Study|Withdrew Consent|0|||
147048169|NCT04747470|530336398|FG006|Overall Study|Withdrew Consent|0|||
147048170|NCT04747470|530336399|FG007|Overall Study|Withdrew Consent|0|||
147048171|NCT04747470|530336400|FG008|Overall Study|Withdrew Consent|0|||
147048172|NCT04747470|530336401|FG009|Overall Study|Withdrew Consent|0|||
147048173|NCT04747470|530336402|FG010|Overall Study|Withdrew Consent|0|||
147048174|NCT04747470|530336392|FG000|Overall Study|Study Terminated by Sponsor|0|||
147048175|NCT04747470|530336393|FG001|Overall Study|Study Terminated by Sponsor|0|||
147048176|NCT04747470|530336394|FG002|Overall Study|Study Terminated by Sponsor|1|||
147048177|NCT04747470|530336395|FG003|Overall Study|Study Terminated by Sponsor|0|||
147048178|NCT04747470|530336396|FG004|Overall Study|Study Terminated by Sponsor|2|||
147048179|NCT04747470|530336397|FG005|Overall Study|Study Terminated by Sponsor|0|||
147048180|NCT04747470|530336398|FG006|Overall Study|Study Terminated by Sponsor|0|||
147048181|NCT04747470|530336399|FG007|Overall Study|Study Terminated by Sponsor|0|||
147048182|NCT04747470|530336400|FG008|Overall Study|Study Terminated by Sponsor|0|||
147048183|NCT04747470|530336401|FG009|Overall Study|Study Terminated by Sponsor|0|||
147048184|NCT04747470|530336402|FG010|Overall Study|Study Terminated by Sponsor|0|||
147048185|NCT04688671|530336406|FG000|Overall Study|Adverse Event|3|||
147048186|NCT04688671|530336407|FG001|Overall Study|Adverse Event|1|||
147048187|NCT04688671|530336406|FG000|Overall Study|Withdrawal by Subject|3|||
147048188|NCT04688671|530336407|FG001|Overall Study|Withdrawal by Subject|1|||
147048189|NCT04688671|530336406|FG000|Overall Study|Lack of Efficacy|1|||
147048190|NCT04688671|530336407|FG001|Overall Study|Lack of Efficacy|1|||
147048191|NCT04688671|530336406|FG000|Overall Study|Protocol Violation|1|||
147048192|NCT04688671|530336407|FG001|Overall Study|Protocol Violation|0|||
147048193|NCT04688671|530336406|FG000|Overall Study|Lost to Follow-up|0|||
146963259|NCT01241591|530027608|FG002|Overall Study|Withdrawal by Subject|2|||
146963260|NCT01241591|530027609|FG003|Overall Study|Withdrawal by Subject|2|||
146963261|NCT01241591|530027606|FG000|Overall Study|Other|0|||
146963262|NCT01241591|530027607|FG001|Overall Study|Other|1|||
146963263|NCT01241591|530027608|FG002|Overall Study|Other|0|||
146963264|NCT01241591|530027609|FG003|Overall Study|Other|1|||
146963265|NCT01241591|530027606|FG000|Overall Study|Adverse Event|3|||
146963266|NCT01241591|530027607|FG001|Overall Study|Adverse Event|11|||
146963267|NCT01241591|530027608|FG002|Overall Study|Adverse Event|12|||
146963268|NCT01241591|530027609|FG003|Overall Study|Adverse Event|4|||
146963269|NCT01945034|530027610|FG000|Overall Study|Medication Error|0|||
146963270|NCT01945034|530027611|FG001|Overall Study|Medication Error|1|||
146963271|NCT01945034|530027612|FG002|Overall Study|Medication Error|0|||
146963272|NCT01945034|530027610|FG000|Overall Study|Withdrawal by Subject|0|||
146963273|NCT01945034|530027611|FG001|Overall Study|Withdrawal by Subject|3|||
146963274|NCT01945034|530027612|FG002|Overall Study|Withdrawal by Subject|1|||
146963275|NCT01945034|530027610|FG000|Overall Study|Other|0|||
146963276|NCT01945034|530027611|FG001|Overall Study|Other|1|||
146963277|NCT01945034|530027612|FG002|Overall Study|Other|3|||
146963278|NCT01945034|530027610|FG000|Overall Study|Lost to Follow-up|0|||
146963279|NCT01945034|530027611|FG001|Overall Study|Lost to Follow-up|0|||
146963280|NCT01945034|530027612|FG002|Overall Study|Lost to Follow-up|2|||
146963281|NCT01945034|530027610|FG000|Overall Study|Protocol Violation|1|||
146963282|NCT01945034|530027611|FG001|Overall Study|Protocol Violation|0|||
146963283|NCT01945034|530027612|FG002|Overall Study|Protocol Violation|1|||
146963284|NCT02389621|530027615|FG000|Treatment Period|Withdrawal by Subject|1|||
146963285|NCT02389621|530027616|FG001|Treatment Period|Withdrawal by Subject|1|||
146963286|NCT02389621|530027615|FG000|Posttreatment Period|Adverse Event|3|||
147048194|NCT04688671|530336407|FG001|Overall Study|Lost to Follow-up|1|||
147048195|NCT01626690|530336408|FG000|Overall Study|Protocol Violation|1|||
147048196|NCT01626690|530336409|FG001|Overall Study|Protocol Violation|0|||
147048197|NCT01626690|530336408|FG000|Overall Study|Adverse Event|1|||
147048198|NCT01626690|530336409|FG001|Overall Study|Adverse Event|0|||
147048199|NCT04720053|530336410|FG000|Overall Study|Lost to Follow-up|12|||
147048200|NCT01960257|530336411|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
147048201|NCT01960257|530336412|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
147048202|NCT01960257|530336413|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
147048203|NCT01960257|530336411|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
147048204|NCT01960257|530336412|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
147048205|NCT01960257|530336413|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
147048206|NCT01960257|530336411|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
147048207|NCT01960257|530336412|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
147048208|NCT01960257|530336413|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
147048209|NCT03908125|530336414|FG000|Overall Study|Withdrawal by Subject|92|||
147048210|NCT03908125|530336414|FG000|Overall Study|Lost to Follow-up|8|||
147048211|NCT04542057|530336418|FG000|Overall Study|Death|3|||
147048212|NCT04542057|530336419|FG001|Overall Study|Death|1|||
147048213|NCT04542057|530336418|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
147048214|NCT04542057|530336419|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
147048215|NCT04542057|530336418|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
147048216|NCT04542057|530336419|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
147048217|NCT04542057|530336418|FG000|Overall Study|Adverse Event|15|||
147048218|NCT04542057|530336419|FG001|Overall Study|Adverse Event|6|||
147048219|NCT04542057|530336418|FG000|Overall Study|COVID-19 adverse event|6|||
147048220|NCT04542057|530336419|FG001|Overall Study|COVID-19 adverse event|4|||
147048221|NCT04542057|530336418|FG000|Overall Study|Lack of Efficacy|2|||
147048222|NCT04542057|530336419|FG001|Overall Study|Lack of Efficacy|5|||
147048223|NCT04542057|530336418|FG000|Overall Study|Study terminated by sponsor|1|||
147048224|NCT04542057|530336419|FG001|Overall Study|Study terminated by sponsor|0|||
147048225|NCT04542057|530336418|FG000|Overall Study|Investigator discretion|2|||
147048226|NCT04542057|530336419|FG001|Overall Study|Investigator discretion|1|||
147048227|NCT04542057|530336418|FG000|Overall Study|Withdrawal by Subject|52|||
147048228|NCT04542057|530336419|FG001|Overall Study|Withdrawal by Subject|30|||
147048229|NCT04542057|530336418|FG000|Overall Study|Lost to Follow-up|8|||
147048230|NCT04542057|530336419|FG001|Overall Study|Lost to Follow-up|11|||
147048231|NCT04542057|530336418|FG000|Overall Study|Other|2|||
147048232|NCT04542057|530336419|FG001|Overall Study|Other|2|||
147048233|NCT00940316|530336422|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
147048234|NCT00940316|530336423|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
147048235|NCT00940316|530336424|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
147048236|NCT00940316|530336422|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
147048237|NCT00940316|530336423|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
147048238|NCT00940316|530336424|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
147048239|NCT00940316|530336422|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
147048240|NCT00940316|530336423|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
147048241|NCT00940316|530336424|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
147048242|NCT00940316|530336422|FG000|Treated After Cycle 5|Adverse Event|0|||
147048243|NCT00940316|530336423|FG001|Treated After Cycle 5|Adverse Event|0|||
147048244|NCT00940316|530336424|FG002|Treated After Cycle 5|Adverse Event|1|||
147048245|NCT00940316|530336422|FG000|Treated After Cycle 5|Progressive disease|0|||
147048246|NCT00940316|530336423|FG001|Treated After Cycle 5|Progressive disease|1|||
147048247|NCT00940316|530336424|FG002|Treated After Cycle 5|Progressive disease|0|||
147048248|NCT03404674|530336426|FG000|Overall Study|Inability to Attend Future Visits|0|||
147048249|NCT03404674|530336427|FG001|Overall Study|Inability to Attend Future Visits|1|||
147048250|NCT03404674|530336428|FG002|Overall Study|Inability to Attend Future Visits|1|||
147048251|NCT03404674|530336429|FG003|Overall Study|Inability to Attend Future Visits|0|||
147048252|NCT03404674|530336430|FG004|Overall Study|Inability to Attend Future Visits|0|||
147048253|NCT03404674|530336431|FG005|Overall Study|Inability to Attend Future Visits|0|||
147048254|NCT03404674|530336426|FG000|Overall Study|Behavioral Problems|0|||
147048255|NCT03404674|530336427|FG001|Overall Study|Behavioral Problems|0|||
147048256|NCT03404674|530336428|FG002|Overall Study|Behavioral Problems|1|||
147048257|NCT03404674|530336429|FG003|Overall Study|Behavioral Problems|0|||
147048258|NCT03404674|530336430|FG004|Overall Study|Behavioral Problems|0|||
147048259|NCT03404674|530336431|FG005|Overall Study|Behavioral Problems|0|||
147048260|NCT03404674|530336426|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
147048261|NCT03404674|530336427|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
147048262|NCT03404674|530336428|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
147048263|NCT03404674|530336429|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
147048264|NCT03404674|530336430|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
147048265|NCT03404674|530336431|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
147048266|NCT02324582|530336432|FG000|Overall Study|Screen Failures|0|||
147048267|NCT02324582|530336433|FG001|Overall Study|Screen Failures|5|||
147048268|NCT00996489|530336435|FG000|Overall Study|Device failure|45|||
147048269|NCT00996489|530336435|FG000|Overall Study|Discontinued|116|||
147048270|NCT02286843|530336444|FG000|Overall Study|Not Treated|4|||
147048271|NCT02286843|530336444|FG000|Overall Study|Protocol Violation|1|||
147048272|NCT02286843|530336444|FG000|Overall Study|Withdrawal by Subject|1|||
147048273|NCT02273388|530336451|FG000|Overall Study|Adverse Event|0|||
147048274|NCT02273388|530336452|FG001|Overall Study|Adverse Event|0|||
147048275|NCT02273388|530336453|FG002|Overall Study|Adverse Event|0|||
147048276|NCT02273388|530336454|FG003|Overall Study|Adverse Event|0|||
147048277|NCT02273388|530336455|FG004|Overall Study|Adverse Event|0|||
147048278|NCT02273388|530336456|FG005|Overall Study|Adverse Event|0|||
147048279|NCT02273388|530336457|FG006|Overall Study|Adverse Event|1|||
147048280|NCT02273388|530336458|FG007|Overall Study|Adverse Event|2|||
147048281|NCT02273388|530336459|FG008|Overall Study|Adverse Event|0|||
147048282|NCT02273388|530336460|FG009|Overall Study|Adverse Event|0|||
147048283|NCT02273388|530336461|FG010|Overall Study|Adverse Event|0|||
147048284|NCT02273388|530336462|FG011|Overall Study|Adverse Event|0|||
147048285|NCT02273388|530336451|FG000|Overall Study|Adverse Event study disease worse|4|||
147048286|NCT02273388|530336452|FG001|Overall Study|Adverse Event study disease worse|3|||
147048287|NCT02273388|530336453|FG002|Overall Study|Adverse Event study disease worse|3|||
147048288|NCT02273388|530336454|FG003|Overall Study|Adverse Event study disease worse|2|||
147048289|NCT02273388|530336455|FG004|Overall Study|Adverse Event study disease worse|4|||
147048290|NCT02273388|530336456|FG005|Overall Study|Adverse Event study disease worse|3|||
147048291|NCT02273388|530336457|FG006|Overall Study|Adverse Event study disease worse|14|||
147048292|NCT02273388|530336458|FG007|Overall Study|Adverse Event study disease worse|6|||
147048293|NCT02273388|530336459|FG008|Overall Study|Adverse Event study disease worse|6|||
147048294|NCT02273388|530336460|FG009|Overall Study|Adverse Event study disease worse|5|||
147048295|NCT02273388|530336461|FG010|Overall Study|Adverse Event study disease worse|10|||
147048296|NCT02273388|530336462|FG011|Overall Study|Adverse Event study disease worse|1|||
147048297|NCT02273388|530336451|FG000|Overall Study|Sponsor decision|0|||
147048298|NCT02273388|530336452|FG001|Overall Study|Sponsor decision|0|||
147048299|NCT02273388|530336453|FG002|Overall Study|Sponsor decision|0|||
147048300|NCT02273388|530336454|FG003|Overall Study|Sponsor decision|0|||
147048301|NCT02273388|530336455|FG004|Overall Study|Sponsor decision|0|||
147048302|NCT02273388|530336456|FG005|Overall Study|Sponsor decision|0|||
147048303|NCT02273388|530336457|FG006|Overall Study|Sponsor decision|0|||
147048304|NCT02273388|530336458|FG007|Overall Study|Sponsor decision|0|||
147048305|NCT02273388|530336459|FG008|Overall Study|Sponsor decision|0|||
147048306|NCT02273388|530336460|FG009|Overall Study|Sponsor decision|0|||
147048307|NCT02273388|530336461|FG010|Overall Study|Sponsor decision|0|||
147048308|NCT02273388|530336462|FG011|Overall Study|Sponsor decision|1|||
147048309|NCT04331808|530336463|FG000|Overall Study|Withdrew consent|1|||
147048310|NCT04331808|530336464|FG001|Overall Study|Withdrew consent|0|||
147048311|NCT04331808|530336465|FG002|Overall Study|Withdrew consent|2|||
147048312|NCT04331808|530336466|FG003|Overall Study|Withdrew consent|3|||
147048313|NCT00952731|530336470|FG000|Overall Study|Drug supply expired|1|||
147048314|NCT00952731|530336471|FG001|Overall Study|Drug supply expired|0|||
147048315|NCT01329900|530336472|FG000|Overall Study|Elevated creatinine/renal function|1|||
147048316|NCT01184079|530336473|FG000|Overall Study|Lost to Follow-up|14|||
147048317|NCT01184079|530336474|FG001|Overall Study|Lost to Follow-up|2|||
147048318|NCT04233073|530336475|FG000|Overall Study|Death|5|||
147048319|NCT01523002|530336480|FG000|Period 1|Withdrawal by Subject|1|||
147048320|NCT01523002|530336481|FG001|Period 1|Withdrawal by Subject|3|||
147048321|NCT01523002|530336480|FG000|Period 1|Lost to Follow-up|1|||
147048322|NCT01523002|530336481|FG001|Period 1|Lost to Follow-up|0|||
147048323|NCT01523002|530336480|FG000|Period 1|Adverse Event|0|||
147048324|NCT01523002|530336481|FG001|Period 1|Adverse Event|8|||
147048325|NCT01523002|530336480|FG000|Period 2|Withdrawal by Subject|4|||
147048326|NCT01523002|530336481|FG001|Period 2|Withdrawal by Subject|1|||
147048327|NCT01523002|530336480|FG000|Period 2|Adverse Event|2|||
147048328|NCT01523002|530336481|FG001|Period 2|Adverse Event|5|||
147048329|NCT01523002|530336480|FG000|Period 3|Withdrawal by Subject|1|||
147048330|NCT01523002|530336481|FG001|Period 3|Withdrawal by Subject|0|||
147048331|NCT01523002|530336480|FG000|Period 3|Adverse Event|3|||
147048332|NCT01523002|530336481|FG001|Period 3|Adverse Event|0|||
147048333|NCT01256502|530336482|FG000|Overall Study|Had scaffold removed|4|||
147048334|NCT01256502|530336482|FG000|Overall Study|Personal reasons|5|||
147048335|NCT01256502|530336482|FG000|Overall Study|Protocol deviation|1|||
147048336|NCT04779879|530336487|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
147048337|NCT04779879|530336488|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
147048338|NCT04779879|530336489|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
147048339|NCT04779879|530336490|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
147048340|NCT04779879|530336491|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
147048341|NCT04779879|530336492|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
147048342|NCT04779879|530336487|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
147048343|NCT04779879|530336488|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
147048344|NCT04779879|530336489|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
147048345|NCT04779879|530336490|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
147048346|NCT04779879|530336491|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
147048347|NCT04779879|530336492|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
147048348|NCT04779879|530336487|FG000|Part C: Up to Week 36|Death|0|||
147048349|NCT04779879|530336488|FG001|Part C: Up to Week 36|Death|0|||
147048350|NCT04779879|530336489|FG002|Part C: Up to Week 36|Death|0|||
147048351|NCT04779879|530336490|FG003|Part C: Up to Week 36|Death|0|||
147048352|NCT04779879|530336491|FG004|Part C: Up to Week 36|Death|0|||
147048353|NCT04779879|530336492|FG005|Part C: Up to Week 36|Death|1|||
147048354|NCT04779879|530336487|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
147048355|NCT04779879|530336488|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
147048356|NCT04779879|530336489|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
147048357|NCT04779879|530336490|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
147048358|NCT04779879|530336491|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
147048359|NCT04779879|530336492|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
147048360|NCT05101343|530336493|FG000|Overall Study|Withdrawal by Subject|2|||
147048361|NCT05101343|530336494|FG001|Overall Study|Withdrawal by Subject|1|||
147048362|NCT02854527|530336495|FG000|Overall Study|Adverse Event|0|||
147048363|NCT02854527|530336496|FG001|Overall Study|Adverse Event|0|||
147048364|NCT02854527|530336497|FG002|Overall Study|Adverse Event|0|||
147048365|NCT02854527|530336498|FG003|Overall Study|Adverse Event|0|||
147048366|NCT02854527|530336499|FG004|Overall Study|Adverse Event|1|||
147048367|NCT02854527|530336500|FG005|Overall Study|Adverse Event|0|||
147048368|NCT02854527|530336501|FG006|Overall Study|Adverse Event|0|||
147048369|NCT02854527|530336502|FG007|Overall Study|Adverse Event|0|||
147048370|NCT02854527|530336503|FG008|Overall Study|Adverse Event|0|||
147048371|NCT02854527|530336504|FG009|Overall Study|Adverse Event|0|||
147048372|NCT02854527|530336495|FG000|Overall Study|Lost to Follow-up|0|||
147048373|NCT02854527|530336496|FG001|Overall Study|Lost to Follow-up|0|||
147048374|NCT02854527|530336497|FG002|Overall Study|Lost to Follow-up|0|||
147048375|NCT02854527|530336498|FG003|Overall Study|Lost to Follow-up|1|||
147048376|NCT02854527|530336499|FG004|Overall Study|Lost to Follow-up|0|||
147048377|NCT02854527|530336500|FG005|Overall Study|Lost to Follow-up|0|||
147048378|NCT02854527|530336501|FG006|Overall Study|Lost to Follow-up|0|||
147048379|NCT02854527|530336502|FG007|Overall Study|Lost to Follow-up|0|||
147048380|NCT02854527|530336503|FG008|Overall Study|Lost to Follow-up|0|||
147048381|NCT02854527|530336504|FG009|Overall Study|Lost to Follow-up|0|||
147048382|NCT01682811|530336507|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
147048383|NCT01682811|530336508|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
147048384|NCT01682811|530336509|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
147048385|NCT01682811|530336510|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
147048386|NCT01682811|530336511|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
147048387|NCT01682811|530336512|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
147048388|NCT01682811|530336513|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
147048389|NCT01682811|530336507|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
147048390|NCT01682811|530336508|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
147048391|NCT01682811|530336509|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
147048392|NCT01682811|530336510|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
147048393|NCT01682811|530336511|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
147048394|NCT01682811|530336512|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
147048395|NCT01682811|530336513|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
147048396|NCT01682811|530336507|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
147048397|NCT01682811|530336508|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
147048398|NCT01682811|530336509|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
147048399|NCT01682811|530336510|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
147048400|NCT01682811|530336511|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
147048401|NCT01682811|530336512|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
147048402|NCT01682811|530336513|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
147048403|NCT01682811|530336507|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
147048404|NCT01682811|530336508|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
147048405|NCT01682811|530336509|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
147048406|NCT01682811|530336510|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
147048407|NCT01682811|530336511|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
147048408|NCT01682811|530336512|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
147048409|NCT01682811|530336513|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
147048410|NCT02603146|530338640|FG000|Overall Study|Lost to Follow-up|5|||
147048411|NCT02603146|530338641|FG001|Overall Study|Lost to Follow-up|6|||
147048412|NCT02603146|530338640|FG000|Overall Study|Withdrawal by Subject|8|||
147048413|NCT02603146|530338641|FG001|Overall Study|Withdrawal by Subject|10|||
147048414|NCT02603146|530338640|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
147048415|NCT02603146|530338641|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
147048416|NCT02603146|530338640|FG000|Overall Study|Participant moved|2|||
147048417|NCT02603146|530338641|FG001|Overall Study|Participant moved|0|||
147048418|NCT02603146|530338640|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
147048419|NCT02603146|530338641|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
147048420|NCT05989672|530338643|FG000|Overall Study|Adverse Event|3|||
147048421|NCT05989672|530338644|FG001|Overall Study|Adverse Event|0|||
147048422|NCT05989672|530338645|FG002|Overall Study|Adverse Event|0|||
147048423|NCT00696423|530338646|FG000|Overall Study|Lost to Follow-up|0|||
147048424|NCT00696423|530338647|FG001|Overall Study|Lost to Follow-up|5|||
147048425|NCT03989102|530338648|FG000|Year 1|Withdrawal by Subject|6|||
147048426|NCT03989102|530338649|FG001|Year 1|Withdrawal by Subject|2|||
147048427|NCT03989102|530338650|FG002|Year 1|Withdrawal by Subject|7|||
147048428|NCT03989102|530338648|FG000|Year 1|Lost to Follow-up|5|||
147048429|NCT03989102|530338649|FG001|Year 1|Lost to Follow-up|2|||
147048430|NCT03989102|530338650|FG002|Year 1|Lost to Follow-up|5|||
147048431|NCT03989102|530338648|FG000|Year 1|Subject met withdrawal criteria|1|||
147048432|NCT03989102|530338649|FG001|Year 1|Subject met withdrawal criteria|0|||
147048433|NCT03989102|530338650|FG002|Year 1|Subject met withdrawal criteria|1|||
147048434|NCT03989102|530338648|FG000|Year 2|Lost to Follow-up|7|||
147048435|NCT03989102|530338649|FG001|Year 2|Lost to Follow-up|3|||
147048436|NCT03989102|530338650|FG002|Year 2|Lost to Follow-up|4|||
147048437|NCT03989102|530338648|FG000|Year 2|Withdrawal by Subject|3|||
147048438|NCT03989102|530338649|FG001|Year 2|Withdrawal by Subject|1|||
147048439|NCT03989102|530338650|FG002|Year 2|Withdrawal by Subject|2|||
147048440|NCT03989102|530338648|FG000|Year 2|Subject non-compliant|3|||
147048441|NCT03989102|530338649|FG001|Year 2|Subject non-compliant|2|||
147048442|NCT03989102|530338650|FG002|Year 2|Subject non-compliant|0|||
147048443|NCT03989102|530338648|FG000|Year 2|Travel|1|||
147048444|NCT03989102|530338649|FG001|Year 2|Travel|0|||
147048445|NCT03989102|530338650|FG002|Year 2|Travel|1|||
147048446|NCT03989102|530338648|FG000|Year 2|P16 missing|4|||
147048447|NCT03989102|530338649|FG001|Year 2|P16 missing|2|||
147048448|NCT03989102|530338650|FG002|Year 2|P16 missing|1|||
147048449|NCT03989102|530338648|FG000|Year 2|P11 missing|1|||
147048450|NCT03989102|530338649|FG001|Year 2|P11 missing|3|||
147048451|NCT03989102|530338650|FG002|Year 2|P11 missing|7|||
147048452|NCT03989102|530338648|FG000|Year 2|Definitive displacement outside the study site|0|||
147048453|NCT03989102|530338649|FG001|Year 2|Definitive displacement outside the study site|1|||
147048454|NCT03989102|530338650|FG002|Year 2|Definitive displacement outside the study site|0|||
147048455|NCT03989102|530338648|FG000|Year 2|Subject missed last study visit|0|||
147048456|NCT03989102|530338649|FG001|Year 2|Subject missed last study visit|1|||
147048457|NCT03989102|530338650|FG002|Year 2|Subject missed last study visit|0|||
147048458|NCT03989102|530338648|FG000|Year 2|Death|0|||
147048459|NCT03989102|530338649|FG001|Year 2|Death|1|||
147048460|NCT03989102|530338650|FG002|Year 2|Death|0|||
147048461|NCT03989102|530338648|FG000|Year 2|Subject not reachable|0|||
147048462|NCT03989102|530338649|FG001|Year 2|Subject not reachable|0|||
147048463|NCT03989102|530338650|FG002|Year 2|Subject not reachable|1|||
147048464|NCT03989102|530338648|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
147048465|NCT03989102|530338649|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
147048466|NCT03989102|530338650|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
147048467|NCT03989102|530338648|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
147048468|NCT03989102|530338649|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
147048469|NCT03989102|530338650|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
147048470|NCT03989102|530338648|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
147048471|NCT03989102|530338649|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
147048472|NCT03989102|530338650|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
147048473|NCT03989102|530338648|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
147048474|NCT03989102|530338649|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
147048475|NCT03989102|530338650|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
147048476|NCT03989102|530338648|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
147048477|NCT03989102|530338649|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
147048478|NCT03989102|530338650|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
147048479|NCT03989102|530338648|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
147048480|NCT03989102|530338649|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
147048481|NCT03989102|530338650|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
147048482|NCT00818766|530338662|FG000|Overall Study|Could not be Contacted on Day 28|11|||
147048483|NCT00818766|530338663|FG001|Overall Study|Could not be Contacted on Day 28|10|||
147048484|NCT00818766|530338662|FG000|Overall Study|Death|1|||
147048485|NCT00818766|530338663|FG001|Overall Study|Death|0|||
147048486|NCT00818766|530338662|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
147048487|NCT00818766|530338663|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
147048488|NCT04515147|530338664|FG000|Overall Study|Withdrawal by Subject|1|||
147048489|NCT04515147|530338665|FG001|Overall Study|Withdrawal by Subject|0|||
147048490|NCT04515147|530338666|FG002|Overall Study|Withdrawal by Subject|10|||
147048491|NCT04515147|530338667|FG003|Overall Study|Withdrawal by Subject|18|||
147048492|NCT04515147|530338668|FG004|Overall Study|Withdrawal by Subject|1|||
147048493|NCT04515147|530338669|FG005|Overall Study|Withdrawal by Subject|8|||
147048494|NCT04515147|530338664|FG000|Overall Study|Lost to Follow-up|0|||
147048495|NCT04515147|530338665|FG001|Overall Study|Lost to Follow-up|1|||
147048496|NCT04515147|530338666|FG002|Overall Study|Lost to Follow-up|5|||
147048497|NCT04515147|530338667|FG003|Overall Study|Lost to Follow-up|6|||
147048498|NCT04515147|530338668|FG004|Overall Study|Lost to Follow-up|2|||
147048499|NCT04515147|530338669|FG005|Overall Study|Lost to Follow-up|1|||
147048500|NCT04515147|530338664|FG000|Overall Study|Adverse Event|0|||
147048501|NCT04515147|530338665|FG001|Overall Study|Adverse Event|0|||
147048502|NCT04515147|530338666|FG002|Overall Study|Adverse Event|0|||
147048503|NCT04515147|530338667|FG003|Overall Study|Adverse Event|2|||
147048504|NCT04515147|530338668|FG004|Overall Study|Adverse Event|0|||
147048505|NCT04515147|530338669|FG005|Overall Study|Adverse Event|0|||
147048506|NCT04515147|530338664|FG000|Overall Study|Miscellaneous|0|||
147048507|NCT04515147|530338665|FG001|Overall Study|Miscellaneous|0|||
147048508|NCT04515147|530338666|FG002|Overall Study|Miscellaneous|0|||
147048509|NCT04515147|530338667|FG003|Overall Study|Miscellaneous|1|||
147048510|NCT04515147|530338668|FG004|Overall Study|Miscellaneous|0|||
147048511|NCT04515147|530338669|FG005|Overall Study|Miscellaneous|1|||
147048512|NCT02760004|530338673|FG000|Overall Study|Lost to Follow-up|13|||
147048513|NCT02760004|530338674|FG001|Overall Study|Lost to Follow-up|22|||
147048514|NCT00970593|530338677|FG000|Overall Study|Adverse Event|1|||
147048515|NCT00970593|530338678|FG001|Overall Study|Adverse Event|1|||
147048516|NCT00970593|530338679|FG002|Overall Study|Adverse Event|0|||
147048517|NCT00970593|530338680|FG003|Overall Study|Adverse Event|0|||
147048518|NCT00970593|530338681|FG004|Overall Study|Adverse Event|0|||
147048519|NCT00970593|530338682|FG005|Overall Study|Adverse Event|0|||
147048520|NCT00970593|530338683|FG006|Overall Study|Adverse Event|0|||
147048521|NCT00970593|530338677|FG000|Overall Study|Discontinuation of study by sponsor|0|||
147048522|NCT00970593|530338678|FG001|Overall Study|Discontinuation of study by sponsor|0|||
147048523|NCT00970593|530338679|FG002|Overall Study|Discontinuation of study by sponsor|5|||
147048524|NCT00970593|530338680|FG003|Overall Study|Discontinuation of study by sponsor|0|||
147048525|NCT00970593|530338681|FG004|Overall Study|Discontinuation of study by sponsor|0|||
147048526|NCT00970593|530338682|FG005|Overall Study|Discontinuation of study by sponsor|0|||
147048527|NCT00970593|530338683|FG006|Overall Study|Discontinuation of study by sponsor|2|||
147048528|NCT00970593|530338677|FG000|Overall Study|Withdrawal by Subject|0|||
147048529|NCT00970593|530338678|FG001|Overall Study|Withdrawal by Subject|0|||
147048530|NCT00970593|530338679|FG002|Overall Study|Withdrawal by Subject|1|||
147048531|NCT00970593|530338680|FG003|Overall Study|Withdrawal by Subject|0|||
147048532|NCT00970593|530338681|FG004|Overall Study|Withdrawal by Subject|0|||
147048533|NCT00970593|530338682|FG005|Overall Study|Withdrawal by Subject|0|||
147048534|NCT00970593|530338683|FG006|Overall Study|Withdrawal by Subject|0|||
147048535|NCT00662649|530338685|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
147048536|NCT00662649|530338686|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
147048537|NCT00662649|530338687|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
147048538|NCT00662649|530338688|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
147048539|NCT00662649|530338689|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
147048540|NCT00662649|530338685|FG000|Core Study (24 Months)|Adverse Event|22|||
147048541|NCT00662649|530338686|FG001|Core Study (24 Months)|Adverse Event|13|||
147048542|NCT00662649|530338687|FG002|Core Study (24 Months)|Adverse Event|18|||
147048543|NCT00662649|530338688|FG003|Core Study (24 Months)|Adverse Event|0|||
147048544|NCT00662649|530338689|FG004|Core Study (24 Months)|Adverse Event|0|||
147048545|NCT00662649|530338685|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
147048546|NCT00662649|530338686|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
146963287|NCT02389621|530027616|FG001|Posttreatment Period|Adverse Event|1|||
146963288|NCT02389621|530027615|FG000|Posttreatment Period|Withdrawal by Subject|3|||
146963289|NCT02389621|530027616|FG001|Posttreatment Period|Withdrawal by Subject|2|||
146963290|NCT02389621|530027615|FG000|Posttreatment Period|Lost to Follow-up|1|||
146963291|NCT02389621|530027616|FG001|Posttreatment Period|Lost to Follow-up|1|||
146963292|NCT02389621|530027615|FG000|Posttreatment Period|Other - Miscellaneous|2|||
146963293|NCT02389621|530027616|FG001|Posttreatment Period|Other - Miscellaneous|0|||
146963294|NCT03323034|530027619|FG000|Overall Study|Lack of Efficacy|5|||
146963295|NCT03323034|530027620|FG001|Overall Study|Lack of Efficacy|5|||
146963296|NCT03323034|530027621|FG002|Overall Study|Lack of Efficacy|6|||
146963297|NCT03323034|530027622|FG003|Overall Study|Lack of Efficacy|5|||
146963298|NCT03323034|530027623|FG004|Overall Study|Lack of Efficacy|5|||
146963299|NCT03323034|530027619|FG000|Overall Study|Physician Decision|0|||
146963300|NCT03323034|530027620|FG001|Overall Study|Physician Decision|0|||
146963301|NCT03323034|530027621|FG002|Overall Study|Physician Decision|0|||
146963302|NCT03323034|530027622|FG003|Overall Study|Physician Decision|0|||
146963303|NCT03323034|530027623|FG004|Overall Study|Physician Decision|1|||
146963304|NCT03323034|530027619|FG000|Overall Study|Withdrawal by Subject|1|||
146963305|NCT03323034|530027620|FG001|Overall Study|Withdrawal by Subject|1|||
146963306|NCT03323034|530027621|FG002|Overall Study|Withdrawal by Subject|0|||
146963307|NCT03323034|530027622|FG003|Overall Study|Withdrawal by Subject|1|||
146963308|NCT03323034|530027623|FG004|Overall Study|Withdrawal by Subject|0|||
146963309|NCT02526017|530027626|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
146963310|NCT02526017|530027627|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
146963311|NCT02526017|530027628|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
146963312|NCT02526017|530027629|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
146963313|NCT02526017|530027630|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
146963314|NCT02526017|530027631|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
146963315|NCT02526017|530027632|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
146963316|NCT02526017|530027633|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
146963317|NCT02526017|530027634|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
147048547|NCT00662649|530338687|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
147048548|NCT00662649|530338688|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
147048549|NCT00662649|530338689|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
147048550|NCT00662649|530338685|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
147048551|NCT00662649|530338686|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
147048552|NCT00662649|530338687|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
147048553|NCT00662649|530338688|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
147048554|NCT00662649|530338689|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
147048555|NCT00662649|530338685|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
147048556|NCT00662649|530338686|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
147048557|NCT00662649|530338687|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
147048558|NCT00662649|530338688|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
147048559|NCT00662649|530338689|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
147048560|NCT00662649|530338685|FG000|Core Study (24 Months)|Protocol Violation|5|||
147048561|NCT00662649|530338686|FG001|Core Study (24 Months)|Protocol Violation|5|||
147048562|NCT00662649|530338687|FG002|Core Study (24 Months)|Protocol Violation|4|||
147048563|NCT00662649|530338688|FG003|Core Study (24 Months)|Protocol Violation|0|||
147048564|NCT00662649|530338689|FG004|Core Study (24 Months)|Protocol Violation|0|||
147048565|NCT00662649|530338685|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
147048566|NCT00662649|530338686|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
147048567|NCT00662649|530338687|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
147048568|NCT00662649|530338688|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
147048569|NCT00662649|530338689|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
147048570|NCT00662649|530338685|FG000|Core Study (24 Months)|Death|1|||
147048571|NCT00662649|530338686|FG001|Core Study (24 Months)|Death|0|||
147048572|NCT00662649|530338687|FG002|Core Study (24 Months)|Death|2|||
147048573|NCT00662649|530338688|FG003|Core Study (24 Months)|Death|0|||
147048574|NCT00662649|530338689|FG004|Core Study (24 Months)|Death|0|||
147048575|NCT00662649|530338685|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
147048576|NCT00662649|530338686|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
147048577|NCT00662649|530338687|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
147048578|NCT00662649|530338688|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
147048579|NCT00662649|530338689|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
147048580|NCT00662649|530338685|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
147048581|NCT00662649|530338686|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
147048582|NCT00662649|530338687|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
147048583|NCT00662649|530338688|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
147048584|NCT00662649|530338689|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
147048585|NCT00662649|530338685|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
147048586|NCT00662649|530338686|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
147048587|NCT00662649|530338687|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
147048588|NCT00662649|530338688|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
147048589|NCT00662649|530338689|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
147048590|NCT00662649|530338685|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
147048591|NCT00662649|530338686|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
147048592|NCT00662649|530338687|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
147048593|NCT00662649|530338688|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
147048594|NCT00662649|530338689|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
147048595|NCT00662649|530338685|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
147048596|NCT00662649|530338686|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
147048597|NCT00662649|530338687|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
147048598|NCT00662649|530338688|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
147048599|NCT00662649|530338689|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
147048600|NCT00662649|530338685|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
147048601|NCT00662649|530338686|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
147048602|NCT00662649|530338687|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
147048603|NCT00662649|530338688|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
147048604|NCT00662649|530338689|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
147048605|NCT00662649|530338685|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
147048606|NCT00662649|530338686|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
147048607|NCT00662649|530338687|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
147048608|NCT00662649|530338688|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
147048609|NCT00662649|530338689|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
147048610|NCT00662649|530338685|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
147048611|NCT00662649|530338686|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
147048612|NCT00662649|530338687|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
147048613|NCT00662649|530338688|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
147048614|NCT00662649|530338689|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
147048615|NCT00662649|530338685|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
147048616|NCT00662649|530338686|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
147048617|NCT00662649|530338687|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
147048618|NCT00662649|530338688|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
147048619|NCT00662649|530338689|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
147048620|NCT01026194|530338691|FG000|Period 1：Double Blind Period|Adverse Event|2|||
147048621|NCT01026194|530338692|FG001|Period 1：Double Blind Period|Adverse Event|1|||
147048622|NCT01026194|530338691|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
147048623|NCT01026194|530338692|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
147048624|NCT01026194|530338691|FG000|Period 1：Double Blind Period|Physician Decision|0|||
147048625|NCT01026194|530338692|FG001|Period 1：Double Blind Period|Physician Decision|4|||
147048626|NCT01026194|530338691|FG000|Period 2：Open-label Period|Adverse Event|4|||
147048627|NCT01026194|530338692|FG001|Period 2：Open-label Period|Adverse Event|5|||
147048628|NCT01026194|530338691|FG000|Period 2：Open-label Period|Physician Decision|3|||
147048629|NCT01026194|530338692|FG001|Period 2：Open-label Period|Physician Decision|1|||
147048630|NCT01026194|530338691|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
147048631|NCT01026194|530338692|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
147048632|NCT00545714|530338693|FG000|Induction Phase (6 Months)|Physician Decision|3|||
147048633|NCT00545714|530338693|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
147048634|NCT00545714|530338693|FG000|Induction Phase (6 Months)|Disease Progression|1|||
147048635|NCT00545714|530338693|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
147048636|NCT00545714|530338693|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
147048637|NCT00545714|530338693|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
147048638|NCT00545714|530338693|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
147048639|NCT00545714|530338693|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
147048640|NCT00545714|530338693|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
147048641|NCT00545714|530338693|FG000|Maintenance Phase (36 Months)|Death|2|||
147048642|NCT02515331|530338698|FG000|Overall Study|Withdrawal by Subject|0|||
147048643|NCT02515331|530338699|FG001|Overall Study|Withdrawal by Subject|0|||
147048644|NCT02515331|530338700|FG002|Overall Study|Withdrawal by Subject|1|||
147048645|NCT02515331|530338698|FG000|Overall Study|Protocol deviation|0|||
147048646|NCT02515331|530338699|FG001|Overall Study|Protocol deviation|0|||
147048647|NCT02515331|530338700|FG002|Overall Study|Protocol deviation|3|||
147048648|NCT02515331|530338698|FG000|Overall Study|Adverse Event|2|||
147048649|NCT02515331|530338699|FG001|Overall Study|Adverse Event|0|||
147048650|NCT02515331|530338700|FG002|Overall Study|Adverse Event|0|||
147048651|NCT03889886|530338703|FG000|Overall Study|Other|0|||
147048652|NCT03889886|530338704|FG001|Overall Study|Other|1|||
147048653|NCT03889886|530338705|FG002|Overall Study|Other|0|||
147048654|NCT03889886|530338706|FG003|Overall Study|Other|1|||
147048655|NCT03889886|530338703|FG000|Overall Study|Withdrawal by Subject|0|||
147048656|NCT03889886|530338704|FG001|Overall Study|Withdrawal by Subject|0|||
147048657|NCT03889886|530338705|FG002|Overall Study|Withdrawal by Subject|1|||
147048658|NCT03889886|530338706|FG003|Overall Study|Withdrawal by Subject|0|||
147048659|NCT03889886|530338703|FG000|Overall Study|Adverse Event|0|||
147048660|NCT03889886|530338704|FG001|Overall Study|Adverse Event|0|||
147048661|NCT03889886|530338705|FG002|Overall Study|Adverse Event|0|||
147048662|NCT03889886|530338706|FG003|Overall Study|Adverse Event|6|||
147048663|NCT04176250|530338707|FG000|Overall Study|Adverse Event|0|||
147048664|NCT04176250|530338708|FG001|Overall Study|Adverse Event|1|||
147048665|NCT04176250|530338709|FG002|Overall Study|Adverse Event|0|||
147048666|NCT04176250|530338710|FG003|Overall Study|Adverse Event|1|||
147048667|NCT04176250|530338711|FG004|Overall Study|Adverse Event|0|||
147048668|NCT04176250|530338712|FG005|Overall Study|Adverse Event|1|||
147048669|NCT04176250|530338707|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
147048670|NCT04176250|530338708|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
147048671|NCT04176250|530338709|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
147048672|NCT04176250|530338710|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
147048673|NCT04176250|530338711|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
147048674|NCT04176250|530338712|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
147048675|NCT04176250|530338707|FG000|Overall Study|Withdrawal by Subject|0|||
147048676|NCT04176250|530338708|FG001|Overall Study|Withdrawal by Subject|0|||
147048677|NCT04176250|530338709|FG002|Overall Study|Withdrawal by Subject|0|||
147048678|NCT04176250|530338710|FG003|Overall Study|Withdrawal by Subject|0|||
147048679|NCT04176250|530338711|FG004|Overall Study|Withdrawal by Subject|0|||
147048680|NCT04176250|530338712|FG005|Overall Study|Withdrawal by Subject|1|||
147048681|NCT04176250|530338707|FG000|Overall Study|Randomized in error|0|||
147048682|NCT04176250|530338708|FG001|Overall Study|Randomized in error|0|||
147048683|NCT04176250|530338709|FG002|Overall Study|Randomized in error|0|||
147048684|NCT04176250|530338710|FG003|Overall Study|Randomized in error|0|||
147048685|NCT04176250|530338711|FG004|Overall Study|Randomized in error|1|||
147048686|NCT04176250|530338712|FG005|Overall Study|Randomized in error|0|||
147048687|NCT00758524|530338713|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
147048688|NCT00758524|530338714|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
147048689|NCT00758524|530338715|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
147048690|NCT00758524|530338716|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147048691|NCT00758524|530338717|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
147048692|NCT00758524|530338718|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
147048693|NCT00758524|530338719|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147048694|NCT00758524|530338720|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147048695|NCT00758524|530338721|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147048696|NCT00758524|530338722|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147048697|NCT00758524|530338723|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147048698|NCT00758524|530338724|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147048699|NCT00758524|530338725|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147048700|NCT00758524|530338726|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147048701|NCT00758524|530338727|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147048702|NCT00758524|530338728|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147048703|NCT00758524|530338729|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147048704|NCT00758524|530338713|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
147048705|NCT00758524|530338714|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147048706|NCT00758524|530338715|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
147048707|NCT00758524|530338716|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
147048708|NCT00758524|530338717|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
147048709|NCT00758524|530338718|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
147048710|NCT00758524|530338719|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147048711|NCT00758524|530338720|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147048712|NCT00758524|530338721|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147048713|NCT00758524|530338722|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147048714|NCT00758524|530338723|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147048715|NCT00758524|530338724|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147048716|NCT00758524|530338725|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147048717|NCT00758524|530338726|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147048718|NCT00758524|530338727|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147048719|NCT00758524|530338728|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147048720|NCT00758524|530338729|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147048721|NCT00758524|530338713|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
147048722|NCT00758524|530338714|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
147048723|NCT00758524|530338715|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
147048724|NCT00758524|530338716|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
147048725|NCT00758524|530338717|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
147048726|NCT00758524|530338718|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
147048727|NCT00758524|530338719|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147048728|NCT00758524|530338720|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147048729|NCT00758524|530338721|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147048730|NCT00758524|530338722|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147048731|NCT00758524|530338723|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147048732|NCT00758524|530338724|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147048733|NCT00758524|530338725|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147048734|NCT00758524|530338726|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147048735|NCT00758524|530338727|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147048736|NCT00758524|530338728|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147048737|NCT00758524|530338729|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147048738|NCT00758524|530338713|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147048739|NCT00758524|530338714|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
147048740|NCT00758524|530338715|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
147048741|NCT00758524|530338716|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147048742|NCT00758524|530338717|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
147048743|NCT00758524|530338718|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
147048744|NCT00758524|530338719|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147048745|NCT00758524|530338720|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147048746|NCT00758524|530338721|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147048747|NCT00758524|530338722|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147048748|NCT00758524|530338723|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147048749|NCT00758524|530338724|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147048750|NCT00758524|530338725|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147048751|NCT00758524|530338726|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147048752|NCT00758524|530338727|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147048753|NCT00758524|530338728|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147048754|NCT00758524|530338729|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147048755|NCT00758524|530338713|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147048756|NCT00758524|530338714|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147048757|NCT00758524|530338715|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
147048758|NCT00758524|530338716|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
147048759|NCT00758524|530338717|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147048760|NCT00758524|530338718|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147048761|NCT00758524|530338719|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147048762|NCT00758524|530338720|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147048763|NCT00758524|530338721|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147048764|NCT00758524|530338722|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147048765|NCT00758524|530338723|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147048766|NCT00758524|530338724|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147048767|NCT00758524|530338725|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147048768|NCT00758524|530338726|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147048769|NCT00758524|530338727|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147048770|NCT00758524|530338728|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147048771|NCT00758524|530338729|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147048772|NCT00758524|530338713|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147048773|NCT00758524|530338714|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147048774|NCT00758524|530338715|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147048775|NCT00758524|530338716|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147048776|NCT00758524|530338717|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
147048777|NCT00758524|530338718|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147048778|NCT00758524|530338719|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147048779|NCT00758524|530338720|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147048780|NCT00758524|530338721|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147048781|NCT00758524|530338722|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147048782|NCT00758524|530338723|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147048783|NCT00758524|530338724|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147048784|NCT00758524|530338725|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147048785|NCT00758524|530338726|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147048786|NCT00758524|530338727|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147048787|NCT00758524|530338728|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147048788|NCT00758524|530338729|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147048789|NCT00758524|530338713|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147048790|NCT00758524|530338714|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
147048791|NCT00758524|530338715|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147048792|NCT00758524|530338716|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147048793|NCT00758524|530338717|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147048794|NCT00758524|530338718|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147048795|NCT00758524|530338719|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147048796|NCT00758524|530338720|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147048797|NCT00758524|530338721|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147048798|NCT00758524|530338722|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147048799|NCT00758524|530338723|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147048800|NCT00758524|530338724|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147048801|NCT00758524|530338725|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147048802|NCT00758524|530338726|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147048803|NCT00758524|530338727|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147048804|NCT00758524|530338728|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147048805|NCT00758524|530338729|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147048806|NCT00758524|530338713|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147048807|NCT00758524|530338714|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
147048808|NCT00758524|530338715|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147048809|NCT00758524|530338716|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147048810|NCT00758524|530338717|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147048811|NCT00758524|530338718|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147048812|NCT00758524|530338719|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147048813|NCT00758524|530338720|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147048814|NCT00758524|530338721|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147048815|NCT00758524|530338722|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147048816|NCT00758524|530338723|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147048817|NCT00758524|530338724|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147048818|NCT00758524|530338725|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147048819|NCT00758524|530338726|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147048820|NCT00758524|530338727|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147048821|NCT00758524|530338728|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147048822|NCT00758524|530338729|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147048823|NCT00758524|530338713|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147048824|NCT00758524|530338714|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147048825|NCT00758524|530338715|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147048826|NCT00758524|530338716|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147048827|NCT00758524|530338717|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147048828|NCT00758524|530338718|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147048829|NCT00758524|530338719|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147048830|NCT00758524|530338720|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147048831|NCT00758524|530338721|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
147048832|NCT00758524|530338722|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147048833|NCT00758524|530338723|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147048834|NCT00758524|530338724|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147048835|NCT00758524|530338725|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147048836|NCT00758524|530338726|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147048837|NCT00758524|530338727|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147048838|NCT00758524|530338728|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147048839|NCT00758524|530338729|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147048840|NCT00758524|530338713|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147048841|NCT00758524|530338714|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147048842|NCT00758524|530338715|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147048843|NCT00758524|530338716|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147048844|NCT00758524|530338717|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147048845|NCT00758524|530338718|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147048846|NCT00758524|530338719|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
147048847|NCT00758524|530338720|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147048848|NCT00758524|530338721|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147048849|NCT00758524|530338722|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147048850|NCT00758524|530338723|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147048851|NCT00758524|530338724|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147048852|NCT00758524|530338725|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147048853|NCT00758524|530338726|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147048854|NCT00758524|530338727|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147048855|NCT00758524|530338728|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147048856|NCT00758524|530338729|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147048857|NCT00276484|530338730|FG000|Overall Study|Adverse Event|4|||
147048858|NCT00276484|530338731|FG001|Overall Study|Adverse Event|7|||
147048859|NCT00276484|530338730|FG000|Overall Study|Lost to Follow-up|1|||
147048860|NCT00276484|530338731|FG001|Overall Study|Lost to Follow-up|1|||
147048861|NCT00276484|530338730|FG000|Overall Study|Protocol Violation|0|||
147048862|NCT00276484|530338731|FG001|Overall Study|Protocol Violation|1|||
147048863|NCT00276484|530338730|FG000|Overall Study|Withdrawal by Subject|4|||
147048864|NCT00276484|530338731|FG001|Overall Study|Withdrawal by Subject|3|||
147048865|NCT00276484|530338730|FG000|Overall Study|Could not take time off work|0|||
147048866|NCT00276484|530338731|FG001|Overall Study|Could not take time off work|1|||
147048867|NCT01431079|530338741|FG000|Overall Study|Lost to Follow-up|35|||
147048868|NCT01431079|530338742|FG001|Overall Study|Lost to Follow-up|39|||
147048869|NCT01202175|530338743|FG000|Overall Study|Lost to Follow-up|2|||
147048870|NCT01202175|530338743|FG000|Overall Study|Withdrawal by Subject|1|||
147048871|NCT01202175|530338743|FG000|Overall Study|Adverse Event|2|||
147048872|NCT03749330|530338748|FG000|Overall Study|Clinicians left work in the CICU|0|||
147048873|NCT03749330|530338749|FG001|Overall Study|Clinicians left work in the CICU|2|||
147048874|NCT03749330|530338750|FG002|Overall Study|Clinicians left work in the CICU|0|||
147048875|NCT03749330|530338751|FG003|Overall Study|Clinicians left work in the CICU|0|||
147048876|NCT03749330|530338752|FG004|Overall Study|Clinicians left work in the CICU|0|||
147048877|NCT03749330|530338753|FG005|Overall Study|Clinicians left work in the CICU|0|||
147048878|NCT02676882|530338759|FG000|Overall Study|Adverse Event|1|||
147048879|NCT02676882|530338760|FG001|Overall Study|Adverse Event|0|||
147048880|NCT02676882|530338759|FG000|Overall Study|Lost to Follow-up|1|||
147048881|NCT02676882|530338760|FG001|Overall Study|Lost to Follow-up|0|||
147048882|NCT02676882|530338759|FG000|Overall Study|Withdrawal by Subject|1|||
147048883|NCT02676882|530338760|FG001|Overall Study|Withdrawal by Subject|2|||
147048884|NCT01518322|530338761|FG000|Overall Study|FeNO measurement was missing|13|||
147048885|NCT01269918|530338762|FG000|Overall Study|Did not receive study drug|0|||
147048886|NCT01269918|530338763|FG001|Overall Study|Did not receive study drug|3|||
147048887|NCT00856193|530338764|FG000|Period 2|Abnormal test procedure results|0|||
147048888|NCT00856193|530338765|FG001|Period 2|Abnormal test procedure results|1|||
147048889|NCT00856193|530338764|FG000|Period 2|Lost to Follow-up|0|||
147048890|NCT00856193|530338765|FG001|Period 2|Lost to Follow-up|1|||
147048891|NCT04660331|530338768|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
147048892|NCT04660331|530338769|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
147048893|NCT04660331|530338770|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
147048894|NCT03624192|530338771|FG000|Overall Study|Lost to Follow-up|1|||
147048895|NCT03624192|530338772|FG001|Overall Study|Lost to Follow-up|1|||
147048896|NCT01487525|530338775|FG000|Overall Study|Withdrawal by Subject|0|||
147048897|NCT01487525|530338776|FG001|Overall Study|Withdrawal by Subject|1|||
147048898|NCT01640249|530338777|FG000|Period 1|Withdrawal by Subject|1|||
147048899|NCT01640249|530338778|FG001|Period 1|Withdrawal by Subject|0|||
147048900|NCT01640249|530338779|FG002|Period 1|Withdrawal by Subject|0|||
147048901|NCT01640249|530338780|FG003|Period 1|Withdrawal by Subject|0|||
147048902|NCT01640249|530338781|FG004|Period 1|Withdrawal by Subject|0|||
147048903|NCT01640249|530338782|FG005|Period 1|Withdrawal by Subject|1|||
147048904|NCT01640249|530338783|FG006|Period 1|Withdrawal by Subject|0|||
147048905|NCT01870778|530338784|FG000|Overall Study|Withdrawal by Subject|8|||
147048906|NCT01870778|530338785|FG001|Overall Study|Withdrawal by Subject|7|||
147048907|NCT01870778|530338784|FG000|Overall Study|Lost to Follow-up|0|||
147048908|NCT01870778|530338785|FG001|Overall Study|Lost to Follow-up|2|||
147048909|NCT00065156|530338786|FG000|Overall Study|Adverse Event|37|||
147048910|NCT00065156|530338786|FG000|Overall Study|Lack of Efficacy|52|||
147048911|NCT00065156|530338786|FG000|Overall Study|Withdrawal by Subject|8|||
147048912|NCT00065156|530338786|FG000|Overall Study|Lost to Follow-up|1|||
147048913|NCT00065156|530338786|FG000|Overall Study|Death|11|||
147048914|NCT00065156|530338786|FG000|Overall Study|Study Closed by Sponsor|2|||
147048915|NCT00065156|530338786|FG000|Overall Study|Disease Progression|7|||
147048916|NCT00065156|530338786|FG000|Overall Study|Investigator Decision|2|||
147048917|NCT00065156|530338786|FG000|Overall Study|Non-Compliance|2|||
147048918|NCT00065156|530338786|FG000|Overall Study|Loss of Response|1|||
147048919|NCT00065156|530338786|FG000|Overall Study|Secondary Malign Disease|1|||
147048920|NCT00100828|530338787|FG000|Overall Study|Physician Decision|6|||
147048921|NCT01176513|530338788|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
147048922|NCT04583735|530338789|FG000|Double-masked Treatment Period|Adverse Event|0|||
147048923|NCT04583735|530338790|FG001|Double-masked Treatment Period|Adverse Event|1|||
147048924|NCT04583735|530338789|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
147048925|NCT04583735|530338790|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
147048926|NCT04583735|530338789|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
147048927|NCT04583735|530338790|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
147048928|NCT04583735|530338789|FG000|Open-label Treatment Period|Adverse Event|1|||
147048929|NCT04583735|530338790|FG001|Open-label Treatment Period|Adverse Event|1|||
147048930|NCT04583735|530338789|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
147048931|NCT04583735|530338790|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
147048932|NCT04583735|530338789|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
147048933|NCT04583735|530338790|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
147048934|NCT01215136|530338791|FG000|Overall Study|Adverse Event|2|||
147048935|NCT01215136|530338792|FG001|Overall Study|Adverse Event|9|||
147048936|NCT01215136|530338791|FG000|Overall Study|Disease Progression|3|||
147048937|NCT01215136|530338792|FG001|Overall Study|Disease Progression|14|||
147048938|NCT01215136|530338791|FG000|Overall Study|Symptomatic Deterioration|1|||
147048939|NCT01215136|530338792|FG001|Overall Study|Symptomatic Deterioration|1|||
147048940|NCT01215136|530338791|FG000|Overall Study|Death|0|||
147048941|NCT01215136|530338792|FG001|Overall Study|Death|2|||
147048942|NCT01215136|530338791|FG000|Overall Study|Withdrawal by Subject|0|||
147048943|NCT01215136|530338792|FG001|Overall Study|Withdrawal by Subject|1|||
147048944|NCT02308124|530338793|FG000|Overall Study|Lost to Follow-up|6|||
147048945|NCT02308124|530338794|FG001|Overall Study|Lost to Follow-up|6|||
147048946|NCT02308124|530338795|FG002|Overall Study|Lost to Follow-up|6|||
147048947|NCT02308124|530338793|FG000|Overall Study|Adverse Event|0|||
147048948|NCT02308124|530338794|FG001|Overall Study|Adverse Event|2|||
147048949|NCT02308124|530338795|FG002|Overall Study|Adverse Event|2|||
147048950|NCT00041132|530338804|FG000|Overall Study|Adverse Event|19|||
147048951|NCT00041132|530338804|FG000|Overall Study|Death|1|||
147048952|NCT00041132|530338804|FG000|Overall Study|Not Eligible|7|||
147048953|NCT00041132|530338804|FG000|Overall Study|Withdrawal by Subject|1|||
147048954|NCT00041132|530338804|FG000|Overall Study|Physician Decision|2|||
147048955|NCT00995774|530338805|FG000|Training Period 2|Withdrawal by Subject|2|||
147048956|NCT00995774|530338806|FG001|Training Period 2|Withdrawal by Subject|0|||
147048957|NCT01808573|530338807|FG000|Overall Study|Death|212|||
147048958|NCT01808573|530338808|FG001|Overall Study|Death|240|||
147048959|NCT01808573|530338807|FG000|Overall Study|Withdrawal by Subject|12|||
147048960|NCT01808573|530338808|FG001|Overall Study|Withdrawal by Subject|10|||
147048961|NCT01808573|530338807|FG000|Overall Study|Lost to Follow-up|3|||
147048962|NCT01808573|530338808|FG001|Overall Study|Lost to Follow-up|0|||
147048963|NCT01808573|530338807|FG000|Overall Study|Discontinuation of study by sponsor|79|||
147048964|NCT01808573|530338808|FG001|Overall Study|Discontinuation of study by sponsor|64|||
147048965|NCT01808573|530338807|FG000|Overall Study|Randomized in Error|1|||
147048966|NCT01808573|530338808|FG001|Overall Study|Randomized in Error|0|||
147048967|NCT00489255|530338811|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
147048968|NCT00489255|530338812|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
147048969|NCT00489255|530338811|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
147048970|NCT00489255|530338812|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
147048971|NCT00489255|530338811|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
147048972|NCT00489255|530338812|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
147048973|NCT00489255|530338811|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
147048974|NCT00489255|530338812|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
147048975|NCT00489255|530338811|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
147048976|NCT00489255|530338812|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
147048977|NCT00489255|530338811|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
147048978|NCT00489255|530338812|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
147048979|NCT00489255|530338811|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
147048980|NCT00489255|530338812|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
147048981|NCT00489255|530338811|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
147048982|NCT00489255|530338812|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
147048983|NCT00489255|530338811|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
147048984|NCT00489255|530338812|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
147048985|NCT00489255|530338811|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
147048986|NCT00489255|530338812|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
147048987|NCT03953612|530338813|FG000|Overall Study|Randomized but did not start|1|||
147048988|NCT03953612|530338814|FG001|Overall Study|Randomized but did not start|1|||
147048989|NCT03953612|530338815|FG002|Overall Study|Randomized but did not start|1|||
147048990|NCT03953612|530338813|FG000|Overall Study|Withdrawal by Subject|2|||
147048991|NCT03953612|530338814|FG001|Overall Study|Withdrawal by Subject|1|||
147048992|NCT03953612|530338815|FG002|Overall Study|Withdrawal by Subject|0|||
147048993|NCT03485352|530338816|FG000|Overall Study|Lost to Follow-up|9|||
147048994|NCT04452669|530340389|FG000|Overall Study|Death|1|||
147048995|NCT04452669|530340390|FG001|Overall Study|Death|4|||
147048996|NCT05126693|530340395|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
147048997|NCT05126693|530340396|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
147048998|NCT05126693|530340395|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
147048999|NCT05126693|530340396|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
147049000|NCT05126693|530340395|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
147049001|NCT05126693|530340396|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
147049002|NCT05525520|530340397|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
147049003|NCT05525520|530340398|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
147049004|NCT05525520|530340397|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
147049005|NCT05525520|530340398|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
147049006|NCT05878093|530340401|FG000|Overall Study|Withdrawal by Subject|3|||
147049007|NCT05878093|530340402|FG001|Overall Study|Withdrawal by Subject|1|||
147049008|NCT02721732|530340403|FG000|Overall Study|Adverse Event|2|||
147049009|NCT02721732|530340404|FG001|Overall Study|Adverse Event|0|||
147049010|NCT02721732|530340405|FG002|Overall Study|Adverse Event|2|||
147049011|NCT02721732|530340406|FG003|Overall Study|Adverse Event|0|||
147049012|NCT02721732|530340407|FG004|Overall Study|Adverse Event|1|||
147049013|NCT02721732|530340408|FG005|Overall Study|Adverse Event|0|||
147049014|NCT02721732|530340409|FG006|Overall Study|Adverse Event|1|||
147049015|NCT02721732|530340410|FG007|Overall Study|Adverse Event|0|||
147049016|NCT02721732|530340411|FG008|Overall Study|Adverse Event|1|||
147049017|NCT02721732|530340412|FG009|Overall Study|Adverse Event|1|||
147049018|NCT02721732|530340403|FG000|Overall Study|Death|0|||
147049019|NCT02721732|530340404|FG001|Overall Study|Death|0|||
147049020|NCT02721732|530340405|FG002|Overall Study|Death|0|||
147049021|NCT02721732|530340406|FG003|Overall Study|Death|0|||
147049022|NCT02721732|530340407|FG004|Overall Study|Death|1|||
147049023|NCT02721732|530340408|FG005|Overall Study|Death|0|||
147049024|NCT02721732|530340409|FG006|Overall Study|Death|1|||
147049025|NCT02721732|530340410|FG007|Overall Study|Death|0|||
147049026|NCT02721732|530340411|FG008|Overall Study|Death|0|||
147049027|NCT02721732|530340412|FG009|Overall Study|Death|1|||
147049028|NCT02721732|530340403|FG000|Overall Study|Lack of Efficacy|12|||
147049029|NCT02721732|530340404|FG001|Overall Study|Lack of Efficacy|11|||
147049030|NCT02721732|530340405|FG002|Overall Study|Lack of Efficacy|18|||
147049031|NCT02721732|530340406|FG003|Overall Study|Lack of Efficacy|5|||
147049032|NCT02721732|530340407|FG004|Overall Study|Lack of Efficacy|21|||
147049033|NCT02721732|530340408|FG005|Overall Study|Lack of Efficacy|2|||
147049034|NCT02721732|530340409|FG006|Overall Study|Lack of Efficacy|8|||
147049035|NCT02721732|530340410|FG007|Overall Study|Lack of Efficacy|11|||
147049036|NCT02721732|530340411|FG008|Overall Study|Lack of Efficacy|10|||
147049037|NCT02721732|530340412|FG009|Overall Study|Lack of Efficacy|20|||
147049038|NCT02721732|530340403|FG000|Overall Study|Physician Decision|0|||
147049039|NCT02721732|530340404|FG001|Overall Study|Physician Decision|0|||
147049040|NCT02721732|530340405|FG002|Overall Study|Physician Decision|1|||
147049041|NCT02721732|530340406|FG003|Overall Study|Physician Decision|0|||
147049042|NCT02721732|530340407|FG004|Overall Study|Physician Decision|0|||
147049043|NCT02721732|530340408|FG005|Overall Study|Physician Decision|0|||
147049044|NCT02721732|530340409|FG006|Overall Study|Physician Decision|0|||
147049045|NCT02721732|530340410|FG007|Overall Study|Physician Decision|0|||
147049046|NCT02721732|530340411|FG008|Overall Study|Physician Decision|0|||
147049047|NCT02721732|530340412|FG009|Overall Study|Physician Decision|0|||
147049048|NCT02721732|530340403|FG000|Overall Study|Withdrawal by Subject|1|||
147049049|NCT02721732|530340404|FG001|Overall Study|Withdrawal by Subject|0|||
147049050|NCT02721732|530340405|FG002|Overall Study|Withdrawal by Subject|0|||
147049051|NCT02721732|530340406|FG003|Overall Study|Withdrawal by Subject|0|||
147049052|NCT02721732|530340407|FG004|Overall Study|Withdrawal by Subject|3|||
147049053|NCT02721732|530340408|FG005|Overall Study|Withdrawal by Subject|0|||
147049054|NCT02721732|530340409|FG006|Overall Study|Withdrawal by Subject|1|||
147049055|NCT02721732|530340410|FG007|Overall Study|Withdrawal by Subject|1|||
147049056|NCT02721732|530340411|FG008|Overall Study|Withdrawal by Subject|0|||
147049057|NCT02721732|530340412|FG009|Overall Study|Withdrawal by Subject|1|||
147049058|NCT02721732|530340403|FG000|Overall Study|Participant Choice|1|||
147049059|NCT02721732|530340404|FG001|Overall Study|Participant Choice|0|||
147049060|NCT02721732|530340405|FG002|Overall Study|Participant Choice|0|||
147049061|NCT02721732|530340406|FG003|Overall Study|Participant Choice|0|||
147049062|NCT02721732|530340407|FG004|Overall Study|Participant Choice|0|||
147049063|NCT02721732|530340408|FG005|Overall Study|Participant Choice|0|||
147049064|NCT02721732|530340409|FG006|Overall Study|Participant Choice|0|||
147049065|NCT02721732|530340410|FG007|Overall Study|Participant Choice|0|||
147049066|NCT02721732|530340411|FG008|Overall Study|Participant Choice|0|||
147049067|NCT02721732|530340412|FG009|Overall Study|Participant Choice|1|||
147049068|NCT02721732|530340403|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147049069|NCT02721732|530340404|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147049070|NCT02721732|530340405|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
147049071|NCT02721732|530340406|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147049072|NCT02721732|530340407|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147049073|NCT02721732|530340408|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
146849971|NCT03738423|529618937|FG001|Overall Study|Randomized but never treated|0|||
146849972|NCT03738423|529618938|FG002|Overall Study|Randomized but never treated|1|||
146849973|NCT03738423|529618939|FG003|Overall Study|Randomized but never treated|1|||
146849974|NCT03738423|529618940|FG004|Overall Study|Randomized but never treated|0|||
146849975|NCT02592876|529618947|FG000|Overall Study|Withdrawal by Subject|3|||
146849976|NCT02592876|529618948|FG001|Overall Study|Withdrawal by Subject|3|||
146849977|NCT02592876|529618947|FG000|Overall Study|Study Termination by Sponsor|32|||
146849978|NCT02592876|529618948|FG001|Overall Study|Study Termination by Sponsor|27|||
146849979|NCT02592876|529618947|FG000|Overall Study|Lost to Follow-up|0|||
146849980|NCT02592876|529618948|FG001|Overall Study|Lost to Follow-up|1|||
146849981|NCT02592876|529618947|FG000|Overall Study|Death|6|||
146849982|NCT02592876|529618948|FG001|Overall Study|Death|9|||
146849983|NCT00611975|529618951|FG000|Overall Study|Withdrawal by Subject|3|||
146849984|NCT00611975|529618952|FG001|Overall Study|Withdrawal by Subject|7|||
146849985|NCT00611975|529618951|FG000|Overall Study|Pregnancy|2|||
146849986|NCT00611975|529618952|FG001|Overall Study|Pregnancy|1|||
146849987|NCT03465904|529618953|FG000|Overall Study|Withdrawal by Subject|9|||
146849988|NCT03465904|529618954|FG001|Overall Study|Withdrawal by Subject|5|||
146849989|NCT03465904|529618953|FG000|Overall Study|Lost to Follow-up|11|||
146849990|NCT03465904|529618954|FG001|Overall Study|Lost to Follow-up|9|||
146849991|NCT03465904|529618953|FG000|Overall Study|Protocol Violation|20|||
146849992|NCT03465904|529618954|FG001|Overall Study|Protocol Violation|15|||
146849993|NCT04625413|529618955|FG000|Overall Study|Hospice|2|||
146849994|NCT04625413|529618955|FG000|Overall Study|Distress|1|||
146849995|NCT04625413|529618955|FG000|Overall Study|Not feeling well|1|||
146849996|NCT01305200|529618956|FG000|Overall Study|Physician Decision|4|||
146849997|NCT01305200|529618957|FG001|Overall Study|Physician Decision|6|||
146849998|NCT01305200|529618958|FG002|Overall Study|Physician Decision|1|||
146849999|NCT01305200|529618956|FG000|Overall Study|Withdrawal by Subject|24|||
146850000|NCT01305200|529618957|FG001|Overall Study|Withdrawal by Subject|21|||
146850001|NCT01305200|529618958|FG002|Overall Study|Withdrawal by Subject|1|||
146850002|NCT01305200|529618956|FG000|Overall Study|Ineligible|1|||
146850003|NCT01305200|529618957|FG001|Overall Study|Ineligible|2|||
146850004|NCT01305200|529618958|FG002|Overall Study|Ineligible|1|||
146850005|NCT01305200|529618956|FG000|Overall Study|Death|0|||
146850006|NCT01305200|529618957|FG001|Overall Study|Death|2|||
146850007|NCT01305200|529618958|FG002|Overall Study|Death|0|||
146850008|NCT03981861|529618959|FG000|Overall Study|Withdrawal by Subject|3|||
146850009|NCT02217332|529620677|FG000|Overall Study|Adverse Event|3|||
146850010|NCT02217332|529620677|FG000|Overall Study|Dose interruption >1 month|1|||
147049074|NCT02721732|530340409|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147049075|NCT02721732|530340410|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147049076|NCT02721732|530340411|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147049077|NCT02721732|530340412|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147049078|NCT02721732|530340403|FG000|Overall Study|Progression and withdrew consent|1|||
147049079|NCT02721732|530340404|FG001|Overall Study|Progression and withdrew consent|1|||
147049080|NCT02721732|530340405|FG002|Overall Study|Progression and withdrew consent|0|||
147049081|NCT02721732|530340406|FG003|Overall Study|Progression and withdrew consent|0|||
147049082|NCT02721732|530340407|FG004|Overall Study|Progression and withdrew consent|0|||
147049083|NCT02721732|530340408|FG005|Overall Study|Progression and withdrew consent|0|||
147049084|NCT02721732|530340409|FG006|Overall Study|Progression and withdrew consent|0|||
147049085|NCT02721732|530340410|FG007|Overall Study|Progression and withdrew consent|0|||
147049086|NCT02721732|530340411|FG008|Overall Study|Progression and withdrew consent|0|||
147049087|NCT02721732|530340412|FG009|Overall Study|Progression and withdrew consent|1|||
147049088|NCT02721732|530340403|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
147049089|NCT02721732|530340404|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
147049090|NCT02721732|530340405|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
147049091|NCT02721732|530340406|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
147049092|NCT02721732|530340407|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
147049093|NCT02721732|530340408|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
147049094|NCT02721732|530340409|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
147049095|NCT02721732|530340410|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
147049096|NCT02721732|530340411|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
147049097|NCT02721732|530340412|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
147049098|NCT04100018|530340418|FG000|Pre-Treatment Period|Not Reported|0|||
147049099|NCT04100018|530340419|FG001|Pre-Treatment Period|Not Reported|4|||
147049100|NCT04100018|530340418|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
147049101|NCT04100018|530340419|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
147049102|NCT04100018|530340418|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
147049103|NCT04100018|530340419|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
147049104|NCT04100018|530340418|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
147049105|NCT04100018|530340419|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
147049106|NCT04100018|530340418|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
147049107|NCT04100018|530340419|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
147049108|NCT04100018|530340418|FG000|Treatment Period|Ongoing Treatment|1|||
147049109|NCT04100018|530340419|FG001|Treatment Period|Ongoing Treatment|0|||
147049110|NCT04100018|530340418|FG000|Treatment Period|Other Reason|26|||
147049111|NCT04100018|530340419|FG001|Treatment Period|Other Reason|37|||
147049112|NCT04100018|530340418|FG000|Treatment Period|Completed treatment as per protocol|1|||
147049113|NCT04100018|530340419|FG001|Treatment Period|Completed treatment as per protocol|2|||
147049114|NCT04100018|530340418|FG000|Treatment Period|Maximum clinical benefit|3|||
147049115|NCT04100018|530340419|FG001|Treatment Period|Maximum clinical benefit|0|||
147049116|NCT04100018|530340418|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
147049117|NCT04100018|530340419|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
147049118|NCT04100018|530340418|FG000|Treatment Period|Study drug toxicity|67|||
147049119|NCT04100018|530340419|FG001|Treatment Period|Study drug toxicity|28|||
147049120|NCT04100018|530340418|FG000|Treatment Period|Disease Progression|284|||
147049121|NCT04100018|530340419|FG001|Treatment Period|Disease Progression|327|||
147049122|NCT04100018|530340418|FG000|Treatment Period|Administrative reasons by sponsor|16|||
147049123|NCT04100018|530340419|FG001|Treatment Period|Administrative reasons by sponsor|30|||
147049124|NCT04100018|530340418|FG000|Treatment Period|Poor/Non-Compliance|1|||
147049125|NCT04100018|530340419|FG001|Treatment Period|Poor/Non-Compliance|0|||
147049126|NCT04100018|530340418|FG000|Treatment Period|Lost to Follow-up|2|||
147049127|NCT04100018|530340419|FG001|Treatment Period|Lost to Follow-up|2|||
147049128|NCT04100018|530340418|FG000|Treatment Period|Death|16|||
147049129|NCT04100018|530340419|FG001|Treatment Period|Death|11|||
147049130|NCT04100018|530340418|FG000|Treatment Period|Participant withdrew consent|10|||
147049131|NCT04100018|530340419|FG001|Treatment Period|Participant withdrew consent|10|||
147049132|NCT04100018|530340418|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
147049133|NCT04100018|530340419|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
147049134|NCT04100018|530340418|FG000|Treatment Period|Adverse Event|14|||
147049135|NCT04100018|530340419|FG001|Treatment Period|Adverse Event|6|||
147049136|NCT04100018|530340418|FG000|Treatment Period|Lack of Efficacy|4|||
147049137|NCT04100018|530340419|FG001|Treatment Period|Lack of Efficacy|2|||
147049138|NCT02848001|530340420|FG000|Overall Study|other reasons|0|||
147049139|NCT02848001|530340421|FG001|Overall Study|other reasons|0|||
147049140|NCT02848001|530340422|FG002|Overall Study|other reasons|1|||
147049141|NCT02848001|530340423|FG003|Overall Study|other reasons|0|||
147049142|NCT02848001|530340424|FG004|Overall Study|other reasons|4|||
147049143|NCT02848001|530340425|FG005|Overall Study|other reasons|1|||
147049144|NCT02848001|530340426|FG006|Overall Study|other reasons|0|||
147049145|NCT02848001|530340427|FG007|Overall Study|other reasons|2|||
147049146|NCT02848001|530340428|FG008|Overall Study|other reasons|2|||
147049147|NCT02848001|530340429|FG009|Overall Study|other reasons|3|||
147049148|NCT02848001|530340430|FG010|Overall Study|other reasons|0|||
147049149|NCT02848001|530340431|FG011|Overall Study|other reasons|1|||
147049150|NCT02848001|530340432|FG012|Overall Study|other reasons|1|||
147049151|NCT02848001|530340433|FG013|Overall Study|other reasons|0|||
147049152|NCT02848001|530340434|FG014|Overall Study|other reasons|0|||
147049153|NCT02848001|530340435|FG015|Overall Study|other reasons|2|||
147049154|NCT02848001|530340436|FG016|Overall Study|other reasons|1|||
147049155|NCT02848001|530340420|FG000|Overall Study|Lack of Efficacy|0|||
147049156|NCT02848001|530340421|FG001|Overall Study|Lack of Efficacy|1|||
147049157|NCT02848001|530340422|FG002|Overall Study|Lack of Efficacy|1|||
147049158|NCT02848001|530340423|FG003|Overall Study|Lack of Efficacy|2|||
147049159|NCT02848001|530340424|FG004|Overall Study|Lack of Efficacy|3|||
147049160|NCT02848001|530340425|FG005|Overall Study|Lack of Efficacy|0|||
147049161|NCT02848001|530340426|FG006|Overall Study|Lack of Efficacy|1|||
147049162|NCT02848001|530340427|FG007|Overall Study|Lack of Efficacy|0|||
147049163|NCT02848001|530340428|FG008|Overall Study|Lack of Efficacy|0|||
147049164|NCT02848001|530340429|FG009|Overall Study|Lack of Efficacy|1|||
147049165|NCT02848001|530340430|FG010|Overall Study|Lack of Efficacy|0|||
147049166|NCT02848001|530340431|FG011|Overall Study|Lack of Efficacy|2|||
147049167|NCT02848001|530340432|FG012|Overall Study|Lack of Efficacy|0|||
147049168|NCT02848001|530340433|FG013|Overall Study|Lack of Efficacy|2|||
147049169|NCT02848001|530340434|FG014|Overall Study|Lack of Efficacy|2|||
147049170|NCT02848001|530340435|FG015|Overall Study|Lack of Efficacy|0|||
147049171|NCT02848001|530340436|FG016|Overall Study|Lack of Efficacy|0|||
147049172|NCT02848001|530340420|FG000|Overall Study|Progressive Disease|2|||
147049173|NCT02848001|530340421|FG001|Overall Study|Progressive Disease|1|||
147049174|NCT02848001|530340422|FG002|Overall Study|Progressive Disease|0|||
147049175|NCT02848001|530340423|FG003|Overall Study|Progressive Disease|4|||
147049176|NCT02848001|530340424|FG004|Overall Study|Progressive Disease|3|||
147049177|NCT02848001|530340425|FG005|Overall Study|Progressive Disease|0|||
147049178|NCT02848001|530340426|FG006|Overall Study|Progressive Disease|4|||
147049179|NCT02848001|530340427|FG007|Overall Study|Progressive Disease|1|||
147049180|NCT02848001|530340428|FG008|Overall Study|Progressive Disease|0|||
147049181|NCT02848001|530340429|FG009|Overall Study|Progressive Disease|2|||
147049182|NCT02848001|530340430|FG010|Overall Study|Progressive Disease|3|||
147049183|NCT02848001|530340431|FG011|Overall Study|Progressive Disease|2|||
147049184|NCT02848001|530340432|FG012|Overall Study|Progressive Disease|1|||
147049185|NCT02848001|530340433|FG013|Overall Study|Progressive Disease|0|||
147049186|NCT02848001|530340434|FG014|Overall Study|Progressive Disease|2|||
147049187|NCT02848001|530340435|FG015|Overall Study|Progressive Disease|4|||
147049188|NCT02848001|530340436|FG016|Overall Study|Progressive Disease|0|||
147049189|NCT02848001|530340420|FG000|Overall Study|Adverse Event|0|||
147049190|NCT02848001|530340421|FG001|Overall Study|Adverse Event|0|||
147049191|NCT02848001|530340422|FG002|Overall Study|Adverse Event|0|||
147049192|NCT02848001|530340423|FG003|Overall Study|Adverse Event|0|||
147049193|NCT02848001|530340424|FG004|Overall Study|Adverse Event|2|||
147049194|NCT02848001|530340425|FG005|Overall Study|Adverse Event|0|||
147049195|NCT02848001|530340426|FG006|Overall Study|Adverse Event|0|||
147049196|NCT02848001|530340427|FG007|Overall Study|Adverse Event|0|||
147049197|NCT02848001|530340428|FG008|Overall Study|Adverse Event|0|||
147049198|NCT02848001|530340429|FG009|Overall Study|Adverse Event|1|||
147049199|NCT02848001|530340430|FG010|Overall Study|Adverse Event|0|||
147049200|NCT02848001|530340431|FG011|Overall Study|Adverse Event|1|||
147049201|NCT02848001|530340432|FG012|Overall Study|Adverse Event|1|||
147049202|NCT02848001|530340433|FG013|Overall Study|Adverse Event|0|||
147049203|NCT02848001|530340434|FG014|Overall Study|Adverse Event|2|||
147049204|NCT02848001|530340435|FG015|Overall Study|Adverse Event|0|||
147049205|NCT02848001|530340436|FG016|Overall Study|Adverse Event|0|||
147049206|NCT02848001|530340420|FG000|Overall Study|Death|0|||
147049207|NCT02848001|530340421|FG001|Overall Study|Death|0|||
147049208|NCT02848001|530340422|FG002|Overall Study|Death|0|||
147049209|NCT02848001|530340423|FG003|Overall Study|Death|1|||
147049210|NCT02848001|530340424|FG004|Overall Study|Death|3|||
147049211|NCT02848001|530340425|FG005|Overall Study|Death|1|||
147049212|NCT02848001|530340426|FG006|Overall Study|Death|2|||
147049213|NCT02848001|530340427|FG007|Overall Study|Death|3|||
147049214|NCT02848001|530340428|FG008|Overall Study|Death|4|||
147049215|NCT02848001|530340429|FG009|Overall Study|Death|1|||
147049216|NCT02848001|530340430|FG010|Overall Study|Death|0|||
147049217|NCT02848001|530340431|FG011|Overall Study|Death|1|||
147049218|NCT02848001|530340432|FG012|Overall Study|Death|3|||
147049219|NCT02848001|530340433|FG013|Overall Study|Death|0|||
147049220|NCT02848001|530340434|FG014|Overall Study|Death|2|||
147049221|NCT02848001|530340435|FG015|Overall Study|Death|3|||
147049222|NCT02848001|530340436|FG016|Overall Study|Death|0|||
147049223|NCT02848001|530340420|FG000|Overall Study|Physician Decision|0|||
147049224|NCT02848001|530340421|FG001|Overall Study|Physician Decision|0|||
147049225|NCT02848001|530340422|FG002|Overall Study|Physician Decision|0|||
147049226|NCT02848001|530340423|FG003|Overall Study|Physician Decision|0|||
147049227|NCT02848001|530340424|FG004|Overall Study|Physician Decision|0|||
147049228|NCT02848001|530340425|FG005|Overall Study|Physician Decision|0|||
147049229|NCT02848001|530340426|FG006|Overall Study|Physician Decision|0|||
147049230|NCT02848001|530340427|FG007|Overall Study|Physician Decision|0|||
147049231|NCT02848001|530340428|FG008|Overall Study|Physician Decision|1|||
147049232|NCT02848001|530340429|FG009|Overall Study|Physician Decision|1|||
147049233|NCT02848001|530340430|FG010|Overall Study|Physician Decision|0|||
147049234|NCT02848001|530340431|FG011|Overall Study|Physician Decision|0|||
147049235|NCT02848001|530340432|FG012|Overall Study|Physician Decision|2|||
147049236|NCT02848001|530340433|FG013|Overall Study|Physician Decision|0|||
147049237|NCT02848001|530340434|FG014|Overall Study|Physician Decision|0|||
147049238|NCT02848001|530340435|FG015|Overall Study|Physician Decision|0|||
147049239|NCT02848001|530340436|FG016|Overall Study|Physician Decision|0|||
147049240|NCT02848001|530340420|FG000|Overall Study|Withdrawal by Subject|0|||
147049241|NCT02848001|530340421|FG001|Overall Study|Withdrawal by Subject|0|||
147049242|NCT02848001|530340422|FG002|Overall Study|Withdrawal by Subject|0|||
147049243|NCT02848001|530340423|FG003|Overall Study|Withdrawal by Subject|0|||
147049244|NCT02848001|530340424|FG004|Overall Study|Withdrawal by Subject|0|||
147049245|NCT02848001|530340425|FG005|Overall Study|Withdrawal by Subject|1|||
147049246|NCT02848001|530340426|FG006|Overall Study|Withdrawal by Subject|1|||
147049247|NCT02848001|530340427|FG007|Overall Study|Withdrawal by Subject|1|||
147049248|NCT02848001|530340428|FG008|Overall Study|Withdrawal by Subject|0|||
147049249|NCT02848001|530340429|FG009|Overall Study|Withdrawal by Subject|0|||
147049250|NCT02848001|530340430|FG010|Overall Study|Withdrawal by Subject|0|||
147049251|NCT02848001|530340431|FG011|Overall Study|Withdrawal by Subject|0|||
147049252|NCT02848001|530340432|FG012|Overall Study|Withdrawal by Subject|0|||
147049253|NCT02848001|530340433|FG013|Overall Study|Withdrawal by Subject|0|||
147049254|NCT02848001|530340434|FG014|Overall Study|Withdrawal by Subject|0|||
147049255|NCT02848001|530340435|FG015|Overall Study|Withdrawal by Subject|0|||
147049256|NCT02848001|530340436|FG016|Overall Study|Withdrawal by Subject|0|||
147049257|NCT00118157|530340440|FG000|Overall Study|Adverse Event|2|||
147049258|NCT00118157|530340440|FG000|Overall Study|Death|8|||
147049259|NCT00118157|530340440|FG000|Overall Study|Withdrawal by Subject|2|||
147049260|NCT01321749|530340444|FG000|Overall Study|Lost to Follow-up|4|||
147049261|NCT01321749|530340445|FG001|Overall Study|Lost to Follow-up|11|||
147049262|NCT01321749|530340444|FG000|Overall Study|Protocol Violation|4|||
147049263|NCT01321749|530340445|FG001|Overall Study|Protocol Violation|7|||
147049264|NCT01321749|530340444|FG000|Overall Study|Withdrawal by Subject|5|||
147049265|NCT01321749|530340445|FG001|Overall Study|Withdrawal by Subject|4|||
147049266|NCT00613171|530340452|FG000|Overall Study|Adverse Event|7|||
147049267|NCT00613171|530340452|FG000|Overall Study|Withdrawal by Subject|3|||
147049268|NCT00613171|530340452|FG000|Overall Study|Reason not Specified|4|||
147049269|NCT01197911|530340453|FG000|Overall Study|Adverse Event|0|||
147049270|NCT01197911|530340454|FG001|Overall Study|Adverse Event|0|||
147049271|NCT01197911|530340455|FG002|Overall Study|Adverse Event|1|||
147049272|NCT01526057|530340458|FG000|Overall Study|Withdrawal by Subject|3|||
147049273|NCT01526057|530340459|FG001|Overall Study|Withdrawal by Subject|2|||
147049274|NCT01526057|530340460|FG002|Overall Study|Withdrawal by Subject|2|||
147049275|NCT01526057|530340458|FG000|Overall Study|Adverse Event|3|||
147049276|NCT01526057|530340459|FG001|Overall Study|Adverse Event|1|||
147049277|NCT01526057|530340460|FG002|Overall Study|Adverse Event|1|||
147049278|NCT01526057|530340458|FG000|Overall Study|Death|1|||
147049279|NCT01526057|530340459|FG001|Overall Study|Death|0|||
147049280|NCT01526057|530340460|FG002|Overall Study|Death|0|||
147049281|NCT01526057|530340458|FG000|Overall Study|Lost to Follow-up|1|||
147049282|NCT01526057|530340459|FG001|Overall Study|Lost to Follow-up|0|||
147049283|NCT01526057|530340460|FG002|Overall Study|Lost to Follow-up|1|||
147049284|NCT01526057|530340458|FG000|Overall Study|Other|1|||
147049285|NCT01526057|530340459|FG001|Overall Study|Other|0|||
147049286|NCT01526057|530340460|FG002|Overall Study|Other|1|||
147049287|NCT01526057|530340458|FG000|Overall Study|Protocol Violation|0|||
147049288|NCT01526057|530340459|FG001|Overall Study|Protocol Violation|0|||
147049289|NCT01526057|530340460|FG002|Overall Study|Protocol Violation|1|||
147049290|NCT02553772|530340465|FG000|Overall Study|Adverse Event|2|||
147049291|NCT02553772|530340466|FG001|Overall Study|Adverse Event|3|||
147049292|NCT02553772|530340465|FG000|Overall Study|Lost to Follow-up|2|||
147049293|NCT02553772|530340466|FG001|Overall Study|Lost to Follow-up|1|||
147049294|NCT02553772|530340465|FG000|Overall Study|Withdrawal of Consent|1|||
147049295|NCT02553772|530340466|FG001|Overall Study|Withdrawal of Consent|1|||
147049296|NCT02553772|530340465|FG000|Overall Study|Lack of Efficacy|1|||
147049297|NCT02553772|530340466|FG001|Overall Study|Lack of Efficacy|0|||
147049298|NCT02553772|530340465|FG000|Overall Study|Other Miscellaneous Reasons|0|||
147049299|NCT02553772|530340466|FG001|Overall Study|Other Miscellaneous Reasons|1|||
147049300|NCT00786409|530340467|FG000|Overall Study|Withdrawal by Subject|2|||
147049301|NCT00786409|530340467|FG000|Overall Study|Adverse Event|2|||
147049302|NCT00786409|530340467|FG000|Overall Study|Pregnancy|2|||
147049303|NCT00786409|530340467|FG000|Overall Study|Lost to Follow-up|1|||
147049304|NCT00610129|530340468|FG000|Overall Study|Not treated since patients ineligible|3|||
147049305|NCT01042093|530340471|FG000|Overall Study|Protocol Violation|2|||
147049306|NCT01042093|530340472|FG001|Overall Study|Protocol Violation|2|||
147049307|NCT01042093|530340473|FG002|Overall Study|Protocol Violation|2|||
147049308|NCT01042093|530340474|FG003|Overall Study|Protocol Violation|3|||
147049309|NCT01042093|530340471|FG000|Overall Study|Withdrawal by Subject|0|||
147049310|NCT01042093|530340472|FG001|Overall Study|Withdrawal by Subject|0|||
147049311|NCT01042093|530340473|FG002|Overall Study|Withdrawal by Subject|0|||
147049312|NCT01042093|530340474|FG003|Overall Study|Withdrawal by Subject|1|||
147049313|NCT00243412|530340480|FG000|Overall Study|Death|0|||
147049314|NCT00243412|530340481|FG001|Overall Study|Death|1|||
147049315|NCT00243412|530340480|FG000|Overall Study|Adverse Event|4|||
147049316|NCT00243412|530340481|FG001|Overall Study|Adverse Event|2|||
147049317|NCT00243412|530340480|FG000|Overall Study|Lost to Follow-up|0|||
147049318|NCT00243412|530340481|FG001|Overall Study|Lost to Follow-up|1|||
147049319|NCT00243412|530340480|FG000|Overall Study|Physician Decision|1|||
147049320|NCT00243412|530340481|FG001|Overall Study|Physician Decision|1|||
147049321|NCT00243412|530340480|FG000|Overall Study|Withdrawal by Subject|4|||
147049322|NCT00243412|530340481|FG001|Overall Study|Withdrawal by Subject|5|||
147049323|NCT00243412|530340480|FG000|Overall Study|Other|1|||
147049324|NCT00243412|530340481|FG001|Overall Study|Other|1|||
147049325|NCT00141778|530340487|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
147049326|NCT00141778|530340488|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
147049327|NCT00141778|530340489|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
147049328|NCT00141778|530340487|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
147049329|NCT00141778|530340488|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
147049330|NCT00141778|530340489|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
147049331|NCT00141778|530340487|FG000|Started Study Medication|Withdrawal by Subject|0|||
147049332|NCT00141778|530340488|FG001|Started Study Medication|Withdrawal by Subject|2|||
147049333|NCT00141778|530340489|FG002|Started Study Medication|Withdrawal by Subject|0|||
147049334|NCT00141778|530340487|FG000|Started Study Medication|Difficulty Swallowing|0|||
147049335|NCT00141778|530340488|FG001|Started Study Medication|Difficulty Swallowing|1|||
147049336|NCT00141778|530340489|FG002|Started Study Medication|Difficulty Swallowing|0|||
147049337|NCT00141778|530340487|FG000|Started Study Medication|Chest Discomfort|0|||
147049338|NCT00141778|530340488|FG001|Started Study Medication|Chest Discomfort|0|||
147049339|NCT00141778|530340489|FG002|Started Study Medication|Chest Discomfort|1|||
147049340|NCT01982955|530340490|FG000|Overall Study|Randomized but not treated|0|||
147049341|NCT01982955|530340491|FG001|Overall Study|Randomized but not treated|0|||
147049342|NCT01982955|530340492|FG002|Overall Study|Randomized but not treated|0|||
147049343|NCT01982955|530340493|FG003|Overall Study|Randomized but not treated|1|||
147049344|NCT01982955|530340494|FG004|Overall Study|Randomized but not treated|0|||
147049345|NCT05655546|530342093|FG000|Overall Study|Withdrawal by Subject|2|||
147049346|NCT05655546|530342094|FG001|Overall Study|Withdrawal by Subject|4|||
147049347|NCT03493685|530342095|FG000|Overall Study|Death|4|||
147049348|NCT03493685|530342096|FG001|Overall Study|Death|3|||
147049349|NCT03493685|530342095|FG000|Overall Study|Lost to Follow-up|3|||
147049350|NCT03493685|530342096|FG001|Overall Study|Lost to Follow-up|2|||
147049351|NCT03493685|530342095|FG000|Overall Study|Physician Decision|2|||
147049352|NCT03493685|530342096|FG001|Overall Study|Physician Decision|0|||
147049353|NCT03493685|530342095|FG000|Overall Study|Withdrawal by Subject|7|||
147049354|NCT03493685|530342096|FG001|Overall Study|Withdrawal by Subject|11|||
147049355|NCT04576507|530342103|FG000|Overall Study|Adverse Event|4|||
147049356|NCT04576507|530342103|FG000|Overall Study|Withdrawal by Subject|1|||
147049357|NCT04467840|530342104|FG000|Overall Study|Death|35|||
147049358|NCT04467840|530342105|FG001|Overall Study|Death|39|||
147049359|NCT04467840|530342104|FG000|Overall Study|Withdrawal by Subject|8|||
147049360|NCT04467840|530342105|FG001|Overall Study|Withdrawal by Subject|4|||
147049361|NCT04467840|530342104|FG000|Overall Study|Adverse Event|2|||
147049362|NCT04467840|530342105|FG001|Overall Study|Adverse Event|0|||
147049363|NCT04467840|530342104|FG000|Overall Study|Lost to Follow-up|1|||
147049364|NCT04467840|530342105|FG001|Overall Study|Lost to Follow-up|3|||
147049365|NCT04467840|530342104|FG000|Overall Study|Physician Decision|1|||
147049366|NCT04467840|530342105|FG001|Overall Study|Physician Decision|0|||
147049367|NCT04467840|530342104|FG000|Overall Study|Other|1|||
147049368|NCT04467840|530342105|FG001|Overall Study|Other|5|||
147049369|NCT04467840|530342104|FG000|Overall Study|Missing study completion status|3|||
147049370|NCT04467840|530342105|FG001|Overall Study|Missing study completion status|1|||
147049371|NCT05201794|530342110|FG000|Overall Study|Withdrawal by Subject|13|||
147049372|NCT05201794|530342111|FG001|Overall Study|Withdrawal by Subject|12|||
147049373|NCT05201794|530342112|FG002|Overall Study|Withdrawal by Subject|14|||
147049374|NCT05201794|530342113|FG003|Overall Study|Withdrawal by Subject|0|||
147049375|NCT05201794|530342110|FG000|Overall Study|Adverse Event|5|||
147049376|NCT05201794|530342111|FG001|Overall Study|Adverse Event|5|||
147049377|NCT05201794|530342112|FG002|Overall Study|Adverse Event|4|||
147049378|NCT05201794|530342113|FG003|Overall Study|Adverse Event|0|||
147049379|NCT05201794|530342110|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
147049380|NCT05201794|530342111|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
147049381|NCT05201794|530342112|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
147049382|NCT05201794|530342113|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
147049383|NCT05201794|530342110|FG000|Overall Study|Non-Compliance With Study Drug|2|||
147049384|NCT05201794|530342111|FG001|Overall Study|Non-Compliance With Study Drug|3|||
147049385|NCT05201794|530342112|FG002|Overall Study|Non-Compliance With Study Drug|3|||
147049386|NCT05201794|530342113|FG003|Overall Study|Non-Compliance With Study Drug|0|||
147049387|NCT05201794|530342110|FG000|Overall Study|Physician Decision|1|||
147049388|NCT05201794|530342111|FG001|Overall Study|Physician Decision|3|||
147049389|NCT05201794|530342112|FG002|Overall Study|Physician Decision|2|||
147049390|NCT05201794|530342113|FG003|Overall Study|Physician Decision|0|||
147049391|NCT05201794|530342110|FG000|Overall Study|Lost to Follow-up|2|||
147049392|NCT05201794|530342111|FG001|Overall Study|Lost to Follow-up|2|||
147049393|NCT05201794|530342112|FG002|Overall Study|Lost to Follow-up|0|||
147049394|NCT05201794|530342113|FG003|Overall Study|Lost to Follow-up|0|||
147049395|NCT05201794|530342110|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
147049396|NCT05201794|530342111|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
147049397|NCT05201794|530342112|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
147049398|NCT05201794|530342113|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
147049399|NCT05201794|530342110|FG000|Overall Study|Protocol Violation|2|||
147049400|NCT05201794|530342111|FG001|Overall Study|Protocol Violation|0|||
147049401|NCT05201794|530342112|FG002|Overall Study|Protocol Violation|1|||
147049402|NCT05201794|530342113|FG003|Overall Study|Protocol Violation|0|||
147049403|NCT05201794|530342110|FG000|Overall Study|Death|1|||
147049404|NCT05201794|530342111|FG001|Overall Study|Death|0|||
147049405|NCT05201794|530342112|FG002|Overall Study|Death|0|||
147049406|NCT05201794|530342113|FG003|Overall Study|Death|0|||
147049407|NCT05201794|530342110|FG000|Overall Study|Site Terminated By Sponsor|0|||
147049408|NCT05201794|530342111|FG001|Overall Study|Site Terminated By Sponsor|1|||
147049409|NCT05201794|530342112|FG002|Overall Study|Site Terminated By Sponsor|0|||
147049410|NCT05201794|530342113|FG003|Overall Study|Site Terminated By Sponsor|0|||
147049411|NCT05201794|530342110|FG000|Overall Study|Other|3|||
147049412|NCT05201794|530342111|FG001|Overall Study|Other|3|||
147049413|NCT05201794|530342112|FG002|Overall Study|Other|3|||
147049414|NCT05201794|530342113|FG003|Overall Study|Other|0|||
147049415|NCT05201794|530342110|FG000|Overall Study|Randomized But Not Treated|1|||
147049416|NCT05201794|530342111|FG001|Overall Study|Randomized But Not Treated|2|||
147049417|NCT05201794|530342112|FG002|Overall Study|Randomized But Not Treated|1|||
147049418|NCT05201794|530342113|FG003|Overall Study|Randomized But Not Treated|0|||
147049419|NCT04653454|530342116|FG000|Overall Study|Withdrawal by Subject|1|||
147049420|NCT04653454|530342116|FG000|Overall Study|Physician Decision|40|||
147049421|NCT00711243|530342117|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
147049422|NCT00711243|530342118|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
147049423|NCT00711243|530342119|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
147049424|NCT00711243|530342120|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
147049425|NCT00711243|530342121|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
147049426|NCT00711243|530342122|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
147049427|NCT00711243|530342117|FG000|Reached First Response/4 Cycles|Death|0|||
147049428|NCT00711243|530342118|FG001|Reached First Response/4 Cycles|Death|0|||
147049429|NCT00711243|530342119|FG002|Reached First Response/4 Cycles|Death|0|||
147049430|NCT00711243|530342120|FG003|Reached First Response/4 Cycles|Death|0|||
147049431|NCT00711243|530342121|FG004|Reached First Response/4 Cycles|Death|0|||
147049432|NCT00711243|530342122|FG005|Reached First Response/4 Cycles|Death|2|||
147049433|NCT00711243|530342117|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
147049434|NCT00711243|530342118|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
147049435|NCT00711243|530342119|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
147049436|NCT00711243|530342120|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
147049437|NCT00711243|530342121|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
147049438|NCT00711243|530342122|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
147049439|NCT00711243|530342117|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
147049440|NCT00711243|530342118|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
147049441|NCT00711243|530342119|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
147049442|NCT00711243|530342120|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
147049443|NCT00711243|530342121|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
147049444|NCT00711243|530342122|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
147049445|NCT00711243|530342117|FG000|Treated Cycle 5 After First Response|Death|0|||
147049446|NCT00711243|530342118|FG001|Treated Cycle 5 After First Response|Death|0|||
147049447|NCT00711243|530342119|FG002|Treated Cycle 5 After First Response|Death|0|||
147049448|NCT00711243|530342120|FG003|Treated Cycle 5 After First Response|Death|0|||
147049449|NCT00711243|530342121|FG004|Treated Cycle 5 After First Response|Death|0|||
147049450|NCT00711243|530342122|FG005|Treated Cycle 5 After First Response|Death|2|||
147049451|NCT00711243|530342117|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
147049452|NCT00711243|530342118|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
147049453|NCT00711243|530342119|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
147049454|NCT00711243|530342120|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
147049455|NCT00711243|530342121|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
147049456|NCT00711243|530342122|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
147049457|NCT00711243|530342117|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
147049458|NCT00711243|530342118|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
147049459|NCT00711243|530342119|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
147049460|NCT00711243|530342120|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
147049461|NCT00711243|530342121|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
147049462|NCT00711243|530342122|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
147049463|NCT01962103|530342123|FG000|Phase 1|Adverse Event|4|||
147049464|NCT01962103|530342124|FG001|Phase 1|Adverse Event|0|||
147049465|NCT01962103|530342125|FG002|Phase 1|Adverse Event|2|||
147049466|NCT01962103|530342126|FG003|Phase 1|Adverse Event|1|||
147049467|NCT01962103|530342127|FG004|Phase 1|Adverse Event|2|||
147049468|NCT01962103|530342128|FG005|Phase 1|Adverse Event|2|||
147049469|NCT01962103|530342129|FG006|Phase 1|Adverse Event|0|||
147049470|NCT01962103|530342130|FG007|Phase 1|Adverse Event|0|||
147049471|NCT01962103|530342131|FG008|Phase 1|Adverse Event|0|||
147049472|NCT01962103|530342123|FG000|Phase 1|Progressive Disease|8|||
147049473|NCT01962103|530342124|FG001|Phase 1|Progressive Disease|6|||
147049474|NCT01962103|530342125|FG002|Phase 1|Progressive Disease|8|||
147049475|NCT01962103|530342126|FG003|Phase 1|Progressive Disease|4|||
147049476|NCT01962103|530342127|FG004|Phase 1|Progressive Disease|5|||
147049477|NCT01962103|530342128|FG005|Phase 1|Progressive Disease|4|||
147049478|NCT01962103|530342129|FG006|Phase 1|Progressive Disease|0|||
147049479|NCT01962103|530342130|FG007|Phase 1|Progressive Disease|0|||
147049480|NCT01962103|530342131|FG008|Phase 1|Progressive Disease|0|||
147049481|NCT01962103|530342123|FG000|Phase 1|Withdrawal by Subject|0|||
147049482|NCT01962103|530342124|FG001|Phase 1|Withdrawal by Subject|0|||
147049483|NCT01962103|530342125|FG002|Phase 1|Withdrawal by Subject|0|||
147049484|NCT01962103|530342126|FG003|Phase 1|Withdrawal by Subject|2|||
147049485|NCT01962103|530342127|FG004|Phase 1|Withdrawal by Subject|0|||
147049486|NCT01962103|530342128|FG005|Phase 1|Withdrawal by Subject|0|||
147049487|NCT01962103|530342129|FG006|Phase 1|Withdrawal by Subject|0|||
147049488|NCT01962103|530342130|FG007|Phase 1|Withdrawal by Subject|0|||
147049489|NCT01962103|530342131|FG008|Phase 1|Withdrawal by Subject|0|||
147049490|NCT01962103|530342123|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
147049491|NCT01962103|530342124|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
147049492|NCT01962103|530342125|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
147049493|NCT01962103|530342126|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
147049494|NCT01962103|530342127|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
147049495|NCT01962103|530342128|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
147049496|NCT01962103|530342129|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
147049497|NCT01962103|530342130|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
147049498|NCT01962103|530342131|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
147049499|NCT01962103|530342123|FG000|Phase 1|Physician Decision|0|||
147049500|NCT01962103|530342124|FG001|Phase 1|Physician Decision|0|||
147049501|NCT01962103|530342125|FG002|Phase 1|Physician Decision|0|||
147049502|NCT01962103|530342126|FG003|Phase 1|Physician Decision|1|||
147049503|NCT01962103|530342127|FG004|Phase 1|Physician Decision|0|||
147049504|NCT01962103|530342128|FG005|Phase 1|Physician Decision|0|||
147049505|NCT01962103|530342129|FG006|Phase 1|Physician Decision|0|||
147049506|NCT01962103|530342130|FG007|Phase 1|Physician Decision|0|||
147049507|NCT01962103|530342131|FG008|Phase 1|Physician Decision|0|||
147049508|NCT01962103|530342123|FG000|Phase 1|Symptomatic Deterioration|3|||
147049509|NCT01962103|530342124|FG001|Phase 1|Symptomatic Deterioration|2|||
147049510|NCT01962103|530342125|FG002|Phase 1|Symptomatic Deterioration|2|||
147049511|NCT01962103|530342126|FG003|Phase 1|Symptomatic Deterioration|2|||
147049512|NCT01962103|530342127|FG004|Phase 1|Symptomatic Deterioration|1|||
147049513|NCT01962103|530342128|FG005|Phase 1|Symptomatic Deterioration|1|||
147049514|NCT01962103|530342129|FG006|Phase 1|Symptomatic Deterioration|0|||
147049515|NCT01962103|530342130|FG007|Phase 1|Symptomatic Deterioration|0|||
147049516|NCT01962103|530342131|FG008|Phase 1|Symptomatic Deterioration|0|||
147049517|NCT01962103|530342123|FG000|Phase 1|Miscellaneous|1|||
147049518|NCT01962103|530342124|FG001|Phase 1|Miscellaneous|0|||
147049519|NCT01962103|530342125|FG002|Phase 1|Miscellaneous|0|||
147049520|NCT01962103|530342126|FG003|Phase 1|Miscellaneous|0|||
147049521|NCT01962103|530342127|FG004|Phase 1|Miscellaneous|0|||
147049522|NCT01962103|530342128|FG005|Phase 1|Miscellaneous|0|||
147049523|NCT01962103|530342129|FG006|Phase 1|Miscellaneous|0|||
147049524|NCT01962103|530342130|FG007|Phase 1|Miscellaneous|0|||
147049525|NCT01962103|530342131|FG008|Phase 1|Miscellaneous|0|||
147049526|NCT01962103|530342123|FG000|Phase 2|Adverse Event|0|||
147049527|NCT01962103|530342124|FG001|Phase 2|Adverse Event|0|||
147049528|NCT01962103|530342125|FG002|Phase 2|Adverse Event|0|||
147049529|NCT01962103|530342126|FG003|Phase 2|Adverse Event|0|||
147049530|NCT01962103|530342127|FG004|Phase 2|Adverse Event|0|||
147049531|NCT01962103|530342128|FG005|Phase 2|Adverse Event|0|||
147049532|NCT01962103|530342129|FG006|Phase 2|Adverse Event|1|||
147049533|NCT01962103|530342130|FG007|Phase 2|Adverse Event|0|||
147049534|NCT01962103|530342131|FG008|Phase 2|Adverse Event|3|||
146850011|NCT02217332|529620677|FG000|Overall Study|Protocol Violation (eligibility)|1|||
146850012|NCT02217332|529620677|FG000|Overall Study|Withdrawal by Subject|1|||
146850013|NCT02217332|529620677|FG000|Overall Study|Lost to Follow-up|1|||
146850014|NCT03573583|529620678|FG000|Overall Study|Lost to Follow-up|1|||
146850015|NCT03573583|529620679|FG001|Overall Study|Lost to Follow-up|0|||
146850016|NCT03573583|529620678|FG000|Overall Study|Withdrawal by Subject|1|||
146850017|NCT03573583|529620679|FG001|Overall Study|Withdrawal by Subject|1|||
146850018|NCT03602066|529620684|FG000|Overall Study|Withdrawal by Subject|2|||
146850019|NCT03602066|529620685|FG001|Overall Study|Withdrawal by Subject|0|||
146850020|NCT03602066|529620684|FG000|Overall Study|Physician Decision|1|||
146850021|NCT03602066|529620685|FG001|Overall Study|Physician Decision|0|||
146850022|NCT00006011|529620693|FG000|Overall Study|Disease progression|13|||
146850023|NCT00006011|529620694|FG001|Overall Study|Disease progression|6|||
146850024|NCT00006011|529620695|FG002|Overall Study|Disease progression|26|||
146850025|NCT00006011|529620693|FG000|Overall Study|Refused further treatment|15|||
146850026|NCT00006011|529620694|FG001|Overall Study|Refused further treatment|13|||
146850027|NCT00006011|529620695|FG002|Overall Study|Refused further treatment|26|||
146850028|NCT00006011|529620693|FG000|Overall Study|Adverse Event|15|||
146850029|NCT00006011|529620694|FG001|Overall Study|Adverse Event|39|||
146850030|NCT00006011|529620695|FG002|Overall Study|Adverse Event|5|||
146850031|NCT00006011|529620693|FG000|Overall Study|Death|0|||
146850032|NCT00006011|529620694|FG001|Overall Study|Death|1|||
146850033|NCT00006011|529620695|FG002|Overall Study|Death|2|||
146850034|NCT00006011|529620693|FG000|Overall Study|Other|4|||
146850035|NCT00006011|529620694|FG001|Overall Study|Other|2|||
146850036|NCT00006011|529620695|FG002|Overall Study|Other|5|||
147049535|NCT01962103|530342123|FG000|Phase 2|Progressive Disease|0|||
146850037|NCT00006011|529620693|FG000|Overall Study|Ineligible|18|||
147049536|NCT01962103|530342124|FG001|Phase 2|Progressive Disease|0|||
147049537|NCT01962103|530342125|FG002|Phase 2|Progressive Disease|0|||
147049538|NCT01962103|530342126|FG003|Phase 2|Progressive Disease|0|||
146850038|NCT00006011|529620694|FG001|Overall Study|Ineligible|16|||
146850039|NCT00006011|529620695|FG002|Overall Study|Ineligible|9|||
146850040|NCT01639560|529620696|FG000|Overall Study|Withdrawal by Subject|9|||
146850041|NCT01639560|529620697|FG001|Overall Study|Withdrawal by Subject|14|||
146850042|NCT01639560|529620696|FG000|Overall Study|Lack of Efficacy|1|||
146850043|NCT01639560|529620697|FG001|Overall Study|Lack of Efficacy|2|||
146850044|NCT01639560|529620696|FG000|Overall Study|Lost to Follow-up|9|||
146850045|NCT01639560|529620697|FG001|Overall Study|Lost to Follow-up|11|||
147049539|NCT01962103|530342127|FG004|Phase 2|Progressive Disease|0|||
147049540|NCT01962103|530342128|FG005|Phase 2|Progressive Disease|0|||
147049541|NCT01962103|530342129|FG006|Phase 2|Progressive Disease|11|||
147049542|NCT01962103|530342130|FG007|Phase 2|Progressive Disease|12|||
147049543|NCT01962103|530342131|FG008|Phase 2|Progressive Disease|11|||
147049544|NCT01962103|530342123|FG000|Phase 2|Symptomatic Deterioration|0|||
147049545|NCT01962103|530342124|FG001|Phase 2|Symptomatic Deterioration|0|||
147049546|NCT01962103|530342125|FG002|Phase 2|Symptomatic Deterioration|0|||
147049547|NCT01962103|530342126|FG003|Phase 2|Symptomatic Deterioration|0|||
147049548|NCT01962103|530342127|FG004|Phase 2|Symptomatic Deterioration|0|||
147049549|NCT01962103|530342128|FG005|Phase 2|Symptomatic Deterioration|0|||
147049550|NCT01962103|530342129|FG006|Phase 2|Symptomatic Deterioration|2|||
147049551|NCT01962103|530342130|FG007|Phase 2|Symptomatic Deterioration|2|||
147049552|NCT01962103|530342131|FG008|Phase 2|Symptomatic Deterioration|0|||
147049553|NCT04179838|530342135|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
147049554|NCT04179838|530342136|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
147049555|NCT04179838|530342135|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
147049556|NCT04179838|530342136|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
147049557|NCT02763046|530342141|FG000|Overall Study|Adverse Event|5|||
147049558|NCT02763046|530342142|FG001|Overall Study|Adverse Event|4|||
147049559|NCT02763046|530342143|FG002|Overall Study|Adverse Event|0|||
147049560|NCT02763046|530342141|FG000|Overall Study|Lack of Efficacy|1|||
147049561|NCT02763046|530342142|FG001|Overall Study|Lack of Efficacy|1|||
147049562|NCT02763046|530342143|FG002|Overall Study|Lack of Efficacy|3|||
147049563|NCT02763046|530342141|FG000|Overall Study|Physician Decision|1|||
147049564|NCT02763046|530342142|FG001|Overall Study|Physician Decision|0|||
147049565|NCT02763046|530342143|FG002|Overall Study|Physician Decision|1|||
147049566|NCT02763046|530342141|FG000|Overall Study|Subject/guardian decision|2|||
147049567|NCT02763046|530342142|FG001|Overall Study|Subject/guardian decision|0|||
147049568|NCT02763046|530342143|FG002|Overall Study|Subject/guardian decision|4|||
147049569|NCT00086684|530342146|FG000|Overall Study|Adverse Event|12|||
147049570|NCT00086684|530342147|FG001|Overall Study|Adverse Event|17|||
147049571|NCT00086684|530342148|FG002|Overall Study|Adverse Event|14|||
147049572|NCT00086684|530342146|FG000|Overall Study|Lack of Efficacy|6|||
147049573|NCT00086684|530342147|FG001|Overall Study|Lack of Efficacy|6|||
147049574|NCT00086684|530342148|FG002|Overall Study|Lack of Efficacy|5|||
147049575|NCT00086684|530342146|FG000|Overall Study|Lost to Follow-up|15|||
147049576|NCT00086684|530342147|FG001|Overall Study|Lost to Follow-up|8|||
147049577|NCT00086684|530342148|FG002|Overall Study|Lost to Follow-up|10|||
147049578|NCT00086684|530342146|FG000|Overall Study|Protocol Violation|8|||
147049579|NCT00086684|530342147|FG001|Overall Study|Protocol Violation|3|||
147049580|NCT00086684|530342148|FG002|Overall Study|Protocol Violation|0|||
147049581|NCT00086684|530342146|FG000|Overall Study|Withdrawal by Subject|0|||
147049582|NCT00086684|530342147|FG001|Overall Study|Withdrawal by Subject|4|||
147049583|NCT00086684|530342148|FG002|Overall Study|Withdrawal by Subject|10|||
147049584|NCT00086684|530342146|FG000|Overall Study|NONCOMPLIANCE|5|||
147049585|NCT00086684|530342147|FG001|Overall Study|NONCOMPLIANCE|7|||
147049586|NCT00086684|530342148|FG002|Overall Study|NONCOMPLIANCE|6|||
147049587|NCT00086684|530342146|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
147049588|NCT00086684|530342147|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
147049589|NCT00086684|530342148|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
147049590|NCT00086684|530342146|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
147049591|NCT00086684|530342147|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
147049592|NCT00086684|530342148|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
147049593|NCT00086684|530342146|FG000|Overall Study|Other|4|||
147049594|NCT00086684|530342147|FG001|Overall Study|Other|2|||
147049595|NCT00086684|530342148|FG002|Overall Study|Other|3|||
147049596|NCT01067105|530342151|FG000|Overall Study|Adverse Event|14|||
147049597|NCT01067105|530342151|FG000|Overall Study|Protocol Violation|48|||
147049598|NCT01067105|530342151|FG000|Overall Study|Withdrawal by Subject|36|||
147049599|NCT01067105|530342151|FG000|Overall Study|Lost to Follow-up|6|||
147049600|NCT01067105|530342151|FG000|Overall Study|Physician Decision|6|||
147049601|NCT01067105|530342151|FG000|Overall Study|Other|31|||
147049602|NCT02203357|530342155|FG000|Overall Study|Lost to Follow-up|58|||
147049603|NCT02203357|530342156|FG001|Overall Study|Lost to Follow-up|66|||
147049604|NCT02203357|530342157|FG002|Overall Study|Lost to Follow-up|70|||
147049605|NCT02439216|530342158|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
147049606|NCT02439216|530342159|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
147049607|NCT02439216|530342160|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
147049608|NCT02439216|530342161|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
147049609|NCT02439216|530342162|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
147049610|NCT02439216|530342163|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
147049611|NCT02439216|530342164|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
147049612|NCT02439216|530342165|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
147049613|NCT02439216|530342166|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
147049614|NCT02439216|530342158|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
147049615|NCT02439216|530342159|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
147049616|NCT02439216|530342160|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
147049617|NCT02439216|530342161|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
147049618|NCT02439216|530342162|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
147049619|NCT02439216|530342163|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
147049620|NCT02439216|530342164|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
147049621|NCT02439216|530342165|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
147049622|NCT02439216|530342166|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
147049623|NCT02439216|530342158|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
147049624|NCT02439216|530342159|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
147049625|NCT02439216|530342160|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
147049626|NCT02439216|530342161|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
147049627|NCT02439216|530342162|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
147049628|NCT02439216|530342163|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
147049629|NCT02439216|530342164|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
147049630|NCT02439216|530342165|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
147049631|NCT02439216|530342166|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
147049632|NCT02439216|530342158|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
147049633|NCT02439216|530342159|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
147049634|NCT02439216|530342160|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
147049635|NCT02439216|530342161|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
147049636|NCT02439216|530342162|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
147049637|NCT02439216|530342163|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
147049638|NCT02439216|530342164|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
147049639|NCT02439216|530342165|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
147049640|NCT02439216|530342166|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
147049641|NCT02439216|530342158|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
147049642|NCT02439216|530342159|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
147049643|NCT02439216|530342160|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
147049644|NCT02439216|530342161|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
147049645|NCT02439216|530342162|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
147049646|NCT02439216|530342163|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
147049647|NCT02439216|530342164|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
147049648|NCT02439216|530342165|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
147049649|NCT02439216|530342166|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
147049650|NCT02094300|530342167|FG000|Overall Study|Death|7|||
147049651|NCT02094300|530342167|FG000|Overall Study|Lost to Follow-up|10|||
147049652|NCT02094300|530342167|FG000|Overall Study|Still be eligible for follow-up|3|||
147049653|NCT02493660|530342172|FG000|Overall Study|Physician Decision|0|||
147049654|NCT02493660|530342173|FG001|Overall Study|Physician Decision|1|||
147049655|NCT02493660|530342172|FG000|Overall Study|Adverse Event|4|||
147049656|NCT02493660|530342173|FG001|Overall Study|Adverse Event|2|||
147049657|NCT02493660|530342172|FG000|Overall Study|Withdrawal by Subject|2|||
147049658|NCT02493660|530342173|FG001|Overall Study|Withdrawal by Subject|3|||
147049659|NCT02493660|530342172|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
147049660|NCT02493660|530342173|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
147049661|NCT02493660|530342172|FG000|Overall Study|Protocol Violation|0|||
147049662|NCT02493660|530342173|FG001|Overall Study|Protocol Violation|1|||
147049663|NCT02493660|530342172|FG000|Overall Study|Death|0|||
147049664|NCT02493660|530342173|FG001|Overall Study|Death|1|||
147049665|NCT02493660|530342172|FG000|Overall Study|Lost to Follow-up|2|||
147049666|NCT02493660|530342173|FG001|Overall Study|Lost to Follow-up|4|||
147049667|NCT01050530|530342176|FG000|Overall Study|Adverse Event|6|||
147049668|NCT01050530|530342177|FG001|Overall Study|Adverse Event|3|||
147049669|NCT01050530|530342176|FG000|Overall Study|Lack of Efficacy|1|||
147049670|NCT01050530|530342177|FG001|Overall Study|Lack of Efficacy|4|||
147049671|NCT01050530|530342176|FG000|Overall Study|Withdrawal by Subject|0|||
147049672|NCT01050530|530342177|FG001|Overall Study|Withdrawal by Subject|3|||
147049673|NCT01050530|530342176|FG000|Overall Study|Protocol Violation|1|||
147049674|NCT01050530|530342177|FG001|Overall Study|Protocol Violation|0|||
147049675|NCT02288312|530342180|FG000|Overall Study|Pregnancy|1|||
147049676|NCT02288312|530342181|FG001|Overall Study|Pregnancy|0|||
147049677|NCT02288312|530342182|FG002|Overall Study|Pregnancy|0|||
147049678|NCT01276041|530342183|FG000|Overall Study|Adverse Event|2|||
147049679|NCT01276041|530342183|FG000|Overall Study|Protocol Violation|1|||
147049680|NCT00725491|530342184|FG000|Overall Study|Adverse Event|3|||
147049681|NCT00725491|530342185|FG001|Overall Study|Adverse Event|2|||
147049682|NCT00725491|530342184|FG000|Overall Study|Pregnancy|0|||
147049683|NCT00725491|530342185|FG001|Overall Study|Pregnancy|3|||
147049684|NCT00725491|530342184|FG000|Overall Study|Risk for hyperstimulation|2|||
147049685|NCT00725491|530342185|FG001|Overall Study|Risk for hyperstimulation|9|||
147049686|NCT00725491|530342184|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
147049687|NCT00725491|530342185|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
147049688|NCT00725491|530342184|FG000|Overall Study|Fertilization failure|0|||
147049689|NCT00725491|530342185|FG001|Overall Study|Fertilization failure|1|||
147049690|NCT00725491|530342184|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
147049691|NCT00725491|530342185|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
147049692|NCT01495000|530342188|FG000|Overall Study|Lost to Follow-up|2|||
147049693|NCT01495000|530342189|FG001|Overall Study|Lost to Follow-up|2|||
147049694|NCT01495000|530342188|FG000|Overall Study|Protocol Violation|1|||
147049695|NCT01495000|530342189|FG001|Overall Study|Protocol Violation|0|||
147049696|NCT01495000|530342188|FG000|Overall Study|Withdrawal by Subject|10|||
147049697|NCT01495000|530342189|FG001|Overall Study|Withdrawal by Subject|10|||
147049698|NCT02070965|530342190|FG000|Overall Study|Lost to Follow-up|0|||
147049699|NCT02070965|530342191|FG001|Overall Study|Lost to Follow-up|1|||
147049700|NCT02070965|530342192|FG002|Overall Study|Lost to Follow-up|0|||
147049701|NCT02070965|530342190|FG000|Overall Study|Withdrawal by Subject|1|||
147049702|NCT02070965|530342191|FG001|Overall Study|Withdrawal by Subject|1|||
147049703|NCT02070965|530342192|FG002|Overall Study|Withdrawal by Subject|1|||
147049704|NCT02070965|530342190|FG000|Overall Study|Subject moved|1|||
147049705|NCT02070965|530342191|FG001|Overall Study|Subject moved|0|||
147049706|NCT02070965|530342192|FG002|Overall Study|Subject moved|0|||
147049707|NCT00942357|530342201|FG000|Overall Study|Ineligible|37|||
147049708|NCT00942357|530342202|FG001|Overall Study|Ineligible|40|||
147049709|NCT03347110|530342205|FG000|Overall Study|Other (Participant is incarcerated)|1|||
147049710|NCT03347110|530342205|FG000|Overall Study|Withdrawal by Subject|9|||
147049711|NCT03347110|530342205|FG000|Overall Study|Lost to Follow-up|1|||
147049712|NCT03347110|530342205|FG000|Overall Study|Lack of Efficacy|2|||
147049713|NCT03347110|530342205|FG000|Overall Study|Adverse Event, non-fatal|9|||
147049714|NCT02105467|530342208|FG000|Period 1|Lost to Follow-up|1|||
147049715|NCT02105467|530342209|FG001|Period 1|Lost to Follow-up|0|||
147049716|NCT02105467|530342208|FG000|Period 1|Death|1|||
147049717|NCT02105467|530342209|FG001|Period 1|Death|0|||
147049718|NCT02105467|530342208|FG000|Period 2|Lost to Follow-up|1|||
147049719|NCT02105467|530342209|FG001|Period 2|Lost to Follow-up|0|||
147049720|NCT02105467|530342208|FG000|Period 2|Death|1|||
147049721|NCT02105467|530342209|FG001|Period 2|Death|0|||
147049722|NCT02105467|530342208|FG000|Period 2|Withdrawal by Subject|0|||
147049723|NCT02105467|530342209|FG001|Period 2|Withdrawal by Subject|2|||
147049724|NCT02105467|530342208|FG000|Period 3|Lost to Follow-up|0|||
147049725|NCT02105467|530342209|FG001|Period 3|Lost to Follow-up|1|||
147049726|NCT00958828|530342212|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
147049727|NCT00958828|530342213|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
147049728|NCT00958828|530342212|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
147049729|NCT00958828|530342213|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
147049730|NCT02687451|530342220|FG000|Overall Study|Withdrawal by Subject|1|||
147049731|NCT02687451|530342221|FG001|Overall Study|Withdrawal by Subject|0|||
147049732|NCT02687451|530342222|FG002|Overall Study|Withdrawal by Subject|0|||
147049733|NCT02687451|530342223|FG003|Overall Study|Withdrawal by Subject|0|||
147049734|NCT02687451|530342224|FG004|Overall Study|Withdrawal by Subject|0|||
147049735|NCT02687451|530342225|FG005|Overall Study|Withdrawal by Subject|1|||
147049736|NCT00707239|530342226|FG000|Overall Study|Adverse Event|5|||
147049737|NCT00707239|530342227|FG001|Overall Study|Adverse Event|3|||
147049738|NCT00707239|530342228|FG002|Overall Study|Adverse Event|2|||
147049739|NCT00707239|530342226|FG000|Overall Study|Death|3|||
147049740|NCT00707239|530342227|FG001|Overall Study|Death|1|||
147049741|NCT00707239|530342228|FG002|Overall Study|Death|3|||
147049742|NCT00707239|530342226|FG000|Overall Study|Physician Decision|1|||
147049743|NCT00707239|530342227|FG001|Overall Study|Physician Decision|1|||
147049744|NCT00707239|530342228|FG002|Overall Study|Physician Decision|2|||
147049745|NCT00707239|530342226|FG000|Overall Study|Protocol Violation|0|||
147049746|NCT00707239|530342227|FG001|Overall Study|Protocol Violation|0|||
147049747|NCT00707239|530342228|FG002|Overall Study|Protocol Violation|1|||
147049748|NCT00707239|530342226|FG000|Overall Study|Lack of Efficacy|1|||
147049749|NCT00707239|530342227|FG001|Overall Study|Lack of Efficacy|2|||
147049750|NCT00707239|530342228|FG002|Overall Study|Lack of Efficacy|0|||
147049751|NCT00707239|530342226|FG000|Overall Study|Randomized, but not treated|1|||
147049752|NCT00707239|530342227|FG001|Overall Study|Randomized, but not treated|1|||
147049753|NCT00707239|530342228|FG002|Overall Study|Randomized, but not treated|1|||
147049754|NCT00707239|530342226|FG000|Overall Study|Other|8|||
147049755|NCT00707239|530342227|FG001|Overall Study|Other|3|||
147049756|NCT00707239|530342228|FG002|Overall Study|Other|5|||
147049757|NCT01778530|530342233|FG000|Overall Study|Progression on study|1|||
147049758|NCT01778530|530342233|FG000|Overall Study|Adverse event/side effect|1|||
147049759|NCT03472014|530342234|FG000|Overall Study|Lost to Follow-up|4|||
147049760|NCT00811733|530342237|FG000|Overall Study|Investigator Discretion|10|||
147049761|NCT00811733|530342238|FG001|Overall Study|Investigator Discretion|8|||
147049762|NCT00811733|530342237|FG000|Overall Study|Withdrawal by Subject|1|||
147049763|NCT00811733|530342238|FG001|Overall Study|Withdrawal by Subject|2|||
147049764|NCT00793871|530342239|FG000|Overall Study|Death|50|||
147049765|NCT00793871|530342239|FG000|Overall Study|Lost to Follow-up|3|||
147049766|NCT00793871|530342239|FG000|Overall Study|Study terminated by the Sponsor|7|||
147049767|NCT02500589|530342240|FG000|Overall Study|Withdrawal by Subject|11|||
147049768|NCT02500589|530342241|FG001|Overall Study|Withdrawal by Subject|14|||
147049769|NCT02500589|530342240|FG000|Overall Study|Lost to Follow-up|10|||
147049770|NCT02500589|530342241|FG001|Overall Study|Lost to Follow-up|12|||
147049771|NCT02500589|530342240|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
147049772|NCT02500589|530342241|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
147049773|NCT02500589|530342240|FG000|Overall Study|Death|7|||
147049774|NCT02500589|530342241|FG001|Overall Study|Death|5|||
147049775|NCT00312338|530342244|FG000|Overall Study|Adverse Event|7|||
147049776|NCT00312338|530342245|FG001|Overall Study|Adverse Event|2|||
147049777|NCT00312338|530342244|FG000|Overall Study|Lost to Follow-up|9|||
147049778|NCT00312338|530342245|FG001|Overall Study|Lost to Follow-up|1|||
147049779|NCT00312338|530342244|FG000|Overall Study|Withdrawal by Subject|4|||
147049780|NCT00312338|530342245|FG001|Overall Study|Withdrawal by Subject|0|||
147049781|NCT00312338|530342244|FG000|Overall Study|Subsequent infection|2|||
147049782|NCT00312338|530342245|FG001|Overall Study|Subsequent infection|0|||
147049783|NCT00262028|530342246|FG000|Overall Study|Withdrawal by Subject|6|||
147049784|NCT00262028|530342247|FG001|Overall Study|Withdrawal by Subject|3|||
147049785|NCT00262028|530342248|FG002|Overall Study|Withdrawal by Subject|6|||
147049786|NCT00262028|530342249|FG003|Overall Study|Withdrawal by Subject|5|||
147049787|NCT00262028|530342250|FG004|Overall Study|Withdrawal by Subject|2|||
147049788|NCT00262028|530342251|FG005|Overall Study|Withdrawal by Subject|3|||
147049789|NCT00262028|530342252|FG006|Overall Study|Withdrawal by Subject|5|||
147049790|NCT00262028|530342253|FG007|Overall Study|Withdrawal by Subject|7|||
147049791|NCT00262028|530342254|FG008|Overall Study|Withdrawal by Subject|2|||
147049792|NCT00262028|530342246|FG000|Overall Study|Lost to Follow-up|7|||
147049793|NCT00262028|530342247|FG001|Overall Study|Lost to Follow-up|7|||
147049794|NCT00262028|530342248|FG002|Overall Study|Lost to Follow-up|5|||
147049795|NCT00262028|530342249|FG003|Overall Study|Lost to Follow-up|5|||
147049796|NCT00262028|530342250|FG004|Overall Study|Lost to Follow-up|4|||
147049797|NCT00262028|530342251|FG005|Overall Study|Lost to Follow-up|3|||
147049798|NCT00262028|530342252|FG006|Overall Study|Lost to Follow-up|3|||
147049799|NCT00262028|530342253|FG007|Overall Study|Lost to Follow-up|5|||
147049800|NCT00262028|530342254|FG008|Overall Study|Lost to Follow-up|6|||
147049801|NCT00262028|530342246|FG000|Overall Study|Administrative Reason|11|||
147049802|NCT00262028|530342247|FG001|Overall Study|Administrative Reason|14|||
147049803|NCT00262028|530342248|FG002|Overall Study|Administrative Reason|9|||
147049804|NCT00262028|530342249|FG003|Overall Study|Administrative Reason|12|||
147049805|NCT00262028|530342250|FG004|Overall Study|Administrative Reason|6|||
147049806|NCT00262028|530342251|FG005|Overall Study|Administrative Reason|7|||
147049807|NCT00262028|530342252|FG006|Overall Study|Administrative Reason|4|||
147049808|NCT00262028|530342253|FG007|Overall Study|Administrative Reason|6|||
147049809|NCT00262028|530342254|FG008|Overall Study|Administrative Reason|10|||
147049810|NCT00262028|530342246|FG000|Overall Study|Protocol Violation|0|||
147049811|NCT00262028|530342247|FG001|Overall Study|Protocol Violation|0|||
147049812|NCT00262028|530342248|FG002|Overall Study|Protocol Violation|0|||
147049813|NCT00262028|530342249|FG003|Overall Study|Protocol Violation|1|||
147049814|NCT00262028|530342250|FG004|Overall Study|Protocol Violation|0|||
147049815|NCT00262028|530342251|FG005|Overall Study|Protocol Violation|0|||
147049816|NCT00262028|530342252|FG006|Overall Study|Protocol Violation|0|||
147049817|NCT00262028|530342253|FG007|Overall Study|Protocol Violation|0|||
147049818|NCT00262028|530342254|FG008|Overall Study|Protocol Violation|0|||
147049819|NCT00262028|530342246|FG000|Overall Study|Unable to classify|0|||
147049820|NCT00262028|530342247|FG001|Overall Study|Unable to classify|3|||
147049821|NCT00262028|530342248|FG002|Overall Study|Unable to classify|0|||
147049822|NCT00262028|530342249|FG003|Overall Study|Unable to classify|0|||
147049823|NCT00262028|530342250|FG004|Overall Study|Unable to classify|0|||
147049824|NCT00262028|530342251|FG005|Overall Study|Unable to classify|0|||
147049825|NCT00262028|530342252|FG006|Overall Study|Unable to classify|0|||
147049826|NCT00262028|530342253|FG007|Overall Study|Unable to classify|0|||
147049827|NCT00262028|530342254|FG008|Overall Study|Unable to classify|1|||
147049828|NCT01169350|530342255|FG000|Overall Study|Physician Decision|3|||
147049829|NCT01169350|530342255|FG000|Overall Study|Lost to Follow-up|2|||
147049830|NCT04870710|530342258|FG000|Overall Study|Lost to Follow-up|3|||
147049831|NCT05724589|530342260|FG000|Overall Study|Lost to Follow-up|1|||
147049832|NCT04075487|530343711|FG000|Overall Study|Withdrawal by Subject|1|||
147049833|NCT05016960|530343714|FG000|Overall Study|Withdrawal by Subject|1|||
147049834|NCT05016960|530343715|FG001|Overall Study|Withdrawal by Subject|9|||
147049835|NCT00116779|530343716|FG000|Overall Study|Adverse Event|4|||
147049836|NCT00116779|530343717|FG001|Overall Study|Adverse Event|2|||
147049837|NCT00116779|530343716|FG000|Overall Study|Protocol Violation|1|||
147049838|NCT00116779|530343717|FG001|Overall Study|Protocol Violation|4|||
147049839|NCT00116779|530343716|FG000|Overall Study|Withdrawal by Subject|4|||
147049840|NCT00116779|530343717|FG001|Overall Study|Withdrawal by Subject|1|||
147049841|NCT00116779|530343716|FG000|Overall Study|Inadequate testosterone suppression|7|||
147049842|NCT00116779|530343717|FG001|Overall Study|Inadequate testosterone suppression|9|||
147049843|NCT00116779|530343716|FG000|Overall Study|Physician Decision|3|||
147049844|NCT00116779|530343717|FG001|Overall Study|Physician Decision|1|||
147049845|NCT00116779|530343716|FG000|Overall Study|Elevated PSA levels|2|||
147049846|NCT00116779|530343717|FG001|Overall Study|Elevated PSA levels|2|||
147049847|NCT01321879|530343718|FG000|Overall Study|Lack of Efficacy|5|||
147049848|NCT01321879|530343718|FG000|Overall Study|Adverse Event|5|||
147049849|NCT01321879|530343718|FG000|Overall Study|Death|3|||
147049850|NCT01321879|530343718|FG000|Overall Study|Withdrawal by Subject|1|||
147049851|NCT03743051|530343719|FG000|Overall Study|Adverse Event|5|||
147049852|NCT03743051|530343720|FG001|Overall Study|Adverse Event|9|||
147049853|NCT03743051|530343719|FG000|Overall Study|Death|27|||
147049854|NCT03743051|530343720|FG001|Overall Study|Death|26|||
147049855|NCT03743051|530343719|FG000|Overall Study|Lost to Follow-up|4|||
147049856|NCT03743051|530343720|FG001|Overall Study|Lost to Follow-up|8|||
147049857|NCT03743051|530343719|FG000|Overall Study|Withdrawal by Subject|32|||
147049858|NCT03743051|530343720|FG001|Overall Study|Withdrawal by Subject|19|||
147049859|NCT03743051|530343719|FG000|Overall Study|Physician Decision|10|||
147049860|NCT03743051|530343720|FG001|Overall Study|Physician Decision|15|||
147049861|NCT03743051|530343719|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
147049862|NCT03743051|530343720|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
147049863|NCT00711087|530343721|FG000|Overall Study|Lost to Follow-up|1|||
147049864|NCT00711087|530343722|FG001|Overall Study|Lost to Follow-up|0|||
147049865|NCT03652051|530343725|FG000|Stage 1|Adverse Event|0|||
147049866|NCT03652051|530343726|FG001|Stage 1|Adverse Event|5|||
147049867|NCT03652051|530343727|FG002|Stage 1|Adverse Event|7|||
147049868|NCT03652051|530343728|FG003|Stage 1|Adverse Event|1|||
147049869|NCT03652051|530343725|FG000|Stage 1|Withdrawal by Subject|0|||
147049870|NCT03652051|530343726|FG001|Stage 1|Withdrawal by Subject|0|||
147049871|NCT03652051|530343727|FG002|Stage 1|Withdrawal by Subject|1|||
147049872|NCT03652051|530343728|FG003|Stage 1|Withdrawal by Subject|0|||
147049873|NCT03652051|530343725|FG000|Stage 2|Adverse Event|0|||
147049874|NCT03652051|530343726|FG001|Stage 2|Adverse Event|2|||
147049875|NCT03652051|530343727|FG002|Stage 2|Adverse Event|1|||
147049876|NCT03652051|530343728|FG003|Stage 2|Adverse Event|0|||
147049877|NCT03652051|530343725|FG000|Stage 2|Protocol Violation|0|||
147049878|NCT03652051|530343726|FG001|Stage 2|Protocol Violation|1|||
147049879|NCT03652051|530343727|FG002|Stage 2|Protocol Violation|6|||
147049880|NCT03652051|530343728|FG003|Stage 2|Protocol Violation|0|||
147049881|NCT03652051|530343725|FG000|Stage 2|Lost to Follow-up|0|||
147049882|NCT03652051|530343726|FG001|Stage 2|Lost to Follow-up|2|||
147049883|NCT03652051|530343727|FG002|Stage 2|Lost to Follow-up|0|||
147049884|NCT03652051|530343728|FG003|Stage 2|Lost to Follow-up|3|||
147049885|NCT03652051|530343725|FG000|Stage 2|Withdrawal by Subject|0|||
147049886|NCT03652051|530343726|FG001|Stage 2|Withdrawal by Subject|11|||
147049887|NCT03652051|530343727|FG002|Stage 2|Withdrawal by Subject|9|||
147049888|NCT03652051|530343728|FG003|Stage 2|Withdrawal by Subject|3|||
147049889|NCT00840749|530343729|FG000|Overall Study|Death|1|||
147049890|NCT00840749|530343730|FG001|Overall Study|Death|2|||
147049891|NCT00840749|530343729|FG000|Overall Study|not treated on study arm|11|||
147049892|NCT00840749|530343730|FG001|Overall Study|not treated on study arm|11|||
147049893|NCT00840749|530343729|FG000|Overall Study|study closed|19|||
147049894|NCT00840749|530343730|FG001|Overall Study|study closed|14|||
147049895|NCT01958437|530343731|FG000|Overall Study|Incidental MRI findings|0|||
147049896|NCT01958437|530343732|FG001|Overall Study|Incidental MRI findings|0|||
147049897|NCT01958437|530343733|FG002|Overall Study|Incidental MRI findings|1|||
147049898|NCT01958437|530343734|FG003|Overall Study|Incidental MRI findings|1|||
147049899|NCT01113892|530343741|FG000|Overall Study|Lost to Follow-up|2|||
147049900|NCT01113892|530343742|FG001|Overall Study|Lost to Follow-up|2|||
147049901|NCT01113892|530343741|FG000|Overall Study|Withdrawal by Subject|1|||
147049902|NCT01113892|530343742|FG001|Overall Study|Withdrawal by Subject|1|||
147049903|NCT01113892|530343741|FG000|Overall Study|Death|2|||
147049904|NCT01113892|530343742|FG001|Overall Study|Death|4|||
147049905|NCT01113892|530343741|FG000|Overall Study|Graft no longer evaluable|9|||
147049906|NCT01113892|530343742|FG001|Overall Study|Graft no longer evaluable|9|||
147049907|NCT02394600|530343743|FG000|Overall Study|Adverse Event|3|||
147049908|NCT02394600|530343744|FG001|Overall Study|Adverse Event|0|||
147049909|NCT02394600|530343743|FG000|Overall Study|Lost to Follow-up|0|||
147049910|NCT02394600|530343744|FG001|Overall Study|Lost to Follow-up|1|||
147049911|NCT02394600|530343743|FG000|Overall Study|Withdrawal by Subject|0|||
147049912|NCT02394600|530343744|FG001|Overall Study|Withdrawal by Subject|1|||
147049913|NCT02394600|530343743|FG000|Overall Study|Protocol Violation|1|||
147049914|NCT02394600|530343744|FG001|Overall Study|Protocol Violation|0|||
147049915|NCT00428246|530343745|FG000|Overall Study|Withdrawal by Subject|0|||
147049916|NCT00428246|530343746|FG001|Overall Study|Withdrawal by Subject|0|||
147049917|NCT00428246|530343747|FG002|Overall Study|Withdrawal by Subject|1|||
147049918|NCT00428246|530343745|FG000|Overall Study|Adverse Event|1|||
147049919|NCT00428246|530343746|FG001|Overall Study|Adverse Event|0|||
147049920|NCT00428246|530343747|FG002|Overall Study|Adverse Event|0|||
147049921|NCT02569801|530343748|FG000|Overall Study|Withdrawal by Subject|9|||
147049922|NCT02569801|530343749|FG001|Overall Study|Withdrawal by Subject|9|||
147049923|NCT02569801|530343748|FG000|Overall Study|Sponsor Decision|13|||
147049924|NCT02569801|530343749|FG001|Overall Study|Sponsor Decision|14|||
147049925|NCT02569801|530343748|FG000|Overall Study|Progressive Disease|2|||
147049926|NCT02569801|530343749|FG001|Overall Study|Progressive Disease|7|||
147049927|NCT02569801|530343748|FG000|Overall Study|Lost to Follow-up|0|||
147049928|NCT02569801|530343749|FG001|Overall Study|Lost to Follow-up|1|||
147049929|NCT02569801|530343748|FG000|Overall Study|Death|12|||
147049930|NCT02569801|530343749|FG001|Overall Study|Death|4|||
147049931|NCT03442751|530343751|FG000|Overall Study|Withdrawal by Subject|3|||
147049932|NCT03442751|530343752|FG001|Overall Study|Withdrawal by Subject|1|||
147049933|NCT03442751|530343751|FG000|Overall Study|Lost to Follow-up|3|||
147049934|NCT03442751|530343752|FG001|Overall Study|Lost to Follow-up|0|||
147049935|NCT01928472|530343754|FG000|Overall Study|Death|0|||
147049936|NCT01928472|530343755|FG001|Overall Study|Death|0|||
147049937|NCT01928472|530343756|FG002|Overall Study|Death|1|||
147049938|NCT01928472|530343757|FG003|Overall Study|Death|0|||
147049939|NCT01928472|530343754|FG000|Overall Study|Withdrawal by Subject|4|||
147049940|NCT01928472|530343755|FG001|Overall Study|Withdrawal by Subject|4|||
147049941|NCT01928472|530343756|FG002|Overall Study|Withdrawal by Subject|1|||
147049942|NCT01928472|530343757|FG003|Overall Study|Withdrawal by Subject|2|||
147049943|NCT01928472|530343754|FG000|Overall Study|Lost to Follow-up|2|||
147049944|NCT01928472|530343755|FG001|Overall Study|Lost to Follow-up|3|||
147049945|NCT01928472|530343756|FG002|Overall Study|Lost to Follow-up|4|||
147049946|NCT01928472|530343757|FG003|Overall Study|Lost to Follow-up|0|||
147049947|NCT01928472|530343754|FG000|Overall Study|Administrative Reason|2|||
147049948|NCT01928472|530343755|FG001|Overall Study|Administrative Reason|1|||
147049949|NCT01928472|530343756|FG002|Overall Study|Administrative Reason|0|||
147049950|NCT01928472|530343757|FG003|Overall Study|Administrative Reason|0|||
147049951|NCT01928472|530343754|FG000|Overall Study|Unclassified|0|||
147049952|NCT01928472|530343755|FG001|Overall Study|Unclassified|0|||
147049953|NCT01928472|530343756|FG002|Overall Study|Unclassified|1|||
147049954|NCT01928472|530343757|FG003|Overall Study|Unclassified|0|||
147049955|NCT02603887|530343759|FG000|Stage 1|Adverse Event|4|||
147049956|NCT02603887|530343759|FG000|Stage 1|Disease progression|1|||
147049957|NCT02603887|530343759|FG000|Stage 2|FDA guidance|1|||
147049958|NCT01308424|530343762|FG000|Baseline Eligibility|Screen Failures|71|||
147049959|NCT01308424|530343763|FG001|Baseline Eligibility|Screen Failures|0|||
147049960|NCT01308424|530343764|FG002|Baseline Eligibility|Screen Failures|0|||
147049961|NCT01308424|530343762|FG000|Randomization|Adverse Event|0|||
147049962|NCT01308424|530343763|FG001|Randomization|Adverse Event|1|||
147049963|NCT01308424|530343764|FG002|Randomization|Adverse Event|1|||
147049964|NCT01308424|530343762|FG000|Randomization|Lost to Follow-up|0|||
147049965|NCT01308424|530343763|FG001|Randomization|Lost to Follow-up|1|||
147049966|NCT01308424|530343764|FG002|Randomization|Lost to Follow-up|0|||
147049967|NCT01308424|530343762|FG000|Randomization|Physician Decision|0|||
147049968|NCT01308424|530343763|FG001|Randomization|Physician Decision|1|||
147049969|NCT01308424|530343764|FG002|Randomization|Physician Decision|1|||
147049970|NCT00948155|530343765|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
147049971|NCT00948155|530343766|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
147049972|NCT00948155|530343765|FG000|Washout 14 Days|Lost to Follow-up|1|||
147049973|NCT00948155|530343766|FG001|Washout 14 Days|Lost to Follow-up|2|||
147049974|NCT03411863|530343767|FG000|Overall Study|Withdrawal by Subject|3|||
147049975|NCT03411863|530343768|FG001|Overall Study|Withdrawal by Subject|1|||
147049976|NCT03411863|530343767|FG000|Overall Study|Physician Decision|0|||
147049977|NCT03411863|530343768|FG001|Overall Study|Physician Decision|1|||
147049978|NCT05767905|530343769|FG000|Overall Study|Adverse Event|0|||
147049979|NCT05767905|530343770|FG001|Overall Study|Adverse Event|0|||
147049980|NCT05767905|530343771|FG002|Overall Study|Adverse Event|1|||
147049981|NCT03535740|530343772|FG000|Overall Study|Death|44|||
147049982|NCT03535740|530343772|FG000|Overall Study|Lost to Follow-up|1|||
147049983|NCT03535740|530343772|FG000|Overall Study|Withdrawal by Subject|13|||
147049984|NCT03535740|530343772|FG000|Overall Study|Site terminated by Sponsor|45|||
147049985|NCT05198518|530343778|FG000|Screening Visit|Deemed unable to participate|58|||
147049986|NCT05198518|530343779|FG001|Screening Visit|Deemed unable to participate|0|||
147049987|NCT05198518|530343780|FG002|Screening Visit|Deemed unable to participate|0|||
147049988|NCT02766335|530343781|FG000|Initial Registration|Adverse Event|6|||
147049989|NCT02766335|530343782|FG001|Initial Registration|Adverse Event|3|||
147049990|NCT02766335|530343783|FG002|Initial Registration|Adverse Event|0|||
147049991|NCT02766335|530343781|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
146850046|NCT01639560|529620696|FG000|Overall Study|Adverse Event|0|||
147049992|NCT02766335|530343782|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
147049993|NCT02766335|530343783|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
147049994|NCT02766335|530343781|FG000|Initial Registration|Progression/relapse|49|||
147049995|NCT02766335|530343782|FG001|Initial Registration|Progression/relapse|15|||
147049996|NCT02766335|530343783|FG002|Initial Registration|Progression/relapse|0|||
147049997|NCT02766335|530343781|FG000|Initial Registration|Death|1|||
147049998|NCT02766335|530343782|FG001|Initial Registration|Death|3|||
147049999|NCT02766335|530343783|FG002|Initial Registration|Death|0|||
147050000|NCT02766335|530343781|FG000|Initial Registration|not protocol specified|1|||
147050001|NCT02766335|530343782|FG001|Initial Registration|not protocol specified|9|||
147050002|NCT02766335|530343783|FG002|Initial Registration|not protocol specified|0|||
147050003|NCT02766335|530343781|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
147050004|NCT02766335|530343782|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
147050005|NCT02766335|530343783|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
147050006|NCT02766335|530343781|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
147050007|NCT02766335|530343782|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
147050008|NCT02766335|530343783|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
147050009|NCT03645863|530343785|FG000|Overall Study|Withdrawal by Subject|1|||
147050010|NCT03645863|530343786|FG001|Overall Study|Withdrawal by Subject|0|||
147050011|NCT03645863|530343787|FG002|Overall Study|Withdrawal by Subject|0|||
147050012|NCT01841593|530343793|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
147050013|NCT01841593|530343794|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
147050014|NCT01841593|530343793|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
147050015|NCT01841593|530343794|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
147050016|NCT03125798|530343796|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
147050017|NCT03125798|530343797|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
147050018|NCT03125798|530343796|FG000|Overall Study|Conversion to thoracotomy|7|||
147050019|NCT03125798|530343797|FG001|Overall Study|Conversion to thoracotomy|7|||
147050020|NCT02635984|530343798|FG000|Overall Study|Lost to Follow-up|2|||
147050021|NCT02635984|530343799|FG001|Overall Study|Lost to Follow-up|4|||
147050022|NCT02635984|530343798|FG000|Overall Study|Study Arm Closed|1|||
147050023|NCT02635984|530343799|FG001|Overall Study|Study Arm Closed|0|||
147050024|NCT00307086|530343800|FG000|Overall Study|ineligible|5|||
147050025|NCT03164551|530343803|FG000|Overall Study|Imaging discontinued prior completion|8|||
147050026|NCT03164551|530343804|FG001|Overall Study|Imaging discontinued prior completion|0|||
147050027|NCT03164551|530343803|FG000|Overall Study|Participant was non-compliant|1|||
147050028|NCT03164551|530343804|FG001|Overall Study|Participant was non-compliant|0|||
147050029|NCT03164551|530343803|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
147050030|NCT03164551|530343804|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
147050031|NCT03164551|530343803|FG000|Overall Study|Other|8|||
147050032|NCT03164551|530343804|FG001|Overall Study|Other|2|||
147050033|NCT01515423|530343805|FG000|Open Label Phase|Adverse Event|57|||
147050034|NCT01515423|530343806|FG001|Open Label Phase|Adverse Event|0|||
147050035|NCT01515423|530343807|FG002|Open Label Phase|Adverse Event|0|||
147050036|NCT01515423|530343805|FG000|Open Label Phase|Death|2|||
147050037|NCT01515423|530343806|FG001|Open Label Phase|Death|0|||
147050038|NCT01515423|530343807|FG002|Open Label Phase|Death|0|||
147050039|NCT01515423|530343805|FG000|Open Label Phase|Lack of Efficacy|117|||
147050040|NCT01515423|530343806|FG001|Open Label Phase|Lack of Efficacy|0|||
147050041|NCT01515423|530343807|FG002|Open Label Phase|Lack of Efficacy|0|||
147050042|NCT01515423|530343805|FG000|Open Label Phase|Lost to Follow-up|21|||
147050043|NCT01515423|530343806|FG001|Open Label Phase|Lost to Follow-up|0|||
147050044|NCT01515423|530343807|FG002|Open Label Phase|Lost to Follow-up|0|||
147050045|NCT01515423|530343805|FG000|Open Label Phase|Withdrawal by Subject|118|||
147050046|NCT01515423|530343806|FG001|Open Label Phase|Withdrawal by Subject|0|||
147050047|NCT01515423|530343807|FG002|Open Label Phase|Withdrawal by Subject|0|||
147050048|NCT01515423|530343805|FG000|Open Label Phase|excluded from DB Phase|70|||
147050049|NCT01515423|530343806|FG001|Open Label Phase|excluded from DB Phase|0|||
147050050|NCT01515423|530343807|FG002|Open Label Phase|excluded from DB Phase|0|||
147050051|NCT01515423|530343805|FG000|Open Label Phase|Other|28|||
147050052|NCT01515423|530343806|FG001|Open Label Phase|Other|0|||
147050053|NCT01515423|530343807|FG002|Open Label Phase|Other|0|||
147050054|NCT01515423|530343805|FG000|DOUBLE BLIND|Adverse Event|0|||
147050055|NCT01515423|530343806|FG001|DOUBLE BLIND|Adverse Event|15|||
147050056|NCT01515423|530343807|FG002|DOUBLE BLIND|Adverse Event|13|||
147050057|NCT01515423|530343805|FG000|DOUBLE BLIND|Death|0|||
147050058|NCT01515423|530343806|FG001|DOUBLE BLIND|Death|1|||
147050059|NCT01515423|530343807|FG002|DOUBLE BLIND|Death|2|||
147050060|NCT01515423|530343805|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
147050061|NCT01515423|530343806|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
147050062|NCT01515423|530343807|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
147050063|NCT01515423|530343805|FG000|DOUBLE BLIND|Pregnancy|0|||
147050064|NCT01515423|530343806|FG001|DOUBLE BLIND|Pregnancy|2|||
147050065|NCT01515423|530343807|FG002|DOUBLE BLIND|Pregnancy|0|||
147050066|NCT01515423|530343805|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
147050067|NCT01515423|530343806|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
147050068|NCT01515423|530343807|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
147050069|NCT01515423|530343805|FG000|DOUBLE BLIND|Other|0|||
147050070|NCT01515423|530343806|FG001|DOUBLE BLIND|Other|6|||
147050071|NCT01515423|530343807|FG002|DOUBLE BLIND|Other|12|||
147050072|NCT01515423|530343805|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
147050073|NCT01515423|530343806|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
147050074|NCT01515423|530343807|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
147050075|NCT01125917|530343816|FG000|Overall Study|Adverse Event|43|||
147050076|NCT01125917|530343816|FG000|Overall Study|Lost to Follow-up|23|||
147050077|NCT01125917|530343816|FG000|Overall Study|Withdrawal by Subject|31|||
147050078|NCT01125917|530343816|FG000|Overall Study|Administrative|223|||
147050079|NCT01125917|530343816|FG000|Overall Study|Lack of Efficacy|19|||
147050080|NCT04421131|530343818|FG000|Overall Study|Lost to Follow-up|1|||
147050081|NCT04421131|530343818|FG000|Overall Study|Protocol Violation|2|||
147050082|NCT04421131|530343818|FG000|Overall Study|App crashed|5|||
147050083|NCT02501928|530343821|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
147050084|NCT02501928|530343822|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
147050085|NCT02501928|530343823|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
147050086|NCT02501928|530343824|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
147050087|NCT02501928|530343825|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
147050088|NCT02501928|530343826|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
147050089|NCT00951496|530343830|FG000|Overall Study|Did not initiate study treatment|10|||
147050090|NCT00951496|530343831|FG001|Overall Study|Did not initiate study treatment|8|||
147050091|NCT00951496|530343832|FG002|Overall Study|Did not initiate study treatment|13|||
147050092|NCT00838526|530343834|FG000|Overall Study|Adverse Event|3|||
147050093|NCT00838526|530343835|FG001|Overall Study|Adverse Event|12|||
147050094|NCT00838526|530343834|FG000|Overall Study|Lost to Follow-up|4|||
147050095|NCT00838526|530343835|FG001|Overall Study|Lost to Follow-up|12|||
147050096|NCT00838526|530343834|FG000|Overall Study|Withdrawal by Subject|4|||
147050097|NCT00838526|530343835|FG001|Overall Study|Withdrawal by Subject|5|||
147050098|NCT00838526|530343834|FG000|Overall Study|Lack of Efficacy|2|||
147050099|NCT00838526|530343835|FG001|Overall Study|Lack of Efficacy|3|||
147050100|NCT00838526|530343834|FG000|Overall Study|Other|11|||
147050101|NCT00838526|530343835|FG001|Overall Study|Other|7|||
147050102|NCT02189837|530343845|FG000|Overall Study|Withdrawal by Subject|2|||
147050103|NCT02189837|530343846|FG001|Overall Study|Withdrawal by Subject|1|||
147050104|NCT02189837|530343847|FG002|Overall Study|Withdrawal by Subject|3|||
147050105|NCT02189837|530343848|FG003|Overall Study|Withdrawal by Subject|1|||
147050106|NCT02189837|530343845|FG000|Overall Study|Sponsor Decision|0|||
147050107|NCT02189837|530343846|FG001|Overall Study|Sponsor Decision|0|||
147050108|NCT02189837|530343847|FG002|Overall Study|Sponsor Decision|0|||
147050109|NCT02189837|530343848|FG003|Overall Study|Sponsor Decision|1|||
147050110|NCT02198963|530343852|FG000|Overall Study|Adverse Event|1|||
147050111|NCT02198963|530343852|FG000|Overall Study|Withdrawal by Subject|6|||
147050112|NCT03629184|530343853|FG000|Overall Study|Withdrawal by Subject|2|||
147050113|NCT03629184|530343854|FG001|Overall Study|Withdrawal by Subject|1|||
147050114|NCT03629184|530343853|FG000|Overall Study|Physician Decision|1|||
147050115|NCT03629184|530343854|FG001|Overall Study|Physician Decision|0|||
147050116|NCT02046603|530343855|FG000|Overall Study|Other|11|||
147050117|NCT02046603|530343856|FG001|Overall Study|Other|66|||
147050118|NCT02046603|530343855|FG000|Overall Study|Protocol Violation|0|||
147050119|NCT02046603|530343856|FG001|Overall Study|Protocol Violation|1|||
147050120|NCT02046603|530343855|FG000|Overall Study|Participant/legal guardian decision|1|||
147050121|NCT02046603|530343856|FG001|Overall Study|Participant/legal guardian decision|3|||
147050122|NCT02046603|530343855|FG000|Overall Study|Physician Decision|2|||
147050123|NCT02046603|530343856|FG001|Overall Study|Physician Decision|1|||
147050124|NCT02046603|530343855|FG000|Overall Study|Lost to Follow-up|1|||
147050125|NCT02046603|530343856|FG001|Overall Study|Lost to Follow-up|2|||
147050126|NCT02046603|530343855|FG000|Overall Study|Death|0|||
147050127|NCT02046603|530343856|FG001|Overall Study|Death|1|||
147050128|NCT02046603|530343855|FG000|Overall Study|Adverse Event|0|||
147050129|NCT02046603|530343856|FG001|Overall Study|Adverse Event|1|||
147050130|NCT03447743|530343857|FG000|Overall Study|Withdrawal by Subject|2|||
147050131|NCT03447743|530343857|FG000|Overall Study|Lost to Follow-up|3|||
147050132|NCT03447743|530343857|FG000|Overall Study|Adverse Event|1|||
147050133|NCT03447743|530343857|FG000|Overall Study|Did not meet criteria to continue|1|||
147050134|NCT05620082|530343862|FG000|Overall Study|Discharged before study end|1|||
147050135|NCT05620082|530343863|FG001|Overall Study|Discharged before study end|4|||
147050136|NCT05620082|530343864|FG002|Overall Study|Discharged before study end|0|||
147050137|NCT05620082|530343862|FG000|Overall Study|Moved to a different ward|1|||
147050138|NCT05620082|530343863|FG001|Overall Study|Moved to a different ward|0|||
147050139|NCT05620082|530343864|FG002|Overall Study|Moved to a different ward|0|||
147050140|NCT05620082|530343862|FG000|Overall Study|Feeling too unwell|1|||
147050141|NCT05620082|530343863|FG001|Overall Study|Feeling too unwell|0|||
147050142|NCT05620082|530343864|FG002|Overall Study|Feeling too unwell|0|||
147050143|NCT00725283|530345490|FG000|Overall Study|Missing Code|3|||
147050144|NCT00725283|530345490|FG000|Overall Study|Death|5|||
147050145|NCT00725283|530345490|FG000|Overall Study|Other|6|||
147050146|NCT00725283|530345490|FG000|Overall Study|Withdrawal by Subject|10|||
147050147|NCT01417156|530345491|FG000|Overall Study|Adverse Event|12|||
147050148|NCT01417156|530345491|FG000|Overall Study|Protocol Violation|2|||
147050149|NCT04620746|530345494|FG000|Overall Study|Adverse Event|2|||
147050150|NCT04620746|530345495|FG001|Overall Study|Adverse Event|0|||
147050151|NCT04620746|530345494|FG000|Overall Study|Uniterpretable skin test|1|||
147050152|NCT04620746|530345495|FG001|Overall Study|Uniterpretable skin test|0|||
147050153|NCT04620746|530345494|FG000|Overall Study|Withdrawal by Subject|0|||
147050154|NCT04620746|530345495|FG001|Overall Study|Withdrawal by Subject|1|||
147050155|NCT03473925|530345496|FG000|Overall Study|Death|48|||
147050156|NCT03473925|530345497|FG001|Overall Study|Death|44|||
147050157|NCT03473925|530345496|FG000|Overall Study|Sponsor Decision|2|||
147050158|NCT03473925|530345497|FG001|Overall Study|Sponsor Decision|7|||
147050159|NCT03473925|530345496|FG000|Overall Study|Withdrawal by Subject|1|||
147050160|NCT03473925|530345497|FG001|Overall Study|Withdrawal by Subject|3|||
147050161|NCT03473925|530345496|FG000|Overall Study|Not Treated|1|||
147050162|NCT03473925|530345497|FG001|Overall Study|Not Treated|1|||
147050163|NCT02756611|530345500|FG000|Overall Study|Death|70|||
147050164|NCT02756611|530345500|FG000|Overall Study|Withdrawal by Subject|2|||
147050165|NCT02756611|530345500|FG000|Overall Study|Lost to Follow-up|3|||
147050166|NCT02756611|530345500|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
147050167|NCT02756611|530345500|FG000|Overall Study|Other|10|||
147050168|NCT00124917|530345508|FG000|Overall Study|Physician Decision|3|||
147050169|NCT03518008|530345509|FG000|Period 2, Second Week of Wear|Family emergency|0|||
147050170|NCT03518008|530345510|FG001|Period 2, Second Week of Wear|Family emergency|1|||
147050171|NCT00476190|530345515|FG000|Overall Study|Ineligible|1|||
147050172|NCT00476190|530345516|FG001|Overall Study|Ineligible|1|||
147050173|NCT00476190|530345515|FG000|Overall Study|Induction Death|2|||
147050174|NCT00476190|530345516|FG001|Overall Study|Induction Death|0|||
147050175|NCT00476190|530345515|FG000|Overall Study|Induction Failure|2|||
147050176|NCT00476190|530345516|FG001|Overall Study|Induction Failure|4|||
147050177|NCT00476190|530345515|FG000|Overall Study|Lost to Follow-up|1|||
147050178|NCT00476190|530345516|FG001|Overall Study|Lost to Follow-up|0|||
147050179|NCT00476190|530345515|FG000|Overall Study|Relapse/Progression|5|||
147050180|NCT00476190|530345516|FG001|Overall Study|Relapse/Progression|2|||
147050181|NCT00476190|530345515|FG000|Overall Study|Remission Death|0|||
147050182|NCT00476190|530345516|FG001|Overall Study|Remission Death|1|||
147050183|NCT00476190|530345515|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
147050184|NCT00476190|530345516|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
147050185|NCT00476190|530345515|FG000|Overall Study|Withdrawal by Subject|6|||
147050186|NCT00476190|530345516|FG001|Overall Study|Withdrawal by Subject|2|||
147050187|NCT00476190|530345515|FG000|Overall Study|Other|9|||
147050188|NCT00476190|530345516|FG001|Overall Study|Other|10|||
147050189|NCT04338022|530345517|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
147050190|NCT04338022|530345518|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
147050191|NCT04338022|530345517|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
147050192|NCT04338022|530345518|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
147050193|NCT04338022|530345517|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
147050194|NCT04338022|530345518|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
147050195|NCT04338022|530345517|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
147050196|NCT04338022|530345518|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
147050197|NCT04338022|530345517|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
147050198|NCT04338022|530345518|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
147050199|NCT04338022|530345517|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
147050200|NCT04338022|530345518|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
147050201|NCT04338022|530345517|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
147050202|NCT04338022|530345518|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
147050203|NCT04338022|530345517|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
147050204|NCT04338022|530345518|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
147050205|NCT04338022|530345517|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
147050206|NCT04338022|530345518|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
147050207|NCT04338022|530345517|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
147050208|NCT04338022|530345518|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
147050209|NCT04338022|530345517|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
147050210|NCT04338022|530345518|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
147050211|NCT04338022|530345517|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
147050212|NCT04338022|530345518|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
147050213|NCT04338022|530345517|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
147050214|NCT04338022|530345518|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
147050215|NCT04338022|530345517|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
147050216|NCT04338022|530345518|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
147050217|NCT04782076|530345525|FG000|Overall Study|Family Emergency|1|||
147050218|NCT02860546|530345526|FG000|Overall Study|Clinical Progression|6|||
147050219|NCT02860546|530345526|FG000|Overall Study|Radiological Progression|12|||
147050220|NCT02466321|530345527|FG000|Overall Study|Death|26|||
147050221|NCT02466321|530345527|FG000|Overall Study|Revision|6|||
147050222|NCT02466321|530345527|FG000|Overall Study|Lost to Follow-up|60|||
147050223|NCT02466321|530345527|FG000|Overall Study|Did not receive study device|1|||
147050224|NCT00281957|530345529|FG000|Overall Study|Adverse Event|7|||
147050225|NCT00281957|530345530|FG001|Overall Study|Adverse Event|2|||
147050226|NCT00281957|530345529|FG000|Overall Study|Death|1|||
147050227|NCT00281957|530345530|FG001|Overall Study|Death|0|||
147050228|NCT00281957|530345529|FG000|Overall Study|Progression/relapse|47|||
147050229|NCT00281957|530345530|FG001|Overall Study|Progression/relapse|35|||
147050230|NCT00281957|530345529|FG000|Overall Study|Not protocol specified|8|||
147050231|NCT00281957|530345530|FG001|Overall Study|Not protocol specified|1|||
147050232|NCT00281957|530345529|FG000|Overall Study|Not eligible|1|||
147050233|NCT00281957|530345530|FG001|Overall Study|Not eligible|2|||
147050234|NCT00281957|530345529|FG000|Overall Study|Did not start treatment|3|||
147050235|NCT00281957|530345530|FG001|Overall Study|Did not start treatment|1|||
147050236|NCT00281957|530345529|FG000|Overall Study|Refusal unrelated to adverse events|0|||
147050237|NCT00281957|530345530|FG001|Overall Study|Refusal unrelated to adverse events|1|||
147050238|NCT01876446|530345531|FG000|Overall Study|Death|0|||
147050239|NCT01876446|530345532|FG001|Overall Study|Death|1|||
147050240|NCT01876446|530345531|FG000|Overall Study|Withdrawal by Subject|1|||
147050241|NCT01876446|530345532|FG001|Overall Study|Withdrawal by Subject|2|||
147050242|NCT01876446|530345531|FG000|Overall Study|Physician Decision|1|||
147050243|NCT01876446|530345532|FG001|Overall Study|Physician Decision|3|||
147050244|NCT00822692|530345542|FG000|Overall Study|Lost to Follow-up|17|||
147050245|NCT00822692|530345543|FG001|Overall Study|Lost to Follow-up|25|||
147050246|NCT03281876|530345545|FG000|Overall Study|Adverse Event|4|||
147050247|NCT03281876|530345546|FG001|Overall Study|Adverse Event|15|||
147050248|NCT03281876|530345545|FG000|Overall Study|Lost to Follow-up|1|||
147050249|NCT03281876|530345546|FG001|Overall Study|Lost to Follow-up|4|||
147050250|NCT03281876|530345545|FG000|Overall Study|Withdrawal by Subject|11|||
147050251|NCT03281876|530345546|FG001|Overall Study|Withdrawal by Subject|15|||
147050252|NCT03281876|530345545|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
147050253|NCT03281876|530345546|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147050254|NCT03281876|530345545|FG000|Overall Study|OTHER|5|||
147050255|NCT03281876|530345546|FG001|Overall Study|OTHER|5|||
147050256|NCT02208089|530345547|FG000|Overall Study|Withdrawal by Subject|1|||
147050257|NCT02208089|530345548|FG001|Overall Study|Withdrawal by Subject|0|||
147050258|NCT02208089|530345547|FG000|Overall Study|Lost to Follow-up|6|||
147050259|NCT02208089|530345548|FG001|Overall Study|Lost to Follow-up|0|||
147050260|NCT02443740|530345549|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
147050261|NCT02443740|530345550|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
147050262|NCT02443740|530345551|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
147050263|NCT02443740|530345552|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
147050264|NCT02443740|530345553|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
147050265|NCT02443740|530345554|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
147050266|NCT02443740|530345555|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
147050267|NCT02443740|530345556|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
147050268|NCT02443740|530345557|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
147050269|NCT02443740|530345558|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
147050270|NCT02443740|530345559|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
147050271|NCT02443740|530345549|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
147050272|NCT02443740|530345550|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147050273|NCT02443740|530345551|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147050274|NCT02443740|530345552|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147050275|NCT02443740|530345553|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147050276|NCT02443740|530345554|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147050277|NCT02443740|530345555|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
147050278|NCT02443740|530345556|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147050279|NCT02443740|530345557|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147050280|NCT02443740|530345558|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147050281|NCT02443740|530345559|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147050282|NCT02443740|530345549|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147050283|NCT02443740|530345550|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147050284|NCT02443740|530345551|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147050285|NCT02443740|530345552|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147050286|NCT02443740|530345553|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147050287|NCT02443740|530345554|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
147050288|NCT02443740|530345555|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147050289|NCT02443740|530345556|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147050290|NCT02443740|530345557|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147050291|NCT02443740|530345558|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147050292|NCT02443740|530345559|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147050293|NCT00456300|530345560|FG000|Overall Study|Adverse Event|1|||
147050294|NCT00456300|530345561|FG001|Overall Study|Adverse Event|0|||
147050295|NCT02452476|530345563|FG000|Overall Study|Death|4|||
147050296|NCT02452476|530345564|FG001|Overall Study|Death|7|||
147050297|NCT02452476|530345563|FG000|Overall Study|Lost to Follow-up|1|||
147050298|NCT02452476|530345564|FG001|Overall Study|Lost to Follow-up|1|||
147050299|NCT02452476|530345563|FG000|Overall Study|Physician Decision|1|||
147050300|NCT02452476|530345564|FG001|Overall Study|Physician Decision|1|||
147050301|NCT02452476|530345563|FG000|Overall Study|Not treated|5|||
147050302|NCT02452476|530345564|FG001|Overall Study|Not treated|1|||
147050303|NCT00683657|530345572|FG000|Overall Study|Adverse Event|0|||
147050304|NCT00683657|530345573|FG001|Overall Study|Adverse Event|1|||
147050305|NCT00683657|530345572|FG000|Overall Study|Subject Withdrew Consent|1|||
147050306|NCT00683657|530345573|FG001|Overall Study|Subject Withdrew Consent|0|||
147050307|NCT03200717|530345579|FG000|Overall Study|Progressive disease|24|||
147050308|NCT03200717|530345580|FG001|Overall Study|Progressive disease|5|||
147050309|NCT03200717|530345579|FG000|Overall Study|Adverse Event|11|||
147050310|NCT03200717|530345580|FG001|Overall Study|Adverse Event|8|||
147050311|NCT03200717|530345579|FG000|Overall Study|Physician Decision|3|||
147050312|NCT03200717|530345580|FG001|Overall Study|Physician Decision|2|||
147050313|NCT03200717|530345579|FG000|Overall Study|Death|2|||
147050314|NCT03200717|530345580|FG001|Overall Study|Death|0|||
147050315|NCT03200717|530345579|FG000|Overall Study|Subject/Guardian Decision|1|||
147050316|NCT03200717|530345580|FG001|Overall Study|Subject/Guardian Decision|0|||
147050317|NCT01461538|530345581|FG000|Overall Study|Death|15|||
147050318|NCT01461538|530345582|FG001|Overall Study|Death|6|||
147050319|NCT01461538|530345583|FG002|Overall Study|Death|2|||
147050320|NCT01461538|530345581|FG000|Overall Study|Study Stopped by Sponsor|2|||
147050321|NCT01461538|530345582|FG001|Overall Study|Study Stopped by Sponsor|1|||
147050322|NCT01461538|530345583|FG002|Overall Study|Study Stopped by Sponsor|0|||
147050323|NCT01461538|530345581|FG000|Overall Study|Withdrawal by Subject|1|||
147050324|NCT01461538|530345582|FG001|Overall Study|Withdrawal by Subject|1|||
147050325|NCT01461538|530345583|FG002|Overall Study|Withdrawal by Subject|0|||
147050326|NCT03552380|530345585|FG000|Study Treatment|Disease Progression|3|||
147050327|NCT03552380|530345586|FG001|Study Treatment|Disease Progression|4|||
147050328|NCT03552380|530345585|FG000|Study Treatment|Adverse Event|2|||
147050329|NCT03552380|530345586|FG001|Study Treatment|Adverse Event|2|||
147050330|NCT03552380|530345585|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
147050331|NCT03552380|530345586|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
147050332|NCT03552380|530345585|FG000|Follow up|Death|3|||
147050333|NCT03552380|530345586|FG001|Follow up|Death|4|||
147050334|NCT03552380|530345585|FG000|Follow up|Site IRB terminated|0|||
147050335|NCT03552380|530345586|FG001|Follow up|Site IRB terminated|1|||
147050336|NCT02461160|530345587|FG000|Overall Study|Lost to Follow-up|0|||
147050337|NCT02461160|530345588|FG001|Overall Study|Lost to Follow-up|0|||
147050338|NCT02461160|530345589|FG002|Overall Study|Lost to Follow-up|0|||
147050339|NCT02461160|530345590|FG003|Overall Study|Lost to Follow-up|0|||
147050340|NCT02461160|530345591|FG004|Overall Study|Lost to Follow-up|0|||
147050341|NCT02461160|530345592|FG005|Overall Study|Lost to Follow-up|0|||
147050342|NCT02461160|530345593|FG006|Overall Study|Lost to Follow-up|0|||
147050343|NCT02461160|530345594|FG007|Overall Study|Lost to Follow-up|1|||
147050344|NCT02461160|530345595|FG008|Overall Study|Lost to Follow-up|0|||
147050345|NCT02461160|530345596|FG009|Overall Study|Lost to Follow-up|0|||
147050346|NCT02461160|530345597|FG010|Overall Study|Lost to Follow-up|0|||
147050347|NCT02461160|530345598|FG011|Overall Study|Lost to Follow-up|0|||
147050348|NCT02461160|530345599|FG012|Overall Study|Lost to Follow-up|0|||
147050349|NCT01112059|530345600|FG000|Overall Study|Withdrawal by Subject|1|||
147050350|NCT01112059|530345601|FG001|Overall Study|Withdrawal by Subject|0|||
147050351|NCT03567980|530345604|FG000|Overall Study|Adverse Event|1|||
147050352|NCT02633787|530345605|FG000|Overall Study|Withdrawal by Subject|1|||
147050353|NCT05373108|530345606|FG000|Overall Study|Withdrawal by Subject|2|||
147050354|NCT00349973|530345607|FG000|Overall Study|Adverse Event|3|||
147050355|NCT00349973|530345608|FG001|Overall Study|Adverse Event|3|||
147050356|NCT00349973|530345607|FG000|Overall Study|Withdrawal by Subject|1|||
147050357|NCT00349973|530345608|FG001|Overall Study|Withdrawal by Subject|0|||
147050358|NCT04871776|530345609|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
147050359|NCT04871776|530345610|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
147050360|NCT04871776|530345611|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
147050361|NCT04871776|530345609|FG000|Overall Study|Did not meet eligibility criteria|1|||
147050362|NCT04871776|530345610|FG001|Overall Study|Did not meet eligibility criteria|1|||
147050363|NCT04871776|530345611|FG002|Overall Study|Did not meet eligibility criteria|1|||
147050364|NCT06389487|530345617|FG000|Overall Study|Lost to Follow-up|9|||
147050365|NCT06389487|530345618|FG001|Overall Study|Lost to Follow-up|5|||
147050366|NCT06389487|530345619|FG002|Overall Study|Lost to Follow-up|13|||
147050367|NCT06389487|530345617|FG000|Overall Study|Protocol Violation|0|||
147050368|NCT06389487|530345618|FG001|Overall Study|Protocol Violation|0|||
147050369|NCT06389487|530345619|FG002|Overall Study|Protocol Violation|2|||
147050370|NCT06389487|530345617|FG000|Overall Study|Withdrawal by Subject|2|||
147050371|NCT06389487|530345618|FG001|Overall Study|Withdrawal by Subject|2|||
147050372|NCT06389487|530345619|FG002|Overall Study|Withdrawal by Subject|1|||
147050373|NCT06389487|530345617|FG000|Overall Study|Other|1|||
147050374|NCT06389487|530345618|FG001|Overall Study|Other|0|||
147050375|NCT06389487|530345619|FG002|Overall Study|Other|1|||
147050376|NCT01168232|530347173|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
147050377|NCT01168232|530347173|FG000|Overall Study|Ineligible- Wrong cell type|6|||
147050378|NCT01168232|530347173|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
147050379|NCT01402570|530347174|FG000|Overall Study|Adverse Event|1|||
147050380|NCT03642262|530347177|FG000|Period 1|Withdrawal by Subject|1|||
147050381|NCT03642262|530347178|FG001|Period 1|Withdrawal by Subject|1|||
147050382|NCT03642262|530347177|FG000|Period 1|Adverse Event|0|||
147050383|NCT03642262|530347178|FG001|Period 1|Adverse Event|1|||
147050384|NCT01557504|530347179|FG000|Overall Study|Physician Decision|1|||
147050385|NCT01557504|530347180|FG001|Overall Study|Physician Decision|0|||
147050386|NCT02572570|530347183|FG000|Overall Study|Study Terminated|27|||
147050387|NCT01103180|530347184|FG000|Overall Study|Withdrawal by Subject|8|||
147050388|NCT01103180|530347185|FG001|Overall Study|Withdrawal by Subject|13|||
147050389|NCT01103180|530347184|FG000|Overall Study|Lost to Follow-up|13|||
147050390|NCT01103180|530347185|FG001|Overall Study|Lost to Follow-up|7|||
147050391|NCT01103180|530347184|FG000|Overall Study|Physician Decision|1|||
147050392|NCT01103180|530347185|FG001|Overall Study|Physician Decision|0|||
147050393|NCT01103180|530347184|FG000|Overall Study|Protocol Violation|0|||
147050394|NCT01103180|530347185|FG001|Overall Study|Protocol Violation|1|||
147050395|NCT01866826|530347186|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
147050396|NCT01866826|530347187|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
147050397|NCT01866826|530347186|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
147050398|NCT01866826|530347187|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
147050399|NCT01866826|530347186|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
147050400|NCT01866826|530347187|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
147050401|NCT00742209|530347189|FG000|Overall Study|Adverse Event|11|||
147050402|NCT00742209|530347190|FG001|Overall Study|Adverse Event|4|||
147050403|NCT00742209|530347191|FG002|Overall Study|Adverse Event|17|||
147050404|NCT00742209|530347192|FG003|Overall Study|Adverse Event|16|||
147050405|NCT00742209|530347193|FG004|Overall Study|Adverse Event|13|||
147050406|NCT00742209|530347189|FG000|Overall Study|Participant Withdrew Consent|8|||
147050407|NCT00742209|530347190|FG001|Overall Study|Participant Withdrew Consent|4|||
147050408|NCT00742209|530347191|FG002|Overall Study|Participant Withdrew Consent|14|||
147050409|NCT00742209|530347192|FG003|Overall Study|Participant Withdrew Consent|7|||
147050410|NCT00742209|530347193|FG004|Overall Study|Participant Withdrew Consent|4|||
147050411|NCT00742209|530347189|FG000|Overall Study|Protocol Violation|6|||
147050412|NCT00742209|530347190|FG001|Overall Study|Protocol Violation|5|||
147050413|NCT00742209|530347191|FG002|Overall Study|Protocol Violation|4|||
147050414|NCT00742209|530347192|FG003|Overall Study|Protocol Violation|5|||
147050415|NCT00742209|530347193|FG004|Overall Study|Protocol Violation|3|||
147050416|NCT00742209|530347189|FG000|Overall Study|Lost to Follow-up|3|||
147050417|NCT00742209|530347190|FG001|Overall Study|Lost to Follow-up|4|||
147050418|NCT00742209|530347191|FG002|Overall Study|Lost to Follow-up|5|||
147050419|NCT00742209|530347192|FG003|Overall Study|Lost to Follow-up|5|||
147050420|NCT00742209|530347193|FG004|Overall Study|Lost to Follow-up|3|||
147050421|NCT00742209|530347189|FG000|Overall Study|Lack of Efficacy|6|||
147050422|NCT00742209|530347190|FG001|Overall Study|Lack of Efficacy|1|||
147050423|NCT00742209|530347191|FG002|Overall Study|Lack of Efficacy|1|||
147050424|NCT00742209|530347192|FG003|Overall Study|Lack of Efficacy|3|||
147050425|NCT00742209|530347193|FG004|Overall Study|Lack of Efficacy|1|||
147050426|NCT00742209|530347189|FG000|Overall Study|Investigator Discretion|0|||
147050427|NCT00742209|530347190|FG001|Overall Study|Investigator Discretion|0|||
147050428|NCT00742209|530347191|FG002|Overall Study|Investigator Discretion|5|||
147050429|NCT00742209|530347192|FG003|Overall Study|Investigator Discretion|1|||
147050430|NCT00742209|530347193|FG004|Overall Study|Investigator Discretion|1|||
147050431|NCT03499067|530347196|FG000|First Intervention|Physician Decision|2|||
147050432|NCT03499067|530347197|FG001|First Intervention|Physician Decision|1|||
147050433|NCT03499067|530347196|FG000|First Intervention|Withdrawal by Subject|3|||
147050434|NCT03499067|530347197|FG001|First Intervention|Withdrawal by Subject|6|||
147050435|NCT02440464|530347198|FG000|Overall Study|Withdrawal by Subject|3|||
147050436|NCT02440464|530347199|FG001|Overall Study|Withdrawal by Subject|2|||
147050437|NCT00324987|530347200|FG000|Overall Study|Adverse Event|2|||
147050438|NCT00324987|530347201|FG001|Overall Study|Adverse Event|1|||
147050439|NCT00324987|530347200|FG000|Overall Study|Withdrawal by Subject|1|||
147050440|NCT00324987|530347201|FG001|Overall Study|Withdrawal by Subject|1|||
147050441|NCT00324987|530347200|FG000|Overall Study|Progression|1|||
147050442|NCT00324987|530347201|FG001|Overall Study|Progression|1|||
147050443|NCT00324987|530347200|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
147050444|NCT00324987|530347201|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
147050445|NCT01960413|530347205|FG000|Overall Study|Withdrawal by Subject|1|||
147050446|NCT01960413|530347206|FG001|Overall Study|Withdrawal by Subject|1|||
147050447|NCT01960413|530347205|FG000|Overall Study|Physician Decision|1|||
147050448|NCT01960413|530347206|FG001|Overall Study|Physician Decision|0|||
147050449|NCT01960413|530347205|FG000|Overall Study|Lost to Follow-up|2|||
147050450|NCT01960413|530347206|FG001|Overall Study|Lost to Follow-up|0|||
147050451|NCT00791778|530347207|FG000|Double-blind Treatment|Adverse Event|49|||
147050452|NCT00791778|530347208|FG001|Double-blind Treatment|Adverse Event|9|||
147050453|NCT00791778|530347207|FG000|Double-blind Treatment|Physician Decision|6|||
147050454|NCT00791778|530347208|FG001|Double-blind Treatment|Physician Decision|26|||
147050455|NCT00791778|530347207|FG000|Double-blind Treatment|Protocol Violation|0|||
147050456|NCT00791778|530347208|FG001|Double-blind Treatment|Protocol Violation|4|||
147050457|NCT00791778|530347207|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
147050458|NCT00791778|530347208|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
147050459|NCT00791778|530347207|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
147050460|NCT00791778|530347208|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
147050461|NCT00791778|530347207|FG000|Follow-up|Withdrawal by Subject|3|||
147050462|NCT00791778|530347208|FG001|Follow-up|Withdrawal by Subject|0|||
147050463|NCT00791778|530347207|FG000|Follow-up|Lost to Follow-up|2|||
147050464|NCT00791778|530347208|FG001|Follow-up|Lost to Follow-up|1|||
147050465|NCT04886596|530347211|FG000|Overall Study|Adverse Event|442|||
147050466|NCT04886596|530347212|FG001|Overall Study|Adverse Event|441|||
147050467|NCT04886596|530347211|FG000|Overall Study|Lost to Follow-up|448|||
147050468|NCT04886596|530347212|FG001|Overall Study|Lost to Follow-up|465|||
147050469|NCT04886596|530347211|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
147050470|NCT04886596|530347212|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
147050471|NCT04886596|530347211|FG000|Overall Study|Migrated/moved from the study area|201|||
147050472|NCT04886596|530347212|FG001|Overall Study|Migrated/moved from the study area|184|||
147050473|NCT04886596|530347211|FG000|Overall Study|Other|298|||
147050474|NCT04886596|530347212|FG001|Overall Study|Other|326|||
147050475|NCT02348112|530347214|FG000|Overall Study|Withdrawal by Subject|32|||
147050476|NCT02348112|530347215|FG001|Overall Study|Withdrawal by Subject|29|||
147050477|NCT02348112|530347214|FG000|Overall Study|Lost to Follow-up|24|||
147050478|NCT02348112|530347215|FG001|Overall Study|Lost to Follow-up|20|||
147050479|NCT02348112|530347214|FG000|Overall Study|Physician Decision|17|||
147050480|NCT02348112|530347215|FG001|Overall Study|Physician Decision|15|||
147050481|NCT02348112|530347214|FG000|Overall Study|Site closed due to PI leaving|0|||
147050482|NCT02348112|530347215|FG001|Overall Study|Site closed due to PI leaving|30|||
147050483|NCT02348112|530347214|FG000|Overall Study|Sponsor withdrawal|0|||
147050484|NCT02348112|530347215|FG001|Overall Study|Sponsor withdrawal|7|||
147050485|NCT02348112|530347214|FG000|Overall Study|Death|0|||
147050486|NCT02348112|530347215|FG001|Overall Study|Death|1|||
147050487|NCT01998841|530347216|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
147050488|NCT01998841|530347217|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
147050489|NCT01998841|530347218|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
147050490|NCT01998841|530347219|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
147050491|NCT01998841|530347220|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
147050492|NCT01998841|530347216|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
147050493|NCT01998841|530347217|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
147050494|NCT01998841|530347218|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
147050495|NCT01998841|530347219|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
147050496|NCT01998841|530347220|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
147050497|NCT02552121|530347221|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
147050498|NCT02552121|530347222|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
147050499|NCT02552121|530347223|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
147050500|NCT02552121|530347224|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
147050501|NCT02552121|530347225|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
147050502|NCT02552121|530347226|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
147050503|NCT02552121|530347227|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
147050504|NCT02552121|530347228|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
147050505|NCT02552121|530347221|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
147050506|NCT02552121|530347222|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
147050507|NCT02552121|530347223|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
147050508|NCT02552121|530347224|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
147050509|NCT02552121|530347225|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
147050510|NCT02552121|530347226|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
147050511|NCT02552121|530347227|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
147050512|NCT02552121|530347228|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
147050513|NCT02552121|530347221|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
147050514|NCT02552121|530347222|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
147050515|NCT02552121|530347223|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
147050516|NCT02552121|530347224|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
147050517|NCT02552121|530347225|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
147050518|NCT02552121|530347226|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
147050519|NCT02552121|530347227|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
147050520|NCT02552121|530347228|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
147050521|NCT02552121|530347221|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
147050522|NCT02552121|530347222|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
147050523|NCT02552121|530347223|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
147050524|NCT02552121|530347224|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
147050525|NCT02552121|530347225|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
147050526|NCT02552121|530347226|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
147050527|NCT02552121|530347227|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
147050528|NCT02552121|530347228|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
147050529|NCT02552121|530347221|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
147050530|NCT02552121|530347222|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
147050531|NCT02552121|530347223|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
147050532|NCT02552121|530347224|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
147050533|NCT02552121|530347225|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
147050534|NCT02552121|530347226|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
147050535|NCT02552121|530347227|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
147050536|NCT02552121|530347228|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
147050537|NCT02552121|530347221|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
147050538|NCT02552121|530347222|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
147050539|NCT02552121|530347223|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
147050540|NCT02552121|530347224|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
147050541|NCT02552121|530347225|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
147050542|NCT02552121|530347226|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
147050543|NCT02552121|530347227|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
147050544|NCT02552121|530347228|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
147050545|NCT02552121|530347221|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
147050546|NCT02552121|530347222|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
147050547|NCT02552121|530347223|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
147050548|NCT02552121|530347224|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
147050549|NCT02552121|530347225|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
147050550|NCT02552121|530347226|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
147050551|NCT02552121|530347227|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
147050552|NCT02552121|530347228|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
147050553|NCT02552121|530347221|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
147050554|NCT02552121|530347222|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
147050555|NCT02552121|530347223|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
147050556|NCT02552121|530347224|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
147050557|NCT02552121|530347225|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
147050558|NCT02552121|530347226|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
147050559|NCT02552121|530347227|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
147050560|NCT02552121|530347228|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
147050561|NCT02552121|530347221|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
147050562|NCT02552121|530347222|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
147050563|NCT02552121|530347223|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
147050564|NCT02552121|530347224|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
147050565|NCT02552121|530347225|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
147050566|NCT02552121|530347226|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
147050567|NCT02552121|530347227|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
147050568|NCT02552121|530347228|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
147050569|NCT02552121|530347221|FG000|Part 2: Cohort Expansion|Death|0|||
147050570|NCT02552121|530347222|FG001|Part 2: Cohort Expansion|Death|0|||
147050571|NCT02552121|530347223|FG002|Part 2: Cohort Expansion|Death|1|||
147050572|NCT02552121|530347224|FG003|Part 2: Cohort Expansion|Death|0|||
147050573|NCT02552121|530347225|FG004|Part 2: Cohort Expansion|Death|0|||
147050574|NCT02552121|530347226|FG005|Part 2: Cohort Expansion|Death|0|||
147050575|NCT02552121|530347227|FG006|Part 2: Cohort Expansion|Death|0|||
147050576|NCT02552121|530347228|FG007|Part 2: Cohort Expansion|Death|0|||
147050577|NCT04052620|530347230|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
147050578|NCT04052620|530347231|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
147050579|NCT04052620|530347230|FG000|Overall Study|Withdrawal by Subject|1|||
147050580|NCT04052620|530347231|FG001|Overall Study|Withdrawal by Subject|0|||
147050581|NCT04052620|530347230|FG000|Overall Study|Lost to Follow-up|1|||
147050582|NCT04052620|530347231|FG001|Overall Study|Lost to Follow-up|1|||
147050583|NCT04052620|530347230|FG000|Overall Study|Adverse Event|1|||
147050584|NCT04052620|530347231|FG001|Overall Study|Adverse Event|0|||
147050585|NCT04052620|530347230|FG000|Overall Study|Subject did not meet study Criteria|0|||
147050586|NCT04052620|530347231|FG001|Overall Study|Subject did not meet study Criteria|1|||
147050587|NCT04052620|530347230|FG000|Overall Study|Screened failure, randomized by mistake|0|||
147050588|NCT04052620|530347231|FG001|Overall Study|Screened failure, randomized by mistake|1|||
147050589|NCT04052620|530347230|FG000|Overall Study|Personal reasons|2|||
147050590|NCT04052620|530347231|FG001|Overall Study|Personal reasons|4|||
147050591|NCT04052620|530347230|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
147050592|NCT04052620|530347231|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
147050593|NCT02201784|530347232|FG000|Overall Study|Failure to achieve adequate block|2|||
147050594|NCT02201784|530347233|FG001|Overall Study|Failure to achieve adequate block|0|||
147050595|NCT00193050|530347234|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
147050596|NCT00193050|530347234|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
147050597|NCT00193050|530347234|FG000|Neoadjuvant Treatment|Physician Decision|2|||
147050598|NCT00193050|530347234|FG000|Neoadjuvant Treatment|Adverse Event|2|||
147050599|NCT00193050|530347234|FG000|Adjuvant|Physician Decision|5|||
147050600|NCT00193050|530347234|FG000|Adjuvant|Intercurrent Hospitalization|3|||
147050601|NCT00193050|530347234|FG000|Adjuvant|Lack of Efficacy|2|||
147050602|NCT00061932|530347235|FG000|Overall Study|Withdrawal by Subject|13|||
147050603|NCT00061932|530347236|FG001|Overall Study|Withdrawal by Subject|4|||
147050604|NCT00916383|530347237|FG000|Overall Study|Adverse Event|1|||
147050605|NCT00916383|530347237|FG000|Overall Study|Death|1|||
147050606|NCT00916383|530347237|FG000|Overall Study|Protocol Violation|1|||
147050607|NCT02899962|530347238|FG000|Open-label Phase|Adverse Event|2|||
147050608|NCT02899962|530347239|FG001|Open-label Phase|Adverse Event|0|||
147050609|NCT02899962|530347240|FG002|Open-label Phase|Adverse Event|0|||
147050610|NCT02899962|530347238|FG000|Open-label Phase|Lost to Follow-up|9|||
147050611|NCT02899962|530347239|FG001|Open-label Phase|Lost to Follow-up|0|||
147050612|NCT02899962|530347240|FG002|Open-label Phase|Lost to Follow-up|0|||
147050613|NCT02899962|530347238|FG000|Open-label Phase|Other reasons|9|||
147050614|NCT02899962|530347239|FG001|Open-label Phase|Other reasons|0|||
147050615|NCT02899962|530347240|FG002|Open-label Phase|Other reasons|0|||
147050616|NCT02899962|530347238|FG000|Open-label Phase|Withdrawal by Subject|7|||
147050617|NCT02899962|530347239|FG001|Open-label Phase|Withdrawal by Subject|0|||
147050618|NCT02899962|530347240|FG002|Open-label Phase|Withdrawal by Subject|0|||
147050619|NCT02899962|530347238|FG000|Maintenance Phase|Adverse Event|0|||
147050620|NCT02899962|530347239|FG001|Maintenance Phase|Adverse Event|2|||
147050621|NCT02899962|530347240|FG002|Maintenance Phase|Adverse Event|1|||
147050622|NCT02899962|530347238|FG000|Maintenance Phase|Death|0|||
147050623|NCT02899962|530347239|FG001|Maintenance Phase|Death|0|||
147050624|NCT02899962|530347240|FG002|Maintenance Phase|Death|1|||
147050625|NCT02899962|530347238|FG000|Maintenance Phase|Lack of Efficacy|0|||
147050626|NCT02899962|530347239|FG001|Maintenance Phase|Lack of Efficacy|20|||
147050627|NCT02899962|530347240|FG002|Maintenance Phase|Lack of Efficacy|16|||
147050628|NCT02899962|530347238|FG000|Maintenance Phase|Lost to Follow-up|0|||
147050629|NCT02899962|530347239|FG001|Maintenance Phase|Lost to Follow-up|12|||
147050630|NCT02899962|530347240|FG002|Maintenance Phase|Lost to Follow-up|14|||
147050631|NCT02899962|530347238|FG000|Maintenance Phase|Other reasons|0|||
147050632|NCT02899962|530347239|FG001|Maintenance Phase|Other reasons|9|||
147050633|NCT02899962|530347240|FG002|Maintenance Phase|Other reasons|13|||
147050634|NCT02899962|530347238|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
147050635|NCT02899962|530347239|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
147050636|NCT02899962|530347240|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
147050637|NCT02899962|530347238|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
147050638|NCT02899962|530347239|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
147050639|NCT02899962|530347240|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
147050640|NCT02899962|530347238|FG000|Maintenance Phase|Withdrawal by Subject|0|||
147050641|NCT02899962|530347239|FG001|Maintenance Phase|Withdrawal by Subject|30|||
147050642|NCT02899962|530347240|FG002|Maintenance Phase|Withdrawal by Subject|36|||
147050643|NCT00258960|530347241|FG000|Overall Study|Death|2|||
147050644|NCT00258960|530347241|FG000|Overall Study|Disease Progression|7|||
147050645|NCT00258960|530347241|FG000|Overall Study|Adverse Event|4|||
147050646|NCT00258960|530347241|FG000|Overall Study|Physician Decision|1|||
147050647|NCT00258960|530347241|FG000|Overall Study|Withdrawal by Subject|1|||
147050648|NCT00258960|530347241|FG000|Overall Study|Mistake|2|||
147050649|NCT00473590|530347242|FG000|Overall Study|Adverse Event|3|||
147050650|NCT00473590|530347243|FG001|Overall Study|Adverse Event|3|||
147050651|NCT00473590|530347242|FG000|Overall Study|Death|4|||
147050652|NCT00473590|530347243|FG001|Overall Study|Death|2|||
147050653|NCT00473590|530347242|FG000|Overall Study|Progression not resulting in death|24|||
147050654|NCT00473590|530347243|FG001|Overall Study|Progression not resulting in death|20|||
147050655|NCT00473590|530347242|FG000|Overall Study|Non-protocol-specified therapy|7|||
147050656|NCT00473590|530347243|FG001|Overall Study|Non-protocol-specified therapy|5|||
147050657|NCT00473590|530347242|FG000|Overall Study|Physician Decision|2|||
147050658|NCT00473590|530347243|FG001|Overall Study|Physician Decision|4|||
147050659|NCT00473590|530347242|FG000|Overall Study|Withdrawal by Subject|5|||
147050660|NCT00473590|530347243|FG001|Overall Study|Withdrawal by Subject|3|||
147050661|NCT00473590|530347242|FG000|Overall Study|Other|0|||
147050662|NCT00473590|530347243|FG001|Overall Study|Other|1|||
147050663|NCT01245283|530347246|FG000|Overall Study|Lost to Follow-up|14|||
147050664|NCT01245283|530347247|FG001|Overall Study|Lost to Follow-up|11|||
147050665|NCT01245283|530347248|FG002|Overall Study|Lost to Follow-up|11|||
147050666|NCT01610492|530347257|FG000|Overall Study|Adverse Event|1|||
147050667|NCT01610492|530347257|FG000|Overall Study|Lack of Efficacy|3|||
147050668|NCT01610492|530347257|FG000|Overall Study|Other: Reached stopping criteria|1|||
147050669|NCT01610492|530347257|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
147050670|NCT03093259|530347259|FG000|Overall Study|Adverse Event|1|||
147050671|NCT03093259|530347260|FG001|Overall Study|Adverse Event|0|||
147050672|NCT03093259|530347259|FG000|Overall Study|Withdrawal by Subject|1|||
147050673|NCT03093259|530347260|FG001|Overall Study|Withdrawal by Subject|0|||
147050674|NCT02575833|530347261|FG000|Overall Study|Withdrawal by Subject|0|||
147050675|NCT02575833|530347262|FG001|Overall Study|Withdrawal by Subject|1|||
147050676|NCT02575833|530347261|FG000|Overall Study|Lost to Follow-up|1|||
147050677|NCT02575833|530347262|FG001|Overall Study|Lost to Follow-up|0|||
147050678|NCT01757275|530347263|FG000|Overall Study|Lost to Follow-up|1|||
147050679|NCT01757275|530347264|FG001|Overall Study|Lost to Follow-up|2|||
147050680|NCT01757275|530347263|FG000|Overall Study|Adverse Event|3|||
147050681|NCT01757275|530347264|FG001|Overall Study|Adverse Event|3|||
147050682|NCT01757275|530347263|FG000|Overall Study|Withdrawal by Subject|2|||
147050683|NCT01757275|530347264|FG001|Overall Study|Withdrawal by Subject|4|||
147050684|NCT01757275|530347263|FG000|Overall Study|Not treated|3|||
147050685|NCT01757275|530347264|FG001|Overall Study|Not treated|4|||
147050686|NCT01821807|530347267|FG000|Overall Study|Lost to Follow-up|3|||
147050687|NCT01821807|530347268|FG001|Overall Study|Lost to Follow-up|1|||
147050688|NCT03367819|530347270|FG000|Overall Study|Adverse Event|4|||
147050689|NCT03367819|530347271|FG001|Overall Study|Adverse Event|4|||
147050690|NCT03367819|530347270|FG000|Overall Study|Progressive Disease|15|||
147050691|NCT03367819|530347271|FG001|Overall Study|Progressive Disease|13|||
147050692|NCT03367819|530347270|FG000|Overall Study|Withdrawal by Subject|1|||
147050693|NCT03367819|530347271|FG001|Overall Study|Withdrawal by Subject|0|||
147050694|NCT03367819|530347270|FG000|Overall Study|Other|4|||
147050695|NCT03367819|530347271|FG001|Overall Study|Other|2|||
147050696|NCT00550459|530347272|FG000|Overall Study|Adverse Event|0|||
147050697|NCT00550459|530347273|FG001|Overall Study|Adverse Event|2|||
147050698|NCT00550459|530347272|FG000|Overall Study|Withdrawal by Subject|1|||
147050699|NCT00550459|530347273|FG001|Overall Study|Withdrawal by Subject|1|||
147050700|NCT01401452|530347274|FG000|Overall Study|Adverse reaction|9|||
147050701|NCT01401452|530347274|FG000|Overall Study|Lost to Follow-up|12|||
147050702|NCT01401452|530347274|FG000|Overall Study|Lack of Efficacy|30|||
147050703|NCT01401452|530347274|FG000|Overall Study|Participant developed breast cancer|1|||
147050704|NCT01401452|530347274|FG000|Overall Study|Tx stopped due to financial reasons|1|||
147050705|NCT01401452|530347274|FG000|Overall Study|Tx stopped by psychiatrist|1|||
147050706|NCT01401452|530347274|FG000|Overall Study|No more visits within the 36 wk followup|4|||
147050707|NCT01401452|530347274|FG000|Overall Study|Subject did not come to follow up visits|2|||
147050708|NCT01401452|530347274|FG000|Overall Study|Subject didn't return for routine visits|1|||
147050709|NCT01401452|530347274|FG000|Overall Study|Subject moved to another city|1|||
147050710|NCT01401452|530347274|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
147050711|NCT01401452|530347274|FG000|Overall Study|Psoriatic arthritis|1|||
147050712|NCT01401452|530347274|FG000|Overall Study|Participant stopped Tx|2|||
147050713|NCT01401452|530347274|FG000|Overall Study|Discontinuation for personal reasons|1|||
147050714|NCT01401452|530347274|FG000|Overall Study|Treatment failure|1|||
147050715|NCT01401452|530347274|FG000|Overall Study|Unsatisfactory output|1|||
147050716|NCT01401452|530347274|FG000|Overall Study|Subject withdrew because of Tx success|1|||
147050717|NCT01401452|530347274|FG000|Overall Study|Subject chose to discontinue treatment|1|||
147050718|NCT01401452|530347274|FG000|Overall Study|Participant withdrew consent|1|||
147050719|NCT00584454|530347275|FG000|Overall Study|Adverse Event|1|||
147050720|NCT00584454|530347275|FG000|Overall Study|Relocation|1|||
147050721|NCT00584454|530347275|FG000|Overall Study|Clinical Hold|2|||
147050722|NCT02404805|530347276|FG000|Overall Study|Withdrawal by Subject|1|||
147050723|NCT02404805|530347277|FG001|Overall Study|Withdrawal by Subject|0|||
147050724|NCT02404805|530347278|FG002|Overall Study|Withdrawal by Subject|0|||
147050725|NCT02404805|530347279|FG003|Overall Study|Withdrawal by Subject|0|||
147050726|NCT02404805|530347280|FG004|Overall Study|Withdrawal by Subject|0|||
147050727|NCT02404805|530347281|FG005|Overall Study|Withdrawal by Subject|0|||
147050728|NCT01742897|530347282|FG000|Overall Study|Adverse Event|3|||
147050729|NCT01742897|530347282|FG000|Overall Study|Withdrawal by Subject|1|||
147050730|NCT01742897|530347282|FG000|Overall Study|Other|1|||
147050731|NCT01459783|530347286|FG000|Baseline to 6 Months|Death|1|||
147050732|NCT01459783|530347287|FG001|Baseline to 6 Months|Death|0|||
147050733|NCT01459783|530347286|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
147050734|NCT01459783|530347287|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
147050735|NCT01459783|530347286|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
147050736|NCT01459783|530347287|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
147050737|NCT01459783|530347286|FG000|6 Months to 12 Months|Death|0|||
147050738|NCT01459783|530347287|FG001|6 Months to 12 Months|Death|1|||
147050739|NCT01459783|530347286|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
147050740|NCT01459783|530347287|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
147050741|NCT01459783|530347286|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
147050742|NCT01459783|530347287|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
147050743|NCT01459783|530347286|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
147050744|NCT01459783|530347287|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
147050745|NCT04211831|530347288|FG000|Overall Study|Withdrawal by Subject|4|||
147050746|NCT04211831|530347289|FG001|Overall Study|Withdrawal by Subject|1|||
147050747|NCT04211831|530347290|FG002|Overall Study|Withdrawal by Subject|1|||
147050748|NCT04211831|530347288|FG000|Overall Study|Protocol Violation|0|||
147050749|NCT04211831|530347289|FG001|Overall Study|Protocol Violation|0|||
147050750|NCT04211831|530347290|FG002|Overall Study|Protocol Violation|1|||
147050751|NCT04211831|530347288|FG000|Overall Study|Adverse Event|0|||
147050752|NCT04211831|530347289|FG001|Overall Study|Adverse Event|1|||
147050753|NCT04211831|530347290|FG002|Overall Study|Adverse Event|0|||
147050754|NCT04211831|530347288|FG000|Overall Study|Lack of Efficacy|0|||
147050755|NCT04211831|530347289|FG001|Overall Study|Lack of Efficacy|0|||
147050756|NCT04211831|530347290|FG002|Overall Study|Lack of Efficacy|1|||
147050757|NCT04211831|530347288|FG000|Overall Study|Lost to Follow-up|0|||
147050758|NCT04211831|530347289|FG001|Overall Study|Lost to Follow-up|0|||
147050759|NCT04211831|530347290|FG002|Overall Study|Lost to Follow-up|2|||
147050760|NCT04211831|530347288|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
147050761|NCT04211831|530347289|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
147050762|NCT04211831|530347290|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
147050763|NCT04211831|530347288|FG000|Overall Study|Other|0|||
147050764|NCT04211831|530347289|FG001|Overall Study|Other|1|||
147050765|NCT04211831|530347290|FG002|Overall Study|Other|0|||
147050766|NCT02456740|530347291|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
147050767|NCT02456740|530347292|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
147050768|NCT02456740|530347293|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
147050769|NCT02456740|530347294|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
147050770|NCT02456740|530347295|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
147050771|NCT02456740|530347296|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
147050772|NCT02456740|530347297|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
147050773|NCT02456740|530347298|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
147050774|NCT02456740|530347299|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
147050775|NCT02456740|530347291|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
147050776|NCT02456740|530347292|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
147050777|NCT02456740|530347293|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
147050778|NCT02456740|530347294|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
147050779|NCT02456740|530347295|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
147050780|NCT02456740|530347296|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
147050781|NCT02456740|530347297|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
147050782|NCT02456740|530347298|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
147050783|NCT02456740|530347299|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
147050784|NCT02456740|530347291|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
147050785|NCT02456740|530347292|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
147050786|NCT02456740|530347293|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
147050787|NCT02456740|530347294|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
147050788|NCT02456740|530347295|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
147050789|NCT02456740|530347296|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
147050790|NCT02456740|530347297|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
147050791|NCT02456740|530347298|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
147050792|NCT02456740|530347299|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
147050793|NCT02456740|530347291|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
147050794|NCT02456740|530347292|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
147050795|NCT02456740|530347293|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
147050796|NCT02456740|530347294|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
147050797|NCT02456740|530347295|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
147050798|NCT02456740|530347296|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
147050799|NCT02456740|530347297|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
147050800|NCT02456740|530347298|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
147050801|NCT02456740|530347299|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
147050802|NCT02456740|530347291|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
147050803|NCT02456740|530347292|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
147050804|NCT02456740|530347293|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
147050805|NCT02456740|530347294|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
147050806|NCT02456740|530347295|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
147050807|NCT02456740|530347296|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
147050808|NCT02456740|530347297|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
147050809|NCT02456740|530347298|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
147050810|NCT02456740|530347299|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
147050811|NCT02456740|530347291|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
147050812|NCT02456740|530347292|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
147050813|NCT02456740|530347293|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
147050814|NCT02456740|530347294|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
147050815|NCT02456740|530347295|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
147050816|NCT02456740|530347296|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
147050817|NCT02456740|530347297|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
147050818|NCT02456740|530347298|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
147050819|NCT02456740|530347299|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
147050820|NCT02456740|530347291|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
147050821|NCT02456740|530347292|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
147050822|NCT02456740|530347293|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
147050823|NCT02456740|530347294|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
147050824|NCT02456740|530347295|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
147050825|NCT02456740|530347296|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
147050826|NCT02456740|530347297|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
147050827|NCT02456740|530347298|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
147050828|NCT02456740|530347299|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
147050829|NCT00967330|530347301|FG000|Overall Study|Protocol Violation|3|||
147050830|NCT00967330|530347302|FG001|Overall Study|Protocol Violation|4|||
147050831|NCT00967330|530347301|FG000|Overall Study|Regular|10|||
147050832|NCT00967330|530347302|FG001|Overall Study|Regular|3|||
147050833|NCT00967330|530347301|FG000|Overall Study|Withdrawal by Subject|6|||
147050834|NCT00967330|530347302|FG001|Overall Study|Withdrawal by Subject|0|||
147050835|NCT00967330|530347301|FG000|Overall Study|Lost to Follow-up|1|||
147050836|NCT00967330|530347302|FG001|Overall Study|Lost to Follow-up|1|||
147050837|NCT00967330|530347301|FG000|Overall Study|Death|102|||
147050838|NCT00967330|530347302|FG001|Overall Study|Death|51|||
147050839|NCT00967330|530347301|FG000|Overall Study|Severe protocol deviation|0|||
147050840|NCT00967330|530347302|FG001|Overall Study|Severe protocol deviation|1|||
147050841|NCT02698163|530347305|FG000|Overall Study|Lost to Follow-up|0|||
147050842|NCT02698163|530347306|FG001|Overall Study|Lost to Follow-up|1|||
147050843|NCT01133067|530347307|FG000|Overall Study|Death|136|||
147050844|NCT01133067|530347307|FG000|Overall Study|Lost to Follow-up|3|||
147050845|NCT00752128|530347308|FG000|Overall Study|Withdrawal by Subject|4|||
147050846|NCT04135937|530347312|FG000|Overall Study|Lost to Follow-up|2|||
147050847|NCT04135937|530347312|FG000|Overall Study|Withdrawal by Subject|1|||
147050848|NCT02548143|530347313|FG000|Overall Study|Adverse Event|1|||
147050849|NCT02548143|530347314|FG001|Overall Study|Adverse Event|0|||
147050850|NCT02548143|530347313|FG000|Overall Study|Withdrawal by Subject|0|||
147050851|NCT02548143|530347314|FG001|Overall Study|Withdrawal by Subject|1|||
147050852|NCT00858273|530347316|FG000|Overall Study|Protocol Violation|3|||
147050853|NCT00858273|530347317|FG001|Overall Study|Protocol Violation|5|||
147050854|NCT00982657|530347318|FG000|Overall Study|Death|1|||
147050855|NCT00982657|530347319|FG001|Overall Study|Death|0|||
147050856|NCT00982657|530347320|FG002|Overall Study|Death|1|||
147050857|NCT00982657|530347321|FG003|Overall Study|Death|1|||
147050858|NCT00982657|530347318|FG000|Overall Study|Withdrawal by Subject|0|||
147050859|NCT00982657|530347319|FG001|Overall Study|Withdrawal by Subject|0|||
147050860|NCT00982657|530347320|FG002|Overall Study|Withdrawal by Subject|1|||
147050861|NCT00982657|530347321|FG003|Overall Study|Withdrawal by Subject|3|||
147050862|NCT00982657|530347318|FG000|Overall Study|Other|0|||
147050863|NCT00982657|530347319|FG001|Overall Study|Other|0|||
147050864|NCT00982657|530347320|FG002|Overall Study|Other|0|||
147050865|NCT00982657|530347321|FG003|Overall Study|Other|4|||
147050866|NCT00982657|530347318|FG000|Overall Study|On going at date of cut-off|0|||
147050867|NCT00982657|530347319|FG001|Overall Study|On going at date of cut-off|0|||
147050868|NCT00982657|530347320|FG002|Overall Study|On going at date of cut-off|0|||
147050869|NCT00982657|530347321|FG003|Overall Study|On going at date of cut-off|1|||
147050870|NCT00625820|530347322|FG000|Overall Study|Withdrawal by Subject|1|||
147050871|NCT04510090|530350018|FG000|FE-HS|Withdrawal by Subject|0|||
147050872|NCT04510090|530350019|FG001|FE-HS|Withdrawal by Subject|0|||
147050873|NCT04510090|530350020|FG002|FE-HS|Withdrawal by Subject|0|||
147050874|NCT04510090|530350021|FG003|FE-HS|Withdrawal by Subject|0|||
147050875|NCT04510090|530350022|FG004|FE-HS|Withdrawal by Subject|1|||
147050876|NCT04510090|530350023|FG005|FE-HS|Withdrawal by Subject|0|||
147050877|NCT04510090|530350024|FG006|FE-HS|Withdrawal by Subject|0|||
147050878|NCT04510090|530350025|FG007|FE-HS|Withdrawal by Subject|0|||
147050879|NCT01749826|530350026|FG000|Overall Study|Study Terminated|20|||
147050880|NCT01749826|530350027|FG001|Overall Study|Study Terminated|0|||
147050881|NCT01922037|530350028|FG000|Overall Study|Withdrawal by Subject|2|||
147050882|NCT01922037|530350029|FG001|Overall Study|Withdrawal by Subject|44|||
147050883|NCT01922037|530350028|FG000|Overall Study|Adverse Event|1|||
147050884|NCT01922037|530350029|FG001|Overall Study|Adverse Event|7|||
147050885|NCT01922037|530350028|FG000|Overall Study|Death|0|||
147050886|NCT01922037|530350029|FG001|Overall Study|Death|5|||
147050887|NCT01922037|530350028|FG000|Overall Study|Pregnancy|0|||
147050888|NCT01922037|530350029|FG001|Overall Study|Pregnancy|2|||
147050889|NCT01922037|530350028|FG000|Overall Study|Participant non-compliance|4|||
147050890|NCT01922037|530350029|FG001|Overall Study|Participant non-compliance|46|||
147050891|NCT01922037|530350028|FG000|Overall Study|Investigator/Sponsor decision|1|||
147050892|NCT01922037|530350029|FG001|Overall Study|Investigator/Sponsor decision|4|||
147050893|NCT01922037|530350028|FG000|Overall Study|Other unspecified|2|||
147050894|NCT01922037|530350029|FG001|Overall Study|Other unspecified|66|||
147050895|NCT05085834|530350030|FG000|Overall Study|Lost to Follow-up|9|||
147050896|NCT05085834|530350031|FG001|Overall Study|Lost to Follow-up|2|||
147050897|NCT05085834|530350030|FG000|Overall Study|Adverse Event|6|||
147050898|NCT05085834|530350031|FG001|Overall Study|Adverse Event|0|||
147050899|NCT05085834|530350030|FG000|Overall Study|Death|1|||
147050900|NCT05085834|530350031|FG001|Overall Study|Death|0|||
147050901|NCT05085834|530350030|FG000|Overall Study|Inability to swallow the pill|0|||
147050902|NCT05085834|530350031|FG001|Overall Study|Inability to swallow the pill|1|||
147050903|NCT03657797|530350037|FG000|Overall Study|Lost to Follow-up|0|||
147050904|NCT03657797|530350038|FG001|Overall Study|Lost to Follow-up|1|||
147050905|NCT03657797|530350039|FG002|Overall Study|Lost to Follow-up|1|||
147050906|NCT03657797|530350040|FG003|Overall Study|Lost to Follow-up|0|||
147050907|NCT03657797|530350037|FG000|Overall Study|Physician Decision|0|||
147050908|NCT03657797|530350038|FG001|Overall Study|Physician Decision|1|||
147050909|NCT03657797|530350039|FG002|Overall Study|Physician Decision|0|||
147050910|NCT03657797|530350040|FG003|Overall Study|Physician Decision|0|||
147050911|NCT03657797|530350037|FG000|Overall Study|Withdrawal by Subject|0|||
147050912|NCT03657797|530350038|FG001|Overall Study|Withdrawal by Subject|1|||
147050913|NCT03657797|530350039|FG002|Overall Study|Withdrawal by Subject|2|||
147050914|NCT03657797|530350040|FG003|Overall Study|Withdrawal by Subject|0|||
147050915|NCT03657797|530350037|FG000|Overall Study|Adverse Event|0|||
147050916|NCT03657797|530350038|FG001|Overall Study|Adverse Event|0|||
147050917|NCT03657797|530350039|FG002|Overall Study|Adverse Event|2|||
147050918|NCT03657797|530350040|FG003|Overall Study|Adverse Event|0|||
147050919|NCT00413699|530350041|FG000|Initial Period|Death|25|||
147050920|NCT00413699|530350042|FG001|Initial Period|Death|30|||
147050921|NCT00413699|530350043|FG002|Initial Period|Death|0|||
147050922|NCT00413699|530350041|FG000|Initial Period|Lack of Efficacy|59|||
147050923|NCT00413699|530350042|FG001|Initial Period|Lack of Efficacy|115|||
147050924|NCT00413699|530350043|FG002|Initial Period|Lack of Efficacy|0|||
147050925|NCT00413699|530350041|FG000|Initial Period|Lost to Follow-up|31|||
147050926|NCT00413699|530350042|FG001|Initial Period|Lost to Follow-up|101|||
147050927|NCT00413699|530350043|FG002|Initial Period|Lost to Follow-up|0|||
147050928|NCT00413699|530350041|FG000|Initial Period|Protocol Violation|38|||
147050929|NCT00413699|530350042|FG001|Initial Period|Protocol Violation|89|||
147050930|NCT00413699|530350043|FG002|Initial Period|Protocol Violation|0|||
147050931|NCT00413699|530350041|FG000|Initial Period|Pregnancy|10|||
147050932|NCT00413699|530350042|FG001|Initial Period|Pregnancy|8|||
147050933|NCT00413699|530350043|FG002|Initial Period|Pregnancy|0|||
147050934|NCT00413699|530350041|FG000|Initial Period|Did not meet entrance criteria|2|||
147050935|NCT00413699|530350042|FG001|Initial Period|Did not meet entrance criteria|2|||
147050936|NCT00413699|530350043|FG002|Initial Period|Did not meet entrance criteria|0|||
147050937|NCT00413699|530350041|FG000|Initial Period|Medication error without adverse event|0|||
147050938|NCT00413699|530350042|FG001|Initial Period|Medication error without adverse event|1|||
147050939|NCT00413699|530350043|FG002|Initial Period|Medication error without adverse event|0|||
147050940|NCT00413699|530350041|FG000|Initial Period|Study terminated by Sponsor|0|||
147050941|NCT00413699|530350042|FG001|Initial Period|Study terminated by Sponsor|1|||
147050942|NCT00413699|530350043|FG002|Initial Period|Study terminated by Sponsor|0|||
147050943|NCT00413699|530350041|FG000|Initial Period|Other|67|||
147050944|NCT00413699|530350042|FG001|Initial Period|Other|211|||
147050945|NCT00413699|530350043|FG002|Initial Period|Other|0|||
147050946|NCT00413699|530350041|FG000|Initial Period|Adverse event related to study drug|178|||
147050947|NCT00413699|530350042|FG001|Initial Period|Adverse event related to study drug|527|||
147050948|NCT00413699|530350043|FG002|Initial Period|Adverse event related to study drug|0|||
147050949|NCT00413699|530350041|FG000|Initial Period|Adverse event not related to study drug|113|||
147050950|NCT00413699|530350042|FG001|Initial Period|Adverse event not related to study drug|248|||
147050951|NCT00413699|530350043|FG002|Initial Period|Adverse event not related to study drug|0|||
147050952|NCT00413699|530350041|FG000|Initial Period|Missing end of study page|0|||
147050953|NCT00413699|530350042|FG001|Initial Period|Missing end of study page|4|||
147050954|NCT00413699|530350043|FG002|Initial Period|Missing end of study page|0|||
147050955|NCT00413699|530350041|FG000|Initial Period|No longer willing to participate|116|||
147050956|NCT00413699|530350042|FG001|Initial Period|No longer willing to participate|368|||
147050957|NCT00413699|530350043|FG002|Initial Period|No longer willing to participate|0|||
147050958|NCT00413699|530350041|FG000|Extension Period|No Longer Willing to Participate|0|||
147050959|NCT00413699|530350042|FG001|Extension Period|No Longer Willing to Participate|0|||
147050960|NCT00413699|530350043|FG002|Extension Period|No Longer Willing to Participate|2|||
147050961|NCT00413699|530350041|FG000|Extension Period|Protocol Violation|0|||
147050962|NCT00413699|530350042|FG001|Extension Period|Protocol Violation|0|||
147050963|NCT00413699|530350043|FG002|Extension Period|Protocol Violation|1|||
147050964|NCT00413699|530350041|FG000|Extension Period|Adverse Event|0|||
147050965|NCT00413699|530350042|FG001|Extension Period|Adverse Event|0|||
147050966|NCT00413699|530350043|FG002|Extension Period|Adverse Event|2|||
147050967|NCT02115269|530350044|FG000|Overall Study|Lost to Follow-up|43|||
147050968|NCT02115269|530350044|FG000|Overall Study|Did not complete patient diary|3|||
147050969|NCT02115269|530350044|FG000|Overall Study|Moved to another city|7|||
147050970|NCT02115269|530350044|FG000|Overall Study|Withdrawal by Subject|2|||
147050971|NCT02115269|530350044|FG000|Overall Study|Didn't take study drug|2|||
147050972|NCT02810457|530350045|FG000|Overall Study|Randomised but no treatment received|2|||
147050973|NCT02810457|530350046|FG001|Overall Study|Randomised but no treatment received|1|||
147050974|NCT02810457|530350045|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
147050975|NCT02810457|530350046|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
147050976|NCT02810457|530350045|FG000|Overall Study|Adverse Event|37|||
147050977|NCT02810457|530350046|FG001|Overall Study|Adverse Event|43|||
147050978|NCT02810457|530350045|FG000|Overall Study|Patient decision|31|||
147050979|NCT02810457|530350046|FG001|Overall Study|Patient decision|35|||
147050980|NCT02810457|530350045|FG000|Overall Study|Patient lost to follow-up|2|||
147050981|NCT02810457|530350046|FG001|Overall Study|Patient lost to follow-up|2|||
147050982|NCT02810457|530350045|FG000|Overall Study|Death|39|||
147050983|NCT02810457|530350046|FG001|Overall Study|Death|28|||
147050984|NCT02810457|530350045|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
147050985|NCT02810457|530350046|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
147050986|NCT02810457|530350045|FG000|Overall Study|Clinical progression|15|||
147050987|NCT02810457|530350046|FG001|Overall Study|Clinical progression|16|||
147050988|NCT02810457|530350045|FG000|Overall Study|Investigator decision|3|||
147050989|NCT02810457|530350046|FG001|Overall Study|Investigator decision|2|||
147050990|NCT02810457|530350045|FG000|Overall Study|Patient ineligibility|3|||
147050991|NCT02810457|530350046|FG001|Overall Study|Patient ineligibility|0|||
147050992|NCT02810457|530350045|FG000|Overall Study|Miscalculated PD|1|||
147050993|NCT02810457|530350046|FG001|Overall Study|Miscalculated PD|0|||
147050994|NCT02810457|530350045|FG000|Overall Study|Physician Decision|0|||
147050995|NCT02810457|530350046|FG001|Overall Study|Physician Decision|1|||
147050996|NCT02750618|530350047|FG000|Overall Study|Withdrawal by Subject|1|||
147050997|NCT01173523|530350057|FG000|Overall Study|Clinical Progression|1|||
147050998|NCT01173523|530350058|FG001|Overall Study|Clinical Progression|1|||
147050999|NCT01173523|530350057|FG000|Overall Study|Progressive Disease|10|||
147051000|NCT01173523|530350058|FG001|Overall Study|Progressive Disease|8|||
147051001|NCT01173523|530350057|FG000|Overall Study|Other|2|||
147051002|NCT01173523|530350058|FG001|Overall Study|Other|3|||
147051003|NCT04429503|530350065|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
147051004|NCT04429503|530350066|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
147051005|NCT04429503|530350067|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
147051006|NCT04429503|530350068|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
147051007|NCT04429503|530350069|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
147051008|NCT04429503|530350070|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
147051009|NCT04429503|530350065|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
147051010|NCT04429503|530350066|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
147051011|NCT04429503|530350067|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
147051012|NCT04429503|530350068|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
147051013|NCT04429503|530350069|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
147051014|NCT04429503|530350070|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
147051015|NCT04429503|530350065|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
147051016|NCT04429503|530350066|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
147051017|NCT04429503|530350067|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
147051018|NCT04429503|530350068|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
147051019|NCT04429503|530350069|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
147051020|NCT04429503|530350070|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
147051021|NCT04429503|530350065|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
147051022|NCT04429503|530350066|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
147051023|NCT04429503|530350067|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
147051024|NCT04429503|530350068|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
147051025|NCT04429503|530350069|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
147051026|NCT04429503|530350070|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
147051027|NCT04429503|530350065|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
147051028|NCT04429503|530350066|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
147051029|NCT04429503|530350067|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
147051030|NCT04429503|530350068|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
147051031|NCT04429503|530350069|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
147051032|NCT04429503|530350070|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
147051033|NCT04429503|530350065|FG000|Main Study (Up to Wk 96)|Death|9|||
147051034|NCT04429503|530350066|FG001|Main Study (Up to Wk 96)|Death|18|||
147051035|NCT04429503|530350067|FG002|Main Study (Up to Wk 96)|Death|5|||
147051036|NCT04429503|530350068|FG003|Main Study (Up to Wk 96)|Death|0|||
147051037|NCT04429503|530350069|FG004|Main Study (Up to Wk 96)|Death|0|||
147051038|NCT04429503|530350070|FG005|Main Study (Up to Wk 96)|Death|0|||
147051039|NCT04429503|530350065|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
147051040|NCT04429503|530350066|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
147051041|NCT04429503|530350067|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
147051042|NCT04429503|530350068|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
147051043|NCT04429503|530350069|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
147051044|NCT04429503|530350070|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
147051045|NCT04429503|530350065|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
147051046|NCT04429503|530350066|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
147051047|NCT04429503|530350067|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
147051048|NCT04429503|530350068|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
147051049|NCT04429503|530350069|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
147051050|NCT04429503|530350070|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
147051051|NCT04429503|530350065|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
147051052|NCT04429503|530350066|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
147051053|NCT04429503|530350067|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
147051054|NCT04429503|530350068|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
147051055|NCT04429503|530350069|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
147051056|NCT04429503|530350070|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
147051057|NCT04429503|530350065|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
147051058|NCT04429503|530350066|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
147051059|NCT04429503|530350067|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
147051060|NCT04429503|530350068|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
147051061|NCT04429503|530350069|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
147051062|NCT04429503|530350070|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
147051063|NCT04429503|530350065|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
147051064|NCT04429503|530350066|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
147051065|NCT04429503|530350067|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
147051066|NCT04429503|530350068|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
147051067|NCT04429503|530350069|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
147051068|NCT04429503|530350070|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
147051069|NCT04429503|530350065|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
147051070|NCT04429503|530350066|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
147051071|NCT04429503|530350067|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
147051072|NCT04429503|530350068|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
147051073|NCT04429503|530350069|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
147051074|NCT04429503|530350070|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
147051075|NCT05516108|530350071|FG000|Overall Study|Time Commitment|3|||
147051076|NCT05516108|530350072|FG001|Overall Study|Time Commitment|1|||
147051077|NCT05516108|530350071|FG000|Overall Study|Reason Unknown|2|||
147051078|NCT05516108|530350072|FG001|Overall Study|Reason Unknown|4|||
147051079|NCT00709995|530350073|FG000|Overall Study|Adverse Event|4|||
147051080|NCT00709995|530350074|FG001|Overall Study|Adverse Event|2|||
147051081|NCT00709995|530350073|FG000|Overall Study|Withdrawal by Subject|1|||
147051082|NCT00709995|530350074|FG001|Overall Study|Withdrawal by Subject|3|||
147051083|NCT02392481|530350075|FG000|Overall Study|Adverse Event|0|||
147051084|NCT02392481|530350076|FG001|Overall Study|Adverse Event|0|||
147051085|NCT02392481|530350077|FG002|Overall Study|Adverse Event|1|||
147051086|NCT02392481|530350078|FG003|Overall Study|Adverse Event|2|||
147051087|NCT02392481|530350075|FG000|Overall Study|Withdrawal by Subject|0|||
147051088|NCT02392481|530350076|FG001|Overall Study|Withdrawal by Subject|0|||
147051089|NCT02392481|530350077|FG002|Overall Study|Withdrawal by Subject|1|||
147051090|NCT02392481|530350078|FG003|Overall Study|Withdrawal by Subject|0|||
147051091|NCT03565900|530350079|FG000|Overall Study|Disposition Unknown|4|||
147051092|NCT03565900|530350080|FG001|Overall Study|Disposition Unknown|1|||
147051093|NCT03565900|530350079|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
147051094|NCT03565900|530350080|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
147051095|NCT03565900|530350079|FG000|Overall Study|Withdrawal by Subject|4|||
147051096|NCT03565900|530350080|FG001|Overall Study|Withdrawal by Subject|5|||
147051097|NCT03565900|530350079|FG000|Overall Study|Randomized By Mistake|0|||
147051098|NCT03565900|530350080|FG001|Overall Study|Randomized By Mistake|2|||
147051099|NCT03565900|530350079|FG000|Overall Study|Physician Decision|7|||
147051100|NCT03565900|530350080|FG001|Overall Study|Physician Decision|11|||
147051101|NCT03565900|530350079|FG000|Overall Study|Death|9|||
147051102|NCT03565900|530350080|FG001|Overall Study|Death|7|||
147051103|NCT02058069|530350083|FG000|Overall Study|Exclusion due to implant size|5|||
147051104|NCT02058069|530350083|FG000|Overall Study|Withdrawal by Subject|6|||
147051105|NCT02222922|530350084|FG000|Overall Study|Death|0|||
146850047|NCT01639560|529620697|FG001|Overall Study|Adverse Event|2|||
147051106|NCT02222922|530350085|FG001|Overall Study|Death|0|||
147051107|NCT02222922|530350086|FG002|Overall Study|Death|0|||
147051108|NCT02222922|530350087|FG003|Overall Study|Death|0|||
147051109|NCT02222922|530350088|FG004|Overall Study|Death|13|||
147051110|NCT02222922|530350089|FG005|Overall Study|Death|0|||
147051111|NCT02222922|530350090|FG006|Overall Study|Death|0|||
147051112|NCT02222922|530350091|FG007|Overall Study|Death|0|||
147051113|NCT02222922|530350092|FG008|Overall Study|Death|2|||
147051114|NCT02222922|530350084|FG000|Overall Study|Lost to Follow-up|0|||
147051115|NCT02222922|530350085|FG001|Overall Study|Lost to Follow-up|0|||
147051116|NCT02222922|530350086|FG002|Overall Study|Lost to Follow-up|1|||
147051117|NCT02222922|530350087|FG003|Overall Study|Lost to Follow-up|0|||
147051118|NCT02222922|530350088|FG004|Overall Study|Lost to Follow-up|9|||
147051119|NCT02222922|530350089|FG005|Overall Study|Lost to Follow-up|1|||
147051120|NCT02222922|530350090|FG006|Overall Study|Lost to Follow-up|0|||
147051121|NCT02222922|530350091|FG007|Overall Study|Lost to Follow-up|0|||
147051122|NCT02222922|530350092|FG008|Overall Study|Lost to Follow-up|0|||
147051123|NCT02222922|530350084|FG000|Overall Study|Other|0|||
147051124|NCT02222922|530350085|FG001|Overall Study|Other|0|||
147051125|NCT02222922|530350086|FG002|Overall Study|Other|0|||
147051126|NCT02222922|530350087|FG003|Overall Study|Other|2|||
147051127|NCT02222922|530350088|FG004|Overall Study|Other|10|||
147051128|NCT02222922|530350089|FG005|Overall Study|Other|2|||
147051129|NCT02222922|530350090|FG006|Overall Study|Other|2|||
147051130|NCT02222922|530350091|FG007|Overall Study|Other|4|||
147051131|NCT02222922|530350092|FG008|Overall Study|Other|1|||
147051132|NCT02222922|530350084|FG000|Overall Study|Participant refused further follow-up|1|||
147051133|NCT02222922|530350085|FG001|Overall Study|Participant refused further follow-up|0|||
147051134|NCT02222922|530350086|FG002|Overall Study|Participant refused further follow-up|0|||
147051135|NCT02222922|530350087|FG003|Overall Study|Participant refused further follow-up|1|||
147051136|NCT02222922|530350088|FG004|Overall Study|Participant refused further follow-up|6|||
147051137|NCT02222922|530350089|FG005|Overall Study|Participant refused further follow-up|0|||
147051138|NCT02222922|530350090|FG006|Overall Study|Participant refused further follow-up|0|||
147051139|NCT02222922|530350091|FG007|Overall Study|Participant refused further follow-up|0|||
147051140|NCT02222922|530350092|FG008|Overall Study|Participant refused further follow-up|3|||
147051141|NCT01254643|530350093|FG000|Overall Study|Withdrawal by Subject|1|||
147051142|NCT03359850|530350094|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
147051143|NCT03359850|530350095|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
147051144|NCT03359850|530350094|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
147051145|NCT03359850|530350095|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
147051146|NCT03359850|530350094|FG000|Extension Phase (Up to 28 Months)|Death|2|||
147051147|NCT03359850|530350095|FG001|Extension Phase (Up to 28 Months)|Death|4|||
147051148|NCT03359850|530350094|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
147051149|NCT03359850|530350095|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
147051150|NCT03359850|530350094|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
147051151|NCT03359850|530350095|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
147051152|NCT03817125|530350113|FG000|Overall Study|Adverse Event|1|||
147051153|NCT03817125|530350114|FG001|Overall Study|Adverse Event|0|||
147051154|NCT03817125|530350113|FG000|Overall Study|Physician Decision|0|||
147051155|NCT03817125|530350114|FG001|Overall Study|Physician Decision|1|||
147051156|NCT03817125|530350113|FG000|Overall Study|Lack of Efficacy|1|||
147051157|NCT03817125|530350114|FG001|Overall Study|Lack of Efficacy|5|||
147051158|NCT02002221|530350115|FG000|Overall Study|Adverse Event|2|||
147051159|NCT02002221|530350116|FG001|Overall Study|Adverse Event|1|||
147051160|NCT02002221|530350115|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147051161|NCT02002221|530350116|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147051162|NCT02002221|530350115|FG000|Overall Study|Patient withdrew consent|0|||
147051163|NCT02002221|530350116|FG001|Overall Study|Patient withdrew consent|1|||
147051164|NCT00942084|530350117|FG000|Overall Study|Death|2|||
147051165|NCT01037218|530350121|FG000|Overall Study|Adverse Event|4|||
147051166|NCT01037218|530350122|FG001|Overall Study|Adverse Event|2|||
147051167|NCT01037218|530350123|FG002|Overall Study|Adverse Event|2|||
147051168|NCT01037218|530350124|FG003|Overall Study|Adverse Event|1|||
147051169|NCT01037218|530350121|FG000|Overall Study|Lack of Efficacy|0|||
147051170|NCT01037218|530350122|FG001|Overall Study|Lack of Efficacy|2|||
147051171|NCT01037218|530350123|FG002|Overall Study|Lack of Efficacy|1|||
147051172|NCT01037218|530350124|FG003|Overall Study|Lack of Efficacy|5|||
147051173|NCT01037218|530350121|FG000|Overall Study|Lost to Follow-up|3|||
147051174|NCT01037218|530350122|FG001|Overall Study|Lost to Follow-up|5|||
147051175|NCT01037218|530350123|FG002|Overall Study|Lost to Follow-up|4|||
147051176|NCT01037218|530350124|FG003|Overall Study|Lost to Follow-up|2|||
147051177|NCT01037218|530350121|FG000|Overall Study|Withdrawal by Subject|6|||
147051178|NCT01037218|530350122|FG001|Overall Study|Withdrawal by Subject|7|||
147051179|NCT01037218|530350123|FG002|Overall Study|Withdrawal by Subject|7|||
147051180|NCT01037218|530350124|FG003|Overall Study|Withdrawal by Subject|4|||
147051181|NCT01037218|530350121|FG000|Overall Study|Partner Withdrew Consent|0|||
147051182|NCT01037218|530350122|FG001|Overall Study|Partner Withdrew Consent|3|||
147051183|NCT01037218|530350123|FG002|Overall Study|Partner Withdrew Consent|2|||
147051184|NCT01037218|530350124|FG003|Overall Study|Partner Withdrew Consent|1|||
147051185|NCT01037218|530350121|FG000|Overall Study|Protocol Violation|0|||
147051186|NCT01037218|530350122|FG001|Overall Study|Protocol Violation|0|||
147051187|NCT01037218|530350123|FG002|Overall Study|Protocol Violation|2|||
147051188|NCT01037218|530350124|FG003|Overall Study|Protocol Violation|2|||
147051189|NCT01037218|530350121|FG000|Overall Study|Various|3|||
147051190|NCT01037218|530350122|FG001|Overall Study|Various|2|||
147051191|NCT01037218|530350123|FG002|Overall Study|Various|3|||
147051192|NCT01037218|530350124|FG003|Overall Study|Various|1|||
147051193|NCT00897715|530350125|FG000|Overall Study|Lost to Follow-up|0|||
147051194|NCT00897715|530350126|FG001|Overall Study|Lost to Follow-up|1|||
147051195|NCT00897715|530350125|FG000|Overall Study|Physician Decision|1|||
147051196|NCT00897715|530350126|FG001|Overall Study|Physician Decision|0|||
147051197|NCT00897715|530350125|FG000|Overall Study|increased risk of infection|1|||
147051198|NCT00897715|530350126|FG001|Overall Study|increased risk of infection|0|||
147051199|NCT02714218|530350127|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147051200|NCT02714218|530350128|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
147051201|NCT02714218|530350129|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147051202|NCT02714218|530350127|FG000|Pre-Treatment Period|Other reasons|0|||
147051203|NCT02714218|530350128|FG001|Pre-Treatment Period|Other reasons|1|||
147051204|NCT02714218|530350129|FG002|Pre-Treatment Period|Other reasons|0|||
147051205|NCT02714218|530350127|FG000|Treatment Period|Disease Progression|55|||
147051206|NCT02714218|530350128|FG001|Treatment Period|Disease Progression|52|||
147051207|NCT02714218|530350129|FG002|Treatment Period|Disease Progression|14|||
147051208|NCT02714218|530350127|FG000|Treatment Period|Study drug toxicity|46|||
147051209|NCT02714218|530350128|FG001|Treatment Period|Study drug toxicity|70|||
147051210|NCT02714218|530350129|FG002|Treatment Period|Study drug toxicity|6|||
147051211|NCT02714218|530350127|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
147051212|NCT02714218|530350128|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
147051213|NCT02714218|530350129|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
147051214|NCT02714218|530350127|FG000|Treatment Period|Request to discontinue treatment|1|||
147051215|NCT02714218|530350128|FG001|Treatment Period|Request to discontinue treatment|4|||
147051216|NCT02714218|530350129|FG002|Treatment Period|Request to discontinue treatment|1|||
147051217|NCT02714218|530350127|FG000|Treatment Period|Participant withdrew consent|2|||
147051218|NCT02714218|530350128|FG001|Treatment Period|Participant withdrew consent|2|||
147051219|NCT02714218|530350129|FG002|Treatment Period|Participant withdrew consent|0|||
147051220|NCT02714218|530350127|FG000|Treatment Period|Maximum clinical benefit|4|||
147051221|NCT02714218|530350128|FG001|Treatment Period|Maximum clinical benefit|2|||
147051222|NCT02714218|530350129|FG002|Treatment Period|Maximum clinical benefit|0|||
147051223|NCT02714218|530350127|FG000|Treatment Period|Administrative reason by sponsor|2|||
147051224|NCT02714218|530350128|FG001|Treatment Period|Administrative reason by sponsor|1|||
147051225|NCT02714218|530350129|FG002|Treatment Period|Administrative reason by sponsor|0|||
147051226|NCT02714218|530350127|FG000|Treatment Period|Other reasons|6|||
147051227|NCT02714218|530350128|FG001|Treatment Period|Other reasons|6|||
147051228|NCT02714218|530350129|FG002|Treatment Period|Other reasons|0|||
147051229|NCT02714218|530350127|FG000|Treatment Period|Completed treatment as per protocol|36|||
147051230|NCT02714218|530350128|FG001|Treatment Period|Completed treatment as per protocol|27|||
147051231|NCT02714218|530350129|FG002|Treatment Period|Completed treatment as per protocol|3|||
147051232|NCT02714218|530350127|FG000|Treatment Period|Not reported|9|||
147051233|NCT02714218|530350128|FG001|Treatment Period|Not reported|6|||
147051234|NCT02714218|530350129|FG002|Treatment Period|Not reported|0|||
147051235|NCT01199939|530350132|FG000|Overall Study|Adverse Event|4|||
147051236|NCT01199939|530350132|FG000|Overall Study|Protocol Violation|3|||
147051237|NCT01199939|530350132|FG000|Overall Study|Lost to Follow-up|2|||
147051238|NCT01199939|530350132|FG000|Overall Study|Reached a virologic endpoint|4|||
147051239|NCT00882518|530350133|FG000|Overall Study|Adverse Event|9|||
147051240|NCT00882518|530350134|FG001|Overall Study|Adverse Event|18|||
147051241|NCT00882518|530350133|FG000|Overall Study|Withdrawal by Subject|9|||
147051242|NCT00882518|530350134|FG001|Overall Study|Withdrawal by Subject|13|||
147051243|NCT00882518|530350133|FG000|Overall Study|Lack of Efficacy|12|||
147051244|NCT00882518|530350134|FG001|Overall Study|Lack of Efficacy|9|||
147051245|NCT00882518|530350133|FG000|Overall Study|Severe non-compliance to protocol|3|||
147051246|NCT00882518|530350134|FG001|Overall Study|Severe non-compliance to protocol|1|||
147051247|NCT00882518|530350133|FG000|Overall Study|Incorrect enrolment|4|||
147051248|NCT00882518|530350134|FG001|Overall Study|Incorrect enrolment|2|||
147051249|NCT00882518|530350133|FG000|Overall Study|Central lab closure for National day|1|||
147051250|NCT00882518|530350134|FG001|Overall Study|Central lab closure for National day|0|||
147051251|NCT00882518|530350133|FG000|Overall Study|Allocating random number by mistake|0|||
147051252|NCT00882518|530350134|FG001|Overall Study|Allocating random number by mistake|1|||
147051253|NCT03238651|530350135|FG000|Overall Study|Other|0|||
147051254|NCT03238651|530350136|FG001|Overall Study|Other|0|||
147051255|NCT03238651|530350137|FG002|Overall Study|Other|0|||
147051256|NCT03238651|530350138|FG003|Overall Study|Other|0|||
147051257|NCT03238651|530350139|FG004|Overall Study|Other|1|||
147051258|NCT03238651|530350135|FG000|Overall Study|Progressive Disease|2|||
147051259|NCT03238651|530350136|FG001|Overall Study|Progressive Disease|2|||
147051260|NCT03238651|530350137|FG002|Overall Study|Progressive Disease|2|||
147051261|NCT03238651|530350138|FG003|Overall Study|Progressive Disease|2|||
147051262|NCT03238651|530350139|FG004|Overall Study|Progressive Disease|0|||
147051263|NCT03238651|530350135|FG000|Overall Study|Withdrawal by Subject|0|||
147051264|NCT03238651|530350136|FG001|Overall Study|Withdrawal by Subject|1|||
147051265|NCT03238651|530350137|FG002|Overall Study|Withdrawal by Subject|0|||
147051266|NCT03238651|530350138|FG003|Overall Study|Withdrawal by Subject|1|||
147051267|NCT03238651|530350139|FG004|Overall Study|Withdrawal by Subject|0|||
147051268|NCT03238651|530350135|FG000|Overall Study|Adverse Event|1|||
147051269|NCT03238651|530350136|FG001|Overall Study|Adverse Event|3|||
147051270|NCT03238651|530350137|FG002|Overall Study|Adverse Event|2|||
147051271|NCT03238651|530350138|FG003|Overall Study|Adverse Event|0|||
147051272|NCT03238651|530350139|FG004|Overall Study|Adverse Event|0|||
147051273|NCT02289729|530350140|FG000|Overall Study|Lack of Efficacy|3|||
147051274|NCT02289729|530350140|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
147051275|NCT02289729|530350140|FG000|Overall Study|Withdrawal by Subject|1|||
147051276|NCT02289729|530350140|FG000|Overall Study|Death|1|||
147051277|NCT00931411|530350141|FG000|First Intervention - 42 Days|Adverse Event|2|||
147051278|NCT00931411|530350142|FG001|First Intervention - 42 Days|Adverse Event|3|||
147051279|NCT00931411|530350141|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
147051280|NCT00931411|530350142|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
147051281|NCT00931411|530350141|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
147051282|NCT00931411|530350142|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
147051283|NCT01949662|530350143|FG000|Overall Study|Death|9|||
147051284|NCT01949662|530350144|FG001|Overall Study|Death|7|||
147051285|NCT01949662|530350143|FG000|Overall Study|Discharged before an agitation event|8|||
147051286|NCT01949662|530350144|FG001|Overall Study|Discharged before an agitation event|3|||
147051287|NCT01949662|530350143|FG000|Overall Study|Dropped out|1|||
147051288|NCT01949662|530350144|FG001|Overall Study|Dropped out|3|||
147051289|NCT01949662|530350143|FG000|Overall Study|Ineligible|0|||
147051290|NCT01949662|530350144|FG001|Overall Study|Ineligible|1|||
147051291|NCT02291237|530350145|FG000|Overall Study|Study Terminated by Sponsor|72|||
147051292|NCT02291237|530350146|FG001|Overall Study|Study Terminated by Sponsor|67|||
147051293|NCT02291237|530350145|FG000|Overall Study|Adverse Event|1|||
147051294|NCT02291237|530350146|FG001|Overall Study|Adverse Event|3|||
147051295|NCT02291237|530350145|FG000|Overall Study|Investigator's Discretion|0|||
147051296|NCT02291237|530350146|FG001|Overall Study|Investigator's Discretion|3|||
147051297|NCT02291237|530350145|FG000|Overall Study|Withdrew Consent|11|||
147051298|NCT02291237|530350146|FG001|Overall Study|Withdrew Consent|11|||
147051299|NCT02291237|530350145|FG000|Overall Study|Lost to Follow-up|0|||
147051300|NCT02291237|530350146|FG001|Overall Study|Lost to Follow-up|2|||
147051301|NCT02291237|530350145|FG000|Overall Study|Subject Required Prohibited Medication|2|||
147051302|NCT02291237|530350146|FG001|Overall Study|Subject Required Prohibited Medication|0|||
147051303|NCT00729937|530350149|FG000|Overall Study|Lost to Follow-up|49|||
147051304|NCT00729937|530350150|FG001|Overall Study|Lost to Follow-up|58|||
147051305|NCT00729937|530350151|FG002|Overall Study|Lost to Follow-up|18|||
147051306|NCT00729937|530350152|FG003|Overall Study|Lost to Follow-up|33|||
147051307|NCT00729937|530350153|FG004|Overall Study|Lost to Follow-up|18|||
147051308|NCT00729937|530350154|FG005|Overall Study|Lost to Follow-up|23|||
147051309|NCT00729937|530350149|FG000|Overall Study|Physician Decision|7|||
147051310|NCT00729937|530350150|FG001|Overall Study|Physician Decision|16|||
147051311|NCT00729937|530350151|FG002|Overall Study|Physician Decision|2|||
147051312|NCT00729937|530350152|FG003|Overall Study|Physician Decision|0|||
147051313|NCT00729937|530350153|FG004|Overall Study|Physician Decision|5|||
147051314|NCT00729937|530350154|FG005|Overall Study|Physician Decision|8|||
147051315|NCT00729937|530350149|FG000|Overall Study|Death|1|||
147051316|NCT00729937|530350150|FG001|Overall Study|Death|0|||
147051317|NCT00729937|530350151|FG002|Overall Study|Death|1|||
147051318|NCT00729937|530350152|FG003|Overall Study|Death|0|||
147051319|NCT00729937|530350153|FG004|Overall Study|Death|0|||
147051320|NCT00729937|530350154|FG005|Overall Study|Death|1|||
147051321|NCT00729937|530350149|FG000|Overall Study|Withdrawal by Subject|3|||
147051322|NCT00729937|530350150|FG001|Overall Study|Withdrawal by Subject|5|||
147051323|NCT00729937|530350151|FG002|Overall Study|Withdrawal by Subject|6|||
147051324|NCT00729937|530350152|FG003|Overall Study|Withdrawal by Subject|0|||
147051325|NCT00729937|530350153|FG004|Overall Study|Withdrawal by Subject|4|||
147051326|NCT00729937|530350154|FG005|Overall Study|Withdrawal by Subject|2|||
147051327|NCT00729937|530350149|FG000|Overall Study|Randomized but not treated|12|||
147051328|NCT00729937|530350150|FG001|Overall Study|Randomized but not treated|6|||
147051329|NCT00729937|530350151|FG002|Overall Study|Randomized but not treated|1|||
147051330|NCT00729937|530350152|FG003|Overall Study|Randomized but not treated|0|||
147051331|NCT00729937|530350153|FG004|Overall Study|Randomized but not treated|1|||
147051332|NCT00729937|530350154|FG005|Overall Study|Randomized but not treated|3|||
147051333|NCT00729937|530350149|FG000|Overall Study|Did not meet eligibility criteria|2|||
147051334|NCT00729937|530350150|FG001|Overall Study|Did not meet eligibility criteria|1|||
147051335|NCT00729937|530350151|FG002|Overall Study|Did not meet eligibility criteria|0|||
147051336|NCT00729937|530350152|FG003|Overall Study|Did not meet eligibility criteria|0|||
146850048|NCT01631227|529620701|FG000|Overall Study|withdrawn consent|27|||
146850049|NCT01631227|529620702|FG001|Overall Study|withdrawn consent|21|||
147051337|NCT00729937|530350153|FG004|Overall Study|Did not meet eligibility criteria|0|||
147051338|NCT00729937|530350154|FG005|Overall Study|Did not meet eligibility criteria|0|||
147051339|NCT00729937|530350149|FG000|Overall Study|Incarcerated|0|||
147051340|NCT00729937|530350150|FG001|Overall Study|Incarcerated|2|||
147051341|NCT00729937|530350151|FG002|Overall Study|Incarcerated|1|||
147051342|NCT00729937|530350152|FG003|Overall Study|Incarcerated|1|||
147051343|NCT00729937|530350153|FG004|Overall Study|Incarcerated|0|||
147051344|NCT00729937|530350154|FG005|Overall Study|Incarcerated|0|||
147051345|NCT01478373|530350156|FG000|Treatment Phase|Protocol Violation|1|||
147051346|NCT01478373|530350156|FG000|Survival Phase|Adverse Event|8|||
147051347|NCT01478373|530350156|FG000|Survival Phase|Protocol Violation|1|||
147051348|NCT01478373|530350156|FG000|Survival Phase|crossover to another study|2|||
147051349|NCT01478373|530350156|FG000|Survival Phase|Progressive Disease|27|||
147051350|NCT01074944|530350159|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
147051351|NCT01074944|530350160|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
147051352|NCT01074944|530350161|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
147051353|NCT01074944|530350162|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
147051354|NCT01074944|530350163|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
147051355|NCT01074944|530350159|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
147051356|NCT01074944|530350160|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
147051357|NCT01074944|530350161|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
147051358|NCT01074944|530350162|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
147051359|NCT01074944|530350163|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
147051360|NCT01074944|530350159|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
147051361|NCT01074944|530350160|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
147051362|NCT01074944|530350161|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
147051363|NCT01074944|530350162|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
147051364|NCT01074944|530350163|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
147051365|NCT01074944|530350159|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
147051366|NCT01074944|530350160|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
147051367|NCT01074944|530350161|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
147051368|NCT01074944|530350162|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
147051369|NCT01074944|530350163|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
147051370|NCT01074944|530350159|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
147051371|NCT01074944|530350160|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
147051372|NCT01074944|530350161|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
147051373|NCT01074944|530350162|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
147051374|NCT01074944|530350163|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
147051375|NCT01074944|530350159|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
147051376|NCT01074944|530350160|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
147051377|NCT01074944|530350161|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
147051378|NCT01074944|530350162|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
147051379|NCT01074944|530350163|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
147051380|NCT01074944|530350159|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
147051381|NCT01074944|530350160|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
147051382|NCT01074944|530350161|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
147051383|NCT01074944|530350162|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
147051384|NCT01074944|530350163|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
147051385|NCT01074944|530350159|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
147051386|NCT01074944|530350160|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
147051387|NCT01074944|530350161|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
147051388|NCT01074944|530350162|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
147051389|NCT01074944|530350163|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
147051390|NCT01074944|530350159|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
147051391|NCT01074944|530350160|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
147051392|NCT01074944|530350161|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
147051393|NCT01074944|530350162|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
147051394|NCT01074944|530350163|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
147051395|NCT01074944|530350159|FG000|Long Term Treatment|Adverse Event|0|||
147051396|NCT01074944|530350160|FG001|Long Term Treatment|Adverse Event|0|||
147051397|NCT01074944|530350161|FG002|Long Term Treatment|Adverse Event|0|||
147051398|NCT01074944|530350162|FG003|Long Term Treatment|Adverse Event|3|||
147051399|NCT01074944|530350163|FG004|Long Term Treatment|Adverse Event|0|||
147051400|NCT01074944|530350159|FG000|Long Term Treatment|Lost to Follow-up|0|||
147051401|NCT01074944|530350160|FG001|Long Term Treatment|Lost to Follow-up|0|||
147051402|NCT01074944|530350161|FG002|Long Term Treatment|Lost to Follow-up|0|||
147051403|NCT01074944|530350162|FG003|Long Term Treatment|Lost to Follow-up|2|||
147051404|NCT01074944|530350163|FG004|Long Term Treatment|Lost to Follow-up|0|||
147051405|NCT01074944|530350159|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
147051406|NCT01074944|530350160|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
147051407|NCT01074944|530350161|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
147051408|NCT01074944|530350162|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
147051409|NCT01074944|530350163|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
147051410|NCT01074944|530350159|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
147051411|NCT01074944|530350160|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
147051412|NCT01074944|530350161|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
147051413|NCT01074944|530350162|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
147051414|NCT01074944|530350163|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
147051415|NCT01074944|530350159|FG000|Long Term Treatment|Withdrawal by Subject|0|||
147051416|NCT01074944|530350160|FG001|Long Term Treatment|Withdrawal by Subject|0|||
147051417|NCT01074944|530350161|FG002|Long Term Treatment|Withdrawal by Subject|0|||
147051418|NCT01074944|530350162|FG003|Long Term Treatment|Withdrawal by Subject|2|||
147051419|NCT01074944|530350163|FG004|Long Term Treatment|Withdrawal by Subject|0|||
147051420|NCT01074944|530350159|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
147051421|NCT01074944|530350160|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
147051422|NCT01074944|530350161|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
147051423|NCT01074944|530350162|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
147051424|NCT01074944|530350163|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
147051425|NCT01074944|530350159|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
147051426|NCT01074944|530350160|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
147051427|NCT01074944|530350161|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
147051428|NCT01074944|530350162|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
147051429|NCT01074944|530350163|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
147051430|NCT01408043|530350165|FG000|Overall Study|unable to collect cells|1|||
147051431|NCT00972595|530350171|FG000|Period 1|Adverse Event|1|||
147051432|NCT00972595|530350172|FG001|Period 1|Adverse Event|0|||
147051433|NCT02586155|530350173|FG000|Overall Study|Adverse Event|2|||
147051434|NCT02586155|530350174|FG001|Overall Study|Adverse Event|3|||
147051435|NCT02586155|530350173|FG000|Overall Study|Withdrawal by Subject|31|||
147051436|NCT02586155|530350174|FG001|Overall Study|Withdrawal by Subject|24|||
147051437|NCT02586155|530350173|FG000|Overall Study|Lost to Follow-up|7|||
147051438|NCT02586155|530350174|FG001|Overall Study|Lost to Follow-up|13|||
147051439|NCT02586155|530350173|FG000|Overall Study|Death|61|||
147051440|NCT02586155|530350174|FG001|Overall Study|Death|72|||
147051441|NCT02586155|530350173|FG000|Overall Study|Other reasons|26|||
147051442|NCT02586155|530350174|FG001|Overall Study|Other reasons|15|||
147051443|NCT01522456|530350175|FG000|Overall Study|Adverse Event|2|||
147051444|NCT01522456|530350175|FG000|Overall Study|Lost to Follow-up|2|||
147051445|NCT01522456|530350175|FG000|Overall Study|Withdrawal by Subject|2|||
147051446|NCT01522456|530350175|FG000|Overall Study|Pregnancy|1|||
147051447|NCT01522456|530350175|FG000|Overall Study|Tolerability Assessment|1|||
147051448|NCT02072980|530350177|FG000|Period 2, Second Wear|Adverse Event|0|||
147051449|NCT02072980|530350178|FG001|Period 2, Second Wear|Adverse Event|1|||
147051450|NCT02431364|530350179|FG000|Overall Study|Adverse Event|0|||
147051451|NCT02431364|530350180|FG001|Overall Study|Adverse Event|1|||
147051452|NCT02431364|530350181|FG002|Overall Study|Adverse Event|0|||
147051453|NCT02431364|530350182|FG003|Overall Study|Adverse Event|0|||
147051454|NCT02431364|530350183|FG004|Overall Study|Adverse Event|0|||
147051455|NCT02431364|530350179|FG000|Overall Study|Randomized but never treated|0|||
147051456|NCT02431364|530350180|FG001|Overall Study|Randomized but never treated|0|||
147051457|NCT02431364|530350181|FG002|Overall Study|Randomized but never treated|0|||
147051458|NCT02431364|530350182|FG003|Overall Study|Randomized but never treated|1|||
147051459|NCT02431364|530350183|FG004|Overall Study|Randomized but never treated|0|||
147051460|NCT02601014|530350184|FG000|Overall Study|Adverse Event|3|||
147051461|NCT02601014|530350185|FG001|Overall Study|Adverse Event|3|||
147051462|NCT02601014|530350184|FG000|Overall Study|Death|3|||
147051463|NCT02601014|530350185|FG001|Overall Study|Death|1|||
147051464|NCT02601014|530350184|FG000|Overall Study|Disease progression|4|||
147051465|NCT02601014|530350185|FG001|Overall Study|Disease progression|8|||
147051466|NCT01168427|530350186|FG000|Overall Study|Patient exited prior to implant|1|||
147051467|NCT01256879|530350189|FG000|Overall Study|Withdrawal by Subject|1|||
147051468|NCT00397514|530350190|FG000|Overall Study|Withdrawal by Subject|1|||
147051469|NCT00397514|530350190|FG000|Overall Study|Pacing wire malfunction|1|||
147051470|NCT00397514|530350190|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
147051471|NCT00397514|530350190|FG000|Overall Study|early extubation|2|||
147051472|NCT00397514|530350190|FG000|Overall Study|poor echocardiographic windows|1|||
147051473|NCT00445146|530350192|FG000|Overall Study|Withdrew Consent|29|||
147051474|NCT00445146|530350192|FG000|Overall Study|Lack of Efficacy|28|||
147051475|NCT00445146|530350192|FG000|Overall Study|Investigator's Discretion|22|||
147051476|NCT00445146|530350192|FG000|Overall Study|Adverse Event|13|||
147051477|NCT00445146|530350192|FG000|Overall Study|Lost to Follow-up|13|||
147051478|NCT00445146|530350192|FG000|Overall Study|Death|9|||
147051479|NCT00445146|530350192|FG000|Overall Study|Protocol Violation|4|||
147051480|NCT00445146|530350192|FG000|Overall Study|Pregnancy|1|||
147051481|NCT00640315|530350193|FG000|Overall Study|Withdrawal by Subject|0|||
147051482|NCT00640315|530350194|FG001|Overall Study|Withdrawal by Subject|1|||
147051483|NCT00725920|530350196|FG000|Overall Study|Lack of Efficacy|3|||
147051484|NCT00725920|530350197|FG001|Overall Study|Lack of Efficacy|6|||
147051485|NCT02623725|530350198|FG000|Overall Study|Non compliance with protocol|9|||
147051486|NCT02623725|530350199|FG001|Overall Study|Non compliance with protocol|3|||
147051487|NCT02623725|530350198|FG000|Overall Study|Serious adverse event|0|||
147051488|NCT02623725|530350199|FG001|Overall Study|Serious adverse event|2|||
147051489|NCT02623725|530350198|FG000|Overall Study|Withdrawal by Subject|7|||
147051490|NCT02623725|530350199|FG001|Overall Study|Withdrawal by Subject|1|||
147051491|NCT04720105|530350202|FG000|Overall Study|Lack of Efficacy|1|||
147051492|NCT04720105|530350202|FG000|Overall Study|Lost to Follow-up|1|||
147051493|NCT04720105|530350202|FG000|Overall Study|Withdrawal by Subject|3|||
147051494|NCT02892331|530350203|FG000|Overall Study|Withdrawal by Subject|0|||
147051495|NCT02892331|530350204|FG001|Overall Study|Withdrawal by Subject|1|||
147051496|NCT02892331|530350205|FG002|Overall Study|Withdrawal by Subject|1|||
147051497|NCT02892331|530350203|FG000|Overall Study|Sick family member|0|||
147051498|NCT02892331|530350204|FG001|Overall Study|Sick family member|0|||
147051499|NCT02892331|530350205|FG002|Overall Study|Sick family member|1|||
147051500|NCT02892331|530350203|FG000|Overall Study|Corona virus pandemic|1|||
147051501|NCT02892331|530350204|FG001|Overall Study|Corona virus pandemic|0|||
147051502|NCT02892331|530350205|FG002|Overall Study|Corona virus pandemic|1|||
147051503|NCT02892331|530350203|FG000|Overall Study|Lost to Follow-up|1|||
147051504|NCT02892331|530350204|FG001|Overall Study|Lost to Follow-up|0|||
147051505|NCT02892331|530350205|FG002|Overall Study|Lost to Follow-up|1|||
147051506|NCT02892331|530350203|FG000|Overall Study|Blood pressure was too elevated|0|||
147051507|NCT02892331|530350204|FG001|Overall Study|Blood pressure was too elevated|1|||
147051508|NCT02892331|530350205|FG002|Overall Study|Blood pressure was too elevated|0|||
147051509|NCT02892331|530350203|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
147051510|NCT02892331|530350204|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
147051511|NCT02892331|530350205|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
147051512|NCT02286713|530350207|FG000|One Week Follow-Up|Death|1|||
147051513|NCT02286713|530350208|FG001|One Week Follow-Up|Death|0|||
147051514|NCT02286713|530350207|FG000|One Week Follow-Up|Lost to Follow-up|17|||
147051515|NCT02286713|530350208|FG001|One Week Follow-Up|Lost to Follow-up|21|||
147051516|NCT02286713|530350207|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
147051517|NCT02286713|530350208|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
147051518|NCT02286713|530350207|FG000|Three Month Follow-Up|Death|1|||
147051519|NCT02286713|530350208|FG001|Three Month Follow-Up|Death|1|||
147051520|NCT02286713|530350207|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
147051521|NCT02286713|530350208|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
147051522|NCT02286713|530350207|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
147051523|NCT02286713|530350208|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
147051524|NCT02286713|530350207|FG000|Six Month Follow-Up|Death|2|||
147051525|NCT02286713|530350208|FG001|Six Month Follow-Up|Death|0|||
147051526|NCT02286713|530350207|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
147051527|NCT02286713|530350208|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
147051528|NCT02654054|530350209|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
147051529|NCT02654054|530350210|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
147051530|NCT02654054|530350211|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
147051531|NCT02654054|530350209|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
147051532|NCT02654054|530350210|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147051533|NCT02654054|530350211|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
147051534|NCT02654054|530350209|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
147051535|NCT02654054|530350210|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
147051536|NCT02654054|530350211|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
147051537|NCT02654054|530350209|FG000|Post-Treatment Follow-Up Period|Other|1|||
147051538|NCT02654054|530350210|FG001|Post-Treatment Follow-Up Period|Other|0|||
147051539|NCT02654054|530350211|FG002|Post-Treatment Follow-Up Period|Other|4|||
147051540|NCT02654054|530350209|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
147051541|NCT02654054|530350210|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
147051542|NCT02654054|530350211|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
147051543|NCT06018129|530350214|FG000|Overall Study|Death|1|||
147051544|NCT06018129|530350215|FG001|Overall Study|Death|1|||
147051545|NCT06018129|530350216|FG002|Overall Study|Death|2|||
147051546|NCT06018129|530350214|FG000|Overall Study|Sponsor Decision|2|||
147051547|NCT06018129|530350215|FG001|Overall Study|Sponsor Decision|2|||
147051548|NCT06018129|530350216|FG002|Overall Study|Sponsor Decision|1|||
147051549|NCT00070564|530352436|FG000|Overall Study|Progression|2|||
147051550|NCT00070564|530352437|FG001|Overall Study|Progression|4|||
147051551|NCT00070564|530352438|FG002|Overall Study|Progression|7|||
147051552|NCT00070564|530352439|FG003|Overall Study|Progression|7|||
147051553|NCT00070564|530352440|FG004|Overall Study|Progression|1|||
147051554|NCT00070564|530352441|FG005|Overall Study|Progression|0|||
147051555|NCT00070564|530352436|FG000|Overall Study|Delinquent|1|||
147051556|NCT00070564|530352437|FG001|Overall Study|Delinquent|4|||
147051557|NCT00070564|530352438|FG002|Overall Study|Delinquent|2|||
147051558|NCT00070564|530352439|FG003|Overall Study|Delinquent|0|||
147051559|NCT00070564|530352440|FG004|Overall Study|Delinquent|0|||
147051560|NCT00070564|530352441|FG005|Overall Study|Delinquent|0|||
147051561|NCT00070564|530352436|FG000|Overall Study|Adverse Event|150|||
147051562|NCT00070564|530352437|FG001|Overall Study|Adverse Event|142|||
147051563|NCT00070564|530352438|FG002|Overall Study|Adverse Event|120|||
147051564|NCT00070564|530352439|FG003|Overall Study|Adverse Event|108|||
147051565|NCT00070564|530352440|FG004|Overall Study|Adverse Event|63|||
147051566|NCT00070564|530352441|FG005|Overall Study|Adverse Event|36|||
147051567|NCT00070564|530352436|FG000|Overall Study|Death|4|||
147051568|NCT00070564|530352437|FG001|Overall Study|Death|1|||
147051569|NCT00070564|530352438|FG002|Overall Study|Death|5|||
147051570|NCT00070564|530352439|FG003|Overall Study|Death|3|||
147051571|NCT00070564|530352440|FG004|Overall Study|Death|0|||
147051572|NCT00070564|530352441|FG005|Overall Study|Death|1|||
147051573|NCT00070564|530352436|FG000|Overall Study|Other, not protocol specified|17|||
147051574|NCT00070564|530352437|FG001|Overall Study|Other, not protocol specified|15|||
147051575|NCT00070564|530352438|FG002|Overall Study|Other, not protocol specified|14|||
147051576|NCT00070564|530352439|FG003|Overall Study|Other, not protocol specified|19|||
147051577|NCT00070564|530352440|FG004|Overall Study|Other, not protocol specified|6|||
147051578|NCT00070564|530352441|FG005|Overall Study|Other, not protocol specified|7|||
147051579|NCT00070564|530352436|FG000|Overall Study|Withdrawal by Subject|26|||
147051580|NCT00070564|530352437|FG001|Overall Study|Withdrawal by Subject|37|||
147051581|NCT00070564|530352438|FG002|Overall Study|Withdrawal by Subject|23|||
147051582|NCT00070564|530352439|FG003|Overall Study|Withdrawal by Subject|30|||
147051583|NCT00070564|530352440|FG004|Overall Study|Withdrawal by Subject|8|||
147051584|NCT00070564|530352441|FG005|Overall Study|Withdrawal by Subject|8|||
147051585|NCT00070564|530352436|FG000|Overall Study|Not reported|0|||
147051586|NCT00070564|530352437|FG001|Overall Study|Not reported|0|||
147051587|NCT00070564|530352438|FG002|Overall Study|Not reported|0|||
147051588|NCT00070564|530352439|FG003|Overall Study|Not reported|0|||
147051589|NCT00070564|530352440|FG004|Overall Study|Not reported|1|||
147051590|NCT00070564|530352441|FG005|Overall Study|Not reported|0|||
147051591|NCT04796961|530352442|FG000|Overall Study|Lost to Follow-up|10|||
147051592|NCT04796961|530352442|FG000|Overall Study|Withdrawal by Subject|3|||
147051593|NCT04796961|530352442|FG000|Overall Study|Left Organization|10|||
147051594|NCT02325973|530352445|FG000|Overall Study|Death|5|||
147051595|NCT02325973|530352445|FG000|Overall Study|Withdrawal by subject or investigator|16|||
147051596|NCT02513160|530352446|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
147051597|NCT02513160|530352447|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
147051598|NCT02513160|530352448|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
147051599|NCT02513160|530352449|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
147051600|NCT02513160|530352446|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
147051601|NCT02513160|530352447|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
147051602|NCT02513160|530352448|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
147051603|NCT02513160|530352449|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
147051604|NCT02513160|530352446|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
147051605|NCT02513160|530352447|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
147051606|NCT02513160|530352448|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
147051607|NCT02513160|530352449|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
147051608|NCT02513160|530352446|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
147051609|NCT02513160|530352447|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
147051610|NCT02513160|530352448|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
147051611|NCT02513160|530352449|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
147051612|NCT02513160|530352446|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
147051613|NCT02513160|530352447|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
147051614|NCT02513160|530352448|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
147051615|NCT02513160|530352449|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
147051616|NCT02513160|530352446|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
147051617|NCT02513160|530352447|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
147051618|NCT02513160|530352448|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
147051619|NCT02513160|530352449|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
147051620|NCT02513160|530352446|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
147051621|NCT02513160|530352447|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
147051622|NCT02513160|530352448|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
147051623|NCT02513160|530352449|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
147051624|NCT02513160|530352446|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
147051625|NCT02513160|530352447|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
147051626|NCT02513160|530352448|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
147051627|NCT02513160|530352449|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
147051628|NCT02513160|530352446|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
147051629|NCT02513160|530352447|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
147051630|NCT02513160|530352448|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
147051631|NCT02513160|530352449|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
147051632|NCT02513160|530352446|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
147051633|NCT02513160|530352447|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
147051634|NCT02513160|530352448|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
147051635|NCT02513160|530352449|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
147051636|NCT02513160|530352446|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
147051637|NCT02513160|530352447|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
147051638|NCT02513160|530352448|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
147051639|NCT02513160|530352449|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
147051640|NCT02513160|530352446|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
147051641|NCT02513160|530352447|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
147051642|NCT02513160|530352448|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
147051643|NCT02513160|530352449|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
147051644|NCT03428958|530352453|FG000|Overall Study|Adverse Event|0|||
147051645|NCT03428958|530352454|FG001|Overall Study|Adverse Event|0|||
147051646|NCT03428958|530352455|FG002|Overall Study|Adverse Event|0|||
147051647|NCT03428958|530352456|FG003|Overall Study|Adverse Event|1|||
147051648|NCT03428958|530352457|FG004|Overall Study|Adverse Event|0|||
147051649|NCT03428958|530352458|FG005|Overall Study|Adverse Event|2|||
147051650|NCT03428958|530352459|FG006|Overall Study|Adverse Event|1|||
147051651|NCT03428958|530352460|FG007|Overall Study|Adverse Event|0|||
147051652|NCT03428958|530352461|FG008|Overall Study|Adverse Event|0|||
147051653|NCT03428958|530352462|FG009|Overall Study|Adverse Event|0|||
147051654|NCT03428958|530352463|FG010|Overall Study|Adverse Event|0|||
147051655|NCT03428958|530352464|FG011|Overall Study|Adverse Event|0|||
147051656|NCT03428958|530352465|FG012|Overall Study|Adverse Event|0|||
147051657|NCT03428958|530352466|FG013|Overall Study|Adverse Event|0|||
147051658|NCT03428958|530352467|FG014|Overall Study|Adverse Event|0|||
147051659|NCT03428958|530352468|FG015|Overall Study|Adverse Event|0|||
147051660|NCT03428958|530352469|FG016|Overall Study|Adverse Event|0|||
147051661|NCT03428958|530352453|FG000|Overall Study|Clinical Progression|2|||
147051662|NCT03428958|530352454|FG001|Overall Study|Clinical Progression|3|||
147051663|NCT03428958|530352455|FG002|Overall Study|Clinical Progression|2|||
147051664|NCT03428958|530352456|FG003|Overall Study|Clinical Progression|1|||
147051665|NCT03428958|530352457|FG004|Overall Study|Clinical Progression|0|||
147051666|NCT03428958|530352458|FG005|Overall Study|Clinical Progression|2|||
147051667|NCT03428958|530352459|FG006|Overall Study|Clinical Progression|0|||
147051668|NCT03428958|530352460|FG007|Overall Study|Clinical Progression|0|||
147051669|NCT03428958|530352461|FG008|Overall Study|Clinical Progression|0|||
147051670|NCT03428958|530352462|FG009|Overall Study|Clinical Progression|0|||
147051671|NCT03428958|530352463|FG010|Overall Study|Clinical Progression|0|||
147051672|NCT03428958|530352464|FG011|Overall Study|Clinical Progression|0|||
147051673|NCT03428958|530352465|FG012|Overall Study|Clinical Progression|0|||
147051674|NCT03428958|530352466|FG013|Overall Study|Clinical Progression|0|||
147051675|NCT03428958|530352467|FG014|Overall Study|Clinical Progression|0|||
147051676|NCT03428958|530352468|FG015|Overall Study|Clinical Progression|0|||
147051677|NCT03428958|530352469|FG016|Overall Study|Clinical Progression|0|||
147051678|NCT03428958|530352453|FG000|Overall Study|Progression per RECIST|6|||
147051679|NCT03428958|530352454|FG001|Overall Study|Progression per RECIST|6|||
147051680|NCT03428958|530352455|FG002|Overall Study|Progression per RECIST|7|||
147051681|NCT03428958|530352456|FG003|Overall Study|Progression per RECIST|4|||
147051682|NCT03428958|530352457|FG004|Overall Study|Progression per RECIST|0|||
147051683|NCT03428958|530352458|FG005|Overall Study|Progression per RECIST|7|||
147051684|NCT03428958|530352459|FG006|Overall Study|Progression per RECIST|8|||
147051685|NCT03428958|530352460|FG007|Overall Study|Progression per RECIST|0|||
147051686|NCT03428958|530352461|FG008|Overall Study|Progression per RECIST|0|||
147051687|NCT03428958|530352462|FG009|Overall Study|Progression per RECIST|0|||
147051688|NCT03428958|530352463|FG010|Overall Study|Progression per RECIST|0|||
147051689|NCT03428958|530352464|FG011|Overall Study|Progression per RECIST|0|||
147051690|NCT03428958|530352465|FG012|Overall Study|Progression per RECIST|1|||
147051691|NCT03428958|530352466|FG013|Overall Study|Progression per RECIST|0|||
147051692|NCT03428958|530352467|FG014|Overall Study|Progression per RECIST|0|||
147051693|NCT03428958|530352468|FG015|Overall Study|Progression per RECIST|0|||
147051694|NCT03428958|530352469|FG016|Overall Study|Progression per RECIST|0|||
147051695|NCT03428958|530352453|FG000|Overall Study|Death|2|||
147051696|NCT03428958|530352454|FG001|Overall Study|Death|2|||
147051697|NCT03428958|530352455|FG002|Overall Study|Death|0|||
147051698|NCT03428958|530352456|FG003|Overall Study|Death|0|||
147051699|NCT03428958|530352457|FG004|Overall Study|Death|0|||
147051700|NCT03428958|530352458|FG005|Overall Study|Death|7|||
147051701|NCT03428958|530352459|FG006|Overall Study|Death|9|||
146850050|NCT01631227|529620701|FG000|Overall Study|Adverse Event|1|||
146850051|NCT01631227|529620702|FG001|Overall Study|Adverse Event|0|||
147051702|NCT03428958|530352460|FG007|Overall Study|Death|6|||
147051703|NCT03428958|530352461|FG008|Overall Study|Death|0|||
147051704|NCT03428958|530352462|FG009|Overall Study|Death|0|||
147051705|NCT03428958|530352463|FG010|Overall Study|Death|3|||
147051706|NCT03428958|530352464|FG011|Overall Study|Death|0|||
147051707|NCT03428958|530352465|FG012|Overall Study|Death|4|||
147051708|NCT03428958|530352466|FG013|Overall Study|Death|0|||
147051709|NCT03428958|530352467|FG014|Overall Study|Death|0|||
147051710|NCT03428958|530352468|FG015|Overall Study|Death|0|||
147051711|NCT03428958|530352469|FG016|Overall Study|Death|0|||
147051712|NCT03428958|530352453|FG000|Overall Study|Lost to Follow-up|0|||
147051713|NCT03428958|530352454|FG001|Overall Study|Lost to Follow-up|0|||
147051714|NCT03428958|530352455|FG002|Overall Study|Lost to Follow-up|0|||
147051715|NCT03428958|530352456|FG003|Overall Study|Lost to Follow-up|0|||
147051716|NCT03428958|530352457|FG004|Overall Study|Lost to Follow-up|0|||
147051717|NCT03428958|530352458|FG005|Overall Study|Lost to Follow-up|1|||
147051718|NCT03428958|530352459|FG006|Overall Study|Lost to Follow-up|1|||
147051719|NCT03428958|530352460|FG007|Overall Study|Lost to Follow-up|0|||
147051720|NCT03428958|530352461|FG008|Overall Study|Lost to Follow-up|0|||
147051721|NCT03428958|530352462|FG009|Overall Study|Lost to Follow-up|0|||
147051722|NCT03428958|530352463|FG010|Overall Study|Lost to Follow-up|0|||
147051723|NCT03428958|530352464|FG011|Overall Study|Lost to Follow-up|0|||
147051724|NCT03428958|530352465|FG012|Overall Study|Lost to Follow-up|0|||
147051725|NCT03428958|530352466|FG013|Overall Study|Lost to Follow-up|0|||
147051726|NCT03428958|530352467|FG014|Overall Study|Lost to Follow-up|0|||
147051727|NCT03428958|530352468|FG015|Overall Study|Lost to Follow-up|0|||
147051728|NCT03428958|530352469|FG016|Overall Study|Lost to Follow-up|0|||
147051729|NCT03428958|530352453|FG000|Overall Study|Physician/Sponsor Decision|1|||
147051730|NCT03428958|530352454|FG001|Overall Study|Physician/Sponsor Decision|0|||
147051731|NCT03428958|530352455|FG002|Overall Study|Physician/Sponsor Decision|1|||
147051732|NCT03428958|530352456|FG003|Overall Study|Physician/Sponsor Decision|0|||
147051733|NCT03428958|530352457|FG004|Overall Study|Physician/Sponsor Decision|0|||
147051734|NCT03428958|530352458|FG005|Overall Study|Physician/Sponsor Decision|2|||
147051735|NCT03428958|530352459|FG006|Overall Study|Physician/Sponsor Decision|2|||
147051736|NCT03428958|530352460|FG007|Overall Study|Physician/Sponsor Decision|2|||
147051737|NCT03428958|530352461|FG008|Overall Study|Physician/Sponsor Decision|0|||
147051738|NCT03428958|530352462|FG009|Overall Study|Physician/Sponsor Decision|0|||
147051739|NCT03428958|530352463|FG010|Overall Study|Physician/Sponsor Decision|2|||
147051740|NCT03428958|530352464|FG011|Overall Study|Physician/Sponsor Decision|0|||
147051741|NCT03428958|530352465|FG012|Overall Study|Physician/Sponsor Decision|4|||
147051742|NCT03428958|530352466|FG013|Overall Study|Physician/Sponsor Decision|0|||
147051743|NCT03428958|530352467|FG014|Overall Study|Physician/Sponsor Decision|0|||
147051744|NCT03428958|530352468|FG015|Overall Study|Physician/Sponsor Decision|0|||
147051745|NCT03428958|530352469|FG016|Overall Study|Physician/Sponsor Decision|0|||
147051746|NCT03428958|530352453|FG000|Overall Study|Withdrawal by Subject|0|||
147051747|NCT03428958|530352454|FG001|Overall Study|Withdrawal by Subject|0|||
147051748|NCT03428958|530352455|FG002|Overall Study|Withdrawal by Subject|2|||
147051749|NCT03428958|530352456|FG003|Overall Study|Withdrawal by Subject|0|||
147051750|NCT03428958|530352457|FG004|Overall Study|Withdrawal by Subject|0|||
147051751|NCT03428958|530352458|FG005|Overall Study|Withdrawal by Subject|2|||
147051752|NCT03428958|530352459|FG006|Overall Study|Withdrawal by Subject|4|||
147051753|NCT03428958|530352460|FG007|Overall Study|Withdrawal by Subject|1|||
147051754|NCT03428958|530352461|FG008|Overall Study|Withdrawal by Subject|0|||
147051755|NCT03428958|530352462|FG009|Overall Study|Withdrawal by Subject|0|||
147051756|NCT03428958|530352463|FG010|Overall Study|Withdrawal by Subject|0|||
147051757|NCT03428958|530352464|FG011|Overall Study|Withdrawal by Subject|0|||
147051758|NCT03428958|530352465|FG012|Overall Study|Withdrawal by Subject|0|||
147051759|NCT03428958|530352466|FG013|Overall Study|Withdrawal by Subject|0|||
147051760|NCT03428958|530352467|FG014|Overall Study|Withdrawal by Subject|0|||
147051761|NCT03428958|530352468|FG015|Overall Study|Withdrawal by Subject|0|||
147051762|NCT03428958|530352469|FG016|Overall Study|Withdrawal by Subject|0|||
147051763|NCT03874117|530352470|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
147051764|NCT03874117|530352471|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
147051765|NCT03874117|530352470|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
147051766|NCT03874117|530352471|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
147051767|NCT03874117|530352470|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
147051768|NCT03874117|530352471|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
147051769|NCT03874117|530352470|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
147051770|NCT03874117|530352471|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
147051771|NCT03874117|530352470|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
147051772|NCT03874117|530352471|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
147051773|NCT05012098|530352472|FG000|Overall Study|Disease progression|5|||
147051774|NCT05012098|530352473|FG001|Overall Study|Disease progression|2|||
147051775|NCT05012098|530352472|FG000|Overall Study|Adverse Event|1|||
147051776|NCT05012098|530352473|FG001|Overall Study|Adverse Event|0|||
147051777|NCT05012098|530352472|FG000|Overall Study|Withdrawal by Subject|1|||
147051778|NCT05012098|530352473|FG001|Overall Study|Withdrawal by Subject|0|||
147051779|NCT05012098|530352472|FG000|Overall Study|Discontinuation per protocol|1|||
147051780|NCT05012098|530352473|FG001|Overall Study|Discontinuation per protocol|0|||
147051781|NCT05258773|530352474|FG000|Overall Study|Screen Failure|1|||
147051782|NCT05258773|530352475|FG001|Overall Study|Screen Failure|1|||
147051783|NCT05258773|530352474|FG000|Overall Study|Adverse Event|1|||
147051784|NCT05258773|530352475|FG001|Overall Study|Adverse Event|0|||
147051785|NCT05258773|530352474|FG000|Overall Study|Withdrawal by Subject|0|||
147051786|NCT05258773|530352475|FG001|Overall Study|Withdrawal by Subject|1|||
147051787|NCT03018288|530352476|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
147051788|NCT03018288|530352477|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
147051789|NCT03018288|530352478|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
147051790|NCT03018288|530352479|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
147051791|NCT03018288|530352476|FG000|Overall Study|Participant withdrew consent.|0|||
147051792|NCT03018288|530352477|FG001|Overall Study|Participant withdrew consent.|0|||
147051793|NCT03018288|530352478|FG002|Overall Study|Participant withdrew consent.|1|||
147051794|NCT03018288|530352479|FG003|Overall Study|Participant withdrew consent.|0|||
147051795|NCT03018288|530352476|FG000|Overall Study|Switched to alternative treatment.|0|||
147051796|NCT03018288|530352477|FG001|Overall Study|Switched to alternative treatment.|0|||
147051797|NCT03018288|530352478|FG002|Overall Study|Switched to alternative treatment.|1|||
147051798|NCT03018288|530352479|FG003|Overall Study|Switched to alternative treatment.|0|||
147051799|NCT03018288|530352476|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
147051800|NCT03018288|530352477|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
147051801|NCT03018288|530352478|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
147051802|NCT03018288|530352479|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
147051803|NCT03018288|530352476|FG000|Overall Study|Screen failures|0|||
147051804|NCT03018288|530352477|FG001|Overall Study|Screen failures|0|||
147051805|NCT03018288|530352478|FG002|Overall Study|Screen failures|0|||
147051806|NCT03018288|530352479|FG003|Overall Study|Screen failures|51|||
147051807|NCT03018288|530352476|FG000|Overall Study|Chose treatment outside of UNC|0|||
147051808|NCT03018288|530352477|FG001|Overall Study|Chose treatment outside of UNC|0|||
147051809|NCT03018288|530352478|FG002|Overall Study|Chose treatment outside of UNC|0|||
147051810|NCT03018288|530352479|FG003|Overall Study|Chose treatment outside of UNC|1|||
147051811|NCT03018288|530352476|FG000|Overall Study|Unable to comply with protocol requirements|1|||
147051812|NCT03018288|530352477|FG001|Overall Study|Unable to comply with protocol requirements|1|||
147051813|NCT03018288|530352478|FG002|Overall Study|Unable to comply with protocol requirements|0|||
147051814|NCT03018288|530352479|FG003|Overall Study|Unable to comply with protocol requirements|1|||
147051815|NCT03018288|530352476|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
147051816|NCT03018288|530352477|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
147051817|NCT03018288|530352478|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
147051818|NCT03018288|530352479|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
147051819|NCT03018288|530352476|FG000|Overall Study|Physician Decision|0|||
147051820|NCT03018288|530352477|FG001|Overall Study|Physician Decision|0|||
147051821|NCT03018288|530352478|FG002|Overall Study|Physician Decision|0|||
147051822|NCT03018288|530352479|FG003|Overall Study|Physician Decision|1|||
147051823|NCT01490086|530352483|FG000|Overall Study|Consent withdrawn|4|||
147051824|NCT01490086|530352484|FG001|Overall Study|Consent withdrawn|4|||
147051825|NCT01490086|530352485|FG002|Overall Study|Consent withdrawn|3|||
147051826|NCT01490086|530352486|FG003|Overall Study|Consent withdrawn|0|||
147051827|NCT01490086|530352487|FG004|Overall Study|Consent withdrawn|1|||
147051828|NCT01490086|530352483|FG000|Overall Study|Non-compliance|0|||
147051829|NCT01490086|530352484|FG001|Overall Study|Non-compliance|1|||
147051830|NCT01490086|530352485|FG002|Overall Study|Non-compliance|0|||
147051831|NCT01490086|530352486|FG003|Overall Study|Non-compliance|0|||
147051832|NCT01490086|530352487|FG004|Overall Study|Non-compliance|0|||
147051833|NCT01490086|530352483|FG000|Overall Study|Abnormal laboratory findings|1|||
147051834|NCT01490086|530352484|FG001|Overall Study|Abnormal laboratory findings|0|||
147051835|NCT01490086|530352485|FG002|Overall Study|Abnormal laboratory findings|0|||
147051836|NCT01490086|530352486|FG003|Overall Study|Abnormal laboratory findings|0|||
147051837|NCT01490086|530352487|FG004|Overall Study|Abnormal laboratory findings|0|||
147051838|NCT01490086|530352483|FG000|Overall Study|Lost to Follow-up|0|||
147051839|NCT01490086|530352484|FG001|Overall Study|Lost to Follow-up|0|||
147051840|NCT01490086|530352485|FG002|Overall Study|Lost to Follow-up|0|||
147051841|NCT01490086|530352486|FG003|Overall Study|Lost to Follow-up|0|||
147051842|NCT01490086|530352487|FG004|Overall Study|Lost to Follow-up|1|||
147051843|NCT01490086|530352483|FG000|Overall Study|Physician Decision|3|||
147051844|NCT01490086|530352484|FG001|Overall Study|Physician Decision|4|||
147051845|NCT01490086|530352485|FG002|Overall Study|Physician Decision|2|||
147051846|NCT01490086|530352486|FG003|Overall Study|Physician Decision|3|||
147051847|NCT01490086|530352487|FG004|Overall Study|Physician Decision|1|||
147051848|NCT01490086|530352483|FG000|Overall Study|Adverse Event|0|||
147051849|NCT01490086|530352484|FG001|Overall Study|Adverse Event|0|||
146850052|NCT01631227|529620701|FG000|Overall Study|administrative|2|||
147051850|NCT01490086|530352485|FG002|Overall Study|Adverse Event|1|||
147051851|NCT01490086|530352486|FG003|Overall Study|Adverse Event|2|||
147051852|NCT01490086|530352487|FG004|Overall Study|Adverse Event|0|||
147051853|NCT01490086|530352483|FG000|Overall Study|Lack of Efficacy|0|||
147051854|NCT01490086|530352484|FG001|Overall Study|Lack of Efficacy|3|||
147051855|NCT01490086|530352485|FG002|Overall Study|Lack of Efficacy|1|||
147051856|NCT01490086|530352486|FG003|Overall Study|Lack of Efficacy|0|||
147051857|NCT01490086|530352487|FG004|Overall Study|Lack of Efficacy|8|||
147051858|NCT01490086|530352483|FG000|Overall Study|Worsening of symptoms|0|||
147051859|NCT01490086|530352484|FG001|Overall Study|Worsening of symptoms|1|||
147051860|NCT01490086|530352485|FG002|Overall Study|Worsening of symptoms|0|||
147051861|NCT01490086|530352486|FG003|Overall Study|Worsening of symptoms|1|||
147051862|NCT01490086|530352487|FG004|Overall Study|Worsening of symptoms|0|||
147051863|NCT01490086|530352483|FG000|Overall Study|Subject uncontrollable and abusive|0|||
147051864|NCT01490086|530352484|FG001|Overall Study|Subject uncontrollable and abusive|1|||
147051865|NCT01490086|530352485|FG002|Overall Study|Subject uncontrollable and abusive|0|||
147051866|NCT01490086|530352486|FG003|Overall Study|Subject uncontrollable and abusive|0|||
147051867|NCT01490086|530352487|FG004|Overall Study|Subject uncontrollable and abusive|0|||
147051868|NCT01490086|530352483|FG000|Overall Study|Subject left hospital|0|||
147051869|NCT01490086|530352484|FG001|Overall Study|Subject left hospital|1|||
147051870|NCT01490086|530352485|FG002|Overall Study|Subject left hospital|0|||
147051871|NCT01490086|530352486|FG003|Overall Study|Subject left hospital|1|||
147051872|NCT01490086|530352487|FG004|Overall Study|Subject left hospital|0|||
147051873|NCT05825404|530352488|FG000|First Intervention (Weeks 2-5)|Death|0|||
147051874|NCT05825404|530352489|FG001|First Intervention (Weeks 2-5)|Death|1|||
147051875|NCT05825404|530352488|FG000|Second Intervention (Weeks 8-11)|Death|0|||
147051876|NCT05825404|530352489|FG001|Second Intervention (Weeks 8-11)|Death|1|||
147051877|NCT01127256|530352490|FG000|Overall Study|Adverse Event|13|||
147051878|NCT01127256|530352491|FG001|Overall Study|Adverse Event|13|||
147051879|NCT01127256|530352490|FG000|Overall Study|Lack of Efficacy|4|||
147051880|NCT01127256|530352491|FG001|Overall Study|Lack of Efficacy|0|||
147051881|NCT01127256|530352490|FG000|Overall Study|Lost to Follow-up|16|||
147051882|NCT01127256|530352491|FG001|Overall Study|Lost to Follow-up|17|||
147051883|NCT01127256|530352490|FG000|Overall Study|Withdrawal by Subject|5|||
147051884|NCT01127256|530352491|FG001|Overall Study|Withdrawal by Subject|9|||
147051885|NCT01127256|530352490|FG000|Overall Study|Protocol Violation|1|||
147051886|NCT01127256|530352491|FG001|Overall Study|Protocol Violation|0|||
147051887|NCT00679211|530352492|FG000|Overall Study|Progressive disease|82|||
147051888|NCT00679211|530352492|FG000|Overall Study|Adverse Event|7|||
147051889|NCT00679211|530352492|FG000|Overall Study|Withdrawal by Subject|2|||
147051890|NCT00679211|530352492|FG000|Overall Study|Physician Decision|5|||
147051891|NCT00679211|530352492|FG000|Overall Study|Refused to undergo protocol procedures|1|||
147051892|NCT00679211|530352492|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
147051893|NCT00679211|530352492|FG000|Overall Study|Other|1|||
147051894|NCT00931528|530352493|FG000|Overall Study|Protocol Violation|9|||
147051895|NCT00931528|530352494|FG001|Overall Study|Protocol Violation|12|||
147051896|NCT00931528|530352493|FG000|Overall Study|Withdrawal by Subject|4|||
147051897|NCT00931528|530352494|FG001|Overall Study|Withdrawal by Subject|12|||
147051898|NCT00931528|530352493|FG000|Overall Study|Lost to Follow-up|6|||
147051899|NCT00931528|530352494|FG001|Overall Study|Lost to Follow-up|13|||
147051900|NCT00931528|530352493|FG000|Overall Study|Assessment outside of Time Frame|22|||
147051901|NCT00931528|530352494|FG001|Overall Study|Assessment outside of Time Frame|23|||
147051902|NCT01730053|530352495|FG000|Overall Study|Participant moved|0|||
147051903|NCT01730053|530352496|FG001|Overall Study|Participant moved|0|||
147051904|NCT01730053|530352497|FG002|Overall Study|Participant moved|1|||
147051905|NCT01730053|530352498|FG003|Overall Study|Participant moved|0|||
147051906|NCT01730053|530352499|FG004|Overall Study|Participant moved|0|||
147051907|NCT01730053|530352500|FG005|Overall Study|Participant moved|0|||
147051908|NCT01730053|530352495|FG000|Overall Study|Physician Decision|0|||
147051909|NCT01730053|530352496|FG001|Overall Study|Physician Decision|0|||
147051910|NCT01730053|530352497|FG002|Overall Study|Physician Decision|0|||
147051911|NCT01730053|530352498|FG003|Overall Study|Physician Decision|1|||
147051912|NCT01730053|530352499|FG004|Overall Study|Physician Decision|0|||
147051913|NCT01730053|530352500|FG005|Overall Study|Physician Decision|0|||
147051914|NCT01730053|530352495|FG000|Overall Study|Adverse Event|2|||
147051915|NCT01730053|530352496|FG001|Overall Study|Adverse Event|6|||
147051916|NCT01730053|530352497|FG002|Overall Study|Adverse Event|3|||
146850053|NCT01631227|529620702|FG001|Overall Study|administrative|1|||
147051917|NCT01730053|530352498|FG003|Overall Study|Adverse Event|3|||
147051918|NCT01730053|530352499|FG004|Overall Study|Adverse Event|2|||
147051919|NCT01730053|530352500|FG005|Overall Study|Adverse Event|2|||
147051920|NCT01730053|530352495|FG000|Overall Study|Poor compliance to protocol|1|||
147051921|NCT01730053|530352496|FG001|Overall Study|Poor compliance to protocol|2|||
147051922|NCT01730053|530352497|FG002|Overall Study|Poor compliance to protocol|2|||
147051923|NCT01730053|530352498|FG003|Overall Study|Poor compliance to protocol|0|||
147051924|NCT01730053|530352499|FG004|Overall Study|Poor compliance to protocol|0|||
147051925|NCT01730053|530352500|FG005|Overall Study|Poor compliance to protocol|2|||
147051926|NCT01730053|530352495|FG000|Overall Study|Other than specified|2|||
147051927|NCT01730053|530352496|FG001|Overall Study|Other than specified|6|||
147051928|NCT01730053|530352497|FG002|Overall Study|Other than specified|5|||
147051929|NCT01730053|530352498|FG003|Overall Study|Other than specified|4|||
147051930|NCT01730053|530352499|FG004|Overall Study|Other than specified|7|||
147051931|NCT01730053|530352500|FG005|Overall Study|Other than specified|9|||
147051932|NCT01470248|530352501|FG000|Overall Study|Withdrawal by Subject|1|||
147051933|NCT05364931|530352508|FG000|Overall Study|Adverse Event|0|||
147051934|NCT05364931|530352509|FG001|Overall Study|Adverse Event|2|||
147051935|NCT05364931|530352510|FG002|Overall Study|Adverse Event|1|||
147051936|NCT05364931|530352511|FG003|Overall Study|Adverse Event|0|||
147051937|NCT05364931|530352508|FG000|Overall Study|Lost to Follow-up|1|||
147051938|NCT05364931|530352509|FG001|Overall Study|Lost to Follow-up|0|||
147051939|NCT05364931|530352510|FG002|Overall Study|Lost to Follow-up|0|||
147051940|NCT05364931|530352511|FG003|Overall Study|Lost to Follow-up|0|||
147051941|NCT05364931|530352508|FG000|Overall Study|Withdrawal by Subject|1|||
147051942|NCT05364931|530352509|FG001|Overall Study|Withdrawal by Subject|1|||
147051943|NCT05364931|530352510|FG002|Overall Study|Withdrawal by Subject|3|||
147051944|NCT05364931|530352511|FG003|Overall Study|Withdrawal by Subject|2|||
147051945|NCT05364931|530352508|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
147051946|NCT05364931|530352509|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
147051947|NCT05364931|530352510|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
147051948|NCT05364931|530352511|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
147051949|NCT05364931|530352508|FG000|Overall Study|Discontinued|1|||
147051950|NCT05364931|530352509|FG001|Overall Study|Discontinued|0|||
147051951|NCT05364931|530352510|FG002|Overall Study|Discontinued|0|||
147051952|NCT05364931|530352511|FG003|Overall Study|Discontinued|0|||
147051953|NCT02243605|530352512|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
147051954|NCT02243605|530352513|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
147051955|NCT02243605|530352512|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
147051956|NCT02243605|530352513|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
147051957|NCT02243605|530352512|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
147051958|NCT02243605|530352513|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
147051959|NCT02243605|530352512|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
147051960|NCT02243605|530352513|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
147051961|NCT02243605|530352512|FG000|Stage 2 - Final Analysis Population|Progression|0|||
147051962|NCT02243605|530352513|FG001|Stage 2 - Final Analysis Population|Progression|1|||
147051963|NCT05842967|530352514|FG000|Period 1: SSA|Adverse Event|1|||
147051964|NCT05842967|530352515|FG001|Period 1: SSA|Adverse Event|1|||
147051965|NCT05842967|530352516|FG002|Period 1: SSA|Adverse Event|0|||
147051966|NCT05842967|530352517|FG003|Period 1: SSA|Adverse Event|0|||
147051967|NCT05842967|530352514|FG000|Period 1: SSA|Death|1|||
147051968|NCT05842967|530352515|FG001|Period 1: SSA|Death|0|||
147051969|NCT05842967|530352516|FG002|Period 1: SSA|Death|0|||
147051970|NCT05842967|530352517|FG003|Period 1: SSA|Death|0|||
147051971|NCT05842967|530352514|FG000|Period 1: SSA|Lost to Follow-up|16|||
147051972|NCT05842967|530352515|FG001|Period 1: SSA|Lost to Follow-up|4|||
147051973|NCT05842967|530352516|FG002|Period 1: SSA|Lost to Follow-up|0|||
147051974|NCT05842967|530352517|FG003|Period 1: SSA|Lost to Follow-up|0|||
147051975|NCT05842967|530352514|FG000|Period 1: SSA|Physician Decision|1|||
147051976|NCT05842967|530352515|FG001|Period 1: SSA|Physician Decision|0|||
147051977|NCT05842967|530352516|FG002|Period 1: SSA|Physician Decision|0|||
147051978|NCT05842967|530352517|FG003|Period 1: SSA|Physician Decision|0|||
147051979|NCT05842967|530352514|FG000|Period 1: SSA|Withdrawal by Subject|2|||
147051980|NCT05842967|530352515|FG001|Period 1: SSA|Withdrawal by Subject|2|||
147051981|NCT05842967|530352516|FG002|Period 1: SSA|Withdrawal by Subject|0|||
147051982|NCT05842967|530352517|FG003|Period 1: SSA|Withdrawal by Subject|0|||
147051983|NCT05842967|530352514|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
147051984|NCT05842967|530352515|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
147051985|NCT05842967|530352516|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
147051986|NCT05842967|530352517|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
147051987|NCT05842967|530352514|FG000|Period 2: SSB|Adverse Event|0|||
147051988|NCT05842967|530352515|FG001|Period 2: SSB|Adverse Event|0|||
147051989|NCT05842967|530352516|FG002|Period 2: SSB|Adverse Event|2|||
147051990|NCT05842967|530352517|FG003|Period 2: SSB|Adverse Event|0|||
147051991|NCT05842967|530352514|FG000|Period 2: SSB|Lost to Follow-up|0|||
147051992|NCT05842967|530352515|FG001|Period 2: SSB|Lost to Follow-up|0|||
147051993|NCT05842967|530352516|FG002|Period 2: SSB|Lost to Follow-up|4|||
147051994|NCT05842967|530352517|FG003|Period 2: SSB|Lost to Follow-up|3|||
147051995|NCT05842967|530352514|FG000|Period 2: SSB|Withdrawal by Subject|0|||
147051996|NCT05842967|530352515|FG001|Period 2: SSB|Withdrawal by Subject|0|||
147051997|NCT05842967|530352516|FG002|Period 2: SSB|Withdrawal by Subject|1|||
147051998|NCT05842967|530352517|FG003|Period 2: SSB|Withdrawal by Subject|0|||
147051999|NCT05842967|530352514|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
147052000|NCT05842967|530352515|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
147052001|NCT05842967|530352516|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
147052002|NCT05842967|530352517|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
147052003|NCT05842967|530352514|FG000|Period 2: SSB|Protocol Violation|0|||
147052004|NCT05842967|530352515|FG001|Period 2: SSB|Protocol Violation|0|||
147052005|NCT05842967|530352516|FG002|Period 2: SSB|Protocol Violation|0|||
147052006|NCT05842967|530352517|FG003|Period 2: SSB|Protocol Violation|1|||
147052007|NCT03103087|530352518|FG000|Overall Study|Did not receive any study drug|1|||
147052008|NCT03103087|530352519|FG001|Overall Study|Did not receive any study drug|0|||
147052009|NCT03103087|530352520|FG002|Overall Study|Did not receive any study drug|0|||
147052010|NCT03103087|530352518|FG000|Overall Study|Protocol Violation|1|||
147052011|NCT03103087|530352519|FG001|Overall Study|Protocol Violation|2|||
147052012|NCT03103087|530352520|FG002|Overall Study|Protocol Violation|1|||
147052013|NCT03103087|530352518|FG000|Overall Study|Lack of Efficacy|2|||
147052014|NCT03103087|530352519|FG001|Overall Study|Lack of Efficacy|1|||
147052015|NCT03103087|530352520|FG002|Overall Study|Lack of Efficacy|1|||
147052016|NCT03103087|530352518|FG000|Overall Study|Pregnancy|0|||
147052017|NCT03103087|530352519|FG001|Overall Study|Pregnancy|0|||
147052018|NCT03103087|530352520|FG002|Overall Study|Pregnancy|1|||
147052019|NCT03103087|530352518|FG000|Overall Study|Adverse Event|2|||
147052020|NCT03103087|530352519|FG001|Overall Study|Adverse Event|15|||
147052021|NCT03103087|530352520|FG002|Overall Study|Adverse Event|6|||
147052022|NCT03103087|530352518|FG000|Overall Study|Withdrawal by Subject|13|||
147052023|NCT03103087|530352519|FG001|Overall Study|Withdrawal by Subject|6|||
147052024|NCT03103087|530352520|FG002|Overall Study|Withdrawal by Subject|6|||
147052025|NCT03103087|530352518|FG000|Overall Study|Lost to Follow-up|4|||
147052026|NCT03103087|530352519|FG001|Overall Study|Lost to Follow-up|2|||
147052027|NCT03103087|530352520|FG002|Overall Study|Lost to Follow-up|7|||
147052028|NCT03103087|530352518|FG000|Overall Study|Other reason not reported|1|||
147052029|NCT03103087|530352519|FG001|Overall Study|Other reason not reported|3|||
147052030|NCT03103087|530352520|FG002|Overall Study|Other reason not reported|5|||
147052031|NCT03511105|530352522|FG000|Overall Study|Adverse Event|1|||
147052032|NCT03511105|530352523|FG001|Overall Study|Adverse Event|0|||
147052033|NCT03511105|530352522|FG000|Overall Study|Withdrew consent|1|||
147052034|NCT03511105|530352523|FG001|Overall Study|Withdrew consent|0|||
147052035|NCT00075816|530352524|FG000|Overall Study|Did not undergo transplantation|14|||
147052036|NCT00075816|530352525|FG001|Overall Study|Did not undergo transplantation|11|||
147052037|NCT01823328|530352526|FG000|Overall Study|Withdrawal by Subject|8|||
147052038|NCT01823328|530352527|FG001|Overall Study|Withdrawal by Subject|6|||
147052039|NCT02019472|530352530|FG000|Overall Study|Adverse Event|14|||
147052040|NCT02019472|530352531|FG001|Overall Study|Adverse Event|23|||
147052041|NCT02019472|530352532|FG002|Overall Study|Adverse Event|17|||
147052042|NCT02019472|530352530|FG000|Overall Study|Death|0|||
147052043|NCT02019472|530352531|FG001|Overall Study|Death|1|||
147052044|NCT02019472|530352532|FG002|Overall Study|Death|1|||
147052045|NCT02019472|530352530|FG000|Overall Study|Lack of Efficacy|7|||
147052046|NCT02019472|530352531|FG001|Overall Study|Lack of Efficacy|4|||
147052047|NCT02019472|530352532|FG002|Overall Study|Lack of Efficacy|4|||
147052048|NCT02019472|530352530|FG000|Overall Study|Lost to Follow-up|0|||
147052049|NCT02019472|530352531|FG001|Overall Study|Lost to Follow-up|2|||
147052050|NCT02019472|530352532|FG002|Overall Study|Lost to Follow-up|1|||
147052051|NCT02019472|530352530|FG000|Overall Study|Physician Decision|1|||
147052052|NCT02019472|530352531|FG001|Overall Study|Physician Decision|2|||
147052053|NCT02019472|530352532|FG002|Overall Study|Physician Decision|0|||
147052054|NCT02019472|530352530|FG000|Overall Study|Pregnancy|1|||
147052055|NCT02019472|530352531|FG001|Overall Study|Pregnancy|2|||
147052056|NCT02019472|530352532|FG002|Overall Study|Pregnancy|2|||
147052057|NCT02019472|530352530|FG000|Overall Study|Withdrawal by Subject|11|||
147052058|NCT02019472|530352531|FG001|Overall Study|Withdrawal by Subject|10|||
147052059|NCT02019472|530352532|FG002|Overall Study|Withdrawal by Subject|11|||
147052060|NCT02019472|530352530|FG000|Overall Study|Other|3|||
147052061|NCT02019472|530352531|FG001|Overall Study|Other|8|||
147052062|NCT02019472|530352532|FG002|Overall Study|Other|6|||
147052063|NCT00513695|530352533|FG000|Overall Study|Discontinued therapy|2|||
147052064|NCT00513695|530352533|FG000|Overall Study|Progression prior to surgery|3|||
147052065|NCT02157935|530352534|FG000|Overall Study|Withdrawal by Subject|25|||
147052066|NCT02157935|530352535|FG001|Overall Study|Withdrawal by Subject|39|||
147052067|NCT02157935|530352534|FG000|Overall Study|Screen failure|1|||
147052068|NCT02157935|530352535|FG001|Overall Study|Screen failure|2|||
147052069|NCT02157935|530352534|FG000|Overall Study|Protocol Violation|1|||
147052070|NCT02157935|530352535|FG001|Overall Study|Protocol Violation|0|||
147052071|NCT02157935|530352534|FG000|Overall Study|Progressive disease|0|||
147052072|NCT02157935|530352535|FG001|Overall Study|Progressive disease|2|||
147052073|NCT02157935|530352534|FG000|Overall Study|Other|5|||
147052074|NCT02157935|530352535|FG001|Overall Study|Other|12|||
147052075|NCT02157935|530352534|FG000|Overall Study|Lack of Efficacy|0|||
147052076|NCT02157935|530352535|FG001|Overall Study|Lack of Efficacy|1|||
147052077|NCT02157935|530352534|FG000|Overall Study|Death|4|||
147052078|NCT02157935|530352535|FG001|Overall Study|Death|4|||
147052079|NCT02157935|530352534|FG000|Overall Study|Adverse Event|3|||
147052080|NCT02157935|530352535|FG001|Overall Study|Adverse Event|5|||
147052081|NCT03192488|530352536|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
147052082|NCT03192488|530352537|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
147052083|NCT03192488|530352538|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
147052084|NCT03192488|530352539|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
147052085|NCT03192488|530352540|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
147052086|NCT03192488|530352541|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
147052087|NCT03192488|530352536|FG000|Third Intervention (d1)|Adverse Event|0|||
147052088|NCT03192488|530352537|FG001|Third Intervention (d1)|Adverse Event|0|||
147052089|NCT03192488|530352538|FG002|Third Intervention (d1)|Adverse Event|0|||
147052090|NCT03192488|530352539|FG003|Third Intervention (d1)|Adverse Event|0|||
147052091|NCT03192488|530352540|FG004|Third Intervention (d1)|Adverse Event|1|||
147052092|NCT03192488|530352541|FG005|Third Intervention (d1)|Adverse Event|0|||
147052093|NCT03588910|530352543|FG000|Overall Study|Withdrawal by Subject|1|||
147052094|NCT03588910|530352544|FG001|Overall Study|Withdrawal by Subject|0|||
147052095|NCT03588910|530352543|FG000|Overall Study|Allergy|2|||
147052096|NCT03588910|530352544|FG001|Overall Study|Allergy|0|||
147052097|NCT03588910|530352543|FG000|Overall Study|Protocol Violation|0|||
147052098|NCT03588910|530352544|FG001|Overall Study|Protocol Violation|3|||
147052099|NCT03588910|530352543|FG000|Overall Study|Did not complete Day 1 Survey|5|||
147052100|NCT03588910|530352544|FG001|Overall Study|Did not complete Day 1 Survey|10|||
147052101|NCT03588910|530352543|FG000|Overall Study|Did not complete Day 7 Survey|5|||
147052102|NCT03588910|530352544|FG001|Overall Study|Did not complete Day 7 Survey|2|||
147052103|NCT02547428|530352545|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
147052104|NCT02547428|530352546|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
147052105|NCT02547428|530352545|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
147052106|NCT02547428|530352546|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
147052107|NCT02547428|530352545|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
147052108|NCT02547428|530352546|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
147052109|NCT02547428|530352545|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
147052110|NCT02547428|530352546|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
147052111|NCT02547428|530352545|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
147052112|NCT02547428|530352546|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
147052113|NCT02547428|530352545|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
147052114|NCT02547428|530352546|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
147052115|NCT02547428|530352545|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
147052116|NCT02547428|530352546|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
147052117|NCT02547428|530352545|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
147052118|NCT02547428|530352546|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
147052119|NCT02302833|530352547|FG000|Overall Study|Lost to Follow-up|3|||
147052120|NCT03664232|530352552|FG000|Overall Study|Withdrawal by Subject|0|||
147052121|NCT03664232|530352553|FG001|Overall Study|Withdrawal by Subject|1|||
147052122|NCT03664232|530352554|FG002|Overall Study|Withdrawal by Subject|0|||
147052123|NCT03664232|530352555|FG003|Overall Study|Withdrawal by Subject|1|||
147052124|NCT03664232|530352552|FG000|Overall Study|Adverse Event|0|||
147052125|NCT03664232|530352553|FG001|Overall Study|Adverse Event|0|||
147052126|NCT03664232|530352554|FG002|Overall Study|Adverse Event|1|||
147052127|NCT03664232|530352555|FG003|Overall Study|Adverse Event|0|||
147052128|NCT03664232|530352552|FG000|Overall Study|Other-Non-compliance with study drug|0|||
147052129|NCT03664232|530352553|FG001|Overall Study|Other-Non-compliance with study drug|1|||
147052130|NCT03664232|530352554|FG002|Overall Study|Other-Non-compliance with study drug|0|||
147052131|NCT03664232|530352555|FG003|Overall Study|Other-Non-compliance with study drug|2|||
147052132|NCT03664232|530352552|FG000|Overall Study|Other-Unspecified|0|||
147052133|NCT03664232|530352553|FG001|Overall Study|Other-Unspecified|3|||
147052134|NCT03664232|530352554|FG002|Overall Study|Other-Unspecified|0|||
147052135|NCT03664232|530352555|FG003|Overall Study|Other-Unspecified|1|||
147052136|NCT03664232|530352552|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
147052137|NCT03664232|530352553|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
147052138|NCT03664232|530352554|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
147052139|NCT03664232|530352555|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
147052140|NCT02717507|530352556|FG000|Overall Study|Lost to Follow-up|5|||
147052141|NCT02717507|530352557|FG001|Overall Study|Lost to Follow-up|8|||
147052142|NCT02717507|530352556|FG000|Overall Study|Pregnancy|1|||
147052143|NCT02717507|530352557|FG001|Overall Study|Pregnancy|1|||
147052144|NCT02717507|530352556|FG000|Overall Study|Protocol Violation|2|||
146850054|NCT00911937|529620705|FG000|Overall Study|Death|1|||
147052145|NCT02717507|530352557|FG001|Overall Study|Protocol Violation|2|||
147052146|NCT02717507|530352556|FG000|Overall Study|Withdrawal by Subject|20|||
147052147|NCT02717507|530352557|FG001|Overall Study|Withdrawal by Subject|20|||
147052148|NCT02717507|530352556|FG000|Overall Study|Relapse|1|||
147052149|NCT02717507|530352557|FG001|Overall Study|Relapse|1|||
147052150|NCT02717507|530352556|FG000|Overall Study|Cardiac Event|2|||
147052151|NCT02717507|530352557|FG001|Overall Study|Cardiac Event|6|||
147052152|NCT05017246|530352558|FG000|Overall Study|Withdrawal by Subject|5|||
147052153|NCT05017246|530352559|FG001|Overall Study|Withdrawal by Subject|3|||
147052154|NCT05017246|530352558|FG000|Overall Study|Determined to be ineligible|0|||
147052155|NCT05017246|530352559|FG001|Overall Study|Determined to be ineligible|1|||
147052156|NCT05017246|530352558|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
147052157|NCT05017246|530352559|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
147052158|NCT05017246|530352558|FG000|Overall Study|Technical failure|1|||
147052159|NCT05017246|530352559|FG001|Overall Study|Technical failure|3|||
147052160|NCT02003209|530352567|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
147052161|NCT02003209|530352568|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
147052162|NCT00638508|530352569|FG000|Overall Study|Physician Decision|5|||
147052163|NCT00638508|530352570|FG001|Overall Study|Physician Decision|2|||
147052164|NCT00485264|530352571|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
147052165|NCT00485264|530352572|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
147052166|NCT00485264|530352573|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
147052167|NCT00485264|530352574|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
147052168|NCT00485264|530352575|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
147052169|NCT00485264|530352576|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
147052170|NCT00485264|530352571|FG000|Overall Study|Death|1|||
147052171|NCT00485264|530352572|FG001|Overall Study|Death|0|||
147052172|NCT00485264|530352573|FG002|Overall Study|Death|0|||
147052173|NCT00485264|530352574|FG003|Overall Study|Death|0|||
147052174|NCT00485264|530352575|FG004|Overall Study|Death|1|||
147052175|NCT00485264|530352576|FG005|Overall Study|Death|0|||
147052176|NCT00485264|530352571|FG000|Overall Study|Adverse Event|1|||
147052177|NCT00485264|530352572|FG001|Overall Study|Adverse Event|0|||
147052178|NCT00485264|530352573|FG002|Overall Study|Adverse Event|2|||
147052179|NCT00485264|530352574|FG003|Overall Study|Adverse Event|3|||
147052180|NCT00485264|530352575|FG004|Overall Study|Adverse Event|1|||
147052181|NCT00485264|530352576|FG005|Overall Study|Adverse Event|3|||
147052182|NCT00485264|530352571|FG000|Overall Study|Pregnancy|4|||
147052183|NCT00485264|530352572|FG001|Overall Study|Pregnancy|0|||
147052184|NCT00485264|530352573|FG002|Overall Study|Pregnancy|0|||
147052185|NCT00485264|530352574|FG003|Overall Study|Pregnancy|0|||
147052186|NCT00485264|530352575|FG004|Overall Study|Pregnancy|0|||
147052187|NCT00485264|530352576|FG005|Overall Study|Pregnancy|0|||
147052188|NCT00485264|530352571|FG000|Overall Study|Disallowed Medication|0|||
147052189|NCT00485264|530352572|FG001|Overall Study|Disallowed Medication|0|||
147052190|NCT00485264|530352573|FG002|Overall Study|Disallowed Medication|0|||
147052191|NCT00485264|530352574|FG003|Overall Study|Disallowed Medication|0|||
147052192|NCT00485264|530352575|FG004|Overall Study|Disallowed Medication|0|||
147052193|NCT00485264|530352576|FG005|Overall Study|Disallowed Medication|1|||
147052194|NCT00485264|530352571|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
147052195|NCT00485264|530352572|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
147052196|NCT00485264|530352573|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
147052197|NCT00485264|530352574|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
147052198|NCT00485264|530352575|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
147052199|NCT00485264|530352576|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
147052200|NCT00485264|530352571|FG000|Overall Study|Lack of Efficacy|0|||
147052201|NCT00485264|530352572|FG001|Overall Study|Lack of Efficacy|1|||
147052202|NCT00485264|530352573|FG002|Overall Study|Lack of Efficacy|0|||
147052203|NCT00485264|530352574|FG003|Overall Study|Lack of Efficacy|0|||
147052204|NCT00485264|530352575|FG004|Overall Study|Lack of Efficacy|0|||
147052205|NCT00485264|530352576|FG005|Overall Study|Lack of Efficacy|0|||
147052206|NCT00485264|530352571|FG000|Overall Study|Guardian Consent Withdrawn|1|||
147052207|NCT00485264|530352572|FG001|Overall Study|Guardian Consent Withdrawn|0|||
147052208|NCT00485264|530352573|FG002|Overall Study|Guardian Consent Withdrawn|0|||
147052209|NCT00485264|530352574|FG003|Overall Study|Guardian Consent Withdrawn|0|||
147052210|NCT00485264|530352575|FG004|Overall Study|Guardian Consent Withdrawn|1|||
147052211|NCT00485264|530352576|FG005|Overall Study|Guardian Consent Withdrawn|0|||
147052212|NCT00485264|530352571|FG000|Overall Study|Physician Decision|0|||
147052213|NCT00485264|530352572|FG001|Overall Study|Physician Decision|2|||
147052214|NCT00485264|530352573|FG002|Overall Study|Physician Decision|0|||
147052215|NCT00485264|530352574|FG003|Overall Study|Physician Decision|0|||
147052216|NCT00485264|530352575|FG004|Overall Study|Physician Decision|0|||
147052217|NCT00485264|530352576|FG005|Overall Study|Physician Decision|0|||
147052218|NCT00485264|530352571|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
147052219|NCT00485264|530352572|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
147052220|NCT00485264|530352573|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
147052221|NCT00485264|530352574|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
147052222|NCT00485264|530352575|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
147052223|NCT00485264|530352576|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
147052224|NCT00485264|530352571|FG000|Overall Study|Not Able to Attend Clinic|5|||
147052225|NCT00485264|530352572|FG001|Overall Study|Not Able to Attend Clinic|0|||
147052226|NCT00485264|530352573|FG002|Overall Study|Not Able to Attend Clinic|0|||
147052227|NCT00485264|530352574|FG003|Overall Study|Not Able to Attend Clinic|1|||
147052228|NCT00485264|530352575|FG004|Overall Study|Not Able to Attend Clinic|1|||
147052229|NCT00485264|530352576|FG005|Overall Study|Not Able to Attend Clinic|2|||
147052230|NCT00485264|530352571|FG000|Overall Study|Non-Compliant|17|||
147052231|NCT00485264|530352572|FG001|Overall Study|Non-Compliant|2|||
147052232|NCT00485264|530352573|FG002|Overall Study|Non-Compliant|1|||
147052233|NCT00485264|530352574|FG003|Overall Study|Non-Compliant|0|||
147052234|NCT00485264|530352575|FG004|Overall Study|Non-Compliant|1|||
147052235|NCT00485264|530352576|FG005|Overall Study|Non-Compliant|0|||
147052236|NCT00485264|530352571|FG000|Overall Study|Lost to Follow-up|2|||
147052237|NCT00485264|530352572|FG001|Overall Study|Lost to Follow-up|1|||
147052238|NCT00485264|530352573|FG002|Overall Study|Lost to Follow-up|1|||
147052239|NCT00485264|530352574|FG003|Overall Study|Lost to Follow-up|0|||
147052240|NCT00485264|530352575|FG004|Overall Study|Lost to Follow-up|0|||
147052241|NCT00485264|530352576|FG005|Overall Study|Lost to Follow-up|1|||
147052242|NCT00485264|530352571|FG000|Overall Study|Other Reason|3|||
147052243|NCT00485264|530352572|FG001|Overall Study|Other Reason|0|||
147052244|NCT00485264|530352573|FG002|Overall Study|Other Reason|0|||
147052245|NCT00485264|530352574|FG003|Overall Study|Other Reason|0|||
147052246|NCT00485264|530352575|FG004|Overall Study|Other Reason|0|||
147052247|NCT00485264|530352576|FG005|Overall Study|Other Reason|0|||
147052248|NCT03500198|530352577|FG000|Overall Study|Lost to Follow-up|0|||
147052249|NCT03500198|530352578|FG001|Overall Study|Lost to Follow-up|1|||
147052250|NCT01514461|530352579|FG000|Overall Study|Adverse Event|2|||
147052251|NCT01514461|530352580|FG001|Overall Study|Adverse Event|1|||
147052252|NCT01514461|530352581|FG002|Overall Study|Adverse Event|3|||
147052253|NCT01514461|530352579|FG000|Overall Study|Physician Decision|1|||
147052254|NCT01514461|530352580|FG001|Overall Study|Physician Decision|1|||
147052255|NCT01514461|530352581|FG002|Overall Study|Physician Decision|0|||
147052256|NCT01514461|530352579|FG000|Overall Study|Patient/guardian decision|1|||
147052257|NCT01514461|530352580|FG001|Overall Study|Patient/guardian decision|1|||
147052258|NCT01514461|530352581|FG002|Overall Study|Patient/guardian decision|1|||
147052259|NCT01514461|530352579|FG000|Overall Study|Death|1|||
147052260|NCT01514461|530352580|FG001|Overall Study|Death|0|||
147052261|NCT01514461|530352581|FG002|Overall Study|Death|0|||
147052262|NCT00654095|530352582|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
147052263|NCT00654095|530352582|FG000|Overall Study|Elevated triglyceride level (2)|1|||
147052264|NCT00654095|530352582|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
147052265|NCT00654095|530352582|FG000|Overall Study|Adverse Event|11|||
147052266|NCT00654095|530352582|FG000|Overall Study|Withdrawal by Subject|5|||
147052267|NCT00654095|530352582|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
147052268|NCT00654095|530352582|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
147052269|NCT00654095|530352582|FG000|Overall Study|Did not meet inclusion criteria|1|||
147052270|NCT00595621|530352588|FG000|Open Label Run in|Adverse Event|1|||
147052271|NCT00595621|530352589|FG001|Open Label Run in|Adverse Event|0|||
147052272|NCT00595621|530352588|FG000|Open Label Run in|Physician Decision|1|||
147052273|NCT00595621|530352589|FG001|Open Label Run in|Physician Decision|0|||
147052274|NCT00595621|530352588|FG000|Open Label Run in|Withdrawal by Subject|1|||
147052275|NCT00595621|530352589|FG001|Open Label Run in|Withdrawal by Subject|0|||
147052276|NCT00595621|530352588|FG000|Randomization and Study|Adverse Event|2|||
147052277|NCT00595621|530352589|FG001|Randomization and Study|Adverse Event|0|||
147052278|NCT00595621|530352588|FG000|Randomization and Study|Withdrawal by Subject|0|||
147052279|NCT00595621|530352589|FG001|Randomization and Study|Withdrawal by Subject|1|||
147052280|NCT02502149|530352591|FG000|Intermediate|Discontinued prematurely|1|||
147052281|NCT02502149|530352592|FG001|Intermediate|Discontinued prematurely|0|||
147052282|NCT02502149|530352593|FG002|Intermediate|Discontinued prematurely|0|||
147052283|NCT02502149|530352594|FG003|Intermediate|Discontinued prematurely|0|||
147052284|NCT02502149|530352595|FG004|Intermediate|Discontinued prematurely|0|||
147052285|NCT02548832|530352596|FG000|Overall Study|Lost to Follow-up|2|||
147052286|NCT02548832|530352597|FG001|Overall Study|Lost to Follow-up|2|||
147052287|NCT02548832|530352598|FG002|Overall Study|Lost to Follow-up|2|||
147052288|NCT02968576|530352599|FG000|Overall Study|Pregnancy|0|||
147052289|NCT02968576|530352600|FG001|Overall Study|Pregnancy|1|||
147052290|NCT01998919|530352601|FG000|Overall Study|Death|2|||
147052291|NCT01998919|530352602|FG001|Overall Study|Death|2|||
147052292|NCT01998919|530352601|FG000|Overall Study|Adverse Event|0|||
147052293|NCT01998919|530352602|FG001|Overall Study|Adverse Event|5|||
147052294|NCT01998919|530352601|FG000|Overall Study|Disease progression|31|||
147052295|NCT01998919|530352602|FG001|Overall Study|Disease progression|22|||
147052296|NCT01998919|530352601|FG000|Overall Study|Withdrawal by Subject|2|||
147052297|NCT01998919|530352602|FG001|Overall Study|Withdrawal by Subject|4|||
147052298|NCT01998919|530352601|FG000|Overall Study|Lost to Follow-up|2|||
147052299|NCT01998919|530352602|FG001|Overall Study|Lost to Follow-up|0|||
147052300|NCT01998919|530352601|FG000|Overall Study|Other|5|||
147052301|NCT01998919|530352602|FG001|Overall Study|Other|2|||
147052302|NCT01068860|530352603|FG000|Overall Study|Withdrawal by Subject|0|||
147052303|NCT01068860|530352604|FG001|Overall Study|Withdrawal by Subject|0|||
147052304|NCT01068860|530352605|FG002|Overall Study|Withdrawal by Subject|0|||
147052305|NCT01068860|530352606|FG003|Overall Study|Withdrawal by Subject|0|||
147052306|NCT01068860|530352607|FG004|Overall Study|Withdrawal by Subject|0|||
147052307|NCT01068860|530352608|FG005|Overall Study|Withdrawal by Subject|2|||
147052308|NCT01068860|530352609|FG006|Overall Study|Withdrawal by Subject|0|||
147052309|NCT01068860|530352610|FG007|Overall Study|Withdrawal by Subject|0|||
147052310|NCT01068860|530352611|FG008|Overall Study|Withdrawal by Subject|0|||
147052311|NCT01068860|530352612|FG009|Overall Study|Withdrawal by Subject|3|||
147052312|NCT01068860|530352603|FG000|Overall Study|Administrative problems; misrandomized|0|||
147052313|NCT01068860|530352604|FG001|Overall Study|Administrative problems; misrandomized|0|||
147052314|NCT01068860|530352605|FG002|Overall Study|Administrative problems; misrandomized|0|||
147052315|NCT01068860|530352606|FG003|Overall Study|Administrative problems; misrandomized|1|||
147052316|NCT01068860|530352607|FG004|Overall Study|Administrative problems; misrandomized|0|||
147052317|NCT01068860|530352608|FG005|Overall Study|Administrative problems; misrandomized|0|||
147052318|NCT01068860|530352609|FG006|Overall Study|Administrative problems; misrandomized|0|||
147052319|NCT01068860|530352610|FG007|Overall Study|Administrative problems; misrandomized|0|||
147052320|NCT01068860|530352611|FG008|Overall Study|Administrative problems; misrandomized|0|||
147052321|NCT01068860|530352612|FG009|Overall Study|Administrative problems; misrandomized|1|||
147052322|NCT01068860|530352603|FG000|Overall Study|Lost to Follow-up|0|||
147052323|NCT01068860|530352604|FG001|Overall Study|Lost to Follow-up|1|||
147052324|NCT01068860|530352605|FG002|Overall Study|Lost to Follow-up|0|||
147052325|NCT01068860|530352606|FG003|Overall Study|Lost to Follow-up|0|||
147052326|NCT01068860|530352607|FG004|Overall Study|Lost to Follow-up|0|||
147052327|NCT01068860|530352608|FG005|Overall Study|Lost to Follow-up|0|||
147052328|NCT01068860|530352609|FG006|Overall Study|Lost to Follow-up|0|||
147052329|NCT01068860|530352610|FG007|Overall Study|Lost to Follow-up|0|||
147052330|NCT01068860|530352611|FG008|Overall Study|Lost to Follow-up|0|||
147052331|NCT01068860|530352612|FG009|Overall Study|Lost to Follow-up|0|||
147052332|NCT02568072|530352613|FG000|Overall Study|Unavailable for appointment|23|||
147052333|NCT02568072|530352613|FG000|Overall Study|Unable to contact|3|||
147052334|NCT02568072|530352613|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
147052335|NCT02568072|530352613|FG000|Overall Study|Withdrawal by Subject|1|||
147052336|NCT02568072|530352613|FG000|Overall Study|Sustained injury, marathon not run|24|||
147052337|NCT00513240|530352618|FG000|Overall Study|Did not have intended surgery|3|||
147052338|NCT00513240|530352619|FG001|Overall Study|Did not have intended surgery|0|||
147052339|NCT00513240|530352618|FG000|Overall Study|Death|3|||
147052340|NCT00513240|530352619|FG001|Overall Study|Death|3|||
147052341|NCT00513240|530352618|FG000|Overall Study|Withdrawal by Subject|7|||
147052342|NCT00513240|530352619|FG001|Overall Study|Withdrawal by Subject|4|||
147052343|NCT05263908|530352620|FG000|Overall Study|No informed consent for publication of study results|397|||
147052344|NCT05263908|530352620|FG000|Overall Study|CRF not collected|1|||
147052345|NCT03711188|530352623|FG000|Overall Study|Disease progression|11|||
147052346|NCT03711188|530352623|FG000|Overall Study|Adverse Event|1|||
147052347|NCT01433471|530352624|FG000|Overall Study|Withdrawal by Subject|0|||
147052348|NCT01433471|530352625|FG001|Overall Study|Withdrawal by Subject|1|||
147052349|NCT03875508|530352628|FG000|Overall Study|Adverse Event|1|||
147052350|NCT03875508|530352628|FG000|Overall Study|Lost to Follow-up|8|||
147052351|NCT03875508|530352628|FG000|Overall Study|Lack of Efficacy|1|||
147052352|NCT03875508|530352628|FG000|Overall Study|Other, not specified|2|||
147052353|NCT02137252|530352629|FG000|Overall Study|trial terminated early|2|||
147052354|NCT02137252|530352630|FG001|Overall Study|trial terminated early|1|||
147052355|NCT00063934|530352632|FG000|Overall Study|Ineligible|1|||
147052356|NCT04341363|530352633|FG000|Overall Study|Adverse Event|1|||
147052357|NCT04341363|530352633|FG000|Overall Study|Withdrawal by Subject|1|||
147052358|NCT01930162|530352634|FG000|Overall Study|Abnormal test procedure result(s)|4|||
147052359|NCT01930162|530352634|FG000|Overall Study|Death|1|||
147052360|NCT02550561|530352635|FG000|Overall Study|Lost to Follow-up|5|||
147052361|NCT02550561|530352635|FG000|Overall Study|Withdrawal by Subject|1|||
147052362|NCT02285361|530352642|FG000|Overall Study|Protocol Violation|43|||
147052363|NCT02285361|530352642|FG000|Overall Study|Lost to Follow-up|5|||
147052364|NCT02285361|530352642|FG000|Overall Study|Not taken GIOTRIF|2|||
147052365|NCT02285361|530352642|FG000|Overall Study|Consented prior to the contract date|1|||
147052366|NCT01283464|530352643|FG000|Overall Study|Lost to Follow-up|0|||
147052367|NCT01283464|530352644|FG001|Overall Study|Lost to Follow-up|1|||
147052368|NCT01283464|530352643|FG000|Overall Study|Withdrawal by Subject|1|||
147052369|NCT01283464|530352644|FG001|Overall Study|Withdrawal by Subject|0|||
147052370|NCT01283464|530352643|FG000|Overall Study|Physician Decision|1|||
147052371|NCT01283464|530352644|FG001|Overall Study|Physician Decision|0|||
147052372|NCT03051100|530352645|FG000|Overall Study|Withdrawal by Subject|1|||
147052373|NCT03051100|530352646|FG001|Overall Study|Withdrawal by Subject|0|||
147052374|NCT01778855|530352647|FG000|Overall Study|Death|0|||
147052375|NCT01778855|530352648|FG001|Overall Study|Death|1|||
147052376|NCT02059135|530352649|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
147052377|NCT02059135|530352650|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
147052378|NCT02059135|530352649|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
147052379|NCT02059135|530352650|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
147052380|NCT02059135|530352649|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
147052381|NCT02059135|530352650|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
147052382|NCT02059135|530352649|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
147052383|NCT02059135|530352650|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
147052384|NCT02059135|530352649|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
147052385|NCT02059135|530352650|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
147052386|NCT02059135|530352649|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
147052387|NCT02059135|530352650|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
147052388|NCT02059135|530352649|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
147052389|NCT02059135|530352650|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
147052390|NCT02059135|530352649|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
147052391|NCT02059135|530352650|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
147052392|NCT04199104|530354322|FG000|Overall Study|Death|148|||
147052393|NCT04199104|530354323|FG001|Overall Study|Death|134|||
147052394|NCT04199104|530354322|FG000|Overall Study|Lost to Follow-up|1|||
147052395|NCT04199104|530354323|FG001|Overall Study|Lost to Follow-up|1|||
147052396|NCT04199104|530354322|FG000|Overall Study|Withdrawal by Subject|4|||
147052397|NCT04199104|530354323|FG001|Overall Study|Withdrawal by Subject|4|||
147052398|NCT04199104|530354322|FG000|Overall Study|Participants Ongoing|103|||
147052399|NCT04199104|530354323|FG001|Overall Study|Participants Ongoing|116|||
147052400|NCT04563754|530354325|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
147052401|NCT04563754|530354326|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
147052402|NCT04563754|530354327|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
147052403|NCT04563754|530354325|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
147052404|NCT04563754|530354326|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
147052405|NCT04563754|530354327|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
147052406|NCT04563754|530354325|FG000|Follow up|Lost to Follow-up|61|||
147052407|NCT04563754|530354326|FG001|Follow up|Lost to Follow-up|23|||
147052408|NCT04563754|530354327|FG002|Follow up|Lost to Follow-up|5|||
147052409|NCT04563754|530354325|FG000|Follow up|Death|0|||
147052410|NCT04563754|530354326|FG001|Follow up|Death|2|||
147052411|NCT04563754|530354327|FG002|Follow up|Death|0|||
147052412|NCT04563754|530354325|FG000|Follow up|Ongoing|0|||
147052413|NCT04563754|530354326|FG001|Follow up|Ongoing|28|||
147052414|NCT04563754|530354327|FG002|Follow up|Ongoing|0|||
147052415|NCT04023396|530354328|FG000|Overall Study|Adverse Event|16|||
147052416|NCT04023396|530354328|FG000|Overall Study|Death|1|||
147052417|NCT04023396|530354328|FG000|Overall Study|Lost to Follow-up|1|||
147052418|NCT04023396|530354328|FG000|Overall Study|Withdrawal by Subject|14|||
147052419|NCT04023396|530354328|FG000|Overall Study|Pregnancy|4|||
147052420|NCT04023396|530354328|FG000|Overall Study|Lack of Efficacy|3|||
147052421|NCT04023396|530354328|FG000|Overall Study|Physician Decision|4|||
147052422|NCT04023396|530354328|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
147052423|NCT04075825|530354331|FG000|Overall Study|Withdrawal by Subject|6|||
147052424|NCT04075825|530354332|FG001|Overall Study|Withdrawal by Subject|8|||
147052425|NCT04075825|530354331|FG000|Overall Study|Physician Decision|3|||
147052426|NCT04075825|530354332|FG001|Overall Study|Physician Decision|1|||
147052427|NCT04075825|530354331|FG000|Overall Study|Lost to Follow-up|5|||
147052428|NCT04075825|530354332|FG001|Overall Study|Lost to Follow-up|1|||
147052429|NCT04075825|530354331|FG000|Overall Study|Participation in New Clinical Trial|1|||
147052430|NCT04075825|530354332|FG001|Overall Study|Participation in New Clinical Trial|1|||
147052431|NCT04075825|530354331|FG000|Overall Study|Reason Not Specified|2|||
147052432|NCT04075825|530354332|FG001|Overall Study|Reason Not Specified|2|||
147052433|NCT02861586|530354336|FG000|Overall Study|Withdrawal by Subject|1|||
147052434|NCT02861586|530354337|FG001|Overall Study|Withdrawal by Subject|2|||
147052435|NCT02861586|530354338|FG002|Overall Study|Withdrawal by Subject|0|||
147052436|NCT02861586|530354339|FG003|Overall Study|Withdrawal by Subject|0|||
147052437|NCT02861586|530354340|FG004|Overall Study|Withdrawal by Subject|0|||
147052438|NCT02861586|530354341|FG005|Overall Study|Withdrawal by Subject|1|||
147052439|NCT02861586|530354342|FG006|Overall Study|Withdrawal by Subject|1|||
147052440|NCT02861586|530354343|FG007|Overall Study|Withdrawal by Subject|0|||
147052441|NCT02861586|530354336|FG000|Overall Study|Lost to Follow-up|3|||
147052442|NCT02861586|530354337|FG001|Overall Study|Lost to Follow-up|1|||
147052443|NCT02861586|530354338|FG002|Overall Study|Lost to Follow-up|1|||
147052444|NCT02861586|530354339|FG003|Overall Study|Lost to Follow-up|0|||
147052445|NCT02861586|530354340|FG004|Overall Study|Lost to Follow-up|0|||
147052446|NCT02861586|530354341|FG005|Overall Study|Lost to Follow-up|3|||
147052447|NCT02861586|530354342|FG006|Overall Study|Lost to Follow-up|0|||
147052448|NCT02861586|530354343|FG007|Overall Study|Lost to Follow-up|0|||
147052449|NCT02861586|530354336|FG000|Overall Study|Adverse Event|0|||
147052450|NCT02861586|530354337|FG001|Overall Study|Adverse Event|0|||
147052451|NCT02861586|530354338|FG002|Overall Study|Adverse Event|0|||
147052452|NCT02861586|530354339|FG003|Overall Study|Adverse Event|0|||
147052453|NCT02861586|530354340|FG004|Overall Study|Adverse Event|0|||
147052454|NCT02861586|530354341|FG005|Overall Study|Adverse Event|1|||
147052455|NCT02861586|530354342|FG006|Overall Study|Adverse Event|0|||
147052456|NCT02861586|530354343|FG007|Overall Study|Adverse Event|0|||
147052457|NCT01439802|530354344|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
147052458|NCT01439802|530354344|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
147052459|NCT01641640|530354350|FG000|Overall Study|Enrolled but not treated|1|||
147052460|NCT01641640|530354350|FG000|Overall Study|Efficacy failure|29|||
147052461|NCT01641640|530354350|FG000|Overall Study|Lost to Follow-up|3|||
147052462|NCT01641640|530354350|FG000|Overall Study|Withdrawal by Subject|2|||
147052463|NCT01641640|530354350|FG000|Overall Study|Adverse Event|1|||
147052464|NCT01234350|530354352|FG000|Overall Study|Adverse Event|277|||
147052465|NCT01234350|530354353|FG001|Overall Study|Adverse Event|92|||
147052466|NCT01234350|530354352|FG000|Overall Study|Withdrawal by Subject|61|||
147052467|NCT01234350|530354353|FG001|Overall Study|Withdrawal by Subject|36|||
147052468|NCT01234350|530354352|FG000|Overall Study|Lost to Follow-up|115|||
147052469|NCT01234350|530354353|FG001|Overall Study|Lost to Follow-up|47|||
147052470|NCT01234350|530354352|FG000|Overall Study|Covers a diverse set of reasons|234|||
147052471|NCT01234350|530354353|FG001|Overall Study|Covers a diverse set of reasons|92|||
147052472|NCT02792517|530354361|FG000|Overall Study|Withdrawal by Subject|10|||
147052473|NCT02792517|530354361|FG000|Overall Study|Decision by Sponsor|7|||
147052474|NCT02792517|530354361|FG000|Overall Study|Lost to Follow-up|3|||
147052475|NCT02570308|530354362|FG000|Overall Study|Death|1|||
147052476|NCT02570308|530354363|FG001|Overall Study|Death|5|||
147052477|NCT02570308|530354364|FG002|Overall Study|Death|4|||
147052478|NCT02570308|530354365|FG003|Overall Study|Death|4|||
147052479|NCT02570308|530354366|FG004|Overall Study|Death|69|||
147052480|NCT02570308|530354362|FG000|Overall Study|Lost to Follow-up|0|||
147052481|NCT02570308|530354363|FG001|Overall Study|Lost to Follow-up|0|||
147052482|NCT02570308|530354364|FG002|Overall Study|Lost to Follow-up|0|||
147052483|NCT02570308|530354365|FG003|Overall Study|Lost to Follow-up|0|||
147052484|NCT02570308|530354366|FG004|Overall Study|Lost to Follow-up|2|||
147052485|NCT02570308|530354362|FG000|Overall Study|Withdrawal by Subject|0|||
147052486|NCT02570308|530354363|FG001|Overall Study|Withdrawal by Subject|0|||
147052487|NCT02570308|530354364|FG002|Overall Study|Withdrawal by Subject|0|||
147052488|NCT02570308|530354365|FG003|Overall Study|Withdrawal by Subject|0|||
147052489|NCT02570308|530354366|FG004|Overall Study|Withdrawal by Subject|1|||
147052490|NCT02570308|530354362|FG000|Overall Study|Other|0|||
147052491|NCT02570308|530354363|FG001|Overall Study|Other|0|||
147052492|NCT02570308|530354364|FG002|Overall Study|Other|0|||
147052493|NCT02570308|530354365|FG003|Overall Study|Other|0|||
147052494|NCT02570308|530354366|FG004|Overall Study|Other|2|||
147052495|NCT02069015|530354367|FG000|Overall Study|Lost to Follow-up|39|||
147052496|NCT02069015|530354368|FG001|Overall Study|Lost to Follow-up|32|||
147052497|NCT02069015|530354367|FG000|Overall Study|Withdrawal by Subject|1|||
147052498|NCT02069015|530354368|FG001|Overall Study|Withdrawal by Subject|1|||
147052499|NCT03335475|530354371|FG000|Overall Study|Did not wear accelerometer|4|||
147052500|NCT03335475|530354372|FG001|Overall Study|Did not wear accelerometer|0|||
147052501|NCT03335475|530354371|FG000|Overall Study|Withdrawal by Subject|0|||
147052502|NCT03335475|530354372|FG001|Overall Study|Withdrawal by Subject|1|||
147052503|NCT06481709|530354373|FG000|Overall Study|Withdrawal by Subject|0|||
147052504|NCT06481709|530354374|FG001|Overall Study|Withdrawal by Subject|0|||
147052505|NCT06481709|530354375|FG002|Overall Study|Withdrawal by Subject|2|||
147052506|NCT06481709|530354376|FG003|Overall Study|Withdrawal by Subject|0|||
147052507|NCT05921903|530354377|FG000|Overall Study|Unsolicited non-SAE|0|||
147052508|NCT05921903|530354378|FG001|Overall Study|Unsolicited non-SAE|1|||
147052509|NCT05921903|530354379|FG002|Overall Study|Unsolicited non-SAE|0|||
147052510|NCT05921903|530354377|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
147052511|NCT05921903|530354378|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
147052512|NCT05921903|530354379|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
147052513|NCT05921903|530354377|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
147052514|NCT05921903|530354378|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
147052515|NCT05921903|530354379|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
147052516|NCT00789854|530354382|FG000|Overall Study|Adverse Event|28|||
147052517|NCT00789854|530354383|FG001|Overall Study|Adverse Event|23|||
147052518|NCT00789854|530354384|FG002|Overall Study|Adverse Event|18|||
147052519|NCT00789854|530354382|FG000|Overall Study|Lost to Follow-up|1|||
147052520|NCT00789854|530354383|FG001|Overall Study|Lost to Follow-up|1|||
147052521|NCT00789854|530354384|FG002|Overall Study|Lost to Follow-up|4|||
147052522|NCT00789854|530354382|FG000|Overall Study|Withdrawal by Subject|9|||
147052523|NCT00789854|530354383|FG001|Overall Study|Withdrawal by Subject|6|||
147052524|NCT00789854|530354384|FG002|Overall Study|Withdrawal by Subject|17|||
147052525|NCT00789854|530354382|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
147052526|NCT00789854|530354383|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
147052527|NCT00789854|530354384|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
147052528|NCT00789854|530354382|FG000|Overall Study|Severe non-compliance to the protocol|3|||
147052529|NCT00789854|530354383|FG001|Overall Study|Severe non-compliance to the protocol|0|||
147052530|NCT00789854|530354384|FG002|Overall Study|Severe non-compliance to the protocol|0|||
147052531|NCT00789854|530354382|FG000|Overall Study|Safety reasons|0|||
147052532|NCT00789854|530354383|FG001|Overall Study|Safety reasons|0|||
147052533|NCT00789854|530354384|FG002|Overall Study|Safety reasons|2|||
147052534|NCT00789854|530354382|FG000|Overall Study|Other|6|||
147052535|NCT00789854|530354383|FG001|Overall Study|Other|0|||
147052536|NCT00789854|530354384|FG002|Overall Study|Other|5|||
147052537|NCT00923013|530354385|FG000|Overall Study|Refused further treatment|0|||
147052538|NCT00923013|530354386|FG001|Overall Study|Refused further treatment|1|||
147052539|NCT00923013|530354387|FG002|Overall Study|Refused further treatment|2|||
147052540|NCT00923013|530354388|FG003|Overall Study|Refused further treatment|0|||
147052541|NCT00923013|530354389|FG004|Overall Study|Refused further treatment|0|||
147052542|NCT00923013|530354390|FG005|Overall Study|Refused further treatment|0|||
147052543|NCT00923013|530354385|FG000|Overall Study|Switched to alternative treatment|0|||
147052544|NCT00923013|530354386|FG001|Overall Study|Switched to alternative treatment|1|||
147052545|NCT00923013|530354387|FG002|Overall Study|Switched to alternative treatment|0|||
147052546|NCT00923013|530354388|FG003|Overall Study|Switched to alternative treatment|0|||
147052547|NCT00923013|530354389|FG004|Overall Study|Switched to alternative treatment|0|||
147052548|NCT00923013|530354390|FG005|Overall Study|Switched to alternative treatment|0|||
147052549|NCT00923013|530354385|FG000|Overall Study|Death on study|2|||
147052550|NCT00923013|530354386|FG001|Overall Study|Death on study|2|||
147052551|NCT00923013|530354387|FG002|Overall Study|Death on study|0|||
147052552|NCT00923013|530354388|FG003|Overall Study|Death on study|1|||
147052553|NCT00923013|530354389|FG004|Overall Study|Death on study|0|||
147052554|NCT00923013|530354390|FG005|Overall Study|Death on study|0|||
147052555|NCT05366010|530354392|FG000|Overall Study|Withdrawal by Subject|1|||
147052556|NCT05366010|530354392|FG000|Overall Study|Protocol Violation|1|||
147052557|NCT05366010|530354392|FG000|Overall Study|Lost to Follow-up|2|||
147052558|NCT05366010|530354392|FG000|Overall Study|Screen Failure|2|||
147052559|NCT05906628|530354393|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
147052560|NCT05906628|530354394|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
147052561|NCT05906628|530354393|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
147052562|NCT05906628|530354394|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
147052563|NCT05906628|530354393|FG000|16-Week DBVC Period|Protocol Violation|4|||
147052564|NCT05906628|530354394|FG001|16-Week DBVC Period|Protocol Violation|2|||
147052565|NCT05906628|530354393|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
147052566|NCT05906628|530354394|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
147052567|NCT05906628|530354393|FG000|16-Week OLE Period|Death|1|||
147052568|NCT05906628|530354394|FG001|16-Week OLE Period|Death|0|||
147052569|NCT05906628|530354393|FG000|16-Week OLE Period|Lost to Follow-up|1|||
147052570|NCT05906628|530354394|FG001|16-Week OLE Period|Lost to Follow-up|1|||
147052571|NCT05906628|530354393|FG000|16-Week OLE Period|Protocol Violation|0|||
147052572|NCT05906628|530354394|FG001|16-Week OLE Period|Protocol Violation|1|||
147052573|NCT05906628|530354393|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
147052574|NCT05906628|530354394|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
147052575|NCT01108718|530354395|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
147052576|NCT01108718|530354396|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
147052577|NCT05317312|530354397|FG000|Overall Study|Withdrawal by Subject|0|||
147052578|NCT05317312|530354398|FG001|Overall Study|Withdrawal by Subject|1|||
147052579|NCT05317312|530354399|FG002|Overall Study|Withdrawal by Subject|0|||
147052580|NCT05317312|530354400|FG003|Overall Study|Withdrawal by Subject|0|||
147052581|NCT05317312|530354397|FG000|Overall Study|Lost to Follow-up|0|||
147052582|NCT05317312|530354398|FG001|Overall Study|Lost to Follow-up|0|||
147052583|NCT05317312|530354399|FG002|Overall Study|Lost to Follow-up|0|||
147052584|NCT05317312|530354400|FG003|Overall Study|Lost to Follow-up|1|||
147052585|NCT05317312|530354397|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
147052586|NCT05317312|530354398|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
147052587|NCT05317312|530354399|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
147052588|NCT05317312|530354400|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
147052589|NCT00837148|530354401|FG000|Overall Study|Adverse Event|1|||
147052590|NCT00837148|530354401|FG000|Overall Study|Death|1|||
147052591|NCT02301169|530354402|FG000|Overall Study|Adverse Event|1|||
147052592|NCT02301169|530354403|FG001|Overall Study|Adverse Event|0|||
147052593|NCT01422213|530354406|FG000|Overall Study|Adverse Event|8|||
147052594|NCT01422213|530354407|FG001|Overall Study|Adverse Event|7|||
147052595|NCT01422213|530354408|FG002|Overall Study|Adverse Event|11|||
147052596|NCT01422213|530354406|FG000|Overall Study|Lack of Efficacy|10|||
147052597|NCT01422213|530354407|FG001|Overall Study|Lack of Efficacy|2|||
147052598|NCT01422213|530354408|FG002|Overall Study|Lack of Efficacy|2|||
147052599|NCT01422213|530354406|FG000|Overall Study|Non-compliance with study drug|0|||
147052600|NCT01422213|530354407|FG001|Overall Study|Non-compliance with study drug|1|||
147052601|NCT01422213|530354408|FG002|Overall Study|Non-compliance with study drug|0|||
147052602|NCT01422213|530354406|FG000|Overall Study|Protocol Violation|0|||
147052603|NCT01422213|530354407|FG001|Overall Study|Protocol Violation|2|||
147052604|NCT01422213|530354408|FG002|Overall Study|Protocol Violation|4|||
147052605|NCT01422213|530354406|FG000|Overall Study|Withdrawal of Consent|7|||
147052606|NCT01422213|530354407|FG001|Overall Study|Withdrawal of Consent|3|||
147052607|NCT01422213|530354408|FG002|Overall Study|Withdrawal of Consent|5|||
147052608|NCT01422213|530354406|FG000|Overall Study|Lost to Follow-up|3|||
147052609|NCT01422213|530354407|FG001|Overall Study|Lost to Follow-up|3|||
147052610|NCT01422213|530354408|FG002|Overall Study|Lost to Follow-up|5|||
147052611|NCT01422213|530354406|FG000|Overall Study|Administrative or Other Reason(s)|5|||
147052612|NCT01422213|530354407|FG001|Overall Study|Administrative or Other Reason(s)|4|||
147052613|NCT01422213|530354408|FG002|Overall Study|Administrative or Other Reason(s)|2|||
147052614|NCT03762265|530354411|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
147052615|NCT03762265|530354412|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
147052616|NCT03762265|530354411|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
147052617|NCT03762265|530354412|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
147052618|NCT03762265|530354411|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
147052619|NCT03762265|530354412|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
147052620|NCT03762265|530354411|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
147052621|NCT03762265|530354412|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
147052622|NCT03762265|530354411|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
147052623|NCT03762265|530354412|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
147052624|NCT03762265|530354411|FG000|BT Period: Weeks 1 to 37|Other|0|||
147052625|NCT03762265|530354412|FG001|BT Period: Weeks 1 to 37|Other|1|||
147052626|NCT03762265|530354411|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
147052627|NCT03762265|530354412|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
147052628|NCT03762265|530354411|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
147052629|NCT03762265|530354412|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
147052630|NCT03762265|530354411|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
147052631|NCT03762265|530354412|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
147052632|NCT03762265|530354411|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
147052633|NCT03762265|530354412|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
147052634|NCT03762265|530354411|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
147052635|NCT03762265|530354412|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
147052636|NCT03762265|530354411|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
147052637|NCT03762265|530354412|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
147052638|NCT03762265|530354411|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
147052639|NCT03762265|530354412|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
147052640|NCT03762265|530354411|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
147052641|NCT03762265|530354412|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
147052642|NCT03762265|530354411|FG000|LTE Period: Weeks 61 to 109|Other|1|||
147052643|NCT03762265|530354412|FG001|LTE Period: Weeks 61 to 109|Other|0|||
147052644|NCT02857816|530354413|FG000|Overall Study|Screen Failure|33|||
147052645|NCT02857816|530354413|FG000|Overall Study|Withdrawal by Subject|4|||
147052646|NCT02857816|530354413|FG000|Overall Study|Lost to Follow-up|1|||
147052647|NCT01320293|530354415|FG000|Overall Study|Lack of Efficacy|1|||
147052648|NCT01320293|530354415|FG000|Overall Study|Adverse Event|1|||
147052649|NCT00470470|530354416|FG000|Overall Study|Adverse Event|2|||
147052650|NCT00470470|530354416|FG000|Overall Study|Death|2|||
147052651|NCT00470470|530354416|FG000|Overall Study|Not treated|1|||
147052652|NCT01532934|530354417|FG000|Overall Study|Lost to Follow-up|11|||
147052653|NCT01532934|530354418|FG001|Overall Study|Lost to Follow-up|11|||
147052654|NCT01532934|530354417|FG000|Overall Study|In controlled environment|3|||
147052655|NCT01532934|530354418|FG001|Overall Study|In controlled environment|2|||
147052656|NCT03483012|530354419|FG000|Overall Study|Lack of Efficacy|6|||
147052657|NCT01597778|530354425|FG000|Overall Study|Death|7|||
147052658|NCT01597778|530354426|FG001|Overall Study|Death|10|||
147052659|NCT01597778|530354425|FG000|Overall Study|Withdrawal by Subject|3|||
147052660|NCT01597778|530354426|FG001|Overall Study|Withdrawal by Subject|4|||
147052661|NCT01597778|530354425|FG000|Overall Study|Adverse Event|1|||
147052662|NCT01597778|530354426|FG001|Overall Study|Adverse Event|1|||
147052663|NCT01597778|530354425|FG000|Overall Study|Protocol Violation|1|||
147052664|NCT01597778|530354426|FG001|Overall Study|Protocol Violation|11|||
147052665|NCT01597778|530354425|FG000|Overall Study|Transplanted off protocol|2|||
147052666|NCT01597778|530354426|FG001|Overall Study|Transplanted off protocol|3|||
147052667|NCT01149863|530354433|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
147052668|NCT03326193|530354434|FG000|Overall Study|Sponsor decision|35|||
147052669|NCT01964976|530354437|FG000|Overall Study|Protocol Violation|31|||
147052670|NCT03918629|530354438|FG000|Overall Study|Adverse Event|19|||
147052671|NCT03918629|530354439|FG001|Overall Study|Adverse Event|20|||
147052672|NCT03918629|530354438|FG000|Overall Study|Death|14|||
147052673|NCT03918629|530354439|FG001|Overall Study|Death|7|||
147052674|NCT03918629|530354438|FG000|Overall Study|Lost to Follow-up|36|||
147052675|NCT03918629|530354439|FG001|Overall Study|Lost to Follow-up|28|||
147052676|NCT03918629|530354438|FG000|Overall Study|Physician Decision|1|||
147052677|NCT03918629|530354439|FG001|Overall Study|Physician Decision|0|||
147052678|NCT03918629|530354438|FG000|Overall Study|Protocol Violation|7|||
147052679|NCT03918629|530354439|FG001|Overall Study|Protocol Violation|4|||
147052680|NCT03918629|530354438|FG000|Overall Study|Withdrawal by Subject|47|||
147052681|NCT03918629|530354439|FG001|Overall Study|Withdrawal by Subject|47|||
147052682|NCT03918629|530354438|FG000|Overall Study|Other|7|||
147052683|NCT03918629|530354439|FG001|Overall Study|Other|11|||
147052684|NCT03918629|530354438|FG000|Overall Study|Randomized but not vaccinated|2|||
147052685|NCT03918629|530354439|FG001|Overall Study|Randomized but not vaccinated|1|||
147052686|NCT01891864|530354440|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
147052687|NCT01891864|530354441|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
147052688|NCT01891864|530354442|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
147052689|NCT01891864|530354443|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
147052690|NCT01891864|530354444|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
147052691|NCT01891864|530354445|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
147052692|NCT01891864|530354440|FG000|Treatment Period 1|Physician Decision|0|||
147052693|NCT01891864|530354441|FG001|Treatment Period 1|Physician Decision|1|||
147052694|NCT01891864|530354442|FG002|Treatment Period 1|Physician Decision|0|||
147052695|NCT01891864|530354443|FG003|Treatment Period 1|Physician Decision|0|||
147052696|NCT01891864|530354444|FG004|Treatment Period 1|Physician Decision|0|||
147052697|NCT01891864|530354445|FG005|Treatment Period 1|Physician Decision|0|||
147052698|NCT01891864|530354440|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
147052699|NCT01891864|530354441|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
147052700|NCT01891864|530354442|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
147052701|NCT01891864|530354443|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
147052702|NCT01891864|530354444|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
147052703|NCT01891864|530354445|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
147052704|NCT01891864|530354440|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
147052705|NCT01891864|530354441|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
147052706|NCT01891864|530354442|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
147052707|NCT01891864|530354443|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
147052708|NCT01891864|530354444|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
147052709|NCT01891864|530354445|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
147052710|NCT01891864|530354440|FG000|Treatment Period 1|Withdrawal by Subject|2|||
147052711|NCT01891864|530354441|FG001|Treatment Period 1|Withdrawal by Subject|5|||
147052712|NCT01891864|530354442|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147052713|NCT01891864|530354443|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147052714|NCT01891864|530354444|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147052715|NCT01891864|530354445|FG005|Treatment Period 1|Withdrawal by Subject|0|||
147052716|NCT01891864|530354440|FG000|Treatment Period 1|Lost to Follow-up|1|||
147052717|NCT01891864|530354441|FG001|Treatment Period 1|Lost to Follow-up|0|||
147052718|NCT01891864|530354442|FG002|Treatment Period 1|Lost to Follow-up|0|||
147052719|NCT01891864|530354443|FG003|Treatment Period 1|Lost to Follow-up|0|||
147052720|NCT01891864|530354444|FG004|Treatment Period 1|Lost to Follow-up|0|||
147052721|NCT01891864|530354445|FG005|Treatment Period 1|Lost to Follow-up|0|||
147052722|NCT01891864|530354440|FG000|Treatment Period 2|Protocol Violation|0|||
147052723|NCT01891864|530354441|FG001|Treatment Period 2|Protocol Violation|0|||
147052724|NCT01891864|530354442|FG002|Treatment Period 2|Protocol Violation|0|||
147052725|NCT01891864|530354443|FG003|Treatment Period 2|Protocol Violation|1|||
147052726|NCT01891864|530354444|FG004|Treatment Period 2|Protocol Violation|0|||
147052727|NCT01891864|530354445|FG005|Treatment Period 2|Protocol Violation|0|||
147052728|NCT01891864|530354440|FG000|Treatment Period 2|Physician Decision|0|||
147052729|NCT01891864|530354441|FG001|Treatment Period 2|Physician Decision|0|||
147052730|NCT01891864|530354442|FG002|Treatment Period 2|Physician Decision|1|||
147052731|NCT01891864|530354443|FG003|Treatment Period 2|Physician Decision|0|||
147052732|NCT01891864|530354444|FG004|Treatment Period 2|Physician Decision|0|||
147052733|NCT01891864|530354445|FG005|Treatment Period 2|Physician Decision|0|||
147052734|NCT01891864|530354440|FG000|Treatment Period 2|Site Termination|0|||
147052735|NCT01891864|530354441|FG001|Treatment Period 2|Site Termination|0|||
147052736|NCT01891864|530354442|FG002|Treatment Period 2|Site Termination|1|||
147052737|NCT01891864|530354443|FG003|Treatment Period 2|Site Termination|2|||
147052738|NCT01891864|530354444|FG004|Treatment Period 2|Site Termination|0|||
147052739|NCT01891864|530354445|FG005|Treatment Period 2|Site Termination|0|||
147052740|NCT01891864|530354440|FG000|Treatment Period 2|Lack of Efficacy|0|||
147052741|NCT01891864|530354441|FG001|Treatment Period 2|Lack of Efficacy|0|||
147052742|NCT01891864|530354442|FG002|Treatment Period 2|Lack of Efficacy|1|||
147052743|NCT01891864|530354443|FG003|Treatment Period 2|Lack of Efficacy|0|||
147052744|NCT01891864|530354444|FG004|Treatment Period 2|Lack of Efficacy|1|||
147052745|NCT01891864|530354445|FG005|Treatment Period 2|Lack of Efficacy|0|||
147052746|NCT01891864|530354440|FG000|Treatment Period 2|Adverse Event|0|||
147052747|NCT01891864|530354441|FG001|Treatment Period 2|Adverse Event|0|||
147052748|NCT01891864|530354442|FG002|Treatment Period 2|Adverse Event|1|||
147052749|NCT01891864|530354443|FG003|Treatment Period 2|Adverse Event|2|||
147052750|NCT01891864|530354444|FG004|Treatment Period 2|Adverse Event|0|||
147052751|NCT01891864|530354445|FG005|Treatment Period 2|Adverse Event|4|||
147052752|NCT01891864|530354440|FG000|Treatment Period 2|Termination of Site|0|||
147052753|NCT01891864|530354441|FG001|Treatment Period 2|Termination of Site|0|||
147052754|NCT01891864|530354442|FG002|Treatment Period 2|Termination of Site|0|||
147052755|NCT01891864|530354443|FG003|Treatment Period 2|Termination of Site|0|||
147052756|NCT01891864|530354444|FG004|Treatment Period 2|Termination of Site|2|||
147052757|NCT01891864|530354445|FG005|Treatment Period 2|Termination of Site|0|||
147052758|NCT01891864|530354440|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147052759|NCT01891864|530354441|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147052760|NCT01891864|530354442|FG002|Treatment Period 2|Withdrawal by Subject|3|||
147052761|NCT01891864|530354443|FG003|Treatment Period 2|Withdrawal by Subject|4|||
147052762|NCT01891864|530354444|FG004|Treatment Period 2|Withdrawal by Subject|1|||
147052763|NCT01891864|530354445|FG005|Treatment Period 2|Withdrawal by Subject|1|||
147052764|NCT01891864|530354440|FG000|Extension Period|Lack of Efficacy|0|||
147052765|NCT01891864|530354441|FG001|Extension Period|Lack of Efficacy|0|||
147052766|NCT01891864|530354442|FG002|Extension Period|Lack of Efficacy|0|||
147052767|NCT01891864|530354443|FG003|Extension Period|Lack of Efficacy|1|||
147052768|NCT01891864|530354444|FG004|Extension Period|Lack of Efficacy|1|||
147052769|NCT01891864|530354445|FG005|Extension Period|Lack of Efficacy|0|||
147052770|NCT01891864|530354440|FG000|Extension Period|Pregnancy|0|||
147052771|NCT01891864|530354441|FG001|Extension Period|Pregnancy|0|||
147052772|NCT01891864|530354442|FG002|Extension Period|Pregnancy|1|||
147052773|NCT01891864|530354443|FG003|Extension Period|Pregnancy|0|||
147052774|NCT01891864|530354444|FG004|Extension Period|Pregnancy|0|||
147052775|NCT01891864|530354445|FG005|Extension Period|Pregnancy|0|||
147052776|NCT01891864|530354440|FG000|Extension Period|Adverse Event|0|||
147052777|NCT01891864|530354441|FG001|Extension Period|Adverse Event|0|||
147052778|NCT01891864|530354442|FG002|Extension Period|Adverse Event|4|||
147052779|NCT01891864|530354443|FG003|Extension Period|Adverse Event|2|||
147052780|NCT01891864|530354444|FG004|Extension Period|Adverse Event|2|||
147052781|NCT01891864|530354445|FG005|Extension Period|Adverse Event|0|||
147052782|NCT01891864|530354440|FG000|Extension Period|Withdrawal by Subject|0|||
147052783|NCT01891864|530354441|FG001|Extension Period|Withdrawal by Subject|0|||
147052784|NCT01891864|530354442|FG002|Extension Period|Withdrawal by Subject|1|||
147052785|NCT01891864|530354443|FG003|Extension Period|Withdrawal by Subject|2|||
147052786|NCT01891864|530354444|FG004|Extension Period|Withdrawal by Subject|4|||
147052787|NCT01891864|530354445|FG005|Extension Period|Withdrawal by Subject|0|||
147052788|NCT01891864|530354440|FG000|Extension Period|Lost to Follow-up|0|||
147052789|NCT01891864|530354441|FG001|Extension Period|Lost to Follow-up|0|||
147052790|NCT01891864|530354442|FG002|Extension Period|Lost to Follow-up|2|||
147052791|NCT01891864|530354443|FG003|Extension Period|Lost to Follow-up|0|||
147052792|NCT01891864|530354444|FG004|Extension Period|Lost to Follow-up|0|||
147052793|NCT01891864|530354445|FG005|Extension Period|Lost to Follow-up|0|||
147052794|NCT04314037|530354452|FG000|Treatment Period 2|Adverse Event|1|||
147052795|NCT04314037|530354453|FG001|Treatment Period 2|Adverse Event|0|||
147052796|NCT04314037|530354452|FG000|Treatment Period 3|Protocol Violation|1|||
147052797|NCT04314037|530354453|FG001|Treatment Period 3|Protocol Violation|0|||
147052798|NCT04314037|530354452|FG000|Treatment Period 3|Adverse Event|0|||
147052799|NCT04314037|530354453|FG001|Treatment Period 3|Adverse Event|1|||
147052800|NCT00273182|530354455|FG000|Overall Study|Death|450|||
147052801|NCT00273182|530354455|FG000|Overall Study|Lost to Follow-up|88|||
147052802|NCT00273182|530354455|FG000|Overall Study|Withdrawal by Subject|257|||
147052803|NCT00273182|530354455|FG000|Overall Study|Device/System Explant|154|||
147052804|NCT00273182|530354455|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
147052805|NCT00856492|530354458|FG000|Overall Study|Ineligible or withdrew consent|1|||
147052806|NCT00856492|530354459|FG001|Overall Study|Ineligible or withdrew consent|1|||
147052807|NCT00856492|530354460|FG002|Overall Study|Ineligible or withdrew consent|2|||
147052808|NCT03832686|530354461|FG000|Overall Study|Lost to Follow-up|6|||
147052809|NCT03832686|530354462|FG001|Overall Study|Lost to Follow-up|9|||
147052810|NCT03832686|530354461|FG000|Overall Study|Discontinued Intervention|5|||
147052811|NCT03832686|530354462|FG001|Overall Study|Discontinued Intervention|4|||
147052812|NCT03323398|530354463|FG000|Overall Study|Other than Specified|0|||
147052813|NCT03323398|530354464|FG001|Overall Study|Other than Specified|1|||
147052814|NCT03323398|530354465|FG002|Overall Study|Other than Specified|2|||
147052815|NCT03323398|530354466|FG003|Overall Study|Other than Specified|0|||
147052816|NCT03323398|530354467|FG004|Overall Study|Other than Specified|0|||
147052817|NCT03323398|530354468|FG005|Overall Study|Other than Specified|0|||
147052818|NCT03323398|530354469|FG006|Overall Study|Other than Specified|1|||
147052819|NCT03323398|530354470|FG007|Overall Study|Other than Specified|0|||
147052820|NCT03323398|530354471|FG008|Overall Study|Other than Specified|2|||
147052821|NCT03323398|530354463|FG000|Overall Study|Lost to Follow-up|1|||
147052822|NCT03323398|530354464|FG001|Overall Study|Lost to Follow-up|2|||
147052823|NCT03323398|530354465|FG002|Overall Study|Lost to Follow-up|1|||
147052824|NCT03323398|530354466|FG003|Overall Study|Lost to Follow-up|0|||
147052825|NCT03323398|530354467|FG004|Overall Study|Lost to Follow-up|0|||
147052826|NCT03323398|530354468|FG005|Overall Study|Lost to Follow-up|0|||
147052827|NCT03323398|530354469|FG006|Overall Study|Lost to Follow-up|0|||
147052828|NCT03323398|530354470|FG007|Overall Study|Lost to Follow-up|0|||
147052829|NCT03323398|530354471|FG008|Overall Study|Lost to Follow-up|0|||
147052830|NCT03323398|530354463|FG000|Overall Study|Death|4|||
147052831|NCT03323398|530354464|FG001|Overall Study|Death|6|||
147052832|NCT03323398|530354465|FG002|Overall Study|Death|2|||
147052833|NCT03323398|530354466|FG003|Overall Study|Death|2|||
147052834|NCT03323398|530354467|FG004|Overall Study|Death|1|||
147052835|NCT03323398|530354468|FG005|Overall Study|Death|2|||
147052836|NCT03323398|530354469|FG006|Overall Study|Death|0|||
147052837|NCT03323398|530354470|FG007|Overall Study|Death|0|||
147052838|NCT03323398|530354471|FG008|Overall Study|Death|6|||
147052839|NCT03323398|530354463|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
147052840|NCT03323398|530354464|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
147052841|NCT03323398|530354465|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
147052842|NCT03323398|530354466|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
147052843|NCT03323398|530354467|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
147052844|NCT03323398|530354468|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
147052845|NCT03323398|530354469|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
147052846|NCT03323398|530354470|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
147052847|NCT03323398|530354471|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
147052848|NCT03323398|530354463|FG000|Overall Study|Withdrawal by Subject|2|||
147052849|NCT03323398|530354464|FG001|Overall Study|Withdrawal by Subject|1|||
147052850|NCT03323398|530354465|FG002|Overall Study|Withdrawal by Subject|3|||
147052851|NCT03323398|530354466|FG003|Overall Study|Withdrawal by Subject|0|||
147052852|NCT03323398|530354467|FG004|Overall Study|Withdrawal by Subject|0|||
147052853|NCT03323398|530354468|FG005|Overall Study|Withdrawal by Subject|1|||
147052854|NCT03323398|530354469|FG006|Overall Study|Withdrawal by Subject|0|||
147052855|NCT03323398|530354470|FG007|Overall Study|Withdrawal by Subject|0|||
147052856|NCT03323398|530354471|FG008|Overall Study|Withdrawal by Subject|0|||
147052857|NCT03323398|530354463|FG000|Overall Study|Participant was Put on Hospice|0|||
147052858|NCT03323398|530354464|FG001|Overall Study|Participant was Put on Hospice|0|||
147052859|NCT03323398|530354465|FG002|Overall Study|Participant was Put on Hospice|0|||
147052860|NCT03323398|530354466|FG003|Overall Study|Participant was Put on Hospice|0|||
147052861|NCT03323398|530354467|FG004|Overall Study|Participant was Put on Hospice|0|||
147052862|NCT03323398|530354468|FG005|Overall Study|Participant was Put on Hospice|0|||
147052863|NCT03323398|530354469|FG006|Overall Study|Participant was Put on Hospice|1|||
147052864|NCT03323398|530354470|FG007|Overall Study|Participant was Put on Hospice|0|||
147052865|NCT03323398|530354471|FG008|Overall Study|Participant was Put on Hospice|0|||
147052866|NCT03323398|530354463|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
147052867|NCT03323398|530354464|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
147052868|NCT03323398|530354465|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
147052869|NCT03323398|530354466|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
147052870|NCT03323398|530354467|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
147052871|NCT03323398|530354468|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
147052872|NCT03323398|530354469|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
147052873|NCT03323398|530354470|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
147052874|NCT03323398|530354471|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
147052875|NCT02235454|530354472|FG000|Overall Study|Withdrawal by Subject|2|||
147052876|NCT03641469|530354473|FG000|Overall Study|Ineligible|2|||
147052877|NCT03641469|530354473|FG000|Overall Study|Withdrawal by Subject|5|||
147052878|NCT03641469|530354473|FG000|Overall Study|Physician Decision|1|||
147052879|NCT03641469|530354473|FG000|Overall Study|Protocol Violation|1|||
147052880|NCT03641469|530354473|FG000|Overall Study|Lost to Follow-up|2|||
147052881|NCT05479435|530354474|FG000|Overall Study|Withdrawal by Subject|1|||
147052882|NCT05479435|530354475|FG001|Overall Study|Withdrawal by Subject|0|||
147052883|NCT05479435|530354476|FG002|Overall Study|Withdrawal by Subject|0|||
147052884|NCT05479435|530354474|FG000|Overall Study|Covid 19|0|||
147052885|NCT05479435|530354475|FG001|Overall Study|Covid 19|0|||
147052886|NCT05479435|530354476|FG002|Overall Study|Covid 19|2|||
147052887|NCT00955617|530354480|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
147052888|NCT00955617|530354481|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
147052889|NCT00955617|530354480|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
147052890|NCT00955617|530354481|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
147052891|NCT00955617|530354480|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
147052892|NCT00955617|530354481|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
147052893|NCT00955617|530354480|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
147052894|NCT00955617|530354481|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
147052895|NCT04581824|530356107|FG000|Overall Study|Lost to Follow-up|1|||
147052896|NCT04581824|530356108|FG001|Overall Study|Lost to Follow-up|0|||
147052897|NCT04581824|530356107|FG000|Overall Study|Withdrawal by Subject|2|||
147052898|NCT04581824|530356108|FG001|Overall Study|Withdrawal by Subject|7|||
147052899|NCT04581824|530356107|FG000|Overall Study|Study terminated by sponsor|37|||
147052900|NCT04581824|530356108|FG001|Overall Study|Study terminated by sponsor|23|||
147052901|NCT04796909|530356109|FG000|Overall Study|Withdrawal by Subject|1|||
147052902|NCT04796909|530356110|FG001|Overall Study|Withdrawal by Subject|1|||
147052903|NCT03879135|530356111|FG000|Overall Study|Physician Decision|0|||
147052904|NCT03879135|530356112|FG001|Overall Study|Physician Decision|0|||
147052905|NCT03879135|530356113|FG002|Overall Study|Physician Decision|0|||
147052906|NCT03879135|530356114|FG003|Overall Study|Physician Decision|1|||
147052907|NCT03879135|530356115|FG004|Overall Study|Physician Decision|0|||
147052908|NCT03879135|530356116|FG005|Overall Study|Physician Decision|0|||
147052909|NCT03879135|530356111|FG000|Overall Study|Withdrawal by Subject|0|||
147052910|NCT03879135|530356112|FG001|Overall Study|Withdrawal by Subject|0|||
147052911|NCT03879135|530356113|FG002|Overall Study|Withdrawal by Subject|0|||
147052912|NCT03879135|530356114|FG003|Overall Study|Withdrawal by Subject|0|||
147052913|NCT03879135|530356115|FG004|Overall Study|Withdrawal by Subject|0|||
147052914|NCT03879135|530356116|FG005|Overall Study|Withdrawal by Subject|1|||
147052915|NCT03879135|530356111|FG000|Overall Study|Site Closed by Sponsor|0|||
147052916|NCT03879135|530356112|FG001|Overall Study|Site Closed by Sponsor|0|||
147052917|NCT03879135|530356113|FG002|Overall Study|Site Closed by Sponsor|0|||
147052918|NCT03879135|530356114|FG003|Overall Study|Site Closed by Sponsor|1|||
147052919|NCT03879135|530356115|FG004|Overall Study|Site Closed by Sponsor|1|||
147052920|NCT03879135|530356116|FG005|Overall Study|Site Closed by Sponsor|0|||
147052921|NCT04162847|530356117|FG000|Overall Study|Withdrawal by Subject|7|||
147052922|NCT04162847|530356118|FG001|Overall Study|Withdrawal by Subject|1|||
147052923|NCT04815083|530356119|FG000|Overall Study|Physician Decision|1|||
147052924|NCT04815083|530356119|FG000|Overall Study|Study pause|2|||
147052925|NCT04815083|530356119|FG000|Overall Study|Screening failure|4|||
147052926|NCT01892501|530356120|FG000|Overall Study|Protocol Violation|2|||
147052927|NCT01892501|530356120|FG000|Overall Study|Puncture not carried out|9|||
147052928|NCT01892501|530356120|FG000|Overall Study|Radiological monitoring not carried out|5|||
147052929|NCT01892501|530356120|FG000|Overall Study|Non-contributory histological result|12|||
147052930|NCT02383017|530356127|FG000|Overall Study|Injury Sustained Outside Study|1|||
147052931|NCT02383017|530356128|FG001|Overall Study|Injury Sustained Outside Study|0|||
147052932|NCT02383017|530356127|FG000|Overall Study|Compliance|3|||
147052933|NCT02383017|530356128|FG001|Overall Study|Compliance|2|||
147052934|NCT02383017|530356127|FG000|Overall Study|Found to be Hypogonadal|1|||
147052935|NCT02383017|530356128|FG001|Overall Study|Found to be Hypogonadal|0|||
147052936|NCT00927589|530356129|FG000|Overall Study|Death|1|||
147052937|NCT00927589|530356129|FG000|Overall Study|Physician Decision|1|||
147052938|NCT00927589|530356129|FG000|Overall Study|Withdrawal by Subject|3|||
147052939|NCT00927589|530356129|FG000|Overall Study|Adverse Event|2|||
147052940|NCT00927589|530356129|FG000|Overall Study|Disease Progression|8|||
147052941|NCT00927589|530356129|FG000|Overall Study|Non-compliance|1|||
147052942|NCT01651117|530356131|FG000|Overall Study|Death|2|||
147052943|NCT01651117|530356132|FG001|Overall Study|Death|3|||
147052944|NCT01651117|530356133|FG002|Overall Study|Death|2|||
147052945|NCT01651117|530356134|FG003|Overall Study|Death|2|||
147052946|NCT02088177|530356135|FG000|Overall Study|Lost to Follow-up|3|||
147052947|NCT00289848|530356136|FG000|Overall Study|Adverse Event|6|||
147052948|NCT00289848|530356137|FG001|Overall Study|Adverse Event|4|||
147052949|NCT00289848|530356136|FG000|Overall Study|Death|1|||
147052950|NCT00289848|530356137|FG001|Overall Study|Death|0|||
147052951|NCT00289848|530356136|FG000|Overall Study|Lack of Efficacy|20|||
147052952|NCT00289848|530356137|FG001|Overall Study|Lack of Efficacy|24|||
147052953|NCT00289848|530356136|FG000|Overall Study|Lost to Follow-up|3|||
147052954|NCT00289848|530356137|FG001|Overall Study|Lost to Follow-up|1|||
147052955|NCT00289848|530356136|FG000|Overall Study|Protocol Violation|5|||
147052956|NCT00289848|530356137|FG001|Overall Study|Protocol Violation|2|||
147052957|NCT00289848|530356136|FG000|Overall Study|Withdrawal by Subject|5|||
147052958|NCT00289848|530356137|FG001|Overall Study|Withdrawal by Subject|11|||
147052959|NCT00289848|530356136|FG000|Overall Study|Patient Moved|6|||
147052960|NCT00289848|530356137|FG001|Overall Study|Patient Moved|2|||
147052961|NCT00289848|530356136|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
147052962|NCT00289848|530356137|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
147052963|NCT01894919|530356138|FG000|Overall Study|Withdrawal by Subject|1|||
147052964|NCT01894919|530356139|FG001|Overall Study|Withdrawal by Subject|0|||
147052965|NCT01894919|530356140|FG002|Overall Study|Withdrawal by Subject|0|||
147052966|NCT01894919|530356141|FG003|Overall Study|Withdrawal by Subject|0|||
147052967|NCT01894919|530356142|FG004|Overall Study|Withdrawal by Subject|1|||
147052968|NCT01894919|530356143|FG005|Overall Study|Withdrawal by Subject|0|||
147052969|NCT01894919|530356144|FG006|Overall Study|Withdrawal by Subject|0|||
147052970|NCT01894919|530356145|FG007|Overall Study|Withdrawal by Subject|0|||
147052971|NCT01894919|530356146|FG008|Overall Study|Withdrawal by Subject|0|||
147052972|NCT01894919|530356147|FG009|Overall Study|Withdrawal by Subject|1|||
146850055|NCT00911937|529620706|FG001|Overall Study|Death|0|||
147052973|NCT01894919|530356148|FG010|Overall Study|Withdrawal by Subject|1|||
147052974|NCT01894919|530356149|FG011|Overall Study|Withdrawal by Subject|0|||
147052975|NCT01894919|530356150|FG012|Overall Study|Withdrawal by Subject|0|||
147052976|NCT01894919|530356138|FG000|Overall Study|Adverse Event|0|||
147052977|NCT01894919|530356139|FG001|Overall Study|Adverse Event|0|||
147052978|NCT01894919|530356140|FG002|Overall Study|Adverse Event|0|||
147052979|NCT01894919|530356141|FG003|Overall Study|Adverse Event|0|||
147052980|NCT01894919|530356142|FG004|Overall Study|Adverse Event|0|||
147052981|NCT01894919|530356143|FG005|Overall Study|Adverse Event|0|||
147052982|NCT01894919|530356144|FG006|Overall Study|Adverse Event|0|||
147052983|NCT01894919|530356145|FG007|Overall Study|Adverse Event|0|||
147052984|NCT01894919|530356146|FG008|Overall Study|Adverse Event|0|||
147052985|NCT01894919|530356147|FG009|Overall Study|Adverse Event|0|||
147052986|NCT01894919|530356148|FG010|Overall Study|Adverse Event|1|||
147052987|NCT01894919|530356149|FG011|Overall Study|Adverse Event|0|||
147052988|NCT01894919|530356150|FG012|Overall Study|Adverse Event|0|||
147052989|NCT01894919|530356138|FG000|Overall Study|Other-Unspecified|1|||
147052990|NCT01894919|530356139|FG001|Overall Study|Other-Unspecified|0|||
147052991|NCT01894919|530356140|FG002|Overall Study|Other-Unspecified|0|||
147052992|NCT01894919|530356141|FG003|Overall Study|Other-Unspecified|0|||
147052993|NCT01894919|530356142|FG004|Overall Study|Other-Unspecified|0|||
147052994|NCT01894919|530356143|FG005|Overall Study|Other-Unspecified|0|||
147052995|NCT01894919|530356144|FG006|Overall Study|Other-Unspecified|0|||
147052996|NCT01894919|530356145|FG007|Overall Study|Other-Unspecified|0|||
147052997|NCT01894919|530356146|FG008|Overall Study|Other-Unspecified|0|||
147052998|NCT01894919|530356147|FG009|Overall Study|Other-Unspecified|0|||
147052999|NCT01894919|530356148|FG010|Overall Study|Other-Unspecified|0|||
147053000|NCT01894919|530356149|FG011|Overall Study|Other-Unspecified|0|||
147053001|NCT01894919|530356150|FG012|Overall Study|Other-Unspecified|0|||
147053002|NCT01894919|530356138|FG000|Overall Study|Lost to Follow-up|0|||
147053003|NCT01894919|530356139|FG001|Overall Study|Lost to Follow-up|0|||
147053004|NCT01894919|530356140|FG002|Overall Study|Lost to Follow-up|0|||
147053005|NCT01894919|530356141|FG003|Overall Study|Lost to Follow-up|0|||
147053006|NCT01894919|530356142|FG004|Overall Study|Lost to Follow-up|2|||
147053007|NCT01894919|530356143|FG005|Overall Study|Lost to Follow-up|0|||
147053008|NCT01894919|530356144|FG006|Overall Study|Lost to Follow-up|0|||
147053009|NCT01894919|530356145|FG007|Overall Study|Lost to Follow-up|0|||
147053010|NCT01894919|530356146|FG008|Overall Study|Lost to Follow-up|0|||
147053011|NCT01894919|530356147|FG009|Overall Study|Lost to Follow-up|0|||
147053012|NCT01894919|530356148|FG010|Overall Study|Lost to Follow-up|0|||
147053013|NCT01894919|530356149|FG011|Overall Study|Lost to Follow-up|0|||
147053014|NCT01894919|530356150|FG012|Overall Study|Lost to Follow-up|0|||
147053015|NCT03428152|530356153|FG000|Overall Study|Physician Decision|4|||
147053016|NCT03428152|530356154|FG001|Overall Study|Physician Decision|2|||
147053017|NCT03428152|530356153|FG000|Overall Study|Protocol Violation|3|||
147053018|NCT03428152|530356154|FG001|Overall Study|Protocol Violation|5|||
147053019|NCT03428152|530356153|FG000|Overall Study|Lack of Efficacy|0|||
147053020|NCT03428152|530356154|FG001|Overall Study|Lack of Efficacy|4|||
147053021|NCT01836471|530356161|FG000|Overall Study|Pregnancy|1|||
147053022|NCT01836471|530356162|FG001|Overall Study|Pregnancy|0|||
147053023|NCT01836471|530356163|FG002|Overall Study|Pregnancy|0|||
147053024|NCT01836471|530356164|FG003|Overall Study|Pregnancy|0|||
147053025|NCT01836471|530356165|FG004|Overall Study|Pregnancy|0|||
147053026|NCT01836471|530356161|FG000|Overall Study|Withdrawal by Subject|3|||
147053027|NCT01836471|530356162|FG001|Overall Study|Withdrawal by Subject|4|||
147053028|NCT01836471|530356163|FG002|Overall Study|Withdrawal by Subject|1|||
147053029|NCT01836471|530356164|FG003|Overall Study|Withdrawal by Subject|0|||
147053030|NCT01836471|530356165|FG004|Overall Study|Withdrawal by Subject|2|||
147053031|NCT01836471|530356161|FG000|Overall Study|Physician Decision|0|||
147053032|NCT01836471|530356162|FG001|Overall Study|Physician Decision|1|||
147053033|NCT01836471|530356163|FG002|Overall Study|Physician Decision|0|||
147053034|NCT01836471|530356164|FG003|Overall Study|Physician Decision|0|||
147053035|NCT01836471|530356165|FG004|Overall Study|Physician Decision|0|||
147053036|NCT01836471|530356161|FG000|Overall Study|Lost to Follow-up|0|||
147053037|NCT01836471|530356162|FG001|Overall Study|Lost to Follow-up|0|||
147053038|NCT01836471|530356163|FG002|Overall Study|Lost to Follow-up|0|||
147053039|NCT01836471|530356164|FG003|Overall Study|Lost to Follow-up|1|||
147053040|NCT01836471|530356165|FG004|Overall Study|Lost to Follow-up|1|||
147053041|NCT01836471|530356161|FG000|Overall Study|Adverse Event|6|||
147053042|NCT01836471|530356162|FG001|Overall Study|Adverse Event|3|||
147053043|NCT01836471|530356163|FG002|Overall Study|Adverse Event|1|||
147053044|NCT01836471|530356164|FG003|Overall Study|Adverse Event|1|||
147053045|NCT01836471|530356165|FG004|Overall Study|Adverse Event|2|||
147053046|NCT01836471|530356161|FG000|Overall Study|Non compliance with tx|1|||
147053047|NCT01836471|530356162|FG001|Overall Study|Non compliance with tx|1|||
147053048|NCT01836471|530356163|FG002|Overall Study|Non compliance with tx|0|||
147053049|NCT01836471|530356164|FG003|Overall Study|Non compliance with tx|0|||
147053050|NCT01836471|530356165|FG004|Overall Study|Non compliance with tx|0|||
147053051|NCT05506046|530356166|FG000|Overall Study|Lost to Follow-up|89|||
147053052|NCT05506046|530356167|FG001|Overall Study|Lost to Follow-up|101|||
147053053|NCT05506046|530356168|FG002|Overall Study|Lost to Follow-up|102|||
147053054|NCT05506046|530356169|FG003|Overall Study|Lost to Follow-up|99|||
147053055|NCT00191477|530356171|FG000|Overall Study|Tumor Recurrence|49|||
147053056|NCT00191477|530356172|FG001|Overall Study|Tumor Recurrence|48|||
147053057|NCT00191477|530356171|FG000|Overall Study|Death, Study Disease|1|||
147053058|NCT00191477|530356172|FG001|Overall Study|Death, Study Disease|1|||
147053059|NCT00191477|530356171|FG000|Overall Study|Death, Other Cause|3|||
147053060|NCT00191477|530356172|FG001|Overall Study|Death, Other Cause|6|||
147053061|NCT00191477|530356171|FG000|Overall Study|Lost to Follow-up|23|||
147053062|NCT00191477|530356172|FG001|Overall Study|Lost to Follow-up|21|||
147053063|NCT00191477|530356171|FG000|Overall Study|Protocol Violation|1|||
147053064|NCT00191477|530356172|FG001|Overall Study|Protocol Violation|1|||
147053065|NCT00191477|530356171|FG000|Overall Study|Treatment Change|2|||
147053066|NCT00191477|530356172|FG001|Overall Study|Treatment Change|0|||
147053067|NCT00191477|530356171|FG000|Overall Study|Withdrawal by Subject|2|||
147053068|NCT00191477|530356172|FG001|Overall Study|Withdrawal by Subject|0|||
147053069|NCT00191477|530356171|FG000|Overall Study|Other|2|||
147053070|NCT00191477|530356172|FG001|Overall Study|Other|0|||
147053071|NCT00191477|530356171|FG000|Overall Study|Not Eligible|41|||
147053072|NCT00191477|530356172|FG001|Overall Study|Not Eligible|38|||
147053073|NCT00191477|530356171|FG000|Overall Study|Pathological Specimen Lost|1|||
147053074|NCT00191477|530356172|FG001|Overall Study|Pathological Specimen Lost|0|||
147053075|NCT00191477|530356171|FG000|Overall Study|Discontinued Prior to Instillation|13|||
147053076|NCT00191477|530356172|FG001|Overall Study|Discontinued Prior to Instillation|14|||
147053077|NCT03776357|530356178|FG000|Overall Study|Lost to Follow-up|3|||
147053078|NCT01286467|530356181|FG000|Overall Study|Death|1|||
147053079|NCT01286467|530356182|FG001|Overall Study|Death|1|||
147053080|NCT01286467|530356183|FG002|Overall Study|Death|1|||
147053081|NCT01286467|530356184|FG003|Overall Study|Death|0|||
147053082|NCT01286467|530356181|FG000|Overall Study|Lost to Follow-up|0|||
147053083|NCT01286467|530356182|FG001|Overall Study|Lost to Follow-up|0|||
147053084|NCT01286467|530356183|FG002|Overall Study|Lost to Follow-up|0|||
147053085|NCT01286467|530356184|FG003|Overall Study|Lost to Follow-up|1|||
147053086|NCT01286467|530356181|FG000|Overall Study|Withdrawal by Subject|0|||
147053087|NCT01286467|530356182|FG001|Overall Study|Withdrawal by Subject|0|||
147053088|NCT01286467|530356183|FG002|Overall Study|Withdrawal by Subject|1|||
147053089|NCT01286467|530356184|FG003|Overall Study|Withdrawal by Subject|0|||
147053090|NCT01286467|530356181|FG000|Overall Study|Physician Decision|0|||
147053091|NCT01286467|530356182|FG001|Overall Study|Physician Decision|0|||
147053092|NCT01286467|530356183|FG002|Overall Study|Physician Decision|0|||
147053093|NCT01286467|530356184|FG003|Overall Study|Physician Decision|1|||
147053094|NCT01286467|530356181|FG000|Overall Study|Disease progression|3|||
147053095|NCT01286467|530356182|FG001|Overall Study|Disease progression|2|||
147053096|NCT01286467|530356183|FG002|Overall Study|Disease progression|2|||
147053097|NCT01286467|530356184|FG003|Overall Study|Disease progression|3|||
147053098|NCT01286467|530356181|FG000|Overall Study|Adverse Event|0|||
147053099|NCT01286467|530356182|FG001|Overall Study|Adverse Event|1|||
147053100|NCT01286467|530356183|FG002|Overall Study|Adverse Event|2|||
147053101|NCT01286467|530356184|FG003|Overall Study|Adverse Event|3|||
147053102|NCT01286467|530356181|FG000|Overall Study|Study drug stop longer than 14 days|0|||
147053103|NCT01286467|530356182|FG001|Overall Study|Study drug stop longer than 14 days|0|||
147053104|NCT01286467|530356183|FG002|Overall Study|Study drug stop longer than 14 days|1|||
147053105|NCT01286467|530356184|FG003|Overall Study|Study drug stop longer than 14 days|0|||
147053106|NCT01058642|530356185|FG000|Treatment Period 1|Adverse Event|0|||
147053107|NCT01058642|530356186|FG001|Treatment Period 1|Adverse Event|1|||
147053108|NCT01058642|530356187|FG002|Treatment Period 1|Adverse Event|1|||
147053109|NCT01058642|530356188|FG003|Treatment Period 1|Adverse Event|0|||
147053110|NCT01058642|530356185|FG000|Treatment Period 1|Physician Decision|0|||
147053111|NCT01058642|530356186|FG001|Treatment Period 1|Physician Decision|0|||
147053112|NCT01058642|530356187|FG002|Treatment Period 1|Physician Decision|1|||
147053113|NCT01058642|530356188|FG003|Treatment Period 1|Physician Decision|0|||
147053114|NCT01058642|530356185|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147053115|NCT01058642|530356186|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147053116|NCT01058642|530356187|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147053117|NCT01058642|530356188|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147053118|NCT01058642|530356185|FG000|Treatment Period 1|Lack of Efficacy|0|||
147053119|NCT01058642|530356186|FG001|Treatment Period 1|Lack of Efficacy|0|||
147053120|NCT01058642|530356187|FG002|Treatment Period 1|Lack of Efficacy|0|||
147053121|NCT01058642|530356188|FG003|Treatment Period 1|Lack of Efficacy|1|||
147053122|NCT01058642|530356185|FG000|Treatment Period 1|Protocol Violation|0|||
147053123|NCT01058642|530356186|FG001|Treatment Period 1|Protocol Violation|0|||
147053124|NCT01058642|530356187|FG002|Treatment Period 1|Protocol Violation|0|||
147053125|NCT01058642|530356188|FG003|Treatment Period 1|Protocol Violation|1|||
147053126|NCT01058642|530356185|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
147053127|NCT01058642|530356186|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
147053128|NCT01058642|530356187|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
147053129|NCT01058642|530356188|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
147053130|NCT02411656|530356192|FG000|Overall Study|Adverse Event|4|||
147053131|NCT02411656|530356192|FG000|Overall Study|Clinical Progression|33|||
147053132|NCT03305848|530356193|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
147053133|NCT03305848|530356193|FG000|Overall Study|Physician Decision|2|||
147053134|NCT02224157|530356195|FG000|Overall Study|Severe non-compliance to protocol|2|||
147053135|NCT02224157|530356196|FG001|Overall Study|Severe non-compliance to protocol|2|||
147053136|NCT02224157|530356195|FG000|Overall Study|Other|13|||
147053137|NCT02224157|530356196|FG001|Overall Study|Other|10|||
147053138|NCT02224157|530356195|FG000|Overall Study|Subject decision|58|||
147053139|NCT02224157|530356196|FG001|Overall Study|Subject decision|50|||
147053140|NCT02224157|530356195|FG000|Overall Study|Prematurely closed site|4|||
147053141|NCT02224157|530356196|FG001|Overall Study|Prematurely closed site|2|||
147053142|NCT02224157|530356195|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
147053143|NCT02224157|530356196|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
147053144|NCT02224157|530356195|FG000|Overall Study|Lost to Follow-up|27|||
147053145|NCT02224157|530356196|FG001|Overall Study|Lost to Follow-up|35|||
147053146|NCT02224157|530356195|FG000|Overall Study|Death|1|||
147053147|NCT02224157|530356196|FG001|Overall Study|Death|1|||
147053148|NCT02224157|530356195|FG000|Overall Study|Adverse Event|1|||
147053149|NCT02224157|530356196|FG001|Overall Study|Adverse Event|3|||
147053150|NCT01060072|530356199|FG000|Overall Study|Adverse Event|1|||
147053151|NCT01060072|530356200|FG001|Overall Study|Adverse Event|1|||
147053152|NCT01060072|530356199|FG000|Overall Study|Physician Decision|0|||
147053153|NCT01060072|530356200|FG001|Overall Study|Physician Decision|2|||
147053154|NCT01060072|530356199|FG000|Overall Study|Protocol Violation|0|||
147053155|NCT01060072|530356200|FG001|Overall Study|Protocol Violation|1|||
147053156|NCT01060072|530356199|FG000|Overall Study|Acute cholecystitis|1|||
147053157|NCT01060072|530356200|FG001|Overall Study|Acute cholecystitis|0|||
147053158|NCT01060072|530356199|FG000|Overall Study|Excluded Medications|0|||
147053159|NCT01060072|530356200|FG001|Overall Study|Excluded Medications|1|||
147053160|NCT00699998|530356203|FG000|Overall Study|Withdrawal by Subject|194|||
147053161|NCT00699998|530356204|FG001|Overall Study|Withdrawal by Subject|83|||
147053162|NCT00699998|530356205|FG002|Overall Study|Withdrawal by Subject|202|||
147053163|NCT00699998|530356206|FG003|Overall Study|Withdrawal by Subject|80|||
147053164|NCT00699998|530356203|FG000|Overall Study|Physician Decision|3|||
147053165|NCT00699998|530356204|FG001|Overall Study|Physician Decision|2|||
147053166|NCT00699998|530356205|FG002|Overall Study|Physician Decision|1|||
147053167|NCT00699998|530356206|FG003|Overall Study|Physician Decision|1|||
147053168|NCT00699998|530356203|FG000|Overall Study|Lost to Follow-up|2|||
147053169|NCT00699998|530356204|FG001|Overall Study|Lost to Follow-up|1|||
147053170|NCT00699998|530356205|FG002|Overall Study|Lost to Follow-up|3|||
147053171|NCT00699998|530356206|FG003|Overall Study|Lost to Follow-up|1|||
147053172|NCT01406574|530356207|FG000|Overall Study|Adverse Event|0|||
147053173|NCT01406574|530356208|FG001|Overall Study|Adverse Event|0|||
147053174|NCT01406574|530356209|FG002|Overall Study|Adverse Event|1|||
147053175|NCT01406574|530356210|FG003|Overall Study|Adverse Event|3|||
147053176|NCT01406574|530356207|FG000|Overall Study|Physician Decision|0|||
147053177|NCT01406574|530356208|FG001|Overall Study|Physician Decision|0|||
147053178|NCT01406574|530356209|FG002|Overall Study|Physician Decision|0|||
147053179|NCT01406574|530356210|FG003|Overall Study|Physician Decision|1|||
147053180|NCT01406574|530356207|FG000|Overall Study|Withdrawal by Subject|0|||
147053181|NCT01406574|530356208|FG001|Overall Study|Withdrawal by Subject|1|||
147053182|NCT01406574|530356209|FG002|Overall Study|Withdrawal by Subject|0|||
147053183|NCT01406574|530356210|FG003|Overall Study|Withdrawal by Subject|0|||
147053184|NCT01406574|530356207|FG000|Overall Study|Definite progression of primary disease|1|||
147053185|NCT01406574|530356208|FG001|Overall Study|Definite progression of primary disease|0|||
147053186|NCT01406574|530356209|FG002|Overall Study|Definite progression of primary disease|0|||
147053187|NCT01406574|530356210|FG003|Overall Study|Definite progression of primary disease|0|||
147053188|NCT04616612|530356217|FG000|Overall Study|Lost to Follow-up|6|||
147053189|NCT04616612|530356218|FG001|Overall Study|Lost to Follow-up|3|||
147053190|NCT04740918|530356219|FG000|Overall Study|Study Terminated by Sponsor|41|||
147053191|NCT04740918|530356220|FG001|Overall Study|Study Terminated by Sponsor|32|||
147053192|NCT04740918|530356219|FG000|Overall Study|Death|3|||
147053193|NCT04740918|530356220|FG001|Overall Study|Death|6|||
147053194|NCT04740918|530356219|FG000|Overall Study|Withdrawal by Subject|5|||
147053195|NCT04740918|530356220|FG001|Overall Study|Withdrawal by Subject|4|||
147053196|NCT04740918|530356219|FG000|Overall Study|Lost to Follow-up|1|||
147053197|NCT04740918|530356220|FG001|Overall Study|Lost to Follow-up|3|||
147053198|NCT04740918|530356219|FG000|Overall Study|Progressive disease|0|||
147053199|NCT04740918|530356220|FG001|Overall Study|Progressive disease|1|||
147053200|NCT03759392|530356223|FG000|Overall Study|Adverse Event|12|||
147053201|NCT03759392|530356224|FG001|Overall Study|Adverse Event|4|||
147053202|NCT03759392|530356223|FG000|Overall Study|Death|2|||
147053203|NCT03759392|530356224|FG001|Overall Study|Death|1|||
147053204|NCT03759392|530356223|FG000|Overall Study|Withdrawal by Subject|2|||
147053205|NCT03759392|530356224|FG001|Overall Study|Withdrawal by Subject|0|||
147053206|NCT03759392|530356223|FG000|Overall Study|Protocol Violation|2|||
147053207|NCT03759392|530356224|FG001|Overall Study|Protocol Violation|0|||
147053208|NCT03759392|530356223|FG000|Overall Study|Physician Decision|0|||
147053209|NCT03759392|530356224|FG001|Overall Study|Physician Decision|1|||
147053210|NCT03759392|530356223|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
147053211|NCT03759392|530356224|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
147053212|NCT03759392|530356223|FG000|Overall Study|No longer able to take medicines|1|||
147053213|NCT03759392|530356224|FG001|Overall Study|No longer able to take medicines|0|||
147053214|NCT03759392|530356223|FG000|Overall Study|Stopped taking study drug|1|||
147053215|NCT03759392|530356224|FG001|Overall Study|Stopped taking study drug|0|||
147053216|NCT01709500|530356225|FG000|Overall Study|Randomized but not treated|0|||
147053217|NCT01709500|530356226|FG001|Overall Study|Randomized but not treated|1|||
147053218|NCT01709500|530356225|FG000|Overall Study|Adverse Event|5|||
147053219|NCT01709500|530356226|FG001|Overall Study|Adverse Event|1|||
147053220|NCT01709500|530356225|FG000|Overall Study|Poor compliance to protocol|2|||
147053221|NCT01709500|530356226|FG001|Overall Study|Poor compliance to protocol|1|||
147053222|NCT01709500|530356225|FG000|Overall Study|Other|3|||
147053223|NCT01709500|530356226|FG001|Overall Study|Other|1|||
147053224|NCT01709500|530356225|FG000|Overall Study|Related to IMP administration|1|||
147053225|NCT01709500|530356226|FG001|Overall Study|Related to IMP administration|0|||
147053226|NCT01709500|530356225|FG000|Overall Study|Treatment ongoing|156|||
147053227|NCT01709500|530356226|FG001|Overall Study|Treatment ongoing|78|||
147053228|NCT03170544|530356227|FG000|Part 1|Lost to Follow-up|1|||
147053229|NCT03170544|530356228|FG001|Part 1|Lost to Follow-up|0|||
147053230|NCT03170544|530356229|FG002|Part 1|Lost to Follow-up|0|||
147053231|NCT03170544|530356230|FG003|Part 1|Lost to Follow-up|0|||
147053232|NCT03170544|530356231|FG004|Part 1|Lost to Follow-up|0|||
147053233|NCT03170544|530356232|FG005|Part 1|Lost to Follow-up|0|||
147053234|NCT03170544|530356233|FG006|Part 1|Lost to Follow-up|0|||
147053235|NCT03170544|530356234|FG007|Part 1|Lost to Follow-up|0|||
147053236|NCT03170544|530356235|FG008|Part 1|Lost to Follow-up|0|||
147053237|NCT03170544|530356236|FG009|Part 1|Lost to Follow-up|0|||
147053238|NCT03170544|530356237|FG010|Part 1|Lost to Follow-up|0|||
147053239|NCT03170544|530356238|FG011|Part 1|Lost to Follow-up|0|||
147053240|NCT03170544|530356227|FG000|Part 1|Not treated|0|||
147053241|NCT03170544|530356228|FG001|Part 1|Not treated|0|||
147053242|NCT03170544|530356229|FG002|Part 1|Not treated|0|||
147053243|NCT03170544|530356230|FG003|Part 1|Not treated|1|||
147053244|NCT03170544|530356231|FG004|Part 1|Not treated|0|||
147053245|NCT03170544|530356232|FG005|Part 1|Not treated|0|||
147053246|NCT03170544|530356233|FG006|Part 1|Not treated|0|||
147053247|NCT03170544|530356234|FG007|Part 1|Not treated|0|||
147053248|NCT03170544|530356235|FG008|Part 1|Not treated|0|||
147053249|NCT03170544|530356236|FG009|Part 1|Not treated|0|||
147053250|NCT03170544|530356237|FG010|Part 1|Not treated|0|||
147053251|NCT03170544|530356238|FG011|Part 1|Not treated|0|||
147053252|NCT00420420|530356241|FG000|Overall Study|Adverse Event|5|||
147053253|NCT00420420|530356242|FG001|Overall Study|Adverse Event|3|||
147053254|NCT00420420|530356241|FG000|Overall Study|Protocol Violation|1|||
147053255|NCT00420420|530356242|FG001|Overall Study|Protocol Violation|1|||
147053256|NCT00420420|530356241|FG000|Overall Study|Withdrawal by Subject|1|||
147053257|NCT00420420|530356242|FG001|Overall Study|Withdrawal by Subject|0|||
147053258|NCT00420420|530356241|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
147053259|NCT00420420|530356242|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
147053260|NCT00868530|530356245|FG000|Overall Study|Adverse Event|3|||
147053261|NCT00868530|530356245|FG000|Overall Study|Lost to Follow-up|1|||
147053262|NCT01609790|530356246|FG000|Overall Study|Protocol Violation|1|||
147053263|NCT01609790|530356247|FG001|Overall Study|Protocol Violation|7|||
147053264|NCT01609790|530356248|FG002|Overall Study|Protocol Violation|8|||
147053265|NCT03985800|530357932|FG000|Overall Study|Death|1|||
147053266|NCT03985800|530357933|FG001|Overall Study|Death|2|||
147053267|NCT03985800|530357932|FG000|Overall Study|Withdrawal by Subject|3|||
147053268|NCT03985800|530357933|FG001|Overall Study|Withdrawal by Subject|6|||
147053269|NCT03985800|530357932|FG000|Overall Study|Protocol Violation|2|||
147053270|NCT03985800|530357933|FG001|Overall Study|Protocol Violation|0|||
147053271|NCT06025721|530357936|FG000|Overall Study|Physician Decision|1|||
147053272|NCT06025721|530357936|FG000|Overall Study|Protocol Violation|1|||
147053273|NCT06025721|530357936|FG000|Overall Study|Incarceration|1|||
147053274|NCT02068508|530357939|FG000|Overall Study|Case report forms uncollected|27|||
147053275|NCT02068508|530357939|FG000|Overall Study|Patient did not visit the study site|1|||
147053276|NCT02068508|530357939|FG000|Overall Study|Protocol Violation|4|||
147053277|NCT00813150|530357940|FG000|Treatment Period|Adverse Event|16|||
147053278|NCT00813150|530357941|FG001|Treatment Period|Adverse Event|15|||
147053279|NCT00813150|530357940|FG000|Treatment Period|Death|2|||
147053280|NCT00813150|530357941|FG001|Treatment Period|Death|0|||
147053281|NCT00813150|530357940|FG000|Treatment Period|Progressive disease|1|||
147053282|NCT00813150|530357941|FG001|Treatment Period|Progressive disease|0|||
147053283|NCT00813150|530357940|FG000|Treatment Period|Complete response|0|||
147053284|NCT00813150|530357941|FG001|Treatment Period|Complete response|1|||
147053285|NCT00813150|530357940|FG000|Treatment Period|Stable disease|1|||
147053286|NCT00813150|530357941|FG001|Treatment Period|Stable disease|2|||
147053287|NCT00813150|530357940|FG000|Treatment Period|Protocol Violation|3|||
147053288|NCT00813150|530357941|FG001|Treatment Period|Protocol Violation|4|||
147053289|NCT00813150|530357940|FG000|Treatment Period|Withdrawal by Subject|5|||
147053290|NCT00813150|530357941|FG001|Treatment Period|Withdrawal by Subject|3|||
147053291|NCT00813150|530357940|FG000|Treatment Period|Non compliance|0|||
147053292|NCT00813150|530357941|FG001|Treatment Period|Non compliance|1|||
147053293|NCT00813150|530357940|FG000|Treatment Period|Reason not specified|3|||
147053294|NCT00813150|530357941|FG001|Treatment Period|Reason not specified|4|||
147053295|NCT00813150|530357940|FG000|Treatment Period|Data not available|1|||
147053296|NCT00813150|530357941|FG001|Treatment Period|Data not available|2|||
147053297|NCT00813150|530357940|FG000|Long Term Follow-up|Death|0|||
147053298|NCT00813150|530357941|FG001|Long Term Follow-up|Death|4|||
147053299|NCT00813150|530357940|FG000|Long Term Follow-up|Other|0|||
147053300|NCT00813150|530357941|FG001|Long Term Follow-up|Other|3|||
147053301|NCT00813150|530357940|FG000|Long Term Follow-up|Lost to Follow-up|2|||
147053302|NCT00813150|530357941|FG001|Long Term Follow-up|Lost to Follow-up|0|||
147053303|NCT00813150|530357940|FG000|Long Term Follow-up|Progression/Relapse|22|||
147053304|NCT00813150|530357941|FG001|Long Term Follow-up|Progression/Relapse|24|||
147053305|NCT05423093|530357949|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
147053306|NCT05423093|530357949|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
147053307|NCT05423093|530357949|FG000|Attended Intervention Session|Lost to Follow-up|3|||
147053308|NCT05423093|530357949|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
147053309|NCT05423093|530357949|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
147053310|NCT04173507|530357952|FG000|Overall Study|On Treatment|3|||
147053311|NCT04173507|530357952|FG000|Overall Study|Adverse Event|3|||
147053312|NCT04173507|530357952|FG000|Overall Study|Progression/Relapse|34|||
147053313|NCT04173507|530357952|FG000|Overall Study|Death|2|||
147053314|NCT02832687|530357953|FG000|Overall Study|Adverse Event|0|||
147053315|NCT02832687|530357954|FG001|Overall Study|Adverse Event|2|||
147053316|NCT00210210|530357955|FG000|Overall Study|Withdrawal by Subject|3|||
147053317|NCT00210210|530357956|FG001|Overall Study|Withdrawal by Subject|2|||
147053318|NCT00210210|530357955|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
147053319|NCT00210210|530357956|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
147053320|NCT04231825|530357957|FG000|Overall Study|Protocol Violation|3|||
147053321|NCT04231825|530357958|FG001|Overall Study|Protocol Violation|3|||
147053322|NCT04231825|530357957|FG000|Overall Study|Lost to Follow-up|0|||
147053323|NCT04231825|530357958|FG001|Overall Study|Lost to Follow-up|1|||
147053324|NCT01662635|530357959|FG000|Overall Study|scarce samples for evaluation|30|||
147053325|NCT01217112|530357962|FG000|Overall Study|Adverse Event|0|||
147053326|NCT01217112|530357963|FG001|Overall Study|Adverse Event|2|||
147053327|NCT01217112|530357964|FG002|Overall Study|Adverse Event|0|||
147053328|NCT01217112|530357965|FG003|Overall Study|Adverse Event|2|||
147053329|NCT01217112|530357966|FG004|Overall Study|Adverse Event|0|||
147053330|NCT01217112|530357962|FG000|Overall Study|Withdrawal by Subject|0|||
147053331|NCT01217112|530357963|FG001|Overall Study|Withdrawal by Subject|0|||
147053332|NCT01217112|530357964|FG002|Overall Study|Withdrawal by Subject|1|||
147053333|NCT01217112|530357965|FG003|Overall Study|Withdrawal by Subject|0|||
147053334|NCT01217112|530357966|FG004|Overall Study|Withdrawal by Subject|0|||
147053335|NCT01217112|530357962|FG000|Overall Study|Physician Decision|0|||
147053336|NCT01217112|530357963|FG001|Overall Study|Physician Decision|0|||
147053337|NCT01217112|530357964|FG002|Overall Study|Physician Decision|0|||
147053338|NCT01217112|530357965|FG003|Overall Study|Physician Decision|0|||
147053339|NCT01217112|530357966|FG004|Overall Study|Physician Decision|1|||
147053340|NCT02596971|530357967|FG000|Overall Study|Death|5|||
147053341|NCT02596971|530357968|FG001|Overall Study|Death|1|||
147053342|NCT02596971|530357969|FG002|Overall Study|Death|5|||
147053343|NCT02596971|530357967|FG000|Overall Study|Withdrawal by Subject|5|||
147053344|NCT02596971|530357968|FG001|Overall Study|Withdrawal by Subject|1|||
147053345|NCT02596971|530357969|FG002|Overall Study|Withdrawal by Subject|4|||
147053346|NCT01401361|530357970|FG000|Overall Study|Withdrawal by Subject|16|||
147053347|NCT01401361|530357970|FG000|Overall Study|Lack of Efficacy|6|||
147053348|NCT01401361|530357970|FG000|Overall Study|Physician Decision|1|||
147053349|NCT01401361|530357970|FG000|Overall Study|Lost to Follow-up|3|||
147053350|NCT01401361|530357970|FG000|Overall Study|Subject/family decision post procedure|2|||
147053351|NCT00595920|530357971|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
147053352|NCT00351468|530357972|FG000|Overall Study|Adverse Event|42|||
147053353|NCT00351468|530357972|FG000|Overall Study|Withdrawal by Subject|39|||
147053354|NCT00351468|530357972|FG000|Overall Study|Various -follow up w clinical team|39|||
147053355|NCT00351468|530357972|FG000|Overall Study|Lack of Efficacy|32|||
147053356|NCT00351468|530357972|FG000|Overall Study|Non-compliance|8|||
147053357|NCT00351468|530357972|FG000|Overall Study|Lost to Follow-up|4|||
147053358|NCT00351468|530357972|FG000|Overall Study|Protocol Violation|3|||
147053359|NCT00611923|530357973|FG000|Overall Study|Withdrawal by Subject|2|||
147053360|NCT00611923|530357974|FG001|Overall Study|Withdrawal by Subject|2|||
147053361|NCT04565145|530357975|FG000|Overall Study|Withdrawal by Subject|1|||
147053362|NCT04565145|530357976|FG001|Overall Study|Withdrawal by Subject|1|||
147053363|NCT03096314|530357977|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
147053364|NCT03096314|530357978|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
147053365|NCT02764762|530357979|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
147053366|NCT02764762|530357979|FG000|Overall Study|Lost to Follow-up|4|||
147053367|NCT02764762|530357979|FG000|Overall Study|Voluntary Withdrawal|8|||
147053368|NCT02764762|530357979|FG000|Overall Study|Site Termination|1|||
147053369|NCT02764762|530357979|FG000|Overall Study|Lack of Efficacy|16|||
147053370|NCT02764762|530357979|FG000|Overall Study|Reason not Specified|1|||
147053371|NCT03318861|530357983|FG000|Overall Study|Death|2|||
147053372|NCT03318861|530357984|FG001|Overall Study|Death|3|||
147053373|NCT03318861|530357985|FG002|Overall Study|Death|3|||
147053374|NCT03318861|530357986|FG003|Overall Study|Death|2|||
147053375|NCT03318861|530357987|FG004|Overall Study|Death|2|||
147053376|NCT03318861|530357983|FG000|Overall Study|Enrolled But Never Treated|0|||
147053377|NCT03318861|530357984|FG001|Overall Study|Enrolled But Never Treated|1|||
147053378|NCT03318861|530357985|FG002|Overall Study|Enrolled But Never Treated|0|||
147053379|NCT03318861|530357986|FG003|Overall Study|Enrolled But Never Treated|1|||
147053380|NCT03318861|530357987|FG004|Overall Study|Enrolled But Never Treated|1|||
147053381|NCT03318861|530357983|FG000|Overall Study|Informed Consent Withdraw|0|||
147053382|NCT03318861|530357984|FG001|Overall Study|Informed Consent Withdraw|0|||
147053383|NCT03318861|530357985|FG002|Overall Study|Informed Consent Withdraw|0|||
147053384|NCT03318861|530357986|FG003|Overall Study|Informed Consent Withdraw|1|||
147053385|NCT03318861|530357987|FG004|Overall Study|Informed Consent Withdraw|0|||
147053386|NCT03318861|530357983|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
147053387|NCT03318861|530357984|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
147053388|NCT03318861|530357985|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
147053389|NCT03318861|530357986|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
147053390|NCT03318861|530357987|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
147053391|NCT00917852|530357988|FG000|Overall Study|Death|6|||
147053392|NCT00471081|530357989|FG000|Active Phase|Protocol Violation|1|||
147053393|NCT00471081|530357990|FG001|Active Phase|Protocol Violation|1|||
147053394|NCT00471081|530357989|FG000|Active Phase|Withdrawal by Subject|0|||
147053395|NCT00471081|530357990|FG001|Active Phase|Withdrawal by Subject|3|||
147053396|NCT00471081|530357989|FG000|Active Phase|Lost to Follow-up|0|||
147053397|NCT00471081|530357990|FG001|Active Phase|Lost to Follow-up|1|||
147053398|NCT00471081|530357989|FG000|Active Phase|Lost health plan/insurance|1|||
147053399|NCT00471081|530357990|FG001|Active Phase|Lost health plan/insurance|8|||
147053400|NCT00471081|530357989|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
147053401|NCT00471081|530357990|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
147053402|NCT00471081|530357989|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
147053403|NCT00471081|530357990|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
147053404|NCT00471081|530357989|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
147053405|NCT00471081|530357990|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
147053406|NCT02844933|530357991|FG000|Overall Study|Discontinued due to premature termination of study|3|||
147053407|NCT02844933|530357992|FG001|Overall Study|Discontinued due to premature termination of study|2|||
147053408|NCT01479465|530357993|FG000|Overall Study|Disease Progression|9|||
147053409|NCT01479465|530357994|FG001|Overall Study|Disease Progression|61|||
147053410|NCT01479465|530357995|FG002|Overall Study|Disease Progression|65|||
147053411|NCT01479465|530357996|FG003|Overall Study|Disease Progression|70|||
147053412|NCT01479465|530357993|FG000|Overall Study|Study Discontinued by Sponsor|0|||
147053413|NCT01479465|530357994|FG001|Overall Study|Study Discontinued by Sponsor|7|||
147053414|NCT01479465|530357995|FG002|Overall Study|Study Discontinued by Sponsor|5|||
147053415|NCT01479465|530357996|FG003|Overall Study|Study Discontinued by Sponsor|3|||
147053416|NCT01479465|530357993|FG000|Overall Study|Adverse Event|0|||
147053417|NCT01479465|530357994|FG001|Overall Study|Adverse Event|3|||
147053418|NCT01479465|530357995|FG002|Overall Study|Adverse Event|6|||
147053419|NCT01479465|530357996|FG003|Overall Study|Adverse Event|4|||
147053420|NCT01479465|530357993|FG000|Overall Study|Investigator Discretion|1|||
147053421|NCT01479465|530357994|FG001|Overall Study|Investigator Discretion|4|||
147053422|NCT01479465|530357995|FG002|Overall Study|Investigator Discretion|2|||
147053423|NCT01479465|530357996|FG003|Overall Study|Investigator Discretion|4|||
147053424|NCT01479465|530357993|FG000|Overall Study|Subject Request|1|||
147053425|NCT01479465|530357994|FG001|Overall Study|Subject Request|3|||
147053426|NCT01479465|530357995|FG002|Overall Study|Subject Request|4|||
147053427|NCT01479465|530357996|FG003|Overall Study|Subject Request|2|||
147053428|NCT01479465|530357993|FG000|Overall Study|Subject Withdrew Consent|0|||
147053429|NCT01479465|530357994|FG001|Overall Study|Subject Withdrew Consent|5|||
147053430|NCT01479465|530357995|FG002|Overall Study|Subject Withdrew Consent|2|||
147053431|NCT01479465|530357996|FG003|Overall Study|Subject Withdrew Consent|1|||
147053432|NCT01479465|530357993|FG000|Overall Study|Protocol Violation|0|||
147053433|NCT01479465|530357994|FG001|Overall Study|Protocol Violation|1|||
147053434|NCT01479465|530357995|FG002|Overall Study|Protocol Violation|1|||
147053435|NCT01479465|530357996|FG003|Overall Study|Protocol Violation|0|||
147053436|NCT01479465|530357993|FG000|Overall Study|Death|0|||
147053437|NCT01479465|530357994|FG001|Overall Study|Death|0|||
147053438|NCT01479465|530357995|FG002|Overall Study|Death|0|||
147053439|NCT01479465|530357996|FG003|Overall Study|Death|1|||
147053440|NCT01479465|530357993|FG000|Overall Study|Lost to Follow-up|0|||
147053441|NCT01479465|530357994|FG001|Overall Study|Lost to Follow-up|0|||
147053442|NCT01479465|530357995|FG002|Overall Study|Lost to Follow-up|1|||
147053443|NCT01479465|530357996|FG003|Overall Study|Lost to Follow-up|0|||
147053444|NCT02393950|530358001|FG000|Overall Study|Adverse Event|1|||
147053445|NCT02393950|530358002|FG001|Overall Study|Adverse Event|0|||
147053446|NCT02393950|530358001|FG000|Overall Study|Withdrawal by Subject|0|||
147053447|NCT02393950|530358002|FG001|Overall Study|Withdrawal by Subject|1|||
147053448|NCT05486091|530358003|FG000|Overall Study|Withdrawal by Subject|1|||
147053449|NCT05486091|530358003|FG000|Overall Study|Lost to Follow-up|2|||
147053450|NCT00370552|530358004|FG000|Overall Study|Adverse Event|2|||
147053451|NCT00370552|530358005|FG001|Overall Study|Adverse Event|2|||
147053452|NCT00370552|530358006|FG002|Overall Study|Adverse Event|2|||
147053453|NCT00370552|530358004|FG000|Overall Study|Disease progression|23|||
147053454|NCT00370552|530358005|FG001|Overall Study|Disease progression|23|||
147053455|NCT00370552|530358006|FG002|Overall Study|Disease progression|15|||
147053456|NCT00370552|530358004|FG000|Overall Study|Maximum clinical benefit|3|||
147053457|NCT00370552|530358005|FG001|Overall Study|Maximum clinical benefit|5|||
147053458|NCT00370552|530358006|FG002|Overall Study|Maximum clinical benefit|5|||
147053459|NCT00370552|530358004|FG000|Overall Study|Poor or noncompliance|0|||
147053460|NCT00370552|530358005|FG001|Overall Study|Poor or noncompliance|0|||
147053461|NCT00370552|530358006|FG002|Overall Study|Poor or noncompliance|1|||
147053462|NCT00370552|530358004|FG000|Overall Study|Study drug toxicity|11|||
147053463|NCT00370552|530358005|FG001|Overall Study|Study drug toxicity|8|||
147053464|NCT00370552|530358006|FG002|Overall Study|Study drug toxicity|6|||
147053465|NCT00370552|530358004|FG000|Overall Study|Withdrawal by Subject|2|||
147053466|NCT00370552|530358005|FG001|Overall Study|Withdrawal by Subject|0|||
147053467|NCT00370552|530358006|FG002|Overall Study|Withdrawal by Subject|1|||
147053468|NCT00370552|530358004|FG000|Overall Study|Still on treatment|1|||
147053469|NCT00370552|530358005|FG001|Overall Study|Still on treatment|3|||
147053470|NCT00370552|530358006|FG002|Overall Study|Still on treatment|2|||
147053471|NCT00370552|530358004|FG000|Overall Study|Never treated|1|||
147053472|NCT00370552|530358005|FG001|Overall Study|Never treated|0|||
147053473|NCT00370552|530358006|FG002|Overall Study|Never treated|0|||
147053474|NCT00370552|530358004|FG000|Overall Study|Physician Decision|1|||
147053475|NCT00370552|530358005|FG001|Overall Study|Physician Decision|1|||
147053476|NCT00370552|530358006|FG002|Overall Study|Physician Decision|0|||
147053477|NCT00370552|530358004|FG000|Overall Study|Investigator decision|2|||
147053478|NCT00370552|530358005|FG001|Overall Study|Investigator decision|1|||
147053479|NCT00370552|530358006|FG002|Overall Study|Investigator decision|0|||
147053480|NCT00370552|530358004|FG000|Overall Study|High risk of allergic reaction|0|||
147053481|NCT00370552|530358005|FG001|Overall Study|High risk of allergic reaction|1|||
147053482|NCT00370552|530358006|FG002|Overall Study|High risk of allergic reaction|0|||
147053483|NCT00370552|530358004|FG000|Overall Study|Planned radiation for palliation|0|||
147053484|NCT00370552|530358005|FG001|Overall Study|Planned radiation for palliation|1|||
147053485|NCT00370552|530358006|FG002|Overall Study|Planned radiation for palliation|0|||
147053486|NCT01062425|530358014|FG000|Overall Study|Protocol Violation|3|||
147053487|NCT01062425|530358015|FG001|Overall Study|Protocol Violation|6|||
147053488|NCT03534687|530358019|FG000|Overall Study|Lost to Follow-up|7|||
147053489|NCT03534687|530358020|FG001|Overall Study|Lost to Follow-up|2|||
147053490|NCT00395629|530358021|FG000|Core Study|Adverse Event|0|||
147053491|NCT00395629|530358022|FG001|Core Study|Adverse Event|3|||
147053492|NCT00395629|530358023|FG002|Core Study|Adverse Event|4|||
147053493|NCT00395629|530358021|FG000|Core Study|Abnormal laboratory value(s)|0|||
147053494|NCT00395629|530358022|FG001|Core Study|Abnormal laboratory value(s)|0|||
147053495|NCT00395629|530358023|FG002|Core Study|Abnormal laboratory value(s)|1|||
147053496|NCT00395629|530358021|FG000|Core Study|Protocol Violation|1|||
147053497|NCT00395629|530358022|FG001|Core Study|Protocol Violation|0|||
147053498|NCT00395629|530358023|FG002|Core Study|Protocol Violation|0|||
147053499|NCT00395629|530358021|FG000|Core Study|Withdrawal by Subject|0|||
147053500|NCT00395629|530358022|FG001|Core Study|Withdrawal by Subject|1|||
147053501|NCT00395629|530358023|FG002|Core Study|Withdrawal by Subject|1|||
147053502|NCT00395629|530358021|FG000|Core Study|Lost to Follow-up|0|||
147053503|NCT00395629|530358022|FG001|Core Study|Lost to Follow-up|0|||
147053504|NCT00395629|530358023|FG002|Core Study|Lost to Follow-up|1|||
147053505|NCT00395629|530358021|FG000|Extension Study|Adverse Event|0|||
147053506|NCT00395629|530358022|FG001|Extension Study|Adverse Event|0|||
147053507|NCT00395629|530358023|FG002|Extension Study|Adverse Event|2|||
147053508|NCT00395629|530358021|FG000|Extension Study|Administrative problems|0|||
147053509|NCT00395629|530358022|FG001|Extension Study|Administrative problems|0|||
147053510|NCT00395629|530358023|FG002|Extension Study|Administrative problems|1|||
147053511|NCT01686373|530358024|FG000|Overall Study|Lost to Follow-up|3|||
147053512|NCT01686373|530358025|FG001|Overall Study|Lost to Follow-up|0|||
147053513|NCT01686373|530358024|FG000|Overall Study|Withdrawal by Subject|0|||
147053514|NCT01686373|530358025|FG001|Overall Study|Withdrawal by Subject|1|||
147053515|NCT01686373|530358024|FG000|Overall Study|Adverse Event|0|||
147053516|NCT01686373|530358025|FG001|Overall Study|Adverse Event|1|||
147053517|NCT03751098|530358028|FG000|Overall Study|Withdrawal by Subject|0|||
147053518|NCT03751098|530358029|FG001|Overall Study|Withdrawal by Subject|1|||
147053519|NCT01592786|530358030|FG000|Overall Study|Adverse Event|60|||
147053520|NCT01592786|530358030|FG000|Overall Study|Lack of Efficacy|19|||
147053521|NCT01592786|530358030|FG000|Overall Study|Protocol Violation|14|||
147053522|NCT01592786|530358030|FG000|Overall Study|Withdrawal by Subject|23|||
147053523|NCT01592786|530358030|FG000|Overall Study|Lost to Follow-up|19|||
147053524|NCT01592786|530358030|FG000|Overall Study|Other|3|||
147053525|NCT03810092|530358031|FG000|Overall Study|no ground support|17|||
147053526|NCT03810092|530358031|FG000|Overall Study|ADL not done at J0|16|||
147053527|NCT03810092|530358031|FG000|Overall Study|No hemoglobin measure at J5|27|||
147053528|NCT04578535|530358035|FG000|Overall Study|Lost to Follow-up|1|||
147053529|NCT04578535|530358036|FG001|Overall Study|Lost to Follow-up|0|||
147053530|NCT04578535|530358037|FG002|Overall Study|Lost to Follow-up|0|||
147053531|NCT04578535|530358038|FG003|Overall Study|Lost to Follow-up|1|||
147053532|NCT04578535|530358039|FG004|Overall Study|Lost to Follow-up|0|||
147053533|NCT04578535|530358040|FG005|Overall Study|Lost to Follow-up|2|||
147053534|NCT04578535|530358035|FG000|Overall Study|Pregnancy|1|||
147053535|NCT04578535|530358036|FG001|Overall Study|Pregnancy|0|||
147053536|NCT04578535|530358037|FG002|Overall Study|Pregnancy|0|||
147053537|NCT04578535|530358038|FG003|Overall Study|Pregnancy|0|||
147053538|NCT04578535|530358039|FG004|Overall Study|Pregnancy|0|||
147053539|NCT04578535|530358040|FG005|Overall Study|Pregnancy|0|||
147053540|NCT04578535|530358035|FG000|Overall Study|Withdrawal by Subject|0|||
147053541|NCT04578535|530358036|FG001|Overall Study|Withdrawal by Subject|0|||
147053542|NCT04578535|530358037|FG002|Overall Study|Withdrawal by Subject|0|||
147053543|NCT04578535|530358038|FG003|Overall Study|Withdrawal by Subject|1|||
147053544|NCT04578535|530358039|FG004|Overall Study|Withdrawal by Subject|1|||
147053545|NCT04578535|530358040|FG005|Overall Study|Withdrawal by Subject|5|||
147053546|NCT04578535|530358035|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
147053547|NCT04578535|530358036|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
147053548|NCT04578535|530358037|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
147053549|NCT04578535|530358038|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
147053550|NCT04578535|530358039|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
147053551|NCT04578535|530358040|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
147053552|NCT00235755|530358041|FG000|4-Week Titration Phase|Adverse Event|6|||
147053553|NCT00235755|530358042|FG001|4-Week Titration Phase|Adverse Event|14|||
147053554|NCT00235755|530358043|FG002|4-Week Titration Phase|Adverse Event|20|||
147053555|NCT00235755|530358041|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
147053556|NCT00235755|530358042|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
147053557|NCT00235755|530358043|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
147053558|NCT00235755|530358041|FG000|4-Week Titration Phase|Protocol Violation|2|||
147053559|NCT00235755|530358042|FG001|4-Week Titration Phase|Protocol Violation|2|||
147053560|NCT00235755|530358043|FG002|4-Week Titration Phase|Protocol Violation|1|||
147053561|NCT00235755|530358041|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
147053562|NCT00235755|530358042|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
147053563|NCT00235755|530358043|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
147053564|NCT00235755|530358041|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
147053565|NCT00235755|530358042|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
147053566|NCT00235755|530358043|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
147053567|NCT00235755|530358041|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
147053568|NCT00235755|530358042|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
147053569|NCT00235755|530358043|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
147053570|NCT00235755|530358041|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
147053571|NCT00235755|530358042|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
147053572|NCT00235755|530358043|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
147053573|NCT00235755|530358041|FG000|12-Week Maintenance Phase|Adverse Event|8|||
147053574|NCT00235755|530358042|FG001|12-Week Maintenance Phase|Adverse Event|12|||
147053575|NCT00235755|530358043|FG002|12-Week Maintenance Phase|Adverse Event|26|||
147053576|NCT00235755|530358041|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
147053577|NCT00235755|530358042|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
147053578|NCT00235755|530358043|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
147053579|NCT00235755|530358041|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
147053580|NCT00235755|530358042|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
147053581|NCT00235755|530358043|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
147053582|NCT00235755|530358041|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
147053583|NCT00235755|530358042|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
147053584|NCT00235755|530358043|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
147053585|NCT00235755|530358041|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
147053586|NCT00235755|530358042|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
147053587|NCT00235755|530358043|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
147053588|NCT00235755|530358041|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
147053589|NCT00235755|530358042|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
147053590|NCT00235755|530358043|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
147053591|NCT03839628|530358044|FG000|Overall Study|Withdrawal by Subject|1|||
147053592|NCT01147068|530358045|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
147053593|NCT01147068|530358046|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
147053594|NCT01147068|530358047|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
147053595|NCT01147068|530358048|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
147053596|NCT01147068|530358049|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
147053597|NCT01147068|530358050|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
147053598|NCT01147068|530358051|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
147053599|NCT01147068|530358045|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
146850056|NCT00911937|529620705|FG000|Overall Study|Lost to Follow-up|8|||
146850057|NCT00911937|529620706|FG001|Overall Study|Lost to Follow-up|5|||
147053600|NCT01147068|530358046|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
147053601|NCT01147068|530358047|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
147053602|NCT01147068|530358048|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
147053603|NCT01147068|530358049|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
147053604|NCT01147068|530358050|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
147053605|NCT01147068|530358051|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
147053606|NCT01147068|530358045|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
147053607|NCT01147068|530358046|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
147053608|NCT01147068|530358047|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
147053609|NCT01147068|530358048|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
147053610|NCT01147068|530358049|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
147053611|NCT01147068|530358050|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
147053612|NCT01147068|530358051|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
147053613|NCT01147068|530358045|FG000|Subjects That Received 2nd Dose|Other|0|||
147053614|NCT01147068|530358046|FG001|Subjects That Received 2nd Dose|Other|3|||
147053615|NCT01147068|530358047|FG002|Subjects That Received 2nd Dose|Other|3|||
147053616|NCT01147068|530358048|FG003|Subjects That Received 2nd Dose|Other|0|||
147053617|NCT01147068|530358049|FG004|Subjects That Received 2nd Dose|Other|1|||
147053618|NCT01147068|530358050|FG005|Subjects That Received 2nd Dose|Other|0|||
147053619|NCT01147068|530358051|FG006|Subjects That Received 2nd Dose|Other|0|||
147053620|NCT01147068|530358045|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
147053621|NCT01147068|530358046|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
147053622|NCT01147068|530358047|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
147053623|NCT01147068|530358048|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
147053624|NCT01147068|530358049|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
147053625|NCT01147068|530358050|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
147053626|NCT01147068|530358051|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
147053627|NCT01147068|530358045|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
147053628|NCT01147068|530358046|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
147053629|NCT01147068|530358047|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
147053630|NCT01147068|530358048|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
147053631|NCT01147068|530358049|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
147053632|NCT01147068|530358050|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
147053633|NCT01147068|530358051|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
147053634|NCT01147068|530358045|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
147053635|NCT01147068|530358046|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
147053636|NCT01147068|530358047|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
147053637|NCT01147068|530358048|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
147053638|NCT01147068|530358049|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
147053639|NCT01147068|530358050|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
147053640|NCT01147068|530358051|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
147053641|NCT03181633|530358052|FG000|Overall Study|Withdrawal by Subject|1|||
147053642|NCT03181633|530358052|FG000|Overall Study|Missing follow-up visit|1|||
147053643|NCT01306305|530358055|FG000|Overall Study|Lost to Follow-up|1|||
147053644|NCT01306305|530358056|FG001|Overall Study|Lost to Follow-up|0|||
147053645|NCT01306305|530358055|FG000|Overall Study|Withdrew consent|1|||
147053646|NCT01306305|530358056|FG001|Overall Study|Withdrew consent|0|||
147053647|NCT04030299|530358057|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
147053648|NCT04030299|530358057|FG000|Overall Study|Withdrawal by Subject|3|||
147053649|NCT00946920|530358058|FG000|Overall Study|Withdrawal by Subject|28|||
147053650|NCT00946920|530358059|FG001|Overall Study|Withdrawal by Subject|15|||
147053651|NCT00946920|530358058|FG000|Overall Study|Lost to Follow-up|2|||
147053652|NCT00946920|530358059|FG001|Overall Study|Lost to Follow-up|2|||
147053653|NCT00946920|530358058|FG000|Overall Study|Physician Decision|5|||
147053654|NCT00946920|530358059|FG001|Overall Study|Physician Decision|2|||
147053655|NCT00946920|530358058|FG000|Overall Study|Adverse Event|41|||
147053656|NCT00946920|530358059|FG001|Overall Study|Adverse Event|14|||
147053657|NCT00946920|530358058|FG000|Overall Study|Protocol Violation|16|||
147053658|NCT00946920|530358059|FG001|Overall Study|Protocol Violation|8|||
147053659|NCT00946920|530358058|FG000|Overall Study|Miscellaneous reasons|18|||
147053660|NCT00946920|530358059|FG001|Overall Study|Miscellaneous reasons|3|||
147053661|NCT02964247|530358060|FG000|Overall Study|Lost to Follow-up|2|||
147053662|NCT02964247|530358061|FG001|Overall Study|Lost to Follow-up|0|||
147053663|NCT02964247|530358060|FG000|Overall Study|Withdrawal by Subject|1|||
147053664|NCT02964247|530358061|FG001|Overall Study|Withdrawal by Subject|2|||
147053665|NCT01288079|530358062|FG000|Overall Study|Withdrawal by Subject|2|||
147053666|NCT01288079|530358063|FG001|Overall Study|Withdrawal by Subject|4|||
147053667|NCT01288079|530358064|FG002|Overall Study|Withdrawal by Subject|1|||
147053668|NCT01288079|530358065|FG003|Overall Study|Withdrawal by Subject|0|||
147053669|NCT01288079|530358062|FG000|Overall Study|Adverse Event|2|||
147053670|NCT01288079|530358063|FG001|Overall Study|Adverse Event|1|||
147053671|NCT01288079|530358064|FG002|Overall Study|Adverse Event|2|||
147053672|NCT01288079|530358065|FG003|Overall Study|Adverse Event|3|||
147053673|NCT01288079|530358062|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
147053674|NCT01288079|530358063|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
147053675|NCT01288079|530358064|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
147053676|NCT01288079|530358065|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
147053677|NCT01288079|530358062|FG000|Overall Study|Condition under Investigation Worsened|0|||
147053678|NCT01288079|530358063|FG001|Overall Study|Condition under Investigation Worsened|0|||
147053679|NCT01288079|530358064|FG002|Overall Study|Condition under Investigation Worsened|0|||
147053680|NCT01288079|530358065|FG003|Overall Study|Condition under Investigation Worsened|1|||
147053681|NCT01288079|530358062|FG000|Overall Study|Lack of Efficacy|2|||
147053682|NCT01288079|530358063|FG001|Overall Study|Lack of Efficacy|2|||
147053683|NCT01288079|530358064|FG002|Overall Study|Lack of Efficacy|0|||
147053684|NCT01288079|530358065|FG003|Overall Study|Lack of Efficacy|2|||
147053685|NCT01288079|530358062|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
147053686|NCT01288079|530358063|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
147053687|NCT01288079|530358064|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
147053688|NCT01288079|530358065|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
147053689|NCT01288079|530358062|FG000|Overall Study|Lost to Follow-up|1|||
147053690|NCT01288079|530358063|FG001|Overall Study|Lost to Follow-up|1|||
147053691|NCT01288079|530358064|FG002|Overall Study|Lost to Follow-up|1|||
147053692|NCT01288079|530358065|FG003|Overall Study|Lost to Follow-up|0|||
147053693|NCT01288079|530358062|FG000|Overall Study|Other or Study Termination|11|||
147053694|NCT01288079|530358063|FG001|Overall Study|Other or Study Termination|15|||
147053695|NCT01288079|530358064|FG002|Overall Study|Other or Study Termination|14|||
147053696|NCT01288079|530358065|FG003|Overall Study|Other or Study Termination|8|||
147053697|NCT01530464|530358066|FG000|Washout (24h)|Withdrawal by Subject|1|||
147053698|NCT01530464|530358067|FG001|Washout (24h)|Withdrawal by Subject|0|||
147053699|NCT01530464|530358066|FG000|Washout (24h)|Withdrawal by Subject|0|||
147053700|NCT01530464|530358067|FG001|Washout (24h)|Withdrawal by Subject|1|||
147053701|NCT02387840|530358068|FG000|Overall Study|Death|0|||
147053702|NCT02387840|530358069|FG001|Overall Study|Death|0|||
147053703|NCT02387840|530358070|FG002|Overall Study|Death|0|||
147053704|NCT02387840|530358071|FG003|Overall Study|Death|0|||
147053705|NCT02387840|530358072|FG004|Overall Study|Death|0|||
147053706|NCT02387840|530358073|FG005|Overall Study|Death|1|||
147053707|NCT02107131|530358074|FG000|Overall Study|Lost to Follow-up|4|||
147053708|NCT02107131|530358075|FG001|Overall Study|Lost to Follow-up|4|||
147053709|NCT02107131|530358074|FG000|Overall Study|Physician Decision|1|||
147053710|NCT02107131|530358075|FG001|Overall Study|Physician Decision|0|||
147053711|NCT02107131|530358074|FG000|Overall Study|Withdrawal by Subject|2|||
147053712|NCT02107131|530358075|FG001|Overall Study|Withdrawal by Subject|0|||
147053713|NCT02107131|530358074|FG000|Overall Study|mental instability|1|||
147053714|NCT02107131|530358075|FG001|Overall Study|mental instability|0|||
147053715|NCT02107131|530358074|FG000|Overall Study|Death|0|||
147053716|NCT02107131|530358075|FG001|Overall Study|Death|1|||
147053717|NCT02107131|530358074|FG000|Overall Study|Protocol Violation|0|||
147053718|NCT02107131|530358075|FG001|Overall Study|Protocol Violation|4|||
147053719|NCT02208362|530358080|FG000|Overall Study|Participant did not complete treatment|0|||
147053720|NCT02208362|530358081|FG001|Overall Study|Participant did not complete treatment|1|||
147053721|NCT02208362|530358082|FG002|Overall Study|Participant did not complete treatment|0|||
147053722|NCT02208362|530358083|FG003|Overall Study|Participant did not complete treatment|0|||
147053723|NCT02208362|530358084|FG004|Overall Study|Participant did not complete treatment|0|||
147053724|NCT02208362|530358085|FG005|Overall Study|Participant did not complete treatment|0|||
147053725|NCT02208362|530358086|FG006|Overall Study|Participant did not complete treatment|1|||
147053726|NCT02208362|530358087|FG007|Overall Study|Participant did not complete treatment|1|||
147053727|NCT02208362|530358088|FG008|Overall Study|Participant did not complete treatment|2|||
147053728|NCT02208362|530358089|FG009|Overall Study|Participant did not complete treatment|0|||
147053729|NCT02208362|530358090|FG010|Overall Study|Participant did not complete treatment|1|||
147053730|NCT02208362|530358091|FG011|Overall Study|Participant did not complete treatment|0|||
147053731|NCT02208362|530358080|FG000|Overall Study|Participant received disallowed treatment|0|||
147053732|NCT02208362|530358081|FG001|Overall Study|Participant received disallowed treatment|0|||
147053733|NCT02208362|530358082|FG002|Overall Study|Participant received disallowed treatment|0|||
147053734|NCT02208362|530358083|FG003|Overall Study|Participant received disallowed treatment|0|||
147053735|NCT02208362|530358084|FG004|Overall Study|Participant received disallowed treatment|0|||
147053736|NCT02208362|530358085|FG005|Overall Study|Participant received disallowed treatment|0|||
147053737|NCT02208362|530358086|FG006|Overall Study|Participant received disallowed treatment|0|||
147053738|NCT02208362|530358087|FG007|Overall Study|Participant received disallowed treatment|0|||
147053739|NCT02208362|530358088|FG008|Overall Study|Participant received disallowed treatment|1|||
147053740|NCT02208362|530358089|FG009|Overall Study|Participant received disallowed treatment|0|||
147053741|NCT02208362|530358090|FG010|Overall Study|Participant received disallowed treatment|0|||
147053742|NCT02208362|530358091|FG011|Overall Study|Participant received disallowed treatment|0|||
147053743|NCT05207865|530359627|FG000|Open-Label Treatment Phase|Adverse Event|7|||
147053744|NCT05207865|530359627|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
147053745|NCT05207865|530359627|FG000|Open-Label Treatment Phase|Non-compliance|3|||
147053746|NCT05207865|530359627|FG000|Open-Label Treatment Phase|Other|17|||
147053747|NCT05207865|530359627|FG000|Open-Label Treatment Phase|Physician Decision|2|||
147053748|NCT05207865|530359627|FG000|Open-Label Treatment Phase|Pregnancy|1|||
147053749|NCT05207865|530359627|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
147053750|NCT05207865|530359627|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
147053751|NCT05207865|530359627|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
147053752|NCT05207865|530359627|FG000|Follow-up Phase|Lost to Follow-up|1|||
147053753|NCT05207865|530359627|FG000|Follow-up Phase|Non-compliance|1|||
147053754|NCT05207865|530359627|FG000|Follow-up Phase|Not reported|2|||
147053755|NCT05207865|530359627|FG000|Follow-up Phase|Not collected|11|||
147053756|NCT02546986|530359628|FG000|Treatment Period|Progressive Disease|20|||
147053757|NCT02546986|530359629|FG001|Treatment Period|Progressive Disease|22|||
147053758|NCT02546986|530359628|FG000|Treatment Period|Adverse Event|14|||
147053759|NCT02546986|530359629|FG001|Treatment Period|Adverse Event|6|||
147053760|NCT02546986|530359628|FG000|Treatment Period|Symptomatic Deterioration|4|||
147053761|NCT02546986|530359629|FG001|Treatment Period|Symptomatic Deterioration|3|||
147053762|NCT02546986|530359628|FG000|Treatment Period|Death|3|||
147053763|NCT02546986|530359629|FG001|Treatment Period|Death|4|||
147053764|NCT02546986|530359628|FG000|Treatment Period|Physician Decision|1|||
147053765|NCT02546986|530359629|FG001|Treatment Period|Physician Decision|2|||
147053766|NCT02546986|530359628|FG000|Treatment Period|Protocol Violation|1|||
147053767|NCT02546986|530359629|FG001|Treatment Period|Protocol Violation|0|||
147053768|NCT02546986|530359628|FG000|Treatment Period|Withdrawal by Subject|1|||
147053769|NCT02546986|530359629|FG001|Treatment Period|Withdrawal by Subject|1|||
147053770|NCT02546986|530359628|FG000|Treatment Period|Non-compliance with Study Drug|0|||
147053771|NCT02546986|530359629|FG001|Treatment Period|Non-compliance with Study Drug|1|||
147053772|NCT02546986|530359628|FG000|Treatment Period|Study Terminated by Sponsor|0|||
147053773|NCT02546986|530359629|FG001|Treatment Period|Study Terminated by Sponsor|1|||
147053774|NCT02546986|530359628|FG000|Treatment Period|Miscellaneous|7|||
147053775|NCT02546986|530359629|FG001|Treatment Period|Miscellaneous|9|||
147053776|NCT02546986|530359628|FG000|Survival Follow-Up Phase|Missing Status|3|||
147053777|NCT02546986|530359629|FG001|Survival Follow-Up Phase|Missing Status|5|||
147053778|NCT02546986|530359628|FG000|Survival Follow-Up Phase|Death|18|||
147053779|NCT02546986|530359629|FG001|Survival Follow-Up Phase|Death|12|||
147053780|NCT02546986|530359628|FG000|Survival Follow-Up Phase|Alive|13|||
147053781|NCT02546986|530359629|FG001|Survival Follow-Up Phase|Alive|16|||
147053782|NCT02546986|530359628|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
147053783|NCT02546986|530359629|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
147053784|NCT00739882|530359630|FG000|Double-blind Period|Adverse Event|1|||
147053785|NCT00739882|530359631|FG001|Double-blind Period|Adverse Event|2|||
147053786|NCT00739882|530359630|FG000|Double-blind Period|Protocol Violation|1|||
147053787|NCT00739882|530359631|FG001|Double-blind Period|Protocol Violation|0|||
147053788|NCT00739882|530359630|FG000|Double-blind Period|Lack of Efficacy|1|||
147053789|NCT00739882|530359631|FG001|Double-blind Period|Lack of Efficacy|1|||
147053790|NCT00739882|530359630|FG000|Double-blind Period|Other|16|||
147053791|NCT00739882|530359631|FG001|Double-blind Period|Other|8|||
147053792|NCT00739882|530359630|FG000|Open-label Period|Adverse Event|1|||
147053793|NCT00739882|530359631|FG001|Open-label Period|Adverse Event|0|||
147053794|NCT00739882|530359630|FG000|Open-label Period|Other|9|||
147053795|NCT00739882|530359631|FG001|Open-label Period|Other|5|||
147053796|NCT04021914|530359632|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
147053797|NCT02844543|530359633|FG000|Overall Study|Withdrawal by Subject|4|||
147053798|NCT02844543|530359633|FG000|Overall Study|Did not meet eligibility criteria|1|||
147053799|NCT00955409|530359634|FG000|Overall Study|Lack of Efficacy|1|||
147053800|NCT00955409|530359635|FG001|Overall Study|Lack of Efficacy|0|||
147053801|NCT00955409|530359636|FG002|Overall Study|Lack of Efficacy|0|||
147053802|NCT00955409|530359637|FG003|Overall Study|Lack of Efficacy|0|||
147053803|NCT00955409|530359638|FG004|Overall Study|Lack of Efficacy|0|||
147053804|NCT00955409|530359639|FG005|Overall Study|Lack of Efficacy|0|||
147053805|NCT00955409|530359640|FG006|Overall Study|Lack of Efficacy|0|||
147053806|NCT00955409|530359641|FG007|Overall Study|Lack of Efficacy|0|||
147053807|NCT00955409|530359642|FG008|Overall Study|Lack of Efficacy|0|||
147053808|NCT00955409|530359643|FG009|Overall Study|Lack of Efficacy|0|||
147053809|NCT00955409|530359634|FG000|Overall Study|Withdrawal by Subject|1|||
147053810|NCT00955409|530359635|FG001|Overall Study|Withdrawal by Subject|0|||
147053811|NCT00955409|530359636|FG002|Overall Study|Withdrawal by Subject|5|||
147053812|NCT00955409|530359637|FG003|Overall Study|Withdrawal by Subject|2|||
147053813|NCT00955409|530359638|FG004|Overall Study|Withdrawal by Subject|0|||
147053814|NCT00955409|530359639|FG005|Overall Study|Withdrawal by Subject|0|||
147053815|NCT00955409|530359640|FG006|Overall Study|Withdrawal by Subject|2|||
147053816|NCT00955409|530359641|FG007|Overall Study|Withdrawal by Subject|0|||
147053817|NCT00955409|530359642|FG008|Overall Study|Withdrawal by Subject|1|||
147053818|NCT00955409|530359643|FG009|Overall Study|Withdrawal by Subject|0|||
147053819|NCT00955409|530359634|FG000|Overall Study|Caregiver Request|2|||
147053820|NCT00955409|530359635|FG001|Overall Study|Caregiver Request|0|||
147053821|NCT00955409|530359636|FG002|Overall Study|Caregiver Request|6|||
147053822|NCT00955409|530359637|FG003|Overall Study|Caregiver Request|5|||
147053823|NCT00955409|530359638|FG004|Overall Study|Caregiver Request|0|||
147053824|NCT00955409|530359639|FG005|Overall Study|Caregiver Request|2|||
147053825|NCT00955409|530359640|FG006|Overall Study|Caregiver Request|3|||
147053826|NCT00955409|530359641|FG007|Overall Study|Caregiver Request|1|||
147053827|NCT00955409|530359642|FG008|Overall Study|Caregiver Request|3|||
147053828|NCT00955409|530359643|FG009|Overall Study|Caregiver Request|0|||
147053829|NCT00955409|530359634|FG000|Overall Study|Investigator Request|0|||
147053830|NCT00955409|530359635|FG001|Overall Study|Investigator Request|0|||
147053831|NCT00955409|530359636|FG002|Overall Study|Investigator Request|1|||
147053832|NCT00955409|530359637|FG003|Overall Study|Investigator Request|0|||
147053833|NCT00955409|530359638|FG004|Overall Study|Investigator Request|0|||
147053834|NCT00955409|530359639|FG005|Overall Study|Investigator Request|0|||
147053835|NCT00955409|530359640|FG006|Overall Study|Investigator Request|0|||
147053836|NCT00955409|530359641|FG007|Overall Study|Investigator Request|0|||
147053837|NCT00955409|530359642|FG008|Overall Study|Investigator Request|0|||
147053838|NCT00955409|530359643|FG009|Overall Study|Investigator Request|0|||
147053839|NCT00955409|530359634|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
147053840|NCT00955409|530359635|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
147053841|NCT00955409|530359636|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
147053842|NCT00955409|530359637|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
147053843|NCT00955409|530359638|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
147053844|NCT00955409|530359639|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
147053845|NCT00955409|530359640|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
147053846|NCT00955409|530359641|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
147053847|NCT00955409|530359642|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
147053848|NCT00955409|530359643|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
147053849|NCT00955409|530359634|FG000|Overall Study|Lost to Follow-up|0|||
147053850|NCT00955409|530359635|FG001|Overall Study|Lost to Follow-up|0|||
147053851|NCT00955409|530359636|FG002|Overall Study|Lost to Follow-up|1|||
147053852|NCT00955409|530359637|FG003|Overall Study|Lost to Follow-up|0|||
147053853|NCT00955409|530359638|FG004|Overall Study|Lost to Follow-up|0|||
147053854|NCT00955409|530359639|FG005|Overall Study|Lost to Follow-up|0|||
147053855|NCT00955409|530359640|FG006|Overall Study|Lost to Follow-up|1|||
147053856|NCT00955409|530359641|FG007|Overall Study|Lost to Follow-up|0|||
147053857|NCT00955409|530359642|FG008|Overall Study|Lost to Follow-up|0|||
147053858|NCT00955409|530359643|FG009|Overall Study|Lost to Follow-up|0|||
147053859|NCT00955409|530359634|FG000|Overall Study|Failed to Return|2|||
147053860|NCT00955409|530359635|FG001|Overall Study|Failed to Return|0|||
147053861|NCT00955409|530359636|FG002|Overall Study|Failed to Return|0|||
147053862|NCT00955409|530359637|FG003|Overall Study|Failed to Return|0|||
147053863|NCT00955409|530359638|FG004|Overall Study|Failed to Return|0|||
147053864|NCT00955409|530359639|FG005|Overall Study|Failed to Return|0|||
147053865|NCT00955409|530359640|FG006|Overall Study|Failed to Return|0|||
147053866|NCT00955409|530359641|FG007|Overall Study|Failed to Return|2|||
147053867|NCT00955409|530359642|FG008|Overall Study|Failed to Return|0|||
147053868|NCT00955409|530359643|FG009|Overall Study|Failed to Return|0|||
147053869|NCT00955409|530359634|FG000|Overall Study|Adverse Event (AE)|2|||
147053870|NCT00955409|530359635|FG001|Overall Study|Adverse Event (AE)|0|||
147053871|NCT00955409|530359636|FG002|Overall Study|Adverse Event (AE)|0|||
147053872|NCT00955409|530359637|FG003|Overall Study|Adverse Event (AE)|0|||
147053873|NCT00955409|530359638|FG004|Overall Study|Adverse Event (AE)|0|||
147053874|NCT00955409|530359639|FG005|Overall Study|Adverse Event (AE)|1|||
147053875|NCT00955409|530359640|FG006|Overall Study|Adverse Event (AE)|2|||
147053876|NCT00955409|530359641|FG007|Overall Study|Adverse Event (AE)|0|||
147053877|NCT00955409|530359642|FG008|Overall Study|Adverse Event (AE)|2|||
147053878|NCT00955409|530359643|FG009|Overall Study|Adverse Event (AE)|0|||
147053879|NCT00955409|530359634|FG000|Overall Study|Reason not Specified|2|||
147053880|NCT00955409|530359635|FG001|Overall Study|Reason not Specified|1|||
147053881|NCT00955409|530359636|FG002|Overall Study|Reason not Specified|13|||
147053882|NCT00955409|530359637|FG003|Overall Study|Reason not Specified|1|||
147053883|NCT00955409|530359638|FG004|Overall Study|Reason not Specified|2|||
147053884|NCT00955409|530359639|FG005|Overall Study|Reason not Specified|0|||
147053885|NCT00955409|530359640|FG006|Overall Study|Reason not Specified|16|||
147053886|NCT00955409|530359641|FG007|Overall Study|Reason not Specified|0|||
147053887|NCT00955409|530359642|FG008|Overall Study|Reason not Specified|8|||
147053888|NCT00955409|530359643|FG009|Overall Study|Reason not Specified|1|||
147053889|NCT00803790|530359644|FG000|Period 1|Adverse Event|0|||
147053890|NCT00803790|530359645|FG001|Period 1|Adverse Event|1|||
147053891|NCT00803790|530359646|FG002|Period 1|Adverse Event|0|||
147053892|NCT00803790|530359647|FG003|Period 1|Adverse Event|0|||
147053893|NCT00803790|530359644|FG000|Period 1|Lost to Follow-up|1|||
147053894|NCT00803790|530359645|FG001|Period 1|Lost to Follow-up|2|||
147053895|NCT00803790|530359646|FG002|Period 1|Lost to Follow-up|0|||
147053896|NCT00803790|530359647|FG003|Period 1|Lost to Follow-up|0|||
147053897|NCT00803790|530359644|FG000|Period 1|Withdrawal by Subject|8|||
147053898|NCT00803790|530359645|FG001|Period 1|Withdrawal by Subject|6|||
147053899|NCT00803790|530359646|FG002|Period 1|Withdrawal by Subject|0|||
147053900|NCT00803790|530359647|FG003|Period 1|Withdrawal by Subject|0|||
147053901|NCT00803790|530359644|FG000|Period 1|positive drug screen or personal reasons|0|||
147053902|NCT00803790|530359645|FG001|Period 1|positive drug screen or personal reasons|3|||
147053903|NCT00803790|530359646|FG002|Period 1|positive drug screen or personal reasons|0|||
147053904|NCT00803790|530359647|FG003|Period 1|positive drug screen or personal reasons|4|||
147053905|NCT00803790|530359644|FG000|Period 1|Protocol Violation|0|||
147053906|NCT00803790|530359645|FG001|Period 1|Protocol Violation|0|||
147053907|NCT00803790|530359646|FG002|Period 1|Protocol Violation|1|||
147053908|NCT00803790|530359647|FG003|Period 1|Protocol Violation|0|||
147053909|NCT00803790|530359644|FG000|Period 2|Adverse Event|0|||
147053910|NCT00803790|530359645|FG001|Period 2|Adverse Event|0|||
147053911|NCT00803790|530359646|FG002|Period 2|Adverse Event|1|||
147053912|NCT00803790|530359647|FG003|Period 2|Adverse Event|1|||
147053913|NCT00803790|530359644|FG000|Period 2|Withdrawal by Subject|1|||
147053914|NCT00803790|530359645|FG001|Period 2|Withdrawal by Subject|0|||
147053915|NCT00803790|530359646|FG002|Period 2|Withdrawal by Subject|0|||
147053916|NCT00803790|530359647|FG003|Period 2|Withdrawal by Subject|0|||
147053917|NCT00803790|530359644|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
147053918|NCT00803790|530359645|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
147053919|NCT00803790|530359646|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
147053920|NCT00803790|530359647|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
147053921|NCT04710576|530359648|FG000|Overall Study|Participants still in the study|73|||
147053922|NCT04710576|530359649|FG001|Overall Study|Participants still in the study|70|||
147053923|NCT04710576|530359650|FG002|Overall Study|Participants still in the study|60|||
147053924|NCT04710576|530359648|FG000|Overall Study|Death|2|||
147053925|NCT04710576|530359649|FG001|Overall Study|Death|7|||
147053926|NCT04710576|530359650|FG002|Overall Study|Death|12|||
147053927|NCT04710576|530359648|FG000|Overall Study|Withdrawal by Subject|4|||
147053928|NCT04710576|530359649|FG001|Overall Study|Withdrawal by Subject|3|||
147053929|NCT04710576|530359650|FG002|Overall Study|Withdrawal by Subject|7|||
147053930|NCT04710576|530359648|FG000|Overall Study|Sponsor decision|1|||
147053931|NCT04710576|530359649|FG001|Overall Study|Sponsor decision|0|||
147053932|NCT04710576|530359650|FG002|Overall Study|Sponsor decision|0|||
147053933|NCT03593525|530359651|FG000|Overall Study|Withdrawal by Subject|1|||
147053934|NCT03593525|530359652|FG001|Overall Study|Withdrawal by Subject|0|||
147053935|NCT03593525|530359651|FG000|Overall Study|Lost to Follow-up|7|||
147053936|NCT03593525|530359652|FG001|Overall Study|Lost to Follow-up|5|||
147053937|NCT04570670|530359658|FG000|Overall Study|Withdrawal by Subject|1|||
147053938|NCT04570670|530359659|FG001|Overall Study|Withdrawal by Subject|0|||
147053939|NCT04335123|530359663|FG000|Overall Study|Withdrawal by Subject|2|||
147053940|NCT04335123|530359664|FG001|Overall Study|Withdrawal by Subject|0|||
147053941|NCT04335123|530359663|FG000|Overall Study|Physician Decision|2|||
147053942|NCT04335123|530359664|FG001|Overall Study|Physician Decision|0|||
147053943|NCT00314340|530359665|FG000|Overall Study|lost interest|1|||
147053944|NCT00957801|530359667|FG000|Overall Study|Withdrawal by Subject|0|||
147053945|NCT00957801|530359668|FG001|Overall Study|Withdrawal by Subject|0|||
147053946|NCT00957801|530359669|FG002|Overall Study|Withdrawal by Subject|0|||
147053947|NCT00957801|530359670|FG003|Overall Study|Withdrawal by Subject|1|||
147053948|NCT02626026|530359674|FG000|Overall Study|Randomized but Never Treated|0|||
147053949|NCT02626026|530359675|FG001|Overall Study|Randomized but Never Treated|0|||
147053950|NCT02626026|530359676|FG002|Overall Study|Randomized but Never Treated|0|||
147053951|NCT02626026|530359677|FG003|Overall Study|Randomized but Never Treated|0|||
147053952|NCT02626026|530359678|FG004|Overall Study|Randomized but Never Treated|1|||
147053953|NCT02626026|530359679|FG005|Overall Study|Randomized but Never Treated|0|||
147053954|NCT00380874|530359682|FG000|Overall Study|Adverse Event|7|||
147053955|NCT00380874|530359683|FG001|Overall Study|Adverse Event|7|||
147053956|NCT00380874|530359682|FG000|Overall Study|Death|1|||
147053957|NCT00380874|530359683|FG001|Overall Study|Death|0|||
147053958|NCT00380874|530359682|FG000|Overall Study|Withdrawal by Subject|2|||
147053959|NCT00380874|530359683|FG001|Overall Study|Withdrawal by Subject|1|||
147053960|NCT00380874|530359682|FG000|Overall Study|Not related to study drug|3|||
147053961|NCT00380874|530359683|FG001|Overall Study|Not related to study drug|2|||
147053962|NCT03380429|530359684|FG000|Overall Study|Physician Decision|0|||
147053963|NCT03380429|530359685|FG001|Overall Study|Physician Decision|1|||
147053964|NCT03380429|530359686|FG002|Overall Study|Physician Decision|0|||
147053965|NCT03380429|530359687|FG003|Overall Study|Physician Decision|1|||
147053966|NCT03380429|530359688|FG004|Overall Study|Physician Decision|1|||
147053967|NCT03380429|530359684|FG000|Overall Study|Withdrawal by Subject|3|||
147053968|NCT03380429|530359685|FG001|Overall Study|Withdrawal by Subject|3|||
147053969|NCT03380429|530359686|FG002|Overall Study|Withdrawal by Subject|5|||
147053970|NCT03380429|530359687|FG003|Overall Study|Withdrawal by Subject|2|||
147053971|NCT03380429|530359688|FG004|Overall Study|Withdrawal by Subject|1|||
147053972|NCT03380429|530359684|FG000|Overall Study|Lost to Follow-up|0|||
147053973|NCT03380429|530359685|FG001|Overall Study|Lost to Follow-up|2|||
147053974|NCT03380429|530359686|FG002|Overall Study|Lost to Follow-up|4|||
147053975|NCT03380429|530359687|FG003|Overall Study|Lost to Follow-up|3|||
147053976|NCT03380429|530359688|FG004|Overall Study|Lost to Follow-up|1|||
147053977|NCT03380429|530359684|FG000|Overall Study|Protocol Violation|1|||
147053978|NCT03380429|530359685|FG001|Overall Study|Protocol Violation|0|||
147053979|NCT03380429|530359686|FG002|Overall Study|Protocol Violation|1|||
147053980|NCT03380429|530359687|FG003|Overall Study|Protocol Violation|0|||
147053981|NCT03380429|530359688|FG004|Overall Study|Protocol Violation|1|||
147053982|NCT03380429|530359684|FG000|Overall Study|Lack of Efficacy|0|||
147053983|NCT03380429|530359685|FG001|Overall Study|Lack of Efficacy|0|||
147053984|NCT03380429|530359686|FG002|Overall Study|Lack of Efficacy|0|||
147053985|NCT03380429|530359687|FG003|Overall Study|Lack of Efficacy|2|||
147053986|NCT03380429|530359688|FG004|Overall Study|Lack of Efficacy|1|||
147053987|NCT03380429|530359684|FG000|Overall Study|Adverse Event|1|||
147053988|NCT03380429|530359685|FG001|Overall Study|Adverse Event|1|||
147053989|NCT03380429|530359686|FG002|Overall Study|Adverse Event|1|||
147053990|NCT03380429|530359687|FG003|Overall Study|Adverse Event|2|||
147053991|NCT03380429|530359688|FG004|Overall Study|Adverse Event|0|||
147053992|NCT01707290|530359695|FG000|Overall Study|Adverse event (AE)|1|||
147053993|NCT01707290|530359696|FG001|Overall Study|Adverse event (AE)|0|||
147053994|NCT01707290|530359695|FG000|Overall Study|Physician Decision|1|||
147053995|NCT01707290|530359696|FG001|Overall Study|Physician Decision|0|||
147053996|NCT01707290|530359695|FG000|Overall Study|Lost to Follow-up|3|||
147053997|NCT01707290|530359696|FG001|Overall Study|Lost to Follow-up|0|||
147053998|NCT01707290|530359695|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
147053999|NCT01707290|530359696|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
147054000|NCT01707290|530359695|FG000|Overall Study|Commercial drug available|60|||
147054001|NCT01707290|530359696|FG001|Overall Study|Commercial drug available|1|||
147054002|NCT01707290|530359695|FG000|Overall Study|Other unspecified|17|||
147054003|NCT01707290|530359696|FG001|Overall Study|Other unspecified|0|||
147054004|NCT01198470|530359697|FG000|Overall Study|Adverse Event|2|||
147054005|NCT02949973|530359698|FG000|Overall Study|Physician Decision|1|||
147054006|NCT00586703|530359699|FG000|Overall Study|Death|12|||
147054007|NCT00806403|530359702|FG000|Overall Study|Death|4|||
147054008|NCT00806403|530359703|FG001|Overall Study|Death|3|||
147054009|NCT01882985|530359704|FG000|Overall Study|Lost to Follow-up|1|||
147054010|NCT01882985|530359704|FG000|Overall Study|Withdrawal by Subject|1|||
147054011|NCT00765102|530359705|FG000|Overall Study|Progressive disease|18|||
147054012|NCT00765102|530359705|FG000|Overall Study|Adverse Event|6|||
147054013|NCT00765102|530359705|FG000|Overall Study|Physician Decision|4|||
147054014|NCT00765102|530359705|FG000|Overall Study|Withdrawal by Subject|2|||
147054015|NCT00765102|530359705|FG000|Overall Study|Protocol Violation|1|||
147054016|NCT04129125|530359712|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
147054017|NCT04129125|530359712|FG000|Overall Study|Study device was not used|3|||
147054018|NCT04383327|530359723|FG000|Overall Study|Lost to Follow-up|112|||
147054019|NCT04383327|530359724|FG001|Overall Study|Lost to Follow-up|14|||
147054020|NCT04383327|530359725|FG002|Overall Study|Lost to Follow-up|78|||
147054021|NCT04383327|530359726|FG003|Overall Study|Lost to Follow-up|13|||
147054022|NCT04383327|530359727|FG004|Overall Study|Lost to Follow-up|110|||
147054023|NCT04383327|530359728|FG005|Overall Study|Lost to Follow-up|13|||
147054024|NCT04383327|530359729|FG006|Overall Study|Lost to Follow-up|74|||
147054025|NCT04383327|530359730|FG007|Overall Study|Lost to Follow-up|13|||
147054026|NCT04383327|530359731|FG008|Overall Study|Lost to Follow-up|78|||
147054027|NCT04383327|530359732|FG009|Overall Study|Lost to Follow-up|10|||
147054028|NCT04383327|530359733|FG010|Overall Study|Lost to Follow-up|160|||
147054029|NCT04383327|530359734|FG011|Overall Study|Lost to Follow-up|13|||
147054030|NCT05271175|530359744|FG000|One Week Follow up|Lost to Follow-up|10|||
147054031|NCT05271175|530359745|FG001|One Week Follow up|Lost to Follow-up|7|||
147054032|NCT05271175|530359746|FG002|One Week Follow up|Lost to Follow-up|5|||
147054033|NCT05271175|530359744|FG000|One Month Follow up|Lost to Follow-up|12|||
147054034|NCT05271175|530359745|FG001|One Month Follow up|Lost to Follow-up|7|||
147054035|NCT05271175|530359746|FG002|One Month Follow up|Lost to Follow-up|9|||
147054036|NCT05271175|530359744|FG000|Six Months Follow up|Lost to Follow-up|8|||
147054037|NCT05271175|530359745|FG001|Six Months Follow up|Lost to Follow-up|2|||
147054038|NCT05271175|530359746|FG002|Six Months Follow up|Lost to Follow-up|2|||
147054039|NCT00226499|530359747|FG000|Overall Study|Adverse Event|10|||
147054040|NCT00226499|530359748|FG001|Overall Study|Adverse Event|6|||
147054041|NCT00226499|530359749|FG002|Overall Study|Adverse Event|3|||
147054042|NCT00226499|530359747|FG000|Overall Study|Others|1064|||
147054043|NCT00226499|530359748|FG001|Overall Study|Others|1066|||
147054044|NCT00226499|530359749|FG002|Overall Study|Others|356|||
147054045|NCT00991887|530359750|FG000|Overall Study|Lost to Follow-up|2|||
147054046|NCT00991887|530359751|FG001|Overall Study|Lost to Follow-up|1|||
147054047|NCT03539302|530359756|FG000|Overall Study|Spontaneous cardio version|0|||
147054048|NCT03539302|530359757|FG001|Overall Study|Spontaneous cardio version|0|||
147054049|NCT03539302|530359758|FG002|Overall Study|Spontaneous cardio version|0|||
147054050|NCT03539302|530359759|FG003|Overall Study|Spontaneous cardio version|0|||
147054051|NCT03539302|530359760|FG004|Overall Study|Spontaneous cardio version|0|||
147054052|NCT03539302|530359761|FG005|Overall Study|Spontaneous cardio version|1|||
147054053|NCT03539302|530359762|FG006|Overall Study|Spontaneous cardio version|1|||
147054054|NCT04564092|530359764|FG000|Overall Study|Withdrawal by Subject|1|||
147054055|NCT03349060|530361129|FG000|Overall Study|Adverse Event|9|||
147054056|NCT03349060|530361130|FG001|Overall Study|Adverse Event|9|||
147054057|NCT03349060|530361131|FG002|Overall Study|Adverse Event|7|||
147054058|NCT03349060|530361129|FG000|Overall Study|Lack of Efficacy|1|||
147054059|NCT03349060|530361130|FG001|Overall Study|Lack of Efficacy|0|||
147054060|NCT03349060|530361131|FG002|Overall Study|Lack of Efficacy|2|||
147054061|NCT03349060|530361129|FG000|Overall Study|Lost to Follow-up|2|||
147054062|NCT03349060|530361130|FG001|Overall Study|Lost to Follow-up|1|||
147054063|NCT03349060|530361131|FG002|Overall Study|Lost to Follow-up|1|||
147054064|NCT03349060|530361129|FG000|Overall Study|Protocol Violation|2|||
147054065|NCT03349060|530361130|FG001|Overall Study|Protocol Violation|2|||
147054066|NCT03349060|530361131|FG002|Overall Study|Protocol Violation|1|||
147054067|NCT03349060|530361129|FG000|Overall Study|Withdrawal by Subject|5|||
147054068|NCT03349060|530361130|FG001|Overall Study|Withdrawal by Subject|3|||
147054069|NCT03349060|530361131|FG002|Overall Study|Withdrawal by Subject|4|||
147054070|NCT03349060|530361129|FG000|Overall Study|Medication error,no linked adverse event|0|||
147054071|NCT03349060|530361130|FG001|Overall Study|Medication error,no linked adverse event|0|||
147054072|NCT03349060|530361131|FG002|Overall Study|Medication error,no linked adverse event|1|||
147054073|NCT03349060|530361129|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
147054074|NCT03349060|530361130|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
147054075|NCT03349060|530361131|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
147054076|NCT03349060|530361129|FG000|Overall Study|Other|2|||
147054077|NCT03349060|530361130|FG001|Overall Study|Other|1|||
147054078|NCT03349060|530361131|FG002|Overall Study|Other|0|||
147054079|NCT00485732|530361132|FG000|Overall Study|Protocol Violation|1|||
147054080|NCT00485732|530361133|FG001|Overall Study|Protocol Violation|3|||
147054081|NCT00485732|530361132|FG000|Overall Study|Withdrawal by Subject|5|||
147054082|NCT00485732|530361133|FG001|Overall Study|Withdrawal by Subject|4|||
147054083|NCT00485732|530361132|FG000|Overall Study|Lost to Follow-up|2|||
147054084|NCT00485732|530361133|FG001|Overall Study|Lost to Follow-up|2|||
147054085|NCT01415518|530361136|FG000|Overall Study|Withdrawal by Subject|2|||
147054086|NCT01415518|530361137|FG001|Overall Study|Withdrawal by Subject|12|||
147054087|NCT01415518|530361136|FG000|Overall Study|Protocol Violation|6|||
147054088|NCT01415518|530361137|FG001|Overall Study|Protocol Violation|8|||
147054089|NCT01415518|530361136|FG000|Overall Study|Lost to Follow-up|3|||
147054090|NCT01415518|530361137|FG001|Overall Study|Lost to Follow-up|5|||
147054091|NCT01415518|530361136|FG000|Overall Study|Adverse Event|3|||
147054092|NCT01415518|530361137|FG001|Overall Study|Adverse Event|4|||
147054093|NCT01415518|530361136|FG000|Overall Study|Death|1|||
147054094|NCT01415518|530361137|FG001|Overall Study|Death|1|||
147054095|NCT01415518|530361136|FG000|Overall Study|Condition under Investigation Worsened|1|||
147054096|NCT01415518|530361137|FG001|Overall Study|Condition under Investigation Worsened|1|||
147054097|NCT02445248|530361139|FG000|Overall Study|Death|45|||
147054098|NCT02445248|530361140|FG001|Overall Study|Death|12|||
147054099|NCT02445248|530361139|FG000|Overall Study|Progressive disease|13|||
147054100|NCT02445248|530361140|FG001|Overall Study|Progressive disease|1|||
147054101|NCT02445248|530361139|FG000|Overall Study|Subject decision|8|||
147054102|NCT02445248|530361140|FG001|Overall Study|Subject decision|0|||
147054103|NCT02445248|530361139|FG000|Overall Study|Physician Decision|5|||
147054104|NCT02445248|530361140|FG001|Overall Study|Physician Decision|0|||
147054105|NCT02445248|530361139|FG000|Overall Study|Adverse Event|1|||
147054106|NCT02445248|530361140|FG001|Overall Study|Adverse Event|0|||
147054107|NCT02445248|530361139|FG000|Overall Study|Lost to Follow-up|1|||
147054108|NCT02445248|530361140|FG001|Overall Study|Lost to Follow-up|0|||
147054109|NCT00471822|530361145|FG000|Overall Study|Protocol Violation|2|||
147054110|NCT02342678|530361153|FG000|Overall Study|Lost to Follow-up|0|||
147054111|NCT02342678|530361154|FG001|Overall Study|Lost to Follow-up|1|||
147054112|NCT02342678|530361153|FG000|Overall Study|Too busy to complete study|0|||
147054113|NCT02342678|530361154|FG001|Overall Study|Too busy to complete study|2|||
147054114|NCT02342678|530361153|FG000|Overall Study|Family illness/emergency|0|||
147054115|NCT02342678|530361154|FG001|Overall Study|Family illness/emergency|1|||
147054116|NCT02342678|530361153|FG000|Overall Study|Illness/medical reason|1|||
147054117|NCT02342678|530361154|FG001|Overall Study|Illness/medical reason|1|||
147054118|NCT01293695|530361158|FG000|Overall Study|Withdrawal by Subject|7|||
147054119|NCT01293695|530361159|FG001|Overall Study|Withdrawal by Subject|1|||
147054120|NCT01293695|530361158|FG000|Overall Study|Lost to Follow-up|8|||
147054121|NCT01293695|530361159|FG001|Overall Study|Lost to Follow-up|6|||
147054122|NCT01082328|530361162|FG000|Overall Study|Adverse Event|1|||
147054123|NCT00031590|530361163|FG000|Overall Study|Adverse Event|1|||
147054124|NCT00031590|530361163|FG000|Overall Study|Withdrawal by parents|2|||
147054125|NCT01568892|530361164|FG000|Open-label Phase|Adverse Event|2|||
147054126|NCT01568892|530361165|FG001|Open-label Phase|Adverse Event|0|||
147054127|NCT01568892|530361164|FG000|Open-label Phase|Lack of Efficacy|4|||
147054128|NCT01568892|530361165|FG001|Open-label Phase|Lack of Efficacy|2|||
147054129|NCT01568892|530361164|FG000|Open-label Phase|Lost to Follow-up|0|||
147054130|NCT01568892|530361165|FG001|Open-label Phase|Lost to Follow-up|1|||
147054131|NCT02375971|530361172|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
147054132|NCT02375971|530361173|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
147054133|NCT02375971|530361174|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
147054134|NCT02375971|530361172|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
147054135|NCT02375971|530361173|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
147054136|NCT02375971|530361174|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
147054137|NCT02375971|530361172|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
147054138|NCT02375971|530361173|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
147054139|NCT02375971|530361174|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
147054140|NCT02375971|530361172|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
147054141|NCT02375971|530361173|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
147054142|NCT02375971|530361174|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
147054143|NCT02375971|530361172|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
147054144|NCT02375971|530361173|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
147054145|NCT02375971|530361174|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
147054146|NCT02375971|530361172|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
147054147|NCT02375971|530361173|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
147054148|NCT02375971|530361174|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
147054149|NCT02375971|530361172|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
147054150|NCT02375971|530361173|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
147054151|NCT02375971|530361174|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
147054152|NCT02375971|530361172|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
147054153|NCT02375971|530361173|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
147054154|NCT02375971|530361174|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
147054155|NCT02755103|530361175|FG000|Overall Study|Lost to Follow-up|17|||
147054156|NCT02755103|530361176|FG001|Overall Study|Lost to Follow-up|15|||
147054157|NCT02755103|530361175|FG000|Overall Study|Death|0|||
147054158|NCT02755103|530361176|FG001|Overall Study|Death|1|||
147054159|NCT02755103|530361175|FG000|Overall Study|Physician Decision|0|||
147054160|NCT02755103|530361176|FG001|Overall Study|Physician Decision|1|||
147054161|NCT02755103|530361175|FG000|Overall Study|Pregnancy|0|||
147054162|NCT02755103|530361176|FG001|Overall Study|Pregnancy|1|||
147054163|NCT02755103|530361175|FG000|Overall Study|Withdrawal by Subject|3|||
147054164|NCT02755103|530361176|FG001|Overall Study|Withdrawal by Subject|0|||
147054165|NCT04177095|530361177|FG000|Overall Study|Withdrawal by Subject|3|||
147054166|NCT04177095|530361177|FG000|Overall Study|Screen Failure|3|||
147054167|NCT04177095|530361177|FG000|Overall Study|Problems with the Trugraf assay|1|||
147054168|NCT00777296|530361178|FG000|Overall Study|Adverse Event|0|||
147054169|NCT00777296|530361179|FG001|Overall Study|Adverse Event|1|||
147054170|NCT00777296|530361180|FG002|Overall Study|Adverse Event|0|||
147054171|NCT00777296|530361181|FG003|Overall Study|Adverse Event|1|||
147054172|NCT00777296|530361178|FG000|Overall Study|Withdrawal by Subject|1|||
147054173|NCT00777296|530361179|FG001|Overall Study|Withdrawal by Subject|0|||
147054174|NCT00777296|530361180|FG002|Overall Study|Withdrawal by Subject|0|||
147054175|NCT00777296|530361181|FG003|Overall Study|Withdrawal by Subject|0|||
147054176|NCT00777296|530361178|FG000|Overall Study|CRF form not completed|0|||
147054177|NCT00777296|530361179|FG001|Overall Study|CRF form not completed|0|||
147054178|NCT00777296|530361180|FG002|Overall Study|CRF form not completed|2|||
147054179|NCT00777296|530361181|FG003|Overall Study|CRF form not completed|0|||
147054180|NCT00658723|530361182|FG000|Overall Study|Lost to Follow-up|0|||
147054181|NCT00658723|530361183|FG001|Overall Study|Lost to Follow-up|2|||
147054182|NCT00658723|530361184|FG002|Overall Study|Lost to Follow-up|2|||
147054183|NCT00658723|530361182|FG000|Overall Study|Death|2|||
147054184|NCT00658723|530361183|FG001|Overall Study|Death|1|||
147054185|NCT00658723|530361184|FG002|Overall Study|Death|4|||
147054186|NCT00658723|530361182|FG000|Overall Study|Scheduling Issue|1|||
147054187|NCT00658723|530361183|FG001|Overall Study|Scheduling Issue|1|||
147054188|NCT00658723|530361184|FG002|Overall Study|Scheduling Issue|0|||
147054189|NCT00658723|530361182|FG000|Overall Study|Withdrawal by Subject|1|||
147054190|NCT00658723|530361183|FG001|Overall Study|Withdrawal by Subject|0|||
147054191|NCT00658723|530361184|FG002|Overall Study|Withdrawal by Subject|1|||
147054192|NCT01139125|530361186|FG000|Overall Study|Withdrawal by Subject|1|||
147054193|NCT02172664|530361194|FG000|Overall Study|Lost to Follow-up|4|||
147054194|NCT02172664|530361195|FG001|Overall Study|Lost to Follow-up|4|||
147054195|NCT02172664|530361194|FG000|Overall Study|Death|1|||
147054196|NCT02172664|530361195|FG001|Overall Study|Death|1|||
147054197|NCT02172664|530361194|FG000|Overall Study|Moved out of area|1|||
147054198|NCT02172664|530361195|FG001|Overall Study|Moved out of area|1|||
147054199|NCT01909934|530361198|FG000|Overall Study|Withdrawal by Subject|3|||
147054200|NCT01909934|530361198|FG000|Overall Study|Lost to Follow-up|1|||
147054201|NCT01909934|530361198|FG000|Overall Study|Death|25|||
147054202|NCT01909934|530361198|FG000|Overall Study|Withdrawal of Informed Consent|1|||
147054203|NCT01909934|530361198|FG000|Overall Study|Reason Not Specified|1|||
147054204|NCT03193853|530361201|FG000|Overall Study|Death|6|||
147054205|NCT01787292|530361202|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
147054206|NCT01787292|530361203|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
147054207|NCT01787292|530361202|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
147054208|NCT01787292|530361203|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
147054209|NCT01827111|530361204|FG000|Overall Study|Disease Progression|1|||
147054210|NCT02962648|530361205|FG000|Overall Study|Withdrawal by Subject|3|||
147054211|NCT02962648|530361205|FG000|Overall Study|Lost to Follow-up|3|||
147054212|NCT02962648|530361205|FG000|Overall Study|Physician Decision|1|||
147054213|NCT02962648|530361205|FG000|Overall Study|Subject had problems with transportation|2|||
147054214|NCT03267212|530361206|FG000|First Intervention|Lost to Follow-up|0|||
147054215|NCT03267212|530361207|FG001|First Intervention|Lost to Follow-up|2|||
147054216|NCT03267212|530361206|FG000|First Intervention|Withdrawal by Subject|1|||
147054217|NCT03267212|530361207|FG001|First Intervention|Withdrawal by Subject|1|||
147054218|NCT03267212|530361206|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
147054219|NCT03267212|530361207|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
147054220|NCT05691712|530361209|FG000|Overall Study|Adverse Event|0|||
147054221|NCT05691712|530361210|FG001|Overall Study|Adverse Event|1|||
147054222|NCT05691712|530361211|FG002|Overall Study|Adverse Event|2|||
147054223|NCT05691712|530361212|FG003|Overall Study|Adverse Event|1|||
147054224|NCT05691712|530361209|FG000|Overall Study|Withdrawal by Subject|2|||
147054225|NCT05691712|530361210|FG001|Overall Study|Withdrawal by Subject|3|||
147054226|NCT05691712|530361211|FG002|Overall Study|Withdrawal by Subject|3|||
147054227|NCT05691712|530361212|FG003|Overall Study|Withdrawal by Subject|1|||
147054228|NCT05691712|530361209|FG000|Overall Study|Death|1|||
147054229|NCT05691712|530361210|FG001|Overall Study|Death|0|||
147054230|NCT05691712|530361211|FG002|Overall Study|Death|0|||
147054231|NCT05691712|530361212|FG003|Overall Study|Death|0|||
147054232|NCT05691712|530361209|FG000|Overall Study|Pregnancy|0|||
147054233|NCT05691712|530361210|FG001|Overall Study|Pregnancy|1|||
147054234|NCT05691712|530361211|FG002|Overall Study|Pregnancy|0|||
147054235|NCT05691712|530361212|FG003|Overall Study|Pregnancy|0|||
147054236|NCT05691712|530361209|FG000|Overall Study|Assigned Treatment by Mistake|1|||
147054237|NCT05691712|530361210|FG001|Overall Study|Assigned Treatment by Mistake|0|||
147054238|NCT05691712|530361211|FG002|Overall Study|Assigned Treatment by Mistake|0|||
147054239|NCT05691712|530361212|FG003|Overall Study|Assigned Treatment by Mistake|1|||
147054240|NCT04837196|530361213|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
147054241|NCT04837196|530361214|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
147054242|NCT04837196|530361215|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
147054243|NCT04837196|530361216|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
147054244|NCT04837196|530361217|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
147054245|NCT04837196|530361213|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
147054246|NCT04837196|530361214|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
147054247|NCT04837196|530361215|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
147054248|NCT04837196|530361216|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
147054249|NCT04837196|530361217|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
147054250|NCT04837196|530361213|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
147054251|NCT04837196|530361214|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
147054252|NCT04837196|530361215|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
147054253|NCT04837196|530361216|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
147054254|NCT04837196|530361217|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
147054255|NCT04837196|530361213|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
147054256|NCT04837196|530361214|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
147054257|NCT04837196|530361215|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
147054258|NCT04837196|530361216|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
147054259|NCT04837196|530361217|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
147054260|NCT04837196|530361213|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
147054261|NCT04837196|530361214|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
147054262|NCT04837196|530361215|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
147054263|NCT04837196|530361216|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
147054264|NCT04837196|530361217|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
147054265|NCT01289678|530361218|FG000|Overall Study|Physician Decision|6|||
147054266|NCT02174627|530361219|FG000|Overall Study|Missing|0|||
147054267|NCT02174627|530361220|FG001|Overall Study|Missing|1|||
147054268|NCT02174627|530361219|FG000|Overall Study|Incorrect enrolment before randomization|0|||
147054269|NCT02174627|530361220|FG001|Overall Study|Incorrect enrolment before randomization|1|||
147054270|NCT02174627|530361219|FG000|Overall Study|Participant decision|84|||
147054271|NCT02174627|530361220|FG001|Overall Study|Participant decision|128|||
147054272|NCT02859337|530361221|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
147054273|NCT02859337|530361222|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
147054274|NCT02859337|530361223|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
147054275|NCT02859337|530361221|FG000|Overall Study|Withdrawal by Subject|3|||
147054276|NCT02859337|530361222|FG001|Overall Study|Withdrawal by Subject|1|||
147054277|NCT02859337|530361223|FG002|Overall Study|Withdrawal by Subject|0|||
147054278|NCT02859337|530361221|FG000|Overall Study|Lost to Follow-up|1|||
147054279|NCT02859337|530361222|FG001|Overall Study|Lost to Follow-up|0|||
147054280|NCT02859337|530361223|FG002|Overall Study|Lost to Follow-up|0|||
147054281|NCT02362360|530361229|FG000|Period 1|Lack of Efficacy|1|||
147054282|NCT02362360|530361230|FG001|Period 1|Lack of Efficacy|0|||
147054283|NCT02362360|530361229|FG000|Period 1|Withdrawal by Subject|2|||
147054284|NCT02362360|530361230|FG001|Period 1|Withdrawal by Subject|1|||
147054285|NCT04146012|530361231|FG000|Overall Study|Study Terminated|30|||
147054286|NCT04146012|530361232|FG001|Overall Study|Study Terminated|15|||
147054287|NCT01546025|530361233|FG000|Overall Study|Lost to Follow-up|0|||
147054288|NCT01546025|530361234|FG001|Overall Study|Lost to Follow-up|1|||
147054289|NCT02729025|530361238|FG000|Overall Study|Sponsor Decision|0|||
147054290|NCT02729025|530361239|FG001|Overall Study|Sponsor Decision|1|||
147054291|NCT05573464|530363114|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
147054292|NCT05573464|530363115|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
147054293|NCT05573464|530363114|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
147054294|NCT05573464|530363115|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
147054295|NCT05573464|530363114|FG000|12-week Treatment Period|Protocol Violation|3|||
147054296|NCT05573464|530363115|FG001|12-week Treatment Period|Protocol Violation|1|||
147054297|NCT05573464|530363114|FG000|12-week Treatment Period|Physician Decision|1|||
147054298|NCT05573464|530363115|FG001|12-week Treatment Period|Physician Decision|2|||
147054299|NCT05573464|530363114|FG000|12-week Treatment Period|Lost to Follow-up|2|||
147054300|NCT05573464|530363115|FG001|12-week Treatment Period|Lost to Follow-up|0|||
147054301|NCT05573464|530363114|FG000|12-week Treatment Period|Adverse Event|20|||
147054302|NCT05573464|530363115|FG001|12-week Treatment Period|Adverse Event|9|||
147054303|NCT05573464|530363114|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
147054304|NCT05573464|530363115|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
147054305|NCT05573464|530363114|FG000|12-week Treatment Period|Randomised, not treated|0|||
147054306|NCT05573464|530363115|FG001|12-week Treatment Period|Randomised, not treated|1|||
147054307|NCT05573464|530363114|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
147054308|NCT05573464|530363115|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
147054309|NCT05573464|530363114|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
147054310|NCT05573464|530363115|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
147054311|NCT05573464|530363114|FG000|52-week Treatment Period|Protocol Violation|1|||
147054312|NCT05573464|530363115|FG001|52-week Treatment Period|Protocol Violation|1|||
147054313|NCT05573464|530363114|FG000|52-week Treatment Period|Physician Decision|2|||
147054314|NCT05573464|530363115|FG001|52-week Treatment Period|Physician Decision|2|||
147054315|NCT05573464|530363114|FG000|52-week Treatment Period|Lost to Follow-up|1|||
147054316|NCT05573464|530363115|FG001|52-week Treatment Period|Lost to Follow-up|1|||
147054317|NCT05573464|530363114|FG000|52-week Treatment Period|Adverse Event|11|||
147054318|NCT05573464|530363115|FG001|52-week Treatment Period|Adverse Event|8|||
147054319|NCT05573464|530363114|FG000|52-week Treatment Period|Death|1|||
147054320|NCT05573464|530363115|FG001|52-week Treatment Period|Death|1|||
147054321|NCT04632927|530363116|FG000|Overall Study|Adverse Event|0|||
147054322|NCT04632927|530363117|FG001|Overall Study|Adverse Event|1|||
147054323|NCT04632927|530363116|FG000|Overall Study|Lack of Efficacy|0|||
147054324|NCT04632927|530363117|FG001|Overall Study|Lack of Efficacy|4|||
147054325|NCT04632927|530363116|FG000|Overall Study|Loss of efficacy|0|||
147054326|NCT04632927|530363117|FG001|Overall Study|Loss of efficacy|1|||
147054327|NCT04632927|530363116|FG000|Overall Study|Non-compliance with study drug|0|||
147054328|NCT04632927|530363117|FG001|Overall Study|Non-compliance with study drug|1|||
147054329|NCT04632927|530363116|FG000|Overall Study|Physician Decision|0|||
147054330|NCT04632927|530363117|FG001|Overall Study|Physician Decision|1|||
147054331|NCT04632927|530363116|FG000|Overall Study|Subject decision|0|||
147054332|NCT04632927|530363117|FG001|Overall Study|Subject decision|1|||
147054333|NCT04632927|530363116|FG000|Overall Study|Withdrawal by Subject|0|||
147054334|NCT04632927|530363117|FG001|Overall Study|Withdrawal by Subject|1|||
147054335|NCT05734157|530363118|FG000|Overall Study|Death|3|||
147054336|NCT05734157|530363118|FG000|Overall Study|Withdrawal by Subject|2|||
147054337|NCT05734157|530363118|FG000|Overall Study|Lost to Follow-up|1|||
147054338|NCT05734157|530363118|FG000|Overall Study|Telephone call|3|||
147054339|NCT04846569|530363119|FG000|Overall Study|Withdrawal by Subject|3|||
147054340|NCT04846569|530363120|FG001|Overall Study|Withdrawal by Subject|1|||
147054341|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
147054342|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
147054343|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
147054344|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
147054345|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
147054346|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
147054347|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
147054348|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
147054349|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
147054350|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
147054351|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
147054352|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
147054353|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
147054354|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
147054355|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
147054356|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
147054357|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
147054358|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
147054359|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
147054360|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
147054361|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
147054362|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
147054363|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
147054364|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
147054365|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
147054366|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
147054367|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
147054368|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
147054369|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
147054370|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
147054371|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
147054372|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
147054373|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
147054374|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
147054375|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
147054376|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
147054377|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
147054378|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
147054379|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
147054380|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
147054381|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
147054382|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
147054383|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
147054384|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
147054385|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
147054386|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
147054387|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
147054388|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
147054389|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
147054390|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
147054391|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
147054392|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
147054393|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|Site closed|0|||
147054394|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|Site closed|0|||
147054395|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|Site closed|1|||
147054396|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|Site closed|0|||
147054397|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
147054398|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
147054399|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
147054400|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
147054401|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
147054402|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
147054403|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
147054404|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
147054405|NCT00838903|530363121|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
147054406|NCT00838903|530363122|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
147054407|NCT00838903|530363123|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
147054408|NCT00838903|530363124|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
147054409|NCT00838903|530363121|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
147054410|NCT00838903|530363122|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
147054411|NCT00838903|530363123|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
147054412|NCT00838903|530363124|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
147054413|NCT00838903|530363121|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
147054414|NCT00838903|530363122|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
147054415|NCT00838903|530363123|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
147054416|NCT00838903|530363124|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
147054417|NCT00838903|530363121|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
147054418|NCT00838903|530363122|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
147054419|NCT00838903|530363123|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
147054420|NCT00838903|530363124|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
147054421|NCT00838903|530363121|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
147054422|NCT00838903|530363122|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
147054423|NCT00838903|530363123|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
147054424|NCT00838903|530363124|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
147054425|NCT00838903|530363121|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
147054426|NCT00838903|530363122|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
147054427|NCT00838903|530363123|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
147054428|NCT00838903|530363124|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
147054429|NCT00838903|530363121|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
147054430|NCT00838903|530363122|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
147054431|NCT00838903|530363123|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
147054432|NCT00838903|530363124|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
147054433|NCT00838903|530363121|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
147054434|NCT00838903|530363122|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
147054435|NCT00838903|530363123|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
147054436|NCT00838903|530363124|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
147054437|NCT00838903|530363121|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
147054438|NCT00838903|530363122|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
147054439|NCT00838903|530363123|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
147054440|NCT00838903|530363124|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
147054441|NCT00838903|530363121|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
147054442|NCT00838903|530363122|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
147054443|NCT00838903|530363123|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
147054444|NCT00838903|530363124|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
147054445|NCT00838903|530363121|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
147054446|NCT00838903|530363122|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
147054447|NCT00838903|530363123|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
147054448|NCT00838903|530363124|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
147054449|NCT00838903|530363121|FG000|Follow-up Period (8 Weeks)|Missing|1|||
147054450|NCT00838903|530363122|FG001|Follow-up Period (8 Weeks)|Missing|2|||
147054451|NCT00838903|530363123|FG002|Follow-up Period (8 Weeks)|Missing|1|||
147054452|NCT00838903|530363124|FG003|Follow-up Period (8 Weeks)|Missing|1|||
147054453|NCT04225715|530363125|FG000|Overall Study|Reason not Specified|1|||
147054454|NCT04225715|530363126|FG001|Overall Study|Reason not Specified|0|||
147054455|NCT04225715|530363127|FG002|Overall Study|Reason not Specified|0|||
147054456|NCT04225715|530363128|FG003|Overall Study|Reason not Specified|0|||
147054457|NCT04225715|530363129|FG004|Overall Study|Reason not Specified|0|||
147054458|NCT04225715|530363130|FG005|Overall Study|Reason not Specified|0|||
147054459|NCT04225715|530363131|FG006|Overall Study|Reason not Specified|0|||
147054460|NCT04225715|530363132|FG007|Overall Study|Reason not Specified|0|||
147054461|NCT04225715|530363133|FG008|Overall Study|Reason not Specified|0|||
147054462|NCT04225715|530363125|FG000|Overall Study|Protocol Violation|1|||
147054463|NCT04225715|530363126|FG001|Overall Study|Protocol Violation|0|||
147054464|NCT04225715|530363127|FG002|Overall Study|Protocol Violation|0|||
147054465|NCT04225715|530363128|FG003|Overall Study|Protocol Violation|0|||
147054466|NCT04225715|530363129|FG004|Overall Study|Protocol Violation|0|||
147054467|NCT04225715|530363130|FG005|Overall Study|Protocol Violation|9|||
147054468|NCT04225715|530363131|FG006|Overall Study|Protocol Violation|0|||
147054469|NCT04225715|530363132|FG007|Overall Study|Protocol Violation|0|||
147054470|NCT04225715|530363133|FG008|Overall Study|Protocol Violation|0|||
147054471|NCT04225715|530363125|FG000|Overall Study|Withdrawal by Subject|4|||
147054472|NCT04225715|530363126|FG001|Overall Study|Withdrawal by Subject|1|||
147054473|NCT04225715|530363127|FG002|Overall Study|Withdrawal by Subject|1|||
147054474|NCT04225715|530363128|FG003|Overall Study|Withdrawal by Subject|0|||
147054475|NCT04225715|530363129|FG004|Overall Study|Withdrawal by Subject|3|||
147054476|NCT04225715|530363130|FG005|Overall Study|Withdrawal by Subject|1|||
147054477|NCT04225715|530363131|FG006|Overall Study|Withdrawal by Subject|1|||
147054478|NCT04225715|530363132|FG007|Overall Study|Withdrawal by Subject|1|||
147054479|NCT04225715|530363133|FG008|Overall Study|Withdrawal by Subject|0|||
147054480|NCT04225715|530363125|FG000|Overall Study|Adverse Event|0|||
147054481|NCT04225715|530363126|FG001|Overall Study|Adverse Event|0|||
147054482|NCT04225715|530363127|FG002|Overall Study|Adverse Event|0|||
147054483|NCT04225715|530363128|FG003|Overall Study|Adverse Event|0|||
147054484|NCT04225715|530363129|FG004|Overall Study|Adverse Event|0|||
147054485|NCT04225715|530363130|FG005|Overall Study|Adverse Event|0|||
147054486|NCT04225715|530363131|FG006|Overall Study|Adverse Event|0|||
147054487|NCT04225715|530363132|FG007|Overall Study|Adverse Event|0|||
147054488|NCT04225715|530363133|FG008|Overall Study|Adverse Event|1|||
147054489|NCT04225715|530363125|FG000|Overall Study|Arm Terminated By Sponsor|0|||
147054490|NCT04225715|530363126|FG001|Overall Study|Arm Terminated By Sponsor|0|||
147054491|NCT04225715|530363127|FG002|Overall Study|Arm Terminated By Sponsor|0|||
147054492|NCT04225715|530363128|FG003|Overall Study|Arm Terminated By Sponsor|0|||
147054493|NCT04225715|530363129|FG004|Overall Study|Arm Terminated By Sponsor|0|||
147054494|NCT04225715|530363130|FG005|Overall Study|Arm Terminated By Sponsor|0|||
147054495|NCT04225715|530363131|FG006|Overall Study|Arm Terminated By Sponsor|0|||
147054496|NCT04225715|530363132|FG007|Overall Study|Arm Terminated By Sponsor|17|||
147054497|NCT04225715|530363133|FG008|Overall Study|Arm Terminated By Sponsor|18|||
147054498|NCT02512302|530363134|FG000|Period 1|Adverse Event|0|||
147054499|NCT02512302|530363135|FG001|Period 1|Adverse Event|1|||
147054500|NCT02512302|530363136|FG002|Period 1|Adverse Event|0|||
147054501|NCT02512302|530363137|FG003|Period 1|Adverse Event|0|||
147054502|NCT02512302|530363138|FG004|Period 1|Adverse Event|0|||
147054503|NCT02512302|530363139|FG005|Period 1|Adverse Event|0|||
147054504|NCT02512302|530363140|FG006|Period 1|Adverse Event|0|||
147054505|NCT02512302|530363141|FG007|Period 1|Adverse Event|0|||
147054506|NCT02512302|530363142|FG008|Period 1|Adverse Event|0|||
147054507|NCT02512302|530363143|FG009|Period 1|Adverse Event|0|||
147054508|NCT02512302|530363134|FG000|Period 2|Adverse Event|0|||
147054509|NCT02512302|530363135|FG001|Period 2|Adverse Event|0|||
147054510|NCT02512302|530363136|FG002|Period 2|Adverse Event|0|||
147054511|NCT02512302|530363137|FG003|Period 2|Adverse Event|0|||
147054512|NCT02512302|530363138|FG004|Period 2|Adverse Event|0|||
147054513|NCT02512302|530363139|FG005|Period 2|Adverse Event|0|||
147054514|NCT02512302|530363140|FG006|Period 2|Adverse Event|0|||
147054515|NCT02512302|530363141|FG007|Period 2|Adverse Event|0|||
147054516|NCT02512302|530363142|FG008|Period 2|Adverse Event|0|||
147054517|NCT02512302|530363143|FG009|Period 2|Adverse Event|1|||
147054518|NCT02512302|530363134|FG000|Period 3|Lost to Follow-up|0|||
147054519|NCT02512302|530363135|FG001|Period 3|Lost to Follow-up|0|||
147054520|NCT02512302|530363136|FG002|Period 3|Lost to Follow-up|1|||
147054521|NCT02512302|530363137|FG003|Period 3|Lost to Follow-up|0|||
147054522|NCT02512302|530363138|FG004|Period 3|Lost to Follow-up|0|||
147054523|NCT02512302|530363139|FG005|Period 3|Lost to Follow-up|0|||
147054524|NCT02512302|530363140|FG006|Period 3|Lost to Follow-up|0|||
147054525|NCT02512302|530363141|FG007|Period 3|Lost to Follow-up|0|||
147054526|NCT02512302|530363142|FG008|Period 3|Lost to Follow-up|0|||
147054527|NCT02512302|530363143|FG009|Period 3|Lost to Follow-up|0|||
147054528|NCT02512302|530363134|FG000|Period 4|Adverse Event|0|||
147054529|NCT02512302|530363135|FG001|Period 4|Adverse Event|0|||
147054530|NCT02512302|530363136|FG002|Period 4|Adverse Event|0|||
147054531|NCT02512302|530363137|FG003|Period 4|Adverse Event|0|||
147054532|NCT02512302|530363138|FG004|Period 4|Adverse Event|0|||
147054533|NCT02512302|530363139|FG005|Period 4|Adverse Event|0|||
147054534|NCT02512302|530363140|FG006|Period 4|Adverse Event|1|||
147054535|NCT02512302|530363141|FG007|Period 4|Adverse Event|0|||
147054536|NCT02512302|530363142|FG008|Period 4|Adverse Event|0|||
147054537|NCT02512302|530363143|FG009|Period 4|Adverse Event|0|||
147054538|NCT00683618|530363144|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
147054539|NCT00683618|530363145|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
147054540|NCT00683618|530363146|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
147054541|NCT00683618|530363144|FG000|Randomised Treatment Period|Protocol Violation|0|||
147054542|NCT00683618|530363145|FG001|Randomised Treatment Period|Protocol Violation|1|||
147054543|NCT00683618|530363146|FG002|Randomised Treatment Period|Protocol Violation|0|||
147054544|NCT00683618|530363144|FG000|Randomised Treatment Period|Adverse Event|2|||
147054545|NCT00683618|530363145|FG001|Randomised Treatment Period|Adverse Event|0|||
147054546|NCT00683618|530363146|FG002|Randomised Treatment Period|Adverse Event|2|||
147054547|NCT00683618|530363144|FG000|Randomised Treatment Period|Reason not provided|0|||
147054548|NCT00683618|530363145|FG001|Randomised Treatment Period|Reason not provided|0|||
147054549|NCT00683618|530363146|FG002|Randomised Treatment Period|Reason not provided|2|||
147054550|NCT00683618|530363144|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
147054551|NCT00683618|530363145|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
147054552|NCT00683618|530363146|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
147054553|NCT00683618|530363144|FG000|Extension Treatment Period|Adverse Event|1|||
147054554|NCT00683618|530363145|FG001|Extension Treatment Period|Adverse Event|0|||
147054555|NCT00683618|530363146|FG002|Extension Treatment Period|Adverse Event|0|||
147054556|NCT00683618|530363144|FG000|Extension Treatment Period|Protocol Violation|1|||
147054557|NCT00683618|530363145|FG001|Extension Treatment Period|Protocol Violation|0|||
147054558|NCT00683618|530363146|FG002|Extension Treatment Period|Protocol Violation|0|||
147054559|NCT01002989|530363147|FG000|Overall Study|exclusion criteria, no consent|5|||
147054560|NCT01611935|530363148|FG000|Overall Study|Family Declined Participation|1|||
147054561|NCT01611935|530363149|FG001|Overall Study|Family Declined Participation|0|||
147054562|NCT05177484|530363150|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
147054563|NCT05177484|530363151|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
147054564|NCT05177484|530363150|FG000|Overall Study|Inadvertently withdrawn|3|||
147054565|NCT05177484|530363151|FG001|Overall Study|Inadvertently withdrawn|1|||
147054566|NCT05177484|530363150|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
147054567|NCT05177484|530363151|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
147054568|NCT02549859|530363152|FG000|Long-term 60 Hz DBS|Study Closed|1|||
147054569|NCT00729612|530363153|FG000|Overall Study|Non evaluable for response|10|||
147054570|NCT04067050|530363156|FG000|One Month|Lost to Follow-up|4|||
147054571|NCT04067050|530363157|FG001|One Month|Lost to Follow-up|0|||
147054572|NCT04067050|530363156|FG000|Two Month|Lost to Follow-up|1|||
147054573|NCT04067050|530363157|FG001|Two Month|Lost to Follow-up|0|||
147054574|NCT04067050|530363156|FG000|Two Month|Adverse Event|1|||
147054575|NCT04067050|530363157|FG001|Two Month|Adverse Event|0|||
147054576|NCT00460603|530363160|FG000|Phase 1|Death|1|||
147054577|NCT00460603|530363161|FG001|Phase 1|Death|0|||
147054578|NCT00460603|530363162|FG002|Phase 1|Death|0|||
147054579|NCT00460603|530363163|FG003|Phase 1|Death|2|||
147054580|NCT00460603|530363164|FG004|Phase 1|Death|0|||
147054581|NCT00460603|530363165|FG005|Phase 1|Death|0|||
147054582|NCT00460603|530363166|FG006|Phase 1|Death|0|||
147054583|NCT00460603|530363167|FG007|Phase 1|Death|0|||
147054584|NCT00460603|530363168|FG008|Phase 1|Death|1|||
147054585|NCT00460603|530363169|FG009|Phase 1|Death|0|||
147054586|NCT00460603|530363170|FG010|Phase 1|Death|0|||
147054587|NCT00460603|530363171|FG011|Phase 1|Death|0|||
147054588|NCT00460603|530363160|FG000|Phase 1|Adverse Event|3|||
147054589|NCT00460603|530363161|FG001|Phase 1|Adverse Event|1|||
147054590|NCT00460603|530363162|FG002|Phase 1|Adverse Event|1|||
147054591|NCT00460603|530363163|FG003|Phase 1|Adverse Event|2|||
147054592|NCT00460603|530363164|FG004|Phase 1|Adverse Event|0|||
147054593|NCT00460603|530363165|FG005|Phase 1|Adverse Event|0|||
147054594|NCT00460603|530363166|FG006|Phase 1|Adverse Event|3|||
147054595|NCT00460603|530363167|FG007|Phase 1|Adverse Event|0|||
147054596|NCT00460603|530363168|FG008|Phase 1|Adverse Event|4|||
147054597|NCT00460603|530363169|FG009|Phase 1|Adverse Event|0|||
147054598|NCT00460603|530363170|FG010|Phase 1|Adverse Event|0|||
147054599|NCT00460603|530363171|FG011|Phase 1|Adverse Event|0|||
147054600|NCT00460603|530363160|FG000|Phase 1|Lack of Efficacy|1|||
147054601|NCT00460603|530363161|FG001|Phase 1|Lack of Efficacy|0|||
147054602|NCT00460603|530363162|FG002|Phase 1|Lack of Efficacy|1|||
147054603|NCT00460603|530363163|FG003|Phase 1|Lack of Efficacy|2|||
147054604|NCT00460603|530363164|FG004|Phase 1|Lack of Efficacy|2|||
147054605|NCT00460603|530363165|FG005|Phase 1|Lack of Efficacy|2|||
147054606|NCT00460603|530363166|FG006|Phase 1|Lack of Efficacy|2|||
147054607|NCT00460603|530363167|FG007|Phase 1|Lack of Efficacy|2|||
147054608|NCT00460603|530363168|FG008|Phase 1|Lack of Efficacy|11|||
147054609|NCT00460603|530363169|FG009|Phase 1|Lack of Efficacy|0|||
147054610|NCT00460603|530363170|FG010|Phase 1|Lack of Efficacy|0|||
147054611|NCT00460603|530363171|FG011|Phase 1|Lack of Efficacy|0|||
147054612|NCT00460603|530363160|FG000|Phase 1|Withdrawal by Subject|1|||
147054613|NCT00460603|530363161|FG001|Phase 1|Withdrawal by Subject|2|||
147054614|NCT00460603|530363162|FG002|Phase 1|Withdrawal by Subject|1|||
147054615|NCT00460603|530363163|FG003|Phase 1|Withdrawal by Subject|1|||
147054616|NCT00460603|530363164|FG004|Phase 1|Withdrawal by Subject|3|||
147054617|NCT00460603|530363165|FG005|Phase 1|Withdrawal by Subject|0|||
147054618|NCT00460603|530363166|FG006|Phase 1|Withdrawal by Subject|1|||
147054619|NCT00460603|530363167|FG007|Phase 1|Withdrawal by Subject|0|||
147054620|NCT00460603|530363168|FG008|Phase 1|Withdrawal by Subject|2|||
147054621|NCT00460603|530363169|FG009|Phase 1|Withdrawal by Subject|0|||
147054622|NCT00460603|530363170|FG010|Phase 1|Withdrawal by Subject|0|||
147054623|NCT00460603|530363171|FG011|Phase 1|Withdrawal by Subject|0|||
147054624|NCT00460603|530363160|FG000|Phase 1|Other|0|||
147054625|NCT00460603|530363161|FG001|Phase 1|Other|3|||
147054626|NCT00460603|530363162|FG002|Phase 1|Other|1|||
147054627|NCT00460603|530363163|FG003|Phase 1|Other|1|||
147054628|NCT00460603|530363164|FG004|Phase 1|Other|1|||
147054629|NCT00460603|530363165|FG005|Phase 1|Other|2|||
147054630|NCT00460603|530363166|FG006|Phase 1|Other|0|||
147054631|NCT00460603|530363167|FG007|Phase 1|Other|1|||
147054632|NCT00460603|530363168|FG008|Phase 1|Other|0|||
147054633|NCT00460603|530363169|FG009|Phase 1|Other|0|||
147054634|NCT00460603|530363170|FG010|Phase 1|Other|0|||
147054635|NCT00460603|530363171|FG011|Phase 1|Other|0|||
147054636|NCT00460603|530363160|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147054637|NCT00460603|530363161|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147054638|NCT00460603|530363162|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147054639|NCT00460603|530363163|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147054640|NCT00460603|530363164|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147054641|NCT00460603|530363165|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147054642|NCT00460603|530363166|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147054643|NCT00460603|530363167|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147054644|NCT00460603|530363168|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147054645|NCT00460603|530363169|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
147054646|NCT00460603|530363170|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147054647|NCT00460603|530363171|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147054648|NCT00460603|530363160|FG000|Phase 2|Adverse Event|0|||
147054649|NCT00460603|530363161|FG001|Phase 2|Adverse Event|0|||
147054650|NCT00460603|530363162|FG002|Phase 2|Adverse Event|0|||
147054651|NCT00460603|530363163|FG003|Phase 2|Adverse Event|0|||
147054652|NCT00460603|530363164|FG004|Phase 2|Adverse Event|0|||
147054653|NCT00460603|530363165|FG005|Phase 2|Adverse Event|0|||
147054654|NCT00460603|530363166|FG006|Phase 2|Adverse Event|0|||
147054655|NCT00460603|530363167|FG007|Phase 2|Adverse Event|0|||
147054656|NCT00460603|530363168|FG008|Phase 2|Adverse Event|0|||
147054657|NCT00460603|530363169|FG009|Phase 2|Adverse Event|12|||
147054658|NCT00460603|530363170|FG010|Phase 2|Adverse Event|9|||
147054659|NCT00460603|530363171|FG011|Phase 2|Adverse Event|10|||
147054660|NCT00460603|530363160|FG000|Phase 2|Death|0|||
147054661|NCT00460603|530363161|FG001|Phase 2|Death|0|||
147054662|NCT00460603|530363162|FG002|Phase 2|Death|0|||
147054663|NCT00460603|530363163|FG003|Phase 2|Death|0|||
147054664|NCT00460603|530363164|FG004|Phase 2|Death|0|||
147054665|NCT00460603|530363165|FG005|Phase 2|Death|0|||
147054666|NCT00460603|530363166|FG006|Phase 2|Death|0|||
147054667|NCT00460603|530363167|FG007|Phase 2|Death|0|||
147054668|NCT00460603|530363168|FG008|Phase 2|Death|0|||
147054669|NCT00460603|530363169|FG009|Phase 2|Death|4|||
147054670|NCT00460603|530363170|FG010|Phase 2|Death|2|||
147054671|NCT00460603|530363171|FG011|Phase 2|Death|2|||
147054672|NCT00460603|530363160|FG000|Phase 2|Protocol Violation|0|||
147054673|NCT00460603|530363161|FG001|Phase 2|Protocol Violation|0|||
147054674|NCT00460603|530363162|FG002|Phase 2|Protocol Violation|0|||
147054675|NCT00460603|530363163|FG003|Phase 2|Protocol Violation|0|||
147054676|NCT00460603|530363164|FG004|Phase 2|Protocol Violation|0|||
147054677|NCT00460603|530363165|FG005|Phase 2|Protocol Violation|0|||
147054678|NCT00460603|530363166|FG006|Phase 2|Protocol Violation|0|||
147054679|NCT00460603|530363167|FG007|Phase 2|Protocol Violation|0|||
147054680|NCT00460603|530363168|FG008|Phase 2|Protocol Violation|0|||
147054681|NCT00460603|530363169|FG009|Phase 2|Protocol Violation|1|||
147054682|NCT00460603|530363170|FG010|Phase 2|Protocol Violation|1|||
147054683|NCT00460603|530363171|FG011|Phase 2|Protocol Violation|0|||
147054684|NCT00460603|530363160|FG000|Phase 2|Lost to Follow-up|0|||
147054685|NCT00460603|530363161|FG001|Phase 2|Lost to Follow-up|0|||
147054686|NCT00460603|530363162|FG002|Phase 2|Lost to Follow-up|0|||
147054687|NCT00460603|530363163|FG003|Phase 2|Lost to Follow-up|0|||
147054688|NCT00460603|530363164|FG004|Phase 2|Lost to Follow-up|0|||
147054689|NCT00460603|530363165|FG005|Phase 2|Lost to Follow-up|0|||
147054690|NCT00460603|530363166|FG006|Phase 2|Lost to Follow-up|0|||
147054691|NCT00460603|530363167|FG007|Phase 2|Lost to Follow-up|0|||
147054692|NCT00460603|530363168|FG008|Phase 2|Lost to Follow-up|0|||
147054693|NCT00460603|530363169|FG009|Phase 2|Lost to Follow-up|1|||
147054694|NCT00460603|530363170|FG010|Phase 2|Lost to Follow-up|0|||
147054695|NCT00460603|530363171|FG011|Phase 2|Lost to Follow-up|0|||
147054696|NCT00460603|530363160|FG000|Phase 2|Other|0|||
147054697|NCT00460603|530363161|FG001|Phase 2|Other|0|||
147054698|NCT00460603|530363162|FG002|Phase 2|Other|0|||
147054699|NCT00460603|530363163|FG003|Phase 2|Other|0|||
147054700|NCT00460603|530363164|FG004|Phase 2|Other|0|||
147054701|NCT00460603|530363165|FG005|Phase 2|Other|0|||
147054702|NCT00460603|530363166|FG006|Phase 2|Other|0|||
147054703|NCT00460603|530363167|FG007|Phase 2|Other|0|||
147054704|NCT00460603|530363168|FG008|Phase 2|Other|0|||
147054705|NCT00460603|530363169|FG009|Phase 2|Other|6|||
147054706|NCT00460603|530363170|FG010|Phase 2|Other|16|||
147054707|NCT00460603|530363171|FG011|Phase 2|Other|7|||
147054708|NCT00460603|530363160|FG000|Phase 2|Objective Progression or Relapse|0|||
147054709|NCT00460603|530363161|FG001|Phase 2|Objective Progression or Relapse|0|||
147054710|NCT00460603|530363162|FG002|Phase 2|Objective Progression or Relapse|0|||
147054711|NCT00460603|530363163|FG003|Phase 2|Objective Progression or Relapse|0|||
147054712|NCT00460603|530363164|FG004|Phase 2|Objective Progression or Relapse|0|||
147054713|NCT00460603|530363165|FG005|Phase 2|Objective Progression or Relapse|0|||
147054714|NCT00460603|530363166|FG006|Phase 2|Objective Progression or Relapse|0|||
147054715|NCT00460603|530363167|FG007|Phase 2|Objective Progression or Relapse|0|||
147054716|NCT00460603|530363168|FG008|Phase 2|Objective Progression or Relapse|0|||
147054717|NCT00460603|530363169|FG009|Phase 2|Objective Progression or Relapse|9|||
147054718|NCT00460603|530363170|FG010|Phase 2|Objective Progression or Relapse|10|||
147054719|NCT00460603|530363171|FG011|Phase 2|Objective Progression or Relapse|17|||
147054720|NCT00460603|530363160|FG000|Phase 2|Global Deterioration of Health Status|0|||
147054721|NCT00460603|530363161|FG001|Phase 2|Global Deterioration of Health Status|0|||
147054722|NCT00460603|530363162|FG002|Phase 2|Global Deterioration of Health Status|0|||
147054723|NCT00460603|530363163|FG003|Phase 2|Global Deterioration of Health Status|0|||
147054724|NCT00460603|530363164|FG004|Phase 2|Global Deterioration of Health Status|0|||
147054725|NCT00460603|530363165|FG005|Phase 2|Global Deterioration of Health Status|0|||
147054726|NCT00460603|530363166|FG006|Phase 2|Global Deterioration of Health Status|0|||
147054727|NCT00460603|530363167|FG007|Phase 2|Global Deterioration of Health Status|0|||
147054728|NCT00460603|530363168|FG008|Phase 2|Global Deterioration of Health Status|0|||
147054729|NCT00460603|530363169|FG009|Phase 2|Global Deterioration of Health Status|0|||
147054730|NCT00460603|530363170|FG010|Phase 2|Global Deterioration of Health Status|1|||
147054731|NCT00460603|530363171|FG011|Phase 2|Global Deterioration of Health Status|0|||
147054732|NCT00460603|530363160|FG000|Phase 2|Withdrawal by Subject|0|||
147054733|NCT00460603|530363161|FG001|Phase 2|Withdrawal by Subject|0|||
147054734|NCT00460603|530363162|FG002|Phase 2|Withdrawal by Subject|0|||
147054735|NCT00460603|530363163|FG003|Phase 2|Withdrawal by Subject|0|||
147054736|NCT00460603|530363164|FG004|Phase 2|Withdrawal by Subject|0|||
147054737|NCT00460603|530363165|FG005|Phase 2|Withdrawal by Subject|0|||
147054738|NCT00460603|530363166|FG006|Phase 2|Withdrawal by Subject|0|||
147054739|NCT00460603|530363167|FG007|Phase 2|Withdrawal by Subject|0|||
147054740|NCT00460603|530363168|FG008|Phase 2|Withdrawal by Subject|0|||
147054741|NCT00460603|530363169|FG009|Phase 2|Withdrawal by Subject|5|||
147054742|NCT00460603|530363170|FG010|Phase 2|Withdrawal by Subject|4|||
147054743|NCT00460603|530363171|FG011|Phase 2|Withdrawal by Subject|5|||
147054744|NCT00460603|530363160|FG000|Phase 2|Randomized, but not treated|0|||
147054745|NCT00460603|530363161|FG001|Phase 2|Randomized, but not treated|0|||
147054746|NCT00460603|530363162|FG002|Phase 2|Randomized, but not treated|0|||
147054747|NCT00460603|530363163|FG003|Phase 2|Randomized, but not treated|0|||
147054748|NCT00460603|530363164|FG004|Phase 2|Randomized, but not treated|0|||
147054749|NCT00460603|530363165|FG005|Phase 2|Randomized, but not treated|0|||
147054750|NCT00460603|530363166|FG006|Phase 2|Randomized, but not treated|0|||
147054751|NCT00460603|530363167|FG007|Phase 2|Randomized, but not treated|0|||
147054752|NCT00460603|530363168|FG008|Phase 2|Randomized, but not treated|0|||
147054753|NCT00460603|530363169|FG009|Phase 2|Randomized, but not treated|3|||
147054754|NCT00460603|530363170|FG010|Phase 2|Randomized, but not treated|0|||
147054755|NCT00460603|530363171|FG011|Phase 2|Randomized, but not treated|0|||
147054756|NCT03003962|530363172|FG000|Overall Study|Withdrawal by Subject|5|||
147054757|NCT03003962|530363173|FG001|Overall Study|Withdrawal by Subject|17|||
147054758|NCT03003962|530363172|FG000|Overall Study|Death|274|||
147054759|NCT03003962|530363173|FG001|Overall Study|Death|277|||
147054760|NCT03003962|530363172|FG000|Overall Study|Participants ongoing at DCO|55|||
147054761|NCT03003962|530363173|FG001|Overall Study|Participants ongoing at DCO|40|||
147054762|NCT03871543|530363174|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
147054763|NCT03871543|530363174|FG000|Period 1|Investigator Error|1|||
147054764|NCT03871543|530363174|FG000|Period 1|Protocol Violation|2|||
147054765|NCT03871543|530363174|FG000|Period 1|COVID-19 Related|1|||
147054766|NCT03871543|530363174|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
147054767|NCT03871543|530363174|FG000|Period 1|Withdrawal by Subject|10|||
147054768|NCT03871543|530363174|FG000|Period 2|Adverse Event|1|||
147054769|NCT03871543|530363174|FG000|Period 2|Withdrawal by Subject|1|||
147054770|NCT00350207|530363177|FG000|Overall Study|Adverse Event|5|||
147054771|NCT00350207|530363178|FG001|Overall Study|Adverse Event|2|||
147054772|NCT00350207|530363179|FG002|Overall Study|Adverse Event|2|||
147054773|NCT00350207|530363177|FG000|Overall Study|Lack of Efficacy|1|||
147054774|NCT00350207|530363178|FG001|Overall Study|Lack of Efficacy|0|||
147054775|NCT00350207|530363179|FG002|Overall Study|Lack of Efficacy|2|||
147054776|NCT00350207|530363177|FG000|Overall Study|Lost to Follow-up|1|||
147054777|NCT00350207|530363178|FG001|Overall Study|Lost to Follow-up|0|||
147054778|NCT00350207|530363179|FG002|Overall Study|Lost to Follow-up|1|||
147054779|NCT00350207|530363177|FG000|Overall Study|Withdrawal by Subject|0|||
147054780|NCT00350207|530363178|FG001|Overall Study|Withdrawal by Subject|1|||
147054781|NCT00350207|530363179|FG002|Overall Study|Withdrawal by Subject|1|||
147054782|NCT00350207|530363177|FG000|Overall Study|Other|1|||
147054783|NCT00350207|530363178|FG001|Overall Study|Other|3|||
147054784|NCT00350207|530363179|FG002|Overall Study|Other|1|||
147054785|NCT03214224|530363180|FG000|Overall Study|Protocol Violation|1|||
147054786|NCT03214224|530363180|FG000|Overall Study|Withdrawal by Subject|2|||
147054787|NCT03214224|530363180|FG000|Overall Study|Practice controls or therapists|6|||
147054788|NCT03802825|530363181|FG000|Overall Study|Lost to follow-up for intervention|12|||
147054789|NCT03802825|530363182|FG001|Overall Study|Lost to follow-up for intervention|3|||
147054790|NCT03802825|530363181|FG000|Overall Study|Received only 1 component of intervention|0|||
147054791|NCT03802825|530363182|FG001|Overall Study|Received only 1 component of intervention|13|||
147054792|NCT01051960|530363189|FG000|Overall Study|Adverse Event|1|||
147054793|NCT00360282|530363190|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
147054794|NCT00360282|530363191|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
147054795|NCT00360282|530363192|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
147054796|NCT00360282|530363193|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
147054797|NCT00360282|530363190|FG000|Second Intervention|Adverse Event|0|||
147054798|NCT00360282|530363191|FG001|Second Intervention|Adverse Event|1|||
147054799|NCT00360282|530363192|FG002|Second Intervention|Adverse Event|0|||
147054800|NCT00360282|530363193|FG003|Second Intervention|Adverse Event|0|||
147054801|NCT04537078|530363196|FG000|Overall Study|Protocol Violation|3|||
147054802|NCT04537078|530363197|FG001|Overall Study|Protocol Violation|2|||
147054803|NCT04537078|530363196|FG000|Overall Study|Lost to Follow-up|1|||
147054804|NCT04537078|530363197|FG001|Overall Study|Lost to Follow-up|0|||
147054805|NCT04537078|530363196|FG000|Overall Study|Withdrawal by Subject|0|||
147054806|NCT04537078|530363197|FG001|Overall Study|Withdrawal by Subject|1|||
147054807|NCT00444535|530363198|FG000|Overall Study|Withdrawal by Subject|5|||
147054808|NCT00444535|530363198|FG000|Overall Study|Physician Decision|5|||
147054809|NCT00444535|530363198|FG000|Overall Study|progressive disease|1|||
147054810|NCT00444535|530363198|FG000|Overall Study|Adverse Event|2|||
147054811|NCT03922308|530363199|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
147054812|NCT03922308|530363200|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
147054813|NCT03922308|530363201|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
147054814|NCT03922308|530363199|FG000|Overall Study|Lost to Follow-up|1|||
147054815|NCT03922308|530363200|FG001|Overall Study|Lost to Follow-up|0|||
147054816|NCT03922308|530363201|FG002|Overall Study|Lost to Follow-up|0|||
147054817|NCT03922308|530363199|FG000|Overall Study|Reason not Specified|0|||
147054818|NCT03922308|530363200|FG001|Overall Study|Reason not Specified|2|||
147054819|NCT03922308|530363201|FG002|Overall Study|Reason not Specified|1|||
147054820|NCT01256450|530363205|FG000|Open-label Titration|Adverse Event|39|||
147054821|NCT01256450|530363206|FG001|Open-label Titration|Adverse Event|0|||
147054822|NCT01256450|530363207|FG002|Open-label Titration|Adverse Event|0|||
147054823|NCT01256450|530363205|FG000|Open-label Titration|Lost to Follow-up|7|||
147054824|NCT01256450|530363206|FG001|Open-label Titration|Lost to Follow-up|0|||
147054825|NCT01256450|530363207|FG002|Open-label Titration|Lost to Follow-up|0|||
147054826|NCT01256450|530363205|FG000|Open-label Titration|Lack of analgesic effect|30|||
147054827|NCT01256450|530363206|FG001|Open-label Titration|Lack of analgesic effect|0|||
147054828|NCT01256450|530363207|FG002|Open-label Titration|Lack of analgesic effect|0|||
147054829|NCT01256450|530363205|FG000|Open-label Titration|Non-compliance|9|||
147054830|NCT01256450|530363206|FG001|Open-label Titration|Non-compliance|0|||
147054831|NCT01256450|530363207|FG002|Open-label Titration|Non-compliance|0|||
147054832|NCT01256450|530363205|FG000|Open-label Titration|Screen failure|1|||
147054833|NCT01256450|530363206|FG001|Open-label Titration|Screen failure|0|||
147054834|NCT01256450|530363207|FG002|Open-label Titration|Screen failure|0|||
147054835|NCT01256450|530363205|FG000|Open-label Titration|Other|13|||
147054836|NCT01256450|530363206|FG001|Open-label Titration|Other|0|||
147054837|NCT01256450|530363207|FG002|Open-label Titration|Other|0|||
147054838|NCT01256450|530363205|FG000|Double-blind Treatment|Adverse Event|0|||
147054839|NCT01256450|530363206|FG001|Double-blind Treatment|Adverse Event|8|||
147054840|NCT01256450|530363207|FG002|Double-blind Treatment|Adverse Event|6|||
147054841|NCT01256450|530363205|FG000|Double-blind Treatment|Lost to Follow-up|0|||
147054842|NCT01256450|530363206|FG001|Double-blind Treatment|Lost to Follow-up|1|||
147054843|NCT01256450|530363207|FG002|Double-blind Treatment|Lost to Follow-up|7|||
147054844|NCT01256450|530363205|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
147054845|NCT01256450|530363206|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
147054846|NCT01256450|530363207|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
147054847|NCT01256450|530363205|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
147054848|NCT01256450|530363206|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
147054849|NCT01256450|530363207|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
147054850|NCT01256450|530363205|FG000|Double-blind Treatment|Non-compliance|0|||
147054851|NCT01256450|530363206|FG001|Double-blind Treatment|Non-compliance|5|||
147054852|NCT01256450|530363207|FG002|Double-blind Treatment|Non-compliance|4|||
147054853|NCT01256450|530363205|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
147054854|NCT01256450|530363206|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
147054855|NCT01256450|530363207|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
147054856|NCT01256450|530363205|FG000|Double-blind Treatment|Other|0|||
147054857|NCT01256450|530363206|FG001|Double-blind Treatment|Other|9|||
147054858|NCT01256450|530363207|FG002|Double-blind Treatment|Other|12|||
147054859|NCT01704495|530363208|FG000|Subjects Randomized|Other Reason|3|||
147054860|NCT01704495|530363209|FG001|Subjects Randomized|Other Reason|2|||
147054861|NCT01704495|530363210|FG002|Subjects Randomized|Other Reason|3|||
147054862|NCT01704495|530363211|FG003|Subjects Randomized|Other Reason|2|||
147054863|NCT01704495|530363208|FG000|Subjects Randomized|Discontinuation criteria met|4|||
147054864|NCT01704495|530363209|FG001|Subjects Randomized|Discontinuation criteria met|2|||
147054865|NCT01704495|530363210|FG002|Subjects Randomized|Discontinuation criteria met|2|||
147054866|NCT01704495|530363211|FG003|Subjects Randomized|Discontinuation criteria met|0|||
147054867|NCT01704495|530363208|FG000|Subjects Randomized|Adverse Event|8|||
147054868|NCT01704495|530363209|FG001|Subjects Randomized|Adverse Event|2|||
147054869|NCT01704495|530363210|FG002|Subjects Randomized|Adverse Event|0|||
147054870|NCT01704495|530363211|FG003|Subjects Randomized|Adverse Event|7|||
147054871|NCT01704495|530363208|FG000|Subjects Randomized|Withdrawal by Subject|5|||
147054872|NCT01704495|530363209|FG001|Subjects Randomized|Withdrawal by Subject|5|||
147054873|NCT01704495|530363210|FG002|Subjects Randomized|Withdrawal by Subject|5|||
147054874|NCT01704495|530363211|FG003|Subjects Randomized|Withdrawal by Subject|5|||
147054875|NCT01704495|530363208|FG000|Subjects Randomized|Protocol Violation|1|||
147054876|NCT01704495|530363209|FG001|Subjects Randomized|Protocol Violation|1|||
147054877|NCT01704495|530363210|FG002|Subjects Randomized|Protocol Violation|2|||
147054878|NCT01704495|530363211|FG003|Subjects Randomized|Protocol Violation|0|||
147054879|NCT01704495|530363208|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
147054880|NCT01704495|530363209|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
147054881|NCT01704495|530363210|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
147054882|NCT01704495|530363211|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
147054883|NCT01704495|530363208|FG000|Optional Safety Extension|Adverse Event|0|||
147054884|NCT01704495|530363209|FG001|Optional Safety Extension|Adverse Event|4|||
147054885|NCT01704495|530363210|FG002|Optional Safety Extension|Adverse Event|0|||
147054886|NCT01704495|530363211|FG003|Optional Safety Extension|Adverse Event|1|||
147054887|NCT01704495|530363208|FG000|Optional Safety Extension|Other reason|27|||
147054888|NCT01704495|530363209|FG001|Optional Safety Extension|Other reason|29|||
147054889|NCT01704495|530363210|FG002|Optional Safety Extension|Other reason|30|||
147054890|NCT01704495|530363211|FG003|Optional Safety Extension|Other reason|28|||
147054891|NCT01704495|530363208|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
147054892|NCT01704495|530363209|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
147054893|NCT01704495|530363210|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
147054894|NCT01704495|530363211|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
147054895|NCT02314026|530363214|FG000|Overall Study|Protocol Violation|28|||
147054896|NCT01139775|530363215|FG000|Overall Study|Adverse Event|0|||
147054897|NCT01139775|530363216|FG001|Overall Study|Adverse Event|6|||
147054898|NCT01139775|530363217|FG002|Overall Study|Adverse Event|2|||
147054899|NCT01139775|530363215|FG000|Overall Study|Protocol Violation|0|||
147054900|NCT01139775|530363216|FG001|Overall Study|Protocol Violation|5|||
147054901|NCT01139775|530363217|FG002|Overall Study|Protocol Violation|0|||
147054902|NCT01139775|530363215|FG000|Overall Study|Withdrawal by Subject|1|||
147054903|NCT01139775|530363216|FG001|Overall Study|Withdrawal by Subject|0|||
147054904|NCT01139775|530363217|FG002|Overall Study|Withdrawal by Subject|2|||
147054905|NCT01139775|530363215|FG000|Overall Study|Physician Decision|0|||
147054906|NCT01139775|530363216|FG001|Overall Study|Physician Decision|2|||
147054907|NCT01139775|530363217|FG002|Overall Study|Physician Decision|2|||
147054908|NCT04760626|530363218|FG000|Overall Study|Withdrawal by Subject|24|||
147054909|NCT04760626|530363219|FG001|Overall Study|Withdrawal by Subject|20|||
147054910|NCT04760626|530363218|FG000|Overall Study|Lost to Follow-up|14|||
147054911|NCT04760626|530363219|FG001|Overall Study|Lost to Follow-up|19|||
147054912|NCT04760626|530363218|FG000|Overall Study|Physician Decision|3|||
147054913|NCT04760626|530363219|FG001|Overall Study|Physician Decision|5|||
147054914|NCT04760626|530363218|FG000|Overall Study|Death|3|||
147054915|NCT04760626|530363219|FG001|Overall Study|Death|6|||
147054916|NCT04760626|530363218|FG000|Overall Study|Site closure|1|||
147054917|NCT04760626|530363219|FG001|Overall Study|Site closure|0|||
147054918|NCT05303194|530363223|FG000|Overall Study|Lost to Follow-up|1|||
147054919|NCT05303194|530363224|FG001|Overall Study|Lost to Follow-up|1|||
147054920|NCT05303194|530363223|FG000|Overall Study|Withdrawal by Subject|0|||
147054921|NCT05303194|530363224|FG001|Overall Study|Withdrawal by Subject|1|||
147054922|NCT01597973|530363227|FG000|Overall Study|Found ineligible before study medication started|4|||
147054923|NCT01597973|530363228|FG001|Overall Study|Found ineligible before study medication started|2|||
147054924|NCT01597973|530363227|FG000|Overall Study|Eligible pathogen not confirmed|14|||
147054925|NCT01597973|530363228|FG001|Overall Study|Eligible pathogen not confirmed|15|||
147054926|NCT01597973|530363227|FG000|Overall Study|LAR not authorized to consent|0|||
147054927|NCT01597973|530363228|FG001|Overall Study|LAR not authorized to consent|1|||
147054928|NCT01597973|530363227|FG000|Overall Study|Ineligible due to early seizures|1|||
147054929|NCT01597973|530363228|FG001|Overall Study|Ineligible due to early seizures|0|||
147054930|NCT01597973|530363227|FG000|Overall Study|Ineligible due to non-target infection|1|||
147054931|NCT01597973|530363228|FG001|Overall Study|Ineligible due to non-target infection|1|||
147054932|NCT02723344|530363229|FG000|Overall Study|Lost to Follow-up|0|||
147054933|NCT02723344|530363230|FG001|Overall Study|Lost to Follow-up|4|||
147054934|NCT04352101|530363231|FG000|Overall Study|Physician Decision|2|||
147054935|NCT04352101|530363232|FG001|Overall Study|Physician Decision|1|||
147054936|NCT00908544|530363234|FG000|Overall Study|Withdrawal by Subject|2|||
147054937|NCT00908544|530363235|FG001|Overall Study|Withdrawal by Subject|4|||
147054938|NCT00908544|530363234|FG000|Overall Study|Lack of Efficacy|0|||
147054939|NCT00908544|530363235|FG001|Overall Study|Lack of Efficacy|1|||
147054940|NCT00908544|530363234|FG000|Overall Study|Pregnancy|1|||
147054941|NCT00908544|530363235|FG001|Overall Study|Pregnancy|0|||
147054942|NCT00908544|530363234|FG000|Overall Study|Relocation abroad|1|||
147054943|NCT00908544|530363235|FG001|Overall Study|Relocation abroad|1|||
147054944|NCT00908544|530363234|FG000|Overall Study|Unable to visit sutdy center|1|||
147054945|NCT00908544|530363235|FG001|Overall Study|Unable to visit sutdy center|0|||
147054946|NCT00740636|530363240|FG000|Overall Study|Adverse Event|0|||
147054947|NCT00740636|530363241|FG001|Overall Study|Adverse Event|2|||
147054948|NCT00740636|530363240|FG000|Overall Study|Patient Ineligible|0|||
147054949|NCT00740636|530363241|FG001|Overall Study|Patient Ineligible|1|||
147054950|NCT00740636|530363240|FG000|Overall Study|Patient Not Treated|0|||
147054951|NCT00740636|530363241|FG001|Overall Study|Patient Not Treated|1|||
147054952|NCT00740636|530363240|FG000|Overall Study|Progressive Disease|1|||
147054953|NCT00740636|530363241|FG001|Overall Study|Progressive Disease|0|||
146850058|NCT00911937|529620705|FG000|Overall Study|Withdrawal by Subject|10|||
147054954|NCT00740636|530363240|FG000|Overall Study|Death|1|||
147054955|NCT00740636|530363241|FG001|Overall Study|Death|0|||
147054956|NCT00529087|530364640|FG000|Overall Study|Adverse Event|10|||
147054957|NCT00529087|530364641|FG001|Overall Study|Adverse Event|13|||
147054958|NCT00529087|530364642|FG002|Overall Study|Adverse Event|4|||
147054959|NCT00529087|530364640|FG000|Overall Study|Lost to Follow-up|6|||
147054960|NCT00529087|530364641|FG001|Overall Study|Lost to Follow-up|4|||
147054961|NCT00529087|530364642|FG002|Overall Study|Lost to Follow-up|1|||
147054962|NCT00529087|530364640|FG000|Overall Study|Protocol Violation|8|||
147054963|NCT00529087|530364641|FG001|Overall Study|Protocol Violation|7|||
147054964|NCT00529087|530364642|FG002|Overall Study|Protocol Violation|6|||
147054965|NCT00529087|530364640|FG000|Overall Study|Withdrawal by Subject|3|||
147054966|NCT00529087|530364641|FG001|Overall Study|Withdrawal by Subject|3|||
147054967|NCT00529087|530364642|FG002|Overall Study|Withdrawal by Subject|3|||
147054968|NCT00529087|530364640|FG000|Overall Study|Protocol deviation|1|||
147054969|NCT00529087|530364641|FG001|Overall Study|Protocol deviation|1|||
147054970|NCT00529087|530364642|FG002|Overall Study|Protocol deviation|2|||
147054971|NCT02954601|530364643|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
147054972|NCT02954601|530364644|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
147054973|NCT02954601|530364645|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
147054974|NCT02954601|530364646|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
147054975|NCT00318474|530364647|FG000|Overall Study|Adverse Event|1|||
147054976|NCT00318474|530364648|FG001|Overall Study|Adverse Event|1|||
147054977|NCT00318474|530364647|FG000|Overall Study|Lost to Follow-up|0|||
147054978|NCT00318474|530364648|FG001|Overall Study|Lost to Follow-up|1|||
147054979|NCT00318474|530364647|FG000|Overall Study|Pregnancy|0|||
147054980|NCT00318474|530364648|FG001|Overall Study|Pregnancy|2|||
147054981|NCT00318474|530364647|FG000|Overall Study|Protocol Violation|1|||
147054982|NCT00318474|530364648|FG001|Overall Study|Protocol Violation|0|||
147054983|NCT00318474|530364647|FG000|Overall Study|Withdrawal by Subject|3|||
147054984|NCT00318474|530364648|FG001|Overall Study|Withdrawal by Subject|2|||
147054985|NCT00318474|530364647|FG000|Overall Study|Fall in GFR|3|||
147054986|NCT00318474|530364648|FG001|Overall Study|Fall in GFR|3|||
147054987|NCT00318474|530364647|FG000|Overall Study|Post-therapy hyperflycemia|0|||
147054988|NCT00318474|530364648|FG001|Overall Study|Post-therapy hyperflycemia|1|||
147054989|NCT00318474|530364647|FG000|Overall Study|Trial terminated|10|||
147054990|NCT00318474|530364648|FG001|Overall Study|Trial terminated|7|||
147054991|NCT01735916|530364657|FG000|Overall Study|Subject not eligible to be randomized|11|||
147054992|NCT01735916|530364658|FG001|Overall Study|Subject not eligible to be randomized|0|||
147054993|NCT01735916|530364659|FG002|Overall Study|Subject not eligible to be randomized|0|||
147054994|NCT01735916|530364657|FG000|Overall Study|Early termination of study by sponsor|4|||
147054995|NCT01735916|530364658|FG001|Overall Study|Early termination of study by sponsor|19|||
147054996|NCT01735916|530364659|FG002|Overall Study|Early termination of study by sponsor|7|||
147054997|NCT01735916|530364657|FG000|Overall Study|Withdrawal by Subject|3|||
147054998|NCT01735916|530364658|FG001|Overall Study|Withdrawal by Subject|0|||
147054999|NCT01735916|530364659|FG002|Overall Study|Withdrawal by Subject|0|||
147055000|NCT03334435|530364667|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
147055001|NCT03334435|530364668|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
147055002|NCT03334435|530364669|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
147055003|NCT03334435|530364670|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
147055004|NCT03334435|530364671|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
147055005|NCT03334435|530364672|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147055006|NCT03334435|530364673|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147055007|NCT03334435|530364674|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147055008|NCT03334435|530364675|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147055009|NCT03334435|530364676|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147055010|NCT03334435|530364677|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147055011|NCT03334435|530364678|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147055012|NCT03334435|530364679|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147055013|NCT03334435|530364680|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147055014|NCT03334435|530364681|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147055015|NCT03334435|530364667|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
147055016|NCT03334435|530364668|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
147055017|NCT03334435|530364669|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
147055018|NCT03334435|530364670|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
147055019|NCT03334435|530364671|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
147055020|NCT03334435|530364672|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147055021|NCT03334435|530364673|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147055022|NCT03334435|530364674|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147055023|NCT03334435|530364675|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147055024|NCT03334435|530364676|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147055025|NCT03334435|530364677|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147055026|NCT03334435|530364678|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147055027|NCT03334435|530364679|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147055028|NCT03334435|530364680|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147055029|NCT03334435|530364681|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147055030|NCT03334435|530364667|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
147055031|NCT03334435|530364668|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
147055032|NCT03334435|530364669|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
147055033|NCT03334435|530364670|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
147055034|NCT03334435|530364671|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
147055035|NCT03334435|530364672|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147055036|NCT03334435|530364673|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147055037|NCT03334435|530364674|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147055038|NCT03334435|530364675|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147055039|NCT03334435|530364676|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147055040|NCT03334435|530364677|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147055041|NCT03334435|530364678|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147055042|NCT03334435|530364679|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147055043|NCT03334435|530364680|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147055044|NCT03334435|530364681|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147055045|NCT03334435|530364667|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
147055046|NCT03334435|530364668|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
147055047|NCT03334435|530364669|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
147055048|NCT03334435|530364670|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
147055049|NCT03334435|530364671|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
147055050|NCT03334435|530364672|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147055051|NCT03334435|530364673|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147055052|NCT03334435|530364674|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147055053|NCT03334435|530364675|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147055054|NCT03334435|530364676|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147055055|NCT03334435|530364677|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147055056|NCT03334435|530364678|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147055057|NCT03334435|530364679|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147055058|NCT03334435|530364680|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147055059|NCT03334435|530364681|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147055060|NCT03334435|530364667|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
147055061|NCT03334435|530364668|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147055062|NCT03334435|530364669|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
147055063|NCT03334435|530364670|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
147055064|NCT03334435|530364671|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
147055065|NCT03334435|530364672|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147055066|NCT03334435|530364673|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147055067|NCT03334435|530364674|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147055068|NCT03334435|530364675|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147055069|NCT03334435|530364676|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147055070|NCT03334435|530364677|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147055071|NCT03334435|530364678|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147055072|NCT03334435|530364679|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147055073|NCT03334435|530364680|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147055074|NCT03334435|530364681|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147055075|NCT03334435|530364667|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
147055076|NCT03334435|530364668|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
147055077|NCT03334435|530364669|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
147055078|NCT03334435|530364670|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
147055079|NCT03334435|530364671|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
147055080|NCT03334435|530364672|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
147055081|NCT03334435|530364673|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
147055082|NCT03334435|530364674|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
147055083|NCT03334435|530364675|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
147055084|NCT03334435|530364676|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
147055085|NCT03334435|530364677|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
147055086|NCT03334435|530364678|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
147055087|NCT03334435|530364679|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
147055088|NCT03334435|530364680|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
147055089|NCT03334435|530364681|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
146850059|NCT00911937|529620706|FG001|Overall Study|Withdrawal by Subject|7|||
146850060|NCT00911937|529620705|FG000|Overall Study|Withdrawn due to pregnancy|1|||
147055090|NCT03334435|530364667|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
147055091|NCT03334435|530364668|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
147055092|NCT03334435|530364669|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
147055093|NCT03334435|530364670|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
147055094|NCT03334435|530364671|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
147055095|NCT03334435|530364672|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
147055096|NCT03334435|530364673|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
147055097|NCT03334435|530364674|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
147055098|NCT03334435|530364675|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
147055099|NCT03334435|530364676|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
147055100|NCT03334435|530364677|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
147055101|NCT03334435|530364678|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
147055102|NCT03334435|530364679|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
147055103|NCT03334435|530364680|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
147055104|NCT03334435|530364681|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
147055105|NCT03334435|530364667|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
147055106|NCT03334435|530364668|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
147055107|NCT03334435|530364669|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
147055108|NCT03334435|530364670|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
147055109|NCT03334435|530364671|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
147055110|NCT03334435|530364672|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
147055111|NCT03334435|530364673|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
147055112|NCT03334435|530364674|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
147055113|NCT03334435|530364675|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
147055114|NCT03334435|530364676|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
147055115|NCT03334435|530364677|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
147055116|NCT03334435|530364678|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
147055117|NCT03334435|530364679|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
147055118|NCT03334435|530364680|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
147055119|NCT03334435|530364681|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
147055120|NCT03334435|530364667|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
147055121|NCT03334435|530364668|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
147055122|NCT03334435|530364669|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
147055123|NCT03334435|530364670|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
147055124|NCT03334435|530364671|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
147055125|NCT03334435|530364672|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
147055126|NCT03334435|530364673|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
147055127|NCT03334435|530364674|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
147055128|NCT03334435|530364675|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
147055129|NCT03334435|530364676|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
147055130|NCT03334435|530364677|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
147055131|NCT03334435|530364678|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
147055132|NCT03334435|530364679|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
147055133|NCT03334435|530364680|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
147055134|NCT03334435|530364681|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
147055135|NCT03334435|530364667|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
147055136|NCT03334435|530364668|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
147055137|NCT03334435|530364669|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
147055138|NCT03334435|530364670|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
147055139|NCT03334435|530364671|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
147055140|NCT03334435|530364672|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
147055141|NCT03334435|530364673|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
147055142|NCT03334435|530364674|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
147055143|NCT03334435|530364675|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
147055144|NCT03334435|530364676|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
147055145|NCT03334435|530364677|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
147055146|NCT03334435|530364678|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
147055147|NCT03334435|530364679|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
147055148|NCT03334435|530364680|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
147055149|NCT03334435|530364681|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
147055150|NCT03334435|530364667|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
147055151|NCT03334435|530364668|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
147055152|NCT03334435|530364669|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
147055153|NCT03334435|530364670|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
147055154|NCT03334435|530364671|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
147055155|NCT03334435|530364672|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
147055156|NCT03334435|530364673|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
147055157|NCT03334435|530364674|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
147055158|NCT03334435|530364675|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
147055159|NCT03334435|530364676|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
147055160|NCT03334435|530364677|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
147055161|NCT03334435|530364678|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
147055162|NCT03334435|530364679|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
147055163|NCT03334435|530364680|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
147055164|NCT03334435|530364681|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
147055165|NCT03334435|530364667|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
147055166|NCT03334435|530364668|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
147055167|NCT03334435|530364669|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
147055168|NCT03334435|530364670|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
147055169|NCT03334435|530364671|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
147055170|NCT03334435|530364672|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
147055171|NCT03334435|530364673|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
147055172|NCT03334435|530364674|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
147055173|NCT03334435|530364675|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
147055174|NCT03334435|530364676|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
147055175|NCT03334435|530364677|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
147055176|NCT03334435|530364678|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
147055177|NCT03334435|530364679|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
147055178|NCT03334435|530364680|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
147055179|NCT03334435|530364681|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
147055180|NCT03334435|530364667|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147055181|NCT03334435|530364668|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147055182|NCT03334435|530364669|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147055183|NCT03334435|530364670|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147055184|NCT03334435|530364671|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147055185|NCT03334435|530364672|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147055186|NCT03334435|530364673|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147055187|NCT03334435|530364674|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147055188|NCT03334435|530364675|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147055189|NCT03334435|530364676|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147055190|NCT03334435|530364677|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147055191|NCT03334435|530364678|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
147055192|NCT03334435|530364679|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147055193|NCT03334435|530364680|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
147055194|NCT03334435|530364681|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147055195|NCT03334435|530364667|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
147055196|NCT03334435|530364668|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
147055197|NCT03334435|530364669|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
147055198|NCT03334435|530364670|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
147055199|NCT03334435|530364671|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
147055200|NCT03334435|530364672|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
147055201|NCT03334435|530364673|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
147055202|NCT03334435|530364674|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
147055203|NCT03334435|530364675|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
147055204|NCT03334435|530364676|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
147055205|NCT03334435|530364677|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
147055206|NCT03334435|530364678|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
147055207|NCT03334435|530364679|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
147055208|NCT03334435|530364680|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
147055209|NCT03334435|530364681|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
147055210|NCT03334435|530364667|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
147055211|NCT03334435|530364668|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
147055212|NCT03334435|530364669|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
147055213|NCT03334435|530364670|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
147055214|NCT03334435|530364671|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
147055215|NCT03334435|530364672|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
147055216|NCT03334435|530364673|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
147055217|NCT03334435|530364674|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
147055218|NCT03334435|530364675|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
147055219|NCT03334435|530364676|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
147055220|NCT03334435|530364677|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
147055221|NCT03334435|530364678|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
147055222|NCT03334435|530364679|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
147055223|NCT03334435|530364680|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
147055224|NCT03334435|530364681|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
147055225|NCT03334435|530364667|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147055226|NCT03334435|530364668|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147055227|NCT03334435|530364669|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147055228|NCT03334435|530364670|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147055229|NCT03334435|530364671|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147055230|NCT03334435|530364672|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
147055231|NCT03334435|530364673|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
147055232|NCT03334435|530364674|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147055233|NCT03334435|530364675|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147055234|NCT03334435|530364676|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147055235|NCT03334435|530364677|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147055236|NCT03334435|530364678|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
147055237|NCT03334435|530364679|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
147055238|NCT03334435|530364680|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
147055239|NCT03334435|530364681|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
147055240|NCT03334435|530364667|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147055241|NCT03334435|530364668|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147055242|NCT03334435|530364669|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147055243|NCT03334435|530364670|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147055244|NCT03334435|530364671|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147055245|NCT03334435|530364672|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
147055246|NCT03334435|530364673|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147055247|NCT03334435|530364674|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147055248|NCT03334435|530364675|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147055249|NCT03334435|530364676|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147055250|NCT03334435|530364677|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
147055251|NCT03334435|530364678|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147055252|NCT03334435|530364679|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147055253|NCT03334435|530364680|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147055254|NCT03334435|530364681|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
147055255|NCT03334435|530364667|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147055256|NCT03334435|530364668|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147055257|NCT03334435|530364669|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147055258|NCT03334435|530364670|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147055259|NCT03334435|530364671|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147055260|NCT03334435|530364672|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147055261|NCT03334435|530364673|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147055262|NCT03334435|530364674|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
147055263|NCT03334435|530364675|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
147055264|NCT03334435|530364676|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147055265|NCT03334435|530364677|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
147055266|NCT03334435|530364678|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
147055267|NCT03334435|530364679|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
147055268|NCT03334435|530364680|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147055269|NCT03334435|530364681|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147055270|NCT03334435|530364667|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147055271|NCT03334435|530364668|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147055272|NCT03334435|530364669|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147055273|NCT03334435|530364670|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147055274|NCT03334435|530364671|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147055275|NCT03334435|530364672|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147055276|NCT03334435|530364673|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147055277|NCT03334435|530364674|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147055278|NCT03334435|530364675|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147055279|NCT03334435|530364676|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147055280|NCT03334435|530364677|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147055281|NCT03334435|530364678|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
147055282|NCT03334435|530364679|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147055283|NCT03334435|530364680|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
147055284|NCT03334435|530364681|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
147055285|NCT03922321|530364682|FG000|Overall Study|Participant Moved|1|||
147055286|NCT03922321|530364682|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
147055287|NCT00495391|530364683|FG000|Overall Study|Lack of Efficacy|34|||
147055288|NCT00495391|530364684|FG001|Overall Study|Lack of Efficacy|18|||
147055289|NCT00495391|530364683|FG000|Overall Study|Withdrawal by Subject|2|||
147055290|NCT00495391|530364684|FG001|Overall Study|Withdrawal by Subject|3|||
147055291|NCT02712320|530364685|FG000|Overall Study|Lost to Follow-up|1|||
147055292|NCT02712320|530364685|FG000|Overall Study|Withdrawal by Subject|1|||
147055293|NCT02712320|530364685|FG000|Overall Study|Transferred to another facility|1|||
147055294|NCT02712320|530364685|FG000|Overall Study|Treating with the prohibited medications|2|||
147055295|NCT03313180|530364686|FG000|Overall Study|Adverse Event|120|||
147055296|NCT03313180|530364686|FG000|Overall Study|Lost to Follow-up|3|||
147055297|NCT03313180|530364686|FG000|Overall Study|Withdrawal by Subject|39|||
147055298|NCT03313180|530364686|FG000|Overall Study|Other than listed above|15|||
147055299|NCT03313180|530364686|FG000|Overall Study|Covid-19 related|2|||
147055300|NCT01697748|530364687|FG000|Overall Study|ineligible skin incision|1|||
147055301|NCT01697748|530364688|FG001|Overall Study|ineligible skin incision|2|||
147055302|NCT01697748|530364687|FG000|Overall Study|ineligible uterine incision|4|||
147055303|NCT01697748|530364688|FG001|Overall Study|ineligible uterine incision|1|||
147055304|NCT01697748|530364687|FG000|Overall Study|Lost to Follow-up|53|||
147055305|NCT01697748|530364688|FG001|Overall Study|Lost to Follow-up|65|||
147055306|NCT03866512|530364689|FG000|Overall Study|Lost to Follow-up|1|||
147055307|NCT03866512|530364690|FG001|Overall Study|Lost to Follow-up|2|||
147055308|NCT03866512|530364691|FG002|Overall Study|Lost to Follow-up|1|||
147055309|NCT03866512|530364689|FG000|Overall Study|Cannulation issues|0|||
147055310|NCT03866512|530364690|FG001|Overall Study|Cannulation issues|1|||
147055311|NCT03866512|530364691|FG002|Overall Study|Cannulation issues|2|||
147055312|NCT00832455|530364696|FG000|Overall Study|Adverse Event|13|||
147055313|NCT00832455|530364696|FG000|Overall Study|Lost to Follow-up|26|||
147055314|NCT00832455|530364696|FG000|Overall Study|Protocol Violation|4|||
147055315|NCT00832455|530364696|FG000|Overall Study|Withdrawal by Subject|17|||
147055316|NCT00832455|530364696|FG000|Overall Study|Screening Failure|2|||
147055317|NCT00832455|530364696|FG000|Overall Study|Stopped Medication|4|||
147055318|NCT00832455|530364696|FG000|Overall Study|Parent misunderstood study|1|||
147055319|NCT00832455|530364696|FG000|Overall Study|Parent dissatisfied|1|||
147055320|NCT00832455|530364696|FG000|Overall Study|No improvement|3|||
147055321|NCT00832455|530364696|FG000|Overall Study|Patient moved|1|||
147055322|NCT03876743|530364698|FG000|Overall Study|Lost to Follow-up|6|||
147055323|NCT03876743|530364699|FG001|Overall Study|Lost to Follow-up|4|||
147055324|NCT03876743|530364700|FG002|Overall Study|Lost to Follow-up|4|||
147055325|NCT03876743|530364701|FG003|Overall Study|Lost to Follow-up|7|||
147055326|NCT03889418|530364702|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
147055327|NCT03889418|530364703|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147055328|NCT03889418|530364704|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147055329|NCT03889418|530364705|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147055330|NCT03889418|530364706|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147055331|NCT03889418|530364707|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147055332|NCT03889418|530364708|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147055333|NCT03889418|530364709|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147055334|NCT03889418|530364710|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147055335|NCT03889418|530364711|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147055336|NCT03889418|530364702|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
147055337|NCT03889418|530364703|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
147055338|NCT03889418|530364704|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
147055339|NCT03889418|530364705|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
147055340|NCT03889418|530364706|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
147055341|NCT03889418|530364707|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
147055342|NCT03889418|530364708|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
147055343|NCT03889418|530364709|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
147055344|NCT03889418|530364710|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
147055345|NCT03889418|530364711|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
147055346|NCT03889418|530364702|FG000|October-December 2019 (Month 7-9)|Death|0|||
147055347|NCT03889418|530364703|FG001|October-December 2019 (Month 7-9)|Death|0|||
147055348|NCT03889418|530364704|FG002|October-December 2019 (Month 7-9)|Death|0|||
147055349|NCT03889418|530364705|FG003|October-December 2019 (Month 7-9)|Death|0|||
147055350|NCT03889418|530364706|FG004|October-December 2019 (Month 7-9)|Death|0|||
147055351|NCT03889418|530364707|FG005|October-December 2019 (Month 7-9)|Death|0|||
147055352|NCT03889418|530364708|FG006|October-December 2019 (Month 7-9)|Death|0|||
147055353|NCT03889418|530364709|FG007|October-December 2019 (Month 7-9)|Death|0|||
147055354|NCT03889418|530364710|FG008|October-December 2019 (Month 7-9)|Death|1|||
147055355|NCT03889418|530364711|FG009|October-December 2019 (Month 7-9)|Death|0|||
147055356|NCT03889418|530364702|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
147055357|NCT03889418|530364703|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
147055358|NCT03889418|530364704|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
147055359|NCT03889418|530364705|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
147055360|NCT03889418|530364706|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
147055361|NCT03889418|530364707|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
147055362|NCT03889418|530364708|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
147055363|NCT03889418|530364709|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
147055364|NCT03889418|530364710|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
147055365|NCT03889418|530364711|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
147055366|NCT03889418|530364702|FG000|April - June 2020 (Month 13-15)|Death|0|||
147055367|NCT03889418|530364703|FG001|April - June 2020 (Month 13-15)|Death|1|||
147055368|NCT03889418|530364704|FG002|April - June 2020 (Month 13-15)|Death|0|||
147055369|NCT03889418|530364705|FG003|April - June 2020 (Month 13-15)|Death|0|||
147055370|NCT03889418|530364706|FG004|April - June 2020 (Month 13-15)|Death|0|||
147055371|NCT03889418|530364707|FG005|April - June 2020 (Month 13-15)|Death|0|||
147055372|NCT03889418|530364708|FG006|April - June 2020 (Month 13-15)|Death|0|||
147055373|NCT03889418|530364709|FG007|April - June 2020 (Month 13-15)|Death|0|||
147055374|NCT03889418|530364710|FG008|April - June 2020 (Month 13-15)|Death|0|||
147055375|NCT03889418|530364711|FG009|April - June 2020 (Month 13-15)|Death|0|||
147055376|NCT03889418|530364702|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147055377|NCT03889418|530364703|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147055378|NCT03889418|530364704|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147055379|NCT03889418|530364705|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
147055380|NCT03889418|530364706|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147055381|NCT03889418|530364707|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147055382|NCT03889418|530364708|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147055383|NCT03889418|530364709|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147055384|NCT03889418|530364710|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147055385|NCT03889418|530364711|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147055386|NCT03889418|530364702|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
147055387|NCT03889418|530364703|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
147055388|NCT03889418|530364704|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
147055389|NCT03889418|530364705|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
147055390|NCT03889418|530364706|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
147055391|NCT03889418|530364707|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
147055392|NCT03889418|530364708|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
147055393|NCT03889418|530364709|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
147055394|NCT03889418|530364710|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
147055395|NCT03889418|530364711|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
147055396|NCT03889418|530364702|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
147055397|NCT03889418|530364703|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
147055398|NCT03889418|530364704|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
147055399|NCT03889418|530364705|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
147055400|NCT03889418|530364706|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
147055401|NCT03889418|530364707|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
147055402|NCT03889418|530364708|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
147055403|NCT03889418|530364709|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
147055404|NCT03889418|530364710|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
147055405|NCT03889418|530364711|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
147055406|NCT00092118|530364713|FG000|Overall Study|Adverse Event|35|||
147055407|NCT00092118|530364714|FG001|Overall Study|Adverse Event|32|||
147055408|NCT00092118|530364713|FG000|Overall Study|Lack of Efficacy|12|||
147055409|NCT00092118|530364714|FG001|Overall Study|Lack of Efficacy|14|||
147055410|NCT00092118|530364713|FG000|Overall Study|Lost to Follow-up|4|||
147055411|NCT00092118|530364714|FG001|Overall Study|Lost to Follow-up|3|||
147055412|NCT00092118|530364713|FG000|Overall Study|Protocol Violation|23|||
147055413|NCT00092118|530364714|FG001|Overall Study|Protocol Violation|25|||
147055414|NCT00092118|530364713|FG000|Overall Study|Withdrawal by Subject|4|||
147055415|NCT00092118|530364714|FG001|Overall Study|Withdrawal by Subject|10|||
147055416|NCT00092118|530364713|FG000|Overall Study|Other|6|||
147055417|NCT00092118|530364714|FG001|Overall Study|Other|5|||
147055418|NCT02025725|530364715|FG000|Overall Study|Adverse Event|5|||
147055419|NCT02025725|530364716|FG001|Overall Study|Adverse Event|0|||
147055420|NCT02025725|530364715|FG000|Overall Study|Lost to Follow-up|2|||
147055421|NCT02025725|530364716|FG001|Overall Study|Lost to Follow-up|0|||
147055422|NCT02025725|530364715|FG000|Overall Study|Protocol Violation|1|||
147055423|NCT02025725|530364716|FG001|Overall Study|Protocol Violation|1|||
147055424|NCT02025725|530364715|FG000|Overall Study|Withdrawal by Subject|3|||
147055425|NCT02025725|530364716|FG001|Overall Study|Withdrawal by Subject|2|||
147055426|NCT02025725|530364715|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
147055427|NCT02025725|530364716|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
147055428|NCT02946463|530364717|FG000|Primary Evaluation Period|Physician Decision|0|||
147055429|NCT02946463|530364718|FG001|Primary Evaluation Period|Physician Decision|1|||
147055430|NCT02946463|530364719|FG002|Primary Evaluation Period|Physician Decision|0|||
147055431|NCT02946463|530364720|FG003|Primary Evaluation Period|Physician Decision|0|||
147055432|NCT02946463|530364717|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
147055433|NCT02946463|530364718|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
147055434|NCT02946463|530364719|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
147055435|NCT02946463|530364720|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
147055436|NCT02946463|530364717|FG000|Extension Period|Death|4|||
147055437|NCT02946463|530364718|FG001|Extension Period|Death|4|||
147055438|NCT02946463|530364719|FG002|Extension Period|Death|0|||
147055439|NCT02946463|530364720|FG003|Extension Period|Death|0|||
147055440|NCT02946463|530364717|FG000|Extension Period|Withdrawal by Subject|4|||
147055441|NCT02946463|530364718|FG001|Extension Period|Withdrawal by Subject|3|||
147055442|NCT02946463|530364719|FG002|Extension Period|Withdrawal by Subject|0|||
147055443|NCT02946463|530364720|FG003|Extension Period|Withdrawal by Subject|0|||
147055444|NCT02946463|530364717|FG000|Extension Period|Other than specified|2|||
147055445|NCT02946463|530364718|FG001|Extension Period|Other than specified|3|||
147055446|NCT02946463|530364719|FG002|Extension Period|Other than specified|2|||
147055447|NCT02946463|530364720|FG003|Extension Period|Other than specified|0|||
147055448|NCT02946463|530364717|FG000|Extension Period|Physician Decision|1|||
147055449|NCT02946463|530364718|FG001|Extension Period|Physician Decision|4|||
147055450|NCT02946463|530364719|FG002|Extension Period|Physician Decision|0|||
147055451|NCT02946463|530364720|FG003|Extension Period|Physician Decision|0|||
147055452|NCT02946463|530364717|FG000|Extension Period|Pregnancy|3|||
147055453|NCT02946463|530364718|FG001|Extension Period|Pregnancy|1|||
147055454|NCT02946463|530364719|FG002|Extension Period|Pregnancy|0|||
147055455|NCT02946463|530364720|FG003|Extension Period|Pregnancy|0|||
147055456|NCT02946463|530364717|FG000|Extension Period|Adverse Event|1|||
147055457|NCT02946463|530364718|FG001|Extension Period|Adverse Event|2|||
147055458|NCT02946463|530364719|FG002|Extension Period|Adverse Event|0|||
147055459|NCT02946463|530364720|FG003|Extension Period|Adverse Event|0|||
147055460|NCT02946463|530364717|FG000|Extension Period|Lost to Follow-up|1|||
147055461|NCT02946463|530364718|FG001|Extension Period|Lost to Follow-up|0|||
147055462|NCT02946463|530364719|FG002|Extension Period|Lost to Follow-up|0|||
147055463|NCT02946463|530364720|FG003|Extension Period|Lost to Follow-up|0|||
147055464|NCT05581641|530364721|FG000|Overall Study|Withdrawal by Subject|0|||
147055465|NCT05581641|530364722|FG001|Overall Study|Withdrawal by Subject|1|||
147055466|NCT05581641|530364723|FG002|Overall Study|Withdrawal by Subject|3|||
147055467|NCT05581641|530364724|FG003|Overall Study|Withdrawal by Subject|1|||
147055468|NCT05581641|530364721|FG000|Overall Study|Lost to Follow-up|0|||
147055469|NCT05581641|530364722|FG001|Overall Study|Lost to Follow-up|1|||
147055470|NCT05581641|530364723|FG002|Overall Study|Lost to Follow-up|0|||
147055471|NCT05581641|530364724|FG003|Overall Study|Lost to Follow-up|1|||
147055472|NCT05581641|530364721|FG000|Overall Study|Protocol Violation|1|||
147055473|NCT05581641|530364722|FG001|Overall Study|Protocol Violation|0|||
147055474|NCT05581641|530364723|FG002|Overall Study|Protocol Violation|0|||
147055475|NCT05581641|530364724|FG003|Overall Study|Protocol Violation|0|||
147055476|NCT05581641|530364721|FG000|Overall Study|Other|1|||
147055477|NCT05581641|530364722|FG001|Overall Study|Other|0|||
147055478|NCT05581641|530364723|FG002|Overall Study|Other|2|||
147055479|NCT05581641|530364724|FG003|Overall Study|Other|1|||
147055480|NCT01924689|530364725|FG000|Overall Study|Death|0|||
147055481|NCT01924689|530364726|FG001|Overall Study|Death|1|||
147055482|NCT01924689|530364727|FG002|Overall Study|Death|0|||
147055483|NCT01924689|530364728|FG003|Overall Study|Death|1|||
147055484|NCT01924689|530364729|FG004|Overall Study|Death|0|||
147055485|NCT01924689|530364730|FG005|Overall Study|Death|0|||
147055486|NCT01924689|530364725|FG000|Overall Study|Disease progression|0|||
147055487|NCT01924689|530364726|FG001|Overall Study|Disease progression|0|||
147055488|NCT01924689|530364727|FG002|Overall Study|Disease progression|2|||
147055489|NCT01924689|530364728|FG003|Overall Study|Disease progression|0|||
147055490|NCT01924689|530364729|FG004|Overall Study|Disease progression|3|||
147055491|NCT01924689|530364730|FG005|Overall Study|Disease progression|2|||
147055492|NCT01924689|530364725|FG000|Overall Study|New therapy or study|3|||
147055493|NCT01924689|530364726|FG001|Overall Study|New therapy or study|2|||
147055494|NCT01924689|530364727|FG002|Overall Study|New therapy or study|1|||
147055495|NCT01924689|530364728|FG003|Overall Study|New therapy or study|4|||
147055496|NCT01924689|530364729|FG004|Overall Study|New therapy or study|2|||
147055497|NCT01924689|530364730|FG005|Overall Study|New therapy or study|0|||
147055498|NCT01924689|530364725|FG000|Overall Study|Withdrawal of consent|0|||
147055499|NCT01924689|530364726|FG001|Overall Study|Withdrawal of consent|0|||
147055500|NCT01924689|530364727|FG002|Overall Study|Withdrawal of consent|1|||
147055501|NCT01924689|530364728|FG003|Overall Study|Withdrawal of consent|1|||
147055502|NCT01924689|530364729|FG004|Overall Study|Withdrawal of consent|0|||
147055503|NCT01924689|530364730|FG005|Overall Study|Withdrawal of consent|0|||
147055504|NCT01924689|530364725|FG000|Overall Study|Other|0|||
147055505|NCT01924689|530364726|FG001|Overall Study|Other|0|||
147055506|NCT01924689|530364727|FG002|Overall Study|Other|0|||
147055507|NCT01924689|530364728|FG003|Overall Study|Other|0|||
147055508|NCT01924689|530364729|FG004|Overall Study|Other|1|||
147055509|NCT01924689|530364730|FG005|Overall Study|Other|0|||
147055510|NCT00468819|530364731|FG000|Overall Study|Withdrawal by Subject|4|||
147055511|NCT00468819|530364732|FG001|Overall Study|Withdrawal by Subject|0|||
147055512|NCT00468819|530364733|FG002|Overall Study|Withdrawal by Subject|1|||
147055513|NCT00468819|530364731|FG000|Overall Study|Lost to Follow-up|0|||
147055514|NCT00468819|530364732|FG001|Overall Study|Lost to Follow-up|0|||
147055515|NCT00468819|530364733|FG002|Overall Study|Lost to Follow-up|1|||
147055516|NCT00468819|530364731|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
147055517|NCT00468819|530364732|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
147055518|NCT00468819|530364733|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
147055519|NCT02492867|530364734|FG000|Overall Study|Alternate therapy|1|||
147055520|NCT02492867|530364734|FG000|Overall Study|Withdrawal by Subject|2|||
147055521|NCT02492867|530364734|FG000|Overall Study|Disease progression after treatment started|1|||
147055522|NCT02492867|530364734|FG000|Overall Study|Death|1|||
147055523|NCT03296527|530364735|FG000|Overall Study|Adverse Event|15|||
147055524|NCT03296527|530364736|FG001|Overall Study|Adverse Event|33|||
147055525|NCT03296527|530364735|FG000|Overall Study|Protocol Deviation|4|||
147055526|NCT03296527|530364736|FG001|Overall Study|Protocol Deviation|0|||
147055527|NCT03296527|530364735|FG000|Overall Study|Participant withdrew consent|3|||
147055528|NCT03296527|530364736|FG001|Overall Study|Participant withdrew consent|1|||
147055529|NCT03296527|530364735|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
147055530|NCT03296527|530364736|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
147055531|NCT03296527|530364735|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
147055532|NCT03296527|530364736|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
147055533|NCT03296527|530364735|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
147055534|NCT03296527|530364736|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
147055535|NCT03296527|530364735|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
147055536|NCT03296527|530364736|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
147055537|NCT03296527|530364735|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
147055538|NCT03296527|530364736|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
147055539|NCT02524847|530364738|FG000|Overall Study|Adverse Event|4|||
147055540|NCT02524847|530364738|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
147055541|NCT02524847|530364738|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
147055542|NCT02524847|530364738|FG000|Overall Study|Death|1|||
147055543|NCT02524847|530364738|FG000|Overall Study|Reason not Specified|1|||
147055544|NCT01326845|530364739|FG000|Overall Study|Administrative Problems|5|||
147055545|NCT01326845|530364740|FG001|Overall Study|Administrative Problems|2|||
147055546|NCT01326845|530364739|FG000|Overall Study|Adverse Event|1|||
147055547|NCT01326845|530364740|FG001|Overall Study|Adverse Event|0|||
147055548|NCT01326845|530364739|FG000|Overall Study|Misisng|1|||
147055549|NCT01326845|530364740|FG001|Overall Study|Misisng|3|||
147055550|NCT00122382|530364743|FG000|Double-Blind Study|Adverse Event|9|||
147055551|NCT00122382|530364744|FG001|Double-Blind Study|Adverse Event|11|||
147055552|NCT00122382|530364745|FG002|Double-Blind Study|Adverse Event|0|||
147055553|NCT00122382|530364743|FG000|Double-Blind Study|Death|2|||
147055554|NCT00122382|530364744|FG001|Double-Blind Study|Death|2|||
147055555|NCT00122382|530364745|FG002|Double-Blind Study|Death|0|||
147055556|NCT00122382|530364743|FG000|Double-Blind Study|Lack of Efficacy|0|||
147055557|NCT00122382|530364744|FG001|Double-Blind Study|Lack of Efficacy|8|||
147055558|NCT00122382|530364745|FG002|Double-Blind Study|Lack of Efficacy|0|||
147055559|NCT00122382|530364743|FG000|Double-Blind Study|Lost to Follow-up|2|||
147055560|NCT00122382|530364744|FG001|Double-Blind Study|Lost to Follow-up|1|||
147055561|NCT00122382|530364745|FG002|Double-Blind Study|Lost to Follow-up|0|||
147055562|NCT00122382|530364743|FG000|Double-Blind Study|Pregnancy|2|||
147055563|NCT00122382|530364744|FG001|Double-Blind Study|Pregnancy|0|||
147055564|NCT00122382|530364745|FG002|Double-Blind Study|Pregnancy|0|||
147055565|NCT00122382|530364743|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
147055566|NCT00122382|530364744|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
147055567|NCT00122382|530364745|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
147055568|NCT00122382|530364743|FG000|Double-Blind Study|Withdrawal of Consent|7|||
147055569|NCT00122382|530364744|FG001|Double-Blind Study|Withdrawal of Consent|3|||
147055570|NCT00122382|530364745|FG002|Double-Blind Study|Withdrawal of Consent|0|||
147055571|NCT00122382|530364743|FG000|Double-Blind Study|Protocol Violation|1|||
147055572|NCT00122382|530364744|FG001|Double-Blind Study|Protocol Violation|0|||
147055573|NCT00122382|530364745|FG002|Double-Blind Study|Protocol Violation|0|||
147055574|NCT00122382|530364743|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
147055575|NCT00122382|530364744|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
147055576|NCT00122382|530364745|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
147055577|NCT00122382|530364743|FG000|Double-Blind Study|Randomized but not treated|0|||
147055578|NCT00122382|530364744|FG001|Double-Blind Study|Randomized but not treated|2|||
147055579|NCT00122382|530364745|FG002|Double-Blind Study|Randomized but not treated|0|||
147055580|NCT00122382|530364743|FG000|Open-Label Study|Adverse Event|0|||
147055581|NCT00122382|530364744|FG001|Open-Label Study|Adverse Event|0|||
147055582|NCT00122382|530364745|FG002|Open-Label Study|Adverse Event|11|||
147055583|NCT00122382|530364743|FG000|Open-Label Study|Death|0|||
147055584|NCT00122382|530364744|FG001|Open-Label Study|Death|0|||
147055585|NCT00122382|530364745|FG002|Open-Label Study|Death|2|||
147055586|NCT00122382|530364743|FG000|Open-Label Study|Lack of Efficacy|0|||
147055587|NCT00122382|530364744|FG001|Open-Label Study|Lack of Efficacy|0|||
147055588|NCT00122382|530364745|FG002|Open-Label Study|Lack of Efficacy|3|||
147055589|NCT00122382|530364743|FG000|Open-Label Study|Lost to Follow-up|0|||
147055590|NCT00122382|530364744|FG001|Open-Label Study|Lost to Follow-up|0|||
147055591|NCT00122382|530364745|FG002|Open-Label Study|Lost to Follow-up|3|||
147055592|NCT00122382|530364743|FG000|Open-Label Study|Pregnancy|0|||
147055593|NCT00122382|530364744|FG001|Open-Label Study|Pregnancy|0|||
147055594|NCT00122382|530364745|FG002|Open-Label Study|Pregnancy|2|||
147055595|NCT00122382|530364743|FG000|Open-Label Study|Poor/Non-Compliance|0|||
147055596|NCT00122382|530364744|FG001|Open-Label Study|Poor/Non-Compliance|0|||
147055597|NCT00122382|530364745|FG002|Open-Label Study|Poor/Non-Compliance|1|||
147055598|NCT00122382|530364743|FG000|Open-Label Study|Withdrawal of Consent|0|||
147055599|NCT00122382|530364744|FG001|Open-Label Study|Withdrawal of Consent|0|||
147055600|NCT00122382|530364745|FG002|Open-Label Study|Withdrawal of Consent|4|||
147055601|NCT01213966|530364751|FG000|Overall Study|Protocol Violation|1|||
147055602|NCT01213966|530364752|FG001|Overall Study|Protocol Violation|0|||
147055603|NCT01213966|530364753|FG002|Overall Study|Protocol Violation|3|||
147055604|NCT01213966|530364754|FG003|Overall Study|Protocol Violation|1|||
147055605|NCT00682786|530364761|FG000|Overall Study|Withdrawal by Subject|2|||
147055606|NCT00682786|530364762|FG001|Overall Study|Withdrawal by Subject|2|||
147055607|NCT00682786|530364761|FG000|Overall Study|Did not receive irinotecan|0|||
147055608|NCT00682786|530364762|FG001|Overall Study|Did not receive irinotecan|1|||
147055609|NCT04762160|530364765|FG000|Overall Study|Study terminated early due to business reasons|5|||
147055610|NCT01591096|530364767|FG000|Overall Study|Adverse Event|1|||
147055611|NCT01831635|530364768|FG000|Overall Study|Withdrawal by Subject|0|||
147055612|NCT01831635|530364769|FG001|Overall Study|Withdrawal by Subject|2|||
147055613|NCT01831635|530364770|FG002|Overall Study|Withdrawal by Subject|0|||
147055614|NCT05966584|530364778|FG000|Overall Study|Lost to Follow-up|1|||
147055615|NCT05142722|530366492|FG000|Overall Study|Lost to Follow-up|16|||
147055616|NCT05142722|530366493|FG001|Overall Study|Lost to Follow-up|38|||
147055617|NCT05142722|530366492|FG000|Overall Study|Withdrawal by Subject|20|||
147055618|NCT05142722|530366493|FG001|Overall Study|Withdrawal by Subject|27|||
147055619|NCT05142722|530366492|FG000|Overall Study|Death|11|||
147055620|NCT05142722|530366493|FG001|Overall Study|Death|17|||
147055621|NCT05142722|530366492|FG000|Overall Study|Physician Decision|0|||
147055622|NCT05142722|530366493|FG001|Overall Study|Physician Decision|1|||
147055623|NCT05142722|530366492|FG000|Overall Study|Participant Moved Away|0|||
147055624|NCT05142722|530366493|FG001|Overall Study|Participant Moved Away|2|||
147055625|NCT05142722|530366492|FG000|Overall Study|Adverse Event|2|||
147055626|NCT05142722|530366493|FG001|Overall Study|Adverse Event|1|||
147055627|NCT02141438|530366494|FG000|Overall Study|Death|1308|||
147055628|NCT02141438|530366494|FG000|Overall Study|Lost to Follow-up|84|||
147055629|NCT02141438|530366494|FG000|Overall Study|Withdrawal by Subject|52|||
147055630|NCT02141438|530366494|FG000|Overall Study|Physician Decision|1|||
147055631|NCT02141438|530366494|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
147055632|NCT05086744|530366495|FG000|Part A|Adverse Event|0|||
147055633|NCT05086744|530366496|FG001|Part A|Adverse Event|1|||
147055634|NCT05086744|530366495|FG000|Part A|Lack of Efficacy|3|||
147055635|NCT05086744|530366496|FG001|Part A|Lack of Efficacy|0|||
147055636|NCT05086744|530366495|FG000|Part A|Protocol deviation|1|||
147055637|NCT05086744|530366496|FG001|Part A|Protocol deviation|0|||
147055638|NCT05086744|530366495|FG000|Part A|Subject decision|1|||
147055639|NCT05086744|530366496|FG001|Part A|Subject decision|0|||
147055640|NCT05086744|530366495|FG000|Part B|Adverse Event|0|||
147055641|NCT05086744|530366496|FG001|Part B|Adverse Event|1|||
147055642|NCT05086744|530366495|FG000|Part B|Lack of Efficacy|0|||
147055643|NCT05086744|530366496|FG001|Part B|Lack of Efficacy|1|||
147055644|NCT05086744|530366495|FG000|Part B|Study terminated by sponsor|1|||
147055645|NCT05086744|530366496|FG001|Part B|Study terminated by sponsor|6|||
147055646|NCT03896503|530366497|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
147055647|NCT03896503|530366498|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
147055648|NCT03896503|530366499|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
147055649|NCT03896503|530366500|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
147055650|NCT03896503|530366501|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
147055651|NCT03896503|530366502|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
147055652|NCT03896503|530366503|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
147055653|NCT03896503|530366504|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
147055654|NCT03896503|530366497|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
147055655|NCT03896503|530366498|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
147055656|NCT03896503|530366499|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
147055657|NCT03896503|530366500|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
147055658|NCT03896503|530366501|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
147055659|NCT03896503|530366502|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
147055660|NCT03896503|530366503|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
147055661|NCT03896503|530366504|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
147055662|NCT03896503|530366497|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
147055663|NCT03896503|530366498|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
147055664|NCT03896503|530366499|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
147055665|NCT03896503|530366500|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
147055666|NCT03896503|530366501|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
147055667|NCT03896503|530366502|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
147055668|NCT03896503|530366503|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
147055669|NCT03896503|530366504|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
147055670|NCT03896503|530366497|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
147055671|NCT03896503|530366498|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
147055672|NCT03896503|530366499|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
147055673|NCT03896503|530366500|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
147055674|NCT03896503|530366501|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
147055675|NCT03896503|530366502|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
147055676|NCT03896503|530366503|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
147055677|NCT03896503|530366504|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
147055678|NCT03896503|530366497|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147055679|NCT03896503|530366498|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147055680|NCT03896503|530366499|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
147055681|NCT03896503|530366500|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147055682|NCT03896503|530366501|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147055683|NCT03896503|530366502|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147055684|NCT03896503|530366503|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
147055685|NCT03896503|530366504|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147055686|NCT03896503|530366497|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
147055687|NCT03896503|530366498|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
147055688|NCT03896503|530366499|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
147055689|NCT03896503|530366500|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
147055690|NCT03896503|530366501|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
147055691|NCT03896503|530366502|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
147055692|NCT03896503|530366503|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
147055693|NCT03896503|530366504|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
147055694|NCT03896503|530366497|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
147055695|NCT03896503|530366498|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
147055696|NCT03896503|530366499|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
147055697|NCT03896503|530366500|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
147055698|NCT03896503|530366501|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
147055699|NCT03896503|530366502|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
147055700|NCT03896503|530366503|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
147055701|NCT03896503|530366504|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
147055702|NCT03896503|530366497|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
147055703|NCT03896503|530366498|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
147055704|NCT03896503|530366499|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
147055705|NCT03896503|530366500|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
147055706|NCT03896503|530366501|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
147055707|NCT03896503|530366502|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
147055708|NCT03896503|530366503|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
147055709|NCT03896503|530366504|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
147055710|NCT03896503|530366497|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
146850061|NCT00911937|529620706|FG001|Overall Study|Withdrawn due to pregnancy|0|||
147055711|NCT03896503|530366498|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
147055712|NCT03896503|530366499|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
147055713|NCT03896503|530366500|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
147055714|NCT03896503|530366501|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
147055715|NCT03896503|530366502|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
147055716|NCT03896503|530366503|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
147055717|NCT03896503|530366504|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
147055718|NCT03896503|530366497|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147055719|NCT03896503|530366498|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147055720|NCT03896503|530366499|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147055721|NCT03896503|530366500|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147055722|NCT03896503|530366501|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147055723|NCT03896503|530366502|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
147055724|NCT03896503|530366503|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147055725|NCT03896503|530366504|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147055726|NCT03896503|530366497|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
147055727|NCT03896503|530366498|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
147055728|NCT03896503|530366499|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
147055729|NCT03896503|530366500|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
147055730|NCT03896503|530366501|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
147055731|NCT03896503|530366502|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
147055732|NCT03896503|530366503|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
147055733|NCT03896503|530366504|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
147055734|NCT00437021|530366505|FG000|Overall Study|Adverse Event|0|||
147055735|NCT00437021|530366506|FG001|Overall Study|Adverse Event|0|||
147055736|NCT00437021|530366507|FG002|Overall Study|Adverse Event|0|||
147055737|NCT00437021|530366508|FG003|Overall Study|Adverse Event|0|||
147055738|NCT00437021|530366509|FG004|Overall Study|Adverse Event|0|||
147055739|NCT00437021|530366510|FG005|Overall Study|Adverse Event|0|||
147055740|NCT00437021|530366511|FG006|Overall Study|Adverse Event|1|||
147055741|NCT00437021|530366512|FG007|Overall Study|Adverse Event|0|||
147055742|NCT00437021|530366513|FG008|Overall Study|Adverse Event|0|||
147055743|NCT00437021|530366514|FG009|Overall Study|Adverse Event|0|||
147055744|NCT00437021|530366515|FG010|Overall Study|Adverse Event|0|||
147055745|NCT00437021|530366516|FG011|Overall Study|Adverse Event|0|||
147055746|NCT00437021|530366505|FG000|Overall Study|Lost to Follow-up|0|||
147055747|NCT00437021|530366506|FG001|Overall Study|Lost to Follow-up|3|||
147055748|NCT00437021|530366507|FG002|Overall Study|Lost to Follow-up|0|||
147055749|NCT00437021|530366508|FG003|Overall Study|Lost to Follow-up|0|||
147055750|NCT00437021|530366509|FG004|Overall Study|Lost to Follow-up|0|||
147055751|NCT00437021|530366510|FG005|Overall Study|Lost to Follow-up|2|||
147055752|NCT00437021|530366511|FG006|Overall Study|Lost to Follow-up|0|||
147055753|NCT00437021|530366512|FG007|Overall Study|Lost to Follow-up|1|||
147055754|NCT00437021|530366513|FG008|Overall Study|Lost to Follow-up|0|||
147055755|NCT00437021|530366514|FG009|Overall Study|Lost to Follow-up|0|||
147055756|NCT00437021|530366515|FG010|Overall Study|Lost to Follow-up|0|||
147055757|NCT00437021|530366516|FG011|Overall Study|Lost to Follow-up|0|||
147055758|NCT00437021|530366505|FG000|Overall Study|Withdrawal by Subject|2|||
147055759|NCT00437021|530366506|FG001|Overall Study|Withdrawal by Subject|1|||
147055760|NCT00437021|530366507|FG002|Overall Study|Withdrawal by Subject|0|||
147055761|NCT00437021|530366508|FG003|Overall Study|Withdrawal by Subject|0|||
147055762|NCT00437021|530366509|FG004|Overall Study|Withdrawal by Subject|0|||
147055763|NCT00437021|530366510|FG005|Overall Study|Withdrawal by Subject|0|||
147055764|NCT00437021|530366511|FG006|Overall Study|Withdrawal by Subject|0|||
147055765|NCT00437021|530366512|FG007|Overall Study|Withdrawal by Subject|0|||
147055766|NCT00437021|530366513|FG008|Overall Study|Withdrawal by Subject|0|||
147055767|NCT00437021|530366514|FG009|Overall Study|Withdrawal by Subject|0|||
147055768|NCT00437021|530366515|FG010|Overall Study|Withdrawal by Subject|0|||
147055769|NCT00437021|530366516|FG011|Overall Study|Withdrawal by Subject|0|||
147055770|NCT01880554|530366517|FG000|Overall Study|Protocol Violation|14|||
147055771|NCT01880554|530366517|FG000|Overall Study|Simon's design requirements|2|||
147055772|NCT05161481|530366518|FG000|Overall Study|Withdrawal of consent|0|||
147055773|NCT05161481|530366519|FG001|Overall Study|Withdrawal of consent|1|||
147055774|NCT05161481|530366520|FG002|Overall Study|Withdrawal of consent|1|||
147055775|NCT05161481|530366518|FG000|Overall Study|Study terminated by sponsor|3|||
147055776|NCT05161481|530366519|FG001|Overall Study|Study terminated by sponsor|3|||
147055777|NCT05161481|530366520|FG002|Overall Study|Study terminated by sponsor|2|||
147055778|NCT05161481|530366518|FG000|Overall Study|Adverse Event|3|||
147055779|NCT05161481|530366519|FG001|Overall Study|Adverse Event|0|||
147055780|NCT05161481|530366520|FG002|Overall Study|Adverse Event|6|||
147055781|NCT05161481|530366518|FG000|Overall Study|Randomised in error and was not treated|1|||
147055782|NCT05161481|530366519|FG001|Overall Study|Randomised in error and was not treated|0|||
147055783|NCT05161481|530366520|FG002|Overall Study|Randomised in error and was not treated|0|||
147055784|NCT05161481|530366518|FG000|Overall Study|Subject decision|0|||
147055785|NCT05161481|530366519|FG001|Overall Study|Subject decision|0|||
147055786|NCT05161481|530366520|FG002|Overall Study|Subject decision|1|||
147055787|NCT01120184|530366529|FG000|Overall Study|Adverse Event|0|||
147055788|NCT01120184|530366530|FG001|Overall Study|Adverse Event|1|||
147055789|NCT01120184|530366531|FG002|Overall Study|Adverse Event|0|||
147055790|NCT01120184|530366529|FG000|Overall Study|Lost to Follow-up|13|||
147055791|NCT01120184|530366530|FG001|Overall Study|Lost to Follow-up|13|||
147055792|NCT01120184|530366531|FG002|Overall Study|Lost to Follow-up|11|||
147055793|NCT01120184|530366529|FG000|Overall Study|Physician Decision|9|||
147055794|NCT01120184|530366530|FG001|Overall Study|Physician Decision|1|||
147055795|NCT01120184|530366531|FG002|Overall Study|Physician Decision|3|||
147055796|NCT01120184|530366529|FG000|Overall Study|Reason not Specified|8|||
147055797|NCT01120184|530366530|FG001|Overall Study|Reason not Specified|3|||
147055798|NCT01120184|530366531|FG002|Overall Study|Reason not Specified|12|||
147055799|NCT01120184|530366529|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
147055800|NCT01120184|530366530|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
147055801|NCT01120184|530366531|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
147055802|NCT01120184|530366529|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
147055803|NCT01120184|530366530|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
147055804|NCT01120184|530366531|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
147055805|NCT01120184|530366529|FG000|Overall Study|Death|170|||
147055806|NCT01120184|530366530|FG001|Overall Study|Death|176|||
147055807|NCT01120184|530366531|FG002|Overall Study|Death|169|||
147055808|NCT00536939|530366533|FG000|Overall Study|Withdrawal by Subject|1|||
147055809|NCT00536939|530366534|FG001|Overall Study|Withdrawal by Subject|0|||
147055810|NCT00536939|530366533|FG000|Overall Study|Other Complicating Disease|1|||
147055811|NCT00536939|530366534|FG001|Overall Study|Other Complicating Disease|0|||
147055812|NCT01894841|530366535|FG000|Overall Study|Withdrawal by Subject|9|||
147055813|NCT01894841|530366536|FG001|Overall Study|Withdrawal by Subject|4|||
147055814|NCT01894841|530366535|FG000|Overall Study|Withdrawn by investigator|2|||
147055815|NCT01894841|530366536|FG001|Overall Study|Withdrawn by investigator|2|||
147055816|NCT01894841|530366535|FG000|Overall Study|Lost to Follow-up|7|||
147055817|NCT01894841|530366536|FG001|Overall Study|Lost to Follow-up|3|||
147055818|NCT04227197|530366558|FG000|Randomization|Protocol Violation|1|||
147055819|NCT04227197|530366559|FG001|Randomization|Protocol Violation|0|||
147055820|NCT04227197|530366558|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
147055821|NCT04227197|530366559|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
147055822|NCT04227197|530366558|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
147055823|NCT04227197|530366559|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
147055824|NCT04227197|530366558|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
147055825|NCT04227197|530366559|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
147055826|NCT04227197|530366558|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
147055827|NCT04227197|530366559|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
147055828|NCT04227197|530366558|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
147055829|NCT04227197|530366559|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
147055830|NCT04227197|530366558|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
147055831|NCT04227197|530366559|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
147055832|NCT01209949|530366569|FG000|Overall Study|Lost to Follow-up|3|||
147055833|NCT00708552|530366574|FG000|Overall Study|Adverse Event|10|||
147055834|NCT00708552|530366575|FG001|Overall Study|Adverse Event|3|||
147055835|NCT00708552|530366576|FG002|Overall Study|Adverse Event|4|||
147055836|NCT00708552|530366577|FG003|Overall Study|Adverse Event|6|||
147055837|NCT00708552|530366574|FG000|Overall Study|Lack of Efficacy|0|||
147055838|NCT00708552|530366575|FG001|Overall Study|Lack of Efficacy|4|||
147055839|NCT00708552|530366576|FG002|Overall Study|Lack of Efficacy|1|||
147055840|NCT00708552|530366577|FG003|Overall Study|Lack of Efficacy|0|||
147055841|NCT00708552|530366574|FG000|Overall Study|Protocol Violation|0|||
147055842|NCT00708552|530366575|FG001|Overall Study|Protocol Violation|0|||
147055843|NCT00708552|530366576|FG002|Overall Study|Protocol Violation|2|||
147055844|NCT00708552|530366577|FG003|Overall Study|Protocol Violation|4|||
147055845|NCT00708552|530366574|FG000|Overall Study|Lost to Follow-up|4|||
147055846|NCT00708552|530366575|FG001|Overall Study|Lost to Follow-up|2|||
147055847|NCT00708552|530366576|FG002|Overall Study|Lost to Follow-up|0|||
147055848|NCT00708552|530366577|FG003|Overall Study|Lost to Follow-up|1|||
147055849|NCT00708552|530366574|FG000|Overall Study|Physician Decision|1|||
147055850|NCT00708552|530366575|FG001|Overall Study|Physician Decision|2|||
147055851|NCT00708552|530366576|FG002|Overall Study|Physician Decision|0|||
147055852|NCT00708552|530366577|FG003|Overall Study|Physician Decision|0|||
147055853|NCT00708552|530366574|FG000|Overall Study|Withdrawal by Subject|12|||
147055854|NCT00708552|530366575|FG001|Overall Study|Withdrawal by Subject|7|||
147055855|NCT00708552|530366576|FG002|Overall Study|Withdrawal by Subject|8|||
147055856|NCT00708552|530366577|FG003|Overall Study|Withdrawal by Subject|10|||
147055857|NCT04878432|530366579|FG000|Overall Study|Adverse Event|1|||
147055858|NCT04878432|530366579|FG000|Overall Study|Death|2|||
147055859|NCT04878432|530366579|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
147055860|NCT04878432|530366579|FG000|Overall Study|Withdrawal by Subject|6|||
147055861|NCT04878432|530366579|FG000|Overall Study|Progressive Disease|7|||
147055862|NCT04878432|530366579|FG000|Overall Study|New Therapy for Study Indication|7|||
147055863|NCT04878432|530366579|FG000|Overall Study|Physician Decision|11|||
147055864|NCT03971071|530366580|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
147055865|NCT03971071|530366581|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
147055866|NCT03971071|530366582|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
147055867|NCT03971071|530366583|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
147055868|NCT03971071|530366584|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
147055869|NCT03971071|530366580|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
147055870|NCT03971071|530366581|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
147055871|NCT03971071|530366582|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
147055872|NCT03971071|530366583|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
147055873|NCT03971071|530366584|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
147055874|NCT03971071|530366580|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
147055875|NCT03971071|530366581|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
147055876|NCT03971071|530366582|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
147055877|NCT03971071|530366583|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
147055878|NCT03971071|530366584|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
147055879|NCT03971071|530366580|FG000|Open-label Treatment Period|Sponsor decision|0|||
147055880|NCT03971071|530366581|FG001|Open-label Treatment Period|Sponsor decision|0|||
147055881|NCT03971071|530366582|FG002|Open-label Treatment Period|Sponsor decision|0|||
147055882|NCT03971071|530366583|FG003|Open-label Treatment Period|Sponsor decision|0|||
147055883|NCT03971071|530366584|FG004|Open-label Treatment Period|Sponsor decision|1|||
147055884|NCT03971071|530366580|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
147055885|NCT03971071|530366581|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
147055886|NCT03971071|530366582|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
147055887|NCT03971071|530366583|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
147055888|NCT03971071|530366584|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
147055889|NCT03971071|530366580|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
147055890|NCT03971071|530366581|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
147055891|NCT03971071|530366582|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
147055892|NCT03971071|530366583|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
147055893|NCT03971071|530366584|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
147055894|NCT03376789|530366586|FG000|Overall Study|Withdrawal by Subject|3|||
147055895|NCT03376789|530366587|FG001|Overall Study|Withdrawal by Subject|5|||
147055896|NCT03376789|530366586|FG000|Overall Study|Protocol Violation|0|||
147055897|NCT03376789|530366587|FG001|Overall Study|Protocol Violation|1|||
147055898|NCT03376789|530366586|FG000|Overall Study|Adverse Event|0|||
147055899|NCT03376789|530366587|FG001|Overall Study|Adverse Event|1|||
147055900|NCT03376789|530366586|FG000|Overall Study|Lost to Follow-up|1|||
147055901|NCT03376789|530366587|FG001|Overall Study|Lost to Follow-up|1|||
147055902|NCT03376789|530366586|FG000|Overall Study|Per sponsor due to noncompliance|1|||
147055903|NCT03376789|530366587|FG001|Overall Study|Per sponsor due to noncompliance|0|||
147055904|NCT03376789|530366586|FG000|Overall Study|Subject off study medication|0|||
147055905|NCT03376789|530366587|FG001|Overall Study|Subject off study medication|1|||
147055906|NCT01565889|530366595|FG000|Part A|Withdrawal by Subject|1|||
147055907|NCT01565889|530366596|FG001|Part A|Withdrawal by Subject|0|||
147055908|NCT01565889|530366597|FG002|Part A|Withdrawal by Subject|0|||
147055909|NCT01565889|530366598|FG003|Part A|Withdrawal by Subject|0|||
147055910|NCT01565889|530366599|FG004|Part A|Withdrawal by Subject|0|||
147055911|NCT01565889|530366600|FG005|Part A|Withdrawal by Subject|0|||
147055912|NCT01565889|530366595|FG000|Part B|Withdrawal by Subject|0|||
147055913|NCT01565889|530366596|FG001|Part B|Withdrawal by Subject|0|||
147055914|NCT01565889|530366597|FG002|Part B|Withdrawal by Subject|0|||
147055915|NCT01565889|530366598|FG003|Part B|Withdrawal by Subject|0|||
147055916|NCT01565889|530366599|FG004|Part B|Withdrawal by Subject|0|||
147055917|NCT01565889|530366600|FG005|Part B|Withdrawal by Subject|1|||
147055918|NCT01565889|530366595|FG000|Part B|Lack of Efficacy|0|||
146850062|NCT00911937|529620705|FG000|Overall Study|Adverse Event|11|||
147055919|NCT01565889|530366596|FG001|Part B|Lack of Efficacy|0|||
147055920|NCT01565889|530366597|FG002|Part B|Lack of Efficacy|0|||
147055921|NCT01565889|530366598|FG003|Part B|Lack of Efficacy|0|||
147055922|NCT01565889|530366599|FG004|Part B|Lack of Efficacy|0|||
147055923|NCT01565889|530366600|FG005|Part B|Lack of Efficacy|2|||
147055924|NCT01565889|530366595|FG000|Part B|Lost to Follow-up|0|||
147055925|NCT01565889|530366596|FG001|Part B|Lost to Follow-up|0|||
147055926|NCT01565889|530366597|FG002|Part B|Lost to Follow-up|0|||
147055927|NCT01565889|530366598|FG003|Part B|Lost to Follow-up|0|||
147055928|NCT01565889|530366599|FG004|Part B|Lost to Follow-up|0|||
147055929|NCT01565889|530366600|FG005|Part B|Lost to Follow-up|1|||
147055930|NCT02166333|530366601|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
147055931|NCT02166333|530366602|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
147055932|NCT02166333|530366603|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
147055933|NCT02166333|530366604|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
147055934|NCT02166333|530366605|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
147055935|NCT02166333|530366606|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
147055936|NCT02166333|530366601|FG000|Stage 1|Death|4|||
147055937|NCT02166333|530366602|FG001|Stage 1|Death|0|||
147055938|NCT02166333|530366603|FG002|Stage 1|Death|2|||
147055939|NCT02166333|530366604|FG003|Stage 1|Death|0|||
147055940|NCT02166333|530366605|FG004|Stage 1|Death|3|||
147055941|NCT02166333|530366606|FG005|Stage 1|Death|2|||
147055942|NCT02166333|530366601|FG000|Stage 1|Lost to Follow-up|12|||
147055943|NCT02166333|530366602|FG001|Stage 1|Lost to Follow-up|0|||
147055944|NCT02166333|530366603|FG002|Stage 1|Lost to Follow-up|6|||
147055945|NCT02166333|530366604|FG003|Stage 1|Lost to Follow-up|0|||
147055946|NCT02166333|530366605|FG004|Stage 1|Lost to Follow-up|3|||
147055947|NCT02166333|530366606|FG005|Stage 1|Lost to Follow-up|3|||
147055948|NCT02166333|530366601|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
147055949|NCT02166333|530366602|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
147055950|NCT02166333|530366603|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
147055951|NCT02166333|530366604|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
147055952|NCT02166333|530366605|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
147055953|NCT02166333|530366606|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
147055954|NCT02166333|530366601|FG000|Stage 2|Death|4|||
147055955|NCT02166333|530366602|FG001|Stage 2|Death|2|||
147055956|NCT02166333|530366603|FG002|Stage 2|Death|1|||
147055957|NCT02166333|530366604|FG003|Stage 2|Death|0|||
147055958|NCT02166333|530366605|FG004|Stage 2|Death|0|||
147055959|NCT02166333|530366606|FG005|Stage 2|Death|1|||
147055960|NCT02166333|530366601|FG000|Stage 2|Lost to Follow-up|23|||
147055961|NCT02166333|530366602|FG001|Stage 2|Lost to Follow-up|4|||
147055962|NCT02166333|530366603|FG002|Stage 2|Lost to Follow-up|11|||
147055963|NCT02166333|530366604|FG003|Stage 2|Lost to Follow-up|9|||
147055964|NCT02166333|530366605|FG004|Stage 2|Lost to Follow-up|3|||
147055965|NCT02166333|530366606|FG005|Stage 2|Lost to Follow-up|6|||
147055966|NCT02269098|530366607|FG000|Overall Study|Lost to Follow-up|14|||
147055967|NCT02269098|530366608|FG001|Overall Study|Lost to Follow-up|9|||
147055968|NCT03644342|530366614|FG000|Overall Study|Adverse Event|2|||
147055969|NCT03644342|530366615|FG001|Overall Study|Adverse Event|0|||
147055970|NCT03644342|530366614|FG000|Overall Study|Protocol Violation|0|||
147055971|NCT03644342|530366615|FG001|Overall Study|Protocol Violation|1|||
147055972|NCT00359424|530366616|FG000|Overall Study|Death|99|||
147055973|NCT00359424|530366617|FG001|Overall Study|Death|58|||
147055974|NCT00359424|530366616|FG000|Overall Study|Lost to Follow-up|19|||
147055975|NCT00359424|530366617|FG001|Overall Study|Lost to Follow-up|7|||
147055976|NCT00359424|530366616|FG000|Overall Study|Withdrawal by Subject|10|||
147055977|NCT00359424|530366617|FG001|Overall Study|Withdrawal by Subject|2|||
147055978|NCT00359424|530366616|FG000|Overall Study|follow up not conducted|2|||
147055979|NCT00359424|530366617|FG001|Overall Study|follow up not conducted|0|||
147055980|NCT02259010|530366620|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
147055981|NCT02462603|530366621|FG000|Overall Study|Investigator Decision|1|||
147055982|NCT02462603|530366621|FG000|Overall Study|Non-Compliance|1|||
147055983|NCT02462603|530366621|FG000|Overall Study|Withdrawal by Subject|2|||
147055984|NCT01445730|530366626|FG000|Overall Study|Adverse Event|1|||
147055985|NCT01445730|530366626|FG000|Overall Study|For the advice of a dentist|1|||
147055986|NCT01445730|530366626|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
147055987|NCT01167140|530366629|FG000|Overall Study|Withdrawal by Subject|1|||
147055988|NCT03805412|530366630|FG000|Overall Study|Lost to Follow-up|0|||
147055989|NCT03805412|530366631|FG001|Overall Study|Lost to Follow-up|1|||
147055990|NCT00848718|530366632|FG000|Overall Study|Adverse Event|2|||
147055991|NCT00848718|530366633|FG001|Overall Study|Adverse Event|2|||
147055992|NCT00848718|530366634|FG002|Overall Study|Adverse Event|1|||
147055993|NCT00848718|530366635|FG003|Overall Study|Adverse Event|1|||
147055994|NCT00848718|530366636|FG004|Overall Study|Adverse Event|1|||
147055995|NCT00848718|530366637|FG005|Overall Study|Adverse Event|0|||
147055996|NCT00848718|530366638|FG006|Overall Study|Adverse Event|0|||
147055997|NCT00848718|530366639|FG007|Overall Study|Adverse Event|1|||
147055998|NCT00848718|530366640|FG008|Overall Study|Adverse Event|1|||
147055999|NCT00848718|530366641|FG009|Overall Study|Adverse Event|0|||
147056000|NCT00848718|530366642|FG010|Overall Study|Adverse Event|0|||
147056001|NCT00848718|530366643|FG011|Overall Study|Adverse Event|0|||
147056002|NCT00848718|530366644|FG012|Overall Study|Adverse Event|2|||
147056003|NCT00848718|530366632|FG000|Overall Study|Lack of Efficacy|0|||
147056004|NCT00848718|530366633|FG001|Overall Study|Lack of Efficacy|0|||
147056005|NCT00848718|530366634|FG002|Overall Study|Lack of Efficacy|1|||
147056006|NCT00848718|530366635|FG003|Overall Study|Lack of Efficacy|0|||
147056007|NCT00848718|530366636|FG004|Overall Study|Lack of Efficacy|0|||
147056008|NCT00848718|530366637|FG005|Overall Study|Lack of Efficacy|0|||
147056009|NCT00848718|530366638|FG006|Overall Study|Lack of Efficacy|1|||
147056010|NCT00848718|530366639|FG007|Overall Study|Lack of Efficacy|0|||
147056011|NCT00848718|530366640|FG008|Overall Study|Lack of Efficacy|0|||
147056012|NCT00848718|530366641|FG009|Overall Study|Lack of Efficacy|0|||
147056013|NCT00848718|530366642|FG010|Overall Study|Lack of Efficacy|0|||
147056014|NCT00848718|530366643|FG011|Overall Study|Lack of Efficacy|0|||
147056015|NCT00848718|530366644|FG012|Overall Study|Lack of Efficacy|0|||
147056016|NCT00848718|530366632|FG000|Overall Study|Physician Decision|0|||
147056017|NCT00848718|530366633|FG001|Overall Study|Physician Decision|1|||
147056018|NCT00848718|530366634|FG002|Overall Study|Physician Decision|0|||
147056019|NCT00848718|530366635|FG003|Overall Study|Physician Decision|0|||
147056020|NCT00848718|530366636|FG004|Overall Study|Physician Decision|1|||
147056021|NCT00848718|530366637|FG005|Overall Study|Physician Decision|1|||
147056022|NCT00848718|530366638|FG006|Overall Study|Physician Decision|0|||
147056023|NCT00848718|530366639|FG007|Overall Study|Physician Decision|0|||
147056024|NCT00848718|530366640|FG008|Overall Study|Physician Decision|1|||
147056025|NCT00848718|530366641|FG009|Overall Study|Physician Decision|2|||
147056026|NCT00848718|530366642|FG010|Overall Study|Physician Decision|0|||
147056027|NCT00848718|530366643|FG011|Overall Study|Physician Decision|0|||
147056028|NCT00848718|530366644|FG012|Overall Study|Physician Decision|1|||
147056029|NCT00848718|530366632|FG000|Overall Study|Progressive disease before treatment|1|||
147056030|NCT00848718|530366633|FG001|Overall Study|Progressive disease before treatment|5|||
147056031|NCT00848718|530366634|FG002|Overall Study|Progressive disease before treatment|1|||
147056032|NCT00848718|530366635|FG003|Overall Study|Progressive disease before treatment|3|||
147056033|NCT00848718|530366636|FG004|Overall Study|Progressive disease before treatment|4|||
147056034|NCT00848718|530366637|FG005|Overall Study|Progressive disease before treatment|4|||
147056035|NCT00848718|530366638|FG006|Overall Study|Progressive disease before treatment|2|||
147056036|NCT00848718|530366639|FG007|Overall Study|Progressive disease before treatment|1|||
147056037|NCT00848718|530366640|FG008|Overall Study|Progressive disease before treatment|2|||
147056038|NCT00848718|530366641|FG009|Overall Study|Progressive disease before treatment|7|||
147056039|NCT00848718|530366642|FG010|Overall Study|Progressive disease before treatment|3|||
147056040|NCT00848718|530366643|FG011|Overall Study|Progressive disease before treatment|6|||
147056041|NCT00848718|530366644|FG012|Overall Study|Progressive disease before treatment|2|||
147056042|NCT00848718|530366632|FG000|Overall Study|Protocol Violation|0|||
147056043|NCT00848718|530366633|FG001|Overall Study|Protocol Violation|1|||
147056044|NCT00848718|530366634|FG002|Overall Study|Protocol Violation|0|||
147056045|NCT00848718|530366635|FG003|Overall Study|Protocol Violation|0|||
147056046|NCT00848718|530366636|FG004|Overall Study|Protocol Violation|0|||
147056047|NCT00848718|530366637|FG005|Overall Study|Protocol Violation|0|||
147056048|NCT00848718|530366638|FG006|Overall Study|Protocol Violation|0|||
147056049|NCT00848718|530366639|FG007|Overall Study|Protocol Violation|1|||
147056050|NCT00848718|530366640|FG008|Overall Study|Protocol Violation|0|||
147056051|NCT00848718|530366641|FG009|Overall Study|Protocol Violation|0|||
147056052|NCT00848718|530366642|FG010|Overall Study|Protocol Violation|0|||
147056053|NCT00848718|530366643|FG011|Overall Study|Protocol Violation|0|||
147056054|NCT00848718|530366644|FG012|Overall Study|Protocol Violation|1|||
147056055|NCT00848718|530366632|FG000|Overall Study|Withdrawal by Subject|1|||
147056056|NCT00848718|530366633|FG001|Overall Study|Withdrawal by Subject|0|||
147056057|NCT00848718|530366634|FG002|Overall Study|Withdrawal by Subject|0|||
147056058|NCT00848718|530366635|FG003|Overall Study|Withdrawal by Subject|1|||
147056059|NCT00848718|530366636|FG004|Overall Study|Withdrawal by Subject|0|||
147056060|NCT00848718|530366637|FG005|Overall Study|Withdrawal by Subject|0|||
147056061|NCT00848718|530366638|FG006|Overall Study|Withdrawal by Subject|0|||
147056062|NCT00848718|530366639|FG007|Overall Study|Withdrawal by Subject|0|||
147056063|NCT00848718|530366640|FG008|Overall Study|Withdrawal by Subject|0|||
147056064|NCT00848718|530366641|FG009|Overall Study|Withdrawal by Subject|0|||
147056065|NCT00848718|530366642|FG010|Overall Study|Withdrawal by Subject|1|||
147056066|NCT00848718|530366643|FG011|Overall Study|Withdrawal by Subject|0|||
147056067|NCT00848718|530366644|FG012|Overall Study|Withdrawal by Subject|0|||
147056068|NCT00848718|530366632|FG000|Overall Study|Progressive disease during treatment|3|||
147056069|NCT00848718|530366633|FG001|Overall Study|Progressive disease during treatment|0|||
147056070|NCT00848718|530366634|FG002|Overall Study|Progressive disease during treatment|3|||
147056071|NCT00848718|530366635|FG003|Overall Study|Progressive disease during treatment|0|||
147056072|NCT00848718|530366636|FG004|Overall Study|Progressive disease during treatment|0|||
147056073|NCT00848718|530366637|FG005|Overall Study|Progressive disease during treatment|0|||
147056074|NCT00848718|530366638|FG006|Overall Study|Progressive disease during treatment|0|||
147056075|NCT00848718|530366639|FG007|Overall Study|Progressive disease during treatment|2|||
147056076|NCT00848718|530366640|FG008|Overall Study|Progressive disease during treatment|0|||
147056077|NCT00848718|530366641|FG009|Overall Study|Progressive disease during treatment|0|||
147056078|NCT00848718|530366642|FG010|Overall Study|Progressive disease during treatment|0|||
147056079|NCT00848718|530366643|FG011|Overall Study|Progressive disease during treatment|0|||
147056080|NCT00848718|530366644|FG012|Overall Study|Progressive disease during treatment|2|||
147056081|NCT02389829|530366650|FG000|Overall Study|Lost to Follow-up|0|||
147056082|NCT02389829|530366651|FG001|Overall Study|Lost to Follow-up|1|||
147056083|NCT00571727|530366652|FG000|Overall Study|Did not enter in this study|1|||
147056084|NCT00571727|530366652|FG000|Overall Study|Non-compliance|4|||
147056085|NCT00571727|530366652|FG000|Overall Study|Lost to Follow-up|30|||
147056086|NCT00571727|530366652|FG000|Overall Study|Poor growth|1|||
147056087|NCT00571727|530366652|FG000|Overall Study|Parent/patient decision|2|||
147056088|NCT00571727|530366652|FG000|Overall Study|Participant transferred to commercial drug|14|||
147056089|NCT00571727|530366652|FG000|Overall Study|Unable to provide study drug|6|||
147056090|NCT00571727|530366652|FG000|Overall Study|On-treatment at end of study|8|||
147056091|NCT03817190|530366653|FG000|Overall Study|Early Termination|13|||
147056092|NCT03817190|530366654|FG001|Overall Study|Early Termination|20|||
147056093|NCT03817190|530366653|FG000|Overall Study|Adverse Event|10|||
147056094|NCT03817190|530366654|FG001|Overall Study|Adverse Event|17|||
147056095|NCT03817190|530366653|FG000|Overall Study|Withdrawal by Subject|12|||
147056096|NCT03817190|530366654|FG001|Overall Study|Withdrawal by Subject|8|||
147056097|NCT03817190|530366653|FG000|Overall Study|Lost to Follow-up|11|||
147056098|NCT03817190|530366654|FG001|Overall Study|Lost to Follow-up|7|||
147056099|NCT03817190|530366653|FG000|Overall Study|Lack of Efficacy|7|||
147056100|NCT03817190|530366654|FG001|Overall Study|Lack of Efficacy|5|||
147056101|NCT03817190|530366653|FG000|Overall Study|Investigator Decision|5|||
147056102|NCT03817190|530366654|FG001|Overall Study|Investigator Decision|1|||
147056103|NCT03817190|530366653|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
147056104|NCT03817190|530366654|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
147056105|NCT03817190|530366653|FG000|Overall Study|Lack of Contact|1|||
147056106|NCT03817190|530366654|FG001|Overall Study|Lack of Contact|0|||
147056107|NCT03817190|530366653|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
147056108|NCT03817190|530366654|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
147056109|NCT05514873|530366655|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
147056110|NCT05514873|530366655|FG000|Main Treatment Period|Adverse Event|2|||
147056111|NCT05514873|530366655|FG000|Extension Treatment Period|Lost to Follow-up|3|||
147056112|NCT03525678|530366656|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
147056113|NCT03525678|530366657|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
147056114|NCT03525678|530366658|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
147056115|NCT03525678|530366659|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
147056116|NCT03525678|530366660|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
147056117|NCT03525678|530366656|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
147056118|NCT03525678|530366657|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
147056119|NCT03525678|530366658|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
147056120|NCT03525678|530366659|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
147056121|NCT03525678|530366660|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
147056122|NCT03525678|530366656|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
147056123|NCT03525678|530366657|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
147056124|NCT03525678|530366658|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
147056125|NCT03525678|530366659|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
147056126|NCT03525678|530366660|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
147056127|NCT03525678|530366656|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
147056128|NCT03525678|530366657|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
147056129|NCT03525678|530366658|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
147056130|NCT03525678|530366659|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
147056131|NCT03525678|530366660|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
147056132|NCT03525678|530366656|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
147056133|NCT03525678|530366657|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
147056134|NCT03525678|530366658|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
147056135|NCT03525678|530366659|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
147056136|NCT03525678|530366660|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
147056137|NCT03525678|530366656|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
147056138|NCT03525678|530366657|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
147056139|NCT03525678|530366658|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
147056140|NCT03525678|530366659|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
147056141|NCT03525678|530366660|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
147056142|NCT03055338|530367761|FG000|Overall Study|Lost to Follow-up|9|||
147056143|NCT03055338|530367762|FG001|Overall Study|Lost to Follow-up|2|||
147056144|NCT03055338|530367763|FG002|Overall Study|Lost to Follow-up|3|||
147056145|NCT03055338|530367761|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
147056146|NCT03055338|530367762|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
147056147|NCT03055338|530367763|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
147056148|NCT03055338|530367761|FG000|Overall Study|Physician Decision|0|||
147056149|NCT03055338|530367762|FG001|Overall Study|Physician Decision|0|||
147056150|NCT03055338|530367763|FG002|Overall Study|Physician Decision|2|||
147056151|NCT03055338|530367761|FG000|Overall Study|Withdrawal by Subject|9|||
147056152|NCT03055338|530367762|FG001|Overall Study|Withdrawal by Subject|8|||
147056153|NCT03055338|530367763|FG002|Overall Study|Withdrawal by Subject|7|||
147056154|NCT00824772|530367764|FG000|Overall Study|Withdrawal by Subject|8|||
147056155|NCT02955355|530367768|FG000|Overall Study|Adverse Event|4|||
147056156|NCT02955355|530367768|FG000|Overall Study|Death|1|||
147056157|NCT02955355|530367768|FG000|Overall Study|Physician Decision|21|||
147056158|NCT02955355|530367768|FG000|Overall Study|Site Terminated by Sponsor|35|||
147056159|NCT02955355|530367768|FG000|Overall Study|Withdrawal by Subject|19|||
147056160|NCT02955355|530367768|FG000|Overall Study|Reason Not Specified|5|||
147056161|NCT01379768|530367771|FG000|Overall Study|Adverse Event|1|||
147056162|NCT01379768|530367772|FG001|Overall Study|Adverse Event|1|||
147056163|NCT01379768|530367773|FG002|Overall Study|Adverse Event|0|||
147056164|NCT01379768|530367771|FG000|Overall Study|Lost to Follow-up|2|||
147056165|NCT01379768|530367772|FG001|Overall Study|Lost to Follow-up|0|||
147056166|NCT01379768|530367773|FG002|Overall Study|Lost to Follow-up|0|||
147056167|NCT02075203|530367778|FG000|Overall Study|Withdrawal by Subject|1|||
147056168|NCT02075203|530367779|FG001|Overall Study|Withdrawal by Subject|0|||
147056169|NCT02075203|530367780|FG002|Overall Study|Withdrawal by Subject|1|||
147056170|NCT02075203|530367778|FG000|Overall Study|Adverse Event|1|||
147056171|NCT02075203|530367779|FG001|Overall Study|Adverse Event|0|||
147056172|NCT02075203|530367780|FG002|Overall Study|Adverse Event|0|||
147056173|NCT02075203|530367778|FG000|Overall Study|participant refused to use contraception|1|||
147056174|NCT02075203|530367779|FG001|Overall Study|participant refused to use contraception|0|||
147056175|NCT02075203|530367780|FG002|Overall Study|participant refused to use contraception|0|||
147056176|NCT00568451|530367789|FG000|Overall Study|Disease Progression|0|||
147056177|NCT00568451|530367790|FG001|Overall Study|Disease Progression|0|||
147056178|NCT00568451|530367791|FG002|Overall Study|Disease Progression|2|||
147056179|NCT00568451|530367792|FG003|Overall Study|Disease Progression|7|||
147056180|NCT05266053|530367793|FG000|Overall Study|Withdrawal by Subject|8|||
147056181|NCT05266053|530367794|FG001|Overall Study|Withdrawal by Subject|4|||
147056182|NCT05344560|530367795|FG000|Period 1|Subject out of visit window|1|||
147056183|NCT05344560|530367796|FG001|Period 1|Subject out of visit window|1|||
147056184|NCT05344560|530367795|FG000|Period 2|Covid-19 Related|1|||
147056185|NCT05344560|530367796|FG001|Period 2|Covid-19 Related|0|||
147056186|NCT05344560|530367795|FG000|Period 2|Adverse Event|1|||
147056187|NCT05344560|530367796|FG001|Period 2|Adverse Event|0|||
147056188|NCT05344560|530367795|FG000|Period 2|Subject out of visit window|1|||
147056189|NCT05344560|530367796|FG001|Period 2|Subject out of visit window|1|||
147056190|NCT05344560|530367795|FG000|Period 3|Subject out of visit window|1|||
147056191|NCT05344560|530367796|FG001|Period 3|Subject out of visit window|0|||
147056192|NCT02996968|530367797|FG000|Overall Study|Withdrawal by Subject|1|||
147056193|NCT02996968|530367798|FG001|Overall Study|Withdrawal by Subject|0|||
147056194|NCT03817853|530367799|FG000|Induction Phase|Adverse Event|5|||
147056195|NCT03817853|530367800|FG001|Induction Phase|Adverse Event|0|||
147056196|NCT03817853|530367801|FG002|Induction Phase|Adverse Event|0|||
147056197|NCT03817853|530367799|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
147056198|NCT03817853|530367800|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
147056199|NCT03817853|530367801|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
147056200|NCT03817853|530367799|FG000|Induction Phase|Physician Decision|2|||
147056201|NCT03817853|530367800|FG001|Induction Phase|Physician Decision|0|||
147056202|NCT03817853|530367801|FG002|Induction Phase|Physician Decision|0|||
147056203|NCT03817853|530367799|FG000|Induction Phase|Progressive Disease|6|||
147056204|NCT03817853|530367800|FG001|Induction Phase|Progressive Disease|0|||
147056205|NCT03817853|530367801|FG002|Induction Phase|Progressive Disease|0|||
147056206|NCT03817853|530367799|FG000|Induction Phase|Withdrawal by Subject|4|||
147056207|NCT03817853|530367800|FG001|Induction Phase|Withdrawal by Subject|0|||
147056208|NCT03817853|530367801|FG002|Induction Phase|Withdrawal by Subject|0|||
147056209|NCT03817853|530367799|FG000|Maintenance Phase|Adverse Event|0|||
147056210|NCT03817853|530367800|FG001|Maintenance Phase|Adverse Event|8|||
147056211|NCT03817853|530367801|FG002|Maintenance Phase|Adverse Event|0|||
147056212|NCT03817853|530367799|FG000|Maintenance Phase|Death|0|||
147056213|NCT03817853|530367800|FG001|Maintenance Phase|Death|5|||
147056214|NCT03817853|530367801|FG002|Maintenance Phase|Death|0|||
147056215|NCT03817853|530367799|FG000|Maintenance Phase|Progressive Disease|0|||
147056216|NCT03817853|530367800|FG001|Maintenance Phase|Progressive Disease|7|||
147056217|NCT03817853|530367801|FG002|Maintenance Phase|Progressive Disease|0|||
147056218|NCT03817853|530367799|FG000|Maintenance Phase|Withdrawal by Subject|0|||
147056219|NCT03817853|530367800|FG001|Maintenance Phase|Withdrawal by Subject|2|||
147056220|NCT03817853|530367801|FG002|Maintenance Phase|Withdrawal by Subject|0|||
147056221|NCT03817853|530367799|FG000|Maintenance Phase|Physician Decision|0|||
147056222|NCT03817853|530367800|FG001|Maintenance Phase|Physician Decision|1|||
147056223|NCT03817853|530367801|FG002|Maintenance Phase|Physician Decision|0|||
147056224|NCT03817853|530367799|FG000|Maintenance Phase|Various reasons|0|||
147056225|NCT03817853|530367800|FG001|Maintenance Phase|Various reasons|4|||
147056226|NCT03817853|530367801|FG002|Maintenance Phase|Various reasons|0|||
147056227|NCT03817853|530367799|FG000|Maintenance Phase|Protocol Deviation|0|||
147056228|NCT03817853|530367800|FG001|Maintenance Phase|Protocol Deviation|1|||
147056229|NCT03817853|530367801|FG002|Maintenance Phase|Protocol Deviation|0|||
147056230|NCT03817853|530367799|FG000|Follow-up Phase|Adverse Event|0|||
147056231|NCT03817853|530367800|FG001|Follow-up Phase|Adverse Event|0|||
147056232|NCT03817853|530367801|FG002|Follow-up Phase|Adverse Event|2|||
147056233|NCT03817853|530367799|FG000|Follow-up Phase|Death|0|||
147056234|NCT03817853|530367800|FG001|Follow-up Phase|Death|0|||
147056235|NCT03817853|530367801|FG002|Follow-up Phase|Death|1|||
147056236|NCT03817853|530367799|FG000|Follow-up Phase|Progressive Disease|0|||
147056237|NCT03817853|530367800|FG001|Follow-up Phase|Progressive Disease|0|||
147056238|NCT03817853|530367801|FG002|Follow-up Phase|Progressive Disease|3|||
147056239|NCT03817853|530367799|FG000|Follow-up Phase|Withdrawal by Subject|0|||
147056240|NCT03817853|530367800|FG001|Follow-up Phase|Withdrawal by Subject|0|||
147056241|NCT03817853|530367801|FG002|Follow-up Phase|Withdrawal by Subject|1|||
147056242|NCT00391768|530367802|FG000|Overall Study|Withdrawal by Subject|0|||
147056243|NCT00391768|530367803|FG001|Overall Study|Withdrawal by Subject|0|||
147056244|NCT00391768|530367804|FG002|Overall Study|Withdrawal by Subject|1|||
147056245|NCT00391768|530367805|FG003|Overall Study|Withdrawal by Subject|0|||
147056246|NCT00391768|530367806|FG004|Overall Study|Withdrawal by Subject|0|||
147056247|NCT00391768|530367807|FG005|Overall Study|Withdrawal by Subject|1|||
147056248|NCT00391768|530367808|FG006|Overall Study|Withdrawal by Subject|1|||
147056249|NCT00391768|530367802|FG000|Overall Study|Lost to Follow-up|0|||
147056250|NCT00391768|530367803|FG001|Overall Study|Lost to Follow-up|0|||
147056251|NCT00391768|530367804|FG002|Overall Study|Lost to Follow-up|0|||
147056252|NCT00391768|530367805|FG003|Overall Study|Lost to Follow-up|1|||
147056253|NCT00391768|530367806|FG004|Overall Study|Lost to Follow-up|2|||
147056254|NCT00391768|530367807|FG005|Overall Study|Lost to Follow-up|2|||
147056255|NCT00391768|530367808|FG006|Overall Study|Lost to Follow-up|3|||
147056256|NCT01620138|530367809|FG000|Overall Study|Withdrawal by Subject|3|||
147056257|NCT01620138|530367810|FG001|Overall Study|Withdrawal by Subject|0|||
147056258|NCT01620138|530367809|FG000|Overall Study|Lack of Efficacy|1|||
147056259|NCT01620138|530367810|FG001|Overall Study|Lack of Efficacy|0|||
147056260|NCT01620138|530367809|FG000|Overall Study|Adverse Event|2|||
147056261|NCT01620138|530367810|FG001|Overall Study|Adverse Event|0|||
147056262|NCT05005507|530367813|FG000|Overall Study|Premature termination of study|1|||
147056263|NCT02556775|530367815|FG000|Overall Study|Withdrawal by Subject|1|||
147056264|NCT02556775|530367816|FG001|Overall Study|Withdrawal by Subject|0|||
147056265|NCT02556775|530367817|FG002|Overall Study|Withdrawal by Subject|1|||
147056266|NCT02556775|530367818|FG003|Overall Study|Withdrawal by Subject|0|||
147056267|NCT02556775|530367815|FG000|Overall Study|Lost to Follow-up|1|||
147056268|NCT02556775|530367816|FG001|Overall Study|Lost to Follow-up|0|||
147056269|NCT02556775|530367817|FG002|Overall Study|Lost to Follow-up|0|||
147056270|NCT02556775|530367818|FG003|Overall Study|Lost to Follow-up|0|||
147056271|NCT02792062|530367821|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
147056272|NCT02792062|530367822|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
147056273|NCT02792062|530367823|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
147056274|NCT02792062|530367824|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
147056275|NCT02792062|530367825|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
147056276|NCT02792062|530367826|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
147056277|NCT01464424|530367831|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
147056278|NCT01464424|530367832|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
147056279|NCT02022202|530367833|FG000|Overall Study|Withdrawal by Subject|2|||
147056280|NCT02022202|530367833|FG000|Overall Study|Disease Progression|3|||
147056281|NCT02022202|530367833|FG000|Overall Study|Desire go to immediately to surgery|3|||
147056282|NCT04390763|530367835|FG000|Safety run-in Part|Adverse Event|4|||
147056283|NCT04390763|530367836|FG001|Safety run-in Part|Adverse Event|0|||
147056284|NCT04390763|530367837|FG002|Safety run-in Part|Adverse Event|0|||
147056285|NCT04390763|530367838|FG003|Safety run-in Part|Adverse Event|0|||
147056286|NCT04390763|530367835|FG000|Safety run-in Part|Physician Decision|1|||
147056287|NCT04390763|530367836|FG001|Safety run-in Part|Physician Decision|0|||
147056288|NCT04390763|530367837|FG002|Safety run-in Part|Physician Decision|0|||
147056289|NCT04390763|530367838|FG003|Safety run-in Part|Physician Decision|0|||
147056290|NCT04390763|530367835|FG000|Safety run-in Part|Progressive Disease|6|||
147056291|NCT04390763|530367836|FG001|Safety run-in Part|Progressive Disease|0|||
147056292|NCT04390763|530367837|FG002|Safety run-in Part|Progressive Disease|0|||
147056293|NCT04390763|530367838|FG003|Safety run-in Part|Progressive Disease|0|||
147056294|NCT04390763|530367835|FG000|Randomized Part|Adverse Event|0|||
147056295|NCT04390763|530367836|FG001|Randomized Part|Adverse Event|11|||
147056296|NCT04390763|530367837|FG002|Randomized Part|Adverse Event|5|||
147056297|NCT04390763|530367838|FG003|Randomized Part|Adverse Event|5|||
147056298|NCT04390763|530367835|FG000|Randomized Part|Death|0|||
147056299|NCT04390763|530367836|FG001|Randomized Part|Death|3|||
147056300|NCT04390763|530367837|FG002|Randomized Part|Death|4|||
147056301|NCT04390763|530367838|FG003|Randomized Part|Death|2|||
147056302|NCT04390763|530367835|FG000|Randomized Part|Physician Decision|0|||
147056303|NCT04390763|530367836|FG001|Randomized Part|Physician Decision|2|||
147056304|NCT04390763|530367837|FG002|Randomized Part|Physician Decision|2|||
147056305|NCT04390763|530367838|FG003|Randomized Part|Physician Decision|9|||
147056306|NCT04390763|530367835|FG000|Randomized Part|Progressive Disease|0|||
147056307|NCT04390763|530367836|FG001|Randomized Part|Progressive Disease|24|||
147056308|NCT04390763|530367837|FG002|Randomized Part|Progressive Disease|31|||
147056309|NCT04390763|530367838|FG003|Randomized Part|Progressive Disease|23|||
147056310|NCT04390763|530367835|FG000|Randomized Part|Study terminated by sponsor|0|||
147056311|NCT04390763|530367836|FG001|Randomized Part|Study terminated by sponsor|1|||
147056312|NCT04390763|530367837|FG002|Randomized Part|Study terminated by sponsor|0|||
147056313|NCT04390763|530367838|FG003|Randomized Part|Study terminated by sponsor|0|||
147056314|NCT04390763|530367835|FG000|Randomized Part|Participant Decision|0|||
147056315|NCT04390763|530367836|FG001|Randomized Part|Participant Decision|5|||
147056316|NCT04390763|530367837|FG002|Randomized Part|Participant Decision|7|||
147056317|NCT04390763|530367838|FG003|Randomized Part|Participant Decision|6|||
147056318|NCT04390763|530367835|FG000|Randomized Part|Not treated|0|||
147056319|NCT04390763|530367836|FG001|Randomized Part|Not treated|4|||
147056320|NCT04390763|530367837|FG002|Randomized Part|Not treated|2|||
147056321|NCT04390763|530367838|FG003|Randomized Part|Not treated|7|||
147056322|NCT04340843|530367839|FG000|Overall Study|Adverse Event|0|||
147056323|NCT04340843|530367840|FG001|Overall Study|Adverse Event|2|||
147056324|NCT04340843|530367839|FG000|Overall Study|Withdrawal by Subject|0|||
147056325|NCT04340843|530367840|FG001|Overall Study|Withdrawal by Subject|2|||
147056326|NCT01956773|530367845|FG000|Overall Study|Lost to Follow-up|628|||
147056327|NCT01956773|530367846|FG001|Overall Study|Lost to Follow-up|1|||
147056328|NCT01383174|530367847|FG000|3 Month Assessment|Death|0|||
147056329|NCT01383174|530367848|FG001|3 Month Assessment|Death|1|||
147056330|NCT01383174|530367847|FG000|3 Month Assessment|Lost to Follow-up|2|||
147056331|NCT01383174|530367848|FG001|3 Month Assessment|Lost to Follow-up|0|||
147056332|NCT01383174|530367847|FG000|3 Month Assessment|Refused to complete|4|||
147056333|NCT01383174|530367848|FG001|3 Month Assessment|Refused to complete|0|||
147056334|NCT01383174|530367847|FG000|6 Month Assessment|Lost to Follow-up|1|||
147056335|NCT01383174|530367848|FG001|6 Month Assessment|Lost to Follow-up|1|||
147056336|NCT01383174|530367847|FG000|6 Month Assessment|Refused to complete|4|||
147056337|NCT01383174|530367848|FG001|6 Month Assessment|Refused to complete|0|||
147056338|NCT01153815|530367849|FG000|Overall Study|Adverse Event|3|||
147056339|NCT01153815|530367850|FG001|Overall Study|Adverse Event|1|||
147056340|NCT01153815|530367849|FG000|Overall Study|Withdrawal by Subject|6|||
147056341|NCT01153815|530367850|FG001|Overall Study|Withdrawal by Subject|4|||
147056342|NCT01786993|530367853|FG000|Overall Study|Death|6|||
147056343|NCT01786993|530367854|FG001|Overall Study|Death|7|||
147056344|NCT01786993|530367853|FG000|Overall Study|Withdrawal by Subject|3|||
147056345|NCT01786993|530367854|FG001|Overall Study|Withdrawal by Subject|2|||
147056346|NCT01786993|530367853|FG000|Overall Study|Lost to Follow-up|0|||
147056347|NCT01786993|530367854|FG001|Overall Study|Lost to Follow-up|1|||
147056348|NCT01786993|530367853|FG000|Overall Study|Subject Non-Compliance|1|||
147056349|NCT01786993|530367854|FG001|Overall Study|Subject Non-Compliance|0|||
147056350|NCT01786993|530367853|FG000|Overall Study|System Explant|1|||
147056351|NCT01786993|530367854|FG001|Overall Study|System Explant|0|||
147056352|NCT01786993|530367853|FG000|Overall Study|Hospice Admission|1|||
147056353|NCT01786993|530367854|FG001|Overall Study|Hospice Admission|0|||
147056354|NCT00450437|530367855|FG000|Overall Study|Withdrawal by Subject|10|||
147056355|NCT00450437|530367856|FG001|Overall Study|Withdrawal by Subject|2|||
147056356|NCT00450437|530367857|FG002|Overall Study|Withdrawal by Subject|0|||
147056357|NCT00450437|530367858|FG003|Overall Study|Withdrawal by Subject|1|||
147056358|NCT00450437|530367855|FG000|Overall Study|Lost to Follow-up|31|||
147056359|NCT00450437|530367856|FG001|Overall Study|Lost to Follow-up|12|||
147056360|NCT00450437|530367857|FG002|Overall Study|Lost to Follow-up|19|||
147056361|NCT00450437|530367858|FG003|Overall Study|Lost to Follow-up|9|||
147056362|NCT00450437|530367855|FG000|Overall Study|Protocol Violation|0|||
147056363|NCT00450437|530367856|FG001|Overall Study|Protocol Violation|1|||
147056364|NCT00450437|530367857|FG002|Overall Study|Protocol Violation|0|||
147056365|NCT00450437|530367858|FG003|Overall Study|Protocol Violation|1|||
147056366|NCT00450437|530367855|FG000|Overall Study|Inappropriate enrollment|4|||
147056367|NCT00450437|530367856|FG001|Overall Study|Inappropriate enrollment|1|||
147056368|NCT00450437|530367857|FG002|Overall Study|Inappropriate enrollment|3|||
147056369|NCT00450437|530367858|FG003|Overall Study|Inappropriate enrollment|0|||
147056370|NCT00450437|530367855|FG000|Overall Study|Administrative reason|0|||
147056371|NCT00450437|530367856|FG001|Overall Study|Administrative reason|0|||
147056372|NCT00450437|530367857|FG002|Overall Study|Administrative reason|1|||
147056373|NCT00450437|530367858|FG003|Overall Study|Administrative reason|0|||
147056374|NCT00450437|530367855|FG000|Overall Study|Unable to Classify|1|||
147056375|NCT00450437|530367856|FG001|Overall Study|Unable to Classify|0|||
147056376|NCT00450437|530367857|FG002|Overall Study|Unable to Classify|1|||
147056377|NCT00450437|530367858|FG003|Overall Study|Unable to Classify|0|||
147056378|NCT02040805|530367859|FG000|Overall Study|Lost to Follow-up|14|||
147056379|NCT02040805|530367860|FG001|Overall Study|Lost to Follow-up|9|||
147056380|NCT02040805|530367859|FG000|Overall Study|Withdrawal by Subject|28|||
147056381|NCT02040805|530367860|FG001|Overall Study|Withdrawal by Subject|41|||
147056382|NCT03591874|530367861|FG000|Overall Study|Adverse Event|4|||
147056383|NCT03591874|530367862|FG001|Overall Study|Adverse Event|0|||
147056384|NCT03591874|530367861|FG000|Overall Study|Withdrawal by Subject|2|||
147056385|NCT03591874|530367862|FG001|Overall Study|Withdrawal by Subject|1|||
147056386|NCT03591874|530367861|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
147056387|NCT03591874|530367862|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
147056388|NCT03591874|530367861|FG000|Overall Study|On Study at Time of Study Termination|12|||
147056389|NCT03591874|530367862|FG001|Overall Study|On Study at Time of Study Termination|6|||
147056390|NCT00071110|530367863|FG000|Overall Study|Protocol Violation|0|||
147056391|NCT00071110|530367864|FG001|Overall Study|Protocol Violation|4|||
147056392|NCT00503698|530367868|FG000|Overall Study|Protocol Violation|5|||
147056393|NCT00503698|530367869|FG001|Overall Study|Protocol Violation|6|||
147056394|NCT00503698|530367868|FG000|Overall Study|Adverse Event|52|||
147056395|NCT00503698|530367869|FG001|Overall Study|Adverse Event|41|||
147056396|NCT00503698|530367868|FG000|Overall Study|Death|1|||
147056397|NCT00503698|530367869|FG001|Overall Study|Death|0|||
147056398|NCT00503698|530367868|FG000|Overall Study|Lack of Efficacy|3|||
147056399|NCT00503698|530367869|FG001|Overall Study|Lack of Efficacy|4|||
147056400|NCT00503698|530367868|FG000|Overall Study|Trial terminated|216|||
147056401|NCT00503698|530367869|FG001|Overall Study|Trial terminated|253|||
147056402|NCT00503698|530367868|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
147056403|NCT00503698|530367869|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
147056404|NCT00503698|530367868|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
147056405|NCT00503698|530367869|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
147056406|NCT00503698|530367868|FG000|Overall Study|Any condition in exclusion criteria|4|||
147056407|NCT00503698|530367869|FG001|Overall Study|Any condition in exclusion criteria|6|||
147056408|NCT00503698|530367868|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
147056409|NCT00503698|530367869|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
147056410|NCT00503698|530367868|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
147056411|NCT00503698|530367869|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
147056412|NCT00503698|530367868|FG000|Overall Study|Critically ill|2|||
147056413|NCT00503698|530367869|FG001|Overall Study|Critically ill|0|||
147056414|NCT00503698|530367868|FG000|Overall Study|Unclassified|48|||
147056415|NCT00503698|530367869|FG001|Overall Study|Unclassified|32|||
147056416|NCT00503698|530367868|FG000|Overall Study|Not exposed to trial drug|11|||
147056417|NCT00503698|530367869|FG001|Overall Study|Not exposed to trial drug|6|||
147056418|NCT03194542|530367871|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
147056419|NCT03194542|530367872|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
147056420|NCT03194542|530367873|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
147056421|NCT03194542|530367874|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
147056422|NCT03194542|530367871|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
147056423|NCT03194542|530367872|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
147056424|NCT03194542|530367873|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
147056425|NCT03194542|530367874|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
147056426|NCT03194542|530367871|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
147056427|NCT03194542|530367872|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
147056428|NCT03194542|530367873|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
147056429|NCT03194542|530367874|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
147056430|NCT03194542|530367871|FG000|Overall Study|Loss of Response|4|||
147056431|NCT03194542|530367872|FG001|Overall Study|Loss of Response|2|||
147056432|NCT03194542|530367873|FG002|Overall Study|Loss of Response|3|||
147056433|NCT03194542|530367874|FG003|Overall Study|Loss of Response|4|||
147056434|NCT03194542|530367871|FG000|Overall Study|Physician Decision|0|||
147056435|NCT03194542|530367872|FG001|Overall Study|Physician Decision|1|||
147056436|NCT03194542|530367873|FG002|Overall Study|Physician Decision|0|||
147056437|NCT03194542|530367874|FG003|Overall Study|Physician Decision|0|||
147056438|NCT03194542|530367871|FG000|Overall Study|Lack of Efficacy|2|||
147056439|NCT03194542|530367872|FG001|Overall Study|Lack of Efficacy|2|||
147056440|NCT03194542|530367873|FG002|Overall Study|Lack of Efficacy|2|||
147056441|NCT03194542|530367874|FG003|Overall Study|Lack of Efficacy|6|||
147056442|NCT03194542|530367871|FG000|Overall Study|Withdrawal by Subject|2|||
147056443|NCT03194542|530367872|FG001|Overall Study|Withdrawal by Subject|1|||
147056444|NCT03194542|530367873|FG002|Overall Study|Withdrawal by Subject|5|||
147056445|NCT03194542|530367874|FG003|Overall Study|Withdrawal by Subject|4|||
147056446|NCT03194542|530367871|FG000|Overall Study|Progressive Disease|1|||
147056447|NCT03194542|530367872|FG001|Overall Study|Progressive Disease|0|||
147056448|NCT03194542|530367873|FG002|Overall Study|Progressive Disease|1|||
147056449|NCT03194542|530367874|FG003|Overall Study|Progressive Disease|1|||
147056450|NCT03194542|530367871|FG000|Overall Study|Adverse Event|1|||
147056451|NCT03194542|530367872|FG001|Overall Study|Adverse Event|2|||
147056452|NCT03194542|530367873|FG002|Overall Study|Adverse Event|0|||
147056453|NCT03194542|530367874|FG003|Overall Study|Adverse Event|5|||
147056454|NCT03194542|530367871|FG000|Overall Study|Death|1|||
147056455|NCT03194542|530367872|FG001|Overall Study|Death|2|||
147056456|NCT03194542|530367873|FG002|Overall Study|Death|0|||
147056457|NCT03194542|530367874|FG003|Overall Study|Death|5|||
147056458|NCT03194542|530367871|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
147056459|NCT03194542|530367872|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
147056460|NCT03194542|530367873|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
147056461|NCT03194542|530367874|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
147056462|NCT03655405|530367875|FG000|Overall Study|Death after initial data collection|4|||
147056463|NCT03655405|530367876|FG001|Overall Study|Death after initial data collection|2|||
147056464|NCT03655405|530367875|FG000|Overall Study|Died before initial data collection|1|||
147056465|NCT03655405|530367876|FG001|Overall Study|Died before initial data collection|2|||
147056466|NCT03655405|530367875|FG000|Overall Study|Protocol Violation|0|||
147056467|NCT03655405|530367876|FG001|Overall Study|Protocol Violation|1|||
147056468|NCT00030901|530367877|FG000|Initial Registration|Ineligible|167|||
147056469|NCT00030901|530367878|FG001|Initial Registration|Ineligible|0|||
147056470|NCT00030901|530367879|FG002|Initial Registration|Ineligible|0|||
147056471|NCT00030901|530367877|FG000|Randomization|Adverse Event|0|||
147056472|NCT00030901|530367878|FG001|Randomization|Adverse Event|11|||
147056473|NCT00030901|530367879|FG002|Randomization|Adverse Event|7|||
147056474|NCT00030901|530367877|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
147056475|NCT00030901|530367878|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
147056476|NCT00030901|530367879|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
147056477|NCT00030901|530367877|FG000|Randomization|Progression/Relapse|0|||
147056478|NCT00030901|530367878|FG001|Randomization|Progression/Relapse|22|||
147056479|NCT00030901|530367879|FG002|Randomization|Progression/Relapse|21|||
147056480|NCT00030901|530367877|FG000|Randomization|Death|0|||
147056481|NCT00030901|530367878|FG001|Randomization|Death|1|||
147056482|NCT00030901|530367879|FG002|Randomization|Death|3|||
147056483|NCT00030901|530367877|FG000|Randomization|Other|0|||
147056484|NCT00030901|530367878|FG001|Randomization|Other|36|||
147056485|NCT00030901|530367879|FG002|Randomization|Other|33|||
147056486|NCT00030901|530367877|FG000|Randomization|Ineligible|0|||
147056487|NCT00030901|530367878|FG001|Randomization|Ineligible|15|||
147056488|NCT00030901|530367879|FG002|Randomization|Ineligible|14|||
147056489|NCT01806051|530367880|FG000|Overall Study|Withdrawal by Subject|6|||
147056490|NCT02576847|530367881|FG000|Overall Study|Adverse Event|27|||
147056491|NCT02576847|530367881|FG000|Overall Study|Lost to Follow-up|22|||
147056492|NCT02576847|530367881|FG000|Overall Study|Physician Decision|1|||
147056493|NCT02576847|530367881|FG000|Overall Study|Pregnancy|1|||
147056494|NCT02576847|530367881|FG000|Overall Study|Protocol Violation|3|||
147056495|NCT02576847|530367881|FG000|Overall Study|Withdrawal by Subject|78|||
147056496|NCT02576847|530367881|FG000|Overall Study|Other|5|||
147056497|NCT04955691|530369612|FG000|Period 2|Discontinued intervention|1|||
147056498|NCT04955691|530369613|FG001|Period 2|Discontinued intervention|2|||
147056499|NCT05795153|530369614|FG000|Overall Study|Adverse Event|2|||
147056500|NCT05795153|530369614|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147056501|NCT05795153|530369614|FG000|Overall Study|Lost to Follow-up|1|||
147056502|NCT05795153|530369614|FG000|Overall Study|Subject decision|2|||
147056503|NCT03760744|530369615|FG000|Overall Study|Lost to Follow-up|3|||
147056504|NCT03760744|530369616|FG001|Overall Study|Lost to Follow-up|0|||
147056505|NCT03668119|530369617|FG000|Pre-treatment|Disease Progression|1|||
147056506|NCT03668119|530369618|FG001|Pre-treatment|Disease Progression|0|||
147056507|NCT03668119|530369617|FG000|Treatment|Disease Progression|76|||
147056508|NCT03668119|530369618|FG001|Treatment|Disease Progression|57|||
147056509|NCT03668119|530369617|FG000|Treatment|Study drug toxicity|19|||
147056510|NCT03668119|530369618|FG001|Treatment|Study drug toxicity|1|||
147056511|NCT03668119|530369617|FG000|Treatment|Death|3|||
147056512|NCT03668119|530369618|FG001|Treatment|Death|0|||
147056513|NCT03668119|530369617|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
147056514|NCT03668119|530369618|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
147056515|NCT03668119|530369617|FG000|Treatment|Withdrawal by Subject|1|||
147056516|NCT03668119|530369618|FG001|Treatment|Withdrawal by Subject|1|||
147056517|NCT03668119|530369617|FG000|Treatment|Participant request to discontinue study treatment|3|||
147056518|NCT03668119|530369618|FG001|Treatment|Participant request to discontinue study treatment|1|||
147056519|NCT03668119|530369617|FG000|Treatment|Maximum Clinical Benefit|0|||
147056520|NCT03668119|530369618|FG001|Treatment|Maximum Clinical Benefit|1|||
147056521|NCT03668119|530369617|FG000|Treatment|Participants completed treatment|27|||
147056522|NCT03668119|530369618|FG001|Treatment|Participants completed treatment|11|||
147056523|NCT03668119|530369617|FG000|Treatment|Other reasons|2|||
147056524|NCT03668119|530369618|FG001|Treatment|Other reasons|1|||
147056525|NCT01068678|530369627|FG000|Overall Study|Lack of Efficacy|3|||
147056526|NCT01068678|530369628|FG001|Overall Study|Lack of Efficacy|2|||
147056527|NCT01068678|530369627|FG000|Overall Study|Protocol Violation|5|||
147056528|NCT01068678|530369628|FG001|Overall Study|Protocol Violation|1|||
147056529|NCT01068678|530369627|FG000|Overall Study|Withdrawal criteria|12|||
147056530|NCT01068678|530369628|FG001|Overall Study|Withdrawal criteria|6|||
147056531|NCT01068678|530369627|FG000|Overall Study|Unclassified|18|||
147056532|NCT01068678|530369628|FG001|Overall Study|Unclassified|15|||
147056533|NCT03058705|530369633|FG000|Overall Study|Withdrawal by Subject|2|||
147056534|NCT03058705|530369633|FG000|Overall Study|Physician Decision|2|||
147056535|NCT05468164|530369645|FG000|Treatment Period 4|Adverse Event|0|||
147056536|NCT05468164|530369646|FG001|Treatment Period 4|Adverse Event|0|||
147056537|NCT05468164|530369647|FG002|Treatment Period 4|Adverse Event|0|||
147056538|NCT05468164|530369648|FG003|Treatment Period 4|Adverse Event|1|||
147056539|NCT03827291|530369649|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
147056540|NCT03827291|530369650|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
147056541|NCT04795466|530369651|FG000|Overall Study|Adverse Event|3|||
147056542|NCT04795466|530369652|FG001|Overall Study|Adverse Event|1|||
147056543|NCT04795466|530369651|FG000|Overall Study|Physician Decision|1|||
147056544|NCT04795466|530369652|FG001|Overall Study|Physician Decision|0|||
147056545|NCT04795466|530369651|FG000|Overall Study|Withdrawal by Subject|2|||
147056546|NCT04795466|530369652|FG001|Overall Study|Withdrawal by Subject|1|||
147056547|NCT04652726|530369653|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
147056548|NCT04652726|530369654|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
147056549|NCT04652726|530369655|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
147056550|NCT04652726|530369653|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
147056551|NCT04652726|530369654|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
147056552|NCT04652726|530369655|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
147056553|NCT01102257|530369662|FG000|Overall Study|Adverse Event|1|||
147056554|NCT01102257|530369663|FG001|Overall Study|Adverse Event|0|||
147056555|NCT01102257|530369662|FG000|Overall Study|Adverse Event|1|||
147056556|NCT01102257|530369663|FG001|Overall Study|Adverse Event|0|||
147056557|NCT03752970|530369664|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
147056558|NCT03752970|530369665|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
147056559|NCT03752970|530369666|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
147056560|NCT03752970|530369664|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
147056561|NCT03752970|530369665|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
147056562|NCT03752970|530369666|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
147056563|NCT03752970|530369664|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
147056564|NCT03752970|530369665|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
147056565|NCT03752970|530369666|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
147056566|NCT03752970|530369664|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
147056567|NCT03752970|530369665|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
147056568|NCT03752970|530369666|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
147056569|NCT03752970|530369664|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
147056570|NCT03752970|530369665|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
147056571|NCT03752970|530369666|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
147056572|NCT03976362|530369667|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
147056573|NCT03976362|530369668|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
147056574|NCT03976362|530369669|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
147056575|NCT03976362|530369667|FG000|Induction Phase|Death|62|||
147056576|NCT03976362|530369668|FG001|Induction Phase|Death|0|||
147056577|NCT03976362|530369669|FG002|Induction Phase|Death|0|||
147056578|NCT03976362|530369667|FG000|Maintenance Phase|Participants Ongoing|0|||
147056579|NCT03976362|530369668|FG001|Maintenance Phase|Participants Ongoing|106|||
147056580|NCT03976362|530369669|FG002|Maintenance Phase|Participants Ongoing|103|||
147056581|NCT03976362|530369667|FG000|Maintenance Phase|Withdrawal by Subject|0|||
147056582|NCT03976362|530369668|FG001|Maintenance Phase|Withdrawal by Subject|4|||
147056583|NCT03976362|530369669|FG002|Maintenance Phase|Withdrawal by Subject|4|||
147056584|NCT03976362|530369667|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
147056585|NCT03976362|530369668|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
147056586|NCT03976362|530369669|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
147056587|NCT03976362|530369667|FG000|Maintenance Phase|Death|0|||
147056588|NCT03976362|530369668|FG001|Maintenance Phase|Death|186|||
147056589|NCT03976362|530369669|FG002|Maintenance Phase|Death|187|||
147056590|NCT04767282|530369670|FG000|Overall Study|Refused or did not begin surveys|6|||
147056591|NCT04767282|530369671|FG001|Overall Study|Refused or did not begin surveys|2|||
147056592|NCT04767282|530369672|FG002|Overall Study|Refused or did not begin surveys|2|||
147056593|NCT04767282|530369670|FG000|Overall Study|Duplicate household previously enrolled|2|||
147056594|NCT04767282|530369671|FG001|Overall Study|Duplicate household previously enrolled|0|||
147056595|NCT04767282|530369672|FG002|Overall Study|Duplicate household previously enrolled|8|||
147056596|NCT04767282|530369670|FG000|Overall Study|Unable to confirm legal guardian|0|||
147056597|NCT04767282|530369671|FG001|Overall Study|Unable to confirm legal guardian|2|||
147056598|NCT04767282|530369672|FG002|Overall Study|Unable to confirm legal guardian|8|||
147056599|NCT04767282|530369670|FG000|Overall Study|Withdrawal by Subject|0|||
147056600|NCT04767282|530369671|FG001|Overall Study|Withdrawal by Subject|0|||
146850063|NCT00911937|529620706|FG001|Overall Study|Adverse Event|25|||
146850064|NCT00911937|529620705|FG000|Overall Study|Lack of Efficacy|11|||
147056601|NCT04767282|530369672|FG002|Overall Study|Withdrawal by Subject|6|||
147056602|NCT04767282|530369670|FG000|Overall Study|Survey comprehension challenges|4|||
147056603|NCT04767282|530369671|FG001|Overall Study|Survey comprehension challenges|0|||
147056604|NCT04767282|530369672|FG002|Overall Study|Survey comprehension challenges|0|||
147056605|NCT02275546|530369677|FG000|Treatment Period 2|Withdrawal by Subject|2|||
147056606|NCT02275546|530369678|FG001|Treatment Period 2|Withdrawal by Subject|1|||
147056607|NCT02275546|530369677|FG000|Treatment Period 2|Protocol Violation|0|||
147056608|NCT02275546|530369678|FG001|Treatment Period 2|Protocol Violation|1|||
147056609|NCT00333983|530369679|FG000|Overall Study|Lost to Follow-up|2|||
147056610|NCT00333983|530369680|FG001|Overall Study|Lost to Follow-up|1|||
147056611|NCT00333983|530369681|FG002|Overall Study|Lost to Follow-up|0|||
147056612|NCT00333983|530369679|FG000|Overall Study|Adverse Event|1|||
147056613|NCT00333983|530369680|FG001|Overall Study|Adverse Event|1|||
147056614|NCT00333983|530369681|FG002|Overall Study|Adverse Event|1|||
147056615|NCT00333983|530369679|FG000|Overall Study|Withdrawal by Subject|0|||
147056616|NCT00333983|530369680|FG001|Overall Study|Withdrawal by Subject|3|||
147056617|NCT00333983|530369681|FG002|Overall Study|Withdrawal by Subject|1|||
147056618|NCT00449865|530369682|FG000|Overall Study|Withdrawal by Subject|110|||
147056619|NCT00449865|530369683|FG001|Overall Study|Withdrawal by Subject|110|||
147056620|NCT00449865|530369682|FG000|Overall Study|Lost to Follow-up|36|||
147056621|NCT00449865|530369683|FG001|Overall Study|Lost to Follow-up|37|||
147056622|NCT00449865|530369682|FG000|Overall Study|Physician Decision|13|||
147056623|NCT00449865|530369683|FG001|Overall Study|Physician Decision|12|||
147056624|NCT00449865|530369682|FG000|Overall Study|Death|31|||
147056625|NCT00449865|530369683|FG001|Overall Study|Death|40|||
147056626|NCT00449865|530369682|FG000|Overall Study|Protocol Violation|8|||
147056627|NCT00449865|530369683|FG001|Overall Study|Protocol Violation|7|||
147056628|NCT00449865|530369682|FG000|Overall Study|Study was stopped|324|||
147056629|NCT00449865|530369683|FG001|Overall Study|Study was stopped|328|||
147056630|NCT00406367|530369684|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
147056631|NCT00406367|530369685|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
147056632|NCT00406367|530369684|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
147056633|NCT00406367|530369685|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
147056634|NCT00406367|530369684|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
147056635|NCT00406367|530369685|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
147056636|NCT00406367|530369684|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
147056637|NCT00406367|530369685|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
147056638|NCT00406367|530369684|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
147056639|NCT00406367|530369685|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
147056640|NCT00406367|530369684|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
147056641|NCT00406367|530369685|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
147056642|NCT00406367|530369684|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
147056643|NCT00406367|530369685|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
147056644|NCT00406367|530369684|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
147056645|NCT00406367|530369685|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
147056646|NCT00406367|530369684|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
147056647|NCT00406367|530369685|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
147056648|NCT00406367|530369684|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
147056649|NCT00406367|530369685|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
147056650|NCT00406367|530369684|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
147056651|NCT00406367|530369685|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
147056652|NCT00406367|530369684|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
147056653|NCT00406367|530369685|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
147056654|NCT00171210|530369686|FG000|Overall Study|Adverse Event|16|||
147056655|NCT00171210|530369687|FG001|Overall Study|Adverse Event|27|||
147056656|NCT00171210|530369686|FG000|Overall Study|Abnormal laboratory value(s)|6|||
147056657|NCT00171210|530369687|FG001|Overall Study|Abnormal laboratory value(s)|3|||
147056658|NCT00171210|530369686|FG000|Overall Study|Abnormal test procedure result(s)|0|||
147056659|NCT00171210|530369687|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147056660|NCT00171210|530369686|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
147056661|NCT00171210|530369687|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
147056662|NCT00171210|530369686|FG000|Overall Study|Protocol Violation|0|||
147056663|NCT00171210|530369687|FG001|Overall Study|Protocol Violation|2|||
147056664|NCT00171210|530369686|FG000|Overall Study|Withdrawal by Subject|32|||
147056665|NCT00171210|530369687|FG001|Overall Study|Withdrawal by Subject|30|||
147056666|NCT00171210|530369686|FG000|Overall Study|Lost to Follow-up|1|||
147056667|NCT00171210|530369687|FG001|Overall Study|Lost to Follow-up|0|||
147056668|NCT00171210|530369686|FG000|Overall Study|Administrative problems|1|||
147056669|NCT00171210|530369687|FG001|Overall Study|Administrative problems|1|||
147056670|NCT00171210|530369686|FG000|Overall Study|Death|2|||
147056671|NCT00171210|530369687|FG001|Overall Study|Death|3|||
147056672|NCT00171210|530369686|FG000|Overall Study|Stopped at end of core|0|||
147056673|NCT00171210|530369687|FG001|Overall Study|Stopped at end of core|32|||
147056674|NCT00171210|530369686|FG000|Overall Study|Stopped at end of extension 1|0|||
147056675|NCT00171210|530369687|FG001|Overall Study|Stopped at end of extension 1|1|||
147056676|NCT03187301|530369690|FG000|Titration Period|Adverse Event|0|||
147056677|NCT03187301|530369691|FG001|Titration Period|Adverse Event|0|||
147056678|NCT03187301|530369692|FG002|Titration Period|Adverse Event|0|||
147056679|NCT03187301|530369693|FG003|Titration Period|Adverse Event|0|||
147056680|NCT03187301|530369694|FG004|Titration Period|Adverse Event|0|||
147056681|NCT03187301|530369695|FG005|Titration Period|Adverse Event|0|||
147056682|NCT03187301|530369696|FG006|Titration Period|Adverse Event|5|||
147056683|NCT03187301|530369690|FG000|Titration Period|Withdrawal by Subject|0|||
147056684|NCT03187301|530369691|FG001|Titration Period|Withdrawal by Subject|0|||
147056685|NCT03187301|530369692|FG002|Titration Period|Withdrawal by Subject|0|||
147056686|NCT03187301|530369693|FG003|Titration Period|Withdrawal by Subject|0|||
147056687|NCT03187301|530369694|FG004|Titration Period|Withdrawal by Subject|0|||
147056688|NCT03187301|530369695|FG005|Titration Period|Withdrawal by Subject|0|||
147056689|NCT03187301|530369696|FG006|Titration Period|Withdrawal by Subject|1|||
147056690|NCT03187301|530369690|FG000|Titration Period|Exclusion Criteria Met|0|||
147056691|NCT03187301|530369691|FG001|Titration Period|Exclusion Criteria Met|0|||
147056692|NCT03187301|530369692|FG002|Titration Period|Exclusion Criteria Met|0|||
147056693|NCT03187301|530369693|FG003|Titration Period|Exclusion Criteria Met|0|||
147056694|NCT03187301|530369694|FG004|Titration Period|Exclusion Criteria Met|0|||
147056695|NCT03187301|530369695|FG005|Titration Period|Exclusion Criteria Met|0|||
147056696|NCT03187301|530369696|FG006|Titration Period|Exclusion Criteria Met|1|||
147056697|NCT03187301|530369690|FG000|Pre-Intervention|Withdrawal by Subject|1|||
147056698|NCT03187301|530369691|FG001|Pre-Intervention|Withdrawal by Subject|0|||
147056699|NCT03187301|530369692|FG002|Pre-Intervention|Withdrawal by Subject|0|||
147056700|NCT03187301|530369693|FG003|Pre-Intervention|Withdrawal by Subject|0|||
147056701|NCT03187301|530369694|FG004|Pre-Intervention|Withdrawal by Subject|0|||
147056702|NCT03187301|530369695|FG005|Pre-Intervention|Withdrawal by Subject|0|||
147056703|NCT03187301|530369696|FG006|Pre-Intervention|Withdrawal by Subject|0|||
147056704|NCT03252535|530369698|FG000|Overall Study|Withdrawal by Subject|1|||
147056705|NCT03252535|530369699|FG001|Overall Study|Withdrawal by Subject|0|||
147056706|NCT03252535|530369700|FG002|Overall Study|Withdrawal by Subject|0|||
147056707|NCT03252535|530369698|FG000|Overall Study|Physician Decision|0|||
147056708|NCT03252535|530369699|FG001|Overall Study|Physician Decision|1|||
147056709|NCT03252535|530369700|FG002|Overall Study|Physician Decision|0|||
147056710|NCT03252535|530369698|FG000|Overall Study|Met discontinuation criteria|0|||
147056711|NCT03252535|530369699|FG001|Overall Study|Met discontinuation criteria|1|||
147056712|NCT03252535|530369700|FG002|Overall Study|Met discontinuation criteria|0|||
147056713|NCT00461630|530369705|FG000|Overall Study|Death|798|||
147056714|NCT00461630|530369706|FG001|Overall Study|Death|732|||
147056715|NCT00461630|530369705|FG000|Overall Study|Lost to Follow-up|108|||
147056716|NCT00461630|530369706|FG001|Overall Study|Lost to Follow-up|95|||
147056717|NCT00442897|530369710|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
147056718|NCT00442897|530369711|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
147056719|NCT00442897|530369710|FG000|Base Study (12 Week Follow-up)|Death|0|||
147056720|NCT00442897|530369711|FG001|Base Study (12 Week Follow-up)|Death|1|||
147056721|NCT00442897|530369710|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
147056722|NCT00442897|530369711|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
147056723|NCT00442897|530369710|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
147056724|NCT00442897|530369711|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
147056725|NCT00442897|530369710|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
147056726|NCT00442897|530369711|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
147056727|NCT00442897|530369710|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
147056728|NCT00442897|530369711|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
147056729|NCT00442897|530369710|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
147056730|NCT00442897|530369711|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
147056731|NCT00442897|530369710|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
147056732|NCT00442897|530369711|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
147056733|NCT04498182|530369712|FG000|Overall Study|Adverse Event|2|||
147056734|NCT04498182|530369713|FG001|Overall Study|Adverse Event|3|||
147056735|NCT04498182|530369714|FG002|Overall Study|Adverse Event|2|||
147056736|NCT04498182|530369712|FG000|Overall Study|Withdrawal of Consent|3|||
147056737|NCT04498182|530369713|FG001|Overall Study|Withdrawal of Consent|4|||
147056738|NCT04498182|530369714|FG002|Overall Study|Withdrawal of Consent|3|||
147056739|NCT04498182|530369712|FG000|Overall Study|Non-Compliant|1|||
147056740|NCT04498182|530369713|FG001|Overall Study|Non-Compliant|0|||
147056741|NCT04498182|530369714|FG002|Overall Study|Non-Compliant|1|||
147056742|NCT04498182|530369712|FG000|Overall Study|Lost to Follow-up|0|||
147056743|NCT04498182|530369713|FG001|Overall Study|Lost to Follow-up|0|||
147056744|NCT04498182|530369714|FG002|Overall Study|Lost to Follow-up|1|||
147056745|NCT04498182|530369712|FG000|Overall Study|Investigator Decision|0|||
147056746|NCT04498182|530369713|FG001|Overall Study|Investigator Decision|0|||
147056747|NCT04498182|530369714|FG002|Overall Study|Investigator Decision|1|||
147056748|NCT04498182|530369712|FG000|Overall Study|Protocol Violation|1|||
147056749|NCT04498182|530369713|FG001|Overall Study|Protocol Violation|0|||
147056750|NCT04498182|530369714|FG002|Overall Study|Protocol Violation|2|||
147056751|NCT00891020|530369718|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
147056752|NCT00891020|530369719|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
147056753|NCT00891020|530369720|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
147056754|NCT00891020|530369718|FG000|24 Week Treatment Period|Death|0|||
147056755|NCT00891020|530369719|FG001|24 Week Treatment Period|Death|2|||
147056756|NCT00891020|530369720|FG002|24 Week Treatment Period|Death|0|||
147056757|NCT00891020|530369718|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
147056758|NCT00891020|530369719|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
147056759|NCT00891020|530369720|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
147056760|NCT00891020|530369718|FG000|24 Week Treatment Period|Failure to return|4|||
147056761|NCT00891020|530369719|FG001|24 Week Treatment Period|Failure to return|5|||
147056762|NCT00891020|530369720|FG002|24 Week Treatment Period|Failure to return|5|||
147056763|NCT00891020|530369718|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
147056764|NCT00891020|530369719|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
147056765|NCT00891020|530369720|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
147056766|NCT00891020|530369718|FG000|24 Week Treatment Period|Other protocol violation|1|||
147056767|NCT00891020|530369719|FG001|24 Week Treatment Period|Other protocol violation|1|||
147056768|NCT00891020|530369720|FG002|24 Week Treatment Period|Other protocol violation|2|||
147056769|NCT00891020|530369718|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
147056770|NCT00891020|530369719|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
147056771|NCT00891020|530369720|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
147056772|NCT00891020|530369718|FG000|24 Week Treatment Period|Withdrew consent|6|||
147056773|NCT00891020|530369719|FG001|24 Week Treatment Period|Withdrew consent|3|||
147056774|NCT00891020|530369720|FG002|24 Week Treatment Period|Withdrew consent|15|||
147056775|NCT00891020|530369718|FG000|24 Week Treatment Period|Administrative/Other|5|||
147056776|NCT00891020|530369719|FG001|24 Week Treatment Period|Administrative/Other|6|||
147056777|NCT00891020|530369720|FG002|24 Week Treatment Period|Administrative/Other|1|||
147056778|NCT00891020|530369718|FG000|Long-term Extension Period|Adverse Event|1|||
147056779|NCT00891020|530369719|FG001|Long-term Extension Period|Adverse Event|11|||
147056780|NCT00891020|530369720|FG002|Long-term Extension Period|Adverse Event|10|||
147056781|NCT00891020|530369718|FG000|Long-term Extension Period|Death|0|||
147056782|NCT00891020|530369719|FG001|Long-term Extension Period|Death|0|||
147056783|NCT00891020|530369720|FG002|Long-term Extension Period|Death|1|||
147056784|NCT00891020|530369718|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
147056785|NCT00891020|530369719|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
147056786|NCT00891020|530369720|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
147056787|NCT00891020|530369718|FG000|Long-term Extension Period|Protocol Violation|0|||
147056788|NCT00891020|530369719|FG001|Long-term Extension Period|Protocol Violation|1|||
147056789|NCT00891020|530369720|FG002|Long-term Extension Period|Protocol Violation|1|||
147056790|NCT00891020|530369718|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
147056791|NCT00891020|530369719|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
147056792|NCT00891020|530369720|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
147056793|NCT00891020|530369718|FG000|Long-term Extension Period|Failure to return|0|||
147056794|NCT00891020|530369719|FG001|Long-term Extension Period|Failure to return|2|||
147056795|NCT00891020|530369720|FG002|Long-term Extension Period|Failure to return|3|||
147056796|NCT00891020|530369718|FG000|Long-term Extension Period|Administrative|1|||
147056797|NCT00891020|530369719|FG001|Long-term Extension Period|Administrative|2|||
147056798|NCT00891020|530369720|FG002|Long-term Extension Period|Administrative|2|||
147056799|NCT00320710|530369728|FG000|Overall Study|Disease progression|24|||
147056800|NCT00320710|530369729|FG001|Overall Study|Disease progression|19|||
147056801|NCT00320710|530369730|FG002|Overall Study|Disease progression|2|||
147056802|NCT00320710|530369728|FG000|Overall Study|Death|10|||
147056803|NCT00320710|530369729|FG001|Overall Study|Death|7|||
147056804|NCT00320710|530369730|FG002|Overall Study|Death|1|||
147056805|NCT00320710|530369728|FG000|Overall Study|Administrative problems|1|||
147056806|NCT00320710|530369729|FG001|Overall Study|Administrative problems|2|||
147056807|NCT00320710|530369730|FG002|Overall Study|Administrative problems|0|||
147056808|NCT00320710|530369728|FG000|Overall Study|Withdrawal by Subject|20|||
147056809|NCT00320710|530369729|FG001|Overall Study|Withdrawal by Subject|26|||
147056810|NCT00320710|530369730|FG002|Overall Study|Withdrawal by Subject|1|||
147056811|NCT00320710|530369728|FG000|Overall Study|Protocol Violation|6|||
147056812|NCT00320710|530369729|FG001|Overall Study|Protocol Violation|5|||
147056813|NCT00320710|530369730|FG002|Overall Study|Protocol Violation|0|||
147056814|NCT00320710|530369728|FG000|Overall Study|Abnormal test procedure result(s)|2|||
147056815|NCT00320710|530369729|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147056816|NCT00320710|530369730|FG002|Overall Study|Abnormal test procedure result(s)|0|||
147056817|NCT00320710|530369728|FG000|Overall Study|Abnormal laboratory value(s)|12|||
147056818|NCT00320710|530369729|FG001|Overall Study|Abnormal laboratory value(s)|3|||
147056819|NCT00320710|530369730|FG002|Overall Study|Abnormal laboratory value(s)|0|||
147056820|NCT00320710|530369728|FG000|Overall Study|Adverse Event|18|||
147056821|NCT00320710|530369729|FG001|Overall Study|Adverse Event|14|||
147056822|NCT00320710|530369730|FG002|Overall Study|Adverse Event|1|||
147056823|NCT00320710|530369728|FG000|Overall Study|Lost to Follow-up|1|||
147056824|NCT00320710|530369729|FG001|Overall Study|Lost to Follow-up|0|||
147056825|NCT00320710|530369730|FG002|Overall Study|Lost to Follow-up|0|||
147056826|NCT00506415|530369732|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
147056827|NCT00506415|530369733|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
147056828|NCT00506415|530369734|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
147056829|NCT00506415|530369735|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
147056830|NCT00506415|530369732|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
147056831|NCT00506415|530369733|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
147056832|NCT00506415|530369734|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
147056833|NCT00506415|530369735|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
147056834|NCT00506415|530369732|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
147056835|NCT00506415|530369733|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
147056836|NCT00506415|530369734|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
147056837|NCT00506415|530369735|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
147056838|NCT00506415|530369732|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
147056839|NCT00506415|530369733|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
147056840|NCT00506415|530369734|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
147056841|NCT00506415|530369735|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
147056842|NCT00506415|530369732|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
147056843|NCT00506415|530369733|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
147056844|NCT00506415|530369734|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
147056845|NCT00506415|530369735|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
147056846|NCT00506415|530369732|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
147056847|NCT00506415|530369733|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
147056848|NCT00506415|530369734|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
147056849|NCT00506415|530369735|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
147056850|NCT00506415|530369732|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
147056851|NCT00506415|530369733|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
147056852|NCT00506415|530369734|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
147056853|NCT00506415|530369735|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
147056854|NCT00506415|530369732|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
147056855|NCT00506415|530369733|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
147056856|NCT00506415|530369734|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
147056857|NCT00506415|530369735|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
147056858|NCT00506415|530369732|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
147056859|NCT00506415|530369733|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
147056860|NCT00506415|530369734|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
147056861|NCT00506415|530369735|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
147056862|NCT00506415|530369732|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
147056863|NCT00506415|530369733|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
147056864|NCT00506415|530369734|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
147056865|NCT00506415|530369735|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
147056866|NCT00506415|530369732|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
147056867|NCT00506415|530369733|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
147056868|NCT00506415|530369734|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
147056869|NCT00506415|530369735|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
147056870|NCT00506415|530369732|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
147056871|NCT00506415|530369733|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
147056872|NCT00506415|530369734|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
147056873|NCT00506415|530369735|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
147056874|NCT00506415|530369732|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
147056875|NCT00506415|530369733|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
147056876|NCT00506415|530369734|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
147056877|NCT00506415|530369735|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
147056878|NCT00506415|530369732|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
147056879|NCT00506415|530369733|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
147056880|NCT00506415|530369734|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
147056881|NCT00506415|530369735|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
147056882|NCT00506415|530369732|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
147056883|NCT00506415|530369733|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
147056884|NCT00506415|530369734|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
147056885|NCT00506415|530369735|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
147056886|NCT00506415|530369732|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
147056887|NCT00506415|530369733|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
147056888|NCT00506415|530369734|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
147056889|NCT00506415|530369735|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
147056890|NCT00506415|530369732|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
147056891|NCT00506415|530369733|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
147056892|NCT00506415|530369734|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
147056893|NCT00506415|530369735|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
147056894|NCT00506415|530369732|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
147056895|NCT00506415|530369733|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
147056896|NCT00506415|530369734|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
147056897|NCT00506415|530369735|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
147056898|NCT00506415|530369732|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
147056899|NCT00506415|530369733|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
147056900|NCT00506415|530369734|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
147056901|NCT00506415|530369735|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
147056902|NCT00506415|530369732|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
147056903|NCT00506415|530369733|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
147056904|NCT00506415|530369734|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
147056905|NCT00506415|530369735|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
147056906|NCT00506415|530369732|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
147056907|NCT00506415|530369733|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
147056908|NCT00506415|530369734|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
147056909|NCT00506415|530369735|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
147056910|NCT00506415|530369732|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
147056911|NCT00506415|530369733|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
147056912|NCT00506415|530369734|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
147056913|NCT00506415|530369735|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
147056914|NCT00506415|530369732|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
147056915|NCT00506415|530369733|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
147056916|NCT00506415|530369734|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
147056917|NCT00506415|530369735|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
147056918|NCT00506415|530369732|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
147056919|NCT00506415|530369733|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
147056920|NCT00506415|530369734|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
147056921|NCT00506415|530369735|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
147056922|NCT00997373|530369736|FG000|Overall Study|Withdrawal by Subject|5|||
147056923|NCT00997373|530369737|FG001|Overall Study|Withdrawal by Subject|0|||
147056924|NCT00997373|530369736|FG000|Overall Study|wrong tumor type|4|||
147056925|NCT00997373|530369737|FG001|Overall Study|wrong tumor type|0|||
147056926|NCT00997373|530369736|FG000|Overall Study|could not have hysterectomy|6|||
147056927|NCT00997373|530369737|FG001|Overall Study|could not have hysterectomy|0|||
147056928|NCT04578457|530369738|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
147056929|NCT04578457|530369738|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
147056930|NCT04578457|530369738|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
147056931|NCT04578457|530369738|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
147056932|NCT02841995|530369745|FG000|Overall Study|Disease progression|5|||
147056933|NCT02841995|530369746|FG001|Overall Study|Disease progression|11|||
147056934|NCT02841995|530369747|FG002|Overall Study|Disease progression|8|||
147056935|NCT02841995|530369745|FG000|Overall Study|Withdrawal by Subject|2|||
147056936|NCT02841995|530369746|FG001|Overall Study|Withdrawal by Subject|4|||
147056937|NCT02841995|530369747|FG002|Overall Study|Withdrawal by Subject|4|||
147056938|NCT02841995|530369745|FG000|Overall Study|Adverse Event|2|||
147056939|NCT02841995|530369746|FG001|Overall Study|Adverse Event|0|||
147056940|NCT02841995|530369747|FG002|Overall Study|Adverse Event|1|||
147056941|NCT02841995|530369745|FG000|Overall Study|Investigator decision|2|||
147056942|NCT02841995|530369746|FG001|Overall Study|Investigator decision|0|||
147056943|NCT02841995|530369747|FG002|Overall Study|Investigator decision|1|||
147056944|NCT02841995|530369745|FG000|Overall Study|Death|0|||
147056945|NCT02841995|530369746|FG001|Overall Study|Death|0|||
147056946|NCT02841995|530369747|FG002|Overall Study|Death|2|||
147056947|NCT02841995|530369745|FG000|Overall Study|Noncompliance to protocol|1|||
147056948|NCT02841995|530369746|FG001|Overall Study|Noncompliance to protocol|0|||
147056949|NCT02841995|530369747|FG002|Overall Study|Noncompliance to protocol|0|||
147056950|NCT02841995|530369745|FG000|Overall Study|Sponsor decision|1|||
147056951|NCT02841995|530369746|FG001|Overall Study|Sponsor decision|0|||
147056952|NCT02841995|530369747|FG002|Overall Study|Sponsor decision|0|||
147056953|NCT02841995|530369745|FG000|Overall Study|Other|4|||
147056954|NCT02841995|530369746|FG001|Overall Study|Other|1|||
147056955|NCT02841995|530369747|FG002|Overall Study|Other|5|||
147056956|NCT03809663|530369748|FG000|Overall Study|Decision by sponsor|24|||
147056957|NCT03809663|530369749|FG001|Overall Study|Decision by sponsor|18|||
147056958|NCT03809663|530369750|FG002|Overall Study|Decision by sponsor|20|||
147056959|NCT03809663|530369751|FG003|Overall Study|Decision by sponsor|20|||
147056960|NCT03809663|530369752|FG004|Overall Study|Decision by sponsor|0|||
147056961|NCT03809663|530369753|FG005|Overall Study|Decision by sponsor|0|||
147056962|NCT03809663|530369748|FG000|Overall Study|Withdrawal by Subject|26|||
147056963|NCT03809663|530369749|FG001|Overall Study|Withdrawal by Subject|22|||
147056964|NCT03809663|530369750|FG002|Overall Study|Withdrawal by Subject|27|||
147056965|NCT03809663|530369751|FG003|Overall Study|Withdrawal by Subject|26|||
147056966|NCT03809663|530369752|FG004|Overall Study|Withdrawal by Subject|0|||
147056967|NCT03809663|530369753|FG005|Overall Study|Withdrawal by Subject|0|||
147056968|NCT03809663|530369748|FG000|Overall Study|Lost to Follow-up|1|||
147056969|NCT03809663|530369749|FG001|Overall Study|Lost to Follow-up|4|||
147056970|NCT03809663|530369750|FG002|Overall Study|Lost to Follow-up|1|||
147056971|NCT03809663|530369751|FG003|Overall Study|Lost to Follow-up|1|||
147056972|NCT03809663|530369752|FG004|Overall Study|Lost to Follow-up|0|||
147056973|NCT03809663|530369753|FG005|Overall Study|Lost to Follow-up|0|||
147056974|NCT01703260|530369755|FG000|Overall Study|Adverse Event|1|||
147056975|NCT01703260|530369756|FG001|Overall Study|Adverse Event|2|||
147056976|NCT01703260|530369757|FG002|Overall Study|Adverse Event|2|||
147056977|NCT01703260|530369755|FG000|Overall Study|Lost to Follow-up|1|||
147056978|NCT01703260|530369756|FG001|Overall Study|Lost to Follow-up|0|||
147056979|NCT01703260|530369757|FG002|Overall Study|Lost to Follow-up|0|||
147056980|NCT01703260|530369755|FG000|Overall Study|Withdrawal by Subject|0|||
147056981|NCT01703260|530369756|FG001|Overall Study|Withdrawal by Subject|0|||
147056982|NCT01703260|530369757|FG002|Overall Study|Withdrawal by Subject|1|||
147056983|NCT01703260|530369755|FG000|Overall Study|Study Termination|1|||
147056984|NCT01703260|530369756|FG001|Overall Study|Study Termination|2|||
147056985|NCT01703260|530369757|FG002|Overall Study|Study Termination|0|||
147056986|NCT00630825|530369760|FG000|Overall Study|Adverse Event|4|||
147056987|NCT00630825|530369761|FG001|Overall Study|Adverse Event|4|||
147056988|NCT00630825|530369762|FG002|Overall Study|Adverse Event|3|||
147056989|NCT00630825|530369763|FG003|Overall Study|Adverse Event|1|||
147056990|NCT00630825|530369760|FG000|Overall Study|Entry Criteria Not Met|1|||
147056991|NCT00630825|530369761|FG001|Overall Study|Entry Criteria Not Met|0|||
147056992|NCT00630825|530369762|FG002|Overall Study|Entry Criteria Not Met|2|||
147056993|NCT00630825|530369763|FG003|Overall Study|Entry Criteria Not Met|1|||
147056994|NCT00630825|530369760|FG000|Overall Study|Lost to Follow-up|1|||
147056995|NCT00630825|530369761|FG001|Overall Study|Lost to Follow-up|1|||
147056996|NCT00630825|530369762|FG002|Overall Study|Lost to Follow-up|1|||
147056997|NCT00630825|530369763|FG003|Overall Study|Lost to Follow-up|1|||
147056998|NCT00630825|530369760|FG000|Overall Study|Physician Decision|1|||
147056999|NCT00630825|530369761|FG001|Overall Study|Physician Decision|0|||
147057000|NCT00630825|530369762|FG002|Overall Study|Physician Decision|0|||
147057001|NCT00630825|530369763|FG003|Overall Study|Physician Decision|0|||
147057002|NCT00630825|530369760|FG000|Overall Study|Withdrawal by Subject|2|||
147057003|NCT00630825|530369761|FG001|Overall Study|Withdrawal by Subject|2|||
147057004|NCT00630825|530369762|FG002|Overall Study|Withdrawal by Subject|2|||
147057005|NCT00630825|530369763|FG003|Overall Study|Withdrawal by Subject|3|||
147057006|NCT02275819|530369764|FG000|Overall Study|Adverse Event|0|||
147057007|NCT02275819|530369765|FG001|Overall Study|Adverse Event|1|||
147057008|NCT01346059|530369766|FG000|Overall Study|Withdrawal by Subject|1|||
147057009|NCT01346059|530369767|FG001|Overall Study|Withdrawal by Subject|0|||
147057010|NCT02211209|530369771|FG000|Overall Study|Investigator judgment|0|||
147057011|NCT02211209|530369772|FG001|Overall Study|Investigator judgment|1|||
147057012|NCT02211209|530369771|FG000|Overall Study|Voluntary withdrawal|1|||
147057013|NCT02211209|530369772|FG001|Overall Study|Voluntary withdrawal|4|||
147057014|NCT02211209|530369771|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
147057015|NCT02211209|530369772|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
147057016|NCT02211209|530369771|FG000|Overall Study|Reason Not Specified|1|||
147057017|NCT02211209|530369772|FG001|Overall Study|Reason Not Specified|0|||
147057018|NCT03123393|530369774|FG000|Overall Study|Study Terminated by Sponsor|6|||
147057019|NCT03123393|530369775|FG001|Overall Study|Study Terminated by Sponsor|9|||
147057020|NCT03123393|530369774|FG000|Overall Study|Withdrawal by Subject|2|||
147057021|NCT03123393|530369775|FG001|Overall Study|Withdrawal by Subject|1|||
147057022|NCT03123393|530369774|FG000|Overall Study|Reason not Specified|13|||
147057023|NCT03123393|530369775|FG001|Overall Study|Reason not Specified|13|||
147057024|NCT00558701|530369777|FG000|Overall Study|Protocol Deviations|1|||
147057025|NCT00558701|530369778|FG001|Overall Study|Protocol Deviations|4|||
147057026|NCT00427648|530369779|FG000|Overall Study|Protocol Violation|1|||
147057027|NCT00427648|530369780|FG001|Overall Study|Protocol Violation|2|||
147057028|NCT00427648|530369779|FG000|Overall Study|Adverse Event|0|||
147057029|NCT00427648|530369780|FG001|Overall Study|Adverse Event|1|||
147057030|NCT02230904|530369781|FG000|Overall Study|Safety follow up could not take place|0|||
147057031|NCT02230904|530369782|FG001|Overall Study|Safety follow up could not take place|1|||
147057032|NCT01464333|530369784|FG000|Overall Study|Adverse Event|34|||
147057033|NCT01464333|530369784|FG000|Overall Study|Lack of Efficacy|72|||
147057034|NCT01464333|530369784|FG000|Overall Study|Withdrawal by Subject|11|||
147057035|NCT01464333|530369784|FG000|Overall Study|Other|4|||
147057036|NCT01464333|530369784|FG000|Overall Study|No Hospital Visit|42|||
147057037|NCT01808066|530369785|FG000|Overall Study|Withdrawal by Subject|15|||
147057038|NCT01252095|530369786|FG000|Overall Study|Disease progression|1|||
147057039|NCT01252095|530369787|FG001|Overall Study|Disease progression|0|||
147057040|NCT01420068|530369788|FG000|Overall Study|Administrative problems|1|||
147057041|NCT01420068|530369789|FG001|Overall Study|Administrative problems|3|||
147057042|NCT01420068|530369788|FG000|Overall Study|Withdrawal by Subject|1|||
147057043|NCT01420068|530369789|FG001|Overall Study|Withdrawal by Subject|2|||
147057044|NCT00745901|530369790|FG000|Overall Study|Adverse Event|3|||
147057045|NCT00745901|530369791|FG001|Overall Study|Adverse Event|4|||
147057046|NCT00745901|530369790|FG000|Overall Study|Protocol Violation|0|||
147057047|NCT00745901|530369791|FG001|Overall Study|Protocol Violation|1|||
147057048|NCT00745901|530369790|FG000|Overall Study|Withdrawal by Subject|1|||
147057049|NCT00745901|530369791|FG001|Overall Study|Withdrawal by Subject|0|||
147057050|NCT00745901|530369790|FG000|Overall Study|Lost to Follow-up|7|||
147057051|NCT00745901|530369791|FG001|Overall Study|Lost to Follow-up|4|||
147057052|NCT00745901|530369790|FG000|Overall Study|Pregnancy|2|||
147057053|NCT00745901|530369791|FG001|Overall Study|Pregnancy|4|||
147057054|NCT00745901|530369790|FG000|Overall Study|Lack of compliance|2|||
147057055|NCT00745901|530369791|FG001|Overall Study|Lack of compliance|2|||
147057056|NCT00745901|530369790|FG000|Overall Study|Patient's next menses did not start with|1|||
147057057|NCT00745901|530369791|FG001|Overall Study|Patient's next menses did not start with|0|||
147057058|NCT00745901|530369790|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
147057059|NCT00745901|530369791|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
147057060|NCT00745901|530369790|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
147057061|NCT00745901|530369791|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
147057062|NCT00745901|530369790|FG000|Overall Study|Patient didn't take any study medication|7|||
147057063|NCT00745901|530369791|FG001|Overall Study|Patient didn't take any study medication|3|||
147057064|NCT00884117|530369794|FG000|Overall Study|Adverse Event|2|||
147057065|NCT00884117|530369794|FG000|Overall Study|Withdrawal by Subject|89|||
147057066|NCT00884117|530369794|FG000|Overall Study|Death|3|||
147057067|NCT00884117|530369794|FG000|Overall Study|Lost to Follow-up|143|||
147057068|NCT00884117|530369794|FG000|Overall Study|Other|12|||
147057069|NCT01753310|530369795|FG000|Overall Study|Entered into open label extension study|25|||
147057070|NCT01753310|530369796|FG001|Overall Study|Entered into open label extension study|22|||
147057071|NCT01753310|530369795|FG000|Overall Study|Adverse Event|1|||
147057072|NCT01753310|530369796|FG001|Overall Study|Adverse Event|0|||
147057073|NCT01753310|530369795|FG000|Overall Study|Lost to Follow-up|2|||
147057074|NCT01753310|530369796|FG001|Overall Study|Lost to Follow-up|0|||
147057075|NCT01753310|530369795|FG000|Overall Study|Subject decision|2|||
147057076|NCT01753310|530369796|FG001|Overall Study|Subject decision|2|||
147057077|NCT01753310|530369795|FG000|Overall Study|Sponsor decision|1|||
147057078|NCT01753310|530369796|FG001|Overall Study|Sponsor decision|0|||
147057079|NCT01753310|530369795|FG000|Overall Study|Withdrawal by Subject|1|||
147057080|NCT01753310|530369796|FG001|Overall Study|Withdrawal by Subject|0|||
147057081|NCT00952068|530369798|FG000|Overall Study|Adverse Event|3|||
147057082|NCT00952068|530369798|FG000|Overall Study|Withdrawal by Subject|4|||
147057083|NCT01890122|530369801|FG000|Overall Study|Adverse Event|1|||
147057084|NCT01890122|530369802|FG001|Overall Study|Adverse Event|1|||
147057085|NCT01890122|530369803|FG002|Overall Study|Adverse Event|1|||
147057086|NCT01890122|530369804|FG003|Overall Study|Adverse Event|2|||
147057087|NCT01890122|530369801|FG000|Overall Study|Major Protocol Deviation|3|||
147057088|NCT01890122|530369802|FG001|Overall Study|Major Protocol Deviation|1|||
147057089|NCT01890122|530369803|FG002|Overall Study|Major Protocol Deviation|0|||
147057090|NCT01890122|530369804|FG003|Overall Study|Major Protocol Deviation|1|||
147057091|NCT01890122|530369801|FG000|Overall Study|Lost to Follow-up|0|||
147057092|NCT01890122|530369802|FG001|Overall Study|Lost to Follow-up|1|||
147057093|NCT01890122|530369803|FG002|Overall Study|Lost to Follow-up|2|||
147057094|NCT01890122|530369804|FG003|Overall Study|Lost to Follow-up|2|||
147057095|NCT01890122|530369801|FG000|Overall Study|Voluntary Withdrawal|8|||
147057096|NCT01890122|530369802|FG001|Overall Study|Voluntary Withdrawal|8|||
147057097|NCT01890122|530369803|FG002|Overall Study|Voluntary Withdrawal|2|||
147057098|NCT01890122|530369804|FG003|Overall Study|Voluntary Withdrawal|11|||
147057099|NCT01890122|530369801|FG000|Overall Study|Lack of Efficacy|14|||
147057100|NCT01890122|530369802|FG001|Overall Study|Lack of Efficacy|24|||
147057101|NCT01890122|530369803|FG002|Overall Study|Lack of Efficacy|7|||
147057102|NCT01890122|530369804|FG003|Overall Study|Lack of Efficacy|41|||
147057103|NCT01890122|530369801|FG000|Overall Study|Reason not Specified|0|||
147057104|NCT01890122|530369802|FG001|Overall Study|Reason not Specified|1|||
147057105|NCT01890122|530369803|FG002|Overall Study|Reason not Specified|1|||
147057106|NCT01890122|530369804|FG003|Overall Study|Reason not Specified|2|||
147057107|NCT01890122|530369801|FG000|Overall Study|Randomized but not Treated|1|||
147057108|NCT01890122|530369802|FG001|Overall Study|Randomized but not Treated|1|||
147057109|NCT01890122|530369803|FG002|Overall Study|Randomized but not Treated|0|||
147057110|NCT01890122|530369804|FG003|Overall Study|Randomized but not Treated|0|||
147057111|NCT02747108|530369808|FG000|Overall Study|Death|2|||
147057112|NCT02747108|530369809|FG001|Overall Study|Death|2|||
147057113|NCT02747108|530369808|FG000|Overall Study|Withdrawal by Subject|1|||
147057114|NCT02747108|530369809|FG001|Overall Study|Withdrawal by Subject|0|||
147057115|NCT02747108|530369808|FG000|Overall Study|Protocol Violation|2|||
147057116|NCT02747108|530369809|FG001|Overall Study|Protocol Violation|0|||
147057117|NCT03769168|530371888|FG000|Overall Study|Adverse Event|0|||
147057118|NCT03769168|530371889|FG001|Overall Study|Adverse Event|1|||
147057119|NCT03769168|530371888|FG000|Overall Study|Lack of Efficacy|2|||
147057120|NCT03769168|530371889|FG001|Overall Study|Lack of Efficacy|4|||
147057121|NCT03769168|530371888|FG000|Overall Study|Post study access to treatment|3|||
147057122|NCT03769168|530371889|FG001|Overall Study|Post study access to treatment|11|||
147057123|NCT03769168|530371888|FG000|Overall Study|Physician Decision|1|||
147057124|NCT03769168|530371889|FG001|Overall Study|Physician Decision|4|||
147057125|NCT03769168|530371888|FG000|Overall Study|Subject Decision|2|||
147057126|NCT03769168|530371889|FG001|Overall Study|Subject Decision|4|||
147057127|NCT03769168|530371888|FG000|Overall Study|Guardian decision|1|||
147057128|NCT03769168|530371889|FG001|Overall Study|Guardian decision|0|||
147057129|NCT05336227|530371890|FG000|Overall Study|Adverse Event|1|||
147057130|NCT05336227|530371891|FG001|Overall Study|Adverse Event|0|||
147057131|NCT05336227|530371890|FG000|Overall Study|Lost to Follow-up|2|||
147057132|NCT05336227|530371891|FG001|Overall Study|Lost to Follow-up|0|||
147057133|NCT05336227|530371890|FG000|Overall Study|Withdrawal by Subject|1|||
147057134|NCT05336227|530371891|FG001|Overall Study|Withdrawal by Subject|0|||
147057135|NCT04050462|530371892|FG000|Overall Study|Withdrawal by Subject|1|||
147057136|NCT04050462|530371893|FG001|Overall Study|Withdrawal by Subject|0|||
147057137|NCT04050462|530371894|FG002|Overall Study|Withdrawal by Subject|0|||
147057138|NCT04066244|530371897|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
147057139|NCT04066244|530371898|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
147057140|NCT04066244|530371899|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
147057141|NCT04066244|530371900|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
147057142|NCT04066244|530371901|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
147057143|NCT04066244|530371902|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
147057144|NCT04066244|530371897|FG000|Part 2 (Cohort 5)|Death|0|||
147057145|NCT04066244|530371898|FG001|Part 2 (Cohort 5)|Death|0|||
147057146|NCT04066244|530371899|FG002|Part 2 (Cohort 5)|Death|0|||
147057147|NCT04066244|530371900|FG003|Part 2 (Cohort 5)|Death|0|||
147057148|NCT04066244|530371901|FG004|Part 2 (Cohort 5)|Death|0|||
147057149|NCT04066244|530371902|FG005|Part 2 (Cohort 5)|Death|2|||
147057150|NCT04066244|530371897|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
147057151|NCT04066244|530371898|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
147057152|NCT04066244|530371899|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
147057153|NCT04066244|530371900|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
147057154|NCT04066244|530371901|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
147057155|NCT04066244|530371902|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
147057156|NCT04066244|530371897|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
147057157|NCT04066244|530371898|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
147057158|NCT04066244|530371899|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
147057159|NCT04066244|530371900|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
147057160|NCT04066244|530371901|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
147057161|NCT04066244|530371902|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
147057162|NCT01467713|530371903|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
147057163|NCT01467713|530371904|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
147057164|NCT01467713|530371905|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
147057165|NCT01467713|530371906|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
147057166|NCT01467713|530371903|FG000|Overall Study|Major Protocol Deviation|2|||
147057167|NCT01467713|530371904|FG001|Overall Study|Major Protocol Deviation|4|||
147057168|NCT01467713|530371905|FG002|Overall Study|Major Protocol Deviation|4|||
147057169|NCT01467713|530371906|FG003|Overall Study|Major Protocol Deviation|1|||
147057170|NCT01467713|530371903|FG000|Overall Study|Lost to Follow-up|9|||
147057171|NCT01467713|530371904|FG001|Overall Study|Lost to Follow-up|12|||
147057172|NCT01467713|530371905|FG002|Overall Study|Lost to Follow-up|6|||
147057173|NCT01467713|530371906|FG003|Overall Study|Lost to Follow-up|9|||
147057174|NCT01467713|530371903|FG000|Overall Study|Voluntary Withdrawal|18|||
147057175|NCT01467713|530371904|FG001|Overall Study|Voluntary Withdrawal|14|||
147057176|NCT01467713|530371905|FG002|Overall Study|Voluntary Withdrawal|21|||
147057177|NCT01467713|530371906|FG003|Overall Study|Voluntary Withdrawal|20|||
147057178|NCT01467713|530371903|FG000|Overall Study|Study Termination|23|||
147057179|NCT01467713|530371904|FG001|Overall Study|Study Termination|33|||
147057180|NCT01467713|530371905|FG002|Overall Study|Study Termination|28|||
147057181|NCT01467713|530371906|FG003|Overall Study|Study Termination|29|||
147057182|NCT01467713|530371903|FG000|Overall Study|Pregnancy|0|||
147057183|NCT01467713|530371904|FG001|Overall Study|Pregnancy|1|||
147057184|NCT01467713|530371905|FG002|Overall Study|Pregnancy|1|||
147057185|NCT01467713|530371906|FG003|Overall Study|Pregnancy|3|||
147057186|NCT01467713|530371903|FG000|Overall Study|Relapse|35|||
147057187|NCT01467713|530371904|FG001|Overall Study|Relapse|25|||
147057188|NCT01467713|530371905|FG002|Overall Study|Relapse|28|||
147057189|NCT01467713|530371906|FG003|Overall Study|Relapse|35|||
147057190|NCT01467713|530371903|FG000|Overall Study|Reason not Specified|6|||
147057191|NCT01467713|530371904|FG001|Overall Study|Reason not Specified|11|||
147057192|NCT01467713|530371905|FG002|Overall Study|Reason not Specified|8|||
147057193|NCT01467713|530371906|FG003|Overall Study|Reason not Specified|7|||
147057194|NCT02525783|530371907|FG000|Overall Study|Lost to Follow-up|10|||
147057195|NCT00866281|530371908|FG000|Overall Study|Adverse Event|1|||
147057196|NCT00866281|530371909|FG001|Overall Study|Adverse Event|0|||
147057197|NCT00866281|530371908|FG000|Overall Study|Withdrawal by participants|3|||
147057198|NCT00866281|530371909|FG001|Overall Study|Withdrawal by participants|0|||
147057199|NCT00866281|530371908|FG000|Overall Study|Disease progression|3|||
147057200|NCT00866281|530371909|FG001|Overall Study|Disease progression|11|||
147057201|NCT00866281|530371908|FG000|Overall Study|New cancer therapy|0|||
147057202|NCT00866281|530371909|FG001|Overall Study|New cancer therapy|4|||
147057203|NCT01100086|530371910|FG000|Period 1|Withdrawal by Subject|1|||
147057204|NCT01100086|530371911|FG001|Period 1|Withdrawal by Subject|0|||
147057205|NCT02612623|530371917|FG000|Overall Study|Withdrawal by Subject|0|||
147057206|NCT02612623|530371918|FG001|Overall Study|Withdrawal by Subject|1|||
147057207|NCT02612623|530371919|FG002|Overall Study|Withdrawal by Subject|0|||
147057208|NCT02612623|530371920|FG003|Overall Study|Withdrawal by Subject|0|||
147057209|NCT02612623|530371917|FG000|Overall Study|Adverse Event|1|||
147057210|NCT02612623|530371918|FG001|Overall Study|Adverse Event|0|||
147057211|NCT02612623|530371919|FG002|Overall Study|Adverse Event|1|||
147057212|NCT02612623|530371920|FG003|Overall Study|Adverse Event|0|||
147057213|NCT00570141|530371925|FG000|Overall Study|Adverse Event|1|||
147057214|NCT00570141|530371925|FG000|Overall Study|Missed visits|1|||
147057215|NCT00570141|530371925|FG000|Overall Study|Lost to Follow-up|1|||
147057216|NCT03270657|530371930|FG000|Overall Study|Withdrawal by Subject|1|||
147057217|NCT00455403|530371931|FG000|Overall Study|Lost to Follow-up|2|||
147057218|NCT00455403|530371932|FG001|Overall Study|Lost to Follow-up|1|||
147057219|NCT00455403|530371931|FG000|Overall Study|Withdrawal by Subject|1|||
147057220|NCT00455403|530371932|FG001|Overall Study|Withdrawal by Subject|3|||
147057221|NCT00455403|530371931|FG000|Overall Study|Protocol Violation|0|||
147057222|NCT00455403|530371932|FG001|Overall Study|Protocol Violation|2|||
147057223|NCT01343043|530371935|FG000|Overall Study|Disease progression before treatment|1|||
147057224|NCT01343043|530371936|FG001|Overall Study|Disease progression before treatment|0|||
147057225|NCT01343043|530371937|FG002|Overall Study|Disease progression before treatment|0|||
147057226|NCT01343043|530371938|FG003|Overall Study|Disease progression before treatment|0|||
147057227|NCT01343043|530371935|FG000|Overall Study|Withdrawal by Subject|1|||
147057228|NCT01343043|530371936|FG001|Overall Study|Withdrawal by Subject|0|||
147057229|NCT01343043|530371937|FG002|Overall Study|Withdrawal by Subject|0|||
147057230|NCT01343043|530371938|FG003|Overall Study|Withdrawal by Subject|0|||
147057231|NCT01343043|530371935|FG000|Overall Study|Death|1|||
147057232|NCT01343043|530371936|FG001|Overall Study|Death|1|||
147057233|NCT01343043|530371937|FG002|Overall Study|Death|0|||
147057234|NCT01343043|530371938|FG003|Overall Study|Death|1|||
147057235|NCT00925704|530371939|FG000|First Intervention|Withdrew consent|0|||
147057236|NCT00925704|530371940|FG001|First Intervention|Withdrew consent|0|||
147057237|NCT00925704|530371941|FG002|First Intervention|Withdrew consent|0|||
147057238|NCT00925704|530371942|FG003|First Intervention|Withdrew consent|1|||
147057239|NCT00925704|530371943|FG004|First Intervention|Withdrew consent|1|||
147057240|NCT00925704|530371944|FG005|First Intervention|Withdrew consent|0|||
147057241|NCT00925704|530371939|FG000|Second Intervention|Withdrawal by Subject|1|||
147057242|NCT00925704|530371940|FG001|Second Intervention|Withdrawal by Subject|0|||
147057243|NCT00925704|530371941|FG002|Second Intervention|Withdrawal by Subject|0|||
147057244|NCT00925704|530371942|FG003|Second Intervention|Withdrawal by Subject|0|||
147057245|NCT00925704|530371943|FG004|Second Intervention|Withdrawal by Subject|1|||
147057246|NCT00925704|530371944|FG005|Second Intervention|Withdrawal by Subject|0|||
147057247|NCT00925704|530371939|FG000|Third Intervention|Withdrew consent|0|||
147057248|NCT00925704|530371940|FG001|Third Intervention|Withdrew consent|0|||
147057249|NCT00925704|530371941|FG002|Third Intervention|Withdrew consent|0|||
147057250|NCT00925704|530371942|FG003|Third Intervention|Withdrew consent|0|||
147057251|NCT00925704|530371943|FG004|Third Intervention|Withdrew consent|0|||
147057252|NCT00925704|530371944|FG005|Third Intervention|Withdrew consent|1|||
147057253|NCT00502242|530371950|FG000|Overall Study|Lack of Efficacy|1|||
147057254|NCT00502242|530371951|FG001|Overall Study|Lack of Efficacy|11|||
147057255|NCT00502242|530371950|FG000|Overall Study|Adverse Event|31|||
147057256|NCT00502242|530371951|FG001|Overall Study|Adverse Event|20|||
147057257|NCT00502242|530371950|FG000|Overall Study|Physician Decision|2|||
147057258|NCT00502242|530371951|FG001|Overall Study|Physician Decision|3|||
147057259|NCT00502242|530371950|FG000|Overall Study|Other - Unspecified|8|||
147057260|NCT00502242|530371951|FG001|Overall Study|Other - Unspecified|14|||
147057261|NCT00502242|530371950|FG000|Overall Study|Protocol Violation|3|||
147057262|NCT00502242|530371951|FG001|Overall Study|Protocol Violation|1|||
147057263|NCT00502242|530371950|FG000|Overall Study|Withdrawal by Subject|6|||
147057264|NCT00502242|530371951|FG001|Overall Study|Withdrawal by Subject|7|||
147057265|NCT03207815|530371952|FG000|Overall Study|Protocol Violation|3|||
147057266|NCT03207815|530371953|FG001|Overall Study|Protocol Violation|1|||
147057267|NCT03207815|530371952|FG000|Overall Study|Adverse Event|1|||
147057268|NCT03207815|530371953|FG001|Overall Study|Adverse Event|2|||
147057269|NCT03207815|530371952|FG000|Overall Study|Lost to Follow-up|1|||
147057270|NCT03207815|530371953|FG001|Overall Study|Lost to Follow-up|2|||
147057271|NCT03207815|530371952|FG000|Overall Study|Investigator's Discretion|1|||
147057272|NCT03207815|530371953|FG001|Overall Study|Investigator's Discretion|1|||
147057273|NCT03207815|530371952|FG000|Overall Study|Lack of Efficacy|0|||
147057274|NCT03207815|530371953|FG001|Overall Study|Lack of Efficacy|1|||
147057275|NCT03207815|530371952|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
147057276|NCT03207815|530371953|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
147057277|NCT03207815|530371952|FG000|Overall Study|Withdrew Consent|1|||
147057278|NCT03207815|530371953|FG001|Overall Study|Withdrew Consent|0|||
147057279|NCT01671007|530371954|FG000|Overall Study|Other reasons than listed|166|||
147057280|NCT01671007|530371955|FG001|Overall Study|Other reasons than listed|373|||
147057281|NCT01671007|530371956|FG002|Overall Study|Other reasons than listed|197|||
147057282|NCT01671007|530371957|FG003|Overall Study|Other reasons than listed|228|||
147057283|NCT01671007|530371958|FG004|Overall Study|Other reasons than listed|14|||
147057284|NCT01671007|530371959|FG005|Overall Study|Other reasons than listed|71|||
147057285|NCT01671007|530371960|FG006|Overall Study|Other reasons than listed|17|||
147057286|NCT01671007|530371961|FG007|Overall Study|Other reasons than listed|66|||
147057287|NCT01671007|530371962|FG008|Overall Study|Other reasons than listed|0|||
147057288|NCT01671007|530371954|FG000|Overall Study|Withdrawal by Subject|36|||
147057289|NCT01671007|530371955|FG001|Overall Study|Withdrawal by Subject|59|||
147057290|NCT01671007|530371956|FG002|Overall Study|Withdrawal by Subject|53|||
147057291|NCT01671007|530371957|FG003|Overall Study|Withdrawal by Subject|58|||
147057292|NCT01671007|530371958|FG004|Overall Study|Withdrawal by Subject|4|||
147057293|NCT01671007|530371959|FG005|Overall Study|Withdrawal by Subject|15|||
147057294|NCT01671007|530371960|FG006|Overall Study|Withdrawal by Subject|1|||
147057295|NCT01671007|530371961|FG007|Overall Study|Withdrawal by Subject|19|||
147057296|NCT01671007|530371962|FG008|Overall Study|Withdrawal by Subject|0|||
147057297|NCT01671007|530371954|FG000|Overall Study|Lost to Follow-up|93|||
147057298|NCT01671007|530371955|FG001|Overall Study|Lost to Follow-up|142|||
147057299|NCT01671007|530371956|FG002|Overall Study|Lost to Follow-up|91|||
147057300|NCT01671007|530371957|FG003|Overall Study|Lost to Follow-up|63|||
147057301|NCT01671007|530371958|FG004|Overall Study|Lost to Follow-up|7|||
147057302|NCT01671007|530371959|FG005|Overall Study|Lost to Follow-up|20|||
147057303|NCT01671007|530371960|FG006|Overall Study|Lost to Follow-up|2|||
147057304|NCT01671007|530371961|FG007|Overall Study|Lost to Follow-up|28|||
147057305|NCT01671007|530371962|FG008|Overall Study|Lost to Follow-up|0|||
147057306|NCT01671007|530371954|FG000|Overall Study|No end of study case report form|3|||
147057307|NCT01671007|530371955|FG001|Overall Study|No end of study case report form|1|||
147057308|NCT01671007|530371956|FG002|Overall Study|No end of study case report form|0|||
147057309|NCT01671007|530371957|FG003|Overall Study|No end of study case report form|2|||
147057310|NCT01671007|530371958|FG004|Overall Study|No end of study case report form|0|||
147057311|NCT01671007|530371959|FG005|Overall Study|No end of study case report form|0|||
147057312|NCT01671007|530371960|FG006|Overall Study|No end of study case report form|0|||
147057313|NCT01671007|530371961|FG007|Overall Study|No end of study case report form|0|||
147057314|NCT01671007|530371962|FG008|Overall Study|No end of study case report form|0|||
147057315|NCT01671007|530371954|FG000|Overall Study|Not eligible|23|||
147057316|NCT01671007|530371955|FG001|Overall Study|Not eligible|76|||
147057317|NCT01671007|530371956|FG002|Overall Study|Not eligible|25|||
147057318|NCT01671007|530371957|FG003|Overall Study|Not eligible|17|||
147057319|NCT01671007|530371958|FG004|Overall Study|Not eligible|0|||
147057320|NCT01671007|530371959|FG005|Overall Study|Not eligible|6|||
147057321|NCT01671007|530371960|FG006|Overall Study|Not eligible|1|||
147057322|NCT01671007|530371961|FG007|Overall Study|Not eligible|19|||
147057323|NCT01671007|530371962|FG008|Overall Study|Not eligible|0|||
147057324|NCT03877068|530371963|FG000|Overall Study|Physician Decision|9|||
147057325|NCT03877068|530371964|FG001|Overall Study|Physician Decision|3|||
147057326|NCT01812109|530371965|FG000|Overall Study|research personnel delay|16|||
147057327|NCT01812109|530371965|FG000|Overall Study|NIRS Unattainable|17|||
147057328|NCT01966120|530371966|FG000|Overall Study|Withdrawal by Subject|0|||
147057329|NCT01966120|530371967|FG001|Overall Study|Withdrawal by Subject|5|||
147057330|NCT01966120|530371966|FG000|Overall Study|Lost to Follow-up|1|||
147057331|NCT01966120|530371967|FG001|Overall Study|Lost to Follow-up|1|||
147057332|NCT01346696|530371968|FG000|Overall Study|Death|1|||
147057333|NCT04630002|530371969|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
147057334|NCT04630002|530371970|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
147057335|NCT04630002|530371971|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
147057336|NCT04630002|530371969|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
147057337|NCT04630002|530371970|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
147057338|NCT04630002|530371971|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
147057339|NCT04630002|530371969|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
147057340|NCT04630002|530371970|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
147057341|NCT04630002|530371971|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
147057342|NCT04630002|530371969|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
147057343|NCT04630002|530371970|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
147057344|NCT04630002|530371971|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
147057345|NCT04630002|530371969|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
147057346|NCT04630002|530371970|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
147057347|NCT04630002|530371971|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
147057348|NCT04630002|530371969|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
147057349|NCT04630002|530371970|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
147057350|NCT04630002|530371971|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
147057351|NCT04630002|530371969|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
147057352|NCT04630002|530371970|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
147057353|NCT04630002|530371971|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
147057354|NCT04630002|530371969|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
147057355|NCT04630002|530371970|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
147057356|NCT04630002|530371971|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
147057357|NCT02182843|530371972|FG000|Overall Study|Withdrawal by Subject|7|||
147057358|NCT02182843|530371972|FG000|Overall Study|Lost to Follow-up|2|||
147057359|NCT02182843|530371972|FG000|Overall Study|Adverse Event|1|||
147057360|NCT04548193|530371976|FG000|Overall Study|Lost to Follow-up|0|||
147057361|NCT04548193|530371977|FG001|Overall Study|Lost to Follow-up|1|||
147057362|NCT04548193|530371976|FG000|Overall Study|Death|0|||
147057363|NCT04548193|530371977|FG001|Overall Study|Death|1|||
147057364|NCT04548193|530371976|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
147057365|NCT04548193|530371977|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
147057366|NCT04548193|530371976|FG000|Overall Study|Withdrawal by Subject|2|||
147057367|NCT04548193|530371977|FG001|Overall Study|Withdrawal by Subject|2|||
147057368|NCT02042014|530371978|FG000|Overall Study|Adverse Event|1|||
147057369|NCT02042014|530371978|FG000|Overall Study|Physician Decision|7|||
147057370|NCT01681212|530371985|FG000|Overall Study|No longer met study criteria|5|||
147057371|NCT01681212|530371985|FG000|Overall Study|Administrative reason by sponsor|1|||
147057372|NCT05047211|530371987|FG000|Overall Study|Lost to Follow-up|8|||
147057373|NCT05047211|530371988|FG001|Overall Study|Lost to Follow-up|5|||
147057374|NCT02187198|530371991|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
147057375|NCT02187198|530371992|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
147057376|NCT02187198|530371991|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
147057377|NCT02187198|530371992|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
147057378|NCT00561392|530371993|FG000|Overall Study|Adverse Event|38|||
147057379|NCT00561392|530371993|FG000|Overall Study|Lack of Efficacy|2|||
147057380|NCT00561392|530371993|FG000|Overall Study|Protocol Violation|1|||
147057381|NCT00561392|530371993|FG000|Overall Study|Withdrawal by Subject|8|||
147057382|NCT00561392|530371993|FG000|Overall Study|Administrative problems|4|||
147057383|NCT03822468|530371994|FG000|Treatment Period|Progressive disease|98|||
147057384|NCT03822468|530371995|FG001|Treatment Period|Progressive disease|94|||
147057385|NCT03822468|530371994|FG000|Treatment Period|Adverse Event|21|||
147057386|NCT03822468|530371995|FG001|Treatment Period|Adverse Event|24|||
147057387|NCT03822468|530371994|FG000|Treatment Period|Withdrawal by Subject|9|||
147057388|NCT03822468|530371995|FG001|Treatment Period|Withdrawal by Subject|5|||
147057389|NCT03822468|530371994|FG000|Treatment Period|Physician Decision|9|||
147057390|NCT03822468|530371995|FG001|Treatment Period|Physician Decision|7|||
147057391|NCT03822468|530371994|FG000|Treatment Period|Protocol Violation|2|||
147057392|NCT03822468|530371995|FG001|Treatment Period|Protocol Violation|1|||
147057393|NCT03822468|530371994|FG000|Treatment Period|Death|2|||
147057394|NCT03822468|530371995|FG001|Treatment Period|Death|3|||
147057395|NCT03822468|530371994|FG000|Treatment Period|Lost to Follow-up|1|||
147057396|NCT03822468|530371995|FG001|Treatment Period|Lost to Follow-up|1|||
147057397|NCT03822468|530371994|FG000|Treatment Period|Sponsor decision|46|||
147057398|NCT03822468|530371995|FG001|Treatment Period|Sponsor decision|53|||
147057399|NCT03822468|530371994|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
147057400|NCT03822468|530371995|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
147057401|NCT03822468|530371994|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
147057402|NCT03822468|530371995|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
147057403|NCT03822468|530371994|FG000|Post-treatment Efficacy Follow-up|Death|1|||
147057404|NCT03822468|530371995|FG001|Post-treatment Efficacy Follow-up|Death|0|||
147057405|NCT03822468|530371994|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
147057406|NCT03822468|530371995|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
147057407|NCT03822468|530371994|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
147057408|NCT03822468|530371995|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
147057409|NCT03822468|530371994|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
147057410|NCT03822468|530371995|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
147057411|NCT03822468|530371994|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
147057412|NCT03822468|530371995|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
147057413|NCT03321968|530371996|FG000|Overall Study|Withdrawal by Subject|1|||
147057414|NCT03321968|530371997|FG001|Overall Study|Withdrawal by Subject|2|||
147057415|NCT03321968|530371998|FG002|Overall Study|Withdrawal by Subject|1|||
147057416|NCT03321968|530371996|FG000|Overall Study|Lost to Follow-up|2|||
147057417|NCT03321968|530371997|FG001|Overall Study|Lost to Follow-up|0|||
147057418|NCT03321968|530371998|FG002|Overall Study|Lost to Follow-up|1|||
147057419|NCT03321968|530371996|FG000|Overall Study|Other than specified|0|||
147057420|NCT03321968|530371997|FG001|Overall Study|Other than specified|0|||
147057421|NCT03321968|530371998|FG002|Overall Study|Other than specified|1|||
147057422|NCT01532518|530371999|FG000|Overall Study|Withdrawal by Subject|0|||
147057423|NCT01532518|530372000|FG001|Overall Study|Withdrawal by Subject|0|||
147057424|NCT01532518|530372001|FG002|Overall Study|Withdrawal by Subject|1|||
147057425|NCT01575834|530372002|FG000|Overall Study|Withdrawal by Subject|352|||
147057426|NCT01575834|530372003|FG001|Overall Study|Withdrawal by Subject|390|||
147057427|NCT01575834|530372002|FG000|Overall Study|Death|81|||
147057428|NCT01575834|530372003|FG001|Overall Study|Death|74|||
147057429|NCT01575834|530372002|FG000|Overall Study|Other|70|||
147057430|NCT01575834|530372003|FG001|Overall Study|Other|70|||
147057431|NCT01575834|530372002|FG000|Overall Study|Adverse Event|63|||
147057432|NCT01575834|530372003|FG001|Overall Study|Adverse Event|61|||
147057433|NCT01575834|530372002|FG000|Overall Study|Lost to Follow-up|55|||
147057434|NCT01575834|530372003|FG001|Overall Study|Lost to Follow-up|68|||
147057435|NCT01575834|530372002|FG000|Overall Study|Noncompliance|52|||
147057436|NCT01575834|530372003|FG001|Overall Study|Noncompliance|27|||
147057437|NCT01575834|530372002|FG000|Overall Study|Administrative decision|15|||
147057438|NCT01575834|530372003|FG001|Overall Study|Administrative decision|33|||
147057439|NCT01575834|530372002|FG000|Overall Study|Ineligibility Determined|5|||
147057440|NCT01575834|530372003|FG001|Overall Study|Ineligibility Determined|8|||
147057441|NCT01575834|530372002|FG000|Overall Study|Protocol Deviation|4|||
147057442|NCT01575834|530372003|FG001|Overall Study|Protocol Deviation|3|||
147057443|NCT01575834|530372002|FG000|Overall Study|Requirement for Alternative Therapy|2|||
147057444|NCT01575834|530372003|FG001|Overall Study|Requirement for Alternative Therapy|4|||
147057445|NCT02155283|530372004|FG000|Overall Study|Lost to Follow-up|3|||
147057446|NCT02155283|530372004|FG000|Overall Study|Withdrawal by Subject|1|||
147057447|NCT02155283|530372004|FG000|Overall Study|Protocol Violation|3|||
147057448|NCT01741688|530372007|FG000|Overall Study|Lack of insurance coverage|2|||
147057449|NCT01741688|530372007|FG000|Overall Study|Withdrawal by Subject|1|||
147057450|NCT02282813|530372012|FG000|Overall Study|Withdrawal by Subject|4|||
147057451|NCT02282813|530372013|FG001|Overall Study|Withdrawal by Subject|5|||
147057452|NCT02282813|530372014|FG002|Overall Study|Withdrawal by Subject|0|||
147057453|NCT02282813|530372012|FG000|Overall Study|Adverse Event|3|||
147057454|NCT02282813|530372013|FG001|Overall Study|Adverse Event|10|||
147057455|NCT02282813|530372014|FG002|Overall Study|Adverse Event|1|||
147057456|NCT02282813|530372012|FG000|Overall Study|Subject non-compliance|1|||
147057457|NCT02282813|530372013|FG001|Overall Study|Subject non-compliance|4|||
147057458|NCT02282813|530372014|FG002|Overall Study|Subject non-compliance|0|||
147057459|NCT02282813|530372012|FG000|Overall Study|Physician Decision|0|||
147057460|NCT02282813|530372013|FG001|Overall Study|Physician Decision|3|||
147057461|NCT02282813|530372014|FG002|Overall Study|Physician Decision|1|||
147057462|NCT02282813|530372012|FG000|Overall Study|Lost to Follow-up|2|||
147057463|NCT02282813|530372013|FG001|Overall Study|Lost to Follow-up|0|||
147057464|NCT02282813|530372014|FG002|Overall Study|Lost to Follow-up|1|||
147057465|NCT02282813|530372012|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
147057466|NCT02282813|530372013|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
147057467|NCT02282813|530372014|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
147057468|NCT02282813|530372012|FG000|Overall Study|Lack of Efficacy|1|||
147057469|NCT02282813|530372013|FG001|Overall Study|Lack of Efficacy|0|||
147057470|NCT02282813|530372014|FG002|Overall Study|Lack of Efficacy|0|||
147057471|NCT02282813|530372012|FG000|Overall Study|Administrative reasons|0|||
147057472|NCT02282813|530372013|FG001|Overall Study|Administrative reasons|1|||
147057473|NCT02282813|530372014|FG002|Overall Study|Administrative reasons|0|||
147057474|NCT00463047|530372016|FG000|Titration Period 1|Adverse Event|10|||
147057475|NCT00463047|530372017|FG001|Titration Period 1|Adverse Event|8|||
147057476|NCT00463047|530372016|FG000|Titration Period 1|Lack of Efficacy|10|||
147057477|NCT00463047|530372017|FG001|Titration Period 1|Lack of Efficacy|4|||
147057478|NCT00463047|530372016|FG000|Titration Period 1|Lost to Follow-up|2|||
147057479|NCT00463047|530372017|FG001|Titration Period 1|Lost to Follow-up|0|||
147057480|NCT00463047|530372016|FG000|Titration Period 1|Non-compliance with study medication|3|||
147057481|NCT00463047|530372017|FG001|Titration Period 1|Non-compliance with study medication|5|||
147057482|NCT00463047|530372016|FG000|Titration Period 1|Protocol Violation|5|||
147057483|NCT00463047|530372017|FG001|Titration Period 1|Protocol Violation|5|||
147057484|NCT00463047|530372016|FG000|Titration Period 1|Withdrawal by Subject|3|||
147057485|NCT00463047|530372017|FG001|Titration Period 1|Withdrawal by Subject|5|||
147057486|NCT00463047|530372016|FG000|Titration Period 1|Non-compliance procedures|4|||
147057487|NCT00463047|530372017|FG001|Titration Period 1|Non-compliance procedures|10|||
147057488|NCT00463047|530372016|FG000|Titration Period 1|Other|0|||
147057489|NCT00463047|530372017|FG001|Titration Period 1|Other|2|||
147057490|NCT00463047|530372016|FG000|Titration Period 2|Adverse Event|9|||
147057491|NCT00463047|530372017|FG001|Titration Period 2|Adverse Event|9|||
147057492|NCT00463047|530372016|FG000|Titration Period 2|Lack of Efficacy|6|||
147057493|NCT00463047|530372017|FG001|Titration Period 2|Lack of Efficacy|4|||
147057494|NCT00463047|530372016|FG000|Titration Period 2|Withdrawal by Subject|1|||
147057495|NCT00463047|530372017|FG001|Titration Period 2|Withdrawal by Subject|0|||
147057496|NCT00463047|530372016|FG000|Titration Period 2|Protocol Violation|2|||
147057497|NCT00463047|530372017|FG001|Titration Period 2|Protocol Violation|3|||
147057498|NCT00463047|530372016|FG000|Titration Period 2|Lost to Follow-up|1|||
147057499|NCT00463047|530372017|FG001|Titration Period 2|Lost to Follow-up|2|||
147057500|NCT00463047|530372016|FG000|Titration Period 2|Non-compliance study medication|4|||
147057501|NCT00463047|530372017|FG001|Titration Period 2|Non-compliance study medication|2|||
147057502|NCT00463047|530372016|FG000|Titration Period 2|Non-compliance procedures|4|||
147057503|NCT00463047|530372017|FG001|Titration Period 2|Non-compliance procedures|1|||
147057504|NCT00463047|530372016|FG000|Titration Period 2|Other|3|||
147057505|NCT00463047|530372017|FG001|Titration Period 2|Other|2|||
147057506|NCT00463047|530372016|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
147057507|NCT00463047|530372017|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
147057508|NCT00463047|530372016|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
147057509|NCT00463047|530372017|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
147057510|NCT00463047|530372016|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
147057511|NCT00463047|530372017|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
147057512|NCT00463047|530372016|FG000|Double-Blind Treatment Period 1|Other|1|||
147057513|NCT00463047|530372017|FG001|Double-Blind Treatment Period 1|Other|0|||
147057514|NCT00463047|530372016|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
147057515|NCT00463047|530372017|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
147057516|NCT00463047|530372016|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
147057517|NCT00463047|530372017|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
147057518|NCT00463047|530372016|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
147057519|NCT00463047|530372017|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
147057520|NCT00739661|530372023|FG000|Overall Study|Adverse Event|2|||
147057521|NCT00739661|530372024|FG001|Overall Study|Adverse Event|0|||
147057522|NCT00739661|530372023|FG000|Overall Study|Physician decision to withdraw patient|1|||
147057523|NCT00739661|530372024|FG001|Overall Study|Physician decision to withdraw patient|0|||
147057524|NCT00739661|530372023|FG000|Overall Study|Patient decision to withdraw|9|||
147057525|NCT00739661|530372024|FG001|Overall Study|Patient decision to withdraw|4|||
147057526|NCT00739661|530372023|FG000|Overall Study|Disease progression, radiographic|33|||
147057527|NCT00739661|530372024|FG001|Overall Study|Disease progression, radiographic|37|||
147057528|NCT00739661|530372023|FG000|Overall Study|Reason for discontinuation not available|1|||
147057529|NCT00739661|530372024|FG001|Overall Study|Reason for discontinuation not available|1|||
147057530|NCT02198664|530372025|FG000|Overall Study|Adverse Event|2|||
147057531|NCT02198664|530372026|FG001|Overall Study|Adverse Event|0|||
147057532|NCT02198664|530372025|FG000|Overall Study|Withdrawal by Subject|11|||
147057533|NCT02198664|530372026|FG001|Overall Study|Withdrawal by Subject|8|||
147057534|NCT02198664|530372025|FG000|Overall Study|Failure to tolerate|2|||
147057535|NCT02198664|530372026|FG001|Overall Study|Failure to tolerate|0|||
147057536|NCT02198664|530372025|FG000|Overall Study|Not stated|1|||
147057537|NCT02198664|530372026|FG001|Overall Study|Not stated|0|||
147057538|NCT02632409|530372027|FG000|Randomized|AE unrelated to study Drug|0|||
147057539|NCT02632409|530372028|FG001|Randomized|AE unrelated to study Drug|1|||
147057540|NCT02632409|530372027|FG000|Randomized|Participant withdrew consent|2|||
147057541|NCT02632409|530372028|FG001|Randomized|Participant withdrew consent|1|||
147057542|NCT02632409|530372027|FG000|Randomized|No Longer meets study criteria|5|||
147057543|NCT02632409|530372028|FG001|Randomized|No Longer meets study criteria|0|||
147057544|NCT02632409|530372027|FG000|Randomized|other reasons|1|||
147057545|NCT02632409|530372028|FG001|Randomized|other reasons|0|||
147057546|NCT02632409|530372027|FG000|Treatment Period|Ongoing Treatment|20|||
147057547|NCT02632409|530372028|FG001|Treatment Period|Ongoing Treatment|21|||
147057548|NCT02632409|530372027|FG000|Treatment Period|Disease Recurrence|147|||
147057549|NCT02632409|530372028|FG001|Treatment Period|Disease Recurrence|90|||
147057550|NCT02632409|530372027|FG000|Treatment Period|Study Drug Toxicity|8|||
147057551|NCT02632409|530372028|FG001|Treatment Period|Study Drug Toxicity|49|||
147057552|NCT02632409|530372027|FG000|Treatment Period|Death|1|||
147057553|NCT02632409|530372028|FG001|Treatment Period|Death|0|||
147057554|NCT02632409|530372027|FG000|Treatment Period|AE unrelated to study drug|15|||
147057555|NCT02632409|530372028|FG001|Treatment Period|AE unrelated to study drug|16|||
147057556|NCT02632409|530372027|FG000|Treatment Period|Request to discontinue treatment|4|||
147057557|NCT02632409|530372028|FG001|Treatment Period|Request to discontinue treatment|19|||
147057558|NCT02632409|530372027|FG000|Treatment Period|Participant withdrew consent|7|||
147057559|NCT02632409|530372028|FG001|Treatment Period|Participant withdrew consent|5|||
147057560|NCT02632409|530372027|FG000|Treatment Period|Lost to Follow-up|0|||
147057561|NCT02632409|530372028|FG001|Treatment Period|Lost to Follow-up|1|||
147057562|NCT02632409|530372027|FG000|Treatment Period|Maximum clinical benefit|1|||
147057563|NCT02632409|530372028|FG001|Treatment Period|Maximum clinical benefit|0|||
147057564|NCT02632409|530372027|FG000|Treatment Period|No longer meets study criteria|3|||
147057565|NCT02632409|530372028|FG001|Treatment Period|No longer meets study criteria|0|||
147057566|NCT02632409|530372027|FG000|Treatment Period|Administrative Reason by sponsor|0|||
147057567|NCT02632409|530372028|FG001|Treatment Period|Administrative Reason by sponsor|1|||
147057568|NCT02632409|530372027|FG000|Treatment Period|Other Reasons|10|||
147057569|NCT02632409|530372028|FG001|Treatment Period|Other Reasons|6|||
147057570|NCT05600283|530372029|FG000|Overall Study|Withdrawal by Subject|3|||
147057571|NCT05600283|530372030|FG001|Overall Study|Withdrawal by Subject|8|||
147057572|NCT05600283|530372029|FG000|Overall Study|invalid individual swab|1|||
147057573|NCT05600283|530372030|FG001|Overall Study|invalid individual swab|0|||
147057574|NCT05600283|530372029|FG000|Overall Study|missing clinician collection|3|||
147057575|NCT05600283|530372030|FG001|Overall Study|missing clinician collection|0|||
147057576|NCT05600283|530372029|FG000|Overall Study|screening failure|0|||
147057577|NCT05600283|530372030|FG001|Overall Study|screening failure|2|||
147057578|NCT02883062|530372031|FG000|Overall Study|Withdrawal by Subject|6|||
147057579|NCT02883062|530372032|FG001|Overall Study|Withdrawal by Subject|0|||
147057580|NCT04426006|530372033|FG000|Inclusion|Protocol Violation|1|||
147057581|NCT04426006|530372033|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
147057582|NCT04426006|530372033|FG000|Inclusion|Blood sample at inclusion not done|1|||
147057583|NCT04426006|530372033|FG000|3 Months|Lost to Follow-up|17|||
147057584|NCT04426006|530372033|FG000|12 Months|Lost to Follow-up|38|||
147057585|NCT00720213|530372036|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
147057586|NCT00720213|530372037|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
147057587|NCT00720213|530372038|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
147057588|NCT04495829|530372044|FG000|Overall Study|Lost to Follow-up|2|||
147057589|NCT04495829|530372044|FG000|Overall Study|Inclusion criterion not met|3|||
147057590|NCT02712554|530372048|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
147057591|NCT02712554|530372049|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
147057592|NCT02712554|530372048|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
147057593|NCT02712554|530372049|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
147057594|NCT02712554|530372048|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
147057595|NCT02712554|530372049|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
147057596|NCT02712554|530372048|FG000|Part B: Qualification Phase|Adverse Event|0|||
147057597|NCT02712554|530372049|FG001|Part B: Qualification Phase|Adverse Event|1|||
147057598|NCT02712554|530372048|FG000|Part B: Treatment Phase|Adverse Event|0|||
147057599|NCT02712554|530372049|FG001|Part B: Treatment Phase|Adverse Event|1|||
147057600|NCT02712554|530372048|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
147057601|NCT02712554|530372049|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
147057602|NCT02712554|530372048|FG000|Part B: Treatment Phase|Other|0|||
147057603|NCT02712554|530372049|FG001|Part B: Treatment Phase|Other|1|||
147057604|NCT02503540|530372050|FG000|Overall Study|Death|2|||
147057605|NCT02503540|530372050|FG000|Overall Study|Withdrawal by Subject|1|||
147057606|NCT01662492|530372051|FG000|Overall Study|Other miscellaneous reasons.|1|||
147057607|NCT01662492|530372052|FG001|Overall Study|Other miscellaneous reasons.|0|||
147057608|NCT01662492|530372053|FG002|Overall Study|Other miscellaneous reasons.|1|||
147057609|NCT01662492|530372051|FG000|Overall Study|Withdrawal by Subject|0|||
147057610|NCT01662492|530372052|FG001|Overall Study|Withdrawal by Subject|0|||
147057611|NCT01662492|530372053|FG002|Overall Study|Withdrawal by Subject|1|||
147057612|NCT01662492|530372051|FG000|Overall Study|Protocol Violation|1|||
147057613|NCT01662492|530372052|FG001|Overall Study|Protocol Violation|0|||
147057614|NCT01662492|530372053|FG002|Overall Study|Protocol Violation|0|||
147057615|NCT01662492|530372051|FG000|Overall Study|Lost to Follow-up|0|||
147057616|NCT01662492|530372052|FG001|Overall Study|Lost to Follow-up|0|||
147057617|NCT01662492|530372053|FG002|Overall Study|Lost to Follow-up|2|||
147057618|NCT01662492|530372051|FG000|Overall Study|Lack of Efficacy|1|||
147057619|NCT01662492|530372052|FG001|Overall Study|Lack of Efficacy|1|||
147057620|NCT01662492|530372053|FG002|Overall Study|Lack of Efficacy|2|||
147057621|NCT01991743|530372054|FG000|Overall Study|external cephalic version not performed|0|||
147057622|NCT01991743|530372055|FG001|Overall Study|external cephalic version not performed|0|||
147057623|NCT01991743|530372056|FG002|Overall Study|external cephalic version not performed|1|||
147057624|NCT01991743|530372057|FG003|Overall Study|external cephalic version not performed|0|||
147057625|NCT05151744|530373812|FG000|Overall Study|Adverse Event|6|||
147057626|NCT05151744|530373813|FG001|Overall Study|Adverse Event|2|||
147057627|NCT05151744|530373812|FG000|Overall Study|Death|1|||
147057628|NCT05151744|530373813|FG001|Overall Study|Death|2|||
147057629|NCT05151744|530373812|FG000|Overall Study|Lack of Efficacy|1|||
147057630|NCT05151744|530373813|FG001|Overall Study|Lack of Efficacy|1|||
147057631|NCT05151744|530373812|FG000|Overall Study|Lost to Follow-up|2|||
147057632|NCT05151744|530373813|FG001|Overall Study|Lost to Follow-up|2|||
147057633|NCT05151744|530373812|FG000|Overall Study|Need for Rescue Treatment|0|||
147057634|NCT05151744|530373813|FG001|Overall Study|Need for Rescue Treatment|1|||
147057635|NCT05151744|530373812|FG000|Overall Study|Non-compliance with Study Drug|0|||
147057636|NCT05151744|530373813|FG001|Overall Study|Non-compliance with Study Drug|1|||
147057637|NCT05151744|530373812|FG000|Overall Study|Reason not Specified|10|||
147057638|NCT05151744|530373813|FG001|Overall Study|Reason not Specified|0|||
147057639|NCT05151744|530373812|FG000|Overall Study|Physician Decision|2|||
147057640|NCT05151744|530373813|FG001|Overall Study|Physician Decision|1|||
147057641|NCT05151744|530373812|FG000|Overall Study|Protocol Violation|1|||
147057642|NCT05151744|530373813|FG001|Overall Study|Protocol Violation|0|||
147057643|NCT05151744|530373812|FG000|Overall Study|Withdrawal by Subject|6|||
147057644|NCT05151744|530373813|FG001|Overall Study|Withdrawal by Subject|3|||
147057645|NCT05228470|530373814|FG000|Overall Study|Death|6|||
147057646|NCT05228470|530373815|FG001|Overall Study|Death|11|||
147057647|NCT05228470|530373814|FG000|Overall Study|Withdrawal by Subject|1|||
147057648|NCT05228470|530373815|FG001|Overall Study|Withdrawal by Subject|8|||
147057649|NCT05228470|530373814|FG000|Overall Study|Ongoing|1|||
147057650|NCT05228470|530373815|FG001|Overall Study|Ongoing|11|||
147057651|NCT04053868|530373816|FG000|Overall Study|Withdrawal by Subject|1|||
147057652|NCT04053868|530373817|FG001|Overall Study|Withdrawal by Subject|0|||
147057653|NCT05731700|530373818|FG000|Overall Study|Death|1|||
147057654|NCT04010240|530373821|FG000|Overall Study|IHC not performed|2299|||
147057655|NCT05400655|530373822|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
147057656|NCT05400655|530373823|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
147057657|NCT05400655|530373824|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
147057658|NCT05400655|530373825|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
147057659|NCT05400655|530373826|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
147057660|NCT05400655|530373827|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
147057661|NCT05400655|530373828|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
147057662|NCT05400655|530373829|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
147057663|NCT05400655|530373830|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
147057664|NCT05400655|530373831|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
147057665|NCT05400655|530373832|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
147057666|NCT05400655|530373833|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
147057667|NCT05400655|530373834|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
147057668|NCT05400655|530373835|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
147057669|NCT05400655|530373836|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
147057670|NCT05400655|530373837|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
147057671|NCT05400655|530373838|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
147057672|NCT05400655|530373839|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
147057673|NCT05400655|530373840|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
147057674|NCT05400655|530373841|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
147057675|NCT05400655|530373842|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
147057676|NCT05400655|530373843|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
147057677|NCT05400655|530373822|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057678|NCT05400655|530373823|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057679|NCT05400655|530373824|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057680|NCT05400655|530373825|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057681|NCT05400655|530373826|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057682|NCT05400655|530373827|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057683|NCT05400655|530373828|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057684|NCT05400655|530373829|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057685|NCT05400655|530373830|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057686|NCT05400655|530373831|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057687|NCT05400655|530373832|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057688|NCT05400655|530373833|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057689|NCT05400655|530373834|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
147057690|NCT05400655|530373835|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057691|NCT05400655|530373836|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057692|NCT05400655|530373837|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057693|NCT05400655|530373838|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
147057694|NCT05400655|530373839|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057695|NCT05400655|530373840|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
147057696|NCT05400655|530373841|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
147057697|NCT05400655|530373842|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057698|NCT05400655|530373843|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147057699|NCT05400655|530373822|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057700|NCT05400655|530373823|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057701|NCT05400655|530373824|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057702|NCT05400655|530373825|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057703|NCT05400655|530373826|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057704|NCT05400655|530373827|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057705|NCT05400655|530373828|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057706|NCT05400655|530373829|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057707|NCT05400655|530373830|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057708|NCT05400655|530373831|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057709|NCT05400655|530373832|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057710|NCT05400655|530373833|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057711|NCT05400655|530373834|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057712|NCT05400655|530373835|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
147057713|NCT05400655|530373836|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057714|NCT05400655|530373837|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057715|NCT05400655|530373838|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
147057716|NCT05400655|530373839|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057717|NCT05400655|530373840|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
147057718|NCT05400655|530373841|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057719|NCT05400655|530373842|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057720|NCT05400655|530373843|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147057721|NCT05400655|530373822|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057722|NCT05400655|530373823|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057723|NCT05400655|530373824|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057724|NCT05400655|530373825|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057725|NCT05400655|530373826|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057726|NCT05400655|530373827|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057727|NCT05400655|530373828|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057728|NCT05400655|530373829|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057729|NCT05400655|530373830|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057730|NCT05400655|530373831|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057731|NCT05400655|530373832|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057732|NCT05400655|530373833|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057733|NCT05400655|530373834|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057734|NCT05400655|530373835|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057735|NCT05400655|530373836|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057736|NCT05400655|530373837|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057737|NCT05400655|530373838|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
147057738|NCT05400655|530373839|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
147057739|NCT05400655|530373840|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
147057740|NCT05400655|530373841|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147057741|NCT05400655|530373842|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
147057742|NCT05400655|530373843|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
147057743|NCT05400655|530373822|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057744|NCT05400655|530373823|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057745|NCT05400655|530373824|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057746|NCT05400655|530373825|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057747|NCT05400655|530373826|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057748|NCT05400655|530373827|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057749|NCT05400655|530373828|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057750|NCT05400655|530373829|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057751|NCT05400655|530373830|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057752|NCT05400655|530373831|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057753|NCT05400655|530373832|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057754|NCT05400655|530373833|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057755|NCT05400655|530373834|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057756|NCT05400655|530373835|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057757|NCT05400655|530373836|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057758|NCT05400655|530373837|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057759|NCT05400655|530373838|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057760|NCT05400655|530373839|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
147057761|NCT05400655|530373840|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
147057762|NCT05400655|530373841|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057763|NCT05400655|530373842|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057764|NCT05400655|530373843|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147057765|NCT05400655|530373822|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057766|NCT05400655|530373823|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057767|NCT05400655|530373824|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057768|NCT05400655|530373825|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057769|NCT05400655|530373826|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057770|NCT05400655|530373827|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057771|NCT05400655|530373828|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057772|NCT05400655|530373829|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057773|NCT05400655|530373830|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057774|NCT05400655|530373831|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057775|NCT05400655|530373832|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057776|NCT05400655|530373833|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057777|NCT05400655|530373834|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057778|NCT05400655|530373835|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057779|NCT05400655|530373836|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057780|NCT05400655|530373837|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057781|NCT05400655|530373838|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
147057782|NCT05400655|530373839|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147057783|NCT05400655|530373840|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
147057784|NCT05400655|530373841|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
147057785|NCT05400655|530373842|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
147057786|NCT05400655|530373843|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
147057787|NCT00570687|530373844|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057788|NCT00570687|530373845|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057789|NCT00570687|530373846|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057790|NCT00570687|530373847|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057791|NCT00570687|530373848|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
147057792|NCT00570687|530373849|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
147057793|NCT00570687|530373850|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
147057794|NCT00570687|530373851|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
147057795|NCT00570687|530373852|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
147057796|NCT00570687|530373853|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
147057797|NCT00570687|530373844|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057798|NCT00570687|530373845|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057799|NCT00570687|530373846|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057800|NCT00570687|530373847|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057801|NCT00570687|530373848|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057802|NCT00570687|530373849|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057803|NCT00570687|530373850|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057804|NCT00570687|530373851|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057805|NCT00570687|530373852|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
147057806|NCT00570687|530373853|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057807|NCT00570687|530373844|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057808|NCT00570687|530373845|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057809|NCT00570687|530373846|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057810|NCT00570687|530373847|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057811|NCT00570687|530373848|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057812|NCT00570687|530373849|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057813|NCT00570687|530373850|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
147057814|NCT00570687|530373851|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057815|NCT00570687|530373852|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057816|NCT00570687|530373853|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147057817|NCT00975611|530373854|FG000|Overall Study|Screen Fail|16|||
147057818|NCT00975611|530373854|FG000|Overall Study|Physician Decision|1|||
147057819|NCT01682226|530373855|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
147057820|NCT01682226|530373855|FG000|Overall Study|Participants did not receive treatment|2|||
147057821|NCT01682226|530373855|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
147057822|NCT03771898|530373856|FG000|Overall Study|Adverse Event|1|||
147057823|NCT03771898|530373857|FG001|Overall Study|Adverse Event|0|||
147057824|NCT03771898|530373858|FG002|Overall Study|Adverse Event|0|||
147057825|NCT03771898|530373859|FG003|Overall Study|Adverse Event|0|||
147057826|NCT03771898|530373860|FG004|Overall Study|Adverse Event|0|||
147057827|NCT03771898|530373856|FG000|Overall Study|Lost to Follow-up|1|||
147057828|NCT03771898|530373857|FG001|Overall Study|Lost to Follow-up|1|||
147057829|NCT03771898|530373858|FG002|Overall Study|Lost to Follow-up|1|||
147057830|NCT03771898|530373859|FG003|Overall Study|Lost to Follow-up|0|||
147057831|NCT03771898|530373860|FG004|Overall Study|Lost to Follow-up|0|||
147057832|NCT03771898|530373856|FG000|Overall Study|Withdrawal by parent/guardian|1|||
147057833|NCT03771898|530373857|FG001|Overall Study|Withdrawal by parent/guardian|1|||
147057834|NCT03771898|530373858|FG002|Overall Study|Withdrawal by parent/guardian|0|||
147057835|NCT03771898|530373859|FG003|Overall Study|Withdrawal by parent/guardian|0|||
147057836|NCT03771898|530373860|FG004|Overall Study|Withdrawal by parent/guardian|0|||
147057837|NCT03771898|530373856|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
147057838|NCT03771898|530373857|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
147057839|NCT03771898|530373858|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
147057840|NCT03771898|530373859|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
147057841|NCT03771898|530373860|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
147057842|NCT03263936|530373861|FG000|Overall Study|Adverse Event|0|||
147057843|NCT03263936|530373862|FG001|Overall Study|Adverse Event|1|||
147057844|NCT03263936|530373863|FG002|Overall Study|Adverse Event|0|||
147057845|NCT03263936|530373861|FG000|Overall Study|Death|0|||
147057846|NCT03263936|530373862|FG001|Overall Study|Death|1|||
147057847|NCT03263936|530373863|FG002|Overall Study|Death|0|||
147057848|NCT05343000|530373864|FG000|Overall Study|Physician Decision|2|||
147057849|NCT03123120|530373865|FG000|Overall Study|Lost to Follow-up|0|||
147057850|NCT03123120|530373866|FG001|Overall Study|Lost to Follow-up|1|||
147057851|NCT03123120|530373865|FG000|Overall Study|Withdrawal by Subject|0|||
147057852|NCT03123120|530373866|FG001|Overall Study|Withdrawal by Subject|1|||
147057853|NCT03135548|530373867|FG000|Overall Study|Lost to Follow-up|3|||
147057854|NCT03135548|530373868|FG001|Overall Study|Lost to Follow-up|0|||
147057855|NCT03135548|530373869|FG002|Overall Study|Lost to Follow-up|0|||
147057856|NCT03135548|530373867|FG000|Overall Study|Withdrawal by Subject|2|||
147057857|NCT03135548|530373868|FG001|Overall Study|Withdrawal by Subject|2|||
147057858|NCT03135548|530373869|FG002|Overall Study|Withdrawal by Subject|1|||
147057859|NCT03135548|530373867|FG000|Overall Study|Other than listed|0|||
147057860|NCT03135548|530373868|FG001|Overall Study|Other than listed|2|||
147057861|NCT03135548|530373869|FG002|Overall Study|Other than listed|2|||
147057862|NCT02632175|530373870|FG000|Overall Study|Withdrawal by Subject|6|||
147057863|NCT02632175|530373870|FG000|Overall Study|Lost to Follow-up|1|||
147057864|NCT02632175|530373870|FG000|Overall Study|Lack of Efficacy|18|||
147057865|NCT02632175|530373870|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
147057866|NCT02632175|530373870|FG000|Overall Study|Subject noncompliance|3|||
147057867|NCT02632175|530373870|FG000|Overall Study|other|2|||
147057868|NCT02088554|530373871|FG000|Overall Study|Exited before procedure|130|||
147057869|NCT02088554|530373871|FG000|Overall Study|Attempted but not implanted|31|||
147057870|NCT02088554|530373871|FG000|Overall Study|Implant not attempted|19|||
147057871|NCT02088554|530373871|FG000|Overall Study|Pending next visit|532|||
147057872|NCT02088554|530373871|FG000|Overall Study|Death|170|||
147057873|NCT02088554|530373871|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
147057874|NCT02088554|530373871|FG000|Overall Study|Lost to Follow-up|23|||
147057875|NCT02088554|530373871|FG000|Overall Study|Explanted|32|||
147057876|NCT02088554|530373871|FG000|Overall Study|Any other reason not covered by previous categories|11|||
147057877|NCT04623216|530373872|FG000|Overall Study|Death|5|||
147057878|NCT04623216|530373873|FG001|Overall Study|Death|2|||
147057879|NCT04623216|530373874|FG002|Overall Study|Death|0|||
147057880|NCT04623216|530373875|FG003|Overall Study|Death|0|||
147057881|NCT04623216|530373872|FG000|Overall Study|Terminated by Sponsor|3|||
147057882|NCT04623216|530373873|FG001|Overall Study|Terminated by Sponsor|2|||
147057883|NCT04623216|530373874|FG002|Overall Study|Terminated by Sponsor|2|||
147057884|NCT04623216|530373875|FG003|Overall Study|Terminated by Sponsor|0|||
147057885|NCT04623216|530373872|FG000|Overall Study|Physician Decision|1|||
147057886|NCT04623216|530373873|FG001|Overall Study|Physician Decision|0|||
147057887|NCT04623216|530373874|FG002|Overall Study|Physician Decision|0|||
147057888|NCT04623216|530373875|FG003|Overall Study|Physician Decision|0|||
147057889|NCT03521154|530373878|FG000|Overall Study|Ongoing study at data cut-off|111|||
147057890|NCT03521154|530373879|FG001|Overall Study|Ongoing study at data cut-off|52|||
147057891|NCT05386680|530373880|FG000|Overall Study|Guardian decision|2|||
147057892|NCT02283268|530373902|FG000|Overall Study|Withdrawal by Subject|1|||
147057893|NCT00454246|530373903|FG000|Overall Study|Adverse Event|2|||
147057894|NCT00454246|530373904|FG001|Overall Study|Adverse Event|2|||
147057895|NCT00454246|530373905|FG002|Overall Study|Adverse Event|0|||
147057896|NCT00454246|530373903|FG000|Overall Study|Violation of selection criteria at entry|6|||
147057897|NCT00454246|530373904|FG001|Overall Study|Violation of selection criteria at entry|0|||
147057898|NCT00454246|530373905|FG002|Overall Study|Violation of selection criteria at entry|0|||
147057899|NCT00454246|530373903|FG000|Overall Study|Protocol Violation|1|||
147057900|NCT00454246|530373904|FG001|Overall Study|Protocol Violation|0|||
147057901|NCT00454246|530373905|FG002|Overall Study|Protocol Violation|0|||
147057902|NCT00454246|530373903|FG000|Overall Study|Refused Treatment|1|||
147057903|NCT00454246|530373904|FG001|Overall Study|Refused Treatment|1|||
147057904|NCT00454246|530373905|FG002|Overall Study|Refused Treatment|0|||
147057905|NCT00454246|530373903|FG000|Overall Study|Failure to return|1|||
147057906|NCT00454246|530373904|FG001|Overall Study|Failure to return|0|||
147057907|NCT00454246|530373905|FG002|Overall Study|Failure to return|0|||
147057908|NCT00454246|530373903|FG000|Overall Study|Early termination of study|62|||
147057909|NCT00454246|530373904|FG001|Overall Study|Early termination of study|26|||
147057910|NCT00454246|530373905|FG002|Overall Study|Early termination of study|9|||
147057911|NCT05326529|530373906|FG000|Overall Study|Lack of Efficacy|0|||
147057912|NCT05326529|530373907|FG001|Overall Study|Lack of Efficacy|1|||
147057913|NCT05326529|530373908|FG002|Overall Study|Lack of Efficacy|0|||
147057914|NCT05326529|530373906|FG000|Overall Study|Physician Decision|0|||
147057915|NCT05326529|530373907|FG001|Overall Study|Physician Decision|0|||
147057916|NCT05326529|530373908|FG002|Overall Study|Physician Decision|2|||
147057917|NCT02126579|530373909|FG000|Overall Study|disease progression|0|||
147057918|NCT02126579|530373910|FG001|Overall Study|disease progression|0|||
147057919|NCT02126579|530373911|FG002|Overall Study|disease progression|0|||
147057920|NCT02126579|530373912|FG003|Overall Study|disease progression|1|||
147057921|NCT02126579|530373913|FG004|Overall Study|disease progression|0|||
147057922|NCT02126579|530373914|FG005|Overall Study|disease progression|0|||
147057923|NCT02126579|530373915|FG006|Overall Study|disease progression|1|||
147057924|NCT01780038|530373917|FG000|Overall Study|Lost to Follow-up|4|||
147057925|NCT01780038|530373918|FG001|Overall Study|Lost to Follow-up|1|||
147057926|NCT02309411|530373919|FG000|Overall Study|Physician Decision|1|||
147057927|NCT02309411|530373920|FG001|Overall Study|Physician Decision|0|||
147057928|NCT02309411|530373921|FG002|Overall Study|Physician Decision|0|||
147057929|NCT02309411|530373919|FG000|Overall Study|Withdrawal by Subject|1|||
147057930|NCT02309411|530373920|FG001|Overall Study|Withdrawal by Subject|1|||
147057931|NCT02309411|530373921|FG002|Overall Study|Withdrawal by Subject|0|||
147057932|NCT03168711|530373924|FG000|Overall Study|Adverse Event|2|||
147057933|NCT03168711|530373925|FG001|Overall Study|Adverse Event|0|||
147057934|NCT03168711|530373924|FG000|Overall Study|Withdrawal by Subject|0|||
147057935|NCT03168711|530373925|FG001|Overall Study|Withdrawal by Subject|1|||
147057936|NCT03168711|530373924|FG000|Overall Study|Death|0|||
147057937|NCT03168711|530373925|FG001|Overall Study|Death|1|||
147057938|NCT04509076|530373926|FG000|Overall Study|Withdrawal by Subject|1|||
147057939|NCT04509076|530373927|FG001|Overall Study|Withdrawal by Subject|2|||
147057940|NCT04509076|530373926|FG000|Overall Study|Lost to Follow-up|1|||
147057941|NCT04509076|530373927|FG001|Overall Study|Lost to Follow-up|2|||
147057942|NCT02588612|530373932|FG000|Overall Study|Physician Decision|1|||
147057943|NCT02588612|530373932|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
147057944|NCT02588612|530373932|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
147057945|NCT02588612|530373932|FG000|Overall Study|Death prior to T-cell infusion|1|||
147057946|NCT03448419|530373942|FG000|Overall Study|Adverse Event|10|||
147057947|NCT03448419|530373943|FG001|Overall Study|Adverse Event|9|||
147057948|NCT03448419|530373942|FG000|Overall Study|Lost to Follow-up|0|||
147057949|NCT03448419|530373943|FG001|Overall Study|Lost to Follow-up|2|||
147057950|NCT03448419|530373942|FG000|Overall Study|Withdrawal by Subject|3|||
147057951|NCT03448419|530373943|FG001|Overall Study|Withdrawal by Subject|1|||
147057952|NCT03448419|530373942|FG000|Overall Study|Not treated|0|||
147057953|NCT03448419|530373943|FG001|Overall Study|Not treated|1|||
147057954|NCT03448419|530373942|FG000|Overall Study|Patient did not attend all visits|0|||
147057955|NCT03448419|530373943|FG001|Overall Study|Patient did not attend all visits|2|||
147057956|NCT03448419|530373942|FG000|Overall Study|Withdrawn by Sponsor|0|||
147057957|NCT03448419|530373943|FG001|Overall Study|Withdrawn by Sponsor|1|||
147057958|NCT00410813|530373946|FG000|Overall Study|Adverse Event|6|||
147057959|NCT00410813|530373947|FG001|Overall Study|Adverse Event|11|||
147057960|NCT00410813|530373946|FG000|Overall Study|Progression|32|||
147057961|NCT00410813|530373947|FG001|Overall Study|Progression|21|||
147057962|NCT00410813|530373946|FG000|Overall Study|Not protocol specified|3|||
147057963|NCT00410813|530373947|FG001|Overall Study|Not protocol specified|4|||
147057964|NCT00410813|530373946|FG000|Overall Study|Ineligible|2|||
147057965|NCT00410813|530373947|FG001|Overall Study|Ineligible|4|||
147057966|NCT00410813|530373946|FG000|Overall Study|Death|0|||
147057967|NCT00410813|530373947|FG001|Overall Study|Death|2|||
147057968|NCT04278417|530373948|FG000|Overall Study|Withdrawal by Subject|20|||
147057969|NCT04278417|530373949|FG001|Overall Study|Withdrawal by Subject|20|||
147057970|NCT04278417|530373948|FG000|Overall Study|Progressive disease|0|||
147057971|NCT04278417|530373949|FG001|Overall Study|Progressive disease|2|||
147057972|NCT04278417|530373948|FG000|Overall Study|Physician Decision|4|||
147057973|NCT04278417|530373949|FG001|Overall Study|Physician Decision|6|||
147057974|NCT04278417|530373948|FG000|Overall Study|Lost to Follow-up|11|||
147057975|NCT04278417|530373949|FG001|Overall Study|Lost to Follow-up|13|||
147057976|NCT04278417|530373948|FG000|Overall Study|Death|8|||
147057977|NCT04278417|530373949|FG001|Overall Study|Death|9|||
147057978|NCT04278417|530373948|FG000|Overall Study|Adverse Event|3|||
147057979|NCT04278417|530373949|FG001|Overall Study|Adverse Event|5|||
147057980|NCT06509438|530373950|FG000|Overall Study|Adverse Event|1|||
147057981|NCT06509438|530373950|FG000|Overall Study|Lost to Follow-up|3|||
147057982|NCT01262872|530373952|FG000|Step 2|Death|0|||
147057983|NCT01262872|530373953|FG001|Step 2|Death|0|||
147057984|NCT01262872|530373954|FG002|Step 2|Death|0|||
147057985|NCT01262872|530373955|FG003|Step 2|Death|1|||
147057986|NCT01262872|530373956|FG004|Step 2|Death|0|||
147057987|NCT01262872|530373957|FG005|Step 2|Death|2|||
147057988|NCT01262872|530373958|FG006|Step 2|Death|2|||
147057989|NCT01262872|530373959|FG007|Step 2|Death|1|||
147057990|NCT01262872|530373952|FG000|Step 2|Protocol Violation|0|||
147057991|NCT01262872|530373953|FG001|Step 2|Protocol Violation|0|||
147057992|NCT01262872|530373954|FG002|Step 2|Protocol Violation|1|||
147057993|NCT01262872|530373955|FG003|Step 2|Protocol Violation|0|||
147057994|NCT01262872|530373956|FG004|Step 2|Protocol Violation|0|||
147057995|NCT01262872|530373957|FG005|Step 2|Protocol Violation|0|||
147057996|NCT01262872|530373958|FG006|Step 2|Protocol Violation|3|||
147057997|NCT01262872|530373959|FG007|Step 2|Protocol Violation|1|||
147057998|NCT01262872|530373952|FG000|Step 2|Withdrawal by Subject|0|||
147057999|NCT01262872|530373953|FG001|Step 2|Withdrawal by Subject|0|||
147058000|NCT01262872|530373954|FG002|Step 2|Withdrawal by Subject|4|||
147058001|NCT01262872|530373955|FG003|Step 2|Withdrawal by Subject|6|||
147058002|NCT01262872|530373956|FG004|Step 2|Withdrawal by Subject|3|||
147058003|NCT01262872|530373957|FG005|Step 2|Withdrawal by Subject|1|||
147058004|NCT01262872|530373958|FG006|Step 2|Withdrawal by Subject|2|||
147058005|NCT01262872|530373959|FG007|Step 2|Withdrawal by Subject|1|||
147058006|NCT01262872|530373952|FG000|Step 2|Migrated/moved from study area|0|||
147058007|NCT01262872|530373953|FG001|Step 2|Migrated/moved from study area|0|||
147058008|NCT01262872|530373954|FG002|Step 2|Migrated/moved from study area|4|||
147058009|NCT01262872|530373955|FG003|Step 2|Migrated/moved from study area|3|||
147058010|NCT01262872|530373956|FG004|Step 2|Migrated/moved from study area|2|||
147058011|NCT01262872|530373957|FG005|Step 2|Migrated/moved from study area|6|||
147058012|NCT01262872|530373958|FG006|Step 2|Migrated/moved from study area|2|||
147058013|NCT01262872|530373959|FG007|Step 2|Migrated/moved from study area|3|||
147058014|NCT01000155|530373960|FG000|Overall Study|Withdrawal by Subject|1|||
147058015|NCT01000155|530373960|FG000|Overall Study|Adverse Event|1|||
147058016|NCT00365794|530373962|FG000|Overall Study|Withdrawal by Subject|2|||
147058017|NCT02554682|530373963|FG000|Overall Study|Lost to Follow-up|11|||
147058018|NCT02554682|530373964|FG001|Overall Study|Lost to Follow-up|9|||
147058019|NCT02554682|530373965|FG002|Overall Study|Lost to Follow-up|4|||
147058020|NCT02554682|530373966|FG003|Overall Study|Lost to Follow-up|3|||
147058021|NCT02554682|530373967|FG004|Overall Study|Lost to Follow-up|2|||
147058022|NCT02554682|530373968|FG005|Overall Study|Lost to Follow-up|1|||
147058023|NCT02554682|530373969|FG006|Overall Study|Lost to Follow-up|6|||
147058024|NCT02554682|530373970|FG007|Overall Study|Lost to Follow-up|6|||
147058025|NCT02554682|530373971|FG008|Overall Study|Lost to Follow-up|2|||
147058026|NCT02554682|530373972|FG009|Overall Study|Lost to Follow-up|2|||
147058027|NCT02554682|530373963|FG000|Overall Study|Withdrawal by Subject|2|||
147058028|NCT02554682|530373964|FG001|Overall Study|Withdrawal by Subject|1|||
147058029|NCT02554682|530373965|FG002|Overall Study|Withdrawal by Subject|0|||
147058030|NCT02554682|530373966|FG003|Overall Study|Withdrawal by Subject|0|||
147058031|NCT02554682|530373967|FG004|Overall Study|Withdrawal by Subject|0|||
147058032|NCT02554682|530373968|FG005|Overall Study|Withdrawal by Subject|0|||
147058033|NCT02554682|530373969|FG006|Overall Study|Withdrawal by Subject|0|||
147058034|NCT02554682|530373970|FG007|Overall Study|Withdrawal by Subject|0|||
147058035|NCT02554682|530373971|FG008|Overall Study|Withdrawal by Subject|0|||
147058036|NCT02554682|530373972|FG009|Overall Study|Withdrawal by Subject|0|||
147058037|NCT02554682|530373963|FG000|Overall Study|Physician Decision|2|||
147058038|NCT02554682|530373964|FG001|Overall Study|Physician Decision|2|||
147058039|NCT02554682|530373965|FG002|Overall Study|Physician Decision|0|||
147058040|NCT02554682|530373966|FG003|Overall Study|Physician Decision|0|||
147058041|NCT02554682|530373967|FG004|Overall Study|Physician Decision|0|||
147058042|NCT02554682|530373968|FG005|Overall Study|Physician Decision|0|||
147058043|NCT02554682|530373969|FG006|Overall Study|Physician Decision|0|||
147058044|NCT02554682|530373970|FG007|Overall Study|Physician Decision|0|||
147058045|NCT02554682|530373971|FG008|Overall Study|Physician Decision|0|||
147058046|NCT02554682|530373972|FG009|Overall Study|Physician Decision|0|||
147058047|NCT02169271|530373973|FG000|Overall Study|Protocol Violation|1|||
147058048|NCT02169271|530373974|FG001|Overall Study|Protocol Violation|2|||
147058049|NCT03711786|530373979|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
147058050|NCT03711786|530373980|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
147058051|NCT03711786|530373979|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
147058052|NCT03711786|530373980|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
147058053|NCT03711786|530373979|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
147058054|NCT03711786|530373980|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
147058055|NCT03711786|530373979|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
147058056|NCT03711786|530373980|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
147058057|NCT03711786|530373979|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
147058058|NCT03711786|530373980|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
147058059|NCT03711786|530373979|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
147058060|NCT03711786|530373980|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
147058061|NCT01611883|530373982|FG000|Overall Study|Adverse Event|1|||
147058062|NCT01611883|530373983|FG001|Overall Study|Adverse Event|1|||
147058063|NCT00734994|530373984|FG000|Overall Study|Withdrawal by Subject|1|||
147058064|NCT01622673|530373985|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147058065|NCT01622673|530373986|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147058066|NCT01622673|530373987|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147058067|NCT01622673|530373988|FG003|Treatment Period 1|Withdrawal by Subject|1|||
147058068|NCT01622673|530373989|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147058069|NCT01622673|530373990|FG005|Treatment Period 1|Withdrawal by Subject|0|||
147058070|NCT01622673|530373985|FG000|Treatment Period 1|Protocol Violation|0|||
147058071|NCT01622673|530373986|FG001|Treatment Period 1|Protocol Violation|1|||
147058072|NCT01622673|530373987|FG002|Treatment Period 1|Protocol Violation|0|||
147058073|NCT01622673|530373988|FG003|Treatment Period 1|Protocol Violation|0|||
147058074|NCT01622673|530373989|FG004|Treatment Period 1|Protocol Violation|0|||
147058075|NCT01622673|530373990|FG005|Treatment Period 1|Protocol Violation|0|||
147058076|NCT01622673|530373985|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147058077|NCT01622673|530373986|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147058078|NCT01622673|530373987|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147058079|NCT01622673|530373988|FG003|Treatment Period 2|Withdrawal by Subject|1|||
147058080|NCT01622673|530373989|FG004|Treatment Period 2|Withdrawal by Subject|0|||
147058081|NCT01622673|530373990|FG005|Treatment Period 2|Withdrawal by Subject|0|||
147058082|NCT01622673|530373985|FG000|Treatment Period 3|Protocol Violation|0|||
147058083|NCT01622673|530373986|FG001|Treatment Period 3|Protocol Violation|1|||
147058084|NCT01622673|530373987|FG002|Treatment Period 3|Protocol Violation|0|||
147058085|NCT01622673|530373988|FG003|Treatment Period 3|Protocol Violation|0|||
147058086|NCT01622673|530373989|FG004|Treatment Period 3|Protocol Violation|0|||
147058087|NCT01622673|530373990|FG005|Treatment Period 3|Protocol Violation|0|||
147058088|NCT00298272|530375639|FG000|Double-blind Phase|Adverse Event|2|||
147058089|NCT00298272|530375640|FG001|Double-blind Phase|Adverse Event|0|||
147058090|NCT00298272|530375639|FG000|Double-blind Phase|Failure to Return|2|||
147058091|NCT00298272|530375640|FG001|Double-blind Phase|Failure to Return|0|||
147058092|NCT00298272|530375639|FG000|Double-blind Phase|Protocol Violation|2|||
147058093|NCT00298272|530375640|FG001|Double-blind Phase|Protocol Violation|0|||
147058094|NCT00298272|530375639|FG000|Double-blind Phase|Withdrawal by Subject|2|||
147058095|NCT00298272|530375640|FG001|Double-blind Phase|Withdrawal by Subject|0|||
147058096|NCT00298272|530375639|FG000|Open Label Retreatment Phase|Adverse Event|1|||
147058097|NCT00298272|530375640|FG001|Open Label Retreatment Phase|Adverse Event|2|||
147058098|NCT00298272|530375639|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
147058099|NCT00298272|530375640|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
147058100|NCT00298272|530375639|FG000|Open Label Retreatment Phase|Failure to Return|1|||
147058101|NCT00298272|530375640|FG001|Open Label Retreatment Phase|Failure to Return|0|||
147058102|NCT00298272|530375639|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
147058103|NCT00298272|530375640|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
147058104|NCT00298272|530375639|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
147058105|NCT00298272|530375640|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
147058106|NCT00298272|530375639|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
147058107|NCT00298272|530375640|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
147058108|NCT00298272|530375639|FG000|Safety Follow-up Phase|Failure to Return|1|||
147058109|NCT00298272|530375640|FG001|Safety Follow-up Phase|Failure to Return|1|||
147058110|NCT00298272|530375639|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
147058111|NCT00298272|530375640|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
147058112|NCT00298272|530375639|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
147058113|NCT00298272|530375640|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
147058114|NCT00915018|530375641|FG000|Overall Study|Death|75|||
147058115|NCT00915018|530375642|FG001|Overall Study|Death|70|||
147058116|NCT00915018|530375641|FG000|Overall Study|Lost to Follow-up|10|||
147058117|NCT00915018|530375642|FG001|Overall Study|Lost to Follow-up|5|||
147058118|NCT00915018|530375641|FG000|Overall Study|Withdrawal by Subject|38|||
147058119|NCT00915018|530375642|FG001|Overall Study|Withdrawal by Subject|27|||
147058120|NCT00915018|530375641|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
147058121|NCT00915018|530375642|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
147058122|NCT00457002|530375643|FG000|Overall Study|Death|40|||
147058123|NCT00457002|530375644|FG001|Overall Study|Death|47|||
147058124|NCT00457002|530375643|FG000|Overall Study|Adverse Event|284|||
147058125|NCT00457002|530375644|FG001|Overall Study|Adverse Event|260|||
147058126|NCT00457002|530375643|FG000|Overall Study|Withdrawal by Subject|299|||
147058127|NCT00457002|530375644|FG001|Overall Study|Withdrawal by Subject|271|||
147058128|NCT00457002|530375643|FG000|Overall Study|Lost to Follow-up|72|||
147058129|NCT00457002|530375644|FG001|Overall Study|Lost to Follow-up|71|||
147058130|NCT00457002|530375643|FG000|Overall Study|Poor/Non-compliance|46|||
147058131|NCT00457002|530375644|FG001|Overall Study|Poor/Non-compliance|33|||
147058132|NCT00457002|530375643|FG000|Overall Study|No longer met criteria|41|||
147058133|NCT00457002|530375644|FG001|Overall Study|No longer met criteria|37|||
147058134|NCT00457002|530375643|FG000|Overall Study|Administrative reason by Sponsor|1|||
147058135|NCT00457002|530375644|FG001|Overall Study|Administrative reason by Sponsor|0|||
147058136|NCT00457002|530375643|FG000|Overall Study|non-specified|29|||
147058137|NCT00457002|530375644|FG001|Overall Study|non-specified|38|||
147058138|NCT00457002|530375643|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
147058139|NCT00457002|530375644|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
147058140|NCT04168112|530375645|FG000|Overall Study|Lost to Follow-up|1|||
147058141|NCT04168112|530375646|FG001|Overall Study|Lost to Follow-up|0|||
147058142|NCT04168112|530375645|FG000|Overall Study|Withdrawal by Subject|1|||
147058143|NCT04168112|530375646|FG001|Overall Study|Withdrawal by Subject|0|||
147058144|NCT02898597|530375647|FG000|Overall Study|Protocol Violation|4|||
147058145|NCT02898597|530375648|FG001|Overall Study|Protocol Violation|2|||
147058146|NCT02898597|530375647|FG000|Overall Study|Lost to Follow-up|0|||
147058147|NCT02898597|530375648|FG001|Overall Study|Lost to Follow-up|9|||
147058148|NCT02898597|530375647|FG000|Overall Study|Death|0|||
147058149|NCT02898597|530375648|FG001|Overall Study|Death|1|||
147058150|NCT00154284|530375649|FG000|Overall Study|Adverse Event|6|||
147058151|NCT00154284|530375650|FG001|Overall Study|Adverse Event|9|||
147058152|NCT00154284|530375649|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147058153|NCT00154284|530375650|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147058154|NCT00154284|530375649|FG000|Overall Study|Lack of Efficacy|1|||
147058155|NCT00154284|530375650|FG001|Overall Study|Lack of Efficacy|2|||
147058156|NCT00154284|530375649|FG000|Overall Study|Protocol Violation|0|||
147058157|NCT00154284|530375650|FG001|Overall Study|Protocol Violation|1|||
147058158|NCT00326716|530375651|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
147058159|NCT00326716|530375652|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
147058160|NCT00326716|530375653|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
147058161|NCT00326716|530375654|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
147058162|NCT00684411|530375655|FG000|Overall Study|New Primary Cancer|1|||
147058163|NCT00684411|530375655|FG000|Overall Study|Disease Progression|10|||
147058164|NCT00684411|530375655|FG000|Overall Study|Adverse Event|1|||
147058165|NCT05253573|530375656|FG000|Overall Study|Death|1|||
147058166|NCT05253573|530375657|FG001|Overall Study|Death|0|||
147058167|NCT01344824|530375658|FG000|Overall Study|Adverse Event|15|||
147058168|NCT01344824|530375658|FG000|Overall Study|Withdrawal by Subject|6|||
147058169|NCT01344824|530375658|FG000|Overall Study|Other complicating disease|1|||
147058170|NCT01344824|530375658|FG000|Overall Study|Progression|15|||
147058171|NCT01085630|530375663|FG000|Overall Study|Insufficient data|1|||
147058172|NCT01085630|530375664|FG001|Overall Study|Insufficient data|0|||
147058173|NCT01085630|530375663|FG000|Overall Study|Ineligible|3|||
147058174|NCT01085630|530375664|FG001|Overall Study|Ineligible|0|||
147058175|NCT02366637|530375670|FG000|First Intervention Period|Adverse Event|0|||
147058176|NCT02366637|530375671|FG001|First Intervention Period|Adverse Event|1|||
147058177|NCT02366637|530375670|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
147058178|NCT02366637|530375671|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
147058179|NCT02366637|530375670|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
147058180|NCT02366637|530375671|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
147058181|NCT01609010|530375672|FG000|Overall Study|Stable disease (SD)|22|||
147058182|NCT01609010|530375673|FG001|Overall Study|Stable disease (SD)|16|||
147058183|NCT01609010|530375672|FG000|Overall Study|Progressive disease (PD)|8|||
147058184|NCT01609010|530375673|FG001|Overall Study|Progressive disease (PD)|10|||
147058185|NCT01609010|530375672|FG000|Overall Study|Adverse Event|3|||
147058186|NCT01609010|530375673|FG001|Overall Study|Adverse Event|6|||
147058187|NCT01609010|530375672|FG000|Overall Study|Withdrawal by Subject|2|||
147058188|NCT01609010|530375673|FG001|Overall Study|Withdrawal by Subject|2|||
147058189|NCT01609010|530375672|FG000|Overall Study|Other|2|||
147058190|NCT01609010|530375673|FG001|Overall Study|Other|0|||
147058191|NCT01609010|530375672|FG000|Overall Study|Other malignancy|1|||
147058192|NCT01609010|530375673|FG001|Overall Study|Other malignancy|0|||
147058193|NCT01609010|530375672|FG000|Overall Study|Pathology review|2|||
147058194|NCT01609010|530375673|FG001|Overall Study|Pathology review|1|||
147058195|NCT01609010|530375672|FG000|Overall Study|Protocol Violation|1|||
147058196|NCT01609010|530375673|FG001|Overall Study|Protocol Violation|1|||
147058197|NCT01609010|530375672|FG000|Overall Study|New cancer|1|||
147058198|NCT01609010|530375673|FG001|Overall Study|New cancer|0|||
147058199|NCT01609010|530375672|FG000|Overall Study|Lost to Follow-up|1|||
147058200|NCT01609010|530375673|FG001|Overall Study|Lost to Follow-up|1|||
147058201|NCT00162981|530375677|FG000|Overall Study|Adverse Event|2|||
147058202|NCT00162981|530375678|FG001|Overall Study|Adverse Event|5|||
147058203|NCT00162981|530375677|FG000|Overall Study|Withdrawal by Subject|1|||
147058204|NCT00162981|530375678|FG001|Overall Study|Withdrawal by Subject|1|||
147058205|NCT00162981|530375677|FG000|Overall Study|Physician Decision|1|||
147058206|NCT00162981|530375678|FG001|Overall Study|Physician Decision|0|||
147058207|NCT04195685|530375679|FG000|Overall Study|Withdrawal by Subject|6|||
147058208|NCT04195685|530375680|FG001|Overall Study|Withdrawal by Subject|2|||
147058209|NCT04195685|530375679|FG000|Overall Study|Lost to Follow-up|1|||
147058210|NCT04195685|530375680|FG001|Overall Study|Lost to Follow-up|4|||
147058211|NCT02220764|530375687|FG000|Overall Study|Lost to Follow-up|3|||
147058212|NCT02220764|530375688|FG001|Overall Study|Lost to Follow-up|1|||
147058213|NCT02220764|530375687|FG000|Overall Study|Death|1|||
147058214|NCT02220764|530375688|FG001|Overall Study|Death|0|||
147058215|NCT02861807|530375689|FG000|Overall Study|Lost to Follow-up|7|||
147058216|NCT02861807|530375690|FG001|Overall Study|Lost to Follow-up|6|||
147058217|NCT02861807|530375689|FG000|Overall Study|Withdrawal by Subject|5|||
147058218|NCT02861807|530375690|FG001|Overall Study|Withdrawal by Subject|8|||
147058219|NCT05000164|530375691|FG000|Overall Study|Adverse Event|1|||
147058220|NCT05000164|530375691|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
147058221|NCT05000164|530375691|FG000|Overall Study|Lens Discomfort|3|||
147058222|NCT05000164|530375691|FG000|Overall Study|Withdrew Consent during Study|2|||
147058223|NCT05000164|530375691|FG000|Overall Study|Subject Withdrawn by PI|2|||
147058224|NCT05000164|530375691|FG000|Overall Study|Other Fractured Test Article|1|||
147058225|NCT01006122|530375692|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
147058226|NCT01006122|530375693|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
147058227|NCT01006122|530375692|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
147058228|NCT01006122|530375693|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
147058229|NCT01006122|530375692|FG000|First Double-blind Intervention Period|Pregnancy|0|||
147058230|NCT01006122|530375693|FG001|First Double-blind Intervention Period|Pregnancy|1|||
147058231|NCT01006122|530375692|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
147058232|NCT01006122|530375693|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
147058233|NCT01006122|530375692|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
147058234|NCT01006122|530375693|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
147058235|NCT01006122|530375692|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
147058236|NCT01006122|530375693|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
147058237|NCT01006122|530375692|FG000|First Double-blind Intervention Period|Other|3|||
147058238|NCT01006122|530375693|FG001|First Double-blind Intervention Period|Other|0|||
147058239|NCT01006122|530375692|FG000|First Double-blind Intervention Period|Adverse Event|0|||
147058240|NCT01006122|530375693|FG001|First Double-blind Intervention Period|Adverse Event|4|||
147058241|NCT01006122|530375692|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
147058242|NCT01006122|530375693|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
147058243|NCT01006122|530375692|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
147058244|NCT01006122|530375693|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
147058245|NCT01006122|530375692|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
147058246|NCT01006122|530375693|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
147058247|NCT01006122|530375692|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
147058248|NCT01006122|530375693|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
147058249|NCT01006122|530375692|FG000|Second Double-blind Intervention Period|Death|0|||
147058250|NCT01006122|530375693|FG001|Second Double-blind Intervention Period|Death|1|||
147058251|NCT03493854|530375694|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
147058252|NCT03493854|530375695|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
147058253|NCT03493854|530375694|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
147058254|NCT03493854|530375695|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
147058255|NCT03493854|530375694|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
147058256|NCT03493854|530375695|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
147058257|NCT03493854|530375694|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
147058258|NCT03493854|530375695|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
147058259|NCT03493854|530375694|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
147058260|NCT03493854|530375695|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
147058261|NCT03493854|530375694|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
147058262|NCT03493854|530375695|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
147058263|NCT03493854|530375694|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
147058264|NCT03493854|530375695|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
147058265|NCT03493854|530375694|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
147058266|NCT03493854|530375695|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
147058267|NCT03493854|530375694|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
147058268|NCT03493854|530375695|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
147058269|NCT03493854|530375694|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
147058270|NCT03493854|530375695|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
147058271|NCT03493854|530375694|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
147058272|NCT03493854|530375695|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
147058273|NCT03493854|530375694|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
147058274|NCT03493854|530375695|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
147058275|NCT03493854|530375694|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
147058276|NCT03493854|530375695|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
147058277|NCT03493854|530375694|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
147058278|NCT03493854|530375695|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
147058279|NCT03493854|530375694|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
147058280|NCT03493854|530375695|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
147058281|NCT03493854|530375694|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
147058282|NCT03493854|530375695|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
147058283|NCT03493854|530375694|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
147058284|NCT03493854|530375695|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
147058285|NCT03493854|530375694|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
147058286|NCT03493854|530375695|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
147058287|NCT01791894|530375698|FG000|Overall Study|Adverse Event|1|||
147058288|NCT02268916|530375703|FG000|Overall Study|Lost to Follow-up|1|||
147058289|NCT02268916|530375704|FG001|Overall Study|Lost to Follow-up|1|||
147058290|NCT02268916|530375703|FG000|Overall Study|Withdrawal by Subject|6|||
147058291|NCT02268916|530375704|FG001|Overall Study|Withdrawal by Subject|5|||
147058292|NCT02268916|530375703|FG000|Overall Study|Participant did not have diabetes|1|||
147058293|NCT02268916|530375704|FG001|Overall Study|Participant did not have diabetes|0|||
147058294|NCT02268916|530375703|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
147058295|NCT02268916|530375704|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
147058296|NCT04526288|530375712|FG000|Overall Study|Disease Progression|1|||
147058297|NCT04526288|530375713|FG001|Overall Study|Disease Progression|0|||
147058298|NCT00594165|530375714|FG000|Overall Study|Major protocol violation|1|||
147058299|NCT00594165|530375714|FG000|Overall Study|Lack of Efficacy|12|||
147058300|NCT00594165|530375714|FG000|Overall Study|Adverse Event|52|||
147058301|NCT00594165|530375714|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
147058302|NCT00594165|530375714|FG000|Overall Study|Subject withdrew consent|27|||
147058303|NCT00594165|530375714|FG000|Overall Study|Study ended per sponsor|102|||
147058304|NCT00594165|530375714|FG000|Overall Study|Lost to Follow-up|4|||
147058305|NCT00594165|530375714|FG000|Overall Study|Other: PI discretion|5|||
147058306|NCT00594165|530375714|FG000|Overall Study|Other: Subject moving|3|||
147058307|NCT00594165|530375714|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
147058308|NCT00594165|530375714|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
147058309|NCT00594165|530375714|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
147058310|NCT00594165|530375714|FG000|Overall Study|Other: Site terminated participation|2|||
147058311|NCT04830969|530375715|FG000|Overall Study|Withdrawal by Subject|6|||
147058312|NCT04830969|530375716|FG001|Overall Study|Withdrawal by Subject|2|||
147058313|NCT04830969|530375715|FG000|Overall Study|Protocol Violation|3|||
147058314|NCT04830969|530375716|FG001|Overall Study|Protocol Violation|9|||
147058315|NCT04830969|530375715|FG000|Overall Study|Lost to Follow-up|4|||
147058316|NCT04830969|530375716|FG001|Overall Study|Lost to Follow-up|4|||
147058317|NCT01422889|530375717|FG000|Overall Study|No Data Entered for Study Stent|9|||
147058318|NCT01580670|530375718|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
147058319|NCT01580670|530375718|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
147058320|NCT00996125|530375719|FG000|Overall Study|Adverse Event|0|||
147058321|NCT00996125|530375720|FG001|Overall Study|Adverse Event|2|||
147058322|NCT00996125|530375719|FG000|Overall Study|Lost to Follow-up|1|||
147058323|NCT00996125|530375720|FG001|Overall Study|Lost to Follow-up|6|||
147058324|NCT00996125|530375719|FG000|Overall Study|Withdrawal by Subject|4|||
147058325|NCT00996125|530375720|FG001|Overall Study|Withdrawal by Subject|3|||
147058326|NCT00488644|530375721|FG000|Overall Study|Not Eligible|1|||
147058327|NCT00488644|530375721|FG000|Overall Study|Not Evaluable|1|||
147058328|NCT04331067|530375722|FG000|Overall Study|Adverse Event|1|||
147058329|NCT04331067|530375723|FG001|Overall Study|Adverse Event|3|||
147058330|NCT04331067|530375724|FG002|Overall Study|Adverse Event|1|||
147058331|NCT04331067|530375722|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
147058332|NCT04331067|530375723|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
147058333|NCT04331067|530375724|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
147058334|NCT04926831|530375727|FG000|Overall Study|Withdrawal by Subject|2|||
147058335|NCT04926831|530375727|FG000|Overall Study|Adverse Event|2|||
147058336|NCT04025879|530375728|FG000|Randomization|Participant withdrew consent|0|||
147058337|NCT04025879|530375729|FG001|Randomization|Participant withdrew consent|1|||
147058338|NCT04025879|530375728|FG000|Randomization|Participant no longer met study criteria|1|||
147058339|NCT04025879|530375729|FG001|Randomization|Participant no longer met study criteria|1|||
147058340|NCT04025879|530375728|FG000|Treatment|Ongoing treatment|10|||
147058341|NCT04025879|530375729|FG001|Treatment|Ongoing treatment|8|||
147058342|NCT04025879|530375728|FG000|Treatment|Disease progression/recurrence|36|||
147058343|NCT04025879|530375729|FG001|Treatment|Disease progression/recurrence|72|||
147058344|NCT04025879|530375728|FG000|Treatment|Study drug toxicity|36|||
147058345|NCT04025879|530375729|FG001|Treatment|Study drug toxicity|13|||
147058346|NCT04025879|530375728|FG000|Treatment|Death|2|||
147058347|NCT04025879|530375729|FG001|Treatment|Death|0|||
147058348|NCT04025879|530375728|FG000|Treatment|Adverse event unrelated to study drug|21|||
147058349|NCT04025879|530375729|FG001|Treatment|Adverse event unrelated to study drug|14|||
147058350|NCT04025879|530375728|FG000|Treatment|Participant request to discontinue study treatment|16|||
147058351|NCT04025879|530375729|FG001|Treatment|Participant request to discontinue study treatment|8|||
147058352|NCT04025879|530375728|FG000|Treatment|Participant withdrew consent|1|||
147058353|NCT04025879|530375729|FG001|Treatment|Participant withdrew consent|3|||
147058354|NCT04025879|530375728|FG000|Treatment|Participant no longer meets study criteria|3|||
147058355|NCT04025879|530375729|FG001|Treatment|Participant no longer meets study criteria|2|||
147058356|NCT04025879|530375728|FG000|Treatment|Lost to Follow-up|1|||
147058357|NCT04025879|530375729|FG001|Treatment|Lost to Follow-up|0|||
147058358|NCT04025879|530375728|FG000|Treatment|Other reasons|15|||
147058359|NCT04025879|530375729|FG001|Treatment|Other reasons|17|||
147058360|NCT04025879|530375728|FG000|Treatment|Administrative reason by sponsor|0|||
147058361|NCT04025879|530375729|FG001|Treatment|Administrative reason by sponsor|1|||
147058362|NCT04025879|530375728|FG000|Treatment|Not reported|2|||
147058363|NCT04025879|530375729|FG001|Treatment|Not reported|0|||
147058364|NCT03482635|530375730|FG000|Overall Study|Lack of Efficacy|0|||
147058365|NCT03482635|530375731|FG001|Overall Study|Lack of Efficacy|0|||
147058366|NCT03482635|530375732|FG002|Overall Study|Lack of Efficacy|1|||
147058367|NCT03482635|530375733|FG003|Overall Study|Lack of Efficacy|3|||
147058368|NCT03482635|530375730|FG000|Overall Study|Adverse Event|2|||
147058369|NCT03482635|530375731|FG001|Overall Study|Adverse Event|2|||
147058370|NCT03482635|530375732|FG002|Overall Study|Adverse Event|0|||
146850065|NCT00911937|529620706|FG001|Overall Study|Lack of Efficacy|6|||
147058371|NCT03482635|530375733|FG003|Overall Study|Adverse Event|3|||
147058372|NCT03482635|530375730|FG000|Overall Study|Withdrawal by Subject|2|||
147058373|NCT03482635|530375731|FG001|Overall Study|Withdrawal by Subject|1|||
147058374|NCT03482635|530375732|FG002|Overall Study|Withdrawal by Subject|0|||
147058375|NCT03482635|530375733|FG003|Overall Study|Withdrawal by Subject|1|||
147058376|NCT03482635|530375730|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
147058377|NCT03482635|530375731|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
147058378|NCT03482635|530375732|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
147058379|NCT03482635|530375733|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
147058380|NCT03482635|530375730|FG000|Overall Study|Not treated|0|||
147058381|NCT03482635|530375731|FG001|Overall Study|Not treated|0|||
147058382|NCT03482635|530375732|FG002|Overall Study|Not treated|0|||
147058383|NCT03482635|530375733|FG003|Overall Study|Not treated|1|||
147058384|NCT03859427|530375739|FG000|Overall Study|Withdrawal by Subject|4|||
147058385|NCT03859427|530375740|FG001|Overall Study|Withdrawal by Subject|7|||
147058386|NCT03859427|530375739|FG000|Overall Study|Decision by sponsor|0|||
147058387|NCT03859427|530375740|FG001|Overall Study|Decision by sponsor|3|||
147058388|NCT03859427|530375739|FG000|Overall Study|Lost to Follow-up|3|||
147058389|NCT03859427|530375740|FG001|Overall Study|Lost to Follow-up|2|||
147058390|NCT03859427|530375739|FG000|Overall Study|Death|22|||
147058391|NCT03859427|530375740|FG001|Overall Study|Death|25|||
147058392|NCT00979654|530375744|FG000|Overall Study|Lost to Follow-up|1|||
147058393|NCT00979654|530375744|FG000|Overall Study|Withdrawal by Subject|22|||
147058394|NCT00979654|530375744|FG000|Overall Study|Death|1|||
147058395|NCT00979654|530375744|FG000|Overall Study|Lack of Efficacy|6|||
147058396|NCT00979654|530375744|FG000|Overall Study|Adverse Event|1|||
147058397|NCT00979654|530375744|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
147058398|NCT00979654|530375744|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
147058399|NCT00979654|530375744|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
147058400|NCT00979654|530375744|FG000|Overall Study|Serious Adverse Event|1|||
147058401|NCT00979654|530375744|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
147058402|NCT01804946|530375747|FG000|Overall Study|Protocol Violation|1|||
147058403|NCT01804946|530375748|FG001|Overall Study|Protocol Violation|0|||
147058404|NCT01804946|530375747|FG000|Overall Study|Adverse Event|0|||
147058405|NCT01804946|530375748|FG001|Overall Study|Adverse Event|1|||
147058406|NCT01804946|530375747|FG000|Overall Study|Insufficient data available|0|||
147058407|NCT01804946|530375748|FG001|Overall Study|Insufficient data available|1|||
147058408|NCT01804946|530375747|FG000|Overall Study|Do not meet inclusion criteria|1|||
147058409|NCT01804946|530375748|FG001|Overall Study|Do not meet inclusion criteria|2|||
147058410|NCT00722137|530375749|FG000|Overall Study|Overt Disease Progression|5|||
147058411|NCT00722137|530375750|FG001|Overall Study|Overt Disease Progression|4|||
147058412|NCT00722137|530375749|FG000|Overall Study|Adverse Event|17|||
147058413|NCT00722137|530375750|FG001|Overall Study|Adverse Event|21|||
147058414|NCT00722137|530375749|FG000|Overall Study|Death|12|||
147058415|NCT00722137|530375750|FG001|Overall Study|Death|7|||
147058416|NCT00722137|530375749|FG000|Overall Study|Withdrawal by Subject|6|||
147058417|NCT00722137|530375750|FG001|Overall Study|Withdrawal by Subject|9|||
147058418|NCT00722137|530375749|FG000|Overall Study|Other Reason Unknown|3|||
147058419|NCT00722137|530375750|FG001|Overall Study|Other Reason Unknown|4|||
147058420|NCT00722137|530375749|FG000|Overall Study|Randomized But Not Treated|2|||
147058421|NCT00722137|530375750|FG001|Overall Study|Randomized But Not Treated|3|||
147058422|NCT03830333|530375751|FG000|Overall Study|Death|0|||
147058423|NCT03830333|530375752|FG001|Overall Study|Death|1|||
147058424|NCT03830333|530375751|FG000|Overall Study|Withdrawal by Subject|5|||
147058425|NCT03830333|530375752|FG001|Overall Study|Withdrawal by Subject|1|||
147058426|NCT03830333|530375751|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
147058427|NCT03830333|530375752|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
147058428|NCT01129557|530375753|FG000|Overall Study|Adverse Event|1|||
147058429|NCT01129557|530375754|FG001|Overall Study|Adverse Event|2|||
147058430|NCT01129557|530375755|FG002|Overall Study|Adverse Event|2|||
147058431|NCT01129557|530375753|FG000|Overall Study|Novartis terminated study early|3|||
147058432|NCT01129557|530375754|FG001|Overall Study|Novartis terminated study early|3|||
147058433|NCT01129557|530375755|FG002|Overall Study|Novartis terminated study early|2|||
147058434|NCT01486446|530375756|FG000|Overall Study|Adverse Event|1|||
147058435|NCT01486446|530375757|FG001|Overall Study|Adverse Event|0|||
147058436|NCT01367886|530375758|FG000|Overall Study|Lost to Follow-up|4|||
147058437|NCT01367886|530375758|FG000|Overall Study|Lack of Efficacy|2|||
147058438|NCT01367886|530375758|FG000|Overall Study|Death|1|||
147058439|NCT00985504|530375761|FG000|Acute Treatment Period|Adverse Event|3|||
147058440|NCT00985504|530375762|FG001|Acute Treatment Period|Adverse Event|4|||
147058441|NCT00985504|530375761|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
147058442|NCT00985504|530375762|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
147058443|NCT00985504|530375761|FG000|Acute Treatment Period|Protocol Violation|2|||
147058444|NCT00985504|530375762|FG001|Acute Treatment Period|Protocol Violation|0|||
147058445|NCT00985504|530375761|FG000|Acute Treatment Period|Sponsor Decision|0|||
147058446|NCT00985504|530375762|FG001|Acute Treatment Period|Sponsor Decision|1|||
147058447|NCT00985504|530375761|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
147058448|NCT00985504|530375762|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
147058449|NCT00985504|530375761|FG000|Optimization Period|Adverse Event|7|||
147058450|NCT00985504|530375762|FG001|Optimization Period|Adverse Event|9|||
147058451|NCT00985504|530375761|FG000|Optimization Period|Death|0|||
147058452|NCT00985504|530375762|FG001|Optimization Period|Death|1|||
147058453|NCT00985504|530375761|FG000|Optimization Period|Lack of Efficacy|5|||
147058454|NCT00985504|530375762|FG001|Optimization Period|Lack of Efficacy|3|||
147058455|NCT00985504|530375761|FG000|Optimization Period|Lost to Follow-up|0|||
147058456|NCT00985504|530375762|FG001|Optimization Period|Lost to Follow-up|1|||
147058457|NCT00985504|530375761|FG000|Optimization Period|Physician Decision|1|||
147058458|NCT00985504|530375762|FG001|Optimization Period|Physician Decision|0|||
147058459|NCT00985504|530375761|FG000|Optimization Period|Protocol Violation|3|||
147058460|NCT00985504|530375762|FG001|Optimization Period|Protocol Violation|1|||
147058461|NCT00985504|530375761|FG000|Optimization Period|Withdrawal by Subject|10|||
147058462|NCT00985504|530375762|FG001|Optimization Period|Withdrawal by Subject|8|||
147058463|NCT04390113|530375771|FG000|Overall Study|Not Treated|0|||
147058464|NCT04390113|530375772|FG001|Overall Study|Not Treated|1|||
147058465|NCT04390113|530375771|FG000|Overall Study|Adverse Event|1|||
147058466|NCT04390113|530375772|FG001|Overall Study|Adverse Event|0|||
147058467|NCT04390113|530375771|FG000|Overall Study|Death|2|||
147058468|NCT04390113|530375772|FG001|Overall Study|Death|1|||
147058469|NCT04390113|530375771|FG000|Overall Study|Physician Decision|1|||
147058470|NCT04390113|530375772|FG001|Overall Study|Physician Decision|3|||
147058471|NCT04390113|530375771|FG000|Overall Study|Study Terminated by Sponsor|5|||
147058472|NCT04390113|530375772|FG001|Overall Study|Study Terminated by Sponsor|3|||
147058473|NCT04390113|530375771|FG000|Overall Study|Withdrawal by Subject|10|||
147058474|NCT04390113|530375772|FG001|Overall Study|Withdrawal by Subject|5|||
147058475|NCT04390113|530375771|FG000|Overall Study|Other|1|||
147058476|NCT04390113|530375772|FG001|Overall Study|Other|0|||
147058477|NCT04390113|530375771|FG000|Overall Study|Missing|0|||
147058478|NCT04390113|530375772|FG001|Overall Study|Missing|1|||
147058479|NCT03379727|530375773|FG000|Overall Study|Lack of Efficacy|73|||
147058480|NCT03379727|530375773|FG000|Overall Study|Adverse Event|32|||
147058481|NCT03379727|530375773|FG000|Overall Study|Death|18|||
147058482|NCT03379727|530375773|FG000|Overall Study|Patient/guardian decision|17|||
147058483|NCT03379727|530375773|FG000|Overall Study|Physician Decision|104|||
147058484|NCT03379727|530375773|FG000|Overall Study|Protocol Violation|4|||
147058485|NCT03379727|530375773|FG000|Overall Study|Lost to Follow-up|1|||
147058486|NCT02418182|530375776|FG000|Overall Study|Unable to re-consent|18|||
147058487|NCT02418182|530375777|FG001|Overall Study|Unable to re-consent|15|||
147058488|NCT02418182|530375776|FG000|Overall Study|Lost to Follow-up|0|||
147058489|NCT02418182|530375777|FG001|Overall Study|Lost to Follow-up|2|||
147058490|NCT02431676|530375778|FG000|Overall Study|no lab obtained|0|||
147058491|NCT02431676|530375779|FG001|Overall Study|no lab obtained|1|||
147058492|NCT02431676|530375780|FG002|Overall Study|no lab obtained|2|||
147058493|NCT03103152|530375781|FG000|Overall Study|Physician Decision|5|||
147058494|NCT03103152|530375782|FG001|Overall Study|Physician Decision|2|||
147058495|NCT03103152|530375783|FG002|Overall Study|Physician Decision|6|||
147058496|NCT03103152|530375784|FG003|Overall Study|Physician Decision|3|||
147058497|NCT03103152|530375785|FG004|Overall Study|Physician Decision|3|||
147058498|NCT03103152|530375786|FG005|Overall Study|Physician Decision|1|||
147058499|NCT03103152|530375781|FG000|Overall Study|Protocol Violation|2|||
147058500|NCT03103152|530375782|FG001|Overall Study|Protocol Violation|2|||
147058501|NCT03103152|530375783|FG002|Overall Study|Protocol Violation|1|||
147058502|NCT03103152|530375784|FG003|Overall Study|Protocol Violation|2|||
147058503|NCT03103152|530375785|FG004|Overall Study|Protocol Violation|1|||
147058504|NCT03103152|530375786|FG005|Overall Study|Protocol Violation|1|||
147058505|NCT03103152|530375781|FG000|Overall Study|Inter-current illness|0|||
147058506|NCT03103152|530375782|FG001|Overall Study|Inter-current illness|0|||
147058507|NCT03103152|530375783|FG002|Overall Study|Inter-current illness|1|||
147058508|NCT03103152|530375784|FG003|Overall Study|Inter-current illness|0|||
147058509|NCT03103152|530375785|FG004|Overall Study|Inter-current illness|0|||
147058510|NCT03103152|530375786|FG005|Overall Study|Inter-current illness|0|||
147058511|NCT03103152|530375781|FG000|Overall Study|Death|0|||
147058512|NCT03103152|530375782|FG001|Overall Study|Death|1|||
147058513|NCT03103152|530375783|FG002|Overall Study|Death|0|||
147058514|NCT03103152|530375784|FG003|Overall Study|Death|0|||
147058515|NCT03103152|530375785|FG004|Overall Study|Death|0|||
147058516|NCT03103152|530375786|FG005|Overall Study|Death|0|||
147058517|NCT03103152|530375781|FG000|Overall Study|Adverse Event|0|||
147058518|NCT03103152|530375782|FG001|Overall Study|Adverse Event|0|||
147058519|NCT03103152|530375783|FG002|Overall Study|Adverse Event|1|||
147058520|NCT03103152|530375784|FG003|Overall Study|Adverse Event|0|||
147058521|NCT03103152|530375785|FG004|Overall Study|Adverse Event|0|||
147058522|NCT03103152|530375786|FG005|Overall Study|Adverse Event|1|||
147058523|NCT03103152|530375781|FG000|Overall Study|Withdrawal by Subject|1|||
147058524|NCT03103152|530375782|FG001|Overall Study|Withdrawal by Subject|0|||
147058525|NCT03103152|530375783|FG002|Overall Study|Withdrawal by Subject|1|||
147058526|NCT03103152|530375784|FG003|Overall Study|Withdrawal by Subject|1|||
147058527|NCT03103152|530375785|FG004|Overall Study|Withdrawal by Subject|1|||
147058528|NCT03103152|530375786|FG005|Overall Study|Withdrawal by Subject|1|||
147058529|NCT03103152|530375781|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
147058530|NCT03103152|530375782|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
147058531|NCT03103152|530375783|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
147058532|NCT03103152|530375784|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
147058533|NCT03103152|530375785|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
147058534|NCT03103152|530375786|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
147058535|NCT03103152|530375781|FG000|Overall Study|Unacceptable side effects|0|||
147058536|NCT03103152|530375782|FG001|Overall Study|Unacceptable side effects|0|||
147058537|NCT03103152|530375783|FG002|Overall Study|Unacceptable side effects|0|||
147058538|NCT03103152|530375784|FG003|Overall Study|Unacceptable side effects|0|||
147058539|NCT03103152|530375785|FG004|Overall Study|Unacceptable side effects|0|||
147058540|NCT03103152|530375786|FG005|Overall Study|Unacceptable side effects|1|||
147058541|NCT03103152|530375781|FG000|Overall Study|Lost to Follow-up|0|||
147058542|NCT03103152|530375782|FG001|Overall Study|Lost to Follow-up|1|||
147058543|NCT03103152|530375783|FG002|Overall Study|Lost to Follow-up|0|||
147058544|NCT03103152|530375784|FG003|Overall Study|Lost to Follow-up|1|||
147058545|NCT03103152|530375785|FG004|Overall Study|Lost to Follow-up|0|||
147058546|NCT03103152|530375786|FG005|Overall Study|Lost to Follow-up|1|||
147058547|NCT03103152|530375781|FG000|Overall Study|Testicular pain|0|||
147058548|NCT03103152|530375782|FG001|Overall Study|Testicular pain|0|||
147058549|NCT03103152|530375783|FG002|Overall Study|Testicular pain|0|||
147058550|NCT03103152|530375784|FG003|Overall Study|Testicular pain|1|||
147058551|NCT03103152|530375785|FG004|Overall Study|Testicular pain|0|||
147058552|NCT03103152|530375786|FG005|Overall Study|Testicular pain|0|||
147058553|NCT03474965|530375787|FG000|Overall Study|Pregnancy|1|||
147058554|NCT03474965|530375788|FG001|Overall Study|Pregnancy|0|||
147058555|NCT03474965|530375789|FG002|Overall Study|Pregnancy|0|||
147058556|NCT03474965|530375790|FG003|Overall Study|Pregnancy|0|||
147058557|NCT03474965|530375787|FG000|Overall Study|Lost to Follow-up|0|||
147058558|NCT03474965|530375788|FG001|Overall Study|Lost to Follow-up|0|||
147058559|NCT03474965|530375789|FG002|Overall Study|Lost to Follow-up|1|||
147058560|NCT03474965|530375790|FG003|Overall Study|Lost to Follow-up|0|||
147058561|NCT03474965|530375787|FG000|Overall Study|Death|1|||
147058562|NCT03474965|530375788|FG001|Overall Study|Death|0|||
147058563|NCT03474965|530375789|FG002|Overall Study|Death|0|||
147058564|NCT03474965|530375790|FG003|Overall Study|Death|0|||
147058565|NCT03474965|530375787|FG000|Overall Study|Adverse Event|1|||
147058566|NCT03474965|530375788|FG001|Overall Study|Adverse Event|0|||
147058567|NCT03474965|530375789|FG002|Overall Study|Adverse Event|0|||
147058568|NCT03474965|530375790|FG003|Overall Study|Adverse Event|1|||
147058569|NCT03474965|530375787|FG000|Overall Study|Physician Decision|3|||
147058570|NCT03474965|530375788|FG001|Overall Study|Physician Decision|1|||
147058571|NCT03474965|530375789|FG002|Overall Study|Physician Decision|2|||
147058572|NCT03474965|530375790|FG003|Overall Study|Physician Decision|0|||
147058573|NCT03474965|530375787|FG000|Overall Study|Participant Decision|7|||
147058574|NCT03474965|530375788|FG001|Overall Study|Participant Decision|0|||
147058575|NCT03474965|530375789|FG002|Overall Study|Participant Decision|1|||
147058576|NCT03474965|530375790|FG003|Overall Study|Participant Decision|0|||
147058577|NCT03474965|530375787|FG000|Overall Study|Guardian Decision|4|||
147058578|NCT03474965|530375788|FG001|Overall Study|Guardian Decision|2|||
147058579|NCT03474965|530375789|FG002|Overall Study|Guardian Decision|7|||
147058580|NCT03474965|530375790|FG003|Overall Study|Guardian Decision|2|||
147058581|NCT03100903|530377569|FG000|Overall Study|Withdrawal by Subject|0|||
147058582|NCT03100903|530377570|FG001|Overall Study|Withdrawal by Subject|0|||
147058583|NCT03100903|530377571|FG002|Overall Study|Withdrawal by Subject|1|||
147058584|NCT04659993|530377572|FG000|Overall Study|Withdrawal by Subject|2|||
147058585|NCT04659993|530377572|FG000|Overall Study|Lost to Follow-up|2|||
147058586|NCT03782792|530377573|FG000|Overall Study|Patient left the country|0|||
147058587|NCT03782792|530377574|FG001|Overall Study|Patient left the country|1|||
147058588|NCT03782792|530377573|FG000|Overall Study|Withdrawal by Subject|1|||
147058589|NCT03782792|530377574|FG001|Overall Study|Withdrawal by Subject|2|||
147058590|NCT05271370|530377575|FG000|Overall Study|Study early termination|8|||
147058591|NCT05271370|530377576|FG001|Overall Study|Study early termination|16|||
147058592|NCT05271370|530377577|FG002|Overall Study|Study early termination|29|||
147058593|NCT03048747|530377579|FG000|Overall Study|Adverse Event|2|||
147058594|NCT03048747|530377579|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
147058595|NCT03048747|530377579|FG000|Overall Study|Physician Decision|1|||
147058596|NCT00833105|530377580|FG000|Overall Study|Withdrawal by Subject|1|||
147058597|NCT00833105|530377580|FG000|Overall Study|Adverse Event|2|||
147058598|NCT03656068|530377581|FG000|Overall Study|Withdrawal by Subject|4|||
147058599|NCT03656068|530377581|FG000|Overall Study|Adverse Event|1|||
147058600|NCT01295671|530377588|FG000|Overall Study|Lost to Follow-up|4|||
147058601|NCT01295671|530377589|FG001|Overall Study|Lost to Follow-up|6|||
147058602|NCT01295671|530377590|FG002|Overall Study|Lost to Follow-up|3|||
147058603|NCT01295671|530377588|FG000|Overall Study|Withdrawal by Subject|3|||
147058604|NCT01295671|530377589|FG001|Overall Study|Withdrawal by Subject|1|||
146850066|NCT00911937|529620705|FG000|Overall Study|Did not meet inclusion criteria|9|||
146850067|NCT00911937|529620706|FG001|Overall Study|Did not meet inclusion criteria|11|||
147058605|NCT01295671|530377590|FG002|Overall Study|Withdrawal by Subject|0|||
147058606|NCT01436370|530377593|FG000|Overall Study|Lost to Follow-up|0|||
147058607|NCT01436370|530377594|FG001|Overall Study|Lost to Follow-up|0|||
147058608|NCT01436370|530377595|FG002|Overall Study|Lost to Follow-up|0|||
147058609|NCT01436370|530377596|FG003|Overall Study|Lost to Follow-up|0|||
147058610|NCT01436370|530377597|FG004|Overall Study|Lost to Follow-up|1|||
147058611|NCT01436370|530377598|FG005|Overall Study|Lost to Follow-up|0|||
147058612|NCT01436370|530377599|FG006|Overall Study|Lost to Follow-up|0|||
147058613|NCT01436370|530377600|FG007|Overall Study|Lost to Follow-up|0|||
147058614|NCT02395848|530377601|FG000|Overall Study|Lost to Follow-up|2|||
147058615|NCT01754129|530377602|FG000|Overall Study|Death|13|||
147058616|NCT01754129|530377602|FG000|Overall Study|Duodopa discontinuation|9|||
147058617|NCT01754129|530377602|FG000|Overall Study|Lost to Follow-up|7|||
147058618|NCT01754129|530377602|FG000|Overall Study|Withdrew consent|1|||
147058619|NCT01754129|530377602|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
147058620|NCT02276560|530377603|FG000|Overall Study|Adverse Event|1|||
147058621|NCT02276560|530377604|FG001|Overall Study|Adverse Event|0|||
147058622|NCT02276560|530377605|FG002|Overall Study|Adverse Event|0|||
147058623|NCT02609607|530377607|FG000|Overall Study|Lost to Follow-up|0|||
147058624|NCT02609607|530377608|FG001|Overall Study|Lost to Follow-up|1|||
147058625|NCT00651261|530377614|FG000|Overall Study|Adverse Event|32|||
147058626|NCT00651261|530377615|FG001|Overall Study|Adverse Event|22|||
147058627|NCT00651261|530377614|FG000|Overall Study|Death|18|||
147058628|NCT00651261|530377615|FG001|Overall Study|Death|18|||
147058629|NCT00651261|530377614|FG000|Overall Study|Withdrawal by Subject|22|||
147058630|NCT00651261|530377615|FG001|Overall Study|Withdrawal by Subject|40|||
147058631|NCT00651261|530377614|FG000|Overall Study|Induction failure|24|||
147058632|NCT00651261|530377615|FG001|Overall Study|Induction failure|35|||
147058633|NCT00651261|530377614|FG000|Overall Study|Disease progression|58|||
147058634|NCT00651261|530377615|FG001|Overall Study|Disease progression|58|||
147058635|NCT00651261|530377614|FG000|Overall Study|Alternative therapy|109|||
147058636|NCT00651261|530377615|FG001|Overall Study|Alternative therapy|107|||
147058637|NCT00651261|530377614|FG000|Overall Study|Other disease or participant decisions|23|||
147058638|NCT00651261|530377615|FG001|Overall Study|Other disease or participant decisions|23|||
147058639|NCT00651261|530377614|FG000|Overall Study|Never treated|5|||
147058640|NCT00651261|530377615|FG001|Overall Study|Never treated|3|||
147058641|NCT02027545|530377617|FG000|Overall Study|Failed to sign HIPAA|0|||
147058642|NCT02027545|530377618|FG001|Overall Study|Failed to sign HIPAA|2|||
147058643|NCT02027545|530377617|FG000|Overall Study|Failed to attend study visit|2|||
147058644|NCT02027545|530377618|FG001|Overall Study|Failed to attend study visit|0|||
147058645|NCT02027545|530377617|FG000|Overall Study|Protocol Violation|1|||
147058646|NCT02027545|530377618|FG001|Overall Study|Protocol Violation|0|||
147058647|NCT02770170|530377619|FG000|Overall Study|Withdrawal by Subject|0|||
147058648|NCT02770170|530377620|FG001|Overall Study|Withdrawal by Subject|0|||
147058649|NCT02770170|530377621|FG002|Overall Study|Withdrawal by Subject|0|||
147058650|NCT02770170|530377622|FG003|Overall Study|Withdrawal by Subject|2|||
147058651|NCT02770170|530377619|FG000|Overall Study|due to pregnancy|1|||
147058652|NCT02770170|530377620|FG001|Overall Study|due to pregnancy|0|||
147058653|NCT02770170|530377621|FG002|Overall Study|due to pregnancy|0|||
147058654|NCT02770170|530377622|FG003|Overall Study|due to pregnancy|0|||
147058655|NCT02770170|530377619|FG000|Overall Study|Lack of Efficacy|2|||
147058656|NCT02770170|530377620|FG001|Overall Study|Lack of Efficacy|0|||
147058657|NCT02770170|530377621|FG002|Overall Study|Lack of Efficacy|0|||
147058658|NCT02770170|530377622|FG003|Overall Study|Lack of Efficacy|1|||
147058659|NCT02770170|530377619|FG000|Overall Study|Adverse Event|4|||
147058660|NCT02770170|530377620|FG001|Overall Study|Adverse Event|3|||
147058661|NCT02770170|530377621|FG002|Overall Study|Adverse Event|5|||
147058662|NCT02770170|530377622|FG003|Overall Study|Adverse Event|3|||
147058663|NCT02770170|530377619|FG000|Overall Study|due to disease worsening|0|||
147058664|NCT02770170|530377620|FG001|Overall Study|due to disease worsening|0|||
147058665|NCT02770170|530377621|FG002|Overall Study|due to disease worsening|0|||
147058666|NCT02770170|530377622|FG003|Overall Study|due to disease worsening|1|||
147058667|NCT03581123|530377625|FG000|2-month Follow-up|Withdrawal by Subject|5|||
147058668|NCT03581123|530377626|FG001|2-month Follow-up|Withdrawal by Subject|4|||
147058669|NCT03581123|530377627|FG002|2-month Follow-up|Withdrawal by Subject|6|||
147058670|NCT03581123|530377628|FG003|2-month Follow-up|Withdrawal by Subject|4|||
147058671|NCT03581123|530377625|FG000|2-month Follow-up|Lost to Follow-up|8|||
147058672|NCT03581123|530377626|FG001|2-month Follow-up|Lost to Follow-up|1|||
147058673|NCT03581123|530377627|FG002|2-month Follow-up|Lost to Follow-up|2|||
147058674|NCT03581123|530377628|FG003|2-month Follow-up|Lost to Follow-up|2|||
147058675|NCT03581123|530377625|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
147058676|NCT03581123|530377626|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
147058677|NCT03581123|530377627|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
147058678|NCT03581123|530377628|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
147058679|NCT03581123|530377625|FG000|6-Month Follow-up|Lost to Follow-up|3|||
147058680|NCT03581123|530377626|FG001|6-Month Follow-up|Lost to Follow-up|3|||
147058681|NCT03581123|530377627|FG002|6-Month Follow-up|Lost to Follow-up|1|||
147058682|NCT03581123|530377628|FG003|6-Month Follow-up|Lost to Follow-up|1|||
147058683|NCT03581123|530377625|FG000|12-Month Follow-up|Lost to Follow-up|4|||
147058684|NCT03581123|530377626|FG001|12-Month Follow-up|Lost to Follow-up|3|||
147058685|NCT03581123|530377627|FG002|12-Month Follow-up|Lost to Follow-up|4|||
147058686|NCT03581123|530377628|FG003|12-Month Follow-up|Lost to Follow-up|5|||
147058687|NCT03351608|530377629|FG000|Overall Study|Lost to Follow-up|0|||
147058688|NCT03351608|530377630|FG001|Overall Study|Lost to Follow-up|1|||
147058689|NCT03351608|530377631|FG002|Overall Study|Lost to Follow-up|1|||
147058690|NCT03351608|530377632|FG003|Overall Study|Lost to Follow-up|1|||
147058691|NCT03351608|530377633|FG004|Overall Study|Lost to Follow-up|1|||
147058692|NCT03351608|530377629|FG000|Overall Study|Physician Decision|1|||
147058693|NCT03351608|530377630|FG001|Overall Study|Physician Decision|0|||
147058694|NCT03351608|530377631|FG002|Overall Study|Physician Decision|0|||
147058695|NCT03351608|530377632|FG003|Overall Study|Physician Decision|2|||
147058696|NCT03351608|530377633|FG004|Overall Study|Physician Decision|1|||
147058697|NCT03351608|530377629|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
147058698|NCT03351608|530377630|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
147058699|NCT03351608|530377631|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
147058700|NCT03351608|530377632|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
147058701|NCT03351608|530377633|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
147058702|NCT03351608|530377629|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147058703|NCT03351608|530377630|FG001|Overall Study|Withdrawal by parent/guardian|0|||
147058704|NCT03351608|530377631|FG002|Overall Study|Withdrawal by parent/guardian|1|||
147058705|NCT03351608|530377632|FG003|Overall Study|Withdrawal by parent/guardian|1|||
147058706|NCT03351608|530377633|FG004|Overall Study|Withdrawal by parent/guardian|0|||
147058707|NCT03351608|530377629|FG000|Overall Study|Other|0|||
147058708|NCT03351608|530377630|FG001|Overall Study|Other|1|||
147058709|NCT03351608|530377631|FG002|Overall Study|Other|1|||
147058710|NCT03351608|530377632|FG003|Overall Study|Other|3|||
147058711|NCT03351608|530377633|FG004|Overall Study|Other|0|||
147058712|NCT02877004|530377634|FG000|Overall Study|Pregnancy|0|||
147058713|NCT02877004|530377635|FG001|Overall Study|Pregnancy|0|||
147058714|NCT02877004|530377636|FG002|Overall Study|Pregnancy|1|||
147058715|NCT02044302|530377638|FG000|Overall Study|study terminated|2|||
147058716|NCT02044302|530377639|FG001|Overall Study|study terminated|0|||
147058717|NCT04610346|530377642|FG000|Overall Study|Withdrawal by Subject|1|||
147058718|NCT04610346|530377643|FG001|Overall Study|Withdrawal by Subject|1|||
147058719|NCT04610346|530377642|FG000|Overall Study|did not complete shelter onboarding|2|||
147058720|NCT04610346|530377643|FG001|Overall Study|did not complete shelter onboarding|1|||
147058721|NCT03309943|530377645|FG000|Overall Study|Withdrawal by Subject|0|||
147058722|NCT03309943|530377646|FG001|Overall Study|Withdrawal by Subject|1|||
147058723|NCT03309943|530377645|FG000|Overall Study|Inappropriate behavior towards staff|0|||
147058724|NCT03309943|530377646|FG001|Overall Study|Inappropriate behavior towards staff|1|||
147058725|NCT02019264|530377652|FG000|Overall Study|Not treated|6|||
147058726|NCT02019264|530377653|FG001|Overall Study|Not treated|4|||
147058727|NCT02019264|530377652|FG000|Overall Study|Lost to Follow-up|50|||
147058728|NCT02019264|530377653|FG001|Overall Study|Lost to Follow-up|47|||
147058729|NCT02019264|530377652|FG000|Overall Study|Withdrawal by Subject|142|||
147058730|NCT02019264|530377653|FG001|Overall Study|Withdrawal by Subject|117|||
147058731|NCT02019264|530377652|FG000|Overall Study|Administrative reason|36|||
147058732|NCT02019264|530377653|FG001|Overall Study|Administrative reason|28|||
147058733|NCT02019264|530377652|FG000|Overall Study|Missing|14|||
147058734|NCT02019264|530377653|FG001|Overall Study|Missing|11|||
147058735|NCT01297517|530377661|FG000|Overall Study|Adverse Event|21|||
147058736|NCT01297517|530377662|FG001|Overall Study|Adverse Event|7|||
147058737|NCT01297517|530377663|FG002|Overall Study|Adverse Event|16|||
147058738|NCT01297517|530377661|FG000|Overall Study|Lost to Follow-up|1|||
147058739|NCT01297517|530377662|FG001|Overall Study|Lost to Follow-up|0|||
147058740|NCT01297517|530377663|FG002|Overall Study|Lost to Follow-up|1|||
147058741|NCT01297517|530377661|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
147058742|NCT01297517|530377662|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
147058743|NCT01297517|530377663|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
147058744|NCT01297517|530377661|FG000|Overall Study|Noncompliance|1|||
147058745|NCT01297517|530377662|FG001|Overall Study|Noncompliance|0|||
147058746|NCT01297517|530377663|FG002|Overall Study|Noncompliance|0|||
147058747|NCT01297517|530377661|FG000|Overall Study|Protocol Violation|1|||
147058748|NCT01297517|530377662|FG001|Overall Study|Protocol Violation|1|||
147058749|NCT01297517|530377663|FG002|Overall Study|Protocol Violation|1|||
147058750|NCT01297517|530377661|FG000|Overall Study|Inadequate Control of IOP|1|||
147058751|NCT01297517|530377662|FG001|Overall Study|Inadequate Control of IOP|1|||
147058752|NCT01297517|530377663|FG002|Overall Study|Inadequate Control of IOP|2|||
147058753|NCT01609296|530377664|FG000|Overall Study|Death|253|||
147058754|NCT01609296|530377664|FG000|Overall Study|Withdrawal by Subject|151|||
147058755|NCT01609296|530377664|FG000|Overall Study|Lost to Follow-up|21|||
147058756|NCT01609296|530377664|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
147058757|NCT01609296|530377664|FG000|Overall Study|missed visit but known to be alive|28|||
147058758|NCT00386360|530377665|FG000|Overall Study|Adverse Event|4|||
147058759|NCT00386360|530377666|FG001|Overall Study|Adverse Event|2|||
147058760|NCT00386360|530377665|FG000|Overall Study|Physician Decision|2|||
147058761|NCT00386360|530377666|FG001|Overall Study|Physician Decision|2|||
147058762|NCT00386360|530377665|FG000|Overall Study|Lost to Follow-up|0|||
147058763|NCT00386360|530377666|FG001|Overall Study|Lost to Follow-up|2|||
147058764|NCT00386360|530377665|FG000|Overall Study|Protocol Violation|0|||
147058765|NCT00386360|530377666|FG001|Overall Study|Protocol Violation|3|||
147058766|NCT00386360|530377665|FG000|Overall Study|Withdrawal by Subject|3|||
147058767|NCT00386360|530377666|FG001|Overall Study|Withdrawal by Subject|6|||
147058768|NCT00386360|530377665|FG000|Overall Study|Did not take any study medication|0|||
147058769|NCT00386360|530377666|FG001|Overall Study|Did not take any study medication|2|||
147058770|NCT00628212|530377667|FG000|Overall Study|Adverse Event|2|||
147058771|NCT00628212|530377668|FG001|Overall Study|Adverse Event|0|||
147058772|NCT00628212|530377669|FG002|Overall Study|Adverse Event|1|||
147058773|NCT00628212|530377670|FG003|Overall Study|Adverse Event|2|||
147058774|NCT00628212|530377667|FG000|Overall Study|Physician Decision|1|||
147058775|NCT00628212|530377668|FG001|Overall Study|Physician Decision|1|||
147058776|NCT00628212|530377669|FG002|Overall Study|Physician Decision|2|||
147058777|NCT00628212|530377670|FG003|Overall Study|Physician Decision|3|||
147058778|NCT00546377|530377671|FG000|Overall Study|Deemed ineligible|1|||
147058779|NCT00546377|530377671|FG000|Overall Study|Adverse Event|6|||
147058780|NCT01684423|530377675|FG000|Overall Study|Withdrawal by Subject|0|||
147058781|NCT01684423|530377676|FG001|Overall Study|Withdrawal by Subject|0|||
147058782|NCT01684423|530377677|FG002|Overall Study|Withdrawal by Subject|1|||
147058783|NCT01684423|530377678|FG003|Overall Study|Withdrawal by Subject|0|||
147058784|NCT01684423|530377679|FG004|Overall Study|Withdrawal by Subject|0|||
147058785|NCT03020992|530377682|FG000|Overall Study|Adverse Event|5|||
147058786|NCT03020992|530377682|FG000|Overall Study|Withdrawal by Subject|1|||
147058787|NCT00529308|530377687|FG000|Overall Study|Withdrawal by Subject|1|||
147058788|NCT00529308|530377688|FG001|Overall Study|Withdrawal by Subject|1|||
147058789|NCT05343364|530377705|FG000|Overall Study|Miscellaneous|0|||
147058790|NCT05343364|530377706|FG001|Overall Study|Miscellaneous|1|||
147058791|NCT03331796|530377707|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
147058792|NCT03331796|530377708|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
147058793|NCT03331796|530377709|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
147058794|NCT03331796|530377707|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
147058795|NCT03331796|530377708|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
147058796|NCT03331796|530377709|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
147058797|NCT03331796|530377707|FG000|Extended Follow-up|Adverse Event|1|||
147058798|NCT03331796|530377708|FG001|Extended Follow-up|Adverse Event|0|||
147058799|NCT03331796|530377709|FG002|Extended Follow-up|Adverse Event|1|||
147058800|NCT03331796|530377707|FG000|Extended Follow-up|Lost to Follow-up|0|||
147058801|NCT03331796|530377708|FG001|Extended Follow-up|Lost to Follow-up|0|||
147058802|NCT03331796|530377709|FG002|Extended Follow-up|Lost to Follow-up|1|||
147058803|NCT03331796|530377707|FG000|Extended Follow-up|Withdrawal by Subject|1|||
147058804|NCT03331796|530377708|FG001|Extended Follow-up|Withdrawal by Subject|0|||
147058805|NCT03331796|530377709|FG002|Extended Follow-up|Withdrawal by Subject|0|||
147058806|NCT03331796|530377707|FG000|Extended Follow-up|Termination of Funding|0|||
147058807|NCT03331796|530377708|FG001|Extended Follow-up|Termination of Funding|1|||
147058808|NCT03331796|530377709|FG002|Extended Follow-up|Termination of Funding|0|||
147058809|NCT01753570|530377710|FG000|Overall Study|Adverse Event|1|||
147058810|NCT01753570|530377711|FG001|Overall Study|Adverse Event|0|||
147058811|NCT01753570|530377712|FG002|Overall Study|Adverse Event|1|||
147058812|NCT01753570|530377710|FG000|Overall Study|Physician Decision|0|||
147058813|NCT01753570|530377711|FG001|Overall Study|Physician Decision|1|||
147058814|NCT01753570|530377712|FG002|Overall Study|Physician Decision|0|||
147058815|NCT01753570|530377710|FG000|Overall Study|Withdrawal by Subject|1|||
147058816|NCT01753570|530377711|FG001|Overall Study|Withdrawal by Subject|4|||
147058817|NCT01753570|530377712|FG002|Overall Study|Withdrawal by Subject|0|||
147058818|NCT02062450|530377714|FG000|Overall Study|No follow-up visit|124|||
147058819|NCT02203721|530377717|FG000|Overall Study|Lost to Follow-up|1|||
147058820|NCT02203721|530377718|FG001|Overall Study|Lost to Follow-up|0|||
147058821|NCT02203721|530377717|FG000|Overall Study|Death|0|||
147058822|NCT02203721|530377718|FG001|Overall Study|Death|2|||
147058823|NCT02203721|530377717|FG000|Overall Study|Illness|0|||
147058824|NCT02203721|530377718|FG001|Overall Study|Illness|1|||
147058825|NCT04745689|530377719|FG000|Overall Study|Death|9|||
147058826|NCT04745689|530377720|FG001|Overall Study|Death|6|||
147058827|NCT04745689|530377719|FG000|Overall Study|Lost to Follow-up|1|||
147058828|NCT04745689|530377720|FG001|Overall Study|Lost to Follow-up|0|||
147058829|NCT04745689|530377719|FG000|Overall Study|Withdrawal by Subject|2|||
147058830|NCT04745689|530377720|FG001|Overall Study|Withdrawal by Subject|0|||
147058831|NCT04745689|530377719|FG000|Overall Study|Study terminated by sponsor|10|||
147058832|NCT04745689|530377720|FG001|Overall Study|Study terminated by sponsor|3|||
147058833|NCT00153179|530377721|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
147058834|NCT00153179|530377722|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
147058835|NCT00153179|530377723|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
147058836|NCT00153179|530377724|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
147058837|NCT02356588|530379671|FG000|Overall Study|Lack of Efficacy|4|||
147058838|NCT02356588|530379672|FG001|Overall Study|Lack of Efficacy|10|||
147058839|NCT02356588|530379671|FG000|Overall Study|Adverse Event|0|||
147058840|NCT02356588|530379672|FG001|Overall Study|Adverse Event|2|||
147058841|NCT02356588|530379671|FG000|Overall Study|Withdrawal by Subject|1|||
147058842|NCT02356588|530379672|FG001|Overall Study|Withdrawal by Subject|0|||
147058843|NCT02356588|530379671|FG000|Overall Study|Protocol Violation|0|||
147058844|NCT02356588|530379672|FG001|Overall Study|Protocol Violation|1|||
147058845|NCT01418378|530379673|FG000|Overall Study|Death|1|||
147058846|NCT01418378|530379674|FG001|Overall Study|Death|2|||
147058847|NCT01418378|530379673|FG000|Overall Study|Physician Decision|0|||
147058848|NCT01418378|530379674|FG001|Overall Study|Physician Decision|1|||
147058849|NCT01418378|530379673|FG000|Overall Study|ligament imbalance|0|||
147058850|NCT01418378|530379674|FG001|Overall Study|ligament imbalance|1|||
147058851|NCT01418378|530379673|FG000|Overall Study|developed chronic myopathy|0|||
147058852|NCT01418378|530379674|FG001|Overall Study|developed chronic myopathy|1|||
147058853|NCT03150719|530379675|FG000|Overall Study|Adverse Event|0|||
147058854|NCT03150719|530379676|FG001|Overall Study|Adverse Event|1|||
147058855|NCT03150719|530379675|FG000|Overall Study|Death|0|||
147058856|NCT03150719|530379676|FG001|Overall Study|Death|1|||
147058857|NCT03150719|530379675|FG000|Overall Study|Other|1|||
147058858|NCT03150719|530379676|FG001|Overall Study|Other|0|||
147058859|NCT01790984|530379677|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
147058860|NCT01790984|530379678|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
147058861|NCT01790984|530379679|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
147058862|NCT01790984|530379680|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
147058863|NCT01051791|530379688|FG000|Overall Study|Failed screening|3|||
147058864|NCT01051791|530379688|FG000|Overall Study|Withdrawal by Subject|1|||
147058865|NCT00288626|530379691|FG000|Overall Study|Death|3|||
147058866|NCT00288626|530379691|FG000|Overall Study|Withdrawal by Subject|4|||
147058867|NCT01372618|530379692|FG000|Overall Study|PI Died. Study Terminated|9|||
147058868|NCT00558467|530379694|FG000|Overall Study|Adverse Event|1|||
147058869|NCT00558467|530379695|FG001|Overall Study|Adverse Event|2|||
147058870|NCT00558467|530379694|FG000|Overall Study|Lack of Efficacy|0|||
147058871|NCT00558467|530379695|FG001|Overall Study|Lack of Efficacy|1|||
147058872|NCT00558467|530379694|FG000|Overall Study|Patient moving out of state|0|||
147058873|NCT00558467|530379695|FG001|Overall Study|Patient moving out of state|1|||
147058874|NCT00507455|530379696|FG000|Overall Study|Adverse Event|3|||
147058875|NCT00507455|530379697|FG001|Overall Study|Adverse Event|3|||
147058876|NCT00507455|530379698|FG002|Overall Study|Adverse Event|6|||
147058877|NCT00507455|530379696|FG000|Overall Study|Withdrawal by Subject|2|||
147058878|NCT00507455|530379697|FG001|Overall Study|Withdrawal by Subject|1|||
147058879|NCT00507455|530379698|FG002|Overall Study|Withdrawal by Subject|2|||
147058880|NCT00507455|530379696|FG000|Overall Study|Protocol Violation|4|||
147058881|NCT00507455|530379697|FG001|Overall Study|Protocol Violation|1|||
147058882|NCT00507455|530379698|FG002|Overall Study|Protocol Violation|1|||
147058883|NCT00507455|530379696|FG000|Overall Study|Lost to Follow-up|2|||
147058884|NCT00507455|530379697|FG001|Overall Study|Lost to Follow-up|0|||
147058885|NCT00507455|530379698|FG002|Overall Study|Lost to Follow-up|2|||
147058886|NCT00507455|530379696|FG000|Overall Study|Lack of Efficacy|0|||
147058887|NCT00507455|530379697|FG001|Overall Study|Lack of Efficacy|1|||
147058888|NCT00507455|530379698|FG002|Overall Study|Lack of Efficacy|0|||
147058889|NCT00507455|530379696|FG000|Overall Study|Other - miscellaneous reason|1|||
147058890|NCT00507455|530379697|FG001|Overall Study|Other - miscellaneous reason|0|||
147058891|NCT00507455|530379698|FG002|Overall Study|Other - miscellaneous reason|1|||
147058892|NCT00931255|530379699|FG000|Overall Study|Follow up biopsy not done|2|||
147058893|NCT00931255|530379700|FG001|Overall Study|Follow up biopsy not done|3|||
147058894|NCT01372995|530379701|FG000|Overall Study|Spouse withdrew participant from study|0|||
147058895|NCT01372995|530379702|FG001|Overall Study|Spouse withdrew participant from study|1|||
147058896|NCT01372995|530379703|FG002|Overall Study|Spouse withdrew participant from study|0|||
147058897|NCT01372995|530379701|FG000|Overall Study|Physician Decision|0|||
147058898|NCT01372995|530379702|FG001|Overall Study|Physician Decision|0|||
147058899|NCT01372995|530379703|FG002|Overall Study|Physician Decision|1|||
147058900|NCT02914613|530379707|FG000|Overall Study|Withdrawal by Subject|1|||
147058901|NCT02914613|530379708|FG001|Overall Study|Withdrawal by Subject|2|||
147058902|NCT02914613|530379707|FG000|Overall Study|Adverse Event|1|||
147058903|NCT02914613|530379708|FG001|Overall Study|Adverse Event|0|||
147058904|NCT03850496|530379713|FG000|Overall Study|Withdrawal by Subject|1|||
147058905|NCT03850496|530379714|FG001|Overall Study|Withdrawal by Subject|0|||
147058906|NCT03850496|530379715|FG002|Overall Study|Withdrawal by Subject|0|||
147058907|NCT03850496|530379713|FG000|Overall Study|Lost to Follow-up|0|||
147058908|NCT03850496|530379714|FG001|Overall Study|Lost to Follow-up|1|||
147058909|NCT03850496|530379715|FG002|Overall Study|Lost to Follow-up|4|||
147058910|NCT00869999|530379723|FG000|Overall Study|Withdrawal by Subject|1|||
147058911|NCT00869999|530379723|FG000|Overall Study|removed prior to starting therapy|1|||
147058912|NCT03363776|530379726|FG000|Overall Study|Progressive disease|2|||
147058913|NCT03363776|530379727|FG001|Overall Study|Progressive disease|3|||
147058914|NCT03363776|530379728|FG002|Overall Study|Progressive disease|1|||
147058915|NCT03363776|530379726|FG000|Overall Study|Study drug toxicity|0|||
147058916|NCT03363776|530379727|FG001|Overall Study|Study drug toxicity|0|||
147058917|NCT03363776|530379728|FG002|Overall Study|Study drug toxicity|1|||
147058918|NCT03363776|530379726|FG000|Overall Study|Death|1|||
147058919|NCT03363776|530379727|FG001|Overall Study|Death|0|||
147058920|NCT03363776|530379728|FG002|Overall Study|Death|0|||
147058921|NCT04157348|530379729|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
147058922|NCT04157348|530379730|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
147058923|NCT04157348|530379729|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
147058924|NCT04157348|530379730|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
147058925|NCT04157348|530379729|FG000|Double-blind Treatment Period|Adverse Event|0|||
147058926|NCT04157348|530379730|FG001|Double-blind Treatment Period|Adverse Event|1|||
147058927|NCT04157348|530379729|FG000|Open-label Extension Period|Adverse Event|1|||
147058928|NCT04157348|530379730|FG001|Open-label Extension Period|Adverse Event|1|||
147058929|NCT04157348|530379729|FG000|Open-label Extension Period|Death|0|||
147058930|NCT04157348|530379730|FG001|Open-label Extension Period|Death|1|||
147058931|NCT04157348|530379729|FG000|Open-label Extension Period|Lack of Efficacy|2|||
147058932|NCT04157348|530379730|FG001|Open-label Extension Period|Lack of Efficacy|2|||
147058933|NCT04157348|530379729|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
147058934|NCT04157348|530379730|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
147058935|NCT04157348|530379729|FG000|Open-label Extension Period|Ongoing|60|||
147058936|NCT04157348|530379730|FG001|Open-label Extension Period|Ongoing|57|||
147058937|NCT04157348|530379729|FG000|Open-label Extension Period|other reasons|1|||
147058938|NCT04157348|530379730|FG001|Open-label Extension Period|other reasons|1|||
147058939|NCT02527434|530379731|FG000|Overall Study|Lost to Follow-up|2|||
147058940|NCT02527434|530379732|FG001|Overall Study|Lost to Follow-up|2|||
147058941|NCT02527434|530379733|FG002|Overall Study|Lost to Follow-up|0|||
147058942|NCT02527434|530379731|FG000|Overall Study|Death|19|||
147058943|NCT02527434|530379732|FG001|Overall Study|Death|6|||
147058944|NCT02527434|530379733|FG002|Overall Study|Death|17|||
147058945|NCT02527434|530379731|FG000|Overall Study|Withdrawal by Subject|5|||
147058946|NCT02527434|530379732|FG001|Overall Study|Withdrawal by Subject|3|||
147058947|NCT02527434|530379733|FG002|Overall Study|Withdrawal by Subject|3|||
147058948|NCT02527434|530379731|FG000|Overall Study|Reason Not Specified|1|||
147058949|NCT02527434|530379732|FG001|Overall Study|Reason Not Specified|0|||
147058950|NCT02527434|530379733|FG002|Overall Study|Reason Not Specified|0|||
147058951|NCT02527434|530379731|FG000|Overall Study|Site closure|1|||
147058952|NCT02527434|530379732|FG001|Overall Study|Site closure|0|||
147058953|NCT02527434|530379733|FG002|Overall Study|Site closure|0|||
147058954|NCT00568061|530379734|FG000|Overall Study|Inclusion / exclusion criteria|5|||
147058955|NCT00568061|530379735|FG001|Overall Study|Inclusion / exclusion criteria|1|||
147058956|NCT00568061|530379734|FG000|Overall Study|Adverse Event|0|||
147058957|NCT00568061|530379735|FG001|Overall Study|Adverse Event|1|||
147058958|NCT05027451|530379736|FG000|Overall Study|Lost to Follow-up|1|||
147058959|NCT05027451|530379737|FG001|Overall Study|Lost to Follow-up|1|||
147058960|NCT02693002|530379739|FG000|Overall Study|Withdrawal by Subject|1|||
147058961|NCT02693002|530379740|FG001|Overall Study|Withdrawal by Subject|0|||
147058962|NCT00812981|530379743|FG000|Overall Study|Other|0|||
147058963|NCT00812981|530379744|FG001|Overall Study|Other|1|||
147058964|NCT04666259|530379749|FG000|Treatment Phase|Physician Decision|9|||
147058965|NCT04666259|530379750|FG001|Treatment Phase|Physician Decision|3|||
147058966|NCT04666259|530379751|FG002|Treatment Phase|Physician Decision|3|||
147058967|NCT04666259|530379749|FG000|Treatment Phase|Adverse Event|3|||
147058968|NCT04666259|530379750|FG001|Treatment Phase|Adverse Event|1|||
147058969|NCT04666259|530379751|FG002|Treatment Phase|Adverse Event|0|||
147058970|NCT04666259|530379749|FG000|Treatment Phase|Subject decision|1|||
147058971|NCT04666259|530379750|FG001|Treatment Phase|Subject decision|2|||
147058972|NCT04666259|530379751|FG002|Treatment Phase|Subject decision|0|||
147058973|NCT04666259|530379749|FG000|Treatment Phase|Progressive disease|0|||
147058974|NCT04666259|530379750|FG001|Treatment Phase|Progressive disease|1|||
147058975|NCT04666259|530379751|FG002|Treatment Phase|Progressive disease|0|||
147058976|NCT04666259|530379749|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
147058977|NCT04666259|530379750|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
147058978|NCT04666259|530379751|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
147058979|NCT04666259|530379749|FG000|Safety Follow-up Phase|Physician Decision|2|||
147058980|NCT04666259|530379750|FG001|Safety Follow-up Phase|Physician Decision|0|||
147058981|NCT04666259|530379751|FG002|Safety Follow-up Phase|Physician Decision|0|||
147058982|NCT04666259|530379749|FG000|Safety Follow-up Phase|Subject decision|1|||
147058983|NCT04666259|530379750|FG001|Safety Follow-up Phase|Subject decision|0|||
147058984|NCT04666259|530379751|FG002|Safety Follow-up Phase|Subject decision|0|||
147058985|NCT04666259|530379749|FG000|Safety Follow-up Phase|Death|0|||
147058986|NCT04666259|530379750|FG001|Safety Follow-up Phase|Death|1|||
147058987|NCT04666259|530379751|FG002|Safety Follow-up Phase|Death|0|||
147058988|NCT04178122|530379752|FG000|Overall Study|Withdrawal by Subject|1|||
147058989|NCT04178122|530379753|FG001|Overall Study|Withdrawal by Subject|1|||
147058990|NCT04178122|530379752|FG000|Overall Study|Death|2|||
147058991|NCT04178122|530379753|FG001|Overall Study|Death|0|||
147058992|NCT04178122|530379752|FG000|Overall Study|Did not complete testing|3|||
147058993|NCT04178122|530379753|FG001|Overall Study|Did not complete testing|13|||
147058994|NCT02677922|530379754|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
147058995|NCT02677922|530379755|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
147058996|NCT02677922|530379756|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
147058997|NCT02677922|530379757|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
147058998|NCT02677922|530379758|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
147058999|NCT02677922|530379759|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
147059000|NCT02677922|530379754|FG000|Treatment Period|Adverse Event|0|||
147059001|NCT02677922|530379755|FG001|Treatment Period|Adverse Event|0|||
147059002|NCT02677922|530379756|FG002|Treatment Period|Adverse Event|1|||
147059003|NCT02677922|530379757|FG003|Treatment Period|Adverse Event|3|||
147059004|NCT02677922|530379758|FG004|Treatment Period|Adverse Event|5|||
147059005|NCT02677922|530379759|FG005|Treatment Period|Adverse Event|2|||
147059006|NCT02677922|530379754|FG000|Treatment Period|Progressive Disease|1|||
147059007|NCT02677922|530379755|FG001|Treatment Period|Progressive Disease|1|||
147059008|NCT02677922|530379756|FG002|Treatment Period|Progressive Disease|0|||
147059009|NCT02677922|530379757|FG003|Treatment Period|Progressive Disease|0|||
147059010|NCT02677922|530379758|FG004|Treatment Period|Progressive Disease|8|||
147059011|NCT02677922|530379759|FG005|Treatment Period|Progressive Disease|7|||
147059012|NCT02677922|530379754|FG000|Treatment Period|Lack of Efficacy|0|||
147059013|NCT02677922|530379755|FG001|Treatment Period|Lack of Efficacy|0|||
147059014|NCT02677922|530379756|FG002|Treatment Period|Lack of Efficacy|0|||
147059015|NCT02677922|530379757|FG003|Treatment Period|Lack of Efficacy|1|||
147059016|NCT02677922|530379758|FG004|Treatment Period|Lack of Efficacy|1|||
147059017|NCT02677922|530379759|FG005|Treatment Period|Lack of Efficacy|6|||
147059018|NCT02677922|530379754|FG000|Treatment Period|Withdrawal by Subject|0|||
147059019|NCT02677922|530379755|FG001|Treatment Period|Withdrawal by Subject|0|||
147059020|NCT02677922|530379756|FG002|Treatment Period|Withdrawal by Subject|1|||
147059021|NCT02677922|530379757|FG003|Treatment Period|Withdrawal by Subject|3|||
147059022|NCT02677922|530379758|FG004|Treatment Period|Withdrawal by Subject|5|||
147059023|NCT02677922|530379759|FG005|Treatment Period|Withdrawal by Subject|5|||
147059024|NCT02677922|530379754|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
147059025|NCT02677922|530379755|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
147059026|NCT02677922|530379756|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
147059027|NCT02677922|530379757|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
147059028|NCT02677922|530379758|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
147059029|NCT02677922|530379759|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
147059030|NCT02677922|530379754|FG000|Treatment Period|Disease Relapse|0|||
147059031|NCT02677922|530379755|FG001|Treatment Period|Disease Relapse|0|||
147059032|NCT02677922|530379756|FG002|Treatment Period|Disease Relapse|0|||
147059033|NCT02677922|530379757|FG003|Treatment Period|Disease Relapse|3|||
147059034|NCT02677922|530379758|FG004|Treatment Period|Disease Relapse|6|||
147059035|NCT02677922|530379759|FG005|Treatment Period|Disease Relapse|1|||
147059036|NCT02677922|530379754|FG000|Treatment Period|Allogeneic HSCT|1|||
147059037|NCT02677922|530379755|FG001|Treatment Period|Allogeneic HSCT|0|||
147059038|NCT02677922|530379756|FG002|Treatment Period|Allogeneic HSCT|0|||
147059039|NCT02677922|530379757|FG003|Treatment Period|Allogeneic HSCT|1|||
147059040|NCT02677922|530379758|FG004|Treatment Period|Allogeneic HSCT|4|||
147059041|NCT02677922|530379759|FG005|Treatment Period|Allogeneic HSCT|1|||
147059042|NCT02677922|530379754|FG000|Treatment Period|Other Reasons|0|||
147059043|NCT02677922|530379755|FG001|Treatment Period|Other Reasons|0|||
147059044|NCT02677922|530379756|FG002|Treatment Period|Other Reasons|0|||
147059045|NCT02677922|530379757|FG003|Treatment Period|Other Reasons|1|||
147059046|NCT02677922|530379758|FG004|Treatment Period|Other Reasons|3|||
147059047|NCT02677922|530379759|FG005|Treatment Period|Other Reasons|5|||
147059048|NCT02677922|530379754|FG000|Treatment Period|Death|0|||
147059049|NCT02677922|530379755|FG001|Treatment Period|Death|0|||
147059050|NCT02677922|530379756|FG002|Treatment Period|Death|0|||
147059051|NCT02677922|530379757|FG003|Treatment Period|Death|0|||
147059052|NCT02677922|530379758|FG004|Treatment Period|Death|12|||
147059053|NCT02677922|530379759|FG005|Treatment Period|Death|1|||
147059054|NCT02677922|530379754|FG000|Treatment Period|Non-compliance with Study Drug|0|||
147059055|NCT02677922|530379755|FG001|Treatment Period|Non-compliance with Study Drug|0|||
147059056|NCT02677922|530379756|FG002|Treatment Period|Non-compliance with Study Drug|0|||
147059057|NCT02677922|530379757|FG003|Treatment Period|Non-compliance with Study Drug|0|||
147059058|NCT02677922|530379758|FG004|Treatment Period|Non-compliance with Study Drug|1|||
147059059|NCT02677922|530379759|FG005|Treatment Period|Non-compliance with Study Drug|0|||
147059060|NCT02677922|530379754|FG000|Treatment Period|Physician Decision|0|||
147059061|NCT02677922|530379755|FG001|Treatment Period|Physician Decision|0|||
147059062|NCT02677922|530379756|FG002|Treatment Period|Physician Decision|0|||
147059063|NCT02677922|530379757|FG003|Treatment Period|Physician Decision|0|||
147059064|NCT02677922|530379758|FG004|Treatment Period|Physician Decision|0|||
147059065|NCT02677922|530379759|FG005|Treatment Period|Physician Decision|1|||
147059066|NCT02677922|530379754|FG000|Treatment Period|Symptomatic Deterioration|0|||
147059067|NCT02677922|530379755|FG001|Treatment Period|Symptomatic Deterioration|0|||
147059068|NCT02677922|530379756|FG002|Treatment Period|Symptomatic Deterioration|0|||
147059069|NCT02677922|530379757|FG003|Treatment Period|Symptomatic Deterioration|0|||
147059070|NCT02677922|530379758|FG004|Treatment Period|Symptomatic Deterioration|1|||
147059071|NCT02677922|530379759|FG005|Treatment Period|Symptomatic Deterioration|0|||
147059072|NCT02105987|530379761|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
147059073|NCT02105987|530379762|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
147059074|NCT02105987|530379763|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
147059075|NCT02105987|530379764|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
147059076|NCT02105987|530379765|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
147059077|NCT02105987|530379766|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
147059078|NCT02105987|530379761|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
147059079|NCT02105987|530379762|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
147059080|NCT02105987|530379763|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
147059081|NCT02105987|530379764|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
147059082|NCT02105987|530379765|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
147059083|NCT02105987|530379766|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
147059084|NCT02105987|530379761|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
147059085|NCT02105987|530379762|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
147059086|NCT02105987|530379763|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
147059087|NCT02105987|530379764|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
147059088|NCT02105987|530379765|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
147059089|NCT02105987|530379766|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
147059090|NCT02105987|530379761|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
147059091|NCT02105987|530379762|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
147059092|NCT02105987|530379763|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
147059093|NCT02105987|530379764|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
147059094|NCT02105987|530379765|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
147059095|NCT02105987|530379766|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
147059096|NCT02105987|530379761|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
147059097|NCT02105987|530379762|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
147059098|NCT02105987|530379763|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
147059099|NCT02105987|530379764|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
147059100|NCT02105987|530379765|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
147059101|NCT02105987|530379766|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
147059102|NCT02105987|530379761|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
147059103|NCT02105987|530379762|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
147059104|NCT02105987|530379763|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
147059105|NCT02105987|530379764|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
147059106|NCT02105987|530379765|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
147059107|NCT02105987|530379766|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
147059108|NCT02105987|530379761|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
147059109|NCT02105987|530379762|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
147059110|NCT02105987|530379763|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
147059111|NCT02105987|530379764|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
147059112|NCT02105987|530379765|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
147059113|NCT02105987|530379766|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
147059114|NCT02105987|530379761|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
147059115|NCT02105987|530379762|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
147059116|NCT02105987|530379763|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
147059117|NCT02105987|530379764|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
147059118|NCT02105987|530379765|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
147059119|NCT02105987|530379766|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
147059120|NCT02105987|530379761|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
147059121|NCT02105987|530379762|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
147059122|NCT02105987|530379763|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
147059123|NCT02105987|530379764|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
147059124|NCT02105987|530379765|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
147059125|NCT02105987|530379766|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
147059126|NCT02105987|530379761|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
147059127|NCT02105987|530379762|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
147059128|NCT02105987|530379763|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
147059129|NCT02105987|530379764|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
147059130|NCT02105987|530379765|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
147059131|NCT02105987|530379766|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
147059132|NCT02105987|530379761|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
147059133|NCT02105987|530379762|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
147059134|NCT02105987|530379763|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
147059135|NCT02105987|530379764|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
147059136|NCT02105987|530379765|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
147059137|NCT02105987|530379766|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
147059138|NCT02105987|530379761|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
147059139|NCT02105987|530379762|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
147059140|NCT02105987|530379763|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
147059141|NCT02105987|530379764|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
147059142|NCT02105987|530379765|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
147059143|NCT02105987|530379766|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
147059144|NCT02105987|530379761|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
147059145|NCT02105987|530379762|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
147059146|NCT02105987|530379763|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
147059147|NCT02105987|530379764|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
147059148|NCT02105987|530379765|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
147059149|NCT02105987|530379766|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
147059150|NCT02105987|530379761|FG000|Continuation Phase|Protocol Violation|0|||
147059151|NCT02105987|530379762|FG001|Continuation Phase|Protocol Violation|0|||
147059152|NCT02105987|530379763|FG002|Continuation Phase|Protocol Violation|0|||
147059153|NCT02105987|530379764|FG003|Continuation Phase|Protocol Violation|0|||
147059154|NCT02105987|530379765|FG004|Continuation Phase|Protocol Violation|1|||
147059155|NCT02105987|530379766|FG005|Continuation Phase|Protocol Violation|0|||
147059156|NCT03926117|530379773|FG000|Overall Study|Unclassified|1|||
147059157|NCT03926117|530379774|FG001|Overall Study|Unclassified|4|||
147059158|NCT03926117|530379775|FG002|Overall Study|Unclassified|1|||
147059159|NCT03926117|530379776|FG003|Overall Study|Unclassified|4|||
147059160|NCT03926117|530379773|FG000|Overall Study|Withdrawal by Subject|3|||
147059161|NCT03926117|530379774|FG001|Overall Study|Withdrawal by Subject|0|||
147059162|NCT03926117|530379775|FG002|Overall Study|Withdrawal by Subject|1|||
147059163|NCT03926117|530379776|FG003|Overall Study|Withdrawal by Subject|1|||
147059164|NCT03926117|530379773|FG000|Overall Study|Lost to Follow-up|0|||
147059165|NCT03926117|530379774|FG001|Overall Study|Lost to Follow-up|2|||
147059166|NCT03926117|530379775|FG002|Overall Study|Lost to Follow-up|1|||
147059167|NCT03926117|530379776|FG003|Overall Study|Lost to Follow-up|0|||
147059168|NCT03926117|530379773|FG000|Overall Study|Adverse Event|1|||
147059169|NCT03926117|530379774|FG001|Overall Study|Adverse Event|2|||
147059170|NCT03926117|530379775|FG002|Overall Study|Adverse Event|3|||
147059171|NCT03926117|530379776|FG003|Overall Study|Adverse Event|1|||
147059172|NCT03926117|530379773|FG000|Overall Study|Randomized but not treated|1|||
147059173|NCT03926117|530379774|FG001|Overall Study|Randomized but not treated|1|||
147059174|NCT03926117|530379775|FG002|Overall Study|Randomized but not treated|0|||
147059175|NCT03926117|530379776|FG003|Overall Study|Randomized but not treated|1|||
147059176|NCT02748356|530379783|FG000|Overall Study|Withdrawal by Subject|1|||
147059177|NCT05107492|530379784|FG000|Overall Study|Lost to Follow-up|1|||
147059178|NCT05107492|530379785|FG001|Overall Study|Lost to Follow-up|0|||
147059179|NCT05236764|530379786|FG000|Overall Study|In follow up (ongoing)|1|||
147059180|NCT05236764|530379786|FG000|Overall Study|Taken off study - secondary graft failure|1|||
147059181|NCT05236764|530379786|FG000|Overall Study|Death|1|||
147059182|NCT05870371|530379787|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
147059183|NCT05870371|530379788|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
147059184|NCT00564850|530379797|FG000|Overall Study|Protocol Violation|2|||
147059185|NCT02640664|530379798|FG000|Epoch 1|Withdrawal of informed consent|1|||
147059186|NCT02640664|530379799|FG001|Epoch 1|Withdrawal of informed consent|0|||
147059187|NCT02640664|530379800|FG002|Epoch 1|Withdrawal of informed consent|0|||
147059188|NCT02640664|530379798|FG000|Epoch 1|Death|0|||
147059189|NCT02640664|530379799|FG001|Epoch 1|Death|0|||
147059190|NCT02640664|530379800|FG002|Epoch 1|Death|1|||
147059191|NCT02640664|530379798|FG000|Epoch 2|Withdrawal of informed consent|3|||
147059192|NCT02640664|530379799|FG001|Epoch 2|Withdrawal of informed consent|4|||
147059193|NCT02640664|530379800|FG002|Epoch 2|Withdrawal of informed consent|2|||
147059194|NCT02640664|530379798|FG000|Epoch 2|Subject/guardian decision|0|||
147059195|NCT02640664|530379799|FG001|Epoch 2|Subject/guardian decision|2|||
147059196|NCT02640664|530379800|FG002|Epoch 2|Subject/guardian decision|2|||
147059197|NCT02640664|530379798|FG000|Epoch 2|Lost to Follow-up|3|||
147059198|NCT02640664|530379799|FG001|Epoch 2|Lost to Follow-up|4|||
147059199|NCT02640664|530379800|FG002|Epoch 2|Lost to Follow-up|1|||
147059200|NCT02640664|530379798|FG000|Epoch 2|Death|0|||
147059201|NCT02640664|530379799|FG001|Epoch 2|Death|0|||
147059202|NCT02640664|530379800|FG002|Epoch 2|Death|1|||
147059203|NCT00314327|530379801|FG000|Overall Study|Withdrawal by Subject|1|||
147059204|NCT01408303|530379802|FG000|Overall Study|Adverse Event|3|||
147059205|NCT01408303|530379803|FG001|Overall Study|Adverse Event|7|||
147059206|NCT01408303|530379804|FG002|Overall Study|Adverse Event|2|||
147059207|NCT01408303|530379802|FG000|Overall Study|Lost to Follow-up|0|||
147059208|NCT01408303|530379803|FG001|Overall Study|Lost to Follow-up|1|||
147059209|NCT01408303|530379804|FG002|Overall Study|Lost to Follow-up|2|||
147059210|NCT01408303|530379802|FG000|Overall Study|Withdrawal by Subject|2|||
147059211|NCT01408303|530379803|FG001|Overall Study|Withdrawal by Subject|3|||
147059212|NCT01408303|530379804|FG002|Overall Study|Withdrawal by Subject|1|||
147059213|NCT01408303|530379802|FG000|Overall Study|Protocol Violation|0|||
147059214|NCT01408303|530379803|FG001|Overall Study|Protocol Violation|1|||
147059215|NCT01408303|530379804|FG002|Overall Study|Protocol Violation|0|||
147059216|NCT01408303|530379802|FG000|Overall Study|Noncompliance|1|||
147059217|NCT01408303|530379803|FG001|Overall Study|Noncompliance|0|||
147059218|NCT01408303|530379804|FG002|Overall Study|Noncompliance|1|||
147059219|NCT00669669|530379806|FG000|Overall Study|To late to start treatment|1|||
147059220|NCT01205776|530379810|FG000|Overall Study|Lost to Follow-up|53|||
147059221|NCT01205776|530379811|FG001|Overall Study|Lost to Follow-up|61|||
147059222|NCT01205776|530379810|FG000|Overall Study|Withdrawal by Subject|11|||
147059223|NCT01205776|530379811|FG001|Overall Study|Withdrawal by Subject|34|||
147059224|NCT04031846|530379814|FG000|Overall Study|Lost to Follow-up|4|||
147059225|NCT04031846|530379815|FG001|Overall Study|Lost to Follow-up|4|||
147059226|NCT04031846|530379814|FG000|Overall Study|Physician Decision|0|||
147059227|NCT04031846|530379815|FG001|Overall Study|Physician Decision|1|||
147059228|NCT04031846|530379814|FG000|Overall Study|Protocol Violation|1|||
147059229|NCT04031846|530379815|FG001|Overall Study|Protocol Violation|1|||
147059230|NCT04031846|530379814|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
147059231|NCT04031846|530379815|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
147059232|NCT01134107|530381669|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
147059233|NCT01134107|530381670|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
147059234|NCT01134107|530381669|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
147059235|NCT01134107|530381670|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
147059236|NCT01134107|530381669|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
147059237|NCT01134107|530381670|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
147059238|NCT01134107|530381669|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
147059239|NCT01134107|530381670|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
147059240|NCT01134107|530381669|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
147059241|NCT01134107|530381670|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
147059242|NCT01134107|530381669|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
147059243|NCT01134107|530381670|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
147059244|NCT01134107|530381669|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
147059245|NCT01134107|530381670|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
147059246|NCT00687271|530381671|FG000|Overall Study|Adverse Event|1|||
147059247|NCT00687271|530381672|FG001|Overall Study|Adverse Event|3|||
147059248|NCT00687271|530381673|FG002|Overall Study|Adverse Event|1|||
147059249|NCT00687271|530381674|FG003|Overall Study|Adverse Event|0|||
147059250|NCT00687271|530381671|FG000|Overall Study|Lost to Follow-up|0|||
147059251|NCT00687271|530381672|FG001|Overall Study|Lost to Follow-up|1|||
147059252|NCT00687271|530381673|FG002|Overall Study|Lost to Follow-up|0|||
147059253|NCT00687271|530381674|FG003|Overall Study|Lost to Follow-up|0|||
147059254|NCT00687271|530381671|FG000|Overall Study|Protocol Violation|2|||
147059255|NCT00687271|530381672|FG001|Overall Study|Protocol Violation|1|||
147059256|NCT00687271|530381673|FG002|Overall Study|Protocol Violation|1|||
147059257|NCT00687271|530381674|FG003|Overall Study|Protocol Violation|0|||
147059258|NCT00687271|530381671|FG000|Overall Study|Withdrawal by Subject|0|||
147059259|NCT00687271|530381672|FG001|Overall Study|Withdrawal by Subject|1|||
147059260|NCT00687271|530381673|FG002|Overall Study|Withdrawal by Subject|3|||
147059261|NCT00687271|530381674|FG003|Overall Study|Withdrawal by Subject|0|||
147059262|NCT05483686|530381676|FG000|Overall Study|Lost to Follow-up|5|||
147059263|NCT05483686|530381677|FG001|Overall Study|Lost to Follow-up|7|||
147059264|NCT05780983|530381678|FG000|Overall Study|Withdrawal by Subject|1|||
147059265|NCT04541589|530381679|FG000|Treatment Period|Adverse Event|8|||
147059266|NCT04541589|530381680|FG001|Treatment Period|Adverse Event|2|||
147059267|NCT04541589|530381679|FG000|Treatment Period|Physician Decision|3|||
147059268|NCT04541589|530381680|FG001|Treatment Period|Physician Decision|1|||
147059269|NCT04541589|530381679|FG000|Treatment Period|Subject decision|7|||
147059270|NCT04541589|530381680|FG001|Treatment Period|Subject decision|4|||
147059271|NCT04541589|530381679|FG000|Treatment Period|Withdrawal by Subject|1|||
147059272|NCT04541589|530381680|FG001|Treatment Period|Withdrawal by Subject|0|||
147059273|NCT04541589|530381679|FG000|Safety Follow-up Period|Adverse Event|2|||
147059274|NCT04541589|530381680|FG001|Safety Follow-up Period|Adverse Event|1|||
147059275|NCT04541589|530381679|FG000|Safety Follow-up Period|Physician Decision|1|||
147059276|NCT04541589|530381680|FG001|Safety Follow-up Period|Physician Decision|0|||
147059277|NCT04541589|530381679|FG000|Safety Follow-up Period|Subject decision|5|||
147059278|NCT04541589|530381680|FG001|Safety Follow-up Period|Subject decision|3|||
147059279|NCT04541589|530381679|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
147059280|NCT04541589|530381680|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
147059281|NCT02727478|530381681|FG000|Overall Study|Withdrawal by Subject|8|||
147059282|NCT02727478|530381682|FG001|Overall Study|Withdrawal by Subject|10|||
147059283|NCT02633293|530381683|FG000|Overall Study|Death|56|||
147059284|NCT02633293|530381683|FG000|Overall Study|Progressive Disease|12|||
147059285|NCT02633293|530381683|FG000|Overall Study|Adverse Event|29|||
147059286|NCT02633293|530381683|FG000|Overall Study|Withdrawal by Subject|41|||
147059287|NCT02633293|530381683|FG000|Overall Study|Protocol Violation|1|||
147059288|NCT02633293|530381683|FG000|Overall Study|Lost to Follow-up|1|||
147059289|NCT02633293|530381683|FG000|Overall Study|Study Terminated by Sponsor|24|||
147059290|NCT02633293|530381683|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
147059291|NCT02633293|530381683|FG000|Overall Study|Lung Transplant|5|||
147059292|NCT02633293|530381683|FG000|Overall Study|Lack of Efficacy|2|||
147059293|NCT02633293|530381683|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
147059294|NCT01017874|530381684|FG000|Overall Study|Withdrawal by Subject|23|||
147059295|NCT01017874|530381685|FG001|Overall Study|Withdrawal by Subject|20|||
147059296|NCT01017874|530381684|FG000|Overall Study|Sponsor decision|3|||
147059297|NCT01017874|530381685|FG001|Overall Study|Sponsor decision|1|||
147059298|NCT01017874|530381684|FG000|Overall Study|Lost to Follow-up|3|||
147059299|NCT01017874|530381685|FG001|Overall Study|Lost to Follow-up|2|||
147059300|NCT01017874|530381684|FG000|Overall Study|Physician Decision|1|||
147059301|NCT01017874|530381685|FG001|Overall Study|Physician Decision|3|||
147059302|NCT00808210|530381686|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
147059303|NCT00808210|530381687|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
147059304|NCT00808210|530381686|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
147059305|NCT00808210|530381687|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
147059306|NCT00808210|530381686|FG000|Double-Blind TX Period|Adverse Event|0|||
147059307|NCT00808210|530381687|FG001|Double-Blind TX Period|Adverse Event|1|||
147059308|NCT00808210|530381686|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
147059309|NCT00808210|530381687|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
147059310|NCT00808210|530381686|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
147059311|NCT00808210|530381687|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
147059312|NCT00808210|530381686|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
147059313|NCT00808210|530381687|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
147059314|NCT00778817|530381692|FG000|Overall Study|Adverse Event|2|||
147059315|NCT00778817|530381692|FG000|Overall Study|Withdrawal by Subject|2|||
147059316|NCT01081769|530381693|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
147059317|NCT01081769|530381694|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
147059318|NCT01081769|530381693|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
147059319|NCT01081769|530381694|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
147059320|NCT01081769|530381693|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
147059321|NCT01081769|530381694|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
147059322|NCT01081769|530381693|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
147059323|NCT01081769|530381694|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
147059324|NCT01081769|530381693|FG000|CORE Intent-To-Treat|Adverse Event|14|||
147059325|NCT01081769|530381694|FG001|CORE Intent-To-Treat|Adverse Event|11|||
147059326|NCT01081769|530381693|FG000|CORE Intent-To-Treat|Death|1|||
147059327|NCT01081769|530381694|FG001|CORE Intent-To-Treat|Death|1|||
147059328|NCT01081769|530381693|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
147059329|NCT01081769|530381694|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
147059330|NCT01081769|530381693|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
147059331|NCT01081769|530381694|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
147059332|NCT01081769|530381693|FG000|CORE Intent-To-Treat|Pregnancy|1|||
147059333|NCT01081769|530381694|FG001|CORE Intent-To-Treat|Pregnancy|0|||
147059334|NCT01081769|530381693|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
147059335|NCT01081769|530381694|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
147059336|NCT01081769|530381693|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
147059337|NCT01081769|530381694|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
147059338|NCT01081769|530381693|FG000|CORE Intent-To-Treat|Other|0|||
147059339|NCT01081769|530381694|FG001|CORE Intent-To-Treat|Other|1|||
147059340|NCT01081769|530381693|FG000|CORE Intent-To-Treat|Ineligibility|3|||
147059341|NCT01081769|530381694|FG001|CORE Intent-To-Treat|Ineligibility|4|||
147059342|NCT01081769|530381693|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
147059343|NCT01081769|530381694|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
147059344|NCT01081769|530381693|FG000|CORE Intent-To-Treat|Patient Moved|2|||
147059345|NCT01081769|530381694|FG001|CORE Intent-To-Treat|Patient Moved|2|||
147059346|NCT00789373|530381707|FG000|Induction|Adverse Event|64|||
147059347|NCT00789373|530381708|FG001|Induction|Adverse Event|0|||
147059348|NCT00789373|530381709|FG002|Induction|Adverse Event|0|||
147059349|NCT00789373|530381707|FG000|Induction|Death Due to study disease|24|||
147059350|NCT00789373|530381708|FG001|Induction|Death Due to study disease|0|||
147059351|NCT00789373|530381709|FG002|Induction|Death Due to study disease|0|||
147059352|NCT00789373|530381707|FG000|Induction|Death due to adverse event|19|||
147059353|NCT00789373|530381708|FG001|Induction|Death due to adverse event|0|||
147059354|NCT00789373|530381709|FG002|Induction|Death due to adverse event|0|||
147059355|NCT00789373|530381707|FG000|Induction|Death due to toxicity|11|||
147059356|NCT00789373|530381708|FG001|Induction|Death due to toxicity|0|||
147059357|NCT00789373|530381709|FG002|Induction|Death due to toxicity|0|||
147059358|NCT00789373|530381707|FG000|Induction|Death due to procedure|1|||
147059359|NCT00789373|530381708|FG001|Induction|Death due to procedure|0|||
147059360|NCT00789373|530381709|FG002|Induction|Death due to procedure|0|||
147059361|NCT00789373|530381707|FG000|Induction|Investigator decision|7|||
147059362|NCT00789373|530381708|FG001|Induction|Investigator decision|0|||
147059363|NCT00789373|530381709|FG002|Induction|Investigator decision|0|||
147059364|NCT00789373|530381707|FG000|Induction|Protocol entry criteria not met|9|||
147059365|NCT00789373|530381708|FG001|Induction|Protocol entry criteria not met|0|||
147059366|NCT00789373|530381709|FG002|Induction|Protocol entry criteria not met|0|||
147059367|NCT00789373|530381707|FG000|Induction|Lost to Follow-up|6|||
147059368|NCT00789373|530381708|FG001|Induction|Lost to Follow-up|0|||
147059369|NCT00789373|530381709|FG002|Induction|Lost to Follow-up|0|||
147059370|NCT00789373|530381707|FG000|Induction|Protocol Violation|1|||
147059371|NCT00789373|530381708|FG001|Induction|Protocol Violation|0|||
147059372|NCT00789373|530381709|FG002|Induction|Protocol Violation|0|||
147059373|NCT00789373|530381707|FG000|Induction|Progressive Disease|220|||
147059374|NCT00789373|530381708|FG001|Induction|Progressive Disease|0|||
147059375|NCT00789373|530381709|FG002|Induction|Progressive Disease|0|||
147059376|NCT00789373|530381707|FG000|Induction|Withdrawal by Subject|37|||
147059377|NCT00789373|530381708|FG001|Induction|Withdrawal by Subject|0|||
147059378|NCT00789373|530381709|FG002|Induction|Withdrawal by Subject|0|||
147059379|NCT00789373|530381707|FG000|Maintenance|Adverse Event|0|||
147059380|NCT00789373|530381708|FG001|Maintenance|Adverse Event|65|||
147059381|NCT00789373|530381709|FG002|Maintenance|Adverse Event|12|||
147059382|NCT00789373|530381707|FG000|Maintenance|Death due to study disease|0|||
147059383|NCT00789373|530381708|FG001|Maintenance|Death due to study disease|3|||
147059384|NCT00789373|530381709|FG002|Maintenance|Death due to study disease|1|||
147059385|NCT00789373|530381707|FG000|Maintenance|Death due to adverse event|0|||
147059386|NCT00789373|530381708|FG001|Maintenance|Death due to adverse event|4|||
147059387|NCT00789373|530381709|FG002|Maintenance|Death due to adverse event|1|||
147059388|NCT00789373|530381707|FG000|Maintenance|Death due to toxicity|0|||
147059389|NCT00789373|530381708|FG001|Maintenance|Death due to toxicity|1|||
147059390|NCT00789373|530381709|FG002|Maintenance|Death due to toxicity|2|||
147059391|NCT00789373|530381707|FG000|Maintenance|Investigator Decision|0|||
147059392|NCT00789373|530381708|FG001|Maintenance|Investigator Decision|4|||
147059393|NCT00789373|530381709|FG002|Maintenance|Investigator Decision|2|||
147059394|NCT00789373|530381707|FG000|Maintenance|Protocol entry criteria not met|0|||
147059395|NCT00789373|530381708|FG001|Maintenance|Protocol entry criteria not met|2|||
147059396|NCT00789373|530381709|FG002|Maintenance|Protocol entry criteria not met|0|||
147059397|NCT00789373|530381707|FG000|Maintenance|Lost to Follow-up|0|||
147059398|NCT00789373|530381708|FG001|Maintenance|Lost to Follow-up|2|||
147059399|NCT00789373|530381709|FG002|Maintenance|Lost to Follow-up|0|||
147059400|NCT00789373|530381707|FG000|Maintenance|Progressive Disease|0|||
147059401|NCT00789373|530381708|FG001|Maintenance|Progressive Disease|253|||
147059402|NCT00789373|530381709|FG002|Maintenance|Progressive Disease|152|||
147059403|NCT00789373|530381707|FG000|Maintenance|Withdrawal by Subject|0|||
147059404|NCT00789373|530381708|FG001|Maintenance|Withdrawal by Subject|21|||
147059405|NCT00789373|530381709|FG002|Maintenance|Withdrawal by Subject|8|||
147059406|NCT00789373|530381707|FG000|Maintenance|Sponsor Decision|0|||
147059407|NCT00789373|530381708|FG001|Maintenance|Sponsor Decision|0|||
147059408|NCT00789373|530381709|FG002|Maintenance|Sponsor Decision|2|||
147059409|NCT00789373|530381707|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
147059410|NCT00789373|530381708|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
147059411|NCT00789373|530381709|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
147059412|NCT01964222|530381712|FG000|Overall Study|Lost to Follow-up|7|||
147059413|NCT01964222|530381713|FG001|Overall Study|Lost to Follow-up|5|||
147059414|NCT01964222|530381712|FG000|Overall Study|Withdrawal by Subject|6|||
147059415|NCT01964222|530381713|FG001|Overall Study|Withdrawal by Subject|6|||
147059416|NCT01964222|530381712|FG000|Overall Study|Screening Failure|2|||
147059417|NCT01964222|530381713|FG001|Overall Study|Screening Failure|0|||
147059418|NCT01019694|530381718|FG000|Overall Study|Adverse Event|12|||
147059419|NCT01019694|530381719|FG001|Overall Study|Adverse Event|16|||
147059420|NCT01019694|530381720|FG002|Overall Study|Adverse Event|19|||
147059421|NCT01019694|530381718|FG000|Overall Study|Protocol Violation|2|||
147059422|NCT01019694|530381719|FG001|Overall Study|Protocol Violation|6|||
147059423|NCT01019694|530381720|FG002|Overall Study|Protocol Violation|4|||
147059424|NCT01019694|530381718|FG000|Overall Study|Lost to Follow-up|5|||
147059425|NCT01019694|530381719|FG001|Overall Study|Lost to Follow-up|3|||
147059426|NCT01019694|530381720|FG002|Overall Study|Lost to Follow-up|3|||
147059427|NCT01019694|530381718|FG000|Overall Study|Withdrawal by Subject|4|||
147059428|NCT01019694|530381719|FG001|Overall Study|Withdrawal by Subject|6|||
147059429|NCT01019694|530381720|FG002|Overall Study|Withdrawal by Subject|12|||
147059430|NCT01019694|530381718|FG000|Overall Study|Not treated|0|||
147059431|NCT01019694|530381719|FG001|Overall Study|Not treated|2|||
147059432|NCT01019694|530381720|FG002|Overall Study|Not treated|3|||
147059433|NCT01019694|530381718|FG000|Overall Study|Other reason (not specified)|1|||
147059434|NCT01019694|530381719|FG001|Overall Study|Other reason (not specified)|5|||
147059435|NCT01019694|530381720|FG002|Overall Study|Other reason (not specified)|6|||
147059436|NCT00026494|530381727|FG000|Overall Study|Withdrawal by Subject|1|||
147059437|NCT00026494|530381728|FG001|Overall Study|Withdrawal by Subject|0|||
147059438|NCT00026494|530381729|FG002|Overall Study|Withdrawal by Subject|1|||
147059439|NCT00026494|530381730|FG003|Overall Study|Withdrawal by Subject|0|||
147059440|NCT00026494|530381727|FG000|Overall Study|Patient non-compliance|1|||
147059441|NCT00026494|530381728|FG001|Overall Study|Patient non-compliance|0|||
147059442|NCT00026494|530381729|FG002|Overall Study|Patient non-compliance|0|||
147059443|NCT00026494|530381730|FG003|Overall Study|Patient non-compliance|0|||
147059444|NCT00026494|530381727|FG000|Overall Study|Patient not treated|0|||
147059445|NCT00026494|530381728|FG001|Overall Study|Patient not treated|0|||
147059446|NCT00026494|530381729|FG002|Overall Study|Patient not treated|2|||
147059447|NCT00026494|530381730|FG003|Overall Study|Patient not treated|0|||
147059448|NCT00026494|530381727|FG000|Overall Study|Clinical progression|0|||
147059449|NCT00026494|530381728|FG001|Overall Study|Clinical progression|0|||
147059450|NCT00026494|530381729|FG002|Overall Study|Clinical progression|3|||
147059451|NCT00026494|530381730|FG003|Overall Study|Clinical progression|0|||
147059452|NCT00441129|530381731|FG000|Overall Study|Withdrawal by Subject|6|||
147059453|NCT00441129|530381732|FG001|Overall Study|Withdrawal by Subject|14|||
147059454|NCT01455597|530381733|FG000|Overall Study|Adverse Event|7|||
147059455|NCT01455597|530381734|FG001|Overall Study|Adverse Event|0|||
147059456|NCT01455597|530381735|FG002|Overall Study|Adverse Event|5|||
147059457|NCT01455597|530381736|FG003|Overall Study|Adverse Event|1|||
147059458|NCT01455597|530381733|FG000|Overall Study|Lack of Efficacy|0|||
147059459|NCT01455597|530381734|FG001|Overall Study|Lack of Efficacy|1|||
147059460|NCT01455597|530381735|FG002|Overall Study|Lack of Efficacy|2|||
147059461|NCT01455597|530381736|FG003|Overall Study|Lack of Efficacy|0|||
147059462|NCT01455597|530381733|FG000|Overall Study|Lost to Follow-up|3|||
147059463|NCT01455597|530381734|FG001|Overall Study|Lost to Follow-up|0|||
147059464|NCT01455597|530381735|FG002|Overall Study|Lost to Follow-up|2|||
147059465|NCT01455597|530381736|FG003|Overall Study|Lost to Follow-up|1|||
147059466|NCT01455597|530381733|FG000|Overall Study|Withdrew Consent|6|||
147059467|NCT01455597|530381734|FG001|Overall Study|Withdrew Consent|5|||
147059468|NCT01455597|530381735|FG002|Overall Study|Withdrew Consent|8|||
147059469|NCT01455597|530381736|FG003|Overall Study|Withdrew Consent|5|||
147059470|NCT01455597|530381733|FG000|Overall Study|Reason not Specified|1|||
147059471|NCT01455597|530381734|FG001|Overall Study|Reason not Specified|2|||
147059472|NCT01455597|530381735|FG002|Overall Study|Reason not Specified|3|||
147059473|NCT01455597|530381736|FG003|Overall Study|Reason not Specified|3|||
147059474|NCT01737710|530381737|FG000|Overall Study|Lost to Follow-up|0|||
147059475|NCT01737710|530381738|FG001|Overall Study|Lost to Follow-up|2|||
147059476|NCT01737710|530381739|FG002|Overall Study|Lost to Follow-up|2|||
147059477|NCT01737710|530381740|FG003|Overall Study|Lost to Follow-up|0|||
147059478|NCT01737710|530381741|FG004|Overall Study|Lost to Follow-up|0|||
147059479|NCT01737710|530381737|FG000|Overall Study|Withdrawal by Subject|1|||
147059480|NCT01737710|530381738|FG001|Overall Study|Withdrawal by Subject|1|||
147059481|NCT01737710|530381739|FG002|Overall Study|Withdrawal by Subject|1|||
147059482|NCT01737710|530381740|FG003|Overall Study|Withdrawal by Subject|0|||
147059483|NCT01737710|530381741|FG004|Overall Study|Withdrawal by Subject|0|||
147059484|NCT01737710|530381737|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
147059485|NCT01737710|530381738|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
147059486|NCT01737710|530381739|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
147059487|NCT01737710|530381740|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
147059488|NCT01737710|530381741|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
147059489|NCT04747886|530381742|FG000|Overall Study|Withdrawal by Subject|1|||
147059490|NCT04747886|530381743|FG001|Overall Study|Withdrawal by Subject|4|||
147059491|NCT03777436|530381744|FG000|Placebo-controlled Phase|Adverse Event|8|||
147059492|NCT03777436|530381745|FG001|Placebo-controlled Phase|Adverse Event|10|||
147059493|NCT03777436|530381746|FG002|Placebo-controlled Phase|Adverse Event|0|||
147059494|NCT03777436|530381744|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
147059495|NCT03777436|530381745|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
147059496|NCT03777436|530381746|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
147059497|NCT03777436|530381744|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
147059498|NCT03777436|530381745|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
147059499|NCT03777436|530381746|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
147059500|NCT03777436|530381744|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
147059501|NCT03777436|530381745|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
147059502|NCT03777436|530381746|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
147059503|NCT03777436|530381744|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
147059504|NCT03777436|530381745|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
147059505|NCT03777436|530381746|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
147059506|NCT03777436|530381744|FG000|Placebo-controlled Phase|Physician Decision|0|||
147059507|NCT03777436|530381745|FG001|Placebo-controlled Phase|Physician Decision|1|||
147059508|NCT03777436|530381746|FG002|Placebo-controlled Phase|Physician Decision|0|||
147059509|NCT03777436|530381744|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
147059510|NCT03777436|530381745|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
147059511|NCT03777436|530381746|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
147059512|NCT03777436|530381744|FG000|Apremilast Extension Phase|Adverse Event|0|||
147059513|NCT03777436|530381745|FG001|Apremilast Extension Phase|Adverse Event|0|||
147059514|NCT03777436|530381746|FG002|Apremilast Extension Phase|Adverse Event|6|||
147059515|NCT03777436|530381744|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
147059516|NCT03777436|530381745|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
147059517|NCT03777436|530381746|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
147059518|NCT03777436|530381744|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
147059519|NCT03777436|530381745|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
147059520|NCT03777436|530381746|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
147059521|NCT03777436|530381744|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
147059522|NCT03777436|530381745|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
147059523|NCT03777436|530381746|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
147059524|NCT03777436|530381744|FG000|Apremilast Extension Phase|Miscellaneous|0|||
147059525|NCT03777436|530381745|FG001|Apremilast Extension Phase|Miscellaneous|0|||
147059526|NCT03777436|530381746|FG002|Apremilast Extension Phase|Miscellaneous|1|||
147059527|NCT00685399|530381747|FG000|Treatment Period 1|Withdrawal by Subject|2|||
147059528|NCT00685399|530381748|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147059529|NCT00685399|530381749|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147059530|NCT00685399|530381750|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147059531|NCT00685399|530381751|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147059532|NCT00685399|530381752|FG005|Treatment Period 1|Withdrawal by Subject|0|||
147059533|NCT00685399|530381753|FG006|Treatment Period 1|Withdrawal by Subject|0|||
147059534|NCT00685399|530381754|FG007|Treatment Period 1|Withdrawal by Subject|0|||
147059535|NCT00685399|530381747|FG000|Treatment Period 1|Protocol Violation|1|||
147059536|NCT00685399|530381748|FG001|Treatment Period 1|Protocol Violation|0|||
147059537|NCT00685399|530381749|FG002|Treatment Period 1|Protocol Violation|0|||
147059538|NCT00685399|530381750|FG003|Treatment Period 1|Protocol Violation|0|||
147059539|NCT00685399|530381751|FG004|Treatment Period 1|Protocol Violation|0|||
147059540|NCT00685399|530381752|FG005|Treatment Period 1|Protocol Violation|0|||
147059541|NCT00685399|530381753|FG006|Treatment Period 1|Protocol Violation|0|||
147059542|NCT00685399|530381754|FG007|Treatment Period 1|Protocol Violation|0|||
147059543|NCT00685399|530381747|FG000|Treatment Period 1|Administrative|2|||
147059544|NCT00685399|530381748|FG001|Treatment Period 1|Administrative|0|||
147059545|NCT00685399|530381749|FG002|Treatment Period 1|Administrative|0|||
147059546|NCT00685399|530381750|FG003|Treatment Period 1|Administrative|0|||
147059547|NCT00685399|530381751|FG004|Treatment Period 1|Administrative|0|||
147059548|NCT00685399|530381752|FG005|Treatment Period 1|Administrative|0|||
147059549|NCT00685399|530381753|FG006|Treatment Period 1|Administrative|0|||
147059550|NCT00685399|530381754|FG007|Treatment Period 1|Administrative|0|||
147059551|NCT00685399|530381747|FG000|Treatment Period 1|Lack of Efficacy|1|||
147059552|NCT00685399|530381748|FG001|Treatment Period 1|Lack of Efficacy|0|||
147059553|NCT00685399|530381749|FG002|Treatment Period 1|Lack of Efficacy|0|||
147059554|NCT00685399|530381750|FG003|Treatment Period 1|Lack of Efficacy|0|||
147059555|NCT00685399|530381751|FG004|Treatment Period 1|Lack of Efficacy|0|||
147059556|NCT00685399|530381752|FG005|Treatment Period 1|Lack of Efficacy|0|||
147059557|NCT00685399|530381753|FG006|Treatment Period 1|Lack of Efficacy|0|||
147059558|NCT00685399|530381754|FG007|Treatment Period 1|Lack of Efficacy|0|||
147059559|NCT00685399|530381747|FG000|Treatment Period 2|Administrative Problems|0|||
147059560|NCT00685399|530381748|FG001|Treatment Period 2|Administrative Problems|2|||
147059561|NCT00685399|530381749|FG002|Treatment Period 2|Administrative Problems|1|||
147059562|NCT00685399|530381750|FG003|Treatment Period 2|Administrative Problems|0|||
147059563|NCT00685399|530381751|FG004|Treatment Period 2|Administrative Problems|0|||
147059564|NCT00685399|530381752|FG005|Treatment Period 2|Administrative Problems|0|||
147059565|NCT00685399|530381753|FG006|Treatment Period 2|Administrative Problems|0|||
147059566|NCT00685399|530381754|FG007|Treatment Period 2|Administrative Problems|0|||
147059567|NCT00685399|530381747|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147059568|NCT00685399|530381748|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147059569|NCT00685399|530381749|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147059570|NCT00685399|530381750|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147059571|NCT00685399|530381751|FG004|Treatment Period 2|Withdrawal by Subject|0|||
147059572|NCT00685399|530381752|FG005|Treatment Period 2|Withdrawal by Subject|0|||
147059573|NCT00685399|530381753|FG006|Treatment Period 2|Withdrawal by Subject|0|||
147059574|NCT00685399|530381754|FG007|Treatment Period 2|Withdrawal by Subject|2|||
147059575|NCT00685399|530381747|FG000|Treatment Period 2|Adverse Event|0|||
147059576|NCT00685399|530381748|FG001|Treatment Period 2|Adverse Event|0|||
147059577|NCT00685399|530381749|FG002|Treatment Period 2|Adverse Event|0|||
147059578|NCT00685399|530381750|FG003|Treatment Period 2|Adverse Event|0|||
147059579|NCT00685399|530381751|FG004|Treatment Period 2|Adverse Event|0|||
147059580|NCT00685399|530381752|FG005|Treatment Period 2|Adverse Event|1|||
147059581|NCT00685399|530381753|FG006|Treatment Period 2|Adverse Event|0|||
147059582|NCT00685399|530381754|FG007|Treatment Period 2|Adverse Event|0|||
147059583|NCT00685399|530381747|FG000|Treatment Period 2|Lack of Efficacy|0|||
147059584|NCT00685399|530381748|FG001|Treatment Period 2|Lack of Efficacy|10|||
147059585|NCT00685399|530381749|FG002|Treatment Period 2|Lack of Efficacy|2|||
147059586|NCT00685399|530381750|FG003|Treatment Period 2|Lack of Efficacy|0|||
147059587|NCT00685399|530381751|FG004|Treatment Period 2|Lack of Efficacy|0|||
147059588|NCT00685399|530381752|FG005|Treatment Period 2|Lack of Efficacy|1|||
147059589|NCT00685399|530381753|FG006|Treatment Period 2|Lack of Efficacy|0|||
147059590|NCT00685399|530381754|FG007|Treatment Period 2|Lack of Efficacy|0|||
147059591|NCT00685399|530381747|FG000|Extension|Administrative Issues|0|||
147059592|NCT00685399|530381748|FG001|Extension|Administrative Issues|0|||
147059593|NCT00685399|530381749|FG002|Extension|Administrative Issues|0|||
147059594|NCT00685399|530381750|FG003|Extension|Administrative Issues|1|||
147059595|NCT00685399|530381751|FG004|Extension|Administrative Issues|0|||
147059596|NCT00685399|530381752|FG005|Extension|Administrative Issues|0|||
147059597|NCT00685399|530381753|FG006|Extension|Administrative Issues|0|||
147059598|NCT00685399|530381754|FG007|Extension|Administrative Issues|0|||
147059599|NCT00685399|530381747|FG000|Extension|Withdrawal by Subject|0|||
147059600|NCT00685399|530381748|FG001|Extension|Withdrawal by Subject|0|||
147059601|NCT00685399|530381749|FG002|Extension|Withdrawal by Subject|0|||
147059602|NCT00685399|530381750|FG003|Extension|Withdrawal by Subject|1|||
147059603|NCT00685399|530381751|FG004|Extension|Withdrawal by Subject|0|||
147059604|NCT00685399|530381752|FG005|Extension|Withdrawal by Subject|0|||
147059605|NCT00685399|530381753|FG006|Extension|Withdrawal by Subject|0|||
147059606|NCT00685399|530381754|FG007|Extension|Withdrawal by Subject|0|||
147059607|NCT00685399|530381747|FG000|Extension|Protocol Violation|0|||
147059608|NCT00685399|530381748|FG001|Extension|Protocol Violation|0|||
147059609|NCT00685399|530381749|FG002|Extension|Protocol Violation|0|||
147059610|NCT00685399|530381750|FG003|Extension|Protocol Violation|1|||
147059611|NCT00685399|530381751|FG004|Extension|Protocol Violation|0|||
147059612|NCT00685399|530381752|FG005|Extension|Protocol Violation|0|||
147059613|NCT00685399|530381753|FG006|Extension|Protocol Violation|0|||
147059614|NCT00685399|530381754|FG007|Extension|Protocol Violation|0|||
147059615|NCT00685399|530381747|FG000|Extension|Lack of Efficacy|0|||
147059616|NCT00685399|530381748|FG001|Extension|Lack of Efficacy|0|||
147059617|NCT00685399|530381749|FG002|Extension|Lack of Efficacy|0|||
147059618|NCT00685399|530381750|FG003|Extension|Lack of Efficacy|2|||
147059619|NCT00685399|530381751|FG004|Extension|Lack of Efficacy|0|||
147059620|NCT00685399|530381752|FG005|Extension|Lack of Efficacy|0|||
147059621|NCT00685399|530381753|FG006|Extension|Lack of Efficacy|0|||
147059622|NCT00685399|530381754|FG007|Extension|Lack of Efficacy|0|||
147059623|NCT00685399|530381747|FG000|Extension|Adverse Event|0|||
147059624|NCT00685399|530381748|FG001|Extension|Adverse Event|0|||
147059625|NCT00685399|530381749|FG002|Extension|Adverse Event|0|||
147059626|NCT00685399|530381750|FG003|Extension|Adverse Event|2|||
147059627|NCT00685399|530381751|FG004|Extension|Adverse Event|0|||
147059628|NCT00685399|530381752|FG005|Extension|Adverse Event|0|||
147059629|NCT00685399|530381753|FG006|Extension|Adverse Event|0|||
147059630|NCT00685399|530381754|FG007|Extension|Adverse Event|0|||
147059631|NCT00656292|530381756|FG000|Overall Study|Withdrawal by Subject|2|||
147059632|NCT00656292|530381757|FG001|Overall Study|Withdrawal by Subject|3|||
147059633|NCT00656292|530381756|FG000|Overall Study|Screen failure|1|||
147059634|NCT00656292|530381757|FG001|Overall Study|Screen failure|2|||
147059635|NCT03674112|530381758|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
147059636|NCT03674112|530381759|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
147059637|NCT03674112|530381758|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
147059638|NCT03674112|530381759|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
147059639|NCT03674112|530381758|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
147059640|NCT03674112|530381759|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
147059641|NCT03674112|530381758|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
147059642|NCT03674112|530381759|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
147059643|NCT03674112|530381758|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
147059644|NCT03674112|530381759|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
147059645|NCT03674112|530381758|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
147059646|NCT03674112|530381759|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
147059647|NCT03674112|530381758|FG000|Follow-Up Period (≥3 Years)|Death|2|||
147059648|NCT03674112|530381759|FG001|Follow-Up Period (≥3 Years)|Death|0|||
147059649|NCT03674112|530381758|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
147059650|NCT03674112|530381759|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
147059651|NCT02684097|530381769|FG000|Overall Study|Lack of Efficacy|13|||
147059652|NCT02684097|530381770|FG001|Overall Study|Lack of Efficacy|6|||
147059653|NCT00462709|530381771|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
147059654|NCT00462709|530381771|FG000|Overall Study|Lost to Follow-up|10|||
147059655|NCT00462709|530381771|FG000|Overall Study|Withdrawal by Subject|8|||
147059656|NCT00462709|530381771|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
147059657|NCT00462709|530381771|FG000|Overall Study|Death|2|||
147059658|NCT00462709|530381771|FG000|Overall Study|Logistical reasons|2|||
147059659|NCT00462709|530381771|FG000|Overall Study|Physician Decision|1|||
147059660|NCT00462709|530381771|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
147059661|NCT02064816|530381772|FG000|Overall Study|Adverse Event|3|||
147059662|NCT02064816|530381773|FG001|Overall Study|Adverse Event|2|||
147059663|NCT02064816|530381772|FG000|Overall Study|Withdrawal by Subject|2|||
147059664|NCT02064816|530381773|FG001|Overall Study|Withdrawal by Subject|1|||
147059665|NCT02064816|530381772|FG000|Overall Study|Lost to Follow-up|2|||
147059666|NCT02064816|530381773|FG001|Overall Study|Lost to Follow-up|1|||
147059667|NCT02064816|530381772|FG000|Overall Study|Therapeutic failure|0|||
147059668|NCT02064816|530381773|FG001|Overall Study|Therapeutic failure|1|||
147059669|NCT02064816|530381772|FG000|Overall Study|Other|1|||
147059670|NCT02064816|530381773|FG001|Overall Study|Other|3|||
147059671|NCT01732458|530381774|FG000|Overall Study|Lost to Follow-up|0|||
147059672|NCT01732458|530381775|FG001|Overall Study|Lost to Follow-up|2|||
147059673|NCT01732458|530381776|FG002|Overall Study|Lost to Follow-up|0|||
147059674|NCT01732458|530381777|FG003|Overall Study|Lost to Follow-up|0|||
147059675|NCT01732458|530381774|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147059676|NCT01732458|530381775|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147059677|NCT01732458|530381776|FG002|Overall Study|Non-Compliance With Study Drug|1|||
147059678|NCT01732458|530381777|FG003|Overall Study|Non-Compliance With Study Drug|0|||
147059679|NCT01732458|530381774|FG000|Overall Study|Physician Decision|1|||
147059680|NCT01732458|530381775|FG001|Overall Study|Physician Decision|2|||
147059681|NCT01732458|530381776|FG002|Overall Study|Physician Decision|2|||
147059682|NCT01732458|530381777|FG003|Overall Study|Physician Decision|0|||
147059683|NCT01732458|530381774|FG000|Overall Study|Protocol Violation|2|||
147059684|NCT01732458|530381775|FG001|Overall Study|Protocol Violation|0|||
147059685|NCT01732458|530381776|FG002|Overall Study|Protocol Violation|0|||
147059686|NCT01732458|530381777|FG003|Overall Study|Protocol Violation|2|||
147059687|NCT01732458|530381774|FG000|Overall Study|Screen Failure|0|||
147059688|NCT01732458|530381775|FG001|Overall Study|Screen Failure|1|||
147059689|NCT01732458|530381776|FG002|Overall Study|Screen Failure|0|||
147059690|NCT01732458|530381777|FG003|Overall Study|Screen Failure|0|||
147059691|NCT01197534|530381778|FG000|Overall Study|Not reported|16|||
147059692|NCT01197534|530381779|FG001|Overall Study|Not reported|10|||
147059693|NCT01197534|530381780|FG002|Overall Study|Not reported|16|||
147059694|NCT01197534|530381778|FG000|Overall Study|Enrolment in long term extension|57|||
147059695|NCT01197534|530381779|FG001|Overall Study|Enrolment in long term extension|66|||
147059696|NCT01197534|530381780|FG002|Overall Study|Enrolment in long term extension|119|||
147059697|NCT01197534|530381778|FG000|Overall Study|Severe non-compliance to protocol|3|||
147059698|NCT01197534|530381779|FG001|Overall Study|Severe non-compliance to protocol|4|||
147059699|NCT01197534|530381780|FG002|Overall Study|Severe non-compliance to protocol|1|||
147059700|NCT01197534|530381778|FG000|Overall Study|Lack of therapeutic response|9|||
147059701|NCT01197534|530381779|FG001|Overall Study|Lack of therapeutic response|4|||
147059702|NCT01197534|530381780|FG002|Overall Study|Lack of therapeutic response|9|||
147059703|NCT01197534|530381778|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
147059704|NCT01197534|530381779|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
147059705|NCT01197534|530381780|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
147059706|NCT01197534|530381778|FG000|Overall Study|Lost to Follow-up|1|||
147059707|NCT01197534|530381779|FG001|Overall Study|Lost to Follow-up|4|||
147059708|NCT01197534|530381780|FG002|Overall Study|Lost to Follow-up|2|||
147059709|NCT01197534|530381778|FG000|Overall Study|Adverse Event|35|||
147059710|NCT01197534|530381779|FG001|Overall Study|Adverse Event|36|||
147059711|NCT01197534|530381780|FG002|Overall Study|Adverse Event|24|||
147059712|NCT04495751|530381787|FG000|Overall Study|Withdrawal by Subject|1|||
147059713|NCT04495751|530381788|FG001|Overall Study|Withdrawal by Subject|0|||
147059714|NCT04495751|530381787|FG000|Overall Study|Lost to Follow-up|1|||
147059715|NCT04495751|530381788|FG001|Overall Study|Lost to Follow-up|0|||
147059716|NCT03289754|530381789|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
147059717|NCT04873934|530381790|FG000|Overall Study|Adverse Event|0|||
147059718|NCT04873934|530381791|FG001|Overall Study|Adverse Event|1|||
147059719|NCT04873934|530381790|FG000|Overall Study|Death|0|||
147059720|NCT04873934|530381791|FG001|Overall Study|Death|2|||
147059721|NCT04873934|530381790|FG000|Overall Study|Lost to Follow-up|13|||
147059722|NCT04873934|530381791|FG001|Overall Study|Lost to Follow-up|9|||
147059723|NCT04873934|530381790|FG000|Overall Study|Physician Decision|1|||
147059724|NCT04873934|530381791|FG001|Overall Study|Physician Decision|1|||
147059725|NCT04873934|530381790|FG000|Overall Study|Protocol deviation|2|||
147059726|NCT04873934|530381791|FG001|Overall Study|Protocol deviation|1|||
147059727|NCT04873934|530381790|FG000|Overall Study|Subject decision|1|||
147059728|NCT04873934|530381791|FG001|Overall Study|Subject decision|8|||
147059729|NCT04873934|530381790|FG000|Overall Study|Withdrew consent|0|||
147059730|NCT04873934|530381791|FG001|Overall Study|Withdrew consent|4|||
147059731|NCT04873934|530381790|FG000|Overall Study|Missing|1|||
147059732|NCT04873934|530381791|FG001|Overall Study|Missing|0|||
147059733|NCT03584854|530381794|FG000|Overall Study|Primary outcome not measured|1|||
147059734|NCT03584854|530381795|FG001|Overall Study|Primary outcome not measured|2|||
147059735|NCT02670525|530381796|FG000|Overall Study|Death|94|||
147059736|NCT02670525|530381797|FG001|Overall Study|Death|14|||
147059737|NCT02670525|530381796|FG000|Overall Study|Lost to Follow-up|4|||
147059738|NCT02670525|530381797|FG001|Overall Study|Lost to Follow-up|1|||
147059739|NCT02670525|530381796|FG000|Overall Study|Subject withdrew consent|1|||
147059740|NCT02670525|530381797|FG001|Overall Study|Subject withdrew consent|0|||
147059741|NCT02670525|530381796|FG000|Overall Study|Unknown, data entry delayed|123|||
147059742|NCT02670525|530381797|FG001|Overall Study|Unknown, data entry delayed|78|||
147059743|NCT01796392|530381798|FG000|Overall Study|Withdrawal by Subject|2|||
147059744|NCT01796392|530381799|FG001|Overall Study|Withdrawal by Subject|0|||
147059745|NCT01796392|530381798|FG000|Overall Study|Death|5|||
147059746|NCT01796392|530381799|FG001|Overall Study|Death|1|||
147059747|NCT01796392|530381798|FG000|Overall Study|Excluded for medical reasons|1|||
147059748|NCT01796392|530381799|FG001|Overall Study|Excluded for medical reasons|2|||
147059749|NCT01796392|530381798|FG000|Overall Study|Lost to Follow-up|1|||
147059750|NCT01796392|530381799|FG001|Overall Study|Lost to Follow-up|0|||
147059751|NCT02505217|530381800|FG000|Overall Study|Withdrawal by Subject|1|||
147059752|NCT02505217|530381801|FG001|Overall Study|Withdrawal by Subject|2|||
147059753|NCT04639219|530381802|FG000|Overall Study|Withdrawal by Subject|8|||
147059754|NCT04639219|530381802|FG000|Overall Study|Lost to Follow-up|6|||
147059755|NCT04639219|530381802|FG000|Overall Study|Death|55|||
147059756|NCT04681066|530381803|FG000|Overall Study|Lost to Follow-up|3|||
147059757|NCT04681066|530381804|FG001|Overall Study|Lost to Follow-up|1|||
147059758|NCT04681066|530381805|FG002|Overall Study|Lost to Follow-up|2|||
147059759|NCT04681066|530381806|FG003|Overall Study|Lost to Follow-up|1|||
147059760|NCT04681066|530381803|FG000|Overall Study|Withdrawal by Subject|2|||
147059761|NCT04681066|530381804|FG001|Overall Study|Withdrawal by Subject|1|||
147059762|NCT04681066|530381805|FG002|Overall Study|Withdrawal by Subject|0|||
147059763|NCT04681066|530381806|FG003|Overall Study|Withdrawal by Subject|3|||
147059764|NCT04681066|530381803|FG000|Overall Study|Death|0|||
147059765|NCT04681066|530381804|FG001|Overall Study|Death|1|||
147059766|NCT04681066|530381805|FG002|Overall Study|Death|0|||
147059767|NCT04681066|530381806|FG003|Overall Study|Death|0|||
147059768|NCT03517540|530381812|FG000|Overall Study|Protocol Violation|2|||
147059769|NCT03517540|530381813|FG001|Overall Study|Protocol Violation|0|||
147059770|NCT03517540|530381814|FG002|Overall Study|Protocol Violation|0|||
147059771|NCT03517540|530381815|FG003|Overall Study|Protocol Violation|1|||
147059772|NCT03517540|530381812|FG000|Overall Study|Adverse Event|9|||
147059773|NCT03517540|530381813|FG001|Overall Study|Adverse Event|3|||
147059774|NCT03517540|530381814|FG002|Overall Study|Adverse Event|8|||
147059775|NCT03517540|530381815|FG003|Overall Study|Adverse Event|1|||
147059776|NCT03517540|530381812|FG000|Overall Study|Withdrawal by Subject|3|||
147059777|NCT03517540|530381813|FG001|Overall Study|Withdrawal by Subject|4|||
147059778|NCT03517540|530381814|FG002|Overall Study|Withdrawal by Subject|1|||
147059779|NCT03517540|530381815|FG003|Overall Study|Withdrawal by Subject|3|||
147059780|NCT01205269|530381816|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
147059781|NCT01205269|530381817|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
147059782|NCT01205269|530381818|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
147059783|NCT01205269|530381819|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
147059784|NCT01205269|530381820|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
147059785|NCT01205269|530381821|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
147059786|NCT01207687|530381822|FG000|Overall Study|Adverse Event|1|||
147059787|NCT01207687|530381822|FG000|Overall Study|Withdrawal by Subject|1|||
147059788|NCT00987337|530381823|FG000|Overall Study|Adverse Event|10|||
147059789|NCT00987337|530381824|FG001|Overall Study|Adverse Event|9|||
147059790|NCT00987337|530381825|FG002|Overall Study|Adverse Event|8|||
147059791|NCT00987337|530381823|FG000|Overall Study|Insufficient Virologic Response|10|||
147059792|NCT00987337|530381824|FG001|Overall Study|Insufficient Virologic Response|7|||
147059793|NCT00987337|530381825|FG002|Overall Study|Insufficient Virologic Response|12|||
147059794|NCT00987337|530381823|FG000|Overall Study|Virologic Breakthrough|2|||
147059795|NCT00987337|530381824|FG001|Overall Study|Virologic Breakthrough|2|||
147059796|NCT00987337|530381825|FG002|Overall Study|Virologic Breakthrough|8|||
147059797|NCT00987337|530381823|FG000|Overall Study|Lost to Follow-up|10|||
147059798|NCT00987337|530381824|FG001|Overall Study|Lost to Follow-up|6|||
147059799|NCT00987337|530381825|FG002|Overall Study|Lost to Follow-up|2|||
147059800|NCT00987337|530381823|FG000|Overall Study|Withdrawal by Subject|6|||
147059801|NCT00987337|530381824|FG001|Overall Study|Withdrawal by Subject|9|||
147059802|NCT00987337|530381825|FG002|Overall Study|Withdrawal by Subject|9|||
147059803|NCT00987337|530381823|FG000|Overall Study|Other|0|||
147059804|NCT00987337|530381824|FG001|Overall Study|Other|2|||
147059805|NCT00987337|530381825|FG002|Overall Study|Other|5|||
147059806|NCT00987337|530381823|FG000|Overall Study|Protocol Violation|1|||
147059807|NCT00987337|530381824|FG001|Overall Study|Protocol Violation|0|||
147059808|NCT00987337|530381825|FG002|Overall Study|Protocol Violation|2|||
147059809|NCT00987337|530381823|FG000|Overall Study|Participant Relapsed|18|||
147059810|NCT00987337|530381824|FG001|Overall Study|Participant Relapsed|20|||
147059811|NCT00987337|530381825|FG002|Overall Study|Participant Relapsed|5|||
147059812|NCT01801865|530381826|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
147059813|NCT01801865|530381826|FG000|Overall Study|Physician Decision|7|||
147059814|NCT03867201|530381827|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
147059815|NCT03867201|530381828|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
147059816|NCT03867201|530381827|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
147059817|NCT03867201|530381828|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
147059818|NCT03867201|530381827|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
147059819|NCT03867201|530381828|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
147059820|NCT03867201|530381827|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
147059821|NCT03867201|530381828|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
147059822|NCT03867201|530381827|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
147059823|NCT03867201|530381828|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
147059824|NCT03867201|530381827|FG000|Open-Label Period From Week 12|Adverse Event|5|||
147059825|NCT03867201|530381828|FG001|Open-Label Period From Week 12|Adverse Event|11|||
147059826|NCT03867201|530381827|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
147059827|NCT03867201|530381828|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
147059828|NCT03867201|530381827|FG000|Open-Label Period From Week 12|Physician Decision|6|||
147059829|NCT03867201|530381828|FG001|Open-Label Period From Week 12|Physician Decision|3|||
147059830|NCT03867201|530381827|FG000|Open-Label Period From Week 12|Pregnancy|2|||
147059831|NCT03867201|530381828|FG001|Open-Label Period From Week 12|Pregnancy|2|||
147059832|NCT03867201|530381827|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
147059833|NCT03867201|530381828|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
147059834|NCT03867201|530381827|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
147059835|NCT03867201|530381828|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
147059836|NCT03867201|530381827|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
147059837|NCT03867201|530381828|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
147059838|NCT03867201|530381827|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
147059839|NCT03867201|530381828|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
147059840|NCT02151851|530383444|FG000|Overall Study|Lack of Efficacy|67|||
147059841|NCT02151851|530383445|FG001|Overall Study|Lack of Efficacy|94|||
147059842|NCT02151851|530383444|FG000|Overall Study|Protocol Violation|0|||
147059843|NCT02151851|530383445|FG001|Overall Study|Protocol Violation|1|||
147059844|NCT02151851|530383444|FG000|Overall Study|Withdrawal by Subject|2|||
147059845|NCT02151851|530383445|FG001|Overall Study|Withdrawal by Subject|5|||
147059846|NCT02151851|530383444|FG000|Overall Study|Medical impairment|1|||
147059847|NCT02151851|530383445|FG001|Overall Study|Medical impairment|0|||
147059848|NCT02151851|530383444|FG000|Overall Study|Low compliance to study visits|0|||
147059849|NCT02151851|530383445|FG001|Overall Study|Low compliance to study visits|1|||
147059850|NCT02151851|530383444|FG000|Overall Study|Subject entered into study in error|0|||
147059851|NCT02151851|530383445|FG001|Overall Study|Subject entered into study in error|1|||
147059852|NCT02151851|530383444|FG000|Overall Study|Adverse Event|6|||
147059853|NCT02151851|530383445|FG001|Overall Study|Adverse Event|28|||
147059854|NCT02159053|530383446|FG000|Overall Study|Death|2|||
147059855|NCT02159053|530383447|FG001|Overall Study|Death|0|||
147059856|NCT02159053|530383448|FG002|Overall Study|Death|1|||
147059857|NCT02159053|530383446|FG000|Overall Study|Physician Decision|0|||
147059858|NCT02159053|530383447|FG001|Overall Study|Physician Decision|1|||
147059859|NCT02159053|530383448|FG002|Overall Study|Physician Decision|1|||
147059860|NCT02159053|530383446|FG000|Overall Study|Lack of Efficacy|3|||
147059861|NCT02159053|530383447|FG001|Overall Study|Lack of Efficacy|4|||
147059862|NCT02159053|530383448|FG002|Overall Study|Lack of Efficacy|7|||
147059863|NCT02159053|530383446|FG000|Overall Study|Adverse Event|7|||
147059864|NCT02159053|530383447|FG001|Overall Study|Adverse Event|6|||
147059865|NCT02159053|530383448|FG002|Overall Study|Adverse Event|5|||
147059866|NCT02159053|530383446|FG000|Overall Study|Participants/guardian decision|8|||
147059867|NCT02159053|530383447|FG001|Overall Study|Participants/guardian decision|10|||
147059868|NCT02159053|530383448|FG002|Overall Study|Participants/guardian decision|6|||
147059869|NCT01540487|530383449|FG000|Overall Study|Protocol Violation|1|||
147059870|NCT01540487|530383450|FG001|Overall Study|Protocol Violation|0|||
147059871|NCT00617890|530383451|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
147059872|NCT00617890|530383452|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
147059873|NCT00617890|530383453|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
147059874|NCT00617890|530383454|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
147059875|NCT00617890|530383451|FG000|Overall Study|Lack of Efficacy|23|||
147059876|NCT00617890|530383452|FG001|Overall Study|Lack of Efficacy|26|||
147059877|NCT00617890|530383453|FG002|Overall Study|Lack of Efficacy|30|||
147059878|NCT00617890|530383454|FG003|Overall Study|Lack of Efficacy|97|||
147059879|NCT00617890|530383451|FG000|Overall Study|Lost to Follow-up|0|||
147059880|NCT00617890|530383452|FG001|Overall Study|Lost to Follow-up|0|||
147059881|NCT00617890|530383453|FG002|Overall Study|Lost to Follow-up|1|||
147059882|NCT00617890|530383454|FG003|Overall Study|Lost to Follow-up|2|||
147059883|NCT00617890|530383451|FG000|Overall Study|Withdrawal by Subject|4|||
147059884|NCT00617890|530383452|FG001|Overall Study|Withdrawal by Subject|1|||
147059885|NCT00617890|530383453|FG002|Overall Study|Withdrawal by Subject|0|||
147059886|NCT00617890|530383454|FG003|Overall Study|Withdrawal by Subject|2|||
147059887|NCT00617890|530383451|FG000|Overall Study|Protocol Violation|2|||
147059888|NCT00617890|530383452|FG001|Overall Study|Protocol Violation|1|||
147059889|NCT00617890|530383453|FG002|Overall Study|Protocol Violation|0|||
147059890|NCT00617890|530383454|FG003|Overall Study|Protocol Violation|0|||
147059891|NCT00617890|530383451|FG000|Overall Study|Adverse Event|1|||
147059892|NCT00617890|530383452|FG001|Overall Study|Adverse Event|0|||
147059893|NCT00617890|530383453|FG002|Overall Study|Adverse Event|3|||
147059894|NCT00617890|530383454|FG003|Overall Study|Adverse Event|8|||
147059895|NCT00617890|530383451|FG000|Overall Study|Not treated|1|||
147059896|NCT00617890|530383452|FG001|Overall Study|Not treated|0|||
147059897|NCT00617890|530383453|FG002|Overall Study|Not treated|1|||
147059898|NCT00617890|530383454|FG003|Overall Study|Not treated|1|||
147059899|NCT03503370|530383455|FG000|Overall Study|Death|3|||
147059900|NCT03503370|530383456|FG001|Overall Study|Death|1|||
147059901|NCT03483961|530383457|FG000|Overall Study|Lost to Follow-up|7|||
147059902|NCT03483961|530383458|FG001|Overall Study|Lost to Follow-up|6|||
147059903|NCT03483961|530383459|FG002|Overall Study|Lost to Follow-up|6|||
147059904|NCT03483961|530383460|FG003|Overall Study|Lost to Follow-up|6|||
147059905|NCT03483961|530383461|FG004|Overall Study|Lost to Follow-up|6|||
147059906|NCT03483961|530383462|FG005|Overall Study|Lost to Follow-up|4|||
147059907|NCT03483961|530383463|FG006|Overall Study|Lost to Follow-up|4|||
147059908|NCT03483961|530383464|FG007|Overall Study|Lost to Follow-up|11|||
147059909|NCT03483961|530383465|FG008|Overall Study|Lost to Follow-up|1|||
147059910|NCT03483961|530383466|FG009|Overall Study|Lost to Follow-up|0|||
147059911|NCT03483961|530383457|FG000|Overall Study|Withdrawal by Subject|3|||
147059912|NCT03483961|530383458|FG001|Overall Study|Withdrawal by Subject|4|||
147059913|NCT03483961|530383459|FG002|Overall Study|Withdrawal by Subject|5|||
147059914|NCT03483961|530383460|FG003|Overall Study|Withdrawal by Subject|3|||
147059915|NCT03483961|530383461|FG004|Overall Study|Withdrawal by Subject|4|||
147059916|NCT03483961|530383462|FG005|Overall Study|Withdrawal by Subject|2|||
147059917|NCT03483961|530383463|FG006|Overall Study|Withdrawal by Subject|1|||
147059918|NCT03483961|530383464|FG007|Overall Study|Withdrawal by Subject|2|||
147059919|NCT03483961|530383465|FG008|Overall Study|Withdrawal by Subject|1|||
147059920|NCT03483961|530383466|FG009|Overall Study|Withdrawal by Subject|0|||
147059921|NCT03483961|530383457|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
147059922|NCT03483961|530383458|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147059923|NCT03483961|530383459|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147059924|NCT03483961|530383460|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147059925|NCT03483961|530383461|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147059926|NCT03483961|530383462|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147059927|NCT03483961|530383463|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147059928|NCT03483961|530383464|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147059929|NCT03483961|530383465|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147059930|NCT03483961|530383466|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147059931|NCT03483961|530383457|FG000|Overall Study|Adverse Event|0|||
147059932|NCT03483961|530383458|FG001|Overall Study|Adverse Event|0|||
147059933|NCT03483961|530383459|FG002|Overall Study|Adverse Event|1|||
147059934|NCT03483961|530383460|FG003|Overall Study|Adverse Event|0|||
147059935|NCT03483961|530383461|FG004|Overall Study|Adverse Event|0|||
147059936|NCT03483961|530383462|FG005|Overall Study|Adverse Event|0|||
147059937|NCT03483961|530383463|FG006|Overall Study|Adverse Event|0|||
147059938|NCT03483961|530383464|FG007|Overall Study|Adverse Event|0|||
147059939|NCT03483961|530383465|FG008|Overall Study|Adverse Event|0|||
147059940|NCT03483961|530383466|FG009|Overall Study|Adverse Event|0|||
147059941|NCT02640950|530383467|FG000|Overall Study|Adverse Event|1|||
147059942|NCT02640950|530383467|FG000|Overall Study|Withdrawal by Subject|1|||
147059943|NCT04545489|530383468|FG000|Overall Study|Withdrawal by Subject|12|||
147059944|NCT04545489|530383469|FG001|Overall Study|Withdrawal by Subject|4|||
147059945|NCT04545489|530383468|FG000|Overall Study|Lost to Follow-up|17|||
147059946|NCT04545489|530383469|FG001|Overall Study|Lost to Follow-up|18|||
147059947|NCT04545489|530383468|FG000|Overall Study|12month BP not collected|4|||
147059948|NCT04545489|530383469|FG001|Overall Study|12month BP not collected|4|||
147059949|NCT00652626|530383470|FG000|Initial Treatment Phase|Adverse Event|0|||
147059950|NCT00652626|530383471|FG001|Initial Treatment Phase|Adverse Event|0|||
147059951|NCT00652626|530383472|FG002|Initial Treatment Phase|Adverse Event|0|||
147059952|NCT00652626|530383473|FG003|Initial Treatment Phase|Adverse Event|0|||
147059953|NCT00652626|530383474|FG004|Initial Treatment Phase|Adverse Event|1|||
147059954|NCT00652626|530383475|FG005|Initial Treatment Phase|Adverse Event|0|||
147059955|NCT00652626|530383476|FG006|Initial Treatment Phase|Adverse Event|0|||
147059956|NCT00652626|530383470|FG000|Initial Treatment Phase|Protocol Violation|0|||
147059957|NCT00652626|530383471|FG001|Initial Treatment Phase|Protocol Violation|0|||
147059958|NCT00652626|530383472|FG002|Initial Treatment Phase|Protocol Violation|0|||
147059959|NCT00652626|530383473|FG003|Initial Treatment Phase|Protocol Violation|1|||
147059960|NCT00652626|530383474|FG004|Initial Treatment Phase|Protocol Violation|0|||
147059961|NCT00652626|530383475|FG005|Initial Treatment Phase|Protocol Violation|0|||
147059962|NCT00652626|530383476|FG006|Initial Treatment Phase|Protocol Violation|0|||
147059963|NCT00652626|530383470|FG000|Initial Treatment Phase|Physician Decision|0|||
147059964|NCT00652626|530383471|FG001|Initial Treatment Phase|Physician Decision|0|||
147059965|NCT00652626|530383472|FG002|Initial Treatment Phase|Physician Decision|0|||
147059966|NCT00652626|530383473|FG003|Initial Treatment Phase|Physician Decision|0|||
147059967|NCT00652626|530383474|FG004|Initial Treatment Phase|Physician Decision|1|||
147059968|NCT00652626|530383475|FG005|Initial Treatment Phase|Physician Decision|0|||
147059969|NCT00652626|530383476|FG006|Initial Treatment Phase|Physician Decision|0|||
147059970|NCT00652626|530383470|FG000|Initial Treatment Phase|Sponsor Request|0|||
147059971|NCT00652626|530383471|FG001|Initial Treatment Phase|Sponsor Request|0|||
147059972|NCT00652626|530383472|FG002|Initial Treatment Phase|Sponsor Request|1|||
147059973|NCT00652626|530383473|FG003|Initial Treatment Phase|Sponsor Request|0|||
147059974|NCT00652626|530383474|FG004|Initial Treatment Phase|Sponsor Request|0|||
147059975|NCT00652626|530383475|FG005|Initial Treatment Phase|Sponsor Request|0|||
147059976|NCT00652626|530383476|FG006|Initial Treatment Phase|Sponsor Request|0|||
147059977|NCT00652626|530383470|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
147059978|NCT00652626|530383471|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
147059979|NCT00652626|530383472|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
147059980|NCT00652626|530383473|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
147059981|NCT00652626|530383474|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
147059982|NCT00652626|530383475|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
147059983|NCT00652626|530383476|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
147059984|NCT00652626|530383470|FG000|Extension Phase|Withdrawal by Subject|0|||
147059985|NCT00652626|530383471|FG001|Extension Phase|Withdrawal by Subject|0|||
147059986|NCT00652626|530383472|FG002|Extension Phase|Withdrawal by Subject|0|||
147059987|NCT00652626|530383473|FG003|Extension Phase|Withdrawal by Subject|0|||
147059988|NCT00652626|530383474|FG004|Extension Phase|Withdrawal by Subject|0|||
147059989|NCT00652626|530383475|FG005|Extension Phase|Withdrawal by Subject|2|||
147059990|NCT00652626|530383476|FG006|Extension Phase|Withdrawal by Subject|0|||
147059991|NCT00652626|530383470|FG000|Extension Phase|Adverse Event|0|||
147059992|NCT00652626|530383471|FG001|Extension Phase|Adverse Event|0|||
147059993|NCT00652626|530383472|FG002|Extension Phase|Adverse Event|0|||
147059994|NCT00652626|530383473|FG003|Extension Phase|Adverse Event|0|||
147059995|NCT00652626|530383474|FG004|Extension Phase|Adverse Event|0|||
147059996|NCT00652626|530383475|FG005|Extension Phase|Adverse Event|2|||
147059997|NCT00652626|530383476|FG006|Extension Phase|Adverse Event|1|||
147059998|NCT00652626|530383470|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
147059999|NCT00652626|530383471|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
147060000|NCT00652626|530383472|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
147060001|NCT00652626|530383473|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
147060002|NCT00652626|530383474|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
147060003|NCT00652626|530383475|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
147060004|NCT00652626|530383476|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
147060005|NCT00652626|530383470|FG000|Extension Phase|Physician Decision|0|||
147060006|NCT00652626|530383471|FG001|Extension Phase|Physician Decision|0|||
147060007|NCT00652626|530383472|FG002|Extension Phase|Physician Decision|0|||
147060008|NCT00652626|530383473|FG003|Extension Phase|Physician Decision|0|||
147060009|NCT00652626|530383474|FG004|Extension Phase|Physician Decision|0|||
147060010|NCT00652626|530383475|FG005|Extension Phase|Physician Decision|1|||
147060011|NCT00652626|530383476|FG006|Extension Phase|Physician Decision|1|||
147060012|NCT00652626|530383470|FG000|Extension Phase|Death|0|||
147060013|NCT00652626|530383471|FG001|Extension Phase|Death|0|||
147060014|NCT00652626|530383472|FG002|Extension Phase|Death|0|||
147060015|NCT00652626|530383473|FG003|Extension Phase|Death|0|||
147060016|NCT00652626|530383474|FG004|Extension Phase|Death|0|||
147060017|NCT00652626|530383475|FG005|Extension Phase|Death|1|||
147060018|NCT00652626|530383476|FG006|Extension Phase|Death|1|||
147060019|NCT04003636|530383477|FG000|Overall Study|Death|409|||
147060020|NCT04003636|530383478|FG001|Overall Study|Death|443|||
147060021|NCT04003636|530383477|FG000|Overall Study|Lost to Follow-up|0|||
147060022|NCT04003636|530383478|FG001|Overall Study|Lost to Follow-up|1|||
147060023|NCT04003636|530383477|FG000|Overall Study|Withdrawal by Subject|5|||
147060024|NCT04003636|530383478|FG001|Overall Study|Withdrawal by Subject|2|||
147060025|NCT04003636|530383477|FG000|Overall Study|Participant On-going|119|||
147060026|NCT04003636|530383478|FG001|Overall Study|Participant On-going|90|||
147060027|NCT02582242|530383479|FG000|Overall Study|Adverse Event|4|||
147060028|NCT02582242|530383480|FG001|Overall Study|Adverse Event|3|||
147060029|NCT02582242|530383479|FG000|Overall Study|Protocol Violation|3|||
147060030|NCT02582242|530383480|FG001|Overall Study|Protocol Violation|1|||
147060031|NCT02582242|530383479|FG000|Overall Study|Lost to Follow-up|0|||
147060032|NCT02582242|530383480|FG001|Overall Study|Lost to Follow-up|1|||
147060033|NCT02582242|530383479|FG000|Overall Study|Withdrawal by Subject|11|||
147060034|NCT02582242|530383480|FG001|Overall Study|Withdrawal by Subject|11|||
147060035|NCT02582242|530383479|FG000|Overall Study|Unclassified|2|||
147060036|NCT02582242|530383480|FG001|Overall Study|Unclassified|1|||
147060037|NCT00300885|530383481|FG000|Treatment|Adverse Event|134|||
147060038|NCT00300885|530383482|FG001|Treatment|Adverse Event|82|||
147060039|NCT00300885|530383481|FG000|Treatment|Death|20|||
147060040|NCT00300885|530383482|FG001|Treatment|Death|7|||
147060041|NCT00300885|530383481|FG000|Treatment|Lack of Efficacy|1|||
147060042|NCT00300885|530383482|FG001|Treatment|Lack of Efficacy|1|||
147060043|NCT00300885|530383481|FG000|Treatment|Lost to Follow-up|3|||
147060044|NCT00300885|530383482|FG001|Treatment|Lost to Follow-up|2|||
147060045|NCT00300885|530383481|FG000|Treatment|Physician Decision|4|||
147060046|NCT00300885|530383482|FG001|Treatment|Physician Decision|5|||
147060047|NCT00300885|530383481|FG000|Treatment|Protocol Violation|11|||
147060048|NCT00300885|530383482|FG001|Treatment|Protocol Violation|11|||
147060049|NCT00300885|530383481|FG000|Treatment|Withdrawal by Subject|26|||
147060050|NCT00300885|530383482|FG001|Treatment|Withdrawal by Subject|23|||
147060051|NCT00300885|530383481|FG000|Treatment|Disease progression|171|||
147060052|NCT00300885|530383482|FG001|Treatment|Disease progression|238|||
147060053|NCT00300885|530383481|FG000|Treatment|Random code broken (subject died)|0|||
147060054|NCT00300885|530383482|FG001|Treatment|Random code broken (subject died)|1|||
147060055|NCT00300885|530383481|FG000|Treatment|Non-compliant with study medication|3|||
147060056|NCT00300885|530383482|FG001|Treatment|Non-compliant with study medication|4|||
147060057|NCT00300885|530383481|FG000|Follow-up|Death|141|||
147060058|NCT00300885|530383482|FG001|Follow-up|Death|163|||
147060059|NCT00300885|530383481|FG000|Follow-up|Lost to Follow-up|11|||
147060060|NCT00300885|530383482|FG001|Follow-up|Lost to Follow-up|7|||
147060061|NCT00300885|530383481|FG000|Follow-up|Withdrawal by Subject|26|||
147060062|NCT00300885|530383482|FG001|Follow-up|Withdrawal by Subject|25|||
147060063|NCT02058537|530383483|FG000|Overall Study|Withdrawal by Subject|1|||
147060064|NCT02101736|530383487|FG000|Overall Study|Protocol Violation|3|||
147060065|NCT02101736|530383488|FG001|Overall Study|Protocol Violation|0|||
147060066|NCT02101736|530383487|FG000|Overall Study|Withdrawal by Subject|1|||
147060067|NCT02101736|530383488|FG001|Overall Study|Withdrawal by Subject|1|||
147060068|NCT00459290|530383489|FG000|Overall Study|Adverse Event|3|||
147060069|NCT00459290|530383489|FG000|Overall Study|Ineligible|2|||
147060070|NCT03691207|530383490|FG000|Overall Study|Death|41|||
147060071|NCT03691207|530383491|FG001|Overall Study|Death|26|||
147060072|NCT03691207|530383490|FG000|Overall Study|Lost to Follow-up|1|||
147060073|NCT03691207|530383491|FG001|Overall Study|Lost to Follow-up|1|||
147060074|NCT03691207|530383490|FG000|Overall Study|Withdrawal by Subject|2|||
147060075|NCT03691207|530383491|FG001|Overall Study|Withdrawal by Subject|8|||
147060076|NCT03691207|530383490|FG000|Overall Study|Sponsor decision|1|||
147060077|NCT03691207|530383491|FG001|Overall Study|Sponsor decision|7|||
147060078|NCT02453334|530383492|FG000|Overall Study|Death|15|||
147060079|NCT02453334|530383493|FG001|Overall Study|Death|13|||
147060080|NCT02453334|530383492|FG000|Overall Study|Adverse Event|2|||
147060081|NCT02453334|530383493|FG001|Overall Study|Adverse Event|1|||
147060082|NCT02453334|530383492|FG000|Overall Study|Lost to Follow-up|5|||
147060083|NCT02453334|530383493|FG001|Overall Study|Lost to Follow-up|9|||
147060084|NCT02453334|530383492|FG000|Overall Study|Physician Decision|1|||
147060085|NCT02453334|530383493|FG001|Overall Study|Physician Decision|0|||
147060086|NCT02453334|530383492|FG000|Overall Study|Withdrawal by Subject|17|||
147060087|NCT02453334|530383493|FG001|Overall Study|Withdrawal by Subject|13|||
147060088|NCT02453334|530383492|FG000|Overall Study|Other reason|1|||
147060089|NCT02453334|530383493|FG001|Overall Study|Other reason|4|||
147060090|NCT02693106|530383497|FG000|Overall Study|No time|3|||
147060091|NCT06028438|530383506|FG000|Overall Study|Adverse Event|3|||
147060092|NCT06028438|530383507|FG001|Overall Study|Adverse Event|9|||
147060093|NCT06028438|530383506|FG000|Overall Study|Lack of Efficacy|1|||
147060094|NCT06028438|530383507|FG001|Overall Study|Lack of Efficacy|1|||
147060095|NCT06028438|530383506|FG000|Overall Study|Lost to Follow-up|1|||
147060096|NCT06028438|530383507|FG001|Overall Study|Lost to Follow-up|0|||
147060097|NCT06028438|530383506|FG000|Overall Study|Withdrawal by Subject|1|||
147060098|NCT06028438|530383507|FG001|Overall Study|Withdrawal by Subject|0|||
147060099|NCT06028438|530383506|FG000|Overall Study|Other|3|||
147060100|NCT06028438|530383507|FG001|Overall Study|Other|3|||
147060101|NCT05625802|530383508|FG000|Overall Study|Lost to Follow-up|1|||
147060102|NCT05625802|530383509|FG001|Overall Study|Lost to Follow-up|0|||
147060103|NCT01954056|530383511|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
147060104|NCT01954056|530383512|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
147060105|NCT00105079|530383513|FG000|Overall Study|Adverse Event|5|||
147060106|NCT00105079|530383514|FG001|Overall Study|Adverse Event|12|||
147060107|NCT00105079|530383513|FG000|Overall Study|Death|3|||
147060108|NCT00105079|530383514|FG001|Overall Study|Death|1|||
147060109|NCT00105079|530383513|FG000|Overall Study|Lost to Follow-up|12|||
147060110|NCT00105079|530383514|FG001|Overall Study|Lost to Follow-up|12|||
147060111|NCT00105079|530383513|FG000|Overall Study|Lack of Efficacy|9|||
147060112|NCT00105079|530383514|FG001|Overall Study|Lack of Efficacy|3|||
147060113|NCT00105079|530383513|FG000|Overall Study|Refused treatment|6|||
147060114|NCT00105079|530383514|FG001|Overall Study|Refused treatment|4|||
147060115|NCT00105079|530383513|FG000|Overall Study|Violation of selection criteria at entry|0|||
147060116|NCT00105079|530383514|FG001|Overall Study|Violation of selection criteria at entry|2|||
147060117|NCT00105079|530383513|FG000|Overall Study|Protocol Violation|1|||
147060118|NCT00105079|530383514|FG001|Overall Study|Protocol Violation|0|||
147060119|NCT00105079|530383513|FG000|Overall Study|Other|3|||
147060120|NCT00105079|530383514|FG001|Overall Study|Other|1|||
147060121|NCT01464593|530383515|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
147060122|NCT03491462|530383523|FG000|Overall Study|Lost to Follow-up|2|||
147060123|NCT03491462|530383524|FG001|Overall Study|Lost to Follow-up|0|||
147060124|NCT03491462|530383523|FG000|Overall Study|Adverse Event|11|||
147060125|NCT03491462|530383524|FG001|Overall Study|Adverse Event|1|||
147060126|NCT03491462|530383523|FG000|Overall Study|Physician Decision|3|||
147060127|NCT03491462|530383524|FG001|Overall Study|Physician Decision|0|||
147060128|NCT03491462|530383523|FG000|Overall Study|Withdrawal by Subject|22|||
147060129|NCT03491462|530383524|FG001|Overall Study|Withdrawal by Subject|15|||
147060130|NCT04938180|530383525|FG000|Overall Study|Adverse Event|1|||
147060131|NCT04468347|530383526|FG000|Overall Study|Withdrawal by Subject|0|||
147060132|NCT04468347|530383527|FG001|Overall Study|Withdrawal by Subject|1|||
147060133|NCT04468347|530383528|FG002|Overall Study|Withdrawal by Subject|3|||
147060134|NCT04468347|530383529|FG003|Overall Study|Withdrawal by Subject|3|||
147060135|NCT04468347|530383526|FG000|Overall Study|Lost to Follow-up|0|||
147060136|NCT04468347|530383527|FG001|Overall Study|Lost to Follow-up|0|||
147060137|NCT04468347|530383528|FG002|Overall Study|Lost to Follow-up|1|||
147060138|NCT04468347|530383529|FG003|Overall Study|Lost to Follow-up|1|||
147060139|NCT04468347|530383526|FG000|Overall Study|Physician Decision|1|||
147060140|NCT04468347|530383527|FG001|Overall Study|Physician Decision|0|||
147060141|NCT04468347|530383528|FG002|Overall Study|Physician Decision|2|||
147060142|NCT04468347|530383529|FG003|Overall Study|Physician Decision|0|||
147060143|NCT04468347|530383526|FG000|Overall Study|Protocol Violation|1|||
147060144|NCT04468347|530383527|FG001|Overall Study|Protocol Violation|0|||
147060145|NCT04468347|530383528|FG002|Overall Study|Protocol Violation|0|||
147060146|NCT04468347|530383529|FG003|Overall Study|Protocol Violation|0|||
147060147|NCT00237458|530383530|FG000|Overall Study|Lack of Efficacy|1|||
147060148|NCT00237458|530383530|FG000|Overall Study|Adverse Event|1|||
147060149|NCT00237458|530383530|FG000|Overall Study|Withdrawal by Subject|1|||
147060150|NCT04339062|530383531|FG000|Overall Study|Death|0|||
147060151|NCT04339062|530383532|FG001|Overall Study|Death|1|||
147060152|NCT03218826|530383533|FG000|Overall Study|Non-compliance with protocol|1|||
147060153|NCT03218826|530383534|FG001|Overall Study|Non-compliance with protocol|0|||
147060154|NCT03218826|530383535|FG002|Overall Study|Non-compliance with protocol|2|||
147060155|NCT03218826|530383536|FG003|Overall Study|Non-compliance with protocol|1|||
147060156|NCT03218826|530383537|FG004|Overall Study|Non-compliance with protocol|1|||
147060157|NCT01276756|530383538|FG000|Overall Study|Lost to Follow-up|2|||
147060158|NCT01276756|530383539|FG001|Overall Study|Lost to Follow-up|0|||
147060159|NCT01276756|530383538|FG000|Overall Study|Adverse Event|3|||
147060160|NCT01276756|530383539|FG001|Overall Study|Adverse Event|2|||
147060161|NCT02589639|530383540|FG000|Overall Study|Lost to Follow-up|1|||
147060162|NCT02589639|530383541|FG001|Overall Study|Lost to Follow-up|0|||
147060163|NCT02589639|530383542|FG002|Overall Study|Lost to Follow-up|0|||
147060164|NCT02589639|530383540|FG000|Overall Study|Protocol Violation|1|||
147060165|NCT02589639|530383541|FG001|Overall Study|Protocol Violation|0|||
147060166|NCT02589639|530383542|FG002|Overall Study|Protocol Violation|0|||
147060167|NCT02589639|530383540|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
147060168|NCT02589639|530383541|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
147060169|NCT02589639|530383542|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
147060170|NCT02589639|530383540|FG000|Overall Study|Adverse Event|4|||
147060171|NCT02589639|530383541|FG001|Overall Study|Adverse Event|5|||
147060172|NCT02589639|530383542|FG002|Overall Study|Adverse Event|3|||
147060173|NCT02589639|530383540|FG000|Overall Study|Other reason than specified above|1|||
147060174|NCT02589639|530383541|FG001|Overall Study|Other reason than specified above|2|||
147060175|NCT02589639|530383542|FG002|Overall Study|Other reason than specified above|1|||
147060176|NCT02589639|530383540|FG000|Overall Study|Not Treated|0|||
147060177|NCT02589639|530383541|FG001|Overall Study|Not Treated|3|||
147060178|NCT02589639|530383542|FG002|Overall Study|Not Treated|0|||
147060179|NCT00703157|530383543|FG000|Overall Study|Lost to Follow-up|0|||
147060180|NCT00703157|530383544|FG001|Overall Study|Lost to Follow-up|1|||
147060181|NCT00703157|530383543|FG000|Overall Study|source data permanently lost/ other|4|||
147060182|NCT00703157|530383544|FG001|Overall Study|source data permanently lost/ other|1|||
147060183|NCT00347009|530383545|FG000|Overall Study|Death|1|||
147060184|NCT00347009|530383545|FG000|Overall Study|Adverse Event|6|||
147060185|NCT00347009|530383545|FG000|Overall Study|Withdrawal by Subject|3|||
147060186|NCT00347009|530383545|FG000|Overall Study|Physician Decision|5|||
147060187|NCT00347009|530383545|FG000|Overall Study|Lost to Follow-up|4|||
147060188|NCT00347009|530383545|FG000|Overall Study|Protocol Violation|2|||
147060189|NCT00347009|530383545|FG000|Overall Study|Adverse Laboratory Experience|1|||
147060190|NCT00347009|530383545|FG000|Overall Study|Insufficient Viral Suppression|3|||
147060191|NCT00347009|530383545|FG000|Overall Study|Increased ALT/HBV DNA|1|||
147060192|NCT00347009|530383545|FG000|Overall Study|Serious Adverse Event|1|||
147060193|NCT05868577|530383546|FG000|Overall Study|Lost to Follow-up|5|||
147060194|NCT05868577|530383547|FG001|Overall Study|Lost to Follow-up|5|||
147060195|NCT02522884|530383548|FG000|Overall Study|Withdrawal by Subject|6|||
147060196|NCT02522884|530383548|FG000|Overall Study|Death|3|||
147060197|NCT02522884|530383548|FG000|Overall Study|Missed 12-month Follow-up|9|||
147060198|NCT00708461|530383549|FG000|Overall Study|Lost to Follow-up|18|||
147060199|NCT00708461|530383550|FG001|Overall Study|Lost to Follow-up|11|||
147060200|NCT00708461|530383549|FG000|Overall Study|Withdrawal by Subject|8|||
147060201|NCT00708461|530383550|FG001|Overall Study|Withdrawal by Subject|9|||
147060202|NCT00708461|530383549|FG000|Overall Study|left workforce|115|||
147060203|NCT00708461|530383550|FG001|Overall Study|left workforce|180|||
147060204|NCT02630251|530383554|FG000|Overall Study|Physician Decision|0|||
147060205|NCT02630251|530383555|FG001|Overall Study|Physician Decision|0|||
147060206|NCT02630251|530383556|FG002|Overall Study|Physician Decision|1|||
147060207|NCT02630251|530383557|FG003|Overall Study|Physician Decision|0|||
147060208|NCT02907177|530383558|FG000|Overall Study|Death|0|||
147060209|NCT02907177|530383559|FG001|Overall Study|Death|1|||
147060210|NCT02907177|530383558|FG000|Overall Study|Physician Decision|3|||
147060211|NCT02907177|530383559|FG001|Overall Study|Physician Decision|3|||
147060212|NCT02907177|530383558|FG000|Overall Study|Withdrawal by Subject|15|||
147060213|NCT02907177|530383559|FG001|Overall Study|Withdrawal by Subject|7|||
147060214|NCT02907177|530383558|FG000|Overall Study|Sponsor's Decision|50|||
147060215|NCT02907177|530383559|FG001|Overall Study|Sponsor's Decision|57|||
147060216|NCT02968173|530383562|FG000|Overall Study|Withdrawal by Subject|1|||
147060217|NCT04586244|530383563|FG000|Overall Study|Lost to Follow-up|1|||
147060218|NCT04586244|530383564|FG001|Overall Study|Lost to Follow-up|0|||
147060219|NCT04586244|530383565|FG002|Overall Study|Lost to Follow-up|0|||
147060220|NCT04586244|530383566|FG003|Overall Study|Lost to Follow-up|1|||
147060221|NCT04586244|530383567|FG004|Overall Study|Lost to Follow-up|0|||
147060222|NCT04586244|530383563|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
147060223|NCT04586244|530383564|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
147060224|NCT04586244|530383565|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
147060225|NCT04586244|530383566|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
147060226|NCT04586244|530383567|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
147060227|NCT03564119|530383570|FG000|Overall Study|Adverse Event|4|||
147060228|NCT03564119|530383571|FG001|Overall Study|Adverse Event|0|||
147060229|NCT03564119|530383570|FG000|Overall Study|Lost to Follow-up|1|||
147060230|NCT03564119|530383571|FG001|Overall Study|Lost to Follow-up|4|||
147060231|NCT03564119|530383570|FG000|Overall Study|Protocol Violation|1|||
147060232|NCT03564119|530383571|FG001|Overall Study|Protocol Violation|0|||
147060233|NCT03564119|530383570|FG000|Overall Study|Withdrawal by Subject|9|||
147060234|NCT03564119|530383571|FG001|Overall Study|Withdrawal by Subject|4|||
147060235|NCT03564119|530383570|FG000|Overall Study|Other Than Specified|0|||
147060236|NCT03564119|530383571|FG001|Overall Study|Other Than Specified|1|||
147060237|NCT00634036|530383572|FG000|Overall Study|Lost to Follow-up|1|||
147060238|NCT00634036|530383573|FG001|Overall Study|Lost to Follow-up|1|||
147060239|NCT00634036|530383572|FG000|Overall Study|Withdrawal by Subject|1|||
147060240|NCT00634036|530383573|FG001|Overall Study|Withdrawal by Subject|1|||
147060241|NCT03896022|530383574|FG000|Overall Study|Withdrawal by Subject|1|||
147060242|NCT03896022|530383575|FG001|Overall Study|Withdrawal by Subject|0|||
147060243|NCT03896022|530383576|FG002|Overall Study|Withdrawal by Subject|0|||
147060244|NCT03896022|530383574|FG000|Overall Study|Did not have procedure|3|||
147060245|NCT03896022|530383575|FG001|Overall Study|Did not have procedure|0|||
147060246|NCT03896022|530383576|FG002|Overall Study|Did not have procedure|0|||
147060247|NCT01500382|530383583|FG000|Washout Period|Study site went out of business|0|||
147060248|NCT01500382|530383584|FG001|Washout Period|Study site went out of business|0|||
147060249|NCT01500382|530383585|FG002|Washout Period|Study site went out of business|1|||
147060250|NCT01500382|530383586|FG003|Washout Period|Study site went out of business|0|||
147060251|NCT06868654|530383587|FG000|Overall Study|Death|4|||
147060252|NCT06868654|530383588|FG001|Overall Study|Death|14|||
147060253|NCT06868654|530383587|FG000|Overall Study|Lost to Follow-up|0|||
147060254|NCT06868654|530383588|FG001|Overall Study|Lost to Follow-up|1|||
147060255|NCT06868654|530383587|FG000|Overall Study|Withdrawal by Subject|5|||
147060256|NCT06868654|530383588|FG001|Overall Study|Withdrawal by Subject|3|||
147060257|NCT06868654|530383587|FG000|Overall Study|Physician Decision|0|||
147060258|NCT06868654|530383588|FG001|Overall Study|Physician Decision|1|||
147060259|NCT06868654|530383587|FG000|Overall Study|Ongoing|23|||
147060260|NCT06868654|530383588|FG001|Overall Study|Ongoing|21|||
147060261|NCT02134015|530383591|FG000|Overall Study|Protocol Violation|0|||
147060262|NCT02134015|530383592|FG001|Overall Study|Protocol Violation|1|||
147060263|NCT02134015|530383591|FG000|Overall Study|Death|2|||
147060264|NCT02134015|530383592|FG001|Overall Study|Death|1|||
147060265|NCT02134015|530383591|FG000|Overall Study|Reason not provided|1|||
147060266|NCT02134015|530383592|FG001|Overall Study|Reason not provided|2|||
147060267|NCT02134015|530383591|FG000|Overall Study|Clinical progression|14|||
147060268|NCT02134015|530383592|FG001|Overall Study|Clinical progression|7|||
147060269|NCT02134015|530383591|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
147060270|NCT02134015|530383592|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
147060271|NCT02134015|530383591|FG000|Overall Study|Study terminated by sponsor|2|||
147060272|NCT02134015|530383592|FG001|Overall Study|Study terminated by sponsor|3|||
147060273|NCT02134015|530383591|FG000|Overall Study|Adverse Event|9|||
147060274|NCT02134015|530383592|FG001|Overall Study|Adverse Event|10|||
147060275|NCT02134015|530383591|FG000|Overall Study|Withdrawal by Subject|3|||
147060276|NCT02134015|530383592|FG001|Overall Study|Withdrawal by Subject|7|||
147060277|NCT05763875|530383597|FG000|Overall Study|Subject decision|5|||
147060278|NCT05763875|530383598|FG001|Overall Study|Subject decision|2|||
147060279|NCT05763875|530383599|FG002|Overall Study|Subject decision|1|||
147060280|NCT05763875|530383597|FG000|Overall Study|Lost to Follow-up|4|||
147060281|NCT05763875|530383598|FG001|Overall Study|Lost to Follow-up|1|||
147060282|NCT05763875|530383599|FG002|Overall Study|Lost to Follow-up|2|||
147060283|NCT05763875|530383597|FG000|Overall Study|Adverse Event|1|||
147060284|NCT05763875|530383598|FG001|Overall Study|Adverse Event|0|||
147060285|NCT05763875|530383599|FG002|Overall Study|Adverse Event|0|||
147060286|NCT01777282|530383600|FG000|Overall Study|Persistent Hyperglycemia|0|||
147060287|NCT01777282|530383601|FG001|Overall Study|Persistent Hyperglycemia|0|||
147060288|NCT01777282|530383602|FG002|Overall Study|Persistent Hyperglycemia|1|||
147060289|NCT01777282|530383603|FG003|Overall Study|Persistent Hyperglycemia|0|||
147060290|NCT01777282|530383604|FG004|Overall Study|Persistent Hyperglycemia|0|||
147060291|NCT01777282|530383600|FG000|Overall Study|New Antidiabetic Medication|0|||
147060292|NCT01777282|530383601|FG001|Overall Study|New Antidiabetic Medication|0|||
147060293|NCT01777282|530383602|FG002|Overall Study|New Antidiabetic Medication|1|||
147060294|NCT01777282|530383603|FG003|Overall Study|New Antidiabetic Medication|0|||
147060295|NCT01777282|530383604|FG004|Overall Study|New Antidiabetic Medication|0|||
147060296|NCT01777282|530383600|FG000|Overall Study|Adverse Event|4|||
147060297|NCT01777282|530383601|FG001|Overall Study|Adverse Event|4|||
147060298|NCT01777282|530383602|FG002|Overall Study|Adverse Event|2|||
147060299|NCT01777282|530383603|FG003|Overall Study|Adverse Event|1|||
147060300|NCT01777282|530383604|FG004|Overall Study|Adverse Event|3|||
147060301|NCT01777282|530383600|FG000|Overall Study|Withdrawal by Subject|4|||
147060302|NCT01777282|530383601|FG001|Overall Study|Withdrawal by Subject|0|||
147060303|NCT01777282|530383602|FG002|Overall Study|Withdrawal by Subject|0|||
147060304|NCT01777282|530383603|FG003|Overall Study|Withdrawal by Subject|1|||
147060305|NCT01777282|530383604|FG004|Overall Study|Withdrawal by Subject|2|||
147060306|NCT01777282|530383600|FG000|Overall Study|Protocol Violation|2|||
147060307|NCT01777282|530383601|FG001|Overall Study|Protocol Violation|0|||
147060308|NCT01777282|530383602|FG002|Overall Study|Protocol Violation|1|||
147060309|NCT01777282|530383603|FG003|Overall Study|Protocol Violation|0|||
147060310|NCT01777282|530383604|FG004|Overall Study|Protocol Violation|2|||
147060311|NCT01777282|530383600|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
147060312|NCT01777282|530383601|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
147060313|NCT01777282|530383602|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
147060314|NCT01777282|530383603|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
147060315|NCT01777282|530383604|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
147060316|NCT03759379|530386017|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
147060317|NCT03759379|530386018|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
147060318|NCT03759379|530386017|FG000|Treatment Period|Death|2|||
147060319|NCT03759379|530386018|FG001|Treatment Period|Death|3|||
147060320|NCT03759379|530386017|FG000|Treatment Period|Lost to Follow-up|1|||
147060321|NCT03759379|530386018|FG001|Treatment Period|Lost to Follow-up|0|||
147060322|NCT03759379|530386017|FG000|Treatment Period|Physician Decision|0|||
147060323|NCT03759379|530386018|FG001|Treatment Period|Physician Decision|1|||
147060324|NCT04021043|530386019|FG000|Overall Study|Adverse Event|3|||
147060325|NCT04021043|530386020|FG001|Overall Study|Adverse Event|1|||
147060326|NCT04021043|530386021|FG002|Overall Study|Adverse Event|1|||
147060327|NCT04021043|530386022|FG003|Overall Study|Adverse Event|0|||
147060328|NCT04021043|530386019|FG000|Overall Study|Death|2|||
147060329|NCT04021043|530386020|FG001|Overall Study|Death|3|||
147060330|NCT04021043|530386021|FG002|Overall Study|Death|1|||
147060331|NCT04021043|530386022|FG003|Overall Study|Death|3|||
147060332|NCT04021043|530386019|FG000|Overall Study|Withdrawal by Subject|1|||
147060333|NCT04021043|530386020|FG001|Overall Study|Withdrawal by Subject|1|||
147060334|NCT04021043|530386021|FG002|Overall Study|Withdrawal by Subject|1|||
147060335|NCT04021043|530386022|FG003|Overall Study|Withdrawal by Subject|6|||
147060336|NCT04021043|530386019|FG000|Overall Study|Discontinued due to disease progression|4|||
147060337|NCT04021043|530386020|FG001|Overall Study|Discontinued due to disease progression|5|||
147060338|NCT04021043|530386021|FG002|Overall Study|Discontinued due to disease progression|7|||
147060339|NCT04021043|530386022|FG003|Overall Study|Discontinued due to disease progression|10|||
147060340|NCT02325414|530386023|FG000|Overall Study|Withdrawal by Subject|3|||
147060341|NCT02325414|530386024|FG001|Overall Study|Withdrawal by Subject|1|||
147060342|NCT02325414|530386023|FG000|Overall Study|Lost to Follow-up|5|||
147060343|NCT02325414|530386024|FG001|Overall Study|Lost to Follow-up|5|||
147060344|NCT05722522|530386025|FG000|Overall Study|Adverse Event|0|||
147060345|NCT05722522|530386026|FG001|Overall Study|Adverse Event|1|||
147060346|NCT04441905|530386027|FG000|Overall Study|Lost to Follow-up|1|||
147060347|NCT04441905|530386028|FG001|Overall Study|Lost to Follow-up|0|||
147060348|NCT04441905|530386029|FG002|Overall Study|Lost to Follow-up|0|||
147060349|NCT04441905|530386030|FG003|Overall Study|Lost to Follow-up|0|||
147060350|NCT04441905|530386031|FG004|Overall Study|Lost to Follow-up|0|||
147060351|NCT04441905|530386032|FG005|Overall Study|Lost to Follow-up|0|||
147060352|NCT04441905|530386027|FG000|Overall Study|Enrolled but treatment not administered|0|||
147060353|NCT04441905|530386028|FG001|Overall Study|Enrolled but treatment not administered|1|||
147060354|NCT04441905|530386029|FG002|Overall Study|Enrolled but treatment not administered|0|||
147060355|NCT04441905|530386030|FG003|Overall Study|Enrolled but treatment not administered|0|||
147060356|NCT04441905|530386031|FG004|Overall Study|Enrolled but treatment not administered|0|||
147060357|NCT04441905|530386032|FG005|Overall Study|Enrolled but treatment not administered|0|||
147060358|NCT04441905|530386027|FG000|Overall Study|Became ineligible after enrollment|0|||
147060359|NCT04441905|530386028|FG001|Overall Study|Became ineligible after enrollment|0|||
147060360|NCT04441905|530386029|FG002|Overall Study|Became ineligible after enrollment|0|||
147060361|NCT04441905|530386030|FG003|Overall Study|Became ineligible after enrollment|0|||
147060362|NCT04441905|530386031|FG004|Overall Study|Became ineligible after enrollment|1|||
147060363|NCT04441905|530386032|FG005|Overall Study|Became ineligible after enrollment|0|||
147060364|NCT03834961|530386035|FG000|Overall Study|Lack of Efficacy|1|||
147060365|NCT03834961|530386036|FG001|Overall Study|Lack of Efficacy|1|||
147060366|NCT03834961|530386037|FG002|Overall Study|Lack of Efficacy|0|||
147060367|NCT03834961|530386035|FG000|Overall Study|Physician Decision|0|||
147060368|NCT03834961|530386036|FG001|Overall Study|Physician Decision|1|||
147060369|NCT03834961|530386037|FG002|Overall Study|Physician Decision|0|||
147060370|NCT04736199|530386040|FG000|Overall Study|Adverse Event|28|||
147060371|NCT04736199|530386041|FG001|Overall Study|Adverse Event|22|||
147060372|NCT04736199|530386040|FG000|Overall Study|Death|9|||
147060373|NCT04736199|530386041|FG001|Overall Study|Death|3|||
147060374|NCT04736199|530386040|FG000|Overall Study|Lost to Follow-up|4|||
147060375|NCT04736199|530386041|FG001|Overall Study|Lost to Follow-up|1|||
147060376|NCT04736199|530386040|FG000|Overall Study|Physician Decision|5|||
147060377|NCT04736199|530386041|FG001|Overall Study|Physician Decision|9|||
147060378|NCT04736199|530386040|FG000|Overall Study|Withdrawal by Subject|21|||
147060379|NCT04736199|530386041|FG001|Overall Study|Withdrawal by Subject|9|||
147060380|NCT04736199|530386040|FG000|Overall Study|Progressive disease|120|||
147060381|NCT04736199|530386041|FG001|Overall Study|Progressive disease|101|||
147060382|NCT04736199|530386040|FG000|Overall Study|Subject decision|13|||
147060383|NCT04736199|530386041|FG001|Overall Study|Subject decision|13|||
147060384|NCT04736199|530386040|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
147060385|NCT04736199|530386041|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
147060386|NCT04736199|530386040|FG000|Overall Study|Additional primary malignancy|1|||
147060387|NCT04736199|530386041|FG001|Overall Study|Additional primary malignancy|0|||
147060388|NCT04736199|530386040|FG000|Overall Study|Non-compliance with study drug|0|||
147060389|NCT04736199|530386041|FG001|Overall Study|Non-compliance with study drug|1|||
147060390|NCT04736199|530386040|FG000|Overall Study|Other reason|0|||
147060391|NCT04736199|530386041|FG001|Overall Study|Other reason|1|||
147060392|NCT04736199|530386040|FG000|Overall Study|Ongoing with study drug|240|||
147060393|NCT04736199|530386041|FG001|Overall Study|Ongoing with study drug|63|||
147060394|NCT04736199|530386040|FG000|Overall Study|Study drug never administered|3|||
147060395|NCT04736199|530386041|FG001|Overall Study|Study drug never administered|0|||
147060396|NCT04770753|530386042|FG000|Overall Study|Randomized, never treated|1|||
147060397|NCT04770753|530386043|FG001|Overall Study|Randomized, never treated|1|||
147060398|NCT04770753|530386042|FG000|Overall Study|Withdrawal by Subject|3|||
147060399|NCT04770753|530386043|FG001|Overall Study|Withdrawal by Subject|1|||
147060400|NCT04770753|530386042|FG000|Overall Study|Adverse Event|2|||
147060401|NCT04770753|530386043|FG001|Overall Study|Adverse Event|0|||
147060402|NCT04770753|530386042|FG000|Overall Study|Pregnancy|1|||
147060403|NCT04770753|530386043|FG001|Overall Study|Pregnancy|0|||
147060404|NCT04770753|530386042|FG000|Overall Study|Other un-specified|1|||
147060405|NCT04770753|530386043|FG001|Overall Study|Other un-specified|0|||
147060406|NCT02775851|530386044|FG000|Overall Study|Adverse Event|1|||
147060407|NCT02775851|530386045|FG001|Overall Study|Adverse Event|10|||
147060408|NCT02775851|530386044|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
147060409|NCT02775851|530386045|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
147060410|NCT02775851|530386044|FG000|Overall Study|Progression/Relapse|0|||
147060411|NCT02775851|530386045|FG001|Overall Study|Progression/Relapse|4|||
147060412|NCT02775851|530386044|FG000|Overall Study|Other - Not Protocol Specified|0|||
147060413|NCT02775851|530386045|FG001|Overall Study|Other - Not Protocol Specified|7|||
147060414|NCT02775851|530386044|FG000|Overall Study|Withdrawal by Subject|1|||
147060415|NCT02775851|530386045|FG001|Overall Study|Withdrawal by Subject|0|||
147060416|NCT04732871|530386046|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
147060417|NCT04732871|530386047|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
147060418|NCT04732871|530386048|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
147060419|NCT04732871|530386046|FG000|Overall Study|Lost to Follow-up|7|||
147060420|NCT04732871|530386047|FG001|Overall Study|Lost to Follow-up|4|||
147060421|NCT04732871|530386048|FG002|Overall Study|Lost to Follow-up|3|||
147060422|NCT04732871|530386046|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
147060423|NCT04732871|530386047|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
147060424|NCT04732871|530386048|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
147060425|NCT04732871|530386046|FG000|Overall Study|Migrated / moved from the study area|5|||
147060426|NCT04732871|530386047|FG001|Overall Study|Migrated / moved from the study area|0|||
147060427|NCT04732871|530386048|FG002|Overall Study|Migrated / moved from the study area|0|||
147060428|NCT04732871|530386046|FG000|Overall Study|Other|1|||
147060429|NCT04732871|530386047|FG001|Overall Study|Other|0|||
147060430|NCT04732871|530386048|FG002|Overall Study|Other|1|||
147060431|NCT04732871|530386046|FG000|Overall Study|Ongoing|6|||
147060432|NCT04732871|530386047|FG001|Overall Study|Ongoing|0|||
147060433|NCT04732871|530386048|FG002|Overall Study|Ongoing|1|||
147060434|NCT04732871|530386046|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
147060435|NCT04732871|530386047|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
147060436|NCT04732871|530386048|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
147060437|NCT04780659|530386049|FG000|Overall Study|Adverse event, serious fatal|3|||
147060438|NCT04780659|530386050|FG001|Overall Study|Adverse event, serious fatal|0|||
147060439|NCT04780659|530386049|FG000|Overall Study|Withdrawal by Subject|3|||
147060440|NCT04780659|530386050|FG001|Overall Study|Withdrawal by Subject|0|||
147060441|NCT04780659|530386049|FG000|Overall Study|Physician Decision|1|||
147060442|NCT04780659|530386050|FG001|Overall Study|Physician Decision|0|||
147060443|NCT04780659|530386049|FG000|Overall Study|Died in original disease|2|||
147060444|NCT04780659|530386050|FG001|Overall Study|Died in original disease|0|||
147060445|NCT04780659|530386049|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
147060446|NCT04780659|530386050|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
147060447|NCT05507437|530386051|FG000|Overall Study|Withdrawal by Subject|1|||
147060448|NCT05507437|530386052|FG001|Overall Study|Withdrawal by Subject|1|||
147060449|NCT05507437|530386051|FG000|Overall Study|Death|3|||
147060450|NCT05507437|530386052|FG001|Overall Study|Death|0|||
147060451|NCT05918055|530386053|FG000|Phase I - Dose Level 1|Ineligible|0|||
147060452|NCT05918055|530386054|FG001|Phase I - Dose Level 1|Ineligible|0|||
147060453|NCT05918055|530386055|FG002|Phase I - Dose Level 1|Ineligible|1|||
147060454|NCT05918055|530386053|FG000|Phase I - Dose Level -1|Physician Decision|1|||
147060455|NCT05918055|530386054|FG001|Phase I - Dose Level -1|Physician Decision|0|||
147060456|NCT05918055|530386055|FG002|Phase I - Dose Level -1|Physician Decision|0|||
147060457|NCT06583096|530386056|FG000|Overall Study|Lost to Follow-up|4|||
147060458|NCT06583096|530386057|FG001|Overall Study|Lost to Follow-up|10|||
147060459|NCT06583096|530386056|FG000|Overall Study|Withdrawal by Subject|0|||
147060460|NCT06583096|530386057|FG001|Overall Study|Withdrawal by Subject|2|||
147060461|NCT02562235|530386058|FG000|Overall Study|Adverse Event|3|||
147060462|NCT03945773|530386059|FG000|Overall Study|Consent Withdrawn|1|||
147060463|NCT03945773|530386060|FG001|Overall Study|Consent Withdrawn|1|||
147060464|NCT03945773|530386059|FG000|Overall Study|Lost to Follow-up|1|||
147060465|NCT03945773|530386060|FG001|Overall Study|Lost to Follow-up|0|||
147060466|NCT03945773|530386059|FG000|Overall Study|Death|46|||
147060467|NCT03945773|530386060|FG001|Overall Study|Death|22|||
147060468|NCT03945773|530386059|FG000|Overall Study|Physician Decision|1|||
147060469|NCT03945773|530386060|FG001|Overall Study|Physician Decision|0|||
147060470|NCT03945773|530386059|FG000|Overall Study|Other|1|||
147060471|NCT03945773|530386060|FG001|Overall Study|Other|0|||
147060472|NCT03945773|530386059|FG000|Overall Study|Ongoing at the time of DCO|4|||
147060473|NCT03945773|530386060|FG001|Overall Study|Ongoing at the time of DCO|3|||
147060474|NCT03595124|530386061|FG000|Overall Study|Physician Decision|1|||
147060475|NCT03595124|530386062|FG001|Overall Study|Physician Decision|1|||
147060476|NCT03595124|530386063|FG002|Overall Study|Physician Decision|1|||
147060477|NCT03595124|530386061|FG000|Overall Study|Ineligible|1|||
147060478|NCT03595124|530386062|FG001|Overall Study|Ineligible|1|||
147060479|NCT03595124|530386063|FG002|Overall Study|Ineligible|0|||
147060480|NCT03595124|530386061|FG000|Overall Study|Disease Progression|4|||
147060481|NCT03595124|530386062|FG001|Overall Study|Disease Progression|1|||
147060482|NCT03595124|530386063|FG002|Overall Study|Disease Progression|4|||
147060483|NCT05610605|530386068|FG000|6-month Assessment|Death|1|||
147060484|NCT05610605|530386069|FG001|6-month Assessment|Death|1|||
147060485|NCT05610605|530386068|FG000|6-month Assessment|Lost to Follow-up|20|||
147060486|NCT05610605|530386069|FG001|6-month Assessment|Lost to Follow-up|0|||
147060487|NCT05610605|530386068|FG000|6-month Assessment|Institutionalized|1|||
147060488|NCT05610605|530386069|FG001|6-month Assessment|Institutionalized|2|||
147060489|NCT05610605|530386068|FG000|12-month Assessment|Death|2|||
147060490|NCT05610605|530386069|FG001|12-month Assessment|Death|1|||
147060491|NCT05610605|530386068|FG000|12-month Assessment|Lost to Follow-up|1|||
147060492|NCT05610605|530386069|FG001|12-month Assessment|Lost to Follow-up|4|||
147060493|NCT05610605|530386068|FG000|12-month Assessment|Institutionalized|2|||
147060494|NCT05610605|530386069|FG001|12-month Assessment|Institutionalized|1|||
147060495|NCT03607422|530386070|FG000|Overall Study|Adverse Event|7|||
147060496|NCT03607422|530386071|FG001|Overall Study|Adverse Event|3|||
147060497|NCT03607422|530386072|FG002|Overall Study|Adverse Event|2|||
147060498|NCT03607422|530386073|FG003|Overall Study|Adverse Event|0|||
147060499|NCT03607422|530386074|FG004|Overall Study|Adverse Event|2|||
147060500|NCT03607422|530386075|FG005|Overall Study|Adverse Event|0|||
147060501|NCT03607422|530386070|FG000|Overall Study|Withdrawal by Subject|11|||
147060502|NCT03607422|530386071|FG001|Overall Study|Withdrawal by Subject|3|||
147060503|NCT03607422|530386072|FG002|Overall Study|Withdrawal by Subject|6|||
147060504|NCT03607422|530386073|FG003|Overall Study|Withdrawal by Subject|2|||
147060505|NCT03607422|530386074|FG004|Overall Study|Withdrawal by Subject|0|||
147060506|NCT03607422|530386075|FG005|Overall Study|Withdrawal by Subject|0|||
147060507|NCT03607422|530386070|FG000|Overall Study|Lost to Follow-up|0|||
147060508|NCT03607422|530386071|FG001|Overall Study|Lost to Follow-up|0|||
147060509|NCT03607422|530386072|FG002|Overall Study|Lost to Follow-up|1|||
147060510|NCT03607422|530386073|FG003|Overall Study|Lost to Follow-up|0|||
147060511|NCT03607422|530386074|FG004|Overall Study|Lost to Follow-up|0|||
147060512|NCT03607422|530386075|FG005|Overall Study|Lost to Follow-up|0|||
147060513|NCT03607422|530386070|FG000|Overall Study|Other|12|||
147060514|NCT03607422|530386071|FG001|Overall Study|Other|4|||
147060515|NCT03607422|530386072|FG002|Overall Study|Other|1|||
147060516|NCT03607422|530386073|FG003|Overall Study|Other|2|||
147060517|NCT03607422|530386074|FG004|Overall Study|Other|0|||
147060518|NCT03607422|530386075|FG005|Overall Study|Other|2|||
147060519|NCT03607422|530386070|FG000|Overall Study|Ongoing at Time of Analysis|8|||
147060520|NCT03607422|530386071|FG001|Overall Study|Ongoing at Time of Analysis|0|||
147060521|NCT03607422|530386072|FG002|Overall Study|Ongoing at Time of Analysis|2|||
147060522|NCT03607422|530386073|FG003|Overall Study|Ongoing at Time of Analysis|1|||
147060523|NCT03607422|530386074|FG004|Overall Study|Ongoing at Time of Analysis|1|||
147060524|NCT03607422|530386075|FG005|Overall Study|Ongoing at Time of Analysis|1|||
147060525|NCT00042289|530386076|FG000|Overall Study|Lost to Follow-up|3|||
147060526|NCT00042289|530386077|FG001|Overall Study|Lost to Follow-up|0|||
147060527|NCT00042289|530386078|FG002|Overall Study|Lost to Follow-up|0|||
147060528|NCT00042289|530386079|FG003|Overall Study|Lost to Follow-up|1|||
147060529|NCT00042289|530386080|FG004|Overall Study|Lost to Follow-up|3|||
147060530|NCT00042289|530386081|FG005|Overall Study|Lost to Follow-up|3|||
147060531|NCT00042289|530386082|FG006|Overall Study|Lost to Follow-up|6|||
147060532|NCT00042289|530386083|FG007|Overall Study|Lost to Follow-up|1|||
147060533|NCT00042289|530386084|FG008|Overall Study|Lost to Follow-up|1|||
147060534|NCT00042289|530386085|FG009|Overall Study|Lost to Follow-up|0|||
147060535|NCT00042289|530386086|FG010|Overall Study|Lost to Follow-up|0|||
147060536|NCT00042289|530386087|FG011|Overall Study|Lost to Follow-up|0|||
147060537|NCT00042289|530386088|FG012|Overall Study|Lost to Follow-up|0|||
147060538|NCT00042289|530386089|FG013|Overall Study|Lost to Follow-up|0|||
147060539|NCT00042289|530386090|FG014|Overall Study|Lost to Follow-up|0|||
147060540|NCT00042289|530386091|FG015|Overall Study|Lost to Follow-up|1|||
147060541|NCT00042289|530386092|FG016|Overall Study|Lost to Follow-up|1|||
147060542|NCT00042289|530386093|FG017|Overall Study|Lost to Follow-up|0|||
147060543|NCT00042289|530386094|FG018|Overall Study|Lost to Follow-up|3|||
147060544|NCT00042289|530386095|FG019|Overall Study|Lost to Follow-up|2|||
147060545|NCT00042289|530386096|FG020|Overall Study|Lost to Follow-up|0|||
147060546|NCT00042289|530386097|FG021|Overall Study|Lost to Follow-up|0|||
147060547|NCT00042289|530386098|FG022|Overall Study|Lost to Follow-up|0|||
147060548|NCT00042289|530386099|FG023|Overall Study|Lost to Follow-up|0|||
147060549|NCT00042289|530386100|FG024|Overall Study|Lost to Follow-up|0|||
147060550|NCT00042289|530386101|FG025|Overall Study|Lost to Follow-up|0|||
147060551|NCT00042289|530386102|FG026|Overall Study|Lost to Follow-up|2|||
147060552|NCT00042289|530386103|FG027|Overall Study|Lost to Follow-up|2|||
147060553|NCT00042289|530386104|FG028|Overall Study|Lost to Follow-up|2|||
147060554|NCT00042289|530386105|FG029|Overall Study|Lost to Follow-up|0|||
147060555|NCT00042289|530386106|FG030|Overall Study|Lost to Follow-up|0|||
147060556|NCT00042289|530386107|FG031|Overall Study|Lost to Follow-up|2|||
147060557|NCT00042289|530386108|FG032|Overall Study|Lost to Follow-up|1|||
147060558|NCT00042289|530386109|FG033|Overall Study|Lost to Follow-up|1|||
147060559|NCT00042289|530386110|FG034|Overall Study|Lost to Follow-up|1|||
147060560|NCT00042289|530386111|FG035|Overall Study|Lost to Follow-up|2|||
147060561|NCT00042289|530386112|FG036|Overall Study|Lost to Follow-up|1|||
147060562|NCT00042289|530386113|FG037|Overall Study|Lost to Follow-up|1|||
147060563|NCT00042289|530386114|FG038|Overall Study|Lost to Follow-up|0|||
147060564|NCT00042289|530386115|FG039|Overall Study|Lost to Follow-up|5|||
147060565|NCT00042289|530386116|FG040|Overall Study|Lost to Follow-up|0|||
147060566|NCT00042289|530386117|FG041|Overall Study|Lost to Follow-up|2|||
147060567|NCT00042289|530386118|FG042|Overall Study|Lost to Follow-up|2|||
147060568|NCT00042289|530386119|FG043|Overall Study|Lost to Follow-up|0|||
147060569|NCT00042289|530386120|FG044|Overall Study|Lost to Follow-up|0|||
147060570|NCT00042289|530386121|FG045|Overall Study|Lost to Follow-up|1|||
147060571|NCT00042289|530386122|FG046|Overall Study|Lost to Follow-up|0|||
147060572|NCT00042289|530386076|FG000|Overall Study|Other reason|0|||
147060573|NCT00042289|530386077|FG001|Overall Study|Other reason|0|||
147060574|NCT00042289|530386078|FG002|Overall Study|Other reason|0|||
147060575|NCT00042289|530386079|FG003|Overall Study|Other reason|2|||
147060576|NCT00042289|530386080|FG004|Overall Study|Other reason|0|||
147060577|NCT00042289|530386081|FG005|Overall Study|Other reason|0|||
147060578|NCT00042289|530386082|FG006|Overall Study|Other reason|0|||
147060579|NCT00042289|530386083|FG007|Overall Study|Other reason|0|||
147060580|NCT00042289|530386084|FG008|Overall Study|Other reason|0|||
147060581|NCT00042289|530386085|FG009|Overall Study|Other reason|0|||
147060582|NCT00042289|530386086|FG010|Overall Study|Other reason|0|||
147060583|NCT00042289|530386087|FG011|Overall Study|Other reason|0|||
147060584|NCT00042289|530386088|FG012|Overall Study|Other reason|0|||
147060585|NCT00042289|530386089|FG013|Overall Study|Other reason|0|||
147060586|NCT00042289|530386090|FG014|Overall Study|Other reason|0|||
147060587|NCT00042289|530386091|FG015|Overall Study|Other reason|0|||
147060588|NCT00042289|530386092|FG016|Overall Study|Other reason|0|||
147060589|NCT00042289|530386093|FG017|Overall Study|Other reason|0|||
147060590|NCT00042289|530386094|FG018|Overall Study|Other reason|1|||
147060591|NCT00042289|530386095|FG019|Overall Study|Other reason|0|||
147060592|NCT00042289|530386096|FG020|Overall Study|Other reason|0|||
147060593|NCT00042289|530386097|FG021|Overall Study|Other reason|0|||
147060594|NCT00042289|530386098|FG022|Overall Study|Other reason|0|||
147060595|NCT00042289|530386099|FG023|Overall Study|Other reason|1|||
147060596|NCT00042289|530386100|FG024|Overall Study|Other reason|0|||
147060597|NCT00042289|530386101|FG025|Overall Study|Other reason|0|||
147060598|NCT00042289|530386102|FG026|Overall Study|Other reason|1|||
147060599|NCT00042289|530386103|FG027|Overall Study|Other reason|0|||
147060600|NCT00042289|530386104|FG028|Overall Study|Other reason|3|||
147060601|NCT00042289|530386105|FG029|Overall Study|Other reason|0|||
147060602|NCT00042289|530386106|FG030|Overall Study|Other reason|0|||
147060603|NCT00042289|530386107|FG031|Overall Study|Other reason|1|||
147060604|NCT00042289|530386108|FG032|Overall Study|Other reason|0|||
147060605|NCT00042289|530386109|FG033|Overall Study|Other reason|1|||
147060606|NCT00042289|530386110|FG034|Overall Study|Other reason|0|||
147060607|NCT00042289|530386111|FG035|Overall Study|Other reason|2|||
147060608|NCT00042289|530386112|FG036|Overall Study|Other reason|0|||
147060609|NCT00042289|530386113|FG037|Overall Study|Other reason|0|||
147060610|NCT00042289|530386114|FG038|Overall Study|Other reason|0|||
147060611|NCT00042289|530386115|FG039|Overall Study|Other reason|0|||
147060612|NCT00042289|530386116|FG040|Overall Study|Other reason|0|||
147060613|NCT00042289|530386117|FG041|Overall Study|Other reason|0|||
147060614|NCT00042289|530386118|FG042|Overall Study|Other reason|0|||
147060615|NCT00042289|530386119|FG043|Overall Study|Other reason|1|||
147060616|NCT00042289|530386120|FG044|Overall Study|Other reason|0|||
147060617|NCT00042289|530386121|FG045|Overall Study|Other reason|0|||
147060618|NCT00042289|530386122|FG046|Overall Study|Other reason|0|||
147060619|NCT00042289|530386076|FG000|Overall Study|Severe debilitation, unable to continue|0|||
147060620|NCT00042289|530386077|FG001|Overall Study|Severe debilitation, unable to continue|0|||
147060621|NCT00042289|530386078|FG002|Overall Study|Severe debilitation, unable to continue|0|||
147060622|NCT00042289|530386079|FG003|Overall Study|Severe debilitation, unable to continue|0|||
147060623|NCT00042289|530386080|FG004|Overall Study|Severe debilitation, unable to continue|0|||
147060624|NCT00042289|530386081|FG005|Overall Study|Severe debilitation, unable to continue|0|||
147060625|NCT00042289|530386082|FG006|Overall Study|Severe debilitation, unable to continue|0|||
147060626|NCT00042289|530386083|FG007|Overall Study|Severe debilitation, unable to continue|0|||
147060627|NCT00042289|530386084|FG008|Overall Study|Severe debilitation, unable to continue|0|||
147060628|NCT00042289|530386085|FG009|Overall Study|Severe debilitation, unable to continue|0|||
147060629|NCT00042289|530386086|FG010|Overall Study|Severe debilitation, unable to continue|0|||
147060630|NCT00042289|530386087|FG011|Overall Study|Severe debilitation, unable to continue|0|||
147060631|NCT00042289|530386088|FG012|Overall Study|Severe debilitation, unable to continue|0|||
147060632|NCT00042289|530386089|FG013|Overall Study|Severe debilitation, unable to continue|0|||
147060633|NCT00042289|530386090|FG014|Overall Study|Severe debilitation, unable to continue|0|||
147060634|NCT00042289|530386091|FG015|Overall Study|Severe debilitation, unable to continue|0|||
147060635|NCT00042289|530386092|FG016|Overall Study|Severe debilitation, unable to continue|0|||
147060636|NCT00042289|530386093|FG017|Overall Study|Severe debilitation, unable to continue|0|||
147060637|NCT00042289|530386094|FG018|Overall Study|Severe debilitation, unable to continue|0|||
147060638|NCT00042289|530386095|FG019|Overall Study|Severe debilitation, unable to continue|0|||
147060639|NCT00042289|530386096|FG020|Overall Study|Severe debilitation, unable to continue|0|||
147060640|NCT00042289|530386097|FG021|Overall Study|Severe debilitation, unable to continue|1|||
147060641|NCT00042289|530386098|FG022|Overall Study|Severe debilitation, unable to continue|0|||
147060642|NCT00042289|530386099|FG023|Overall Study|Severe debilitation, unable to continue|1|||
147060643|NCT00042289|530386100|FG024|Overall Study|Severe debilitation, unable to continue|0|||
147060644|NCT00042289|530386101|FG025|Overall Study|Severe debilitation, unable to continue|0|||
147060645|NCT00042289|530386102|FG026|Overall Study|Severe debilitation, unable to continue|0|||
147060646|NCT00042289|530386103|FG027|Overall Study|Severe debilitation, unable to continue|1|||
147060647|NCT00042289|530386104|FG028|Overall Study|Severe debilitation, unable to continue|0|||
147060648|NCT00042289|530386105|FG029|Overall Study|Severe debilitation, unable to continue|0|||
147060649|NCT00042289|530386106|FG030|Overall Study|Severe debilitation, unable to continue|0|||
147060650|NCT00042289|530386107|FG031|Overall Study|Severe debilitation, unable to continue|1|||
147060651|NCT00042289|530386108|FG032|Overall Study|Severe debilitation, unable to continue|1|||
147060652|NCT00042289|530386109|FG033|Overall Study|Severe debilitation, unable to continue|0|||
147060653|NCT00042289|530386110|FG034|Overall Study|Severe debilitation, unable to continue|0|||
147060654|NCT00042289|530386111|FG035|Overall Study|Severe debilitation, unable to continue|0|||
147060655|NCT00042289|530386112|FG036|Overall Study|Severe debilitation, unable to continue|0|||
147060656|NCT00042289|530386113|FG037|Overall Study|Severe debilitation, unable to continue|0|||
147060657|NCT00042289|530386114|FG038|Overall Study|Severe debilitation, unable to continue|0|||
147060658|NCT00042289|530386115|FG039|Overall Study|Severe debilitation, unable to continue|0|||
147060659|NCT00042289|530386116|FG040|Overall Study|Severe debilitation, unable to continue|0|||
147060660|NCT00042289|530386117|FG041|Overall Study|Severe debilitation, unable to continue|0|||
147060661|NCT00042289|530386118|FG042|Overall Study|Severe debilitation, unable to continue|0|||
147060662|NCT00042289|530386119|FG043|Overall Study|Severe debilitation, unable to continue|0|||
147060663|NCT00042289|530386120|FG044|Overall Study|Severe debilitation, unable to continue|0|||
147060664|NCT00042289|530386121|FG045|Overall Study|Severe debilitation, unable to continue|0|||
147060665|NCT00042289|530386122|FG046|Overall Study|Severe debilitation, unable to continue|0|||
147060666|NCT00042289|530386076|FG000|Overall Study|Site closed|0|||
147060667|NCT00042289|530386077|FG001|Overall Study|Site closed|0|||
147060668|NCT00042289|530386078|FG002|Overall Study|Site closed|0|||
147060669|NCT00042289|530386079|FG003|Overall Study|Site closed|0|||
147060670|NCT00042289|530386080|FG004|Overall Study|Site closed|0|||
147060671|NCT00042289|530386081|FG005|Overall Study|Site closed|0|||
147060672|NCT00042289|530386082|FG006|Overall Study|Site closed|0|||
147060673|NCT00042289|530386083|FG007|Overall Study|Site closed|0|||
147060674|NCT00042289|530386084|FG008|Overall Study|Site closed|0|||
147060675|NCT00042289|530386085|FG009|Overall Study|Site closed|0|||
147060676|NCT00042289|530386086|FG010|Overall Study|Site closed|0|||
147060677|NCT00042289|530386087|FG011|Overall Study|Site closed|0|||
147060678|NCT00042289|530386088|FG012|Overall Study|Site closed|0|||
147060679|NCT00042289|530386089|FG013|Overall Study|Site closed|0|||
147060680|NCT00042289|530386090|FG014|Overall Study|Site closed|0|||
147060681|NCT00042289|530386091|FG015|Overall Study|Site closed|0|||
147060682|NCT00042289|530386092|FG016|Overall Study|Site closed|0|||
147060683|NCT00042289|530386093|FG017|Overall Study|Site closed|0|||
147060684|NCT00042289|530386094|FG018|Overall Study|Site closed|0|||
147060685|NCT00042289|530386095|FG019|Overall Study|Site closed|0|||
147060686|NCT00042289|530386096|FG020|Overall Study|Site closed|0|||
147060687|NCT00042289|530386097|FG021|Overall Study|Site closed|0|||
147060688|NCT00042289|530386098|FG022|Overall Study|Site closed|0|||
147060689|NCT00042289|530386099|FG023|Overall Study|Site closed|0|||
147060690|NCT00042289|530386100|FG024|Overall Study|Site closed|0|||
147060691|NCT00042289|530386101|FG025|Overall Study|Site closed|0|||
147060692|NCT00042289|530386102|FG026|Overall Study|Site closed|0|||
147060693|NCT00042289|530386103|FG027|Overall Study|Site closed|0|||
147060694|NCT00042289|530386104|FG028|Overall Study|Site closed|0|||
147060695|NCT00042289|530386105|FG029|Overall Study|Site closed|0|||
147060696|NCT00042289|530386106|FG030|Overall Study|Site closed|0|||
147060697|NCT00042289|530386107|FG031|Overall Study|Site closed|3|||
147060698|NCT00042289|530386108|FG032|Overall Study|Site closed|0|||
147060699|NCT00042289|530386109|FG033|Overall Study|Site closed|0|||
147060700|NCT00042289|530386110|FG034|Overall Study|Site closed|0|||
147060701|NCT00042289|530386111|FG035|Overall Study|Site closed|0|||
147060702|NCT00042289|530386112|FG036|Overall Study|Site closed|1|||
147060703|NCT00042289|530386113|FG037|Overall Study|Site closed|0|||
147060704|NCT00042289|530386114|FG038|Overall Study|Site closed|0|||
147060705|NCT00042289|530386115|FG039|Overall Study|Site closed|0|||
147060706|NCT00042289|530386116|FG040|Overall Study|Site closed|0|||
147060707|NCT00042289|530386117|FG041|Overall Study|Site closed|0|||
147060708|NCT00042289|530386118|FG042|Overall Study|Site closed|1|||
147060709|NCT00042289|530386119|FG043|Overall Study|Site closed|0|||
147060710|NCT00042289|530386120|FG044|Overall Study|Site closed|0|||
147060711|NCT00042289|530386121|FG045|Overall Study|Site closed|0|||
147060712|NCT00042289|530386122|FG046|Overall Study|Site closed|0|||
147060713|NCT00042289|530386076|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
147060714|NCT00042289|530386077|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
147060715|NCT00042289|530386078|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
147060716|NCT00042289|530386079|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
147060717|NCT00042289|530386080|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
147060718|NCT00042289|530386081|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
147060719|NCT00042289|530386082|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
147060720|NCT00042289|530386083|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
147060721|NCT00042289|530386084|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
147060722|NCT00042289|530386085|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
147060723|NCT00042289|530386086|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
147060724|NCT00042289|530386087|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
147060725|NCT00042289|530386088|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
147060726|NCT00042289|530386089|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
147060727|NCT00042289|530386090|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
147060728|NCT00042289|530386091|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
147060729|NCT00042289|530386092|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
147060730|NCT00042289|530386093|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
147060731|NCT00042289|530386094|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
147060732|NCT00042289|530386095|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
147060733|NCT00042289|530386096|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
147060734|NCT00042289|530386097|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
147060735|NCT00042289|530386098|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
147060736|NCT00042289|530386099|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
147060737|NCT00042289|530386100|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
147060738|NCT00042289|530386101|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
147060739|NCT00042289|530386102|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
147060740|NCT00042289|530386103|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
147060741|NCT00042289|530386104|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
147060742|NCT00042289|530386105|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
147060743|NCT00042289|530386106|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
147060744|NCT00042289|530386107|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
147060745|NCT00042289|530386108|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
147060746|NCT00042289|530386109|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
147060747|NCT00042289|530386110|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
147060748|NCT00042289|530386111|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
147060749|NCT00042289|530386112|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
147060750|NCT00042289|530386113|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
147060751|NCT00042289|530386114|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
147060752|NCT00042289|530386115|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
147060753|NCT00042289|530386116|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
147060754|NCT00042289|530386117|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
147060755|NCT00042289|530386118|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
147060756|NCT00042289|530386119|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
147060757|NCT00042289|530386120|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
147060758|NCT00042289|530386121|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
147060759|NCT00042289|530386122|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
147060760|NCT00042289|530386076|FG000|Overall Study|Protocol Violation|0|||
147060761|NCT00042289|530386077|FG001|Overall Study|Protocol Violation|0|||
147060762|NCT00042289|530386078|FG002|Overall Study|Protocol Violation|0|||
147060763|NCT00042289|530386079|FG003|Overall Study|Protocol Violation|0|||
147060764|NCT00042289|530386080|FG004|Overall Study|Protocol Violation|0|||
147060765|NCT00042289|530386081|FG005|Overall Study|Protocol Violation|1|||
147060766|NCT00042289|530386082|FG006|Overall Study|Protocol Violation|0|||
147060767|NCT00042289|530386083|FG007|Overall Study|Protocol Violation|1|||
147060768|NCT00042289|530386084|FG008|Overall Study|Protocol Violation|0|||
147060769|NCT00042289|530386085|FG009|Overall Study|Protocol Violation|0|||
147060770|NCT00042289|530386086|FG010|Overall Study|Protocol Violation|0|||
147060771|NCT00042289|530386087|FG011|Overall Study|Protocol Violation|0|||
147060772|NCT00042289|530386088|FG012|Overall Study|Protocol Violation|0|||
147060773|NCT00042289|530386089|FG013|Overall Study|Protocol Violation|0|||
147060774|NCT00042289|530386090|FG014|Overall Study|Protocol Violation|0|||
147060775|NCT00042289|530386091|FG015|Overall Study|Protocol Violation|0|||
147060776|NCT00042289|530386092|FG016|Overall Study|Protocol Violation|0|||
147060777|NCT00042289|530386093|FG017|Overall Study|Protocol Violation|0|||
147060778|NCT00042289|530386094|FG018|Overall Study|Protocol Violation|0|||
147060779|NCT00042289|530386095|FG019|Overall Study|Protocol Violation|0|||
147060780|NCT00042289|530386096|FG020|Overall Study|Protocol Violation|0|||
147060781|NCT00042289|530386097|FG021|Overall Study|Protocol Violation|0|||
147060782|NCT00042289|530386098|FG022|Overall Study|Protocol Violation|0|||
147060783|NCT00042289|530386099|FG023|Overall Study|Protocol Violation|1|||
147060784|NCT00042289|530386100|FG024|Overall Study|Protocol Violation|1|||
147060785|NCT00042289|530386101|FG025|Overall Study|Protocol Violation|0|||
147060786|NCT00042289|530386102|FG026|Overall Study|Protocol Violation|2|||
147060787|NCT00042289|530386103|FG027|Overall Study|Protocol Violation|0|||
147060788|NCT00042289|530386104|FG028|Overall Study|Protocol Violation|0|||
147060789|NCT00042289|530386105|FG029|Overall Study|Protocol Violation|0|||
147060790|NCT00042289|530386106|FG030|Overall Study|Protocol Violation|1|||
147060791|NCT00042289|530386107|FG031|Overall Study|Protocol Violation|0|||
147060792|NCT00042289|530386108|FG032|Overall Study|Protocol Violation|0|||
147060793|NCT00042289|530386109|FG033|Overall Study|Protocol Violation|0|||
147060794|NCT00042289|530386110|FG034|Overall Study|Protocol Violation|0|||
147060795|NCT00042289|530386111|FG035|Overall Study|Protocol Violation|0|||
147060796|NCT00042289|530386112|FG036|Overall Study|Protocol Violation|0|||
147060797|NCT00042289|530386113|FG037|Overall Study|Protocol Violation|0|||
147060798|NCT00042289|530386114|FG038|Overall Study|Protocol Violation|0|||
147060799|NCT00042289|530386115|FG039|Overall Study|Protocol Violation|0|||
147060800|NCT00042289|530386116|FG040|Overall Study|Protocol Violation|0|||
147060801|NCT00042289|530386117|FG041|Overall Study|Protocol Violation|1|||
147060802|NCT00042289|530386118|FG042|Overall Study|Protocol Violation|1|||
147060803|NCT00042289|530386119|FG043|Overall Study|Protocol Violation|1|||
147060804|NCT00042289|530386120|FG044|Overall Study|Protocol Violation|0|||
147060805|NCT00042289|530386121|FG045|Overall Study|Protocol Violation|0|||
147060806|NCT00042289|530386122|FG046|Overall Study|Protocol Violation|0|||
147060807|NCT00042289|530386076|FG000|Overall Study|Withdrawal by Subject|4|||
147060808|NCT00042289|530386077|FG001|Overall Study|Withdrawal by Subject|1|||
147060809|NCT00042289|530386078|FG002|Overall Study|Withdrawal by Subject|0|||
147060810|NCT00042289|530386079|FG003|Overall Study|Withdrawal by Subject|2|||
147060811|NCT00042289|530386080|FG004|Overall Study|Withdrawal by Subject|0|||
147060812|NCT00042289|530386081|FG005|Overall Study|Withdrawal by Subject|2|||
147060813|NCT00042289|530386082|FG006|Overall Study|Withdrawal by Subject|0|||
147060814|NCT00042289|530386083|FG007|Overall Study|Withdrawal by Subject|0|||
147060815|NCT00042289|530386084|FG008|Overall Study|Withdrawal by Subject|0|||
147060816|NCT00042289|530386085|FG009|Overall Study|Withdrawal by Subject|1|||
147060817|NCT00042289|530386086|FG010|Overall Study|Withdrawal by Subject|0|||
147060818|NCT00042289|530386087|FG011|Overall Study|Withdrawal by Subject|0|||
147060819|NCT00042289|530386088|FG012|Overall Study|Withdrawal by Subject|2|||
147060820|NCT00042289|530386089|FG013|Overall Study|Withdrawal by Subject|0|||
147060821|NCT00042289|530386090|FG014|Overall Study|Withdrawal by Subject|0|||
147060822|NCT00042289|530386091|FG015|Overall Study|Withdrawal by Subject|0|||
147060823|NCT00042289|530386092|FG016|Overall Study|Withdrawal by Subject|0|||
147060824|NCT00042289|530386093|FG017|Overall Study|Withdrawal by Subject|0|||
147060825|NCT00042289|530386094|FG018|Overall Study|Withdrawal by Subject|0|||
147060826|NCT00042289|530386095|FG019|Overall Study|Withdrawal by Subject|0|||
147060827|NCT00042289|530386096|FG020|Overall Study|Withdrawal by Subject|0|||
147060828|NCT00042289|530386097|FG021|Overall Study|Withdrawal by Subject|1|||
147060829|NCT00042289|530386098|FG022|Overall Study|Withdrawal by Subject|1|||
147060830|NCT00042289|530386099|FG023|Overall Study|Withdrawal by Subject|1|||
147060831|NCT00042289|530386100|FG024|Overall Study|Withdrawal by Subject|0|||
147060832|NCT00042289|530386101|FG025|Overall Study|Withdrawal by Subject|0|||
147060833|NCT00042289|530386102|FG026|Overall Study|Withdrawal by Subject|1|||
147060834|NCT00042289|530386103|FG027|Overall Study|Withdrawal by Subject|0|||
147060835|NCT00042289|530386104|FG028|Overall Study|Withdrawal by Subject|2|||
147060836|NCT00042289|530386105|FG029|Overall Study|Withdrawal by Subject|0|||
147060837|NCT00042289|530386106|FG030|Overall Study|Withdrawal by Subject|0|||
147060838|NCT00042289|530386107|FG031|Overall Study|Withdrawal by Subject|1|||
147060839|NCT00042289|530386108|FG032|Overall Study|Withdrawal by Subject|2|||
147060840|NCT00042289|530386109|FG033|Overall Study|Withdrawal by Subject|1|||
147060841|NCT00042289|530386110|FG034|Overall Study|Withdrawal by Subject|0|||
147060842|NCT00042289|530386111|FG035|Overall Study|Withdrawal by Subject|0|||
147060843|NCT00042289|530386112|FG036|Overall Study|Withdrawal by Subject|0|||
147060844|NCT00042289|530386113|FG037|Overall Study|Withdrawal by Subject|1|||
147060845|NCT00042289|530386114|FG038|Overall Study|Withdrawal by Subject|0|||
147060846|NCT00042289|530386115|FG039|Overall Study|Withdrawal by Subject|0|||
147060847|NCT00042289|530386116|FG040|Overall Study|Withdrawal by Subject|0|||
147060848|NCT00042289|530386117|FG041|Overall Study|Withdrawal by Subject|0|||
147060849|NCT00042289|530386118|FG042|Overall Study|Withdrawal by Subject|1|||
147060850|NCT00042289|530386119|FG043|Overall Study|Withdrawal by Subject|0|||
147060851|NCT00042289|530386120|FG044|Overall Study|Withdrawal by Subject|0|||
147060852|NCT00042289|530386121|FG045|Overall Study|Withdrawal by Subject|0|||
147060853|NCT00042289|530386122|FG046|Overall Study|Withdrawal by Subject|0|||
147060854|NCT04588259|530386123|FG000|Run-in period|Run-in failure|0|||
147060855|NCT04588259|530386124|FG001|Run-in period|Run-in failure|23|||
147060856|NCT04588259|530386123|FG000|Run-in period|Withdrawn before randomisation|0|||
147060857|NCT04588259|530386124|FG001|Run-in period|Withdrawn before randomisation|8|||
147060858|NCT04588259|530386123|FG000|Treatment period|Withdrawal by Subject|6|||
147060859|NCT04588259|530386124|FG001|Treatment period|Withdrawal by Subject|6|||
147060860|NCT03973996|530386125|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
147060861|NCT03973996|530386126|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
147060862|NCT03973996|530386127|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
147060863|NCT03973996|530386128|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
147060864|NCT04832971|530386129|FG000|Double-Blind (DB) Treatment Period|Death|1|||
147060865|NCT04832971|530386130|FG001|Double-Blind (DB) Treatment Period|Death|0|||
147060866|NCT04832971|530386131|FG002|Double-Blind (DB) Treatment Period|Death|0|||
147060867|NCT04832971|530386132|FG003|Double-Blind (DB) Treatment Period|Death|0|||
147060868|NCT04832971|530386133|FG004|Double-Blind (DB) Treatment Period|Death|0|||
147060869|NCT04832971|530386134|FG005|Double-Blind (DB) Treatment Period|Death|0|||
147060870|NCT04832971|530386135|FG006|Double-Blind (DB) Treatment Period|Death|0|||
147060871|NCT04832971|530386136|FG007|Double-Blind (DB) Treatment Period|Death|0|||
147060872|NCT04832971|530386137|FG008|Double-Blind (DB) Treatment Period|Death|0|||
147060873|NCT04832971|530386138|FG009|Double-Blind (DB) Treatment Period|Death|0|||
146850068|NCT00911937|529620705|FG000|Overall Study|Protocol Violation|14|||
147060874|NCT04832971|530386129|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
147060875|NCT04832971|530386130|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
147060876|NCT04832971|530386131|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
147060877|NCT04832971|530386132|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147060878|NCT04832971|530386133|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147060879|NCT04832971|530386134|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147060880|NCT04832971|530386135|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147060881|NCT04832971|530386136|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147060882|NCT04832971|530386137|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147060883|NCT04832971|530386138|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147060884|NCT04832971|530386129|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
147060885|NCT04832971|530386130|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
147060886|NCT04832971|530386131|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
147060887|NCT04832971|530386132|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
147060888|NCT04832971|530386133|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147060889|NCT04832971|530386134|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147060890|NCT04832971|530386135|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147060891|NCT04832971|530386136|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147060892|NCT04832971|530386137|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147060893|NCT04832971|530386138|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147060894|NCT04832971|530386129|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147060895|NCT04832971|530386130|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
147060896|NCT04832971|530386131|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147060897|NCT04832971|530386132|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147060898|NCT04832971|530386133|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147060899|NCT04832971|530386134|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147060900|NCT04832971|530386135|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147060901|NCT04832971|530386136|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147060902|NCT04832971|530386137|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147060903|NCT04832971|530386138|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147060904|NCT04832971|530386129|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
147060905|NCT04832971|530386130|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
147060906|NCT04832971|530386131|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
147060907|NCT04832971|530386132|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
147060908|NCT04832971|530386133|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
147060909|NCT04832971|530386134|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
147060910|NCT04832971|530386135|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
147060911|NCT04832971|530386136|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
147060912|NCT04832971|530386137|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
147060913|NCT04832971|530386138|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
147060914|NCT04832971|530386129|FG000|Open-Label Extension (OLE) Period|Death|0|||
147060915|NCT04832971|530386130|FG001|Open-Label Extension (OLE) Period|Death|0|||
147060916|NCT04832971|530386131|FG002|Open-Label Extension (OLE) Period|Death|0|||
147060917|NCT04832971|530386132|FG003|Open-Label Extension (OLE) Period|Death|0|||
147060918|NCT04832971|530386133|FG004|Open-Label Extension (OLE) Period|Death|0|||
147060919|NCT04832971|530386134|FG005|Open-Label Extension (OLE) Period|Death|0|||
147060920|NCT04832971|530386135|FG006|Open-Label Extension (OLE) Period|Death|0|||
147060921|NCT04832971|530386136|FG007|Open-Label Extension (OLE) Period|Death|1|||
147060922|NCT04832971|530386137|FG008|Open-Label Extension (OLE) Period|Death|0|||
147060923|NCT04832971|530386138|FG009|Open-Label Extension (OLE) Period|Death|0|||
147060924|NCT04832971|530386129|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147060925|NCT04832971|530386130|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147060926|NCT04832971|530386131|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147060927|NCT04832971|530386132|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147060928|NCT04832971|530386133|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147060929|NCT04832971|530386134|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147060930|NCT04832971|530386135|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
147060931|NCT04832971|530386136|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
147060932|NCT04832971|530386137|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147060933|NCT04832971|530386138|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147060934|NCT04832971|530386129|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
147060935|NCT04832971|530386130|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
147060936|NCT04832971|530386131|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
147060937|NCT04832971|530386132|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
147060938|NCT04832971|530386133|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
147060939|NCT04832971|530386134|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
147060940|NCT04832971|530386135|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
147060941|NCT04832971|530386136|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
147060942|NCT04832971|530386137|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
147060943|NCT04832971|530386138|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
147060944|NCT04832971|530386129|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147060945|NCT04832971|530386130|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147060946|NCT04832971|530386131|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147060947|NCT04832971|530386132|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147060948|NCT04832971|530386133|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
147060949|NCT04832971|530386134|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
147060950|NCT04832971|530386135|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147060951|NCT04832971|530386136|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
147060952|NCT04832971|530386137|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
147060953|NCT04832971|530386138|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
147060954|NCT04832971|530386129|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
147060955|NCT04832971|530386130|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
147060956|NCT04832971|530386131|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
147060957|NCT04832971|530386132|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
147060958|NCT04832971|530386133|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
147060959|NCT04832971|530386134|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
147060960|NCT04832971|530386135|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
147060961|NCT04832971|530386136|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
147060962|NCT04832971|530386137|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
147060963|NCT04832971|530386138|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
147060964|NCT04460885|530386139|FG000|Overall Study|Withdrawal by Subject|6|||
147060965|NCT04460885|530386140|FG001|Overall Study|Withdrawal by Subject|8|||
147060966|NCT04460885|530386139|FG000|Overall Study|Site closure|1|||
147060967|NCT04460885|530386140|FG001|Overall Study|Site closure|0|||
147060968|NCT04460885|530386139|FG000|Overall Study|Death|5|||
147060969|NCT04460885|530386140|FG001|Overall Study|Death|4|||
147060970|NCT04460885|530386139|FG000|Overall Study|Physician Decision|2|||
147060971|NCT04460885|530386140|FG001|Overall Study|Physician Decision|1|||
147060972|NCT04460885|530386139|FG000|Overall Study|Lost to Follow-up|4|||
147060973|NCT04460885|530386140|FG001|Overall Study|Lost to Follow-up|4|||
147060974|NCT01920932|530386144|FG000|Overall Study|Death|1|||
147060975|NCT01920932|530386144|FG000|Overall Study|Withdrawal of consent|1|||
147060976|NCT04974047|530386148|FG000|Overall Study|Sponsor Ended Study|20|||
147060977|NCT04974047|530386149|FG001|Overall Study|Sponsor Ended Study|22|||
147060978|NCT04974047|530386148|FG000|Overall Study|Death|8|||
147060979|NCT04974047|530386149|FG001|Overall Study|Death|17|||
147060980|NCT04974047|530386148|FG000|Overall Study|Lost to Follow-up|2|||
147060981|NCT04974047|530386149|FG001|Overall Study|Lost to Follow-up|0|||
147060982|NCT04974047|530386148|FG000|Overall Study|Withdrawal by Subject|0|||
147060983|NCT04974047|530386149|FG001|Overall Study|Withdrawal by Subject|1|||
147060984|NCT03391466|530386150|FG000|Overall Study|Death|84|||
147060985|NCT03391466|530386151|FG001|Overall Study|Death|91|||
147060986|NCT03391466|530386150|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
147060987|NCT03391466|530386151|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
147060988|NCT03391466|530386150|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
147060989|NCT03391466|530386151|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
147060990|NCT03391466|530386150|FG000|Overall Study|Lost to Follow-up|9|||
147060991|NCT03391466|530386151|FG001|Overall Study|Lost to Follow-up|5|||
147060992|NCT03391466|530386150|FG000|Overall Study|Reason Not Specified|2|||
147060993|NCT03391466|530386151|FG001|Overall Study|Reason Not Specified|2|||
147060994|NCT03391466|530386150|FG000|Overall Study|Investigator Decision|0|||
147060995|NCT03391466|530386151|FG001|Overall Study|Investigator Decision|1|||
147060996|NCT03584152|530386154|FG000|Overall Study|Discontinued intervention|7|||
147060997|NCT03584152|530386155|FG001|Overall Study|Discontinued intervention|4|||
147060998|NCT04024462|530386156|FG000|Overall Study|Withdrawal by Subject|6|||
147060999|NCT04024462|530386157|FG001|Overall Study|Withdrawal by Subject|7|||
147061000|NCT04024462|530386156|FG000|Overall Study|Progressive Disease|0|||
147061001|NCT04024462|530386157|FG001|Overall Study|Progressive Disease|1|||
147061002|NCT04024462|530386156|FG000|Overall Study|Adverse Event|0|||
147061003|NCT04024462|530386157|FG001|Overall Study|Adverse Event|1|||
147061004|NCT04024462|530386156|FG000|Overall Study|Death|0|||
147061005|NCT04024462|530386157|FG001|Overall Study|Death|1|||
147061006|NCT04024462|530386156|FG000|Overall Study|Lost to Follow-up|1|||
147061007|NCT04024462|530386157|FG001|Overall Study|Lost to Follow-up|0|||
147061008|NCT04024462|530386156|FG000|Overall Study|Ongoing in the Study|94|||
147061009|NCT04024462|530386157|FG001|Overall Study|Ongoing in the Study|89|||
147061010|NCT03055013|530386161|FG000|Overall Study|Adverse Event|78|||
147061011|NCT03055013|530386162|FG001|Overall Study|Adverse Event|0|||
147061012|NCT03055013|530386161|FG000|Overall Study|Death|6|||
147061013|NCT03055013|530386162|FG001|Overall Study|Death|0|||
147061014|NCT03055013|530386161|FG000|Overall Study|Disease relapse|33|||
147061015|NCT03055013|530386162|FG001|Overall Study|Disease relapse|0|||
147061016|NCT03055013|530386161|FG000|Overall Study|Withdrawal by Subject|28|||
147061017|NCT03055013|530386162|FG001|Overall Study|Withdrawal by Subject|0|||
147061018|NCT03055013|530386161|FG000|Overall Study|Other complicating disease|5|||
147061019|NCT03055013|530386162|FG001|Overall Study|Other complicating disease|0|||
147061020|NCT03055013|530386161|FG000|Overall Study|Physician Decision|1|||
147061021|NCT03055013|530386162|FG001|Overall Study|Physician Decision|0|||
147061022|NCT03055013|530386161|FG000|Overall Study|Benign mass/non-RCC|4|||
147061023|NCT03055013|530386162|FG001|Overall Study|Benign mass/non-RCC|0|||
147061024|NCT03055013|530386161|FG000|Overall Study|Enrolled in another trial|1|||
147061025|NCT03055013|530386162|FG001|Overall Study|Enrolled in another trial|0|||
147061026|NCT03055013|530386161|FG000|Overall Study|Non-protocol therapy|1|||
147061027|NCT03055013|530386162|FG001|Overall Study|Non-protocol therapy|0|||
147061028|NCT03055013|530386161|FG000|Overall Study|Incompliance|1|||
147061029|NCT03055013|530386162|FG001|Overall Study|Incompliance|0|||
147061030|NCT03055013|530386161|FG000|Overall Study|Insurance issues|1|||
147061031|NCT03055013|530386162|FG001|Overall Study|Insurance issues|0|||
147061032|NCT03055013|530386161|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
147061033|NCT03055013|530386162|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
147061034|NCT03055013|530386161|FG000|Overall Study|Did not receive nivolumab|10|||
147061035|NCT03055013|530386162|FG001|Overall Study|Did not receive nivolumab|0|||
147061036|NCT03055013|530386161|FG000|Overall Study|Did not receive surgery|0|||
147061037|NCT03055013|530386162|FG001|Overall Study|Did not receive surgery|28|||
147061038|NCT02502266|530386163|FG000|Overall Study|Adverse Event|0|||
147061039|NCT02502266|530386164|FG001|Overall Study|Adverse Event|0|||
147061040|NCT02502266|530386165|FG002|Overall Study|Adverse Event|0|||
147061041|NCT02502266|530386166|FG003|Overall Study|Adverse Event|0|||
147061042|NCT02502266|530386167|FG004|Overall Study|Adverse Event|1|||
147061043|NCT02502266|530386168|FG005|Overall Study|Adverse Event|1|||
147061044|NCT02502266|530386169|FG006|Overall Study|Adverse Event|1|||
147061045|NCT02502266|530386163|FG000|Overall Study|Withdrawal by Subject|30|||
147061046|NCT02502266|530386164|FG001|Overall Study|Withdrawal by Subject|15|||
147061047|NCT02502266|530386165|FG002|Overall Study|Withdrawal by Subject|16|||
147061048|NCT02502266|530386166|FG003|Overall Study|Withdrawal by Subject|0|||
147061049|NCT02502266|530386167|FG004|Overall Study|Withdrawal by Subject|0|||
147061050|NCT02502266|530386168|FG005|Overall Study|Withdrawal by Subject|0|||
147061051|NCT02502266|530386169|FG006|Overall Study|Withdrawal by Subject|0|||
147061052|NCT02502266|530386163|FG000|Overall Study|Still on Treatment|0|||
147061053|NCT02502266|530386164|FG001|Overall Study|Still on Treatment|0|||
147061054|NCT02502266|530386165|FG002|Overall Study|Still on Treatment|1|||
147061055|NCT02502266|530386166|FG003|Overall Study|Still on Treatment|0|||
147061056|NCT02502266|530386167|FG004|Overall Study|Still on Treatment|0|||
147061057|NCT02502266|530386168|FG005|Overall Study|Still on Treatment|0|||
147061058|NCT02502266|530386169|FG006|Overall Study|Still on Treatment|0|||
147061059|NCT02502266|530386163|FG000|Overall Study|Other Reasons|19|||
147061060|NCT02502266|530386164|FG001|Overall Study|Other Reasons|6|||
147061061|NCT02502266|530386165|FG002|Overall Study|Other Reasons|14|||
147061062|NCT02502266|530386166|FG003|Overall Study|Other Reasons|0|||
147061063|NCT02502266|530386167|FG004|Overall Study|Other Reasons|1|||
147061064|NCT02502266|530386168|FG005|Overall Study|Other Reasons|1|||
147061065|NCT02502266|530386169|FG006|Overall Study|Other Reasons|0|||
147061066|NCT02502266|530386163|FG000|Overall Study|Arm 4 Discontinued|0|||
147061067|NCT02502266|530386164|FG001|Overall Study|Arm 4 Discontinued|0|||
147061068|NCT02502266|530386165|FG002|Overall Study|Arm 4 Discontinued|0|||
147061069|NCT02502266|530386166|FG003|Overall Study|Arm 4 Discontinued|52|||
147061070|NCT02502266|530386167|FG004|Overall Study|Arm 4 Discontinued|0|||
147061071|NCT02502266|530386168|FG005|Overall Study|Arm 4 Discontinued|0|||
147061072|NCT02502266|530386169|FG006|Overall Study|Arm 4 Discontinued|0|||
147061073|NCT02502266|530386163|FG000|Overall Study|Never treated|0|||
147061074|NCT02502266|530386164|FG001|Overall Study|Never treated|0|||
147061075|NCT02502266|530386165|FG002|Overall Study|Never treated|0|||
147061076|NCT02502266|530386166|FG003|Overall Study|Never treated|0|||
147061077|NCT02502266|530386167|FG004|Overall Study|Never treated|0|||
147061078|NCT02502266|530386168|FG005|Overall Study|Never treated|1|||
147061079|NCT02502266|530386169|FG006|Overall Study|Never treated|0|||
147061080|NCT03466346|530386170|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
147061081|NCT03466346|530386171|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
147061082|NCT03466346|530386172|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
147061083|NCT03466346|530386173|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
147061084|NCT03466346|530386174|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
147061085|NCT03466346|530386170|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
147061086|NCT03466346|530386171|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
147061087|NCT03466346|530386172|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
147061088|NCT03466346|530386173|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
147061089|NCT03466346|530386174|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
147061090|NCT03466346|530386170|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
147061091|NCT03466346|530386171|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
147061092|NCT03466346|530386172|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
147061093|NCT03466346|530386173|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
147061094|NCT03466346|530386174|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
147061095|NCT03466346|530386170|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
147061096|NCT03466346|530386171|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
147061097|NCT03466346|530386172|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
147061098|NCT03466346|530386173|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
147061099|NCT03466346|530386174|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
147061100|NCT03466346|530386170|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
147061101|NCT03466346|530386171|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
147061102|NCT03466346|530386172|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
147061103|NCT03466346|530386173|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
147061104|NCT03466346|530386174|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
147061105|NCT03466346|530386170|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
147061106|NCT03466346|530386171|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
147061107|NCT03466346|530386172|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
147061108|NCT03466346|530386173|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
147061109|NCT03466346|530386174|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
147061110|NCT03466346|530386170|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
147061111|NCT03466346|530386171|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
147061112|NCT03466346|530386172|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
147061113|NCT03466346|530386173|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
147061114|NCT03466346|530386174|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
147061115|NCT00433511|530386183|FG000|Step 1|Adverse Event|50|||
147061116|NCT00433511|530386184|FG001|Step 1|Adverse Event|157|||
147061117|NCT00433511|530386185|FG002|Step 1|Adverse Event|153|||
147061118|NCT00433511|530386183|FG000|Step 1|Withdrawal by Subject|45|||
147061119|NCT00433511|530386184|FG001|Step 1|Withdrawal by Subject|143|||
147061120|NCT00433511|530386185|FG002|Step 1|Withdrawal by Subject|154|||
147061121|NCT00433511|530386183|FG000|Step 1|Death|3|||
147061122|NCT00433511|530386184|FG001|Step 1|Death|1|||
147061123|NCT00433511|530386185|FG002|Step 1|Death|1|||
147061124|NCT00433511|530386183|FG000|Step 1|Physician Decision|1|||
147061125|NCT00433511|530386184|FG001|Step 1|Physician Decision|4|||
147061126|NCT00433511|530386185|FG002|Step 1|Physician Decision|3|||
147061127|NCT00433511|530386183|FG000|Step 1|Never started protocol therapy|28|||
147061128|NCT00433511|530386184|FG001|Step 1|Never started protocol therapy|64|||
147061129|NCT00433511|530386185|FG002|Step 1|Never started protocol therapy|66|||
147061130|NCT00433511|530386183|FG000|Step 1|Alternative therapy|2|||
147061131|NCT00433511|530386184|FG001|Step 1|Alternative therapy|1|||
147061132|NCT00433511|530386185|FG002|Step 1|Alternative therapy|3|||
147061133|NCT00433511|530386183|FG000|Step 1|Disease progression, relapse|5|||
147061134|NCT00433511|530386184|FG001|Step 1|Disease progression, relapse|3|||
147061135|NCT00433511|530386185|FG002|Step 1|Disease progression, relapse|3|||
147061136|NCT00433511|530386183|FG000|Step 1|Other complicating disease|2|||
147061137|NCT00433511|530386184|FG001|Step 1|Other complicating disease|6|||
147061138|NCT00433511|530386185|FG002|Step 1|Other complicating disease|3|||
147061139|NCT00433511|530386183|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
147061140|NCT00433511|530386184|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
147061141|NCT00433511|530386185|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
147061142|NCT00433511|530386183|FG000|Step 1|Suspected recurrence|0|||
147061143|NCT00433511|530386184|FG001|Step 1|Suspected recurrence|1|||
147061144|NCT00433511|530386185|FG002|Step 1|Suspected recurrence|0|||
147061145|NCT00433511|530386183|FG000|Step 1|Insurance/drug distribution issues|0|||
147061146|NCT00433511|530386184|FG001|Step 1|Insurance/drug distribution issues|1|||
147061147|NCT00433511|530386185|FG002|Step 1|Insurance/drug distribution issues|2|||
147061148|NCT00433511|530386183|FG000|Step 1|Patient moved|0|||
147061149|NCT00433511|530386184|FG001|Step 1|Patient moved|0|||
147061150|NCT00433511|530386185|FG002|Step 1|Patient moved|1|||
147061151|NCT00433511|530386183|FG000|Step 2 (Arm D)|Adverse Event|0|||
147061152|NCT00433511|530386184|FG001|Step 2 (Arm D)|Adverse Event|0|||
147061153|NCT00433511|530386185|FG002|Step 2 (Arm D)|Adverse Event|135|||
147061154|NCT00433511|530386183|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
147061155|NCT00433511|530386184|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
147061156|NCT00433511|530386185|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
147061157|NCT00433511|530386183|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
147061158|NCT00433511|530386184|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
147061159|NCT00433511|530386185|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
147061160|NCT00433511|530386183|FG000|Step 2 (Arm D)|Physician Decision|0|||
147061161|NCT00433511|530386184|FG001|Step 2 (Arm D)|Physician Decision|0|||
147061162|NCT00433511|530386185|FG002|Step 2 (Arm D)|Physician Decision|9|||
147061163|NCT00433511|530386183|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
147061164|NCT00433511|530386184|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
147061165|NCT00433511|530386185|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
147061166|NCT00433511|530386183|FG000|Step 2 (Arm D)|Other complicating disease|0|||
147061167|NCT00433511|530386184|FG001|Step 2 (Arm D)|Other complicating disease|0|||
147061168|NCT00433511|530386185|FG002|Step 2 (Arm D)|Other complicating disease|3|||
147061169|NCT00433511|530386183|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
147061170|NCT00433511|530386184|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
147061171|NCT00433511|530386185|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
147061172|NCT00433511|530386183|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
147061173|NCT00433511|530386184|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
147061174|NCT00433511|530386185|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
147061175|NCT00433511|530386183|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
147061176|NCT00433511|530386184|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
147061177|NCT00433511|530386185|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
147061178|NCT00433511|530386183|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
147061179|NCT00433511|530386184|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
147061180|NCT00433511|530386185|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
147061181|NCT05274750|530386186|FG000|Overall Study|Adverse Event|0|||
147061182|NCT05274750|530386187|FG001|Overall Study|Adverse Event|1|||
147061183|NCT05274750|530386186|FG000|Overall Study|Lost to Follow-up|2|||
147061184|NCT05274750|530386187|FG001|Overall Study|Lost to Follow-up|3|||
147061185|NCT05274750|530386186|FG000|Overall Study|Physician Decision|3|||
147061186|NCT05274750|530386187|FG001|Overall Study|Physician Decision|0|||
147061187|NCT05274750|530386186|FG000|Overall Study|Withdrawal by Subject|10|||
147061188|NCT05274750|530386187|FG001|Overall Study|Withdrawal by Subject|9|||
147061189|NCT05274750|530386186|FG000|Overall Study|GCP Violation|0|||
147061190|NCT05274750|530386187|FG001|Overall Study|GCP Violation|4|||
147061191|NCT05274750|530386186|FG000|Overall Study|Randomized, not treated|0|||
147061192|NCT05274750|530386187|FG001|Overall Study|Randomized, not treated|1|||
147061193|NCT05282823|530386188|FG000|Overall Study|Withdrawal by Subject|9|||
147061194|NCT05282823|530386188|FG000|Overall Study|Adverse Event|1|||
147061195|NCT05282823|530386188|FG000|Overall Study|did not meet protocol criteria|2|||
147061196|NCT05282823|530386188|FG000|Overall Study|Withdrawal by Subject|7|||
147061197|NCT05569174|530386189|FG000|Overall Study|Adverse Event|0|||
147061198|NCT05569174|530386190|FG001|Overall Study|Adverse Event|1|||
147061199|NCT05569174|530386189|FG000|Overall Study|Lack of compliance|0|||
147061200|NCT05569174|530386190|FG001|Overall Study|Lack of compliance|1|||
147061201|NCT05569174|530386189|FG000|Overall Study|Withdrawal of consent|0|||
147061202|NCT05569174|530386190|FG001|Overall Study|Withdrawal of consent|1|||
147061203|NCT05569174|530386189|FG000|Overall Study|Participant wish|0|||
147061204|NCT05569174|530386190|FG001|Overall Study|Participant wish|1|||
147061205|NCT05569174|530386189|FG000|Overall Study|Lost to Follow-up|0|||
147061206|NCT05569174|530386190|FG001|Overall Study|Lost to Follow-up|1|||
147061207|NCT05352815|530386191|FG000|Overall Study|Withdrawal by Subject|28|||
147061208|NCT05352815|530386192|FG001|Overall Study|Withdrawal by Subject|24|||
147061209|NCT05352815|530386191|FG000|Overall Study|Lost to Follow-up|4|||
147061210|NCT05352815|530386192|FG001|Overall Study|Lost to Follow-up|7|||
147061211|NCT05352815|530386191|FG000|Overall Study|Death|2|||
147061212|NCT05352815|530386192|FG001|Overall Study|Death|3|||
147061213|NCT05352815|530386191|FG000|Overall Study|Site closure|1|||
147061214|NCT05352815|530386192|FG001|Overall Study|Site closure|0|||
147061215|NCT04328623|530386197|FG000|Overall Study|Protocol Violation|0|||
147061216|NCT04328623|530386198|FG001|Overall Study|Protocol Violation|1|||
147061217|NCT02312557|530386202|FG000|Overall Study|Survival follow-up|4|||
147061218|NCT03895086|530386203|FG000|Overall Study|Early termination study|1|||
147061219|NCT03895086|530386204|FG001|Overall Study|Early termination study|0|||
147061220|NCT01976936|530386205|FG000|Overall Study|Did not receive at least 9 doses|9|||
147061221|NCT01976936|530386206|FG001|Overall Study|Did not receive at least 9 doses|4|||
147061222|NCT05687032|530386207|FG000|Treatment Phase|Adverse Event|13|||
147061223|NCT05687032|530386207|FG000|Treatment Phase|Death|1|||
147061224|NCT05687032|530386207|FG000|Treatment Phase|Physician Decision|3|||
147061225|NCT05687032|530386207|FG000|Treatment Phase|Progressive disease|9|||
147061226|NCT05687032|530386207|FG000|Treatment Phase|Withdrawal by Subject|5|||
146850069|NCT00911937|529620706|FG001|Overall Study|Protocol Violation|23|||
146850070|NCT00911937|529620705|FG000|Overall Study|Randomized but not treated|13|||
146850071|NCT00911937|529620706|FG001|Overall Study|Randomized but not treated|13|||
146850072|NCT00911937|529620705|FG000|Overall Study|Other|9|||
146850073|NCT00911937|529620706|FG001|Overall Study|Other|5|||
146850074|NCT00964886|529620713|FG000|Overall Study|Lost to Follow-up|2|||
147061227|NCT05687032|530386207|FG000|Follow-Up Phase|Death|16|||
147061228|NCT05687032|530386207|FG000|Follow-Up Phase|Ongoing|26|||
147061229|NCT05452239|530386208|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
147061230|NCT05452239|530386209|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
147061231|NCT05452239|530386208|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
147061232|NCT05452239|530386209|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
147061233|NCT05452239|530386208|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
147061234|NCT05452239|530386209|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
147061235|NCT05452239|530386208|FG000|Placebo-controlled Period|Randomized but not treated|2|||
147061236|NCT05452239|530386209|FG001|Placebo-controlled Period|Randomized but not treated|2|||
147061237|NCT05452239|530386208|FG000|Placebo-controlled Period|Other than specified|1|||
147061238|NCT05452239|530386209|FG001|Placebo-controlled Period|Other than specified|1|||
147061239|NCT05452239|530386208|FG000|Open-label Period|Withdrawal by Subject|2|||
147061240|NCT05452239|530386209|FG001|Open-label Period|Withdrawal by Subject|1|||
147061241|NCT05452239|530386208|FG000|Open-label Period|Lost to Follow-up|3|||
147061242|NCT05452239|530386209|FG001|Open-label Period|Lost to Follow-up|0|||
147061243|NCT05452239|530386208|FG000|Open-label Period|Other than specified|1|||
147061244|NCT05452239|530386209|FG001|Open-label Period|Other than specified|2|||
147061245|NCT06408870|530386210|FG000|Washout period|Withdrawal by Subject|1|||
147061246|NCT06408870|530386211|FG001|Washout period|Withdrawal by Subject|0|||
147061247|NCT06408870|530386210|FG000|Washout period|Adverse Event|2|||
147061248|NCT06408870|530386211|FG001|Washout period|Adverse Event|0|||
147061249|NCT06129149|530386214|FG000|Overall Study|Death|1|||
147061250|NCT04649359|530386216|FG000|Overall Study|Withdrawal by Subject|7|||
147061251|NCT04649359|530386217|FG001|Overall Study|Withdrawal by Subject|7|||
147061252|NCT04649359|530386216|FG000|Overall Study|Death|41|||
147061253|NCT04649359|530386217|FG001|Overall Study|Death|26|||
147061254|NCT04649359|530386216|FG000|Overall Study|Ongoing in the study|75|||
147061255|NCT04649359|530386217|FG001|Overall Study|Ongoing in the study|31|||
147061256|NCT03912662|530386218|FG000|Overall Study|Adverse Event|3|||
147061257|NCT03912662|530386218|FG000|Overall Study|Adverse Event and Death|1|||
147061258|NCT03912662|530386218|FG000|Overall Study|Death|1|||
147061259|NCT03912662|530386218|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
147061260|NCT03912662|530386218|FG000|Overall Study|Mesh Removal|1|||
147061261|NCT03912662|530386218|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
147061262|NCT03912662|530386218|FG000|Overall Study|Early study termination|20|||
147061263|NCT04656652|530386221|FG000|Overall Study|Lost to Follow-up|2|||
147061264|NCT04656652|530386222|FG001|Overall Study|Lost to Follow-up|2|||
147061265|NCT04656652|530386221|FG000|Overall Study|Death|213|||
147061266|NCT04656652|530386222|FG001|Overall Study|Death|212|||
147061267|NCT04656652|530386221|FG000|Overall Study|Other|1|||
147061268|NCT04656652|530386222|FG001|Overall Study|Other|0|||
147061269|NCT04656652|530386221|FG000|Overall Study|Withdrawal by Subject|15|||
147061270|NCT04656652|530386222|FG001|Overall Study|Withdrawal by Subject|29|||
147061271|NCT01385176|530386232|FG000|Randomization Phase|Death|1|||
147061272|NCT01385176|530386233|FG001|Randomization Phase|Death|2|||
147061273|NCT01385176|530386232|FG000|6-18 Month All VNS Active|Death|1|||
147061274|NCT01385176|530386233|FG001|6-18 Month All VNS Active|Death|2|||
147061275|NCT01385176|530386232|FG000|6-18 Month All VNS Active|Physician Decision|0|||
147061276|NCT01385176|530386233|FG001|6-18 Month All VNS Active|Physician Decision|1|||
147061277|NCT01385176|530386232|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
147061278|NCT01385176|530386233|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
147061279|NCT01385176|530386232|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
147061280|NCT01385176|530386233|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
147061281|NCT02306161|530386234|FG000|Overall Study|Death|1|||
147061282|NCT02306161|530386235|FG001|Overall Study|Death|3|||
147061283|NCT02306161|530386234|FG000|Overall Study|Lack of Efficacy|20|||
147061284|NCT02306161|530386235|FG001|Overall Study|Lack of Efficacy|43|||
147061285|NCT02306161|530386234|FG000|Overall Study|Physician Decision|30|||
147061286|NCT02306161|530386235|FG001|Overall Study|Physician Decision|18|||
147061287|NCT02306161|530386234|FG000|Overall Study|Withdrawal by Subject|4|||
147061288|NCT02306161|530386235|FG001|Overall Study|Withdrawal by Subject|0|||
147061289|NCT02306161|530386234|FG000|Overall Study|Ineligible|9|||
147061290|NCT02306161|530386235|FG001|Overall Study|Ineligible|5|||
147061291|NCT05911841|530386236|FG000|Induction Period|Study Terminated by Sponsor|2|||
147061292|NCT05911841|530386237|FG001|Induction Period|Study Terminated by Sponsor|0|||
147061293|NCT05911841|530386238|FG002|Induction Period|Study Terminated by Sponsor|14|||
147061294|NCT05911841|530386239|FG003|Induction Period|Study Terminated by Sponsor|6|||
147061295|NCT05911841|530386240|FG004|Induction Period|Study Terminated by Sponsor|0|||
147061296|NCT05911841|530386241|FG005|Induction Period|Study Terminated by Sponsor|0|||
147061297|NCT05911841|530386242|FG006|Induction Period|Study Terminated by Sponsor|0|||
147061298|NCT05911841|530386243|FG007|Induction Period|Study Terminated by Sponsor|0|||
147061299|NCT05911841|530386244|FG008|Induction Period|Study Terminated by Sponsor|0|||
147061300|NCT05911841|530386245|FG009|Induction Period|Study Terminated by Sponsor|0|||
147061301|NCT05911841|530386236|FG000|Induction Period|Withdrawal by Subject|4|||
147061302|NCT05911841|530386237|FG001|Induction Period|Withdrawal by Subject|3|||
147061303|NCT05911841|530386238|FG002|Induction Period|Withdrawal by Subject|4|||
147061304|NCT05911841|530386239|FG003|Induction Period|Withdrawal by Subject|6|||
147061305|NCT05911841|530386240|FG004|Induction Period|Withdrawal by Subject|0|||
147061306|NCT05911841|530386241|FG005|Induction Period|Withdrawal by Subject|0|||
147061307|NCT05911841|530386242|FG006|Induction Period|Withdrawal by Subject|0|||
147061308|NCT05911841|530386243|FG007|Induction Period|Withdrawal by Subject|0|||
147061309|NCT05911841|530386244|FG008|Induction Period|Withdrawal by Subject|0|||
147061310|NCT05911841|530386245|FG009|Induction Period|Withdrawal by Subject|0|||
147061311|NCT05911841|530386236|FG000|Induction Period|Lack of Efficacy|3|||
146850075|NCT00964886|529620714|FG001|Overall Study|Lost to Follow-up|2|||
147061312|NCT05911841|530386237|FG001|Induction Period|Lack of Efficacy|0|||
147061313|NCT05911841|530386238|FG002|Induction Period|Lack of Efficacy|3|||
147061314|NCT05911841|530386239|FG003|Induction Period|Lack of Efficacy|3|||
147061315|NCT05911841|530386240|FG004|Induction Period|Lack of Efficacy|0|||
147061316|NCT05911841|530386241|FG005|Induction Period|Lack of Efficacy|0|||
147061317|NCT05911841|530386242|FG006|Induction Period|Lack of Efficacy|0|||
147061318|NCT05911841|530386243|FG007|Induction Period|Lack of Efficacy|0|||
147061319|NCT05911841|530386244|FG008|Induction Period|Lack of Efficacy|0|||
147061320|NCT05911841|530386245|FG009|Induction Period|Lack of Efficacy|0|||
147061321|NCT05911841|530386236|FG000|Induction Period|Adverse Event|3|||
147061322|NCT05911841|530386237|FG001|Induction Period|Adverse Event|1|||
147061323|NCT05911841|530386238|FG002|Induction Period|Adverse Event|2|||
147061324|NCT05911841|530386239|FG003|Induction Period|Adverse Event|0|||
147061325|NCT05911841|530386240|FG004|Induction Period|Adverse Event|0|||
147061326|NCT05911841|530386241|FG005|Induction Period|Adverse Event|0|||
147061327|NCT05911841|530386242|FG006|Induction Period|Adverse Event|0|||
147061328|NCT05911841|530386243|FG007|Induction Period|Adverse Event|0|||
147061329|NCT05911841|530386244|FG008|Induction Period|Adverse Event|0|||
147061330|NCT05911841|530386245|FG009|Induction Period|Adverse Event|0|||
147061331|NCT05911841|530386236|FG000|Induction Period|Assigned Treatment by Mistake|0|||
147061332|NCT05911841|530386237|FG001|Induction Period|Assigned Treatment by Mistake|1|||
147061333|NCT05911841|530386238|FG002|Induction Period|Assigned Treatment by Mistake|0|||
147061334|NCT05911841|530386239|FG003|Induction Period|Assigned Treatment by Mistake|1|||
147061335|NCT05911841|530386240|FG004|Induction Period|Assigned Treatment by Mistake|0|||
147061336|NCT05911841|530386241|FG005|Induction Period|Assigned Treatment by Mistake|0|||
147061337|NCT05911841|530386242|FG006|Induction Period|Assigned Treatment by Mistake|0|||
147061338|NCT05911841|530386243|FG007|Induction Period|Assigned Treatment by Mistake|0|||
147061339|NCT05911841|530386244|FG008|Induction Period|Assigned Treatment by Mistake|0|||
147061340|NCT05911841|530386245|FG009|Induction Period|Assigned Treatment by Mistake|0|||
147061341|NCT05911841|530386236|FG000|Induction Period|Lost to Follow-up|0|||
147061342|NCT05911841|530386237|FG001|Induction Period|Lost to Follow-up|0|||
147061343|NCT05911841|530386238|FG002|Induction Period|Lost to Follow-up|1|||
147061344|NCT05911841|530386239|FG003|Induction Period|Lost to Follow-up|1|||
147061345|NCT05911841|530386240|FG004|Induction Period|Lost to Follow-up|0|||
147061346|NCT05911841|530386241|FG005|Induction Period|Lost to Follow-up|0|||
147061347|NCT05911841|530386242|FG006|Induction Period|Lost to Follow-up|0|||
147061348|NCT05911841|530386243|FG007|Induction Period|Lost to Follow-up|0|||
147061349|NCT05911841|530386244|FG008|Induction Period|Lost to Follow-up|0|||
147061350|NCT05911841|530386245|FG009|Induction Period|Lost to Follow-up|0|||
147061351|NCT05911841|530386236|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
147061352|NCT05911841|530386237|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
147061353|NCT05911841|530386238|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
147061354|NCT05911841|530386239|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
147061355|NCT05911841|530386240|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
147061356|NCT05911841|530386241|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
147061357|NCT05911841|530386242|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
147061358|NCT05911841|530386243|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
147061359|NCT05911841|530386244|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
147061360|NCT05911841|530386245|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
147061361|NCT05911841|530386236|FG000|Maintenance Period|Lack of Efficacy|0|||
147061362|NCT05911841|530386237|FG001|Maintenance Period|Lack of Efficacy|0|||
147061363|NCT05911841|530386238|FG002|Maintenance Period|Lack of Efficacy|0|||
147061364|NCT05911841|530386239|FG003|Maintenance Period|Lack of Efficacy|0|||
147061365|NCT05911841|530386240|FG004|Maintenance Period|Lack of Efficacy|1|||
147061366|NCT05911841|530386241|FG005|Maintenance Period|Lack of Efficacy|0|||
147061367|NCT05911841|530386242|FG006|Maintenance Period|Lack of Efficacy|1|||
147061368|NCT05911841|530386243|FG007|Maintenance Period|Lack of Efficacy|0|||
147061369|NCT05911841|530386244|FG008|Maintenance Period|Lack of Efficacy|0|||
147061370|NCT05911841|530386245|FG009|Maintenance Period|Lack of Efficacy|0|||
147061371|NCT05911841|530386236|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
147061372|NCT05911841|530386237|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
147061373|NCT05911841|530386238|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
147061374|NCT05911841|530386239|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
147061375|NCT05911841|530386240|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
147061376|NCT05911841|530386241|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
147061377|NCT05911841|530386242|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
147061378|NCT05911841|530386243|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
147061379|NCT05911841|530386244|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
147061380|NCT05911841|530386245|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
147061381|NCT05911841|530386236|FG000|Maintenance Period|Withdrawal by Subject|0|||
147061382|NCT05911841|530386237|FG001|Maintenance Period|Withdrawal by Subject|0|||
147061383|NCT05911841|530386238|FG002|Maintenance Period|Withdrawal by Subject|0|||
147061384|NCT05911841|530386239|FG003|Maintenance Period|Withdrawal by Subject|0|||
147061385|NCT05911841|530386240|FG004|Maintenance Period|Withdrawal by Subject|0|||
147061386|NCT05911841|530386241|FG005|Maintenance Period|Withdrawal by Subject|1|||
147061387|NCT05911841|530386242|FG006|Maintenance Period|Withdrawal by Subject|0|||
147061388|NCT05911841|530386243|FG007|Maintenance Period|Withdrawal by Subject|1|||
147061389|NCT05911841|530386244|FG008|Maintenance Period|Withdrawal by Subject|0|||
147061390|NCT05911841|530386245|FG009|Maintenance Period|Withdrawal by Subject|0|||
147061391|NCT05911841|530386236|FG000|Maintenance Period|Adverse Event|0|||
147061392|NCT05911841|530386237|FG001|Maintenance Period|Adverse Event|0|||
147061393|NCT05911841|530386238|FG002|Maintenance Period|Adverse Event|0|||
147061394|NCT05911841|530386239|FG003|Maintenance Period|Adverse Event|0|||
147061395|NCT05911841|530386240|FG004|Maintenance Period|Adverse Event|0|||
147061396|NCT05911841|530386241|FG005|Maintenance Period|Adverse Event|0|||
147061397|NCT05911841|530386242|FG006|Maintenance Period|Adverse Event|0|||
147061398|NCT05911841|530386243|FG007|Maintenance Period|Adverse Event|1|||
147061399|NCT05911841|530386244|FG008|Maintenance Period|Adverse Event|0|||
147061400|NCT05911841|530386245|FG009|Maintenance Period|Adverse Event|0|||
147061401|NCT05911841|530386236|FG000|Escape Period|Adverse Event|0|||
147061402|NCT05911841|530386237|FG001|Escape Period|Adverse Event|0|||
147061403|NCT05911841|530386238|FG002|Escape Period|Adverse Event|0|||
147061404|NCT05911841|530386239|FG003|Escape Period|Adverse Event|0|||
147061405|NCT05911841|530386240|FG004|Escape Period|Adverse Event|0|||
147061406|NCT05911841|530386241|FG005|Escape Period|Adverse Event|0|||
147061407|NCT05911841|530386242|FG006|Escape Period|Adverse Event|0|||
147061408|NCT05911841|530386243|FG007|Escape Period|Adverse Event|0|||
147061409|NCT05911841|530386244|FG008|Escape Period|Adverse Event|0|||
147061410|NCT05911841|530386245|FG009|Escape Period|Adverse Event|1|||
147061411|NCT05911841|530386236|FG000|Escape Period|Lack of Efficacy|0|||
147061412|NCT05911841|530386237|FG001|Escape Period|Lack of Efficacy|0|||
147061413|NCT05911841|530386238|FG002|Escape Period|Lack of Efficacy|0|||
147061414|NCT05911841|530386239|FG003|Escape Period|Lack of Efficacy|0|||
147061415|NCT05911841|530386240|FG004|Escape Period|Lack of Efficacy|0|||
147061416|NCT05911841|530386241|FG005|Escape Period|Lack of Efficacy|0|||
147061417|NCT05911841|530386242|FG006|Escape Period|Lack of Efficacy|0|||
147061418|NCT05911841|530386243|FG007|Escape Period|Lack of Efficacy|0|||
147061419|NCT05911841|530386244|FG008|Escape Period|Lack of Efficacy|0|||
147061420|NCT05911841|530386245|FG009|Escape Period|Lack of Efficacy|31|||
147061421|NCT05911841|530386236|FG000|Escape Period|Lost to Follow-up|0|||
147061422|NCT05911841|530386237|FG001|Escape Period|Lost to Follow-up|0|||
147061423|NCT05911841|530386238|FG002|Escape Period|Lost to Follow-up|0|||
147061424|NCT05911841|530386239|FG003|Escape Period|Lost to Follow-up|0|||
147061425|NCT05911841|530386240|FG004|Escape Period|Lost to Follow-up|0|||
147061426|NCT05911841|530386241|FG005|Escape Period|Lost to Follow-up|0|||
147061427|NCT05911841|530386242|FG006|Escape Period|Lost to Follow-up|0|||
147061428|NCT05911841|530386243|FG007|Escape Period|Lost to Follow-up|0|||
147061429|NCT05911841|530386244|FG008|Escape Period|Lost to Follow-up|0|||
147061430|NCT05911841|530386245|FG009|Escape Period|Lost to Follow-up|1|||
147061431|NCT05911841|530386236|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147061432|NCT05911841|530386237|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147061433|NCT05911841|530386238|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147061434|NCT05911841|530386239|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147061435|NCT05911841|530386240|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147061436|NCT05911841|530386241|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147061437|NCT05911841|530386242|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147061438|NCT05911841|530386243|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147061439|NCT05911841|530386244|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147061440|NCT05911841|530386245|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
147061441|NCT05911841|530386236|FG000|Escape Period|Site Terminated by Sponsor|0|||
147061442|NCT05911841|530386237|FG001|Escape Period|Site Terminated by Sponsor|0|||
147061443|NCT05911841|530386238|FG002|Escape Period|Site Terminated by Sponsor|0|||
147061444|NCT05911841|530386239|FG003|Escape Period|Site Terminated by Sponsor|0|||
147061445|NCT05911841|530386240|FG004|Escape Period|Site Terminated by Sponsor|0|||
147061446|NCT05911841|530386241|FG005|Escape Period|Site Terminated by Sponsor|0|||
147061447|NCT05911841|530386242|FG006|Escape Period|Site Terminated by Sponsor|0|||
147061448|NCT05911841|530386243|FG007|Escape Period|Site Terminated by Sponsor|0|||
147061449|NCT05911841|530386244|FG008|Escape Period|Site Terminated by Sponsor|0|||
147061450|NCT05911841|530386245|FG009|Escape Period|Site Terminated by Sponsor|1|||
147061451|NCT05911841|530386236|FG000|Escape Period|Study Terminated by Sponsor|0|||
147061452|NCT05911841|530386237|FG001|Escape Period|Study Terminated by Sponsor|0|||
147061453|NCT05911841|530386238|FG002|Escape Period|Study Terminated by Sponsor|0|||
147061454|NCT05911841|530386239|FG003|Escape Period|Study Terminated by Sponsor|0|||
147061455|NCT05911841|530386240|FG004|Escape Period|Study Terminated by Sponsor|0|||
147061456|NCT05911841|530386241|FG005|Escape Period|Study Terminated by Sponsor|0|||
147061457|NCT05911841|530386242|FG006|Escape Period|Study Terminated by Sponsor|0|||
147061458|NCT05911841|530386243|FG007|Escape Period|Study Terminated by Sponsor|0|||
147061459|NCT05911841|530386244|FG008|Escape Period|Study Terminated by Sponsor|0|||
147061460|NCT05911841|530386245|FG009|Escape Period|Study Terminated by Sponsor|34|||
147061461|NCT05911841|530386236|FG000|Escape Period|Withdrawal by Subject|0|||
147061462|NCT05911841|530386237|FG001|Escape Period|Withdrawal by Subject|0|||
147061463|NCT05911841|530386238|FG002|Escape Period|Withdrawal by Subject|0|||
147061464|NCT05911841|530386239|FG003|Escape Period|Withdrawal by Subject|0|||
147061465|NCT05911841|530386240|FG004|Escape Period|Withdrawal by Subject|0|||
147061466|NCT05911841|530386241|FG005|Escape Period|Withdrawal by Subject|0|||
147061467|NCT05911841|530386242|FG006|Escape Period|Withdrawal by Subject|0|||
147061468|NCT05911841|530386243|FG007|Escape Period|Withdrawal by Subject|0|||
147061469|NCT05911841|530386244|FG008|Escape Period|Withdrawal by Subject|0|||
147061470|NCT05911841|530386245|FG009|Escape Period|Withdrawal by Subject|10|||
147061471|NCT03880019|530386246|FG000|Overall Study|Competing disease|1|||
147061472|NCT03934099|530386247|FG000|Overall Study|Adverse Event|0|||
147061473|NCT03934099|530386248|FG001|Overall Study|Adverse Event|3|||
147061474|NCT03934099|530386249|FG002|Overall Study|Adverse Event|1|||
147061475|NCT03934099|530386250|FG003|Overall Study|Adverse Event|0|||
147061476|NCT03934099|530386247|FG000|Overall Study|Lost to Follow-up|1|||
147061477|NCT03934099|530386248|FG001|Overall Study|Lost to Follow-up|2|||
147061478|NCT03934099|530386249|FG002|Overall Study|Lost to Follow-up|1|||
147061479|NCT03934099|530386250|FG003|Overall Study|Lost to Follow-up|1|||
147061480|NCT03934099|530386247|FG000|Overall Study|Protocol Violation|1|||
147061481|NCT03934099|530386248|FG001|Overall Study|Protocol Violation|0|||
147061482|NCT03934099|530386249|FG002|Overall Study|Protocol Violation|0|||
147061483|NCT03934099|530386250|FG003|Overall Study|Protocol Violation|0|||
147061484|NCT03934099|530386247|FG000|Overall Study|Withdrawal by Subject|2|||
147061485|NCT03934099|530386248|FG001|Overall Study|Withdrawal by Subject|0|||
147061486|NCT03934099|530386249|FG002|Overall Study|Withdrawal by Subject|1|||
147061487|NCT03934099|530386250|FG003|Overall Study|Withdrawal by Subject|1|||
147061488|NCT03934099|530386247|FG000|Overall Study|Other reasons|0|||
147061489|NCT03934099|530386248|FG001|Overall Study|Other reasons|1|||
147061490|NCT03934099|530386249|FG002|Overall Study|Other reasons|0|||
147061491|NCT03934099|530386250|FG003|Overall Study|Other reasons|0|||
147061492|NCT05595369|530387236|FG000|Overall Study|Adverse Event|2|||
147061493|NCT05595369|530387237|FG001|Overall Study|Adverse Event|0|||
147061494|NCT05595369|530387238|FG002|Overall Study|Adverse Event|0|||
147061495|NCT05595369|530387236|FG000|Overall Study|Lost to Follow-up|11|||
147061496|NCT05595369|530387237|FG001|Overall Study|Lost to Follow-up|10|||
147061497|NCT05595369|530387238|FG002|Overall Study|Lost to Follow-up|10|||
147061498|NCT05595369|530387236|FG000|Overall Study|Physician Decision|1|||
147061499|NCT05595369|530387237|FG001|Overall Study|Physician Decision|0|||
147061500|NCT05595369|530387238|FG002|Overall Study|Physician Decision|0|||
147061501|NCT05595369|530387236|FG000|Overall Study|Withdrawal by Subject|5|||
147061502|NCT05595369|530387237|FG001|Overall Study|Withdrawal by Subject|7|||
147061503|NCT05595369|530387238|FG002|Overall Study|Withdrawal by Subject|6|||
147061504|NCT05595369|530387236|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
147061505|NCT05595369|530387237|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
147061506|NCT05595369|530387238|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
147061507|NCT05595369|530387236|FG000|Overall Study|Study Drug Non-compliance|0|||
147061508|NCT05595369|530387237|FG001|Overall Study|Study Drug Non-compliance|1|||
147061509|NCT05595369|530387238|FG002|Overall Study|Study Drug Non-compliance|0|||
147061510|NCT05595369|530387236|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
147061511|NCT05595369|530387237|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
147061512|NCT05595369|530387238|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
147061513|NCT05628285|530387239|FG000|Overall Study|Lost to Follow-up|1|||
147061514|NCT02339506|530387240|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
147061515|NCT02339506|530387241|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
147061516|NCT02339506|530387240|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
147061517|NCT02339506|530387241|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
147061518|NCT02869867|530387243|FG000|Overall Study|Protocol Violation|1|||
147061519|NCT02869867|530387244|FG001|Overall Study|Protocol Violation|0|||
147061520|NCT02869867|530387243|FG000|Overall Study|Lost to Follow-up|5|||
147061521|NCT02869867|530387244|FG001|Overall Study|Lost to Follow-up|5|||
147061522|NCT05218499|530387245|FG000|Overall Study|Not treated|1|||
147061523|NCT05218499|530387246|FG001|Overall Study|Not treated|1|||
147061524|NCT05218499|530387247|FG002|Overall Study|Not treated|8|||
147061525|NCT05218499|530387245|FG000|Overall Study|Death|2|||
147061526|NCT05218499|530387246|FG001|Overall Study|Death|0|||
147061527|NCT05218499|530387247|FG002|Overall Study|Death|0|||
147061528|NCT05218499|530387245|FG000|Overall Study|Other than listed|3|||
147061529|NCT05218499|530387246|FG001|Overall Study|Other than listed|7|||
147061530|NCT05218499|530387247|FG002|Overall Study|Other than listed|10|||
147061531|NCT05218499|530387245|FG000|Overall Study|Protocol deviation|5|||
147061532|NCT05218499|530387246|FG001|Overall Study|Protocol deviation|6|||
147061533|NCT05218499|530387247|FG002|Overall Study|Protocol deviation|4|||
147061534|NCT05218499|530387245|FG000|Overall Study|Technical problems|0|||
147061535|NCT05218499|530387246|FG001|Overall Study|Technical problems|1|||
147061536|NCT05218499|530387247|FG002|Overall Study|Technical problems|0|||
147061537|NCT05218499|530387245|FG000|Overall Study|Burden of trial procedures|0|||
147061538|NCT05218499|530387246|FG001|Overall Study|Burden of trial procedures|1|||
147061539|NCT05218499|530387247|FG002|Overall Study|Burden of trial procedures|2|||
147061540|NCT05218499|530387245|FG000|Overall Study|Clinical disease progression|6|||
147061541|NCT05218499|530387246|FG001|Overall Study|Clinical disease progression|6|||
147061542|NCT05218499|530387247|FG002|Overall Study|Clinical disease progression|11|||
147061543|NCT05218499|530387245|FG000|Overall Study|Objective disease progression|44|||
147061544|NCT05218499|530387246|FG001|Overall Study|Objective disease progression|61|||
147061545|NCT05218499|530387247|FG002|Overall Study|Objective disease progression|42|||
147061546|NCT05218499|530387245|FG000|Overall Study|Adverse Event|11|||
147061547|NCT05218499|530387246|FG001|Overall Study|Adverse Event|36|||
147061548|NCT05218499|530387247|FG002|Overall Study|Adverse Event|9|||
147061549|NCT05218499|530387245|FG000|Overall Study|On treatment at time of snapshot|18|||
147061550|NCT05218499|530387246|FG001|Overall Study|On treatment at time of snapshot|29|||
147061551|NCT05218499|530387247|FG002|Overall Study|On treatment at time of snapshot|0|||
147061552|NCT04530552|530387251|FG000|Overall Study|Physician Decision|0|||
147061553|NCT04530552|530387252|FG001|Overall Study|Physician Decision|1|||
147061554|NCT04530552|530387251|FG000|Overall Study|Withdrawal by Subject|0|||
147061555|NCT04530552|530387252|FG001|Overall Study|Withdrawal by Subject|1|||
147061556|NCT04530552|530387251|FG000|Overall Study|Adverse Event|0|||
147061557|NCT04530552|530387252|FG001|Overall Study|Adverse Event|1|||
147061558|NCT04530552|530387251|FG000|Overall Study|No surgery|0|||
147061559|NCT04530552|530387252|FG001|Overall Study|No surgery|1|||
147061560|NCT05162586|530387253|FG000|Overall Study|Other|0|||
147061561|NCT05162586|530387254|FG001|Overall Study|Other|0|||
147061562|NCT05162586|530387255|FG002|Overall Study|Other|0|||
147061563|NCT05162586|530387256|FG003|Overall Study|Other|0|||
147061564|NCT05162586|530387257|FG004|Overall Study|Other|1|||
147061565|NCT05162586|530387258|FG005|Overall Study|Other|0|||
147061566|NCT05162586|530387259|FG006|Overall Study|Other|2|||
147061567|NCT05162586|530387260|FG007|Overall Study|Other|2|||
147061568|NCT05162586|530387253|FG000|Overall Study|Lack of Efficacy|0|||
147061569|NCT05162586|530387254|FG001|Overall Study|Lack of Efficacy|0|||
147061570|NCT05162586|530387255|FG002|Overall Study|Lack of Efficacy|0|||
147061571|NCT05162586|530387256|FG003|Overall Study|Lack of Efficacy|0|||
147061572|NCT05162586|530387257|FG004|Overall Study|Lack of Efficacy|1|||
147061573|NCT05162586|530387258|FG005|Overall Study|Lack of Efficacy|0|||
147061574|NCT05162586|530387259|FG006|Overall Study|Lack of Efficacy|0|||
147061575|NCT05162586|530387260|FG007|Overall Study|Lack of Efficacy|1|||
147061576|NCT05162586|530387253|FG000|Overall Study|Lost to Follow-up|0|||
147061577|NCT05162586|530387254|FG001|Overall Study|Lost to Follow-up|0|||
147061578|NCT05162586|530387255|FG002|Overall Study|Lost to Follow-up|0|||
147061579|NCT05162586|530387256|FG003|Overall Study|Lost to Follow-up|0|||
147061580|NCT05162586|530387257|FG004|Overall Study|Lost to Follow-up|2|||
147061581|NCT05162586|530387258|FG005|Overall Study|Lost to Follow-up|0|||
147061582|NCT05162586|530387259|FG006|Overall Study|Lost to Follow-up|0|||
147061583|NCT05162586|530387260|FG007|Overall Study|Lost to Follow-up|2|||
147061584|NCT05162586|530387253|FG000|Overall Study|Non-Compliance|0|||
147061585|NCT05162586|530387254|FG001|Overall Study|Non-Compliance|1|||
147061586|NCT05162586|530387255|FG002|Overall Study|Non-Compliance|0|||
147061587|NCT05162586|530387256|FG003|Overall Study|Non-Compliance|0|||
147061588|NCT05162586|530387257|FG004|Overall Study|Non-Compliance|1|||
147061589|NCT05162586|530387258|FG005|Overall Study|Non-Compliance|0|||
147061590|NCT05162586|530387259|FG006|Overall Study|Non-Compliance|0|||
147061591|NCT05162586|530387260|FG007|Overall Study|Non-Compliance|1|||
147061592|NCT05162586|530387253|FG000|Overall Study|Withdrawal by Subject|2|||
147061593|NCT05162586|530387254|FG001|Overall Study|Withdrawal by Subject|0|||
147061594|NCT05162586|530387255|FG002|Overall Study|Withdrawal by Subject|0|||
147061595|NCT05162586|530387256|FG003|Overall Study|Withdrawal by Subject|0|||
147061596|NCT05162586|530387257|FG004|Overall Study|Withdrawal by Subject|7|||
147061597|NCT05162586|530387258|FG005|Overall Study|Withdrawal by Subject|6|||
147061598|NCT05162586|530387259|FG006|Overall Study|Withdrawal by Subject|2|||
147061599|NCT05162586|530387260|FG007|Overall Study|Withdrawal by Subject|2|||
147061600|NCT05162586|530387253|FG000|Overall Study|Adverse Event|2|||
147061601|NCT05162586|530387254|FG001|Overall Study|Adverse Event|0|||
147061602|NCT05162586|530387255|FG002|Overall Study|Adverse Event|1|||
147061603|NCT05162586|530387256|FG003|Overall Study|Adverse Event|2|||
147061604|NCT05162586|530387257|FG004|Overall Study|Adverse Event|4|||
147061605|NCT05162586|530387258|FG005|Overall Study|Adverse Event|1|||
147061606|NCT05162586|530387259|FG006|Overall Study|Adverse Event|5|||
147061607|NCT05162586|530387260|FG007|Overall Study|Adverse Event|2|||
146850076|NCT00964886|529620715|FG002|Overall Study|Lost to Follow-up|6|||
147061608|NCT05555615|530387261|FG000|Overall Study|Adverse Event|7|||
147061609|NCT05555615|530387261|FG000|Overall Study|Lack of Efficacy|12|||
147061610|NCT05555615|530387261|FG000|Overall Study|Lost to Follow-up|10|||
147061611|NCT05555615|530387261|FG000|Overall Study|Noncompliance with study drug|5|||
147061612|NCT05555615|530387261|FG000|Overall Study|Physician Decision|2|||
147061613|NCT05555615|530387261|FG000|Overall Study|Study terminated by sponsor|80|||
147061614|NCT05555615|530387261|FG000|Overall Study|Prohibited medication use|2|||
147061615|NCT05555615|530387261|FG000|Overall Study|Withdrawal by Subject|20|||
147061616|NCT05555615|530387261|FG000|Overall Study|Not further specified|4|||
147061617|NCT03377361|530387262|FG000|Pre-Treatment|Subject withdrew consent|0|||
147061618|NCT03377361|530387263|FG001|Pre-Treatment|Subject withdrew consent|0|||
147061619|NCT03377361|530387264|FG002|Pre-Treatment|Subject withdrew consent|0|||
147061620|NCT03377361|530387265|FG003|Pre-Treatment|Subject withdrew consent|0|||
147061621|NCT03377361|530387266|FG004|Pre-Treatment|Subject withdrew consent|0|||
147061622|NCT03377361|530387267|FG005|Pre-Treatment|Subject withdrew consent|0|||
147061623|NCT03377361|530387268|FG006|Pre-Treatment|Subject withdrew consent|0|||
147061624|NCT03377361|530387269|FG007|Pre-Treatment|Subject withdrew consent|3|||
147061625|NCT03377361|530387270|FG008|Pre-Treatment|Subject withdrew consent|1|||
147061626|NCT03377361|530387271|FG009|Pre-Treatment|Subject withdrew consent|0|||
147061627|NCT03377361|530387262|FG000|Pre-Treatment|Not Reported|0|||
147061628|NCT03377361|530387263|FG001|Pre-Treatment|Not Reported|0|||
147061629|NCT03377361|530387264|FG002|Pre-Treatment|Not Reported|0|||
147061630|NCT03377361|530387265|FG003|Pre-Treatment|Not Reported|0|||
147061631|NCT03377361|530387266|FG004|Pre-Treatment|Not Reported|0|||
147061632|NCT03377361|530387267|FG005|Pre-Treatment|Not Reported|0|||
147061633|NCT03377361|530387268|FG006|Pre-Treatment|Not Reported|0|||
147061634|NCT03377361|530387269|FG007|Pre-Treatment|Not Reported|0|||
147061635|NCT03377361|530387270|FG008|Pre-Treatment|Not Reported|3|||
147061636|NCT03377361|530387271|FG009|Pre-Treatment|Not Reported|0|||
147061637|NCT03377361|530387262|FG000|Treatment Period|Disease Progression|3|||
147061638|NCT03377361|530387263|FG001|Treatment Period|Disease Progression|2|||
147061639|NCT03377361|530387264|FG002|Treatment Period|Disease Progression|5|||
147061640|NCT03377361|530387265|FG003|Treatment Period|Disease Progression|3|||
147061641|NCT03377361|530387266|FG004|Treatment Period|Disease Progression|3|||
147061642|NCT03377361|530387267|FG005|Treatment Period|Disease Progression|3|||
147061643|NCT03377361|530387268|FG006|Treatment Period|Disease Progression|6|||
147061644|NCT03377361|530387269|FG007|Treatment Period|Disease Progression|106|||
147061645|NCT03377361|530387270|FG008|Treatment Period|Disease Progression|48|||
147061646|NCT03377361|530387271|FG009|Treatment Period|Disease Progression|59|||
147061647|NCT03377361|530387262|FG000|Treatment Period|Study Drug Toxicity|0|||
147061648|NCT03377361|530387263|FG001|Treatment Period|Study Drug Toxicity|0|||
147061649|NCT03377361|530387264|FG002|Treatment Period|Study Drug Toxicity|0|||
147061650|NCT03377361|530387265|FG003|Treatment Period|Study Drug Toxicity|1|||
147061651|NCT03377361|530387266|FG004|Treatment Period|Study Drug Toxicity|0|||
147061652|NCT03377361|530387267|FG005|Treatment Period|Study Drug Toxicity|0|||
147061653|NCT03377361|530387268|FG006|Treatment Period|Study Drug Toxicity|0|||
147061654|NCT03377361|530387269|FG007|Treatment Period|Study Drug Toxicity|7|||
147061655|NCT03377361|530387270|FG008|Treatment Period|Study Drug Toxicity|2|||
147061656|NCT03377361|530387271|FG009|Treatment Period|Study Drug Toxicity|16|||
147061657|NCT03377361|530387262|FG000|Treatment Period|Death|0|||
147061658|NCT03377361|530387263|FG001|Treatment Period|Death|0|||
147061659|NCT03377361|530387264|FG002|Treatment Period|Death|1|||
147061660|NCT03377361|530387265|FG003|Treatment Period|Death|0|||
147061661|NCT03377361|530387266|FG004|Treatment Period|Death|0|||
147061662|NCT03377361|530387267|FG005|Treatment Period|Death|0|||
147061663|NCT03377361|530387268|FG006|Treatment Period|Death|0|||
147061664|NCT03377361|530387269|FG007|Treatment Period|Death|2|||
147061665|NCT03377361|530387270|FG008|Treatment Period|Death|1|||
147061666|NCT03377361|530387271|FG009|Treatment Period|Death|3|||
147061667|NCT03377361|530387262|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
147061668|NCT03377361|530387263|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
147061669|NCT03377361|530387264|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
147061670|NCT03377361|530387265|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
147061671|NCT03377361|530387266|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
147061672|NCT03377361|530387267|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
147061673|NCT03377361|530387268|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
147061674|NCT03377361|530387269|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
147061675|NCT03377361|530387270|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
147061676|NCT03377361|530387271|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
147061677|NCT03377361|530387262|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
147061678|NCT03377361|530387263|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
147061679|NCT03377361|530387264|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
147061680|NCT03377361|530387265|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
147061681|NCT03377361|530387266|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
147061682|NCT03377361|530387267|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
147061683|NCT03377361|530387268|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
147061684|NCT03377361|530387269|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
147061685|NCT03377361|530387270|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
147061686|NCT03377361|530387271|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
147061687|NCT03377361|530387262|FG000|Treatment Period|Subject Withdrew Consent|0|||
147061688|NCT03377361|530387263|FG001|Treatment Period|Subject Withdrew Consent|0|||
147061689|NCT03377361|530387264|FG002|Treatment Period|Subject Withdrew Consent|0|||
147061690|NCT03377361|530387265|FG003|Treatment Period|Subject Withdrew Consent|0|||
147061691|NCT03377361|530387266|FG004|Treatment Period|Subject Withdrew Consent|0|||
147061692|NCT03377361|530387267|FG005|Treatment Period|Subject Withdrew Consent|0|||
147061693|NCT03377361|530387268|FG006|Treatment Period|Subject Withdrew Consent|0|||
147061694|NCT03377361|530387269|FG007|Treatment Period|Subject Withdrew Consent|0|||
147061695|NCT03377361|530387270|FG008|Treatment Period|Subject Withdrew Consent|2|||
147061696|NCT03377361|530387271|FG009|Treatment Period|Subject Withdrew Consent|1|||
147061697|NCT03377361|530387262|FG000|Treatment Period|No longer meets study criteria|0|||
147061698|NCT03377361|530387263|FG001|Treatment Period|No longer meets study criteria|1|||
147061699|NCT03377361|530387264|FG002|Treatment Period|No longer meets study criteria|0|||
147061700|NCT03377361|530387265|FG003|Treatment Period|No longer meets study criteria|0|||
147061701|NCT03377361|530387266|FG004|Treatment Period|No longer meets study criteria|0|||
147061702|NCT03377361|530387267|FG005|Treatment Period|No longer meets study criteria|0|||
147061703|NCT03377361|530387268|FG006|Treatment Period|No longer meets study criteria|0|||
147061704|NCT03377361|530387269|FG007|Treatment Period|No longer meets study criteria|1|||
147061705|NCT03377361|530387270|FG008|Treatment Period|No longer meets study criteria|0|||
147061706|NCT03377361|530387271|FG009|Treatment Period|No longer meets study criteria|0|||
147061707|NCT03377361|530387262|FG000|Treatment Period|Other Reasons|0|||
147061708|NCT03377361|530387263|FG001|Treatment Period|Other Reasons|0|||
147061709|NCT03377361|530387264|FG002|Treatment Period|Other Reasons|0|||
147061710|NCT03377361|530387265|FG003|Treatment Period|Other Reasons|3|||
147061711|NCT03377361|530387266|FG004|Treatment Period|Other Reasons|0|||
147061712|NCT03377361|530387267|FG005|Treatment Period|Other Reasons|0|||
147061713|NCT03377361|530387268|FG006|Treatment Period|Other Reasons|0|||
147061714|NCT03377361|530387269|FG007|Treatment Period|Other Reasons|2|||
147061715|NCT03377361|530387270|FG008|Treatment Period|Other Reasons|0|||
147061716|NCT03377361|530387271|FG009|Treatment Period|Other Reasons|1|||
147061717|NCT03698994|530387286|FG000|Overall Study|Adverse Event|2|||
147061718|NCT03698994|530387286|FG000|Overall Study|Death|1|||
147061719|NCT03698994|530387286|FG000|Overall Study|Physician Decision|1|||
147061720|NCT03698994|530387286|FG000|Overall Study|Withdrawal by Subject|3|||
147061721|NCT03698994|530387286|FG000|Overall Study|Progressive Disease|12|||
147061722|NCT02567435|530387287|FG000|Overall Study|Death|1|||
147061723|NCT02567435|530387288|FG001|Overall Study|Death|1|||
147061724|NCT02567435|530387289|FG002|Overall Study|Death|0|||
147061725|NCT02567435|530387290|FG003|Overall Study|Death|0|||
147061726|NCT02567435|530387287|FG000|Overall Study|Ineligible|1|||
147061727|NCT02567435|530387288|FG001|Overall Study|Ineligible|3|||
147061728|NCT02567435|530387289|FG002|Overall Study|Ineligible|0|||
147061729|NCT02567435|530387290|FG003|Overall Study|Ineligible|0|||
147061730|NCT02567435|530387287|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
147061731|NCT02567435|530387288|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
147061732|NCT02567435|530387289|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
147061733|NCT02567435|530387290|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
147061734|NCT02166463|530387291|FG000|Overall Study|Lost to Follow-up|0|||
147061735|NCT02166463|530387292|FG001|Overall Study|Lost to Follow-up|1|||
147061736|NCT02166463|530387291|FG000|Overall Study|Physician Decision|10|||
147061737|NCT02166463|530387292|FG001|Overall Study|Physician Decision|10|||
147061738|NCT02166463|530387291|FG000|Overall Study|Ineligible|11|||
147061739|NCT02166463|530387292|FG001|Overall Study|Ineligible|2|||
147061740|NCT02166463|530387291|FG000|Overall Study|Progressive Disease|9|||
147061741|NCT02166463|530387292|FG001|Overall Study|Progressive Disease|6|||
147061742|NCT02166463|530387291|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
147061743|NCT02166463|530387292|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
147061744|NCT02166463|530387291|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
147061745|NCT02166463|530387292|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
147061746|NCT02166463|530387291|FG000|Overall Study|Refusal of further protocol therapy|5|||
147061747|NCT02166463|530387292|FG001|Overall Study|Refusal of further protocol therapy|6|||
147061748|NCT05082025|530387293|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
147061749|NCT04458922|530387299|FG000|Overall Study|Withdrawal by Subject|1|||
147061750|NCT04458922|530387300|FG001|Overall Study|Withdrawal by Subject|0|||
147061751|NCT04458922|530387301|FG002|Overall Study|Withdrawal by Subject|2|||
147061752|NCT04458922|530387299|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
147061753|NCT04458922|530387300|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
147061754|NCT04458922|530387301|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
147061755|NCT04458922|530387299|FG000|Overall Study|Adverse Event|1|||
147061756|NCT04458922|530387300|FG001|Overall Study|Adverse Event|0|||
147061757|NCT04458922|530387301|FG002|Overall Study|Adverse Event|0|||
147061758|NCT04458922|530387299|FG000|Overall Study|Started new study|0|||
147061759|NCT04458922|530387300|FG001|Overall Study|Started new study|0|||
147061760|NCT04458922|530387301|FG002|Overall Study|Started new study|1|||
147061761|NCT04458922|530387299|FG000|Overall Study|Progressive disease|6|||
147061762|NCT04458922|530387300|FG001|Overall Study|Progressive disease|8|||
147061763|NCT04458922|530387301|FG002|Overall Study|Progressive disease|2|||
147061764|NCT04458922|530387299|FG000|Overall Study|Death|1|||
147061765|NCT04458922|530387300|FG001|Overall Study|Death|0|||
147061766|NCT04458922|530387301|FG002|Overall Study|Death|2|||
147061767|NCT04458922|530387299|FG000|Overall Study|Participant started chemotherapy|0|||
147061768|NCT04458922|530387300|FG001|Overall Study|Participant started chemotherapy|1|||
147061769|NCT04458922|530387301|FG002|Overall Study|Participant started chemotherapy|0|||
147061770|NCT03025035|530387302|FG000|Overall Study|Death|2|||
147061771|NCT03025035|530387302|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
147061772|NCT02921256|530387303|FG000|Arm 1a v. Arm II|Adverse Event|6|||
147061773|NCT02921256|530387304|FG001|Arm 1a v. Arm II|Adverse Event|15|||
147061774|NCT02921256|530387305|FG002|Arm 1a v. Arm II|Adverse Event|0|||
147061775|NCT02921256|530387303|FG000|Arm 1a v. Arm II|Death|0|||
147061776|NCT02921256|530387304|FG001|Arm 1a v. Arm II|Death|2|||
147061777|NCT02921256|530387305|FG002|Arm 1a v. Arm II|Death|0|||
147061778|NCT02921256|530387303|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
147061779|NCT02921256|530387304|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
147061780|NCT02921256|530387305|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
147061781|NCT02921256|530387303|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
147061782|NCT02921256|530387304|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
147061783|NCT02921256|530387305|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
147061784|NCT02921256|530387303|FG000|Arm 1a v. Arm II|Physician Decision|1|||
147061785|NCT02921256|530387304|FG001|Arm 1a v. Arm II|Physician Decision|1|||
147061786|NCT02921256|530387305|FG002|Arm 1a v. Arm II|Physician Decision|0|||
147061787|NCT02921256|530387303|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
147061788|NCT02921256|530387304|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
147061789|NCT02921256|530387305|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
147061790|NCT02921256|530387303|FG000|Arm Ib v Arm III|Adverse Event|9|||
147061791|NCT02921256|530387304|FG001|Arm Ib v Arm III|Adverse Event|0|||
147061792|NCT02921256|530387305|FG002|Arm Ib v Arm III|Adverse Event|4|||
147061793|NCT02921256|530387303|FG000|Arm Ib v Arm III|Death|1|||
147061794|NCT02921256|530387304|FG001|Arm Ib v Arm III|Death|0|||
147061795|NCT02921256|530387305|FG002|Arm Ib v Arm III|Death|1|||
147061796|NCT02921256|530387303|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
147061797|NCT02921256|530387304|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
147061798|NCT02921256|530387305|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
147061799|NCT02921256|530387303|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
147061800|NCT02921256|530387304|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
147061801|NCT02921256|530387305|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
147061802|NCT02921256|530387303|FG000|Arm Ib v Arm III|Physician Decision|4|||
147061803|NCT02921256|530387304|FG001|Arm Ib v Arm III|Physician Decision|0|||
147061804|NCT02921256|530387305|FG002|Arm Ib v Arm III|Physician Decision|1|||
147061805|NCT02921256|530387303|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
147061806|NCT02921256|530387304|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
147061807|NCT02921256|530387305|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
147061808|NCT05030584|530387308|FG000|Overall Study|Adverse Event|17|||
147061809|NCT05030584|530387309|FG001|Overall Study|Adverse Event|2|||
147061810|NCT05030584|530387308|FG000|Overall Study|Lack of Efficacy|0|||
147061811|NCT05030584|530387309|FG001|Overall Study|Lack of Efficacy|6|||
147061812|NCT05030584|530387308|FG000|Overall Study|Lost to Follow-up|5|||
147061813|NCT05030584|530387309|FG001|Overall Study|Lost to Follow-up|2|||
147061814|NCT05030584|530387308|FG000|Overall Study|Non-Compliance with Study Drug|2|||
147061815|NCT05030584|530387309|FG001|Overall Study|Non-Compliance with Study Drug|3|||
147061816|NCT05030584|530387308|FG000|Overall Study|Other reason|4|||
147061817|NCT05030584|530387309|FG001|Overall Study|Other reason|3|||
147061818|NCT05030584|530387308|FG000|Overall Study|Physician Decision|1|||
147061819|NCT05030584|530387309|FG001|Overall Study|Physician Decision|4|||
147061820|NCT05030584|530387308|FG000|Overall Study|Protocol Violation|0|||
147061821|NCT05030584|530387309|FG001|Overall Study|Protocol Violation|2|||
147061822|NCT05030584|530387308|FG000|Overall Study|Randomized by Mistake|0|||
147061823|NCT05030584|530387309|FG001|Overall Study|Randomized by Mistake|2|||
147061824|NCT05030584|530387308|FG000|Overall Study|Withdrawal by Subject|21|||
147061825|NCT05030584|530387309|FG001|Overall Study|Withdrawal by Subject|28|||
147061826|NCT05030584|530387308|FG000|Overall Study|Technical Problems|0|||
147061827|NCT05030584|530387309|FG001|Overall Study|Technical Problems|1|||
147061828|NCT05030584|530387308|FG000|Overall Study|Completed post-treatment/FU visits|41|||
147061829|NCT05030584|530387309|FG001|Overall Study|Completed post-treatment/FU visits|31|||
147061830|NCT04848480|530387310|FG000|Main Phase (26 Weeks)|Death|1|||
147061831|NCT04848480|530387311|FG001|Main Phase (26 Weeks)|Death|0|||
147061832|NCT04848480|530387310|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
147061833|NCT04848480|530387311|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
147061834|NCT04848480|530387310|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
147061835|NCT04848480|530387311|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
147061836|NCT04848480|530387310|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
147061837|NCT04848480|530387311|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
147061838|NCT04848480|530387310|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
147061839|NCT04848480|530387311|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
147061840|NCT04848480|530387310|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
147061841|NCT04848480|530387311|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
147061842|NCT02615938|530387312|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
147061843|NCT02615938|530387313|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
147061844|NCT02615938|530387314|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
147061845|NCT02615938|530387315|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
147061846|NCT02615938|530387312|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
147061847|NCT02615938|530387313|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
147061848|NCT02615938|530387314|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
147061849|NCT02615938|530387315|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
147061850|NCT02615938|530387312|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
147061851|NCT02615938|530387313|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
147061852|NCT02615938|530387314|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
147061853|NCT02615938|530387315|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
147061854|NCT05063448|530387321|FG000|Overall Study|Withdrawal by Subject|1|||
147061855|NCT04428151|530389117|FG000|Overall Study|Death|100|||
147061856|NCT04428151|530389118|FG001|Overall Study|Death|86|||
147061857|NCT04428151|530389119|FG002|Overall Study|Death|57|||
147061858|NCT04428151|530389117|FG000|Overall Study|Lost to Follow-up|1|||
147061859|NCT04428151|530389118|FG001|Overall Study|Lost to Follow-up|1|||
147061860|NCT04428151|530389119|FG002|Overall Study|Lost to Follow-up|0|||
147061861|NCT04428151|530389117|FG000|Overall Study|Withdrawal by Subject|2|||
147061862|NCT04428151|530389118|FG001|Overall Study|Withdrawal by Subject|2|||
147061863|NCT04428151|530389119|FG002|Overall Study|Withdrawal by Subject|3|||
147061864|NCT04428151|530389117|FG000|Overall Study|Participant Ongoing in Study|41|||
147061865|NCT04428151|530389118|FG001|Overall Study|Participant Ongoing in Study|53|||
147061866|NCT04428151|530389119|FG002|Overall Study|Participant Ongoing in Study|28|||
147061867|NCT04777331|530389120|FG000|DBT Period|Death|2|||
147061868|NCT04777331|530389121|FG001|DBT Period|Death|1|||
147061869|NCT04777331|530389122|FG002|DBT Period|Death|0|||
147061870|NCT04777331|530389120|FG000|DBT Period|Reason not Specified|1|||
147061871|NCT04777331|530389121|FG001|DBT Period|Reason not Specified|1|||
147061872|NCT04777331|530389122|FG002|DBT Period|Reason not Specified|0|||
147061873|NCT04777331|530389120|FG000|DBT Period|Physician Decision|4|||
147061874|NCT04777331|530389121|FG001|DBT Period|Physician Decision|0|||
147061875|NCT04777331|530389122|FG002|DBT Period|Physician Decision|0|||
147061876|NCT04777331|530389120|FG000|DBT Period|Withdrawal by Subject|12|||
147061877|NCT04777331|530389121|FG001|DBT Period|Withdrawal by Subject|11|||
147061878|NCT04777331|530389122|FG002|DBT Period|Withdrawal by Subject|0|||
147061879|NCT04777331|530389120|FG000|DBT Period|Randomized but not Treated|1|||
147061880|NCT04777331|530389121|FG001|DBT Period|Randomized but not Treated|3|||
147061881|NCT04777331|530389122|FG002|DBT Period|Randomized but not Treated|0|||
147061882|NCT04777331|530389120|FG000|OLE Period|Ongoing in OLE|0|||
147061883|NCT04777331|530389121|FG001|OLE Period|Ongoing in OLE|0|||
147061884|NCT04777331|530389122|FG002|OLE Period|Ongoing in OLE|534|||
147061885|NCT02642042|530389123|FG000|Overall Study|Adverse Event|22|||
147061886|NCT02642042|530389123|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
147061887|NCT02642042|530389123|FG000|Overall Study|Progression/Relapse|28|||
147061888|NCT02642042|530389123|FG000|Overall Study|Death|1|||
147061889|NCT02642042|530389123|FG000|Overall Study|Not Protocol Specified|2|||
147061890|NCT03375320|530389124|FG000|Overall Study|Adverse Event|34|||
147061891|NCT03375320|530389125|FG001|Overall Study|Adverse Event|9|||
147061892|NCT03375320|530389126|FG002|Overall Study|Adverse Event|10|||
147061893|NCT03375320|530389127|FG003|Overall Study|Adverse Event|0|||
147061894|NCT03375320|530389124|FG000|Overall Study|Death|6|||
147061895|NCT03375320|530389125|FG001|Overall Study|Death|3|||
147061896|NCT03375320|530389126|FG002|Overall Study|Death|0|||
147061897|NCT03375320|530389127|FG003|Overall Study|Death|0|||
147061898|NCT03375320|530389124|FG000|Overall Study|Withdrawal by Subject|7|||
147061899|NCT03375320|530389125|FG001|Overall Study|Withdrawal by Subject|4|||
147061900|NCT03375320|530389126|FG002|Overall Study|Withdrawal by Subject|5|||
147061901|NCT03375320|530389127|FG003|Overall Study|Withdrawal by Subject|4|||
147061902|NCT03375320|530389124|FG000|Overall Study|Progressive disease|55|||
147061903|NCT03375320|530389125|FG001|Overall Study|Progressive disease|41|||
147061904|NCT03375320|530389126|FG002|Overall Study|Progressive disease|29|||
147061905|NCT03375320|530389127|FG003|Overall Study|Progressive disease|24|||
147061906|NCT03375320|530389124|FG000|Overall Study|Alternative treatment|6|||
147061907|NCT03375320|530389125|FG001|Overall Study|Alternative treatment|1|||
147061908|NCT03375320|530389126|FG002|Overall Study|Alternative treatment|1|||
147061909|NCT03375320|530389127|FG003|Overall Study|Alternative treatment|0|||
147061910|NCT03375320|530389124|FG000|Overall Study|Other disease|1|||
147061911|NCT03375320|530389125|FG001|Overall Study|Other disease|1|||
147061912|NCT03375320|530389126|FG002|Overall Study|Other disease|3|||
147061913|NCT03375320|530389127|FG003|Overall Study|Other disease|0|||
147061914|NCT03375320|530389124|FG000|Overall Study|Withdrawal prior to initiation|2|||
147061915|NCT03375320|530389125|FG001|Overall Study|Withdrawal prior to initiation|2|||
147061916|NCT03375320|530389126|FG002|Overall Study|Withdrawal prior to initiation|1|||
147061917|NCT03375320|530389127|FG003|Overall Study|Withdrawal prior to initiation|0|||
147061918|NCT03375320|530389124|FG000|Overall Study|Physician Decision|1|||
147061919|NCT03375320|530389125|FG001|Overall Study|Physician Decision|1|||
147061920|NCT03375320|530389126|FG002|Overall Study|Physician Decision|1|||
147061921|NCT03375320|530389127|FG003|Overall Study|Physician Decision|1|||
147061922|NCT03375320|530389124|FG000|Overall Study|Non-compliance|1|||
147061923|NCT03375320|530389125|FG001|Overall Study|Non-compliance|0|||
147061924|NCT03375320|530389126|FG002|Overall Study|Non-compliance|0|||
147061925|NCT03375320|530389127|FG003|Overall Study|Non-compliance|0|||
147061926|NCT04108468|530389128|FG000|Overall Study|Physician Decision|0|||
147061927|NCT04108468|530389129|FG001|Overall Study|Physician Decision|1|||
147061928|NCT04108468|530389128|FG000|Overall Study|Lost to Follow-up|0|||
147061929|NCT04108468|530389129|FG001|Overall Study|Lost to Follow-up|1|||
147061930|NCT04108468|530389128|FG000|Overall Study|Non-compliance|1|||
147061931|NCT04108468|530389129|FG001|Overall Study|Non-compliance|1|||
147061932|NCT04108468|530389128|FG000|Overall Study|Unable to attend final visit|2|||
147061933|NCT04108468|530389129|FG001|Overall Study|Unable to attend final visit|0|||
147061934|NCT04108468|530389128|FG000|Overall Study|Missed study medication|0|||
147061935|NCT04108468|530389129|FG001|Overall Study|Missed study medication|1|||
147061936|NCT03348631|530389130|FG000|Overall Study|Not Eligible, No treatment|0|||
147061937|NCT03348631|530389131|FG001|Overall Study|Not Eligible, No treatment|1|||
147061938|NCT03348631|530389130|FG000|Overall Study|Not Eligible, Treated|2|||
147061939|NCT03348631|530389131|FG001|Overall Study|Not Eligible, Treated|0|||
147061940|NCT03348631|530389130|FG000|Overall Study|Eligible, No Treatment|1|||
147061941|NCT03348631|530389131|FG001|Overall Study|Eligible, No Treatment|0|||
147061942|NCT03047213|530389132|FG000|Overall Study|Withdrawal by Subject|2|||
147061943|NCT03047213|530389133|FG001|Overall Study|Withdrawal by Subject|0|||
147061944|NCT03047213|530389132|FG000|Overall Study|Adverse Event|2|||
147061945|NCT03047213|530389133|FG001|Overall Study|Adverse Event|0|||
147061946|NCT03260023|530389134|FG000|Overall Study|Adverse Event|0|||
147061947|NCT03260023|530389135|FG001|Overall Study|Adverse Event|0|||
147061948|NCT03260023|530389136|FG002|Overall Study|Adverse Event|4|||
147061949|NCT03260023|530389137|FG003|Overall Study|Adverse Event|4|||
147061950|NCT03260023|530389138|FG004|Overall Study|Adverse Event|4|||
147061951|NCT03260023|530389139|FG005|Overall Study|Adverse Event|1|||
147061952|NCT03260023|530389140|FG006|Overall Study|Adverse Event|2|||
147061953|NCT03260023|530389134|FG000|Overall Study|Clinical Progression|0|||
147061954|NCT03260023|530389135|FG001|Overall Study|Clinical Progression|1|||
147061955|NCT03260023|530389136|FG002|Overall Study|Clinical Progression|3|||
147061956|NCT03260023|530389137|FG003|Overall Study|Clinical Progression|1|||
147061957|NCT03260023|530389138|FG004|Overall Study|Clinical Progression|0|||
147061958|NCT03260023|530389139|FG005|Overall Study|Clinical Progression|0|||
147061959|NCT03260023|530389140|FG006|Overall Study|Clinical Progression|0|||
147061960|NCT03260023|530389134|FG000|Overall Study|Physician Decision|0|||
147061961|NCT03260023|530389135|FG001|Overall Study|Physician Decision|0|||
147061962|NCT03260023|530389136|FG002|Overall Study|Physician Decision|0|||
147061963|NCT03260023|530389137|FG003|Overall Study|Physician Decision|1|||
147061964|NCT03260023|530389138|FG004|Overall Study|Physician Decision|1|||
147061965|NCT03260023|530389139|FG005|Overall Study|Physician Decision|0|||
147061966|NCT03260023|530389140|FG006|Overall Study|Physician Decision|0|||
147061967|NCT03260023|530389134|FG000|Overall Study|Withdrawal by Subject|0|||
147061968|NCT03260023|530389135|FG001|Overall Study|Withdrawal by Subject|0|||
147061969|NCT03260023|530389136|FG002|Overall Study|Withdrawal by Subject|0|||
147061970|NCT03260023|530389137|FG003|Overall Study|Withdrawal by Subject|0|||
147061971|NCT03260023|530389138|FG004|Overall Study|Withdrawal by Subject|3|||
147061972|NCT03260023|530389139|FG005|Overall Study|Withdrawal by Subject|0|||
147061973|NCT03260023|530389140|FG006|Overall Study|Withdrawal by Subject|0|||
147061974|NCT03260023|530389134|FG000|Overall Study|Under trial intervention|0|||
147061975|NCT03260023|530389135|FG001|Overall Study|Under trial intervention|0|||
147061976|NCT03260023|530389136|FG002|Overall Study|Under trial intervention|2|||
147061977|NCT03260023|530389137|FG003|Overall Study|Under trial intervention|5|||
147061978|NCT03260023|530389138|FG004|Overall Study|Under trial intervention|3|||
147061979|NCT03260023|530389139|FG005|Overall Study|Under trial intervention|0|||
147061980|NCT03260023|530389140|FG006|Overall Study|Under trial intervention|0|||
147061981|NCT03388632|530389141|FG000|Triplet C|Clinical progression|0|||
147061982|NCT03388632|530389142|FG001|Triplet C|Clinical progression|0|||
147061983|NCT03388632|530389143|FG002|Triplet C|Clinical progression|0|||
147061984|NCT03388632|530389144|FG003|Triplet C|Clinical progression|0|||
147061985|NCT03388632|530389145|FG004|Triplet C|Clinical progression|1|||
147061986|NCT03388632|530389146|FG005|Triplet C|Clinical progression|0|||
147061987|NCT03388632|530389147|FG006|Triplet C|Clinical progression|0|||
147061988|NCT03388632|530389148|FG007|Triplet C|Clinical progression|0|||
147061989|NCT03388632|530389149|FG008|Triplet C|Clinical progression|0|||
147061990|NCT03388632|530389141|FG000|Triplet C|42-day lapse in tx|0|||
147061991|NCT03388632|530389142|FG001|Triplet C|42-day lapse in tx|0|||
147061992|NCT03388632|530389143|FG002|Triplet C|42-day lapse in tx|0|||
147061993|NCT03388632|530389144|FG003|Triplet C|42-day lapse in tx|0|||
147061994|NCT03388632|530389145|FG004|Triplet C|42-day lapse in tx|1|||
147061995|NCT03388632|530389146|FG005|Triplet C|42-day lapse in tx|0|||
147061996|NCT03388632|530389147|FG006|Triplet C|42-day lapse in tx|0|||
147061997|NCT03388632|530389148|FG007|Triplet C|42-day lapse in tx|0|||
147061998|NCT03388632|530389149|FG008|Triplet C|42-day lapse in tx|0|||
147061999|NCT03388632|530389141|FG000|Triplet C|Adverse Event|0|||
147062000|NCT03388632|530389142|FG001|Triplet C|Adverse Event|0|||
147062001|NCT03388632|530389143|FG002|Triplet C|Adverse Event|0|||
147062002|NCT03388632|530389144|FG003|Triplet C|Adverse Event|0|||
147062003|NCT03388632|530389145|FG004|Triplet C|Adverse Event|0|||
147062004|NCT03388632|530389146|FG005|Triplet C|Adverse Event|0|||
147062005|NCT03388632|530389147|FG006|Triplet C|Adverse Event|0|||
147062006|NCT03388632|530389148|FG007|Triplet C|Adverse Event|0|||
147062007|NCT03388632|530389149|FG008|Triplet C|Adverse Event|1|||
147062008|NCT03388632|530389141|FG000|Triplet C|Switched to alternative treatment|0|||
147062009|NCT03388632|530389142|FG001|Triplet C|Switched to alternative treatment|0|||
147062010|NCT03388632|530389143|FG002|Triplet C|Switched to alternative treatment|0|||
147062011|NCT03388632|530389144|FG003|Triplet C|Switched to alternative treatment|0|||
147062012|NCT03388632|530389145|FG004|Triplet C|Switched to alternative treatment|0|||
147062013|NCT03388632|530389146|FG005|Triplet C|Switched to alternative treatment|0|||
147062014|NCT03388632|530389147|FG006|Triplet C|Switched to alternative treatment|0|||
147062015|NCT03388632|530389148|FG007|Triplet C|Switched to alternative treatment|1|||
147062016|NCT03388632|530389149|FG008|Triplet C|Switched to alternative treatment|0|||
147062017|NCT03388632|530389141|FG000|Triplet C|Participant choice|0|||
147062018|NCT03388632|530389142|FG001|Triplet C|Participant choice|0|||
147062019|NCT03388632|530389143|FG002|Triplet C|Participant choice|0|||
147062020|NCT03388632|530389144|FG003|Triplet C|Participant choice|0|||
147062021|NCT03388632|530389145|FG004|Triplet C|Participant choice|0|||
147062022|NCT03388632|530389146|FG005|Triplet C|Participant choice|1|||
147062023|NCT03388632|530389147|FG006|Triplet C|Participant choice|0|||
147062024|NCT03388632|530389148|FG007|Triplet C|Participant choice|0|||
147062025|NCT03388632|530389149|FG008|Triplet C|Participant choice|0|||
147062026|NCT05035407|530389150|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
147062027|NCT05035407|530389151|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
147062028|NCT05035407|530389152|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
147062029|NCT05035407|530389153|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
147062030|NCT05035407|530389154|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
147062031|NCT05035407|530389155|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
147062032|NCT04220021|530389156|FG000|Overall Study|Withdrawal by Subject|11|||
147062033|NCT04220021|530389156|FG000|Overall Study|Physician Decision|2|||
147062034|NCT04220021|530389156|FG000|Overall Study|Non-study related illness|5|||
147062035|NCT03892746|530389159|FG000|Overall Study|Withdrawal by Subject|2|||
147062036|NCT03892746|530389160|FG001|Overall Study|Withdrawal by Subject|1|||
147062037|NCT03892746|530389159|FG000|Overall Study|Lost to Follow-up|2|||
147062038|NCT03892746|530389160|FG001|Overall Study|Lost to Follow-up|0|||
147062039|NCT02783690|530389161|FG000|Overall Study|Withdrawal by Subject|3|||
147062040|NCT02783690|530389162|FG001|Overall Study|Withdrawal by Subject|3|||
147062041|NCT02421939|530389163|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
147062042|NCT02421939|530389164|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
147062043|NCT02421939|530389163|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
147062044|NCT02421939|530389164|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
147062045|NCT02421939|530389163|FG000|Randomization Period: Up to 3 Years|Death|38|||
147062046|NCT02421939|530389164|FG001|Randomization Period: Up to 3 Years|Death|10|||
147062047|NCT02421939|530389163|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
147062048|NCT02421939|530389164|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
147062049|NCT02421939|530389163|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
147062050|NCT02421939|530389164|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
147062051|NCT02421939|530389163|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
147062052|NCT02421939|530389164|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
147062053|NCT02421939|530389163|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
147062054|NCT02421939|530389164|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
147062055|NCT02421939|530389163|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
147062056|NCT02421939|530389164|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
147062057|NCT02421939|530389163|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
147062058|NCT02421939|530389164|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
147062059|NCT02421939|530389163|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
147062060|NCT02421939|530389164|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
147062061|NCT02421939|530389163|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
147062062|NCT02421939|530389164|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
147062063|NCT02421939|530389163|FG000|Long Term Follow up: up to 3 Years|Death|118|||
147062064|NCT02421939|530389164|FG001|Long Term Follow up: up to 3 Years|Death|65|||
147062065|NCT02421939|530389163|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
147062066|NCT02421939|530389164|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
147062067|NCT04004000|530389173|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
147062068|NCT06121609|530389174|FG000|Overall Study|Lack of Efficacy|0|||
147062069|NCT06121609|530389175|FG001|Overall Study|Lack of Efficacy|0|||
147062070|NCT06121609|530389176|FG002|Overall Study|Lack of Efficacy|45|||
147062071|NCT02115282|530389177|FG000|Overall Study|Disease progression during treatment|216|||
147062072|NCT02115282|530389178|FG001|Overall Study|Disease progression during treatment|229|||
147062073|NCT02115282|530389177|FG000|Overall Study|Adverse Event|49|||
147062074|NCT02115282|530389178|FG001|Overall Study|Adverse Event|23|||
147062075|NCT02115282|530389177|FG000|Overall Study|Death|1|||
147062076|NCT02115282|530389178|FG001|Overall Study|Death|3|||
147062077|NCT02115282|530389177|FG000|Overall Study|Alternative therapy|1|||
147062078|NCT02115282|530389178|FG001|Overall Study|Alternative therapy|1|||
147062079|NCT02115282|530389177|FG000|Overall Study|Complicating disease|0|||
147062080|NCT02115282|530389178|FG001|Overall Study|Complicating disease|3|||
147062081|NCT02115282|530389177|FG000|Overall Study|Withdrawal by Subject|12|||
147062082|NCT02115282|530389178|FG001|Overall Study|Withdrawal by Subject|10|||
147062083|NCT02115282|530389177|FG000|Overall Study|Symptomatic progression/deterioration|7|||
147062084|NCT02115282|530389178|FG001|Overall Study|Symptomatic progression/deterioration|18|||
147062085|NCT02115282|530389177|FG000|Overall Study|Non-compliance|5|||
147062086|NCT02115282|530389178|FG001|Overall Study|Non-compliance|1|||
147062087|NCT02115282|530389177|FG000|Overall Study|Protocol Violation|2|||
147062088|NCT02115282|530389178|FG001|Overall Study|Protocol Violation|2|||
147062089|NCT02115282|530389177|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
147062090|NCT02115282|530389178|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
147062091|NCT02115282|530389177|FG000|Overall Study|Not start protocol therapy|9|||
147062092|NCT02115282|530389178|FG001|Overall Study|Not start protocol therapy|10|||
147062093|NCT06494761|530389179|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
147062094|NCT06494761|530389179|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
147062095|NCT06393127|530389183|FG000|Washout period|Withdrawal by Subject|1|||
147062096|NCT06393127|530389184|FG001|Washout period|Withdrawal by Subject|0|||
147062097|NCT06393127|530389183|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
147062098|NCT06393127|530389184|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
147062099|NCT02446600|530389185|FG000|Overall Study|Never treated|20|||
147062100|NCT02446600|530389186|FG001|Overall Study|Never treated|2|||
147062101|NCT02446600|530389187|FG002|Overall Study|Never treated|6|||
147062102|NCT02446600|530389188|FG003|Overall Study|Never treated|0|||
147062103|NCT02446600|530389185|FG000|Overall Study|Withdrawal by Subject|19|||
147062104|NCT02446600|530389186|FG001|Overall Study|Withdrawal by Subject|5|||
147062105|NCT02446600|530389187|FG002|Overall Study|Withdrawal by Subject|17|||
147062106|NCT02446600|530389188|FG003|Overall Study|Withdrawal by Subject|0|||
147062107|NCT02446600|530389185|FG000|Overall Study|Ineligible|1|||
147062108|NCT02446600|530389186|FG001|Overall Study|Ineligible|4|||
147062109|NCT02446600|530389187|FG002|Overall Study|Ineligible|4|||
147062110|NCT02446600|530389188|FG003|Overall Study|Ineligible|1|||
147062111|NCT02446600|530389185|FG000|Overall Study|Duplicate Enrollment|0|||
147062112|NCT02446600|530389186|FG001|Overall Study|Duplicate Enrollment|1|||
147062113|NCT02446600|530389187|FG002|Overall Study|Duplicate Enrollment|0|||
147062114|NCT02446600|530389188|FG003|Overall Study|Duplicate Enrollment|0|||
147062115|NCT04865289|530389189|FG000|Overall Study|Death|34|||
147062116|NCT04865289|530389190|FG001|Overall Study|Death|25|||
147062117|NCT04865289|530389189|FG000|Overall Study|Physician Decision|27|||
147062118|NCT04865289|530389190|FG001|Overall Study|Physician Decision|27|||
147062119|NCT04865289|530389189|FG000|Overall Study|Sponsor Decision|11|||
147062120|NCT04865289|530389190|FG001|Overall Study|Sponsor Decision|1|||
147062121|NCT04865289|530389189|FG000|Overall Study|Withdrawal by Subject|2|||
147062122|NCT04865289|530389190|FG001|Overall Study|Withdrawal by Subject|3|||
147062123|NCT04770779|530389192|FG000|Overall Study|Randomized, never treated|0|||
147062124|NCT04770779|530389193|FG001|Overall Study|Randomized, never treated|1|||
147062125|NCT04770779|530389192|FG000|Overall Study|Adverse Event|9|||
147062126|NCT04770779|530389193|FG001|Overall Study|Adverse Event|1|||
147062127|NCT04770779|530389192|FG000|Overall Study|Withdrawal by Subject|7|||
147062128|NCT04770779|530389193|FG001|Overall Study|Withdrawal by Subject|1|||
147062129|NCT04770779|530389192|FG000|Overall Study|Pregnancy|0|||
147062130|NCT04770779|530389193|FG001|Overall Study|Pregnancy|1|||
147062131|NCT02799602|530389194|FG000|Overall Study|Protocol Violation|1|||
147062132|NCT02799602|530389195|FG001|Overall Study|Protocol Violation|0|||
147062133|NCT02799602|530389194|FG000|Overall Study|Physician Decision|5|||
147062134|NCT02799602|530389195|FG001|Overall Study|Physician Decision|6|||
147062135|NCT02799602|530389194|FG000|Overall Study|Lost to Follow-up|4|||
147062136|NCT02799602|530389195|FG001|Overall Study|Lost to Follow-up|2|||
147062137|NCT02799602|530389194|FG000|Overall Study|Additional primary malignancy|11|||
147062138|NCT02799602|530389195|FG001|Overall Study|Additional primary malignancy|6|||
147062139|NCT02799602|530389194|FG000|Overall Study|Non-compliance with study drug|14|||
147062140|NCT02799602|530389195|FG001|Overall Study|Non-compliance with study drug|12|||
147062141|NCT02799602|530389194|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
147062142|NCT02799602|530389195|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
147062143|NCT02799602|530389194|FG000|Overall Study|Withdrawal by Subject|26|||
147062144|NCT02799602|530389195|FG001|Overall Study|Withdrawal by Subject|40|||
147062145|NCT02799602|530389194|FG000|Overall Study|Progressive disease - clinical progression|131|||
147062146|NCT02799602|530389195|FG001|Overall Study|Progressive disease - clinical progression|276|||
147062147|NCT02799602|530389194|FG000|Overall Study|Progressive disease - radiological progression|90|||
147062148|NCT02799602|530389195|FG001|Overall Study|Progressive disease - radiological progression|133|||
147062149|NCT02799602|530389194|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
147062150|NCT02799602|530389195|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
147062151|NCT02799602|530389194|FG000|Overall Study|Death|9|||
147062152|NCT02799602|530389195|FG001|Overall Study|Death|5|||
147062153|NCT02799602|530389194|FG000|Overall Study|Other|287|||
147062154|NCT02799602|530389195|FG001|Overall Study|Other|118|||
147062155|NCT02799602|530389194|FG000|Overall Study|Study drug never administered|0|||
147062156|NCT02799602|530389195|FG001|Overall Study|Study drug never administered|3|||
147062157|NCT03692052|530389196|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
147062158|NCT03692052|530389196|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
147062159|NCT03692052|530389196|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
147062160|NCT03692052|530389196|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
147062161|NCT03342196|530389197|FG000|Overall Study|Physician Decision|1|||
147062162|NCT02466971|530389200|FG000|Overall Study|eligible and never treated|14|||
147062163|NCT02466971|530389201|FG001|Overall Study|eligible and never treated|20|||
147062164|NCT02466971|530389200|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
147062165|NCT02466971|530389201|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
147062166|NCT02466971|530389200|FG000|Overall Study|ineligible and treated|1|||
147062167|NCT02466971|530389201|FG001|Overall Study|ineligible and treated|0|||
147062168|NCT02466971|530389200|FG000|Overall Study|ineligible and never treated|0|||
147062169|NCT02466971|530389201|FG001|Overall Study|ineligible and never treated|1|||
147062170|NCT04596540|530389208|FG000|Overall Study|Withdrawal by Subject|9|||
147062171|NCT04596540|530389209|FG001|Overall Study|Withdrawal by Subject|8|||
147062172|NCT04596540|530389210|FG002|Overall Study|Withdrawal by Subject|5|||
147062173|NCT04596540|530389208|FG000|Overall Study|Lost to Follow-up|1|||
147062174|NCT04596540|530389209|FG001|Overall Study|Lost to Follow-up|2|||
147062175|NCT04596540|530389210|FG002|Overall Study|Lost to Follow-up|1|||
147062176|NCT04596540|530389208|FG000|Overall Study|Sponsor Decision|2|||
147062177|NCT04596540|530389209|FG001|Overall Study|Sponsor Decision|0|||
147062178|NCT04596540|530389210|FG002|Overall Study|Sponsor Decision|0|||
147062179|NCT04596540|530389208|FG000|Overall Study|Physician Decision|0|||
147062180|NCT04596540|530389209|FG001|Overall Study|Physician Decision|1|||
147062181|NCT04596540|530389210|FG002|Overall Study|Physician Decision|1|||
147062182|NCT04596540|530389208|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
147062183|NCT04596540|530389209|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
147062184|NCT04596540|530389210|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
147062185|NCT04596540|530389208|FG000|Overall Study|Other Than Specified|5|||
147062186|NCT04596540|530389209|FG001|Overall Study|Other Than Specified|5|||
147062187|NCT04596540|530389210|FG002|Overall Study|Other Than Specified|2|||
147062188|NCT03210714|530389214|FG000|Overall Study|Adverse Event|6|||
147062189|NCT03210714|530389214|FG000|Overall Study|Physician Decision|1|||
147062190|NCT03210714|530389214|FG000|Overall Study|Progressive disease|11|||
147062191|NCT03210714|530389214|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
147062192|NCT02867592|530389217|FG000|Overall Study|Adverse Event|3|||
147062193|NCT02867592|530389218|FG001|Overall Study|Adverse Event|0|||
147062194|NCT02867592|530389219|FG002|Overall Study|Adverse Event|2|||
147062195|NCT02867592|530389220|FG003|Overall Study|Adverse Event|1|||
147062196|NCT02867592|530389221|FG004|Overall Study|Adverse Event|1|||
147062197|NCT02867592|530389222|FG005|Overall Study|Adverse Event|5|||
147062198|NCT02867592|530389217|FG000|Overall Study|Death|0|||
147062199|NCT02867592|530389218|FG001|Overall Study|Death|0|||
147062200|NCT02867592|530389219|FG002|Overall Study|Death|0|||
147062201|NCT02867592|530389220|FG003|Overall Study|Death|1|||
147062202|NCT02867592|530389221|FG004|Overall Study|Death|0|||
147062203|NCT02867592|530389222|FG005|Overall Study|Death|1|||
147062204|NCT02867592|530389217|FG000|Overall Study|Lack of Efficacy|8|||
147062205|NCT02867592|530389218|FG001|Overall Study|Lack of Efficacy|10|||
147062206|NCT02867592|530389219|FG002|Overall Study|Lack of Efficacy|8|||
147062207|NCT02867592|530389220|FG003|Overall Study|Lack of Efficacy|8|||
147062208|NCT02867592|530389221|FG004|Overall Study|Lack of Efficacy|12|||
147062209|NCT02867592|530389222|FG005|Overall Study|Lack of Efficacy|17|||
147062210|NCT02867592|530389217|FG000|Overall Study|Physician Decision|1|||
147062211|NCT02867592|530389218|FG001|Overall Study|Physician Decision|2|||
147062212|NCT02867592|530389219|FG002|Overall Study|Physician Decision|2|||
147062213|NCT02867592|530389220|FG003|Overall Study|Physician Decision|0|||
147062214|NCT02867592|530389221|FG004|Overall Study|Physician Decision|5|||
147062215|NCT02867592|530389222|FG005|Overall Study|Physician Decision|1|||
147062216|NCT02867592|530389217|FG000|Overall Study|Protocol Violation|0|||
147062217|NCT02867592|530389218|FG001|Overall Study|Protocol Violation|0|||
147062218|NCT02867592|530389219|FG002|Overall Study|Protocol Violation|0|||
147062219|NCT02867592|530389220|FG003|Overall Study|Protocol Violation|0|||
147062220|NCT02867592|530389221|FG004|Overall Study|Protocol Violation|1|||
147062221|NCT02867592|530389222|FG005|Overall Study|Protocol Violation|1|||
147062222|NCT02867592|530389217|FG000|Overall Study|Withdrawal by Subject|0|||
147062223|NCT02867592|530389218|FG001|Overall Study|Withdrawal by Subject|1|||
147062224|NCT02867592|530389219|FG002|Overall Study|Withdrawal by Subject|0|||
147062225|NCT02867592|530389220|FG003|Overall Study|Withdrawal by Subject|1|||
147062226|NCT02867592|530389221|FG004|Overall Study|Withdrawal by Subject|3|||
147062227|NCT02867592|530389222|FG005|Overall Study|Withdrawal by Subject|3|||
147062228|NCT02867592|530389217|FG000|Overall Study|Ineligible|1|||
147062229|NCT02867592|530389218|FG001|Overall Study|Ineligible|1|||
147062230|NCT02867592|530389219|FG002|Overall Study|Ineligible|0|||
147062231|NCT02867592|530389220|FG003|Overall Study|Ineligible|0|||
147062232|NCT02867592|530389221|FG004|Overall Study|Ineligible|2|||
147062233|NCT02867592|530389222|FG005|Overall Study|Ineligible|0|||
147062234|NCT02867592|530389217|FG000|Overall Study|No Treatment|1|||
147062235|NCT02867592|530389218|FG001|Overall Study|No Treatment|0|||
147062236|NCT02867592|530389219|FG002|Overall Study|No Treatment|0|||
147062237|NCT02867592|530389220|FG003|Overall Study|No Treatment|0|||
147062238|NCT02867592|530389221|FG004|Overall Study|No Treatment|0|||
147062239|NCT02867592|530389222|FG005|Overall Study|No Treatment|0|||
147062240|NCT02867592|530389217|FG000|Overall Study|Still on Therapy|0|||
147062241|NCT02867592|530389218|FG001|Overall Study|Still on Therapy|0|||
147062242|NCT02867592|530389219|FG002|Overall Study|Still on Therapy|0|||
147062243|NCT02867592|530389220|FG003|Overall Study|Still on Therapy|0|||
147062244|NCT02867592|530389221|FG004|Overall Study|Still on Therapy|1|||
147062245|NCT02867592|530389222|FG005|Overall Study|Still on Therapy|0|||
147062246|NCT02867592|530389217|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
147062247|NCT02867592|530389218|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
147062248|NCT02867592|530389219|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
147062249|NCT02867592|530389220|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
147062250|NCT02867592|530389221|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
147062251|NCT02867592|530389222|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
147062252|NCT02867592|530389217|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
147062253|NCT02867592|530389218|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
147062254|NCT02867592|530389219|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
147062255|NCT02867592|530389220|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
147062256|NCT02867592|530389221|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
147062257|NCT02867592|530389222|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
147062258|NCT00803179|530389223|FG000|Overall Study|Lost to Follow-up|3|||
147062259|NCT03358472|530389224|FG000|Overall Study|Death|6|||
147062260|NCT03358472|530389225|FG001|Overall Study|Death|3|||
147062261|NCT03358472|530389226|FG002|Overall Study|Death|10|||
147062262|NCT03358472|530389224|FG000|Overall Study|Physician Decision|0|||
147062263|NCT03358472|530389225|FG001|Overall Study|Physician Decision|1|||
147062264|NCT03358472|530389226|FG002|Overall Study|Physician Decision|0|||
147062265|NCT03358472|530389224|FG000|Overall Study|Withdrawal by Subject|0|||
147062266|NCT03358472|530389225|FG001|Overall Study|Withdrawal by Subject|0|||
147062267|NCT03358472|530389226|FG002|Overall Study|Withdrawal by Subject|1|||
147062268|NCT03358472|530389224|FG000|Overall Study|On-going at clinical cut off date|9|||
147062269|NCT03358472|530389225|FG001|Overall Study|On-going at clinical cut off date|6|||
147062270|NCT03358472|530389226|FG002|Overall Study|On-going at clinical cut off date|5|||
147062271|NCT03974022|530389228|FG000|Overall Study|Death|0|||
147062272|NCT03974022|530389229|FG001|Overall Study|Death|1|||
147062273|NCT03974022|530389230|FG002|Overall Study|Death|0|||
147062274|NCT03974022|530389231|FG003|Overall Study|Death|2|||
147062275|NCT03974022|530389232|FG004|Overall Study|Death|0|||
147062276|NCT03974022|530389233|FG005|Overall Study|Death|1|||
147062277|NCT03974022|530389234|FG006|Overall Study|Death|0|||
147062278|NCT03974022|530389235|FG007|Overall Study|Death|2|||
147062279|NCT03974022|530389236|FG008|Overall Study|Death|1|||
147062280|NCT03974022|530389237|FG009|Overall Study|Death|4|||
147062281|NCT03974022|530389238|FG010|Overall Study|Death|0|||
147062282|NCT03974022|530389239|FG011|Overall Study|Death|0|||
147062283|NCT03974022|530389240|FG012|Overall Study|Death|0|||
147062284|NCT03974022|530389241|FG013|Overall Study|Death|33|||
147062285|NCT03974022|530389242|FG014|Overall Study|Death|40|||
147062286|NCT03974022|530389228|FG000|Overall Study|Withdrawal by Subject|0|||
147062287|NCT03974022|530389229|FG001|Overall Study|Withdrawal by Subject|0|||
147062288|NCT03974022|530389230|FG002|Overall Study|Withdrawal by Subject|0|||
147062289|NCT03974022|530389231|FG003|Overall Study|Withdrawal by Subject|0|||
147062290|NCT03974022|530389232|FG004|Overall Study|Withdrawal by Subject|0|||
147062291|NCT03974022|530389233|FG005|Overall Study|Withdrawal by Subject|4|||
147062292|NCT03974022|530389234|FG006|Overall Study|Withdrawal by Subject|4|||
147062293|NCT03974022|530389235|FG007|Overall Study|Withdrawal by Subject|2|||
147062294|NCT03974022|530389236|FG008|Overall Study|Withdrawal by Subject|2|||
147062295|NCT03974022|530389237|FG009|Overall Study|Withdrawal by Subject|3|||
147062296|NCT03974022|530389238|FG010|Overall Study|Withdrawal by Subject|0|||
147062297|NCT03974022|530389239|FG011|Overall Study|Withdrawal by Subject|1|||
147062298|NCT03974022|530389240|FG012|Overall Study|Withdrawal by Subject|0|||
147062299|NCT03974022|530389241|FG013|Overall Study|Withdrawal by Subject|3|||
147062300|NCT03974022|530389242|FG014|Overall Study|Withdrawal by Subject|9|||
147062301|NCT03974022|530389228|FG000|Overall Study|Lost to Follow-up|0|||
147062302|NCT03974022|530389229|FG001|Overall Study|Lost to Follow-up|0|||
147062303|NCT03974022|530389230|FG002|Overall Study|Lost to Follow-up|0|||
147062304|NCT03974022|530389231|FG003|Overall Study|Lost to Follow-up|0|||
147062305|NCT03974022|530389232|FG004|Overall Study|Lost to Follow-up|0|||
147062306|NCT03974022|530389233|FG005|Overall Study|Lost to Follow-up|0|||
147062307|NCT03974022|530389234|FG006|Overall Study|Lost to Follow-up|1|||
147062308|NCT03974022|530389235|FG007|Overall Study|Lost to Follow-up|0|||
147062309|NCT03974022|530389236|FG008|Overall Study|Lost to Follow-up|0|||
147062310|NCT03974022|530389237|FG009|Overall Study|Lost to Follow-up|0|||
147062311|NCT03974022|530389238|FG010|Overall Study|Lost to Follow-up|0|||
147062312|NCT03974022|530389239|FG011|Overall Study|Lost to Follow-up|0|||
147062313|NCT03974022|530389240|FG012|Overall Study|Lost to Follow-up|0|||
147062314|NCT03974022|530389241|FG013|Overall Study|Lost to Follow-up|1|||
147062315|NCT03974022|530389242|FG014|Overall Study|Lost to Follow-up|1|||
147062316|NCT03974022|530389228|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
147062317|NCT03974022|530389229|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
147062318|NCT03974022|530389230|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
147062319|NCT03974022|530389231|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
147062320|NCT03974022|530389232|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
147062321|NCT03974022|530389233|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
147062322|NCT03974022|530389234|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
147062323|NCT03974022|530389235|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
147062324|NCT03974022|530389236|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
147062325|NCT03974022|530389237|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
147062326|NCT03974022|530389238|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
147062327|NCT03974022|530389239|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
147062328|NCT03974022|530389240|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
147062329|NCT03974022|530389241|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
147062330|NCT03974022|530389242|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
147062331|NCT05516758|530389243|FG000|Overall Study|Adverse Event|5|||
147062332|NCT05516758|530389244|FG001|Overall Study|Adverse Event|1|||
147062333|NCT05516758|530389245|FG002|Overall Study|Adverse Event|3|||
147062334|NCT05516758|530389246|FG003|Overall Study|Adverse Event|0|||
147062335|NCT05516758|530389247|FG004|Overall Study|Adverse Event|1|||
147062336|NCT05516758|530389248|FG005|Overall Study|Adverse Event|3|||
147062337|NCT05516758|530389249|FG006|Overall Study|Adverse Event|5|||
147062338|NCT05516758|530389243|FG000|Overall Study|Assigned treatment by mistake|1|||
147062339|NCT05516758|530389244|FG001|Overall Study|Assigned treatment by mistake|0|||
147062340|NCT05516758|530389245|FG002|Overall Study|Assigned treatment by mistake|0|||
147062341|NCT05516758|530389246|FG003|Overall Study|Assigned treatment by mistake|0|||
147062342|NCT05516758|530389247|FG004|Overall Study|Assigned treatment by mistake|1|||
147062343|NCT05516758|530389248|FG005|Overall Study|Assigned treatment by mistake|0|||
147062344|NCT05516758|530389249|FG006|Overall Study|Assigned treatment by mistake|0|||
147062345|NCT05516758|530389243|FG000|Overall Study|Lack of Efficacy|6|||
147062346|NCT05516758|530389244|FG001|Overall Study|Lack of Efficacy|0|||
147062347|NCT05516758|530389245|FG002|Overall Study|Lack of Efficacy|2|||
147062348|NCT05516758|530389246|FG003|Overall Study|Lack of Efficacy|0|||
147062349|NCT05516758|530389247|FG004|Overall Study|Lack of Efficacy|3|||
147062350|NCT05516758|530389248|FG005|Overall Study|Lack of Efficacy|6|||
147062351|NCT05516758|530389249|FG006|Overall Study|Lack of Efficacy|3|||
147062352|NCT05516758|530389243|FG000|Overall Study|Lost to Follow-up|2|||
147062353|NCT05516758|530389244|FG001|Overall Study|Lost to Follow-up|0|||
147062354|NCT05516758|530389245|FG002|Overall Study|Lost to Follow-up|2|||
147062355|NCT05516758|530389246|FG003|Overall Study|Lost to Follow-up|0|||
147062356|NCT05516758|530389247|FG004|Overall Study|Lost to Follow-up|3|||
147062357|NCT05516758|530389248|FG005|Overall Study|Lost to Follow-up|2|||
147062358|NCT05516758|530389249|FG006|Overall Study|Lost to Follow-up|1|||
147062359|NCT05516758|530389243|FG000|Overall Study|Other- As reported by the site|2|||
147062360|NCT05516758|530389244|FG001|Overall Study|Other- As reported by the site|1|||
147062361|NCT05516758|530389245|FG002|Overall Study|Other- As reported by the site|8|||
147062362|NCT05516758|530389246|FG003|Overall Study|Other- As reported by the site|1|||
147062363|NCT05516758|530389247|FG004|Overall Study|Other- As reported by the site|2|||
147062364|NCT05516758|530389248|FG005|Overall Study|Other- As reported by the site|3|||
147062365|NCT05516758|530389249|FG006|Overall Study|Other- As reported by the site|8|||
147062366|NCT05516758|530389243|FG000|Overall Study|Physician Decision|1|||
147062367|NCT05516758|530389244|FG001|Overall Study|Physician Decision|0|||
147062368|NCT05516758|530389245|FG002|Overall Study|Physician Decision|7|||
147062369|NCT05516758|530389246|FG003|Overall Study|Physician Decision|0|||
147062370|NCT05516758|530389247|FG004|Overall Study|Physician Decision|1|||
147062371|NCT05516758|530389248|FG005|Overall Study|Physician Decision|1|||
147062372|NCT05516758|530389249|FG006|Overall Study|Physician Decision|2|||
147062373|NCT05516758|530389243|FG000|Overall Study|Protocol Deviation|1|||
147062374|NCT05516758|530389244|FG001|Overall Study|Protocol Deviation|0|||
147062375|NCT05516758|530389245|FG002|Overall Study|Protocol Deviation|0|||
147062376|NCT05516758|530389246|FG003|Overall Study|Protocol Deviation|0|||
147062377|NCT05516758|530389247|FG004|Overall Study|Protocol Deviation|0|||
147062378|NCT05516758|530389248|FG005|Overall Study|Protocol Deviation|1|||
147062379|NCT05516758|530389249|FG006|Overall Study|Protocol Deviation|5|||
147062380|NCT05516758|530389243|FG000|Overall Study|Withdrawal by Subject|11|||
147062381|NCT05516758|530389244|FG001|Overall Study|Withdrawal by Subject|1|||
147062382|NCT05516758|530389245|FG002|Overall Study|Withdrawal by Subject|15|||
147062383|NCT05516758|530389246|FG003|Overall Study|Withdrawal by Subject|2|||
147062384|NCT05516758|530389247|FG004|Overall Study|Withdrawal by Subject|7|||
147062385|NCT05516758|530389248|FG005|Overall Study|Withdrawal by Subject|7|||
147062386|NCT05516758|530389249|FG006|Overall Study|Withdrawal by Subject|6|||
147062387|NCT05516758|530389243|FG000|Overall Study|Death|1|||
147062388|NCT05516758|530389244|FG001|Overall Study|Death|0|||
147062389|NCT05516758|530389245|FG002|Overall Study|Death|0|||
147062390|NCT05516758|530389246|FG003|Overall Study|Death|0|||
147062391|NCT05516758|530389247|FG004|Overall Study|Death|0|||
147062392|NCT05516758|530389248|FG005|Overall Study|Death|0|||
147062393|NCT05516758|530389249|FG006|Overall Study|Death|0|||
147062394|NCT05516758|530389243|FG000|Overall Study|Non-compliance With Study Drug|0|||
147062395|NCT05516758|530389244|FG001|Overall Study|Non-compliance With Study Drug|0|||
147062396|NCT05516758|530389245|FG002|Overall Study|Non-compliance With Study Drug|1|||
147062397|NCT05516758|530389246|FG003|Overall Study|Non-compliance With Study Drug|0|||
147062398|NCT05516758|530389247|FG004|Overall Study|Non-compliance With Study Drug|0|||
147062399|NCT05516758|530389248|FG005|Overall Study|Non-compliance With Study Drug|0|||
147062400|NCT05516758|530389249|FG006|Overall Study|Non-compliance With Study Drug|0|||
147062401|NCT05516758|530389243|FG000|Overall Study|Site Terminated by Sponsor|2|||
147062402|NCT05516758|530389244|FG001|Overall Study|Site Terminated by Sponsor|0|||
147062403|NCT05516758|530389245|FG002|Overall Study|Site Terminated by Sponsor|0|||
147062404|NCT05516758|530389246|FG003|Overall Study|Site Terminated by Sponsor|0|||
147062405|NCT05516758|530389247|FG004|Overall Study|Site Terminated by Sponsor|0|||
147062406|NCT05516758|530389248|FG005|Overall Study|Site Terminated by Sponsor|0|||
147062407|NCT05516758|530389249|FG006|Overall Study|Site Terminated by Sponsor|0|||
147062408|NCT05516758|530389243|FG000|Overall Study|Study Terminated by Sponsor|4|||
147062409|NCT05516758|530389244|FG001|Overall Study|Study Terminated by Sponsor|0|||
147062410|NCT05516758|530389245|FG002|Overall Study|Study Terminated by Sponsor|3|||
147062411|NCT05516758|530389246|FG003|Overall Study|Study Terminated by Sponsor|0|||
147062412|NCT05516758|530389247|FG004|Overall Study|Study Terminated by Sponsor|2|||
147062413|NCT05516758|530389248|FG005|Overall Study|Study Terminated by Sponsor|3|||
147062414|NCT05516758|530389249|FG006|Overall Study|Study Terminated by Sponsor|0|||
147062415|NCT05516758|530389243|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
147062416|NCT05516758|530389244|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
147062417|NCT05516758|530389245|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
147062418|NCT05516758|530389246|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
147062419|NCT05516758|530389247|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
147062420|NCT05516758|530389248|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
147062421|NCT05516758|530389249|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
147062422|NCT05516758|530389243|FG000|Overall Study|Other|0|||
147062423|NCT05516758|530389244|FG001|Overall Study|Other|0|||
147062424|NCT05516758|530389245|FG002|Overall Study|Other|0|||
147062425|NCT05516758|530389246|FG003|Overall Study|Other|0|||
147062426|NCT05516758|530389247|FG004|Overall Study|Other|0|||
147062427|NCT05516758|530389248|FG005|Overall Study|Other|0|||
147062428|NCT05516758|530389249|FG006|Overall Study|Other|1|||
147062429|NCT04158648|530389250|FG000|Overall Study|Ongoing in the Study|69|||
147062430|NCT04158648|530389250|FG000|Overall Study|Withdrawal by Subject|4|||
147062431|NCT04589650|530389252|FG000|Overall Study|Subject decision|6|||
147062432|NCT04589650|530389253|FG001|Overall Study|Subject decision|2|||
147062433|NCT04589650|530389254|FG002|Overall Study|Subject decision|2|||
147062434|NCT04589650|530389255|FG003|Overall Study|Subject decision|0|||
147062435|NCT04589650|530389256|FG004|Overall Study|Subject decision|0|||
147062436|NCT04589650|530389257|FG005|Overall Study|Subject decision|0|||
147062437|NCT04589650|530389252|FG000|Overall Study|Adverse Event|3|||
147062438|NCT04589650|530389253|FG001|Overall Study|Adverse Event|1|||
147062439|NCT04589650|530389254|FG002|Overall Study|Adverse Event|1|||
147062440|NCT04589650|530389255|FG003|Overall Study|Adverse Event|1|||
147062441|NCT04589650|530389256|FG004|Overall Study|Adverse Event|0|||
147062442|NCT04589650|530389257|FG005|Overall Study|Adverse Event|1|||
147062443|NCT04589650|530389252|FG000|Overall Study|Physician Decision|1|||
147062444|NCT04589650|530389253|FG001|Overall Study|Physician Decision|1|||
147062445|NCT04589650|530389254|FG002|Overall Study|Physician Decision|0|||
147062446|NCT04589650|530389255|FG003|Overall Study|Physician Decision|0|||
147062447|NCT04589650|530389256|FG004|Overall Study|Physician Decision|0|||
147062448|NCT04589650|530389257|FG005|Overall Study|Physician Decision|0|||
147062449|NCT04589650|530389252|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147062450|NCT04589650|530389253|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147062451|NCT04589650|530389254|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
147062452|NCT04589650|530389255|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
147062453|NCT04589650|530389256|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
147062454|NCT04589650|530389257|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
147062455|NCT04589650|530389252|FG000|Overall Study|Death|0|||
147062456|NCT04589650|530389253|FG001|Overall Study|Death|0|||
147062457|NCT04589650|530389254|FG002|Overall Study|Death|0|||
147062458|NCT04589650|530389255|FG003|Overall Study|Death|1|||
147062459|NCT04589650|530389256|FG004|Overall Study|Death|0|||
147062460|NCT04589650|530389257|FG005|Overall Study|Death|0|||
147062461|NCT04589650|530389252|FG000|Overall Study|Guardian Decision|0|||
147062462|NCT04589650|530389253|FG001|Overall Study|Guardian Decision|0|||
147062463|NCT04589650|530389254|FG002|Overall Study|Guardian Decision|0|||
147062464|NCT04589650|530389255|FG003|Overall Study|Guardian Decision|1|||
147062465|NCT04589650|530389256|FG004|Overall Study|Guardian Decision|0|||
147062466|NCT04589650|530389257|FG005|Overall Study|Guardian Decision|0|||
147062467|NCT04935879|530389265|FG000|Overall Study|Adverse Event|2|||
147062468|NCT04935879|530389266|FG001|Overall Study|Adverse Event|1|||
147062469|NCT04935879|530389265|FG000|Overall Study|Lost to Follow-up|1|||
147062470|NCT04935879|530389266|FG001|Overall Study|Lost to Follow-up|1|||
147062471|NCT04935879|530389265|FG000|Overall Study|Pregnancy|2|||
147062472|NCT04935879|530389266|FG001|Overall Study|Pregnancy|3|||
147062473|NCT04935879|530389265|FG000|Overall Study|Withdrawal by Subject|8|||
147062474|NCT04935879|530389266|FG001|Overall Study|Withdrawal by Subject|6|||
147062475|NCT04935879|530389265|FG000|Overall Study|Other|3|||
147062476|NCT04935879|530389266|FG001|Overall Study|Other|3|||
147062477|NCT05032066|530389267|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
147062478|NCT05032066|530389268|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
147062479|NCT05032066|530389269|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
147062480|NCT05032066|530389267|FG000|Part 1: Core Phase|Physician Decision|0|||
147062481|NCT05032066|530389268|FG001|Part 1: Core Phase|Physician Decision|1|||
147062482|NCT05032066|530389269|FG002|Part 1: Core Phase|Physician Decision|1|||
147062483|NCT05032066|530389267|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
147062484|NCT05032066|530389268|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
147062485|NCT05032066|530389269|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
147062486|NCT05032066|530389267|FG000|Part 1: Core Phase|Death|3|||
147062487|NCT05032066|530389268|FG001|Part 1: Core Phase|Death|4|||
147062488|NCT05032066|530389269|FG002|Part 1: Core Phase|Death|2|||
147062489|NCT05032066|530389267|FG000|Part 1: Core Phase|Adverse Event|2|||
147062490|NCT05032066|530389268|FG001|Part 1: Core Phase|Adverse Event|3|||
147062491|NCT05032066|530389269|FG002|Part 1: Core Phase|Adverse Event|0|||
147062492|NCT05032066|530389267|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
147062493|NCT05032066|530389268|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
147062494|NCT05032066|530389269|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
147062495|NCT05032066|530389267|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
147062496|NCT05032066|530389268|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
147062497|NCT05032066|530389269|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
147062498|NCT05032066|530389267|FG000|Part 2: Extension Phase|Physician Decision|1|||
147062499|NCT05032066|530389268|FG001|Part 2: Extension Phase|Physician Decision|2|||
147062500|NCT05032066|530389269|FG002|Part 2: Extension Phase|Physician Decision|0|||
147062501|NCT05032066|530389267|FG000|Part 2: Extension Phase|Death|2|||
147062502|NCT05032066|530389268|FG001|Part 2: Extension Phase|Death|4|||
147062503|NCT05032066|530389269|FG002|Part 2: Extension Phase|Death|5|||
147062504|NCT02101853|530389272|FG000|Block 1 Induction|Adverse Event|11|||
147062505|NCT02101853|530389273|FG001|Block 1 Induction|Adverse Event|0|||
147062506|NCT02101853|530389274|FG002|Block 1 Induction|Adverse Event|0|||
147062507|NCT02101853|530389275|FG003|Block 1 Induction|Adverse Event|0|||
147062508|NCT02101853|530389276|FG004|Block 1 Induction|Adverse Event|0|||
147062509|NCT02101853|530389277|FG005|Block 1 Induction|Adverse Event|0|||
147062510|NCT02101853|530389272|FG000|Block 1 Induction|Death|20|||
147062511|NCT02101853|530389273|FG001|Block 1 Induction|Death|0|||
147062512|NCT02101853|530389274|FG002|Block 1 Induction|Death|0|||
147062513|NCT02101853|530389275|FG003|Block 1 Induction|Death|0|||
147062514|NCT02101853|530389276|FG004|Block 1 Induction|Death|0|||
147062515|NCT02101853|530389277|FG005|Block 1 Induction|Death|0|||
147062516|NCT02101853|530389272|FG000|Block 1 Induction|Lack of Efficacy|6|||
147062517|NCT02101853|530389273|FG001|Block 1 Induction|Lack of Efficacy|0|||
147062518|NCT02101853|530389274|FG002|Block 1 Induction|Lack of Efficacy|0|||
147062519|NCT02101853|530389275|FG003|Block 1 Induction|Lack of Efficacy|0|||
147062520|NCT02101853|530389276|FG004|Block 1 Induction|Lack of Efficacy|0|||
147062521|NCT02101853|530389277|FG005|Block 1 Induction|Lack of Efficacy|0|||
147062522|NCT02101853|530389272|FG000|Block 1 Induction|Physician Decision|61|||
147062523|NCT02101853|530389273|FG001|Block 1 Induction|Physician Decision|0|||
147062524|NCT02101853|530389274|FG002|Block 1 Induction|Physician Decision|0|||
147062525|NCT02101853|530389275|FG003|Block 1 Induction|Physician Decision|0|||
147062526|NCT02101853|530389276|FG004|Block 1 Induction|Physician Decision|0|||
147062527|NCT02101853|530389277|FG005|Block 1 Induction|Physician Decision|0|||
147062528|NCT02101853|530389272|FG000|Block 1 Induction|Protocol Violation|2|||
147062529|NCT02101853|530389273|FG001|Block 1 Induction|Protocol Violation|0|||
147062530|NCT02101853|530389274|FG002|Block 1 Induction|Protocol Violation|0|||
147062531|NCT02101853|530389275|FG003|Block 1 Induction|Protocol Violation|0|||
147062532|NCT02101853|530389276|FG004|Block 1 Induction|Protocol Violation|0|||
147062533|NCT02101853|530389277|FG005|Block 1 Induction|Protocol Violation|0|||
147062534|NCT02101853|530389272|FG000|Block 1 Induction|Withdrawal by Subject|65|||
147062535|NCT02101853|530389273|FG001|Block 1 Induction|Withdrawal by Subject|0|||
147062536|NCT02101853|530389274|FG002|Block 1 Induction|Withdrawal by Subject|0|||
147062537|NCT02101853|530389275|FG003|Block 1 Induction|Withdrawal by Subject|0|||
147062538|NCT02101853|530389276|FG004|Block 1 Induction|Withdrawal by Subject|0|||
147062539|NCT02101853|530389277|FG005|Block 1 Induction|Withdrawal by Subject|0|||
147062540|NCT02101853|530389272|FG000|Block 1 Induction|Ineligible|8|||
147062541|NCT02101853|530389273|FG001|Block 1 Induction|Ineligible|0|||
147062542|NCT02101853|530389274|FG002|Block 1 Induction|Ineligible|0|||
147062543|NCT02101853|530389275|FG003|Block 1 Induction|Ineligible|0|||
147062544|NCT02101853|530389276|FG004|Block 1 Induction|Ineligible|0|||
147062545|NCT02101853|530389277|FG005|Block 1 Induction|Ineligible|0|||
147062546|NCT02101853|530389272|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
147062547|NCT02101853|530389273|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
147062548|NCT02101853|530389274|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
147062549|NCT02101853|530389275|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
147062550|NCT02101853|530389276|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
147062551|NCT02101853|530389277|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
147062552|NCT02101853|530389272|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
147062553|NCT02101853|530389273|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147062554|NCT02101853|530389274|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147062555|NCT02101853|530389275|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147062556|NCT02101853|530389276|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147062557|NCT02101853|530389277|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147062558|NCT02101853|530389272|FG000|Post Induction Randomization|Adverse Event|0|||
147062559|NCT02101853|530389273|FG001|Post Induction Randomization|Adverse Event|3|||
147062560|NCT02101853|530389274|FG002|Post Induction Randomization|Adverse Event|8|||
147062561|NCT02101853|530389275|FG003|Post Induction Randomization|Adverse Event|4|||
147062562|NCT02101853|530389276|FG004|Post Induction Randomization|Adverse Event|4|||
147062563|NCT02101853|530389277|FG005|Post Induction Randomization|Adverse Event|0|||
147062564|NCT02101853|530389272|FG000|Post Induction Randomization|Death|0|||
147062565|NCT02101853|530389273|FG001|Post Induction Randomization|Death|9|||
147062566|NCT02101853|530389274|FG002|Post Induction Randomization|Death|2|||
147062567|NCT02101853|530389275|FG003|Post Induction Randomization|Death|2|||
147062568|NCT02101853|530389276|FG004|Post Induction Randomization|Death|0|||
147062569|NCT02101853|530389277|FG005|Post Induction Randomization|Death|0|||
147062570|NCT02101853|530389272|FG000|Post Induction Randomization|Lack of Efficacy|0|||
147062571|NCT02101853|530389273|FG001|Post Induction Randomization|Lack of Efficacy|14|||
147062572|NCT02101853|530389274|FG002|Post Induction Randomization|Lack of Efficacy|23|||
147062573|NCT02101853|530389275|FG003|Post Induction Randomization|Lack of Efficacy|18|||
147062574|NCT02101853|530389276|FG004|Post Induction Randomization|Lack of Efficacy|21|||
147062575|NCT02101853|530389277|FG005|Post Induction Randomization|Lack of Efficacy|0|||
147062576|NCT02101853|530389272|FG000|Post Induction Randomization|Physician Decision|0|||
147062577|NCT02101853|530389273|FG001|Post Induction Randomization|Physician Decision|43|||
147062578|NCT02101853|530389274|FG002|Post Induction Randomization|Physician Decision|23|||
147062579|NCT02101853|530389275|FG003|Post Induction Randomization|Physician Decision|14|||
147062580|NCT02101853|530389276|FG004|Post Induction Randomization|Physician Decision|14|||
147062581|NCT02101853|530389277|FG005|Post Induction Randomization|Physician Decision|0|||
147062582|NCT02101853|530389272|FG000|Post Induction Randomization|Protocol Violation|0|||
147062583|NCT02101853|530389273|FG001|Post Induction Randomization|Protocol Violation|3|||
147062584|NCT02101853|530389274|FG002|Post Induction Randomization|Protocol Violation|0|||
147062585|NCT02101853|530389275|FG003|Post Induction Randomization|Protocol Violation|0|||
147062586|NCT02101853|530389276|FG004|Post Induction Randomization|Protocol Violation|0|||
147062587|NCT02101853|530389277|FG005|Post Induction Randomization|Protocol Violation|0|||
147062588|NCT02101853|530389272|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
147062589|NCT02101853|530389273|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
147062590|NCT02101853|530389274|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
147062591|NCT02101853|530389275|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
147062592|NCT02101853|530389276|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
147062593|NCT02101853|530389277|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
147062594|NCT02101853|530389272|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147062595|NCT02101853|530389273|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147062596|NCT02101853|530389274|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147062597|NCT02101853|530389275|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
147062598|NCT02101853|530389276|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147062599|NCT02101853|530389277|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147062600|NCT02101853|530389272|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
147062601|NCT02101853|530389273|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
147062602|NCT02101853|530389274|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
147062603|NCT02101853|530389275|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
147062604|NCT02101853|530389276|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
147062605|NCT02101853|530389277|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
147062606|NCT02101853|530389272|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
147062607|NCT02101853|530389273|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
147062608|NCT02101853|530389274|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
147062609|NCT02101853|530389275|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
147062610|NCT02101853|530389276|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
147062611|NCT02101853|530389277|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
147062612|NCT02101853|530389272|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
147062613|NCT02101853|530389273|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
147062614|NCT02101853|530389274|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
147062615|NCT02101853|530389275|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
147062616|NCT02101853|530389276|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
147062617|NCT02101853|530389277|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
147062618|NCT02101853|530389272|FG000|Blinatumomab Salvage Therapy|Death|0|||
147062619|NCT02101853|530389273|FG001|Blinatumomab Salvage Therapy|Death|0|||
147062620|NCT02101853|530389274|FG002|Blinatumomab Salvage Therapy|Death|0|||
147062621|NCT02101853|530389275|FG003|Blinatumomab Salvage Therapy|Death|0|||
147062622|NCT02101853|530389276|FG004|Blinatumomab Salvage Therapy|Death|0|||
147062623|NCT02101853|530389277|FG005|Blinatumomab Salvage Therapy|Death|2|||
147062624|NCT02101853|530389272|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
147062625|NCT02101853|530389273|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
147062626|NCT02101853|530389274|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
147062627|NCT02101853|530389275|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
147062628|NCT02101853|530389276|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
147062629|NCT02101853|530389277|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
147062630|NCT02101853|530389272|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
147062631|NCT02101853|530389273|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
147062632|NCT02101853|530389274|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
147062633|NCT02101853|530389275|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
147062634|NCT02101853|530389276|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
147062635|NCT02101853|530389277|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
147062636|NCT02101853|530389272|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
147062637|NCT02101853|530389273|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
147062638|NCT02101853|530389274|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
147062639|NCT02101853|530389275|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
147062640|NCT02101853|530389276|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
147062641|NCT02101853|530389277|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
147062642|NCT02112916|530389278|FG000|Overall Study|Adverse Event|6|||
147062643|NCT02112916|530389279|FG001|Overall Study|Adverse Event|9|||
147062644|NCT02112916|530389280|FG002|Overall Study|Adverse Event|3|||
147062645|NCT02112916|530389281|FG003|Overall Study|Adverse Event|2|||
147062646|NCT02112916|530389278|FG000|Overall Study|Death|9|||
147062647|NCT02112916|530389279|FG001|Overall Study|Death|9|||
147062648|NCT02112916|530389280|FG002|Overall Study|Death|3|||
147062649|NCT02112916|530389281|FG003|Overall Study|Death|4|||
147062650|NCT02112916|530389278|FG000|Overall Study|Lost to Follow-up|1|||
147062651|NCT02112916|530389279|FG001|Overall Study|Lost to Follow-up|0|||
147062652|NCT02112916|530389280|FG002|Overall Study|Lost to Follow-up|0|||
147062653|NCT02112916|530389281|FG003|Overall Study|Lost to Follow-up|0|||
147062654|NCT02112916|530389278|FG000|Overall Study|Physician Decision|94|||
147062655|NCT02112916|530389279|FG001|Overall Study|Physician Decision|72|||
147062656|NCT02112916|530389280|FG002|Overall Study|Physician Decision|24|||
147062657|NCT02112916|530389281|FG003|Overall Study|Physician Decision|15|||
147062658|NCT02112916|530389278|FG000|Overall Study|Withdrawal by Subject|5|||
147062659|NCT02112916|530389279|FG001|Overall Study|Withdrawal by Subject|3|||
147062660|NCT02112916|530389280|FG002|Overall Study|Withdrawal by Subject|1|||
147062661|NCT02112916|530389281|FG003|Overall Study|Withdrawal by Subject|1|||
147062662|NCT02112916|530389278|FG000|Overall Study|Ineligible|4|||
147062663|NCT02112916|530389279|FG001|Overall Study|Ineligible|8|||
147062664|NCT02112916|530389280|FG002|Overall Study|Ineligible|3|||
147062665|NCT02112916|530389281|FG003|Overall Study|Ineligible|8|||
147062666|NCT02112916|530389278|FG000|Overall Study|Inevaluable|6|||
147062667|NCT02112916|530389279|FG001|Overall Study|Inevaluable|4|||
147062668|NCT02112916|530389280|FG002|Overall Study|Inevaluable|5|||
147062669|NCT02112916|530389281|FG003|Overall Study|Inevaluable|5|||
147062670|NCT02112916|530389278|FG000|Overall Study|Refusal of further protocol therapy|19|||
147062671|NCT02112916|530389279|FG001|Overall Study|Refusal of further protocol therapy|16|||
147062672|NCT02112916|530389280|FG002|Overall Study|Refusal of further protocol therapy|1|||
147062673|NCT02112916|530389281|FG003|Overall Study|Refusal of further protocol therapy|7|||
147062674|NCT02112916|530389278|FG000|Overall Study|Development of SMN|1|||
147062675|NCT02112916|530389279|FG001|Overall Study|Development of SMN|0|||
147062676|NCT02112916|530389280|FG002|Overall Study|Development of SMN|0|||
147062677|NCT02112916|530389281|FG003|Overall Study|Development of SMN|1|||
147062678|NCT02112916|530389278|FG000|Overall Study|Relapse/Progression|10|||
147062679|NCT02112916|530389279|FG001|Overall Study|Relapse/Progression|18|||
147062680|NCT02112916|530389280|FG002|Overall Study|Relapse/Progression|15|||
147062681|NCT02112916|530389281|FG003|Overall Study|Relapse/Progression|2|||
147062682|NCT02112916|530389278|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
147062683|NCT02112916|530389279|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
147062684|NCT02112916|530389280|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
147062685|NCT02112916|530389281|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
147062686|NCT02112916|530389278|FG000|Overall Study|Still on Therapy|44|||
147062687|NCT02112916|530389279|FG001|Overall Study|Still on Therapy|47|||
147062688|NCT02112916|530389280|FG002|Overall Study|Still on Therapy|3|||
147062689|NCT02112916|530389281|FG003|Overall Study|Still on Therapy|2|||
147062690|NCT02112916|530389278|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
147062691|NCT02112916|530389279|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
147062692|NCT02112916|530389280|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
147062693|NCT02112916|530389281|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
147062694|NCT02112916|530389278|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
147062695|NCT02112916|530389279|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
147062696|NCT02112916|530389280|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
147062697|NCT02112916|530389281|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
147062698|NCT06178991|530389282|FG000|Overall Study|Withdrawal by Subject|2|||
147062699|NCT06178991|530389283|FG001|Overall Study|Withdrawal by Subject|6|||
147062700|NCT06178991|530389284|FG002|Overall Study|Withdrawal by Subject|44|||
147062701|NCT06178991|530389285|FG003|Overall Study|Withdrawal by Subject|23|||
147062702|NCT06178991|530389286|FG004|Overall Study|Withdrawal by Subject|7|||
147062703|NCT06178991|530389287|FG005|Overall Study|Withdrawal by Subject|7|||
147062704|NCT06178991|530389288|FG006|Overall Study|Withdrawal by Subject|7|||
147062705|NCT06178991|530389289|FG007|Overall Study|Withdrawal by Subject|5|||
147062706|NCT06178991|530389282|FG000|Overall Study|Lost to Follow-up|2|||
147062707|NCT06178991|530389283|FG001|Overall Study|Lost to Follow-up|4|||
147062708|NCT06178991|530389284|FG002|Overall Study|Lost to Follow-up|133|||
147062709|NCT06178991|530389285|FG003|Overall Study|Lost to Follow-up|65|||
147062710|NCT06178991|530389286|FG004|Overall Study|Lost to Follow-up|68|||
147062711|NCT06178991|530389287|FG005|Overall Study|Lost to Follow-up|57|||
147062712|NCT06178991|530389288|FG006|Overall Study|Lost to Follow-up|25|||
147062713|NCT06178991|530389289|FG007|Overall Study|Lost to Follow-up|18|||
147062714|NCT06178991|530389282|FG000|Overall Study|Death|1|||
147062715|NCT06178991|530389283|FG001|Overall Study|Death|0|||
147062716|NCT06178991|530389284|FG002|Overall Study|Death|2|||
147062717|NCT06178991|530389285|FG003|Overall Study|Death|1|||
147062718|NCT06178991|530389286|FG004|Overall Study|Death|1|||
147062719|NCT06178991|530389287|FG005|Overall Study|Death|0|||
147062720|NCT06178991|530389288|FG006|Overall Study|Death|1|||
147062721|NCT06178991|530389289|FG007|Overall Study|Death|1|||
147062722|NCT06178991|530389282|FG000|Overall Study|Randomized but not Vaccinated|4|||
146850077|NCT00964886|529620716|FG003|Overall Study|Lost to Follow-up|4|||
147062723|NCT06178991|530389283|FG001|Overall Study|Randomized but not Vaccinated|1|||
147062724|NCT06178991|530389284|FG002|Overall Study|Randomized but not Vaccinated|15|||
147062725|NCT06178991|530389285|FG003|Overall Study|Randomized but not Vaccinated|9|||
147062726|NCT06178991|530389286|FG004|Overall Study|Randomized but not Vaccinated|8|||
147062727|NCT06178991|530389287|FG005|Overall Study|Randomized but not Vaccinated|4|||
147062728|NCT06178991|530389288|FG006|Overall Study|Randomized but not Vaccinated|2|||
147062729|NCT06178991|530389289|FG007|Overall Study|Randomized but not Vaccinated|2|||
147062730|NCT06178991|530389282|FG000|Overall Study|Other: Unspecified|0|||
147062731|NCT06178991|530389283|FG001|Overall Study|Other: Unspecified|1|||
147062732|NCT06178991|530389284|FG002|Overall Study|Other: Unspecified|7|||
147062733|NCT06178991|530389285|FG003|Overall Study|Other: Unspecified|6|||
147062734|NCT06178991|530389286|FG004|Overall Study|Other: Unspecified|1|||
147062735|NCT06178991|530389287|FG005|Overall Study|Other: Unspecified|1|||
147062736|NCT06178991|530389288|FG006|Overall Study|Other: Unspecified|1|||
147062737|NCT06178991|530389289|FG007|Overall Study|Other: Unspecified|0|||
147062738|NCT06178991|530389282|FG000|Overall Study|Physician Decision|0|||
147062739|NCT06178991|530389283|FG001|Overall Study|Physician Decision|0|||
147062740|NCT06178991|530389284|FG002|Overall Study|Physician Decision|2|||
147062741|NCT06178991|530389285|FG003|Overall Study|Physician Decision|0|||
147062742|NCT06178991|530389286|FG004|Overall Study|Physician Decision|2|||
147062743|NCT06178991|530389287|FG005|Overall Study|Physician Decision|1|||
147062744|NCT06178991|530389288|FG006|Overall Study|Physician Decision|0|||
147062745|NCT06178991|530389289|FG007|Overall Study|Physician Decision|0|||
147062746|NCT06178991|530389282|FG000|Overall Study|Protocol Violation|0|||
147062747|NCT06178991|530389283|FG001|Overall Study|Protocol Violation|0|||
147062748|NCT06178991|530389284|FG002|Overall Study|Protocol Violation|1|||
147062749|NCT06178991|530389285|FG003|Overall Study|Protocol Violation|0|||
147062750|NCT06178991|530389286|FG004|Overall Study|Protocol Violation|0|||
147062751|NCT06178991|530389287|FG005|Overall Study|Protocol Violation|0|||
147062752|NCT06178991|530389288|FG006|Overall Study|Protocol Violation|0|||
147062753|NCT06178991|530389289|FG007|Overall Study|Protocol Violation|0|||
147062754|NCT04739800|530389290|FG000|Overall Study|Adverse Event|2|||
147062755|NCT04739800|530389291|FG001|Overall Study|Adverse Event|1|||
147062756|NCT04739800|530389292|FG002|Overall Study|Adverse Event|4|||
147062757|NCT04739800|530389293|FG003|Overall Study|Adverse Event|5|||
147062758|NCT04739800|530389290|FG000|Overall Study|Never Treated|2|||
147062759|NCT04739800|530389291|FG001|Overall Study|Never Treated|0|||
147062760|NCT04739800|530389292|FG002|Overall Study|Never Treated|1|||
147062761|NCT04739800|530389293|FG003|Overall Study|Never Treated|1|||
147062762|NCT04739800|530389290|FG000|Overall Study|On Treatment|5|||
147062763|NCT04739800|530389291|FG001|Overall Study|On Treatment|9|||
147062764|NCT04739800|530389292|FG002|Overall Study|On Treatment|9|||
147062765|NCT04739800|530389293|FG003|Overall Study|On Treatment|9|||
147062766|NCT04739800|530389290|FG000|Overall Study|Symptomatic Deterioration|1|||
147062767|NCT04739800|530389291|FG001|Overall Study|Symptomatic Deterioration|1|||
147062768|NCT04739800|530389292|FG002|Overall Study|Symptomatic Deterioration|3|||
147062769|NCT04739800|530389293|FG003|Overall Study|Symptomatic Deterioration|0|||
147062770|NCT04739800|530389290|FG000|Overall Study|Withdrawal by Subject|1|||
147062771|NCT04739800|530389291|FG001|Overall Study|Withdrawal by Subject|2|||
147062772|NCT04739800|530389292|FG002|Overall Study|Withdrawal by Subject|1|||
147062773|NCT04739800|530389293|FG003|Overall Study|Withdrawal by Subject|3|||
147062774|NCT04739800|530389290|FG000|Overall Study|Other Reason|1|||
147062775|NCT04739800|530389291|FG001|Overall Study|Other Reason|3|||
147062776|NCT04739800|530389292|FG002|Overall Study|Other Reason|5|||
147062777|NCT04739800|530389293|FG003|Overall Study|Other Reason|4|||
147062778|NCT04526665|530389298|FG000|Overall Study|Withdrawal by Subject|6|||
147062779|NCT04526665|530389299|FG001|Overall Study|Withdrawal by Subject|3|||
147062780|NCT04526665|530389298|FG000|Overall Study|Adverse Event|4|||
147062781|NCT04526665|530389299|FG001|Overall Study|Adverse Event|1|||
147062782|NCT04526665|530389298|FG000|Overall Study|Physician Decision|2|||
147062783|NCT04526665|530389299|FG001|Overall Study|Physician Decision|2|||
147062784|NCT04526665|530389298|FG000|Overall Study|Death|2|||
147062785|NCT04526665|530389299|FG001|Overall Study|Death|0|||
147062786|NCT04526665|530389298|FG000|Overall Study|Other|0|||
147062787|NCT04526665|530389299|FG001|Overall Study|Other|1|||
147062788|NCT06070610|530389300|FG000|Washout period|Adverse Event|1|||
147062789|NCT06070610|530389300|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
147062790|NCT04880850|530389303|FG000|Overall Study|Death|2|||
147062791|NCT04880850|530389304|FG001|Overall Study|Death|1|||
147062792|NCT04880850|530389303|FG000|Overall Study|Lost to Follow-up|3|||
147062793|NCT04880850|530389304|FG001|Overall Study|Lost to Follow-up|6|||
147062794|NCT04880850|530389303|FG000|Overall Study|Physician Decision|2|||
147062795|NCT04880850|530389304|FG001|Overall Study|Physician Decision|1|||
147062796|NCT04880850|530389303|FG000|Overall Study|Withdrawal by Subject|9|||
147062797|NCT04880850|530389304|FG001|Overall Study|Withdrawal by Subject|10|||
147062798|NCT02485860|530389305|FG000|Overall Study|Lost to Follow-up|4|||
147062799|NCT02485860|530389306|FG001|Overall Study|Lost to Follow-up|1|||
147062800|NCT02485860|530389305|FG000|Overall Study|Physician Decision|1|||
147062801|NCT02485860|530389306|FG001|Overall Study|Physician Decision|2|||
147062802|NCT02485860|530389305|FG000|Overall Study|Health context (COVID-19)|1|||
147062803|NCT02485860|530389306|FG001|Overall Study|Health context (COVID-19)|0|||
147062804|NCT04091451|530389953|FG000|Overall Study|Adverse Event|15|||
147062805|NCT04091451|530389954|FG001|Overall Study|Adverse Event|10|||
147062806|NCT04091451|530389953|FG000|Overall Study|Lost to Follow-up|8|||
147062807|NCT04091451|530389954|FG001|Overall Study|Lost to Follow-up|8|||
147062808|NCT04091451|530389953|FG000|Overall Study|Protocol Violation|5|||
147062809|NCT04091451|530389954|FG001|Overall Study|Protocol Violation|4|||
147062810|NCT04091451|530389953|FG000|Overall Study|Withdrawal by Subject|21|||
147062811|NCT04091451|530389954|FG001|Overall Study|Withdrawal by Subject|27|||
147062812|NCT04091451|530389953|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
147062813|NCT04091451|530389954|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
147062814|NCT04091451|530389953|FG000|Overall Study|Migrated/moved from the study area|3|||
147062815|NCT04091451|530389954|FG001|Overall Study|Migrated/moved from the study area|5|||
147062816|NCT04091451|530389953|FG000|Overall Study|Suspected HZ episode|1|||
147062817|NCT04091451|530389954|FG001|Overall Study|Suspected HZ episode|0|||
147062818|NCT03907488|530389957|FG000|Overall Study|Adverse Event|20|||
147062819|NCT03907488|530389958|FG001|Overall Study|Adverse Event|20|||
147062820|NCT03907488|530389957|FG000|Overall Study|Withdrawal by Subject|9|||
147062821|NCT03907488|530389958|FG001|Overall Study|Withdrawal by Subject|13|||
147062822|NCT03907488|530389957|FG000|Overall Study|Lack of Efficacy|0|||
147062823|NCT03907488|530389958|FG001|Overall Study|Lack of Efficacy|9|||
147062824|NCT03907488|530389957|FG000|Overall Study|Death|3|||
147062825|NCT03907488|530389958|FG001|Overall Study|Death|8|||
147062826|NCT03907488|530389957|FG000|Overall Study|not protocol specified|5|||
147062827|NCT03907488|530389958|FG001|Overall Study|not protocol specified|8|||
147062828|NCT03907488|530389957|FG000|Overall Study|Ineligible|9|||
147062829|NCT03907488|530389958|FG001|Overall Study|Ineligible|15|||
147062830|NCT04704219|530389962|FG000|Overall Study|Screen Failure|1|||
147062831|NCT04704219|530389962|FG000|Overall Study|Withdrawal by Subject|1|||
147062832|NCT04704219|530389962|FG000|Overall Study|Death|78|||
147062833|NCT04704219|530389962|FG000|Overall Study|Participants Ongoing|80|||
147062834|NCT02839707|530389964|FG000|Phase I|Not eligible for analysis|9|||
147062835|NCT02839707|530389965|FG001|Phase I|Not eligible for analysis|0|||
147062836|NCT02839707|530389966|FG002|Phase I|Not eligible for analysis|0|||
147062837|NCT02839707|530389964|FG000|Phase II|Not treated according to protocol|4|||
147062838|NCT02839707|530389965|FG001|Phase II|Not treated according to protocol|0|||
147062839|NCT02839707|530389966|FG002|Phase II|Not treated according to protocol|2|||
147062840|NCT02839707|530389964|FG000|Phase III|Not treated according to protocol|0|||
147062841|NCT02839707|530389965|FG001|Phase III|Not treated according to protocol|0|||
147062842|NCT02839707|530389966|FG002|Phase III|Not treated according to protocol|4|||
147062843|NCT02890355|530389967|FG000|Overall Study|Adverse Event|5|||
147062844|NCT02890355|530389968|FG001|Overall Study|Adverse Event|5|||
147062845|NCT02890355|530389967|FG000|Overall Study|Refusal unrelated to adverse event|5|||
147062846|NCT02890355|530389968|FG001|Overall Study|Refusal unrelated to adverse event|10|||
147062847|NCT02890355|530389967|FG000|Overall Study|Progression/relapse|46|||
147062848|NCT02890355|530389968|FG001|Overall Study|Progression/relapse|39|||
147062849|NCT02890355|530389967|FG000|Overall Study|Not protocol specified|3|||
147062850|NCT02890355|530389968|FG001|Overall Study|Not protocol specified|4|||
147062851|NCT03570892|530389969|FG000|Overall Study|Death|51|||
147062852|NCT03570892|530389970|FG001|Overall Study|Death|45|||
147062853|NCT03570892|530389969|FG000|Overall Study|Subject decision|5|||
147062854|NCT03570892|530389970|FG001|Overall Study|Subject decision|3|||
147062855|NCT03570892|530389969|FG000|Overall Study|Protocol Violation|1|||
147062856|NCT03570892|530389970|FG001|Overall Study|Protocol Violation|4|||
147062857|NCT03570892|530389969|FG000|Overall Study|Physician Decision|0|||
147062858|NCT03570892|530389970|FG001|Overall Study|Physician Decision|2|||
147062859|NCT03586479|530389976|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
147062860|NCT03586479|530389977|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
147062861|NCT03586479|530389978|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
147062862|NCT03586479|530389976|FG000|Overall Study|Protocol Violation|2|||
147062863|NCT03586479|530389977|FG001|Overall Study|Protocol Violation|0|||
147062864|NCT03586479|530389978|FG002|Overall Study|Protocol Violation|0|||
147062865|NCT03586479|530389976|FG000|Overall Study|Lost to Follow-up|1|||
147062866|NCT03586479|530389977|FG001|Overall Study|Lost to Follow-up|1|||
147062867|NCT03586479|530389978|FG002|Overall Study|Lost to Follow-up|2|||
147062868|NCT03586479|530389976|FG000|Overall Study|Behavioral Issues|1|||
147062869|NCT03586479|530389977|FG001|Overall Study|Behavioral Issues|0|||
147062870|NCT03586479|530389978|FG002|Overall Study|Behavioral Issues|0|||
147062871|NCT05938920|530389979|FG000|Overall Study|Adverse Event|1|||
147062872|NCT05938920|530389980|FG001|Overall Study|Adverse Event|3|||
147062873|NCT05938920|530389981|FG002|Overall Study|Adverse Event|2|||
147062874|NCT05938920|530389982|FG003|Overall Study|Adverse Event|1|||
147062875|NCT05938920|530389979|FG000|Overall Study|Death|0|||
147062876|NCT05938920|530389980|FG001|Overall Study|Death|1|||
147062877|NCT05938920|530389981|FG002|Overall Study|Death|0|||
147062878|NCT05938920|530389982|FG003|Overall Study|Death|0|||
147062879|NCT05938920|530389979|FG000|Overall Study|Lost to Follow-up|0|||
147062880|NCT05938920|530389980|FG001|Overall Study|Lost to Follow-up|0|||
147062881|NCT05938920|530389981|FG002|Overall Study|Lost to Follow-up|1|||
147062882|NCT05938920|530389982|FG003|Overall Study|Lost to Follow-up|0|||
147062883|NCT05938920|530389979|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
147062884|NCT05938920|530389980|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
147062885|NCT05938920|530389981|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
147062886|NCT05938920|530389982|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
147062887|NCT05938920|530389979|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
147062888|NCT05938920|530389980|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
147062889|NCT05938920|530389981|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
147062890|NCT05938920|530389982|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
147062891|NCT05938920|530389979|FG000|Overall Study|Participant Refused to Come In|0|||
147062892|NCT05938920|530389980|FG001|Overall Study|Participant Refused to Come In|0|||
147062893|NCT05938920|530389981|FG002|Overall Study|Participant Refused to Come In|1|||
147062894|NCT05938920|530389982|FG003|Overall Study|Participant Refused to Come In|0|||
147062895|NCT02634710|530389983|FG000|Overall Study|Death|4|||
147062896|NCT02180867|530389984|FG000|Overall Study|Adverse Event|3|||
147062897|NCT02180867|530389985|FG001|Overall Study|Adverse Event|4|||
147062898|NCT02180867|530389986|FG002|Overall Study|Adverse Event|1|||
147062899|NCT02180867|530389987|FG003|Overall Study|Adverse Event|5|||
147062900|NCT02180867|530389988|FG004|Overall Study|Adverse Event|0|||
147062901|NCT02180867|530389989|FG005|Overall Study|Adverse Event|0|||
147062902|NCT02180867|530389990|FG006|Overall Study|Adverse Event|0|||
147062903|NCT02180867|530389984|FG000|Overall Study|Death|0|||
147062904|NCT02180867|530389985|FG001|Overall Study|Death|0|||
147062905|NCT02180867|530389986|FG002|Overall Study|Death|0|||
147062906|NCT02180867|530389987|FG003|Overall Study|Death|0|||
147062907|NCT02180867|530389988|FG004|Overall Study|Death|1|||
147062908|NCT02180867|530389989|FG005|Overall Study|Death|0|||
147062909|NCT02180867|530389990|FG006|Overall Study|Death|0|||
147062910|NCT02180867|530389984|FG000|Overall Study|Lack of Efficacy|0|||
147062911|NCT02180867|530389985|FG001|Overall Study|Lack of Efficacy|2|||
147062912|NCT02180867|530389986|FG002|Overall Study|Lack of Efficacy|0|||
147062913|NCT02180867|530389987|FG003|Overall Study|Lack of Efficacy|1|||
147062914|NCT02180867|530389988|FG004|Overall Study|Lack of Efficacy|6|||
147062915|NCT02180867|530389989|FG005|Overall Study|Lack of Efficacy|0|||
147062916|NCT02180867|530389990|FG006|Overall Study|Lack of Efficacy|1|||
147062917|NCT02180867|530389984|FG000|Overall Study|Physician Decision|1|||
147062918|NCT02180867|530389985|FG001|Overall Study|Physician Decision|3|||
147062919|NCT02180867|530389986|FG002|Overall Study|Physician Decision|1|||
147062920|NCT02180867|530389987|FG003|Overall Study|Physician Decision|10|||
147062921|NCT02180867|530389988|FG004|Overall Study|Physician Decision|9|||
147062922|NCT02180867|530389989|FG005|Overall Study|Physician Decision|3|||
147062923|NCT02180867|530389990|FG006|Overall Study|Physician Decision|4|||
147062924|NCT02180867|530389984|FG000|Overall Study|Withdrawal by Subject|0|||
147062925|NCT02180867|530389985|FG001|Overall Study|Withdrawal by Subject|0|||
147062926|NCT02180867|530389986|FG002|Overall Study|Withdrawal by Subject|0|||
147062927|NCT02180867|530389987|FG003|Overall Study|Withdrawal by Subject|1|||
147062928|NCT02180867|530389988|FG004|Overall Study|Withdrawal by Subject|1|||
147062929|NCT02180867|530389989|FG005|Overall Study|Withdrawal by Subject|0|||
147062930|NCT02180867|530389990|FG006|Overall Study|Withdrawal by Subject|0|||
147062931|NCT02180867|530389984|FG000|Overall Study|Ineligible|1|||
147062932|NCT02180867|530389985|FG001|Overall Study|Ineligible|2|||
147062933|NCT02180867|530389986|FG002|Overall Study|Ineligible|0|||
147062934|NCT02180867|530389987|FG003|Overall Study|Ineligible|3|||
147062935|NCT02180867|530389988|FG004|Overall Study|Ineligible|5|||
147062936|NCT02180867|530389989|FG005|Overall Study|Ineligible|0|||
147062937|NCT02180867|530389990|FG006|Overall Study|Ineligible|0|||
147062938|NCT02180867|530389984|FG000|Overall Study|Repeat Eligibility Studies|0|||
147062939|NCT02180867|530389985|FG001|Overall Study|Repeat Eligibility Studies|0|||
147062940|NCT02180867|530389986|FG002|Overall Study|Repeat Eligibility Studies|0|||
147062941|NCT02180867|530389987|FG003|Overall Study|Repeat Eligibility Studies|0|||
147062942|NCT02180867|530389988|FG004|Overall Study|Repeat Eligibility Studies|1|||
147062943|NCT02180867|530389989|FG005|Overall Study|Repeat Eligibility Studies|0|||
147062944|NCT02180867|530389990|FG006|Overall Study|Repeat Eligibility Studies|0|||
147062945|NCT02180867|530389984|FG000|Overall Study|Refusal of further protocol therapy|1|||
147062946|NCT02180867|530389985|FG001|Overall Study|Refusal of further protocol therapy|0|||
147062947|NCT02180867|530389986|FG002|Overall Study|Refusal of further protocol therapy|2|||
147062948|NCT02180867|530389987|FG003|Overall Study|Refusal of further protocol therapy|6|||
147062949|NCT02180867|530389988|FG004|Overall Study|Refusal of further protocol therapy|4|||
147062950|NCT02180867|530389989|FG005|Overall Study|Refusal of further protocol therapy|0|||
147062951|NCT02180867|530389990|FG006|Overall Study|Refusal of further protocol therapy|0|||
147062952|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
147062953|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
147062954|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
147062955|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
147062956|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
147062957|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
147062958|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
147062959|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
147062960|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
147062961|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
147062962|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
147062963|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
147062964|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
147062965|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
147062966|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
147062967|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
147062968|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
147062969|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
147062970|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
147062971|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
147062972|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
147062973|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
147062974|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
147062975|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
147062976|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
147062977|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
147062978|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
147062979|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
147062980|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
147062981|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
147062982|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
147062983|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
147062984|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
147062985|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
147062986|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
147062987|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
147062988|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
147062989|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
147062990|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
147062991|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
147062992|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
147062993|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
147062994|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
147062995|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
147062996|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
147062997|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
147062998|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
147062999|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
147063000|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
147063001|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
147063002|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
147063003|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
147063004|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
147063005|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
147063006|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
147063007|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
147063008|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
147063009|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
147063010|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
147063011|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
147063012|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
147063013|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
147063014|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
147063015|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
147063016|NCT00217737|530389991|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
147063017|NCT00217737|530389992|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
147063018|NCT00217737|530389993|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
147063019|NCT00217737|530389994|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
147063020|NCT00217737|530389991|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
147063021|NCT00217737|530389992|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
147063022|NCT00217737|530389993|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
147063023|NCT00217737|530389994|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
147063024|NCT00217737|530389991|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
147063025|NCT00217737|530389992|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
147063026|NCT00217737|530389993|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
147063027|NCT00217737|530389994|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
147063028|NCT00217737|530389991|FG000|Step 2 Randomization/Registration|Study suspension|0|||
147063029|NCT00217737|530389992|FG001|Step 2 Randomization/Registration|Study suspension|45|||
147063030|NCT00217737|530389993|FG002|Step 2 Randomization/Registration|Study suspension|0|||
147063031|NCT00217737|530389994|FG003|Step 2 Randomization/Registration|Study suspension|0|||
147063032|NCT00217737|530389991|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
147063033|NCT00217737|530389992|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
147063034|NCT00217737|530389993|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
147063035|NCT00217737|530389994|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
147063036|NCT00217737|530389991|FG000|Step 2 Randomization/Registration|Death|2|||
147063037|NCT00217737|530389992|FG001|Step 2 Randomization/Registration|Death|3|||
147063038|NCT00217737|530389993|FG002|Step 2 Randomization/Registration|Death|0|||
147063039|NCT00217737|530389994|FG003|Step 2 Randomization/Registration|Death|0|||
147063040|NCT00217737|530389991|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
147063041|NCT00217737|530389992|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
147063042|NCT00217737|530389993|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
147063043|NCT00217737|530389994|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
147063044|NCT00217737|530389991|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
147063045|NCT00217737|530389992|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
147063046|NCT00217737|530389993|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
147063047|NCT00217737|530389994|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
147063048|NCT00217737|530389991|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
147063049|NCT00217737|530389992|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
147063050|NCT00217737|530389993|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
147063051|NCT00217737|530389994|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
147063052|NCT00217737|530389991|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
147063053|NCT00217737|530389992|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
147063054|NCT00217737|530389993|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
147063055|NCT00217737|530389994|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
147063056|NCT00217737|530389991|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
147063057|NCT00217737|530389992|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
147063058|NCT00217737|530389993|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
147063059|NCT00217737|530389994|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
147063060|NCT00217737|530389991|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
147063061|NCT00217737|530389992|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
147063062|NCT00217737|530389993|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
147063063|NCT00217737|530389994|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
147063064|NCT00217737|530389991|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
147063065|NCT00217737|530389992|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
147063066|NCT00217737|530389993|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
147063067|NCT00217737|530389994|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
147063068|NCT00217737|530389991|FG000|Step 2 Randomization/Registration|Other|1|||
147063069|NCT00217737|530389992|FG001|Step 2 Randomization/Registration|Other|2|||
147063070|NCT00217737|530389993|FG002|Step 2 Randomization/Registration|Other|0|||
147063071|NCT00217737|530389994|FG003|Step 2 Randomization/Registration|Other|0|||
147063072|NCT03213704|530389995|FG000|Overall Study|Physician Decision|3|||
147063073|NCT03213704|530389995|FG000|Overall Study|Protocol Violation|1|||
147063074|NCT03213704|530389995|FG000|Overall Study|Progressive disease|4|||
147063075|NCT04284774|530389999|FG000|Overall Study|Progressive disease|5|||
147063076|NCT04129450|530390010|FG000|Overall Study|Lost to Follow-up|20|||
147063077|NCT04129450|530390011|FG001|Overall Study|Lost to Follow-up|10|||
147063078|NCT04129450|530390010|FG000|Overall Study|Withdrawal by Subject|9|||
147063079|NCT04129450|530390011|FG001|Overall Study|Withdrawal by Subject|5|||
147063080|NCT04129450|530390010|FG000|Overall Study|Work Family Obligations|2|||
147063081|NCT04129450|530390011|FG001|Overall Study|Work Family Obligations|0|||
147063082|NCT04129450|530390010|FG000|Overall Study|Other|3|||
147063083|NCT04129450|530390011|FG001|Overall Study|Other|0|||
147063084|NCT04680533|530390099|FG000|Overall Study|Screen failure|1|||
146850078|NCT00964886|529620713|FG000|Overall Study|Withdrawal by Subject|6|||
146850079|NCT00964886|529620714|FG001|Overall Study|Withdrawal by Subject|2|||
146850080|NCT00964886|529620715|FG002|Overall Study|Withdrawal by Subject|5|||
146850081|NCT00964886|529620716|FG003|Overall Study|Withdrawal by Subject|3|||
146850082|NCT00964886|529620713|FG000|Overall Study|Adverse Event|3|||
146850083|NCT00964886|529620714|FG001|Overall Study|Adverse Event|1|||
146850084|NCT00964886|529620715|FG002|Overall Study|Adverse Event|5|||
146850085|NCT00964886|529620716|FG003|Overall Study|Adverse Event|2|||
146850086|NCT00964886|529620713|FG000|Overall Study|Protocol Violation|0|||
146850087|NCT00964886|529620714|FG001|Overall Study|Protocol Violation|2|||
146850088|NCT00964886|529620715|FG002|Overall Study|Protocol Violation|0|||
146850089|NCT00964886|529620716|FG003|Overall Study|Protocol Violation|0|||
146850090|NCT03500159|529620718|FG000|Overall Study|Study Terminated|2|||
146850091|NCT03500159|529620719|FG001|Overall Study|Study Terminated|1|||
146850092|NCT03484273|529620724|FG000|Overall Study|Equipment Malfunction|1|||
146850093|NCT03484273|529620724|FG000|Overall Study|Data excluded from analysis|1|||
146850094|NCT00468104|529620728|FG000|First Intervention|Protocol Violation|2|||
146850095|NCT00468104|529620729|FG001|First Intervention|Protocol Violation|1|||
146850096|NCT00468104|529620728|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
146850097|NCT00468104|529620729|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
146850098|NCT00468104|529620728|FG000|First Intervention|died within 3 weeks|1|||
146850099|NCT00468104|529620729|FG001|First Intervention|died within 3 weeks|0|||
146850100|NCT00468104|529620728|FG000|First Intervention|malposition/blocked chest tube tube|2|||
146850101|NCT00468104|529620729|FG001|First Intervention|malposition/blocked chest tube tube|0|||
146850102|NCT00468104|529620728|FG000|First Intervention|large lung mass with minimal effusion|1|||
146850103|NCT00468104|529620729|FG001|First Intervention|large lung mass with minimal effusion|0|||
146850104|NCT00468104|529620728|FG000|First Intervention|associated prolonged pneumothorax|1|||
146850105|NCT00468104|529620729|FG001|First Intervention|associated prolonged pneumothorax|0|||
146850106|NCT00468104|529620728|FG000|First Intervention|trapped lung|1|||
146850107|NCT00468104|529620729|FG001|First Intervention|trapped lung|0|||
146850108|NCT00468104|529620728|FG000|Second Intervention|Withdrawal by Subject|5|||
146850109|NCT00468104|529620729|FG001|Second Intervention|Withdrawal by Subject|2|||
146850110|NCT00468104|529620728|FG000|Second Intervention|discarded for malposition of chest tube|0|||
146850111|NCT00468104|529620729|FG001|Second Intervention|discarded for malposition of chest tube|2|||
146850112|NCT01263665|529620730|FG000|Overall Study|Withdrew Consent|1|||
146850113|NCT01263665|529620730|FG000|Overall Study|Lost to Follow-up|3|||
146850114|NCT01263665|529620730|FG000|Overall Study|Death|2|||
146850115|NCT01263665|529620730|FG000|Overall Study|Amputation above the ankle|1|||
146850116|NCT01263665|529620730|FG000|Overall Study|Surgical Bypass|2|||
146850117|NCT02706899|529620733|FG000|Overall Study|Withdrawal by Subject|1|||
146850118|NCT02706899|529620734|FG001|Overall Study|Withdrawal by Subject|0|||
146850119|NCT02706899|529620733|FG000|Overall Study|Death|8|||
146850120|NCT02706899|529620734|FG001|Overall Study|Death|0|||
146850121|NCT02706899|529620733|FG000|Overall Study|Study Termination by Sponsor|4|||
146850122|NCT02706899|529620734|FG001|Overall Study|Study Termination by Sponsor|6|||
146850123|NCT00324675|529620735|FG000|Overall Study|Adverse Event|1|||
146850124|NCT00324675|529620736|FG001|Overall Study|Adverse Event|0|||
146850125|NCT00381615|529620737|FG000|Overall Study|Withdrawal by Subject|1|||
146850126|NCT00381615|529620738|FG001|Overall Study|Withdrawal by Subject|3|||
146850127|NCT00381615|529620739|FG002|Overall Study|Withdrawal by Subject|0|||
146850128|NCT00381615|529620740|FG003|Overall Study|Withdrawal by Subject|1|||
146850129|NCT00381615|529620737|FG000|Overall Study|Lost to Follow-up|3|||
146850130|NCT00381615|529620738|FG001|Overall Study|Lost to Follow-up|2|||
146850131|NCT00381615|529620739|FG002|Overall Study|Lost to Follow-up|0|||
146850132|NCT00381615|529620740|FG003|Overall Study|Lost to Follow-up|1|||
146850133|NCT00381615|529620737|FG000|Overall Study|Protocol Violation|0|||
146850134|NCT00381615|529620738|FG001|Overall Study|Protocol Violation|0|||
146850135|NCT00381615|529620739|FG002|Overall Study|Protocol Violation|1|||
146850136|NCT00381615|529620740|FG003|Overall Study|Protocol Violation|0|||
146850137|NCT04811131|529620747|FG000|Overall Study|Adverse Event|0|||
146850138|NCT04811131|529620748|FG001|Overall Study|Adverse Event|0|||
146850139|NCT04811131|529620749|FG002|Overall Study|Adverse Event|1|||
146850140|NCT04811131|529620750|FG003|Overall Study|Adverse Event|0|||
146850141|NCT04811131|529620747|FG000|Overall Study|Lack of Efficacy|0|||
146850142|NCT04811131|529620748|FG001|Overall Study|Lack of Efficacy|0|||
146850143|NCT04811131|529620749|FG002|Overall Study|Lack of Efficacy|0|||
146850144|NCT04811131|529620750|FG003|Overall Study|Lack of Efficacy|1|||
146850145|NCT04811131|529620747|FG000|Overall Study|Lost to Follow-up|0|||
146850146|NCT04811131|529620748|FG001|Overall Study|Lost to Follow-up|1|||
146850147|NCT04811131|529620749|FG002|Overall Study|Lost to Follow-up|0|||
146850148|NCT04811131|529620750|FG003|Overall Study|Lost to Follow-up|0|||
146850149|NCT04811131|529620747|FG000|Overall Study|Sponsor request|31|||
146850150|NCT04811131|529620748|FG001|Overall Study|Sponsor request|35|||
146850151|NCT04811131|529620749|FG002|Overall Study|Sponsor request|27|||
146850152|NCT04811131|529620750|FG003|Overall Study|Sponsor request|10|||
146850153|NCT04811131|529620747|FG000|Overall Study|Withdrawal by Subject|3|||
146850154|NCT04811131|529620748|FG001|Overall Study|Withdrawal by Subject|1|||
146850155|NCT04811131|529620749|FG002|Overall Study|Withdrawal by Subject|3|||
146850156|NCT04811131|529620750|FG003|Overall Study|Withdrawal by Subject|1|||
146850157|NCT02217475|529620754|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
146850158|NCT02217475|529620755|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
146850159|NCT02217475|529620756|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
146850160|NCT02217475|529620754|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
146850161|NCT02217475|529620755|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
146850162|NCT02217475|529620756|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
146850163|NCT02217475|529620754|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
146850164|NCT02217475|529620755|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
146850165|NCT02217475|529620756|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
146850166|NCT02217475|529620754|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
146850167|NCT02217475|529620755|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
146850168|NCT02217475|529620756|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
146850169|NCT02217475|529620754|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
146850170|NCT02217475|529620755|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
146850171|NCT02217475|529620756|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
146850172|NCT02217475|529620754|FG000|Discontinued After Period 1|Adverse Event|1|||
146850173|NCT02217475|529620755|FG001|Discontinued After Period 1|Adverse Event|2|||
146850174|NCT02217475|529620756|FG002|Discontinued After Period 1|Adverse Event|0|||
146850175|NCT02217475|529620754|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
146850176|NCT02217475|529620755|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
146850177|NCT02217475|529620756|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
146850178|NCT02217475|529620754|FG000|Discontinued After Period 1|Physician Decision|0|||
146850179|NCT02217475|529620755|FG001|Discontinued After Period 1|Physician Decision|0|||
146850180|NCT02217475|529620756|FG002|Discontinued After Period 1|Physician Decision|1|||
146850181|NCT02217475|529620754|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
146850182|NCT02217475|529620755|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
146850183|NCT02217475|529620756|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
146850184|NCT02217475|529620754|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
146850185|NCT02217475|529620755|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
146850186|NCT02217475|529620756|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
146850187|NCT02217475|529620754|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
146850188|NCT02217475|529620755|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
146850189|NCT02217475|529620756|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
146850190|NCT02217475|529620754|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
146850191|NCT02217475|529620755|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
146850192|NCT02217475|529620756|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
146850193|NCT02217475|529620754|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
146850194|NCT02217475|529620755|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
146850195|NCT02217475|529620756|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
146850196|NCT04738292|529620761|FG000|Overall Study|Death|1|||
146850197|NCT00371683|529620762|FG000|DB Treatment Period-Randomized Patients|Death|1|||
146850198|NCT00371683|529620763|FG001|DB Treatment Period-Randomized Patients|Death|1|||
146850199|NCT00371683|529620762|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
146850200|NCT00371683|529620763|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
146850201|NCT00371683|529620762|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
146850202|NCT00371683|529620763|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
146850203|NCT00371683|529620762|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
146850204|NCT00371683|529620763|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
146850205|NCT00371683|529620762|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
146850206|NCT00371683|529620763|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
146850207|NCT00371683|529620762|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
146850208|NCT00371683|529620763|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
146850209|NCT00371683|529620762|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
146850210|NCT00371683|529620763|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
146850211|NCT00371683|529620762|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
146850212|NCT00371683|529620763|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
146850213|NCT00371683|529620762|FG000|Follow-Up Period - Randomized Patients|Death|0|||
146850214|NCT00371683|529620763|FG001|Follow-Up Period - Randomized Patients|Death|2|||
146850215|NCT00371683|529620762|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
146850216|NCT00371683|529620763|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
146850217|NCT00371683|529620762|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
146850218|NCT00371683|529620763|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
146850219|NCT03181789|529620765|FG000|Overall Study|Withdrawal by Subject|0|||
146850220|NCT03181789|529620766|FG001|Overall Study|Withdrawal by Subject|1|||
146850221|NCT03181789|529620767|FG002|Overall Study|Withdrawal by Subject|1|||
146850222|NCT03181789|529620768|FG003|Overall Study|Withdrawal by Subject|0|||
146850223|NCT03181789|529620765|FG000|Overall Study|Lost to Follow-up|7|||
146850224|NCT03181789|529620766|FG001|Overall Study|Lost to Follow-up|1|||
146850225|NCT03181789|529620767|FG002|Overall Study|Lost to Follow-up|0|||
146850226|NCT03181789|529620768|FG003|Overall Study|Lost to Follow-up|0|||
146850227|NCT03181789|529620765|FG000|Overall Study|Participant unable to adhere to visit|0|||
146850228|NCT03181789|529620766|FG001|Overall Study|Participant unable to adhere to visit|1|||
146850229|NCT03181789|529620767|FG002|Overall Study|Participant unable to adhere to visit|0|||
146850230|NCT03181789|529620768|FG003|Overall Study|Participant unable to adhere to visit|0|||
146850231|NCT01131182|529620769|FG000|Overall Study|Withdrawal by Subject|1|||
146850232|NCT01131182|529620770|FG001|Overall Study|Withdrawal by Subject|1|||
146850233|NCT01131182|529620769|FG000|Overall Study|Lost to Follow-up|14|||
146850234|NCT01131182|529620770|FG001|Overall Study|Lost to Follow-up|15|||
146850235|NCT01131182|529620769|FG000|Overall Study|Other Reason|1|||
146850236|NCT01131182|529620770|FG001|Overall Study|Other Reason|0|||
146850237|NCT03001076|529620771|FG000|Overall Study|Withdrawal by patient|2|||
146850238|NCT03001076|529620772|FG001|Overall Study|Withdrawal by patient|0|||
146850239|NCT03001076|529620771|FG000|Overall Study|Other|1|||
146850240|NCT03001076|529620772|FG001|Overall Study|Other|0|||
146850241|NCT03001076|529620771|FG000|Overall Study|Adverse Event|3|||
146850242|NCT03001076|529620772|FG001|Overall Study|Adverse Event|3|||
146850243|NCT03001076|529620771|FG000|Overall Study|Sponsor decision|1|||
146850244|NCT03001076|529620772|FG001|Overall Study|Sponsor decision|0|||
146850245|NCT03001076|529620771|FG000|Overall Study|Lost to Follow-up|0|||
146850246|NCT03001076|529620772|FG001|Overall Study|Lost to Follow-up|2|||
146850247|NCT04602221|529620773|FG000|Overall Study|Discontinuation of trial treatment|0|||
146850248|NCT04602221|529620774|FG001|Overall Study|Discontinuation of trial treatment|0|||
146850249|NCT04602221|529620775|FG002|Overall Study|Discontinuation of trial treatment|1|||
146850250|NCT04602221|529620776|FG003|Overall Study|Discontinuation of trial treatment|0|||
146850251|NCT04602221|529620777|FG004|Overall Study|Discontinuation of trial treatment|0|||
146850252|NCT04602221|529620778|FG005|Overall Study|Discontinuation of trial treatment|0|||
146850253|NCT04602221|529620779|FG006|Overall Study|Discontinuation of trial treatment|0|||
146850254|NCT04602221|529620780|FG007|Overall Study|Discontinuation of trial treatment|0|||
146850255|NCT04602221|529620781|FG008|Overall Study|Discontinuation of trial treatment|0|||
146850256|NCT04602221|529620782|FG009|Overall Study|Discontinuation of trial treatment|0|||
146850257|NCT04602221|529620783|FG010|Overall Study|Discontinuation of trial treatment|0|||
146850258|NCT04602221|529620784|FG011|Overall Study|Discontinuation of trial treatment|0|||
146850259|NCT04602221|529620785|FG012|Overall Study|Discontinuation of trial treatment|0|||
146850260|NCT04602221|529620786|FG013|Overall Study|Discontinuation of trial treatment|0|||
146850261|NCT04602221|529620787|FG014|Overall Study|Discontinuation of trial treatment|0|||
146850262|NCT04602221|529620788|FG015|Overall Study|Discontinuation of trial treatment|0|||
146850263|NCT04602221|529620789|FG016|Overall Study|Discontinuation of trial treatment|0|||
146850264|NCT04602221|529620790|FG017|Overall Study|Discontinuation of trial treatment|0|||
146850265|NCT04602221|529620773|FG000|Overall Study|Other than listed|0|||
146850266|NCT04602221|529620774|FG001|Overall Study|Other than listed|0|||
146850267|NCT04602221|529620775|FG002|Overall Study|Other than listed|0|||
146850268|NCT04602221|529620776|FG003|Overall Study|Other than listed|0|||
146850269|NCT04602221|529620777|FG004|Overall Study|Other than listed|0|||
146850270|NCT04602221|529620778|FG005|Overall Study|Other than listed|0|||
146850271|NCT04602221|529620779|FG006|Overall Study|Other than listed|0|||
146850272|NCT04602221|529620780|FG007|Overall Study|Other than listed|0|||
146850273|NCT04602221|529620781|FG008|Overall Study|Other than listed|0|||
146850274|NCT04602221|529620782|FG009|Overall Study|Other than listed|0|||
146850275|NCT04602221|529620783|FG010|Overall Study|Other than listed|0|||
146850276|NCT04602221|529620784|FG011|Overall Study|Other than listed|0|||
146850277|NCT04602221|529620785|FG012|Overall Study|Other than listed|0|||
146850278|NCT04602221|529620786|FG013|Overall Study|Other than listed|0|||
146850279|NCT04602221|529620787|FG014|Overall Study|Other than listed|0|||
146850280|NCT04602221|529620788|FG015|Overall Study|Other than listed|1|||
146850281|NCT04602221|529620789|FG016|Overall Study|Other than listed|0|||
146850282|NCT04602221|529620790|FG017|Overall Study|Other than listed|1|||
146850283|NCT04602221|529620773|FG000|Overall Study|Withdrawal by Subject|0|||
146850284|NCT04602221|529620774|FG001|Overall Study|Withdrawal by Subject|0|||
146850285|NCT04602221|529620775|FG002|Overall Study|Withdrawal by Subject|0|||
146850286|NCT04602221|529620776|FG003|Overall Study|Withdrawal by Subject|0|||
146850287|NCT04602221|529620777|FG004|Overall Study|Withdrawal by Subject|0|||
146850288|NCT04602221|529620778|FG005|Overall Study|Withdrawal by Subject|0|||
146850289|NCT04602221|529620779|FG006|Overall Study|Withdrawal by Subject|0|||
146850290|NCT04602221|529620780|FG007|Overall Study|Withdrawal by Subject|0|||
146850291|NCT04602221|529620781|FG008|Overall Study|Withdrawal by Subject|0|||
146850292|NCT04602221|529620782|FG009|Overall Study|Withdrawal by Subject|0|||
146850293|NCT04602221|529620783|FG010|Overall Study|Withdrawal by Subject|0|||
146850294|NCT04602221|529620784|FG011|Overall Study|Withdrawal by Subject|0|||
146850295|NCT04602221|529620785|FG012|Overall Study|Withdrawal by Subject|1|||
146850296|NCT04602221|529620786|FG013|Overall Study|Withdrawal by Subject|0|||
146850297|NCT04602221|529620787|FG014|Overall Study|Withdrawal by Subject|0|||
146850298|NCT04602221|529620788|FG015|Overall Study|Withdrawal by Subject|0|||
146850299|NCT04602221|529620789|FG016|Overall Study|Withdrawal by Subject|0|||
146850300|NCT04602221|529620790|FG017|Overall Study|Withdrawal by Subject|0|||
146850301|NCT04602221|529620773|FG000|Overall Study|Lost to Follow-up|0|||
146850302|NCT04602221|529620774|FG001|Overall Study|Lost to Follow-up|0|||
146850303|NCT04602221|529620775|FG002|Overall Study|Lost to Follow-up|0|||
146850304|NCT04602221|529620776|FG003|Overall Study|Lost to Follow-up|0|||
146850305|NCT04602221|529620777|FG004|Overall Study|Lost to Follow-up|0|||
146850306|NCT04602221|529620778|FG005|Overall Study|Lost to Follow-up|1|||
146850307|NCT04602221|529620779|FG006|Overall Study|Lost to Follow-up|0|||
146850308|NCT04602221|529620780|FG007|Overall Study|Lost to Follow-up|0|||
146850309|NCT04602221|529620781|FG008|Overall Study|Lost to Follow-up|0|||
146850310|NCT04602221|529620782|FG009|Overall Study|Lost to Follow-up|0|||
146850311|NCT04602221|529620783|FG010|Overall Study|Lost to Follow-up|0|||
146850312|NCT04602221|529620784|FG011|Overall Study|Lost to Follow-up|0|||
146850313|NCT04602221|529620785|FG012|Overall Study|Lost to Follow-up|0|||
146850314|NCT04602221|529620786|FG013|Overall Study|Lost to Follow-up|0|||
146850315|NCT04602221|529620787|FG014|Overall Study|Lost to Follow-up|0|||
146850316|NCT04602221|529620788|FG015|Overall Study|Lost to Follow-up|0|||
146850317|NCT04602221|529620789|FG016|Overall Study|Lost to Follow-up|0|||
146850318|NCT04602221|529620790|FG017|Overall Study|Lost to Follow-up|0|||
146850319|NCT01056718|529620791|FG000|Overall Study|Withdrawal by Subject|2|||
146850320|NCT01056718|529620791|FG000|Overall Study|Ischemia on baseline stress test|1|||
146850321|NCT02270515|529620792|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
146850322|NCT02270515|529620792|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
146850323|NCT02270515|529620792|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
146850324|NCT02270515|529620792|FG000|Intervention Period 1: 0-6 Months|Death|7|||
146850325|NCT02270515|529620792|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
146850326|NCT02270515|529620792|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
146850327|NCT02270515|529620792|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
146850328|NCT02270515|529620792|FG000|Intervention Period 2: 6-12 Months|Death|5|||
146850329|NCT02270515|529620792|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
146850330|NCT02270515|529620792|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
146850331|NCT02270515|529620792|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
146850332|NCT02270515|529620792|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
146850333|NCT02270515|529620792|FG000|Intervention Period 3: 12-18 Months|Death|3|||
146850334|NCT02270515|529620792|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
146850335|NCT01139580|529620793|FG000|Overall Study|Adverse Event|5|||
146850336|NCT01139580|529620794|FG001|Overall Study|Adverse Event|4|||
146850337|NCT01139580|529620793|FG000|Overall Study|Lost to Follow-up|9|||
146850338|NCT01139580|529620794|FG001|Overall Study|Lost to Follow-up|1|||
146850339|NCT01139580|529620793|FG000|Overall Study|Lack of Efficacy|0|||
146850340|NCT01139580|529620794|FG001|Overall Study|Lack of Efficacy|2|||
146850341|NCT01139580|529620793|FG000|Overall Study|Withdrawal by Subject|6|||
146850342|NCT01139580|529620794|FG001|Overall Study|Withdrawal by Subject|9|||
146850343|NCT01139580|529620793|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
146850344|NCT01139580|529620794|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
146850345|NCT01139580|529620793|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
146850346|NCT01139580|529620794|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
146850347|NCT01139580|529620793|FG000|Overall Study|Misrandomized|1|||
146850348|NCT01139580|529620794|FG001|Overall Study|Misrandomized|0|||
146850349|NCT01139580|529620793|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
146850350|NCT01139580|529620794|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
146850351|NCT01139580|529620793|FG000|Overall Study|Participant Randomization in Error|0|||
146850352|NCT01139580|529620794|FG001|Overall Study|Participant Randomization in Error|1|||
146850353|NCT00633880|529620795|FG000|Open Label Titration|Lack of Efficacy|1|||
146850354|NCT00633880|529620796|FG001|Open Label Titration|Lack of Efficacy|0|||
146850355|NCT00633880|529620797|FG002|Open Label Titration|Lack of Efficacy|0|||
146850356|NCT00633880|529620795|FG000|Open Label Titration|Adverse Event|13|||
146850357|NCT00633880|529620796|FG001|Open Label Titration|Adverse Event|0|||
146850358|NCT00633880|529620797|FG002|Open Label Titration|Adverse Event|0|||
146850359|NCT00633880|529620795|FG000|Open Label Titration|Treatment Failure|55|||
146850360|NCT00633880|529620796|FG001|Open Label Titration|Treatment Failure|0|||
146850361|NCT00633880|529620797|FG002|Open Label Titration|Treatment Failure|0|||
146850362|NCT00633880|529620795|FG000|Open Label Titration|Protocol Violation|6|||
146850363|NCT00633880|529620796|FG001|Open Label Titration|Protocol Violation|0|||
146850364|NCT00633880|529620797|FG002|Open Label Titration|Protocol Violation|0|||
146850365|NCT00633880|529620795|FG000|Open Label Titration|Physician Decision|1|||
146850366|NCT00633880|529620796|FG001|Open Label Titration|Physician Decision|0|||
146850367|NCT00633880|529620797|FG002|Open Label Titration|Physician Decision|0|||
146850368|NCT00633880|529620795|FG000|Open Label Titration|Withdrawal by Subject|4|||
146850369|NCT00633880|529620796|FG001|Open Label Titration|Withdrawal by Subject|0|||
146850370|NCT00633880|529620797|FG002|Open Label Titration|Withdrawal by Subject|0|||
146850371|NCT00350103|529620798|FG000|Overall Study|Adverse Event|12|||
146850372|NCT00350103|529620799|FG001|Overall Study|Adverse Event|29|||
146850373|NCT00350103|529620800|FG002|Overall Study|Adverse Event|17|||
146850374|NCT00350103|529620798|FG000|Overall Study|Lack of Efficacy|5|||
146850375|NCT00350103|529620799|FG001|Overall Study|Lack of Efficacy|1|||
146850376|NCT00350103|529620800|FG002|Overall Study|Lack of Efficacy|3|||
146850377|NCT00350103|529620798|FG000|Overall Study|Withdrawal by Subject|6|||
146850378|NCT00350103|529620799|FG001|Overall Study|Withdrawal by Subject|6|||
146850379|NCT00350103|529620800|FG002|Overall Study|Withdrawal by Subject|8|||
146850380|NCT00350103|529620798|FG000|Overall Study|Protocol Violation|0|||
146850381|NCT00350103|529620799|FG001|Overall Study|Protocol Violation|0|||
146850382|NCT00350103|529620800|FG002|Overall Study|Protocol Violation|1|||
146850383|NCT00350103|529620798|FG000|Overall Study|Unsatisfactory Compliance|2|||
146850384|NCT00350103|529620799|FG001|Overall Study|Unsatisfactory Compliance|2|||
146850385|NCT00350103|529620800|FG002|Overall Study|Unsatisfactory Compliance|1|||
146850386|NCT00350103|529620798|FG000|Overall Study|Investigator´s decision|1|||
146850387|NCT00350103|529620799|FG001|Overall Study|Investigator´s decision|1|||
146850388|NCT00350103|529620800|FG002|Overall Study|Investigator´s decision|0|||
146850389|NCT00350103|529620798|FG000|Overall Study|Exclusion criteria met|0|||
146850390|NCT00350103|529620799|FG001|Overall Study|Exclusion criteria met|0|||
146850391|NCT00350103|529620800|FG002|Overall Study|Exclusion criteria met|1|||
146850392|NCT00350103|529620798|FG000|Overall Study|Patient relocated|0|||
146850393|NCT00350103|529620799|FG001|Overall Study|Patient relocated|0|||
146850394|NCT00350103|529620800|FG002|Overall Study|Patient relocated|1|||
146850395|NCT00350103|529620798|FG000|Overall Study|Need for prohibited medication|1|||
146850396|NCT00350103|529620799|FG001|Overall Study|Need for prohibited medication|0|||
146850397|NCT00350103|529620800|FG002|Overall Study|Need for prohibited medication|0|||
146850398|NCT00350103|529620798|FG000|Overall Study|Personal reasons|0|||
146850399|NCT00350103|529620799|FG001|Overall Study|Personal reasons|0|||
146850400|NCT00350103|529620800|FG002|Overall Study|Personal reasons|1|||
146850401|NCT00350103|529620798|FG000|Overall Study|Patient stopped feeling pain|1|||
146850402|NCT00350103|529620799|FG001|Overall Study|Patient stopped feeling pain|0|||
146850403|NCT00350103|529620800|FG002|Overall Study|Patient stopped feeling pain|0|||
146850404|NCT00350103|529620798|FG000|Overall Study|PR greater than 250ms|0|||
146850405|NCT00350103|529620799|FG001|Overall Study|PR greater than 250ms|0|||
146850406|NCT00350103|529620800|FG002|Overall Study|PR greater than 250ms|1|||
146850407|NCT00350103|529620798|FG000|Overall Study|Wrong calculation of QT interval|0|||
146850408|NCT00350103|529620799|FG001|Overall Study|Wrong calculation of QT interval|0|||
146850409|NCT00350103|529620800|FG002|Overall Study|Wrong calculation of QT interval|1|||
146850410|NCT00350103|529620798|FG000|Overall Study|Sponsor mistake|1|||
146850411|NCT00350103|529620799|FG001|Overall Study|Sponsor mistake|0|||
146850412|NCT00350103|529620800|FG002|Overall Study|Sponsor mistake|0|||
146850413|NCT00350103|529620798|FG000|Overall Study|Randomization mistake|0|||
146850414|NCT00350103|529620799|FG001|Overall Study|Randomization mistake|1|||
146850415|NCT00350103|529620800|FG002|Overall Study|Randomization mistake|1|||
146850416|NCT00350103|529620798|FG000|Overall Study|Sponsor´s decision|0|||
146850417|NCT00350103|529620799|FG001|Overall Study|Sponsor´s decision|1|||
146850418|NCT00350103|529620800|FG002|Overall Study|Sponsor´s decision|0|||
146850419|NCT00350103|529620798|FG000|Overall Study|Lost, Reason unknown|1|||
146850420|NCT00350103|529620799|FG001|Overall Study|Lost, Reason unknown|1|||
146850421|NCT00350103|529620800|FG002|Overall Study|Lost, Reason unknown|0|||
146850422|NCT02842151|529620801|FG000|Overall Study|Adverse Event|1|||
146850423|NCT02842151|529620801|FG000|Overall Study|Subject moved too far away|1|||
146850424|NCT02559895|529620802|FG000|Overall Study|Adverse Event|3|||
146850425|NCT02559895|529620803|FG001|Overall Study|Adverse Event|3|||
146850426|NCT02559895|529620804|FG002|Overall Study|Adverse Event|2|||
146850427|NCT02559895|529620805|FG003|Overall Study|Adverse Event|1|||
146850428|NCT02559895|529620802|FG000|Overall Study|Lack of Efficacy|2|||
146850429|NCT02559895|529620803|FG001|Overall Study|Lack of Efficacy|3|||
146850430|NCT02559895|529620804|FG002|Overall Study|Lack of Efficacy|2|||
146850431|NCT02559895|529620805|FG003|Overall Study|Lack of Efficacy|8|||
146850432|NCT02559895|529620802|FG000|Overall Study|Lost to Follow-up|22|||
146850433|NCT02559895|529620803|FG001|Overall Study|Lost to Follow-up|16|||
146850434|NCT02559895|529620804|FG002|Overall Study|Lost to Follow-up|12|||
146850435|NCT02559895|529620805|FG003|Overall Study|Lost to Follow-up|17|||
146850436|NCT02559895|529620802|FG000|Overall Study|Physician Decision|1|||
146850437|NCT02559895|529620803|FG001|Overall Study|Physician Decision|1|||
146850438|NCT02559895|529620804|FG002|Overall Study|Physician Decision|3|||
146850439|NCT02559895|529620805|FG003|Overall Study|Physician Decision|0|||
146850440|NCT02559895|529620802|FG000|Overall Study|Withdrawal by Subject|16|||
146850441|NCT02559895|529620803|FG001|Overall Study|Withdrawal by Subject|9|||
146850442|NCT02559895|529620804|FG002|Overall Study|Withdrawal by Subject|20|||
146850443|NCT02559895|529620805|FG003|Overall Study|Withdrawal by Subject|9|||
146850444|NCT02559895|529620802|FG000|Overall Study|Study Burden|10|||
146850445|NCT02559895|529620803|FG001|Overall Study|Study Burden|16|||
146850446|NCT02559895|529620804|FG002|Overall Study|Study Burden|12|||
146850447|NCT02559895|529620805|FG003|Overall Study|Study Burden|22|||
146850448|NCT02559895|529620802|FG000|Overall Study|Other|1|||
146850449|NCT02559895|529620803|FG001|Overall Study|Other|5|||
146850450|NCT02559895|529620804|FG002|Overall Study|Other|3|||
146850451|NCT02559895|529620805|FG003|Overall Study|Other|3|||
146850452|NCT00760474|529620809|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
146850453|NCT00760474|529620810|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
146850454|NCT00760474|529620809|FG000|Placebo Washout Period|Other|0|||
146850455|NCT00760474|529620810|FG001|Placebo Washout Period|Other|1|||
146850456|NCT00760474|529620809|FG000|Period 2 (P2)|Lost to Follow-up|1|||
146850457|NCT00760474|529620810|FG001|Period 2 (P2)|Lost to Follow-up|0|||
146850458|NCT00760474|529620809|FG000|Period 2 (P2)|Adverse Event|0|||
146850459|NCT00760474|529620810|FG001|Period 2 (P2)|Adverse Event|1|||
146850460|NCT00513305|529620811|FG000|Overall Study|Adverse Event|6|||
146850461|NCT00513305|529620812|FG001|Overall Study|Adverse Event|2|||
146850462|NCT00513305|529620811|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
146850463|NCT00513305|529620812|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
146850464|NCT00513305|529620811|FG000|Overall Study|Lack of Efficacy|8|||
146850465|NCT00513305|529620812|FG001|Overall Study|Lack of Efficacy|13|||
146850466|NCT00513305|529620811|FG000|Overall Study|Withdrawal by Subject|1|||
146850467|NCT00513305|529620812|FG001|Overall Study|Withdrawal by Subject|2|||
146850468|NCT00513305|529620811|FG000|Overall Study|Disease progression|8|||
146850469|NCT00513305|529620812|FG001|Overall Study|Disease progression|5|||
146850470|NCT00513305|529620811|FG000|Overall Study|Eligible for stem cell transplant|1|||
146850471|NCT00513305|529620812|FG001|Overall Study|Eligible for stem cell transplant|0|||
146850472|NCT00513305|529620811|FG000|Overall Study|Hematologic counts did not recover|1|||
146850473|NCT00513305|529620812|FG001|Overall Study|Hematologic counts did not recover|0|||
146850474|NCT00513305|529620811|FG000|Overall Study|Physician Decision|1|||
146850475|NCT00513305|529620812|FG001|Overall Study|Physician Decision|0|||
146850476|NCT00513305|529620811|FG000|Overall Study|Persistent hypocellularity|0|||
146850477|NCT00513305|529620812|FG001|Overall Study|Persistent hypocellularity|1|||
146850478|NCT00513305|529620811|FG000|Overall Study|Sponsor Decision|0|||
146850479|NCT00513305|529620812|FG001|Overall Study|Sponsor Decision|2|||
146850480|NCT01262027|529620813|FG000|Overall Study|Adverse Event|1|||
146850481|NCT01262027|529620813|FG000|Overall Study|Withdrawal by Subject|3|||
146850482|NCT01262027|529620813|FG000|Overall Study|Protocol Violation|1|||
146850483|NCT03014479|529620814|FG000|Overall Study|Adverse Event|0|||
146850484|NCT03014479|529620815|FG001|Overall Study|Adverse Event|1|||
146850485|NCT03014479|529620814|FG000|Overall Study|Voluntary Withdrawal|0|||
146850486|NCT03014479|529620815|FG001|Overall Study|Voluntary Withdrawal|2|||
146850487|NCT03014479|529620814|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
146850488|NCT03014479|529620815|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
146850489|NCT01394978|529620818|FG000|Overall Study|Withdrawal by Subject|2|||
146850490|NCT01394978|529620819|FG001|Overall Study|Withdrawal by Subject|4|||
146850491|NCT01394978|529620818|FG000|Overall Study|Lost to Follow-up|13|||
146850492|NCT01394978|529620819|FG001|Overall Study|Lost to Follow-up|20|||
146850493|NCT01394978|529620818|FG000|Overall Study|Death|6|||
146850494|NCT01394978|529620819|FG001|Overall Study|Death|7|||
146850495|NCT02217501|529620820|FG000|Overall Study|Death|3|||
146850496|NCT02217501|529620821|FG001|Overall Study|Death|4|||
146850497|NCT02019667|529620822|FG000|First Intervention (6 Months)|Adverse Event|0|||
146850498|NCT02019667|529620823|FG001|First Intervention (6 Months)|Adverse Event|1|||
146850499|NCT02019667|529620822|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
146850500|NCT02019667|529620823|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
146850501|NCT02019667|529620822|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
146850502|NCT02019667|529620823|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
146850503|NCT05453201|529620824|FG000|Overall Study|Withdrawal by Subject|1|||
146850504|NCT01934790|529620825|FG000|Treatment|Adverse Event|3|||
146850505|NCT01934790|529620825|FG000|Treatment|Clinical progression|6|||
146850506|NCT01934790|529620825|FG000|Treatment|Radiological progression|4|||
146850507|NCT01934790|529620825|FG000|Treatment|Withdrawal by Subject|2|||
146850508|NCT01934790|529620825|FG000|Treatment|Study drug never administered|1|||
146850509|NCT01934790|529620825|FG000|Active Follow up|Death|20|||
146850510|NCT01934790|529620825|FG000|Active Follow up|Physician Decision|2|||
146850511|NCT01934790|529620825|FG000|Active Follow up|Progressive disease|1|||
146850512|NCT01934790|529620825|FG000|Active Follow up|Other reason|1|||
146850513|NCT03798691|529620826|FG000|Overall Study|Lost to Follow-up|2|||
146850514|NCT03798691|529620827|FG001|Overall Study|Lost to Follow-up|2|||
146850515|NCT01147536|529620833|FG000|Overall Study|Administrative study close|2|||
146850516|NCT01147536|529620833|FG000|Overall Study|Death|1|||
146850517|NCT03762200|529620834|FG000|Overall Study|Death|2|||
146850518|NCT05559476|529620839|FG000|Overall Study|Adverse Event|2|||
146850519|NCT05559476|529620840|FG001|Overall Study|Adverse Event|0|||
146850520|NCT05559476|529620839|FG000|Overall Study|Lost to Follow-up|13|||
146850521|NCT05559476|529620840|FG001|Overall Study|Lost to Follow-up|12|||
146850522|NCT05559476|529620839|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
146850523|NCT05559476|529620840|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
146850524|NCT05559476|529620839|FG000|Overall Study|Other|0|||
146850525|NCT05559476|529620840|FG001|Overall Study|Other|2|||
146850526|NCT05110690|529620841|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
146850527|NCT05110690|529620841|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
146850528|NCT05110690|529620841|FG000|Completion of Intervention|Lost to Follow-up|1|||
146850529|NCT05110690|529620841|FG000|Completion of Intervention|Death|1|||
146850530|NCT05110690|529620841|FG000|Completion of Intervention|Withdrawal by Subject|2|||
146963318|NCT00536991|530027636|FG000|Overall Study|Withdrawal by Subject|10|||
146963319|NCT00536991|530027636|FG000|Overall Study|Physician Decision|1|||
146963320|NCT00536991|530027636|FG000|Overall Study|patient ineligible|2|||
146963321|NCT00054639|530027637|FG000|Overall Study|Lack of Efficacy|1|||
146963322|NCT00054639|530027637|FG000|Overall Study|Physician Decision|1|||
146963323|NCT01600755|530027638|FG000|Overall Study|Withdrawal by Subject|6|||
146963324|NCT01366846|530027643|FG000|Overall Study|Withdrawal by Subject|2|||
146963325|NCT01366846|530027644|FG001|Overall Study|Withdrawal by Subject|0|||
146963326|NCT01366846|530027645|FG002|Overall Study|Withdrawal by Subject|0|||
146963327|NCT01366846|530027646|FG003|Overall Study|Withdrawal by Subject|0|||
146963328|NCT01366846|530027643|FG000|Overall Study|Communication Difficulties|1|||
146963329|NCT01366846|530027644|FG001|Overall Study|Communication Difficulties|4|||
146963330|NCT01366846|530027645|FG002|Overall Study|Communication Difficulties|0|||
146963331|NCT01366846|530027646|FG003|Overall Study|Communication Difficulties|1|||
146963332|NCT01366846|530027643|FG000|Overall Study|Scheduling Conflicts|0|||
146963333|NCT01366846|530027644|FG001|Overall Study|Scheduling Conflicts|0|||
146963334|NCT01366846|530027645|FG002|Overall Study|Scheduling Conflicts|1|||
146963335|NCT01366846|530027646|FG003|Overall Study|Scheduling Conflicts|0|||
146963336|NCT05299359|530027649|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
146963337|NCT05299359|530027650|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
146963338|NCT05299359|530027649|FG000|Main Part: Day 1 up to Day 366|Other|2|||
146963339|NCT05299359|530027650|FG001|Main Part: Day 1 up to Day 366|Other|0|||
146963340|NCT05299359|530027649|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
146963341|NCT05299359|530027650|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
146963342|NCT05299359|530027649|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
146963343|NCT05299359|530027650|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
146963344|NCT05299359|530027649|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
146963345|NCT05299359|530027650|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
146963346|NCT05299359|530027649|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
146963347|NCT05299359|530027650|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
146963348|NCT05299359|530027649|FG000|Extension Part: Day 1 to Day 366|Other|0|||
146963349|NCT05299359|530027650|FG001|Extension Part: Day 1 to Day 366|Other|1|||
146963350|NCT04780776|530027655|FG000|Titration Week 1-5|Lost to Follow-up|2|||
146963351|NCT04780776|530027656|FG001|Titration Week 1-5|Lost to Follow-up|8|||
146963352|NCT04780776|530027655|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
146963353|NCT04780776|530027656|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
146963354|NCT04780776|530027655|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
146963355|NCT04780776|530027656|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
146963356|NCT03113760|530027657|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
146963357|NCT03113760|530027658|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
146963358|NCT03113760|530027659|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
146963359|NCT03113760|530027660|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
146963360|NCT03113760|530027657|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
146963361|NCT03113760|530027658|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
146963362|NCT03113760|530027659|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
146963363|NCT03113760|530027660|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
146963364|NCT03113760|530027657|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
146963365|NCT03113760|530027658|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
146963366|NCT03113760|530027659|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
146963367|NCT03113760|530027660|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
146963368|NCT02506101|530027661|FG000|Overall Study|Transportation issues|1|||
146963369|NCT02506101|530027662|FG001|Overall Study|Transportation issues|0|||
146963370|NCT02506101|530027661|FG000|Overall Study|No enrollment and staff unavailability|1|||
146963371|NCT02506101|530027662|FG001|Overall Study|No enrollment and staff unavailability|0|||
146963372|NCT01308476|530027663|FG000|Overall Study|Lost to Follow-up|2|||
146963373|NCT01308476|530027664|FG001|Overall Study|Lost to Follow-up|2|||
146963374|NCT01308476|530027663|FG000|Overall Study|Other|1|||
146963375|NCT01308476|530027664|FG001|Overall Study|Other|0|||
146963376|NCT02696382|530027665|FG000|Overall Study|Death|7|||
146963377|NCT02696382|530027666|FG001|Overall Study|Death|2|||
146963378|NCT02696382|530027665|FG000|Overall Study|Withdrawal by Subject|5|||
146963379|NCT02696382|530027666|FG001|Overall Study|Withdrawal by Subject|12|||
146963380|NCT02696382|530027665|FG000|Overall Study|Lost to Follow-up|4|||
146963381|NCT02696382|530027666|FG001|Overall Study|Lost to Follow-up|7|||
146963382|NCT00423137|530027670|FG000|Overall Study|Lost to Follow-up|0|||
146963383|NCT00423137|530027671|FG001|Overall Study|Lost to Follow-up|0|||
146963384|NCT00423137|530027672|FG002|Overall Study|Lost to Follow-up|1|||
146963385|NCT00423137|530027673|FG003|Overall Study|Lost to Follow-up|0|||
146963386|NCT00423137|530027670|FG000|Overall Study|Protocol Violation|0|||
146963387|NCT00423137|530027671|FG001|Overall Study|Protocol Violation|0|||
146963388|NCT00423137|530027672|FG002|Overall Study|Protocol Violation|0|||
146963389|NCT00423137|530027673|FG003|Overall Study|Protocol Violation|1|||
146963390|NCT00423137|530027670|FG000|Overall Study|Adverse Event Study disease worse|1|||
146963391|NCT00423137|530027671|FG001|Overall Study|Adverse Event Study disease worse|0|||
146963392|NCT00423137|530027672|FG002|Overall Study|Adverse Event Study disease worse|3|||
146963393|NCT00423137|530027673|FG003|Overall Study|Adverse Event Study disease worse|1|||
146963394|NCT00423137|530027670|FG000|Overall Study|Adverse Event Other|0|||
146963395|NCT00423137|530027671|FG001|Overall Study|Adverse Event Other|0|||
146963396|NCT00423137|530027672|FG002|Overall Study|Adverse Event Other|2|||
146963397|NCT00423137|530027673|FG003|Overall Study|Adverse Event Other|0|||
146963398|NCT03246152|530027674|FG000|Overall Study|Lost to Follow-up|2|||
146963399|NCT03246152|530027674|FG000|Overall Study|Protocol Violation|1|||
146963400|NCT01243762|530027676|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
146963401|NCT01243762|530027677|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
146963402|NCT01243762|530027678|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
146963403|NCT01243762|530027679|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
146963404|NCT01243762|530027680|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
146963405|NCT01243762|530027681|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
146963406|NCT01243762|530027682|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
146963407|NCT01243762|530027676|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
146963408|NCT01243762|530027677|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
146963409|NCT01243762|530027678|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
146963410|NCT01243762|530027679|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
146963411|NCT01243762|530027680|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
146963412|NCT01243762|530027681|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
146963413|NCT01243762|530027682|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
146963414|NCT01243762|530027676|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
146963415|NCT01243762|530027677|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
146963416|NCT01243762|530027678|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
146963417|NCT01243762|530027679|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
146963418|NCT01243762|530027680|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
146963419|NCT01243762|530027681|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
146963420|NCT01243762|530027682|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
146963421|NCT01243762|530027676|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
146963422|NCT01243762|530027677|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
146963423|NCT01243762|530027678|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
146963424|NCT01243762|530027679|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
146963425|NCT01243762|530027680|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
146963426|NCT01243762|530027681|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
146963427|NCT01243762|530027682|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
146963428|NCT01243762|530027676|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
146963429|NCT01243762|530027677|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
146963430|NCT01243762|530027678|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
146963431|NCT01243762|530027679|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
146963432|NCT01243762|530027680|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
146963433|NCT01243762|530027681|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
146963434|NCT01243762|530027682|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
146963435|NCT01243762|530027676|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
146963436|NCT01243762|530027677|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
146963437|NCT01243762|530027678|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
146963438|NCT01243762|530027679|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
146963439|NCT01243762|530027680|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
146963440|NCT01243762|530027681|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
146963441|NCT01243762|530027682|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
146963442|NCT01243762|530027676|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
146963443|NCT01243762|530027677|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
146963444|NCT01243762|530027678|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
146963445|NCT01243762|530027679|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
146963446|NCT01243762|530027680|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
146963447|NCT01243762|530027681|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
146963448|NCT01243762|530027682|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
146963449|NCT01243762|530027676|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
146963450|NCT01243762|530027677|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
146963451|NCT01243762|530027678|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
146963452|NCT01243762|530027679|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
146963453|NCT01243762|530027680|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
146963454|NCT01243762|530027681|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
146963455|NCT01243762|530027682|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
146963456|NCT00003526|530027683|FG000|Overall Study|Not evaluable|6|||
146963457|NCT02059265|530027684|FG000|Overall Study|Ineligible|4|||
146963458|NCT04196023|530027685|FG000|Overall Study|Withdrawal by Subject|0|||
146963459|NCT04196023|530027686|FG001|Overall Study|Withdrawal by Subject|1|||
146963460|NCT04196023|530027685|FG000|Overall Study|Adverse Event|3|||
146963461|NCT04196023|530027686|FG001|Overall Study|Adverse Event|1|||
146963462|NCT04196023|530027685|FG000|Overall Study|Lost to Follow-up|0|||
146963463|NCT04196023|530027686|FG001|Overall Study|Lost to Follow-up|1|||
146963464|NCT03358407|530027691|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146963465|NCT03358407|530027692|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146963466|NCT03358407|530027693|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
146963467|NCT03358407|530027694|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146963468|NCT03358407|530027695|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146963469|NCT03358407|530027696|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146963470|NCT03358407|530027697|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146963471|NCT03358407|530027698|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146963472|NCT03358407|530027699|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146963473|NCT03358407|530027700|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146963474|NCT03358407|530027691|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963475|NCT03358407|530027692|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963476|NCT03358407|530027693|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963477|NCT03358407|530027694|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963478|NCT03358407|530027695|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
146963479|NCT03358407|530027696|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963480|NCT03358407|530027697|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963481|NCT03358407|530027698|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963482|NCT03358407|530027699|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963483|NCT03358407|530027700|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963484|NCT03358407|530027691|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
146963485|NCT03358407|530027692|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
146963486|NCT03358407|530027693|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
146963487|NCT03358407|530027694|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
146963488|NCT03358407|530027695|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
146963489|NCT03358407|530027696|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
146963490|NCT03358407|530027697|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
146963491|NCT03358407|530027698|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
146963492|NCT03358407|530027699|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
146963493|NCT03358407|530027700|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
146963494|NCT03358407|530027691|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
146963495|NCT03358407|530027692|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
146963496|NCT03358407|530027693|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
146963497|NCT03358407|530027694|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
146963498|NCT03358407|530027695|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
146963499|NCT03358407|530027696|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
146963500|NCT03358407|530027697|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
146963501|NCT03358407|530027698|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
146963502|NCT03358407|530027699|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
146963503|NCT03358407|530027700|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
146963504|NCT03358407|530027691|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963505|NCT03358407|530027692|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963506|NCT03358407|530027693|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963507|NCT03358407|530027694|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963508|NCT03358407|530027695|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963509|NCT03358407|530027696|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
146963510|NCT03358407|530027697|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
146963511|NCT03358407|530027698|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963512|NCT03358407|530027699|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963513|NCT03358407|530027700|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146963514|NCT03358407|530027691|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
146963515|NCT03358407|530027692|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
146963516|NCT03358407|530027693|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
146963517|NCT03358407|530027694|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
146963518|NCT03358407|530027695|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
146963519|NCT03358407|530027696|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
146963520|NCT03358407|530027697|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
146963521|NCT03358407|530027698|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
146963522|NCT03358407|530027699|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
146963523|NCT03358407|530027700|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
146963524|NCT00483574|530027701|FG000|Overall Study|Adverse Event|6|||
146963525|NCT00483574|530027702|FG001|Overall Study|Adverse Event|0|||
146963526|NCT00483574|530027701|FG000|Overall Study|Protocol Violation|28|||
146963527|NCT00483574|530027702|FG001|Overall Study|Protocol Violation|9|||
146963528|NCT00483574|530027701|FG000|Overall Study|Lost to Follow-up|16|||
146963529|NCT00483574|530027702|FG001|Overall Study|Lost to Follow-up|4|||
146963530|NCT00483574|530027701|FG000|Overall Study|Withdrawal by Subject|52|||
146963531|NCT00483574|530027702|FG001|Overall Study|Withdrawal by Subject|0|||
146963532|NCT03605758|530027703|FG000|Overall Study|Lost to Follow-up|2|||
146963533|NCT03605758|530027704|FG001|Overall Study|Lost to Follow-up|1|||
146963534|NCT03605758|530027703|FG000|Overall Study|Illness|0|||
146963535|NCT03605758|530027704|FG001|Overall Study|Illness|1|||
146963536|NCT03605758|530027703|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
146963537|NCT03605758|530027704|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
146963538|NCT04366258|530027707|FG000|Baseline Assessments|Screen Failure|21|||
146963539|NCT04366258|530027707|FG000|Baseline Assessments|Early Termination|3|||
146963540|NCT02940392|530027712|FG000|Overall Study|Lost to Follow-up|3|||
146963541|NCT02940392|530027712|FG000|Overall Study|Retreatment|3|||
146963542|NCT02940392|530027712|FG000|Overall Study|Death|2|||
146963543|NCT03205046|530027714|FG000|Overall Study|Death|10|||
146963544|NCT03205046|530027715|FG001|Overall Study|Death|6|||
146963545|NCT03205046|530027714|FG000|Overall Study|Withdrawal by Subject|1|||
146963546|NCT03205046|530027715|FG001|Overall Study|Withdrawal by Subject|2|||
146963547|NCT03205046|530027714|FG000|Overall Study|Lost to Follow-up|0|||
146963548|NCT03205046|530027715|FG001|Overall Study|Lost to Follow-up|1|||
146963549|NCT03205046|530027714|FG000|Overall Study|Study terminated by sponsor|2|||
146963550|NCT03205046|530027715|FG001|Overall Study|Study terminated by sponsor|1|||
146963551|NCT01023815|530027716|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
146963552|NCT01023815|530027717|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
146963553|NCT01023815|530027718|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
146963554|NCT01023815|530027719|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
146963555|NCT01023815|530027716|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
146963556|NCT01023815|530027717|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
146963557|NCT01023815|530027718|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
146963558|NCT01023815|530027719|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
146963559|NCT01023815|530027716|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
146963560|NCT01023815|530027717|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
146963561|NCT01023815|530027718|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
146963562|NCT01023815|530027719|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
146963563|NCT01023815|530027716|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
146963564|NCT01023815|530027717|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
146963565|NCT01023815|530027718|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
146963566|NCT01023815|530027719|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
146963567|NCT01023815|530027716|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
146963568|NCT01023815|530027717|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
146963569|NCT01023815|530027718|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
146963570|NCT01023815|530027719|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
146963571|NCT00634933|530027730|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
146963572|NCT00634933|530027731|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
146963573|NCT00634933|530027732|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
146963574|NCT00634933|530027733|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
146963575|NCT00634933|530027734|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
146963576|NCT00634933|530027730|FG000|Part A: Baseline to Week 24|Death|1|||
146963577|NCT00634933|530027731|FG001|Part A: Baseline to Week 24|Death|0|||
146963578|NCT00634933|530027732|FG002|Part A: Baseline to Week 24|Death|0|||
146963579|NCT00634933|530027733|FG003|Part A: Baseline to Week 24|Death|0|||
146963580|NCT00634933|530027734|FG004|Part A: Baseline to Week 24|Death|0|||
146963581|NCT00634933|530027730|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
146963582|NCT00634933|530027731|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
146963583|NCT00634933|530027732|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
146963584|NCT00634933|530027733|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
146963585|NCT00634933|530027734|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
146963586|NCT00634933|530027730|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
146963587|NCT00634933|530027731|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
146963588|NCT00634933|530027732|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
146963589|NCT00634933|530027733|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
146963590|NCT00634933|530027734|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
146963591|NCT00634933|530027730|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
146963592|NCT00634933|530027731|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
146963593|NCT00634933|530027732|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
146963594|NCT00634933|530027733|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
146963595|NCT00634933|530027734|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
146963596|NCT00634933|530027730|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
146963597|NCT00634933|530027731|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
146963598|NCT00634933|530027732|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
146963599|NCT00634933|530027733|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
146963600|NCT00634933|530027734|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
146963601|NCT00634933|530027730|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
146963602|NCT00634933|530027731|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
146963603|NCT00634933|530027732|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
146963604|NCT00634933|530027733|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
146963605|NCT00634933|530027734|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
146963606|NCT00634933|530027730|FG000|Part A: Baseline to Week 24|Other|1|||
146963607|NCT00634933|530027731|FG001|Part A: Baseline to Week 24|Other|8|||
146963608|NCT00634933|530027732|FG002|Part A: Baseline to Week 24|Other|5|||
146963609|NCT00634933|530027733|FG003|Part A: Baseline to Week 24|Other|0|||
146963610|NCT00634933|530027734|FG004|Part A: Baseline to Week 24|Other|0|||
146963611|NCT00634933|530027730|FG000|Between Part A and Part B|Physician Decision|0|||
146963612|NCT00634933|530027731|FG001|Between Part A and Part B|Physician Decision|1|||
146963613|NCT00634933|530027732|FG002|Between Part A and Part B|Physician Decision|0|||
146963614|NCT00634933|530027733|FG003|Between Part A and Part B|Physician Decision|0|||
146963615|NCT00634933|530027734|FG004|Between Part A and Part B|Physician Decision|0|||
146963616|NCT00634933|530027730|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
146963617|NCT00634933|530027731|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
146963618|NCT00634933|530027732|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
146963619|NCT00634933|530027733|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
146963620|NCT00634933|530027734|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
146963621|NCT00634933|530027730|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
146963622|NCT00634933|530027731|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
146963623|NCT00634933|530027732|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
146963624|NCT00634933|530027733|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
146963625|NCT00634933|530027734|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
146963626|NCT00634933|530027730|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
146963627|NCT00634933|530027731|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
146963628|NCT00634933|530027732|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
146963629|NCT00634933|530027733|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
146963630|NCT00634933|530027734|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
146963631|NCT00634933|530027730|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
146963632|NCT00634933|530027731|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
146963633|NCT00634933|530027732|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
146963634|NCT00634933|530027733|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
146963635|NCT00634933|530027734|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
146963636|NCT00634933|530027730|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
146963637|NCT00634933|530027731|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
146963638|NCT00634933|530027732|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
146963639|NCT00634933|530027733|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
146963640|NCT00634933|530027734|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
146963641|NCT00634933|530027730|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
146963642|NCT00634933|530027731|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
146963643|NCT00634933|530027732|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
146963644|NCT00634933|530027733|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
146963645|NCT00634933|530027734|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
146963646|NCT00634933|530027730|FG000|Part B: Week 24 to Week 52|Other|0|||
146963647|NCT00634933|530027731|FG001|Part B: Week 24 to Week 52|Other|0|||
146963648|NCT00634933|530027732|FG002|Part B: Week 24 to Week 52|Other|5|||
146963649|NCT00634933|530027733|FG003|Part B: Week 24 to Week 52|Other|0|||
146963650|NCT00634933|530027734|FG004|Part B: Week 24 to Week 52|Other|1|||
146963651|NCT02058849|530027735|FG000|Overall Study|Hospitalization|1|||
146963652|NCT02058849|530027736|FG001|Overall Study|Hospitalization|1|||
146963653|NCT02058849|530027735|FG000|Overall Study|Death|1|||
146963654|NCT02058849|530027736|FG001|Overall Study|Death|0|||
146963655|NCT02058849|530027735|FG000|Overall Study|Lost to Follow-up|1|||
146963656|NCT02058849|530027736|FG001|Overall Study|Lost to Follow-up|0|||
146963657|NCT02058849|530027735|FG000|Overall Study|Withdrawal by Subject|4|||
146963658|NCT02058849|530027736|FG001|Overall Study|Withdrawal by Subject|0|||
146963659|NCT01694849|530027737|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
146963660|NCT01694849|530027738|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
146963661|NCT01694849|530027739|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
146963662|NCT01694849|530027737|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
146963663|NCT01694849|530027738|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
146963664|NCT01694849|530027739|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
146963665|NCT01694849|530027737|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
146963666|NCT01694849|530027738|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
146963667|NCT01694849|530027739|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
146963668|NCT01694849|530027737|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
146963669|NCT01694849|530027738|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
146963670|NCT01694849|530027739|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
146963671|NCT01694849|530027737|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
146963672|NCT01694849|530027738|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
146963673|NCT01694849|530027739|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
146963674|NCT01694849|530027737|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
146963675|NCT01694849|530027738|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
146963676|NCT01694849|530027739|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
146963677|NCT01694849|530027737|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
146963678|NCT01694849|530027738|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
146963679|NCT01694849|530027739|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
146963680|NCT01694849|530027737|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
146963681|NCT01694849|530027738|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
146963682|NCT01694849|530027739|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
146963683|NCT02219477|530027740|FG000|Overall Study|Adverse Event|0|||
146963684|NCT02219477|530027741|FG001|Overall Study|Adverse Event|1|||
146963685|NCT02219477|530027742|FG002|Overall Study|Adverse Event|1|||
146963686|NCT02219477|530027740|FG000|Overall Study|Withdrawal by Subject|0|||
146963687|NCT02219477|530027741|FG001|Overall Study|Withdrawal by Subject|1|||
146963688|NCT02219477|530027742|FG002|Overall Study|Withdrawal by Subject|0|||
146963689|NCT01683565|530027745|FG000|Overall Study|Lost to Follow-up|2|||
146963690|NCT01683565|530027746|FG001|Overall Study|Lost to Follow-up|0|||
146963691|NCT01683565|530027745|FG000|Overall Study|Discontinued Intervention|1|||
146963692|NCT01683565|530027746|FG001|Overall Study|Discontinued Intervention|1|||
146963693|NCT04479358|530027747|FG000|Overall Study|Withdrawal by Subject|0|||
146963694|NCT04479358|530027748|FG001|Overall Study|Withdrawal by Subject|0|||
146963695|NCT04479358|530027749|FG002|Overall Study|Withdrawal by Subject|1|||
146963696|NCT04479358|530027750|FG003|Overall Study|Withdrawal by Subject|0|||
146963697|NCT04479358|530027751|FG004|Overall Study|Withdrawal by Subject|0|||
146963698|NCT04479358|530027752|FG005|Overall Study|Withdrawal by Subject|1|||
146963699|NCT04410991|530027762|FG000|Overall Study|Poor compliance to protocol|5|||
146963700|NCT04410991|530027763|FG001|Overall Study|Poor compliance to protocol|4|||
146963701|NCT04410991|530027762|FG000|Overall Study|Withdrawal by Subject|59|||
146963702|NCT04410991|530027763|FG001|Overall Study|Withdrawal by Subject|55|||
146963703|NCT04410991|530027762|FG000|Overall Study|Other|10|||
146963704|NCT04410991|530027763|FG001|Overall Study|Other|4|||
146963705|NCT00764465|530027764|FG000|Overall Study|Adverse Event|2|||
146963706|NCT00764465|530027765|FG001|Overall Study|Adverse Event|0|||
146963707|NCT00764465|530027766|FG002|Overall Study|Adverse Event|0|||
146963708|NCT00764465|530027767|FG003|Overall Study|Adverse Event|1|||
146963709|NCT00764465|530027768|FG004|Overall Study|Adverse Event|1|||
146963710|NCT00764465|530027769|FG005|Overall Study|Adverse Event|1|||
146963711|NCT00764465|530027764|FG000|Overall Study|Withdrawal by Subject|0|||
146963712|NCT00764465|530027765|FG001|Overall Study|Withdrawal by Subject|1|||
146963713|NCT00764465|530027766|FG002|Overall Study|Withdrawal by Subject|1|||
146963714|NCT00764465|530027767|FG003|Overall Study|Withdrawal by Subject|0|||
146963715|NCT00764465|530027768|FG004|Overall Study|Withdrawal by Subject|0|||
146963716|NCT00764465|530027769|FG005|Overall Study|Withdrawal by Subject|0|||
146963717|NCT01195662|530027771|FG000|Double Blind Treatment Period|Adverse Event|4|||
146963718|NCT01195662|530027772|FG001|Double Blind Treatment Period|Adverse Event|1|||
146963719|NCT01195662|530027773|FG002|Double Blind Treatment Period|Adverse Event|2|||
146963720|NCT01195662|530027771|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
146963721|NCT01195662|530027772|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
146963722|NCT01195662|530027773|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
146963723|NCT01195662|530027771|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
146963724|NCT01195662|530027772|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
146963725|NCT01195662|530027773|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
146963726|NCT01195662|530027771|FG000|Double Blind Treatment Period|Administrative reason|2|||
146963727|NCT01195662|530027772|FG001|Double Blind Treatment Period|Administrative reason|1|||
146963728|NCT01195662|530027773|FG002|Double Blind Treatment Period|Administrative reason|1|||
146963729|NCT01195662|530027771|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
146963730|NCT01195662|530027772|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
146963731|NCT01195662|530027773|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
146963732|NCT01195662|530027771|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
146963733|NCT01195662|530027772|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
146963734|NCT01195662|530027773|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
146963735|NCT01195662|530027771|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
146963736|NCT01195662|530027772|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
146963737|NCT01195662|530027773|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
146963738|NCT01195662|530027771|FG000|Double Blind Treatment Period|Non-specified|3|||
146963739|NCT01195662|530027772|FG001|Double Blind Treatment Period|Non-specified|0|||
146963740|NCT01195662|530027773|FG002|Double Blind Treatment Period|Non-specified|0|||
146963741|NCT01195662|530027771|FG000|Double Blind Treatment Period|Missing disposition information|0|||
146963742|NCT01195662|530027772|FG001|Double Blind Treatment Period|Missing disposition information|1|||
146963743|NCT01195662|530027773|FG002|Double Blind Treatment Period|Missing disposition information|1|||
146963744|NCT01195662|530027771|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
146963745|NCT01195662|530027772|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
146963746|NCT01195662|530027773|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
146963747|NCT01195662|530027771|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
146963748|NCT01195662|530027772|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
146963749|NCT01195662|530027773|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
146963750|NCT01250418|530027775|FG000|Overall Study|monitor data failure|1|||
146963751|NCT01250418|530027776|FG001|Overall Study|monitor data failure|1|||
146963752|NCT01761565|530027777|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
